Citrus Sinensis ID: 037916

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-
Protein Sequence
SDVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKNASAISVFGNSKLCGGIPEFQLPICGLEKSKHKRLTIAVKLAAAIISVLVGILLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSILLGPKTVSNKQKAIPILLEVRSYGPKLKEVRA
Secondary Structure (PSIPRED)
cccccccccccccHHHHcccccccEEEEcccEEEccccHHHHccccccEEEcccccccccccccccccccccccccccccccEEEcccccccccccHHHHHcccccccEEccccEEcccccccccccccccEEEccccEEEEcccHHHHccccccEEEccccccEEEccccccccccccccccccccccccccccccccccccEEEcccccccccccHHHHcccccccHHccccccccccccHHHHcccccccEEcccccccccccHHHHccccccEEEcccccccccccccccccccccEEEcccccccccccHHHHcccccccccccccccEEEcccccccccccHHHHcccccccccccccccccccccccccccEEEEEHHHHHHHHHHHHHHHHHccccccccccccccEEEEEEEccccEEEEEEEEEcccccccHHHHHHHHHHccccccccccEEEEEEcccccccEEEEEEEcccccccccccccccccccccccccccccHHHHHHHHHHHHHHHcccccccccccEEcccccccccccccccccccccccccccccccccccccEEccccccccccccccccccccccccccHHHHHHHHHcccccccccccccccHHHHHHHHcccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccHHHHHHHHHHHHHHHccccccccccccccHHHHccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccccccccHHHHHcccccEEEEcccccccccccHHHccccccEEEEcccccccccccHHHcccccccEEEcccccEEEEEEccccccccccHHHHcccccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHccccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHcccccccEEEcccccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHcccccccEEEEcccccccccccccccccccEEEEEccccccccccHHHcccccccEEEcccccccccccHHHcccccHHHHHccccccccEEccccEEEEEEEcccccEEEEEEEEccccccccccHHHHHHHHHHcHHHHHHHEHEEcccccccccccEEEEEEEcccccHHHHHccccccccccccccEccHHHHHHHHHHHHHHHHHHHccccccEEEEccccccEEEcccccEEHcHccHHHHEcccccccEEEEEEccEEEccccHHcccccEcccccHHHHHHHHHHHHcccccccccccccccHHHHHHHHcccccHHHccHHHHHHcccccHHHccccccccccHHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHcccccccccccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
sdvgvnrvqggipldfgftlpnllflslgfnqitgvipssmfnasKLEVFQVTsnnltgevpsefgkatKAYCVQNCNQHlkhldinnnnfggllpgcicNFSITLETLIFnsnkifrsipagigkfINLQTLhmwdnqlsgtispaIGELQNLVTLAINtnklsgnippsiGNLKKLLQLYLIENFLqvsipsslgqcqsLTTINLsynnlsgtippqlmdltslsvgldlsrnqlvgslpteVGKLINLEILFISRNMLECEILSTLGscikleqlklggnlfqgpiplslsslrglrvldlsqnnisgEIPKFLVELQLVQNLNlsyndlegviptegvfknasaisvfgnsklcggipefqlpicglekskHKRLTIAVKLAAAIISVLVGILLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLhhgaskssIAECSALRNIRHKNLVKILTVCsgvdykgddFKALVYEFMHNgsleewlhpvsgadktveapkcLNFLQRINIAIDVACALKYlhhdcqpttahcdlkpsnvlldheMTAHVADfglakllppahlqtssigvkgtigyiapaeyglgsevsingdvYSYGILLLELMtrkrpsdimfegnmnlhnfartvlpdhvmdivdstlladdedltitSNQRQRQARINNIMECLISVVRIGVacsmespqdrmNMTIVVHELQSIKsillgpktvsnkqkaIPILLEvrsygpklkevra
Flexible Loop (DISEMBL)
sdvgvnrvqggipldfGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQlvgslptevGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKNASAISVFGNSKLCGGIPEFQLPICGLEKSKHKRLTIAVKLAAAIISVLVGILLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLladdedltitsnqrqrqaRINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSIllgpktvsnkqkaipillevrsygpklkevra
Low Complexity Region (SEG)
SDVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPlslsslrglrvldlsQNNISGEIPKFlvelqlvqnlnlSYNDLEGVIPTEGVFKNASAISVFGNSKLCGGIPEFQLPICGLEKSKHKRLTIAVKLAAAIISVLVGILLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSILLGPKTVSNKQKAIPILLEVRSYGPKLKEVRA
Disordered region (IsUnstruct)
*****NRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKNASAISVFGNSKLCGGIPEFQLPICGLEKSKHKRLTIAVKLAAAIISVLVGILLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSILLGPKTVSNKQKAIPILLEVRS**********
Disordered Region (DISOPRED)
SDVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKNASAISVFGNSKLCGGIPE*******************VKLAAAIISVLVGILLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSG*****EAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP************GTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDED***********ARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIK**********************************
Disordered Region (DISEMBL)
SDVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKNASAISVFGNSKLCGGIPEFQLPICGLEKSKHKRLTIAVKLAAAIISVLVGILLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSILLGPKTVSNKQKAIPILLEVRSYGPKLKEVRA
Disordered Region (DISPRO)
****VNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKNASAISVFGNSKLCGGIPEFQLPICGLEKSKHKRLTIAVKLAAAIISVLVGILLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGA****EAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLT*********ARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKS*********************************
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
SDVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKNASAISVFGNSKLCGGIPEFQLPICGLEKSKHKRLTIAVKLAAAIISVLVGILLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSILLGPKTVSNKQKAIPILLEVRSYGPKLKEVRA
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	741	2.2.26 [Sep-21-2011]
C0LGP4	1010	Probable LRR receptor-lik	yes	no	0.925	0.679	0.414	1e-152
Q9SD62	1025	Putative receptor-like pr	no	no	0.924	0.668	0.428	1e-150
C0LGT6	1031	LRR receptor-like serine/	no	no	0.921	0.662	0.406	1e-149
Q9ZUI0	980	Putative leucine-rich rep	no	no	0.920	0.695	0.315	1e-92
C0LGX3	993	LRR receptor-like serine/	no	no	0.927	0.691	0.337	4e-88
Q9M2Z1	1002	Leucine-rich repeat recep	no	no	0.909	0.672	0.306	1e-83
Q9M0G7	1013	Leucine-rich repeat recep	no	no	0.897	0.656	0.307	3e-83
Q9FIZ3	1252	LRR receptor-like serine/	no	no	0.870	0.515	0.316	2e-81
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.869	0.515	0.316	7e-81
Q9LVP0	1102	Probable leucine-rich rep	no	no	0.867	0.583	0.307	2e-79

>sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1

 Score =  539 bits (1388), Expect = e-152,   Method: Compositional matrix adjust.
 Identities = 322/777 (41%), Positives = 447/777 (57%), Gaps = 91/777 (11%)

Query: 3   VGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVP 62
           +G N   G +  D G  LPNLL  ++G N  TG IP+++ N S LE   +  NNLTG +P
Sbjct: 241 IGYNHFSGRLRPDLGILLPNLLSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIP 300

Query: 63  SEFGKATKA---------------------YCVQNCNQHLKHLDINNNNFGGLLPGCICN 101
           + FG                            + NC Q L+ L I  N  GG LP  I N
Sbjct: 301 T-FGNVPNLKLLFLHTNSLGSDSSRDLEFLTSLTNCTQ-LETLGIGRNRLGGDLPISIAN 358

Query: 102 FSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINT 161
            S  L TL      I  SIP  IG  INLQ L +  N LSG +  ++G+L NL  L++ +
Sbjct: 359 LSAKLVTLDLGGTLISGSIPYDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFS 418

Query: 162 NKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLM 221
           N+LSG IP  IGN+  L  L L  N  +  +P+SLG C  L  + +  N L+GTIP ++M
Sbjct: 419 NRLSGGIPAFIGNMTMLETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIM 478

Query: 222 DLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLG 281
            +  L + LD+S N L+GSLP ++G L NL  L +  N L  ++  TLG+C+ +E L L 
Sbjct: 479 KIQQL-LRLDMSGNSLIGSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLE 537

Query: 282 GNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEG 341
           GNLF G IP  L  L G++ +DLS N++SG IP++      ++ LNLS+N+LEG +P +G
Sbjct: 538 GNLFYGDIP-DLKGLVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKG 596

Query: 342 VFKNASAISVFGNSKLCGGIPEFQLPICGLEKSKHKRLTIAVKLAAAIISVLVGI----L 397
           +F+NA+ +S+ GN+ LCGGI  FQL  C L ++       + +L   +I V VGI    L
Sbjct: 597 IFENATTVSIVGNNDLCGGIMGFQLKPC-LSQAPSVVKKHSSRLKKVVIGVSVGITLLLL 655

Query: 398 LFVSFLFLCW------------------------------------------IDMGSFGS 415
           LF++ + L W                                          +  GSFG+
Sbjct: 656 LFMASVTLIWLRKRKKNKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGT 715

Query: 416 VYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD 475
           VYK +L   K ++AVKVLN+   GA KS +AEC +L++IRH+NLVK+LT CS +D++G++
Sbjct: 716 VYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNE 775

Query: 476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPT 535
           F+AL+YEFM NGSL+ WLHP    ++     + L  L+R+NIAIDVA  L YLH  C   
Sbjct: 776 FRALIYEFMPNGSLDMWLHPEE-VEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEP 834

Query: 536 TAHCDLKPSNVLLDHEMTAHVADFGLAKLL-----PPAHLQTSSIGVKGTIGYIAPAEYG 590
            AHCDLKPSNVLLD ++TAHV+DFGLA+LL          Q SS GV+GTIGY AP EYG
Sbjct: 835 IAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAP-EYG 893

Query: 591 LGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLA 650
           +G + SINGDVYS+GILLLE+ T KRP++ +F GN  L+++ ++ LP+ ++DIVD ++L 
Sbjct: 894 VGGQPSINGDVYSFGILLLEMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDESILH 953

Query: 651 DDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIK 707
               +               ++ECL  V  +G+ C  ESP +R+  +IVV EL SI+
Sbjct: 954 IGLRVGFP------------VVECLTMVFEVGLRCCEESPMNRLATSIVVKELISIR 998

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1

 Score =  531 bits (1368), Expect = e-150,   Method: Compositional matrix adjust.
 Identities = 332/775 (42%), Positives = 449/775 (57%), Gaps = 90/775 (11%)

Query: 6    NRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEF 65
            N   G +  DFG  LPNL  L +G N  TG IP ++ N S L    + SN+LTG++P  F
Sbjct: 259  NSFSGTLRPDFGSLLPNLQILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSF 318

Query: 66   GKATKAY---------------------CVQNCNQHLKHLDINNNNFGGLLPGCICNFSI 104
            G+                           + NC+Q L++L++  N  GG LP  I N S 
Sbjct: 319  GRLQNLLLLGLNNNSLGNYSSGDLDFLGALTNCSQ-LQYLNVGFNKLGGQLPVFIANLST 377

Query: 105  TLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKL 164
             L  L    N I  SIP GIG  ++LQTL + +N L+G + P++GEL  L  + + +N L
Sbjct: 378  QLTELSLGGNLISGSIPHGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGL 437

Query: 165  SGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLT 224
            SG IP S+GN+  L  LYL+ N  + SIPSSLG C  L  +NL  N L+G+IP +LM+L 
Sbjct: 438  SGEIPSSLGNISGLTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELP 497

Query: 225  SLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNL 284
            SL V L++S N LVG L  ++GKL  L  L +S N L  +I  TL +C+ LE L L GN 
Sbjct: 498  SLVV-LNVSFNLLVGPLRQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNS 556

Query: 285  FQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFK 344
            F GPIP  +  L GLR LDLS+NN+SG IP+++     +QNLNLS N+ +G +PTEGVF+
Sbjct: 557  FVGPIP-DIRGLTGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFR 615

Query: 345  NASAISVFGNSKLCGGIPEFQLPICGLE-----KSKHKRLTIAVKLAAAIISVLVGILLF 399
            N SA+SVFGN  LCGGIP  QL  C +E      S  K +TI V    A + +L   +++
Sbjct: 616  NTSAMSVFGNINLCGGIPSLQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLCLCVVY 675

Query: 400  VSFLFL--------------------CWIDMGSFGSVYK--------------------- 418
            + +  L                     + +  S+  +YK                     
Sbjct: 676  LCWYKLRVKSVRANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFK 735

Query: 419  GILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA 478
            G L      +A+KVLNL   GA+KS IAEC AL  IRH+NLVK++T+CS  D++G+DF+A
Sbjct: 736  GFLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRA 795

Query: 479  LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAH 538
            LVYEFM NG+L+ WLHP    ++T    + L    R+NIAIDVA AL YLH  C    AH
Sbjct: 796  LVYEFMPNGNLDMWLHP-DEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAH 854

Query: 539  CDLKPSNVLLDHEMTAHVADFGLAKLL-----PPAHLQTSSIGVKGTIGYIAPAEYGLGS 593
            CD+KPSN+LLD ++TAHV+DFGLA+LL        H+Q SS GV+GTIGY AP EYG+G 
Sbjct: 855  CDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAP-EYGMGG 913

Query: 594  EVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPD-HVMDIVDSTLLADD 652
              SI GDVYS+GI+LLE+ T KRP++ +F   + LH+F ++ L     +DI D T+L   
Sbjct: 914  HPSIMGDVYSFGIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETIL--- 970

Query: 653  EDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIK 707
                     R   A+  N++ECL  V R+GV+CS ESP +R++M   + +L SI+
Sbjct: 971  ---------RGAYAQHFNMVECLTLVFRVGVSCSEESPVNRISMAEAISKLVSIR 1016

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1

 Score =  530 bits (1365), Expect = e-149,   Method: Compositional matrix adjust.
 Identities = 319/784 (40%), Positives = 441/784 (56%), Gaps = 101/784 (12%)

Query: 6    NRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEF 65
            N   G +  DFG+ LPNL  L LG NQ TG IP ++ N S LE F ++SN L+G +P  F
Sbjct: 251  NSFSGNLRADFGYLLPNLRRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSF 310

Query: 66   GKATKAY---------------------CVQNCNQHLKHLDINNNNFGGLLPGCICNFSI 104
            GK    +                      V NC Q L++LD+  N  GG LP  I N S 
Sbjct: 311  GKLRNLWWLGIRNNSLGNNSSSGLEFIGAVANCTQ-LEYLDVGYNRLGGELPASIANLST 369

Query: 105  TLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKL 164
            TL +L    N I  +IP  IG  ++LQ L +  N LSG +  + G+L NL  + + +N +
Sbjct: 370  TLTSLFLGQNLISGTIPHDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAI 429

Query: 165  SGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLT 224
            SG IP   GN+ +L +L+L  N     IP SLG+C+ L  + +  N L+GTIP +++ + 
Sbjct: 430  SGEIPSYFGNMTRLQKLHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIP 489

Query: 225  SLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNL 284
            SL+  +DLS N L G  P EVGKL  L  L  S N L  ++   +G C+ +E L + GN 
Sbjct: 490  SLAY-IDLSNNFLTGHFPEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNS 548

Query: 285  FQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFK 344
            F G IP  +S L  L+ +D S NN+SG IP++L  L  ++NLNLS N  EG +PT GVF+
Sbjct: 549  FDGAIP-DISRLVSLKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFR 607

Query: 345  NASAISVFGNSKLCGGIPEFQLPICGLEKSKHKR--LTIAVKLAAAIISVLVGILLFVSF 402
            NA+A+SVFGN+ +CGG+ E QL  C ++ S  KR  L++  K+ + I   +  +LL +  
Sbjct: 608  NATAVSVFGNTNICGGVREMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIV 667

Query: 403  LFLCW---------------------------------------------IDMGSFGSVY 417
              LCW                                             I  G+FG+V+
Sbjct: 668  ASLCWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVF 727

Query: 418  KGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK 477
            KG+L     ++AVKVLNLL HGA+KS +AEC   + IRH+NLVK++TVCS +D +G+DF+
Sbjct: 728  KGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFR 787

Query: 478  ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTA 537
            ALVYEFM  GSL+ WL  +   ++  +  + L   +++NIAIDVA AL+YLH  C    A
Sbjct: 788  ALVYEFMPKGSLDMWLQ-LEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVA 846

Query: 538  HCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHL-----QTSSIGVKGTIGYIAPAEYGLG 592
            HCD+KPSN+LLD ++TAHV+DFGLA+LL          Q SS GV+GTIGY AP EYG+G
Sbjct: 847  HCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAP-EYGMG 905

Query: 593  SEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADD 652
             + SI GDVYS+GILLLE+ + K+P+D  F G+ NLH++ +++L                
Sbjct: 906  GQPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYNLHSYTKSILSG-------------- 951

Query: 653  EDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSILLG 712
                 TS+        N I E L  V+++G+ CS E P+DRM     V EL SI+S    
Sbjct: 952  ----CTSS-----GGSNAIDEGLRLVLQVGIKCSEEYPRDRMRTDEAVRELISIRSKFFS 1002

Query: 713  PKTV 716
             KT 
Sbjct: 1003 SKTT 1006

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1

 Score =  341 bits (874), Expect = 1e-92,   Method: Compositional matrix adjust.
 Identities = 259/820 (31%), Positives = 403/820 (49%), Gaps = 138/820 (16%)

Query: 2   DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEV 61
           D+  N + G IPL++   L  L FL L  N++TG +PSS+ N++ L+   + SN L+GE+
Sbjct: 172 DLSNNSLTGEIPLNYHCHLKELRFLLLWSNKLTGTVPSSLSNSTNLKWMDLESNMLSGEL 231

Query: 62  PS---------EFGKATKAYCVQNCN--------------QHLKHLDINNNNFGGLLPGC 98
           PS         +F   +  + V + N                L+ L++  N+ GG +   
Sbjct: 232 PSQVISKMPQLQFLYLSYNHFVSHNNNTNLEPFFASLANSSDLQELELAGNSLGGEITSS 291

Query: 99  ICNFSITLETLIFNSNKIFRSIPAGIG------------------------KFINLQTLH 134
           + + S+ L  +  + N+I  SIP  I                         K   L+ ++
Sbjct: 292 VRHLSVNLVQIHLDQNRIHGSIPPEISNLLNLTLLNLSSNLLSGPIPRELCKLSKLERVY 351

Query: 135 MWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPS 194
           + +N L+G I   +G++  L  L ++ N LSG+IP S GNL +L +L L  N L  ++P 
Sbjct: 352 LSNNHLTGEIPMELGDIPRLGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQ 411

Query: 195 SLGQCQSLTTINLSYNNLSGTIPPQLM-DLTSLSVGLDLSRNQLVGSLPTEVGKLINLEI 253
           SLG+C +L  ++LS+NNL+GTIP +++ +L +L + L+LS N L G +P E+ K+  +  
Sbjct: 412 SLGKCINLEILDLSHNNLTGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSKMDMVLS 471

Query: 254 LFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEI 313
           + +S N L  +I   LGSCI LE L L  N F   +P SL  L  L+ LD+S N ++G I
Sbjct: 472 VDLSSNELSGKIPPQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAI 531

Query: 314 PKFLVELQLVQNLNLSYNDLEGVIPTEGVFKNASAISVFGNSKLCGGIPEFQLPICGLEK 373
           P    +   +++LN S+N L G +  +G F   +  S  G+S LCG I   Q   C   K
Sbjct: 532 PPSFQQSSTLKHLNFSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGSIKGMQ--AC---K 586

Query: 374 SKHKRLTIAVKLAAAIISVLVGILLFVSFLFLCWIDMGSFGSVY--KGILDEGK------ 425
            KHK  ++ + +  ++I+  V  L    +  +     G   +VY  + + DE K      
Sbjct: 587 KKHKYPSVLLPVLLSLIATPV--LCVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQNDP 644

Query: 426 ---------------------------------------TIIAVKVLN----LLHHGASK 442
                                                  T +AVKVL+    L   G+ K
Sbjct: 645 KYPRISYQQLIAATGGFNASSLIGSGRFGHVYKGVLRNNTKVAVKVLDPKTALEFSGSFK 704

Query: 443 SSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKT 502
               EC  L+  RH+NL++I+T CS        F ALV   M NGSLE  L+P   + K 
Sbjct: 705 ---RECQILKRTRHRNLIRIITTCS-----KPGFNALVLPLMPNGSLERHLYPGEYSSKN 756

Query: 503 VEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLA 562
                 L+ +Q +NI  DVA  + YLHH       HCDLKPSN+LLD EMTA V DFG++
Sbjct: 757 ------LDLIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGIS 810

Query: 563 KLLPPAHLQTS-----SIGVK-----GTIGYIAPAEYGLGSEVSINGDVYSYGILLLELM 612
           +L+       S     S G       G++GYIAP EYG+G   S +GDVYS+G+LLLE++
Sbjct: 811 RLVQGVEETVSTDDSVSFGSTDGLLCGSVGYIAP-EYGMGKRASTHGDVYSFGVLLLEIV 869

Query: 613 TRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIM 672
           + +RP+D++     +LH F ++  PD +  I+       ++ L+    Q + +       
Sbjct: 870 SGRRPTDVLVNEGSSLHEFMKSHYPDSLEGII-------EQALSRWKPQGKPEKCEKLWR 922

Query: 673 ECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSILLG 712
           E ++ ++ +G+ C+  +P  R +M  V HE+  +K  L  
Sbjct: 923 EVILEMIELGLVCTQYNPSTRPDMLDVAHEMGRLKEYLFA 962

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGX3|HSL2_ARATH LRR receptor-like serine/threonine-protein kinase HSL2 OS=Arabidopsis thaliana GN=HSL2 PE=2 SV=1

 Score =  326 bits (836), Expect = 4e-88,   Method: Compositional matrix adjust.
 Identities = 258/764 (33%), Positives = 377/764 (49%), Gaps = 77/764 (10%)

Query: 2   DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEV 61
           D+ +N + G IP   G  L ++  + L  N+++G +P S+ N ++L  F V+ NNLTGE+
Sbjct: 250 DLAMNSLTGEIPESIG-RLESVYQIELYDNRLSGKLPESIGNLTELRNFDVSQNNLTGEL 308

Query: 62  PSE--------FGKATKAYC-----VQNCNQHLKHLDINNNNFGGLLPGCICNFSITLET 108
           P +        F      +      V   N +L    I NN+F G LP  +  FS  +  
Sbjct: 309 PEKIAALQLISFNLNDNFFTGGLPDVVALNPNLVEFKIFNNSFTGTLPRNLGKFS-EISE 367

Query: 109 LIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNI 168
              ++N+    +P  +     LQ +  + NQLSG I  + G+  +L  + +  NKLSG +
Sbjct: 368 FDVSTNRFSGELPPYLCYRRKLQKIITFSNQLSGEIPESYGDCHSLNYIRMADNKLSGEV 427

Query: 169 PPSIGNLKKLLQLYLIEN-FLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLS 227
           P     L  L +L L  N  LQ SIP S+ + + L+ + +S NN SG IP +L DL  L 
Sbjct: 428 PARFWELP-LTRLELANNNQLQGSIPPSISKARHLSQLEISANNFSGVIPVKLCDLRDLR 486

Query: 228 VGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQG 287
           V +DLSRN  +GS+P+ + KL NLE + +  NML+ EI S++ SC +L +L L  N  +G
Sbjct: 487 V-IDLSRNSFLGSIPSCINKLKNLERVEMQENMLDGEIPSSVSSCTELTELNLSNNRLRG 545

Query: 288 PIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKNAS 347
            IP  L  L  L  LDLS N ++GEIP  L+ L+L Q  N+S N L G IP+ G  ++  
Sbjct: 546 GIPPELGDLPVLNYLDLSNNQLTGEIPAELLRLKLNQ-FNVSDNKLYGKIPS-GFQQDIF 603

Query: 348 AISVFGNSKLCGGIPEFQLPI--CGLEKSKHKRLTIAVKLAAAIISVLVGILLFVSFLFL 405
             S  GN  LC   P    PI  C  ++     L I++    A+   LV + +    LF 
Sbjct: 604 RPSFLGNPNLCA--PNLD-PIRPCRSKRETRYILPISILCIVALTGALVWLFIKTKPLFK 660

Query: 406 CW-----------------------------IDMGSFGSVYKGILDEGKTIIAVKVLNLL 436
                                          I  G  G VY+  L  G+T+   K+    
Sbjct: 661 RKPKRTNKITIFQRVGFTEEDIYPQLTEDNIIGSGGSGLVYRVKLKSGQTLAVKKLWGET 720

Query: 437 HHGASKSSI--AECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLH 494
                  S+  +E   L  +RH N+VK+L  C+     G++F+ LVYEFM NGSL + LH
Sbjct: 721 GQKTESESVFRSEVETLGRVRHGNIVKLLMCCN-----GEEFRFLVYEFMENGSLGDVLH 775

Query: 495 PVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTA 554
               ++K   A   L++  R +IA+  A  L YLHHD  P   H D+K +N+LLDHEM  
Sbjct: 776 ----SEKEHRAVSPLDWTTRFSIAVGAAQGLSYLHHDSVPPIVHRDVKSNNILLDHEMKP 831

Query: 555 HVADFGLAKLLPPAH----LQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLE 610
            VADFGLAK L           S   V G+ GYIAP EYG  S+V+   DVYS+G++LLE
Sbjct: 832 RVADFGLAKPLKREDNDGVSDVSMSCVAGSYGYIAP-EYGYTSKVNEKSDVYSFGVVLLE 890

Query: 611 LMTRKRPSDIMFEGNMNLHNFARTVL-----PDHVMDIVDSTLLADDEDLTITSNQRQRQ 665
           L+T KRP+D  F  N ++  FA         P      ++   L +  DL+   + + + 
Sbjct: 891 LITGKRPNDSSFGENKDIVKFAMEAALCYPSPSAEDGAMNQDSLGNYRDLSKLVDPKMKL 950

Query: 666 ARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSI 709
           +      E +  V+ + + C+   P +R  M  VV  L+  KS+
Sbjct: 951 S--TREYEEIEKVLDVALLCTSSFPINRPTMRKVVELLKEKKSL 992

Receptor-like serine/threonine-kinase acting on substrates that controls floral organ abscission. Regulated by the 'INFLORESCENCE DEFICIENT IN ABSCISSION' (IDA) family of ligands.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1

 Score =  311 bits (796), Expect = 1e-83,   Method: Compositional matrix adjust.
 Identities = 260/848 (30%), Positives = 386/848 (45%), Gaps = 174/848 (20%)

Query: 3   VGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSM-------------FNA----- 44
           +G N   G IP  +G T P L +L++  N++TG IP  +             +NA     
Sbjct: 173 LGGNYFSGKIPATYG-TWPVLEYLAVSGNELTGKIPPEIGNLTTLRELYIGYYNAFENGL 231

Query: 45  -------SKLEVFQVTSNNLTGEVPSEFGKATK---------AYCVQNCNQ-----HLKH 83
                  S+L  F   +  LTGE+P E GK  K         A+      +      LK 
Sbjct: 232 PPEIGNLSELVRFDAANCGLTGEIPPEIGKLQKLDTLFLQVNAFTGTITQELGLISSLKS 291

Query: 84  LDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGT 143
           +D++NN F G +P         L  L    NK++ +IP  IG+   L+ L +W+N  +G+
Sbjct: 292 MDLSNNMFTGEIPTSFSQLK-NLTLLNLFRNKLYGAIPEFIGEMPELEVLQLWENNFTGS 350

Query: 144 ISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLT 203
           I   +GE   LV L +++NKL+G +PP++ +  +L+ L  + NFL  SIP SLG+C+SLT
Sbjct: 351 IPQKLGENGRLVILDLSSNKLTGTLPPNMCSGNRLMTLITLGNFLFGSIPDSLGKCESLT 410

Query: 204 TINLSYNNLSGTIPPQLMDLTSLSV------------------------GLDLSRNQLVG 239
            I +  N L+G+IP +L  L  LS                          + LS NQL G
Sbjct: 411 RIRMGENFLNGSIPKELFGLPKLSQVELQDNYLTGELPISGGGVSGDLGQISLSNNQLSG 470

Query: 240 SLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGL 299
           SLP  +G L  ++ L +  N     I   +G   +L +L    NLF G I   +S  + L
Sbjct: 471 SLPAAIGNLSGVQKLLLDGNKFSGSIPPEIGRLQQLSKLDFSHNLFSGRIAPEISRCKLL 530

Query: 300 RVLDLSQNNISGEIPKFLVELQLVQNLNL------------------------SYNDLEG 335
             +DLS+N +SG+IP  L  ++++  LNL                        SYN+L G
Sbjct: 531 TFVDLSRNELSGDIPNELTGMKILNYLNLSRNHLVGSIPVTIASMQSLTSVDFSYNNLSG 590

Query: 336 VIPTEGVFKNASAISVFGNSKLCGGIPEFQLPICGLEKSKHKRLTIAVK----------- 384
           ++P+ G F   +  S  GNS LCG  P       G  +S  K L+   K           
Sbjct: 591 LVPSTGQFSYFNYTSFVGNSHLCG--PYLGPCGKGTHQSHVKPLSATTKLLLVLGLLFCS 648

Query: 385 LAAAIISVLVG-------------ILLFVSFLFLC-----------WIDMGSFGSVYKGI 420
           +  AI++++               +  F    F C            I  G  G VYKG 
Sbjct: 649 MVFAIVAIIKARSLRNASEAKAWRLTAFQRLDFTCDDVLDSLKEDNIIGKGGAGIVYKGT 708

Query: 421 LDEGKTIIAVKVLNLLHHGASKSS--IAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA 478
           + +G  ++AVK L  + HG+S      AE   L  IRH+++V++L  CS       +   
Sbjct: 709 MPKGD-LVAVKRLATMSHGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCS-----NHETNL 762

Query: 479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAH 538
           LVYE+M NGSL E LH   G          L++  R  IA++ A  L YLHHDC P   H
Sbjct: 763 LVYEYMPNGSLGEVLHGKKGGH--------LHWNTRYKIALEAAKGLCYLHHDCSPLIVH 814

Query: 539 CDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSIN 598
            D+K +N+LLD    AHVADFGLAK L  +        + G+ GYIAP EY    +V   
Sbjct: 815 RDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAP-EYAYTLKVDEK 873

Query: 599 GDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVL---PDHVMDIVDSTLLADDEDL 655
            DVYS+G++LLEL+T K+P     +G +++  + R++     D V+ ++D          
Sbjct: 874 SDVYSFGVVLLELITGKKPVGEFGDG-VDIVQWVRSMTDSNKDCVLKVID---------- 922

Query: 656 TITSNQRQRQARINNI-MECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSILLGPK 714
                      R++++ +  +  V  + + C  E   +R  M  VV  L  I      PK
Sbjct: 923 ----------LRLSSVPVHEVTHVFYVALLCVEEQAVERPTMREVVQILTEI------PK 966

Query: 715 TVSNKQKA 722
              +KQ+A
Sbjct: 967 IPLSKQQA 974

Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M0G7|PXL2_ARATH Leucine-rich repeat receptor-like protein kinase PXL2 OS=Arabidopsis thaliana GN=PXL2 PE=2 SV=1

 Score =  310 bits (793), Expect = 3e-83,   Method: Compositional matrix adjust.
 Identities = 254/825 (30%), Positives = 377/825 (45%), Gaps = 160/825 (19%)

Query: 3   VGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVP 62
           +G N  +G IP +FG  + +L +L L   +++G IPS +     LE   +  NN TG +P
Sbjct: 219 LGYNEFKGPIPPEFG-NINSLKYLDLAIGKLSGEIPSELGKLKSLETLLLYENNFTGTIP 277

Query: 63  SEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPA 122
            E G  T           LK LD ++N   G +P  I          +   NK+  SIP 
Sbjct: 278 REIGSITT----------LKVLDFSDNALTGEIPMEITKLKNLQLLNLMR-NKLSGSIPP 326

Query: 123 GIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLY 182
            I     LQ L +W+N LSG +   +G+   L  L +++N  SG IP ++ N   L +L 
Sbjct: 327 AISSLAQLQVLELWNNTLSGELPSDLGKNSPLQWLDVSSNSFSGEIPSTLCNKGNLTKLI 386

Query: 183 LIENFLQVSIPSSLGQCQSLTTIN------------------------LSYNNLSGTIPP 218
           L  N     IP++L  CQSL  +                         L+ N LSG IP 
Sbjct: 387 LFNNTFTGQIPATLSTCQSLVRVRMQNNLLNGSIPIGFGKLEKLQRLELAGNRLSGGIPG 446

Query: 219 QLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQL 278
            + D  SLS  +D SRNQ+  SLP+ +  + NL+   ++ N +  E+      C  L  L
Sbjct: 447 DISDSVSLSF-IDFSRNQIRSSLPSTILSIHNLQAFLVADNFISGEVPDQFQDCPSLSNL 505

Query: 279 KLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPK------FLVELQLVQN------- 325
            L  N   G IP S++S   L  L+L  NN++GEIP+       L  L L  N       
Sbjct: 506 DLSSNTLTGTIPSSIASCEKLVSLNLRNNNLTGEIPRQITTMSALAVLDLSNNSLTGVLP 565

Query: 326 -----------LNLSYNDLEGVIPTEGVFKNASAISVFGNSKLCGGIPEFQLPICGLEKS 374
                      LN+SYN L G +P  G  K  +   + GNS LCGG+    LP C    S
Sbjct: 566 ESIGTSPALELLNVSYNKLTGPVPINGFLKTINPDDLRGNSGLCGGV----LPPC----S 617

Query: 375 KHKRLT----------IAVKLAAAIISVL-VGILLFVS-FLFLCW--------------- 407
           K +R T          I       I SVL +GIL  V+  L+  W               
Sbjct: 618 KFQRATSSHSSLHGKRIVAGWLIGIASVLALGILTIVTRTLYKKWYSNGFCGDETASKGE 677

Query: 408 ---------------------------IDMGSFGSVYKGILDEGKTIIAVKVLNL----L 436
                                      I MG+ G VYK  +    T++AVK L      +
Sbjct: 678 WPWRLMAFHRLGFTASDILACIKESNMIGMGATGIVYKAEMSRSSTVLAVKKLWRSAADI 737

Query: 437 HHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPV 496
             G +   + E + L  +RH+N+V++L    G  Y  D    +VYEFM NG+L + +H  
Sbjct: 738 EDGTTGDFVGEVNLLGKLRHRNIVRLL----GFLYN-DKNMMIVYEFMLNGNLGDAIHGK 792

Query: 497 SGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV 556
           + A + +     ++++ R NIA+ VA  L YLHHDC P   H D+K +N+LLD  + A +
Sbjct: 793 NAAGRLL-----VDWVSRYNIALGVAHGLAYLHHDCHPPVIHRDIKSNNILLDANLDARI 847

Query: 557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKR 616
           ADFGLA+++  A  + +   V G+ GYIAP EYG   +V    D+YSYG++LLEL+T +R
Sbjct: 848 ADFGLARMM--ARKKETVSMVAGSYGYIAP-EYGYTLKVDEKIDIYSYGVVLLELLTGRR 904

Query: 617 PSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLI 676
           P +  F  ++++  + R  + D++        L +  D  +  N R  Q       E ++
Sbjct: 905 PLEPEFGESVDIVEWVRRKIRDNIS-------LEEALDPNV-GNCRYVQ-------EEML 949

Query: 677 SVVRIGVACSMESPQDRMNMTIVVHELQSIKSILLGPKTVSNKQK 721
            V++I + C+ + P+DR +M  V+  L   K     P+  SN  +
Sbjct: 950 LVLQIALLCTTKLPKDRPSMRDVISMLGEAK-----PRRKSNSNE 989

Involved in the regulation of procambium maintenance and polarity during vascular-tissue development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2

 Score =  304 bits (778), Expect = 2e-81,   Method: Compositional matrix adjust.
 Identities = 253/799 (31%), Positives = 370/799 (46%), Gaps = 154/799 (19%)

Query: 6    NRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEF 65
            NR+ G IP   G  L +L  L L  N++ G IP+S+ N  ++ V  +  N L+G +PS F
Sbjct: 467  NRLSGEIPSSIG-RLKDLTRLHLRENELVGNIPASLGNCHQMTVIDLADNQLSGSIPSSF 525

Query: 66   GKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSI----- 120
            G  T           L+   I NN+  G LP  + N    L  + F+SNK   SI     
Sbjct: 526  GFLTA----------LELFMIYNNSLQGNLPDSLINLK-NLTRINFSSNKFNGSISPLCG 574

Query: 121  ------------------PAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTN 162
                              P  +GK  NL  L +  NQ +G I    G++  L  L I+ N
Sbjct: 575  SSSYLSFDVTENGFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKISELSLLDISRN 634

Query: 163  KLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMD 222
             LSG IP  +G  KKL  + L  N+L   IP+ LG+   L  + LS N   G++P ++  
Sbjct: 635  SLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFS 694

Query: 223  LTSL----------------SVG-------LDLSRNQLVGSLPTEVGKLINLEILFISRN 259
            LT++                 +G       L+L  NQL G LP+ +GKL  L  L +SRN
Sbjct: 695  LTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSRN 754

Query: 260  MLECEILSTLGSCIKLEQ-LKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLV 318
             L  EI   +G    L+  L L  N F G IP ++S+L  L  LDLS N + GE+P  + 
Sbjct: 755  ALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIG 814

Query: 319  ELQLVQNLNLSYNDLEGVIPTEGVFKNASAISVFGNSKLCGGIPEFQLPICGLEKSKHKR 378
            +++ +  LNLSYN+LEG +  +  F    A +  GN+ LCG      L  C    SK++R
Sbjct: 815  DMKSLGYLNLSYNNLEGKLKKQ--FSRWQADAFVGNAGLCGS----PLSHCNRAGSKNQR 868

Query: 379  ---------LTIAVKLAAAIISVLVGILLFV------------------------SFLF- 404
                     ++    LAA  + VLV IL F                         + LF 
Sbjct: 869  SLSPKTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLFS 928

Query: 405  -------LCWIDM---------------GSFGSVYKGILDEGKTIIAVKVLNLLHHGASK 442
                   + W D+               G  G VYK  L  G+TI   K+L      ++K
Sbjct: 929  NGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKILWKDDLMSNK 988

Query: 443  SSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKT 502
            S   E   L  IRH++LVK++  CS    K D    L+YE+M NGS+ +WLH    A++ 
Sbjct: 989  SFNREVKTLGTIRHRHLVKLMGYCSS---KADGLNLLIYEYMANGSVWDWLH----ANEN 1041

Query: 503  VEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLA 562
             +  + L +  R+ IA+ +A  ++YLH+DC P   H D+K SNVLLD  + AH+ DFGLA
Sbjct: 1042 TKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLA 1101

Query: 563  KLLPPAHLQT--SSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDI 620
            K+L   +     S+    G+ GYIAP EY    + +   DVYS GI+L+E++T K P++ 
Sbjct: 1102 KILTGNYDTNTESNTMFAGSYGYIAP-EYAYSLKATEKSDVYSMGIVLMEIVTGKMPTEA 1160

Query: 621  MFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQR--QARINNIMEC---- 674
            MF+   ++  +  TVL                 D    S  R++   + + +++ C    
Sbjct: 1161 MFDEETDMVRWVETVL-----------------DTPPGSEAREKLIDSELKSLLPCEEEA 1203

Query: 675  LISVVRIGVACSMESPQDR 693
               V+ I + C+   PQ+R
Sbjct: 1204 AYQVLEIALQCTKSYPQER 1222

Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  302 bits (773), Expect = 7e-81,   Method: Compositional matrix adjust.
 Identities = 242/764 (31%), Positives = 364/764 (47%), Gaps = 120/764 (15%)

Query: 2    DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEV 61
            D+  N++ G IP  FGF L  L  L L  N + G +P S+ +   L    ++ N L G +
Sbjct: 510  DLADNQLSGSIPSSFGF-LKGLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNGTI 568

Query: 62   PSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIP 121
                G ++               D+ NN F   +P  + N S  L+ L    N++   IP
Sbjct: 569  HPLCGSSSYL-----------SFDVTNNGFEDEIPLELGN-SQNLDRLRLGKNQLTGKIP 616

Query: 122  AGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQL 181
              +GK   L  L M  N L+GTI   +   + L  + +N N LSG IPP +G L +L +L
Sbjct: 617  WTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGEL 676

Query: 182  YLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSL 241
             L  N    S+P+ L  C  L  ++L  N+L+G+IP ++ +L +L+V L+L +NQ  GSL
Sbjct: 677  KLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNV-LNLDKNQFSGSL 735

Query: 242  PTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQ-LKLGGNLFQGPIPLSLSSLRGLR 300
            P  +GKL  L  L +SRN L  EI   +G    L+  L L  N F G IP ++ +L  L 
Sbjct: 736  PQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLE 795

Query: 301  VLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKNASAISVFGNSKLCGG 360
             LDLS N ++GE+P  + +++ +  LN+S+N+L G +  +  F    A S  GN+ LCG 
Sbjct: 796  TLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKKQ--FSRWPADSFLGNTGLCGS 853

Query: 361  IPEFQLPICGLEKSKHKRLTIAVKLAAAIISVL-----VGILLFVSFLF----------- 404
                 L  C   +S +K+  ++ + +  IIS +     +G+++ V  LF           
Sbjct: 854  ----PLSRCNRVRSNNKQQGLSAR-SVVIISAISALTAIGLMILVIALFFKQRHDFFKKV 908

Query: 405  ------------------------------LCWIDM---------------GSFGSVYKG 419
                                          + W D+               G  G VYK 
Sbjct: 909  GHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKA 968

Query: 420  ILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL 479
             L+ G+T+   K+L      ++KS   E   L  IRH++LVK++  CS    K +    L
Sbjct: 969  ELENGETVAVKKILWKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSS---KSEGLNLL 1025

Query: 480  VYEFMHNGSLEEWLHPVSGADKTV--EAPKCLNFLQRINIAIDVACALKYLHHDCQPTTA 537
            +YE+M NGS+ +WLH     DK V  +  K L++  R+ IA+ +A  ++YLHHDC P   
Sbjct: 1026 IYEYMKNGSIWDWLH----EDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIV 1081

Query: 538  HCDLKPSNVLLDHEMTAHVADFGLAKLLPP--AHLQTSSIGVKGTIGYIAPAEYGLGSEV 595
            H D+K SNVLLD  M AH+ DFGLAK+L         S+     + GYIAP EY    + 
Sbjct: 1082 HRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIAP-EYAYSLKA 1140

Query: 596  SINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLP------DHVMDIVDSTLL 649
            +   DVYS GI+L+E++T K P+D +F   M++  +  T L       D ++D     LL
Sbjct: 1141 TEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVRWVETHLEVAGSARDKLIDPKLKPLL 1200

Query: 650  ADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDR 693
              +ED                       V+ I + C+  SPQ+R
Sbjct: 1201 PFEED-------------------AACQVLEIALQCTKTSPQER 1225

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1

 Score =  297 bits (761), Expect = 2e-79,   Method: Compositional matrix adjust.
 Identities = 240/781 (30%), Positives = 374/781 (47%), Gaps = 138/781 (17%)

Query: 6    NRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEF 65
            N++ G IP++   TL NL  L L  N +TG IP        L + Q+  N+L+G +P + 
Sbjct: 347  NQLTGTIPVELS-TLKNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQNSLSGTIPPKL 405

Query: 66   GKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIG 125
            G  +  +           LD+++N+  G +P  +C  S  +  L   +N +  +IP GI 
Sbjct: 406  GWYSDLWV----------LDMSDNHLSGRIPSYLCLHS-NMIILNLGTNNLSGNIPTGIT 454

Query: 126  KFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIE 185
                L  L +  N L G     + +  N+  + +  N+  G+IP  +GN   L +L L +
Sbjct: 455  TCKTLVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNCSALQRLQLAD 514

Query: 186  NFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEV 245
            N     +P  +G    L T+N+S N L+G +P ++ +   L   LD+  N   G+LP+EV
Sbjct: 515  NGFTGELPREIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQR-LDMCCNNFSGTLPSEV 573

Query: 246  GKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRV-LDL 304
            G L  LE+L +S N L   I   LG+  +L +L++GGNLF G IP  L SL GL++ L+L
Sbjct: 574  GSLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNL 633

Query: 305  SQNNISGEIPKFLVELQLVQ------------------------NLNLSYNDLEGVIPTE 340
            S N ++GEIP  L  L +++                          N SYN L G IP  
Sbjct: 634  SYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIP-- 691

Query: 341  GVFKNASAISVFGNSKLCGGIPEFQ-------LPICGLEKSKHKRLTIAVKLAAAIIS-- 391
             + +N S  S  GN  LC G P  Q        P     K    R +  + + AA+I   
Sbjct: 692  -LLRNISMSSFIGNEGLC-GPPLNQCIQTQPFAPSQSTGKPGGMRSSKIIAITAAVIGGV 749

Query: 392  --VLVGILLFV------------------------------SFLFLCWI----------- 408
              +L+ +++++                               F F   +           
Sbjct: 750  SLMLIALIVYLMRRPVRTVASSAQDGQPSEMSLDIYFPPKEGFTFQDLVAATDNFDESFV 809

Query: 409  -DMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSI-----AECSALRNIRHKNLVKI 462
               G+ G+VYK +L  G T+ AVK L   H G + +++     AE   L NIRH+N+VK+
Sbjct: 810  VGRGACGTVYKAVLPAGYTL-AVKKLASNHEGGNNNNVDNSFRAEILTLGNIRHRNIVKL 868

Query: 463  LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKC-LNFLQRINIAIDV 521
               C   +++G +   L+YE+M  GSL E LH           P C L++ +R  IA+  
Sbjct: 869  HGFC---NHQGSNL--LLYEYMPKGSLGEILH----------DPSCNLDWSKRFKIALGA 913

Query: 522  ACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTI 581
            A  L YLHHDC+P   H D+K +N+LLD +  AHV DFGLAK++   H ++ S  + G+ 
Sbjct: 914  AQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPHSKSMS-AIAGSY 972

Query: 582  GYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM 641
            GYIAP EY    +V+   D+YSYG++LLEL+T K P   + +G  ++ N+ R+ +    +
Sbjct: 973  GYIAP-EYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPIDQGG-DVVNWVRSYIRRDAL 1030

Query: 642  D--IVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIV 699
               ++D+ L  +DE                 I+  +++V++I + C+  SP  R +M  V
Sbjct: 1031 SSGVLDARLTLEDE----------------RIVSHMLTVLKIALLCTSVSPVARPSMRQV 1074

Query: 700  V 700
            V
Sbjct: 1075 V 1075

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	741
359486510	965	PREDICTED: probable LRR receptor-like se	0.954	0.732	0.536	0.0
224097752	1025	predicted protein [Populus trichocarpa]	0.956	0.691	0.509	0.0
224097750	1023	predicted protein [Populus trichocarpa]	0.954	0.691	0.501	0.0
255581223	1015	receptor-kinase, putative [Ricinus commu	0.946	0.690	0.495	0.0
224121306	966	predicted protein [Populus trichocarpa]	0.941	0.722	0.497	0.0
224119022	1021	predicted protein [Populus trichocarpa]	0.939	0.681	0.489	0.0
359482058	1040	PREDICTED: probable LRR receptor-like se	0.950	0.676	0.473	0.0
224081190	1011	predicted protein [Populus trichocarpa]	0.944	0.692	0.478	0.0
147853780	1904	hypothetical protein VITISV_030954 [Viti	0.950	0.369	0.472	0.0
224127492	1022	predicted protein [Populus trichocarpa]	0.954	0.691	0.470	0.0

>gi|359486510|ref|XP_002271317.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like, partial [Vitis vinifera]

 Score =  759 bits (1961), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 414/771 (53%), Positives = 522/771 (67%), Gaps = 64/771 (8%)

Query: 3   VGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVP 62
           V  N + G +P + G TLPNL  LSL  N+ TG IP S+ NAS LE F    NNLTG+VP
Sbjct: 184 VSFNHLHGNLPSNLGITLPNLQDLSLSGNRFTGSIPVSLSNASNLEYFSCNGNNLTGKVP 243

Query: 63  S-EFGKATKAYCVQNCN------------------QHLKHLDINNNNFGGLLPGCICNFS 103
           S E  +    + V + N                   +L+ L +N NNFGG+LP  I N+S
Sbjct: 244 SLEKLQRLHFFSVTSNNLGNGEIEDLGFLSSLTNVSNLEVLALNVNNFGGVLPESIGNWS 303

Query: 104 ITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNK 163
             L TL+ + NKI  SIPAGIG  ++L+ L MW+NQLSG+I   IG+LQNL  L +  NK
Sbjct: 304 TKLATLLLDGNKIGGSIPAGIGNLVSLERLEMWENQLSGSIPVDIGKLQNLRVLMLIKNK 363

Query: 164 LSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDL 223
           LSG +P S+GNL+ L+QL L  N+ Q  IPSSLG+CQ+L  ++LS NNLSGTIPPQ++ L
Sbjct: 364 LSGILPSSLGNLENLIQLVLGRNYFQGKIPSSLGKCQNLLFLDLSLNNLSGTIPPQVVSL 423

Query: 224 TSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGN 283
           +SLS+ LD+S N+L G+LP EVG L NL +L +S NML   I S++GSC  LE L + GN
Sbjct: 424 SSLSISLDISDNRLTGALPIEVGNLKNLGVLDVSNNMLSGGIPSSVGSCTSLEYLSMKGN 483

Query: 284 LFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVF 343
            FQG IP S SSLRG+R+LDLS NN+SG+IP+FL ++   Q +NLSYND EG++PTEGVF
Sbjct: 484 FFQGSIPSSFSSLRGIRILDLSHNNLSGKIPEFLQDIHF-QLVNLSYNDFEGILPTEGVF 542

Query: 344 KNASAISVFGNSKLCGGIPEFQLPICGLEKSKHKRLTIAVKLAAAIISVLVGILLFVSFL 403
           KN SA S+ GNSKLCGGIPEFQLP C L++ K + L++A+K+  A +S L+ I   +SFL
Sbjct: 543 KNVSATSIMGNSKLCGGIPEFQLPKCNLQEPKKRGLSLALKIIIATVSGLLAITCVLSFL 602

Query: 404 FLCW-------------------------------------IDMGSFGSVYKGILDEGKT 426
              W                                     I +GSFGSVYKGILD   T
Sbjct: 603 IFLWLRKKKGEPASSSSEKSLLKVSYQSLLRATDGFSSSNLIGVGSFGSVYKGILDHDGT 662

Query: 427 IIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHN 486
            IAVKVLNLL  GASKS IAEC ALRNIRH+NLVK+LT CSGVDY+G+DFKA+VYEFM N
Sbjct: 663 AIAVKVLNLLRKGASKSFIAECEALRNIRHRNLVKVLTACSGVDYQGNDFKAVVYEFMVN 722

Query: 487 GSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNV 546
           GSLE+WLHP     +    P+ LNFLQR+NIAIDVACAL YLHH CQ    HCDLKPSNV
Sbjct: 723 GSLEQWLHPTPTTAEASAPPRKLNFLQRLNIAIDVACALDYLHHQCQTPIVHCDLKPSNV 782

Query: 547 LLDHEMTAHVADFGLAKLLPPA-----HLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDV 601
           LLD EMT HV DFG+AK LP A      +Q+SSIG++GTIGY AP EYG+GSEVS +GDV
Sbjct: 783 LLDTEMTGHVGDFGIAKFLPEAATRVPEIQSSSIGIRGTIGYAAP-EYGMGSEVSTSGDV 841

Query: 602 YSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQ 661
           YS+GILLLE+ T KRP++ MF+ ++N+HNF +T +P+ V +I D  LL +  ++  T++Q
Sbjct: 842 YSFGILLLEMFTGKRPTEDMFKDSLNIHNFVKTAVPERVAEIADPVLLQEGVEMDNTTSQ 901

Query: 662 RQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSILLG 712
           R R A  ++  ECLIS+  IG+ACS E P++R N+T    EL S++ I LG
Sbjct: 902 R-RMASSHDAQECLISIFGIGLACSAELPRERKNITDAAAELNSVRDIFLG 951

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224097752|ref|XP_002311067.1| predicted protein [Populus trichocarpa] gi|222850887|gb|EEE88434.1| predicted protein [Populus trichocarpa]

 Score =  713 bits (1841), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 395/775 (50%), Positives = 509/775 (65%), Gaps = 66/775 (8%)

Query: 3    VGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVP 62
            V VN++ G +P D G TLPNL  L + FN+ +G IP +  NAS + V ++++NNLTG VP
Sbjct: 251  VPVNQLHGNLPPDLGLTLPNLEILLMSFNRFSGSIPPTFSNASTIAVIELSNNNLTGRVP 310

Query: 63   SEFGKATKAYCVQNCN-------------------QHLKHLDINNNNFGGLLPGCICNFS 103
                 +   + + + N                     L+ L IN+NNFGGLLP  I NFS
Sbjct: 311  DLSSLSKLRWLIVDVNYLGNGNDDDLSFLPPLANKTSLEELSINDNNFGGLLPKIISNFS 370

Query: 104  ITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNK 163
              L+ + F  N+I  SIP+GIG  I L TL +  NQL+G I  +IG+LQNL  LA+  NK
Sbjct: 371  ENLKRMTFGRNQIRGSIPSGIGNLIGLDTLGLEMNQLTGVIPNSIGKLQNLGVLALGGNK 430

Query: 164  LSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDL 223
            +SGNIP S+GN+  LL++YL  N LQ  IPSSLG CQ+L  ++L  NNLSG+IP +++ +
Sbjct: 431  ISGNIPSSMGNITSLLEVYLSANNLQGRIPSSLGNCQNLLILHLDQNNLSGSIPKEVISI 490

Query: 224  TSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGN 283
             S S  L LS NQL GSLP EVGKL NL    +S N L  EI  TLGSC+ LE L + GN
Sbjct: 491  PSSSRILVLSENQLTGSLPLEVGKLANLGYFNLSHNRLSGEIPRTLGSCVSLEFLYMEGN 550

Query: 284  LFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVF 343
            LFQGPIP SLSSLR L++L+LS NN+SGEIPKFL EL+L+ +L+LS+N+LEG +P +G+F
Sbjct: 551  LFQGPIPESLSSLRALQILNLSHNNLSGEIPKFLAELKLLTSLDLSFNNLEGEVPVQGIF 610

Query: 344  KNASAISVFGNSKLCGGIPEFQLPICGLEKSKHKRLTIAVKLAAAIISVLVGILLFVSFL 403
              AS  S+ GN KLCGG+P+  L  C  +KS+  + +  +KL  AI    VGI+L VS++
Sbjct: 611  ARASGFSMLGNKKLCGGMPQLNLSRCTSKKSRKLKSSTKLKLIIAIPCGFVGIILVVSYM 670

Query: 404  FLC--------------W------------------------IDMGSFGSVYKGILDEGK 425
                             W                        I  GSFGSVYKGIL    
Sbjct: 671  LFFFLKEKKSRPASGSPWESTFQRVAYEDLLQATNGFSPANLIGAGSFGSVYKGILRSDG 730

Query: 426  TIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMH 485
              +AVKV NLL  GASKS +AEC+AL NIRH+NLVK+LT CSG+D++G+DFKALVYEFM 
Sbjct: 731  AAVAVKVFNLLREGASKSFMAECAALINIRHRNLVKVLTACSGIDFQGNDFKALVYEFMV 790

Query: 486  NGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSN 545
            NGSLEEWLHP   +D+     + L+ LQR+NIAIDVA AL YLH+ CQ    HCDLKPSN
Sbjct: 791  NGSLEEWLHPAQISDEA-HRRRDLSLLQRLNIAIDVASALDYLHNHCQIAIVHCDLKPSN 849

Query: 546  VLLDHEMTAHVADFGLAKLLPPAHL-----QTSSIGVKGTIGYIAPAEYGLGSEVSINGD 600
            VLLD ++TAHV DFGLA+LLP A       QTSSIG+KGTIGY AP EYGLGSEVS  GD
Sbjct: 850  VLLDGDLTAHVGDFGLARLLPQASHQLCLDQTSSIGLKGTIGYAAP-EYGLGSEVSPYGD 908

Query: 601  VYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSN 660
            VYSYGILLLE+ T +RP+D +F+  +NLHNFA+T LP  V +++D  L+ + E+   + +
Sbjct: 909  VYSYGILLLEVFTGRRPTDGLFKDGLNLHNFAKTALPISVAEVLDPVLVTEAEE--TSGD 966

Query: 661  QRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSILLGPKT 715
              +R + I N MECL ++V++GVACS E P++RM ++ V  EL+ I+ ILLGP+T
Sbjct: 967  ASRRMSHIGNHMECLAAIVKVGVACSAEFPRERMEISSVAVELRRIRHILLGPQT 1021

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224097750|ref|XP_002311066.1| predicted protein [Populus trichocarpa] gi|222850886|gb|EEE88433.1| predicted protein [Populus trichocarpa]

 Score =  700 bits (1807), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 388/773 (50%), Positives = 505/773 (65%), Gaps = 66/773 (8%)

Query: 5    VNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSE 64
            +N++ G +P + G TLPNL   ++  NQ  G+IPS++ NASK+   Q+ +N+ TG+VPS 
Sbjct: 251  LNQLYGILPPELGLTLPNLDTFNILSNQFRGLIPSTLSNASKISDLQLRNNSFTGKVPSL 310

Query: 65   FGKATKAYCVQNCNQ-------------------HLKHLDINNNNFGGLLPGCICNFSIT 105
             G       V N N                     L+ L IN+NNFGG+LP  +CNFS  
Sbjct: 311  AGLHNLQRLVLNFNNLGNNEDDDLGFLYPLANTTSLEILAINHNNFGGVLPEIVCNFSTK 370

Query: 106  LETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLS 165
            L  +I   N +  SIP  IGK I L TL +  NQL+G I  +IG+LQ L    IN NK+S
Sbjct: 371  LRIMIIGENNLRGSIPTEIGKLIGLDTLGLELNQLTGIIPSSIGKLQRLGVFNINGNKIS 430

Query: 166  GNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTS 225
            GNIP S+GN+  LL++Y   N LQ  IPSSLG CQ+L  + L  NNLSG+IP +++ ++S
Sbjct: 431  GNIPSSLGNITSLLEVYFFANNLQGRIPSSLGNCQNLLMLRLDQNNLSGSIPKEVLGISS 490

Query: 226  LSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLF 285
            LS+ LDL+ NQL+G LP+EVGKL++L  L + +N L  EI   L SC+ LE L LG N F
Sbjct: 491  LSMYLDLAENQLIGPLPSEVGKLVHLGGLNVYKNRLSGEIPGILSSCVSLEHLNLGPNFF 550

Query: 286  QGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKN 345
            QG IP SLSSLR L++L+LS NN+SG+IPKFL E +L+ +L+LS+N+LEG +P +GVF  
Sbjct: 551  QGSIPESLSSLRALQILNLSHNNLSGKIPKFLAEFKLLTSLDLSFNNLEGEVPVQGVFAR 610

Query: 346  ASAISVFGNSKLCGGIPEFQLPICGLEKSKHKRLTIAVKLAAAIISVLVGILLFVSFLFL 405
            AS  S+ GN KLCGG P+  L  C  +KS+  + +  +KL  AI    VGI+L VS++  
Sbjct: 611  ASGFSMLGNKKLCGGRPQLNLSRCTSKKSRKLKSSTKMKLIIAIPCGFVGIILLVSYMLF 670

Query: 406  C--------------W------------------------IDMGSFGSVYKGILDEGKTI 427
                           W                        I  GSFGSVYKGIL      
Sbjct: 671  FLLKEKKSRPASGSPWESTFQRVAYEDLLQATKGFSPANLIGAGSFGSVYKGILRSDGAA 730

Query: 428  IAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNG 487
            +AVKV NLL  GASKS +AEC+AL NIRH+NLVK+LT CSG+D++G+DFKALVYEFM NG
Sbjct: 731  VAVKVFNLLREGASKSFMAECAALINIRHRNLVKVLTACSGIDFQGNDFKALVYEFMVNG 790

Query: 488  SLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVL 547
            SLEEWLHPV  +D+     + L+ LQR+NIAIDVA AL YLH+ CQ   AHCDLKPSNVL
Sbjct: 791  SLEEWLHPVQISDEA-HVRRDLSLLQRLNIAIDVASALDYLHNHCQIAVAHCDLKPSNVL 849

Query: 548  LDHEMTAHVADFGLAKLLPPAHL-----QTSSIGVKGTIGYIAPAEYGLGSEVSINGDVY 602
            LD +MTAHV DFGLA+LLP A       QTSSIG+KGTIGY AP EYGLGSEVS  GDVY
Sbjct: 850  LDGDMTAHVGDFGLARLLPQASHQLCLDQTSSIGLKGTIGYAAP-EYGLGSEVSPYGDVY 908

Query: 603  SYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQR 662
            SYGILLLE+ T +RP++ +F+  +NLHNFA+T LP  V +++D  L+ + E+   + +  
Sbjct: 909  SYGILLLEVFTGRRPTNGLFKDGLNLHNFAKTALPISVAEVLDPVLVTEAEE--TSGDAS 966

Query: 663  QRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSILLGPKT 715
            +R + I N MECL ++V++GVACS E P++RM ++ V  EL+ I+ ILLGP+T
Sbjct: 967  RRMSHIGNHMECLAAIVKVGVACSAEFPRERMEISSVAVELRRIRHILLGPQT 1019

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255581223|ref|XP_002531424.1| receptor-kinase, putative [Ricinus communis] gi|223528974|gb|EEF30966.1| receptor-kinase, putative [Ricinus communis]

 Score =  687 bits (1772), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 382/771 (49%), Positives = 474/771 (61%), Gaps = 70/771 (9%)

Query: 2    DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEV 61
            ++  N++QG +P + G TLPNL   ++  N   G IPSS  NAS L    ++ N LTG V
Sbjct: 249  NIVYNQIQGRLPSNLGITLPNLQVFAIARNDFIGSIPSSFSNASNLVWLIMSENKLTGRV 308

Query: 62   PS-------------------EFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNF 102
            PS                   E         + NC  +L  L+I+NN F G+LP  I NF
Sbjct: 309  PSLEQLHNLQILGLGYNYLGLEANDLDFVSSLVNCT-NLWRLEIHNNKFHGVLPESISNF 367

Query: 103  SITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTN 162
            S T   L+   N I   IP+ I   +NL+ L M +NQLSG I    G L  L  L +  N
Sbjct: 368  STTFSQLVIAENNIAGRIPSSISNLVNLERLEMANNQLSGNIPSNFGNLNMLKVLHLFGN 427

Query: 163  KLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMD 222
            KLSG IP S+GNL  LL L   +N LQ  IPSSL +C++L  ++L+ NNLSG+IP Q+  
Sbjct: 428  KLSGTIPSSLGNLTMLLTLSFYDNNLQGRIPSSLAECENLMVLDLAKNNLSGSIPLQVFG 487

Query: 223  LTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGG 282
            L+SLS+ LDLS N   G +P EVG L +LE L IS NML   I  +LGSCIKLE L L G
Sbjct: 488  LSSLSIALDLSANHFTGVIPMEVGNLKDLEQLGISDNMLSGRIPDSLGSCIKLEVLALQG 547

Query: 283  NLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGV 342
            N F G +P SLSSLRGLRVLD S NN+SGEIP+FL    L+++LNLSYN+ EG +P EG+
Sbjct: 548  NFFDGLVPSSLSSLRGLRVLDFSSNNLSGEIPEFLQSFDLLESLNLSYNNFEGRVPVEGI 607

Query: 343  FKNASAISVFGNSKLCGGIPEFQLPICGLEKSKHKRLTIAVKLAAAIISVLVGILLFVSF 402
            F+NAS   V GN KLCGGIPEF L  C  +  K  +LT+ +K+  + I  L+G+   + F
Sbjct: 608  FRNASTTLVMGNDKLCGGIPEFHLAKCNAKSPK--KLTLLLKIVISTICSLLGLSFILIF 665

Query: 403  LFLCW-------------------------------------IDMGSFGSVYKGILDEGK 425
                W                                     I  GSFG VYKG LDEG 
Sbjct: 666  ALTFWLRKKKEEPTSDPYGHLLLNVSFQSLLRATDGFSSANLIGRGSFGHVYKGFLDEGN 725

Query: 426  TIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMH 485
              IAVKVLNLLHHGAS S IAEC ALRNIRH+NLVK+LT CSG+DY+G+DFKALVYE+M 
Sbjct: 726  VTIAVKVLNLLHHGASTSFIAECEALRNIRHRNLVKVLTACSGIDYQGNDFKALVYEYMV 785

Query: 486  NGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSN 545
            NGSLEEWLHP+   ++ VE P+ LN LQR+NIAIDVA AL YLH+ C     HCDLKPSN
Sbjct: 786  NGSLEEWLHPIPRTEE-VEPPRSLNLLQRLNIAIDVASALDYLHNQCTTPIVHCDLKPSN 844

Query: 546  VLLDHEMTAHVADFGLAKLLPPAH-----LQTSSIGVKGTIGYIAPAEYGLGSEVSINGD 600
            VLLD EM  HV+DFGLAK+L  +       Q+SSIGV+GT+G+ AP EYG+GS VS  GD
Sbjct: 845  VLLDSEMNGHVSDFGLAKILSESTNSFPVSQSSSIGVRGTVGF-APPEYGVGSNVSTYGD 903

Query: 601  VYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSN 660
            VYSYGILLLEL T KRP+D MF+ ++NLHNFA     D + ++ D  LL +    T    
Sbjct: 904  VYSYGILLLELFTGKRPTDDMFKEDLNLHNFAEIAFRDQLAEVADPILLQE----TAVRE 959

Query: 661  QRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSILL 711
             R    +   + ECL S++RIGVACS E PQ+RM +  VV  L +I+  L+
Sbjct: 960  TRLNSRKCQRLEECLFSMLRIGVACSTEMPQERMKINDVVTGLHAIRDKLV 1010

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224121306|ref|XP_002330794.1| predicted protein [Populus trichocarpa] gi|222872596|gb|EEF09727.1| predicted protein [Populus trichocarpa]

 Score =  678 bits (1750), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 371/745 (49%), Positives = 496/745 (66%), Gaps = 47/745 (6%)

Query: 6   NRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEF 65
           N++QG +P D G   P L+ L++G NQITG IP S+ N+S LE   +  N  TG VPS  
Sbjct: 214 NQLQGTLPSDLGNEFPYLVELNVGDNQITGSIPISLSNSSYLERLTIAINGFTGNVPS-L 272

Query: 66  GKATKAYCVQNCNQHL-----KHLD---------------INNNNFGGLLPGCICNFSIT 105
            K  K + +     HL     + LD               IN NNFGG+LP  I NF+ +
Sbjct: 273 EKMHKLWWLSISTNHLGTGEARDLDFLSTVSNATSLQLMAINVNNFGGMLPSAITNFT-S 331

Query: 106 LETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLS 165
           L  +  +SN+IF SIPAG+G  +NL+ L+M  NQ +G I   IG+LQ L  L +  NKLS
Sbjct: 332 LSIMTLDSNRIFGSIPAGLGNLVNLEMLYMGKNQFTGDIPEEIGKLQQLKKLGLQGNKLS 391

Query: 166 GNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTS 225
           GNIP S GNL  L  LY+ ++ L+ SIP  LG+C +L  +NLS NNL+G IP +++ + S
Sbjct: 392 GNIPSSFGNLTLLTHLYMYQSSLKGSIPPELGKCLNLLLLNLSQNNLTGAIPKEVLSIPS 451

Query: 226 LSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLF 285
           L++ +DLSRN L+GSLPTEVG L NL IL IS NML  EI  TLGSC++LE L +  N F
Sbjct: 452 LTIYMDLSRNNLIGSLPTEVGTLTNLGILDISHNMLSGEIPGTLGSCVRLESLFMQNNFF 511

Query: 286 QGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKN 345
           QG IP S  SLRGL+VL+LS NN++G IP F ++ + +  LNLS+N+ EG++PT+GVF+N
Sbjct: 512 QGTIPSSFISLRGLQVLNLSHNNLTGSIPDFFLDFRALATLNLSFNNFEGLVPTDGVFRN 571

Query: 346 ASAISVFGNSKLCGGIPEFQLPICGLEKSKHKRLTIAVKLAA-----------AIISVLV 394
           +SA+SV GNSKLCGGI EFQL  C  + +K  RLT+A+KL             ++  +  
Sbjct: 572 SSAVSVVGNSKLCGGIAEFQLLECNFKGTKKGRLTLAMKLRKKVEPTPTSPENSVFQMSY 631

Query: 395 GILLFVS--FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALR 452
             LL  +  F     + +G FGSVYKGILD  + ++AVKVLNLL+  ASKS  AEC  LR
Sbjct: 632 RSLLKATDGFSLTNLLGVGGFGSVYKGILDNDEKLVAVKVLNLLNPRASKSFKAECEVLR 691

Query: 453 NIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVS-GADKTVEAPKCLNF 511
           N+RH+NLVK+LT CSG DY+G+DFKALVYEFM NGSLEEWLHP++ G D+  E+ + LNF
Sbjct: 692 NVRHRNLVKLLTACSGSDYQGNDFKALVYEFMVNGSLEEWLHPITPGIDEARESSRSLNF 751

Query: 512 LQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPA--- 568
           +QR+NIAID++CAL+YLH  C+    HCDLKPSNVLLD EM  HV DFGLA+  P A   
Sbjct: 752 VQRLNIAIDISCALEYLHRGCRTPIVHCDLKPSNVLLDDEMIGHVGDFGLARFFPEATNN 811

Query: 569 --HLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNM 626
               ++S+ GV+GTIGY AP EYG+G+EVS +GDV+SYGILLLE+ + KRP+D++FE ++
Sbjct: 812 LSFNRSSTNGVRGTIGYTAP-EYGMGNEVSTSGDVFSYGILLLEMFSGKRPTDVIFEDSL 870

Query: 627 NLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACS 686
           NLH + +  LP  V +I+D  L+ +     I   +       + + +C++SV  +G+ACS
Sbjct: 871 NLHTYMKAALPGKVEEILDPILVQE-----IKGERSSSYMWNSKVQDCVVSVFEVGIACS 925

Query: 687 MESPQDRMNMTIVVHELQSIKSILL 711
            E P +RM+++ V  ELQ+IK  LL
Sbjct: 926 AELPSERMDISEVTAELQAIKEKLL 950

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224119022|ref|XP_002331306.1| predicted protein [Populus trichocarpa] gi|222873889|gb|EEF11020.1| predicted protein [Populus trichocarpa]

 Score =  675 bits (1742), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 379/775 (48%), Positives = 486/775 (62%), Gaps = 79/775 (10%)

Query: 2    DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEV 61
            D+G N   G +P D G +LPNL F S+  NQ TG IP S+ NAS +E+ QV+ NNLTGEV
Sbjct: 246  DIGFNLFHGNLPSDIGISLPNLEFFSIASNQFTGSIPVSISNASNIELLQVSLNNLTGEV 305

Query: 62   PS-----------------EFGKATKAYCVQNCNQH--LKHLDINNNNFGGLLPGCICNF 102
            P+                   G+A     + +      L++L I  NNFGG LP  I N 
Sbjct: 306  PTLEKLHRLNFFTLFSNHLGSGQANDLSFLSSLTNATTLEYLSIKRNNFGGELPKQISNL 365

Query: 103  SITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTN 162
            S  L  +    N I  SIPAGI K +NL+   + +N++SG I  +IGELQNL  L ++ N
Sbjct: 366  STMLGVISLPENNILGSIPAGIEKLVNLKVFDVGNNKISGIIPSSIGELQNLEGLVLDYN 425

Query: 163  KLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMD 222
             LSG IP S+GNL KL+ LYL +N L+ SIPSSLG C+ L  + L  NNLSG IPP L  
Sbjct: 426  NLSGRIPSSVGNLTKLMALYLGDNSLEGSIPSSLGNCKKLLVLTLCGNNLSGDIPPGLFG 485

Query: 223  LTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGG 282
            + SL + +  S+N   GSLP E+GKLINLE L +S NML  EI S+LG CI LE L +  
Sbjct: 486  IFSL-LYICFSKNHFSGSLPIEIGKLINLEFLDVSGNMLSGEIPSSLGGCISLEDLYMNS 544

Query: 283  NLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGV 342
            N F G IP +LSSLRG+   + S NN+SG+IP+F      ++ L+LSYN+ EG+IP EG+
Sbjct: 545  NFFHGSIPSALSSLRGVLQFNFSHNNLSGKIPEFFQGFNSLEMLDLSYNNFEGMIPDEGI 604

Query: 343  FKNASAISVFGNSKLCGGIPEFQLPICGLEKSKHKRLTIAVKLAAAIISVLVGILLFVSF 402
            FKN++A+SV GNS+LCGG  E  LP C + + K  RL + +K+A   I+VL+ + L V+ 
Sbjct: 605  FKNSTAVSVIGNSQLCGGNTELGLPRCKVHQPK--RLKLKLKIAIFAITVLLALALVVTC 662

Query: 403  LFLC-------------------------------------WIDMGSFGSVYKGILDEGK 425
            LFLC                                      + +GSFGSVYKG+LD+  
Sbjct: 663  LFLCSSRRKRREIKLSSMRNELLEVSYQILLKATNGFSSSNLVGIGSFGSVYKGMLDQNG 722

Query: 426  TIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMH 485
             +IAVKVLNL+  GAS+S IAEC ALRNIRH+NLVK+LT CS +DY G+DFKA+VYEFM 
Sbjct: 723  MVIAVKVLNLMRQGASRSFIAECEALRNIRHRNLVKVLTACSSIDYHGNDFKAIVYEFMA 782

Query: 486  NGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSN 545
            NGSLE+WLHP      T         LQR+NIAIDVACAL+YLHH C+   AHCDLKPSN
Sbjct: 783  NGSLEDWLHPTGTGGGTTLTLNL---LQRLNIAIDVACALEYLHHHCEMPIAHCDLKPSN 839

Query: 546  VLLDHEMTAHVADFGLAKLLPPAHL-----QTSSIGVKGTIGYIAPAEYGLGSEVSINGD 600
            VLLD E+T HV DFGLAK L  A L     +++SIGV+GTIGY AP EYG+G EVS  GD
Sbjct: 840  VLLDDELTGHVGDFGLAKFLSGASLDYPTNESTSIGVRGTIGY-APPEYGVGGEVSAYGD 898

Query: 601  VYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLL-----ADDEDL 655
             YSYGILLLE+ T KRP+D MF    NLHNF +  +P+ V  I D TLL      DD+  
Sbjct: 899  TYSYGILLLEMFTGKRPTDEMFREGSNLHNFVKRAVPEQVKQITDPTLLQEEPTGDDDKH 958

Query: 656  TITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSIL 710
             I+S +  R       +ECL S++RIG++CS+E P++RM ++  V +L S+++ L
Sbjct: 959  EISSMRNSRP------LECLNSILRIGISCSVEFPRERMKISDAVAQLHSVRNEL 1007

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359482058|ref|XP_002274540.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score =  670 bits (1728), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 367/775 (47%), Positives = 487/775 (62%), Gaps = 71/775 (9%)

Query: 6    NRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEF 65
            N++ G +P D  FTLPNL  L++G N  TG +PSS+ NAS L  F +T +N TG+V  +F
Sbjct: 259  NKLYGSLPWDLAFTLPNLQVLNIGNNDFTGSLPSSLSNASNLLEFDITMSNFTGKVSIDF 318

Query: 66   GKATKAY---------------------CVQNCNQHLKHLDINNNNFGGLLPGCICNFSI 104
            G     +                      +  C + LK LD++ + FGG+LP  I N S 
Sbjct: 319  GGMPNLWGLFLASNPLGKGEADDLSFLNSLMKC-RALKVLDLSGSQFGGVLPNSIANLST 377

Query: 105  TLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKL 164
             L  L  ++N++  +IP GIG  +NL  L + +N  +G+I   IG LQ L  + ++ N+L
Sbjct: 378  QLMKLKLDNNQLSGTIPPGIGNLVNLTDLILANNDFTGSIPVLIGNLQMLGRIDLSRNQL 437

Query: 165  SGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLT 224
            SG+IP S+GN+ +L  L+L  N L   IPSS G    L  ++LSYN+L+GTIP ++MDL 
Sbjct: 438  SGHIPSSLGNITRLYSLHLQNNHLSGKIPSSFGNLLYLQELDLSYNSLNGTIPEKVMDLV 497

Query: 225  SLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNL 284
            SL++ L+L+RNQL G LP+EV KL NL  L +S N L  EI   LGSC+ LE L + GN 
Sbjct: 498  SLTISLNLARNQLTGLLPSEVRKLKNLGHLDVSENKLSGEIPDGLGSCLTLEHLHMEGNF 557

Query: 285  FQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFK 344
            F+G IP S  SLRGL  LDLS+NN+SG+IP+FL +L L  NLNLS+N+ EG +PT+GVF 
Sbjct: 558  FKGSIPPSFISLRGLLDLDLSRNNLSGQIPEFLQQLSL-SNLNLSFNNFEGQLPTKGVFN 616

Query: 345  NASAISVFGNSKLCGGIPEFQLPICGLEKSKHKRLTIAVKLAAAIISVLVGILLFVSFLF 404
            NA++ SV GN+KLCGGIPE  LP C + K K       +KL   +++  +G++L +S L 
Sbjct: 617  NATSTSVAGNNKLCGGIPELHLPACPVTKPKTGESKRGLKLMIGLLTGFLGLVLIMSLLV 676

Query: 405  LC---------------------------------------WIDMGSFGSVYKGILDEGK 425
            +                                         I  G FGSVYKGIL + +
Sbjct: 677  INRLRRVKREPSQTSASSKDLILNVSYDGLFKATGGFSSANLIGTGGFGSVYKGILGQDE 736

Query: 426  TIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMH 485
            T++AVKV+ L   GA KS  AEC ALRNIRH+NLVK+LT CS VDY+G+DFKALVYEFM 
Sbjct: 737  TVVAVKVIQLHQRGAVKSFKAECEALRNIRHRNLVKVLTTCSSVDYQGNDFKALVYEFMP 796

Query: 486  NGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSN 545
            NGSLE WLHPV   D+  +  + L+  QR+NIAIDVA AL YLHH C     HCDLKPSN
Sbjct: 797  NGSLENWLHPVPTPDEINDVLRILSLPQRLNIAIDVASALDYLHHHCHKPIVHCDLKPSN 856

Query: 546  VLLDHEMTAHVADFGLAKLLPPAH-----LQTSSIGVKGTIGYIAPAEYGLGSEVSINGD 600
            +LLD++MTAHV DFGLA+ +P A       Q+SSIG+KGTIGY AP EYG+G++VS  GD
Sbjct: 857  ILLDNDMTAHVGDFGLARFIPEAAGRSHPSQSSSIGLKGTIGYAAP-EYGMGTKVSALGD 915

Query: 601  VYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLL---ADDEDLTI 657
             YSYGILLLE+ T KRP++ MF   +NLHNF +  LP+ + DI+D   L   A +E+ T 
Sbjct: 916  TYSYGILLLEMFTGKRPTESMFSDQLNLHNFVKMALPERIADIIDPFFLSSEAKEEETTA 975

Query: 658  TSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSILLG 712
              +      +   + ECLIS++RIGV+CS+ESP++RM +T  + ELQ I+ ILLG
Sbjct: 976  ADSSNLAHMKREKMHECLISILRIGVSCSLESPRERMAITEAIKELQLIRKILLG 1030

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224081190|ref|XP_002306327.1| predicted protein [Populus trichocarpa] gi|222855776|gb|EEE93323.1| predicted protein [Populus trichocarpa]

 Score =  669 bits (1727), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 370/774 (47%), Positives = 497/774 (64%), Gaps = 74/774 (9%)

Query: 3    VGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVP 62
            +G N++ G +P D G  LPNL +L + FN + G IP+++ NASK+ +  ++ NNLTG++P
Sbjct: 249  LGQNQLHGSLPPDLGLNLPNLAYLVINFNHLNGPIPATLSNASKIFLVDLSYNNLTGKIP 308

Query: 63   ---------------SEFGKATKA-----YCVQNCNQHLKHLDINNNNFGGLLPGCICNF 102
                           ++ G   +      Y + N + +L+ L IN+NNFGG+LP  + NF
Sbjct: 309  DLASLPDLQKLLVHHNDLGNGEEDDLSFLYTLAN-STNLESLGINDNNFGGVLPEIVSNF 367

Query: 103  SITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTN 162
            S  L+ + F  N+I  SIP  IG  I+L TL +  NQL G I  +IG+LQNL  L +N N
Sbjct: 368  STNLKGITFGRNQIHGSIPTEIGNLISLDTLSLETNQLHGIIPSSIGKLQNLAALYLNEN 427

Query: 163  KLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMD 222
            K+SG+IP S+GN+  L+++   +N LQ +IP+SLG    L  ++LS NNLSG IP +++ 
Sbjct: 428  KISGSIPSSLGNITSLVEVSFAQNNLQGTIPASLGNWHKLLILDLSQNNLSGPIPKEVLG 487

Query: 223  LTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGG 282
            ++SLSV L L  NQL GSLP+EVG+L+NL  L +S+N L  EI  +L SC  LE L LGG
Sbjct: 488  ISSLSVLLYLHDNQLTGSLPSEVGQLVNLGFLRVSKNRLSGEIPKSLDSCKSLEGLDLGG 547

Query: 283  NLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGV 342
            N F+GP+P  LSSLR L++L LS NN+SG+IP+FL + +L++ L+LSYND EG +P +GV
Sbjct: 548  NFFEGPVP-DLSSLRALQMLLLSYNNLSGQIPQFLKDFKLLETLDLSYNDFEGEVPEQGV 606

Query: 343  FKNASAISVFGNSKLCGGIPEFQLPICGLEKSKHKRLTIAVKLAAAIISVLVGILLFVSF 402
            F+N S ISV GN KLCGGIP+  LP C   +    +    + L  AI    +GI+L  SF
Sbjct: 607  FENTSRISVQGNKKLCGGIPQLDLPKCTSNEPARPKSHTKLILIIAIPCGFLGIVLMTSF 666

Query: 403  LFL-------------CW------------------------IDMGSFGSVYKGILDEGK 425
            L                W                        +  G+FGSVY+G L    
Sbjct: 667  LLFYSRKTKDEPASGPSWESSFQRLTYQDLLQATDGFSSSNLVGAGAFGSVYRGTLTSDG 726

Query: 426  TIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMH 485
             ++AVKVLNLL  GASKS +AEC+AL NIRH+NLVK++T CS  D++G+DFKALVYEFM 
Sbjct: 727  AVVAVKVLNLLRKGASKSFMAECAALINIRHRNLVKVITACSSNDFQGNDFKALVYEFMV 786

Query: 486  NGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSN 545
            NGSLEEWLHPV  +D T E  + L+ +QR+NIAIDVA AL YLH+ CQ    HCDLKPSN
Sbjct: 787  NGSLEEWLHPVHISDVTPET-RNLDLVQRLNIAIDVASALDYLHNHCQVPVVHCDLKPSN 845

Query: 546  VLLDHEMTAHVADFGLAKLLPPAHLQ-----TSSIGVKGTIGYIAPAEYGLGSEVSINGD 600
            VLL  +MTA V DFGLA+ LP A  Q     +SS+G+KGTIGY AP EYG+GSEVS  GD
Sbjct: 846  VLLGDDMTACVGDFGLARFLPEASNQLPADESSSVGLKGTIGYAAP-EYGMGSEVSTYGD 904

Query: 601  VYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSN 660
            VYSYGILLLE+ T +RP+D MF+   NLHN+A+ VLPD+V++ VD TL   +E   +  N
Sbjct: 905  VYSYGILLLEMFTGRRPTDGMFKDGHNLHNYAKMVLPDNVLEFVDPTLREHEE---MNHN 961

Query: 661  QRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSILLGPK 714
                +     +MEC++S++++G+ACS E P +RM +  VV EL  I+ +L G K
Sbjct: 962  DDSHK-----VMECMVSIIKVGLACSAELPGERMGIANVVVELHRIREMLDGRK 1010

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147853780|emb|CAN83822.1| hypothetical protein VITISV_030954 [Vitis vinifera]

 Score =  665 bits (1716), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 366/775 (47%), Positives = 486/775 (62%), Gaps = 71/775 (9%)

Query: 6    NRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEF 65
            N++ G +P D  FTLPNL  L++G N  TG +PSS+ NAS L  F +T +N TG+V  +F
Sbjct: 290  NKLYGSLPWDLAFTLPNLQVLNIGNNDFTGPLPSSLSNASNLLEFDITMSNFTGKVSIDF 349

Query: 66   GKATKAY---------------------CVQNCNQHLKHLDINNNNFGGLLPGCICNFSI 104
            G     +                      +  C + LK LD++ + FGG+LP  I N S 
Sbjct: 350  GGMPNLWGLFLASNPLGKGEADDLSFLNSLMKC-RALKVLDLSGSQFGGVLPNSIANLST 408

Query: 105  TLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKL 164
             L  L  ++N++  +IP GIG  +NL  L + +N  +G+I   IG LQ L  + ++ N+L
Sbjct: 409  QLMKLKLDNNQLSGTIPPGIGNLVNLTDLILANNDFTGSIPVLIGNLQMLGRIDLSRNQL 468

Query: 165  SGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLT 224
            SG+IP S+GN+ +L  L+L  N L   IPSS G    L  ++LSYN+L+GTIP ++MDL 
Sbjct: 469  SGHIPSSLGNITRLYSLHLQNNHLSGKIPSSFGNLLYLQELDLSYNSLNGTIPEKVMDLV 528

Query: 225  SLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNL 284
            SL++ L+L+RNQL G LP+EV KL NL  L +S N L  EI   LGSC+ LE L + GN 
Sbjct: 529  SLTISLNLARNQLTGLLPSEVRKLKNLGHLDVSENKLSGEIPDGLGSCLTLEHLHMEGNF 588

Query: 285  FQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFK 344
            F+G IP S  SLRGL  LDLS+NN+SG+IP+FL +L L  NLNLS+N+ EG +PT+GVF 
Sbjct: 589  FKGSIPPSFISLRGLLDLDLSRNNLSGQIPEFLQQLSL-SNLNLSFNNFEGQLPTKGVFN 647

Query: 345  NASAISVFGNSKLCGGIPEFQLPICGLEKSKHKRLTIAVKLAAAIISVLVGILLFVSFLF 404
            NA++ SV GN+KLCGGIPE  LP C + K K       +KL   +++  +G++L +S L 
Sbjct: 648  NATSTSVAGNNKLCGGIPELHLPACPVTKPKTGESKRGLKLMIGLLTGFLGLVLIMSLLV 707

Query: 405  LC---------------------------------------WIDMGSFGSVYKGILDEGK 425
            +                                         I  G FGSVYKG L + +
Sbjct: 708  INRLRRVKREPSQTSASSKDLILNVSYDGLFKATGGFSSANLIGTGGFGSVYKGXLGQDE 767

Query: 426  TIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMH 485
            T++AVKV+ L   GA KS  AEC ALRNIRH+NLVK+LT CS VDY+G+DFKALVYEFM 
Sbjct: 768  TVVAVKVIQLHQRGAVKSFKAECEALRNIRHRNLVKVLTTCSSVDYQGNDFKALVYEFMP 827

Query: 486  NGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSN 545
            NGSLE WLHPV   D+  +  + L+  QR+NIAIDVA AL YLHH C     HCDLKPSN
Sbjct: 828  NGSLENWLHPVPTPDEINDVLRILSLPQRLNIAIDVASALDYLHHHCHKPIVHCDLKPSN 887

Query: 546  VLLDHEMTAHVADFGLAKLLPPAH-----LQTSSIGVKGTIGYIAPAEYGLGSEVSINGD 600
            +LLD++MTAHV DFGLA+ +P A       Q+SSIG+KGTIGY AP EYG+G++VS  GD
Sbjct: 888  ILLDNDMTAHVGDFGLARFIPEAAGRSHPSQSSSIGLKGTIGYAAP-EYGMGTKVSALGD 946

Query: 601  VYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLL---ADDEDLTI 657
             YSYGILLLE+ T KRP++ MF   +NLHNF +  LP+ + DI+D   L   A +E+ T 
Sbjct: 947  TYSYGILLLEMFTGKRPTESMFSDQLNLHNFVKMALPERIADIIDPFFLSSEAKEEETTA 1006

Query: 658  TSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSILLG 712
              +      +   + ECLIS++RIGV+CS+ESP++RM +T  + ELQ I+ ILLG
Sbjct: 1007 ADSSNLAHMKREKMHECLISILRIGVSCSLESPRERMAITEAIKELQLIRKILLG 1061

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224127492|ref|XP_002329291.1| predicted protein [Populus trichocarpa] gi|222870745|gb|EEF07876.1| predicted protein [Populus trichocarpa]

 Score =  664 bits (1712), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 362/770 (47%), Positives = 489/770 (63%), Gaps = 63/770 (8%)

Query: 5    VNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVP-- 62
            VN++ G +P   G TLPNL   ++  NQ  G+IP++  NAS L  FQ+ SNN  G+VP  
Sbjct: 253  VNQLYGSLPHTLGLTLPNLQVFNIHTNQFGGLIPATFSNASNLLSFQIGSNNFNGKVPPL 312

Query: 63   -------------SEFGKATK-----AYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSI 104
                         +  GK         Y + N    L+ LD ++NNFGG+LP  + NFS 
Sbjct: 313  SSSHDLQVLGVGDNNLGKGENNDLNFVYPLANNMTSLEALDTSDNNFGGVLPEIVSNFST 372

Query: 105  TLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKL 164
             L  + F  N+I  SIP  IG  INL+ L +  NQL+G I  ++G+LQ L  L +N NK+
Sbjct: 373  KLMKMTFARNQIRGSIPTQIGNLINLEALGLETNQLTGMIPSSMGKLQKLSDLFLNGNKI 432

Query: 165  SGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLT 224
            SG IP S+GN+  L ++ +  N L+ SIP SLG  Q L ++ LS NNLSG IP +L+ + 
Sbjct: 433  SGMIPSSMGNMTSLGRVNMRLNNLEGSIPPSLGNWQKLLSLALSQNNLSGPIPKELVSIP 492

Query: 225  SLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNL 284
            SLS+ L LS N+L GSLP E+ KL+NL  L +S+N    EI  +LGSC+ LE L L  N 
Sbjct: 493  SLSMYLVLSENELTGSLPIEMEKLVNLGYLDVSKNRFSGEIPKSLGSCVSLESLHLEENF 552

Query: 285  FQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFK 344
             QGPIP++LSSLR ++ L+LS NN++G+IP+FL + +L+++LNLS+ND EG +P +G F+
Sbjct: 553  LQGPIPITLSSLRAIQELNLSYNNLTGQIPEFLEDFKLLESLNLSFNDFEGEVPVQGAFQ 612

Query: 345  NASAISVFGNSKLCGGIPEFQLPIC-GLEKSKHKRLTIAVKLAAAIISVLVGILLFVSFL 403
            N SAIS+FGN KLCGGIP+  L  C   E +  K  T  + +  ++   L G++L +SFL
Sbjct: 613  NTSAISIFGNKKLCGGIPQLNLTRCPSSEPTNSKSPTKLIWIIGSVCGFL-GVILIISFL 671

Query: 404  -FLCW--------------------------------------IDMGSFGSVYKGILDEG 424
             F C+                                      I  GSFGSV+KGIL   
Sbjct: 672  LFYCFRKKKDKPAASQPSLETSFPRVAYEDLLGATDGFSSANLIGEGSFGSVFKGILGPD 731

Query: 425  KTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFM 484
            K ++AVKVLNLL  GASKS +AEC AL++IRH+NLVK+LT CS +D++G+DFKALVYEFM
Sbjct: 732  KIVVAVKVLNLLRKGASKSFMAECEALKSIRHRNLVKLLTTCSSIDFQGNDFKALVYEFM 791

Query: 485  HNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPS 544
             NG+LEEWLHPV  +D+    PK L+ + R+NIAI +A AL YLHHDCQ    HCDLKPS
Sbjct: 792  VNGNLEEWLHPVQTSDE-ANGPKALDLMHRLNIAIHMASALNYLHHDCQMPIIHCDLKPS 850

Query: 545  NVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSY 604
            N+LLD  MTAHV DFGLA+    A  QTSS+G+KGTIGY AP EYG+G +VS  GDVYSY
Sbjct: 851  NILLDTNMTAHVGDFGLARFHSEASNQTSSVGLKGTIGYAAP-EYGIGGKVSTYGDVYSY 909

Query: 605  GILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQR 664
            GILLLE+ T KRP D MF+  +NLH++A+  LPD ++++VD  L+ +   +  +      
Sbjct: 910  GILLLEMFTGKRPVDGMFKDGLNLHSYAKMALPDRIVEVVDPLLVREIRSVNSSDEMGMY 969

Query: 665  QARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSILLGPK 714
                + I  CL++++++GVACS+E P++RM++  VV EL  IK  LLG +
Sbjct: 970  HIGPHEISACLMTIIKMGVACSVELPRERMDIGDVVTELNRIKDTLLGTR 1019

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	741
TAIR|locus:2075661	1025	AT3G47110 [Arabidopsis thalian	0.385	0.279	0.5	1.3e-141
TAIR|locus:2079142	1010	AT3G47570 [Arabidopsis thalian	0.384	0.282	0.5	9.5e-135
TAIR|locus:2075631	1009	AT3G47090 [Arabidopsis thalian	0.384	0.282	0.467	6.5e-131
TAIR|locus:2149922	1031	EFR "EF-TU receptor" [Arabidop	0.306	0.220	0.538	7.1e-131
UNIPROTKB|Q40640	1025	Xa21 "Receptor kinase-like pro	0.392	0.283	0.493	1.2e-127
TAIR|locus:2079157	1011	AT3G47580 [Arabidopsis thalian	0.385	0.282	0.475	5.2e-127
TAIR|locus:2175703	502	AT5G39390 [Arabidopsis thalian	0.306	0.452	0.555	3.3e-90
TAIR|locus:2047525	980	AT2G24130 [Arabidopsis thalian	0.377	0.285	0.375	8.1e-86
UNIPROTKB|O24435	813	O24435 "Receptor kinase-like p	0.529	0.482	0.342	4e-85
TAIR|locus:2120362	1249	GSO1 "GASSHO1" [Arabidopsis th	0.476	0.282	0.327	1e-74

TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)]

 Score = 733 (263.1 bits), Expect = 1.3e-141, Sum P(2) = 1.3e-141
 Identities = 153/306 (50%), Positives = 205/306 (66%)

Query:   408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
             I  G+FG+V+KG L      +A+KVLNL   GA+KS IAEC AL  IRH+NLVK++T+CS
Sbjct:   725 IGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICS 784

Query:   468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
               D++G+DF+ALVYEFM NG+L+ WLHP    ++T    + L    R+NIAIDVA AL Y
Sbjct:   785 SSDFEGNDFRALVYEFMPNGNLDMWLHP-DEIEETGNPSRTLGLFARLNIAIDVASALVY 843

Query:   528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL-----PPAHLQTSSIGVKGTIG 582
             LH  C    AHCD+KPSN+LLD ++TAHV+DFGLA+LL        H+Q SS GV+GTIG
Sbjct:   844 LHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIG 903

Query:   583 YIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDH-VM 641
             Y AP EYG+G   SI GDVYS+GI+LLE+ T KRP++ +F   + LH+F ++ L     +
Sbjct:   904 YAAP-EYGMGGHPSIMGDVYSFGIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQKRQAL 962

Query:   642 DIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH 701
             DI D T+L            R   A+  N++ECL  V R+GV+CS ESP +R++M   + 
Sbjct:   963 DITDETIL------------RGAYAQHFNMVECLTLVFRVGVSCSEESPVNRISMAEAIS 1010

Query:   702 ELQSIK 707
             +L SI+
Sbjct:  1011 KLVSIR 1016

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)]

 Score = 748 (268.4 bits), Expect = 9.5e-135, Sum P(2) = 9.5e-135
 Identities = 153/306 (50%), Positives = 211/306 (68%)

Query:   408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
             +  GSFG+VYK +L   K ++AVKVLN+   GA KS +AEC +L++IRH+NLVK+LT CS
Sbjct:   708 VGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACS 767

Query:   468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
              +D++G++F+AL+YEFM NGSL+ WLHP    ++     + L  L+R+NIAIDVA  L Y
Sbjct:   768 SIDFQGNEFRALIYEFMPNGSLDMWLHPEE-VEEIHRPSRTLTLLERLNIAIDVASVLDY 826

Query:   528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL-----PPAHLQTSSIGVKGTIG 582
             LH  C    AHCDLKPSNVLLD ++TAHV+DFGLA+LL          Q SS GV+GTIG
Sbjct:   827 LHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIG 886

Query:   583 YIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMD 642
             Y AP EYG+G + SINGDVYS+GILLLE+ T KRP++ +F GN  L+++ ++ LP+ ++D
Sbjct:   887 YAAP-EYGVGGQPSINGDVYSFGILLLEMFTGKRPTNELFGGNFTLNSYTKSALPERILD 945

Query:   643 IVDSTLLADDEDLTITSNQRQRQARIN-NIMECLISVVRIGVACSMESPQDRMNMTIVVH 701
             IVD ++L     + +         R+   ++ECL  V  +G+ C  ESP +R+  +IVV 
Sbjct:   946 IVDESIL----HIGL---------RVGFPVVECLTMVFEVGLRCCEESPMNRLATSIVVK 992

Query:   702 ELQSIK 707
             EL SI+
Sbjct:   993 ELISIR 998

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)]

 Score = 715 (256.8 bits), Expect = 6.5e-131, Sum P(2) = 6.5e-131
 Identities = 143/306 (46%), Positives = 205/306 (66%)

Query:   408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
             +  GSFG+V+K +L     I+AVKVLN+   GA KS +AEC +L++IRH+NLVK+LT C+
Sbjct:   707 VGSGSFGTVFKALLQTENKIVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACA 766

Query:   468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
              +D++G++F+AL+YEFM NGSL++WLHP    ++     + L  L+R+NIAIDVA  L Y
Sbjct:   767 SIDFQGNEFRALIYEFMPNGSLDKWLHPEE-VEEIHRPSRTLTLLERLNIAIDVASVLDY 825

Query:   528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL-----PPAHLQTSSIGVKGTIG 582
             LH  C    AHCDLKPSN+LLD ++TAHV+DFGLA+LL          Q SS GV+GTIG
Sbjct:   826 LHVHCHEPIAHCDLKPSNILLDDDLTAHVSDFGLARLLLKFDQESFFNQLSSAGVRGTIG 885

Query:   583 YIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMD 642
             Y AP EYG+G + SI+GDVYS+G+L+LE+ T KRP++ +F GN  L+++ +  LP+ V+D
Sbjct:   886 YAAP-EYGMGGQPSIHGDVYSFGVLVLEMFTGKRPTNELFGGNFTLNSYTKAALPERVLD 944

Query:   643 IVDSTLLADDEDLTITSNQRQRQARIN-NIMECLISVVRIGVACSMESPQDRMNMTIVVH 701
             I D ++L                 R+   ++ECL  ++ +G+ C  ESP +R+  +    
Sbjct:   945 IADKSILHSG-------------LRVGFPVLECLKGILDVGLRCCEESPLNRLATSEAAK 991

Query:   702 ELQSIK 707
             EL SI+
Sbjct:   992 ELISIR 997

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009507 "chloroplast" evidence=IDA

TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)]

 Score = 646 (232.5 bits), Expect = 7.1e-131, Sum P(3) = 7.1e-131
 Identities = 126/234 (53%), Positives = 173/234 (73%)

Query:   408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
             I  G+FG+V+KG+L     ++AVKVLNLL HGA+KS +AEC   + IRH+NLVK++TVCS
Sbjct:   718 IGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCS 777

Query:   468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
              +D +G+DF+ALVYEFM  GSL+ WL  +   ++  +  + L   +++NIAIDVA AL+Y
Sbjct:   778 SLDSEGNDFRALVYEFMPKGSLDMWLQ-LEDLERVNDHSRSLTPAEKLNIAIDVASALEY 836

Query:   528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL----PPAHL-QTSSIGVKGTIG 582
             LH  C    AHCD+KPSN+LLD ++TAHV+DFGLA+LL      + L Q SS GV+GTIG
Sbjct:   837 LHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIG 896

Query:   583 YIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVL 636
             Y AP EYG+G + SI GDVYS+GILLLE+ + K+P+D  F G+ NLH++ +++L
Sbjct:   897 YAAP-EYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYNLHSYTKSIL 949

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010204 "defense response signaling pathway, resistance gene-independent" evidence=IMP

GO:0016045 "detection of bacterium" evidence=RCA;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0002764 "immune response-regulating signaling pathway" evidence=IMP

GO:0009626 "plant-type hypersensitive response" evidence=IMP

GO:0019199 "transmembrane receptor protein kinase activity" evidence=TAS

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050776 "regulation of immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 697 (250.4 bits), Expect = 1.2e-127, Sum P(2) = 1.2e-127
 Identities = 152/308 (49%), Positives = 207/308 (67%)

Query:   411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
             GSFGSVYKG L+  +  +AVKVL L +  A KS  AEC ALRN+RH+NLVKI+T+CS +D
Sbjct:   717 GSFGSVYKGKLNI-QDHVAVKVLKLENPKALKSFTAECEALRNMRHRNLVKIVTICSSID 775

Query:   471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH- 529
              +G+DFKA+VY+FM NGSLE+W+HP +  D+  +  + LN  +R+ I +DVACAL YLH 
Sbjct:   776 NRGNDFKAIVYDFMPNGSLEDWIHPETN-DQADQ--RHLNLHRRVTILLDVACALDYLHR 832

Query:   530 HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAH--LQ--TSSIGVKGTIGYIA 585
             H  +P   HCD+K SNVLLD +M AHV DFGLA++L      +Q  TSS+G  GTIGY A
Sbjct:   833 HGPEPVV-HCDIKSSNVLLDSDMVAHVGDFGLARILVDGTSLIQQSTSSMGFIGTIGYAA 891

Query:   586 PAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVD 645
             P EYG+G   S +GD+YSYGIL+LE++T KRP+D  F  ++ L  +    L   V D+VD
Sbjct:   892 P-EYGVGLIASTHGDIYSYGILVLEIVTGKRPTDSTFRPDLGLRQYVELGLHGRVTDVVD 950

Query:   646 STLLADDED-LTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQ 704
             + L+ D E+ L  T+N   R+     I EC++ ++R+G++CS E P  R     ++ EL 
Sbjct:   951 TKLILDSENWLNSTNNSPCRR-----ITECIVWLLRLGLSCSQELPSSRTPTGDIIDELN 1005

Query:   705 SIKSILLG 712
             +IK  L G
Sbjct:  1006 AIKQNLSG 1013

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)]

 Score = 704 (252.9 bits), Expect = 5.2e-127, Sum P(2) = 5.2e-127
 Identities = 145/305 (47%), Positives = 202/305 (66%)

Query:   408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
             +  GSFG+V+K +L     I+AVKVLN+   GA KS +AEC +L++ RH+NLVK+LT C+
Sbjct:   709 VGSGSFGTVFKALLPTESKIVAVKVLNMQRRGAMKSFMAECESLKDTRHRNLVKLLTACA 768

Query:   468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
               D++G++F+AL+YE++ NGS++ WLHP    ++    P+ L  L+R+NI IDVA  L Y
Sbjct:   769 STDFQGNEFRALIYEYLPNGSVDMWLHPEE-VEEIRRPPRTLTLLERLNIVIDVASVLDY 827

Query:   528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL----PPAHL-QTSSIGVKGTIG 582
             LH  C    AHCDLKPSNVLL+ ++TAHV+DFGLA+LL      + L Q SS GV+GTIG
Sbjct:   828 LHVHCHEPIAHCDLKPSNVLLEDDLTAHVSDFGLARLLLKFDKESFLNQLSSAGVRGTIG 887

Query:   583 YIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMD 642
             Y AP EYG+G + SI+GDVYS+G+LLLE+ T KRP+D +F GN+ LH++ +  LP+ V +
Sbjct:   888 YAAP-EYGMGGQPSIHGDVYSFGVLLLEMFTGKRPTDELFGGNLTLHSYTKLALPEKVFE 946

Query:   643 IVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE 702
             I D  +L       I      R A      ECL  V+ +G+ C  E P +R+  + V  E
Sbjct:   947 IADKAILH------IGLRVGFRTA------ECLTLVLEVGLRCCEEYPTNRLATSEVAKE 994

Query:   703 LQSIK 707
             L SI+
Sbjct:   995 LISIR 999

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2175703 AT5G39390 [Arabidopsis thaliana (taxid:3702)]

 Score = 655 (235.6 bits), Expect = 3.3e-90, Sum P(4) = 3.3e-90
 Identities = 130/234 (55%), Positives = 169/234 (72%)

Query:   408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
             I  G+F  V+KG+L   + ++AVKVLNLL HGA+KS IAEC + + IRH+NL K++TVCS
Sbjct:   215 IGSGNFSDVFKGLLGLEEKLVAVKVLNLLKHGATKSFIAECESFKGIRHRNLAKLITVCS 274

Query:   468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
              +D +G+DF+ALVYEFM  GSL+ WL P    +      + L F +++NIAIDVA AL+Y
Sbjct:   275 SLDSQGNDFRALVYEFMPKGSLDMWLQP-EDLESANNHSRSLTFAEKVNIAIDVASALEY 333

Query:   528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL----PPAHL-QTSSIGVKGTIG 582
             LH  C    AHCD+KPSNVLLD ++TAHV+DFGLA+LL        L Q SS GV+GTIG
Sbjct:   334 LHVYCHDPVAHCDIKPSNVLLDDDLTAHVSDFGLARLLYNFDEKTFLNQFSSAGVRGTIG 393

Query:   583 YIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVL 636
             Y AP EYG+GS+ SI GDVYS+G+LLLE+ T K+P+D  F G  NLH + ++VL
Sbjct:   394 YAAP-EYGMGSKPSIQGDVYSFGVLLLEMFTGKKPTDNSFGGGYNLHGYTKSVL 446

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)]

 Score = 476 (172.6 bits), Expect = 8.1e-86, Sum P(2) = 8.1e-86
 Identities = 119/317 (37%), Positives = 173/317 (54%)

Query:   408 IDMGSFGSVYKGILDEGKTIIAVKVLN----LLHHGASKSSIAECSALRNIRHKNLVKIL 463
             I  G FG VYKG+L    T +AVKVL+    L   G+ K    EC  L+  RH+NL++I+
Sbjct:   667 IGSGRFGHVYKGVL-RNNTKVAVKVLDPKTALEFSGSFKR---ECQILKRTRHRNLIRII 722

Query:   464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
             T CS        F ALV   M NGSLE  L+P   + K       L+ +Q +NI  DVA 
Sbjct:   723 TTCSK-----PGFNALVLPLMPNGSLERHLYPGEYSSKN------LDLIQLVNICSDVAE 771

Query:   524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTS-----SIG-- 576
              + YLHH       HCDLKPSN+LLD EMTA V DFG+++L+       S     S G  
Sbjct:   772 GIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDDSVSFGST 831

Query:   577 ---VKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFAR 633
                + G++GYIAP EYG+G   S +GDVYS+G+LLLE+++ +RP+D++     +LH F +
Sbjct:   832 DGLLCGSVGYIAP-EYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSSLHEFMK 890

Query:   634 TVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDR 693
             +  PD +  I++  L       +    Q + +       E ++ ++ +G+ C+  +P  R
Sbjct:   891 SHYPDSLEGIIEQAL-------SRWKPQGKPEKCEKLWREVILEMIELGLVCTQYNPSTR 943

Query:   694 MNMTIVVHELQSIKSIL 710
              +M  V HE+  +K  L
Sbjct:   944 PDMLDVAHEMGRLKEYL 960

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

UNIPROTKB|O24435 O24435 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 596 (214.9 bits), Expect = 4.0e-85, Sum P(2) = 4.0e-85
 Identities = 137/400 (34%), Positives = 205/400 (51%)

Query:     6 NRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEF 65
             N+  G IP   G    N+   ++G N  +GV+P  +     L+  ++       E  +++
Sbjct:   257 NQFHGRIPASIG-NASNISIFTIGLNSFSGVVPPEIGRMRNLQRLELPETLSEAEETNDW 315

Query:    66 GKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIG 125
                T    + NC+ +L+ +++    FGG+LP  + N S +L +L    NKI  S+P  IG
Sbjct:   316 KFMT---ALTNCS-NLQEVELGGCKFGGVLPDSVSNLSSSLVSLSIRDNKISGSLPRDIG 371

Query:   126 KFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIE 185
               +NLQ L + +N L+G++  +  +L+NL  L ++ NKL G++P +IGNL +L  + +  
Sbjct:   372 NLVNLQYLSLANNSLTGSLPSSFSKLKNLRRLTVDNNKLIGSLPLTIGNLTQLTNMEVQF 431

Query:   186 NFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEV 245
             N    +IPS+LG    L  INL +NN  G IP ++  + +LS  LD+S N L GS+P E+
Sbjct:   432 NAFGGTIPSTLGNLTKLFQINLGHNNFIGQIPIEIFSIPALSEILDVSHNNLEGSIPKEI 491

Query:   246 GKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPXXXXXXXXXXXXXXX 305
             GKL N+       N L  E  ST+G C  L+ L L  N   G IP               
Sbjct:   492 GKLKNIVEFHADSNKLSGENPSTIGECQLLQHLFLQNNFLNGSIPIALTQLKGLDTLDLS 551

Query:   306 QNNISGEIPKFXXXXXXXXXXXXSYNDLEGVIPTEGVFKNASAISVFGNSKLCGGIPEFQ 365
              NN+SG+IP              S+N   G +PT GVF NAS I + GN+ +CGGIPE  
Sbjct:   552 GNNLSGQIPMSLGDMPLLHSLNLSFNSFHGEVPTNGVFANASEIYIQGNAHICGGIPELH 611

Query:   366 LPICGLEKSKHKRLTIAVKLAAAIISVLVGILLFVSFLFL 405
             LP C L+  K K+  I   L   ++  LV  L   S L++
Sbjct:   612 LPTCSLKSRKKKKHQI---LLLVVVICLVSTLAVFSLLYM 648

GO:0004672 "protein kinase activity" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0016567 "protein ubiquitination" evidence=IDA

GO:0042742 "defense response to bacterium" evidence=IMP

TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)]

 Score = 437 (158.9 bits), Expect = 1.0e-74, Sum P(2) = 1.0e-74
 Identities = 122/372 (32%), Positives = 178/372 (47%)

Query:     6 NRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEF 65
             N + G IP   G  +  L +LSL  NQ+ G+IP S+ +   L+   +++NNLTGE+P EF
Sbjct:   249 NSLTGEIPSQLG-EMSQLQYLSLMANQLQGLIPKSLADLGNLQTLDLSANNLTGEIPEEF 307

Query:    66 GKATKAYCVQNCNQHL-----KHLDINNNNFGGL-LPGCICNFSI--------TLETLIF 111
                ++   +   N HL     K +  NN N   L L G   +  I        +L+ L  
Sbjct:   308 WNMSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGEIPVELSKCQSLKQLDL 367

Query:   112 NSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPS 171
             ++N +  SIP  + + + L  L++ +N L GT+SP+I  L NL  L +  N L G +P  
Sbjct:   368 SNNSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKE 427

Query:   172 IGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLD 231
             I  L+KL  L+L EN     IP  +G C SL  I++  N+  G IPP +  L  L++ L 
Sbjct:   428 ISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNL-LH 486

Query:   232 LSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPX 291
             L +N+LVG LP  +G    L IL ++ N L   I S+ G    LEQL L  N  QG +P 
Sbjct:   487 LRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPD 546

Query:   292 XXXXXXXXXXXXXXQNNISGEIPKFXXXXXXXXXXXXSYNDLEGVIPTE-GVFKNASAIS 350
                            N ++G I               + N  E  IP E G  +N   + 
Sbjct:   547 SLISLRNLTRINLSHNRLNGTIHPLCGSSSYLSFDVTN-NGFEDEIPLELGNSQNLDRLR 605

Query:   351 VFGNSKLCGGIP 362
             + G ++L G IP
Sbjct:   606 L-GKNQLTGKIP 616

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0008544 "epidermis development" evidence=IGI

GO:0009790 "embryo development" evidence=IGI

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: eugene3.00080287 hypothetical protein (1025 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	741
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-74
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	6e-46
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-45
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	3e-34
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	5e-34
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-33
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	8e-32
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-31
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	6e-29
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-28
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-27
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	9e-25
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-23
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-21
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-21
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	6e-21
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-20
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	8e-20
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-19
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-18
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-18
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-18
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-18
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	4e-18
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	4e-18
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	7e-18
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-17
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-17
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	4e-17
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-16
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	4e-16
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-15
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-15
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-15
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-15
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	8e-15
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	8e-15
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	9e-15
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-14
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-14
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-14
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-14
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	4e-14
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	8e-14
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-13
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-13
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-13
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-13
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-13
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-13
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	4e-13
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-13
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	6e-13
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	7e-13
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	8e-13
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	1e-12
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-12
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-12
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-12
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-12
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-12
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-12
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-12
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	5e-12
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	6e-12
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	7e-12
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	8e-12
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-11
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-11
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-11
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-11
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-11
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-11
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-11
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-11
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-11
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	5e-11
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	7e-11
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	8e-11
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	8e-11
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	8e-11
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	9e-11
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-10
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-10
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-10
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-10
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-10
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-10
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-10
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-10
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	5e-10
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	5e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-10
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	6e-10
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	8e-10
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	8e-10
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	9e-10
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-09
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-09
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-09
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-09
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-09
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-09
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-09
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-09
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-09
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-09
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-09
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-09
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-09
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	5e-09
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	6e-09
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	6e-09
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	8e-09
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	8e-09
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	9e-09
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	9e-09
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	9e-09
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-08
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-08
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-08
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-08
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-08
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-08
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-08
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-08
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-08
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	3e-08
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-08
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-08
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	4e-08
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-08
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	5e-08
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	5e-08
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	5e-08
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	5e-08
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	5e-08
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	6e-08
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	7e-08
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	7e-08
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	7e-08
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	9e-08
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	9e-08
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-07
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-07
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-07
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-07
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-07
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-07
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-07
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-07
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-07
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-07
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-07
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	3e-07
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-07
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-07
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-07
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-07
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-07
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-07
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-07
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-07
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-07
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	4e-07
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	4e-07
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	4e-07
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	4e-07
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	4e-07
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	5e-07
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	5e-07
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	6e-07
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	7e-07
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	7e-07
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	7e-07
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	8e-07
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	9e-07
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	9e-07
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	9e-07
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	9e-07
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	9e-07
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-06
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-06
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-06
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-06
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-06
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-06
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-06
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-06
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-06
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-06
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-06
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-06
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-06
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-06
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-06
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-06
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-06
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-06
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-06
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-06
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	4e-06
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	4e-06
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	4e-06
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	5e-06
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	6e-06
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	6e-06
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	6e-06
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	6e-06
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	8e-06
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	9e-06
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-05
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-05
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-05
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-05
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-05
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-05
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-05
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-05
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-05
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-05
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-05
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-05
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-05
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-05
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-05
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-05
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-05
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-05
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-05
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-05
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-05
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-05
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-05
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	4e-05
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	4e-05
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	4e-05
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	5e-05
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	5e-05
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	6e-05
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	7e-05
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	7e-05
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	8e-05
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	9e-05
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-04
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-04
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-04
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-04
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-04
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-04
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-04
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-04
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-04
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-04
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-04
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	2e-04
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-04
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-04
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-04
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-04
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	4e-04
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	4e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	6e-04
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	6e-04
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	6e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	7e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	7e-04
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	7e-04
COG5238	388	COG5238, RNA1, Ran GTPase-activating protein (RanG	8e-04
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	8e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.001
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	0.001
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	0.001
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	0.001
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	0.002
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	0.002
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	0.002
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	0.002
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.003
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	0.003
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	0.003
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	0.003
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	0.003
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	0.004

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  260 bits (665), Expect = 1e-74
 Identities = 224/794 (28%), Positives = 347/794 (43%), Gaps = 147/794 (18%)

Query: 3   VGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVP 62
           +G N + G IP + G  L +L  L L +N +TG IPSS+ N   L+   +  N L+G +P
Sbjct: 219 LGYNNLSGEIPYEIG-GLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIP 277

Query: 63  -SEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIP 121
            S F             Q L  LD+++N+  G +P  +      LE L   SN     IP
Sbjct: 278 PSIFSL-----------QKLISLDLSDNSLSGEIPELVIQLQ-NLEILHLFSNNFTGKIP 325

Query: 122 AGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQL 181
             +     LQ L +W N+ SG I   +G+  NL  L ++TN L+G IP  + +   L +L
Sbjct: 326 VALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKL 385

Query: 182 YLIENFLQVSIPSSLGQCQSLTTINL------------------------SYNNLSGTIP 217
            L  N L+  IP SLG C+SL  + L                        S NNL G I 
Sbjct: 386 ILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRIN 445

Query: 218 PQLMDLTSLSV----------------------GLDLSRNQLVGSLPTEVGKLINLEILF 255
            +  D+ SL +                       LDLSRNQ  G++P ++G L  L  L 
Sbjct: 446 SRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLK 505

Query: 256 ISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPK 315
           +S N L  EI   L SC KL  L L  N   G IP S S +  L  LDLSQN +SGEIPK
Sbjct: 506 LSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPK 565

Query: 316 FLVELQLVQNLNLSYNDLEGVIPTEGVFKNASAISVFGNSKLCGGIPEFQLPICG-LEKS 374
            L  ++ +  +N+S+N L G +P+ G F   +A +V GN  LCGG     LP C  + K+
Sbjct: 566 NLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKT 625

Query: 375 KHKRLTIAVKLAAAIISVLVGI------------------------LLFVSFLFLCWIDM 410
                 I   L A ++  LV                          L F        I +
Sbjct: 626 PSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITI 685

Query: 411 ---------------GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIR 455
                          G  G+ YKG   +      VK +N + +    S IA+   +  ++
Sbjct: 686 NDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDV-NSIPSSEIAD---MGKLQ 741

Query: 456 HKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRI 515
           H N+VK++ +C     + +    L++E++   +L E L             + L++ +R 
Sbjct: 742 HPNIVKLIGLC-----RSEKGAYLIHEYIEGKNLSEVL-------------RNLSWERRR 783

Query: 516 NIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSI 575
            IAI +A AL++LH  C P     +L P  +++D +   H+      +L  P  L T + 
Sbjct: 784 KIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL------RLSLPGLLCTDTK 837

Query: 576 GVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV 635
               +  Y+AP E     +++   D+Y +G++L+EL+T K P+D  F  + ++  +AR  
Sbjct: 838 CFISS-AYVAP-ETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYC 895

Query: 636 LPDHVMDI-VDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRM 694
             D  +D+ +D ++  D     ++ NQ +           ++ V+ + + C+   P  R 
Sbjct: 896 YSDCHLDMWIDPSIRGD-----VSVNQNE-----------IVEVMNLALHCTATDPTARP 939

Query: 695 NMTIVVHELQSIKS 708
               V+  L+S   
Sbjct: 940 CANDVLKTLESASR 953

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  176 bits (448), Expect = 6e-46
 Identities = 121/339 (35%), Positives = 179/339 (52%), Gaps = 17/339 (5%)

Query: 26  LSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLD 85
           + L    I+G I S++F    ++   +++N L+G +P +    + +         L++L+
Sbjct: 74  IDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSS---------LRYLN 124

Query: 86  INNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTIS 145
           ++NNNF G +P         LETL  ++N +   IP  IG F +L+ L +  N L G I 
Sbjct: 125 LSNNNFTGSIPR---GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIP 181

Query: 146 PAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTI 205
            ++  L +L  L + +N+L G IP  +G +K L  +YL  N L   IP  +G   SL  +
Sbjct: 182 NSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHL 241

Query: 206 NLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEI 265
           +L YNNL+G IP  L +L +L   L L +N+L G +P  +  L  L  L +S N L  EI
Sbjct: 242 DLVYNNLTGPIPSSLGNLKNLQY-LFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEI 300

Query: 266 LSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQN 325
              +     LE L L  N F G IP++L+SL  L+VL L  N  SGEIPK L +   +  
Sbjct: 301 PELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTV 360

Query: 326 LNLSYNDLEGVIPTEGVFK--NASAISVFGNSKLCGGIP 362
           L+LS N+L G IP EG+    N   + +F NS L G IP
Sbjct: 361 LDLSTNNLTGEIP-EGLCSSGNLFKLILFSNS-LEGEIP 397

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  173 bits (441), Expect = 4e-45
 Identities = 121/322 (37%), Positives = 169/322 (52%), Gaps = 15/322 (4%)

Query: 18  FTLPNLLFLSLGFNQITGVIPSSMFN-ASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQN 76
           F LP +  ++L  NQ++G IP  +F  +S L    +++NN TG +P              
Sbjct: 90  FRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPN-------- 141

Query: 77  CNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMW 136
               L+ LD++NN   G +P  I +FS +L+ L    N +   IP  +    +L+ L + 
Sbjct: 142 ----LETLDLSNNMLSGEIPNDIGSFS-SLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLA 196

Query: 137 DNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSL 196
            NQL G I   +G++++L  + +  N LSG IP  IG L  L  L L+ N L   IPSSL
Sbjct: 197 SNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSL 256

Query: 197 GQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFI 256
           G  ++L  + L  N LSG IPP +  L  L + LDLS N L G +P  V +L NLEIL +
Sbjct: 257 GNLKNLQYLFLYQNKLSGPIPPSIFSLQKL-ISLDLSDNSLSGEIPELVIQLQNLEILHL 315

Query: 257 SRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKF 316
             N    +I   L S  +L+ L+L  N F G IP +L     L VLDLS NN++GEIP+ 
Sbjct: 316 FSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEG 375

Query: 317 LVELQLVQNLNLSYNDLEGVIP 338
           L     +  L L  N LEG IP
Sbjct: 376 LCSSGNLFKLILFSNSLEGEIP 397

Length = 968

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  129 bits (327), Expect = 3e-34
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 23/207 (11%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA-ECSALRNIRHKNLVKILTVC 466
           +  G FG+VY     +    +A+K++      +    +  E   L+ + H N+VK+  V 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 467 SGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALK 526
                + ++   LV E+   GSL++ L          E    L+  + + I + +   L+
Sbjct: 61  -----EDENHLYLVMEYCEGGSLKDLLK---------ENEGKLSEDEILRILLQILEGLE 106

Query: 527 YLH-HDCQPTTAHCDLKPSNVLLDH-EMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYI 584
           YLH +       H DLKP N+LLD       +ADFGL+KLL        +I   GT  Y+
Sbjct: 107 YLHSNGI----IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV--GTPAYM 160

Query: 585 APAEYGLGSEVSINGDVYSYGILLLEL 611
           AP         S   D++S G++L EL
Sbjct: 161 APEVLLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  130 bits (330), Expect = 5e-34
 Identities = 66/244 (27%), Positives = 106/244 (43%), Gaps = 29/244 (11%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGV 469
           GSFG VY     +   ++A+KV+         +  + E   L+ ++H N+V++  V    
Sbjct: 10  GSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV---- 65

Query: 470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH 529
            ++ +D   LV E+   G L + L               L+  +       +  AL+YLH
Sbjct: 66  -FEDEDKLYLVMEYCEGGDLFDLLK----------KRGRLSEDEARFYLRQILSALEYLH 114

Query: 530 -HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAE 588
                    H DLKP N+LLD +    +ADFGLA+ L P    T+ +   GT  Y+AP E
Sbjct: 115 SKGI----VHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV---GTPEYMAP-E 166

Query: 589 YGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTL 648
             LG       D++S G++L EL+T K P    F G+  L    + +             
Sbjct: 167 VLLGKGYGKAVDIWSLGVILYELLTGKPP----FPGDDQLLELFKKIGKPKPPFPPPEWD 222

Query: 649 LADD 652
           ++ +
Sbjct: 223 ISPE 226

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  128 bits (325), Expect = 2e-33
 Identities = 66/209 (31%), Positives = 95/209 (45%), Gaps = 22/209 (10%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSG 468
           GSFG+VYK        I+AVK+L          +++  E   LR + H N+V+++     
Sbjct: 10  GSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI----D 65

Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL 528
                D    LV E+   G L ++L               L+  +   IA+ +   L+YL
Sbjct: 66  AFEDKDHL-YLVMEYCEGGDLFDYL----------SRGGPLSEDEAKKIALQILRGLEYL 114

Query: 529 HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAE 588
           H +      H DLKP N+LLD      +ADFGLAK L      +S     GT  Y+AP  
Sbjct: 115 HSN---GIIHRDLKPENILLDENGVVKIADFGLAKKL--LKSSSSLTTFVGTPWYMAPEV 169

Query: 589 YGLGSEVSINGDVYSYGILLLELMTRKRP 617
              G+      DV+S G++L EL+T K P
Sbjct: 170 LLGGNGYGPKVDVWSLGVILYELLTGKPP 198

Length = 260

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  124 bits (313), Expect = 8e-32
 Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 35/215 (16%)

Query: 411 GSFGSVYKGIL----DEGKTIIAVKVLNLLHHGASKSSIA----ECSALRNIRHKNLVKI 462
           G+FG VYKG L    +  +T +AVK L     GAS+        E S ++ + H N+V++
Sbjct: 10  GAFGEVYKGTLKGDGEGTETKVAVKTLK---EGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVA 522
           L VC+    +G+    +V E+M  G L ++L          +  + L     + +A+ +A
Sbjct: 67  LGVCT----QGEPLY-IVTEYMPGGDLLDFLR---------KHGEKLTLKDLLQMALQIA 112

Query: 523 CALKYLH-HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTI 581
             ++YL   +      H DL   N L+   +   ++DFGL++ +          G K  I
Sbjct: 113 KGMEYLESKNF----VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPI 168

Query: 582 GYIAP--AEYGLGSEVSINGDVYSYGILLLELMTR 614
            ++AP   + G   + +   DV+S+G+LL E+ T 
Sbjct: 169 KWMAPESLKDG---KFTSKSDVWSFGVLLWEIFTL 200

Length = 258

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  131 bits (331), Expect = 2e-31
 Identities = 105/309 (33%), Positives = 152/309 (49%), Gaps = 25/309 (8%)

Query: 78  NQHLKHL-DINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMW 136
           N  LK+L + N++    L  G  CN S  + ++  +   I   I + I +   +QT+++ 
Sbjct: 42  NDPLKYLSNWNSSADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLS 101

Query: 137 DNQLSGTISPAI-----------------------GELQNLVTLAINTNKLSGNIPPSIG 173
           +NQLSG I   I                       G + NL TL ++ N LSG IP  IG
Sbjct: 102 NNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIG 161

Query: 174 NLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLS 233
           +   L  L L  N L   IP+SL    SL  + L+ N L G IP +L  + SL   + L 
Sbjct: 162 SFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKW-IYLG 220

Query: 234 RNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSL 293
            N L G +P E+G L +L  L +  N L   I S+LG+   L+ L L  N   GPIP S+
Sbjct: 221 YNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSI 280

Query: 294 SSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKNASAISVFG 353
            SL+ L  LDLS N++SGEIP+ +++LQ ++ L+L  N+  G IP          +    
Sbjct: 281 FSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLW 340

Query: 354 NSKLCGGIP 362
           ++K  G IP
Sbjct: 341 SNKFSGEIP 349

Length = 968

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  115 bits (291), Expect = 6e-29
 Identities = 63/220 (28%), Positives = 100/220 (45%), Gaps = 39/220 (17%)

Query: 408 IDMGSFGSVYKGIL----DEGKTIIAVKVLNLLHHGASKSSIA----ECSALRNIRHKNL 459
           +  G+FG VYKG L    D  +  +AVK L      AS+  I     E   +R + H N+
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLK---EDASEQQIEEFLREARIMRKLDHPNI 63

Query: 460 VKILTVCSGVD--YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINI 517
           VK+L VC+  +          +V E+M  G L ++L            PK L+    ++ 
Sbjct: 64  VKLLGVCTEEEPLM-------IVMEYMPGGDLLDYLR--------KNRPKELSLSDLLSF 108

Query: 518 AIDVACALKYLH-HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIG 576
           A+ +A  ++YL   +      H DL   N L+   +   ++DFGL++ L          G
Sbjct: 109 ALQIARGMEYLESKNF----IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGG 164

Query: 577 VKGTIGYIAP--AEYGLGSEVSINGDVYSYGILLLELMTR 614
            K  I ++AP   + G  +  S   DV+S+G+LL E+ T 
Sbjct: 165 -KLPIRWMAPESLKEGKFTSKS---DVWSFGVLLWEIFTL 200

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  114 bits (287), Expect = 2e-28
 Identities = 61/217 (28%), Positives = 97/217 (44%), Gaps = 26/217 (11%)

Query: 408 IDMGSFGSVYKGIL---DEGKTIIAVKVLNLLHHGASKSSI----AECSALRNIRHKNLV 460
           +  G+FG VYKG L   D   T +AVK L      AS+        E   ++ + H N+V
Sbjct: 3   LGEGAFGEVYKGKLKGKDGKTTEVAVKTL---KEDASEEERKDFLKEARVMKKLGHPNVV 59

Query: 461 KILTVCSGVD--YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIA 518
           ++L VC+  +  Y       LV E+M  G L ++L   S           L+    ++ A
Sbjct: 60  RLLGVCTEEEPLY-------LVLEYMEGGDLLDYLR-KSRPVFPSPEKSTLSLKDLLSFA 111

Query: 519 IDVACALKYLH-HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I +A  ++YL          H DL   N L+  ++   ++DFGL++ +          G 
Sbjct: 112 IQIAKGMEYLASKKF----VHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGG 167

Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTR 614
           K  I ++AP E       +   DV+S+G+LL E+ T 
Sbjct: 168 KLPIRWMAP-ESLKDGIFTSKSDVWSFGVLLWEIFTL 203

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  110 bits (278), Expect = 3e-27
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 36/218 (16%)

Query: 408 IDMGSFGSVYKGIL----DEGKTIIAVKVLNLLHHGASKSSIA----ECSALRNIRHKNL 459
           +  G+FG VYKG L     + K  +AVK L      AS+  I     E   +R + H N+
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLK---EDASEQQIEEFLREARIMRKLDHPNV 63

Query: 460 VKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI 519
           VK+L VC+    + +    +V E+M  G L  +L               L+    ++ A+
Sbjct: 64  VKLLGVCT----EEEPLY-IVMEYMEGGDLLSYLRKNRPK---------LSLSDLLSFAL 109

Query: 520 DVACALKYLH-HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK 578
            +A  ++YL   +      H DL   N L+   +   ++DFGL++ L          G K
Sbjct: 110 QIARGMEYLESKNF----IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGG-K 164

Query: 579 GTIGYIAP--AEYGLGSEVSINGDVYSYGILLLELMTR 614
             I ++AP   + G  +  S   DV+S+G+LL E+ T 
Sbjct: 165 LPIRWMAPESLKEGKFTSKS---DVWSFGVLLWEIFTL 199

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  103 bits (260), Expect = 9e-25
 Identities = 56/221 (25%), Positives = 93/221 (42%), Gaps = 43/221 (19%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSS--IAECSALRNIRHKNLVKILTVCSG 468
           GSFGSVY  +  +   ++AVK + L      +      E   L +++H N+V+       
Sbjct: 11  GSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVR------- 63

Query: 469 VDYKGDDFKA------LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVA 522
             Y G +         +  E++  GSL   L       + V        +++      + 
Sbjct: 64  --YYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV--------IRKY--TRQIL 111

Query: 523 CALKYLH-HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTI 581
             L YLH +       H D+K +N+L+D +    +ADFG AK L        +  V+GT 
Sbjct: 112 EGLAYLHSNG----IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTP 167

Query: 582 GYIAP-----AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
            ++AP      EYG  +      D++S G  ++E+ T K P
Sbjct: 168 YWMAPEVIRGEEYGRAA------DIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 99.7 bits (249), Expect = 2e-23
 Identities = 67/212 (31%), Positives = 101/212 (47%), Gaps = 32/212 (15%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGA--SKSSIAECSALRNIRHKNLVKILTVCSG 468
           G FG V+ G  + G T +AVK L     G    ++ + E   ++ +RH  LV++  VCS 
Sbjct: 17  GQFGEVWMGTWN-GTTKVAVKTLK---PGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72

Query: 469 VD--YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALK 526
            +  Y       +V E+M  GSL ++L    G          L   Q +++A  +A  + 
Sbjct: 73  EEPIY-------IVTEYMSKGSLLDFLKSGEGKK--------LRLPQLVDMAAQIAEGMA 117

Query: 527 YLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP 586
           YL         H DL   N+L+   +   +ADFGLA+L+      T+  G K  I + AP
Sbjct: 118 YLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY-TAREGAKFPIKWTAP 173

Query: 587 --AEYGLGSEVSINGDVYSYGILLLELMTRKR 616
             A YG     +I  DV+S+GILL E++T  R
Sbjct: 174 EAANYG---RFTIKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 94.4 bits (235), Expect = 2e-21
 Identities = 66/209 (31%), Positives = 101/209 (48%), Gaps = 30/209 (14%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVL---NLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           G FG V++G L + +  +A+K+L   +LL     +    E  AL+ +RHK+L+ +  VCS
Sbjct: 17  GYFGEVWEG-LWKNRVRVAIKILKSDDLLKQQDFQK---EVQALKRLRHKHLISLFAVCS 72

Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
                G+    ++ E M  GSL  +L    G    V           I++A  VA  + Y
Sbjct: 73  V----GEPV-YIITELMEKGSLLAFLRSPEGQVLPVA--------SLIDMACQVAEGMAY 119

Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP-PAHLQTSS-IGVKGTIGYIA 585
           L    +  + H DL   N+L+  ++   VADFGLA+L+    +L +   I  K T    A
Sbjct: 120 LE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWT----A 172

Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMTR 614
           P     G+  S   DV+S+GILL E+ T 
Sbjct: 173 PEAASHGT-FSTKSDVWSFGILLYEMFTY 200

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 94.0 bits (234), Expect = 2e-21
 Identities = 68/208 (32%), Positives = 101/208 (48%), Gaps = 24/208 (11%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHG--ASKSSIAECSALRNIRHKNLVKILTVCSG 468
           G FG V++G+ +   T +AVK L     G    K  +AE   ++ +RH  L+++  VC+ 
Sbjct: 17  GQFGEVWEGLWN-NTTPVAVKTLK---PGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72

Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL 528
                ++   +V E M  GSL E+L           A + L   Q I++A  VA  + YL
Sbjct: 73  -----EEPIYIVTELMKYGSLLEYLQG--------GAGRALKLPQLIDMAAQVASGMAYL 119

Query: 529 HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAE 588
                    H DL   NVL+       VADFGLA+++    +  +  G K  I + AP E
Sbjct: 120 E---AQNYIHRDLAARNVLVGENNICKVADFGLARVIK-EDIYEAREGAKFPIKWTAP-E 174

Query: 589 YGLGSEVSINGDVYSYGILLLELMTRKR 616
             L +  SI  DV+S+GILL E++T  R
Sbjct: 175 AALYNRFSIKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 92.8 bits (231), Expect = 6e-21
 Identities = 64/204 (31%), Positives = 96/204 (47%), Gaps = 25/204 (12%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           I  G FG V  G    G+ + AVK L      A+++ +AE S +  +RH NLV++L V  
Sbjct: 14  IGKGEFGDVMLGDY-RGQKV-AVKCLKD-DSTAAQAFLAEASVMTTLRHPNLVQLLGVVL 70

Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
                  +   +V E+M  GSL ++L     A         +   Q++  A+DV   ++Y
Sbjct: 71  Q-----GNPLYIVTEYMAKGSLVDYLRSRGRA--------VITLAQQLGFALDVCEGMEY 117

Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPA 587
           L    +    H DL   NVL+  ++ A V+DFGLAK       Q    G K  + + AP 
Sbjct: 118 LE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK----EASQGQDSG-KLPVKWTAPE 169

Query: 588 EYGLGSEVSINGDVYSYGILLLEL 611
                 + S   DV+S+GILL E+
Sbjct: 170 ALREK-KFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 91.5 bits (228), Expect = 2e-20
 Identities = 63/210 (30%), Positives = 95/210 (45%), Gaps = 25/210 (11%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA-ECSALRNIRHKNLVKILTVCSGV 469
           GS G VYK        I A+K +++      +  +  E   LR+     +VK    C G 
Sbjct: 12  GSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK----CYGA 67

Query: 470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEA--PKCLNFLQRINIAIDVACALKY 527
            YK  +  ++V E+M  GSL + L       K V       L +     IA  +   L Y
Sbjct: 68  FYKEGEI-SIVLEYMDGGSLADLL-------KKVGKIPEPVLAY-----IARQILKGLDY 114

Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPA 587
           LH        H D+KPSN+L++ +    +ADFG++K+L     Q ++    GT+ Y++P 
Sbjct: 115 LHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF--VGTVTYMSP- 169

Query: 588 EYGLGSEVSINGDVYSYGILLLELMTRKRP 617
           E   G   S   D++S G+ LLE    K P
Sbjct: 170 ERIQGESYSYAADIWSLGLTLLECALGKFP 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 89.2 bits (222), Expect = 8e-20
 Identities = 61/214 (28%), Positives = 92/214 (42%), Gaps = 35/214 (16%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G FG VYK         +A+KV+ L      +  I E   L+  +H N+VK      G  
Sbjct: 11  GGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYY----GSY 66

Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
            K D+   +V EF   GSL++ L             + L   Q   +  ++   L+YLH 
Sbjct: 67  LKKDELW-IVMEFCSGGSLKDLLK---------STNQTLTESQIAYVCKELLKGLEYLHS 116

Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
           +      H D+K +N+LL  +    + DFGL+  L     + + +   GT  ++AP    
Sbjct: 117 NGI---IHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---GTPYWMAP---- 166

Query: 591 LGSEVSING-------DVYSYGILLLELMTRKRP 617
              EV ING       D++S GI  +EL   K P
Sbjct: 167 ---EV-INGKPYDYKADIWSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 88.6 bits (219), Expect = 2e-19
 Identities = 64/206 (31%), Positives = 104/206 (50%), Gaps = 21/206 (10%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G FG V+ G  + G T +A+K L      + ++ + E   ++ +RH+ LV++  V S   
Sbjct: 17  GCFGEVWMGTWN-GTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS--- 71

Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
              ++   +V E+M  GSL ++L    G        K L   Q +++A  +A  + Y+  
Sbjct: 72  ---EEPIYIVTEYMSKGSLLDFLKGEMG--------KYLRLPQLVDMAAQIASGMAYVE- 119

Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
             +    H DL+ +N+L+   +   VADFGLA+L+      T+  G K  I + AP E  
Sbjct: 120 --RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAP-EAA 175

Query: 591 LGSEVSINGDVYSYGILLLELMTRKR 616
           L    +I  DV+S+GILL EL T+ R
Sbjct: 176 LYGRFTIKSDVWSFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 88.6 bits (218), Expect = 1e-18
 Identities = 69/288 (23%), Positives = 114/288 (39%), Gaps = 35/288 (12%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNL---LHHGASKSSIAECSALRNIRH-KNLVKILTVC 466
           GSFG VY       + ++A+KVL           +  + E   L ++ H  N+VK+    
Sbjct: 11  GSFGEVYLARD---RKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDF- 66

Query: 467 SGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALK 526
               ++ +    LV E++  GSLE+ L  +            L+  + + I   +  AL+
Sbjct: 67  ----FQDEGSLYLVMEYVDGGSLEDLLKKIG-------RKGPLSESEALFILAQILSALE 115

Query: 527 YLHHDCQPTTAHCDLKPSNVLLDHE-MTAHVADFGLAKLLP----PAHLQTSSIGVKGTI 581
           YLH        H D+KP N+LLD +     + DFGLAKLLP     + +        GT 
Sbjct: 116 YLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172

Query: 582 GYIAPAEYGLGSEVSING--DVYSYGILLLELMTRKRP------SDIMFEGNMNLHNFAR 633
           GY+AP      S    +   D++S GI L EL+T   P      S    +    +     
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT 232

Query: 634 TVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRI 681
             L   +       +     DL      +  + R+++  +    ++  
Sbjct: 233 PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280

Length = 384

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 85.7 bits (212), Expect = 1e-18
 Identities = 58/204 (28%), Positives = 100/204 (49%), Gaps = 21/204 (10%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G +G VY+G+  +    +AVK L        +  + E + ++ I+H NLV++L VC+   
Sbjct: 17  GQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--- 72

Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
            +   F  ++ EFM  G+L ++L      ++       L     + +A  ++ A++YL  
Sbjct: 73  -REPPF-YIITEFMTYGNLLDYLRE---CNRQEVNAVVL-----LYMATQISSAMEYLE- 121

Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
             +    H DL   N L+       VADFGL++L+      T+  G K  I + AP    
Sbjct: 122 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPE--S 176

Query: 591 LG-SEVSINGDVYSYGILLLELMT 613
           L  ++ SI  DV+++G+LL E+ T
Sbjct: 177 LAYNKFSIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 85.1 bits (210), Expect = 2e-18
 Identities = 64/206 (31%), Positives = 103/206 (50%), Gaps = 21/206 (10%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G FG V+ G  + G T +AVK L      + +S + E   ++ +RH  LV++  V S   
Sbjct: 17  GQFGEVWMGTWN-GNTKVAVKTLKP-GTMSPESFLEEAQIMKKLRHDKLVQLYAVVS--- 71

Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
              ++   +V E+M  GSL ++L    G        + L     +++A  VA  + Y+  
Sbjct: 72  ---EEPIYIVTEYMSKGSLLDFLKDGEG--------RALKLPNLVDMAAQVAAGMAYIE- 119

Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
             +    H DL+ +N+L+   +   +ADFGLA+L+      T+  G K  I + AP E  
Sbjct: 120 --RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-TARQGAKFPIKWTAP-EAA 175

Query: 591 LGSEVSINGDVYSYGILLLELMTRKR 616
           L    +I  DV+S+GILL EL+T+ R
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 84.9 bits (210), Expect = 3e-18
 Identities = 69/233 (29%), Positives = 113/233 (48%), Gaps = 28/233 (12%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSS--IAECSALRNIRHKNLVKILTVCSG 468
           G FG V+ G  + G T +A+K L     G+      +AE + ++ ++H  LV++  V + 
Sbjct: 17  GQFGEVWMGYYN-GHTKVAIKSLK---QGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT- 71

Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL 528
                 +   ++ E+M NGSL ++L       KT E  K L   + I++A  +A  + ++
Sbjct: 72  -----QEPIYIITEYMENGSLVDFL-------KTPEGIK-LTINKLIDMAAQIAEGMAFI 118

Query: 529 HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAE 588
               +    H DL+ +N+L+   +   +ADFGLA+L+      T+  G K  I + AP  
Sbjct: 119 E---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEA 174

Query: 589 YGLGSEVSINGDVYSYGILLLELMTRKR---PSDIMFEGNMNLHNFARTVLPD 638
              G+  +I  DV+S+GILL E++T  R   P     E   NL    R   PD
Sbjct: 175 INYGT-FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPD 226

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 84.3 bits (208), Expect = 4e-18
 Identities = 68/209 (32%), Positives = 102/209 (48%), Gaps = 25/209 (11%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           I  G FG V  G  D     +AVK +   +   +++ +AE S +  +RH NLV++L V  
Sbjct: 14  IGKGEFGDVMLG--DYRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVI- 68

Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
            V+ KG  +  +V E+M  GSL ++L       ++V    CL     +  ++DV  A++Y
Sbjct: 69  -VEEKGGLY--IVTEYMAKGSLVDYLR---SRGRSVLGGDCL-----LKFSLDVCEAMEY 117

Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPA 587
           L  +      H DL   NVL+  +  A V+DFGL K        T  + VK T    AP 
Sbjct: 118 LEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DTGKLPVKWT----AP- 168

Query: 588 EYGLGSEVSINGDVYSYGILLLELMTRKR 616
           E     + S   DV+S+GILL E+ +  R
Sbjct: 169 EALREKKFSTKSDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 84.3 bits (209), Expect = 4e-18
 Identities = 69/224 (30%), Positives = 101/224 (45%), Gaps = 40/224 (17%)

Query: 408 IDMGSFGSVYKGI-LDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNLVKILT 464
           I  G+FG VY  + LD G  ++AVK + +        K    E   L  ++H NLVK   
Sbjct: 8   IGGGTFGKVYTAVNLDTG-ELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK--- 63

Query: 465 VCSGVDYKGDDFKALVYEFMH---NGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDV 521
              GV+   +     VY FM     G+LEE L      D+ V        ++   + +  
Sbjct: 64  -YYGVEVHREK----VYIFMEYCSGGTLEELLEHGRILDEHV--------IRVYTLQLLE 110

Query: 522 ACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIG----- 576
              L YLH        H D+KP+N+ LDH     + DFG A  L      T+++G     
Sbjct: 111 G--LAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN---NTTTMGEEVQS 162

Query: 577 VKGTIGYIAPAEYGLGSEVSING---DVYSYGILLLELMTRKRP 617
           + GT  Y+AP E   G +   +G   D++S G ++LE+ T KRP
Sbjct: 163 LAGTPAYMAP-EVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 83.8 bits (208), Expect = 7e-18
 Identities = 56/211 (26%), Positives = 91/211 (43%), Gaps = 27/211 (12%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSA----LRNIRHKNLVKILTVC 466
           G+FG VYKG+  E    +A+K ++L      + ++         L+N++H N+VK +   
Sbjct: 11  GAFGVVYKGLNLETGDFVAIKQISL--EKIKEEALKSIMQEIDLLKNLKHPNIVKYIGS- 67

Query: 467 SGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALK 526
                +  D   ++ E+  NGSL + +    G                      V   L 
Sbjct: 68  ----IETSDSLYIILEYAENGSLRQIIKK-FG---------PFPESLVAVYVYQVLQGLA 113

Query: 527 YLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP 586
           YLH   +    H D+K +N+L   +    +ADFG+A  L       +S  V GT  ++AP
Sbjct: 114 YLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYWMAP 168

Query: 587 AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
            E    S  S   D++S G  ++EL+T   P
Sbjct: 169 -EVIEMSGASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 82.0 bits (202), Expect = 2e-17
 Identities = 64/206 (31%), Positives = 102/206 (49%), Gaps = 21/206 (10%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G FG V+ G  + G T +A+K L        ++ + E   ++ +RH  LV +  V S   
Sbjct: 17  GCFGEVWMGTWN-GTTKVAIKTLKP-GTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS--- 71

Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
              ++   +V EFM  GSL ++L    G        K L   Q +++A  +A  + Y+  
Sbjct: 72  ---EEPIYIVTEFMGKGSLLDFLKEGDG--------KYLKLPQLVDMAAQIADGMAYIE- 119

Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
             +    H DL+ +N+L+   +   +ADFGLA+L+      T+  G K  I + AP E  
Sbjct: 120 --RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-TARQGAKFPIKWTAP-EAA 175

Query: 591 LGSEVSINGDVYSYGILLLELMTRKR 616
           L    +I  DV+S+GILL EL+T+ R
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 81.4 bits (202), Expect = 3e-17
 Identities = 60/220 (27%), Positives = 93/220 (42%), Gaps = 44/220 (20%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLN---LLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           GSFG V      +   + A+KVL    ++     + ++ E + L  I H  +VK     +
Sbjct: 4   GSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK--LHYA 61

Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRIN---------IA 518
              ++ ++   LV E+   G L                    + L +            A
Sbjct: 62  ---FQTEEKLYLVLEYAPGGEL-------------------FSHLSKEGRFSEERARFYA 99

Query: 519 IDVACALKYLH-HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
            ++  AL+YLH         + DLKP N+LLD +    + DFGLAK L     +T++   
Sbjct: 100 AEIVLALEYLHSLG----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTF-- 153

Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
            GT  Y+AP E  LG       D +S G+LL E++T K P
Sbjct: 154 CGTPEYLAP-EVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 82.1 bits (203), Expect = 4e-17
 Identities = 62/214 (28%), Positives = 90/214 (42%), Gaps = 22/214 (10%)

Query: 411 GSFGSVYKGILD--EGKT--IIAVKVLNLLHHGASKSSIA-ECSALRNIRHKNLVKILTV 465
           G FG V     D     T   +AVK LN       +S    E   LR + H+N+VK   V
Sbjct: 15  GHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGV 74

Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
           C      G     L+ E++ +GSL ++L         +   + L F      +  +   +
Sbjct: 75  CEK---PGGRSLRLIMEYLPSGSLRDYLQ---RHRDQINLKRLLLF------SSQICKGM 122

Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAH-LQTSSIGVKGTIGYI 584
            YL         H DL   N+L++ E    ++DFGLAK+LP            +  I + 
Sbjct: 123 DYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY 179

Query: 585 APAEYGLGSEVSINGDVYSYGILLLELMTRKRPS 618
           AP E    S+ S   DV+S+G+ L EL T   PS
Sbjct: 180 AP-ECLRTSKFSSASDVWSFGVTLYELFTYGDPS 212

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 79.7 bits (197), Expect = 3e-16
 Identities = 58/210 (27%), Positives = 94/210 (44%), Gaps = 28/210 (13%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKNLVKILTVCSG 468
           G++G VYK        I+A+K + L     G  K+++ E   L+ + H N++K+L V   
Sbjct: 10  GTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVF-- 67

Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL 528
                 D   LV+EFM      +    +    + +      ++L ++         L + 
Sbjct: 68  --RHKGDL-YLVFEFMD----TDLYKLIKDRQRGLPESLIKSYLYQL------LQGLAFC 114

Query: 529 H-HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL-PPAHLQTSSIGVKGTIGYIAP 586
           H H       H DLKP N+L++ E    +ADFGLA+    P    T  +    T  Y AP
Sbjct: 115 HSHGI----LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV---VTRWYRAP 167

Query: 587 AEYGLGSEV-SINGDVYSYGILLLELMTRK 615
            E  LG +  S   D++S G +  EL++R+
Sbjct: 168 -ELLLGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 79.2 bits (196), Expect = 4e-16
 Identities = 65/285 (22%), Positives = 111/285 (38%), Gaps = 55/285 (19%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLN---LLHHGASKSSIAECSAL-RNIRHKNLVKILTVC 466
           GSF +V      E     A+K+L+   L+     K    E   L R   H  ++K+    
Sbjct: 12  GSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYT- 70

Query: 467 SGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALK 526
               ++ ++    V E+  NG L +++               L+       A ++  AL+
Sbjct: 71  ----FQDEENLYFVLEYAPNGELLQYIRKYG----------SLDEKCTRFYAAEILLALE 116

Query: 527 YLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK-------- 578
           YLH        H DLKP N+LLD +M   + DFG AK+L P     S+ G          
Sbjct: 117 YLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173

Query: 579 ----------GTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNL 628
                     GT  Y++P E         + D+++ G ++ +++T K P    F G+   
Sbjct: 174 KNRRRFASFVGTAEYVSP-ELLNEKPAGKSSDLWALGCIIYQMLTGKPP----FRGSNEY 228

Query: 629 HNFARTV---------LPDHVMDIVDSTLLADDED-LTITSNQRQ 663
             F + +          P    D+++  L+ D +D L +     +
Sbjct: 229 LTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDE 273

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 77.8 bits (192), Expect = 1e-15
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 25/216 (11%)

Query: 410 MGSFGSVYKGI-LDEGKTI---IAVKVL-NLLHHGASKSSIAECSALRNIRHKNLVKILT 464
            G+FG+VYKG+ + EG+ +   +A+KVL       A+K  + E   + ++ H ++V++L 
Sbjct: 17  SGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLG 76

Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
           +C            L+ + M  G L +++               +     +N  + +A  
Sbjct: 77  ICLSSQV------QLITQLMPLGCLLDYVRNHKDN---------IGSQYLLNWCVQIAKG 121

Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYI 584
           + YL    +    H DL   NVL+       + DFGLAKLL     +  + G K  I ++
Sbjct: 122 MSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM 178

Query: 585 APAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSD 619
           A  E  L    +   DV+SYG+ + ELMT   +P +
Sbjct: 179 AL-ESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 75.9 bits (187), Expect = 3e-15
 Identities = 68/243 (27%), Positives = 106/243 (43%), Gaps = 34/243 (13%)

Query: 400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSS--IAECSALRNIRHK 457
               FL  +  G FG V+ G    GK  +A+K   ++  GA      I E   +  + H 
Sbjct: 4   SELTFLKELGSGQFGVVHLGKW-RGKIDVAIK---MIREGAMSEDDFIEEAKVMMKLSHP 59

Query: 458 NLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINI 517
           NLV++  VC+    +   F  +V E+M NG L  +L          E    L     +++
Sbjct: 60  NLVQLYGVCT---KQRPIF--IVTEYMANGCLLNYLR---------ERKGKLGTEWLLDM 105

Query: 518 AIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
             DV  A++YL  +      H DL   N L+  +    V+DFGLA+ +      TSS G 
Sbjct: 106 CSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-TSSQGT 161

Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLP 637
           K  + + AP E    S  S   DV+S+G+L+ E+ +         EG M    F+ + + 
Sbjct: 162 KFPVKW-APPEVFDYSRFSSKSDVWSFGVLMWEVFS---------EGKMPYERFSNSEVV 211

Query: 638 DHV 640
           + V
Sbjct: 212 ESV 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 75.8 bits (187), Expect = 4e-15
 Identities = 59/226 (26%), Positives = 96/226 (42%), Gaps = 33/226 (14%)

Query: 402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLN---LLHHGASKSSIAECSALRNIRHKN 458
           F  L  I  G+FG V      + K + A+K +N    +  G+ ++ + E   L+ + H  
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61

Query: 459 LVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWL-HPVSGADKTVEAPKCLNFLQRINI 517
           LV    +     ++ ++   LV + +  G L   L   V  +++ V          +  I
Sbjct: 62  LVN---LWY--SFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQV----------KFWI 106

Query: 518 AIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
             ++  AL+YLH        H D+KP N+LLD +   H+ DF +A  + P    T +   
Sbjct: 107 C-EIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP---DTLTTST 159

Query: 578 KGTIGYIAP---AEYGLGSEVSINGDVYSYGILLLELMTRKRPSDI 620
            GT GY+AP      G    V    D +S G+   E +  KRP   
Sbjct: 160 SGTPGYMAPEVLCRQGYSVAV----DWWSLGVTAYECLRGKRPYRG 201

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 75.8 bits (187), Expect = 4e-15
 Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 28/213 (13%)

Query: 408 IDMGSFGSVYKGILDE-GKTIIAVKVLNLLHHGASKSS----IAECSALRNIRHKNLVKI 462
           I  G FG V +G L   GK  I V +   L  G+S       + E S +    H N++++
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAI-KTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRL 70

Query: 463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVA 522
                GV  K      ++ E+M NGSL+++L    G              Q + +   +A
Sbjct: 71  E----GVVTKSRPV-MIITEYMENGSLDKFLRENDGK---------FTVGQLVGMLRGIA 116

Query: 523 CALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIG 582
             +KYL         H DL   N+L++  +   V+DFGL++ L  +    ++ G K  I 
Sbjct: 117 SGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIR 173

Query: 583 YIAPA--EYGLGSEVSINGDVYSYGILLLELMT 613
           + AP    Y   +  S   DV+S+GI++ E+M+
Sbjct: 174 WTAPEAIAYRKFTSAS---DVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 74.8 bits (185), Expect = 8e-15
 Identities = 61/244 (25%), Positives = 100/244 (40%), Gaps = 50/244 (20%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGAS--KSSIAECSALRNIRHKNLVKILTV 465
           I  GSFG VY         +  +K ++L +      + ++ E   L+ + H N++K    
Sbjct: 8   IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIK---- 63

Query: 466 CSGVDYKGDDFKA-----LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAID 520
                Y  + F+      +V E+   G L + +       K     + L++   + + + 
Sbjct: 64  -----YY-ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWF--VQLCL- 114

Query: 521 VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL-PPAHLQTSSIGVKG 579
              ALKYLH        H D+KP N+ L       + DFG++K+L     L  + +   G
Sbjct: 115 ---ALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV---G 165

Query: 580 TIGYIAPAEYGLGSEVSING-------DVYSYGILLLELMTRKRPSDIMFEGNMNLHNFA 632
           T  Y++P       E+           D++S G +L EL T K P    FEG  NL   A
Sbjct: 166 TPYYLSP-------EL-CQNKPYNYKSDIWSLGCVLYELCTLKHP----FEGE-NLLELA 212

Query: 633 RTVL 636
             +L
Sbjct: 213 LKIL 216

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 74.7 bits (183), Expect = 8e-15
 Identities = 59/203 (29%), Positives = 102/203 (50%), Gaps = 20/203 (9%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G FG V+ G  +   T +AVK L      + ++ + E + ++ ++H  LV++  V +   
Sbjct: 17  GQFGEVWMGYYNN-STKVAVKTLKP-GTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK-- 72

Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
              ++   ++ E+M  GSL ++L    G    V  PK ++F  +I      A  + Y+  
Sbjct: 73  ---EEPIYIITEYMAKGSLLDFLKSDEGG--KVLLPKLIDFSAQI------AEGMAYIE- 120

Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
             +    H DL+ +NVL+   +   +ADFGLA+++      T+  G K  I + AP    
Sbjct: 121 --RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPEAIN 177

Query: 591 LGSEVSINGDVYSYGILLLELMT 613
            GS  +I  DV+S+GILL E++T
Sbjct: 178 FGS-FTIKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 74.6 bits (183), Expect = 9e-15
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 27/209 (12%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           I  G FG+V +G     K  +AVK  N+     +++ + E + +  + HKNLV++L V  
Sbjct: 14  IGEGEFGAVLQGEYTGQK--VAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGV-- 67

Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
            + + G     +V E M  G+L  +L   +     V   + L F      ++DVA  ++Y
Sbjct: 68  -ILHNG---LYIVMELMSKGNLVNFLR--TRGRALVSVIQLLQF------SLDVAEGMEY 115

Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPA 587
           L         H DL   N+L+  +  A V+DFGLA++     +  S + VK T    AP 
Sbjct: 116 LE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-VDNSKLPVKWT----AP- 166

Query: 588 EYGLGSEVSINGDVYSYGILLLELMTRKR 616
           E     + S   DV+SYG+LL E+ +  R
Sbjct: 167 EALKHKKFSSKSDVWSYGVLLWEVFSYGR 195

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 28/218 (12%)

Query: 408 IDMGSFGSVYKGILD-EGKTIIAVKVLNLLHHGASKSS---IAECSALRNIRHKNLVKIL 463
           I  G FG V++GIL   G+  +AV +  L      K     ++E S +    H N++++ 
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72

Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            V +   +K      ++ E+M NG+L+++L    G           +  Q + +   +A 
Sbjct: 73  GVVT--KFKP---AMIITEYMENGALDKYLRDHDGE---------FSSYQLVGMLRGIAA 118

Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL---PPAHLQTSSIGVKGT 580
            +KYL         H DL   N+L++  +   V+DFGL+++L   P     TS  G K  
Sbjct: 119 GMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTS--GGKIP 173

Query: 581 IGYIAPAEYGLGSEVSINGDVYSYGILLLELMTR-KRP 617
           I + AP         S + DV+S+GI++ E+M+  +RP
Sbjct: 174 IRWTAPEAIAYRKFTSAS-DVWSFGIVMWEVMSFGERP 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 74.0 bits (182), Expect = 2e-14
 Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 15/208 (7%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVL-NLLHHGASKSSIA----ECSALRNIRHKNLVKILTV 465
           G+FG ++ GIL + K     +V    +   AS+  +     E   L  + H+N++ IL V
Sbjct: 17  GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76

Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
           C     +  +   ++Y +M+ G+L+ +L      +     P+ L+  Q +++AI +AC +
Sbjct: 77  CI----EDGEPPFVLYPYMNWGNLKLFLQQCRLGEANN--PQALSTQQLVHMAIQIACGM 130

Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            YLH   +    H D+   N ++D E+   + D  L++ L P             + ++A
Sbjct: 131 SYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMA 187

Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMT 613
             E  +  E S   DV+S+G+LL ELMT
Sbjct: 188 L-ESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 73.3 bits (181), Expect = 3e-14
 Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 28/213 (13%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKNLVKILTV 465
           +  G++G VYK    +   I+A+K + L +   G   +++ E S L+ ++H N+VK+L V
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDV 66

Query: 466 CSGVD--YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
                  Y       LV+E+     L+++L       +        N ++ I     +  
Sbjct: 67  IHTERKLY-------LVFEYCDM-DLKKYLD-----KRPGPLS--PNLIKSI--MYQLLR 109

Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGY 583
            L Y H        H DLKP N+L++ +    +ADFGLA+      L+T +  V  T+ Y
Sbjct: 110 GLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIP-LRTYTHEVV-TLWY 164

Query: 584 IAPAEYGLGSEV-SINGDVYSYGILLLELMTRK 615
            AP E  LGS+  S   D++S G +  E++T K
Sbjct: 165 RAP-EILLGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 75.6 bits (186), Expect = 4e-14
 Identities = 55/179 (30%), Positives = 74/179 (41%), Gaps = 32/179 (17%)

Query: 229 GLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGP 288
           GL L    L G +P ++ KL +L+ + +S N +   I  +LGS   LE L L  N F G 
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481

Query: 289 IPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKNASA 348
           IP SL  L  LR+L+L+ N++SG +P  L                 G         N   
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAAL-----------------GGRLLHRASFN--- 521

Query: 349 ISVFGNSKLCGGIPEFQLPICGLEKSKHKRLTIAVKLAAAIISVLVGILLFVSFLFLCW 407
                N+ LC GIP   L  CG        L++  K+  A   V V  L  V      W
Sbjct: 522 --FTDNAGLC-GIP--GLRACG------PHLSVGAKIGIA-FGVSVAFLFLVICAMCWW 568

Length = 623

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 73.3 bits (180), Expect = 4e-14
 Identities = 56/218 (25%), Positives = 102/218 (46%), Gaps = 31/218 (14%)

Query: 411 GSFGSVYKGIL-----DEGKTIIAVKVLNLLHHGASKSSI-AECSALRNIRHKNLVKILT 464
           G+FG VYKG L         T +A+K L        +     E   + +++H N+V +L 
Sbjct: 16  GAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLG 75

Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWL---HPVSG---ADKTVEAPKCLNFLQRINIA 518
           VC+      +    +++E++ +G L E+L    P S              L+    ++IA
Sbjct: 76  VCTK-----EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130

Query: 519 IDVACALKYL--HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPA---HLQTS 573
           I +A  ++YL  HH       H DL   N L+   +T  ++DFGL++ +  A    +Q+ 
Sbjct: 131 IQIAAGMEYLSSHHFV-----HRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185

Query: 574 SIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLEL 611
           S+     + ++ P E  L  + +   D++S+G++L E+
Sbjct: 186 SL---LPVRWMPP-EAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 72.3 bits (177), Expect = 8e-14
 Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 30/211 (14%)

Query: 411 GSFGSVYKGI-LDEGKTI---IAVKVLNLLHHGASKSSIAECS----ALRNIRHKNLVKI 462
           G FG+V+KGI + EG +I   +A+K +      + + +  E +    A+ ++ H  +V++
Sbjct: 18  GVFGTVHKGIWIPEGDSIKIPVAIKTI---QDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74

Query: 463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVA 522
           L +C G   +      LV +    GSL + +     +         L+  + +N  + +A
Sbjct: 75  LGICPGASLQ------LVTQLSPLGSLLDHVRQHRDS---------LDPQRLLNWCVQIA 119

Query: 523 CALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIG 582
             + YL         H +L   N+LL  +    +ADFG+A LL P   +      K  I 
Sbjct: 120 KGMYYLEEHRM---VHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK 176

Query: 583 YIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
           ++A  E  L    +   DV+SYG+ + E+M+
Sbjct: 177 WMA-LESILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 21/206 (10%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G FG V+    ++  T +AVK +         + +AE + ++ ++H  LVK+  V +   
Sbjct: 17  GQFGEVWMATYNK-HTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAVVT--- 71

Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
               +   ++ EFM  GSL ++L    G       PK ++F  +I      A  + ++  
Sbjct: 72  ---KEPIYIITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQI------AEGMAFIE- 119

Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
             Q    H DL+ +N+L+   +   +ADFGLA+++      T+  G K  I + AP    
Sbjct: 120 --QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPEAIN 176

Query: 591 LGSEVSINGDVYSYGILLLELMTRKR 616
            GS  +I  DV+S+GILL+E++T  R
Sbjct: 177 FGS-FTIKSDVWSFGILLMEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 71.1 bits (175), Expect = 1e-13
 Identities = 67/225 (29%), Positives = 97/225 (43%), Gaps = 31/225 (13%)

Query: 401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLV 460
            F  L  +  GS+GSVYK I  E   ++A+KV+ +      +  I E S L+      +V
Sbjct: 4   VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIV 61

Query: 461 KILTVCSGVDYKGDDFKA----LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRIN 516
           K         Y G  FK     +V E+   GS       VS   K     K L   +   
Sbjct: 62  K---------YYGSYFKNTDLWIVMEYCGAGS-------VSDIMKITN--KTLTEEEIAA 103

Query: 517 IAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIG 576
           I       L+YLH        H D+K  N+LL+ E  A +ADFG++  L     + ++  
Sbjct: 104 ILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-- 158

Query: 577 VKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP-SDI 620
           V GT  ++AP E       +   D++S GI  +E+   K P SDI
Sbjct: 159 VIGTPFWMAP-EVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDI 202

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 71.0 bits (174), Expect = 2e-13
 Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 16/211 (7%)

Query: 411 GSFGSVYKGIL--DEGKTI-IAVKVLNLLHHGASKSS--IAECSALRNIRHKNLVKILTV 465
           G FGSV +G L  D+G  + +AVK + L  H  S+    ++E + +++  H N++K++ V
Sbjct: 10  GEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGV 69

Query: 466 CSGVDYKGDDFKALV-YEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
           C          K +V   FM +G L  +L       +    P+ L     +   +D+A  
Sbjct: 70  CFEASSLQKIPKPMVILPFMKHGDLHSFLL----YSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYI 584
           ++YL +       H DL   N +L  +MT  VADFGL+K +            K  + +I
Sbjct: 126 MEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182

Query: 585 APAEYGLGSEV-SINGDVYSYGILLLELMTR 614
           A     L   V +   DV+++G+ + E+ TR
Sbjct: 183 AIES--LADRVYTSKSDVWAFGVTMWEIATR 211

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 73/300 (24%), Positives = 126/300 (42%), Gaps = 60/300 (20%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGA--SKSSIAECSALRNIRHKNLVKILTV 465
           I  G FG V+ G   E K  +A+K +     GA   +  I E   +  + H  LV++  V
Sbjct: 12  IGSGQFGLVWLGYWLE-KRKVAIKTI---REGAMSEEDFIEEAQVMMKLSHPKLVQLYGV 67

Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSG--ADKTVEAPKCLNFLQRINIAIDVAC 523
           C+           LV+EFM +G L ++L    G  + +T+           + + +DV  
Sbjct: 68  CTE-----RSPICLVFEFMEHGCLSDYLRAQRGKFSQETL-----------LGMCLDVCE 111

Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGY 583
            + YL         H DL   N L+       V+DFG+ + +      TSS G K  + +
Sbjct: 112 GMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-TSSTGTKFPVKW 167

Query: 584 IAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDI 643
            +P  +   S+ S   DV+S+G+L+ E+ +         EG     N + +       ++
Sbjct: 168 SSPEVFSF-SKYSSKSDVWSFGVLMWEVFS---------EGKTPYENRSNS-------EV 210

Query: 644 VDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHEL 703
           V+          TI +  R  + R+        SV  +   C  E P+DR + ++++H+L
Sbjct: 211 VE----------TINAGFRLYKPRL-----ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 70.7 bits (174), Expect = 2e-13
 Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 35/215 (16%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKNLVKILTVCSG 468
           G++G VYK    +   ++A+K + + +   G   ++I E   L+ +RH N+V++  + + 
Sbjct: 10  GTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTS 69

Query: 469 VDYKGDDFKALVYEFM-H--NGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
              KG  +  +V+E+M H   G L+      + +       KC    Q +         L
Sbjct: 70  -KGKGSIY--MVFEYMDHDLTGLLDSPEVKFTESQI-----KCY-MKQLLE-------GL 113

Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
           +YLH +      H D+K SN+L++++    +ADFGLA+     +    +  V  T+ Y  
Sbjct: 114 QYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRP 169

Query: 586 PAEYGLGS-----EVSINGDVYSYGILLLELMTRK 615
           P E  LG+     EV    D++S G +L EL   K
Sbjct: 170 P-ELLLGATRYGPEV----DMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 70.3 bits (173), Expect = 4e-13
 Identities = 58/219 (26%), Positives = 96/219 (43%), Gaps = 43/219 (19%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLH-----HGASKSSIAECSALRNIRHKNLVKILTV 465
           G++  VYK    E   I+A+K + L        G + +++ E   L+ ++H N++ +L V
Sbjct: 11  GTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDV 70

Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLH----PVSGADKTVEAPKCLNFLQRINIAIDV 521
                +       LV+EFM    LE+ +      ++ AD      K    L  +      
Sbjct: 71  -----FGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADI-----KSY-MLMTLR----- 113

Query: 522 ACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL--PPAHLQTSSIGVKG 579
              L+YLH +      H DLKP+N+L+  +    +ADFGLA+    P   +    +    
Sbjct: 114 --GLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV---- 164

Query: 580 TIGYIAPAEYGLGSE---VSINGDVYSYGILLLELMTRK 615
           T  Y AP E   G+    V +  D++S G +  EL+ R 
Sbjct: 165 TRWYRAP-ELLFGARHYGVGV--DMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 70.2 bits (172), Expect = 4e-13
 Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 31/219 (14%)

Query: 411 GSFGSVYKG-----ILDEGKTIIAVKVL-NLLHHGASKSSIAECSALRNIRHKNLVKILT 464
           G+FG V+ G       +  K ++AVK L     + A K    E   L N +H+N+VK   
Sbjct: 16  GAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYG 75

Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWL--HPVSGADKTVEAPKC--LNFLQRINIAID 520
           VC+    +GD    +V+E+M +G L ++L  H    A           L   Q + IA+ 
Sbjct: 76  VCT----EGDPP-IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130

Query: 521 VACALKYL--HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK 578
           +A  + YL   H       H DL   N L+ +++   + DFG+++ +      T    V 
Sbjct: 131 IASGMVYLASQH-----FVHRDLATRNCLVGYDLVVKIGDFGMSRDV----YTTDYYRVG 181

Query: 579 GT----IGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
           G     I ++ P E  +  + +   DV+S+G++L E+ T
Sbjct: 182 GHTMLPIRWMPP-ESIMYRKFTTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 71.8 bits (176), Expect = 6e-13
 Identities = 36/90 (40%), Positives = 53/90 (58%), Gaps = 1/90 (1%)

Query: 157 LAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTI 216
           L ++   L G IP  I  L+ L  + L  N ++ +IP SLG   SL  ++LSYN+ +G+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 217 PPQLMDLTSLSVGLDLSRNQLVGSLPTEVG 246
           P  L  LTSL + L+L+ N L G +P  +G
Sbjct: 483 PESLGQLTSLRI-LNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 69.4 bits (170), Expect = 6e-13
 Identities = 72/249 (28%), Positives = 115/249 (46%), Gaps = 47/249 (18%)

Query: 411 GSFGSVYKGI-LDEGKTIIAVKVLNLLHHGA-SKSSIA----ECSALRNIRHKNLVKILT 464
           GSFGSVY+G+ LD+G    AVK ++L   G   + ++     E + L  ++H N+V+ L 
Sbjct: 11  GSFGSVYEGLNLDDG-DFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYL- 68

Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
              G + + D+    + E +  GSL + L       + V       + ++I         
Sbjct: 69  ---GTEREEDNLYIFL-ELVPGGSLAKLLKKYGSFPEPVIR----LYTRQI------LLG 114

Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYI 584
           L+YLH      T H D+K +N+L+D      +ADFG+AK +       S    KG+  ++
Sbjct: 115 LEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS---FKGSPYWM 168

Query: 585 AP------AEYGLGSEVSINGDVYSYGILLLELMTRKRP-SDIMFEGNMNLHNFART--- 634
           AP        YGL +      D++S G  +LE+ T K P S    EG   +    R+   
Sbjct: 169 APEVIAQQGGYGLAA------DIWSLGCTVLEMATGKPPWSQ--LEGVAAVFKIGRSKEL 220

Query: 635 -VLPDHVMD 642
             +PDH+ D
Sbjct: 221 PPIPDHLSD 229

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 70.2 bits (172), Expect = 7e-13
 Identities = 65/220 (29%), Positives = 102/220 (46%), Gaps = 39/220 (17%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA-ECSALRNIRHKNLVKILTVC 466
           I  G+ G+VYK I      + A+KV+   H    +  I  E   LR++ H N+VK    C
Sbjct: 82  IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK----C 137

Query: 467 SGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALK 526
             +     + + L+ EFM  GSLE       G     E      FL   ++A  +   + 
Sbjct: 138 HDMFDHNGEIQVLL-EFMDGGSLE-------GTHIADEQ-----FLA--DVARQILSGIA 182

Query: 527 YLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQT-----SSIGVKGTI 581
           YLH   +    H D+KPSN+L++      +ADFG++++L     QT     SS+   GTI
Sbjct: 183 YLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILA----QTMDPCNSSV---GTI 232

Query: 582 GYIAP----AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
            Y++P     +   G+     GD++S G+ +LE    + P
Sbjct: 233 AYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272

Length = 353

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 68.8 bits (169), Expect = 8e-13
 Identities = 56/217 (25%), Positives = 88/217 (40%), Gaps = 22/217 (10%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSS--IAECSALRNIRHKNLVKILTV 465
           I  GSFG+V K        I+  K ++  +    +    ++E + LR ++H N+V+    
Sbjct: 8   IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY-- 65

Query: 466 CSGVDYKGDDFKALVY---EFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVA 522
               D   D     +Y   E+   G L + +       K +E       L ++ +     
Sbjct: 66  ----DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLL----- 116

Query: 523 CALKYLHH--DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGT 580
            AL   H+  D   T  H DLKP+N+ LD      + DFGLAK+L        +    GT
Sbjct: 117 -ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTY--VGT 173

Query: 581 IGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
             Y++P E           D++S G L+ EL     P
Sbjct: 174 PYYMSP-EQLNHMSYDEKSDIWSLGCLIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 70.0 bits (171), Expect = 1e-12
 Identities = 82/243 (33%), Positives = 128/243 (52%), Gaps = 12/243 (4%)

Query: 99  ICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTIS--PAIGELQNLVT 156
           +   S++    +   +    S   G    +NL  L   D  L+   S    + EL NL +
Sbjct: 61  LLPSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNISELLELTNLTS 120

Query: 157 LAINTNKLSGNIPPSIGNLKKLLQ-LYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGT 215
           L ++ N ++ +IPP IG LK  L+ L L +N ++ S+PS L    +L  ++LS+N+LS  
Sbjct: 121 LDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-D 177

Query: 216 IPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKL 275
           +P  L +L++L+  LDLS N++   LP E+  L  LE L +S N +  E+LS+L +   L
Sbjct: 178 LPKLLSNLSNLNN-LDLSGNKI-SDLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNL 234

Query: 276 EQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEG 335
             L+L  N  +  +P S+ +L  L  LDLS N IS  I   L  L  ++ L+LS N L  
Sbjct: 235 SGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSN 291

Query: 336 VIP 338
            +P
Sbjct: 292 ALP 294

Length = 394

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 68.8 bits (169), Expect = 1e-12
 Identities = 54/206 (26%), Positives = 88/206 (42%), Gaps = 23/206 (11%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA-ECSALRNIRHKNLVKILTVC 466
           I  G+ G VYK         +A+K + L     +K  I  E   +++ +H N+V      
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLR--KQNKELIINEILIMKDCKHPNIVDYYD-- 82

Query: 467 SGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALK 526
               Y   D   +V E+M  GSL + +               +N  Q   +  +V   L+
Sbjct: 83  ---SYLVGDELWVVMEYMDGGSLTDIITQN---------FVRMNEPQIAYVCREVLQGLE 130

Query: 527 YLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP 586
           YLH        H D+K  N+LL  + +  +ADFG A  L     + +S+ V GT  ++AP
Sbjct: 131 YLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV-V-GTPYWMAP 185

Query: 587 AEYGLGSEVSINGDVYSYGILLLELM 612
            E     +     D++S GI+ +E+ 
Sbjct: 186 -EVIKRKDYGPKVDIWSLGIMCIEMA 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 68.5 bits (168), Expect = 1e-12
 Identities = 54/221 (24%), Positives = 94/221 (42%), Gaps = 39/221 (17%)

Query: 411 GSFGSVYKGIL-----DEGKTIIAVKVLNLLHHGASKSS-----IAECSALRNIRHKNLV 460
           GSFG VY+G+       E +T +A+K +N      +        + E S ++     ++V
Sbjct: 17  GSFGMVYEGLAKGVVKGEPETRVAIKTVN----ENASMRERIEFLNEASVMKEFNCHHVV 72

Query: 461 KILTVCSGVDYKGDDFKALV-YEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI 519
           ++L V S     G     LV  E M  G L+ +L       +           + I +A 
Sbjct: 73  RLLGVVS----TGQ--PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAA 126

Query: 520 DVACALKYLH--HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTS--SI 575
           ++A  + YL           H DL   N ++  ++T  + DFG+ + +     +T     
Sbjct: 127 EIADGMAYLAAKKFV-----HRDLAARNCMVAEDLTVKIGDFGMTRDI----YETDYYRK 177

Query: 576 GVKGT--IGYIAPAEYGLGSEV-SINGDVYSYGILLLELMT 613
           G KG   + ++AP    L   V +   DV+S+G++L E+ T
Sbjct: 178 GGKGLLPVRWMAPES--LKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 68.9 bits (168), Expect = 1e-12
 Identities = 61/208 (29%), Positives = 102/208 (49%), Gaps = 24/208 (11%)

Query: 411 GSFGSVYKGI-LDEGKTI---IAVKVLN-LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G+FG+VYKGI + EG+T+   +A+K+LN      A+   + E   + ++ H +LV++L V
Sbjct: 18  GAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGV 77

Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
           C     +      LV + M +G L +++H         E    +     +N  + +A  +
Sbjct: 78  CLSPTIQ------LVTQLMPHGCLLDYVH---------EHKDNIGSQLLLNWCVQIAKGM 122

Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            YL    +    H DL   NVL+       + DFGLA+LL     + ++ G K  I ++A
Sbjct: 123 MYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMA 179

Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMT 613
             E     + +   DV+SYG+ + ELMT
Sbjct: 180 -LECIHYRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 70.2 bits (172), Expect = 2e-12
 Identities = 38/85 (44%), Positives = 53/85 (62%), Gaps = 1/85 (1%)

Query: 137 DNQ-LSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSS 195
           DNQ L G I   I +L++L ++ ++ N + GNIPPS+G++  L  L L  N    SIP S
Sbjct: 426 DNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPES 485

Query: 196 LGQCQSLTTINLSYNNLSGTIPPQL 220
           LGQ  SL  +NL+ N+LSG +P  L
Sbjct: 486 LGQLTSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 68.3 bits (167), Expect = 2e-12
 Identities = 62/218 (28%), Positives = 103/218 (47%), Gaps = 27/218 (12%)

Query: 404 FLCWIDMGSFGSV----YKGILDEGKTIIAVKVLNLLHHGAS--KSSIAECSALRNIRHK 457
           F+  +  G+FGSV    Y  + D    ++AVK L   H  A   +    E   L++++H 
Sbjct: 8   FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQ--HSTAEHLRDFEREIEILKSLQHD 65

Query: 458 NLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINI 517
           N+VK   VC      G     LV E++  GSL ++L       + ++  K L +  +I  
Sbjct: 66  NIVKYKGVCYS---AGRRNLRLVMEYLPYGSLRDYL---QKHRERLDHRKLLLYASQICK 119

Query: 518 AIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP--PAHLQTSSI 575
            ++   + +Y+H D         L   N+L++ E    + DFGL K+LP    + +    
Sbjct: 120 GMEYLGSKRYVHRD---------LATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREP 170

Query: 576 GVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
           G +  I + AP E    S+ S+  DV+S+G++L EL T
Sbjct: 171 G-ESPIFWYAP-ESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 68.1 bits (167), Expect = 2e-12
 Identities = 61/216 (28%), Positives = 101/216 (46%), Gaps = 27/216 (12%)

Query: 408 IDMGSFGSVYKGI-LDEGKTIIAVKVLN--LLHHGASKSSIAECSALRNIR---HKNLVK 461
           I  G++G+VYK   L+ G+  +A+K +   L   G   S++ E + L+ +    H N+V+
Sbjct: 7   IGEGAYGTVYKARDLNTGR-FVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVR 65

Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWL--HPVSGADKTVEAPKCLNFLQRINIAI 519
           +L VC G     +    LV+E +    L  +L   P  G    +      + ++++   +
Sbjct: 66  LLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPG----LPPETIKDLMRQLLRGV 120

Query: 520 DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKG 579
           D      +LH        H DLKP N+L+  +    +ADFGLA++       TS   V  
Sbjct: 121 D------FLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTS---VVV 168

Query: 580 TIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRK 615
           T+ Y AP E  L S  +   D++S G +  EL  R+
Sbjct: 169 TLWYRAP-EVLLQSSYATPVDMWSVGCIFAELFRRR 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 55/218 (25%), Positives = 91/218 (41%), Gaps = 33/218 (15%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA-ECSALRNIRH---KNLVKIL 463
           I  G++G+VY+G       ++A+K++NL       S I  E + L  +R     N+ K  
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITK-- 66

Query: 464 TVCSGVDYKGDDFKA----LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI 519
                  Y G   K     ++ E+   GS+           +T+     +       I  
Sbjct: 67  -------YYGSYLKGPRLWIIMEYAEGGSV-----------RTLMKAGPIAEKYISVIIR 108

Query: 520 DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKG 579
           +V  ALKY+H        H D+K +N+L+ +     + DFG+A LL     + S+    G
Sbjct: 109 EVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTF--VG 163

Query: 580 TIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
           T  ++AP     G       D++S GI + E+ T   P
Sbjct: 164 TPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPP 201

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 68.0 bits (166), Expect = 2e-12
 Identities = 63/219 (28%), Positives = 92/219 (42%), Gaps = 34/219 (15%)

Query: 411 GSFGSV----YKGILDEGKTIIAVKVLNLLHHGASKSS-IAECSALRNIRHKNLVKILTV 465
           G FG V    Y    D    ++AVK L       + S    E + L+ + H+N+VK    
Sbjct: 15  GHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGC 74

Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPK-CLNFLQRINIAIDVACA 524
           CS    +G     L+ E++  GSL ++L            PK  LN  Q +  A  +   
Sbjct: 75  CSE---QGGKGLQLIMEYVPLGSLRDYL------------PKHKLNLAQLLLFAQQICEG 119

Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHL--QTSSIGVKGTIG 582
           + YLH        H DL   NVLLD++    + DFGLAK +P  H   +    G    + 
Sbjct: 120 MAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG-DSPVF 175

Query: 583 YIAP---AEYGLGSEVSINGDVYSYGILLLELMTRKRPS 618
           + A     E     + S   DV+S+G+ L EL+T     
Sbjct: 176 WYAVECLKEN----KFSYASDVWSFGVTLYELLTHCDSK 210

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 66.8 bits (163), Expect = 5e-12
 Identities = 66/227 (29%), Positives = 104/227 (45%), Gaps = 33/227 (14%)

Query: 408 IDMGSFGSVYK----GIL-DEGKTIIAVKVLNLLHHGASKSSIA----ECSALRNIRHKN 458
           I  G+FG V++    G+L  E  T++AVK   +L   AS    A    E + +    H N
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVK---MLKEEASADMQADFQREAALMAEFDHPN 69

Query: 459 LVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWL------------HPVSGADKTVEAP 506
           +VK+L VC+     G     L++E+M  G L E+L            H  S A K    P
Sbjct: 70  IVKLLGVCA----VGKPM-CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124

Query: 507 KCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP 566
             L+  +++ IA  VA  + YL    +    H DL   N L+   M   +ADFGL++ + 
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181

Query: 567 PAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
            A    +S      I ++ P E    +  +   DV++YG++L E+ +
Sbjct: 182 SADYYKASENDAIPIRWM-PPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 66.4 bits (162), Expect = 6e-12
 Identities = 62/218 (28%), Positives = 100/218 (45%), Gaps = 26/218 (11%)

Query: 408 IDMGSFGSVYKGILDE-GK--TIIAVKVLNLLHHGASKSS-IAECSALRNIRHKNLVKIL 463
           I  G FG V +G L   GK    +A+K L   +    +   ++E S +    H N++ + 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL- 70

Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
               GV  K      ++ EFM NG+L+ +L    G             +Q + +   +A 
Sbjct: 71  ---EGVVTKSRPV-MIITEFMENGALDSFLRQNDGQ---------FTVIQLVGMLRGIAA 117

Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL---PPAHLQTSSIGVKGT 580
            +KYL    +    H DL   N+L++  +   V+DFGL++ L         TSS+G K  
Sbjct: 118 GMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIP 174

Query: 581 IGYIAPAEYGLGSEVSINGDVYSYGILLLELMTR-KRP 617
           I + AP         S + DV+SYGI++ E+M+  +RP
Sbjct: 175 IRWTAPEAIAYRKFTSAS-DVWSYGIVMWEVMSYGERP 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 66.4 bits (162), Expect = 7e-12
 Identities = 62/214 (28%), Positives = 105/214 (49%), Gaps = 29/214 (13%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKV--LNLLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           I  G++G VYK        ++A+K   L+    G   ++I E S L+ + H N+VK+L V
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67

Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLH--PVSGADKTVEAPKCLNFLQRINIAIDVAC 523
                   ++   LV+EF+H   L++++   P+SG    +  P   ++L ++   +    
Sbjct: 68  I-----HTENKLYLVFEFLHQ-DLKKFMDASPLSG----IPLPLIKSYLFQLLQGLAFCH 117

Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP-PAHLQTSSIGVKGTIG 582
           + + LH D         LKP N+L++ E    +ADFGLA+    P    T  +    T+ 
Sbjct: 118 SHRVLHRD---------LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV---VTLW 165

Query: 583 YIAPAEYGLGSEV-SINGDVYSYGILLLELMTRK 615
           Y AP E  LG +  S   D++S G +  E++TR+
Sbjct: 166 YRAP-EILLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 66.0 bits (161), Expect = 8e-12
 Identities = 73/267 (27%), Positives = 114/267 (42%), Gaps = 28/267 (10%)

Query: 402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNL 459
           F  L  I  GSFG V+K +    K + A+K ++L  ++    + +I E   L  +    +
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 460 VKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI 519
           ++     S +D        +V E+  NG L + L    G       P   + + R  I I
Sbjct: 62  IRYYE--SFLD---KGKLNIVMEYAENGDLHKLLKMQRGR------PLPEDQVWRFFIQI 110

Query: 520 DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKG 579
            +   L +LH        H D+K  N+ LD      + D G+AKLL       ++I   G
Sbjct: 111 LLG--LAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTI--VG 163

Query: 580 TIGYIAPAEYGLGSEVSIN--GDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLP 637
           T  Y++P    L  +   N   DV++ G++L E  T K P D   +G + L    R V P
Sbjct: 164 TPYYLSPE---LCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALIL-KIIRGVFP 219

Query: 638 DHVMDIVDSTLLADDEDLTITSNQRQR 664
              +  + S  LA   D  +T + RQR
Sbjct: 220 P--VSQMYSQQLAQLIDQCLTKDYRQR 244

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 65.4 bits (160), Expect = 1e-11
 Identities = 58/209 (27%), Positives = 89/209 (42%), Gaps = 25/209 (11%)

Query: 411 GSFGSVYKGILDE--GKTI-IAVKVLNLLHHGASKSSI-AECSALRNIRHKNLVKILTVC 466
           G+FGSV KG+     GK + +AVK L   H  A K     E S +  + H  +V+++ VC
Sbjct: 6   GNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVC 65

Query: 467 SGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALK 526
                KG+    LV E    G L ++L       + +              A  VA  + 
Sbjct: 66  -----KGEPL-MLVMELAPLGPLLKYLK----KRREIPVSDLKEL------AHQVAMGMA 109

Query: 527 YLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL-PPAHLQTSSIGVKGTIGYIA 585
           YL         H DL   NVLL +   A ++DFG+++ L   +    ++   +  + + A
Sbjct: 110 YLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYA 166

Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMTR 614
           P     G   S   DV+SYG+ L E  + 
Sbjct: 167 PECINYGK-FSSKSDVWSYGVTLWEAFSY 194

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 66.1 bits (161), Expect = 1e-11
 Identities = 63/225 (28%), Positives = 104/225 (46%), Gaps = 29/225 (12%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLL--HHGASKSSIAECSALRNIR---HKNLVKI 462
           I +G++G+VYK         +A+K + +     G   S++ E + L+ +    H N+V++
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCL--NFLQRINIAID 520
           + VC+      +    LV+E + +  L  +L  V       E  K L   FL        
Sbjct: 68  MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFL-------- 118

Query: 521 VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGT 580
               L +LH +C     H DLKP N+L+       +ADFGLA++     +  + + V  T
Sbjct: 119 --RGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY-SCQMALTPVVV--T 170

Query: 581 IGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGN 625
           + Y AP E  L S  +   D++S G +  E M R++P   +F GN
Sbjct: 171 LWYRAP-EVLLQSTYATPVDMWSVGCIFAE-MFRRKP---LFCGN 210

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 66.2 bits (162), Expect = 1e-11
 Identities = 61/221 (27%), Positives = 96/221 (43%), Gaps = 42/221 (19%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKNLVKILTV 465
           I  G++G VY+        I+A+K + + +   G   SS+ E + L N+RH N+V++  V
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74

Query: 466 CSG---------VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRIN 516
             G         ++Y   D  +L+              P S +       KC        
Sbjct: 75  VVGKHLDSIFLVMEYCEQDLASLLDNMPT---------PFSES-----QVKC-------- 112

Query: 517 IAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL-PPAHLQTSSI 575
           + + +   L+YLH +      H DLK SN+LL  +    +ADFGLA+    PA   T  +
Sbjct: 113 LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKV 169

Query: 576 GVKGTIGYIAPAEYGLGSEVSING-DVYSYGILLLELMTRK 615
               T+ Y AP E  LG        D+++ G +L EL+  K
Sbjct: 170 ---VTLWYRAP-ELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 65.6 bits (160), Expect = 1e-11
 Identities = 60/222 (27%), Positives = 98/222 (44%), Gaps = 32/222 (14%)

Query: 408 IDMGSFGSVYKGIL------DEGKTIIAVKVLNLLHHGASKSS----IAECSALRNIRHK 457
           +  G+FG VY+G          G   +AVK L     GA+       + E   + N  H 
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLR---KGATDQEKKEFLKEAHLMSNFNHP 59

Query: 458 NLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINI 517
           N+VK+L VC  +    ++ + ++ E M  G L   L  +  A      P  L   + ++I
Sbjct: 60  NIVKLLGVC--LL---NEPQYIIMELMEGGDL---LSYLRDARVERFGPPLLTLKELLDI 111

Query: 518 AIDVACALKYLHHDCQPTTAHCDLKPSNVLL-----DHEMTAHVADFGLAK-LLPPAHLQ 571
            +DVA    YL    Q    H DL   N L+     D +    + DFGLA+ +    + +
Sbjct: 112 CLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYR 168

Query: 572 TSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
               G    + ++AP E  L  + +   DV+S+G+L+ E++T
Sbjct: 169 KEGEG-LLPVRWMAP-ESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 65.4 bits (160), Expect = 1e-11
 Identities = 61/212 (28%), Positives = 93/212 (43%), Gaps = 30/212 (14%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA-ECSALRNIRHKNLVKILTVCSGV 469
           G+ G V K +      I+AVK + L  + A +  I  E   L       +V         
Sbjct: 12  GNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFY-- 69

Query: 470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRI--NIAIDVACALKY 527
              GD    +  E+M  GSL++ L  V G              +RI   IA+ V   L Y
Sbjct: 70  -NNGDISICM--EYMDGGSLDKILKEVQGR-----------IPERILGKIAVAVLKGLTY 115

Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK--GTIGYIA 585
           LH   +    H D+KPSN+L++      + DFG++  L       +S+     GT  Y+A
Sbjct: 116 LHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQL------VNSLAKTFVGTSSYMA 167

Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
           P E   G++ S+  D++S G+ L+EL T + P
Sbjct: 168 P-ERIQGNDYSVKSDIWSLGLSLIELATGRFP 198

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 66.1 bits (161), Expect = 2e-11
 Identities = 71/244 (29%), Positives = 111/244 (45%), Gaps = 20/244 (8%)

Query: 19  TLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCN 78
            L  L  L L  N++   I S +   + L    + +NN+T ++P   G            
Sbjct: 91  NLLPLPSLDLNLNRLRSNI-SELLELTNLTSLDLDNNNIT-DIPPLIGLLKS-------- 140

Query: 79  QHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDN 138
            +LK LD+++N     LP  + N    L+ L  + N +   +P  +    NL  L +  N
Sbjct: 141 -NLKELDLSDNKIE-SLPSPLRNL-PNLKNLDLSFNDL-SDLPKLLSNLSNLNNLDLSGN 196

Query: 139 QLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQ 198
           ++S  + P I  L  L  L ++ N +   +  S+ NLK L  L L  N L+  +P S+G 
Sbjct: 197 KIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGN 253

Query: 199 CQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISR 258
             +L T++LS N +S      L  LT+L   LDLS N L  +LP     L+ LE+L    
Sbjct: 254 LSNLETLDLSNNQIS--SISSLGSLTNLRE-LDLSGNSLSNALPLIALLLLLLELLLNLL 310

Query: 259 NMLE 262
             L+
Sbjct: 311 LTLK 314

Length = 394

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 61/209 (29%), Positives = 95/209 (45%), Gaps = 22/209 (10%)

Query: 411 GSFGSV----YKGILDEGKTIIAVKVLNLLHHGASKSSI-AECSALRNIRHKNLVKILTV 465
           G FG V    Y    D     +AVK L     G   + +  E   LRN+ H+N+VK   +
Sbjct: 15  GHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGI 74

Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
           C+     G +   L+ EF+ +GSL+E+L P +           +N  Q++  A+ +   +
Sbjct: 75  CTE---DGGNGIKLIMEFLPSGSLKEYL-PRNKNK--------INLKQQLKYAVQICKGM 122

Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPP-AHLQTSSIGVKGTIGYI 584
            YL         H DL   NVL++ E    + DFGL K +       T    +   + + 
Sbjct: 123 DYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY 179

Query: 585 APAEYGLGSEVSINGDVYSYGILLLELMT 613
           AP E  + S+  I  DV+S+G+ L EL+T
Sbjct: 180 AP-ECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 64.6 bits (157), Expect = 3e-11
 Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 28/222 (12%)

Query: 411 GSFGSVYKG-----ILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G+FG V+       + ++ K ++AVK L      A +    E   L  ++H+++V+   V
Sbjct: 16  GAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGV 75

Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTV------EAPKCLNFLQRINIAI 519
           C+    +G     +V+E+M +G L  +L    G D  +       AP  L   Q + IA 
Sbjct: 76  CT----EGRPL-LMVFEYMRHGDLNRFLRS-HGPDAKILAGGEDVAPGQLTLGQMLAIAS 129

Query: 520 DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKG 579
            +A  + YL         H DL   N L+   +   + DFG+++ +      T    V G
Sbjct: 130 QIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI----YSTDYYRVGG 182

Query: 580 -TIGYI--APAEYGLGSEVSINGDVYSYGILLLELMTR-KRP 617
            T+  I   P E  L  + +   D++S+G++L E+ T  K+P
Sbjct: 183 RTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 64.1 bits (156), Expect = 3e-11
 Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 26/219 (11%)

Query: 404 FLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSS--IAECSALRNIRHKNLVK 461
           FL  +  G FG V  G    G+  +A+K   ++  G+      I E   +  + H+ LV+
Sbjct: 8   FLKELGTGQFGVVKYGKW-RGQYDVAIK---MIKEGSMSEDEFIEEAKVMMKLSHEKLVQ 63

Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDV 521
           +  VC+           +V E+M NG L  +L          E  K     Q + +  DV
Sbjct: 64  LYGVCTK-----QRPIYIVTEYMSNGCLLNYLR---------EHGKRFQPSQLLEMCKDV 109

Query: 522 ACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTI 581
              + YL         H DL   N L+D +    V+DFGL++ +      TSS+G K  +
Sbjct: 110 CEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TSSVGSKFPV 165

Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMTR-KRPSD 619
            +  P E  L S+ S   DV+++G+L+ E+ +  K P +
Sbjct: 166 RWSPP-EVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYE 203

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 64.0 bits (156), Expect = 5e-11
 Identities = 64/222 (28%), Positives = 110/222 (49%), Gaps = 28/222 (12%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLL--HHGASKSSIAECSALRNIRHKNLVKILTV 465
           I  G++G VYKG   +   I+A+K + L     G   ++I E S L+ ++H N+V +  V
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                   +    L++EF+ +  L+++L  +    + ++A    ++L +I   I    + 
Sbjct: 68  -----LMQESRLYLIFEFL-SMDLKKYLDSL-PKGQYMDAELVKSYLYQILQGILFCHSR 120

Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP-PAHLQTSSIGVKGTIGYI 584
           + LH D         LKP N+L+D++    +ADFGLA+    P  + T  +    T+ Y 
Sbjct: 121 RVLHRD---------LKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEV---VTLWYR 168

Query: 585 APAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGN 625
           AP E  LGS   S   D++S G +  E+ T K+P   +F G+
Sbjct: 169 AP-EVLLGSPRYSTPVDIWSIGTIFAEMAT-KKP---LFHGD 205

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 63.3 bits (154), Expect = 7e-11
 Identities = 62/229 (27%), Positives = 105/229 (45%), Gaps = 34/229 (14%)

Query: 411 GSFGSVYK-GILDEGKTIIAVKVLNLLHHGASKSS----------IAECSALR-NIRHKN 458
           G+FG VYK    + G+ ++A+K +N+ +    K            ++E + ++  +RH N
Sbjct: 11  GAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPN 70

Query: 459 LVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRI-NI 517
           +V+         +  +D   +V + +    L E  H  S  +K     +     +RI NI
Sbjct: 71  IVRYYKT-----FLENDRLYIVMDLIEGAPLGE--HFNSLKEKKQRFTE-----ERIWNI 118

Query: 518 AIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
            + +  AL+YLH + +    H DL P+N++L  +    + DFGLAK   P    TS   V
Sbjct: 119 FVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTS---V 173

Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNM 626
            GTI Y  P E           DV+++G +L ++ T + P    +  NM
Sbjct: 174 VGTILYSCP-EIVKNEPYGEKADVWAFGCILYQMCTLQPP---FYSTNM 218

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 63.1 bits (153), Expect = 8e-11
 Identities = 54/210 (25%), Positives = 95/210 (45%), Gaps = 15/210 (7%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSS----IAECSALRNIRHKNLVKILTVC 466
           G FGSV +G L++  +I+ V V  +     ++S     ++E   ++   H N+++++ VC
Sbjct: 10  GEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVC 69

Query: 467 -SGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
              V+ +G     ++  FM +G L  +L      D     P  +     +    D+A  +
Sbjct: 70  LQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQM----LVKFMTDIASGM 125

Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
           +YL      +  H DL   N +L+  M   VADFGL+K +            K  + +IA
Sbjct: 126 EYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIA 182

Query: 586 PAEYGLGSEV-SINGDVYSYGILLLELMTR 614
                L   V +   DV+S+G+ + E+ TR
Sbjct: 183 IES--LADRVYTTKSDVWSFGVTMWEIATR 210

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 63.0 bits (153), Expect = 8e-11
 Identities = 62/240 (25%), Positives = 106/240 (44%), Gaps = 36/240 (15%)

Query: 411 GSFGSVY--KGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSG 468
           G+FG V+  +   D+   II    +  +      ++  EC  L+ + H N+++       
Sbjct: 11  GAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE---- 66

Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL 528
            ++  D    +V E+   G+L E++      +  ++    L+F  +I +A         L
Sbjct: 67  -NFLEDKALMIVMEYAPGGTLAEYIQ--KRCNSLLDEDTILHFFVQILLA---------L 114

Query: 529 HHDCQPTTAHCDLKPSNVLLD-HEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPA 587
           HH       H DLK  N+LLD H+M   + DFG++K+L     ++ +  V GT  YI+P 
Sbjct: 115 HHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS---KSKAYTVVGTPCYISP- 170

Query: 588 EYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDST 647
           E   G   +   D+++ G +L EL + KR     FE            LP  V+ I+  T
Sbjct: 171 ELCEGKPYNQKSDIWALGCVLYELASLKRA----FEA---------ANLPALVLKIMSGT 217

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 63.0 bits (154), Expect = 8e-11
 Identities = 60/216 (27%), Positives = 91/216 (42%), Gaps = 30/216 (13%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLN---LLHHGASKSSIAECSALRNIRHKNLVKILT 464
           I  G++G V+         I A+KV+    ++        + E   L   +   +VK+  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL-- 58

Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
             S   ++G     LV E++  G L   L  V   D+ V          RI IA ++  A
Sbjct: 59  YYS---FQGKKNLYLVMEYLPGGDLASLLENVGSLDEDV---------ARIYIA-EIVLA 105

Query: 525 LKYLH-HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKL------LPPAHLQTSSIGV 577
           L+YLH +       H DLKP N+L+D      + DFGL+K+      +     +     +
Sbjct: 106 LEYLHSNGI----IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRI 161

Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
            GT  YIAP E  LG   S   D +S G +L E + 
Sbjct: 162 VGTPDYIAP-EVILGQGHSKTVDWWSLGCILYEFLV 196

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 63.0 bits (153), Expect = 9e-11
 Identities = 63/218 (28%), Positives = 96/218 (44%), Gaps = 28/218 (12%)

Query: 408 IDMGSFGSVYKGILD-EGKTIIAVKVLNLLHHGASKSS---IAECSALRNIRHKNLVKIL 463
           I  G FG V  G L   GK  I V +  L      K     ++E S +    H N++ + 
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL- 70

Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
               GV  K      +V E+M NGSL+ +L    G             +Q + +   +A 
Sbjct: 71  ---EGVVTKSKPV-MIVTEYMENGSLDAFLRKHDGQ---------FTVIQLVGMLRGIAS 117

Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL---PPAHLQTSSIGVKGT 580
            +KYL         H DL   N+L++  +   V+DFGL+++L   P A   T   G K  
Sbjct: 118 GMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR--GGKIP 172

Query: 581 IGYIAPAEYGLGSEVSINGDVYSYGILLLELMTR-KRP 617
           I + AP       + +   DV+SYGI++ E+M+  +RP
Sbjct: 173 IRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERP 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 62.4 bits (151), Expect = 1e-10
 Identities = 59/217 (27%), Positives = 98/217 (45%), Gaps = 20/217 (9%)

Query: 411 GSFGSV-----YKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G+FG V     Y    ++ K ++AVK L      A K    E   L N++H+++VK   V
Sbjct: 16  GAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGV 75

Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEA----PKCLNFLQRINIAIDV 521
           C     +GD    +V+E+M +G L ++L    G D  + A    P  L   Q ++IA  +
Sbjct: 76  C----VEGDPL-IMVFEYMKHGDLNKFLR-AHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129

Query: 522 ACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTI 581
           A  + YL         H DL   N L+   +   + DFG+++ +               I
Sbjct: 130 AAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186

Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMTR-KRP 617
            ++ P E  +  + +   DV+S G++L E+ T  K+P
Sbjct: 187 RWM-PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 68/253 (26%), Positives = 112/253 (44%), Gaps = 35/253 (13%)

Query: 408 IDMGSFGSVYKGI-LDEGKTIIAVKVLNLL--HHGASKSSIAECSALRNIR---HKNLVK 461
           I  G++G V+K   L  G   +A+K + +     G   S+I E + LR++    H N+V+
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDV 521
           +  VC+      +    LV+E + +  L  +L  V       E  K        ++   +
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIK--------DMMFQL 119

Query: 522 ACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTI 581
              L +LH        H DLKP N+L+       +ADFGLA++      Q +   V  T+
Sbjct: 120 LRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVVVTL 173

Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM 641
            Y AP E  L S  +   D++S G +  E M R++P   +F G+ ++         D + 
Sbjct: 174 WYRAP-EVLLQSSYATPVDLWSVGCIFAE-MFRRKP---LFRGSSDV---------DQLG 219

Query: 642 DIVDSTLLADDED 654
            I+D   L  +ED
Sbjct: 220 KILDVIGLPGEED 232

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 60/210 (28%), Positives = 92/210 (43%), Gaps = 26/210 (12%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNL-LHHGASKSSIAECSALRNIRHKNLVKILTVC 466
           I  G+FG VYKG+L +G T +AVK     L     +  + E   L+   H N+VK++ VC
Sbjct: 3   IGKGNFGDVYKGVL-KGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 467 SGVD--YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
                 Y       +V E +  GSL  +L               L   + + +++D A  
Sbjct: 62  VQKQPIY-------IVMELVPGGSLLTFLRKKKNR---------LTVKKLLQMSLDAAAG 105

Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGT-IGY 583
           ++YL         H DL   N L+       ++DFG+++      + T S G+K   I +
Sbjct: 106 MEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRE-EEGGIYTVSDGLKQIPIKW 161

Query: 584 IAPAEYGLGSEVSINGDVYSYGILLLELMT 613
            AP     G   +   DV+SYGILL E  +
Sbjct: 162 TAPEALNYG-RYTSESDVWSYGILLWETFS 190

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 61.8 bits (151), Expect = 2e-10
 Identities = 61/224 (27%), Positives = 91/224 (40%), Gaps = 47/224 (20%)

Query: 401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLN---LLHHGASKSSIAECSALRNIRHK 457
            F F+  +  GSFG V            A+K+L+   ++     +  + E   L++IRH 
Sbjct: 2   DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHP 61

Query: 458 NLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINI 517
            LV +        ++ D    LV E++  G L   L             K      R   
Sbjct: 62  FLVNLYGS-----FQDDSNLYLVMEYVPGGELFSHLR------------KS----GRFPE 100

Query: 518 ------AIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQ 571
                 A  V  AL+YLH        + DLKP N+LLD +    + DFG AK +     +
Sbjct: 101 PVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG---R 154

Query: 572 TSSIGVKGTIGYIAPAEY----GLGSEVSINGDVYSYGILLLEL 611
           T ++   GT  Y+AP E     G G  V    D ++ GIL+ E+
Sbjct: 155 TYTLC--GTPEYLAP-EIILSKGYGKAV----DWWALGILIYEM 191

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 61.7 bits (150), Expect = 3e-10
 Identities = 52/224 (23%), Positives = 91/224 (40%), Gaps = 43/224 (19%)

Query: 405 LCWIDMGSFGSVYKGILDEGKTIIAVKVLNL--------LHHGASKSSIAECSALRNIRH 456
           +  +  G+FG V+       +   A+KV+ +          H  ++  +     L+ + H
Sbjct: 6   IKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRV-----LKEVSH 60

Query: 457 KNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRIN 516
             ++++    +        F  ++ E++  G L  +L        +        F     
Sbjct: 61  PFIIRLF--WT---EHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTG-----LFY---- 106

Query: 517 IAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIG 576
            A ++ CAL+YLH        + DLKP N+LLD E    + DFG AK L     +T ++ 
Sbjct: 107 -ASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL---RDRTWTLC 159

Query: 577 VKGTIGYIAP---AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
             GT  Y+AP      G    V    D ++ GIL+ E++    P
Sbjct: 160 --GTPEYLAPEVIQSKGHNKAV----DWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 61.6 bits (149), Expect = 3e-10
 Identities = 59/217 (27%), Positives = 106/217 (48%), Gaps = 27/217 (12%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGV 469
           G++ +V+KG     + ++A+K + L H  GA  ++I E S L+N++H N+V +  +    
Sbjct: 16  GTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII--- 72

Query: 470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH 529
               +    LV+E++ +  L+++L              C N +   N+ I +   L+ L 
Sbjct: 73  --HTERCLTLVFEYLDS-DLKQYLD------------NCGNLMSMHNVKIFMFQLLRGLS 117

Query: 530 HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEY 589
           +  +    H DLKP N+L++ +    +ADFGLA+      + T +   +    +  P + 
Sbjct: 118 YCHKRKILHRDLKPQNLLINEKGELKLADFGLAR---AKSVPTKTYSNEVVTLWYRPPDV 174

Query: 590 GLGS-EVSINGDVYSYGILLLELMTRKRPSDIMFEGN 625
            LGS E S   D++  G +L E+ T  RP   MF G+
Sbjct: 175 LLGSTEYSTPIDMWGVGCILYEMAT-GRP---MFPGS 207

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 61.2 bits (148), Expect = 4e-10
 Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 36/221 (16%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           I  GSFG VYKGI +  K ++A+K+++L          AE   + +I+ +  + +L+ C 
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--------AE-DEIEDIQQE--ITVLSQCD 60

Query: 468 G---VDYKGDDFKA----LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAID 520
                 Y G   K     ++ E++  GS  + L P       +E       L+ I   +D
Sbjct: 61  SPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP-----GPLEETYIATILREILKGLD 115

Query: 521 VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGT 580
                 YLH +      H D+K +NVLL  +    +ADFG+A  L    ++ ++    GT
Sbjct: 116 ------YLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF--VGT 164

Query: 581 IGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP-SDI 620
             ++AP E    S      D++S GI  +EL   + P SD+
Sbjct: 165 PFWMAP-EVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 204

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 60.9 bits (148), Expect = 4e-10
 Identities = 52/212 (24%), Positives = 83/212 (39%), Gaps = 31/212 (14%)

Query: 411 GSFGSVYKGILDE--GKTI-IAVKVL---NLLHHGASKSSIAECSALRNIRHKNLVKILT 464
           GSFG V +G      GK I +AVK L    L         + E + + ++ H+NL+++  
Sbjct: 6   GSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYG 63

Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
           V             +V E    GSL + L   +     +      ++      A+ +A  
Sbjct: 64  VVL------THPLMMVTELAPLGSLLDRLRKDALGHFLI--STLCDY------AVQIANG 109

Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAH-LQTSSIGVKGTIGY 583
           ++YL         H DL   N+LL  +    + DFGL + LP           +K    +
Sbjct: 110 MRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAW 166

Query: 584 IAPA--EYGLGSEVSINGDVYSYGILLLELMT 613
            AP        S  S   DV+ +G+ L E+ T
Sbjct: 167 CAPESLRTRTFSHAS---DVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 60.6 bits (147), Expect = 5e-10
 Identities = 64/219 (29%), Positives = 94/219 (42%), Gaps = 29/219 (13%)

Query: 408 IDMGSFGSVYKGIL---DEGKTIIAVKVLNLLHHGASKSS-IAECSALRNIRHKNLVKIL 463
           I  G FG VY G L   D  K   AVK LN +         + E   +++  H N++ +L
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            +C       +    +V  +M +G L  ++   +  + TV+          I   + VA 
Sbjct: 63  GIC----LPSEGSPLVVLPYMKHGDLRNFIRSET-HNPTVK--------DLIGFGLQVAK 109

Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLA-----KLLPPAHLQTSSIGVK 578
            ++YL         H DL   N +LD   T  VADFGLA     K     H  T   G K
Sbjct: 110 GMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHT---GAK 163

Query: 579 GTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
             + ++A  E     + +   DV+S+G+LL ELMTR  P
Sbjct: 164 LPVKWMA-LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 201

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 60.7 bits (147), Expect = 5e-10
 Identities = 58/212 (27%), Positives = 93/212 (43%), Gaps = 18/212 (8%)

Query: 411 GSFGSVYKGIL---DEGKTIIAVKVLNLLHHGASKSSIAEC----SALRNIRHKNLVKIL 463
           G FGSV +  L   D     +AVK+L       S S I E     + ++   H N++K++
Sbjct: 10  GEFGSVREAQLKSEDGSFQKVAVKMLKA--DIFSSSDIEEFLREAACMKEFDHPNVIKLI 67

Query: 464 TVCSGVDYKGD-DFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVA 522
            V      KG      ++  FM +G L  +L       +  E P  L     +   ID+A
Sbjct: 68  GVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL----MSRIGEEPFTLPLQTLVRFMIDIA 123

Query: 523 CALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIG 582
             ++YL         H DL   N +L+  MT  VADFGL+K +            K  + 
Sbjct: 124 SGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVK 180

Query: 583 YIAPAEYGLGSEVSINGDVYSYGILLLELMTR 614
           ++A  E    +  + + DV+++G+ + E+MTR
Sbjct: 181 WLA-LESLADNVYTTHSDVWAFGVTMWEIMTR 211

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 62.1 bits (151), Expect = 6e-10
 Identities = 28/78 (35%), Positives = 46/78 (58%)

Query: 120 IPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLL 179
           IP  I K  +LQ++++  N + G I P++G + +L  L ++ N  +G+IP S+G L  L 
Sbjct: 434 IPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLR 493

Query: 180 QLYLIENFLQVSIPSSLG 197
            L L  N L   +P++LG
Sbjct: 494 ILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 61.0 bits (148), Expect = 6e-10
 Identities = 69/236 (29%), Positives = 96/236 (40%), Gaps = 56/236 (23%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSS-------IAECSALRNIRHKNLV 460
           I  GSFG+VY         ++A+K ++     + K S       I E   L+ +RH N +
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSY----SGKQSNEKWQDIIKEVRFLQQLRHPNTI 78

Query: 461 KILTVCSGVDYKGDDFKA----LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRIN 516
                    +YKG   +     LV E+            +  A   +E  K    LQ + 
Sbjct: 79  ---------EYKGCYLREHTAWLVMEYC-----------LGSASDILEVHK--KPLQEVE 116

Query: 517 IAI---DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTS 573
           IA         L YLH        H D+K  N+LL    T  +ADFG A L+ PA+    
Sbjct: 117 IAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN---- 169

Query: 574 SIGVKGTIGYIAPAEYGLGSEVSING--DVYSYGILLLELMTRKRPSDIMFEGNMN 627
                GT  ++AP       E   +G  DV+S GI  +EL  RK P   +F  NMN
Sbjct: 170 --SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP---LF--NMN 218

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 60.1 bits (146), Expect = 8e-10
 Identities = 57/204 (27%), Positives = 82/204 (40%), Gaps = 22/204 (10%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSI-AECSALRNIRHKNLVKILTVCSGV 469
           G+ GSV K  L     I A+K +    +   +  I  E    ++ +   +VK        
Sbjct: 12  GAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLD- 70

Query: 470 DYKGDDFKALVYEFMHNGSLEEWLHPV-SGADKTVEAPKCLNFLQRINIAIDVACALKYL 528
             +      +  E+   GSL+     V     +  E       L +I  A  V   L YL
Sbjct: 71  --ESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKV-----LGKI--AESVLKGLSYL 121

Query: 529 HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV-KGTIGYIAPA 587
           H        H D+KPSN+LL  +    + DFG++       L  S  G   GT  Y+AP 
Sbjct: 122 H---SRKIIHRDIKPSNILLTRKGQVKLCDFGVS-----GELVNSLAGTFTGTSFYMAP- 172

Query: 588 EYGLGSEVSINGDVYSYGILLLEL 611
           E   G   SI  DV+S G+ LLE+
Sbjct: 173 ERIQGKPYSITSDVWSLGLTLLEV 196

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 62.2 bits (151), Expect = 8e-10
 Identities = 57/203 (28%), Positives = 88/203 (43%), Gaps = 35/203 (17%)

Query: 428 IAVKVLNLLHHGAS------KSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVY 481
           +A+K+L              +   A C+ L    H N+V +L   SG           V+
Sbjct: 6   VAIKLLRTDAPEEEHQRARFRRETALCARLY---HPNIVALLD--SGE--APPGLLFAVF 58

Query: 482 EFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDL 541
           E++   +L E L     AD  + A +    + ++  A+  ACA     H+      H DL
Sbjct: 59  EYVPGRTLREVL----AADGALPAGETGRLMLQVLDAL--ACA-----HNQGIV--HRDL 105

Query: 542 KPSNVLL---DHEMTAHVADFGLAKLLPPAHLQ-----TSSIGVKGTIGYIAPAEYGLGS 593
           KP N+++        A V DFG+  LLP          T +  V GT  Y AP E   G 
Sbjct: 106 KPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAP-EQLRGE 164

Query: 594 EVSINGDVYSYGILLLELMTRKR 616
            V+ N D+Y++G++ LE +T +R
Sbjct: 165 PVTPNSDLYAWGLIFLECLTGQR 187

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 60.0 bits (146), Expect = 9e-10
 Identities = 60/225 (26%), Positives = 90/225 (40%), Gaps = 41/225 (18%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNLVKILTVCSG 468
           G+ G V+K    E    +A+K + L  L  G    ++ E  AL+  +H  +VK+L V   
Sbjct: 11  GAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFP- 69

Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL 528
               G  F  LV E+M    L E L          +  K       +         + Y+
Sbjct: 70  ---HGSGF-VLVMEYM-PSDLSEVLRDEERPLPEAQV-KSY-MRMLLK-------GVAYM 115

Query: 529 HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL--PPAHLQTSSIGVKGTIGYIAP 586
           H        H DLKP+N+L+  +    +ADFGLA+L       L +  +    T  Y AP
Sbjct: 116 H---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV---ATRWYRAP 169

Query: 587 AE--YG---LGSEVSINGDVYSYGILLLELMTRKRP-----SDIM 621
            E  YG       V    D+++ G +  EL+    P     +DI 
Sbjct: 170 -ELLYGARKYDPGV----DLWAVGCIFAELL-NGSPLFPGENDIE 208

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 60.2 bits (147), Expect = 1e-09
 Identities = 64/236 (27%), Positives = 100/236 (42%), Gaps = 43/236 (18%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNL----LHHGASKSSIAECSALRNIRHKNLVKIL 463
           I  G++G V   +       +A+K ++     L     K  + E   LR++RH+N++ +L
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDA--KRILREIKLLRHLRHENIIGLL 65

Query: 464 TVCSGVDYKGDDFKAL--VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDV 521
            +        +DF  +  V E M    L + +   S    T +      FL +I      
Sbjct: 66  DILRPPSP--EDFNDVYIVTELMET-DLHKVIK--SPQPLTDD--HIQYFLYQI------ 112

Query: 522 ACALKYLHHDCQPTTA---HCDLKPSNVLLDHEMTAHVADFGLAKLL--PPAHLQTSSIG 576
              LKYLH      +A   H DLKPSN+L++      + DFGLA+ +          +  
Sbjct: 113 LRGLKYLH------SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEY 166

Query: 577 VKGTIGYIAPAEYGLGSE---VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLH 629
           V  T  Y AP E  L S     +I  D++S G +  EL+TRK     +F G   + 
Sbjct: 167 VV-TRWYRAP-ELLLSSSRYTKAI--DIWSVGCIFAELLTRK----PLFPGRDYID 214

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 59.9 bits (145), Expect = 1e-09
 Identities = 41/139 (29%), Positives = 66/139 (47%), Gaps = 12/139 (8%)

Query: 479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAH 538
           LV   M+ G L   ++ V   +     P+   +  +I         L++LH   Q    +
Sbjct: 70  LVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQI------ISGLEHLH---QRRIIY 120

Query: 539 CDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSIN 598
            DLKP NVLLD++    ++D GLA  L     Q+ + G  GT G++AP E   G E   +
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAVELKDG--QSKTKGYAGTPGFMAP-ELLQGEEYDFS 177

Query: 599 GDVYSYGILLLELMTRKRP 617
            D ++ G+ L E++  + P
Sbjct: 178 VDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 59.5 bits (144), Expect = 1e-09
 Identities = 64/223 (28%), Positives = 111/223 (49%), Gaps = 32/223 (14%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGAS----KSSI-----AECSALRNIRHKN 458
           I  GSFGSVY G+      ++AVK + L    AS    K S+      E + L+ ++H+N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 459 LVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIA 518
           +V+ L      D+       +  E++  GS+   L+   GA    E     NF+++I   
Sbjct: 68  IVQYLGSSLDADHLN-----IFLEYVPGGSVAALLN-NYGA---FEETLVRNFVRQI--- 115

Query: 519 IDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIG-- 576
                 L YLH+       H D+K +N+L+D++    ++DFG++K L    L T + G  
Sbjct: 116 ---LKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGAR 169

Query: 577 --VKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
             ++G++ ++AP E    +  +   D++S G L++E++T K P
Sbjct: 170 PSLQGSVFWMAP-EVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 64/223 (28%), Positives = 113/223 (50%), Gaps = 33/223 (14%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNL-LHHGASKSSIAECSALRNIRHKNLVKILTVCSGV 469
           G++ +VYKG       I+A+K ++L    G   ++I E S ++ ++H+N+V++  V    
Sbjct: 11  GTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI--- 67

Query: 470 DYKGDDFKALVYEFMHNGSLEEWL--HPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
               ++   LV+E+M +  L++++  H V GA   ++     +F  ++   I      + 
Sbjct: 68  --HTENKLMLVFEYM-DKDLKKYMDTHGVRGA---LDPNTVKSFTYQLLKGIAFCHENRV 121

Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKL--LPPAHLQTSSIGVKGTIGYIA 585
           LH D         LKP N+L++      +ADFGLA+   +P   + T S  V  T+ Y A
Sbjct: 122 LHRD---------LKPQNLLINKRGELKLADFGLARAFGIP---VNTFSNEVV-TLWYRA 168

Query: 586 PAEYGLGSEV-SINGDVYSYGILLLELMTRKRPSDIMFEGNMN 627
           P +  LGS   S + D++S G ++ E++T  RP   +F G  N
Sbjct: 169 P-DVLLGSRTYSTSIDIWSVGCIMAEMIT-GRP---LFPGTNN 206

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 64/249 (25%), Positives = 104/249 (41%), Gaps = 42/249 (16%)

Query: 411 GSFGSVYKGI-LDEGKTIIAVKVLNL--LHHGASKSSIA---ECSALRNIRHKNLVKILT 464
           G+FG VY    +D G+ + AVK +          K   A   E   L+N++H+ +V+   
Sbjct: 13  GAFGRVYLCYDVDTGREL-AVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ--- 68

Query: 465 VCSGVDYKG---DDFKALVY-EFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAID 520
                 Y G   DD    ++ E+M  GS+++ L       +TV        L+       
Sbjct: 69  ------YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILE------- 115

Query: 521 VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSI-GVKG 579
               ++YLH +      H D+K +N+L D      + DFG +K L       + +  V G
Sbjct: 116 ---GVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTG 169

Query: 580 TIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP-SDIMFEGNMNLHNFART---- 634
           T  +++P E   G       DV+S G  ++E++T K P ++  FE    +   A      
Sbjct: 170 TPYWMSP-EVISGEGYGRKADVWSVGCTVVEMLTEKPPWAE--FEAMAAIFKIATQPTNP 226

Query: 635 VLPDHVMDI 643
            LP HV   
Sbjct: 227 QLPSHVSPD 235

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 59.2 bits (143), Expect = 2e-09
 Identities = 58/220 (26%), Positives = 97/220 (44%), Gaps = 23/220 (10%)

Query: 411 GSFGSV-----YKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G+FG V     Y     + K ++AVK L      A K    E   L N++H+++VK   V
Sbjct: 16  GAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGV 75

Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTV-------EAPKCLNFLQRINIA 518
           C      GD    +V+E+M +G L ++L    G D  +       +A   L   Q ++IA
Sbjct: 76  CG----DGDPL-IMVFEYMKHGDLNKFLR-AHGPDAMILVDGQPRQAKGELGLSQMLHIA 129

Query: 519 IDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK 578
             +A  + YL         H DL   N L+   +   + DFG+++ +             
Sbjct: 130 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186

Query: 579 GTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTR-KRP 617
             I ++ P E  +  + +   DV+S+G++L E+ T  K+P
Sbjct: 187 LPIRWM-PPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 59.2 bits (143), Expect = 2e-09
 Identities = 57/218 (26%), Positives = 101/218 (46%), Gaps = 29/218 (13%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKILTVCSGV 469
           G++ +V+KG     + ++A+K + L H  GA  ++I E S L++++H N+V +  +    
Sbjct: 17  GTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV--- 73

Query: 470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH 529
               D    LV+E++ +  L++++              C N +   N+ I +   L+ L 
Sbjct: 74  --HTDKSLTLVFEYL-DKDLKQYMD------------DCGNIMSMHNVKIFLYQILRGLA 118

Query: 530 HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGL--AKLLPPAHLQTSSIGVKGTIGYIAPA 587
           +  +    H DLKP N+L++      +ADFGL  AK +P        +    T+ Y  P 
Sbjct: 119 YCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV----TLWYRPPD 174

Query: 588 EYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGN 625
                SE S   D++  G +  E M   RP   +F G+
Sbjct: 175 VLLGSSEYSTQIDMWGVGCIFFE-MASGRP---LFPGS 208

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 58.4 bits (142), Expect = 2e-09
 Identities = 60/231 (25%), Positives = 92/231 (39%), Gaps = 62/231 (26%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA----ECSALRNIRHKNLVKILTVC 466
           GSFG VYK I      ++A+KV++L     ++  I     E   L   R   + K     
Sbjct: 12  GSFGEVYKAIDKRTNQVVAIKVIDLEE---AEDEIEDIQQEIQFLSQCRSPYITK----- 63

Query: 467 SGVDYKG---DDFK-ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI--- 519
               Y G      K  ++ E+   GS  + L P    D+T              IA    
Sbjct: 64  ----YYGSFLKGSKLWIIMEYCGGGSCLDLLKP-GKLDETY-------------IAFILR 105

Query: 520 DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKG 579
           +V   L+YLH +      H D+K +N+LL  E    +ADFG++       L ++      
Sbjct: 106 EVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNT 157

Query: 580 TIG---YIAPAEYGLGSEVSING------DVYSYGILLLELMTRKRP-SDI 620
            +G   ++AP       EV          D++S GI  +EL   + P SD+
Sbjct: 158 FVGTPFWMAP-------EVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL 201

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 58.5 bits (142), Expect = 3e-09
 Identities = 63/229 (27%), Positives = 101/229 (44%), Gaps = 51/229 (22%)

Query: 401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNL 459
           ++  L  +  GS+ +VYKG       ++A+K + L H  GA  ++I E S L++++H N+
Sbjct: 6   TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANI 65

Query: 460 V---------KILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLN 510
           V         K LT              LV+E++    L++++              C  
Sbjct: 66  VTLHDIIHTKKTLT--------------LVFEYLDT-DLKQYMD------------DCGG 98

Query: 511 FLQRINIAI---DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGL--AKLL 565
            L   N+ +    +   L Y H        H DLKP N+L+       +ADFGL  AK +
Sbjct: 99  GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSV 155

Query: 566 PPAHLQTSSIGVKGTIGYIAPAEYGLGS-EVSINGDVYSYGILLLELMT 613
           P    +T S  V  T+ Y  P +  LGS E S + D++  G +  E+ T
Sbjct: 156 PS---KTYSNEVV-TLWY-RPPDVLLGSTEYSTSLDMWGVGCIFYEMAT 199

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 58.9 bits (142), Expect = 3e-09
 Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 28/210 (13%)

Query: 411 GSFGSVYKGI-LDEGKTI---IAVKVL-NLLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G+FG+VYKG+ + EG+ +   +A+K L       A+K  + E   + ++ + ++ ++L +
Sbjct: 18  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 77

Query: 466 C--SGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
           C  S V         L+ + M  G L +++          E    +     +N  + +A 
Sbjct: 78  CLTSTVQ--------LITQLMPFGCLLDYVR---------EHKDNIGSQYLLNWCVQIAK 120

Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGY 583
            + YL    +    H DL   NVL+       + DFGLAKLL     +  + G K  I +
Sbjct: 121 GMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKW 177

Query: 584 IAPAEYGLGSEVSINGDVYSYGILLLELMT 613
           +A  E  L    +   DV+SYG+ + ELMT
Sbjct: 178 MA-LESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 58.4 bits (141), Expect = 3e-09
 Identities = 57/215 (26%), Positives = 100/215 (46%), Gaps = 25/215 (11%)

Query: 401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNL-LHHGASKSSIAECSALRNIRHKNL 459
           S+L L  +  GS+ +VYKGI      ++A+KV+++    G   ++I E S L+ ++H N+
Sbjct: 6   SYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANI 65

Query: 460 VKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI 519
           V +  +         +    V+E+MH   L +++         ++ P  L+         
Sbjct: 66  VLLHDII-----HTKETLTFVFEYMHT-DLAQYM---------IQHPGGLHPYNVRLFMF 110

Query: 520 DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLA--KLLPPAHLQTSSIGV 577
            +   L Y+H        H DLKP N+L+ +     +ADFGLA  K +P    QT S  V
Sbjct: 111 QLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPS---QTYSSEV 164

Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELM 612
             T+ Y  P      ++ S   D++  G + +E++
Sbjct: 165 V-TLWYRPPDVLLGATDYSSALDIWGAGCIFIEML 198

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 58.6 bits (142), Expect = 3e-09
 Identities = 75/243 (30%), Positives = 112/243 (46%), Gaps = 43/243 (17%)

Query: 402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKNL 459
           F  +  I  G++G VYK    +   ++A+K + L +   G   ++I E   LR + H+N+
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68

Query: 460 VKILTVCSGVDYKGD--DFKA------LVYEFM-HN--GSLEEWLHPVSGADKTVEAPKC 508
           V +  +   V  K D  DFK       LV+E+M H+  G LE      SG     E    
Sbjct: 69  VNLKEI---VTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLE------SGLVHFSEDHIK 119

Query: 509 LNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPA 568
               Q +         L Y H   +    H D+K SN+LL+++    +ADFGLA+L    
Sbjct: 120 SFMKQLLE-------GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSE 169

Query: 569 HLQTSSIGVKGTIGYIAPAEYGLGSEV---SINGDVYSYGILLLELMTRKRPSDIMFEGN 625
             +  +  V  T+ Y  P E  LG E    +I  DV+S G +L EL T K+P   +F+ N
Sbjct: 170 ESRPYTNKVI-TLWY-RPPELLLGEERYGPAI--DVWSCGCILGELFT-KKP---IFQAN 221

Query: 626 MNL 628
             L
Sbjct: 222 QEL 224

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 58.1 bits (141), Expect = 4e-09
 Identities = 53/221 (23%), Positives = 87/221 (39%), Gaps = 39/221 (17%)

Query: 404 FLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG--ASKSSIAECSALRNIRHKNLVK 461
            L  +  G++G V K        I+A+K            K+++ E   LR +RH+N+V 
Sbjct: 5   VLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVN 64

Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDV 521
           +        ++      LV+E++    LE       G     +A +   + Q +      
Sbjct: 65  LKEA-----FRRKGRLYLVFEYVERTLLELLEASPGGLPP--DAVRSYIW-QLLQ----- 111

Query: 522 ACALKYLH-HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL--PPAHLQTSSIGVK 578
             A+ Y H H+      H D+KP N+L+       + DFG A+ L   PA   T  +   
Sbjct: 112 --AIAYCHSHNI----IHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV--- 162

Query: 579 GTIGYIAP------AEYGLGSEVSINGDVYSYGILLLELMT 613
            T  Y AP        YG         DV++ G ++ EL+ 
Sbjct: 163 ATRWYRAPELLVGDTNYGKPV------DVWAIGCIMAELLD 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 57.4 bits (139), Expect = 5e-09
 Identities = 57/220 (25%), Positives = 89/220 (40%), Gaps = 24/220 (10%)

Query: 404 FLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGAS-KSSIAECSALRNIRHKNLVKI 462
            +  I +G+   VY  I       +A+K ++L     S      E  A+    H N+VK 
Sbjct: 5   LIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVK- 63

Query: 463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWL---HPVSGADKTVEAPKCLNFLQRINIAI 519
               S V     D   LV  ++  GSL + +   +P  G D+ + A           +  
Sbjct: 64  -YYTSFVV---GDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIA----------TVLK 109

Query: 520 DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGL-AKLLPPAHLQTSS-IGV 577
           +V   L+YLH + Q    H D+K  N+LL  + +  +ADFG+ A L              
Sbjct: 110 EVLKGLEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTF 166

Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
            GT  ++AP             D++S+GI  +EL T   P
Sbjct: 167 VGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAP 206

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 57.7 bits (139), Expect = 6e-09
 Identities = 55/217 (25%), Positives = 104/217 (47%), Gaps = 27/217 (12%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKILTVCSGV 469
           G++ +VYKG       ++A+K + L H  GA  ++I E S L++++H N+V +  +    
Sbjct: 17  GTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII--- 73

Query: 470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH 529
               +    LV+E++ +  L+++L              C N +   N+ + +   L+ L+
Sbjct: 74  --HTEKSLTLVFEYL-DKDLKQYLD------------DCGNSINMHNVKLFLFQLLRGLN 118

Query: 530 HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEY 589
           +  +    H DLKP N+L++      +ADFGLA+      + T +   +    +  P + 
Sbjct: 119 YCHRRKVLHRDLKPQNLLINERGELKLADFGLAR---AKSIPTKTYSNEVVTLWYRPPDI 175

Query: 590 GLGS-EVSINGDVYSYGILLLELMTRKRPSDIMFEGN 625
            LGS + S   D++  G +  E+ T  RP   +F G+
Sbjct: 176 LLGSTDYSTQIDMWGVGCIFYEMST-GRP---LFPGS 208

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 57.5 bits (140), Expect = 6e-09
 Identities = 42/160 (26%), Positives = 67/160 (41%), Gaps = 29/160 (18%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIR-------HKNLVKIL 463
           G+FGSVY     E   ++A+K +          S  EC  LR ++       H N+VK+ 
Sbjct: 10  GTFGSVYLARNKETGELVAIKKMK-----KKFYSWEECMNLREVKSLRKLNEHPNIVKLK 64

Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            V     ++ +D    V+E+M  G+L      +          K  +     +I   +  
Sbjct: 65  EV-----FRENDELYFVFEYM-EGNL---YQLMKDRKG-----KPFSESVIRSIIYQILQ 110

Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAK 563
            L ++H        H DLKP N+L+       +ADFGLA+
Sbjct: 111 GLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAR 147

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 57.3 bits (138), Expect = 8e-09
 Identities = 44/147 (29%), Positives = 68/147 (46%), Gaps = 15/147 (10%)

Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
           Y+  D   LV   M+ G L+   H     +   E  + + +      A ++ C L+ LH 
Sbjct: 69  YETKDALCLVLTLMNGGDLK--FHIYHMGEAGFEEGRAVFY------AAEICCGLEDLH- 119

Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
             Q    + DLKP N+LLD      ++D GLA  +P    QT   G  GT+GY+AP E  
Sbjct: 120 --QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG--QTIK-GRVGTVGYMAP-EVV 173

Query: 591 LGSEVSINGDVYSYGILLLELMTRKRP 617
                + + D ++ G LL E++  + P
Sbjct: 174 KNERYTFSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 57.1 bits (138), Expect = 8e-09
 Identities = 51/223 (22%), Positives = 99/223 (44%), Gaps = 33/223 (14%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNL------LHHGASKSSI----AECSALRNIRHK 457
           I  G++G VY  +      ++AVK + L       H    K  +    +E   L+++ H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 458 NLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINI 517
           N+V+ L    G +   +++ ++  E++  GS+   L      +      + + F      
Sbjct: 69  NIVQYL----GFE-TTEEYLSIFLEYVPGGSIGSCLRTYGRFE-----EQLVRFFTE--- 115

Query: 518 AIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
              V   L YLH        H DLK  N+L+D +    ++DFG++K     +    ++ +
Sbjct: 116 --QVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSM 170

Query: 578 KGTIGYIAP---AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
           +G++ ++AP     Y  G    +  D++S G ++LE+   +RP
Sbjct: 171 QGSVFWMAPEVIHSYSQGYSAKV--DIWSLGCVVLEMFAGRRP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 57.3 bits (139), Expect = 9e-09
 Identities = 53/198 (26%), Positives = 88/198 (44%), Gaps = 37/198 (18%)

Query: 442 KSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA--LVYEFMHNGSLEEWLHPVSGA 499
           K ++ E   LR+ +H N++ I  +   +   G DFK   +V + M     E  LH +  +
Sbjct: 49  KRTLRELKILRHFKHDNIIAIRDI---LRPPGADFKDVYVVMDLM-----ESDLHHIIHS 100

Query: 500 DKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF 559
           D+ +       FL ++         LKY+H        H DLKPSN+L++ +    + DF
Sbjct: 101 DQPLTEEHIRYFLYQL------LRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDF 151

Query: 560 GLAKLLPPAHLQTSSIGVKG-------TIGYIAPAEYGLGS-EVSINGDVYSYGILLLEL 611
           G+A+      L +S    K        T  Y AP E  L   E +   D++S G +  E+
Sbjct: 152 GMARG-----LSSSPTEHKYFMTEYVATRWYRAP-ELLLSLPEYTTAIDMWSVGCIFAEM 205

Query: 612 MTRKRPSDIMFEGNMNLH 629
           + R++    +F G   +H
Sbjct: 206 LGRRQ----LFPGKNYVH 219

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 56.9 bits (137), Expect = 9e-09
 Identities = 75/302 (24%), Positives = 115/302 (38%), Gaps = 57/302 (18%)

Query: 411 GSFGSVYKGI-LDEGKTI---IAVKVLNL-LHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G+FG+VYKGI + +G+ +   +A+KVL       A+K  + E   +  +    + ++L +
Sbjct: 18  GAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGI 77

Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
           C     +      LV + M  G L          D   E    +     +N  + +A  +
Sbjct: 78  CLTSTVQ------LVTQLMPYGCL---------LDYVRENKDRIGSQDLLNWCVQIAKGM 122

Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            YL    +    H DL   NVL+       + DFGLA+LL     +  + G K  I ++A
Sbjct: 123 SYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMA 179

Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVLPDHVMDIV 644
             E  L    +   DV+SYG+ + ELMT   +P D                +PD      
Sbjct: 180 -LESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD----------GIPAREIPD------ 222

Query: 645 DSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQ 704
              LL   E L                  C I V  I V C M   + R     +V E  
Sbjct: 223 ---LLEKGERLPQPPI-------------CTIDVYMIMVKCWMIDSECRPRFRELVDEFS 266

Query: 705 SI 706
            +
Sbjct: 267 RM 268

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 57.2 bits (139), Expect = 9e-09
 Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 30/215 (13%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKNLVKILTV 465
           I+ G++G VY+    +   I+A+K L +     G   +S+ E + L  ++H N+V +  V
Sbjct: 13  IEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEV 72

Query: 466 CSGVDYKGDDFKALVYEFMHN---GSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVA 522
             G      D   +V E++ +     +E    P   ++      KCL  LQ ++      
Sbjct: 73  VVG---SNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEV-----KCL-MLQLLS------ 117

Query: 523 CALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP-PAHLQTSSIGVKGTI 581
             + +LH +      H DLK SN+LL++     + DFGLA+    P    T  + V  T+
Sbjct: 118 -GVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLV-V--TL 170

Query: 582 GYIAPAEYGLG-SEVSINGDVYSYGILLLELMTRK 615
            Y AP E  LG  E S   D++S G +  EL+T+K
Sbjct: 171 WYRAP-ELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 56.9 bits (137), Expect = 1e-08
 Identities = 41/147 (27%), Positives = 68/147 (46%), Gaps = 15/147 (10%)

Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
           Y+  D   LV   M+ G L+   H  +  +   E  + L +      A ++ C L+ LH 
Sbjct: 69  YETKDALCLVLTIMNGGDLK--FHIYNMGNPGFEEERALFY------AAEILCGLEDLH- 119

Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
             +  T + DLKP N+LLD      ++D GLA  +P        +   GT+GY+AP E  
Sbjct: 120 --RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV---GTVGYMAP-EVL 173

Query: 591 LGSEVSINGDVYSYGILLLELMTRKRP 617
                +++ D +  G L+ E++  + P
Sbjct: 174 NNQRYTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 57.0 bits (137), Expect = 1e-08
 Identities = 69/238 (28%), Positives = 97/238 (40%), Gaps = 48/238 (20%)

Query: 402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNL---LHHGASKSSIAECSALRNIRHKN 458
           F+ L  I  GSFG+VY         ++AVK ++      +   +  I E   L+ ++H N
Sbjct: 23  FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82

Query: 459 LVKILTVCSGVDYKGDDFKA----LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQR 514
            +         +YKG   K     LV E+            +  A   +E  K    LQ 
Sbjct: 83  TI---------EYKGCYLKEHTAWLVMEYC-----------LGSASDLLEVHK--KPLQE 120

Query: 515 INIAIDVACALK---YLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQ 571
           + IA     AL+   YLH        H D+K  N+LL       +ADFG A    PA+  
Sbjct: 121 VEIAAITHGALQGLAYLHSHNM---IHRDIKAGNILLTEPGQVKLADFGSASKSSPAN-- 175

Query: 572 TSSIGVKGTIGYIAPAEYGLGSEVSING--DVYSYGILLLELMTRKRPSDIMFEGNMN 627
                  GT  ++AP       E   +G  DV+S GI  +EL  RK P   +F  NMN
Sbjct: 176 ----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP---LF--NMN 224

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 56.6 bits (137), Expect = 1e-08
 Identities = 64/219 (29%), Positives = 100/219 (45%), Gaps = 42/219 (19%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKNLVKILTVCSG 468
           G++G VYK        I+A+K + L     G   ++I E S L+ + H N+V++L V   
Sbjct: 10  GTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVH- 68

Query: 469 VDYKGDDFKA-LVYEFMHNGSLEEWL--HPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                 + K  LV+EF+    L++++   P++G D  +     L  L +          +
Sbjct: 69  -----SENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPL-IKSYLYQLLQ---------GI 112

Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKG------ 579
            Y H        H DLKP N+L+D E    +ADFGLA+           + V+       
Sbjct: 113 AYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAF--------GVPVRTYTHEVV 161

Query: 580 TIGYIAPAEYGLGS-EVSINGDVYSYGILLLELMTRKRP 617
           T+ Y AP E  LGS + S   D++S G +  E M  +RP
Sbjct: 162 TLWYRAP-EILLGSRQYSTPVDIWSIGCIFAE-MVNRRP 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 57.0 bits (138), Expect = 1e-08
 Identities = 61/227 (26%), Positives = 98/227 (43%), Gaps = 33/227 (14%)

Query: 441 SKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA--LVYEFMHNGSLEEWLHPVSG 498
           +K ++ E   LR++ H+N++ I  +        + F    +VYE M        LH +  
Sbjct: 48  AKRTLREIKLLRHLDHENVIAIKDIMPPPHR--EAFNDVYIVYELMDTD-----LHQIIR 100

Query: 499 ADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD 558
           + +T+    C  FL ++         LKY+H        H DLKPSN+LL+      + D
Sbjct: 101 SSQTLSDDHCQYFLYQL------LRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICD 151

Query: 559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPS 618
           FGLA+         +   V  T  Y AP      SE +   DV+S G +  EL+ RK P 
Sbjct: 152 FGLARTTSEKGDFMTEYVV--TRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK-P- 207

Query: 619 DIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQ 665
             +F G   +H          + +++ S     +EDL    N++ R+
Sbjct: 208 --LFPGKDYVHQLKL------ITELLGS---PSEEDLGFIRNEKARR 243

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 59/217 (27%), Positives = 98/217 (45%), Gaps = 35/217 (16%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           I  GSFG V+KGI +  + ++A+K+++L          AE   + +I+ +  + +L+ C 
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--------AE-DEIEDIQQE--ITVLSQCD 60

Query: 468 G---VDYKGDDFKA----LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAID 520
                 Y G   K     ++ E++  GS  + L P          P  L+  Q   I  +
Sbjct: 61  SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP---------GP--LDETQIATILRE 109

Query: 521 VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGT 580
           +   L YLH +      H D+K +NVLL       +ADFG+A  L    ++ ++    GT
Sbjct: 110 ILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF--VGT 164

Query: 581 IGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
             ++AP E    S      D++S GI  +EL   + P
Sbjct: 165 PFWMAP-EVIKQSAYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 54/205 (26%), Positives = 88/205 (42%), Gaps = 21/205 (10%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVL-NLLHHGASKSSIAECSALRNIRHKNLVKILTVC 466
           I  G+FG V+ G L    T +AVK     L        + E   L+   H N+V+++ VC
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 467 SGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALK 526
           +    K   +  +V E +  G    +L          E P+ L   + I +  + A  ++
Sbjct: 63  T---QKQPIY--IVMELVQGGDFLTFLRT--------EGPR-LKVKELIQMVENAAAGME 108

Query: 527 YLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGT-IGYIA 585
           YL         H DL   N L+  +    ++DFG+++      +  S+ G+K   + + A
Sbjct: 109 YLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDG-VYASTGGMKQIPVKWTA 164

Query: 586 PAEYGLGSEVSINGDVYSYGILLLE 610
           P     G   S   DV+S+GILL E
Sbjct: 165 PEALNYG-RYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 56.6 bits (136), Expect = 2e-08
 Identities = 73/261 (27%), Positives = 108/261 (41%), Gaps = 52/261 (19%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGAS---KSSIAECSALRNIRHKNLVKILT 464
           I  GSFG+VY         ++A+K ++     ++   +  I E   L+ I+H N      
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN------ 86

Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWL---HPVSGADKTVEAPKCLNFLQRINIAIDV 521
               ++YKG       Y   H      WL   + +  A   +E  K    LQ + IA   
Sbjct: 87  ---SIEYKG------CYLREHTA----WLVMEYCLGSASDLLEVHK--KPLQEVEIAAIT 131

Query: 522 ACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTI 581
             AL+ L +       H D+K  N+LL       +ADFG A +  PA+         GT 
Sbjct: 132 HGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN------SFVGTP 185

Query: 582 GYIAPAEYGLGSEVSING--DVYSYGILLLELMTRKRPSDIMFEGNMN----LHNFARTV 635
            ++AP       E   +G  DV+S GI  +EL  RK P   +F  NMN    L++ A+  
Sbjct: 186 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP---LF--NMNAMSALYHIAQNE 240

Query: 636 LP--------DHVMDIVDSTL 648
            P        D+  + VDS L
Sbjct: 241 SPTLQSNEWSDYFRNFVDSCL 261

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 56.4 bits (137), Expect = 2e-08
 Identities = 61/193 (31%), Positives = 87/193 (45%), Gaps = 45/193 (23%)

Query: 456 HKNLVKILTVCSGVDYKGDDFKA--LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQ 513
           H N+VK+L V      K ++ K   LV+E+M     E  LH V  A          N L+
Sbjct: 66  HPNIVKLLNV-----IKAENDKDIYLVFEYM-----ETDLHAVIRA----------NILE 105

Query: 514 RIN---IAIDVACALKYLHHDCQPTTA---HCDLKPSNVLLDHEMTAHVADFGLAKLLPP 567
            ++   I   +  ALKY+H      +    H DLKPSN+LL+ +    +ADFGLA+ L  
Sbjct: 106 DVHKRYIMYQLLKALKYIH------SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159

Query: 568 AHLQTSSIGVK----GTIGYIAPAEYGLGSEVSING-DVYSYGILLLELMTRKRPSDIMF 622
              +     V      T  Y AP E  LGS     G D++S G +L E M   +P   +F
Sbjct: 160 -LEENPENPVLTDYVATRWYRAP-EILLGSTRYTKGVDMWSVGCILGE-MLLGKP---LF 213

Query: 623 EGNMNLHNFARTV 635
            G   L+   + +
Sbjct: 214 PGTSTLNQLEKII 226

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 55.9 bits (135), Expect = 2e-08
 Identities = 35/106 (33%), Positives = 54/106 (50%), Gaps = 8/106 (7%)

Query: 517 IAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIG 576
           IA+ +  AL+YLH   + +  H D+KPSNVL++      + DFG++  L  +  +T   G
Sbjct: 108 IAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAG 165

Query: 577 VKGTIGYIAPAEY---GLGSEVSINGDVYSYGILLLELMTRKRPSD 619
            K    Y+AP             +  DV+S GI ++EL T + P D
Sbjct: 166 CK---PYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 55.6 bits (134), Expect = 3e-08
 Identities = 34/100 (34%), Positives = 47/100 (47%), Gaps = 7/100 (7%)

Query: 518 AIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           A  + C L++LH   Q    + DLKP NVLLD      ++D GLA  L          G 
Sbjct: 101 AAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGR 154

Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
            GT GY+AP E   G     + D ++ G  L E++  + P
Sbjct: 155 AGTPGYMAP-EVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 55.0 bits (132), Expect = 3e-08
 Identities = 61/205 (29%), Positives = 88/205 (42%), Gaps = 29/205 (14%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNL-LHHGASKSSIAECSALRNIRHKNLVKILTVCSGV 469
           G+FG V+KG L + KT +AVK     L        ++E   L+   H N+VK++ VC+  
Sbjct: 6   GNFGEVFKGTLKD-KTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQR 64

Query: 470 D--YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
              Y       +V E +  G    +L       KT          Q +  A+D A  + Y
Sbjct: 65  QPIY-------IVMELVPGGDFLSFLRKKKDELKTK---------QLVKFALDAAAGMAY 108

Query: 528 LH-HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGT-IGYIA 585
           L   +C     H DL   N L+       ++DFG+++         SS G+K   I + A
Sbjct: 109 LESKNC----IHRDLAARNCLVGENNVLKISDFGMSRQEDDG--IYSSSGLKQIPIKWTA 162

Query: 586 PAEYGLGSEVSINGDVYSYGILLLE 610
           P     G   S   DV+SYGILL E
Sbjct: 163 PEALNYGRYSS-ESDVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 55.2 bits (133), Expect = 3e-08
 Identities = 56/213 (26%), Positives = 92/213 (43%), Gaps = 27/213 (12%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G++G VY       +  IA+K +        +    E +    ++H+N+V+ L    G D
Sbjct: 19  GTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYL----GSD 74

Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
            +   FK +  E +  GSL   L    G  K  E    + F  +      +   LKYLH 
Sbjct: 75  SENGFFK-IFMEQVPGGSLSALLRSKWGPLKDNEQ--TIIFYTK-----QILEGLKYLHD 126

Query: 531 DCQPTTAHCDLKPSNVLLD-HEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP--- 586
           +      H D+K  NVL++ +     ++DFG +K L   +  T +    GT+ Y+AP   
Sbjct: 127 N---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF--TGTLQYMAPEVI 181

Query: 587 --AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
                G G+      D++S G  ++E+ T K P
Sbjct: 182 DKGPRGYGAP----ADIWSLGCTIVEMATGKPP 210

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 55.0 bits (132), Expect = 4e-08
 Identities = 57/216 (26%), Positives = 101/216 (46%), Gaps = 29/216 (13%)

Query: 411 GSFGSVYKGIL-----DEGKTIIAVKVLNLLHHGASKSS----IAECSALRNIRHKNLVK 461
           GSFG VY+GI      DE +T +A+K +N     AS       + E S ++     ++V+
Sbjct: 17  GSFGMVYEGIAKGVVKDEPETRVAIKTVN---EAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKT--VEAPKCLNFLQRINIAI 519
           +L V S    +G     ++ E M  G L+ +L  +    +   V+AP  L   + I +A 
Sbjct: 74  LLGVVS----QGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLK--KMIQMAG 126

Query: 520 DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKG 579
           ++A  + YL+ +      H DL   N ++  + T  + DFG+ + +          G KG
Sbjct: 127 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK--GGKG 181

Query: 580 --TIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
              + +++P     G   +   DV+S+G++L E+ T
Sbjct: 182 LLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 54.7 bits (131), Expect = 4e-08
 Identities = 57/221 (25%), Positives = 99/221 (44%), Gaps = 35/221 (15%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           I  GSFG V+KGI +  + ++A+K+++L          AE   + +I+ +  + +L+ C 
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--------AE-DEIEDIQQE--ITVLSQCD 60

Query: 468 G---VDYKGDDFKA----LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAID 520
                 Y G   K     ++ E++  GS  + L            P   +  Q   +  +
Sbjct: 61  SPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA---------GP--FDEFQIATMLKE 109

Query: 521 VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGT 580
           +   L YLH +      H D+K +NVLL  +    +ADFG+A  L    ++ ++    GT
Sbjct: 110 ILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF--VGT 164

Query: 581 IGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIM 621
             ++AP E    S      D++S GI  +EL   + P+  M
Sbjct: 165 PFWMAP-EVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 54.6 bits (132), Expect = 5e-08
 Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 29/207 (14%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G++G VYK        ++A+KV+ L      +    E S L+  RH N+V          
Sbjct: 14  GTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFG-----S 68

Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
           Y   D   +V E+   GSL++      G          L+ LQ   +  +    L YLH 
Sbjct: 69  YLRRDKLWIVMEYCGGGSLQDIYQVTRGP---------LSELQIAYVCRETLKGLAYLHE 119

Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK----GTIGYIAP 586
                  H D+K +N+LL  +    +ADFG++  L      T++I  +    GT  ++AP
Sbjct: 120 T---GKIHRDIKGANILLTEDGDVKLADFGVSAQL------TATIAKRKSFIGTPYWMAP 170

Query: 587 AEYGLGSEVSING--DVYSYGILLLEL 611
               +  +   +G  D+++ GI  +EL
Sbjct: 171 EVAAVERKGGYDGKCDIWALGITAIEL 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 55.1 bits (132), Expect = 5e-08
 Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 25/205 (12%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKILTVCSGV 469
           GS+ +VYKG       ++A+KV+ L    G   ++I E S L+ ++H N+V +  +    
Sbjct: 16  GSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII--- 72

Query: 470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH 529
                +   LV+E++H   L +++    G             L   N+ + +   L+ L 
Sbjct: 73  --HTKETLTLVFEYVHT-DLCQYMDKHPGG------------LHPENVKLFLFQLLRGLS 117

Query: 530 HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP-PAHLQTSSIGVKGTIGYIAPAE 588
           +  Q    H DLKP N+L+       +ADFGLA+    P+H  ++ +    T+ Y  P +
Sbjct: 118 YIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEV---VTLWY-RPPD 173

Query: 589 YGLGS-EVSINGDVYSYGILLLELM 612
             LGS E S   D++  G + +E++
Sbjct: 174 VLLGSTEYSTCLDMWGVGCIFVEMI 198

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 54.7 bits (132), Expect = 5e-08
 Identities = 60/230 (26%), Positives = 100/230 (43%), Gaps = 38/230 (16%)

Query: 405 LCWIDMGSFGSVYKGIL-----DEGKTIIAVKVLNLLHHGASKSS-IAECSALRNI-RHK 457
              +  G+FG V K            + +AVK+L         S  ++E   ++ I +HK
Sbjct: 17  GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 76

Query: 458 NLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLH------PVSGADKTVEAPKCLNF 511
           N++ +L VC+    +G  +  +V E+  +G+L ++L         +  D      + L  
Sbjct: 77  NIINLLGVCTQ---EGPLY--VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131

Query: 512 LQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLL--DHEMTAHVADFGLAKLLPPAH 569
              ++ A  VA  +++L         H DL   NVL+  DH M   +ADFGLA+      
Sbjct: 132 KDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMK--IADFGLAR-----D 181

Query: 570 LQTSSIGVKGTIG-----YIAPAEYGLGSEV-SINGDVYSYGILLLELMT 613
           +       K T G     ++AP    L   V +   DV+S+G+LL E+ T
Sbjct: 182 IHHIDYYRKTTNGRLPVKWMAPE--ALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 55.2 bits (133), Expect = 5e-08
 Identities = 34/100 (34%), Positives = 53/100 (53%), Gaps = 6/100 (6%)

Query: 518 AIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           A ++ C L++LH        + DLK  NVLLD +    +ADFG+ K       + S+   
Sbjct: 102 AAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC- 157

Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
            GT  YIAP E   G + + + D +S+G+LL E++  + P
Sbjct: 158 -GTPDYIAP-EILKGQKYNESVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 54.9 bits (132), Expect = 5e-08
 Identities = 67/228 (29%), Positives = 96/228 (42%), Gaps = 34/228 (14%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLN---LLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           GSFG V    L E   + AVKVL    +L     + ++ E   L   R+   +  L  C 
Sbjct: 6   GSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCC- 64

Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
              ++  D    V EF++ G L   +  +  + +  EA            A ++  AL +
Sbjct: 65  ---FQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARF-------YAAEITSALMF 111

Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP- 586
           LH        + DLK  NVLLDHE    +ADFG+ K        TS+    GT  YIAP 
Sbjct: 112 LH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC--GTPDYIAPE 166

Query: 587 --AEYGLGSEVSINGDVYSYGILLLELMTRKRP-----SDIMFEGNMN 627
              E   G  V    D ++ G+LL E++    P      D +FE  +N
Sbjct: 167 ILQEMLYGPSV----DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 210

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 55.0 bits (132), Expect = 6e-08
 Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 24/218 (11%)

Query: 411 GSFGSVYK----GILDEGKTIIAVKVLNLLHHGASKSS----IAECSALRNI-RHKNLVK 461
           G FG V +    GI            + +L   A+       I+E   ++ I +HKN++ 
Sbjct: 23  GCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIIN 82

Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHP--VSGADKTVEAPKC----LNFLQRI 515
           +L VC+    +G  +  ++ E+   G+L E+L      G D T +  K     L+F   +
Sbjct: 83  LLGVCT---QEGPLY--VIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137

Query: 516 NIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSI 575
           + A  VA  ++YL         H DL   NVL+  +    +ADFGLA+ +        + 
Sbjct: 138 SCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS 194

Query: 576 GVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             +  + ++AP E       +   DV+S+GIL+ E+ T
Sbjct: 195 NGRLPVKWMAP-EALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 55.6 bits (134), Expect = 7e-08
 Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 1/90 (1%)

Query: 84  LDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGT 143
           L ++N    G +P  I      L+++  + N I  +IP  +G   +L+ L +  N  +G+
Sbjct: 423 LGLDNQGLRGFIPNDISKLR-HLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481

Query: 144 ISPAIGELQNLVTLAINTNKLSGNIPPSIG 173
           I  ++G+L +L  L +N N LSG +P ++G
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 54.1 bits (130), Expect = 7e-08
 Identities = 63/225 (28%), Positives = 97/225 (43%), Gaps = 31/225 (13%)

Query: 410 MGSFGSVYKGILDEGKTIIAVKV-LNLLHHGA--SKSSIAECSALRNIRHKNLVKILTVC 466
           M   GS   G++  GK    +KV +  ++ GA   +  I E   +  + H  LV++  VC
Sbjct: 9   MKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68

Query: 467 SGVDYKGDDFKAL--VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
           +         K L  V EFM NG L  +L    G      +   L     +++  DV   
Sbjct: 69  T-------QQKPLYIVTEFMENGCLLNYLRQRQG----KLSKDML-----LSMCQDVCEG 112

Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYI 584
           ++YL    + +  H DL   N L+       V+DFG+ + +      TSS G K  + + 
Sbjct: 113 MEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TSSSGAKFPVKWS 168

Query: 585 APAEYGLGSEVSINGDVYSYGILLLELMTR-KRPSDIMFEGNMNL 628
            P E    S+ S   DV+S+G+L+ E+ T  K P    FE   N 
Sbjct: 169 PP-EVFNFSKYSSKSDVWSFGVLMWEVFTEGKMP----FEKKSNY 208

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 54.4 bits (131), Expect = 7e-08
 Identities = 74/320 (23%), Positives = 115/320 (35%), Gaps = 86/320 (26%)

Query: 411 GSFGSVYKGIL-----DEGKTIIAVKVLNLLHHGASKSS-IAECSALRNIRHKNLVKILT 464
           G+FG VY+G+      D  +  +AVK L        +S  + E   +    H+N+V+   
Sbjct: 17  GAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR--- 73

Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
              GV ++    + ++ E M  G L+ +L          E P  L     +  A DVA  
Sbjct: 74  -LIGVSFERLP-RFILLELMAGGDLKSFLRE---NRPRPERPSSLTMKDLLFCARDVAKG 128

Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHE---MTAHVADFGLAK--------------LLPP 567
            KYL  +      H D+   N LL  +     A +ADFG+A+              +LP 
Sbjct: 129 CKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLP- 184

Query: 568 AHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNM- 626
                    +K       P E  L    +   DV+S+G+LL E+ +          G M 
Sbjct: 185 ---------IKWM-----PPEAFLDGIFTSKTDVWSFGVLLWEIFSL---------GYMP 221

Query: 627 --NLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVA 684
                N         VM+ V                      R++    C   V RI   
Sbjct: 222 YPGRTN-------QEVMEFV------------------TGGGRLDPPKGCPGPVYRIMTD 256

Query: 685 CSMESPQDRMNMTIVVHELQ 704
           C   +P+DR N   ++  +Q
Sbjct: 257 CWQHTPEDRPNFATILERIQ 276

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 54.3 bits (131), Expect = 9e-08
 Identities = 36/109 (33%), Positives = 51/109 (46%), Gaps = 14/109 (12%)

Query: 518 AIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAK--LLPPAHLQTSSI 575
           A ++   L++LH   +    + DLK  NVLLD E    +ADFG+ K  +L      T   
Sbjct: 102 AAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC- 157

Query: 576 GVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEG 624
              GT  YIAP E           D ++ G+LL E++  + P    FEG
Sbjct: 158 ---GTPDYIAP-EILSYQPYGPAVDWWALGVLLYEMLAGQSP----FEG 198

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 53.9 bits (129), Expect = 9e-08
 Identities = 54/217 (24%), Positives = 100/217 (46%), Gaps = 29/217 (13%)

Query: 413 FGSVYKGIL-----DEGKTIIAVKVLNLLHHGASKSSIAECSALRN-IRHKNLVKILTVC 466
           FG VYKG L      E    +A+K L     G  +      + +R+ ++H N+V +L V 
Sbjct: 18  FGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVV 77

Query: 467 SGVDYKGDDFKALVYEFMHNGSLEEWL-----HPVSGA---DKTVEAPKCLNFLQRINIA 518
           +      +   ++++ +  +  L E+L     H   G+   DKTV++   L     ++I 
Sbjct: 78  TK-----EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS--TLEPADFVHIV 130

Query: 519 IDVACALKYL--HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIG 576
             +A  +++L  HH       H DL   NVL+  ++   ++D GL + +  A        
Sbjct: 131 TQIAAGMEFLSSHHVV-----HKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGN 185

Query: 577 VKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
               I +++P     G + SI+ D++SYG++L E+ +
Sbjct: 186 SLLPIRWMSPEAIMYG-KFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 54.2 bits (130), Expect = 1e-07
 Identities = 40/124 (32%), Positives = 62/124 (50%), Gaps = 8/124 (6%)

Query: 496 VSGADKTVEAPKCLNF-LQRINI-AIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMT 553
           ++G D       C  F L R    A ++ C L++LH        + DLK  N+LLD +  
Sbjct: 78  LNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGH 134

Query: 554 AHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             +ADFG+ K       +T +    GT  YIAP E  LG + + + D +S+G+LL E++ 
Sbjct: 135 IKIADFGMCKENMLGDAKTCTFC--GTPDYIAP-EILLGQKYNTSVDWWSFGVLLYEMLI 191

Query: 614 RKRP 617
            + P
Sbjct: 192 GQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 53.9 bits (129), Expect = 1e-07
 Identities = 47/176 (26%), Positives = 81/176 (46%), Gaps = 16/176 (9%)

Query: 445 IAECSALRNI-RHKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHP--VSGADK 501
           ++E   ++ I +HKN++ +L  C+    +      LV E+   G+L E+L      G D 
Sbjct: 65  VSEMEMMKMIGKHKNIINLLGACT----QDGPLYVLV-EYASKGNLREYLRARRPPGMDY 119

Query: 502 TVEAPKC----LNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA 557
           + +  K     L F   ++ A  VA  ++YL         H DL   NVL+  +    +A
Sbjct: 120 SFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIA 176

Query: 558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
           DFGLA+ +        +   +  + ++AP E       +   DV+S+G+LL E+ T
Sbjct: 177 DFGLARDVHNIDYYKKTTNGRLPVKWMAP-EALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 54.0 bits (130), Expect = 1e-07
 Identities = 56/185 (30%), Positives = 75/185 (40%), Gaps = 28/185 (15%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLN---LLHHGASKSSIAECSAL-RNIRHKNLVKIL 463
           I  GSFG V            AVKVL    +L     K  +AE + L +N++H  LV   
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV--- 59

Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQ-RINI-AIDV 521
                          L Y F     L   L  V+G +      +  +F + R    A ++
Sbjct: 60  --------------GLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEI 105

Query: 522 ACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTI 581
           A AL YLH        + DLKP N+LLD +    + DFGL K        TS+    GT 
Sbjct: 106 ASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC--GTP 160

Query: 582 GYIAP 586
            Y+AP
Sbjct: 161 EYLAP 165

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 53.4 bits (128), Expect = 1e-07
 Identities = 67/270 (24%), Positives = 115/270 (42%), Gaps = 54/270 (20%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSI--------AECSALRNIRHKNLVKI 462
           G++G+VY G+ ++G+ +IAVK + L    ++  +          E   L++++H N+V+ 
Sbjct: 11  GAYGTVYCGLTNQGQ-LIAVKQVEL--DTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67

Query: 463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVA 522
           L  C       D+  ++  EF+  GS+   L+      + V        L          
Sbjct: 68  LGTC-----LDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD--------- 113

Query: 523 CALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP--PAHLQTSSI--GVK 578
             + YLH++C     H D+K +NV+L       + DFG A+ L     H   S++   + 
Sbjct: 114 -GVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMH 169

Query: 579 GTIGYIAPA---EYGLGSEVSINGDVYSYGILLLELMTRKRP-------SDIMFEGNMNL 628
           GT  ++AP    E G G +     D++S G  + E+ T K P       + + + G    
Sbjct: 170 GTPYWMAPEVINESGYGRK----SDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGA--- 222

Query: 629 HNFARTVLPDH----VMDIVDSTLLADDED 654
           H      LPD      +D V S L  D  +
Sbjct: 223 HRGLMPRLPDSFSAAAIDFVTSCLTRDQHE 252

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 53.2 bits (128), Expect = 2e-07
 Identities = 59/221 (26%), Positives = 103/221 (46%), Gaps = 27/221 (12%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNLVKILTV 465
           I  G++G+V+K    E   I+A+K + L     G   S++ E   L+ ++HKN+V++  V
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                   D    LV+E+  +  L+++    +G    ++     +F+ ++         L
Sbjct: 68  -----LHSDKKLTLVFEYC-DQDLKKYFDSCNG---DIDPEIVKSFMFQL---------L 109

Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
           K L         H DLKP N+L++      +ADFGLA+         S+  V  T+ Y  
Sbjct: 110 KGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV--TLWYRP 167

Query: 586 PAEYGLGSEV-SINGDVYSYGILLLELMTRKRPSDIMFEGN 625
           P +   G+++ S + D++S G +  EL    RP   +F GN
Sbjct: 168 P-DVLFGAKLYSTSIDMWSAGCIFAELANAGRP---LFPGN 204

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 53.5 bits (128), Expect = 2e-07
 Identities = 48/172 (27%), Positives = 81/172 (47%), Gaps = 34/172 (19%)

Query: 456 HKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLH---------PVSGADKTVEAP 506
           H N++ +L  C   +++G  +  L  E+  +G+L ++L            + A+ T    
Sbjct: 67  HPNIINLLGAC---EHRG--YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST- 120

Query: 507 KCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP 566
             L+  Q ++ A DVA  + YL    Q    H DL   N+L+     A +ADFGL++   
Sbjct: 121 --LSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--- 172

Query: 567 PAHLQTSSIGVKGTIGYIAPAEY----GLGSEV-SINGDVYSYGILLLELMT 613
                   + VK T+G + P  +     L   V + N DV+SYG+LL E+++
Sbjct: 173 -----GQEVYVKKTMGRL-PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 52.8 bits (127), Expect = 2e-07
 Identities = 58/226 (25%), Positives = 89/226 (39%), Gaps = 45/226 (19%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNLVK------- 461
           GS+GSVYK          A+K ++L  +     + ++ E   L ++ H N++        
Sbjct: 11  GSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD 70

Query: 462 ILTVCSGVDYK--GDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRI-NIA 518
              +C  ++Y   GD  KA+         + E                     Q I  I 
Sbjct: 71  GNKLCIVMEYAPFGDLSKAISKRKKKRKLIPE---------------------QEIWRIF 109

Query: 519 IDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK 578
           I +   L+ LH   +    H DLK +N+LL       + D G++K+L     +T      
Sbjct: 110 IQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKT----QI 162

Query: 579 GTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEG 624
           GT  Y+AP E   G   S   D++S G LL E+ T   P    FE 
Sbjct: 163 GTPHYMAP-EVWKGRPYSYKSDIWSLGCLLYEMATFAPP----FEA 203

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 53.3 bits (128), Expect = 2e-07
 Identities = 56/217 (25%), Positives = 96/217 (44%), Gaps = 38/217 (17%)

Query: 411 GSFGSVYK----GILDEGKTI-IAVKVLNLLHHGASKSSI-AECSALRNI-RHKNLVKIL 463
           G+FG V +    G+      + +AVK+L    H + + ++ +E   + ++  H+N+V +L
Sbjct: 46  GAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLL 105

Query: 464 TVC--SGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDV 521
             C   G          ++ E+   G L  +L      +  +     L+F      +  V
Sbjct: 106 GACTIGGPIL-------VITEYCCYGDLLNFLR--RKRESFLTLEDLLSF------SYQV 150

Query: 522 ACALKYL-HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGT 580
           A  + +L   +C     H DL   NVLL H     + DFGLA+ +    +  S+  VKG 
Sbjct: 151 AKGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDI----MNDSNYVVKGN 202

Query: 581 ----IGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
               + ++AP E       +   DV+SYGILL E+ +
Sbjct: 203 ARLPVKWMAP-ESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 52.6 bits (127), Expect = 2e-07
 Identities = 39/105 (37%), Positives = 50/105 (47%), Gaps = 20/105 (19%)

Query: 521 VAC---ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           +AC   A +YLH+       + DLKP N+LLD      + DFG AK L          G 
Sbjct: 99  IACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKL--------KSGQ 147

Query: 578 K-----GTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
           K     GT  Y+AP E  L      + D +S GILL EL+T + P
Sbjct: 148 KTWTFCGTPEYVAP-EIILNKGYDFSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 53.2 bits (128), Expect = 2e-07
 Identities = 61/217 (28%), Positives = 97/217 (44%), Gaps = 28/217 (12%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVK-VLNLLHHGASKSSI-AECSALRNIRHKNLVKILTV 465
           I  GS+G V   I       +A+K + ++  H +  + I  E   LR +RH ++V+I  +
Sbjct: 8   IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67

Query: 466 CSGVDYKGDDFKAL--VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
                 +  +FK +  V+E M     E  LH V  A+  +       FL ++        
Sbjct: 68  MLPPSRR--EFKDIYVVFELM-----ESDLHQVIKANDDLTPEHHQFFLYQL------LR 114

Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL----PPAHLQTSSIGVKG 579
           ALKY+H        H DLKP N+L + +    + DFGLA++     P A   T  +    
Sbjct: 115 ALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV---A 168

Query: 580 TIGYIAPAEYG-LGSEVSINGDVYSYGILLLELMTRK 615
           T  Y AP   G   S+ +   D++S G +  E++T K
Sbjct: 169 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 57/231 (24%), Positives = 100/231 (43%), Gaps = 45/231 (19%)

Query: 411 GSFGSVYKGILDE-----GKTIIAVKVLNLLHHGASKSS----IAECSALRNIRHKNLVK 461
           G FG V K          G T +AVK   +L   AS S     ++E + L+ + H +++K
Sbjct: 11  GEFGKVVKATAFRLKGRAGYTTVAVK---MLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLH------------PVSGADKTVEAP--K 507
           +   CS      D    L+ E+   GSL  +L               +     ++ P  +
Sbjct: 68  LYGACSQ-----DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122

Query: 508 CLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL-- 565
            L     I+ A  ++  ++YL    +    H DL   NVL+       ++DFGL++ +  
Sbjct: 123 ALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYE 179

Query: 566 PPAHLQTSS--IGVKGTIGYIAPAEYGLGSEV-SINGDVYSYGILLLELMT 613
             ++++ S   I VK    ++A     L   + +   DV+S+G+LL E++T
Sbjct: 180 EDSYVKRSKGRIPVK----WMAIES--LFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 53.0 bits (127), Expect = 3e-07
 Identities = 61/228 (26%), Positives = 102/228 (44%), Gaps = 13/228 (5%)

Query: 129 NLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFL 188
              T    +         +  E   +  LA+N +  +  + PS  +    L L       
Sbjct: 26  YHTTPQSINL----NFPDSNLESVAVNRLALNLSSNTLLLLPSSLSRLLSLDLLSPSGIS 81

Query: 189 QVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKL 248
            +    +L     L +++L+ N L   I   L++LT+L+  LDL  N +   +P  +G L
Sbjct: 82  SLDGSENLLNLLPLPSLDLNLNRLRSNISE-LLELTNLT-SLDLDNNNIT-DIPPLIGLL 138

Query: 249 -INLEILFISRNMLECEILSTLGSCIKLEQLKLGGN-LFQGPIPLSLSSLRGLRVLDLSQ 306
             NL+ L +S N +E  + S L +   L+ L L  N L    +P  LS+L  L  LDLS 
Sbjct: 139 KSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSD--LPKLLSNLSNLNNLDLSG 195

Query: 307 NNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKNASAISVFGN 354
           N IS ++P  +  L  ++ L+LS N +  ++ +    KN S + +  N
Sbjct: 196 NKIS-DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNN 242

Length = 394

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 52.2 bits (125), Expect = 3e-07
 Identities = 59/217 (27%), Positives = 91/217 (41%), Gaps = 30/217 (13%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSS---IAECSALRNIRHKNLVKILT 464
           I  G FG V  G ++ G T   V V  L    + +     + E    R+++H NL++ L 
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 465 VCSGV-DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            C+ V  Y       LV EF   G L+ +L     A+     P  L   QR+  A ++A 
Sbjct: 63  QCTEVTPY------LLVMEFCPLGDLKGYLRSCRKAELMTPDPTTL---QRM--ACEIAL 111

Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGY 583
            L +LH +      H DL   N LL  ++T  + D+GL+          +   +   + +
Sbjct: 112 GLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRW 168

Query: 584 IAPAEYGLGSEVSIN---------GDVYSYGILLLEL 611
           IAP    L  EV  N          +V+S G+ + EL
Sbjct: 169 IAPE---LVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 53.1 bits (128), Expect = 3e-07
 Identities = 64/267 (23%), Positives = 110/267 (41%), Gaps = 52/267 (19%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLL-HHGASKSSIAECSALRNIRHKNLVKILTVCSGV 469
           G++G V           +A+K ++   H    + ++ E   LR  +H+N++ IL +    
Sbjct: 16  GAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPP 75

Query: 470 DYKGDDFKA--LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC---- 523
            +  + F    +V E M     E  L+ +               ++  +++ D       
Sbjct: 76  SF--ESFNDVYIVQELM-----ETDLYKL---------------IKTQHLSNDHIQYFLY 113

Query: 524 ----ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIG-VK 578
                LKY+H        H DLKPSN+LL+      + DFGLA++  P H  T  +    
Sbjct: 114 QILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYV 170

Query: 579 GTIGYIAPAEYGLGS-EVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLP 637
            T  Y AP E  L S   +   D++S G +L E+++  RP   +F G   LH        
Sbjct: 171 ATRWYRAP-EIMLNSKGYTKAIDIWSVGCILAEMLSN-RP---LFPGKDYLHQL------ 219

Query: 638 DHVMDIVDSTLLADDEDLTITSNQRQR 664
           + ++ ++ +      EDL    + R R
Sbjct: 220 NLILGVLGT---PSQEDLNCIISLRAR 243

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 53.3 bits (128), Expect = 3e-07
 Identities = 63/260 (24%), Positives = 107/260 (41%), Gaps = 45/260 (17%)

Query: 478 ALVYEFMHNGSLEEWLHPVSGADKT-VEAPKCLNFLQRINIAIDVACALKYLHHDCQPTT 536
           ALV ++ + G L + +   +  ++T  E    L F+Q           L  +HH      
Sbjct: 115 ALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQ----------VLLAVHHVHSKHM 164

Query: 537 AHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK--GTIGYIAPAEYGLGSE 594
            H D+K +N+LL       + DFG +K+   A   +  +G    GT  Y+AP E      
Sbjct: 165 IHRDIKSANILLCSNGLVKLGDFGFSKMY--AATVSDDVGRTFCGTPYYVAP-EIWRRKP 221

Query: 595 VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHN-FARTV------LPDHV---MDIV 644
            S   D++S G+LL EL+T KRP    F+G  N+     +T+      LP  +   M  +
Sbjct: 222 YSKKADMFSLGVLLYELLTLKRP----FDGE-NMEEVMHKTLAGRYDPLPPSISPEMQEI 276

Query: 645 DSTLLADDEDLTITSNQRQRQARINNIMEC--LISVVR--IGVACSMESPQDRMNMTIVV 700
            + LL+ D        +R   +++ N+  C   IS +   +        P        + 
Sbjct: 277 VTALLSSD------PKRRPSSSKLLNMPICKLFISGLLEIVQTQPGFSGPLR----DTIS 326

Query: 701 HELQSIKSILLGPKTVSNKQ 720
            ++Q  K +L   +    +Q
Sbjct: 327 RQIQQTKQLLQVERRRIVRQ 346

Length = 496

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 52.7 bits (127), Expect = 3e-07
 Identities = 62/238 (26%), Positives = 94/238 (39%), Gaps = 54/238 (22%)

Query: 402 FLFLCWIDMGSFGSVYKGILDEGKT--IIAVKVL---NLLHHGASKSSIAECSALRNIRH 456
           +     I  G++G VYK     GK     A+K        + G S+S+  E + LR ++H
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61

Query: 457 KNLVKILTVCSG---------VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPK 507
           +N+V ++ V             DY   D   ++               +      V   K
Sbjct: 62  ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKR-----VSIP--PSMV---K 111

Query: 508 CLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLL--DHEMTAHV--ADFGLAK 563
            L + Q +N        + YLH        H DLKP+N+L+  +      V   D GLA+
Sbjct: 112 SLLW-QILN-------GVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160

Query: 564 -----LLPPAHLQTSSIGVKGTIGYIAPAEYGLGSE---VSINGDVYSYGILLLELMT 613
                L P A L      V  TI Y AP E  LG+     +I  D+++ G +  EL+T
Sbjct: 161 LFNAPLKPLADLD----PVVVTIWYRAP-ELLLGARHYTKAI--DIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 52.5 bits (126), Expect = 3e-07
 Identities = 61/213 (28%), Positives = 94/213 (44%), Gaps = 26/213 (12%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKNLVKILTV 465
           I  G++G VYK         IA+K + L     G   ++I E S L+ ++H N+V++  V
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69

Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                   +    LV+E++    L+   H  S  D          +L +I   I    + 
Sbjct: 70  V-----HSEKRLYLVFEYL---DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH 121

Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTA-HVADFGLAKLLP-PAHLQTSSIGVKGTIGY 583
           + LH          DLKP N+L+D    A  +ADFGLA+    P    T  +    T+ Y
Sbjct: 122 RVLHR---------DLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEV---VTLWY 169

Query: 584 IAPAEYGLGS-EVSINGDVYSYGILLLELMTRK 615
            AP E  LGS   S   D++S G +  E++ +K
Sbjct: 170 RAP-EILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 52.4 bits (126), Expect = 3e-07
 Identities = 53/212 (25%), Positives = 86/212 (40%), Gaps = 25/212 (11%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G+FG VYK    E     A K++ +      +  + E   L   +H N+V +        
Sbjct: 16  GAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEA----- 70

Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
           Y  ++   ++ EF   G+L+            +E  + L   Q   +   +  AL +LH 
Sbjct: 71  YFYENKLWILIEFCDGGALD---------SIMLELERGLTEPQIRYVCRQMLEALNFLHS 121

Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGL-AKLLPPAHLQTSSIGVKGTIGYIAP--- 586
                  H DLK  N+LL  +    +ADFG+ AK       + + I   GT  ++AP   
Sbjct: 122 H---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI---GTPYWMAPEVV 175

Query: 587 -AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
             E    +      D++S GI L+EL   + P
Sbjct: 176 ACETFKDNPYDYKADIWSLGITLIELAQMEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 52.1 bits (125), Expect = 3e-07
 Identities = 52/226 (23%), Positives = 95/226 (42%), Gaps = 25/226 (11%)

Query: 408 IDMGSFGSVYKGI-LDEGKTII--AVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILT 464
           I  G F  VYK I L +G+ +    V++  ++   A +  + E   L+ + H N++K L 
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69

Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
             S ++   ++   +V E    G L   +       + +       +       + +  A
Sbjct: 70  --SFIE---NNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYF------VQLCSA 118

Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYI 584
           L+++H        H D+KP+NV +       + D GL +          S+   GT  Y+
Sbjct: 119 LEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGTPYYM 173

Query: 585 APAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGN-MNLH 629
           +P E    +  +   D++S G LL E+   + P    F G+ MNL+
Sbjct: 174 SP-ERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNLY 214

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 52.4 bits (125), Expect = 3e-07
 Identities = 76/295 (25%), Positives = 117/295 (39%), Gaps = 61/295 (20%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSS-----IAECSALRNIRHKNLVKI 462
           I  GSFG+VY         ++A+K ++  + G   +      I E   L+ +RH N +  
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMS--YSGKQSNEKWQDIIKEVRFLQKLRHPNTI-- 78

Query: 463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWL---HPVSGADKTVEAPKCLNFLQRINIAI 519
                   Y+G       Y   H      WL   + +  A   +E  K    LQ + IA 
Sbjct: 79  -------QYRG------CYLREHTA----WLVMEYCLGSASDLLEVHK--KPLQEVEIAA 119

Query: 520 DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKG 579
               AL+ L +       H D+K  N+LL       + DFG A ++ PA+         G
Sbjct: 120 VTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------XFVG 173

Query: 580 TIGYIAPAEYGLGSEVSING--DVYSYGILLLELMTRKRPSDIMFEGNMN----LHNFAR 633
           T  ++AP       E   +G  DV+S GI  +EL  RK P   +F  NMN    L++ A+
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP---LF--NMNAMSALYHIAQ 228

Query: 634 TVLP--------DHVMDIVDSTLLADDEDLTITS---NQR--QRQARINNIMECL 675
              P        ++  + VDS L    +D   +      R   R+     IM+ +
Sbjct: 229 NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLI 283

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 52.4 bits (126), Expect = 3e-07
 Identities = 40/171 (23%), Positives = 76/171 (44%), Gaps = 38/171 (22%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTV 465
           I  G+FG V+K    + K I+A+K + + +   G   +++ E   L+ ++H+N+V ++ +
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79

Query: 466 CSGVDYKGDDFKA---LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVA 522
           C       + +K    LV+EF          H ++G             L   N+   ++
Sbjct: 80  CRTKATPYNRYKGSFYLVFEFCE--------HDLAG------------LLSNKNVKFTLS 119

Query: 523 ----------CALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAK 563
                       L Y+H +      H D+K +N+L+  +    +ADFGLA+
Sbjct: 120 EIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 52.3 bits (125), Expect = 4e-07
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 19/210 (9%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIR-HKNLVKILTVC 466
           I  G++G V+K +  +  +  AVK+L+ +H    +   AE + L+ +  H N+VK   + 
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMY 84

Query: 467 SGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALK 526
              D K  D   LV E  + GS+ + +       + +E P          IA  +  AL 
Sbjct: 85  YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPI---------IAYILHEALM 135

Query: 527 YLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGL-AKLLPPAHLQTSSIGVKGTIGYIA 585
            L H     T H D+K +N+LL  E    + DFG+ A+L      + +S+   GT  ++A
Sbjct: 136 GLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV---GTPFWMA 192

Query: 586 P----AEYGLGSEVSINGDVYSYGILLLEL 611
           P     E  L S      DV+S GI  +EL
Sbjct: 193 PEVIACEQQLDSTYDARCDVWSLGITAIEL 222

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 51.9 bits (124), Expect = 4e-07
 Identities = 51/216 (23%), Positives = 101/216 (46%), Gaps = 25/216 (11%)

Query: 412 SFGSVYKGIL----DEGKTIIAVKVLNLLHHGASKSSIA-ECSALRNIRHKNLVKILTVC 466
           +FG +YKG L     +   ++A+K L  +++         E S +  + H N+V +L V 
Sbjct: 17  AFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVV 76

Query: 467 SGVDYKGDDFKALVYEFMHNGSLEEWL-----HPVSGA----DKTVEAPKCLNFLQRINI 517
           +      +    +++E+++ G L E+L     H   G     D TV++   L+    ++I
Sbjct: 77  TQ-----EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSS--LDHGDFLHI 129

Query: 518 AIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           AI +A  ++YL         H DL   N+L+  ++   ++D GL++ +  A         
Sbjct: 130 AIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKS 186

Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
              I ++ P     G + S + D++S+G++L E+ +
Sbjct: 187 LLPIRWMPPEAIMYG-KFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 51.9 bits (124), Expect = 4e-07
 Identities = 48/231 (20%), Positives = 92/231 (39%), Gaps = 23/231 (9%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVK---VLNLLHHGASKSSIAECSALRNIRHKNLVKILT 464
           I  G F  VY+         +A+K   + +L+   A    I E   L+ + H N++K   
Sbjct: 10  IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69

Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
                 +  D+   +V E    G L   +       + +       +       + +  A
Sbjct: 70  -----SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYF------VQLCSA 118

Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYI 584
           L+++H        H D+KP+NV +       + D GL +    +   T++  + GT  Y+
Sbjct: 119 LEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYM 173

Query: 585 APAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV 635
           +P E    +  +   D++S G LL E+   + P    +   MNL++  + +
Sbjct: 174 SP-ERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNLYSLCKKI 220

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 51.8 bits (124), Expect = 4e-07
 Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 46/217 (21%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNL-LHHGASKSSIAECSALRNIRHKNLVKILTVCSG- 468
           G+ G+VYK      + I+AVKV+ L +     K  ++E            ++IL  C   
Sbjct: 12  GNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSE------------LEILYKCDSP 59

Query: 469 --VDYKGDDFK----ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVA 522
             + + G  F     ++  EFM  GSL+ +        + +        L RI +A+   
Sbjct: 60  YIIGFYGAFFVENRISICTEFMDGGSLDVY--------RKIPEH----VLGRIAVAV--- 104

Query: 523 CALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK--GT 580
             +K L +       H D+KPSN+L++      + DFG++  L       +SI     GT
Sbjct: 105 --VKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL------VNSIAKTYVGT 156

Query: 581 IGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
             Y+AP E   G +  I+ DV+S GI  +EL   + P
Sbjct: 157 NAYMAP-ERISGEQYGIHSDVWSLGISFMELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 51.8 bits (124), Expect = 4e-07
 Identities = 55/226 (24%), Positives = 93/226 (41%), Gaps = 42/226 (18%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGAS------KSSIAECSALRNIRHKNLVK 461
           +  G+F S Y+    +  T++AVK +  + + +S      ++   E   +  + H ++++
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDV 521
                 G   +   F   V E+M  GS+   L       + V        L+        
Sbjct: 68  ----MLGATCEDSHFNLFV-EWMAGGSVSHLLSKYGAFKEAVIINYTEQLLR-------- 114

Query: 522 ACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH---VADFGLAKLLPPAHLQTSSIGVK 578
              L YLH +      H D+K +N+L+D   T     +ADFG A     A L     G  
Sbjct: 115 --GLSYLHEN---QIIHRDVKGANLLIDS--TGQRLRIADFGAA-----ARLAAKGTGAG 162

Query: 579 -------GTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
                  GTI ++AP E   G +   + DV+S G +++E+ T K P
Sbjct: 163 EFQGQLLGTIAFMAP-EVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 51.9 bits (124), Expect = 5e-07
 Identities = 36/111 (32%), Positives = 57/111 (51%), Gaps = 11/111 (9%)

Query: 518 AIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           A ++ C L++LH        + DLK  NV+LD +    +ADFG+ K       + S+   
Sbjct: 102 AAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC- 157

Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP-----SDIMFE 623
            GT  YIAP E   G + + + D +S+G+LL E++  + P      D +FE
Sbjct: 158 -GTPDYIAP-EILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFE 206

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 51.5 bits (123), Expect = 5e-07
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 25/205 (12%)

Query: 411 GSFGSVYKGILD-EGKTI-IAVKVLNLLHHGASKSSI-AECSALRNIRHKNLVKILTVCS 467
           G+FG V KG+     K I +A+KVL   +  + +  +  E   +  + +  +V+++ VC 
Sbjct: 6   GNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE 65

Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
                  +   LV E    G L ++L   SG    +     +  + +      V+  +KY
Sbjct: 66  A------EALMLVMEMASGGPLNKFL---SGKKDEITVSNVVELMHQ------VSMGMKY 110

Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPP--AHLQTSSIGVKGTIGYIA 585
           L         H DL   NVLL ++  A ++DFGL+K L    ++ +  S G K  + + A
Sbjct: 111 LE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG-KWPLKWYA 166

Query: 586 PAEYGLGSEVSINGDVYSYGILLLE 610
           P E     + S   DV+SYGI + E
Sbjct: 167 P-ECINFRKFSSRSDVWSYGITMWE 190

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 51.8 bits (124), Expect = 6e-07
 Identities = 62/231 (26%), Positives = 101/231 (43%), Gaps = 44/231 (19%)

Query: 405 LCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGA--SKSSIAECSALRNIRHKNLVKI 462
           L  +  G++GSV   I       +A+K L+        +K +  E + L++++H+N++ +
Sbjct: 20  LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGL 79

Query: 463 LTV-CSGVDYKG-DDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAID 520
           L V  S V      DF  LV  +M     +   HP+S  DK       + +L        
Sbjct: 80  LDVFTSAVSGDEFQDF-YLVMPYMQTDLQKIMGHPLS-EDK-------VQYL-----VYQ 125

Query: 521 VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGT 580
           + C LKY+H        H DLKP N+ ++ +    + DFGLA+     H      G   T
Sbjct: 126 MLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVT 177

Query: 581 IGYIAPAEYGLGSEVSING-------DVYSYGILLLELMTRKRPSDIMFEG 624
             Y AP       EV +N        D++S G ++ E++T K     +F+G
Sbjct: 178 RWYRAP-------EVILNWMHYNQTVDIWSVGCIMAEMLTGK----TLFKG 217

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 51.5 bits (123), Expect = 7e-07
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 12/190 (6%)

Query: 427 IIAVKVLNL-LHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMH 485
           ++AVK+L   +   A    + E   +  +++ N++++L VC       DD   ++ E+M 
Sbjct: 46  LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVS-----DDPLCMITEYME 100

Query: 486 NGSLEEWLHPVSGADKTVEAPK--CLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKP 543
           NG L ++L           A     ++    + +A+ +A  +KYL         H DL  
Sbjct: 101 NGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLAT 157

Query: 544 SNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYS 603
            N L+ +  T  +ADFG+++ L               I ++A     LG + +   DV++
Sbjct: 158 RNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG-KFTTASDVWA 216

Query: 604 YGILLLELMT 613
           +G+ L E+ T
Sbjct: 217 FGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 51.4 bits (123), Expect = 7e-07
 Identities = 54/213 (25%), Positives = 93/213 (43%), Gaps = 28/213 (13%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           I  G+ G+VY  I       +A+K +NL      +  I E   +R  +H N+V  L    
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLD--- 83

Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
              Y   D   +V E++  GSL +           V    C++  Q   +  +   AL++
Sbjct: 84  --SYLVGDELWVVMEYLAGGSLTD-----------VVTETCMDEGQIAAVCRECLQALEF 130

Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP- 586
           LH +      H D+K  N+LL  + +  + DFG    + P   + S++   GT  ++AP 
Sbjct: 131 LHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM--VGTPYWMAPE 185

Query: 587 --AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
                  G +V    D++S GI+ +E++  + P
Sbjct: 186 VVTRKAYGPKV----DIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 50.8 bits (121), Expect = 7e-07
 Identities = 54/213 (25%), Positives = 93/213 (43%), Gaps = 23/213 (10%)

Query: 411 GSFGSVYKGI-LDEGKTIIAVKV-LNLLHHGASKS-SIAECSA--LRNIRHKNLVKILTV 465
           G+FG VY    +D G+ + A +V  +      SK  S  EC    L+N++H+ +V+    
Sbjct: 13  GAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGC 72

Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                 + +    +  E+M  GS+++ L       ++V        L+           +
Sbjct: 73  LRD---RAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILE----------GM 119

Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSI-GVKGTIGYI 584
            YLH +      H D+K +N+L D      + DFG +K L    +  + I  V GT  ++
Sbjct: 120 SYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWM 176

Query: 585 APAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
           +P E   G       DV+S G  ++E++T K P
Sbjct: 177 SP-EVISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 51.0 bits (122), Expect = 8e-07
 Identities = 54/218 (24%), Positives = 89/218 (40%), Gaps = 42/218 (19%)

Query: 411 GSFGSVYKGILDE-------GKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKIL 463
           G+F  ++KGI  E        KT + +KVL+  H   S+S     S +  + HK+LV   
Sbjct: 6   GTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNY 65

Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            VC      GD+   +V E++  GSL+ +L          +    +N   ++ +A  +A 
Sbjct: 66  GVCVC----GDE-SIMVQEYVKFGSLDTYLK---------KNKNLINISWKLEVAKQLAW 111

Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGT--- 580
           AL +L         H ++   NVLL  E           K   P  ++ S  G+  T   
Sbjct: 112 ALHFLE---DKGLTHGNVCAKNVLLIRE--------EDRKTGNPPFIKLSDPGISITVLP 160

Query: 581 -------IGYIAPAEYGLGSEVSINGDVYSYGILLLEL 611
                  I ++ P        +S+  D +S+G  L E+
Sbjct: 161 KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEI 198

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 50.7 bits (121), Expect = 9e-07
 Identities = 55/206 (26%), Positives = 96/206 (46%), Gaps = 27/206 (13%)

Query: 411 GSFGSVYKGILDEGKT--IIAVKVL-NLLHHGASKSS-IAECSALRNIRHKNLVKILTVC 466
           G+FG+V KG+    K+   +AVK+L N  +  A K   + E + ++ + +  +V+++ +C
Sbjct: 6   GNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGIC 65

Query: 467 SGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALK 526
               +       LV E    G L ++L      +K V        + +      V+  +K
Sbjct: 66  EAESW------MLVMELAELGPLNKFLQ----KNKHVTEKNITELVHQ------VSMGMK 109

Query: 527 YLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPP--AHLQTSSIGVKGTIGYI 584
           YL    +    H DL   NVLL  +  A ++DFGL+K L     + +  + G K  + + 
Sbjct: 110 YLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG-KWPVKWY 165

Query: 585 APAEYGLGSEVSINGDVYSYGILLLE 610
           AP E     + S   DV+S+G+L+ E
Sbjct: 166 AP-ECMNYYKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 50.9 bits (122), Expect = 9e-07
 Identities = 53/212 (25%), Positives = 99/212 (46%), Gaps = 23/212 (10%)

Query: 411 GSFGSVY----KGILDEGK-TIIAVKVLNLLHHGASKSSI-AECSALRNIRHKNLVKILT 464
           G FG V+    KGI +EG  T++ VK L        +S    E    R + HKN+V++L 
Sbjct: 16  GEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLG 75

Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
           +C     +  +   ++ E+   G L+++L      D+ ++ P  L+  Q++ +   +A  
Sbjct: 76  LC-----REAEPHYMILEYTDLGDLKQFLRATKSKDEKLK-PPPLSTKQKVALCTQIALG 129

Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPA---HLQTSSIGVKGTI 581
           + +L         H DL   N L+  +    V+   L+K +  +    L+ + I ++   
Sbjct: 130 MDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLR--- 183

Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
            ++AP E     + S   DV+S+G+L+ E+ T
Sbjct: 184 -WLAP-EAVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 50.9 bits (121), Expect = 9e-07
 Identities = 51/213 (23%), Positives = 94/213 (44%), Gaps = 28/213 (13%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           I  G+ G+V+  I       +A+K +NL      +  I E   ++ +++ N+V  L    
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLD--- 83

Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
              +   D   +V E++  GSL +           V    C++  Q   +  +   AL++
Sbjct: 84  --SFLVGDELFVVMEYLAGGSLTD-----------VVTETCMDEAQIAAVCRECLQALEF 130

Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP- 586
           LH +      H D+K  NVLL  + +  + DFG    + P   + S++   GT  ++AP 
Sbjct: 131 LHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTM--VGTPYWMAPE 185

Query: 587 --AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
                  G +V    D++S GI+ +E++  + P
Sbjct: 186 VVTRKAYGPKV----DIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 50.9 bits (121), Expect = 9e-07
 Identities = 53/213 (24%), Positives = 92/213 (43%), Gaps = 28/213 (13%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           I  G+ G+VY  I       +A+K +NL      +  I E   +R  ++ N+V  L    
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLD--- 83

Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
              Y   D   +V E++  GSL +           V    C++  Q   +  +   AL +
Sbjct: 84  --SYLVGDELWVVMEYLAGGSLTD-----------VVTETCMDEGQIAAVCRECLQALDF 130

Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP- 586
           LH +      H D+K  N+LL  + +  + DFG    + P   + S++   GT  ++AP 
Sbjct: 131 LHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM--VGTPYWMAPE 185

Query: 587 --AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
                  G +V    D++S GI+ +E++  + P
Sbjct: 186 VVTRKAYGPKV----DIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 50.6 bits (121), Expect = 9e-07
 Identities = 57/261 (21%), Positives = 98/261 (37%), Gaps = 46/261 (17%)

Query: 408 IDMGSFGSVYKGILDEGKTI---IAVKVL---NLLHHGASKSSIAECSALRNIRHKNLVK 461
           I  G+FGSVY   L + ++     A+KVL   +++    +K+ +    A R I       
Sbjct: 4   ISKGAFGSVY---LAKKRSTGDYFAIKVLKKSDMI----AKNQVTNVKAERAIMMIQGES 56

Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDV 521
                    ++  D+  LV E+++ G     +  + G     E               +V
Sbjct: 57  PYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLP---EDWAK-------QYIAEV 106

Query: 522 ACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAK--LLPPAHLQTSSIGVKG 579
              ++ LH        H D+KP N+L+D      + DFGL++  L              G
Sbjct: 107 VLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK--------FVG 155

Query: 580 TIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP-----SDIMFE----GNMNLHN 630
           T  Y+AP E  LG       D +S G ++ E +    P      D +F+      +N   
Sbjct: 156 TPDYLAP-ETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPE 214

Query: 631 FARTVLPDHVMDIVDSTLLAD 651
             +       +D+++  L  D
Sbjct: 215 EVKEFCSPEAVDLINRLLCMD 235

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 51.2 bits (122), Expect = 1e-06
 Identities = 55/222 (24%), Positives = 95/222 (42%), Gaps = 48/222 (21%)

Query: 415 SVYKGILDEGKTIIAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYK 472
           + Y  +LD     +A+K L+    +   +K +  E   ++ + HKN++ +L V       
Sbjct: 35  AAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV------- 84

Query: 473 GDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAID----------VA 522
                     F    SLEE+   V    + ++A    N  Q I + +D          + 
Sbjct: 85  ----------FTPQKSLEEF-QDVYLVMELMDA----NLCQVIQMELDHERMSYLLYQML 129

Query: 523 CALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIG 582
           C +K+LH        H DLKPSN+++  + T  + DFGLA+    + + T  +  +    
Sbjct: 130 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR---- 182

Query: 583 YIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEG 624
           Y    E  LG     N D++S G ++ E++  K    I+F G
Sbjct: 183 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK----ILFPG 220

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 51.0 bits (122), Expect = 1e-06
 Identities = 43/131 (32%), Positives = 63/131 (48%), Gaps = 25/131 (19%)

Query: 518 AIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAK--LLPPAHLQTSSI 575
           A +V  AL +LH   +    + DLK  N+LLD E    +ADFG+ K  +L      T   
Sbjct: 102 AAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC- 157

Query: 576 GVKGTIGYIAPA-----EYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHN 630
              GT  YIAP      EYG     S+  D ++ G+L+ E+M  + P    FE + N  +
Sbjct: 158 ---GTPDYIAPEILQELEYG----PSV--DWWALGVLMYEMMAGQPP----FEAD-NEDD 203

Query: 631 FARTVLPDHVM 641
              ++L D V+
Sbjct: 204 LFESILHDDVL 214

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 50.8 bits (121), Expect = 1e-06
 Identities = 58/213 (27%), Positives = 92/213 (43%), Gaps = 25/213 (11%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNI-RHKNLVKILTVC 466
           I  G++G VYK    +  ++ AVK+L+ +     +   AE + L+++  H N+VK     
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFY--- 85

Query: 467 SGVDYKGDDFKA----LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVA 522
            G+ YK D        LV E  + GS+ E +  +           C   L    I+  + 
Sbjct: 86  -GMFYKADKLVGGQLWLVLELCNGGSVTELVKGLL---------ICGQRLDEAMISYILY 135

Query: 523 CALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIG 582
            AL  L H       H D+K +N+LL  E    + DFG++  L    L+ ++    GT  
Sbjct: 136 GALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT--SVGTPF 193

Query: 583 YIAP----AEYGLGSEVSINGDVYSYGILLLEL 611
           ++AP     E           DV+S GI  +EL
Sbjct: 194 WMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 58/217 (26%), Positives = 90/217 (41%), Gaps = 35/217 (16%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G+FG VYK    E   + A KV+        +  + E   L    H  +VK+L       
Sbjct: 23  GAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGA----- 77

Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC-----AL 525
           +  D    ++ EF   G+++  +  +   D+ +  P+           I V C     AL
Sbjct: 78  FYWDGKLWIMIEFCPGGAVDAIMLEL---DRGLTEPQ-----------IQVICRQMLEAL 123

Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGL-AKLLPPAHLQTSSIGVKGTIGYI 584
           +YLH        H DLK  NVLL  +    +ADFG+ AK +     + S I   GT  ++
Sbjct: 124 QYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI---GTPYWM 177

Query: 585 AP----AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
           AP     E    +      D++S GI L+E+   + P
Sbjct: 178 APEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 214

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 50.1 bits (120), Expect = 1e-06
 Identities = 43/167 (25%), Positives = 70/167 (41%), Gaps = 24/167 (14%)

Query: 405 LCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA--ECSALRNIRHKNLVKI 462
           L  I  GS+G V+K    E   I+A+K             IA  E   L+ ++H NLV +
Sbjct: 6   LSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNL 65

Query: 463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEA-PKCLNFLQRINIAIDV 521
           + V     ++      LV+E+  +  L E           +E  P+ +       I    
Sbjct: 66  IEV-----FRRKRKLHLVFEYCDHTVLNE-----------LEKNPRGVPEHLIKKIIWQT 109

Query: 522 ACALKYLH-HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPP 567
             A+ + H H+C     H D+KP N+L+  +    + DFG A++L  
Sbjct: 110 LQAVNFCHKHNC----IHRDVKPENILITKQGQIKLCDFGFARILTG 152

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 50.2 bits (120), Expect = 2e-06
 Identities = 62/227 (27%), Positives = 98/227 (43%), Gaps = 46/227 (20%)

Query: 411 GSFGSVY---KGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRN-IRHKNLVKILTVC 466
           GSFG V+   K    +   + A+KVL        K+++     +R+ +R K    IL   
Sbjct: 7   GSFGKVFLVRKITGPDAGQLYAMKVLK-------KATLK----VRDRVRTKMERDIL--- 52

Query: 467 SGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQ---RINIAIDVAC 523
              +        L Y F   G L   L  + G D      K + F +   +  +A ++A 
Sbjct: 53  --AEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELAL 109

Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGY 583
           AL +LH        + DLKP N+LLD E    + DFGL+K       +  +    GT+ Y
Sbjct: 110 ALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEY 164

Query: 584 IAPAEYGLGSEV------SINGDVYSYGILLLELMTRKRPSDIMFEG 624
           +AP       EV      + + D +S+G+L+ E++T   P    F+G
Sbjct: 165 MAP-------EVVNRRGHTQSADWWSFGVLMFEMLTGSLP----FQG 200

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 54/214 (25%), Positives = 96/214 (44%), Gaps = 25/214 (11%)

Query: 411 GSFGSVYKGILD-----EGKTIIAVKVLNLLHHGASKSS----IAECSALRNIRHKNLVK 461
           GSFG VY+G        E +T +AVK +N     AS       + E S ++     ++V+
Sbjct: 17  GSFGMVYEGNARDIIKGEAETRVAVKTVN---ESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDV 521
           +L V S    KG     +V E M +G L+ +L  +    +           + I +A ++
Sbjct: 74  LLGVVS----KGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 128

Query: 522 ACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKG-- 579
           A  + YL+        H DL   N ++ H+ T  + DFG+ + +          G KG  
Sbjct: 129 ADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK--GGKGLL 183

Query: 580 TIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
            + ++AP     G   + + D++S+G++L E+ +
Sbjct: 184 PVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 50.1 bits (119), Expect = 2e-06
 Identities = 51/213 (23%), Positives = 93/213 (43%), Gaps = 28/213 (13%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           I  G+ G+VY  +       +A++ +NL      +  I E   +R  ++ N+V  L    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD--- 84

Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
              Y   D   +V E++  GSL +           V    C++  Q   +  +   AL++
Sbjct: 85  --SYLVGDELWVVMEYLAGGSLTD-----------VVTETCMDEGQIAAVCRECLQALEF 131

Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP- 586
           LH +      H D+K  N+LL  + +  + DFG    + P   + S++   GT  ++AP 
Sbjct: 132 LHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM--VGTPYWMAPE 186

Query: 587 --AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
                  G +V    D++S GI+ +E++  + P
Sbjct: 187 VVTRKAYGPKV----DIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 50.2 bits (120), Expect = 2e-06
 Identities = 35/105 (33%), Positives = 56/105 (53%), Gaps = 8/105 (7%)

Query: 518 AIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKL-LPPAHLQTSSIG 576
           + +++ AL +LH   +    + DLK  NVLLD E    + D+G+ K  + P    TS+  
Sbjct: 102 SAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT-TSTFC 157

Query: 577 VKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIM 621
             GT  YIAP E   G +   + D ++ G+L+ E+M  + P DI+
Sbjct: 158 --GTPNYIAP-EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 199

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 50.4 bits (121), Expect = 2e-06
 Identities = 59/240 (24%), Positives = 99/240 (41%), Gaps = 71/240 (29%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNL----LHHGASKSSIAECSALRNIRHKNLVKILTVC 466
           G++G V      +    +A+K L+       H   K +  E   L+++ H+N++ +L V 
Sbjct: 26  GAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHA--KRTYRELRLLKHMDHENVIGLLDVF 83

Query: 467 SGVDYKGDDFKA--LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFL---QRIN----- 516
           +      +DF+   LV   M             GAD        LN +   Q+++     
Sbjct: 84  TP-ASSLEDFQDVYLVTHLM-------------GAD--------LNNIVKCQKLSDDHIQ 121

Query: 517 -IAIDVACALKYLHHDCQPTTA---HCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQT 572
            +   +   LKY+H      +A   H DLKPSN+ ++ +    + DFGLA+     H   
Sbjct: 122 FLVYQILRGLKYIH------SAGIIHRDLKPSNIAVNEDCELKILDFGLAR-----HTDD 170

Query: 573 SSIGVKGTIGYIAPAEYGLGSEVSING-------DVYSYGILLLELMTRKRPSDIMFEGN 625
              G   T  Y AP       E+ +N        D++S G ++ EL+T K     +F G+
Sbjct: 171 EMTGYVATRWYRAP-------EIMLNWMHYNQTVDIWSVGCIMAELLTGK----TLFPGS 219

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 58/221 (26%), Positives = 97/221 (43%), Gaps = 30/221 (13%)

Query: 411 GSFGSVYKGI---LDEGK----TIIAVKVLNLLHHGASKSS----IAECSALRNI-RHKN 458
           G FG V       LD+ K    T +AVK   +L   A++      I+E   ++ I +HKN
Sbjct: 29  GCFGQVVMAEAIGLDKEKPNRVTKVAVK---MLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 459 LVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSG-ADKTVEAPKC-----LNFL 512
           ++ +L  C+      D    ++ E+   G+L E+L        +    P       L+F 
Sbjct: 86  IINLLGACTQ-----DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140

Query: 513 QRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQT 572
             ++ A  VA  ++YL         H DL   NVL+  +    +ADFGLA+ +       
Sbjct: 141 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 197

Query: 573 SSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
            +   +  + ++AP E       +   DV+S+G+LL E+ T
Sbjct: 198 KTTNGRLPVKWMAP-EALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 38/121 (31%), Positives = 62/121 (51%), Gaps = 9/121 (7%)

Query: 518 AIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKL-LPPAHLQTSSIG 576
           A ++  AL +LH   +    + DLK  NVLLD +    + D+G+ K  L P    ++  G
Sbjct: 102 AAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCG 158

Query: 577 VKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEG-NMNLHNFARTV 635
              T  YIAP E   G E   + D ++ G+L+ E+M  + P DI+ +  +MN  ++   V
Sbjct: 159 ---TPNYIAP-EILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV 214

Query: 636 L 636
           +
Sbjct: 215 I 215

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 32/100 (32%), Positives = 49/100 (49%), Gaps = 7/100 (7%)

Query: 518 AIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           A ++ C L+ LH +      + DLKP N+LLD      ++D GLA  +P         G 
Sbjct: 108 AAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIR---GR 161

Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
            GT+GY+AP E       + + D +  G L+ E++  K P
Sbjct: 162 VGTVGYMAP-EVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 49.7 bits (118), Expect = 3e-06
 Identities = 37/103 (35%), Positives = 55/103 (53%), Gaps = 8/103 (7%)

Query: 520 DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKL-LPPAHLQTSSIGVK 578
           +++ AL YLH   +    + DLK  NVLLD E    + D+G+ K  L P    T+S    
Sbjct: 104 EISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTS-TFC 157

Query: 579 GTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIM 621
           GT  YIAP E   G +   + D ++ G+L+ E+M  + P DI+
Sbjct: 158 GTPNYIAP-EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 199

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 49.5 bits (118), Expect = 3e-06
 Identities = 37/145 (25%), Positives = 70/145 (48%), Gaps = 18/145 (12%)

Query: 427 IIAVKVLNLLHHGASKSS----IAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYE 482
           ++AVK   +L   A+K++    + E   +  ++  N++++L VC  +     D   ++ E
Sbjct: 48  LVAVK---MLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVC--IT---SDPLCMITE 99

Query: 483 FMHNGSLEEWL--HPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCD 540
           +M NG L ++L  H    A +  +    +++   I +A  +A  +KYL         H D
Sbjct: 100 YMENGDLNQFLSRHEPQEAAEKADVVT-ISYSTLIFMATQIASGMKYLS---SLNFVHRD 155

Query: 541 LKPSNVLLDHEMTAHVADFGLAKLL 565
           L   N L+    T  +ADFG+++ L
Sbjct: 156 LATRNCLVGKNYTIKIADFGMSRNL 180

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 49.6 bits (118), Expect = 3e-06
 Identities = 54/185 (29%), Positives = 80/185 (43%), Gaps = 28/185 (15%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLN---LLHHGASKSSIAECSAL-RNIRHKNLVKIL 463
           I  GSFG V         +  AVKVL    +L        +AE + L +N++H  LV   
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV--- 59

Query: 464 TVCSGVDYKGDDFKAL--VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDV 521
               G+ Y     + L  V ++++ G L  + H        ++  +C    +    A +V
Sbjct: 60  ----GLHYSFQTAEKLYFVLDYVNGGEL--FFH--------LQRERCFLEPRARFYAAEV 105

Query: 522 ACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTI 581
           A A+ YLH        + DLKP N+LLD +    + DFGL K        TS+    GT 
Sbjct: 106 ASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC--GTP 160

Query: 582 GYIAP 586
            Y+AP
Sbjct: 161 EYLAP 165

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 49.7 bits (119), Expect = 3e-06
 Identities = 33/104 (31%), Positives = 48/104 (46%), Gaps = 9/104 (8%)

Query: 523 CALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSS--IGVKGT 580
           C LKY+H        H DLKP N+L++ +    + DFGLA+       + +        T
Sbjct: 116 CGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVAT 172

Query: 581 IGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEG 624
             Y AP         +   DV+S G +L EL+ RK P   +F+G
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK-P---VFKG 212

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 49.0 bits (117), Expect = 3e-06
 Identities = 55/222 (24%), Positives = 89/222 (40%), Gaps = 39/222 (17%)

Query: 408 IDMGSFGSVYKGI--LDEGKTI-IAVKVLNLLHHGASKSSI-AECSALRNIRHKNLVKIL 463
           I  G FG VY+G+    E + I +AVK        + +     E   +R   H ++VK++
Sbjct: 14  IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLI 73

Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            V +      ++   +V E    G L  +L     +         L+    I  +  ++ 
Sbjct: 74  GVIT------ENPVWIVMELAPLGELRSYLQVNKYS---------LDLASLILYSYQLST 118

Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGY 583
           AL YL         H D+   NVL+       + DFGL++ L       +S G K  I +
Sbjct: 119 ALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKG-KLPIKW 174

Query: 584 IAPAEYGLGSEVSIN-------GDVYSYGILLLE-LMTRKRP 617
           +AP         SIN        DV+ +G+ + E LM   +P
Sbjct: 175 MAPE--------SINFRRFTSASDVWMFGVCMWEILMLGVKP 208

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 49.0 bits (117), Expect = 3e-06
 Identities = 45/148 (30%), Positives = 64/148 (43%), Gaps = 19/148 (12%)

Query: 514 RINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAK-LLPPAHLQT 572
           R+ IA ++  AL +LH   Q    + D+K  N+LLD E    + DFGL+K  L     + 
Sbjct: 108 RVYIA-EIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERA 163

Query: 573 SSIGVKGTIGYIAP-----AEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMN 627
            S    GTI Y+AP        G    V    D +S G+L  EL+T   P  +  E N  
Sbjct: 164 YSFC--GTIEYMAPEVIRGGSGGHDKAV----DWWSLGVLTFELLTGASPFTVDGEQNSQ 217

Query: 628 LHNFARTVLPDHVMDIVDSTLLADDEDL 655
               +R +L          T+ A+  D 
Sbjct: 218 -SEISRRILKSKPP--FPKTMSAEARDF 242

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 49.4 bits (118), Expect = 3e-06
 Identities = 69/246 (28%), Positives = 100/246 (40%), Gaps = 61/246 (24%)

Query: 411 GSFGSVYKGILDEGKT---IIAVKVLNLLHHGASKSSIAECSALRNI----RHKNLVKIL 463
           G +G V++     G     I A+KVL       ++   A   A RNI    +H  +V   
Sbjct: 7   GGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVD-- 64

Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI-DVA 522
                          L+Y F   G L   L  +SG +  +        L+R  I + D A
Sbjct: 65  ---------------LIYAFQTGGKLYLILEYLSGGELFMH-------LEREGIFMEDTA 102

Query: 523 C--------ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSS 574
           C        AL++LH        + DLKP N+LLD +    + DFGL K     H  T +
Sbjct: 103 CFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVT 157

Query: 575 IGVKGTIGYIAP---AEYGLGSEVSINGDVYSYGILLLELMT---------RKRPSDIMF 622
               GTI Y+AP      G G  V    D +S G L+ +++T         RK+  D + 
Sbjct: 158 HTFCGTIEYMAPEILMRSGHGKAV----DWWSLGALMYDMLTGAPPFTAENRKKTIDKIL 213

Query: 623 EGNMNL 628
           +G +NL
Sbjct: 214 KGKLNL 219

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 49.3 bits (118), Expect = 4e-06
 Identities = 55/215 (25%), Positives = 90/215 (41%), Gaps = 55/215 (25%)

Query: 428 IAVKVL-----NLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA--LV 480
           +A+K L     N+ H   +K +  E   ++ + HKN++ +L V +      ++F+   LV
Sbjct: 44  VAIKKLSRPFQNVTH---AKRAYRELVLMKLVNHKNIIGLLNVFTP-QKSLEEFQDVYLV 99

Query: 481 YEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAID----------VACALKYLHH 530
            E M                         N  Q I + +D          + C +K+LH 
Sbjct: 100 MELMDA-----------------------NLCQVIQMDLDHERMSYLLYQMLCGIKHLH- 135

Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
                  H DLKPSN+++  + T  + DFGLA+    + + T  +    T  Y AP E  
Sbjct: 136 --SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTRYYRAP-EVI 189

Query: 591 LGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGN 625
           LG     N D++S G ++ E M R     ++F G 
Sbjct: 190 LGMGYKENVDIWSVGCIMGE-MIRGT---VLFPGT 220

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 49.3 bits (117), Expect = 4e-06
 Identities = 62/228 (27%), Positives = 99/228 (43%), Gaps = 39/228 (17%)

Query: 406 CWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           C +  G++G VYK    +GK      +  +   G S S+  E + LR ++H N++ +  V
Sbjct: 7   CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKV 66

Query: 466 -CSGVDYKGDDFKALVYEFMHNGSLEEW----LHPVSGADKT-VEAPKCL--NFLQRINI 517
             S  D K       V+        + W     H  S A+K  V+ P+ +  + L +I  
Sbjct: 67  FLSHADRK-------VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI-- 117

Query: 518 AIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMT----AHVADFGLAKLL-----PPA 568
            +D    + YLH +      H DLKP+N+L+  E        +AD G A+L      P A
Sbjct: 118 -LD---GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLA 170

Query: 569 HLQTSSIGVKGTIGYIAPAEYGLGSEVSING-DVYSYGILLLELMTRK 615
            L    +    T  Y AP E  LG+       D+++ G +  EL+T +
Sbjct: 171 DLDPVVV----TFWYRAP-ELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 48.8 bits (117), Expect = 4e-06
 Identities = 58/227 (25%), Positives = 96/227 (42%), Gaps = 40/227 (17%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSI-AECSALRNI-RHKNLVKILTV 465
           I  G++G VYK    +   ++A+K+++++     +  I  E + LR    H N+      
Sbjct: 14  IGEGTYGKVYKARHKKTGQLVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATF--- 68

Query: 466 CSGVDYK-----GDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAID 520
             G   K      DD   LV E    GS+ + +  +    K ++    + ++ R     +
Sbjct: 69  -YGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEE-WIAYILR-----E 121

Query: 521 VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV--ADFGLAKLLPPAHLQTSSIGVK 578
               L YLH   +    H D+K  N+LL     A V   DFG++     A L  S++G +
Sbjct: 122 TLRGLAYLH---ENKVIHRDIKGQNILLTKN--AEVKLVDFGVS-----AQLD-STLGRR 170

Query: 579 GT-IG---YIAP----AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
            T IG   ++AP     +    +      DV+S GI  +EL   K P
Sbjct: 171 NTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 48.5 bits (115), Expect = 5e-06
 Identities = 60/217 (27%), Positives = 90/217 (41%), Gaps = 35/217 (16%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G+FG VYK    E   + A KV++       +  + E   L +  H N+VK+L       
Sbjct: 16  GAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF---- 71

Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC-----AL 525
           Y  ++   L+ EF   G+++  +         +E  + L   Q     I V C     AL
Sbjct: 72  YYENNLWILI-EFCAGGAVDAVM---------LELERPLTEPQ-----IRVVCKQTLEAL 116

Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGL-AKLLPPAHLQTSSIGVKGTIGYI 584
            YLH +      H DLK  N+L   +    +ADFG+ AK       + S I   GT  ++
Sbjct: 117 NYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI---GTPYWM 170

Query: 585 AP----AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
           AP     E           DV+S GI L+E+   + P
Sbjct: 171 APEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 48.0 bits (114), Expect = 6e-06
 Identities = 56/217 (25%), Positives = 86/217 (39%), Gaps = 20/217 (9%)

Query: 401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSA--LRNIRHKN 458
           ++ F+  +  GS+G V             +K LNL +    +   AE  A  L  ++H N
Sbjct: 1   AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPN 60

Query: 459 LVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIA 518
           +V       G     D    +V  F   G L   L    G        K L   Q +   
Sbjct: 61  IVAYRESWEG----EDGLLYIVMGFCEGGDLYHKLKEQKG--------KLLPENQVVEWF 108

Query: 519 IDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK 578
           + +A AL+YLH   +    H DLK  NV L       V D G+A++L       S++   
Sbjct: 109 VQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTL--I 163

Query: 579 GTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRK 615
           GT  Y++P  +      +   DV++ G  + E+ T K
Sbjct: 164 GTPYYMSPELFS-NKPYNYKSDVWALGCCVYEMATLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 48.5 bits (116), Expect = 6e-06
 Identities = 41/162 (25%), Positives = 77/162 (47%), Gaps = 26/162 (16%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHH---GASKSSIAECSALRNIRHKNLVKILTVCS 467
           G+FG VYK    +   ++A+K + L+H+   G   +++ E   L+ ++H N+V ++ +  
Sbjct: 19  GTFGEVYKARQIKTGRVVALKKI-LMHNEKDGFPITALREIKILKKLKHPNVVPLIDMA- 76

Query: 468 GVDYKGDDFKA-----LVYEFMHNGSLEEWLHPVSGADKTVEAPKC-LNFLQRINIAIDV 521
            V+      +      +V  +M         H +SG    +E P   L   Q     + +
Sbjct: 77  -VERPDKSKRKRGSVYMVTPYMD--------HDLSG---LLENPSVKLTESQIKCYMLQL 124

Query: 522 ACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAK 563
              + YLH   +    H D+K +N+L+D++    +ADFGLA+
Sbjct: 125 LEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLAR 163

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 48.9 bits (116), Expect = 6e-06
 Identities = 53/220 (24%), Positives = 95/220 (43%), Gaps = 45/220 (20%)

Query: 428 IAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMH 485
           +AVK L+    +   +K +  E   L+ + HKN++ +L V                 F  
Sbjct: 49  VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV-----------------FTP 91

Query: 486 NGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAID----------VACALKYLHHDCQPT 535
             SLEE+   V    + ++A    N  Q I++ +D          + C +K+LH      
Sbjct: 92  QKSLEEF-QDVYLVMELMDA----NLCQVIHMELDHERMSYLLYQMLCGIKHLH---SAG 143

Query: 536 TAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEV 595
             H DLKPSN+++  + T  + DFGLA+      + T  +  +    Y    E  LG   
Sbjct: 144 IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTR----YYRAPEVILGMGY 199

Query: 596 SINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV 635
             N D++S G ++ EL+       ++F+G  ++  + + +
Sbjct: 200 KENVDIWSVGCIMGELVK----GSVIFQGTDHIDQWNKVI 235

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 48.5 bits (116), Expect = 6e-06
 Identities = 48/233 (20%), Positives = 91/233 (39%), Gaps = 55/233 (23%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIR------HKNLVK 461
            +     +           ++AVKVL      AS ++  +   L+ ++        N+ +
Sbjct: 33  SEKAFAENDNAD----APVLVAVKVLR---PDASDNARED--FLKEVKILSRLSDPNIAR 83

Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTV-EAPKCLNFLQRINIAID 520
           +L VC+      D    ++ E+M NG L ++L         +    K L+F   + +A  
Sbjct: 84  LLGVCTV-----DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQ 138

Query: 521 VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAK--------------LLP 566
           +A  ++YL         H DL   N L+    T  +ADFG+++               LP
Sbjct: 139 IASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLP 195

Query: 567 PAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT--RKRP 617
              +   S+               L  + +   DV+++G+ L E++T  R++P
Sbjct: 196 IRWMAWESV---------------LLGKFTTKSDVWAFGVTLWEILTLCREQP 233

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 48.1 bits (115), Expect = 8e-06
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 26/217 (11%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGAS-KSSIAECSALRNIRHKNLVKILTVC 466
           I  G+FG+V K +     TI+AVK +         K  + +   +  +R  +   I+   
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVV--MRSSDCPYIVKFY 69

Query: 467 SGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRI--NIAIDVACA 524
             +  +GD +  +  E M + SL+++        K V         + I   IA+    A
Sbjct: 70  GALFREGDCW--ICMELM-DISLDKFY-------KYVYEVLKSVIPEEILGKIAVATVKA 119

Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYI 584
           L YL  + +    H D+KPSN+LLD      + DFG++  L  +  +T   G +    Y+
Sbjct: 120 LNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCR---PYM 174

Query: 585 APAEYGLGSEVS----INGDVYSYGILLLELMTRKRP 617
           AP    +         +  DV+S GI L E+ T K P
Sbjct: 175 APER--IDPSARDGYDVRSDVWSLGITLYEVATGKFP 209

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 48.1 bits (114), Expect = 9e-06
 Identities = 61/228 (26%), Positives = 99/228 (43%), Gaps = 39/228 (17%)

Query: 406 CWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           C +  G++G VYK    +GK      +  +   G S S+  E + LR ++H N++ +  V
Sbjct: 7   CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKV 66

Query: 466 -CSGVDYKGDDFKALVYEFMHNGSLEEW----LHPVSGADKT-VEAPKCL--NFLQRINI 517
             S  D K       V+        + W     H  S A+K  ++ P+ +  + L +I  
Sbjct: 67  FLSHSDRK-------VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQI-- 117

Query: 518 AIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMT----AHVADFGLAKLL-----PPA 568
            +D    + YLH +      H DLKP+N+L+  E        +AD G A+L      P A
Sbjct: 118 -LD---GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLA 170

Query: 569 HLQTSSIGVKGTIGYIAPAEYGLGSEVSING-DVYSYGILLLELMTRK 615
            L    +    T  Y AP E  LG+       D+++ G +  EL+T +
Sbjct: 171 DLDPVVV----TFWYRAP-ELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 48.3 bits (115), Expect = 1e-05
 Identities = 20/61 (32%), Positives = 33/61 (54%), Gaps = 1/61 (1%)

Query: 6   NRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEF 65
           N ++G IP   G ++ +L  L L +N   G IP S+   + L +  +  N+L+G VP+  
Sbjct: 452 NSIRGNIPPSLG-SITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510

Query: 66  G 66
           G
Sbjct: 511 G 511

Length = 623

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 43/158 (27%), Positives = 70/158 (44%), Gaps = 21/158 (13%)

Query: 463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPV--SGADKTVEAPKCLNFLQR-INIAI 519
             V     Y+  D   LV   M+ G L+  ++ +   G D+           QR I  A 
Sbjct: 61  FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDE-----------QRAIFYAA 109

Query: 520 DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKG 579
           ++ C L+ L  +      + DLKP N+LLD      ++D GLA  +P      +  G  G
Sbjct: 110 ELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---TVRGRVG 163

Query: 580 TIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
           T+GY+AP E     + + + D +  G L+ E++  + P
Sbjct: 164 TVGYMAP-EVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 57/227 (25%), Positives = 95/227 (41%), Gaps = 44/227 (19%)

Query: 408 IDMGSFGSVYKGIL--DEGKTIIAVKVLNLLHHGASKSSIA-ECSALRNI-RHKNLVKIL 463
           I  G+FG V + ++  D  K   A+K+L            A E   L  +  H N++ +L
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69

Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVS------------GADKTVEAPKCLNF 511
             C    Y       +  E+   G+L ++L                G   T+ + + L F
Sbjct: 70  GACENRGYL-----YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124

Query: 512 LQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQ 571
                 A DVA  ++YL    +    H DL   NVL+   + + +ADFGL++        
Sbjct: 125 ------ASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR-------- 167

Query: 572 TSSIGVKGTIGYIAPAEY----GLGSEV-SINGDVYSYGILLLELMT 613
              + VK T+G + P  +     L   V +   DV+S+G+LL E+++
Sbjct: 168 GEEVYVKKTMGRL-PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 47.2 bits (112), Expect = 1e-05
 Identities = 54/220 (24%), Positives = 96/220 (43%), Gaps = 34/220 (15%)

Query: 408 IDMGSFGSVYKGILD-EGKTIIAVKVLNLLHHGASKSS----IAECSALRNIRHKNLVKI 462
           +  G FG + +G L    K  + V + + L  G S       +AE   L    H N+V++
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAI-HTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71

Query: 463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVA 522
                GV  +G+    +V E+M NG+L+ +L    G          L   Q + +   +A
Sbjct: 72  ----EGVITRGNTM-MIVTEYMSNGALDSFLRKHEGQ---------LVAGQLMGMLPGLA 117

Query: 523 CALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQT--SSIGVKGT 580
             +KYL    +    H  L    VL++ ++   ++ F     L     +   +++  K  
Sbjct: 118 SGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFRR---LQEDKSEAIYTTMSGKSP 171

Query: 581 IGYIAPA--EYGLGSEVSINGDVYSYGILLLELMTR-KRP 617
           + + AP   +Y   S  S   DV+S+GI++ E+M+  +RP
Sbjct: 172 VLWAAPEAIQYHHFSSAS---DVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 53/233 (22%), Positives = 99/233 (42%), Gaps = 48/233 (20%)

Query: 415 SVYKGILDEGKTIIAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYK 472
           + Y  IL+     +A+K L+    +   +K +  E   ++ + HKN++ +L V       
Sbjct: 42  AAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV------- 91

Query: 473 GDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAID----------VA 522
                     F    SLEE+   V    + ++A    N  Q I + +D          + 
Sbjct: 92  ----------FTPQKSLEEF-QDVYIVMELMDA----NLCQVIQMELDHERMSYLLYQML 136

Query: 523 CALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIG 582
           C +K+LH        H DLKPSN+++  + T  + DFGLA+    + + T  +  +    
Sbjct: 137 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR---- 189

Query: 583 YIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV 635
           Y    E  LG     N D++S G ++ E++       ++F G  ++  + + +
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG----VLFPGTDHIDQWNKVI 238

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 47.6 bits (113), Expect = 1e-05
 Identities = 40/113 (35%), Positives = 56/113 (49%), Gaps = 16/113 (14%)

Query: 520 DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAK-LLPPAHLQTSSIGVK 578
           ++  AL++LH   +    + D+K  N+LLD E    + DFGL+K  L     +T S    
Sbjct: 113 EIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFC-- 167

Query: 579 GTIGYIAP----AEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMN 627
           GTI Y+AP     + G G  V    D +S GIL+ EL+T   P     EG  N
Sbjct: 168 GTIEYMAPEIIRGKGGHGKAV----DWWSLGILIFELLTGASP--FTLEGERN 214

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 47/231 (20%), Positives = 95/231 (41%), Gaps = 23/231 (9%)

Query: 408 IDMGSFGSVYKG--ILDEGKTIIA-VKVLNLLHHGASKSSIAECSALRNIRHKNLVKILT 464
           I  G F  VY+   +LD     +  V++  ++   A +  + E   L+ + H N++K L 
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69

Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
                 +  D+   +V E    G L + +       + +       +       + +  A
Sbjct: 70  -----SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYF------VQLCSA 118

Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYI 584
           ++++H        H D+KP+NV +       + D GL +    +   T++  + GT  Y+
Sbjct: 119 VEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYM 173

Query: 585 APAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV 635
           +P E    +  +   D++S G LL E+   + P    +   MNL +  + +
Sbjct: 174 SP-ERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNLFSLCQKI 220

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 46.9 bits (111), Expect = 2e-05
 Identities = 56/218 (25%), Positives = 87/218 (39%), Gaps = 32/218 (14%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKI----L 463
           I  G FG VY     +   + A+K L+       K    E  AL      +LV       
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLD---KKRIKMKQGETLALNERIMLSLVSTGDCPF 58

Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            VC    +   D    + + M+ G L   L     +   V + K + F      A ++  
Sbjct: 59  IVCMTYAFHTPDKLCFILDLMNGGDLHYHL-----SQHGVFSEKEMRFY-----ATEIIL 108

Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLA----KLLPPAHLQTSSIGVKG 579
            L+++H+       + DLKP+N+LLD      ++D GLA    K  P A +        G
Sbjct: 109 GLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--------G 157

Query: 580 TIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
           T GY+AP     G+    + D +S G +L +L+    P
Sbjct: 158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 47.0 bits (112), Expect = 2e-05
 Identities = 34/104 (32%), Positives = 49/104 (47%), Gaps = 8/104 (7%)

Query: 517 IAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIG 576
           + + +  AL YL         H D+KPSN+LLD      + DFG++  L  +  +T S  
Sbjct: 119 MTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS-- 174

Query: 577 VKGTIGYIAPAEY---GLGSEVSINGDVYSYGILLLELMTRKRP 617
             G   Y+AP          +  I  DV+S GI L+EL T + P
Sbjct: 175 -AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 46.8 bits (111), Expect = 2e-05
 Identities = 55/217 (25%), Positives = 85/217 (39%), Gaps = 26/217 (11%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSS---IAECSALRNIRHKNLVKILT 464
           I  G FG V  G    G +   V V  L            + E    R + H N+++ L 
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 465 VC-SGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            C   + Y       LV EF   G L+ +L    G    +        LQR+  A +VA 
Sbjct: 63  QCIESIPY------LLVLEFCPLGDLKNYLRSNRGMVAQMAQKD---VLQRM--ACEVAS 111

Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLA-KLLPPAHLQTSSIGVKGTIG 582
            L +LH   Q    H DL   N  L  +++  + D+GLA +  P  +  T        + 
Sbjct: 112 GLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV-PLR 167

Query: 583 YIAP---AEYG---LGSEVSINGDVYSYGILLLELMT 613
           ++AP      G   L  + +   +++S G+ + EL T
Sbjct: 168 WLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 47.1 bits (112), Expect = 2e-05
 Identities = 56/211 (26%), Positives = 89/211 (42%), Gaps = 33/211 (15%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLN---LLHHGASKSSIAECSALRNIRHKNLVKILT 464
           +  GSFG V            A+K L    +L     +    E S L  + H  +V ++ 
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMM- 84

Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
            CS   ++ ++    + EF+  G L   L          +A +  N + +   A ++  A
Sbjct: 85  -CS---FQDENRVYFLLEFVVGGELFTHLR---------KAGRFPNDVAKFYHA-ELVLA 130

Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYI 584
            +YLH        + DLKP N+LLD++    V DFG AK +P       +  + GT  Y+
Sbjct: 131 FEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP-----DRTFTLCGTPEYL 182

Query: 585 AP---AEYGLGSEVSINGDVYSYGILLLELM 612
           AP      G G  V    D ++ G+LL E +
Sbjct: 183 APEVIQSKGHGKAV----DWWTMGVLLYEFI 209

Length = 329

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 46.6 bits (110), Expect = 2e-05
 Identities = 52/213 (24%), Positives = 94/213 (44%), Gaps = 28/213 (13%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           I  GS G V    +     ++AVK ++L      +    E   +R+ +H+N+V++     
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN--- 84

Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
              Y   D   +V EF+  G+L + +      ++ + A  CL  L+          AL  
Sbjct: 85  --SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-AAVCLAVLK----------ALSV 131

Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP- 586
           LH        H D+K  ++LL H+    ++DFG    +     +  S+   GT  ++AP 
Sbjct: 132 LHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL--VGTPYWMAPE 186

Query: 587 --AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
             +    G EV    D++S GI+++E++  + P
Sbjct: 187 LISRLPYGPEV----DIWSLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 46.9 bits (111), Expect = 2e-05
 Identities = 64/213 (30%), Positives = 97/213 (45%), Gaps = 32/213 (15%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           I  G+FG VY+    + + I A+KVL+      +K  +A     RNI  + L+       
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSK-KEIVAKKEVAHTIGERNILVRTLLDESPFIV 59

Query: 468 GV--DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
           G+   ++ D    LV ++M  G L  W     G      A        +  IA ++  AL
Sbjct: 60  GLKFSFQTDSDLYLVTDYMSGGELF-WHLQKEGRFSEDRA--------KFYIA-ELVLAL 109

Query: 526 KYLH-HDCQPTTAHCDLKPSNVLLDHEMTAHVA--DFGLAKLLPPAHLQTSSIGVKGTIG 582
           ++LH +D      + DLKP N+LLD   T H+A  DFGL+K     +  T++    GT  
Sbjct: 110 EHLHKYD----IVYRDLKPENILLD--ATGHIALCDFGLSKANLTDNKTTNTFC--GTTE 161

Query: 583 YIAPA----EYGLGSEVSINGDVYSYGILLLEL 611
           Y+AP     E G    V    D +S G+L+ E+
Sbjct: 162 YLAPEVLLDEKGYTKHV----DFWSLGVLVFEM 190

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 46.6 bits (110), Expect = 3e-05
 Identities = 53/218 (24%), Positives = 94/218 (43%), Gaps = 24/218 (11%)

Query: 411 GSFGSVYKGI---LDEGKTIIAVKV-LNLLHHGASKSSIA----ECSALRNI-RHKNLVK 461
           G FG V       +D+ K   AV V + +L   A++  ++    E   ++ I +HKN++ 
Sbjct: 26  GCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIN 85

Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLH---PVS---GADKTVEAPKCLNFLQRI 515
           +L  C+      D    ++ E+   G+L E+L    P       D      + + F   +
Sbjct: 86  LLGACTQ-----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140

Query: 516 NIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSI 575
           +    VA  ++YL         H DL   NVL+       +ADFGLA+ +        + 
Sbjct: 141 SCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTT 197

Query: 576 GVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             +  + ++AP E       +   DV+S+G+L+ E+ T
Sbjct: 198 NGRLPVKWMAP-EALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 46.2 bits (109), Expect = 3e-05
 Identities = 62/242 (25%), Positives = 100/242 (41%), Gaps = 28/242 (11%)

Query: 411 GSFGSVYKGI-LDEGKTIIAVKV-LNLLHHGASKSSIA-ECSA--LRNIRHKNLVKILTV 465
           G+FG VY     D G+ +   +V  +      SK   A EC    L+N+RH  +V+    
Sbjct: 13  GAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGC 72

Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
               D +       V E+M  GS+++ L       + V        LQ ++         
Sbjct: 73  LR--DPEEKKLSIFV-EYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVS--------- 120

Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSI-GVKGTIGYI 584
            YLH +      H D+K +N+L D      + DFG +K +    +  + I  V GT  ++
Sbjct: 121 -YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWM 176

Query: 585 APAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFA----RTVLPDHV 640
           +P E   G       DV+S    ++E++T K P    +E    +   A    + +LPD V
Sbjct: 177 SP-EVISGEGYGRKADVWSVACTVVEMLTEKPPWA-EYEAMAAIFKIATQPTKPMLPDGV 234

Query: 641 MD 642
            D
Sbjct: 235 SD 236

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 46.6 bits (110), Expect = 3e-05
 Identities = 39/140 (27%), Positives = 67/140 (47%), Gaps = 17/140 (12%)

Query: 478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTA 537
           ++  E M  GSL++ L       + +        L +++IA  V   L YL    Q    
Sbjct: 79  SICMEHMDGGSLDQVLKEAKRIPEEI--------LGKVSIA--VLRGLAYLREKHQ--IM 126

Query: 538 HCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSI 597
           H D+KPSN+L++      + DFG++  L    + + +    GT  Y++P E   G+  S+
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSP-ERLQGTHYSV 181

Query: 598 NGDVYSYGILLLELMTRKRP 617
             D++S G+ L+EL   + P
Sbjct: 182 QSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 46.5 bits (111), Expect = 3e-05
 Identities = 60/245 (24%), Positives = 90/245 (36%), Gaps = 67/245 (27%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVL--------NLLHHGASKSSIAECSALRNIRHKNL 459
           +  G  G V+   L     + A+KVL        N +    ++  I     L  + H  L
Sbjct: 9   LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEI-----LATLDHPFL 63

Query: 460 VKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI 519
             +        ++ + +  LV ++   G L   L    G   + E  +   F      A 
Sbjct: 64  PTLYA-----SFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVAR---FY-----AA 110

Query: 520 DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV--ADFGLAKLLPPAHLQTSSIGV 577
           +V  AL+YLH        + DLKP N+LL HE + H+  +DF L+K         S    
Sbjct: 111 EVLLALEYLH--LL-GIVYRDLKPENILL-HE-SGHIMLSDFDLSKQSDVEPPPVSKALR 165

Query: 578 K---------------------------GTIGYIAP---AEYGLGSEVSINGDVYSYGIL 607
           K                           GT  YIAP   +  G GS V    D ++ GIL
Sbjct: 166 KGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV----DWWTLGIL 221

Query: 608 LLELM 612
           L E++
Sbjct: 222 LYEML 226

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 45.9 bits (109), Expect = 3e-05
 Identities = 50/213 (23%), Positives = 90/213 (42%), Gaps = 31/213 (14%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNLVKILTVCSG 468
           G+FG        E  +++  K +NL  L     + ++ E   L  ++H N++        
Sbjct: 11  GAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNII-------- 62

Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSG---ADKTVEAPKCLNFLQRINIA--IDVAC 523
                    A    FM + +L   +   +G    DK V     L F + + +     +  
Sbjct: 63  ---------AYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQL-FEEEMVLWYLFQIVS 112

Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGY 583
           A+ Y+H   +    H D+K  N+ L       + DFG++K+L   +    +  V GT  Y
Sbjct: 113 AVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYY 167

Query: 584 IAPAEYGLGSEVSINGDVYSYGILLLELMTRKR 616
           ++P E   G + +   D+++ G +L EL+T KR
Sbjct: 168 MSP-ELCQGVKYNFKSDIWALGCVLYELLTLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 46.6 bits (110), Expect = 3e-05
 Identities = 65/257 (25%), Positives = 108/257 (42%), Gaps = 32/257 (12%)

Query: 402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLN---LLHHGASKSSIAECSALRNIRHKN 458
           F  L  I  G+FG V    L     + A+K+LN   +L    +     E   L N  ++ 
Sbjct: 3   FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62

Query: 459 LVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIA 518
           +  +        ++ ++   LV ++   G L   L  +S  +  +       +L  + IA
Sbjct: 63  ITTLHYA-----FQDENNLYLVMDYYVGGDL---LTLLSKFEDRLPEDMARFYLAEMVIA 114

Query: 519 IDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFG-LAKLLPPAHLQTSSIGV 577
           ID    L Y+H D         +KP N+L+D      +ADFG   KL+    +Q SS+ V
Sbjct: 115 IDSVHQLHYVHRD---------IKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ-SSVAV 164

Query: 578 KGTIGYIAPA-----EYGLGSEVSINGDVYSYGILLLELMTRKRP--SDIMFEGNMNLHN 630
            GT  YI+P      E G G +     D +S G+ + E++  + P  ++ + E    + N
Sbjct: 165 -GTPDYISPEILQAMEDGKG-KYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222

Query: 631 FA-RTVLPDHVMDIVDS 646
              R   P  V D+ + 
Sbjct: 223 HKERFQFPAQVTDVSED 239

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 46.1 bits (109), Expect = 3e-05
 Identities = 63/240 (26%), Positives = 101/240 (42%), Gaps = 29/240 (12%)

Query: 408 IDMGSFGSVY--KGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           I  GSFG +Y  K   D    +I    L  +     ++S  E   L  ++H N+V   T 
Sbjct: 8   IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIV---TF 64

Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
            +     G  F  +V E+   G L + ++   G        + L++       + ++  L
Sbjct: 65  FASFQENGRLF--IVMEYCDGGDLMKRINRQRGV--LFSEDQILSWF------VQISLGL 114

Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHE-MTAHVADFGLAKLLPPA-HLQTSSIGVKGTIGY 583
           K++H        H D+K  N+ L    M A + DFG+A+ L  +  L  + +G   T  Y
Sbjct: 115 KHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVG---TPYY 168

Query: 584 IAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDI 643
           ++P E       +   D++S G +L EL T K P    FEGN NLH     +   +   I
Sbjct: 169 LSP-EICQNRPYNNKTDIWSLGCVLYELCTLKHP----FEGN-NLHQLVLKICQGYFAPI 222

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 46.3 bits (110), Expect = 3e-05
 Identities = 35/107 (32%), Positives = 51/107 (47%), Gaps = 16/107 (14%)

Query: 518 AIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAK--LLPPAHLQTSSI 575
           A ++A  L +LH        + DLK  NV+LD E    +ADFG+ K  +      +T   
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC- 162

Query: 576 GVKGTIGYIAP---AEYGLGSEVSINGDVYSYGILLLELMTRKRPSD 619
              GT  YIAP   A    G  V    D +++G+LL E++  + P D
Sbjct: 163 ---GTPDYIAPEIIAYQPYGKSV----DWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 46.1 bits (109), Expect = 3e-05
 Identities = 39/152 (25%), Positives = 73/152 (48%), Gaps = 24/152 (15%)

Query: 427 IIAVKVLNLLHHGASKSS----IAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYE 482
           ++AVK   +L   A+K++    + E   L  ++  N++++L VC  VD   +D   ++ E
Sbjct: 48  LVAVK---ILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVC--VD---EDPLCMITE 99

Query: 483 FMHNGSLEEWLHPVSGADKTVEAPK---------CLNFLQRINIAIDVACALKYLHHDCQ 533
           +M NG L ++L      DK                +++   +++A+ +A  +KYL     
Sbjct: 100 YMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SS 156

Query: 534 PTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL 565
               H DL   N L+   +T  +ADFG+++ L
Sbjct: 157 LNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 46.3 bits (110), Expect = 3e-05
 Identities = 55/235 (23%), Positives = 92/235 (39%), Gaps = 53/235 (22%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNL----LHHGASKSSIAEC----SALRNIR------H 456
           G++G V K        I+A+K + +          +  +  C    + LR ++      H
Sbjct: 20  GTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKH 79

Query: 457 KNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRIN 516
           +N++ ++ V     Y   DF  LV + M            S   K V+    L   Q   
Sbjct: 80  ENIMGLVDV-----YVEGDFINLVMDIMA-----------SDLKKVVDRKIRLTESQVKC 123

Query: 517 IAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLA-------------- 562
           I + +   L  LH   +    H DL P+N+ ++ +    +ADFGLA              
Sbjct: 124 ILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180

Query: 563 -KLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSE-VSINGDVYSYGILLLELMTRK 615
            + +      TS +    T+ Y AP E  +G+E      D++S G +  EL+T K
Sbjct: 181 DETMQRREEMTSKV---VTLWYRAP-ELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 46.1 bits (109), Expect = 4e-05
 Identities = 36/93 (38%), Positives = 52/93 (55%), Gaps = 10/93 (10%)

Query: 523 CALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA--DFGLAKLLPPAHLQTSSIGVKGT 580
           CAL+ LH   +    + DLKP N+LLD+    H+A  DFGL KL      +T++    GT
Sbjct: 104 CALENLH---KFNVIYRDLKPENILLDY--QGHIALCDFGLCKLNMKDDDKTNTFC--GT 156

Query: 581 IGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             Y+AP E  LG   +   D ++ G+LL E++T
Sbjct: 157 PEYLAP-ELLLGHGYTKAVDWWTLGVLLYEMLT 188

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 46.0 bits (109), Expect = 4e-05
 Identities = 59/222 (26%), Positives = 100/222 (45%), Gaps = 32/222 (14%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVK--VLNLLHHGASKSSIAECSALRNIRHKN-LVKILT 464
           I  G++G VYK        ++A+K   L +   G   +++ E S L+ +     +V++L 
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68

Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKT-VEAPKCLNFLQRINIAIDVAC 523
           V    +  G     LV+E++ +  L++++          + A    +F+ ++        
Sbjct: 69  VEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL-------- 119

Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHE-MTAHVADFGLAKLLPPAHLQTSSIGVKG--- 579
            LK + H  +    H DLKP N+L+D +     +AD GL +          SI VK    
Sbjct: 120 -LKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF--------SIPVKSYTH 170

Query: 580 ---TIGYIAPAEYGLGS-EVSINGDVYSYGILLLELMTRKRP 617
              T+ Y AP E  LGS   S   D++S G +  E M+RK+P
Sbjct: 171 EIVTLWYRAP-EVLLGSTHYSTPVDIWSVGCIFAE-MSRKQP 210

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 45.6 bits (108), Expect = 4e-05
 Identities = 34/104 (32%), Positives = 51/104 (49%), Gaps = 13/104 (12%)

Query: 517 IAIDVACALKYL---HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTS 573
           IA+ V   L YL   H        H D+KPSN+L++      + DFG++  L  +   T 
Sbjct: 108 IAVAVVEGLTYLYNVHR-----IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT- 161

Query: 574 SIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
                GT  Y++P E   G + ++  DV+S GI ++EL   K P
Sbjct: 162 ---FVGTSTYMSP-ERIQGGKYTVKSDVWSLGISIIELALGKFP 201

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 45.8 bits (108), Expect = 5e-05
 Identities = 64/256 (25%), Positives = 110/256 (42%), Gaps = 42/256 (16%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLN---LLHHGASKSSIAECSALRNIRHKNLVKILT 464
           I  G+FG V    +   + I A+K+LN   +L         AE +  R  R+   V +  
Sbjct: 9   IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKR-------AETACFREERN---VLVNG 58

Query: 465 VCSGVD-----YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI 519
            C  +      ++ +++  LV ++   G L   L  +S  +  +       ++  + +AI
Sbjct: 59  DCQWITTLHYAFQDENYLYLVMDYYVGGDL---LTLLSKFEDRLPEDMARFYIAEMVLAI 115

Query: 520 DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFG-LAKLLPPAHLQTSSIGVK 578
                L Y+H D         +KP NVLLD      +ADFG   K+     +Q SS+ V 
Sbjct: 116 HSIHQLHYVHRD---------IKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ-SSVAV- 164

Query: 579 GTIGYIAPA-----EYGLGSEVSINGDVYSYGILLLELMTRKRP--SDIMFEGNMNLHNF 631
           GT  YI+P      E G+G +     D +S G+ + E++  + P  ++ + E    + N 
Sbjct: 165 GTPDYISPEILQAMEDGMG-KYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 223

Query: 632 -ARTVLPDHVMDIVDS 646
             R   P H+ D+ + 
Sbjct: 224 EERFQFPSHITDVSEE 239

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 45.5 bits (108), Expect = 5e-05
 Identities = 51/212 (24%), Positives = 85/212 (40%), Gaps = 36/212 (16%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA--ECSALRNIRHKNLVKILTVCSG 468
           GS+G V K    E   I+A+K             IA  E   L+ +RH+NLV ++ V   
Sbjct: 12  GSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-- 69

Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL 528
              +      LV+EF+ +  L++              P  L+  +       +   +++ 
Sbjct: 70  ---RRKKRLYLVFEFVDHTVLDDLEK----------YPNGLDESRVRKYLFQILRGIEFC 116

Query: 529 HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP-PAHLQTSSIGVKGTIGYIAP- 586
           H        H D+KP N+L+       + DFG A+ L  P  + T  +    T  Y AP 
Sbjct: 117 HSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV---ATRWYRAPE 170

Query: 587 -----AEYGLGSEVSINGDVYSYGILLLELMT 613
                 +YG         D+++ G L+ E++T
Sbjct: 171 LLVGDTKYGRAV------DIWAVGCLVTEMLT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 46.3 bits (110), Expect = 6e-05
 Identities = 34/131 (25%), Positives = 56/131 (42%), Gaps = 26/131 (19%)

Query: 515 INIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLA--KLLPPAHLQT 572
           ++I   +   ++Y+H        H DLKP N+LL       + D+G A  K L    L  
Sbjct: 116 LSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD 172

Query: 573 SSIGVK--------------GTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT----- 613
             +  +              GT  Y+AP E  LG   S + D+Y+ G++L +++T     
Sbjct: 173 IDVDERNICYSSMTIPGKIVGTPDYMAP-ERLLGVPASESTDIYALGVILYQMLTLSFPY 231

Query: 614 -RKRPSDIMFE 623
            RK+   I + 
Sbjct: 232 RRKKGRKISYR 242

Length = 932

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 45.4 bits (107), Expect = 7e-05
 Identities = 36/110 (32%), Positives = 54/110 (49%), Gaps = 12/110 (10%)

Query: 513 QRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQT 572
           Q +  A +++  L +LH   +    + DLK  NV+LD E    +ADFG+ K      + T
Sbjct: 102 QAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTT 158

Query: 573 SSIGVKGTIGYIAP---AEYGLGSEVSINGDVYSYGILLLELMTRKRPSD 619
            +    GT  YIAP   A    G  V    D ++YG+LL E++  + P D
Sbjct: 159 RTFC--GTPDYIAPEIIAYQPYGKSV----DWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 45.4 bits (107), Expect = 7e-05
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 43/216 (19%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV      +    +AVK L+     ++H   +K +  E   L++++H+N++ +L V
Sbjct: 28  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDV 84

Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEW-----LHPVSGAD--KTVEAPKCLNFLQRINIA 518
                            F    SLEE+     +  + GAD    V+  K  +    +   
Sbjct: 85  -----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD--DHVQFL 125

Query: 519 I-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I  +   LKY+H        H DLKPSN+ ++ +    + DFGLA+     H      G 
Sbjct: 126 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 177

Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             T  Y AP         +   D++S G ++ EL+T
Sbjct: 178 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 213

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 45.0 bits (106), Expect = 8e-05
 Identities = 52/183 (28%), Positives = 79/183 (43%), Gaps = 24/183 (13%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLN---LLHHGASKSSIAECSAL-RNIRHKNLVKIL 463
           I  GSFG V            AVKVL    +L+    K  +AE + L +N++H  LV + 
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL- 61

Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
                  ++  +    V +F++ G L   L      +++   P+      R   A ++A 
Sbjct: 62  ----HYSFQTTEKLYFVLDFVNGGELFFHLQ----RERSFPEPRA-----RFYAA-EIAS 107

Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGY 583
           AL YLH        + DLKP N+LLD +    + DFGL K         ++    GT  Y
Sbjct: 108 ALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEY 162

Query: 584 IAP 586
           +AP
Sbjct: 163 LAP 165

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 44.5 bits (105), Expect = 9e-05
 Identities = 28/83 (33%), Positives = 39/83 (46%), Gaps = 12/83 (14%)

Query: 540 DLKPSNVLLDHEMTAHVADFGLA----KLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEV 595
           DLKP+N+LLD      ++D GLA    K  P A +        GT GY+AP     G   
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--------GTHGYMAPEVLQKGVAY 173

Query: 596 SINGDVYSYGILLLELMTRKRPS 618
             + D +S G +L +L+    P 
Sbjct: 174 DSSADWFSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 44.5 bits (105), Expect = 1e-04
 Identities = 62/219 (28%), Positives = 100/219 (45%), Gaps = 36/219 (16%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSG-- 468
           G++GSVYK +       +A+K + L         + E S    I  +  + IL       
Sbjct: 12  GNYGSVYKVLHRPTGVTMAMKEIRL--------ELDE-SKFNQIIME--LDILHKAVSPY 60

Query: 469 -VDYKGDDF-KALVY---EFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            VD+ G  F +  VY   E+M  GSL++     +G   T   P+  + L+RI  A  V  
Sbjct: 61  IVDFYGAFFIEGAVYMCMEYMDAGSLDKL---YAGGVATEGIPE--DVLRRITYA--VVK 113

Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGY 583
            LK+L  +      H D+KP+NVL++      + DFG++  L  A L  ++IG +    Y
Sbjct: 114 GLKFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNL-VASLAKTNIGCQ---SY 167

Query: 584 IAPAEYGLGS-----EVSINGDVYSYGILLLELMTRKRP 617
           +AP     G        ++  DV+S G+ +LE+   + P
Sbjct: 168 MAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 44.3 bits (105), Expect = 1e-04
 Identities = 40/136 (29%), Positives = 67/136 (49%), Gaps = 17/136 (12%)

Query: 482 EFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDL 541
           E M  GSL++ L       K    P+  N L +I+IA  V   L YL    +    H D+
Sbjct: 79  EHMDGGSLDQVLK------KAGRIPE--NILGKISIA--VLRGLTYLREKHK--IMHRDV 126

Query: 542 KPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDV 601
           KPSN+L++      + DFG++  L    + + +    GT  Y++P E   G+  ++  D+
Sbjct: 127 KPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSP-ERLQGTHYTVQSDI 181

Query: 602 YSYGILLLELMTRKRP 617
           +S G+ L+E+   + P
Sbjct: 182 WSLGLSLVEMAIGRYP 197

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 44.6 bits (105), Expect = 1e-04
 Identities = 60/248 (24%), Positives = 103/248 (41%), Gaps = 52/248 (20%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGA--SKSSIAECSALRNIRHKNLVKILTVCSG 468
           G++G+V   +       +A+K L         +K +  E   L++++H+N++ +L V + 
Sbjct: 26  GAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTP 85

Query: 469 VDYKGDDFKA--LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALK 526
            D   D F    LV  FM     +   H     D+       + FL        +   LK
Sbjct: 86  -DLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDR-------IQFL-----VYQMLKGLK 132

Query: 527 YLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP 586
           Y+H        H DLKP N+ ++ +    + DFGLA+        +   G   T  Y AP
Sbjct: 133 YIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVTRWYRAP 184

Query: 587 AEYGLGSEVSING-------DVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDH 639
                  EV +N        D++S G ++ E++T K     +F+G+ +L         D 
Sbjct: 185 -------EVILNWMHYTQTVDIWSVGCIMAEMLTGKP----LFKGHDHL---------DQ 224

Query: 640 VMDIVDST 647
           +M+I+  T
Sbjct: 225 LMEIMKVT 232

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 44.3 bits (105), Expect = 1e-04
 Identities = 55/218 (25%), Positives = 90/218 (41%), Gaps = 33/218 (15%)

Query: 402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLN--LLHHGASKSSI-AECSALRNIRHKN 458
           F  L  +  G +G V+     +   I+A+K +   LL        +  E   L   + + 
Sbjct: 3   FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62

Query: 459 LVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIA 518
           LVK+L       ++ D++  L  E++  G     L+   G      A        R  +A
Sbjct: 63  LVKLL-----YAFQDDEYLYLAMEYVPGGDFRTLLNN-LGVLSEDHA--------RFYMA 108

Query: 519 IDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV--ADFGLAK-LLPPAHLQTSSI 575
            ++  A+  LH   +    H DLKP N L+D   + H+   DFGL+K ++  A+      
Sbjct: 109 -EMFEAVDALH---ELGYIHRDLKPENFLIDA--SGHIKLTDFGLSKGIVTYAN------ 156

Query: 576 GVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
            V G+  Y+AP E   G       D +S G +L E + 
Sbjct: 157 SVVGSPDYMAP-EVLRGKGYDFTVDYWSLGCMLYEFLC 193

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 44.0 bits (104), Expect = 1e-04
 Identities = 51/213 (23%), Positives = 93/213 (43%), Gaps = 28/213 (13%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           I  GS G V           +AVK ++L      +    E   +R+ +H N+V++ +   
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYS--- 83

Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
              Y   D   +V EF+  G+L + +      ++ + A  CL  L+          AL +
Sbjct: 84  --SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-ATVCLAVLK----------ALSF 130

Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP- 586
           LH        H D+K  ++LL  +    ++DFG    +     +  S+   GT  ++AP 
Sbjct: 131 LHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL--VGTPYWMAPE 185

Query: 587 --AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
             +    G+EV    D++S GI+++E++  + P
Sbjct: 186 VISRLPYGTEV----DIWSLGIMVIEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 44.4 bits (105), Expect = 2e-04
 Identities = 27/92 (29%), Positives = 46/92 (50%), Gaps = 11/92 (11%)

Query: 8   VQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGK 67
           ++G IP D    L +L  ++L  N I G IP S+ + + LEV  ++ N+  G +P   G+
Sbjct: 430 LRGFIPNDIS-KLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQ 488

Query: 68  ATKAYCVQNCNQHLKHLDINNNNFGGLLPGCI 99
            T           L+ L++N N+  G +P  +
Sbjct: 489 LTS----------LRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 44.0 bits (104), Expect = 2e-04
 Identities = 29/124 (23%), Positives = 50/124 (40%), Gaps = 35/124 (28%)

Query: 26  LSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLD 85
           L L    + G IP+ +     L+   ++ N++ G +P   G  T           L+ LD
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITS----------LEVLD 472

Query: 86  INNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTIS 145
           ++ N+F G                         SIP  +G+  +L+ L++  N LSG + 
Sbjct: 473 LSYNSFNG-------------------------SIPESLGQLTSLRILNLNGNSLSGRVP 507

Query: 146 PAIG 149
            A+G
Sbjct: 508 AALG 511

Length = 623

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 44.5 bits (105), Expect = 2e-04
 Identities = 43/160 (26%), Positives = 70/160 (43%), Gaps = 21/160 (13%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVL---NLLHHGASKSSIAECSALRNIRHKNLVKILT 464
           I  G+FG VY G       + AVKV+   ++++        AE  AL   +   +V +  
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71

Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
                +        LV E++  G ++  LH     D+       + ++       +VA A
Sbjct: 72  SLQSANNV-----YLVMEYLIGGDVKSLLHIYGYFDE----EMAVKYIS------EVALA 116

Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKL 564
           L YLH   +    H DLKP N+L+ +E    + DFGL+K+
Sbjct: 117 LDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 43.8 bits (103), Expect = 2e-04
 Identities = 52/183 (28%), Positives = 81/183 (44%), Gaps = 24/183 (13%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLN---LLHHGASKSSIAECSAL-RNIRHKNLVKIL 463
           I  GSFG V        +   AVKVL    +L     K  ++E + L +N++H  LV + 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL- 61

Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
                  ++  D    V ++++ G L  + H        ++  +C    +    A ++A 
Sbjct: 62  ----HFSFQTADKLYFVLDYINGGEL--FYH--------LQRERCFLEPRARFYAAEIAS 107

Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGY 583
           AL YLH        + DLKP N+LLD +    + DFGL K     +  TS+    GT  Y
Sbjct: 108 ALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC--GTPEY 162

Query: 584 IAP 586
           +AP
Sbjct: 163 LAP 165

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 43.9 bits (103), Expect = 2e-04
 Identities = 39/140 (27%), Positives = 68/140 (48%), Gaps = 17/140 (12%)

Query: 478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTA 537
           ++  E M  GSL++ L       K    P+    L +++IA  V   L YL    +    
Sbjct: 79  SICMEHMDGGSLDQVL------KKAGRIPE--QILGKVSIA--VIKGLTYLRE--KHKIM 126

Query: 538 HCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSI 597
           H D+KPSN+L++      + DFG++  L    + + +    GT  Y++P E   G+  S+
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSP-ERLQGTHYSV 181

Query: 598 NGDVYSYGILLLELMTRKRP 617
             D++S G+ L+E+   + P
Sbjct: 182 QSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 60/243 (24%), Positives = 100/243 (41%), Gaps = 30/243 (12%)

Query: 411 GSFGSVYKGI-LDEGKTIIAVKVLNLLHHGASKS---SIAECSA--LRNIRHKNLVKILT 464
           G+FG VY     D G+ + AVK +         S   +  EC    L+N+ H+ +V+   
Sbjct: 13  GAFGRVYLCYDADTGREL-AVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYG 71

Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
                  +     ++  E M  GS+++ L       + V        L+ ++        
Sbjct: 72  CLRDPMERT---LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVS-------- 120

Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSI-GVKGTIGY 583
             YLH +      H D+K +N+L D      + DFG +K L    L  + +  V GT  +
Sbjct: 121 --YLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYW 175

Query: 584 IAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFA----RTVLPDH 639
           ++P E   G       D++S G  ++E++T ++P    FE    +   A      VLP H
Sbjct: 176 MSP-EVISGEGYGRKADIWSVGCTVVEMLT-EKPPWAEFEAMAAIFKIATQPTNPVLPPH 233

Query: 640 VMD 642
           V D
Sbjct: 234 VSD 236

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 43.9 bits (103), Expect = 2e-04
 Identities = 62/254 (24%), Positives = 106/254 (41%), Gaps = 67/254 (26%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV        +  +AVK L+     L+H   ++ +  E   L++++H+N++ +L V
Sbjct: 26  GAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIH---ARRTYRELRLLKHMKHENVIGLLDV 82

Query: 466 CSGVDYKGDDFKA--LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRIN------I 517
            +      ++F    LV   M             GAD      KC    Q+++      +
Sbjct: 83  FTPAT-SIENFNEVYLVTNLM-------------GADLN-NIVKC----QKLSDEHVQFL 123

Query: 518 AIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
              +   LKY+H        H DLKPSNV ++ +    + DFGLA+       Q      
Sbjct: 124 IYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR-------QADD--- 170

Query: 578 KGTIGYIAPAEYGLGSEVSING-------DVYSYGILLLELMTRKRPSDIMFEGNMNLHN 630
               GY+A   Y    E+ +N        D++S G ++ EL+  K     +F GN  +  
Sbjct: 171 -EMTGYVATRWY-RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK----ALFPGNDYIDQ 224

Query: 631 FARTVLPDHVMDIV 644
             R      +M++V
Sbjct: 225 LKR------IMEVV 232

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 43.5 bits (103), Expect = 2e-04
 Identities = 60/241 (24%), Positives = 95/241 (39%), Gaps = 36/241 (14%)

Query: 129 NLQTLHMWDNQLSGTISPAIGEL----QNLVTLAINTNKLSGNIPPSIG-------NLKK 177
            LQ L +  N L    + A+        +L  L ++ N+  G IP  +            
Sbjct: 24  CLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNET-GRIPRGLQSLLQGLTKGCG 82

Query: 178 LLQLYLIEN---FLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMD-LTSLSVGL--- 230
           L +L L +N        +  SL +  SL  + L+ N L       L   L  L   L   
Sbjct: 83  LQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKL 142

Query: 231 DLSRNQLVGSLPTEVGKLI----NLEILFISRNMLECEILSTLGSCIK----LEQLKLGG 282
            L RN+L G+    + K +    +L+ L ++ N +    +  L   +K    LE L L  
Sbjct: 143 VLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNN 202

Query: 283 NLF--QGPIPLS--LSSLRGLRVLDLSQNNISGEI-----PKFLVELQLVQNLNLSYNDL 333
           N    +G   L+  L+SL+ L VL+L  NN++           L     +  L+LS ND+
Sbjct: 203 NGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDI 262

Query: 334 E 334
            
Sbjct: 263 T 263

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 43.6 bits (103), Expect = 3e-04
 Identities = 47/167 (28%), Positives = 73/167 (43%), Gaps = 25/167 (14%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVC--SG 468
           GS G V+  +  +    +AVK + L    + K ++ E   +R + H N+VK+  V   SG
Sbjct: 16  GSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSG 75

Query: 469 VDYKGD-----DFKAL--VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDV 521
            D   D     +  ++  V E+M     E  L  V       E    L   Q +      
Sbjct: 76  SDLTEDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLSEEHARLFMYQLLR----- 125

Query: 522 ACALKYLHHDCQPTTAHCDLKPSNVLLDHE-MTAHVADFGLAKLLPP 567
              LKY+H        H DLKP+NV ++ E +   + DFGLA+++ P
Sbjct: 126 --GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDP 167

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 43.3 bits (102), Expect = 3e-04
 Identities = 28/80 (35%), Positives = 42/80 (52%), Gaps = 9/80 (11%)

Query: 538 HCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGT----IGYIAPAEYGLGS 593
           H D+   NVLL     A + DFGLA+ +    +  S+  VKG     + ++AP E     
Sbjct: 235 HRDVAARNVLLTDGRVAKICDFGLARDI----MNDSNYVVKGNARLPVKWMAP-ESIFDC 289

Query: 594 EVSINGDVYSYGILLLELMT 613
             ++  DV+SYGILL E+ +
Sbjct: 290 VYTVQSDVWSYGILLWEIFS 309

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 43.2 bits (102), Expect = 3e-04
 Identities = 38/115 (33%), Positives = 55/115 (47%), Gaps = 22/115 (19%)

Query: 511 FLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV--ADFG-LAKLLPP 567
           +L  + +AID    L Y+H D         +KP NVLLD     H+  ADFG   +LL  
Sbjct: 107 YLAEMVLAIDSVHQLGYVHRD---------IKPDNVLLD--KNGHIRLADFGSCLRLLAD 155

Query: 568 AHLQTSSIGVKGTIGYIAP-----AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
             +Q S++ V GT  YI+P      E G G       D +S G+ + E++  + P
Sbjct: 156 GTVQ-SNVAV-GTPDYISPEILQAMEDGKGR-YGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 42.8 bits (100), Expect = 3e-04
 Identities = 59/221 (26%), Positives = 93/221 (42%), Gaps = 32/221 (14%)

Query: 408 IDMGSFGSVYKGIL--DEGKTIIAVKVLN-LLHHGASKSSIAECSALRNI-RHKNLVKIL 463
           I  G+FG V K  +  D  +   A+K +         +    E   L  +  H N++ +L
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHP--VSGADKTVE----APKCLNFLQRINI 517
             C    Y       L  E+  +G+L ++L    V   D            L+  Q ++ 
Sbjct: 63  GACEHRGYL-----YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 117

Query: 518 AIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           A DVA  + YL    Q    H DL   N+L+     A +ADFGL++           + V
Sbjct: 118 AADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR--------GQEVYV 166

Query: 578 KGTIGYIAPAEY----GLGSEV-SINGDVYSYGILLLELMT 613
           K T+G + P  +     L   V + N DV+SYG+LL E+++
Sbjct: 167 KKTMGRL-PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 42.7 bits (100), Expect = 4e-04
 Identities = 47/193 (24%), Positives = 88/193 (45%), Gaps = 28/193 (14%)

Query: 428 IAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNG 487
           +AVK ++L      +    E   +R+  H+N+V +        Y   D   +V EF+  G
Sbjct: 50  VAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYN-----SYLVGDELWVVMEFLEGG 104

Query: 488 SLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVL 547
           +L + +      ++ + A  CL+ L+          AL YLH+       H D+K  ++L
Sbjct: 105 ALTDIVTHTRMNEEQI-ATVCLSVLR----------ALSYLHNQ---GVIHRDIKSDSIL 150

Query: 548 LDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP---AEYGLGSEVSINGDVYSY 604
           L  +    ++DFG    +     +  S+   GT  ++AP   +    G+EV    D++S 
Sbjct: 151 LTSDGRIKLSDFGFCAQVSKEVPKRKSL--VGTPYWMAPEVISRLPYGTEV----DIWSL 204

Query: 605 GILLLELMTRKRP 617
           GI+++E++  + P
Sbjct: 205 GIMVIEMIDGEPP 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 43.1 bits (102), Expect = 4e-04
 Identities = 72/294 (24%), Positives = 112/294 (38%), Gaps = 63/294 (21%)

Query: 402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLN---LLHHGASKSSIAECSALRNIRHKN 458
           F  +  I  G+FG V+     +   + A+KVL    ++         AE   L +     
Sbjct: 3   FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPW 62

Query: 459 LVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIA 518
           +VK+    S  D   ++   LV E+M  G L   L       K V   +   F     IA
Sbjct: 63  IVKL--YYSFQD---EEHLYLVMEYMPGGDLMNLL-----IRKDVFPEETARFY----IA 108

Query: 519 IDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV--ADFGLAKLLPPAHLQTSSIG 576
            ++  AL  +H   +    H D+KP N+L+D     H+  ADFGL K +  A  +   + 
Sbjct: 109 -ELVLALDSVH---KLGFIHRDIKPDNILID--ADGHIKLADFGLCKKMNKAKDREYYLN 162

Query: 577 ---------------------------VKGTIGYIAPAEYGLGSEVSINGDVYSYGILLL 609
                                        GT  YIAP E   G+   +  D +S G++L 
Sbjct: 163 DSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAP-EVLRGTPYGLECDWWSLGVILY 221

Query: 610 ELMTRKRP--SDIMFEGNMNLHNFART-VLPDHV------MDIVDSTLLADDED 654
           E++    P  SD + E    + N+  +   P         +D++   LL D ED
Sbjct: 222 EMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICR-LLCDPED 274

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 38.3 bits (90), Expect = 6e-04
 Identities = 22/58 (37%), Positives = 29/58 (50%), Gaps = 3/58 (5%)

Query: 181 LYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQ-LMDLTSLSVGLDLSRNQL 237
           L L  N L V    +     +L  ++LS NNL+ +I P+    L SL   LDLS N L
Sbjct: 5   LDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLT-SISPEAFSGLPSLRS-LDLSGNNL 60

Length = 60

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 42.1 bits (99), Expect = 6e-04
 Identities = 52/221 (23%), Positives = 92/221 (41%), Gaps = 47/221 (21%)

Query: 411 GSFGSVYKGIL----DEGKTIIAVKVLNLLH-----HGASKSSIAECSALRNIRHKNLVK 461
           G+F ++YKG+L    D        +V  +L      H  S +     S +  + HK+LVK
Sbjct: 6   GTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVK 65

Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDV 521
           +  VC   +        +V E++  G L+ +LH              ++   ++++A  +
Sbjct: 66  LYGVCVRDEN------IMVEEYVKFGPLDVFLH---------REKNNVSLHWKLDVAKQL 110

Query: 522 ACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTI 581
           A AL YL         H ++   N+L        VA +GL +   P  ++ S  G+  T+
Sbjct: 111 ASALHYLEDK---KLVHGNVCGKNIL--------VARYGLNEGYVP-FIKLSDPGIPITV 158

Query: 582 G----------YIAPAEY-GLGSEVSINGDVYSYGILLLEL 611
                      +IAP       + ++I  D +S+G  LLE+
Sbjct: 159 LSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEI 199

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 42.2 bits (99), Expect = 6e-04
 Identities = 53/256 (20%), Positives = 94/256 (36%), Gaps = 69/256 (26%)

Query: 370 GLEKSKHKRLTIAVKLAAAIISVLVGILLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIA 429
           GL  +K K   +   L   +I  L                 GS G V+          + 
Sbjct: 51  GLIPTKQKAREVVASLGYTVIKTLTP---------------GSEGRVFVATKPGQPDPVV 95

Query: 430 VKVLNLLHHGASKSSIAECSALRNIRHKNLVKIL-TVCSGV-------DYKGDDFKALVY 481
           +K+      G   +++ E   L+N+ H +++++  T+ SG         Y  D     +Y
Sbjct: 96  LKI------GQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSD-----LY 144

Query: 482 EFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDL 541
            ++   S      P+      +             I   +   L+YLH        H D+
Sbjct: 145 TYLTKRS-----RPLPIDQALI-------------IEKQILEGLRYLH---AQRIIHRDV 183

Query: 542 KPSNVLLDHEMTAHVADFGLAK--LLPPAHLQTSSIGVKGTIGYIAP---AEYGLGSEVS 596
           K  N+ ++      + D G A+  ++ PA L     G+ GT+   AP   A     S+  
Sbjct: 184 KTENIFINDVDQVCIGDLGAAQFPVVAPAFL-----GLAGTVETNAPEVLARDKYNSKA- 237

Query: 597 INGDVYSYGILLLELM 612
              D++S GI+L E++
Sbjct: 238 ---DIWSAGIVLFEML 250

Length = 357

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 37.9 bits (89), Expect = 7e-04
 Identities = 20/60 (33%), Positives = 31/60 (51%)

Query: 274 KLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDL 333
            L+ L L  N        +   L  L+VLDLS NN++   P+    L  +++L+LS N+L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 41.9 bits (98), Expect = 7e-04
 Identities = 30/107 (28%), Positives = 55/107 (51%), Gaps = 9/107 (8%)

Query: 516 NIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAK--LLPPAHLQTS 573
           NI  D+   L+Y+H   +   +H D+KP N+++D     ++ D+G+A   ++   H++ S
Sbjct: 130 NIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYS 186

Query: 574 SIGV---KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
                  +GT+ Y A  +   G+ V+  GD+ S G  +L+    K P
Sbjct: 187 KEQKDLHRGTL-YYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLP 232

Length = 294

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 41.9 bits (98), Expect = 7e-04
 Identities = 40/123 (32%), Positives = 58/123 (47%), Gaps = 18/123 (14%)

Query: 518 AIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           A ++A  L +LH        + DLK  NV+LD E    +ADFG+ K      + T +   
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFC- 162

Query: 578 KGTIGYIAP---AEYGLGSEVSINGDVYSYGILLLELMTRKRP-----SDIMFEGNMNLH 629
            GT  YIAP   A    G  V    D +++G+LL E++  + P      D +F+  M  H
Sbjct: 163 -GTPDYIAPEIIAYQPYGKSV----DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME-H 216

Query: 630 NFA 632
           N A
Sbjct: 217 NVA 219

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|227563 COG5238, RNA1, Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification]

 Score = 42.2 bits (99), Expect = 8e-04
 Identities = 41/146 (28%), Positives = 56/146 (38%), Gaps = 18/146 (12%)

Query: 196 LGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLD---LSRNQLVGSLPTEVGKLINLE 252
           L +C  L  ++LS N      P +L DL S S  L    L+ N   G  P   G+     
Sbjct: 88  LLKCPRLQKVDLSDNAFGSEFPEELGDLISSSTDLVHLKLNNN---GLGPIAGGR----- 139

Query: 253 ILFISRNMLECEILSTLGSCIKLEQLKLGGN-LFQGPIPLS---LSSLRGLRVLDLSQNN 308
              I + +             KLE +  G N L  G   LS   L S   L+ + + QN 
Sbjct: 140 ---IGKALFHLAYNKKAADKPKLEVVICGRNRLENGSKELSAALLESHENLKEVKIQQNG 196

Query: 309 ISGEIPKFLVELQLVQNLNLSYNDLE 334
           I  E    L  L L  + +L   DL+
Sbjct: 197 IRPEGVTMLAFLGLFYSHSLEVLDLQ 222

Length = 388

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 41.6 bits (97), Expect = 8e-04
 Identities = 54/218 (24%), Positives = 90/218 (41%), Gaps = 25/218 (11%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           I  G++G VYK        + A+KV+ L           E   +++ +H N+V       
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFG--- 73

Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
              Y   D   +  EF   GSL++  H        V  P  L+  Q   ++ +    L Y
Sbjct: 74  --SYLRRDKLWICMEFCGGGSLQDIYH--------VTGP--LSESQIAYVSRETLQGLYY 121

Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPA 587
           LH   +    H D+K +N+LL       +ADFG++  +     +  S    GT  ++AP 
Sbjct: 122 LHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSF--IGTPYWMAPE 176

Query: 588 EYGLGSEVSING--DVYSYGILLLELMTRKRPSDIMFE 623
              +  +   N   D+++ GI  +EL   + P   MF+
Sbjct: 177 VAAVERKGGYNQLCDIWAVGITAIELAELQPP---MFD 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 37.1 bits (87), Expect = 0.001
 Identities = 21/61 (34%), Positives = 30/61 (49%), Gaps = 2/61 (3%)

Query: 153 NLVTLAINTNKLSGNIPPSI-GNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNN 211
           NL +L ++ N+L+  IP      L  L  L L  N L    P +     SL +++LS NN
Sbjct: 1   NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59

Query: 212 L 212
           L
Sbjct: 60  L 60

Length = 60

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 41.7 bits (98), Expect = 0.001
 Identities = 61/227 (26%), Positives = 101/227 (44%), Gaps = 35/227 (15%)

Query: 408 IDMGSFGSVYKGILD--EGKTIIAVKVLNLLHHGAS-KSSIAECSALRNIRHKNLVKILT 464
           I  G+FG V+  + D  +GK +   K+ N+  +  S K    E   L   +H N++  L 
Sbjct: 8   IGYGAFGVVW-SVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALD 66

Query: 465 VCSGVDYKGDDFKAL--VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVA 522
           +        D F+ +  V E M +      LH +  + + + +     FL +I       
Sbjct: 67  ILQPPHI--DPFEEIYVVTELMQSD-----LHKIIVSPQPLSSDHVKVFLYQI------L 113

Query: 523 CALKYLHHDCQPTTA---HCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKG 579
             LKYLH      +A   H D+KP N+L++      + DFGLA++  P   +  +  V  
Sbjct: 114 RGLKYLH------SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV- 166

Query: 580 TIGYIAPAEYGLGSEVSING-DVYSYGILLLELMTRKRPSDIMFEGN 625
           T  Y AP E  +GS    +  D++S G +  EL+ R+    I+F+  
Sbjct: 167 TQYYRAP-EILMGSRHYTSAVDIWSVGCIFAELLGRR----ILFQAQ 208

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 41.4 bits (97), Expect = 0.001
 Identities = 28/80 (35%), Positives = 40/80 (50%), Gaps = 9/80 (11%)

Query: 538 HCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGT----IGYIAPAEYGLGS 593
           H DL   N+LL H     + DFGLA+ +       S+  VKG     + ++AP E     
Sbjct: 237 HRDLAARNILLTHGRITKICDFGLARDIR----NDSNYVVKGNARLPVKWMAP-ESIFNC 291

Query: 594 EVSINGDVYSYGILLLELMT 613
             +   DV+SYGILL E+ +
Sbjct: 292 VYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 41.3 bits (97), Expect = 0.001
 Identities = 32/107 (29%), Positives = 50/107 (46%), Gaps = 12/107 (11%)

Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYI 584
           LKY+H        H DLKPSN+L++      + DFGLA++  P        G   T  Y 
Sbjct: 121 LKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDP-----QMTGYVSTRYYR 172

Query: 585 APAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNF 631
           AP       +  +  D++S G +  E++  K P   +F G  +++ F
Sbjct: 173 APEIMLTWQKYDVEVDIWSAGCIFAEMLEGK-P---LFPGKDHVNQF 215

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 41.4 bits (97), Expect = 0.002
 Identities = 25/69 (36%), Positives = 37/69 (53%), Gaps = 3/69 (4%)

Query: 301 VLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKNASAISV--FGNSKLC 358
            +DLS  NISG+I   +  L  +Q +NLS N L G IP + +F  +S++      N+   
Sbjct: 73  SIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIP-DDIFTTSSSLRYLNLSNNNFT 131

Query: 359 GGIPEFQLP 367
           G IP   +P
Sbjct: 132 GSIPRGSIP 140

Length = 968

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 40.8 bits (95), Expect = 0.002
 Identities = 48/197 (24%), Positives = 92/197 (46%), Gaps = 36/197 (18%)

Query: 428 IAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYK----GDDFKALVYEF 483
           +AVK+++L      +    E   +R+ +H+N+V++        YK    G++   L+ EF
Sbjct: 49  VAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEM--------YKSYLVGEELWVLM-EF 99

Query: 484 MHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKP 543
           +  G+L + +      ++ + A  C + LQ          AL YLH        H D+K 
Sbjct: 100 LQGGALTDIVSQTRLNEEQI-ATVCESVLQ----------ALCYLHSQ---GVIHRDIKS 145

Query: 544 SNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP---AEYGLGSEVSINGD 600
            ++LL  +    ++DFG    +     +  S+   GT  ++AP   +    G+EV    D
Sbjct: 146 DSILLTLDGRVKLSDFGFCAQISKDVPKRKSL--VGTPYWMAPEVISRTPYGTEV----D 199

Query: 601 VYSYGILLLELMTRKRP 617
           ++S GI+++E++  + P
Sbjct: 200 IWSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 40.8 bits (95), Expect = 0.002
 Identities = 57/220 (25%), Positives = 89/220 (40%), Gaps = 35/220 (15%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA-ECSALRNIRHKNLVKILTVCSGV 469
           G++G VYK        + AVK++ L   G   S I  E   ++  +H N+V         
Sbjct: 20  GTYGDVYKARNLHTGELAAVKIIKL-EPGDDFSLIQQEIFMVKECKHCNIVAYFG----- 73

Query: 470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH 529
            Y   +   +  E+   GSL++  H      +   A  C   LQ           L YLH
Sbjct: 74  SYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQ----------GLAYLH 123

Query: 530 HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEY 589
              +    H D+K +N+LL       +ADFG+A  +     +  S    GT  ++AP   
Sbjct: 124 SKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSF--IGTPYWMAPEV- 177

Query: 590 GLGSEVSING------DVYSYGILLLELMTRKRPSDIMFE 623
              + V  NG      D+++ GI  +EL   + P   MF+
Sbjct: 178 ---AAVEKNGGYNQLCDIWAVGITAIELAELQPP---MFD 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 41.1 bits (96), Expect = 0.002
 Identities = 30/93 (32%), Positives = 42/93 (45%), Gaps = 11/93 (11%)

Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGY 583
           A++YLH +      H D+K  N+ ++H     + DFG A   P         G  GTI  
Sbjct: 194 AIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWAGTIAT 249

Query: 584 IAP---AEYGLGSEVSINGDVYSYGILLLELMT 613
            AP   A    G  V    D++S GI+L E+ T
Sbjct: 250 NAPELLARDPYGPAV----DIWSAGIVLFEMAT 278

Length = 391

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 36.0 bits (84), Expect = 0.003
 Identities = 22/60 (36%), Positives = 27/60 (45%)

Query: 250 NLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNI 309
           NL+ L +S N L             L+ L L GN      P + S L  LR LDLS NN+
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 40.1 bits (93), Expect = 0.003
 Identities = 55/218 (25%), Positives = 89/218 (40%), Gaps = 30/218 (13%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA-ECSALRNI-RHKNLVKILTVCSG 468
           G++G VYKG   +   + A+KV+++   G  +  I  E + L+    H+N+         
Sbjct: 17  GTYGQVYKGRHVKTGQLAAIKVMDVT--GDEEEEIKQEINMLKKYSHHRNIATYYGAFIK 74

Query: 469 VDYKG-DDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
            +  G DD   LV EF   GS+ + +    G           N L+   IA      L+ 
Sbjct: 75  KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG-----------NTLKEEWIAYICREILRG 123

Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK----GTIGY 583
           L H  Q    H D+K  NVLL       + DFG++  L        ++G +    GT  +
Sbjct: 124 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL------DRTVGRRNTFIGTPYW 177

Query: 584 IAP----AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
           +AP     +    +      D++S GI  +E+     P
Sbjct: 178 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 40.0 bits (93), Expect = 0.003
 Identities = 35/123 (28%), Positives = 58/123 (47%), Gaps = 16/123 (13%)

Query: 520 DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKG 579
           ++  AL++LH   +    + D+K  N+LLD      + DFGL+K      ++  +    G
Sbjct: 113 EIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCG 168

Query: 580 TIGYIAP-----AEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLH-NFAR 633
           TI Y+AP      + G    V    D +S G+L+ EL+T   P  +  +G  N     +R
Sbjct: 169 TIEYMAPDIVRGGDGGHDKAV----DWWSMGVLMYELLTGASPFTV--DGEKNSQAEISR 222

Query: 634 TVL 636
            +L
Sbjct: 223 RIL 225

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 39.8 bits (93), Expect = 0.003
 Identities = 63/231 (27%), Positives = 104/231 (45%), Gaps = 44/231 (19%)

Query: 408 IDMGSFGSVYKGIL----DEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNLVK 461
           I  GSFG   K IL    ++GK  + +K +N+  +     + S  E + L N++H N+V+
Sbjct: 8   IGEGSFG---KAILVKSKEDGKQYV-IKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ 63

Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGAD--KTVEAPKCLNFL--QRINI 517
                    Y+          F  NG+L   +    G D  K + A + + F   Q ++ 
Sbjct: 64  ---------YQ--------ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW 106

Query: 518 AIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL-PPAHLQTSSIG 576
            + +  ALK++H        H D+K  N+ L  + T  + DFG+A++L     L  + I 
Sbjct: 107 FVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI- 162

Query: 577 VKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFE-GNM 626
             GT  Y++P E       +   D+++ G +L E+ T K      FE GNM
Sbjct: 163 --GTPYYLSP-EICENRPYNNKSDIWALGCVLYEMCTLKHA----FEAGNM 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 39.8 bits (93), Expect = 0.003
 Identities = 52/179 (29%), Positives = 73/179 (40%), Gaps = 36/179 (20%)

Query: 503 VEAPKCLNFLQRIN-IAIDVA--------CALKYLHHDCQPTTAHCDLKPSNVLLDHEMT 553
           VE   C   L+ I  + +D+A         AL+YLH+       H DLKP N+L+     
Sbjct: 83  VEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGH 139

Query: 554 AHVADFGLAKL--------LPPAHL-----QTSSIGVKGTIGYIAPA---EYGLGSEVSI 597
             + DFGL+K+        L   H+     +     V GT  YIAP      G G  V  
Sbjct: 140 IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPV-- 197

Query: 598 NGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLT 656
             D ++ GI+L E +    P    F G+     F + +  D      D  L AD +DL 
Sbjct: 198 --DWWAMGIILYEFLVGCVP----FFGDTPEELFGQVISDDIEWPEGDEALPADAQDLI 250

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 39.5 bits (92), Expect = 0.004
 Identities = 30/108 (27%), Positives = 49/108 (45%), Gaps = 14/108 (12%)

Query: 479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAH 538
           LV   M+ G L+   H  +  ++ +E  + +++  +I       C + +LH        +
Sbjct: 70  LVMSLMNGGDLK--YHIYNVGERGLEMERVIHYSAQI------TCGILHLH---SMDIVY 118

Query: 539 CDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP 586
            D+KP NVLLD +    ++D GLA  L      T   G     GY+AP
Sbjct: 119 RDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTN---GYMAP 163

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	741
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.98
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.98
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.98
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.98
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.98
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.98
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.96
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.96
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.96
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.96
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.95
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.95
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.95
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.94
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.94
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.93
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.92
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.92
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.91
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.91
PLN00181	793	protein SPA1-RELATED; Provisional	99.91
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.91
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.91
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.91
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.9
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.89
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.89
PRK09188	365	serine/threonine protein kinase; Provisional	99.89
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.89
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.88
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.87
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.85
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.85
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.84
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.82
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.82
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.81
PRK12274	218	serine/threonine protein kinase; Provisional	99.81
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.81
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.79
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.79
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.78
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.77
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.77
PRK10345	210	hypothetical protein; Provisional	99.76
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.76
smart00090	237	RIO RIO-like kinase.	99.75
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.74
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.68
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.68
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.68
PRK14879	211	serine/threonine protein kinase; Provisional	99.68
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.65
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.64
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.62
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.6
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.56
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.53
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.52
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.52
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.5
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.49
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.47
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.37
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.36
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.32
PLN03150	623	hypothetical protein; Provisional	99.31
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.29
KOG1243	690	consensus Protein kinase [General function predict	99.29
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.28
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.26
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.26
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.26
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.23
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.21
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.21
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.21
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.15
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.15
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.15
PLN03150	623	hypothetical protein; Provisional	99.12
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.07
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.03
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.02
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.02
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	99.0
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.99
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.96
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.94
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.93
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.89
KOG3087	229	consensus Serine/threonine protein kinase [General	98.85
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.82
COG4248	637	Uncharacterized protein with protein kinase and he	98.81
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.8
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.75
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.74
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.53
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.51
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.48
PRK09902	216	hypothetical protein; Provisional	98.47
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.46
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.45

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=7.1e-82  Score=763.67  Aligned_cols=659  Identities=30%  Similarity=0.456  Sum_probs=478.0

Q ss_pred             CCCCCcccccCChhhhhCCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhcc--c---
Q 037916            2 DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQ--N---   76 (741)
Q Consensus         2 dl~~n~~~~~ip~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~--~---   76 (741)
                      ||++|++.+.+|..+. .+++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|.+++++..+.  .   
T Consensus       242 ~L~~n~l~~~~p~~l~-~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~  320 (968)
T PLN00113        242 DLVYNNLTGPIPSSLG-NLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNF  320 (968)
T ss_pred             ECcCceeccccChhHh-CCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCcc
Confidence            5677777777777776 778888888888888777777777778888888888877777777777666511000  0   


Q ss_pred             ---------cCCCccEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCcc
Q 037916           77 ---------CNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPA  147 (741)
Q Consensus        77 ---------~~~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~  147 (741)
                               ..++|+.|+|++|++.+..|..+..+. +|+.|++++|++.+..|..+..+++|+.|++++|++.+..|..
T Consensus       321 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~-~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~  399 (968)
T PLN00113        321 TGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHN-NLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKS  399 (968)
T ss_pred             CCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCC-CCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHH
Confidence                     012244455555554444444444444 4555555555554444555555555555555555555555555


Q ss_pred             ccCCCcCcEEEcccCCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCccccccccce
Q 037916          148 IGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLS  227 (741)
Q Consensus       148 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  227 (741)
                      +..+++|+.|+|++|++++..|..|.++++|+.|+|++|.+++.+|..+..+++|+.|+|++|++.+.+|..+ ..++|+
T Consensus       400 ~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~  478 (968)
T PLN00113        400 LGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLE  478 (968)
T ss_pred             HhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccce
Confidence            5556666666666666666666666666666666666666666666666666666777777776666666544 346777


Q ss_pred             eEEEcCCCccCCCCChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCC
Q 037916          228 VGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQN  307 (741)
Q Consensus       228 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  307 (741)
                      . |++++|++.+..|..|.++++|+.|+|++|++.+..|..+..+++|++|+|++|.+++.+|..|..+++|+.|+|++|
T Consensus       479 ~-L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  557 (968)
T PLN00113        479 N-LDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQN  557 (968)
T ss_pred             E-EECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCC
Confidence            6 999999999899999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCccchhhhccccCCcccccCcccccccCCccccCCcccccccCCCCccccCCCCCCCccCccccCCCceEEEeehhH
Q 037916          308 NISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKNASAISVFGNSKLCGGIPEFQLPICGLEKSKHKRLTIAVKLAA  387 (741)
Q Consensus       308 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  387 (741)
                      ++++.+|..+..+++|+.|++++|++++.+|..+.+..+....+.||+..|+..+....+.|.... +...+...+..++
T Consensus       558 ~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~-~~~~~~~~~~~~~  636 (968)
T PLN00113        558 QLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVR-KTPSWWFYITCTL  636 (968)
T ss_pred             cccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCcccc-ccceeeeehhHHH
Confidence            999999999999999999999999999999998888888889999999999877665566665332 2222222232222


Q ss_pred             HHHHHHHHHHHHHHH-H----------------------------------------HhhhcccCceeeEEEEEEcCCCe
Q 037916          388 AIISVLVGILLFVSF-L----------------------------------------FLCWIDMGSFGSVYKGILDEGKT  426 (741)
Q Consensus       388 ~~~~~~~~~~~~~~y-~----------------------------------------~~~~ig~G~~g~V~~a~~~~~~~  426 (741)
                      +++.+++.+++...+ .                                        ....||+|+||.||+|++..++.
T Consensus       637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~  716 (968)
T PLN00113        637 GAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGM  716 (968)
T ss_pred             HHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCc
Confidence            221111111111111 0                                        01248999999999999988999


Q ss_pred             EEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEEEecccCCChhhhccCCCCCCcccCcc
Q 037916          427 IIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAP  506 (741)
Q Consensus       427 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~  506 (741)
                      .||+|.++...    .....|++.+++++|||||+++++|.     ++...|+||||+++|+|.++++            
T Consensus       717 ~vavK~~~~~~----~~~~~~~~~l~~l~HpnIv~~~~~~~-----~~~~~~lv~Ey~~~g~L~~~l~------------  775 (968)
T PLN00113        717 QFVVKEINDVN----SIPSSEIADMGKLQHPNIVKLIGLCR-----SEKGAYLIHEYIEGKNLSEVLR------------  775 (968)
T ss_pred             EEEEEEccCCc----cccHHHHHHHhhCCCCCcceEEEEEE-----cCCCCEEEEeCCCCCcHHHHHh------------
Confidence            99999986322    12245688999999999999999964     3457899999999999999984            


Q ss_pred             cccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecccccccCCCCcccccccccccccccCc
Q 037916          507 KCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP  586 (741)
Q Consensus       507 ~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aP  586 (741)
                       .++|.++.+++.|+++||+|||..+.++|+||||||+||+++.++.+++. ||.+......      ....+|+.|+||
T Consensus       776 -~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~------~~~~~t~~y~aP  847 (968)
T PLN00113        776 -NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD------TKCFISSAYVAP  847 (968)
T ss_pred             -cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC------CCccccccccCc
Confidence             26888999999999999999996656699999999999999998888775 6554432211      113578999999


Q ss_pred             ccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcc-hhHhhhhcccCCcchhhhhhhhHHHH
Q 037916          587 AEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDH-VMDIVDSTLLADDEDLTITSNQRQRQ  665 (741)
Q Consensus       587 Ee~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~d~~l~~~~~~~~~~~~~~~~~  665 (741)
                       |+..+..++.++|||||||++|||++|+.||+...........|.+...... ...++|+.+.....            
T Consensus       848 -E~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------  914 (968)
T PLN00113        848 -ETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVS------------  914 (968)
T ss_pred             -ccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCC------------
Confidence             5556778999999999999999999999999755444455555554433322 33344433322111            


Q ss_pred             HhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHhhc
Q 037916          666 ARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSILL  711 (741)
Q Consensus       666 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~  711 (741)
                          ...++..++.+++.+||+.||++||||.||++.|+++.+..+
T Consensus       915 ----~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~  956 (968)
T PLN00113        915 ----VNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS  956 (968)
T ss_pred             ----ccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccc
Confidence                112445678899999999999999999999999998876443

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-47  Score=379.36  Aligned_cols=256  Identities=20%  Similarity=0.247  Sum_probs=204.5

Q ss_pred             HHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc-------CcchhHHHHHHHHHhcCCCceeeEeeeecCcc
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH-------GASKSSIAECSALRNIRHKNLVKILTVCSGVD  470 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  470 (741)
                      +...|.+.+.+|+|+||.|-+|..+.+|+.||||++++...       .......+|+++|++++||+||+++++     
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~-----  244 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDF-----  244 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeee-----
Confidence            45668889999999999999999999999999999974221       122345799999999999999999999     


Q ss_pred             ccCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCC
Q 037916          471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDH  550 (741)
Q Consensus       471 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~  550 (741)
                      ++..+..|+||||++||+|.+.+-..          +.+.+...+.+++|++.|+.|||+.   ||+||||||+|||+..
T Consensus       245 f~~~ds~YmVlE~v~GGeLfd~vv~n----------k~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~  311 (475)
T KOG0615|consen  245 FEVPDSSYMVLEYVEGGELFDKVVAN----------KYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSN  311 (475)
T ss_pred             eecCCceEEEEEEecCccHHHHHHhc----------cccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEecc
Confidence            56666889999999999999998644          5677778889999999999999999   9999999999999976


Q ss_pred             C---CceEEeecccccccCCCCcccccccccccccccCcccccCCC--CCCCccCchhHHHHHHHHHcCCCCCCccccCC
Q 037916          551 E---MTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGS--EVSINGDVYSYGILLLELMTRKRPSDIMFEGN  625 (741)
Q Consensus       551 ~---~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~--~~~~~~DIwSlG~il~elltg~~p~~~~~~~~  625 (741)
                      +   ..+||+|||+|+..+.....   ...+|||.|.|||.+...+  .+..++||||+||++|-+++|.+||.......
T Consensus       312 ~~e~~llKItDFGlAK~~g~~sfm---~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~  388 (475)
T KOG0615|consen  312 DAEDCLLKITDFGLAKVSGEGSFM---KTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP  388 (475)
T ss_pred             CCcceEEEecccchhhccccceeh---hhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc
Confidence            5   68999999999988755433   3378999999997665433  34568999999999999999999997443332


Q ss_pred             cchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          626 MNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       626 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      ....+.....+.-..                            ....+..++..++|.+||..||++|||+.|+++-
T Consensus       389 sl~eQI~~G~y~f~p----------------------------~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  389 SLKEQILKGRYAFGP----------------------------LQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             cHHHHHhcCcccccC----------------------------hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence            223333222222110                            0122556778899999999999999999999853

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-46  Score=370.09  Aligned_cols=255  Identities=24%  Similarity=0.302  Sum_probs=206.9

Q ss_pred             HHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeecc-CcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc-
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLL-HHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD-  475 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~-  475 (741)
                      .....+.++.||+|..|+||+++++.+++.+|+|++... +....+++.+|+++++..+||+||++|+.|.     ... 
T Consensus        77 ~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~-----~~~~  151 (364)
T KOG0581|consen   77 SLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFY-----SNGE  151 (364)
T ss_pred             CHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEE-----eCCc
Confidence            345678889999999999999999999999999999633 3345678899999999999999999999963     333 


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHh-cCCCCceecCCCCCCeEeCCCCce
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH-DCQPTTAHCDLKPSNVLLDHEMTA  554 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivHrDlkp~NIll~~~~~~  554 (741)
                      .++|+||||++|||+++++..          +.+++...-+|+.+|++||.|||+ .   +||||||||+|||++..|.|
T Consensus       152 ~isI~mEYMDgGSLd~~~k~~----------g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeV  218 (364)
T KOG0581|consen  152 EISICMEYMDGGSLDDILKRV----------GRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEV  218 (364)
T ss_pred             eEEeehhhcCCCCHHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCE
Confidence            699999999999999998744          558899999999999999999996 6   99999999999999999999


Q ss_pred             EEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhh
Q 037916          555 HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       555 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  634 (741)
                      ||||||.+..+...-    .....||..|||| |-..+..|+.++||||||++++|+.+|+.||.........       
T Consensus       219 KicDFGVS~~lvnS~----a~tfvGT~~YMsP-ERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~-------  286 (364)
T KOG0581|consen  219 KICDFGVSGILVNSI----ANTFVGTSAYMSP-ERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLD-------  286 (364)
T ss_pred             EeccccccHHhhhhh----cccccccccccCh-hhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCC-------
Confidence            999999998876652    2336799999999 5567889999999999999999999999998743121112       


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHH-HHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIM-ECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                           ..+.++.........               .+. .+.+++..++..||+.||.+|||++|+++-
T Consensus       287 -----~~~Ll~~Iv~~ppP~---------------lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  287 -----IFELLCAIVDEPPPR---------------LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             -----HHHHHHHHhcCCCCC---------------CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                 122222222111110               011 356778999999999999999999998864

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-45  Score=385.72  Aligned_cols=248  Identities=23%  Similarity=0.297  Sum_probs=207.5

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeec---cCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNL---LHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      +|...+.||+|||+.||.+++..+|+.||+|++.+   ......+...+|+++.++|+|||||+++++     |++.+++
T Consensus        19 ~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~-----FEDs~nV   93 (592)
T KOG0575|consen   19 RYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHF-----FEDSNNV   93 (592)
T ss_pred             eeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeE-----eecCCce
Confidence            48888999999999999999988999999999974   234456778899999999999999999999     7888899


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      |+|.|+|..++|..+++.+          +.+++.+++.+++||+.||.|||+.   +|+|||||..|+|++++.+|||+
T Consensus        94 YivLELC~~~sL~el~Krr----------k~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIg  160 (592)
T KOG0575|consen   94 YIVLELCHRGSLMELLKRR----------KPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIG  160 (592)
T ss_pred             EEEEEecCCccHHHHHHhc----------CCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEec
Confidence            9999999999999999743          7799999999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCC
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      |||+|..+..++...  ...+|||.|.|| |++.....+..+||||+|||||.|+.|++||+..     .+.+....   
T Consensus       161 DFGLAt~le~~~Erk--~TlCGTPNYIAP-EVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk-----~vkety~~---  229 (592)
T KOG0575|consen  161 DFGLATQLEYDGERK--KTLCGTPNYIAP-EVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK-----TVKETYNK---  229 (592)
T ss_pred             ccceeeeecCccccc--ceecCCCcccCh-hHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc-----hHHHHHHH---
Confidence            999999887554332  237899999999 5556788899999999999999999999999722     11111111   


Q ss_pred             cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          638 DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       638 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                               .-..++                ..+........+||.++|+.||.+|||+++|+.-
T Consensus       230 ---------Ik~~~Y----------------~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  230 ---------IKLNEY----------------SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             ---------HHhcCc----------------ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                     111111                1112334556799999999999999999999964

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-45  Score=380.05  Aligned_cols=265  Identities=31%  Similarity=0.405  Sum_probs=211.1

Q ss_pred             HHHHHHHhhhcccCceeeEEEEEEcCCCeE-EEEEEeeccCcCc--chhHHHHHHHHHhcCCCceeeEeeeecCccccCC
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGILDEGKTI-IAVKVLNLLHHGA--SKSSIAECSALRNIRHKNLVKILTVCSGVDYKGD  474 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~-vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~  474 (741)
                      .+....+.+.||+|+||+||+|.++  |+. ||+|++.......  .+.+.+|+.+|++++|||||+++|+|...    .
T Consensus        39 ~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~----~  112 (362)
T KOG0192|consen   39 DPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSP----P  112 (362)
T ss_pred             ChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC----C
Confidence            3455667778999999999999997  445 9999997533222  45899999999999999999999998432    2


Q ss_pred             ceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCC-ceecCCCCCCeEeCCCC-
Q 037916          475 DFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPT-TAHCDLKPSNVLLDHEM-  552 (741)
Q Consensus       475 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~-ivHrDlkp~NIll~~~~-  552 (741)
                      ...++||||+++|+|.++++..        ....+++..+++++.||++||.|||+.   + ||||||||+|||++.++ 
T Consensus       113 ~~~~iVtEy~~~GsL~~~l~~~--------~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~  181 (362)
T KOG0192|consen  113 GSLCIVTEYMPGGSLSVLLHKK--------RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGK  181 (362)
T ss_pred             CceEEEEEeCCCCcHHHHHhhc--------ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCC
Confidence            2689999999999999999752        236799999999999999999999999   8 99999999999999998 


Q ss_pred             ceEEeecccccccCCCCcccccccccccccccCcccccC-CCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhh
Q 037916          553 TAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGL-GSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNF  631 (741)
Q Consensus       553 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~-~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~  631 (741)
                      ++||+|||+++......  .......||+.|||||.+.. ...|+.|+||||||+++|||+||+.||...........  
T Consensus       182 ~~KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~--  257 (362)
T KOG0192|consen  182 TLKIADFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASA--  257 (362)
T ss_pred             EEEECCCccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHH--
Confidence            99999999998765432  22233679999999955433 56899999999999999999999999974432111110  


Q ss_pred             hhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHhhc
Q 037916          632 ARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSILL  711 (741)
Q Consensus       632 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~  711 (741)
                                 .+.....                  ...+.++++.+..++.+||..||++||++.|++..|+.+.....
T Consensus       258 -----------v~~~~~R------------------p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~  308 (362)
T KOG0192|consen  258 -----------VVVGGLR------------------PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS  308 (362)
T ss_pred             -----------HHhcCCC------------------CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence                       1100111                  11122467789999999999999999999999999999988665


Q ss_pred             C
Q 037916          712 G  712 (741)
Q Consensus       712 ~  712 (741)
                      .
T Consensus       309 ~  309 (362)
T KOG0192|consen  309 S  309 (362)
T ss_pred             c
Confidence            3

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.6e-47  Score=356.29  Aligned_cols=264  Identities=22%  Similarity=0.318  Sum_probs=208.7

Q ss_pred             HHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeec--cCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccC-C
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKG-D  474 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~-~  474 (741)
                      -...|+|.++||+|+||+||++.+..+|..||.|.++-  -+.....+...|+.+|++|+|||||+++++-    +.. .
T Consensus        17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~----f~~~~   92 (375)
T KOG0591|consen   17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHS----FIEDN   92 (375)
T ss_pred             cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHh----hhccc
Confidence            34679999999999999999999999999999999872  2334456788999999999999999999853    333 3


Q ss_pred             ceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCC-CCceecCCCCCCeEeCCCCc
Q 037916          475 DFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQ-PTTAHCDLKPSNVLLDHEMT  553 (741)
Q Consensus       475 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~-~~ivHrDlkp~NIll~~~~~  553 (741)
                      .-.+||||||.+|+|.+.++..+.      ..+.+++..+++++.|++.||..+|+... .-|+||||||.||+++.+|.
T Consensus        93 evlnivmE~c~~GDLsqmIk~~K~------qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gv  166 (375)
T KOG0591|consen   93 EVLNIVMELCDAGDLSQMIKHFKK------QKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGV  166 (375)
T ss_pred             hhhHHHHHhhcccCHHHHHHHHHh------ccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCc
Confidence            348999999999999999975432      23679999999999999999999999432 23999999999999999999


Q ss_pred             eEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhh
Q 037916          554 AHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFAR  633 (741)
Q Consensus       554 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~  633 (741)
                      |||+|||+++.........  ...+|||.||+| |...+.+|+.|+||||+||++|||+.-+.||...     ++.+.-.
T Consensus       167 vKLGDfGL~r~l~s~~tfA--~S~VGTPyYMSP-E~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~L~~  238 (375)
T KOG0591|consen  167 VKLGDFGLGRFLSSKTTFA--HSLVGTPYYMSP-ERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLSLCK  238 (375)
T ss_pred             eeeccchhHhHhcchhHHH--HhhcCCCcccCH-HHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHHHHH
Confidence            9999999999887653322  336799999999 6667889999999999999999999999998621     3333322


Q ss_pred             hcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHH
Q 037916          634 TVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQS  705 (741)
Q Consensus       634 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  705 (741)
                      +........+.                          .......+.+|+..|+..||+.||+...++..+..
T Consensus       239 KI~qgd~~~~p--------------------------~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  239 KIEQGDYPPLP--------------------------DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             HHHcCCCCCCc--------------------------HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence            22111110000                          12446678899999999999999997666555544

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=8.9e-46  Score=353.26  Aligned_cols=275  Identities=20%  Similarity=0.292  Sum_probs=207.1

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc--CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      .|+.+.++|+|+||.||+|+++++|+.||||++.....  ...+...+|+++|++++|||+|.++++     +......+
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEV-----Frrkrklh   77 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEV-----FRRKRKLH   77 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHH-----HHhcceeE
Confidence            58999999999999999999999999999999964332  223456899999999999999999999     56677899


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      +|+|||+.--|.+ ++..         ....+...+.+++.|++.|+.|+|++   ++|||||||+||||+.+|.+||||
T Consensus        78 LVFE~~dhTvL~e-Le~~---------p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCD  144 (396)
T KOG0593|consen   78 LVFEYCDHTVLHE-LERY---------PNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCD  144 (396)
T ss_pred             EEeeecchHHHHH-HHhc---------cCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEecc
Confidence            9999997644444 4322         35578888999999999999999999   999999999999999999999999


Q ss_pred             cccccccCC-CCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCC
Q 037916          559 FGLAKLLPP-AHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       559 Fg~a~~~~~-~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      ||+|+.... +..++   ..+.|.+|+|||.+.....|+..+||||+||++.||++|.+-|..  +.+.+....++..+.
T Consensus       145 FGFAR~L~~pgd~YT---DYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG--~SDiDQLy~I~ktLG  219 (396)
T KOG0593|consen  145 FGFARTLSAPGDNYT---DYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPG--RSDIDQLYLIRKTLG  219 (396)
T ss_pred             chhhHhhcCCcchhh---hhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCC--cchHHHHHHHHHHHc
Confidence            999998874 33333   356899999997777778999999999999999999999998762  222222222222222


Q ss_pred             ---cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          638 ---DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       638 ---~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                         +....++...-....  .+. +............+.....+++++.+|++.||++|++.+|++.
T Consensus       220 ~L~prhq~iF~~N~~F~G--v~l-P~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  220 NLIPRHQSIFSSNPFFHG--VRL-PEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             ccCHHHHHHhccCCceee--eec-CCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence               222233322111000  000 0111111222233455567899999999999999999999884

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-45  Score=367.35  Aligned_cols=200  Identities=30%  Similarity=0.496  Sum_probs=178.0

Q ss_pred             HHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeecc--CcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLL--HHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      ..+.|.+.++||+|+||+||+|+++.++..||||.+.+.  .....+....|+.+|+.++|||||++++++     ..++
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~-----~~~~   82 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI-----EDDD   82 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE-----ecCC
Confidence            346799999999999999999999999999999999754  344566778999999999999999999994     5566


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCC----
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHE----  551 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~----  551 (741)
                      ++|+|||||.||+|.+|++..          ..+++..++.++.|++.||++||++   +||||||||.|||++..    
T Consensus        83 ~i~lVMEyC~gGDLs~yi~~~----------~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~  149 (429)
T KOG0595|consen   83 FIYLVMEYCNGGDLSDYIRRR----------GRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARND  149 (429)
T ss_pred             eEEEEEEeCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCC
Confidence            999999999999999999855          4689999999999999999999999   99999999999999764    


Q ss_pred             --CceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCC
Q 037916          552 --MTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSD  619 (741)
Q Consensus       552 --~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~  619 (741)
                        -.+||+|||+|+...+.....+   .+|++.|||| |++....|+.|+|+||+|+++|++++|+.||+
T Consensus       150 ~~~~LKIADFGfAR~L~~~~~a~t---lcGSplYMAP-EV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~  215 (429)
T KOG0595|consen  150 TSPVLKIADFGFARFLQPGSMAET---LCGSPLYMAP-EVIMSQQYDAKADLWSIGTILYQCLTGKPPFD  215 (429)
T ss_pred             CCceEEecccchhhhCCchhHHHH---hhCCccccCH-HHHHhccccchhhHHHHHHHHHHHHhCCCCcc
Confidence              4689999999999876544332   6799999999 66667899999999999999999999999997

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-44  Score=377.66  Aligned_cols=277  Identities=38%  Similarity=0.632  Sum_probs=226.8

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      ..|.-...||+|+||.||+|... ++..||||+++.......++|.+|+.++.+++|||+|+++|||.+..    ...++
T Consensus        75 ~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~----~~~~L  149 (361)
T KOG1187|consen   75 NNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGG----EHRLL  149 (361)
T ss_pred             hCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCC----ceEEE
Confidence            56777789999999999999998 45899999886433221456999999999999999999999995422    26899


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      |+|||++|+|.++++...+       . .++|.++++|+.++|+||+|||+.+.+.||||||||+|||+|+++.+||+||
T Consensus       150 VYEym~nGsL~d~L~~~~~-------~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDF  221 (361)
T KOG1187|consen  150 VYEYMPNGSLEDHLHGKKG-------E-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDF  221 (361)
T ss_pred             EEEccCCCCHHHHhCCCCC-------C-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCc
Confidence            9999999999999985421       1 6899999999999999999999998889999999999999999999999999


Q ss_pred             ccccccCC-CCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccc-cCCcchhhhhhhcCC
Q 037916          560 GLAKLLPP-AHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMF-EGNMNLHNFARTVLP  637 (741)
Q Consensus       560 g~a~~~~~-~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~-~~~~~~~~~~~~~~~  637 (741)
                      |+|+..+. .......  ..||.+|+|| |+...+..+.|+||||||+++.|++||+.|.+... .+...+..|+...+.
T Consensus       222 GLa~~~~~~~~~~~~~--~~gt~gY~~P-Ey~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~  298 (361)
T KOG1187|consen  222 GLAKLGPEGDTSVSTT--VMGTFGYLAP-EYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE  298 (361)
T ss_pred             cCcccCCccccceeee--cCCCCccCCh-hhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence            99976654 2211111  1699999999 66666889999999999999999999999887543 334457888766665


Q ss_pred             c-chhHhhhhccc-CCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHh
Q 037916          638 D-HVMDIVDSTLL-ADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSI  709 (741)
Q Consensus       638 ~-~~~~~~d~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  709 (741)
                      . ...+++|+.+. ..+.                 ..++..++.+++.+|++.+|.+||+|.||+++|+.+...
T Consensus       299 ~~~~~eiiD~~l~~~~~~-----------------~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  299 EGKLREIVDPRLKEGEYP-----------------DEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             CcchhheeCCCccCCCCC-----------------hHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence            5 58889998876 3332                 114667799999999999999999999999999666544

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-45  Score=373.16  Aligned_cols=276  Identities=19%  Similarity=0.231  Sum_probs=212.9

Q ss_pred             HHHHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcch-hHHHHHHHHHhcC-CCceeeEeeeecCccccC
Q 037916          396 ILLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASK-SSIAECSALRNIR-HKNLVKILTVCSGVDYKG  473 (741)
Q Consensus       396 ~~~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~-~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~  473 (741)
                      +.+..+|.++++||.|+||.||+|+...++..||||.++..-....+ .-.+|+..|++++ |||||++.+++    .+.
T Consensus         6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi----~d~   81 (538)
T KOG0661|consen    6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVI----RDN   81 (538)
T ss_pred             hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHh----hcc
Confidence            35668999999999999999999999999999999999754433332 2368999999998 99999999995    233


Q ss_pred             CceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCc
Q 037916          474 DDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMT  553 (741)
Q Consensus       474 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~  553 (741)
                      ....|+||||| ..+|.++++.+         +..+++..++.|+.||++||+|+|.+   |+.|||+||||||+.....
T Consensus        82 ~~~L~fVfE~M-d~NLYqLmK~R---------~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~  148 (538)
T KOG0661|consen   82 DRILYFVFEFM-DCNLYQLMKDR---------NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDV  148 (538)
T ss_pred             CceEeeeHHhh-hhhHHHHHhhc---------CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccce
Confidence            33899999999 56999999854         47799999999999999999999999   9999999999999998999


Q ss_pred             eEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhh
Q 037916          554 AHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFAR  633 (741)
Q Consensus       554 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~  633 (741)
                      +||+|||+|+.+.....++.   .+-|.+|+|||.++..+.|+.+.||||+|||++|+.+-++-|...    .++.+...
T Consensus       149 iKiaDFGLARev~SkpPYTe---YVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~----sE~Dqi~K  221 (538)
T KOG0661|consen  149 IKIADFGLAREVRSKPPYTE---YVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGA----SEIDQIYK  221 (538)
T ss_pred             eEecccccccccccCCCcch---hhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCC----cHHHHHHH
Confidence            99999999998876554443   567999999999999999999999999999999999998876532    22222222


Q ss_pred             hc--C-CcchhHhhh-----hcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          634 TV--L-PDHVMDIVD-----STLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       634 ~~--~-~~~~~~~~d-----~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      ..  + .+...++..     ..+......       ........-...+..+..+++.+|+.|||++||||+|.++.
T Consensus       222 Ic~VLGtP~~~~~~eg~~La~~mnf~~P~-------~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  222 ICEVLGTPDKDSWPEGYNLASAMNFRFPQ-------VKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHHhCCCccccchhHHHHHHHhccCCCc-------CCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            11  1 111111110     111111110       00001111223466788899999999999999999999986

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.5e-43  Score=332.79  Aligned_cols=275  Identities=21%  Similarity=0.267  Sum_probs=215.1

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC--cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      .+|...+++|+|.||.||+|++..+|+.||||.++...  ........+|+..|+.++|+||+.++++     |......
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~-----F~~~~~l   76 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDV-----FPHKSNL   76 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhh-----ccCCCce
Confidence            36899999999999999999999999999999998543  2335577899999999999999999999     5667789


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      .+|+||++. +|+..++..         ...++..+++.++.++++|++|||++   .|+||||||.|+||+.+|.+||+
T Consensus        77 ~lVfEfm~t-dLe~vIkd~---------~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiA  143 (318)
T KOG0659|consen   77 SLVFEFMPT-DLEVVIKDK---------NIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIA  143 (318)
T ss_pred             EEEEEeccc-cHHHHhccc---------ccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEee
Confidence            999999964 999999743         46789999999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhh---hhh
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNF---ART  634 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~---~~~  634 (741)
                      |||+|+....+......  .+-|.+|+|||.+.+...|+..+||||.|||+.||+-|.+-|.    ++.++.+.   .+.
T Consensus       144 DFGLAr~f~~p~~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fp----G~sDidQL~~If~~  217 (318)
T KOG0659|consen  144 DFGLARFFGSPNRIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFP----GDSDIDQLSKIFRA  217 (318)
T ss_pred             cccchhccCCCCccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCC----CCchHHHHHHHHHH
Confidence            99999988766544333  2579999999777777899999999999999999999886543    33333333   222


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      .-.+...+|.+-.-..++......+...    .......+..+..+++.+||.+||.+|+|++|+++.
T Consensus       218 LGTP~~~~WP~~~~lpdY~~~~~~P~~~----~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  218 LGTPTPDQWPEMTSLPDYVKIQQFPKPP----LNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             cCCCCcccCccccccccHHHHhcCCCCc----cccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            2222233333322233332211111111    111334556677999999999999999999999875

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.8e-43  Score=357.66  Aligned_cols=283  Identities=22%  Similarity=0.221  Sum_probs=213.3

Q ss_pred             HHHHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC--cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccC
Q 037916          396 ILLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKG  473 (741)
Q Consensus       396 ~~~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  473 (741)
                      ..-...|+.+++||+|.||.||+|++..+|+.||+|.++...  ........+|+.+|++|+||||+++.+...+.   .
T Consensus       113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---~  189 (560)
T KOG0600|consen  113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---L  189 (560)
T ss_pred             ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---C
Confidence            344567999999999999999999999999999999998544  44566778999999999999999999986532   2


Q ss_pred             CceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCc
Q 037916          474 DDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMT  553 (741)
Q Consensus       474 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~  553 (741)
                      ...+|+|+|||+. +|.-++..         ..-.+++.+++.+++|++.||+|+|++   ||+|||||.+|||||.+|.
T Consensus       190 ~~siYlVFeYMdh-DL~GLl~~---------p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~  256 (560)
T KOG0600|consen  190 SGSIYLVFEYMDH-DLSGLLSS---------PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGV  256 (560)
T ss_pred             CceEEEEEecccc-hhhhhhcC---------CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCC
Confidence            4689999999965 88888763         235689999999999999999999999   9999999999999999999


Q ss_pred             eEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhh--
Q 037916          554 AHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNF--  631 (741)
Q Consensus       554 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~--  631 (741)
                      +||+|||+|+++....... .+..+-|.+|+|||.++....|+.++|+||.|||+.||+.|++.|.    +..++.+.  
T Consensus       257 LKiaDFGLAr~y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~----G~tEveQl~k  331 (560)
T KOG0600|consen  257 LKIADFGLARFYTPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQ----GRTEVEQLHK  331 (560)
T ss_pred             EEeccccceeeccCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcC----CccHHHHHHH
Confidence            9999999999776554322 3446679999999888888899999999999999999999999875    22222222  


Q ss_pred             -hhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          632 -ARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       632 -~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                       ....-.+....|....+ +....  ....+..+..........+...++|+..+|..||++|.||.++++.
T Consensus       332 IfklcGSP~e~~W~~~kL-P~~~~--~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  332 IFKLCGSPTEDYWPVSKL-PHATI--FKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             HHHHhCCCChhccccccC-Ccccc--cCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence             21111111111110000 00000  0001111111122234556778899999999999999999998853

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-43  Score=365.82  Aligned_cols=258  Identities=29%  Similarity=0.431  Sum_probs=212.7

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      ..+.++++||+|.||+||.|.+. ....||+|.++.. ....+.|.+|+.+|++|+|++||+++++|..     +..+||
T Consensus       206 ~~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~-----~~piyI  278 (468)
T KOG0197|consen  206 EELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTK-----QEPIYI  278 (468)
T ss_pred             HHHHHHHHhcCCccceEEEEEEc-CCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEec-----CCceEE
Confidence            44678999999999999999997 4558999999854 3445788899999999999999999999843     227899


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      |||||+.|+|.+|++..        ....+...+.+.++.|||+|++||+++   ++|||||...||||+++..+||+||
T Consensus       279 VtE~m~~GsLl~yLr~~--------~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDF  347 (468)
T KOG0197|consen  279 VTEYMPKGSLLDYLRTR--------EGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDF  347 (468)
T ss_pred             EEEecccCcHHHHhhhc--------CCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEccc
Confidence            99999999999999852        235688889999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcCCc
Q 037916          560 GLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       560 g~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      |+|+...++. +.......-...|.|| |.+..+.++.|+|||||||+|||++| |+.||..+     ...+.+      
T Consensus       348 GLAr~~~d~~-Y~~~~~~kfPIkWtAP-Ea~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m-----sn~ev~------  414 (468)
T KOG0197|consen  348 GLARLIGDDE-YTASEGGKFPIKWTAP-EALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGM-----SNEEVL------  414 (468)
T ss_pred             ccccccCCCc-eeecCCCCCCceecCH-HHHhhCCcccccceeehhhhHHHHhccCCCCCCCC-----CHHHHH------
Confidence            9999555443 3333333356789999 55667789999999999999999999 78886522     111111      


Q ss_pred             chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHh
Q 037916          639 HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSI  709 (741)
Q Consensus       639 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  709 (741)
                                           +...++++.+.+..|++.+.++|..||..+|++|||++.+...++++...
T Consensus       415 ---------------------~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  415 ---------------------ELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             ---------------------HHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence                                 12234455666778999999999999999999999999999999888753

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-43  Score=363.26  Aligned_cols=251  Identities=24%  Similarity=0.318  Sum_probs=208.1

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeec---cCcCcchhHHHHHHHHHhc-CCCceeeEeeeecCccccCCc
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNL---LHHGASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      .+|.+.+.||+|+|++|++|++..+++.||||++.+   ......+....|-.+|.+| .||.|+++|..     |+++.
T Consensus        73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~T-----FQD~~  147 (604)
T KOG0592|consen   73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFT-----FQDEE  147 (604)
T ss_pred             hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEE-----eeccc
Confidence            468999999999999999999999999999999963   2334456777899999999 89999999998     67788


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..|+|+||+++|+|.++|++.          ..+++...+.++.||+.||+|||++   |||||||||+|||+|++|++|
T Consensus       148 sLYFvLe~A~nGdll~~i~K~----------Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhik  214 (604)
T KOG0592|consen  148 SLYFVLEYAPNGDLLDLIKKY----------GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIK  214 (604)
T ss_pred             ceEEEEEecCCCcHHHHHHHh----------CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEE
Confidence            999999999999999999865          5688899999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcc---------ccc--ccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccC
Q 037916          556 VADFGLAKLLPPAHLQ---------TSS--IGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEG  624 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~---------~~~--~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~  624 (741)
                      |+|||.|+.+.+....         ...  ...+||..|++| |++..+..+..+|||+||||+|+|+.|.+||...   
T Consensus       215 ITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSP-ElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~---  290 (604)
T KOG0592|consen  215 ITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSP-ELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAA---  290 (604)
T ss_pred             EeeccccccCChhhccccCccCcccccCcccceeeeecccCH-HHhcCCCCCcccchHHHHHHHHHHhcCCCCCccc---
Confidence            9999999988654221         111  447899999999 7778889999999999999999999999998622   


Q ss_pred             CcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          625 NMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       625 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                       .++.             ++.+.+.-                ....++..++.+.+|+.+.|..||.+|+|++||.+-
T Consensus       291 -Neyl-------------iFqkI~~l----------------~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  291 -NEYL-------------IFQKIQAL----------------DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             -cHHH-------------HHHHHHHh----------------cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence             1111             11111111                111223445678899999999999999999888764

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2e-43  Score=349.40  Aligned_cols=199  Identities=31%  Similarity=0.379  Sum_probs=177.8

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCce
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      ..|++++.||+|+||+||.++.+++++.+|+|++++..   ....+...+|..+|.+++||+||+++..     |++...
T Consensus        25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ys-----FQt~~k   99 (357)
T KOG0598|consen   25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYS-----FQTEEK   99 (357)
T ss_pred             hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEe-----cccCCe
Confidence            56899999999999999999999999999999997533   2345667889999999999999999987     788889


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .|+|+||+.||.|..++++.          ..+++..++.++.+|+.||.|||++   |||||||||+|||+|.+|+++|
T Consensus       100 LylVld~~~GGeLf~hL~~e----------g~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~L  166 (357)
T KOG0598|consen  100 LYLVLDYLNGGELFYHLQRE----------GRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKL  166 (357)
T ss_pred             EEEEEeccCCccHHHHHHhc----------CCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEE
Confidence            99999999999999999744          6789999999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCC
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSD  619 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~  619 (741)
                      +|||+|+.........  ...+||+.|||| |++.+..|+..+|+||+|+++|||++|.+||.
T Consensus       167 tDFgL~k~~~~~~~~t--~tfcGT~eYmAP-Eil~~~gy~~~vDWWsLGillYeML~G~pPF~  226 (357)
T KOG0598|consen  167 TDFGLCKEDLKDGDAT--RTFCGTPEYMAP-EILLGKGYDKAVDWWSLGILLYEMLTGKPPFY  226 (357)
T ss_pred             eccccchhcccCCCcc--ccccCCccccCh-HHHhcCCCCcccchHhHHHHHHHHhhCCCCCc
Confidence            9999998655443222  237899999999 66677799999999999999999999999986

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-42  Score=349.58  Aligned_cols=258  Identities=27%  Similarity=0.339  Sum_probs=200.3

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      ..|...+.||+|+||.||++.+.++|...|||.+........+.+.+|+.+|++++|||||+++|.....  ++ ..+++
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~--~~-~~~~i   93 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSR--EN-DEYNI   93 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccc--cC-eeeEe
Confidence            4578889999999999999999988999999999754333356689999999999999999999963211  11 36899


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCC-CCceEEee
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDH-EMTAHVAD  558 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~-~~~~kL~D  558 (741)
                      .|||+++|+|.+++....         ..+++..++.+.+||++||+|||++   |||||||||+|||++. ++.+||+|
T Consensus        94 ~mEy~~~GsL~~~~~~~g---------~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaD  161 (313)
T KOG0198|consen   94 FMEYAPGGSLSDLIKRYG---------GKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLAD  161 (313)
T ss_pred             eeeccCCCcHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEecc
Confidence            999999999999998551         1589999999999999999999999   9999999999999999 79999999


Q ss_pred             cccccccCC-CCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcc-hhhhhhhcC
Q 037916          559 FGLAKLLPP-AHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMN-LHNFARTVL  636 (741)
Q Consensus       559 Fg~a~~~~~-~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~-~~~~~~~~~  636 (741)
                      ||.+..... ...........||+.|||||.+..+.....++||||+||++.||+||+.||......... +........
T Consensus       162 FG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~  241 (313)
T KOG0198|consen  162 FGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSL  241 (313)
T ss_pred             CccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCC
Confidence            999987663 111222334679999999966654434446999999999999999999998743110000 000000000


Q ss_pred             CcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHH
Q 037916          637 PDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHEL  703 (741)
Q Consensus       637 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  703 (741)
                      |                               ..+...+....+++.+|++.||++||||.|+++..
T Consensus       242 P-------------------------------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  242 P-------------------------------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP  277 (313)
T ss_pred             C-------------------------------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence            0                               01123345677999999999999999999999875

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=6.2e-42  Score=331.34  Aligned_cols=284  Identities=22%  Similarity=0.222  Sum_probs=210.6

Q ss_pred             HHHHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC--cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccC
Q 037916          396 ILLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKG  473 (741)
Q Consensus       396 ~~~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  473 (741)
                      +--...|+.+.+|++|+||.||+|+++.+++.||+|+++...  ....-...+|+.+|.+.+|||||.+-.+..+..   
T Consensus        72 Crsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~---  148 (419)
T KOG0663|consen   72 CRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN---  148 (419)
T ss_pred             cccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc---
Confidence            344578999999999999999999999999999999998533  333446689999999999999999999976543   


Q ss_pred             CceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCc
Q 037916          474 DDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMT  553 (741)
Q Consensus       474 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~  553 (741)
                      -+.+|+|||||+. +|..++...         .+++...+++-++.|+++|++|||..   .|+||||||+|+|+++.|.
T Consensus       149 ~d~iy~VMe~~Eh-DLksl~d~m---------~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~  215 (419)
T KOG0663|consen  149 MDKIYIVMEYVEH-DLKSLMETM---------KQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGI  215 (419)
T ss_pred             cceeeeeHHHHHh-hHHHHHHhc---------cCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCc
Confidence            4569999999965 999999754         36789999999999999999999999   9999999999999999999


Q ss_pred             eEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhh
Q 037916          554 AHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFAR  633 (741)
Q Consensus       554 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~  633 (741)
                      +||+|||+|+.++.+.  ...+..+-|.+|+|||.++....|++++|+||+|||+.|++++++-|....+ ..++....+
T Consensus       216 lKiaDFGLAR~ygsp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE-~dQl~~If~  292 (419)
T KOG0663|consen  216 LKIADFGLAREYGSPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSE-IDQLDKIFK  292 (419)
T ss_pred             EEecccchhhhhcCCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCch-HHHHHHHHH
Confidence            9999999999988763  2334466799999998888888999999999999999999999988752211 111222221


Q ss_pred             hc-CCcc-hhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHH--HHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          634 TV-LPDH-VMDIVDSTLLADDEDLTITSNQRQRQARINNIME--CLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       634 ~~-~~~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      .. .|.. .+.-+...-.  ..  ..................  ..+.-.+++...+.+||.+|.||.|.++-
T Consensus       293 llGtPte~iwpg~~~lp~--~k--~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  293 LLGTPSEAIWPGYSELPA--VK--KMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             HhCCCccccCCCccccch--hh--ccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence            11 1110 1100000000  00  000000000000011111  33667899999999999999999998864

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-42  Score=342.57  Aligned_cols=290  Identities=21%  Similarity=0.237  Sum_probs=219.0

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEee--ccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      ..|..++.||.|+||.|+.|.++.+|+.||+|.+.  .......++..+|+.+++.++|+||+.+++++.......-..+
T Consensus        22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv  101 (359)
T KOG0660|consen   22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV  101 (359)
T ss_pred             ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence            34566889999999999999999999999999986  3444556788899999999999999999999766444556689


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      |+|+|+| +.+|.+.++..          +.++...+..+++|+++||.|+|+.   +|+||||||.|++++.+..+||+
T Consensus       102 YiV~elM-etDL~~iik~~----------~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~  167 (359)
T KOG0660|consen  102 YLVFELM-ETDLHQIIKSQ----------QDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKIC  167 (359)
T ss_pred             EEehhHH-hhHHHHHHHcC----------ccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEec
Confidence            9999999 66999999754          4588999999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhh--hhhc
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNF--ARTV  635 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~--~~~~  635 (741)
                      |||+|+...........+....|.+|+|||.++....|+.+.||||+|||+.||++|++-|.    +...+.++  +...
T Consensus       168 DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFp----G~d~v~Ql~lI~~~  243 (359)
T KOG0660|consen  168 DFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFP----GKDYVHQLQLILEL  243 (359)
T ss_pred             cccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCC----CCchHHHHHHHHHh
Confidence            99999988654333334556789999999888888999999999999999999999999875    22222222  2222


Q ss_pred             CCcchhHhhhhcccCCcchhhhh-hhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH--HHHHHH
Q 037916          636 LPDHVMDIVDSTLLADDEDLTIT-SNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE--LQSIKS  708 (741)
Q Consensus       636 ~~~~~~~~~d~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i~~  708 (741)
                      .+....+.+...-..... .... ..+..+.......+...+...+|+.+||..||.+|+|++|.++-  ++....
T Consensus       244 lGtP~~e~l~~i~s~~ar-~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hd  318 (359)
T KOG0660|consen  244 LGTPSEEDLQKIRSEKAR-PYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHD  318 (359)
T ss_pred             cCCCCHHHHHHhccHHHH-HHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcC
Confidence            222111111111100000 0000 01112222233344566778899999999999999999999864  554443

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-42  Score=356.39  Aligned_cols=252  Identities=21%  Similarity=0.269  Sum_probs=209.1

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      ...|.-.++||+|+.|.||.|+...+++.||||++........+-..+|+.+|+..+|+|||.+++.+     -.++..|
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sy-----lv~deLW  346 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSY-----LVGDELW  346 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHh-----cccceeE
Confidence            35688888999999999999999999999999999877777777889999999999999999999984     4456899


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      +|||||+||+|.+.+..           ..+++.++..|++++++||+|||.+   ||+|||||.+|||++.+|.+||+|
T Consensus       347 VVMEym~ggsLTDvVt~-----------~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltD  412 (550)
T KOG0578|consen  347 VVMEYMEGGSLTDVVTK-----------TRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTD  412 (550)
T ss_pred             EEEeecCCCchhhhhhc-----------ccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEee
Confidence            99999999999999864           3489999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCc
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      ||+|..+........  ..+|||.|||| |+.....|++|+||||||++++||+.|++||-.    +..+..+......+
T Consensus       413 FGFcaqi~~~~~KR~--TmVGTPYWMAP-EVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln----E~PlrAlyLIa~ng  485 (550)
T KOG0578|consen  413 FGFCAQISEEQSKRS--TMVGTPYWMAP-EVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN----ENPLRALYLIATNG  485 (550)
T ss_pred             eeeeeccccccCccc--cccCCCCccch-hhhhhcccCccccchhhhhHHHHHhcCCCCccC----CChHHHHHHHhhcC
Confidence            999998876654332  36799999999 566778999999999999999999999999742    11111111110000


Q ss_pred             chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          639 HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       639 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                                .                +...........+.+++.+||+.||++||++.|+++-
T Consensus       486 ----------~----------------P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  486 ----------T----------------PKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             ----------C----------------CCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence                      0                0111123445678899999999999999999999864

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-42  Score=343.03  Aligned_cols=264  Identities=22%  Similarity=0.272  Sum_probs=206.9

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcC-cchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG-ASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      ..|++.+.||.|..+.||+|+....+..||||++...... ..+.+++|+..|+.++||||++++..     |..+...|
T Consensus        26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~s-----Fvv~~~LW  100 (516)
T KOG0582|consen   26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCS-----FVVDSELW  100 (516)
T ss_pred             cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEE-----EEecceeE
Confidence            4689999999999999999999999999999999854433 35788999999999999999999998     45566899


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      +||.||.+|++.+.++..        ....+++..+..|.+++++||.|||.+   |.||||||+.||||+.+|.|||+|
T Consensus       101 vVmpfMa~GS~ldIik~~--------~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLad  169 (516)
T KOG0582|consen  101 VVMPFMAGGSLLDIIKTY--------YPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLAD  169 (516)
T ss_pred             EeehhhcCCcHHHHHHHH--------ccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcC
Confidence            999999999999998743        335589999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCccc-cc-ccccccccccCccc-ccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhc
Q 037916          559 FGLAKLLPPAHLQT-SS-IGVKGTIGYIAPAE-YGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV  635 (741)
Q Consensus       559 Fg~a~~~~~~~~~~-~~-~~~~gt~~y~aPEe-~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~  635 (741)
                      ||.+..+-...... .. ....||++|||||. ......|+.|+||||||++..|+.+|..||...-.    ++-.....
T Consensus       170 Fgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP----mkvLl~tL  245 (516)
T KOG0582|consen  170 FGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP----MKVLLLTL  245 (516)
T ss_pred             ceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh----HHHHHHHh
Confidence            99987765543211 11 33579999999977 44456799999999999999999999999873211    11111111


Q ss_pred             CCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          636 LPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       636 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      .... ....                  +.....++.......+.+++..|++.||.+|||++++++-
T Consensus       246 qn~p-p~~~------------------t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  246 QNDP-PTLL------------------TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             cCCC-CCcc------------------cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence            0000 0000                  0000111223344578899999999999999999999864

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=8.3e-41  Score=405.27  Aligned_cols=346  Identities=35%  Similarity=0.553  Sum_probs=260.4

Q ss_pred             CCCCCcccccCChhhhhCCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCc
Q 037916            2 DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHL   81 (741)
Q Consensus         2 dl~~n~~~~~ip~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L   81 (741)
                      ||++|++.+.+|..+. .+++|++|+|++|++++..|..|.++++|++|+|++|++++..|..+.++++          |
T Consensus       218 ~L~~n~l~~~~p~~l~-~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~----------L  286 (968)
T PLN00113        218 YLGYNNLSGEIPYEIG-GLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQK----------L  286 (968)
T ss_pred             ECcCCccCCcCChhHh-cCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccC----------c
Confidence            6899999999999998 8999999999999999999999999999999999999999999999988876          6


Q ss_pred             cEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEccc
Q 037916           82 KHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINT  161 (741)
Q Consensus        82 ~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~  161 (741)
                      ++|+|++|++.+..|..+.++. +|+.|++++|.+.+..|..+..+++|++|+|++|.+++..|..+..+++|+.|+|++
T Consensus       287 ~~L~Ls~n~l~~~~p~~~~~l~-~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~  365 (968)
T PLN00113        287 ISLDLSDNSLSGEIPELVIQLQ-NLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLST  365 (968)
T ss_pred             CEEECcCCeeccCCChhHcCCC-CCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCC
Confidence            6666666666666666555555 566666666666555555555566666666666655555555555555555555555


Q ss_pred             CCCCCcCcc------------------------cccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCC
Q 037916          162 NKLSGNIPP------------------------SIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIP  217 (741)
Q Consensus       162 N~l~~~~~~------------------------~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p  217 (741)
                      |++++..|.                        .+..+++|+.|+|++|++++..|..|..+++|+.|++++|++++.+|
T Consensus       366 n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~  445 (968)
T PLN00113        366 NNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRIN  445 (968)
T ss_pred             CeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccC
Confidence            555544444                        44555555555555555555555555555555555555555555555


Q ss_pred             ccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCccCCCCChhcccCc
Q 037916          218 PQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLR  297 (741)
Q Consensus       218 ~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  297 (741)
                      ..+..+++|+. |+|++|++.+.+|..+ ..++|+.|+|++|++++..+..|..+++|+.|+|++|++.+.+|..+.+++
T Consensus       446 ~~~~~l~~L~~-L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  523 (968)
T PLN00113        446 SRKWDMPSLQM-LSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCK  523 (968)
T ss_pred             hhhccCCCCcE-EECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCcc
Confidence            55555666665 6666666665555544 346778888888888888888899999999999999999999999999999


Q ss_pred             cCCeeeCCCCcCCCccchhhhccccCCcccccCcccccccCCc-cccCCcccccccCCCCccccCC
Q 037916          298 GLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTE-GVFKNASAISVFGNSKLCGGIP  362 (741)
Q Consensus       298 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~~~~~~~~~n~~~c~~~~  362 (741)
                      +|++|+|++|.+++.+|..|..+++|+.|+|++|++++.+|.. .....+..+++.+|+..+ .+|
T Consensus       524 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~-~~p  588 (968)
T PLN00113        524 KLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHG-SLP  588 (968)
T ss_pred             CCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCccee-eCC
Confidence            9999999999999999999999999999999999999887765 456778999999997554 444

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-43  Score=359.60  Aligned_cols=342  Identities=22%  Similarity=0.225  Sum_probs=229.6

Q ss_pred             CCCCCcccccCChhhhhCCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCc
Q 037916            2 DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHL   81 (741)
Q Consensus         2 dl~~n~~~~~ip~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L   81 (741)
                      |||+|++. .|...+|.++++|+.++|..|.++ .+|..-....+|+.|+|.+|.|+.+..+++.-++.          |
T Consensus        84 dlsnNkl~-~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~a----------l  151 (873)
T KOG4194|consen   84 DLSNNKLS-HIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPA----------L  151 (873)
T ss_pred             eccccccc-cCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhh----------h
Confidence            78999998 555566669999999999999998 67766666677999999999999877777777766          6


Q ss_pred             cEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEccc
Q 037916           82 KHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINT  161 (741)
Q Consensus        82 ~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~  161 (741)
                      +.||||.|.|+.+.-.+|..-. ++++|+|++|.|+......|.+|.+|.+|.|++|+|+.+++..|..|++|+.|+|..
T Consensus       152 rslDLSrN~is~i~~~sfp~~~-ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnr  230 (873)
T KOG4194|consen  152 RSLDLSRNLISEIPKPSFPAKV-NIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNR  230 (873)
T ss_pred             hhhhhhhchhhcccCCCCCCCC-CceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccc
Confidence            6677777766655555555433 666677777766666666666666666666777776666666666666666666666


Q ss_pred             CCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCCC
Q 037916          162 NKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSL  241 (741)
Q Consensus       162 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~  241 (741)
                      |+|.-..--+|.+|++|+.|.|..|.|.....+.|..|.++++|+|+.|+++..-..+++++++|+. |+||+|.|..+.
T Consensus       231 N~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~-L~lS~NaI~rih  309 (873)
T KOG4194|consen  231 NRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQ-LDLSYNAIQRIH  309 (873)
T ss_pred             cceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhh-hccchhhhheee
Confidence            6665333445666666666666666666666666666666666666666666555666666666665 666666666666


Q ss_pred             ChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccc---hhhh
Q 037916          242 PTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIP---KFLV  318 (741)
Q Consensus       242 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~---~~~~  318 (741)
                      ++.++..++|+.|+||+|+|+...++.|..+..|++|+|++|.|..+...+|.++++|+.|||++|.|+..+.   ..|.
T Consensus       310 ~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~  389 (873)
T KOG4194|consen  310 IDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFN  389 (873)
T ss_pred             cchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhc
Confidence            6666666666666666666666666666666666666666666666555666666666666666666654433   2355


Q ss_pred             ccccCCcccccCcccccccCCc-cccCCcccccccCCCCc
Q 037916          319 ELQLVQNLNLSYNDLEGVIPTE-GVFKNASAISVFGNSKL  357 (741)
Q Consensus       319 ~l~~L~~L~l~~N~l~~~~~~~-~~~~~~~~~~~~~n~~~  357 (741)
                      ++++|+.|+|.||+|..++... ..+..++.+++.+|+..
T Consensus       390 gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~Naia  429 (873)
T KOG4194|consen  390 GLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIA  429 (873)
T ss_pred             cchhhhheeecCceeeecchhhhccCcccceecCCCCcce
Confidence            5666666666666666544332 23455555666655443

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-41  Score=355.59  Aligned_cols=249  Identities=22%  Similarity=0.271  Sum_probs=210.8

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCce
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      +-|++.+.||.|+.|.|.+|++..+|+.+|||++.+..   ......+.+|+.+|+-+.||||+++|++     +++..+
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydV-----we~~~~   86 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDV-----WENKQH   86 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeee-----eccCce
Confidence            56899999999999999999999999999999997431   2234567899999999999999999999     678889


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .|+|.||++||.|++++-..          ..+++.++.++++||+.|+.|+|..   +|+|||+||+|+|+|..+.+||
T Consensus        87 lylvlEyv~gGELFdylv~k----------G~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKI  153 (786)
T KOG0588|consen   87 LYLVLEYVPGGELFDYLVRK----------GPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKI  153 (786)
T ss_pred             EEEEEEecCCchhHHHHHhh----------CCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEee
Confidence            99999999999999998643          6789999999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcC
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVL  636 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  636 (741)
                      +|||+|....++....+   .+|.|+|.|||.+.+..+.+.++||||+|||+|.++||+.||+     +.++.....+..
T Consensus       154 ADFGMAsLe~~gklLeT---SCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd-----DdNir~LLlKV~  225 (786)
T KOG0588|consen  154 ADFGMASLEVPGKLLET---SCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD-----DDNIRVLLLKVQ  225 (786)
T ss_pred             eccceeecccCCccccc---cCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC-----CccHHHHHHHHH
Confidence            99999987766654433   4699999999777777778999999999999999999999997     334444433322


Q ss_pred             CcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          637 PDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       637 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      .+.                            +..+...+.+..+|+++|+..||++|.|+.||++-
T Consensus       226 ~G~----------------------------f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  226 RGV----------------------------FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             cCc----------------------------ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence            221                            11123456677899999999999999999999875

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-41  Score=351.14  Aligned_cols=266  Identities=25%  Similarity=0.372  Sum_probs=209.0

Q ss_pred             HHHHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc--CcchhHHHHHHHHHhcCCCceeeEeeeecCccccC
Q 037916          396 ILLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKG  473 (741)
Q Consensus       396 ~~~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  473 (741)
                      .+....+.+..+||+|.||+||+|.|..   .||||+++....  +..+.|.+|+.++++-+|.||+-+.|+|...    
T Consensus       388 eIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p----  460 (678)
T KOG0193|consen  388 EIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP----  460 (678)
T ss_pred             ccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC----
Confidence            3455667788999999999999999973   399999986443  3457889999999999999999999997432    


Q ss_pred             CceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCc
Q 037916          474 DDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMT  553 (741)
Q Consensus       474 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~  553 (741)
                        ...||+.+|+|.+|+.+++..         +..+.+.+.+.|++||++|+.|||++   +|||||||..||++.++++
T Consensus       461 --~~AIiTqwCeGsSLY~hlHv~---------etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~k  526 (678)
T KOG0193|consen  461 --PLAIITQWCEGSSLYTHLHVQ---------ETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLK  526 (678)
T ss_pred             --ceeeeehhccCchhhhhccch---------hhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCc
Confidence              239999999999999999844         46689999999999999999999999   9999999999999999999


Q ss_pred             eEEeecccccccCCCCcccccccccccccccCcccccC--CCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhh
Q 037916          554 AHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGL--GSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNF  631 (741)
Q Consensus       554 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~--~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~  631 (741)
                      |||+|||++..-..-..........|...|||||.+..  ..+|++.+||||||||+|||++|..||.....+ ..+-..
T Consensus       527 VkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d-qIifmV  605 (678)
T KOG0193|consen  527 VKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD-QIIFMV  605 (678)
T ss_pred             EEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh-heEEEe
Confidence            99999999865432221222223458899999975543  357999999999999999999999998722111 111111


Q ss_pred             hhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHhh
Q 037916          632 ARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSIL  710 (741)
Q Consensus       632 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  710 (741)
                      -+.+.......+                           ...|++++.+|+..||+.++++||.+.+|+..|+.+....
T Consensus       606 GrG~l~pd~s~~---------------------------~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~  657 (678)
T KOG0193|consen  606 GRGYLMPDLSKI---------------------------RSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL  657 (678)
T ss_pred             cccccCccchhh---------------------------hccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence            111111111111                           1367889999999999999999999999999998888753

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-41  Score=353.04  Aligned_cols=257  Identities=23%  Similarity=0.277  Sum_probs=204.6

Q ss_pred             HHHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeecc----Cc-CcchhHHHHHHHHHhcC-CCceeeEeeeecCcc
Q 037916          397 LLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLL----HH-GASKSSIAECSALRNIR-HKNLVKILTVCSGVD  470 (741)
Q Consensus       397 ~~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~  470 (741)
                      ...+.|.+.+.||+|+||.|+.|.+..++..||+|+++..    .. ...+...+|+.++++++ ||||++++++     
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev-----   88 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEV-----   88 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEE-----
Confidence            3456799999999999999999999999999999987643    11 23456678999999998 9999999999     


Q ss_pred             ccCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCC
Q 037916          471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDH  550 (741)
Q Consensus       471 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~  550 (741)
                      +......|+||||+.||+|.+++...          ..+.+..+..+++|++.|++|+|++   ||+||||||+||+++.
T Consensus        89 ~~t~~~~~ivmEy~~gGdL~~~i~~~----------g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~  155 (370)
T KOG0583|consen   89 FATPTKIYIVMEYCSGGDLFDYIVNK----------GRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDG  155 (370)
T ss_pred             EecCCeEEEEEEecCCccHHHHHHHc----------CCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecC
Confidence            55666799999999999999999743          5678889999999999999999999   9999999999999999


Q ss_pred             C-CceEEeecccccccC-CCCcccccccccccccccCcccccCCC-CCCCccCchhHHHHHHHHHcCCCCCCccccCCcc
Q 037916          551 E-MTAHVADFGLAKLLP-PAHLQTSSIGVKGTIGYIAPAEYGLGS-EVSINGDVYSYGILLLELMTRKRPSDIMFEGNMN  627 (741)
Q Consensus       551 ~-~~~kL~DFg~a~~~~-~~~~~~~~~~~~gt~~y~aPEe~~~~~-~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~  627 (741)
                      + +.+||+|||++.... ....   ....+||+.|+|||.+.... +.+.++||||+||++|.|++|+.||++     ..
T Consensus       156 ~~~~~Kl~DFG~s~~~~~~~~~---l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d-----~~  227 (370)
T KOG0583|consen  156 NEGNLKLSDFGLSAISPGEDGL---LKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD-----SN  227 (370)
T ss_pred             CCCCEEEeccccccccCCCCCc---ccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-----cc
Confidence            9 999999999999874 2222   23367999999996655545 456999999999999999999999984     12


Q ss_pred             hhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHH-HHHHHHHhhcccccCCCCCCCHHHHHHHHHHH
Q 037916          628 LHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMEC-LISVVRIGVACSMESPQDRMNMTIVVHELQSI  706 (741)
Q Consensus       628 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  706 (741)
                      ............            .                ..+... ...+..++.+|+..||.+|+|+.||+ .-.-+
T Consensus       228 ~~~l~~ki~~~~------------~----------------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~  278 (370)
T KOG0583|consen  228 VPNLYRKIRKGE------------F----------------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWF  278 (370)
T ss_pred             HHHHHHHHhcCC------------c----------------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhh
Confidence            111222111110            0                000111 45577999999999999999999999 55444


Q ss_pred             HH
Q 037916          707 KS  708 (741)
Q Consensus       707 ~~  708 (741)
                      ..
T Consensus       279 ~~  280 (370)
T KOG0583|consen  279 QK  280 (370)
T ss_pred             cc
Confidence            44

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=4e-41  Score=345.36  Aligned_cols=247  Identities=27%  Similarity=0.351  Sum_probs=205.6

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc--CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      .|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+...  .+.+...+|+++++.++|||||.++++     |+...+.|
T Consensus         3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~es-----fEt~~~~~   77 (808)
T KOG0597|consen    3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLES-----FETSAHLW   77 (808)
T ss_pred             chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHh-----hcccceEE
Confidence            58889999999999999999999999999999975433  235668899999999999999999999     78888999


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      +|+||+.| +|..++...          ..+++..+..++.|++.||.|||+.   +|.|||+||.|||++..|++|++|
T Consensus        78 vVte~a~g-~L~~il~~d----------~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~Klcd  143 (808)
T KOG0597|consen   78 VVTEYAVG-DLFTILEQD----------GKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCD  143 (808)
T ss_pred             EEehhhhh-hHHHHHHhc----------cCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeech
Confidence            99999966 999999743          7799999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCc
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      ||+|+.+.....  ..+.+.|||.|||| |+..+.+|+..+|.||+||++||+++|++||...     .+.+.+.     
T Consensus       144 Fg~Ar~m~~~t~--vltsikGtPlYmAP-Elv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-----si~~Lv~-----  210 (808)
T KOG0597|consen  144 FGLARAMSTNTS--VLTSIKGTPLYMAP-ELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-----SITQLVK-----  210 (808)
T ss_pred             hhhhhhcccCce--eeeeccCcccccCH-HHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-----HHHHHHH-----
Confidence            999998876433  23447799999999 5666899999999999999999999999998511     1111222     


Q ss_pred             chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          639 HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       639 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                             .....+..                .+......+..++...+..||.+|.|..+++.-
T Consensus       211 -------~I~~d~v~----------------~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  211 -------SILKDPVK----------------PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             -------HHhcCCCC----------------CcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence                   11111111                011345567889999999999999999998753

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-41  Score=341.73  Aligned_cols=248  Identities=24%  Similarity=0.325  Sum_probs=203.0

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      .|...++||+|+||.||+|.+..+++.||+|++.... ....++.++|+.++.+++++||.++|+.     +-.+...|+
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygs-----yl~g~~Lwi   88 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGS-----YLKGTKLWI   88 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhh-----eeecccHHH
Confidence            4777899999999999999999999999999998543 3446788999999999999999999998     445668999


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      +||||.||++.+.++..          ..+.+..+.-++++++.|+.|+|..   +.+|||||+.||++..+|.+||+||
T Consensus        89 iMey~~gGsv~~lL~~~----------~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~Df  155 (467)
T KOG0201|consen   89 IMEYCGGGSVLDLLKSG----------NILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADF  155 (467)
T ss_pred             HHHHhcCcchhhhhccC----------CCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEec
Confidence            99999999999998743          3346667777899999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcc
Q 037916          560 GLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDH  639 (741)
Q Consensus       560 g~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  639 (741)
                      |.+..+.......  ...+||+.|||||. ..+..|+.|+||||||++.+||.+|.+|+.....  +.+.-.+.+..++.
T Consensus       156 gVa~ql~~~~~rr--~tfvGTPfwMAPEV-I~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP--mrvlflIpk~~PP~  230 (467)
T KOG0201|consen  156 GVAGQLTNTVKRR--KTFVGTPFWMAPEV-IKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP--MRVLFLIPKSAPPR  230 (467)
T ss_pred             ceeeeeechhhcc--ccccccccccchhh-hccccccchhhhhhhhHHHHHHhcCCCCCcccCc--ceEEEeccCCCCCc
Confidence            9998876654333  34679999999954 4577899999999999999999999999874332  22221222222221


Q ss_pred             hhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          640 VMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       640 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      .        .+                      .+...+.+++..|++.||+.||||.++++
T Consensus       231 L--------~~----------------------~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  231 L--------DG----------------------DFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             c--------cc----------------------ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            1        11                      33456889999999999999999999875

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.1e-40  Score=353.64  Aligned_cols=272  Identities=21%  Similarity=0.281  Sum_probs=202.6

Q ss_pred             HHHHHHHhhhcccCceeeEEEEEEc-----CCCeEEEEEEeeccC-cCcchhHHHHHHHHHhc-CCCceeeEeeeecCcc
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGILD-----EGKTIIAVKVLNLLH-HGASKSSIAECSALRNI-RHKNLVKILTVCSGVD  470 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~  470 (741)
                      ...+|++.++||+|+||.||+|.+.     .++..||+|+++... ....+.+.+|+.+++.+ +||||++++++|.   
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~---   81 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT---   81 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec---
Confidence            3468999999999999999999852     345689999987432 22345678999999999 8999999999863   


Q ss_pred             ccCCceEEEEEecccCCChhhhccCCCCCCcc------------------------------------------------
Q 037916          471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKT------------------------------------------------  502 (741)
Q Consensus       471 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~------------------------------------------------  502 (741)
                       ......++||||+++|+|.+++...+.....                                                
T Consensus        82 -~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (338)
T cd05102          82 -KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP  160 (338)
T ss_pred             -CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence             3345689999999999999998643211000                                                


Q ss_pred             ----cCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecccccccCCCCccccccccc
Q 037916          503 ----VEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK  578 (741)
Q Consensus       503 ----~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~  578 (741)
                          ......+++.++..++.||++||+|||+.   +|+||||||+||+++.++.+||+|||+++...............
T Consensus       161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~  237 (338)
T cd05102         161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSAR  237 (338)
T ss_pred             hhccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCC
Confidence                00023478888999999999999999999   99999999999999999999999999998654332222222234


Q ss_pred             ccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcCCcchhHhhhhcccCCcchhhh
Q 037916          579 GTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTI  657 (741)
Q Consensus       579 gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  657 (741)
                      ++..|+||| +..+..++.++|||||||++|||++ |..||.......    .+........        ..        
T Consensus       238 ~~~~y~aPE-~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~----~~~~~~~~~~--------~~--------  296 (338)
T cd05102         238 LPLKWMAPE-SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE----EFCQRLKDGT--------RM--------  296 (338)
T ss_pred             CCccccCcH-HhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH----HHHHHHhcCC--------CC--------
Confidence            677899995 4456778999999999999999997 999986321110    0100000000        00        


Q ss_pred             hhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHH
Q 037916          658 TSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKS  708 (741)
Q Consensus       658 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  708 (741)
                                 ..+..+++.+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus       297 -----------~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         297 -----------RAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             -----------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                       0011234568899999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-41  Score=315.87  Aligned_cols=272  Identities=18%  Similarity=0.216  Sum_probs=216.6

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      .+|+|.+++|+|||+.||++....++..||+|++.....+..+..++|++..++++||||+++++++....-+.....|+
T Consensus        21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yl  100 (302)
T KOG2345|consen   21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYL  100 (302)
T ss_pred             ceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEE
Confidence            47999999999999999999998899999999998777677888899999999999999999999876544445667999


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      +++|+..|+|.+.+.....      ....+++.+++.|+.++++||++||+. .++++||||||.||++.+++.++|.||
T Consensus       101 l~Pyy~~Gsl~d~i~~~k~------kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~  173 (302)
T KOG2345|consen  101 LLPYYKRGSLLDEIERLKI------KGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDL  173 (302)
T ss_pred             EeehhccccHHHHHHHHhh------cCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEec
Confidence            9999999999999875422      224689999999999999999999998 445999999999999999999999999


Q ss_pred             ccccccCCCC-------cccccccccccccccCccccc--CCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhh
Q 037916          560 GLAKLLPPAH-------LQTSSIGVKGTIGYIAPAEYG--LGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHN  630 (741)
Q Consensus       560 g~a~~~~~~~-------~~~~~~~~~gt~~y~aPEe~~--~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~  630 (741)
                      |.+...+-..       ..........|..|+|||.+.  .+...++++|||||||++|+|+.|..||+..+.....+.-
T Consensus       174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL  253 (302)
T KOG2345|consen  174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL  253 (302)
T ss_pred             cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE
Confidence            9998764211       011122344789999996442  3456789999999999999999999999866554333322


Q ss_pred             hhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHH
Q 037916          631 FARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIK  707 (741)
Q Consensus       631 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  707 (741)
                      .+...   +.                          .++.....++.+.+++.+|++.||.+||++.|++..++.+.
T Consensus       254 Av~n~---q~--------------------------s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  254 AVQNA---QI--------------------------SIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             eeecc---cc--------------------------ccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence            22110   00                          00001124577899999999999999999999999987653

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-40  Score=334.32  Aligned_cols=259  Identities=23%  Similarity=0.272  Sum_probs=201.0

Q ss_pred             HHHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc--------------CcchhHHHHHHHHHhcCCCceeeE
Q 037916          397 LLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH--------------GASKSSIAECSALRNIRHKNLVKI  462 (741)
Q Consensus       397 ~~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~hpnIv~~  462 (741)
                      ..+..|++++.||+|.||.|-+|++..+++.||||++.+...              ...+...+|+.+|++++|||||++
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            455679999999999999999999999999999999963211              113577899999999999999999


Q ss_pred             eeeecCccccCCceEEEEEecccCCChhhhccCCCCCCcccCcccc-cCHHHHHHHHHHHHHHHHHHHhcCCCCceecCC
Q 037916          463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKC-LNFLQRINIAIDVACALKYLHHDCQPTTAHCDL  541 (741)
Q Consensus       463 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~-~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDl  541 (741)
                      +++..+   +..+.+|+|+|||..|.+...-           .+.+ +++.++++++++++.||+|||.+   |||||||
T Consensus       174 iEvLDD---P~s~~~YlVley~s~G~v~w~p-----------~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDI  236 (576)
T KOG0585|consen  174 IEVLDD---PESDKLYLVLEYCSKGEVKWCP-----------PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDI  236 (576)
T ss_pred             EEeecC---cccCceEEEEEeccCCccccCC-----------CCcccccHHHHHHHHHHHHHHHHHHHhc---Ceecccc
Confidence            999653   4467899999999887764422           2234 89999999999999999999999   9999999


Q ss_pred             CCCCeEeCCCCceEEeecccccccCCCCc---ccccccccccccccCcccccCC---CCCCCccCchhHHHHHHHHHcCC
Q 037916          542 KPSNVLLDHEMTAHVADFGLAKLLPPAHL---QTSSIGVKGTIGYIAPAEYGLG---SEVSINGDVYSYGILLLELMTRK  615 (741)
Q Consensus       542 kp~NIll~~~~~~kL~DFg~a~~~~~~~~---~~~~~~~~gt~~y~aPEe~~~~---~~~~~~~DIwSlG~il~elltg~  615 (741)
                      ||+|+|++++|+|||+|||.+........   ........|||.|+|||....+   ...+.+.||||+||++|.++.|+
T Consensus       237 KPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~  316 (576)
T KOG0585|consen  237 KPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQ  316 (576)
T ss_pred             chhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhcc
Confidence            99999999999999999999986633211   1112225699999999766553   34678899999999999999999


Q ss_pred             CCCCccccCCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCC
Q 037916          616 RPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMN  695 (741)
Q Consensus       616 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs  695 (741)
                      .||...+    .+. .        ...++...+..                  +..++..+.+.+|+.++|..||++|.+
T Consensus       317 ~PF~~~~----~~~-l--------~~KIvn~pL~f------------------P~~pe~~e~~kDli~~lL~KdP~~Ri~  365 (576)
T KOG0585|consen  317 LPFFDDF----ELE-L--------FDKIVNDPLEF------------------PENPEINEDLKDLIKRLLEKDPEQRIT  365 (576)
T ss_pred             CCcccch----HHH-H--------HHHHhcCcccC------------------CCcccccHHHHHHHHHHhhcChhheee
Confidence            9985221    110 1        11222222211                  111245677889999999999999999


Q ss_pred             HHHHHHHH
Q 037916          696 MTIVVHEL  703 (741)
Q Consensus       696 ~~evl~~L  703 (741)
                      ..+|....
T Consensus       366 l~~ik~Hp  373 (576)
T KOG0585|consen  366 LPDIKLHP  373 (576)
T ss_pred             hhhheecc
Confidence            99987543

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-40  Score=316.20  Aligned_cols=197  Identities=27%  Similarity=0.337  Sum_probs=176.8

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcC---cchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG---ASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      ...|++++.||.|+||.|.+++.+.+|..+|+|++++...-   ..+...+|..+|+.+.||+++++++.     +.+..
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t-----~~d~~  117 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGT-----FKDNS  117 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEe-----eccCC
Confidence            36799999999999999999999999999999999754332   23455789999999999999999998     56677


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..|+||||++||.|..++++.          ..+++..++.++.||+.||+|||+.   +|++|||||+|||+|.+|.+|
T Consensus       118 ~lymvmeyv~GGElFS~Lrk~----------~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iK  184 (355)
T KOG0616|consen  118 NLYMVMEYVPGGELFSYLRKS----------GRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIK  184 (355)
T ss_pred             eEEEEEeccCCccHHHHHHhc----------CCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEE
Confidence            999999999999999999865          5689999999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCC
Q 037916          556 VADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSD  619 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~  619 (741)
                      |+|||+|+.....     ....+|||.|+|| |+.....|+.++|+|||||++|||+.|.+||.
T Consensus       185 itDFGFAK~v~~r-----T~TlCGTPeYLAP-Eii~sk~ynkavDWWalGVLIYEMlaG~pPF~  242 (355)
T KOG0616|consen  185 ITDFGFAKRVSGR-----TWTLCGTPEYLAP-EIIQSKGYNKAVDWWALGVLIYEMLAGYPPFY  242 (355)
T ss_pred             EEeccceEEecCc-----EEEecCCccccCh-HHhhcCCCCcchhHHHHHHHHHHHHcCCCCCc
Confidence            9999999987644     2337899999999 66678899999999999999999999999986

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.5e-41  Score=332.60  Aligned_cols=286  Identities=21%  Similarity=0.225  Sum_probs=208.1

Q ss_pred             HHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEEE
Q 037916          402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVY  481 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv~  481 (741)
                      |.-.+.+|+|+||.||+|....+++.||||.+-.    +.+.-.+|+.+|+.++|||||++..+|......+.-+..+||
T Consensus        26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~----d~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl  101 (364)
T KOG0658|consen   26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQ----DKRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL  101 (364)
T ss_pred             EEeeEEEeecccceEEEEEEcCCCceeEEEEecC----CCCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence            4456789999999999999999999999999743    223345799999999999999999988654422233567899


Q ss_pred             ecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCC-CceEEeecc
Q 037916          482 EFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHE-MTAHVADFG  560 (741)
Q Consensus       482 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~-~~~kL~DFg  560 (741)
                      |||+. +|.++++....      ....++...++-+..||.+||+|||+.   ||+||||||.|+|+|.+ |.+||||||
T Consensus       102 eymP~-tL~~~~r~~~~------~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFG  171 (364)
T KOG0658|consen  102 EYMPE-TLYRVIRHYTR------ANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFG  171 (364)
T ss_pred             HhchH-HHHHHHHHHhh------cCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCC
Confidence            99965 99998874211      125577778888999999999999998   99999999999999987 899999999


Q ss_pred             cccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcch
Q 037916          561 LAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHV  640 (741)
Q Consensus       561 ~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  640 (741)
                      .|+....+....+   ...|..|+|||-+.+...|+.+.||||.|||+.||+-|++-|.. ..+..++...+.. +....
T Consensus       172 SAK~L~~~epniS---YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG-~s~~dQL~eIik~-lG~Pt  246 (364)
T KOG0658|consen  172 SAKVLVKGEPNIS---YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPG-DSSVDQLVEIIKV-LGTPT  246 (364)
T ss_pred             cceeeccCCCcee---EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCC-CCHHHHHHHHHHH-hCCCC
Confidence            9998876654432   44688999998788888999999999999999999999998763 1222333333333 22222


Q ss_pred             hHhhhhcccCCcchhhhhhhhHHHHHhH-hhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH--HHHHHHh
Q 037916          641 MDIVDSTLLADDEDLTITSNQRQRQARI-NNIMECLISVVRIGVACSMESPQDRMNMTIVVHE--LQSIKSI  709 (741)
Q Consensus       641 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i~~~  709 (741)
                      .+.+..+.........   ..-....+. ......+++.++++.++++++|.+|.++.|++..  +..++..
T Consensus       247 ~e~I~~mn~~y~~~~~---p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  247 REDIKSMNPNYTEFKF---PQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             HHHHhhcCcccccccC---cccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence            2222222211111000   000001100 1233556788999999999999999999999854  5555543

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.4e-39  Score=322.49  Aligned_cols=289  Identities=20%  Similarity=0.230  Sum_probs=206.9

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc--CcchhHHHHHHHHHhcCCCc-eeeEeeeecCcc-ccCC
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKN-LVKILTVCSGVD-YKGD  474 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpn-Iv~~~~~~~~~~-~~~~  474 (741)
                      ...|..+++||+|+||+||+|+...+|+.||+|.++....  .......+|+.++++++|+| ||++++++.... +...
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            5678999999999999999999999999999999985433  34567789999999999999 999999974322 1223


Q ss_pred             ceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCce
Q 037916          475 DFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTA  554 (741)
Q Consensus       475 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~  554 (741)
                      ...++||||+ .-+|.+++.......      ...+...++.+++||+.||+|||++   +|+||||||.||+|+++|.+
T Consensus        90 ~~l~lvfe~~-d~DL~~ymd~~~~~~------~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~l  159 (323)
T KOG0594|consen   90 GKLYLVFEFL-DRDLKKYMDSLPKKP------QGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVL  159 (323)
T ss_pred             ceEEEEEEee-cccHHHHHHhccccc------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcE
Confidence            3789999999 459999997653211      3456678999999999999999999   99999999999999999999


Q ss_pred             EEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhh
Q 037916          555 HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       555 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  634 (741)
                      ||+|||+|+...-+..  ..+...+|.+|+|||.++....|+..+||||+||+++||++++.-|....+. .++....+.
T Consensus       160 KlaDFGlAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~-~ql~~If~~  236 (323)
T KOG0594|consen  160 KLADFGLARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI-DQLFRIFRL  236 (323)
T ss_pred             eeeccchHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH-HHHHHHHHH
Confidence            9999999986653322  2334568999999977777778999999999999999999999887633221 111111111


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      .-.+....|..-...+++..  ...............+.......+++.+|++++|.+|.|++.+++.
T Consensus       237 lGtP~e~~Wp~v~~~~~~k~--~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  237 LGTPNEKDWPGVSSLPDYKA--PFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             cCCCCccCCCCccccccccc--cCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            11111111111000111110  0000000001111111122468899999999999999999999875

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=5.9e-40  Score=337.68  Aligned_cols=251  Identities=22%  Similarity=0.273  Sum_probs=197.9

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCce
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      ..|++++.||+|+||.||+|+-+.+|..+|+|++++..   ....+....|-++|...++|.||++|..     |++..+
T Consensus       141 ~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYs-----FQD~~~  215 (550)
T KOG0605|consen  141 DDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYS-----FQDKEY  215 (550)
T ss_pred             ccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEE-----ecCCCe
Confidence            57899999999999999999999999999999998543   3445677889999999999999999988     778889


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .|+||||++||++..++...          ..+++..++.++.+++.|++.+|..   |+|||||||+|+|||..|++||
T Consensus       216 LYLiMEylPGGD~mTLL~~~----------~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKL  282 (550)
T KOG0605|consen  216 LYLIMEYLPGGDMMTLLMRK----------DTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKL  282 (550)
T ss_pred             eEEEEEecCCccHHHHHHhc----------CcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEee
Confidence            99999999999999998754          6789999999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCC----------------------Ccc-----cc------------------cccccccccccCcccccC
Q 037916          557 ADFGLAKLLPPA----------------------HLQ-----TS------------------SIGVKGTIGYIAPAEYGL  591 (741)
Q Consensus       557 ~DFg~a~~~~~~----------------------~~~-----~~------------------~~~~~gt~~y~aPEe~~~  591 (741)
                      +|||+|.-....                      ...     ..                  ....+|||.|+|| |++.
T Consensus       283 SDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAP-EVll  361 (550)
T KOG0605|consen  283 SDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAP-EVLL  361 (550)
T ss_pred             ccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccch-HHHh
Confidence            999998433210                      000     00                  0114599999999 5556


Q ss_pred             CCCCCCccCchhHHHHHHHHHcCCCCCCccccCC--cchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHh
Q 037916          592 GSEVSINGDVYSYGILLLELMTRKRPSDIMFEGN--MNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARIN  669 (741)
Q Consensus       592 ~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~  669 (741)
                      +..|+..+|+||+|||||||+.|.+||.......  ..+..|-.....+                               
T Consensus       362 ~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP-------------------------------  410 (550)
T KOG0605|consen  362 GKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFP-------------------------------  410 (550)
T ss_pred             cCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCC-------------------------------
Confidence            6779999999999999999999999997332211  1122221111110                               


Q ss_pred             hHHHHHHHHHHHhhcccccCCCCCCC---HHHHHH
Q 037916          670 NIMECLISVVRIGVACSMESPQDRMN---MTIVVH  701 (741)
Q Consensus       670 ~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~  701 (741)
                      ....+..+..++|.+|+. ||++|-.   ++||.+
T Consensus       411 ~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~  444 (550)
T KOG0605|consen  411 EEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKK  444 (550)
T ss_pred             CcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhc
Confidence            011233567789999998 9999975   555543

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-40  Score=339.69  Aligned_cols=251  Identities=24%  Similarity=0.392  Sum_probs=202.9

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      |....-++++|.|+.|.||+|+.+  ++.||||+++..       -..++.-|++|+||||+.+.|+|...     ..+|
T Consensus       123 Fe~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqs-----PcyC  188 (904)
T KOG4721|consen  123 FEEISELEWLGSGAQGAVFLGRLH--NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQS-----PCYC  188 (904)
T ss_pred             HHHhhhhhhhccCcccceeeeecc--CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCC-----ceeE
Confidence            333445678999999999999996  788999988522       23467889999999999999999643     3789


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      ||||||..|-|...++..          ..+.......+..+||.|+.|||.+   .|||||||.-||||+.+..|||+|
T Consensus       189 IiMEfCa~GqL~~VLka~----------~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsD  255 (904)
T KOG4721|consen  189 IIMEFCAQGQLYEVLKAG----------RPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISD  255 (904)
T ss_pred             EeeeccccccHHHHHhcc----------CccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEecc
Confidence            999999999999999744          5677778889999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCc
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      ||-++...+.   .+...++||..|||| |+....+.++|+||||||||+|||+||..||.+.....     .++..-..
T Consensus       256 FGTS~e~~~~---STkMSFaGTVaWMAP-EvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA-----IIwGVGsN  326 (904)
T KOG4721|consen  256 FGTSKELSDK---STKMSFAGTVAWMAP-EVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA-----IIWGVGSN  326 (904)
T ss_pred             ccchHhhhhh---hhhhhhhhhHhhhCH-HHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe-----eEEeccCC
Confidence            9999877654   334457899999999 67788899999999999999999999999987432211     11111111


Q ss_pred             chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHhhc
Q 037916          639 HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSILL  711 (741)
Q Consensus       639 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~  711 (741)
                      .+                          ...-+..|++.+.-|+..||+..|..||++.+++.-|+=....+.
T Consensus       327 sL--------------------------~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell  373 (904)
T KOG4721|consen  327 SL--------------------------HLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELL  373 (904)
T ss_pred             cc--------------------------cccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHh
Confidence            11                          111234788889999999999999999999999998876654433

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.5e-40  Score=325.46  Aligned_cols=250  Identities=20%  Similarity=0.262  Sum_probs=207.0

Q ss_pred             HHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCc---chhHHHHHHHHHhcCCCceeeEeeeecCccccCC
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGA---SKSSIAECSALRNIRHKNLVKILTVCSGVDYKGD  474 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~  474 (741)
                      +--+|++.+.||+|.||.|-+|+.+..|+.||||.+++.....   .-.+.+|+++|..++||||+.+|++     |++.
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEV-----FENk  125 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEV-----FENK  125 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhh-----hcCC
Confidence            4468999999999999999999998899999999997544433   3456789999999999999999999     7888


Q ss_pred             ceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCce
Q 037916          475 DFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTA  554 (741)
Q Consensus       475 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~  554 (741)
                      +.+.|||||..+|.|++|+...          ..+++.+++++++||..|+.|+|.+   +++|||||.+|||+|.++.+
T Consensus       126 dKIvivMEYaS~GeLYDYiSer----------~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~Ni  192 (668)
T KOG0611|consen  126 DKIVIVMEYASGGELYDYISER----------GSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNI  192 (668)
T ss_pred             ceEEEEEEecCCccHHHHHHHh----------ccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCe
Confidence            8999999999999999999755          6789999999999999999999999   99999999999999999999


Q ss_pred             EEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhh
Q 037916          555 HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       555 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  634 (741)
                      ||+|||++-.+.......   ..+|++-|.+||.+-...+-++.+|-||+|+++|.++.|..||+.     .+...+++.
T Consensus       193 KIADFGLSNly~~~kfLq---TFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG-----~Dhk~lvrQ  264 (668)
T KOG0611|consen  193 KIADFGLSNLYADKKFLQ---TFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG-----RDHKRLVRQ  264 (668)
T ss_pred             eeeccchhhhhccccHHH---HhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC-----chHHHHHHH
Confidence            999999998876655433   367999999995554444557999999999999999999999972     222233333


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      .-.+...+                             ++.+....-||++||..+|+.|.|+.+|..-
T Consensus       265 Is~GaYrE-----------------------------P~~PSdA~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  265 ISRGAYRE-----------------------------PETPSDASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             hhcccccC-----------------------------CCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence            22221111                             1223445678999999999999999998753

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-41  Score=350.61  Aligned_cols=345  Identities=22%  Similarity=0.217  Sum_probs=316.2

Q ss_pred             CCCCcccccCChhhhhCCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCcc
Q 037916            3 VGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLK   82 (741)
Q Consensus         3 l~~n~~~~~ip~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~   82 (741)
                      |..|.++ .||.-.. ...+|+.|+|.+|.|+.+..+.+..++.|++||||.|.|+.+.-..|..-.          +++
T Consensus       109 l~~N~Lt-~IP~f~~-~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~----------ni~  176 (873)
T KOG4194|consen  109 LNKNELT-RIPRFGH-ESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKV----------NIK  176 (873)
T ss_pred             eccchhh-hcccccc-cccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCC----------Cce
Confidence            5567777 8995554 677799999999999999999999999999999999999976666676644          499


Q ss_pred             EEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcccC
Q 037916           83 HLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTN  162 (741)
Q Consensus        83 ~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N  162 (741)
                      +|+|++|.|+.+..+.|..+. +|.+|.|+.|+|+...+..|..|++|+.|+|..|+|.-..--.|.+|++|+.|.|..|
T Consensus       177 ~L~La~N~It~l~~~~F~~ln-sL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN  255 (873)
T KOG4194|consen  177 KLNLASNRITTLETGHFDSLN-SLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRN  255 (873)
T ss_pred             EEeeccccccccccccccccc-hheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhc
Confidence            999999999999999999999 9999999999999999999999999999999999999655778999999999999999


Q ss_pred             CCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCCCC
Q 037916          163 KLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLP  242 (741)
Q Consensus       163 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p  242 (741)
                      +|+....++|.++.++++|+|..|+++..-.+++.+|+.|+.|+||+|.|..+.++.+...++|++ ||||+|+|+...+
T Consensus       256 ~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~-LdLs~N~i~~l~~  334 (873)
T KOG4194|consen  256 DISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKE-LDLSSNRITRLDE  334 (873)
T ss_pred             CcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhccccee-EeccccccccCCh
Confidence            999999999999999999999999999888999999999999999999999999999999999998 9999999998889


Q ss_pred             hhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCccCCCC---ChhcccCccCCeeeCCCCcCCCccchhhhc
Q 037916          243 TEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPI---PLSLSSLRGLRVLDLSQNNISGEIPKFLVE  319 (741)
Q Consensus       243 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  319 (741)
                      ..|..|..|++|.|++|.|..+-..+|.++++|++|||++|.|+..+   ...|.+|++|+.|+|.+|+|..+.-.+|.+
T Consensus       335 ~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsg  414 (873)
T KOG4194|consen  335 GSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSG  414 (873)
T ss_pred             hHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhcc
Confidence            99999999999999999999999999999999999999999998655   346899999999999999999888899999


Q ss_pred             cccCCcccccCcccccccCCccccCCcccccccCCCCccccC
Q 037916          320 LQLVQNLNLSYNDLEGVIPTEGVFKNASAISVFGNSKLCGGI  361 (741)
Q Consensus       320 l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~  361 (741)
                      +..|+.|||.+|.|.++-|....-..+.++.+...+.+|.+-
T Consensus       415 l~~LE~LdL~~NaiaSIq~nAFe~m~Lk~Lv~nSssflCDCq  456 (873)
T KOG4194|consen  415 LEALEHLDLGDNAIASIQPNAFEPMELKELVMNSSSFLCDCQ  456 (873)
T ss_pred             CcccceecCCCCcceeecccccccchhhhhhhcccceEEecc
Confidence            999999999999999988877444478888888888888753

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.9e-40  Score=360.36  Aligned_cols=270  Identities=24%  Similarity=0.384  Sum_probs=215.7

Q ss_pred             HHHHhhhcccCceeeEEEEEEc-----CCCeEEEEEEeeccCcC-cchhHHHHHHHHHhcCCCceeeEeeeecCccccCC
Q 037916          401 SFLFLCWIDMGSFGSVYKGILD-----EGKTIIAVKVLNLLHHG-ASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGD  474 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~-----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~  474 (741)
                      ..++.+.||+|+||+||+|+..     +....||||.++..... ...+|++|++++..++|||||+++|+|..     +
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~-----~  561 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE-----G  561 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc-----C
Confidence            3456788999999999999874     34567999999855444 67899999999999999999999999854     4


Q ss_pred             ceEEEEEecccCCChhhhccCCCCCCcccCc----ccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCC
Q 037916          475 DFKALVYEFMHNGSLEEWLHPVSGADKTVEA----PKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDH  550 (741)
Q Consensus       475 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~  550 (741)
                      +..|+|+|||..|||.+|+............    +.+++..+.+.|+.|||.||+||-++   .+|||||-..|+||.+
T Consensus       562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge  638 (774)
T KOG1026|consen  562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGE  638 (774)
T ss_pred             CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceecc
Confidence            4789999999999999999754322222111    44589999999999999999999999   9999999999999999


Q ss_pred             CCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchh
Q 037916          551 EMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLH  629 (741)
Q Consensus       551 ~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~  629 (741)
                      +..|||+|||+++..-..+.+.....-.-..+||||| ....+++|+++|||||||++||+++ |+.||......  ++.
T Consensus       639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppE-sIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~--EVI  715 (774)
T KOG1026|consen  639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPE-SILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ--EVI  715 (774)
T ss_pred             ceEEEecccccchhhhhhhhhcccCCceeeeecCCHH-HhhcCcccchhhhhhhhhhhhhhhccccCcccccchH--HHH
Confidence            9999999999999877666555432333477999995 4567789999999999999999998 89998633221  111


Q ss_pred             hhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHh
Q 037916          630 NFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSI  709 (741)
Q Consensus       630 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  709 (741)
                      +.+           -+..+                   .+.+..|+.++.+||..||+.+|++||+++||-.+|+...+.
T Consensus       716 e~i-----------~~g~l-------------------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  716 ECI-----------RAGQL-------------------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             HHH-----------HcCCc-------------------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence            111           11111                   223458999999999999999999999999999999988765


Q ss_pred             hc
Q 037916          710 LL  711 (741)
Q Consensus       710 ~~  711 (741)
                      ..
T Consensus       766 s~  767 (774)
T KOG1026|consen  766 SP  767 (774)
T ss_pred             Cc
Confidence            43

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-40  Score=358.73  Aligned_cols=267  Identities=20%  Similarity=0.179  Sum_probs=210.6

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcC-CCceeeEeeeecC-ccccC-CceE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIR-HKNLVKILTVCSG-VDYKG-DDFK  477 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~-~~~~~-~~~~  477 (741)
                      .++|.+.|.+|||+.||.|.+...+..||+|++-..+....+...+|+++|+.|+ |+|||.|++.... ..... ...+
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev  117 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV  117 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence            3567889999999999999999887999999987666667788899999999996 9999999994222 21122 3578


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      ++.||||+||.|-+++..+.        ...+++.++++|+.|+++|+++||.. .++|||||||-||||++.+|..|||
T Consensus       118 llLmEyC~gg~Lvd~mn~Rl--------q~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLC  188 (738)
T KOG1989|consen  118 LLLMEYCKGGSLVDFMNTRL--------QTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLC  188 (738)
T ss_pred             EeehhhccCCcHHHHHHHHH--------hccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeC
Confidence            89999999999999997441        13489999999999999999999987 7789999999999999999999999


Q ss_pred             ecccccccCCCCccc-------ccccccccccccCcccc--cCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcch
Q 037916          558 DFGLAKLLPPAHLQT-------SSIGVKGTIGYIAPAEY--GLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNL  628 (741)
Q Consensus       558 DFg~a~~~~~~~~~~-------~~~~~~gt~~y~aPEe~--~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~  628 (741)
                      |||.|...-......       .......|+.|+|||.+  ..+..+++|+|||++||+||.|+....||+....-...-
T Consensus       189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIln  268 (738)
T KOG1989|consen  189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILN  268 (738)
T ss_pred             cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEe
Confidence            999987543332111       11123479999999754  456789999999999999999999999997321111100


Q ss_pred             hhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHH
Q 037916          629 HNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKS  708 (741)
Q Consensus       629 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  708 (741)
                      ..                                   +.++..+.....+.+||+.||+.||++||++.||++.+-.+..
T Consensus       269 g~-----------------------------------Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~  313 (738)
T KOG1989|consen  269 GN-----------------------------------YSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN  313 (738)
T ss_pred             cc-----------------------------------ccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence            00                                   0111123556778999999999999999999999999988886


Q ss_pred             hhc
Q 037916          709 ILL  711 (741)
Q Consensus       709 ~~~  711 (741)
                      ...
T Consensus       314 ~~~  316 (738)
T KOG1989|consen  314 KPC  316 (738)
T ss_pred             CCC
Confidence            443

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-41  Score=310.60  Aligned_cols=252  Identities=20%  Similarity=0.239  Sum_probs=200.5

Q ss_pred             HHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeec--cCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      +-..|.+.+.||+|+|+.||++.+..+|+.+|+|+++.  .+....+.+.+|+++.+.++|||||++.+.     +....
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~t-----i~~~~   83 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS-----IQEES   83 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhh-----hcccc
Confidence            34579999999999999999999999999999999862  233456788899999999999999999998     56677


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCC---CC
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDH---EM  552 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~---~~  552 (741)
                      +.|+|+|+|.|++|..-|-.          +...++..+-+.++||++||.|+|.+   +|||||+||+|+++..   ..
T Consensus        84 ~~ylvFe~m~G~dl~~eIV~----------R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A  150 (355)
T KOG0033|consen   84 FHYLVFDLVTGGELFEDIVA----------REFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGA  150 (355)
T ss_pred             eeEEEEecccchHHHHHHHH----------HHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCC
Confidence            99999999999998765532          25678888899999999999999999   9999999999999953   34


Q ss_pred             ceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhh
Q 037916          553 TAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFA  632 (741)
Q Consensus       553 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~  632 (741)
                      .+||+|||+|........   ..+..|||.|||| |+....+|+..+|||+.|+|+|-++.|.+||..... ..-+.+..
T Consensus       151 ~vKL~~FGvAi~l~~g~~---~~G~~GtP~fmaP-Evvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~-~rlye~I~  225 (355)
T KOG0033|consen  151 AVKLADFGLAIEVNDGEA---WHGFAGTPGYLSP-EVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-HRLYEQIK  225 (355)
T ss_pred             ceeecccceEEEeCCccc---cccccCCCcccCH-HHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH-HHHHHHHh
Confidence            799999999998874332   3346799999999 666778999999999999999999999999862111 11111111


Q ss_pred             hhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHH
Q 037916          633 RTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVV  700 (741)
Q Consensus       633 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  700 (741)
                      .                +.+.-         ..   ..++...+...+|+++|+..||.+|.|+.|.+
T Consensus       226 ~----------------g~yd~---------~~---~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL  265 (355)
T KOG0033|consen  226 A----------------GAYDY---------PS---PEWDTVTPEAKSLIRRMLTVNPKKRITADEAL  265 (355)
T ss_pred             c----------------cccCC---------CC---cccCcCCHHHHHHHHHHhccChhhhccHHHHh
Confidence            1                11110         00   01123455677999999999999999999876

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.4e-39  Score=339.93  Aligned_cols=281  Identities=21%  Similarity=0.255  Sum_probs=197.0

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc-CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      ..|++.++||+|+||.||+|++..+++.||+|+++.... .....+.+|+.+++.++||||+++++++     .++...+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~   79 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII-----HTKETLT   79 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEE-----ecCCeEE
Confidence            468899999999999999999998999999999874332 2234677899999999999999999994     4566899


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      +||||+. ++|.+++...         ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        80 lv~e~~~-~~l~~~~~~~---------~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~D  146 (303)
T cd07869          80 LVFEYVH-TDLCQYMDKH---------PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLAD  146 (303)
T ss_pred             EEEECCC-cCHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECC
Confidence            9999995 6888777532         23477888999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCc
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      ||.+........  ......||+.|+|||.+.....++.++||||+||++|+|++|..||....+....+..........
T Consensus       147 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  224 (303)
T cd07869         147 FGLARAKSVPSH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTP  224 (303)
T ss_pred             CCcceeccCCCc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCC
Confidence            999875433221  122345899999997665556789999999999999999999999974322111111111111000


Q ss_pred             chhHhhhhcccCCcchhhhh-hhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          639 HVMDIVDSTLLADDEDLTIT-SNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       639 ~~~~~~d~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ....+............... ........... .......+.+++.+|++.||++|||+.|+++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         225 NEDTWPGVHSLPHFKPERFTLYSPKNLRQAWN-KLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             ChhhccchhhccccccccccccCCccHHHHhh-ccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            00000000000000000000 00000000000 0012345779999999999999999999985

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.3e-39  Score=344.68  Aligned_cols=286  Identities=20%  Similarity=0.202  Sum_probs=198.2

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeecc--CcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLL--HHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      +|++.+.||+|+||.||+|++..++..||+|+++..  .......+.+|+.++++++||||+++++++...........|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            378889999999999999999989999999998632  122334678899999999999999999987543333344689


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      +||||+ +++|.+++...          ..+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        81 lv~e~~-~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~D  146 (338)
T cd07859          81 VVFELM-ESDLHQVIKAN----------DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICD  146 (338)
T ss_pred             EEEecC-CCCHHHHHHhc----------ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEcc
Confidence            999999 56898888633          4578899999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCc-ccccccccccccccCcccccC-CCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcC
Q 037916          559 FGLAKLLPPAHL-QTSSIGVKGTIGYIAPAEYGL-GSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVL  636 (741)
Q Consensus       559 Fg~a~~~~~~~~-~~~~~~~~gt~~y~aPEe~~~-~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  636 (741)
                      ||.++....... ........||+.|+|||.+.. ...++.++||||+||++|||++|+.||.....  ......+....
T Consensus       147 fg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~--~~~~~~~~~~~  224 (338)
T cd07859         147 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV--VHQLDLITDLL  224 (338)
T ss_pred             CccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHHHh
Confidence            999976533221 111223468999999965432 25789999999999999999999999863211  11111111111


Q ss_pred             CcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          637 PDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       637 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      .....+.................................+.+.+++.+||+.||++|||++|+++.
T Consensus       225 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         225 GTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             CCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            110000000000000000000000000000000111234567899999999999999999999964

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=6.9e-39  Score=333.80  Aligned_cols=279  Identities=21%  Similarity=0.275  Sum_probs=197.8

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      ..|++.++||+|+||.||+|++..++..||+|+++... ......+.+|+.++++++||||+++++++     ..+...+
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~   79 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII-----HTERCLT   79 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEE-----cCCCeEE
Confidence            46889999999999999999999999999999997433 22345677899999999999999999984     4566899


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      +||||++ ++|.+++...         ...+++..+..++.||+.||+|||+.   ||+||||||+||+++.++.+||+|
T Consensus        80 lv~e~~~-~~l~~~l~~~---------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~D  146 (288)
T cd07871          80 LVFEYLD-SDLKQYLDNC---------GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLAD  146 (288)
T ss_pred             EEEeCCC-cCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECc
Confidence            9999996 5998887532         13467888999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCc
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      ||.++.......  ......+++.|+|||.+.....++.++||||+||++|+|++|+.||...... ..+...... ...
T Consensus       147 fG~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~-~~~  222 (288)
T cd07871         147 FGLARAKSVPTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK-EELHLIFRL-LGT  222 (288)
T ss_pred             CcceeeccCCCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHH-hCC
Confidence            999876433221  1122457999999976655677899999999999999999999998632111 111111111 110


Q ss_pred             chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          639 HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       639 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ...+..........- .........................+++.+|+++||.+|||++|+++
T Consensus       223 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         223 PTEETWPGITSNEEF-RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             CChHHhhccccchhh-hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            000000000000000 00000000000000111123456789999999999999999999974

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-39  Score=338.71  Aligned_cols=243  Identities=24%  Similarity=0.282  Sum_probs=200.4

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhc-CCCceeeEeeeecCccccCC
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKGD  474 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~  474 (741)
                      ...|.+++.||+|+||+|++|..+.+++.+|||++++..   ..+.+....|.+++... +||.+++++..     |+..
T Consensus       367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~-----fQT~  441 (694)
T KOG0694|consen  367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSC-----FQTK  441 (694)
T ss_pred             ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccc-----cccC
Confidence            356889999999999999999999999999999998543   34556778898888777 59999999998     7888


Q ss_pred             ceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCce
Q 037916          475 DFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTA  554 (741)
Q Consensus       475 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~  554 (741)
                      +++|+||||+.||++..+++           ...+++..++.++..|+.||.|||++   |||+||||.+|||+|.+|++
T Consensus       442 ~~l~fvmey~~Ggdm~~~~~-----------~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~  507 (694)
T KOG0694|consen  442 EHLFFVMEYVAGGDLMHHIH-----------TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHV  507 (694)
T ss_pred             CeEEEEEEecCCCcEEEEEe-----------cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcE
Confidence            89999999999999665554           25689999999999999999999999   99999999999999999999


Q ss_pred             EEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhh
Q 037916          555 HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       555 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  634 (741)
                      ||+|||+|+..-.....  ....+|||.|+|| |++.+..|+.++|+|||||+||||+.|+.||....            
T Consensus       508 kiADFGlcKe~m~~g~~--TsTfCGTpey~aP-Eil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd------------  572 (694)
T KOG0694|consen  508 KIADFGLCKEGMGQGDR--TSTFCGTPEFLAP-EVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD------------  572 (694)
T ss_pred             EecccccccccCCCCCc--cccccCChhhcCh-hhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC------------
Confidence            99999999876533322  2337899999999 77788999999999999999999999999987221            


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCH
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNM  696 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  696 (741)
                           -.+++|..+..+...                +.-+..+...|+++++..+|++|-.+
T Consensus       573 -----Eee~FdsI~~d~~~y----------------P~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  573 -----EEEVFDSIVNDEVRY----------------PRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             -----HHHHHHHHhcCCCCC----------------CCcccHHHHHHHHHHhccCcccccCC
Confidence                 123333333322210                11344567799999999999999866

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3e-38  Score=327.64  Aligned_cols=252  Identities=22%  Similarity=0.317  Sum_probs=194.9

Q ss_pred             hhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCc---chhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEEEe
Q 037916          406 CWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGA---SKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYE  482 (741)
Q Consensus       406 ~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv~e  482 (741)
                      ..||+|+++.||+|.+  +++.||+|+++......   .+.+.+|+.++++++||||+++++++.+.. .+....++|||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~E  102 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLILE  102 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEEE
Confidence            4589999999999998  58899999997543322   356779999999999999999999874311 23457899999


Q ss_pred             cccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecccc
Q 037916          483 FMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLA  562 (741)
Q Consensus       483 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~a  562 (741)
                      |+++|+|.+++...          ..+++.....++.|++.||.|||+..  +++||||||+||++++++.+||+|||++
T Consensus       103 y~~~g~L~~~l~~~----------~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~  170 (283)
T PHA02988        103 YCTRGYLREVLDKE----------KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLE  170 (283)
T ss_pred             eCCCCcHHHHHhhC----------CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchH
Confidence            99999999998643          45788889999999999999999732  7889999999999999999999999999


Q ss_pred             cccCCCCcccccccccccccccCcccccC-CCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcchh
Q 037916          563 KLLPPAHLQTSSIGVKGTIGYIAPAEYGL-GSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM  641 (741)
Q Consensus       563 ~~~~~~~~~~~~~~~~gt~~y~aPEe~~~-~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  641 (741)
                      ........     ...|+..|+|||.+.. ...++.++|||||||++|||++|+.||.....     .+.........  
T Consensus       171 ~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~-----~~~~~~i~~~~--  238 (283)
T PHA02988        171 KILSSPPF-----KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT-----KEIYDLIINKN--  238 (283)
T ss_pred             hhhccccc-----cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHhcC--
Confidence            86543321     2347899999954432 26789999999999999999999999863211     11111100000  


Q ss_pred             HhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHH
Q 037916          642 DIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKS  708 (741)
Q Consensus       642 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  708 (741)
                            ..                  ...+..++..+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus       239 ------~~------------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        239 ------NS------------------LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             ------CC------------------CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence                  00                  00011345678899999999999999999999999987753

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.5e-38  Score=334.20  Aligned_cols=272  Identities=21%  Similarity=0.312  Sum_probs=198.0

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcC----------------CCeEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceee
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDE----------------GKTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVK  461 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~  461 (741)
                      ..+|++.++||+|+||.||+|.+..                ++..||+|+++... .....++.+|+.++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            4678899999999999999998642                34579999987432 223456889999999999999999


Q ss_pred             EeeeecCccccCCceEEEEEecccCCChhhhccCCCCCCcc---------cCcccccCHHHHHHHHHHHHHHHHHHHhcC
Q 037916          462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKT---------VEAPKCLNFLQRINIAIDVACALKYLHHDC  532 (741)
Q Consensus       462 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~---------~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~  532 (741)
                      +++++     .+....++||||+++++|.+++.........         ......+++..+..++.|++.||.|||+. 
T Consensus        84 ~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-  157 (304)
T cd05096          84 LLGVC-----VDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL-  157 (304)
T ss_pred             EEEEE-----ecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC-
Confidence            99995     3445789999999999999988543211110         11224578888999999999999999999 


Q ss_pred             CCCceecCCCCCCeEeCCCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHH
Q 037916          533 QPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELM  612 (741)
Q Consensus       533 ~~~ivHrDlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ell  612 (741)
                        +|+||||||+||+++.++.+||+|||.++...............++..|+|||. ..+..++.++|||||||++|||+
T Consensus       158 --~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~~~~Dv~slG~~l~el~  234 (304)
T cd05096         158 --NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWEC-ILMGKFTTASDVWAFGVTLWEIL  234 (304)
T ss_pred             --CccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHH-HhcCCCCchhhhHHHHHHHHHHH
Confidence              999999999999999999999999999986544332222222345788999954 45667899999999999999998


Q ss_pred             c--CCCCCCccccCCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCC
Q 037916          613 T--RKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESP  690 (741)
Q Consensus       613 t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP  690 (741)
                      +  +..||......  ........        .........               ....+..++..+.+++.+||+.||
T Consensus       235 ~~~~~~p~~~~~~~--~~~~~~~~--------~~~~~~~~~---------------~~~~~~~~~~~~~~li~~cl~~~p  289 (304)
T cd05096         235 MLCKEQPYGELTDE--QVIENAGE--------FFRDQGRQV---------------YLFRPPPCPQGLYELMLQCWSRDC  289 (304)
T ss_pred             HccCCCCCCcCCHH--HHHHHHHH--------Hhhhccccc---------------cccCCCCCCHHHHHHHHHHccCCc
Confidence            7  55676532111  11100000        000000000               000112345678999999999999


Q ss_pred             CCCCCHHHHHHHHH
Q 037916          691 QDRMNMTIVVHELQ  704 (741)
Q Consensus       691 ~~RPs~~evl~~L~  704 (741)
                      ++|||+.||.+.|+
T Consensus       290 ~~RPs~~~i~~~l~  303 (304)
T cd05096         290 RERPSFSDIHAFLT  303 (304)
T ss_pred             hhCcCHHHHHHHHh
Confidence            99999999998875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.9e-38  Score=330.05  Aligned_cols=251  Identities=22%  Similarity=0.299  Sum_probs=193.9

Q ss_pred             HHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc---CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH---GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      |++.+.||+|+||.||+|.+..+++.||+|.+.....   .....+.+|+.++++++|++|+++++++     .+.+..+
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~-----~~~~~~~   76 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAY-----ETKDALC   76 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEE-----ccCCeEE
Confidence            6778899999999999999998999999999864321   2234567899999999999999999984     4556899


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      +||||+++|+|.+++....        ...+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|
T Consensus        77 lv~e~~~~g~L~~~~~~~~--------~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~D  145 (285)
T cd05631          77 LVLTIMNGGDLKFHIYNMG--------NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISD  145 (285)
T ss_pred             EEEEecCCCcHHHHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEee
Confidence            9999999999988875321        13478889999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCc
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      ||++.........   ....||..|+|| |+..+..++.++||||+||++|||++|+.||....... .....       
T Consensus       146 fg~~~~~~~~~~~---~~~~g~~~y~aP-E~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~~-------  213 (285)
T cd05631         146 LGLAVQIPEGETV---RGRVGTVGYMAP-EVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV-KREEV-------  213 (285)
T ss_pred             CCCcEEcCCCCee---cCCCCCCCccCH-hhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch-hHHHH-------
Confidence            9999875433221   234589999999 55567788999999999999999999999987321110 00000       


Q ss_pred             chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCC-----HHHHHH
Q 037916          639 HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMN-----MTIVVH  701 (741)
Q Consensus       639 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  701 (741)
                            +.......               ..........+.+++.+||+.||++||+     ++|+++
T Consensus       214 ------~~~~~~~~---------------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         214 ------DRRVKEDQ---------------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             ------HHHhhccc---------------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence                  00000000               0001123456789999999999999997     677775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.1e-39  Score=331.95  Aligned_cols=253  Identities=21%  Similarity=0.273  Sum_probs=208.6

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcC--cchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG--ASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      ..|..++.+|+|+||.++.++++.+++.||+|.+......  ..+....|+.+++++.|||||.+.+.|    ..++...
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~----~~~~~~l   79 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSF----EEDGQLL   79 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccch----hcCCceE
Confidence            5699999999999999999999999999999999754433  344678899999999999999999995    3344459


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      +|||+||+||++.+.+...+        ...+++..+..++.|++.|+.|||++   .|+|||||+.||+++.++.|||+
T Consensus        80 ~Ivm~Y~eGg~l~~~i~~~k--------~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLg  148 (426)
T KOG0589|consen   80 CIVMEYCEGGDLAQLIKEQK--------GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLG  148 (426)
T ss_pred             EEEEeecCCCCHHHHHHHHh--------hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeec
Confidence            99999999999999998653        25688999999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCC
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      |||+|+.+.......  ..+.||+.|++| |+..+.+|+.|+||||+||++|||++-+++|...     +....+.+...
T Consensus       149 DfGlaK~l~~~~~~a--~tvvGTp~YmcP-Eil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~-----~m~~Li~ki~~  220 (426)
T KOG0589|consen  149 DFGLAKILNPEDSLA--STVVGTPYYMCP-EILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS-----NMSELILKINR  220 (426)
T ss_pred             chhhhhhcCCchhhh--heecCCCcccCH-HHhCCCCCCccCcchhhcchHHHHHhcccccCcc-----chHHHHHHHhh
Confidence            999999987764222  236799999999 7788999999999999999999999999998722     22222221111


Q ss_pred             cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          638 DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       638 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      .        ...                   +.+.....++..++..|+..+|+.||++.+++..
T Consensus       221 ~--------~~~-------------------Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  221 G--------LYS-------------------PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             c--------cCC-------------------CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            1        111                   1122445678899999999999999999999987

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3e-38  Score=340.40  Aligned_cols=269  Identities=22%  Similarity=0.301  Sum_probs=200.1

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcC-----CCeEEEEEEeeccCc-CcchhHHHHHHHHHhc-CCCceeeEeeeecCccc
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDE-----GKTIIAVKVLNLLHH-GASKSSIAECSALRNI-RHKNLVKILTVCSGVDY  471 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~  471 (741)
                      ...|++.+.||+|+||.||+|++..     ++..||+|+++.... ...+.+.+|+.+++.+ +|||||+++++|     
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~-----  111 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC-----  111 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe-----
Confidence            4578999999999999999998643     335799999974322 2245678899999999 899999999985     


Q ss_pred             cCCceEEEEEecccCCChhhhccCCCCC----------------------------------------------------
Q 037916          472 KGDDFKALVYEFMHNGSLEEWLHPVSGA----------------------------------------------------  499 (741)
Q Consensus       472 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------------------------------------------  499 (741)
                      ......++||||+++|+|.+++......                                                    
T Consensus       112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (374)
T cd05106         112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS  191 (374)
T ss_pred             cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence            3455889999999999999988532110                                                    


Q ss_pred             --------CcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecccccccCCCCcc
Q 037916          500 --------DKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQ  571 (741)
Q Consensus       500 --------~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~  571 (741)
                              .........+++.++++++.||+.||+|||++   ||+||||||+||++++++.+||+|||++.........
T Consensus       192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~  268 (374)
T cd05106         192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY  268 (374)
T ss_pred             cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence                    00001123578889999999999999999999   9999999999999999999999999999765443222


Q ss_pred             cccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcCCcchhHhhhhcccC
Q 037916          572 TSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLA  650 (741)
Q Consensus       572 ~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  650 (741)
                      .......++..|+||| +..+..++.++|||||||++|||++ |+.||....... .+...            .......
T Consensus       269 ~~~~~~~~~~~y~aPE-~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~------------~~~~~~~  334 (374)
T cd05106         269 VVKGNARLPVKWMAPE-SIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKM------------VKRGYQM  334 (374)
T ss_pred             eeccCCCCccceeCHH-HhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHH------------HHcccCc
Confidence            2222233567899995 4456779999999999999999997 999986332111 11111            1000000


Q ss_pred             CcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHH
Q 037916          651 DDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIK  707 (741)
Q Consensus       651 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  707 (741)
                      ..                  +...+..+.+++.+||+.||++|||+.||++.|+++.
T Consensus       335 ~~------------------~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         335 SR------------------PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             cC------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            00                  0012456889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.6e-38  Score=329.64  Aligned_cols=278  Identities=21%  Similarity=0.245  Sum_probs=197.3

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC--cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      +|++.+.||+|+||.||+|++..+++.||+|+++...  ....+.+.+|+.+++.++||||+++++++     ......|
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~   76 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-----RRRGKLY   76 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-----ecCCEEE
Confidence            4888999999999999999999999999999997432  22345678899999999999999999984     4566899


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      +||||++++.+..+...          ...+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|
T Consensus        77 lv~e~~~~~~l~~~~~~----------~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~D  143 (287)
T cd07848          77 LVFEYVEKNMLELLEEM----------PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCD  143 (287)
T ss_pred             EEEecCCCCHHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEee
Confidence            99999988776655431          13578888999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhh--cC
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART--VL  636 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~--~~  636 (741)
                      ||.+......... ......|++.|+||| +..+..++.++||||+||++|||++|+.||......+ ........  ..
T Consensus       144 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE-~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~  220 (287)
T cd07848         144 FGFARNLSEGSNA-NYTEYVATRWYRSPE-LLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID-QLFTIQKVLGPL  220 (287)
T ss_pred             ccCcccccccccc-cccccccccccCCcH-HHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhhCCC
Confidence            9999876433221 122345899999995 4456678999999999999999999999986422111 01111000  01


Q ss_pred             CcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          637 PDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       637 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      +...........  ...........................+.+++.+||+.||++|||++|+++
T Consensus       221 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         221 PAEQMKLFYSNP--RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             CHHHHHhhhccc--hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            111001000000  000000000000000000111234567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.6e-38  Score=336.49  Aligned_cols=242  Identities=20%  Similarity=0.230  Sum_probs=190.6

Q ss_pred             hhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEEEe
Q 037916          406 CWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYE  482 (741)
Q Consensus       406 ~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv~e  482 (741)
                      +.||+|+||.||+|++..+++.||+|+++...   ......+.+|+.++++++||||++++++     +......|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~-----~~~~~~~~lv~e   75 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYS-----FQTHDRLCFVME   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEE-----EEcCCEEEEEEe
Confidence            36899999999999999999999999997432   2233456789999999999999999998     455668999999


Q ss_pred             cccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecccc
Q 037916          483 FMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLA  562 (741)
Q Consensus       483 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~a  562 (741)
                      |+++++|.+++...          ..+++..+..++.||+.||+|||+.   ||+||||||+||+++.++.+||+|||++
T Consensus        76 ~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a  142 (323)
T cd05571          76 YANGGELFFHLSRE----------RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLC  142 (323)
T ss_pred             CCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCC
Confidence            99999999988643          4578889999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcchhH
Q 037916          563 KLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMD  642 (741)
Q Consensus       563 ~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  642 (741)
                      +.......  ......||+.|+|| |+..+..++.++||||+||++|||++|+.||.....     .........     
T Consensus       143 ~~~~~~~~--~~~~~~gt~~y~aP-E~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-----~~~~~~~~~-----  209 (323)
T cd05571         143 KEGISDGA--TMKTFCGTPEYLAP-EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELILM-----  209 (323)
T ss_pred             cccccCCC--cccceecCccccCh-hhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH-----HHHHHHHHc-----
Confidence            75432211  12235689999999 555677889999999999999999999999862111     001000000     


Q ss_pred             hhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCC-----CHHHHHH
Q 037916          643 IVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRM-----NMTIVVH  701 (741)
Q Consensus       643 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  701 (741)
                             ...                ..+......+.+++.+||+.||++||     ++.|+++
T Consensus       210 -------~~~----------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         210 -------EEI----------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             -------CCC----------------CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence                   000                00112345678999999999999999     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=3.6e-38  Score=340.11  Aligned_cols=268  Identities=21%  Similarity=0.277  Sum_probs=199.7

Q ss_pred             HHHHHHhhhcccCceeeEEEEEE-----cCCCeEEEEEEeeccC-cCcchhHHHHHHHHHhc-CCCceeeEeeeecCccc
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGIL-----DEGKTIIAVKVLNLLH-HGASKSSIAECSALRNI-RHKNLVKILTVCSGVDY  471 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~  471 (741)
                      ..+|++.+.||+|+||.||+|++     ..++..||+|+++... ....+.+.+|+.+++.+ +||||++++++|     
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~-----  108 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC-----  108 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee-----
Confidence            45688999999999999999974     3456789999987432 22345678899999999 899999999995     


Q ss_pred             cCCceEEEEEecccCCChhhhccCCCCCCcc-------------------------------------------------
Q 037916          472 KGDDFKALVYEFMHNGSLEEWLHPVSGADKT-------------------------------------------------  502 (741)
Q Consensus       472 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~-------------------------------------------------  502 (741)
                      ......++||||+++|+|.+++...+.....                                                 
T Consensus       109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  188 (375)
T cd05104         109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS  188 (375)
T ss_pred             ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence            4455789999999999999998643210000                                                 


Q ss_pred             ----------------cCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecccccccC
Q 037916          503 ----------------VEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP  566 (741)
Q Consensus       503 ----------------~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~a~~~~  566 (741)
                                      ......+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||++....
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~  265 (375)
T cd05104         189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIR  265 (375)
T ss_pred             cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceecc
Confidence                            00113578889999999999999999999   99999999999999999999999999998665


Q ss_pred             CCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcCCcchhHhhh
Q 037916          567 PAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVLPDHVMDIVD  645 (741)
Q Consensus       567 ~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  645 (741)
                      ............++..|+||| ...+..++.++|||||||++|||++ |..||...... ......            +.
T Consensus       266 ~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-~~~~~~------------~~  331 (375)
T cd05104         266 NDSNYVVKGNARLPVKWMAPE-SIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-SKFYKM------------IK  331 (375)
T ss_pred             CcccccccCCCCCCcceeChh-HhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-HHHHHH------------HH
Confidence            433222222233567799995 5566788999999999999999998 88887632111 011111            11


Q ss_pred             hcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHH
Q 037916          646 STLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSI  706 (741)
Q Consensus       646 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  706 (741)
                      ......                  .+...+..+.+++.+||+.||++|||+.||++.|++.
T Consensus       332 ~~~~~~------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         332 EGYRML------------------SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             hCccCC------------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            000000                  0011245688999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=5.2e-38  Score=336.91  Aligned_cols=252  Identities=23%  Similarity=0.337  Sum_probs=192.9

Q ss_pred             HHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc-CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCce
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      .+..|+++++||+|+||.||+|++..+++.||+|++..... ...+.+.+|+.+++.++|+||++++++     +.....
T Consensus        72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~-----~~~~~~  146 (353)
T PLN00034         72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDM-----FDHNGE  146 (353)
T ss_pred             CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeE-----eccCCe
Confidence            34678899999999999999999998999999999864322 224567899999999999999999998     455668


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .++||||+++++|....              ...+..+..++.||+.||+|||+.   +|+||||||+||++++++.+||
T Consensus       147 ~~lv~e~~~~~~L~~~~--------------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL  209 (353)
T PLN00034        147 IQVLLEFMDGGSLEGTH--------------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKI  209 (353)
T ss_pred             EEEEEecCCCCcccccc--------------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEE
Confidence            99999999999986542              234567788999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccccccCccccc----CCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhh
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG----LGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFA  632 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~----~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~  632 (741)
                      +|||++........  ......||..|+|||.+.    .+...+.++|||||||++|||++|+.||.....  ..+....
T Consensus       210 ~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~--~~~~~~~  285 (353)
T PLN00034        210 ADFGVSRILAQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ--GDWASLM  285 (353)
T ss_pred             cccccceecccccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--ccHHHHH
Confidence            99999986543221  112346899999997542    233456799999999999999999999862111  1111111


Q ss_pred             hhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          633 RTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       633 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      .....            ...               ......+...+.+++.+||+.||++|||+.|+++.
T Consensus       286 ~~~~~------------~~~---------------~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        286 CAICM------------SQP---------------PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             HHHhc------------cCC---------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00000            000               00011334568899999999999999999999874

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=359.39  Aligned_cols=271  Identities=24%  Similarity=0.376  Sum_probs=215.8

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCC-----eEEEEEEeecc-CcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccC
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGK-----TIIAVKVLNLL-HHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKG  473 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  473 (741)
                      ...++...||+|+||.||.|....-.     ..||+|.++.. +.+...+|.+|..+|+.++|||||+++|+|.+     
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~-----  766 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD-----  766 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC-----
Confidence            34556677999999999999985322     34899988743 34556789999999999999999999999843     


Q ss_pred             CceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCc
Q 037916          474 DDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMT  553 (741)
Q Consensus       474 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~  553 (741)
                      ....+|++|||++|+|..|+++.+.....   ...++....+.++.|||+|+.||+++   ++|||||...|+|++....
T Consensus       767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~---~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~  840 (1025)
T KOG1095|consen  767 SGPPLILLEYMEGGDLLSFLRESRPAPFQ---PSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRV  840 (1025)
T ss_pred             CCCcEEEehhcccCcHHHHHHhcccccCC---CCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCc
Confidence            44789999999999999999876544333   46688999999999999999999999   9999999999999999999


Q ss_pred             eEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhh
Q 037916          554 AHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFA  632 (741)
Q Consensus       554 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~  632 (741)
                      |||+|||+|+.+.....+.......-...|||| |.+..+.++.|+|||||||++||++| |..||.....  .++..  
T Consensus       841 VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~P-Esl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n--~~v~~--  915 (1025)
T KOG1095|consen  841 VKIADFGLARDIYDKDYYRKHGEAMLPVKWMPP-ESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN--FEVLL--  915 (1025)
T ss_pred             EEEcccchhHhhhhchheeccCccccceecCCH-HHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch--HHHHH--
Confidence            999999999966655544433222335689999 55566899999999999999999999 8888762211  11100  


Q ss_pred             hhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHhhcC
Q 037916          633 RTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSILLG  712 (741)
Q Consensus       633 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~  712 (741)
                       .                           ...+.+.+.+..|++.++++|..||+.+|++||++..+++.+..+.+...+
T Consensus       916 -~---------------------------~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~  967 (1025)
T KOG1095|consen  916 -D---------------------------VLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG  967 (1025)
T ss_pred             -H---------------------------HHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence             0                           011113444568899999999999999999999999999999999986654


Q ss_pred             Cc
Q 037916          713 PK  714 (741)
Q Consensus       713 ~~  714 (741)
                      ..
T Consensus       968 ~~  969 (1025)
T KOG1095|consen  968 TI  969 (1025)
T ss_pred             Cc
Confidence            43

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-38  Score=331.70  Aligned_cols=245  Identities=21%  Similarity=0.255  Sum_probs=194.2

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      .|++.+.||+|+||.||+|.+..+++.||+|+++...   ....+.+.+|+.++++++||||++++++     +.+....
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~-----~~~~~~~   76 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWT-----EHDQRFL   76 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhh-----hccCCeE
Confidence            4788999999999999999999899999999986422   1234567789999999999999999988     4556789


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      |+||||+++|+|.+++...          ..+++..+..++.|++.||+|||+.   ||+||||||+||+++.++.+||+
T Consensus        77 ~lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~  143 (291)
T cd05612          77 YMLMEYVPGGELFSYLRNS----------GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLT  143 (291)
T ss_pred             EEEEeCCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEE
Confidence            9999999999999998643          4578888899999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCC
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      |||++.......     ....||+.|+||| +..+..++.++||||+||++|+|++|+.||.....     ......   
T Consensus       144 Dfg~~~~~~~~~-----~~~~gt~~y~aPE-~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~-----~~~~~~---  209 (291)
T cd05612         144 DFGFAKKLRDRT-----WTLCGTPEYLAPE-VIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP-----FGIYEK---  209 (291)
T ss_pred             ecCcchhccCCc-----ccccCChhhcCHH-HHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHH---
Confidence            999998654321     1245899999995 55667789999999999999999999999863211     000100   


Q ss_pred             cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCC-----HHHHHHH
Q 037916          638 DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMN-----MTIVVHE  702 (741)
Q Consensus       638 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  702 (741)
                           +.....                    ..+......+.+++.+||+.||.+||+     ++|+++.
T Consensus       210 -----i~~~~~--------------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         210 -----ILAGKL--------------------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             -----HHhCCc--------------------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence                 000000                    000122345789999999999999995     7777644

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.1e-38  Score=299.91  Aligned_cols=263  Identities=23%  Similarity=0.323  Sum_probs=208.7

Q ss_pred             HHHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCc--------chhHHHHHHHHHhc-CCCceeeEeeeec
Q 037916          397 LLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGA--------SKSSIAECSALRNI-RHKNLVKILTVCS  467 (741)
Q Consensus       397 ~~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l-~hpnIv~~~~~~~  467 (741)
                      -++..|..-+.+|.|..+.|.++.++.+|..+|+|++.......        .+.-..|+.+|+++ .||+|+++.++  
T Consensus        14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~--   91 (411)
T KOG0599|consen   14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV--   91 (411)
T ss_pred             hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee--
Confidence            35667888999999999999999999999999999996322111        23346799999998 79999999999  


Q ss_pred             CccccCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeE
Q 037916          468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVL  547 (741)
Q Consensus       468 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIl  547 (741)
                         ++...+.++|+|.|+.|.|.+++...          ..+++...++|++|+.+|++|||.+   .||||||||+|||
T Consensus        92 ---yes~sF~FlVFdl~prGELFDyLts~----------VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENIL  155 (411)
T KOG0599|consen   92 ---YESDAFVFLVFDLMPRGELFDYLTSK----------VTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENIL  155 (411)
T ss_pred             ---ccCcchhhhhhhhcccchHHHHhhhh----------eeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhhee
Confidence               67777999999999999999999643          6689999999999999999999999   9999999999999


Q ss_pred             eCCCCceEEeecccccccCCCCcccccccccccccccCccccc-----CCCCCCCccCchhHHHHHHHHHcCCCCCCccc
Q 037916          548 LDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG-----LGSEVSINGDVYSYGILLLELMTRKRPSDIMF  622 (741)
Q Consensus       548 l~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~-----~~~~~~~~~DIwSlG~il~elltg~~p~~~~~  622 (741)
                      ++++..+||+|||+|....++....   ..+|||+|.|||.+.     ....|+..+|+||+|++||.++.|.+||-.  
T Consensus       156 lddn~~i~isDFGFa~~l~~GekLr---elCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH--  230 (411)
T KOG0599|consen  156 LDDNMNIKISDFGFACQLEPGEKLR---ELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH--  230 (411)
T ss_pred             eccccceEEeccceeeccCCchhHH---HhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH--
Confidence            9999999999999999887765433   378999999997542     345689999999999999999999999851  


Q ss_pred             cCCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          623 EGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       623 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      ..++-+..++.    ++..++                       +-++..+......+++.+|++.||.+|.|++|+++-
T Consensus       231 RkQmlMLR~Im----eGkyqF-----------------------~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH  283 (411)
T KOG0599|consen  231 RKQMLMLRMIM----EGKYQF-----------------------RSPEWADISATVKDLISRLLQVDPTKRITAKEALAH  283 (411)
T ss_pred             HHHHHHHHHHH----hccccc-----------------------CCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence            11111111111    111111                       112233556678899999999999999999999864


Q ss_pred             --HHHHHHh
Q 037916          703 --LQSIKSI  709 (741)
Q Consensus       703 --L~~i~~~  709 (741)
                        +..+...
T Consensus       284 pff~q~~~~  292 (411)
T KOG0599|consen  284 PFFIQIAQQ  292 (411)
T ss_pred             hHHHHHHHh
Confidence              4444443

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-38  Score=330.71  Aligned_cols=240  Identities=25%  Similarity=0.312  Sum_probs=187.7

Q ss_pred             cccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEEEecc
Q 037916          408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFM  484 (741)
Q Consensus       408 ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv~e~~  484 (741)
                      ||+|+||.||+|++..+++.||+|+++...   ......+.+|+.++++++||||+++++++     ......|+||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~   75 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSF-----QSPEKLYLVLAFI   75 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEE-----ecCCeEEEEEcCC
Confidence            799999999999999899999999997422   23345677899999999999999999984     5566899999999


Q ss_pred             cCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecccccc
Q 037916          485 HNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKL  564 (741)
Q Consensus       485 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~a~~  564 (741)
                      ++|+|.+++...          ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        76 ~~g~L~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~  142 (312)
T cd05585          76 NGGELFHHLQRE----------GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKL  142 (312)
T ss_pred             CCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECccccc
Confidence            999999998643          4578889999999999999999999   999999999999999999999999999875


Q ss_pred             cCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcchhHhh
Q 037916          565 LPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIV  644 (741)
Q Consensus       565 ~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  644 (741)
                      ......  ......||+.|+||| +..+..++.++||||+||++|||++|+.||...     ............      
T Consensus       143 ~~~~~~--~~~~~~gt~~y~aPE-~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~-----~~~~~~~~~~~~------  208 (312)
T cd05585         143 NMKDDD--KTNTFCGTPEYLAPE-LLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE-----NVNEMYRKILQE------  208 (312)
T ss_pred             CccCCC--ccccccCCcccCCHH-HHcCCCCCCccceechhHHHHHHHhCCCCcCCC-----CHHHHHHHHHcC------
Confidence            432221  122356899999995 556677899999999999999999999998621     111111111000      


Q ss_pred             hhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCC---HHHHHH
Q 037916          645 DSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMN---MTIVVH  701 (741)
Q Consensus       645 d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~  701 (741)
                        ..                    ..+......+.+++.+||+.||++||+   +.|++.
T Consensus       209 --~~--------------------~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         209 --PL--------------------RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             --CC--------------------CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence              00                    001123456789999999999999986   455543

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.4e-37  Score=323.36  Aligned_cols=266  Identities=24%  Similarity=0.400  Sum_probs=202.4

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCC-----eEEEEEEeeccCc-CcchhHHHHHHHHHhcCCCceeeEeeeecCcccc
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGK-----TIIAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKILTVCSGVDYK  472 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  472 (741)
                      +..|++.+.||+|+||.||+|.+...+     ..||+|.++.... .....+.+|+.++++++||||+++++++     .
T Consensus         4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-----~   78 (283)
T cd05048           4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVC-----T   78 (283)
T ss_pred             hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEE-----c
Confidence            457899999999999999999986544     6899999864322 2235678899999999999999999985     4


Q ss_pred             CCceEEEEEecccCCChhhhccCCCCCCcc------cCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCe
Q 037916          473 GDDFKALVYEFMHNGSLEEWLHPVSGADKT------VEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNV  546 (741)
Q Consensus       473 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~------~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NI  546 (741)
                      .....+++|||+++++|.+++.........      ......+++.+++.++.|++.||+|||+.   +++||||||+||
T Consensus        79 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Ni  155 (283)
T cd05048          79 KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNC  155 (283)
T ss_pred             CCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceE
Confidence            455789999999999999998643211100      01114578889999999999999999999   999999999999


Q ss_pred             EeCCCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCC
Q 037916          547 LLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGN  625 (741)
Q Consensus       547 ll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~  625 (741)
                      ++++++.+||+|||++................+++.|+|||. ..+..++.++|||||||++|||++ |..||...... 
T Consensus       156 l~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~-  233 (283)
T cd05048         156 LVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEA-ILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ-  233 (283)
T ss_pred             EEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHH-hccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH-
Confidence            999999999999999986544332222223446888999954 456678999999999999999998 99998632111 


Q ss_pred             cchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHH
Q 037916          626 MNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQS  705 (741)
Q Consensus       626 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  705 (741)
                          +..         ..+.....                  ...+..++..+.+++.+||+.||++|||++||++.|+.
T Consensus       234 ----~~~---------~~i~~~~~------------------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         234 ----EVI---------EMIRSRQL------------------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             ----HHH---------HHHHcCCc------------------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence                011         11100000                  00112456789999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=8.3e-38  Score=332.20  Aligned_cols=199  Identities=25%  Similarity=0.316  Sum_probs=170.2

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc-CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      ..|+++++||+|+||.||+|++..++..||+|+++.... .....+.+|++++++++||||+++++++     ..+...+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~   79 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDGEIS   79 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EECCEEE
Confidence            468899999999999999999999999999999875322 2345688999999999999999999985     4456899


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      +||||+++++|.+++...          ..+++..+..++.|++.||.|||+..  +|+||||||+||+++.++.+||+|
T Consensus        80 lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~D  147 (331)
T cd06649          80 ICMEHMDGGSLDQVLKEA----------KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCD  147 (331)
T ss_pred             EEeecCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEcc
Confidence            999999999999998643          34788889999999999999999852  699999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCc
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDI  620 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~  620 (741)
                      ||++........    ....|++.|+||| +..+..++.++||||+||++|||++|+.||..
T Consensus       148 fg~~~~~~~~~~----~~~~g~~~y~aPE-~~~~~~~~~~~DiwslG~il~el~tg~~p~~~  204 (331)
T cd06649         148 FGVSGQLIDSMA----NSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP  204 (331)
T ss_pred             Cccccccccccc----ccCCCCcCcCCHh-HhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            999876543221    2245899999994 55667799999999999999999999999863

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=3.3e-38  Score=334.79  Aligned_cols=245  Identities=22%  Similarity=0.209  Sum_probs=194.3

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCce
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      ..|++.+.||+|+||.||+|++..+++.||+|+++...   ....+.+.+|+.++++++||||+++++++     .++..
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~   92 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSF-----QDENR   92 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EcCCE
Confidence            56889999999999999999999999999999997432   22345678899999999999999999984     55668


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .|+||||+++|+|.+++...          ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||
T Consensus        93 ~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl  159 (329)
T PTZ00263         93 VYFLLEFVVGGELFTHLRKA----------GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKV  159 (329)
T ss_pred             EEEEEcCCCCChHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEE
Confidence            99999999999999998643          3577888889999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcC
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVL  636 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  636 (741)
                      +|||++.......     ....||+.|+||| +..+..++.++|||||||++|+|++|..||....    . ........
T Consensus       160 ~Dfg~~~~~~~~~-----~~~~gt~~y~aPE-~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~----~-~~~~~~i~  228 (329)
T PTZ00263        160 TDFGFAKKVPDRT-----FTLCGTPEYLAPE-VIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT----P-FRIYEKIL  228 (329)
T ss_pred             eeccCceEcCCCc-----ceecCChhhcCHH-HHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC----H-HHHHHHHh
Confidence            9999998664322     1246899999995 5566678999999999999999999999985211    0 00111000


Q ss_pred             CcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCC-----HHHHHH
Q 037916          637 PDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMN-----MTIVVH  701 (741)
Q Consensus       637 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  701 (741)
                      ..        ...  .                  +......+.+++.+||+.||++||+     +.|++.
T Consensus       229 ~~--------~~~--~------------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        229 AG--------RLK--F------------------PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             cC--------CcC--C------------------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            00        000  0                  0012345679999999999999997     577663

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=9e-38  Score=326.04  Aligned_cols=279  Identities=22%  Similarity=0.285  Sum_probs=194.8

Q ss_pred             HHHHhhhcccCceeeEEEEEEc-CCCeEEEEEEeeccCc--CcchhHHHHHHHHHhc---CCCceeeEeeeecCccccCC
Q 037916          401 SFLFLCWIDMGSFGSVYKGILD-EGKTIIAVKVLNLLHH--GASKSSIAECSALRNI---RHKNLVKILTVCSGVDYKGD  474 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~~~~~~~  474 (741)
                      .|++.+.||+|+||.||+|++. .++..||+|+++....  .......+|+.+++.+   +||||++++++|........
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            4888999999999999999985 3578899999874322  2234556777777665   69999999999754433455


Q ss_pred             ceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCce
Q 037916          475 DFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTA  554 (741)
Q Consensus       475 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~  554 (741)
                      ...++||||+. ++|.+++...        ....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus        82 ~~~~lv~e~~~-~~l~~~~~~~--------~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~  149 (290)
T cd07862          82 TKLTLVFEHVD-QDLTTYLDKV--------PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQI  149 (290)
T ss_pred             CcEEEEEccCC-CCHHHHHHhC--------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCE
Confidence            67899999995 6899888643        123478889999999999999999999   99999999999999999999


Q ss_pred             EEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhh
Q 037916          555 HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       555 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  634 (741)
                      ||+|||.+.......   ......||+.|+||| ...+..++.++||||+||++|||++|+.||...... ..+......
T Consensus       150 kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE-~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~-~~~~~i~~~  224 (290)
T cd07862         150 KLADFGLARIYSFQM---ALTSVVVTLWYRAPE-VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDV  224 (290)
T ss_pred             EEccccceEeccCCc---ccccccccccccChH-HHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH-HHHHHHHHH
Confidence            999999997654331   122345899999995 445667899999999999999999999998632211 111111111


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      .......++.........     ..................+.+.+++.+||+.||++|||+.|+++
T Consensus       225 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         225 IGLPGEEDWPRDVALPRQ-----AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hCCCChhhchhhhcccch-----hccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            000000000000000000     00000000000011234566789999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=7.4e-38  Score=331.27  Aligned_cols=242  Identities=20%  Similarity=0.227  Sum_probs=189.3

Q ss_pred             hhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEEEe
Q 037916          406 CWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYE  482 (741)
Q Consensus       406 ~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv~e  482 (741)
                      +.||+|+||.||+|++..++..||+|+++...   ......+.+|+.+++.++||||+++++++     ......|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~E   75 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDRLCFVME   75 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCEEEEEEe
Confidence            46899999999999999899999999997432   22334567899999999999999999984     45668999999


Q ss_pred             cccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecccc
Q 037916          483 FMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLA  562 (741)
Q Consensus       483 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~a  562 (741)
                      |+++|+|..++...          ..+++..++.++.|++.||+|||+.   ||+||||||+||+++.++.+||+|||++
T Consensus        76 ~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~  142 (323)
T cd05595          76 YANGGELFFHLSRE----------RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLC  142 (323)
T ss_pred             CCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHh
Confidence            99999999888533          4578899999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcchhH
Q 037916          563 KLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMD  642 (741)
Q Consensus       563 ~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  642 (741)
                      ........  ......||+.|+||| +..+..++.++||||+||++|||++|+.||......     .........    
T Consensus       143 ~~~~~~~~--~~~~~~gt~~y~aPE-~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-----~~~~~~~~~----  210 (323)
T cd05595         143 KEGISDGA--TMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----RLFELILME----  210 (323)
T ss_pred             ccccCCCC--ccccccCCcCcCCcc-cccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-----HHHHHHhcC----
Confidence            75332211  112245899999995 556678899999999999999999999998622110     000000000    


Q ss_pred             hhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCC-----CHHHHHH
Q 037916          643 IVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRM-----NMTIVVH  701 (741)
Q Consensus       643 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  701 (741)
                              ...                .+....+.+.+++.+||+.||++||     ++.++++
T Consensus       211 --------~~~----------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         211 --------EIR----------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             --------CCC----------------CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence                    000                0012345677999999999999998     7888775

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.4e-37  Score=328.80  Aligned_cols=271  Identities=21%  Similarity=0.255  Sum_probs=202.2

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEc-----CCCeEEEEEEeeccC-cCcchhHHHHHHHHHhc-CCCceeeEeeeecCccc
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILD-----EGKTIIAVKVLNLLH-HGASKSSIAECSALRNI-RHKNLVKILTVCSGVDY  471 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~  471 (741)
                      ..+|++.+.||+|+||.||+|.+.     .+++.||+|+++... ....+.+..|+.+++++ +||||++++++|.    
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~----   81 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT----   81 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe----
Confidence            468999999999999999999753     245789999986322 22234567899999999 8999999999873    


Q ss_pred             cCCceEEEEEecccCCChhhhccCCCCCCc--------------------------------------------------
Q 037916          472 KGDDFKALVYEFMHNGSLEEWLHPVSGADK--------------------------------------------------  501 (741)
Q Consensus       472 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~--------------------------------------------------  501 (741)
                      ..+...+++|||+++++|.+++........                                                  
T Consensus        82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (337)
T cd05054          82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE  161 (337)
T ss_pred             cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence            345578999999999999998854221000                                                  


Q ss_pred             -ccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecccccccCCCCccccccccccc
Q 037916          502 -TVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGT  580 (741)
Q Consensus       502 -~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt  580 (741)
                       .......+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||++................++
T Consensus       162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~  238 (337)
T cd05054         162 GDELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP  238 (337)
T ss_pred             hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence             000013578999999999999999999999   9999999999999999999999999999876443322222224467


Q ss_pred             ccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhh
Q 037916          581 IGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITS  659 (741)
Q Consensus       581 ~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~  659 (741)
                      ..|+|| |+..+..++.++||||+||++|||++ |..||...... ..+......            .....        
T Consensus       239 ~~y~aP-E~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~-~~~~~~~~~------------~~~~~--------  296 (337)
T cd05054         239 LKWMAP-ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID-EEFCRRLKE------------GTRMR--------  296 (337)
T ss_pred             ccccCc-HHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc-HHHHHHHhc------------cCCCC--------
Confidence            789999 44566789999999999999999998 99998632111 001000000            00000        


Q ss_pred             hhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHH
Q 037916          660 NQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKS  708 (741)
Q Consensus       660 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  708 (741)
                                .+......+.+++.+||+.+|++||++.|+++.|+++.+
T Consensus       297 ----------~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         297 ----------APEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             ----------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                      011234568899999999999999999999999998775

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-38  Score=333.41  Aligned_cols=259  Identities=24%  Similarity=0.359  Sum_probs=201.5

Q ss_pred             HHhhhcccCceeeEEEEEEcCCCe---E-EEEEEeec---cCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          403 LFLCWIDMGSFGSVYKGILDEGKT---I-IAVKVLNL---LHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       403 ~~~~~ig~G~~g~V~~a~~~~~~~---~-vavK~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      .+.++||+|+||.||+|+.+..+.   . ||+|..+.   .......++.+|+++|++++|||||++||++.     ...
T Consensus       160 ~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~-----~~~  234 (474)
T KOG0194|consen  160 ELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV-----LEE  234 (474)
T ss_pred             cccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc-----CCC
Confidence            345899999999999999864322   3 89999874   22445678899999999999999999999964     344


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      .+++|||+|.||+|.++++..         ...++..+...++.+.++||+|||++   +++||||-.+|+|++.++.+|
T Consensus       235 Pl~ivmEl~~gGsL~~~L~k~---------~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vK  302 (474)
T KOG0194|consen  235 PLMLVMELCNGGSLDDYLKKN---------KKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVK  302 (474)
T ss_pred             ccEEEEEecCCCcHHHHHHhC---------CCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEE
Confidence            789999999999999999865         23588999999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhh
Q 037916          556 VADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  634 (741)
                      |+|||+++....-....  ....-...|+||| ......+++++|||||||++||+++ |..||......  .....+  
T Consensus       303 ISDFGLs~~~~~~~~~~--~~~klPirWLAPE-tl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--~v~~kI--  375 (474)
T KOG0194|consen  303 ISDFGLSRAGSQYVMKK--FLKKLPIRWLAPE-TLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--EVKAKI--  375 (474)
T ss_pred             eCccccccCCcceeecc--ccccCcceecChh-hhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--HHHHHH--
Confidence            99999987654211111  1122457899995 4555699999999999999999999 78897633111  111111  


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHhhcC
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSILLG  712 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~  712 (741)
                       ...                          ..+...+...+..+..++.+||..||++||||.++.+.++.+.....+
T Consensus       376 -~~~--------------------------~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  376 -VKN--------------------------GYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             -Hhc--------------------------CccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence             000                          001111224466788889999999999999999999999999987664

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=9.8e-38  Score=330.92  Aligned_cols=243  Identities=20%  Similarity=0.253  Sum_probs=190.7

Q ss_pred             hhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEEEe
Q 037916          406 CWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYE  482 (741)
Q Consensus       406 ~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv~e  482 (741)
                      +.||+|+||.||+|.+..+++.||+|+++...   ......+.+|+.+++.++||||++++++     +......|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~-----~~~~~~~~lv~E   75 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYS-----FQTKDRLCFVME   75 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEE-----EEcCCEEEEEEe
Confidence            36899999999999999999999999997432   2234567789999999999999999988     455668999999


Q ss_pred             cccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecccc
Q 037916          483 FMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLA  562 (741)
Q Consensus       483 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~a  562 (741)
                      |+++|+|..++...          ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        76 y~~~g~L~~~l~~~----------~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~  142 (328)
T cd05593          76 YVNGGELFFHLSRE----------RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLC  142 (328)
T ss_pred             CCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCC
Confidence            99999999888533          4578899999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcchhH
Q 037916          563 KLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMD  642 (741)
Q Consensus       563 ~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  642 (741)
                      +.......  ......||+.|+||| +..+..++.++||||+||++|+|++|+.||.....     ..........    
T Consensus       143 ~~~~~~~~--~~~~~~gt~~y~aPE-~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~-----~~~~~~~~~~----  210 (328)
T cd05593         143 KEGITDAA--TMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELILME----  210 (328)
T ss_pred             ccCCCccc--ccccccCCcCccChh-hhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH-----HHHHHHhccC----
Confidence            75432211  112346899999995 55667789999999999999999999999863211     1111110000    


Q ss_pred             hhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCC-----CHHHHHHH
Q 037916          643 IVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRM-----NMTIVVHE  702 (741)
Q Consensus       643 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  702 (741)
                              ...                .+......+.+++.+||+.||++||     ++.|+++.
T Consensus       211 --------~~~----------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         211 --------DIK----------------FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             --------Ccc----------------CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence                    000                0012345677999999999999997     88988753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-38  Score=334.46  Aligned_cols=253  Identities=19%  Similarity=0.258  Sum_probs=197.0

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      .|++.+.||+|+||.||+|++..+++.||+|+++...   ......+.+|+.+++.++||||++++++     +..+...
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~-----~~~~~~~   76 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYA-----FQDDEYL   76 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEE-----EEcCCEE
Confidence            4788999999999999999999899999999997432   2234567789999999999999999998     4556689


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      |+||||+++++|.+++...          ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+
T Consensus        77 ~lv~e~~~g~~L~~~l~~~----------~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~  143 (333)
T cd05600          77 YLAMEYVPGGDFRTLLNNL----------GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLT  143 (333)
T ss_pred             EEEEeCCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEE
Confidence            9999999999999998643          4578889999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCC
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      |||++.....     ......||+.|+||| +..+..++.++||||+||++|||++|..||......+ .+... ... .
T Consensus       144 Dfg~a~~~~~-----~~~~~~gt~~y~aPE-~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~i-~~~-~  214 (333)
T cd05600         144 DFGLSKGIVT-----YANSVVGSPDYMAPE-VLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE-TWENL-KYW-K  214 (333)
T ss_pred             eCcCCccccc-----ccCCcccCccccChh-HhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH-HHHHH-Hhc-c
Confidence            9999976543     122346899999995 5556689999999999999999999999986321100 00000 000 0


Q ss_pred             cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          638 DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       638 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      .    .+..   ....               .........+.+++.+||..+|++|||+.|+++.
T Consensus       215 ~----~~~~---~~~~---------------~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         215 E----TLQR---PVYD---------------DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             c----cccC---CCCC---------------ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            0    0000   0000               0001234567899999999999999999999865

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.5e-37  Score=328.29  Aligned_cols=261  Identities=24%  Similarity=0.339  Sum_probs=200.2

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCe----EEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCC
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKT----IIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGD  474 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~  474 (741)
                      ..|++.+.||+|+||.||+|.+..++.    .||+|+++... ....+++..|+.+++.++||||++++++|..      
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~------   80 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------   80 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC------
Confidence            468999999999999999999865554    48999986432 2334677889999999999999999999742      


Q ss_pred             ceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCce
Q 037916          475 DFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTA  554 (741)
Q Consensus       475 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~  554 (741)
                      ...++++||+++|+|.+++...         ...+++..++.++.||+.||+|||+.   +|+||||||+||+++.++.+
T Consensus        81 ~~~~~v~e~~~~g~l~~~l~~~---------~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~  148 (316)
T cd05108          81 STVQLITQLMPFGCLLDYVREH---------KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHV  148 (316)
T ss_pred             CCceeeeecCCCCCHHHHHHhc---------cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcE
Confidence            2467999999999999998643         23477888899999999999999999   99999999999999999999


Q ss_pred             EEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhh
Q 037916          555 HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFAR  633 (741)
Q Consensus       555 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~  633 (741)
                      ||+|||.++...............++..|+||| +..+..++.++|||||||++||+++ |..||+....  ..+.....
T Consensus       149 kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE-~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~--~~~~~~~~  225 (316)
T cd05108         149 KITDFGLAKLLGADEKEYHAEGGKVPIKWMALE-SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILE  225 (316)
T ss_pred             EEccccccccccCCCcceeccCCccceeecChH-HhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHh
Confidence            999999998765433222222233467899995 5566788999999999999999998 9999863211  01111110


Q ss_pred             hcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHhhc
Q 037916          634 TVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSILL  711 (741)
Q Consensus       634 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~  711 (741)
                      .            ....                  ..+..+...+.+++.+||+.||++|||+.|++..+..+.+...
T Consensus       226 ~------------~~~~------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~  273 (316)
T cd05108         226 K------------GERL------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ  273 (316)
T ss_pred             C------------CCCC------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCc
Confidence            0            0000                  0001234567899999999999999999999999988876443

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-38  Score=295.12  Aligned_cols=248  Identities=22%  Similarity=0.272  Sum_probs=202.7

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCce
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      .+|++.+.||+|.||.||.|+.+.++-.||+|++-+..   .....++.+|+++-+.|+||||.++|++     +-+...
T Consensus        22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~-----fhd~~r   96 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGY-----FHDSKR   96 (281)
T ss_pred             hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhh-----eeccce
Confidence            56899999999999999999999999999999986432   2345678899999999999999999999     456669


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      +|+++||..+|++...+...+        ...+++.....++.|+|.|+.|+|.+   +|+||||||+|+|++..+.+||
T Consensus        97 iyLilEya~~gel~k~L~~~~--------~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lki  165 (281)
T KOG0580|consen   97 IYLILEYAPRGELYKDLQEGR--------MKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKI  165 (281)
T ss_pred             eEEEEEecCCchHHHHHHhcc--------cccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeec
Confidence            999999999999999887432        24577778889999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcC
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVL  636 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  636 (741)
                      +|||.+...+...    ....+||..|.+| |...+..++.++|+|++|+..||++.|.+||+... .+..+....... 
T Consensus       166 AdfGwsV~~p~~k----R~tlcgt~dyl~p-Emv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k~~-  238 (281)
T KOG0580|consen  166 ADFGWSVHAPSNK----RKTLCGTLDYLPP-EMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRKVD-  238 (281)
T ss_pred             cCCCceeecCCCC----ceeeecccccCCH-hhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHHcc-
Confidence            9999987654322    2236799999999 66678889999999999999999999999998443 111222111110 


Q ss_pred             CcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          637 PDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       637 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                                                     ...+........++|.+|+..+|.+|.+..|+++
T Consensus       239 -------------------------------~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  239 -------------------------------LKFPSTISGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             -------------------------------ccCCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence                                           1111244566779999999999999999999875

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.2e-37  Score=320.67  Aligned_cols=256  Identities=21%  Similarity=0.287  Sum_probs=197.2

Q ss_pred             HHHHHhhhcccCceeeEEEEEEc---CCCeEEEEEEeeccCc-CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILD---EGKTIIAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~---~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      ..|++.+.||+|+||.||+|.+.   ..+..||+|.++.... .....+.+|+.++++++||||+++++++     ..+.
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~   79 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVI-----TRGN   79 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEE-----ecCC
Confidence            46888999999999999999874   4567899999874322 2345678999999999999999999985     4456


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..++||||+++|+|.+++...         ...+++.+++.++.|++.||+|||+.   +++||||||+||+++.++.+|
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~---------~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~  147 (266)
T cd05064          80 TMMIVTEYMSNGALDSFLRKH---------EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCK  147 (266)
T ss_pred             CcEEEEEeCCCCcHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEE
Confidence            899999999999999998642         13578899999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhh
Q 037916          556 VADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  634 (741)
                      ++|||.+.......... .....++..|+||| ...+..++.++|||||||++||+++ |..||......  ....... 
T Consensus       148 l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~-  222 (266)
T cd05064         148 ISGFRRLQEDKSEAIYT-TMSGKSPVLWAAPE-AIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--DVIKAVE-  222 (266)
T ss_pred             ECCCcccccccccchhc-ccCCCCceeecCHH-HHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHH-
Confidence            99999876543222111 11223567899995 5566788999999999999999775 99998632111  0000000 


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHH
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSI  706 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  706 (741)
                                +...                   ...+..++..+.+++.+||+.+|++|||+.|+.+.|+.+
T Consensus       223 ----------~~~~-------------------~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         223 ----------DGFR-------------------LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             ----------CCCC-------------------CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                      0000                   001123456788999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.5e-37  Score=336.11  Aligned_cols=268  Identities=22%  Similarity=0.306  Sum_probs=200.2

Q ss_pred             HHHHhhhcccCceeeEEEEEEcC-----CCeEEEEEEeeccCc-CcchhHHHHHHHHHhcC-CCceeeEeeeecCccccC
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDE-----GKTIIAVKVLNLLHH-GASKSSIAECSALRNIR-HKNLVKILTVCSGVDYKG  473 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~  473 (741)
                      .|++.++||+|+||.||+|++..     .+..||+|+++.... ...+.+.+|+.+++++. ||||++++++|     ..
T Consensus        38 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~-----~~  112 (400)
T cd05105          38 GLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC-----TK  112 (400)
T ss_pred             ceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE-----cc
Confidence            57788999999999999998742     235799999964322 23456789999999996 99999999995     44


Q ss_pred             CceEEEEEecccCCChhhhccCCCCCCcc---------------------------------------------------
Q 037916          474 DDFKALVYEFMHNGSLEEWLHPVSGADKT---------------------------------------------------  502 (741)
Q Consensus       474 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~---------------------------------------------------  502 (741)
                      ....|+||||+++|+|.+++...+.....                                                   
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (400)
T cd05105         113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML  192 (400)
T ss_pred             CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence            55799999999999999988643210000                                                   


Q ss_pred             -----------------------------------cCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeE
Q 037916          503 -----------------------------------VEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVL  547 (741)
Q Consensus       503 -----------------------------------~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIl  547 (741)
                                                         ......+++..+..++.|+++||+|||+.   +|+||||||+||+
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nil  269 (400)
T cd05105         193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVL  269 (400)
T ss_pred             hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEE
Confidence                                               00113478888899999999999999999   9999999999999


Q ss_pred             eCCCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCc
Q 037916          548 LDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNM  626 (741)
Q Consensus       548 l~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~  626 (741)
                      ++.++.+||+|||++................++..|+||| ...+..++.++|||||||++|||++ |..||........
T Consensus       270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~  348 (400)
T cd05105         270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPE-SIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST  348 (400)
T ss_pred             EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChh-hhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH
Confidence            9999999999999998664433222222344678899995 4456778999999999999999997 8999863211110


Q ss_pred             chhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHH
Q 037916          627 NLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSI  706 (741)
Q Consensus       627 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  706 (741)
                      ..             ..+.....                  ......++..+.+++.+||+.||++|||+.+|.+.|+++
T Consensus       349 ~~-------------~~~~~~~~------------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l  397 (400)
T cd05105         349 FY-------------NKIKSGYR------------------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL  397 (400)
T ss_pred             HH-------------HHHhcCCC------------------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence            00             00000000                  000123456788999999999999999999999999876


Q ss_pred             HH
Q 037916          707 KS  708 (741)
Q Consensus       707 ~~  708 (741)
                      .+
T Consensus       398 ~~  399 (400)
T cd05105         398 LP  399 (400)
T ss_pred             cC
Confidence            53

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.9e-37  Score=321.74  Aligned_cols=269  Identities=23%  Similarity=0.372  Sum_probs=204.4

Q ss_pred             HHHHHhhhcccCceeeEEEEEE-----cCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCC
Q 037916          400 VSFLFLCWIDMGSFGSVYKGIL-----DEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGD  474 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~-----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~  474 (741)
                      ..|.+.+.||+|+||.||++..     ..++..||+|.++.......+.+.+|+.++++++||||+++++++     ...
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~   79 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVC-----VEG   79 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecC
Confidence            4678899999999999999985     235677999998754444456788999999999999999999995     345


Q ss_pred             ceEEEEEecccCCChhhhccCCCCCCcc---cCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCC
Q 037916          475 DFKALVYEFMHNGSLEEWLHPVSGADKT---VEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHE  551 (741)
Q Consensus       475 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~  551 (741)
                      ...++||||+++++|.+++.........   ......+++.+++.++.|++.||+|||+.   |++||||||+||+++++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~  156 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN  156 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccC
Confidence            6889999999999999998643211110   01123589999999999999999999999   99999999999999999


Q ss_pred             CceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhh
Q 037916          552 MTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHN  630 (741)
Q Consensus       552 ~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~  630 (741)
                      +.+||+|||.+................++..|+|| |...+..++.++|||||||++|+|++ |..||.......     
T Consensus       157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-----  230 (288)
T cd05093         157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPP-ESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-----  230 (288)
T ss_pred             CcEEeccCCccccccCCceeecCCCCCccccccCH-HHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----
Confidence            99999999999866443222222223357789999 55566788999999999999999998 899875321110     


Q ss_pred             hhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHh
Q 037916          631 FARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSI  709 (741)
Q Consensus       631 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  709 (741)
                      .........        ...                   ....++..+.+++.+||+.||.+|||+.||.+.|+++.+.
T Consensus       231 ~~~~i~~~~--------~~~-------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         231 VIECITQGR--------VLQ-------------------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             HHHHHHcCC--------cCC-------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            000000000        000                   0012345688999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.7e-37  Score=321.58  Aligned_cols=267  Identities=20%  Similarity=0.325  Sum_probs=198.9

Q ss_pred             HHHHHHHhhhcccCceeeEEEEEEc-----CCCeEEEEEEeeccCc-CcchhHHHHHHHHHhcCCCceeeEeeeecCccc
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGILD-----EGKTIIAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKILTVCSGVDY  471 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  471 (741)
                      ...+|++.+.||+|+||.||+|.+.     .++..||+|+++.... .....+.+|+.+++.++||||+++++++     
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----   78 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV-----   78 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----
Confidence            3467999999999999999999874     2456799998863221 2234577899999999999999999985     


Q ss_pred             cCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCC
Q 037916          472 KGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHE  551 (741)
Q Consensus       472 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~  551 (741)
                      ..+...++||||+++++|.+++...+...........+++..+..++.|++.||+|||+.   +++||||||+||+++++
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~  155 (277)
T cd05062          79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED  155 (277)
T ss_pred             cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCC
Confidence            445578999999999999999864322111111123467888999999999999999999   99999999999999999


Q ss_pred             CceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhh
Q 037916          552 MTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHN  630 (741)
Q Consensus       552 ~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~  630 (741)
                      +.+||+|||.+................+++.|+||| +..+..++.++|||||||++|||++ |..||.....     ..
T Consensus       156 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~-----~~  229 (277)
T cd05062         156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE-SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-----EQ  229 (277)
T ss_pred             CCEEECCCCCccccCCcceeecCCCCccCHhhcChh-HhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HH
Confidence            999999999987654433222222234577899995 4556778999999999999999999 6888752211     11


Q ss_pred             hhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHH
Q 037916          631 FARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQS  705 (741)
Q Consensus       631 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  705 (741)
                      ....        ..+.... .                  ....++..+.+++.+||+.||++|||+.|+++.|++
T Consensus       230 ~~~~--------~~~~~~~-~------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         230 VLRF--------VMEGGLL-D------------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             HHHH--------HHcCCcC-C------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            1110        0000000 0                  001234568899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=3.3e-37  Score=320.06  Aligned_cols=265  Identities=25%  Similarity=0.379  Sum_probs=201.5

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcC-----CCeEEEEEEeeccCcC-cchhHHHHHHHHHhcCCCceeeEeeeecCcccc
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDE-----GKTIIAVKVLNLLHHG-ASKSSIAECSALRNIRHKNLVKILTVCSGVDYK  472 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  472 (741)
                      ...|.+.+.||+|+||.||+|.+..     ++..||+|.++..... ..+.+.+|+.+++.++||||+++++++     .
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~   78 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVC-----T   78 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEE-----e
Confidence            3568999999999999999998743     3678999998754333 346788999999999999999999995     4


Q ss_pred             CCceEEEEEecccCCChhhhccCCCCCCcc----cCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEe
Q 037916          473 GDDFKALVYEFMHNGSLEEWLHPVSGADKT----VEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLL  548 (741)
Q Consensus       473 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~----~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll  548 (741)
                      .....++||||+++++|.+++.........    ......+++.++..++.|++.|+.|||+.   +++||||||+||++
T Consensus        79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili  155 (280)
T cd05049          79 EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLV  155 (280)
T ss_pred             cCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEE
Confidence            456899999999999999998754211100    12234578889999999999999999999   99999999999999


Q ss_pred             CCCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcc
Q 037916          549 DHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMN  627 (741)
Q Consensus       549 ~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~  627 (741)
                      +.++.+||+|||.+................+++.|+||| +..+..++.++||||+||++|||++ |..||......  .
T Consensus       156 ~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~--~  232 (280)
T cd05049         156 GYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPE-SIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE--E  232 (280)
T ss_pred             cCCCeEEECCcccceecccCcceecCCCCcccceecChh-hhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH--H
Confidence            999999999999987654332222222234578899995 5566779999999999999999998 99998522111  0


Q ss_pred             hhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHH
Q 037916          628 LHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQ  704 (741)
Q Consensus       628 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  704 (741)
                      ......   ..        ....                   .....+..+.+++.+||+.||++|||+.||++.|+
T Consensus       233 ~~~~~~---~~--------~~~~-------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         233 VIECIT---QG--------RLLQ-------------------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             HHHHHH---cC--------CcCC-------------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            100000   00        0000                   00123466889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3e-37  Score=333.59  Aligned_cols=272  Identities=19%  Similarity=0.228  Sum_probs=194.6

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      ..|.++++||+|+||.||+|.+..+++.||+|...      ...+.+|+.++++++||||+++++++     ......++
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~l  160 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTF-----TYNKFTCL  160 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEE-----EECCeeEE
Confidence            46999999999999999999999999999999753      23567899999999999999999984     45568899


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      |||++ +++|..++...          ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus       161 v~e~~-~~~L~~~l~~~----------~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DF  226 (391)
T PHA03212        161 ILPRY-KTDLYCYLAAK----------RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDF  226 (391)
T ss_pred             EEecC-CCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeC
Confidence            99999 56888887533          3478889999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCcccc--CC----cchhhhhh
Q 037916          560 GLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFE--GN----MNLHNFAR  633 (741)
Q Consensus       560 g~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~--~~----~~~~~~~~  633 (741)
                      |+|........ .......||+.|+|| |+..+..++.++||||+||++|||++|..||.....  +.    ..+.....
T Consensus       227 G~a~~~~~~~~-~~~~~~~gt~~y~aP-E~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~  304 (391)
T PHA03212        227 GAACFPVDINA-NKYYGWAGTIATNAP-ELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIR  304 (391)
T ss_pred             Ccccccccccc-cccccccCccCCCCh-hhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHH
Confidence            99975432211 112235699999999 555667889999999999999999999988642211  10    11111111


Q ss_pred             hcC------CcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          634 TVL------PDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       634 ~~~------~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ...      +......++...............   ....+......+..+.+++.+||++||++|||++|+++
T Consensus       305 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        305 RSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPG---SRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             HhcCChhhcCcchhHHHHHHHHHHHhccCCCCC---CCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence            100      000000000000000000000000   00011112244667889999999999999999999985

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.2e-37  Score=318.96  Aligned_cols=257  Identities=19%  Similarity=0.227  Sum_probs=198.7

Q ss_pred             HHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceE
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      ....|++.+.||+|+||.||+|++..+++.||+|+++.........+.+|+.++++++||||+++++++     ..+...
T Consensus         7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~-----~~~~~~   81 (267)
T cd06646           7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY-----LSREKL   81 (267)
T ss_pred             chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEE-----EeCCEE
Confidence            345799999999999999999999889999999999754444455678899999999999999999985     445688


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      ++||||+++++|.+++...          ..+++.++..++.|++.||.|||+.   +|+||||||+||+++.++.+||+
T Consensus        82 ~iv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~  148 (267)
T cd06646          82 WICMEYCGGGSLQDIYHVT----------GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLA  148 (267)
T ss_pred             EEEEeCCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEC
Confidence            9999999999999988532          3578889999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccccccCccccc--CCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhc
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG--LGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV  635 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~--~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~  635 (741)
                      |||.+.........  .....|+..|+|||.+.  ....++.++||||+||++|||++|+.||......... ..+....
T Consensus       149 dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~-~~~~~~~  225 (267)
T cd06646         149 DFGVAAKITATIAK--RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-FLMSKSN  225 (267)
T ss_pred             cCccceeecccccc--cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh-eeeecCC
Confidence            99999866432211  12245788999996543  2445788999999999999999999998532111100 0000000


Q ss_pred             CCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          636 LPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       636 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      ...       +...                    .....+..+.+++.+||..||++|||++++++.
T Consensus       226 ~~~-------~~~~--------------------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  265 (267)
T cd06646         226 FQP-------PKLK--------------------DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH  265 (267)
T ss_pred             CCC-------CCCc--------------------cccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence            000       0000                    001223567899999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.3e-37  Score=345.95  Aligned_cols=253  Identities=19%  Similarity=0.214  Sum_probs=197.2

Q ss_pred             HHHhhhcccCceeeEEEEEEcCC-CeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEE
Q 037916          402 FLFLCWIDMGSFGSVYKGILDEG-KTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALV  480 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv  480 (741)
                      |.+.+.||+|+||.||+|....+ +..||+|.+..........+.+|+.+++.++|||||++++++     ..++..|+|
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~-----~~~~~~~lv  143 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDF-----KSDDKLLLI  143 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEE-----EECCEEEEE
Confidence            77889999999999999998777 788999987544444445677899999999999999999995     455689999


Q ss_pred             EecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecc
Q 037916          481 YEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFG  560 (741)
Q Consensus       481 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg  560 (741)
                      |||+++|+|.+++....      .....+++.++..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||
T Consensus       144 ~E~~~gg~L~~~l~~~~------~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFg  214 (478)
T PTZ00267        144 MEYGSGGDLNKQIKQRL------KEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFG  214 (478)
T ss_pred             EECCCCCCHHHHHHHHH------hccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCc
Confidence            99999999998875321      1124578889999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcch
Q 037916          561 LAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHV  640 (741)
Q Consensus       561 ~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  640 (741)
                      +++...............||+.|+|| |+..+..++.++||||+||++|||++|+.||.....     ..          
T Consensus       215 la~~~~~~~~~~~~~~~~gt~~y~aP-E~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-----~~----------  278 (478)
T PTZ00267        215 FSKQYSDSVSLDVASSFCGTPYYLAP-ELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-----RE----------  278 (478)
T ss_pred             CceecCCccccccccccCCCccccCH-hHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-----HH----------
Confidence            99876543322223335699999999 555667889999999999999999999999862211     11          


Q ss_pred             hHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          641 MDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       641 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                        ++.....+...               ..+..+...+.+++.+||..||++|||+.|++.
T Consensus       279 --~~~~~~~~~~~---------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        279 --IMQQVLYGKYD---------------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             --HHHHHHhCCCC---------------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence              11111111000               000123356789999999999999999999874

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.8e-37  Score=306.96  Aligned_cols=257  Identities=23%  Similarity=0.280  Sum_probs=204.5

Q ss_pred             HHHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccC
Q 037916          397 LLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKG  473 (741)
Q Consensus       397 ~~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  473 (741)
                      +-+..|+++++||.|.-|.||+|+.+.++..+|+|++.+..   .....+.+.|-+||+.++||.++.+|+.     ++.
T Consensus        74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~-----fet  148 (459)
T KOG0610|consen   74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYAS-----FET  148 (459)
T ss_pred             cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhe-----eec
Confidence            34567999999999999999999999999999999997433   3345567789999999999999999999     677


Q ss_pred             CceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCc
Q 037916          474 DDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMT  553 (741)
Q Consensus       474 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~  553 (741)
                      +.+.|+|||||+||+|..+.++.        ..+.+++..++.++.+++-||+|||-.   |||.|||||+||||.++|+
T Consensus       149 ~~~~cl~meyCpGGdL~~LrqkQ--------p~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGH  217 (459)
T KOG0610|consen  149 DKYSCLVMEYCPGGDLHSLRQKQ--------PGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGH  217 (459)
T ss_pred             cceeEEEEecCCCccHHHHHhhC--------CCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCc
Confidence            88999999999999999998754        347799999999999999999999999   9999999999999999999


Q ss_pred             eEEeecccccccCCC--------------------------------C-c---------------------ccccccccc
Q 037916          554 AHVADFGLAKLLPPA--------------------------------H-L---------------------QTSSIGVKG  579 (741)
Q Consensus       554 ~kL~DFg~a~~~~~~--------------------------------~-~---------------------~~~~~~~~g  579 (741)
                      +-|+||.++......                                . .                     .......+|
T Consensus       218 IMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVG  297 (459)
T KOG0610|consen  218 IMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVG  297 (459)
T ss_pred             EEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccc
Confidence            999999987544210                                0 0                     001123558


Q ss_pred             cccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhh
Q 037916          580 TIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITS  659 (741)
Q Consensus       580 t~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~  659 (741)
                      |-.|.|| |+..+...+.++|+|+|||++|||+.|..||...... ..+...+.+            .+.          
T Consensus       298 ThEYlAP-EvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~-~Tl~NIv~~------------~l~----------  353 (459)
T KOG0610|consen  298 THEYLAP-EVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNK-ETLRNIVGQ------------PLK----------  353 (459)
T ss_pred             ccccccc-eeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCch-hhHHHHhcC------------CCc----------
Confidence            9999999 6667888899999999999999999999998633221 111111111            110          


Q ss_pred             hhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCC----HHHHHH
Q 037916          660 NQRQRQARINNIMECLISVVRIGVACSMESPQDRMN----MTIVVH  701 (741)
Q Consensus       660 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~evl~  701 (741)
                              +...++....+.+||++.|..||.+|..    +.||.+
T Consensus       354 --------Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~  391 (459)
T KOG0610|consen  354 --------FPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR  391 (459)
T ss_pred             --------CCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence                    1111234566789999999999999998    777764

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=3.9e-37  Score=327.06  Aligned_cols=199  Identities=24%  Similarity=0.322  Sum_probs=169.4

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      ..|++.++||+|+||.||+|.+..++..||+|+++... ......+.+|++++++++||||++++++|     ......+
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~   79 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDGEIS   79 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEE-----EECCEEE
Confidence            57999999999999999999999899999999987432 22345678999999999999999999995     4456899


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      +||||+++++|.+++...          ..+++..+..++.|++.||.|||+..  +|+||||||+||+++.++.+||+|
T Consensus        80 lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~D  147 (333)
T cd06650          80 ICMEHMDGGSLDQVLKKA----------GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCD  147 (333)
T ss_pred             EEEecCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEee
Confidence            999999999999998643          34778888999999999999999742  799999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCc
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDI  620 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~  620 (741)
                      ||++.......    .....|+..|+||| +..+..++.++||||+||++|++++|+.||..
T Consensus       148 fg~~~~~~~~~----~~~~~~~~~y~aPE-~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~  204 (333)
T cd06650         148 FGVSGQLIDSM----ANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP  204 (333)
T ss_pred             CCcchhhhhhc----cccCCCCccccCHH-HhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            99987553321    12245899999995 55667789999999999999999999999863

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.6e-37  Score=330.16  Aligned_cols=247  Identities=22%  Similarity=0.251  Sum_probs=193.7

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCC-eEEEEEEeeccC---cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCC
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGK-TIIAVKVLNLLH---HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGD  474 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~-~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~  474 (741)
                      ...|.+.+.||+|+||.||+|.+..++ ..||+|++....   ....+.+.+|+.+++.++||||+++++++     .++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~  103 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF-----KDE  103 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE-----EeC
Confidence            457899999999999999999876544 789999986422   23345677899999999999999999994     456


Q ss_pred             ceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCce
Q 037916          475 DFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTA  554 (741)
Q Consensus       475 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~  554 (741)
                      ...|+||||+++|+|.+++...          ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+
T Consensus       104 ~~~~lv~Ey~~~g~L~~~i~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~i  170 (340)
T PTZ00426        104 SYLYLVLEFVIGGEFFTFLRRN----------KRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFI  170 (340)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCE
Confidence            6899999999999999998643          4578888999999999999999999   99999999999999999999


Q ss_pred             EEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhh
Q 037916          555 HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       555 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  634 (741)
                      ||+|||++.......     ....||+.|+||| +..+..++.++||||+||++|||++|..||.....    . .....
T Consensus       171 kL~DFG~a~~~~~~~-----~~~~gt~~y~aPE-~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~----~-~~~~~  239 (340)
T PTZ00426        171 KMTDFGFAKVVDTRT-----YTLCGTPEYIAPE-ILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP----L-LIYQK  239 (340)
T ss_pred             EEecCCCCeecCCCc-----ceecCChhhcCHH-HHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH----H-HHHHH
Confidence            999999998654321     2246899999995 44567789999999999999999999999863211    0 00000


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCC-----CHHHHHHH
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRM-----NMTIVVHE  702 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  702 (741)
                              +......  .                  +......+.+++.+|++.||++|+     |++|+++.
T Consensus       240 --------i~~~~~~--~------------------p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        240 --------ILEGIIY--F------------------PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             --------HhcCCCC--C------------------CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence                    0000000  0                  011234567899999999999995     78887754

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-39  Score=308.23  Aligned_cols=251  Identities=24%  Similarity=0.285  Sum_probs=204.7

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      ..|.++++||+|+||.||+|.++++|+.||+|.+..  ..+..++.+|+.+|++++.|+||++||.+     -.....|+
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSY-----FK~sDLWI  105 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSY-----FKHSDLWI  105 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhh-----ccCCceEe
Confidence            357889999999999999999999999999999874  34567889999999999999999999984     44557999


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      |||||..|+..+.++.+         ++.+++.++..+.++-++||+|||..   .-+|||||..|||++.+|.+||+||
T Consensus       106 VMEYCGAGSiSDI~R~R---------~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADF  173 (502)
T KOG0574|consen  106 VMEYCGAGSISDIMRAR---------RKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADF  173 (502)
T ss_pred             ehhhcCCCcHHHHHHHh---------cCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhc
Confidence            99999999999998743         47799999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcc
Q 037916          560 GLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDH  639 (741)
Q Consensus       560 g~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  639 (741)
                      |.|....+.-.  ....+.|||.|||| |+...-.|..++||||+|++..||..|++||.+...-..-   ++....+  
T Consensus       174 GVAGQLTDTMA--KRNTVIGTPFWMAP-EVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI---FMIPT~P--  245 (502)
T KOG0574|consen  174 GVAGQLTDTMA--KRNTVIGTPFWMAP-EVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI---FMIPTKP--  245 (502)
T ss_pred             cccchhhhhHH--hhCccccCcccccH-HHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee---EeccCCC--
Confidence            99987654322  22336799999999 5556667899999999999999999999998743221100   1111111  


Q ss_pred             hhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          640 VMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       640 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                                               .+.+..+.+-...+.+++++|+...|++|-|+.++++-
T Consensus       246 -------------------------PPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  246 -------------------------PPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             -------------------------CCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence                                     11122233445678899999999999999999998753

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=6e-37  Score=316.76  Aligned_cols=265  Identities=23%  Similarity=0.371  Sum_probs=199.6

Q ss_pred             HHHhhhcccCceeeEEEEEEcCC---CeEEEEEEeeccCc--CcchhHHHHHHHHHhcCCCceeeEeeeecCccc-cCCc
Q 037916          402 FLFLCWIDMGSFGSVYKGILDEG---KTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKNLVKILTVCSGVDY-KGDD  475 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~~~---~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~-~~~~  475 (741)
                      |.+.+.||+|+||.||+|....+   +..||+|+++....  .....+.+|+..++.++||||+++++++..... ....
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            46788999999999999997643   47899999874322  223567889999999999999999998754332 2334


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..+++|||+++++|..++...+..    .....+++..+..++.|++.||+|||+.   +++||||||+||++++++.+|
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~----~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~k  153 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLG----GLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVC  153 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhcc----CCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEE
Confidence            579999999999999988543211    1124588899999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhh
Q 037916          556 VADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  634 (741)
                      |+|||.++...............++..|+||| ...+..++.++|||||||++|||++ |..||.....  ........ 
T Consensus       154 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe-~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~--~~~~~~~~-  229 (273)
T cd05035         154 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIE-SLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN--HEIYDYLR-  229 (273)
T ss_pred             ECCccceeeccccccccccccccCCccccCHh-hcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHH-
Confidence            99999998765443322222233567899995 5567788999999999999999999 8888753211  01100000 


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHH
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSI  706 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  706 (741)
                                    .....               ..+..++..+.+++.+||+.||++|||+.|+++.|+++
T Consensus       230 --------------~~~~~---------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         230 --------------HGNRL---------------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             --------------cCCCC---------------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                          00000               00113456788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=4.5e-37  Score=315.51  Aligned_cols=256  Identities=27%  Similarity=0.439  Sum_probs=203.3

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      ...|++.++||.|+||.||+|.+.. +..||+|+++.........+.+|+.+++.++||||+++++++     .+....+
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   78 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVC-----SVGEPVY   78 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeE-----ecCCCeE
Confidence            3579999999999999999999986 889999999765554566788999999999999999999985     4455789


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      +||||+++++|.+++....        ...+++.++..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|
T Consensus        79 lv~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d  147 (261)
T cd05148          79 IITELMEKGSLLAFLRSPE--------GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVAD  147 (261)
T ss_pred             EEEeecccCCHHHHHhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEcc
Confidence            9999999999999997431        24578889999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcCC
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      ||.+...........  ...++..|+|||. ..+..++.++||||||+++|++++ |+.||.....     .+...    
T Consensus       148 ~g~~~~~~~~~~~~~--~~~~~~~~~~PE~-~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~-----~~~~~----  215 (261)
T cd05148         148 FGLARLIKEDVYLSS--DKKIPYKWTAPEA-ASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN-----HEVYD----  215 (261)
T ss_pred             ccchhhcCCcccccc--CCCCceEecCHHH-HccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH-----HHHHH----
Confidence            999987654322211  2346778999954 456678899999999999999998 8999863211     00000    


Q ss_pred             cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHH
Q 037916          638 DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSI  706 (741)
Q Consensus       638 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  706 (741)
                           .+.....                  ...+..+++.+.+++.+||+.||++|||+.|+++.|+.+
T Consensus       216 -----~~~~~~~------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         216 -----QITAGYR------------------MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             -----HHHhCCc------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence                 0000000                  001123456788999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-37  Score=315.15  Aligned_cols=251  Identities=20%  Similarity=0.229  Sum_probs=205.5

Q ss_pred             HHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc--CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      +.+.|.+.+.||+|.|+.|-+|++.-+|..||||++.+..-  .....+..|++.|+-++|||||++|++     .....
T Consensus        16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEV-----iDTQT   90 (864)
T KOG4717|consen   16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEV-----IDTQT   90 (864)
T ss_pred             eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeeh-----hcccc
Confidence            34569999999999999999999999999999999975332  234567899999999999999999999     56777


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEe-CCCCce
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLL-DHEMTA  554 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll-~~~~~~  554 (741)
                      ..|+|+|.-.+|+|++||-+.         ...+.+.-+.+++.||+.|+.|+|..   -+|||||||+||.+ .+-|-|
T Consensus        91 KlyLiLELGD~GDl~DyImKH---------e~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlV  158 (864)
T KOG4717|consen   91 KLYLILELGDGGDLFDYIMKH---------EEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLV  158 (864)
T ss_pred             eEEEEEEecCCchHHHHHHhh---------hccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCce
Confidence            999999999999999998654         35688889999999999999999999   99999999999976 556899


Q ss_pred             EEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhh
Q 037916          555 HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       555 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  634 (741)
                      ||.|||++-...++.....   .+|...|-|||.++...+..+++||||+|||+|-+++|+.||+...+.+.- ..    
T Consensus       159 KLTDFGFSNkf~PG~kL~T---sCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL-Tm----  230 (864)
T KOG4717|consen  159 KLTDFGFSNKFQPGKKLTT---SCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL-TM----  230 (864)
T ss_pred             EeeeccccccCCCcchhhc---ccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh-hh----
Confidence            9999999987766654333   579999999977777777889999999999999999999999854332211 11    


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                              ++|    ..+                ..+.....++.+||..||..||.+|.|.+||+.
T Consensus       231 --------ImD----CKY----------------tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  231 --------IMD----CKY----------------TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             --------hhc----ccc----------------cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence                    111    000                012244566779999999999999999988864

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=4.1e-37  Score=321.14  Aligned_cols=270  Identities=24%  Similarity=0.371  Sum_probs=205.2

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEc-----CCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccC
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILD-----EGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKG  473 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  473 (741)
                      ...|.+.+.||+|+||.||+|.+.     .++..|++|.++.......+.+.+|+.++++++||||+++++++     ..
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~   78 (291)
T cd05094           4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVC-----GD   78 (291)
T ss_pred             hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEE-----cc
Confidence            356788899999999999999863     34567999998654444456788999999999999999999995     44


Q ss_pred             CceEEEEEecccCCChhhhccCCCCCCc------ccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeE
Q 037916          474 DDFKALVYEFMHNGSLEEWLHPVSGADK------TVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVL  547 (741)
Q Consensus       474 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIl  547 (741)
                      ....++||||+++++|.+++........      .......+++..++.++.|++.|++|||++   +|+||||||+||+
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil  155 (291)
T cd05094          79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCL  155 (291)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEE
Confidence            5578999999999999999864321100      001123478999999999999999999999   9999999999999


Q ss_pred             eCCCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCc
Q 037916          548 LDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNM  626 (741)
Q Consensus       548 l~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~  626 (741)
                      ++.++.+||+|||.+................++..|+|| |...+..++.++|||||||++|||++ |..||......  
T Consensus       156 ~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--  232 (291)
T cd05094         156 VGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPP-ESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT--  232 (291)
T ss_pred             EccCCcEEECCCCcccccCCCceeecCCCCCcceeecCh-HHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--
Confidence            999999999999999766543322222234467889999 45566778999999999999999998 99997532111  


Q ss_pred             chhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHH
Q 037916          627 NLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSI  706 (741)
Q Consensus       627 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  706 (741)
                      .   .........        .. .                  ....++..+.+++.+||+.||++|||+.+|++.|+++
T Consensus       233 ~---~~~~~~~~~--------~~-~------------------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~  282 (291)
T cd05094         233 E---VIECITQGR--------VL-E------------------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL  282 (291)
T ss_pred             H---HHHHHhCCC--------CC-C------------------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence            0   110000000        00 0                  0012345688999999999999999999999999999


Q ss_pred             HHh
Q 037916          707 KSI  709 (741)
Q Consensus       707 ~~~  709 (741)
                      .+.
T Consensus       283 ~~~  285 (291)
T cd05094         283 GKA  285 (291)
T ss_pred             Hhh
Confidence            764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.4e-37  Score=325.71  Aligned_cols=278  Identities=21%  Similarity=0.272  Sum_probs=198.1

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc-CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      ..|.+.++||+|+||.||+|++..+++.||+|.++.... .....+.+|+.++++++||||+++++++     ..+...+
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~   80 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV-----HTDKSLT   80 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEE-----eeCCeEE
Confidence            458889999999999999999998999999999874332 2344677899999999999999999995     4456899


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      +||||++ ++|.+++...         ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        81 lv~e~~~-~~l~~~~~~~---------~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~D  147 (309)
T cd07872          81 LVFEYLD-KDLKQYMDDC---------GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLAD  147 (309)
T ss_pred             EEEeCCC-CCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECc
Confidence            9999996 4888877532         23478888999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCc
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      ||.+.........  .....+++.|+|||.+.....++.++||||+||++|+|++|+.||...... ......... ...
T Consensus       148 fg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~-~~~~~~~~~-~~~  223 (309)
T cd07872         148 FGLARAKSVPTKT--YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE-DELHLIFRL-LGT  223 (309)
T ss_pred             cccceecCCCccc--cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHH-hCC
Confidence            9998764332211  122457899999976665667899999999999999999999998633211 111111111 111


Q ss_pred             chhHhhhhcccCC-cchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          639 HVMDIVDSTLLAD-DEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       639 ~~~~~~d~~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ...+......... ..... .... ...............+.+++.+|++.||++|||+.|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         224 PTEETWPGISSNDEFKNYN-FPKY-KPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             CCHHHHhhhcchhhhhhhh-cCcc-CCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            0000000000000 00000 0000 000001111234556789999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1e-37  Score=330.33  Aligned_cols=195  Identities=27%  Similarity=0.351  Sum_probs=168.5

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcC-C-----CceeeEeeeecCccccCC
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIR-H-----KNLVKILTVCSGVDYKGD  474 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----pnIv~~~~~~~~~~~~~~  474 (741)
                      +|++.+.||+|+||.|.+|.+..+++.||||+++. ......+...|+.+|..++ |     -|+|+++++     +...
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN-~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~-----F~fr  260 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN-KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDY-----FYFR  260 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeecc-ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeec-----cccc
Confidence            89999999999999999999999999999999974 2344567778999999996 3     389999999     5667


Q ss_pred             ceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCC--
Q 037916          475 DFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEM--  552 (741)
Q Consensus       475 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~--  552 (741)
                      ++.|||+|.+ ..+|.++++.+        ....++...++.++.||+.||.+||+.   +|||+||||||||+.+.+  
T Consensus       261 ~HlciVfELL-~~NLYellK~n--------~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~  328 (586)
T KOG0667|consen  261 NHLCIVFELL-STNLYELLKNN--------KFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRS  328 (586)
T ss_pred             cceeeeehhh-hhhHHHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcC
Confidence            7999999999 56999999865        235589999999999999999999999   999999999999996543  


Q ss_pred             ceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCC
Q 037916          553 TAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSD  619 (741)
Q Consensus       553 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~  619 (741)
                      .+||+|||.|........     ....+..|+|| |+..|.+|+.+.||||||||+.||++|.+-|.
T Consensus       329 ~vKVIDFGSSc~~~q~vy-----tYiQSRfYRAP-EVILGlpY~~~IDmWSLGCIlAEL~tG~PLfp  389 (586)
T KOG0667|consen  329 RIKVIDFGSSCFESQRVY-----TYIQSRFYRAP-EVILGLPYDTAIDMWSLGCILAELFTGEPLFP  389 (586)
T ss_pred             ceeEEecccccccCCcce-----eeeeccccccc-hhhccCCCCCccceeehhhhHHhHhcCccccC
Confidence            899999999987655433     23468899999 66678899999999999999999999987654

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=4.2e-37  Score=316.88  Aligned_cols=262  Identities=19%  Similarity=0.282  Sum_probs=202.0

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCce
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      ..|++.+.||+|+||.||+|++..+++.||+|.++...   ......+.+|+.+++.++||||+++++++     .....
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~   76 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSF-----IEDNE   76 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeE-----EECCe
Confidence            46889999999999999999998899999999886422   22234678899999999999999999984     44568


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .+++|||+++++|.+++.....      ....+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~------~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l  147 (267)
T cd08228          77 LNIVLELADAGDLSQMIKYFKK------QKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKL  147 (267)
T ss_pred             EEEEEEecCCCcHHHHHHHhhh------ccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEE
Confidence            8999999999999988753211      123478888999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcC
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVL  636 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  636 (741)
                      +|||.+.........  .....|++.|+||| ...+..++.++||||+|+++|||++|+.||.....   ....+.....
T Consensus       148 ~d~g~~~~~~~~~~~--~~~~~~~~~~~aPE-~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~---~~~~~~~~~~  221 (267)
T cd08228         148 GDLGLGRFFSSKTTA--AHSLVGTPYYMSPE-RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLFSLCQKIE  221 (267)
T ss_pred             CccccceeccchhHH--HhcCCCCccccChh-hhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc---cHHHHHHHHh
Confidence            999998876543221  11245888999995 44566788999999999999999999999852211   1111111100


Q ss_pred             CcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHH
Q 037916          637 PDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIK  707 (741)
Q Consensus       637 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  707 (741)
                      .            ....              .......+..+.+++.+||..+|++|||+.||++.+++++
T Consensus       222 ~------------~~~~--------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         222 Q------------CDYP--------------PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             c------------CCCC--------------CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence            0            0000              0001133466889999999999999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=6.3e-37  Score=314.83  Aligned_cols=257  Identities=25%  Similarity=0.392  Sum_probs=200.7

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      ...|.+.+.||+|+||.||+|.+..+++.||+|+++.. ....+.+.+|+.++++++||||+++++++     ..+...+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   78 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPFY   78 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEE-----cCCCCcE
Confidence            34678889999999999999999988999999998642 23345788999999999999999999985     3455789


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      ++|||+++++|.+++....        ...+++..++.++.|+++||+|||+.   +++||||||+||++++++.+||+|
T Consensus        79 lv~e~~~~~~L~~~~~~~~--------~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~d  147 (263)
T cd05052          79 IITEFMTYGNLLDYLRECN--------RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVAD  147 (263)
T ss_pred             EEEEeCCCCcHHHHHHhCC--------CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCC
Confidence            9999999999999986431        23478888999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcCC
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      ||.+.......... .....++..|+||| ...+..++.++|||||||++|||++ |..||....     .......   
T Consensus       148 f~~~~~~~~~~~~~-~~~~~~~~~y~aPE-~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~-----~~~~~~~---  217 (263)
T cd05052         148 FGLSRLMTGDTYTA-HAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYEL---  217 (263)
T ss_pred             Cccccccccceeec-cCCCCCccccCCHH-HhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHH---
Confidence            99998765432211 11123466899995 5566778999999999999999998 888875221     1111111   


Q ss_pred             cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHH
Q 037916          638 DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSI  706 (741)
Q Consensus       638 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  706 (741)
                            +.......                  .+..++..+.+++.+||+.||++|||+.|+++.|+.+
T Consensus       218 ------~~~~~~~~------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         218 ------LEKGYRME------------------RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             ------HHCCCCCC------------------CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence                  10000000                  0112356788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=6.8e-37  Score=312.44  Aligned_cols=249  Identities=23%  Similarity=0.322  Sum_probs=191.1

Q ss_pred             hhcccCceeeEEEEEEcCCCeEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEEEecc
Q 037916          406 CWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFM  484 (741)
Q Consensus       406 ~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv~e~~  484 (741)
                      +.||+|+||.||+|++..+++.||+|.+.... ......+.+|+.++++++||||++++++|     ......++||||+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~   75 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC-----TQKQPIYIVMELV   75 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----cCCCCeEEEEeec
Confidence            46999999999999998899999999876322 22345688999999999999999999995     3455789999999


Q ss_pred             cCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecccccc
Q 037916          485 HNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKL  564 (741)
Q Consensus       485 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~a~~  564 (741)
                      ++++|.+++...         ...+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.+..
T Consensus        76 ~~~~L~~~~~~~---------~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  143 (252)
T cd05084          76 QGGDFLTFLRTE---------GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSRE  143 (252)
T ss_pred             cCCcHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcc
Confidence            999999998632         13478889999999999999999999   999999999999999999999999999876


Q ss_pred             cCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcCCcchhHh
Q 037916          565 LPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVLPDHVMDI  643 (741)
Q Consensus       565 ~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  643 (741)
                      ..............++..|+||| ...+..++.++||||+||++||+++ |..||......  .            ....
T Consensus       144 ~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--~------------~~~~  208 (252)
T cd05084         144 EEDGVYASTGGMKQIPVKWTAPE-ALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--Q------------TREA  208 (252)
T ss_pred             cccccccccCCCCCCceeecCch-hhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--H------------HHHH
Confidence            54322111111122345799995 4456678999999999999999997 88887532110  0            0111


Q ss_pred             hhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHH
Q 037916          644 VDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQ  704 (741)
Q Consensus       644 ~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  704 (741)
                      +.......                  .+..++..+.+++.+||+.||++|||+.|+++.|+
T Consensus       209 ~~~~~~~~------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         209 IEQGVRLP------------------CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             HHcCCCCC------------------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            11000000                  01133567889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-37  Score=320.83  Aligned_cols=256  Identities=23%  Similarity=0.345  Sum_probs=210.9

Q ss_pred             HHhhhcccCceeeEEEEEEcC----CCeEEEEEEeec-cCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceE
Q 037916          403 LFLCWIDMGSFGSVYKGILDE----GKTIIAVKVLNL-LHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       403 ~~~~~ig~G~~g~V~~a~~~~----~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      +..+.||+|.||.||+|.+..    ..--||||..+. ...+..+.|..|..+|+.++|||||+++|+|.+      ...
T Consensus       392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e------~P~  465 (974)
T KOG4257|consen  392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE------QPM  465 (974)
T ss_pred             cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec------cce
Confidence            456789999999999999853    234589999875 344557789999999999999999999999853      358


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      |||||.++-|.|..|++.+         ...++......++.||+.||+|||+.   ..|||||...|||+.....|||+
T Consensus       466 WivmEL~~~GELr~yLq~n---------k~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLa  533 (974)
T KOG4257|consen  466 WIVMELAPLGELREYLQQN---------KDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLA  533 (974)
T ss_pred             eEEEecccchhHHHHHHhc---------cccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeec
Confidence            9999999999999999854         35688888899999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcC
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVL  636 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~  636 (741)
                      |||+++.+.+...+.... ..-...|||| |-.....++.++|||-|||+|||+++ |..||......+.-..       
T Consensus       534 DFGLSR~~ed~~yYkaS~-~kLPIKWmaP-ESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~-------  604 (974)
T KOG4257|consen  534 DFGLSRYLEDDAYYKASR-GKLPIKWMAP-ESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGH-------  604 (974)
T ss_pred             ccchhhhccccchhhccc-cccceeecCc-cccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEE-------
Confidence            999999998877666543 2346789999 55567789999999999999999876 9999974433221110       


Q ss_pred             CcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHhh
Q 037916          637 PDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSIL  710 (741)
Q Consensus       637 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  710 (741)
                                               ...+.+.+.++.|++.+..|+.+||.+||.+||.+.|+...|+++.+..
T Consensus       605 -------------------------iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qee  653 (974)
T KOG4257|consen  605 -------------------------IENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEE  653 (974)
T ss_pred             -------------------------ecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHh
Confidence                                     0011223345689999999999999999999999999999999998733

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=9.1e-37  Score=314.39  Aligned_cols=255  Identities=21%  Similarity=0.252  Sum_probs=197.5

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      ...|.+.+.||+|+||.||+|++..+++.||+|+++.........+.+|+.+++.++||||+++++++     ......+
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~-----~~~~~~~   82 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSY-----LRRDKLW   82 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEE-----EeCCEEE
Confidence            35799999999999999999999989999999999755444445678899999999999999999984     4566899


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      +||||+++++|.+++...          ..+++.++..++.|++.|+.|||+.   |++|+||||+||+++.++.+||+|
T Consensus        83 lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~d  149 (267)
T cd06645          83 ICMEFCGGGSLQDIYHVT----------GPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLAD  149 (267)
T ss_pred             EEEeccCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECc
Confidence            999999999999988633          4578899999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCccccc--CCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcC
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG--LGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVL  636 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~--~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  636 (741)
                      ||.+........  ......|+..|+|||.+.  ....++.++||||+||++|+|++|..||........ .........
T Consensus       150 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-~~~~~~~~~  226 (267)
T cd06645         150 FGVSAQITATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMTKSNF  226 (267)
T ss_pred             ceeeeEccCccc--ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-HHhhhccCC
Confidence            999876543221  112345899999996542  245688999999999999999999999853211110 000000000


Q ss_pred             CcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          637 PDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       637 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ..       +...                    .....+..+.+++.+||+.||++|||+++|++
T Consensus       227 ~~-------~~~~--------------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         227 QP-------PKLK--------------------DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             CC-------Cccc--------------------ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            00       0000                    00012345778999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.6e-37  Score=329.36  Aligned_cols=243  Identities=20%  Similarity=0.229  Sum_probs=189.1

Q ss_pred             hhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEEEe
Q 037916          406 CWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYE  482 (741)
Q Consensus       406 ~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv~e  482 (741)
                      +.||+|+||.||+|.+..+++.||+|+++...   ......+..|+.+++.++||||++++++     +......|+|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~-----~~~~~~~~lv~E   75 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYS-----FQTHDRLCFVME   75 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEE-----EEcCCEEEEEEe
Confidence            46899999999999999899999999997432   2233456789999999999999999988     455668999999


Q ss_pred             cccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHh-cCCCCceecCCCCCCeEeCCCCceEEeeccc
Q 037916          483 FMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH-DCQPTTAHCDLKPSNVLLDHEMTAHVADFGL  561 (741)
Q Consensus       483 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~  561 (741)
                      |+++|+|..++...          ..+++..+..++.||+.||+|||+ .   +|+||||||+||+++.++.+||+|||+
T Consensus        76 ~~~~~~L~~~l~~~----------~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~  142 (325)
T cd05594          76 YANGGELFFHLSRE----------RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGL  142 (325)
T ss_pred             CCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCC
Confidence            99999999888533          457889999999999999999997 7   999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcchh
Q 037916          562 AKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM  641 (741)
Q Consensus       562 a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  641 (741)
                      ++........  .....||+.|+||| +..+..++.++||||+||++|+|++|+.||.....     ..........   
T Consensus       143 ~~~~~~~~~~--~~~~~gt~~y~aPE-~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~-----~~~~~~i~~~---  211 (325)
T cd05594         143 CKEGIKDGAT--MKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELILME---  211 (325)
T ss_pred             CeecCCCCcc--cccccCCcccCCHH-HHccCCCCCccccccccceeeeeccCCCCCCCCCH-----HHHHHHHhcC---
Confidence            8754322111  12245899999995 55667889999999999999999999999852211     0010000000   


Q ss_pred             HhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCC-----CHHHHHHH
Q 037916          642 DIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRM-----NMTIVVHE  702 (741)
Q Consensus       642 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  702 (741)
                               ...                .+....+.+.+++.+||+.||++|+     ++.|+++-
T Consensus       212 ---------~~~----------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         212 ---------EIR----------------FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             ---------CCC----------------CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence                     000                0012245677999999999999997     89988753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.5e-37  Score=327.68  Aligned_cols=245  Identities=23%  Similarity=0.275  Sum_probs=188.2

Q ss_pred             HHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHH---HhcCCCceeeEeeeecCccccCCc
Q 037916          402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSAL---RNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      |++++.||+|+||.||+|.+..+++.||+|+++...   ....+.+..|+.++   +.++||||++++++     +....
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~-----~~~~~   75 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFAC-----FQTED   75 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeE-----EEcCC
Confidence            567889999999999999999899999999997432   22234555666554   56689999999998     45566


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..|+||||+++++|..++..           ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+|
T Consensus        76 ~~~lv~E~~~~~~L~~~~~~-----------~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~k  141 (324)
T cd05589          76 HVCFVMEYAAGGDLMMHIHT-----------DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVK  141 (324)
T ss_pred             EEEEEEcCCCCCcHHHHhhc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEE
Confidence            89999999999999888752           3578999999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhc
Q 037916          556 VADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV  635 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~  635 (741)
                      |+|||+++.......  ......|++.|+||| +..+..++.++|||||||++|||++|+.||.....     .....  
T Consensus       142 L~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE-~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~-----~~~~~--  211 (324)
T cd05589         142 IADFGLCKEGMGFGD--RTSTFCGTPEFLAPE-VLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE-----EEVFD--  211 (324)
T ss_pred             eCcccCCccCCCCCC--cccccccCccccCHh-HhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH-----HHHHH--
Confidence            999999875432221  122356899999995 55667789999999999999999999999863211     00100  


Q ss_pred             CCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCC-----CHHHHHH
Q 037916          636 LPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRM-----NMTIVVH  701 (741)
Q Consensus       636 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  701 (741)
                            .+......                    .+...+..+.+++.+||+.||++||     ++.++++
T Consensus       212 ------~i~~~~~~--------------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         212 ------SIVNDEVR--------------------YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             ------HHHhCCCC--------------------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence                  00000000                    0012345678999999999999999     4666654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1e-36  Score=316.93  Aligned_cols=269  Identities=23%  Similarity=0.314  Sum_probs=200.5

Q ss_pred             HHH-HHhhhcccCceeeEEEEEE----cCCCeEEEEEEeeccCc-CcchhHHHHHHHHHhcCCCceeeEeeeecCccccC
Q 037916          400 VSF-LFLCWIDMGSFGSVYKGIL----DEGKTIIAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKG  473 (741)
Q Consensus       400 ~~y-~~~~~ig~G~~g~V~~a~~----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  473 (741)
                      .+| ++.+.||+|+||.||++.+    ..++..||+|+++.... .....+.+|+.++++++||||+++++++..   ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~   79 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSE---QG   79 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CC
Confidence            345 8899999999999988653    34678899999874322 234567889999999999999999998642   23


Q ss_pred             CceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCc
Q 037916          474 DDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMT  553 (741)
Q Consensus       474 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~  553 (741)
                      ....+++|||+++++|.+++..           ..+++.+++.++.|++.||.|||+.   +|+||||||+||+++.++.
T Consensus        80 ~~~~~lv~e~~~~~~l~~~~~~-----------~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~  145 (283)
T cd05080          80 GKGLQLIMEYVPLGSLRDYLPK-----------HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRL  145 (283)
T ss_pred             CceEEEEecCCCCCCHHHHHHH-----------cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCc
Confidence            4568999999999999999853           2478999999999999999999999   9999999999999999999


Q ss_pred             eEEeecccccccCCCCccc-ccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhh
Q 037916          554 AHVADFGLAKLLPPAHLQT-SSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFA  632 (741)
Q Consensus       554 ~kL~DFg~a~~~~~~~~~~-~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~  632 (741)
                      +||+|||.+.......... ......++..|+||| ...+..++.++||||||+++|||++|..||......   +....
T Consensus       146 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE-~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~---~~~~~  221 (283)
T cd05080         146 VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVE-CLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK---FEEMI  221 (283)
T ss_pred             EEEeecccccccCCcchhhccCCCCCCCceeeCHh-HhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch---hhhhh
Confidence            9999999998765432211 111123566799995 555667899999999999999999999997532111   11111


Q ss_pred             hhcCC----cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHH
Q 037916          633 RTVLP----DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIK  707 (741)
Q Consensus       633 ~~~~~----~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  707 (741)
                      .....    ....+..+....                  ...+..++..+.+++.+||+.||++|||+++|++.|+++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         222 GPKQGQMTVVRLIELLERGMR------------------LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             cccccccchhhhhhhhhcCCC------------------CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            11000    001111111100                  0011234567899999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2e-37  Score=334.90  Aligned_cols=278  Identities=18%  Similarity=0.178  Sum_probs=197.2

Q ss_pred             HHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC--cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      |++.+.||+|+||.||+|.+..+++.||+|++....  ....+.+.+|+.+++.++||||+++++++...........|+
T Consensus         2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l   81 (372)
T cd07853           2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYV   81 (372)
T ss_pred             CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEE
Confidence            678899999999999999998899999999986321  223456788999999999999999999964332222237899


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      ||||+. ++|.+++...          ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        82 v~e~~~-~~l~~~~~~~----------~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Df  147 (372)
T cd07853          82 VTELMQ-SDLHKIIVSP----------QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDF  147 (372)
T ss_pred             Eeeccc-cCHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccc
Confidence            999995 5888877532          4578899999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCC-c
Q 037916          560 GLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLP-D  638 (741)
Q Consensus       560 g~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~-~  638 (741)
                      |++......... ......+++.|+|||.+.....++.++||||+||++|||++|+.||...... ..+. .+..... +
T Consensus       148 g~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~-~i~~~~g~~  224 (372)
T cd07853         148 GLARVEEPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI-QQLD-LITDLLGTP  224 (372)
T ss_pred             cceeecccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH-HHHH-HHHHHcCCC
Confidence            999865433211 1222457899999976655566899999999999999999999998632111 1111 1111111 0


Q ss_pred             chhHhhh------hcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          639 HVMDIVD------STLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       639 ~~~~~~d------~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      ...++..      ..+.....      ................+.+.+++.+||+.||++|||+.|+++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         225 SLEAMRSACEGARAHILRGPH------KPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             CHHHHHHhhHHHHHHHHhCCC------CCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence            0111000      00000000      0000000000111235668899999999999999999999864

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.8e-37  Score=328.61  Aligned_cols=252  Identities=21%  Similarity=0.241  Sum_probs=191.9

Q ss_pred             HHHhhhcccCceeeEEEEEEc---CCCeEEEEEEeeccC----cCcchhHHHHHHHHHhc-CCCceeeEeeeecCccccC
Q 037916          402 FLFLCWIDMGSFGSVYKGILD---EGKTIIAVKVLNLLH----HGASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKG  473 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~  473 (741)
                      |++++.||+|+||.||+|++.   .+++.||+|+++...    ....+.+..|+.+++.+ +||+|++++++     +..
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~-----~~~   76 (332)
T cd05614           2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYA-----FQT   76 (332)
T ss_pred             ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEE-----Eec
Confidence            778899999999999999874   468899999997422    12234567899999999 58999999988     455


Q ss_pred             CceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCc
Q 037916          474 DDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMT  553 (741)
Q Consensus       474 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~  553 (741)
                      ....++||||+++|+|.+++...          ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.
T Consensus        77 ~~~~~lv~e~~~~g~L~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~  143 (332)
T cd05614          77 EAKLHLILDYVSGGEMFTHLYQR----------DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGH  143 (332)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCC
Confidence            66899999999999999988633          4578889999999999999999999   9999999999999999999


Q ss_pred             eEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhh
Q 037916          554 AHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFAR  633 (741)
Q Consensus       554 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~  633 (741)
                      +||+|||++.......... .....||+.|+|||.+.....++.++|||||||++|||++|..||....... ....+..
T Consensus       144 ~kl~DfG~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~~~~  221 (332)
T cd05614         144 VVLTDFGLSKEFLSEEKER-TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN-TQSEVSR  221 (332)
T ss_pred             EEEeeCcCCccccccCCCc-cccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC-CHHHHHH
Confidence            9999999987653322211 1235689999999665544568899999999999999999999986321111 1111111


Q ss_pred             hcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCC-----CHHHHHH
Q 037916          634 TVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRM-----NMTIVVH  701 (741)
Q Consensus       634 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  701 (741)
                      ..            ......                .+......+.+++.+||+.||++||     +++|+++
T Consensus       222 ~~------------~~~~~~----------------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         222 RI------------LKCDPP----------------FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             HH------------hcCCCC----------------CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            00            000000                0012345677999999999999999     6777765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.1e-36  Score=315.76  Aligned_cols=258  Identities=23%  Similarity=0.320  Sum_probs=196.0

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCe----EEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCC
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKT----IIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGD  474 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~  474 (741)
                      ..|++.+.||+|+||.||+|.+..++.    .|++|.+.... .....++..|+..+++++||||+++++++.      +
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~------~   80 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP------G   80 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC------C
Confidence            568889999999999999999976665    46777764221 122345677888889999999999999852      2


Q ss_pred             ceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCce
Q 037916          475 DFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTA  554 (741)
Q Consensus       475 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~  554 (741)
                      ...++++||+++|+|.+++...         ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+
T Consensus        81 ~~~~~i~e~~~~gsL~~~l~~~---------~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~  148 (279)
T cd05111          81 ASLQLVTQLSPLGSLLDHVRQH---------RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIV  148 (279)
T ss_pred             CccEEEEEeCCCCcHHHHHHhc---------ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcE
Confidence            3467899999999999998643         23578899999999999999999999   99999999999999999999


Q ss_pred             EEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhh
Q 037916          555 HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFAR  633 (741)
Q Consensus       555 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~  633 (741)
                      ||+|||.++...............++..|+||| ...+..++.++|||||||++||+++ |..||......  ...    
T Consensus       149 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE-~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~~----  221 (279)
T cd05111         149 QIADFGVADLLYPDDKKYFYSEHKTPIKWMALE-SILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--EVP----  221 (279)
T ss_pred             EEcCCccceeccCCCcccccCCCCCcccccCHH-HhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHH----
Confidence            999999998664433222222345778899995 4456678999999999999999998 99998632110  111    


Q ss_pred             hcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHH
Q 037916          634 TVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKS  708 (741)
Q Consensus       634 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  708 (741)
                              +++........                  ...+...+.+++.+||..||++|||+.|+++.|..+.+
T Consensus       222 --------~~~~~~~~~~~------------------~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         222 --------DLLEKGERLAQ------------------PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             --------HHHHCCCcCCC------------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence                    11110000000                  01123456789999999999999999999999988775

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.7e-37  Score=339.29  Aligned_cols=288  Identities=18%  Similarity=0.215  Sum_probs=198.1

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccc---cCCce
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDY---KGDDF  476 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~---~~~~~  476 (741)
                      ..|.+.+.||+|+||.||+|.+..+++.||+|++...    .....+|+.+++.++||||+++++++....+   .....
T Consensus        66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  141 (440)
T PTZ00036         66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF  141 (440)
T ss_pred             CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence            4689999999999999999999989999999988532    2344579999999999999999887643221   12235


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCC-ceE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEM-TAH  555 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~-~~k  555 (741)
                      .++||||++ +++.+++....      .....+++..++.++.||+.||+|||+.   +|+||||||+||+++.++ .+|
T Consensus       142 l~lvmE~~~-~~l~~~~~~~~------~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vk  211 (440)
T PTZ00036        142 LNVVMEFIP-QTVHKYMKHYA------RNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLK  211 (440)
T ss_pred             EEEEEecCC-ccHHHHHHHHh------hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCcee
Confidence            779999996 47777664221      1124588889999999999999999999   999999999999998665 799


Q ss_pred             EeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhc
Q 037916          556 VADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV  635 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~  635 (741)
                      |+|||+|+........   ....||+.|+|||.+.....++.++||||+||++|||++|.+||...... ..+.......
T Consensus       212 L~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-~~~~~i~~~~  287 (440)
T PTZ00036        212 LCDFGSAKNLLAGQRS---VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV-DQLVRIIQVL  287 (440)
T ss_pred             eeccccchhccCCCCc---ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHh
Confidence            9999999866433221   22458999999966655567999999999999999999999998632111 1111111111


Q ss_pred             CCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH--HHHHHH
Q 037916          636 LPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE--LQSIKS  708 (741)
Q Consensus       636 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i~~  708 (741)
                      ..+....+..  .......... ............+...+..+.+++.+||++||++|||+.|+++.  ++.+..
T Consensus       288 ~~p~~~~~~~--~~~~~~~~~~-~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~  359 (440)
T PTZ00036        288 GTPTEDQLKE--MNPNYADIKF-PDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD  359 (440)
T ss_pred             CCCCHHHHHH--hchhhhcccC-CccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence            1111100000  0000000000 00000000111112345678899999999999999999999854  455443

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.1e-36  Score=316.58  Aligned_cols=266  Identities=21%  Similarity=0.316  Sum_probs=198.8

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcC-----CCeEEEEEEeeccCcC-cchhHHHHHHHHHhcCCCceeeEeeeecCcccc
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDE-----GKTIIAVKVLNLLHHG-ASKSSIAECSALRNIRHKNLVKILTVCSGVDYK  472 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  472 (741)
                      ...|.+.++||+|+||.||+|.+..     .+..||+|+++..... ..+.+.+|+.+++.++||||+++++++     .
T Consensus         4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~-----~   78 (283)
T cd05091           4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVV-----T   78 (283)
T ss_pred             HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEE-----c
Confidence            4578999999999999999998753     3578999998743222 235577899999999999999999995     3


Q ss_pred             CCceEEEEEecccCCChhhhccCCCC------CCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCe
Q 037916          473 GDDFKALVYEFMHNGSLEEWLHPVSG------ADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNV  546 (741)
Q Consensus       473 ~~~~~~lv~e~~~~gsL~~~l~~~~~------~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NI  546 (741)
                      .....++++||+.+++|.+++.....      ..........+++..+..++.|++.||+|+|+.   +|+||||||+||
T Consensus        79 ~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Ni  155 (283)
T cd05091          79 KEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNV  155 (283)
T ss_pred             CCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhhe
Confidence            44578999999999999999752210      000111124578888999999999999999999   999999999999


Q ss_pred             EeCCCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCC
Q 037916          547 LLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGN  625 (741)
Q Consensus       547 ll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~  625 (741)
                      ++++++.+||+|||+++...............+++.|+|||. ..+..++.++||||+||++|||++ |..||.....  
T Consensus       156 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--  232 (283)
T cd05091         156 LVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEA-IMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--  232 (283)
T ss_pred             EecCCCceEecccccccccccchheeeccCccCCccccCHHH-HhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH--
Confidence            999999999999999886644332222222346788999954 455678999999999999999998 8888752211  


Q ss_pred             cchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHH
Q 037916          626 MNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQS  705 (741)
Q Consensus       626 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  705 (741)
                         .+........        ....                   .+..++..+.+++.+||+.+|++||+++||+..|+.
T Consensus       233 ---~~~~~~i~~~--------~~~~-------------------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         233 ---QDVIEMIRNR--------QVLP-------------------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             ---HHHHHHHHcC--------CcCC-------------------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence               1111110000        0000                   012345668899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6.2e-37  Score=324.36  Aligned_cols=243  Identities=22%  Similarity=0.246  Sum_probs=187.5

Q ss_pred             hhhcccCceeeEEEEEEc---CCCeEEEEEEeeccC----cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceE
Q 037916          405 LCWIDMGSFGSVYKGILD---EGKTIIAVKVLNLLH----HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       405 ~~~ig~G~~g~V~~a~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      ++.||+|+||.||+|++.   .+++.||+|+++...    ......+.+|+.+++.++||||+++++++     ..+...
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~~   75 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAF-----QTGGKL   75 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEE-----ecCCeE
Confidence            367999999999999873   468899999997422    12234567899999999999999999984     456689


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      |+||||+++++|.+++...          ..+.+..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        76 ~lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~  142 (323)
T cd05584          76 YLILEYLSGGELFMHLERE----------GIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLT  142 (323)
T ss_pred             EEEEeCCCCchHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEe
Confidence            9999999999999988643          4467788888999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCC
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      |||+++........  .....||+.|+||| +..+..++.++||||+||++|||++|+.||.....     .....    
T Consensus       143 Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE-~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~-----~~~~~----  210 (323)
T cd05584         143 DFGLCKESIHEGTV--THTFCGTIEYMAPE-ILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR-----KKTID----  210 (323)
T ss_pred             eCcCCeecccCCCc--ccccCCCccccChh-hccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH-----HHHHH----
Confidence            99998754322211  12246899999995 55566788999999999999999999999863211     01111    


Q ss_pred             cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCC-----CHHHHHH
Q 037916          638 DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRM-----NMTIVVH  701 (741)
Q Consensus       638 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  701 (741)
                          .+.....    .                .+......+.+++.+||+.||++||     ++.++++
T Consensus       211 ----~~~~~~~----~----------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         211 ----KILKGKL----N----------------LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             ----HHHcCCC----C----------------CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence                1110000    0                0012245678999999999999999     7888766

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=4.1e-37  Score=325.56  Aligned_cols=243  Identities=24%  Similarity=0.275  Sum_probs=187.7

Q ss_pred             hhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhc-CCCceeeEeeeecCccccCCceEEEEE
Q 037916          406 CWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKGDDFKALVY  481 (741)
Q Consensus       406 ~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~~~~lv~  481 (741)
                      +.||+|+||.||+|++..+++.||+|+++...   ......+..|..+++.+ +||||++++++     +......|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~-----~~~~~~~~lv~   75 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCC-----FQTKDRLFFVM   75 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeE-----EEcCCeEEEEE
Confidence            46899999999999999899999999997432   22334566788888766 89999999998     45566899999


Q ss_pred             ecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeeccc
Q 037916          482 EFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGL  561 (741)
Q Consensus       482 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~  561 (741)
                      ||+++++|..++...          ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        76 E~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~  142 (321)
T cd05591          76 EYVNGGDLMFQIQRS----------RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGM  142 (321)
T ss_pred             eCCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeeccc
Confidence            999999999888643          4578888999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcchh
Q 037916          562 AKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM  641 (741)
Q Consensus       562 a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  641 (741)
                      +.........  .....||+.|+||| +..+..++.++||||+||++|||++|+.||......     ........    
T Consensus       143 ~~~~~~~~~~--~~~~~gt~~y~aPE-~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~-----~~~~~i~~----  210 (321)
T cd05591         143 CKEGILNGVT--TTTFCGTPDYIAPE-ILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED-----DLFESILH----  210 (321)
T ss_pred             ceecccCCcc--ccccccCccccCHH-HHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH-----HHHHHHHc----
Confidence            8754332211  22345899999995 556678899999999999999999999998632110     11111000    


Q ss_pred             HhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCC-------CHHHHHHH
Q 037916          642 DIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRM-------NMTIVVHE  702 (741)
Q Consensus       642 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-------s~~evl~~  702 (741)
                              ....                .+......+.+++.+||+.||++||       ++.++++.
T Consensus       211 --------~~~~----------------~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         211 --------DDVL----------------YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             --------CCCC----------------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence                    0000                0001234577999999999999999       67777643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=8.4e-37  Score=315.57  Aligned_cols=264  Identities=23%  Similarity=0.380  Sum_probs=196.7

Q ss_pred             HHhhhcccCceeeEEEEEEcCCCe--EEEEEEeecc--CcCcchhHHHHHHHHHhcCCCceeeEeeeecCccc-cCCceE
Q 037916          403 LFLCWIDMGSFGSVYKGILDEGKT--IIAVKVLNLL--HHGASKSSIAECSALRNIRHKNLVKILTVCSGVDY-KGDDFK  477 (741)
Q Consensus       403 ~~~~~ig~G~~g~V~~a~~~~~~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~-~~~~~~  477 (741)
                      .+.+.||+|+||.||+|.+..++.  .||+|.++..  .....+.+.+|+.+++.++||||++++++|..... ......
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            467889999999999999876664  6899988643  22334667889999999999999999998743221 122357


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      +++|||+++|+|.+++...+..    .....+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~----~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~  154 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLG----DCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVA  154 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhccc----CCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEEC
Confidence            8999999999999887432111    1124578999999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcC
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVL  636 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~  636 (741)
                      |||.++...............+++.|+||| ...+..++.++|||||||++||+++ |+.||.....  .........  
T Consensus       155 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe-~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~~~~~~~--  229 (272)
T cd05075         155 DFGLSKKIYNGDYYRQGRIAKMPVKWIAIE-SLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--SEIYDYLRQ--  229 (272)
T ss_pred             CCCcccccCcccceecCCcccCCcccCCHH-HccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHc--
Confidence            999998765433222222234677899995 5556778999999999999999999 7888863211  111000000  


Q ss_pred             CcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHH
Q 037916          637 PDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSI  706 (741)
Q Consensus       637 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  706 (741)
                       ..        ...                   ....++..+.+++.+||+.||++|||+.|+++.|+.+
T Consensus       230 -~~--------~~~-------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         230 -GN--------RLK-------------------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             -CC--------CCC-------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence             00        000                   0112345688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=3.5e-37  Score=333.73  Aligned_cols=201  Identities=22%  Similarity=0.297  Sum_probs=168.0

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      .|++++.||+|+||.||+|++..+++.||+|+++...   ......+.+|+.++++++||||+++++++     .+....
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~-----~~~~~~   76 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSF-----QDKDNL   76 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEE-----ecCCEE
Confidence            4778899999999999999999999999999997432   22345678899999999999999999994     456689


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      |+||||+++|+|.+++...          ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++++||+
T Consensus        77 ~lv~E~~~gg~L~~~l~~~----------~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~  143 (381)
T cd05626          77 YFVMDYIPGGDMMSLLIRM----------EVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLT  143 (381)
T ss_pred             EEEEecCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEe
Confidence            9999999999999998643          3578888899999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCc---------------------------------------------ccccccccccccccCcccccCC
Q 037916          558 DFGLAKLLPPAHL---------------------------------------------QTSSIGVKGTIGYIAPAEYGLG  592 (741)
Q Consensus       558 DFg~a~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPEe~~~~  592 (741)
                      |||++........                                             ........||+.|+||| +..+
T Consensus       144 DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE-~~~~  222 (381)
T cd05626         144 DFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPE-VLLR  222 (381)
T ss_pred             eCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHH-HHcC
Confidence            9999754311000                                             00011246999999995 5556


Q ss_pred             CCCCCccCchhHHHHHHHHHcCCCCCCc
Q 037916          593 SEVSINGDVYSYGILLLELMTRKRPSDI  620 (741)
Q Consensus       593 ~~~~~~~DIwSlG~il~elltg~~p~~~  620 (741)
                      ..++.++||||+||++|||++|..||..
T Consensus       223 ~~~~~~~DiwSlG~il~elltG~~Pf~~  250 (381)
T cd05626         223 KGYTQLCDWWSVGVILFEMLVGQPPFLA  250 (381)
T ss_pred             CCCCCccceeehhhHHHHHHhCCCCCcC
Confidence            7789999999999999999999999863

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=6.7e-37  Score=319.15  Aligned_cols=279  Identities=23%  Similarity=0.285  Sum_probs=195.3

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc--CcchhHHHHHHHHHhc---CCCceeeEeeeecCccccCCc
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH--GASKSSIAECSALRNI---RHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      +|++.+.||+|+||.||+|++..+++.||+|.++....  .......+|+.+++.+   +||||+++++++.........
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            37888999999999999999999999999999874322  2233556777777665   799999999987554334456


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..+++|||+. ++|.+++...        ....+++..+..++.|++.||+|||+.   ||+||||||+||+++.++.+|
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~--------~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~k  148 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKV--------PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVK  148 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEE
Confidence            7899999996 5888887643        123478899999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhc
Q 037916          556 VADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV  635 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~  635 (741)
                      |+|||.+........   .....||..|+|||. ..+..++.++||||+||++|+|++|.+||...... ..+.......
T Consensus       149 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~-~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~  223 (288)
T cd07863         149 LADFGLARIYSCQMA---LTPVVVTLWYRAPEV-LLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGKIFDLI  223 (288)
T ss_pred             ECccCccccccCccc---CCCccccccccCchH-hhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH-HHHHHHHHHh
Confidence            999999986643321   122457899999954 45667899999999999999999999998532111 1111111100


Q ss_pred             CCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          636 LPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       636 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      .......+....-....     ...............+..+.+.+++.+|++.||++|||+.|++.
T Consensus       224 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         224 GLPPEDDWPRDVTLPRG-----AFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             CCCChhhCccccccccc-----ccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            00000000000000000     00000000001111234566789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.6e-37  Score=342.28  Aligned_cols=261  Identities=23%  Similarity=0.239  Sum_probs=199.7

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc--CcchhHHHHHHHHHhcCCCceeeEeeeecCccc---cCC
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKNLVKILTVCSGVDY---KGD  474 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~---~~~  474 (741)
                      .+|.+.+.||+|+||.||+|++..+++.||+|+++....  .....+.+|+.++..++|+||+++++.+.....   ...
T Consensus        32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~  111 (496)
T PTZ00283         32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV  111 (496)
T ss_pred             CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence            368889999999999999999998999999999874322  234467789999999999999998877542211   111


Q ss_pred             ceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCce
Q 037916          475 DFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTA  554 (741)
Q Consensus       475 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~  554 (741)
                      ...++||||+++|+|.++++....      ....+++..+..++.|++.||.|+|+.   +|+||||||+||+++.++.+
T Consensus       112 ~~i~lV~Ey~~~gsL~~~l~~~~~------~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~v  182 (496)
T PTZ00283        112 LMIALVLDYANAGDLRQEIKSRAK------TNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLV  182 (496)
T ss_pred             eEEEEEEeCCCCCcHHHHHHHhhc------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCE
Confidence            246899999999999999864311      124588889999999999999999999   99999999999999999999


Q ss_pred             EEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhh
Q 037916          555 HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       555 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  634 (741)
                      ||+|||+++...............||+.|+|| |+..+..++.++|||||||++|||++|+.||...     ........
T Consensus       183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aP-E~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~-----~~~~~~~~  256 (496)
T PTZ00283        183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAP-EIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE-----NMEEVMHK  256 (496)
T ss_pred             EEEecccCeeccccccccccccccCCcceeCH-HHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC-----CHHHHHHH
Confidence            99999999866543222222335699999999 5556677999999999999999999999998621     11111111


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                                  .......               ..+..+++.+.+++.+||+.||++|||+.|+++.
T Consensus       257 ------------~~~~~~~---------------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        257 ------------TLAGRYD---------------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             ------------HhcCCCC---------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence                        1110000               0011334668899999999999999999999763

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=8e-37  Score=313.69  Aligned_cols=256  Identities=24%  Similarity=0.372  Sum_probs=198.8

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      ...|++.++||+|+||.||+|.+. ++..||+|.+.... ...+.+.+|+.++++++||||+++++++     ......+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   77 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVV-----TKEEPIY   77 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEE-----cCCCCcE
Confidence            467899999999999999999976 56779999876432 2356788999999999999999999984     4556789


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      ++|||+++++|.+++...        ....+++.++..++.|++.||+|||+.   +++||||||+||+++.++.+||+|
T Consensus        78 lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~d  146 (261)
T cd05072          78 IITEYMAKGSLLDFLKSD--------EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIAD  146 (261)
T ss_pred             EEEecCCCCcHHHHHHHh--------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECC
Confidence            999999999999998643        124577888899999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcCC
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      ||.+......... ......++..|+||| +..+..++.++|||||||++|+|++ |..||......  ...........
T Consensus       147 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~~  222 (261)
T cd05072         147 FGLARVIEDNEYT-AREGAKFPIKWTAPE-AINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--DVMSALQRGYR  222 (261)
T ss_pred             CccceecCCCcee-ccCCCccceecCCHH-HhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--HHHHHHHcCCC
Confidence            9999876543221 112234567899995 4456678899999999999999998 99998632111  11111100000


Q ss_pred             cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHH
Q 037916          638 DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSI  706 (741)
Q Consensus       638 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  706 (741)
                      .                              +....++..+.+++.+||..+|++|||++++.+.|+++
T Consensus       223 ~------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         223 M------------------------------PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             C------------------------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence            0                              00012345688999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=5.7e-37  Score=324.01  Aligned_cols=239  Identities=26%  Similarity=0.279  Sum_probs=185.5

Q ss_pred             hhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhc-CCCceeeEeeeecCccccCCceEEEEE
Q 037916          406 CWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKGDDFKALVY  481 (741)
Q Consensus       406 ~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~~~~lv~  481 (741)
                      +.||+|+||.||+|++..+++.||+|+++...   ....+.+..|..+++.+ +||||++++++     +......|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~-----~~~~~~~~iv~   75 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCC-----FQTPDRLFFVM   75 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeE-----EEcCCEEEEEE
Confidence            36899999999999999899999999997422   22344566788888776 79999999998     45566899999


Q ss_pred             ecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeeccc
Q 037916          482 EFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGL  561 (741)
Q Consensus       482 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~  561 (741)
                      ||+++|+|.+++...          ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        76 Ey~~~g~L~~~i~~~----------~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~  142 (320)
T cd05590          76 EFVNGGDLMFHIQKS----------RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGM  142 (320)
T ss_pred             cCCCCchHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCC
Confidence            999999999988643          4578889999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcchh
Q 037916          562 AKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM  641 (741)
Q Consensus       562 a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  641 (741)
                      +........  ......||+.|+||| +..+..++.++||||+||++|+|++|+.||.....     ...........  
T Consensus       143 ~~~~~~~~~--~~~~~~gt~~y~aPE-~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-----~~~~~~i~~~~--  212 (320)
T cd05590         143 CKEGIFNGK--TTSTFCGTPDYIAPE-ILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-----DDLFEAILNDE--  212 (320)
T ss_pred             CeecCcCCC--cccccccCccccCHH-HHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-----HHHHHHHhcCC--
Confidence            875432221  122346899999995 55667789999999999999999999999863211     11111110000  


Q ss_pred             HhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHH
Q 037916          642 DIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTI  698 (741)
Q Consensus       642 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  698 (741)
                                ..                .+......+.+++.+||+.||++||++.+
T Consensus       213 ----------~~----------------~~~~~~~~~~~li~~~L~~dP~~R~~~~~  243 (320)
T cd05590         213 ----------VV----------------YPTWLSQDAVDILKAFMTKNPTMRLGSLT  243 (320)
T ss_pred             ----------CC----------------CCCCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence                      00                00112356789999999999999999833

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=7.7e-37  Score=324.34  Aligned_cols=194  Identities=26%  Similarity=0.308  Sum_probs=163.6

Q ss_pred             hhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhc-CCCceeeEeeeecCccccCCceEEEEE
Q 037916          406 CWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKGDDFKALVY  481 (741)
Q Consensus       406 ~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~~~~lv~  481 (741)
                      +.||+|+||.||+|++..+++.||+|+++...   ....+.+..|..+++.+ +||||+++++++     ......|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~-----~~~~~~~lv~   75 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF-----QTESRLFFVI   75 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE-----EcCCEEEEEE
Confidence            36899999999999999999999999997432   22234567899999888 799999999984     5566899999


Q ss_pred             ecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeeccc
Q 037916          482 EFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGL  561 (741)
Q Consensus       482 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~  561 (741)
                      ||+++|+|.+++...          ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        76 e~~~~g~L~~~~~~~----------~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~  142 (329)
T cd05588          76 EFVSGGDLMFHMQRQ----------RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGM  142 (329)
T ss_pred             eCCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCcc
Confidence            999999999887532          4588999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCc
Q 037916          562 AKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDI  620 (741)
Q Consensus       562 a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~  620 (741)
                      ++.......  ......||+.|+||| +..+..++.++||||+||++|+|++|+.||+.
T Consensus       143 ~~~~~~~~~--~~~~~~gt~~y~aPE-~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~  198 (329)
T cd05588         143 CKEGIRPGD--TTSTFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  198 (329)
T ss_pred             ccccccCCC--ccccccCCccccCHH-HHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence            875322211  112356899999995 55667889999999999999999999999963

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-36  Score=313.04  Aligned_cols=257  Identities=23%  Similarity=0.347  Sum_probs=198.8

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCC---CeEEEEEEeeccCc-CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEG---KTIIAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      ..|++.+.||+|+||.||+|.+...   ...||+|+++.... .....+.+|+.++++++||||+++++++     ....
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   78 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVV-----TKSR   78 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEE-----ecCC
Confidence            4688999999999999999998643   46799999864332 2345678899999999999999999984     4556


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..+++|||+++++|.+++...         ...+++..+..++.|++.|++|||+.   +|+||||||+||++++++.+|
T Consensus        79 ~~~iv~e~~~~~~L~~~~~~~---------~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~  146 (266)
T cd05033          79 PVMIITEYMENGSLDKFLREN---------DGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCK  146 (266)
T ss_pred             ceEEEEEcCCCCCHHHHHHhc---------cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEE
Confidence            789999999999999998643         13578999999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhh
Q 037916          556 VADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  634 (741)
                      |+|||.+................++..|+||| ...+..++.++||||||+++|++++ |..||......  ........
T Consensus       147 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe-~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~  223 (266)
T cd05033         147 VSDFGLSRRLEDSEATYTTKGGKIPIRWTAPE-AIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--DVIKAVED  223 (266)
T ss_pred             ECccchhhcccccccceeccCCCCCccccChh-hhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--HHHHHHHc
Confidence            99999998775222211111233567899995 5556778999999999999999998 99998532111  00000000


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHH
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSI  706 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  706 (741)
                      ..           ..                   +.+..+++.+.+++.+||+.+|++||++.||++.|+++
T Consensus       224 ~~-----------~~-------------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         224 GY-----------RL-------------------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             CC-----------CC-------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            00           00                   00113356688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-37  Score=325.50  Aligned_cols=246  Identities=23%  Similarity=0.289  Sum_probs=197.0

Q ss_pred             cccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEEEecccCC
Q 037916          408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNG  487 (741)
Q Consensus       408 ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv~e~~~~g  487 (741)
                      ||+|.||+||.|++..+...+|||-+.............|+...++++|.|||+++|.|     ..+.+.-|.||-++||
T Consensus       583 LGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEqVPGG  657 (1226)
T KOG4279|consen  583 LGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQVPGG  657 (1226)
T ss_pred             eecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeecCCCC
Confidence            99999999999999999999999999866666777889999999999999999999995     3445888999999999


Q ss_pred             ChhhhccCCCCCCcccCccccc--CHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeC-CCCceEEeecccccc
Q 037916          488 SLEEWLHPVSGADKTVEAPKCL--NFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLD-HEMTAHVADFGLAKL  564 (741)
Q Consensus       488 sL~~~l~~~~~~~~~~~~~~~~--~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~-~~~~~kL~DFg~a~~  564 (741)
                      +|.++++..         ..++  ++.++-.+.+||++||.|||+.   .|||||||-+||||+ -.|.+||+|||-++.
T Consensus       658 SLSsLLrsk---------WGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKR  725 (1226)
T KOG4279|consen  658 SLSSLLRSK---------WGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKR  725 (1226)
T ss_pred             cHHHHHHhc---------cCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchh
Confidence            999999743         1333  6778888999999999999999   999999999999996 578999999999987


Q ss_pred             cCCCCcccccccccccccccCcccccCC-CCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcchhHh
Q 037916          565 LPPAHLQTSSIGVKGTIGYIAPAEYGLG-SEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDI  643 (741)
Q Consensus       565 ~~~~~~~~~~~~~~gt~~y~aPEe~~~~-~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  643 (741)
                      ...-...+  ....||..|||||.+-.| ..|+.++|||||||++.||.||++||.........+.+..  .+..     
T Consensus       726 LAginP~T--ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVG--myKv-----  796 (1226)
T KOG4279|consen  726 LAGINPCT--ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVG--MYKV-----  796 (1226)
T ss_pred             hccCCccc--cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhc--ceec-----
Confidence            65332211  225699999999665444 4699999999999999999999999974433222111100  0000     


Q ss_pred             hhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          644 VDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       644 ~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                                             ....+.+.......++.+|+.+||.+||+++++++.
T Consensus       797 -----------------------HP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D  832 (1226)
T KOG4279|consen  797 -----------------------HPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD  832 (1226)
T ss_pred             -----------------------CCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence                                   011234556677899999999999999999999865

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=8.2e-37  Score=317.76  Aligned_cols=272  Identities=25%  Similarity=0.349  Sum_probs=199.9

Q ss_pred             HHHHhhhcccCceeeEEEEEE----cCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCce
Q 037916          401 SFLFLCWIDMGSFGSVYKGIL----DEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      .|++.+.||+|+||.||+|..    ..++..||+|.++.......+.+.+|+.++++++||||+++++++..   .+...
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~   81 (284)
T cd05081           5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AGRRN   81 (284)
T ss_pred             cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEcc---CCCCc
Confidence            578889999999999999984    45688999999875544445678899999999999999999998642   33456


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .++||||+++++|.+++...         ...+++..+..++.|++.||+|||+.   ||+||||||+||+++.++.+||
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~---------~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l  149 (284)
T cd05081          82 LRLVMEYLPYGSLRDYLQKH---------RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKI  149 (284)
T ss_pred             eEEEEEecCCCCHHHHHHhc---------CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEE
Confidence            89999999999999998632         13478889999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccc-cccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhc
Q 037916          557 ADFGLAKLLPPAHLQTS-SIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV  635 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~-~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~  635 (741)
                      +|||.+........... .....++..|+||| ...+..++.++||||+||++|||++|..|+.....   .+.......
T Consensus       150 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~---~~~~~~~~~  225 (284)
T cd05081         150 GDFGLTKVLPQDKEYYKVREPGESPIFWYAPE-SLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA---EFMRMMGND  225 (284)
T ss_pred             CCCcccccccCCCcceeecCCCCCceEeeCHH-HhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch---hhhhhcccc
Confidence            99999987654322111 11122345699995 55667789999999999999999998877542111   000000000


Q ss_pred             CC--cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHH
Q 037916          636 LP--DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSI  706 (741)
Q Consensus       636 ~~--~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  706 (741)
                      ..  .....+.+. ....              ........++..+.+++.+||+.+|++|||+.||++.|+.+
T Consensus       226 ~~~~~~~~~~~~~-~~~~--------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         226 KQGQMIVYHLIEL-LKNN--------------GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             cccccchHHHHHH-HhcC--------------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            00  000111100 0000              00011123456788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=7.2e-37  Score=324.41  Aligned_cols=246  Identities=22%  Similarity=0.252  Sum_probs=185.4

Q ss_pred             hhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhc-CCCceeeEeeeecCccccCCceEEEEE
Q 037916          406 CWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKGDDFKALVY  481 (741)
Q Consensus       406 ~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~~~~lv~  481 (741)
                      +.||+|+||.||+|++..+++.||+|+++...   ......+..|+.++.++ +||||++++++     +......++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~-----~~~~~~~~lv~   75 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC-----FQTESRLFFVI   75 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeE-----EEeCCEEEEEE
Confidence            36899999999999999999999999997532   22334567788888776 89999999998     45566899999


Q ss_pred             ecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeeccc
Q 037916          482 EFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGL  561 (741)
Q Consensus       482 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~  561 (741)
                      ||+++|+|..++...          ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        76 E~~~~~~L~~~~~~~----------~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~  142 (329)
T cd05618          76 EYVNGGDLMFHMQRQ----------RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGM  142 (329)
T ss_pred             eCCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCc
Confidence            999999998887533          4578889999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcchh
Q 037916          562 AKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM  641 (741)
Q Consensus       562 a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  641 (741)
                      ++.......  ......||+.|+|| |+..+..++.++||||+||++|||++|+.||............        ...
T Consensus       143 ~~~~~~~~~--~~~~~~gt~~y~aP-E~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~--------~~~  211 (329)
T cd05618         143 CKEGLRPGD--TTSTFCGTPNYIAP-EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN--------TED  211 (329)
T ss_pred             cccccCCCC--ccccccCCccccCH-HHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccc--------cHH
Confidence            875432211  11235689999999 5556778899999999999999999999999632111100000        000


Q ss_pred             HhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCH
Q 037916          642 DIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNM  696 (741)
Q Consensus       642 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  696 (741)
                      ...........                ..+......+.+++.+||+.||++|||+
T Consensus       212 ~~~~~i~~~~~----------------~~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         212 YLFQVILEKQI----------------RIPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             HHHHHHhcCCC----------------CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence            00000000000                0011234567799999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.9e-38  Score=328.16  Aligned_cols=249  Identities=21%  Similarity=0.350  Sum_probs=199.1

Q ss_pred             HHhhhcccCceeeEEEEEEcCCCeEEEEEEeec----cCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          403 LFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNL----LHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       403 ~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~----~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      ++...||+|+|-+||+|.+..+|..||.-.++.    ......+++..|+.+|+.|+||||+++|++|.+..   ....-
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~---n~~in  119 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTD---NKTIN  119 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCC---Cceee
Confidence            455679999999999999999999998765542    12333578899999999999999999999976433   35578


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCC-CceEEe
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHE-MTAHVA  557 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~-~~~kL~  557 (741)
                      +|+|.+..|+|..|.++.          +..+...++.|++||++||.|||++ .|+|||||||-+||+|+.+ |.|||+
T Consensus       120 ~iTEL~TSGtLr~Y~kk~----------~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIG  188 (632)
T KOG0584|consen  120 FITELFTSGTLREYRKKH----------RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIG  188 (632)
T ss_pred             eeeecccCCcHHHHHHHh----------ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeec
Confidence            999999999999999876          4577788999999999999999998 8999999999999999865 799999


Q ss_pred             ecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCC
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      |+|+|..........    +.|||.|||||.|  ...|++.+||||||++|+||+|+.+||........-|+.......|
T Consensus       189 DLGLAtl~r~s~aks----vIGTPEFMAPEmY--EE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP  262 (632)
T KOG0584|consen  189 DLGLATLLRKSHAKS----VIGTPEFMAPEMY--EENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKP  262 (632)
T ss_pred             chhHHHHhhccccce----eccCccccChHHH--hhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCH
Confidence            999999876544322    6799999999766  4789999999999999999999999986433222222222222222


Q ss_pred             cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          638 DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       638 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      ..+..+-                              -+.+.++|.+|+.. .++|||+.|+++.
T Consensus       263 ~sl~kV~------------------------------dPevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  263 AALSKVK------------------------------DPEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             HHhhccC------------------------------CHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence            2222222                              14577999999999 9999999999864

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=7e-37  Score=322.75  Aligned_cols=241  Identities=22%  Similarity=0.277  Sum_probs=184.4

Q ss_pred             hhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHh-cCCCceeeEeeeecCccccCCceEEEEE
Q 037916          406 CWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRN-IRHKNLVKILTVCSGVDYKGDDFKALVY  481 (741)
Q Consensus       406 ~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~hpnIv~~~~~~~~~~~~~~~~~~lv~  481 (741)
                      +.||+|+||.||+|++..+++.||+|+++...   ....+....|..++.. .+||||++++++     +..+...|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~-----~~~~~~~~lv~   75 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCT-----FQTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeE-----EEcCCEEEEEE
Confidence            46899999999999999899999999997432   2223444566667665 489999999998     45566899999


Q ss_pred             ecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeeccc
Q 037916          482 EFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGL  561 (741)
Q Consensus       482 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~  561 (741)
                      ||+++|+|.+++...          ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        76 e~~~gg~L~~~~~~~----------~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~  142 (316)
T cd05592          76 EYLNGGDLMFHIQSS----------GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGM  142 (316)
T ss_pred             cCCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcC
Confidence            999999999988643          4578888999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcchh
Q 037916          562 AKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM  641 (741)
Q Consensus       562 a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  641 (741)
                      +........  ......||+.|+||| +..+..++.++||||+||++|||++|+.||.....     .+........   
T Consensus       143 a~~~~~~~~--~~~~~~gt~~y~aPE-~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-----~~~~~~i~~~---  211 (316)
T cd05592         143 CKENMNGEG--KASTFCGTPDYIAPE-ILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-----DELFDSILND---  211 (316)
T ss_pred             CeECCCCCC--ccccccCCccccCHH-HHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHcC---
Confidence            975433221  122356899999995 55667789999999999999999999999863211     1111100000   


Q ss_pred             HhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHH-HHH
Q 037916          642 DIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMT-IVV  700 (741)
Q Consensus       642 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl  700 (741)
                           .  ...                  +..+...+.+++.+||+.||++||++. +++
T Consensus       212 -----~--~~~------------------~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         212 -----R--PHF------------------PRWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             -----C--CCC------------------CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence                 0  000                  012234567899999999999999875 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.3e-36  Score=315.34  Aligned_cols=248  Identities=23%  Similarity=0.295  Sum_probs=189.1

Q ss_pred             cccCceeeEEEEEEcCCCeEEEEEEeeccCcC---cchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEEEecc
Q 037916          408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG---ASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFM  484 (741)
Q Consensus       408 ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv~e~~  484 (741)
                      ||+|+||.||+|.+..+++.||+|.+......   ..+.+..|+.+++.++||||+++.+++     ..+...++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~   75 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF-----QTKTDLCLVMTIM   75 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEE-----cCCCeEEEEEeCC
Confidence            79999999999999989999999998643221   234567899999999999999999884     4566899999999


Q ss_pred             cCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecccccc
Q 037916          485 HNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKL  564 (741)
Q Consensus       485 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~a~~  564 (741)
                      ++|+|..++....      .....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.+..
T Consensus        76 ~~g~L~~~~~~~~------~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~  146 (280)
T cd05608          76 NGGDLRYHIYNVD------EENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVE  146 (280)
T ss_pred             CCCCHHHHHHhcc------ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcccee
Confidence            9999988774321      1124588999999999999999999999   999999999999999999999999999976


Q ss_pred             cCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcchhHhh
Q 037916          565 LPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIV  644 (741)
Q Consensus       565 ~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  644 (741)
                      .......  .....||+.|+|| |...+..++.++||||+||++|||++|+.||....... ............      
T Consensus       147 ~~~~~~~--~~~~~g~~~y~aP-E~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~------  216 (280)
T cd05608         147 LKDGQSK--TKGYAGTPGFMAP-ELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQRILND------  216 (280)
T ss_pred             cCCCCcc--ccccCCCcCccCH-HHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch-hHHHHHHhhccc------
Confidence            5443221  1234689999999 55566788999999999999999999999986321110 000000000000      


Q ss_pred             hhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCC-----CHHHHHH
Q 037916          645 DSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRM-----NMTIVVH  701 (741)
Q Consensus       645 d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  701 (741)
                            .                ...+...+..+.+++.+||+.||++||     |++|+++
T Consensus       217 ------~----------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         217 ------S----------------VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             ------C----------------CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence                  0                000113456688999999999999999     5666665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.6e-37  Score=318.21  Aligned_cols=251  Identities=29%  Similarity=0.454  Sum_probs=188.1

Q ss_pred             HhhhcccCceeeEEEEEEc----CCCeEEEEEEeeccCc-CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          404 FLCWIDMGSFGSVYKGILD----EGKTIIAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       404 ~~~~ig~G~~g~V~~a~~~----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      +.+.||.|+||.||+|.+.    ..+..|+||+++.... ...+.+.+|++.+++++||||++++++|.     .....+
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~-----~~~~~~   77 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCI-----ENEPLF   77 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEE-----SSSSEE
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccc-----cccccc
Confidence            3568999999999999997    5578899999964322 23578899999999999999999999974     334589


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      +||||+++|+|.+++...        ....+++.++..|+.|+++||.|||+.   +++|+||+++||+++.++.+||+|
T Consensus        78 lv~e~~~~g~L~~~L~~~--------~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~  146 (259)
T PF07714_consen   78 LVMEYCPGGSLDDYLKSK--------NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSD  146 (259)
T ss_dssp             EEEE--TTEBHHHHHHHT--------CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEES
T ss_pred             cccccccccccccccccc--------ccccccccccccccccccccccccccc---cccccccccccccccccccccccc
Confidence            999999999999999743        124588999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcCC
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      ||.+................+...|+||| ......++.++||||||+++||+++ |+.||.....     .++......
T Consensus       147 f~~~~~~~~~~~~~~~~~~~~~~~~~aPE-~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~-----~~~~~~~~~  220 (259)
T PF07714_consen  147 FGLSRPISEKSKYKNDSSQQLPLRYLAPE-VLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN-----EEIIEKLKQ  220 (259)
T ss_dssp             TTTGEETTTSSSEEESTTSESGGGGS-HH-HHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH-----HHHHHHHHT
T ss_pred             ccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccc-----ccccccccc
Confidence            99998774332222223344778999995 5555668999999999999999999 6788753211     111111100


Q ss_pred             cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHH
Q 037916          638 DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHEL  703 (741)
Q Consensus       638 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  703 (741)
                      .        ..                   ...+..++..+.+++.+||..||++|||+.|+++.|
T Consensus       221 ~--------~~-------------------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  221 G--------QR-------------------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             T--------EE-------------------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             c--------cc-------------------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            0        00                   001113456788999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-37  Score=317.35  Aligned_cols=252  Identities=21%  Similarity=0.280  Sum_probs=194.2

Q ss_pred             HHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc---CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH---GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      |++.+.||+|+||.||++.+..+++.||+|++.....   .....+.+|+.++++++||||+++++++     ..++..+
T Consensus         2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~   76 (285)
T cd05605           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETKDALC   76 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeee-----cCCCeEE
Confidence            7788999999999999999988999999999864221   2234567899999999999999999984     4556899


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      +||||+++|+|.+++...        ....+++..+..++.|++.||.|||+.   +|+||||||+||++++++.++|+|
T Consensus        77 lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~D  145 (285)
T cd05605          77 LVLTLMNGGDLKFHIYNM--------GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISD  145 (285)
T ss_pred             EEEeccCCCcHHHHHHhc--------CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEee
Confidence            999999999999887532        113578899999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCc
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      ||.+.........   ....|++.|+||| +..+..++.++||||+||++||+++|+.||..... ........      
T Consensus       146 fg~~~~~~~~~~~---~~~~~~~~y~aPE-~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~-~~~~~~~~------  214 (285)
T cd05605         146 LGLAVEIPEGETI---RGRVGTVGYMAPE-VVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE-KVKREEVE------  214 (285)
T ss_pred             CCCceecCCCCcc---ccccCCCCccCcH-HhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch-hhHHHHHH------
Confidence            9999875433221   2245899999995 55667789999999999999999999999863211 00000000      


Q ss_pred             chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCC-----CHHHHHHH
Q 037916          639 HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRM-----NMTIVVHE  702 (741)
Q Consensus       639 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  702 (741)
                         ..+....                   .......+..+.+++.+||+.||++||     +++++++.
T Consensus       215 ---~~~~~~~-------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         215 ---RRVKEDQ-------------------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             ---HHhhhcc-------------------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence               0000000                   000113455678999999999999999     77777553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.2e-36  Score=327.29  Aligned_cols=204  Identities=26%  Similarity=0.281  Sum_probs=167.6

Q ss_pred             HHHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeecc--CcCcchhHHHHHHHHHhcCCCceeeEeeeecCcc-ccC
Q 037916          397 LLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLL--HHGASKSSIAECSALRNIRHKNLVKILTVCSGVD-YKG  473 (741)
Q Consensus       397 ~~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~~  473 (741)
                      .+..+|++.+.||+|+||.||+|.+..++..||+|+++..  .......+.+|+.+++.++||||+++++++.... ...
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence            4567899999999999999999999989999999998632  2233456778999999999999999999864322 122


Q ss_pred             CceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCc
Q 037916          474 DDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMT  553 (741)
Q Consensus       474 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~  553 (741)
                      ....|+||||+.+ ++.+.+.            ..+++..+..++.|++.||+|||+.   ||+||||||+||+++.++.
T Consensus        98 ~~~~~lv~e~~~~-~l~~~~~------------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~  161 (359)
T cd07876          98 FQDVYLVMELMDA-NLCQVIH------------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCT  161 (359)
T ss_pred             cceeEEEEeCCCc-CHHHHHh------------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCC
Confidence            3457999999954 6666653            2367788889999999999999999   9999999999999999999


Q ss_pred             eEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCc
Q 037916          554 AHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDI  620 (741)
Q Consensus       554 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~  620 (741)
                      +||+|||++........   .....||+.|+||| ...+..++.++||||+||++|+|++|+.||..
T Consensus       162 ~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE-~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~  224 (359)
T cd07876         162 LKILDFGLARTACTNFM---MTPYVVTRYYRAPE-VILGMGYKENVDIWSVGCIMGELVKGSVIFQG  224 (359)
T ss_pred             EEEecCCCccccccCcc---CCCCcccCCCCCch-hccCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence            99999999975433221   12245899999995 55667889999999999999999999999963

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.6e-36  Score=310.44  Aligned_cols=251  Identities=24%  Similarity=0.340  Sum_probs=193.8

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      ..|++.+.||+|+||.||+|.+. ++..+|+|.++.. ....+.+.+|+.++++++||||+++++++     ......++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~i   76 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVC-----TQQKPLYI   76 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEE-----ccCCCEEE
Confidence            46888999999999999999986 4567999987632 23346788999999999999999999985     44557899


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      ||||+++|+|.+++...         ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        77 v~e~~~~~~L~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~  144 (256)
T cd05114          77 VTEFMENGCLLNYLRQR---------QGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDF  144 (256)
T ss_pred             EEEcCCCCcHHHHHHhC---------ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCC
Confidence            99999999999988633         12478889999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcCCc
Q 037916          560 GLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       560 g~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      |.+.......... .....++..|+||| ...+..++.++||||||+++||+++ |+.||.....     .+........
T Consensus       145 g~~~~~~~~~~~~-~~~~~~~~~y~aPE-~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~-----~~~~~~i~~~  217 (256)
T cd05114         145 GMTRYVLDDEYTS-SSGAKFPVKWSPPE-VFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN-----YEVVEMISRG  217 (256)
T ss_pred             CCccccCCCceec-cCCCCCchhhCChh-hcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHHHCC
Confidence            9987654332211 12233566899995 4556678999999999999999999 8999862211     0011100000


Q ss_pred             chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHH
Q 037916          639 HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHEL  703 (741)
Q Consensus       639 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  703 (741)
                      .        ....                   +...+..+.+++.+||+.||++|||+.|+++.|
T Consensus       218 ~--------~~~~-------------------~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         218 F--------RLYR-------------------PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             C--------CCCC-------------------CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            0        0000                   001234678999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.5e-36  Score=314.44  Aligned_cols=248  Identities=22%  Similarity=0.288  Sum_probs=188.5

Q ss_pred             cccCceeeEEEEEEcCCCeEEEEEEeeccCc---CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEEEecc
Q 037916          408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHH---GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFM  484 (741)
Q Consensus       408 ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv~e~~  484 (741)
                      ||+|+||.||++.+..+++.||+|.+.....   ........|++++++++||||++++++     +..+.+.++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~-----~~~~~~~~lv~e~~   75 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYA-----FESKTHLCLVMSLM   75 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEE-----EecCCeEEEEEecC
Confidence            7999999999999998999999999863221   123345679999999999999999998     45566899999999


Q ss_pred             cCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecccccc
Q 037916          485 HNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKL  564 (741)
Q Consensus       485 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~a~~  564 (741)
                      ++++|.+++...        ....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.+..
T Consensus        76 ~g~~L~~~~~~~--------~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~  144 (277)
T cd05607          76 NGGDLKYHIYNV--------GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVE  144 (277)
T ss_pred             CCCCHHHHHHhc--------cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeee
Confidence            999999887532        123478888899999999999999999   999999999999999999999999999876


Q ss_pred             cCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcchhHhh
Q 037916          565 LPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIV  644 (741)
Q Consensus       565 ~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  644 (741)
                      .......   ....|+..|+||| +..+..++.++||||+||++|||++|+.||....... ............      
T Consensus       145 ~~~~~~~---~~~~~~~~y~aPE-~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~-~~~~~~~~~~~~------  213 (277)
T cd05607         145 LKDGKTI---TQRAGTNGYMAPE-ILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV-AKEELKRRTLED------  213 (277)
T ss_pred             cCCCcee---eccCCCCCccCHH-HHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh-hHHHHHHHhhcc------
Confidence            6443221   2245899999995 4456669999999999999999999999986321110 101111100000      


Q ss_pred             hhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHH
Q 037916          645 DSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHEL  703 (741)
Q Consensus       645 d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  703 (741)
                        .....                   .......+.+++.+||+.||++||++.|+++.+
T Consensus       214 --~~~~~-------------------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         214 --EVKFE-------------------HQNFTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             --ccccc-------------------cccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence              00000                   012345678999999999999999998876433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1e-36  Score=325.97  Aligned_cols=283  Identities=18%  Similarity=0.169  Sum_probs=197.9

Q ss_pred             HHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc--CcchhHHHHHHHHHhcCCCceeeEeeeecCccc-cCC
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKNLVKILTVCSGVDY-KGD  474 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~-~~~  474 (741)
                      +..+|++++.||+|+||.||+|.+..+++.||+|+++....  ...+.+.+|+.++++++||||+++++++..... ...
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            44689999999999999999999998999999999864221  223456789999999999999999998643221 223


Q ss_pred             ceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCce
Q 037916          475 DFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTA  554 (741)
Q Consensus       475 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~  554 (741)
                      ...|++||++ +++|.+++..           ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~~-----------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~  157 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVKC-----------QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCEL  157 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCE
Confidence            4578999988 7899888752           3478899999999999999999999   99999999999999999999


Q ss_pred             EEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhh
Q 037916          555 HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       555 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  634 (741)
                      ||+|||++.......     ....||+.|+|||.+.....++.++||||+||++|+|++|+.||...... ..+..+...
T Consensus       158 kl~Dfg~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~  231 (343)
T cd07878         158 RILDFGLARQADDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-DQLKRIMEV  231 (343)
T ss_pred             EEcCCccceecCCCc-----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHH
Confidence            999999998654321     22458999999976655567899999999999999999999998632110 011111110


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      . .....+.................................+.+.+++.+|++.||++|||+.|+++.
T Consensus       232 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         232 V-GTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             h-CCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0 000001110000000000000000000000000001123457899999999999999999999964

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.8e-36  Score=316.74  Aligned_cols=268  Identities=21%  Similarity=0.328  Sum_probs=201.6

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCC-----CeEEEEEEeeccCc-CcchhHHHHHHHHHhc-CCCceeeEeeeecCccc
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEG-----KTIIAVKVLNLLHH-GASKSSIAECSALRNI-RHKNLVKILTVCSGVDY  471 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~  471 (741)
                      ...|++.+.||+|+||.||+|.+...     ...||+|.++.... .....+.+|+.+++++ +||||+++++++     
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~-----   85 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC-----   85 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE-----
Confidence            45788899999999999999998633     37899999874321 2234577899999999 899999999985     


Q ss_pred             cCCceEEEEEecccCCChhhhccCCCCCCc------ccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCC
Q 037916          472 KGDDFKALVYEFMHNGSLEEWLHPVSGADK------TVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSN  545 (741)
Q Consensus       472 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~N  545 (741)
                      ..+...+++|||+++|+|.+++........      .......+++..++.++.|++.||+|||+.   +|+||||||+|
T Consensus        86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~N  162 (293)
T cd05053          86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARN  162 (293)
T ss_pred             cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Cccccccceee
Confidence            345578999999999999999864321000      001235688999999999999999999999   99999999999


Q ss_pred             eEeCCCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccC
Q 037916          546 VLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEG  624 (741)
Q Consensus       546 Ill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~  624 (741)
                      |+++.++.+||+|||.++...............++..|+||| ...+..++.++|||||||++||+++ |..||....  
T Consensus       163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--  239 (293)
T cd05053         163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP--  239 (293)
T ss_pred             EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHH-HhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC--
Confidence            999999999999999998765443222222233567899995 4456778999999999999999997 888875221  


Q ss_pred             CcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHH
Q 037916          625 NMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQ  704 (741)
Q Consensus       625 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  704 (741)
                         ..+...         ........                  ..+..+...+.+++.+||+.||++|||+.|+++.|+
T Consensus       240 ---~~~~~~---------~~~~~~~~------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~  289 (293)
T cd05053         240 ---VEELFK---------LLKEGYRM------------------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLD  289 (293)
T ss_pred             ---HHHHHH---------HHHcCCcC------------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHH
Confidence               111111         00000000                  001133456889999999999999999999999998


Q ss_pred             HHH
Q 037916          705 SIK  707 (741)
Q Consensus       705 ~i~  707 (741)
                      ++.
T Consensus       290 ~~~  292 (293)
T cd05053         290 RML  292 (293)
T ss_pred             Hhh
Confidence            875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.8e-36  Score=316.24  Aligned_cols=266  Identities=20%  Similarity=0.331  Sum_probs=199.6

Q ss_pred             HHHhhhcccCceeeEEEEEEcC-----CCeEEEEEEeeccCc-CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          402 FLFLCWIDMGSFGSVYKGILDE-----GKTIIAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      |++.+.||+|+||.||+|.+..     ....||+|.+..... ...+.+.+|+.+++.++||||+++++.|     ....
T Consensus         2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~   76 (290)
T cd05045           2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGAC-----SQDG   76 (290)
T ss_pred             ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecCC
Confidence            6788999999999999998742     335789998864322 2245678899999999999999999985     3455


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCc--------------ccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCC
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADK--------------TVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDL  541 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~--------------~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDl  541 (741)
                      ..+++|||+.+++|.+++...+....              .......+++.+++.++.|++.||+|||+.   +|+||||
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~di  153 (290)
T cd05045          77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDL  153 (290)
T ss_pred             CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhh
Confidence            78999999999999999864322110              011224588999999999999999999999   9999999


Q ss_pred             CCCCeEeCCCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCc
Q 037916          542 KPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDI  620 (741)
Q Consensus       542 kp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~  620 (741)
                      ||+||++++++.+||+|||.++...............++..|+|||. ..+..++.++||||||+++|||++ |..||..
T Consensus       154 kp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~-~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~  232 (290)
T cd05045         154 AARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIES-LFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG  232 (290)
T ss_pred             hhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHH-HccCCcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence            99999999999999999999976543322222222345678999954 456778999999999999999998 9999852


Q ss_pred             cccCCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHH
Q 037916          621 MFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVV  700 (741)
Q Consensus       621 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  700 (741)
                      ...     .         ...+..........                  +..+...+.+++.+||+.||++||++.|++
T Consensus       233 ~~~-----~---------~~~~~~~~~~~~~~------------------~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~  280 (290)
T cd05045         233 IAP-----E---------RLFNLLKTGYRMER------------------PENCSEEMYNLMLTCWKQEPDKRPTFADIS  280 (290)
T ss_pred             CCH-----H---------HHHHHHhCCCCCCC------------------CCCCCHHHHHHHHHHccCCcccCCCHHHHH
Confidence            211     0         11111111110000                  112345688999999999999999999999


Q ss_pred             HHHHHHHH
Q 037916          701 HELQSIKS  708 (741)
Q Consensus       701 ~~L~~i~~  708 (741)
                      +.|+++..
T Consensus       281 ~~l~~~~~  288 (290)
T cd05045         281 KELEKMMV  288 (290)
T ss_pred             HHHHHHHh
Confidence            99998763

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=6.2e-37  Score=324.62  Aligned_cols=241  Identities=24%  Similarity=0.280  Sum_probs=186.6

Q ss_pred             HHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhcCCC-ceeeEeeeecCccccCCceE
Q 037916          402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNIRHK-NLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp-nIv~~~~~~~~~~~~~~~~~  477 (741)
                      |++++.||+|+||.||+|.+..+++.||+|+++...   ....+.+..|..++..+.|+ +|++++++     +...+..
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~-----~~~~~~~   76 (324)
T cd05587           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSC-----FQTMDRL   76 (324)
T ss_pred             ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEE-----EEcCCEE
Confidence            778899999999999999999899999999997432   23345667889999988764 68888887     4456689


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      |+||||+++|+|.+++...          ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        77 ~lv~E~~~~g~L~~~~~~~----------~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~  143 (324)
T cd05587          77 YFVMEYVNGGDLMYHIQQV----------GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIA  143 (324)
T ss_pred             EEEEcCCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEe
Confidence            9999999999999988633          3478888999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCC
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      |||++........  ......||+.|+||| +..+..++.++||||+||++|+|++|+.||.....     ......   
T Consensus       144 Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE-~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-----~~~~~~---  212 (324)
T cd05587         144 DFGMCKENIFGGK--TTRTFCGTPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-----DELFQS---  212 (324)
T ss_pred             ecCcceecCCCCC--ceeeecCCccccChh-hhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----HHHHHH---
Confidence            9999875322111  122346899999995 55667789999999999999999999999863211     001110   


Q ss_pred             cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCH
Q 037916          638 DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNM  696 (741)
Q Consensus       638 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  696 (741)
                           +.+...  ..                  +......+.+++.+||..||++||++
T Consensus       213 -----i~~~~~--~~------------------~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         213 -----IMEHNV--SY------------------PKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             -----HHcCCC--CC------------------CCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence                 000000  00                  01223457799999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.5e-36  Score=315.63  Aligned_cols=266  Identities=21%  Similarity=0.353  Sum_probs=198.8

Q ss_pred             HHHHHHhhhcccCceeeEEEEEE----cCCCeEEEEEEeeccCc-CcchhHHHHHHHHHhcCCCceeeEeeeecCccccC
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGIL----DEGKTIIAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKG  473 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  473 (741)
                      +..|++.+.||+|+||.||+|..    ..++..||+|.++.... .....+.+|+.++++++||||+++++++     ..
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~   78 (283)
T cd05090           4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVV-----TQ   78 (283)
T ss_pred             hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEE-----ec
Confidence            45688999999999999999985    34567899999874222 2235678899999999999999999984     45


Q ss_pred             CceEEEEEecccCCChhhhccCCCCCC-------cccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCe
Q 037916          474 DDFKALVYEFMHNGSLEEWLHPVSGAD-------KTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNV  546 (741)
Q Consensus       474 ~~~~~lv~e~~~~gsL~~~l~~~~~~~-------~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NI  546 (741)
                      +...|+||||+++++|.+++.......       ........+++.++..++.|++.||+|||+.   +|+||||||+||
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~ni  155 (283)
T cd05090          79 EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNI  155 (283)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceE
Confidence            567899999999999999985321100       0011123578888999999999999999999   999999999999


Q ss_pred             EeCCCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCC
Q 037916          547 LLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGN  625 (741)
Q Consensus       547 ll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~  625 (741)
                      +++.++.+||+|||++................++..|+||| +..+..++.++|||||||++|||++ |..||.....  
T Consensus       156 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--  232 (283)
T cd05090         156 LIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPE-AIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--  232 (283)
T ss_pred             EEcCCCcEEeccccccccccCCcceecccCCCccceecChH-HhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--
Confidence            99999999999999998664433222222334577899995 5556678999999999999999998 8888752110  


Q ss_pred             cchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHH
Q 037916          626 MNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQS  705 (741)
Q Consensus       626 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  705 (741)
                      ....+.......           ..                   ....++..+.+++.+||+.||++||++.+|++.|..
T Consensus       233 ~~~~~~~~~~~~-----------~~-------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         233 QEVIEMVRKRQL-----------LP-------------------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHHHHcCCc-----------CC-------------------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            011111110000           00                   011234568899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-37  Score=330.84  Aligned_cols=200  Identities=24%  Similarity=0.303  Sum_probs=169.2

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      .|++++.||+|+||.||+|++..+++.||+|+++...   ......+.+|+.+++.++||||++++++     +.++...
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~-----~~~~~~~   76 (364)
T cd05599           2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYS-----FQDENYL   76 (364)
T ss_pred             CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEE-----EEcCCeE
Confidence            4788999999999999999999999999999997432   2233456789999999999999999998     4566789


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      |+||||+++|+|.+++...          ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+
T Consensus        77 ~lv~E~~~~g~L~~~l~~~----------~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~  143 (364)
T cd05599          77 YLIMEYLPGGDMMTLLMKK----------DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLS  143 (364)
T ss_pred             EEEECCCCCcHHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEe
Confidence            9999999999999998643          4578899999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCccc------------------------------------ccccccccccccCcccccCCCCCCCccCc
Q 037916          558 DFGLAKLLPPAHLQT------------------------------------SSIGVKGTIGYIAPAEYGLGSEVSINGDV  601 (741)
Q Consensus       558 DFg~a~~~~~~~~~~------------------------------------~~~~~~gt~~y~aPEe~~~~~~~~~~~DI  601 (741)
                      |||++..........                                    ......||+.|+||| +..+..++.++||
T Consensus       144 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE-~~~~~~~~~~~Di  222 (364)
T cd05599         144 DFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPE-VFLQTGYNKECDW  222 (364)
T ss_pred             ecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHH-HHcCCCCCCeeee
Confidence            999987543211000                                    001235899999995 5566778999999


Q ss_pred             hhHHHHHHHHHcCCCCCC
Q 037916          602 YSYGILLLELMTRKRPSD  619 (741)
Q Consensus       602 wSlG~il~elltg~~p~~  619 (741)
                      ||+||++|||++|..||.
T Consensus       223 wSlG~il~el~~G~~Pf~  240 (364)
T cd05599         223 WSLGVIMYEMLVGYPPFC  240 (364)
T ss_pred             ecchhHHHHhhcCCCCCC
Confidence            999999999999999986

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-36  Score=315.47  Aligned_cols=265  Identities=20%  Similarity=0.297  Sum_probs=199.5

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCC-----CeEEEEEEeeccCc-CcchhHHHHHHHHHhcCCCceeeEeeeecCcccc
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEG-----KTIIAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKILTVCSGVDYK  472 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  472 (741)
                      ...|++.+.||+|+||.||+|.+...     +..||+|.+..... .....+.+|+.+++.++||||+++++++     .
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~   79 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVV-----S   79 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEE-----c
Confidence            45788899999999999999998643     47899999863321 2234677899999999999999999995     4


Q ss_pred             CCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCC
Q 037916          473 GDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEM  552 (741)
Q Consensus       473 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~  552 (741)
                      .....++||||+++++|.+++...............+++..+..++.|++.||.|||+.   +|+||||||+||+++.++
T Consensus        80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~  156 (277)
T cd05032          80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDL  156 (277)
T ss_pred             CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCC
Confidence            45688999999999999999864322111101123478889999999999999999999   999999999999999999


Q ss_pred             ceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhh
Q 037916          553 TAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNF  631 (741)
Q Consensus       553 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~  631 (741)
                      .+||+|||.++...............++..|+||| ...+..++.++|||||||++||+++ |..||.....  ......
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--~~~~~~  233 (277)
T cd05032         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE-SLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN--EEVLKF  233 (277)
T ss_pred             CEEECCcccchhhccCcccccCCCCCccccccCHH-HHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH--HHHHHH
Confidence            99999999987665443222222234678899995 4456678999999999999999998 8889752111  111111


Q ss_pred             hhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHH
Q 037916          632 ARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQ  704 (741)
Q Consensus       632 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  704 (741)
                      ...            .....                  .+..++..+.+++.+||+.+|++|||+.|+++.|+
T Consensus       234 ~~~------------~~~~~------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         234 VID------------GGHLD------------------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             Hhc------------CCCCC------------------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            100            00000                  01123567889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-37  Score=331.39  Aligned_cols=253  Identities=23%  Similarity=0.264  Sum_probs=197.3

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      +|.+.+.||+|+||.||+|++..+++.||+|+++...   ......+.+|+.+++.++||||++++++     +.++.+.
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~-----~~~~~~~   76 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYS-----FQDEEHL   76 (350)
T ss_pred             CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhh-----eecCCeE
Confidence            4788999999999999999999899999999997432   2334567889999999999999999988     4566789


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      |+||||+++++|.+++...          ..+++..++.++.|++.||+|||+.   ||+||||||+||+++.++.+||+
T Consensus        77 ~lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~  143 (350)
T cd05573          77 YLVMEYMPGGDLMNLLIRK----------DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLA  143 (350)
T ss_pred             EEEEcCCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEee
Confidence            9999999999999998643          4578889999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCC---------------------------cccccccccccccccCcccccCCCCCCCccCchhHHHHHHH
Q 037916          558 DFGLAKLLPPAH---------------------------LQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLE  610 (741)
Q Consensus       558 DFg~a~~~~~~~---------------------------~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~e  610 (741)
                      |||.+.......                           .........||+.|+|| |+..+..++.++|||||||++||
T Consensus       144 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP-E~~~~~~~~~~~DiwSlG~il~e  222 (350)
T cd05573         144 DFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAP-EVLRGTPYGLECDWWSLGVILYE  222 (350)
T ss_pred             cCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCH-HHHcCCCCCCceeeEecchhhhh
Confidence            999998665432                           00112234589999999 55566688999999999999999


Q ss_pred             HHcCCCCCCccccCCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCC
Q 037916          611 LMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESP  690 (741)
Q Consensus       611 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP  690 (741)
                      |++|+.||......     ........     +. .....                  ......++.+.+++.+|+. ||
T Consensus       223 ll~g~~Pf~~~~~~-----~~~~~i~~-----~~-~~~~~------------------p~~~~~~~~~~~li~~ll~-dp  272 (350)
T cd05573         223 MLYGFPPFYSDTLQ-----ETYNKIIN-----WK-ESLRF------------------PPDPPVSPEAIDLICRLLC-DP  272 (350)
T ss_pred             hccCCCCCCCCCHH-----HHHHHHhc-----cC-CcccC------------------CCCCCCCHHHHHHHHHHcc-Ch
Confidence            99999998632210     00000000     00 00000                  0000134567899999997 99


Q ss_pred             CCCCC-HHHHHHH
Q 037916          691 QDRMN-MTIVVHE  702 (741)
Q Consensus       691 ~~RPs-~~evl~~  702 (741)
                      ++||+ +.|+++.
T Consensus       273 ~~R~~s~~~ll~h  285 (350)
T cd05573         273 EDRLGSFEEIKSH  285 (350)
T ss_pred             hhcCCCHHHHhcC
Confidence            99999 9999874

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-36  Score=319.26  Aligned_cols=251  Identities=24%  Similarity=0.265  Sum_probs=202.6

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcC---cchhHHHHHHHHHhcC-CCceeeEeeeecCccccCC
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG---ASKSSIAECSALRNIR-HKNLVKILTVCSGVDYKGD  474 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~  474 (741)
                      ...|++.+.||.|.||.||+|+.+.+|+.+|+|++.+....   ..+...+|+.+|+++. |||||.++++     +++.
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~-----~e~~  108 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDA-----FEDP  108 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEE-----EEcC
Confidence            34688889999999999999999999999999999754332   3458899999999998 9999999999     6677


Q ss_pred             ceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCC---
Q 037916          475 DFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHE---  551 (741)
Q Consensus       475 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~---  551 (741)
                      ..+++|||++.||.|.+.+...           .+++..+..+++|++.|+.|||+.   ||+||||||+|+|+...   
T Consensus       109 ~~~~lvmEL~~GGeLfd~i~~~-----------~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~  174 (382)
T KOG0032|consen  109 DSVYLVMELCEGGELFDRIVKK-----------HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEG  174 (382)
T ss_pred             CeEEEEEEecCCchHHHHHHHc-----------cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCC
Confidence            7999999999999999998632           288999999999999999999999   99999999999999643   


Q ss_pred             -CceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhh
Q 037916          552 -MTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHN  630 (741)
Q Consensus       552 -~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~  630 (741)
                       +.+|++|||++......   ......+||+.|+|| |+.....|+..+||||+|+++|.|++|..||....+..... .
T Consensus       175 ~~~ik~~DFGla~~~~~~---~~~~~~~Gtp~y~AP-Evl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-~  249 (382)
T KOG0032|consen  175 SGRIKLIDFGLAKFIKPG---ERLHTIVGTPEYVAP-EVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-A  249 (382)
T ss_pred             CCcEEEeeCCCceEccCC---ceEeeecCCccccCc-hhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-H
Confidence             47999999999987762   223346799999999 55566889999999999999999999999986332211111 1


Q ss_pred             hhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          631 FARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       631 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      .....+     ++-++                       ........+.+++..|+..||.+|+|+.++++
T Consensus       250 i~~~~~-----~f~~~-----------------------~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  250 ILRGDF-----DFTSE-----------------------PWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             HHcCCC-----CCCCC-----------------------CccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence            111100     01110                       11234566789999999999999999999998

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.1e-36  Score=321.20  Aligned_cols=241  Identities=23%  Similarity=0.265  Sum_probs=185.1

Q ss_pred             hhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhc-CCCceeeEeeeecCccccCCceEEEEE
Q 037916          406 CWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKGDDFKALVY  481 (741)
Q Consensus       406 ~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~~~~lv~  481 (741)
                      +.||+|+||.||+|++..+++.||+|+++...   .........|..++... +||||++++++     +...++.|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~-----~~~~~~~~lv~   75 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCT-----FQTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEE-----EEeCCEEEEEE
Confidence            46999999999999999999999999997432   22334556777777654 89999999998     45566899999


Q ss_pred             ecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeeccc
Q 037916          482 EFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGL  561 (741)
Q Consensus       482 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~  561 (741)
                      ||+.+|+|.+++...          ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.
T Consensus        76 E~~~~g~L~~~i~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~  142 (316)
T cd05620          76 EFLNGGDLMFHIQDK----------GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGM  142 (316)
T ss_pred             CCCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCC
Confidence            999999999988632          4578888999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcchh
Q 037916          562 AKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM  641 (741)
Q Consensus       562 a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  641 (741)
                      ++.......  ......||+.|+||| +..+..++.++||||+||++|||++|+.||.....  ...........     
T Consensus       143 ~~~~~~~~~--~~~~~~gt~~y~aPE-~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~--~~~~~~~~~~~-----  212 (316)
T cd05620         143 CKENVFGDN--RASTFCGTPDYIAPE-ILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE--DELFESIRVDT-----  212 (316)
T ss_pred             CeecccCCC--ceeccCCCcCccCHH-HHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--HHHHHHHHhCC-----
Confidence            874322211  122356899999994 55667889999999999999999999999862211  00000000000     


Q ss_pred             HhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHH-HHH
Q 037916          642 DIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMT-IVV  700 (741)
Q Consensus       642 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl  700 (741)
                              ...                  +......+.+++.+||+.||++||++. +++
T Consensus       213 --------~~~------------------~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         213 --------PHY------------------PRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             --------CCC------------------CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence                    000                  001234577899999999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.6e-36  Score=314.76  Aligned_cols=260  Identities=25%  Similarity=0.334  Sum_probs=198.3

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCe----EEEEEEeeccCc-CcchhHHHHHHHHHhcCCCceeeEeeeecCccccC
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKT----IIAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKG  473 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  473 (741)
                      ...|++.+.||+|+||.||+|++..++.    .||+|+++.... .....+.+|+.+++.++||||+++++++..     
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----   80 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-----   80 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-----
Confidence            3568889999999999999999866665    489999864322 234567789999999999999999998632     


Q ss_pred             CceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCc
Q 037916          474 DDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMT  553 (741)
Q Consensus       474 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~  553 (741)
                       ...+++|||+++|+|.+++...         ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.
T Consensus        81 -~~~~l~~~~~~~g~l~~~l~~~---------~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~  147 (279)
T cd05109          81 -STVQLVTQLMPYGCLLDYVREN---------KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNH  147 (279)
T ss_pred             -CCcEEEEEcCCCCCHHHHHhhc---------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCc
Confidence             2467999999999999998643         23578899999999999999999999   9999999999999999999


Q ss_pred             eEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhh
Q 037916          554 AHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFA  632 (741)
Q Consensus       554 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~  632 (741)
                      +||+|||.++...............++..|+|||. ..+..++.++|||||||++||+++ |..||+....  .....+.
T Consensus       148 ~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~-~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~  224 (279)
T cd05109         148 VKITDFGLARLLDIDETEYHADGGKVPIKWMALES-ILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--REIPDLL  224 (279)
T ss_pred             EEECCCCceeecccccceeecCCCccchhhCCHHH-hccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHH
Confidence            99999999987654322211122235678999954 456678999999999999999998 8899863211  1111111


Q ss_pred             hhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHh
Q 037916          633 RTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSI  709 (741)
Q Consensus       633 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  709 (741)
                      ......                              .....++..+.+++.+||..||++||++.|+++.++.+...
T Consensus       225 ~~~~~~------------------------------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05109         225 EKGERL------------------------------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD  271 (279)
T ss_pred             HCCCcC------------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence            110000                              00112345678999999999999999999999998777543

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.5e-36  Score=322.38  Aligned_cols=271  Identities=22%  Similarity=0.285  Sum_probs=200.0

Q ss_pred             HHHHHHhhhcccCceeeEEEEEE-----cCCCeEEEEEEeeccC-cCcchhHHHHHHHHHhc-CCCceeeEeeeecCccc
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGIL-----DEGKTIIAVKVLNLLH-HGASKSSIAECSALRNI-RHKNLVKILTVCSGVDY  471 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~  471 (741)
                      ..+|++.+.||+|+||.||+|.+     ..+++.||+|+++... ......+.+|+.++.++ +||||++++++|.    
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~----   81 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT----   81 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceee----
Confidence            46899999999999999999985     2467899999997432 22345677899999999 6899999999863    


Q ss_pred             cCCceEEEEEecccCCChhhhccCCCCCCcc-------------------------------------------------
Q 037916          472 KGDDFKALVYEFMHNGSLEEWLHPVSGADKT-------------------------------------------------  502 (741)
Q Consensus       472 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~-------------------------------------------------  502 (741)
                      ..+...+++|||+++|+|.+++.........                                                 
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (343)
T cd05103          82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV  161 (343)
T ss_pred             cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence            3345689999999999999998643211000                                                 


Q ss_pred             --------cCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecccccccCCCCccccc
Q 037916          503 --------VEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSS  574 (741)
Q Consensus       503 --------~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~  574 (741)
                              ......+++.++..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||++............
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  238 (343)
T cd05103         162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK  238 (343)
T ss_pred             hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhc
Confidence                    00113478888999999999999999999   9999999999999999999999999999765433222222


Q ss_pred             ccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcCCcchhHhhhhcccCCcc
Q 037916          575 IGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDE  653 (741)
Q Consensus       575 ~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  653 (741)
                      ....++..|+|||. ..+..++.++||||||+++|++++ |..||....... .   ...         .+.......  
T Consensus       239 ~~~~~~~~y~aPE~-~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~---~~~---------~~~~~~~~~--  302 (343)
T cd05103         239 GDARLPLKWMAPET-IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-E---FCR---------RLKEGTRMR--  302 (343)
T ss_pred             CCCCCCcceECcHH-hcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-H---HHH---------HHhccCCCC--
Confidence            22335678999954 456678999999999999999997 888985321100 0   000         000000000  


Q ss_pred             hhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHH
Q 037916          654 DLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKS  708 (741)
Q Consensus       654 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  708 (741)
                                      .+....+.+.+++.+||+.||++|||+.||++.|+.+.+
T Consensus       303 ----------------~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         303 ----------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             ----------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                            000123457899999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.4e-36  Score=320.28  Aligned_cols=241  Identities=22%  Similarity=0.300  Sum_probs=185.2

Q ss_pred             hhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHh-cCCCceeeEeeeecCccccCCceEEEEE
Q 037916          406 CWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRN-IRHKNLVKILTVCSGVDYKGDDFKALVY  481 (741)
Q Consensus       406 ~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~hpnIv~~~~~~~~~~~~~~~~~~lv~  481 (741)
                      +.||+|+||.||+|++..+++.||+|+++...   .........|..+++. ++||||+++++++     .+....++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~   75 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTF-----QTKENLFFVM   75 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEE-----EeCCEEEEEE
Confidence            46899999999999999899999999997432   2233455677778776 4999999999984     4566899999


Q ss_pred             ecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeeccc
Q 037916          482 EFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGL  561 (741)
Q Consensus       482 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~  561 (741)
                      ||+++|+|.+++...          ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        76 ey~~~g~L~~~l~~~----------~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~  142 (316)
T cd05619          76 EYLNGGDLMFHIQSC----------HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGM  142 (316)
T ss_pred             eCCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCc
Confidence            999999999998632          3578888999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcchh
Q 037916          562 AKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM  641 (741)
Q Consensus       562 a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  641 (741)
                      +........  ......||+.|+||| +..+..++.++||||+||++|||++|+.||.....     ......       
T Consensus       143 ~~~~~~~~~--~~~~~~gt~~y~aPE-~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-----~~~~~~-------  207 (316)
T cd05619         143 CKENMLGDA--KTCTFCGTPDYIAPE-ILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE-----EELFQS-------  207 (316)
T ss_pred             ceECCCCCC--ceeeecCCccccCHH-HHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH-----HHHHHH-------
Confidence            875322211  112345899999995 55667789999999999999999999999863211     111100       


Q ss_pred             HhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHH-HHH
Q 037916          642 DIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMT-IVV  700 (741)
Q Consensus       642 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl  700 (741)
                        +... ....                  +......+.+++.+||+.||++||++. ++.
T Consensus       208 --i~~~-~~~~------------------~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         208 --IRMD-NPCY------------------PRWLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             --HHhC-CCCC------------------CccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence              0000 0000                  001234577999999999999999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=8.7e-37  Score=322.45  Aligned_cols=242  Identities=23%  Similarity=0.248  Sum_probs=188.7

Q ss_pred             hhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhc-CCCceeeEeeeecCccccCCceEEEEE
Q 037916          406 CWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKGDDFKALVY  481 (741)
Q Consensus       406 ~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~~~~lv~  481 (741)
                      +.||+|+||.||+|.+..+++.||+|+++...   ......+..|..+++.+ +||||+++++++     ......|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~-----~~~~~~~lv~   75 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCF-----QTKDRLFFVM   75 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence            46899999999999999899999999997432   22344567788888877 799999999984     5566899999


Q ss_pred             ecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeeccc
Q 037916          482 EFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGL  561 (741)
Q Consensus       482 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~  561 (741)
                      ||+++|+|..++...          ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        76 e~~~~~~L~~~~~~~----------~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~  142 (318)
T cd05570          76 EYVNGGDLMFHIQRS----------GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGM  142 (318)
T ss_pred             cCCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCC
Confidence            999999999888633          3588999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcchh
Q 037916          562 AKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM  641 (741)
Q Consensus       562 a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  641 (741)
                      +.........  .....||+.|+|| |+..+..++.++||||+||++|+|++|+.||.....     ......       
T Consensus       143 ~~~~~~~~~~--~~~~~g~~~y~aP-E~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~-----~~~~~~-------  207 (318)
T cd05570         143 CKEGILGGVT--TSTFCGTPDYIAP-EILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE-----DELFQS-------  207 (318)
T ss_pred             CeecCcCCCc--ccceecCccccCH-HHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH-----HHHHHH-------
Confidence            8753222211  1224589999999 555677889999999999999999999999863211     111110       


Q ss_pred             HhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCH-----HHHHH
Q 037916          642 DIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNM-----TIVVH  701 (741)
Q Consensus       642 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~  701 (741)
                       +......                    .+...+..+.+++.+||..||++|||+     .++++
T Consensus       208 -i~~~~~~--------------------~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         208 -ILEDEVR--------------------YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             -HHcCCCC--------------------CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence             0000000                    001234567899999999999999999     77764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=4.2e-36  Score=317.62  Aligned_cols=206  Identities=23%  Similarity=0.295  Sum_probs=162.6

Q ss_pred             hhhcccCceeeEEEEEEc--CCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEEEe
Q 037916          405 LCWIDMGSFGSVYKGILD--EGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYE  482 (741)
Q Consensus       405 ~~~ig~G~~g~V~~a~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv~e  482 (741)
                      .++||+|+||.||+|++.  .+++.||+|.++..  .......+|+.++++++||||+++++++..   ..+...|++||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e   80 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLS---HADRKVWLLFD   80 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEec---CCCcEEEEEEe
Confidence            468999999999999975  46788999998632  234567889999999999999999998642   33557899999


Q ss_pred             cccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEe----CCCCceEEee
Q 037916          483 FMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLL----DHEMTAHVAD  558 (741)
Q Consensus       483 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll----~~~~~~kL~D  558 (741)
                      |+ +++|.+++........ ......+++..++.++.|++.||+|||+.   +|+||||||+|||+    +..+.+||+|
T Consensus        81 ~~-~~~l~~~~~~~~~~~~-~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~D  155 (317)
T cd07868          81 YA-EHDLWHIIKFHRASKA-NKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIAD  155 (317)
T ss_pred             cc-CCCHHHHHHhcccccc-cCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEee
Confidence            99 4588887753321111 11223578889999999999999999999   99999999999999    4567899999


Q ss_pred             cccccccCCCCc-ccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCc
Q 037916          559 FGLAKLLPPAHL-QTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDI  620 (741)
Q Consensus       559 Fg~a~~~~~~~~-~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~  620 (741)
                      ||++........ ........||+.|+|||.+.....++.++||||+||++|+|++|+.||..
T Consensus       156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~  218 (317)
T cd07868         156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             cCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence            999987643321 11122356899999997665556789999999999999999999999964

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=8.2e-37  Score=323.55  Aligned_cols=238  Identities=24%  Similarity=0.249  Sum_probs=183.0

Q ss_pred             hhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHH-HHHhcCCCceeeEeeeecCccccCCceEEEEE
Q 037916          406 CWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECS-ALRNIRHKNLVKILTVCSGVDYKGDDFKALVY  481 (741)
Q Consensus       406 ~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv~  481 (741)
                      +.||+|+||.||+|++..+++.||+|++....   ......+..|.. +++.++||||++++++     +.+....|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~-----~~~~~~~~lv~   75 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYS-----FQTADKLYFVL   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEE-----EEeCCEEEEEE
Confidence            46899999999999999999999999997432   122234445544 4577899999999998     45566899999


Q ss_pred             ecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeeccc
Q 037916          482 EFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGL  561 (741)
Q Consensus       482 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~  561 (741)
                      ||+++|+|..++...          ..+++..+..++.||+.||+|||+.   ||+||||||+||+++.++.+||+|||+
T Consensus        76 e~~~~g~L~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~  142 (323)
T cd05575          76 DYVNGGELFFHLQRE----------RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGL  142 (323)
T ss_pred             cCCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCC
Confidence            999999999988633          4578888999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcchh
Q 037916          562 AKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM  641 (741)
Q Consensus       562 a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  641 (741)
                      +........  ......||+.|+||| +..+..++.++|||||||++|||++|..||....     ..+....       
T Consensus       143 ~~~~~~~~~--~~~~~~gt~~y~aPE-~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~-----~~~~~~~-------  207 (323)
T cd05575         143 CKEGIEHSK--TTSTFCGTPEYLAPE-VLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-----TAEMYDN-------  207 (323)
T ss_pred             CcccccCCC--ccccccCChhhcChh-hhcCCCCCccccccccchhhhhhhcCCCCCCCCC-----HHHHHHH-------
Confidence            875432221  122346899999995 5566778999999999999999999999986321     1111111       


Q ss_pred             HhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHH
Q 037916          642 DIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMT  697 (741)
Q Consensus       642 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  697 (741)
                       +......                    ........+.+++.+||+.||++||++.
T Consensus       208 -i~~~~~~--------------------~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         208 -ILNKPLR--------------------LKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             -HHcCCCC--------------------CCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence             1100000                    0012245678999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=7.4e-37  Score=328.47  Aligned_cols=204  Identities=25%  Similarity=0.275  Sum_probs=168.4

Q ss_pred             HHHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC--cCcchhHHHHHHHHHhcCCCceeeEeeeecCcc-ccC
Q 037916          397 LLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSGVD-YKG  473 (741)
Q Consensus       397 ~~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~~  473 (741)
                      .+..+|++.+.||+|+||.||+|.+..+++.||+|+++...  ......+.+|+.+++.++||||+++++++.... ...
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            45678999999999999999999999899999999986432  223456778999999999999999999864322 123


Q ss_pred             CceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCc
Q 037916          474 DDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMT  553 (741)
Q Consensus       474 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~  553 (741)
                      ....|+||||+++ ++.+++.            ..+++..+..++.|+++||+|||+.   ||+||||||+||+++.++.
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~------------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~  157 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQ------------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCT  157 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHh------------hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCC
Confidence            3467999999954 6777664            2367888899999999999999999   9999999999999999999


Q ss_pred             eEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCc
Q 037916          554 AHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDI  620 (741)
Q Consensus       554 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~  620 (741)
                      +||+|||+++.......   .....||+.|+||| +..+..++.++||||+||++|+|++|+.||..
T Consensus       158 ~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE-~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  220 (355)
T cd07874         158 LKILDFGLARTAGTSFM---MTPYVVTRYYRAPE-VILGMGYKENVDIWSVGCIMGEMVRHKILFPG  220 (355)
T ss_pred             EEEeeCcccccCCCccc---cCCccccCCccCHH-HHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            99999999986543321   12245899999995 55667789999999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=8.8e-37  Score=346.90  Aligned_cols=272  Identities=19%  Similarity=0.248  Sum_probs=203.2

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc---CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCce
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH---GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      ++|++.++||+|+||.||+|++..+++.||+|+++....   ...+++.+|+.++++++||||+++++++     .+++.
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~-----~d~~~   76 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSIC-----SDGDP   76 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEE-----eeCCE
Confidence            468899999999999999999998999999999864221   1245678999999999999999999985     44568


Q ss_pred             EEEEEecccCCChhhhccCCCCCC-cccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGAD-KTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      .++||||++|++|.+++....... .........++..++.++.||++||+|||+.   ||+||||||+||+++.++.+|
T Consensus        77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vK  153 (932)
T PRK13184         77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVV  153 (932)
T ss_pred             EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEE
Confidence            899999999999999886421111 0011123456778899999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCc----------------ccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCC
Q 037916          556 VADFGLAKLLPPAHL----------------QTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSD  619 (741)
Q Consensus       556 L~DFg~a~~~~~~~~----------------~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~  619 (741)
                      |+|||.+........                ........||+.|+||| ...+..++.++||||+||++|||++|+.||.
T Consensus       154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE-~l~g~~~S~kSDIWSLGVILyELLTG~~PF~  232 (932)
T PRK13184        154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPE-RLLGVPASESTDIYALGVILYQMLTLSFPYR  232 (932)
T ss_pred             EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHH-HhcCCCCCcHhHHHHHHHHHHHHHHCCCCCC
Confidence            999999986621100                00111245999999995 5567788999999999999999999999986


Q ss_pred             ccccCCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCC-CHHH
Q 037916          620 IMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRM-NMTI  698 (741)
Q Consensus       620 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~e  698 (741)
                      .........    ......             ..             ......+.+..+.+++.+|+..||++|| ++++
T Consensus       233 ~~~~~ki~~----~~~i~~-------------P~-------------~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~ee  282 (932)
T PRK13184        233 RKKGRKISY----RDVILS-------------PI-------------EVAPYREIPPFLSQIAMKALAVDPAERYSSVQE  282 (932)
T ss_pred             Ccchhhhhh----hhhccC-------------hh-------------hccccccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence            311100000    000000             00             0000113456688999999999999996 6778


Q ss_pred             HHHHHHHHHHhh
Q 037916          699 VVHELQSIKSIL  710 (741)
Q Consensus       699 vl~~L~~i~~~~  710 (741)
                      +++.|+...+..
T Consensus       283 Ll~~Le~~lq~~  294 (932)
T PRK13184        283 LKQDLEPHLQGS  294 (932)
T ss_pred             HHHHHHHHHhcC
Confidence            888888877643

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-37  Score=319.71  Aligned_cols=246  Identities=27%  Similarity=0.303  Sum_probs=195.2

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcC---cchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG---ASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      .|.-++.||.|+||.||-|++..+.+.||||.+.-....   .-.++.+|+..|+++.|||++.|-|+     |-.+...
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgC-----yLre~Ta  101 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGC-----YLREHTA  101 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccce-----eeccchH
Confidence            577788999999999999999999999999999743333   33567899999999999999999998     4455678


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      |+||||| -|+-.+++.-.         .+++.+.++..|+.+.+.||+|||+.   +.||||||..|||+++.|.|||+
T Consensus       102 WLVMEYC-lGSAsDlleVh---------kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLa  168 (948)
T KOG0577|consen  102 WLVMEYC-LGSASDLLEVH---------KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLA  168 (948)
T ss_pred             HHHHHHH-hccHHHHHHHH---------hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeec
Confidence            9999999 56888877533         36788899999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccccccCccccc--CCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhc
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG--LGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV  635 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~--~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~  635 (741)
                      |||.|..+.+..      .++|||.|||||.++  ..+.|+-|+||||+|+++.|+...++|.-.+.. ...+-..+.. 
T Consensus       169 DFGSAsi~~PAn------sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA-MSALYHIAQN-  240 (948)
T KOG0577|consen  169 DFGSASIMAPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-MSALYHIAQN-  240 (948)
T ss_pred             cccchhhcCchh------cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH-HHHHHHHHhc-
Confidence            999998765442      256999999997653  467899999999999999999999999542210 0000001110 


Q ss_pred             CCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          636 LPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       636 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      .++.        +.                     ..+-...+..++..||+.=|.+|||..++++
T Consensus       241 esPt--------Lq---------------------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  241 ESPT--------LQ---------------------SNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             CCCC--------CC---------------------CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence            0000        00                     0133456788999999999999999988764

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=4.4e-37  Score=326.86  Aligned_cols=253  Identities=19%  Similarity=0.172  Sum_probs=195.2

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc---CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH---GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      .|.+.+.||+|+||.||+|.+..+++.||+|+++....   ...+.+.+|+.+++.++||||+++++++     .+....
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~-----~~~~~~   76 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF-----QDKDNL   76 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCeE
Confidence            47788999999999999999999999999999974322   2345677899999999999999999984     456689


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      |+||||+++|+|.+++...         ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+
T Consensus        77 ~lv~e~~~~~~L~~~l~~~---------~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~  144 (330)
T cd05601          77 YLVMEYQPGGDLLSLLNRY---------EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLA  144 (330)
T ss_pred             EEEECCCCCCCHHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEec
Confidence            9999999999999998643         23578889999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccccccCcccccC-----CCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhh
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGL-----GSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFA  632 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~-----~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~  632 (741)
                      |||++......... ......||+.|+|||.+..     ...++.++||||+||++|||++|+.||......    . ..
T Consensus       145 Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~----~-~~  218 (330)
T cd05601         145 DFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA----K-TY  218 (330)
T ss_pred             cCCCCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH----H-HH
Confidence            99999876543322 1122458999999965532     456789999999999999999999998632110    0 00


Q ss_pred             hhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          633 RTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       633 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      .        .+.........                .........+.+++.+|+. ||++|||+.++++
T Consensus       219 ~--------~i~~~~~~~~~----------------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         219 N--------NIMNFQRFLKF----------------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             H--------HHHcCCCccCC----------------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            0        00000000000                0001234567789999998 9999999999885

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.1e-36  Score=313.41  Aligned_cols=262  Identities=26%  Similarity=0.343  Sum_probs=197.4

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcC-----CCeEEEEEEeeccCc-CcchhHHHHHHHHHhcCCCceeeEeeeecCcccc
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDE-----GKTIIAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKILTVCSGVDYK  472 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  472 (741)
                      ...|.+.+.||+|+||.||+|.+..     .+..||+|.++.... .....+.+|+.++++++|+||+++++++.     
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----   79 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSF-----   79 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----
Confidence            3568899999999999999999976     678899998863322 22356788999999999999999999853     


Q ss_pred             CCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCC
Q 037916          473 GDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEM  552 (741)
Q Consensus       473 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~  552 (741)
                      +....++||||+++++|.+++...+...   .....+++.+++.++.||+.||+|||+.   +++||||||+||+++.++
T Consensus        80 ~~~~~~lv~e~~~g~~L~~~i~~~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~  153 (277)
T cd05036          80 ERLPRFILLELMAGGDLKSFLRENRPRP---ERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKG  153 (277)
T ss_pred             cCCCcEEEEecCCCCCHHHHHHHhCCCC---CCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccC
Confidence            3456799999999999999986542111   1123588999999999999999999999   999999999999998654


Q ss_pred             ---ceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcch
Q 037916          553 ---TAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNL  628 (741)
Q Consensus       553 ---~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~  628 (741)
                         .+||+|||.++................+..|+|||. ..+..++.++|||||||++|||++ |..||......  ..
T Consensus       154 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~--~~  230 (277)
T cd05036         154 PGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEA-FLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ--EV  230 (277)
T ss_pred             CCcceEeccCccccccCCccceecCCCCCccHhhCCHHH-HhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HH
Confidence               699999999987643322211112234568999954 456779999999999999999997 99998632111  11


Q ss_pred             hhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHH
Q 037916          629 HNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQ  704 (741)
Q Consensus       629 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  704 (741)
                      ..            .+.......                  .+..++..+.+++.+||+.+|++|||+.||++.|+
T Consensus       231 ~~------------~~~~~~~~~------------------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         231 ME------------FVTGGGRLD------------------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HH------------HHHcCCcCC------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            11            110000000                  01133467889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.8e-36  Score=316.78  Aligned_cols=250  Identities=21%  Similarity=0.277  Sum_probs=197.9

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      ..|++.+.||+|+||.||+|.+..+++.||+|.+........+.+.+|+.+++.+.||||+++++.+     ..+.+.|+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~-----~~~~~~~l   94 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY-----LVGDELWV   94 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEE-----EeCCEEEE
Confidence            4788899999999999999999889999999999765555556788999999999999999999985     34568999


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      ||||+++++|.+++..           ..+++.++..++.|++.||+|||+.   ||+||||||+||+++.++.+||+||
T Consensus        95 v~e~~~~~~L~~~~~~-----------~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~df  160 (296)
T cd06654          95 VMEYLAGGSLTDVVTE-----------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDF  160 (296)
T ss_pred             eecccCCCCHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECcc
Confidence            9999999999999852           2467888999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcc
Q 037916          560 GLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDH  639 (741)
Q Consensus       560 g~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  639 (741)
                      |.+.........  .....|++.|+||| ...+..++.++|||||||++|+|++|+.||....... ..........+. 
T Consensus       161 g~~~~~~~~~~~--~~~~~~~~~y~aPE-~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~-  235 (296)
T cd06654         161 GFCAQITPEQSK--RSTMVGTPYWMAPE-VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYLIATNGTPE-  235 (296)
T ss_pred             ccchhccccccc--cCcccCCccccCHH-HHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH-hHHHHhcCCCCC-
Confidence            998765433211  12245889999995 5556678899999999999999999999986321110 000000000000 


Q ss_pred             hhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          640 VMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       640 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                              .                    .........+.+++.+||..||++|||+.|+++
T Consensus       236 --------~--------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         236 --------L--------------------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             --------C--------------------CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence                    0                    001133456789999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-36  Score=309.14  Aligned_cols=255  Identities=31%  Similarity=0.456  Sum_probs=198.6

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      ...|++.+.||+|++|.||+|.+. +++.||+|.++... ...+.+.+|+.++++++||||+++++++     ...+..+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   77 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVC-----TLEEPIY   77 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEE-----ecCCCee
Confidence            356888999999999999999986 46789999987433 2356788999999999999999999984     4455789


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      ++|||+++++|.+++....        ...+++.++..++.|++.|+.|||+.   +|+||||||+||++++++.+||+|
T Consensus        78 lv~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d  146 (261)
T cd05068          78 IVTELMKYGSLLEYLQGGA--------GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVAD  146 (261)
T ss_pred             eeeecccCCcHHHHHhccC--------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECC
Confidence            9999999999999986431        24578999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcCC
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      ||.+......... .......+..|+|| |+..+..++.++||||||+++||+++ |+.||......     ...     
T Consensus       147 fg~~~~~~~~~~~-~~~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~~~-----  214 (261)
T cd05068         147 FGLARVIKEDIYE-AREGAKFPIKWTAP-EAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA-----EVL-----  214 (261)
T ss_pred             cceEEEccCCccc-ccCCCcCceeccCc-cccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH-----HHH-----
Confidence            9999876533211 11112234579999 55566788999999999999999999 99998632110     000     


Q ss_pred             cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHH
Q 037916          638 DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQS  705 (741)
Q Consensus       638 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  705 (741)
                          ..++.....                  .....++..+.+++.+||+.||++||++.++++.|++
T Consensus       215 ----~~~~~~~~~------------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         215 ----QQVDQGYRM------------------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             ----HHHHcCCCC------------------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence                000000000                  0011234678899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.1e-36  Score=315.21  Aligned_cols=268  Identities=21%  Similarity=0.321  Sum_probs=198.5

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEc-----CCCeEEEEEEeeccCc-CcchhHHHHHHHHHhcCCCceeeEeeeecCcccc
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILD-----EGKTIIAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKILTVCSGVDYK  472 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  472 (741)
                      ..+|++.+.||+|+||.||+|.++     ..+..||+|.++.... .....+.+|+.+++.++||||+++++++     .
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~   79 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVV-----S   79 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----c
Confidence            468999999999999999999764     2356899998763321 2234567899999999999999999985     3


Q ss_pred             CCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCC
Q 037916          473 GDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEM  552 (741)
Q Consensus       473 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~  552 (741)
                      .....++||||+++|+|.+++................++..+..++.|++.||.|||+.   +|+||||||+||+++.++
T Consensus        80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~  156 (288)
T cd05061          80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDF  156 (288)
T ss_pred             CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCC
Confidence            45578999999999999999965322111111224456778889999999999999999   999999999999999999


Q ss_pred             ceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhh
Q 037916          553 TAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNF  631 (741)
Q Consensus       553 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~  631 (741)
                      .+||+|||.++...............++..|+||| ...+..++.++|||||||++|||++ |..||.....     .+.
T Consensus       157 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE-~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~-----~~~  230 (288)
T cd05061         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE-SLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-----EQV  230 (288)
T ss_pred             cEEECcCCccccccccccccccCCCcccccccCHH-HhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH-----HHH
Confidence            99999999988654433222222233567899995 4556678999999999999999998 7888752211     111


Q ss_pred             hhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHH
Q 037916          632 ARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIK  707 (741)
Q Consensus       632 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  707 (741)
                      ...        +.+.....                   ....+++.+.+++.+||+.||++|||+.|+++.+++..
T Consensus       231 ~~~--------~~~~~~~~-------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         231 LKF--------VMDGGYLD-------------------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             HHH--------HHcCCCCC-------------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            110        00000000                   01123467889999999999999999999999887653

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.7e-36  Score=326.55  Aligned_cols=255  Identities=20%  Similarity=0.198  Sum_probs=196.3

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      ...|++.+.||+|+||.||+|++..+++.||+|+++...   ......+.+|+.+++.++||||++++++     +.++.
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~-----~~~~~  116 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYA-----FQDDK  116 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEE-----EecCC
Confidence            467999999999999999999999999999999996422   2233456789999999999999999988     45667


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..|+||||+++|+|.+++..           ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+|
T Consensus       117 ~~~lv~Ey~~gg~L~~~l~~-----------~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~k  182 (370)
T cd05596         117 YLYMVMEYMPGGDLVNLMSN-----------YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLK  182 (370)
T ss_pred             EEEEEEcCCCCCcHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEE
Confidence            89999999999999998853           2367778888999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcccccccccccccccCcccccCC---CCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhh
Q 037916          556 VADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLG---SEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFA  632 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~---~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~  632 (741)
                      |+|||.+.......... .....||+.|+|||.+...   ..++.++||||+||++|||++|+.||.....     ....
T Consensus       183 L~DfG~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----~~~~  256 (370)
T cd05596         183 LADFGTCMKMDANGMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-----VGTY  256 (370)
T ss_pred             EEeccceeeccCCCccc-CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH-----HHHH
Confidence            99999998664332211 1234699999999655432   3588999999999999999999999863211     0011


Q ss_pred             hhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCC--CCCHHHHHHH
Q 037916          633 RTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQD--RMNMTIVVHE  702 (741)
Q Consensus       633 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  702 (741)
                      .        .+.+.......                +........+.+++.+|++.+|++  |||+.|+++-
T Consensus       257 ~--------~i~~~~~~~~~----------------~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         257 S--------KIMDHKNSLTF----------------PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             H--------HHHcCCCcCCC----------------CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            1        11110000000                000123456779999999999988  9999999754

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.5e-36  Score=312.12  Aligned_cols=272  Identities=24%  Similarity=0.331  Sum_probs=199.4

Q ss_pred             HHHHhhhcccCceeeEEEEEE----cCCCeEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          401 SFLFLCWIDMGSFGSVYKGIL----DEGKTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      -|++++.||+|+||.||+|.+    ..++..||+|.++... ....+.+.+|+.++++++||||+++++++..   .+..
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~   81 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE---DGGN   81 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEec---CCCC
Confidence            378999999999999999985    3568889999987432 2234578899999999999999999998642   2245


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..++||||+++++|.+++...         ...+++..+..++.|++.||+|||+.   ||+||||||+||+++.++.+|
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~---------~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~  149 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRN---------KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVK  149 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhc---------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEE
Confidence            689999999999999998532         13478899999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcc-cccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhh
Q 037916          556 VADFGLAKLLPPAHLQ-TSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~-~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  634 (741)
                      |+|||.+......... .......++..|+||| ...+..++.++|||||||++||++++..|+......   .......
T Consensus       150 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE-~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~---~~~~~~~  225 (284)
T cd05079         150 IGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPE-CLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTL---FLKMIGP  225 (284)
T ss_pred             ECCCccccccccCccceeecCCCCCCccccCHH-HhccCCCCccccchhhhhhhhhhhcCCCCCccccch---hhhhccc
Confidence            9999999866433221 1112244677899995 445667899999999999999999988765321110   0000000


Q ss_pred             cCCcc-hhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHH
Q 037916          635 VLPDH-VMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSI  706 (741)
Q Consensus       635 ~~~~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  706 (741)
                      ..... .....+....               ....+....++..+.+++.+||+.||++|||++++++.++.+
T Consensus       226 ~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         226 THGQMTVTRLVRVLEE---------------GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             ccccccHHHHHHHHHc---------------CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            00000 0000000000               000111123456799999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.8e-36  Score=310.70  Aligned_cols=262  Identities=19%  Similarity=0.266  Sum_probs=202.4

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc---CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCce
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH---GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      ..|.+.+.||+|+||.||+|.+..++..||+|.+.....   ....++.+|+.+++.++||||+++++++     ..+..
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~   76 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASF-----IEDNE   76 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhhee-----EeCCe
Confidence            468999999999999999999988999999998864222   2235677899999999999999999984     44568


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .+++|||+++++|.+++.....      ....+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.++|
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~------~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l  147 (267)
T cd08229          77 LNIVLELADAGDLSRMIKHFKK------QKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKL  147 (267)
T ss_pred             EEEEEEecCCCCHHHHHHHhhc------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEE
Confidence            8999999999999998863211      124578899999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcC
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVL  636 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  636 (741)
                      +|||.+.........  .....|+..|+||| ...+..++.++||||||+++|+|++|..||.....   ....+.....
T Consensus       148 ~dfg~~~~~~~~~~~--~~~~~~~~~~~ape-~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~  221 (267)
T cd08229         148 GDLGLGRFFSSKTTA--AHSLVGTPYYMSPE-RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLYSLCKKIE  221 (267)
T ss_pred             CcchhhhccccCCcc--cccccCCcCccCHH-HhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc---hHHHHhhhhh
Confidence            999998765433221  12245888999995 55566788999999999999999999999852211   1111111000


Q ss_pred             CcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHH
Q 037916          637 PDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIK  707 (741)
Q Consensus       637 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  707 (741)
                      .         ......                 ........+.+++.+||..||++|||+.+|++.++++.
T Consensus       222 ~---------~~~~~~-----------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         222 Q---------CDYPPL-----------------PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             c---------CCCCCC-----------------CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            0         000000                 00124567889999999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=4.4e-36  Score=311.92  Aligned_cols=253  Identities=23%  Similarity=0.275  Sum_probs=196.2

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALV  480 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv  480 (741)
                      .|++.+.||+|+||.||+|.+..++..+|+|.+........+.+.+|+.+++.++||||+++++++     ..+...++|
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~-----~~~~~~~~v   80 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF-----YYENNLWIL   80 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEE-----eeCCEEEEE
Confidence            378999999999999999999989999999998754444456788899999999999999999985     345688999


Q ss_pred             EecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecc
Q 037916          481 YEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFG  560 (741)
Q Consensus       481 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg  560 (741)
                      |||+++++|..++...         ...+++..+..++.|+++||.|||+.   +++||||||+||+++.++.+||+|||
T Consensus        81 ~e~~~~~~l~~~~~~~---------~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg  148 (282)
T cd06643          81 IEFCAGGAVDAVMLEL---------ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFG  148 (282)
T ss_pred             EEecCCCcHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccc
Confidence            9999999998887532         24578899999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccccccccCccccc----CCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcC
Q 037916          561 LAKLLPPAHLQTSSIGVKGTIGYIAPAEYG----LGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVL  636 (741)
Q Consensus       561 ~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~----~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  636 (741)
                      .+........  ......++..|+|||.+.    .+..++.++||||+||++|+|++|+.||....... ......... 
T Consensus       149 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~~~~~~-  224 (282)
T cd06643         149 VSAKNTRTIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKSE-  224 (282)
T ss_pred             cccccccccc--ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH-HHHHHhhcC-
Confidence            9876543221  112245889999996543    34567889999999999999999999986321100 000000000 


Q ss_pred             CcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          637 PDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       637 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      ..        ..                    ..+...+..+.+++.+||+.||++|||+.++++.
T Consensus       225 ~~--------~~--------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         225 PP--------TL--------------------AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             CC--------CC--------------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00        00                    0011234567899999999999999999988643

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.9e-36  Score=325.87  Aligned_cols=269  Identities=20%  Similarity=0.290  Sum_probs=199.7

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEc-----CCCeEEEEEEeeccCcC-cchhHHHHHHHHHhcC-CCceeeEeeeecCccc
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILD-----EGKTIIAVKVLNLLHHG-ASKSSIAECSALRNIR-HKNLVKILTVCSGVDY  471 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~-----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~  471 (741)
                      ...|.+.++||+|+||.||+|+++     ..+..||+|+++..... ..+.+.+|+.++.++. |||||+++++|.    
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~----  111 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT----  111 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc----
Confidence            346778899999999999999964     34578999999743222 2346788999999997 999999999963    


Q ss_pred             cCCceEEEEEecccCCChhhhccCCCCCCc--------------------------------------------------
Q 037916          472 KGDDFKALVYEFMHNGSLEEWLHPVSGADK--------------------------------------------------  501 (741)
Q Consensus       472 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~--------------------------------------------------  501 (741)
                       .....++||||+++|+|.++++..+....                                                  
T Consensus       112 -~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (401)
T cd05107         112 -KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV  190 (401)
T ss_pred             -cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence             34578999999999999999865321000                                                  


Q ss_pred             --------------------------------------ccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCC
Q 037916          502 --------------------------------------TVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKP  543 (741)
Q Consensus       502 --------------------------------------~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp  543 (741)
                                                            .......+++..++.++.|++.||+|||+.   +|+||||||
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp  267 (401)
T cd05107         191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAA  267 (401)
T ss_pred             chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCc
Confidence                                                  001123467888899999999999999999   999999999


Q ss_pred             CCeEeCCCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccc
Q 037916          544 SNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMF  622 (741)
Q Consensus       544 ~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~  622 (741)
                      +||++++++.+||+|||+++...............++..|+||| ...+..++.++|||||||++|||++ |..||....
T Consensus       268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~  346 (401)
T cd05107         268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPE-SIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP  346 (401)
T ss_pred             ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChH-HhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            99999999999999999998654332212222234678899995 4456678999999999999999998 888975221


Q ss_pred             cCCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          623 EGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       623 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      ..+ .            ....+......                  ..+..+...+.+++.+||..+|++||+++||++.
T Consensus       347 ~~~-~------------~~~~~~~~~~~------------------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         347 MNE-Q------------FYNAIKRGYRM------------------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             chH-H------------HHHHHHcCCCC------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            100 0            00111000000                  0011234678899999999999999999999999


Q ss_pred             HHHHH
Q 037916          703 LQSIK  707 (741)
Q Consensus       703 L~~i~  707 (741)
                      |+.+.
T Consensus       396 L~~~~  400 (401)
T cd05107         396 VGDLL  400 (401)
T ss_pred             HHHHh
Confidence            98764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.7e-36  Score=326.33  Aligned_cols=200  Identities=25%  Similarity=0.286  Sum_probs=169.3

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      .|++++.||+|+||.||+|.+..+++.||+|+++...   ......+.+|+.++++++||||+++++.     +.+....
T Consensus         2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~-----~~~~~~~   76 (363)
T cd05628           2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYS-----FQDKLNL   76 (363)
T ss_pred             CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEE-----EecCCeE
Confidence            4788999999999999999999899999999997432   2223466789999999999999999998     4566689


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      |+||||+++|+|.+++...          ..+++..+..++.|++.||+|||+.   ||+||||||+|||++.++.+||+
T Consensus        77 ~lv~E~~~gg~L~~~l~~~----------~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~  143 (363)
T cd05628          77 YLIMEFLPGGDMMTLLMKK----------DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLS  143 (363)
T ss_pred             EEEEcCCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEe
Confidence            9999999999999998643          4578899999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCcc---------------------------------cccccccccccccCcccccCCCCCCCccCchhH
Q 037916          558 DFGLAKLLPPAHLQ---------------------------------TSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSY  604 (741)
Q Consensus       558 DFg~a~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSl  604 (741)
                      |||+++........                                 .......||+.|+||| +..+..++.++||||+
T Consensus       144 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE-~~~~~~~~~~~DvwSl  222 (363)
T cd05628         144 DFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPE-VFMQTGYNKLCDWWSL  222 (363)
T ss_pred             eccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHH-HHcCCCCCCchhhhhh
Confidence            99998754321100                                 0012346999999995 5556778999999999


Q ss_pred             HHHHHHHHcCCCCCC
Q 037916          605 GILLLELMTRKRPSD  619 (741)
Q Consensus       605 G~il~elltg~~p~~  619 (741)
                      ||++|||++|+.||.
T Consensus       223 Gvil~ell~G~~Pf~  237 (363)
T cd05628         223 GVIMYEMLIGYPPFC  237 (363)
T ss_pred             HHHHHHHHhCCCCCC
Confidence            999999999999986

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.2e-36  Score=322.31  Aligned_cols=241  Identities=24%  Similarity=0.277  Sum_probs=186.6

Q ss_pred             HHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc---CcchhHHHHHHHHHhc-CCCceeeEeeeecCccccCCceE
Q 037916          402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH---GASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      |.+.+.||+|+||.||+|++..+++.||+|+++....   ...+....|..++..+ +|++|+++++++     ...+..
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~~   76 (323)
T cd05616           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-----QTMDRL   76 (323)
T ss_pred             ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-----ecCCEE
Confidence            6788999999999999999998999999999974321   2233456677777776 589999999884     556689


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      |+||||+++|+|.+++...          ..+++.++..++.|++.||+|||+.   +|+||||||+|||++.++.+||+
T Consensus        77 ~lv~E~~~~g~L~~~~~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~  143 (323)
T cd05616          77 YFVMEYVNGGDLMYQIQQV----------GRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIA  143 (323)
T ss_pred             EEEEcCCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEc
Confidence            9999999999999888633          4578889999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCC
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      |||++........  ......||+.|+|| |+..+..++.++||||+||++|||++|+.||.....     ......   
T Consensus       144 DfG~~~~~~~~~~--~~~~~~gt~~y~aP-E~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-----~~~~~~---  212 (323)
T cd05616         144 DFGMCKENMWDGV--TTKTFCGTPDYIAP-EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----DELFQS---  212 (323)
T ss_pred             cCCCceecCCCCC--ccccCCCChhhcCH-HHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH-----HHHHHH---
Confidence            9999875432221  11235689999999 555677889999999999999999999999863211     011110   


Q ss_pred             cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCH
Q 037916          638 DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNM  696 (741)
Q Consensus       638 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  696 (741)
                           +......                    .+......+.+++.+|++.||++|+++
T Consensus       213 -----i~~~~~~--------------------~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         213 -----IMEHNVA--------------------YPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             -----HHhCCCC--------------------CCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence                 0000000                    001223557799999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=5e-36  Score=308.83  Aligned_cols=262  Identities=20%  Similarity=0.299  Sum_probs=203.2

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCce
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      ..|++.+.||+|+||.||+|.+..+++.||+|.++...   ....+.+.+|+.++++++|++|+++++++     ...+.
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~-----~~~~~   76 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASF-----IENNE   76 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeee-----ecCCe
Confidence            36888999999999999999999899999999886322   22345778999999999999999999985     44568


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .++||||+++++|.+++....      .....+++.++..++.|++.||.|||+.   ||+||||+|+||+++.++.++|
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l  147 (267)
T cd08224          77 LNIVLELADAGDLSRMIKHFK------KQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKL  147 (267)
T ss_pred             EEEEEecCCCCCHHHHHHHhc------ccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEE
Confidence            899999999999999885421      1124578889999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcC
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVL  636 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  636 (741)
                      +|||.+.........  .....++..|+||| ...+..++.++||||+||++|++++|+.||....   ...........
T Consensus       148 ~d~~~~~~~~~~~~~--~~~~~~~~~y~apE-~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~  221 (267)
T cd08224         148 GDLGLGRFFSSKTTA--AHSLVGTPYYMSPE-RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLYSLCKKIE  221 (267)
T ss_pred             eccceeeeccCCCcc--cceecCCccccCHH-HhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC---ccHHHHHhhhh
Confidence            999998765433211  12245788999995 4456778999999999999999999999985221   11111111100


Q ss_pred             CcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHH
Q 037916          637 PDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIK  707 (741)
Q Consensus       637 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  707 (741)
                                  ......              ......+..+.+++.+||..+|++|||+.+|++.++++.
T Consensus       222 ------------~~~~~~--------------~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         222 ------------KCDYPP--------------LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             ------------cCCCCC--------------CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence                        000000              000133456889999999999999999999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.1e-36  Score=313.86  Aligned_cols=265  Identities=23%  Similarity=0.343  Sum_probs=200.1

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEc-----CCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccC
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILD-----EGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKG  473 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  473 (741)
                      +.+|.+.++||+|+||.||+|...     .++..||+|.++.........+.+|+.+++.++||||+++++++     ..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~   78 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVC-----TE   78 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEE-----ec
Confidence            456778899999999999999753     35678999998755555566889999999999999999999984     44


Q ss_pred             CceEEEEEecccCCChhhhccCCCCCC-----cccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEe
Q 037916          474 DDFKALVYEFMHNGSLEEWLHPVSGAD-----KTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLL  548 (741)
Q Consensus       474 ~~~~~lv~e~~~~gsL~~~l~~~~~~~-----~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll  548 (741)
                      ....+++|||+++++|.+++.......     ........+++..++.++.|++.|++|||+.   +++||||||+||++
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~  155 (280)
T cd05092          79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLV  155 (280)
T ss_pred             CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEE
Confidence            557899999999999999986432110     0011123578899999999999999999999   99999999999999


Q ss_pred             CCCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcc
Q 037916          549 DHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMN  627 (741)
Q Consensus       549 ~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~  627 (741)
                      ++++.+||+|||.+................+++.|+|| |...+..++.++|||||||++|||++ |..||......+  
T Consensus       156 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--  232 (280)
T cd05092         156 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPP-ESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE--  232 (280)
T ss_pred             cCCCCEEECCCCceeEcCCCceeecCCCccccccccCH-HHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH--
Confidence            99999999999998765433222222223356789999 45566778999999999999999998 899985321110  


Q ss_pred             hhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHH
Q 037916          628 LHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQ  704 (741)
Q Consensus       628 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  704 (741)
                      .........+                              ...+..++..+.+++.+||+.||++||++.||++.|+
T Consensus       233 ~~~~~~~~~~------------------------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         233 AIECITQGRE------------------------------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             HHHHHHcCcc------------------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            0000000000                              0001133466889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=4.2e-36  Score=315.60  Aligned_cols=272  Identities=21%  Similarity=0.319  Sum_probs=204.2

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEc-------CCCeEEEEEEeeccC-cCcchhHHHHHHHHHhc-CCCceeeEeeeecCc
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILD-------EGKTIIAVKVLNLLH-HGASKSSIAECSALRNI-RHKNLVKILTVCSGV  469 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  469 (741)
                      ...|.+.+.||+|+||.||+|++.       .++..||+|.++... ....+.+.+|+.+++.+ +||||+++++++   
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~---   90 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC---   90 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE---
Confidence            467889999999999999999752       234579999986322 23345688999999999 899999999985   


Q ss_pred             cccCCceEEEEEecccCCChhhhccCCCCCCcc------cCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCC
Q 037916          470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKT------VEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKP  543 (741)
Q Consensus       470 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~------~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp  543 (741)
                        ......+++|||+++++|.+++...+.....      ......+++.++..++.|+++||.|||+.   ||+||||||
T Consensus        91 --~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp  165 (304)
T cd05101          91 --TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAA  165 (304)
T ss_pred             --ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeeccccc
Confidence              4456789999999999999998754221110      01234578889999999999999999999   999999999


Q ss_pred             CCeEeCCCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccc
Q 037916          544 SNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMF  622 (741)
Q Consensus       544 ~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~  622 (741)
                      +||+++.++.+||+|||.++...............+++.|+||| ...+..++.++||||||+++|++++ |..||... 
T Consensus       166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-  243 (304)
T cd05101         166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-  243 (304)
T ss_pred             ceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCch-hhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC-
Confidence            99999999999999999998765433222222234667899995 4456678999999999999999998 77776421 


Q ss_pred             cCCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          623 EGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       623 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                          ....+........         .                  ...+..++..+.+++.+||..+|++|||+.|+++.
T Consensus       244 ----~~~~~~~~~~~~~---------~------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         244 ----PVEELFKLLKEGH---------R------------------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             ----CHHHHHHHHHcCC---------c------------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence                1111111100000         0                  00011345678899999999999999999999999


Q ss_pred             HHHHHHhhc
Q 037916          703 LQSIKSILL  711 (741)
Q Consensus       703 L~~i~~~~~  711 (741)
                      |+++....+
T Consensus       293 l~~~~~~~~  301 (304)
T cd05101         293 LDRILTLTT  301 (304)
T ss_pred             HHHHHHhhh
Confidence            999876543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=5.2e-37  Score=332.29  Aligned_cols=201  Identities=23%  Similarity=0.327  Sum_probs=168.2

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      .|++++.||+|+||.||+|++..+++.||+|++....   ......+.+|+.++++++||||+++++.     +.+++..
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~-----~~~~~~~   76 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYS-----FQDKDNL   76 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEE-----EEcCCEE
Confidence            4889999999999999999999999999999986422   2234567789999999999999999998     4566789


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      |+||||+++|+|.+++...          ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        77 ~lv~E~~~~g~L~~~i~~~----------~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~  143 (376)
T cd05598          77 YFVMDYIPGGDMMSLLIRL----------GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLT  143 (376)
T ss_pred             EEEEeCCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEE
Confidence            9999999999999998643          3577888889999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCC-----------------------------------------cccccccccccccccCcccccCCCCCC
Q 037916          558 DFGLAKLLPPAH-----------------------------------------LQTSSIGVKGTIGYIAPAEYGLGSEVS  596 (741)
Q Consensus       558 DFg~a~~~~~~~-----------------------------------------~~~~~~~~~gt~~y~aPEe~~~~~~~~  596 (741)
                      |||+|.......                                         .........||+.|+|| |+..+..++
T Consensus       144 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP-E~~~~~~~~  222 (376)
T cd05598         144 DFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAP-EVLLRTGYT  222 (376)
T ss_pred             eCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCH-HHHcCCCCC
Confidence            999975321000                                         00001124699999999 555677789


Q ss_pred             CccCchhHHHHHHHHHcCCCCCCc
Q 037916          597 INGDVYSYGILLLELMTRKRPSDI  620 (741)
Q Consensus       597 ~~~DIwSlG~il~elltg~~p~~~  620 (741)
                      .++||||+||++|||++|+.||..
T Consensus       223 ~~~DiwSlGvilyell~G~~Pf~~  246 (376)
T cd05598         223 QLCDWWSVGVILYEMLVGQPPFLA  246 (376)
T ss_pred             cceeeeeccceeeehhhCCCCCCC
Confidence            999999999999999999999863

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6.4e-37  Score=323.74  Aligned_cols=239  Identities=23%  Similarity=0.245  Sum_probs=185.9

Q ss_pred             hhcccCceeeEEEEEE---cCCCeEEEEEEeeccCc--CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEE
Q 037916          406 CWIDMGSFGSVYKGIL---DEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALV  480 (741)
Q Consensus       406 ~~ig~G~~g~V~~a~~---~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv  480 (741)
                      +.||+|+||.||++++   ..+++.||+|+++....  .....+..|+.++++++||||+++++++     ..+...|+|
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~lv   76 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAF-----QTEGKLYLI   76 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEE-----EcCCEEEEE
Confidence            5799999999999986   35789999999974322  2234567899999999999999999984     456689999


Q ss_pred             EecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecc
Q 037916          481 YEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFG  560 (741)
Q Consensus       481 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg  560 (741)
                      |||+++|+|.+++...          ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        77 ~e~~~~~~L~~~l~~~----------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg  143 (318)
T cd05582          77 LDFLRGGDLFTRLSKE----------VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFG  143 (318)
T ss_pred             EcCCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeecc
Confidence            9999999999988532          4578999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcch
Q 037916          561 LAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHV  640 (741)
Q Consensus       561 ~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  640 (741)
                      .+........  ......||+.|+||| ...+..++.++|||||||++|||++|+.||.....     ......      
T Consensus       144 ~~~~~~~~~~--~~~~~~g~~~y~aPE-~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-----~~~~~~------  209 (318)
T cd05582         144 LSKESIDHEK--KAYSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR-----KETMTM------  209 (318)
T ss_pred             CCcccCCCCC--ceecccCChhhcCHH-HHcCCCCCCccceeccceEeeeeccCCCCCCCCCH-----HHHHHH------
Confidence            9876543321  122356899999994 55566788999999999999999999999863211     001100      


Q ss_pred             hHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHH
Q 037916          641 MDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTI  698 (741)
Q Consensus       641 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  698 (741)
                        +..... .                   .+......+.+++.+||+.||++|||+.+
T Consensus       210 --i~~~~~-~-------------------~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         210 --ILKAKL-G-------------------MPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             --HHcCCC-C-------------------CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence              000000 0                   00123456779999999999999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=6.4e-36  Score=315.59  Aligned_cols=274  Identities=22%  Similarity=0.325  Sum_probs=203.2

Q ss_pred             HHHHHHHhhhcccCceeeEEEEEEc-------CCCeEEEEEEeeccC-cCcchhHHHHHHHHHhc-CCCceeeEeeeecC
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGILD-------EGKTIIAVKVLNLLH-HGASKSSIAECSALRNI-RHKNLVKILTVCSG  468 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~  468 (741)
                      ...+|.+.++||+|+||.||+|++.       .....||+|.++... ......+..|+.+++++ +||||++++++|  
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~--   87 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC--   87 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE--
Confidence            3467889999999999999999863       235679999987422 22245677899999999 699999999985  


Q ss_pred             ccccCCceEEEEEecccCCChhhhccCCCCCCc------ccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCC
Q 037916          469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADK------TVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLK  542 (741)
Q Consensus       469 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlk  542 (741)
                         ......+++|||+++|+|.+++........      .......+++.++..++.|++.||.|||+.   |++|||||
T Consensus        88 ---~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlk  161 (314)
T cd05099          88 ---TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLA  161 (314)
T ss_pred             ---ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeecccc
Confidence               344578999999999999999865321110      011224588999999999999999999999   99999999


Q ss_pred             CCCeEeCCCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCcc
Q 037916          543 PSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIM  621 (741)
Q Consensus       543 p~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~  621 (741)
                      |+||+++.++.+||+|||.++...............++..|+||| ...+..++.++|||||||++|++++ |..||...
T Consensus       162 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~  240 (314)
T cd05099         162 ARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI  240 (314)
T ss_pred             ceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHH-HHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999998665332221111123456799995 4456778999999999999999999 88887522


Q ss_pred             ccCCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          622 FEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       622 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      .     ......         .......                  ...+..++.++.+++.+||+.||++|||+.|+++
T Consensus       241 ~-----~~~~~~---------~~~~~~~------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         241 P-----VEELFK---------LLREGHR------------------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             C-----HHHHHH---------HHHcCCC------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            1     111111         0000000                  0001133456889999999999999999999999


Q ss_pred             HHHHHHHhhcC
Q 037916          702 ELQSIKSILLG  712 (741)
Q Consensus       702 ~L~~i~~~~~~  712 (741)
                      .|+++......
T Consensus       289 ~l~~~~~~~~~  299 (314)
T cd05099         289 ALDKVLAAVSE  299 (314)
T ss_pred             HHHHHHHHhcC
Confidence            99998765543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.6e-37  Score=330.18  Aligned_cols=200  Identities=23%  Similarity=0.264  Sum_probs=167.4

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      .|.++++||+|+||.||+|.+..+++.||+|++....   ....+.+.+|+.++++++||||++++++     +.+..+.
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~-----~~~~~~~   76 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYS-----FQDAQYL   76 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEE-----EEcCCee
Confidence            4788899999999999999999999999999986422   2234567789999999999999999999     4566689


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      |+||||+++|+|.+++...          ..+++..+..++.|++.||+|||+.   ||+||||||+||+++.++.+||+
T Consensus        77 ~lv~E~~~gg~L~~~l~~~----------~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~  143 (377)
T cd05629          77 YLIMEFLPGGDLMTMLIKY----------DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLS  143 (377)
T ss_pred             EEEEeCCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEe
Confidence            9999999999999998643          4578888899999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCc------------cc---------------------------------ccccccccccccCcccccCC
Q 037916          558 DFGLAKLLPPAHL------------QT---------------------------------SSIGVKGTIGYIAPAEYGLG  592 (741)
Q Consensus       558 DFg~a~~~~~~~~------------~~---------------------------------~~~~~~gt~~y~aPEe~~~~  592 (741)
                      |||+++.......            ..                                 ......||+.|+||| +..+
T Consensus       144 DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE-~~~~  222 (377)
T cd05629         144 DFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE-IFLQ  222 (377)
T ss_pred             ecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHH-HHcc
Confidence            9999863221000            00                                 001235899999995 5566


Q ss_pred             CCCCCccCchhHHHHHHHHHcCCCCCC
Q 037916          593 SEVSINGDVYSYGILLLELMTRKRPSD  619 (741)
Q Consensus       593 ~~~~~~~DIwSlG~il~elltg~~p~~  619 (741)
                      ..++.++||||+||++|||++|..||.
T Consensus       223 ~~~~~~~DiwSlGvil~elltG~~Pf~  249 (377)
T cd05629         223 QGYGQECDWWSLGAIMFECLIGWPPFC  249 (377)
T ss_pred             CCCCCceeeEecchhhhhhhcCCCCCC
Confidence            778999999999999999999999986

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.7e-37  Score=314.46  Aligned_cols=253  Identities=20%  Similarity=0.255  Sum_probs=191.6

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEee--ccCcCcchhHHHHHHHHHhc-CCCceeeEeeeecCccccCCceE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLN--LLHHGASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      .|+++++||+||.+.||++... +.+.||+|.+.  ..+......+.+|+..|.+| .|.+||++++|     .-.+.+.
T Consensus       362 ~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DY-----Ev~d~~l  435 (677)
T KOG0596|consen  362 EYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDY-----EVTDGYL  435 (677)
T ss_pred             hhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeee-----eccCceE
Confidence            5999999999999999999987 45667777664  23344567889999999999 58999999999     5567799


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      |+||||- ..+|..+++...+         ..+.-.++.+..||+.|+.++|..   ||||.||||.|+|+- .|.+||+
T Consensus       436 YmvmE~G-d~DL~kiL~k~~~---------~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLI  501 (677)
T KOG0596|consen  436 YMVMECG-DIDLNKILKKKKS---------IDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLI  501 (677)
T ss_pred             EEEeecc-cccHHHHHHhccC---------CCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEee
Confidence            9999976 5699999975422         122126788999999999999999   999999999999984 5689999


Q ss_pred             ecccccccCCCCcccccccccccccccCcccccCC----------CCCCCccCchhHHHHHHHHHcCCCCCCccccCCcc
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLG----------SEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMN  627 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~----------~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~  627 (741)
                      |||.|..+..+.........+||+.||+||.+...          -..+.++||||+|||+|+|+.|+.||.........
T Consensus       502 DFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aK  581 (677)
T KOG0596|consen  502 DFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAK  581 (677)
T ss_pred             eechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHH
Confidence            99999988877665556667899999999755321          12678999999999999999999998632111111


Q ss_pred             hhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          628 LHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       628 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                                  +..+.++.-.-.+.             ..    ....++.+++..||.+||.+|||+.|+++.
T Consensus       582 ------------l~aI~~P~~~Iefp-------------~~----~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  582 ------------LHAITDPNHEIEFP-------------DI----PENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             ------------HHhhcCCCcccccc-------------CC----CCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence                        11111110000000             00    001228899999999999999999999864

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=3.6e-36  Score=314.92  Aligned_cols=272  Identities=23%  Similarity=0.337  Sum_probs=199.4

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCC----------------CeEEEEEEeeccCc-CcchhHHHHHHHHHhcCCCceee
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEG----------------KTIIAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVK  461 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~----------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~  461 (741)
                      ...|++.++||+|+||.||+|.+...                +..||+|.+..... ...+.+.+|+.++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            35789999999999999999987643                35689999874322 23457788999999999999999


Q ss_pred             EeeeecCccccCCceEEEEEecccCCChhhhccCCCCCCcc-cCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecC
Q 037916          462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKT-VEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCD  540 (741)
Q Consensus       462 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrD  540 (741)
                      +++++     ..+...+++|||+++++|.+++......... ......+++..++.++.|++.||+|||+.   +|+|||
T Consensus        84 ~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~d  155 (296)
T cd05051          84 LLGVC-----TVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRD  155 (296)
T ss_pred             EEEEE-----ecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccc
Confidence            99995     3446889999999999999998654211100 11223688999999999999999999999   999999


Q ss_pred             CCCCCeEeCCCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc--CCCCC
Q 037916          541 LKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT--RKRPS  618 (741)
Q Consensus       541 lkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt--g~~p~  618 (741)
                      |||+||+++.++.++|+|||.+................++..|+||| ...+..++.++|||||||++||+++  |..||
T Consensus       156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~  234 (296)
T cd05051         156 LATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWE-SVLLGKFTTKSDVWAFGVTLWEILTLCREQPY  234 (296)
T ss_pred             cchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHH-HhhcCCCCccchhhhhHHHHHHHHhcCCCCCC
Confidence            99999999999999999999987654433222222344678899995 4456678999999999999999998  66776


Q ss_pred             CccccCCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHH
Q 037916          619 DIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTI  698 (741)
Q Consensus       619 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  698 (741)
                      ......  .................                       ....+..++..+.+++.+||+.||++|||+.|
T Consensus       235 ~~~~~~--~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~e  289 (296)
T cd05051         235 EHLTDQ--QVIENAGHFFRDDGRQI-----------------------YLPRPPNCPKDIYELMLECWRRDEEDRPTFRE  289 (296)
T ss_pred             CCcChH--HHHHHHHhccccccccc-----------------------cCCCccCCCHHHHHHHHHHhccChhcCCCHHH
Confidence            522110  00000000000000000                       00001123467899999999999999999999


Q ss_pred             HHHHHH
Q 037916          699 VVHELQ  704 (741)
Q Consensus       699 vl~~L~  704 (741)
                      |++.|+
T Consensus       290 l~~~L~  295 (296)
T cd05051         290 IHLFLQ  295 (296)
T ss_pred             HHHHhc
Confidence            999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.5e-36  Score=318.51  Aligned_cols=276  Identities=20%  Similarity=0.274  Sum_probs=198.1

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceE
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      +..|++.++||+|+||.||+|++..+++.||+|.++... ......+.+|+.++++++||||+++++++     ..+...
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~-----~~~~~~   79 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII-----HTEKSL   79 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEE-----ecCCeE
Confidence            356889999999999999999999899999999987433 22344677899999999999999999994     456689


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      ++||||++ ++|.+++...         ...+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        80 ~lv~e~~~-~~l~~~l~~~---------~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~  146 (301)
T cd07873          80 TLVFEYLD-KDLKQYLDDC---------GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLA  146 (301)
T ss_pred             EEEEeccc-cCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEEC
Confidence            99999996 5898887532         23477888999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCC
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      |||.+.........  .....+++.|+|||.+.....++.++||||+||++|+|++|+.||...... .... .+.....
T Consensus       147 dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~-~~~~-~~~~~~~  222 (301)
T cd07873         147 DFGLARAKSIPTKT--YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE-EQLH-FIFRILG  222 (301)
T ss_pred             cCcchhccCCCCCc--ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHH-HHHHHcC
Confidence            99998764432211  122347889999976655567889999999999999999999998632111 0111 1111111


Q ss_pred             ----cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          638 ----DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       638 ----~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                          .....+.+........     ...................+.+++.+|+..||.+|||++|+++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         223 TPTEETWPGILSNEEFKSYN-----YPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             CCChhhchhhhccccccccc-----cCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                0011111100000000     0000000000111133456789999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=3.5e-36  Score=307.86  Aligned_cols=252  Identities=25%  Similarity=0.355  Sum_probs=194.0

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      ..|++.+.||+|+||.||.|.+. ++..||+|.++.. ....+.+.+|+.++++++||||+++++++     ......++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   76 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVC-----TKQRPIYI   76 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEE-----ccCCCcEE
Confidence            46888999999999999999886 4556999988643 22346788999999999999999999995     34456899


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      +|||+.+++|.+++...         ...+++.+++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+||
T Consensus        77 v~e~~~~~~l~~~i~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~  144 (256)
T cd05113          77 VTEYMSNGCLLNYLREH---------GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDF  144 (256)
T ss_pred             EEEcCCCCcHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCC
Confidence            99999999999998642         12478899999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcCCc
Q 037916          560 GLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       560 g~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      |.++........ ......++..|+||| ...+..++.++|||||||++|+|++ |..||......  ........... 
T Consensus       145 g~~~~~~~~~~~-~~~~~~~~~~y~~pe-~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~~-  219 (256)
T cd05113         145 GLSRYVLDDEYT-SSVGSKFPVRWSPPE-VLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--ETVEKVSQGLR-  219 (256)
T ss_pred             ccceecCCCcee-ecCCCccChhhCCHH-HHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHhcCCC-
Confidence            998765443221 112233567899995 4455678999999999999999998 99998622110  00000000000 


Q ss_pred             chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHH
Q 037916          639 HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQ  704 (741)
Q Consensus       639 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  704 (741)
                                ...                   +......+.+++.+||+.||++|||+.++++.++
T Consensus       220 ----------~~~-------------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         220 ----------LYR-------------------PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             ----------CCC-------------------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence                      000                   0012456889999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=9.8e-37  Score=347.71  Aligned_cols=262  Identities=19%  Similarity=0.226  Sum_probs=198.7

Q ss_pred             HHHHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC--cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccC
Q 037916          396 ILLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKG  473 (741)
Q Consensus       396 ~~~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  473 (741)
                      ...+..|+++++||+|+||.||+|.+..++..||+|++....  ......+..|+.++++++|||||+++++|..   ..
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d---e~   85 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLN---KA   85 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe---cC
Confidence            445678999999999999999999999999999999987432  2234567889999999999999999998642   33


Q ss_pred             CceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCC----CCceecCCCCCCeEeC
Q 037916          474 DDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQ----PTTAHCDLKPSNVLLD  549 (741)
Q Consensus       474 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~----~~ivHrDlkp~NIll~  549 (741)
                      ...+|+||||+++++|.+++....      .....+++..++.|+.||+.||+|||+...    .+||||||||+|||++
T Consensus        86 ~~~lyIVMEY~~gGSL~~lL~k~~------~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~  159 (1021)
T PTZ00266         86 NQKLYILMEFCDAGDLSRNIQKCY------KMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLS  159 (1021)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHHh------hccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEee
Confidence            457899999999999999986421      112458899999999999999999998511    2599999999999996


Q ss_pred             C-----------------CCceEEeecccccccCCCCcccccccccccccccCcccccC-CCCCCCccCchhHHHHHHHH
Q 037916          550 H-----------------EMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGL-GSEVSINGDVYSYGILLLEL  611 (741)
Q Consensus       550 ~-----------------~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~-~~~~~~~~DIwSlG~il~el  611 (741)
                      .                 .+.+||+|||++.........   ....||+.|+|||.+.. ...++.++|||||||++|+|
T Consensus       160 s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~---~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYEL  236 (1021)
T PTZ00266        160 TGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMA---HSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL  236 (1021)
T ss_pred             cCccccccccccccccCCCCceEEccCCccccccccccc---cccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHH
Confidence            4                 235899999999866433221   22468999999965543 34688999999999999999


Q ss_pred             HcCCCCCCccccCCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCC
Q 037916          612 MTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQ  691 (741)
Q Consensus       612 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~  691 (741)
                      ++|..||...    .....+........           ...                 ....+..+.+||..||..+|+
T Consensus       237 LTGk~PF~~~----~~~~qli~~lk~~p-----------~lp-----------------i~~~S~eL~dLI~~~L~~dPe  284 (1021)
T PTZ00266        237 CSGKTPFHKA----NNFSQLISELKRGP-----------DLP-----------------IKGKSKELNILIKNLLNLSAK  284 (1021)
T ss_pred             HHCCCCCCcC----CcHHHHHHHHhcCC-----------CCC-----------------cCCCCHHHHHHHHHHhcCChh
Confidence            9999998621    11111111100000           000                 011245688999999999999


Q ss_pred             CCCCHHHHHH
Q 037916          692 DRMNMTIVVH  701 (741)
Q Consensus       692 ~RPs~~evl~  701 (741)
                      +|||+.|++.
T Consensus       285 eRPSa~QlL~  294 (1021)
T PTZ00266        285 ERPSALQCLG  294 (1021)
T ss_pred             HCcCHHHHhc
Confidence            9999999985

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.9e-36  Score=306.30  Aligned_cols=251  Identities=26%  Similarity=0.376  Sum_probs=194.3

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      ..|++.+.||+|+||.||+|.+. ++..+|+|+++... .....+.+|+.++++++||||+++++++     ......++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~l   76 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVC-----TKQRPIFI   76 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEE-----cCCCceEE
Confidence            46889999999999999999986 56789999986322 2345678899999999999999999984     44557899


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      ||||+++++|.+++...         ...+++..++.++.|++.|++|||+.   +++||||||+||+++.++.+||+||
T Consensus        77 v~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~df  144 (256)
T cd05059          77 VTEYMANGCLLNYLRER---------KGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDF  144 (256)
T ss_pred             EEecCCCCCHHHHHHhc---------ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCc
Confidence            99999999999998643         13578899999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcCCc
Q 037916          560 GLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       560 g~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      |.++......... .....++..|+||| +..+..++.++||||||+++|++++ |..||......  ..   ...    
T Consensus       145 g~~~~~~~~~~~~-~~~~~~~~~y~~Pe-~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~---~~~----  213 (256)
T cd05059         145 GLARYVLDDQYTS-SQGTKFPVKWAPPE-VFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--EV---VES----  213 (256)
T ss_pred             ccceecccccccc-cCCCCCCccccCHH-HhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--HH---HHH----
Confidence            9987654332211 11122455799995 5456778999999999999999999 88998632111  00   000    


Q ss_pred             chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHH
Q 037916          639 HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHEL  703 (741)
Q Consensus       639 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  703 (741)
                           +.....                  ...+..++..+.+++.+||..+|++|||+.|+++.|
T Consensus       214 -----~~~~~~------------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         214 -----VSAGYR------------------LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             -----HHcCCc------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence                 000000                  000112456788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-36  Score=310.88  Aligned_cols=255  Identities=22%  Similarity=0.290  Sum_probs=199.5

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      ..+|++.++||.|+||.||+|.+..++..||+|+++.......+.+..|+.++++++||||+++++++     ..+...|
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   78 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAY-----FYENKLW   78 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEE-----ecCCeEE
Confidence            45799999999999999999999888999999999755444556788999999999999999999994     4566899


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      +||||+++++|.+++...         ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|
T Consensus        79 lv~e~~~~~~L~~~~~~~---------~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d  146 (280)
T cd06611          79 ILIEFCDGGALDSIMLEL---------ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLAD  146 (280)
T ss_pred             EEeeccCCCcHHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEcc
Confidence            999999999999998632         24588899999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCccccc----CCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhh
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG----LGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~----~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  634 (741)
                      ||.+.........  .....+++.|+|||.+.    ....++.++||||+||++|+|++|+.||...... .........
T Consensus       147 ~g~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~  223 (280)
T cd06611         147 FGVSAKNKSTLQK--RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-RVLLKILKS  223 (280)
T ss_pred             Cccchhhcccccc--cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-HHHHHHhcC
Confidence            9988765432211  12245889999997553    2355788999999999999999999998632110 000000000


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      . ..        .                    ...+......+.+++.+||+.||++|||+.++++.
T Consensus       224 ~-~~--------~--------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         224 E-PP--------T--------------------LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             C-CC--------C--------------------cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            0 00        0                    00011234567899999999999999999999764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.9e-36  Score=315.59  Aligned_cols=273  Identities=19%  Similarity=0.304  Sum_probs=198.4

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcC----------------CCeEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceee
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDE----------------GKTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVK  461 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~  461 (741)
                      ..+|++.++||+|+||.||++.+..                ++..||+|+++... .....++.+|+.+++.++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            3578999999999999999986532                34579999987432 223457889999999999999999


Q ss_pred             EeeeecCccccCCceEEEEEecccCCChhhhccCCCCCCcc-cCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecC
Q 037916          462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKT-VEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCD  540 (741)
Q Consensus       462 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrD  540 (741)
                      +++++     ......++||||+++++|.+++......... ......+++.++..++.|++.||+|||+.   +++|||
T Consensus        84 ~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~d  155 (296)
T cd05095          84 LLAVC-----ITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRD  155 (296)
T ss_pred             EEEEE-----ecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Ceeccc
Confidence            99985     4455789999999999999998654221111 12224578889999999999999999999   999999


Q ss_pred             CCCCCeEeCCCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc--CCCCC
Q 037916          541 LKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT--RKRPS  618 (741)
Q Consensus       541 lkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt--g~~p~  618 (741)
                      |||+||+++.++.++|+|||.+................++..|+|||.. .++.++.++|||||||++|||++  |..||
T Consensus       156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~-~~~~~~~~~DiwSlG~~l~el~~~~~~~p~  234 (296)
T cd05095         156 LATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESI-LLGKFTTASDVWAFGVTLWEILTLCKEQPY  234 (296)
T ss_pred             CChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHH-hcCCccchhhhhHHHHHHHHHHHhCCCCCc
Confidence            9999999999999999999999765433222212223346789999644 45678999999999999999998  67787


Q ss_pred             CccccCCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHH
Q 037916          619 DIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTI  698 (741)
Q Consensus       619 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  698 (741)
                      ......     +....     .............               ......++..+.+++.+||+.||++|||+.|
T Consensus       235 ~~~~~~-----~~~~~-----~~~~~~~~~~~~~---------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~  289 (296)
T cd05095         235 SQLSDE-----QVIEN-----TGEFFRDQGRQVY---------------LPKPALCPDSLYKLMLSCWRRNAKERPSFQE  289 (296)
T ss_pred             cccChH-----HHHHH-----HHHHHhhcccccc---------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHH
Confidence            522111     11100     0011100000000               0001134567889999999999999999999


Q ss_pred             HHHHHHH
Q 037916          699 VVHELQS  705 (741)
Q Consensus       699 vl~~L~~  705 (741)
                      |++.|++
T Consensus       290 i~~~l~~  296 (296)
T cd05095         290 IHATLLE  296 (296)
T ss_pred             HHHHHhC
Confidence            9998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3.4e-36  Score=316.73  Aligned_cols=271  Identities=23%  Similarity=0.329  Sum_probs=202.1

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcC-------CCeEEEEEEeeccC-cCcchhHHHHHHHHHhc-CCCceeeEeeeecCc
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDE-------GKTIIAVKVLNLLH-HGASKSSIAECSALRNI-RHKNLVKILTVCSGV  469 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  469 (741)
                      ...|.+.+.||+|+||.||+|.+..       +...||+|.++... ......+..|+.+++.+ +||||++++++|   
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~---   93 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC---   93 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE---
Confidence            3678999999999999999998742       23569999987432 22334677899999999 799999999995   


Q ss_pred             cccCCceEEEEEecccCCChhhhccCCCCCCc------ccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCC
Q 037916          470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADK------TVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKP  543 (741)
Q Consensus       470 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp  543 (741)
                        ......|+||||+++|+|.+++...+....      .......+++.+++.++.|++.||+|||+.   |++||||||
T Consensus        94 --~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp  168 (307)
T cd05098          94 --TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAA  168 (307)
T ss_pred             --ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccH
Confidence              345578999999999999999975422110      001224588899999999999999999999   999999999


Q ss_pred             CCeEeCCCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccc
Q 037916          544 SNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMF  622 (741)
Q Consensus       544 ~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~  622 (741)
                      +||+++.++.+||+|||.+................+++.|+||| ...+..++.++||||+||++|||++ |..||... 
T Consensus       169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~-  246 (307)
T cd05098         169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPE-ALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-  246 (307)
T ss_pred             HheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChH-HhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC-
Confidence            99999999999999999987654322211111122456899995 4456778999999999999999998 88887521 


Q ss_pred             cCCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          623 EGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       623 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                          ........         +.....                  ...+..+...+.+++.+||..+|++|||+.||++.
T Consensus       247 ----~~~~~~~~---------~~~~~~------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         247 ----PVEELFKL---------LKEGHR------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             ----CHHHHHHH---------HHcCCC------------------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence                11111110         000000                  00111335678899999999999999999999999


Q ss_pred             HHHHHHhh
Q 037916          703 LQSIKSIL  710 (741)
Q Consensus       703 L~~i~~~~  710 (741)
                      |+++.+..
T Consensus       296 l~~~~~~~  303 (307)
T cd05098         296 LDRILALT  303 (307)
T ss_pred             HHHHHHHh
Confidence            99988754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=4e-36  Score=311.94  Aligned_cols=268  Identities=22%  Similarity=0.384  Sum_probs=204.3

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcC----CCeEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccC
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDE----GKTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKG  473 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  473 (741)
                      ..+|.+.+.||+|+||.||+|.+..    ++..||+|+++... ....+.+.+|+.++++++||||+++++++    ...
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~----~~~   80 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVC----IED   80 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE----ecC
Confidence            3578889999999999999999875    36889999886322 22345678899999999999999999986    333


Q ss_pred             CceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCc
Q 037916          474 DDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMT  553 (741)
Q Consensus       474 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~  553 (741)
                      +...++++||+++++|.+++.......  ......+++.++..++.|++.||+|||+.   +++||||||+||++++++.
T Consensus        81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~--~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~  155 (280)
T cd05043          81 GEPPFVLYPYMNWGNLKLFLQQCRLGE--ANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQ  155 (280)
T ss_pred             CCCCEEEEEcCCCCcHHHHHHhccccc--cccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCc
Confidence            567899999999999999986432211  11224688999999999999999999999   9999999999999999999


Q ss_pred             eEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhh
Q 037916          554 AHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFA  632 (741)
Q Consensus       554 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~  632 (741)
                      +||+|||+++...............++..|+||| ...+..++.++|||||||++||+++ |+.||....  ...+..+.
T Consensus       156 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE-~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~~~~~~~  232 (280)
T cd05043         156 VKITDNALSRDLFPMDYHCLGDNENRPVKWMALE-SLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID--PFEMAAYL  232 (280)
T ss_pred             EEECCCCCcccccCCceEEeCCCCCcchhccCHH-HHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC--HHHHHHHH
Confidence            9999999998664433222222234677899995 5556778999999999999999999 999986321  11111111


Q ss_pred             hhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHH
Q 037916          633 RTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKS  708 (741)
Q Consensus       633 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  708 (741)
                      ....            ..                  .....+++.+.+++.+||..||++|||+.|+++.|+++.+
T Consensus       233 ~~~~------------~~------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         233 KDGY------------RL------------------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             HcCC------------CC------------------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            1100            00                  0011334668899999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=4.2e-36  Score=315.19  Aligned_cols=269  Identities=22%  Similarity=0.310  Sum_probs=199.0

Q ss_pred             HHHHHHHhhhcccCceeeEEEEEEcCCCeE--EEEEEeeccC-cCcchhHHHHHHHHHhc-CCCceeeEeeeecCccccC
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGILDEGKTI--IAVKVLNLLH-HGASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKG  473 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~--vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~  473 (741)
                      -+..|++.+.||+|+||.||+|.+..++..  +|+|.++... ......+.+|+.++.++ +||||+++++++     ..
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~-----~~   79 (303)
T cd05088           5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EH   79 (303)
T ss_pred             chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE-----CC
Confidence            356789999999999999999998766654  5777665322 22345677899999999 899999999995     44


Q ss_pred             CceEEEEEecccCCChhhhccCCCCCCcc------cCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeE
Q 037916          474 DDFKALVYEFMHNGSLEEWLHPVSGADKT------VEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVL  547 (741)
Q Consensus       474 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~------~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIl  547 (741)
                      +...|+||||+++++|.+++.........      ......+++.+++.++.|++.|++|||+.   ||+||||||+||+
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nil  156 (303)
T cd05088          80 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNIL  156 (303)
T ss_pred             CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEE
Confidence            56799999999999999998644211100      01123578999999999999999999999   9999999999999


Q ss_pred             eCCCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCc
Q 037916          548 LDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNM  626 (741)
Q Consensus       548 l~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~  626 (741)
                      ++.++.+||+|||++.......   ......++..|+||| +..+..++.++|||||||++||+++ |..||.....   
T Consensus       157 i~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---  229 (303)
T cd05088         157 VGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIE-SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---  229 (303)
T ss_pred             ecCCCcEEeCccccCcccchhh---hcccCCCcccccCHH-HHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh---
Confidence            9999999999999986432111   111122456799995 5566678999999999999999998 9999852211   


Q ss_pred             chhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHH
Q 037916          627 NLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSI  706 (741)
Q Consensus       627 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  706 (741)
                        ....... +        .....                  ..+...+..+.+++.+||+.+|++||++.++++.++++
T Consensus       230 --~~~~~~~-~--------~~~~~------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~  280 (303)
T cd05088         230 --AELYEKL-P--------QGYRL------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  280 (303)
T ss_pred             --HHHHHHH-h--------cCCcC------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence              0111100 0        00000                  00012345678999999999999999999999999888


Q ss_pred             HHhh
Q 037916          707 KSIL  710 (741)
Q Consensus       707 ~~~~  710 (741)
                      ....
T Consensus       281 ~~~~  284 (303)
T cd05088         281 LEER  284 (303)
T ss_pred             HHhh
Confidence            7544

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=8.8e-37  Score=331.08  Aligned_cols=200  Identities=23%  Similarity=0.312  Sum_probs=167.2

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      .|+++++||+|+||.||+|++..+++.||+|++....   ......+.+|+.++++++||||+++++++     .++...
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~-----~~~~~~   76 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDNL   76 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEE-----EeCCEE
Confidence            4788999999999999999999999999999987432   22345678899999999999999999994     556689


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      |+||||+++|+|.+++...          ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+
T Consensus        77 ~lv~E~~~gg~L~~~l~~~----------~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~  143 (382)
T cd05625          77 YFVMDYIPGGDMMSLLIRM----------GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLT  143 (382)
T ss_pred             EEEEeCCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEe
Confidence            9999999999999998643          3477888899999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCC---------------------------------------------cccccccccccccccCcccccCC
Q 037916          558 DFGLAKLLPPAH---------------------------------------------LQTSSIGVKGTIGYIAPAEYGLG  592 (741)
Q Consensus       558 DFg~a~~~~~~~---------------------------------------------~~~~~~~~~gt~~y~aPEe~~~~  592 (741)
                      |||++.......                                             .........||+.|+||| +..+
T Consensus       144 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE-~~~~  222 (382)
T cd05625         144 DFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPE-VLLR  222 (382)
T ss_pred             ECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHH-HhcC
Confidence            999975321000                                             000011245899999995 5566


Q ss_pred             CCCCCccCchhHHHHHHHHHcCCCCCC
Q 037916          593 SEVSINGDVYSYGILLLELMTRKRPSD  619 (741)
Q Consensus       593 ~~~~~~~DIwSlG~il~elltg~~p~~  619 (741)
                      ..++.++||||+||++|||++|+.||.
T Consensus       223 ~~~~~~~DiwSlGvil~elltG~~Pf~  249 (382)
T cd05625         223 TGYTQLCDWWSVGVILYEMLVGQPPFL  249 (382)
T ss_pred             CCCCCeeeEEechHHHHHHHhCCCCCC
Confidence            778999999999999999999999986

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=7.1e-36  Score=306.71  Aligned_cols=255  Identities=27%  Similarity=0.424  Sum_probs=197.5

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      ..+|++.++||+|+||.||+|.+..+ ..||+|+++... ...+.+.+|+.++++++||||+++++++     . ....+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~-----~-~~~~~   76 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVV-----S-EEPIY   76 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEE-----C-CCCcE
Confidence            46799999999999999999998754 569999987432 2345788999999999999999999874     2 23578


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      +||||+++|+|.+++...        ....+++..+..++.|+++||+|+|+.   +++||||||+||++++++.+||+|
T Consensus        77 lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~d  145 (262)
T cd05071          77 IVTEYMSKGSLLDFLKGE--------MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVAD  145 (262)
T ss_pred             EEEEcCCCCcHHHHHhhc--------cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEecc
Confidence            999999999999998642        123468889999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcCC
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      ||.+.......... .....++..|+||| +..+..++.++||||+||++|++++ |..||......     .....   
T Consensus       146 fg~~~~~~~~~~~~-~~~~~~~~~y~~PE-~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~-----~~~~~---  215 (262)
T cd05071         146 FGLARLIEDNEYTA-RQGAKFPIKWTAPE-AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----EVLDQ---  215 (262)
T ss_pred             CCceeecccccccc-ccCCcccceecCHh-HhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH-----HHHHH---
Confidence            99997665432211 11234667899995 5566778999999999999999999 88887532111     00000   


Q ss_pred             cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHH
Q 037916          638 DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSI  706 (741)
Q Consensus       638 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  706 (741)
                            ......                  .....+++..+.+++.+||+.||++|||+.++++.|+..
T Consensus       216 ------~~~~~~------------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         216 ------VERGYR------------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             ------HhcCCC------------------CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence                  000000                  000123456788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=4.5e-36  Score=307.14  Aligned_cols=251  Identities=27%  Similarity=0.370  Sum_probs=195.9

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      ...|++.+.||+|+||.||+|...  +..||+|..+.  ....+.+.+|+.++++++|+|++++++++    +..+...+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~----~~~~~~~~   76 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVI----VEEKGGLY   76 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCC--CchHHHHHHHHHHHHhCCCCCeeeEEEEE----EcCCCceE
Confidence            356888999999999999999875  77899999863  23345788999999999999999999875    34455789


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      ++|||+++++|.+++....        ...+++..+..++.|++.||+|||+.   |++||||||+||++++++.+||+|
T Consensus        77 lv~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~d  145 (256)
T cd05082          77 IVTEYMAKGSLVDYLRSRG--------RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSD  145 (256)
T ss_pred             EEEECCCCCcHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecC
Confidence            9999999999999986431        13478889999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcCC
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      ||.+.......     ....++..|+||| +..+..++.++|||||||++|+|++ |+.||...     .........  
T Consensus       146 fg~~~~~~~~~-----~~~~~~~~y~aPE-~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~-----~~~~~~~~~--  212 (256)
T cd05082         146 FGLTKEASSTQ-----DTGKLPVKWTAPE-ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-----PLKDVVPRV--  212 (256)
T ss_pred             CccceeccccC-----CCCccceeecCHH-HHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHH--
Confidence            99987543322     1123566899995 5566778999999999999999997 99997521     111111110  


Q ss_pred             cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHH
Q 037916          638 DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSI  706 (741)
Q Consensus       638 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  706 (741)
                             .......                  ....++..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       213 -------~~~~~~~------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         213 -------EKGYKMD------------------APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             -------hcCCCCC------------------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence                   0000000                  0113456788999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.3e-36  Score=309.07  Aligned_cols=250  Identities=21%  Similarity=0.253  Sum_probs=196.4

Q ss_pred             HHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEE
Q 037916          402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALV  480 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv  480 (741)
                      |++.+.||+|+||.||++.+..+++.||+|.++... ....+.+.+|+.+++.++||||+++++.     +.++...|++
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-----~~~~~~~~lv   76 (255)
T cd08219           2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES-----FEADGHLYIV   76 (255)
T ss_pred             ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEE-----EEECCEEEEE
Confidence            778899999999999999999899999999986422 2344667889999999999999999998     4566789999


Q ss_pred             EecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecc
Q 037916          481 YEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFG  560 (741)
Q Consensus       481 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg  560 (741)
                      |||+++++|.+++....        ...+++..+..++.|++.||.|||+.   +|+|+||||+||++++++.++++|||
T Consensus        77 ~e~~~~~~l~~~~~~~~--------~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg  145 (255)
T cd08219          77 MEYCDGGDLMQKIKLQR--------GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFG  145 (255)
T ss_pred             EeeCCCCcHHHHHHhcc--------CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccC
Confidence            99999999999875321        23468888999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcch
Q 037916          561 LAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHV  640 (741)
Q Consensus       561 ~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  640 (741)
                      .+..........  ....|++.|+|| |+..+..++.++||||+|+++|+|++|..||....     ............ 
T Consensus       146 ~~~~~~~~~~~~--~~~~~~~~~~aP-E~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~-----~~~~~~~~~~~~-  216 (255)
T cd08219         146 SARLLTSPGAYA--CTYVGTPYYVPP-EIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS-----WKNLILKVCQGS-  216 (255)
T ss_pred             cceeeccccccc--ccccCCccccCH-HHHccCCcCchhhhhhhchhheehhhccCCCCCCC-----HHHHHHHHhcCC-
Confidence            987664432211  224588899999 45566678999999999999999999999986221     111111100000 


Q ss_pred             hHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          641 MDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       641 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                                 ..               ..+......+.+++.+||+.||++|||+.|++.+
T Consensus       217 -----------~~---------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         217 -----------YK---------------PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             -----------CC---------------CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                       00               0001233457799999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.1e-36  Score=326.01  Aligned_cols=204  Identities=24%  Similarity=0.272  Sum_probs=168.7

Q ss_pred             HHHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC--cCcchhHHHHHHHHHhcCCCceeeEeeeecCcc-ccC
Q 037916          397 LLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSGVD-YKG  473 (741)
Q Consensus       397 ~~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~~  473 (741)
                      .+..+|.+.+.||+|+||.||+|.+..+++.||+|++....  ......+.+|+.+++.++||||+++++++.... ...
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~  100 (364)
T cd07875          21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  100 (364)
T ss_pred             chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence            34578999999999999999999999899999999986422  233456778999999999999999999864322 223


Q ss_pred             CceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCc
Q 037916          474 DDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMT  553 (741)
Q Consensus       474 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~  553 (741)
                      ....|+||||++ +++.+++.            ..+++..+..++.|+++||+|||++   +|+||||||+||+++.++.
T Consensus       101 ~~~~~lv~e~~~-~~l~~~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~  164 (364)
T cd07875         101 FQDVYIVMELMD-ANLCQVIQ------------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCT  164 (364)
T ss_pred             cCeEEEEEeCCC-CCHHHHHH------------hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCc
Confidence            346899999995 47777764            2367788899999999999999999   9999999999999999999


Q ss_pred             eEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCc
Q 037916          554 AHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDI  620 (741)
Q Consensus       554 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~  620 (741)
                      +||+|||+++.......   .....||+.|+|| |+..+..++.++||||+||++|+|++|+.||..
T Consensus       165 ~kL~DfG~a~~~~~~~~---~~~~~~t~~y~aP-E~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  227 (364)
T cd07875         165 LKILDFGLARTAGTSFM---MTPYVVTRYYRAP-EVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG  227 (364)
T ss_pred             EEEEeCCCccccCCCCc---ccCCcccCCcCCH-HHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Confidence            99999999986543321   1224589999999 555677889999999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=7.1e-36  Score=311.99  Aligned_cols=254  Identities=23%  Similarity=0.258  Sum_probs=197.2

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      ...|+++++||.|+||.||+|++..++..||+|++........+.+.+|+.+++.++||||+++++++     ..+...+
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   85 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF-----YWDGKLW   85 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEE-----EeCCeEE
Confidence            46799999999999999999999988999999999765545566788899999999999999999985     3455899


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      +||||+++++|..++...         ...+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.+||+|
T Consensus        86 lv~e~~~~~~l~~~~~~~---------~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~d  153 (292)
T cd06644          86 IMIEFCPGGAVDAIMLEL---------DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLAD  153 (292)
T ss_pred             EEEecCCCCcHHHHHHhh---------cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEcc
Confidence            999999999998877532         23478899999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCccccc----CCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhh
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG----LGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~----~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  634 (741)
                      ||.+........  ......+++.|+|||.+.    ....++.++|||||||++|+|++|..||..... ...+..+...
T Consensus       154 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-~~~~~~~~~~  230 (292)
T cd06644         154 FGVSAKNVKTLQ--RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-MRVLLKIAKS  230 (292)
T ss_pred             Cccceecccccc--ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-HHHHHHHhcC
Confidence            999875433211  112245788999996553    234578899999999999999999999863211 0000000000


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ..+         ..                    .........+.+++.+||+.||++||++.|+++
T Consensus       231 ~~~---------~~--------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         231 EPP---------TL--------------------SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             CCc---------cC--------------------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            000         00                    001123346789999999999999999999976

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=4.5e-36  Score=314.21  Aligned_cols=268  Identities=21%  Similarity=0.290  Sum_probs=199.7

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCe--EEEEEEeecc-CcCcchhHHHHHHHHHhc-CCCceeeEeeeecCccccCCc
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKT--IIAVKVLNLL-HHGASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      ..|++.+.||+|+||.||+|.+..++.  .+++|.++.. .....+.+.+|+.+++++ +||||+++++++     ....
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-----~~~~   76 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGAC-----ENRG   76 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEE-----ccCC
Confidence            468899999999999999999876654  4688887632 222345678899999999 799999999985     4455


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCc------ccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeC
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADK------TVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLD  549 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~  549 (741)
                      ..+++|||+++++|.+++........      .......+++..++.++.|++.||+|||+.   +|+||||||+||+++
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~  153 (297)
T cd05089          77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVG  153 (297)
T ss_pred             cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEEC
Confidence            78999999999999999864321110      011123588899999999999999999999   999999999999999


Q ss_pred             CCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcch
Q 037916          550 HEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNL  628 (741)
Q Consensus       550 ~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~  628 (741)
                      .++.+||+|||++........   ......+..|+||| ...+..++.++|||||||++|||++ |..||.....     
T Consensus       154 ~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE-~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~-----  224 (297)
T cd05089         154 ENLASKIADFGLSRGEEVYVK---KTMGRLPVRWMAIE-SLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC-----  224 (297)
T ss_pred             CCCeEEECCcCCCccccceec---cCCCCcCccccCch-hhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-----
Confidence            999999999999864322111   11112355799995 5556678999999999999999997 9999863211     


Q ss_pred             hhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHH
Q 037916          629 HNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKS  708 (741)
Q Consensus       629 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  708 (741)
                      .......         ......                  ..+..++..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       225 ~~~~~~~---------~~~~~~------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~  277 (297)
T cd05089         225 AELYEKL---------PQGYRM------------------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE  277 (297)
T ss_pred             HHHHHHH---------hcCCCC------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            1111110         000000                  0011234568899999999999999999999999999987


Q ss_pred             hhc
Q 037916          709 ILL  711 (741)
Q Consensus       709 ~~~  711 (741)
                      ...
T Consensus       278 ~~~  280 (297)
T cd05089         278 ARK  280 (297)
T ss_pred             hhc
Confidence            653

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=9.1e-36  Score=305.64  Aligned_cols=255  Identities=28%  Similarity=0.450  Sum_probs=197.4

Q ss_pred             HHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceE
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      ...+|++.++||+|+||.||+|.+. ++..||+|.++.... ..+.+.+|+.++++++||+|+++++++.      ....
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~~   75 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS------EEPI   75 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC------CCCc
Confidence            4568999999999999999999886 566799999875332 3467889999999999999999998842      2357


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      +++|||+++++|.+++...        ....+++.++..++.|++.||+|||+.   +++||||||+||++++++.++|+
T Consensus        76 ~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~  144 (260)
T cd05070          76 YIVTEYMSKGSLLDFLKDG--------EGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIA  144 (260)
T ss_pred             EEEEEecCCCcHHHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeC
Confidence            8999999999999998642        123478899999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcC
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVL  636 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~  636 (741)
                      |||.+.......... .....++..|+||| +..+..++.++||||||+++|++++ |..||......  .   ....  
T Consensus       145 dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~---~~~~--  215 (260)
T cd05070         145 DFGLARLIEDNEYTA-RQGAKFPIKWTAPE-AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR--E---VLEQ--  215 (260)
T ss_pred             CceeeeeccCccccc-ccCCCCCccccChH-HHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH--H---HHHH--
Confidence            999998664432111 11223566899995 4556778999999999999999999 88898632110  0   1000  


Q ss_pred             CcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHH
Q 037916          637 PDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQS  705 (741)
Q Consensus       637 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  705 (741)
                             +......                  ..+...+..+.+++.+||..||++|||+.++.+.|++
T Consensus       216 -------~~~~~~~------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         216 -------VERGYRM------------------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             -------HHcCCCC------------------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                   0000000                  0011334568899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.8e-36  Score=315.23  Aligned_cols=278  Identities=21%  Similarity=0.242  Sum_probs=196.0

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC--cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      +|++.+.||+|+||.||+|++..+|+.||+|.++...  ......+.+|+.++++++||||++++++     +.+....+
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~-----~~~~~~~~   75 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV-----LHSDKKLT   75 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHH-----hccCCceE
Confidence            3778899999999999999999899999999987432  2223567789999999999999999998     45566899


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      +||||+. ++|.+++...         ...+++..++.++.||++||.|||+.   +|+||||||+||+++.++.+||+|
T Consensus        76 lv~e~~~-~~l~~~~~~~---------~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d  142 (284)
T cd07839          76 LVFEYCD-QDLKKYFDSC---------NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLAD  142 (284)
T ss_pred             EEEecCC-CCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECc
Confidence            9999996 5888876532         24578999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCc
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      ||.+........  ......++..|+|||.+.....++.++||||+||++|+|++|..|+.........+..........
T Consensus       143 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~  220 (284)
T cd07839         143 FGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP  220 (284)
T ss_pred             cchhhccCCCCC--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCC
Confidence            999876543221  112234788999997665555679999999999999999999988642221111111111111000


Q ss_pred             chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          639 HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       639 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ....+..........   ...................+.+.+++.+||+.||++|||+.|+++
T Consensus       221 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         221 TEESWPGVSKLPDYK---PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             ChHHhHHhhhccccc---ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            000000000000000   000000000001111234567789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=4.6e-36  Score=312.30  Aligned_cols=278  Identities=21%  Similarity=0.258  Sum_probs=195.8

Q ss_pred             HHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC--cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      |++.+.||+|++|.||+|++..++..||+|+++...  ....+.+.+|+.++++++||||+++++++     .++...|+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~   76 (285)
T cd07861           2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVL-----MQESRLYL   76 (285)
T ss_pred             ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEE-----eeCCeEEE
Confidence            678899999999999999999899999999986432  22345678899999999999999999994     45668999


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      ||||++ ++|.+++....       ....+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        77 v~e~~~-~~l~~~~~~~~-------~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df  145 (285)
T cd07861          77 IFEFLS-MDLKKYLDSLP-------KGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADF  145 (285)
T ss_pred             EEecCC-CCHHHHHhcCC-------CCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcc
Confidence            999996 68888875431       124578899999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcc
Q 037916          560 GLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDH  639 (741)
Q Consensus       560 g~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  639 (741)
                      |.+........  ......+++.|+|||.+.....++.++||||+||++|+|++|+.||....... .............
T Consensus       146 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~~  222 (285)
T cd07861         146 GLARAFGIPVR--VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID-QLFRIFRILGTPT  222 (285)
T ss_pred             cceeecCCCcc--cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCC
Confidence            99876543221  11223468899999666555667899999999999999999999986321110 0000000000000


Q ss_pred             hhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          640 VMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       640 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                       ...... .. ...+.....................+++.+++.+||..||++|||+.||++
T Consensus       223 -~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         223 -EDVWPG-VT-SLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             -hhhhhc-ch-hhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence             000000 00 000000000000000000111124567789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.4e-36  Score=320.33  Aligned_cols=241  Identities=24%  Similarity=0.250  Sum_probs=183.5

Q ss_pred             hhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHH-HHHhcCCCceeeEeeeecCccccCCceEEEEE
Q 037916          406 CWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECS-ALRNIRHKNLVKILTVCSGVDYKGDDFKALVY  481 (741)
Q Consensus       406 ~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv~  481 (741)
                      +.||+|+||.||+|++..+++.||+|++....   ......+..|.. +++.++||||++++++     +...+..|+||
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~-----~~~~~~~~lv~   75 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFS-----FQTADKLYFVL   75 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEE-----EEcCCeEEEEE
Confidence            46999999999999999899999999997422   112233344443 4677899999999998     45566899999


Q ss_pred             ecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeeccc
Q 037916          482 EFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGL  561 (741)
Q Consensus       482 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~  561 (741)
                      ||+++++|.+++...          ..+.+..+..++.||++||+|||+.   ||+||||||+||+++.++.+||+|||+
T Consensus        76 e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~  142 (325)
T cd05602          76 DYINGGELFYHLQRE----------RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGL  142 (325)
T ss_pred             eCCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCC
Confidence            999999999988643          4467788888999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcchh
Q 037916          562 AKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM  641 (741)
Q Consensus       562 a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  641 (741)
                      ++.......  ......||+.|+||| +..+..++.++||||+||++|+|++|..||.....     ......       
T Consensus       143 a~~~~~~~~--~~~~~~gt~~y~aPE-~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~-------  207 (325)
T cd05602         143 CKENIEHNG--TTSTFCGTPEYLAPE-VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-----AEMYDN-------  207 (325)
T ss_pred             CcccccCCC--CcccccCCccccCHH-HHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH-----HHHHHH-------
Confidence            875432221  122356899999995 55667889999999999999999999999862211     111110       


Q ss_pred             HhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHH
Q 037916          642 DIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVV  700 (741)
Q Consensus       642 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  700 (741)
                       +......                    ........+.+++.+||+.||.+||++.+.+
T Consensus       208 -i~~~~~~--------------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         208 -ILNKPLQ--------------------LKPNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             -HHhCCcC--------------------CCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence             0000000                    0012345678999999999999999987543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1e-35  Score=304.57  Aligned_cols=249  Identities=24%  Similarity=0.358  Sum_probs=189.7

Q ss_pred             hcccCceeeEEEEEEc--CCCeEEEEEEeeccCc-CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEEEec
Q 037916          407 WIDMGSFGSVYKGILD--EGKTIIAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEF  483 (741)
Q Consensus       407 ~ig~G~~g~V~~a~~~--~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv~e~  483 (741)
                      .||+|+||.||+|.+.  .++..||+|+++.... ...+.+.+|+.++++++||||+++++++.      ....++||||
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~------~~~~~lv~e~   75 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE------AEALMLVMEM   75 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc------CCCeEEEEEe
Confidence            4899999999999875  4556799999864322 22456789999999999999999999852      2367999999


Q ss_pred             ccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeeccccc
Q 037916          484 MHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAK  563 (741)
Q Consensus       484 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~a~  563 (741)
                      +++++|.+++...         ...+++..+.+++.|++.||+|||++   +++||||||+||+++.++.+||+|||.+.
T Consensus        76 ~~~~~L~~~l~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~  143 (257)
T cd05115          76 ASGGPLNKFLSGK---------KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSK  143 (257)
T ss_pred             CCCCCHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccc
Confidence            9999999998632         23578899999999999999999999   99999999999999999999999999997


Q ss_pred             ccCCCCcc-cccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcCCcchh
Q 037916          564 LLPPAHLQ-TSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVLPDHVM  641 (741)
Q Consensus       564 ~~~~~~~~-~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  641 (741)
                      ........ .......++..|+||| ...+..++.++|||||||++|++++ |..||......  ...            
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~------------  208 (257)
T cd05115         144 ALGADDSYYKARSAGKWPLKWYAPE-CINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP--EVM------------  208 (257)
T ss_pred             cccCCccceeccCCCCCCcccCCHH-HHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH--HHH------------
Confidence            55433211 1111122357899995 4456678999999999999999996 99998632111  010            


Q ss_pred             HhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHH
Q 037916          642 DIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSI  706 (741)
Q Consensus       642 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  706 (741)
                      ..+.......                  .+..+++++.+++.+||..||++||++.+|.+.|+.+
T Consensus       209 ~~~~~~~~~~------------------~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         209 SFIEQGKRLD------------------CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             HHHHCCCCCC------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            1111000000                  0113456788999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=7.7e-37  Score=292.82  Aligned_cols=290  Identities=21%  Similarity=0.197  Sum_probs=206.8

Q ss_pred             HHHHHHHHhhhcccCceeeEEEEEEcCCC----eEEEEEEeeccC--cCcchhHHHHHHHHHhcCCCceeeEeeeecCcc
Q 037916          397 LLFVSFLFLCWIDMGSFGSVYKGILDEGK----TIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSGVD  470 (741)
Q Consensus       397 ~~~~~y~~~~~ig~G~~g~V~~a~~~~~~----~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  470 (741)
                      .....|+++++||+|.||.||+|...++.    ..+|+|.++...  ........+|+.+++.++||||+.+..++.   
T Consensus        21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl---   97 (438)
T KOG0666|consen   21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFL---   97 (438)
T ss_pred             HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHh---
Confidence            34567999999999999999999765433    278999997432  234567789999999999999999999863   


Q ss_pred             ccCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCC
Q 037916          471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDH  550 (741)
Q Consensus       471 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~  550 (741)
                       ..+..+++++||.+. +|...|+-.+...     ...++...++.|+.||+.|+.|||++   -|+||||||+||||..
T Consensus        98 -~~d~~v~l~fdYAEh-DL~~II~fHr~~~-----~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmg  167 (438)
T KOG0666|consen   98 -SHDKKVWLLFDYAEH-DLWHIIKFHRASK-----AKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMG  167 (438)
T ss_pred             -ccCceEEEEehhhhh-hHHHHHHHhccch-----hccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEec
Confidence             336689999999965 9999987553322     24688888999999999999999999   9999999999999987


Q ss_pred             C----CceEEeecccccccCCCCccc-ccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCC
Q 037916          551 E----MTAHVADFGLAKLLPPAHLQT-SSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGN  625 (741)
Q Consensus       551 ~----~~~kL~DFg~a~~~~~~~~~~-~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~  625 (741)
                      +    |.|||+|||+++....+-... ....++-|.+|+|||.++....|+.+.||||+|||+.||++-++-|.......
T Consensus       168 dgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~  247 (438)
T KOG0666|consen  168 DGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKI  247 (438)
T ss_pred             cCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhc
Confidence            7    899999999999887653222 33446689999999888888899999999999999999999988875332111


Q ss_pred             cchhhhhhhcCCcchhHhhhhcccCCcchhhhh---hhh-------HH-------HHHhHhhHHHHHHHHHHHhhccccc
Q 037916          626 MNLHNFARTVLPDHVMDIVDSTLLADDEDLTIT---SNQ-------RQ-------RQARINNIMECLISVVRIGVACSME  688 (741)
Q Consensus       626 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~---~~~-------~~-------~~~~~~~~~~~~~~l~~li~~cl~~  688 (741)
                      ..-.    .+..+.+..+++-...+...+....   +..       +.       -.........-.+...+|+.+++.+
T Consensus       248 ~~~~----Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~y  323 (438)
T KOG0666|consen  248 KTKN----PFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTY  323 (438)
T ss_pred             ccCC----CchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhcc
Confidence            1000    0001112222221111111111000   000       00       0001111111223478999999999


Q ss_pred             CCCCCCCHHHHHHHH
Q 037916          689 SPQDRMNMTIVVHEL  703 (741)
Q Consensus       689 dP~~RPs~~evl~~L  703 (741)
                      ||-+|.|++|.++-.
T Consensus       324 DP~kRIta~qAleh~  338 (438)
T KOG0666|consen  324 DPIKRITAEQALEHP  338 (438)
T ss_pred             CchhhccHHHHhccc
Confidence            999999999998764

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.4e-36  Score=324.87  Aligned_cols=201  Identities=22%  Similarity=0.275  Sum_probs=169.8

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      ...|++.+.||+|+||.||+|++..+++.||+|+++...   ......+.+|+.+++.++||||++++++     +.++.
T Consensus        42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~-----~~~~~  116 (370)
T cd05621          42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCA-----FQDDK  116 (370)
T ss_pred             HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEE-----EEcCC
Confidence            467999999999999999999999999999999986421   2233456789999999999999999998     45667


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..|+||||+++|+|.+++..           ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+|
T Consensus       117 ~~~lv~Ey~~gg~L~~~l~~-----------~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~k  182 (370)
T cd05621         117 YLYMVMEYMPGGDLVNLMSN-----------YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLK  182 (370)
T ss_pred             EEEEEEcCCCCCcHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEE
Confidence            89999999999999999853           2367788899999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcccccccccccccccCcccccCC---CCCCCccCchhHHHHHHHHHcCCCCCC
Q 037916          556 VADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLG---SEVSINGDVYSYGILLLELMTRKRPSD  619 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~---~~~~~~~DIwSlG~il~elltg~~p~~  619 (741)
                      |+|||.|......... ......||+.|+|||.+...   ..++.++||||+||++|||++|+.||.
T Consensus       183 L~DFG~a~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~  248 (370)
T cd05621         183 LADFGTCMKMDETGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY  248 (370)
T ss_pred             EEecccceecccCCce-ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCC
Confidence            9999999876433221 11235699999999665432   347899999999999999999999986

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=7.6e-36  Score=310.44  Aligned_cols=274  Identities=25%  Similarity=0.326  Sum_probs=203.1

Q ss_pred             HHHHHhhhcccCceeeEEEEEEc----CCCeEEEEEEeeccCcC-cchhHHHHHHHHHhcCCCceeeEeeeecCccccCC
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILD----EGKTIIAVKVLNLLHHG-ASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGD  474 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~  474 (741)
                      ..|++.+.||+|+||.||+|.+.    .++..||+|+++..... ..+.+.+|+.+++.+.||||+++++++..   .++
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~---~~~   80 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEK---PGG   80 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeec---CCC
Confidence            35788899999999999999864    34789999999754332 35678899999999999999999998642   235


Q ss_pred             ceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCce
Q 037916          475 DFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTA  554 (741)
Q Consensus       475 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~  554 (741)
                      ...+++|||+++++|.+++...         ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+
T Consensus        81 ~~~~lv~e~~~~~~l~~~l~~~---------~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~  148 (284)
T cd05038          81 RSLRLIMEYLPSGSLRDYLQRH---------RDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLV  148 (284)
T ss_pred             CceEEEEecCCCCCHHHHHHhC---------ccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCE
Confidence            6789999999999999998643         12588899999999999999999999   99999999999999999999


Q ss_pred             EEeecccccccCCCCcc-cccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhh
Q 037916          555 HVADFGLAKLLPPAHLQ-TSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFAR  633 (741)
Q Consensus       555 kL~DFg~a~~~~~~~~~-~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~  633 (741)
                      ||+|||.+......... .......++..|+||| ...+..++.++||||||+++|||++|..|+.........   +..
T Consensus       149 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe-~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~---~~~  224 (284)
T cd05038         149 KISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPE-CLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR---MIG  224 (284)
T ss_pred             EEcccccccccccCCcceeccCCCCCcccccCcH-HHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc---ccc
Confidence            99999999876533221 1111223556799995 445667899999999999999999999997532221111   000


Q ss_pred             hcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHH
Q 037916          634 TVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSI  706 (741)
Q Consensus       634 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  706 (741)
                      ..........+...+...              ........++..+.+++.+||+.+|++|||+.||+++|+.+
T Consensus       225 ~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         225 IAQGQMIVTRLLELLKEG--------------ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             cccccccHHHHHHHHHcC--------------CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            000000000000000000              00111123456789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.8e-36  Score=321.21  Aligned_cols=241  Identities=24%  Similarity=0.240  Sum_probs=183.6

Q ss_pred             hhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHH-HHHhcCCCceeeEeeeecCccccCCceEEEEE
Q 037916          406 CWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECS-ALRNIRHKNLVKILTVCSGVDYKGDDFKALVY  481 (741)
Q Consensus       406 ~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv~  481 (741)
                      +.||+|+||.||+|.+..+++.||+|++....   ......+..|.. +++.++||||++++++     +...+..|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~-----~~~~~~~~lv~   75 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYS-----FQTTEKLYFVL   75 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEE-----EecCCEEEEEE
Confidence            46899999999999999999999999997432   122334455554 4677899999999998     45566899999


Q ss_pred             ecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeeccc
Q 037916          482 EFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGL  561 (741)
Q Consensus       482 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~  561 (741)
                      ||+++|+|..++...          ..+++..+..++.||+.||+|||+.   ||+||||||+||+++.++.+||+|||+
T Consensus        76 e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~  142 (325)
T cd05604          76 DFVNGGELFFHLQRE----------RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGL  142 (325)
T ss_pred             cCCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCC
Confidence            999999998887533          4578889999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcchh
Q 037916          562 AKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM  641 (741)
Q Consensus       562 a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  641 (741)
                      +........  ......||+.|+||| +..+..++.++||||+||++|||++|..||....     .......       
T Consensus       143 ~~~~~~~~~--~~~~~~gt~~y~aPE-~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~-----~~~~~~~-------  207 (325)
T cd05604         143 CKEGIAQSD--TTTTFCGTPEYLAPE-VIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD-----VAEMYDN-------  207 (325)
T ss_pred             cccCCCCCC--CcccccCChhhCCHH-HHcCCCCCCcCccccccceehhhhcCCCCCCCCC-----HHHHHHH-------
Confidence            875322211  122356899999995 5566778999999999999999999999986321     1111111       


Q ss_pred             HhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHH
Q 037916          642 DIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVV  700 (741)
Q Consensus       642 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  700 (741)
                       +.......                    .......+.+++.+|++.||.+||++.+.+
T Consensus       208 -~~~~~~~~--------------------~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~  245 (325)
T cd05604         208 -ILHKPLVL--------------------RPGASLTAWSILEELLEKDRQRRLGAKEDF  245 (325)
T ss_pred             -HHcCCccC--------------------CCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence             11000000                    001234577899999999999999986433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=3e-36  Score=319.52  Aligned_cols=244  Identities=23%  Similarity=0.280  Sum_probs=186.4

Q ss_pred             hhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhc-CCCceeeEeeeecCccccCCceEEEEE
Q 037916          406 CWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKGDDFKALVY  481 (741)
Q Consensus       406 ~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~~~~lv~  481 (741)
                      +.||+|+||.||+|.+..+++.||+|+++...   ....+.+.+|+.++.++ +||+|++++++     +......|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~-----~~~~~~~~lv~   75 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSC-----FQTTSRLFLVI   75 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEE-----EEeCCEEEEEE
Confidence            36999999999999999999999999997432   22334567899998888 69999999998     45566899999


Q ss_pred             ecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeeccc
Q 037916          482 EFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGL  561 (741)
Q Consensus       482 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~  561 (741)
                      ||+++|+|..++...          ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        76 e~~~~~~L~~~~~~~----------~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~  142 (327)
T cd05617          76 EYVNGGDLMFHMQRQ----------RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGM  142 (327)
T ss_pred             eCCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEecccc
Confidence            999999999887532          4588999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCC-cchhhhhhhcCCcch
Q 037916          562 AKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGN-MNLHNFARTVLPDHV  640 (741)
Q Consensus       562 a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~  640 (741)
                      ++.......  ......||+.|+|| |+..+..++.++||||+||++|||++|..||....... .........      
T Consensus       143 ~~~~~~~~~--~~~~~~gt~~y~aP-E~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~------  213 (327)
T cd05617         143 CKEGLGPGD--TTSTFCGTPNYIAP-EILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQ------  213 (327)
T ss_pred             ceeccCCCC--ceecccCCcccCCH-HHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHH------
Confidence            875332211  11235689999999 55567788999999999999999999999996322111 111111000      


Q ss_pred             hHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHH
Q 037916          641 MDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMT  697 (741)
Q Consensus       641 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  697 (741)
                       .+.....                    ..+......+.+++.+||+.||++||++.
T Consensus       214 -~~~~~~~--------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~  249 (327)
T cd05617         214 -VILEKPI--------------------RIPRFLSVKASHVLKGFLNKDPKERLGCQ  249 (327)
T ss_pred             -HHHhCCC--------------------CCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence             0000000                    00112235577999999999999999864

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=7.8e-36  Score=312.88  Aligned_cols=261  Identities=21%  Similarity=0.312  Sum_probs=198.7

Q ss_pred             HHHHHHHhhhcccCceeeEEEEEE-----cCCCeEEEEEEeeccCc-CcchhHHHHHHHHHhc-CCCceeeEeeeecCcc
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGIL-----DEGKTIIAVKVLNLLHH-GASKSSIAECSALRNI-RHKNLVKILTVCSGVD  470 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~  470 (741)
                      ...+|.+.+.||+|+||.||+|.+     ..++..||+|+++.... ...+.+.+|+.+++++ +||||+++++++    
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~----  108 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGAC----  108 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEE----
Confidence            346789999999999999999985     33456899999874322 2245678899999999 799999999985    


Q ss_pred             ccCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCC
Q 037916          471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDH  550 (741)
Q Consensus       471 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~  550 (741)
                       ......++||||+++|+|.+++....        ...+++.++..++.|++.||+|||+.   +|+|+||||+||+++.
T Consensus       109 -~~~~~~~lv~e~~~~~~L~~~i~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~  176 (302)
T cd05055         109 -TIGGPILVITEYCCYGDLLNFLRRKR--------ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTH  176 (302)
T ss_pred             -ecCCceEEEEEcCCCCcHHHHHHhCC--------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcC
Confidence             34557899999999999999986431        12378999999999999999999999   9999999999999999


Q ss_pred             CCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchh
Q 037916          551 EMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLH  629 (741)
Q Consensus       551 ~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~  629 (741)
                      ++.+||+|||.+................++..|+||| ...+..++.++||||+||++||+++ |..||...... ..+ 
T Consensus       177 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~-~~~-  253 (302)
T cd05055         177 GKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPE-SIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD-SKF-  253 (302)
T ss_pred             CCeEEECCCcccccccCCCceeecCCCCcccccCCHh-hhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch-HHH-
Confidence            9999999999998665432211112234577899995 4456678999999999999999998 99998632111 000 


Q ss_pred             hhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHH
Q 037916          630 NFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSI  706 (741)
Q Consensus       630 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  706 (741)
                                 ...++.......                  ....+..+.+++.+||+.+|++|||+.|+++.|+++
T Consensus       254 -----------~~~~~~~~~~~~------------------~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         254 -----------YKLIKEGYRMAQ------------------PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             -----------HHHHHcCCcCCC------------------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                       011110000000                  011235688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=6.6e-36  Score=305.88  Aligned_cols=250  Identities=23%  Similarity=0.296  Sum_probs=197.5

Q ss_pred             HHHhhhcccCceeeEEEEEEcCCCeEEEEEEeecc--CcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLL--HHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      |.+.+.||+|++|.||+|.+..+++.||+|.+...  .....+.+.+|+.++++++||||+++++++     ......++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   76 (256)
T cd08529           2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESF-----LDKGKLNI   76 (256)
T ss_pred             ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeee-----ccCCEEEE
Confidence            67788999999999999999989999999998642  233456778899999999999999999984     44568999


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      ||||+++++|.+++....        ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+||
T Consensus        77 v~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df  145 (256)
T cd08529          77 VMEYAENGDLHKLLKMQR--------GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDL  145 (256)
T ss_pred             EEEeCCCCcHHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEccc
Confidence            999999999999986431        24578889999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcc
Q 037916          560 GLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDH  639 (741)
Q Consensus       560 g~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  639 (741)
                      |.+..........  ....|++.|+|| |+..+..++.++|||||||++|+|++|+.||......     .....     
T Consensus       146 ~~~~~~~~~~~~~--~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~-----  212 (256)
T cd08529         146 GVAKLLSDNTNFA--NTIVGTPYYLSP-ELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG-----ALILK-----  212 (256)
T ss_pred             ccceeccCccchh--hccccCccccCH-HHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-----HHHHH-----
Confidence            9988765432221  224588899999 5556677899999999999999999999998632210     00110     


Q ss_pred             hhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          640 VMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       640 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                         ...    ....               ......+..+.+++.+||+.+|++||++.|+++.
T Consensus       213 ---~~~----~~~~---------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         213 ---IIR----GVFP---------------PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             ---HHc----CCCC---------------CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence               000    0000               0001334668899999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=7.1e-36  Score=311.03  Aligned_cols=276  Identities=19%  Similarity=0.232  Sum_probs=198.1

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc--CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      +|++.+.||+|+||.||+|++..+++.||+|++.....  ...+.+.+|+.++++++||||+++++++     ......+
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~   76 (286)
T cd07847           2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVF-----RRKRKLH   76 (286)
T ss_pred             ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEE-----eeCCEEE
Confidence            57888999999999999999998899999999864322  2335678899999999999999999984     4566899


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      +||||++++++..++...          ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|
T Consensus        77 ~v~e~~~~~~l~~~~~~~----------~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~d  143 (286)
T cd07847          77 LVFEYCDHTVLNELEKNP----------RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCD  143 (286)
T ss_pred             EEEeccCccHHHHHHhCC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECc
Confidence            999999998888876432          3478999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCc--chhhhhhhcC
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNM--NLHNFARTVL  636 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~--~~~~~~~~~~  636 (741)
                      ||.+.........  .....++..|+|||.+.....++.++||||+|+++|+|++|+.||......+.  ..........
T Consensus       144 fg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  221 (286)
T cd07847         144 FGFARILTGPGDD--YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLI  221 (286)
T ss_pred             cccceecCCCccc--ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            9999876543321  11234788999997665556788999999999999999999999863321110  0000000111


Q ss_pred             CcchhHhhhhccc-CCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          637 PDHVMDIVDSTLL-ADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       637 ~~~~~~~~d~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      +. ..+..+.... .............    ...........+.+++.+||+.||++|||+.|++.
T Consensus       222 ~~-~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         222 PR-HQQIFSTNQFFKGLSIPEPETREP----LESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             hH-HhhhcccccccccccCCCcccccC----HHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            00 0001000000 0000000000000    00011123567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.3e-36  Score=305.03  Aligned_cols=249  Identities=24%  Similarity=0.329  Sum_probs=192.3

Q ss_pred             hhcccCceeeEEEEEEcCCC---eEEEEEEeeccCc-CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEEE
Q 037916          406 CWIDMGSFGSVYKGILDEGK---TIIAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVY  481 (741)
Q Consensus       406 ~~ig~G~~g~V~~a~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv~  481 (741)
                      ++||+|+||.||+|.+...+   ..||+|.++.... ...+.+.+|+.++++++||||+++++++.      ....++||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~~~~~~v~   74 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK------GEPLMLVM   74 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc------CCceEEEE
Confidence            47999999999999875444   7899999874332 23456788999999999999999999852      33579999


Q ss_pred             ecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeeccc
Q 037916          482 EFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGL  561 (741)
Q Consensus       482 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~  561 (741)
                      ||+++++|.+++...          ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||.
T Consensus        75 e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~  141 (257)
T cd05060          75 ELAPLGPLLKYLKKR----------REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGM  141 (257)
T ss_pred             EeCCCCcHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccc
Confidence            999999999999643          3578889999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCccc-ccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcCCcc
Q 037916          562 AKLLPPAHLQT-SSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVLPDH  639 (741)
Q Consensus       562 a~~~~~~~~~~-~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  639 (741)
                      +.......... ......++..|+|||. ..+..++.++|||||||++|++++ |..||.....  ..+........+. 
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~~~~~~~-  217 (257)
T cd05060         142 SRALGAGSDYYRATTAGRWPLKWYAPEC-INYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAMLESGERL-  217 (257)
T ss_pred             cceeecCCcccccccCccccccccCHHH-hcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHHcCCcC-
Confidence            98664432211 1111224567999954 466678999999999999999998 9999863211  1111111110000 


Q ss_pred             hhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHH
Q 037916          640 VMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSI  706 (741)
Q Consensus       640 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  706 (741)
                                                   ..+..++..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       218 -----------------------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         218 -----------------------------PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             -----------------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence                                         00113346788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=9e-37  Score=314.49  Aligned_cols=268  Identities=22%  Similarity=0.316  Sum_probs=210.3

Q ss_pred             HHHHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCc-chhHHHHHHHHHhcCCCceeeEeeeecCccccCC
Q 037916          396 ILLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGA-SKSSIAECSALRNIRHKNLVKILTVCSGVDYKGD  474 (741)
Q Consensus       396 ~~~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~  474 (741)
                      ...-....+.++||+|.||+|.+|.-. .+..||+|.++...... ..+|.+|+++|.+++|||||+++++|...     
T Consensus       534 EfPRs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D-----  607 (807)
T KOG1094|consen  534 EFPRSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQD-----  607 (807)
T ss_pred             hcchhheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecC-----
Confidence            444566788999999999999999987 47899999998654443 47899999999999999999999999543     


Q ss_pred             ceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCce
Q 037916          475 DFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTA  554 (741)
Q Consensus       475 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~  554 (741)
                      +.++++||||+.|+|.+|+..+.       . .........+|+.||+.|++||.+.   ++||||+.+.|+|++.++++
T Consensus       608 ePicmI~EYmEnGDLnqFl~ahe-------a-pt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~i  676 (807)
T KOG1094|consen  608 DPLCMITEYMENGDLNQFLSAHE-------L-PTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTI  676 (807)
T ss_pred             CchHHHHHHHhcCcHHHHHHhcc-------C-cccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccE
Confidence            36899999999999999997541       1 1134455678999999999999999   99999999999999999999


Q ss_pred             EEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc--CCCCCCccccCCcchhhhh
Q 037916          555 HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT--RKRPSDIMFEGNMNLHNFA  632 (741)
Q Consensus       555 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt--g~~p~~~~~~~~~~~~~~~  632 (741)
                      ||+|||+++..-....+.......-..+|||||.+ .-++.++++|||+||+++||+++  ...||....+++  ..+-.
T Consensus       677 KiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsi-llgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~--vven~  753 (807)
T KOG1094|consen  677 KIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESI-LLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ--VVENA  753 (807)
T ss_pred             EecCcccccccccCCceeeecceeeeeeehhHHHH-HhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH--HHHhh
Confidence            99999999977666666555445567899999655 45678999999999999999755  778987443321  11111


Q ss_pred             hhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHH
Q 037916          633 RTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSI  706 (741)
Q Consensus       633 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  706 (741)
                      ....+..-..                       .-...+.-|+..+.+++.+||..|-++|||++++..-|++.
T Consensus       754 ~~~~~~~~~~-----------------------~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  754 GEFFRDQGRQ-----------------------VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             hhhcCCCCcc-----------------------eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            1111111000                       01123457888999999999999999999999999888764

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.2e-35  Score=306.34  Aligned_cols=258  Identities=21%  Similarity=0.270  Sum_probs=186.1

Q ss_pred             hhcccCceeeEEEEEEc--CCCeEEEEEEeeccCc-CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEEEe
Q 037916          406 CWIDMGSFGSVYKGILD--EGKTIIAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYE  482 (741)
Q Consensus       406 ~~ig~G~~g~V~~a~~~--~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv~e  482 (741)
                      +.||+|+||.||+|.+.  .++..+|+|.++.... .....+.+|+.++++++||||+++++++.     +....++|||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e   75 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCT-----EVTPYLLVME   75 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----CCCCcEEEEE
Confidence            46899999999999864  3456799998864332 22346788999999999999999999853     4457899999


Q ss_pred             cccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecccc
Q 037916          483 FMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLA  562 (741)
Q Consensus       483 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~a  562 (741)
                      |+++|+|.+++......     .....++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||.+
T Consensus        76 ~~~~g~L~~~l~~~~~~-----~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~  147 (269)
T cd05087          76 FCPLGDLKGYLRSCRKA-----ELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLS  147 (269)
T ss_pred             CCCCCcHHHHHHHhhhc-----ccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCcccc
Confidence            99999999998643211     113456777888999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCCcccccccccccccccCcccccCC------CCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhc
Q 037916          563 KLLPPAHLQTSSIGVKGTIGYIAPAEYGLG------SEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTV  635 (741)
Q Consensus       563 ~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~------~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  635 (741)
                      ................++..|+|||.+...      ..++.++|||||||++|||++ |+.||......+.  ....   
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~--~~~~---  222 (269)
T cd05087         148 HNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV--LTYT---  222 (269)
T ss_pred             ccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH--HHHH---
Confidence            765433322222234578889999654321      235789999999999999996 9999863321110  0000   


Q ss_pred             CCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHH
Q 037916          636 LPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQ  704 (741)
Q Consensus       636 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  704 (741)
                      .........++...                      ....+.+.+++.+|| .+|++|||++||++.|+
T Consensus       223 ~~~~~~~~~~~~~~----------------------~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         223 VREQQLKLPKPRLK----------------------LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             hhcccCCCCCCccC----------------------CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            00000000111110                      012345678999999 58999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=6.6e-36  Score=312.78  Aligned_cols=252  Identities=21%  Similarity=0.263  Sum_probs=199.2

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      ...|++.++||+|+||.||+|.+..+++.||+|.+........+.+.+|+.+++.++||||+++++++     ..+...|
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~   92 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY-----LVGDELW   92 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCEEE
Confidence            47899999999999999999999889999999999765545556778899999999999999999985     4556899


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      +||||+++++|.+++..           ..+++.++..++.|++.||.|||+.   +++||||||+||+++.++.+||+|
T Consensus        93 lv~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~D  158 (297)
T cd06656          93 VVMEYLAGGSLTDVVTE-----------TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTD  158 (297)
T ss_pred             EeecccCCCCHHHHHHh-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECc
Confidence            99999999999998852           3467888999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCc
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      ||.+..........  ....+++.|+||| ...+..++.++||||+||++|++++|..||........... ......+.
T Consensus       159 fg~~~~~~~~~~~~--~~~~~~~~y~aPE-~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-~~~~~~~~  234 (297)
T cd06656         159 FGFCAQITPEQSKR--STMVGTPYWMAPE-VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-IATNGTPE  234 (297)
T ss_pred             CccceEccCCccCc--CcccCCccccCHH-HHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-eccCCCCC
Confidence            99987654432211  2245888999995 45567788999999999999999999999863211110000 00000000


Q ss_pred             chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          639 HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       639 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                                                   ...+...+..+.+++.+||..||++|||+.++++.
T Consensus       235 -----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         235 -----------------------------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             -----------------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                                         00011234557789999999999999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=5.4e-36  Score=309.00  Aligned_cols=257  Identities=23%  Similarity=0.362  Sum_probs=197.0

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCe---EEEEEEeecc-CcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKT---IIAVKVLNLL-HHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      ..|++.+.||+|+||.||+|.+..++.   .||+|+++.. .......+..|+.+++.++||||+++++++     .++.
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~   78 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKSR   78 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEE-----CCCC
Confidence            568889999999999999999876554   6999998643 222345788999999999999999999984     4556


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..++||||+++++|.+++...         ...+++.+++.++.|++.||+|||+.   |++||||||+||+++.++.+|
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~k  146 (269)
T cd05065          79 PVMIITEFMENGALDSFLRQN---------DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCK  146 (269)
T ss_pred             ceEEEEecCCCCcHHHHHhhC---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEE
Confidence            789999999999999998643         13478889999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCccccccccc---ccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhh
Q 037916          556 VADFGLAKLLPPAHLQTSSIGVK---GTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNF  631 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~~~~~~~~---gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~  631 (741)
                      |+|||.+................   .+..|+||| ...+..++.++||||+||++||+++ |..||......  .....
T Consensus       147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE-~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--~~~~~  223 (269)
T cd05065         147 VSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPE-AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DVINA  223 (269)
T ss_pred             ECCCccccccccCccccccccccCCCcceeecCHh-HhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--HHHHH
Confidence            99999987654432211111111   245799995 5566778999999999999999886 99998532110  11111


Q ss_pred             hhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHH
Q 037916          632 ARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSI  706 (741)
Q Consensus       632 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  706 (741)
                      +....+                              .....+++..+.+++.+||+.+|++||++.+|+..|+.+
T Consensus       224 i~~~~~------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         224 IEQDYR------------------------------LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             HHcCCc------------------------------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            100000                              001123456688999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=3.2e-36  Score=318.82  Aligned_cols=238  Identities=24%  Similarity=0.257  Sum_probs=181.7

Q ss_pred             hhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHH-HHHhcCCCceeeEeeeecCccccCCceEEEEE
Q 037916          406 CWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECS-ALRNIRHKNLVKILTVCSGVDYKGDDFKALVY  481 (741)
Q Consensus       406 ~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv~  481 (741)
                      +.||+|+||.||+|++..+++.||+|++....   ......+..|.. +++.++||||+++++++     .+.+..|+||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~-----~~~~~~~lv~   75 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF-----QTAEKLYFVL   75 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCEEEEEE
Confidence            36899999999999999899999999986422   122334445554 57888999999999884     5566899999


Q ss_pred             ecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeeccc
Q 037916          482 EFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGL  561 (741)
Q Consensus       482 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~  561 (741)
                      ||+++++|..++...          ..+++..+..++.||++||.|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        76 e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~  142 (321)
T cd05603          76 DYVNGGELFFHLQRE----------RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGL  142 (321)
T ss_pred             cCCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCC
Confidence            999999998887532          4577888899999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcchh
Q 037916          562 AKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM  641 (741)
Q Consensus       562 a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  641 (741)
                      ++.......  ......||+.|+||| ...+..++.++||||+||++|||++|..||....     .......       
T Consensus       143 ~~~~~~~~~--~~~~~~gt~~y~aPE-~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~~~~~~-------  207 (321)
T cd05603         143 CKEGVEPEE--TTSTFCGTPEYLAPE-VLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-----VSQMYDN-------  207 (321)
T ss_pred             CccCCCCCC--ccccccCCcccCCHH-HhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC-----HHHHHHH-------
Confidence            875432221  122346899999995 4556778999999999999999999999986321     1111111       


Q ss_pred             HhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHH
Q 037916          642 DIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMT  697 (741)
Q Consensus       642 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  697 (741)
                       +......                    .+......+.+++.+||+.||++||++.
T Consensus       208 -i~~~~~~--------------------~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         208 -ILHKPLQ--------------------LPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             -HhcCCCC--------------------CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence             0000000                    0012234678999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.1e-36  Score=306.54  Aligned_cols=252  Identities=20%  Similarity=0.248  Sum_probs=195.1

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc-----CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH-----GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      .|.+.+.||+|++|.||.|.+..+++.||+|.+.....     .....+.+|+.++++++||||+++++++     ..+.
T Consensus         3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~   77 (263)
T cd06625           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCL-----RDDE   77 (263)
T ss_pred             cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ccCC
Confidence            47889999999999999999988999999999864321     1234677899999999999999999994     4556


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..++||||+++++|.+++...          ..+++..+..++.|++.||.|||+.   +|+||||+|+||+++.++.++
T Consensus        78 ~~~~v~e~~~~~~l~~~~~~~----------~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~  144 (263)
T cd06625          78 TLSIFMEYMPGGSVKDQLKAY----------GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVK  144 (263)
T ss_pred             eEEEEEEECCCCcHHHHHHHh----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEE
Confidence            899999999999999988643          3477888899999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcccc-cccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhh
Q 037916          556 VADFGLAKLLPPAHLQTS-SIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~~~-~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  634 (741)
                      |+|||.+........... .....|+..|+|| |+..+..++.++||||+|+++|++++|+.||.....    .......
T Consensus       145 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~  219 (263)
T cd06625         145 LGDFGASKRLQTICSSGTGMKSVTGTPYWMSP-EVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA----MAAIFKI  219 (263)
T ss_pred             EeecccceeccccccccccccCCCcCccccCc-ceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch----HHHHHHH
Confidence            999999876543221111 1224578899999 555566789999999999999999999999863211    0000000


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                               .......                  ..+..+...+.+++.+||..+|++|||+.|+++.
T Consensus       220 ---------~~~~~~~------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         220 ---------ATQPTNP------------------QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             ---------hccCCCC------------------CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence                     0000000                  0011334567899999999999999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.8e-36  Score=313.69  Aligned_cols=272  Identities=20%  Similarity=0.310  Sum_probs=195.9

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCC--------------CeEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEe
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEG--------------KTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKIL  463 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~--------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~  463 (741)
                      ..+|++.++||+|+||.||+|++...              ...||+|.++... ......+.+|++++++++||||++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            35789999999999999999987532              2358999986432 22345678899999999999999999


Q ss_pred             eeecCccccCCceEEEEEecccCCChhhhccCCCCCC--cccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCC
Q 037916          464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGAD--KTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDL  541 (741)
Q Consensus       464 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDl  541 (741)
                      +++     ......++||||+++++|.+++.......  ........+++..+..++.|++.||+|||+.   +++||||
T Consensus        84 ~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dl  155 (295)
T cd05097          84 GVC-----VSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDL  155 (295)
T ss_pred             EEE-----cCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---Ceecccc
Confidence            995     44557899999999999999985431100  0001112467888999999999999999999   9999999


Q ss_pred             CCCCeEeCCCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc--CCCCCC
Q 037916          542 KPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT--RKRPSD  619 (741)
Q Consensus       542 kp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt--g~~p~~  619 (741)
                      ||+||++++++.+||+|||.+................++..|+|||. ..+..++.++|||||||++|+|++  |..||.
T Consensus       156 kp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~  234 (295)
T cd05097         156 ATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWES-ILLGKFTTASDVWAFGVTLWEMFTLCKEQPYS  234 (295)
T ss_pred             ChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhh-hccCCcCchhhHHHHHHHHHHHHHcCCCCCCc
Confidence            99999999999999999999876543322222222345778999954 456678999999999999999988  566765


Q ss_pred             ccccCCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHH
Q 037916          620 IMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIV  699 (741)
Q Consensus       620 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev  699 (741)
                      ......     .....     ....+.......               ......+++.+.+++.+||+.||++|||+.+|
T Consensus       235 ~~~~~~-----~~~~~-----~~~~~~~~~~~~---------------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i  289 (295)
T cd05097         235 LLSDEQ-----VIENT-----GEFFRNQGRQIY---------------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKI  289 (295)
T ss_pred             ccChHH-----HHHHH-----HHhhhhcccccc---------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence            221110     00000     000000000000               00011234678999999999999999999999


Q ss_pred             HHHHH
Q 037916          700 VHELQ  704 (741)
Q Consensus       700 l~~L~  704 (741)
                      ++.|+
T Consensus       290 ~~~l~  294 (295)
T cd05097         290 HHFLR  294 (295)
T ss_pred             HHHHh
Confidence            99886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-36  Score=321.91  Aligned_cols=290  Identities=19%  Similarity=0.236  Sum_probs=203.8

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      ..|.+.+.||+|+||.||+|.+..+++.||+|+++... ......+.+|+.++++++||||+++++++....+......|
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   84 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY   84 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence            57899999999999999999999899999999986422 23345677899999999999999999987655545556789


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      ++|||+. +++.+++..           ..+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        85 lv~e~~~-~~l~~~~~~-----------~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~d  149 (336)
T cd07849          85 IVQELME-TDLYKLIKT-----------QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICD  149 (336)
T ss_pred             EEehhcc-cCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECc
Confidence            9999995 588777642           3578889999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCccc-ccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCC
Q 037916          559 FGLAKLLPPAHLQT-SSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       559 Fg~a~~~~~~~~~~-~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      ||++.......... ......|++.|+|||.+.....++.++||||+||++|+|++|+.||.....  ......+.....
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~--~~~~~~~~~~~~  227 (336)
T cd07849         150 FGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY--LHQLNLILGVLG  227 (336)
T ss_pred             ccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHcC
Confidence            99987654332211 112345889999997665556789999999999999999999999853211  000011111111


Q ss_pred             cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH--HHHH
Q 037916          638 DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE--LQSI  706 (741)
Q Consensus       638 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i  706 (741)
                      ....+..+................................+.+++.+||+.||++|||+.|+++.  ++..
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~  298 (336)
T cd07849         228 TPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY  298 (336)
T ss_pred             CCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence            10001111000000000000000000000001112335678899999999999999999999986  5433

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=5.1e-36  Score=333.14  Aligned_cols=197  Identities=23%  Similarity=0.304  Sum_probs=159.9

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCC------CceeeEeeeecCcccc
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRH------KNLVKILTVCSGVDYK  472 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------pnIv~~~~~~~~~~~~  472 (741)
                      ..+|++.++||+|+||.||+|.+..+++.||||+++... ........|+.+++.++|      ++++++++++.    .
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~----~  202 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ----N  202 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE----c
Confidence            357999999999999999999999899999999996421 223445667777777644      45888888863    2


Q ss_pred             CCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHh-cCCCCceecCCCCCCeEeCCC
Q 037916          473 GDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH-DCQPTTAHCDLKPSNVLLDHE  551 (741)
Q Consensus       473 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivHrDlkp~NIll~~~  551 (741)
                      ...+.|+|||++ +++|.+++...          ..+++..+..|+.||+.||+|||+ .   |||||||||+|||++.+
T Consensus       203 ~~~~~~iv~~~~-g~~l~~~l~~~----------~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~  268 (467)
T PTZ00284        203 ETGHMCIVMPKY-GPCLLDWIMKH----------GPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETS  268 (467)
T ss_pred             CCceEEEEEecc-CCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecC
Confidence            345789999998 77898888633          457888999999999999999997 6   99999999999999876


Q ss_pred             C----------------ceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCC
Q 037916          552 M----------------TAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRK  615 (741)
Q Consensus       552 ~----------------~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~  615 (741)
                      +                .+||+|||.+......     .....||+.|+||| +..+..++.++|||||||++|||++|+
T Consensus       269 ~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE-~~~~~~~~~~~DiwSlGvil~elltG~  342 (467)
T PTZ00284        269 DTVVDPVTNRALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPE-VVLGLGWMYSTDMWSMGCIIYELYTGK  342 (467)
T ss_pred             CcccccccccccCCCCceEEECCCCccccCccc-----cccccCCccccCcH-HhhcCCCCcHHHHHHHHHHHHHHHhCC
Confidence            5                4999999987643221     22356899999994 556778999999999999999999999


Q ss_pred             CCCCc
Q 037916          616 RPSDI  620 (741)
Q Consensus       616 ~p~~~  620 (741)
                      .||+.
T Consensus       343 ~pf~~  347 (467)
T PTZ00284        343 LLYDT  347 (467)
T ss_pred             CCCCC
Confidence            99963

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=9.9e-36  Score=316.92  Aligned_cols=272  Identities=22%  Similarity=0.328  Sum_probs=202.9

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcC-------CCeEEEEEEeeccC-cCcchhHHHHHHHHHhc-CCCceeeEeeeecCcc
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDE-------GKTIIAVKVLNLLH-HGASKSSIAECSALRNI-RHKNLVKILTVCSGVD  470 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~  470 (741)
                      .+|++.+.||+|+||.||+|++..       .+..||+|.++... ....+.+.+|+.+++++ +||||++++++|.   
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~---   88 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT---   88 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc---
Confidence            468899999999999999998642       23478999886322 22345778899999999 8999999999953   


Q ss_pred             ccCCceEEEEEecccCCChhhhccCCCCCCc------ccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCC
Q 037916          471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADK------TVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPS  544 (741)
Q Consensus       471 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~  544 (741)
                        .....+++|||+++|+|.+++........      .......+++.++..++.|++.||+|||+.   ||+||||||+
T Consensus        89 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~  163 (334)
T cd05100          89 --QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAAR  163 (334)
T ss_pred             --cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccc
Confidence              44578999999999999999865321110      011234588899999999999999999999   9999999999


Q ss_pred             CeEeCCCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCcccc
Q 037916          545 NVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFE  623 (741)
Q Consensus       545 NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~  623 (741)
                      ||+++.++.+||+|||.++...............++..|+||| ...+..++.++|||||||++|||++ |..||...  
T Consensus       164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~--  240 (334)
T cd05100         164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI--  240 (334)
T ss_pred             eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHH-HhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC--
Confidence            9999999999999999998665432222222233456899995 4456778999999999999999998 88887522  


Q ss_pred             CCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHH
Q 037916          624 GNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHEL  703 (741)
Q Consensus       624 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  703 (741)
                         ....+........         ..                  +.+..++..+.+++.+||+.+|++|||+.|+++.|
T Consensus       241 ---~~~~~~~~~~~~~---------~~------------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l  290 (334)
T cd05100         241 ---PVEELFKLLKEGH---------RM------------------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL  290 (334)
T ss_pred             ---CHHHHHHHHHcCC---------CC------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence               1111111100000         00                  00113345688999999999999999999999999


Q ss_pred             HHHHHhhcC
Q 037916          704 QSIKSILLG  712 (741)
Q Consensus       704 ~~i~~~~~~  712 (741)
                      +.+......
T Consensus       291 ~~~~~~~~~  299 (334)
T cd05100         291 DRVLTVTST  299 (334)
T ss_pred             HHHhhhcCC
Confidence            999865543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.8e-36  Score=310.73  Aligned_cols=254  Identities=27%  Similarity=0.399  Sum_probs=194.9

Q ss_pred             HHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcch--hHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASK--SSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      |++++.||+|+||.||+|.+..+++.||+|++.........  ...+|+.++++++||||+++++++     ......++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~~   75 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVF-----QDDNYLYI   75 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEE-----EESSEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccc-----cccccccc
Confidence            56788999999999999999999999999999854332222  234599999999999999999994     44668999


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      ||||+++++|.+++..          ...+++..+..++.|+++||++||+.   +|+|+||||+||+++.++.++|+||
T Consensus        76 v~~~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Df  142 (260)
T PF00069_consen   76 VMEYCPGGSLQDYLQK----------NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDF  142 (260)
T ss_dssp             EEEEETTEBHHHHHHH----------HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSG
T ss_pred             cccccccccccccccc----------cccccccccccccccccccccccccc---ccccccccccccccccccccccccc
Confidence            9999999899999862          25678999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcc
Q 037916          560 GLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDH  639 (741)
Q Consensus       560 g~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  639 (741)
                      |.+......  ........++..|+|||.+..+..++.++||||+|+++|+|++|..||.....  ............. 
T Consensus       143 g~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~--~~~~~~~~~~~~~-  217 (260)
T PF00069_consen  143 GSSVKLSEN--NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS--DDQLEIIEKILKR-  217 (260)
T ss_dssp             TTTEESTST--TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH--HHHHHHHHHHHHT-
T ss_pred             ccccccccc--ccccccccccccccccccccccccccccccccccccccccccccccccccccc--hhhhhhhhhcccc-
Confidence            999764221  12222355899999996544378899999999999999999999999873300  0000000000000 


Q ss_pred             hhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          640 VMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       640 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                        ...                     ............+.+++.+||+.||++|||+.|+++
T Consensus       218 --~~~---------------------~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  218 --PLP---------------------SSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             --HHH---------------------HHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             --ccc---------------------ccccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              000                     000000011267899999999999999999999975

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.1e-35  Score=308.33  Aligned_cols=250  Identities=24%  Similarity=0.303  Sum_probs=191.6

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      .|++++.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.++++++||||+++++++     ......++
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~l   76 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF-----FVENRISI   76 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----EECCEEEE
Confidence            3678899999999999999998899999999986432 22235678899999999999999999995     44567899


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      ||||+++++|..+.              .+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.+||+||
T Consensus        77 v~e~~~~~~l~~~~--------------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~df  139 (279)
T cd06619          77 CTEFMDGGSLDVYR--------------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDF  139 (279)
T ss_pred             EEecCCCCChHHhh--------------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeC
Confidence            99999999986542              256778889999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcc
Q 037916          560 GLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDH  639 (741)
Q Consensus       560 g~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  639 (741)
                      |.+.......    .....|+..|+||| +..+..++.++||||+||++|+|++|+.||...........       ...
T Consensus       140 g~~~~~~~~~----~~~~~~~~~y~aPE-~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~-------~~~  207 (279)
T cd06619         140 GVSTQLVNSI----AKTYVGTNAYMAPE-RISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLM-------PLQ  207 (279)
T ss_pred             Ccceeccccc----ccCCCCChhhcCce-eecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccc-------hHH
Confidence            9997654332    12245899999995 55566789999999999999999999999864322111100       000


Q ss_pred             hhH-hhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          640 VMD-IVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       640 ~~~-~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      ... +.+... ...                 ........+.+++.+||+.||++||+++|+++.
T Consensus       208 ~~~~~~~~~~-~~~-----------------~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         208 LLQCIVDEDP-PVL-----------------PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             HHHHHhccCC-CCC-----------------CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            000 000000 000                 001123467899999999999999999999864

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=9.9e-36  Score=304.79  Aligned_cols=248  Identities=23%  Similarity=0.347  Sum_probs=190.3

Q ss_pred             hhcccCceeeEEEEEE--cCCCeEEEEEEeeccCc--CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEEE
Q 037916          406 CWIDMGSFGSVYKGIL--DEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVY  481 (741)
Q Consensus       406 ~~ig~G~~g~V~~a~~--~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv~  481 (741)
                      ++||+|+||.||+|.+  ..++..||+|+++....  ...+.+.+|+.+++.++||||+++++++.      ....++||
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~lv~   74 (257)
T cd05116           1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE------AESWMLVM   74 (257)
T ss_pred             CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc------CCCcEEEE
Confidence            3689999999999975  45678999999864322  23456788999999999999999999852      23568999


Q ss_pred             ecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeeccc
Q 037916          482 EFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGL  561 (741)
Q Consensus       482 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~  561 (741)
                      ||+++++|.+++...          ..+++..+..++.|++.||+|+|+.   +|+||||||+||+++.++.+||+|||.
T Consensus        75 e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~  141 (257)
T cd05116          75 ELAELGPLNKFLQKN----------KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGL  141 (257)
T ss_pred             ecCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCcc
Confidence            999999999998532          3578889999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCccc-ccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcCCcc
Q 037916          562 AKLLPPAHLQT-SSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVLPDH  639 (741)
Q Consensus       562 a~~~~~~~~~~-~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  639 (741)
                      +.......... ......++..|+|||. .....++.++|||||||++|||++ |..||......  .....        
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~--------  210 (257)
T cd05116         142 SKALGADENYYKAKTHGKWPVKWYAPEC-MNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--EVTQM--------  210 (257)
T ss_pred             ccccCCCCCeeeecCCCCCCccccCHhH-hccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHH--------
Confidence            98765432211 1111234578999954 456678899999999999999998 99998632111  11111        


Q ss_pred             hhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHH
Q 037916          640 VMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQS  705 (741)
Q Consensus       640 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  705 (741)
                          ++......                  .+..++..+.+++.+||+.||++||++.+|.+.|++
T Consensus       211 ----i~~~~~~~------------------~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         211 ----IESGERME------------------CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             ----HHCCCCCC------------------CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence                11100000                  011345668899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.8e-35  Score=305.58  Aligned_cols=258  Identities=20%  Similarity=0.240  Sum_probs=197.4

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhc-CCCceeeEeeeecCcccc-CCce
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNI-RHKNLVKILTVCSGVDYK-GDDF  476 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~-~~~~  476 (741)
                      -+.|++.+.||+|+||.||+|.+..+++.||+|++.... .....+..|+.+++++ +||||+++++++...... ....
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ   83 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence            467999999999999999999999899999999987532 3345678899999998 799999999997543211 1346


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .|++|||+++++|.+++....        ...+++..+..++.|++.|++|||+.   +|+||||||+||++++++.+||
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~~--------~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l  152 (272)
T cd06637          84 LWLVMEFCGAGSVTDLIKNTK--------GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKL  152 (272)
T ss_pred             EEEEEEcCCCCcHHHHHHhcc--------CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEE
Confidence            899999999999999986421        23578888999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccC----CCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhh
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGL----GSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFA  632 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~----~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~  632 (741)
                      +|||++........  ......|+..|+|||.+..    +..++.++||||+||++|||++|..||......    ....
T Consensus       153 ~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~----~~~~  226 (272)
T cd06637         153 VDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM----RALF  226 (272)
T ss_pred             ccCCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH----HHHH
Confidence            99999876543221  1223558999999965532    346788999999999999999999998632111    0000


Q ss_pred             hhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          633 RTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       633 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      .. ....     .....                     ...++..+.+++.+||..||++|||+.|+++
T Consensus       227 ~~-~~~~-----~~~~~---------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         227 LI-PRNP-----APRLK---------------------SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             HH-hcCC-----CCCCC---------------------CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            00 0000     00000                     0123356789999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.4e-35  Score=311.92  Aligned_cols=206  Identities=23%  Similarity=0.305  Sum_probs=161.9

Q ss_pred             hhhcccCceeeEEEEEEcC--CCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEEEe
Q 037916          405 LCWIDMGSFGSVYKGILDE--GKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYE  482 (741)
Q Consensus       405 ~~~ig~G~~g~V~~a~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv~e  482 (741)
                      ..+||+|+||.||+|++..  ++..||+|.++..  .....+.+|+.++++++||||+++++++..   ..+...++|||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e   80 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT--GISMSACREIALLRELKHPNVIALQKVFLS---HSDRKVWLLFD   80 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCC--CCcHHHHHHHHHHHhCCCCCeeeEEEEEec---cCCCeEEEEEe
Confidence            3579999999999999753  5678999988632  234567889999999999999999998642   34557899999


Q ss_pred             cccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEe----CCCCceEEee
Q 037916          483 FMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLL----DHEMTAHVAD  558 (741)
Q Consensus       483 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll----~~~~~~kL~D  558 (741)
                      |+. ++|.+++........ ......+++..+..++.|++.||.|||+.   +|+||||||+||++    +.++.+||+|
T Consensus        81 ~~~-~~l~~~~~~~~~~~~-~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~D  155 (317)
T cd07867          81 YAE-HDLWHIIKFHRASKA-NKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIAD  155 (317)
T ss_pred             eeC-CcHHHHHHhhhcccc-CCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEee
Confidence            985 588877753221111 11223578889999999999999999999   99999999999999    4567999999


Q ss_pred             cccccccCCCCcc-cccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCc
Q 037916          559 FGLAKLLPPAHLQ-TSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDI  620 (741)
Q Consensus       559 Fg~a~~~~~~~~~-~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~  620 (741)
                      ||+++........ .......||+.|+|||.+.....++.++||||+||++|||++|+.||..
T Consensus       156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~  218 (317)
T cd07867         156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             ccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence            9999876543221 1122345899999996665556789999999999999999999999863

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-36  Score=321.15  Aligned_cols=192  Identities=26%  Similarity=0.292  Sum_probs=158.6

Q ss_pred             cccCceeeEEEEEEcCCCeEEEEEEeeccCc---CcchhHHHHHHHHHhc---CCCceeeEeeeecCccccCCceEEEEE
Q 037916          408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHH---GASKSSIAECSALRNI---RHKNLVKILTVCSGVDYKGDDFKALVY  481 (741)
Q Consensus       408 ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~~~~~~~~~~~lv~  481 (741)
                      ||+|+||.||+|++..+++.||+|++.....   ........|..++...   +||||++++++     +......|+||
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~-----~~~~~~~~lv~   75 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFS-----FQTDSDLYLVT   75 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEE-----EecCCeEEEEE
Confidence            7999999999999998999999999864221   1223344566666655   69999999998     45566899999


Q ss_pred             ecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeeccc
Q 037916          482 EFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGL  561 (741)
Q Consensus       482 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~  561 (741)
                      ||+++|+|.+++...          ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        76 e~~~~g~L~~~l~~~----------~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~  142 (330)
T cd05586          76 DYMSGGELFWHLQKE----------GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGL  142 (330)
T ss_pred             cCCCCChHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCc
Confidence            999999999888633          4578889999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCC
Q 037916          562 AKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSD  619 (741)
Q Consensus       562 a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~  619 (741)
                      +........  ......||+.|+|||.+.....++.++||||+||++|+|++|+.||.
T Consensus       143 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~  198 (330)
T cd05586         143 SKANLTDNK--TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFY  198 (330)
T ss_pred             CcCCCCCCC--CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCC
Confidence            875432221  12235689999999766555568999999999999999999999986

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=7.4e-36  Score=311.24  Aligned_cols=266  Identities=25%  Similarity=0.367  Sum_probs=198.4

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEc-----CCCeEEEEEEeeccCc-CcchhHHHHHHHHHhcCCCceeeEeeeecCcccc
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILD-----EGKTIIAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKILTVCSGVDYK  472 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  472 (741)
                      ..+|++.+.||+|+||.||+|.+.     .++..||+|+++.... .....+.+|+.++++++||||+++++++     .
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~-----~   78 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVC-----A   78 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEE-----c
Confidence            457899999999999999999874     3578899999864322 2245678899999999999999999985     3


Q ss_pred             CCceEEEEEecccCCChhhhccCCCCCCc------------ccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecC
Q 037916          473 GDDFKALVYEFMHNGSLEEWLHPVSGADK------------TVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCD  540 (741)
Q Consensus       473 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------------~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrD  540 (741)
                      .+...+++|||+++++|.+++........            .......+++..++.++.|++.||+|||+.   +++|||
T Consensus        79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~d  155 (288)
T cd05050          79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRD  155 (288)
T ss_pred             CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---Ceeccc
Confidence            45578999999999999999864321110            011123578889999999999999999999   999999


Q ss_pred             CCCCCeEeCCCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCC
Q 037916          541 LKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSD  619 (741)
Q Consensus       541 lkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~  619 (741)
                      |||+||+++.++.+||+|||.+................++..|+||| ...+..++.++|||||||++|||++ |..||.
T Consensus       156 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~  234 (288)
T cd05050         156 LATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPE-SIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY  234 (288)
T ss_pred             ccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHH-HHhcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            99999999999999999999987654332211112223466799995 4456778999999999999999997 888875


Q ss_pred             ccccCCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHH
Q 037916          620 IMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIV  699 (741)
Q Consensus       620 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev  699 (741)
                      ....     .+....        +.+.....                   .+..++..+.+++.+||+.||++|||+.|+
T Consensus       235 ~~~~-----~~~~~~--------~~~~~~~~-------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el  282 (288)
T cd05050         235 GMAH-----EEVIYY--------VRDGNVLS-------------------CPDNCPLELYNLMRLCWSKLPSDRPSFASI  282 (288)
T ss_pred             CCCH-----HHHHHH--------HhcCCCCC-------------------CCCCCCHHHHHHHHHHcccCcccCCCHHHH
Confidence            2211     111110        00000000                   011234678899999999999999999999


Q ss_pred             HHHHHH
Q 037916          700 VHELQS  705 (741)
Q Consensus       700 l~~L~~  705 (741)
                      ++.|++
T Consensus       283 ~~~l~~  288 (288)
T cd05050         283 NRILQR  288 (288)
T ss_pred             HHHhhC
Confidence            999863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=3.7e-36  Score=318.23  Aligned_cols=242  Identities=24%  Similarity=0.289  Sum_probs=187.0

Q ss_pred             HHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhcC-CCceeeEeeeecCccccCCceE
Q 037916          402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNIR-HKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      |.+.+.||+|+||.||+|.+..+++.||+|+++...   ....+.+..|..+++.+. |++|++++++     +...+..
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~-----~~~~~~~   76 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSC-----FQTVDRL   76 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeE-----EecCCEE
Confidence            567789999999999999999999999999997432   223345677888888875 5778888887     4556689


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      |+||||+++|+|.+++...          ..+++.++..++.|++.||+|||+.   ||+||||||+||+++.++.+||+
T Consensus        77 ~lv~Ey~~~g~L~~~i~~~----------~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~  143 (323)
T cd05615          77 YFVMEYVNGGDLMYHIQQV----------GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIA  143 (323)
T ss_pred             EEEEcCCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEe
Confidence            9999999999999988643          4588899999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCC
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      |||++.........  .....||+.|+||| +..+..++.++||||+||++|+|++|+.||.....     .....    
T Consensus       144 Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE-~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-----~~~~~----  211 (323)
T cd05615         144 DFGMCKEHMVDGVT--TRTFCGTPDYIAPE-IIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-----DELFQ----  211 (323)
T ss_pred             ccccccccCCCCcc--ccCccCCccccCHH-HHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH-----HHHHH----
Confidence            99998754322211  12245899999995 55667789999999999999999999999863211     00111    


Q ss_pred             cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHH
Q 037916          638 DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMT  697 (741)
Q Consensus       638 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  697 (741)
                          .+......                    .+......+.+++.+||+.||++|++..
T Consensus       212 ----~i~~~~~~--------------------~p~~~~~~~~~li~~~l~~~p~~R~~~~  247 (323)
T cd05615         212 ----SIMEHNVS--------------------YPKSLSKEAVSICKGLMTKHPSKRLGCG  247 (323)
T ss_pred             ----HHHhCCCC--------------------CCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence                01100000                    0012234577899999999999999853

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.4e-35  Score=305.89  Aligned_cols=258  Identities=22%  Similarity=0.279  Sum_probs=183.8

Q ss_pred             hhcccCceeeEEEEEEcC--CCeEEEEEEeeccCc-CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEEEe
Q 037916          406 CWIDMGSFGSVYKGILDE--GKTIIAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYE  482 (741)
Q Consensus       406 ~~ig~G~~g~V~~a~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv~e  482 (741)
                      ++||+|+||.||+|....  ....+|+|.+..... .....+.+|+.+++.++||||+++++.|     ......++|||
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~-----~~~~~~~lv~e   75 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQC-----IESIPYLLVLE   75 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEE-----CCCCceEEEEE
Confidence            469999999999997532  345788887753322 2234577899999999999999999985     34557899999


Q ss_pred             cccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecccc
Q 037916          483 FMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLA  562 (741)
Q Consensus       483 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~a  562 (741)
                      |+++|+|.+++...+..     .....++.....++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||.+
T Consensus        76 ~~~~g~L~~~l~~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~  147 (269)
T cd05042          76 FCPLGDLKNYLRSNRGM-----VAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLA  147 (269)
T ss_pred             eCCCCcHHHHHHhcccc-----ccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccc
Confidence            99999999998654211     112346777889999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCCcccccccccccccccCccccc------CCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhc
Q 037916          563 KLLPPAHLQTSSIGVKGTIGYIAPAEYG------LGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTV  635 (741)
Q Consensus       563 ~~~~~~~~~~~~~~~~gt~~y~aPEe~~------~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  635 (741)
                      ................++..|+|||.+.      ....++.++||||+||++|||++ |..||......+ .+...... 
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~~~-  225 (269)
T cd05042         148 LEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-VLKQVVRE-  225 (269)
T ss_pred             cccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHHHhhc-
Confidence            7544332222222234677899996542      23457889999999999999999 788875321110 01100000 


Q ss_pred             CCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHH
Q 037916          636 LPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQ  704 (741)
Q Consensus       636 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  704 (741)
                         ....+.++..                      .......+.+++..|| .||++|||++||++.|.
T Consensus       226 ---~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         226 ---QDIKLPKPQL----------------------DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             ---cCccCCCCcc----------------------cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence               0000000000                      0123455667888898 49999999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9e-36  Score=325.64  Aligned_cols=195  Identities=24%  Similarity=0.297  Sum_probs=164.4

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      ...|.+.+.||+|+||.||+|.+..+++.||+|...      .....+|+.++++++|||||++++++     ..+...+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~-----~~~~~~~  236 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVR-----VVGGLTC  236 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEE-----EECCEEE
Confidence            446999999999999999999999999999999642      23467899999999999999999985     3455789


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      +|||++ .++|.+++...         ...+++.+++.++.|++.||.|||+.   ||+||||||+|||++.++.+||+|
T Consensus       237 lv~e~~-~~~L~~~l~~~---------~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~D  303 (461)
T PHA03211        237 LVLPKY-RSDLYTYLGAR---------LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGD  303 (461)
T ss_pred             EEEEcc-CCCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcc
Confidence            999999 46888887532         23588999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCC
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPS  618 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~  618 (741)
                      ||+++...............||+.|+|| |+..+..++.++|||||||++|||++|..|+
T Consensus       304 FGla~~~~~~~~~~~~~~~~GT~~Y~AP-E~~~~~~~~~~sDvwSlGviL~El~~g~~~l  362 (461)
T PHA03211        304 FGAACFARGSWSTPFHYGIAGTVDTNAP-EVLAGDPYTPSVDIWSAGLVIFEAAVHTASL  362 (461)
T ss_pred             cCCceecccccccccccccCCCcCCcCH-HHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence            9999865443222222335699999999 5556677899999999999999999988764

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-35  Score=305.15  Aligned_cols=253  Identities=23%  Similarity=0.293  Sum_probs=197.9

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALV  480 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv  480 (741)
                      .|++.+.||.|+||.||+|.+..+++.+|+|++........+.+.+|+.++++++||||++++++     +..+...|++
T Consensus         4 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~-----~~~~~~~~l~   78 (262)
T cd06613           4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS-----YLRRDKLWIV   78 (262)
T ss_pred             ceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEE-----EEeCCEEEEE
Confidence            57888999999999999999988899999999986555556788999999999999999999998     4556689999


Q ss_pred             EecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecc
Q 037916          481 YEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFG  560 (741)
Q Consensus       481 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg  560 (741)
                      |||+++++|.+++...         ...+++.++..++.|++.||+|||+.   +++|+||+|+||+++.++.+||+|||
T Consensus        79 ~e~~~~~~l~~~~~~~---------~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g  146 (262)
T cd06613          79 MEYCGGGSLQDIYQVT---------RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFG  146 (262)
T ss_pred             EeCCCCCcHHHHHHhh---------ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccc
Confidence            9999999999988632         14578889999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccccccccCcccccCCC---CCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCC
Q 037916          561 LAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGS---EVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       561 ~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~---~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      .+........  ......++..|+|||.+ .+.   .++.++||||+||++|+|++|+.||......... .........
T Consensus       147 ~~~~~~~~~~--~~~~~~~~~~y~~Pe~~-~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~-~~~~~~~~~  222 (262)
T cd06613         147 VSAQLTATIA--KRKSFIGTPYWMAPEVA-AVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL-FLISKSNFP  222 (262)
T ss_pred             cchhhhhhhh--ccccccCCccccCchhh-cccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhccCC
Confidence            9876543221  11224578899999544 444   7889999999999999999999998632111000 000000000


Q ss_pred             cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          638 DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       638 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ..                           ........+..+.+++.+||..||++|||+.+|+.
T Consensus       223 ~~---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         223 PP---------------------------KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             Cc---------------------------cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00                           00011233456889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.5e-36  Score=326.03  Aligned_cols=198  Identities=24%  Similarity=0.289  Sum_probs=166.4

Q ss_pred             HHHHHHHhhhcccCceeeEEEEEEc--CCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGILD--EGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      +...|.+++.||+|+||.||+|...  ..+..||+|.+...     ....+|+.++++++||||++++++     +....
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~-----~~~~~  159 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHA-----YRWKS  159 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeee-----EeeCC
Confidence            3457999999999999999999864  35678999987532     345689999999999999999998     45566


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..|+|||++. ++|.+++...          ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+|
T Consensus       160 ~~~lv~e~~~-~~l~~~l~~~----------~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~  225 (392)
T PHA03207        160 TVCMVMPKYK-CDLFTYVDRS----------GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAV  225 (392)
T ss_pred             EEEEEehhcC-CCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEE
Confidence            8999999994 6888887422          4588999999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCc
Q 037916          556 VADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDI  620 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~  620 (741)
                      |+|||++................||+.|+|| |+..+..++.++||||+||++|||++|+.||..
T Consensus       226 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aP-E~~~~~~~~~~~DvwslGvil~el~~g~~pf~~  289 (392)
T PHA03207        226 LGDFGAACKLDAHPDTPQCYGWSGTLETNSP-ELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFG  289 (392)
T ss_pred             EccCccccccCcccccccccccccccCccCH-hHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            9999999766544333223345699999999 555677889999999999999999999999853

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=8.3e-36  Score=311.75  Aligned_cols=251  Identities=21%  Similarity=0.268  Sum_probs=198.7

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      .+|++.+.||.|+||.||+|.+..+++.||+|.+........+.+.+|+.+++.++||||+++++++     ..+...++
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~l   93 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF-----LVGDELFV   93 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeE-----ecCceEEE
Confidence            4588899999999999999999889999999999765555566788999999999999999999985     45568999


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      ||||+++++|.+++..           ..+++.++..++.|++.|++|||+.   |++||||||+||+++.++.+||+||
T Consensus        94 v~e~~~~~~L~~~~~~-----------~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~df  159 (296)
T cd06655          94 VMEYLAGGSLTDVVTE-----------TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDF  159 (296)
T ss_pred             EEEecCCCcHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccC
Confidence            9999999999998852           3478899999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcc
Q 037916          560 GLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDH  639 (741)
Q Consensus       560 g~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  639 (741)
                      |.+.........  .....++..|+||| ...+..++.++|||||||++|++++|+.||........ ........ ...
T Consensus       160 g~~~~~~~~~~~--~~~~~~~~~y~aPE-~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-~~~~~~~~-~~~  234 (296)
T cd06655         160 GFCAQITPEQSK--RSTMVGTPYWMAPE-VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYLIATNG-TPE  234 (296)
T ss_pred             ccchhccccccc--CCCcCCCccccCcc-hhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhcC-Ccc
Confidence            998765433221  12245888999995 44566788999999999999999999999863211100 00000000 000


Q ss_pred             hhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          640 VMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       640 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                                                  ...+...+..+.+++.+||..||++|||+.++++.
T Consensus       235 ----------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         235 ----------------------------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             ----------------------------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence                                        00011334567899999999999999999999854

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-35  Score=310.65  Aligned_cols=201  Identities=25%  Similarity=0.355  Sum_probs=166.8

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc-CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      ..|++.+.||+|++|.||+|.+..+++.||+|.+..... .....+.+|+.++++++||||+++++++     .++...+
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~   79 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII-----HTKKTLT   79 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEE-----ecCCeEE
Confidence            468899999999999999999988899999999874322 2234567899999999999999999994     4566899


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      +||||+. ++|.+++...         ...+++..+..++.|+++||.|||+.   +|+||||||+||+++.++.+||+|
T Consensus        80 lv~e~~~-~~L~~~~~~~---------~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~d  146 (291)
T cd07844          80 LVFEYLD-TDLKQYMDDC---------GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLAD  146 (291)
T ss_pred             EEEecCC-CCHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECc
Confidence            9999996 5999887633         13578889999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCc
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDI  620 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~  620 (741)
                      ||.+.........  .....++..|+|||.+.....++.++||||+|+++|+|++|+.||..
T Consensus       147 fg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~  206 (291)
T cd07844         147 FGLARAKSVPSKT--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPG  206 (291)
T ss_pred             cccccccCCCCcc--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            9998754322111  11234678899996555556688999999999999999999999863

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.3e-35  Score=306.88  Aligned_cols=263  Identities=22%  Similarity=0.241  Sum_probs=200.3

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceE
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      ...|++++.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+++++.++||||+++++++     ......
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~   78 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF-----LNENNI   78 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeE-----ecCCEE
Confidence            357999999999999999999999899999999986432 23356788999999999999999999995     445689


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      ++||||+++++|.+++...          ..+++..+..++.|++.||.|||+..  +++||||||+||+++.++.++|+
T Consensus        79 ~lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~  146 (284)
T cd06620          79 CMCMEFMDCGSLDRIYKKG----------GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLC  146 (284)
T ss_pred             EEEEecCCCCCHHHHHHhc----------cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEc
Confidence            9999999999999988632          35788899999999999999999732  89999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCC
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      |||++........    ....|+..|+||| ...+..++.++|||||||++|++++|+.||.........      ...+
T Consensus       147 d~gl~~~~~~~~~----~~~~~~~~~~aPE-~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~------~~~~  215 (284)
T cd06620         147 DFGVSGELINSIA----DTFVGTSTYMSPE-RIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDG------QDDP  215 (284)
T ss_pred             cCCcccchhhhcc----CccccCcccCCHH-HHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhh------hhhh
Confidence            9999865432211    1245899999995 445668899999999999999999999999743221100      0000


Q ss_pred             cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHH
Q 037916          638 DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHEL  703 (741)
Q Consensus       638 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  703 (741)
                      ....+.+.........             . ....+++..+.+++.+||+.||++|||+.|+++..
T Consensus       216 ~~~~~~~~~~~~~~~~-------------~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         216 MGILDLLQQIVQEPPP-------------R-LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             hHHHHHHHHHhhccCC-------------C-CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            0111111111110000             0 00012456788999999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.2e-35  Score=306.12  Aligned_cols=258  Identities=24%  Similarity=0.355  Sum_probs=197.5

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCC---CeEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCC
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEG---KTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGD  474 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~  474 (741)
                      ..+|++.+.||+|+||.||+|.+..+   +..||+|.++... ....+.+.+|+.++++++||||+++++++     ..+
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~   77 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKS   77 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecC
Confidence            35788999999999999999988533   3479999886432 22345778899999999999999999985     445


Q ss_pred             ceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCce
Q 037916          475 DFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTA  554 (741)
Q Consensus       475 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~  554 (741)
                      +..++||||+++++|.+++...         ...+++.++..++.|++.|++|||+.   +++||||||+||+++.++.+
T Consensus        78 ~~~~lv~e~~~~~~L~~~~~~~---------~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~  145 (267)
T cd05066          78 KPVMIVTEYMENGSLDAFLRKH---------DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVC  145 (267)
T ss_pred             CccEEEEEcCCCCCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeE
Confidence            6789999999999999998643         13478889999999999999999999   99999999999999999999


Q ss_pred             EEeecccccccCCCCcccc-cccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhh
Q 037916          555 HVADFGLAKLLPPAHLQTS-SIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFA  632 (741)
Q Consensus       555 kL~DFg~a~~~~~~~~~~~-~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~  632 (741)
                      ||+|||.+........... .....++..|+||| ...+..++.++|||||||++||+++ |..||......  ......
T Consensus       146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe-~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--~~~~~~  222 (267)
T cd05066         146 KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE-AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--DVIKAI  222 (267)
T ss_pred             EeCCCCcccccccccceeeecCCCccceeecCHh-HhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--HHHHHH
Confidence            9999999987654322111 11122356899994 5566778999999999999999886 99998632111  011111


Q ss_pred             hhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHH
Q 037916          633 RTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSI  706 (741)
Q Consensus       633 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  706 (741)
                      .....                              ......+++.+.+++.+||+.+|++|||+.++++.|+++
T Consensus       223 ~~~~~------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         223 EEGYR------------------------------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             hCCCc------------------------------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            00000                              000112345678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.5e-35  Score=303.96  Aligned_cols=256  Identities=25%  Similarity=0.388  Sum_probs=198.4

Q ss_pred             HHHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCce
Q 037916          397 LLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       397 ~~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      +....|++.++||+|+||.||+|... +++.||+|.+.... .....+.+|+.++++++||||+++++++      ....
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~------~~~~   74 (260)
T cd05067           3 VPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVV------TQEP   74 (260)
T ss_pred             cchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEE------ccCC
Confidence            34567999999999999999999976 57889999987433 3346788999999999999999999874      2346


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .+++|||+.+++|.+++...        ....+++.++..++.|++.||+|||+.   +++||||||+||+++.++.++|
T Consensus        75 ~~~v~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l  143 (260)
T cd05067          75 IYIITEYMENGSLVDFLKTP--------EGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKI  143 (260)
T ss_pred             cEEEEEcCCCCCHHHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEE
Confidence            89999999999999988643        123578889999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhc
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTV  635 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  635 (741)
                      +|||.+......... ......++..|+|| |+..+..++.++||||||+++||+++ |+.||......  .........
T Consensus       144 ~dfg~~~~~~~~~~~-~~~~~~~~~~y~~p-e~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~  219 (260)
T cd05067         144 ADFGLARLIEDNEYT-AREGAKFPIKWTAP-EAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP--EVIQNLERG  219 (260)
T ss_pred             ccCcceeecCCCCcc-cccCCcccccccCH-HHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH--HHHHHHHcC
Confidence            999999766532221 11223456789999 55566778999999999999999998 99998632111  111010000


Q ss_pred             CCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHH
Q 037916          636 LPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQS  705 (741)
Q Consensus       636 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  705 (741)
                      ...                              ......+..+.+++.+||..+|++|||++++.+.|+.
T Consensus       220 ~~~------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         220 YRM------------------------------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CCC------------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            000                              0001234568899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.8e-35  Score=308.03  Aligned_cols=263  Identities=22%  Similarity=0.260  Sum_probs=199.4

Q ss_pred             HHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhc-CCCceeeEeeeecCccccCCce
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      ....|++.+.||+|+||.||+|.+..+++.||+|+++.. ......+.+|+.+++++ +||||+++++++.......+..
T Consensus        16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   94 (286)
T cd06638          16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQ   94 (286)
T ss_pred             cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCe
Confidence            456789999999999999999999989999999988642 22345677899999999 7999999999875444455678


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .++||||+++++|.+++....      .....+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||
T Consensus        95 ~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl  165 (286)
T cd06638          95 LWLVLELCNGGSVTDLVKGFL------KRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKL  165 (286)
T ss_pred             EEEEEeecCCCCHHHHHHHhh------ccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEE
Confidence            999999999999999875321      1124578888999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccC----CCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhh
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGL----GSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFA  632 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~----~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~  632 (741)
                      +|||.+.........  .....|++.|+|||.+..    +..++.++||||+||++|||++|+.||.....    .....
T Consensus       166 ~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~----~~~~~  239 (286)
T cd06638         166 VDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP----MRALF  239 (286)
T ss_pred             ccCCceeecccCCCc--cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch----hHHHh
Confidence            999998766433211  122458999999965432    34578999999999999999999999863211    00000


Q ss_pred             hhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          633 RTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       633 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      . ..........                         .+..+...+.+++.+||+.||++|||+.|+++.
T Consensus       240 ~-~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         240 K-IPRNPPPTLH-------------------------QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             h-ccccCCCccc-------------------------CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            0 0000000000                         000123457899999999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.1e-35  Score=309.02  Aligned_cols=251  Identities=21%  Similarity=0.292  Sum_probs=193.4

Q ss_pred             HHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcC---cchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG---ASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      |++.+.||+|+||.||+|.+..+++.||+|.+......   ....+.+|+.++++++|++|+.+++.+     ...+..+
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~   76 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAY-----ETKDALC   76 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEE-----ecCCEEE
Confidence            56778899999999999999999999999998643221   223467899999999999999999984     4456899


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      +||||+++++|.+++...        ....+++.++..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|
T Consensus        77 lv~e~~~g~~L~~~l~~~--------~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~D  145 (285)
T cd05630          77 LVLTLMNGGDLKFHIYHM--------GEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISD  145 (285)
T ss_pred             EEEEecCCCcHHHHHHHh--------cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEee
Confidence            999999999999988532        113478889999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCc
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      ||.+.........   ....|+..|+||| +..+..++.++||||+||++|+|++|+.||....... ....        
T Consensus       146 fg~~~~~~~~~~~---~~~~g~~~y~aPE-~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-~~~~--------  212 (285)
T cd05630         146 LGLAVHVPEGQTI---KGRVGTVGYMAPE-VVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KREE--------  212 (285)
T ss_pred             ccceeecCCCccc---cCCCCCccccChH-HHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc-hHHH--------
Confidence            9998765433221   2245899999995 5566778999999999999999999999986321100 0000        


Q ss_pred             chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCC-----HHHHHH
Q 037916          639 HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMN-----MTIVVH  701 (741)
Q Consensus       639 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  701 (741)
                       .....+...                   ..........+.+++.+||+.||++|||     +.|+++
T Consensus       213 -~~~~~~~~~-------------------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         213 -VERLVKEVQ-------------------EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             -HHhhhhhhh-------------------hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence             000000000                   0001123456789999999999999999     788886

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.2e-35  Score=312.50  Aligned_cols=196  Identities=25%  Similarity=0.328  Sum_probs=167.2

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc-CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      .|++.++||+|+||.||+|.+..++..||+|.++.... .....+.+|++++++++||||+++++++     ..+...++
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~l   76 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAF-----YSDGEISI   76 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----eeCCEEEE
Confidence            47888999999999999999998999999999864322 2234577899999999999999999995     45668999


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHh-cCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH-DCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      ||||+++++|.++++..          ..+++..+..++.|+++||.|||+ .   +++||||||+||+++.++.+||+|
T Consensus        77 v~ey~~~~~L~~~l~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dl~p~nil~~~~~~~~l~d  143 (308)
T cd06615          77 CMEHMDGGSLDQVLKKA----------GRIPENILGKISIAVLRGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCD  143 (308)
T ss_pred             EeeccCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhhC---CEEECCCChHHEEEecCCcEEEcc
Confidence            99999999999998643          447888899999999999999997 5   899999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCC
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSD  619 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~  619 (741)
                      ||.+........    ....|+..|+||| ...+..++.++|||||||++|++++|+.||.
T Consensus       144 fg~~~~~~~~~~----~~~~~~~~~~aPE-~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~  199 (308)
T cd06615         144 FGVSGQLIDSMA----NSFVGTRSYMSPE-RLQGTHYTVQSDIWSLGLSLVEMAIGRYPIP  199 (308)
T ss_pred             CCCccccccccc----ccCCCCcCccChh-HhcCCCCCccchHHHHHHHHHHHHhCCCCCC
Confidence            999875533221    2245889999995 4566778999999999999999999999986

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.5e-35  Score=305.49  Aligned_cols=257  Identities=24%  Similarity=0.377  Sum_probs=196.5

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCe---EEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKT---IIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      ..|+..+.||+|+||.||+|.+..++.   .||+|.++... ....+.+..|+.++++++||||+++++++     ....
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   79 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVV-----TKFK   79 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----ccCC
Confidence            467888999999999999999865443   79999886432 22345678899999999999999999995     4455


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..++||||+++++|.+++...         ...+++.++..++.|++.|++|||+.   +++||||||+||+++.++.+|
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~~---------~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~k  147 (268)
T cd05063          80 PAMIITEYMENGALDKYLRDH---------DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECK  147 (268)
T ss_pred             CcEEEEEcCCCCCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEE
Confidence            789999999999999998632         13478889999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcccc-cccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhh
Q 037916          556 VADFGLAKLLPPAHLQTS-SIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFAR  633 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~~~-~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~  633 (741)
                      |+|||.+........... ......+..|+||| +..+..++.++|||||||++||+++ |..||......     ....
T Consensus       148 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE-~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~-----~~~~  221 (268)
T cd05063         148 VSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPE-AIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH-----EVMK  221 (268)
T ss_pred             ECCCccceecccccccceeccCCCcCceecCHH-HhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH-----HHHH
Confidence            999999876643321111 11122345799995 5556678999999999999999997 99998532110     1111


Q ss_pred             hcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHH
Q 037916          634 TVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSI  706 (741)
Q Consensus       634 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  706 (741)
                      .         +.....                  .+...+++..+.+++.+||+.||++||++.+|++.|+++
T Consensus       222 ~---------i~~~~~------------------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         222 A---------INDGFR------------------LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             H---------HhcCCC------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            0         000000                  000113456788999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2e-35  Score=303.52  Aligned_cols=253  Identities=25%  Similarity=0.383  Sum_probs=187.9

Q ss_pred             hhcccCceeeEEEEEEcC---CCeEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEEE
Q 037916          406 CWIDMGSFGSVYKGILDE---GKTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVY  481 (741)
Q Consensus       406 ~~ig~G~~g~V~~a~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv~  481 (741)
                      +.||+|+||.||+|.+..   .+..||+|.+.... ....+.+.+|+.+++.++||||+++++++.    ..+...+++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----~~~~~~~lv~   76 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICL----PSEGSPLVVL   76 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEee----cCCCCcEEEE
Confidence            368999999999998642   35679999885322 223457788999999999999999999763    3345678999


Q ss_pred             ecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeeccc
Q 037916          482 EFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGL  561 (741)
Q Consensus       482 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~  561 (741)
                      ||+.+++|.+++...         ....++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||.
T Consensus        77 e~~~~~~L~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~  144 (262)
T cd05058          77 PYMKHGDLRNFIRSE---------THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGL  144 (262)
T ss_pred             ecCCCCCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccc
Confidence            999999999998643         12356677888999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcc--cccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcC-CCCCCccccCCcchhhhhhhcCCc
Q 037916          562 AKLLPPAHLQ--TSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTR-KRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       562 a~~~~~~~~~--~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      +.........  .......++..|+||| ...+..++.++|||||||++|||++| .+||.....  ........     
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--~~~~~~~~-----  216 (262)
T cd05058         145 ARDIYDKEYYSVHNHTGAKLPVKWMALE-SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS--FDITVYLL-----  216 (262)
T ss_pred             cccccCCcceeecccccCcCCccccChh-HhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHh-----
Confidence            9765432211  1111234677899995 44566789999999999999999995 555542110  00000000     


Q ss_pred             chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHH
Q 037916          639 HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIK  707 (741)
Q Consensus       639 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  707 (741)
                                .+...               .....++..+.+++.+||..+|++||++.||++.|+++.
T Consensus       217 ----------~~~~~---------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         217 ----------QGRRL---------------LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             ----------cCCCC---------------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence                      00000               000123456889999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.2e-35  Score=308.99  Aligned_cols=251  Identities=22%  Similarity=0.289  Sum_probs=191.9

Q ss_pred             HHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc---CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH---GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      |+..+.||+|+||.||+|.+..+++.||+|.+.....   .....+.+|+.++++++|++|+++++++     ..++..+
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~   76 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAY-----ETKDALC   76 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEE-----ecCCEEE
Confidence            5667889999999999999998999999999864322   2234567899999999999999999884     4566899


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      ++|||+++++|.+++...        ....+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|
T Consensus        77 lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~D  145 (285)
T cd05632          77 LVLTIMNGGDLKFHIYNM--------GNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISD  145 (285)
T ss_pred             EEEEeccCccHHHHHHHh--------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEec
Confidence            999999999999887532        113588999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCc
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      ||.+.........   ....|+..|+||| +..+..++.++||||+||++|++++|..||....... ............
T Consensus       146 fg~~~~~~~~~~~---~~~~g~~~~~aPE-~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~-~~~~~~~~~~~~  220 (285)
T cd05632         146 LGLAVKIPEGESI---RGRVGTVGYMAPE-VLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV-KREEVDRRVLET  220 (285)
T ss_pred             CCcceecCCCCcc---cCCCCCcCccChH-HhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhhhcc
Confidence            9998765432211   2246899999995 4556778999999999999999999999986321100 000000000000


Q ss_pred             chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCC-----HHHHHH
Q 037916          639 HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMN-----MTIVVH  701 (741)
Q Consensus       639 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  701 (741)
                      . .                           .........+.+++.+||+.||++|||     +.|+++
T Consensus       221 ~-~---------------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         221 E-E---------------------------VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             c-c---------------------------ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence            0 0                           001123456789999999999999999     555554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.7e-35  Score=303.79  Aligned_cols=241  Identities=22%  Similarity=0.321  Sum_probs=183.0

Q ss_pred             hhcccCceeeEEEEEEcC------------CCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccC
Q 037916          406 CWIDMGSFGSVYKGILDE------------GKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKG  473 (741)
Q Consensus       406 ~~ig~G~~g~V~~a~~~~------------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  473 (741)
                      +.||+|+||.||+|+...            ....||+|++..........+.+|+.+++.++||||+++++++.     .
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~-----~   75 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCV-----R   75 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEe-----c
Confidence            368999999999998532            23368999886544444557788899999999999999999963     3


Q ss_pred             CceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCc
Q 037916          474 DDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMT  553 (741)
Q Consensus       474 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~  553 (741)
                      ....++||||+++++|..++...         ...+++..++.++.||++||+|||+.   +|+||||||+||+++.++.
T Consensus        76 ~~~~~lv~e~~~~~~l~~~~~~~---------~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~  143 (262)
T cd05077          76 DVENIMVEEFVEFGPLDLFMHRK---------SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGI  143 (262)
T ss_pred             CCCCEEEEecccCCCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCc
Confidence            45679999999999998887532         23578888999999999999999999   9999999999999987653


Q ss_pred             -------eEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHH-cCCCCCCccccCC
Q 037916          554 -------AHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELM-TRKRPSDIMFEGN  625 (741)
Q Consensus       554 -------~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ell-tg~~p~~~~~~~~  625 (741)
                             +|++|||.+......      ....++..|+|||.+..+..++.++|||||||++|||+ +|..||.....  
T Consensus       144 ~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--  215 (262)
T cd05077         144 DGECGPFIKLSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL--  215 (262)
T ss_pred             cCCCCceeEeCCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch--
Confidence                   899999998654322      12347888999965555677899999999999999997 58888652110  


Q ss_pred             cchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHH
Q 037916          626 MNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHEL  703 (741)
Q Consensus       626 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  703 (741)
                      ....            .+........                    ......+.+++.+||+.||++||++.||++.+
T Consensus       216 ~~~~------------~~~~~~~~~~--------------------~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         216 AEKE------------RFYEGQCMLV--------------------TPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             hHHH------------HHHhcCccCC--------------------CCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            0000            0000000000                    01134578999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-37  Score=317.45  Aligned_cols=255  Identities=22%  Similarity=0.289  Sum_probs=202.3

Q ss_pred             HHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceE
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      .-..|.|+..||.|+||.||+|..+.++...|.|++........+++.-|+++|..++||+||++++.     |..++..
T Consensus        30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~a-----yy~enkL  104 (1187)
T KOG0579|consen   30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSA-----YYFENKL  104 (1187)
T ss_pred             HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHH-----HhccCce
Confidence            34568999999999999999999998998899999987677778899999999999999999999998     4456689


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      ||+.|||.||-+...+-..         ...+.+.++.-+++|++.||.|||+.   .|||||||..|||++-+|.++|+
T Consensus       105 wiliEFC~GGAVDaimlEL---------~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLA  172 (1187)
T KOG0579|consen  105 WILIEFCGGGAVDAIMLEL---------GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLA  172 (1187)
T ss_pred             EEEEeecCCchHhHHHHHh---------ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeee
Confidence            9999999999988877533         46789999999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccccccCccccc----CCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhh
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG----LGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFAR  633 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~----~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~  633 (741)
                      |||.+.......  .......|||+|||||.+.    ...+|+.++||||||+++.||..+.+|....     +......
T Consensus       173 DFGVSAKn~~t~--qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel-----npMRVll  245 (1187)
T KOG0579|consen  173 DFGVSAKNKSTR--QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL-----NPMRVLL  245 (1187)
T ss_pred             cccccccchhHH--hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc-----chHHHHH
Confidence            999986543322  1223367999999997553    4578999999999999999999999995421     1100000


Q ss_pred             hcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          634 TVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       634 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ..-.            ...             +..-.+..-...+.+++.+||..||+.||++.|+++
T Consensus       246 KiaK------------SeP-------------PTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  246 KIAK------------SEP-------------PTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             HHhh------------cCC-------------CcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            0000            000             000011122345779999999999999999999874

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1e-35  Score=320.40  Aligned_cols=201  Identities=22%  Similarity=0.265  Sum_probs=169.4

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      ...|++.+.||+|+||.||+|++..+++.||+|++....   ......+.+|+.+++.++||||++++++     +.++.
T Consensus        42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~-----~~~~~  116 (371)
T cd05622          42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA-----FQDDR  116 (371)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEE-----EEcCC
Confidence            468999999999999999999999999999999986322   2223456789999999999999999998     45567


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..|+||||+++|+|.+++..           ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+|
T Consensus       117 ~~~lv~Ey~~gg~L~~~~~~-----------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ik  182 (371)
T cd05622         117 YLYMVMEYMPGGDLVNLMSN-----------YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLK  182 (371)
T ss_pred             EEEEEEcCCCCCcHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEE
Confidence            89999999999999999853           2367778889999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcccccccccccccccCcccccCC---CCCCCccCchhHHHHHHHHHcCCCCCC
Q 037916          556 VADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLG---SEVSINGDVYSYGILLLELMTRKRPSD  619 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~---~~~~~~~DIwSlG~il~elltg~~p~~  619 (741)
                      |+|||++.......... .....||+.|+|||.+...   ..++.++||||+||++|||++|..||.
T Consensus       183 L~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~  248 (371)
T cd05622         183 LADFGTCMKMNKEGMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY  248 (371)
T ss_pred             EEeCCceeEcCcCCccc-ccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCC
Confidence            99999998765432211 2235699999999655332   247899999999999999999999986

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.5e-35  Score=314.57  Aligned_cols=201  Identities=19%  Similarity=0.176  Sum_probs=162.6

Q ss_pred             HhhhcccC--ceeeEEEEEEcCCCeEEEEEEeeccC--cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          404 FLCWIDMG--SFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       404 ~~~~ig~G--~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      +++.||+|  +|++||++.++.+++.||+|+++...  ....+.+.+|+.+++.++||||++++++|     ..++..++
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~-----~~~~~~~l   76 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATF-----IADNELWV   76 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----EECCEEEE
Confidence            56789999  78999999999999999999997432  22334567899999999999999999995     44568999


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      ||||+++|+|.+++....        ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.++++||
T Consensus        77 v~e~~~~~~l~~~~~~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~  145 (327)
T cd08227          77 VTSFMAYGSAKDLICTHF--------MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGL  145 (327)
T ss_pred             EEeccCCCcHHHHHHhhc--------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEccc
Confidence            999999999999986431        13478889999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcc-----cccccccccccccCcccccCC-CCCCCccCchhHHHHHHHHHcCCCCCCc
Q 037916          560 GLAKLLPPAHLQ-----TSSIGVKGTIGYIAPAEYGLG-SEVSINGDVYSYGILLLELMTRKRPSDI  620 (741)
Q Consensus       560 g~a~~~~~~~~~-----~~~~~~~gt~~y~aPEe~~~~-~~~~~~~DIwSlG~il~elltg~~p~~~  620 (741)
                      +.+.........     .......++..|+|||.+... ..++.++||||+||++|||++|+.||..
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  212 (327)
T cd08227         146 RSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD  212 (327)
T ss_pred             chhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            865443221110     001112467789999665443 4689999999999999999999999964

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=5.7e-35  Score=302.70  Aligned_cols=249  Identities=23%  Similarity=0.289  Sum_probs=197.5

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      ..|+.+++||.|+||.||+|.+..++..||+|+++... ......+.+|+.+++++.||||+++++++     .++...+
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   78 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKGTKLW   78 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECCEEE
Confidence            56889999999999999999998889999999987432 23345678899999999999999999995     4556899


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      +||||+++++|.+++..           ..+++.++..++.|++.||+|+|+.   +++|+||+|+||+++.++.++|+|
T Consensus        79 lv~e~~~~~~L~~~i~~-----------~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~d  144 (277)
T cd06640          79 IIMEYLGGGSALDLLRA-----------GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLAD  144 (277)
T ss_pred             EEEecCCCCcHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcc
Confidence            99999999999998853           2367788889999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCc
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      ||.+.........  .....++..|+||| +..+..++.++|||||||++|||++|..||.........  ..       
T Consensus       145 fg~~~~~~~~~~~--~~~~~~~~~y~apE-~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~~-------  212 (277)
T cd06640         145 FGVAGQLTDTQIK--RNTFVGTPFWMAPE-VIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL--FL-------  212 (277)
T ss_pred             cccceeccCCccc--cccccCcccccCHh-HhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh--hh-------
Confidence            9999766443221  12245788999995 555667899999999999999999999998632111000  00       


Q ss_pred             chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          639 HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       639 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                           ......                  ......++..+.+++.+||+.+|++||++.|+++.
T Consensus       213 -----~~~~~~------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         213 -----IPKNNP------------------PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             -----hhcCCC------------------CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence                 000000                  00112345678899999999999999999999765

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-35  Score=302.23  Aligned_cols=257  Identities=25%  Similarity=0.405  Sum_probs=198.1

Q ss_pred             hhcccCceeeEEEEEEcCC---CeEEEEEEeeccCcCc-chhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEEE
Q 037916          406 CWIDMGSFGSVYKGILDEG---KTIIAVKVLNLLHHGA-SKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVY  481 (741)
Q Consensus       406 ~~ig~G~~g~V~~a~~~~~---~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv~  481 (741)
                      +.||+|+||.||+|.+...   +..||+|+++...... .+.+.+|+..++.++|+||+++++++     ......++||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~lv~   75 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVC-----TEEEPLYLVL   75 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeee-----cCCCceEEEE
Confidence            4699999999999999865   8899999997543332 56788999999999999999999995     3466899999


Q ss_pred             ecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeeccc
Q 037916          482 EFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGL  561 (741)
Q Consensus       482 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~  561 (741)
                      ||+++++|.+++....... .......+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||.
T Consensus        76 e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~  151 (262)
T cd00192          76 EYMEGGDLLDYLRKSRPVF-PSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGL  151 (262)
T ss_pred             EeccCCcHHHHHhhccccc-cccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccc
Confidence            9999999999987431110 001125689999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcCCcch
Q 037916          562 AKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVLPDHV  640 (741)
Q Consensus       562 a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  640 (741)
                      +................++..|+|||. .....++.++||||+||++|+|++ |..||.....     ......      
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~~------  219 (262)
T cd00192         152 SRDVYDDDYYRKKTGGKLPIRWMAPES-LKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-----EEVLEY------  219 (262)
T ss_pred             ccccccccccccccCCCcCccccCHHH-hccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHH------
Confidence            987765432222233457889999954 445578999999999999999999 6999863311     111110      


Q ss_pred             hHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHH
Q 037916          641 MDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQ  704 (741)
Q Consensus       641 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  704 (741)
                        ..+..                   ....+..++.++.+++.+||+.||++|||+.|+++.|+
T Consensus       220 --~~~~~-------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         220 --LRKGY-------------------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             --HHcCC-------------------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence              00000                   00011233567889999999999999999999998763

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.5e-35  Score=308.66  Aligned_cols=279  Identities=22%  Similarity=0.215  Sum_probs=200.2

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC--cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      .|++.+.||+|+||.||+|.+..+++.||+|++....  ....+.+.+|+.++++++||||+++++++     ..+...+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~   75 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVF-----PHGSGFV   75 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCeeE
Confidence            3788899999999999999998889999999997543  23356788999999999999999999994     4566899


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      +||||+ +++|.+++...         ...+++.+++.++.|+++||+|||+.   +++|+||||+||+++.++.++|+|
T Consensus        76 ~v~e~~-~~~L~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~d  142 (286)
T cd07832          76 LVMEYM-PSDLSEVLRDE---------ERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIAD  142 (286)
T ss_pred             EEeccc-CCCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEee
Confidence            999999 99999998643         14588899999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCc
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      ||.+........ .......|+..|+|||.+.....++.++||||+||++|||++|.+||..... ...+..........
T Consensus       143 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~-~~~~~~~~~~~~~~  220 (286)
T cd07832         143 FGLARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND-IEQLAIVFRTLGTP  220 (286)
T ss_pred             eeecccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH-HHHHHHHHHHcCCC
Confidence            999887654322 1122245889999997665556678999999999999999999877753211 11111111111000


Q ss_pred             chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          639 HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       639 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ....+.+-....+...  ................+....+.+++.+|+..||++|||++++++
T Consensus       221 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         221 NEETWPGLTSLPDYNK--ITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             ChHHHhhccCcchhhc--ccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            0000000000000000  000000000000111234578899999999999999999999975

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.7e-36  Score=308.09  Aligned_cols=241  Identities=22%  Similarity=0.327  Sum_probs=183.9

Q ss_pred             hhcccCceeeEEEEEEcCCCe-------EEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          406 CWIDMGSFGSVYKGILDEGKT-------IIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       406 ~~ig~G~~g~V~~a~~~~~~~-------~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      +.||+|+||.||+|.+...+.       .||+|.+........+.+.+|+.+++.++||||+++++++.     .+...+
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~-----~~~~~~   75 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCV-----CGDESI   75 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEE-----eCCCcE
Confidence            369999999999999865443       48888886544444567788999999999999999999953     445789


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCc-----
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMT-----  553 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~-----  553 (741)
                      +||||+++|+|.+++...         ...+++..++.++.||+.||+|||+.   +|+||||||+||+++.++.     
T Consensus        76 lv~e~~~~g~L~~~l~~~---------~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~  143 (258)
T cd05078          76 MVQEYVKFGSLDTYLKKN---------KNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGN  143 (258)
T ss_pred             EEEecCCCCcHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCC
Confidence            999999999999998643         13478888999999999999999999   9999999999999987764     


Q ss_pred             ---eEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCC-CCCCccccCCcchh
Q 037916          554 ---AHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRK-RPSDIMFEGNMNLH  629 (741)
Q Consensus       554 ---~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~-~p~~~~~~~~~~~~  629 (741)
                         ++++|||.+.......      ...++..|+|||.+.....++.++||||+||++||+++|. .||......  ...
T Consensus       144 ~~~~~l~d~g~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~--~~~  215 (258)
T cd05078         144 PPFIKLSDPGISITVLPKE------ILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ--KKL  215 (258)
T ss_pred             CceEEecccccccccCCch------hccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH--HHH
Confidence               6999999886543321      1347889999976655566899999999999999999985 554311100  000


Q ss_pred             hhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHH
Q 037916          630 NFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHEL  703 (741)
Q Consensus       630 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  703 (741)
                                  ........  .                  +......+.+++.+||+.||++|||++|+++.|
T Consensus       216 ------------~~~~~~~~--~------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         216 ------------QFYEDRHQ--L------------------PAPKWTELANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             ------------HHHHcccc--C------------------CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence                        00000000  0                  001224578999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.5e-35  Score=301.56  Aligned_cols=250  Identities=24%  Similarity=0.307  Sum_probs=198.3

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      ..|++.+.||+|+||.||+|.+..++..||+|.++....  .+.+.+|++++++++||||+++++++     ......|+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~l   75 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSY-----FKNTDLWI   75 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeee-----ecCCcEEE
Confidence            368899999999999999999998889999999874322  67888999999999999999999985     44568999


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      +|||+++++|.+++...         ...+++..+..++.|+++|+.|||+.   +++||||+|+||+++.++.+||+||
T Consensus        76 ~~e~~~~~~L~~~l~~~---------~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~df  143 (256)
T cd06612          76 VMEYCGAGSVSDIMKIT---------NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADF  143 (256)
T ss_pred             EEecCCCCcHHHHHHhC---------ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEccc
Confidence            99999999999998532         24578999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcc
Q 037916          560 GLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDH  639 (741)
Q Consensus       560 g~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  639 (741)
                      |.+.........  .....++..|+||| +..+..++.++||||||+++|+|++|+.||..........  .......  
T Consensus       144 g~~~~~~~~~~~--~~~~~~~~~y~~PE-~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~--~~~~~~~--  216 (256)
T cd06612         144 GVSGQLTDTMAK--RNTVIGTPFWMAPE-VIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF--MIPNKPP--  216 (256)
T ss_pred             ccchhcccCccc--cccccCCccccCHH-HHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh--hhccCCC--
Confidence            999876543211  12244788999995 5566788999999999999999999999986321111000  0000000  


Q ss_pred             hhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          640 VMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       640 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                                ..                ..........+.+++.+||+.||++|||+.||++
T Consensus       217 ----------~~----------------~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         217 ----------PT----------------LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             ----------CC----------------CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence                      00                0001123456889999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-36  Score=288.17  Aligned_cols=258  Identities=20%  Similarity=0.229  Sum_probs=200.9

Q ss_pred             HHHHHHH-hhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhc-CCCceeeEeeeecCccccCCc
Q 037916          398 LFVSFLF-LCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       398 ~~~~y~~-~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      +...|.+ .+.||-|-.|.|..+.++.+++.+|+|++.     +....++|++..-.. .|||||.+++++... +.+..
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-----Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs-~~~rk  132 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-----DSPKARREVELHWMASGHPHIVSIIDVYENS-YQGRK  132 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHh-----cCHHHHhHhhhhhhhcCCCceEEeehhhhhh-ccCce
Confidence            3455665 367999999999999999999999999985     245567788775444 799999999996432 45566


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCC---CC
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDH---EM  552 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~---~~  552 (741)
                      ...+|||.|+||.|...++..        ....+++.++-.|++||..|+.|||+.   +|.||||||+|+|...   +.
T Consensus       133 cLLiVmE~meGGeLfsriq~~--------g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na  201 (400)
T KOG0604|consen  133 CLLIVMECMEGGELFSRIQDR--------GDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNA  201 (400)
T ss_pred             eeEeeeecccchHHHHHHHHc--------ccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCc
Confidence            778999999999999998755        236689999999999999999999999   9999999999999964   45


Q ss_pred             ceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhh
Q 037916          553 TAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFA  632 (741)
Q Consensus       553 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~  632 (741)
                      .+||+|||+|+........   ...+-||.|.|| |++....|+..+|+||+||++|-|++|.+||.....  ..+.--+
T Consensus       202 ~lKLtDfGFAK~t~~~~~L---~TPc~TPyYvaP-evlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg--~aispgM  275 (400)
T KOG0604|consen  202 PLKLTDFGFAKETQEPGDL---MTPCFTPYYVAP-EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG--LAISPGM  275 (400)
T ss_pred             ceEecccccccccCCCccc---cCCcccccccCH-HHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC--ccCChhH
Confidence            8999999999976543322   235689999999 666777899999999999999999999999974322  1111111


Q ss_pred             hhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          633 RTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       633 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      +..+.....++.+                       +++.+..++..++|+.+|+.+|.+|.|+.|++.
T Consensus       276 k~rI~~gqy~FP~-----------------------pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  276 KRRIRTGQYEFPE-----------------------PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             HhHhhccCccCCC-----------------------hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            2222222222221                       223466778889999999999999999999874

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=6.9e-36  Score=321.38  Aligned_cols=200  Identities=26%  Similarity=0.295  Sum_probs=169.2

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      .|++++.||+|+||.||+|.+..+++.||+|+++...   ......+.+|+.++.+++||+|+++++.     +.+....
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~-----~~~~~~~   76 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYS-----FQDKRNL   76 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEE-----EEcCCEE
Confidence            4778899999999999999999999999999997422   2234567789999999999999999998     4566789


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      |+||||+++|+|.+++...          ..+++..+..++.|++.||+|||+.   ||+||||||+||+++.++.+||+
T Consensus        77 ~lv~E~~~gg~L~~~l~~~----------~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~  143 (360)
T cd05627          77 YLIMEFLPGGDMMTLLMKK----------DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLS  143 (360)
T ss_pred             EEEEeCCCCccHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEe
Confidence            9999999999999998643          4578889999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCcc---------------------------------cccccccccccccCcccccCCCCCCCccCchhH
Q 037916          558 DFGLAKLLPPAHLQ---------------------------------TSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSY  604 (741)
Q Consensus       558 DFg~a~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSl  604 (741)
                      |||++.........                                 .......||+.|+|| |+..+..++.++||||+
T Consensus       144 DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP-E~~~~~~~~~~~DiwSl  222 (360)
T cd05627         144 DFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAP-EVFMQTGYNKLCDWWSL  222 (360)
T ss_pred             eccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCH-HHHcCCCCCCcceeccc
Confidence            99998754321100                                 001124699999999 55567788999999999


Q ss_pred             HHHHHHHHcCCCCCC
Q 037916          605 GILLLELMTRKRPSD  619 (741)
Q Consensus       605 G~il~elltg~~p~~  619 (741)
                      ||++|||++|+.||.
T Consensus       223 Gvilyel~tG~~Pf~  237 (360)
T cd05627         223 GVIMYEMLIGYPPFC  237 (360)
T ss_pred             cceeeecccCCCCCC
Confidence            999999999999986

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-35  Score=302.00  Aligned_cols=251  Identities=27%  Similarity=0.379  Sum_probs=197.7

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      ...|++.+.||.|+||.||+|...  ++.||+|.++.... ..+++.+|+.++++++|+||+++++++     .+....+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   76 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVV-----LQGNPLY   76 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEE-----cCCCCeE
Confidence            357889999999999999999985  78899999975433 456788999999999999999999995     3456789


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      +||||+++++|.+++....        ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|
T Consensus        77 ~v~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d  145 (256)
T cd05039          77 IVTEYMAKGSLVDYLRSRG--------RAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSD  145 (256)
T ss_pred             EEEEecCCCcHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcc
Confidence            9999999999999986431        13588999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcCC
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      ||.++.......     ...++..|+|||. .....++.++||||+|+++|++++ |..||.....     ....     
T Consensus       146 ~g~~~~~~~~~~-----~~~~~~~~~ape~-~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~-----  209 (256)
T cd05039         146 FGLAKEASQGQD-----SGKLPVKWTAPEA-LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----KDVV-----  209 (256)
T ss_pred             cccccccccccc-----cCCCcccccCchh-hcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHH-----
Confidence            999987643221     1234667999954 456678899999999999999997 9999852211     1000     


Q ss_pred             cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHH
Q 037916          638 DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSI  706 (741)
Q Consensus       638 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  706 (741)
                          ..+......                  ..+..+++.+.+++.+||..+|++|||+.|+++.|+.+
T Consensus       210 ----~~~~~~~~~------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         210 ----PHVEKGYRM------------------EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             ----HHHhcCCCC------------------CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence                000000000                  00112356788999999999999999999999999754

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=6.1e-36  Score=311.53  Aligned_cols=271  Identities=21%  Similarity=0.262  Sum_probs=197.7

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcC--cchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG--ASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      .|++.+.||+|+||.||+|.+..+++.||+|++......  ..+.+.+|+++++.++||||+++++++     .++...+
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   76 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRLY   76 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeEE
Confidence            477889999999999999999888999999998643222  345678899999999999999999994     5566899


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      +||||++++++..+....          ..+++.++..++.|+++||+|||+.   +++||||+|+||++++++.+||+|
T Consensus        77 lv~e~~~~~~l~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~d  143 (286)
T cd07846          77 LVFEFVDHTVLDDLEKYP----------NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCD  143 (286)
T ss_pred             EEEecCCccHHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEe
Confidence            999999998888876422          3478899999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhh--cC
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART--VL  636 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~--~~  636 (741)
                      ||.+.........  .....++..|+|||.+.....++.++||||||+++|||++|+.||...... .........  ..
T Consensus       144 fg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~-~~~~~~~~~~~~~  220 (286)
T cd07846         144 FGFARTLAAPGEV--YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI-DQLYHIIKCLGNL  220 (286)
T ss_pred             eeeeeeccCCccc--cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH-HHHHHHHHHhCCC
Confidence            9998765443221  122457889999976655566789999999999999999999988522110 000000000  00


Q ss_pred             CcchhHhhh------hcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          637 PDHVMDIVD------STLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       637 ~~~~~~~~d------~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ........+      ........         ............+..+.+++.+||+.||++|||+.|+++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         221 IPRHQEIFQKNPLFAGMRLPEVK---------EIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             chhhHHHhccchHhhcccccccc---------CcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            000011110      00000000         000001112244677899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.2e-35  Score=306.97  Aligned_cols=240  Identities=20%  Similarity=0.283  Sum_probs=181.6

Q ss_pred             hcccCceeeEEEEEEcC------------------------CCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeE
Q 037916          407 WIDMGSFGSVYKGILDE------------------------GKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKI  462 (741)
Q Consensus       407 ~ig~G~~g~V~~a~~~~------------------------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~  462 (741)
                      .||+|+||.||+|....                        ....||+|++..........+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999998532                        124689998865443344567788999999999999999


Q ss_pred             eeeecCccccCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCC
Q 037916          463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLK  542 (741)
Q Consensus       463 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlk  542 (741)
                      +++|.     .....++||||+++|+|..++...         ...+++..+..++.|+++||+|||+.   +|+|||||
T Consensus        82 ~~~~~-----~~~~~~lv~ey~~~g~L~~~l~~~---------~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlk  144 (274)
T cd05076          82 HGVCV-----RGSENIMVEEFVEHGPLDVCLRKE---------KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVC  144 (274)
T ss_pred             EEEEE-----eCCceEEEEecCCCCcHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCC
Confidence            99964     345789999999999999988532         24578888999999999999999999   99999999


Q ss_pred             CCCeEeCCCC-------ceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHH-cC
Q 037916          543 PSNVLLDHEM-------TAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELM-TR  614 (741)
Q Consensus       543 p~NIll~~~~-------~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ell-tg  614 (741)
                      |+||++++.+       .+|++|||.+.......      ...++..|+|||.+.....++.++|||||||++||++ +|
T Consensus       145 p~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~~------~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g  218 (274)
T cd05076         145 AKNILLARLGLAEGTSPFIKLSDPGVSFTALSRE------ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDG  218 (274)
T ss_pred             cccEEEeccCcccCccceeeecCCcccccccccc------ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence            9999997643       48999999876432221      1346788999976655567899999999999999984 68


Q ss_pred             CCCCCccccCCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCC
Q 037916          615 KRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRM  694 (741)
Q Consensus       615 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  694 (741)
                      ..||......  ....            ........ .                   ......+.+++.+||+.+|++||
T Consensus       219 ~~p~~~~~~~--~~~~------------~~~~~~~~-~-------------------~~~~~~~~~li~~cl~~~p~~Rp  264 (274)
T cd05076         219 EVPLKERTPS--EKER------------FYEKKHRL-P-------------------EPSCKELATLISQCLTYEPTQRP  264 (274)
T ss_pred             CCCccccChH--HHHH------------HHHhccCC-C-------------------CCCChHHHHHHHHHcccChhhCc
Confidence            8887632111  1001            11100000 0                   01123578999999999999999


Q ss_pred             CHHHHHHHH
Q 037916          695 NMTIVVHEL  703 (741)
Q Consensus       695 s~~evl~~L  703 (741)
                      |+.||++.|
T Consensus       265 s~~~il~~L  273 (274)
T cd05076         265 SFRTILRDL  273 (274)
T ss_pred             CHHHHHHhh
Confidence            999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-35  Score=303.84  Aligned_cols=257  Identities=23%  Similarity=0.321  Sum_probs=190.8

Q ss_pred             hcccCceeeEEEEEEcCCCe--EEEEEEeeccC-cCcchhHHHHHHHHHhc-CCCceeeEeeeecCccccCCceEEEEEe
Q 037916          407 WIDMGSFGSVYKGILDEGKT--IIAVKVLNLLH-HGASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKGDDFKALVYE  482 (741)
Q Consensus       407 ~ig~G~~g~V~~a~~~~~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~~~~lv~e  482 (741)
                      .||+|+||.||+|.+..++.  .+|+|.++... ....+.+.+|+.+++++ +||||+++++++     ......++|||
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~-----~~~~~~~lv~e   76 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHRGYLYLAIE   76 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEE-----ecCCCceEEEE
Confidence            58999999999999977665  46888876322 23345778899999999 899999999995     34457899999


Q ss_pred             cccCCChhhhccCCCCCCc------ccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          483 FMHNGSLEEWLHPVSGADK------TVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       483 ~~~~gsL~~~l~~~~~~~~------~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      |+++++|.+++...+....      .......+++.++..++.|++.||+|||+.   +++||||||+||++++++.+||
T Consensus        77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl  153 (270)
T cd05047          77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKI  153 (270)
T ss_pred             eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEE
Confidence            9999999999865421110      011123578899999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhc
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTV  635 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  635 (741)
                      +|||++......   ........+..|+||| +.....++.++|||||||++|||++ |..||.....     .......
T Consensus       154 ~dfgl~~~~~~~---~~~~~~~~~~~y~apE-~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-----~~~~~~~  224 (270)
T cd05047         154 ADFGLSRGQEVY---VKKTMGRLPVRWMAIE-SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----AELYEKL  224 (270)
T ss_pred             CCCCCccccchh---hhccCCCCccccCChH-HHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH-----HHHHHHH
Confidence            999998532211   1111122356799995 5566778999999999999999997 9999853211     1111110


Q ss_pred             CCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHH
Q 037916          636 LPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIK  707 (741)
Q Consensus       636 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  707 (741)
                               ......                  .....+...+.+++.+||..||.+|||+.|+++.|+++.
T Consensus       225 ---------~~~~~~------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         225 ---------PQGYRL------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             ---------hCCCCC------------------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence                     000000                  001123456789999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.9e-35  Score=304.97  Aligned_cols=249  Identities=24%  Similarity=0.317  Sum_probs=196.5

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      ..|...+.||+|+||.||+|.+..++..||+|.++... ....+.+.+|+.++++++||||+++++++     ..+...+
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   78 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY-----LKGTKLW   78 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccc-----ccCCceE
Confidence            46889999999999999999998889999999987432 22345678999999999999999999984     4566899


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      +||||+++++|.+++..           ..+++..+..++.|+++|+.|||+.   +++|+||+|+||+++.++.+||+|
T Consensus        79 lv~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~d  144 (277)
T cd06642          79 IIMEYLGGGSALDLLKP-----------GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLAD  144 (277)
T ss_pred             EEEEccCCCcHHHHhhc-----------CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEcc
Confidence            99999999999998852           3467888999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCc
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      ||.+........  ......|+..|+||| +..+..++.++|||||||++||+++|+.||.......  ...........
T Consensus       145 fg~~~~~~~~~~--~~~~~~~~~~y~aPE-~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~  219 (277)
T cd06642         145 FGVAGQLTDTQI--KRNTFVGTPFWMAPE-VIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR--VLFLIPKNSPP  219 (277)
T ss_pred             ccccccccCcch--hhhcccCcccccCHH-HhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh--HHhhhhcCCCC
Confidence            999876543321  112235788999995 5566678999999999999999999999986321110  00000000000


Q ss_pred             chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          639 HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       639 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                              ..                      ...++..+.+++.+||+.+|++|||+.|+++.
T Consensus       220 --------~~----------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         220 --------TL----------------------EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             --------CC----------------------CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence                    00                      01234567899999999999999999999974

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.9e-35  Score=301.36  Aligned_cols=251  Identities=22%  Similarity=0.287  Sum_probs=195.6

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc--CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      .|++.+.||+|++|.||++.+..+++.||+|.+.....  ...+.+.+|+.++++++|||++++++.+.    ......+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~   76 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWE----GEDGLLY   76 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec----CCCCEEE
Confidence            37889999999999999999998899999999864322  23456788999999999999999998742    2344689


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      ++|||+++++|.+++...        ....+++.+++.++.|++.|++|||+.   +++||||||+||+++.++.++|+|
T Consensus        77 lv~e~~~~~~l~~~l~~~--------~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~d  145 (257)
T cd08223          77 IVMGFCEGGDLYHKLKEQ--------KGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGD  145 (257)
T ss_pred             EEecccCCCcHHHHHHHh--------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEec
Confidence            999999999999998642        124578999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCc
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      ||.+........  ......+++.|+||| +..+..++.++||||+||++|++++|+.||....     .......    
T Consensus       146 f~~~~~~~~~~~--~~~~~~~~~~y~aPE-~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~-----~~~~~~~----  213 (257)
T cd08223         146 LGIARVLENQCD--MASTLIGTPYYMSPE-LFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD-----MNSLVYR----  213 (257)
T ss_pred             ccceEEecccCC--ccccccCCcCccChh-HhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-----HHHHHHH----
Confidence            999976643321  112245789999994 5566778899999999999999999999986211     1111100    


Q ss_pred             chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          639 HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       639 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                          +..... ...                  .....+.+.+++.+||+.||++|||+.|+++
T Consensus       214 ----~~~~~~-~~~------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         214 ----IIEGKL-PPM------------------PKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             ----HHhcCC-CCC------------------ccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                000000 000                  0133456889999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-35  Score=305.52  Aligned_cols=260  Identities=25%  Similarity=0.365  Sum_probs=199.7

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCe----EEEEEEeeccCc-CcchhHHHHHHHHHhcCCCceeeEeeeecCccccC
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKT----IIAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKG  473 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  473 (741)
                      ...|++.+.||+|+||.||+|.+..++.    .||+|..+.... .....+.+|+.++++++||||++++++|..     
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----   80 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-----   80 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-----
Confidence            4678999999999999999999865544    689998864332 234567889999999999999999998742     


Q ss_pred             CceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCc
Q 037916          474 DDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMT  553 (741)
Q Consensus       474 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~  553 (741)
                       ...++||||+++|+|.+++...         ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.
T Consensus        81 -~~~~~v~e~~~~g~L~~~l~~~---------~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~  147 (279)
T cd05057          81 -SQVQLITQLMPLGCLLDYVRNH---------KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQH  147 (279)
T ss_pred             -CceEEEEecCCCCcHHHHHHhc---------cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCe
Confidence             4789999999999999998643         23478899999999999999999999   9999999999999999999


Q ss_pred             eEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhh
Q 037916          554 AHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFA  632 (741)
Q Consensus       554 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~  632 (741)
                      +||+|||.++...............++..|+|||. .....++.++|||||||++||+++ |+.||+....  ..+.+..
T Consensus       148 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~-~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~  224 (279)
T cd05057         148 VKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES-ILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA--VEIPDLL  224 (279)
T ss_pred             EEECCCcccccccCcccceecCCCcccccccCHHH-hhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH--HHHHHHH
Confidence            99999999987654322221112224568999954 456678899999999999999998 9999863211  0111111


Q ss_pred             hhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHh
Q 037916          633 RTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSI  709 (741)
Q Consensus       633 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  709 (741)
                      .....           ..                   .+..+...+.+++.+||..||++|||+.++++.|+++.+.
T Consensus       225 ~~~~~-----------~~-------------------~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05057         225 EKGER-----------LP-------------------QPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD  271 (279)
T ss_pred             hCCCC-----------CC-------------------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence            10000           00                   0012234578999999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-35  Score=315.20  Aligned_cols=201  Identities=23%  Similarity=0.267  Sum_probs=168.7

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeecc---CcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLL---HHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      .|++.+.||+|+||.||+|++..+++.||+|+++..   .....+.+.+|+.+++.++|+||++++++     +.++.+.
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~-----~~~~~~~   76 (331)
T cd05597           2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYA-----FQDENNL   76 (331)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEE-----EecCCeE
Confidence            478899999999999999999989999999999642   22234557789999999999999999998     4556689


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      |+||||+++|+|.+++...         ...+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        77 ~lv~e~~~g~~L~~~l~~~---------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~  144 (331)
T cd05597          77 YLVMDYYVGGDLLTLLSKF---------EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLA  144 (331)
T ss_pred             EEEEecCCCCcHHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEE
Confidence            9999999999999998632         23578888999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccccccCcccccC----CCCCCCccCchhHHHHHHHHHcCCCCCC
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGL----GSEVSINGDVYSYGILLLELMTRKRPSD  619 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~----~~~~~~~~DIwSlG~il~elltg~~p~~  619 (741)
                      |||.+.......... .....||+.|+|||.+..    ...++.++||||+||++|+|++|+.||.
T Consensus       145 Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~  209 (331)
T cd05597         145 DFGSCLRLLADGTVQ-SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFY  209 (331)
T ss_pred             ECCceeecCCCCCcc-ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCC
Confidence            999987654332211 112458999999965542    3457889999999999999999999986

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-37  Score=327.28  Aligned_cols=256  Identities=25%  Similarity=0.397  Sum_probs=208.8

Q ss_pred             HhhhcccCceeeEEEEEEcCCC---eEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          404 FLCWIDMGSFGSVYKGILDEGK---TIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       404 ~~~~ig~G~~g~V~~a~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      |.+.||.|.||+|++|+.+..+   ..||||.++... .....+|..|+.+|-+++||||+++-|+     ......++|
T Consensus       633 Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGV-----VTks~PvMI  707 (996)
T KOG0196|consen  633 IEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGV-----VTKSKPVMI  707 (996)
T ss_pred             EEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEE-----EecCceeEE
Confidence            3345999999999999987554   569999998543 3346689999999999999999999999     455668999


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      |+|||++|+|+.|++.+.         ..+++.+...+.++|+.|+.||-+.   ++|||||...||||+.+-.+|++||
T Consensus       708 iTEyMENGsLDsFLR~~D---------GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDF  775 (996)
T KOG0196|consen  708 ITEYMENGSLDSFLRQND---------GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDF  775 (996)
T ss_pred             EhhhhhCCcHHHHHhhcC---------CceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccc
Confidence            999999999999998662         4488889999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCc-ccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcCC
Q 037916          560 GLAKLLPPAHL-QTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       560 g~a~~~~~~~~-~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      |+++...++.. ..+..+-.-..+|.|| |.......+.++||||||++|||.++ |..||-++...             
T Consensus       776 GLSRvledd~~~~ytt~GGKIPiRWTAP-EAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ-------------  841 (996)
T KOG0196|consen  776 GLSRVLEDDPEAAYTTLGGKIPIRWTAP-EAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-------------  841 (996)
T ss_pred             cceeecccCCCccccccCCccceeecCh-hHhhhcccCchhhccccceEEEEecccCCCcccccchH-------------
Confidence            99998865542 1111111235689999 55677889999999999999999887 88887533211             


Q ss_pred             cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHh
Q 037916          638 DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSI  709 (741)
Q Consensus       638 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  709 (741)
                          +.+               ......++.+.+++|+..|.+||..||++|-.+||.+.||+..|.++...
T Consensus       842 ----dVI---------------kaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn  894 (996)
T KOG0196|consen  842 ----DVI---------------KAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN  894 (996)
T ss_pred             ----HHH---------------HHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence                111               11123445556779999999999999999999999999999999998863

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.8e-35  Score=303.27  Aligned_cols=249  Identities=23%  Similarity=0.329  Sum_probs=193.4

Q ss_pred             HHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCc---------chhHHHHHHHHHhcCCCceeeEeeeecCcccc
Q 037916          402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGA---------SKSSIAECSALRNIRHKNLVKILTVCSGVDYK  472 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  472 (741)
                      |.+.+.||+|++|.||+|.+..+++.||+|.+.......         .+.+.+|+.++++++||||+++++++     .
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~   76 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSS-----L   76 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----E
Confidence            677889999999999999998889999999886432221         24567899999999999999999984     4


Q ss_pred             CCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCC
Q 037916          473 GDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEM  552 (741)
Q Consensus       473 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~  552 (741)
                      .....+++|||+++++|.+++...          ..+++..+..++.|++.||+|||+.   +++||||+|+||+++.++
T Consensus        77 ~~~~~~lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~  143 (267)
T cd06628          77 DADHLNIFLEYVPGGSVAALLNNY----------GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKG  143 (267)
T ss_pred             eCCccEEEEEecCCCCHHHHHHhc----------cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCC
Confidence            456889999999999999998643          3477888899999999999999999   999999999999999999


Q ss_pred             ceEEeecccccccCCCCccc----ccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcch
Q 037916          553 TAHVADFGLAKLLPPAHLQT----SSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNL  628 (741)
Q Consensus       553 ~~kL~DFg~a~~~~~~~~~~----~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~  628 (741)
                      .+||+|||.++.........    ......|+..|+||| ...+..++.++||||+||++|++++|+.||.....    .
T Consensus       144 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe-~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~  218 (267)
T cd06628         144 GIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE-VVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ----L  218 (267)
T ss_pred             CEEecccCCCcccccccccCCccccccccCCCcCccChh-HhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH----H
Confidence            99999999988765321111    111234788999995 44566788999999999999999999999863211    0


Q ss_pred             hhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          629 HNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       629 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ....         .... .....                  .+...+..+.+++.+||+.||++||++.||++
T Consensus       219 ~~~~---------~~~~-~~~~~------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         219 QAIF---------KIGE-NASPE------------------IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             HHHH---------HHhc-cCCCc------------------CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            0000         0000 00000                  01133466789999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=5.8e-35  Score=301.05  Aligned_cols=256  Identities=20%  Similarity=0.265  Sum_probs=181.3

Q ss_pred             hhcccCceeeEEEEEEcCC--CeEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEEEe
Q 037916          406 CWIDMGSFGSVYKGILDEG--KTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYE  482 (741)
Q Consensus       406 ~~ig~G~~g~V~~a~~~~~--~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv~e  482 (741)
                      +.||+|+||.||+|....+  ...+++|.++... ....+.+.+|+.+++.++||||+++++.|.     .....|+|||
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----~~~~~~lv~e   75 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCV-----EAIPYLLVFE   75 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEec-----CCCccEEEEe
Confidence            3699999999999976422  3356677665332 233467889999999999999999999953     4457899999


Q ss_pred             cccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecccc
Q 037916          483 FMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLA  562 (741)
Q Consensus       483 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~a  562 (741)
                      |+++|+|.+++......      ....++..+..++.|+++||+|||+.   +++||||||+||+++.++.+||+|||.+
T Consensus        76 ~~~~~~L~~~l~~~~~~------~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~  146 (268)
T cd05086          76 YCELGDLKSYLSQEQWH------RRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIG  146 (268)
T ss_pred             cCCCCcHHHHHHhhhcc------cccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccc
Confidence            99999999998643111      13356667789999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCCcccccccccccccccCcccccC------CCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhc
Q 037916          563 KLLPPAHLQTSSIGVKGTIGYIAPAEYGL------GSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTV  635 (741)
Q Consensus       563 ~~~~~~~~~~~~~~~~gt~~y~aPEe~~~------~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  635 (741)
                      ................++..|+|||.+..      ...++.++|||||||++|||++ |..||.....     .......
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-----~~~~~~~  221 (268)
T cd05086         147 PSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-----REVLNHV  221 (268)
T ss_pred             cccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHH
Confidence            64332221122223457889999965422      2345789999999999999997 5667752211     1111111


Q ss_pred             CCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHH
Q 037916          636 LPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHEL  703 (741)
Q Consensus       636 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  703 (741)
                      .........++....                      ...+.+.+++..|| .+|++|||++||++.|
T Consensus       222 ~~~~~~~~~~~~~~~----------------------~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l  266 (268)
T cd05086         222 IKDQQVKLFKPQLEL----------------------PYSERWYEVLQFCW-LSPEKRATAEEVHRLL  266 (268)
T ss_pred             HhhcccccCCCccCC----------------------CCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence            111111111111111                      12345678889999 6899999999999887

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2.1e-35  Score=308.35  Aligned_cols=201  Identities=25%  Similarity=0.382  Sum_probs=165.0

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc-CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      ..|.+.+.||+|+||.||+|.+..++..||+|+++.... .....+.+|+.+++.++|+||+++++++     ..+...|
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~~~~   79 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII-----HTKETLT   79 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEE-----ecCCeEE
Confidence            468889999999999999999988899999999864332 2234667899999999999999999984     4556889


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      +||||+. +++.+++...         ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        80 lv~e~~~-~~l~~~~~~~---------~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~D  146 (291)
T cd07870          80 FVFEYMH-TDLAQYMIQH---------PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLAD  146 (291)
T ss_pred             EEEeccc-CCHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEec
Confidence            9999995 6777766422         13466778889999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCc
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDI  620 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~  620 (741)
                      ||.++........  .....+++.|+|||.+.....++.++||||+||++|+|++|..||+.
T Consensus       147 fg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~  206 (291)
T cd07870         147 FGLARAKSIPSQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPG  206 (291)
T ss_pred             cccccccCCCCCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            9998764432211  12234788999996554445678899999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.7e-35  Score=298.63  Aligned_cols=248  Identities=26%  Similarity=0.369  Sum_probs=191.2

Q ss_pred             hhcccCceeeEEEEEEcCCCeEEEEEEeeccCcC-cchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEEEecc
Q 037916          406 CWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG-ASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFM  484 (741)
Q Consensus       406 ~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv~e~~  484 (741)
                      ++||+|+||.||+|.+.. ++.||+|.++..... ..+.+.+|+.++++++||||+++++++     .+....++||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~v~e~~   74 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC-----VQKQPIYIVMELV   74 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEE-----ecCCCeEEEEEcC
Confidence            469999999999999986 899999998743332 345788999999999999999999984     4556889999999


Q ss_pred             cCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecccccc
Q 037916          485 HNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKL  564 (741)
Q Consensus       485 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~a~~  564 (741)
                      ++++|.+++...         ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||.+..
T Consensus        75 ~~~~l~~~l~~~---------~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~  142 (251)
T cd05041          75 PGGSLLTFLRKK---------KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRE  142 (251)
T ss_pred             CCCcHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeecccccc
Confidence            999999998532         13467888899999999999999999   999999999999999999999999999976


Q ss_pred             cCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcCCcchhHh
Q 037916          565 LPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVLPDHVMDI  643 (741)
Q Consensus       565 ~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  643 (741)
                      ..............++..|+||| ...++.++.++||||+||++|++++ |..||......  ....            .
T Consensus       143 ~~~~~~~~~~~~~~~~~~y~~PE-~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--~~~~------------~  207 (251)
T cd05041         143 EEGGIYTVSDGLKQIPIKWTAPE-ALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--QTRE------------R  207 (251)
T ss_pred             ccCCcceeccccCcceeccCChH-hhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--HHHH------------H
Confidence            54322211111123456799995 4456678999999999999999999 88887532111  0000            0


Q ss_pred             hhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHH
Q 037916          644 VDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQ  704 (741)
Q Consensus       644 ~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  704 (741)
                      +......                  ..+...+..+.+++.+||+.+|++|||+.|+++.|+
T Consensus       208 ~~~~~~~------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         208 IESGYRM------------------PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             HhcCCCC------------------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            0000000                  001133457889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-36  Score=312.42  Aligned_cols=258  Identities=26%  Similarity=0.413  Sum_probs=210.4

Q ss_pred             hhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEEEecc
Q 037916          405 LCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFM  484 (741)
Q Consensus       405 ~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv~e~~  484 (741)
                      -.+||.|.||.||.|.|+...-.||||.++. +....++|.+|+.+|+.++|||+|+++++|..     +...|||+|||
T Consensus       272 khKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~-----EpPFYIiTEfM  345 (1157)
T KOG4278|consen  272 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTH-----EPPFYIITEFM  345 (1157)
T ss_pred             eeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhcc-----CCCeEEEEecc
Confidence            4579999999999999999999999999974 34557899999999999999999999999853     34689999999


Q ss_pred             cCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecccccc
Q 037916          485 HNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKL  564 (741)
Q Consensus       485 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~a~~  564 (741)
                      ..|+|.+|+++..        +...+....+.++.||..|++||..+   .+|||||...|.||.++..||++|||+++.
T Consensus       346 ~yGNLLdYLRecn--------r~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRl  414 (1157)
T KOG4278|consen  346 CYGNLLDYLRECN--------RSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRL  414 (1157)
T ss_pred             cCccHHHHHHHhc--------hhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhh
Confidence            9999999998652        23455566778999999999999999   999999999999999999999999999999


Q ss_pred             cCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcCCcchhHh
Q 037916          565 LPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVLPDHVMDI  643 (741)
Q Consensus       565 ~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  643 (741)
                      +..+. +....+..-...|.|||- +....++.|+|||+|||++||+.| |-.||...     ++.+         +.++
T Consensus       415 MtgDT-YTAHAGAKFPIKWTAPEs-LAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi-----dlSq---------VY~L  478 (1157)
T KOG4278|consen  415 MTGDT-YTAHAGAKFPIKWTAPES-LAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DLSQ---------VYGL  478 (1157)
T ss_pred             hcCCc-eecccCccCcccccCccc-ccccccccchhhHHHHHHHHHHHhcCCCCCCCc-----cHHH---------HHHH
Confidence            87543 333333445678999954 456678999999999999999988 77776521     1111         2233


Q ss_pred             hhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHhhcCC
Q 037916          644 VDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSILLGP  713 (741)
Q Consensus       644 ~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~  713 (741)
                      ++                  +.++++.+..|++.+++||+.||+|.|.+||++.|+-+.++.+-..-...
T Consensus       479 LE------------------kgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sSis  530 (1157)
T KOG4278|consen  479 LE------------------KGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSSIS  530 (1157)
T ss_pred             Hh------------------ccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcccccc
Confidence            32                  23445556789999999999999999999999999999998887544433

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-35  Score=302.45  Aligned_cols=248  Identities=24%  Similarity=0.289  Sum_probs=196.4

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      +|.+.+.||.|++|.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++     .++...|+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~   76 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSF-----LKGSKLWI   76 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEE-----EECCeEEE
Confidence            5889999999999999999999899999999987433 23345678899999999999999999984     44568999


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      |+||+++++|.+++..           ..+++..+..++.|++.|+.|||+.   +++||||+|+||++++++.++|+||
T Consensus        77 v~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~  142 (274)
T cd06609          77 IMEYCGGGSCLDLLKP-----------GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADF  142 (274)
T ss_pred             EEEeeCCCcHHHHHhh-----------cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccc
Confidence            9999999999999862           2578899999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcc
Q 037916          560 GLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDH  639 (741)
Q Consensus       560 g~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  639 (741)
                      |.+.........  .....+++.|+||| +..+..++.++|||||||++|++++|+.||......  ..........+..
T Consensus       143 g~~~~~~~~~~~--~~~~~~~~~y~~PE-~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~  217 (274)
T cd06609         143 GVSGQLTSTMSK--RNTFVGTPFWMAPE-VIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM--RVLFLIPKNNPPS  217 (274)
T ss_pred             ccceeecccccc--cccccCCccccChh-hhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH--HHHHHhhhcCCCC
Confidence            999877543211  12245788999995 455666999999999999999999999998632110  0000000000000


Q ss_pred             hhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          640 VMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       640 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                                  ..                 ...++..+.+++.+||..||++|||++++++
T Consensus       218 ------------~~-----------------~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         218 ------------LE-----------------GNKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             ------------Cc-----------------ccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence                        00                 0013456789999999999999999999976

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.3e-35  Score=306.02  Aligned_cols=254  Identities=22%  Similarity=0.252  Sum_probs=194.4

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      .|++++.||+|+||.||+|.+..++..||+|.++... ......+.+|+.++++++||||+++++++     ......++
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~l   76 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF-----FIEGAVYM   76 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhe-----ecCCeEEE
Confidence            5899999999999999999999899999999986432 22245678899999999999999999984     45668999


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      ||||+++++|..++....       ....+++..+..++.|++.||.|||+..  +|+||||||+||+++.++.+||+||
T Consensus        77 v~e~~~~~~l~~~~~~~~-------~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~df  147 (286)
T cd06622          77 CMEYMDAGSLDKLYAGGV-------ATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDF  147 (286)
T ss_pred             EEeecCCCCHHHHHHhcc-------ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeec
Confidence            999999999999886320       1235889999999999999999999632  8999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccccccCcccccCC-----CCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhh
Q 037916          560 GLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLG-----SEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       560 g~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~-----~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  634 (741)
                      |.+........    ....+++.|+|||.+...     ..++.++||||+||++|++++|+.||......  ......  
T Consensus       148 g~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~--  219 (286)
T cd06622         148 GVSGNLVASLA----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA--NIFAQL--  219 (286)
T ss_pred             CCcccccCCcc----ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh--hHHHHH--
Confidence            99876543221    123478899999655322     23588999999999999999999998632110  000000  


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                            ..+.+....                   ..+..+...+.+++.+||+.+|++||++.|++.
T Consensus       220 ------~~~~~~~~~-------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         220 ------SAIVDGDPP-------------------TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             ------HHHhhcCCC-------------------CCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence                  000000000                   011234566789999999999999999999886

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=5.1e-35  Score=300.10  Aligned_cols=253  Identities=27%  Similarity=0.410  Sum_probs=195.0

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      .+|.+.++||+|++|.||+|.+..+ ..||+|.+.... ...+.+.+|+.++++++|||++++++++.      ....++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~~   77 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS------EEPIYI   77 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc------CCCcEE
Confidence            5688999999999999999998744 468999876432 23457789999999999999999998842      235789


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      +|||+++++|.+++...        ....+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+||
T Consensus        78 v~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~df  146 (260)
T cd05069          78 VTEFMGKGSLLDFLKEG--------DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADF  146 (260)
T ss_pred             EEEcCCCCCHHHHHhhC--------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCC
Confidence            99999999999998643        123478889999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcCCc
Q 037916          560 GLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       560 g~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      |.+......... ......++..|+||| ...+..++.++||||+|+++|++++ |..||......  ........... 
T Consensus       147 g~~~~~~~~~~~-~~~~~~~~~~y~~Pe-~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~-  221 (260)
T cd05069         147 GLARLIEDNEYT-ARQGAKFPIKWTAPE-AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR--EVLEQVERGYR-  221 (260)
T ss_pred             ccceEccCCccc-ccCCCccchhhCCHH-HhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC-
Confidence            999765433211 111233567899995 5566778999999999999999999 89998632111  00000000000 


Q ss_pred             chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHH
Q 037916          639 HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQS  705 (741)
Q Consensus       639 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  705 (741)
                                 .                  ..+...+..+.+++.+||..||++||++++|++.|++
T Consensus       222 -----------~------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         222 -----------M------------------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             -----------C------------------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                       0                  0011334668899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.7e-35  Score=301.86  Aligned_cols=256  Identities=21%  Similarity=0.279  Sum_probs=193.5

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcC----------cchhHHHHHHHHHhcCCCceeeEeeeecCcc
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG----------ASKSSIAECSALRNIRHKNLVKILTVCSGVD  470 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~----------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  470 (741)
                      .|.+.+.||.|+||.||+|.+..+++.||+|.++.....          ..+.+..|+.+++.++||||+++++++    
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~----   77 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFE----   77 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEe----
Confidence            467788999999999999999888999999988632111          123567899999999999999999985    


Q ss_pred             ccCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCC
Q 037916          471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDH  550 (741)
Q Consensus       471 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~  550 (741)
                       ......++||||+++++|.+++...          ..+++..+..++.|++.||.|||+.   +++||||+|+||+++.
T Consensus        78 -~~~~~~~lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~  143 (272)
T cd06629          78 -TTEEYLSIFLEYVPGGSIGSCLRTY----------GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDA  143 (272)
T ss_pred             -ccCCceEEEEecCCCCcHHHHHhhc----------cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcC
Confidence             4456889999999999999998643          3578888899999999999999999   9999999999999999


Q ss_pred             CCceEEeecccccccCCCCcccccccccccccccCcccccCCC-CCCCccCchhHHHHHHHHHcCCCCCCccccCCcchh
Q 037916          551 EMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGS-EVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLH  629 (741)
Q Consensus       551 ~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~-~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~  629 (741)
                      ++.++|+|||.+................|+..|+|||.+.... .++.++||||+|+++|++++|..||.....    ..
T Consensus       144 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~~  219 (272)
T cd06629         144 DGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA----IA  219 (272)
T ss_pred             CCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch----HH
Confidence            9999999999997654322212222345888999996554333 478999999999999999999999852111    10


Q ss_pred             hhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          630 NFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       630 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ..... ........+...                      ...+++..+.+++.+||..||++|||+.||++
T Consensus       220 ~~~~~-~~~~~~~~~~~~----------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         220 AMFKL-GNKRSAPPIPPD----------------------VSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             HHHHh-hccccCCcCCcc----------------------ccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            01000 000000000000                      01133567889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=4.8e-35  Score=299.53  Aligned_cols=251  Identities=20%  Similarity=0.295  Sum_probs=198.1

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC--cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      +|++.+.||.|+||.||.++...+++.||+|.+....  ......+.+|+.++++++|+||+++++++     .+....+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~   75 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHF-----MDDNTLL   75 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEE-----ecCCeEE
Confidence            4788999999999999999999999999999986432  23345678999999999999999999995     4456899


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      ++|||+++++|.+++....        ...+++..+..++.|++.||+|||+.   +++||||+|+||++++++.+||+|
T Consensus        76 ~~~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d  144 (256)
T cd08221          76 IEMEYANGGTLYDKIVRQK--------GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGD  144 (256)
T ss_pred             EEEEecCCCcHHHHHHhcc--------ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECc
Confidence            9999999999999986431        24578889999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCc
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      ||.+........  ......+++.|+||| +..+..++.++||||+|+++|+|++|..||+....     .....     
T Consensus       145 ~~~~~~~~~~~~--~~~~~~~~~~y~ape-~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----~~~~~-----  211 (256)
T cd08221         145 FGISKILGSEYS--MAETVVGTPYYMSPE-LCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP-----LNLVV-----  211 (256)
T ss_pred             CcceEEcccccc--cccccCCCccccCHh-hcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH-----HHHHH-----
Confidence            999987654332  122345899999995 44566688999999999999999999999862110     01111     


Q ss_pred             chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          639 HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       639 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                         .+.......                   .....+..+.+++.+||..+|++|||+.|+++.
T Consensus       212 ---~~~~~~~~~-------------------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         212 ---KIVQGNYTP-------------------VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             ---HHHcCCCCC-------------------CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence               000000000                   001334568899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-36  Score=317.52  Aligned_cols=287  Identities=22%  Similarity=0.261  Sum_probs=205.9

Q ss_pred             HHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCcc-ccCCceEEE
Q 037916          402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVD-YKGDDFKAL  479 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~~~~~~~l  479 (741)
                      |...+.||+|+||.||+|+++.+|+.||||.++... ....+...+|+++|++++|||||+++++=.... +-......+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            556788999999999999999999999999997433 344567789999999999999999999721110 011345689


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeC--CCC--ceE
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLD--HEM--TAH  555 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~--~~~--~~k  555 (741)
                      |||||.||||...+..-       +....+++.+.+.+..+++.||.|||++   |||||||||.||++-  .+|  ..|
T Consensus        95 vmEyC~gGsL~~~L~~P-------EN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyK  164 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSP-------ENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYK  164 (732)
T ss_pred             EEeecCCCcHHHHhcCc-------ccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEe
Confidence            99999999999999743       2335689999999999999999999999   999999999999983  334  579


Q ss_pred             EeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhc
Q 037916          556 VADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV  635 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~  635 (741)
                      |+|||.|+..++...   .....||..|.+||.+...+.|+..+|.|||||++|++.||..||... .+.....+.+...
T Consensus       165 LtDfG~Arel~d~s~---~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~-~~pk~~~~~~~~~  240 (732)
T KOG4250|consen  165 LTDFGAARELDDNSL---FTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF-GGPKNNKEIMWHI  240 (732)
T ss_pred             eecccccccCCCCCe---eeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC-CCccccchhhhhh
Confidence            999999998887653   344789999999965554688999999999999999999999999743 2322222222211


Q ss_pred             C---CcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCC--CHHHHHHHHHHHHH
Q 037916          636 L---PDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRM--NMTIVVHELQSIKS  708 (741)
Q Consensus       636 ~---~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP--s~~evl~~L~~i~~  708 (741)
                      .   +..+.-...+...+..     ..+.. -+............+-.++..++.++|++|-  ...+....+.+|..
T Consensus       241 ~tkkp~~v~i~~~~~eNgpv-----~~s~~-lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~  312 (732)
T KOG4250|consen  241 ITKKPSGVAIGAQEEENGPV-----EWSST-LPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN  312 (732)
T ss_pred             hccCCCceeEeeecccCCce-----eeecc-CCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence            1   1111111111110000     00000 0001111223344566777788889999998  77777777777765

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3.7e-35  Score=302.93  Aligned_cols=258  Identities=21%  Similarity=0.291  Sum_probs=198.1

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCC---CeEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEG---KTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      ..|.+.+.||+|+||.||+|.+...   ...||+|...... ....+.+.+|+.++++++||||+++++++.     + .
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~-~   79 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVIT-----E-N   79 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEc-----C-C
Confidence            3577889999999999999997543   4578999886433 233457889999999999999999999853     2 3


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..++||||+++++|.+++...         ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+|
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~  147 (270)
T cd05056          80 PVWIVMELAPLGELRSYLQVN---------KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVK  147 (270)
T ss_pred             CcEEEEEcCCCCcHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeE
Confidence            468999999999999998642         13478899999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhh
Q 037916          556 VADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  634 (741)
                      |+|||.+........... ....++..|+||| ......++.++||||||+++||+++ |..||.......  .......
T Consensus       148 l~d~g~~~~~~~~~~~~~-~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--~~~~~~~  223 (270)
T cd05056         148 LGDFGLSRYLEDESYYKA-SKGKLPIKWMAPE-SINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND--VIGRIEN  223 (270)
T ss_pred             EccCceeeecccccceec-CCCCccccccChh-hhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHc
Confidence            999999987654422211 1223456899995 4456678999999999999999986 999986332110  0000000


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHh
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSI  709 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  709 (741)
                      ..                              ....+..++..+.+++.+||..+|++|||+.|+++.|+.+...
T Consensus       224 ~~------------------------------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         224 GE------------------------------RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             CC------------------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            00                              0000113456788999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.2e-35  Score=308.58  Aligned_cols=260  Identities=25%  Similarity=0.352  Sum_probs=197.2

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCe----EEEEEEeeccCc-CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCC
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKT----IIAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGD  474 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~  474 (741)
                      ..|+..+.||+|+||.||+|.+..++.    .||+|.+..... .....+.+|+.+++.++||||++++++|..      
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~------   80 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS------   80 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC------
Confidence            467888999999999999999876665    578888764322 123357789999999999999999998632      


Q ss_pred             ceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCce
Q 037916          475 DFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTA  554 (741)
Q Consensus       475 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~  554 (741)
                      ...++++||+++|+|.+++...         ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus        81 ~~~~~v~e~~~~g~l~~~~~~~---------~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~  148 (303)
T cd05110          81 PTIQLVTQLMPHGCLLDYVHEH---------KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHV  148 (303)
T ss_pred             CCceeeehhcCCCCHHHHHHhc---------ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCce
Confidence            2357899999999999998643         13478888999999999999999999   99999999999999999999


Q ss_pred             EEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhh
Q 037916          555 HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFAR  633 (741)
Q Consensus       555 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~  633 (741)
                      ||+|||.++...............++..|+||| ...+..++.++|||||||++||+++ |..||.....  .....+..
T Consensus       149 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE-~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~~~~~~~~  225 (303)
T cd05110         149 KITDFGLARLLEGDEKEYNADGGKMPIKWMALE-CIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--REIPDLLE  225 (303)
T ss_pred             EEccccccccccCcccccccCCCccccccCCHH-HhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHH
Confidence            999999998765332222222234577899995 4566778999999999999999997 8899853211  11111111


Q ss_pred             hcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHhh
Q 037916          634 TVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSIL  710 (741)
Q Consensus       634 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  710 (741)
                      ....            .                  .....+...+.+++.+||..+|++||++.|+++.++.+....
T Consensus       226 ~~~~------------~------------------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~  272 (303)
T cd05110         226 KGER------------L------------------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP  272 (303)
T ss_pred             CCCC------------C------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence            0000            0                  000123356789999999999999999999999999886543

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=6.3e-35  Score=311.26  Aligned_cols=278  Identities=23%  Similarity=0.298  Sum_probs=200.0

Q ss_pred             HHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeecc--CcCcchhHHHHHHHHHhc-CCCceeeEeeeecCccccCC
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLL--HHGASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKGD  474 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~  474 (741)
                      +..+|++.+.||+|+||.||+|.+..+++.||+|.+...  .......+.+|+.+++++ +||||++++++|..   .+.
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~---~~~   81 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA---END   81 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc---CCC
Confidence            567899999999999999999999888999999988532  222344567899999999 99999999998642   234


Q ss_pred             ceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCce
Q 037916          475 DFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTA  554 (741)
Q Consensus       475 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~  554 (741)
                      ...|+||||++ ++|.+++..           ..+++..+..++.|++.||+|||+.   ||+||||||+||+++.++.+
T Consensus        82 ~~~~lv~e~~~-~~L~~~~~~-----------~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~  146 (337)
T cd07852          82 KDIYLVFEYME-TDLHAVIRA-----------NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRV  146 (337)
T ss_pred             ceEEEEecccc-cCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcE
Confidence            56899999996 599888752           2467788889999999999999999   99999999999999999999


Q ss_pred             EEeecccccccCCCCcc---cccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhh
Q 037916          555 HVADFGLAKLLPPAHLQ---TSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNF  631 (741)
Q Consensus       555 kL~DFg~a~~~~~~~~~---~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~  631 (741)
                      ||+|||.+.........   .......|+..|+|||.+.....++.++||||||+++|+|++|+.||....... .....
T Consensus       147 kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~-~~~~~  225 (337)
T cd07852         147 KLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN-QLEKI  225 (337)
T ss_pred             EEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH-HHHHH
Confidence            99999999866443221   122234588999999766666678899999999999999999999986321111 11111


Q ss_pred             hhhcCC-c-c-hhHh----hhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          632 ARTVLP-D-H-VMDI----VDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       632 ~~~~~~-~-~-~~~~----~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      ...... . . ...+    .+..+.....        .............+..+.+++.+||+.||++|||+.++++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         226 IEVIGPPSAEDIESIKSPFAATMLDSLPS--------RPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHhCCCCHHHHHHHHhhhHHHhhhhccc--------ccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            110000 0 0 0000    0000000000        00000011112245678999999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=3.7e-35  Score=302.75  Aligned_cols=254  Identities=24%  Similarity=0.389  Sum_probs=191.7

Q ss_pred             hcccCceeeEEEEEEcCCC------eEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          407 WIDMGSFGSVYKGILDEGK------TIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       407 ~ig~G~~g~V~~a~~~~~~------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      .||+|+||.||+|++....      ..||+|.+.... ......+.+|+.+++.++||||+++++++     ......++
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~   76 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVC-----LLNEPQYI   76 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeee-----cCCCCeEE
Confidence            5899999999999986433      689999886432 23456788999999999999999999985     34457899


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCC-----ce
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEM-----TA  554 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~-----~~  554 (741)
                      ||||+++++|.+++.......   .....+++.++..++.|++.||+|||+.   +++|+||||+||+++.++     .+
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~  150 (269)
T cd05044          77 IMELMEGGDLLSYLRDARVER---FGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVV  150 (269)
T ss_pred             EEeccCCCcHHHHHHHhhhcc---cCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcce
Confidence            999999999999986432111   0224478899999999999999999999   999999999999999877     89


Q ss_pred             EEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhh
Q 037916          555 HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFAR  633 (741)
Q Consensus       555 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~  633 (741)
                      ||+|||.+................++..|+||| +..++.++.++|||||||++|+|++ |..||.....  ....... 
T Consensus       151 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--~~~~~~~-  226 (269)
T cd05044         151 KIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPE-SLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN--QEVLQHV-  226 (269)
T ss_pred             EECCcccccccccccccccCcccCCCccccCHH-HHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH--HHHHHHH-
Confidence            999999987654332222222234567899995 4566778999999999999999998 9999862211  1111100 


Q ss_pred             hcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHH
Q 037916          634 TVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQ  704 (741)
Q Consensus       634 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  704 (741)
                                 ....                  ........+..+.+++.+||+.+|++||++.||++.|+
T Consensus       227 -----------~~~~------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         227 -----------TAGG------------------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             -----------hcCC------------------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence                       0000                  00011234567889999999999999999999999886

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.3e-35  Score=316.44  Aligned_cols=191  Identities=20%  Similarity=0.324  Sum_probs=160.1

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      ..|++++.||+|+||.||+|++..++..||+|+...      .....|+.++++++||||+++++++     ......++
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~l  134 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTL-----VSGAITCM  134 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheE-----EeCCeeEE
Confidence            469999999999999999999998899999998532      2335699999999999999999985     44567899


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      |||++ .++|.+++...         ...+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.+||+||
T Consensus       135 v~e~~-~~~l~~~l~~~---------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~Df  201 (357)
T PHA03209        135 VLPHY-SSDLYTYLTKR---------SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDL  201 (357)
T ss_pred             EEEcc-CCcHHHHHHhc---------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecC
Confidence            99999 46888887532         24578999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCC
Q 037916          560 GLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPS  618 (741)
Q Consensus       560 g~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~  618 (741)
                      |.++......   ......||+.|+||| +..+..++.++|||||||++|||+++..|+
T Consensus       202 G~a~~~~~~~---~~~~~~gt~~y~aPE-~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        202 GAAQFPVVAP---AFLGLAGTVETNAPE-VLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             ccccccccCc---ccccccccccccCCe-ecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            9987543221   112345899999995 555677899999999999999999865554

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=8.7e-35  Score=302.21  Aligned_cols=259  Identities=20%  Similarity=0.225  Sum_probs=197.1

Q ss_pred             HHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhc-CCCceeeEeeeecCccc-cCCc
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNI-RHKNLVKILTVCSGVDY-KGDD  475 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~-~~~~  475 (741)
                      .-+.|++.+.||.|+||.||+|.+..+++.||+|++.... .....+..|+.+++++ +||||+++++++..... ....
T Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   92 (282)
T cd06636          14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDD   92 (282)
T ss_pred             hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCC
Confidence            3468999999999999999999999899999999986432 2345677899999988 79999999998743211 2356


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..|++|||+++|+|.+++...+        ...+++..+..++.|++.|++|||+.   +|+||||||+||++++++.++
T Consensus        93 ~~~iv~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~  161 (282)
T cd06636          93 QLWLVMEFCGAGSVTDLVKNTK--------GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVK  161 (282)
T ss_pred             EEEEEEEeCCCCcHHHHHHHcc--------CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEE
Confidence            7899999999999999886431        13467788889999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcccccccccccccccCcccccC----CCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhh
Q 037916          556 VADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGL----GSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNF  631 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~----~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~  631 (741)
                      |+|||.+........  ......|+..|+|||.+..    ...++.++||||+||++|||++|..||....... .....
T Consensus       162 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~-~~~~~  238 (282)
T cd06636         162 LVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR-ALFLI  238 (282)
T ss_pred             EeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh-hhhhH
Confidence            999999875543211  1122458899999976542    3567889999999999999999999986321100 00000


Q ss_pred             hhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          632 ARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       632 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                                  .. ......                 ....++..+.+++.+||+.||++|||+.|+++
T Consensus       239 ------------~~-~~~~~~-----------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         239 ------------PR-NPPPKL-----------------KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             ------------hh-CCCCCC-----------------cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence                        00 000000                 00123457889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-35  Score=296.85  Aligned_cols=274  Identities=24%  Similarity=0.311  Sum_probs=197.1

Q ss_pred             hcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHh--cCCCceeeEeeeecCccccCCceEEEEEecc
Q 037916          407 WIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRN--IRHKNLVKILTVCSGVDYKGDDFKALVYEFM  484 (741)
Q Consensus       407 ~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~~~~~~~~~~~~~~~~~~lv~e~~  484 (741)
                      .||+|.||.||+|...  ++.||||++..   .....+++|-++.+.  ++|+||++++++-...+ .....+++|+||.
T Consensus       217 li~~Grfg~V~KaqL~--~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t-~~~~eywLVt~fh  290 (534)
T KOG3653|consen  217 LIGRGRFGCVWKAQLD--NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGT-ADRMEYWLVTEFH  290 (534)
T ss_pred             HhhcCccceeehhhcc--CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCC-ccccceeEEeeec
Confidence            3899999999999996  68999999963   445678888888765  58999999998732211 1234789999999


Q ss_pred             cCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcC------CCCceecCCCCCCeEeCCCCceEEee
Q 037916          485 HNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDC------QPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       485 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~------~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      +.|+|.+|++.           ..++|....+|+.-+++||+|||+..      +|+|+|||||..||||..|+++.|+|
T Consensus       291 ~kGsL~dyL~~-----------ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD  359 (534)
T KOG3653|consen  291 PKGSLCDYLKA-----------NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD  359 (534)
T ss_pred             cCCcHHHHHHh-----------ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence            99999999974           46899999999999999999999863      57899999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCC-----CccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhh
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVS-----INGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFAR  633 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~-----~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~  633 (741)
                      ||+|...............+||.+|||||.+-..-...     .+.||||+|.|+|||+++..-+..  ..-..+.-...
T Consensus       360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~--~~vp~Yqlpfe  437 (534)
T KOG3653|consen  360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADP--GPVPEYQLPFE  437 (534)
T ss_pred             cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccC--CCCCcccCchh
Confidence            99999887665555555578999999995442221222     458999999999999996543210  00011111111


Q ss_pred             hcCCc--chhHhh----hhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHH
Q 037916          634 TVLPD--HVMDIV----DSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIK  707 (741)
Q Consensus       634 ~~~~~--~~~~~~----d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  707 (741)
                      ..+..  ...++.    .+...+...           ..+..  -..+..+.+.+..||..||+.|.|+.=|.+++.++.
T Consensus       438 ~evG~hPt~e~mq~~VV~kK~RP~~p-----------~~W~~--h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~  504 (534)
T KOG3653|consen  438 AEVGNHPTLEEMQELVVRKKQRPKIP-----------DAWRK--HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM  504 (534)
T ss_pred             HHhcCCCCHHHHHHHHHhhccCCCCh-----------hhhhc--CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence            11111  011111    111110000           00000  033567889999999999999999999999999888


Q ss_pred             HhhcC
Q 037916          708 SILLG  712 (741)
Q Consensus       708 ~~~~~  712 (741)
                      .....
T Consensus       505 ~~~~~  509 (534)
T KOG3653|consen  505 MLWED  509 (534)
T ss_pred             ccCCc
Confidence            76654

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=4.4e-35  Score=307.02  Aligned_cols=275  Identities=20%  Similarity=0.199  Sum_probs=197.0

Q ss_pred             HHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcC-----cchhHHHHHHHHHhcCCCceeeEeeeecCccccCCce
Q 037916          402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG-----ASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      |.+.+.||+|+||.||+|.+..+++.||+|.++.....     ....+..|+.++++++|+||+++++++     .+...
T Consensus         2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~   76 (298)
T cd07841           2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVF-----GHKSN   76 (298)
T ss_pred             ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhhee-----ecCCE
Confidence            77888999999999999999888999999999754322     234567899999999999999999995     44668


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .++||||+ +++|.+++...         ...+++..+..++.||++||.|||+.   +|+||||||+||+++.++.+||
T Consensus        77 ~~lv~e~~-~~~L~~~i~~~---------~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l  143 (298)
T cd07841          77 INLVFEFM-ETDLEKVIKDK---------SIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKL  143 (298)
T ss_pred             EEEEEccc-CCCHHHHHhcc---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEE
Confidence            99999999 88999998643         12588999999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcC
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVL  636 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  636 (741)
                      +|||.+..........  ....+++.|+|||.+.....++.++||||+||++|||++|..||...... ..+........
T Consensus       144 ~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~-~~~~~~~~~~~  220 (298)
T cd07841         144 ADFGLARSFGSPNRKM--THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI-DQLGKIFEALG  220 (298)
T ss_pred             ccceeeeeccCCCccc--cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH-HHHHHHHHHcC
Confidence            9999998765432111  12346788999976655567889999999999999999997776532110 11111111100


Q ss_pred             CcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          637 PDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       637 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ......+.+.........    ...................+.+++.+||++||++|||+.|+++
T Consensus       221 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         221 TPTEENWPGVTSLPDYVE----FKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             CCchhhhhhccccccccc----ccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            000000000000000000    0000000001111234567889999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.5e-35  Score=300.04  Aligned_cols=255  Identities=27%  Similarity=0.432  Sum_probs=197.8

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      ...|++.+.||+|+||.||+|.+. ++..||+|.++... ...+++.+|+.++++++||||+++++++     ......+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   77 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVC-----SEEEPIY   77 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeee-----ecCCceE
Confidence            457889999999999999999986 56789999987432 3356788999999999999999999984     4455789


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      +||||+++++|.+++....        ...+++.++..++.|++.|+.|||+.   +++|+||||+||+++.++.+||+|
T Consensus        78 ~v~e~~~~~~L~~~i~~~~--------~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d  146 (261)
T cd05034          78 IVTEYMSKGSLLDFLKSGE--------GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIAD  146 (261)
T ss_pred             EEEeccCCCCHHHHHhccc--------cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECc
Confidence            9999999999999986431        23578899999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcCC
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      ||.+......... ......++..|+||| ...+..++.++||||+|+++|++++ |+.||...... ......... ..
T Consensus       147 ~g~~~~~~~~~~~-~~~~~~~~~~y~~PE-~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-~~~~~~~~~-~~  222 (261)
T cd05034         147 FGLARLIEDDEYT-AREGAKFPIKWTAPE-AANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR-EVLEQVERG-YR  222 (261)
T ss_pred             cccceeccchhhh-hhhccCCCccccCHH-HhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHcC-CC
Confidence            9998866542211 111223456899995 5556778999999999999999998 99998522110 000000000 00


Q ss_pred             cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHH
Q 037916          638 DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQS  705 (741)
Q Consensus       638 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  705 (741)
                                 ..                   .+...+..+.+++.+||+.+|++||+++|+.+.|+.
T Consensus       223 -----------~~-------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         223 -----------MP-------------------RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             -----------CC-------------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence                       00                   001224568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2.5e-35  Score=313.90  Aligned_cols=286  Identities=18%  Similarity=0.197  Sum_probs=201.7

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC--cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      ..|++.+.||+|+||.||+|.+..+++.||+|++....  ......+.+|+.++++++||||+++++++.... ......
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~   83 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKDV   83 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCceE
Confidence            56889999999999999999999999999999987432  233456778999999999999999998864322 344578


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      ++||||+. ++|.+++...          ..+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+
T Consensus        84 ~lv~e~~~-~~l~~~~~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~  149 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSD----------QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIG  149 (334)
T ss_pred             EEEEehhh-hhHHHHhccC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEec
Confidence            99999995 6898888532          4488999999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCccc--ccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhc
Q 037916          558 DFGLAKLLPPAHLQT--SSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV  635 (741)
Q Consensus       558 DFg~a~~~~~~~~~~--~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~  635 (741)
                      |||.+..........  ......|+..|+|||.+.....++.++||||+||++|+|++|+.||......  .........
T Consensus       150 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~--~~~~~~~~~  227 (334)
T cd07855         150 DFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV--HQLKLILSV  227 (334)
T ss_pred             ccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH--HHHHHHHHH
Confidence            999997654332211  1122458889999976655567899999999999999999999998632111  011111111


Q ss_pred             CCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          636 LPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       636 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      ......+.++.............................++.+.+++.+||+.||++|||+.|++..
T Consensus       228 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         228 LGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            1111111111000000000000000000000001112346778999999999999999999998874

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.8e-35  Score=307.08  Aligned_cols=251  Identities=20%  Similarity=0.247  Sum_probs=195.0

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      ..|.....||+|+||.||++.+..++..||+|.+........+.+.+|+.+++.++||||+++++.+     ..++..++
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~-----~~~~~~~l   96 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY-----LVGDELWV   96 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhe-----ecCCeEEE
Confidence            3456667899999999999999888999999998754444556788999999999999999999984     45568999


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      ||||+++++|.+++..           ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        97 v~e~~~~~~L~~~~~~-----------~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~df  162 (292)
T cd06658          97 VMEFLEGGALTDIVTH-----------TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDF  162 (292)
T ss_pred             EEeCCCCCcHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccC
Confidence            9999999999998742           2367888999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcc
Q 037916          560 GLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDH  639 (741)
Q Consensus       560 g~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  639 (741)
                      |.+.........  .....|+..|+||| +..+..++.++||||+|+++||+++|+.||.....  ...........+. 
T Consensus       163 g~~~~~~~~~~~--~~~~~~~~~y~aPE-~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--~~~~~~~~~~~~~-  236 (292)
T cd06658         163 GFCAQVSKEVPK--RKSLVGTPYWMAPE-VISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP--LQAMRRIRDNLPP-  236 (292)
T ss_pred             cchhhccccccc--CceeecCccccCHH-HHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhcCCC-
Confidence            998765432211  12245889999995 55666788999999999999999999999862111  0000000000000 


Q ss_pred             hhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          640 VMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       640 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                             ...                    ........+.+++.+||..||++|||+.|+++.
T Consensus       237 -------~~~--------------------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         237 -------RVK--------------------DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             -------ccc--------------------cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence                   000                    001223457789999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=8.6e-35  Score=304.01  Aligned_cols=279  Identities=20%  Similarity=0.202  Sum_probs=197.4

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc--CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      ..|++.+.||.|+||.||+|.+..+++.||+|.++....  .....+.+|+.++++++||||+++++++...   +....
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---~~~~~   81 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGS---NLDKI   81 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEec---CCCcE
Confidence            579999999999999999999998899999999974332  2233567899999999999999999986422   23689


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      |+||||++ ++|.+++...         ...+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+
T Consensus        82 ~lv~e~~~-~~L~~~~~~~---------~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~  148 (293)
T cd07843          82 YMVMEYVE-HDLKSLMETM---------KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKIC  148 (293)
T ss_pred             EEEehhcC-cCHHHHHHhc---------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEe
Confidence            99999996 5898887633         13578999999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCC
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      |||.+.........  .....+++.|+|||.+.....++.++||||+|+++|+|++|..||..... ...+.........
T Consensus       149 d~g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~-~~~~~~~~~~~~~  225 (293)
T cd07843         149 DFGLAREYGSPLKP--YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSE-IDQLNKIFKLLGT  225 (293)
T ss_pred             ecCceeeccCCccc--cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCC
Confidence            99999876544211  12244788999997665555678999999999999999999999863211 1111111111000


Q ss_pred             cc--hhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHH--HHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          638 DH--VMDIVDSTLLADDEDLTITSNQRQRQARINNIME--CLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       638 ~~--~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ..  ....+.........    ................  ..+.+.+++.+||+.||++|||+.|+++
T Consensus       226 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         226 PTEKIWPGFSELPGAKKK----TFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             CchHHHHHhhccchhccc----ccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            00  00000000000000    0000000000000011  3566889999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=5.5e-35  Score=299.27  Aligned_cols=250  Identities=23%  Similarity=0.325  Sum_probs=192.6

Q ss_pred             hhcccCceeeEEEEEEcC-CC--eEEEEEEeeccCc-CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEEE
Q 037916          406 CWIDMGSFGSVYKGILDE-GK--TIIAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVY  481 (741)
Q Consensus       406 ~~ig~G~~g~V~~a~~~~-~~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv~  481 (741)
                      +.||+|++|.||+|.+.. .+  ..||+|.++.... ...+.+.+|+.++++++||||+++++++.     + ...++||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~-~~~~~v~   74 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVL-----T-HPLMMVT   74 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEc-----C-CeEEEEE
Confidence            468999999999999854 23  3699999975444 44567889999999999999999999853     3 6789999


Q ss_pred             ecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeeccc
Q 037916          482 EFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGL  561 (741)
Q Consensus       482 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~  561 (741)
                      ||+++++|.+++....        ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||.
T Consensus        75 e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~  143 (257)
T cd05040          75 ELAPLGSLLDRLRKDA--------LGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGL  143 (257)
T ss_pred             EecCCCcHHHHHHhcc--------cccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccc
Confidence            9999999999987431        13578999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCc-ccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcCCcc
Q 037916          562 AKLLPPAHL-QTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVLPDH  639 (741)
Q Consensus       562 a~~~~~~~~-~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  639 (741)
                      +........ ........++..|+|| |...+..++.++|||||||++|+|++ |..||......     +.....    
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~y~~p-E~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~~~~~~----  213 (257)
T cd05040         144 MRALPQNEDHYVMEEHLKVPFAWCAP-ESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS-----QILKKI----  213 (257)
T ss_pred             cccccccccceecccCCCCCceecCH-HHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHH----
Confidence            987654321 1111224467889999 55566778999999999999999998 99998522111     000000    


Q ss_pred             hhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHH
Q 037916          640 VMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQ  704 (741)
Q Consensus       640 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  704 (741)
                           .....                 ........+..+.+++.+||+.+|++|||+.|+++.|.
T Consensus       214 -----~~~~~-----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         214 -----DKEGE-----------------RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             -----HhcCC-----------------cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence                 00000                 00001123466889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=3.2e-35  Score=312.55  Aligned_cols=201  Identities=23%  Similarity=0.259  Sum_probs=167.6

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeecc---CcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLL---HHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      .|++.+.||+|+||.||++++..+++.||+|++...   .......+..|+.++..++|++|+++++++     .+....
T Consensus         2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~   76 (332)
T cd05623           2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF-----QDENNL   76 (332)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecCCEE
Confidence            477889999999999999999989999999998632   122234567889999999999999999984     556689


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      |+||||+++|+|.+++...         ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+
T Consensus        77 ~lv~ey~~~g~L~~~l~~~---------~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~  144 (332)
T cd05623          77 YLVMDYYVGGDLLTLLSKF---------EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLA  144 (332)
T ss_pred             EEEEeccCCCcHHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEe
Confidence            9999999999999998642         13478888899999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccccccCccccc----CCCCCCCccCchhHHHHHHHHHcCCCCCC
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG----LGSEVSINGDVYSYGILLLELMTRKRPSD  619 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~----~~~~~~~~~DIwSlG~il~elltg~~p~~  619 (741)
                      |||++......... ......||+.|+|||.+.    ....++.++|||||||++|||++|+.||.
T Consensus       145 DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~  209 (332)
T cd05623         145 DFGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY  209 (332)
T ss_pred             ecchheecccCCcc-eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCC
Confidence            99998755332221 112245899999996553    23568899999999999999999999986

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2e-35  Score=314.83  Aligned_cols=290  Identities=20%  Similarity=0.195  Sum_probs=202.9

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeecc--CcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLL--HHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      ..|.+.+.||+|+||.||+|.+..+++.||+|.++..  .......+.+|+.+++.++||||+++++++...........
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   84 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV   84 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence            4688899999999999999999999999999998642  22234566789999999999999999998654332333468


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      |+||||+. ++|.+++...          ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+
T Consensus        85 ~lv~e~~~-~~L~~~~~~~----------~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~  150 (337)
T cd07858          85 YIVYELMD-TDLHQIIRSS----------QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKIC  150 (337)
T ss_pred             EEEEeCCC-CCHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEC
Confidence            99999994 6898888533          4588899999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCC
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      |||.+........  ......++..|+|||.+.....++.++||||+||++|+|++|+.||.....  ............
T Consensus       151 Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~  226 (337)
T cd07858         151 DFGLARTTSEKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY--VHQLKLITELLG  226 (337)
T ss_pred             cCccccccCCCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHHHhC
Confidence            9999986644321  112245788999997665556689999999999999999999999863211  000000110000


Q ss_pred             cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH--HHHHH
Q 037916          638 DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE--LQSIK  707 (741)
Q Consensus       638 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i~  707 (741)
                      ....+..+............................+...+.+++.+||+.||++|||+.|+++.  ++.+.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~  298 (337)
T cd07858         227 SPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH  298 (337)
T ss_pred             CCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence            00000000000000000000000000000001112456778999999999999999999999977  65543

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=6.2e-35  Score=304.77  Aligned_cols=261  Identities=23%  Similarity=0.271  Sum_probs=197.2

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhc-CCCceeeEeeeecCccccCCceE
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      ...|.+.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++++ +|||++++++++...+.......
T Consensus        21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~   99 (291)
T cd06639          21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL   99 (291)
T ss_pred             CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence            356889999999999999999999899999999986422 2345677899999998 89999999999754333334578


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      ++||||+++++|.++++...      .....+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+
T Consensus       100 ~lv~ey~~~~sL~~~~~~~~------~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~  170 (291)
T cd06639         100 WLVLELCNGGSVTELVKGLL------ICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLV  170 (291)
T ss_pred             EEEEEECCCCcHHHHHHHhh------hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEe
Confidence            99999999999999885321      1124578889999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccccccCcccccCC----CCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhh
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLG----SEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFAR  633 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~----~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~  633 (741)
                      |||.+..........  ....|+..|+|||.+...    ..++.++||||+||++|||++|+.||....... .+.....
T Consensus       171 dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~-~~~~~~~  247 (291)
T cd06639         171 DFGVSAQLTSTRLRR--NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK-TLFKIPR  247 (291)
T ss_pred             ecccchhcccccccc--cCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH-HHHHHhc
Confidence            999988654332211  224578899999654332    236899999999999999999999986321110 0000000


Q ss_pred             hcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          634 TVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       634 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      .. ..   .+                         ....+....+.+++.+||+.||++||++.|+++
T Consensus       248 ~~-~~---~~-------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         248 NP-PP---TL-------------------------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             CC-CC---CC-------------------------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            00 00   00                         001123346889999999999999999999975

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=4.6e-35  Score=306.28  Aligned_cols=252  Identities=21%  Similarity=0.238  Sum_probs=196.5

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      ...|....+||+|+||.||+|.+..+++.||+|+++.......+.+.+|+.+++.++||||+++++++     ..+...+
T Consensus        20 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~   94 (297)
T cd06659          20 RSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY-----LVGEELW   94 (297)
T ss_pred             hhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhhe-----eeCCeEE
Confidence            34566777899999999999999888999999999755445556788999999999999999999984     4566899


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      ++|||+++++|.+++..           ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|
T Consensus        95 iv~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~d  160 (297)
T cd06659          95 VLMEFLQGGALTDIVSQ-----------TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSD  160 (297)
T ss_pred             EEEecCCCCCHHHHHhh-----------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEee
Confidence            99999999999987742           3478889999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCc
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      ||.+........  ......|+..|+||| +..+..++.++||||+||++|||++|+.||.....  .............
T Consensus       161 fg~~~~~~~~~~--~~~~~~~~~~y~aPE-~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~  235 (297)
T cd06659         161 FGFCAQISKDVP--KRKSLVGTPYWMAPE-VISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP--VQAMKRLRDSPPP  235 (297)
T ss_pred             chhHhhcccccc--cccceecCccccCHH-HHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhccCCC
Confidence            999875543321  112245889999995 55566789999999999999999999999862211  0000000000000


Q ss_pred             chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          639 HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       639 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      .        ..                    ........+.+++.+||+.+|++||++.|+++.
T Consensus       236 ~--------~~--------------------~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         236 K--------LK--------------------NAHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             C--------cc--------------------ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            0        00                    001223457799999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-34  Score=300.60  Aligned_cols=249  Identities=22%  Similarity=0.286  Sum_probs=195.9

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC-cCcchhHHHHHHHHHhcC---CCceeeEeeeecCccccCCce
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH-HGASKSSIAECSALRNIR---HKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      .|++.+.||+|+||.||+|.+..+++.||+|.++... ....+.+.+|+.++++++   |||++++++++     ..+..
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~-----~~~~~   76 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSY-----LKGPR   76 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeee-----eeCCE
Confidence            4888999999999999999998899999999987432 233456788999999986   99999999985     44568


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .++||||+++++|.+++..           ..+++..+..++.|++.||.|||+.   +|+||||+|+||+++.++.++|
T Consensus        77 ~~lv~e~~~~~~L~~~~~~-----------~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l  142 (277)
T cd06917          77 LWIIMEYAEGGSVRTLMKA-----------GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKL  142 (277)
T ss_pred             EEEEEecCCCCcHHHHHHc-----------cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEE
Confidence            8999999999999998752           2478889999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcC
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVL  636 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  636 (741)
                      +|||.+.........  .....|+..|+|||.+..+..++.++|||||||++|+|++|..||......     .......
T Consensus       143 ~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-----~~~~~~~  215 (277)
T cd06917         143 CDFGVAALLNQNSSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-----RAMMLIP  215 (277)
T ss_pred             ccCCceeecCCCccc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-----hhhhccc
Confidence            999999876544321  222458889999976655666889999999999999999999998632110     0000000


Q ss_pred             CcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          637 PDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       637 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ....     +.+..                     ...+..+.+++.+||+.||++||++.|+++
T Consensus       216 ~~~~-----~~~~~---------------------~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         216 KSKP-----PRLED---------------------NGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             cCCC-----CCCCc---------------------ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            0000     00000                     013456789999999999999999999986

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=5.8e-35  Score=298.93  Aligned_cols=250  Identities=20%  Similarity=0.265  Sum_probs=196.7

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC--cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      +|++.+.||+|+||.||.+.+..+++.||+|.+....  ....+.+.+|+.++++++||||++++++     +....+.+
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~-----~~~~~~~~   75 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES-----FEENGNLY   75 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEee-----ecCCCeEE
Confidence            3788899999999999999999899999999987432  2234577889999999999999999998     45566899


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      +||||+.+++|.+++....        ...+++.++..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|
T Consensus        76 lv~e~~~~~~l~~~~~~~~--------~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d  144 (256)
T cd08218          76 IVMDYCEGGDLYKKINAQR--------GVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGD  144 (256)
T ss_pred             EEEecCCCCcHHHHHHhcc--------CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEee
Confidence            9999999999999886421        13467888999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCc
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      ||.+.........  .....|++.|+|| |+..+..++.++|||||||++|++++|+.||....     .          
T Consensus       145 ~~~~~~~~~~~~~--~~~~~~~~~~~~p-e~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-----~----------  206 (256)
T cd08218         145 FGIARVLNSTVEL--ARTCIGTPYYLSP-EICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN-----M----------  206 (256)
T ss_pred             ccceeecCcchhh--hhhccCCccccCH-HHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC-----H----------
Confidence            9999765443211  1123478899999 55566778899999999999999999999985211     1          


Q ss_pred             chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          639 HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       639 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                        .+.++....+...               ..+......+.+++.+||+.+|++||++.||++
T Consensus       207 --~~~~~~~~~~~~~---------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         207 --KNLVLKIIRGSYP---------------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             --HHHHHHHhcCCCC---------------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence              1111111111110               001133566889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-35  Score=301.90  Aligned_cols=261  Identities=22%  Similarity=0.289  Sum_probs=199.7

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhc-CCCceeeEeeeecCccc-cCCce
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNI-RHKNLVKILTVCSGVDY-KGDDF  476 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~-~~~~~  476 (741)
                      ..+|++.+.||+|++|.||+|.+..+++.||+|++..... ..+.+.+|+.+++++ +||||+++++++..... .....
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ   83 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence            4689999999999999999999988899999999875332 346788999999999 79999999999754332 23557


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .++||||+++++|.+++....      .....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l  154 (275)
T cd06608          84 LWLVMELCGGGSVTDLVKGLR------KKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKL  154 (275)
T ss_pred             EEEEEEcCCCCcHHHHHHHHh------hcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEE
Confidence            899999999999999886431      1124578889999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccC----CCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhh
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGL----GSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFA  632 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~----~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~  632 (741)
                      +|||.+.........  .....|+..|+|||.+..    ...++.++||||+||++|++++|..||...... ....+..
T Consensus       155 ~d~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~  231 (275)
T cd06608         155 VDFGVSAQLDSTLGR--RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-RALFKIP  231 (275)
T ss_pred             CCCccceecccchhh--hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-HHHHHhh
Confidence            999998765433211  122458889999965432    345788999999999999999999998632111 0111100


Q ss_pred             hhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          633 RTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       633 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ....+                             ...........+.+++.+||..||++|||+.|+++
T Consensus       232 ~~~~~-----------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         232 RNPPP-----------------------------TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             ccCCC-----------------------------CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            00000                             00001124567889999999999999999999975

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=7.6e-35  Score=296.92  Aligned_cols=247  Identities=26%  Similarity=0.336  Sum_probs=188.5

Q ss_pred             hhcccCceeeEEEEEEcCCCeEEEEEEeeccCc-CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEEEecc
Q 037916          406 CWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFM  484 (741)
Q Consensus       406 ~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv~e~~  484 (741)
                      +.||+|+||.||+|... ++..||+|+++.... .....+.+|+.++++++||||+++++++     ......++||||+
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~   74 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC-----TQRQPIYIVMELV   74 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEE-----ecCCccEEEEECC
Confidence            36899999999999876 688899999864322 2234678899999999999999999995     3445789999999


Q ss_pred             cCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecccccc
Q 037916          485 HNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKL  564 (741)
Q Consensus       485 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~a~~  564 (741)
                      ++++|.+++...         ...+++..+..++.|++.||.|+|+.   +++||||||+||+++.++.+||+|||.+..
T Consensus        75 ~~~~L~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~  142 (250)
T cd05085          75 PGGDFLSFLRKK---------KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQ  142 (250)
T ss_pred             CCCcHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCcccee
Confidence            999999988532         13467889999999999999999999   999999999999999999999999999875


Q ss_pred             cCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcCCcchhHh
Q 037916          565 LPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVLPDHVMDI  643 (741)
Q Consensus       565 ~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  643 (741)
                      ........ .....++..|+||| +..+..++.++||||||+++|++++ |..||......     .....         
T Consensus       143 ~~~~~~~~-~~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~-----~~~~~---------  206 (250)
T cd05085         143 EDDGIYSS-SGLKQIPIKWTAPE-ALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-----QAREQ---------  206 (250)
T ss_pred             cccccccc-CCCCCCcccccCHH-HhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH-----HHHHH---------
Confidence            44322111 11123466799995 5566778999999999999999998 99998632111     00000         


Q ss_pred             hhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHH
Q 037916          644 VDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQ  704 (741)
Q Consensus       644 ~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  704 (741)
                      +.......                  .+..++..+.+++.+||+.+|++|||+.|+++.|.
T Consensus       207 ~~~~~~~~------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         207 VEKGYRMS------------------CPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             HHcCCCCC------------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            00000000                  01123467889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1e-34  Score=299.26  Aligned_cols=247  Identities=22%  Similarity=0.267  Sum_probs=188.7

Q ss_pred             hhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEEEeccc
Q 037916          406 CWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMH  485 (741)
Q Consensus       406 ~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv~e~~~  485 (741)
                      ..||+|+||.||+|.+..++..||+|.+........+.+.+|+.++++++|+||+++++++     ..+...++||||++
T Consensus        14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~~   88 (268)
T cd06624          14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD-----SENGFFKIFMEQVP   88 (268)
T ss_pred             EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeee-----ccCCEEEEEEecCC
Confidence            4699999999999999888999999998755444556788999999999999999999985     44568999999999


Q ss_pred             CCChhhhccCCCCCCcccCccccc--CHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCC-CCceEEeecccc
Q 037916          486 NGSLEEWLHPVSGADKTVEAPKCL--NFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDH-EMTAHVADFGLA  562 (741)
Q Consensus       486 ~gsL~~~l~~~~~~~~~~~~~~~~--~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~-~~~~kL~DFg~a  562 (741)
                      +++|.+++....         ..+  ++..+..++.|++.||+|||+.   +|+||||||+||+++. ++.+||+|||.+
T Consensus        89 ~~~L~~~l~~~~---------~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~  156 (268)
T cd06624          89 GGSLSALLRSKW---------GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTS  156 (268)
T ss_pred             CCCHHHHHHHhc---------ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhh
Confidence            999999986321         123  6778888999999999999999   9999999999999976 679999999998


Q ss_pred             cccCCCCcccccccccccccccCcccccCC-CCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcchh
Q 037916          563 KLLPPAHLQTSSIGVKGTIGYIAPAEYGLG-SEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM  641 (741)
Q Consensus       563 ~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~-~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  641 (741)
                      ........  ......|++.|+|||.+... ..++.++||||+|+++|++++|..||.........  .+......    
T Consensus       157 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~--~~~~~~~~----  228 (268)
T cd06624         157 KRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA--MFKVGMFK----  228 (268)
T ss_pred             eecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh--Hhhhhhhc----
Confidence            76543221  11223478899999655332 34789999999999999999999998632111000  00000000    


Q ss_pred             HhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          642 DIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       642 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                               ..               ...+....+.+.+++.+||+.+|++|||+.|+++
T Consensus       229 ---------~~---------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         229 ---------IH---------------PEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             ---------cC---------------CCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence                     00               0001133456789999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=8.2e-35  Score=299.71  Aligned_cols=259  Identities=22%  Similarity=0.278  Sum_probs=199.8

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      .|++.+.||.|+||.||+|....++..||+|++.... ....+.+.+|+.+++.++|+||+++++.+     ..+...++
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~i   76 (267)
T cd06610           2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF-----VVGDELWL   76 (267)
T ss_pred             cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEE-----eeCCEEEE
Confidence            4788999999999999999998889999999986432 22456788999999999999999999984     45668999


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      |||++++++|.+++....       ....+++..+..++.|++.||+|||+.   |++||||+|+||++++++.+||+||
T Consensus        77 v~e~~~~~~l~~~~~~~~-------~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df  146 (267)
T cd06610          77 VMPYLSGGSLLDIMKSSY-------PRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADF  146 (267)
T ss_pred             EEeccCCCcHHHHHHHhc-------ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccc
Confidence            999999999999986431       123578889999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCccc--ccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCC
Q 037916          560 GLAKLLPPAHLQT--SSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       560 g~a~~~~~~~~~~--~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      |.+..........  ......|+..|+|||.+.....++.++|||||||++|+|++|+.||...... ..+....... +
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-~~~~~~~~~~-~  224 (267)
T cd06610         147 GVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM-KVLMLTLQND-P  224 (267)
T ss_pred             chHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh-hhHHHHhcCC-C
Confidence            9987766543221  2223458899999966555547899999999999999999999998632111 0111111100 0


Q ss_pred             cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          638 DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       638 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      .        ......                 .....+..+.+++.+||..||++|||+.|+++
T Consensus       225 ~--------~~~~~~-----------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         225 P--------SLETGA-----------------DYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             C--------CcCCcc-----------------ccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            0        000000                 01134567889999999999999999999975

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.1e-34  Score=298.63  Aligned_cols=252  Identities=19%  Similarity=0.253  Sum_probs=189.9

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc-----CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH-----GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      .|++.+.||+|+||.||+|.+..++..||+|+++....     .....+.+|+.++++++||||+++++++..   ....
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~   79 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRD---RAEK   79 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc---CCCC
Confidence            47888999999999999999988899999999864321     123457789999999999999999998532   2245


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..+++|||+++++|.+++...          ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+|
T Consensus        80 ~~~l~~e~~~~~~L~~~l~~~----------~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~  146 (266)
T cd06651          80 TLTIFMEYMPGGSVKDQLKAY----------GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVK  146 (266)
T ss_pred             EEEEEEeCCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEE
Confidence            789999999999999998633          3467888899999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcc-cccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhh
Q 037916          556 VADFGLAKLLPPAHLQ-TSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~-~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  634 (741)
                      |+|||.+......... .......++..|+||| ...+..++.++||||+||++||+++|+.||.....    .....  
T Consensus       147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~----~~~~~--  219 (266)
T cd06651         147 LGDFGASKRLQTICMSGTGIRSVTGTPYWMSPE-VISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA----MAAIF--  219 (266)
T ss_pred             EccCCCccccccccccCCccccCCccccccCHH-HhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch----HHHHH--
Confidence            9999998765432111 1112245788999995 44567789999999999999999999999863211    00000  


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                             ..........                  .+....+.+.+++ +||..+|++|||++||++
T Consensus       220 -------~~~~~~~~~~------------------~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         220 -------KIATQPTNPQ------------------LPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             -------HHhcCCCCCC------------------CchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence                   0000000000                  0112234456666 688899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1e-34  Score=300.18  Aligned_cols=265  Identities=24%  Similarity=0.353  Sum_probs=195.3

Q ss_pred             HHHhhhcccCceeeEEEEEEc---CCCeEEEEEEeeccC--cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccC-Cc
Q 037916          402 FLFLCWIDMGSFGSVYKGILD---EGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKG-DD  475 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~-~~  475 (741)
                      |.+.+.||+|+||.||+|.+.   .+++.||+|+++...  ....+++.+|+.++++++||||+++++++......+ ..
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567889999999999999864   357899999986432  223456788999999999999999999864322111 12


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..++++||+.+|+|.+++......    .....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+|
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~----~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~k  153 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIG----EEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVC  153 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhccc----CCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEE
Confidence            357899999999998887432111    1113478888999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhh
Q 037916          556 VADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  634 (741)
                      |+|||.++...............+++.|++|| ......++.++|||||||++|++++ |+.||.....  .........
T Consensus       154 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe-~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~~~~~~~~  230 (273)
T cd05074         154 VADFGLSKKIYSGDYYRQGCASKLPVKWLALE-SLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEIYNYLIK  230 (273)
T ss_pred             ECcccccccccCCcceecCCCccCchhhcCHh-HHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HHHHHHHHc
Confidence            99999998665433222222234567899995 4456678899999999999999999 8888752211  111111100


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHH
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSI  706 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  706 (741)
                      ...          ..                    ....++..+.+++.+||+.+|++|||+.|+++.|+++
T Consensus       231 ~~~----------~~--------------------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         231 GNR----------LK--------------------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CCc----------CC--------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            000          00                    0012345788999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-35  Score=308.18  Aligned_cols=209  Identities=23%  Similarity=0.275  Sum_probs=169.2

Q ss_pred             HHHHhhhcccCceeeEEEEEEcC--CCeEEEEEEeeccC---cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDE--GKTIIAVKVLNLLH---HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      +|.+.++||+|+||.||+|.+..  +++.||+|.+....   ....+...+|+.++++++||||+++++++..   ....
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~   77 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLE---HADK   77 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeC---CCCc
Confidence            37788999999999999999987  78999999997532   3445677889999999999999999999642   2236


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCC----C
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDH----E  551 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~----~  551 (741)
                      ..++||||++ +++.+++......     ....+++..+..++.|++.||+|||+.   +|+||||||+||+++.    +
T Consensus        78 ~~~lv~e~~~-~~l~~~~~~~~~~-----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~  148 (316)
T cd07842          78 SVYLLFDYAE-HDLWQIIKFHRQA-----KRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPER  148 (316)
T ss_pred             eEEEEEeCCC-cCHHHHHHhhccC-----CCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCcc
Confidence            8999999996 4777766432111     113578889999999999999999999   9999999999999999    8


Q ss_pred             CceEEeecccccccCCCCc-ccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCcc
Q 037916          552 MTAHVADFGLAKLLPPAHL-QTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIM  621 (741)
Q Consensus       552 ~~~kL~DFg~a~~~~~~~~-~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~  621 (741)
                      +.+||+|||.+........ ........++..|+|||.+.....++.++|||||||++|+|++|+.||...
T Consensus       149 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~  219 (316)
T cd07842         149 GVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGR  219 (316)
T ss_pred             ceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence            9999999999987654322 112223457889999976655567899999999999999999999999744

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=3.6e-35  Score=311.84  Aligned_cols=201  Identities=23%  Similarity=0.276  Sum_probs=168.2

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      .|.+.+.||+|+||.||++++..+++.||+|+++...   ......+.+|..+++.++|++|++++++     +.+.+..
T Consensus         2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~-----~~~~~~~   76 (331)
T cd05624           2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYA-----FQDENYL   76 (331)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEE-----EEcCCEE
Confidence            4788999999999999999999999999999986421   2233456788999999999999999998     4556789


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      |+||||+++|+|.+++...         ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        77 ~lv~Ey~~gg~L~~~l~~~---------~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~  144 (331)
T cd05624          77 YLVMDYYVGGDLLTLLSKF---------EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLA  144 (331)
T ss_pred             EEEEeCCCCCcHHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEE
Confidence            9999999999999998642         13578888899999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccccccCcccccCC----CCCCCccCchhHHHHHHHHHcCCCCCC
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLG----SEVSINGDVYSYGILLLELMTRKRPSD  619 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~----~~~~~~~DIwSlG~il~elltg~~p~~  619 (741)
                      |||++.......... .....||+.|+|||.+...    ..++.++||||+||++|+|++|+.||.
T Consensus       145 DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~  209 (331)
T cd05624         145 DFGSCLKMNQDGTVQ-SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY  209 (331)
T ss_pred             eccceeeccCCCcee-eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCcc
Confidence            999997665432211 1224589999999654321    467899999999999999999999986

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=8.2e-35  Score=298.03  Aligned_cols=251  Identities=27%  Similarity=0.440  Sum_probs=195.1

Q ss_pred             HHhhhcccCceeeEEEEEEcCCC----eEEEEEEeeccCcC-cchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceE
Q 037916          403 LFLCWIDMGSFGSVYKGILDEGK----TIIAVKVLNLLHHG-ASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       403 ~~~~~ig~G~~g~V~~a~~~~~~----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      ++.+.||.|+||.||+|.+...+    ..||+|+++..... ..+.+..|+..++.++|+||+++++++     ......
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~   76 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVC-----TEEEPL   76 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEE-----cCCCee
Confidence            46788999999999999998665    89999999754332 456788999999999999999999995     344689


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      +++|||+++++|.+++....        ...+++.++..++.|++.||+|||+.   +++||||||+||+++.++.++|+
T Consensus        77 ~~i~e~~~~~~l~~~~~~~~--------~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~  145 (258)
T smart00219       77 MIVMEYMEGGDLLDYLRKNR--------PKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKIS  145 (258)
T ss_pred             EEEEeccCCCCHHHHHHhhh--------hccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEc
Confidence            99999999999999986431        11178999999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcC
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVL  636 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~  636 (741)
                      |||.+............ ...+++.|+|||.. .+..++.++||||+|+++|+|++ |..||...     ..........
T Consensus       146 dfg~~~~~~~~~~~~~~-~~~~~~~y~~Pe~~-~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~-----~~~~~~~~~~  218 (258)
T smart00219      146 DFGLSRDLYDDDYYKKK-GGKLPIRWMAPESL-KDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM-----SNEEVLEYLK  218 (258)
T ss_pred             ccCCceecccccccccc-cCCCcccccChHHh-ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHh
Confidence            99999876654322221 22367899999554 66778999999999999999998 78887531     1111111000


Q ss_pred             CcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHH
Q 037916          637 PDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHEL  703 (741)
Q Consensus       637 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  703 (741)
                      ...        ..                   ......+..+.+++.+||+.||++|||+.|+++.|
T Consensus       219 ~~~--------~~-------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      219 KGY--------RL-------------------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             cCC--------CC-------------------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            000        00                   00112356688999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=5.8e-35  Score=303.87  Aligned_cols=275  Identities=24%  Similarity=0.257  Sum_probs=194.9

Q ss_pred             HHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC--cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      |++++.||.|++|.||+|.+..+++.||+|.++...  ......+.+|++++++++||||+++++++     .++...++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~~   76 (284)
T cd07860           2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLYL   76 (284)
T ss_pred             ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhc-----ccCCcEEE
Confidence            778899999999999999999899999999986432  22235678999999999999999999984     45668999


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      ||||+. ++|.+++...        ....+++..+..++.|++.||+|||+.   +++||||+|+||+++.++.+||+||
T Consensus        77 v~e~~~-~~l~~~~~~~--------~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~df  144 (284)
T cd07860          77 VFEFLH-QDLKKFMDAS--------PLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADF  144 (284)
T ss_pred             Eeeccc-cCHHHHHHhC--------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeec
Confidence            999995 6888887543        124578889999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCc-
Q 037916          560 GLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPD-  638 (741)
Q Consensus       560 g~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-  638 (741)
                      |.+.........  .....++..|+|||.+.....++.++|||||||++|+|++|+.||...... ....+........ 
T Consensus       145 g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~  221 (284)
T cd07860         145 GLARAFGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-DQLFRIFRTLGTPD  221 (284)
T ss_pred             cchhhcccCccc--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCCC
Confidence            998765433211  122346889999976655556789999999999999999999998632111 1111111110000 


Q ss_pred             c-hhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          639 H-VMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       639 ~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      . ....+...  ....   .....................+.+++.+||+.||++|||++|+++
T Consensus       222 ~~~~~~~~~~--~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         222 EVVWPGVTSL--PDYK---PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             hhhhhhhhHH--HHHH---hhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            0 00000000  0000   000000000000011123456789999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=6.4e-35  Score=302.02  Aligned_cols=263  Identities=21%  Similarity=0.332  Sum_probs=197.5

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcC-----CCeEEEEEEeeccCcC-cchhHHHHHHHHHhcCCCceeeEeeeecCccccC
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDE-----GKTIIAVKVLNLLHHG-ASKSSIAECSALRNIRHKNLVKILTVCSGVDYKG  473 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  473 (741)
                      ..|++++.||+|+||.||+|+.+.     +.+.||+|.+...... ..+.+.+|+.++++++||||+++++++     .+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~   79 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLC-----RE   79 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEE-----CC
Confidence            568889999999999999999753     4567999988643332 346788999999999999999999985     44


Q ss_pred             CceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCc
Q 037916          474 DDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMT  553 (741)
Q Consensus       474 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~  553 (741)
                      ....++||||+++++|.+++........ ......+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~-~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~  155 (275)
T cd05046          80 AEPHYMILEYTDLGDLKQFLRATKSKDE-KLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQRE  155 (275)
T ss_pred             CCcceEEEEecCCCcHHHHHHhcccccc-cccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCc
Confidence            5578999999999999999875421110 01123589999999999999999999999   9999999999999999999


Q ss_pred             eEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhh
Q 037916          554 AHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFA  632 (741)
Q Consensus       554 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~  632 (741)
                      ++++|||.+......... ......++..|+||| ...+..++.++||||+|+++|++++ |..||......     ...
T Consensus       156 ~~l~~~~~~~~~~~~~~~-~~~~~~~~~~y~~PE-~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~-----~~~  228 (275)
T cd05046         156 VKVSLLSLSKDVYNSEYY-KLRNALIPLRWLAPE-AVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE-----EVL  228 (275)
T ss_pred             EEEcccccccccCccccc-ccCCceeEEeecChh-hhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH-----HHH
Confidence            999999998754332211 122234677899995 4455668899999999999999998 78887522110     111


Q ss_pred             hhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHH
Q 037916          633 RTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQ  704 (741)
Q Consensus       633 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  704 (741)
                      .......        ..                  ......++..+.+++.+||+.||++|||+.|+++.|.
T Consensus       229 ~~~~~~~--------~~------------------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         229 NRLQAGK--------LE------------------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             HHHHcCC--------cC------------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            1000000        00                  0001133467889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.2e-34  Score=296.56  Aligned_cols=251  Identities=25%  Similarity=0.388  Sum_probs=193.8

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      ..|++.+.||+|+||.||+|.+. .+..+|+|.++... .....+.+|+.++++++||+|+++++++     ......++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~   76 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVC-----TERSPICL   76 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEE-----ccCCceEE
Confidence            46888999999999999999886 46789999886432 2345788999999999999999999984     44557899


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      ||||+++++|.+++...         ...+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+||
T Consensus        77 v~e~~~~~~L~~~~~~~---------~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~  144 (256)
T cd05112          77 VFEFMEHGCLSDYLRAQ---------RGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDF  144 (256)
T ss_pred             EEEcCCCCcHHHHHHhC---------ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCC
Confidence            99999999999988633         13468888999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcCCc
Q 037916          560 GLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       560 g~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      |.+......... ......++..|+||| ...+..++.++||||+|+++||+++ |..||.....     ..........
T Consensus       145 g~~~~~~~~~~~-~~~~~~~~~~~~aPe-~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----~~~~~~~~~~  217 (256)
T cd05112         145 GMTRFVLDDQYT-SSTGTKFPVKWSSPE-VFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-----SEVVETINAG  217 (256)
T ss_pred             cceeecccCccc-ccCCCccchhhcCHh-HhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-----HHHHHHHhCC
Confidence            998765433221 111223567899995 4456778899999999999999998 9999863211     1111110000


Q ss_pred             chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHH
Q 037916          639 HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHEL  703 (741)
Q Consensus       639 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  703 (741)
                               .....                  +...+..+.+++.+||+.+|++|||+.|+++.|
T Consensus       218 ---------~~~~~------------------~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         218 ---------FRLYK------------------PRLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             ---------CCCCC------------------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence                     00000                  001235688999999999999999999999887

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=9.1e-35  Score=297.73  Aligned_cols=249  Identities=24%  Similarity=0.295  Sum_probs=194.2

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc-----CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH-----GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      +|+..+.||+|+||.||+|....++..||+|.+.....     ...+.+.+|+.+++.++||||+++++++     ..+.
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~   75 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE-----REED   75 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE-----ecCC
Confidence            36778899999999999999988899999999874332     2345678899999999999999999984     4556


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..+++|||+++++|.+++...          ..+++..+..++.|++.|++|||+.   +|+|+||+|+||+++.++.+|
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~k  142 (258)
T cd06632          76 NLYIFLELVPGGSLAKLLKKY----------GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVK  142 (258)
T ss_pred             eEEEEEEecCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEE
Confidence            899999999999999998633          3477888899999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhc
Q 037916          556 VADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV  635 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~  635 (741)
                      |+|||.+.......   ......|+..|+|||.+.....++.++|+||+||++|++++|+.||.....    ......  
T Consensus       143 l~d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~----~~~~~~--  213 (258)
T cd06632         143 LADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG----VAAVFK--  213 (258)
T ss_pred             EccCccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH----HHHHHH--
Confidence            99999987654432   112345889999996654433488999999999999999999999863221    000000  


Q ss_pred             CCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          636 LPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       636 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                             ........                  ..+....+.+.+++.+||+.+|++|||+.|+++
T Consensus       214 -------~~~~~~~~------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         214 -------IGRSKELP------------------PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             -------HHhcccCC------------------CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence                   00000000                  001123456788999999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=6.2e-35  Score=300.34  Aligned_cols=253  Identities=23%  Similarity=0.314  Sum_probs=197.0

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc-CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      .|++.+.||+|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.++++++||||+++++++     ......++
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~l   76 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF-----YNNGDISI   76 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheee-----ecCCEEEE
Confidence            47889999999999999999998999999999875432 3345678899999999999999999985     44568999


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHh-cCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH-DCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      +|||+++++|.+++...         ...+++..+..++.|++.|++|+|+ .   +++||||||+||++++++.+||+|
T Consensus        77 v~e~~~~~~L~~~~~~~---------~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d  144 (265)
T cd06605          77 CMEYMDGGSLDKILKEV---------QGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCD  144 (265)
T ss_pred             EEEecCCCcHHHHHHHc---------cCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEee
Confidence            99999999999998643         1457888889999999999999999 8   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCc
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      ||.+..........    ..++..|+||| +..+..++.++||||+|+++|++++|..||.................   
T Consensus       145 ~g~~~~~~~~~~~~----~~~~~~y~~PE-~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---  216 (265)
T cd06605         145 FGVSGQLVNSLAKT----FVGTSSYMAPE-RIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI---  216 (265)
T ss_pred             cccchhhHHHHhhc----ccCChhccCHH-HHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHH---
Confidence            99987653321111    45788999995 55666889999999999999999999999864322111111111111   


Q ss_pred             chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          639 HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       639 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                               .......             . ........+.+++.+||..||++|||+.|++.
T Consensus       217 ---------~~~~~~~-------------~-~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         217 ---------VNEPPPR-------------L-PSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             ---------hcCCCCC-------------C-ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence                     0000000             0 00014556889999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.9e-34  Score=300.44  Aligned_cols=264  Identities=23%  Similarity=0.234  Sum_probs=196.6

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc-CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      +|++.++||.|++|.||+|.+..+++.||+|.+..... .....+.+|++++++++||||++++++|..   ......++
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~~~l   78 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLD---ESSSSIGI   78 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEc---cCCCeEEE
Confidence            46778899999999999999988999999999874322 234568899999999999999999998642   23457899


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      ||||+++++|.+++.....      ....+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+||
T Consensus        79 v~e~~~~~~L~~~l~~~~~------~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~df  149 (287)
T cd06621          79 AMEYCEGGSLDSIYKKVKK------RGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDF  149 (287)
T ss_pred             EEEecCCCCHHHHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeec
Confidence            9999999999988753211      124578888999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcc
Q 037916          560 GLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDH  639 (741)
Q Consensus       560 g~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  639 (741)
                      |.+........    ....++..|+||| ...+..++.++||||+||++|+|++|..||...........+.........
T Consensus       150 g~~~~~~~~~~----~~~~~~~~y~~pE-~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  224 (287)
T cd06621         150 GVSGELVNSLA----GTFTGTSFYMAPE-RIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP  224 (287)
T ss_pred             ccccccccccc----ccccCCccccCHH-HhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC
Confidence            99875543221    1234788999995 556677899999999999999999999998743211011011100000000


Q ss_pred             hhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          640 VMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       640 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      ...     +....                .......+.+.+++.+||+.||++|||+.|+++.
T Consensus       225 ~~~-----~~~~~----------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~  266 (287)
T cd06621         225 NPE-----LKDEP----------------GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH  266 (287)
T ss_pred             chh-----hccCC----------------CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence            000     00000                0000124568899999999999999999999873

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.1e-34  Score=298.53  Aligned_cols=250  Identities=22%  Similarity=0.284  Sum_probs=191.0

Q ss_pred             HHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcC------cchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG------ASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      |++.+.||.|+||.||+|... +++.+|+|.++.....      ....+.+|+.++++++|+||+++++++     .+..
T Consensus         2 ~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~   75 (265)
T cd06631           2 WTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTC-----LDDN   75 (265)
T ss_pred             ccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEe-----ecCC
Confidence            678899999999999999875 7889999998643211      124577899999999999999999995     3456


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..+++|||+++++|.+++...          ..+++..+..++.|++.||+|||+.   +|+|+||+|+||+++.++.+|
T Consensus        76 ~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~  142 (265)
T cd06631          76 TISIFMEFVPGGSISSILNRF----------GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIK  142 (265)
T ss_pred             eEEEEEecCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEE
Confidence            899999999999999998643          3467888899999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCc----ccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhh
Q 037916          556 VADFGLAKLLPPAHL----QTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNF  631 (741)
Q Consensus       556 L~DFg~a~~~~~~~~----~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~  631 (741)
                      |+|||.+........    ........|+..|+||| +..+..++.++||||+||++|++++|..||......    ...
T Consensus       143 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~----~~~  217 (265)
T cd06631         143 LIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE-VINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL----AAM  217 (265)
T ss_pred             eccchhhHhhhhccccccccccccccCCCccccChh-hhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH----HHH
Confidence            999999876532111    11112245889999995 555667889999999999999999999998632110    000


Q ss_pred             hhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          632 ARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       632 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ........   .. +..                      .......+.+++.+||+.+|++|||+.|+++
T Consensus       218 ~~~~~~~~---~~-~~~----------------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         218 FYIGAHRG---LM-PRL----------------------PDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             HHhhhccC---CC-CCC----------------------CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00000000   00 000                      0123456789999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=9.7e-35  Score=298.68  Aligned_cols=253  Identities=22%  Similarity=0.266  Sum_probs=197.1

Q ss_pred             HHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC--cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      |++.+.||.|+||.||+|.+..++..||+|+++...  ....+.+..|+.++++++||||+++++++..   ..+...++
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~~~   78 (265)
T cd08217           2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIID---RSNQTLYI   78 (265)
T ss_pred             ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeec---CCCCEEEE
Confidence            778899999999999999999899999999986432  2234567789999999999999999997542   33557899


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHH-----hcCCCCceecCCCCCCeEeCCCCce
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH-----HDCQPTTAHCDLKPSNVLLDHEMTA  554 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH-----~~~~~~ivHrDlkp~NIll~~~~~~  554 (741)
                      +|||+++++|.+++....      .....+++..++.++.|++.||+|||     +.   +++|+||||+||+++.++.+
T Consensus        79 ~~e~~~~~~L~~~l~~~~------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~  149 (265)
T cd08217          79 VMEYCEGGDLAQLIQKCK------KERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNV  149 (265)
T ss_pred             EehhccCCCHHHHHHHHh------hcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCE
Confidence            999999999999986431      12346888999999999999999999     77   99999999999999999999


Q ss_pred             EEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhh
Q 037916          555 HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       555 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  634 (741)
                      ||+|||.+.........  .....+++.|+||| ...+..++.++||||||+++|+|++|..||....     ...+...
T Consensus       150 kl~d~g~~~~~~~~~~~--~~~~~~~~~~~~pE-~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~  221 (265)
T cd08217         150 KLGDFGLAKILGHDSSF--AKTYVGTPYYMSPE-QLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN-----QLQLASK  221 (265)
T ss_pred             EEecccccccccCCccc--ccccccCCCccChh-hhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC-----HHHHHHH
Confidence            99999999876544321  12245899999995 4556678899999999999999999999986321     1111111


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                               +.......                  .....+..+.+++.+|++.+|++|||+.||++
T Consensus       222 ---------~~~~~~~~------------------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         222 ---------IKEGKFRR------------------IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             ---------HhcCCCCC------------------CccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                     00000000                  01133467889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.2e-34  Score=301.14  Aligned_cols=276  Identities=17%  Similarity=0.178  Sum_probs=193.6

Q ss_pred             HHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC-cCcchhHHHHHHHHHhcC-CCceeeEeeeecCccccCCceEEE
Q 037916          402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH-HGASKSSIAECSALRNIR-HKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      |++.++||+|+||.||+|.+..++..||+|+++... ........+|+.+++++. ||||+++++++.+.   .....++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~l   77 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLAL   77 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEEE
Confidence            567889999999999999999899999999987432 222234457888888885 99999999996421   2257899


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      ||||++ +++.+++...         ...+++.++..++.|++.||+|||+.   +++||||+|+||+++. +.+||+||
T Consensus        78 v~e~~~-~~l~~~l~~~---------~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~df  143 (282)
T cd07831          78 VFELMD-MNLYELIKGR---------KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADF  143 (282)
T ss_pred             EEecCC-ccHHHHHHhc---------cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEec
Confidence            999996 5888777532         13578999999999999999999999   9999999999999999 99999999


Q ss_pred             ccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcc
Q 037916          560 GLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDH  639 (741)
Q Consensus       560 g~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  639 (741)
                      |.+..........   ...++..|+|||.+..+..++.++||||+||++|||++|..||.....  ..............
T Consensus       144 g~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~--~~~~~~~~~~~~~~  218 (282)
T cd07831         144 GSCRGIYSKPPYT---EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE--LDQIAKIHDVLGTP  218 (282)
T ss_pred             ccccccccCCCcC---CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH--HHHHHHHHHHcCCC
Confidence            9998664332211   234788999997666666788999999999999999999999863211  11111111111111


Q ss_pred             hhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          640 VMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       640 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ...+.. ........ ...................+..+.+++.+||+.||++|||+.|+++
T Consensus       219 ~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         219 DAEVLK-KFRKSRHM-NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             CHHHHH-hhcccccc-cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            111100 00000000 0000000000001111244678999999999999999999999975

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.7e-34  Score=299.19  Aligned_cols=244  Identities=20%  Similarity=0.235  Sum_probs=183.4

Q ss_pred             hcccCceeeEEEEEEcCCCeEEEEEEeeccCcC---cchhHHHHHHHHH---hcCCCceeeEeeeecCccccCCceEEEE
Q 037916          407 WIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG---ASKSSIAECSALR---NIRHKNLVKILTVCSGVDYKGDDFKALV  480 (741)
Q Consensus       407 ~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~---~l~hpnIv~~~~~~~~~~~~~~~~~~lv  480 (741)
                      .||+|+||.||+|.+..+++.||+|.+......   ....+.+|..+++   ..+||+|+.+++++     ..++..++|
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv   75 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAF-----HTPDKLCFI   75 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEE-----ecCCeEEEE
Confidence            389999999999999989999999998643221   1222334443333   34799999999884     445688999


Q ss_pred             EecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecc
Q 037916          481 YEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFG  560 (741)
Q Consensus       481 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg  560 (741)
                      |||+++++|.+++...          ..+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||
T Consensus        76 ~e~~~~~~L~~~i~~~----------~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg  142 (279)
T cd05633          76 LDLMNGGDLHYHLSQH----------GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLG  142 (279)
T ss_pred             EecCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCC
Confidence            9999999999988633          4589999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcch
Q 037916          561 LAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHV  640 (741)
Q Consensus       561 ~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  640 (741)
                      .+........    ....|+..|+|||.+..+..++.++||||+||++|+|++|..||.........  ........   
T Consensus       143 ~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~~~~~~~---  213 (279)
T cd05633         143 LACDFSKKKP----HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDRMTLT---  213 (279)
T ss_pred             cceeccccCc----cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH--HHHHHhhc---
Confidence            9875433211    12358999999976554567889999999999999999999998632211100  00000000   


Q ss_pred             hHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCC-----CHHHHHHH
Q 037916          641 MDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRM-----NMTIVVHE  702 (741)
Q Consensus       641 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  702 (741)
                             ..                  ...+...+..+.+++.+||..||++||     |++|+++.
T Consensus       214 -------~~------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         214 -------VN------------------VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             -------CC------------------cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence                   00                  000113346788999999999999999     58888774

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.2e-35  Score=309.26  Aligned_cols=251  Identities=21%  Similarity=0.271  Sum_probs=201.6

Q ss_pred             HHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcC--cchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG--ASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      -.+.|.+.+.||+|.|+.|.+|++..++..||+|++++....  ....+.+|+++|+.++|||||+++.+     .....
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v-----~~t~~  128 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSV-----IETEA  128 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeee-----eeecc
Confidence            345689999999999999999999999999999999754332  23457899999999999999999999     56677


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..|+||||+.+|.+++|+...          ....+..+..++.|+..|++|+|++   .|||||||++||+++.+..+|
T Consensus       129 ~lylV~eya~~ge~~~yl~~~----------gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnik  195 (596)
T KOG0586|consen  129 TLYLVMEYASGGELFDYLVKH----------GRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIK  195 (596)
T ss_pred             eeEEEEEeccCchhHHHHHhc----------ccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhccccccccee
Confidence            899999999999999999765          3345577888999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhc
Q 037916          556 VADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV  635 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~  635 (741)
                      |+|||++..........+   .+|++.|.|||.+....+.++.+|+||+|+++|.++.|..||+...     +...-...
T Consensus       196 IaDfgfS~~~~~~~~lqt---~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~-----lk~Lr~rv  267 (596)
T KOG0586|consen  196 IADFGFSTFFDYGLMLQT---FCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN-----LKELRPRV  267 (596)
T ss_pred             eeccccceeecccccccc---cCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc-----cccccchh
Confidence            999999998876554433   5799999999666666677899999999999999999999997321     11111111


Q ss_pred             CCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          636 LPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       636 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      +.... .+ .-                          -...+..+++++++..+|.+|++++++.+.
T Consensus       268 l~gk~-rI-p~--------------------------~ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  268 LRGKY-RI-PF--------------------------YMSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             eeeee-cc-cc--------------------------eeechhHHHHHHhhccCccccCCHHHhhhh
Confidence            11100 00 00                          112234588999999999999999999865

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.3e-34  Score=302.36  Aligned_cols=252  Identities=21%  Similarity=0.267  Sum_probs=198.3

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      ...|.+.+.||+|+||.||+|.+..++..||+|.+........+.+.+|+.+++.++||||+++++++     ...+..|
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~   92 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY-----LVGDELW   92 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhhee-----eeCCcEE
Confidence            47899999999999999999999888999999998754444456778899999999999999999985     4456889


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      +|+||+++++|.+++..           ..+++.++..++.|++.||.|||+.   |++||||||+||+++.++.+||+|
T Consensus        93 lv~e~~~~~~L~~~~~~-----------~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~d  158 (293)
T cd06647          93 VVMEYLAGGSLTDVVTE-----------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTD  158 (293)
T ss_pred             EEEecCCCCcHHHHHhh-----------cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEcc
Confidence            99999999999999853           2467888899999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCc
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      ||.+..........  ....+++.|+||| +..+..++.++|||||||++|++++|+.||....... ......... ..
T Consensus       159 fg~~~~~~~~~~~~--~~~~~~~~y~~PE-~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~-~~~~~~~~~-~~  233 (293)
T cd06647         159 FGFCAQITPEQSKR--STMVGTPYWMAPE-VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-ALYLIATNG-TP  233 (293)
T ss_pred             Ccceeccccccccc--ccccCChhhcCch-hhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh-heeehhcCC-CC
Confidence            99887654432211  2245888999995 4455678899999999999999999999986321110 000000000 00


Q ss_pred             chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          639 HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       639 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      .                            ..........+.+++.+||..+|++||++.|++..
T Consensus       234 ~----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         234 E----------------------------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             C----------------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0                            00011234567799999999999999999999865

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-35  Score=293.64  Aligned_cols=281  Identities=20%  Similarity=0.211  Sum_probs=207.0

Q ss_pred             HHHHHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcC--CC----ceeeEeeeecC
Q 037916          395 GILLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIR--HK----NLVKILTVCSG  468 (741)
Q Consensus       395 ~~~~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--hp----nIv~~~~~~~~  468 (741)
                      |..+..+|.+...+|+|.||.|-.+.++.++..||+|+++.. ....+...-|+++++++.  .|    -+|++.+|   
T Consensus        84 gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w---  159 (415)
T KOG0671|consen   84 GDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDW---  159 (415)
T ss_pred             ccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh---
Confidence            456678999999999999999999999999999999999743 234566678999999993  23    37788887   


Q ss_pred             ccccCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEe
Q 037916          469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLL  548 (741)
Q Consensus       469 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll  548 (741)
                        ++-.++.|||+|.+ |.|+.+++..+        .-.+++..+++.|+.|++++++|||+.   +++|.||||+||++
T Consensus       160 --FdyrghiCivfell-G~S~~dFlk~N--------~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILf  225 (415)
T KOG0671|consen  160 --FDYRGHICIVFELL-GLSTFDFLKEN--------NYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILF  225 (415)
T ss_pred             --hhccCceEEEEecc-ChhHHHHhccC--------CccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEE
Confidence              56677999999988 77999999854        235688999999999999999999999   99999999999998


Q ss_pred             CC--------------------CCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHH
Q 037916          549 DH--------------------EMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILL  608 (741)
Q Consensus       549 ~~--------------------~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il  608 (741)
                      ..                    +..+|++|||.|....+..     ..++.|..|+|| |+..+-.++.++||||+|||+
T Consensus       226 vss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAP-EViLgLGwS~pCDvWSiGCIL  299 (415)
T KOG0671|consen  226 VSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAP-EVILGLGWSQPCDVWSIGCIL  299 (415)
T ss_pred             eccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCc-hheeccCcCCccCceeeeeEE
Confidence            32                    2358999999998765544     225679999999 666788999999999999999


Q ss_pred             HHHHcCCCCCCccccCCcchhhhhhhcCCcchhHhhhhc----------ccCCcchh----hhhh-hhHHHHHhHhhHHH
Q 037916          609 LELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDST----------LLADDEDL----TITS-NQRQRQARINNIME  673 (741)
Q Consensus       609 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~----------l~~~~~~~----~~~~-~~~~~~~~~~~~~~  673 (741)
                      +|+++|..-|....  +.+-..++.....+-...++.+.          +.......    +... ..............
T Consensus       300 ~ElytG~~LFqtHe--n~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~  377 (415)
T KOG0671|consen  300 VELYTGETLFQTHE--NLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDL  377 (415)
T ss_pred             EEeeccceecccCC--cHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcH
Confidence            99999999876332  21211333333332222222222          10000000    0000 01111112223335


Q ss_pred             HHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          674 CLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       674 ~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ....+.+|+++||.+||.+|+|+.|++.
T Consensus       378 e~~~LfDLl~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  378 EHVQLFDLLRRMLEFDPARRITLREALS  405 (415)
T ss_pred             HHhHHHHHHHHHHccCccccccHHHHhc
Confidence            5667999999999999999999999875

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.2e-34  Score=297.46  Aligned_cols=254  Identities=23%  Similarity=0.357  Sum_probs=195.2

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      ..+|.+.++||+|+||.||+|.+. .+..||+|.++.. ....+.+.+|+.++++++|+||+++++++.     . ...+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~-~~~~   76 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-----K-EPIY   76 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEc-----C-CCeE
Confidence            456889999999999999999876 5667999988642 223457788999999999999999999853     2 4679


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      ++|||+++++|.+++....        ....++.++..++.|++.||.|||+.   +++||||||+||+++.++.+||+|
T Consensus        77 ~v~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d  145 (260)
T cd05073          77 IITEFMAKGSLLDFLKSDE--------GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIAD  145 (260)
T ss_pred             EEEEeCCCCcHHHHHHhCC--------ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECC
Confidence            9999999999999986431        23467888999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcCC
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      ||.+......... ......++..|+||| +.....++.++|||||||++|++++ |..||......  ...........
T Consensus       146 ~~~~~~~~~~~~~-~~~~~~~~~~y~~PE-~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~~  221 (260)
T cd05073         146 FGLARVIEDNEYT-AREGAKFPIKWTAPE-AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRALERGYR  221 (260)
T ss_pred             CcceeeccCCCcc-cccCCcccccccCHh-HhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHhCCCC
Confidence            9998765433221 111233567799995 5556778999999999999999998 89998632110  11111000000


Q ss_pred             cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHH
Q 037916          638 DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQS  705 (741)
Q Consensus       638 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  705 (741)
                      .                              ......+..+.+++.+||..+|++||++.++.+.|+.
T Consensus       222 ~------------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         222 M------------------------------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             C------------------------------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            0                              0001234568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.5e-34  Score=303.13  Aligned_cols=209  Identities=22%  Similarity=0.312  Sum_probs=168.5

Q ss_pred             HHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc--CcchhHHHHHHHHHhcCCCceeeEeeeecCccc---c
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKNLVKILTVCSGVDY---K  472 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~---~  472 (741)
                      ....|++.++||+|+||.||+|.+..+++.||+|.+.....  .......+|+.++++++||||++++++|.....   .
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            44679999999999999999999998999999999864322  223355689999999999999999998754321   1


Q ss_pred             CCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCC
Q 037916          473 GDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEM  552 (741)
Q Consensus       473 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~  552 (741)
                      .....++||||+. +++.+++...         ...+++.++..++.|++.||+|||+.   +++|+||||+||+++.++
T Consensus        90 ~~~~~~lv~e~~~-~~l~~~l~~~---------~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~  156 (310)
T cd07865          90 YKGSFYLVFEFCE-HDLAGLLSNK---------NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDG  156 (310)
T ss_pred             CCceEEEEEcCCC-cCHHHHHHhc---------ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCC
Confidence            2345799999995 5888777532         13578999999999999999999999   999999999999999999


Q ss_pred             ceEEeecccccccCCCCcc--cccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCC
Q 037916          553 TAHVADFGLAKLLPPAHLQ--TSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSD  619 (741)
Q Consensus       553 ~~kL~DFg~a~~~~~~~~~--~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~  619 (741)
                      .+||+|||.+.........  .......++..|+|||.+.....++.++||||+|+++|||++|..||.
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~  225 (310)
T cd07865         157 ILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQ  225 (310)
T ss_pred             cEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCC
Confidence            9999999999766433211  111224478889999766555567899999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-36  Score=338.17  Aligned_cols=252  Identities=23%  Similarity=0.263  Sum_probs=197.5

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeecc--CcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLL--HHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      +|.-..+||.|.||.||.|...++|...|+|-++..  .....+...+|..++..++|||+|++||+     .-..+.++
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGV-----EvHRekv~ 1310 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGV-----EVHREKVY 1310 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCce-----eecHHHHH
Confidence            455566899999999999999999999999988733  33445677899999999999999999998     45566899


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      |.||||++|+|.+.+...          ...++.....+..|++.|++|||+.   |||||||||+||+++.+|.+|++|
T Consensus      1311 IFMEyC~~GsLa~ll~~g----------ri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~D 1377 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHG----------RIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGD 1377 (1509)
T ss_pred             HHHHHhccCcHHHHHHhc----------chhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeec
Confidence            999999999999998633          3355666677899999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCc--ccccccccccccccCcccccCC--CCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhh
Q 037916          559 FGLAKLLPPAHL--QTSSIGVKGTIGYIAPAEYGLG--SEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       559 Fg~a~~~~~~~~--~~~~~~~~gt~~y~aPEe~~~~--~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  634 (741)
                      ||.|..+..+..  ...-....||+.|||||.+...  ....-++||||+|||..||+||+.||........-+-.....
T Consensus      1378 FGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~g 1457 (1509)
T KOG4645|consen 1378 FGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAG 1457 (1509)
T ss_pred             ccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhcc
Confidence            999998876531  1122346699999999766543  346688999999999999999999997443322111111111


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ..|.-                               +.....+-.+++..|++.||++|.++.|+++
T Consensus      1458 h~Pq~-------------------------------P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1458 HKPQI-------------------------------PERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             CCCCC-------------------------------chhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence            11111                               1123445568899999999999999987765

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1e-34  Score=297.56  Aligned_cols=239  Identities=24%  Similarity=0.383  Sum_probs=183.9

Q ss_pred             hhcccCceeeEEEEEEcCCC----------eEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          406 CWIDMGSFGSVYKGILDEGK----------TIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       406 ~~ig~G~~g~V~~a~~~~~~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      +.||+|+||.||+|.+..++          ..|++|++...... ...+.+|+.+++.++||||+++++++..      .
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~   73 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR------D   73 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec------C
Confidence            46899999999999998666          45888887643322 5678899999999999999999998632      4


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCC---
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEM---  552 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~---  552 (741)
                      ..++||||+++|+|.+++...         ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++   
T Consensus        74 ~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~  141 (259)
T cd05037          74 ENIMVEEYVKFGPLDVFLHRE---------KNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNE  141 (259)
T ss_pred             CcEEEEEcCCCCcHHHHHHhh---------ccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCcccc
Confidence            579999999999999998643         12578888999999999999999999   999999999999999887   


Q ss_pred             ----ceEEeecccccccCCCCcccccccccccccccCcccccCC-CCCCCccCchhHHHHHHHHHc-CCCCCCccccCCc
Q 037916          553 ----TAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLG-SEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNM  626 (741)
Q Consensus       553 ----~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~-~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~  626 (741)
                          .+||+|||.+.......      ...++..|+|||.+... ..++.++||||+||++|++++ |..||.....  .
T Consensus       142 ~~~~~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~--~  213 (259)
T cd05037         142 GYVPFIKLSDPGIPITVLSRE------ERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS--S  213 (259)
T ss_pred             CCceeEEeCCCCccccccccc------ccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc--h
Confidence                79999999988654311      13367789999654433 378999999999999999999 5777653211  0


Q ss_pred             chhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHH
Q 037916          627 NLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHEL  703 (741)
Q Consensus       627 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  703 (741)
                      ....+..           ........                     ....+.+++.+||..+|++|||+.||++.|
T Consensus       214 ~~~~~~~-----------~~~~~~~~---------------------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         214 EKERFYQ-----------DQHRLPMP---------------------DCAELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             hHHHHHh-----------cCCCCCCC---------------------CchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            1000000           00000000                     015678999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=3.3e-35  Score=327.12  Aligned_cols=260  Identities=22%  Similarity=0.267  Sum_probs=190.3

Q ss_pred             HHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeecc-CcCcchhHHHHHHHHHhcCCCceeeEeeeecCccc-----
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLL-HHGASKSSIAECSALRNIRHKNLVKILTVCSGVDY-----  471 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~-----  471 (741)
                      ....|+.++.||+||||.||+++.+-+|+.||||++... .........+|+.++.+|+|||||+||..+.+...     
T Consensus       477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~  556 (1351)
T KOG1035|consen  477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL  556 (1351)
T ss_pred             HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence            346789999999999999999999999999999999743 23334567789999999999999999976543210     


Q ss_pred             --------------------------------------------------c------------------C----------
Q 037916          472 --------------------------------------------------K------------------G----------  473 (741)
Q Consensus       472 --------------------------------------------------~------------------~----------  473 (741)
                                                                        .                  +          
T Consensus       557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~  636 (1351)
T KOG1035|consen  557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS  636 (1351)
T ss_pred             cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence                                                              0                  0          


Q ss_pred             -----------------------C--------ceEEEEEecccCCChhhhccCCCCCCcccCccccc-CHHHHHHHHHHH
Q 037916          474 -----------------------D--------DFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCL-NFLQRINIAIDV  521 (741)
Q Consensus       474 -----------------------~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~-~~~~~~~i~~qi  521 (741)
                                             +        ...||-||||+..++.++++.+          ... .....++++++|
T Consensus       637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N----------~~~~~~d~~wrLFreI  706 (1351)
T KOG1035|consen  637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN----------HFNSQRDEAWRLFREI  706 (1351)
T ss_pred             CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc----------ccchhhHHHHHHHHHH
Confidence                                   1        3467889999887777777643          111 345678999999


Q ss_pred             HHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecccccccC----------------CCCcccccccccccccccC
Q 037916          522 ACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP----------------PAHLQTSSIGVKGTIGYIA  585 (741)
Q Consensus       522 ~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~a~~~~----------------~~~~~~~~~~~~gt~~y~a  585 (741)
                      ++||+|+|+.   |||||||||.||++++++.|||+|||+|....                .+......++..||.-|+|
T Consensus       707 lEGLaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvA  783 (1351)
T KOG1035|consen  707 LEGLAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVA  783 (1351)
T ss_pred             HHHHHHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeec
Confidence            9999999999   99999999999999999999999999998721                0111223455779999999


Q ss_pred             cccccCCC--CCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHH
Q 037916          586 PAEYGLGS--EVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQ  663 (741)
Q Consensus       586 PEe~~~~~--~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~  663 (741)
                      ||.+....  .|+.|+|+||+|||++||+.   ||....+....+...-...+|.. ..+.+                  
T Consensus       784 PEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~-~~f~~------------------  841 (1351)
T KOG1035|consen  784 PELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEP-ADFFD------------------  841 (1351)
T ss_pred             HHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCC-ccccc------------------
Confidence            96554444  69999999999999999986   55422221111111111111111 11111                  


Q ss_pred             HHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          664 RQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       664 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                               ...+.=.++|++|+++||.+||||.|++.
T Consensus       842 ---------~~~~~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  842 ---------PEHPEEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             ---------ccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence                     11223347899999999999999999885

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.8e-34  Score=300.07  Aligned_cols=274  Identities=20%  Similarity=0.232  Sum_probs=197.9

Q ss_pred             HHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc-CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEE
Q 037916          402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALV  480 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv  480 (741)
                      |++.++||.|++|.||+|++..++..||+|+++.... .....+.+|+.++++++||||+++++++     .+.+..++|
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv   76 (284)
T cd07836           2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI-----HTENKLMLV   76 (284)
T ss_pred             ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeE-----eeCCcEEEE
Confidence            7788999999999999999998999999999975432 2345677899999999999999999995     445678999


Q ss_pred             EecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecc
Q 037916          481 YEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFG  560 (741)
Q Consensus       481 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg  560 (741)
                      |||++ ++|.+++....       ....+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||
T Consensus        77 ~e~~~-~~l~~~~~~~~-------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g  145 (284)
T cd07836          77 FEYMD-KDLKKYMDTHG-------VRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFG  145 (284)
T ss_pred             EecCC-ccHHHHHHhcC-------CCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecc
Confidence            99997 48888875431       124588999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCc--
Q 037916          561 LAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPD--  638 (741)
Q Consensus       561 ~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~--  638 (741)
                      .+........  ......++..|+|||.+.....++.++||||+||++|++++|+.||...... ..+..........  
T Consensus       146 ~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~~~  222 (284)
T cd07836         146 LARAFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE-DQLLKIFRIMGTPTE  222 (284)
T ss_pred             hhhhhcCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCCh
Confidence            9875543221  1122347889999976655566789999999999999999999998633211 1111111111000  


Q ss_pred             -chhHhhhh-cccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          639 -HVMDIVDS-TLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       639 -~~~~~~d~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                       ....+.+. .......       ...........+.....+.+++.+|++.||++||++.|+++
T Consensus       223 ~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         223 STWPGISQLPEYKPTFP-------RYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             hhHHHHhcCchhccccc-------CCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence             01111100 0000000       00000111112234667889999999999999999999875

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.4e-34  Score=295.84  Aligned_cols=248  Identities=25%  Similarity=0.371  Sum_probs=192.6

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      ...|++.+.||+|+||.||++..  +++.||+|.++..  ...+.+.+|+.++++++||||+++++++.     . +..+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~-~~~~   74 (254)
T cd05083           5 LQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVIL-----H-NGLY   74 (254)
T ss_pred             HHHceeeeeeccCCCCceEeccc--CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEc-----C-CCcE
Confidence            46789999999999999999975  5778999998642  23457889999999999999999999853     2 2468


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      ++|||+++++|.+++...        ....+++..+..++.|++.|+.|||+.   |++||||||+||+++.++.+||+|
T Consensus        75 ~v~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~D  143 (254)
T cd05083          75 IVMELMSKGNLVNFLRTR--------GRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSD  143 (254)
T ss_pred             EEEECCCCCCHHHHHHhc--------CcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECC
Confidence            999999999999998643        123478888999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcCC
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      ||.+.......     .....+..|+||| ...+..++.++||||+||++|+|++ |+.||.....     ....     
T Consensus       144 fg~~~~~~~~~-----~~~~~~~~y~~pe-~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----~~~~-----  207 (254)
T cd05083         144 FGLARVGSMGV-----DNSKLPVKWTAPE-ALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL-----KEVK-----  207 (254)
T ss_pred             CccceeccccC-----CCCCCCceecCHH-HhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH-----HHHH-----
Confidence            99987543221     1123456899995 5566778999999999999999997 9999863211     1110     


Q ss_pred             cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHH
Q 037916          638 DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQS  705 (741)
Q Consensus       638 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  705 (741)
                          +.+.......                  ....++..+.+++.+||+.+|++||+++++++.|+.
T Consensus       208 ----~~~~~~~~~~------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         208 ----ECVEKGYRME------------------PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             ----HHHhCCCCCC------------------CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence                1111000000                  011335678899999999999999999999998853

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.2e-34  Score=296.45  Aligned_cols=249  Identities=21%  Similarity=0.332  Sum_probs=194.3

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC--cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+....  ......+.+|+.++++++||||+++++.     +..+...+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~-----~~~~~~~~   75 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN-----FLEDKALM   75 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeee-----EecCCEEE
Confidence            3778899999999999999999899999999987432  2234567889999999999999999998     44566899


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCC-CceEEe
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHE-MTAHVA  557 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~-~~~kL~  557 (741)
                      +||||+++++|.+++....        ...+++..+..++.|+++|++|||++   +++||||+|+||+++.+ +.+||+
T Consensus        76 lv~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~  144 (256)
T cd08220          76 IVMEYAPGGTLAEYIQKRC--------NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIG  144 (256)
T ss_pred             EEEecCCCCCHHHHHHHhc--------ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEc
Confidence            9999999999999986431        23478889999999999999999999   99999999999999865 468999


Q ss_pred             ecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCC
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      |||.+.........   ....++..|+||| ...+..++.++||||+|+++|++++|..||.....     ......   
T Consensus       145 d~~~~~~~~~~~~~---~~~~~~~~y~aPE-~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-----~~~~~~---  212 (256)
T cd08220         145 DFGISKILSSKSKA---YTVVGTPCYISPE-LCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL-----PALVLK---  212 (256)
T ss_pred             cCCCceecCCCccc---cccccCCcccCch-hccCCCCCcccchHHHHHHHHHHHhCCCCcccCch-----HHHHHH---
Confidence            99999876543221   1245788999995 44566788999999999999999999999863211     111110   


Q ss_pred             cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          638 DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       638 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                           ........                   .+...+..+.+++.+||+.||++|||+.|+++
T Consensus       213 -----~~~~~~~~-------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         213 -----IMSGTFAP-------------------ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             -----HHhcCCCC-------------------CCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                 00000000                   00123456889999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.2e-34  Score=304.74  Aligned_cols=256  Identities=21%  Similarity=0.217  Sum_probs=194.1

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc---CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH---GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      .|.+.+.||+|+||.||+|.+..+++.||+|.++....   ...+.+.+|+.+++.++||||+++++.+     ..+.+.
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~   76 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF-----ETKRHL   76 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ecCCEE
Confidence            47788999999999999999999999999999874332   2334677899999999999999999984     456689


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      ++||||+++++|.+++...          ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+
T Consensus        77 ~lv~e~~~g~~L~~~l~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~  143 (305)
T cd05609          77 CMVMEYVEGGDCATLLKNI----------GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLT  143 (305)
T ss_pred             EEEEecCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEe
Confidence            9999999999999998643          3478888899999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCc-------------ccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccC
Q 037916          558 DFGLAKLLPPAHL-------------QTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEG  624 (741)
Q Consensus       558 DFg~a~~~~~~~~-------------~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~  624 (741)
                      |||.++.......             ........++..|+|||. ..+..++.++|||||||++||+++|..||....  
T Consensus       144 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~--  220 (305)
T cd05609         144 DFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEV-ILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT--  220 (305)
T ss_pred             eCCCccccCcCccccccccccccchhhccccCCccCccccCchh-ccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--
Confidence            9999864211100             001112347889999954 456678999999999999999999999985211  


Q ss_pred             CcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHH
Q 037916          625 NMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQ  704 (741)
Q Consensus       625 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  704 (741)
                         ..++.........   ..    ..                  .....+..+.+++.+||+.||++||++.++.+.++
T Consensus       221 ---~~~~~~~~~~~~~---~~----~~------------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~  272 (305)
T cd05609         221 ---PEELFGQVISDDI---EW----PE------------------GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ  272 (305)
T ss_pred             ---HHHHHHHHHhccc---CC----CC------------------ccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence               1111111000000   00    00                  00123456789999999999999999776666664


Q ss_pred             H
Q 037916          705 S  705 (741)
Q Consensus       705 ~  705 (741)
                      .
T Consensus       273 ~  273 (305)
T cd05609         273 H  273 (305)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.4e-34  Score=304.73  Aligned_cols=278  Identities=24%  Similarity=0.235  Sum_probs=196.5

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc--CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCce
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      ...|++.+.||+|+||.||+|.+..+++.||+|+++....  .......+|+.++++++|+||+++++++.+   .....
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~   82 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVG---KHLDS   82 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEec---CCCCe
Confidence            3568899999999999999999998999999999874322  223355689999999999999999998642   22346


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .++||||+. ++|.+++...         ...+++.++..++.|++.||+|||+.   +++||||||+||+++.++.+||
T Consensus        83 ~~lv~e~~~-~~l~~~l~~~---------~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL  149 (309)
T cd07845          83 IFLVMEYCE-QDLASLLDNM---------PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKI  149 (309)
T ss_pred             EEEEEecCC-CCHHHHHHhc---------ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEE
Confidence            899999995 5888887532         14578899999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcC
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVL  636 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  636 (741)
                      +|||.+.........  .....++..|+|||.+.....++.++||||+||++|||++|+.||...... ..+.... ...
T Consensus       150 ~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~-~~~~~~~-~~~  225 (309)
T cd07845         150 ADFGLARTYGLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI-EQLDLII-QLL  225 (309)
T ss_pred             CccceeeecCCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHH-Hhc
Confidence            999999876543211  122335788999976655567899999999999999999999998632111 1111111 111


Q ss_pred             Ccc---hhHhhhhc-ccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          637 PDH---VMDIVDST-LLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       637 ~~~---~~~~~d~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ...   .....+.. ..............     .........+.+.+++.+|+++||++|||+.|++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         226 GTPNESIWPGFSDLPLVGKFTLPKQPYNN-----LKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             CCCChhhchhhhcccccccccccCCCCCc-----hHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            100   00000000 00000000000000     00001123456789999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-34  Score=302.13  Aligned_cols=277  Identities=19%  Similarity=0.232  Sum_probs=196.9

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC--cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      +|++.+.||+|+||.||+|.+..+++.||+|+++...  ....+.+.+|+.++++++|+||+++++++     ..+...+
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   76 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAF-----RRKGRLY   76 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheE-----EECCEEE
Confidence            5788899999999999999999889999999987432  23346788999999999999999999995     3456899


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      +||||++++.+..+....          ..+++..+..++.|++.|+.|||+.   +++||||+|+||++++++.+||+|
T Consensus        77 iv~e~~~~~~l~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d  143 (288)
T cd07833          77 LVFEYVERTLLELLEASP----------GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCD  143 (288)
T ss_pred             EEEecCCCCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEe
Confidence            999999887776655322          3478889999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhh--cC
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART--VL  636 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~--~~  636 (741)
                      ||.+........ .......++..|+|||.+.....++.++||||+|+++|++++|+.||......+ ........  ..
T Consensus       144 ~g~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~  221 (288)
T cd07833         144 FGFARALRARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID-QLYLIQKCLGPL  221 (288)
T ss_pred             eecccccCCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCC
Confidence            999887654432 111224578899999655444488999999999999999999999986321110 00000000  00


Q ss_pred             CcchhHhhh--hcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          637 PDHVMDIVD--STLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       637 ~~~~~~~~d--~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      +........  .......    .................++..+.+++.+||..+|++|||++++++
T Consensus       222 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         222 PPSHQELFSSNPRFAGVA----FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             CHHHhhhcccCccccccc----cCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            000000000  0000000    000000000000001123677899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.7e-34  Score=300.11  Aligned_cols=254  Identities=21%  Similarity=0.255  Sum_probs=188.4

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc-CcchhHHHHHHH-HHhcCCCceeeEeeeecCccccCCceEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH-GASKSSIAECSA-LRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      .|++.+.||+|+||.||+|.+..+++.||+|+++.... .....+..|+.. ++..+||||+++++++     ..+...|
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~-----~~~~~~~   76 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGAL-----FREGDVW   76 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEE-----ecCCcEE
Confidence            47788999999999999999998999999999874322 223345556665 5667999999999995     3455789


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      ++|||++ ++|.+++.....      ....+++..++.++.|++.||+|||+++  +++||||||+||+++.++.+||+|
T Consensus        77 lv~e~~~-~~l~~~l~~~~~------~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~d  147 (283)
T cd06617          77 ICMEVMD-TSLDKFYKKVYD------KGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCD  147 (283)
T ss_pred             EEhhhhc-ccHHHHHHHhcc------CCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEee
Confidence            9999995 688887753211      1246889999999999999999999743  899999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccC---CCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhc
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGL---GSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV  635 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~---~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~  635 (741)
                      ||.+........   .....++..|+|||.+..   ...++.++||||+||++|+|++|+.||.....   ......   
T Consensus       148 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~---  218 (283)
T cd06617         148 FGISGYLVDSVA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT---PFQQLK---  218 (283)
T ss_pred             cccccccccccc---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc---CHHHHH---
Confidence            999876543221   122357889999965532   14568899999999999999999999863211   111110   


Q ss_pred             CCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          636 LPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       636 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                            ........ ...                 ....+..+.+++.+||..+|++|||+.|+++
T Consensus       219 ------~~~~~~~~-~~~-----------------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         219 ------QVVEEPSP-QLP-----------------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             ------HHHhcCCC-CCC-----------------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                  00000000 000                 0123466889999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=3e-35  Score=277.13  Aligned_cols=255  Identities=22%  Similarity=0.240  Sum_probs=192.9

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC-cCcchhHHHHHHHHHhc-CCCceeeEeeeecCccccCCce
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH-HGASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      ....+++..||.|+.|.||+++++.+|...|||.+.... .+..+++...++++..- ++|+||+.+|+|     -.+..
T Consensus        91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyF-----i~n~d  165 (391)
T KOG0983|consen   91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYF-----ITNTD  165 (391)
T ss_pred             hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEE-----eeCch
Confidence            345677888999999999999999999999999997433 33445666677766544 589999999994     45567


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      +++.||.|. .-+..+++..         ..++++.-+-++...++.||.||.+++  +|+|||+||+|||+|+.|.+|+
T Consensus       166 V~IcMelMs-~C~ekLlkri---------k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKl  233 (391)
T KOG0983|consen  166 VFICMELMS-TCAEKLLKRI---------KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKL  233 (391)
T ss_pred             HHHHHHHHH-HHHHHHHHHh---------cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEe
Confidence            899999983 3555555432         245777777789999999999999886  9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccC--CCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhh
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGL--GSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~--~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  634 (741)
                      ||||.+..+.++....   ...|.+.|||||.+-.  ...|+.++||||||++++|+.||+.||.....+-..+..... 
T Consensus       234 CDFGIsGrlvdSkAht---rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-  309 (391)
T KOG0983|consen  234 CDFGISGRLVDSKAHT---RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-  309 (391)
T ss_pred             ecccccceeecccccc---cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-
Confidence            9999998776654332   3469999999976643  356899999999999999999999998742221111111111 


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      ..++.        +.+                    .....+.+.+++..||..|+.+||...++++-
T Consensus       310 ~ePP~--------L~~--------------------~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  310 EEPPL--------LPG--------------------HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             cCCCC--------CCc--------------------ccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            11111        100                    01245678899999999999999999998763

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=3.2e-34  Score=295.78  Aligned_cols=254  Identities=24%  Similarity=0.375  Sum_probs=193.4

Q ss_pred             HHHhhhcccCceeeEEEEEEcC-CCeEEEEEEeeccCc----------CcchhHHHHHHHHHh-cCCCceeeEeeeecCc
Q 037916          402 FLFLCWIDMGSFGSVYKGILDE-GKTIIAVKVLNLLHH----------GASKSSIAECSALRN-IRHKNLVKILTVCSGV  469 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~~-~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~-l~hpnIv~~~~~~~~~  469 (741)
                      |++.+.||+|+||.||+|.+.. +++.+|+|.+.....          ....++..|+.++.+ ++||||+++++++   
T Consensus         2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~---   78 (269)
T cd08528           2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTF---   78 (269)
T ss_pred             chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeE---
Confidence            7889999999999999999986 678999998863221          122345678887765 7999999999995   


Q ss_pred             cccCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHh-cCCCCceecCCCCCCeEe
Q 037916          470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH-DCQPTTAHCDLKPSNVLL  548 (741)
Q Consensus       470 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivHrDlkp~NIll  548 (741)
                        ..+...+++|||+++++|.+++....      .....+++..++.++.|++.||.|||+ .   +++|+||+|+||++
T Consensus        79 --~~~~~~~lv~e~~~~~~l~~~l~~~~------~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~  147 (269)
T cd08528          79 --LENDRLYIVMDLIEGAPLGEHFNSLK------EKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIML  147 (269)
T ss_pred             --ccCCeEEEEEecCCCCcHHHHHHHHH------hccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEE
Confidence              45568999999999999998874321      112457888999999999999999996 5   89999999999999


Q ss_pred             CCCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcch
Q 037916          549 DHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNL  628 (741)
Q Consensus       549 ~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~  628 (741)
                      +.++.+||+|||.+.......   ......|+..|+||| ...+..++.++||||||+++|++++|+.||....     .
T Consensus       148 ~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe-~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~-----~  218 (269)
T cd08528         148 GEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPE-IVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN-----M  218 (269)
T ss_pred             CCCCcEEEecccceeeccccc---ccccccCcccCcChh-hhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC-----H
Confidence            999999999999998655433   122345888999995 4456678999999999999999999999985221     1


Q ss_pred             hhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHH
Q 037916          629 HNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQ  704 (741)
Q Consensus       629 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  704 (741)
                      ......        +.+.......                  .......+.+++.+||+.||++||++.||.++++
T Consensus       219 ~~~~~~--------~~~~~~~~~~------------------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         219 LSLATK--------IVEAVYEPLP------------------EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             HHHHHH--------HhhccCCcCC------------------cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            111100        0000000000                  0022356889999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.3e-34  Score=296.61  Aligned_cols=253  Identities=23%  Similarity=0.305  Sum_probs=194.6

Q ss_pred             HHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcC------cchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG------ASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      |+..+.||+|++|.||+|.+..+++.||+|+++.....      ..+.+.+|+.++++++||||+++++++     .+.+
T Consensus         2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~   76 (268)
T cd06630           2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT-----CEDS   76 (268)
T ss_pred             ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee-----ccCC
Confidence            67788999999999999999889999999998743211      235678899999999999999999994     4566


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCC-ce
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEM-TA  554 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~-~~  554 (741)
                      ..++||||+++++|.+++...          ..+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++ .+
T Consensus        77 ~~~~v~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~  143 (268)
T cd06630          77 HFNLFVEWMAGGSVSHLLSKY----------GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRL  143 (268)
T ss_pred             eEEEEEeccCCCcHHHHHHHh----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEE
Confidence            899999999999999998643          3578888999999999999999999   999999999999998776 69


Q ss_pred             EEeecccccccCCCCccc--ccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhh
Q 037916          555 HVADFGLAKLLPPAHLQT--SSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFA  632 (741)
Q Consensus       555 kL~DFg~a~~~~~~~~~~--~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~  632 (741)
                      ||+|||.+..........  ......++..|+|||. ..+..++.++||||+|+++|++++|..||...... .... ..
T Consensus       144 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~-~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~-~~  220 (268)
T cd06630         144 RIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV-LRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS-NHLA-LI  220 (268)
T ss_pred             EEcccccccccccccccCCccccccccccceeCHhH-hccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc-chHH-HH
Confidence            999999987765432111  1122457889999954 45677899999999999999999999998522110 0000 00


Q ss_pred             hhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          633 RTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       633 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                              ..........                  ..+....+.+.+++.+||..+|++|||+.|+++
T Consensus       221 --------~~~~~~~~~~------------------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         221 --------FKIASATTAP------------------SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             --------HHHhccCCCC------------------CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence                    0000000000                  011234567889999999999999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.8e-34  Score=295.19  Aligned_cols=252  Identities=25%  Similarity=0.293  Sum_probs=200.3

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc-CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      .|++.+.||+|++|.||+|.+..+++.||+|++..... .....+.+|+..+++++||||+++++++     ......++
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~l   76 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF-----YKEGEISI   76 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----ccCCeEEE
Confidence            47788999999999999999998899999999875433 3456788999999999999999999995     44568999


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHh-cCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH-DCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      ||||+++++|.+++...          ..+++..+..++.|+++|++|||+ .   +++||||+|+||+++.++.++|+|
T Consensus        77 v~e~~~~~~L~~~l~~~----------~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~d  143 (264)
T cd06623          77 VLEYMDGGSLADLLKKV----------GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIAD  143 (264)
T ss_pred             EEEecCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEcc
Confidence            99999999999998643          457889999999999999999999 8   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCc
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      ||.+..........  ....++..|+||| ...+..++.++||||||+++|++++|+.||.....  ....+.....   
T Consensus       144 f~~~~~~~~~~~~~--~~~~~~~~y~~pE-~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--~~~~~~~~~~---  215 (264)
T cd06623         144 FGISKVLENTLDQC--NTFVGTVTYMSPE-RIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ--PSFFELMQAI---  215 (264)
T ss_pred             CccceecccCCCcc--cceeecccccCHh-hhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc--cCHHHHHHHH---
Confidence            99998765433221  1245788999994 55666889999999999999999999999864322  0111111110   


Q ss_pred             chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHH-HHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          639 HVMDIVDSTLLADDEDLTITSNQRQRQARINNIME-CLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       639 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                           ........                   ... .+..+.+++.+||..+|++|||+.|+++.
T Consensus       216 -----~~~~~~~~-------------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         216 -----CDGPPPSL-------------------PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             -----hcCCCCCC-------------------CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                 00000000                   011 45678899999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=4.1e-34  Score=296.28  Aligned_cols=248  Identities=24%  Similarity=0.299  Sum_probs=194.8

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      .|++.+.||+|+||.||+|.+..++..||+|++.... ....+.+.+|+.++++++||||+++++++     ..+...++
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~l   79 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKDTKLWI   79 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEE-----EeCCeEEE
Confidence            4788999999999999999998889999999986332 22345678899999999999999999984     45668999


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      ||||+++++|.+++..           ..+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+||
T Consensus        80 v~e~~~~~~l~~~i~~-----------~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~df  145 (277)
T cd06641          80 IMEYLGGGSALDLLEP-----------GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADF  145 (277)
T ss_pred             EEEeCCCCcHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeec
Confidence            9999999999998852           3478889999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcc
Q 037916          560 GLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDH  639 (741)
Q Consensus       560 g~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  639 (741)
                      |.+.........  .....++..|+||| ...+...+.++||||+||++|++++|..||......  .   ....     
T Consensus       146 g~~~~~~~~~~~--~~~~~~~~~y~~PE-~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~---~~~~-----  212 (277)
T cd06641         146 GVAGQLTDTQIK--RNTFVGTPFWMAPE-VIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM--K---VLFL-----  212 (277)
T ss_pred             ccceecccchhh--hccccCCccccChh-hhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH--H---HHHH-----
Confidence            998765433211  12245788999995 555667889999999999999999999998632110  0   0000     


Q ss_pred             hhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          640 VMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       640 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                          +.......                  .....+..+.+++.+||+.+|++||++.|+++.
T Consensus       213 ----~~~~~~~~------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         213 ----IPKNNPPT------------------LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             ----HhcCCCCC------------------CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                00000000                  001234567899999999999999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.9e-34  Score=295.43  Aligned_cols=252  Identities=19%  Similarity=0.214  Sum_probs=190.1

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc-----CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH-----GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      .|++.+.||+|+||.||.|.+..++..||+|.+.....     ...+.+.+|+.++++++||||+++++++.+   ....
T Consensus         3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~   79 (265)
T cd06652           3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRD---PMER   79 (265)
T ss_pred             cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEecc---CCCc
Confidence            47788999999999999999998999999998863221     123467789999999999999999998532   1235


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..+++|||+++++|.+++...          ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+|
T Consensus        80 ~~~~v~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~  146 (265)
T cd06652          80 TLSIFMEHMPGGSIKDQLKSY----------GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVK  146 (265)
T ss_pred             eEEEEEEecCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEE
Confidence            688999999999999998632          3467788899999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcc-cccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhh
Q 037916          556 VADFGLAKLLPPAHLQ-TSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~-~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  634 (741)
                      |+|||.+......... .......|+..|+|||.+ .+..++.++|||||||++|++++|+.||.....    .......
T Consensus       147 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~----~~~~~~~  221 (265)
T cd06652         147 LGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI-SGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA----MAAIFKI  221 (265)
T ss_pred             ECcCccccccccccccccccccCCCCccccChhhh-cCCCCCcchhHHHHHHHHHHHhhCCCCCCccch----HHHHHHH
Confidence            9999998765432111 111224588899999544 556789999999999999999999999862210    0000000


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ....         ...                  ..+......+.+++.+|+. +|++||+++||++
T Consensus       222 ~~~~---------~~~------------------~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         222 ATQP---------TNP------------------VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             hcCC---------CCC------------------CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            0000         000                  0011334567788889984 9999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-36  Score=281.79  Aligned_cols=210  Identities=21%  Similarity=0.308  Sum_probs=175.8

Q ss_pred             HHHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeec--cCcCcchhHHHHHHHHHhcCCCceeeEeeeecCcccc--
Q 037916          397 LLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYK--  472 (741)
Q Consensus       397 ~~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~--  472 (741)
                      ...+.|+-..+||+|.||+||+|+.+.+++.||+|++-.  ..........+|+++++.++|+|++.++++|......  
T Consensus        14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~   93 (376)
T KOG0669|consen   14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTN   93 (376)
T ss_pred             ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcc
Confidence            345678999999999999999999999999999987642  3345567788999999999999999999998664322  


Q ss_pred             -CCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCC
Q 037916          473 -GDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHE  551 (741)
Q Consensus       473 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~  551 (741)
                       +....|+||.+|+. +|.-++...         ...++..++.+++.++..||.|+|..   .|+|||+||+|+||+.+
T Consensus        94 r~r~t~ylVf~~ceh-DLaGlLsn~---------~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~d  160 (376)
T KOG0669|consen   94 RDRATFYLVFDFCEH-DLAGLLSNR---------KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKD  160 (376)
T ss_pred             cccceeeeeHHHhhh-hHHHHhcCc---------cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCC
Confidence             23348999999965 888888632         35689999999999999999999999   99999999999999999


Q ss_pred             CceEEeecccccccCCCCc--ccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCC
Q 037916          552 MTAHVADFGLAKLLPPAHL--QTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSD  619 (741)
Q Consensus       552 ~~~kL~DFg~a~~~~~~~~--~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~  619 (741)
                      |.+||+|||+++....+..  ....+..+-|.+|++||.++....|+++.|||..|||+.||.+|.+-+.
T Consensus       161 gilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimq  230 (376)
T KOG0669|consen  161 GILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQ  230 (376)
T ss_pred             ceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCcccc
Confidence            9999999999976543321  2223345569999999888888999999999999999999999998765

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.9e-34  Score=300.54  Aligned_cols=260  Identities=23%  Similarity=0.245  Sum_probs=191.1

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc-CcchhHHHHHHHHHhcC-CCceeeEeeeecCccccCCceE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH-GASKSSIAECSALRNIR-HKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      ..|...+.||+|+||.||++.+..+++.||+|.+..... .....+.+|+.++.++. ||||+++++++     ..+...
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~-----~~~~~~   78 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGAL-----FREGDC   78 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEE-----ecCCcE
Confidence            467888999999999999999999999999999864322 23456788999999996 99999999984     345578


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      +++|||+. +++.++.....     ......+++..+..++.|++.||+|||+..  +++||||||+||+++.++.+||+
T Consensus        79 ~~~~e~~~-~~l~~l~~~~~-----~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~  150 (288)
T cd06616          79 WICMELMD-ISLDKFYKYVY-----EVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLC  150 (288)
T ss_pred             EEEEeccc-CCHHHHHHHHH-----HhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEe
Confidence            99999985 46555432100     001245788899999999999999999632  89999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccccccCcccccCC--CCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhc
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLG--SEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV  635 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~--~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~  635 (741)
                      |||++.........   ....|+..|+|||.+...  ..++.++||||+||++|+|++|+.||....    .........
T Consensus       151 dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~~~~  223 (288)
T cd06616         151 DFGISGQLVDSIAK---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN----SVFDQLTQV  223 (288)
T ss_pred             ecchhHHhccCCcc---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc----hHHHHHhhh
Confidence            99998765433211   123478899999665444  378999999999999999999999986321    100011110


Q ss_pred             CCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          636 LPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       636 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      .....     +.+...                  ....++..+.+++.+||+.||++|||+.||++.
T Consensus       224 ~~~~~-----~~~~~~------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         224 VKGDP-----PILSNS------------------EEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             cCCCC-----CcCCCc------------------CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00000     000000                  001245678899999999999999999999874

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=3.6e-34  Score=297.80  Aligned_cols=249  Identities=20%  Similarity=0.246  Sum_probs=194.0

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALV  480 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv  480 (741)
                      .|.-.+.||+|++|.||+|.+..+++.||+|+++.......+.+.+|+.+++.++||||+++++++     ...+..+++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~-----~~~~~~~~v   94 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY-----LVGDELWVV   94 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEE-----EcCCeEEEE
Confidence            355567899999999999999888999999998754444456678899999999999999999984     455688999


Q ss_pred             EecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecc
Q 037916          481 YEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFG  560 (741)
Q Consensus       481 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg  560 (741)
                      +||+++++|.+++..           ..+++..+..++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||
T Consensus        95 ~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g  160 (285)
T cd06648          95 MEFLEGGALTDIVTH-----------TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFG  160 (285)
T ss_pred             EeccCCCCHHHHHHh-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccc
Confidence            999999999998853           2467888999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcch
Q 037916          561 LAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHV  640 (741)
Q Consensus       561 ~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  640 (741)
                      .+.........  .....|++.|+||| ...+..++.++||||+||++|+|++|+.||....    . ........... 
T Consensus       161 ~~~~~~~~~~~--~~~~~~~~~y~aPE-~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~----~-~~~~~~~~~~~-  231 (285)
T cd06648         161 FCAQVSKEVPR--RKSLVGTPYWMAPE-VISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP----P-LQAMKRIRDNL-  231 (285)
T ss_pred             cchhhccCCcc--cccccCCccccCHH-HhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC----H-HHHHHHHHhcC-
Confidence            88755432211  12245889999995 4556678999999999999999999999985211    0 00000000000 


Q ss_pred             hHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          641 MDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       641 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                          ....                    ......+..+.+++.+||..+|++|||+.|+++
T Consensus       232 ----~~~~--------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         232 ----PPKL--------------------KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             ----CCCC--------------------cccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence                0000                    000123456889999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=3.4e-34  Score=294.65  Aligned_cols=253  Identities=24%  Similarity=0.321  Sum_probs=195.5

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcC--cchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG--ASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      +|.+.+.||+|+||.||+|.+..+++.||+|+++.....  ..+.+..|+.++++++|+||+++++++     ......+
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~   75 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVE-----VHREKVY   75 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeE-----ecCCEEE
Confidence            477889999999999999999888999999999754432  456788999999999999999999984     4556899


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      +|+||+++++|.+++...          ..+++..+..++.|++.||.|||+.   +|+|+||+|+||+++.++.+||+|
T Consensus        76 lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d  142 (264)
T cd06626          76 IFMEYCSGGTLEELLEHG----------RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGD  142 (264)
T ss_pred             EEEecCCCCcHHHHHhhc----------CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcc
Confidence            999999999999998632          3467888899999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccc--cccccccccccCcccccCCCC---CCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhh
Q 037916          559 FGLAKLLPPAHLQTS--SIGVKGTIGYIAPAEYGLGSE---VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFAR  633 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~--~~~~~gt~~y~aPEe~~~~~~---~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~  633 (741)
                      ||.+...........  .....++..|+|||.+ .+..   .+.++||||||+++|++++|+.||......   ......
T Consensus       143 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~-~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~---~~~~~~  218 (264)
T cd06626         143 FGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI-TGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE---FQIMFH  218 (264)
T ss_pred             cccccccCCCCCcccccccCCcCCcCccChhhc-cCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch---HHHHHH
Confidence            999887654322111  1124578899999554 4433   889999999999999999999998632111   000000


Q ss_pred             hcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          634 TVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       634 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      .....      ...                    ..........+.+++.+||+.||++|||+.|++.
T Consensus       219 ~~~~~------~~~--------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         219 VGAGH------KPP--------------------IPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             HhcCC------CCC--------------------CCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00000      000                    0000122456779999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-34  Score=255.77  Aligned_cols=277  Identities=22%  Similarity=0.252  Sum_probs=199.5

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC--cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      .|.-+++||+|.||+||+|+.+++++.||+|.++..+  ........+|+-+++.++|.|||+++++     ...+....
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dv-----lhsdkklt   77 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV-----LHSDKKLT   77 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhh-----hccCceeE
Confidence            4778899999999999999999999999999998433  3345678899999999999999999999     45566889


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      +|+||| ..+|..|....         ...++...++.++.|+++||.|+|++   .+.|||+||.|.+|+.+|.+|++|
T Consensus        78 lvfe~c-dqdlkkyfdsl---------ng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelklad  144 (292)
T KOG0662|consen   78 LVFEFC-DQDLKKYFDSL---------NGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLAD  144 (292)
T ss_pred             EeHHHh-hHHHHHHHHhc---------CCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecc
Confidence            999999 56998887643         24578888999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCC-CCccccCCcchhhhhhhcCC
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP-SDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p-~~~~~~~~~~~~~~~~~~~~  637 (741)
                      ||+++..+-+...  .....-|.+|++|..+....-|++..|+||.||++.|+.....| |.. .+.+.++....+..-.
T Consensus       145 fglarafgipvrc--ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg-~dvddqlkrif~~lg~  221 (292)
T KOG0662|consen  145 FGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG-NDVDDQLKRIFRLLGT  221 (292)
T ss_pred             cchhhhcCCceEe--eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCC-CcHHHHHHHHHHHhCC
Confidence            9999876544321  12244699999997777777899999999999999999874444 431 1222233333332221


Q ss_pred             cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          638 DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       638 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      .....+..-.-.+++.....-   .....+....+.....=.+++++.+.-+|.+|.++++.++
T Consensus       222 p~ed~wps~t~lpdyk~yp~y---pattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  222 PTEDQWPSMTKLPDYKPYPIY---PATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             CccccCCccccCCCCcccCCc---cccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            111111111111111110000   0011111112222333457788888889999999998775

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-34  Score=298.53  Aligned_cols=280  Identities=20%  Similarity=0.226  Sum_probs=197.8

Q ss_pred             HHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC--cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      |++.+.||+|+||.||+|.+..+++.||+|+++...  ......+.+|+.++++++|||++++++++...   .....++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~l   77 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSK---GKGSIYM   77 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecC---CCCcEEE
Confidence            567889999999999999999889999999998543  23345678899999999999999999996422   1368999


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      ||||++ ++|.+++...         ...+++..++.++.|+++||+|||+.   +++|+||+|+||++++++.+||+||
T Consensus        78 v~e~~~-~~l~~~~~~~---------~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~  144 (287)
T cd07840          78 VFEYMD-HDLTGLLDSP---------EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADF  144 (287)
T ss_pred             Eecccc-ccHHHHHhcc---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccc
Confidence            999996 5888887532         13578899999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcc
Q 037916          560 GLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDH  639 (741)
Q Consensus       560 g~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  639 (741)
                      |.+........ .......++..|+|||.+.....++.++||||||+++|||++|+.||..... ...+...........
T Consensus       145 g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~-~~~~~~~~~~~~~~~  222 (287)
T cd07840         145 GLARPYTKRNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE-LEQLEKIFELCGSPT  222 (287)
T ss_pred             cceeeccCCCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCc
Confidence            99987654431 1122245688899996555555688999999999999999999999863221 111111111100000


Q ss_pred             hhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHH-HHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          640 VMDIVDSTLLADDEDLTITSNQRQRQARINNIME-CLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       640 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ...+.+-........  ................. ++..+.+++.+||+.+|++|||+.++++
T Consensus       223 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         223 DENWPGVSKLPWFEN--LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hhhccccccchhhhh--ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            000000000000000  00000000000011112 3678899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.5e-34  Score=301.83  Aligned_cols=263  Identities=20%  Similarity=0.221  Sum_probs=183.6

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCC---CeEEEEEEeeccCcCcc-----------hhHHHHHHHHHhcCCCceeeEeee
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEG---KTIIAVKVLNLLHHGAS-----------KSSIAECSALRNIRHKNLVKILTV  465 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~---~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~hpnIv~~~~~  465 (741)
                      ..|.+.+.||+|+||.||+|.+..+   +..+|+|+.........           .....+...++.+.|++|++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            5789999999999999999999876   66778876542221110           011223344556789999999987


Q ss_pred             ecCccccCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCC
Q 037916          466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSN  545 (741)
Q Consensus       466 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~N  545 (741)
                      +.... ......+++||++ ..++.+.+...          ...++..+..++.|++.||+|||+.   +|+||||||+|
T Consensus        92 ~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~N  156 (294)
T PHA02882         92 GSFKR-CRMYYRFILLEKL-VENTKEIFKRI----------KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPEN  156 (294)
T ss_pred             eeEec-CCceEEEEEEehh-ccCHHHHHHhh----------ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHH
Confidence            53211 1223557888887 34666665422          2346777889999999999999999   99999999999


Q ss_pred             eEeCCCCceEEeecccccccCCCCc-----ccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCc
Q 037916          546 VLLDHEMTAHVADFGLAKLLPPAHL-----QTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDI  620 (741)
Q Consensus       546 Ill~~~~~~kL~DFg~a~~~~~~~~-----~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~  620 (741)
                      |+++.++.+||+|||+|+.......     ........||+.|+|| ++..+..++.++||||+||++|||++|+.||..
T Consensus       157 ill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ap-e~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~  235 (294)
T PHA02882        157 IMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGL-DAHNGACVTRRGDLESLGYCMLKWAGIKLPWKG  235 (294)
T ss_pred             EEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCH-HHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCc
Confidence            9999999999999999976543211     1111224599999999 566678899999999999999999999999974


Q ss_pred             cccCCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHH
Q 037916          621 MFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVV  700 (741)
Q Consensus       621 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  700 (741)
                      ......... ...       .+++.....+..                 ....+++.+.+++..||+.+|++||++.+++
T Consensus       236 ~~~~~~~~~-~~~-------~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~  290 (294)
T PHA02882        236 FGHNGNLIH-AAK-------CDFIKRLHEGKI-----------------KIKNANKFIYDFIECVTKLSYEEKPDYDALI  290 (294)
T ss_pred             cccchHHHH-HhH-------HHHHHHhhhhhh-----------------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHH
Confidence            321111110 000       011110000000                 0123456788999999999999999999999


Q ss_pred             HHH
Q 037916          701 HEL  703 (741)
Q Consensus       701 ~~L  703 (741)
                      +.+
T Consensus       291 ~~~  293 (294)
T PHA02882        291 KIF  293 (294)
T ss_pred             Hhh
Confidence            876

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=5.4e-34  Score=299.97  Aligned_cols=249  Identities=27%  Similarity=0.274  Sum_probs=192.1

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc---CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH---GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      ..+|.+.+.||+|+||.||+|.+..+++.||+|++.....   ...+.+.+|+.+++.++||||++++++|     .+..
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~-----~~~~   88 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCY-----LREH   88 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----EeCC
Confidence            3568999999999999999999988899999999863322   2234677899999999999999999995     3455


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..++||||+. |++.+++...         ...+++..+..++.|++.||.|||+.   +|+||||+|+||++++++.+|
T Consensus        89 ~~~lv~e~~~-g~l~~~~~~~---------~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~k  155 (307)
T cd06607          89 TAWLVMEYCL-GSASDILEVH---------KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVK  155 (307)
T ss_pred             eEEEEHHhhC-CCHHHHHHHc---------ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEE
Confidence            7899999996 5777766422         13478899999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcccccccccccccccCccccc--CCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhh
Q 037916          556 VADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG--LGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFAR  633 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~--~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~  633 (741)
                      |+|||.+.......      ...++..|+|||.+.  ....++.++||||||+++|||++|+.||.......     .. 
T Consensus       156 L~dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~-----~~-  223 (307)
T cd06607         156 LADFGSASLVSPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-----AL-  223 (307)
T ss_pred             EeecCcceecCCCC------CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH-----HH-
Confidence            99999987654321      234788999996553  24568899999999999999999999985321100     00 


Q ss_pred             hcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          634 TVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       634 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                             ....... ....                 ........+.+++.+||+.||++||++.+|+..
T Consensus       224 -------~~~~~~~-~~~~-----------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         224 -------YHIAQND-SPTL-----------------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             -------HHHhcCC-CCCC-----------------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                   0000000 0000                 011245568899999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-35  Score=325.31  Aligned_cols=201  Identities=26%  Similarity=0.321  Sum_probs=179.1

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeec---cCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCce
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNL---LHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      ..|.|++.||+|+||.|..++++.+++.||+|++++   ........|..|-++|..-+.+-||+++..     |+++.+
T Consensus        75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyA-----FQD~~~  149 (1317)
T KOG0612|consen   75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYA-----FQDERY  149 (1317)
T ss_pred             HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHH-----hcCccc
Confidence            589999999999999999999999999999999975   445566788999999999999999999877     788999


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .|+|||||+||+|-.++...          ..+++.-++.++..|+-||.-+|+.   |+|||||||+|||+|..|++||
T Consensus       150 LYlVMdY~pGGDlltLlSk~----------~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikL  216 (1317)
T KOG0612|consen  150 LYLVMDYMPGGDLLTLLSKF----------DRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKL  216 (1317)
T ss_pred             eEEEEecccCchHHHHHhhc----------CCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEee
Confidence            99999999999999999754          2588888999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccccccCccccc---CC-CCCCCccCchhHHHHHHHHHcCCCCCC
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG---LG-SEVSINGDVYSYGILLLELMTRKRPSD  619 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~---~~-~~~~~~~DIwSlG~il~elltg~~p~~  619 (741)
                      +|||.|-.+...+...... .+|||.|.+||.+.   .+ +.|+..+|+||+||++|||+.|..||.
T Consensus       217 ADFGsClkm~~dG~V~s~~-aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY  282 (1317)
T KOG0612|consen  217 ADFGSCLKMDADGTVRSSV-AVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY  282 (1317)
T ss_pred             ccchhHHhcCCCCcEEecc-ccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch
Confidence            9999998887665544433 56999999996542   23 679999999999999999999999986

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-35  Score=294.55  Aligned_cols=263  Identities=23%  Similarity=0.330  Sum_probs=203.1

Q ss_pred             HHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC-------cCcchhHHHHHHHHHhcCCCceeeEeeeecCcc
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH-------HGASKSSIAECSALRNIRHKNLVKILTVCSGVD  470 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  470 (741)
                      +..+|.++..||+|+|++||+|.+....+.||||+-....       ....+...+|.++.+.|+||.||++|+++.   
T Consensus       461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfs---  537 (775)
T KOG1151|consen  461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFS---  537 (775)
T ss_pred             hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeee---
Confidence            5578889999999999999999999899999999875321       223455678999999999999999999974   


Q ss_pred             ccCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeC-
Q 037916          471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLD-  549 (741)
Q Consensus       471 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~-  549 (741)
                       -+.+..|-|+|||+|.+|.-|++..          +.+++.+++.|+.||+.||.||.+. .++|||-||||.|||+. 
T Consensus       538 -lDtdsFCTVLEYceGNDLDFYLKQh----------klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~  605 (775)
T KOG1151|consen  538 -LDTDSFCTVLEYCEGNDLDFYLKQH----------KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVN  605 (775)
T ss_pred             -eccccceeeeeecCCCchhHHHHhh----------hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEec
Confidence             3455789999999999999999865          6789999999999999999999987 88999999999999994 


Q ss_pred             --CCCceEEeecccccccCCCCccc-----ccccccccccccCcccccCC---CCCCCccCchhHHHHHHHHHcCCCCCC
Q 037916          550 --HEMTAHVADFGLAKLLPPAHLQT-----SSIGVKGTIGYIAPAEYGLG---SEVSINGDVYSYGILLLELMTRKRPSD  619 (741)
Q Consensus       550 --~~~~~kL~DFg~a~~~~~~~~~~-----~~~~~~gt~~y~aPEe~~~~---~~~~~~~DIwSlG~il~elltg~~p~~  619 (741)
                        ..|.+||+|||+++.+.+.....     ......||.+|.+||.+.-+   ..++.|+||||+|||+|.++.|+.||.
T Consensus       606 GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFG  685 (775)
T KOG1151|consen  606 GTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFG  685 (775)
T ss_pred             CcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCC
Confidence              35789999999999997654321     12235699999999887655   457899999999999999999999996


Q ss_pred             ccccCCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHH
Q 037916          620 IMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIV  699 (741)
Q Consensus       620 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev  699 (741)
                      ..-.....+. ...         ++...-.                 .++..+....+...+|++||.+--++|....|+
T Consensus       686 hnqsQQdILq-eNT---------IlkAtEV-----------------qFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qL  738 (775)
T KOG1151|consen  686 HNQSQQDILQ-ENT---------ILKATEV-----------------QFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQL  738 (775)
T ss_pred             CchhHHHHHh-hhc---------hhcceec-----------------cCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHH
Confidence            3221111100 000         0000000                 001112334456789999999999999998888


Q ss_pred             HHH
Q 037916          700 VHE  702 (741)
Q Consensus       700 l~~  702 (741)
                      ...
T Consensus       739 A~d  741 (775)
T KOG1151|consen  739 ACD  741 (775)
T ss_pred             ccC
Confidence            754

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-34  Score=299.14  Aligned_cols=275  Identities=24%  Similarity=0.269  Sum_probs=195.4

Q ss_pred             HHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC--cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      |++.+.||.|++|.||+|.+..++..||+|++....  ....+.+.+|+.+++.++|||++++++++     .++...|+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~-----~~~~~~~i   75 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVV-----HSENKLYL   75 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhhee-----ccCCeEEE
Confidence            577889999999999999998899999999987433  22335678899999999999999999995     44568999


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      +|||+ +++|.+++....        ...+++..+..++.|+++||+|||+.   +++||||+|+||+++.++.++|+||
T Consensus        76 v~e~~-~~~l~~~~~~~~--------~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df  143 (283)
T cd07835          76 VFEFL-DLDLKKYMDSSP--------LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADF  143 (283)
T ss_pred             EEecc-CcCHHHHHhhCC--------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeec
Confidence            99999 468999886431        13578999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcc
Q 037916          560 GLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDH  639 (741)
Q Consensus       560 g~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  639 (741)
                      |.+.........  .....++..|+|||.+.....++.++||||+|+++|+|++|+.||...... .......+......
T Consensus       144 ~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~  220 (283)
T cd07835         144 GLARAFGVPVRT--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI-DQLFRIFRTLGTPD  220 (283)
T ss_pred             ccccccCCCccc--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCC
Confidence            999765432211  112346889999965555556789999999999999999999998632111 01111111100000


Q ss_pred             --hhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          640 --VMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       640 --~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                        ........  .+..  ...... ...............+.+++.+||+.||++|||++|+++
T Consensus       221 ~~~~~~~~~~--~~~~--~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         221 EDVWPGVTSL--PDYK--PTFPKW-ARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hHHhhhhhhc--hhhh--hhcccc-cccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence              00000000  0000  000000 000000111223457889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=3.2e-34  Score=300.06  Aligned_cols=285  Identities=18%  Similarity=0.180  Sum_probs=196.4

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC--cCcchhHHHHHHHHHhcC-CCceeeEeeeecCccccCCceE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIR-HKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      .|++.+.||+|+||.||+|.+..+++.||+|+++...  ......+.+|+.+++.+. ||||+++++++...........
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~   81 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL   81 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence            4788899999999999999999899999999986432  223456788999999994 6999999998754332233458


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCC-CCceEE
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDH-EMTAHV  556 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~-~~~~kL  556 (741)
                      |+||||+++ +|.+++......     ....+++..++.++.||++||.|||+.   +|+||||||+||+++. ++.+||
T Consensus        82 ~lv~e~~~~-~l~~~~~~~~~~-----~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl  152 (295)
T cd07837          82 YLVFEYLDS-DLKKFMDSNGRG-----PGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKI  152 (295)
T ss_pred             EEEeeccCc-CHHHHHHHhccc-----CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEE
Confidence            999999975 888887543111     124578999999999999999999999   9999999999999998 889999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcC
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVL  636 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  636 (741)
                      +|||.+.........  .....+++.|+|||.+.....++.++||||||+++|+|++|..||....... .+........
T Consensus       153 ~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~  229 (295)
T cd07837         153 ADLGLGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ-QLLHIFKLLG  229 (295)
T ss_pred             eecccceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHhC
Confidence            999998765432111  1123468889999766555678999999999999999999999986321100 0111111000


Q ss_pred             CcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          637 PDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       637 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ......+..........  . .... .........+.....+.+++.+||..||++|||+.|++.
T Consensus       230 ~~~~~~~~~~~~~~~~~--~-~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         230 TPTEQVWPGVSKLRDWH--E-FPQW-KPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             CCChhhCcchhhccchh--h-cCcc-cchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            00000000000000000  0 0000 000000111234667889999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.3e-34  Score=300.26  Aligned_cols=243  Identities=24%  Similarity=0.234  Sum_probs=192.8

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      .|++.+.||+|+||.||+|.+..+++.||+|+++...   ....+.+.+|+.++++++||||+++++++     .++...
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   76 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSF-----QDDSNL   76 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCeE
Confidence            4788899999999999999999899999999986432   22345678899999999999999999984     556689


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      ++||||+++++|.+++...          ..+++..+..++.|+++||.|||+.   +|+||||+|+||+++.++.+||+
T Consensus        77 ~~v~e~~~~~~L~~~~~~~----------~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~  143 (290)
T cd05580          77 YLVMEYVPGGELFSHLRKS----------GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKIT  143 (290)
T ss_pred             EEEEecCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEe
Confidence            9999999999999998643          4578889999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCC
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      |||.+......     .....+++.|+|||. ..+..++.++||||+|+++|+|++|+.||.....     ......   
T Consensus       144 dfg~~~~~~~~-----~~~~~~~~~y~aPE~-~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~---  209 (290)
T cd05580         144 DFGFAKRVKGR-----TYTLCGTPEYLAPEI-ILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP-----IQIYEK---  209 (290)
T ss_pred             eCCCccccCCC-----CCCCCCCccccChhh-hcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHH---
Confidence            99998876543     122458899999954 4556788999999999999999999999863210     000000   


Q ss_pred             cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCC-----CHHHHH
Q 037916          638 DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRM-----NMTIVV  700 (741)
Q Consensus       638 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl  700 (741)
                           ...    ...                ..+......+.+++.+||..||++||     +++|++
T Consensus       210 -----~~~----~~~----------------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~  252 (290)
T cd05580         210 -----ILE----GKV----------------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK  252 (290)
T ss_pred             -----Hhc----CCc----------------cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence                 000    000                00012235677999999999999999     666665

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-34  Score=290.37  Aligned_cols=271  Identities=21%  Similarity=0.339  Sum_probs=207.3

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHh--cCCCceeeEeeeecCccccCCceE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRN--IRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      ...++.+.||+|.||+||+|.|+  |+.||||++.   ..+.+.+.+|.++.+.  ++|+||..+++.-. .+...-...
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~---srdE~SWfrEtEIYqTvmLRHENILgFIaaD~-~~~gs~TQL  284 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFS---SRDERSWFRETEIYQTVMLRHENILGFIAADN-KDNGSWTQL  284 (513)
T ss_pred             heeEEEEEecCccccceeecccc--CCceEEEEec---ccchhhhhhHHHHHHHHHhccchhhhhhhccc-cCCCceEEE
Confidence            33456788999999999999998  8889999995   4456678888888875  59999999988621 111223368


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhc-----CCCCceecCCCCCCeEeCCCC
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHD-----CQPTTAHCDLKPSNVLLDHEM  552 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-----~~~~ivHrDlkp~NIll~~~~  552 (741)
                      |+|++|.+.|||++|+..           ..++....++++.-+|.||++||..     .+|.|.|||||..||||..++
T Consensus       285 wLvTdYHe~GSL~DyL~r-----------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~  353 (513)
T KOG2052|consen  285 WLVTDYHEHGSLYDYLNR-----------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG  353 (513)
T ss_pred             EEeeecccCCcHHHHHhh-----------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC
Confidence            999999999999999973           4578889999999999999999976     368899999999999999999


Q ss_pred             ceEEeecccccccCCC--CcccccccccccccccCcccccCCCC-----CCCccCchhHHHHHHHHHcC----------C
Q 037916          553 TAHVADFGLAKLLPPA--HLQTSSIGVKGTIGYIAPAEYGLGSE-----VSINGDVYSYGILLLELMTR----------K  615 (741)
Q Consensus       553 ~~kL~DFg~a~~~~~~--~~~~~~~~~~gt~~y~aPEe~~~~~~-----~~~~~DIwSlG~il~elltg----------~  615 (741)
                      .+.|+|+|+|......  .........+||.+|||||.+-..-.     .=..+||||||.|+||+.-+          +
T Consensus       354 ~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~  433 (513)
T KOG2052|consen  354 TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQ  433 (513)
T ss_pred             cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhc
Confidence            9999999999876654  22233445679999999964422111     11458999999999998763          3


Q ss_pred             CCCCccccCCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCC
Q 037916          616 RPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMN  695 (741)
Q Consensus       616 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs  695 (741)
                      .||.+..+.+..+.++....--......+...+..                     .++...+.++|+.||..+|+-|-|
T Consensus       434 ~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s---------------------~~~l~~m~klMkeCW~~Np~aRlt  492 (513)
T KOG2052|consen  434 LPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKS---------------------DPALRVMAKLMKECWYANPAARLT  492 (513)
T ss_pred             CCcccCCCCCCCHHHHhcceeecccCCCCCccccc---------------------CHHHHHHHHHHHHhhcCCchhhhH
Confidence            67777766666666655443332222222222221                     245677899999999999999999


Q ss_pred             HHHHHHHHHHHHH
Q 037916          696 MTIVVHELQSIKS  708 (741)
Q Consensus       696 ~~evl~~L~~i~~  708 (741)
                      +--+.+.|.++.+
T Consensus       493 ALriKKtl~~l~~  505 (513)
T KOG2052|consen  493 ALRIKKTLAKLSN  505 (513)
T ss_pred             HHHHHHHHHHHhc
Confidence            9999999988875

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.5e-34  Score=296.25  Aligned_cols=247  Identities=25%  Similarity=0.323  Sum_probs=195.1

Q ss_pred             HHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc---CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH---GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      |++.+.||.|+||.||+|.+..++..||+|++.....   ...+.+.+|+.++++++||||++++++     +.++...+
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-----~~~~~~~~   76 (258)
T cd05578           2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYS-----FQDEENMY   76 (258)
T ss_pred             ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHh-----hcCCCeEE
Confidence            7788999999999999999998899999999974322   235678889999999999999999988     45667899


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      +||||+.+++|.+++...          ..+++..+..++.|+++||.|||+.   +++|+||+|+||++++++.++|+|
T Consensus        77 lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d  143 (258)
T cd05578          77 LVVDLLLGGDLRYHLSQK----------VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITD  143 (258)
T ss_pred             EEEeCCCCCCHHHHHHhc----------CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEee
Confidence            999999999999998632          3578889999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCc
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      ||.+........   .....|+..|+||| +..+..++.++||||+|+++|++++|..||......  ....+...    
T Consensus       144 ~~~~~~~~~~~~---~~~~~~~~~y~~PE-~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~----  213 (258)
T cd05578         144 FNIATKVTPDTL---TTSTSGTPGYMAPE-VLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIRAK----  213 (258)
T ss_pred             cccccccCCCcc---ccccCCChhhcCHH-HHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHHHHH----
Confidence            999886654321   12345888999995 555666899999999999999999999998632211  01111100    


Q ss_pred             chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCH--HHHH
Q 037916          639 HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNM--TIVV  700 (741)
Q Consensus       639 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~evl  700 (741)
                           ...   ..                ...+...+..+.+++.+||+.||++||++  +|++
T Consensus       214 -----~~~---~~----------------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         214 -----QET---AD----------------VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             -----hcc---cc----------------ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence                 000   00                00011334678899999999999999999  5554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=3.3e-34  Score=307.59  Aligned_cols=203  Identities=24%  Similarity=0.274  Sum_probs=168.2

Q ss_pred             HHHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeecc--CcCcchhHHHHHHHHHhcCCCceeeEeeeecCcc-ccC
Q 037916          397 LLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLL--HHGASKSSIAECSALRNIRHKNLVKILTVCSGVD-YKG  473 (741)
Q Consensus       397 ~~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~~  473 (741)
                      .+..+|++.+.||+|+||.||+|.+..+++.||+|++...  .......+.+|+.++++++||||+++++++.... +.+
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            4567899999999999999999999999999999998632  2223456678999999999999999999864322 223


Q ss_pred             CceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCc
Q 037916          474 DDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMT  553 (741)
Q Consensus       474 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~  553 (741)
                      ....|+||||+. ++|.+.+..            .++...+..++.|++.||+|||+.   ||+||||||+||+++.++.
T Consensus        93 ~~~~~lv~e~~~-~~l~~~~~~------------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~  156 (353)
T cd07850          93 FQDVYLVMELMD-ANLCQVIQM------------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCT  156 (353)
T ss_pred             cCcEEEEEeccC-CCHHHHHhh------------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCC
Confidence            346899999995 588887742            277888899999999999999999   9999999999999999999


Q ss_pred             eEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCC
Q 037916          554 AHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSD  619 (741)
Q Consensus       554 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~  619 (741)
                      +||+|||.+........   .....++..|+||| ...+..++.++||||+||++|+|++|+.||.
T Consensus       157 ~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE-~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~  218 (353)
T cd07850         157 LKILDFGLARTAGTSFM---MTPYVVTRYYRAPE-VILGMGYKENVDIWSVGCIMGEMIRGTVLFP  218 (353)
T ss_pred             EEEccCccceeCCCCCC---CCCCcccccccCHH-HHhCCCCCCchhhHhHHHHHHHHHHCCCCCC
Confidence            99999999986644322   12235788999995 5566788999999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=5.3e-34  Score=297.36  Aligned_cols=248  Identities=22%  Similarity=0.281  Sum_probs=193.3

Q ss_pred             HHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEEE
Q 037916          402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVY  481 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv~  481 (741)
                      |....+||+|+||.||+|....+++.||+|++..........+.+|+.+++.++||||+++++++     ..++..++||
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~   96 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY-----LVGDELWVVM   96 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEE-----EeCCEEEEEE
Confidence            45567899999999999999889999999998644444456688899999999999999999984     4566899999


Q ss_pred             ecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeeccc
Q 037916          482 EFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGL  561 (741)
Q Consensus       482 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~  561 (741)
                      ||+++++|.+++..           ..+++..+..++.|++.|++|||+.   |++||||+|+||+++.++.++|+|||.
T Consensus        97 e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~  162 (292)
T cd06657          97 EFLEGGALTDIVTH-----------TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGF  162 (292)
T ss_pred             ecCCCCcHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEccccc
Confidence            99999999988742           2367888999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcchh
Q 037916          562 AKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM  641 (741)
Q Consensus       562 a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  641 (741)
                      +........  ......|++.|+||| ...+..++.++||||+|+++|++++|..||....  ............+..  
T Consensus       163 ~~~~~~~~~--~~~~~~~~~~y~~pE-~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~--~~~~~~~~~~~~~~~--  235 (292)
T cd06657         163 CAQVSKEVP--RRKSLVGTPYWMAPE-LISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMIRDNLPPK--  235 (292)
T ss_pred             ceecccccc--cccccccCccccCHH-HhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhhCCcc--
Confidence            876543221  112245788999995 5556678899999999999999999999985210  001001111101100  


Q ss_pred             HhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          642 DIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       642 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                            ..                    .....+..+.+++.+||+.||.+||++.|+++
T Consensus       236 ------~~--------------------~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         236 ------LK--------------------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             ------cC--------------------CcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence                  00                    00123455778999999999999999999887

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-34  Score=302.01  Aligned_cols=253  Identities=23%  Similarity=0.260  Sum_probs=194.2

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcC---cchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG---ASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      .|++.+.||+|+||.||+|.+..+++.||+|.+......   ..+.+..|+.+++.++||||+++++++     ......
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~   76 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-----QTETYL   76 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-----ecCCEE
Confidence            477889999999999999999988999999999743322   345678899999999999999999984     456689


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      |+||||+.+++|.+++...        ....+++..+..++.|+++||+|||+.   +++||||||+||+++.++.++|+
T Consensus        77 ~lv~e~~~~~~L~~~~~~~--------~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~  145 (316)
T cd05574          77 CLVMDYCPGGELFRLLQRQ--------PGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLS  145 (316)
T ss_pred             EEEEEecCCCCHHHHHHhC--------CCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEe
Confidence            9999999999999998633        124578889999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCccc---------------------------ccccccccccccCcccccCCCCCCCccCchhHHHHHHH
Q 037916          558 DFGLAKLLPPAHLQT---------------------------SSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLE  610 (741)
Q Consensus       558 DFg~a~~~~~~~~~~---------------------------~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~e  610 (741)
                      |||.+..........                           ......|+..|+||| +..+..++.++||||||+++|+
T Consensus       146 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE-~~~~~~~~~~~Di~slG~ll~~  224 (316)
T cd05574         146 DFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAVDWWTLGILLYE  224 (316)
T ss_pred             ecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHH-HHcCCCCCchHHHHHHHHHHHH
Confidence            999987653221100                           011235788999995 4556678999999999999999


Q ss_pred             HHcCCCCCCccccCCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCC
Q 037916          611 LMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESP  690 (741)
Q Consensus       611 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP  690 (741)
                      |++|..||...... ..+.            .+.+.....                  ......+..+.+++.+||..||
T Consensus       225 l~~g~~pf~~~~~~-~~~~------------~~~~~~~~~------------------~~~~~~~~~~~~li~~~l~~~p  273 (316)
T cd05574         225 MLYGTTPFKGSNRD-ETFS------------NILKKEVTF------------------PGSPPVSSSARDLIRKLLVKDP  273 (316)
T ss_pred             HhhCCCCCCCCchH-HHHH------------HHhcCCccC------------------CCccccCHHHHHHHHHHccCCH
Confidence            99999998632111 0110            111000000                  0001135678899999999999


Q ss_pred             CCCCC----HHHHHH
Q 037916          691 QDRMN----MTIVVH  701 (741)
Q Consensus       691 ~~RPs----~~evl~  701 (741)
                      ++|||    +.|++.
T Consensus       274 ~~R~s~~~~~~~ll~  288 (316)
T cd05574         274 SKRLGSKRGAAEIKQ  288 (316)
T ss_pred             hHCCCchhhHHHHHc
Confidence            99999    555554

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.2e-33  Score=292.72  Aligned_cols=243  Identities=21%  Similarity=0.244  Sum_probs=182.8

Q ss_pred             hcccCceeeEEEEEEcCCCeEEEEEEeeccCcCc---chhHHHHH---HHHHhcCCCceeeEeeeecCccccCCceEEEE
Q 037916          407 WIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGA---SKSSIAEC---SALRNIRHKNLVKILTVCSGVDYKGDDFKALV  480 (741)
Q Consensus       407 ~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~---~~~~~~E~---~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv  480 (741)
                      .||+|+||.||+|.+..+++.||+|.+.......   ...+..|.   ..++...||+|++++++     +...+..++|
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~-----~~~~~~~~~v   75 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA-----FHTPDKLSFI   75 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeee-----eecCCEEEEE
Confidence            3799999999999998889999999986432211   11233343   33445589999999988     4556689999


Q ss_pred             EecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecc
Q 037916          481 YEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFG  560 (741)
Q Consensus       481 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg  560 (741)
                      |||++|++|.+++...          ..+++..++.++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        76 ~e~~~g~~L~~~l~~~----------~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg  142 (278)
T cd05606          76 LDLMNGGDLHYHLSQH----------GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLG  142 (278)
T ss_pred             EecCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCc
Confidence            9999999999988532          4588999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcch
Q 037916          561 LAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHV  640 (741)
Q Consensus       561 ~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  640 (741)
                      .+........    ....|+..|+|||.+..+..++.++||||+||++|+|++|+.||........  .........   
T Consensus       143 ~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~~---  213 (278)
T cd05606         143 LACDFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLT---  213 (278)
T ss_pred             CccccCccCC----cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch--HHHHHHhhc---
Confidence            9875533221    1235899999997665555789999999999999999999999863211110  000000000   


Q ss_pred             hHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCC-----CHHHHHH
Q 037916          641 MDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRM-----NMTIVVH  701 (741)
Q Consensus       641 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  701 (741)
                         ...                      ..+......+.+++.+|+..||++||     ++.|+++
T Consensus       214 ---~~~----------------------~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         214 ---MAV----------------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             ---cCC----------------------CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence               000                      00012245688999999999999999     8999885

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=8.6e-34  Score=297.85  Aligned_cols=287  Identities=22%  Similarity=0.223  Sum_probs=200.1

Q ss_pred             HHHHHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC--cCcchhHHHHHHHHHhcCCCceeeEeeeecCcc--
Q 037916          395 GILLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSGVD--  470 (741)
Q Consensus       395 ~~~~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--  470 (741)
                      |.+....|++.+.||+|+||.||+|.+..+++.||+|+++...  ......+.+|+.++++++||||+++++++.+..  
T Consensus         2 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~   81 (302)
T cd07864           2 GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA   81 (302)
T ss_pred             chhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence            3456678999999999999999999999889999999997432  223346678999999999999999999874322  


Q ss_pred             ---ccCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeE
Q 037916          471 ---YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVL  547 (741)
Q Consensus       471 ---~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIl  547 (741)
                         ..+....++||||+++ ++..++...         ...+++..+..++.|++.||+|||+.   +|+||||||+||+
T Consensus        82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~---------~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nil  148 (302)
T cd07864          82 LDFKKDKGAFYLVFEYMDH-DLMGLLESG---------LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNIL  148 (302)
T ss_pred             hhccccCCcEEEEEcccCc-cHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEE
Confidence               1123478999999965 776766432         13578899999999999999999999   9999999999999


Q ss_pred             eCCCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcc
Q 037916          548 LDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMN  627 (741)
Q Consensus       548 l~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~  627 (741)
                      +++++.+||+|||.+........ .......++..|+|||.+.....++.++||||+||++|+|++|+.||..... ...
T Consensus       149 i~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-~~~  226 (302)
T cd07864         149 LNNKGQIKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-LAQ  226 (302)
T ss_pred             ECCCCcEEeCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHH
Confidence            99999999999999986654322 1112234677899997665555678999999999999999999999863211 111


Q ss_pred             hhhhhhhcCCcc---hhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          628 LHNFARTVLPDH---VMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       628 ~~~~~~~~~~~~---~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      +...........   ..++.......... ....    ............+..+.+++.+||+.||++|||+.++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         227 LELISRLCGSPCPAVWPDVIKLPYFNTMK-PKKQ----YRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             HHHHHHHhCCCChhhcccccccccccccc-cccc----cccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            111111100000   00000000000000 0000    000000011123567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-35  Score=292.90  Aligned_cols=243  Identities=23%  Similarity=0.316  Sum_probs=193.9

Q ss_pred             hhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEEEe
Q 037916          406 CWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYE  482 (741)
Q Consensus       406 ~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv~e  482 (741)
                      +.||+|+||+||-++.+.+|+.+|+|.+.+..   .....-..+|-.++++++.+.||.+-..     |+..+..|+||.
T Consensus       191 RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYA-----feTkd~LClVLt  265 (591)
T KOG0986|consen  191 RVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYA-----FETKDALCLVLT  265 (591)
T ss_pred             EEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeee-----ecCCCceEEEEE
Confidence            35999999999999999999999999986322   2233455789999999999999988766     678889999999


Q ss_pred             cccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecccc
Q 037916          483 FMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLA  562 (741)
Q Consensus       483 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~a  562 (741)
                      .|.||+|.-+|....        ...+++..++.++.+|+.||++||..   +||.||+||+|||+|+.|+++|+|.|+|
T Consensus       266 lMNGGDLkfHiyn~g--------~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLA  334 (591)
T KOG0986|consen  266 LMNGGDLKFHIYNHG--------NPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLA  334 (591)
T ss_pred             eecCCceeEEeeccC--------CCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceE
Confidence            999999999987552        25689999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcchhH
Q 037916          563 KLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMD  642 (741)
Q Consensus       563 ~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  642 (741)
                      ..++......   +.+||.+|||| |+..++.|+..+|+||+||++|||+.|+.||....+              ....+
T Consensus       335 vei~~g~~~~---~rvGT~GYMAP-Evl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke--------------Kvk~e  396 (591)
T KOG0986|consen  335 VEIPEGKPIR---GRVGTVGYMAP-EVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE--------------KVKRE  396 (591)
T ss_pred             EecCCCCccc---cccCcccccCH-HHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh--------------hhhHH
Confidence            9887765433   34799999999 555666799999999999999999999999852111              11122


Q ss_pred             hhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHH
Q 037916          643 IVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMT  697 (741)
Q Consensus       643 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  697 (741)
                      -+|.+...+..               ..+....++..+|.+..|..||++|-...
T Consensus       397 Evdrr~~~~~~---------------ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  397 EVDRRTLEDPE---------------EYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             HHHHHHhcchh---------------hcccccCHHHHHHHHHHHccCHHHhccCC
Confidence            23322222211               11124456677888888999999997544

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=6.5e-34  Score=302.16  Aligned_cols=289  Identities=18%  Similarity=0.226  Sum_probs=194.3

Q ss_pred             hhhcccC--ceeeEEEEEEcCCCeEEEEEEeeccCc--CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEE
Q 037916          405 LCWIDMG--SFGSVYKGILDEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALV  480 (741)
Q Consensus       405 ~~~ig~G--~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv  480 (741)
                      ...||+|  +||.||+|.+..+++.||+|++.....  ...+.+.+|+.+++.++||||+++++++     ..+...++|
T Consensus         3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~-----~~~~~~~~v   77 (328)
T cd08226           3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVF-----TTGSWLWVI   77 (328)
T ss_pred             HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeE-----ecCCceEEE
Confidence            3467776  999999999998999999999874322  2245678899999999999999999995     456688999


Q ss_pred             EecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecc
Q 037916          481 YEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFG  560 (741)
Q Consensus       481 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg  560 (741)
                      |||+.++++.+++....        ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+|++||+
T Consensus        78 ~e~~~~~~l~~~l~~~~--------~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~  146 (328)
T cd08226          78 SPFMAYGSANSLLKTYF--------PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLS  146 (328)
T ss_pred             EecccCCCHHHHHHhhc--------ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechH
Confidence            99999999999886431        13478888899999999999999999   99999999999999999999999998


Q ss_pred             cccccCCCCccc-----ccccccccccccCcccccCC-CCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhh
Q 037916          561 LAKLLPPAHLQT-----SSIGVKGTIGYIAPAEYGLG-SEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       561 ~a~~~~~~~~~~-----~~~~~~gt~~y~aPEe~~~~-~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  634 (741)
                      .+..........     ......++..|+|||.+..+ ..++.++||||+||++|+|++|..||................
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~  226 (328)
T cd08226         147 HLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGP  226 (328)
T ss_pred             HHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCC
Confidence            654332211100     00112245679999665433 457899999999999999999999986432211111000000


Q ss_pred             c--------CCcchhHhhhhcccCCc--chhhhh----hhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHH
Q 037916          635 V--------LPDHVMDIVDSTLLADD--EDLTIT----SNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVV  700 (741)
Q Consensus       635 ~--------~~~~~~~~~d~~l~~~~--~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  700 (741)
                      .        .+.....+.+.......  ......    ...............+...+.+++.+||++||++|||+.|++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l  306 (328)
T cd08226         227 PYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLL  306 (328)
T ss_pred             CCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHh
Confidence            0        00000000000000000  000000    000000011122335667889999999999999999999998


Q ss_pred             HH--HHHHHHh
Q 037916          701 HE--LQSIKSI  709 (741)
Q Consensus       701 ~~--L~~i~~~  709 (741)
                      +.  +..+.+.
T Consensus       307 ~~~~~~~~~~~  317 (328)
T cd08226         307 SHAFFKQVKEQ  317 (328)
T ss_pred             hCHHHHHHHHh
Confidence            54  5555543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.8e-34  Score=304.49  Aligned_cols=292  Identities=20%  Similarity=0.205  Sum_probs=204.4

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC--cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      +|++.+.||.|++|.||+|.+..+++.||+|++....  ....+.+.+|+.+++.++||||+++++++...........|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4788899999999999999998889999999987433  33456788999999999999999999986443222334789


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      ++|||++ ++|.+++...          ..+++..+..++.|++.||+|||+.   ||+||||||+||+++.++.++|+|
T Consensus        81 lv~e~~~-~~l~~~l~~~----------~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~d  146 (330)
T cd07834          81 IVTELME-TDLHKVIKSP----------QPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICD  146 (330)
T ss_pred             EEecchh-hhHHHHHhCC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcc
Confidence            9999996 5898888643          3688999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcc-cccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCC
Q 037916          559 FGLAKLLPPAHLQ-TSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       559 Fg~a~~~~~~~~~-~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      ||.+......... .......++..|+|||.+.....++.++||||+|+++|+|++|..||....... .+...... ..
T Consensus       147 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~-~~  224 (330)
T cd07834         147 FGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID-QLNLIVEV-LG  224 (330)
T ss_pred             cCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHh-cC
Confidence            9999876554310 112224578899999655444488999999999999999999999986332110 01111000 00


Q ss_pred             cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH--HHHHHH
Q 037916          638 DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE--LQSIKS  708 (741)
Q Consensus       638 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i~~  708 (741)
                      ....+................................+..+.+++.+||++||++|||+.++++.  ++++..
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         225 TPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             CCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence            00000000000000000000000000000111112346678999999999999999999999975  555554

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=1.1e-36  Score=315.45  Aligned_cols=338  Identities=26%  Similarity=0.367  Sum_probs=291.3

Q ss_pred             CCCCCCccc-ccCChhhhhCCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCC
Q 037916            1 SDVGVNRVQ-GGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQ   79 (741)
Q Consensus         1 ~dl~~n~~~-~~ip~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~   79 (741)
                      .|+|+|.++ +..|.+.- .|++++.|-|...++. .+|+.++.+.+|++|.+++|++. .+-+.+..++.         
T Consensus        12 vDfsgNDFsg~~FP~~v~-qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~---------   79 (1255)
T KOG0444|consen   12 VDFSGNDFSGDRFPHDVE-QMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPR---------   79 (1255)
T ss_pred             ccccCCcCCCCcCchhHH-HhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchh---------
Confidence            389999999 56788887 8999999999999998 78999999999999999999998 44456666665         


Q ss_pred             CccEEECcCCcCccc-CCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEE
Q 037916           80 HLKHLDINNNNFGGL-LPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLA  158 (741)
Q Consensus        80 ~L~~L~Ls~N~l~~~-~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~  158 (741)
                       |+.+++..|++... +|..++.+. .|+.|+|++|++ ...|..+..-+++-+|+||+|+|..|+...|-+|+.|-.||
T Consensus        80 -LRsv~~R~N~LKnsGiP~diF~l~-dLt~lDLShNqL-~EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLD  156 (1255)
T KOG0444|consen   80 -LRSVIVRDNNLKNSGIPTDIFRLK-DLTILDLSHNQL-REVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLD  156 (1255)
T ss_pred             -hHHHhhhccccccCCCCchhcccc-cceeeecchhhh-hhcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhc
Confidence             88888888888733 667777777 888899999988 66788888888888899999998888878888888888899


Q ss_pred             cccCCCCCcCcccccCCcccceeeccCccccc-------------------------ccCcccccCCCCCEEeccCcccc
Q 037916          159 INTNKLSGNIPPSIGNLKKLLQLYLIENFLQV-------------------------SIPSSLGQCQSLTTINLSYNNLS  213 (741)
Q Consensus       159 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~-------------------------~~~~~~~~l~~L~~L~L~~N~l~  213 (741)
                      ||+|++. .+|+.+..|..|++|+|++|.+..                         -+|.++.++.+|..+|||.|++.
T Consensus       157 LS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp  235 (1255)
T KOG0444|consen  157 LSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP  235 (1255)
T ss_pred             cccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC
Confidence            9999887 667778888888888888886542                         25777888889999999999998


Q ss_pred             ccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCccCC-CCChh
Q 037916          214 GTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQG-PIPLS  292 (741)
Q Consensus       214 ~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~  292 (741)
                       .+|+.+.++.+|.. |+||+|+|+ .+.-..+...+|++|+||+|+++ ..|++++.+++|+.|++.+|+++- -+|..
T Consensus       236 -~vPecly~l~~Lrr-LNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSG  311 (1255)
T KOG0444|consen  236 -IVPECLYKLRNLRR-LNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSG  311 (1255)
T ss_pred             -cchHHHhhhhhhhe-eccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccc
Confidence             89999999999997 999999998 56666778889999999999998 689999999999999999998863 37889


Q ss_pred             cccCccCCeeeCCCCcCCCccchhhhccccCCcccccCcccccccCCccccCCcccccccCCCCccc
Q 037916          293 LSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKNASAISVFGNSKLCG  359 (741)
Q Consensus       293 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~  359 (741)
                      ++.|.+|+.+..++|++. .+|+.++.+.+|+.|.|+.|.+-+.|......+.+..+++..||.+--
T Consensus       312 IGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLiTLPeaIHlL~~l~vLDlreNpnLVM  377 (1255)
T KOG0444|consen  312 IGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLITLPEAIHLLPDLKVLDLRENPNLVM  377 (1255)
T ss_pred             hhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhcccccceeechhhhhhcCCcceeeccCCcCccC
Confidence            999999999999999998 899999999999999999999999988888899999999999987653

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.8e-33  Score=289.46  Aligned_cols=245  Identities=19%  Similarity=0.245  Sum_probs=187.2

Q ss_pred             HHHHHHHhhhc--ccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhc-CCCceeeEeeeecCccccCC
Q 037916          398 LFVSFLFLCWI--DMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKGD  474 (741)
Q Consensus       398 ~~~~y~~~~~i--g~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~  474 (741)
                      ....|.+.+.+  |+|+||.||++....++..+|+|++.......     .|+.....+ +||||+++++++     ...
T Consensus        12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~-----~~~   81 (267)
T PHA03390         12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSV-----TTL   81 (267)
T ss_pred             HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEE-----ecC
Confidence            44677888877  99999999999999999999999986432211     122222222 799999999995     445


Q ss_pred             ceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCC-c
Q 037916          475 DFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEM-T  553 (741)
Q Consensus       475 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~-~  553 (741)
                      +..++||||+++++|.+++...          ..+++.++..++.|+++||.|||+.   +++||||||+||+++.++ .
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~----------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~  148 (267)
T PHA03390         82 KGHVLIMDYIKDGDLFDLLKKE----------GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDR  148 (267)
T ss_pred             CeeEEEEEcCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCe
Confidence            5899999999999999998643          3688999999999999999999999   999999999999999988 9


Q ss_pred             eEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhh
Q 037916          554 AHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFAR  633 (741)
Q Consensus       554 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~  633 (741)
                      ++|+|||.+.......      ...++..|+||| +..+..++.++||||+||++|+|++|+.||............+..
T Consensus       149 ~~l~dfg~~~~~~~~~------~~~~~~~y~aPE-~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~  221 (267)
T PHA03390        149 IYLCDYGLCKIIGTPS------CYDGTLDYFSPE-KIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLK  221 (267)
T ss_pred             EEEecCccceecCCCc------cCCCCCcccChh-hhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHH
Confidence            9999999987654322      134788999995 555667899999999999999999999998733322222222211


Q ss_pred             hcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCC-HHHHHH
Q 037916          634 TVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMN-MTIVVH  701 (741)
Q Consensus       634 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~  701 (741)
                      .. ..        .                    ........+.+.+++.+||+.||++||+ ++|+++
T Consensus       222 ~~-~~--------~--------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        222 RQ-QK--------K--------------------LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             hh-cc--------c--------------------CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            11 00        0                    0001134566889999999999999996 588874

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.3e-33  Score=293.91  Aligned_cols=251  Identities=23%  Similarity=0.267  Sum_probs=197.1

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      ..|++.+.||+|++|.||+|.+..++..||+|+++.... ..+.+.+|++.++.++|+||+++++++     ......|+
T Consensus        19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~l   92 (286)
T cd06614          19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSY-----LVGDELWV   92 (286)
T ss_pred             ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEE-----EECCEEEE
Confidence            457888999999999999999988899999999975433 456778999999999999999999985     34568999


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      ++||+++++|.+++...         ...+++..+..++.|++.||+|||+.   |++|+||+|+||+++.++.+||+||
T Consensus        93 v~e~~~~~~L~~~l~~~---------~~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~  160 (286)
T cd06614          93 VMEYMDGGSLTDIITQN---------FVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADF  160 (286)
T ss_pred             EEeccCCCcHHHHHHHh---------ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECcc
Confidence            99999999999998743         13688899999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcc
Q 037916          560 GLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDH  639 (741)
Q Consensus       560 g~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  639 (741)
                      |.+........  ......++..|+||| +..+..++.++||||||+++|++++|..||...... .........     
T Consensus       161 ~~~~~~~~~~~--~~~~~~~~~~y~~PE-~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-~~~~~~~~~-----  231 (286)
T cd06614         161 GFAAQLTKEKS--KRNSVVGTPYWMAPE-VIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-RALFLITTK-----  231 (286)
T ss_pred             chhhhhccchh--hhccccCCcccCCHh-HhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhc-----
Confidence            98876543321  112234788999995 455667899999999999999999999998522110 000000000     


Q ss_pred             hhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          640 VMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       640 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                             ....                 ......++..+.+++.+||+.+|.+|||+.|+++
T Consensus       232 -------~~~~-----------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         232 -------GIPP-----------------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             -------CCCC-----------------CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence                   0000                 0001124566889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=5.4e-34  Score=303.28  Aligned_cols=285  Identities=18%  Similarity=0.169  Sum_probs=194.7

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCC--CeEEEEEEeeccC--cCcchhHHHHHHHHHhc-CCCceeeEeeeecCccccCCc
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEG--KTIIAVKVLNLLH--HGASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      +|.+.+.||+|+||.||+|.+..+  +..||+|.++...  ....+.+.+|+.+++++ +||||+++++++... .....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVF-PGNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeec-cccCC
Confidence            377889999999999999999877  8899999986322  22245677899999999 599999999875322 12334


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..+++|||+. ++|.+++...          ..+++..++.++.|++.||+|||+.   ||+||||||+||+++.++.+|
T Consensus        80 ~~~~~~e~~~-~~L~~~l~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~k  145 (332)
T cd07857          80 ELYLYEELME-ADLHQIIRSG----------QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELK  145 (332)
T ss_pred             cEEEEEeccc-CCHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEE
Confidence            6789999984 6898888533          4578899999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcc--cccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhh
Q 037916          556 VADFGLAKLLPPAHLQ--TSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFAR  633 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~--~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~  633 (741)
                      |+|||.+.........  .......|+..|+|||.......++.++||||+||++|++++|..||...... ..+.....
T Consensus       146 l~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~-~~~~~~~~  224 (332)
T cd07857         146 ICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV-DQLNQILQ  224 (332)
T ss_pred             eCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH-HHHHHHHH
Confidence            9999999865433211  11122458999999965555567899999999999999999999998632110 01111111


Q ss_pred             hcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          634 TVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       634 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      .. .....+...................................+.+++.+|++.||++|||+.|+++.
T Consensus       225 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         225 VL-GTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             Hh-CCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            00 000000000000000000000000000000000011234578899999999999999999998754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-34  Score=278.56  Aligned_cols=200  Identities=25%  Similarity=0.308  Sum_probs=173.2

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcC---cchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG---ASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      ...|.+++.||+|.||.|-+++.+.+++.+|+|++++.-..   ....-..|-++|+..+||.+..+...     ++..+
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYs-----FQt~d  241 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYS-----FQTQD  241 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhh-----hccCc
Confidence            35789999999999999999999999999999999853322   23344568899999999998877655     77888


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      +.|+||||..||.|.-++...          ..+++...+.+-..|+.||.|||++   +||.||||.+|.++|++|++|
T Consensus       242 rlCFVMeyanGGeLf~HLsre----------r~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIK  308 (516)
T KOG0690|consen  242 RLCFVMEYANGGELFFHLSRE----------RVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIK  308 (516)
T ss_pred             eEEEEEEEccCceEeeehhhh----------hcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceE
Confidence            999999999999999888643          6688888899999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCC
Q 037916          556 VADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSD  619 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~  619 (741)
                      |+|||+|+..-...  ......+|||.|.|| |++....|+.++|+|.+|||||||++|+.||.
T Consensus       309 itDFGLCKE~I~~g--~t~kTFCGTPEYLAP-EVleDnDYgraVDWWG~GVVMYEMmCGRLPFy  369 (516)
T KOG0690|consen  309 ITDFGLCKEEIKYG--DTTKTFCGTPEYLAP-EVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFY  369 (516)
T ss_pred             eeecccchhccccc--ceeccccCChhhcCc-hhhccccccceeehhhhhHHHHHHHhccCccc
Confidence            99999998643322  223347899999999 67788899999999999999999999999986

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.8e-33  Score=295.79  Aligned_cols=252  Identities=27%  Similarity=0.267  Sum_probs=193.6

Q ss_pred             HHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc---CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCC
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH---GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGD  474 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~  474 (741)
                      ....|...+.||+|+||.||+|.+..++..||+|++.....   .....+.+|+.++++++|||++++++++     .++
T Consensus        23 ~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~   97 (317)
T cd06635          23 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCY-----LRE   97 (317)
T ss_pred             chhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----eeC
Confidence            33558899999999999999999988899999999864322   2234677899999999999999999995     345


Q ss_pred             ceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCce
Q 037916          475 DFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTA  554 (741)
Q Consensus       475 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~  554 (741)
                      ...++||||+. |++.+++...         ...+++.++..++.|++.|+.|||+.   +|+||||+|+||+++.++.+
T Consensus        98 ~~~~lv~e~~~-g~l~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~  164 (317)
T cd06635          98 HTAWLVMEYCL-GSASDLLEVH---------KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQV  164 (317)
T ss_pred             CeEEEEEeCCC-CCHHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCE
Confidence            57899999996 5777776422         24478899999999999999999999   99999999999999999999


Q ss_pred             EEeecccccccCCCCcccccccccccccccCccccc--CCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhh
Q 037916          555 HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG--LGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFA  632 (741)
Q Consensus       555 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~--~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~  632 (741)
                      ||+|||.+......      ....|++.|+|||.+.  ..+.++.++|||||||++|+|++|..||...... .......
T Consensus       165 kl~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~~~~~~  237 (317)
T cd06635         165 KLADFGSASIASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIA  237 (317)
T ss_pred             EEecCCCccccCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHH
Confidence            99999998754332      1235788999996553  3456889999999999999999999997522100 0000000


Q ss_pred             hhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHH
Q 037916          633 RTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQ  704 (741)
Q Consensus       633 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  704 (741)
                      ....+            .                  .......+.+.+++.+||+.+|++||++.||++..-
T Consensus       238 ~~~~~------------~------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~  279 (317)
T cd06635         238 QNESP------------T------------------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF  279 (317)
T ss_pred             hccCC------------C------------------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence            00000            0                  001123456789999999999999999999997653

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=5.4e-34  Score=291.88  Aligned_cols=250  Identities=21%  Similarity=0.285  Sum_probs=194.1

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC--cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      +|.+.+.||.|+||.||+|.+..++..||+|.+....  ....+.+.+|+.+++.++|+||+++++.+     ......+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~-----~~~~~~~   75 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF-----QENGRLF   75 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee-----ccCCeEE
Confidence            3678889999999999999999899999999986432  12345677899999999999999999984     4556899


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCC-ceEEe
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEM-TAHVA  557 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~-~~kL~  557 (741)
                      +|+||+++++|.+++....        ...+++..+..++.|+++||.|||+.   +++|+||||+||++++++ .+||+
T Consensus        76 lv~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~  144 (257)
T cd08225          76 IVMEYCDGGDLMKRINRQR--------GVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLG  144 (257)
T ss_pred             EEEecCCCCcHHHHHHhcc--------CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEec
Confidence            9999999999999986431        13468889999999999999999999   999999999999998886 57999


Q ss_pred             ecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCC
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      |||.+.........  .....|++.|+||| +..+..++.++||||||+++|++++|..||....     ..+.......
T Consensus       145 d~~~~~~~~~~~~~--~~~~~~~~~~~ape-~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~  216 (257)
T cd08225         145 DFGIARQLNDSMEL--AYTCVGTPYYLSPE-ICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-----LHQLVLKICQ  216 (257)
T ss_pred             ccccchhccCCccc--ccccCCCccccCHH-HHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHhc
Confidence            99998766543211  11235888999995 5555678899999999999999999999986221     1111111111


Q ss_pred             cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          638 DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       638 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      .        .....                   ....+..+.+++.+||..+|++|||+.|+++
T Consensus       217 ~--------~~~~~-------------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         217 G--------YFAPI-------------------SPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             c--------cCCCC-------------------CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            0        00000                   0122356889999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=3.6e-34  Score=305.77  Aligned_cols=285  Identities=19%  Similarity=0.203  Sum_probs=196.8

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccc--------
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDY--------  471 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~--------  471 (741)
                      .+|.+.+.||.|+||.||+|.+..+++.||+|.+........+.+.+|+.++++++||||+++++++.....        
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            578899999999999999999999999999999976555556678899999999999999999987543211        


Q ss_pred             -cCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCC
Q 037916          472 -KGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDH  550 (741)
Q Consensus       472 -~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~  550 (741)
                       ......|+||||++ ++|.+++..           ..+++..++.++.|++.||.|||+.   ||+||||||+||+++.
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~~-----------~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~  149 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLEQ-----------GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINT  149 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcC
Confidence             11235799999996 588887742           2478889999999999999999999   9999999999999974


Q ss_pred             -CCceEEeecccccccCCCCccc-ccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcch
Q 037916          551 -EMTAHVADFGLAKLLPPAHLQT-SSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNL  628 (741)
Q Consensus       551 -~~~~kL~DFg~a~~~~~~~~~~-~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~  628 (741)
                       ++.+||+|||.+.......... ......++..|+|||.+..+..++.++||||+||++|+|++|+.||....... ..
T Consensus       150 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~~  228 (342)
T cd07854         150 EDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE-QM  228 (342)
T ss_pred             CCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HH
Confidence             5578999999987653321111 11223478899999766566678899999999999999999999986332110 11


Q ss_pred             hhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          629 HNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       629 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      ...... .+....+............... ...................+.+++.+||+.||++|||+.|+++.
T Consensus       229 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         229 QLILES-VPVVREEDRNELLNVIPSFVRN-DGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             HHHHHh-cCCCChHHhhhhhhhhhhhhhh-cccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence            111110 0000000000000000000000 00000000000111234568899999999999999999999853

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-34  Score=300.67  Aligned_cols=254  Identities=24%  Similarity=0.327  Sum_probs=200.7

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcC---CCeEEEEEEeeccCcC-cchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDE---GKTIIAVKVLNLLHHG-ASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~---~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      ......++||+|.||.|++|.|..   +...||||.++..... ...+|.+|+.+|.+|+|||++++||+..+      .
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~------q  183 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD------Q  183 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc------c
Confidence            345678899999999999999963   3456999999854433 57899999999999999999999999532      4


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ...+|||.++.|+|.+.+++.        ....+-......++.||+.||.||.++   +.|||||-..|+++-....||
T Consensus       184 p~mMV~ELaplGSLldrLrka--------~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVK  252 (1039)
T KOG0199|consen  184 PAMMVFELAPLGSLLDRLRKA--------KKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVK  252 (1039)
T ss_pred             hhhHHhhhcccchHHHHHhhc--------cccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceee
Confidence            678999999999999988742        234567777889999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcccc-cccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhh
Q 037916          556 VADFGLAKLLPPAHLQTS-SIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFAR  633 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~~~-~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~  633 (741)
                      |+|||+.+..+.....-. .....-...|+|| |.+....++.++|||+|||++|||+| |+.||.....  .       
T Consensus       253 I~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaP-EsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g--~-------  322 (1039)
T KOG0199|consen  253 ICDFGLMRALGENEDMYVMAPQRKVPFAWCAP-ESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG--I-------  322 (1039)
T ss_pred             eecccceeccCCCCcceEecCCCcCcccccCH-hHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH--H-------
Confidence            999999998876543222 2223346689999 55677889999999999999999999 7788752100  0       


Q ss_pred             hcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHH
Q 037916          634 TVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHEL  703 (741)
Q Consensus       634 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  703 (741)
                           .+.+.+|                  ...+...+..|++++++++..||..+|++|||+..|.+.+
T Consensus       323 -----qIL~~iD------------------~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  323 -----QILKNID------------------AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             -----HHHHhcc------------------ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence                 0111111                  1112334458899999999999999999999999998554

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-33  Score=294.09  Aligned_cols=277  Identities=21%  Similarity=0.224  Sum_probs=194.9

Q ss_pred             HHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcC-cchhHHHHHHHHHhcC-CCceeeEeeeecCccccCCceEEE
Q 037916          402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG-ASKSSIAECSALRNIR-HKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      |.+.+.||+|++|.||+|....+++.||+|.+...... ......+|+..+++++ ||||+++++++     ..+...++
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~-----~~~~~~~l   75 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVF-----RENDELYF   75 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHh-----hcCCcEEE
Confidence            56788999999999999999888999999998643221 2223457899999998 99999999984     44668999


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      ||||+ +++|.+++....        ...+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+||
T Consensus        76 v~e~~-~~~l~~~~~~~~--------~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~  143 (283)
T cd07830          76 VFEYM-EGNLYQLMKDRK--------GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADF  143 (283)
T ss_pred             EEecC-CCCHHHHHHhcc--------cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeec
Confidence            99999 789988886431        13578999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcc
Q 037916          560 GLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDH  639 (741)
Q Consensus       560 g~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  639 (741)
                      |.+.........   ....++..|+|||.+.....++.++||||||++++++++|+.||......+ .+.......-...
T Consensus       144 ~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~-~~~~~~~~~~~~~  219 (283)
T cd07830         144 GLAREIRSRPPY---TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID-QLYKICSVLGTPT  219 (283)
T ss_pred             ccceeccCCCCc---CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH-HHHHHHHhcCCCC
Confidence            999766443221   224478899999777666778999999999999999999999985331111 1110000000000


Q ss_pred             hhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          640 VMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       640 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ...+.+.........  .....................+.+++++||+.||++|||++|++.
T Consensus       220 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         220 KQDWPEGYKLASKLG--FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             hhhhhhHhhhhcccc--ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            000000000000000  000000000000001122467889999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=6.1e-34  Score=300.32  Aligned_cols=288  Identities=18%  Similarity=0.182  Sum_probs=197.5

Q ss_pred             HHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc--CcchhHHHHHHHHHhcCCCceeeEeeeecCccc---c
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKNLVKILTVCSGVDY---K  472 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~---~  472 (741)
                      ...+|.+.+.||+|+||.||+|.+..+++.||+|++.....  .......+|+.++++++||||+++++++.....   .
T Consensus         6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   85 (311)
T cd07866           6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR   85 (311)
T ss_pred             ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence            35789999999999999999999998999999999864322  223466789999999999999999988643221   2


Q ss_pred             CCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCC
Q 037916          473 GDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEM  552 (741)
Q Consensus       473 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~  552 (741)
                      .....++||||+. +++...+...         ...+++..+..++.|+++||+|||+.   +|+||||||+||++++++
T Consensus        86 ~~~~~~lv~~~~~-~~l~~~~~~~---------~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~  152 (311)
T cd07866          86 KRGSVYMVTPYMD-HDLSGLLENP---------SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQG  152 (311)
T ss_pred             cCceEEEEEecCC-cCHHHHHhcc---------ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCC
Confidence            2346799999995 4777766432         24588999999999999999999999   999999999999999999


Q ss_pred             ceEEeecccccccCCCCcc---------cccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCcccc
Q 037916          553 TAHVADFGLAKLLPPAHLQ---------TSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFE  623 (741)
Q Consensus       553 ~~kL~DFg~a~~~~~~~~~---------~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~  623 (741)
                      .+||+|||.+.........         .......+++.|+|||.+.....++.++||||+||++|||++|+.||.....
T Consensus       153 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~  232 (311)
T cd07866         153 ILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD  232 (311)
T ss_pred             CEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH
Confidence            9999999999765432211         1112245688899996665556689999999999999999999999863211


Q ss_pred             CCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          624 GNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       624 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      . .................+.+................  ............+.+.+++.+||+.||++|||+.|++.
T Consensus       233 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         233 I-DQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNY--PRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             H-HHHHHHHHHhCCCChhhchhhhhcccccccccCCCC--CccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            1 111111110000000000000000000000000000  00000011123356889999999999999999999874

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=2.1e-33  Score=296.69  Aligned_cols=280  Identities=19%  Similarity=0.170  Sum_probs=189.0

Q ss_pred             HHHhhhcccCceeeEEEEEEcCCCeEEEEEEeecc--CcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLL--HHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      |.+.+.+|.|+++  |.++...+++.||+|+++..  .....+.+..|+.+++.++||||+++++++     ......++
T Consensus         4 ~~i~~~~~~~~~v--~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~-----~~~~~~~~   76 (314)
T cd08216           4 TLIGKCFEDLMIV--HLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF-----IVDSELYV   76 (314)
T ss_pred             hhhhHhhcCCceE--EEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhhee-----ecCCeEEE
Confidence            4455555555554  55555557999999999743  233456788999999999999999999984     45668899


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      +|||+++++|.+++....        ...+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        77 ~~e~~~~~~l~~~l~~~~--------~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~  145 (314)
T cd08216          77 VSPLMAYGSCEDLLKTHF--------PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGL  145 (314)
T ss_pred             EEeccCCCCHHHHHHHhc--------ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecC
Confidence            999999999999986431        13477888899999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCc-----ccccccccccccccCcccccCC-CCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhh
Q 037916          560 GLAKLLPPAHL-----QTSSIGVKGTIGYIAPAEYGLG-SEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFAR  633 (741)
Q Consensus       560 g~a~~~~~~~~-----~~~~~~~~gt~~y~aPEe~~~~-~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~  633 (741)
                      |.+........     ........++..|+|||.+... ..++.++||||+||++|||++|..||............ ..
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~-~~  224 (314)
T cd08216         146 RYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEK-VR  224 (314)
T ss_pred             ccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-Hh
Confidence            98875543211     1111223477889999655433 45889999999999999999999998743211111110 00


Q ss_pred             hcCCc----chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          634 TVLPD----HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       634 ~~~~~----~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      ...+.    ...............  ......................+.+++.+||.+||++|||++|+++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         225 GTVPCLLDKSTYPLYEDSMSQSRS--SNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             ccCccccccCchhhhcCCcCcccc--cccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence            00000    000000000000000  00000000001111122345678899999999999999999999874

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=9.7e-34  Score=300.32  Aligned_cols=278  Identities=20%  Similarity=0.232  Sum_probs=195.7

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeecc--CcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCce
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLL--HHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      ..+|++.+.||.|+||.||+|.+..+++.||+|++...  .....+.+.+|+.++++++||||+++++++.    .....
T Consensus         9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~----~~~~~   84 (328)
T cd07856           9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFI----SPLED   84 (328)
T ss_pred             ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEe----cCCCc
Confidence            45789999999999999999999999999999988532  2223456778999999999999999999863    33457


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .+++|||+ +++|.+++..           ..+++..+..++.|+++||+|||+.   +|+||||+|+||+++.++.+||
T Consensus        85 ~~lv~e~~-~~~L~~~~~~-----------~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l  149 (328)
T cd07856          85 IYFVTELL-GTDLHRLLTS-----------RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKI  149 (328)
T ss_pred             EEEEeehh-ccCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEe
Confidence            89999998 6689888752           2367777888999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcC
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVL  636 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  636 (741)
                      +|||.+.......     ....++..|+|||.+..+..++.++||||+||++|++++|+.||.....  ...........
T Consensus       150 ~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~--~~~~~~~~~~~  222 (328)
T cd07856         150 CDFGLARIQDPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH--VNQFSIITDLL  222 (328)
T ss_pred             CccccccccCCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHh
Confidence            9999987543221     1234688899997655556789999999999999999999999863211  00000111111


Q ss_pred             CcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          637 PDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       637 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      .....++.+........+.......................+.+++.+||+.+|++|||+.|++..
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         223 GTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             CCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            111111111110000000000000000000001111335678899999999999999999998754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.2e-33  Score=287.41  Aligned_cols=253  Identities=22%  Similarity=0.258  Sum_probs=198.1

Q ss_pred             HHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc--CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      |.+.+.||+|++|.||+|.+..+++.|++|+++....  ...+.+.+|+.++++++||||+++++.+...   .....++
T Consensus         2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~l   78 (260)
T cd06606           2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDE---EKNTLNI   78 (260)
T ss_pred             ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecC---CCCeEEE
Confidence            6677899999999999999998999999999875432  3456788999999999999999999985322   1268899


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      +|||+++++|.+++...          ..+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.+||+||
T Consensus        79 v~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~  145 (260)
T cd06606          79 FLEYVSGGSLSSLLKKF----------GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADF  145 (260)
T ss_pred             EEEecCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccc
Confidence            99999999999998643          3688999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcc
Q 037916          560 GLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDH  639 (741)
Q Consensus       560 g~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  639 (741)
                      |.+................++..|+||| ...+...+.++||||+|+++|++++|..||.....   ... ........ 
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~y~~pE-~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~-~~~~~~~~-  219 (260)
T cd06606         146 GCAKRLGDIETGEGTGSVRGTPYWMAPE-VIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN---PMA-ALYKIGSS-  219 (260)
T ss_pred             ccEEecccccccccccCCCCCccccCHh-hhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---hHH-HHHhcccc-
Confidence            9998776553211122345888999995 55556689999999999999999999999863320   000 00000000 


Q ss_pred             hhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          640 VMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       640 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                             ....                  ..+...+..+.+++.+|++.||++||++.|+++
T Consensus       220 -------~~~~------------------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         220 -------GEPP------------------EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             -------CCCc------------------CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence                   0000                  001123567889999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.5e-33  Score=300.38  Aligned_cols=279  Identities=19%  Similarity=0.207  Sum_probs=194.4

Q ss_pred             HHHHHH-hhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCc--------------chhHHHHHHHHHhcCCCceeeEe
Q 037916          399 FVSFLF-LCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGA--------------SKSSIAECSALRNIRHKNLVKIL  463 (741)
Q Consensus       399 ~~~y~~-~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~hpnIv~~~  463 (741)
                      ..+|.. .+.||.|+||.||+|.+..+++.||+|+++......              ...+.+|+.++++++||||++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            356764 467999999999999999899999999986432211              12467899999999999999999


Q ss_pred             eeecCccccCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCC
Q 037916          464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKP  543 (741)
Q Consensus       464 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp  543 (741)
                      +++     ..+...++||||+. ++|.+++...          ..+++..+..++.|++.||+|||+.   +|+||||+|
T Consensus        87 ~~~-----~~~~~~~lv~e~~~-~~l~~~l~~~----------~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~  147 (335)
T PTZ00024         87 DVY-----VEGDFINLVMDIMA-SDLKKVVDRK----------IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSP  147 (335)
T ss_pred             EEE-----ecCCcEEEEEeccc-cCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccH
Confidence            994     45568999999995 6899888532          4578889999999999999999999   999999999


Q ss_pred             CCeEeCCCCceEEeecccccccCCCCc------------ccccccccccccccCcccccCCCCCCCccCchhHHHHHHHH
Q 037916          544 SNVLLDHEMTAHVADFGLAKLLPPAHL------------QTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLEL  611 (741)
Q Consensus       544 ~NIll~~~~~~kL~DFg~a~~~~~~~~------------~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~el  611 (741)
                      +||+++.++.+||+|||.+........            ........++..|+|||.+.....++.++||||+||++|+|
T Consensus       148 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el  227 (335)
T PTZ00024        148 ANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAEL  227 (335)
T ss_pred             HHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHH
Confidence            999999999999999999976652110            01111234678899997665445678999999999999999


Q ss_pred             HcCCCCCCccccCCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCC
Q 037916          612 MTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQ  691 (741)
Q Consensus       612 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~  691 (741)
                      ++|..||......+ .+..............+.+..........    ..................+.+++.+||+.||+
T Consensus       228 ~tg~~p~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~  302 (335)
T PTZ00024        228 LTGKPLFPGENEID-QLGRIFELLGTPNEDNWPQAKKLPLYTEF----TPRKPKDLKTIFPNASDDAIDLLQSLLKLNPL  302 (335)
T ss_pred             HhCCCCCCCCCHHH-HHHHHHHHhCCCchhhCcchhhccccccc----CcCCcccHHHhCcCCChHHHHHHHHHcCCCch
Confidence            99999986332110 11111110000000000000000000000    00000000011123356688999999999999


Q ss_pred             CCCCHHHHHH
Q 037916          692 DRMNMTIVVH  701 (741)
Q Consensus       692 ~RPs~~evl~  701 (741)
                      +|||+.|++.
T Consensus       303 ~R~s~~~~l~  312 (335)
T PTZ00024        303 ERISAKEALK  312 (335)
T ss_pred             hccCHHHHhc
Confidence            9999999986

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=9.8e-34  Score=296.17  Aligned_cols=277  Identities=21%  Similarity=0.227  Sum_probs=192.5

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc--CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      .|++.+.||+|++|.||+|.+..+++.||+|.++....  ...+.+.+|+.++++++||||+++++++     .+....|
T Consensus         3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   77 (294)
T PLN00009          3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVV-----HSEKRLY   77 (294)
T ss_pred             ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEE-----ecCCeEE
Confidence            57888999999999999999998999999999864322  2235678899999999999999999994     4566899


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCC-CCceEEe
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDH-EMTAHVA  557 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~-~~~~kL~  557 (741)
                      +||||++ +++.+++...        .....++..+..++.||+.||+|||+.   +++||||+|+||+++. ++.+||+
T Consensus        78 lv~e~~~-~~l~~~~~~~--------~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~  145 (294)
T PLN00009         78 LVFEYLD-LDLKKHMDSS--------PDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLA  145 (294)
T ss_pred             EEEeccc-ccHHHHHHhC--------CCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEc
Confidence            9999995 5888877532        112356778889999999999999999   9999999999999985 4579999


Q ss_pred             ecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCC
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      |||.+........  ......+++.|+|||.+.....++.++||||+||++|+|++|..||......+ .+....... .
T Consensus       146 dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~-~~~~~~~~~-~  221 (294)
T PLN00009        146 DFGLARAFGIPVR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID-ELFKIFRIL-G  221 (294)
T ss_pred             ccccccccCCCcc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHh-C
Confidence            9999976543211  11223478899999655455568899999999999999999999986321111 111110000 0


Q ss_pred             cchhHhhhhc-ccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          638 DHVMDIVDST-LLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       638 ~~~~~~~d~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      .......+.. -..+...   ..................+.+.+++.+|++.||++||++.|+++
T Consensus       222 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        222 TPNEETWPGVTSLPDYKS---AFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             CCChhhccccccchhhhh---hcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0000000000 0000000   00000000000011223456889999999999999999999986

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.2e-34  Score=318.75  Aligned_cols=281  Identities=17%  Similarity=0.182  Sum_probs=185.2

Q ss_pred             HHHHHHHHhhhcccCceeeEEEEEEcCCC-eEEEEEEe--------------e---ccCcCcchhHHHHHHHHHhcCCCc
Q 037916          397 LLFVSFLFLCWIDMGSFGSVYKGILDEGK-TIIAVKVL--------------N---LLHHGASKSSIAECSALRNIRHKN  458 (741)
Q Consensus       397 ~~~~~y~~~~~ig~G~~g~V~~a~~~~~~-~~vavK~~--------------~---~~~~~~~~~~~~E~~~l~~l~hpn  458 (741)
                      .+...|+++++||+|+||.||+|..+... ..++.|.+              .   .........+.+|+.++++++|||
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence            45678999999999999999998764322 11222211              0   001112345678999999999999


Q ss_pred             eeeEeeeecCccccCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCcee
Q 037916          459 LVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAH  538 (741)
Q Consensus       459 Iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH  538 (741)
                      |+++++++     ...+..|+|||++ ++++.+++.....     .........++..++.|++.||.|||++   +|+|
T Consensus       225 Iv~l~~~~-----~~~~~~~lv~e~~-~~~l~~~l~~~~~-----~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiH  290 (501)
T PHA03210        225 ILKIEEIL-----RSEANTYMITQKY-DFDLYSFMYDEAF-----DWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIH  290 (501)
T ss_pred             cCcEeEEE-----EECCeeEEEEecc-ccCHHHHHhhccc-----cccccccHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence            99999994     4556789999998 4577777643211     0112234566778999999999999999   9999


Q ss_pred             cCCCCCCeEeCCCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCC-
Q 037916          539 CDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP-  617 (741)
Q Consensus       539 rDlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p-  617 (741)
                      |||||+|||++.++.+||+|||++.......... .....||..|+||| +..+..++.++|||||||++|||++|..+ 
T Consensus       291 rDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE-~~~~~~~~~~~DiwSlGvil~ell~~~~~p  368 (501)
T PHA03210        291 RDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAF-DYGWVGTVATNSPE-ILAGDGYCEITDIWSCGLILLDMLSHDFCP  368 (501)
T ss_pred             CCCCHHHEEECCCCCEEEEeCCCceecCcccccc-cccccCCcCCCCch-hhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence            9999999999999999999999998765432211 22356899999994 55667789999999999999999998754 


Q ss_pred             CCccccC-Ccchhhhhhhc------CCcc---hhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccc
Q 037916          618 SDIMFEG-NMNLHNFARTV------LPDH---VMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSM  687 (741)
Q Consensus       618 ~~~~~~~-~~~~~~~~~~~------~~~~---~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  687 (741)
                      |...... ...+.+.....      ++..   ..++++........   ...      ............+.+++.+||+
T Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~---~~~------~~~~~~~~~~~~~~~li~kmL~  439 (501)
T PHA03210        369 IGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAG---HSV------PPLIRNLGLPADFEYPLVKMLT  439 (501)
T ss_pred             ccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCc---cch------hhHHHhcCCChHHHHHHHHHhc
Confidence            3321111 01111111110      1111   11111110000000   000      0000011234567788999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 037916          688 ESPQDRMNMTIVVHE  702 (741)
Q Consensus       688 ~dP~~RPs~~evl~~  702 (741)
                      +||++|||+.|+++.
T Consensus       440 ~DP~~Rpsa~elL~h  454 (501)
T PHA03210        440 FDWHLRPGAAELLAL  454 (501)
T ss_pred             cCcccCcCHHHHhhC
Confidence            999999999999863

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-33  Score=293.77  Aligned_cols=274  Identities=22%  Similarity=0.226  Sum_probs=197.0

Q ss_pred             HHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcC--cchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG--ASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      |.+.+.||+|++|.||+|.+..+++.+|+|.++.....  ....+.+|+.++++++||||+++++++     ..+...++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~   75 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVF-----RHKGDLYL   75 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhh-----ccCCCEEE
Confidence            56778999999999999999889999999998743322  345678899999999999999999984     45568999


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      ||||+++ ++.+++...         ...+++.++..++.|+++||.|||+.   +|+|+||||+||+++.++.+||+||
T Consensus        76 v~e~~~~-~l~~~l~~~---------~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df  142 (283)
T cd05118          76 VFEFMDT-DLYKLIKDR---------QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADF  142 (283)
T ss_pred             EEeccCC-CHHHHHHhh---------cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeee
Confidence            9999964 888877532         14578899999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCC--
Q 037916          560 GLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLP--  637 (741)
Q Consensus       560 g~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~--  637 (741)
                      |.+.......  .......++..|+|||.+.....++.++||||+|+++|++++|+.||...... ..+.........  
T Consensus       143 ~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~~~~~~~~~  219 (283)
T cd05118         143 GLARSFGSPV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI-DQLFKIFRTLGTPD  219 (283)
T ss_pred             eeeEecCCCc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHcCCCc
Confidence            9997765543  11222457889999966554447899999999999999999999998632111 011111110000  


Q ss_pred             -cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          638 -DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       638 -~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                       .....+.+......     .....................+.+++.+||+.||.+||++.|++.
T Consensus       220 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         220 PEVWPKFTSLARNYK-----FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hHhcccchhhhhhhh-----hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence             00000000000000     000000000001112345678999999999999999999999975

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.2e-33  Score=290.80  Aligned_cols=242  Identities=23%  Similarity=0.300  Sum_probs=184.3

Q ss_pred             cccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEEEecc
Q 037916          408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFM  484 (741)
Q Consensus       408 ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv~e~~  484 (741)
                      ||+|+||.||+|.+..+++.||+|++....   ......+.+|+.++++++||||+++++++     ...+..|+||||+
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~   75 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-----ETKDDLCLVMTLM   75 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE-----ecCCeEEEEEecC
Confidence            699999999999999899999999986432   22234557899999999999999999884     4556899999999


Q ss_pred             cCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecccccc
Q 037916          485 HNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKL  564 (741)
Q Consensus       485 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~a~~  564 (741)
                      ++++|.+++....        ...+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.+||+|||.+..
T Consensus        76 ~~~~L~~~l~~~~--------~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~  144 (277)
T cd05577          76 NGGDLKYHIYNVG--------EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVE  144 (277)
T ss_pred             CCCcHHHHHHHcC--------cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhh
Confidence            9999999886431        13578899999999999999999999   999999999999999999999999999876


Q ss_pred             cCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcchhHhh
Q 037916          565 LPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIV  644 (741)
Q Consensus       565 ~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  644 (741)
                      ......   .....++..|+|||. ..+..++.++||||+||++|+|++|+.||...... ............       
T Consensus       145 ~~~~~~---~~~~~~~~~y~~PE~-~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~-------  212 (277)
T cd05577         145 LKGGKK---IKGRAGTPGYMAPEV-LQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK-VEKEELKRRTLE-------  212 (277)
T ss_pred             hccCCc---cccccCCCCcCCHHH-hcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc-ccHHHHHhcccc-------
Confidence            543211   122347889999954 45566899999999999999999999998632211 000000000000       


Q ss_pred             hhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHH
Q 037916          645 DSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTI  698 (741)
Q Consensus       645 d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  698 (741)
                            ..               ...+....+.+.+++.+||+.||++||++.|
T Consensus       213 ------~~---------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~  245 (277)
T cd05577         213 ------MA---------------VEYPDKFSPEAKDLCEALLQKDPEKRLGCRG  245 (277)
T ss_pred             ------cc---------------ccCCccCCHHHHHHHHHHccCChhHccCCCc
Confidence                  00               0001123456789999999999999994444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.3e-33  Score=286.05  Aligned_cols=249  Identities=26%  Similarity=0.323  Sum_probs=196.7

Q ss_pred             HHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEEE
Q 037916          402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVY  481 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv~  481 (741)
                      |.+.+.||+|++|.||+|.+..+++.|++|++..........+.+|+.++++++||+|+++++++     ......++++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~l~~   76 (253)
T cd05122           2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY-----LKKDELWIVM   76 (253)
T ss_pred             ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEE-----ecCCeEEEEE
Confidence            67788999999999999999888999999999754444567788999999999999999999984     4456889999


Q ss_pred             ecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeeccc
Q 037916          482 EFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGL  561 (741)
Q Consensus       482 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~  561 (741)
                      ||+++++|.+++...         ...+++..+..++.|+++||.|||+.   +++||||+|+||++++++.++|+|||.
T Consensus        77 e~~~~~~L~~~~~~~---------~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~  144 (253)
T cd05122          77 EFCSGGSLKDLLKST---------NQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGL  144 (253)
T ss_pred             ecCCCCcHHHHHhhc---------CCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeeccc
Confidence            999999999998643         14578999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcchh
Q 037916          562 AKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM  641 (741)
Q Consensus       562 a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  641 (741)
                      +........   .....++..|+||| +..+..++.++||||+|+++|++++|+.||......  ............   
T Consensus       145 ~~~~~~~~~---~~~~~~~~~~~~PE-~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~---  215 (253)
T cd05122         145 SAQLSDTKA---RNTMVGTPYWMAPE-VINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM--KALFKIATNGPP---  215 (253)
T ss_pred             ccccccccc---ccceecCCcccCHH-HHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH--HHHHHHHhcCCC---
Confidence            987654432   22345888999995 555566889999999999999999999998622100  000000000000   


Q ss_pred             HhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          642 DIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       642 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ..                         ......+..+.+++.+||+.||++|||+.|+++
T Consensus       216 ~~-------------------------~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         216 GL-------------------------RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             Cc-------------------------CcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            00                         000112456889999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-33  Score=301.30  Aligned_cols=287  Identities=20%  Similarity=0.186  Sum_probs=197.7

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC--cCcchhHHHHHHHHHhcCCCceeeEeeeecCccc-cCCc
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSGVDY-KGDD  475 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~-~~~~  475 (741)
                      ..+|.+.+.||+|+||.||+|.+..+++.||+|+++...  ......+.+|+.++++++||||+++++++..... ....
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            357888899999999999999998889999999986422  2223467889999999999999999998643221 1224


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..++||||+. .++.++..            ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+|
T Consensus        94 ~~~lv~e~~~-~~l~~~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~k  157 (342)
T cd07879          94 DFYLVMPYMQ-TDLQKIMG------------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELK  157 (342)
T ss_pred             eEEEEecccc-cCHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEE
Confidence            5799999995 47766542            2478888999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhc
Q 037916          556 VADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV  635 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~  635 (741)
                      |+|||.+......     .....++..|+|||.+.....++.++|||||||++|||++|+.||..... ...+..... .
T Consensus       158 L~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~-~~~~~~~~~-~  230 (342)
T cd07879         158 ILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY-LDQLTQILK-V  230 (342)
T ss_pred             EeeCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHH-h
Confidence            9999998764322     12245788999996665556789999999999999999999999863211 001111111 0


Q ss_pred             CCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH--HHHHHH
Q 037916          636 LPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE--LQSIKS  708 (741)
Q Consensus       636 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i~~  708 (741)
                      .+....++.+..........................+.....+.+++.+||+.||++|||+.|++..  +++.++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         231 TGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             cCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence            0000000000000000000000000000000000111234568899999999999999999999954  777654

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-34  Score=292.12  Aligned_cols=249  Identities=23%  Similarity=0.327  Sum_probs=196.1

Q ss_pred             HHHHH--hhhcccCceeeEEEEEEcCCCeEEEEEEeeccC--cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          400 VSFLF--LCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       400 ~~y~~--~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      ..|+|  .+.||+|.||+||-|.++.+|+.||||++.+..  .......++|+.+|++++||.||.+-..     ++..+
T Consensus       562 tvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M-----~ET~e  636 (888)
T KOG4236|consen  562 TVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECM-----FETPE  636 (888)
T ss_pred             HHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEe-----ecCCc
Confidence            34655  468999999999999999999999999997432  2334678899999999999999999988     56777


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCC---C
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHE---M  552 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~---~  552 (741)
                      .+++|||-+. |+..+.|-..        ....+++.....++.||+.||.|||.+   +|+|+||||+|||+...   -
T Consensus       637 rvFVVMEKl~-GDMLEMILSs--------EkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FP  704 (888)
T KOG4236|consen  637 RVFVVMEKLH-GDMLEMILSS--------EKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFP  704 (888)
T ss_pred             eEEEEehhhc-chHHHHHHHh--------hcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCC
Confidence            9999999995 5655554322        235688888899999999999999999   99999999999999653   3


Q ss_pred             ceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhh
Q 037916          553 TAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFA  632 (741)
Q Consensus       553 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~  632 (741)
                      ++||||||+|+.+++.....   .+.|||.|.|| |++..+.|...-|+||+|+|+|.-++|..||....+-.+++....
T Consensus       705 QvKlCDFGfARiIgEksFRr---sVVGTPAYLaP-EVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAa  780 (888)
T KOG4236|consen  705 QVKLCDFGFARIIGEKSFRR---SVVGTPAYLAP-EVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAA  780 (888)
T ss_pred             ceeeccccceeecchhhhhh---hhcCCccccCH-HHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccc
Confidence            89999999999998776544   37799999999 667788899999999999999999999999974333222222222


Q ss_pred             hhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHH
Q 037916          633 RTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVV  700 (741)
Q Consensus       633 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  700 (741)
                      - .++...                              +.+.....+++|...++..-.+|.|.++-+
T Consensus       781 F-MyPp~P------------------------------W~eis~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  781 F-MYPPNP------------------------------WSEISPEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             c-ccCCCc------------------------------hhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence            2 222221                              123345566888888888888888887654

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.7e-33  Score=287.64  Aligned_cols=243  Identities=24%  Similarity=0.287  Sum_probs=189.1

Q ss_pred             cccCceeeEEEEEEcCCCeEEEEEEeeccCc---CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEEEecc
Q 037916          408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHH---GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFM  484 (741)
Q Consensus       408 ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv~e~~  484 (741)
                      ||.|++|.||+|++..+++.||+|++.....   ...+.+.+|+.++++++||||+++++++     .++...+++|||+
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~   75 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTF-----KDKKYIYMLMEYC   75 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeE-----EcCCccEEEEecC
Confidence            6999999999999998899999999874322   2345688899999999999999999984     4566899999999


Q ss_pred             cCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecccccc
Q 037916          485 HNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKL  564 (741)
Q Consensus       485 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~a~~  564 (741)
                      ++++|.+++...          ..+++..+..++.|++.||+|+|+.   +++|+||+|+||+++.++.+||+|||.+..
T Consensus        76 ~~~~L~~~l~~~----------~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~  142 (262)
T cd05572          76 LGGELWTILRDR----------GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKK  142 (262)
T ss_pred             CCCcHHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccc
Confidence            999999998643          3478888999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcchhHhh
Q 037916          565 LPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIV  644 (741)
Q Consensus       565 ~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  644 (741)
                      .....   ......++..|+||| ...+..++.++|+||+|+++|++++|..||.......   .....        .+.
T Consensus       143 ~~~~~---~~~~~~~~~~~~~PE-~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~--------~~~  207 (262)
T cd05572         143 LKSGQ---KTWTFCGTPEYVAPE-IILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP---MEIYN--------DIL  207 (262)
T ss_pred             cCccc---ccccccCCcCccChh-HhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH---HHHHH--------HHh
Confidence            65432   112245788999995 4556678999999999999999999999986332111   00111        000


Q ss_pred             hhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCC-----HHHHHH
Q 037916          645 DSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMN-----MTIVVH  701 (741)
Q Consensus       645 d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  701 (741)
                      +......                  .+......+.+++.+||..||++||+     ++|+++
T Consensus       208 ~~~~~~~------------------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         208 KGNGKLE------------------FPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             ccCCCCC------------------CCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            0000000                  01122467889999999999999999     566554

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-33  Score=288.67  Aligned_cols=244  Identities=21%  Similarity=0.226  Sum_probs=182.9

Q ss_pred             hhcccCceeeEEEEEEcCCCeEEEEEEeeccCcC---cchhHHHHHHHH-HhcCCCceeeEeeeecCccccCCceEEEEE
Q 037916          406 CWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG---ASKSSIAECSAL-RNIRHKNLVKILTVCSGVDYKGDDFKALVY  481 (741)
Q Consensus       406 ~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l-~~l~hpnIv~~~~~~~~~~~~~~~~~~lv~  481 (741)
                      +.||+|+||.||+|.+..+++.||+|+++.....   ....+..|..++ ...+||||+++++++     ..++..|+||
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~   76 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF-----QSKDYLYLVM   76 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeE-----EcCCeEEEEE
Confidence            5799999999999999888999999998643211   122334454443 445899999999994     4566899999


Q ss_pred             ecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeeccc
Q 037916          482 EFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGL  561 (741)
Q Consensus       482 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~  561 (741)
                      ||+++++|.+++...          ..+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.+||+|||.
T Consensus        77 e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~  143 (260)
T cd05611          77 EYLNGGDCASLIKTL----------GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGL  143 (260)
T ss_pred             eccCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeeccc
Confidence            999999999998643          3578888999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcchh
Q 037916          562 AKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM  641 (741)
Q Consensus       562 a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  641 (741)
                      +......      ....++..|+|||.+ .+..++.++||||+|+++|++++|..||.....     ......       
T Consensus       144 ~~~~~~~------~~~~~~~~y~~pe~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~-------  204 (260)
T cd05611         144 SRNGLEN------KKFVGTPDYLAPETI-LGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP-----DAVFDN-------  204 (260)
T ss_pred             ceecccc------ccCCCCcCccChhhh-cCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH-----HHHHHH-------
Confidence            8754321      123478899999554 455689999999999999999999999863211     111000       


Q ss_pred             HhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHH
Q 037916          642 DIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHEL  703 (741)
Q Consensus       642 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  703 (741)
                       +.........                .....+++.+.+++.+||+.||++|||+.++.+.+
T Consensus       205 -~~~~~~~~~~----------------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         205 -ILSRRINWPE----------------EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             -HHhcccCCCC----------------cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence             0000000000                00113456788999999999999999887665543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=5e-33  Score=292.61  Aligned_cols=250  Identities=26%  Similarity=0.270  Sum_probs=191.6

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc---CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH---GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      -..|...+.||+|+||.||+|++..++..||+|.+.....   ....++.+|+.+++.++|+|++++++++     ....
T Consensus        14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   88 (308)
T cd06634          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY-----LREH   88 (308)
T ss_pred             HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEE-----EcCC
Confidence            3458889999999999999999998899999999863221   2234567899999999999999999985     3456


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..++||||+. |++.+++...         ...+++.++..++.|++.|+.|||+.   +++||||+|+||+++.++.+|
T Consensus        89 ~~~lv~e~~~-~~l~~~~~~~---------~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~k  155 (308)
T cd06634          89 TAWLVMEYCL-GSASDLLEVH---------KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVK  155 (308)
T ss_pred             eeEEEEEccC-CCHHHHHHHc---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEE
Confidence            8899999995 5887776422         13478889999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcccccccccccccccCccccc--CCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhh
Q 037916          556 VADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG--LGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFAR  633 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~--~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~  633 (741)
                      |+|||.+......      ....+++.|+|||.+.  ....++.++|||||||++|+|++|..||...... ........
T Consensus       156 l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~  228 (308)
T cd06634         156 LGDFGSASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQ  228 (308)
T ss_pred             ECCcccceeecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-HHHHHHhh
Confidence            9999998765432      1235788999996543  2356788999999999999999999997532110 00000000


Q ss_pred             hcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHH
Q 037916          634 TVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHEL  703 (741)
Q Consensus       634 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  703 (741)
                      ...+.             .                 ........+.+++.+||..+|++||++.++++.-
T Consensus       229 ~~~~~-------------~-----------------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         229 NESPA-------------L-----------------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             cCCCC-------------c-----------------CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence            00000             0                 0112345678999999999999999999998763

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-33  Score=288.96  Aligned_cols=278  Identities=21%  Similarity=0.248  Sum_probs=194.0

Q ss_pred             HHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc--CcchhHHHHHHHHHhc---CCCceeeEeeeecCccccCCce
Q 037916          402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH--GASKSSIAECSALRNI---RHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      |++.+.||+|+||.||+|.+..+++.||+|+++....  .....+.+|+.+++++   +||||+++++++..........
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            5677899999999999999988899999999974322  2234456787777665   6999999999976544333345


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .+++|||+. ++|.+++....        ...+++..++.++.|+++||.|||+.   +++|+||+|+||+++.++.+||
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~--------~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l  148 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCP--------KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKI  148 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHcc--------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEE
Confidence            899999996 58888876431        12478899999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcC
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVL  636 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  636 (741)
                      +|||.+.........   ....++..|+||| ...+..++.++||||+||++|+|++|..||..... ...+..+.....
T Consensus       149 ~dfg~~~~~~~~~~~---~~~~~~~~~~~PE-~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~~  223 (287)
T cd07838         149 ADFGLARIYSFEMAL---TSVVVTLWYRAPE-VLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE-ADQLDKIFDVIG  223 (287)
T ss_pred             eccCcceeccCCccc---ccccccccccChH-HhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh-HHHHHHHHHHcC
Confidence            999999876543221   1234788999995 44566789999999999999999999998863211 111111111111


Q ss_pred             CcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          637 PDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       637 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ......+.....   ..  .................+....+.+++.+||+.||++||++.|++.
T Consensus       224 ~~~~~~~~~~~~---~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         224 LPSEEEWPRNVS---LP--RSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             CCChHhcCCCcc---cc--hhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            100000000000   00  0000000000011112244577889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.2e-33  Score=288.54  Aligned_cols=246  Identities=24%  Similarity=0.305  Sum_probs=189.2

Q ss_pred             cccCceeeEEEEEEcCCCeEEEEEEeeccCc---CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEEEecc
Q 037916          408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHH---GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFM  484 (741)
Q Consensus       408 ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv~e~~  484 (741)
                      ||.|+||.||+|.+..+++.||+|++.....   ...+.+.+|+.++++++||||+++++.     +..+...|++|||+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~-----~~~~~~~~lv~e~~   75 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYS-----FQGKKNLYLVMEYL   75 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHh-----eecCcEEEEEEecC
Confidence            6899999999999998899999999864332   345567889999999999999999987     45567899999999


Q ss_pred             cCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecccccc
Q 037916          485 HNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKL  564 (741)
Q Consensus       485 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~a~~  564 (741)
                      ++++|.+++...          ..+++..+..++.|+++||+|||+.   +++||||+|+||+++.++.+||+|||++..
T Consensus        76 ~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~  142 (265)
T cd05579          76 PGGDLASLLENV----------GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKV  142 (265)
T ss_pred             CCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchh
Confidence            999999998643          3578889999999999999999999   999999999999999999999999999876


Q ss_pred             cCCCCcc------cccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCc
Q 037916          565 LPPAHLQ------TSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       565 ~~~~~~~------~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      .......      .......++..|+|||. ......+.++||||||+++|++++|..||.....     ......    
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~-~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~~~~----  212 (265)
T cd05579         143 GLVRRQINLNDDEKEDKRIVGTPDYIAPEV-ILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP-----EEIFQN----  212 (265)
T ss_pred             cccCcccccccccccccCcccCccccCHHH-hcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-----HHHHHH----
Confidence            5433211      12223457889999954 4555688999999999999999999999863211     000000    


Q ss_pred             chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHH
Q 037916          639 HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHEL  703 (741)
Q Consensus       639 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  703 (741)
                              .......              .......+..+.+++.+||+.+|++|||+.++.+.|
T Consensus       213 --------~~~~~~~--------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         213 --------ILNGKIE--------------WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             --------HhcCCcC--------------CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence                    0000000              000001246678999999999999999996665554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=6.9e-33  Score=292.14  Aligned_cols=252  Identities=27%  Similarity=0.266  Sum_probs=191.9

Q ss_pred             HHHHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcC---cchhHHHHHHHHHhcCCCceeeEeeeecCcccc
Q 037916          396 ILLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG---ASKSSIAECSALRNIRHKNLVKILTVCSGVDYK  472 (741)
Q Consensus       396 ~~~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  472 (741)
                      .-....|...++||+|+||.||+|++..+++.||+|++......   ....+.+|+.+++.++|||++++++++     .
T Consensus        17 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~   91 (313)
T cd06633          17 DDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCY-----L   91 (313)
T ss_pred             CCHHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEE-----E
Confidence            33445577888999999999999999889999999998743222   234567899999999999999999995     4


Q ss_pred             CCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCC
Q 037916          473 GDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEM  552 (741)
Q Consensus       473 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~  552 (741)
                      +....|+||||+. +++.+++...         ...+++.++..++.|++.|+.|||+.   |++||||+|+||+++.++
T Consensus        92 ~~~~~~lv~e~~~-~~l~~~l~~~---------~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~  158 (313)
T cd06633          92 KEHTAWLVMEYCL-GSASDLLEVH---------KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPG  158 (313)
T ss_pred             eCCEEEEEEecCC-CCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCC
Confidence            4568899999995 5777776432         24578889999999999999999999   999999999999999999


Q ss_pred             ceEEeecccccccCCCCcccccccccccccccCccccc--CCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhh
Q 037916          553 TAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG--LGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHN  630 (741)
Q Consensus       553 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~--~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~  630 (741)
                      .+||+|||.+......      ....|+..|+|||.+.  ....++.++|||||||++|+|++|..||...... .....
T Consensus       159 ~~kL~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~-~~~~~  231 (313)
T cd06633         159 QVKLADFGSASKSSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYH  231 (313)
T ss_pred             CEEEeecCCCcccCCC------CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHH
Confidence            9999999998643221      1245888999996653  3456889999999999999999999997532110 00000


Q ss_pred             hhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          631 FARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       631 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      ......+.         .                     ........+.+++.+||+.+|++||++.+++..
T Consensus       232 ~~~~~~~~---------~---------------------~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         232 IAQNDSPT---------L---------------------QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             HHhcCCCC---------C---------------------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00000000         0                     001223457789999999999999999999853

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=3.2e-33  Score=286.05  Aligned_cols=252  Identities=22%  Similarity=0.330  Sum_probs=198.0

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc--CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      +|.+.+.||.|+||.||+|.+..++..||+|++.....  ...+.+.+|+++++.++|||++++++.+     ..+...+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~-----~~~~~~~   75 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESF-----EEKGKLC   75 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEE-----ecCCEEE
Confidence            36788899999999999999998899999999975432  3455678899999999999999999984     4456899


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      +||||+++++|.+++....      .....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|
T Consensus        76 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d  146 (258)
T cd08215          76 IVMEYADGGDLSQKIKKQK------KEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGD  146 (258)
T ss_pred             EEEEecCCCcHHHHHHHhh------ccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECC
Confidence            9999999999999986431      1125688999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCc
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      ||.+........  ......|++.|+||| ...+..++.++||||+|+++|+|++|..||....     ........   
T Consensus       147 ~~~~~~~~~~~~--~~~~~~~~~~y~~pe-~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~~~~~~~~---  215 (258)
T cd08215         147 FGISKVLSSTVD--LAKTVVGTPYYLSPE-LCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-----LLELALKI---  215 (258)
T ss_pred             ccceeecccCcc--eecceeeeecccChh-HhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-----HHHHHHHH---
Confidence            999987654431  112245888999995 4556678899999999999999999999986221     11111110   


Q ss_pred             chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          639 HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       639 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                           ........                   +......+.+++.+||..+|++|||+.|+++
T Consensus       216 -----~~~~~~~~-------------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         216 -----LKGQYPPI-------------------PSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             -----hcCCCCCC-------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                 00000000                   0123456789999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-33  Score=270.91  Aligned_cols=271  Identities=18%  Similarity=0.234  Sum_probs=203.5

Q ss_pred             HHHHHHH-hhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhc-CCCceeeEeeeecCccccCCc
Q 037916          398 LFVSFLF-LCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       398 ~~~~y~~-~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      +...|++ .+.||+|+|+.|-.+....++..||||++.+.......+..+|++++.+. .|+||++++++     |+++.
T Consensus        75 F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLief-----FEdd~  149 (463)
T KOG0607|consen   75 FEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEF-----FEDDT  149 (463)
T ss_pred             HHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHH-----hcccc
Confidence            4556766 46799999999999999999999999999876555567888999999988 69999999999     77888


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCC---
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEM---  552 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~---  552 (741)
                      ..|+|||-|.||+|...|.+.          ..+++.++.++.++|+.||.|||.+   ||.|||+||+|||..+..   
T Consensus       150 ~FYLVfEKm~GGplLshI~~~----------~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vs  216 (463)
T KOG0607|consen  150 RFYLVFEKMRGGPLLSHIQKR----------KHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVS  216 (463)
T ss_pred             eEEEEEecccCchHHHHHHHh----------hhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcC
Confidence            999999999999999999754          7799999999999999999999999   999999999999997654   


Q ss_pred             ceEEeecccccccCCCC-----cccccccccccccccCccccc----CCCCCCCccCchhHHHHHHHHHcCCCCCCcccc
Q 037916          553 TAHVADFGLAKLLPPAH-----LQTSSIGVKGTIGYIAPAEYG----LGSEVSINGDVYSYGILLLELMTRKRPSDIMFE  623 (741)
Q Consensus       553 ~~kL~DFg~a~~~~~~~-----~~~~~~~~~gt~~y~aPEe~~----~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~  623 (741)
                      -+||+||.++.-+....     ........+|+..|||||.+-    ....|+.++|.||+|||+|-|++|.+||...-.
T Consensus       217 PvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg  296 (463)
T KOG0607|consen  217 PVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCG  296 (463)
T ss_pred             ceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccC
Confidence            58999998765433211     111122356899999997542    235689999999999999999999999975433


Q ss_pred             CCcchhhhhhhcC-CcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          624 GNMNLHNFARTVL-PDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       624 ~~~~~~~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      .+-.   |-+... +.-...++++.-.+.++-            ....+........+++...+..||.+|-++.+++.
T Consensus       297 ~dCG---WdrGe~Cr~CQ~~LFesIQEGkYeF------------PdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  297 ADCG---WDRGEVCRVCQNKLFESIQEGKYEF------------PDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             CcCC---ccCCCccHHHHHHHHHHHhccCCcC------------ChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            2211   111000 000122222222222210            01112344556678888888899999999988876

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.6e-34  Score=303.38  Aligned_cols=282  Identities=18%  Similarity=0.178  Sum_probs=196.5

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC--cCcchhHHHHHHHHHhcCCCceeeEeeeecCccc-cCCc
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSGVDY-KGDD  475 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~-~~~~  475 (741)
                      ..+|++.+.||+|++|.||+|++..+++.||+|++....  ....+.+.+|+.++++++||||+++++++..... ....
T Consensus        14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07851          14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ   93 (343)
T ss_pred             cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence            456888999999999999999999899999999986421  2233556789999999999999999987533221 1223


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..++|+||+ +++|.+++..           ..+++..+..++.|+++||+|||+.   ||+||||||+||+++.++.+|
T Consensus        94 ~~~lv~e~~-~~~L~~~~~~-----------~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~k  158 (343)
T cd07851          94 DVYLVTHLM-GADLNNIVKC-----------QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELK  158 (343)
T ss_pred             cEEEEEecC-CCCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEE
Confidence            589999999 6799998852           3478899999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhc
Q 037916          556 VADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV  635 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~  635 (741)
                      |+|||.+......     .....++..|+|||.+.....++.++||||+||++|++++|+.||..... ...+..... .
T Consensus       159 L~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~-~~~~~~i~~-~  231 (343)
T cd07851         159 ILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH-IDQLKRIMN-L  231 (343)
T ss_pred             Ecccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHH-h
Confidence            9999999865432     12235788999996655445788999999999999999999999863211 001111111 0


Q ss_pred             CCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          636 LPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       636 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      .......+.+..............................+.+.+++.+||+.||++|||+.||++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         232 VGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             cCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence            1100011111000000000000000000000000111235678899999999999999999998753

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.1e-33  Score=299.78  Aligned_cols=287  Identities=18%  Similarity=0.158  Sum_probs=199.0

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC--cCcchhHHHHHHHHHhcCCCceeeEeeeecCccc-cCCc
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSGVDY-KGDD  475 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~-~~~~  475 (741)
                      ..+|++++.||+|+||.||+|.+..++..||+|++....  ....+.+.+|+.++++++||||+++++++..... ....
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07880          14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH   93 (343)
T ss_pred             ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence            457999999999999999999999899999999986322  1223467789999999999999999998643221 1123


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..++||||+ +++|.+++..           ..+++..+..++.|+++||+|||+.   ||+||||||+||+++.++.+|
T Consensus        94 ~~~lv~e~~-~~~l~~~~~~-----------~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~k  158 (343)
T cd07880          94 DFYLVMPFM-GTDLGKLMKH-----------EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELK  158 (343)
T ss_pred             eEEEEEecC-CCCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEE
Confidence            568999999 7799888752           3478889999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhc
Q 037916          556 VADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV  635 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~  635 (741)
                      |+|||.+.......     ....+++.|+|||.+.....++.++||||+||++|++++|..||...... ..+.......
T Consensus       159 l~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~~~~~~  232 (343)
T cd07880         159 ILDFGLARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL-DQLMEIMKVT  232 (343)
T ss_pred             EeecccccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhc
Confidence            99999987654321     12347889999966654456889999999999999999999998632110 0111111100


Q ss_pred             CCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH--HHHHHH
Q 037916          636 LPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH--ELQSIK  707 (741)
Q Consensus       636 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i~  707 (741)
                      .. ...++.+............................+...+.+++.+|+..||++|||+.++++  -++...
T Consensus       233 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~  305 (343)
T cd07880         233 GT-PSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH  305 (343)
T ss_pred             CC-CCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence            00 001111100000000000000000000000111234556889999999999999999999994  355443

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.9e-33  Score=286.28  Aligned_cols=250  Identities=23%  Similarity=0.253  Sum_probs=196.3

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC--cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      +|++.++||+|+||.||++.+..+++.||+|.+....  ......+.+|+.++++++||||+++++++     .+....+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   75 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF-----LDGNKLC   75 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhh-----ccCCEEE
Confidence            3778899999999999999999899999999987432  22344667899999999999999999884     4456899


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      +||||+++++|.+++....      .....+++..+..++.|++.||+|||+.   |++|+||+|+||+++.++.+||+|
T Consensus        76 ~v~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d  146 (256)
T cd08530          76 IVMEYAPFGDLSKAISKRK------KKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGD  146 (256)
T ss_pred             EEehhcCCCCHHHHHHHHH------hhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEee
Confidence            9999999999999986421      1124578889999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCc
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      ||.+........    ....+++.|+|| |...+..++.++|+||+|+++|++++|+.||......  .+......    
T Consensus       147 ~g~~~~~~~~~~----~~~~~~~~~~~P-e~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--~~~~~~~~----  215 (256)
T cd08530         147 LGISKVLKKNMA----KTQIGTPHYMAP-EVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ--DLRYKVQR----  215 (256)
T ss_pred             ccchhhhccCCc----ccccCCccccCH-HHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhc----
Confidence            999987655411    124478899999 4556677889999999999999999999998632110  00000000    


Q ss_pred             chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          639 HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       639 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                                 ....               .........+.+++.+||..+|++|||+.|+++
T Consensus       216 -----------~~~~---------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         216 -----------GKYP---------------PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             -----------CCCC---------------CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                       0000               001134566889999999999999999999975

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-33  Score=284.61  Aligned_cols=248  Identities=25%  Similarity=0.323  Sum_probs=196.2

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc--CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      +|++.+.||+|++|.||+|.+..+++.||+|.+.....  ...+.+.+|++++++++|||++++++++     .++...+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   75 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSI-----ETSDSLY   75 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEE-----EeCCEEE
Confidence            37788999999999999999988899999999975433  3446788999999999999999999984     4456899


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      ++|||+++++|.+++...          ..+++..+..++.|++.|+.|||+.   ||+||||+|+||+++.++.+||+|
T Consensus        76 ~v~e~~~~~~L~~~~~~~----------~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d  142 (254)
T cd06627          76 IILEYAENGSLRQIIKKF----------GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLAD  142 (254)
T ss_pred             EEEecCCCCcHHHHHHhc----------cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEec
Confidence            999999999999998633          4578999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCc
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      ||.+.........  .....++..|+|||.. .+..++.++||||+|+++|++++|..||....    ........... 
T Consensus       143 ~~~~~~~~~~~~~--~~~~~~~~~y~~pe~~-~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~----~~~~~~~~~~~-  214 (254)
T cd06627         143 FGVATKLNDVSKD--DASVVGTPYWMAPEVI-EMSGASTASDIWSLGCTVIELLTGNPPYYDLN----PMAALFRIVQD-  214 (254)
T ss_pred             cccceecCCCccc--ccccccchhhcCHhhh-cCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc----HHHHHHHHhcc-
Confidence            9999876544321  1224588899999554 45558899999999999999999999986321    11101000000 


Q ss_pred             chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          639 HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       639 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      .            ..               ..+....+.+.+++.+||..+|++|||+.|++.
T Consensus       215 ~------------~~---------------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         215 D------------HP---------------PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             C------------CC---------------CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            0            00               000123456789999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-33  Score=286.25  Aligned_cols=252  Identities=19%  Similarity=0.217  Sum_probs=191.5

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC-----cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH-----HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      .|.+.+.||+|+||.||+|.+..++..||+|.+....     ......+.+|+.++++++||||+++++++..   ....
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~---~~~~   79 (264)
T cd06653           3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRD---PEEK   79 (264)
T ss_pred             ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEc---CCCC
Confidence            5788999999999999999999899999999875321     1223467889999999999999999998632   2245


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..+++|||+++++|.+++...          ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++
T Consensus        80 ~~~~v~e~~~~~~L~~~~~~~----------~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~  146 (264)
T cd06653          80 KLSIFVEYMPGGSIKDQLKAY----------GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVK  146 (264)
T ss_pred             EEEEEEEeCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEE
Confidence            688999999999999988632          3467888899999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcc-cccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhh
Q 037916          556 VADFGLAKLLPPAHLQ-TSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~-~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  634 (741)
                      |+|||.++........ .......++..|+||| +..+..++.++|||||||++|++++|+.||....    ........
T Consensus       147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~  221 (264)
T cd06653         147 LGDFGASKRIQTICMSGTGIKSVTGTPYWMSPE-VISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE----AMAAIFKI  221 (264)
T ss_pred             ECccccccccccccccCccccccCCcccccCHh-hhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC----HHHHHHHH
Confidence            9999999765322111 1112245889999995 4456678899999999999999999999986321    11101000


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ...+         ..                  ...+....+.+.+++.+||+ +|..|||+.+++.
T Consensus       222 ~~~~---------~~------------------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         222 ATQP---------TK------------------PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             HcCC---------CC------------------CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            0000         00                  00112334668899999999 5799999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2e-35  Score=277.49  Aligned_cols=259  Identities=24%  Similarity=0.266  Sum_probs=191.4

Q ss_pred             HHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc-CcchhHHHHHHHHHh-cCCCceeeEeeeecCccccCCceEEE
Q 037916          402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH-GASKSSIAECSALRN-IRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~-l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      .+-+..||.|+||+|++-.++..|+..|||.++.... .+.+++..|.++..+ -++||||++||.+    | .+...|+
T Consensus        66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~----F-~EGdcWi  140 (361)
T KOG1006|consen   66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGAL----F-SEGDCWI  140 (361)
T ss_pred             HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhh----h-cCCceee
Confidence            3456789999999999999999999999999985433 445677788876544 4799999999996    3 3457899


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      .||.| ..|+..+.+..-     ......+++.-.-+|....+.||.||....  .|||||+||+|||++..|.+|||||
T Consensus       141 CMELM-d~SlDklYk~vy-----~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDF  212 (361)
T KOG1006|consen  141 CMELM-DISLDKLYKRVY-----SVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDF  212 (361)
T ss_pred             eHHHH-hhhHHHHHHHHH-----HHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecc
Confidence            99999 558776654210     011244677777778888899999999775  9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccccccCcccccCCCC-CCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCc
Q 037916          560 GLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       560 g~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~-~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      |.+....++-..   +.-.|...|||||.+..... |+.++||||+|+++||+.||..||......-.++.+.+....+ 
T Consensus       213 GIcGqLv~SiAk---T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp-  288 (361)
T KOG1006|consen  213 GICGQLVDSIAK---TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPP-  288 (361)
T ss_pred             cchHhHHHHHHh---hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCC-
Confidence            999776554322   22458999999987765544 9999999999999999999999976332211111111111100 


Q ss_pred             chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          639 HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       639 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                              .+..+.                 ...+....+.+++..|+..|-.+||...++++.
T Consensus       289 --------~l~~~~-----------------~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  289 --------ILLFDK-----------------ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             --------eecCcc-----------------cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence                    011110                 112345678899999999999999999998764

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-33  Score=288.62  Aligned_cols=274  Identities=22%  Similarity=0.220  Sum_probs=196.3

Q ss_pred             HHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC--cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      |++.+.||+|++|.||+|....+++.||+|+++...  ....+.+..|+.++++++||||+++++++     .+....++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~~   75 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVI-----HTERKLYL   75 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhh-----hcCCceEE
Confidence            456788999999999999999889999999997543  33346678899999999999999999984     44568999


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      ||||++ ++|.+++...         ...+++..+..++.|++.||+|||+.   +|+||||+|+||++++++.+||+||
T Consensus        76 v~e~~~-~~l~~~i~~~---------~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~  142 (282)
T cd07829          76 VFEYCD-MDLKKYLDKR---------PGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADF  142 (282)
T ss_pred             EecCcC-cCHHHHHHhh---------ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecC
Confidence            999996 5999998643         13588999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCc-
Q 037916          560 GLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPD-  638 (741)
Q Consensus       560 g~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-  638 (741)
                      |.+.........  .....++..|+|||.+.....++.++||||+||++||+++|..||...... ..+.......... 
T Consensus       143 g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~  219 (282)
T cd07829         143 GLARAFGIPLRT--YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI-DQLFKIFQILGTPT  219 (282)
T ss_pred             CcccccCCCccc--cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHHHhCCCc
Confidence            998766443211  112345778999976655558899999999999999999999998532110 0011111100000 


Q ss_pred             -chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          639 -HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       639 -~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                       ...............     .............+.....+.+++.+||+.||++||++.|++.
T Consensus       220 ~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         220 EESWPGVTKLPDYKPT-----FPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             HHHHHhhccccccccc-----ccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence             000000000000000     0000000000111122567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=3.8e-33  Score=291.95  Aligned_cols=254  Identities=21%  Similarity=0.241  Sum_probs=188.8

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc-CcchhHHHHHHHHHhc-CCCceeeEeeeecCccccCCce
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH-GASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      +..|++.+.||+|+||.||+|.+..+++.||+|.++.... .....+..|+.++.+. .||||++++++|     .....
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~   88 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYF-----ITDSD   88 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheee-----ecCCe
Confidence            4678899999999999999999998899999999974332 2234456677766666 599999999995     44558


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHh-cCCCCceecCCCCCCeEeCCCCceE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH-DCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      .|++|||+ ++++.+++...         ...+++..+..++.|++.||+|||+ .   +|+||||+|+||++++++.+|
T Consensus        89 ~~~v~e~~-~~~l~~l~~~~---------~~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~k  155 (296)
T cd06618          89 VFICMELM-STCLDKLLKRI---------QGPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVK  155 (296)
T ss_pred             EEEEeecc-CcCHHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEE
Confidence            99999998 45777766432         2357888899999999999999997 5   899999999999999999999


Q ss_pred             EeecccccccCCCCcccccccccccccccCcccccCC---CCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhh
Q 037916          556 VADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLG---SEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFA  632 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~---~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~  632 (741)
                      |+|||.+.........   ....++..|+|||.+...   ..++.++||||||+++|+|++|+.||.........+..  
T Consensus       156 L~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~--  230 (296)
T cd06618         156 LCDFGISGRLVDSKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTK--  230 (296)
T ss_pred             ECccccchhccCCCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHH--
Confidence            9999998765433222   123478899999655332   34789999999999999999999998632111000000  


Q ss_pred             hhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          633 RTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       633 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                                ..+.... ...                ....++..+.+++.+||..||++|||+.++++.
T Consensus       231 ----------~~~~~~~-~~~----------------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         231 ----------ILQEEPP-SLP----------------PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             ----------HhcCCCC-CCC----------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                      0000000 000                000234568899999999999999999999865

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=7.8e-33  Score=288.76  Aligned_cols=252  Identities=22%  Similarity=0.272  Sum_probs=189.7

Q ss_pred             HHHhhhcccCceeeEEEEEEc---CCCeEEEEEEeeccC----cCcchhHHHHHHHHHhc-CCCceeeEeeeecCccccC
Q 037916          402 FLFLCWIDMGSFGSVYKGILD---EGKTIIAVKVLNLLH----HGASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKG  473 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~  473 (741)
                      |++.+.||.|+||.||+|.+.   .+|..||+|+++...    ....+.+.+|+.+++++ +|++|++++++     ++.
T Consensus         2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~-----~~~   76 (290)
T cd05613           2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA-----FQT   76 (290)
T ss_pred             ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeE-----eec
Confidence            678899999999999999884   478899999987422    12235677899999999 68999999988     455


Q ss_pred             CceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCc
Q 037916          474 DDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMT  553 (741)
Q Consensus       474 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~  553 (741)
                      +...|+||||+++++|.+++...          ..+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.
T Consensus        77 ~~~~~lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~  143 (290)
T cd05613          77 DTKLHLILDYINGGELFTHLSQR----------ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGH  143 (290)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCC
Confidence            66889999999999999998643          3477888889999999999999999   9999999999999999999


Q ss_pred             eEEeecccccccCCCCcccccccccccccccCcccccCC-CCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhh
Q 037916          554 AHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLG-SEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFA  632 (741)
Q Consensus       554 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~-~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~  632 (741)
                      +||+|||.+......... ......|+..|+|||.+... ..++.++||||+|+++|++++|..||..... ......+ 
T Consensus       144 ~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~~~-  220 (290)
T cd05613         144 VVLTDFGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-KNSQAEI-  220 (290)
T ss_pred             EEEeeCccceeccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc-cccHHHH-
Confidence            999999998765433221 11224588999999765433 3568899999999999999999999852111 0111111 


Q ss_pred             hhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCC-----CHHHHHH
Q 037916          633 RTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRM-----NMTIVVH  701 (741)
Q Consensus       633 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  701 (741)
                                 .+........                .+......+.+++.+||+.||++||     ++.++++
T Consensus       221 -----------~~~~~~~~~~----------------~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         221 -----------SRRILKSEPP----------------YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             -----------HHHhhccCCC----------------CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence                       1110000000                0112345678999999999999997     5666654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.7e-33  Score=297.39  Aligned_cols=283  Identities=19%  Similarity=0.184  Sum_probs=195.9

Q ss_pred             HHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC--cCcchhHHHHHHHHHhcCCCceeeEeeeecCcc-ccCC
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSGVD-YKGD  474 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~~~  474 (741)
                      +..+|.+.+.||+|+||.||+|.+..+++.||+|+++...  ....+.+.+|+.++++++||||+++++++.... +...
T Consensus        15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (345)
T cd07877          15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   94 (345)
T ss_pred             ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence            3367899999999999999999998899999999986422  122356778999999999999999999864322 1223


Q ss_pred             ceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCce
Q 037916          475 DFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTA  554 (741)
Q Consensus       475 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~  554 (741)
                      ...+++++++ +++|.+++..           ..+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+
T Consensus        95 ~~~~lv~~~~-~~~L~~~~~~-----------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~  159 (345)
T cd07877          95 NDVYLVTHLM-GADLNNIVKC-----------QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL  159 (345)
T ss_pred             ccEEEEehhc-ccCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCE
Confidence            4578899887 7899887752           2478889999999999999999999   99999999999999999999


Q ss_pred             EEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhh
Q 037916          555 HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       555 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  634 (741)
                      ||+|||.+......     .....++..|+|||.+.....++.++||||+||++|+|++|+.||..... ...+......
T Consensus       160 kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~-~~~~~~~~~~  233 (345)
T cd07877         160 KILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-IDQLKLILRL  233 (345)
T ss_pred             EEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHH
Confidence            99999998754322     12245788999996655446788999999999999999999999853211 1111111111


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      . ......+..................................+.+++.+|++.||++|||+.|++..
T Consensus       234 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         234 V-GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             h-CCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            0 000001100000000000000000000000000001234567899999999999999999999865

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=5.2e-33  Score=288.42  Aligned_cols=249  Identities=24%  Similarity=0.326  Sum_probs=194.8

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhcC-CCceeeEeeeecCccccCCce
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNIR-HKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      .|.+.+.||+|+||.||+|.+..+++.||+|++....   ....+.+.+|+.+++++. ||||++++++     +.+...
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~-----~~~~~~   76 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYT-----FQDEEN   76 (280)
T ss_pred             CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHH-----hcCCce
Confidence            4778899999999999999999899999999986422   222456778999999998 9999999998     455668


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .++||||+++++|.+++...          ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l  143 (280)
T cd05581          77 LYFVLEYAPNGELLQYIRKY----------GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKI  143 (280)
T ss_pred             EEEEEcCCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEe
Confidence            99999999999999998643          3689999999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcc------------------cccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCC
Q 037916          557 ADFGLAKLLPPAHLQ------------------TSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPS  618 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~------------------~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~  618 (741)
                      +|||.+.........                  .......++..|+||| ...+..++.++||||+|++++++++|+.||
T Consensus       144 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe-~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  222 (280)
T cd05581         144 TDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPE-LLNEKPAGKSSDLWALGCIIYQMLTGKPPF  222 (280)
T ss_pred             cCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHH-HhCCCCCChhhhHHHHHHHHHHHHhCCCCC
Confidence            999998766543211                  1112244788999995 555667889999999999999999999998


Q ss_pred             CccccCCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCH--
Q 037916          619 DIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNM--  696 (741)
Q Consensus       619 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--  696 (741)
                      .....    ... ..        ...+...                    ..+...++.+.+++.+||+.||++|||+  
T Consensus       223 ~~~~~----~~~-~~--------~~~~~~~--------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~  269 (280)
T cd05581         223 RGSNE----YLT-FQ--------KILKLEY--------------------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNE  269 (280)
T ss_pred             CCccH----HHH-HH--------HHHhcCC--------------------CCCCccCHHHHHHHHHHhcCCHhhCCCccc
Confidence            63211    000 00        0000000                    0011224568899999999999999999  


Q ss_pred             --HHHHH
Q 037916          697 --TIVVH  701 (741)
Q Consensus       697 --~evl~  701 (741)
                        .|+++
T Consensus       270 ~~~~ll~  276 (280)
T cd05581         270 GYDELKA  276 (280)
T ss_pred             CHHHHhc
Confidence              66653

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-33  Score=296.00  Aligned_cols=251  Identities=29%  Similarity=0.416  Sum_probs=202.3

Q ss_pred             cccCceeeEEEEEEcCCC----eEEEEEEeec-cCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEEEe
Q 037916          408 IDMGSFGSVYKGILDEGK----TIIAVKVLNL-LHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYE  482 (741)
Q Consensus       408 ig~G~~g~V~~a~~~~~~----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv~e  482 (741)
                      ||+|+||+||+|.+-..+    .+||+|++.. .......++..|+-+|.+++|||+++++++|...      ...||++
T Consensus       704 LGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s------~~qlvtq  777 (1177)
T KOG1025|consen  704 LGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS------TLQLVTQ  777 (1177)
T ss_pred             eccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc------hHHHHHH
Confidence            999999999999985444    4689998863 3334567889999999999999999999998532      2789999


Q ss_pred             cccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecccc
Q 037916          483 FMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLA  562 (741)
Q Consensus       483 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~a  562 (741)
                      |++.|+|.+|++..         +..+.....+.|..||++||.|||.+   ++|||||-..||||....++||.|||+|
T Consensus       778 ~mP~G~LlDyvr~h---------r~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla  845 (1177)
T KOG1025|consen  778 LMPLGCLLDYVREH---------RDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLA  845 (1177)
T ss_pred             hcccchHHHHHHHh---------hccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchh
Confidence            99999999999865         34567778899999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcCCcchh
Q 037916          563 KLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVLPDHVM  641 (741)
Q Consensus       563 ~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  641 (741)
                      +....+...-......-.+.|||= |......++.++|||||||++||++| |..|++...-              +++.
T Consensus       846 ~ll~~d~~ey~~~~gK~pikwmal-e~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~--------------~eI~  910 (1177)
T KOG1025|consen  846 KLLAPDEKEYSAPGGKVPIKWMAL-ESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA--------------EEIP  910 (1177)
T ss_pred             hccCcccccccccccccCcHHHHH-HHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH--------------HHhh
Confidence            988766443333333346678888 55567789999999999999999999 8888762210              0111


Q ss_pred             HhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHh
Q 037916          642 DIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSI  709 (741)
Q Consensus       642 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  709 (741)
                      ++++                  .+.+.+.++.|..+++.++.+||..|++.||+++|+..++.++.+.
T Consensus       911 dlle------------------~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard  960 (1177)
T KOG1025|consen  911 DLLE------------------KGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD  960 (1177)
T ss_pred             HHHh------------------ccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence            1111                  1223445668889999999999999999999999999999888764

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.5e-32  Score=286.36  Aligned_cols=256  Identities=22%  Similarity=0.247  Sum_probs=192.0

Q ss_pred             HHHhhhcccCceeeEEEEEEc---CCCeEEEEEEeeccC----cCcchhHHHHHHHHHhc-CCCceeeEeeeecCccccC
Q 037916          402 FLFLCWIDMGSFGSVYKGILD---EGKTIIAVKVLNLLH----HGASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKG  473 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~  473 (741)
                      |++.+.||+|+||.||+|++.   .+++.||+|+++...    ....+.+.+|+.+++++ +||+|+++++.     +..
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~-----~~~   76 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYA-----FQT   76 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhhee-----eec
Confidence            677889999999999999864   467889999987422    22345677899999999 69999999988     455


Q ss_pred             CceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCc
Q 037916          474 DDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMT  553 (741)
Q Consensus       474 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~  553 (741)
                      +...++||||+++++|.+++...          ..+++..+..++.|+++||.|||+.   +++||||||+||+++.++.
T Consensus        77 ~~~~~lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~  143 (288)
T cd05583          77 DTKLHLILDYVNGGELFTHLYQR----------EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGH  143 (288)
T ss_pred             CCEEEEEEecCCCCcHHHHHhhc----------CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCC
Confidence            66889999999999999988532          3478888999999999999999999   9999999999999999999


Q ss_pred             eEEeecccccccCCCCcccccccccccccccCcccccCCC-CCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhh
Q 037916          554 AHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGS-EVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFA  632 (741)
Q Consensus       554 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~-~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~  632 (741)
                      ++|+|||.+.......... .....|+..|+|||.+.... ..+.++||||+|+++|+|++|..||..... ......+.
T Consensus       144 ~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~-~~~~~~~~  221 (288)
T cd05583         144 VVLTDFGLSKEFLAEEEER-AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE-QNSQSEIS  221 (288)
T ss_pred             EEEEECccccccccccccc-cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcc-cchHHHHH
Confidence            9999999987654332211 12245788999996543322 368899999999999999999999852111 00011111


Q ss_pred             hhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHH
Q 037916          633 RTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQS  705 (741)
Q Consensus       633 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  705 (741)
                      ..        ...    ...                ..+......+.+++.+||+.||++|||+.++.+.|+.
T Consensus       222 ~~--------~~~----~~~----------------~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         222 RR--------ILK----SKP----------------PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             HH--------HHc----cCC----------------CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence            10        000    000                0011234567899999999999999999988877654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.2e-32  Score=282.50  Aligned_cols=251  Identities=19%  Similarity=0.226  Sum_probs=189.8

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC-----cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH-----HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      +|.+.+.||+|+||.||++.+...+..+++|+++...     ......+..|+.+++.++||||+++++++     .+..
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   75 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASF-----LERD   75 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHH-----hcCC
Confidence            4788899999999999999998777777777775322     12233566789999999999999999984     4455


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..++||||+++++|.+++....      .....+++..++.++.|+++|+.|||+.   +++|+||+|+||+++. +.+|
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~  145 (260)
T cd08222          76 AFCIITEYCEGRDLDCKLEELK------HTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLK  145 (260)
T ss_pred             ceEEEEEeCCCCCHHHHHHHHh------hcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEe
Confidence            7899999999999998875321      1124588999999999999999999999   9999999999999975 5799


Q ss_pred             EeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhc
Q 037916          556 VADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV  635 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~  635 (741)
                      |+|||.+.........  .....|++.|+||| ...+..++.++||||+|+++|++++|..||....     ........
T Consensus       146 l~d~g~~~~~~~~~~~--~~~~~~~~~~~~pe-~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-----~~~~~~~~  217 (260)
T cd08222         146 IGDFGVSRLLMGSCDL--ATTFTGTPYYMSPE-ALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-----FLSVVLRI  217 (260)
T ss_pred             ecccCceeecCCCccc--ccCCCCCcCccCHH-HHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHH
Confidence            9999998766433221  12245788999995 4456678889999999999999999999985211     11111100


Q ss_pred             CCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          636 LPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       636 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ...            ...               ..+..++..+.+++.+||..||++||++.|+++
T Consensus       218 ~~~------------~~~---------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         218 VEG------------PTP---------------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             HcC------------CCC---------------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            000            000               001134567889999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.98  E-value=4.3e-35  Score=289.87  Aligned_cols=342  Identities=30%  Similarity=0.420  Sum_probs=228.2

Q ss_pred             CCCCCcccccCChhhhhCCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhcc---c--
Q 037916            2 DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQ---N--   76 (741)
Q Consensus         2 dl~~n~~~~~ip~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~---~--   76 (741)
                      |.|+|++. .+|..+. ++.++..|+.++|.+. ..|+.++.+..|+.|+..+|+|+ ..|..+..+.++.-..   +  
T Consensus        97 ~vs~n~ls-~lp~~i~-s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l  172 (565)
T KOG0472|consen   97 NVSHNKLS-ELPEQIG-SLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKL  172 (565)
T ss_pred             hcccchHh-hccHHHh-hhhhhhhhhcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccch
Confidence            45677777 7777777 6777777777777777 56667777777777777777777 5666666665511000   0  


Q ss_pred             --------cCCCccEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccc
Q 037916           77 --------CNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAI  148 (741)
Q Consensus        77 --------~~~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~  148 (741)
                              .++.|++||+.+|-++ .+|..+..+. +|+.|+|..|+|. ..| .|.++..|++|+++.|+|+.++....
T Consensus       173 ~~l~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~-~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~  248 (565)
T KOG0472|consen  173 KALPENHIAMKRLKHLDCNSNLLE-TLPPELGGLE-SLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEHL  248 (565)
T ss_pred             hhCCHHHHHHHHHHhcccchhhhh-cCChhhcchh-hhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHHh
Confidence                    0123555555555554 4444455554 5555555555552 233 55555556666666666654444444


Q ss_pred             cCCCcCcEEEcccCCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccc--------------
Q 037916          149 GELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSG--------------  214 (741)
Q Consensus       149 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~--------------  214 (741)
                      .++.+|.+|||..|+++ ..|+.+.-+.+|.+||+++|.|+ ..|..++++ .|+.|-+.+|.+..              
T Consensus       249 ~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vL  325 (565)
T KOG0472|consen  249 KHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVL  325 (565)
T ss_pred             cccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHH
Confidence            56666666777777766 56666666666777777777666 455566666 66666666666520              


Q ss_pred             --------------------------------------------------cCCccccc----------------------
Q 037916          215 --------------------------------------------------TIPPQLMD----------------------  222 (741)
Q Consensus       215 --------------------------------------------------~~p~~~~~----------------------  222 (741)
                                                                        .+|+..+.                      
T Consensus       326 KyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~elPk  405 (565)
T KOG0472|consen  326 KYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLCELPK  405 (565)
T ss_pred             HHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHhhhhh
Confidence                                                              11111110                      


Q ss_pred             ----cccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCccCCCCChhcccCcc
Q 037916          223 ----LTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRG  298 (741)
Q Consensus       223 ----l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  298 (741)
                          +..+...+++++|.+. .+|..++.+++|..|+|++|-+.. .|..++.+..|+.|++++|++. ..|.....+..
T Consensus       406 ~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln~-LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~  482 (565)
T KOG0472|consen  406 RLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLND-LPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQT  482 (565)
T ss_pred             hhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhhh-cchhhhhhhhhheecccccccc-cchHHHhhHHH
Confidence                0111111333444443 566777788888888888888874 5666777777888888888888 67877777777


Q ss_pred             CCeeeCCCCcCCCccchhhhccccCCcccccCcccccccCCccccCCcccccccCCCCc
Q 037916          299 LRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKNASAISVFGNSKL  357 (741)
Q Consensus       299 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~  357 (741)
                      |+.+-.++|++....|+.+.++.+|..|||.+|.+..+||..+.+.++..+.+.|||..
T Consensus       483 lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  483 LETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             HHHHHhccccccccChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecCCccC
Confidence            88888888889877788899999999999999999999999999999999999999865

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.98  E-value=5.9e-33  Score=292.62  Aligned_cols=243  Identities=22%  Similarity=0.199  Sum_probs=191.4

Q ss_pred             HHHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhc-CCCceeeEeeeecCccccCCc
Q 037916          397 LLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       397 ~~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      .....|.+...+|.|+|+.|-.+.+..+++..++|++...    ..+..+|+.++... +||||+++.++     +.++.
T Consensus       319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v-----~~~~~  389 (612)
T KOG0603|consen  319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDV-----YEDGK  389 (612)
T ss_pred             CcchhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecce-----ecCCc
Confidence            4567899999999999999999999999999999999643    23445667665554 89999999999     56677


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEe-CCCCce
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLL-DHEMTA  554 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll-~~~~~~  554 (741)
                      +.|+|||.+.|+-+.+.+...          . .....+..|+++|+.|+.|||++   |||||||||+|||+ +..+++
T Consensus       390 ~~~~v~e~l~g~ell~ri~~~----------~-~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~l  455 (612)
T KOG0603|consen  390 EIYLVMELLDGGELLRRIRSK----------P-EFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHL  455 (612)
T ss_pred             eeeeeehhccccHHHHHHHhc----------c-hhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcE
Confidence            999999999998777766432          1 22266778999999999999999   99999999999999 588999


Q ss_pred             EEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhh
Q 037916          555 HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       555 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  634 (741)
                      +|+|||.++.....     ....+-|..|.|| |+....+|++++||||+|+++|+|++|+.||...-.+    .+....
T Consensus       456 rltyFG~a~~~~~~-----~~tp~~t~~y~AP-Evl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~----~ei~~~  525 (612)
T KOG0603|consen  456 RLTYFGFWSELERS-----CDTPALTLQYVAP-EVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG----IEIHTR  525 (612)
T ss_pred             EEEEechhhhCchh-----hcccchhhcccCh-hhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch----HHHHHh
Confidence            99999999877654     2224568899999 5556889999999999999999999999998733222    111111


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      ...+...                              ........+|+.+||+.||.+||+|.|+..-
T Consensus       526 i~~~~~s------------------------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h  563 (612)
T KOG0603|consen  526 IQMPKFS------------------------------ECVSDEAKDLLQQLLQVDPALRLGADEIGAH  563 (612)
T ss_pred             hcCCccc------------------------------cccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence            1111111                              2344567799999999999999999998753

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=9.6e-33  Score=280.02  Aligned_cols=295  Identities=20%  Similarity=0.195  Sum_probs=211.2

Q ss_pred             HHHHHHHHHHHH-HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcC-----C---Cc
Q 037916          388 AIISVLVGILLF-VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIR-----H---KN  458 (741)
Q Consensus       388 ~~~~~~~~~~~~-~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---pn  458 (741)
                      +|..|-+|.++. ++|.+.++||.|.|++||+|.+....+.||+|+.+.. ....+....|+.+|++++     |   .+
T Consensus        65 GYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~  143 (590)
T KOG1290|consen   65 GYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKC  143 (590)
T ss_pred             CCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCce
Confidence            455666778888 8999999999999999999999999999999999743 234566788999999882     3   47


Q ss_pred             eeeEeeeecCccccCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCcee
Q 037916          459 LVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAH  538 (741)
Q Consensus       459 Iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH  538 (741)
                      ||++++.|.... .++.++|+|+|++ |-+|..+|...        .-+.++...++.|++||+.||.|||..|  ||||
T Consensus       144 VV~LlD~FkhsG-pNG~HVCMVfEvL-GdnLLklI~~s--------~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIH  211 (590)
T KOG1290|consen  144 VVQLLDHFKHSG-PNGQHVCMVFEVL-GDNLLKLIKYS--------NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIH  211 (590)
T ss_pred             eeeeeccceecC-CCCcEEEEEehhh-hhHHHHHHHHh--------CCCCCcHHHHHHHHHHHHHHHHHHHHhc--Cccc
Confidence            999999976543 6788999999999 77999998754        1255888999999999999999999988  9999


Q ss_pred             cCCCCCCeEeCCC-----------C-------------------------------------------------------
Q 037916          539 CDLKPSNVLLDHE-----------M-------------------------------------------------------  552 (741)
Q Consensus       539 rDlkp~NIll~~~-----------~-------------------------------------------------------  552 (741)
                      .||||+|||+...           +                                                       
T Consensus       212 TDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~  291 (590)
T KOG1290|consen  212 TDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGL  291 (590)
T ss_pred             cCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccc
Confidence            9999999998210           0                                                       


Q ss_pred             --------------------------------------------------------------------------------
Q 037916          553 --------------------------------------------------------------------------------  552 (741)
Q Consensus       553 --------------------------------------------------------------------------------  552 (741)
                                                                                                      
T Consensus       292 ~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~  371 (590)
T KOG1290|consen  292 EGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSP  371 (590)
T ss_pred             ccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCc
Confidence                                                                                            


Q ss_pred             --------------------ceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHH
Q 037916          553 --------------------TAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELM  612 (741)
Q Consensus       553 --------------------~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ell  612 (741)
                                          +|||+|||.|......     .+.-..|..|+|| |++.+..|++.+||||++|++|||.
T Consensus       372 ~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~kh-----FT~DIQTRQYRap-EVllGsgY~~~ADiWS~AC~~FELa  445 (590)
T KOG1290|consen  372 GTIASNPLVNPDIPLPECDIRVKIADLGNACWVHKH-----FTEDIQTRQYRAP-EVLLGSGYSTSADIWSTACMAFELA  445 (590)
T ss_pred             cccccccccCCCCCCCccceeEEEeeccchhhhhhh-----hchhhhhhhccCc-ceeecCCCCCchhHHHHHHHHHHhh
Confidence                                0233333333322111     0112258899999 6667889999999999999999999


Q ss_pred             cCCCCCCcccc-----CCcchhhhhhhc--C-------CcchhHhhhhcccCCc-chhhhhhhhHHHHHhHhhHHHHHHH
Q 037916          613 TRKRPSDIMFE-----GNMNLHNFARTV--L-------PDHVMDIVDSTLLADD-EDLTITSNQRQRQARINNIMECLIS  677 (741)
Q Consensus       613 tg~~p~~~~~~-----~~~~~~~~~~~~--~-------~~~~~~~~d~~l~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  677 (741)
                      ||...|+....     ++..+..++.-.  +       ....++++++...-.. ...+.-.....-........+...+
T Consensus       446 TGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~  525 (590)
T KOG1290|consen  446 TGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQ  525 (590)
T ss_pred             cCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHH
Confidence            99998864321     122233332211  1       1224455554322111 1111111112222333455678889


Q ss_pred             HHHHhhcccccCCCCCCCHHHHHH
Q 037916          678 VVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       678 l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      +.+++.-||+.+|++||||.+.++
T Consensus       526 fsdFL~PmLef~PeKR~tA~~cl~  549 (590)
T KOG1290|consen  526 FSDFLSPMLEFDPEKRPTAAQCLK  549 (590)
T ss_pred             HHHHHHHHHhcCccccccHHHHhc
Confidence            999999999999999999999875

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.98  E-value=5.9e-32  Score=275.57  Aligned_cols=237  Identities=26%  Similarity=0.278  Sum_probs=186.7

Q ss_pred             cccCceeeEEEEEEcCCCeEEEEEEeeccCcC---cchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEEEecc
Q 037916          408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG---ASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFM  484 (741)
Q Consensus       408 ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv~e~~  484 (741)
                      ||.|+||.||++.+..+++.||+|+++.....   ....+..|+.++++++||||+++++.     ++.+...++||||+
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-----~~~~~~~~~v~e~~   75 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYA-----FQTEEKLYLVLEYA   75 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHH-----eecCCeeEEEEecC
Confidence            69999999999999888999999998743322   34567889999999999999999988     45677899999999


Q ss_pred             cCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecccccc
Q 037916          485 HNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKL  564 (741)
Q Consensus       485 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~a~~  564 (741)
                      ++++|.+++...          ..+++..+..++.|+++|+.|+|+.   +++|+||+|+||+++.++.++|+|||.+..
T Consensus        76 ~~~~L~~~l~~~----------~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~  142 (250)
T cd05123          76 PGGELFSHLSKE----------GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKE  142 (250)
T ss_pred             CCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCccee
Confidence            999999998643          3578899999999999999999999   999999999999999999999999999876


Q ss_pred             cCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcchhHhh
Q 037916          565 LPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIV  644 (741)
Q Consensus       565 ~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  644 (741)
                      ......  ......++..|+||| ...+...+.++|+||||+++|++++|..||.....     .......        .
T Consensus       143 ~~~~~~--~~~~~~~~~~~~~Pe-~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~--------~  206 (250)
T cd05123         143 LSSEGS--RTNTFCGTPEYLAPE-VLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----KEIYEKI--------L  206 (250)
T ss_pred             cccCCC--cccCCcCCccccChH-HhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHH--------h
Confidence            644321  122345788999995 44566688999999999999999999999863211     1111110        0


Q ss_pred             hhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHH
Q 037916          645 DSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTI  698 (741)
Q Consensus       645 d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  698 (741)
                      .....                    .+...+..+.+++.+||..||++|||+.+
T Consensus       207 ~~~~~--------------------~~~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         207 KDPLR--------------------FPEFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             cCCCC--------------------CCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence            00000                    00122456789999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.98  E-value=3.2e-32  Score=312.95  Aligned_cols=146  Identities=29%  Similarity=0.410  Sum_probs=128.3

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc---CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCce
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH---GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      ..|.++++||+|+||.||+|.+..+++.||+|+++....   .....+..|+.+++.++||||+++++++     ....+
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~~   78 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL-----QSANN   78 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE-----EECCE
Confidence            468889999999999999999998999999999974322   1235678899999999999999999884     45668


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .|+||||+.+++|.+++...          ..+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||
T Consensus        79 ~~lVmEy~~g~~L~~li~~~----------~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL  145 (669)
T cd05610          79 VYLVMEYLIGGDVKSLLHIY----------GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKL  145 (669)
T ss_pred             EEEEEeCCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEE
Confidence            99999999999999998643          3477888899999999999999999   9999999999999999999999


Q ss_pred             eeccccc
Q 037916          557 ADFGLAK  563 (741)
Q Consensus       557 ~DFg~a~  563 (741)
                      +|||+++
T Consensus       146 ~DFGls~  152 (669)
T cd05610         146 TDFGLSK  152 (669)
T ss_pred             EeCCCCc
Confidence            9999885

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.98  E-value=1.2e-32  Score=253.14  Aligned_cols=278  Identities=19%  Similarity=0.252  Sum_probs=203.2

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcC-CCceeeEeeeecCccccCCceE
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIR-HKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      ...|++++++|+|.|++||.|....+.+.++||+++..   ..+.+.+|+.+|+.+. ||||++++++..+.   .....
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp---~Sktp  110 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDP---ESKTP  110 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCc---cccCc
Confidence            35799999999999999999999888999999999743   3467889999999996 99999999986543   34567


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCC-ceEE
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEM-TAHV  556 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~-~~kL  556 (741)
                      .+++||+.+.+...+.             +.++...++.++.+++.||.|+|+.   ||+|||+||.|++||... .++|
T Consensus       111 aLiFE~v~n~Dfk~ly-------------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrl  174 (338)
T KOG0668|consen  111 SLIFEYVNNTDFKQLY-------------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRL  174 (338)
T ss_pred             hhHhhhhccccHHHHh-------------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeee
Confidence            8999999988877765             3467778899999999999999999   999999999999999754 7999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcC
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVL  636 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  636 (741)
                      +|+|+|.+..+......   ...+..|.-||.+..-..|+..-|+|||||++..|+..+.||-...+...++...+...-
T Consensus       175 IDWGLAEFYHp~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLG  251 (338)
T KOG0668|consen  175 IDWGLAEFYHPGKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLG  251 (338)
T ss_pred             eecchHhhcCCCceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhC
Confidence            99999998876654443   345677889977777788999999999999999999999998533333233333333322


Q ss_pred             CcchhHhhhhcccCCcchhhhhhhh--HHHHHhHhhH--H-HHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          637 PDHVMDIVDSTLLADDEDLTITSNQ--RQRQARINNI--M-ECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       637 ~~~~~~~~d~~l~~~~~~~~~~~~~--~~~~~~~~~~--~-~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ..+....+++.-..-...-......  +....++...  . -..++..+++.+.+.+|..+|+|++|.+.
T Consensus       252 t~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  252 TDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             hHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence            2233333332221111110000000  0000111000  0 11256779999999999999999999875

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-32  Score=248.78  Aligned_cols=217  Identities=22%  Similarity=0.279  Sum_probs=172.1

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC-cCcchhHHHHHHHHHh-cCCCceeeEeeeecCccccCCceE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH-HGASKSSIAECSALRN-IRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~-l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      .....+..||+|++|.|=+-++..+|...|+|.++..- ....++...|+++..+ ..+|++|++||.     +.++..+
T Consensus        46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa-----~~regdv  120 (282)
T KOG0984|consen   46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGA-----LFREGDV  120 (282)
T ss_pred             hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehh-----hhccccE
Confidence            44556788999999999999999999999999997422 3344566778887555 479999999997     5566789


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      |+.||.| .-||..+.++.      ......+++.-+-+|+..+++||.|||++.  .|+|||+||+|||++.+|+||+|
T Consensus       121 wIcME~M-~tSldkfy~~v------~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiC  191 (282)
T KOG0984|consen  121 WICMELM-DTSLDKFYRKV------LKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKIC  191 (282)
T ss_pred             EEeHHHh-hhhHHHHHHHH------HhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEc
Confidence            9999999 45888876532      122356788888899999999999999986  99999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccccccCccccc---CCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhh
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG---LGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFAR  633 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~---~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~  633 (741)
                      |||.+....++-....   ..|...|||||.+-   ....|+.|+||||+|+++.||.+++.||+..+..-..+.+.+.
T Consensus       192 DFGIsG~L~dSiAkt~---daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe  267 (282)
T KOG0984|consen  192 DFGISGYLVDSIAKTM---DAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE  267 (282)
T ss_pred             ccccceeehhhhHHHH---hcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence            9999987766533221   34888999997543   2347899999999999999999999999865444444444433

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=7e-32  Score=272.53  Aligned_cols=223  Identities=20%  Similarity=0.144  Sum_probs=172.5

Q ss_pred             CceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEEEecccCCChh
Q 037916          411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLE  490 (741)
Q Consensus       411 G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~  490 (741)
                      |.+|.||++++..+++.||+|+++...     ....|...+....||||+++++++     .+....++||||+++|+|.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~   73 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYI-----VSEDSVFLVLQHAEGGKLW   73 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhhe-----ecCCeEEEEEecCCCCCHH
Confidence            899999999999999999999986432     233455555566799999999984     4566899999999999999


Q ss_pred             hhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecccccccCCCCc
Q 037916          491 EWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHL  570 (741)
Q Consensus       491 ~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  570 (741)
                      +++...          ..+++..+..++.|++.||+|+|+.   +|+||||||+||+++.++.++++|||.+....... 
T Consensus        74 ~~l~~~----------~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-  139 (237)
T cd05576          74 SHISKF----------LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-  139 (237)
T ss_pred             HHHHHh----------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc-
Confidence            988533          3478899999999999999999999   99999999999999999999999999876554321 


Q ss_pred             ccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcchhHhhhhcccC
Q 037916          571 QTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLA  650 (741)
Q Consensus       571 ~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  650 (741)
                          ....++..|+||| ...+..++.++||||+||++||+++|..|+......   ......          +      
T Consensus       140 ----~~~~~~~~y~aPE-~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~---~~~~~~----------~------  195 (237)
T cd05576         140 ----DGEAVENMYCAPE-VGGISEETEACDWWSLGAILFELLTGKTLVECHPSG---INTHTT----------L------  195 (237)
T ss_pred             ----ccCCcCccccCCc-ccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh---cccccc----------c------
Confidence                1233577899995 555667889999999999999999999886421000   000000          0      


Q ss_pred             CcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHH
Q 037916          651 DDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIV  699 (741)
Q Consensus       651 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev  699 (741)
                                        ..+......+.+++.+|++.||++|||+.+.
T Consensus       196 ------------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~  226 (237)
T cd05576         196 ------------------NIPEWVSEEARSLLQQLLQFNPTERLGAGVA  226 (237)
T ss_pred             ------------------CCcccCCHHHHHHHHHHccCCHHHhcCCCcc
Confidence                              0001223567799999999999999997443

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.97  E-value=4.2e-34  Score=296.30  Aligned_cols=316  Identities=27%  Similarity=0.385  Sum_probs=240.9

Q ss_pred             CCCCcccccCChhhhhCCCCCcEEEcccCccccc-CCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCc
Q 037916            3 VGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGV-IPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHL   81 (741)
Q Consensus         3 l~~n~~~~~ip~~~~~~l~~L~~L~L~~n~i~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L   81 (741)
                      +++|++. ++-..+. .||.|+.++++.|++... +|..+..|..|++||||+|+++ ..|..+...++          +
T Consensus        62 ~~HN~L~-~vhGELs-~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn----------~  128 (1255)
T KOG0444|consen   62 MAHNQLI-SVHGELS-DLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKN----------S  128 (1255)
T ss_pred             hhhhhhH-hhhhhhc-cchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcC----------c
Confidence            4566665 5555555 677777777777777533 5667777888888888888887 67777777665          7


Q ss_pred             cEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEccc
Q 037916           82 KHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINT  161 (741)
Q Consensus        82 ~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~  161 (741)
                      -.|+||+|+|..++...|.++. .|-.|+|++|++ ...|..+..|.+|++|+|++|.+.......+-.+++|++|.+++
T Consensus       129 iVLNLS~N~IetIPn~lfinLt-DLLfLDLS~NrL-e~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~  206 (1255)
T KOG0444|consen  129 IVLNLSYNNIETIPNSLFINLT-DLLFLDLSNNRL-EMLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSN  206 (1255)
T ss_pred             EEEEcccCccccCCchHHHhhH-hHhhhccccchh-hhcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhccc
Confidence            7888888888755555666666 788888888887 55666677788888888888877655555566667777888877


Q ss_pred             CCCC-CcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCC
Q 037916          162 NKLS-GNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGS  240 (741)
Q Consensus       162 N~l~-~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~  240 (741)
                      .+-+ ..+|.++.++.+|..+|||.|.+. ..|+.+..+++|+.|+||+|+|+ .+.........+.. |+||.|+++ .
T Consensus       207 TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEt-LNlSrNQLt-~  282 (1255)
T KOG0444|consen  207 TQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLET-LNLSRNQLT-V  282 (1255)
T ss_pred             ccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhh-hccccchhc-c
Confidence            6543 256778888888888888888887 77888888888888888888887 66666666677776 888888888 7


Q ss_pred             CChhhcCCCCCcEEEeccccccc-hhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccchhhhc
Q 037916          241 LPTEVGKLINLEILFISRNMLEC-EILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVE  319 (741)
Q Consensus       241 ~p~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  319 (741)
                      +|.++.+|++|+.|++.+|+++- -+|+.++.+.+|+++.+++|.+. ..|..++.+..|+.|.|+.|++- .+|+.+.-
T Consensus       283 LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHl  360 (1255)
T KOG0444|consen  283 LPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHL  360 (1255)
T ss_pred             chHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhh
Confidence            88888888888888888888763 35777888888888888888887 78888888888888888888887 67888888


Q ss_pred             cccCCcccccCcccccccCC
Q 037916          320 LQLVQNLNLSYNDLEGVIPT  339 (741)
Q Consensus       320 l~~L~~L~l~~N~l~~~~~~  339 (741)
                      ++.|+.||+..|+=---||.
T Consensus       361 L~~l~vLDlreNpnLVMPPK  380 (1255)
T KOG0444|consen  361 LPDLKVLDLRENPNLVMPPK  380 (1255)
T ss_pred             cCCcceeeccCCcCccCCCC
Confidence            88888888888875444443

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-31  Score=289.88  Aligned_cols=257  Identities=20%  Similarity=0.253  Sum_probs=205.7

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhc-CCCceeeEeeeecCccccCCceEEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      .|+|.+.||.|.+|.||+++.+.+++.+|+|+.... ....++...|..+++.. +|||++.+|+++.-.+-..++..|+
T Consensus        20 ~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWL   98 (953)
T KOG0587|consen   20 IFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWL   98 (953)
T ss_pred             ccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEE
Confidence            367888999999999999999999999999998753 34456777889999887 7999999999987666567789999


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      |||||.+||..++++...        ...+.|..+..|++.++.|+.+||..   .++|||||-.|||++.++.|||+||
T Consensus        99 VMEfC~gGSVTDLVKn~~--------g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDF  167 (953)
T KOG0587|consen   99 VMEFCGGGSVTDLVKNTK--------GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDF  167 (953)
T ss_pred             EeeccCCccHHHHHhhhc--------ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeee
Confidence            999999999999998653        35688999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccccccCcccccCC----CCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhc
Q 037916          560 GLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLG----SEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV  635 (741)
Q Consensus       560 g~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~----~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~  635 (741)
                      |.+..........  ....||+.|||||.+...    ..|+..+|+||+|++..||.-|.+|+.++..-..-+.      
T Consensus       168 GvSaQldsT~grR--nT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~------  239 (953)
T KOG0587|consen  168 GVSAQLDSTVGRR--NTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFL------  239 (953)
T ss_pred             eeeeeeecccccc--cCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhcc------
Confidence            9998765443222  225699999999765433    3477889999999999999999999764432111100      


Q ss_pred             CCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          636 LPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       636 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      +                        .+...+....+..-.+++.++|..|+..|-++||++.++++
T Consensus       240 I------------------------pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  240 I------------------------PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             C------------------------CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            0                        00111122223344677889999999999999999998874

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.9e-32  Score=271.40  Aligned_cols=198  Identities=27%  Similarity=0.340  Sum_probs=167.7

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhc-CCCceeeEeeeecCccccCCce
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      .|.++..||+|+||.|.+|..+.+.+.+|||++++.-   ..+.+--..|-++|.-- +-|.++++..+     ++.-+.
T Consensus       350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHSc-----FQTmDR  424 (683)
T KOG0696|consen  350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSC-----FQTMDR  424 (683)
T ss_pred             ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHH-----hhhhhh
Confidence            5778899999999999999999999999999998432   22334445677777655 56788898887     566679


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .|+||||+.||+|--.+++.          ..+.+..+..++.+|+-||-|||++   ||+.||||.+||++|.+|++||
T Consensus       425 LyFVMEyvnGGDLMyhiQQ~----------GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi  491 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHIQQV----------GKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKI  491 (683)
T ss_pred             eeeEEEEecCchhhhHHHHh----------cccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEe
Confidence            99999999999999888755          4566778889999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCC
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSD  619 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~  619 (741)
                      +|||+++.--.+..  +....+|||.|+|| |+....+|+.++|+||+||++|||+.|++||+
T Consensus       492 ~DFGmcKEni~~~~--TTkTFCGTPdYiAP-EIi~YqPYgksvDWWa~GVLLyEmlaGQpPFd  551 (683)
T KOG0696|consen  492 ADFGMCKENIFDGV--TTKTFCGTPDYIAP-EIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD  551 (683)
T ss_pred             eecccccccccCCc--ceeeecCCCccccc-ceEEecccccchhHHHHHHHHHHHHcCCCCCC
Confidence            99999986543332  22347899999999 66678899999999999999999999999997

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=6.2e-32  Score=261.14  Aligned_cols=201  Identities=26%  Similarity=0.319  Sum_probs=177.0

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeec---cCcCcchhHHHHHHHHHhc-CCCceeeEeeeecCccccCCc
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNL---LHHGASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      ..|.+++.||+|+|++|..++...+.+.+|+|++++   ...+..+-.+.|-.+..+. +||.+|.+..+     ++.+.
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhsc-----fqtes  324 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSC-----FQTES  324 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhh-----hcccc
Confidence            568899999999999999999999999999999984   3344455667888888776 79999999988     77888


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..++|.||++||+|--++++.          ..++++.++.+...|+-||.|||++   |||.||||.+|||+|..|++|
T Consensus       325 rlffvieyv~ggdlmfhmqrq----------rklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghik  391 (593)
T KOG0695|consen  325 RLFFVIEYVNGGDLMFHMQRQ----------RKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIK  391 (593)
T ss_pred             eEEEEEEEecCcceeeehhhh----------hcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCcee
Confidence            999999999999998877643          5689999999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCcc
Q 037916          556 VADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIM  621 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~  621 (741)
                      |+|+|+++..-.+...+  ...+|||.|.|| |++.+..|+..+|+|++|++|+||+.|+.||+..
T Consensus       392 ltdygmcke~l~~gd~t--stfcgtpnyiap-eilrgeeygfsvdwwalgvlmfemmagrspfdiv  454 (593)
T KOG0695|consen  392 LTDYGMCKEGLGPGDTT--STFCGTPNYIAP-EILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIV  454 (593)
T ss_pred             ecccchhhcCCCCCccc--ccccCCCcccch-hhhcccccCceehHHHHHHHHHHHHcCCCCccee
Confidence            99999998765444333  237899999999 7788999999999999999999999999999854

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=5.4e-31  Score=298.07  Aligned_cols=266  Identities=23%  Similarity=0.347  Sum_probs=203.7

Q ss_pred             HHhhhcccCceeeEEEEEEc---C----CCeEEEEEEeeccC-cCcchhHHHHHHHHHhc-CCCceeeEeeeecCccccC
Q 037916          403 LFLCWIDMGSFGSVYKGILD---E----GKTIIAVKVLNLLH-HGASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKG  473 (741)
Q Consensus       403 ~~~~~ig~G~~g~V~~a~~~---~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~  473 (741)
                      .+.+.+|+|.||.||+|...   .    ....||||.++... ....+.+..|+.+|+.+ +||||+.++++|..     
T Consensus       299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~-----  373 (609)
T KOG0200|consen  299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ-----  373 (609)
T ss_pred             cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc-----
Confidence            45568999999999999753   1    25679999997433 23456788999999998 69999999999854     


Q ss_pred             CceEEEEEecccCCChhhhccCCC-CCCccc---Ccc--cccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeE
Q 037916          474 DDFKALVYEFMHNGSLEEWLHPVS-GADKTV---EAP--KCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVL  547 (741)
Q Consensus       474 ~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~---~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIl  547 (741)
                      ....++|+||+..|+|.++++..+ ......   ...  ..++....+.++.||+.|++||++.   ++|||||-..|||
T Consensus       374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVL  450 (609)
T KOG0200|consen  374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVL  450 (609)
T ss_pred             CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEE
Confidence            557899999999999999998765 100000   011  2488899999999999999999999   9999999999999


Q ss_pred             eCCCCceEEeecccccccCCCCcccccccc-cccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCC
Q 037916          548 LDHEMTAHVADFGLAKLLPPAHLQTSSIGV-KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGN  625 (741)
Q Consensus       548 l~~~~~~kL~DFg~a~~~~~~~~~~~~~~~-~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~  625 (741)
                      +.++..+||+|||+|+.......+...... .-...|||||.+ ....++.|+|||||||++||++| |..||.... ..
T Consensus       451 i~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl-~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~-~~  528 (609)
T KOG0200|consen  451 ITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESL-FDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP-PT  528 (609)
T ss_pred             ecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHh-ccCcccccchhhHHHHHHHHHhhCCCCCCCCCC-cH
Confidence            999999999999999977665544322111 023459999554 55899999999999999999999 788875210 00


Q ss_pred             cchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHH
Q 037916          626 MNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQS  705 (741)
Q Consensus       626 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  705 (741)
                      ..            +.+.                  ...+.+...+..|.+++.++|+.||..+|++||++.|+.+.++.
T Consensus       529 ~~------------l~~~------------------l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~  578 (609)
T KOG0200|consen  529 EE------------LLEF------------------LKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK  578 (609)
T ss_pred             HH------------HHHH------------------HhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence            00            0111                  11222334455778899999999999999999999999999999


Q ss_pred             HHH
Q 037916          706 IKS  708 (741)
Q Consensus       706 i~~  708 (741)
                      ...
T Consensus       579 ~l~  581 (609)
T KOG0200|consen  579 HLQ  581 (609)
T ss_pred             HHH
Confidence            654

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=6.5e-31  Score=294.46  Aligned_cols=280  Identities=17%  Similarity=0.133  Sum_probs=170.1

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCC----CeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecC-ccccCC
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEG----KTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSG-VDYKGD  474 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~~  474 (741)
                      ..|.+.+.||+|+||.||+|++..+    +..||+|.++...  ..+....|  .++...+.+++.++..+.. .....+
T Consensus       132 ~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~--~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~  207 (566)
T PLN03225        132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG--AVEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKE  207 (566)
T ss_pred             CCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc--hhHHHHHH--HHHhhchhhHHHHHHhhhcccccccC
Confidence            3577888999999999999999888    8999999875321  11111111  1222222333322222111 001345


Q ss_pred             ceEEEEEecccCCChhhhccCCCCC----------CcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCC
Q 037916          475 DFKALVYEFMHNGSLEEWLHPVSGA----------DKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPS  544 (741)
Q Consensus       475 ~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~  544 (741)
                      ...++||||+.+++|.+++......          ..............+..++.|++.||+|||+.   +|+||||||+
T Consensus       208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~  284 (566)
T PLN03225        208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQ  284 (566)
T ss_pred             CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHH
Confidence            6789999999999999988643100          00000011122344668999999999999999   9999999999


Q ss_pred             CeEeCC-CCceEEeecccccccCCCCcccccccccccccccCcccccCCC---------------------CCCCccCch
Q 037916          545 NVLLDH-EMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGS---------------------EVSINGDVY  602 (741)
Q Consensus       545 NIll~~-~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~---------------------~~~~~~DIw  602 (741)
                      |||++. ++.+||+|||+|+......... .....+++.|+|||.+....                     .++.++|||
T Consensus       285 NILl~~~~~~~KL~DFGlA~~l~~~~~~~-~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw  363 (566)
T PLN03225        285 NIIFSEGSGSFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY  363 (566)
T ss_pred             HEEEeCCCCcEEEEeCCCccccccccccC-CcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence            999986 5799999999998654332211 12356899999997553221                     234567999


Q ss_pred             hHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCC--cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHH
Q 037916          603 SYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLP--DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVR  680 (741)
Q Consensus       603 SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  680 (741)
                      |+||++|||+++..|++..      ...+......  .....+... ......      .  ......+..........+
T Consensus       364 SlGviL~el~~~~~~~~~~------~~~~~~~l~~~~~~~~~~~~~-~~~~~~------~--~~~~~~~~~d~~~~~~~d  428 (566)
T PLN03225        364 SAGLIFLQMAFPNLRSDSN------LIQFNRQLKRNDYDLVAWRKL-VEPRAS------P--DLRRGFEVLDLDGGAGWE  428 (566)
T ss_pred             HHHHHHHHHHhCcCCCchH------HHHHHHHHHhcCCcHHHHHHh-hccccc------h--hhhhhhhhccccchHHHH
Confidence            9999999999987765421      1111111000  000010000 000000      0  000001111112334568


Q ss_pred             HhhcccccCCCCCCCHHHHHHH
Q 037916          681 IGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       681 li~~cl~~dP~~RPs~~evl~~  702 (741)
                      |+.+|++.||++|||+.|+++-
T Consensus       429 Li~~mL~~dP~kR~ta~e~L~H  450 (566)
T PLN03225        429 LLKSMMRFKGRQRISAKAALAH  450 (566)
T ss_pred             HHHHHccCCcccCCCHHHHhCC
Confidence            9999999999999999999873

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.4e-32  Score=277.50  Aligned_cols=247  Identities=22%  Similarity=0.288  Sum_probs=196.4

Q ss_pred             HHHHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcC---cchhHHHHHHHHHhcCCCceeeEeeeecCcccc
Q 037916          396 ILLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG---ASKSSIAECSALRNIRHKNLVKILTVCSGVDYK  472 (741)
Q Consensus       396 ~~~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  472 (741)
                      .+-+..+.++..||-|+||.|=++........+|+|++++....   ..+....|-.+|...+.|.||++|-.     |.
T Consensus       416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrT-----fr  490 (732)
T KOG0614|consen  416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRT-----FR  490 (732)
T ss_pred             ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHH-----hc
Confidence            44566788888999999999999998765556899999754433   34456679999999999999999998     67


Q ss_pred             CCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCC
Q 037916          473 GDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEM  552 (741)
Q Consensus       473 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~  552 (741)
                      +..++|+.||-|-||.++..++..          ..++..+.+.++..+++|++|||++   +||.|||||+|.+++.+|
T Consensus       491 d~kyvYmLmEaClGGElWTiLrdR----------g~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~G  557 (732)
T KOG0614|consen  491 DSKYVYMLMEACLGGELWTILRDR----------GSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRG  557 (732)
T ss_pred             cchhhhhhHHhhcCchhhhhhhhc----------CCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCC
Confidence            788999999999999999999754          5678888899999999999999999   999999999999999999


Q ss_pred             ceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhh
Q 037916          553 TAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFA  632 (741)
Q Consensus       553 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~  632 (741)
                      -+||.|||+|+.+..+...   ...+|||.|.|| |+..+...+.++|.||+|+.+||+++|.+||...    ..+..+.
T Consensus       558 y~KLVDFGFAKki~~g~KT---wTFcGTpEYVAP-EIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~----dpmktYn  629 (732)
T KOG0614|consen  558 YLKLVDFGFAKKIGSGRKT---WTFCGTPEYVAP-EIILNKGHDRAVDYWALGILIYELLTGSPPFSGV----DPMKTYN  629 (732)
T ss_pred             ceEEeehhhHHHhccCCce---eeecCCcccccc-hhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCC----chHHHHH
Confidence            9999999999998766432   237899999999 5555667789999999999999999999998622    1111111


Q ss_pred             hhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCC
Q 037916          633 RTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMN  695 (741)
Q Consensus       633 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs  695 (741)
                      . .            +.+.+              .+..+........+++++.+..+|.+|-.
T Consensus       630 ~-I------------LkGid--------------~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  630 L-I------------LKGID--------------KIEFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             H-H------------Hhhhh--------------hhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence            1 0            00000              01112234455678888999999999975

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.97  E-value=2.2e-33  Score=277.83  Aligned_cols=327  Identities=28%  Similarity=0.390  Sum_probs=249.9

Q ss_pred             CCCCcccccCChhhhhCCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCcc
Q 037916            3 VGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLK   82 (741)
Q Consensus         3 l~~n~~~~~ip~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~   82 (741)
                      .++|+|+ ++|.+++ .+..+..|++.+|.++...|+.+ +++.|+.||..+|-++ .+|..++.+.+          |.
T Consensus       144 ~~~N~i~-slp~~~~-~~~~l~~l~~~~n~l~~l~~~~i-~m~~L~~ld~~~N~L~-tlP~~lg~l~~----------L~  209 (565)
T KOG0472|consen  144 ATNNQIS-SLPEDMV-NLSKLSKLDLEGNKLKALPENHI-AMKRLKHLDCNSNLLE-TLPPELGGLES----------LE  209 (565)
T ss_pred             ccccccc-cCchHHH-HHHHHHHhhccccchhhCCHHHH-HHHHHHhcccchhhhh-cCChhhcchhh----------hH
Confidence            3455665 5566665 56666666666666664333333 3666666666666666 55666666665          99


Q ss_pred             EEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcccC
Q 037916           83 HLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTN  162 (741)
Q Consensus        83 ~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N  162 (741)
                      .|+|.+|+|. .+| .|...+ .|.+|+++.|+|.....+....|.+|.+|||..|+++ ..|+.+..+.+|++||||+|
T Consensus       210 ~LyL~~Nki~-~lP-ef~gcs-~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN  285 (565)
T KOG0472|consen  210 LLYLRRNKIR-FLP-EFPGCS-LLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNN  285 (565)
T ss_pred             HHHhhhcccc-cCC-CCCccH-HHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCC
Confidence            9999999999 566 677777 8999999999995554455569999999999999999 67888999999999999999


Q ss_pred             CCCCcCcccccCCcccceeeccCcccccc---------------------------------------------------
Q 037916          163 KLSGNIPPSIGNLKKLLQLYLIENFLQVS---------------------------------------------------  191 (741)
Q Consensus       163 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~---------------------------------------------------  191 (741)
                      .|+ .+|.+++++ .|+.|-+.+|.+..+                                                   
T Consensus       286 ~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~  363 (565)
T KOG0472|consen  286 DIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIIT  363 (565)
T ss_pred             ccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhh
Confidence            999 678899999 999999999987641                                                   


Q ss_pred             -------------cCcccccCCC---CCEEeccCcccc-----------------------ccCCccccccccceeEEEc
Q 037916          192 -------------IPSSLGQCQS---LTTINLSYNNLS-----------------------GTIPPQLMDLTSLSVGLDL  232 (741)
Q Consensus       192 -------------~~~~~~~l~~---L~~L~L~~N~l~-----------------------~~~p~~~~~l~~L~~~L~L  232 (741)
                                   +|+....-..   .+..+++.|++.                       +.+|..++.++++.. |+|
T Consensus       364 tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~-L~L  442 (565)
T KOG0472|consen  364 TKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLCELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTF-LDL  442 (565)
T ss_pred             hhhhcccccccccCCHHHHHHhhhcceEEEecccchHhhhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhccee-eec
Confidence                         0110000001   334455555442                       366777889999998 999


Q ss_pred             CCCccCCCCChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCc
Q 037916          233 SRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGE  312 (741)
Q Consensus       233 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  312 (741)
                      ++|-+. .+|..++.+..|+.|++|.|++.. .|.....+..|+.+-.++|++..+.+..+.+|.+|..|||.+|.|. .
T Consensus       443 ~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr~-lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~  519 (565)
T KOG0472|consen  443 SNNLLN-DLPEEMGSLVRLQTLNLSFNRFRM-LPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-Q  519 (565)
T ss_pred             ccchhh-hcchhhhhhhhhheeccccccccc-chHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-h
Confidence            999998 788999999999999999999984 5666666777888888889999888888999999999999999999 7


Q ss_pred             cchhhhccccCCcccccCcccccccCCcccc-CCcccccccCC
Q 037916          313 IPKFLVELQLVQNLNLSYNDLEGVIPTEGVF-KNASAISVFGN  354 (741)
Q Consensus       313 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-~~~~~~~~~~n  354 (741)
                      +|..++++++|+.|++.||+|. .|+..... +...-+.+.++
T Consensus       520 IPp~LgnmtnL~hLeL~gNpfr-~Pr~~iLmkgT~aiL~ylrd  561 (565)
T KOG0472|consen  520 IPPILGNMTNLRHLELDGNPFR-QPRHQILMKGTAAILSYLRD  561 (565)
T ss_pred             CChhhccccceeEEEecCCccC-CCHHHHhccChHHHHHHhcc
Confidence            8889999999999999999999 55544322 33444444444

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-32  Score=259.34  Aligned_cols=283  Identities=19%  Similarity=0.202  Sum_probs=197.5

Q ss_pred             HhhhcccCceeeEEEEEEcCCCeEEEEEEeec--cCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEEE
Q 037916          404 FLCWIDMGSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVY  481 (741)
Q Consensus       404 ~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv~  481 (741)
                      ..+-||.|+||.||.+++..+|+.||+|++..  ..-...+++.+|+.++..++|.||...++........--...|+++
T Consensus        57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T  136 (449)
T KOG0664|consen   57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT  136 (449)
T ss_pred             CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence            34569999999999999999999999998852  2223457788999999999999999998874322211122468899


Q ss_pred             ecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeeccc
Q 037916          482 EFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGL  561 (741)
Q Consensus       482 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~  561 (741)
                      |.| ..+|...|-          .++.++...++-+.+||++||.|||+.   +|.||||||.|.|++.+..+||||||+
T Consensus       137 ELm-QSDLHKIIV----------SPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGL  202 (449)
T KOG0664|consen  137 ELM-QSDLHKIIV----------SPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGL  202 (449)
T ss_pred             HHH-Hhhhhheec----------cCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEeccccc
Confidence            998 458888874          346788888999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcchh
Q 037916          562 AKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM  641 (741)
Q Consensus       562 a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  641 (741)
                      |+..+..... ..+...-|..|+|||.+++...|+.++||||.|||+.|++.++.-|..  .+..+..+++.+.+.....
T Consensus       203 ARvee~d~~~-hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQA--q~PiqQL~lItdLLGTPs~  279 (449)
T KOG0664|consen  203 ARTWDQRDRL-NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQA--AGPIEQLQMIIDLLGTPSQ  279 (449)
T ss_pred             ccccchhhhh-hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhc--cChHHHHHHHHHHhCCCcH
Confidence            9876544332 233345688999998888888999999999999999999999888752  2223333333333332211


Q ss_pred             HhhhhcccCCcch-hhhh--hhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHH
Q 037916          642 DIVDSTLLADDED-LTIT--SNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHEL  703 (741)
Q Consensus       642 ~~~d~~l~~~~~~-~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  703 (741)
                      +-..-...+.... .+..  .......+...-..........+..+++..||++|.+..+.+...
T Consensus       280 EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  280 EAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             HHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence            1111000000000 0000  000000111111112223455777889999999999998887653

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=6.7e-31  Score=273.05  Aligned_cols=203  Identities=22%  Similarity=0.297  Sum_probs=167.7

Q ss_pred             hcccCceeeEEEEEEcCCCeEEEEEEeeccCc---CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEEEec
Q 037916          407 WIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH---GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEF  483 (741)
Q Consensus       407 ~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv~e~  483 (741)
                      .||-|+||+|.+++..++...||+|.+++.+.   ........|-+||...+.+-||++|..     |++.+..|+||+|
T Consensus       636 ~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyyS-----FQDkdnLYFVMdY  710 (1034)
T KOG0608|consen  636 TIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYS-----FQDKDNLYFVMDY  710 (1034)
T ss_pred             eecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE-----eccCCceEEEEec
Confidence            49999999999999998999999999875432   233455779999999999999999987     6788899999999


Q ss_pred             ccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeeccccc
Q 037916          484 MHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAK  563 (741)
Q Consensus       484 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~a~  563 (741)
                      ++||++-.++-+.          ..+.+..++.++.++.+|+++.|..   |+|||||||+|||||.+|++||+|||+|.
T Consensus       711 IPGGDmMSLLIrm----------gIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCT  777 (1034)
T KOG0608|consen  711 IPGGDMMSLLIRM----------GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCT  777 (1034)
T ss_pred             cCCccHHHHHHHh----------ccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccc
Confidence            9999999887543          5688888999999999999999999   99999999999999999999999999985


Q ss_pred             ccCCC---------Cc--c-----------------------------cccccccccccccCcccccCCCCCCCccCchh
Q 037916          564 LLPPA---------HL--Q-----------------------------TSSIGVKGTIGYIAPAEYGLGSEVSINGDVYS  603 (741)
Q Consensus       564 ~~~~~---------~~--~-----------------------------~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwS  603 (741)
                      -....         ..  .                             ..--..+||+.|+|| |++....|+..+|+||
T Consensus       778 GfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiap-evl~r~g~~q~cdwws  856 (1034)
T KOG0608|consen  778 GFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAP-EVLARTGYTQLCDWWS  856 (1034)
T ss_pred             cceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccCh-HHhcccCccccchhhH
Confidence            33110         00  0                             000114599999999 5556677899999999


Q ss_pred             HHHHHHHHHcCCCCCCccccCCcch
Q 037916          604 YGILLLELMTRKRPSDIMFEGNMNL  628 (741)
Q Consensus       604 lG~il~elltg~~p~~~~~~~~~~~  628 (741)
                      .|||+|||+.|+.||.....++..+
T Consensus       857 ~gvil~em~~g~~pf~~~tp~~tq~  881 (1034)
T KOG0608|consen  857 VGVILYEMLVGQPPFLADTPGETQY  881 (1034)
T ss_pred             hhHHHHHHhhCCCCccCCCCCccee
Confidence            9999999999999997665555443

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=7.6e-30  Score=278.22  Aligned_cols=277  Identities=16%  Similarity=0.165  Sum_probs=179.5

Q ss_pred             HHHHhhhcccCceeeEEEEEEc----------------CCCeEEEEEEeeccCcCcc--------------hhHHHHHHH
Q 037916          401 SFLFLCWIDMGSFGSVYKGILD----------------EGKTIIAVKVLNLLHHGAS--------------KSSIAECSA  450 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~----------------~~~~~vavK~~~~~~~~~~--------------~~~~~E~~~  450 (741)
                      .|.+.++||+|+||.||+|.+.                ..++.||||.++.......              +....|+.+
T Consensus       146 ~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~  225 (507)
T PLN03224        146 DFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYM  225 (507)
T ss_pred             CceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHH
Confidence            5888999999999999999752                2456799999864332222              223346667


Q ss_pred             HHhcCCCc-----eeeEeeeecCcc---ccCCceEEEEEecccCCChhhhccCCCCCC--------------cccCcccc
Q 037916          451 LRNIRHKN-----LVKILTVCSGVD---YKGDDFKALVYEFMHNGSLEEWLHPVSGAD--------------KTVEAPKC  508 (741)
Q Consensus       451 l~~l~hpn-----Iv~~~~~~~~~~---~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------------~~~~~~~~  508 (741)
                      +.+++|.+     +++++++|....   .......++||||+++++|.++++...+..              ........
T Consensus       226 l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~  305 (507)
T PLN03224        226 CAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDK  305 (507)
T ss_pred             HHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccccc
Confidence            77776654     467777764321   112346899999999999999987432110              00111234


Q ss_pred             cCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecccccccCCCCcccccccccccccccCccc
Q 037916          509 LNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAE  588 (741)
Q Consensus       509 ~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe  588 (741)
                      .++..+..++.|++.||.|+|+.   +|+||||||+||+++.++.+||+|||++........... ....+|+.|+|||+
T Consensus       306 ~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~-~~g~~tp~Y~aPE~  381 (507)
T PLN03224        306 RDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNP-LYGMLDPRYSPPEE  381 (507)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCc-cccCCCcceeChhh
Confidence            57788899999999999999999   999999999999999999999999999976543322111 11235789999987


Q ss_pred             ccCCCC-------------------C--CCccCchhHHHHHHHHHcCCC-CCCccccCCcchhhhhhhcCCcchhHhhhh
Q 037916          589 YGLGSE-------------------V--SINGDVYSYGILLLELMTRKR-PSDIMFEGNMNLHNFARTVLPDHVMDIVDS  646 (741)
Q Consensus       589 ~~~~~~-------------------~--~~~~DIwSlG~il~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  646 (741)
                      +.....                   +  ..+.||||+||++|+|++|.. ||.....-...+..+.     .....+.. 
T Consensus       382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~-----~~~~~~r~-  455 (507)
T PLN03224        382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYD-----NDLNRWRM-  455 (507)
T ss_pred             hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhcc-----chHHHHHh-
Confidence            643211                   1  234799999999999999875 6542211111111000     00000000 


Q ss_pred             cccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCC---CCCCCHHHHHH
Q 037916          647 TLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESP---QDRMNMTIVVH  701 (741)
Q Consensus       647 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~evl~  701 (741)
                       ....             ...++......+...+++.+|+..+|   .+|+|++|+++
T Consensus       456 -~~~~-------------~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        456 -YKGQ-------------KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             -hccc-------------CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence             0000             00011112345667899999999766   68999999975

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=8e-30  Score=258.10  Aligned_cols=239  Identities=28%  Similarity=0.349  Sum_probs=186.3

Q ss_pred             ceeeEEEEEEcCCCeEEEEEEeeccCcCc-chhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEEEecccCCChh
Q 037916          412 SFGSVYKGILDEGKTIIAVKVLNLLHHGA-SKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLE  490 (741)
Q Consensus       412 ~~g~V~~a~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~  490 (741)
                      +||.||+|.+..+++.||+|++....... .+.+.+|+..+++++|+||+++++++.     .....+++|||+++++|.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~l~~e~~~~~~L~   75 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFE-----DEDKLYLVMEYCDGGDLF   75 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhhee-----eCCEEEEEEeCCCCCCHH
Confidence            58999999999889999999997544333 578899999999999999999999853     345889999999999999


Q ss_pred             hhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecccccccCCCCc
Q 037916          491 EWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHL  570 (741)
Q Consensus       491 ~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  570 (741)
                      +++...          ..+++..+..++.++++++.|||+.   +++|+||+|+||+++.++.++|+|||.+....... 
T Consensus        76 ~~~~~~----------~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-  141 (244)
T smart00220       76 DLLKKR----------GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-  141 (244)
T ss_pred             HHHHhc----------cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc-
Confidence            998643          2278889999999999999999999   99999999999999999999999999998765542 


Q ss_pred             ccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcchhHhhhhcccC
Q 037916          571 QTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLA  650 (741)
Q Consensus       571 ~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  650 (741)
                        ......++..|+||| ...+..++.++||||+|++++++++|..||....... ...+.......           ..
T Consensus       142 --~~~~~~~~~~~~~pE-~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~-~~~~~~~~~~~-----------~~  206 (244)
T smart00220      142 --LLTTFVGTPEYMAPE-VLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL-ELFKKIGKPKP-----------PF  206 (244)
T ss_pred             --ccccccCCcCCCCHH-HHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHhccCC-----------CC
Confidence              122245788999995 4456677889999999999999999999986321110 00000000000           00


Q ss_pred             CcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          651 DDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       651 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ...                 ....+..+.+++.+||..+|++||++.++++
T Consensus       207 ~~~-----------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      207 PPP-----------------EWKISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             ccc-----------------cccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence            000                 0003467889999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=9.4e-31  Score=281.83  Aligned_cols=244  Identities=25%  Similarity=0.312  Sum_probs=183.0

Q ss_pred             HhhhcccCceee-EEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhc-CCCceeeEeeeecCccccCCceEEEEE
Q 037916          404 FLCWIDMGSFGS-VYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKGDDFKALVY  481 (741)
Q Consensus       404 ~~~~ig~G~~g~-V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~~~~lv~  481 (741)
                      --+.+|.|+.|+ ||+|.+.  ++.||||++-   .+..+-..+|+..++.- .|||||++|+.     ..+..+.||..
T Consensus       513 ~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll---~e~~~~A~rEi~lL~eSD~H~NviRyyc~-----E~d~qF~YIal  582 (903)
T KOG1027|consen  513 PKEILGYGSNGTVVFRGVYE--GREVAVKRLL---EEFFDFAQREIQLLQESDEHPNVIRYYCS-----EQDRQFLYIAL  582 (903)
T ss_pred             cHHHcccCCCCcEEEEEeeC--CceehHHHHh---hHhHHHHHHHHHHHHhccCCCceEEEEee-----ccCCceEEEEe
Confidence            356688998874 7999995  8899999984   33445678999999887 69999999988     67788999999


Q ss_pred             ecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCC---C--CceEE
Q 037916          482 EFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDH---E--MTAHV  556 (741)
Q Consensus       482 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~---~--~~~kL  556 (741)
                      |.| ..+|.++++.. +.+..     .......+.+..|++.||++||+.   +||||||||.||||+.   +  .+++|
T Consensus       583 ELC-~~sL~dlie~~-~~d~~-----~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~i  652 (903)
T KOG1027|consen  583 ELC-ACSLQDLIESS-GLDVE-----MQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKI  652 (903)
T ss_pred             hHh-hhhHHHHHhcc-ccchh-----hcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEe
Confidence            999 56999999853 11111     111134467889999999999999   9999999999999976   3  47999


Q ss_pred             eecccccccCCCCccc-ccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcC-CCCCCccccCCcchhhhhhh
Q 037916          557 ADFGLAKLLPPAHLQT-SSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTR-KRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~-~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg-~~p~~~~~~~~~~~~~~~~~  634 (741)
                      +|||+++....+.... ......||-+|+|| |++....-+.++||||+||++|+.++| .+||.+..+.+.++..-...
T Consensus       653 SDfglsKkl~~~~sS~~r~s~~sGt~GW~AP-E~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~  731 (903)
T KOG1027|consen  653 SDFGLSKKLAGGKSSFSRLSGGSGTSGWQAP-EQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYT  731 (903)
T ss_pred             cccccccccCCCcchhhcccCCCCcccccCH-HHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccc
Confidence            9999999887653322 23456799999999 555555667799999999999999986 89997554433332111110


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHH
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVV  700 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  700 (741)
                      ...          +...                    .++  ...+||.+|+.+||..||+|.+|+
T Consensus       732 L~~----------L~~~--------------------~d~--eA~dLI~~ml~~dP~~RPsa~~VL  765 (903)
T KOG1027|consen  732 LVH----------LEPL--------------------PDC--EAKDLISRMLNPDPQLRPSATDVL  765 (903)
T ss_pred             eee----------eccC--------------------chH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence            000          0000                    012  466999999999999999999998

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=1.1e-30  Score=269.65  Aligned_cols=199  Identities=23%  Similarity=0.345  Sum_probs=171.4

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC--------cCcchhHHHHHHHHHhcC---CCceeeEeeeec
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH--------HGASKSSIAECSALRNIR---HKNLVKILTVCS  467 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~  467 (741)
                      ++.|..++.+|+|+||.|+.|.++.....|++|.+.+.+        ........-|+++|..++   |+||++++++  
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf--  637 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF--  637 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe--
Confidence            456899999999999999999999999999999986432        122334467999999996   9999999999  


Q ss_pred             CccccCCceEEEEEecc-cCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCe
Q 037916          468 GVDYKGDDFKALVYEFM-HNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNV  546 (741)
Q Consensus       468 ~~~~~~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NI  546 (741)
                         |++++++|++||-- +|.+|+++|...          ..+++.++..|++||+.|+++||+.   ||||||||-+||
T Consensus       638 ---FEddd~yyl~te~hg~gIDLFd~IE~k----------p~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenv  701 (772)
T KOG1152|consen  638 ---FEDDDYYYLETEVHGEGIDLFDFIEFK----------PRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENV  701 (772)
T ss_pred             ---eecCCeeEEEecCCCCCcchhhhhhcc----------CccchHHHHHHHHHHHhcccccccc---CceecccccccE
Confidence               78888999999974 456899999644          6688999999999999999999999   999999999999


Q ss_pred             EeCCCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCC
Q 037916          547 LLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSD  619 (741)
Q Consensus       547 ll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~  619 (741)
                      .++.+|-+||+|||.|.....+....    .+||..|.|||.+....+.+..-|||++|+++|.++....||.
T Consensus       702 ivd~~g~~klidfgsaa~~ksgpfd~----f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  702 IVDSNGFVKLIDFGSAAYTKSGPFDV----FVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             EEecCCeEEEeeccchhhhcCCCcce----eeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            99999999999999998877665443    5699999999655555566888999999999999999998875

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=6.7e-30  Score=240.95  Aligned_cols=257  Identities=16%  Similarity=0.202  Sum_probs=190.5

Q ss_pred             HHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhc-CCCceeeEeeeecCccccCCce
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      +...|.|.+.+|+|.||.+-+|+++.+++.+|+|.+... ....++|.+|..---.| .|.||+.-|++.    ++..+.
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~va----Fqt~d~   96 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVA----FQTSDA   96 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHH----hhcCce
Confidence            456799999999999999999999999999999998642 33457788888654445 589999988875    777788


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCC-C-Cce
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDH-E-MTA  554 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~-~-~~~  554 (741)
                      ++++|||++.|+|.+-+..           ..+.+....+++.|++.|+.|||++   ++||||||.+||||-. + .++
T Consensus        97 YvF~qE~aP~gdL~snv~~-----------~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rv  162 (378)
T KOG1345|consen   97 YVFVQEFAPRGDLRSNVEA-----------AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRV  162 (378)
T ss_pred             EEEeeccCccchhhhhcCc-----------ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEE
Confidence            9999999999999998753           3467778899999999999999999   9999999999999943 3 489


Q ss_pred             EEeecccccccCCCCcccccccccccccccCcccccCC----CCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhh
Q 037916          555 HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLG----SEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHN  630 (741)
Q Consensus       555 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~----~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~  630 (741)
                      ||||||.++..+.....     ...+..|.+||+...-    -...+.+|||.||+++|.++||..||......+..+.+
T Consensus       163 KlcDFG~t~k~g~tV~~-----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~  237 (378)
T KOG1345|consen  163 KLCDFGLTRKVGTTVKY-----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWE  237 (378)
T ss_pred             EeeecccccccCceehh-----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHH
Confidence            99999998865543222     2246679999754321    23567899999999999999999999844333444443


Q ss_pred             hhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHH
Q 037916          631 FARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHEL  703 (741)
Q Consensus       631 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  703 (741)
                      |..-...... ...                        ....-..+.+.++.++-+.++|++|--..++.++.
T Consensus       238 ~~~w~~rk~~-~~P------------------------~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r  285 (378)
T KOG1345|consen  238 WEQWLKRKNP-ALP------------------------KKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR  285 (378)
T ss_pred             HHHHhcccCc-cCc------------------------hhhcccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence            3321111000 000                        00112345677888899999999996666655553

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.96  E-value=2e-30  Score=264.27  Aligned_cols=290  Identities=19%  Similarity=0.199  Sum_probs=213.1

Q ss_pred             HHHHHHHHHHHHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcC------CCceee
Q 037916          388 AIISVLVGILLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIR------HKNLVK  461 (741)
Q Consensus       388 ~~~~~~~~~~~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------hpnIv~  461 (741)
                      +|+.+.+|.++=.+|.+....|+|-|+.|.+|.+...|..||||+++.. ....+.-.+|+++|++|+      --|+++
T Consensus       420 GYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclr  498 (752)
T KOG0670|consen  420 GYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLR  498 (752)
T ss_pred             ceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHH
Confidence            4556677888999999999999999999999999988999999999743 233455678999999994      347888


Q ss_pred             EeeeecCccccCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCC
Q 037916          462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDL  541 (741)
Q Consensus       462 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDl  541 (741)
                      ++-.     |...++.|+|+|-+ .-+|.+.++..+       ....+....+..++.|+.-||..|..+   ||+|.||
T Consensus       499 l~r~-----F~hknHLClVFE~L-slNLRevLKKyG-------~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDI  562 (752)
T KOG0670|consen  499 LFRH-----FKHKNHLCLVFEPL-SLNLREVLKKYG-------RNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADI  562 (752)
T ss_pred             HHHH-----hhhcceeEEEehhh-hchHHHHHHHhC-------cccceeehHHHHHHHHHHHHHHHHHhc---Ceeeccc
Confidence            8877     56778999999988 568999998653       234577888999999999999999999   9999999


Q ss_pred             CCCCeEeCCC-CceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCc
Q 037916          542 KPSNVLLDHE-MTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDI  620 (741)
Q Consensus       542 kp~NIll~~~-~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~  620 (741)
                      ||+||||++. ..+||||||.|....+......    .-+..|.|| |++.|..|+...|+||+||++||+.||+..|..
T Consensus       563 KPDNiLVNE~k~iLKLCDfGSA~~~~eneitPY----LVSRFYRaP-EIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG  637 (752)
T KOG0670|consen  563 KPDNILVNESKNILKLCDFGSASFASENEITPY----LVSRFYRAP-EIILGLPYDYPIDTWSVGCTLYELYTGKILFPG  637 (752)
T ss_pred             CccceEeccCcceeeeccCccccccccccccHH----HHHHhccCc-ceeecCcccCCccceeeceeeEEeeccceecCC
Confidence            9999999876 4799999999988776544332    235689999 677788999999999999999999999998763


Q ss_pred             cccCCcchhhhhhhc---CCcc-------hhHhhhhcccCCcchh------------------hhhhhhHHH-HHhHhhH
Q 037916          621 MFEGNMNLHNFARTV---LPDH-------VMDIVDSTLLADDEDL------------------TITSNQRQR-QARINNI  671 (741)
Q Consensus       621 ~~~~~~~~~~~~~~~---~~~~-------~~~~~d~~l~~~~~~~------------------~~~~~~~~~-~~~~~~~  671 (741)
                      ....  ++..++...   ++..       ....+|..+...+...                  +........ +.....-
T Consensus       638 ~TNN--~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq  715 (752)
T KOG0670|consen  638 RTNN--QMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQ  715 (752)
T ss_pred             CCcH--HHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchh
Confidence            3222  222222111   1111       1122222221111100                  000011111 1122333


Q ss_pred             HHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          672 MECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       672 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ......+.+|+.+|+..||++|.|..|.++
T Consensus       716 ~~~~~~~rdLLdkml~LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  716 PKIVQQLRDLLDKMLILDPEKRITVNQALK  745 (752)
T ss_pred             HHHHHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            456778999999999999999999999875

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=1.3e-29  Score=250.27  Aligned_cols=272  Identities=22%  Similarity=0.342  Sum_probs=210.5

Q ss_pred             HHHHHHHhhhcccCceeeEEEEEEcCCC-----eEEEEEEeecc-CcCcchhHHHHHHHHHhcCCCceeeEeeeecCccc
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGILDEGK-----TIIAVKVLNLL-HHGASKSSIAECSALRNIRHKNLVKILTVCSGVDY  471 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  471 (741)
                      .-.+++....+-+|.||.||+|.+++..     +.|-+|.++.. +......+..|.-.+..+.|||+..+.+++.    
T Consensus       282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i----  357 (563)
T KOG1024|consen  282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI----  357 (563)
T ss_pred             hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe----
Confidence            4456777778999999999999876433     23555555421 1222345567777788889999999999984    


Q ss_pred             cCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCC
Q 037916          472 KGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHE  551 (741)
Q Consensus       472 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~  551 (741)
                      ++....++++.++.-|+|..|+...++.+.  ...+.++..+...++.|++.|++|||.+   +|||.||...|.+||+.
T Consensus       358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~--~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~  432 (563)
T KOG1024|consen  358 EDYATPFVLYPATGVGNLKSFLQICRGDDP--SYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQ  432 (563)
T ss_pred             eccCcceEEEeccCcchHHHHHHHhccCCC--ccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhh
Confidence            456678899999988999999986654332  2345677788899999999999999999   99999999999999999


Q ss_pred             CceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhh
Q 037916          552 MTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHN  630 (741)
Q Consensus       552 ~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~  630 (741)
                      -++||+|=.+++..-+.+...-.........||+| |.+....|+.++||||||+++|||+| |+.|+.+...  .++..
T Consensus       433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMsl-Eal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP--fEm~~  509 (563)
T KOG1024|consen  433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSL-EALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP--FEMEH  509 (563)
T ss_pred             eeEEeccchhccccCcccccccCCCCCCcccccCH-HHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH--HHHHH
Confidence            99999999999887776665555555577899999 56678899999999999999999998 8889752211  11111


Q ss_pred             hhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHhh
Q 037916          631 FARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSIL  710 (741)
Q Consensus       631 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  710 (741)
                      +..                              .+++.-++-+|++++..+|.-||..+|++||+++|+..-|.+....+
T Consensus       510 ylk------------------------------dGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql  559 (563)
T KOG1024|consen  510 YLK------------------------------DGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL  559 (563)
T ss_pred             HHh------------------------------ccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence            111                              12333445589999999999999999999999999999998877554


Q ss_pred             c
Q 037916          711 L  711 (741)
Q Consensus       711 ~  711 (741)
                      +
T Consensus       560 t  560 (563)
T KOG1024|consen  560 T  560 (563)
T ss_pred             h
Confidence            3

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.96  E-value=6.5e-30  Score=247.17  Aligned_cols=277  Identities=19%  Similarity=0.183  Sum_probs=195.3

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeec--cCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccc-cCCce
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDY-KGDDF  476 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~-~~~~~  476 (741)
                      .+|.-++.+|.|.- .|..|.+.-.+++||+|....  ......++..+|..++..++|+||++++.++..... ..-..
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            45667788999988 888899988999999998752  223446778899999999999999999999753221 22345


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .|+|||+| .++|.+.+.            ..++-.++..|+.|+++|+.|+|+.   ||+||||||+||++..+..+||
T Consensus        96 ~y~v~e~m-~~nl~~vi~------------~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi  159 (369)
T KOG0665|consen   96 VYLVMELM-DANLCQVIL------------MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKI  159 (369)
T ss_pred             HHHHHHhh-hhHHHHHHH------------HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheee
Confidence            89999999 569999886            2356678889999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcC
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVL  636 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  636 (741)
                      .|||.|......   ...+....|..|+|||... +..+.+.+||||+||++.||++|..-|.    +...+.+|.....
T Consensus       160 ~dfg~ar~e~~~---~~mtpyVvtRyyrapevil-~~~~ke~vdiwSvGci~gEli~~~Vlf~----g~d~idQ~~ki~~  231 (369)
T KOG0665|consen  160 LDFGLARTEDTD---FMMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGELILGTVLFP----GKDHIDQWNKIIE  231 (369)
T ss_pred             ccchhhcccCcc---cccCchhheeeccCchhee-ccCCcccchhhhhhhHHHHHhhceEEec----CchHHHHHHHHHH
Confidence            999999865433   2334466899999995554 4459999999999999999999998764    4444555543221


Q ss_pred             C--cchhHhhhhcc-------cCCcchhhhhhhhH----HHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          637 P--DHVMDIVDSTL-------LADDEDLTITSNQR----QRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       637 ~--~~~~~~~d~~l-------~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      .  ..-.++.+...       ....+.........    ..........-......+++.+||..||++|.|+++++.
T Consensus       232 ~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  232 QLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             HhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence            0  00001111000       00000000000000    000000011122345678999999999999999999875

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.96  E-value=4e-30  Score=269.84  Aligned_cols=254  Identities=23%  Similarity=0.280  Sum_probs=200.1

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      ..|+.++++|.|+||.||+|++..+++..|+|+++........-.+.|+-+++..+|||||.+++-     +...+..|+
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gs-----ylr~dklwi   89 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGS-----YLRRDKLWI   89 (829)
T ss_pred             cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhh-----hhhhcCcEE
Confidence            468899999999999999999999999999999997766677788899999999999999999998     566678999


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      .||||.||+|.+..+..          .++++.++...++..++|++|+|+.   |-+|||||-.||++++.|.+|++||
T Consensus        90 cMEycgggslQdiy~~T----------gplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDf  156 (829)
T KOG0576|consen   90 CMEYCGGGSLQDIYHVT----------GPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADF  156 (829)
T ss_pred             EEEecCCCcccceeeec----------ccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeeccc
Confidence            99999999999987643          6789999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccccccCcccc--cCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCC
Q 037916          560 GLAKLLPPAHLQTSSIGVKGTIGYIAPAEY--GLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       560 g~a~~~~~~~~~~~~~~~~gt~~y~aPEe~--~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      |.+..+......  .....||+.|||||..  ...+.|..++|||++|+...|+-.-++|......  +....++.+   
T Consensus       157 gvsaqitati~K--rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp--mr~l~LmTk---  229 (829)
T KOG0576|consen  157 GVSAQITATIAK--RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP--MRALFLMTK---  229 (829)
T ss_pred             Cchhhhhhhhhh--hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch--HHHHHHhhc---
Confidence            998776543222  2346799999999643  2456799999999999999999887777321100  000000000   


Q ss_pred             cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          638 DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       638 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                          .-+++.-..+.                   ..-.+.+-++++.|+..+|.+|||++.++.
T Consensus       230 ----S~~qpp~lkDk-------------------~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  230 ----SGFQPPTLKDK-------------------TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             ----cCCCCCcccCC-------------------ccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence                00111111111                   122345678999999999999999988764

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.95  E-value=1.3e-28  Score=247.43  Aligned_cols=282  Identities=21%  Similarity=0.268  Sum_probs=201.6

Q ss_pred             HHHHHHHHhhhcccCceeeEEEEEEcC---CCeEEEEEEeeccCcCcchhHHHHHHHHHhc-CCCceeeEeeeecCcccc
Q 037916          397 LLFVSFLFLCWIDMGSFGSVYKGILDE---GKTIIAVKVLNLLHHGASKSSIAECSALRNI-RHKNLVKILTVCSGVDYK  472 (741)
Q Consensus       397 ~~~~~y~~~~~ig~G~~g~V~~a~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~  472 (741)
                      .+...|..+.+||+|.|+.||+|.+..   ..+.||+|.+..  .....+..+|+++|..+ .+.||+++.++     +.
T Consensus        33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~--ts~p~ri~~El~~L~~~gG~~ni~~~~~~-----~r  105 (418)
T KOG1167|consen   33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYR--TSSPSRILNELEMLYRLGGSDNIIKLNGC-----FR  105 (418)
T ss_pred             hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccc--ccCchHHHHHHHHHHHhccchhhhcchhh-----hc
Confidence            344578999999999999999999876   788999999864  33456788999999999 58999999998     67


Q ss_pred             CCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCC-
Q 037916          473 GDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHE-  551 (741)
Q Consensus       473 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~-  551 (741)
                      .++.+.+||||++.....++..             .++...+..+++.+..||.++|..   |||||||||.|++.+.. 
T Consensus       106 nnd~v~ivlp~~~H~~f~~l~~-------------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t  169 (418)
T KOG1167|consen  106 NNDQVAIVLPYFEHDRFRDLYR-------------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRT  169 (418)
T ss_pred             cCCeeEEEecccCccCHHHHHh-------------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCcccccccccc
Confidence            7889999999999988888874             356788999999999999999999   99999999999999864 


Q ss_pred             CceEEeecccccccCCC----------------------------------Cccc--------ccccccccccccCcccc
Q 037916          552 MTAHVADFGLAKLLPPA----------------------------------HLQT--------SSIGVKGTIGYIAPAEY  589 (741)
Q Consensus       552 ~~~kL~DFg~a~~~~~~----------------------------------~~~~--------~~~~~~gt~~y~aPEe~  589 (741)
                      +.-.|+|||+|......                                  ....        ......||++|+|||.+
T Consensus       170 ~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL  249 (418)
T KOG1167|consen  170 QRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVL  249 (418)
T ss_pred             CCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHH
Confidence            68899999999721100                                  0000        01124599999999888


Q ss_pred             cCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcchhHh---hhhcccCC------cchhhhhhh
Q 037916          590 GLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDI---VDSTLLAD------DEDLTITSN  660 (741)
Q Consensus       590 ~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~d~~l~~~------~~~~~~~~~  660 (741)
                      ...+..++++||||.|+|+..+++++.||-...++-..+.+.+...-...+...   .+..+...      .........
T Consensus       250 ~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~  329 (418)
T KOG1167|consen  250 FRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFE  329 (418)
T ss_pred             hhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchh
Confidence            888889999999999999999999999985443333333333222211111110   00100000      000000000


Q ss_pred             hH------H-HH--HhHhhHHHH-HHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          661 QR------Q-RQ--ARINNIMEC-LISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       661 ~~------~-~~--~~~~~~~~~-~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ..      . ..  .......++ +..+++++.+|++.||.+|.|++|.++
T Consensus       330 s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  330 TLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             ccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence            00      0 00  111122233 337899999999999999999999885

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.95  E-value=1.1e-29  Score=276.00  Aligned_cols=341  Identities=27%  Similarity=0.360  Sum_probs=257.2

Q ss_pred             CCCCCcccccCChhhhhCCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccc--c--
Q 037916            2 DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQN--C--   77 (741)
Q Consensus         2 dl~~n~~~~~ip~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~--~--   77 (741)
                      +++.|.|. +.|.+.. ++.+|++|+|.+|+++ ..|..+..+.+|++|+++.|++. ..|..+..++.+-....  +  
T Consensus        74 n~s~n~i~-~vp~s~~-~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~  149 (1081)
T KOG0618|consen   74 NLSRNYIR-SVPSSCS-NMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEK  149 (1081)
T ss_pred             ccchhhHh-hCchhhh-hhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchh
Confidence            46777777 7887777 8899999999999888 78889999999999999999988 55655555443211100  0  


Q ss_pred             --------------------------CCCccE-EECcCCcCcccCCchhhcc----------------cccccEEEccCC
Q 037916           78 --------------------------NQHLKH-LDINNNNFGGLLPGCICNF----------------SITLETLIFNSN  114 (741)
Q Consensus        78 --------------------------~~~L~~-L~Ls~N~l~~~~~~~~~~l----------------~~~L~~L~L~~n  114 (741)
                                                ...|++ |||+.|.+....-..+.++                -.+|+.|+.++|
T Consensus       150 ~~~lg~~~ik~~~l~~n~l~~~~~~~i~~l~~~ldLr~N~~~~~dls~~~~l~~l~c~rn~ls~l~~~g~~l~~L~a~~n  229 (1081)
T KOG0618|consen  150 IQRLGQTSIKKLDLRLNVLGGSFLIDIYNLTHQLDLRYNEMEVLDLSNLANLEVLHCERNQLSELEISGPSLTALYADHN  229 (1081)
T ss_pred             hhhhccccchhhhhhhhhcccchhcchhhhheeeecccchhhhhhhhhccchhhhhhhhcccceEEecCcchheeeeccC
Confidence                                      012333 6666665551111100000                013445555555


Q ss_pred             cccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCcccccCCcccceeeccCcccccccCc
Q 037916          115 KIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPS  194 (741)
Q Consensus       115 ~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~  194 (741)
                      .+....+....  .+|+++++++|++++++ ++...+.+|+.|+..+|+|+ .+|..+...++|+.|.+..|.++ -+|.
T Consensus       230 ~l~~~~~~p~p--~nl~~~dis~n~l~~lp-~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~  304 (1081)
T KOG0618|consen  230 PLTTLDVHPVP--LNLQYLDISHNNLSNLP-EWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPP  304 (1081)
T ss_pred             cceeecccccc--ccceeeecchhhhhcch-HHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCC
Confidence            55433332222  37888888888888554 88888888888888888886 67777777888888888888887 5566


Q ss_pred             ccccCCCCCEEeccCccccccCCccccc--------------------------cccceeEEEcCCCccCCCCChhhcCC
Q 037916          195 SLGQCQSLTTINLSYNNLSGTIPPQLMD--------------------------LTSLSVGLDLSRNQLVGSLPTEVGKL  248 (741)
Q Consensus       195 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~--------------------------l~~L~~~L~Ls~N~l~~~~p~~~~~l  248 (741)
                      ...++++|++|+|..|+|. .+|+.|..                          +..|+. |++.+|.++...-..+.+.
T Consensus       305 ~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~-LylanN~Ltd~c~p~l~~~  382 (1081)
T KOG0618|consen  305 FLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQE-LYLANNHLTDSCFPVLVNF  382 (1081)
T ss_pred             cccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHH-HHHhcCcccccchhhhccc
Confidence            6777889999999999987 56654432                          223444 8899999998777788999


Q ss_pred             CCCcEEEeccccccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccchhhhccccCCcccc
Q 037916          249 INLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNL  328 (741)
Q Consensus       249 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l  328 (741)
                      ++|+.|+|++|+|..++...+.++..|++|+||+|+++ .+|..+..++.|++|...+|+|. ..| .+..++.|+.+|+
T Consensus       383 ~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDl  459 (1081)
T KOG0618|consen  383 KHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDL  459 (1081)
T ss_pred             cceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEec
Confidence            99999999999999999999999999999999999999 67899999999999999999998 677 7899999999999


Q ss_pred             cCcccccccCCccc-cCCcccccccCCCC
Q 037916          329 SYNDLEGVIPTEGV-FKNASAISVFGNSK  356 (741)
Q Consensus       329 ~~N~l~~~~~~~~~-~~~~~~~~~~~n~~  356 (741)
                      +.|+|+...-.... .++++.++++||+|
T Consensus       460 S~N~L~~~~l~~~~p~p~LkyLdlSGN~~  488 (1081)
T KOG0618|consen  460 SCNNLSEVTLPEALPSPNLKYLDLSGNTR  488 (1081)
T ss_pred             ccchhhhhhhhhhCCCcccceeeccCCcc
Confidence            99999887655433 38899999999986

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.95  E-value=8.2e-27  Score=230.30  Aligned_cols=212  Identities=27%  Similarity=0.412  Sum_probs=176.9

Q ss_pred             cccCceeeEEEEEEcCCCeEEEEEEeeccCcC-cchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEEEecccC
Q 037916          408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG-ASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHN  486 (741)
Q Consensus       408 ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv~e~~~~  486 (741)
                      ||+|++|.||++....+++.+++|++...... ..+.+.+|+..++.+.|++|+++++++     ......+++|||+.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~~~~e~~~~   75 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF-----EDENHLYLVMEYCEG   75 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeee-----ecCCeEEEEEecCCC
Confidence            68999999999999878999999999743322 246788999999999999999999995     344688999999998


Q ss_pred             CChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCC-CCceEEeeccccccc
Q 037916          487 GSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDH-EMTAHVADFGLAKLL  565 (741)
Q Consensus       487 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~-~~~~kL~DFg~a~~~  565 (741)
                      ++|.+++....         ..+++..+..++.++++++.+||+.   +++|+||+|.||+++. ++.++|+|||.+...
T Consensus        76 ~~l~~~~~~~~---------~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~  143 (215)
T cd00180          76 GSLKDLLKENE---------GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLL  143 (215)
T ss_pred             CcHHHHHHhcc---------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEc
Confidence            99999986321         3578889999999999999999999   9999999999999999 899999999999866


Q ss_pred             CCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcchhHhhh
Q 037916          566 PPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVD  645 (741)
Q Consensus       566 ~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  645 (741)
                      .....  ......+...|++||........+.++|+|++|++++++                                  
T Consensus       144 ~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------  187 (215)
T cd00180         144 TSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------  187 (215)
T ss_pred             cCCcc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------
Confidence            54321  112244788899996553333788999999999999998                                  


Q ss_pred             hcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          646 STLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       646 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                                                    ..+.+++.+|++.||++||++.++++.
T Consensus       188 ------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 ------------------------------PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             ------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                                          135688999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.94  E-value=5.2e-29  Score=246.82  Aligned_cols=323  Identities=22%  Similarity=0.249  Sum_probs=253.6

Q ss_pred             cCChhhhhCCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCccEEECcCCc
Q 037916           11 GIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNN   90 (741)
Q Consensus        11 ~ip~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~   90 (741)
                      .||.++.   +..+.++|..|+|+.+.+.+|+.+.+|+.||||+|+|+.+-|++|.++.++         ++-+++++|+
T Consensus        60 eVP~~LP---~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l---------~~Lvlyg~Nk  127 (498)
T KOG4237|consen   60 EVPANLP---PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASL---------LSLVLYGNNK  127 (498)
T ss_pred             cCcccCC---CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhh---------hHHHhhcCCc
Confidence            7788877   889999999999999999999999999999999999999999999999872         5555666699


Q ss_pred             CcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCcc
Q 037916           91 FGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPP  170 (741)
Q Consensus        91 l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  170 (741)
                      |+.+..+.|.++. .|+.|.+.-|++..+..+.|..|++|..|.|..|.+..+...+|..+..++++.+..|.+-.    
T Consensus       128 I~~l~k~~F~gL~-slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~ic----  202 (498)
T KOG4237|consen  128 ITDLPKGAFGGLS-SLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFIC----  202 (498)
T ss_pred             hhhhhhhHhhhHH-HHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCcccc----
Confidence            9988888999998 89999999999999999999999999999999999998877899999999999999998542    


Q ss_pred             cccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCccccc-cccceeEEEcCCCccCCCCC-hhhcCC
Q 037916          171 SIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMD-LTSLSVGLDLSRNQLVGSLP-TEVGKL  248 (741)
Q Consensus       171 ~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~~L~Ls~N~l~~~~p-~~~~~l  248 (741)
                       ..+++.+... +.-      .|..+++..-.....|.++++...-+..|.. +.++...+....+... +.| ..|..|
T Consensus       203 -dCnL~wla~~-~a~------~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~-~cP~~cf~~L  273 (498)
T KOG4237|consen  203 -DCNLPWLADD-LAM------NPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDS-ICPAKCFKKL  273 (498)
T ss_pred             -ccccchhhhH-Hhh------chhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCC-cChHHHHhhc
Confidence             2334443332 122      2334555556666667777776444444432 2233221333333333 444 478999


Q ss_pred             CCCcEEEeccccccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccchhhhccccCCcccc
Q 037916          249 INLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNL  328 (741)
Q Consensus       249 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l  328 (741)
                      ++|+.|+|++|+|+.+...+|.++..+++|+|..|+|..+....|.++..|+.|+|.+|+|+...|.+|..+.+|.+|+|
T Consensus       274 ~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l  353 (498)
T KOG4237|consen  274 PNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNL  353 (498)
T ss_pred             ccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeeh
Confidence            99999999999999999999999999999999999999888889999999999999999999899999999999999999


Q ss_pred             cCcccccccCCccccCCcccccccCCCCcccc
Q 037916          329 SYNDLEGVIPTEGVFKNASAISVFGNSKLCGG  360 (741)
Q Consensus       329 ~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~  360 (741)
                      -.|++.+..--.+...+++.-...|| -.|+.
T Consensus       354 ~~Np~~CnC~l~wl~~Wlr~~~~~~~-~~Cq~  384 (498)
T KOG4237|consen  354 LSNPFNCNCRLAWLGEWLRKKSVVGN-PRCQS  384 (498)
T ss_pred             ccCcccCccchHHHHHHHhhCCCCCC-CCCCC
Confidence            99999877655544444444344555 34553

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.94  E-value=4.2e-26  Score=228.08  Aligned_cols=199  Identities=29%  Similarity=0.374  Sum_probs=167.8

Q ss_pred             HHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcC-cchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEE
Q 037916          402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG-ASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALV  480 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv  480 (741)
                      |.+.+.||.|++|.||+|....+++.+|+|.+...... ..+.+.+|+..+++++|+|++++++++     ......+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~-----~~~~~~~~v   75 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVF-----EDPEPLYLV   75 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeee-----ecCCceEEE
Confidence            45678899999999999999988899999999754443 567888999999999999999999984     344578999


Q ss_pred             EecccCCChhhhccCCCCCCcccCcccc-cCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          481 YEFMHNGSLEEWLHPVSGADKTVEAPKC-LNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       481 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~-~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      +||+++++|.+++...          .. +++..+..++.+++.++.+||+.   +++|+|++|+||+++.++.++|+||
T Consensus        76 ~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~  142 (225)
T smart00221       76 MEYCEGGDLFDYLRKK----------GGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADF  142 (225)
T ss_pred             EeccCCCCHHHHHHhc----------ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeC
Confidence            9999999999998643          22 67888999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCC
Q 037916          560 GLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSD  619 (741)
Q Consensus       560 g~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~  619 (741)
                      |.+......... ......++..|++||.......++.++|||++|++++++++|+.||.
T Consensus       143 g~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~  201 (225)
T smart00221      143 GLARFIHRDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS  201 (225)
T ss_pred             ceeeEecCcccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence            999876554210 11224577889999654355677889999999999999999999986

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.93  E-value=2.1e-25  Score=251.42  Aligned_cols=260  Identities=26%  Similarity=0.357  Sum_probs=134.7

Q ss_pred             CcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCccEEECcCCcCcccCCchhhcc
Q 037916           23 LLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNF  102 (741)
Q Consensus        23 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l  102 (741)
                      -..|+|++|.|+ .+|..+.  ++|+.|+|++|+|+ .+|..   .+          +|++|+|++|+|+.+ |..    
T Consensus       203 ~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~----------~Lk~LdLs~N~LtsL-P~l----  260 (788)
T PRK15387        203 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PP----------ELRTLEVSGNQLTSL-PVL----  260 (788)
T ss_pred             CcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CC----------CCcEEEecCCccCcc-cCc----
Confidence            445556666555 3444443  25555666666555 23321   11          256666666665533 221    


Q ss_pred             cccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCcccccCCcccceee
Q 037916          103 SITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLY  182 (741)
Q Consensus       103 ~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  182 (741)
                      ..+|+.|++++|.+.. +|..+   .+|+.|+|++|+|+.++ .   .+++|+.|+|++|+|+++ |..   ..+|+.|+
T Consensus       261 p~sL~~L~Ls~N~L~~-Lp~lp---~~L~~L~Ls~N~Lt~LP-~---~p~~L~~LdLS~N~L~~L-p~l---p~~L~~L~  328 (788)
T PRK15387        261 PPGLLELSIFSNPLTH-LPALP---SGLCKLWIFGNQLTSLP-V---LPPGLQELSVSDNQLASL-PAL---PSELCKLW  328 (788)
T ss_pred             ccccceeeccCCchhh-hhhch---hhcCEEECcCCcccccc-c---cccccceeECCCCccccC-CCC---cccccccc
Confidence            1255566666665533 22221   34556666666665432 2   134566666666666532 221   12455566


Q ss_pred             ccCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEecccccc
Q 037916          183 LIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLE  262 (741)
Q Consensus       183 L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  262 (741)
                      +++|.|++ +|..   ..+|++|+|++|+|+ .+|...   .+|.. |++++|+|.+ +|..   ..+|+.|+|++|+|+
T Consensus       329 Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls-~LP~lp---~~L~~-L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt  395 (788)
T PRK15387        329 AYNNQLTS-LPTL---PSGLQELSVSDNQLA-SLPTLP---SELYK-LWAYNNRLTS-LPAL---PSGLKELIVSGNRLT  395 (788)
T ss_pred             cccCcccc-cccc---ccccceEecCCCccC-CCCCCC---cccce-ehhhcccccc-Cccc---ccccceEEecCCccc
Confidence            66666653 3321   135666666666666 344322   23443 6666666663 3432   235666666666666


Q ss_pred             chhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccchhhhccccCCcccccCcccccccC
Q 037916          263 CEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIP  338 (741)
Q Consensus       263 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  338 (741)
                      .++. .   .++|+.|++++|+|++ +|..+   .+|+.|+|++|+|+ .+|..+.+++.|+.|+|++|+|++..+
T Consensus       396 ~LP~-l---~s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~  462 (788)
T PRK15387        396 SLPV-L---PSELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTL  462 (788)
T ss_pred             CCCC-c---ccCCCEEEccCCcCCC-CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHH
Confidence            4322 1   2456666666666664 34322   34566666666666 456666666666666666666665544

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.92  E-value=1.4e-24  Score=244.85  Aligned_cols=262  Identities=26%  Similarity=0.286  Sum_probs=209.6

Q ss_pred             CCCCCcccccCChhhhhCCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCc
Q 037916            2 DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHL   81 (741)
Q Consensus         2 dl~~n~~~~~ip~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L   81 (741)
                      ||+.|.+. ++|..++   ++|+.|+|++|+|+. +|.   .+++|++|+|++|+|+ .+|..+   +          +|
T Consensus       207 dLs~~~Lt-sLP~~l~---~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lt-sLP~lp---~----------sL  264 (788)
T PRK15387        207 NVGESGLT-TLPDCLP---AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLT-SLPVLP---P----------GL  264 (788)
T ss_pred             EcCCCCCC-cCCcchh---cCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccC-cccCcc---c----------cc
Confidence            68999998 8999887   689999999999995 554   3689999999999999 445432   2          39


Q ss_pred             cEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEccc
Q 037916           82 KHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINT  161 (741)
Q Consensus        82 ~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~  161 (741)
                      +.|+|++|.|+.+ |..    ..+|+.|++++|++... |.   .+++|+.|+|++|+|+++. ..   ..+|+.|++++
T Consensus       265 ~~L~Ls~N~L~~L-p~l----p~~L~~L~Ls~N~Lt~L-P~---~p~~L~~LdLS~N~L~~Lp-~l---p~~L~~L~Ls~  331 (788)
T PRK15387        265 LELSIFSNPLTHL-PAL----PSGLCKLWIFGNQLTSL-PV---LPPGLQELSVSDNQLASLP-AL---PSELCKLWAYN  331 (788)
T ss_pred             ceeeccCCchhhh-hhc----hhhcCEEECcCCccccc-cc---cccccceeECCCCccccCC-CC---ccccccccccc
Confidence            9999999999843 432    23799999999999654 43   2468999999999999753 32   24688999999


Q ss_pred             CCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCCC
Q 037916          162 NKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSL  241 (741)
Q Consensus       162 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~  241 (741)
                      |+|++ +|..   ..+|+.|+|++|+|++ +|..   ..+|+.|++++|+|+ .+|...   .+|+. |+|++|+|++ +
T Consensus       332 N~L~~-LP~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~-~LP~l~---~~L~~-LdLs~N~Lt~-L  397 (788)
T PRK15387        332 NQLTS-LPTL---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SLPALP---SGLKE-LIVSGNRLTS-L  397 (788)
T ss_pred             Ccccc-cccc---ccccceEecCCCccCC-CCCC---Ccccceehhhccccc-cCcccc---cccce-EEecCCcccC-C
Confidence            99985 4432   2579999999999995 5543   357899999999999 577643   46776 9999999995 5


Q ss_pred             ChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccchhhhcc
Q 037916          242 PTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVEL  320 (741)
Q Consensus       242 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  320 (741)
                      |..   .++|+.|++++|+|+++ |..   ..+|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..+..+
T Consensus       398 P~l---~s~L~~LdLS~N~LssI-P~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~l  468 (788)
T PRK15387        398 PVL---PSELKELMVSGNRLTSL-PML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREI  468 (788)
T ss_pred             CCc---ccCCCEEEccCCcCCCC-Ccc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHHH
Confidence            543   36899999999999975 333   346899999999999 678899999999999999999998887776443

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.92  E-value=4.3e-27  Score=233.24  Aligned_cols=278  Identities=18%  Similarity=0.177  Sum_probs=188.8

Q ss_pred             ccEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEccc-ccccccCCccccCCCcCcEEEc
Q 037916           81 LKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWD-NQLSGTISPAIGELQNLVTLAI  159 (741)
Q Consensus        81 L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~-N~i~~~~~~~~~~l~~L~~L~L  159 (741)
                      -+.++|..|+|+.++|..|..+. +|+.|+|++|+|+.+-|++|.+|.+|.+|-+-+ |+|+.+..++|.+|..|+.|.+
T Consensus        69 tveirLdqN~I~~iP~~aF~~l~-~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll  147 (498)
T KOG4237|consen   69 TVEIRLDQNQISSIPPGAFKTLH-RLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL  147 (498)
T ss_pred             ceEEEeccCCcccCChhhccchh-hhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence            45566666666666666666665 666666666666666666666666665554444 6666666666666666666666


Q ss_pred             ccCCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCcccc------------ccCCccccccccce
Q 037916          160 NTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLS------------GTIPPQLMDLTSLS  227 (741)
Q Consensus       160 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~------------~~~p~~~~~l~~L~  227 (741)
                      .-|++..+..++|..+++|..|.|.+|.+..+.-.+|.++.+++++.+..|.+.            -..|-.+++..-..
T Consensus       148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~  227 (498)
T KOG4237|consen  148 NANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVS  227 (498)
T ss_pred             ChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecc
Confidence            666666666666666666666666666666444446666666666666666522            12233333333332


Q ss_pred             eEEEcCCCccCCCCChhhcCC-CCCc-EEEeccccccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCC
Q 037916          228 VGLDLSRNQLVGSLPTEVGKL-INLE-ILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLS  305 (741)
Q Consensus       228 ~~L~Ls~N~l~~~~p~~~~~l-~~L~-~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  305 (741)
                      - ..|.++++..+.+..|... ..+. .+....+....-+...|..+++|++|+|++|+|+++.+.+|.++..++.|.|.
T Consensus       228 p-~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~  306 (498)
T KOG4237|consen  228 P-YRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLT  306 (498)
T ss_pred             h-HHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcC
Confidence            2 4455556655555544332 1221 12222334444455679999999999999999999999999999999999999


Q ss_pred             CCcCCCccchhhhccccCCcccccCcccccccCCccc-cCCcccccccCCCCcccc
Q 037916          306 QNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGV-FKNASAISVFGNSKLCGG  360 (741)
Q Consensus       306 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~~~~~~~~~~~n~~~c~~  360 (741)
                      .|+|.......|.++..|+.|+|.+|+|+.+.|.... ...+..+.+.+|||.|.+
T Consensus       307 ~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC  362 (498)
T KOG4237|consen  307 RNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNC  362 (498)
T ss_pred             cchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCcc
Confidence            9999988889999999999999999999998876522 345788999999999964

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.91  E-value=6.8e-27  Score=254.47  Aligned_cols=334  Identities=25%  Similarity=0.311  Sum_probs=204.5

Q ss_pred             CCCCCcccccCChhhhhCCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCc
Q 037916            2 DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHL   81 (741)
Q Consensus         2 dl~~n~~~~~ip~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L   81 (741)
                      |||.|++. ..|..+- .+.+|+.|+++.|.|. ..|.+..++.+|++|+|.+|.+. ..|..+..+++          |
T Consensus        51 ~lsnn~~~-~fp~~it-~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lkn----------l  116 (1081)
T KOG0618|consen   51 DLSNNQIS-SFPIQIT-LLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKN----------L  116 (1081)
T ss_pred             eccccccc-cCCchhh-hHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhc----------c
Confidence            56666665 6666665 5667777777777776 45566667777777777777776 66777766655          7


Q ss_pred             cEEECcCCcCcccCCchhhcccccccEEEcc-------------------CCcccccCCccccCCCCccEEEcccccccc
Q 037916           82 KHLDINNNNFGGLLPGCICNFSITLETLIFN-------------------SNKIFRSIPAGIGKFINLQTLHMWDNQLSG  142 (741)
Q Consensus        82 ~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~-------------------~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~  142 (741)
                      +.||+|.|++. ..|..+..+. .++.+..+                   .|.+.+.++..+..+++  .|+|.+|.+..
T Consensus       117 ~~LdlS~N~f~-~~Pl~i~~lt-~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~~  192 (1081)
T KOG0618|consen  117 QYLDLSFNHFG-PIPLVIEVLT-AEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEMEV  192 (1081)
T ss_pred             cccccchhccC-CCchhHHhhh-HHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcchhhhhe--eeecccchhhh
Confidence            77888887776 5565555444 33333333                   33334444444444444  48888888762


Q ss_pred             cCCccccCCCcCcE--------------------EEcccCCCCCcCcccccCCcccceeeccCcccccccCcccccCCCC
Q 037916          143 TISPAIGELQNLVT--------------------LAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSL  202 (741)
Q Consensus       143 ~~~~~~~~l~~L~~--------------------L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L  202 (741)
                      .   .+..+.+|+.                    |+.++|.++.. ...+ --.+|+++++++|+++ .+|++++.+.+|
T Consensus       193 ~---dls~~~~l~~l~c~rn~ls~l~~~g~~l~~L~a~~n~l~~~-~~~p-~p~nl~~~dis~n~l~-~lp~wi~~~~nl  266 (1081)
T KOG0618|consen  193 L---DLSNLANLEVLHCERNQLSELEISGPSLTALYADHNPLTTL-DVHP-VPLNLQYLDISHNNLS-NLPEWIGACANL  266 (1081)
T ss_pred             h---hhhhccchhhhhhhhcccceEEecCcchheeeeccCcceee-cccc-ccccceeeecchhhhh-cchHHHHhcccc
Confidence            1   1222233333                    33333333211 1111 1135666666666666 344666667777


Q ss_pred             CEEeccCcccc----------------------ccCCccccccccceeEEEcCCCccCCCCChhhcC-------------
Q 037916          203 TTINLSYNNLS----------------------GTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGK-------------  247 (741)
Q Consensus       203 ~~L~L~~N~l~----------------------~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~-------------  247 (741)
                      +.|+..+|+|+                      .-+|.....+++|.. |||..|+|...++..|.-             
T Consensus       267 e~l~~n~N~l~~lp~ri~~~~~L~~l~~~~nel~yip~~le~~~sL~t-LdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n  345 (1081)
T KOG0618|consen  267 EALNANHNRLVALPLRISRITSLVSLSAAYNELEYIPPFLEGLKSLRT-LDLQSNNLPSLPDNFLAVLNASLNTLNVSSN  345 (1081)
T ss_pred             eEecccchhHHhhHHHHhhhhhHHHHHhhhhhhhhCCCcccccceeee-eeehhccccccchHHHhhhhHHHHHHhhhhc
Confidence            77777766664                      034444445555554 666666665322222211             


Q ss_pred             ------------CCCCcEEEeccccccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccch
Q 037916          248 ------------LINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPK  315 (741)
Q Consensus       248 ------------l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  315 (741)
                                  ++.|+.|++.+|.++......+.++++|+.|+|++|+|...+...+.++..|+.|+||+|+++ .+|.
T Consensus       346 ~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~  424 (1081)
T KOG0618|consen  346 KLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPD  424 (1081)
T ss_pred             cccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhH
Confidence                        123555555666666555566667788888888888888666666788888888888888887 5678


Q ss_pred             hhhccccCCcccccCcccccccCCccccCCcccccccCCCCccccCC
Q 037916          316 FLVELQLVQNLNLSYNDLEGVIPTEGVFKNASAISVFGNSKLCGGIP  362 (741)
Q Consensus       316 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~~  362 (741)
                      ...++..|++|...+|++...| .....+.++-++++.|...-..++
T Consensus       425 tva~~~~L~tL~ahsN~l~~fP-e~~~l~qL~~lDlS~N~L~~~~l~  470 (1081)
T KOG0618|consen  425 TVANLGRLHTLRAHSNQLLSFP-ELAQLPQLKVLDLSCNNLSEVTLP  470 (1081)
T ss_pred             HHHhhhhhHHHhhcCCceeech-hhhhcCcceEEecccchhhhhhhh
Confidence            8888888888888888887665 666677788888888865544443

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=8.9e-24  Score=205.33  Aligned_cols=201  Identities=19%  Similarity=0.274  Sum_probs=171.5

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhc-CCCceeeEeeeecCccccCCceEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      ..|++.++||+|+||.+|.|+..-++++||||.-..  .....++..|.+..+.| ..+.|..+|.+     .+.+-+-.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYF-----GqeG~~Ni  100 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYF-----GQEGKYNI  100 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeee-----ccccchhh
Confidence            358999999999999999999988999999998653  33456788899999888 46899998877     56667889


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCC-----c
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEM-----T  553 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~-----~  553 (741)
                      +|||.+ |.||+++..-.         ...++..++..++.|++.-++|+|++   .+|.|||||+|+||...+     .
T Consensus       101 LVidLL-GPSLEDLFD~C---------gR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~  167 (449)
T KOG1165|consen  101 LVIDLL-GPSLEDLFDLC---------GRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANV  167 (449)
T ss_pred             hhhhhh-CcCHHHHHHHh---------cCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCce
Confidence            999998 88998887644         25689999999999999999999999   999999999999997643     6


Q ss_pred             eEEeecccccccCCCCc-----ccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCcc
Q 037916          554 AHVADFGLAKLLPPAHL-----QTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIM  621 (741)
Q Consensus       554 ~kL~DFg~a~~~~~~~~-----~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~  621 (741)
                      +.++|||+|+.+.++..     +.......||.+||+- ....+.+.+...|.-|+|-|+++.+-|..||...
T Consensus       168 IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSI-NTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL  239 (449)
T KOG1165|consen  168 IHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSI-NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL  239 (449)
T ss_pred             EEEEeccchhhhcCccccccCccccccccccceeeeEe-eccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence            89999999999876643     2334456699999998 6777889999999999999999999999999743

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.91  E-value=7.9e-25  Score=258.36  Aligned_cols=202  Identities=17%  Similarity=0.216  Sum_probs=134.7

Q ss_pred             hcCC-CceeeEeeeecCcc--ccCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHH
Q 037916          453 NIRH-KNLVKILTVCSGVD--YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH  529 (741)
Q Consensus       453 ~l~h-pnIv~~~~~~~~~~--~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH  529 (741)
                      .++| +||++++++|....  ......++.+|||+ +++|.+++...         ...+++.+++.+++||++||+|||
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---------~~~~~~~~~~~i~~qi~~al~~lH   97 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---------DRSVDAFECFHVFRQIVEIVNAAH   97 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---------cccccHHHHHHHHHHHHHHHHHHH
Confidence            4556 57888888753211  11223567788987 67999999632         245889999999999999999999


Q ss_pred             hcCCCCceecCCCCCCeEeCCCC-------------------ceEEeecccccccCCCCc--------------cccccc
Q 037916          530 HDCQPTTAHCDLKPSNVLLDHEM-------------------TAHVADFGLAKLLPPAHL--------------QTSSIG  576 (741)
Q Consensus       530 ~~~~~~ivHrDlkp~NIll~~~~-------------------~~kL~DFg~a~~~~~~~~--------------~~~~~~  576 (741)
                      ++   ||+||||||+|||++..+                   .+|++|||+++.......              ......
T Consensus        98 ~~---gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (793)
T PLN00181         98 SQ---GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQIL  174 (793)
T ss_pred             hC---CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccc
Confidence            99   999999999999996544                   455666666543211000              000011


Q ss_pred             ccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcchhHhhhhcccCCcchhh
Q 037916          577 VKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLT  656 (741)
Q Consensus       577 ~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  656 (741)
                      ..||+.|+|||. ..+..++.++|||||||++|||++|..|+....   ..+........++.                 
T Consensus       175 ~~gt~~Y~APE~-~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---~~~~~~~~~~~~~~-----------------  233 (793)
T PLN00181        175 AMEMSWYTSPEE-DNGSSSNCASDVYRLGVLLFELFCPVSSREEKS---RTMSSLRHRVLPPQ-----------------  233 (793)
T ss_pred             cCCCcceEChhh-hccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---HHHHHHHHhhcChh-----------------
Confidence            347889999954 456678999999999999999999888764210   00000000000000                 


Q ss_pred             hhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          657 ITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       657 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                                    ..........++.+||..||.+|||+.|+++.
T Consensus       234 --------------~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        234 --------------ILLNWPKEASFCLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             --------------hhhcCHHHHHHHHHhCCCChhhCcChHHHhhc
Confidence                          00112234577889999999999999999863

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=3.5e-24  Score=199.16  Aligned_cols=205  Identities=22%  Similarity=0.307  Sum_probs=169.8

Q ss_pred             HHHHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCC-CceeeEeeeecCccccCC
Q 037916          396 ILLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRH-KNLVKILTVCSGVDYKGD  474 (741)
Q Consensus       396 ~~~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~~~~  474 (741)
                      .+..+.|.++++||+|+||.+|.|.....|..||+|+-+  ..........|..+.+.+++ ..|..+..+     ..+.
T Consensus        11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es--~~a~hpqL~yEskvY~iL~~g~GiP~i~~y-----~~e~   83 (341)
T KOG1163|consen   11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLES--SKAKHPQLLYESKVYRILQGGVGIPHIRHY-----GTEK   83 (341)
T ss_pred             heeccceEEEEeecCCchhheeeeeeccCCceEEEEeec--ccCCCcchhHHHHHHHHhccCCCCchhhhh-----cccc
Confidence            345578999999999999999999999999999999865  34456678889999999965 677777776     4556


Q ss_pred             ceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCC---C
Q 037916          475 DFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDH---E  551 (741)
Q Consensus       475 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~---~  551 (741)
                      .+-.+||+.+ |.||+++..-.         ...++..+++.++-|++.-++|+|.+   +.+||||||+|+|..-   .
T Consensus        84 ~ynvlVMdLL-GPsLEdLfnfC---------~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~  150 (341)
T KOG1163|consen   84 DYNVLVMDLL-GPSLEDLFNFC---------SRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHC  150 (341)
T ss_pred             ccceeeeecc-CccHHHHHHHH---------hhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeecccccc
Confidence            6889999998 88999887533         25588999999999999999999999   9999999999999964   3


Q ss_pred             CceEEeecccccccCCCCc-----ccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCcc
Q 037916          552 MTAHVADFGLAKLLPPAHL-----QTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIM  621 (741)
Q Consensus       552 ~~~kL~DFg~a~~~~~~~~-----~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~  621 (741)
                      ..+.++|||+|+...+...     +.......||.+|.+- ....+.+.+...|+-|+|.++.+.--|..||...
T Consensus       151 ~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASi-nAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQgl  224 (341)
T KOG1163|consen  151 NKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASI-NAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGL  224 (341)
T ss_pred             ceEEEEeccchhhhccccccccCccccCCccceeeeehhh-hhhhhhhhhhhhhhhhhcceeeeeecCCCccccc
Confidence            5799999999988765422     2334456699999887 5556677889999999999999999999999744

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.91  E-value=5.8e-24  Score=204.15  Aligned_cols=169  Identities=21%  Similarity=0.233  Sum_probs=123.0

Q ss_pred             CChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecccccccC
Q 037916          487 GSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP  566 (741)
Q Consensus       487 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~a~~~~  566 (741)
                      |+|.++++..         ...+++.+++.++.|++.||.|||+.   +      ||+||+++.++.+|+  ||.+....
T Consensus         1 GsL~~~l~~~---------~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~   60 (176)
T smart00750        1 VSLADILEVR---------GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKT   60 (176)
T ss_pred             CcHHHHHHHh---------CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeec
Confidence            5788888632         24589999999999999999999999   6      999999999999999  99988654


Q ss_pred             CCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcchhHhhhh
Q 037916          567 PAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDS  646 (741)
Q Consensus       567 ~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  646 (741)
                      ...       ..||+.|+||| +..+..++.++|||||||++|||++|+.||.........+..+......         
T Consensus        61 ~~~-------~~g~~~y~aPE-~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~---------  123 (176)
T smart00750       61 PEQ-------SRVDPYFMAPE-VIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPA---------  123 (176)
T ss_pred             ccc-------CCCcccccChH-HhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhcc---------
Confidence            321       24889999995 5567788999999999999999999999986322111111111111000         


Q ss_pred             cccCCcchhhhhhhhHHHHHhHhhHHHHH--HHHHHHhhcccccCCCCCCCHHHHHHHHHHHHH
Q 037916          647 TLLADDEDLTITSNQRQRQARINNIMECL--ISVVRIGVACSMESPQDRMNMTIVVHELQSIKS  708 (741)
Q Consensus       647 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  708 (741)
                         ..... .            .......  ..+.+++.+||..||++|||+.|+++.+..+..
T Consensus       124 ---~~~~~-~------------~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      124 ---DDPRD-R------------SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             ---CCccc-c------------ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence               00000 0            0001112  358899999999999999999999998876653

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PLN03210 Resistant to P

Probab=99.91  E-value=4e-23  Score=251.09  Aligned_cols=318  Identities=23%  Similarity=0.268  Sum_probs=190.3

Q ss_pred             CChhhhhCCCCCcEEEcccCc------ccccCCccCCCCC-CCcEEEeecCcCcccCCchhhhhhhhhhccccCCCccEE
Q 037916           12 IPLDFGFTLPNLLFLSLGFNQ------ITGVIPSSMFNAS-KLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHL   84 (741)
Q Consensus        12 ip~~~~~~l~~L~~L~L~~n~------i~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L   84 (741)
                      ++.+.|..|++|+.|.+.++.      +...+|..|..++ +|+.|++.+|.++ .+|..|. ..          +|+.|
T Consensus       549 i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f~-~~----------~L~~L  616 (1153)
T PLN03210        549 IHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNFR-PE----------NLVKL  616 (1153)
T ss_pred             ecHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcCC-cc----------CCcEE
Confidence            344444566666666665443      2223455555543 4666666666665 4455442 22          26666


Q ss_pred             ECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCC
Q 037916           85 DINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKL  164 (741)
Q Consensus        85 ~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l  164 (741)
                      +|++|+|. .++..+..+. +|+.|+|++|.....+| .+..+++|++|+|++|..-..+|..+..+++|+.|++++|..
T Consensus       617 ~L~~s~l~-~L~~~~~~l~-~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~  693 (1153)
T PLN03210        617 QMQGSKLE-KLWDGVHSLT-GLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCEN  693 (1153)
T ss_pred             ECcCcccc-ccccccccCC-CCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCC
Confidence            66666665 3444445555 56666666554334444 255566666666666554445555566666666666665432


Q ss_pred             CCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCccc------------------------
Q 037916          165 SGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQL------------------------  220 (741)
Q Consensus       165 ~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~------------------------  220 (741)
                      -..+|..+ ++++|+.|+|++|.....+|..   .++|+.|+|++|.+. .+|..+                        
T Consensus       694 L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~~l~~L~~L~l~~~~~~~l~~~~~~  768 (1153)
T PLN03210        694 LEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNLRLENLDELILCEMKSEKLWERVQP  768 (1153)
T ss_pred             cCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccccccccccccccccchhhccccccc
Confidence            22444433 4556666666655433333322   235555555555554 333321                        


Q ss_pred             ------cccccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCccCCCCChhcc
Q 037916          221 ------MDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLS  294 (741)
Q Consensus       221 ------~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  294 (741)
                            ...++|+. |+|++|...+.+|..++++++|+.|+|++|...+..|... .+++|+.|+|++|.....+|..  
T Consensus       769 l~~~~~~~~~sL~~-L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~--  844 (1153)
T PLN03210        769 LTPLMTMLSPSLTR-LFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI--  844 (1153)
T ss_pred             cchhhhhccccchh-eeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc--
Confidence                  12346666 8888887776788888888888888888864333344443 6788888888887554445543  


Q ss_pred             cCccCCeeeCCCCcCCCccchhhhccccCCcccccC-cccccccCCccccCCcccccccCCC
Q 037916          295 SLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSY-NDLEGVIPTEGVFKNASAISVFGNS  355 (741)
Q Consensus       295 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~-N~l~~~~~~~~~~~~~~~~~~~~n~  355 (741)
                       .++|+.|+|++|.|+ .+|..+..+++|+.|+|++ |.++++++....+..+..+++.+.+
T Consensus       845 -~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C~  904 (1153)
T PLN03210        845 -STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDCG  904 (1153)
T ss_pred             -ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCCc
Confidence             357888888888887 5777888888889998888 5677766655556666666665543

syringae 6; Provisional

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.90  E-value=1.7e-24  Score=204.32  Aligned_cols=252  Identities=22%  Similarity=0.327  Sum_probs=188.0

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeecc--CcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLL--HHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      +...++.+|.+...|+.|+|++.  |..+++|+++..  .....++|..|+-.++-+.||||..+++.|...     ...
T Consensus       190 ~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp-----pnl  262 (448)
T KOG0195|consen  190 SSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP-----PNL  262 (448)
T ss_pred             hhhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC-----CCc
Confidence            44567889999999999999997  455677887632  234467889999999999999999999998543     478


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      .++..||+.|+|+..+++..        ....+..++.+++.++++|++|||+. .+-|.--.|....++||++.+++|.
T Consensus       263 v~isq~mp~gslynvlhe~t--------~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltaris  333 (448)
T KOG0195|consen  263 VIISQYMPFGSLYNVLHEQT--------SVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARIS  333 (448)
T ss_pred             eEeeeeccchHHHHHHhcCc--------cEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhhee
Confidence            99999999999999998652        24567788999999999999999998 4445555789999999999887764


Q ss_pred             --ecccccccCCCCcccccccccccccccCcccccCCCC--CCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhh
Q 037916          558 --DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSE--VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFAR  633 (741)
Q Consensus       558 --DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~--~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~  633 (741)
                        |--+         .....+....|.||+||.+.....  .-.++|+|||++++||+.|+..||.+...-+..++.   
T Consensus       334 mad~kf---------sfqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki---  401 (448)
T KOG0195|consen  334 MADTKF---------SFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI---  401 (448)
T ss_pred             ccccee---------eeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh---
Confidence              3222         122233446789999966544332  236789999999999999999998743221111111   


Q ss_pred             hcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHH
Q 037916          634 TVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIK  707 (741)
Q Consensus       634 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  707 (741)
                                                  ...+.+...++....-+.+++.-|++.||.+||.+..|+-.|+++.
T Consensus       402 ----------------------------aleglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  402 ----------------------------ALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             ----------------------------hhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence                                        1111222223344556778999999999999999999999998764

>PLN03210 Resistant to P

Probab=99.89  E-value=1.3e-22  Score=246.66  Aligned_cols=297  Identities=20%  Similarity=0.260  Sum_probs=191.0

Q ss_pred             cccCChhhhhCCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCccEEECcC
Q 037916            9 QGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINN   88 (741)
Q Consensus         9 ~~~ip~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~Ls~   88 (741)
                      ...+|..+..-.++|+.|++.+|.++ .+|..| ...+|+.|+|++|+|. .++..+..+++          |+.|+|++
T Consensus       577 ~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~----------Lk~L~Ls~  643 (1153)
T PLN03210        577 RWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTG----------LRNIDLRG  643 (1153)
T ss_pred             eeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCCC----------CCEEECCC
Confidence            33455555422234666666666665 445554 3566666666666665 44444554443          66666665


Q ss_pred             CcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcC
Q 037916           89 NNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNI  168 (741)
Q Consensus        89 N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~  168 (741)
                      |+....+|. +..++ +|++|+|++|.....+|..+..+++|+.|+|++|.--+.+|..+ ++++|+.|+|++|.....+
T Consensus       644 ~~~l~~ip~-ls~l~-~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~  720 (1153)
T PLN03210        644 SKNLKEIPD-LSMAT-NLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSF  720 (1153)
T ss_pred             CCCcCcCCc-cccCC-cccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCcccc
Confidence            543223442 34444 56666666655445556666666666666666543222333322 4555555555555433333


Q ss_pred             cccccCCcccceeeccCcccccccCc------------------------------ccccCCCCCEEeccCccccccCCc
Q 037916          169 PPSIGNLKKLLQLYLIENFLQVSIPS------------------------------SLGQCQSLTTINLSYNNLSGTIPP  218 (741)
Q Consensus       169 ~~~~~~l~~L~~L~L~~N~i~~~~~~------------------------------~~~~l~~L~~L~L~~N~l~~~~p~  218 (741)
                      |..   ..+|++|+|++|.+.. +|.                              .+...++|+.|+|++|...+.+|.
T Consensus       721 p~~---~~nL~~L~L~~n~i~~-lP~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~  796 (1153)
T PLN03210        721 PDI---STNISWLDLDETAIEE-FPSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPS  796 (1153)
T ss_pred             ccc---cCCcCeeecCCCcccc-ccccccccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccCh
Confidence            321   2344555555555442 222                              122346889999999987778999


Q ss_pred             cccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCccCCCCChhcccCcc
Q 037916          219 QLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRG  298 (741)
Q Consensus       219 ~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  298 (741)
                      .+.++++|+. |++++|...+.+|..+ .+++|+.|+|++|......+..   .++|+.|+|++|.++ .+|.++..+++
T Consensus       797 si~~L~~L~~-L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~  870 (1153)
T PLN03210        797 SIQNLHKLEH-LEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSN  870 (1153)
T ss_pred             hhhCCCCCCE-EECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCC
Confidence            9999999998 9999986555677665 7999999999997654333332   468999999999999 57889999999


Q ss_pred             CCeeeCCCC-cCCCccchhhhccccCCcccccCcc
Q 037916          299 LRVLDLSQN-NISGEIPKFLVELQLVQNLNLSYND  332 (741)
Q Consensus       299 L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~l~~N~  332 (741)
                      |+.|+|++| ++. .+|..+..+++|+.+++++|.
T Consensus       871 L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~  904 (1153)
T PLN03210        871 LSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG  904 (1153)
T ss_pred             CCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence            999999994 555 577778889999999999885

syringae 6; Provisional

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.89  E-value=1.6e-22  Score=212.96  Aligned_cols=265  Identities=21%  Similarity=0.194  Sum_probs=194.7

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCC-eEEEEEEeeccCcCcchhHHHHHHHHHhcCC----CceeeEeeeecCccccCCc
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGK-TIIAVKVLNLLHHGASKSSIAECSALRNIRH----KNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----pnIv~~~~~~~~~~~~~~~  475 (741)
                      .|.+.++||+|+||.||.|.+..++ ..+|+|+...........+..|..++..+..    +++.++++...    ..+.
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~   94 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED   94 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence            7999999999999999999997664 6789998875433333377889999988862    68888888731    3566


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCC----
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHE----  551 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~----  551 (741)
                      +.|+||+.+ |.+|.++.....        ...++..++.+|+.|++.+|+++|+.   |++||||||+|+.+...    
T Consensus        95 ~~~iVM~l~-G~sL~dl~~~~~--------~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~  162 (322)
T KOG1164|consen   95 FNFIVMSLL-GPSLEDLRKRNP--------PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSE  162 (322)
T ss_pred             eeEEEEecc-CccHHHHHHhCC--------CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcc
Confidence            889999988 889999875441        36789999999999999999999999   99999999999999865    


Q ss_pred             -CceEEeeccccc--ccCCCCc-----ccc-cccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccc
Q 037916          552 -MTAHVADFGLAK--LLPPAHL-----QTS-SIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMF  622 (741)
Q Consensus       552 -~~~kL~DFg~a~--~~~~~~~-----~~~-~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~  622 (741)
                       ..+.|.|||+|+  .......     ... .....||..|+++ ....+.+.+.+.|+||++.++.++..|..||....
T Consensus       163 ~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~-~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~  241 (322)
T KOG1164|consen  163 VRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASI-NVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALE  241 (322)
T ss_pred             cceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccH-HHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence             369999999998  3222211     111 1234599999999 78888899999999999999999999999996332


Q ss_pred             cCCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          623 EGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       623 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      .... ...+...         ........                  .....+..+.++...+-+.+..++|....+...
T Consensus       242 ~~~~-~~~~~~~---------~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  242 MTDL-KSKFEKD---------PRKLLTDR------------------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             ccch-HHHHHHH---------hhhhcccc------------------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            2111 1111000         00000000                  001123445555555556899999999999999


Q ss_pred             HHHHHHhh
Q 037916          703 LQSIKSIL  710 (741)
Q Consensus       703 L~~i~~~~  710 (741)
                      +++.....
T Consensus       294 l~~~~~~~  301 (322)
T KOG1164|consen  294 LKDVFDSE  301 (322)
T ss_pred             HHHHHHhc
Confidence            88877654

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=5.1e-23  Score=215.41  Aligned_cols=163  Identities=23%  Similarity=0.192  Sum_probs=125.1

Q ss_pred             HHHHHHHhhhcccCceeeEEEEEEcC-CCeEEEEEEeecc-----CcCcchhHHHHHHHHHhcCCCceee-EeeeecCcc
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGILDE-GKTIIAVKVLNLL-----HHGASKSSIAECSALRNIRHKNLVK-ILTVCSGVD  470 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~-~~~~~~~~~  470 (741)
                      +...|.+.+.||+|+||.||+|++.. +++.||||+....     .......+.+|+.++++++|+||+. ++++     
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-----   90 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-----   90 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-----
Confidence            34569999999999999999999875 6788899986522     1112456889999999999999985 4432     


Q ss_pred             ccCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCC-CCCCeEeC
Q 037916          471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDL-KPSNVLLD  549 (741)
Q Consensus       471 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDl-kp~NIll~  549 (741)
                          ...|+||||++|++|... ...          .      ...++.|+++||.|||+.   ||+|||| ||+||+++
T Consensus        91 ----~~~~LVmE~~~G~~L~~~-~~~----------~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~  146 (365)
T PRK09188         91 ----GKDGLVRGWTEGVPLHLA-RPH----------G------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMG  146 (365)
T ss_pred             ----CCcEEEEEccCCCCHHHh-Ccc----------c------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEc
Confidence                246999999999999632 100          0      135788999999999999   9999999 99999999


Q ss_pred             CCCceEEeecccccccCCCCcccc------cccccccccccCcccc
Q 037916          550 HEMTAHVADFGLAKLLPPAHLQTS------SIGVKGTIGYIAPAEY  589 (741)
Q Consensus       550 ~~~~~kL~DFg~a~~~~~~~~~~~------~~~~~gt~~y~aPEe~  589 (741)
                      .++.+||+|||+|+..........      -....+++.|+|||.+
T Consensus       147 ~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~  192 (365)
T PRK09188        147 PDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDAL  192 (365)
T ss_pred             CCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccC
Confidence            999999999999987754431111      1235578889999544

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.89  E-value=3.7e-23  Score=235.03  Aligned_cols=266  Identities=24%  Similarity=0.362  Sum_probs=199.4

Q ss_pred             CCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCccEEECcCCcCcccCCchhh
Q 037916           21 PNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCIC  100 (741)
Q Consensus        21 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~  100 (741)
                      .+.+.|+|+++.++. +|..+.  ++|+.|+|++|+|+ .+|..+.  +          +|++|+|++|+|++ +|..+.
T Consensus       178 ~~~~~L~L~~~~Lts-LP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~----------nL~~L~Ls~N~Lts-LP~~l~  240 (754)
T PRK15370        178 NNKTELRLKILGLTT-IPACIP--EQITTLILDNNELK-SLPENLQ--G----------NIKTLYANSNQLTS-IPATLP  240 (754)
T ss_pred             cCceEEEeCCCCcCc-CCcccc--cCCcEEEecCCCCC-cCChhhc--c----------CCCEEECCCCcccc-CChhhh
Confidence            567899999999984 566553  57999999999999 5565443  2          39999999999984 455443


Q ss_pred             cccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCcccccCCcccce
Q 037916          101 NFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQ  180 (741)
Q Consensus       101 ~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  180 (741)
                      .   +|+.|+|++|++. .+|..+.  .+|+.|+|++|+|+.+ |..+.  ++|+.|+|++|+|+. +|..+.  ++|+.
T Consensus       241 ~---~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~~L-P~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~  308 (754)
T PRK15370        241 D---TIQEMELSINRIT-ELPERLP--SALQSLDLFHNKISCL-PENLP--EELRYLSVYDNSIRT-LPAHLP--SGITH  308 (754)
T ss_pred             c---cccEEECcCCccC-cCChhHh--CCCCEEECcCCccCcc-ccccC--CCCcEEECCCCcccc-Ccccch--hhHHH
Confidence            2   7999999999986 4566654  4799999999999854 55443  479999999999985 455443  47899


Q ss_pred             eeccCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEecccc
Q 037916          181 LYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNM  260 (741)
Q Consensus       181 L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  260 (741)
                      |++++|.++. +|..+.  ++|+.|++++|.++ .+|..+.  ++|+. |+|++|+|+ .+|..+.  ++|+.|+|++|+
T Consensus       309 L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~-L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~  378 (754)
T PRK15370        309 LNVQSNSLTA-LPETLP--PGLKTLEAGENALT-SLPASLP--PELQV-LDVSKNQIT-VLPETLP--PTITTLDVSRNA  378 (754)
T ss_pred             HHhcCCcccc-CCcccc--ccceeccccCCccc-cCChhhc--CcccE-EECCCCCCC-cCChhhc--CCcCEEECCCCc
Confidence            9999999984 555443  68999999999998 5776664  67887 999999998 5666553  689999999999


Q ss_pred             ccchhhhhccccccccEEEeCCCccCCCCChhc----ccCccCCeeeCCCCcCCCccchhhhccccCCcccccCcccccc
Q 037916          261 LECEILSTLGSCIKLEQLKLGGNLFQGPIPLSL----SSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGV  336 (741)
Q Consensus       261 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~----~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~  336 (741)
                      |+.+++. +.  ..|+.|++++|+|.. +|..+    ..++++..|+|.+|.++.      ..+.+|+.| ++.+.+.|.
T Consensus       379 Lt~LP~~-l~--~sL~~LdLs~N~L~~-LP~sl~~~~~~~~~l~~L~L~~Npls~------~tl~~L~~L-l~s~~~~gp  447 (754)
T PRK15370        379 LTNLPEN-LP--AALQIMQASRNNLVR-LPESLPHFRGEGPQPTRIIVEYNPFSE------RTIQNMQRL-MSSVGYQGP  447 (754)
T ss_pred             CCCCCHh-HH--HHHHHHhhccCCccc-CchhHHHHhhcCCCccEEEeeCCCccH------HHHHHHHHh-hhcccccCC
Confidence            9976544 32  369999999999984 45443    445889999999999872      344455555 445555543

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.88  E-value=1.9e-22  Score=229.26  Aligned_cols=247  Identities=24%  Similarity=0.399  Sum_probs=173.4

Q ss_pred             CCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCccEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccc
Q 037916           45 SKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGI  124 (741)
Q Consensus        45 ~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~  124 (741)
                      .+...|+|++++++ .+|..+..            +|+.|+|++|+|++ +|..+.  . +|++|++++|++.. +|..+
T Consensus       178 ~~~~~L~L~~~~Lt-sLP~~Ip~------------~L~~L~Ls~N~Lts-LP~~l~--~-nL~~L~Ls~N~Lts-LP~~l  239 (754)
T PRK15370        178 NNKTELRLKILGLT-TIPACIPE------------QITTLILDNNELKS-LPENLQ--G-NIKTLYANSNQLTS-IPATL  239 (754)
T ss_pred             cCceEEEeCCCCcC-cCCccccc------------CCcEEEecCCCCCc-CChhhc--c-CCCEEECCCCcccc-CChhh
Confidence            35678888888888 45654432            38888888888884 444433  2 78888888888854 45555


Q ss_pred             cCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCE
Q 037916          125 GKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTT  204 (741)
Q Consensus       125 ~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~  204 (741)
                      .  .+|+.|+|++|+|+.+ |..+.  .+|+.|+|++|+|+ .+|..+.  ++|+.|+|++|+|+. +|..+.  ++|+.
T Consensus       240 ~--~~L~~L~Ls~N~L~~L-P~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~  308 (754)
T PRK15370        240 P--DTIQEMELSINRITEL-PERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITH  308 (754)
T ss_pred             h--ccccEEECcCCccCcC-ChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHH
Confidence            4  3788888888888844 44443  47888888888888 4565554  478888888888884 454443  47888


Q ss_pred             EeccCccccccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCc
Q 037916          205 INLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNL  284 (741)
Q Consensus       205 L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  284 (741)
                      |++++|+++ .+|..+.  ++|+. |++++|.+++ +|..+.  ++|+.|+|++|+|+.+ |..+  .++|+.|+|++|+
T Consensus       309 L~Ls~N~Lt-~LP~~l~--~sL~~-L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~~L-P~~l--p~~L~~LdLs~N~  378 (754)
T PRK15370        309 LNVQSNSLT-ALPETLP--PGLKT-LEAGENALTS-LPASLP--PELQVLDVSKNQITVL-PETL--PPTITTLDVSRNA  378 (754)
T ss_pred             HHhcCCccc-cCCcccc--cccee-ccccCCcccc-CChhhc--CcccEEECCCCCCCcC-Chhh--cCCcCEEECCCCc
Confidence            888888887 4565443  56776 8888888884 555553  6888888888888754 3333  2578888888888


Q ss_pred             cCCCCChhcccCccCCeeeCCCCcCCCccchhh----hccccCCcccccCcccc
Q 037916          285 FQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFL----VELQLVQNLNLSYNDLE  334 (741)
Q Consensus       285 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~----~~l~~L~~L~l~~N~l~  334 (741)
                      |+. +|..+.  ..|+.|++++|+|++ +|..+    ..++.+..|++.+|+++
T Consensus       379 Lt~-LP~~l~--~sL~~LdLs~N~L~~-LP~sl~~~~~~~~~l~~L~L~~Npls  428 (754)
T PRK15370        379 LTN-LPENLP--AALQIMQASRNNLVR-LPESLPHFRGEGPQPTRIIVEYNPFS  428 (754)
T ss_pred             CCC-CCHhHH--HHHHHHhhccCCccc-CchhHHHHhhcCCCccEEEeeCCCcc
Confidence            885 444443  368888888888873 44433    33477788888888886

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=3.1e-23  Score=231.43  Aligned_cols=253  Identities=17%  Similarity=0.164  Sum_probs=182.6

Q ss_pred             HhhhcccCceeeEEEEEEcCCCeEEEEEEeecc--CcCc----chhHHHHHHHHHhcCCCceeeEeeeecCccccCCceE
Q 037916          404 FLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLL--HHGA----SKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       404 ~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~----~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      ....+|.|++|.|+.+........++.|.++..  ....    ...+..|+-+-..+.|||++..+..+...     ...
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~-----~~~  396 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEI-----DGI  396 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhc-----ccc
Confidence            345689999998888888766776777765421  1111    11234466666778999998877774322     233


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      .-+||||++ +|..++...          ..+...++-.+++|++.|++|+|+.   ||.|||+|++|+++..+|.+||+
T Consensus       397 ~~~mE~~~~-Dlf~~~~~~----------~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~  462 (601)
T KOG0590|consen  397 LQSMEYCPY-DLFSLVMSN----------GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKII  462 (601)
T ss_pred             hhhhhcccH-HHHHHHhcc----------cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEe
Confidence            334999998 999988632          3567778888999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCcc--cccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhh-
Q 037916          558 DFGLAKLLPPAHLQ--TSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART-  634 (741)
Q Consensus       558 DFg~a~~~~~~~~~--~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~-  634 (741)
                      |||.+....-+...  ....+..|+..|+|||++..........||||.|+++..|.+|+.||......+..+...... 
T Consensus       463 Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~  542 (601)
T KOG0590|consen  463 DFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSD  542 (601)
T ss_pred             ecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcccc
Confidence            99998765444332  444567799999999776665566677999999999999999999998654444332100000 


Q ss_pred             --cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          635 --VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       635 --~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                        ....+..                           ......+..-..++.+|++.||.+|.|+++|++.
T Consensus       543 ~~~~~~~~~---------------------------~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d  585 (601)
T KOG0590|consen  543 QRNIFEGPN---------------------------RLLSLLPRETRIIIYRMLQLDPTKRITIEQILND  585 (601)
T ss_pred             ccccccChH---------------------------HHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence              0000011                           1112445556688999999999999999999874

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.85  E-value=1.4e-21  Score=189.80  Aligned_cols=179  Identities=10%  Similarity=0.060  Sum_probs=134.7

Q ss_pred             HHHHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchh---------HHHHHHHHHhcCCCceeeEeeee
Q 037916          396 ILLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKS---------SIAECSALRNIRHKNLVKILTVC  466 (741)
Q Consensus       396 ~~~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~hpnIv~~~~~~  466 (741)
                      -++-.+|.+++.+|.|+||.||++..  ++..+|+|+++.........         +.+|+..+.++.||+|..+.+++
T Consensus        27 ~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~  104 (232)
T PRK10359         27 DFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY  104 (232)
T ss_pred             HHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence            56678899999999999999999766  36679999997433322222         57899999999999999998875


Q ss_pred             cCccc---cCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCC
Q 037916          467 SGVDY---KGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKP  543 (741)
Q Consensus       467 ~~~~~---~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp  543 (741)
                      .....   ......+++|||++|.+|.++..              ++.    ....+++.++..+|+.   |++|||+||
T Consensus       105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp  163 (232)
T PRK10359        105 LLAERKTLRYAHTYIMLIEYIEGVELNDMPE--------------ISE----DVKAKIKASIESLHQH---GMVSGDPHK  163 (232)
T ss_pred             eecccccccccCCeEEEEEEECCccHHHhhh--------------ccH----HHHHHHHHHHHHHHHc---CCccCCCCh
Confidence            42211   11345799999999999988732              121    2456999999999999   999999999


Q ss_pred             CCeEeCCCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc
Q 037916          544 SNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT  613 (741)
Q Consensus       544 ~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt  613 (741)
                      +||+++.+| ++|+|||...........               +.+.....+..++||||+|+++.....
T Consensus       164 ~Nili~~~g-i~liDfg~~~~~~e~~a~---------------d~~vler~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        164 GNFIVSKNG-LRIIDLSGKRCTAQRKAK---------------DRIDLERHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             HHEEEeCCC-EEEEECCCcccccchhhH---------------HHHHHHhHhcccccccceeEeehHHHH
Confidence            999999988 999999987654322111               123334456689999999999876543

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.85  E-value=2.7e-20  Score=197.78  Aligned_cols=261  Identities=26%  Similarity=0.337  Sum_probs=190.8

Q ss_pred             HHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcC---cchhHHHHHHHHHhcCCC-ceeeEeeeecCccccCCceE
Q 037916          402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG---ASKSSIAECSALRNIRHK-NLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp-nIv~~~~~~~~~~~~~~~~~  477 (741)
                      |.+.+.||.|+||.||++.+.   ..+|+|.+......   ....+.+|+.+++.+.|+ +|+++++++     ......
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~   73 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF-----QDEGSL   73 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEE-----ecCCEE
Confidence            567788999999999999997   77899998743332   356788999999999988 799999985     334458


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCC-ceEE
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEM-TAHV  556 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~-~~kL  556 (741)
                      +++++++.++++.+++......       ..+.......++.|++.++.|+|+.   +++|||+||+||+++..+ .+++
T Consensus        74 ~~~~~~~~~~~l~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l  143 (384)
T COG0515          74 YLVMEYVDGGSLEDLLKKIGRK-------GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKL  143 (384)
T ss_pred             EEEEecCCCCcHHHHHHhcccc-------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEE
Confidence            9999999999999776533100       2578888999999999999999999   999999999999999988 7999


Q ss_pred             eecccccccCCCCccc----ccccccccccccCcccccCC--CCCCCccCchhHHHHHHHHHcCCCCCCccccC--Ccch
Q 037916          557 ADFGLAKLLPPAHLQT----SSIGVKGTIGYIAPAEYGLG--SEVSINGDVYSYGILLLELMTRKRPSDIMFEG--NMNL  628 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~----~~~~~~gt~~y~aPEe~~~~--~~~~~~~DIwSlG~il~elltg~~p~~~~~~~--~~~~  628 (741)
                      +|||.+..........    ......|+..|+|||.+...  ..++...|+||+|++++++++|..||......  ....
T Consensus       144 ~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~  223 (384)
T COG0515         144 IDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQT  223 (384)
T ss_pred             eccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHH
Confidence            9999998655443221    23446799999999655443  57889999999999999999999996532211  0011


Q ss_pred             hhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          629 HNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       629 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      ..........        .......       ....       ......+.+++..|+..+|..|.++.+....
T Consensus       224 ~~~~~~~~~~--------~~~~~~~-------~~~~-------~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         224 LKIILELPTP--------SLASPLS-------PSNP-------ELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             HHHHHhcCCc--------ccccccC-------cccc-------chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            1111110000        0000000       0000       1223467788899999999999999887775

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.84  E-value=6e-21  Score=183.94  Aligned_cols=141  Identities=15%  Similarity=0.085  Sum_probs=106.9

Q ss_pred             hhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCc---------chh-----------------HHHHHHHHHhcCCCc
Q 037916          405 LCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGA---------SKS-----------------SIAECSALRNIRHKN  458 (741)
Q Consensus       405 ~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~---------~~~-----------------~~~E~~~l~~l~hpn  458 (741)
                      .+.||+|+||.||+|.+. +|+.||+|+++......         ..+                 ...|+..+.++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            467999999999999997 89999999997532111         111                 234999999998776


Q ss_pred             eeeEeeeecCccccCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHH-HhcCCCCce
Q 037916          459 LVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL-HHDCQPTTA  537 (741)
Q Consensus       459 Iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L-H~~~~~~iv  537 (741)
                      +.....+     .. . ..++||||++|+++......          ...++..++..++.|++.+|.++ |+.   ||+
T Consensus        81 v~~p~~~-----~~-~-~~~iVmE~i~g~~l~~~~~~----------~~~~~~~~~~~i~~qi~~~L~~l~H~~---gii  140 (190)
T cd05147          81 IPCPEPI-----LL-K-SHVLVMEFIGDDGWAAPRLK----------DAPLSESKARELYLQVIQIMRILYQDC---RLV  140 (190)
T ss_pred             CCCCcEE-----Ee-c-CCEEEEEEeCCCCCcchhhh----------cCCCCHHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence            6433222     11 1 23899999988766544321          13477888999999999999999 688   999


Q ss_pred             ecCCCCCCeEeCCCCceEEeecccccccCC
Q 037916          538 HCDLKPSNVLLDHEMTAHVADFGLAKLLPP  567 (741)
Q Consensus       538 HrDlkp~NIll~~~~~~kL~DFg~a~~~~~  567 (741)
                      ||||||+||+++ ++.++|+|||+|.....
T Consensus       141 HrDlkP~NIli~-~~~v~LiDFG~a~~~~~  169 (190)
T cd05147         141 HADLSEYNLLYH-DGKLYIIDVSQSVEHDH  169 (190)
T ss_pred             cCCCCHHHEEEE-CCcEEEEEccccccCCC
Confidence            999999999998 47899999999975543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.82  E-value=1.9e-21  Score=205.83  Aligned_cols=283  Identities=25%  Similarity=0.286  Sum_probs=148.6

Q ss_pred             EEEcccCccc-ccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCccEEECcCCcCcccCCchhhccc
Q 037916           25 FLSLGFNQIT-GVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFS  103 (741)
Q Consensus        25 ~L~L~~n~i~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~  103 (741)
                      .|+|+.+.++ ......|..+.+|++|+|++|.++......+....      ...+.|++|++++|.+.+. +..+    
T Consensus         2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l------~~~~~l~~l~l~~~~~~~~-~~~~----   70 (319)
T cd00116           2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASAL------RPQPSLKELCLSLNETGRI-PRGL----   70 (319)
T ss_pred             ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHH------hhCCCceEEeccccccCCc-chHH----
Confidence            4667777776 33444555666777777777777532111111100      0112366667666665520 1100    


Q ss_pred             ccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCc---CcEEEcccCCCCC----cCcccccCC-
Q 037916          104 ITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQN---LVTLAINTNKLSG----NIPPSIGNL-  175 (741)
Q Consensus       104 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~---L~~L~L~~N~l~~----~~~~~~~~l-  175 (741)
                                    ...+..+..+++|+.|+|++|.+.+..+..+..+.+   |+.|++++|++++    .+...+..+ 
T Consensus        71 --------------~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~  136 (319)
T cd00116          71 --------------QSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLP  136 (319)
T ss_pred             --------------HHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCC
Confidence                          112233444555555555555555444444443333   6666666665542    112233444 


Q ss_pred             cccceeeccCccccc----ccCcccccCCCCCEEeccCcccccc----CCccccccccceeEEEcCCCccCCCC----Ch
Q 037916          176 KKLLQLYLIENFLQV----SIPSSLGQCQSLTTINLSYNNLSGT----IPPQLMDLTSLSVGLDLSRNQLVGSL----PT  243 (741)
Q Consensus       176 ~~L~~L~L~~N~i~~----~~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~~L~Ls~N~l~~~~----p~  243 (741)
                      ++|+.|+|++|.+++    .++..+..+++|++|+|++|.+++.    ++..+..+++|+. |+|++|.+.+..    ..
T Consensus       137 ~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~-L~L~~n~i~~~~~~~l~~  215 (319)
T cd00116         137 PALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEV-LDLNNNGLTDEGASALAE  215 (319)
T ss_pred             CCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCE-EeccCCccChHHHHHHHH
Confidence            556666666666552    1233445555666666666666521    2223334445665 666666665322    23


Q ss_pred             hhcCCCCCcEEEeccccccchhhhhccc-----cccccEEEeCCCccCC----CCChhcccCccCCeeeCCCCcCCCc--
Q 037916          244 EVGKLINLEILFISRNMLECEILSTLGS-----CIKLEQLKLGGNLFQG----PIPLSLSSLRGLRVLDLSQNNISGE--  312 (741)
Q Consensus       244 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-----l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~--  312 (741)
                      .+..+++|++|++++|.++......+..     .++|+.|++++|.++.    .....+..+++|+++++++|.++..  
T Consensus       216 ~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~  295 (319)
T cd00116         216 TLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGA  295 (319)
T ss_pred             HhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHH
Confidence            3455667777777777776533333322     3577777777777752    1233445556777777777777743  


Q ss_pred             --cchhhhcc-ccCCcccccCccc
Q 037916          313 --IPKFLVEL-QLVQNLNLSYNDL  333 (741)
Q Consensus       313 --~~~~~~~l-~~L~~L~l~~N~l  333 (741)
                        ....+... +.|+.|++.+|++
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~  319 (319)
T cd00116         296 QLLAESLLEPGNELESLWVKDDSF  319 (319)
T ss_pred             HHHHHHHhhcCCchhhcccCCCCC
Confidence              33334444 5666777766654

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.82  E-value=9.8e-20  Score=176.37  Aligned_cols=141  Identities=18%  Similarity=0.110  Sum_probs=108.8

Q ss_pred             hhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCc--------------------------chhHHHHHHHHHhcCCCc
Q 037916          405 LCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGA--------------------------SKSSIAECSALRNIRHKN  458 (741)
Q Consensus       405 ~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~hpn  458 (741)
                      .+.||+|++|.||+|.+. +|+.||||+++......                          ......|...+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            467999999999999987 89999999997542110                          112357889999999988


Q ss_pred             eeeEeeeecCccccCCceEEEEEecccCCChhhh-ccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHh-cCCCCc
Q 037916          459 LVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEW-LHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH-DCQPTT  536 (741)
Q Consensus       459 Iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~i  536 (741)
                      |.....+..     .  ..++||||++|+++... +.           ...++..+...++.|++.++.++|+ .   ||
T Consensus        81 i~~p~~~~~-----~--~~~lVmE~~~g~~~~~~~l~-----------~~~~~~~~~~~i~~~l~~~l~~lH~~~---gi  139 (190)
T cd05145          81 VPVPEPILL-----K--KNVLVMEFIGDDGSPAPRLK-----------DVPLEEEEAEELYEQVVEQMRRLYQEA---GL  139 (190)
T ss_pred             CCCceEEEe-----c--CCEEEEEEecCCCchhhhhh-----------hccCCHHHHHHHHHHHHHHHHHHHHhC---CE
Confidence            754333311     1  24899999988754332 22           1235677888999999999999999 8   99


Q ss_pred             eecCCCCCCeEeCCCCceEEeecccccccCCC
Q 037916          537 AHCDLKPSNVLLDHEMTAHVADFGLAKLLPPA  568 (741)
Q Consensus       537 vHrDlkp~NIll~~~~~~kL~DFg~a~~~~~~  568 (741)
                      +||||||+||+++ ++.++|+|||++.....+
T Consensus       140 vHrDlkP~NIll~-~~~~~liDFG~a~~~~~~  170 (190)
T cd05145         140 VHGDLSEYNILYH-DGKPYIIDVSQAVELDHP  170 (190)
T ss_pred             ecCCCChhhEEEE-CCCEEEEEcccceecCCC
Confidence            9999999999998 789999999999866543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.81  E-value=6.9e-20  Score=182.27  Aligned_cols=201  Identities=23%  Similarity=0.260  Sum_probs=140.0

Q ss_pred             CCCceeeEeeeecCcc----------------------ccCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHH
Q 037916          455 RHKNLVKILTVCSGVD----------------------YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFL  512 (741)
Q Consensus       455 ~hpnIv~~~~~~~~~~----------------------~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~  512 (741)
                      +|||||+++++|.+.-                      +......|+||..++ .+|.+|+...           ..+..
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~-----------~~s~r  341 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR-----------HRSYR  341 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC-----------CCchH
Confidence            5999999998864311                      122445789999884 5999998633           24555


Q ss_pred             HHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEe--CCCC--ceEEeecccccccCCCC----ccccccccccccccc
Q 037916          513 QRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLL--DHEM--TAHVADFGLAKLLPPAH----LQTSSIGVKGTIGYI  584 (741)
Q Consensus       513 ~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll--~~~~--~~kL~DFg~a~~~~~~~----~~~~~~~~~gt~~y~  584 (741)
                      ...-++.|+++|+.|||.+   ||.|||+|.+|||+  |+|+  .+.|+|||+|-......    .........|...-|
T Consensus       342 ~~~~~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lm  418 (598)
T KOG4158|consen  342 TGRVILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLM  418 (598)
T ss_pred             HHHHHHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceec
Confidence            6677999999999999999   99999999999999  3443  67899999986443321    111223345788899


Q ss_pred             CcccccCCC-C----CCCccCchhHHHHHHHHHcCCCCCCccccCCcch--hhhhhhcCCcchhHhhhhcccCCcchhhh
Q 037916          585 APAEYGLGS-E----VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNL--HNFARTVLPDHVMDIVDSTLLADDEDLTI  657 (741)
Q Consensus       585 aPEe~~~~~-~----~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  657 (741)
                      |||....-. +    .-.|+|.|+.|.+.||+++...||..  .+++.+  ..+-...++                    
T Consensus       419 APEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~--rGem~L~~r~Yqe~qLP--------------------  476 (598)
T KOG4158|consen  419 APEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK--RGEMLLDTRTYQESQLP--------------------  476 (598)
T ss_pred             chhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccc--cchheechhhhhhhhCC--------------------
Confidence            996442211 1    12689999999999999999999863  222211  111111111                    


Q ss_pred             hhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHH
Q 037916          658 TSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHEL  703 (741)
Q Consensus       658 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  703 (741)
                                 ..+..++..+.+++...++.||.+|++..-...+|
T Consensus       477 -----------alp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  477 -----------ALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             -----------CCcccCChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence                       11235567788999999999999999987666655

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=9.6e-20  Score=172.76  Aligned_cols=185  Identities=18%  Similarity=0.106  Sum_probs=137.5

Q ss_pred             HhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCc----chhHHHHHHHHHhcC-CCceeeEeeeecCccccCCceEE
Q 037916          404 FLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGA----SKSSIAECSALRNIR-HKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       404 ~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      +...|++|+||+||.+..  .+.+|+.+.+.....-.    ...+.+|+++|+++. |++|++++++         ...+
T Consensus         6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---------~~~~   74 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW---------DGRH   74 (218)
T ss_pred             cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---------cCEE
Confidence            456799999999997776  57778877775322211    124688999999995 5889999886         1468


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCC-CCCCeEeCCCCceEEe
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDL-KPSNVLLDHEMTAHVA  557 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDl-kp~NIll~~~~~~kL~  557 (741)
                      ++|||+.|.+|.+....                 ....++.|++++|.++|+.   ||+|||| ||+||+++.++.++|+
T Consensus        75 lvmeyI~G~~L~~~~~~-----------------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LI  134 (218)
T PRK12274         75 LDRSYLAGAAMYQRPPR-----------------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVI  134 (218)
T ss_pred             EEEeeecCccHHhhhhh-----------------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEE
Confidence            99999999888654310                 1134788999999999999   9999999 7999999999999999


Q ss_pred             ecccccccCCCCcc----c--c-----cccccccccccCcccccCCCCCC-CccCchhHHHHHHHHHcCCCCCC
Q 037916          558 DFGLAKLLPPAHLQ----T--S-----SIGVKGTIGYIAPAEYGLGSEVS-INGDVYSYGILLLELMTRKRPSD  619 (741)
Q Consensus       558 DFg~a~~~~~~~~~----~--~-----~~~~~gt~~y~aPEe~~~~~~~~-~~~DIwSlG~il~elltg~~p~~  619 (741)
                      |||+|.........    .  .     ..-...++.|++|+|-..-...+ ...++++.|+.+|.++|+..++-
T Consensus       135 DFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~  208 (218)
T PRK12274        135 DFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW  208 (218)
T ss_pred             ECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence            99999865543310    0  0     00123678888886653333333 55688899999999999998864

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.81  E-value=4.5e-21  Score=202.97  Aligned_cols=276  Identities=21%  Similarity=0.205  Sum_probs=160.3

Q ss_pred             CCCCCccc-ccCChhhhhCCCCCcEEEcccCccccc----CCccCCCCCCCcEEEeecCcCcc------cCCchhhhhhh
Q 037916            2 DVGVNRVQ-GGIPLDFGFTLPNLLFLSLGFNQITGV----IPSSMFNASKLEVFQVTSNNLTG------EVPSEFGKATK   70 (741)
Q Consensus         2 dl~~n~~~-~~ip~~~~~~l~~L~~L~L~~n~i~~~----~~~~~~~l~~L~~L~L~~N~l~~------~~~~~~~~l~~   70 (741)
                      ||+.+.+. +..+.- +..+++|++|+|+++.++..    ++..+...++|++|+++++.+.+      .++..|..+  
T Consensus         4 ~L~~~~l~~~~~~~~-~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~--   80 (319)
T cd00116           4 SLKGELLKTERATEL-LPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKG--   80 (319)
T ss_pred             ccccCcccccchHHH-HHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhc--
Confidence            67888888 444444 44889999999999999543    45667788899999999998873      112233333  


Q ss_pred             hhhccccCCCccEEECcCCcCcccCCchhhcccc--cccEEEccCCcccc----cCCccccCC-CCccEEEccccccccc
Q 037916           71 AYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSI--TLETLIFNSNKIFR----SIPAGIGKF-INLQTLHMWDNQLSGT  143 (741)
Q Consensus        71 ~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~--~L~~L~L~~n~i~~----~~~~~~~~l-~~L~~L~L~~N~i~~~  143 (741)
                              ++|+.|++++|.+.+..+..+..+..  +|++|++++|++..    .+...+..+ ++|+.|+|++|.+++.
T Consensus        81 --------~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~  152 (319)
T cd00116          81 --------CGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGA  152 (319)
T ss_pred             --------CceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCch
Confidence                    35999999999988666666655551  27777777777652    222344455 6777777777777632


Q ss_pred             ----CCccccCCCcCcEEEcccCCCCCc----CcccccCCcccceeeccCccccccc----CcccccCCCCCEEeccCcc
Q 037916          144 ----ISPAIGELQNLVTLAINTNKLSGN----IPPSIGNLKKLLQLYLIENFLQVSI----PSSLGQCQSLTTINLSYNN  211 (741)
Q Consensus       144 ----~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~i~~~~----~~~~~~l~~L~~L~L~~N~  211 (741)
                          ....+..+++|++|+|++|.+++.    ++..+..+++|+.|+|++|.+++..    +..+..+++|++|++++|+
T Consensus       153 ~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~  232 (319)
T cd00116         153 SCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNN  232 (319)
T ss_pred             HHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCc
Confidence                233455556677777777666531    2223344455666666666554221    2233344455555555555


Q ss_pred             ccccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccc----hhhhhccccccccEEEeCCCccCC
Q 037916          212 LSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLEC----EILSTLGSCIKLEQLKLGGNLFQG  287 (741)
Q Consensus       212 l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~  287 (741)
                      +++.....+...                    .....+.|+.|++++|.++.    .....+..+++|+.|++++|.+..
T Consensus       233 l~~~~~~~l~~~--------------------~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~  292 (319)
T cd00116         233 LTDAGAAALASA--------------------LLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGE  292 (319)
T ss_pred             CchHHHHHHHHH--------------------HhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcH
Confidence            442111111100                    00012566666666666642    123344445666667777776664


Q ss_pred             C----CChhcccC-ccCCeeeCCCCc
Q 037916          288 P----IPLSLSSL-RGLRVLDLSQNN  308 (741)
Q Consensus       288 ~----~~~~~~~l-~~L~~L~Ls~N~  308 (741)
                      .    ....+... +.|+.|++.+|.
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (319)
T cd00116         293 EGAQLLAESLLEPGNELESLWVKDDS  318 (319)
T ss_pred             HHHHHHHHHHhhcCCchhhcccCCCC
Confidence            3    23333333 566777776664

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.79  E-value=1.4e-19  Score=181.10  Aligned_cols=240  Identities=18%  Similarity=0.180  Sum_probs=143.0

Q ss_pred             hhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcC---cchhHHHHHHHHHhcC----------CCceeeEeeeecC---
Q 037916          405 LCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG---ASKSSIAECSALRNIR----------HKNLVKILTVCSG---  468 (741)
Q Consensus       405 ~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~----------hpnIv~~~~~~~~---  468 (741)
                      .+.||.|+++.||.+++.++++.+|+|++......   ..+++.+|.-....+.          |-.++.-++....   
T Consensus        17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~   96 (288)
T PF14531_consen   17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK   96 (288)
T ss_dssp             EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred             ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence            45699999999999999999999999998633322   2344444543333321          1111111111100   


Q ss_pred             cc----ccCCc-----eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceec
Q 037916          469 VD----YKGDD-----FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHC  539 (741)
Q Consensus       469 ~~----~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHr  539 (741)
                      ..    ..+..     ..+++|+-+ .++|.+++.......   ..........+..+..|+++.+++||+.   |++|+
T Consensus        97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~---~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg  169 (288)
T PF14531_consen   97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRA---QTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG  169 (288)
T ss_dssp             -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHT---TTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred             CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcc---cccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence            00    01111     236788877 568887754210000   0023344556677889999999999999   99999


Q ss_pred             CCCCCCeEeCCCCceEEeecccccccCCCCcccccccccccccccCcccccC-------CCCCCCccCchhHHHHHHHHH
Q 037916          540 DLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGL-------GSEVSINGDVYSYGILLLELM  612 (741)
Q Consensus       540 Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~-------~~~~~~~~DIwSlG~il~ell  612 (741)
                      ||+|+|++++.+|.++|+||+.....+.....     ...+..|.+||....       .-.++.+.|.|++|+++|.|.
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW  244 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW  244 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence            99999999999999999999887655432211     123566778853222       134788999999999999999


Q ss_pred             cCCCCCCccccCCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCC
Q 037916          613 TRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQD  692 (741)
Q Consensus       613 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~  692 (741)
                      ++..||+....+......             +     ..                   +.+.++.+..||..+|++||++
T Consensus       245 C~~lPf~~~~~~~~~~~~-------------f-----~~-------------------C~~~Pe~v~~LI~~lL~~~~~~  287 (288)
T PF14531_consen  245 CGRLPFGLSSPEADPEWD-------------F-----SR-------------------CRDMPEPVQFLIRGLLQRNPED  287 (288)
T ss_dssp             HSS-STCCCGGGSTSGGG-------------G-----TT-------------------SS---HHHHHHHHHHT-SSGGG
T ss_pred             HccCCCCCCCcccccccc-------------c-----hh-------------------cCCcCHHHHHHHHHHccCCccc
Confidence            999999743222111110             0     01                   1155778899999999999999


Q ss_pred             C
Q 037916          693 R  693 (741)
Q Consensus       693 R  693 (741)
                      |
T Consensus       288 R  288 (288)
T PF14531_consen  288 R  288 (288)
T ss_dssp             S
T ss_pred             C
Confidence            8

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.79  E-value=5e-21  Score=169.08  Aligned_cols=179  Identities=26%  Similarity=0.407  Sum_probs=137.2

Q ss_pred             CCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcE
Q 037916          174 NLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEI  253 (741)
Q Consensus       174 ~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~  253 (741)
                      ++.+++.|.|++|+++ .+|..+..+.+|+.|++++|+|. .+|..++.+++|+. |+++-|++. +.|..|+.++.|+.
T Consensus        31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~-lnvgmnrl~-~lprgfgs~p~lev  106 (264)
T KOG0617|consen   31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRI-LNVGMNRLN-ILPRGFGSFPALEV  106 (264)
T ss_pred             chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhh-eecchhhhh-cCccccCCCchhhh
Confidence            3455666666666666 44555666677777777777776 66777777777776 777777776 67777778888888


Q ss_pred             EEeccccccc-hhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccchhhhccccCCcccccCcc
Q 037916          254 LFISRNMLEC-EILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYND  332 (741)
Q Consensus       254 L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~  332 (741)
                      |||.+|++.. ..|+.|-.+..|+.|+|+.|.+. .+|..++.+++|+.|.+.+|.+- .+|..++.+++|++|++.+|.
T Consensus       107 ldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnr  184 (264)
T KOG0617|consen  107 LDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNR  184 (264)
T ss_pred             hhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccce
Confidence            8888777764 56777888888999999999998 78888999999999999999998 689999999999999999999


Q ss_pred             cccccCCcccc---CCcccccccCCCCcc
Q 037916          333 LEGVIPTEGVF---KNASAISVFGNSKLC  358 (741)
Q Consensus       333 l~~~~~~~~~~---~~~~~~~~~~n~~~c  358 (741)
                      ++-.||..+..   .+.+......|||..
T Consensus       185 l~vlppel~~l~l~~~k~v~r~E~NPwv~  213 (264)
T KOG0617|consen  185 LTVLPPELANLDLVGNKQVMRMEENPWVN  213 (264)
T ss_pred             eeecChhhhhhhhhhhHHHHhhhhCCCCC
Confidence            99888876543   334556667777753

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.78  E-value=6.3e-20  Score=203.59  Aligned_cols=248  Identities=16%  Similarity=0.152  Sum_probs=174.2

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC-cCcchhHH---HHHHHHHhcCCCceeeEeeeecCccccCCce
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH-HGASKSSI---AECSALRNIRHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~---~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      .|...+.+|.+.|=+|.+|+++ .|. |+||++-+.. ....+.+.   .|++ ...++|||++.+..+     ......
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~-----~~t~kA   95 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKV-----LVTDKA   95 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHH-----HHhhHH
Confidence            5667788999999999999998 455 8899986443 23334443   4444 455699999998877     455567


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .|+|-+|+.. +|.+.+..+          ..+...+.+.|+-|++.||.-+|..   ||+|||||.+||||+.=.=+.|
T Consensus        96 AylvRqyvkh-nLyDRlSTR----------PFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~L  161 (1431)
T KOG1240|consen   96 AYLVRQYVKH-NLYDRLSTR----------PFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYL  161 (1431)
T ss_pred             HHHHHHHHhh-hhhhhhccc----------hHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhh
Confidence            7899999854 899988643          6678888899999999999999999   9999999999999987667899


Q ss_pred             eecccccccC--CCC---cccccccccccccccCcccccCCC---------C-CCCccCchhHHHHHHHHHc-CCCCCCc
Q 037916          557 ADFGLAKLLP--PAH---LQTSSIGVKGTIGYIAPAEYGLGS---------E-VSINGDVYSYGILLLELMT-RKRPSDI  620 (741)
Q Consensus       557 ~DFg~a~~~~--~~~---~~~~~~~~~gt~~y~aPEe~~~~~---------~-~~~~~DIwSlG~il~ellt-g~~p~~~  620 (741)
                      +||..-+..-  ++.   .............|.|||.+..+.         . .+++-||||+||++.|+++ |++||+.
T Consensus       162 tDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L  241 (1431)
T KOG1240|consen  162 TDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL  241 (1431)
T ss_pred             hcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH
Confidence            9997654332  111   111111122345799998654321         2 5688999999999999977 6888862


Q ss_pred             cccCCcchhhhhhhcCC--cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHH
Q 037916          621 MFEGNMNLHNFARTVLP--DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTI  698 (741)
Q Consensus       621 ~~~~~~~~~~~~~~~~~--~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  698 (741)
                      .        +...-.-.  ......++..-                          -..+.+++..|++.||++|-++++
T Consensus       242 S--------QL~aYr~~~~~~~e~~Le~Ie--------------------------d~~~Rnlil~Mi~rdPs~RlSAed  287 (1431)
T KOG1240|consen  242 S--------QLLAYRSGNADDPEQLLEKIE--------------------------DVSLRNLILSMIQRDPSKRLSAED  287 (1431)
T ss_pred             H--------HHHhHhccCccCHHHHHHhCc--------------------------CccHHHHHHHHHccCchhccCHHH
Confidence            1        11110000  00111111000                          124668999999999999999999


Q ss_pred             HHHHHH
Q 037916          699 VVHELQ  704 (741)
Q Consensus       699 vl~~L~  704 (741)
                      .++...
T Consensus       288 yL~~yr  293 (1431)
T KOG1240|consen  288 YLQKYR  293 (1431)
T ss_pred             HHHhhh
Confidence            998843

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.77  E-value=5.3e-19  Score=188.10  Aligned_cols=220  Identities=23%  Similarity=0.338  Sum_probs=157.6

Q ss_pred             HHhcCCCceeeEeeeecCccccCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHh
Q 037916          451 LRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH  530 (741)
Q Consensus       451 l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~  530 (741)
                      |+.+.|.|+.++++.+..     +...++|.+||..|+|.+.+...         ...+++.-...++++++.||+|+|+
T Consensus         1 l~~l~h~n~~~f~g~~~~-----~~~~~~i~~~c~rGsl~D~i~~~---------~~~~d~~F~~s~~rdi~~Gl~ylh~   66 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVD-----GPEMIVIWEYCSRGSLLDILSNE---------DIKLDYFFILSFIRDISKGLAYLHN   66 (484)
T ss_pred             CcccchhhhhhheeeEec-----CCceEEEEeeecCccHHhHHhcc---------ccCccHHHHHHHHHHHHHHHHHHhc
Confidence            457899999999999753     35889999999999999999742         3557777788899999999999998


Q ss_pred             cCCCCc-eecCCCCCCeEeCCCCceEEeecccccccCCCCcccccccccccccccCcccccCC--C----CCCCccCchh
Q 037916          531 DCQPTT-AHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLG--S----EVSINGDVYS  603 (741)
Q Consensus       531 ~~~~~i-vHrDlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~--~----~~~~~~DIwS  603 (741)
                      .   .| .|+.+++.|.++|..+.+||+|||+.................-..-|.|||.+...  .    ..+.++||||
T Consensus        67 s---~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs  143 (484)
T KOG1023|consen   67 S---PIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYS  143 (484)
T ss_pred             C---cceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeeh
Confidence            8   55 99999999999999999999999998876531111111222345679999544322  1    1477899999


Q ss_pred             HHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhh
Q 037916          604 YGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGV  683 (741)
Q Consensus       604 lG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  683 (741)
                      ||++++|+++.+.||+........ .+.+..... .....+.                    +......+..+.+..++.
T Consensus       144 ~~ii~~ei~~r~~~~~~~~~~~~~-~eii~~~~~-~~~~~~r--------------------P~i~~~~e~~~~l~~l~~  201 (484)
T KOG1023|consen  144 FGIIMYEILFRSGPFDLRNLVEDP-DEIILRVKK-GGSNPFR--------------------PSIELLNELPPELLLLVA  201 (484)
T ss_pred             HHHHHHHHHhccCccccccccCCh-HHHHHHHHh-cCCCCcC--------------------cchhhhhhcchHHHHHHH
Confidence            999999999999999753322221 111111000 0000000                    000001144557889999


Q ss_pred             cccccCCCCCCCHHHHHHHHHHHHHh
Q 037916          684 ACSMESPQDRMNMTIVVHELQSIKSI  709 (741)
Q Consensus       684 ~cl~~dP~~RPs~~evl~~L~~i~~~  709 (741)
                      .||..+|++||++++|-..++.+...
T Consensus       202 ~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  202 RCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             HhcccChhhCccHHHHHhhhhhhccc
Confidence            99999999999999999988777653

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.77  E-value=1.1e-20  Score=167.01  Aligned_cols=157  Identities=33%  Similarity=0.556  Sum_probs=111.7

Q ss_pred             ccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCC
Q 037916          124 IGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLT  203 (741)
Q Consensus       124 ~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~  203 (741)
                      +..+.+.+.|.||+|+++ ..|..+..+.+|+.|++++|+|. .+|..++.+++|+.|+++-|++. ..|..|+.++.|+
T Consensus        29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le  105 (264)
T KOG0617|consen   29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE  105 (264)
T ss_pred             ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence            344566777777777777 44555677777788888888877 66777777888888888877776 6777888888888


Q ss_pred             EEeccCcccc-ccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCC
Q 037916          204 TINLSYNNLS-GTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGG  282 (741)
Q Consensus       204 ~L~L~~N~l~-~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  282 (741)
                      .|||.+|+++ ..+|..|+.++.|.- |+|+.|.+. .+|..++++++|+.|.+..|.+- ..|..++.++.|++|++.+
T Consensus       106 vldltynnl~e~~lpgnff~m~tlra-lyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqg  182 (264)
T KOG0617|consen  106 VLDLTYNNLNENSLPGNFFYMTTLRA-LYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQG  182 (264)
T ss_pred             hhhccccccccccCCcchhHHHHHHH-HHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccc
Confidence            8888888776 357778888888776 888888877 66777777777777776666655 2444555555555555555


Q ss_pred             CccC
Q 037916          283 NLFQ  286 (741)
Q Consensus       283 N~l~  286 (741)
                      |+++
T Consensus       183 nrl~  186 (264)
T KOG0617|consen  183 NRLT  186 (264)
T ss_pred             ceee
Confidence            5555

>PRK10345 hypothetical protein; Provisional

Probab=99.76  E-value=3.3e-18  Score=166.16  Aligned_cols=136  Identities=16%  Similarity=0.186  Sum_probs=103.3

Q ss_pred             hhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhc-----CCCceeeEeeeecCccccCCce-EE
Q 037916          405 LCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNI-----RHKNLVKILTVCSGVDYKGDDF-KA  478 (741)
Q Consensus       405 ~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~~~~~~~~~~~~~~~~-~~  478 (741)
                      .+.||+|+||.||.  +..++.. +||++........+.+.+|+.+++.+     .||||+++++++....  +... ..
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~--g~g~v~~   81 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC--GTGYVYD   81 (210)
T ss_pred             cceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC--CCeEEEE
Confidence            45799999999995  6555555 68988754444567789999999999     5799999999963211  1124 34


Q ss_pred             EEEec--ccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHH-HHHHhcCCCCceecCCCCCCeEeCC----C
Q 037916          479 LVYEF--MHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL-KYLHHDCQPTTAHCDLKPSNVLLDH----E  551 (741)
Q Consensus       479 lv~e~--~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL-~~LH~~~~~~ivHrDlkp~NIll~~----~  551 (741)
                      +||||  +.+++|.++++..           .+++.  ..++.|++.++ +|||+.   +|+||||||+||+++.    +
T Consensus        82 ~I~e~~G~~~~tL~~~l~~~-----------~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~  145 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQC-----------RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESE  145 (210)
T ss_pred             EEecCCCCcchhHHHHHHcc-----------cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCC
Confidence            78999  5578999999632           13333  35678888787 999999   9999999999999974    3


Q ss_pred             CceEEeeccc
Q 037916          552 MTAHVADFGL  561 (741)
Q Consensus       552 ~~~kL~DFg~  561 (741)
                      +.++|+||+.
T Consensus       146 ~~~~LiDg~G  155 (210)
T PRK10345        146 VIPVVCDNIG  155 (210)
T ss_pred             CcEEEEECCC
Confidence            4899999543

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.76  E-value=1.6e-18  Score=196.98  Aligned_cols=194  Identities=19%  Similarity=0.162  Sum_probs=150.6

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcC---CCceeeEeeeecCccccCCceE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIR---HKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      .|.|-+.||+|+||.||+|...+ |+.||+|+-+....-   +|.--.+++.+|+   -+-|..+...     +...+..
T Consensus       699 ~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a-----~~~~~~S  769 (974)
T KOG1166|consen  699 KFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSA-----HVFQNAS  769 (974)
T ss_pred             eEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHH-----HccCCcc
Confidence            46778899999999999999986 999999997643321   2223334455555   1233333333     2234456


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCC-------
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDH-------  550 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~-------  550 (741)
                      ++|+||.+.|+|.+++...          +.+++.-++.++.|++.-+++||..   +|||+||||+|+++..       
T Consensus       770 ~lv~ey~~~Gtlld~~N~~----------~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~  836 (974)
T KOG1166|consen  770 VLVSEYSPYGTLLDLINTN----------KVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSD  836 (974)
T ss_pred             eeeeeccccccHHHhhccC----------CCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCc
Confidence            8999999999999999633          6688888999999999999999999   9999999999999943       


Q ss_pred             CCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCC
Q 037916          551 EMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP  617 (741)
Q Consensus       551 ~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p  617 (741)
                      ...++|+|||.+..+.--.........++|-.+-.+ |+..|..|+..+|.|.++.+++.|+.|++-
T Consensus       837 ~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~-EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  837 SKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCI-EMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             ccceEEEecccceeeeEcCCCcEEeeeeccccchhH-HHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            347999999999776533223334456788888889 777899999999999999999999999853

>smart00090 RIO RIO-like kinase

Probab=99.75  E-value=7.3e-18  Score=168.13  Aligned_cols=144  Identities=17%  Similarity=0.105  Sum_probs=110.9

Q ss_pred             HHHHhhhcccCceeeEEEEE-EcCCCeEEEEEEeeccCcCc------------------------chhHHHHHHHHHhcC
Q 037916          401 SFLFLCWIDMGSFGSVYKGI-LDEGKTIIAVKVLNLLHHGA------------------------SKSSIAECSALRNIR  455 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~-~~~~~~~vavK~~~~~~~~~------------------------~~~~~~E~~~l~~l~  455 (741)
                      .|.+.+.||+|++|.||+|. +..+|+.||+|+++......                        ...+.+|+..++++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            48889999999999999999 65689999999997432100                        012467999999997


Q ss_pred             C--CceeeEeeeecCccccCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCC
Q 037916          456 H--KNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQ  533 (741)
Q Consensus       456 h--pnIv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~  533 (741)
                      +  ..+++++++         ...++||||+++.++..+....          ......+...++.|++.++.+||+.  
T Consensus       109 ~~~i~~p~~~~~---------~~~~lV~E~~~g~~L~~~~~~~----------~~~~~~~~~~i~~qi~~~l~~LH~~--  167 (237)
T smart00090      109 EAGVPVPKPIAW---------RRNVLVMEFIGGDGLPAPRLKD----------VEPEEEEEFELYDDILEEMRKLYKE--  167 (237)
T ss_pred             hcCCCCCeeeEe---------cCceEEEEEecCCccccccccc----------CCcchHHHHHHHHHHHHHHHHHHhc--
Confidence            5  334455543         1248999999888887654211          2244556678999999999999999  


Q ss_pred             CC-ceecCCCCCCeEeCCCCceEEeecccccccCC
Q 037916          534 PT-TAHCDLKPSNVLLDHEMTAHVADFGLAKLLPP  567 (741)
Q Consensus       534 ~~-ivHrDlkp~NIll~~~~~~kL~DFg~a~~~~~  567 (741)
                       | |+||||||+||+++ ++.++|+|||.+.....
T Consensus       168 -g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~~  200 (237)
T smart00090      168 -GELVHGDLSEYNILVH-DGKVVIIDVSQSVELDH  200 (237)
T ss_pred             -CCEEeCCCChhhEEEE-CCCEEEEEChhhhccCC
Confidence             9 99999999999999 88999999999875443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.74  E-value=6.2e-19  Score=187.04  Aligned_cols=185  Identities=28%  Similarity=0.305  Sum_probs=150.9

Q ss_pred             cccCceeeEEEEEE---cCCCeEEEEEEeeccCcCc--chhHHHHHHHHHhcC-CCceeeEeeeecCccccCCceEEEEE
Q 037916          408 IDMGSFGSVYKGIL---DEGKTIIAVKVLNLLHHGA--SKSSIAECSALRNIR-HKNLVKILTVCSGVDYKGDDFKALVY  481 (741)
Q Consensus       408 ig~G~~g~V~~a~~---~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~~~~lv~  481 (741)
                      +|+|+||.|++++-   .+.+.-+|+|+.++.....  ......|..++...+ ||.+|++...     ++.+...++++
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhya-----fqt~~kl~l~l   76 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYA-----FQTDGKLYLIL   76 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeee-----eccccchhHhh
Confidence            68999999987643   3467789999987433221  124455777788886 9999999887     66777899999


Q ss_pred             ecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeeccc
Q 037916          482 EFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGL  561 (741)
Q Consensus       482 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~  561 (741)
                      +|..||.+...+...          ..+.+.....+...++-|++++|+.   +|+|||+|++||+++.+|++++.|||.
T Consensus        77 d~~rgg~lft~l~~~----------~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfgl  143 (612)
T KOG0603|consen   77 DFLRGGDLFTRLSKE----------VMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGL  143 (612)
T ss_pred             hhcccchhhhccccC----------CchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchh
Confidence            999999998887644          4566777778888999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCC
Q 037916          562 AKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSD  619 (741)
Q Consensus       562 a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~  619 (741)
                      ++..-.....      +||..|||||.. .  .....+|.||||++++||+||..||.
T Consensus       144 ske~v~~~~~------cgt~eymApEI~-~--gh~~a~D~ws~gvl~felltg~~pf~  192 (612)
T KOG0603|consen  144 SKEAVKEKIA------CGTYEYRAPEII-N--GHLSAADWWSFGVLAFELLTGTLPFG  192 (612)
T ss_pred             hhHhHhhhhc------ccchhhhhhHhh-h--ccCCcccchhhhhhHHHHhhCCCCCc
Confidence            9876544322      689999999544 3  55688999999999999999999986

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.68  E-value=4.7e-18  Score=177.02  Aligned_cols=124  Identities=26%  Similarity=0.448  Sum_probs=104.5

Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      +.||.|++|...+|.+|+...+.       ....++.....++.|++.|++|   +   +.+|||+||.||+...+..+|
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~-------~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~k  396 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRT-------GEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLK  396 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCc-------ccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhh
Confidence            57899999999999999974422       2446777889999999999999   7   999999999999999999999


Q ss_pred             EeecccccccCCCC----cccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc
Q 037916          556 VADFGLAKLLPPAH----LQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT  613 (741)
Q Consensus       556 L~DFg~a~~~~~~~----~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt  613 (741)
                      |+|||+........    .....+...||..||+||++ .+..|+.|+||||+|++++|++.
T Consensus       397 IgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi-~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  397 IGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQI-RGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             hhhhhheeecccCCcccchhhhhhhcccccccCCHHHH-hhhhhhhhcchhhHHHHHHHHHH
Confidence            99999988766544    12233445699999999655 67889999999999999999988

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.68  E-value=2.5e-16  Score=153.84  Aligned_cols=136  Identities=16%  Similarity=0.120  Sum_probs=106.8

Q ss_pred             HHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcC----------------------cchhHHHHHHHHHhcCCC--
Q 037916          402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG----------------------ASKSSIAECSALRNIRHK--  457 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l~hp--  457 (741)
                      |.+.+.||+|+||.||+|... +++.||||+++.....                      .......|+.++..+.|+  
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            888899999999999999886 7999999997642210                      011356788888888777  


Q ss_pred             ceeeEeeeecCccccCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCce
Q 037916          458 NLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTA  537 (741)
Q Consensus       458 nIv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~iv  537 (741)
                      .+++.++.         ...++||||++|++|......                .....++.+++.++.++|+.   ||+
T Consensus        96 ~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~~----------------~~~~~~~~~i~~~l~~lh~~---gi~  147 (198)
T cd05144          96 PVPKPIDW---------NRHAVVMEYIDGVELYRVRVL----------------EDPEEVLDEILEEIVKAYKH---GII  147 (198)
T ss_pred             CCCceeec---------CCceEEEEEeCCcchhhcccc----------------ccHHHHHHHHHHHHHHHHHC---CCC
Confidence            44444432         235899999999998765420                13456889999999999999   999


Q ss_pred             ecCCCCCCeEeCCCCceEEeecccccccC
Q 037916          538 HCDLKPSNVLLDHEMTAHVADFGLAKLLP  566 (741)
Q Consensus       538 HrDlkp~NIll~~~~~~kL~DFg~a~~~~  566 (741)
                      ||||||+||++++++.++|+|||.+....
T Consensus       148 H~Dl~p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         148 HGDLSEFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             cCCCCcccEEEcCCCcEEEEECCccccCC
Confidence            99999999999999999999999986443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.68  E-value=1.2e-17  Score=185.77  Aligned_cols=164  Identities=29%  Similarity=0.347  Sum_probs=117.9

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      ..|..++.|..|+||.||..+++.+.+++|+|+-+. .     .+.+-  ++.....|.                    .
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq-~-----lilRn--ilt~a~npf--------------------v  134 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ-N-----LILRN--ILTFAGNPF--------------------V  134 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhccccc-c-----hhhhc--cccccCCcc--------------------e
Confidence            457889999999999999999999999999965331 1     01000  122222222                    2


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      |      |+=...++..          ..++.        +++.+++|+|+.   ||+|||+||+|.+|..-|++|++||
T Consensus       135 v------gDc~tllk~~----------g~lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDf  187 (1205)
T KOG0606|consen  135 V------GDCATLLKNI----------GPLPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDF  187 (1205)
T ss_pred             e------chhhhhcccC----------CCCcc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccch
Confidence            2      2323333221          11211        237899999999   9999999999999999999999999


Q ss_pred             ccccccCCC--------C-----cccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCC
Q 037916          560 GLAKLLPPA--------H-----LQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSD  619 (741)
Q Consensus       560 g~a~~~~~~--------~-----~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~  619 (741)
                      |+++.....        .     .......++||+.|+|| |+.....|+..+|+|++|+|+||.+.|..||.
T Consensus       188 gLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaP-eVilrqgygkpvdwwamGiIlyeFLVgcvpff  259 (1205)
T KOG0606|consen  188 GLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAP-EVILRQGYGKPVDWWAMGIILYEFLVGCVPFF  259 (1205)
T ss_pred             hhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccCh-hhhhhhccCCCccHHHHHHHHHHHheeeeecc
Confidence            998764321        0     11123346799999999 55566789999999999999999999999986

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.68  E-value=2.6e-16  Score=155.70  Aligned_cols=134  Identities=17%  Similarity=0.225  Sum_probs=106.9

Q ss_pred             hhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCc--------chhHHHHHHHHHhcCCCceeeEeeeecCccccCCceE
Q 037916          406 CWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGA--------SKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       406 ~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      +.||+|++|.||+|.+  .+..|++|+........        ...+.+|+.++..+.|++|+....++.     +....
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-----~~~~~   74 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFV-----DPENF   74 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEE-----eCCCC
Confidence            5789999999999988  46778999865322111        134678999999999888765555532     23467


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      +++|||++|++|.+++...             .. ....++.+++.+|.++|+.   +++|||++|+||+++ ++.++|+
T Consensus        75 ~lv~e~~~G~~L~~~~~~~-------------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~li  136 (211)
T PRK14879         75 IIVMEYIEGEPLKDLINSN-------------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLI  136 (211)
T ss_pred             EEEEEEeCCcCHHHHHHhc-------------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEE
Confidence            8999999999999987522             11 6778999999999999999   999999999999999 7899999


Q ss_pred             ecccccc
Q 037916          558 DFGLAKL  564 (741)
Q Consensus       558 DFg~a~~  564 (741)
                      |||.+..
T Consensus       137 Df~~a~~  143 (211)
T PRK14879        137 DFGLAEF  143 (211)
T ss_pred             ECCcccC
Confidence            9998763

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.65  E-value=1.8e-17  Score=185.46  Aligned_cols=257  Identities=21%  Similarity=0.216  Sum_probs=190.1

Q ss_pred             HHHHhhhcccCceeeEEEEEEc-CCCeEEEEEEeeccC--cCcchhHHHHHHHHHhcC-CCceeeEeeeecCccccCCce
Q 037916          401 SFLFLCWIDMGSFGSVYKGILD-EGKTIIAVKVLNLLH--HGASKSSIAECSALRNIR-HKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      .|.+.+.||+|+|+.|-.+... .....+|.|.+....  ....+....|..+-+.+. |+|++++++.     ....+.
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~-----~~~~~~   95 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEP-----SSSPRS   95 (601)
T ss_pred             cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCc-----cCCCcc
Confidence            4677788999999999888773 344556777665332  222333345666666665 9999999998     566778


Q ss_pred             EEEEEecccCCChhhhc-cCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHH-hcCCCCceecCCCCCCeEeCCCC-c
Q 037916          477 KALVYEFMHNGSLEEWL-HPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH-HDCQPTTAHCDLKPSNVLLDHEM-T  553 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~~~~ivHrDlkp~NIll~~~~-~  553 (741)
                      .+++++|..|+++.+.+ ...         ....+......++.|+..++.|+| ..   ++.|||+||+|.+++..+ .
T Consensus        96 ~~~~~~~s~g~~~f~~i~~~~---------~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~  163 (601)
T KOG0590|consen   96 YLLSLSYSDGGSLFSKISHPD---------STGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSA  163 (601)
T ss_pred             cccccCcccccccccccccCC---------ccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCc
Confidence            99999999999998888 322         113444556678999999999999 88   999999999999999999 9


Q ss_pred             eEEeecccccccCC-CCcccccccccc-cccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhh
Q 037916          554 AHVADFGLAKLLPP-AHLQTSSIGVKG-TIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNF  631 (741)
Q Consensus       554 ~kL~DFg~a~~~~~-~~~~~~~~~~~g-t~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~  631 (741)
                      .+++|||+|..... ...........| ++.|+|||.........+..|+||.|+++..+++|..||+........+..|
T Consensus       164 l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~  243 (601)
T KOG0590|consen  164 LKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSW  243 (601)
T ss_pred             ccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceee
Confidence            99999999988876 444444455668 9999999655544677889999999999999999999998665555444444


Q ss_pred             hhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          632 ARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       632 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      ...........                            .........+++.+++..+|+.|.+.+++...
T Consensus       244 ~~~~~~~~~~~----------------------------~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d  286 (601)
T KOG0590|consen  244 KSNKGRFTQLP----------------------------WNSISDQAHDLLHKILKENPSNRLSIEELKLD  286 (601)
T ss_pred             cccccccccCc----------------------------cccCChhhhhcccccccCCchhcccccccccc
Confidence            43321100000                            01223345688889999999999999887643

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.64  E-value=8.6e-16  Score=150.46  Aligned_cols=130  Identities=19%  Similarity=0.229  Sum_probs=100.2

Q ss_pred             hcccCceeeEEEEEEcCCCeEEEEEEeeccCcC--------cchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          407 WIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG--------ASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       407 ~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      .||+|+||.||+|.+  .+..|++|+.......        ...++.+|+.+++.+.|+++.....++.     .....+
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-----~~~~~~   73 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDV-----DPDNKT   73 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEE-----ECCCCE
Confidence            389999999999996  4678999986532111        1245568999999998876443333321     233568


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      +||||++|++|.+++...          ..       .++.|++.+|.++|+.   |++|||++|+||+++ ++.++++|
T Consensus        74 lv~e~~~g~~l~~~~~~~----------~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liD  132 (199)
T TIGR03724        74 IVMEYIEGKPLKDVIEEG----------ND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLID  132 (199)
T ss_pred             EEEEEECCccHHHHHhhc----------HH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEE
Confidence            999999999999887421          10       6899999999999999   999999999999999 78999999


Q ss_pred             cccccc
Q 037916          559 FGLAKL  564 (741)
Q Consensus       559 Fg~a~~  564 (741)
                      ||.+..
T Consensus       133 fg~a~~  138 (199)
T TIGR03724       133 FGLGKY  138 (199)
T ss_pred             CCCCcC
Confidence            998764

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.62  E-value=1.5e-15  Score=170.99  Aligned_cols=134  Identities=21%  Similarity=0.220  Sum_probs=104.7

Q ss_pred             HHHhhhcccCceeeEEEEEEcCCCeEEEEEEeec--cCcC------cchhHHHHHHHHHhcCCCceeeEeeeecCccccC
Q 037916          402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNL--LHHG------ASKSSIAECSALRNIRHKNLVKILTVCSGVDYKG  473 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~--~~~~------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  473 (741)
                      |...+.||+|+||.||+|.+...  .+++|+...  ....      ..+++.+|+.+++.++|++++....++.     .
T Consensus       335 ~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-----~  407 (535)
T PRK09605        335 KIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDV-----D  407 (535)
T ss_pred             cCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEE-----e
Confidence            35578899999999999998633  344443321  1111      1245778999999999999887666532     2


Q ss_pred             CceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCc
Q 037916          474 DDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMT  553 (741)
Q Consensus       474 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~  553 (741)
                      ....++||||+++++|.+++.                  ....++.|++++|.+||+.   +++|||+||+||++ .++.
T Consensus       408 ~~~~~lv~E~~~g~~L~~~l~------------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~  465 (535)
T PRK09605        408 PEEKTIVMEYIGGKDLKDVLE------------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDR  465 (535)
T ss_pred             CCCCEEEEEecCCCcHHHHHH------------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCc
Confidence            335689999999999988773                  2467899999999999999   99999999999999 6779


Q ss_pred             eEEeecccccc
Q 037916          554 AHVADFGLAKL  564 (741)
Q Consensus       554 ~kL~DFg~a~~  564 (741)
                      ++|+|||+++.
T Consensus       466 ~~liDFGla~~  476 (535)
T PRK09605        466 LYLIDFGLGKY  476 (535)
T ss_pred             EEEEeCccccc
Confidence            99999999874

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.60  E-value=3.7e-15  Score=144.41  Aligned_cols=136  Identities=19%  Similarity=0.169  Sum_probs=96.9

Q ss_pred             hhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCc--chh----------------------HHHHHHHHHhcCCC--c
Q 037916          405 LCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGA--SKS----------------------SIAECSALRNIRHK--N  458 (741)
Q Consensus       405 ~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~E~~~l~~l~hp--n  458 (741)
                      .+.||+|+||.||+|.+. +++.||+|+++......  ...                      ...|...+.++.+.  .
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            467999999999999987 78999999987432111  111                      13455555555433  2


Q ss_pred             eeeEeeeecCccccCCceEEEEEecccCCChhhh-ccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHh-cCCCCc
Q 037916          459 LVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEW-LHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH-DCQPTT  536 (741)
Q Consensus       459 Iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~i  536 (741)
                      +.+.+++         ...++||||++++++... +...            ....+...++.+++.++.++|. .   +|
T Consensus        81 ~~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~~------------~~~~~~~~~~~~~~~~l~~lh~~~---~i  136 (187)
T cd05119          81 VPKPIDL---------NRHVLVMEFIGGDGIPAPRLKDV------------RLLEDPEELYDQILELMRKLYREA---GL  136 (187)
T ss_pred             CCceEec---------CCCEEEEEEeCCCCccChhhhhh------------hhcccHHHHHHHHHHHHHHHhhcc---Cc
Confidence            4444443         135899999988554321 1110            0014567899999999999999 8   99


Q ss_pred             eecCCCCCCeEeCCCCceEEeecccccccC
Q 037916          537 AHCDLKPSNVLLDHEMTAHVADFGLAKLLP  566 (741)
Q Consensus       537 vHrDlkp~NIll~~~~~~kL~DFg~a~~~~  566 (741)
                      +||||||+||+++ ++.++|+|||.+....
T Consensus       137 vH~Dl~p~Nili~-~~~~~liDfg~a~~~~  165 (187)
T cd05119         137 VHGDLSEYNILVD-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             CcCCCChhhEEEE-CCcEEEEECccccccc
Confidence            9999999999999 8899999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.56  E-value=2.9e-14  Score=132.83  Aligned_cols=135  Identities=21%  Similarity=0.217  Sum_probs=109.5

Q ss_pred             HhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCC--CceeeEeeeecCccccCCceEEEEE
Q 037916          404 FLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRH--KNLVKILTVCSGVDYKGDDFKALVY  481 (741)
Q Consensus       404 ~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~~~~~~~~~~~lv~  481 (741)
                      +++.||+|.++.||++....  ..+++|..+....  ...+.+|+.+++.+.|  .++++++++     ....+..+++|
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~-----~~~~~~~~~v~   72 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLAS-----GESDGWSYLLM   72 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEE-----cCCCCccEEEE
Confidence            35789999999999999863  6789999864322  4578899999999976  588898887     34446789999


Q ss_pred             ecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeeccc
Q 037916          482 EFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGL  561 (741)
Q Consensus       482 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~  561 (741)
                      ||++++++..+                 +......++.+++++++++|.....+++|+|++|+||+++..+.++++|||.
T Consensus        73 e~~~g~~~~~~-----------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~  135 (155)
T cd05120          73 EWIEGETLDEV-----------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEY  135 (155)
T ss_pred             EecCCeecccC-----------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccc
Confidence            99988766543                 3345567899999999999986334799999999999999989999999998


Q ss_pred             ccc
Q 037916          562 AKL  564 (741)
Q Consensus       562 a~~  564 (741)
                      +..
T Consensus       136 ~~~  138 (155)
T cd05120         136 AGY  138 (155)
T ss_pred             ccC
Confidence            864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.53  E-value=6.2e-14  Score=140.23  Aligned_cols=138  Identities=14%  Similarity=0.061  Sum_probs=102.1

Q ss_pred             hcc-cCceeeEEEEEEcCCCeEEEEEEeeccC-------------cCcchhHHHHHHHHHhcCCCce--eeEeeeecCcc
Q 037916          407 WID-MGSFGSVYKGILDEGKTIIAVKVLNLLH-------------HGASKSSIAECSALRNIRHKNL--VKILTVCSGVD  470 (741)
Q Consensus       407 ~ig-~G~~g~V~~a~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~hpnI--v~~~~~~~~~~  470 (741)
                      .|| .|+.|+||.+...  +..+|+|.+....             ......+.+|+.++.++.|++|  ++.++++....
T Consensus        38 ~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         38 VVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             eeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            477 7889999998875  6778999885211             0123456789999999988774  66776632211


Q ss_pred             ccCCceEEEEEecccC-CChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeC
Q 037916          471 YKGDDFKALVYEFMHN-GSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLD  549 (741)
Q Consensus       471 ~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~  549 (741)
                       ......++|||+++| .+|.+++...           .++..    .+.+++.++.+||+.   ||+||||||+|||++
T Consensus       116 -~~~~~~~lV~e~l~G~~~L~~~l~~~-----------~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~  176 (239)
T PRK01723        116 -GLFYRADILIERIEGARDLVALLQEA-----------PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLD  176 (239)
T ss_pred             -CcceeeeEEEEecCCCCCHHHHHhcC-----------CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEc
Confidence             111124699999987 6898887521           12322    367899999999999   999999999999999


Q ss_pred             CCCceEEeeccccccc
Q 037916          550 HEMTAHVADFGLAKLL  565 (741)
Q Consensus       550 ~~~~~kL~DFg~a~~~  565 (741)
                      .++.++|+|||.+...
T Consensus       177 ~~~~v~LIDfg~~~~~  192 (239)
T PRK01723        177 PDGKFWLIDFDRGELR  192 (239)
T ss_pred             CCCCEEEEECCCcccC
Confidence            9899999999988753

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.52  E-value=6.8e-16  Score=160.86  Aligned_cols=191  Identities=34%  Similarity=0.490  Sum_probs=149.4

Q ss_pred             ccEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcc
Q 037916           81 LKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAIN  160 (741)
Q Consensus        81 L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~  160 (741)
                      -...||+.|++. .+|..++.+. .|+.+.|..|.| ..+|..+.+|..|+.|||+.|+++ ..|..++.|+ |+.|-++
T Consensus        77 t~~aDlsrNR~~-elp~~~~~f~-~Le~liLy~n~~-r~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~s  151 (722)
T KOG0532|consen   77 TVFADLSRNRFS-ELPEEACAFV-SLESLILYHNCI-RTIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVS  151 (722)
T ss_pred             hhhhhccccccc-cCchHHHHHH-HHHHHHHHhccc-eecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEe
Confidence            567788888887 6777777777 788888888887 778888888888899999999988 5566677776 8899999


Q ss_pred             cCCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCC
Q 037916          161 TNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGS  240 (741)
Q Consensus       161 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~  240 (741)
                      +|+++ .+|+.++.+..|..||.+.|.|. .+|..++++.+|+.|.+..|++. .+|+.+..|+ |.. ||+|.|++. .
T Consensus       152 NNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~Lp-Li~-lDfScNkis-~  225 (722)
T KOG0532|consen  152 NNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLP-LIR-LDFSCNKIS-Y  225 (722)
T ss_pred             cCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCc-eee-eecccCcee-e
Confidence            99998 67778888888999999999888 67778888889999999999988 7888888654 444 899999988 7


Q ss_pred             CChhhcCCCCCcEEEeccccccchhhhhcccccc---ccEEEeCCC
Q 037916          241 LPTEVGKLINLEILFISRNMLECEILSTLGSCIK---LEQLKLGGN  283 (741)
Q Consensus       241 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~---L~~L~L~~N  283 (741)
                      +|-.|.+|+.|++|-|.+|.|.. +|..++...+   -++|+..-+
T Consensus       226 iPv~fr~m~~Lq~l~LenNPLqS-PPAqIC~kGkVHIFKyL~~qA~  270 (722)
T KOG0532|consen  226 LPVDFRKMRHLQVLQLENNPLQS-PPAQICEKGKVHIFKYLSTQAC  270 (722)
T ss_pred             cchhhhhhhhheeeeeccCCCCC-ChHHHHhccceeeeeeecchhc
Confidence            88888888888888888888873 4444443222   244554444

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.52  E-value=6.1e-16  Score=161.20  Aligned_cols=183  Identities=28%  Similarity=0.389  Sum_probs=128.0

Q ss_pred             cCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCE
Q 037916          125 GKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTT  204 (741)
Q Consensus       125 ~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~  204 (741)
                      ..|..-...||+.|++. .+|..+..+..|+.|.|..|.|. .+|.++.++..|++|||+.|+++ ..|..++.|+ |+.
T Consensus        72 ~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkv  147 (722)
T KOG0532|consen   72 YDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKV  147 (722)
T ss_pred             ccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-cee
Confidence            34445566777777777 55666666777777777777776 66777777777777777777776 5666666654 777


Q ss_pred             EeccCccccccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCc
Q 037916          205 INLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNL  284 (741)
Q Consensus       205 L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  284 (741)
                      |-+++|+++ .+|+.++.+..|.. ||.+.|.|. .+|..++.+.+|+.|.+..|++... |..+..|+ |..||+|.|+
T Consensus       148 li~sNNkl~-~lp~~ig~~~tl~~-ld~s~nei~-slpsql~~l~slr~l~vrRn~l~~l-p~El~~Lp-Li~lDfScNk  222 (722)
T KOG0532|consen  148 LIVSNNKLT-SLPEEIGLLPTLAH-LDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLEDL-PEELCSLP-LIRLDFSCNK  222 (722)
T ss_pred             EEEecCccc-cCCcccccchhHHH-hhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhhhC-CHHHhCCc-eeeeecccCc
Confidence            777777776 77777777677765 777777777 5666777777777777777777743 33444443 7777777777


Q ss_pred             cCCCCChhcccCccCCeeeCCCCcCCCccchhhh
Q 037916          285 FQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLV  318 (741)
Q Consensus       285 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  318 (741)
                      ++ .+|-.|..|+.|++|-|.+|.|. .+|..++
T Consensus       223 is-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC  254 (722)
T KOG0532|consen  223 IS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQIC  254 (722)
T ss_pred             ee-ecchhhhhhhhheeeeeccCCCC-CChHHHH
Confidence            77 57777777777777777777777 4555543

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.50  E-value=3.2e-15  Score=146.04  Aligned_cols=195  Identities=20%  Similarity=0.290  Sum_probs=134.4

Q ss_pred             eEEEEEEcCCCeEEEEEEeeccCcC----cchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEEEecccCCChh
Q 037916          415 SVYKGILDEGKTIIAVKVLNLLHHG----ASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLE  490 (741)
Q Consensus       415 ~V~~a~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~  490 (741)
                      .||.+.++..|.+|+.-.+......    ..+....-+..+-++.|.|+|+++.|+.+..+++.....+++|||..|++.
T Consensus        81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~  160 (458)
T KOG1266|consen   81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK  160 (458)
T ss_pred             HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence            3566666666665554333211111    111122233445566899999999999888877888899999999999999


Q ss_pred             hhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecccccccC--CC
Q 037916          491 EWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP--PA  568 (741)
Q Consensus       491 ~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~a~~~~--~~  568 (741)
                      +++++.+..      ...+......+|+.||+.||.|||+. .|.|+|+++..+-|++..+|-+|++--.-.....  ..
T Consensus       161 ~fLkrt~~~------~~a~~~~~wkkw~tqIlsal~yLhs~-~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~  233 (458)
T KOG1266|consen  161 QFLKRTKKN------QKALFQKAWKKWCTQILSALSYLHSC-DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNS  233 (458)
T ss_pred             HHHHHHHHh------hhhhhHHHHHHHHHHHHhhhhhhhcc-CCccccCCcchhheeecCCceEEecccCccccchhhhh
Confidence            999754322      24466677789999999999999987 8999999999999999999988875211111000  00


Q ss_pred             CcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCC
Q 037916          569 HLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP  617 (741)
Q Consensus       569 ~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p  617 (741)
                      ..........+-++|.|| ++......+.++|||+||+...||..+..-
T Consensus       234 ~~~~Ek~~~~~~~g~~a~-~sg~~tn~~~a~dIy~fgmcAlemailEiq  281 (458)
T KOG1266|consen  234 TREAEKSVNTSLPGFSAP-ESGTTTNTTGASDIYKFGMCALEMAILEIQ  281 (458)
T ss_pred             hhHhhhhccccCCccccC-CcCcccccccchhhhhhhHHHHHHHHheec
Confidence            001111112367789999 665555667889999999999999887653

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.49  E-value=3.3e-14  Score=154.88  Aligned_cols=200  Identities=34%  Similarity=0.473  Sum_probs=115.1

Q ss_pred             EEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCC-cCcEEEcccCCCCCcCcccccCCcccceeeccCc
Q 037916          108 TLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQ-NLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIEN  186 (741)
Q Consensus       108 ~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  186 (741)
                      .++++.|.+. .....+..++.++.|++.+|.++.+ +.....+. +|+.|++++|++. .+|..+..+++|+.|++++|
T Consensus        97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~~i-~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N  173 (394)
T COG4886          97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNITDI-PPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN  173 (394)
T ss_pred             eeeccccccc-cCchhhhcccceeEEecCCcccccC-ccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence            3555555541 1222333445566666666666633 23333342 5666666666665 34445566666666666666


Q ss_pred             ccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccchhh
Q 037916          187 FLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEIL  266 (741)
Q Consensus       187 ~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~  266 (741)
                      +++ .+|.....+++|+.|++++|+++ .+|........|.+ |++++|.+. ..+..+.++.++..|.+++|++... +
T Consensus       174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~-l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~~-~  248 (394)
T COG4886         174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEE-LDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDL-P  248 (394)
T ss_pred             hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhh-hhhcCCcce-ecchhhhhcccccccccCCceeeec-c
Confidence            666 33333335566666666666666 55554444444555 666666433 3445566666666666666666532 5


Q ss_pred             hhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccchhh
Q 037916          267 STLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFL  317 (741)
Q Consensus       267 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~  317 (741)
                      ..++.+++|+.|++++|+++.+..  +..+.+|+.|++++|.++..+|...
T Consensus       249 ~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~  297 (394)
T COG4886         249 ESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIA  297 (394)
T ss_pred             chhccccccceecccccccccccc--ccccCccCEEeccCccccccchhhh
Confidence            556666667777777777774433  6667777777777777765555443

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.47  E-value=1e-13  Score=151.00  Aligned_cols=201  Identities=32%  Similarity=0.480  Sum_probs=138.3

Q ss_pred             EEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCC-CccEEEcccccccccCCccccCCCcCcEEEccc
Q 037916           83 HLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFI-NLQTLHMWDNQLSGTISPAIGELQNLVTLAINT  161 (741)
Q Consensus        83 ~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~-~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~  161 (741)
                      .|+++.|.+... ......+. .++.|++.+|.++. ++.....+. +|+.|++++|+|.. ++..+..+++|+.|++++
T Consensus        97 ~l~~~~~~~~~~-~~~~~~~~-~l~~L~l~~n~i~~-i~~~~~~~~~nL~~L~l~~N~i~~-l~~~~~~l~~L~~L~l~~  172 (394)
T COG4886          97 SLDLNLNRLRSN-ISELLELT-NLTSLDLDNNNITD-IPPLIGLLKSNLKELDLSDNKIES-LPSPLRNLPNLKNLDLSF  172 (394)
T ss_pred             eeeccccccccC-chhhhccc-ceeEEecCCccccc-Cccccccchhhcccccccccchhh-hhhhhhccccccccccCC
Confidence            577777776422 22333444 67777777777744 444455553 78888888888773 335677778888888888


Q ss_pred             CCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCCC
Q 037916          162 NKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSL  241 (741)
Q Consensus       162 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~  241 (741)
                      |+++ .+|.....+++|+.|++++|+++ .+|.....+..|++|.+++|++. ..+..+.++..+.. +.+++|++. ..
T Consensus       173 N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~-l~l~~n~~~-~~  247 (394)
T COG4886         173 NDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSG-LELSNNKLE-DL  247 (394)
T ss_pred             chhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccc-cccCCceee-ec
Confidence            8887 44555556777888888888887 45555445556888888888654 56667777777776 777888776 34


Q ss_pred             ChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCccCCCCChhcc
Q 037916          242 PTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLS  294 (741)
Q Consensus       242 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  294 (741)
                      +..++.+++++.|++++|.++.+..  +..+.+|+.|++++|.+....+....
T Consensus       248 ~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~~  298 (394)
T COG4886         248 PESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIAL  298 (394)
T ss_pred             cchhccccccceecccccccccccc--ccccCccCEEeccCccccccchhhhc
Confidence            6677777888888888888886555  77778888888888888766554443

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.37  E-value=1.5e-12  Score=141.75  Aligned_cols=142  Identities=20%  Similarity=0.179  Sum_probs=97.1

Q ss_pred             hhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcc----------------------------------------hhHH
Q 037916          406 CWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGAS----------------------------------------KSSI  445 (741)
Q Consensus       406 ~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~  445 (741)
                      +.||.|++|.||+|+.+ +|+.||||+.+.......                                        -++.
T Consensus       123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            56999999999999987 789999999864211000                                        0234


Q ss_pred             HHHHHHHhc----CCCceeeEeeeecCccccCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHH
Q 037916          446 AECSALRNI----RHKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDV  521 (741)
Q Consensus       446 ~E~~~l~~l----~hpnIv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi  521 (741)
                      +|+..+.++    +|..-+.+-.++.    ......++||||++|++|.++.....         ...   ....++.++
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~----~~~~~~vLvmE~i~G~~L~~~~~~~~---------~~~---~~~~ia~~~  265 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYW----DRTSERVLTMEWIDGIPLSDIAALDE---------AGL---DRKALAENL  265 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEeh----hhcCCceEEEEeECCcccccHHHHHh---------cCC---CHHHHHHHH
Confidence            455555554    2322233333321    12234689999999999988754210         011   123466666


Q ss_pred             HH-HHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecccccccCC
Q 037916          522 AC-ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPP  567 (741)
Q Consensus       522 ~~-aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~a~~~~~  567 (741)
                      +. .+..+|..   |++|+|++|.||+++.++.++++|||++...++
T Consensus       266 ~~~~l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       266 ARSFLNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             HHHHHHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            65 46788988   999999999999999999999999999976643

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.36  E-value=6.7e-13  Score=141.73  Aligned_cols=199  Identities=24%  Similarity=0.291  Sum_probs=155.3

Q ss_pred             HHHHhhhccc--CceeeEEEEEE--cCCCeEEEEEEeeccCc--CcchhHHHHHHHHHhc-CCCceeeEeeeecCccccC
Q 037916          401 SFLFLCWIDM--GSFGSVYKGIL--DEGKTIIAVKVLNLLHH--GASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKG  473 (741)
Q Consensus       401 ~y~~~~~ig~--G~~g~V~~a~~--~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~  473 (741)
                      ++.+.+.+|.  |.+|.||.+..  ..++..+|+|.-+....  ....+-.+|+...+.+ .|++.++.+..     +++
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~-----~e~  189 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA-----WEG  189 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcc-----ccc
Confidence            4567788999  99999999998  88899999998542222  3334445677666666 58999997666     667


Q ss_pred             CceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHH----HHHHHHhcCCCCceecCCCCCCeEeC
Q 037916          474 DDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC----ALKYLHHDCQPTTAHCDLKPSNVLLD  549 (741)
Q Consensus       474 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~----aL~~LH~~~~~~ivHrDlkp~NIll~  549 (741)
                      .+..++-+|++ +.++.++.+..         ...++....+....+...    |+.++|+.   .++|-|+||+||+..
T Consensus       190 ~~~lfiqtE~~-~~sl~~~~~~~---------~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~  256 (524)
T KOG0601|consen  190 SGILFIQTELC-GESLQSYCHTP---------CNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTT  256 (524)
T ss_pred             CCcceeeeccc-cchhHHhhhcc---------cccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecc
Confidence            77899999998 57888887632         233566677788888888    99999999   999999999999999


Q ss_pred             CC-CceEEeecccccccCCCCccccc---ccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCC
Q 037916          550 HE-MTAHVADFGLAKLLPPAHLQTSS---IGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSD  619 (741)
Q Consensus       550 ~~-~~~kL~DFg~a~~~~~~~~~~~~---~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~  619 (741)
                      .+ ...+++|||....+.+.......   ....|...|++|| +. .+-++.+.|||++|.++.+..++..+..
T Consensus       257 ~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke-~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~  328 (524)
T KOG0601|consen  257 SDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKE-LL-NGLATFASDIFSLGEVILEAILGSHLPS  328 (524)
T ss_pred             cccceeecCCcceeEEccCCccccceeeeecCCCCceEeChh-hh-ccccchHhhhcchhhhhHhhHhhccccc
Confidence            99 78999999999888766532221   2224778899994 43 5678899999999999999999877643

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.32  E-value=5.2e-13  Score=128.87  Aligned_cols=205  Identities=24%  Similarity=0.203  Sum_probs=130.1

Q ss_pred             ccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCcccccCCcccceeeccCc-ccccccCcccccCCCC
Q 037916          124 IGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIEN-FLQVSIPSSLGQCQSL  202 (741)
Q Consensus       124 ~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N-~i~~~~~~~~~~l~~L  202 (741)
                      +..+++|+.+.+|.+.-..+. +.-..-+.|+++...+.-++.. | .+-....+.-+.-+.- -.+|..-..+.....|
T Consensus       210 l~~f~~l~~~~~s~~~~~~i~-~~~~~kptl~t~~v~~s~~~~~-~-~l~pe~~~~D~~~~E~~t~~G~~~~~~dTWq~L  286 (490)
T KOG1259|consen  210 LNAFRNLKTLKFSALSTENIV-DIELLKPTLQTICVHNTTIQDV-P-SLLPETILADPSGSEPSTSNGSALVSADTWQEL  286 (490)
T ss_pred             hHHhhhhheeeeeccchhhee-ceeecCchhheeeeeccccccc-c-cccchhhhcCccCCCCCccCCceEEecchHhhh
Confidence            344456666666666543222 1112225577777766665421 1 1111122222111111 1222333334445678


Q ss_pred             CEEeccCccccccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCC
Q 037916          203 TTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGG  282 (741)
Q Consensus       203 ~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  282 (741)
                      ++|||++|.|+ .+.+...-++.++. |++|+|.|.. + +.+..+++|+.||||+|.++. ..++-..+.+++.|.|++
T Consensus       287 telDLS~N~I~-~iDESvKL~Pkir~-L~lS~N~i~~-v-~nLa~L~~L~~LDLS~N~Ls~-~~Gwh~KLGNIKtL~La~  361 (490)
T KOG1259|consen  287 TELDLSGNLIT-QIDESVKLAPKLRR-LILSQNRIRT-V-QNLAELPQLQLLDLSGNLLAE-CVGWHLKLGNIKTLKLAQ  361 (490)
T ss_pred             hhccccccchh-hhhhhhhhccceeE-Eeccccceee-e-hhhhhcccceEeecccchhHh-hhhhHhhhcCEeeeehhh
Confidence            88888888887 67777777788887 8888888873 3 237788888888888888874 445556778888888888


Q ss_pred             CccCCCCChhcccCccCCeeeCCCCcCCCcc-chhhhccccCCcccccCcccccccC
Q 037916          283 NLFQGPIPLSLSSLRGLRVLDLSQNNISGEI-PKFLVELQLVQNLNLSYNDLEGVIP  338 (741)
Q Consensus       283 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~l~~N~l~~~~~  338 (741)
                      |.|..  -..+..+-+|..||+++|+|.... -..+++++-|+.|.|.+|++.+.+.
T Consensus       362 N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd  416 (490)
T KOG1259|consen  362 NKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD  416 (490)
T ss_pred             hhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence            88873  234667788888999999887432 2457788888888888888887653

>PLN03150 hypothetical protein; Provisional

Probab=99.31  E-value=7.4e-12  Score=142.67  Aligned_cols=112  Identities=32%  Similarity=0.444  Sum_probs=93.7

Q ss_pred             CcEEEeccccccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccchhhhccccCCcccccC
Q 037916          251 LEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSY  330 (741)
Q Consensus       251 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~  330 (741)
                      ++.|+|++|.+.+..+..++.+++|+.|+|++|++++.+|..+..+++|+.|+|++|++++.+|..+..+++|+.|+|++
T Consensus       420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~  499 (623)
T PLN03150        420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG  499 (623)
T ss_pred             EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence            77888888888888888888888888899988888888888888888899999999998888888888888899999999


Q ss_pred             cccccccCCcc--ccCCcccccccCCCCccccCC
Q 037916          331 NDLEGVIPTEG--VFKNASAISVFGNSKLCGGIP  362 (741)
Q Consensus       331 N~l~~~~~~~~--~~~~~~~~~~~~n~~~c~~~~  362 (741)
                      |++++.+|...  ...++..+.+.+|+..|+.+.
T Consensus       500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~  533 (623)
T PLN03150        500 NSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG  533 (623)
T ss_pred             CcccccCChHHhhccccCceEEecCCccccCCCC
Confidence            98888887652  123456788899999998653

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.29  E-value=3.4e-13  Score=147.10  Aligned_cols=192  Identities=24%  Similarity=0.261  Sum_probs=89.6

Q ss_pred             ccEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcc
Q 037916           81 LKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAIN  160 (741)
Q Consensus        81 L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~  160 (741)
                      ++.+++..|.|.. .-..+..+. +|+.|++.+|+|..+. ..+..+++|++|+|++|+|+.+.  .+..++.|+.|+++
T Consensus        74 l~~l~l~~n~i~~-~~~~l~~~~-~l~~l~l~~n~i~~i~-~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l~  148 (414)
T KOG0531|consen   74 LKELNLRQNLIAK-ILNHLSKLK-SLEALDLYDNKIEKIE-NLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELNLS  148 (414)
T ss_pred             HHhhccchhhhhh-hhccccccc-ceeeeeccccchhhcc-cchhhhhcchheecccccccccc--chhhccchhhheec
Confidence            4555555555552 222233344 5555566655553322 12455556666666666665432  23444456666666


Q ss_pred             cCCCCCcCcccccCCcccceeeccCcccccccC-cccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCC
Q 037916          161 TNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIP-SSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVG  239 (741)
Q Consensus       161 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~  239 (741)
                      +|.|+.+  ..|..+++|+.+++++|++....+ . ...+.+|+.+++++|.+.  ....+..+..+.. +++..|.++.
T Consensus       149 ~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~--~i~~~~~~~~l~~-~~l~~n~i~~  222 (414)
T KOG0531|consen  149 GNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIR--EIEGLDLLKKLVL-LSLLDNKISK  222 (414)
T ss_pred             cCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchh--cccchHHHHHHHH-hhccccccee
Confidence            6666532  234445556666666665553333 1 344555555556655554  1122333333333 4555555542


Q ss_pred             CCChhhcCCC--CCcEEEeccccccchhhhhccccccccEEEeCCCccC
Q 037916          240 SLPTEVGKLI--NLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQ  286 (741)
Q Consensus       240 ~~p~~~~~l~--~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  286 (741)
                      .-+  +..+.  +|+.+++++|++.... ..+..+.++..|++.+|++.
T Consensus       223 ~~~--l~~~~~~~L~~l~l~~n~i~~~~-~~~~~~~~l~~l~~~~n~~~  268 (414)
T KOG0531|consen  223 LEG--LNELVMLHLRELYLSGNRISRSP-EGLENLKNLPVLDLSSNRIS  268 (414)
T ss_pred             ccC--cccchhHHHHHHhcccCcccccc-ccccccccccccchhhcccc
Confidence            221  11111  2455555555544221 33334444444444444444

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.29  E-value=1.5e-11  Score=132.39  Aligned_cols=173  Identities=17%  Similarity=0.209  Sum_probs=128.3

Q ss_pred             EE-EEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEEEecccCCChhhhcc
Q 037916          416 VY-KGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLH  494 (741)
Q Consensus       416 V~-~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~  494 (741)
                      +| .|..+.++.+|.|..++...........+.+..|+.++||+|++|++.     ++.+...|+|+|.+.  .|..+++
T Consensus        27 ~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t-----~e~~~~~ylvTErV~--Pl~~~lk   99 (690)
T KOG1243|consen   27 LWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDT-----TEEEGTLYLVTERVR--PLETVLK   99 (690)
T ss_pred             cccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhh-----hcccCceEEEeeccc--cHHHHHH
Confidence            45 466777899999999986554444556778888999999999999998     566678999999984  5777775


Q ss_pred             CCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecccccccCCCCccccc
Q 037916          495 PVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSS  574 (741)
Q Consensus       495 ~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~  574 (741)
                      ..             ....+...+.||+.||.|||+.+  +++|++|.-+-|+|+..|..||++|..+.....-....  
T Consensus       100 ~l-------------~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~--  162 (690)
T KOG1243|consen  100 EL-------------GKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPA--  162 (690)
T ss_pred             Hh-------------HHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCccc--
Confidence            32             24445567899999999998664  99999999999999999999999998876443222100  


Q ss_pred             ccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCC
Q 037916          575 IGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRK  615 (741)
Q Consensus       575 ~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~  615 (741)
                      ....---.|..|++.-..   +...|.|-|||+++|++.|.
T Consensus       163 ~~~~~~~s~~~P~~~~~s---~~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  163 KSLYLIESFDDPEEIDPS---EWSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             ccchhhhcccChhhcCcc---ccchhhhhHHHHHHHHhCcc
Confidence            001112246667543211   14569999999999999993

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.28  E-value=4e-11  Score=114.34  Aligned_cols=139  Identities=19%  Similarity=0.125  Sum_probs=98.2

Q ss_pred             hhhcccCceeeEEEEEEcC------CCeEEEEEEeeccCcC----------c------------chhH----HHHHHHHH
Q 037916          405 LCWIDMGSFGSVYKGILDE------GKTIIAVKVLNLLHHG----------A------------SKSS----IAECSALR  452 (741)
Q Consensus       405 ~~~ig~G~~g~V~~a~~~~------~~~~vavK~~~~~~~~----------~------------~~~~----~~E~~~l~  452 (741)
                      ...||.|.=+.||.|....      .+..+|+|+++.....          .            .+.+    .+|+..|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3568999999999998753      3578999998621100          0            1112    37899998


Q ss_pred             hcCC--CceeeEeeeecCccccCCceEEEEEecccCCChhh-hccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHH-
Q 037916          453 NIRH--KNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEE-WLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL-  528 (741)
Q Consensus       453 ~l~h--pnIv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L-  528 (741)
                      ++..  -++++.+++         ...++||||+.+..+.. .++.           ..++..+...+..+++.+|..+ 
T Consensus        82 rl~~~Gv~vP~pi~~---------~~~~lvME~Ig~~~~~~~~Lkd-----------~~~~~~~~~~i~~~i~~~l~~l~  141 (197)
T cd05146          82 RMQKAGIPCPEVVVL---------KKHVLVMSFIGDDQVPAPKLKD-----------AKLNDEEMKNAYYQVLSMMKQLY  141 (197)
T ss_pred             HHHHcCCCCCeEEEe---------cCCEEEEEEcCCCCccchhhhc-----------cccCHHHHHHHHHHHHHHHHHHH
Confidence            8842  456666654         14589999996543321 1211           1234445667889999999998 


Q ss_pred             HhcCCCCceecCCCCCCeEeCCCCceEEeecccccccCC
Q 037916          529 HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPP  567 (741)
Q Consensus       529 H~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~a~~~~~  567 (741)
                      |..   |||||||++.||+++ ++.++|+|||.+.....
T Consensus       142 H~~---glVHGDLs~~NIL~~-~~~v~iIDF~qav~~~h  176 (197)
T cd05146         142 KEC---NLVHADLSEYNMLWH-DGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             HhC---CeecCCCCHHHEEEE-CCcEEEEECCCceeCCC
Confidence            888   999999999999996 46899999999876544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.26  E-value=4.7e-13  Score=146.02  Aligned_cols=268  Identities=22%  Similarity=0.205  Sum_probs=167.0

Q ss_pred             CCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCccEEECcCCcCcccCCchhh
Q 037916           21 PNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCIC  100 (741)
Q Consensus        21 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~  100 (741)
                      +.++.++...+.+....-. ...+..++.++++.|.|.. .-..+..+++          |+.|++.+|+|..+.. .+.
T Consensus        49 ~~~~~~~~~~~~~~~~~~~-~~~l~~l~~l~l~~n~i~~-~~~~l~~~~~----------l~~l~l~~n~i~~i~~-~l~  115 (414)
T KOG0531|consen   49 SDLEEIDLIFNLDGSDEDL-VESLTSLKELNLRQNLIAK-ILNHLSKLKS----------LEALDLYDNKIEKIEN-LLS  115 (414)
T ss_pred             chhhhhcchhccccchhhh-HHHhHhHHhhccchhhhhh-hhcccccccc----------eeeeeccccchhhccc-chh
Confidence            4445555555544322111 1456667777777777773 1122344433          7777777777774433 244


Q ss_pred             cccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCc-ccccCCcccc
Q 037916          101 NFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIP-PSIGNLKKLL  179 (741)
Q Consensus       101 ~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~  179 (741)
                      .+. +|+.|++++|.|..+.  .+..++.|+.|++++|.|+.+  ..|..+.+|+.+++++|++..+.+ . ...+.+|+
T Consensus       116 ~~~-~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~  189 (414)
T KOG0531|consen  116 SLV-NLQVLDLSFNKITKLE--GLSTLTLLKELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLE  189 (414)
T ss_pred             hhh-cchheecccccccccc--chhhccchhhheeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchH
Confidence            455 7778888888775543  356666788888888888744  345557888888888888875544 2 46778888


Q ss_pred             eeeccCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccc
Q 037916          180 QLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRN  259 (741)
Q Consensus       180 ~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  259 (741)
                      .+++.+|.+..  ...+..+..+..+++..|.++..-+........|+. +++++|.+. ..+..+..+.++..|++++|
T Consensus       190 ~l~l~~n~i~~--i~~~~~~~~l~~~~l~~n~i~~~~~l~~~~~~~L~~-l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n  265 (414)
T KOG0531|consen  190 ELDLGGNSIRE--IEGLDLLKKLVLLSLLDNKISKLEGLNELVMLHLRE-LYLSGNRIS-RSPEGLENLKNLPVLDLSSN  265 (414)
T ss_pred             HHhccCCchhc--ccchHHHHHHHHhhcccccceeccCcccchhHHHHH-HhcccCccc-cccccccccccccccchhhc
Confidence            88888888763  334444556666688888887332211111112665 888888887 34366778888899999988


Q ss_pred             cccchhhhhccccccccEEEeCCCccCCCC---Chh-cccCccCCeeeCCCCcCCCcc
Q 037916          260 MLECEILSTLGSCIKLEQLKLGGNLFQGPI---PLS-LSSLRGLRVLDLSQNNISGEI  313 (741)
Q Consensus       260 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~-~~~l~~L~~L~Ls~N~l~~~~  313 (741)
                      ++...  ..+...+.+..+.+..|.+....   ... ....+.++...+..|.+....
T Consensus       266 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (414)
T KOG0531|consen  266 RISNL--EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKIS  321 (414)
T ss_pred             ccccc--ccccccchHHHhccCcchhcchhhhhccccccccccccccccccCcccccc
Confidence            88743  33445566777777777766321   111 344566666777777666443

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.26  E-value=1.5e-11  Score=135.11  Aligned_cols=151  Identities=17%  Similarity=0.115  Sum_probs=96.9

Q ss_pred             HHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcC----------------------------------cc--
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG----------------------------------AS--  441 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~----------------------------------~~--  441 (741)
                      ++..|.. +.||+|++|.||+|+.+.+|+.||||+.++.-..                                  ..  
T Consensus       118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~  196 (537)
T PRK04750        118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT  196 (537)
T ss_pred             HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence            4566776 7899999999999999877999999999743100                                  00  


Q ss_pred             ----hhHHHHHHHHHhc----CCCceeeEeeeecCccccCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHH
Q 037916          442 ----KSSIAECSALRNI----RHKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQ  513 (741)
Q Consensus       442 ----~~~~~E~~~l~~l----~hpnIv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~  513 (741)
                          -++.+|+..+.++    .+...+.+-.++    .+-....++||||++|+++.++-.-..    .......+....
T Consensus       197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~----~d~st~~VLvmE~i~G~~l~d~~~l~~----~g~d~~~la~~~  268 (537)
T PRK04750        197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVY----WDYCSETVMVMERMYGIPVSDVAALRA----AGTDMKLLAERG  268 (537)
T ss_pred             HHHhhCHHHHHHHHHHHHHHccCCCCeecceee----cccCCCceEEEeeecCccHHhHHHHHh----cCCCHHHHHHHH
Confidence                1233455444444    233333333332    122335689999999999977421100    000011233333


Q ss_pred             HHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCC----ceEEeecccccccCC
Q 037916          514 RINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEM----TAHVADFGLAKLLPP  567 (741)
Q Consensus       514 ~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~----~~kL~DFg~a~~~~~  567 (741)
                      +..++.|+.       ..   |++|+|+||.||+++.++    .++++|||++...+.
T Consensus       269 v~~~~~Qif-------~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        269 VEVFFTQVF-------RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHHHHHHH-------hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            333444443       45   999999999999999887    999999999987754

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.26  E-value=3.1e-11  Score=114.84  Aligned_cols=131  Identities=18%  Similarity=0.135  Sum_probs=95.3

Q ss_pred             hhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCc-eeeEeeeecCccccCCceEEEEEec
Q 037916          405 LCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKN-LVKILTVCSGVDYKGDDFKALVYEF  483 (741)
Q Consensus       405 ~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~~~~~~~~~~~~~~~~~~lv~e~  483 (741)
                      ++.++.|.++.||+++..  +..|++|+...... ....+.+|+.+++.+.+.+ +++++.+.     .  ...++||||
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~-----~--~~~~lv~e~   72 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD-----P--ETGVLITEF   72 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe-----C--CCCeEEEEe
Confidence            356889999999999875  77899999753321 2345678999998886544 34555542     1  134799999


Q ss_pred             ccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcC--CCCceecCCCCCCeEeCCCCceEEeeccc
Q 037916          484 MHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDC--QPTTAHCDLKPSNVLLDHEMTAHVADFGL  561 (741)
Q Consensus       484 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--~~~ivHrDlkp~NIll~~~~~~kL~DFg~  561 (741)
                      ++|.++...-.                  ....++.+++++|+.||+..  ..+++|+|++|.||+++ ++.++++|||.
T Consensus        73 i~G~~l~~~~~------------------~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~  133 (170)
T cd05151          73 IEGSELLTEDF------------------SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEY  133 (170)
T ss_pred             cCCCccccccc------------------cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccc
Confidence            99987754300                  11235679999999999981  11259999999999998 66899999998


Q ss_pred             ccc
Q 037916          562 AKL  564 (741)
Q Consensus       562 a~~  564 (741)
                      +..
T Consensus       134 a~~  136 (170)
T cd05151         134 AGM  136 (170)
T ss_pred             ccC
Confidence            763

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.23  E-value=1.2e-11  Score=115.62  Aligned_cols=125  Identities=31%  Similarity=0.283  Sum_probs=38.1

Q ss_pred             CCCCCEEeccCccccccCCcccc-ccccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccchhhhhccccccccE
Q 037916          199 CQSLTTINLSYNNLSGTIPPQLM-DLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQ  277 (741)
Q Consensus       199 l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  277 (741)
                      ..+++.|+|++|+|+ .+. .+. .+.+|+. |+||+|.|+. ++ .+..+++|++|++++|+|+.+.......+++|++
T Consensus        18 ~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~-L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~   92 (175)
T PF14580_consen   18 PVKLRELNLRGNQIS-TIE-NLGATLDKLEV-LDLSNNQITK-LE-GLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQE   92 (175)
T ss_dssp             --------------------S--TT-TT--E-EE-TTS--S---T-T----TT--EEE--SS---S-CHHHHHH-TT--E
T ss_pred             ccccccccccccccc-ccc-chhhhhcCCCE-EECCCCCCcc-cc-CccChhhhhhcccCCCCCCccccchHHhCCcCCE
Confidence            344555666666655 222 233 3455554 6666666653 22 3555666666666666666543332334666666


Q ss_pred             EEeCCCccCCCCC-hhcccCccCCeeeCCCCcCCCcc---chhhhccccCCcccc
Q 037916          278 LKLGGNLFQGPIP-LSLSSLRGLRVLDLSQNNISGEI---PKFLVELQLVQNLNL  328 (741)
Q Consensus       278 L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~---~~~~~~l~~L~~L~l  328 (741)
                      |+|++|+|..... ..+..+++|+.|+|.+|.++...   ...+..+|+|+.||-
T Consensus        93 L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~  147 (175)
T PF14580_consen   93 LYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG  147 (175)
T ss_dssp             EE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred             EECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence            6666666654322 34556677777777777766321   123455666666653

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.21  E-value=4.6e-12  Score=122.47  Aligned_cols=199  Identities=25%  Similarity=0.244  Sum_probs=122.5

Q ss_pred             cccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcccC-CCCCcCcccccCCcccceeec
Q 037916          105 TLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTN-KLSGNIPPSIGNLKKLLQLYL  183 (741)
Q Consensus       105 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L  183 (741)
                      +|..+.++.+.-..+ .+....-+.|+++...+.-++..  +.+-....+..+.-+.- -..|..-........|++|||
T Consensus       215 ~l~~~~~s~~~~~~i-~~~~~~kptl~t~~v~~s~~~~~--~~l~pe~~~~D~~~~E~~t~~G~~~~~~dTWq~LtelDL  291 (490)
T KOG1259|consen  215 NLKTLKFSALSTENI-VDIELLKPTLQTICVHNTTIQDV--PSLLPETILADPSGSEPSTSNGSALVSADTWQELTELDL  291 (490)
T ss_pred             hhheeeeeccchhhe-eceeecCchhheeeeeccccccc--ccccchhhhcCccCCCCCccCCceEEecchHhhhhhccc
Confidence            555555555543221 11122234677777766655421  11222222222222111 112222223344456777888


Q ss_pred             cCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccc
Q 037916          184 IENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLEC  263 (741)
Q Consensus       184 ~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  263 (741)
                      ++|.|+ .+.++..-++.++.|++++|.|. .+. .+..+++|+. ||||+|.++ .+.++=.++.|+++|.|+.|.|..
T Consensus       292 S~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~-LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE~  366 (490)
T KOG1259|consen  292 SGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQL-LDLSGNLLA-ECVGWHLKLGNIKTLKLAQNKIET  366 (490)
T ss_pred             cccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceE-eecccchhH-hhhhhHhhhcCEeeeehhhhhHhh
Confidence            888777 55666677778888888888876 332 2677777776 888888877 455566677888888888888763


Q ss_pred             hhhhhccccccccEEEeCCCccCCCC-ChhcccCccCCeeeCCCCcCCCcc
Q 037916          264 EILSTLGSCIKLEQLKLGGNLFQGPI-PLSLSSLRGLRVLDLSQNNISGEI  313 (741)
Q Consensus       264 ~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~  313 (741)
                        .+.+..+-+|..||+++|+|.... ...++++|-|+.|.|.+|.|.+++
T Consensus       367 --LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v  415 (490)
T KOG1259|consen  367 --LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV  415 (490)
T ss_pred             --hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence              345566677888888888887432 246788999999999999998543

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.21  E-value=2.7e-12  Score=130.58  Aligned_cols=212  Identities=22%  Similarity=0.181  Sum_probs=114.2

Q ss_pred             cccEEEccCCcccccCC-ccccCCCCccEEEcccccccccCC--ccccCCCcCcEEEcccCCCCCcCccc-ccCCcccce
Q 037916          105 TLETLIFNSNKIFRSIP-AGIGKFINLQTLHMWDNQLSGTIS--PAIGELQNLVTLAINTNKLSGNIPPS-IGNLKKLLQ  180 (741)
Q Consensus       105 ~L~~L~L~~n~i~~~~~-~~~~~l~~L~~L~L~~N~i~~~~~--~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~  180 (741)
                      +|+...|.+..+..... .....+++++.||||+|-+....+  .....|++|+.|+|+.|++..-.... -..++.|+.
T Consensus       122 kL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~  201 (505)
T KOG3207|consen  122 KLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQ  201 (505)
T ss_pred             hhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhhe
Confidence            67777887777633221 356677888888888888765432  34567788888888888876322211 123556666


Q ss_pred             eeccCccccccc-CcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCCCC--hhhcCCCCCcEEEec
Q 037916          181 LYLIENFLQVSI-PSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLP--TEVGKLINLEILFIS  257 (741)
Q Consensus       181 L~L~~N~i~~~~-~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls  257 (741)
                      |.|+.|.++.-. ......+|+|+.|+|.+|............+..|+. |||++|++.. .+  ...+.++.|+.|+++
T Consensus       202 L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~-LdLs~N~li~-~~~~~~~~~l~~L~~Lnls  279 (505)
T KOG3207|consen  202 LVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQE-LDLSNNNLID-FDQGYKVGTLPGLNQLNLS  279 (505)
T ss_pred             EEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhh-ccccCCcccc-cccccccccccchhhhhcc
Confidence            777766665321 122334566666666666422222233334445554 6666666542 22  234445555555555


Q ss_pred             cccccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCc-cchhhhccccCCcccccCcccccc
Q 037916          258 RNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGE-IPKFLVELQLVQNLNLSYNDLEGV  336 (741)
Q Consensus       258 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~  336 (741)
                      .+.+..+-.....                  .-.-...+++|++|+++.|+|... .-..+..+++|+.|.+..|.|+..
T Consensus       280 ~tgi~si~~~d~~------------------s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~e  341 (505)
T KOG3207|consen  280 STGIASIAEPDVE------------------SLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNKE  341 (505)
T ss_pred             ccCcchhcCCCcc------------------chhhhcccccceeeecccCccccccccchhhccchhhhhhccccccccc
Confidence            5554432111110                  000023445666666666666421 112344456666677777777644

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.21  E-value=1.2e-11  Score=115.57  Aligned_cols=66  Identities=27%  Similarity=0.256  Sum_probs=18.5

Q ss_pred             ccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCc-ccccCCcccceeeccCcccc
Q 037916          124 IGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIP-PSIGNLKKLLQLYLIENFLQ  189 (741)
Q Consensus       124 ~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~i~  189 (741)
                      +..+++|++|+|++|+|+.+.......+++|++|+|++|+|..... ..++.+++|+.|+|.+|.+.
T Consensus        60 l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~  126 (175)
T PF14580_consen   60 LPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC  126 (175)
T ss_dssp             ----TT--EEE--SS---S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred             ccChhhhhhcccCCCCCCccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence            4445555555555555554322222345555555555555543211 23344455555555555544

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.15  E-value=2.1e-12  Score=127.89  Aligned_cols=95  Identities=22%  Similarity=0.329  Sum_probs=54.1

Q ss_pred             CCCCCcEEEcccCccccc----CCccCCCCCCCcEEEeecC---cCcccCCchhhhhhhhhhccccCCCccEEECcCCcC
Q 037916           19 TLPNLLFLSLGFNQITGV----IPSSMFNASKLEVFQVTSN---NLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNF   91 (741)
Q Consensus        19 ~l~~L~~L~L~~n~i~~~----~~~~~~~l~~L~~L~L~~N---~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l   91 (741)
                      .+..++.|+|++|.+...    +-..+.+.++|+.-++|+=   ++...+|.++..+.+  -+..|. +|++||||.|-+
T Consensus        28 ~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~--aL~~~~-~L~~ldLSDNA~  104 (382)
T KOG1909|consen   28 PMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSK--ALLGCP-KLQKLDLSDNAF  104 (382)
T ss_pred             ccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHH--HHhcCC-ceeEeecccccc
Confidence            467788888888888532    3345566778888887652   222234444443332  122333 588888888877


Q ss_pred             cccCCchhhccc---ccccEEEccCCcc
Q 037916           92 GGLLPGCICNFS---ITLETLIFNSNKI  116 (741)
Q Consensus        92 ~~~~~~~~~~l~---~~L~~L~L~~n~i  116 (741)
                      ....+..|..+-   .+|++|+|.+|.+
T Consensus       105 G~~g~~~l~~ll~s~~~L~eL~L~N~Gl  132 (382)
T KOG1909|consen  105 GPKGIRGLEELLSSCTDLEELYLNNCGL  132 (382)
T ss_pred             CccchHHHHHHHHhccCHHHHhhhcCCC
Confidence            654444333221   1455666666555

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.15  E-value=8.4e-12  Score=123.77  Aligned_cols=133  Identities=25%  Similarity=0.342  Sum_probs=88.2

Q ss_pred             CCCCEEeccCccccc----cCCccccccccceeEEEcCCCccCCC----CChhhcCCCCCcEEEeccccccch----hhh
Q 037916          200 QSLTTINLSYNNLSG----TIPPQLMDLTSLSVGLDLSRNQLVGS----LPTEVGKLINLEILFISRNMLECE----ILS  267 (741)
Q Consensus       200 ~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~~~  267 (741)
                      +.|+.+..++|++-.    .+-..|...+.|.. +.++.|.|...    +...|..+++|+.|||..|-++..    ...
T Consensus       157 ~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~lee-vr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~Lak  235 (382)
T KOG1909|consen  157 PKLRVFICGRNRLENGGATALAEAFQSHPTLEE-VRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAK  235 (382)
T ss_pred             cceEEEEeeccccccccHHHHHHHHHhccccce-EEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHH
Confidence            567777777777652    11223445566665 77777776522    123466778888888888877743    445


Q ss_pred             hccccccccEEEeCCCccCCCCChhcc-----cCccCCeeeCCCCcCCCc----cchhhhccccCCcccccCccc
Q 037916          268 TLGSCIKLEQLKLGGNLFQGPIPLSLS-----SLRGLRVLDLSQNNISGE----IPKFLVELQLVQNLNLSYNDL  333 (741)
Q Consensus       268 ~~~~l~~L~~L~L~~N~l~~~~~~~~~-----~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~l~~N~l  333 (741)
                      +++.+++|++|+++.+.+......+|.     ..++|++|.|.+|.|+..    +.......+.|..|+|++|.+
T Consensus       236 aL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l  310 (382)
T KOG1909|consen  236 ALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL  310 (382)
T ss_pred             HhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence            666778888888888888765544442     357888888888888632    223445567788888888887

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.15  E-value=5.5e-12  Score=128.34  Aligned_cols=211  Identities=19%  Similarity=0.197  Sum_probs=101.2

Q ss_pred             CCCCCcEEEcccCcccccCC-ccCCCCCCCcEEEeecCcCcccCC--chhhhhhhhhhccccCCCccEEECcCCcCcccC
Q 037916           19 TLPNLLFLSLGFNQITGVIP-SSMFNASKLEVFQVTSNNLTGEVP--SEFGKATKAYCVQNCNQHLKHLDINNNNFGGLL   95 (741)
Q Consensus        19 ~l~~L~~L~L~~n~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~--~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~   95 (741)
                      ++.+|+...|.+..+..... .....+++++.||||+|-++...+  .....++          +|+.|+||.|++..-.
T Consensus       119 n~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp----------~Le~LNls~Nrl~~~~  188 (505)
T KOG3207|consen  119 NLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLP----------SLENLNLSSNRLSNFI  188 (505)
T ss_pred             hHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcc----------cchhcccccccccCCc
Confidence            45667777777776652211 355566777777777776663221  1122232          3667777777665222


Q ss_pred             CchhhcccccccEEEccCCccccc-CCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCcccccC
Q 037916           96 PGCICNFSITLETLIFNSNKIFRS-IPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGN  174 (741)
Q Consensus        96 ~~~~~~l~~~L~~L~L~~n~i~~~-~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  174 (741)
                      .........+|+.|.|+.|.++.. +......+++|+.|+|+.|..-.+......-+..|++|||++|++.. .+.    
T Consensus       189 ~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~-~~~----  263 (505)
T KOG3207|consen  189 SSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLID-FDQ----  263 (505)
T ss_pred             cccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccc-ccc----
Confidence            222221222455555555555321 11112334455555555553222333333444445555555554432 110    


Q ss_pred             CcccceeeccCcccccccCcccccCCCCCEEeccCcccccc-CCcc-----ccccccceeEEEcCCCccCCC-CChhhcC
Q 037916          175 LKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGT-IPPQ-----LMDLTSLSVGLDLSRNQLVGS-LPTEVGK  247 (741)
Q Consensus       175 l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~-~p~~-----~~~l~~L~~~L~Ls~N~l~~~-~p~~~~~  247 (741)
                                        -...+.++.|+.|+++.+.|.+. .|+.     ...+++|+. |+++.|+|... .-..+..
T Consensus       264 ------------------~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~-L~i~~N~I~~w~sl~~l~~  324 (505)
T KOG3207|consen  264 ------------------GYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEY-LNISENNIRDWRSLNHLRT  324 (505)
T ss_pred             ------------------ccccccccchhhhhccccCcchhcCCCccchhhhccccccee-eecccCccccccccchhhc
Confidence                              02233344444444444444421 1111     233455555 66666666421 1134556


Q ss_pred             CCCCcEEEeccccccc
Q 037916          248 LINLEILFISRNMLEC  263 (741)
Q Consensus       248 l~~L~~L~Ls~N~l~~  263 (741)
                      +++|+.|....|.|+.
T Consensus       325 l~nlk~l~~~~n~ln~  340 (505)
T KOG3207|consen  325 LENLKHLRITLNYLNK  340 (505)
T ss_pred             cchhhhhhcccccccc
Confidence            6778888888888774

>PLN03150 hypothetical protein; Provisional

Probab=99.12  E-value=1.2e-10  Score=132.98  Aligned_cols=112  Identities=35%  Similarity=0.478  Sum_probs=102.3

Q ss_pred             ceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCC
Q 037916          226 LSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLS  305 (741)
Q Consensus       226 L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  305 (741)
                      +.. |+|++|.+.+.+|..++.+++|+.|+|++|.+.+..|..++.+++|+.|+|++|++++.+|..+..+++|+.|+|+
T Consensus       420 v~~-L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        420 IDG-LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEE-EECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            454 9999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCcCCCccchhhhcc-ccCCcccccCcccccccC
Q 037916          306 QNNISGEIPKFLVEL-QLVQNLNLSYNDLEGVIP  338 (741)
Q Consensus       306 ~N~l~~~~~~~~~~l-~~L~~L~l~~N~l~~~~~  338 (741)
                      +|++++.+|..+..+ .++..+++++|+..+-.|
T Consensus       499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p  532 (623)
T PLN03150        499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP  532 (623)
T ss_pred             CCcccccCChHHhhccccCceEEecCCccccCCC
Confidence            999999999988764 467789999998655433

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.07  E-value=7.5e-11  Score=126.19  Aligned_cols=196  Identities=21%  Similarity=0.187  Sum_probs=144.4

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEc-CCCeEEEEEEeeccCcCcchh--HHHHHHHHHhc-CCCceeeEeeeecCccccCC
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILD-EGKTIIAVKVLNLLHHGASKS--SIAECSALRNI-RHKNLVKILTVCSGVDYKGD  474 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~-~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~  474 (741)
                      ...|..+..||.|.|+.|+....+ .++..|++|...........+  -..|+.+...+ .|.++++++..+     ...
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W-----~~~  338 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSW-----SQL  338 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCc-----ccc
Confidence            345677889999999999998776 678889999876433322222  23455555555 588888877764     334


Q ss_pred             ceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCC-Cc
Q 037916          475 DFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHE-MT  553 (741)
Q Consensus       475 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~-~~  553 (741)
                      ...|+--|||++++....+.-          ...+++..++++..|++.++.++|+.   .++|+|+||+||++..+ +.
T Consensus       339 r~~~ip~e~~~~~s~~l~~~~----------~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~  405 (524)
T KOG0601|consen  339 RQGYIPLEFCEGGSSSLRSVT----------SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFF  405 (524)
T ss_pred             ccccCchhhhcCcchhhhhHH----------HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhh
Confidence            466799999999887665521          24577778889999999999999999   99999999999999886 78


Q ss_pred             eEEeecccccccCCCCccccccccccccccc-CcccccCCCCCCCccCchhHHHHHHHHHcCCCC
Q 037916          554 AHVADFGLAKLLPPAHLQTSSIGVKGTIGYI-APAEYGLGSEVSINGDVYSYGILLLELMTRKRP  617 (741)
Q Consensus       554 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~-aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p  617 (741)
                      .+++|||.+..+.-....     ..+.-+++ .+|.+.....+..++|++|||..+.+..++..-
T Consensus       406 ~~~~~~~~~t~~~~~~~~-----~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l  465 (524)
T KOG0601|consen  406 SKLGDFGCWTRLAFSSGV-----FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL  465 (524)
T ss_pred             hhccccccccccceeccc-----ccccccccccchhhccccccccccccccccccccccccCccc
Confidence            899999998642211111     11233344 244777777888999999999999999998753

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.03  E-value=2.7e-09  Score=101.54  Aligned_cols=126  Identities=20%  Similarity=0.203  Sum_probs=82.3

Q ss_pred             eEEEEEEcCCCeEEEEEEeeccCcC---------------------c-----chhHHHHHHHHHhcCCC--ceeeEeeee
Q 037916          415 SVYKGILDEGKTIIAVKVLNLLHHG---------------------A-----SKSSIAECSALRNIRHK--NLVKILTVC  466 (741)
Q Consensus       415 ~V~~a~~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~E~~~l~~l~hp--nIv~~~~~~  466 (741)
                      .||.|... ++..+|+|+.+.....                     .     .....+|.+.|.++..-  ++++.+++-
T Consensus         1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            48999986 6889999998632110                     0     12346799999999654  567777651


Q ss_pred             cCccccCCceEEEEEeccc--CCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHH-HHhcCCCCceecCCCC
Q 037916          467 SGVDYKGDDFKALVYEFMH--NGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY-LHHDCQPTTAHCDLKP  543 (741)
Q Consensus       467 ~~~~~~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~-LH~~~~~~ivHrDlkp  543 (741)
                               ..++||||++  |..+..+...            .++......++.+++..+.. +|..   ||+|+|+.+
T Consensus        80 ---------~~~ivME~I~~~G~~~~~l~~~------------~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~  135 (188)
T PF01163_consen   80 ---------RNVIVMEYIGEDGVPLPRLKDV------------DLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSE  135 (188)
T ss_dssp             ---------TTEEEEE--EETTEEGGCHHHC------------GGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-ST
T ss_pred             ---------CCEEEEEecCCCccchhhHHhc------------cccchhHHHHHHHHHHHHHHHHHhc---CceecCCCh
Confidence                     3479999998  5555444321            11133456678888886666 5687   999999999


Q ss_pred             CCeEeCCCCceEEeecccccccC
Q 037916          544 SNVLLDHEMTAHVADFGLAKLLP  566 (741)
Q Consensus       544 ~NIll~~~~~~kL~DFg~a~~~~  566 (741)
                      .||+++++ .+.++|||.+....
T Consensus       136 ~NIlv~~~-~~~iIDf~qav~~~  157 (188)
T PF01163_consen  136 YNILVDDG-KVYIIDFGQAVDSS  157 (188)
T ss_dssp             TSEEEETT-CEEE--GTTEEETT
T ss_pred             hhEEeecc-eEEEEecCcceecC
Confidence            99999887 99999999987554

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.02  E-value=7.5e-11  Score=132.41  Aligned_cols=201  Identities=23%  Similarity=0.276  Sum_probs=140.1

Q ss_pred             HHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      +.+++-+-+|+++.++.+.-..++...+.|+.....   ....+....+-.+.-...+|-+++...-     +......+
T Consensus       806 ~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s-----~~~rsP~~  880 (1205)
T KOG0606|consen  806 FEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPS-----FPCRSPLP  880 (1205)
T ss_pred             ceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCC-----CCCCCCcc
Confidence            445667889999999998887777666777654221   1112222223222223345666655443     34455789


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      ++|+|+.+++|...++...          +.+..-.+.....+..+.++||+.   .+.|||++|.|.++..+++.++.|
T Consensus       881 L~~~~~~~~~~~Skl~~~~----------~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~  947 (1205)
T KOG0606|consen  881 LVGHYLNGGDLPSKLHNSG----------CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTD  947 (1205)
T ss_pred             hhhHHhccCCchhhhhcCC----------CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCc
Confidence            9999999999999887552          233333445667788999999998   899999999999999999999999


Q ss_pred             cccccccCCC-------------------------Ccc----cccccccccccccCcccccCCCCCCCccCchhHHHHHH
Q 037916          559 FGLAKLLPPA-------------------------HLQ----TSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLL  609 (741)
Q Consensus       559 Fg~a~~~~~~-------------------------~~~----~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~  609 (741)
                      ||.....+..                         ...    .......||+.|.+|| ...+......+|+|+.|++++
T Consensus       948 ~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe-~~lg~~hgs~ad~~~~g~~l~ 1026 (1205)
T KOG0606|consen  948 FGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPE-ILLGRRHGSAADWWSSGVCLF 1026 (1205)
T ss_pred             cccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCc-ccccccCCCcchhhhhhhhhh
Confidence            9843222100                         000    1123355899999995 555667788899999999999


Q ss_pred             HHHcCCCCCCcc
Q 037916          610 ELMTRKRPSDIM  621 (741)
Q Consensus       610 elltg~~p~~~~  621 (741)
                      |.++|..||+..
T Consensus      1027 e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 1027 EVLTGIPPFNAE 1038 (1205)
T ss_pred             hhhcCCCCCCCc
Confidence            999999998743

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.02  E-value=3.7e-09  Score=105.32  Aligned_cols=145  Identities=21%  Similarity=0.178  Sum_probs=104.3

Q ss_pred             hhcccCceeeEEEEEEcCCCeEEEEEEeeccCc-CcchhHHHHHHHHHhcCC--CceeeEeeeecCccccCCceEEEEEe
Q 037916          406 CWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH-GASKSSIAECSALRNIRH--KNLVKILTVCSGVDYKGDDFKALVYE  482 (741)
Q Consensus       406 ~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~~~~~~~~~~~lv~e  482 (741)
                      +.|+.|.++.||++... +|..+++|+...... .....+.+|+.+++.+.+  ..+.+++.+.....  .....++|||
T Consensus         4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~--~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS--VLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC--ccCCceEEEE
Confidence            56899999999999886 357899999764322 135578899999999865  34567777642211  1135689999


Q ss_pred             cccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcC------------------------------
Q 037916          483 FMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDC------------------------------  532 (741)
Q Consensus       483 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~------------------------------  532 (741)
                      |++|.++.+.+..           ..++..+...++.+++++|..||+..                              
T Consensus        81 ~i~G~~l~~~~~~-----------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (223)
T cd05154          81 RVDGRVLRDRLLR-----------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDAS  149 (223)
T ss_pred             EeCCEecCCCCCC-----------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhh
Confidence            9999888775421           12455566667777777777777421                              


Q ss_pred             -----------------------CCCceecCCCCCCeEeCC--CCceEEeecccccc
Q 037916          533 -----------------------QPTTAHCDLKPSNVLLDH--EMTAHVADFGLAKL  564 (741)
Q Consensus       533 -----------------------~~~ivHrDlkp~NIll~~--~~~~kL~DFg~a~~  564 (741)
                                             ...++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         150 RTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             cccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                                   246799999999999998  56789999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=99.00  E-value=2.5e-10  Score=87.71  Aligned_cols=58  Identities=31%  Similarity=0.437  Sum_probs=23.9

Q ss_pred             ccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCC
Q 037916          106 LETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNK  163 (741)
Q Consensus       106 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~  163 (741)
                      |++|++++|+|..+.+..|.++++|++|+|++|+|+.+.+++|.++++|++|++++|+
T Consensus         3 L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~   60 (61)
T PF13855_consen    3 LESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN   60 (61)
T ss_dssp             ESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred             CcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence            3444444444433333344444444444444444444434444444444444444443

...

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.99  E-value=3e-10  Score=87.22  Aligned_cols=60  Identities=38%  Similarity=0.412  Sum_probs=35.5

Q ss_pred             CCcEEEeccccccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcC
Q 037916          250 NLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNI  309 (741)
Q Consensus       250 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  309 (741)
                      +|++|++++|+|+.+.+..|.++++|++|++++|+++.+.+.+|.++++|++|++++|+|
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            455566666666655555566666666666666666555555566666666666666553

...

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.96  E-value=4.9e-09  Score=96.16  Aligned_cols=128  Identities=22%  Similarity=0.223  Sum_probs=93.1

Q ss_pred             hhcccCceeeEEEEEEcCCCeEEEEEEeeccCcC--------cchhHHHHHHHHHhcCC--CceeeEeeeecCccccCCc
Q 037916          406 CWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG--------ASKSSIAECSALRNIRH--KNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       406 ~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~~~~~~~~  475 (741)
                      ..+++|+=+.||.+.+.  |..+++|.-.+....        ..++..+|+.++.++.-  -+++.++++       +.+
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv-------D~~   72 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV-------DPD   72 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE-------cCC
Confidence            35789999999999875  445666654221111        12344679999888743  344455655       234


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ...|+|||++|..|.+++...                 ...++..+=.-+.-||..   ||+|+||.++||++..++ +.
T Consensus        73 ~~~I~me~I~G~~lkd~l~~~-----------------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~  131 (204)
T COG3642          73 NGLIVMEYIEGELLKDALEEA-----------------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IY  131 (204)
T ss_pred             CCEEEEEEeCChhHHHHHHhc-----------------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EE
Confidence            567999999998888887522                 144677777788899999   999999999999997764 99


Q ss_pred             Eeeccccc
Q 037916          556 VADFGLAK  563 (741)
Q Consensus       556 L~DFg~a~  563 (741)
                      ++|||++.
T Consensus       132 ~IDfGLg~  139 (204)
T COG3642         132 FIDFGLGE  139 (204)
T ss_pred             EEECCccc
Confidence            99999986

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.94  E-value=7.3e-09  Score=100.76  Aligned_cols=137  Identities=20%  Similarity=0.155  Sum_probs=100.7

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcC----------------------cchhHHHHHHHHHhcCCC-
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG----------------------ASKSSIAECSALRNIRHK-  457 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l~hp-  457 (741)
                      .+.+...||-|.=+.||.|.+. .|.++|+|.-+.....                      .....++|.++|+++.-. 
T Consensus        92 ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G  170 (304)
T COG0478          92 VEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG  170 (304)
T ss_pred             HHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence            4667889999999999999997 6889999975421100                      123456899999998654 


Q ss_pred             -ceeeEeeeecCccccCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCc
Q 037916          458 -NLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTT  536 (741)
Q Consensus       458 -nIv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~i  536 (741)
                       .|++.+++         +..++|||+++|-.|...-               ++......++..|++-+..+-..   ||
T Consensus       171 ~~VP~P~~~---------nRHaVvMe~ieG~eL~~~r---------------~~~en~~~il~~il~~~~~~~~~---Gi  223 (304)
T COG0478         171 VKVPKPIAW---------NRHAVVMEYIEGVELYRLR---------------LDVENPDEILDKILEEVRKAYRR---GI  223 (304)
T ss_pred             CCCCCcccc---------ccceeeeehcccceeeccc---------------CcccCHHHHHHHHHHHHHHHHHc---Cc
Confidence             67776665         3678999999886665432               11222334556666666666667   99


Q ss_pred             eecCCCCCCeEeCCCCceEEeeccccccc
Q 037916          537 AHCDLKPSNVLLDHEMTAHVADFGLAKLL  565 (741)
Q Consensus       537 vHrDlkp~NIll~~~~~~kL~DFg~a~~~  565 (741)
                      ||+|+.+-||+++++|.+.++||-.+...
T Consensus       224 VHGDlSefNIlV~~dg~~~vIDwPQ~v~~  252 (304)
T COG0478         224 VHGDLSEFNILVTEDGDIVVIDWPQAVPI  252 (304)
T ss_pred             cccCCchheEEEecCCCEEEEeCcccccC
Confidence            99999999999999999999999766543

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.93  E-value=1e-09  Score=127.75  Aligned_cols=149  Identities=25%  Similarity=0.270  Sum_probs=101.9

Q ss_pred             CCCcEEEcccCcccccCCccCCCCCCCcEEEeecCc--CcccCCchhhhhhhhhhccccCCCccEEECcCCcCcccCCch
Q 037916           21 PNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNN--LTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGC   98 (741)
Q Consensus        21 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~--l~~~~~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~   98 (741)
                      ...+...+-+|++. .++.+.. .++|++|-+..|.  +..+.+..|..++.          |+.|||++|.=-+.+|..
T Consensus       523 ~~~rr~s~~~~~~~-~~~~~~~-~~~L~tLll~~n~~~l~~is~~ff~~m~~----------LrVLDLs~~~~l~~LP~~  590 (889)
T KOG4658|consen  523 NSVRRMSLMNNKIE-HIAGSSE-NPKLRTLLLQRNSDWLLEISGEFFRSLPL----------LRVLDLSGNSSLSKLPSS  590 (889)
T ss_pred             hheeEEEEeccchh-hccCCCC-CCccceEEEeecchhhhhcCHHHHhhCcc----------eEEEECCCCCccCcCChH
Confidence            66788888888876 3444433 3478888888885  55344444555654          888888887666678888


Q ss_pred             hhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCC--CCcCcccccCCc
Q 037916           99 ICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKL--SGNIPPSIGNLK  176 (741)
Q Consensus        99 ~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l--~~~~~~~~~~l~  176 (741)
                      +.++- +|++|+|++..| ..+|..+.+|..|.+|++..+.-...+++....|++|++|.+..-..  +...-..+..+.
T Consensus       591 I~~Li-~LryL~L~~t~I-~~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le  668 (889)
T KOG4658|consen  591 IGELV-HLRYLDLSDTGI-SHLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLE  668 (889)
T ss_pred             Hhhhh-hhhcccccCCCc-cccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhccc
Confidence            88887 888888888887 46788888888888888888776656677777788888888765542  222222334444


Q ss_pred             ccceeec
Q 037916          177 KLLQLYL  183 (741)
Q Consensus       177 ~L~~L~L  183 (741)
                      +|+.|..
T Consensus       669 ~L~~ls~  675 (889)
T KOG4658|consen  669 HLENLSI  675 (889)
T ss_pred             chhhhee
Confidence            4444444

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.89  E-value=2e-09  Score=125.50  Aligned_cols=128  Identities=19%  Similarity=0.340  Sum_probs=73.3

Q ss_pred             CCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCccEEECcCCc--CcccCCchhhcccccccEEEccCCcccccCCc
Q 037916           45 SKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNN--FGGLLPGCICNFSITLETLIFNSNKIFRSIPA  122 (741)
Q Consensus        45 ~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~--l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~  122 (741)
                      ...+...+-+|++. ..+......           .|++|-+..|.  +.......|..++ .|..|||++|.-.+.+|.
T Consensus       523 ~~~rr~s~~~~~~~-~~~~~~~~~-----------~L~tLll~~n~~~l~~is~~ff~~m~-~LrVLDLs~~~~l~~LP~  589 (889)
T KOG4658|consen  523 NSVRRMSLMNNKIE-HIAGSSENP-----------KLRTLLLQRNSDWLLEISGEFFRSLP-LLRVLDLSGNSSLSKLPS  589 (889)
T ss_pred             hheeEEEEeccchh-hccCCCCCC-----------ccceEEEeecchhhhhcCHHHHhhCc-ceEEEECCCCCccCcCCh
Confidence            55566666666665 222222211           26666666664  4433333444455 666666666655566666


Q ss_pred             cccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCcccccCCcccceeeccCc
Q 037916          123 GIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIEN  186 (741)
Q Consensus       123 ~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  186 (741)
                      .++.|-+|++|+|++..|+ ..|..+.+|..|.+|++..+.-...+|.....|++|++|.+..-
T Consensus       590 ~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s  652 (889)
T KOG4658|consen  590 SIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRS  652 (889)
T ss_pred             HHhhhhhhhcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeecc
Confidence            6666666666666666666 45566666666666666666544444555555666666666543

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.85  E-value=1.5e-08  Score=92.41  Aligned_cols=140  Identities=19%  Similarity=0.216  Sum_probs=95.2

Q ss_pred             HhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcC--------cchhHHHHHHHHHhcCCCc--eeeEeeeecCccccC
Q 037916          404 FLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG--------ASKSSIAECSALRNIRHKN--LVKILTVCSGVDYKG  473 (741)
Q Consensus       404 ~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~hpn--Iv~~~~~~~~~~~~~  473 (741)
                      .+..+-+|+-+.|+++.+.  |+.++||.--.....        ...+..+|++.+.++.--.  +.+++.+       +
T Consensus        11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~-------D   81 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFI-------D   81 (229)
T ss_pred             cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEE-------e
Confidence            3456789999999999995  777777753211111        1245567888888774222  2233322       2


Q ss_pred             CceEEEEEecccC-CChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCC
Q 037916          474 DDFKALVYEFMHN-GSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEM  552 (741)
Q Consensus       474 ~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~  552 (741)
                      ...-.++|||++| .++.+++.....        ..........++++|=+.+.-||..   +|+|+||..+||++..++
T Consensus        82 ~~~~~i~ME~~~g~~~vk~~i~~~~~--------~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~  150 (229)
T KOG3087|consen   82 TYGGQIYMEFIDGASTVKDFILSTME--------DESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDG  150 (229)
T ss_pred             cCCCeEEEEeccchhHHHHHHHHHcc--------CcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCC
Confidence            2345799999976 378888753311        1112222357888999999999999   999999999999997655


Q ss_pred             ---ceEEeeccccc
Q 037916          553 ---TAHVADFGLAK  563 (741)
Q Consensus       553 ---~~kL~DFg~a~  563 (741)
                         .+.++|||++.
T Consensus       151 ~~~~~~lIdfgls~  164 (229)
T KOG3087|consen  151 NQITPILIDFGLSS  164 (229)
T ss_pred             CcCceEEEeecchh
Confidence               46899999975

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.82  E-value=1e-10  Score=125.70  Aligned_cols=130  Identities=29%  Similarity=0.284  Sum_probs=86.5

Q ss_pred             CCCEEeccCccccccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccchhhhhccccccccEEEe
Q 037916          201 SLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKL  280 (741)
Q Consensus       201 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  280 (741)
                      .|.+.+.++|.+. .....+.-++.++. |+|++|+++..  +.+..+++|++|||++|.++.++--...++. |+.|.|
T Consensus       165 ~L~~a~fsyN~L~-~mD~SLqll~ale~-LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~l  239 (1096)
T KOG1859|consen  165 KLATASFSYNRLV-LMDESLQLLPALES-LNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNL  239 (1096)
T ss_pred             hHhhhhcchhhHH-hHHHHHHHHHHhhh-hccchhhhhhh--HHHHhcccccccccccchhccccccchhhhh-heeeee
Confidence            4666667777776 55566666666665 77777777632  2666777777777777777755444444555 777888


Q ss_pred             CCCccCCCCChhcccCccCCeeeCCCCcCCCccc-hhhhccccCCcccccCccccccc
Q 037916          281 GGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIP-KFLVELQLVQNLNLSYNDLEGVI  337 (741)
Q Consensus       281 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~  337 (741)
                      .+|.++..  ..+.+|++|+.|||++|-|.+... ..++.+..|..|+|.||++.+.+
T Consensus       240 rnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p  295 (1096)
T KOG1859|consen  240 RNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP  295 (1096)
T ss_pred             cccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence            88877733  245677788888888887765322 33466677778888888877654

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.81  E-value=1.5e-07  Score=96.23  Aligned_cols=275  Identities=13%  Similarity=0.073  Sum_probs=161.1

Q ss_pred             hhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhc-CCCceeeEeeeecC--ccccCCceEEEEE
Q 037916          405 LCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNI-RHKNLVKILTVCSG--VDYKGDDFKALVY  481 (741)
Q Consensus       405 ~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~--~~~~~~~~~~lv~  481 (741)
                      .+.||+|+-+.+|-.-.-.+   .+.|++.........   ..+..|... .||-+-.-+.|=..  ..-..+....+.|
T Consensus        16 gr~LgqGgea~ly~l~e~~d---~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm   89 (637)
T COG4248          16 GRPLGQGGEADLYTLGEVRD---QVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM   89 (637)
T ss_pred             CccccCCccceeeecchhhc---hhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence            45699999999996544311   355887643222211   122223332 56643321111000  0012233377888


Q ss_pred             ecccCC-ChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecc
Q 037916          482 EFMHNG-SLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFG  560 (741)
Q Consensus       482 e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg  560 (741)
                      +.+.+. ....++......    ..-....|.-.++.++.++.+.+.||+.   |.+-+|+.++|+|+++++.|+|.|=.
T Consensus        90 P~v~g~~pI~~~y~p~tRR----qs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsD  162 (637)
T COG4248          90 PKVSGKEPIHMIYSPATRR----QSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSD  162 (637)
T ss_pred             ccCCCccchhhhcCchhhc----ccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccc
Confidence            888664 233333321110    1124477888999999999999999999   99999999999999999999999865


Q ss_pred             cccccCCCCcccccccccccccccCccccc----CCCCCCCccCchhHHHHHHHHHcC-CCCCCccccCCc---chh-hh
Q 037916          561 LAKLLPPAHLQTSSIGVKGTIGYIAPAEYG----LGSEVSINGDVYSYGILLLELMTR-KRPSDIMFEGNM---NLH-NF  631 (741)
Q Consensus       561 ~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~----~~~~~~~~~DIwSlG~il~elltg-~~p~~~~~~~~~---~~~-~~  631 (741)
                      .-.....+   ......+|...|.+||...    .+..-+...|-|.+|+++++++.| ++||........   .+. ..
T Consensus       163 sfqi~~ng---~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~I  239 (637)
T COG4248         163 SFQINANG---TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDI  239 (637)
T ss_pred             ceeeccCC---ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhh
Confidence            44433222   1222356889999996432    233456778999999999999876 999875422111   111 00


Q ss_pred             hhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhccccc--CCCCCCCHHHHHHHHHHHHHh
Q 037916          632 ARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSME--SPQDRMNMTIVVHELQSIKSI  709 (741)
Q Consensus       632 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~--dP~~RPs~~evl~~L~~i~~~  709 (741)
                      ....+...    -+ ...+.           ...+......-.++++..++.+|+..  .+.-|||++..+..|..+.+.
T Consensus       240 a~g~f~ya----~~-~~~g~-----------~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~  303 (637)
T COG4248         240 AHGRFAYA----SD-QRRGL-----------KPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ  303 (637)
T ss_pred             hcceeeec----hh-ccCCC-----------CCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence            00000000    00 00000           00000011123356677888889875  356899999999999988876


Q ss_pred             hc
Q 037916          710 LL  711 (741)
Q Consensus       710 ~~  711 (741)
                      +.
T Consensus       304 L~  305 (637)
T COG4248         304 LK  305 (637)
T ss_pred             hh
Confidence            55

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.80  E-value=2e-07  Score=97.95  Aligned_cols=181  Identities=18%  Similarity=0.186  Sum_probs=135.3

Q ss_pred             ceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEEEecccC-CChh
Q 037916          412 SFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHN-GSLE  490 (741)
Q Consensus       412 ~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv~e~~~~-gsL~  490 (741)
                      -..+.|++....+|..|++|+++............-+++++++.|+|||++.+++....+ ++...++|++|+++ ++|.
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF-~D~SlvlvYDYyP~s~TL~  366 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTF-GDLSLVLVYDYYPSSPTLY  366 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhcc-CcceEEEEEecCCCCchHH
Confidence            446789999999999999999964444444445566888999999999999999764433 34468999999886 4777


Q ss_pred             hhccCCCCCC-----cccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeeccccccc
Q 037916          491 EWLHPVSGAD-----KTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL  565 (741)
Q Consensus       491 ~~l~~~~~~~-----~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~a~~~  565 (741)
                      ++........     .........++...+.++.|+..||.++|+.   |..-+-|.|.+|+++.+.+++|...|.....
T Consensus       367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl  443 (655)
T KOG3741|consen  367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVL  443 (655)
T ss_pred             HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeee
Confidence            7654332211     2233445678889999999999999999999   9999999999999999999999988776543


Q ss_pred             CCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCC
Q 037916          566 PPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKR  616 (741)
Q Consensus       566 ~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~  616 (741)
                      ..+.              .+|  +    ..-.+-|.=.+|.+++.+.+|..
T Consensus       444 ~~d~--------------~~~--l----e~~Qq~D~~~lG~ll~aLAt~~~  474 (655)
T KOG3741|consen  444 QEDP--------------TEP--L----ESQQQNDLRDLGLLLLALATGTE  474 (655)
T ss_pred             cCCC--------------Ccc--h----hHHhhhhHHHHHHHHHHHhhccc
Confidence            3221              122  1    11245688899999999999954

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.75  E-value=1.3e-07  Score=95.62  Aligned_cols=145  Identities=13%  Similarity=0.030  Sum_probs=95.2

Q ss_pred             hcccCceeeEEEEEEcCCCeEEEEEEeeccCcC-----------cchhHHHHHHHHHhcCCCc--eeeEeeeecCccccC
Q 037916          407 WIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG-----------ASKSSIAECSALRNIRHKN--LVKILTVCSGVDYKG  473 (741)
Q Consensus       407 ~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~hpn--Iv~~~~~~~~~~~~~  473 (741)
                      .+-......|++...  .|+.|.||........           ....+.+|...+.++..-+  +++.+++........
T Consensus        29 ~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         29 VFRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             EEecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            344444445667665  4778999977422110           1114678888887773222  223333321111111


Q ss_pred             CceEEEEEecccCC-ChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCC--
Q 037916          474 DDFKALVYEFMHNG-SLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDH--  550 (741)
Q Consensus       474 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~--  550 (741)
                      ....++|||++++. +|.+++....        ....+......++.+++..+.-||..   ||+|+|+++.|||++.  
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~--------~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~  175 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWA--------TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPF  175 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhc--------ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccc
Confidence            33578999999875 7888874210        12234556678999999999999999   9999999999999975  


Q ss_pred             -----CCceEEeecccccc
Q 037916          551 -----EMTAHVADFGLAKL  564 (741)
Q Consensus       551 -----~~~~kL~DFg~a~~  564 (741)
                           ++.+.++||+.+..
T Consensus       176 ~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        176 PGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             cCCCCCceEEEEECCcccc
Confidence                 46899999998753

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.74  E-value=7.9e-10  Score=119.07  Aligned_cols=181  Identities=25%  Similarity=0.257  Sum_probs=133.0

Q ss_pred             cccccCCcccceeeccCcccccccCcccccC-CCCCEEeccCcccc----------ccCCccccccccceeEEEcCCCcc
Q 037916          169 PPSIGNLKKLLQLYLIENFLQVSIPSSLGQC-QSLTTINLSYNNLS----------GTIPPQLMDLTSLSVGLDLSRNQL  237 (741)
Q Consensus       169 ~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l-~~L~~L~L~~N~l~----------~~~p~~~~~l~~L~~~L~Ls~N~l  237 (741)
                      |-.+..+.+|+.|.|.++.|..  ...+..+ ..|++|-.. |.++          |.+-..+. ...|.. .+.++|.+
T Consensus       102 pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC~-~Sl~Al~~v~ascggd~~ns~~-Wn~L~~-a~fsyN~L  176 (1096)
T KOG1859|consen  102 PISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLICH-NSLDALRHVFASCGGDISNSPV-WNKLAT-ASFSYNRL  176 (1096)
T ss_pred             CceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhhhh-ccHHHHHHHHHHhccccccchh-hhhHhh-hhcchhhH
Confidence            4466778899999999988863  1112222 244555433 3222          11111111 234555 89999999


Q ss_pred             CCCCChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccchhh
Q 037916          238 VGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFL  317 (741)
Q Consensus       238 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~  317 (741)
                      . .....+.-++.|+.|+|++|+++...  .+..+++|++|||+.|.++.+..-...++. |..|.|++|.++..  ..+
T Consensus       177 ~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN~l~tL--~gi  250 (1096)
T KOG1859|consen  177 V-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNNALTTL--RGI  250 (1096)
T ss_pred             H-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-heeeeecccHHHhh--hhH
Confidence            8 67788999999999999999999644  889999999999999999966555555655 99999999999843  356


Q ss_pred             hccccCCcccccCccccccc--CCccccCCcccccccCCCCcccc
Q 037916          318 VELQLVQNLNLSYNDLEGVI--PTEGVFKNASAISVFGNSKLCGG  360 (741)
Q Consensus       318 ~~l~~L~~L~l~~N~l~~~~--~~~~~~~~~~~~~~~~n~~~c~~  360 (741)
                      .++.+|+.||+++|-|.+--  ...+....+..+++.|||..|..
T Consensus       251 e~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p  295 (1096)
T KOG1859|consen  251 ENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP  295 (1096)
T ss_pred             HhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence            78999999999999998643  23355677889999999988854

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.53  E-value=9.5e-07  Score=86.53  Aligned_cols=111  Identities=21%  Similarity=0.225  Sum_probs=80.8

Q ss_pred             chhHHHHHHHHHhcCCC--ceeeEeeeecCccccCCceEEEEEecccCC-ChhhhccCCCCCCcccCcccccCHHHHHHH
Q 037916          441 SKSSIAECSALRNIRHK--NLVKILTVCSGVDYKGDDFKALVYEFMHNG-SLEEWLHPVSGADKTVEAPKCLNFLQRINI  517 (741)
Q Consensus       441 ~~~~~~E~~~l~~l~hp--nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~~~~~i  517 (741)
                      .....+|...+..+..-  .+++.+++..... ......++|||++++. +|.+++...          ...+......+
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~-~~~~~s~lite~l~~~~~L~~~~~~~----------~~~~~~~~~~l  123 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRK-GGGYRSYLITEALPGAQDLRDLLQQW----------EQLDPSQRREL  123 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcC-CCceeEEEEEEeCCCcccHHHHHHhh----------cccchhhHHHH
Confidence            34567888887777322  2344555432211 1124568999999874 799988642          11445566789


Q ss_pred             HHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCC---ceEEeeccccccc
Q 037916          518 AIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEM---TAHVADFGLAKLL  565 (741)
Q Consensus       518 ~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~---~~kL~DFg~a~~~  565 (741)
                      +.++++.++-||+.   ||+|+|+++.|||++.++   .+.++||+-++..
T Consensus       124 l~~l~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  124 LRALARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHHHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            99999999999999   999999999999998887   8999999987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.51  E-value=1e-08  Score=88.44  Aligned_cols=108  Identities=21%  Similarity=0.264  Sum_probs=48.3

Q ss_pred             CcEEEeecCcCcccCCchhhhhhhhhhccccCCCccEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccC
Q 037916           47 LEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGK  126 (741)
Q Consensus        47 L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~  126 (741)
                      +..|+|++++|. .+++....+.+       ..+|+..+|++|.+.. .|..|....+.+++|+|++|+| ..+|..+..
T Consensus        29 ~h~ldLssc~lm-~i~davy~l~~-------~~el~~i~ls~N~fk~-fp~kft~kf~t~t~lNl~~nei-sdvPeE~Aa   98 (177)
T KOG4579|consen   29 LHFLDLSSCQLM-YIADAVYMLSK-------GYELTKISLSDNGFKK-FPKKFTIKFPTATTLNLANNEI-SDVPEELAA   98 (177)
T ss_pred             hhhcccccchhh-HHHHHHHHHhC-------CceEEEEecccchhhh-CCHHHhhccchhhhhhcchhhh-hhchHHHhh
Confidence            444555555554 33444444433       1234445555555552 2322222222445555555554 223333555


Q ss_pred             CCCccEEEcccccccccCCccccCCCcCcEEEcccCCCC
Q 037916          127 FINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLS  165 (741)
Q Consensus       127 l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~  165 (741)
                      ++.|+.|+++.|.+. ..|..+..|.+|..|+..+|.+.
T Consensus        99 m~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~  136 (177)
T KOG4579|consen   99 MPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA  136 (177)
T ss_pred             hHHhhhcccccCccc-cchHHHHHHHhHHHhcCCCCccc
Confidence            555555555555544 33333444444444444444444

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.48  E-value=1.7e-08  Score=87.00  Aligned_cols=105  Identities=22%  Similarity=0.141  Sum_probs=46.9

Q ss_pred             CCEEeccCccccccCCccccc---cccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccchhhhhccccccccEE
Q 037916          202 LTTINLSYNNLSGTIPPQLMD---LTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQL  278 (741)
Q Consensus       202 L~~L~L~~N~l~~~~p~~~~~---l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  278 (741)
                      +..++|++++|- .+++....   ...|+. ++|++|.+...++..-...+.++.|+|++|.|+.++. .+..++.|+.|
T Consensus        29 ~h~ldLssc~lm-~i~davy~l~~~~el~~-i~ls~N~fk~fp~kft~kf~t~t~lNl~~neisdvPe-E~Aam~aLr~l  105 (177)
T KOG4579|consen   29 LHFLDLSSCQLM-YIADAVYMLSKGYELTK-ISLSDNGFKKFPKKFTIKFPTATTLNLANNEISDVPE-ELAAMPALRSL  105 (177)
T ss_pred             hhhcccccchhh-HHHHHHHHHhCCceEEE-EecccchhhhCCHHHhhccchhhhhhcchhhhhhchH-HHhhhHHhhhc
Confidence            344555555543 33333222   223333 4555555553333222333445555555555553222 24445555555


Q ss_pred             EeCCCccCCCCChhcccCccCCeeeCCCCcCC
Q 037916          279 KLGGNLFQGPIPLSLSSLRGLRVLDLSQNNIS  310 (741)
Q Consensus       279 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  310 (741)
                      +++.|.+. ..|..+..|.+|-.|+..+|.+.
T Consensus       106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~  136 (177)
T KOG4579|consen  106 NLRFNPLN-AEPRVIAPLIKLDMLDSPENARA  136 (177)
T ss_pred             ccccCccc-cchHHHHHHHhHHHhcCCCCccc
Confidence            55555554 33444444555555555555444

>PRK09902 hypothetical protein; Provisional

Probab=98.47  E-value=2.9e-06  Score=81.19  Aligned_cols=143  Identities=17%  Similarity=0.111  Sum_probs=100.1

Q ss_pred             cccCceeeEEEEEEcCCCeEEEEEEeec------cCcCcchhHHHHHHHHHhcCC--CceeeEeeeecCccccCCceEEE
Q 037916          408 IDMGSFGSVYKGILDEGKTIIAVKVLNL------LHHGASKSSIAECSALRNIRH--KNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       408 ig~G~~g~V~~a~~~~~~~~vavK~~~~------~~~~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      -|+||.+.|++....  |..+=+|.-..      ...-....+.+|+..++++..  -.+.+.. ++...........+|
T Consensus        26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L  102 (216)
T PRK09902         26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL  102 (216)
T ss_pred             cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence            356899999998775  33566776531      002345688999999988842  2244444 222111223345789


Q ss_pred             EEecccC-CChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCc--eEE
Q 037916          480 VYEFMHN-GSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMT--AHV  556 (741)
Q Consensus       480 v~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~--~kL  556 (741)
                      |+|-+.+ .+|.+++...        .....+......+..++++.+.-||+.   |+.|+|+.+.||+++.++.  +++
T Consensus       103 VTe~L~g~~~L~~~l~~~--------~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~l  171 (216)
T PRK09902        103 VTEDMAGFISIADWYAQH--------AVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGF  171 (216)
T ss_pred             EEEeCCCCccHHHHHhcC--------CcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEE
Confidence            9998753 4888887532        112345666778999999999999999   9999999999999986666  999


Q ss_pred             eecccccc
Q 037916          557 ADFGLAKL  564 (741)
Q Consensus       557 ~DFg~a~~  564 (741)
                      +||..++.
T Consensus       172 IDlEk~r~  179 (216)
T PRK09902        172 LDLEKSRR  179 (216)
T ss_pred             EEhhccch
Confidence            99987654

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.46  E-value=1.4e-06  Score=79.47  Aligned_cols=130  Identities=15%  Similarity=0.129  Sum_probs=93.3

Q ss_pred             HHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCcee-eEeeeecCccccCCceEEEE
Q 037916          402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLV-KILTVCSGVDYKGDDFKALV  480 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv-~~~~~~~~~~~~~~~~~~lv  480 (741)
                      -.+.+.||+|.+|.||++.++  +..+|+|+-+  .......+..|+++++.+.-.++. ++|.|-         ..++.
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr--~ds~r~~l~kEakiLeil~g~~~~p~vy~yg---------~~~i~   90 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRR--RDSPRRNLEKEAKILEILAGEGVTPEVYFYG---------EDFIR   90 (201)
T ss_pred             hhhhhhhhcccccEEEEeecc--CceEEEEEec--CCcchhhHHHHHHHHHHhhhcCCCceEEEec---------hhhhh
Confidence            356788999999999999997  6689999876  344567889999999998766654 666551         23456


Q ss_pred             EecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCC-CCCeEeCCCCceEEeec
Q 037916          481 YEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLK-PSNVLLDHEMTAHVADF  559 (741)
Q Consensus       481 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlk-p~NIll~~~~~~kL~DF  559 (741)
                      |||+.|..|.++....             +    .+-...++++---|-..   ||-|+.|. |..+++..++.+.|+||
T Consensus        91 me~i~G~~L~~~~~~~-------------~----rk~l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDF  150 (201)
T COG2112          91 MEYIDGRPLGKLEIGG-------------D----RKHLLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDF  150 (201)
T ss_pred             hhhhcCcchhhhhhcc-------------c----HHHHHHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEc
Confidence            9999888887765311             1    12234455553344555   99999998 65555555559999999


Q ss_pred             ccccc
Q 037916          560 GLAKL  564 (741)
Q Consensus       560 g~a~~  564 (741)
                      ..|+.
T Consensus       151 d~At~  155 (201)
T COG2112         151 DSATF  155 (201)
T ss_pred             cchhh
Confidence            98874

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.45  E-value=6.7e-08  Score=105.20  Aligned_cols=95  Identities=21%  Similarity=0.425  Sum_probs=73.1

Q ss_pred             HHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecccccccCCCCccc-----cc--ccccccccccCcccccCC
Q 037916          520 DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQT-----SS--IGVKGTIGYIAPAEYGLG  592 (741)
Q Consensus       520 qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~-----~~--~~~~gt~~y~aPEe~~~~  592 (741)
                      +++.|+.|+|..  +++||++|.|++|.++..+.+||++|+++.....+..+.     ..  .-......|.|| |+..+
T Consensus       107 ~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~ap-E~~~~  183 (700)
T KOG2137|consen  107 NVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAP-EYLLG  183 (700)
T ss_pred             cccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccc-hhhcc
Confidence            345899999976  499999999999999999999999999987665522111     00  012245689999 56566


Q ss_pred             CCCCCccCchhHHHHHHHHHcCCCC
Q 037916          593 SEVSINGDVYSYGILLLELMTRKRP  617 (741)
Q Consensus       593 ~~~~~~~DIwSlG~il~elltg~~p  617 (741)
                      ...+.++|+||+|+.+|.+..|..+
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~  208 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKS  208 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcc
Confidence            7889999999999999999855444

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	741
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		3e-30
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		7e-21
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		4e-30
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		1e-20
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		3e-28
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-27
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-18
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-18
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-18
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-17
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-17
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-17
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-17
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-17
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-17
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-17
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-17
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-17
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-17
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-17
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-17
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		3e-17
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		1e-14
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		4e-17
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-17
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		4e-17
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		4e-17
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		6e-17
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		8e-17
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		8e-17
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		8e-17
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-16
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-16
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-16
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-16
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-16
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-16
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-16
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-16
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-16
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-16
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-16
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-16
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-16
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-16
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-16
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-16
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-16
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		4e-16
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		5e-16
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-14
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-14
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		5e-14
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		5e-14
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		6e-14
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		6e-14
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		6e-14
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		7e-14
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		7e-14
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		7e-14
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		7e-14
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		7e-14
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		7e-14
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		8e-14
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-13
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-13
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-13
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-13
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-13
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-13
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-13
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-13
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-13
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-13
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-13
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-13
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-13
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		6e-13
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-13
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		9e-13
4h58_A	275	Braf In Complex With Compound 3 Length = 275		9e-13
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		9e-13
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-12
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-12
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-12
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-12
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-12
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-12
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-12
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-12
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-12
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-12
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-12
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-12
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-12
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-12
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-12
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-12
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-12
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-12
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-12
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-12
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-12
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-12
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-12
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-12
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-12
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-12
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-12
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-12
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-12
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-12
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-12
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-12
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-12
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-12
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-12
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-12
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-12
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-12
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-12
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-12
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-12
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-12
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-12
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		4e-12
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		4e-12
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		4e-12
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		4e-12
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-12
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		4e-12
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		7e-12
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		8e-12
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-11
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-11
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-11
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-11
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-11
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		3e-11
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		4e-11
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-11
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		4e-11
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		5e-11
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		6e-11
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		7e-11
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-11
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-10
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-10
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-10
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-10
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-10
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-10
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-10
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-10
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-10
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-10
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-10
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		4e-10
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		4e-10
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		4e-10
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-10
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-10
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		5e-10
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		5e-10
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		5e-10
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		5e-10
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		7e-10
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		7e-10
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		7e-10
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-09
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-09
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-09
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-09
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-09
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-09
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-09
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-09
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-09
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-09
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-09
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-09
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-09
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-09
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-09
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-09
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-09
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-09
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-09
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-09
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-09
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-09
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-09
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-09
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-09
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-09
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-09
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-09
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-09
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-09
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-09
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-09
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-09
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-09
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-09
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-09
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-09
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-09
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-09
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-09
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-09
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-09
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-09
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		4e-09
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		5e-09
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		5e-09
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		5e-09
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		5e-09
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		5e-09
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		5e-09
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-09
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		5e-09
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		6e-09
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		6e-09
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		6e-09
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		6e-09
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		6e-09
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		6e-09
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		7e-09
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		7e-09
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		7e-09
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		7e-09
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-09
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-09
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		7e-09
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		7e-09
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-09
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		7e-09
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		7e-09
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-09
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		7e-09
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		8e-09
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		8e-09
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		8e-09
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		8e-09
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		8e-09
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		8e-09
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		8e-09
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		8e-09
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		8e-09
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		8e-09
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		8e-09
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		8e-09
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		8e-09
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		8e-09
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		8e-09
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		9e-09
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		9e-09
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		9e-09
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-09
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-08
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-08
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-08
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-08
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-08
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-08
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-08
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-08
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-08
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-08
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-08
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-08
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-08
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-08
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-08
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-08
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-08
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-08
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-08
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-08
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-08
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-08
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-08
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-08
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-08
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-08
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-08
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-08
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-08
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-08
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-08
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-08
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-08
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-08
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-08
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-08
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-08
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-08
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-08
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-08
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-08
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-08
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-08
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		3e-08
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-08
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-08
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-08
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		4e-08
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		4e-08
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		4e-08
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-08
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		4e-08
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		4e-08
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		4e-08
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		5e-08
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		5e-08
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		5e-08
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-08
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		5e-08
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		5e-08
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		5e-08
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		5e-08
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-08
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		5e-08
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		5e-08
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		5e-08
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-08
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		5e-08
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		6e-08
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		6e-08
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		6e-08
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		6e-08
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		6e-08
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		6e-08
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		6e-08
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		6e-08
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-08
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		6e-08
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		6e-08
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-08
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		6e-08
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-08
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		6e-08
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		6e-08
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		6e-08
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		7e-08
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		7e-08
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		7e-08
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		7e-08
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		7e-08
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		7e-08
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		7e-08
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		7e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		7e-08
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-08
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		7e-08
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		7e-08
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		8e-08
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		8e-08
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		8e-08
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		8e-08
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		8e-08
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		8e-08
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		9e-08
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		9e-08
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-07
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-07
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-07
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-07
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-07
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-07
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-07
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-07
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-07
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-07
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-07
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-07
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-07
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-07
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-07
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-07
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-07
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-07
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-07
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-07
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-07
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-07
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-07
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-07
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-07
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-07
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		2e-07
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-07
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-07
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-07
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-07
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-07
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-07
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-07
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-07
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-07
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-07
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-07
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-07
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-07
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-07
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-07
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		3e-07
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-07
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-07
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		4e-07
2o6q_A	270	Structural Diversity Of The Hagfish Variable Lympho		4e-07
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		5e-07
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		6e-07
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		6e-07
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		7e-07
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		7e-07
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		7e-07
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		8e-07
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		9e-07
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-06
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-06
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-06
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-06
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-06
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-06
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-06
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-06
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-06
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-06
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-06
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-06
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-06
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-06
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-06
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-06
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-06
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-06
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-06
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-06
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-06
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-06
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-06
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-06
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-06
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-06
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-06
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-06
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-06
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-06
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-06
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-06
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-06
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-06
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-06
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-06
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-06
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-06
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-06
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-06
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-06
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-06
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-06
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-06
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-06
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-06
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-06
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-06
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-06
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-06
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-06
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		4e-06
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-06
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-06
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		4e-06
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		4e-06
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-06
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		4e-06
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-06
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		4e-06
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-06
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		5e-06
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-06
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		5e-06
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		5e-06
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-06
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		5e-06
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		5e-06
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		5e-06
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		5e-06
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		5e-06
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-06
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		5e-06
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-06
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		5e-06
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		5e-06
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		5e-06
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		6e-06
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		6e-06
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		6e-06
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		6e-06
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		6e-06
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-06
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		6e-06
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		6e-06
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		6e-06
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		7e-06
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		7e-06
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		7e-06
1fvr_A	327	Tie2 Kinase Domain Length = 327		7e-06
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		7e-06
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		8e-06
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		8e-06
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		8e-06
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		8e-06
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		9e-06
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		9e-06
3b2t_A	311	Structure Of Phosphotransferase Length = 311		9e-06
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-05
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-05
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-05
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-05
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-05
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-05
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-05
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-05
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-05
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-05
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-05
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-05
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-05
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-05
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-05
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-05
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-05
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-05
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-05
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-05
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-05
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-05
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-05
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-05
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-05
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-05
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-05
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-05
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-05
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-05
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-05
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-05
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-05
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-05
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-05
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-05
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-05
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-05
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-05
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-05
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-05
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-05
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-05
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-05
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-05
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-05
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-05
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-05
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-05
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-05
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-05
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-05
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-05
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-05
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-05
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-05
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-05
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-05
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		3e-05
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-05
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-05
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-05
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-05
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-05
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-05
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		3e-05
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-05
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-05
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-05
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-05
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-05
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		4e-05
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-05
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		4e-05
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		4e-05
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		4e-05
4fie_A	423	Full-Length Human Pak4 Length = 423		4e-05
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		4e-05
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-05
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		5e-05
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-05
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		5e-05
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		5e-05
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		5e-05
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		5e-05
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		5e-05
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-05
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		6e-05
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		6e-05
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		6e-05
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		6e-05
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-05
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		7e-05
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		7e-05
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		7e-05
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		8e-05
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		8e-05
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		8e-05
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		8e-05
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		8e-05
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		8e-05
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		9e-05
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		9e-05
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		9e-05
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		9e-05
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		9e-05
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		9e-05
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-04
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-04
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-04
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-04
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-04
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-04
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-04
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-04
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-04
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-04
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-04
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-04
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-04
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-04
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-04
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-04
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-04
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-04
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-04
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-04
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-04
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-04
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-04
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-04
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-04
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-04
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-04
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-04
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-04
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-04
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-04
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-04
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-04
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-04
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-04
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-04
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-04
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-04
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-04
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-04
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-04
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-04
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-04
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-04
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-04
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-04
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-04
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-04
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-04
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-04
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-04
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-04
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-04
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-04
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-04
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-04
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-04
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-04
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-04
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-04
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-04
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-04
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-04
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-04
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-04
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-04
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-04
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-04
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-04
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-04
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-04
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-04
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-04
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-04
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-04
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-04
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-04
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-04
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-04
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-04
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-04
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-04
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-04
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-04
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-04
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-04
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-04
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-04
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-04
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-04
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-04
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-04
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-04
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-04
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-04
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-04
3rfs_A	272	Design Of A Binding Scaffold Based On Variable Lymp		3e-04
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-04
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-04
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-04
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-04
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		3e-04
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-04
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		4e-04
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-04
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		4e-04
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		4e-04
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		4e-04
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		4e-04
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-04
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-04
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-04
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		4e-04
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		4e-04
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		4e-04
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		4e-04
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		4e-04
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-04
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		5e-04
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-04
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		5e-04
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		5e-04
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		6e-04
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-04
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		7e-04
4fl3_A	635	Structural And Biophysical Characterization Of The		7e-04
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		7e-04
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		7e-04
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		7e-04
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		7e-04
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		7e-04
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		8e-04
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		8e-04
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		8e-04
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-04
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		8e-04
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-04
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		8e-04
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		8e-04
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		9e-04
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		9e-04
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		9e-04
4fl2_A	636	Structural And Biophysical Characterization Of The		9e-04
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		9e-04
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		9e-04
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		9e-04
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		9e-04
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		9e-04

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  130 bits (327), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 105/307 (34%), Positives = 153/307 (49%), Gaps = 22/307 (7%)
Query: 2   DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNA-SKLEVFQVTSNNLTGE 60
           ++  N+  G IP      L +L +LSL  N+ TG IP  +  A   L    ++ N+  G 
Sbjct: 250 NISSNQFVGPIP---PLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGA 306
Query: 61  VPSEFGKATKAYCVQNCNQH---------------LKHLDINNNNFGGLLPGCICNFSIT 105
           VP  FG  +    +   + +               LK LD++ N F G LP  + N S +
Sbjct: 307 VPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSAS 366
Query: 106 LETLIFNSNKIFRSIPAGIGKFIN--LQTLHMWDNQLSGTISPAIGELQNLVTLAINTNK 163
           L TL  +SN     I   + +     LQ L++ +N  +G I P +     LV+L ++ N 
Sbjct: 367 LLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNY 426
Query: 164 LSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDL 223
           LSG IP S+G+L KL  L L  N L+  IP  L   ++L T+ L +N+L+G IP  L + 
Sbjct: 427 LSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNC 486
Query: 224 TSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGN 283
           T+L+  + LS N+L G +P  +G+L NL IL +S N     I + LG C  L  L L  N
Sbjct: 487 TNLNW-ISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTN 545
Query: 284 LFQGPIP 290
           LF G IP
Sbjct: 546 LFNGTIP 552

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 99.4 bits (246), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 102/363 (28%), Positives = 150/363 (41%), Gaps = 42/363 (11%)
Query: 31  NQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNN 90
           N  TG IP ++ N S+L    ++ N L+G +PS  G  +K          L+ L +  N 
Sbjct: 401 NGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSK----------LRDLKLWLNM 450
Query: 91  FGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGE 150
             G +P  +  +  TLETLI + N +   IP+G+    NL  + + +N+L+G I   IG 
Sbjct: 451 LEGEIPQELM-YVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGR 509
Query: 151 LQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINL--- 207
           L+NL  L ++ N  SGNIP  +G+ + L+ L L  N    +IP+++ +       N    
Sbjct: 510 LENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAG 569
Query: 208 ----------------SYNNL---SGTIPPQLMDLTSLSVGLDLSRNQLVGSLPT--EVG 246
                              NL    G    QL  L++ +     SR     + PT    G
Sbjct: 570 KRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNG 629
Query: 247 KLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPXXXXXXXXXXXXXXXQ 306
            ++ L++   S NML   I   +GS   L  L LG N   G IP                
Sbjct: 630 SMMFLDM---SYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSS 686
Query: 307 NNISGEIPKFXXXXXXXXXXXXSYNDLEGVIPTEGVFKNASAISVFGNSKLCGGIPEFQL 366
           N + G IP+             S N+L G IP  G F+         N  LCG    + L
Sbjct: 687 NKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCG----YPL 742
Query: 367 PIC 369
           P C
Sbjct: 743 PRC 745

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  130 bits (326), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 105/307 (34%), Positives = 153/307 (49%), Gaps = 22/307 (7%)
Query: 2   DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNA-SKLEVFQVTSNNLTGE 60
           ++  N+  G IP      L +L +LSL  N+ TG IP  +  A   L    ++ N+  G 
Sbjct: 253 NISSNQFVGPIP---PLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGA 309
Query: 61  VPSEFGKATKAYCVQNCNQH---------------LKHLDINNNNFGGLLPGCICNFSIT 105
           VP  FG  +    +   + +               LK LD++ N F G LP  + N S +
Sbjct: 310 VPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSAS 369
Query: 106 LETLIFNSNKIFRSIPAGIGKFI--NLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNK 163
           L TL  +SN     I   + +     LQ L++ +N  +G I P +     LV+L ++ N 
Sbjct: 370 LLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNY 429
Query: 164 LSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDL 223
           LSG IP S+G+L KL  L L  N L+  IP  L   ++L T+ L +N+L+G IP  L + 
Sbjct: 430 LSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNC 489
Query: 224 TSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGN 283
           T+L+  + LS N+L G +P  +G+L NL IL +S N     I + LG C  L  L L  N
Sbjct: 490 TNLNW-ISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTN 548
Query: 284 LFQGPIP 290
           LF G IP
Sbjct: 549 LFNGTIP 555

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 102/363 (28%), Positives = 150/363 (41%), Gaps = 42/363 (11%)
Query: 31  NQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNN 90
           N  TG IP ++ N S+L    ++ N L+G +PS  G  +K          L+ L +  N 
Sbjct: 404 NGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSK----------LRDLKLWLNM 453
Query: 91  FGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGE 150
             G +P  +  +  TLETLI + N +   IP+G+    NL  + + +N+L+G I   IG 
Sbjct: 454 LEGEIPQELM-YVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGR 512
Query: 151 LQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINL--- 207
           L+NL  L ++ N  SGNIP  +G+ + L+ L L  N    +IP+++ +       N    
Sbjct: 513 LENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAG 572
Query: 208 ----------------SYNNL---SGTIPPQLMDLTSLSVGLDLSRNQLVGSLPT--EVG 246
                              NL    G    QL  L++ +     SR     + PT    G
Sbjct: 573 KRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNG 632
Query: 247 KLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPXXXXXXXXXXXXXXXQ 306
            ++ L++   S NML   I   +GS   L  L LG N   G IP                
Sbjct: 633 SMMFLDM---SYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSS 689
Query: 307 NNISGEIPKFXXXXXXXXXXXXSYNDLEGVIPTEGVFKNASAISVFGNSKLCGGIPEFQL 366
           N + G IP+             S N+L G IP  G F+         N  LCG    + L
Sbjct: 690 NKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCG----YPL 745
Query: 367 PIC 369
           P C
Sbjct: 746 PRC 748

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  124 bits (310), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 96/295 (32%), Positives = 142/295 (48%), Gaps = 29/295 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGV 469
           G FG VYKG L +G T++AVK L      G       E   +    H+NL+++   C   
Sbjct: 49  GGFGKVYKGRLADG-TLVAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP 107
Query: 470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH 529
             +      LVY +M NGS+       S   +  E+   L++ +R  IA+  A  L YLH
Sbjct: 108 TER-----LLVYPYMANGSV------ASCLRERPESQPPLDWPKRQRIALGSARGLAYLH 156
Query: 530 HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEY 589
             C P   H D+K +N+LLD E  A V DFGLAKL+           V+GTIG+IAP EY
Sbjct: 157 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXX-AVRGTIGHIAP-EY 214
Query: 590 GLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLL 649
               + S   DV+ YG++LLEL+T +R  D+       L N    +L D V  ++    L
Sbjct: 215 LSTGKSSEKTDVFGYGVMLLELITGQRAFDL-----ARLANDDDVMLLDWVKGLLKEKKL 269
Query: 650 ADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQ 704
               D+ +  N +          E +  ++++ + C+  SP +R  M+ VV  L+
Sbjct: 270 EALVDVDLQGNYKD---------EEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 315

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  120 bits (302), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 90/294 (30%), Positives = 137/294 (46%), Gaps = 27/294 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G FG VYKG L +G  +   ++      G       E   +    H+NL+++   C    
Sbjct: 41  GGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 100
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
            +      LVY +M NGS+   L       +  E+   L++ +R  IA+  A  L YLH 
Sbjct: 101 ER-----LLVYPYMANGSVASCLR------ERPESQPPLDWPKRQRIALGSARGLAYLHD 149
Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
            C P   H D+K +N+LLD E  A V DFGLAKL+           V+G IG+IAP EY 
Sbjct: 150 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXX-AVRGXIGHIAP-EYL 207
Query: 591 LGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLA 650
              + S   DV+ YG++LLEL+T +R  D+       L N    +L D V  ++    L 
Sbjct: 208 STGKSSEKTDVFGYGVMLLELITGQRAFDL-----ARLANDDDVMLLDWVKGLLKEKKLE 262
Query: 651 DDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQ 704
              D+ +  N +          E +  ++++ + C+  SP +R  M+ VV  L+
Sbjct: 263 ALVDVDLQGNYKD---------EEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 104/207 (50%), Gaps = 23/207 (11%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVL----NLLHHGASKSSIAECSALRNIRHKNLVKILTVC 466
           G FG VYKG ++   T +AVK L    ++      +    E   +   +H+NLV++L   
Sbjct: 42  GGFGVVYKGYVN--NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL--- 96
Query: 467 SGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALK 526
            G    GDD   LVY +M NGSL + L  + G       P  L++  R  IA   A  + 
Sbjct: 97  -GFSSDGDDL-CLVYVYMPNGSLLDRLSCLDGT-----PP--LSWHMRCKIAQGAANGIN 147
Query: 527 YLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP 586
           +LH +      H D+K +N+LLD   TA ++DFGLA+             + GT  Y+AP
Sbjct: 148 FLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAP 204
Query: 587 AEYGLGSEVSINGDVYSYGILLLELMT 613
               L  E++   D+YS+G++LLE++T
Sbjct: 205 E--ALRGEITPKSDIYSFGVVLLEIIT 229

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 103/207 (49%), Gaps = 23/207 (11%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVL----NLLHHGASKSSIAECSALRNIRHKNLVKILTVC 466
           G FG VYKG ++   T +AVK L    ++      +    E   +   +H+NLV++L   
Sbjct: 36  GGFGVVYKGYVN--NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL--- 90
Query: 467 SGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALK 526
            G    GDD   LVY +M NGSL + L  + G          L++  R  IA   A  + 
Sbjct: 91  -GFSSDGDDL-CLVYVYMPNGSLLDRLSCLDGTPP-------LSWHMRCKIAQGAANGIN 141
Query: 527 YLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP 586
           +LH +      H D+K +N+LLD   TA ++DFGLA+             + GT  Y+AP
Sbjct: 142 FLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAP 198
Query: 587 AEYGLGSEVSINGDVYSYGILLLELMT 613
               L  E++   D+YS+G++LLE++T
Sbjct: 199 E--ALRGEITPKSDIYSFGVVLLEIIT 223

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 104/207 (50%), Gaps = 23/207 (11%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVL----NLLHHGASKSSIAECSALRNIRHKNLVKILTVC 466
           G FG VYKG ++   T +AVK L    ++      +    E   +   +H+NLV++L   
Sbjct: 42  GGFGVVYKGYVN--NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL--- 96
Query: 467 SGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALK 526
            G    GDD   LVY +M NGSL + L  + G       P  L++  R  IA   A  + 
Sbjct: 97  -GFSSDGDDL-CLVYVYMPNGSLLDRLSCLDGT-----PP--LSWHMRCKIAQGAANGIN 147
Query: 527 YLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP 586
           +LH +      H D+K +N+LLD   TA ++DFGLA+             + GT  Y+AP
Sbjct: 148 FLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAP 204
Query: 587 AEYGLGSEVSINGDVYSYGILLLELMT 613
               L  E++   D+YS+G++LLE++T
Sbjct: 205 E--ALRGEITPKSDIYSFGVVLLEIIT 229

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 131/283 (46%), Gaps = 52/283 (18%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G FG V+ G  + G T +A+K L      + ++ + E   ++ +RH+ LV++  V S   
Sbjct: 19  GCFGEVWMGTWN-GTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS--- 73
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
              ++   +V E+M  GSL ++L   +G        K L   Q +++A  +A  + Y+  
Sbjct: 74  ---EEPIXIVTEYMSKGSLLDFLKGETG--------KYLRLPQLVDMAAQIASGMAYVE- 121
Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
             +    H DL+ +N+L+   +   VADFGLA+L+   +  T+  G K  I + AP E  
Sbjct: 122 --RMNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEXTARQGAKFPIKWTAP-EAA 177
Query: 591 LGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLA 650
           L    +I  DV+S+GILL EL T+ R   + + G +N     R VL              
Sbjct: 178 LYGRFTIKSDVWSFGILLTELTTKGR---VPYPGMVN-----REVL-------------- 215
Query: 651 DDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDR 693
                    +Q +R  R+    EC  S+  +   C  + P++R
Sbjct: 216 ---------DQVERGYRMPCPPECPESLHDLMCQCWRKEPEER 249

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 130/283 (45%), Gaps = 52/283 (18%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G FG V+ G  + G T +A+K L      + ++ + E   ++ +RH+ LV++  V S   
Sbjct: 22  GCFGEVWMGTWN-GTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS--- 76
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
              ++   +V E+M  GSL ++L   +G        K L   Q +++A  +A  + Y+  
Sbjct: 77  ---EEPIYIVTEYMSKGSLLDFLKGETG--------KYLRLPQLVDMAAQIASGMAYVE- 124
Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
             +    H DL+ +N+L+   +   VADFGLA+L+      T+  G K  I + AP E  
Sbjct: 125 --RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAP-EAA 180
Query: 591 LGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLA 650
           L    +I  DV+S+GILL EL T+ R   + + G +N     R VL              
Sbjct: 181 LYGRFTIKSDVWSFGILLTELTTKGR---VPYPGMVN-----REVL-------------- 218
Query: 651 DDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDR 693
                    +Q +R  R+    EC  S+  +   C  + P++R
Sbjct: 219 ---------DQVERGYRMPCPPECPESLHDLMCQCWRKEPEER 252

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/208 (33%), Positives = 105/208 (50%), Gaps = 22/208 (10%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           I  G FG VYKG+L +G  + A+K          +    E   L   RH +LV ++  C 
Sbjct: 47  IGHGVFGKVYKGVLRDGAKV-ALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFC- 104
Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
             D + +    L+Y++M NG+L+  L+   G+D    +   +++ QR+ I I  A  L Y
Sbjct: 105 --DERNE--MILIYKYMENGNLKRHLY---GSDLPTMS---MSWEQRLEICIGAARGLHY 154
Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKL---LPPAHLQTSSIGVKGTIGYI 584
           LH        H D+K  N+LLD      + DFG++K    L   HL      VKGT+GYI
Sbjct: 155 LH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXV---VKGTLGYI 208
Query: 585 APAEYGLGSEVSINGDVYSYGILLLELM 612
            P EY +   ++   DVYS+G++L E++
Sbjct: 209 DP-EYFIKGRLTEKSDVYSFGVVLFEVL 235

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 131/283 (46%), Gaps = 52/283 (18%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G FG V+ G  + G T +A+K L      + ++ + E   ++ +RH+ LV++  V S   
Sbjct: 26  GCFGEVWMGTWN-GTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS--- 80
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
              ++   +V E+M+ GSL ++L   +G        K L   Q ++++  +A  + Y+  
Sbjct: 81  ---EEPIYIVTEYMNKGSLLDFLKGETG--------KYLRLPQLVDMSAQIASGMAYVE- 128
Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
             +    H DL+ +N+L+   +   VADFGLA+L+      T+  G K  I + AP E  
Sbjct: 129 --RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEW-TARQGAKFPIKWTAP-EAA 184
Query: 591 LGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLA 650
           L    +I  DV+S+GILL EL T+ R   + + G +N     R VL              
Sbjct: 185 LYGRFTIKSDVWSFGILLTELTTKGR---VPYPGMVN-----REVL-------------- 222
Query: 651 DDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDR 693
                    +Q +R  R+    EC  S+  +   C  + P++R
Sbjct: 223 ---------DQVERGYRMPCPPECPESLHDLMCQCWRKEPEER 256

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 106/209 (50%), Gaps = 21/209 (10%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           +  G FG V+ G  + G T +A+K L      + ++ + E   ++ +RH+ LV++  V S
Sbjct: 192 LGQGCFGEVWMGTWN-GTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
                 ++   +V E+M  GSL ++L   +G        K L   Q +++A  +A  + Y
Sbjct: 250 ------EEPIYIVTEYMSKGSLLDFLKGETG--------KYLRLPQLVDMAAQIASGMAY 295
Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPA 587
           +    +    H DL+ +N+L+   +   VADFGLA+L+      T+  G K  I + AP 
Sbjct: 296 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAP- 350
Query: 588 EYGLGSEVSINGDVYSYGILLLELMTRKR 616
           E  L    +I  DV+S+GILL EL T+ R
Sbjct: 351 EAALYGRFTIKSDVWSFGILLTELTTKGR 379

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 106/209 (50%), Gaps = 21/209 (10%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           +  G FG V+ G  + G T +A+K L      + ++ + E   ++ +RH+ LV++  V S
Sbjct: 192 LGQGCFGEVWMGTWN-GTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
                 ++   +V E+M  GSL ++L   +G        K L   Q +++A  +A  + Y
Sbjct: 250 ------EEPIYIVTEYMSKGSLLDFLKGETG--------KYLRLPQLVDMAAQIASGMAY 295
Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPA 587
           +    +    H DL+ +N+L+   +   VADFGLA+L+      T+  G K  I + AP 
Sbjct: 296 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAP- 350
Query: 588 EYGLGSEVSINGDVYSYGILLLELMTRKR 616
           E  L    +I  DV+S+GILL EL T+ R
Sbjct: 351 EAALYGRFTIKSDVWSFGILLTELTTKGR 379

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/208 (33%), Positives = 105/208 (50%), Gaps = 22/208 (10%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           I  G FG VYKG+L +G  + A+K          +    E   L   RH +LV ++  C 
Sbjct: 47  IGHGVFGKVYKGVLRDGAKV-ALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFC- 104
Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
             D + +    L+Y++M NG+L+  L+   G+D    +   +++ QR+ I I  A  L Y
Sbjct: 105 --DERNE--MILIYKYMENGNLKRHLY---GSDLPTMS---MSWEQRLEICIGAARGLHY 154
Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKL---LPPAHLQTSSIGVKGTIGYI 584
           LH        H D+K  N+LLD      + DFG++K    L   HL      VKGT+GYI
Sbjct: 155 LH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXV---VKGTLGYI 208
Query: 585 APAEYGLGSEVSINGDVYSYGILLLELM 612
            P EY +   ++   DVYS+G++L E++
Sbjct: 209 DP-EYFIKGRLTEKSDVYSFGVVLFEVL 235

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 104/206 (50%), Gaps = 21/206 (10%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G FG V+ G  + G T +A+K L      + ++ + E   ++ IRH+ LV++  V S   
Sbjct: 29  GCFGEVWMGTWN-GTTRVAIKTLKP-GTMSPEAFLQEAQVMKKIRHEKLVQLYAVVS--- 83
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
              ++   +V E+M  GSL ++L    G        K L   Q +++A  +A  + Y+  
Sbjct: 84  ---EEPIYIVTEYMSKGSLLDFLKGEMG--------KYLRLPQLVDMAAQIASGMAYVE- 131
Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
             +    H DL+ +N+L+   +   VADFGLA+L+      T+  G K  I + AP E  
Sbjct: 132 --RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAP-EAA 187
Query: 591 LGSEVSINGDVYSYGILLLELMTRKR 616
           L    +I  DV+S+GILL EL T+ R
Sbjct: 188 LYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 131/286 (45%), Gaps = 52/286 (18%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           +  G FG V+ G  + G T +A+K L      + ++ + E   ++ +RH+ LV++  V S
Sbjct: 275 LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
                 ++   +V E+M  GSL ++L   +G        K L   Q +++A  +A  + Y
Sbjct: 333 ------EEPIYIVTEYMSKGSLLDFLKGETG--------KYLRLPQLVDMAAQIASGMAY 378
Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPA 587
           +    +    H DL+ +N+L+   +   VADFGLA+L+      T+  G K  I + AP 
Sbjct: 379 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAP- 433
Query: 588 EYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDST 647
           E  L    +I  DV+S+GILL EL T+ R   + + G +N     R VL           
Sbjct: 434 EAALYGRFTIKSDVWSFGILLTELTTKGR---VPYPGMVN-----REVL----------- 474
Query: 648 LLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDR 693
                       +Q +R  R+    EC  S+  +   C  + P++R
Sbjct: 475 ------------DQVERGYRMPCPPECPESLHDLMCQCWRKEPEER 508

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 131/283 (46%), Gaps = 52/283 (18%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G FG V+ G  + G T +A+K L      + ++ + E   ++ +RH+ LV++  V S   
Sbjct: 26  GCFGEVWMGTWN-GTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS--- 80
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
              ++   +V E+M+ GSL ++L   +G        K L   Q ++++  +A  + Y+  
Sbjct: 81  ---EEPIYIVTEYMNKGSLLDFLKGETG--------KYLRLPQLVDMSAQIASGMAYVE- 128
Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
             +    H DL+ +N+L+   +   VADFGLA+L+      T+  G K  I + AP E  
Sbjct: 129 --RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAP-EAA 184
Query: 591 LGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLA 650
           L    +I  DV+S+GILL EL T+ R   + + G +N     R VL              
Sbjct: 185 LYGRFTIKSDVWSFGILLTELTTKGR---VPYPGMVN-----REVL-------------- 222
Query: 651 DDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDR 693
                    +Q +R  R+    EC  S+  +   C  + P++R
Sbjct: 223 ---------DQVERGYRMPCPPECPESLHDLMCQCWRKEPEER 256

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 106/209 (50%), Gaps = 21/209 (10%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           +  G FG V+ G  + G T +A+K L      + ++ + E   ++ +RH+ LV++  V S
Sbjct: 192 LGQGCFGEVWMGTWN-GTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
                 ++   +V E+M  GSL ++L   +G        K L   Q +++A  +A  + Y
Sbjct: 250 ------EEPIYIVGEYMSKGSLLDFLKGETG--------KYLRLPQLVDMAAQIASGMAY 295
Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPA 587
           +    +    H DL+ +N+L+   +   VADFGLA+L+      T+  G K  I + AP 
Sbjct: 296 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAP- 350
Query: 588 EYGLGSEVSINGDVYSYGILLLELMTRKR 616
           E  L    +I  DV+S+GILL EL T+ R
Sbjct: 351 EAALYGRFTIKSDVWSFGILLTELTTKGR 379

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 129/283 (45%), Gaps = 52/283 (18%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G FG V+ G  + G T +A+K L      + ++ + E   ++ +RH+ LV++  V S   
Sbjct: 18  GCFGEVWMGTWN-GTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS--- 72
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
              ++   +V E+M  GSL ++L    G        K L   Q +++A  +A  + Y+  
Sbjct: 73  ---EEPIYIVTEYMSKGSLLDFLKGEMG--------KYLRLPQLVDMAAQIASGMAYVE- 120
Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
             +    H DL+ +N+L+   +   VADFGLA+L+      T+  G K  I + AP E  
Sbjct: 121 --RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAP-EAA 176
Query: 591 LGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLA 650
           L    +I  DV+S+GILL EL T+ R   + + G +N     R VL              
Sbjct: 177 LYGRFTIKSDVWSFGILLTELTTKGR---VPYPGMVN-----REVL-------------- 214
Query: 651 DDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDR 693
                    +Q +R  R+    EC  S+  +   C  + P++R
Sbjct: 215 ---------DQVERGYRMPCPPECPESLHDLMCQCWRKDPEER 248

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 109/247 (44%), Gaps = 11/247 (4%)
Query: 77  CNQHLKHLDINNNNFGGL-------LPGCICNFSITLETLIFNSNKIFRSIPAGIGKFIN 129
           C+   +   +NN +  GL       +P  + N        I   N +   IP  I K   
Sbjct: 43  CDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQ 102
Query: 130 LQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQ 189
           L  L++    +SG I   + +++ LVTL  + N LSG +PPSI +L  L+ +    N + 
Sbjct: 103 LHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRIS 162
Query: 190 VSIPSSLGQCQSL-TTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKL 248
            +IP S G    L T++ +S N L+G IPP   +L    V  DLSRN L G      G  
Sbjct: 163 GAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFV--DLSRNMLEGDASVLFGSD 220
Query: 249 INLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPXXXXXXXXXXXXXXXQNN 308
            N + + +++N L  + L  +G    L  L L  N   G +P                NN
Sbjct: 221 KNTQKIHLAKNSLAFD-LGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNN 279
Query: 309 ISGEIPK 315
           + GEIP+
Sbjct: 280 LCGEIPQ 286

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 106/251 (42%), Gaps = 7/251 (2%)
Query: 120 IPAGIGKFINLQTLHMWD-NQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKL 178
           IP+ +     L  L++   N L G I PAI +L  L  L I    +SG IP  +  +K L
Sbjct: 68  IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTL 127
Query: 179 LQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLV 238
           + L    N L  ++P S+    +L  I    N +SG IP      + L   + +SRN+L 
Sbjct: 128 VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLT 187
Query: 239 GSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPXXXXXXXX 298
           G +P     L NL  + +SRNMLE +     GS    +++ L  N     +         
Sbjct: 188 GKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKN 245
Query: 299 XXXXXXXQNNISGEIPKFXXXXXXXXXXXXSYNDLEGVIPTEGVFKNASAISVFGNSKLC 358
                   N I G +P+             S+N+L G IP  G  +    +S + N+K  
Sbjct: 246 LNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFD-VSAYANNKCL 304
Query: 359 GGIPEFQLPIC 369
            G P   LP C
Sbjct: 305 CGSP---LPAC 312

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 129/283 (45%), Gaps = 52/283 (18%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G FG V+ G  + G T +A+K L      + ++ + E   ++ +RH+ LV++  V S   
Sbjct: 20  GCFGEVWMGTWN-GTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS--- 74
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
              ++   +V E+M  GSL ++L    G        K L   Q +++A  +A  + Y+  
Sbjct: 75  ---EEPIYIVTEYMSKGSLLDFLKGEMG--------KYLRLPQLVDMAAQIASGMAYVE- 122
Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
             +    H DL+ +N+L+   +   VADFGLA+L+      T+  G K  I + AP E  
Sbjct: 123 --RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAP-EAA 178
Query: 591 LGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLA 650
           L    +I  DV+S+GILL EL T+ R   + + G +N     R VL              
Sbjct: 179 LYGRFTIKSDVWSFGILLTELTTKGR---VPYPGMVN-----REVL-------------- 216
Query: 651 DDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDR 693
                    +Q +R  R+    EC  S+  +   C  + P++R
Sbjct: 217 ---------DQVERGYRMPCPPECPESLHDLMCQCWRKDPEER 250

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 104/206 (50%), Gaps = 21/206 (10%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G FG V+ G  + G T +A+K L      + ++ + E   ++ +RH+ LV++  V S   
Sbjct: 29  GCFGEVWMGTWN-GTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS--- 83
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
              ++   +V E+M  GSL ++L    G        K L   Q +++A  +A  + Y+  
Sbjct: 84  ---EEPIYIVIEYMSKGSLLDFLKGEMG--------KYLRLPQLVDMAAQIASGMAYVE- 131
Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
             +    H DL+ +N+L+   +   VADFGLA+L+      T+  G K  I + AP E  
Sbjct: 132 --RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAP-EAA 187
Query: 591 LGSEVSINGDVYSYGILLLELMTRKR 616
           L    +I  DV+S+GILL EL T+ R
Sbjct: 188 LYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 104/206 (50%), Gaps = 21/206 (10%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G FG V+ G  + G T +A+K L      + ++ + E   ++ +RH+ LV++  V S   
Sbjct: 29  GCFGEVWMGTWN-GTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS--- 83
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
              ++   +V E+M  GSL ++L    G        K L   Q +++A  +A  + Y+  
Sbjct: 84  ---EEPIYIVIEYMSKGSLLDFLKGEMG--------KYLRLPQLVDMAAQIASGMAYVE- 131
Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
             +    H DL+ +N+L+   +   VADFGLA+L+      T+  G K  I + AP E  
Sbjct: 132 --RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEX-TARQGAKFPIKWTAP-EAA 187
Query: 591 LGSEVSINGDVYSYGILLLELMTRKR 616
           L    +I  DV+S+GILL EL T+ R
Sbjct: 188 LYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 104/206 (50%), Gaps = 21/206 (10%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G FG V+ G  + G T +A+K L      + ++ + E   ++ +RH+ LV++  V S   
Sbjct: 29  GCFGEVWMGTWN-GTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS--- 83
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
              ++   +V E+M  GSL ++L    G        K L   Q +++A  +A  + Y+  
Sbjct: 84  ---EEPIYIVTEYMSKGSLLDFLKGEMG--------KYLRLPQLVDMAAQIASGMAYVE- 131
Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
             +    H DL+ +N+L+   +   VADFGLA+L+      T+  G K  I + AP E  
Sbjct: 132 --RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAP-EAA 187
Query: 591 LGSEVSINGDVYSYGILLLELMTRKR 616
           L    +I  DV+S+GILL EL T+ R
Sbjct: 188 LYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 129/283 (45%), Gaps = 52/283 (18%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G FG V+ G  + G T +A+K L      + ++ + E   ++ +RH+ LV++  V S   
Sbjct: 29  GCFGEVWMGTWN-GTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS--- 83
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
              ++   +V E+M  GSL ++L    G        K L   Q +++A  +A  + Y+  
Sbjct: 84  ---EEPIYIVCEYMSKGSLLDFLKGEMG--------KYLRLPQLVDMAAQIASGMAYVE- 131
Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
             +    H DL+ +N+L+   +   VADFGLA+L+      T+  G K  I + AP E  
Sbjct: 132 --RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAP-EAA 187
Query: 591 LGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLA 650
           L    +I  DV+S+GILL EL T+ R   + + G +N     R VL              
Sbjct: 188 LYGRFTIKSDVWSFGILLTELTTKGR---VPYPGMVN-----REVL-------------- 225
Query: 651 DDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDR 693
                    +Q +R  R+    EC  S+  +   C  + P++R
Sbjct: 226 ---------DQVERGYRMPCPPECPESLHDLMCQCWRKDPEER 259

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 100/207 (48%), Gaps = 23/207 (11%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVL----NLLHHGASKSSIAECSALRNIRHKNLVKILTVC 466
           G FG VYKG ++   T +AVK L    ++      +    E       +H+NLV++L   
Sbjct: 33  GGFGVVYKGYVN--NTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELL--- 87
Query: 467 SGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALK 526
            G    GDD   LVY +  NGSL + L  + G          L++  R  IA   A  + 
Sbjct: 88  -GFSSDGDDL-CLVYVYXPNGSLLDRLSCLDGTPP-------LSWHXRCKIAQGAANGIN 138
Query: 527 YLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP 586
           +LH +      H D+K +N+LLD   TA ++DFGLA+             + GT  Y AP
Sbjct: 139 FLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAP 195
Query: 587 AEYGLGSEVSINGDVYSYGILLLELMT 613
               L  E++   D+YS+G++LLE++T
Sbjct: 196 E--ALRGEITPKSDIYSFGVVLLEIIT 220

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 105/209 (50%), Gaps = 21/209 (10%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           +  G FG V+ G  + G T +A+K L    + + ++ + E   ++ +RH+ LV++  V S
Sbjct: 193 LGQGCFGEVWMGTWN-GTTRVAIKTLKP-GNMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 250
Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
                 ++   +V E+M  GSL ++L    G        K L   Q +++A  +A  + Y
Sbjct: 251 ------EEPIYIVTEYMSKGSLLDFLKGEMG--------KYLRLPQLVDMAAQIASGMAY 296
Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPA 587
           +    +    H DL+ +N+L+   +   VADFGL +L+      T+  G K  I + AP 
Sbjct: 297 VE---RMNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEY-TARQGAKFPIKWTAP- 351
Query: 588 EYGLGSEVSINGDVYSYGILLLELMTRKR 616
           E  L    +I  DV+S+GILL EL T+ R
Sbjct: 352 EAALYGRFTIKSDVWSFGILLTELTTKGR 380

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 76/283 (26%), Positives = 130/283 (45%), Gaps = 52/283 (18%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G FG V+ G  + G T +A+K L      + +S + E   ++ ++H  LV++  V S   
Sbjct: 20  GQFGEVWMGTWN-GNTKVAIKTLKP-GTMSPESFLEEAQIMKKLKHDKLVQLYAVVS--- 74
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
              ++   +V E+M+ GSL ++L    G        + L     +++A  VA  + Y+  
Sbjct: 75  ---EEPIYIVTEYMNKGSLLDFLKDGEG--------RALKLPNLVDMAAQVAAGMAYIE- 122
Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
             +    H DL+ +N+L+ + +   +ADFGLA+L+      T+  G K  I + AP E  
Sbjct: 123 --RMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNE-XTARQGAKFPIKWTAP-EAA 178
Query: 591 LGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLA 650
           L    +I  DV+S+GILL EL+T+ R   + + G  N     R VL              
Sbjct: 179 LYGRFTIKSDVWSFGILLTELVTKGR---VPYPGMNN-----REVL-------------- 216
Query: 651 DDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDR 693
                     Q +R  R+    +C IS+  + + C  + P++R
Sbjct: 217 ---------EQVERGYRMPCPQDCPISLHELMIHCWKKDPEER 250

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 128/283 (45%), Gaps = 52/283 (18%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G FG V+ G  + G T +A+K L      + ++ + E   ++ +RH+ LV++  V S   
Sbjct: 29  GCFGEVWMGTWN-GTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS--- 83
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
              ++   +V E+M  GSL ++L    G        K L   Q +++A  +A  + Y+  
Sbjct: 84  ---EEPIYIVTEYMSKGSLLDFLKGEMG--------KYLRLPQLVDMAAQIASGMAYVE- 131
Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
             +    H DL  +N+L+   +   VADFGLA+L+      T+  G K  I + AP E  
Sbjct: 132 --RMNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAP-EAA 187
Query: 591 LGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLA 650
           L    +I  DV+S+GILL EL T+ R   + + G +N     R VL              
Sbjct: 188 LYGRFTIKSDVWSFGILLTELTTKGR---VPYPGMVN-----REVL-------------- 225
Query: 651 DDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDR 693
                    +Q +R  R+    EC  S+  +   C  + P++R
Sbjct: 226 ---------DQVERGYRMPCPPECPESLHDLMCQCWRKDPEER 259

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/222 (31%), Positives = 114/222 (51%), Gaps = 25/222 (11%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVL--NLLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           I  GSFG+V++   +   + +AVK+L     H       + E + ++ +RH N+V  +  
Sbjct: 45  IGAGSFGTVHRA--EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM-- 100
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
             G   +  +  ++V E++  GSL   LH  SGA +       L+  +R+++A DVA  +
Sbjct: 101 --GAVTQPPNL-SIVTEYLSRGSLYRLLH-KSGAREQ------LDERRRLSMAYDVAKGM 150
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            YLH+   P   H +LK  N+L+D + T  V DFGL++L     L  SS    GT  ++A
Sbjct: 151 NYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL--SSKSAAGTPEWMA 207
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMN 627
           P E       +   DVYS+G++L EL T ++P      GN+N
Sbjct: 208 P-EVLRDEPSNEKSDVYSFGVILWELATLQQPW-----GNLN 243

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 117/234 (50%), Gaps = 28/234 (11%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGA--SKSSIAECSALRNIRHKNLVKILTVCSG 468
           G FG V+ G  + G T +AVK L     G+    + +AE + ++ ++H+ LV++  V + 
Sbjct: 30  GQFGEVWMGYYN-GHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT- 84
Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL 528
                 +   ++ E+M NGSL ++L   SG   T+         + +++A  +A  + ++
Sbjct: 85  -----QEPIYIITEYMENGSLVDFLKTPSGIKLTIN--------KLLDMAAQIAEGMAFI 131
Query: 529 HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAE 588
               +    H DL+ +N+L+   ++  +ADFGLA+L+      T+  G K  I + AP  
Sbjct: 132 E---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEA 187
Query: 589 YGLGSEVSINGDVYSYGILLLELMTRKR---PSDIMFEGNMNLHNFARTVLPDH 639
              G+  +I  DV+S+GILL E++T  R   P     E   NL    R V PD+
Sbjct: 188 INYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 240

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 117/232 (50%), Gaps = 24/232 (10%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G FG V+ G  + G T +AVK L      +  + +AE + ++ ++H+ LV++  V +   
Sbjct: 33  GQFGEVWMGYYN-GHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVVT--- 87
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
               +   ++ E+M NGSL ++L   SG   T+         + +++A  +A  + ++  
Sbjct: 88  ---QEPIYIITEYMENGSLVDFLKTPSGIKLTIN--------KLLDMAAQIAEGMAFIE- 135
Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
             +    H DL+ +N+L+   ++  +ADFGLA+L+   +  T+  G K  I + AP    
Sbjct: 136 --ERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEAIN 192
Query: 591 LGSEVSINGDVYSYGILLLELMTRKR---PSDIMFEGNMNLHNFARTVLPDH 639
            G+  +I  DV+S+GILL E++T  R   P     E   NL    R V PD+
Sbjct: 193 YGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 243

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 116/232 (50%), Gaps = 24/232 (10%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G FG V+ G  + G T +AVK L      +  + +AE + ++ ++H+ LV++  V +   
Sbjct: 30  GQFGEVWMGYYN-GHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVVT--- 84
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
               +   ++ E+M NGSL ++L   SG   T+         + +++A  +A  + ++  
Sbjct: 85  ---QEPIYIITEYMENGSLVDFLKTPSGIKLTIN--------KLLDMAAQIAEGMAFIE- 132
Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
             +    H DL+ +N+L+   ++  +ADFGLA+L+      T+  G K  I + AP    
Sbjct: 133 --ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX-TAREGAKFPIKWTAPEAIN 189
Query: 591 LGSEVSINGDVYSYGILLLELMTRKR---PSDIMFEGNMNLHNFARTVLPDH 639
            G+  +I  DV+S+GILL E++T  R   P     E   NL    R V PD+
Sbjct: 190 YGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 240

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 111/222 (50%), Gaps = 25/222 (11%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVL--NLLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           I  GSFG+V++   +   + +AVK+L     H       + E + ++ +RH N+V  +  
Sbjct: 45  IGAGSFGTVHRA--EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
            +          ++V E++  GSL   LH  SGA +       L+  +R+++A DVA  +
Sbjct: 103 VTQPPNL-----SIVTEYLSRGSLYRLLH-KSGAREQ------LDERRRLSMAYDVAKGM 150
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            YLH+   P   H DLK  N+L+D + T  V DFGL++L     L +      GT  ++A
Sbjct: 151 NYLHNR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAA--GTPEWMA 207
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMN 627
           P E       +   DVYS+G++L EL T ++P      GN+N
Sbjct: 208 P-EVLRDEPSNEKSDVYSFGVILWELATLQQPW-----GNLN 243

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 117/234 (50%), Gaps = 28/234 (11%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGA--SKSSIAECSALRNIRHKNLVKILTVCSG 468
           G FG V+ G  + G T +AVK L     G+    + +AE + ++ ++H+ LV++  V + 
Sbjct: 29  GQFGEVWMGYYN-GHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT- 83
Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL 528
                 +   ++ E+M NGSL ++L   SG   T+         + +++A  +A  + ++
Sbjct: 84  -----QEPIYIITEYMENGSLVDFLKTPSGIKLTIN--------KLLDMAAQIAEGMAFI 130
Query: 529 HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAE 588
               +    H DL+ +N+L+   ++  +ADFGLA+L+      T+  G K  I + AP  
Sbjct: 131 E---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEA 186
Query: 589 YGLGSEVSINGDVYSYGILLLELMTRKR---PSDIMFEGNMNLHNFARTVLPDH 639
              G+  +I  DV+S+GILL E++T  R   P     E   NL    R V PD+
Sbjct: 187 INYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 239

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 116/232 (50%), Gaps = 24/232 (10%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G FG V+ G  + G T +AVK L      +  + +AE + ++ ++H+ LV++  V +   
Sbjct: 32  GQFGEVWMGYYN-GHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVVT--- 86
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
               +   ++ E+M NGSL ++L   SG   T+         + +++A  +A  + ++  
Sbjct: 87  ---QEPIYIITEYMENGSLVDFLKTPSGIKLTIN--------KLLDMAAQIAEGMAFIE- 134
Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
             +    H DL+ +N+L+   ++  +ADFGLA+L+      T+  G K  I + AP    
Sbjct: 135 --ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX-TAREGAKFPIKWTAPEAIN 191
Query: 591 LGSEVSINGDVYSYGILLLELMTRKR---PSDIMFEGNMNLHNFARTVLPDH 639
            G+  +I  DV+S+GILL E++T  R   P     E   NL    R V PD+
Sbjct: 192 YGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 242

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 117/234 (50%), Gaps = 28/234 (11%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGA--SKSSIAECSALRNIRHKNLVKILTVCSG 468
           G FG V+ G  + G T +AVK L     G+    + +AE + ++ ++H+ LV++  V + 
Sbjct: 19  GQFGEVWMGYYN-GHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT- 73
Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL 528
                 +   ++ E+M NGSL ++L   SG   T+         + +++A  +A  + ++
Sbjct: 74  -----QEPIYIITEYMENGSLVDFLKTPSGIKLTIN--------KLLDMAAQIAEGMAFI 120
Query: 529 HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAE 588
               +    H DL+ +N+L+   ++  +ADFGLA+L+      T+  G K  I + AP  
Sbjct: 121 E---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEA 176
Query: 589 YGLGSEVSINGDVYSYGILLLELMTRKR---PSDIMFEGNMNLHNFARTVLPDH 639
              G+  +I  DV+S+GILL E++T  R   P     E   NL    R V PD+
Sbjct: 177 INYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 229

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 117/234 (50%), Gaps = 28/234 (11%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGA--SKSSIAECSALRNIRHKNLVKILTVCSG 468
           G FG V+ G  + G T +AVK L     G+    + +AE + ++ ++H+ LV++  V + 
Sbjct: 25  GQFGEVWMGYYN-GHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT- 79
Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL 528
                 +   ++ E+M NGSL ++L   SG   T+         + +++A  +A  + ++
Sbjct: 80  -----QEPIYIITEYMENGSLVDFLKTPSGIKLTIN--------KLLDMAAQIAEGMAFI 126
Query: 529 HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAE 588
               +    H DL+ +N+L+   ++  +ADFGLA+L+      T+  G K  I + AP  
Sbjct: 127 E---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-XTAREGAKFPIKWTAPEA 182
Query: 589 YGLGSEVSINGDVYSYGILLLELMTRKR---PSDIMFEGNMNLHNFARTVLPDH 639
              G+  +I  DV+S+GILL E++T  R   P     E   NL    R V PD+
Sbjct: 183 INYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 235

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 116/232 (50%), Gaps = 24/232 (10%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G FG V+ G  + G T +AVK L      +  + +AE + ++ ++H+ LV++  V +   
Sbjct: 26  GQFGEVWMGYYN-GHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVVT--- 80
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
               +   ++ E+M NGSL ++L   SG   T+         + +++A  +A  + ++  
Sbjct: 81  ---QEPIYIITEYMENGSLVDFLKTPSGIKLTIN--------KLLDMAAQIAEGMAFIE- 128
Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
             +    H DL+ +N+L+   ++  +ADFGLA+L+      T+  G K  I + AP    
Sbjct: 129 --ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-XTAREGAKFPIKWTAPEAIN 185
Query: 591 LGSEVSINGDVYSYGILLLELMTRKR---PSDIMFEGNMNLHNFARTVLPDH 639
            G+  +I  DV+S+GILL E++T  R   P     E   NL    R V PD+
Sbjct: 186 YGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 236

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 117/234 (50%), Gaps = 28/234 (11%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGA--SKSSIAECSALRNIRHKNLVKILTVCSG 468
           G FG V+ G  + G T +AVK L     G+    + +AE + ++ ++H+ LV++  V + 
Sbjct: 24  GQFGEVWMGYYN-GHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT- 78
Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL 528
                 +   ++ E+M NGSL ++L   SG   T+         + +++A  +A  + ++
Sbjct: 79  -----QEPIYIITEYMENGSLVDFLKTPSGIKLTIN--------KLLDMAAQIAEGMAFI 125
Query: 529 HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAE 588
               +    H DL+ +N+L+   ++  +ADFGLA+L+      T+  G K  I + AP  
Sbjct: 126 E---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEA 181
Query: 589 YGLGSEVSINGDVYSYGILLLELMTRKR---PSDIMFEGNMNLHNFARTVLPDH 639
              G+  +I  DV+S+GILL E++T  R   P     E   NL    R V PD+
Sbjct: 182 INYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 234

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 117/234 (50%), Gaps = 28/234 (11%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGA--SKSSIAECSALRNIRHKNLVKILTVCSG 468
           G FG V+ G  + G T +AVK L     G+    + +AE + ++ ++H+ LV++  V + 
Sbjct: 24  GQFGEVWMGYYN-GHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT- 78
Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL 528
                 +   ++ E+M NGSL ++L   SG   T+         + +++A  +A  + ++
Sbjct: 79  -----QEPIYIITEYMENGSLVDFLKTPSGIKLTIN--------KLLDMAAQIAEGMAFI 125
Query: 529 HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAE 588
               +    H DL+ +N+L+   ++  +ADFGLA+L+      T+  G K  I + AP  
Sbjct: 126 E---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX-TAREGAKFPIKWTAPEA 181
Query: 589 YGLGSEVSINGDVYSYGILLLELMTRKR---PSDIMFEGNMNLHNFARTVLPDH 639
              G+  +I  DV+S+GILL E++T  R   P     E   NL    R V PD+
Sbjct: 182 INYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 234

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 103/206 (50%), Gaps = 21/206 (10%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G FG V+ G  + G T +A+K L      + ++ + E   ++ +RH+ LV++  V S   
Sbjct: 29  GCFGEVWMGTWN-GTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS--- 83
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
              ++   +V E+M  G L ++L    G        K L   Q +++A  +A  + Y+  
Sbjct: 84  ---EEPIYIVMEYMSKGCLLDFLKGEMG--------KYLRLPQLVDMAAQIASGMAYVE- 131
Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
             +    H DL+ +N+L+   +   VADFGLA+L+      T+  G K  I + AP E  
Sbjct: 132 --RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAP-EAA 187
Query: 591 LGSEVSINGDVYSYGILLLELMTRKR 616
           L    +I  DV+S+GILL EL T+ R
Sbjct: 188 LYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 128/283 (45%), Gaps = 52/283 (18%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G FG V+ G  + G T +A+K L      + ++ + E   ++ +RH+ LV++  V S   
Sbjct: 29  GCFGEVWMGTWN-GTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS--- 83
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
              ++   +V E+M  G L ++L    G        K L   Q +++A  +A  + Y+  
Sbjct: 84  ---EEPIYIVTEYMSKGCLLDFLKGEMG--------KYLRLPQLVDMAAQIASGMAYVE- 131
Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
             +    H DL+ +N+L+   +   VADFGLA+L+      T+  G K  I + AP E  
Sbjct: 132 --RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAP-EAA 187
Query: 591 LGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLA 650
           L    +I  DV+S+GILL EL T+ R   + + G +N     R VL              
Sbjct: 188 LYGRFTIKSDVWSFGILLTELTTKGR---VPYPGMVN-----REVL-------------- 225
Query: 651 DDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDR 693
                    +Q +R  R+    EC  S+  +   C  + P++R
Sbjct: 226 ---------DQVERGYRMPCPPECPESLHDLMCQCWRKDPEER 259

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 117/234 (50%), Gaps = 28/234 (11%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGA--SKSSIAECSALRNIRHKNLVKILTVCSG 468
           G FG V+ G  + G T +AVK L     G+    + +AE + ++ ++H+ LV++  V + 
Sbjct: 34  GQFGEVWMGYYN-GHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT- 88
Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL 528
                 +   ++ E+M NGSL ++L   SG   T+         + +++A  +A  + ++
Sbjct: 89  -----QEPIYIITEYMENGSLVDFLKTPSGIKLTIN--------KLLDMAAQIAEGMAFI 135
Query: 529 HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAE 588
               +    H DL+ +N+L+   ++  +ADFGLA+L+      T+  G K  I + AP  
Sbjct: 136 E---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEA 191
Query: 589 YGLGSEVSINGDVYSYGILLLELMTRKR---PSDIMFEGNMNLHNFARTVLPDH 639
              G+  +I  DV+S+GILL E++T  R   P     E   NL    R V PD+
Sbjct: 192 INYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 244

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 117/234 (50%), Gaps = 28/234 (11%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGA--SKSSIAECSALRNIRHKNLVKILTVCSG 468
           G FG V+ G  + G T +AVK L     G+    + +AE + ++ ++H+ LV++  V + 
Sbjct: 24  GQFGEVWMGYYN-GHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT- 78
Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL 528
                 +   ++ E+M NGSL ++L   SG   T+         + +++A  +A  + ++
Sbjct: 79  -----QEPIYIITEYMENGSLVDFLKTPSGIKLTIN--------KLLDMAAQIAEGMAFI 125
Query: 529 HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAE 588
               +    H DL+ +N+L+   ++  +ADFGLA+L+      T+  G K  I + AP  
Sbjct: 126 E---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-XTAREGAKFPIKWTAPEA 181
Query: 589 YGLGSEVSINGDVYSYGILLLELMTRKR---PSDIMFEGNMNLHNFARTVLPDH 639
              G+  +I  DV+S+GILL E++T  R   P     E   NL    R V PD+
Sbjct: 182 INYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 234

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 117/234 (50%), Gaps = 28/234 (11%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGA--SKSSIAECSALRNIRHKNLVKILTVCSG 468
           G  G V+ G  + G T +AVK L     G+    + +AE + ++ ++H+ LV++  V + 
Sbjct: 24  GQAGEVWMGYYN-GHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT- 78
Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL 528
                 +   ++ E+M NGSL ++L   SG   T+         + +++A  +A  + ++
Sbjct: 79  -----QEPIYIITEYMENGSLVDFLKTPSGIKLTIN--------KLLDMAAQIAEGMAFI 125
Query: 529 HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAE 588
               +    H DL+ +N+L+   ++  +ADFGLA+L+  A   T+  G K  I + AP  
Sbjct: 126 E---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEX-TAREGAKFPIKWTAPEA 181
Query: 589 YGLGSEVSINGDVYSYGILLLELMTRKR---PSDIMFEGNMNLHNFARTVLPDH 639
              G+  +I  DV+S+GILL E++T  R   P     E   NL    R V PD+
Sbjct: 182 INYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 234

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 116/232 (50%), Gaps = 24/232 (10%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G FG V+ G  + G T +AVK L      +  + +AE + ++ ++H+ LV++  V +   
Sbjct: 20  GQFGEVWMGYYN-GHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVVT--- 74
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
               +   ++ E+M NGSL ++L   SG   T+         + +++A  +A  + ++  
Sbjct: 75  ---QEPIYIITEYMENGSLVDFLKTPSGIKLTIN--------KLLDMAAQIAEGMAFIE- 122
Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
             +    H +L+ +N+L+   ++  +ADFGLA+L+      T+  G K  I + AP    
Sbjct: 123 --ERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAIN 179
Query: 591 LGSEVSINGDVYSYGILLLELMTRKR---PSDIMFEGNMNLHNFARTVLPDH 639
            G+  +I  DV+S+GILL E++T  R   P     E   NL    R V PD+
Sbjct: 180 YGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 230

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 104/209 (49%), Gaps = 27/209 (12%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G FG V+    ++  T +AVK +      + ++ +AE + ++ ++H  LVK+  V +   
Sbjct: 26  GQFGEVWMATYNK-HTKVAVKTMKP-GSMSVEAFLAEANVMKTLQHDKLVKLHAVVT--- 80
Query: 471 YKGDDFKALVY---EFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
                 K  +Y   EFM  GSL ++L    G+ + +  PK ++F  +I   +       Y
Sbjct: 81  ------KEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRNY 132
Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPA 587
           +H D         L+ +N+L+   +   +ADFGLA+++      T+  G K  I + AP 
Sbjct: 133 IHRD---------LRAANILVSASLVCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPE 182
Query: 588 EYGLGSEVSINGDVYSYGILLLELMTRKR 616
               GS  +I  DV+S+GILL+E++T  R
Sbjct: 183 AINFGS-FTIKSDVWSFGILLMEIVTYGR 210

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 103/209 (49%), Gaps = 27/209 (12%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G FG V+    ++  T +AVK +        ++ +AE + ++ ++H  LVK+  V +   
Sbjct: 199 GQFGEVWMATYNK-HTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHAVVT--- 253
Query: 471 YKGDDFKALVY---EFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
                 K  +Y   EFM  GSL ++L    G+ + +  PK ++F  +I   +       Y
Sbjct: 254 ------KEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRNY 305
Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPA 587
           +H D         L+ +N+L+   +   +ADFGLA+++      T+  G K  I + AP 
Sbjct: 306 IHRD---------LRAANILVSASLVCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPE 355
Query: 588 EYGLGSEVSINGDVYSYGILLLELMTRKR 616
               GS  +I  DV+S+GILL+E++T  R
Sbjct: 356 AINFGS-FTIKSDVWSFGILLMEIVTYGR 383

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G +G VY+G+  +    +AVK L        +  + E + ++ I+H NLV++L VC+   
Sbjct: 29  GQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--- 84
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
            +   F  ++ EFM  G+L ++L   +  +        +N +  + +A  ++ A++YL  
Sbjct: 85  -REPPFYIII-EFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYLE- 133
Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
             +    H DL   N L+       VADFGL++L+      T+  G K  I + AP    
Sbjct: 134 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLA 190
Query: 591 LGSEVSINGDVYSYGILLLELMT 613
             ++ SI  DV+++G+LL E+ T
Sbjct: 191 Y-NKFSIKSDVWAFGVLLWEIAT 212

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G +G VY+G+  +    +AVK L        +  + E + ++ I+H NLV++L VC+   
Sbjct: 25  GQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--- 80
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
            +   F  ++ EFM  G+L ++L   +  +        +N +  + +A  ++ A++YL  
Sbjct: 81  -REPPF-YIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYLE- 129
Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
             +    H DL   N L+       VADFGL++L+      T+  G K  I + AP    
Sbjct: 130 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAPAGAKFPIKWTAPESLA 186
Query: 591 LGSEVSINGDVYSYGILLLELMT 613
             ++ SI  DV+++G+LL E+ T
Sbjct: 187 Y-NKFSIKSDVWAFGVLLWEIAT 208

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G +G VY+G+  +    +AVK L        +  + E + ++ I+H NLV++L VC+   
Sbjct: 25  GQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--- 80
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
            +   F  ++ EFM  G+L ++L   +  +        +N +  + +A  ++ A++YL  
Sbjct: 81  -REPPFYIII-EFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYLE- 129
Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
             +    H DL   N L+       VADFGL++L+      T+  G K  I + AP    
Sbjct: 130 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTAPESLA 186
Query: 591 LGSEVSINGDVYSYGILLLELMT 613
             ++ SI  DV+++G+LL E+ T
Sbjct: 187 Y-NKFSIKSDVWAFGVLLWEIAT 208

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G +G VY+G+  +    +AVK L        +  + E + ++ I+H NLV++L VC+   
Sbjct: 29  GQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--- 84
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
            +   F  ++ EFM  G+L ++L   +  +        +N +  + +A  ++ A++YL  
Sbjct: 85  -REPPF-YIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYLE- 133
Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
             +    H DL   N L+       VADFGL++L+      T+  G K  I + AP    
Sbjct: 134 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLA 190
Query: 591 LGSEVSINGDVYSYGILLLELMT 613
             ++ SI  DV+++G+LL E+ T
Sbjct: 191 Y-NKFSIKSDVWAFGVLLWEIAT 212

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G +G VY+G+  +    +AVK L        +  + E + ++ I+H NLV++L VC+   
Sbjct: 29  GQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--- 84
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
            +   F  ++ EFM  G+L ++L   +  +        +N +  + +A  ++ A++YL  
Sbjct: 85  -REPPF-YIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYLE- 133
Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
             +    H DL   N L+       VADFGL++L+      T+  G K  I + AP    
Sbjct: 134 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTAPESLA 190
Query: 591 LGSEVSINGDVYSYGILLLELMT 613
             ++ SI  DV+++G+LL E+ T
Sbjct: 191 Y-NKFSIKSDVWAFGVLLWEIAT 212

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G +G VY+G+  +    +AVK L        +  + E + ++ I+H NLV++L VC+   
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--- 79
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
            +   F  ++ EFM  G+L ++L   +  +        +N +  + +A  ++ A++YL  
Sbjct: 80  -REPPF-YIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYLE- 128
Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
             +    H DL   N L+       VADFGL++L+      T+  G K  I + AP    
Sbjct: 129 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLA 185
Query: 591 LGSEVSINGDVYSYGILLLELMT 613
             ++ SI  DV+++G+LL E+ T
Sbjct: 186 Y-NKFSIKSDVWAFGVLLWEIAT 207

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G +G VY+G+  +    +AVK L        +  + E + ++ I+H NLV++L VC+   
Sbjct: 37  GQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--- 92
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
            +   F  ++ EFM  G+L ++L   +  +        +N +  + +A  ++ A++YL  
Sbjct: 93  -REPPF-YIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYLE- 141
Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
             +    H DL   N L+       VADFGL++L+      T+  G K  I + AP    
Sbjct: 142 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLA 198
Query: 591 LGSEVSINGDVYSYGILLLELMT 613
             ++ SI  DV+++G+LL E+ T
Sbjct: 199 Y-NKFSIKSDVWAFGVLLWEIAT 220

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G +G VY+G+  +    +AVK L        +  + E + ++ I+H NLV++L VC+   
Sbjct: 26  GQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--- 81
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
            +   F  ++ EFM  G+L ++L   +  +        +N +  + +A  ++ A++YL  
Sbjct: 82  -REPPF-YIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYLE- 130
Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
             +    H DL   N L+       VADFGL++L+      T+  G K  I + AP    
Sbjct: 131 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAPAGAKFPIKWTAPESLA 187
Query: 591 LGSEVSINGDVYSYGILLLELMT 613
             ++ SI  DV+++G+LL E+ T
Sbjct: 188 Y-NKFSIKSDVWAFGVLLWEIAT 209

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G +G VY+G+  +    +AVK L        +  + E + ++ I+H NLV++L VC+   
Sbjct: 29  GQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--- 84
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
            +   F  ++ EFM  G+L ++L   +  +        +N +  + +A  ++ A++YL  
Sbjct: 85  -REPPF-YIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYLE- 133
Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
             +    H DL   N L+       VADFGL++L+      T+  G K  I + AP    
Sbjct: 134 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLA 190
Query: 591 LGSEVSINGDVYSYGILLLELMT 613
             ++ SI  DV+++G+LL E+ T
Sbjct: 191 Y-NKFSIKSDVWAFGVLLWEIAT 212

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G +G VY+G+  +    +AVK L        +  + E + ++ I+H NLV++L VC+   
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--- 79
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
            +   F  ++ EFM  G+L ++L   +  +        +N +  + +A  ++ A++YL  
Sbjct: 80  -REPPF-YIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYLE- 128
Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
             +    H DL   N L+       VADFGL++L+      T+  G K  I + AP    
Sbjct: 129 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLA 185
Query: 591 LGSEVSINGDVYSYGILLLELMT 613
             ++ SI  DV+++G+LL E+ T
Sbjct: 186 Y-NKFSIKSDVWAFGVLLWEIAT 207

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G +G VY+G+  +    +AVK L        +  + E + ++ I+H NLV++L VC+   
Sbjct: 26  GQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--- 81
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
            +   F  ++ EFM  G+L ++L   +  +        +N +  + +A  ++ A++YL  
Sbjct: 82  -REPPF-YIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYLE- 130
Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
             +    H DL   N L+       VADFGL++L+      T+  G K  I + AP    
Sbjct: 131 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLA 187
Query: 591 LGSEVSINGDVYSYGILLLELMT 613
             ++ SI  DV+++G+LL E+ T
Sbjct: 188 Y-NKFSIKSDVWAFGVLLWEIAT 209

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G +G VY+G+  +    +AVK L        +  + E + ++ I+H NLV++L VC+   
Sbjct: 28  GQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--- 83
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
            +   F  ++ EFM  G+L ++L   +  +        +N +  + +A  ++ A++YL  
Sbjct: 84  -REPPF-YIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYLE- 132
Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
             +    H DL   N L+       VADFGL++L+      T+  G K  I + AP    
Sbjct: 133 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLA 189
Query: 591 LGSEVSINGDVYSYGILLLELMT 613
             ++ SI  DV+++G+LL E+ T
Sbjct: 190 Y-NKFSIKSDVWAFGVLLWEIAT 211

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G +G VY+G+  +    +AVK L        +  + E + ++ I+H NLV++L VC+   
Sbjct: 26  GQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--- 81
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
            +   F  ++ EFM  G+L ++L   +  +        +N +  + +A  ++ A++YL  
Sbjct: 82  -REPPF-YIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYLE- 130
Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
             +    H DL   N L+       VADFGL++L+      T+  G K  I + AP    
Sbjct: 131 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLA 187
Query: 591 LGSEVSINGDVYSYGILLLELMT 613
             ++ SI  DV+++G+LL E+ T
Sbjct: 188 Y-NKFSIKSDVWAFGVLLWEIAT 209

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G FG VY+G+  +    +AVK L        +  + E + ++ I+H NLV++L VC+   
Sbjct: 22  GQFGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--- 77
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
            +   F  ++ EFM  G+L ++L   +  +        ++ +  + +A  ++ A++YL  
Sbjct: 78  -REPPF-YIITEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAMEYLE- 126
Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
             +    H DL   N L+       VADFGL++L+      T+  G K  I + AP    
Sbjct: 127 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTAPESLA 183
Query: 591 LGSEVSINGDVYSYGILLLELMT 613
             ++ SI  DV+++G+LL E+ T
Sbjct: 184 Y-NKFSIKSDVWAFGVLLWEIAT 205

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 97/214 (45%), Gaps = 25/214 (11%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSI--AECSALRNIRHKNLVKILTV 465
           I  GSFG+VYKG   +    +AVK+L ++     +      E + LR  RH N++  +  
Sbjct: 44  IGSGSFGTVYKG---KWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFM-- 98
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                Y   D  A+V ++    SL + LH        V+  K     Q I+IA   A  +
Sbjct: 99  ----GYMTKDNLAIVTQWCEGSSLYKHLH--------VQETK-FQMFQLIDIARQTAQGM 145
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            YLH        H D+K +N+ L   +T  + DFGLA +              G++ ++A
Sbjct: 146 DYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMA 202
Query: 586 PAEYGL--GSEVSINGDVYSYGILLLELMTRKRP 617
           P    +   +  S   DVYSYGI+L ELMT + P
Sbjct: 203 PEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELP 236

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 23/216 (10%)
Query: 404 FLCWIDMGSFGSV----YKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNL 459
           FL  +  G+FGSV    Y  + D    ++AVK L        +    E   L++++H N+
Sbjct: 17  FLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 460 VKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI 519
           VK   VC      G     L+ EF+  GSL E+L       + ++  K L +  +I   +
Sbjct: 77  VKYKGVCYSA---GRRNLKLIMEFLPYGSLREYLQK---HKERIDHIKLLQYTSQICKGM 130
Query: 520 DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKG 579
           +     +Y+H D         L   N+L+++E    + DFGL K+LP    +   +   G
Sbjct: 131 EYLGTKRYIHRD---------LATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPG 180
Query: 580 T--IGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
              I + AP E    S+ S+  DV+S+G++L EL T
Sbjct: 181 ESPIFWYAP-ESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 100/209 (47%), Gaps = 37/209 (17%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G FG V+    ++  T +AVK +        ++ +AE + ++ ++H  LVK+  V +   
Sbjct: 193 GQFGEVWMATYNK-HTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHAVVT--- 247
Query: 471 YKGDDFKALVY---EFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
                 K  +Y   EFM  GSL ++L    G+ + +  PK ++F  +I   +       Y
Sbjct: 248 ------KEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRNY 299
Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPA 587
           +H D         L+ +N+L+   +   +ADFGLA+           +G K  I + AP 
Sbjct: 300 IHRD---------LRAANILVSASLVCKIADFGLAR-----------VGAKFPIKWTAPE 339
Query: 588 EYGLGSEVSINGDVYSYGILLLELMTRKR 616
               GS  +I  DV+S+GILL+E++T  R
Sbjct: 340 AINFGS-FTIKSDVWSFGILLMEIVTYGR 367

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 102/219 (46%), Gaps = 29/219 (13%)
Query: 408 IDMGSFGSVYKGIL--DEGKTIIAVKVLNLLHHGASKSSI---AECSALRNIRHKNLVKI 462
           I  G FG VYKG+L    GK  + V +  L      K  +    E   +    H N++++
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVA 522
             V S   YK      ++ E+M NG+L+++L    G           + LQ + +   +A
Sbjct: 112 EGVIS--KYKP---MMIITEYMENGALDKFLREKDGE---------FSVLQLVGMLRGIA 157
Query: 523 CALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL---PPAHLQTSSIGVKG 579
             +KYL         H DL   N+L++  +   V+DFGL+++L   P A   TS  G K 
Sbjct: 158 AGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS--GGKI 212
Query: 580 TIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTR-KRP 617
            I + AP         S + DV+S+GI++ E+MT  +RP
Sbjct: 213 PIRWTAPEAISYRKFTSAS-DVWSFGIVMWEVMTYGERP 250

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G +G VY+G+  +    +AVK L        +  + E + ++ I+H NLV++L VC+   
Sbjct: 22  GQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--- 77
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
            +   F  ++ EFM  G+L ++L   +  +        ++ +  + +A  ++ A++YL  
Sbjct: 78  -REPPFYIII-EFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAMEYLE- 126
Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
             +    H DL   N L+       VADFGL++L+      T+  G K  I + AP    
Sbjct: 127 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTAPESLA 183
Query: 591 LGSEVSINGDVYSYGILLLELMT 613
             ++ SI  DV+++G+LL E+ T
Sbjct: 184 Y-NKFSIKSDVWAFGVLLWEIAT 205

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G +G VY+G+  +    +AVK L        +  + E + ++ I+H NLV++L VC+   
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--- 79
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
            +   F  ++ EFM  G+L ++L   +  +        ++ +  + +A  ++ A++YL  
Sbjct: 80  -REPPFYIII-EFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAMEYLE- 128
Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
             +    H DL   N L+       VADFGL++L+      T+  G K  I + AP    
Sbjct: 129 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLA 185
Query: 591 LGSEVSINGDVYSYGILLLELMT 613
             ++ SI  DV+++G+LL E+ T
Sbjct: 186 Y-NKFSIKSDVWAFGVLLWEIAT 207

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G +G VY+G+  +    +AVK L        +  + E + ++ I+H NLV++L VC+   
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--- 79
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
            +   F  ++ EFM  G+L ++L   +  +        ++ +  + +A  ++ A++YL  
Sbjct: 80  -REPPFYIII-EFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAMEYLE- 128
Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
             +    H DL   N L+       VADFGL++L+      T+  G K  I + AP    
Sbjct: 129 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLA 185
Query: 591 LGSEVSINGDVYSYGILLLELMT 613
             ++ SI  DV+++G+LL E+ T
Sbjct: 186 Y-NKFSIKSDVWAFGVLLWEIAT 207

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G +G VY+G+  +    +AVK L        +  + E + ++ I+H NLV++L VC+   
Sbjct: 29  GQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--- 84
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
            +   F  ++ EFM  G+L ++L   +  +        ++ +  + +A  ++ A++YL  
Sbjct: 85  -REPPF-YIITEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAMEYLE- 133
Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
             +    H DL   N L+       VADFGL++L+      T+  G K  I + AP    
Sbjct: 134 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLA 190
Query: 591 LGSEVSINGDVYSYGILLLELMT 613
             ++ SI  DV+++G+LL E+ T
Sbjct: 191 Y-NKFSIKSDVWAFGVLLWEIAT 212

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G +G VY+G+  +    +AVK L        +  + E + ++ I+H NLV++L VC+   
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--- 79
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
            +   F  ++ EFM  G+L ++L   +  +        ++ +  + +A  ++ A++YL  
Sbjct: 80  -REPPF-YIITEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAMEYLE- 128
Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
             +    H DL   N L+       VADFGL++L+      T+  G K  I + AP    
Sbjct: 129 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLA 185
Query: 591 LGSEVSINGDVYSYGILLLELMT 613
             ++ SI  DV+++G+LL E+ T
Sbjct: 186 Y-NKFSIKSDVWAFGVLLWEIAT 207

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G +G VY+G+  +    +AVK L        +  + E + ++ I+H NLV++L VC+   
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--- 79
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
            +   F  ++ EFM  G+L ++L   +  +        ++ +  + +A  ++ A++YL  
Sbjct: 80  -REPPF-YIITEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAMEYLE- 128
Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
             +    H DL   N L+       VADFGL++L+      T+  G K  I + AP    
Sbjct: 129 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLA 185
Query: 591 LGSEVSINGDVYSYGILLLELMT 613
             ++ SI  DV+++G+LL E+ T
Sbjct: 186 Y-NKFSIKSDVWAFGVLLWEIAT 207

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G +G VY+G+  +    +AVK L        +  + E + ++ I+H NLV++L VC+   
Sbjct: 22  GQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--- 77
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
            +   F  ++ EFM  G+L ++L   +  +        ++ +  + +A  ++ A++YL  
Sbjct: 78  -REPPF-YIITEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAMEYLE- 126
Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
             +    H DL   N L+       VADFGL++L+      T+  G K  I + AP    
Sbjct: 127 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTF-TAHAGAKFPIKWTAPESLA 183
Query: 591 LGSEVSINGDVYSYGILLLELMT 613
             ++ SI  DV+++G+LL E+ T
Sbjct: 184 Y-NKFSIKSDVWAFGVLLWEIAT 205

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G +G VY+G+  +    +AVK L        +  + E + ++ I+H NLV++L VC+   
Sbjct: 270 GQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--- 325
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
            +   F  ++ EFM  G+L ++L   +  +        +N +  + +A  ++ A++YL  
Sbjct: 326 -REPPF-YIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYLE- 374
Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
             +    H +L   N L+       VADFGL++L+      T+  G K  I + AP    
Sbjct: 375 --KKNFIHRNLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLA 431
Query: 591 LGSEVSINGDVYSYGILLLELMT 613
             ++ SI  DV+++G+LL E+ T
Sbjct: 432 Y-NKFSIKSDVWAFGVLLWEIAT 453

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 97/214 (45%), Gaps = 25/214 (11%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASK--SSIAECSALRNIRHKNLVKILTV 465
           I  GSFG+VYKG   +    +AVK+LN+      +  +   E   LR  RH N++  +  
Sbjct: 16  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
            +          A+V ++    SL   LH +               ++ I+IA   A  +
Sbjct: 73  STAPQL------AIVTQWCEGSSLYHHLHIIETK---------FEMIKLIDIARQTAQGM 117
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            YLH     +  H DLK +N+ L  ++T  + DFGLA +            + G+I ++A
Sbjct: 118 DYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174
Query: 586 PAEYGLGSE--VSINGDVYSYGILLLELMTRKRP 617
           P    +  +   S   DVY++GI+L ELMT + P
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 97/214 (45%), Gaps = 25/214 (11%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASK--SSIAECSALRNIRHKNLVKILTV 465
           I  GSFG+VYKG   +    +AVK+LN+      +  +   E   LR  RH N++  +  
Sbjct: 16  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM-- 70
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                Y      A+V ++    SL   LH +               ++ I+IA   A  +
Sbjct: 71  ----GYSTKPQLAIVTQWCEGSSLYHHLHIIETK---------FEMIKLIDIARQTAQGM 117
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            YLH     +  H DLK +N+ L  ++T  + DFGLA +            + G+I ++A
Sbjct: 118 DYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174
Query: 586 PAEYGLGSE--VSINGDVYSYGILLLELMTRKRP 617
           P    +  +   S   DVY++GI+L ELMT + P
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 23/216 (10%)
Query: 404 FLCWIDMGSFGSV----YKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNL 459
           FL  +  G+FGSV    Y  + D    ++AVK L        +    E   L++++H N+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 460 VKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI 519
           VK   VC      G     L+ E++  GSL ++L       + ++  K L +  +I   +
Sbjct: 74  VKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGM 127
Query: 520 DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP--PAHLQTSSIGV 577
           +     +Y+H D         L   N+L+++E    + DFGL K+LP      +    G 
Sbjct: 128 EYLGTKRYIHRD---------LATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPG- 177
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
           +  I + AP E    S+ S+  DV+S+G++L EL T
Sbjct: 178 ESPIFWYAP-ESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 101/203 (49%), Gaps = 20/203 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G FG V+ G  +   T +AVK L      + ++ + E + ++ ++H  LV++  V +   
Sbjct: 24  GQFGEVWMGYYN-NSTKVAVKTLKP-GTMSVQAFLEEANLMKTLQHDKLVRLYAVVTR-- 79
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
              ++   ++ E+M  GSL ++L    G    V  PK ++F      +  +A  + Y+  
Sbjct: 80  ---EEPIYIITEYMAKGSLLDFLKSDEGG--KVLLPKLIDF------SAQIAEGMAYIE- 127
Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
             +    H DL+ +NVL+   +   +ADFGLA+++      T+  G K  I + AP    
Sbjct: 128 --RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPEAIN 184
Query: 591 LGSEVSINGDVYSYGILLLELMT 613
            G   +I  DV+S+GILL E++T
Sbjct: 185 FGC-FTIKSDVWSFGILLYEIVT 206

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 23/216 (10%)
Query: 404 FLCWIDMGSFGSV----YKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNL 459
           FL  +  G+FGSV    Y  + D    ++AVK L        +    E   L++++H N+
Sbjct: 18  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 77
Query: 460 VKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI 519
           VK   VC      G     L+ E++  GSL ++L       + ++  K L +  +I   +
Sbjct: 78  VKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGM 131
Query: 520 DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKG 579
           +     +Y+H D         L   N+L+++E    + DFGL K+LP    +   +   G
Sbjct: 132 EYLGTKRYIHRD---------LATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPG 181
Query: 580 T--IGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
              I + AP E    S+ S+  DV+S+G++L EL T
Sbjct: 182 ESPIFWYAP-ESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 23/216 (10%)
Query: 404 FLCWIDMGSFGSV----YKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNL 459
           FL  +  G+FGSV    Y  + D    ++AVK L        +    E   L++++H N+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 460 VKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI 519
           VK   VC      G     L+ E++  GSL ++L       + ++  K L +  +I   +
Sbjct: 74  VKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGM 127
Query: 520 DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKG 579
           +     +Y+H D         L   N+L+++E    + DFGL K+LP    +   +   G
Sbjct: 128 EYLGTKRYIHRD---------LATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPG 177
Query: 580 T--IGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
              I + AP E    S+ S+  DV+S+G++L EL T
Sbjct: 178 ESPIFWYAP-ESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 23/216 (10%)
Query: 404 FLCWIDMGSFGSV----YKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNL 459
           FL  +  G+FGSV    Y  + D    ++AVK L        +    E   L++++H N+
Sbjct: 13  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 72
Query: 460 VKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI 519
           VK   VC      G     L+ E++  GSL ++L       + ++  K L +  +I   +
Sbjct: 73  VKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGM 126
Query: 520 DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKG 579
           +     +Y+H D         L   N+L+++E    + DFGL K+LP    +   +   G
Sbjct: 127 EYLGTKRYIHRD---------LATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPG 176
Query: 580 T--IGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
              I + AP E    S+ S+  DV+S+G++L EL T
Sbjct: 177 ESPIFWYAP-ESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 97/214 (45%), Gaps = 25/214 (11%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASK--SSIAECSALRNIRHKNLVKILTV 465
           I  GSFG+VYKG   +    +AVK+LN+      +  +   E   LR  RH N++  +  
Sbjct: 21  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM-- 75
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                Y      A+V ++    SL   LH +               ++ I+IA   A  +
Sbjct: 76  ----GYSTKPQLAIVTQWCEGSSLYHHLHIIETK---------FEMIKLIDIARQTAQGM 122
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            YLH     +  H DLK +N+ L  ++T  + DFGLA +            + G+I ++A
Sbjct: 123 DYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 179
Query: 586 PAEYGLGSE--VSINGDVYSYGILLLELMTRKRP 617
           P    +  +   S   DVY++GI+L ELMT + P
Sbjct: 180 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 97/214 (45%), Gaps = 25/214 (11%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASK--SSIAECSALRNIRHKNLVKILTV 465
           I  GSFG+VYKG   +    +AVK+LN+      +  +   E   LR  RH N++  +  
Sbjct: 18  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM-- 72
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                Y      A+V ++    SL   LH +               ++ I+IA   A  +
Sbjct: 73  ----GYSTKPQLAIVTQWCEGSSLYHHLHIIETK---------FEMIKLIDIARQTAQGM 119
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            YLH     +  H DLK +N+ L  ++T  + DFGLA +            + G+I ++A
Sbjct: 120 DYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 176
Query: 586 PAEYGLGSE--VSINGDVYSYGILLLELMTRKRP 617
           P    +  +   S   DVY++GI+L ELMT + P
Sbjct: 177 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 210

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 23/216 (10%)
Query: 404 FLCWIDMGSFGSV----YKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNL 459
           FL  +  G+FGSV    Y  + D    ++AVK L        +    E   L++++H N+
Sbjct: 45  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104
Query: 460 VKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI 519
           VK   VC      G     L+ E++  GSL ++L       + ++  K L +  +I   +
Sbjct: 105 VKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGM 158
Query: 520 DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKG 579
           +     +Y+H D         L   N+L+++E    + DFGL K+LP    +   +   G
Sbjct: 159 EYLGTKRYIHRD---------LATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPG 208
Query: 580 T--IGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
              I + AP E    S+ S+  DV+S+G++L EL T
Sbjct: 209 ESPIFWYAP-ESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 23/216 (10%)
Query: 404 FLCWIDMGSFGSV----YKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNL 459
           FL  +  G+FGSV    Y  + D    ++AVK L        +    E   L++++H N+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 460 VKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI 519
           VK   VC      G     L+ E++  GSL ++L       + ++  K L +  +I   +
Sbjct: 74  VKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGM 127
Query: 520 DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKG 579
           +     +Y+H D         L   N+L+++E    + DFGL K+LP    +   +   G
Sbjct: 128 EYLGTKRYIHRD---------LATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPG 177
Query: 580 T--IGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
              I + AP E    S+ S+  DV+S+G++L EL T
Sbjct: 178 ESPIFWYAP-ESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 97/214 (45%), Gaps = 25/214 (11%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASK--SSIAECSALRNIRHKNLVKILTV 465
           I  GSFG+VYKG   +    +AVK+LN+      +  +   E   LR  RH N++  +  
Sbjct: 21  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM-- 75
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                Y      A+V ++    SL   LH +               ++ I+IA   A  +
Sbjct: 76  ----GYSTKPQLAIVTQWCEGSSLYHHLHIIETK---------FEMIKLIDIARQTAQGM 122
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            YLH     +  H DLK +N+ L  ++T  + DFGLA +            + G+I ++A
Sbjct: 123 DYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 179
Query: 586 PAEYGLGSE--VSINGDVYSYGILLLELMTRKRP 617
           P    +  +   S   DVY++GI+L ELMT + P
Sbjct: 180 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 23/216 (10%)
Query: 404 FLCWIDMGSFGSV----YKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNL 459
           FL  +  G+FGSV    Y  + D    ++AVK L        +    E   L++++H N+
Sbjct: 12  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 71
Query: 460 VKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI 519
           VK   VC      G     L+ E++  GSL ++L       + ++  K L +  +I   +
Sbjct: 72  VKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGM 125
Query: 520 DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKG 579
           +     +Y+H D         L   N+L+++E    + DFGL K+LP    +   +   G
Sbjct: 126 EYLGTKRYIHRD---------LATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPG 175
Query: 580 T--IGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
              I + AP E    S+ S+  DV+S+G++L EL T
Sbjct: 176 ESPIFWYAP-ESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 23/216 (10%)
Query: 404 FLCWIDMGSFGSV----YKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNL 459
           FL  +  G+FGSV    Y  + D    ++AVK L        +    E   L++++H N+
Sbjct: 17  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 460 VKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI 519
           VK   VC      G     L+ E++  GSL ++L   +   + ++  K L +  +I   +
Sbjct: 77  VKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQAHA---ERIDHIKLLQYTSQICKGM 130
Query: 520 DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKG 579
           +     +Y+H D         L   N+L+++E    + DFGL K+LP    +   +   G
Sbjct: 131 EYLGTKRYIHRD---------LATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPG 180
Query: 580 T--IGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
              I + AP E    S+ S+  DV+S+G++L EL T
Sbjct: 181 ESPIFWYAP-ESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 23/216 (10%)
Query: 404 FLCWIDMGSFGSV----YKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNL 459
           FL  +  G+FGSV    Y  + D    ++AVK L        +    E   L++++H N+
Sbjct: 32  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 91
Query: 460 VKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI 519
           VK   VC      G     L+ E++  GSL ++L       + ++  K L +  +I   +
Sbjct: 92  VKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGM 145
Query: 520 DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKG 579
           +     +Y+H D         L   N+L+++E    + DFGL K+LP    +   +   G
Sbjct: 146 EYLGTKRYIHRD---------LATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPG 195
Query: 580 T--IGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
              I + AP E    S+ S+  DV+S+G++L EL T
Sbjct: 196 ESPIFWYAP-ESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 23/216 (10%)
Query: 404 FLCWIDMGSFGSV----YKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNL 459
           FL  +  G+FGSV    Y  + D    ++AVK L        +    E   L++++H N+
Sbjct: 17  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 460 VKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI 519
           VK   VC      G     L+ E++  GSL ++L       + ++  K L +  +I   +
Sbjct: 77  VKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGM 130
Query: 520 DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKG 579
           +     +Y+H D         L   N+L+++E    + DFGL K+LP    +   +   G
Sbjct: 131 EYLGTKRYIHRD---------LATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPG 180
Query: 580 T--IGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
              I + AP E    S+ S+  DV+S+G++L EL T
Sbjct: 181 ESPIFWYAP-ESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 23/216 (10%)
Query: 404 FLCWIDMGSFGSV----YKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNL 459
           FL  +  G+FGSV    Y  + D    ++AVK L        +    E   L++++H N+
Sbjct: 32  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 91
Query: 460 VKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI 519
           VK   VC      G     L+ E++  GSL ++L       + ++  K L +  +I   +
Sbjct: 92  VKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGM 145
Query: 520 DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKG 579
           +     +Y+H D         L   N+L+++E    + DFGL K+LP    +   +   G
Sbjct: 146 EYLGTKRYIHRD---------LATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPG 195
Query: 580 T--IGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
              I + AP E    S+ S+  DV+S+G++L EL T
Sbjct: 196 ESPIFWYAP-ESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 101/203 (49%), Gaps = 20/203 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G FG V+ G  +   T +AVK L      + ++ + E + ++ ++H  LV++  V +   
Sbjct: 23  GQFGEVWMGYYN-NSTKVAVKTLKP-GTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK-- 78
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
              ++   ++ EFM  GSL ++L    G    V  PK ++F      +  +A  + Y+  
Sbjct: 79  ---EEPIYIITEFMAKGSLLDFLKSDEGG--KVLLPKLIDF------SAQIAEGMAYIE- 126
Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
             +    H DL+ +NVL+   +   +ADFGLA+++      T+  G K  I + AP    
Sbjct: 127 --RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPEAIN 183
Query: 591 LGSEVSINGDVYSYGILLLELMT 613
            G   +I  +V+S+GILL E++T
Sbjct: 184 FGC-FTIKSNVWSFGILLYEIVT 205

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 23/216 (10%)
Query: 404 FLCWIDMGSFGSV----YKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNL 459
           FL  +  G+FGSV    Y  + D    ++AVK L        +    E   L++++H N+
Sbjct: 19  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 78
Query: 460 VKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI 519
           VK   VC      G     L+ E++  GSL ++L       + ++  K L +  +I   +
Sbjct: 79  VKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGM 132
Query: 520 DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKG 579
           +     +Y+H D         L   N+L+++E    + DFGL K+LP    +   +   G
Sbjct: 133 EYLGTKRYIHRD---------LATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPG 182
Query: 580 T--IGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
              I + AP E    S+ S+  DV+S+G++L EL T
Sbjct: 183 ESPIFWYAP-ESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 97/214 (45%), Gaps = 25/214 (11%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASK--SSIAECSALRNIRHKNLVKILTV 465
           I  GSFG+VYKG   +    +AVK+LN+      +  +   E   LR  RH N++  +  
Sbjct: 43  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG- 98
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                Y      A+V ++    SL   LH +               ++ I+IA   A  +
Sbjct: 99  -----YSTKPQLAIVTQWCEGSSLYHHLHIIETK---------FEMIKLIDIARQTAQGM 144
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            YLH     +  H DLK +N+ L  ++T  + DFGLA +            + G+I ++A
Sbjct: 145 DYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 201
Query: 586 PAEYGLGSE--VSINGDVYSYGILLLELMTRKRP 617
           P    +  +   S   DVY++GI+L ELMT + P
Sbjct: 202 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 235

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 23/216 (10%)
Query: 404 FLCWIDMGSFGSV----YKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNL 459
           FL  +  G+FGSV    Y  + D    ++AVK L        +    E   L++++H N+
Sbjct: 21  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 80
Query: 460 VKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI 519
           VK   VC      G     L+ E++  GSL ++L       + ++  K L +  +I   +
Sbjct: 81  VKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGM 134
Query: 520 DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKG 579
           +     +Y+H D         L   N+L+++E    + DFGL K+LP    +   +   G
Sbjct: 135 EYLGTKRYIHRD---------LATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPG 184
Query: 580 T--IGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
              I + AP E    S+ S+  DV+S+G++L EL T
Sbjct: 185 ESPIFWYAP-ESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 97/214 (45%), Gaps = 25/214 (11%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASK--SSIAECSALRNIRHKNLVKILTV 465
           I  GSFG+VYKG   +    +AVK+LN+      +  +   E   LR  RH N++  +  
Sbjct: 44  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG- 99
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                Y      A+V ++    SL   LH +               ++ I+IA   A  +
Sbjct: 100 -----YSTKPQLAIVTQWCEGSSLYHHLHIIETK---------FEMIKLIDIARQTAQGM 145
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            YLH     +  H DLK +N+ L  ++T  + DFGLA +            + G+I ++A
Sbjct: 146 DYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 202
Query: 586 PAEYGLGSE--VSINGDVYSYGILLLELMTRKRP 617
           P    +  +   S   DVY++GI+L ELMT + P
Sbjct: 203 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 23/216 (10%)
Query: 404 FLCWIDMGSFGSV----YKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNL 459
           FL  +  G+FGSV    Y  + D    ++AVK L        +    E   L++++H N+
Sbjct: 20  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 79
Query: 460 VKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI 519
           VK   VC      G     L+ E++  GSL ++L       + ++  K L +  +I   +
Sbjct: 80  VKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGM 133
Query: 520 DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKG 579
           +     +Y+H D         L   N+L+++E    + DFGL K+LP    +   +   G
Sbjct: 134 EYLGTKRYIHRD---------LATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPG 183
Query: 580 T--IGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
              I + AP E    S+ S+  DV+S+G++L EL T
Sbjct: 184 ESPIFWYAP-ESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 408 IDMGSFGSVYKGIL--DEGKTI-IAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKIL 463
           I  G FG VY G L  ++GK I  AVK LN +   G     + E   +++  H N++ +L
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            +C     + +    +V  +M +G L  ++            P   +    I   + VA 
Sbjct: 97  GIC----LRSEGSPLVVLPYMKHGDLRNFIR------NETHNPTVKDL---IGFGLQVAK 143
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQT--SSIGVKGTI 581
            +KYL         H DL   N +LD + T  VADFGLA+ +      +  +  G K  +
Sbjct: 144 GMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPV 200
Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
            ++A  E     + +   DV+S+G+LL ELMTR  P
Sbjct: 201 KWMA-LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 408 IDMGSFGSVYKGIL--DEGKTI-IAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKIL 463
           I  G FG VY G L  ++GK I  AVK LN +   G     + E   +++  H N++ +L
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            +C     + +    +V  +M +G L  ++            P   +    I   + VA 
Sbjct: 116 GIC----LRSEGSPLVVLPYMKHGDLRNFIR------NETHNPTVKDL---IGFGLQVAK 162
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQT--SSIGVKGTI 581
            +KYL         H DL   N +LD + T  VADFGLA+ +      +  +  G K  +
Sbjct: 163 GMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 219
Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
            ++A  E     + +   DV+S+G+LL ELMTR  P
Sbjct: 220 KWMA-LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 254

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 408 IDMGSFGSVYKGIL--DEGKTI-IAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKIL 463
           I  G FG VY G L  ++GK I  AVK LN +   G     + E   +++  H N++ +L
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            +C     + +    +V  +M +G L  ++            P   +    I   + VA 
Sbjct: 117 GIC----LRSEGSPLVVLPYMKHGDLRNFIR------NETHNPTVKDL---IGFGLQVAK 163
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQT--SSIGVKGTI 581
            +KYL         H DL   N +LD + T  VADFGLA+ +      +  +  G K  +
Sbjct: 164 GMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 220
Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
            ++A  E     + +   DV+S+G+LL ELMTR  P
Sbjct: 221 KWMA-LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 255

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 102/209 (48%), Gaps = 25/209 (11%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           I  G FG V  G  D     +AVK +   +   +++ +AE S +  +RH NLV++L V  
Sbjct: 29  IGKGEFGDVMLG--DYRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVI- 83
Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
            V+ KG  +  +V E+M  GSL ++L       ++V    CL     +  ++DV  A++Y
Sbjct: 84  -VEEKGGLY--IVTEYMAKGSLVDYLRSRG---RSVLGGDCL-----LKFSLDVCEAMEY 132
Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPA 587
           L  +      H DL   NVL+  +  A V+DFGL K        T  + VK T    AP 
Sbjct: 133 LEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DTGKLPVKWT----AP- 183
Query: 588 EYGLGSEVSINGDVYSYGILLLELMTRKR 616
           E     + S   DV+S+GILL E+ +  R
Sbjct: 184 EALREKKFSTKSDVWSFGILLWEIYSFGR 212

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 408 IDMGSFGSVYKGIL--DEGKTI-IAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKIL 463
           I  G FG VY G L  ++GK I  AVK LN +   G     + E   +++  H N++ +L
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            +C     + +    +V  +M +G L  ++            P   +    I   + VA 
Sbjct: 98  GIC----LRSEGSPLVVLPYMKHGDLRNFIR------NETHNPTVKDL---IGFGLQVAK 144
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQT--SSIGVKGTI 581
            +KYL         H DL   N +LD + T  VADFGLA+ +      +  +  G K  +
Sbjct: 145 GMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 201
Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
            ++A  E     + +   DV+S+G+LL ELMTR  P
Sbjct: 202 KWMA-LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 102/209 (48%), Gaps = 25/209 (11%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           I  G FG V  G  D     +AVK +   +   +++ +AE S +  +RH NLV++L V  
Sbjct: 14  IGKGEFGDVMLG--DYRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVI- 68
Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
            V+ KG  +  +V E+M  GSL ++L       ++V    CL     +  ++DV  A++Y
Sbjct: 69  -VEEKGGLY--IVTEYMAKGSLVDYLR---SRGRSVLGGDCL-----LKFSLDVCEAMEY 117
Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPA 587
           L  +      H DL   NVL+  +  A V+DFGL K        T  + VK T    AP 
Sbjct: 118 LEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DTGKLPVKWT----AP- 168
Query: 588 EYGLGSEVSINGDVYSYGILLLELMTRKR 616
           E     + S   DV+S+GILL E+ +  R
Sbjct: 169 EALREKKFSTKSDVWSFGILLWEIYSFGR 197

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 102/209 (48%), Gaps = 25/209 (11%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           I  G FG V  G  D     +AVK +   +   +++ +AE S +  +RH NLV++L V  
Sbjct: 20  IGKGEFGDVMLG--DYRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVI- 74
Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
            V+ KG  +  +V E+M  GSL ++L       ++V    CL     +  ++DV  A++Y
Sbjct: 75  -VEEKGGLY--IVTEYMAKGSLVDYLRSRG---RSVLGGDCL-----LKFSLDVCEAMEY 123
Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPA 587
           L  +      H DL   NVL+  +  A V+DFGL K        T  + VK T    AP 
Sbjct: 124 LEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DTGKLPVKWT----AP- 174
Query: 588 EYGLGSEVSINGDVYSYGILLLELMTRKR 616
           E    +  S   DV+S+GILL E+ +  R
Sbjct: 175 EALREAAFSTKSDVWSFGILLWEIYSFGR 203

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 33/224 (14%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G FG V+K  L      +AVK+  L     S  S  E  +   ++H+NL++ +      +
Sbjct: 26  GRFGCVWKAQL--MNDFVAVKIFPL-QDKQSWQSEREIFSTPGMKHENLLQFIAA----E 78
Query: 471 YKGDDFKA---LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
            +G + +    L+  F   GSL ++L               + + +  ++A  ++  L Y
Sbjct: 79  KRGSNLEVELWLITAFHDKGSLTDYL-----------KGNIITWNELCHVAETMSRGLSY 127
Query: 528 LHHDC--------QPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKG 579
           LH D         +P+ AH D K  NVLL  ++TA +ADFGLA    P      + G  G
Sbjct: 128 LHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVG 187
Query: 580 TIGYIAP----AEYGLGSEVSINGDVYSYGILLLELMTRKRPSD 619
           T  Y+AP           +  +  D+Y+ G++L EL++R + +D
Sbjct: 188 TRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 113/251 (45%), Gaps = 26/251 (10%)
Query: 408 IDMGSFGSVYKGIL--DEGKTI-IAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKIL 463
           I  G FG VY G L  ++GK I  AVK LN +   G     + E   +++  H N++ +L
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            +C     + +    +V  +M +G L  ++            P   +    I   + VA 
Sbjct: 90  GIC----LRSEGSPLVVLPYMKHGDLRNFIR------NETHNPTVKDL---IGFGLQVAK 136
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQT--SSIGVKGTI 581
            +KYL         H DL   N +LD + T  VADFGLA+ +      +  +  G K  +
Sbjct: 137 GMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 193
Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP--SDI-MFEGNMNLHNFARTVLPD 638
            ++A  E     + +   DV+S+G+LL ELMTR  P   D+  F+  + L    R + P+
Sbjct: 194 KWMA-LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE 252
Query: 639 HVMDIVDSTLL 649
           +  D +   +L
Sbjct: 253 YCPDPLYEVML 263

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 408 IDMGSFGSVYKGIL--DEGKTI-IAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKIL 463
           I  G FG VY G L  ++GK I  AVK LN +   G     + E   +++  H N++ +L
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            +C     + +    +V  +M +G L  ++            P   +    I   + VA 
Sbjct: 96  GIC----LRSEGSPLVVLPYMKHGDLRNFIR------NETHNPTVKDL---IGFGLQVAK 142
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQT--SSIGVKGTI 581
            +KYL         H DL   N +LD + T  VADFGLA+ +      +  +  G K  +
Sbjct: 143 GMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 199
Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
            ++A  E     + +   DV+S+G+LL ELMTR  P
Sbjct: 200 KWMA-LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 408 IDMGSFGSVYKGIL--DEGKTI-IAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKIL 463
           I  G FG VY G L  ++GK I  AVK LN +   G     + E   +++  H N++ +L
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            +C     + +    +V  +M +G L  ++            P   +    I   + VA 
Sbjct: 97  GIC----LRSEGSPLVVLPYMKHGDLRNFIR------NETHNPTVKDL---IGFGLQVAK 143
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQT--SSIGVKGTI 581
            +KYL         H DL   N +LD + T  VADFGLA+ +      +  +  G K  +
Sbjct: 144 GMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 200
Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
            ++A  E     + +   DV+S+G+LL ELMTR  P
Sbjct: 201 KWMA-LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 408 IDMGSFGSVYKGIL--DEGKTI-IAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKIL 463
           I  G FG VY G L  ++GK I  AVK LN +   G     + E   +++  H N++ +L
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            +C     + +    +V  +M +G L  ++            P   +    I   + VA 
Sbjct: 95  GIC----LRSEGSPLVVLPYMKHGDLRNFIR------NETHNPTVKDL---IGFGLQVAK 141
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQT--SSIGVKGTI 581
            +KYL         H DL   N +LD + T  VADFGLA+ +      +  +  G K  +
Sbjct: 142 GMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 198
Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
            ++A  E     + +   DV+S+G+LL ELMTR  P
Sbjct: 199 KWMA-LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 233

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 96/214 (44%), Gaps = 25/214 (11%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASK--SSIAECSALRNIRHKNLVKILTV 465
           I  GSFG+VYKG   +    +AVK+LN+      +  +   E   LR  RH N++  +  
Sbjct: 16  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM-- 70
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                Y      A+V ++    SL   LH +               ++ I+IA   A  +
Sbjct: 71  ----GYSTKPQLAIVTQWCEGSSLYHHLHIIETK---------FEMIKLIDIARQTAQGM 117
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            YLH     +  H DLK +N+ L  ++T  + DFGLA              + G+I ++A
Sbjct: 118 DYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 174
Query: 586 PAEYGLGSE--VSINGDVYSYGILLLELMTRKRP 617
           P    +  +   S   DVY++GI+L ELMT + P
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 23/216 (10%)
Query: 404 FLCWIDMGSFGSV----YKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNL 459
           FL  +  G+FGSV    Y  + D    ++AVK L        +    E   L++++H N+
Sbjct: 15  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 74
Query: 460 VKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI 519
           VK   VC      G     L+ E++  GSL ++L       + ++  K L +  +I   +
Sbjct: 75  VKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGM 128
Query: 520 DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP--PAHLQTSSIGV 577
           +     +Y+H +         L   N+L+++E    + DFGL K+LP    + +    G 
Sbjct: 129 EYLGTKRYIHRN---------LATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPG- 178
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
           +  I + AP E    S+ S+  DV+S+G++L EL T
Sbjct: 179 ESPIFWYAP-ESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G +G VY G+  +    +AVK L        +  + E + ++ I+H NLV++L VC+   
Sbjct: 43  GQYGEVYVGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--- 98
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
              +    +V E+M  G+L ++L   +  + T         +  + +A  ++ A++YL  
Sbjct: 99  --LEPPFYIVTEYMPYGNLLDYLRECNREEVTA--------VVLLYMATQISSAMEYLE- 147
Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
             +    H DL   N L+       VADFGL++L+      T+  G K  I + AP    
Sbjct: 148 --KKNFIHRDLAARNCLVGENHVVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLA 204
Query: 591 LGSEVSINGDVYSYGILLLELMT 613
             +  SI  DV+++G+LL E+ T
Sbjct: 205 YNT-FSIKSDVWAFGVLLWEIAT 226

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 408 IDMGSFGSVYKGIL--DEGKTI-IAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKIL 463
           I  G FG VY G L  ++GK I  AVK LN +   G     + E   +++  H N++ +L
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            +C     + +    +V  +M +G L  ++            P   +    I   + VA 
Sbjct: 98  GIC----LRSEGSPLVVLPYMKHGDLRNFIR------NETHNPTVKDL---IGFGLQVAK 144
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQT--SSIGVKGTI 581
            +KYL         H DL   N +LD + T  VADFGLA+ +      +  +  G K  +
Sbjct: 145 GMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 201
Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
            ++A  E     + +   DV+S+G+LL ELMTR  P
Sbjct: 202 KWMA-LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 408 IDMGSFGSVYKGIL--DEGKTI-IAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKIL 463
           I  G FG VY G L  ++GK I  AVK LN +   G     + E   +++  H N++ +L
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            +C     + +    +V  +M +G L  ++            P   +    I   + VA 
Sbjct: 93  GIC----LRSEGSPLVVLPYMKHGDLRNFIR------NETHNPTVKDL---IGFGLQVAK 139
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQT--SSIGVKGTI 581
            +KYL         H DL   N +LD + T  VADFGLA+ +      +  +  G K  +
Sbjct: 140 GMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 196
Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
            ++A  E     + +   DV+S+G+LL ELMTR  P
Sbjct: 197 KWMA-LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 231

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 408 IDMGSFGSVYKGIL--DEGKTI-IAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKIL 463
           I  G FG VY G L  ++GK I  AVK LN +   G     + E   +++  H N++ +L
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            +C     + +    +V  +M +G L  ++            P   +    I   + VA 
Sbjct: 157 GIC----LRSEGSPLVVLPYMKHGDLRNFIR------NETHNPTVKDL---IGFGLQVAK 203
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQT--SSIGVKGTI 581
            +K+L         H DL   N +LD + T  VADFGLA+ +      +  +  G K  +
Sbjct: 204 GMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 260
Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
            ++A  E     + +   DV+S+G+LL ELMTR  P
Sbjct: 261 KWMA-LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 295

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G +G VY+G+  +    +AVK L        +  + E + ++ I+H NLV++L VC+   
Sbjct: 231 GQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--- 286
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
            +   F  ++ EFM  G+L ++L   +  +        ++ +  + +A  ++ A++YL  
Sbjct: 287 -REPPF-YIITEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAMEYLE- 335
Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
             +    H +L   N L+       VADFGL++L+      T+  G K  I + AP    
Sbjct: 336 --KKNFIHRNLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLA 392
Query: 591 LGSEVSINGDVYSYGILLLELMT 613
             ++ SI  DV+++G+LL E+ T
Sbjct: 393 Y-NKFSIKSDVWAFGVLLWEIAT 414

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 96/214 (44%), Gaps = 25/214 (11%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASK--SSIAECSALRNIRHKNLVKILTV 465
           I  GSFG+VYKG   +    +AVK+LN+      +  +   E   LR  RH N++  +  
Sbjct: 36  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG- 91
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                Y      A+V ++    SL   LH +               ++ I+IA   A  +
Sbjct: 92  -----YSTKPQLAIVTQWCEGSSLYHHLHIIETK---------FEMIKLIDIARQTAQGM 137
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            YLH     +  H DLK +N+ L  ++T  + DFGLA              + G+I ++A
Sbjct: 138 DYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 194
Query: 586 PAEYGLGSE--VSINGDVYSYGILLLELMTRKRP 617
           P    +  +   S   DVY++GI+L ELMT + P
Sbjct: 195 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 228

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 408 IDMGSFGSVYKGIL--DEGKTI-IAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKIL 463
           I  G FG VY G L  ++GK I  AVK LN +   G     + E   +++  H N++ +L
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            +C     + +    +V  +M +G L  ++            P   +    I   + VA 
Sbjct: 98  GIC----LRSEGSPLVVLPYMKHGDLRNFIR------NETHNPTVKDL---IGFGLQVAK 144
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQT--SSIGVKGTI 581
            +K+L         H DL   N +LD + T  VADFGLA+ +      +  +  G K  +
Sbjct: 145 GMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 201
Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
            ++A  E     + +   DV+S+G+LL ELMTR  P
Sbjct: 202 KWMA-LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 408 IDMGSFGSVYKGIL--DEGKTI-IAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKIL 463
           I  G FG VY G L  ++GK I  AVK LN +   G     + E   +++  H N++ +L
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            +C     + +    +V  +M +G L  ++            P   +    I   + VA 
Sbjct: 99  GIC----LRSEGSPLVVLPYMKHGDLRNFIR------NETHNPTVKDL---IGFGLQVAK 145
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQT--SSIGVKGTI 581
            +K+L         H DL   N +LD + T  VADFGLA+ +      +  +  G K  +
Sbjct: 146 GMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 202
Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
            ++A  E     + +   DV+S+G+LL ELMTR  P
Sbjct: 203 KWMA-LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 408 IDMGSFGSVYKGIL--DEGKTI-IAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKIL 463
           I  G FG VY G L  ++GK I  AVK LN +   G     + E   +++  H N++ +L
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            +C     + +    +V  +M +G L  ++            P   +    I   + VA 
Sbjct: 96  GIC----LRSEGSPLVVLPYMKHGDLRNFIR------NETHNPTVKDL---IGFGLQVAK 142
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQT--SSIGVKGTI 581
            +K+L         H DL   N +LD + T  VADFGLA+ +      +  +  G K  +
Sbjct: 143 GMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 199
Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
            ++A  E     + +   DV+S+G+LL ELMTR  P
Sbjct: 200 KWMA-LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 408 IDMGSFGSVYKGIL--DEGKTI-IAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKIL 463
           I  G FG VY G L  ++GK I  AVK LN +   G     + E   +++  H N++ +L
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            +C     + +    +V  +M +G L  ++            P   +    I   + VA 
Sbjct: 98  GIC----LRSEGSPLVVLPYMKHGDLRNFIR------NETHNPTVKDL---IGFGLQVAK 144
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQT--SSIGVKGTI 581
            +K+L         H DL   N +LD + T  VADFGLA+ +      +  +  G K  +
Sbjct: 145 GMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 201
Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
            ++A  E     + +   DV+S+G+LL ELMTR  P
Sbjct: 202 KWMA-LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 408 IDMGSFGSVYKGIL--DEGKTI-IAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKIL 463
           I  G FG VY G L  ++GK I  AVK LN +   G     + E   +++  H N++ +L
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            +C     + +    +V  +M +G L  ++            P   +    I   + VA 
Sbjct: 99  GIC----LRSEGSPLVVLPYMKHGDLRNFIR------NETHNPTVKDL---IGFGLQVAK 145
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQT--SSIGVKGTI 581
            +K+L         H DL   N +LD + T  VADFGLA+ +      +  +  G K  +
Sbjct: 146 GMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPV 202
Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
            ++A  E     + +   DV+S+G+LL ELMTR  P
Sbjct: 203 KWMA-LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 408 IDMGSFGSVYKGIL--DEGKTI-IAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKIL 463
           I  G FG VY G L  ++GK I  AVK LN +   G     + E   +++  H N++ +L
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            +C     + +    +V  +M +G L  ++            P   +    I   + VA 
Sbjct: 103 GIC----LRSEGSPLVVLPYMKHGDLRNFIR------NETHNPTVKDL---IGFGLQVAK 149
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQT--SSIGVKGTI 581
            +K+L         H DL   N +LD + T  VADFGLA+ +      +  +  G K  +
Sbjct: 150 GMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 206
Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
            ++A  E     + +   DV+S+G+LL ELMTR  P
Sbjct: 207 KWMA-LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 241

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 96/214 (44%), Gaps = 25/214 (11%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASK--SSIAECSALRNIRHKNLVKILTV 465
           I  GSFG+VYKG   +    +AVK+LN+      +  +   E   LR  RH N++  +  
Sbjct: 44  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG- 99
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                Y      A+V ++    SL   LH +               ++ I+IA   A  +
Sbjct: 100 -----YSTKPQLAIVTQWCEGSSLYHHLHIIETK---------FEMIKLIDIARQTAQGM 145
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            YLH     +  H DLK +N+ L  ++T  + DFGLA              + G+I ++A
Sbjct: 146 DYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 202
Query: 586 PAEYGLGSE--VSINGDVYSYGILLLELMTRKRP 617
           P    +  +   S   DVY++GI+L ELMT + P
Sbjct: 203 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 102/209 (48%), Gaps = 25/209 (11%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           I  G FG V  G  D     +AVK +   +   +++ +AE S +  +RH NLV++L V  
Sbjct: 201 IGKGEFGDVMLG--DYRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVI- 255
Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
            V+ KG  +  +V E+M  GSL ++L       ++V    CL     +  ++DV  A++Y
Sbjct: 256 -VEEKGGLY--IVTEYMAKGSLVDYLR---SRGRSVLGGDCL-----LKFSLDVCEAMEY 304
Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPA 587
           L  +      H DL   NVL+  +  A V+DFGL K        T  + VK T    AP 
Sbjct: 305 LEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DTGKLPVKWT----AP- 355
Query: 588 EYGLGSEVSINGDVYSYGILLLELMTRKR 616
           E     + S   DV+S+GILL E+ +  R
Sbjct: 356 EALREKKFSTKSDVWSFGILLWEIYSFGR 384

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 121/272 (44%), Gaps = 41/272 (15%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASK--SSIAECSALRNIRHKNLVKILTV 465
           I  GSFG+VYKG   +    +AVK+LN+      +  +   E   LR  RH N++  +  
Sbjct: 20  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG- 75
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                Y      A+V ++    SL   LH    ++   E  K       I+IA   A  +
Sbjct: 76  -----YSTKPQLAIVTQWCEGSSLYHHLH---ASETKFEMKKL------IDIARQTARGM 121
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            YLH     +  H DLK +N+ L  + T  + DFGLA +            + G+I ++A
Sbjct: 122 DYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 178
Query: 586 PAEYGL--GSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDI 643
           P    +   +  S   DVY++GI+L ELMT + P         N++N       D ++++
Sbjct: 179 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS-------NINN------RDQIIEM 225
Query: 644 VDSTLLADDEDLTITSNQRQRQARINNIMECL 675
           V    L+ D    + SN  +R  R+  + ECL
Sbjct: 226 VGRGSLSPDLS-KVRSNCPKRMKRL--MAECL 254

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 102/208 (49%), Gaps = 24/208 (11%)
Query: 411 GSFGSVYKGI-LDEGKTI---IAVKVLN-LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G+FG+VYKGI + EG+T+   +A+K+LN      A+   + E   + ++ H +LV++L V
Sbjct: 26  GAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGV 85
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
           C     +      LV + M +G L E++H         E    +     +N  + +A  +
Sbjct: 86  CLSPTIQ------LVTQLMPHGCLLEYVH---------EHKDNIGSQLLLNWCVQIAKGM 130
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            YL    +    H DL   NVL+       + DFGLA+LL     + ++ G K  I ++A
Sbjct: 131 MYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMA 187
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMT 613
             E     + +   DV+SYG+ + ELMT
Sbjct: 188 -LECIHYRKFTHQSDVWSYGVTIWELMT 214

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 102/208 (49%), Gaps = 24/208 (11%)
Query: 411 GSFGSVYKGI-LDEGKTI---IAVKVLN-LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G+FG+VYKGI + EG+T+   +A+K+LN      A+   + E   + ++ H +LV++L V
Sbjct: 49  GAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGV 108
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
           C     +      LV + M +G L E++H         E    +     +N  + +A  +
Sbjct: 109 CLSPTIQ------LVTQLMPHGCLLEYVH---------EHKDNIGSQLLLNWCVQIAKGM 153
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            YL    +    H DL   NVL+       + DFGLA+LL     + ++ G K  I ++A
Sbjct: 154 MYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMA 210
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMT 613
             E     + +   DV+SYG+ + ELMT
Sbjct: 211 -LECIHYRKFTHQSDVWSYGVTIWELMT 237

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 24/208 (11%)
Query: 411 GSFGSVYKGI-LDEGKTIIAVKVLNLLHHGASKSSIAECS----ALRNIRHKNLVKILTV 465
           G FG+V+KG+ + EG++I     + ++   + + S    +    A+ ++ H ++V++L +
Sbjct: 42  GVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGL 101
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
           C G   +      LV +++  GSL + +    GA      P+ L     +N  + +A  +
Sbjct: 102 CPGSSLQ------LVTQYLPLGSLLDHVRQHRGA----LGPQLL-----LNWGVQIAKGM 146
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            YL    +    H +L   NVLL       VADFG+A LLPP   Q      K  I ++A
Sbjct: 147 YYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA 203
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMT 613
                 G + +   DV+SYG+ + ELMT
Sbjct: 204 LESIHFG-KYTHQSDVWSYGVTVWELMT 230

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 120/272 (44%), Gaps = 41/272 (15%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASK--SSIAECSALRNIRHKNLVKILTV 465
           I  GSFG+VYKG   +    +AVK+LN+      +  +   E   LR  RH N++  +  
Sbjct: 32  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
            +          A+V ++    SL   LH    ++   E  K       I+IA   A  +
Sbjct: 89  STAPQL------AIVTQWCEGSSLYHHLH---ASETKFEMKKL------IDIARQTARGM 133
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            YLH     +  H DLK +N+ L  + T  + DFGLA              + G+I ++A
Sbjct: 134 DYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 190
Query: 586 PAEYGL--GSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDI 643
           P    +   +  S   DVY++GI+L ELMT + P         N++N       D ++++
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS-------NINN------RDQIIEM 237
Query: 644 VDSTLLADDEDLTITSNQRQRQARINNIMECL 675
           V    L+ D    + SN  +R  R+  + ECL
Sbjct: 238 VGRGSLSPDLS-KVRSNCPKRMKRL--MAECL 266

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 24/208 (11%)
Query: 411 GSFGSVYKGI-LDEGKTIIAVKVLNLLHHGASKSSIAECS----ALRNIRHKNLVKILTV 465
           G FG+V+KG+ + EG++I     + ++   + + S    +    A+ ++ H ++V++L +
Sbjct: 24  GVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGL 83
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
           C G   +      LV +++  GSL + +    GA      P+ L     +N  + +A  +
Sbjct: 84  CPGSSLQ------LVTQYLPLGSLLDHVRQHRGA----LGPQLL-----LNWGVQIAKGM 128
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            YL    +    H +L   NVLL       VADFG+A LLPP   Q      K  I ++A
Sbjct: 129 YYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA 185
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMT 613
                 G + +   DV+SYG+ + ELMT
Sbjct: 186 LESIHFG-KYTHQSDVWSYGVTVWELMT 212

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 120/272 (44%), Gaps = 41/272 (15%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASK--SSIAECSALRNIRHKNLVKILTV 465
           I  GSFG+VYKG   +    +AVK+LN+      +  +   E   LR  RH N++  +  
Sbjct: 32  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG- 87
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                Y      A+V ++    SL   LH    ++   E  K       I+IA   A  +
Sbjct: 88  -----YSTKPQLAIVTQWCEGSSLYHHLH---ASETKFEMKKL------IDIARQTARGM 133
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            YLH     +  H DLK +N+ L  + T  + DFGLA              + G+I ++A
Sbjct: 134 DYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 190
Query: 586 PAEYGL--GSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDI 643
           P    +   +  S   DVY++GI+L ELMT + P         N++N       D ++++
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS-------NINN------RDQIIEM 237
Query: 644 VDSTLLADDEDLTITSNQRQRQARINNIMECL 675
           V    L+ D    + SN  +R  R+  + ECL
Sbjct: 238 VGRGSLSPDLS-KVRSNCPKRMKRL--MAECL 266

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 100/210 (47%), Gaps = 15/210 (7%)
Query: 411 GSFGSVYKGIL--DEGKTI-IAVKVLNLLHHGASK--SSIAECSALRNIRHKNLVKILTV 465
           G FGSV +G L  ++G ++ +AVK + L +    +    ++E + +++  H N++++L V
Sbjct: 45  GEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGV 104
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
           C  +  +G     ++  FM  G L  +L       +    PK +     +   +D+A  +
Sbjct: 105 CIEMSSQGIPKPMVILPFMKYGDLHTYLL----YSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
           +YL +       H DL   N +L  +MT  VADFGL+K +            K  + +IA
Sbjct: 161 EYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 217
Query: 586 PAEYGLGSEV-SINGDVYSYGILLLELMTR 614
                L   V +   DV+++G+ + E+ TR
Sbjct: 218 IE--SLADRVYTSKSDVWAFGVTMWEIATR 245

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 70/302 (23%), Positives = 127/302 (42%), Gaps = 45/302 (14%)
Query: 411 GSFGSVYKGIL--DEGKTI-IAVKVL--NLLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G FGSV +  L  ++G  + +AVK+L  +++     +  + E + ++   H ++ K++ V
Sbjct: 34  GEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGV 93
Query: 466 CSGVDYKGD-DFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
                 KG      ++  FM +G L    H    A +  E P  L     +   +D+AC 
Sbjct: 94  SLRSRAKGRLPIPMVILPFMKHGDL----HAFLLASRIGENPFNLPLQTLVRFMVDIACG 149
Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYI 584
           ++YL         H DL   N +L  +MT  VADFGL++ +            K  + ++
Sbjct: 150 MEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL 206
Query: 585 APAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIV 644
           A  E    +  +++ DV+++G+ + E+MTR +      E N  ++N+             
Sbjct: 207 A-LESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE-NAEIYNY------------- 251
Query: 645 DSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQ 704
                       I  N      R+    EC+  V  +   C    P+ R + T +  EL+
Sbjct: 252 -----------LIGGN------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELE 294
Query: 705 SI 706
           +I
Sbjct: 295 NI 296

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 100/214 (46%), Gaps = 27/214 (12%)
Query: 408 IDMGSFGSVYKGILD---EGKTIIAVKVLNLLHHGASKSS-IAECSALRNIRHKNLVKIL 463
           I  G FG V +G L    + ++ +A+K L   +    +   ++E S +    H N++++ 
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 83
Query: 464 TVCSGVDYKGDDFKALVY-EFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVA 522
            V +      +    ++  EFM NG+L+ +L    G             +Q + +   +A
Sbjct: 84  GVVT------NSMPVMILTEFMENGALDSFLRLNDGQ---------FTVIQLVGMLRGIA 128
Query: 523 CALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAH---LQTSSIGVKG 579
             ++YL    + +  H DL   N+L++  +   V+DFGL++ L        +TSS+G K 
Sbjct: 129 SGMRYL---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKI 185
Query: 580 TIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
            I + AP         S + D +SYGI++ E+M+
Sbjct: 186 PIRWTAPEAIAFRKFTSAS-DAWSYGIVMWEVMS 218

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 115/274 (41%), Gaps = 32/274 (11%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           +  G+FG V K         +A+K +        K+ I E   L  + H N+VK+   C 
Sbjct: 17  VGRGAFGVVCKAKWRAKD--VAIKQIE--SESERKAFIVELRQLSRVNHPNIVKLYGACL 72
Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
                  +   LV E+   GSL   LH   GA    E          ++  +  +  + Y
Sbjct: 73  -------NPVCLVMEYAEGGSLYNVLH---GA----EPLPYYTAAHAMSWCLQCSQGVAY 118
Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTA-HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP 586
           LH        H DLKP N+LL    T   + DFG A       +QT     KG+  ++AP
Sbjct: 119 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA-----CDIQTHMTNNKGSAAWMAP 173
Query: 587 AEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIM----FEGNMNLHNFARTVLPDHVMD 642
            E   GS  S   DV+S+GI+L E++TR++P D +    F     +HN  R  L  ++  
Sbjct: 174 -EVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPK 232
Query: 643 IVDSTLLADDEDLTITSNQRQRQARINNIMECLI 676
            ++S +       +   +QR     I  IM  L+
Sbjct: 233 PIESLMT---RCWSKDPSQRPSMEEIVKIMTHLM 263

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 103/224 (45%), Gaps = 34/224 (15%)
Query: 411 GSFGSVYKG-ILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGV 469
           G FG V+K  +L+E    +AVK+  +     S  +  E  +L  ++H+N+++ +    G 
Sbjct: 35  GRFGCVWKAQLLNE---YVAVKIFPI-QDKQSWQNEYEVYSLPGMKHENILQFI----GA 86
Query: 470 DYKGDDFKA---LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALK 526
           + +G        L+  F   GSL ++L               +++ +  +IA  +A  L 
Sbjct: 87  EKRGTSVDVDLWLITAFHEKGSLSDFL-----------KANVVSWNELCHIAETMARGLA 135
Query: 527 YLHHDC-------QPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKG 579
           YLH D        +P  +H D+K  NVLL + +TA +ADFGLA           + G  G
Sbjct: 136 YLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVG 195
Query: 580 TIGYIAP----AEYGLGSEVSINGDVYSYGILLLELMTRKRPSD 619
           T  Y+AP           +  +  D+Y+ G++L EL +R   +D
Sbjct: 196 TRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 115/274 (41%), Gaps = 32/274 (11%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           +  G+FG V K         +A+K +        K+ I E   L  + H N+VK+   C 
Sbjct: 16  VGRGAFGVVCKAKWRAKD--VAIKQIE--SESERKAFIVELRQLSRVNHPNIVKLYGACL 71
Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
                  +   LV E+   GSL   LH   GA    E          ++  +  +  + Y
Sbjct: 72  -------NPVCLVMEYAEGGSLYNVLH---GA----EPLPYYTAAHAMSWCLQCSQGVAY 117
Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTA-HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP 586
           LH        H DLKP N+LL    T   + DFG A       +QT     KG+  ++AP
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA-----CDIQTHMTNNKGSAAWMAP 172
Query: 587 AEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIM----FEGNMNLHNFARTVLPDHVMD 642
            E   GS  S   DV+S+GI+L E++TR++P D +    F     +HN  R  L  ++  
Sbjct: 173 -EVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPK 231
Query: 643 IVDSTLLADDEDLTITSNQRQRQARINNIMECLI 676
            ++S +       +   +QR     I  IM  L+
Sbjct: 232 PIESLMT---RCWSKDPSQRPSMEEIVKIMTHLM 262

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 104/229 (45%), Gaps = 40/229 (17%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRN--IRHKNLVKILTV 465
           I  G +G+VYKG LDE    +AVKV +  +    ++ I E +  R   + H N+ + +  
Sbjct: 21  IGRGRYGAVYKGSLDERP--VAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVG 75
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
              V   G     LV E+  NGSL ++L           +    +++    +A  V   L
Sbjct: 76  DERVTADGRMEYLLVMEYYPNGSLXKYL-----------SLHTSDWVSSCRLAHSVTRGL 124
Query: 526 KYLHHDC------QPTTAHCDLKPSNVLLDHEMTAHVADFGLA------KLLPPAHLQTS 573
            YLH +       +P  +H DL   NVL+ ++ T  ++DFGL+      +L+ P     +
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184
Query: 574 SIGVKGTIGYIAPAEYGLGSEVSING--------DVYSYGILLLELMTR 614
           +I   GTI Y+AP    L   V++          D+Y+ G++  E+  R
Sbjct: 185 AISEVGTIRYMAPE--VLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 101/216 (46%), Gaps = 31/216 (14%)
Query: 408 IDMGSFGSVYKGILD---EGKTIIAVKVLNLLHHGASKSS-IAECSALRNIRHKNLVKIL 463
           I  G FG V +G L    + ++ +A+K L   +    +   ++E S +    H N++++ 
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 81
Query: 464 TVCSGVDYKGDDFKALVY-EFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVA 522
            V +      +    ++  EFM NG+L+ +L    G             +Q + +   +A
Sbjct: 82  GVVT------NSMPVMILTEFMENGALDSFLRLNDGQ---------FTVIQLVGMLRGIA 126
Query: 523 CALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP-----PAHLQTSSIGV 577
             ++YL    + +  H DL   N+L++  +   V+DFGL++ L      P +  TSS+G 
Sbjct: 127 SGMRYL---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTY--TSSLGG 181
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
           K  I + AP         S + D +SYGI++ E+M+
Sbjct: 182 KIPIRWTAPEAIAFRKFTSAS-DAWSYGIVMWEVMS 216

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 25/215 (11%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLL--HHGASKSSIAECSALRNIR---HKNLVKI 462
           I +G++G+VYK         +A+K + +     G   S++ E + LR +    H N+V++
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCL--NFLQRINIAID 520
           + VC+      +    LV+E + +  L  +L          E  K L   FL+       
Sbjct: 72  MDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQFLR------- 123
Query: 521 VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGT 580
               L +LH +C     H DLKP N+L+    T  +ADFGLA++      Q +   V  T
Sbjct: 124 ---GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALFPVVVT 174
Query: 581 IGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRK 615
           + Y AP E  L S  +   D++S G +  E+  RK
Sbjct: 175 LWYRAP-EVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 25/215 (11%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLL--HHGASKSSIAECSALRNIR---HKNLVKI 462
           I +G++G+VYK         +A+K + +     G   S++ E + LR +    H N+V++
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCL--NFLQRINIAID 520
           + VC+      +    LV+E + +  L  +L          E  K L   FL+       
Sbjct: 72  MDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQFLR------- 123
Query: 521 VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGT 580
               L +LH +C     H DLKP N+L+    T  +ADFGLA++      Q +   V  T
Sbjct: 124 ---GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALAPVVVT 174
Query: 581 IGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRK 615
           + Y AP E  L S  +   D++S G +  E+  RK
Sbjct: 175 LWYRAP-EVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 25/208 (12%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNLVKILTVCSG 468
           G++G VYK    +G+ I+A+K + L     G   ++I E S L+ + H N+V ++ V   
Sbjct: 32  GTYGVVYKAKDSQGR-IVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS 90
Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL 528
                +    LV+EFM     E+ L  V   +KT         LQ   I I +   L+ +
Sbjct: 91  -----ERCLTLVFEFM-----EKDLKKVLDENKTG--------LQDSQIKIYLYQLLRGV 132
Query: 529 HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP-PAHLQTSSIGVKGTIGYIAPA 587
            H  Q    H DLKP N+L++ +    +ADFGLA+    P    T  +    T+ Y AP 
Sbjct: 133 AHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEV---VTLWYRAPD 189
Query: 588 EYGLGSEVSINGDVYSYGILLLELMTRK 615
                 + S + D++S G +  E++T K
Sbjct: 190 VLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 25/208 (12%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNLVKILTVCSG 468
           G++G VYK    +G+ I+A+K + L     G   ++I E S L+ + H N+V ++ V   
Sbjct: 32  GTYGVVYKAKDSQGR-IVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS 90
Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL 528
                +    LV+EFM     E+ L  V   +KT         LQ   I I +   L+ +
Sbjct: 91  -----ERCLTLVFEFM-----EKDLKKVLDENKTG--------LQDSQIKIYLYQLLRGV 132
Query: 529 HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP-PAHLQTSSIGVKGTIGYIAPA 587
            H  Q    H DLKP N+L++ +    +ADFGLA+    P    T  +    T+ Y AP 
Sbjct: 133 AHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEV---VTLWYRAPD 189
Query: 588 EYGLGSEVSINGDVYSYGILLLELMTRK 615
                 + S + D++S G +  E++T K
Sbjct: 190 VLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 25/215 (11%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLL--HHGASKSSIAECSALRNIR---HKNLVKI 462
           I +G++G+VYK         +A+K + +     G   S++ E + LR +    H N+V++
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCL--NFLQRINIAID 520
           + VC+      +    LV+E + +  L  +L          E  K L   FL+       
Sbjct: 72  MDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQFLR------- 123
Query: 521 VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGT 580
               L +LH +C     H DLKP N+L+    T  +ADFGLA++      Q +   V  T
Sbjct: 124 ---GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALDPVVVT 174
Query: 581 IGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRK 615
           + Y AP E  L S  +   D++S G +  E+  RK
Sbjct: 175 LWYRAP-EVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 92/209 (44%), Gaps = 22/209 (10%)
Query: 411 GSFGSV----YKGILDEGKTIIAVKVLNLLHHGASKSSIA-ECSALRNIRHKNLVKILTV 465
           G FG V    Y    D     +AVK L     G   + +  E   LRN+ H+N+VK   +
Sbjct: 20  GHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGI 79
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
           C+     G +   L+ EF+ +GSL+E+L               +N  Q++  A+ +   +
Sbjct: 80  CTE---DGGNGIKLIMEFLPSGSLKEYLPKNKNK---------INLKQQLKYAVQICKGM 127
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP-PAHLQTSSIGVKGTIGYI 584
            YL         H DL   NVL++ E    + DFGL K +       T        + + 
Sbjct: 128 DYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY 184
Query: 585 APAEYGLGSEVSINGDVYSYGILLLELMT 613
           AP E  + S+  I  DV+S+G+ L EL+T
Sbjct: 185 AP-ECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 92/209 (44%), Gaps = 22/209 (10%)
Query: 411 GSFGSV----YKGILDEGKTIIAVKVLNLLHHGASKSSIA-ECSALRNIRHKNLVKILTV 465
           G FG V    Y    D     +AVK L     G   + +  E   LRN+ H+N+VK   +
Sbjct: 32  GHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGI 91
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
           C+     G +   L+ EF+ +GSL+E+L               +N  Q++  A+ +   +
Sbjct: 92  CTE---DGGNGIKLIMEFLPSGSLKEYLPKNKNK---------INLKQQLKYAVQICKGM 139
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP-PAHLQTSSIGVKGTIGYI 584
            YL         H DL   NVL++ E    + DFGL K +       T        + + 
Sbjct: 140 DYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY 196
Query: 585 APAEYGLGSEVSINGDVYSYGILLLELMT 613
           AP E  + S+  I  DV+S+G+ L EL+T
Sbjct: 197 AP-ECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 30/220 (13%)
Query: 408 IDMGSFGSVYKGILD---EGKTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKIL 463
           I  G FG V  G L    + +  +A+K L   +     +  ++E S +    H N++ + 
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHL- 99
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
               GV  K      ++ EFM NGSL+ +L    G             +Q + +   +A 
Sbjct: 100 ---EGVVTKSTPV-MIITEFMENGSLDSFLRQNDGQ---------FTVIQLVGMLRGIAA 146
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP-----PAHLQTSSIGVK 578
            +KYL         H DL   N+L++  +   V+DFGL++ L      P +  TS++G K
Sbjct: 147 GMKYL---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY--TSALGGK 201
Query: 579 GTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTR-KRP 617
             I + AP         S + DV+SYGI++ E+M+  +RP
Sbjct: 202 IPIRWTAPEAIQYRKFTSAS-DVWSYGIVMWEVMSYGERP 240

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 34/221 (15%)
Query: 408 IDMGSFGSVYKGILD---EGKTIIAVKVLNLLHHGASKSS-IAECSALRNIRHKNLVK-- 461
           I +G FG V  G L    + +  +A+K L   +    +   ++E S +    H N++   
Sbjct: 37  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 96
Query: 462 -ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAID 520
            ++T C  V         ++ E+M NGSL+ +L    G             +Q + +   
Sbjct: 97  GVVTKCKPV--------MIITEYMENGSLDAFLRKNDGR---------FTVIQLVGMLRG 139
Query: 521 VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL---PPAHLQTSSIGV 577
           +   +KYL      +  H DL   N+L++  +   V+DFG++++L   P A   T   G 
Sbjct: 140 IGSGMKYLS---DMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR--GG 194
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTR-KRP 617
           K  I + AP         S + DV+SYGI++ E+M+  +RP
Sbjct: 195 KIPIRWTAPEAIAYRKFTSAS-DVWSYGIVMWEVMSYGERP 234

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 106/244 (43%), Gaps = 26/244 (10%)
Query: 399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKN 458
           F  F  L  I  GSFG V     ++ K + A+K +N       K    E + +RN+    
Sbjct: 14  FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMN-------KQKCVERNEVRNV---- 62
Query: 459 LVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQR-INI 517
             K L +  G+++       L Y F     +   +  + G D      + ++F +  + +
Sbjct: 63  -FKELQIMQGLEHPF--LVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKL 119
Query: 518 AI-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIG 576
            I ++  AL YL +       H D+KP N+LLD     H+ DF +A +LP    +T    
Sbjct: 120 FICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP---RETQITT 173
Query: 577 VKGTIGYIAPAEYG--LGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMN--LHNFA 632
           + GT  Y+AP  +    G+  S   D +S G+   EL+  +RP  I    +    +H F 
Sbjct: 174 MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE 233
Query: 633 RTVL 636
            TV+
Sbjct: 234 TTVV 237

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 98/216 (45%), Gaps = 33/216 (15%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN--LLHHGASKSSIA-ECSALRNIRHKNLVKILTVCS 467
           GSFG V           +A+K++N  +L     +  I  E S LR +RH +++K+  V  
Sbjct: 24  GSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVI- 82
Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
               K  D   +V E+  N    E    +   DK  E  +   F Q+I        A++Y
Sbjct: 83  ----KSKDEIIMVIEYAGN----ELFDYIVQRDKMSEQ-EARRFFQQI------ISAVEY 127
Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP- 586
            H   +    H DLKP N+LLD  +   +ADFGL+ ++   +   +S    G+  Y AP 
Sbjct: 128 CH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPE 181
Query: 587 ---AEYGLGSEVSINGDVYSYGILLLELMTRKRPSD 619
               +   G EV    DV+S G++L  ++ R+ P D
Sbjct: 182 VISGKLYAGPEV----DVWSCGVILYVMLCRRLPFD 213

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 19/212 (8%)
Query: 411 GSFGSV-----YKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G+FG V     Y    ++ K ++AVK L      A K    E   L N++H+++VK   V
Sbjct: 24  GAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGV 83
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEA----PKCLNFLQRINIAIDV 521
           C     +GD    +V+E+M +G L ++L    G D  + A    P  L   Q ++IA  +
Sbjct: 84  CV----EGDPL-IMVFEYMKHGDLNKFLR-AHGPDAVLMAEGNPPTELTQSQMLHIAQQI 137
Query: 522 ACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTI 581
           A  + YL         H DL   N L+   +   + DFG+++ +               I
Sbjct: 138 AAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 194
Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
            ++ P E  +  + +   DV+S G++L E+ T
Sbjct: 195 RWM-PPESIMYRKFTTESDVWSLGVVLWEIFT 225

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 98/216 (45%), Gaps = 33/216 (15%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN--LLHHGASKSSIA-ECSALRNIRHKNLVKILTVCS 467
           GSFG V           +A+K++N  +L     +  I  E S LR +RH +++K+  V  
Sbjct: 25  GSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVI- 83
Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
               K  D   +V E+  N    E    +   DK  E  +   F Q+I        A++Y
Sbjct: 84  ----KSKDEIIMVIEYAGN----ELFDYIVQRDKMSEQ-EARRFFQQI------ISAVEY 128
Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP- 586
            H   +    H DLKP N+LLD  +   +ADFGL+ ++   +   +S    G+  Y AP 
Sbjct: 129 CH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPE 182
Query: 587 ---AEYGLGSEVSINGDVYSYGILLLELMTRKRPSD 619
               +   G EV    DV+S G++L  ++ R+ P D
Sbjct: 183 VISGKLYAGPEV----DVWSCGVILYVMLCRRLPFD 214

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 98/216 (45%), Gaps = 33/216 (15%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN--LLHHGASKSSIA-ECSALRNIRHKNLVKILTVCS 467
           GSFG V           +A+K++N  +L     +  I  E S LR +RH +++K+  V  
Sbjct: 15  GSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVI- 73
Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
               K  D   +V E+  N    E    +   DK  E  +   F Q+I        A++Y
Sbjct: 74  ----KSKDEIIMVIEYAGN----ELFDYIVQRDKMSEQ-EARRFFQQI------ISAVEY 118
Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP- 586
            H   +    H DLKP N+LLD  +   +ADFGL+ ++   +   +S    G+  Y AP 
Sbjct: 119 CH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPE 172
Query: 587 ---AEYGLGSEVSINGDVYSYGILLLELMTRKRPSD 619
               +   G EV    DV+S G++L  ++ R+ P D
Sbjct: 173 VISGKLYAGPEV----DVWSCGVILYVMLCRRLPFD 204

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 98/216 (45%), Gaps = 33/216 (15%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN--LLHHGASKSSIA-ECSALRNIRHKNLVKILTVCS 467
           GSFG V           +A+K++N  +L     +  I  E S LR +RH +++K+  V  
Sbjct: 19  GSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVI- 77
Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
               K  D   +V E+  N    E    +   DK  E  +   F Q+I        A++Y
Sbjct: 78  ----KSKDEIIMVIEYAGN----ELFDYIVQRDKMSEQ-EARRFFQQI------ISAVEY 122
Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP- 586
            H   +    H DLKP N+LLD  +   +ADFGL+ ++   +   +S    G+  Y AP 
Sbjct: 123 CH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPE 176
Query: 587 ---AEYGLGSEVSINGDVYSYGILLLELMTRKRPSD 619
               +   G EV    DV+S G++L  ++ R+ P D
Sbjct: 177 VISGKLYAGPEV----DVWSCGVILYVMLCRRLPFD 208

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 34/221 (15%)
Query: 408 IDMGSFGSVYKGILD---EGKTIIAVKVLNLLHHGASKSS-IAECSALRNIRHKNLVK-- 461
           I +G FG V  G L    + +  +A+K L   +    +   ++E S +    H N++   
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 81
Query: 462 -ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAID 520
            ++T C  V         ++ E+M NGSL+ +L    G             +Q + +   
Sbjct: 82  GVVTKCKPV--------MIITEYMENGSLDAFLRKNDGR---------FTVIQLVGMLRG 124
Query: 521 VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL---PPAHLQTSSIGV 577
           +   +KYL      +  H DL   N+L++  +   V+DFG++++L   P A   T   G 
Sbjct: 125 IGSGMKYLS---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR--GG 179
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTR-KRP 617
           K  I + AP         S + DV+SYGI++ E+M+  +RP
Sbjct: 180 KIPIRWTAPEAIAYRKFTSAS-DVWSYGIVMWEVMSYGERP 219

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 34/221 (15%)
Query: 408 IDMGSFGSVYKGILD---EGKTIIAVKVLNLLHHGASKSS-IAECSALRNIRHKNLVK-- 461
           I +G FG V  G L    + +  +A+K L   +    +   ++E S +    H N++   
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 75
Query: 462 -ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAID 520
            ++T C  V         ++ E+M NGSL+ +L    G             +Q + +   
Sbjct: 76  GVVTKCKPV--------MIITEYMENGSLDAFLRKNDGR---------FTVIQLVGMLRG 118
Query: 521 VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL---PPAHLQTSSIGV 577
           +   +KYL      +  H DL   N+L++  +   V+DFG++++L   P A   T   G 
Sbjct: 119 IGSGMKYLS---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR--GG 173
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTR-KRP 617
           K  I + AP         S + DV+SYGI++ E+M+  +RP
Sbjct: 174 KIPIRWTAPEAIAYRKFTSAS-DVWSYGIVMWEVMSYGERP 213

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 74/303 (24%), Positives = 124/303 (40%), Gaps = 60/303 (19%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGA--SKSSIAECSALRNIRHKNLVKILTV 465
           I  G FG V+ G     K  +A+K +     GA   +  I E   +  + H  LV++  V
Sbjct: 18  IGSGQFGLVHLGYW-LNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 73
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSG--ADKTVEAPKCLNFLQRINIAIDVAC 523
           C            LV+EFM +G L ++L    G  A +T+           + + +DV  
Sbjct: 74  C-----LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL-----------LGMCLDVCE 117
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGY 583
            + YL   C     H DL   N L+       V+DFG+ + +      TSS G K  + +
Sbjct: 118 GMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKW 173
Query: 584 IAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDI 643
            +P  +   S  S   DV+S+G+L+ E+ +         EG +   N +           
Sbjct: 174 ASPEVFSF-SRYSSKSDVWSFGVLMWEVFS---------EGKIPYENRS----------- 212
Query: 644 VDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHEL 703
            +S ++ D     I++  R  + R+ +       V +I   C  E P+DR   + ++ +L
Sbjct: 213 -NSEVVED-----ISTGFRLYKPRLAS-----THVYQIMNHCWRERPEDRPAFSRLLRQL 261
Query: 704 QSI 706
             I
Sbjct: 262 AEI 264

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 109/272 (40%), Gaps = 59/272 (21%)
Query: 408 IDMGSFGSVYKGILD-EGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVC 466
           I  G FG V+K     +GKT +  +V        ++ +  E  AL  + H N+V      
Sbjct: 20  IGSGGFGQVFKAKHRIDGKTYVIRRV-----KYNNEKAEREVKALAKLDHVNIVHYNGCW 74
Query: 467 SGVDYK----GDDFKALVY--------------------EFMHNGSLEEWLHPVSGA--D 500
            G DY      D  ++  Y                    EF   G+LE+W+    G   D
Sbjct: 75  DGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLD 134
Query: 501 KTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFG 560
           K +     L   ++I   +D   + K +H D         LKPSN+ L       + DFG
Sbjct: 135 KVL----ALELFEQITKGVDYIHSKKLIHRD---------LKPSNIFLVDTKQVKIGDFG 181
Query: 561 LAKLLPPAHLQTSSIGVKGTIGYIAPAE---YGLGSEVSINGDVYSYGILLLELMTRKRP 617
           L   L     +T S   KGT+ Y++P +      G EV    D+Y+ G++L EL+     
Sbjct: 182 LVTSLKNDGKRTRS---KGTLRYMSPEQISSQDYGKEV----DLYALGLILAELL---HV 231
Query: 618 SDIMFEGNMNLHNFARTVLPDHVMDIVDSTLL 649
            D  FE +    +    ++ D + D  + TLL
Sbjct: 232 CDTAFETSKFFTDLRDGIISD-IFDKKEKTLL 262

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 74/303 (24%), Positives = 124/303 (40%), Gaps = 60/303 (19%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGA--SKSSIAECSALRNIRHKNLVKILTV 465
           I  G FG V+ G     K  +A+K +     GA   +  I E   +  + H  LV++  V
Sbjct: 13  IGSGQFGLVHLGYW-LNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 68
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSG--ADKTVEAPKCLNFLQRINIAIDVAC 523
           C            LV+EFM +G L ++L    G  A +T+           + + +DV  
Sbjct: 69  C-----LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL-----------LGMCLDVCE 112
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGY 583
            + YL   C     H DL   N L+       V+DFG+ + +      TSS G K  + +
Sbjct: 113 GMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKW 168
Query: 584 IAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDI 643
            +P  +   S  S   DV+S+G+L+ E+ +         EG +   N +           
Sbjct: 169 ASPEVFSF-SRYSSKSDVWSFGVLMWEVFS---------EGKIPYENRS----------- 207
Query: 644 VDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHEL 703
            +S ++ D     I++  R  + R+ +       V +I   C  E P+DR   + ++ +L
Sbjct: 208 -NSEVVED-----ISTGFRLYKPRLAS-----THVYQIMNHCWKERPEDRPAFSRLLRQL 256
Query: 704 QSI 706
             I
Sbjct: 257 AEI 259

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 74/303 (24%), Positives = 124/303 (40%), Gaps = 60/303 (19%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGA--SKSSIAECSALRNIRHKNLVKILTV 465
           I  G FG V+ G     K  +A+K +     GA   +  I E   +  + H  LV++  V
Sbjct: 15  IGSGQFGLVHLGYW-LNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 70
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSG--ADKTVEAPKCLNFLQRINIAIDVAC 523
           C            LV+EFM +G L ++L    G  A +T+           + + +DV  
Sbjct: 71  C-----LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL-----------LGMCLDVCE 114
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGY 583
            + YL   C     H DL   N L+       V+DFG+ + +      TSS G K  + +
Sbjct: 115 GMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKW 170
Query: 584 IAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDI 643
            +P  +   S  S   DV+S+G+L+ E+ +         EG +   N +           
Sbjct: 171 ASPEVFSF-SRYSSKSDVWSFGVLMWEVFS---------EGKIPYENRS----------- 209
Query: 644 VDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHEL 703
            +S ++ D     I++  R  + R+ +       V +I   C  E P+DR   + ++ +L
Sbjct: 210 -NSEVVED-----ISTGFRLYKPRLAS-----THVYQIMNHCWKERPEDRPAFSRLLRQL 258
Query: 704 QSI 706
             I
Sbjct: 259 AEI 261

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 28/218 (12%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASK-----SSIAECSALRNIR---HKNL 459
           I +G++G+VYK         +A+K + + + G        S++ E + LR +    H N+
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 460 VKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCL--NFLQRINI 517
           V+++ VC+      +    LV+E + +  L  +L          E  K L   FL+    
Sbjct: 77  VRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQFLR---- 131
Query: 518 AIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
                  L +LH +C     H DLKP N+L+    T  +ADFGLA++      Q +   V
Sbjct: 132 ------GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALTPV 179
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRK 615
             T+ Y AP E  L S  +   D++S G +  E+  RK
Sbjct: 180 VVTLWYRAP-EVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 89/212 (41%), Gaps = 19/212 (8%)
Query: 411 GSFGSVYKGI-LDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGV 469
           G FG V + I  D G+ +   +    L     +    E   ++ + H N+V    V  G+
Sbjct: 25  GGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGL 84
Query: 470 DYKG-DDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL 528
                +D   L  E+   G L ++L+         E P          +  D++ AL+YL
Sbjct: 85  QKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPI-------RTLLSDISSALRYL 137
Query: 529 HHDCQPTTAHCDLKPSNVLLD---HEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
           H +      H DLKP N++L      +   + D G AK L    L T  +   GT+ Y+A
Sbjct: 138 HEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV---GTLQYLA 191
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
           P E     + ++  D +S+G L  E +T  RP
Sbjct: 192 P-ELLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 89/212 (41%), Gaps = 19/212 (8%)
Query: 411 GSFGSVYKGI-LDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGV 469
           G FG V + I  D G+ +   +    L     +    E   ++ + H N+V    V  G+
Sbjct: 26  GGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGL 85
Query: 470 DYKG-DDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL 528
                +D   L  E+   G L ++L+         E P          +  D++ AL+YL
Sbjct: 86  QKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPI-------RTLLSDISSALRYL 138
Query: 529 HHDCQPTTAHCDLKPSNVLLD---HEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
           H +      H DLKP N++L      +   + D G AK L    L T  +   GT+ Y+A
Sbjct: 139 HEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV---GTLQYLA 192
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
           P E     + ++  D +S+G L  E +T  RP
Sbjct: 193 P-ELLEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 76/162 (46%), Gaps = 20/162 (12%)
Query: 456 HKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRI 515
           H+N+V ++ V      + DD   LV E++   +L E+          +E+   L+    I
Sbjct: 70  HQNIVSMIDVD-----EEDDCYYLVMEYIEGPTLSEY----------IESHGPLSVDTAI 114
Query: 516 NIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSI 575
           N    +   +K+ H        H D+KP N+L+D   T  + DFG+AK L    L T + 
Sbjct: 115 NFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-TQTN 170
Query: 576 GVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
            V GT+ Y +P E   G       D+YS GI+L E++  + P
Sbjct: 171 HVLGTVQYFSP-EQAKGEATDECTDIYSIGIVLYEMLVGEPP 211

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 113/242 (46%), Gaps = 33/242 (13%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNLVKILTV 465
           I  G++G VYK        ++A+K + L     G   ++I E S L+ + H N+VK+L V
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                   ++   LV+EF+H   L++++   + A   +  P   ++L ++   +    + 
Sbjct: 71  IHT-----ENKLYLVFEFLHQ-DLKKFMD--ASALTGIPLPLIKSYLFQLLQGLSFCHSH 122
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL-PPAHLQTSSIGVKGTIGYI 584
           + LH D         LKP N+L++ E    +ADFGLA+    P    T  +    T+ Y 
Sbjct: 123 RVLHRD---------LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV---VTLWYR 170
Query: 585 APAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV----LPDH 639
           AP E  LG +  S   D++S G +  E++TR+     +F G+  +    R       PD 
Sbjct: 171 AP-EILLGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRIFRTLGTPDE 225
Query: 640 VM 641
           V+
Sbjct: 226 VV 227

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 109/239 (45%), Gaps = 34/239 (14%)
Query: 404 FLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSS--IAECSALRNIRHKNLVK 461
           FL  +  G FG V  G    G+  +A+K   ++  G+      I E   + N+ H+ LV+
Sbjct: 28  FLKELGTGQFGVVKYGKW-RGQYDVAIK---MIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 83
Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDV 521
           +  VC+    +   F  ++ E+M NG L  +L  +    +T          Q + +  DV
Sbjct: 84  LYGVCTK---QRPIF--IITEYMANGCLLNYLREMRHRFQTQ---------QLLEMCKDV 129
Query: 522 ACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTI 581
             A++YL         H DL   N L++ +    V+DFGL++ +     +TSS+G K  +
Sbjct: 130 CEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-ETSSVGSKFPV 185
Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHV 640
            + +P E  + S+ S   D++++G+L+ E+ +          G M    F  +   +H+
Sbjct: 186 RW-SPPEVLMYSKFSSKSDIWAFGVLMWEIYSL---------GKMPYERFTNSETAEHI 234

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 73/305 (23%), Positives = 127/305 (41%), Gaps = 60/305 (19%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGA--SKSSIAECSALRNIRHKNLVKILTV 465
           I  G FG V+ G     K  +A+K +     GA   +  I E   +  + H  LV++  V
Sbjct: 15  IGSGQFGLVHLGYW-LNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 70
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSG--ADKTVEAPKCLNFLQRINIAIDVAC 523
           C            LV+EFM +G L ++L    G  A +T+           + + +DV  
Sbjct: 71  C-----LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL-----------LGMCLDVCE 114
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGY 583
            + YL    + +  H DL   N L+       V+DFG+ + +      TSS G K  + +
Sbjct: 115 GMAYLE---EASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKW 170
Query: 584 IAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDI 643
            +P  +   S  S   DV+S+G+L+ E+ +         EG +   N +           
Sbjct: 171 ASPEVFSF-SRYSSKSDVWSFGVLMWEVFS---------EGKIPYENRS----------- 209
Query: 644 VDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHEL 703
            +S ++ D     I++  R  + R+ +       V +I   C  E P+DR   + ++ +L
Sbjct: 210 -NSEVVED-----ISTGFRLYKPRLAS-----THVYQIMNHCWKERPEDRPAFSRLLRQL 258
Query: 704 QSIKS 708
            +I +
Sbjct: 259 AAIAA 263

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 113/242 (46%), Gaps = 33/242 (13%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNLVKILTV 465
           I  G++G VYK        ++A+K + L     G   ++I E S L+ + H N+VK+L V
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 77
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                   ++   LV+EF+H   L++++   + A   +  P   ++L ++   +    + 
Sbjct: 78  IHT-----ENKLYLVFEFLHQ-DLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH 129
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP-PAHLQTSSIGVKGTIGYI 584
           + LH D         LKP N+L++ E    +ADFGLA+    P    T  +    T+ Y 
Sbjct: 130 RVLHRD---------LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV---VTLWYR 177
Query: 585 APAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV----LPDH 639
           AP E  LG +  S   D++S G +  E++TR+     +F G+  +    R       PD 
Sbjct: 178 AP-EILLGXKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRIFRTLGTPDE 232
Query: 640 VM 641
           V+
Sbjct: 233 VV 234

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 26/217 (11%)
Query: 408 IDMGSFGSVYKGILD-EGKTIIAVKVLNL---LHHGASKSSIAECSALRNIRHKNLVKIL 463
           I  G FG V  G L   GK  +AV +  L         +  + E S +    H N+V + 
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHL- 109
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
               GV  +G     +V EFM NG+L+ +L    G             +Q + +   +A 
Sbjct: 110 ---EGVVTRGKPV-MIVIEFMENGALDAFLRKHDGQ---------FTVIQLVGMLRGIAA 156
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP--PAHLQTSSIGVKGTI 581
            ++YL         H DL   N+L++  +   V+DFGL++++   P  + T++ G K  +
Sbjct: 157 GMRYL---ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTT-GGKIPV 212
Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMTR-KRP 617
            + AP         S + DV+SYGI++ E+M+  +RP
Sbjct: 213 RWTAPEAIQYRKFTSAS-DVWSYGIVMWEVMSYGERP 248

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 104/246 (42%), Gaps = 49/246 (19%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA-------ECSALRNIRHKNLV 460
           I  G FG V+KG L + K+++A+K L L         I        E   + N+ H N+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 461 KILTVCSGVDYKGDDFKALVYEFMHNGSLEEWL----HPVSGADKTVEAPKCLNFLQRIN 516
           K+  +         +   +V EF+  G L   L    HP+  + K             + 
Sbjct: 87  KLYGLMH-------NPPRMVMEFVPCGDLYHRLLDKAHPIKWSVK-------------LR 126
Query: 517 IAIDVACALKYLHHDCQPTTAHCDLKPSNVLL-----DHEMTAHVADFGLAKLLPPAHLQ 571
           + +D+A  ++Y+ +   P   H DL+  N+ L     +  + A VADFGL+        Q
Sbjct: 127 LMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS--------Q 177
Query: 572 TSSIGVKGTIG---YIAPAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMN 627
            S   V G +G   ++AP   G   E  +   D YS+ ++L  ++T + P D    G + 
Sbjct: 178 QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK 237
Query: 628 LHNFAR 633
             N  R
Sbjct: 238 FINMIR 243

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 93/208 (44%), Gaps = 25/208 (12%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKV-LNLLHHGASKSSIAECSALRNIRHKNLVKILTVC 466
           I  G++G VYK   + G+T    K+ L     G   ++I E S L+ ++H N+VK+  V 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 467 SGVDYKGDDFKALVYEFMH-NGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                     K LV  F H +  L++ L    G  ++V A   L  LQ +N        +
Sbjct: 70  HTK-------KRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFL--LQLLN-------GI 113
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP-PAHLQTSSIGVKGTIGYI 584
            Y H        H DLKP N+L++ E    +ADFGLA+    P    T  I    T+ Y 
Sbjct: 114 AYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEI---VTLWYR 167
Query: 585 APAEYGLGSEVSINGDVYSYGILLLELM 612
           AP       + S   D++S G +  E++
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMV 195

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 113/242 (46%), Gaps = 33/242 (13%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNLVKILTV 465
           I  G++G VYK        ++A+K + L     G   ++I E S L+ + H N+VK+L V
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                   ++   LV+EF+H   L++++   + A   +  P   ++L ++   +    + 
Sbjct: 71  IHT-----ENKLYLVFEFLHQ-DLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL-PPAHLQTSSIGVKGTIGYI 584
           + LH D         LKP N+L++ E    +ADFGLA+    P    T  +    T+ Y 
Sbjct: 123 RVLHRD---------LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV---VTLWYR 170
Query: 585 APAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV----LPDH 639
           AP E  LG +  S   D++S G +  E++TR+     +F G+  +    R       PD 
Sbjct: 171 AP-EILLGXKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRIFRTLGTPDE 225
Query: 640 VM 641
           V+
Sbjct: 226 VV 227

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 113/242 (46%), Gaps = 33/242 (13%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNLVKILTV 465
           I  G++G VYK        ++A+K + L     G   ++I E S L+ + H N+VK+L V
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 77
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                   ++   LV+EF+H   L++++   + A   +  P   ++L ++   +    + 
Sbjct: 78  IHT-----ENKLYLVFEFLHQ-DLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH 129
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP-PAHLQTSSIGVKGTIGYI 584
           + LH D         LKP N+L++ E    +ADFGLA+    P    T  +    T+ Y 
Sbjct: 130 RVLHRD---------LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV---VTLWYR 177
Query: 585 APAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV----LPDH 639
           AP E  LG +  S   D++S G +  E++TR+     +F G+  +    R       PD 
Sbjct: 178 AP-EILLGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRIFRTLGTPDE 232
Query: 640 VM 641
           V+
Sbjct: 233 VV 234

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 93/216 (43%), Gaps = 30/216 (13%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G FG   K    E   ++ +K L        ++ + E   +R + H N++K +    GV 
Sbjct: 21  GCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFI----GVL 76
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
           YK D     + E++  G+L        G  K++++     + QR++ A D+A  + YLH 
Sbjct: 77  YK-DKRLNFITEYIKGGTLR-------GIIKSMDSQ--YPWSQRVSFAKDIASGMAYLH- 125
Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIG------------VK 578
                  H DL   N L+       VADFGLA+L+     Q   +             V 
Sbjct: 126 --SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183
Query: 579 GTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTR 614
           G   ++AP E   G       DV+S+GI+L E++ R
Sbjct: 184 GNPYWMAP-EMINGRSYDEKVDVFSFGIVLCEIIGR 218

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 113/242 (46%), Gaps = 33/242 (13%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNLVKILTV 465
           I  G++G VYK        ++A+K + L     G   ++I E S L+ + H N+VK+L V
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                   ++   LV+EF+H   L++++   + A   +  P   ++L ++   +    + 
Sbjct: 71  IHT-----ENKLYLVFEFLHQ-DLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP-PAHLQTSSIGVKGTIGYI 584
           + LH D         LKP N+L++ E    +ADFGLA+    P    T  +    T+ Y 
Sbjct: 123 RVLHRD---------LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV---VTLWYR 170
Query: 585 APAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV----LPDH 639
           AP E  LG +  S   D++S G +  E++TR+     +F G+  +    R       PD 
Sbjct: 171 AP-EILLGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRIFRTLGTPDE 225
Query: 640 VM 641
           V+
Sbjct: 226 VV 227

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 113/242 (46%), Gaps = 33/242 (13%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNLVKILTV 465
           I  G++G VYK        ++A+K + L     G   ++I E S L+ + H N+VK+L V
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                   ++   LV+EF+H   L++++   + A   +  P   ++L ++   +    + 
Sbjct: 70  IHT-----ENKLYLVFEFLHQ-DLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL-PPAHLQTSSIGVKGTIGYI 584
           + LH D         LKP N+L++ E    +ADFGLA+    P    T  +    T+ Y 
Sbjct: 122 RVLHRD---------LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV---VTLWYR 169
Query: 585 APAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV----LPDH 639
           AP E  LG +  S   D++S G +  E++TR+     +F G+  +    R       PD 
Sbjct: 170 AP-EILLGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRIFRTLGTPDE 224
Query: 640 VM 641
           V+
Sbjct: 225 VV 226

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 97/224 (43%), Gaps = 39/224 (17%)
Query: 408 IDMGSFGSVYKG--ILDEGKTIIAVKVLNLLHHGASKSSIA----ECSALRNIRHKNLVK 461
           I +G FG VY+   I DE    +AVK            +I     E      ++H N++ 
Sbjct: 15  IGIGGFGKVYRAFWIGDE----VAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDV 521
           +  VC     K  +   LV EF   G L   L     + K +  P  L     +N A+ +
Sbjct: 71  LRGVC----LKEPNL-CLVMEFARGGPLNRVL-----SGKRI-PPDIL-----VNWAVQI 114
Query: 522 ACALKYLHHDCQPTTAHCDLKPSNVLLDHEMT--------AHVADFGLAKLLPPAHLQTS 573
           A  + YLH +      H DLK SN+L+  ++           + DFGLA+       +T+
Sbjct: 115 ARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EWHRTT 170
Query: 574 SIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
            +   G   ++AP E    S  S   DV+SYG+LL EL+T + P
Sbjct: 171 KMSAAGAYAWMAP-EVIRASMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 28/218 (12%)
Query: 408 IDMGSFGSVYKGIL---DEGKTIIAVKVLNLLHHGASKSS-IAECSALRNIRHKNLVKIL 463
           +  G FG V  G L    + +  +A+K L + +    +   + E S +    H N++++ 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL- 111
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
               GV  K      +V E+M NGSL+ +L                  +Q + +   +A 
Sbjct: 112 ---EGVVTKSKPV-MIVTEYMENGSLDSFLRKHDAQ---------FTVIQLVGMLRGIAS 158
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL---PPAHLQTSSIGVKGT 580
            +KYL         H DL   N+L++  +   V+DFGLA++L   P A   T   G K  
Sbjct: 159 GMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTR--GGKIP 213
Query: 581 IGYIAPAEYGLGSEVSINGDVYSYGILLLELMTR-KRP 617
           I + +P         S + DV+SYGI+L E+M+  +RP
Sbjct: 214 IRWTSPEAIAYRKFTSAS-DVWSYGIVLWEVMSYGERP 250

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 113/242 (46%), Gaps = 33/242 (13%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNLVKILTV 465
           I  G++G VYK        ++A+K + L     G   ++I E S L+ + H N+VK+L V
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                   ++   LV+EF+H   L++++   + A   +  P   ++L ++   +    + 
Sbjct: 72  IHT-----ENKLYLVFEFLHQ-DLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP-PAHLQTSSIGVKGTIGYI 584
           + LH D         LKP N+L++ E    +ADFGLA+    P    T  +    T+ Y 
Sbjct: 124 RVLHRD---------LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV---VTLWYR 171
Query: 585 APAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV----LPDH 639
           AP E  LG +  S   D++S G +  E++TR+     +F G+  +    R       PD 
Sbjct: 172 AP-EILLGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRIFRTLGTPDE 226
Query: 640 VM 641
           V+
Sbjct: 227 VV 228

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 113/242 (46%), Gaps = 33/242 (13%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNLVKILTV 465
           I  G++G VYK        ++A+K + L     G   ++I E S L+ + H N+VK+L V
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                   ++   LV+EF+H   L++++   + A   +  P   ++L ++   +    + 
Sbjct: 71  IHT-----ENKLYLVFEFLHQ-DLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL-PPAHLQTSSIGVKGTIGYI 584
           + LH D         LKP N+L++ E    +ADFGLA+    P    T  +    T+ Y 
Sbjct: 123 RVLHRD---------LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV---VTLWYR 170
Query: 585 APAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV----LPDH 639
           AP E  LG +  S   D++S G +  E++TR+     +F G+  +    R       PD 
Sbjct: 171 AP-EILLGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRIFRTLGTPDE 225
Query: 640 VM 641
           V+
Sbjct: 226 VV 227

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 73/303 (24%), Positives = 123/303 (40%), Gaps = 60/303 (19%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSS--IAECSALRNIRHKNLVKILTV 465
           I  G FG V+ G     K  +A+K +     G+      I E   +  + H  LV++  V
Sbjct: 35  IGSGQFGLVHLGYW-LNKDKVAIKTIK---EGSMSEDDFIEEAEVMMKLSHPKLVQLYGV 90
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSG--ADKTVEAPKCLNFLQRINIAIDVAC 523
           C            LV+EFM +G L ++L    G  A +T+           + + +DV  
Sbjct: 91  C-----LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL-----------LGMCLDVCE 134
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGY 583
            + YL   C     H DL   N L+       V+DFG+ + +      TSS G K  + +
Sbjct: 135 GMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKW 190
Query: 584 IAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDI 643
            +P  +   S  S   DV+S+G+L+ E+ +         EG +   N +           
Sbjct: 191 ASPEVFSF-SRYSSKSDVWSFGVLMWEVFS---------EGKIPYENRS----------- 229
Query: 644 VDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHEL 703
            +S ++ D     I++  R  + R+ +       V +I   C  E P+DR   + ++ +L
Sbjct: 230 -NSEVVED-----ISTGFRLYKPRLAS-----THVYQIMNHCWKERPEDRPAFSRLLRQL 278
Query: 704 QSI 706
             I
Sbjct: 279 AEI 281

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 108/239 (45%), Gaps = 34/239 (14%)
Query: 404 FLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSS--IAECSALRNIRHKNLVK 461
           FL  +  G FG V  G    G+  +A+K   ++  G+      I E   + N+ H+ LV+
Sbjct: 8   FLKELGTGQFGVVKYGKW-RGQYDVAIK---MIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDV 521
           +  VC+    +   F  ++ E+M NG L  +L  +    +T          Q + +  DV
Sbjct: 64  LYGVCTK---QRPIF--IITEYMANGCLLNYLREMRHRFQTQ---------QLLEMCKDV 109
Query: 522 ACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTI 581
             A++YL         H DL   N L++ +    V+DFGL++ +      TSS+G K  +
Sbjct: 110 CEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPV 165
Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHV 640
            + +P E  + S+ S   D++++G+L+ E+ +          G M    F  +   +H+
Sbjct: 166 RW-SPPEVLMYSKFSSKSDIWAFGVLMWEIYSL---------GKMPYERFTNSETAEHI 214

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 113/242 (46%), Gaps = 33/242 (13%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNLVKILTV 465
           I  G++G VYK        ++A+K + L     G   ++I E S L+ + H N+VK+L V
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                   ++   LV+EF+H   L++++   + A   +  P   ++L ++   +    + 
Sbjct: 70  IHT-----ENKLYLVFEFLHQ-DLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL-PPAHLQTSSIGVKGTIGYI 584
           + LH D         LKP N+L++ E    +ADFGLA+    P    T  +    T+ Y 
Sbjct: 122 RVLHRD---------LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV---VTLWYR 169
Query: 585 APAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV----LPDH 639
           AP E  LG +  S   D++S G +  E++TR+     +F G+  +    R       PD 
Sbjct: 170 AP-EILLGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRIFRTLGTPDE 224
Query: 640 VM 641
           V+
Sbjct: 225 VV 226

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 104/232 (44%), Gaps = 26/232 (11%)
Query: 408 IDMGSFGSVYKGI-LDEGKTIIAVKVLNLL--HHGASKSSIAECSALRNIR---HKNLVK 461
           I  G++G V+K   L  G   +A+K + +     G   S+I E + LR++    H N+V+
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDV 521
           +  VC+      +    LV+E + +  L  +L  V       E  K + F         +
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMF--------QL 129
Query: 522 ACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTI 581
              L +LH        H DLKP N+L+       +ADFGLA++      Q +   V  T+
Sbjct: 130 LRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTL 183
Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFAR 633
            Y AP E  L S  +   D++S G +  E M R++P   +F G+ ++    +
Sbjct: 184 WYRAP-EVLLQSSYATPVDLWSVGCIFAE-MFRRKP---LFRGSSDVDQLGK 230

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 30/220 (13%)
Query: 408 IDMGSFGSVYKGILD---EGKTIIAVKVLNLLHHGASKSS-IAECSALRNIRHKNLVKIL 463
           I  G FG V  G L    + +  +A+K L   +    +   ++E S +    H N++ + 
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHL- 73
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
               GV  K      ++ EFM NGSL+ +L    G             +Q + +   +A 
Sbjct: 74  ---EGVVTKSTPV-MIITEFMENGSLDSFLRQNDGQ---------FTVIQLVGMLRGIAA 120
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP-----PAHLQTSSIGVK 578
            +KYL         H  L   N+L++  +   V+DFGL++ L      P +  TS++G K
Sbjct: 121 GMKYL---ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY--TSALGGK 175
Query: 579 GTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTR-KRP 617
             I + AP         S + DV+SYGI++ E+M+  +RP
Sbjct: 176 IPIRWTAPEAIQYRKFTSAS-DVWSYGIVMWEVMSYGERP 214

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 104/232 (44%), Gaps = 26/232 (11%)
Query: 408 IDMGSFGSVYKGI-LDEGKTIIAVKVLNLL--HHGASKSSIAECSALRNIR---HKNLVK 461
           I  G++G V+K   L  G   +A+K + +     G   S+I E + LR++    H N+V+
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDV 521
           +  VC+      +    LV+E + +  L  +L  V       E  K + F         +
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMF--------QL 129
Query: 522 ACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTI 581
              L +LH        H DLKP N+L+       +ADFGLA++      Q +   V  T+
Sbjct: 130 LRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTL 183
Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFAR 633
            Y AP E  L S  +   D++S G +  E M R++P   +F G+ ++    +
Sbjct: 184 WYRAP-EVLLQSSYATPVDLWSVGCIFAE-MFRRKP---LFRGSSDVDQLGK 230

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 104/232 (44%), Gaps = 26/232 (11%)
Query: 408 IDMGSFGSVYKGI-LDEGKTIIAVKVLNLL--HHGASKSSIAECSALRNIR---HKNLVK 461
           I  G++G V+K   L  G   +A+K + +     G   S+I E + LR++    H N+V+
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDV 521
           +  VC+      +    LV+E + +  L  +L  V       E  K + F         +
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMF--------QL 129
Query: 522 ACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTI 581
              L +LH        H DLKP N+L+       +ADFGLA++      Q +   V  T+
Sbjct: 130 LRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTL 183
Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFAR 633
            Y AP E  L S  +   D++S G +  E M R++P   +F G+ ++    +
Sbjct: 184 WYRAP-EVLLQSSYATPVDLWSVGCIFAE-MFRRKP---LFRGSSDVDQLGK 230

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 74/303 (24%), Positives = 123/303 (40%), Gaps = 60/303 (19%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGA--SKSSIAECSALRNIRHKNLVKILTV 465
           I  G FG V+ G     K  +A+K +     GA   +  I E   +  + H  LV++  V
Sbjct: 16  IGSGQFGLVHLGYW-LNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSG--ADKTVEAPKCLNFLQRINIAIDVAC 523
           C            LV EFM +G L ++L    G  A +T+           + + +DV  
Sbjct: 72  C-----LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETL-----------LGMCLDVCE 115
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGY 583
            + YL   C     H DL   N L+       V+DFG+ + +      TSS G K  + +
Sbjct: 116 GMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKW 171
Query: 584 IAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDI 643
            +P  +   S  S   DV+S+G+L+ E+ +         EG +   N +           
Sbjct: 172 ASPEVFSF-SRYSSKSDVWSFGVLMWEVFS---------EGKIPYENRS----------- 210
Query: 644 VDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHEL 703
            +S ++ D     I++  R  + R+ +       V +I   C  E P+DR   + ++ +L
Sbjct: 211 -NSEVVED-----ISTGFRLYKPRLAS-----THVYQIMNHCWRERPEDRPAFSRLLRQL 259
Query: 704 QSI 706
             I
Sbjct: 260 AEI 262

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 109/230 (47%), Gaps = 29/230 (12%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNLVKILTV 465
           I  G++G VYK        ++A+K + L     G   ++I E S L+ + H N+VK+L V
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 74
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                   ++   LV+EF+H   L++++   + A   +  P   ++L ++   +    + 
Sbjct: 75  IHT-----ENKLYLVFEFLHQ-DLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH 126
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL-PPAHLQTSSIGVKGTIGYI 584
           + LH D         LKP N+L++ E    +ADFGLA+    P    T  +    T+ Y 
Sbjct: 127 RVLHRD---------LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV---VTLWYR 174
Query: 585 APAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFAR 633
           AP E  LG +  S   D++S G +  E++TR+     +F G+  +    R
Sbjct: 175 AP-EILLGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFR 219

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 107/259 (41%), Gaps = 46/259 (17%)
Query: 408 IDMGSFGSVYKGILD-EGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVC 466
           I  G FG V+K     +GKT + +K +   +  A +    E  AL  + H N+V      
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYV-IKRVKYNNEKAER----EVKALAKLDHVNIVHYNGCW 73
Query: 467 SGVDYKGDDFKA-----------LVYEFMHNGSLEEWLHPVSGA--DKTVEAPKCLNFLQ 513
            G DY  +               +  EF   G+LE+W+    G   DK +     L   +
Sbjct: 74  DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL----ALELFE 129
Query: 514 RINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTS 573
           +I   +D      Y+H        + DLKPSN+ L       + DFGL   L     +  
Sbjct: 130 QITKGVD------YIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXR 180
Query: 574 SIGVKGTIGYIAPAE---YGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHN 630
           S   KGT+ Y++P +      G EV    D+Y+ G++L EL+      D  FE +    +
Sbjct: 181 S---KGTLRYMSPEQISSQDYGKEV----DLYALGLILAELL---HVCDTAFETSKFFTD 230
Query: 631 FARTVLPDHVMDIVDSTLL 649
               ++ D + D  + TLL
Sbjct: 231 LRDGIISD-IFDKKEKTLL 248

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 108/239 (45%), Gaps = 34/239 (14%)
Query: 404 FLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSS--IAECSALRNIRHKNLVK 461
           FL  +  G FG V  G    G+  +A+K   ++  G+      I E   + N+ H+ LV+
Sbjct: 13  FLKELGTGQFGVVKYGKW-RGQYDVAIK---MIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 68
Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDV 521
           +  VC+    +   F  ++ E+M NG L  +L  +    +T          Q + +  DV
Sbjct: 69  LYGVCTK---QRPIF--IITEYMANGCLLNYLREMRHRFQTQ---------QLLEMCKDV 114
Query: 522 ACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTI 581
             A++YL         H DL   N L++ +    V+DFGL++ +      TSS+G K  +
Sbjct: 115 CEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPV 170
Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHV 640
            + +P E  + S+ S   D++++G+L+ E+ +          G M    F  +   +H+
Sbjct: 171 RW-SPPEVLMYSKFSSKSDIWAFGVLMWEIYSL---------GKMPYERFTNSETAEHI 219

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 25/208 (12%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKV-LNLLHHGASKSSIAECSALRNIRHKNLVKILTVC 466
           I  G++G VYK   + G+T    K+ L     G   ++I E S L+ ++H N+VK+  V 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 467 SGVDYKGDDFKALVYEFMH-NGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                     K LV  F H +  L++ L    G  ++V A   L  LQ +N        +
Sbjct: 70  HTK-------KRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFL--LQLLN-------GI 113
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP-PAHLQTSSIGVKGTIGYI 584
            Y H        H DLKP N+L++ E    +ADFGLA+    P    T  +    T+ Y 
Sbjct: 114 AYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEV---VTLWYR 167
Query: 585 APAEYGLGSEVSINGDVYSYGILLLELM 612
           AP       + S   D++S G +  E++
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMV 195

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 25/208 (12%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKV-LNLLHHGASKSSIAECSALRNIRHKNLVKILTVC 466
           I  G++G VYK   + G+T    K+ L     G   ++I E S L+ ++H N+VK+  V 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 467 SGVDYKGDDFKALVYEFMH-NGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                     K LV  F H +  L++ L    G  ++V A   L  LQ +N        +
Sbjct: 70  HTK-------KRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFL--LQLLN-------GI 113
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP-PAHLQTSSIGVKGTIGYI 584
            Y H        H DLKP N+L++ E    +ADFGLA+    P    T  +    T+ Y 
Sbjct: 114 AYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEV---VTLWYR 167
Query: 585 APAEYGLGSEVSINGDVYSYGILLLELM 612
           AP       + S   D++S G +  E++
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMV 195

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 28/218 (12%)
Query: 408 IDMGSFGSVYKGIL---DEGKTIIAVKVLNLLHHGASKSS-IAECSALRNIRHKNLVKIL 463
           +  G FG V  G L    + +  +A+K L + +    +   + E S +    H N++++ 
Sbjct: 41  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL- 99
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
               GV  K      +V E+M NGSL+ +L                  +Q + +   +A 
Sbjct: 100 ---EGVVTKSKPV-MIVTEYMENGSLDSFLRKHDAQ---------FTVIQLVGMLRGIAS 146
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL---PPAHLQTSSIGVKGT 580
            +KYL         H DL   N+L++  +   V+DFGL+++L   P A   T   G K  
Sbjct: 147 GMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR--GGKIP 201
Query: 581 IGYIAPAEYGLGSEVSINGDVYSYGILLLELMTR-KRP 617
           I + +P         S + DV+SYGI+L E+M+  +RP
Sbjct: 202 IRWTSPEAIAYRKFTSAS-DVWSYGIVLWEVMSYGERP 238

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 28/218 (12%)
Query: 408 IDMGSFGSVYKGIL---DEGKTIIAVKVLNLLHHGASKSS-IAECSALRNIRHKNLVKIL 463
           +  G FG V  G L    + +  +A+K L + +    +   + E S +    H N++++ 
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL- 82
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
               GV  K      +V E+M NGSL+ +L                  +Q + +   +A 
Sbjct: 83  ---EGVVTKSKPV-MIVTEYMENGSLDSFLRKHDAQ---------FTVIQLVGMLRGIAS 129
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL---PPAHLQTSSIGVKGT 580
            +KYL         H DL   N+L++  +   V+DFGL+++L   P A   T   G K  
Sbjct: 130 GMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR--GGKIP 184
Query: 581 IGYIAPAEYGLGSEVSINGDVYSYGILLLELMTR-KRP 617
           I + +P         S + DV+SYGI+L E+M+  +RP
Sbjct: 185 IRWTSPEAIAYRKFTSAS-DVWSYGIVLWEVMSYGERP 221

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 81/175 (46%), Gaps = 21/175 (12%)
Query: 483 FMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLK 542
           +  NG L +++  +   D+T     C  F        ++  AL+YLH        H DLK
Sbjct: 113 YAKNGCLLKYIRKIGSFDET-----CTRFY-----TAEIVSALEYLHGK---GIIHRDLK 159
Query: 543 PSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVY 602
           P N+LL+ +M   + DFG AK+L P   Q  +    GT  Y++P E       S + D++
Sbjct: 160 PENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP-ELLTEKSASKSSDLW 218
Query: 603 SYGILLLELMT-----RKRPSDIMFEGNMNL-HNFARTVLPDHVMDIVDSTLLAD 651
           + G ++ +L+      R     ++F+  + L ++F     P    D+V+  L+ D
Sbjct: 219 ALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK-ARDLVEKLLVLD 272

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 108/239 (45%), Gaps = 34/239 (14%)
Query: 404 FLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSS--IAECSALRNIRHKNLVK 461
           FL  +  G FG V  G    G+  +A+K   ++  G+      I E   + N+ H+ LV+
Sbjct: 12  FLKELGTGQFGVVKYGKW-RGQYDVAIK---MIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 67
Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDV 521
           +  VC+    +   F  ++ E+M NG L  +L  +    +T          Q + +  DV
Sbjct: 68  LYGVCTK---QRPIF--IITEYMANGCLLNYLREMRHRFQTQ---------QLLEMCKDV 113
Query: 522 ACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTI 581
             A++YL         H DL   N L++ +    V+DFGL++ +      TSS+G K  +
Sbjct: 114 CEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPV 169
Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHV 640
            + +P E  + S+ S   D++++G+L+ E+ +          G M    F  +   +H+
Sbjct: 170 RW-SPPEVLMYSKFSSKSDIWAFGVLMWEIYSL---------GKMPYERFTNSETAEHI 218

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 108/239 (45%), Gaps = 34/239 (14%)
Query: 404 FLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSS--IAECSALRNIRHKNLVK 461
           FL  +  G FG V  G    G+  +A+K   ++  G+      I E   + N+ H+ LV+
Sbjct: 28  FLKELGTGQFGVVKYGKW-RGQYDVAIK---MIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 83
Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDV 521
           +  VC+    +   F  ++ E+M NG L  +L  +    +T          Q + +  DV
Sbjct: 84  LYGVCTK---QRPIF--IITEYMANGCLLNYLREMRHRFQTQ---------QLLEMCKDV 129
Query: 522 ACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTI 581
             A++YL         H DL   N L++ +    V+DFGL++ +      TSS+G K  +
Sbjct: 130 CEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPV 185
Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHV 640
            + +P E  + S+ S   D++++G+L+ E+ +          G M    F  +   +H+
Sbjct: 186 RW-SPPEVLMYSKFSSKSDIWAFGVLMWEIYSL---------GKMPYERFTNSETAEHI 234

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 99/208 (47%), Gaps = 20/208 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNL-LHHGASKSSIAECSALRNIRHKNLVKILTVCSGV 469
           G++ +VYKG+       +A+K + L    G   ++I E S ++ ++H+N+V++  V    
Sbjct: 16  GTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHT- 74
Query: 470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTV-EAPKCLNFLQRINIAIDVACALKYL 528
               ++   LV+EFM N  L++++       +TV   P+ L           +   L + 
Sbjct: 75  ----ENKLTLVFEFMDN-DLKKYM-----DSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124
Query: 529 HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP-PAHLQTSSIGVKGTIGYIAPA 587
           H +      H DLKP N+L++      + DFGLA+    P +  +S +    T+ Y AP 
Sbjct: 125 HEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEV---VTLWYRAPD 178
Query: 588 EYGLGSEVSINGDVYSYGILLLELMTRK 615
                   S + D++S G +L E++T K
Sbjct: 179 VLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 108/239 (45%), Gaps = 34/239 (14%)
Query: 404 FLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSS--IAECSALRNIRHKNLVK 461
           FL  +  G FG V  G    G+  +A+K   ++  G+      I E   + N+ H+ LV+
Sbjct: 19  FLKELGTGQFGVVKYGKW-RGQYDVAIK---MIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 74
Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDV 521
           +  VC+    +   F  ++ E+M NG L  +L  +    +T          Q + +  DV
Sbjct: 75  LYGVCTK---QRPIF--IITEYMANGCLLNYLREMRHRFQTQ---------QLLEMCKDV 120
Query: 522 ACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTI 581
             A++YL         H DL   N L++ +    V+DFGL++ +      TSS+G K  +
Sbjct: 121 CEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPV 176
Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHV 640
            + +P E  + S+ S   D++++G+L+ E+ +          G M    F  +   +H+
Sbjct: 177 RW-SPPEVLMYSKFSSKSDIWAFGVLMWEIYSL---------GKMPYERFTNSETAEHI 225

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 96/223 (43%), Gaps = 25/223 (11%)
Query: 399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSI--AECSALRNIRH 456
           F    FL  ++    G ++KG   +G  I+ VKVL +      KS     EC  LR   H
Sbjct: 9   FKQLNFLTKLNENHSGELWKGRW-QGNDIV-VKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 457 KNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRIN 516
            N++ +L  C            L+  +M  GSL   LH   G +  V+  + + F     
Sbjct: 67  PNVLPVLGACQS---PPAPHPTLITHWMPYGSLYNVLH--EGTNFVVDQSQAVKF----- 116
Query: 517 IAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIG 576
            A+D+A  + +L H  +P      L   +V++D +MTA ++       +        S G
Sbjct: 117 -ALDMARGMAFL-HTLEPLIPRHALNSRSVMIDEDMTARIS-------MADVKFSFQSPG 167
Query: 577 VKGTIGYIAPAEYGLGSEVS--INGDVYSYGILLLELMTRKRP 617
                 ++AP       E +   + D++S+ +LL EL+TR+ P
Sbjct: 168 RMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVP 210

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 28/218 (12%)
Query: 408 IDMGSFGSVYKGIL---DEGKTIIAVKVLNLLHHGASKSS-IAECSALRNIRHKNLVKIL 463
           +  G FG V  G L    + +  +A+K L + +    +   + E S +    H N++++ 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL- 111
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
               GV  K      +V E+M NGSL+ +L                  +Q + +   +A 
Sbjct: 112 ---EGVVTKSKPV-MIVTEYMENGSLDSFLRKHDAQ---------FTVIQLVGMLRGIAS 158
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL---PPAHLQTSSIGVKGT 580
            +KYL         H DL   N+L++  +   V+DFGL+++L   P A   T   G K  
Sbjct: 159 GMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR--GGKIP 213
Query: 581 IGYIAPAEYGLGSEVSINGDVYSYGILLLELMTR-KRP 617
           I + +P         S + DV+SYGI+L E+M+  +RP
Sbjct: 214 IRWTSPEAIAYRKFTSAS-DVWSYGIVLWEVMSYGERP 250

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 83/177 (46%), Gaps = 25/177 (14%)
Query: 483 FMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLK 542
           +  NG L +++  +   D+T     C  F        ++  AL+YLH        H DLK
Sbjct: 110 YAKNGELLKYIRKIGSFDET-----CTRFY-----TAEIVSALEYLHGK---GIIHRDLK 156
Query: 543 PSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSI--NGD 600
           P N+LL+ +M   + DFG AK+L P   Q  +    GT  Y++P    L +E S   + D
Sbjct: 157 PENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE---LLTEKSACKSSD 213
Query: 601 VYSYGILLLELMT-----RKRPSDIMFEGNMNL-HNFARTVLPDHVMDIVDSTLLAD 651
           +++ G ++ +L+      R     ++F+  + L ++F     P    D+V+  L+ D
Sbjct: 214 LWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK-ARDLVEKLLVLD 269

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 28/218 (12%)
Query: 408 IDMGSFGSVYKGIL---DEGKTIIAVKVLNLLHHGASKSS-IAECSALRNIRHKNLVKIL 463
           +  G FG V  G L    + +  +A+K L + +    +   + E S +    H N++++ 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL- 111
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
               GV  K      +V E+M NGSL+ +L                  +Q + +   +A 
Sbjct: 112 ---EGVVTKSKPV-MIVTEYMENGSLDSFLRKHDAQ---------FTVIQLVGMLRGIAS 158
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL---PPAHLQTSSIGVKGT 580
            +KYL         H DL   N+L++  +   V+DFGL+++L   P A   T   G K  
Sbjct: 159 GMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR--GGKIP 213
Query: 581 IGYIAPAEYGLGSEVSINGDVYSYGILLLELMTR-KRP 617
           I + +P         S + DV+SYGI+L E+M+  +RP
Sbjct: 214 IRWTSPEAIAYRKFTSAS-DVWSYGIVLWEVMSYGERP 250

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 28/218 (12%)
Query: 408 IDMGSFGSVYKGIL---DEGKTIIAVKVLNLLHHGASKSS-IAECSALRNIRHKNLVKIL 463
           +  G FG V  G L    + +  +A+K L + +    +   + E S +    H N++++ 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL- 111
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
               GV  K      +V E+M NGSL+ +L                  +Q + +   +A 
Sbjct: 112 ---EGVVTKSKPV-MIVTEYMENGSLDSFLRKHDAQ---------FTVIQLVGMLRGIAS 158
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL---PPAHLQTSSIGVKGT 580
            +KYL         H DL   N+L++  +   V+DFGL+++L   P A   T   G K  
Sbjct: 159 GMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR--GGKIP 213
Query: 581 IGYIAPAEYGLGSEVSINGDVYSYGILLLELMTR-KRP 617
           I + +P         S + DV+SYGI+L E+M+  +RP
Sbjct: 214 IRWTSPEAIAYRKFTSAS-DVWSYGIVLWEVMSYGERP 250

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 28/218 (12%)
Query: 408 IDMGSFGSVYKGIL---DEGKTIIAVKVLNLLHHGASKSS-IAECSALRNIRHKNLVKIL 463
           +  G FG V  G L    + +  +A+K L + +    +   + E S +    H N++++ 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL- 111
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
               GV  K      +V E+M NGSL+ +L                  +Q + +   +A 
Sbjct: 112 ---EGVVTKSKPV-MIVTEYMENGSLDSFLRKHDAQ---------FTVIQLVGMLRGIAS 158
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL---PPAHLQTSSIGVKGT 580
            +KYL         H DL   N+L++  +   V+DFGL+++L   P A   T   G K  
Sbjct: 159 GMKYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR--GGKIP 213
Query: 581 IGYIAPAEYGLGSEVSINGDVYSYGILLLELMTR-KRP 617
           I + +P         S + DV+SYGI+L E+M+  +RP
Sbjct: 214 IRWTSPEAIAYRKFTSAS-DVWSYGIVLWEVMSYGERP 250

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 83/177 (46%), Gaps = 25/177 (14%)
Query: 483 FMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLK 542
           +  NG L +++  +   D+T     C  F        ++  AL+YLH        H DLK
Sbjct: 89  YAKNGELLKYIRKIGSFDET-----CTRFY-----TAEIVSALEYLHGK---GIIHRDLK 135
Query: 543 PSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSI--NGD 600
           P N+LL+ +M   + DFG AK+L P   Q  +    GT  Y++P    L +E S   + D
Sbjct: 136 PENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE---LLTEKSACKSSD 192
Query: 601 VYSYGILLLELMT-----RKRPSDIMFEGNMNL-HNFARTVLPDHVMDIVDSTLLAD 651
           +++ G ++ +L+      R     ++F+  + L ++F     P    D+V+  L+ D
Sbjct: 193 LWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK-ARDLVEKLLVLD 248

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 28/218 (12%)
Query: 408 IDMGSFGSVYKGIL---DEGKTIIAVKVLNLLHHGASKSS-IAECSALRNIRHKNLVKIL 463
           +  G FG V  G L    + +  +A+K L + +    +   + E S +    H N++++ 
Sbjct: 51  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL- 109
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
               GV  K      +V E+M NGSL+ +L                  +Q + +   +A 
Sbjct: 110 ---EGVVTKSKPV-MIVTEYMENGSLDSFLRKHDAQ---------FTVIQLVGMLRGIAS 156
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL---PPAHLQTSSIGVKGT 580
            +KYL         H DL   N+L++  +   V+DFGL+++L   P A   T   G K  
Sbjct: 157 GMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR--GGKIP 211
Query: 581 IGYIAPAEYGLGSEVSINGDVYSYGILLLELMTR-KRP 617
           I + +P         S + DV+SYGI+L E+M+  +RP
Sbjct: 212 IRWTSPEAIAYRKFTSAS-DVWSYGIVLWEVMSYGERP 248

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 28/218 (12%)
Query: 408 IDMGSFGSVYKGIL---DEGKTIIAVKVLNLLHHGASKSS-IAECSALRNIRHKNLVKIL 463
           +  G FG V  G L    + +  +A+K L + +    +   + E S +    H N++++ 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL- 111
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
               GV  K      +V E+M NGSL+ +L                  +Q + +   +A 
Sbjct: 112 ---EGVVTKSKPV-MIVTEYMENGSLDSFLRKHDAQ---------FTVIQLVGMLRGIAS 158
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL---PPAHLQTSSIGVKGT 580
            +KYL         H DL   N+L++  +   V+DFGL ++L   P A   T   G K  
Sbjct: 159 GMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR--GGKIP 213
Query: 581 IGYIAPAEYGLGSEVSINGDVYSYGILLLELMTR-KRP 617
           I + +P         S + DV+SYGI+L E+M+  +RP
Sbjct: 214 IRWTSPEAIAYRKFTSAS-DVWSYGIVLWEVMSYGERP 250

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 28/218 (12%)
Query: 408 IDMGSFGSVYKGIL---DEGKTIIAVKVLNLLHHGASKSS-IAECSALRNIRHKNLVKIL 463
           +  G FG V  G L    + +  +A+K L + +    +   + E S +    H N++++ 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL- 111
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
               GV  K      +V E+M NGSL+ +L                  +Q + +   +A 
Sbjct: 112 ---EGVVTKSKPV-MIVTEYMENGSLDSFLRKHDAQ---------FTVIQLVGMLRGIAS 158
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL---PPAHLQTSSIGVKGT 580
            +KYL         H DL   N+L++  +   V+DFGL+++L   P A   T   G K  
Sbjct: 159 GMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR--GGKIP 213
Query: 581 IGYIAPAEYGLGSEVSINGDVYSYGILLLELMTR-KRP 617
           I + +P         S + DV+SYGI+L E+M+  +RP
Sbjct: 214 IRWTSPEAIAYRKFTSAS-DVWSYGIVLWEVMSYGERP 250

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 83/177 (46%), Gaps = 25/177 (14%)
Query: 483 FMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLK 542
           +  NG L +++  +   D+T     C  F        ++  AL+YLH        H DLK
Sbjct: 88  YAKNGELLKYIRKIGSFDET-----CTRFY-----TAEIVSALEYLHGK---GIIHRDLK 134
Query: 543 PSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSI--NGD 600
           P N+LL+ +M   + DFG AK+L P   Q  +    GT  Y++P    L +E S   + D
Sbjct: 135 PENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE---LLTEKSACKSSD 191
Query: 601 VYSYGILLLELMT-----RKRPSDIMFEGNMNL-HNFARTVLPDHVMDIVDSTLLAD 651
           +++ G ++ +L+      R     ++F+  + L ++F     P    D+V+  L+ D
Sbjct: 192 LWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK-ARDLVEKLLVLD 247

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 79/337 (23%), Positives = 131/337 (38%), Gaps = 63/337 (18%)
Query: 411 GSFGSVYKGIL-----DEGKTIIAVKVLNLLHHGASK-SSIAECSALRNIRHKNLVKILT 464
           G+FG VY+G +     D     +AVK L  ++    +   + E   +    H+N+V+   
Sbjct: 56  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR--- 112
Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
            C GV  +    + ++ E M  G L+ +L            P  L  L  +++A D+AC 
Sbjct: 113 -CIGVSLQSLP-RFILLELMAGGDLKSFLRETR---PRPSQPSSLAMLDLLHVARDIACG 167
Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA---DFGLAKLLPPAHLQTSSIGVKGTI 581
            +YL  +      H D+   N LL       VA   DFG+A+ +  A            +
Sbjct: 168 CQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 224
Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM 641
            ++ P  +  G   S   D +S+G+LL E+ +          G M   + +       V+
Sbjct: 225 KWMPPEAFMEGIFTS-KTDTWSFGVLLWEIFSL---------GYMPYPSKSN----QEVL 270
Query: 642 DIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH 701
           + V S                    R++    C   V RI   C    P+DR N  I+  
Sbjct: 271 EFVTSG------------------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAII-- 310
Query: 702 ELQSIKSILLGPKTVSNKQKAIPILLEVRSYGPKLKE 738
            L+ I+     P  ++    A+PI      YGP ++E
Sbjct: 311 -LERIEYCTQDPDVINT---ALPI-----EYGPLVEE 338

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 83/177 (46%), Gaps = 25/177 (14%)
Query: 483 FMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLK 542
           +  NG L +++  +   D+T     C  F        ++  AL+YLH        H DLK
Sbjct: 111 YAKNGELLKYIRKIGSFDET-----CTRFY-----TAEIVSALEYLHGK---GIIHRDLK 157
Query: 543 PSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSI--NGD 600
           P N+LL+ +M   + DFG AK+L P   Q  +    GT  Y++P    L +E S   + D
Sbjct: 158 PENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPE---LLTEKSACKSSD 214
Query: 601 VYSYGILLLELMT-----RKRPSDIMFEGNMNL-HNFARTVLPDHVMDIVDSTLLAD 651
           +++ G ++ +L+      R     ++F+  + L ++F     P    D+V+  L+ D
Sbjct: 215 LWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK-ARDLVEKLLVLD 270

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 83/177 (46%), Gaps = 25/177 (14%)
Query: 483 FMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLK 542
           +  NG L +++  +   D+T     C  F        ++  AL+YLH        H DLK
Sbjct: 90  YAKNGELLKYIRKIGSFDET-----CTRFY-----TAEIVSALEYLHGK---GIIHRDLK 136
Query: 543 PSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSI--NGD 600
           P N+LL+ +M   + DFG AK+L P   Q  +    GT  Y++P    L +E S   + D
Sbjct: 137 PENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE---LLTEKSACKSSD 193
Query: 601 VYSYGILLLELMT-----RKRPSDIMFEGNMNL-HNFARTVLPDHVMDIVDSTLLAD 651
           +++ G ++ +L+      R     ++F+  + L ++F     P    D+V+  L+ D
Sbjct: 194 LWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK-ARDLVEKLLVLD 249

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 22/215 (10%)
Query: 411 GSFGSV-----YKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G+FG V     Y     + K ++AVK L      A K    E   L N++H+++VK   V
Sbjct: 26  GAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGV 85
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTV-------EAPKCLNFLQRINIA 518
           C      GD    +V+E+M +G L ++L    G D  +       +A   L   Q ++IA
Sbjct: 86  CG----DGDPL-IMVFEYMKHGDLNKFLR-AHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 519 IDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK 578
             +A  + YL         H DL   N L+   +   + DFG+++ +             
Sbjct: 140 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 579 GTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             I ++ P E  +  + +   DV+S+G++L E+ T
Sbjct: 197 LPIRWM-PPESIMYRKFTTESDVWSFGVILWEIFT 230

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 83/177 (46%), Gaps = 25/177 (14%)
Query: 483 FMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLK 542
           +  NG L +++  +   D+T     C  F        ++  AL+YLH        H DLK
Sbjct: 91  YAKNGELLKYIRKIGSFDET-----CTRFY-----TAEIVSALEYLHGK---GIIHRDLK 137
Query: 543 PSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSI--NGD 600
           P N+LL+ +M   + DFG AK+L P   Q  +    GT  Y++P    L +E S   + D
Sbjct: 138 PENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE---LLTEKSACKSSD 194
Query: 601 VYSYGILLLELMT-----RKRPSDIMFEGNMNL-HNFARTVLPDHVMDIVDSTLLAD 651
           +++ G ++ +L+      R     ++F+  + L ++F     P    D+V+  L+ D
Sbjct: 195 LWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK-ARDLVEKLLVLD 250

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 83/177 (46%), Gaps = 25/177 (14%)
Query: 483 FMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLK 542
           +  NG L +++  +   D+T     C  F        ++  AL+YLH        H DLK
Sbjct: 110 YAKNGELLKYIRKIGSFDET-----CTRFY-----TAEIVSALEYLHGK---GIIHRDLK 156
Query: 543 PSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSI--NGD 600
           P N+LL+ +M   + DFG AK+L P   Q  +    GT  Y++P    L +E S   + D
Sbjct: 157 PENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE---LLTEKSACKSSD 213
Query: 601 VYSYGILLLELMT-----RKRPSDIMFEGNMNL-HNFARTVLPDHVMDIVDSTLLAD 651
           +++ G ++ +L+      R     ++F+  + L ++F     P    D+V+  L+ D
Sbjct: 214 LWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK-ARDLVEKLLVLD 269

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/246 (25%), Positives = 103/246 (41%), Gaps = 49/246 (19%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA-------ECSALRNIRHKNLV 460
           I  G FG V+KG L + K+++A+K L L         I        E   + N+ H N+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 461 KILTVCSGVDYKGDDFKALVYEFMHNGSLEEWL----HPVSGADKTVEAPKCLNFLQRIN 516
           K+  +         +   +V EF+  G L   L    HP+  + K             + 
Sbjct: 87  KLYGLMH-------NPPRMVMEFVPCGDLYHRLLDKAHPIKWSVK-------------LR 126
Query: 517 IAIDVACALKYLHHDCQPTTAHCDLKPSNVLL-----DHEMTAHVADFGLAKLLPPAHLQ 571
           + +D+A  ++Y+ +   P   H DL+  N+ L     +  + A VADFG +        Q
Sbjct: 127 LMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTS--------Q 177
Query: 572 TSSIGVKGTIG---YIAPAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMN 627
            S   V G +G   ++AP   G   E  +   D YS+ ++L  ++T + P D    G + 
Sbjct: 178 QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK 237
Query: 628 LHNFAR 633
             N  R
Sbjct: 238 FINMIR 243

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 112/242 (46%), Gaps = 33/242 (13%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNLVKILTV 465
           I  G++G VYK        ++A+K + L     G   ++I E S L+ + H N+VK+L V
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                   ++   LV+EF+H   L++++   + A   +  P   ++L ++   +    + 
Sbjct: 71  IHT-----ENKLYLVFEFLHQ-DLKDFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL-PPAHLQTSSIGVKGTIGYI 584
           + LH D         LKP N+L++ E    +ADFGLA+    P       +    T+ Y 
Sbjct: 123 RVLHRD---------LKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VTLWYR 170
Query: 585 APAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV----LPDH 639
           AP E  LG +  S   D++S G +  E++TR+     +F G+  +    R       PD 
Sbjct: 171 AP-EILLGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRIFRTLGTPDE 225
Query: 640 VM 641
           V+
Sbjct: 226 VV 227

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 83/177 (46%), Gaps = 25/177 (14%)
Query: 483 FMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLK 542
           +  NG L +++  +   D+T     C  F        ++  AL+YLH        H DLK
Sbjct: 114 YAKNGELLKYIRKIGSFDET-----CTRFY-----TAEIVSALEYLHGK---GIIHRDLK 160
Query: 543 PSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSI--NGD 600
           P N+LL+ +M   + DFG AK+L P   Q  +    GT  Y++P    L +E S   + D
Sbjct: 161 PENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE---LLTEKSACKSSD 217
Query: 601 VYSYGILLLELMT-----RKRPSDIMFEGNMNL-HNFARTVLPDHVMDIVDSTLLAD 651
           +++ G ++ +L+      R     ++F+  + L ++F     P    D+V+  L+ D
Sbjct: 218 LWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK-ARDLVEKLLVLD 273

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 83/177 (46%), Gaps = 25/177 (14%)
Query: 483 FMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLK 542
           +  NG L +++  +   D+T     C  F        ++  AL+YLH        H DLK
Sbjct: 95  YAKNGELLKYIRKIGSFDET-----CTRFY-----TAEIVSALEYLHGK---GIIHRDLK 141
Query: 543 PSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSI--NGD 600
           P N+LL+ +M   + DFG AK+L P   Q  +    GT  Y++P    L +E S   + D
Sbjct: 142 PENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE---LLTEKSACKSSD 198
Query: 601 VYSYGILLLELMT-----RKRPSDIMFEGNMNL-HNFARTVLPDHVMDIVDSTLLAD 651
           +++ G ++ +L+      R     ++F+  + L ++F     P    D+V+  L+ D
Sbjct: 199 LWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK-ARDLVEKLLVLD 254

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 112/242 (46%), Gaps = 33/242 (13%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNLVKILTV 465
           I  G++G VYK        ++A+K + L     G   ++I E S L+ + H N+VK+L V
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                   ++   LV+EF+H   L++++   + A   +  P   ++L ++   +    + 
Sbjct: 74  IHT-----ENKLYLVFEFLHQ-DLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP-PAHLQTSSIGVKGTIGYI 584
           + LH D         LKP N+L++ E    +ADFGLA+    P       +    T+ Y 
Sbjct: 126 RVLHRD---------LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VTLWYR 173
Query: 585 APAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV----LPDH 639
           AP E  LG +  S   D++S G +  E++TR+     +F G+  +    R       PD 
Sbjct: 174 AP-EILLGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRIFRTLGTPDE 228
Query: 640 VM 641
           V+
Sbjct: 229 VV 230

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 112/242 (46%), Gaps = 33/242 (13%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNLVKILTV 465
           I  G++G VYK        ++A+K + L     G   ++I E S L+ + H N+VK+L V
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                   ++   LV+EF+H   L++++   + A   +  P   ++L ++   +    + 
Sbjct: 72  IHT-----ENKLYLVFEFLHQ-DLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP-PAHLQTSSIGVKGTIGYI 584
           + LH D         LKP N+L++ E    +ADFGLA+    P       +    T+ Y 
Sbjct: 124 RVLHRD---------LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VTLWYR 171
Query: 585 APAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV----LPDH 639
           AP E  LG +  S   D++S G +  E++TR+     +F G+  +    R       PD 
Sbjct: 172 AP-EILLGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRIFRTLGTPDE 226
Query: 640 VM 641
           V+
Sbjct: 227 VV 228

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 112/242 (46%), Gaps = 33/242 (13%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNLVKILTV 465
           I  G++G VYK        ++A+K + L     G   ++I E S L+ + H N+VK+L V
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 74
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                   ++   LV+EF+H   L++++   + A   +  P   ++L ++   +    + 
Sbjct: 75  IHT-----ENKLYLVFEFLHQ-DLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH 126
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP-PAHLQTSSIGVKGTIGYI 584
           + LH D         LKP N+L++ E    +ADFGLA+    P       +    T+ Y 
Sbjct: 127 RVLHRD---------LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VTLWYR 174
Query: 585 APAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV----LPDH 639
           AP E  LG +  S   D++S G +  E++TR+     +F G+  +    R       PD 
Sbjct: 175 AP-EILLGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRIFRTLGTPDE 229
Query: 640 VM 641
           V+
Sbjct: 230 VV 231

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 112/242 (46%), Gaps = 33/242 (13%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNLVKILTV 465
           I  G++G VYK        ++A+K + L     G   ++I E S L+ + H N+VK+L V
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                   ++   LV+EF+H   L++++   + A   +  P   ++L ++   +    + 
Sbjct: 71  IHT-----ENKLYLVFEFLHQ-DLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL-PPAHLQTSSIGVKGTIGYI 584
           + LH D         LKP N+L++ E    +ADFGLA+    P       +    T+ Y 
Sbjct: 123 RVLHRD---------LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VTLWYR 170
Query: 585 APAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV----LPDH 639
           AP E  LG +  S   D++S G +  E++TR+     +F G+  +    R       PD 
Sbjct: 171 AP-EILLGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRIFRTLGTPDE 225
Query: 640 VM 641
           V+
Sbjct: 226 VV 227

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 112/242 (46%), Gaps = 33/242 (13%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNLVKILTV 465
           I  G++G VYK        ++A+K + L     G   ++I E S L+ + H N+VK+L V
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                   ++   LV+EF+H   L++++   + A   +  P   ++L ++   +    + 
Sbjct: 74  IHT-----ENKLYLVFEFLHQ-DLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP-PAHLQTSSIGVKGTIGYI 584
           + LH D         LKP N+L++ E    +ADFGLA+    P       +    T+ Y 
Sbjct: 126 RVLHRD---------LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VTLWYR 173
Query: 585 APAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV----LPDH 639
           AP E  LG +  S   D++S G +  E++TR+     +F G+  +    R       PD 
Sbjct: 174 AP-EILLGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRIFRTLGTPDE 228
Query: 640 VM 641
           V+
Sbjct: 229 VV 230

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 112/242 (46%), Gaps = 33/242 (13%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNLVKILTV 465
           I  G++G VYK        ++A+K + L     G   ++I E S L+ + H N+VK+L V
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                   ++   LV+EF+H   L++++   + A   +  P   ++L ++   +    + 
Sbjct: 73  IHT-----ENKLYLVFEFLHQ-DLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP-PAHLQTSSIGVKGTIGYI 584
           + LH D         LKP N+L++ E    +ADFGLA+    P       +    T+ Y 
Sbjct: 125 RVLHRD---------LKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VTLWYR 172
Query: 585 APAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV----LPDH 639
           AP E  LG +  S   D++S G +  E++TR+     +F G+  +    R       PD 
Sbjct: 173 AP-EILLGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRIFRTLGTPDE 227
Query: 640 VM 641
           V+
Sbjct: 228 VV 229

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 112/242 (46%), Gaps = 33/242 (13%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNLVKILTV 465
           I  G++G VYK        ++A+K + L     G   ++I E S L+ + H N+VK+L V
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                   ++   LV+EF+H   L++++   + A   +  P   ++L ++   +    + 
Sbjct: 73  IHT-----ENKLYLVFEFLHQ-DLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP-PAHLQTSSIGVKGTIGYI 584
           + LH D         LKP N+L++ E    +ADFGLA+    P       +    T+ Y 
Sbjct: 125 RVLHRD---------LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VTLWYR 172
Query: 585 APAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV----LPDH 639
           AP E  LG +  S   D++S G +  E++TR+     +F G+  +    R       PD 
Sbjct: 173 AP-EILLGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRIFRTLGTPDE 227
Query: 640 VM 641
           V+
Sbjct: 228 VV 229

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 63/246 (25%), Positives = 102/246 (41%), Gaps = 49/246 (19%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA-------ECSALRNIRHKNLV 460
           I  G FG V+KG L + K+++A+K L L         I        E   + N+ H N+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 461 KILTVCSGVDYKGDDFKALVYEFMHNGSLEEWL----HPVSGADKTVEAPKCLNFLQRIN 516
           K+  +             +V EF+  G L   L    HP+  + K             + 
Sbjct: 87  KLYGLMHNP-------PRMVMEFVPCGDLYHRLLDKAHPIKWSVK-------------LR 126
Query: 517 IAIDVACALKYLHHDCQPTTAHCDLKPSNVLL-----DHEMTAHVADFGLAKLLPPAHLQ 571
           + +D+A  ++Y+ +   P   H DL+  N+ L     +  + A VADF L+        Q
Sbjct: 127 LMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLS--------Q 177
Query: 572 TSSIGVKGTIG---YIAPAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMN 627
            S   V G +G   ++AP   G   E  +   D YS+ ++L  ++T + P D    G + 
Sbjct: 178 QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK 237
Query: 628 LHNFAR 633
             N  R
Sbjct: 238 FINMIR 243

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 112/242 (46%), Gaps = 33/242 (13%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNLVKILTV 465
           I  G++G VYK        ++A+K + L     G   ++I E S L+ + H N+VK+L V
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                   ++   LV+EF+H   L++++   + A   +  P   ++L ++   +    + 
Sbjct: 73  IHT-----ENKLYLVFEFLHQ-DLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP-PAHLQTSSIGVKGTIGYI 584
           + LH D         LKP N+L++ E    +ADFGLA+    P       +    T+ Y 
Sbjct: 125 RVLHRD---------LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VTLWYR 172
Query: 585 APAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV----LPDH 639
           AP E  LG +  S   D++S G +  E++TR+     +F G+  +    R       PD 
Sbjct: 173 AP-EILLGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRIFRTLGTPDE 227
Query: 640 VM 641
           V+
Sbjct: 228 VV 229

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 112/242 (46%), Gaps = 33/242 (13%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNLVKILTV 465
           I  G++G VYK        ++A+K + L     G   ++I E S L+ + H N+VK+L V
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                   ++   LV+EF+H   L++++   + A   +  P   ++L ++   +    + 
Sbjct: 70  IHT-----ENKLYLVFEFLHQ-DLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL-PPAHLQTSSIGVKGTIGYI 584
           + LH D         LKP N+L++ E    +ADFGLA+    P       +    T+ Y 
Sbjct: 122 RVLHRD---------LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VTLWYR 169
Query: 585 APAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV----LPDH 639
           AP E  LG +  S   D++S G +  E++TR+     +F G+  +    R       PD 
Sbjct: 170 AP-EILLGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRIFRTLGTPDE 224
Query: 640 VM 641
           V+
Sbjct: 225 VV 226

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 112/242 (46%), Gaps = 33/242 (13%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNLVKILTV 465
           I  G++G VYK        ++A+K + L     G   ++I E S L+ + H N+VK+L V
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                   ++   LV+EF+H   L++++   + A   +  P   ++L ++   +    + 
Sbjct: 71  IHT-----ENKLYLVFEFLHQ-DLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP-PAHLQTSSIGVKGTIGYI 584
           + LH D         LKP N+L++ E    +ADFGLA+    P       +    T+ Y 
Sbjct: 123 RVLHRD---------LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VTLWYR 170
Query: 585 APAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV----LPDH 639
           AP E  LG +  S   D++S G +  E++TR+     +F G+  +    R       PD 
Sbjct: 171 AP-EILLGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRIFRTLGTPDE 225
Query: 640 VM 641
           V+
Sbjct: 226 VV 227

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 112/242 (46%), Gaps = 33/242 (13%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNLVKILTV 465
           I  G++G VYK        ++A+K + L     G   ++I E S L+ + H N+VK+L V
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                   ++   LV+EF+H   L++++   + A   +  P   ++L ++   +    + 
Sbjct: 72  IHT-----ENKLYLVFEFLHQ-DLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP-PAHLQTSSIGVKGTIGYI 584
           + LH D         LKP N+L++ E    +ADFGLA+    P       +    T+ Y 
Sbjct: 124 RVLHRD---------LKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VTLWYR 171
Query: 585 APAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV----LPDH 639
           AP E  LG +  S   D++S G +  E++TR+     +F G+  +    R       PD 
Sbjct: 172 AP-EILLGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRIFRTLGTPDE 226
Query: 640 VM 641
           V+
Sbjct: 227 VV 228

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 112/242 (46%), Gaps = 33/242 (13%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNLVKILTV 465
           I  G++G VYK        ++A+K + L     G   ++I E S L+ + H N+VK+L V
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                   ++   LV+EF+H   L++++   + A   +  P   ++L ++   +    + 
Sbjct: 70  IHT-----ENKLYLVFEFLHQ-DLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL-PPAHLQTSSIGVKGTIGYI 584
           + LH D         LKP N+L++ E    +ADFGLA+    P       +    T+ Y 
Sbjct: 122 RVLHRD---------LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VTLWYR 169
Query: 585 APAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV----LPDH 639
           AP E  LG +  S   D++S G +  E++TR+     +F G+  +    R       PD 
Sbjct: 170 AP-EILLGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRIFRTLGTPDE 224
Query: 640 VM 641
           V+
Sbjct: 225 VV 226

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 113/242 (46%), Gaps = 33/242 (13%)
Query: 408 IDMGSFGSVYKGILD-EGKTIIAVKV-LNLLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           I  G++G VYK      G+ +   K+ L+    G   ++I E S L+ + H N+VK+L V
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                   ++   LV+EF+H   L++++   + A   +  P   ++L ++   +    + 
Sbjct: 71  IHT-----ENKLYLVFEFLHQ-DLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL-PPAHLQTSSIGVKGTIGYI 584
           + LH D         LKP N+L++ E    +ADFGLA+    P    T  +    T+ Y 
Sbjct: 123 RVLHRD---------LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV---VTLWYR 170
Query: 585 APAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV----LPDH 639
           AP E  LG +  S   D++S G +  E++TR+     +F G+  +    R       PD 
Sbjct: 171 AP-EILLGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRIFRTLGTPDE 225
Query: 640 VM 641
           V+
Sbjct: 226 VV 227

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 112/242 (46%), Gaps = 33/242 (13%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNLVKILTV 465
           I  G++G VYK        ++A+K + L     G   ++I E S L+ + H N+VK+L V
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                   ++   LV+EF+H   L++++   + A   +  P   ++L ++   +    + 
Sbjct: 71  IHT-----ENKLYLVFEFLHQ-DLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL-PPAHLQTSSIGVKGTIGYI 584
           + LH D         LKP N+L++ E    +ADFGLA+    P       +    T+ Y 
Sbjct: 123 RVLHRD---------LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VTLWYR 170
Query: 585 APAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV----LPDH 639
           AP E  LG +  S   D++S G +  E++TR+     +F G+  +    R       PD 
Sbjct: 171 AP-EILLGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRIFRTLGTPDE 225
Query: 640 VM 641
           V+
Sbjct: 226 VV 227

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 113/242 (46%), Gaps = 33/242 (13%)
Query: 408 IDMGSFGSVYKGILD-EGKTIIAVKV-LNLLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           I  G++G VYK      G+ +   K+ L+    G   ++I E S L+ + H N+VK+L V
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                   ++   LV+EF+H   L++++   + A   +  P   ++L ++   +    + 
Sbjct: 70  IHT-----ENKLYLVFEFLHQ-DLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL-PPAHLQTSSIGVKGTIGYI 584
           + LH D         LKP N+L++ E    +ADFGLA+    P    T  +    T+ Y 
Sbjct: 122 RVLHRD---------LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV---VTLWYR 169
Query: 585 APAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV----LPDH 639
           AP E  LG +  S   D++S G +  E++TR+     +F G+  +    R       PD 
Sbjct: 170 AP-EILLGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRIFRTLGTPDE 224
Query: 640 VM 641
           V+
Sbjct: 225 VV 226

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 83/177 (46%), Gaps = 25/177 (14%)
Query: 483 FMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLK 542
           +  NG L +++  +   D+T     C  F        ++  AL+YLH        H DLK
Sbjct: 111 YAKNGELLKYIRKIGSFDET-----CTRFY-----TAEIVSALEYLHGK---GIIHRDLK 157
Query: 543 PSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSI--NGD 600
           P N+LL+ +M   + DFG AK+L P   Q  +    GT  Y++P    L +E S   + D
Sbjct: 158 PENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE---LLTEKSACKSSD 214
Query: 601 VYSYGILLLELMT-----RKRPSDIMFEGNMNL-HNFARTVLPDHVMDIVDSTLLAD 651
           +++ G ++ +L+      R     ++F+  + L ++F     P    D+V+  L+ D
Sbjct: 215 LWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK-ARDLVEKLLVLD 270

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 83/177 (46%), Gaps = 25/177 (14%)
Query: 483 FMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLK 542
           +  NG L +++  +   D+T     C  F        ++  AL+YLH        H DLK
Sbjct: 113 YAKNGELLKYIRKIGSFDET-----CTRFY-----TAEIVSALEYLHGK---GIIHRDLK 159
Query: 543 PSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSI--NGD 600
           P N+LL+ +M   + DFG AK+L P   Q  +    GT  Y++P    L +E S   + D
Sbjct: 160 PENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE---LLTEKSACKSSD 216
Query: 601 VYSYGILLLELMT-----RKRPSDIMFEGNMNL-HNFARTVLPDHVMDIVDSTLLAD 651
           +++ G ++ +L+      R     ++F+  + L ++F     P    D+V+  L+ D
Sbjct: 217 LWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK-ARDLVEKLLVLD 272

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 83/177 (46%), Gaps = 25/177 (14%)
Query: 483 FMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLK 542
           +  NG L +++  +   D+T     C  F        ++  AL+YLH        H DLK
Sbjct: 113 YAKNGELLKYIRKIGSFDET-----CTRFY-----TAEIVSALEYLHGK---GIIHRDLK 159
Query: 543 PSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSI--NGD 600
           P N+LL+ +M   + DFG AK+L P   Q  +    GT  Y++P    L +E S   + D
Sbjct: 160 PENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE---LLTEKSACKSSD 216
Query: 601 VYSYGILLLELMT-----RKRPSDIMFEGNMNL-HNFARTVLPDHVMDIVDSTLLAD 651
           +++ G ++ +L+      R     ++F+  + L ++F     P    D+V+  L+ D
Sbjct: 217 LWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK-ARDLVEKLLVLD 272

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 83/177 (46%), Gaps = 25/177 (14%)
Query: 483 FMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLK 542
           +  NG L +++  +   D+T     C  F        ++  AL+YLH        H DLK
Sbjct: 114 YAKNGELLKYIRKIGSFDET-----CTRFY-----TAEIVSALEYLHGK---GIIHRDLK 160
Query: 543 PSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSI--NGD 600
           P N+LL+ +M   + DFG AK+L P   Q  +    GT  Y++P    L +E S   + D
Sbjct: 161 PENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE---LLTEKSACKSSD 217
Query: 601 VYSYGILLLELMT-----RKRPSDIMFEGNMNL-HNFARTVLPDHVMDIVDSTLLAD 651
           +++ G ++ +L+      R     ++F+  + L ++F     P    D+V+  L+ D
Sbjct: 218 LWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK-ARDLVEKLLVLD 273

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 68/139 (48%), Gaps = 12/139 (8%)
Query: 479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAH 538
           LV   M+ G +   ++ V   +   + P+ + +  +I         L++LH   Q    +
Sbjct: 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQI------VSGLEHLH---QRNIIY 312
Query: 539 CDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSIN 598
            DLKP NVLLD +    ++D GLA  L     QT + G  GT G++AP E  LG E   +
Sbjct: 313 RDLKPENVLLDDDGNVRISDLGLAVELKAG--QTKTKGYAGTPGFMAP-ELLLGEEYDFS 369
Query: 599 GDVYSYGILLLELMTRKRP 617
            D ++ G+ L E++  + P
Sbjct: 370 VDYFALGVTLYEMIAARGP 388

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 68/139 (48%), Gaps = 12/139 (8%)
Query: 479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAH 538
           LV   M+ G +   ++ V   +   + P+ + +  +I         L++LH   Q    +
Sbjct: 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQI------VSGLEHLH---QRNIIY 312
Query: 539 CDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSIN 598
            DLKP NVLLD +    ++D GLA  L     QT + G  GT G++AP E  LG E   +
Sbjct: 313 RDLKPENVLLDDDGNVRISDLGLAVELKAG--QTKTKGYAGTPGFMAP-ELLLGEEYDFS 369
Query: 599 GDVYSYGILLLELMTRKRP 617
            D ++ G+ L E++  + P
Sbjct: 370 VDYFALGVTLYEMIAARGP 388

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 83/177 (46%), Gaps = 25/177 (14%)
Query: 483 FMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLK 542
           +  NG L +++  +   D+T     C  F        ++  AL+YLH        H DLK
Sbjct: 111 YAKNGELLKYIRKIGSFDET-----CTRFY-----TAEIVSALEYLHGK---GIIHRDLK 157
Query: 543 PSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSI--NGD 600
           P N+LL+ +M   + DFG AK+L P   Q  +    GT  Y++P    L +E S   + D
Sbjct: 158 PENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE---LLTEKSACKSSD 214
Query: 601 VYSYGILLLELMT-----RKRPSDIMFEGNMNL-HNFARTVLPDHVMDIVDSTLLAD 651
           +++ G ++ +L+      R     ++F+  + L ++F     P    D+V+  L+ D
Sbjct: 215 LWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK-ARDLVEKLLVLD 270

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 112/242 (46%), Gaps = 33/242 (13%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNLVKILTV 465
           I  G++G VYK        ++A+K + L     G   ++I E S L+ + H N+VK+L V
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                   ++   LV+EF+H   L++++   + A   +  P   ++L ++   +    + 
Sbjct: 71  IHT-----ENKLYLVFEFLHQ-DLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL-PPAHLQTSSIGVKGTIGYI 584
           + LH D         LKP N+L++ E    +ADFGLA+    P       +    T+ Y 
Sbjct: 123 RVLHRD---------LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VTLWYR 170
Query: 585 APAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV----LPDH 639
           AP E  LG +  S   D++S G +  E++TR+     +F G+  +    R       PD 
Sbjct: 171 AP-EILLGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRIFRTLGTPDE 225
Query: 640 VM 641
           V+
Sbjct: 226 VV 227

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 83/177 (46%), Gaps = 25/177 (14%)
Query: 483 FMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLK 542
           +  NG L +++  +   D+T     C  F        ++  AL+YLH        H DLK
Sbjct: 111 YAKNGELLKYIRKIGSFDET-----CTRFY-----TAEIVSALEYLHGK---GIIHRDLK 157
Query: 543 PSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSI--NGD 600
           P N+LL+ +M   + DFG AK+L P   Q  +    GT  Y++P    L +E S   + D
Sbjct: 158 PENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE---LLTEKSACKSSD 214
Query: 601 VYSYGILLLELMT-----RKRPSDIMFEGNMNL-HNFARTVLPDHVMDIVDSTLLAD 651
           +++ G ++ +L+      R     ++F+  + L ++F     P    D+V+  L+ D
Sbjct: 215 LWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK-ARDLVEKLLVLD 270

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 79/337 (23%), Positives = 130/337 (38%), Gaps = 63/337 (18%)
Query: 411 GSFGSVYKGIL-----DEGKTIIAVKVL-NLLHHGASKSSIAECSALRNIRHKNLVKILT 464
           G+FG VY+G +     D     +AVK L  +         + E   +  + H+N+V+   
Sbjct: 56  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR--- 112
Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
            C GV  +    + ++ E M  G L+ +L            P  L  L  +++A D+AC 
Sbjct: 113 -CIGVSLQSLP-RFILLELMAGGDLKSFLRETR---PRPSQPSSLAMLDLLHVARDIACG 167
Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA---DFGLAKLLPPAHLQTSSIGVKGTI 581
            +YL  +      H D+   N LL       VA   DFG+A+ +  A            +
Sbjct: 168 CQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 224
Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM 641
            ++ P  +  G   S   D +S+G+LL E+ +          G M   + +       V+
Sbjct: 225 KWMPPEAFMEGIFTS-KTDTWSFGVLLWEIFSL---------GYMPYPSKSN----QEVL 270
Query: 642 DIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH 701
           + V S                    R++    C   V RI   C    P+DR N  I+  
Sbjct: 271 EFVTSG------------------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAII-- 310
Query: 702 ELQSIKSILLGPKTVSNKQKAIPILLEVRSYGPKLKE 738
            L+ I+     P  ++    A+PI      YGP ++E
Sbjct: 311 -LERIEYCTQDPDVINT---ALPI-----EYGPLVEE 338

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 83/177 (46%), Gaps = 25/177 (14%)
Query: 483 FMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLK 542
           +  NG L +++  +   D+T     C  F        ++  AL+YLH        H DLK
Sbjct: 113 YAKNGELLKYIRKIGSFDET-----CTRFY-----TAEIVSALEYLHGK---GIIHRDLK 159
Query: 543 PSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSI--NGD 600
           P N+LL+ +M   + DFG AK+L P   Q  +    GT  Y++P    L +E S   + D
Sbjct: 160 PENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE---LLTEKSACKSSD 216
Query: 601 VYSYGILLLELMT-----RKRPSDIMFEGNMNL-HNFARTVLPDHVMDIVDSTLLAD 651
           +++ G ++ +L+      R     ++F+  + L ++F     P    D+V+  L+ D
Sbjct: 217 LWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK-ARDLVEKLLVLD 272

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 101/234 (43%), Gaps = 33/234 (14%)
Query: 429 AVKVLNLLH---HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMH 485
           A+K+L   H            E   +  + H   VK L  C    ++ D+       +  
Sbjct: 66  AIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK-LYFC----FQDDEKLYFGLSYAK 120
Query: 486 NGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSN 545
           NG L +++  +   D+T     C  F        ++  AL+YLH        H DLKP N
Sbjct: 121 NGELLKYIRKIGSFDET-----CTRFY-----TAEIVSALEYLHGK---GIIHRDLKPEN 167
Query: 546 VLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSI--NGDVYS 603
           +LL+ +M   + DFG AK+L P   Q  +    GT  Y++P    L +E S   + D+++
Sbjct: 168 ILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE---LLTEKSACKSSDLWA 224
Query: 604 YGILLLELMT-----RKRPSDIMFEGNMNL-HNFARTVLPDHVMDIVDSTLLAD 651
            G ++ +L+      R     ++F+  + L ++F     P    D+V+  L+ D
Sbjct: 225 LGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK-ARDLVEKLLVLD 277

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 97/213 (45%), Gaps = 23/213 (10%)
Query: 411 GSFGSVYKG-----ILDEGKTIIAVKVLNLLHHGASKSSIA---ECSALRNIRHKNLVKI 462
           GSFG VY+G     I  E +T +AVK +N     + +  I    E S ++     ++V++
Sbjct: 28  GSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHVVRL 85
Query: 463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVA 522
           L V S    KG     +V E M +G L+ +L  +    +           + I +A ++A
Sbjct: 86  LGVVS----KGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 523 CALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKG--T 580
             + YL+        H DL   N ++ H+ T  + DFG+ + +          G KG   
Sbjct: 141 DGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDI--XETDXXRKGGKGLLP 195
Query: 581 IGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
           + ++AP     G   + + D++S+G++L E+ +
Sbjct: 196 VRWMAPESLKDGV-FTTSSDMWSFGVVLWEITS 227

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 68/139 (48%), Gaps = 12/139 (8%)
Query: 479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAH 538
           LV   M+ G +   ++ V   +   + P+ + +  +I         L++LH   Q    +
Sbjct: 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQI------VSGLEHLH---QRNIIY 312
Query: 539 CDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSIN 598
            DLKP NVLLD +    ++D GLA  L     QT + G  GT G++AP E  LG E   +
Sbjct: 313 RDLKPENVLLDDDGNVRISDLGLAVELKAG--QTKTKGYAGTPGFMAP-ELLLGEEYDFS 369
Query: 599 GDVYSYGILLLELMTRKRP 617
            D ++ G+ L E++  + P
Sbjct: 370 VDYFALGVTLYEMIAARGP 388

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 68/139 (48%), Gaps = 12/139 (8%)
Query: 479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAH 538
           LV   M+ G +   ++ V   +   + P+ + +  +I         L++LH   Q    +
Sbjct: 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQI------VSGLEHLH---QRNIIY 312
Query: 539 CDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSIN 598
            DLKP NVLLD +    ++D GLA  L     QT + G  GT G++AP E  LG E   +
Sbjct: 313 RDLKPENVLLDDDGNVRISDLGLAVELKAG--QTKTKGYAGTPGFMAP-ELLLGEEYDFS 369
Query: 599 GDVYSYGILLLELMTRKRP 617
            D ++ G+ L E++  + P
Sbjct: 370 VDYFALGVTLYEMIAARGP 388

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 28/218 (12%)
Query: 408 IDMGSFGSVYKGIL---DEGKTIIAVKVLNLLHHGASKSS-IAECSALRNIRHKNLVKIL 463
           +  G FG V  G L    + +  +A+K L + +    +   + E S +    H N++++ 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL- 111
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
               GV  K      +V E M NGSL+ +L                  +Q + +   +A 
Sbjct: 112 ---EGVVTKSKPV-MIVTEXMENGSLDSFLRKHDAQ---------FTVIQLVGMLRGIAS 158
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL---PPAHLQTSSIGVKGT 580
            +KYL         H DL   N+L++  +   V+DFGL+++L   P A   T   G K  
Sbjct: 159 GMKYL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR--GGKIP 213
Query: 581 IGYIAPAEYGLGSEVSINGDVYSYGILLLELMTR-KRP 617
           I + +P         S + DV+SYGI+L E+M+  +RP
Sbjct: 214 IRWTSPEAIAYRKFTSAS-DVWSYGIVLWEVMSYGERP 250

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 97/213 (45%), Gaps = 23/213 (10%)
Query: 411 GSFGSVYKG-----ILDEGKTIIAVKVLNLLHHGASKSSIA---ECSALRNIRHKNLVKI 462
           GSFG VY+G     I  E +T +AVK +N     + +  I    E S ++     ++V++
Sbjct: 28  GSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHVVRL 85
Query: 463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVA 522
           L V S    KG     +V E M +G L+ +L  +    +           + I +A ++A
Sbjct: 86  LGVVS----KGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 523 CALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKG--T 580
             + YL+        H DL   N ++ H+ T  + DFG+ + +          G KG   
Sbjct: 141 DGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDI--XETDXXRKGGKGLLP 195
Query: 581 IGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
           + ++AP     G   + + D++S+G++L E+ +
Sbjct: 196 VRWMAPESLKDGV-FTTSSDMWSFGVVLWEITS 227

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 107/239 (44%), Gaps = 34/239 (14%)
Query: 404 FLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSS--IAECSALRNIRHKNLVK 461
           FL  +  G FG V  G    G+  +A+K   ++  G+      I E   + N+ H+ LV+
Sbjct: 13  FLKELGTGQFGVVKYGKW-RGQYDVAIK---MIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 68
Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDV 521
           +  VC+    +   F  ++ E+M NG L  +L  +    +T          Q + +  DV
Sbjct: 69  LYGVCTK---QRPIF--IITEYMANGCLLNYLREMRHRFQTQ---------QLLEMCKDV 114
Query: 522 ACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTI 581
             A++YL         H DL   N L++ +    V+DFGL++ +      TSS G K  +
Sbjct: 115 CEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSRGSKFPV 170
Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHV 640
            + +P E  + S+ S   D++++G+L+ E+ +          G M    F  +   +H+
Sbjct: 171 RW-SPPEVLMYSKFSSKSDIWAFGVLMWEIYSL---------GKMPYERFTNSETAEHI 219

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 28/218 (12%)
Query: 408 IDMGSFGSVYKGIL---DEGKTIIAVKVLNLLHHGASKSS-IAECSALRNIRHKNLVKIL 463
           +  G FG V  G L    + +  +A+K L + +    +   + E S +    H N++++ 
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL- 82
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
               GV  K      +V E M NGSL+ +L                  +Q + +   +A 
Sbjct: 83  ---EGVVTKSKPV-MIVTEXMENGSLDSFLRKHDAQ---------FTVIQLVGMLRGIAS 129
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL---PPAHLQTSSIGVKGT 580
            +KYL         H DL   N+L++  +   V+DFGL+++L   P A   T   G K  
Sbjct: 130 GMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR--GGKIP 184
Query: 581 IGYIAPAEYGLGSEVSINGDVYSYGILLLELMTR-KRP 617
           I + +P         S + DV+SYGI+L E+M+  +RP
Sbjct: 185 IRWTSPEAIAYRKFTSAS-DVWSYGIVLWEVMSYGERP 221

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 79/337 (23%), Positives = 129/337 (38%), Gaps = 63/337 (18%)
Query: 411 GSFGSVYKGIL-----DEGKTIIAVKVL-NLLHHGASKSSIAECSALRNIRHKNLVKILT 464
           G+FG VY+G +     D     +AVK L  +         + E   +    H+N+V+   
Sbjct: 33  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR--- 89
Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
            C GV  +    + ++ E M  G L+ +L            P  L  L  +++A D+AC 
Sbjct: 90  -CIGVSLQSLP-RFILLELMAGGDLKSFLRETR---PRPSQPSSLAMLDLLHVARDIACG 144
Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA---DFGLAKLLPPAHLQTSSIGVKGTI 581
            +YL  +      H D+   N LL       VA   DFG+A+ +  A            +
Sbjct: 145 CQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 201
Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM 641
            ++ P  +  G   S   D +S+G+LL E+ +          G M   + +       V+
Sbjct: 202 KWMPPEAFMEGIFTS-KTDTWSFGVLLWEIFSL---------GYMPYPSKSN----QEVL 247
Query: 642 DIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH 701
           + V S                    R++    C   V RI   C    P+DR N  I+  
Sbjct: 248 EFVTSG------------------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAII-- 287
Query: 702 ELQSIKSILLGPKTVSNKQKAIPILLEVRSYGPKLKE 738
            L+ I+     P  ++    A+PI      YGP ++E
Sbjct: 288 -LERIEYCTQDPDVINT---ALPI-----EYGPLVEE 315

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 29/226 (12%)
Query: 408 IDMGSFGSVYK----GILD-EGKTIIAVKVLNLLHHGASKSSIA-ECSALRNIRHKNLVK 461
           I  G+FG V++    G+L  E  T++AVK+L        ++    E + +    + N+VK
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSG--------ADKTVEA------PK 507
           +L VC+     G     L++E+M  G L E+L  +S         +D +  A      P 
Sbjct: 115 LLGVCA----VGKPM-CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 508 CLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPP 567
            L+  +++ IA  VA  + YL    +    H DL   N L+   M   +ADFGL++ +  
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226
Query: 568 AHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
           A    +       I ++ P E    +  +   DV++YG++L E+ +
Sbjct: 227 ADYYKADGNDAIPIRWM-PPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 79/337 (23%), Positives = 129/337 (38%), Gaps = 63/337 (18%)
Query: 411 GSFGSVYKGIL-----DEGKTIIAVKVL-NLLHHGASKSSIAECSALRNIRHKNLVKILT 464
           G+FG VY+G +     D     +AVK L  +         + E   +    H+N+V+   
Sbjct: 56  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR--- 112
Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
            C GV  +    + ++ E M  G L+ +L            P  L  L  +++A D+AC 
Sbjct: 113 -CIGVSLQSLP-RFILMELMAGGDLKSFLRETR---PRPSQPSSLAMLDLLHVARDIACG 167
Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA---DFGLAKLLPPAHLQTSSIGVKGTI 581
            +YL  +      H D+   N LL       VA   DFG+A+ +  A            +
Sbjct: 168 CQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 224
Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM 641
            ++ P  +  G   S   D +S+G+LL E+ +          G M   + +       V+
Sbjct: 225 KWMPPEAFMEGIFTS-KTDTWSFGVLLWEIFSL---------GYMPYPSKSN----QEVL 270
Query: 642 DIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH 701
           + V S                    R++    C   V RI   C    P+DR N  I+  
Sbjct: 271 EFVTSG------------------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAII-- 310
Query: 702 ELQSIKSILLGPKTVSNKQKAIPILLEVRSYGPKLKE 738
            L+ I+     P  ++    A+PI      YGP ++E
Sbjct: 311 -LERIEYCTQDPDVINT---ALPI-----EYGPLVEE 338

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 78/337 (23%), Positives = 130/337 (38%), Gaps = 63/337 (18%)
Query: 411 GSFGSVYKGIL-----DEGKTIIAVKVL-NLLHHGASKSSIAECSALRNIRHKNLVKILT 464
           G+FG VY+G +     D     +AVK L  +         + E   +  + H+N+V+   
Sbjct: 42  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR--- 98
Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
            C GV  +    + ++ E M  G L+ +L            P  L  L  +++A D+AC 
Sbjct: 99  -CIGVSLQSLP-RFILLELMAGGDLKSFLRETR---PRPSQPSSLAMLDLLHVARDIACG 153
Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHE---MTAHVADFGLAKLLPPAHLQTSSIGVKGTI 581
            +YL  +      H D+   N LL        A + DFG+A+ +  A            +
Sbjct: 154 CQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 210
Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM 641
            ++ P  +  G   S   D +S+G+LL E+ +          G M   + +       V+
Sbjct: 211 KWMPPEAFMEGIFTS-KTDTWSFGVLLWEIFSL---------GYMPYPSKSN----QEVL 256
Query: 642 DIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH 701
           + V S                    R++    C   V RI   C    P+DR N  I+  
Sbjct: 257 EFVTSG------------------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAII-- 296
Query: 702 ELQSIKSILLGPKTVSNKQKAIPILLEVRSYGPKLKE 738
            L+ I+     P  ++    A+PI      YGP ++E
Sbjct: 297 -LERIEYCTQDPDVINT---ALPI-----EYGPLVEE 324

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 83/177 (46%), Gaps = 25/177 (14%)
Query: 483 FMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLK 542
           +  NG L +++  +   D+T     C  F        ++  AL+YLH        H DLK
Sbjct: 116 YAKNGELLKYIRKIGSFDET-----CTRFY-----TAEIVSALEYLHGK---GIIHRDLK 162
Query: 543 PSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSI--NGD 600
           P N+LL+ +M   + DFG AK+L P   Q  +    GT  Y++P    L +E S   + D
Sbjct: 163 PENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE---LLTEKSACKSSD 219
Query: 601 VYSYGILLLELMT-----RKRPSDIMFEGNMNL-HNFARTVLPDHVMDIVDSTLLAD 651
           +++ G ++ +L+      R     ++F+  + L ++F     P    D+V+  L+ D
Sbjct: 220 LWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPAAFFPK-ARDLVEKLLVLD 275

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 97/213 (45%), Gaps = 23/213 (10%)
Query: 411 GSFGSVYKG-----ILDEGKTIIAVKVLNLLHHGASKSSIA---ECSALRNIRHKNLVKI 462
           GSFG VY+G     I  E +T +AVK +N     + +  I    E S ++     ++V++
Sbjct: 25  GSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHVVRL 82
Query: 463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVA 522
           L V S    KG     +V E M +G L+ +L  +    +           + I +A ++A
Sbjct: 83  LGVVS----KGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 137
Query: 523 CALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKG--T 580
             + YL+        H DL   N ++ H+ T  + DFG+ + +          G KG   
Sbjct: 138 DGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI--XETDXXRKGGKGLLP 192
Query: 581 IGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
           + ++AP     G   + + D++S+G++L E+ +
Sbjct: 193 VRWMAPESLKDGV-FTTSSDMWSFGVVLWEITS 224

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 111/242 (45%), Gaps = 33/242 (13%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNLVKILTV 465
           I  G++G VYK        ++A+K + L     G   ++I E S L+ + H N+VK+L V
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                   ++   LV+EF+H   L+ ++   + A   +  P   ++L ++   +    + 
Sbjct: 74  IHT-----ENKLYLVFEFLHQ-DLKTFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP-PAHLQTSSIGVKGTIGYI 584
           + LH D         LKP N+L++ E    +ADFGLA+    P       +    T+ Y 
Sbjct: 126 RVLHRD---------LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VTLWYR 173
Query: 585 APAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV----LPDH 639
           AP E  LG +  S   D++S G +  E++TR+     +F G+  +    R       PD 
Sbjct: 174 AP-EILLGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRIFRTLGTPDE 228
Query: 640 VM 641
           V+
Sbjct: 229 VV 230

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 108/230 (46%), Gaps = 29/230 (12%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNLVKILTV 465
           I  G++G VYK        ++A+K + L     G   ++I E S L+ + H N+VK+L V
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                   ++   LV+EF+H   L++++   + A   +  P   ++L ++   +    + 
Sbjct: 72  IHT-----ENKLYLVFEFLHQ-DLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP-PAHLQTSSIGVKGTIGYI 584
           + LH D         LKP N+L++ E    +ADFGLA+    P       +    T+ Y 
Sbjct: 124 RVLHRD---------LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VTLWYR 171
Query: 585 APAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFAR 633
           AP E  LG +  S   D++S G +  E++TR+     +F G+  +    R
Sbjct: 172 AP-EILLGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFR 216

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 78/337 (23%), Positives = 129/337 (38%), Gaps = 63/337 (18%)
Query: 411 GSFGSVYKGIL-----DEGKTIIAVKVL-NLLHHGASKSSIAECSALRNIRHKNLVKILT 464
           G+FG VY+G +     D     +AVK L  +         + E   +    H+N+V+   
Sbjct: 58  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR--- 114
Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
            C GV  +    + ++ E M  G L+ +L            P  L  L  +++A D+AC 
Sbjct: 115 -CIGVSLQSLP-RFILLELMAGGDLKSFLRETR---PRPSQPSSLAMLDLLHVARDIACG 169
Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHE---MTAHVADFGLAKLLPPAHLQTSSIGVKGTI 581
            +YL  +      H D+   N LL        A + DFG+A+ +  A            +
Sbjct: 170 CQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 226
Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM 641
            ++ P  +  G   S   D +S+G+LL E+ +          G M   + +       V+
Sbjct: 227 KWMPPEAFMEGIFTS-KTDTWSFGVLLWEIFSL---------GYMPYPSKSN----QEVL 272
Query: 642 DIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH 701
           + V S                    R++    C   V RI   C    P+DR N  I+  
Sbjct: 273 EFVTSG------------------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAII-- 312
Query: 702 ELQSIKSILLGPKTVSNKQKAIPILLEVRSYGPKLKE 738
            L+ I+     P  ++    A+PI      YGP ++E
Sbjct: 313 -LERIEYCTQDPDVINT---ALPI-----EYGPLVEE 340

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 78/337 (23%), Positives = 129/337 (38%), Gaps = 63/337 (18%)
Query: 411 GSFGSVYKGIL-----DEGKTIIAVKVL-NLLHHGASKSSIAECSALRNIRHKNLVKILT 464
           G+FG VY+G +     D     +AVK L  +         + E   +    H+N+V+   
Sbjct: 41  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR--- 97
Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
            C GV  +    + ++ E M  G L+ +L            P  L  L  +++A D+AC 
Sbjct: 98  -CIGVSLQSLP-RFILLELMAGGDLKSFLRETR---PRPSQPSSLAMLDLLHVARDIACG 152
Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHE---MTAHVADFGLAKLLPPAHLQTSSIGVKGTI 581
            +YL  +      H D+   N LL        A + DFG+A+ +  A            +
Sbjct: 153 CQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 209
Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM 641
            ++ P  +  G   S   D +S+G+LL E+ +          G M   + +       V+
Sbjct: 210 KWMPPEAFMEGIFTS-KTDTWSFGVLLWEIFSL---------GYMPYPSKSN----QEVL 255
Query: 642 DIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH 701
           + V S                    R++    C   V RI   C    P+DR N  I+  
Sbjct: 256 EFVTSG------------------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAII-- 295
Query: 702 ELQSIKSILLGPKTVSNKQKAIPILLEVRSYGPKLKE 738
            L+ I+     P  ++    A+PI      YGP ++E
Sbjct: 296 -LERIEYCTQDPDVINT---ALPI-----EYGPLVEE 323

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 78/337 (23%), Positives = 129/337 (38%), Gaps = 63/337 (18%)
Query: 411 GSFGSVYKGIL-----DEGKTIIAVKVL-NLLHHGASKSSIAECSALRNIRHKNLVKILT 464
           G+FG VY+G +     D     +AVK L  +         + E   +    H+N+V+   
Sbjct: 41  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR--- 97
Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
            C GV  +    + ++ E M  G L+ +L            P  L  L  +++A D+AC 
Sbjct: 98  -CIGVSLQSLP-RFILMELMAGGDLKSFLRETR---PRPSQPSSLAMLDLLHVARDIACG 152
Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHE---MTAHVADFGLAKLLPPAHLQTSSIGVKGTI 581
            +YL  +      H D+   N LL        A + DFG+A+ +  A            +
Sbjct: 153 CQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 209
Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM 641
            ++ P  +  G   S   D +S+G+LL E+ +          G M   + +       V+
Sbjct: 210 KWMPPEAFMEGIFTS-KTDTWSFGVLLWEIFSL---------GYMPYPSKSN----QEVL 255
Query: 642 DIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH 701
           + V S                    R++    C   V RI   C    P+DR N  I+  
Sbjct: 256 EFVTSG------------------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAII-- 295
Query: 702 ELQSIKSILLGPKTVSNKQKAIPILLEVRSYGPKLKE 738
            L+ I+     P  ++    A+PI      YGP ++E
Sbjct: 296 -LERIEYCTQDPDVINT---ALPI-----EYGPLVEE 323

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 99/212 (46%), Gaps = 21/212 (9%)
Query: 411 GSFGSVYKG-----ILDEGKTIIAVKVLNLLHHGASKSSIA---ECSALRNIRHKNLVKI 462
           GSFG VY+G     I  E +T +AVK +N     + +  I    E S ++     ++V++
Sbjct: 28  GSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHVVRL 85
Query: 463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVA 522
           L V S    KG     +V E M +G L+ +L  +    +           + I +A ++A
Sbjct: 86  LGVVS----KGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 523 CALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAK-LLPPAHLQTSSIGVKGTI 581
             + YL+        H DL   N ++ H+ T  + DFG+ + +   A+ +    G+   +
Sbjct: 141 DGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLL-PV 196
Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
            ++AP     G   + + D++S+G++L E+ +
Sbjct: 197 RWMAPESLKDGV-FTTSSDMWSFGVVLWEITS 227

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 79/175 (45%), Gaps = 21/175 (12%)
Query: 483 FMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLK 542
           +  NG L +++  +   D+T     C  F        ++  AL+YLH        H DLK
Sbjct: 113 YAKNGELLKYIRKIGSFDET-----CTRFY-----TAEIVSALEYLHGKG---IIHRDLK 159
Query: 543 PSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVY 602
           P N+LL+ +M   + DFG AK+L P   Q  +    GT  Y++P E         + D++
Sbjct: 160 PENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP-ELLTEKSAXKSSDLW 218
Query: 603 SYGILLLELMT-----RKRPSDIMFEGNMNL-HNFARTVLPDHVMDIVDSTLLAD 651
           + G ++ +L+      R     ++F   + L ++F     P    D+V+  L+ D
Sbjct: 219 ALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPK-ARDLVEKLLVLD 272

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 103/215 (47%), Gaps = 27/215 (12%)
Query: 411 GSFGSVYKGIL-----DEGKTIIAVKVLNLLHHGASKSSIA---ECSALRNIRHKNLVKI 462
           GSFG VY+G+      DE +T +A+K +N     + +  I    E S ++     ++V++
Sbjct: 36  GSFGMVYEGVAKGVVKDEPETRVAIKTVN--EAASMRERIEFLNEASVMKEFNCHHVVRL 93
Query: 463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPV--SGADKTVEAPKCLNFLQRINIAID 520
           L V S    +G     ++ E M  G L+ +L  +  + A+  V AP  L+  + I +A +
Sbjct: 94  LGVVS----QGQP-TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS--KMIQMAGE 146
Query: 521 VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKG- 579
           +A  + YL+ +      H DL   N ++  + T  + DFG+ + +          G KG 
Sbjct: 147 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI--YETDYYRKGGKGL 201
Query: 580 -TIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             + +++P     G   +   DV+S+G++L E+ T
Sbjct: 202 LPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIAT 235

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 79/337 (23%), Positives = 129/337 (38%), Gaps = 63/337 (18%)
Query: 411 GSFGSVYKGIL-----DEGKTIIAVKVL-NLLHHGASKSSIAECSALRNIRHKNLVKILT 464
           G+FG VY+G +     D     +AVK L  +         + E   +    H+N+V+   
Sbjct: 82  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR--- 138
Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
            C GV  +    + ++ E M  G L+ +L            P  L  L  +++A D+AC 
Sbjct: 139 -CIGVSLQSLP-RFILLELMAGGDLKSFLRETR---PRPSQPSSLAMLDLLHVARDIACG 193
Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA---DFGLAKLLPPAHLQTSSIGVKGTI 581
            +YL  +      H D+   N LL       VA   DFG+A+ +  A            +
Sbjct: 194 CQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPV 250
Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM 641
            ++ P  +  G   S   D +S+G+LL E+ +          G M   + +       V+
Sbjct: 251 KWMPPEAFMEGIFTS-KTDTWSFGVLLWEIFSL---------GYMPYPSKSN----QEVL 296
Query: 642 DIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH 701
           + V S                    R++    C   V RI   C    P+DR N  I+  
Sbjct: 297 EFVTSG------------------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAII-- 336
Query: 702 ELQSIKSILLGPKTVSNKQKAIPILLEVRSYGPKLKE 738
            L+ I+     P  ++    A+PI      YGP ++E
Sbjct: 337 -LERIEYCTQDPDVINT---ALPI-----EYGPLVEE 364

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 78/337 (23%), Positives = 129/337 (38%), Gaps = 63/337 (18%)
Query: 411 GSFGSVYKGIL-----DEGKTIIAVKVL-NLLHHGASKSSIAECSALRNIRHKNLVKILT 464
           G+FG VY+G +     D     +AVK L  +         + E   +    H+N+V+   
Sbjct: 42  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR--- 98
Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
            C GV  +    + ++ E M  G L+ +L            P  L  L  +++A D+AC 
Sbjct: 99  -CIGVSLQSLP-RFILLELMAGGDLKSFLRETR---PRPSQPSSLAMLDLLHVARDIACG 153
Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHE---MTAHVADFGLAKLLPPAHLQTSSIGVKGTI 581
            +YL  +      H D+   N LL        A + DFG+A+ +  A            +
Sbjct: 154 CQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 210
Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM 641
            ++ P  +  G   S   D +S+G+LL E+ +          G M   + +       V+
Sbjct: 211 KWMPPEAFMEGIFTS-KTDTWSFGVLLWEIFSL---------GYMPYPSKSN----QEVL 256
Query: 642 DIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH 701
           + V S                    R++    C   V RI   C    P+DR N  I+  
Sbjct: 257 EFVTSG------------------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAII-- 296
Query: 702 ELQSIKSILLGPKTVSNKQKAIPILLEVRSYGPKLKE 738
            L+ I+     P  ++    A+PI      YGP ++E
Sbjct: 297 -LERIEYCTQDPDVINT---ALPI-----EYGPLVEE 324

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 28/218 (12%)
Query: 408 IDMGSFGSVYKGILD---EGKTIIAVKVLNLLHHGASKSS-IAECSALRNIRHKNLVKIL 463
           I  G FG V  G L    + +  +A+K L + +    +   + E S +    H N++ + 
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHL- 88
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
               GV  K      +V E+M NGSL+ +L    G             +Q + +   ++ 
Sbjct: 89  ---EGVVTKSKPV-MIVTEYMENGSLDTFLKKNDGQ---------FTVIQLVGMLRGISA 135
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL---PPAHLQTSSIGVKGT 580
            +KYL         H DL   N+L++  +   V+DFGL+++L   P A   T   G K  
Sbjct: 136 GMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR--GGKIP 190
Query: 581 IGYIAPAEYGLGSEVSINGDVYSYGILLLELMTR-KRP 617
           I + AP         S + DV+SYGI++ E+++  +RP
Sbjct: 191 IRWTAPEAIAFRKFTSAS-DVWSYGIVMWEVVSYGERP 227

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 94/217 (43%), Gaps = 32/217 (14%)
Query: 410 MGSFGSVYKGILDEGKTIIAVKVLN---LLHHGASKSSIAECSALRNIRHKNLVKILTVC 466
           +G+FG V  G        +AVK+LN   +           E   L+  RH +++K+  V 
Sbjct: 21  VGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI 80
Query: 467 SGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALK 526
           S       DF  +V E++  G L +++         VE  +     Q+I  A+D      
Sbjct: 81  S----TPTDF-FMVMEYVSGGELFDYI----CKHGRVEEMEARRLFQQILSAVD------ 125
Query: 527 YLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP 586
           Y H   +    H DLKP NVLLD  M A +ADFGL+ ++       +S    G+  Y AP
Sbjct: 126 YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAP 179
Query: 587 ----AEYGLGSEVSINGDVYSYGILLLELMTRKRPSD 619
                    G EV    D++S G++L  L+    P D
Sbjct: 180 EVISGRLYAGPEV----DIWSCGVILYALLCGTLPFD 212

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 82/177 (46%), Gaps = 25/177 (14%)
Query: 483 FMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLK 542
           +  NG L +++  +   D+T     C  F        ++  AL+YLH        H DLK
Sbjct: 113 YAKNGELLKYIRKIGSFDET-----CTRFY-----TAEIVSALEYLHGK---GIIHRDLK 159
Query: 543 PSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSI--NGD 600
           P N+LL+ +M   + DFG AK+L P   Q  +    GT  Y++P    L +E S   + D
Sbjct: 160 PENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE---LLTEKSACKSSD 216
Query: 601 VYSYGILLLELMT-----RKRPSDIMFEGNMNL-HNFARTVLPDHVMDIVDSTLLAD 651
           +++ G ++ +L+      R     ++F   + L ++F     P    D+V+  L+ D
Sbjct: 217 LWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPK-ARDLVEKLLVLD 272

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 78/337 (23%), Positives = 129/337 (38%), Gaps = 63/337 (18%)
Query: 411 GSFGSVYKGIL-----DEGKTIIAVKVL-NLLHHGASKSSIAECSALRNIRHKNLVKILT 464
           G+FG VY+G +     D     +AVK L  +         + E   +    H+N+V+   
Sbjct: 48  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR--- 104
Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
            C GV  +    + ++ E M  G L+ +L            P  L  L  +++A D+AC 
Sbjct: 105 -CIGVSLQSLP-RFILLELMAGGDLKSFLRETR---PRPSQPSSLAMLDLLHVARDIACG 159
Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHE---MTAHVADFGLAKLLPPAHLQTSSIGVKGTI 581
            +YL  +      H D+   N LL        A + DFG+A+ +  A            +
Sbjct: 160 CQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 216
Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM 641
            ++ P  +  G   S   D +S+G+LL E+ +          G M   + +       V+
Sbjct: 217 KWMPPEAFMEGIFTS-KTDTWSFGVLLWEIFSL---------GYMPYPSKSN----QEVL 262
Query: 642 DIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH 701
           + V S                    R++    C   V RI   C    P+DR N  I+  
Sbjct: 263 EFVTSG------------------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAII-- 302
Query: 702 ELQSIKSILLGPKTVSNKQKAIPILLEVRSYGPKLKE 738
            L+ I+     P  ++    A+PI      YGP ++E
Sbjct: 303 -LERIEYCTQDPDVINT---ALPI-----EYGPLVEE 330

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 103/215 (47%), Gaps = 27/215 (12%)
Query: 411 GSFGSVYKGIL-----DEGKTIIAVKVLNLLHHGASKSSIA---ECSALRNIRHKNLVKI 462
           GSFG VY+G+      DE +T +A+K +N     + +  I    E S ++     ++V++
Sbjct: 26  GSFGMVYEGVAKGVVKDEPETRVAIKTVN--EAASMRERIEFLNEASVMKEFNCHHVVRL 83
Query: 463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPV--SGADKTVEAPKCLNFLQRINIAID 520
           L V S    +G     ++ E M  G L+ +L  +  + A+  V AP  L+  + I +A +
Sbjct: 84  LGVVS----QGQP-TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS--KMIQMAGE 136
Query: 521 VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKG- 579
           +A  + YL+ +      H DL   N ++  + T  + DFG+ + +          G KG 
Sbjct: 137 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK--GGKGL 191
Query: 580 -TIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             + +++P     G   +   DV+S+G++L E+ T
Sbjct: 192 LPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIAT 225

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 90/195 (46%), Gaps = 25/195 (12%)
Query: 428 IAVKVLNLLHHGASKSS-IAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHN 486
           +A+K L   +    +   ++E S +    H N++++     GV  +G     +V E+M N
Sbjct: 80  VAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL----EGVVTRGR-LAMIVTEYMEN 134
Query: 487 GSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNV 546
           GSL+ +L    G             +Q + +   V   ++YL         H DL   NV
Sbjct: 135 GSLDTFLRTHDGQ---------FTIMQLVGMLRGVGAGMRYL---SDLGYVHRDLAARNV 182
Query: 547 LLDHEMTAHVADFGLAKLL---PPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYS 603
           L+D  +   V+DFGL+++L   P A   T+  G K  I + AP      +  S   DV+S
Sbjct: 183 LVDSNLVCKVSDFGLSRVLEDDPDAAXTTT--GGKIPIRWTAPEAIAFRT-FSSASDVWS 239
Query: 604 YGILLLELMTR-KRP 617
           +G+++ E++   +RP
Sbjct: 240 FGVVMWEVLAYGERP 254

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 90/195 (46%), Gaps = 25/195 (12%)
Query: 428 IAVKVLNLLHHGASKSS-IAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHN 486
           +A+K L   +    +   ++E S +    H N++++     GV  +G     +V E+M N
Sbjct: 80  VAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL----EGVVTRGR-LAMIVTEYMEN 134
Query: 487 GSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNV 546
           GSL+ +L    G             +Q + +   V   ++YL         H DL   NV
Sbjct: 135 GSLDTFLRTHDGQ---------FTIMQLVGMLRGVGAGMRYL---SDLGYVHRDLAARNV 182
Query: 547 LLDHEMTAHVADFGLAKLL---PPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYS 603
           L+D  +   V+DFGL+++L   P A   T+  G K  I + AP      +  S   DV+S
Sbjct: 183 LVDSNLVCKVSDFGLSRVLEDDPDAAYTTT--GGKIPIRWTAPEAIAFRT-FSSASDVWS 239
Query: 604 YGILLLELMTR-KRP 617
           +G+++ E++   +RP
Sbjct: 240 FGVVMWEVLAYGERP 254

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 122/283 (43%), Gaps = 37/283 (13%)
Query: 405 LCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGAS-KSSIAECSALRNIRHKNLVKIL 463
           L +I  G++G V        KT +A+K ++   H    + ++ E   L   RH+N++ I 
Sbjct: 48  LQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIR 107
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            +      +    +A+   ++    +E  L+ +  + +      C    Q       +  
Sbjct: 108 DIL-----RASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQ-------ILR 155
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK-GTIG 582
            LKY+H        H DLKPSN+L++      + DFGLA++  P H  T  +     T  
Sbjct: 156 GLKYIH---SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRW 212
Query: 583 YIAPAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM 641
           Y AP E  L S+  + + D++S G +L E+++  RP   +F G   L         +H++
Sbjct: 213 YRAP-EIMLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQL------NHIL 261
Query: 642 DIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVA 684
            I+ S      EDL    N + R     N ++ L S  ++  A
Sbjct: 262 GILGS---PSQEDLNCIINMKAR-----NYLQSLPSKTKVAWA 296

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 98/219 (44%), Gaps = 31/219 (14%)
Query: 411 GSFGSVYKG-----ILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G+FG V+       + ++ K ++AVK L      A +    E   L  ++H+++V+   V
Sbjct: 29  GAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGV 88
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHP-------VSGADKTVEAPKCLNFLQRINIA 518
           C+    +G     +V+E+M +G L  +L         ++G +    AP  L   Q + +A
Sbjct: 89  CT----EGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDV--APGPLGLGQLLAVA 141
Query: 519 IDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK 578
             VA  + YL         H DL   N L+   +   + DFG+++ +      T    V 
Sbjct: 142 SQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI----YSTDYYRVG 194
Query: 579 GT----IGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
           G     I ++ P E  L  + +   DV+S+G++L E+ T
Sbjct: 195 GRTMLPIRWM-PPESILYRKFTTESDVWSFGVVLWEIFT 232

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 97/205 (47%), Gaps = 23/205 (11%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKILTVCSGV 469
           G++ +VYKG       ++A+K + L H  GA  ++I E S L++++H N+V +  +    
Sbjct: 13  GTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT- 71
Query: 470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH 529
               +    LV+E++ +  L+++L              C N +   N+ + +   L+ L 
Sbjct: 72  ----EKSLTLVFEYL-DKDLKQYL------------DDCGNIINMHNVKLFLFQLLRGLA 114
Query: 530 HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEY 589
           +  +    H DLKP N+L++      +ADFGLA+      + T +   +    +  P + 
Sbjct: 115 YCHRQKVLHRDLKPQNLLINERGELKLADFGLAR---AKSIPTKTYDNEVVTLWYRPPDI 171
Query: 590 GLGS-EVSINGDVYSYGILLLELMT 613
            LGS + S   D++  G +  E+ T
Sbjct: 172 LLGSTDYSTQIDMWGVGCIFYEMAT 196

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 28/218 (12%)
Query: 408 IDMGSFGSVYKGIL---DEGKTIIAVKVLNLLHHGASKSS-IAECSALRNIRHKNLVKIL 463
           +  G FG V  G L    + +  +A+K L + +    +   + E S +    H N++++ 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL- 111
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
               GV  K      +V E M NGSL+ +L                  +Q + +   +A 
Sbjct: 112 ---EGVVTKSKPV-MIVTEXMENGSLDSFLRKHDAQ---------FTVIQLVGMLRGIAS 158
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL---PPAHLQTSSIGVKGT 580
            +KYL         H DL   N+L++  +   V+DFGL+++L   P A   T   G K  
Sbjct: 159 GMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR--GGKIP 213
Query: 581 IGYIAPAEYGLGSEVSINGDVYSYGILLLELMTR-KRP 617
           I + +P         S + DV+SYGI+L E+M+  +RP
Sbjct: 214 IRWTSPEAIAYRKFTSAS-DVWSYGIVLWEVMSYGERP 250

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 78/337 (23%), Positives = 129/337 (38%), Gaps = 63/337 (18%)
Query: 411 GSFGSVYKGIL-----DEGKTIIAVKVL-NLLHHGASKSSIAECSALRNIRHKNLVKILT 464
           G+FG VY+G +     D     +AVK L  +         + E   +    H+N+V+   
Sbjct: 42  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR--- 98
Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
            C GV  +    + ++ E M  G L+ +L            P  L  L  +++A D+AC 
Sbjct: 99  -CIGVSLQSLP-RFILLELMAGGDLKSFLRETR---PRPSQPSSLAMLDLLHVARDIACG 153
Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHE---MTAHVADFGLAKLLPPAHLQTSSIGVKGTI 581
            +YL  +      H D+   N LL        A + DFG+A+ +  A            +
Sbjct: 154 CQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPV 210
Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM 641
            ++ P  +  G   S   D +S+G+LL E+ +          G M   + +       V+
Sbjct: 211 KWMPPEAFMEGIFTS-KTDTWSFGVLLWEIFSL---------GYMPYPSKSN----QEVL 256
Query: 642 DIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH 701
           + V S                    R++    C   V RI   C    P+DR N  I+  
Sbjct: 257 EFVTSG------------------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAII-- 296
Query: 702 ELQSIKSILLGPKTVSNKQKAIPILLEVRSYGPKLKE 738
            L+ I+     P  ++    A+PI      YGP ++E
Sbjct: 297 -LERIEYCTQDPDVINT---ALPI-----EYGPLVEE 324

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 98/219 (44%), Gaps = 31/219 (14%)
Query: 411 GSFGSVYKG-----ILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G+FG V+       + ++ K ++AVK L      A +    E   L  ++H+++V+   V
Sbjct: 52  GAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGV 111
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHP-------VSGADKTVEAPKCLNFLQRINIA 518
           C+    +G     +V+E+M +G L  +L         ++G +    AP  L   Q + +A
Sbjct: 112 CT----EGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDV--APGPLGLGQLLAVA 164
Query: 519 IDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK 578
             VA  + YL         H DL   N L+   +   + DFG+++ +      T    V 
Sbjct: 165 SQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI----YSTDYYRVG 217
Query: 579 GT----IGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
           G     I ++ P E  L  + +   DV+S+G++L E+ T
Sbjct: 218 GRTMLPIRWM-PPESILYRKFTTESDVWSFGVVLWEIFT 255

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 79/337 (23%), Positives = 129/337 (38%), Gaps = 63/337 (18%)
Query: 411 GSFGSVYKGIL-----DEGKTIIAVKVL-NLLHHGASKSSIAECSALRNIRHKNLVKILT 464
           G+FG VY+G +     D     +AVK L  +         + E   +    H+N+V+   
Sbjct: 59  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR--- 115
Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
            C GV  +    + ++ E M  G L+ +L            P  L  L  +++A D+AC 
Sbjct: 116 -CIGVSLQSLP-RFILLELMAGGDLKSFLRETR---PRPSQPSSLAMLDLLHVARDIACG 170
Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA---DFGLAKLLPPAHLQTSSIGVKGTI 581
            +YL  +      H D+   N LL       VA   DFG+A+ +  A            +
Sbjct: 171 CQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPV 227
Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM 641
            ++ P  +  G   S   D +S+G+LL E+ +          G M   + +       V+
Sbjct: 228 KWMPPEAFMEGIFTS-KTDTWSFGVLLWEIFSL---------GYMPYPSKSN----QEVL 273
Query: 642 DIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH 701
           + V S                    R++    C   V RI   C    P+DR N  I+  
Sbjct: 274 EFVTSG------------------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAII-- 313
Query: 702 ELQSIKSILLGPKTVSNKQKAIPILLEVRSYGPKLKE 738
            L+ I+     P  ++    A+PI      YGP ++E
Sbjct: 314 -LERIEYCTQDPDVINT---ALPI-----EYGPLVEE 341

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 78/337 (23%), Positives = 129/337 (38%), Gaps = 63/337 (18%)
Query: 411 GSFGSVYKGIL-----DEGKTIIAVKVL-NLLHHGASKSSIAECSALRNIRHKNLVKILT 464
           G+FG VY+G +     D     +AVK L  +         + E   +    H+N+V+   
Sbjct: 68  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR--- 124
Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
            C GV  +    + ++ E M  G L+ +L            P  L  L  +++A D+AC 
Sbjct: 125 -CIGVSLQSLP-RFILLELMAGGDLKSFLRETR---PRPSQPSSLAMLDLLHVARDIACG 179
Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHE---MTAHVADFGLAKLLPPAHLQTSSIGVKGTI 581
            +YL  +      H D+   N LL        A + DFG+A+ +  A            +
Sbjct: 180 CQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 236
Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM 641
            ++ P  +  G   S   D +S+G+LL E+ +          G M   + +       V+
Sbjct: 237 KWMPPEAFMEGIFTS-KTDTWSFGVLLWEIFSL---------GYMPYPSKSN----QEVL 282
Query: 642 DIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH 701
           + V S                    R++    C   V RI   C    P+DR N  I+  
Sbjct: 283 EFVTSG------------------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAII-- 322
Query: 702 ELQSIKSILLGPKTVSNKQKAIPILLEVRSYGPKLKE 738
            L+ I+     P  ++    A+PI      YGP ++E
Sbjct: 323 -LERIEYCTQDPDVINT---ALPI-----EYGPLVEE 350

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 93/217 (42%), Gaps = 32/217 (14%)
Query: 410 MGSFGSVYKGILDEGKTIIAVKVLN---LLHHGASKSSIAECSALRNIRHKNLVKILTVC 466
           +G+FG V  G        +AVK+LN   +           E   L+  RH +++K+  V 
Sbjct: 21  VGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI 80
Query: 467 SGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALK 526
           S       DF  +V E++  G L +++         VE  +     Q+I  A+D      
Sbjct: 81  S----TPTDF-FMVMEYVSGGELFDYI----CKHGRVEEMEARRLFQQILSAVD------ 125
Query: 527 YLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP 586
           Y H   +    H DLKP NVLLD  M A +ADFGL+ ++        S    G+  Y AP
Sbjct: 126 YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSC---GSPNYAAP 179
Query: 587 ----AEYGLGSEVSINGDVYSYGILLLELMTRKRPSD 619
                    G EV    D++S G++L  L+    P D
Sbjct: 180 EVISGRLYAGPEV----DIWSCGVILYALLCGTLPFD 212

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 98/219 (44%), Gaps = 31/219 (14%)
Query: 411 GSFGSVYKG-----ILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G+FG V+       + ++ K ++AVK L      A +    E   L  ++H+++V+   V
Sbjct: 23  GAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGV 82
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHP-------VSGADKTVEAPKCLNFLQRINIA 518
           C+    +G     +V+E+M +G L  +L         ++G +    AP  L   Q + +A
Sbjct: 83  CT----EGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDV--APGPLGLGQLLAVA 135
Query: 519 IDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK 578
             VA  + YL         H DL   N L+   +   + DFG+++ +      T    V 
Sbjct: 136 SQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI----YSTDYYRVG 188
Query: 579 GT----IGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
           G     I ++ P E  L  + +   DV+S+G++L E+ T
Sbjct: 189 GRTMLPIRWM-PPESILYRKFTTESDVWSFGVVLWEIFT 226

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 71/306 (23%), Positives = 113/306 (36%), Gaps = 60/306 (19%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVK-VLNLLHHGASKSSIAECSALRNIRHKNLVKILTVC 466
           I  G+FG V+ G L    T++AVK     L        + E   L+   H N+V+++ VC
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 467 SGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALK 526
           +           +V E +  G    +L    GA   V+       LQ +    D A  ++
Sbjct: 182 T-----QKQPIYIVMELVQGGDFLTFLR-TEGARLRVK-----TLLQMVG---DAAAGME 227
Query: 527 YLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP 586
           YL   C     H DL   N L+  +    ++DFG+++         S    +  + + AP
Sbjct: 228 YLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAP 284
Query: 587 AEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDS 646
                G   S   DV+S+GILL E  +                    +  P+        
Sbjct: 285 EALNYG-RYSSESDVWSFGILLWETFS-----------------LGASPYPN-------- 318
Query: 647 TLLADDEDLTITSNQRQRQ-----ARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH 701
                       SNQ+ R+      R+     C  +V R+   C    P  R + + +  
Sbjct: 319 -----------LSNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367
Query: 702 ELQSIK 707
           ELQSI+
Sbjct: 368 ELQSIR 373

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 73/307 (23%), Positives = 119/307 (38%), Gaps = 62/307 (20%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVK-VLNLLHHGASKSSIAECSALRNIRHKNLVKILTVC 466
           I  G+FG V+ G L    T++AVK     L        + E   L+   H N+V+++ VC
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 467 SGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALK 526
           +    K   +  +V E +  G    +L    GA   V+       LQ +    D A  ++
Sbjct: 182 T---QKQPIY--IVMELVQGGDFLTFLR-TEGARLRVK-----TLLQMVG---DAAAGME 227
Query: 527 YLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGT-IGYIA 585
           YL   C     H DL   N L+  +    ++DFG+++      +  +S G++   + + A
Sbjct: 228 YLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADG-VXAASGGLRQVPVKWTA 283
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVD 645
           P     G   S   DV+S+GILL E  +                    +  P+       
Sbjct: 284 PEALNYG-RYSSESDVWSFGILLWETFS-----------------LGASPYPN------- 318
Query: 646 STLLADDEDLTITSNQRQRQ-----ARINNIMECLISVVRIGVACSMESPQDRMNMTIVV 700
                        SNQ+ R+      R+     C  +V R+   C    P  R + + + 
Sbjct: 319 ------------LSNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIY 366
Query: 701 HELQSIK 707
            ELQSI+
Sbjct: 367 QELQSIR 373

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 101/215 (46%), Gaps = 27/215 (12%)
Query: 411 GSFGSVYKGIL-----DEGKTIIAVKVLNLLHHGASKSSIA---ECSALRNIRHKNLVKI 462
           GSFG VY+G+      DE +T +A+K +N     + +  I    E S ++     ++V++
Sbjct: 21  GSFGMVYEGVAKGVVKDEPETRVAIKTVN--EAASMRERIEFLNEASVMKEFNCHHVVRL 78
Query: 463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGA--DKTVEAPKCLNFLQRINIAID 520
           L V S    +G     ++ E M  G L+ +L  +     +  V AP  L+  + I +A +
Sbjct: 79  LGVVS----QGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAGE 131
Query: 521 VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKG- 579
           +A  + YL+ +      H DL   N ++  + T  + DFG+ + +          G KG 
Sbjct: 132 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI--XETDXXRKGGKGL 186
Query: 580 -TIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             + +++P     G   +   DV+S+G++L E+ T
Sbjct: 187 LPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIAT 220

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 99/242 (40%), Gaps = 39/242 (16%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVL---NLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           G FG+VY     + K I+A+KVL    L   G       E     ++RH N++++     
Sbjct: 24  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL----- 78
Query: 468 GVDYKGDDFKA-LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI-DVACAL 525
              Y  D  +  L+ E+   G + + L  +S  D+           QR    I ++A AL
Sbjct: 79  -YGYFHDATRVYLILEYAPRGEVYKELQKLSKFDE-----------QRTATYITELANAL 126
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            Y H        H D+KP N+LL       +ADFG +   P +   T    + GT+ Y+ 
Sbjct: 127 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDYL- 178
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART-----VLPDHV 640
           P E   G       D++S G+L  E +  K P    FE N     + R        PD V
Sbjct: 179 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFV 234
Query: 641 MD 642
            +
Sbjct: 235 TE 236

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 97/213 (45%), Gaps = 23/213 (10%)
Query: 411 GSFGSVYKG-----ILDEGKTIIAVKVLNLLHHGASKSSIA---ECSALRNIRHKNLVKI 462
           GSFG VY+G     I  E +T +AVK +N     + +  I    E S ++     ++V++
Sbjct: 28  GSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHVVRL 85
Query: 463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVA 522
           L V S    KG     +V E M +G L+ +L  +    +           + I +A ++A
Sbjct: 86  LGVVS----KGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 523 CALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKG--T 580
             + YL+        H DL   N ++ H+ T  + DFG+ + +          G KG   
Sbjct: 141 DGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI--YETDYYRKGGKGLLP 195
Query: 581 IGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
           + ++AP     G   + + D++S+G++L E+ +
Sbjct: 196 VRWMAPESLKDGV-FTTSSDMWSFGVVLWEITS 227

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 411 GSFGSVYKGI-LDEGKTI-IAVKVLNLLHH---GASKSSIAECSALRNIRHKNLVKILTV 465
           G+FG+VYKG+ + EG+ + I V ++ L       A+K  + E   + ++ + ++ ++L +
Sbjct: 60  GAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 119
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
           C     +      L+ + M  G L          D   E    +     +N  + +A  +
Sbjct: 120 CLTSTVQ------LITQLMPFGCL---------LDYVREHKDNIGSQYLLNWCVQIAKGM 164
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            YL         H DL   NVL+       + DFGLAKLL     +  + G K  I ++A
Sbjct: 165 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 221
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMT 613
             E  L    +   DV+SYG+ + ELMT
Sbjct: 222 -LESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 98/242 (40%), Gaps = 39/242 (16%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVL---NLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           G FG+VY     + K I+A+KVL    L   G       E     ++RH N++++     
Sbjct: 24  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL----- 78
Query: 468 GVDYKGDDFKA-LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI-DVACAL 525
              Y  D  +  L+ E+   G + + L  +S  D+           QR    I ++A AL
Sbjct: 79  -YGYFHDATRVYLILEYAPRGEVYKELQKLSKFDE-----------QRTATYITELANAL 126
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            Y H        H D+KP N+LL       +ADFG +   P     +    + GT+ Y+ 
Sbjct: 127 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRXXLXGTLDYL- 178
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART-----VLPDHV 640
           P E   G       D++S G+L  E +  K P    FE N     + R        PD V
Sbjct: 179 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFV 234
Query: 641 MD 642
            +
Sbjct: 235 TE 236

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 97/213 (45%), Gaps = 23/213 (10%)
Query: 411 GSFGSVYKG-----ILDEGKTIIAVKVLNLLHHGASKSSIA---ECSALRNIRHKNLVKI 462
           GSFG VY+G     I  E +T +AVK +N     + +  I    E S ++     ++V++
Sbjct: 27  GSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHVVRL 84
Query: 463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVA 522
           L V S    KG     +V E M +G L+ +L  +    +           + I +A ++A
Sbjct: 85  LGVVS----KGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 139
Query: 523 CALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKG--T 580
             + YL+        H DL   N ++ H+ T  + DFG+ + +          G KG   
Sbjct: 140 DGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI--YETDYYRKGGKGLLP 194
Query: 581 IGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
           + ++AP     G   + + D++S+G++L E+ +
Sbjct: 195 VRWMAPESLKDGV-FTTSSDMWSFGVVLWEITS 226

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 101/215 (46%), Gaps = 27/215 (12%)
Query: 411 GSFGSVYKGIL-----DEGKTIIAVKVLNLLHHGASKSSIA---ECSALRNIRHKNLVKI 462
           GSFG VY+G+      DE +T +A+K +N     + +  I    E S ++     ++V++
Sbjct: 30  GSFGMVYEGVAKGVVKDEPETRVAIKTVN--EAASMRERIEFLNEASVMKEFNCHHVVRL 87
Query: 463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGA--DKTVEAPKCLNFLQRINIAID 520
           L V S    +G     ++ E M  G L+ +L  +     +  V AP  L+  + I +A +
Sbjct: 88  LGVVS----QGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAGE 140
Query: 521 VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKG- 579
           +A  + YL+ +      H DL   N ++  + T  + DFG+ + +          G KG 
Sbjct: 141 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI--XETDXXRKGGKGL 195
Query: 580 -TIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             + +++P     G   +   DV+S+G++L E+ T
Sbjct: 196 LPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIAT 229

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 99/242 (40%), Gaps = 39/242 (16%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVL---NLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           G FG+VY     + K I+A+KVL    L   G       E     ++RH N++++     
Sbjct: 20  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL----- 74
Query: 468 GVDYKGDDFKA-LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI-DVACAL 525
              Y  D  +  L+ E+   G++   L  +S  D+           QR    I ++A AL
Sbjct: 75  -YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----------QRTATYITELANAL 122
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            Y H        H D+KP N+LL       +ADFG +   P +   T S    GT+ Y+ 
Sbjct: 123 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLS----GTLDYL- 174
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART-----VLPDHV 640
           P E   G       D++S G+L  E +  K P    FE N     + R        PD V
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFV 230
Query: 641 MD 642
            +
Sbjct: 231 TE 232

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 104/239 (43%), Gaps = 24/239 (10%)
Query: 380 TIAVKLAAAIISVLVGILLFVSFLFLCWIDMGSFGSVYKGI-LDEGKTI---IAVKVLN- 434
            + ++   A    L+ IL    F  +  +  G+FG+VYKG+ + EG+ +   +A+K L  
Sbjct: 2   AMGIRSGEAPNQALLRILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 61
Query: 435 LLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLH 494
                A+K  + E   + ++ + ++ ++L +C     +      L+ + M  G L     
Sbjct: 62  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LIMQLMPFGCL----- 110
Query: 495 PVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTA 554
                D   E    +     +N  + +A  + YL         H DL   NVL+      
Sbjct: 111 ----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 163
Query: 555 HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
            + DFGLAKLL     +  + G K  I ++A  E  L    +   DV+SYG+ + ELMT
Sbjct: 164 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMA-LESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 104/239 (43%), Gaps = 24/239 (10%)
Query: 380 TIAVKLAAAIISVLVGILLFVSFLFLCWIDMGSFGSVYKGI-LDEGKTI---IAVKVLN- 434
            + ++   A    L+ IL    F  +  +  G+FG+VYKG+ + EG+ +   +A+K L  
Sbjct: 2   AMGIRSGEAPNQALLRILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 61
Query: 435 LLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLH 494
                A+K  + E   + ++ + ++ ++L +C     +      L+ + M  G L     
Sbjct: 62  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCL----- 110
Query: 495 PVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTA 554
                D   E    +     +N  + +A  + YL         H DL   NVL+      
Sbjct: 111 ----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 163
Query: 555 HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
            + DFGLAKLL     +  + G K  I ++A  E  L    +   DV+SYG+ + ELMT
Sbjct: 164 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMA-LESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 97/221 (43%), Gaps = 27/221 (12%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTV 465
           I  G++G+V+K    E   I+A+K + L     G   S++ E   L+ ++HKN+V++  V
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                   D    LV+EF  +  L+++    +G D   E  K   F         +   L
Sbjct: 70  LHS-----DKKLTLVFEFC-DQDLKKYFDSCNG-DLDPEIVKSFLF--------QLLKGL 114
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP-PAHLQTSSIGVKGTIGYI 584
            + H        H DLKP N+L++      +ADFGLA+    P    ++ +    T+ Y 
Sbjct: 115 GFCHSR---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEV---VTLWYR 168
Query: 585 APAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGN 625
            P         S + D++S G +  EL    RP   +F GN
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAARP---LFPGN 206

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 411 GSFGSVYKGI-LDEGKTI---IAVKVLNL-LHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G+FG+VYKGI + +G+ +   +A+KVL       A+K  + E   +  +    + ++L +
Sbjct: 28  GAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRLLGI 87
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
           C     +      LV + M  G L          D   E    L     +N  + +A  +
Sbjct: 88  CLTSTVQ------LVTQLMPYGCL---------LDHVRENRGRLGSQDLLNWCMQIAKGM 132
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            YL  D +    H DL   NVL+       + DFGLA+LL     +  + G K  I ++A
Sbjct: 133 SYLE-DVR--LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMA 189
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMT 613
             E  L    +   DV+SYG+ + ELMT
Sbjct: 190 -LESILRRRFTHQSDVWSYGVTVWELMT 216

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 411 GSFGSVYKGI-LDEGKTI---IAVKVLN-LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G+FG+VYKG+ + EG+ +   +A+K L       A+K  + E   + ++ + ++ ++L +
Sbjct: 27  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 86
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
           C     +      L+ + M  G L          D   E    +     +N  + +A  +
Sbjct: 87  CLTSTVQ------LIMQLMPFGXL---------LDYVREHKDNIGSQYLLNWCVQIAKGM 131
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            YL         H DL   NVL+       + DFGLAKLL     +  + G K  I ++A
Sbjct: 132 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 188
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMT 613
             E  L    +   DV+SYG+ + ELMT
Sbjct: 189 -LESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 107/230 (46%), Gaps = 29/230 (12%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNLVKILTV 465
           I  G++G VYK        ++A+K + L     G   ++I E S L+ + H N+VK+L V
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                   ++   LV+E +H   L+ ++   + A   +  P   ++L ++   +    + 
Sbjct: 70  IHT-----ENKLYLVFEHVHQ-DLKTFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL-PPAHLQTSSIGVKGTIGYI 584
           + LH D         LKP N+L++ E    +ADFGLA+    P    T  +    T+ Y 
Sbjct: 122 RVLHRD---------LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV---VTLWYR 169
Query: 585 APAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFAR 633
           AP E  LG +  S   D++S G +  E++TR+     +F G+  +    R
Sbjct: 170 AP-EILLGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFR 214

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 411 GSFGSVYKGI-LDEGKTI---IAVKVLN-LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G+FG+VYKG+ + EG+ +   +A+K L       A+K  + E   + ++ + ++ ++L +
Sbjct: 30  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 89
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
           C     +      L+ + M  G L          D   E    +     +N  + +A  +
Sbjct: 90  CLTSTVQ------LIMQLMPFGCL---------LDYVREHKDNIGSQYLLNWCVQIAKGM 134
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            YL         H DL   NVL+       + DFGLAKLL     +  + G K  I ++A
Sbjct: 135 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 191
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMT 613
             E  L    +   DV+SYG+ + ELMT
Sbjct: 192 -LESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 99/242 (40%), Gaps = 39/242 (16%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVL---NLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           G FG+VY     + K I+A+KVL    L   G       E     ++RH N++++     
Sbjct: 24  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL----- 78
Query: 468 GVDYKGDDFKA-LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI-DVACAL 525
              Y  D  +  L+ E+   G++   L  +S  D+           QR    I ++A AL
Sbjct: 79  -YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----------QRTATYITELANAL 126
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            Y H        H D+KP N+LL       +ADFG +   P +   T    + GT+ Y+ 
Sbjct: 127 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDYL- 178
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART-----VLPDHV 640
           P E   G       D++S G+L  E +  K P    FE N     + R        PD V
Sbjct: 179 PPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFV 234
Query: 641 MD 642
            +
Sbjct: 235 TE 236

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 99/242 (40%), Gaps = 39/242 (16%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVL---NLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           G FG+VY     + K I+A+KVL    L   G       E     ++RH N++++     
Sbjct: 45  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL----- 99
Query: 468 GVDYKGDDFKA-LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI-DVACAL 525
              Y  D  +  L+ E+   G++   L  +S  D+           QR    I ++A AL
Sbjct: 100 -YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----------QRTATYITELANAL 147
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            Y H        H D+KP N+LL       +ADFG +   P +   T    + GT+ Y+ 
Sbjct: 148 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDYL- 199
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART-----VLPDHV 640
           P E   G       D++S G+L  E +  K P    FE N     + R        PD V
Sbjct: 200 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFV 255
Query: 641 MD 642
            +
Sbjct: 256 TE 257

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 99/242 (40%), Gaps = 39/242 (16%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVL---NLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           G FG+VY     + K I+A+KVL    L   G       E     ++RH N++++     
Sbjct: 22  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL----- 76
Query: 468 GVDYKGDDFKA-LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI-DVACAL 525
              Y  D  +  L+ E+   G++   L  +S  D+           QR    I ++A AL
Sbjct: 77  -YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----------QRTATYITELANAL 124
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            Y H        H D+KP N+LL       +ADFG +   P +   T    + GT+ Y+ 
Sbjct: 125 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDYL- 176
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART-----VLPDHV 640
           P E   G       D++S G+L  E +  K P    FE N     + R        PD V
Sbjct: 177 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFV 232
Query: 641 MD 642
            +
Sbjct: 233 TE 234

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 99/242 (40%), Gaps = 39/242 (16%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVL---NLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           G FG+VY     + K I+A+KVL    L   G       E     ++RH N++++     
Sbjct: 20  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL----- 74
Query: 468 GVDYKGDDFKA-LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI-DVACAL 525
              Y  D  +  L+ E+   G++   L  +S  D+           QR    I ++A AL
Sbjct: 75  -YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----------QRTATYITELANAL 122
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            Y H        H D+KP N+LL       +ADFG +   P +   T    + GT+ Y+ 
Sbjct: 123 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDT----LCGTLDYL- 174
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART-----VLPDHV 640
           P E   G       D++S G+L  E +  K P    FE N     + R        PD V
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFV 230
Query: 641 MD 642
            +
Sbjct: 231 TE 232

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 411 GSFGSVYKGI-LDEGKTI---IAVKVLN-LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G+FG+VYKG+ + EG+ +   +A+K L       A+K  + E   + ++ + ++ ++L +
Sbjct: 26  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 85
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
           C     +      L+ + M  G L          D   E    +     +N  + +A  +
Sbjct: 86  CLTSTVQ------LIMQLMPFGCL---------LDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            YL         H DL   NVL+       + DFGLAKLL     +  + G K  I ++A
Sbjct: 131 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMT 613
             E  L    +   DV+SYG+ + ELMT
Sbjct: 188 -LESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 411 GSFGSVYKGI-LDEGKTI---IAVKVLN-LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G+FG+VYKG+ + EG+ +   +A+K L       A+K  + E   + ++ + ++ ++L +
Sbjct: 29  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 88
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
           C     +      L+ + M  G L          D   E    +     +N  + +A  +
Sbjct: 89  CLTSTVQ------LIMQLMPFGCL---------LDYVREHKDNIGSQYLLNWCVQIAKGM 133
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            YL         H DL   NVL+       + DFGLAKLL     +  + G K  I ++A
Sbjct: 134 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMT 613
             E  L    +   DV+SYG+ + ELMT
Sbjct: 191 -LESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 100/228 (43%), Gaps = 24/228 (10%)
Query: 391 SVLVGILLFVSFLFLCWIDMGSFGSVYKGI-LDEGKTI---IAVKVLN-LLHHGASKSSI 445
             L+ IL    F  +  +  G+FG+VYKG+ + EG+ +   +A+K L       A+K  +
Sbjct: 6   QALLRILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL 65
Query: 446 AECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEA 505
            E   + ++ + ++ ++L +C     +      L+ + M  G L          D   E 
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCL---------LDYVREH 110
Query: 506 PKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL 565
              +     +N  + +A  + YL         H DL   NVL+       + DFGLAKLL
Sbjct: 111 KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167
Query: 566 PPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
                +  + G K  I ++A  E  L    +   DV+SYG+ + ELMT
Sbjct: 168 GAEEKEYHAEGGKVPIKWMA-LESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 99/242 (40%), Gaps = 39/242 (16%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVL---NLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           G FG+VY     + K I+A+KVL    L   G       E     ++RH N++++     
Sbjct: 19  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL----- 73
Query: 468 GVDYKGDDFKA-LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI-DVACAL 525
              Y  D  +  L+ E+   G++   L  +S  D+           QR    I ++A AL
Sbjct: 74  -YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----------QRTATYITELANAL 121
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            Y H        H D+KP N+LL       +ADFG +   P +   T    + GT+ Y+ 
Sbjct: 122 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDYL- 173
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART-----VLPDHV 640
           P E   G       D++S G+L  E +  K P    FE N     + R        PD V
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFV 229
Query: 641 MD 642
            +
Sbjct: 230 TE 231

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 99/242 (40%), Gaps = 39/242 (16%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVL---NLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           G FG+VY     + K I+A+KVL    L   G       E     ++RH N++++     
Sbjct: 24  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL----- 78
Query: 468 GVDYKGDDFKA-LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI-DVACAL 525
              Y  D  +  L+ E+   G++   L  +S  D+           QR    I ++A AL
Sbjct: 79  -YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----------QRTATYITELANAL 126
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            Y H        H D+KP N+LL       +ADFG +   P +   T    + GT+ Y+ 
Sbjct: 127 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDYL- 178
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART-----VLPDHV 640
           P E   G       D++S G+L  E +  K P    FE N     + R        PD V
Sbjct: 179 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFV 234
Query: 641 MD 642
            +
Sbjct: 235 TE 236

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 411 GSFGSVYKGI-LDEGKTI---IAVKVLN-LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G+FG+VYKG+ + EG+ +   +A+K L       A+K  + E   + ++ + ++ ++L +
Sbjct: 26  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 85
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
           C     +      L+ + M  G L          D   E    +     +N  + +A  +
Sbjct: 86  CLTSTVQ------LITQLMPFGXL---------LDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            YL         H DL   NVL+       + DFGLAKLL     +  + G K  I ++A
Sbjct: 131 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMT 613
             E  L    +   DV+SYG+ + ELMT
Sbjct: 188 -LESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 411 GSFGSVYKGI-LDEGKTI---IAVKVLN-LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G+FG+VYKG+ + EG+ +   +A+K L       A+K  + E   + ++ + ++ ++L +
Sbjct: 28  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 87
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
           C     +      L+ + M  G L          D   E    +     +N  + +A  +
Sbjct: 88  CLTSTVQ------LIMQLMPFGCL---------LDYVREHKDNIGSQYLLNWCVQIAKGM 132
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            YL         H DL   NVL+       + DFGLAKLL     +  + G K  I ++A
Sbjct: 133 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMT 613
             E  L    +   DV+SYG+ + ELMT
Sbjct: 190 -LESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 104/239 (43%), Gaps = 24/239 (10%)
Query: 380 TIAVKLAAAIISVLVGILLFVSFLFLCWIDMGSFGSVYKGI-LDEGKTI---IAVKVLN- 434
            + ++   A    L+ IL    F  +  +  G+FG+VYKG+ + EG+ +   +A+K L  
Sbjct: 2   AMGIRSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 61
Query: 435 LLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLH 494
                A+K  + E   + ++ + ++ ++L +C     +      L+ + M  G L     
Sbjct: 62  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCL----- 110
Query: 495 PVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTA 554
                D   E    +     +N  + +A  + YL         H DL   NVL+      
Sbjct: 111 ----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 163
Query: 555 HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
            + DFGLAKLL     +  + G K  I ++A  E  L    +   DV+SYG+ + ELMT
Sbjct: 164 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMA-LESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 27/210 (12%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHH-----GASKSSIAECSALRNIRHKNLVKILTV 465
           G F +VYK        I+A+K + L H      G +++++ E   L+ + H N++ +L  
Sbjct: 21  GQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLL-- 78
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                +K +   +LV++FM     E  L  +   +  V  P  +     + +       L
Sbjct: 79  -DAFGHKSN--ISLVFDFM-----ETDLEVIIKDNSLVLTPSHIKAYMLMTLQ-----GL 125
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
           +YLH   Q    H DLKP+N+LLD      +ADFGLAK     +       V  T  Y A
Sbjct: 126 EYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV--TRWYRA 180
Query: 586 PAEYGLGSEV-SINGDVYSYGILLLELMTR 614
           P E   G+ +  +  D+++ G +L EL+ R
Sbjct: 181 P-ELLFGARMYGVGVDMWAVGCILAELLLR 209

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 411 GSFGSVYKGI-LDEGKTI---IAVKVLN-LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G+FG+VYKG+ + EG+ +   +A+K L       A+K  + E   + ++ + ++ ++L +
Sbjct: 27  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 86
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
           C     +      L+ + M  G L          D   E    +     +N  + +A  +
Sbjct: 87  CLTSTVQ------LIMQLMPFGCL---------LDYVREHKDNIGSQYLLNWCVQIAKGM 131
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            YL         H DL   NVL+       + DFGLAKLL     +  + G K  I ++A
Sbjct: 132 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 188
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMT 613
             E  L    +   DV+SYG+ + ELMT
Sbjct: 189 -LESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 101/215 (46%), Gaps = 27/215 (12%)
Query: 411 GSFGSVYKGIL-----DEGKTIIAVKVLNLLHHGASKSSIA---ECSALRNIRHKNLVKI 462
           GSFG VY+G+      DE +T +A+K +N     + +  I    E S ++     ++V++
Sbjct: 29  GSFGMVYEGVAKGVVKDEPETRVAIKTVN--EAASMRERIEFLNEASVMKEFNCHHVVRL 86
Query: 463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGA--DKTVEAPKCLNFLQRINIAID 520
           L V S    +G     ++ E M  G L+ +L  +     +  V AP  L+  + I +A +
Sbjct: 87  LGVVS----QGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAGE 139
Query: 521 VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKG- 579
           +A  + YL+ +      H DL   N ++  + T  + DFG+ + +          G KG 
Sbjct: 140 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI--YETDYYRKGGKGL 194
Query: 580 -TIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             + +++P     G   +   DV+S+G++L E+ T
Sbjct: 195 LPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIAT 228

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 99/242 (40%), Gaps = 39/242 (16%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVL---NLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           G FG+VY     + K I+A+KVL    L   G       E     ++RH N++++     
Sbjct: 36  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL----- 90
Query: 468 GVDYKGDDFKA-LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI-DVACAL 525
              Y  D  +  L+ E+   G++   L  +S  D+           QR    I ++A AL
Sbjct: 91  -YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----------QRTATYITELANAL 138
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            Y H        H D+KP N+LL       +ADFG +   P +   T    + GT+ Y+ 
Sbjct: 139 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDYL- 190
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART-----VLPDHV 640
           P E   G       D++S G+L  E +  K P    FE N     + R        PD V
Sbjct: 191 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFV 246
Query: 641 MD 642
            +
Sbjct: 247 TE 248

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 411 GSFGSVYKGI-LDEGKTI---IAVKVLN-LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G+FG+VYKG+ + EG+ +   +A+K L       A+K  + E   + ++ + ++ ++L +
Sbjct: 26  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 85
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
           C     +      L+ + M  G L          D   E    +     +N  + +A  +
Sbjct: 86  CLTSTVQ------LITQLMPFGCL---------LDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            YL         H DL   NVL+       + DFGLAKLL     +  + G K  I ++A
Sbjct: 131 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMT 613
             E  L    +   DV+SYG+ + ELMT
Sbjct: 188 -LESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 101/215 (46%), Gaps = 27/215 (12%)
Query: 411 GSFGSVYKGIL-----DEGKTIIAVKVLNLLHHGASKSSIA---ECSALRNIRHKNLVKI 462
           GSFG VY+G+      DE +T +A+K +N     + +  I    E S ++     ++V++
Sbjct: 36  GSFGMVYEGVAKGVVKDEPETRVAIKTVN--EAASMRERIEFLNEASVMKEFNCHHVVRL 93
Query: 463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGA--DKTVEAPKCLNFLQRINIAID 520
           L V S    +G     ++ E M  G L+ +L  +     +  V AP  L+  + I +A +
Sbjct: 94  LGVVS----QGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAGE 146
Query: 521 VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKG- 579
           +A  + YL+ +      H DL   N ++  + T  + DFG+ + +          G KG 
Sbjct: 147 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI--YETDYYRKGGKGL 201
Query: 580 -TIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             + +++P     G   +   DV+S+G++L E+ T
Sbjct: 202 LPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIAT 235

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 100/217 (46%), Gaps = 29/217 (13%)
Query: 413 FGSVYKGIL-----DEGKTIIAVKVLNLLHHGASKSSIAECSALR-NIRHKNLVKILTVC 466
           FG VYKG L      E    +A+K L     G  +      + LR  ++H N+V +L V 
Sbjct: 39  FGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVV 98
Query: 467 SGVDYKGDDFKALVYEFMHNGSLEEWL-----HPVSGA---DKTVEAPKCLNFLQRINIA 518
           +      D   ++++ +  +G L E+L     H   G+   D+TV++   L     +++ 
Sbjct: 99  TK-----DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS--ALEPPDFVHLV 151
Query: 519 IDVACALKYL--HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIG 576
             +A  ++YL  HH       H DL   NVL+  ++   ++D GL + +  A        
Sbjct: 152 AQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 206
Query: 577 VKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
               I ++AP     G + SI+ D++SYG++L E+ +
Sbjct: 207 SLLPIRWMAPEAIMYG-KFSIDSDIWSYGVVLWEVFS 242

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 100/235 (42%), Gaps = 42/235 (17%)
Query: 402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVK 461
           F  L  I  GSFG VYKGI +  K ++A+K+++L         I +            + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQE-----------IT 69
Query: 462 ILTVCSG---VDYKGDDFKA----LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQR 514
           +L+ C       Y G   K+    ++ E++  GS  + L P          P    ++  
Sbjct: 70  VLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLKP---------GPLEETYIA- 119
Query: 515 INIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSS 574
             I  ++   L YLH + +    H D+K +NVLL  +    +ADFG+A  L    ++ + 
Sbjct: 120 -TILREILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNX 175
Query: 575 IGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLH 629
               GT  ++AP E    S      D++S GI  +EL   + P       N +LH
Sbjct: 176 F--VGTPFWMAP-EVIKQSAYDFKADIWSLGITAIELAKGEPP-------NSDLH 220

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 411 GSFGSVYKGI-LDEGKTI---IAVKVLN-LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G+FG+VYKG+ + EG+ +   +A+K L       A+K  + E   + ++ + ++ ++L +
Sbjct: 29  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 88
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
           C     +      L+ + M  G L          D   E    +     +N  + +A  +
Sbjct: 89  CLTSTVQ------LITQLMPFGCL---------LDYVREHKDNIGSQYLLNWCVQIAKGM 133
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            YL         H DL   NVL+       + DFGLAKLL     +  + G K  I ++A
Sbjct: 134 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMT 613
             E  L    +   DV+SYG+ + ELMT
Sbjct: 191 -LESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 411 GSFGSVYKGI-LDEGKTI---IAVKVLN-LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G+FG+VYKG+ + EG+ +   +A+K L       A+K  + E   + ++ + ++ ++L +
Sbjct: 28  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 87
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
           C     +      L+ + M  G L          D   E    +     +N  + +A  +
Sbjct: 88  CLTSTVQ------LITQLMPFGCL---------LDYVREHKDNIGSQYLLNWCVQIAKGM 132
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            YL         H DL   NVL+       + DFGLAKLL     +  + G K  I ++A
Sbjct: 133 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMT 613
             E  L    +   DV+SYG+ + ELMT
Sbjct: 190 -LESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 100/213 (46%), Gaps = 23/213 (10%)
Query: 411 GSFGSVYKGIL-----DEGKTIIAVKVLNLLHHGASK-SSIAECSALRNIRHKNLVKILT 464
           GSFG VY+G+      DE +T +A+K +N       +   + E S ++     ++V++L 
Sbjct: 23  GSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG 82
Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGA--DKTVEAPKCLNFLQRINIAIDVA 522
           V S    +G     ++ E M  G L+ +L  +     +  V AP  L+  + I +A ++A
Sbjct: 83  VVS----QGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAGEIA 135
Query: 523 CALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKG--T 580
             + YL+ +      H DL   N ++  + T  + DFG+ + +          G KG   
Sbjct: 136 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK--GGKGLLP 190
Query: 581 IGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
           + +++P     G   +   DV+S+G++L E+ T
Sbjct: 191 VRWMSPESLKDGV-FTTYSDVWSFGVVLWEIAT 222

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 411 GSFGSVYKGI-LDEGKTI---IAVKVLN-LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G+FG+VYKG+ + EG+ +   +A+K L       A+K  + E   + ++ + ++ ++L +
Sbjct: 26  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 85
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
           C     +      L+ + M  G L          D   E    +     +N  + +A  +
Sbjct: 86  CLTSTVQ------LITQLMPFGCL---------LDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            YL         H DL   NVL+       + DFGLAKLL     +  + G K  I ++A
Sbjct: 131 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMT 613
             E  L    +   DV+SYG+ + ELMT
Sbjct: 188 -LESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 101/215 (46%), Gaps = 27/215 (12%)
Query: 411 GSFGSVYKGIL-----DEGKTIIAVKVLNLLHHGASKSSIA---ECSALRNIRHKNLVKI 462
           GSFG VY+G+      DE +T +A+K +N     + +  I    E S ++     ++V++
Sbjct: 27  GSFGMVYEGVAKGVVKDEPETRVAIKTVN--EAASMRERIEFLNEASVMKEFNCHHVVRL 84
Query: 463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGA--DKTVEAPKCLNFLQRINIAID 520
           L V S    +G     ++ E M  G L+ +L  +     +  V AP  L+  + I +A +
Sbjct: 85  LGVVS----QGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAGE 137
Query: 521 VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKG- 579
           +A  + YL+ +      H DL   N ++  + T  + DFG+ + +          G KG 
Sbjct: 138 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK--GGKGL 192
Query: 580 -TIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             + +++P     G   +   DV+S+G++L E+ T
Sbjct: 193 LPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIAT 226

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 100/228 (43%), Gaps = 24/228 (10%)
Query: 391 SVLVGILLFVSFLFLCWIDMGSFGSVYKGI-LDEGKTI---IAVKVLN-LLHHGASKSSI 445
             L+ IL    F  +  +  G+FG+VYKG+ + EG+ +   +A+K L       A+K  +
Sbjct: 31  QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL 90
Query: 446 AECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEA 505
            E   + ++ + ++ ++L +C     +      L+ + M  G L          D   E 
Sbjct: 91  DEAYVMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCL---------LDYVREH 135
Query: 506 PKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL 565
              +     +N  + +A  + YL         H DL   NVL+       + DFGLAKLL
Sbjct: 136 KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 192
Query: 566 PPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
                +  + G K  I ++A  E  L    +   DV+SYG+ + ELMT
Sbjct: 193 GAEEKEYHAEGGKVPIKWMA-LESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 92/215 (42%), Gaps = 36/215 (16%)
Query: 411 GSFGSV----YKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVK 461
           G FG V    Y    D    ++AVK L       L  G  +    E   LR + H+++VK
Sbjct: 19  GHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQR----EIEILRTLYHEHIVK 74
Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPK-CLNFLQRINIAID 520
               C     +G+    LV E++  GSL ++L            P+ C+   Q +  A  
Sbjct: 75  YKGCCED---QGEKSVQLVMEYVPLGSLRDYL------------PRHCVGLAQLLLFAQQ 119
Query: 521 VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGT 580
           +   + YLH        H  L   NVLLD++    + DFGLAK +P  H +   +   G 
Sbjct: 120 ICEGMAYLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGH-EYYRVREDGD 175
Query: 581 --IGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             + + AP E     +     DV+S+G+ L EL+T
Sbjct: 176 SPVFWYAP-ECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 411 GSFGSVYKGI-LDEGKTI---IAVKVLN-LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G+FG+VYKG+ + EG+ +   +A+K L       A+K  + E   + ++ + ++ ++L +
Sbjct: 29  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 88
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
           C     +      L+ + M  G L          D   E    +     +N  + +A  +
Sbjct: 89  CLTSTVQ------LITQLMPFGCL---------LDYVREHKDNIGSQYLLNWCVQIAKGM 133
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            YL         H DL   NVL+       + DFGLAKLL     +  + G K  I ++A
Sbjct: 134 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMT 613
             E  L    +   DV+SYG+ + ELMT
Sbjct: 191 -LESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 92/215 (42%), Gaps = 36/215 (16%)
Query: 411 GSFGSV----YKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVK 461
           G FG V    Y    D    ++AVK L       L  G  +    E   LR + H+++VK
Sbjct: 20  GHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQR----EIEILRTLYHEHIVK 75
Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPK-CLNFLQRINIAID 520
               C     +G+    LV E++  GSL ++L            P+ C+   Q +  A  
Sbjct: 76  YKGCCED---QGEKSVQLVMEYVPLGSLRDYL------------PRHCVGLAQLLLFAQQ 120
Query: 521 VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGT 580
           +   + YLH        H  L   NVLLD++    + DFGLAK +P  H +   +   G 
Sbjct: 121 ICEGMAYLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGH-EYYRVREDGD 176
Query: 581 --IGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             + + AP E     +     DV+S+G+ L EL+T
Sbjct: 177 SPVFWYAP-ECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 99/242 (40%), Gaps = 39/242 (16%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVL---NLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           G FG+VY     + K I+A+KVL    L   G       E     ++RH N++++     
Sbjct: 18  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL----- 72
Query: 468 GVDYKGDDFKA-LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI-DVACAL 525
              Y  D  +  L+ E+   G++   L  +S  D+           QR    I ++A AL
Sbjct: 73  -YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----------QRTATYITELANAL 120
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            Y H        H D+KP N+LL       +ADFG +   P +   T    + GT+ Y+ 
Sbjct: 121 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDYL- 172
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART-----VLPDHV 640
           P E   G       D++S G+L  E +  K P    FE N     + R        PD V
Sbjct: 173 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFV 228
Query: 641 MD 642
            +
Sbjct: 229 TE 230

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 411 GSFGSVYKGI-LDEGKTI---IAVKVLN-LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G+FG+VYKG+ + EG+ +   +A+K L       A+K  + E   + ++ + ++ ++L +
Sbjct: 36  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 95
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
           C     +      L+ + M  G L          D   E    +     +N  + +A  +
Sbjct: 96  CLTSTVQ------LITQLMPFGCL---------LDYVREHKDNIGSQYLLNWCVQIAKGM 140
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            YL         H DL   NVL+       + DFGLAKLL     +  + G K  I ++A
Sbjct: 141 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 197
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMT 613
             E  L    +   DV+SYG+ + ELMT
Sbjct: 198 -LESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 411 GSFGSVYKGI-LDEGKTI---IAVKVLN-LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G+FG+VYKG+ + EG+ +   +A+K L       A+K  + E   + ++ + ++ ++L +
Sbjct: 29  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 88
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
           C     +      L+ + M  G L          D   E    +     +N  + +A  +
Sbjct: 89  CLTSTVQ------LITQLMPFGCL---------LDYVREHKDNIGSQYLLNWCVQIAKGM 133
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            YL         H DL   NVL+       + DFGLAKLL     +  + G K  I ++A
Sbjct: 134 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMT 613
             E  L    +   DV+SYG+ + ELMT
Sbjct: 191 -LESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 101/215 (46%), Gaps = 27/215 (12%)
Query: 411 GSFGSVYKGIL-----DEGKTIIAVKVLNLLHHGASKSSIA---ECSALRNIRHKNLVKI 462
           GSFG VY+G+      DE +T +A+K +N     + +  I    E S ++     ++V++
Sbjct: 29  GSFGMVYEGVAKGVVKDEPETRVAIKTVN--EAASMRERIEFLNEASVMKEFNCHHVVRL 86
Query: 463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGA--DKTVEAPKCLNFLQRINIAID 520
           L V S    +G     ++ E M  G L+ +L  +     +  V AP  L+  + I +A +
Sbjct: 87  LGVVS----QGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAGE 139
Query: 521 VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKG- 579
           +A  + YL+ +      H DL   N ++  + T  + DFG+ + +          G KG 
Sbjct: 140 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK--GGKGL 194
Query: 580 -TIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             + +++P     G   +   DV+S+G++L E+ T
Sbjct: 195 LPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIAT 228

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 91/213 (42%), Gaps = 32/213 (15%)
Query: 411 GSFGSV----YKGILDEGKTIIAVKVLNLLHHGASKSSIA-ECSALRNIRHKNLVKILTV 465
           G FG V    Y    D    ++AVK L        +S    E   LR + H++++K    
Sbjct: 42  GHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGC 101
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
           C      G     LV E++  GSL ++L        ++   + L F Q+I   +    A 
Sbjct: 102 CEDA---GAASLQLVMEYVPLGSLRDYL-----PRHSIGLAQLLLFAQQICEGMAYLHAQ 153
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGT--IGY 583
            Y+H D         L   NVLLD++    + DFGLAK +P  H +   +   G   + +
Sbjct: 154 HYIHRD---------LAARNVLLDNDRLVKIGDFGLAKAVPEGH-EXYRVREDGDSPVFW 203
Query: 584 IAP---AEYGLGSEVSINGDVYSYGILLLELMT 613
            AP    EY    +     DV+S+G+ L EL+T
Sbjct: 204 YAPECLKEY----KFYYASDVWSFGVTLYELLT 232

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 100/213 (46%), Gaps = 23/213 (10%)
Query: 411 GSFGSVYKGIL-----DEGKTIIAVKVLNLLHHGASK-SSIAECSALRNIRHKNLVKILT 464
           GSFG VY+G+      DE +T +A+K +N       +   + E S ++     ++V++L 
Sbjct: 30  GSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG 89
Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGA--DKTVEAPKCLNFLQRINIAIDVA 522
           V S    +G     ++ E M  G L+ +L  +     +  V AP  L+  + I +A ++A
Sbjct: 90  VVS----QGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAGEIA 142
Query: 523 CALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKG--T 580
             + YL+ +      H DL   N ++  + T  + DFG+ + +          G KG   
Sbjct: 143 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK--GGKGLLP 197
Query: 581 IGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
           + +++P     G   +   DV+S+G++L E+ T
Sbjct: 198 VRWMSPESLKDGV-FTTYSDVWSFGVVLWEIAT 229

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 101/215 (46%), Gaps = 27/215 (12%)
Query: 411 GSFGSVYKGIL-----DEGKTIIAVKVLNLLHHGASKSSIA---ECSALRNIRHKNLVKI 462
           GSFG VY+G+      DE +T +A+K +N     + +  I    E S ++     ++V++
Sbjct: 58  GSFGMVYEGVAKGVVKDEPETRVAIKTVN--EAASMRERIEFLNEASVMKEFNCHHVVRL 115
Query: 463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGA--DKTVEAPKCLNFLQRINIAID 520
           L V S    +G     ++ E M  G L+ +L  +     +  V AP  L+  + I +A +
Sbjct: 116 LGVVS----QGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAGE 168
Query: 521 VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKG- 579
           +A  + YL+ +      H DL   N ++  + T  + DFG+ + +          G KG 
Sbjct: 169 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK--GGKGL 223
Query: 580 -TIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             + +++P     G   +   DV+S+G++L E+ T
Sbjct: 224 LPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIAT 257

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 94/215 (43%), Gaps = 16/215 (7%)
Query: 401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKN 458
            +  L  I  GS+G   K        I+  K L+   +     +  ++E + LR ++H N
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 459 LVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIA 518
           +V+       +D + +    +V E+   G L       S   K  +  + L+    + + 
Sbjct: 67  IVRYYDRI--ID-RTNTTLYIVMEYCEGGDL------ASVITKGTKERQYLDEEFVLRVM 117
Query: 519 IDVACALKYLHH--DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIG 576
             +  ALK  H   D   T  H DLKP+NV LD +    + DFGLA++L   H  + +  
Sbjct: 118 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKA 175
Query: 577 VKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLEL 611
             GT  Y++P +    S  +   D++S G LL EL
Sbjct: 176 FVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYEL 209

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 38/216 (17%)
Query: 411 GSFGSV----YKGILDEGKTIIAVKVLNL----LHHGASKSSIAECSALRNIRHKNLVKI 462
           G FG V    Y    D    ++AVK L       H    K  I     LR + H++++K 
Sbjct: 25  GHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEI---DILRTLYHEHIIKY 81
Query: 463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVA 522
              C     +G+    LV E++  GSL ++L        ++   + L F Q+I   +   
Sbjct: 82  KGCCED---QGEKSLQLVMEYVPLGSLRDYL-----PRHSIGLAQLLLFAQQICEGMAYL 133
Query: 523 CALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGT-- 580
            A  Y+H +         L   NVLLD++    + DFGLAK +P  H +   +   G   
Sbjct: 134 HAQHYIHRN---------LAARNVLLDNDRLVKIGDFGLAKAVPEGH-EYYRVREDGDSP 183
Query: 581 IGYIAP---AEYGLGSEVSINGDVYSYGILLLELMT 613
           + + AP    EY    +     DV+S+G+ L EL+T
Sbjct: 184 VFWYAPECLKEY----KFYYASDVWSFGVTLYELLT 215

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 99/242 (40%), Gaps = 39/242 (16%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVL---NLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           G FG+VY     + K I+A+KVL    L   G       E     ++RH N++++     
Sbjct: 23  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL----- 77
Query: 468 GVDYKGDDFKA-LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI-DVACAL 525
              Y  D  +  L+ E+   G++   L  +S  D+           QR    I ++A AL
Sbjct: 78  -YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----------QRTATYITELANAL 125
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            Y H        H D+KP N+LL       +ADFG +   P +   T    + GT+ Y+ 
Sbjct: 126 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDYL- 177
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART-----VLPDHV 640
           P E   G       D++S G+L  E +  K P    FE N     + R        PD V
Sbjct: 178 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFV 233
Query: 641 MD 642
            +
Sbjct: 234 TE 235

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 411 GSFGSVYKGI-LDEGKTI---IAVKVLN-LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G+FG+VYKG+ + EG+ +   +A+K L       A+K  + E   + ++ + ++ ++L +
Sbjct: 32  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 91
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
           C     +      L+ + M  G L          D   E    +     +N  + +A  +
Sbjct: 92  CLTSTVQ------LITQLMPFGCL---------LDYVREHKDNIGSQYLLNWCVQIAKGM 136
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            YL         H DL   NVL+       + DFGLAKLL     +  + G K  I ++A
Sbjct: 137 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 193
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMT 613
             E  L    +   DV+SYG+ + ELMT
Sbjct: 194 -LESILHRIYTHQSDVWSYGVTVWELMT 220

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 46/209 (22%)
Query: 429 AVKVLNLLHHGA---------SKSSIAECSALRNIR-HKNLVKILTVCSGVDYKGDDFKA 478
           AVK++++   G+          ++++ E   LR +  H N++++        Y+ + F  
Sbjct: 46  AVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT-----YETNTFFF 100
Query: 479 LVYEFMHNGSLEEWL-HPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTA 537
           LV++ M  G L ++L   V+ ++K  E  K +  L      ++V CAL  L+        
Sbjct: 101 LVFDLMKKGELFDYLTEKVTLSEK--ETRKIMRAL------LEVICALHKLN------IV 146
Query: 538 HCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPA---------E 588
           H DLKP N+LLD +M   + DFG +  L P     S   V GT  Y+AP           
Sbjct: 147 HRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRS---VCGTPSYLAPEIIECSMNDNH 203
Query: 589 YGLGSEVSINGDVYSYGILLLELMTRKRP 617
            G G EV    D++S G+++  L+    P
Sbjct: 204 PGYGKEV----DMWSTGVIMYTLLAGSPP 228

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 112/242 (46%), Gaps = 33/242 (13%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNLVKILTV 465
           I  G++G VYK        ++A+K + L     G   ++I E S L+ + H N+VK+L V
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                   ++   LV+EF+ +  L++++   + A   +  P   ++L ++   +    + 
Sbjct: 73  IHT-----ENKLYLVFEFL-SMDLKDFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP-PAHLQTSSIGVKGTIGYI 584
           + LH D         LKP N+L++ E    +ADFGLA+    P       +    T+ Y 
Sbjct: 125 RVLHRD---------LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VTLWYR 172
Query: 585 APAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV----LPDH 639
           AP E  LG +  S   D++S G +  E++TR+     +F G+  +    R       PD 
Sbjct: 173 AP-EILLGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRIFRTLGTPDE 227
Query: 640 VM 641
           V+
Sbjct: 228 VV 229

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 100/217 (46%), Gaps = 29/217 (13%)
Query: 413 FGSVYKGIL-----DEGKTIIAVKVLNLLHHGASKSSIAECSALR-NIRHKNLVKILTVC 466
           FG VYKG L      E    +A+K L     G  +      + LR  ++H N+V +L V 
Sbjct: 22  FGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVV 81
Query: 467 SGVDYKGDDFKALVYEFMHNGSLEEWL-----HPVSGA---DKTVEAPKCLNFLQRINIA 518
           +      D   ++++ +  +G L E+L     H   G+   D+TV++   L     +++ 
Sbjct: 82  TK-----DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS--ALEPPDFVHLV 134
Query: 519 IDVACALKYL--HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIG 576
             +A  ++YL  HH       H DL   NVL+  ++   ++D GL + +  A        
Sbjct: 135 AQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189
Query: 577 VKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
               I ++AP     G + SI+ D++SYG++L E+ +
Sbjct: 190 SLLPIRWMAPEAIMYG-KFSIDSDIWSYGVVLWEVFS 225

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 99/242 (40%), Gaps = 39/242 (16%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVL---NLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           G FG+VY     + K I+A+KVL    L   G       E     ++RH N++++     
Sbjct: 22  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL----- 76
Query: 468 GVDYKGDDFKA-LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI-DVACAL 525
              Y  D  +  L+ E+   G++   L  +S  D+           QR    I ++A AL
Sbjct: 77  -YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----------QRTATYITELANAL 124
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            Y H        H D+KP N+LL       +ADFG +   P +   T    + GT+ Y+ 
Sbjct: 125 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDYL- 176
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART-----VLPDHV 640
           P E   G       D++S G+L  E +  K P    FE N     + R        PD V
Sbjct: 177 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFV 232
Query: 641 MD 642
            +
Sbjct: 233 TE 234

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 112/242 (46%), Gaps = 33/242 (13%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNLVKILTV 465
           I  G++G VYK        ++A+K + L     G   ++I E S L+ + H N+VK+L V
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                   ++   LV+EF+ +  L++++   + A   +  P   ++L ++   +    + 
Sbjct: 74  IHT-----ENKLYLVFEFL-SMDLKDFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL-PPAHLQTSSIGVKGTIGYI 584
           + LH D         LKP N+L++ E    +ADFGLA+    P       +    T+ Y 
Sbjct: 126 RVLHRD---------LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VTLWYR 173
Query: 585 APAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV----LPDH 639
           AP E  LG +  S   D++S G +  E++TR+     +F G+  +    R       PD 
Sbjct: 174 AP-EILLGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRIFRTLGTPDE 228
Query: 640 VM 641
           V+
Sbjct: 229 VV 230

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 104/243 (42%), Gaps = 48/243 (19%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN--LLHHGASKSSIA-ECSALRNIRHKNLVKILTVCS 467
           GSFG V      + +  +A+K ++  LL        +  E S L+ +RH +++K+  V +
Sbjct: 20  GSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVIT 79
Query: 468 G-------VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAID 520
                   ++Y G +    + E                  K +   +   F Q+I     
Sbjct: 80  TPTDIVMVIEYAGGELFDYIVE-----------------KKRMTEDEGRRFFQQI----- 117
Query: 521 VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGT 580
             CA++Y H   +    H DLKP N+LLD  +   +ADFGL+ ++   +   +S    G+
Sbjct: 118 -ICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GS 170
Query: 581 IGYIAP----AEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNM-NLHNFARTV 635
             Y AP     +   G EV    DV+S GI+L  ++  + P D  F  N+    N    V
Sbjct: 171 PNYAAPEVINGKLYAGPEV----DVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYV 226
Query: 636 LPD 638
           +PD
Sbjct: 227 MPD 229

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 96/223 (43%), Gaps = 35/223 (15%)
Query: 402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVK 461
           F  L  I  GSFG V+KGI +  + ++A+K+++L             +       +  + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE-----------EAEDEIEDIQQEIT 77
Query: 462 ILTVCSG---VDYKGDDFK----ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQR 514
           +L+ C       Y G   K     ++ E++  GS  + L P          P  L+  Q 
Sbjct: 78  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP---------GP--LDETQI 126
Query: 515 INIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSS 574
             I  ++   L YLH + +    H D+K +NVLL       +ADFG+A  L    ++ ++
Sbjct: 127 ATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT 183
Query: 575 IGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
               GT  ++AP E    S      D++S GI  +EL   + P
Sbjct: 184 F--VGTPFWMAP-EVIKQSAYDSKADIWSLGITAIELARGEPP 223

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 411 GSFGSVYKGI-LDEGKTI---IAVKVLN-LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G+FG+VYKG+ + EG+ +   +A+K L       A+K  + E   + ++ + ++ ++L +
Sbjct: 20  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 79
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
           C     +      L+ + M  G L          D   E    +     +N  + +A  +
Sbjct: 80  CLTSTVQ------LITQLMPFGCL---------LDYVREHKDNIGSQYLLNWCVQIAKGM 124
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            YL         H DL   NVL+       + DFGLAKLL     +  + G K  I ++A
Sbjct: 125 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMT 613
             E  L    +   DV+SYG+ + ELMT
Sbjct: 182 -LESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 411 GSFGSVYKGI-LDEGKTI---IAVKVLN-LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G+FG+VYKG+ + EG+ +   +A+K L       A+K  + E   + ++ + ++ ++L +
Sbjct: 23  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 82
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
           C     +      L+ + M  G L          D   E    +     +N  + +A  +
Sbjct: 83  CLTSTVQ------LITQLMPFGCL---------LDYVREHKDNIGSQYLLNWCVQIAEGM 127
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            YL         H DL   NVL+       + DFGLAKLL     +  + G K  I ++A
Sbjct: 128 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 184
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMT 613
             E  L    +   DV+SYG+ + ELMT
Sbjct: 185 -LESILHRIYTHQSDVWSYGVTVWELMT 211

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 94/215 (43%), Gaps = 16/215 (7%)
Query: 401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKN 458
            +  L  I  GS+G   K        I+  K L+   +     +  ++E + LR ++H N
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 459 LVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIA 518
           +V+       +D + +    +V E+   G L       S   K  +  + L+    + + 
Sbjct: 67  IVRYYDRI--ID-RTNTTLYIVMEYCEGGDL------ASVITKGTKERQYLDEEFVLRVM 117
Query: 519 IDVACALKYLHH--DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIG 576
             +  ALK  H   D   T  H DLKP+NV LD +    + DFGLA++L   H +  +  
Sbjct: 118 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDEDFAKE 175
Query: 577 VKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLEL 611
             GT  Y++P +    S  +   D++S G LL EL
Sbjct: 176 FVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYEL 209

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 112/242 (46%), Gaps = 33/242 (13%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNLVKILTV 465
           I  G++G VYK        ++A+K + L     G   ++I E S L+ + H N+VK+L V
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                   ++   LV+EF+ +  L++++   + A   +  P   ++L ++   +    + 
Sbjct: 74  IHT-----ENKLYLVFEFL-SMDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP-PAHLQTSSIGVKGTIGYI 584
           + LH D         LKP N+L++ E    +ADFGLA+    P       +    T+ Y 
Sbjct: 126 RVLHRD---------LKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VTLWYR 173
Query: 585 APAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV----LPDH 639
           AP E  LG +  S   D++S G +  E++TR+     +F G+  +    R       PD 
Sbjct: 174 AP-EILLGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRIFRTLGTPDE 228
Query: 640 VM 641
           V+
Sbjct: 229 VV 230

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 98/242 (40%), Gaps = 39/242 (16%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVL---NLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           G FG+VY     + K I+A+KVL    L   G       E     ++RH N++++     
Sbjct: 22  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL----- 76
Query: 468 GVDYKGDDFKA-LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI-DVACAL 525
              Y  D  +  L+ E+   G++   L  +S  D+           QR    I ++A AL
Sbjct: 77  -YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----------QRTATYITELANAL 124
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            Y H        H D+KP N+LL       +ADFG +   P     +    + GT+ Y+ 
Sbjct: 125 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRAALCGTLDYL- 176
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART-----VLPDHV 640
           P E   G       D++S G+L  E +  K P    FE N     + R        PD V
Sbjct: 177 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFV 232
Query: 641 MD 642
            +
Sbjct: 233 TE 234

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 98/242 (40%), Gaps = 39/242 (16%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVL---NLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           G FG+VY     + K I+A+KVL    L   G       E     ++RH N++++     
Sbjct: 19  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL----- 73
Query: 468 GVDYKGDDFKA-LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI-DVACAL 525
              Y  D  +  L+ E+   G++   L  +S  D+           QR    I ++A AL
Sbjct: 74  -YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----------QRTATYITELANAL 121
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            Y H        H D+KP N+LL       +ADFG +   P     +    + GT+ Y+ 
Sbjct: 122 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRAALCGTLDYL- 173
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART-----VLPDHV 640
           P E   G       D++S G+L  E +  K P    FE N     + R        PD V
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFV 229
Query: 641 MD 642
            +
Sbjct: 230 TE 231

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 112/242 (46%), Gaps = 33/242 (13%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNLVKILTV 465
           I  G++G VYK        ++A+K + L     G   ++I E S L+ + H N+VK+L V
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                   ++   LV+EF+ +  L++++   + A   +  P   ++L ++   +    + 
Sbjct: 72  IHT-----ENKLYLVFEFL-SMDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP-PAHLQTSSIGVKGTIGYI 584
           + LH D         LKP N+L++ E    +ADFGLA+    P       +    T+ Y 
Sbjct: 124 RVLHRD---------LKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VTLWYR 171
Query: 585 APAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV----LPDH 639
           AP E  LG +  S   D++S G +  E++TR+     +F G+  +    R       PD 
Sbjct: 172 AP-EILLGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRIFRTLGTPDE 226
Query: 640 VM 641
           V+
Sbjct: 227 VV 228

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 99/242 (40%), Gaps = 39/242 (16%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVL---NLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           G FG+VY     + K I+A+KVL    L   G       E     ++RH N++++     
Sbjct: 16  GKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL----- 70
Query: 468 GVDYKGDDFKA-LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI-DVACAL 525
              Y  D  +  L+ E+   G++   L  +S  D+           QR    I ++A AL
Sbjct: 71  -YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----------QRTATYITELANAL 118
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            Y H        H D+KP N+LL       +ADFG +   P +   T    + GT+ Y+ 
Sbjct: 119 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDYL- 170
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART-----VLPDHV 640
           P E   G       D++S G+L  E +  K P    FE N     + R        PD V
Sbjct: 171 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFV 226
Query: 641 MD 642
            +
Sbjct: 227 TE 228

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 46/209 (22%)
Query: 429 AVKVLNLLHHGA---------SKSSIAECSALRNIR-HKNLVKILTVCSGVDYKGDDFKA 478
           AVK++++   G+          ++++ E   LR +  H N++++        Y+ + F  
Sbjct: 33  AVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT-----YETNTFFF 87
Query: 479 LVYEFMHNGSLEEWL-HPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTA 537
           LV++ M  G L ++L   V+ ++K  E  K +  L      ++V CAL  L+        
Sbjct: 88  LVFDLMKKGELFDYLTEKVTLSEK--ETRKIMRAL------LEVICALHKLN------IV 133
Query: 538 HCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPA---------E 588
           H DLKP N+LLD +M   + DFG +  L P         V GT  Y+AP           
Sbjct: 134 HRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE---VCGTPSYLAPEIIECSMNDNH 190
Query: 589 YGLGSEVSINGDVYSYGILLLELMTRKRP 617
            G G EV    D++S G+++  L+    P
Sbjct: 191 PGYGKEV----DMWSTGVIMYTLLAGSPP 215

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 98/242 (40%), Gaps = 39/242 (16%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVL---NLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           G FG+VY     + K I+A+KVL    L   G       E     ++RH N++++     
Sbjct: 19  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL----- 73
Query: 468 GVDYKGDDFKA-LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI-DVACAL 525
              Y  D  +  L+ E+   G++   L  +S  D+           QR    I ++A AL
Sbjct: 74  -YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----------QRTATYITELANAL 121
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            Y H        H D+KP N+LL       +ADFG +   P     +    + GT+ Y+ 
Sbjct: 122 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTDLCGTLDYL- 173
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART-----VLPDHV 640
           P E   G       D++S G+L  E +  K P    FE N     + R        PD V
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFV 229
Query: 641 MD 642
            +
Sbjct: 230 TE 231

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 94/215 (43%), Gaps = 16/215 (7%)
Query: 401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKN 458
            +  L  I  GS+G   K        I+  K L+   +     +  ++E + LR ++H N
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 459 LVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIA 518
           +V+       +D + +    +V E+   G L       S   K  +  + L+    + + 
Sbjct: 67  IVRYYDRI--ID-RTNTTLYIVMEYCEGGDL------ASVITKGTKERQYLDEEFVLRVM 117
Query: 519 IDVACALKYLHH--DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIG 576
             +  ALK  H   D   T  H DLKP+NV LD +    + DFGLA++L   H  + +  
Sbjct: 118 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKT 175
Query: 577 VKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLEL 611
             GT  Y++P +    S  +   D++S G LL EL
Sbjct: 176 FVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYEL 209

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 98/242 (40%), Gaps = 39/242 (16%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVL---NLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           G FG+VY     + K I+A+KVL    L   G       E     ++RH N++++     
Sbjct: 20  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL----- 74
Query: 468 GVDYKGDDFKA-LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI-DVACAL 525
              Y  D  +  L+ E+   G++   L  +S  D+           QR    I ++A AL
Sbjct: 75  -YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----------QRTATYITELANAL 122
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            Y H        H D+KP N+LL       +ADFG +   P     +    + GT+ Y+ 
Sbjct: 123 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTDLCGTLDYL- 174
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART-----VLPDHV 640
           P E   G       D++S G+L  E +  K P    FE N     + R        PD V
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFV 230
Query: 641 MD 642
            +
Sbjct: 231 TE 232

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 102/214 (47%), Gaps = 24/214 (11%)
Query: 411 GSFGSVYK----GILDEGKTI-IAVKVLNLLHHGASKSSI-AECSALRNI-RHKNLVKIL 463
           G+FG V +    G+  E   + +AVK+L    H   K ++ +E   + ++ +H+N+V +L
Sbjct: 49  GAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLL 108
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
             C+   + G     ++ E+   G L  +L   + AD   E  + L     ++ +  VA 
Sbjct: 109 GACT---HGGPVL--VITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQ 163
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGT--- 580
            + +L         H D+   NVLL +   A + DFGLA+ +    +  S+  VKG    
Sbjct: 164 GMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI----MNDSNYIVKGNARL 216
Query: 581 -IGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
            + ++AP E       ++  DV+SYGILL E+ +
Sbjct: 217 PVKWMAP-ESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 98/242 (40%), Gaps = 39/242 (16%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVL---NLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           G FG+VY     + K I+A+KVL    L   G       E     ++RH N++++     
Sbjct: 19  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL----- 73
Query: 468 GVDYKGDDFKA-LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI-DVACAL 525
              Y  D  +  L+ E+   G++   L  +S  D+           QR    I ++A AL
Sbjct: 74  -YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----------QRTATYITELANAL 121
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            Y H        H D+KP N+LL       +ADFG +   P     +    + GT+ Y+ 
Sbjct: 122 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTDLCGTLDYL- 173
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART-----VLPDHV 640
           P E   G       D++S G+L  E +  K P    FE N     + R        PD V
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFV 229
Query: 641 MD 642
            +
Sbjct: 230 TE 231

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 98/242 (40%), Gaps = 39/242 (16%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVL---NLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           G FG+VY     + K I+A+KVL    L   G       E     ++RH N++++     
Sbjct: 19  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL----- 73
Query: 468 GVDYKGDDFKA-LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI-DVACAL 525
              Y  D  +  L+ E+   G++   L  +S  D+           QR    I ++A AL
Sbjct: 74  -YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----------QRTATYITELANAL 121
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            Y H        H D+KP N+LL       +ADFG +   P     +    + GT+ Y+ 
Sbjct: 122 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTELCGTLDYL- 173
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART-----VLPDHV 640
           P E   G       D++S G+L  E +  K P    FE N     + R        PD V
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFV 229
Query: 641 MD 642
            +
Sbjct: 230 TE 231

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 87/218 (39%), Gaps = 41/218 (18%)
Query: 411 GSFGSV----YKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVC 466
           G+FGSV    Y  + D    ++AVK L        +    E   L+ +    +VK   V 
Sbjct: 18  GNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVS 77
Query: 467 SGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALK 526
            G    G     LV E++ +G L                    +FLQR    +D +  L 
Sbjct: 78  YG---PGRPELRLVMEYLPSGCLR-------------------DFLQRHRARLDASRLLL 115
Query: 527 YLHHDCQ-------PTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK- 578
           Y    C+           H DL   N+L++ E    +ADFGLAKLLP   L      V+ 
Sbjct: 116 YSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP---LDKDXXVVRE 172
Query: 579 ---GTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
                I + AP      +  S   DV+S+G++L EL T
Sbjct: 173 PGQSPIFWYAPESLS-DNIFSRQSDVWSFGVVLYELFT 209

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 91/216 (42%), Gaps = 38/216 (17%)
Query: 411 GSFGSV----YKGILDEGKTIIAVKVLNL----LHHGASKSSIAECSALRNIRHKNLVKI 462
           G FG V    Y    D    ++AVK L       H    K  I     LR + H++++K 
Sbjct: 25  GHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEI---DILRTLYHEHIIKY 81
Query: 463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVA 522
              C     +G+    LV E++  GSL ++L   S           +   Q +  A  + 
Sbjct: 82  KGCCED---QGEKSLQLVMEYVPLGSLRDYLPRHS-----------IGLAQLLLFAQQIC 127
Query: 523 CALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGT-- 580
             + YLH        H +L   NVLLD++    + DFGLAK +P  H +   +   G   
Sbjct: 128 EGMAYLH---SQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGH-EYYRVREDGDSP 183
Query: 581 IGYIAP---AEYGLGSEVSINGDVYSYGILLLELMT 613
           + + AP    EY    +     DV+S+G+ L EL+T
Sbjct: 184 VFWYAPECLKEY----KFYYASDVWSFGVTLYELLT 215

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 98/242 (40%), Gaps = 39/242 (16%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVL---NLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           G FG+VY     + K I+A+KVL    L   G       E     ++RH N++++     
Sbjct: 21  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL----- 75
Query: 468 GVDYKGDDFKA-LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI-DVACAL 525
              Y  D  +  L+ E+   G++   L  +S  D+           QR    I ++A AL
Sbjct: 76  -YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----------QRTATYITELANAL 123
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            Y H        H D+KP N+LL       +ADFG +   P     +    + GT+ Y+ 
Sbjct: 124 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRXXLCGTLDYL- 175
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART-----VLPDHV 640
           P E   G       D++S G+L  E +  K P    FE N     + R        PD V
Sbjct: 176 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFV 231
Query: 641 MD 642
            +
Sbjct: 232 TE 233

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 96/223 (43%), Gaps = 35/223 (15%)
Query: 402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVK 461
           F  L  I  GSFG V+KGI +  + ++A+K+++L             +       +  + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE-----------EAEDEIEDIQQEIT 57
Query: 462 ILTVCSG---VDYKGDDFK----ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQR 514
           +L+ C       Y G   K     ++ E++  GS  + L P          P  L+  Q 
Sbjct: 58  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP---------GP--LDETQI 106
Query: 515 INIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSS 574
             I  ++   L YLH + +    H D+K +NVLL       +ADFG+A  L    ++ ++
Sbjct: 107 ATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT 163
Query: 575 IGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
               GT  ++AP E    S      D++S GI  +EL   + P
Sbjct: 164 F--VGTPFWMAP-EVIKQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 98/242 (40%), Gaps = 39/242 (16%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVL---NLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           G FG+VY     + K I+A+KVL    L   G       E     ++RH N++++     
Sbjct: 24  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL----- 78
Query: 468 GVDYKGDDFKA-LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI-DVACAL 525
              Y  D  +  L+ E+   G++   L  +S  D+           QR    I ++A AL
Sbjct: 79  -YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----------QRTATYITELANAL 126
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            Y H        H D+KP N+LL       +ADFG +   P     +    + GT+ Y+ 
Sbjct: 127 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTDLCGTLDYL- 178
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART-----VLPDHV 640
           P E   G       D++S G+L  E +  K P    FE N     + R        PD V
Sbjct: 179 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFV 234
Query: 641 MD 642
            +
Sbjct: 235 TE 236

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 100/215 (46%), Gaps = 27/215 (12%)
Query: 411 GSFGSVYKGIL-----DEGKTIIAVKVLNLLHHGASKSSIA---ECSALRNIRHKNLVKI 462
           GSFG VY+G+      DE +T +A+K +N     + +  I    E S ++     ++V++
Sbjct: 23  GSFGMVYEGVAKGVVKDEPETRVAIKTVN--EAASMRERIEFLNEASVMKEFNCHHVVRL 80
Query: 463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGA--DKTVEAPKCLNFLQRINIAID 520
           L V S    +G     ++ E M  G L+ +L  +     +  V AP  L+  + I +A +
Sbjct: 81  LGVVS----QGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAGE 133
Query: 521 VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKG- 579
           +A  + YL+ +      H DL   N  +  + T  + DFG+ + +          G KG 
Sbjct: 134 IADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRK--GGKGL 188
Query: 580 -TIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             + +++P     G   +   DV+S+G++L E+ T
Sbjct: 189 LPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIAT 222

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 102/238 (42%), Gaps = 34/238 (14%)
Query: 401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLN---LLHHGASKSSIAECSALRNIRHK 457
           +F F+  +  GSFG V    + E   + AVKVL    +L     + ++ E   L   R+ 
Sbjct: 24  NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNH 83
Query: 458 NLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINI 517
             +  L  C    ++  D    V EF++ G L   +  +  + +  EA            
Sbjct: 84  PFLTQLFCC----FQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARF-------Y 129
Query: 518 AIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           A ++  AL +LH        + DLK  NVLLDHE    +ADFG+ K      + T++   
Sbjct: 130 AAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC- 185
Query: 578 KGTIGYIAPA---EYGLGSEVSINGDVYSYGILLLELMTRKRP-----SDIMFEGNMN 627
            GT  YIAP    E   G  V    D ++ G+LL E++    P      D +FE  +N
Sbjct: 186 -GTPDYIAPEILQEMLYGPAV----DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 238

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 102/214 (47%), Gaps = 24/214 (11%)
Query: 411 GSFGSVYK----GILDEGKTI-IAVKVLNLLHHGASKSSI-AECSALRNI-RHKNLVKIL 463
           G+FG V +    G+  E   + +AVK+L    H   K ++ +E   + ++ +H+N+V +L
Sbjct: 57  GAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLL 116
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
             C+   + G     ++ E+   G L  +L   + AD   E  + L     ++ +  VA 
Sbjct: 117 GACT---HGGPVL--VITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQ 171
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGT--- 580
            + +L         H D+   NVLL +   A + DFGLA+ +    +  S+  VKG    
Sbjct: 172 GMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI----MNDSNYIVKGNARL 224
Query: 581 -IGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
            + ++AP E       ++  DV+SYGILL E+ +
Sbjct: 225 PVKWMAP-ESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 98/242 (40%), Gaps = 39/242 (16%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVL---NLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           G FG+VY     + K I+A+KVL    L   G       E     ++RH N++++     
Sbjct: 19  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL----- 73
Query: 468 GVDYKGDDFKA-LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI-DVACAL 525
              Y  D  +  L+ E+   G++   L  +S  D+           QR    I ++A AL
Sbjct: 74  -YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----------QRTATYITELANAL 121
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            Y H        H D+KP N+LL       +ADFG +   P     +    + GT+ Y+ 
Sbjct: 122 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTXLCGTLDYL- 173
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART-----VLPDHV 640
           P E   G       D++S G+L  E +  K P    FE N     + R        PD V
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFV 229
Query: 641 MD 642
            +
Sbjct: 230 TE 231

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 94/217 (43%), Gaps = 32/217 (14%)
Query: 410 MGSFGSVYKGILDEGKTIIAVKVLN---LLHHGASKSSIAECSALRNIRHKNLVKILTVC 466
           +G+FG V  G  +     +AVK+LN   +           E   L+  RH +++K+  V 
Sbjct: 26  VGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI 85
Query: 467 SGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALK 526
           S      D F  +V E++  G L +++      +  ++  +     Q+I   +D      
Sbjct: 86  ST---PSDIF--MVMEYVSGGELFDYI----CKNGRLDEKESRRLFQQILSGVD------ 130
Query: 527 YLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP 586
           Y H   +    H DLKP NVLLD  M A +ADFGL+ ++        S    G+  Y AP
Sbjct: 131 YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSC---GSPNYAAP 184
Query: 587 ----AEYGLGSEVSINGDVYSYGILLLELMTRKRPSD 619
                    G EV    D++S G++L  L+    P D
Sbjct: 185 EVISGRLYAGPEV----DIWSSGVILYALLCGTLPFD 217

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 98/242 (40%), Gaps = 39/242 (16%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVL---NLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           G FG+VY     + K I+A+KVL    L   G       E     ++RH N++++     
Sbjct: 19  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL----- 73
Query: 468 GVDYKGDDFKA-LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI-DVACAL 525
              Y  D  +  L+ E+   G++   L  +S  D+           QR    I ++A AL
Sbjct: 74  -YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----------QRTATYITELANAL 121
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            Y H        H D+KP N+LL       +ADFG +   P     +    + GT+ Y+ 
Sbjct: 122 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRXXLCGTLDYL- 173
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART-----VLPDHV 640
           P E   G       D++S G+L  E +  K P    FE N     + R        PD V
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFV 229
Query: 641 MD 642
            +
Sbjct: 230 TE 231

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 87/215 (40%), Gaps = 25/215 (11%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSS----IAECSALRNIRHKNLVKIL 463
           I  GSF +VYKG+  E  T + V    L     +KS       E   L+ ++H N+V+  
Sbjct: 34  IGRGSFKTVYKGLDTE--TTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFY 91
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
                   KG     LV E   +G+L+ +L         V    C   L+          
Sbjct: 92  DSWEST-VKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILK---------- 140
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEM-TAHVADFGLAKLLPPAHLQTSSIGVKGTIG 582
            L++LH    P   H DLK  N+ +     +  + D GLA L   +  +     V GT  
Sbjct: 141 GLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK----AVIGTPE 195
Query: 583 YIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
           + AP  Y    + S+  DVY++G   LE  T + P
Sbjct: 196 FXAPEXYEEKYDESV--DVYAFGXCXLEXATSEYP 228

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 99/228 (43%), Gaps = 24/228 (10%)
Query: 391 SVLVGILLFVSFLFLCWIDMGSFGSVYKGI-LDEGKTI---IAVKVLN-LLHHGASKSSI 445
             L+ IL    F  +  +  G+FG+VYKG+ + EG+ +   +A+K L       A+K  +
Sbjct: 8   QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL 67
Query: 446 AECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEA 505
            E   + ++ + ++ ++L +C     +      L+ + M  G L          D   E 
Sbjct: 68  DEAYVMASVDNPHVCRLLGICLTSTVQ------LIMQLMPFGCL---------LDYVREH 112
Query: 506 PKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL 565
              +     +N  + +A  + YL         H DL   NVL+       + DFG AKLL
Sbjct: 113 KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLL 169
Query: 566 PPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
                +  + G K  I ++A  E  L    +   DV+SYG+ + ELMT
Sbjct: 170 GAEEKEYHAEGGKVPIKWMA-LESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 103/239 (43%), Gaps = 24/239 (10%)
Query: 380 TIAVKLAAAIISVLVGILLFVSFLFLCWIDMGSFGSVYKGI-LDEGKTI---IAVKVLN- 434
            + ++   A    L+ IL    F  +  +  G+FG+VYKG+ + EG+ +   +A+K L  
Sbjct: 2   AMGIRSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 61
Query: 435 LLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLH 494
                A+K  + E   + ++ + ++ ++L +C     +      L+ + M  G L     
Sbjct: 62  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCL----- 110
Query: 495 PVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTA 554
                D   E    +     +N  + +A  + YL         H DL   NVL+      
Sbjct: 111 ----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 163
Query: 555 HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
            + DFG AKLL     +  + G K  I ++A  E  L    +   DV+SYG+ + ELMT
Sbjct: 164 KITDFGRAKLLGAEEKEYHAEGGKVPIKWMA-LESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 88/219 (40%), Gaps = 43/219 (19%)
Query: 411 GSFGSV----YKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVC 466
           G+FGSV    Y  + D    ++AVK L        +    E   L+ +    +VK   V 
Sbjct: 21  GNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVS 80
Query: 467 SGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALK 526
            G    G     LV E++ +G L                    +FLQR    +D +  L 
Sbjct: 81  YG---PGRQSLRLVMEYLPSGCLR-------------------DFLQRHRARLDASRLLL 118
Query: 527 YLHHDCQ-------PTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK- 578
           Y    C+           H DL   N+L++ E    +ADFGLAKLLP   L      V+ 
Sbjct: 119 YSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP---LDKDYYVVRE 175
Query: 579 ---GTIGYIAPAEYGLGSEV-SINGDVYSYGILLLELMT 613
                I + AP    L   + S   DV+S+G++L EL T
Sbjct: 176 PGQSPIFWYAPE--SLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 99/242 (40%), Gaps = 39/242 (16%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVL---NLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           G FG+VY     + K I+A+KVL    L   G       E     ++RH N++++     
Sbjct: 21  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL----- 75
Query: 468 GVDYKGDDFKA-LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI-DVACAL 525
              Y  D  +  L+ E+   G++   L  +S  D+           QR    I ++A AL
Sbjct: 76  -YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----------QRTATYITELANAL 123
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            Y H        H D+KP N+LL       +A+FG +   P +   T    + GT+ Y+ 
Sbjct: 124 SYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTT----LCGTLDYL- 175
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART-----VLPDHV 640
           P E   G       D++S G+L  E +  K P    FE N     + R        PD V
Sbjct: 176 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFV 231
Query: 641 MD 642
            +
Sbjct: 232 TE 233

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 95/216 (43%), Gaps = 34/216 (15%)
Query: 411 GSFGSVYKGILDE-------GKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKIL 463
           G+F  ++KG+  E        +T + +KVL+  H   S+S     S +  + HK+LV   
Sbjct: 19  GTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNY 78
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            VC    + GD+   LV EF+  GSL+ +L          +   C+N L ++ +A  +A 
Sbjct: 79  GVC----FCGDE-NILVQEFVKFGSLDTYLK---------KNKNCINILWKLEVAKQLAW 124
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV------ 577
           A+ +L  +   T  H ++   N+LL  E      +    KL  P      SI V      
Sbjct: 125 AMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG----ISITVLPKDIL 177
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
           +  I ++ P        +++  D +S+G  L E+ +
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 98/242 (40%), Gaps = 39/242 (16%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVL---NLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           G FG+VY     + K I+A+KVL    L   G       E     ++RH N++++     
Sbjct: 22  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL----- 76
Query: 468 GVDYKGDDFKA-LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI-DVACAL 525
              Y  D  +  L+ E+   G++   L  +S  D+           QR    I ++A AL
Sbjct: 77  -YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----------QRTATYITELANAL 124
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            Y H        H D+KP N+LL       +ADFG +   P     +    + GT+ Y+ 
Sbjct: 125 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRXXLCGTLDYL- 176
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART-----VLPDHV 640
           P E   G       D++S G+L  E +  K P    FE N     + R        PD V
Sbjct: 177 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFV 232
Query: 641 MD 642
            +
Sbjct: 233 TE 234

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 98/242 (40%), Gaps = 39/242 (16%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVL---NLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           G FG+VY     + K I+A+KVL    L   G       E     ++RH N++++     
Sbjct: 45  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL----- 99
Query: 468 GVDYKGDDFKA-LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI-DVACAL 525
              Y  D  +  L+ E+   G++   L  +S  D+           QR    I ++A AL
Sbjct: 100 -YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----------QRTATYITELANAL 147
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            Y H        H D+KP N+LL       +ADFG +   P     +    + GT+ Y+ 
Sbjct: 148 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRDDLCGTLDYL- 199
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART-----VLPDHV 640
           P E   G       D++S G+L  E +  K P    FE N     + R        PD V
Sbjct: 200 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFV 255
Query: 641 MD 642
            +
Sbjct: 256 TE 257

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 97/221 (43%), Gaps = 27/221 (12%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTV 465
           I  G++G+V+K    E   I+A+K + L     G   S++ E   L+ ++HKN+V++  V
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                   D    LV+EF  +  L+++    +G D   E  K   F         +   L
Sbjct: 70  LHS-----DKKLTLVFEFC-DQDLKKYFDSCNG-DLDPEIVKSFLF--------QLLKGL 114
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP-PAHLQTSSIGVKGTIGYI 584
            + H        H DLKP N+L++      +A+FGLA+    P    ++ +    T+ Y 
Sbjct: 115 GFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEV---VTLWYR 168
Query: 585 APAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGN 625
            P         S + D++S G +  EL    RP   +F GN
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP---LFPGN 206

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 24/208 (11%)
Query: 411 GSFGSVYKGI-LDEGKTI---IAVKVLN-LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G+FG+VYKG+ + EG+ +   +A+K L       A+K  + E   + ++ + ++ ++L +
Sbjct: 28  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 87
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
           C     +      L+ + M  G L          D   E    +     +N  + +A  +
Sbjct: 88  CLTSTVQ------LIMQLMPFGCL---------LDYVREHKDNIGSQYLLNWCVQIAKGM 132
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            YL         H DL   NVL+       + DFG AKLL     +  + G K  I ++A
Sbjct: 133 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMT 613
             E  L    +   DV+SYG+ + ELMT
Sbjct: 190 -LESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 46/209 (22%)
Query: 429 AVKVLNLLHHGA---------SKSSIAECSALRNIR-HKNLVKILTVCSGVDYKGDDFKA 478
           AVK++++   G+          ++++ E   LR +  H N++++        Y+ + F  
Sbjct: 46  AVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT-----YETNTFFF 100
Query: 479 LVYEFMHNGSLEEWL-HPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTA 537
           LV++ M  G L ++L   V+ ++K  E  K +  L      ++V CAL  L+        
Sbjct: 101 LVFDLMKKGELFDYLTEKVTLSEK--ETRKIMRAL------LEVICALHKLN------IV 146
Query: 538 HCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPA---------E 588
           H DLKP N+LLD +M   + DFG +  L P         V GT  Y+AP           
Sbjct: 147 HRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE---VCGTPSYLAPEIIECSMNDNH 203
Query: 589 YGLGSEVSINGDVYSYGILLLELMTRKRP 617
            G G EV    D++S G+++  L+    P
Sbjct: 204 PGYGKEV----DMWSTGVIMYTLLAGSPP 228

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 24/208 (11%)
Query: 411 GSFGSVYKGI-LDEGKTI---IAVKVLN-LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G+FG+VYKG+ + EG+ +   +A+K L       A+K  + E   + ++ + ++ ++L +
Sbjct: 30  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 89
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
           C     +      L+ + M  G L          D   E    +     +N  + +A  +
Sbjct: 90  CLTSTVQ------LIMQLMPFGCL---------LDYVREHKDNIGSQYLLNWCVQIAKGM 134
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            YL         H DL   NVL+       + DFG AKLL     +  + G K  I ++A
Sbjct: 135 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 191
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMT 613
             E  L    +   DV+SYG+ + ELMT
Sbjct: 192 -LESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 88/219 (40%), Gaps = 43/219 (19%)
Query: 411 GSFGSV----YKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVC 466
           G+FGSV    Y  + D    ++AVK L        +    E   L+ +    +VK   V 
Sbjct: 22  GNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVS 81
Query: 467 SGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALK 526
            G    G     LV E++ +G L                    +FLQR    +D +  L 
Sbjct: 82  YG---PGRQSLRLVMEYLPSGCLR-------------------DFLQRHRARLDASRLLL 119
Query: 527 YLHHDCQ-------PTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK- 578
           Y    C+           H DL   N+L++ E    +ADFGLAKLLP   L      V+ 
Sbjct: 120 YSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP---LDKDYYVVRE 176
Query: 579 ---GTIGYIAPAEYGLGSEV-SINGDVYSYGILLLELMT 613
                I + AP    L   + S   DV+S+G++L EL T
Sbjct: 177 PGQSPIFWYAPE--SLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 95/223 (42%), Gaps = 35/223 (15%)
Query: 402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVK 461
           F  L  I  GSFG V+KGI +  + ++A+K+++L             +       +  + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE-----------EAEDEIEDIQQEIT 72
Query: 462 ILTVCSG---VDYKGDDFK----ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQR 514
           +L+ C       Y G   K     ++ E++  GS  + L P          P  L+  Q 
Sbjct: 73  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP---------GP--LDETQI 121
Query: 515 INIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSS 574
             I  ++   L YLH + +    H D+K +NVLL       +ADFG+A  L    ++ + 
Sbjct: 122 ATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNX 178
Query: 575 IGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
               GT  ++AP E    S      D++S GI  +EL   + P
Sbjct: 179 F--VGTPFWMAP-EVIKQSAYDSKADIWSLGITAIELARGEPP 218

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 99/228 (43%), Gaps = 24/228 (10%)
Query: 391 SVLVGILLFVSFLFLCWIDMGSFGSVYKGI-LDEGKTI---IAVKVLN-LLHHGASKSSI 445
             L+ IL    F  +  +  G+FG+VYKG+ + EG+ +   +A+K L       A+K  +
Sbjct: 8   QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL 67
Query: 446 AECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEA 505
            E   + ++ + ++ ++L +C     +      L+ + M  G L          D   E 
Sbjct: 68  DEAYVMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCL---------LDYVREH 112
Query: 506 PKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL 565
              +     +N  + +A  + YL         H DL   NVL+       + DFG AKLL
Sbjct: 113 KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLL 169
Query: 566 PPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
                +  + G K  I ++A  E  L    +   DV+SYG+ + ELMT
Sbjct: 170 GAEEKEYHAEGGKVPIKWMA-LESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 88/219 (40%), Gaps = 43/219 (19%)
Query: 411 GSFGSV----YKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVC 466
           G+FGSV    Y  + D    ++AVK L        +    E   L+ +    +VK   V 
Sbjct: 34  GNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVS 93
Query: 467 SGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALK 526
            G    G     LV E++ +G L                    +FLQR    +D +  L 
Sbjct: 94  YG---PGRQSLRLVMEYLPSGCLR-------------------DFLQRHRARLDASRLLL 131
Query: 527 YLHHDCQ-------PTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK- 578
           Y    C+           H DL   N+L++ E    +ADFGLAKLLP   L      V+ 
Sbjct: 132 YSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP---LDKDYYVVRE 188
Query: 579 ---GTIGYIAPAEYGLGSEV-SINGDVYSYGILLLELMT 613
                I + AP    L   + S   DV+S+G++L EL T
Sbjct: 189 PGQSPIFWYAPE--SLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 97/242 (40%), Gaps = 39/242 (16%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVL---NLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           G FG+VY       K I+A+KVL    L   G       E     ++RH N++++     
Sbjct: 19  GKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL----- 73
Query: 468 GVDYKGDDFKA-LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI-DVACAL 525
              Y  D  +  L+ E+   G++   L  +S  D+           QR    I ++A AL
Sbjct: 74  -YGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDE-----------QRTATYITELANAL 121
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            Y H        H D+KP N+LL       +ADFG +   P     +    + GT+ Y+ 
Sbjct: 122 SYCH---SKKVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRAALCGTLDYL- 173
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART-----VLPDHV 640
           P E   G       D++S G+L  E +  K P    FE N     + R        PD V
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQDTYKRISRVEFTFPDFV 229
Query: 641 MD 642
            +
Sbjct: 230 TE 231

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 115/271 (42%), Gaps = 48/271 (17%)
Query: 405 LCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGAS-KSSIAECSALRNIRHKNLVKIL 463
           L +I  G++G V     +  K  +A+K ++   H    + ++ E   L   RH+N++ I 
Sbjct: 48  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI- 106
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
                     D  +A   E M +  L   L    GAD           L+  +++ D  C
Sbjct: 107 ---------NDIIRAPTIEQMKDVYLVTHL---MGAD-------LYKLLKTQHLSNDHIC 147
Query: 524 --------ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSI 575
                    LKY+H        H DLKPSN+LL+      + DFGLA++  P H  T  +
Sbjct: 148 YFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFL 204
Query: 576 G-VKGTIGYIAPAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFAR 633
                T  Y AP E  L S+  + + D++S G +L E+++  RP   +F G   L     
Sbjct: 205 TEYVATRWYRAP-EIMLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQL-- 257
Query: 634 TVLPDHVMDIVDSTLLADDEDLTITSNQRQR 664
               +H++ I+ S      EDL    N + R
Sbjct: 258 ----NHILGILGS---PSQEDLNCIINLKAR 281

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 98/242 (40%), Gaps = 39/242 (16%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVL---NLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           G FG+VY     + K I+A+KVL    L   G       E     ++RH N++++     
Sbjct: 22  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL----- 76
Query: 468 GVDYKGDDFKA-LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI-DVACAL 525
              Y  D  +  L+ E+   G++   L  +S  D+           QR    I ++A AL
Sbjct: 77  -YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----------QRTATYITELANAL 124
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            Y H        H D+KP N+LL       +ADFG +   P     +    + GT+ Y+ 
Sbjct: 125 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRDDLCGTLDYL- 176
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART-----VLPDHV 640
           P E   G       D++S G+L  E +  K P    FE N     + R        PD V
Sbjct: 177 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFV 232
Query: 641 MD 642
            +
Sbjct: 233 TE 234

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 95/223 (42%), Gaps = 35/223 (15%)
Query: 402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVK 461
           F  L  I  GSFG V+KGI +  + ++A+K+++L             +       +  + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE-----------EAEDEIEDIQQEIT 57
Query: 462 ILTVCSG---VDYKGDDFK----ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQR 514
           +L+ C       Y G   K     ++ E++  GS  + L P          P  L+  Q 
Sbjct: 58  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP---------GP--LDETQI 106
Query: 515 INIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSS 574
             I  ++   L YLH + +    H D+K +NVLL       +ADFG+A  L    ++ + 
Sbjct: 107 ATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNX 163
Query: 575 IGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
               GT  ++AP E    S      D++S GI  +EL   + P
Sbjct: 164 F--VGTPFWMAP-EVIKQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 24/208 (11%)
Query: 411 GSFGSVYKGI-LDEGKTI---IAVKVLN-LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G+FG+VYKG+ + EG+ +   +A+K L       A+K  + E   + ++ + ++ ++L +
Sbjct: 26  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 85
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
           C     +      L+ + M  G L          D   E    +     +N  + +A  +
Sbjct: 86  CLTSTVQ------LITQLMPFGCL---------LDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            YL         H DL   NVL+       + DFG AKLL     +  + G K  I ++A
Sbjct: 131 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMT 613
             E  L    +   DV+SYG+ + ELMT
Sbjct: 188 -LESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 99/242 (40%), Gaps = 39/242 (16%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVL---NLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           G FG+VY     + K I+A+KVL    L   G       E     ++RH N++++     
Sbjct: 22  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL----- 76
Query: 468 GVDYKGDDFKA-LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI-DVACAL 525
              Y  D  +  L+ E+   G++   L  +S  D+           QR    I ++A AL
Sbjct: 77  -YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----------QRTATYITELANAL 124
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            Y H        H D+KP N+LL       +A+FG +   P +   T    + GT+ Y+ 
Sbjct: 125 SYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTT----LCGTLDYL- 176
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART-----VLPDHV 640
           P E   G       D++S G+L  E +  K P    FE N     + R        PD V
Sbjct: 177 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFV 232
Query: 641 MD 642
            +
Sbjct: 233 TE 234

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 97/227 (42%), Gaps = 35/227 (15%)
Query: 402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVK 461
           F  L  I  GSFG V+KGI +  + ++A+K+++L             +       +  + 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE-----------EAEDEIEDIQQEIT 73
Query: 462 ILTVCSG---VDYKGDDFKA----LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQR 514
           +L+ C       Y G   K     ++ E++  GS  + L            P   +  Q 
Sbjct: 74  VLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRA---------GP--FDEFQI 122
Query: 515 INIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSS 574
             +  ++   L YLH + +    H D+K +NVLL  +    +ADFG+A  L    ++ ++
Sbjct: 123 ATMLKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT 179
Query: 575 IGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIM 621
               GT  ++AP E    S      D++S GI  +EL   + P+  M
Sbjct: 180 F--VGTPFWMAP-EVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 223

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 27/209 (12%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHK----NLVKILTVC 466
           G+FGSV +G+    K  I V  + +L  G  K+   E      I H+     +V+++ VC
Sbjct: 21  GNFGSVRQGVYRMRKKQIDV-AIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC 79
Query: 467 SGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALK 526
                   +   LV E    G L ++L    G  + +        L ++++       +K
Sbjct: 80  QA------EALMLVMEMAGGGPLHKFL---VGKREEIPVSNVAELLHQVSMG------MK 124
Query: 527 YLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL--PPAHLQTSSIGVKGTIGYI 584
           YL    +    H DL   NVLL +   A ++DFGL+K L    ++    S G K  + + 
Sbjct: 125 YLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG-KWPLKWY 180
Query: 585 APAEYGLGSEVSINGDVYSYGILLLELMT 613
           AP       + S   DV+SYG+ + E ++
Sbjct: 181 APECINF-RKFSSRSDVWSYGVTMWEALS 208

>pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/185 (32%), Positives = 86/185 (46%), Gaps = 8/185 (4%)
Query: 82  KHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFI-NLQTLHMWDNQL 140
           K LD+ +N    L P    +    L  L  N NK+ +++PAGI K + NL+TL + DN+L
Sbjct: 40  KKLDLQSNKLSSL-PSKAFHRLTKLRLLYLNDNKL-QTLPAGIFKELKNLETLWVTDNKL 97
Query: 141 SGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSL-GQC 199
                    +L NL  L ++ N+L    P    +L KL  L L  N LQ S+P  +  + 
Sbjct: 98  QALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKL 156
Query: 200 QSLTTINLSYNNLSGTIPPQLMD-LTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISR 258
            SL  + L YNN    +P    D LT L   L L  NQL          L  L++L +  
Sbjct: 157 TSLKELRL-YNNQLKRVPEGAFDKLTELKT-LKLDNNQLKRVPEGAFDSLEKLKMLQLQE 214
Query: 259 NMLEC 263
           N  +C
Sbjct: 215 NPWDC 219

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 95/209 (45%), Gaps = 26/209 (12%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           GS+GSVYK I  E   I+A+K + +      +  I E S ++     ++VK      G  
Sbjct: 40  GSYGSVYKAIHKETGQIVAIKQVPV--ESDLQEIIKEISIMQQCDSPHVVKYY----GSY 93
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
           +K  D   +V E+   GS+ +    +   +KT+   +    LQ           L+YLH 
Sbjct: 94  FKNTDL-WIVMEYCGAGSVSDI---IRLRNKTLTEDEIATILQ------STLKGLEYLHF 143
Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
                  H D+K  N+LL+ E  A +ADFG+A  L     + +   V GT  ++AP    
Sbjct: 144 ---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNX--VIGTPFWMAPE--- 195
Query: 591 LGSEVSIN--GDVYSYGILLLELMTRKRP 617
           +  E+  N   D++S GI  +E+   K P
Sbjct: 196 VIQEIGYNCVADIWSLGITAIEMAEGKPP 224

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 94/216 (43%), Gaps = 34/216 (15%)
Query: 411 GSFGSVYKGILDE-------GKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKIL 463
           G+F  ++KG+  E        +T + +KVL+  H   S+S     S +  + HK+LV   
Sbjct: 19  GTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNY 78
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            VC      GD+   LV EF+  GSL+ +L          +   C+N L ++ +A  +A 
Sbjct: 79  GVCVC----GDE-NILVQEFVKFGSLDTYLK---------KNKNCINILWKLEVAKQLAA 124
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV------ 577
           A+ +L  +   T  H ++   N+LL  E      +    KL  P      SI V      
Sbjct: 125 AMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG----ISITVLPKDIL 177
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
           +  I ++ P        +++  D +S+G  L E+ +
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 102/229 (44%), Gaps = 41/229 (17%)
Query: 411 GSFGSVYK----GILDEGKTI-IAVKVLNLLHHGASKSSI-AECSALRNI-RHKNLVKIL 463
           G+FG V      GI   G +I +AVK+L      + + ++ +E   +  +  H+N+V +L
Sbjct: 56  GAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLL 115
Query: 464 TVC--SGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGA----------DKTVEAPKCLN- 510
             C  SG  Y       L++E+   G L  +L                 K +E  + LN 
Sbjct: 116 GACTLSGPIY-------LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 511 --FLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPA 568
             F   +  A  VA  +++L      +  H DL   NVL+ H     + DFGLA+ +   
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDI--- 222
Query: 569 HLQTSSIGVKGT----IGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
            +  S+  V+G     + ++AP     G   +I  DV+SYGILL E+ +
Sbjct: 223 -MSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFS 269

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 77/320 (24%), Positives = 128/320 (40%), Gaps = 62/320 (19%)
Query: 408 IDMGSFGSVYKG-ILDEGKTII--AVKVLNLLHHGAS-KSSIAECSALRNIRHKNLVKIL 463
           I  G FG VY G  +D+ +  I  A+K L+ +      ++ + E   +R + H N++ ++
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
               G+    +    ++  +M +G L +++      + TV+          I+  + VA 
Sbjct: 89  ----GIMLPPEGLPHVLLPYMCHGDLLQFIRS-PQRNPTVK--------DLISFGLQVAR 135
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGY 583
            ++YL    +    H DL   N +LD   T  VADFGLA+ +    L      V+     
Sbjct: 136 GMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDI----LDREYYSVQQHRHA 188
Query: 584 IAPAEY-GLGS----EVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPD 638
             P ++  L S      +   DV+S+G+LL EL+TR  P                   P 
Sbjct: 189 RLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAP-------------------PY 229
Query: 639 HVMDIVDST-LLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMT 697
             +D  D T  LA                R+     C  S+ ++   C    P  R    
Sbjct: 230 RHIDPFDLTHFLAQGR-------------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFR 276
Query: 698 IVVHELQSIKSILLGPKTVS 717
           ++V E++ I S LLG   V 
Sbjct: 277 VLVGEVEQIVSALLGDHYVQ 296

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 93/213 (43%), Gaps = 28/213 (13%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           I  G+ G+VY  +       +A++ +NL      +  I E   +R  ++ N+V  L    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD--- 84
Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
              Y   D   +V E++  GSL +           V    C++  Q   +  +   AL++
Sbjct: 85  --SYLVGDELWVVMEYLAGGSLTD-----------VVTETCMDEGQIAAVCRECLQALEF 131
Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP- 586
           LH +      H D+K  N+LL  + +  + DFG    + P   + S++   GT  ++AP 
Sbjct: 132 LHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM--VGTPYWMAPE 186
Query: 587 --AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
                  G +V    D++S GI+ +E++  + P
Sbjct: 187 VVTRKAYGPKV----DIWSLGIMAIEMIEGEPP 215

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 99/234 (42%), Gaps = 27/234 (11%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN---LLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           GSF  VY+         +A+K+++   +   G  +    E      ++H +++++     
Sbjct: 22  GSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNY-- 79
Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
              ++  ++  LV E  HNG +  +L       K     +  +F+ +I         + Y
Sbjct: 80  ---FEDSNYVYLVLEMCHNGEMNRYL---KNRVKPFSENEARHFMHQI------ITGMLY 127
Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPA 587
           LH        H DL  SN+LL   M   +ADFGLA  L   H +  ++   GT  YI+P 
Sbjct: 128 LH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC--GTPNYISP- 181
Query: 588 EYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM 641
           E    S   +  DV+S G +   L+  + P    F+ +   +   + VL D+ M
Sbjct: 182 EIATRSAHGLESDVWSLGCMFYTLLIGRPP----FDTDTVKNTLNKVVLADYEM 231

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 111/242 (45%), Gaps = 33/242 (13%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNLVKILTV 465
           I  G++G VYK        ++A+K + L     G   ++I E S L+ + H N+VK+L V
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                   ++   LV+E + +  L++++   + A   +  P   ++L ++   +    + 
Sbjct: 74  IH-----TENKLYLVFEHV-DQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP-PAHLQTSSIGVKGTIGYI 584
           + LH          DLKP N+L++ E    +ADFGLA+    P       +    T+ Y 
Sbjct: 126 RVLHR---------DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VTLWYR 173
Query: 585 APAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV----LPDH 639
           AP E  LG +  S   D++S G +  E++TR+     +F G+  +    R       PD 
Sbjct: 174 AP-EILLGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRIFRTLGTPDE 228
Query: 640 VM 641
           V+
Sbjct: 229 VV 230

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 26/213 (12%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSS--IAECSALRNIRHKNLVKILTVCSG 468
           G FG V  G   +G+  +AVK++     G+        E   +  + H  LVK   VCS 
Sbjct: 19  GQFGVVKLGKW-KGQYDVAVKMIK---EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL 528
            +Y       +V E++ NG L   L+ +    K +E        Q + +  DV   + +L
Sbjct: 75  -EYP----IYIVTEYISNGCL---LNYLRSHGKGLEPS------QLLEMCYDVCEGMAFL 120
Query: 529 HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAE 588
                    H DL   N L+D ++   V+DFG+ + +       SS+G K  + + AP  
Sbjct: 121 E---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-VSSVGTKFPVKWSAPEV 176
Query: 589 YGLGSEVSINGDVYSYGILLLELMTR-KRPSDI 620
           +    + S   DV+++GIL+ E+ +  K P D+
Sbjct: 177 FHY-FKYSSKSDVWAFGILMWEVFSLGKMPYDL 208

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 51/100 (51%), Gaps = 7/100 (7%)
Query: 518 AIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           A ++ C L+ LH +      + DLKP N+LLD      ++D GLA  +P      +  G 
Sbjct: 292 AAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGR 345
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
            GT+GY+AP E       + + D ++ G LL E++  + P
Sbjct: 346 VGTVGYMAP-EVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 51/100 (51%), Gaps = 7/100 (7%)
Query: 518 AIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           A ++ C L+ LH +      + DLKP N+LLD      ++D GLA  +P      +  G 
Sbjct: 292 AAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGR 345
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
            GT+GY+AP E       + + D ++ G LL E++  + P
Sbjct: 346 VGTVGYMAP-EVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 90/223 (40%), Gaps = 25/223 (11%)
Query: 399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSI--AECSALRNIRH 456
           F    FL  ++    G ++KG   +G  I+ VKVL +      KS     EC  LR   H
Sbjct: 9   FKQLNFLTKLNENHSGELWKGRW-QGNDIV-VKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 457 KNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRIN 516
            N++ +L  C            L+  +   GSL   LH   G +  V+  + + F     
Sbjct: 67  PNVLPVLGACQSPPAP---HPTLITHWXPYGSLYNVLH--EGTNFVVDQSQAVKF----- 116
Query: 517 IAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIG 576
            A+D A    +L H  +P      L   +V +D + TA ++   +            S G
Sbjct: 117 -ALDXARGXAFL-HTLEPLIPRHALNSRSVXIDEDXTARISXADVK-------FSFQSPG 167
Query: 577 VKGTIGYIAPAEYGLGSEVS--INGDVYSYGILLLELMTRKRP 617
                 ++AP       E +   + D +S+ +LL EL+TR+ P
Sbjct: 168 RXYAPAWVAPEALQKKPEDTNRRSADXWSFAVLLWELVTREVP 210

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 92/213 (43%), Gaps = 28/213 (13%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           I  G+ G+VY  +       +A++ +NL      +  I E   +R  ++ N+V  L    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD--- 84
Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
              Y   D   +V E++  GSL +           V    C++  Q   +  +   AL++
Sbjct: 85  --SYLVGDELWVVMEYLAGGSLTD-----------VVTETCMDEGQIAAVCRECLQALEF 131
Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP- 586
           LH +      H D+K  N+LL  + +  + DFG    + P   + S +   GT  ++AP 
Sbjct: 132 LHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEM--VGTPYWMAPE 186
Query: 587 --AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
                  G +V    D++S GI+ +E++  + P
Sbjct: 187 VVTRKAYGPKV----DIWSLGIMAIEMIEGEPP 215

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 92/213 (43%), Gaps = 28/213 (13%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           I  G+ G+VY  +       +A++ +NL      +  I E   +R  ++ N+V  L    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD--- 84
Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
              Y   D   +V E++  GSL +           V    C++  Q   +  +   AL++
Sbjct: 85  --SYLVGDELWVVMEYLAGGSLTD-----------VVTETCMDEGQIAAVCRECLQALEF 131
Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP- 586
           LH +      H D+K  N+LL  + +  + DFG    + P   + S +   GT  ++AP 
Sbjct: 132 LHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXM--VGTPYWMAPE 186
Query: 587 --AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
                  G +V    D++S GI+ +E++  + P
Sbjct: 187 VVTRKAYGPKV----DIWSLGIMAIEMIEGEPP 215

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 92/213 (43%), Gaps = 28/213 (13%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           I  G+ G+VY  +       +A++ +NL      +  I E   +R  ++ N+V  L    
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD--- 85
Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
              Y   D   +V E++  GSL +           V    C++  Q   +  +   AL++
Sbjct: 86  --SYLVGDELWVVMEYLAGGSLTD-----------VVTETCMDEGQIAAVCRECLQALEF 132
Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP- 586
           LH +      H D+K  N+LL  + +  + DFG    + P   + S +   GT  ++AP 
Sbjct: 133 LHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXM--VGTPYWMAPE 187
Query: 587 --AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
                  G +V    D++S GI+ +E++  + P
Sbjct: 188 VVTRKAYGPKV----DIWSLGIMAIEMIEGEPP 216

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 111/263 (42%), Gaps = 32/263 (12%)
Query: 405 LCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGAS-KSSIAECSALRNIRHKNLVKIL 463
           L +I  G++G V     +  K  +A+K ++   H    + ++ E   L   RH+N++ I 
Sbjct: 26  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 85
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            +      +      +V + M     E  L+ +           C    Q       +  
Sbjct: 86  DIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQ-------ILR 133
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIG-VKGTIG 582
            LKY+H        H DLKPSN+LL+      + DFGLA++  P H  T  +     T  
Sbjct: 134 GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 190
Query: 583 YIAPAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM 641
           Y AP E  L S+  + + D++S G +L E+++  RP   +F G   L         +H++
Sbjct: 191 YRAP-EIMLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQL------NHIL 239
Query: 642 DIVDSTLLADDEDLTITSNQRQR 664
            I+ S    + EDL    N + R
Sbjct: 240 GILGS---PEQEDLNCIINLKAR 259

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 67/140 (47%), Gaps = 15/140 (10%)
Query: 479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAH 538
           +V E++   +L + +H         E P  +   + I +  D   AL + H   Q    H
Sbjct: 110 IVMEYVDGVTLRDIVH--------TEGP--MTPKRAIEVIADACQALNFSH---QNGIIH 156
Query: 539 CDLKPSNVLLDHEMTAHVADFGLAKLLPPA-HLQTSSIGVKGTIGYIAPAEYGLGSEVSI 597
            D+KP+N+++       V DFG+A+ +  + +  T +  V GT  Y++P E   G  V  
Sbjct: 157 RDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP-EQARGDSVDA 215
Query: 598 NGDVYSYGILLLELMTRKRP 617
             DVYS G +L E++T + P
Sbjct: 216 RSDVYSLGCVLYEVLTGEPP 235

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 67/140 (47%), Gaps = 15/140 (10%)
Query: 479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAH 538
           +V E++   +L + +H         E P  +   + I +  D   AL + H   Q    H
Sbjct: 93  IVMEYVDGVTLRDIVH--------TEGP--MTPKRAIEVIADACQALNFSH---QNGIIH 139
Query: 539 CDLKPSNVLLDHEMTAHVADFGLAKLLPPA-HLQTSSIGVKGTIGYIAPAEYGLGSEVSI 597
            D+KP+N+++       V DFG+A+ +  + +  T +  V GT  Y++P E   G  V  
Sbjct: 140 RDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP-EQARGDSVDA 198
Query: 598 NGDVYSYGILLLELMTRKRP 617
             DVYS G +L E++T + P
Sbjct: 199 RSDVYSLGCVLYEVLTGEPP 218

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 67/140 (47%), Gaps = 15/140 (10%)
Query: 479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAH 538
           +V E++   +L + +H         E P  +   + I +  D   AL + H   Q    H
Sbjct: 93  IVMEYVDGVTLRDIVH--------TEGP--MTPKRAIEVIADACQALNFSH---QNGIIH 139
Query: 539 CDLKPSNVLLDHEMTAHVADFGLAKLLPPA-HLQTSSIGVKGTIGYIAPAEYGLGSEVSI 597
            D+KP+N+++       V DFG+A+ +  + +  T +  V GT  Y++P E   G  V  
Sbjct: 140 RDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP-EQARGDSVDA 198
Query: 598 NGDVYSYGILLLELMTRKRP 617
             DVYS G +L E++T + P
Sbjct: 199 RSDVYSLGCVLYEVLTGEPP 218

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 67/140 (47%), Gaps = 15/140 (10%)
Query: 479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAH 538
           +V E++   +L + +H         E P  +   + I +  D   AL + H   Q    H
Sbjct: 93  IVMEYVDGVTLRDIVH--------TEGP--MTPKRAIEVIADACQALNFSH---QNGIIH 139
Query: 539 CDLKPSNVLLDHEMTAHVADFGLAKLLPPA-HLQTSSIGVKGTIGYIAPAEYGLGSEVSI 597
            D+KP+N+++       V DFG+A+ +  + +  T +  V GT  Y++P E   G  V  
Sbjct: 140 RDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP-EQARGDSVDA 198
Query: 598 NGDVYSYGILLLELMTRKRP 617
             DVYS G +L E++T + P
Sbjct: 199 RSDVYSLGCVLYEVLTGEPP 218

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 67/140 (47%), Gaps = 15/140 (10%)
Query: 479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAH 538
           +V E++   +L + +H         E P  +   + I +  D   AL + H   Q    H
Sbjct: 93  IVMEYVDGVTLRDIVH--------TEGP--MTPKRAIEVIADACQALNFSH---QNGIIH 139
Query: 539 CDLKPSNVLLDHEMTAHVADFGLAKLLPPA-HLQTSSIGVKGTIGYIAPAEYGLGSEVSI 597
            D+KP+N+++       V DFG+A+ +  + +  T +  V GT  Y++P E   G  V  
Sbjct: 140 RDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP-EQARGDSVDA 198
Query: 598 NGDVYSYGILLLELMTRKRP 617
             DVYS G +L E++T + P
Sbjct: 199 RSDVYSLGCVLYEVLTGEPP 218

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 110/263 (41%), Gaps = 32/263 (12%)
Query: 405 LCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGAS-KSSIAECSALRNIRHKNLVKIL 463
           L +I  G++G V     +  K  +A+K ++   H    + ++ E   L   RH+N++ I 
Sbjct: 28  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 87
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            +      +      +V + M     E  L+ +           C    Q       +  
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQ-------ILR 135
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIG-VKGTIG 582
            LKY+H        H DLKPSN+LL+      + DFGLA++  P H  T  +     T  
Sbjct: 136 GLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 583 YIAPAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM 641
           Y AP E  L S+  + + D++S G +L E+++  RP   +F G   L         +H++
Sbjct: 193 YRAP-EIMLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQL------NHIL 241
Query: 642 DIVDSTLLADDEDLTITSNQRQR 664
            I+ S      EDL    N + R
Sbjct: 242 GILGS---PSQEDLNXIINLKAR 261

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 98/242 (40%), Gaps = 39/242 (16%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVL---NLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           G FG+VY     + K I+A+KVL    L   G       E     ++RH N++++     
Sbjct: 23  GKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRL----- 77
Query: 468 GVDYKGDDFKA-LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI-DVACAL 525
              Y  D  +  L+ E+   G++   L  +S  D+           QR    I ++A AL
Sbjct: 78  -YGYFHDATRVYLILEYAPLGTVYRELQKLSRFDE-----------QRTATYITELANAL 125
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            Y H        H D+KP N+LL       +ADFG +   P +   T    + GT+ Y+ 
Sbjct: 126 SYCH---SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDT----LCGTLDYL- 177
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART-----VLPDHV 640
           P E   G       D++S G+L  E +    P    FE +     + R        PD V
Sbjct: 178 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPP----FEAHTYQETYRRISRVEFTFPDFV 233
Query: 641 MD 642
            +
Sbjct: 234 TE 235

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 98/242 (40%), Gaps = 39/242 (16%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVL---NLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           G FG+VY     + K I+A+KVL    L   G       E     ++RH N++++     
Sbjct: 23  GKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRL----- 77
Query: 468 GVDYKGDDFKA-LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI-DVACAL 525
              Y  D  +  L+ E+   G++   L  +S  D+           QR    I ++A AL
Sbjct: 78  -YGYFHDATRVYLILEYAPLGTVYRELQKLSRFDE-----------QRTATYITELANAL 125
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            Y H        H D+KP N+LL       +ADFG +   P +   T    + GT+ Y+ 
Sbjct: 126 SYCH---SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTT----LCGTLDYL- 177
Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART-----VLPDHV 640
           P E   G       D++S G+L  E +    P    FE +     + R        PD V
Sbjct: 178 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPP----FEAHTYQETYRRISRVEFTFPDFV 233
Query: 641 MD 642
            +
Sbjct: 234 TE 235

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 110/263 (41%), Gaps = 32/263 (12%)
Query: 405 LCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGA-SKSSIAECSALRNIRHKNLVKIL 463
           L +I  G++G V     +  K  +A+K ++   H    + ++ E   L   RH+N++ I 
Sbjct: 32  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGIN 91
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            +      +      +V + M     E  L+ +           C    Q       +  
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQ-------ILR 139
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIG-VKGTIG 582
            LKY+H        H DLKPSN+LL+      + DFGLA++  P H  T  +     T  
Sbjct: 140 GLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 583 YIAPAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM 641
           Y AP E  L S+  + + D++S G +L E+++  RP   +F G   L         +H++
Sbjct: 197 YRAP-EIMLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQL------NHIL 245
Query: 642 DIVDSTLLADDEDLTITSNQRQR 664
            I+ S      EDL    N + R
Sbjct: 246 GILGS---PSQEDLNCIINLKAR 265

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 110/263 (41%), Gaps = 32/263 (12%)
Query: 405 LCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGAS-KSSIAECSALRNIRHKNLVKIL 463
           L +I  G++G V     +  K  +A+K ++   H    + ++ E   L   RH+N++ I 
Sbjct: 32  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            +      +      +V + M     E  L+ +           C    Q       +  
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQ-------ILR 139
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIG-VKGTIG 582
            LKY+H        H DLKPSN+LL+      + DFGLA++  P H  T  +     T  
Sbjct: 140 GLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 583 YIAPAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM 641
           Y AP E  L S+  + + D++S G +L E+++  RP   +F G   L         +H++
Sbjct: 197 YRAP-EIMLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQL------NHIL 245
Query: 642 DIVDSTLLADDEDLTITSNQRQR 664
            I+ S      EDL    N + R
Sbjct: 246 GILGS---PSQEDLNCIINLKAR 265

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 110/263 (41%), Gaps = 32/263 (12%)
Query: 405 LCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGAS-KSSIAECSALRNIRHKNLVKIL 463
           L +I  G++G V     +  K  +A+K ++   H    + ++ E   L   RH+N++ I 
Sbjct: 28  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 87
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            +      +      +V + M     E  L+ +           C    Q       +  
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQ-------ILR 135
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIG-VKGTIG 582
            LKY+H        H DLKPSN+LL+      + DFGLA++  P H  T  +     T  
Sbjct: 136 GLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 583 YIAPAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM 641
           Y AP E  L S+  + + D++S G +L E+++  RP   +F G   L         +H++
Sbjct: 193 YRAP-EIMLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQL------NHIL 241
Query: 642 DIVDSTLLADDEDLTITSNQRQR 664
            I+ S      EDL    N + R
Sbjct: 242 GILGS---PSQEDLNCIINLKAR 261

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 77/164 (46%), Gaps = 24/164 (14%)
Query: 457 KNLVKILT--------VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKC 508
           KN ++I+T         C G+    D+   ++YE+M N S+ ++       DK      C
Sbjct: 91  KNELQIITDIKNEYCLTCEGIITNYDEV-YIIYEYMENDSILKFDEYFFVLDKNYT---C 146
Query: 509 LNFLQRINIAID-VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPP 567
              +Q I   I  V  +  Y+H+  +    H D+KPSN+L+D      ++DFG ++ +  
Sbjct: 147 FIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD 204
Query: 568 AHLQTSSIGVKGTIGYIAPAEYGLGSEVSING---DVYSYGILL 608
             ++    G +GT  ++ P      +E S NG   D++S GI L
Sbjct: 205 KKIK----GSRGTYEFMPPE--FFSNESSYNGAKVDIWSLGICL 242

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 110/263 (41%), Gaps = 32/263 (12%)
Query: 405 LCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGAS-KSSIAECSALRNIRHKNLVKIL 463
           L +I  G++G V     +  K  +A+K ++   H    + ++ E   L   RH+N++ I 
Sbjct: 28  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 87
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            +      +      +V + M     E  L+ +           C    Q       +  
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQ-------ILR 135
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIG-VKGTIG 582
            LKY+H        H DLKPSN+LL+      + DFGLA++  P H  T  +     T  
Sbjct: 136 GLKYIH---SANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 583 YIAPAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM 641
           Y AP E  L S+  + + D++S G +L E+++  RP   +F G   L         +H++
Sbjct: 193 YRAP-EIMLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQL------NHIL 241
Query: 642 DIVDSTLLADDEDLTITSNQRQR 664
            I+ S      EDL    N + R
Sbjct: 242 GILGS---PSQEDLNXIINLKAR 261

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/262 (24%), Positives = 107/262 (40%), Gaps = 30/262 (11%)
Query: 405 LCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGAS-KSSIAECSALRNIRHKNLVKIL 463
           L +I  G++G V     +  K  +A+K ++   H    + ++ E   L   RH+N++ I 
Sbjct: 32  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            +      +      +V + M     E  L+ +           C    Q       +  
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQ-------ILR 139
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGY 583
            LKY+H        H DLKPSN+LL+      + DFGLA++  P H  T  +       +
Sbjct: 140 GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRW 196
Query: 584 IAPAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMD 642
               E  L S+  + + D++S G +L E+++  RP   +F G   L         +H++ 
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQL------NHILG 246
Query: 643 IVDSTLLADDEDLTITSNQRQR 664
           I+ S      EDL    N + R
Sbjct: 247 ILGS---PSQEDLNCIINLKAR 265

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/262 (24%), Positives = 107/262 (40%), Gaps = 30/262 (11%)
Query: 405 LCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGAS-KSSIAECSALRNIRHKNLVKIL 463
           L +I  G++G V     +  K  +A+K ++   H    + ++ E   L   RH+N++ I 
Sbjct: 33  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 92
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            +      +      +V + M     E  L+ +           C    Q       +  
Sbjct: 93  DIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQ-------ILR 140
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGY 583
            LKY+H        H DLKPSN+LL+      + DFGLA++  P H  T  +       +
Sbjct: 141 GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRW 197
Query: 584 IAPAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMD 642
               E  L S+  + + D++S G +L E+++  RP   +F G   L         +H++ 
Sbjct: 198 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQL------NHILG 247
Query: 643 IVDSTLLADDEDLTITSNQRQR 664
           I+ S      EDL    N + R
Sbjct: 248 ILGS---PSQEDLNCIINLKAR 266

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 90/213 (42%), Gaps = 28/213 (13%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVL---NLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           G FG+VY     + K I+A+KVL    L   G       E     ++RH N++++     
Sbjct: 26  GKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM----- 80
Query: 468 GVDYKGDDFK-ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALK 526
             +Y  D  +  L+ EF   G L + L      D+   A     F++      ++A AL 
Sbjct: 81  -YNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA----TFME------ELADALH 129
Query: 527 YLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP 586
           Y H   +    H D+KP N+L+ ++    +ADFG +   P    +       GT+ Y+ P
Sbjct: 130 YCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC----GTLDYL-P 181
Query: 587 AEYGLGSEVSINGDVYSYGILLLELMTRKRPSD 619
            E   G       D++  G+L  E +    P D
Sbjct: 182 PEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 100/233 (42%), Gaps = 48/233 (20%)
Query: 415 SVYKGILDEGKTIIAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYK 472
           + Y  +LD     +A+K L+    +   +K +  E   ++ + HKN++ +L V       
Sbjct: 42  AAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNV------- 91
Query: 473 GDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAID----------VA 522
                     F    +LEE    V    + ++A    N  Q I + +D          + 
Sbjct: 92  ----------FTPQKTLEE-FQDVYLVMELMDA----NLXQVIQMELDHERMSYLLYQML 136
Query: 523 CALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIG 582
           C +K+LH        H DLKPSN+++  + T  + DFGLA+    + + T  +    T  
Sbjct: 137 CGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYV---VTRY 190
Query: 583 YIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV 635
           Y AP E  LG     N D++S G ++ E++  K    I+F G   +  + + +
Sbjct: 191 YRAP-EVILGMGYKENVDIWSVGCIMGEMVRHK----ILFPGRDYIDQWNKVI 238

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 90/213 (42%), Gaps = 28/213 (13%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVL---NLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           G FG+VY     + K I+A+KVL    L   G       E     ++RH N++++     
Sbjct: 25  GKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM----- 79
Query: 468 GVDYKGDDFK-ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALK 526
             +Y  D  +  L+ EF   G L + L      D+   A     F++      ++A AL 
Sbjct: 80  -YNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA----TFME------ELADALH 128
Query: 527 YLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP 586
           Y H   +    H D+KP N+L+ ++    +ADFG +   P    +       GT+ Y+ P
Sbjct: 129 YCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC----GTLDYL-P 180
Query: 587 AEYGLGSEVSINGDVYSYGILLLELMTRKRPSD 619
            E   G       D++  G+L  E +    P D
Sbjct: 181 PEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 95/220 (43%), Gaps = 31/220 (14%)
Query: 402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSI----AECSALRNIRHK 457
           F+F   +  G+FG V+   L E ++    +V+  ++   S+  +    AE   L+++ H 
Sbjct: 24  FIFKRKLGSGAFGDVH---LVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 458 NLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINI 517
           N++KI  V    DY       +V E    G L E +       K +        ++++  
Sbjct: 81  NIIKIFEVFE--DYHN---MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQM-- 133
Query: 518 AIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH----VADFGLAKLLPPAHLQTS 573
                 AL Y H        H DLKP N+L   + + H    + DFGLA+L         
Sbjct: 134 ----MNALAYFHSQ---HVVHKDLKPENILF-QDTSPHSPIKIIDFGLAELFKS---DEH 182
Query: 574 SIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
           S    GT  Y+AP  +    +V+   D++S G+++  L+T
Sbjct: 183 STNAAGTALYMAPEVF--KRDVTFKCDIWSAGVVMYFLLT 220

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 110/263 (41%), Gaps = 32/263 (12%)
Query: 405 LCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGAS-KSSIAECSALRNIRHKNLVKIL 463
           L +I  G++G V     +  K  +A+K ++   H    + ++ E   L   RH+N++ I 
Sbjct: 48  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 107
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            +      +      +V + M     E  L+ +           C    Q       +  
Sbjct: 108 DIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQ-------ILR 155
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIG-VKGTIG 582
            LKY+H        H DLKPSN+LL+      + DFGLA++  P H  T  +     T  
Sbjct: 156 GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 212
Query: 583 YIAPAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM 641
           Y AP E  L S+  + + D++S G +L E+++  RP   +F G   L         +H++
Sbjct: 213 YRAP-EIMLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQL------NHIL 261
Query: 642 DIVDSTLLADDEDLTITSNQRQR 664
            I+ S      EDL    N + R
Sbjct: 262 GILGS---PSQEDLNCIINLKAR 281

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 101/237 (42%), Gaps = 48/237 (20%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTVCSG 468
           G   + Y  +LD     +A+K L+    +   +K +  E   ++ + HKN++ +L V   
Sbjct: 38  GIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNV--- 91
Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAID-------- 520
                         F    +LEE    V    + ++A    N  Q I + +D        
Sbjct: 92  --------------FTPQKTLEE-FQDVYLVMELMDA----NLCQVIQMELDHERMSYLL 132
Query: 521 --VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK 578
             + C +K+LH        H DLKPSN+++  + T  + DFGLA+    + + T  +   
Sbjct: 133 YQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYV--- 186
Query: 579 GTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV 635
            T  Y AP E  LG     N D++S G ++ E++  K    I+F G   +  + + +
Sbjct: 187 VTRYYRAP-EVILGMGYKENVDIWSVGCIMGEMVRHK----ILFPGRDYIDQWNKVI 238

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 93/213 (43%), Gaps = 28/213 (13%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           I  G+ G+VY  +       +A++ +NL      +  I E   +R  ++ N+V  L    
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD--- 85
Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
              Y   D   +V E++  GSL +           V    C++  Q   +  +   AL++
Sbjct: 86  --SYLVGDELWVVMEYLAGGSLTD-----------VVTETCMDEGQIAAVCRECLQALEF 132
Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP- 586
           LH +      H ++K  N+LL  + +  + DFG    + P   + S++   GT  ++AP 
Sbjct: 133 LHSN---QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM--VGTPYWMAPE 187
Query: 587 --AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
                  G +V    D++S GI+ +E++  + P
Sbjct: 188 VVTRKAYGPKV----DIWSLGIMAIEMIEGEPP 216

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 105/232 (45%), Gaps = 24/232 (10%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVK--VLNLLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           I  G+FG V+K    +    +A+K  ++     G   +++ E   L+ ++H+N+V ++ +
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 466 CSGVDYKGDDFKA---LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVA 522
           C       +  KA   LV++F          H ++G    V     L+ ++R+   +   
Sbjct: 86  CRTKASPYNRCKASIYLVFDFCE--------HDLAGLLSNVLVKFTLSEIKRVMQML--L 135
Query: 523 CALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPA-HLQTSSIGVKGTI 581
             L Y+H +      H D+K +NVL+  +    +ADFGLA+    A + Q +    +   
Sbjct: 136 NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVT 192
Query: 582 GYIAPAEYGLGS-EVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFA 632
            +  P E  LG  +     D++  G ++ E+ TR   S IM +GN   H  A
Sbjct: 193 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR---SPIM-QGNTEQHQLA 240

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 110/263 (41%), Gaps = 32/263 (12%)
Query: 405 LCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGAS-KSSIAECSALRNIRHKNLVKIL 463
           L +I  G++G V     +  K  +A+K ++   H    + ++ E   L   RH+N++ I 
Sbjct: 36  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 95
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            +      +      +V + M     E  L+ +           C    Q       +  
Sbjct: 96  DIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQ-------ILR 143
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIG-VKGTIG 582
            LKY+H        H DLKPSN+LL+      + DFGLA++  P H  T  +     T  
Sbjct: 144 GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 200
Query: 583 YIAPAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM 641
           Y AP E  L S+  + + D++S G +L E+++  RP   +F G   L         +H++
Sbjct: 201 YRAP-EIMLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQL------NHIL 249
Query: 642 DIVDSTLLADDEDLTITSNQRQR 664
            I+ S      EDL    N + R
Sbjct: 250 GILGS---PSQEDLNCIINLKAR 269

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 110/263 (41%), Gaps = 32/263 (12%)
Query: 405 LCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGAS-KSSIAECSALRNIRHKNLVKIL 463
           L +I  G++G V     +  K  +A+K ++   H    + ++ E   L   RH+N++ I 
Sbjct: 28  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 87
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            +      +      +V + M     E  L+ +           C    Q       +  
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQ-------ILR 135
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIG-VKGTIG 582
            LKY+H        H DLKPSN+LL+      + DFGLA++  P H  T  +     T  
Sbjct: 136 GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 583 YIAPAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM 641
           Y AP E  L S+  + + D++S G +L E+++  RP   +F G   L         +H++
Sbjct: 193 YRAP-EIMLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQL------NHIL 241
Query: 642 DIVDSTLLADDEDLTITSNQRQR 664
            I+ S      EDL    N + R
Sbjct: 242 GILGS---PSQEDLNCIINLKAR 261

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 50/100 (50%), Gaps = 9/100 (9%)
Query: 518 AIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           A +V  AL+YLH        + DLKP N+LLD      + DFG AK +P       +  +
Sbjct: 112 AAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYXL 163
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
            GT  YIAP E       + + D +S+GIL+ E++    P
Sbjct: 164 CGTPDYIAP-EVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 97/218 (44%), Gaps = 24/218 (11%)
Query: 411 GSFGSVYKGI---LDEGKTIIAVKV-LNLLHHGASKSS----IAECSALRNI-RHKNLVK 461
           G+FG V       +D+ K   AV V + +L   A++      ++E   ++ I +HKN++ 
Sbjct: 46  GAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIN 105
Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVS--GADKTVEAPKC----LNFLQRI 515
           +L  C+      D    ++ E+   G+L E+L      G + + +  +     + F   +
Sbjct: 106 LLGACTQ-----DGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLV 160
Query: 516 NIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSI 575
           +    +A  ++YL         H DL   NVL+       +ADFGLA+ +        + 
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTT 217
Query: 576 GVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             +  + ++AP E       +   DV+S+G+L+ E+ T
Sbjct: 218 NGRLPVKWMAP-EALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 110/263 (41%), Gaps = 32/263 (12%)
Query: 405 LCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGAS-KSSIAECSALRNIRHKNLVKIL 463
           L +I  G++G V     +  K  +A+K ++   H    + ++ E   L   RH+N++ I 
Sbjct: 26  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 85
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            +      +      +V + M     E  L+ +           C    Q       +  
Sbjct: 86  DIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQ-------ILR 133
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIG-VKGTIG 582
            LKY+H        H DLKPSN+LL+      + DFGLA++  P H  T  +     T  
Sbjct: 134 GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 190
Query: 583 YIAPAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM 641
           Y AP E  L S+  + + D++S G +L E+++  RP   +F G   L         +H++
Sbjct: 191 YRAP-EIMLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQL------NHIL 239
Query: 642 DIVDSTLLADDEDLTITSNQRQR 664
            I+ S      EDL    N + R
Sbjct: 240 GILGS---PSQEDLNCIINLKAR 259

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 110/263 (41%), Gaps = 32/263 (12%)
Query: 405 LCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGAS-KSSIAECSALRNIRHKNLVKIL 463
           L +I  G++G V     +  K  +A+K ++   H    + ++ E   L   RH+N++ I 
Sbjct: 30  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 89
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            +      +      +V + M     E  L+ +           C    Q       +  
Sbjct: 90  DIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQ-------ILR 137
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIG-VKGTIG 582
            LKY+H        H DLKPSN+LL+      + DFGLA++  P H  T  +     T  
Sbjct: 138 GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 194
Query: 583 YIAPAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM 641
           Y AP E  L S+  + + D++S G +L E+++  RP   +F G   L         +H++
Sbjct: 195 YRAP-EIMLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQL------NHIL 243
Query: 642 DIVDSTLLADDEDLTITSNQRQR 664
            I+ S      EDL    N + R
Sbjct: 244 GILGS---PSQEDLNCIINLKAR 263

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 110/263 (41%), Gaps = 32/263 (12%)
Query: 405 LCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGAS-KSSIAECSALRNIRHKNLVKIL 463
           L +I  G++G V     +  K  +A+K ++   H    + ++ E   L   RH+N++ I 
Sbjct: 33  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 92
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            +      +      +V + M     E  L+ +           C    Q       +  
Sbjct: 93  DIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQ-------ILR 140
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIG-VKGTIG 582
            LKY+H        H DLKPSN+LL+      + DFGLA++  P H  T  +     T  
Sbjct: 141 GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 197
Query: 583 YIAPAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM 641
           Y AP E  L S+  + + D++S G +L E+++  RP   +F G   L         +H++
Sbjct: 198 YRAP-EIMLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQL------NHIL 246
Query: 642 DIVDSTLLADDEDLTITSNQRQR 664
            I+ S      EDL    N + R
Sbjct: 247 GILGS---PSQEDLNCIINLKAR 266

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 110/263 (41%), Gaps = 32/263 (12%)
Query: 405 LCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGAS-KSSIAECSALRNIRHKNLVKIL 463
           L +I  G++G V     +  K  +A+K ++   H    + ++ E   L   RH+N++ I 
Sbjct: 34  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 93
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            +      +      +V + M     E  L+ +           C    Q       +  
Sbjct: 94  DIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQ-------ILR 141
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIG-VKGTIG 582
            LKY+H        H DLKPSN+LL+      + DFGLA++  P H  T  +     T  
Sbjct: 142 GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 198
Query: 583 YIAPAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM 641
           Y AP E  L S+  + + D++S G +L E+++  RP   +F G   L         +H++
Sbjct: 199 YRAP-EIMLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQL------NHIL 247
Query: 642 DIVDSTLLADDEDLTITSNQRQR 664
            I+ S      EDL    N + R
Sbjct: 248 GILGS---PSQEDLNCIINLKAR 267

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 110/263 (41%), Gaps = 32/263 (12%)
Query: 405 LCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGAS-KSSIAECSALRNIRHKNLVKIL 463
           L +I  G++G V     +  K  +A+K ++   H    + ++ E   L   RH+N++ I 
Sbjct: 25  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 84
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            +      +      +V + M     E  L+ +           C    Q       +  
Sbjct: 85  DIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQ-------ILR 132
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIG-VKGTIG 582
            LKY+H        H DLKPSN+LL+      + DFGLA++  P H  T  +     T  
Sbjct: 133 GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 189
Query: 583 YIAPAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM 641
           Y AP E  L S+  + + D++S G +L E+++  RP   +F G   L         +H++
Sbjct: 190 YRAP-EIMLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQL------NHIL 238
Query: 642 DIVDSTLLADDEDLTITSNQRQR 664
            I+ S      EDL    N + R
Sbjct: 239 GILGS---PSQEDLNCIINLKAR 258

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 110/263 (41%), Gaps = 32/263 (12%)
Query: 405 LCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGAS-KSSIAECSALRNIRHKNLVKIL 463
           L +I  G++G V     +  K  +A+K ++   H    + ++ E   L   RH+N++ I 
Sbjct: 32  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            +      +      +V + M     E  L+ +           C    Q       +  
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQ-------ILR 139
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIG-VKGTIG 582
            LKY+H        H DLKPSN+LL+      + DFGLA++  P H  T  +     T  
Sbjct: 140 GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 583 YIAPAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM 641
           Y AP E  L S+  + + D++S G +L E+++  RP   +F G   L         +H++
Sbjct: 197 YRAP-EIMLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQL------NHIL 245
Query: 642 DIVDSTLLADDEDLTITSNQRQR 664
            I+ S      EDL    N + R
Sbjct: 246 GILGS---PSQEDLNCIINLKAR 265

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 98/218 (44%), Gaps = 24/218 (11%)
Query: 411 GSFGSVY--KGI-LDEGKTIIAVKV-LNLLHHGASKSS----IAECSALRNI-RHKNLVK 461
           G+FG V   + I LD+ K     KV + +L   A++      I+E   ++ I +HKN++ 
Sbjct: 80  GAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIIN 139
Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVS------GADKTVEAPKCLNFLQRI 515
           +L  C+      D    ++ E+   G+L E+L            + +    + L+    +
Sbjct: 140 LLGACTQ-----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 516 NIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSI 575
           + A  VA  ++YL         H DL   NVL+  +    +ADFGLA+ +        + 
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 251
Query: 576 GVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             +  + ++AP E       +   DV+S+G+LL E+ T
Sbjct: 252 NGRLPVKWMAP-EALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 110/263 (41%), Gaps = 32/263 (12%)
Query: 405 LCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGAS-KSSIAECSALRNIRHKNLVKIL 463
           L +I  G++G V     +  K  +A+K ++   H    + ++ E   L   RH+N++ I 
Sbjct: 28  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 87
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            +      +      +V + M     E  L+ +           C    Q       +  
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQ-------ILR 135
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIG-VKGTIG 582
            LKY+H        H DLKPSN+LL+      + DFGLA++  P H  T  +     T  
Sbjct: 136 GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 583 YIAPAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM 641
           Y AP E  L S+  + + D++S G +L E+++  RP   +F G   L         +H++
Sbjct: 193 YRAP-EIMLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQL------NHIL 241
Query: 642 DIVDSTLLADDEDLTITSNQRQR 664
            I+ S      EDL    N + R
Sbjct: 242 GILGS---PSQEDLNCIINLKAR 261

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 95/221 (42%), Gaps = 31/221 (14%)
Query: 402 FLFLCWIDMGSFGS--VYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNL 459
           ++ L  I  GSFG   + K   D  + +I    ++ +     + S  E + L N++H N+
Sbjct: 26  YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI 85
Query: 460 VKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGAD--KTVEAPKCLNFL--QRI 515
           V+                     F  NGSL   +    G D  K + A K + F   Q +
Sbjct: 86  VQYRE-----------------SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQIL 128
Query: 516 NIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL-PPAHLQTSS 574
           +  + +  ALK++H        H D+K  N+ L  + T  + DFG+A++L     L  + 
Sbjct: 129 DWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARAC 185
Query: 575 IGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRK 615
           I   GT  Y++P E       +   D+++ G +L EL T K
Sbjct: 186 I---GTPYYLSP-EICENKPYNNKSDIWALGCVLYELCTLK 222

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 97/218 (44%), Gaps = 24/218 (11%)
Query: 411 GSFGSVYKGI---LDEGKTIIAVKV-LNLLHHGASKSS----IAECSALRNI-RHKNLVK 461
           G+FG V       +D+ K   AV V + +L   A++      ++E   ++ I +HKN++ 
Sbjct: 46  GAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIN 105
Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVS--GADKTVEAPKC----LNFLQRI 515
           +L  C+      D    ++ E+   G+L E+L      G + + +  +     + F   +
Sbjct: 106 LLGACTQ-----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 516 NIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSI 575
           +    +A  ++YL         H DL   NVL+       +ADFGLA+ +        + 
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTT 217
Query: 576 GVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             +  + ++AP E       +   DV+S+G+L+ E+ T
Sbjct: 218 NGRLPVKWMAP-EALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 98/218 (44%), Gaps = 24/218 (11%)
Query: 411 GSFGSVY--KGI-LDEGKTIIAVKV-LNLLHHGASKSS----IAECSALRNI-RHKNLVK 461
           G+FG V   + I LD+ K     KV + +L   A++      I+E   ++ I +HKN++ 
Sbjct: 39  GAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIIN 98
Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGA------DKTVEAPKCLNFLQRI 515
           +L  C+      D    ++ E+   G+L E+L            + +    + L+    +
Sbjct: 99  LLGACTQ-----DGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLV 153
Query: 516 NIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSI 575
           + A  VA  ++YL         H DL   NVL+  +    +ADFGLA+ +        + 
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTT 210
Query: 576 GVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             +  + ++AP E       +   DV+S+G+LL E+ T
Sbjct: 211 NGRLPVKWMAP-EALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 68/142 (47%), Gaps = 19/142 (13%)
Query: 479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAH 538
           +V E++   +L + +H         E P  +   + I +  D   AL + H   Q    H
Sbjct: 93  IVMEYVDGVTLRDIVH--------TEGP--MTPKRAIEVIADACQALNFSH---QNGIIH 139
Query: 539 CDLKPSNVLLDHEMTAHVADFGLAKLLPPAH---LQTSSIGVKGTIGYIAPAEYGLGSEV 595
            D+KP+N+L+       V DFG+A+ +  +     QT++  V GT  Y++P E   G  V
Sbjct: 140 RDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAA--VIGTAQYLSP-EQARGDSV 196
Query: 596 SINGDVYSYGILLLELMTRKRP 617
               DVYS G +L E++T + P
Sbjct: 197 DARSDVYSLGCVLYEVLTGEPP 218

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 110/263 (41%), Gaps = 32/263 (12%)
Query: 405 LCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGAS-KSSIAECSALRNIRHKNLVKIL 463
           L +I  G++G V     +  K  +A+K ++   H    + ++ E   L   RH+N++ I 
Sbjct: 32  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            +      +      +V + M     E  L+ +           C    Q       +  
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKCQHLSNDHICYFLYQ-------ILR 139
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIG-VKGTIG 582
            LKY+H        H DLKPSN+LL+      + DFGLA++  P H  T  +     T  
Sbjct: 140 GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 583 YIAPAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM 641
           Y AP E  L S+  + + D++S G +L E+++  RP   +F G   L         +H++
Sbjct: 197 YRAP-EIMLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQL------NHIL 245
Query: 642 DIVDSTLLADDEDLTITSNQRQR 664
            I+ S      EDL    N + R
Sbjct: 246 GILGS---PSQEDLNCIINLKAR 265

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 19/209 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G++G VY G     +  IA+K +       S+    E +  ++++HKN+V+ L       
Sbjct: 19  GTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG-----S 73
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
           +  + F  +  E +  GSL   L    G  K  E  + + F  +      +   LKYLH 
Sbjct: 74  FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNE--QTIGFYTK-----QILEGLKYLHD 126
Query: 531 DCQPTTAHCDLKPSNVLLD-HEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEY 589
           +      H D+K  NVL++ +     ++DFG +K L  A +   +    GT+ Y+AP   
Sbjct: 127 N---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRL--AGINPCTETFTGTLQYMAPEII 181
Query: 590 GLGSE-VSINGDVYSYGILLLELMTRKRP 617
             G        D++S G  ++E+ T K P
Sbjct: 182 DKGPRGYGKAADIWSLGCTIIEMATGKPP 210

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 98/218 (44%), Gaps = 24/218 (11%)
Query: 411 GSFGSVYKGI---LDEGKTIIAVKV-LNLLHHGASKSS----IAECSALRNI-RHKNLVK 461
           G+FG V       +D+ K   AV V + +L   A++      ++E   ++ I +HKN++ 
Sbjct: 46  GAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIN 105
Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVS--GADKTVEAPKC----LNFLQRI 515
           +L  C+      D    ++ E+   G+L E+L      G + + +  +     + F   +
Sbjct: 106 LLGACTQ-----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 516 NIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSI 575
           +    +A  ++YL         H DL   NVL+       +ADFGLA+ +       ++ 
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTT 217
Query: 576 GVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             +  + ++AP E       +   DV+S+G+L+ E+ T
Sbjct: 218 NGRLPVKWMAP-EALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 98/218 (44%), Gaps = 24/218 (11%)
Query: 411 GSFGSVY--KGI-LDEGKTIIAVKV-LNLLHHGASKSS----IAECSALRNI-RHKNLVK 461
           G+FG V   + I LD+ K     KV + +L   A++      I+E   ++ I +HKN++ 
Sbjct: 39  GAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIIN 98
Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVS------GADKTVEAPKCLNFLQRI 515
           +L  C+      D    ++ E+   G+L E+L            + +    + L+    +
Sbjct: 99  LLGACTQ-----DGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 516 NIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSI 575
           + A  VA  ++YL         H DL   NVL+  +    +ADFGLA+ +        + 
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 210
Query: 576 GVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             +  + ++AP E       +   DV+S+G+LL E+ T
Sbjct: 211 NGRLPVKWMAP-EALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 98/218 (44%), Gaps = 24/218 (11%)
Query: 411 GSFGSVY--KGI-LDEGKTIIAVKV-LNLLHHGASKSS----IAECSALRNI-RHKNLVK 461
           G+FG V   + I LD+ K     KV + +L   A++      I+E   ++ I +HKN++ 
Sbjct: 32  GAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIIN 91
Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVS------GADKTVEAPKCLNFLQRI 515
           +L  C+      D    ++ E+   G+L E+L            + +    + L+    +
Sbjct: 92  LLGACTQ-----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 146
Query: 516 NIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSI 575
           + A  VA  ++YL         H DL   NVL+  +    +ADFGLA+ +        + 
Sbjct: 147 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 203
Query: 576 GVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             +  + ++AP E       +   DV+S+G+LL E+ T
Sbjct: 204 NGRLPVKWMAP-EALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 19/209 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G++G VY G     +  IA+K +       S+    E +  ++++HKN+V+ L       
Sbjct: 33  GTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG-----S 87
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
           +  + F  +  E +  GSL   L    G  K  E  + + F  +      +   LKYLH 
Sbjct: 88  FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNE--QTIGFYTK-----QILEGLKYLHD 140
Query: 531 DCQPTTAHCDLKPSNVLLD-HEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEY 589
           +      H D+K  NVL++ +     ++DFG +K L  A +   +    GT+ Y+AP   
Sbjct: 141 N---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRL--AGINPCTETFTGTLQYMAPEII 195
Query: 590 GLGSE-VSINGDVYSYGILLLELMTRKRP 617
             G        D++S G  ++E+ T K P
Sbjct: 196 DKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 97/218 (44%), Gaps = 24/218 (11%)
Query: 411 GSFGSVYKGI---LDEGKTIIAVKV-LNLLHHGASKSS----IAECSALRNI-RHKNLVK 461
           G+FG V       +D+ K   AV V + +L   A++      ++E   ++ I +HKN++ 
Sbjct: 46  GAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIN 105
Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVS--GADKTVEAPKC----LNFLQRI 515
           +L  C+      D    ++ E+   G+L E+L      G + + +  +     + F   +
Sbjct: 106 LLGACTQ-----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 516 NIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSI 575
           +    +A  ++YL         H DL   NVL+       +ADFGLA+ +        + 
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTT 217
Query: 576 GVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             +  + ++AP E       +   DV+S+G+L+ E+ T
Sbjct: 218 NGRLPVKWMAP-EALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 98/218 (44%), Gaps = 24/218 (11%)
Query: 411 GSFGSVY--KGI-LDEGKTIIAVKV-LNLLHHGASKSS----IAECSALRNI-RHKNLVK 461
           G+FG V   + I LD+ K     KV + +L   A++      I+E   ++ I +HKN++ 
Sbjct: 28  GAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIIN 87
Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVS------GADKTVEAPKCLNFLQRI 515
           +L  C+      D    ++ E+   G+L E+L            + +    + L+    +
Sbjct: 88  LLGACTQ-----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 142
Query: 516 NIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSI 575
           + A  VA  ++YL         H DL   NVL+  +    +ADFGLA+ +        + 
Sbjct: 143 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 199
Query: 576 GVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             +  + ++AP E       +   DV+S+G+LL E+ T
Sbjct: 200 NGRLPVKWMAP-EALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 97/218 (44%), Gaps = 24/218 (11%)
Query: 411 GSFGSVYKGI---LDEGKTIIAVKV-LNLLHHGASKSS----IAECSALRNI-RHKNLVK 461
           G+FG V       +D+ K   AV V + +L   A++      ++E   ++ I +HKN++ 
Sbjct: 46  GAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKNIIN 105
Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVS--GADKTVEAPKC----LNFLQRI 515
           +L  C+      D    ++ E+   G+L E+L      G + + +  +     + F   +
Sbjct: 106 LLGACTQ-----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 516 NIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSI 575
           +    +A  ++YL         H DL   NVL+       +ADFGLA+ +        + 
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 576 GVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             +  + ++AP E       +   DV+S+G+L+ E+ T
Sbjct: 218 NGRLPVKWMAP-EALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 98/218 (44%), Gaps = 24/218 (11%)
Query: 411 GSFGSVY--KGI-LDEGKTIIAVKV-LNLLHHGASKSS----IAECSALRNI-RHKNLVK 461
           G+FG V   + I LD+ K     KV + +L   A++      I+E   ++ I +HKN++ 
Sbjct: 39  GAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIIN 98
Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVS------GADKTVEAPKCLNFLQRI 515
           +L  C+      D    ++ E+   G+L E+L            + +    + L+    +
Sbjct: 99  LLGACTQ-----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 516 NIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSI 575
           + A  VA  ++YL         H DL   NVL+  +    +ADFGLA+ +        + 
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 210
Query: 576 GVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             +  + ++AP E       +   DV+S+G+LL E+ T
Sbjct: 211 NGRLPVKWMAP-EALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 110/263 (41%), Gaps = 32/263 (12%)
Query: 405 LCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGAS-KSSIAECSALRNIRHKNLVKIL 463
           L +I  G++G V     +  K  +A+K ++   H    + ++ E   L   RH+N++ I 
Sbjct: 30  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGIN 89
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            +      +      +V + M     E  L+ +           C    Q       +  
Sbjct: 90  DIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQ-------ILR 137
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIG-VKGTIG 582
            LKY+H        H DLKPSN+LL+      + DFGLA++  P H  T  +     T  
Sbjct: 138 GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 194
Query: 583 YIAPAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM 641
           Y AP E  L S+  + + D++S G +L E+++  RP   +F G   L         +H++
Sbjct: 195 YRAP-EIMLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQL------NHIL 243
Query: 642 DIVDSTLLADDEDLTITSNQRQR 664
            I+ S      EDL    N + R
Sbjct: 244 GILGS---PSQEDLNCIINLKAR 263

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 55/105 (52%), Gaps = 8/105 (7%)
Query: 518 AIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKL-LPPAHLQTSSIG 576
           + +++ AL YLH   +    + DLK  NVLLD E    + D+G+ K  L P    ++   
Sbjct: 159 SAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC- 214
Query: 577 VKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIM 621
             GT  YIAP E   G +   + D ++ G+L+ E+M  + P DI+
Sbjct: 215 --GTPNYIAP-EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 256

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 98/218 (44%), Gaps = 24/218 (11%)
Query: 411 GSFGSVY--KGI-LDEGKTIIAVKV-LNLLHHGASKSS----IAECSALRNI-RHKNLVK 461
           G+FG V   + I LD+ K     KV + +L   A++      I+E   ++ I +HKN++ 
Sbjct: 31  GAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIIN 90
Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVS------GADKTVEAPKCLNFLQRI 515
           +L  C+      D    ++ E+   G+L E+L            + +    + L+    +
Sbjct: 91  LLGACTQ-----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 145
Query: 516 NIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSI 575
           + A  VA  ++YL         H DL   NVL+  +    +ADFGLA+ +        + 
Sbjct: 146 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 202
Query: 576 GVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             +  + ++AP E       +   DV+S+G+LL E+ T
Sbjct: 203 NGRLPVKWMAP-EALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 98/218 (44%), Gaps = 24/218 (11%)
Query: 411 GSFGSVY--KGI-LDEGKTIIAVKV-LNLLHHGASKSS----IAECSALRNI-RHKNLVK 461
           G+FG V   + I LD+ K     KV + +L   A++      I+E   ++ I +HKN++ 
Sbjct: 24  GAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIIN 83
Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGA------DKTVEAPKCLNFLQRI 515
           +L  C+      D    ++ E+   G+L E+L            + +    + L+    +
Sbjct: 84  LLGACTQ-----DGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 138
Query: 516 NIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSI 575
           + A  VA  ++YL         H DL   NVL+  +    +ADFGLA+ +        + 
Sbjct: 139 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 576 GVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             +  + ++AP E       +   DV+S+G+LL E+ T
Sbjct: 196 NGRLPVKWMAP-EALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 97/218 (44%), Gaps = 24/218 (11%)
Query: 411 GSFGSVYKGI---LDEGKTIIAVKV-LNLLHHGASKSS----IAECSALRNI-RHKNLVK 461
           G+FG V       +D+ K   AV V + +L   A++      ++E   ++ I +HKN++ 
Sbjct: 46  GAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIT 105
Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVS--GADKTVEAPKC----LNFLQRI 515
           +L  C+      D    ++ E+   G+L E+L      G + + +  +     + F   +
Sbjct: 106 LLGACTQ-----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 516 NIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSI 575
           +    +A  ++YL         H DL   NVL+       +ADFGLA+ +        + 
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 576 GVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             +  + ++AP E       +   DV+S+G+L+ E+ T
Sbjct: 218 NGRLPVKWMAP-EALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 66/263 (25%), Positives = 110/263 (41%), Gaps = 32/263 (12%)
Query: 405 LCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGAS-KSSIAECSALRNIRHKNLVKIL 463
           L +I  G++G V     +  K  +A++ ++   H    + ++ E   L   RH+N++ I 
Sbjct: 32  LSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            +      +      +V + M     E  L+ +           C    Q       +  
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQ-------ILR 139
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIG-VKGTIG 582
            LKY+H        H DLKPSN+LL+      + DFGLA++  P H  T  +     T  
Sbjct: 140 GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 583 YIAPAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM 641
           Y AP E  L S+  + + D++S G +L E+++  RP   +F G   L         +H++
Sbjct: 197 YRAP-EIMLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQL------NHIL 245
Query: 642 DIVDSTLLADDEDLTITSNQRQR 664
            I+ S      EDL    N + R
Sbjct: 246 GILGS---PSQEDLNCIINLKAR 265

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/231 (21%), Positives = 94/231 (40%), Gaps = 23/231 (9%)
Query: 408 IDMGSFGSVYKG--ILDEGKTIIA-VKVLNLLHHGASKSSIAECSALRNIRHKNLVKILT 464
           I  G F  VY+   +LD     +  V++ +L+   A    I E   L+ + H N++K   
Sbjct: 40  IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 99
Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
                 +  D+   +V E    G L   +       + +       +       + +  A
Sbjct: 100 -----SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYF------VQLCSA 148
Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYI 584
           L+++H        H D+KP+NV +       + D GL +    +   T++  + GT  Y+
Sbjct: 149 LEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYM 203
Query: 585 APAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV 635
           +P E    +  +   D++S G LL E+   + P    +   MNL++  + +
Sbjct: 204 SP-ERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNLYSLCKKI 250

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 97/218 (44%), Gaps = 24/218 (11%)
Query: 411 GSFGSVYKGI---LDEGKTIIAVKV-LNLLHHGASKSS----IAECSALRNI-RHKNLVK 461
           G+FG V       +D+ K   AV V + +L   A++      ++E   ++ I +HKN++ 
Sbjct: 46  GAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIH 105
Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVS--GADKTVEAPKC----LNFLQRI 515
           +L  C+      D    ++ E+   G+L E+L      G + + +  +     + F   +
Sbjct: 106 LLGACTQ-----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 516 NIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSI 575
           +    +A  ++YL         H DL   NVL+       +ADFGLA+ +        + 
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 576 GVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             +  + ++AP E       +   DV+S+G+L+ E+ T
Sbjct: 218 NGRLPVKWMAP-EALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 27/209 (12%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHK----NLVKILTVC 466
           G+FGSV +G+    K  I V  + +L  G  K+   E      I H+     +V+++ VC
Sbjct: 347 GNFGSVRQGVYRMRKKQIDV-AIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC 405
Query: 467 SGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALK 526
                   +   LV E    G L ++L    G  + +        L ++++       +K
Sbjct: 406 QA------EALMLVMEMAGGGPLHKFL---VGKREEIPVSNVAELLHQVSMG------MK 450
Query: 527 YLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL--PPAHLQTSSIGVKGTIGYI 584
           YL    +    H +L   NVLL +   A ++DFGL+K L    ++    S G K  + + 
Sbjct: 451 YLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG-KWPLKWY 506
Query: 585 APAEYGLGSEVSINGDVYSYGILLLELMT 613
           AP       + S   DV+SYG+ + E ++
Sbjct: 507 APECINF-RKFSSRSDVWSYGVTMWEALS 534

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 101/237 (42%), Gaps = 48/237 (20%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTVCSG 468
           G   + Y  +LD     +A+K L+    +   +K +  E   ++ + HKN++ +L V   
Sbjct: 32  GIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV--- 85
Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAID-------- 520
                         F    +LEE    V    + ++A    N  Q I + +D        
Sbjct: 86  --------------FTPQKTLEE-FQDVYLVMELMDA----NLCQVIQMELDHERMSYLL 126
Query: 521 --VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK 578
             + C +K+LH        H DLKPSN+++  + T  + DFGLA+    + + T  +   
Sbjct: 127 YQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV--- 180
Query: 579 GTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV 635
            T  Y AP E  LG     N D++S G ++ E++  K    I+F G   +  + + +
Sbjct: 181 VTRYYRAP-EVILGMGYKENVDIWSVGCIMGEMVRHK----ILFPGRDYIDQWNKVI 232

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 101/237 (42%), Gaps = 48/237 (20%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTVCSG 468
           G   + Y  +LD     +A+K L+    +   +K +  E   ++ + HKN++ +L V   
Sbjct: 31  GIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV--- 84
Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAID-------- 520
                         F    +LEE    V    + ++A    N  Q I + +D        
Sbjct: 85  --------------FTPQKTLEE-FQDVYLVMELMDA----NLCQVIQMELDHERMSYLL 125
Query: 521 --VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK 578
             + C +K+LH        H DLKPSN+++  + T  + DFGLA+    + + T  +   
Sbjct: 126 YQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV--- 179
Query: 579 GTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV 635
            T  Y AP E  LG     N D++S G ++ E++  K    I+F G   +  + + +
Sbjct: 180 VTRYYRAP-EVILGMGYKENVDIWSVGCIMGEMVRHK----ILFPGRDYIDQWNKVI 231

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 37/105 (35%), Positives = 56/105 (53%), Gaps = 8/105 (7%)
Query: 518 AIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKL-LPPAHLQTSSIG 576
           + +++ AL YLH   +    + DLK  NVLLD E    + D+G+ K  L P    T+S  
Sbjct: 127 SAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSXF 181
Query: 577 VKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIM 621
             GT  YIAP E   G +   + D ++ G+L+ E+M  + P DI+
Sbjct: 182 C-GTPNYIAP-EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 224

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 105/235 (44%), Gaps = 24/235 (10%)
Query: 405 LCWIDMGSFGSVYKGILDEGKTIIAVK--VLNLLHHGASKSSIAECSALRNIRHKNLVKI 462
           L  I  G+FG V+K    +    +A+K  ++     G   +++ E   L+ ++H+N+V +
Sbjct: 23  LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNL 82
Query: 463 LTVCSGVDYKGDDFKA---LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI 519
           + +C       +  K    LV++F          H ++G    V     L+ ++R+   +
Sbjct: 83  IEICRTKASPYNRCKGSIYLVFDFCE--------HDLAGLLSNVLVKFTLSEIKRVMQML 134
Query: 520 DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPA-HLQTSSIGVK 578
                L Y+H +      H D+K +NVL+  +    +ADFGLA+    A + Q +    +
Sbjct: 135 --LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNR 189
Query: 579 GTIGYIAPAEYGLGS-EVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFA 632
               +  P E  LG  +     D++  G ++ E+ TR   S IM +GN   H  A
Sbjct: 190 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR---SPIM-QGNTEQHQLA 240

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 98/218 (44%), Gaps = 24/218 (11%)
Query: 411 GSFGSVY--KGI-LDEGKTIIAVKV-LNLLHHGASKSS----IAECSALRNI-RHKNLVK 461
           G+FG V   + I LD+ K     KV + +L   A++      I+E   ++ I +HKN++ 
Sbjct: 39  GAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIIN 98
Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGA------DKTVEAPKCLNFLQRI 515
           +L  C+      D    ++ E+   G+L E+L            + +    + L+    +
Sbjct: 99  LLGACTQ-----DGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 153
Query: 516 NIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSI 575
           + A  VA  ++YL         H DL   NVL+  +    +ADFGLA+ +        + 
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 210
Query: 576 GVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             +  + ++AP E       +   DV+S+G+LL E+ T
Sbjct: 211 NGRLPVKWMAP-EALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 102/237 (43%), Gaps = 48/237 (20%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTVCSG 468
           G   + Y  +LD     +A+K L+    +   +K +  E   ++ + HKN++ +L V   
Sbjct: 76  GIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV--- 129
Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAID-------- 520
                         F    +LEE+   V    + ++A    N  Q I + +D        
Sbjct: 130 --------------FTPQKTLEEF-QDVYLVMELMDA----NLCQVIQMELDHERMSYLL 170
Query: 521 --VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK 578
             + C +K+LH        H DLKPSN+++  + T  + DFGLA+    + + T  +   
Sbjct: 171 YQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV--- 224
Query: 579 GTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV 635
            T  Y AP E  LG     N D++S G ++ E++  K    I+F G   +  + + +
Sbjct: 225 VTRYYRAP-EVILGMGYKENVDIWSVGCIMGEMVRHK----ILFPGRDYIDQWNKVI 276

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 110/263 (41%), Gaps = 32/263 (12%)
Query: 405 LCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGAS-KSSIAECSALRNIRHKNLVKIL 463
           L +I  G++G V     +  K  +A+K ++   H    + ++ E   L   RH+N++ I 
Sbjct: 30  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGIN 89
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            +      +      +V + M     E  L+ +           C    Q       +  
Sbjct: 90  DIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQ-------ILR 137
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIG-VKGTIG 582
            LKY+H        H DLKPSN+LL+      + DFGLA++  P H  T  +     T  
Sbjct: 138 GLKYIH---SANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRW 194
Query: 583 YIAPAEYGLGSE-VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM 641
           Y AP E  L S+  + + D++S G +L E+++  RP   +F G   L         +H++
Sbjct: 195 YRAP-EIMLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQL------NHIL 243
Query: 642 DIVDSTLLADDEDLTITSNQRQR 664
            I+ S      EDL    N + R
Sbjct: 244 GILGS---PSQEDLNCGINLKAR 263

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 66/252 (26%), Positives = 104/252 (41%), Gaps = 54/252 (21%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIR-------HKNLVKIL 463
           G++G V+K I      ++AVK +      A ++S       R I        H+N+V +L
Sbjct: 20  GAYGIVWKSIDRRTGEVVAVKKI----FDAFQNSTDAQRTFREIMILTELSGHENIVNLL 75
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            V        D    LV+++M     E  LH V  A+        L  + +  +   +  
Sbjct: 76  NVLRA---DNDRDVYLVFDYM-----ETDLHAVIRAN-------ILEPVHKQYVVYQLIK 120
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK----- 578
            +KYLH        H D+KPSN+LL+ E    VADFGL++        T++I +      
Sbjct: 121 VIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 579 --------------GTIGYIAPAEYGLGSEVSING-DVYSYGILLLELMTRKRPSDIMFE 623
                          T  Y AP E  LGS     G D++S G +L E++  K     +F 
Sbjct: 178 ENFDDDQPILTDYVATRWYRAP-EILLGSTKYTKGIDMWSLGCILGEILCGKP----IFP 232
Query: 624 GNMNLHNFARTV 635
           G+  ++   R +
Sbjct: 233 GSSTMNQLERII 244

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 101/237 (42%), Gaps = 48/237 (20%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTVCSG 468
           G   + Y  +LD     +A+K L+    +   +K +  E   ++ + HKN++ +L V   
Sbjct: 38  GIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV--- 91
Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAID-------- 520
                         F    +LEE    V    + ++A    N  Q I + +D        
Sbjct: 92  --------------FTPQKTLEE-FQDVYLVMELMDA----NLCQVIQMELDHERMSYLL 132
Query: 521 --VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK 578
             + C +K+LH        H DLKPSN+++  + T  + DFGLA+    + + T  +   
Sbjct: 133 YQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV--- 186
Query: 579 GTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV 635
            T  Y AP E  LG     N D++S G ++ E++  K    I+F G   +  + + +
Sbjct: 187 VTRYYRAP-EVILGMGYKENVDIWSVGCIMGEMVRHK----ILFPGRDYIDQWNKVI 238

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 59/283 (20%), Positives = 115/283 (40%), Gaps = 47/283 (16%)
Query: 346 ASAISVFGNSKLCGGIPEFQLPICGLEKSKHKRLTIAVKLAAAIISVLVGILLFVSFLFL 405
            + +S   ++ +  G+ E++LP     +    +LT+   L                    
Sbjct: 50  TTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGE------------------ 91
Query: 406 CWIDMGSFGSVYKGI---LDEGKTIIAVKV-LNLLHHGASKSS----IAECSALRNI-RH 456
                G FG V       +D+ K   AV V + +L   A++      ++E   ++ I +H
Sbjct: 92  -----GCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 457 KNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVS--GADKTVEAPKC----LN 510
           KN++ +L  C+      D    ++ E+   G+L E+L      G + + +  +     + 
Sbjct: 147 KNIINLLGACTQ-----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 201
Query: 511 FLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHL 570
           F   ++    +A  ++YL         H DL   NVL+       +ADFGLA+ +     
Sbjct: 202 FKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDY 258
Query: 571 QTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
              +   +  + ++AP E       +   DV+S+G+L+ E+ T
Sbjct: 259 YKKTTNGRLPVKWMAP-EALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 101/237 (42%), Gaps = 48/237 (20%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTVCSG 468
           G   + Y  +LD     +A+K L+    +   +K +  E   ++ + HKN++ +L V   
Sbjct: 39  GIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV--- 92
Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAID-------- 520
                         F    +LEE    V    + ++A    N  Q I + +D        
Sbjct: 93  --------------FTPQKTLEE-FQDVYLVMELMDA----NLCQVIQMELDHERMSYLL 133
Query: 521 --VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK 578
             + C +K+LH        H DLKPSN+++  + T  + DFGLA+    + + T  +   
Sbjct: 134 YQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV--- 187
Query: 579 GTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV 635
            T  Y AP E  LG     N D++S G ++ E++  K    I+F G   +  + + +
Sbjct: 188 VTRYYRAP-EVILGMGYKENVDIWSVGCIMGEMVRHK----ILFPGRDYIDQWNKVI 239

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 101/237 (42%), Gaps = 48/237 (20%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTVCSG 468
           G   + Y  +LD     +A+K L+    +   +K +  E   ++ + HKN++ +L V   
Sbjct: 38  GIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV--- 91
Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAID-------- 520
                         F    +LEE    V    + ++A    N  Q I + +D        
Sbjct: 92  --------------FTPQKTLEE-FQDVYLVMELMDA----NLCQVIQMELDHERMSYLL 132
Query: 521 --VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK 578
             + C +K+LH        H DLKPSN+++  + T  + DFGLA+    + + T  +   
Sbjct: 133 YQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV--- 186
Query: 579 GTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV 635
            T  Y AP E  LG     N D++S G ++ E++  K    I+F G   +  + + +
Sbjct: 187 VTRYYRAP-EVILGMGYKENVDIWSVGCIMGEMVRHK----ILFPGRDYIDQWNKVI 238

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 101/237 (42%), Gaps = 48/237 (20%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTVCSG 468
           G   + Y  +LD     +A+K L+    +   +K +  E   ++ + HKN++ +L V   
Sbjct: 32  GIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV--- 85
Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAID-------- 520
                         F    +LEE    V    + ++A    N  Q I + +D        
Sbjct: 86  --------------FTPQKTLEE-FQDVYLVMELMDA----NLCQVIQMELDHERMSYLL 126
Query: 521 --VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK 578
             + C +K+LH        H DLKPSN+++  + T  + DFGLA+    + + T  +   
Sbjct: 127 YQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV--- 180
Query: 579 GTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV 635
            T  Y AP E  LG     N D++S G ++ E++  K    I+F G   +  + + +
Sbjct: 181 VTRYYRAP-EVILGMGYKENVDIWSVGCIMGEMVRHK----ILFPGRDYIDQWNKVI 232

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 101/237 (42%), Gaps = 48/237 (20%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTVCSG 468
           G   + Y  +LD     +A+K L+    +   +K +  E   ++ + HKN++ +L V   
Sbjct: 37  GIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV--- 90
Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAID-------- 520
                         F    +LEE    V    + ++A    N  Q I + +D        
Sbjct: 91  --------------FTPQKTLEE-FQDVYLVMELMDA----NLCQVIQMELDHERMSYLL 131
Query: 521 --VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK 578
             + C +K+LH        H DLKPSN+++  + T  + DFGLA+    + + T  +   
Sbjct: 132 YQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV--- 185
Query: 579 GTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV 635
            T  Y AP E  LG     N D++S G ++ E++  K    I+F G   +  + + +
Sbjct: 186 VTRYYRAP-EVILGMGYKENVDIWSVGCIMGEMVRHK----ILFPGRDYIDQWNKVI 237

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 101/237 (42%), Gaps = 48/237 (20%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTVCSG 468
           G   + Y  +LD     +A+K L+    +   +K +  E   ++ + HKN++ +L V   
Sbjct: 39  GIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV--- 92
Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAID-------- 520
                         F    +LEE    V    + ++A    N  Q I + +D        
Sbjct: 93  --------------FTPQKTLEE-FQDVYLVMELMDA----NLCQVIQMELDHERMSYLL 133
Query: 521 --VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK 578
             + C +K+LH        H DLKPSN+++  + T  + DFGLA+    + + T  +   
Sbjct: 134 YQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV--- 187
Query: 579 GTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV 635
            T  Y AP E  LG     N D++S G ++ E++  K    I+F G   +  + + +
Sbjct: 188 VTRYYRAP-EVILGMGYKENVDIWSVGCIMGEMVRHK----ILFPGRDYIDQWNKVI 239

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 90/216 (41%), Gaps = 33/216 (15%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G+FG VYK    E   + A KV++       +  + E   L +  H N+VK+L       
Sbjct: 48  GAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF---- 103
Query: 471 YKGDDFKALVYEFMHNGSLE----EWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALK 526
           Y  ++   L+ EF   G+++    E   P++ +   V   + L+             AL 
Sbjct: 104 YYENNLWILI-EFCAGGAVDAVMLELERPLTESQIQVVCKQTLD-------------ALN 149
Query: 527 YLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGL-AKLLPPAHLQTSSIGVKGTIGYIA 585
           YLH +      H DLK  N+L   +    +ADFG+ AK       + S I   GT  ++A
Sbjct: 150 YLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI---GTPYWMA 203
Query: 586 PA----EYGLGSEVSINGDVYSYGILLLELMTRKRP 617
           P     E           DV+S GI L+E+   + P
Sbjct: 204 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 90/216 (41%), Gaps = 33/216 (15%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G+FG VYK    E   + A KV++       +  + E   L +  H N+VK+L       
Sbjct: 48  GAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF---- 103
Query: 471 YKGDDFKALVYEFMHNGSLE----EWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALK 526
           Y  ++   L+ EF   G+++    E   P++ +   V   + L+             AL 
Sbjct: 104 YYENNLWILI-EFCAGGAVDAVMLELERPLTESQIQVVCKQTLD-------------ALN 149
Query: 527 YLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGL-AKLLPPAHLQTSSIGVKGTIGYIA 585
           YLH +      H DLK  N+L   +    +ADFG+ AK       + S I   GT  ++A
Sbjct: 150 YLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFI---GTPYWMA 203
Query: 586 PA----EYGLGSEVSINGDVYSYGILLLELMTRKRP 617
           P     E           DV+S GI L+E+   + P
Sbjct: 204 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 37/105 (35%), Positives = 56/105 (53%), Gaps = 8/105 (7%)
Query: 518 AIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKL-LPPAHLQTSSIG 576
           + +++ AL YLH   +    + DLK  NVLLD E    + D+G+ K  L P    T+S  
Sbjct: 112 SAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSXF 166
Query: 577 VKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIM 621
             GT  YIAP E   G +   + D ++ G+L+ E+M  + P DI+
Sbjct: 167 C-GTPNYIAP-EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 209

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 102/237 (43%), Gaps = 48/237 (20%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTVCSG 468
           G   + Y  +LD     +A+K L+    +   +K +  E   ++ + HKN++ +L V   
Sbjct: 76  GIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV--- 129
Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAID-------- 520
                         F    +LEE+   V    + ++A    N  Q I + +D        
Sbjct: 130 --------------FTPQKTLEEF-QDVYLVMELMDA----NLCQVIQMELDHERMSYLL 170
Query: 521 --VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK 578
             + C +K+LH        H DLKPSN+++  + T  + DFGLA+    + + T  +   
Sbjct: 171 YQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV--- 224
Query: 579 GTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV 635
            T  Y AP E  LG     N D++S G ++ E++  K    I+F G   +  + + +
Sbjct: 225 VTRYYRAP-EVILGMGYKENVDIWSVGCIMGEMVRHK----ILFPGRDYIDQWNKVI 276

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 84/342 (24%), Positives = 140/342 (40%), Gaps = 55/342 (16%)
Query: 382 AVKLAAAIISVLVGILLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKV----LNLLH 437
           A   A  I  VLV       ++   ++  G F   ++    + K + A K+    L L  
Sbjct: 3   AAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKP 62
Query: 438 HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVS 497
           H   K S+ E S  R++ H+++V          ++ +DF  +V E     SL E LH   
Sbjct: 63  HQREKMSM-EISIHRSLAHQHVVGFHGF-----FEDNDFVFVVLELCRRRSLLE-LH--- 112
Query: 498 GADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA 557
              K +  P+   +L++I +        +YLH +      H DLK  N+ L+ ++   + 
Sbjct: 113 KRRKALTEPEARYYLRQIVLGC------QYLHRN---RVIHRDLKLGNLFLNEDLEVKIG 163
Query: 558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAP---AEYGLGSEVSINGDVYSYGILLLELMTR 614
           DFGLA  +     +  ++   GT  YIAP   ++ G   EV    DV+S G ++  L+  
Sbjct: 164 DFGLATKVEYDGERKKTLC--GTPNYIAPEVLSKKGHSFEV----DVWSIGCIMYTLLVG 217
Query: 615 KRPSDIMFEGNMNLHNFART-----VLPDHVMDIVDS---TLLADDEDLTITSNQRQRQ- 665
           K P    FE +     + R       +P H+  +  S    +L  D     T N+     
Sbjct: 218 KPP----FETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDE 273
Query: 666 --------ARINNIMECLISVVRIGVACSMESPQDRMNMTIV 699
                   AR+   + CL    R  +A S   P +R  +T++
Sbjct: 274 FFTSGYIPARLP--ITCLTIPPRFSIAPSSLDPSNRKPLTVL 313

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 37/105 (35%), Positives = 56/105 (53%), Gaps = 8/105 (7%)
Query: 518 AIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKL-LPPAHLQTSSIG 576
           + +++ AL YLH   +    + DLK  NVLLD E    + D+G+ K  L P    T+S  
Sbjct: 116 SAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSXF 170
Query: 577 VKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIM 621
             GT  YIAP E   G +   + D ++ G+L+ E+M  + P DI+
Sbjct: 171 C-GTPNYIAP-EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 213

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 36/223 (16%)
Query: 408 IDMGSFGSVYKG-ILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNI-----RHKNLVK 461
           I  G+FG V K  I  +G  + A   +  +   ASK    + +    +      H N++ 
Sbjct: 23  IGEGNFGQVLKARIKKDGLRMDAA--IKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 80
Query: 462 ILTVCSGVDYKGDDFKALVY-------EFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQR 514
           +L  C   +++G  + A+ Y       +F+    + E     + A+ T      L+  Q 
Sbjct: 81  LLGAC---EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST---LSSQQL 134
Query: 515 INIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSS 574
           ++ A DVA  + YL    Q    H DL   N+L+     A +ADFGL++           
Sbjct: 135 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--------GQE 183
Query: 575 IGVKGTIGYIAPAEYGLG----SEVSINGDVYSYGILLLELMT 613
           + VK T+G +      +     S  + N DV+SYG+LL E+++
Sbjct: 184 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 36/223 (16%)
Query: 408 IDMGSFGSVYKG-ILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNI-----RHKNLVK 461
           I  G+FG V K  I  +G  + A   +  +   ASK    + +    +      H N++ 
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAA--IKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 462 ILTVCSGVDYKGDDFKALVY-------EFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQR 514
           +L  C   +++G  + A+ Y       +F+    + E     + A+ T      L+  Q 
Sbjct: 91  LLGAC---EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST---LSSQQL 144
Query: 515 INIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSS 574
           ++ A DVA  + YL    Q    H DL   N+L+     A +ADFGL++           
Sbjct: 145 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--------GQE 193
Query: 575 IGVKGTIGYIAPAEYGLG----SEVSINGDVYSYGILLLELMT 613
           + VK T+G +      +     S  + N DV+SYG+LL E+++
Sbjct: 194 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 103/225 (45%), Gaps = 33/225 (14%)
Query: 411 GSFGSVYK----GILDEGKTI-IAVKVLNLLHHGASKSSI-AECSALRNI-RHKNLVKIL 463
           G+FG V +    G+  E   + +AVK+L    H   K ++ +E   + ++ +H+N+V +L
Sbjct: 42  GAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLL 101
Query: 464 TVCSG-------VDY--KGD--DFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFL 512
             C+         +Y   GD  +F     E M   SL     P  G DK  E  + L   
Sbjct: 102 GACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDP-EGLDK--EDGRPLELR 158
Query: 513 QRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQT 572
             ++ +  VA  + +L         H D+   NVLL +   A + DFGLA+ +    +  
Sbjct: 159 DLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI----MND 211
Query: 573 SSIGVKGT----IGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
           S+  VKG     + ++AP E       ++  DV+SYGILL E+ +
Sbjct: 212 SNYIVKGNARLPVKWMAP-ESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 41/138 (29%), Positives = 64/138 (46%), Gaps = 10/138 (7%)
Query: 479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQ---RINIAIDVACALKYLHHDCQPT 535
           L Y F   G L   L  + G D      K + F +   +  +A ++A AL +LH      
Sbjct: 91  LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELALALDHLH---SLG 146
Query: 536 TAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEV 595
             + DLKP N+LLD E    + DFGL+K       +  +    GT+ Y+AP         
Sbjct: 147 IIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRGHT 204
Query: 596 SINGDVYSYGILLLELMT 613
             + D +S+G+L+ E++T
Sbjct: 205 Q-SADWWSFGVLMFEMLT 221

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 90/218 (41%), Gaps = 35/218 (16%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSS---IAECSALRNIRHKNLVKILT 464
           I  GSFG+VY         ++A+K ++     +++     I E   L+ +RH N ++   
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ--- 118
Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWL---HPVSGADKTVEAPKCLNFLQRINIAIDV 521
                 Y+G       Y   H      WL   + +  A   +E  K    LQ + IA   
Sbjct: 119 ------YRG------CYLREHTA----WLVMEYCLGSASDLLEVHK--KPLQEVEIAAVT 160
Query: 522 ACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTI 581
             AL+ L +       H D+K  N+LL       + DFG A ++ PA+         GT 
Sbjct: 161 HGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX------FVGTP 214
Query: 582 GYIAPAEYGLGSEVSING--DVYSYGILLLELMTRKRP 617
            ++AP       E   +G  DV+S GI  +EL  RK P
Sbjct: 215 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 41/138 (29%), Positives = 64/138 (46%), Gaps = 10/138 (7%)
Query: 479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQ---RINIAIDVACALKYLHHDCQPT 535
           L Y F   G L   L  + G D      K + F +   +  +A ++A AL +LH      
Sbjct: 92  LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELALALDHLH---SLG 147
Query: 536 TAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEV 595
             + DLKP N+LLD E    + DFGL+K       +  +    GT+ Y+AP         
Sbjct: 148 IIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRGHT 205
Query: 596 SINGDVYSYGILLLELMT 613
             + D +S+G+L+ E++T
Sbjct: 206 Q-SADWWSFGVLMFEMLT 222

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 104/232 (44%), Gaps = 24/232 (10%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVK--VLNLLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           I  G+FG V+K    +    +A+K  ++     G   +++ E   L+ ++H+N+V ++ +
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 466 CSGVDYKGDDFKA---LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVA 522
           C       +  K    LV++F          H ++G    V     L+ ++R+   +   
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCE--------HDLAGLLSNVLVKFTLSEIKRVMQML--L 135
Query: 523 CALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPA-HLQTSSIGVKGTI 581
             L Y+H +      H D+K +NVL+  +    +ADFGLA+    A + Q +    +   
Sbjct: 136 NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVT 192
Query: 582 GYIAPAEYGLGS-EVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFA 632
            +  P E  LG  +     D++  G ++ E+ TR   S IM +GN   H  A
Sbjct: 193 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR---SPIM-QGNTEQHQLA 240

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 51/220 (23%), Positives = 91/220 (41%), Gaps = 29/220 (13%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSI-AECSALRNIRHKNLVKILTVC--- 466
           G FG V++          A+K + L +   ++  +  E  AL  + H  +V+        
Sbjct: 16  GGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEK 75
Query: 467 -SGVDYKGDDFKALVY---EFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVA 522
            +    +    K  +Y   +     +L++W++     ++  E   CL+      I + +A
Sbjct: 76  NTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER-ERSVCLH------IFLQIA 128
Query: 523 CALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLA----------KLLPPAHLQT 572
            A+++LH        H DLKPSN+    +    V DFGL            +L P     
Sbjct: 129 EAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185
Query: 573 SSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELM 612
              G  GT  Y++P +   G+  S   D++S G++L EL+
Sbjct: 186 RHTGQVGTKLYMSPEQIH-GNSYSHKVDIFSLGLILFELL 224

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 86/200 (43%), Gaps = 35/200 (17%)
Query: 428 IAVKVLNLLHHGASKSSIAEC-SALRNIRH--KNLVKILTVCSGVD-YKGDDFKALVYEF 483
            AVK++ +     S   + E   A R   H  + +     + + +D Y+   F  LV++ 
Sbjct: 122 FAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDL 181
Query: 484 MHNGSLEEWL-HPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLK 542
           M  G L ++L   V+ ++K   +           I   +  A+ +LH +      H DLK
Sbjct: 182 MRKGELFDYLTEKVALSEKETRS-----------IMRSLLEAVSFLHAN---NIVHRDLK 227
Query: 543 PSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP---------AEYGLGS 593
           P N+LLD  M   ++DFG +  L P         + GT GY+AP            G G 
Sbjct: 228 PENILLDDNMQIRLSDFGFSCHLEPGEKLRE---LCGTPGYLAPEILKCSMDETHPGYGK 284
Query: 594 EVSINGDVYSYGILLLELMT 613
           EV    D+++ G++L  L+ 
Sbjct: 285 EV----DLWACGVILFTLLA 300

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 96/218 (44%), Gaps = 24/218 (11%)
Query: 411 GSFGSVYKGI---LDEGKTIIAVKV-LNLLHHGASKSS----IAECSALRNI-RHKNLVK 461
           G FG V       +D+ K   AV V + +L   A++      ++E   ++ I +HKN++ 
Sbjct: 33  GCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIN 92
Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVS--GADKTVEAPKC----LNFLQRI 515
           +L  C+      D    ++ E+   G+L E+L      G + + +  +     + F   +
Sbjct: 93  LLGACTQ-----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 147
Query: 516 NIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSI 575
           +    +A  ++YL         H DL   NVL+       +ADFGLA+ +        + 
Sbjct: 148 SCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTT 204
Query: 576 GVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             +  + ++AP E       +   DV+S+G+L+ E+ T
Sbjct: 205 NGRLPVKWMAP-EALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 96/218 (44%), Gaps = 24/218 (11%)
Query: 411 GSFGSVYKGI---LDEGKTIIAVKV-LNLLHHGASKSS----IAECSALRNI-RHKNLVK 461
           G FG V       +D+ K   AV V + +L   A++      ++E   ++ I +HKN++ 
Sbjct: 35  GCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIN 94
Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVS--GADKTVEAPKC----LNFLQRI 515
           +L  C+      D    ++ E+   G+L E+L      G + + +  +     + F   +
Sbjct: 95  LLGACTQ-----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 149
Query: 516 NIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSI 575
           +    +A  ++YL         H DL   NVL+       +ADFGLA+ +        + 
Sbjct: 150 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 206
Query: 576 GVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             +  + ++AP E       +   DV+S+G+L+ E+ T
Sbjct: 207 NGRLPVKWMAP-EALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/124 (31%), Positives = 61/124 (49%), Gaps = 8/124 (6%)
Query: 496 VSGADKTVEAPKCLNF-LQRINI-AIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMT 553
           ++G D       C  F L R    A ++   L++LH        + DLK  N+LLD +  
Sbjct: 101 LNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGH 157
Query: 554 AHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             +ADFG+ K       +T+     GT  YIAP E  LG + + + D +S+G+LL E++ 
Sbjct: 158 IKIADFGMCKENMLGDAKTNEFC--GTPDYIAP-EILLGQKYNHSVDWWSFGVLLYEMLI 214
Query: 614 RKRP 617
            + P
Sbjct: 215 GQSP 218

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 96/218 (44%), Gaps = 24/218 (11%)
Query: 411 GSFGSVYKGI---LDEGKTIIAVKV-LNLLHHGASKSS----IAECSALRNI-RHKNLVK 461
           G FG V       +D+ K   AV V + +L   A++      ++E   ++ I +HKN++ 
Sbjct: 38  GCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIN 97
Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVS--GADKTVEAPKC----LNFLQRI 515
           +L  C+      D    ++ E+   G+L E+L      G + + +  +     + F   +
Sbjct: 98  LLGACTQ-----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 152
Query: 516 NIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSI 575
           +    +A  ++YL         H DL   NVL+       +ADFGLA+ +        + 
Sbjct: 153 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 209
Query: 576 GVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             +  + ++AP E       +   DV+S+G+L+ E+ T
Sbjct: 210 NGRLPVKWMAP-EALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 97/228 (42%), Gaps = 33/228 (14%)
Query: 400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLN---LLHHGASKSSIAECSALRNIRH 456
             F FL  +  GSFG V        + + A+K+L    ++     + ++ E   L  +  
Sbjct: 19  TDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDK 78
Query: 457 KNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRIN 516
              +  L  C    ++  D    V E+++ G L   ++ +    K  E        Q + 
Sbjct: 79  PPFLTQLHSC----FQTVDRLYFVMEYVNGGDL---MYHIQQVGKFKEP-------QAVF 124
Query: 517 IAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQ--TSS 574
            A +++  L +LH   +    + DLK  NV+LD E    +ADFG+ K     H+    ++
Sbjct: 125 YAAEISIGLFFLH---KRGIIYRDLKLDNVMLDSEGHIKIADFGMCK----EHMMDGVTT 177
Query: 575 IGVKGTIGYIAP---AEYGLGSEVSINGDVYSYGILLLELMTRKRPSD 619
               GT  YIAP   A    G  V    D ++YG+LL E++  + P D
Sbjct: 178 REFCGTPDYIAPEIIAYQPYGKSV----DWWAYGVLLYEMLAGQPPFD 221

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 90/218 (41%), Gaps = 35/218 (16%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSS---IAECSALRNIRHKNLVKILT 464
           I  GSFG+VY         ++A+K ++     +++     I E   L+ +RH N ++   
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ--- 79
Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWL---HPVSGADKTVEAPKCLNFLQRINIAIDV 521
                 Y+G       Y   H      WL   + +  A   +E  K    LQ + IA   
Sbjct: 80  ------YRG------CYLREHTA----WLVMEYCLGSASDLLEVHK--KPLQEVEIAAVT 121
Query: 522 ACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTI 581
             AL+ L +       H D+K  N+LL       + DFG A ++ PA+         GT 
Sbjct: 122 HGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX------FVGTP 175
Query: 582 GYIAPAEYGLGSEVSING--DVYSYGILLLELMTRKRP 617
            ++AP       E   +G  DV+S GI  +EL  RK P
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 65/142 (45%), Gaps = 10/142 (7%)
Query: 479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQ---RINIAIDVACALKYLHHDCQPT 535
           L Y F   G L   L  + G D      K + F +   +  +A ++A  L +LH      
Sbjct: 95  LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELALGLDHLH---SLG 150
Query: 536 TAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEV 595
             + DLKP N+LLD E    + DFGL+K       +  +    GT+ Y+AP         
Sbjct: 151 IIYRDLKPENILLDEEGHIKLTDFGLSK--EAIDHEKKAYSFCGTVEYMAPEVVNRQGH- 207
Query: 596 SINGDVYSYGILLLELMTRKRP 617
           S + D +SYG+L+ E++T   P
Sbjct: 208 SHSADWWSYGVLMFEMLTGSLP 229

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/124 (31%), Positives = 61/124 (49%), Gaps = 8/124 (6%)
Query: 496 VSGADKTVEAPKCLNF-LQRINI-AIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMT 553
           ++G D       C  F L R    A ++   L++LH        + DLK  N+LLD +  
Sbjct: 100 LNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGH 156
Query: 554 AHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             +ADFG+ K       +T+     GT  YIAP E  LG + + + D +S+G+LL E++ 
Sbjct: 157 IKIADFGMCKENMLGDAKTNXFC--GTPDYIAP-EILLGQKYNHSVDWWSFGVLLYEMLI 213
Query: 614 RKRP 617
            + P
Sbjct: 214 GQSP 217

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 83/338 (24%), Positives = 139/338 (41%), Gaps = 55/338 (16%)
Query: 386 AAAIISVLVGILLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKV----LNLLHHGAS 441
           A  I  VLV       ++   ++  G F   ++    + K + A K+    L L  H   
Sbjct: 3   AKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE 62
Query: 442 KSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADK 501
           K S+ E S  R++ H+++V          ++ +DF  +V E     SL E LH      K
Sbjct: 63  KMSM-EISIHRSLAHQHVVGFHGF-----FEDNDFVFVVLELCRRRSLLE-LH---KRRK 112
Query: 502 TVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGL 561
            +  P+   +L++I +        +YLH +      H DLK  N+ L+ ++   + DFGL
Sbjct: 113 ALTEPEARYYLRQIVLGC------QYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGL 163
Query: 562 AKLLPPAHLQTSSIGVKGTIGYIAP---AEYGLGSEVSINGDVYSYGILLLELMTRKRPS 618
           A  +     +  ++   GT  YIAP   ++ G   EV    DV+S G ++  L+  K P 
Sbjct: 164 ATKVEYDGERKKTLC--GTPNYIAPEVLSKKGHSFEV----DVWSIGCIMYTLLVGKPP- 216
Query: 619 DIMFEGNMNLHNFART-----VLPDHVMDIVDS---TLLADDEDLTITSNQRQRQ----- 665
              FE +     + R       +P H+  +  S    +L  D     T N+         
Sbjct: 217 ---FETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 273
Query: 666 ----ARINNIMECLISVVRIGVACSMESPQDRMNMTIV 699
               AR+   + CL    R  +A S   P +R  +T++
Sbjct: 274 GYIPARLP--ITCLTIPPRFSIAPSSLDPSNRKPLTVL 309

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/138 (29%), Positives = 64/138 (46%), Gaps = 10/138 (7%)
Query: 479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQ---RINIAIDVACALKYLHHDCQPT 535
           L Y F   G L   L  + G D      K + F +   +  +A ++A AL +LH      
Sbjct: 91  LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELALALDHLH---SLG 146
Query: 536 TAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEV 595
             + DLKP N+LLD E    + DFGL+K       +  +    GT+ Y+AP         
Sbjct: 147 IIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRGHT 204
Query: 596 SINGDVYSYGILLLELMT 613
             + D +S+G+L+ E++T
Sbjct: 205 Q-SADWWSFGVLMFEMLT 221

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 104/232 (44%), Gaps = 24/232 (10%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVK--VLNLLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           I  G+FG V+K    +    +A+K  ++     G   +++ E   L+ ++H+N+V ++ +
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 466 CSGVDYKGDDFKA---LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVA 522
           C       +  K    LV++F          H ++G    V     L+ ++R+   +   
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCE--------HDLAGLLSNVLVKFTLSEIKRVMQML--L 134
Query: 523 CALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPA-HLQTSSIGVKGTI 581
             L Y+H +      H D+K +NVL+  +    +ADFGLA+    A + Q +    +   
Sbjct: 135 NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVT 191
Query: 582 GYIAPAEYGLGS-EVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFA 632
            +  P E  LG  +     D++  G ++ E+ TR   S IM +GN   H  A
Sbjct: 192 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR---SPIM-QGNTEQHQLA 239

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 85/205 (41%), Gaps = 23/205 (11%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G+FG V++          A K +   H    ++   E   +  +RH  LV +        
Sbjct: 168 GAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA----- 222
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
           ++ D+   ++YEFM  G L      V+     +   + + +++++       C  K L H
Sbjct: 223 FEDDNEMVMIYEFMSGGEL---FEKVADEHNKMSEDEAVEYMRQV-------C--KGLCH 270
Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVA--DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAE 588
             +    H DLKP N++   + +  +   DFGL   L P   + S     GT  + AP E
Sbjct: 271 MHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP---KQSVKVTTGTAEFAAP-E 326
Query: 589 YGLGSEVSINGDVYSYGILLLELMT 613
              G  V    D++S G+L   L++
Sbjct: 327 VAEGKPVGYYTDMWSVGVLSYILLS 351

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 102/231 (44%), Gaps = 57/231 (24%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRN--------IRHKNLVKI 462
           G +G V++G+   G+++ AVK+          SS  E S  R         +RH N++  
Sbjct: 19  GRYGEVWRGLW-HGESV-AVKIF---------SSRDEQSWFRETEIYNTVLLRHDNILGF 67
Query: 463 LTVCSGVDYKGDDFK-ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDV 521
             + S +  +    +  L+  +  +GSL ++L       +T+E    L       +A+  
Sbjct: 68  --IASDMTSRNSSTQLWLITHYHEHGSLYDFLQ-----RQTLEPHLALR------LAVSA 114
Query: 522 ACALKYLHHDC-----QPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTS--- 573
           AC L +LH +      +P  AH D K  NVL+   +   +AD GLA +    H Q S   
Sbjct: 115 ACGLAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVM----HSQGSDYL 170
Query: 574 SIGVK---GTIGYIAPAEYGLGSEVSIN-------GDVYSYGILLLELMTR 614
            IG     GT  Y+AP    L  ++  +        D++++G++L E+  R
Sbjct: 171 DIGNNPRVGTKRYMAPEV--LDEQIRTDCFESYKWTDIWAFGLVLWEIARR 219

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 89/216 (41%), Gaps = 33/216 (15%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G+FG VYK    E   + A KV+        +  I E   L    H  +VK+L       
Sbjct: 22  GAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA----- 76
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPK----CLNFLQRINIAIDVACALK 526
           Y  D    ++ EF   G+++  +  +   D+ +  P+    C   L+          AL 
Sbjct: 77  YYHDGKLWIMIEFCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLE----------ALN 123
Query: 527 YLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGL-AKLLPPAHLQTSSIGVKGTIGYIA 585
           +LH        H DLK  NVL+  E    +ADFG+ AK L     + S I   GT  ++A
Sbjct: 124 FLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI---GTPYWMA 177
Query: 586 PA----EYGLGSEVSINGDVYSYGILLLELMTRKRP 617
           P     E    +      D++S GI L+E+   + P
Sbjct: 178 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 213

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 77/161 (47%), Gaps = 17/161 (10%)
Query: 479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRIN--IAIDVACALKYLHHDCQPTT 536
           L+Y F   G L   L  +SG +  ++  +   F++        +++ AL +LH   Q   
Sbjct: 86  LIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH---QKGI 142
Query: 537 AHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVS 596
            + DLKP N++L+H+    + DFGL K     H  T +    GTI Y+AP E  + S  +
Sbjct: 143 IYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHXFCGTIEYMAP-EILMRSGHN 199
Query: 597 INGDVYSYGILLLELMT---------RKRPSDIMFEGNMNL 628
              D +S G L+ +++T         RK+  D + +  +NL
Sbjct: 200 RAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNL 240

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 91/210 (43%), Gaps = 19/210 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA-ECSALRNIRHKNLVKILTVCSGV 469
           G++G V   +    +  +AVK++++        +I  E    + + H+N+VK      G 
Sbjct: 17  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY----GH 72
Query: 470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH 529
             +G+  + L  E+   G L + + P  G    +  P    F  ++         + YLH
Sbjct: 73  RREGN-IQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQL------MAGVVYLH 121
Query: 530 HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEY 589
                   H D+KP N+LLD      ++DFGLA +    + +     + GT+ Y+AP   
Sbjct: 122 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 590 GLGSEVSINGDVYSYGILLLELMTRKRPSD 619
                 +   DV+S GI+L  ++  + P D
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 89/216 (41%), Gaps = 33/216 (15%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G+FG VYK    E   + A KV+        +  I E   L    H  +VK+L       
Sbjct: 30  GAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA----- 84
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPK----CLNFLQRINIAIDVACALK 526
           Y  D    ++ EF   G+++  +  +   D+ +  P+    C   L+          AL 
Sbjct: 85  YYHDGKLWIMIEFCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLE----------ALN 131
Query: 527 YLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGL-AKLLPPAHLQTSSIGVKGTIGYIA 585
           +LH        H DLK  NVL+  E    +ADFG+ AK L     + S I   GT  ++A
Sbjct: 132 FLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI---GTPYWMA 185
Query: 586 PA----EYGLGSEVSINGDVYSYGILLLELMTRKRP 617
           P     E    +      D++S GI L+E+   + P
Sbjct: 186 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 85/205 (41%), Gaps = 23/205 (11%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G+FG V++          A K +   H    ++   E   +  +RH  LV +        
Sbjct: 62  GAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA----- 116
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
           ++ D+   ++YEFM  G L      V+     +   + + +++++       C  K L H
Sbjct: 117 FEDDNEMVMIYEFMSGGEL---FEKVADEHNKMSEDEAVEYMRQV-------C--KGLCH 164
Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVA--DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAE 588
             +    H DLKP N++   + +  +   DFGL   L P   + S     GT  + AP E
Sbjct: 165 MHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP---KQSVKVTTGTAEFAAP-E 220
Query: 589 YGLGSEVSINGDVYSYGILLLELMT 613
              G  V    D++S G+L   L++
Sbjct: 221 VAEGKPVGYYTDMWSVGVLSYILLS 245

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 77/161 (47%), Gaps = 17/161 (10%)
Query: 479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRIN--IAIDVACALKYLHHDCQPTT 536
           L+Y F   G L   L  +SG +  ++  +   F++        +++ AL +LH   Q   
Sbjct: 86  LIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH---QKGI 142
Query: 537 AHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVS 596
            + DLKP N++L+H+    + DFGL K     H  T +    GTI Y+AP E  + S  +
Sbjct: 143 IYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHTFCGTIEYMAP-EILMRSGHN 199
Query: 597 INGDVYSYGILLLELMT---------RKRPSDIMFEGNMNL 628
              D +S G L+ +++T         RK+  D + +  +NL
Sbjct: 200 RAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNL 240

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 91/210 (43%), Gaps = 19/210 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA-ECSALRNIRHKNLVKILTVCSGV 469
           G++G V   +    +  +AVK++++        +I  E    + + H+N+VK      G 
Sbjct: 17  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFY----GH 72
Query: 470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH 529
             +G+  + L  E+   G L + + P  G    +  P    F  ++         + YLH
Sbjct: 73  RREGN-IQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQL------MAGVVYLH 121
Query: 530 HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEY 589
                   H D+KP N+LLD      ++DFGLA +    + +     + GT+ Y+AP   
Sbjct: 122 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 590 GLGSEVSINGDVYSYGILLLELMTRKRPSD 619
                 +   DV+S GI+L  ++  + P D
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 91/210 (43%), Gaps = 19/210 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA-ECSALRNIRHKNLVKILTVCSGV 469
           G++G V   +    +  +AVK++++        +I  E    + + H+N+VK      G 
Sbjct: 18  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFY----GH 73
Query: 470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH 529
             +G+  + L  E+   G L + + P  G    +  P    F  ++         + YLH
Sbjct: 74  RREGN-IQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQL------MAGVVYLH 122
Query: 530 HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEY 589
                   H D+KP N+LLD      ++DFGLA +    + +     + GT+ Y+AP   
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 179
Query: 590 GLGSEVSINGDVYSYGILLLELMTRKRPSD 619
                 +   DV+S GI+L  ++  + P D
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 91/210 (43%), Gaps = 19/210 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA-ECSALRNIRHKNLVKILTVCSGV 469
           G++G V   +    +  +AVK++++        +I  E    + + H+N+VK      G 
Sbjct: 17  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY----GH 72
Query: 470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH 529
             +G+  + L  E+   G L + + P  G    +  P    F  ++         + YLH
Sbjct: 73  RREGN-IQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQL------MAGVVYLH 121
Query: 530 HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEY 589
                   H D+KP N+LLD      ++DFGLA +    + +     + GT+ Y+AP   
Sbjct: 122 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 590 GLGSEVSINGDVYSYGILLLELMTRKRPSD 619
                 +   DV+S GI+L  ++  + P D
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 92/231 (39%), Gaps = 34/231 (14%)
Query: 411 GSFGSVYKGILD--EGKTI-IAVKVLN---LLHHGASKSSIAECSALRNIRHKNLVKILT 464
           GSFG V +G  D   GKT+ +AVK L    L    A    I E +A+ ++ H+NL+++  
Sbjct: 29  GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG 88
Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
           V      K      +V E    GSL + L    G          L  L R   A+ VA  
Sbjct: 89  VVLTPPMK------MVTELAPLGSLLDRLRKHQGH-------FLLGTLSRY--AVQVAEG 133
Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV-----KG 579
           + YL         H DL   N+LL       + DFGL + LP    Q     V     K 
Sbjct: 134 MGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP----QNDDHXVMQEHRKV 186
Query: 580 TIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHN 630
              + AP      +  S   D + +G+ L E+ T  +   I   G+  LH 
Sbjct: 187 PFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK 236

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 91/218 (41%), Gaps = 27/218 (12%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLN---LLHHGASKSSIAECSALRNIRHKNLVKILT 464
           I  G+FG V    L     + A+K+LN   +L    +     E   L N   K +  +  
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141
Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
                 ++ D+   LV ++   G L   L  +S  +  +       +L  + IAID    
Sbjct: 142 A-----FQDDNNLYLVMDYYVGGDL---LTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ 193
Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLA-KLLPPAHLQTSSIGVKGTIGY 583
           L Y+H D         +KP N+L+D      +ADFG   KL+    +Q SS+ V GT  Y
Sbjct: 194 LHYVHRD---------IKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ-SSVAV-GTPDY 242
Query: 584 IAP----AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
           I+P    A  G         D +S G+ + E++  + P
Sbjct: 243 ISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 93/234 (39%), Gaps = 34/234 (14%)
Query: 411 GSFGSVYKGILD--EGKTI-IAVKVLN---LLHHGASKSSIAECSALRNIRHKNLVKILT 464
           GSFG V +G  D   GKT+ +AVK L    L    A    I E +A+ ++ H+NL+++  
Sbjct: 19  GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG 78
Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
           V      K      +V E    GSL + L    G          L  L R   A+ VA  
Sbjct: 79  VVLTPPMK------MVTELAPLGSLLDRLRKHQGH-------FLLGTLSRY--AVQVAEG 123
Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV-----KG 579
           + YL         H DL   N+LL       + DFGL + LP    Q     V     K 
Sbjct: 124 MGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP----QNDDHXVMQEHRKV 176
Query: 580 TIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFAR 633
              + AP      +  S   D + +G+ L E+ T  +   I   G+  LH   +
Sbjct: 177 PFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 93/234 (39%), Gaps = 34/234 (14%)
Query: 411 GSFGSVYKGILD--EGKTI-IAVKVLN---LLHHGASKSSIAECSALRNIRHKNLVKILT 464
           GSFG V +G  D   GKT+ +AVK L    L    A    I E +A+ ++ H+NL+++  
Sbjct: 23  GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG 82
Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
           V      K      +V E    GSL + L    G          L  L R   A+ VA  
Sbjct: 83  VVLTPPMK------MVTELAPLGSLLDRLRKHQGH-------FLLGTLSRY--AVQVAEG 127
Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV-----KG 579
           + YL         H DL   N+LL       + DFGL + LP    Q     V     K 
Sbjct: 128 MGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP----QNDDHYVMQEHRKV 180
Query: 580 TIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFAR 633
              + AP      +  S   D + +G+ L E+ T  +   I   G+  LH   +
Sbjct: 181 PFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 233

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 91/210 (43%), Gaps = 19/210 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA-ECSALRNIRHKNLVKILTVCSGV 469
           G++G V   +    +  +AVK++++        +I  E    + + H+N+VK      G 
Sbjct: 17  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY----GH 72
Query: 470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH 529
             +G+  + L  E+   G L + + P  G    +  P    F  ++         + YLH
Sbjct: 73  RREGN-IQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQL------MAGVVYLH 121
Query: 530 HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEY 589
                   H D+KP N+LLD      ++DFGLA +    + +     + GT+ Y+AP   
Sbjct: 122 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 590 GLGSEVSINGDVYSYGILLLELMTRKRPSD 619
                 +   DV+S GI+L  ++  + P D
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 101/237 (42%), Gaps = 48/237 (20%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTVCSG 468
           G   + Y  IL+     +A+K L+    +   +K +  E   ++ + HKN++ +L V   
Sbjct: 32  GIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV--- 85
Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAID-------- 520
                         F    SLEE    V    + ++A    N  Q I + +D        
Sbjct: 86  --------------FTPQKSLEE-FQDVYIVMELMDA----NLCQVIQMELDHERMSYLL 126
Query: 521 --VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK 578
             + C +K+LH        H DLKPSN+++  + T  + DFGLA+    + + T  +   
Sbjct: 127 YQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV--- 180
Query: 579 GTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV 635
            T  Y AP E  LG     N D++S G ++ E++  K    I+F G   +  + + +
Sbjct: 181 VTRYYRAP-EVILGMGYKENVDLWSVGCIMGEMVCHK----ILFPGRDYIDQWNKVI 232

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 100/231 (43%), Gaps = 51/231 (22%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNI--RHKNLVKILTV 465
           I  G FG V++G    G+ + AVK+ +       +S   E    + +  RH+N++  +  
Sbjct: 50  IGKGRFGEVWRGKW-RGEEV-AVKIFS---SREERSWFREAEIYQTVMLRHENILGFI-- 102
Query: 466 CSGVDYKGDDFKA---LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVA 522
               D K +       LV ++  +GSL ++L+  +    TVE          I +A+  A
Sbjct: 103 --AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEG--------MIKLALSTA 149
Query: 523 CALKYLHHDC-----QPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
             L +LH +      +P  AH DLK  N+L+    T  +AD GLA     A   T +I +
Sbjct: 150 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA---TDTIDI 206
Query: 578 K-----GTIGYIAPAEYGLGSEVSIN---------GDVYSYGILLLELMTR 614
                 GT  Y+AP       + SIN          D+Y+ G++  E+  R
Sbjct: 207 APNHRVGTKRYMAPEVL----DDSINMKHFESFKRADIYAMGLVFWEIARR 253

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 101/243 (41%), Gaps = 41/243 (16%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           I  G +G V+ G     K  +AVKV       AS     E      +RH+N++  +    
Sbjct: 45  IGKGRYGEVWMGKWRGEK--VAVKVF-FTTEEASWFRETEIYQTVLMRHENILGFI---- 97
Query: 468 GVDYKGDDFKALVY---EFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
             D KG      +Y   ++  NGSL ++L   +   K++           + +A      
Sbjct: 98  AADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSM-----------LKLAYSSVSG 146
Query: 525 LKYLHHDC-----QPTTAHCDLKPSNVLLDHEMTAHVADFGLA-KLLPPAHLQTSSIGVK 578
           L +LH +      +P  AH DLK  N+L+    T  +AD GLA K +      T+ + + 
Sbjct: 147 LCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFIS----DTNEVDIP 202
Query: 579 -----GTIGYIAPA--EYGLGS---EVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNL 628
                GT  Y+ P   +  L     +  I  D+YS+G++L E+  R     I+ E  +  
Sbjct: 203 PNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262
Query: 629 HNF 631
           H+ 
Sbjct: 263 HDL 265

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 100/231 (43%), Gaps = 51/231 (22%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNI--RHKNLVKILTV 465
           I  G FG V++G    G+ + AVK+ +       +S   E    + +  RH+N++  +  
Sbjct: 37  IGKGRFGEVWRGKW-RGEEV-AVKIFS---SREERSWFREAEIYQTVMLRHENILGFI-- 89
Query: 466 CSGVDYKGDDFKA---LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVA 522
               D K +       LV ++  +GSL ++L+  +    TVE          I +A+  A
Sbjct: 90  --AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGM--------IKLALSTA 136
Query: 523 CALKYLHHDC-----QPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
             L +LH +      +P  AH DLK  N+L+    T  +AD GLA     A   T +I +
Sbjct: 137 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA---TDTIDI 193
Query: 578 K-----GTIGYIAPAEYGLGSEVSIN---------GDVYSYGILLLELMTR 614
                 GT  Y+AP       + SIN          D+Y+ G++  E+  R
Sbjct: 194 APNHRVGTKRYMAPEVL----DDSINMKHFESFKRADIYAMGLVFWEIARR 240

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 25/216 (11%)
Query: 401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLN---LLHHGASKSSIAECSAL-RNIRH 456
            F FL  I  GSFG V        +   AVKVL    +L     K  ++E + L +N++H
Sbjct: 39  DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKH 98
Query: 457 KNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRIN 516
             LV +        ++  D    V ++++ G L  + H        ++  +C    +   
Sbjct: 99  PFLVGL-----HFSFQTADKLYFVLDYINGGEL--FYH--------LQRERCFLEPRARF 143
Query: 517 IAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIG 576
            A ++A AL YLH        + DLKP N+LLD +    + DFGL K     +  TS+  
Sbjct: 144 YAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC 200
Query: 577 VKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELM 612
             GT  Y+AP E           D +  G +L E++
Sbjct: 201 --GTPEYLAP-EVLHKQPYDRTVDWWCLGAVLYEML 233

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/237 (23%), Positives = 99/237 (41%), Gaps = 48/237 (20%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTVCSG 468
           G   + Y  IL+     +A+K L+    +   +K +  E   ++ + HKN++ +L V   
Sbjct: 43  GIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV--- 96
Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAID-------- 520
                         F    SLEE    V    + ++A    N  Q I + +D        
Sbjct: 97  --------------FTPQKSLEE-FQDVYIVMELMDA----NLCQVIQMELDHERMSYLL 137
Query: 521 --VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK 578
             + C +K+LH        H DLKPSN+++  + T  + DFGLA+    + + T  +  +
Sbjct: 138 YQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 194
Query: 579 GTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV 635
               Y    E  LG     N D++S G ++ E++  K    I+F G   +  + + +
Sbjct: 195 ----YYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK----ILFPGRDYIDQWNKVI 243

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 89/216 (41%), Gaps = 33/216 (15%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G+FG VYK    E   + A KV++       +  + E   L +  H N+VK+L       
Sbjct: 48  GAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF---- 103
Query: 471 YKGDDFKALVYEFMHNGSLE----EWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALK 526
           Y  ++   L+ EF   G+++    E   P++ +   V   + L+             AL 
Sbjct: 104 YYENNLWILI-EFCAGGAVDAVMLELERPLTESQIQVVCKQTLD-------------ALN 149
Query: 527 YLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGL-AKLLPPAHLQTSSIGVKGTIGYIA 585
           YLH +      H DLK  N+L   +    +ADFG+ AK       +   I   GT  ++A
Sbjct: 150 YLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFI---GTPYWMA 203
Query: 586 PA----EYGLGSEVSINGDVYSYGILLLELMTRKRP 617
           P     E           DV+S GI L+E+   + P
Sbjct: 204 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 91/210 (43%), Gaps = 19/210 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA-ECSALRNIRHKNLVKILTVCSGV 469
           G++G V   +    +  +AVK++++        +I  E    + + H+N+VK      G 
Sbjct: 18  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY----GH 73
Query: 470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH 529
             +G+  + L  E+   G L + + P    D  +  P    F  ++         + YLH
Sbjct: 74  RREGN-IQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQL------MAGVVYLH 122
Query: 530 HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEY 589
                   H D+KP N+LLD      ++DFGLA +    + +     + GT+ Y+AP   
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 590 GLGSEVSINGDVYSYGILLLELMTRKRPSD 619
                 +   DV+S GI+L  ++  + P D
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 91/210 (43%), Gaps = 19/210 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA-ECSALRNIRHKNLVKILTVCSGV 469
           G++G V   +    +  +AVK++++        +I  E    + + H+N+VK      G 
Sbjct: 17  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY----GH 72
Query: 470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH 529
             +G+  + L  E+   G L + + P  G    +  P    F  ++         + YLH
Sbjct: 73  RREGN-IQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQL------MAGVVYLH 121
Query: 530 HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEY 589
                   H D+KP N+LLD      ++DFGLA +    + +     + GT+ Y+AP   
Sbjct: 122 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 590 GLGSEVSINGDVYSYGILLLELMTRKRPSD 619
                 +   DV+S GI+L  ++  + P D
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 91/210 (43%), Gaps = 19/210 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA-ECSALRNIRHKNLVKILTVCSGV 469
           G++G V   +    +  +AVK++++        +I  E    + + H+N+VK      G 
Sbjct: 17  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY----GH 72
Query: 470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH 529
             +G+  + L  E+   G L + + P  G    +  P    F  ++         + YLH
Sbjct: 73  RREGN-IQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQL------MAGVVYLH 121
Query: 530 HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEY 589
                   H D+KP N+LLD      ++DFGLA +    + +     + GT+ Y+AP   
Sbjct: 122 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 590 GLGSEVSINGDVYSYGILLLELMTRKRPSD 619
                 +   DV+S GI+L  ++  + P D
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 92/231 (39%), Gaps = 34/231 (14%)
Query: 411 GSFGSVYKGILD--EGKTI-IAVKVLN---LLHHGASKSSIAECSALRNIRHKNLVKILT 464
           GSFG V +G  D   GKT+ +AVK L    L    A    I E +A+ ++ H+NL+++  
Sbjct: 29  GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG 88
Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
           V      K      +V E    GSL + L    G          L  L R   A+ VA  
Sbjct: 89  VVLTPPMK------MVTELAPLGSLLDRLRKHQGH-------FLLGTLSRY--AVQVAEG 133
Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV-----KG 579
           + YL         H DL   N+LL       + DFGL + LP    Q     V     K 
Sbjct: 134 MGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP----QNDDHYVMQEHRKV 186
Query: 580 TIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHN 630
              + AP      +  S   D + +G+ L E+ T  +   I   G+  LH 
Sbjct: 187 PFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK 236

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 100/231 (43%), Gaps = 51/231 (22%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNI--RHKNLVKILTV 465
           I  G FG V++G    G+ + AVK+ +       +S   E    + +  RH+N++  +  
Sbjct: 17  IGKGRFGEVWRGKW-RGEEV-AVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFI-- 69
Query: 466 CSGVDYKGDDFKA---LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVA 522
               D K +       LV ++  +GSL ++L+  +    TVE          I +A+  A
Sbjct: 70  --AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGM--------IKLALSTA 116
Query: 523 CALKYLHHDC-----QPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
             L +LH +      +P  AH DLK  N+L+    T  +AD GLA     A   T +I +
Sbjct: 117 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA---TDTIDI 173
Query: 578 K-----GTIGYIAPAEYGLGSEVSIN---------GDVYSYGILLLELMTR 614
                 GT  Y+AP       + SIN          D+Y+ G++  E+  R
Sbjct: 174 APNHRVGTKRYMAPEVL----DDSINMKHFESFKRADIYAMGLVFWEIARR 220

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 86/214 (40%), Gaps = 24/214 (11%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGA-SKSSIAECSALRNIRHKNLVKILTVCSGV 469
           G++G V          I+A+K +        +  ++ E   L++ +H+N++ I  +    
Sbjct: 22  GAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPD 81
Query: 470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH 529
            ++  +   ++ E M        LH V       +        Q +        A+K LH
Sbjct: 82  SFENFNEVYIIQELMQTD-----LHRVISTQMLSDDHIQYFIYQTLR-------AVKVLH 129
Query: 530 HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL--------PPAHLQTSSIGVKGTI 581
                   H DLKPSN+L++      V DFGLA+++         P   Q+  +    T 
Sbjct: 130 GS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATR 186
Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMTRK 615
            Y AP      ++ S   DV+S G +L EL  R+
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 91/210 (43%), Gaps = 19/210 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA-ECSALRNIRHKNLVKILTVCSGV 469
           G++G V   +    +  +AVK++++        +I  E    + + H+N+VK      G 
Sbjct: 17  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY----GH 72
Query: 470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH 529
             +G+  + L  E+   G L + + P  G    +  P    F  ++         + YLH
Sbjct: 73  RREGN-IQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQL------MAGVVYLH 121
Query: 530 HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEY 589
                   H D+KP N+LLD      ++DFGLA +    + +     + GT+ Y+AP   
Sbjct: 122 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 590 GLGSEVSINGDVYSYGILLLELMTRKRPSD 619
                 +   DV+S GI+L  ++  + P D
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 92/231 (39%), Gaps = 34/231 (14%)
Query: 411 GSFGSVYKGILD--EGKTI-IAVKVLN---LLHHGASKSSIAECSALRNIRHKNLVKILT 464
           GSFG V +G  D   GKT+ +AVK L    L    A    I E +A+ ++ H+NL+++  
Sbjct: 19  GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG 78
Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
           V      K      +V E    GSL + L    G          L  L R   A+ VA  
Sbjct: 79  VVLTPPMK------MVTELAPLGSLLDRLRKHQGH-------FLLGTLSRY--AVQVAEG 123
Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV-----KG 579
           + YL         H DL   N+LL       + DFGL + LP    Q     V     K 
Sbjct: 124 MGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP----QNDDHYVMQEHRKV 176
Query: 580 TIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHN 630
              + AP      +  S   D + +G+ L E+ T  +   I   G+  LH 
Sbjct: 177 PFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK 226

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 100/231 (43%), Gaps = 51/231 (22%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNI--RHKNLVKILTV 465
           I  G FG V++G    G+ + AVK+ +       +S   E    + +  RH+N++  +  
Sbjct: 11  IGKGRFGEVWRGKW-RGEEV-AVKIFS---SREERSWFREAEIYQTVMLRHENILGFI-- 63
Query: 466 CSGVDYKGDDFKA---LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVA 522
               D K +       LV ++  +GSL ++L+  +    TVE          I +A+  A
Sbjct: 64  --AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGM--------IKLALSTA 110
Query: 523 CALKYLHHDC-----QPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
             L +LH +      +P  AH DLK  N+L+    T  +AD GLA     A   T +I +
Sbjct: 111 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA---TDTIDI 167
Query: 578 K-----GTIGYIAPAEYGLGSEVSIN---------GDVYSYGILLLELMTR 614
                 GT  Y+AP       + SIN          D+Y+ G++  E+  R
Sbjct: 168 APNHRVGTKRYMAPEVL----DDSINMKHFESFKRADIYAMGLVFWEIARR 214

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 100/231 (43%), Gaps = 51/231 (22%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNI--RHKNLVKILTV 465
           I  G FG V++G    G+ + AVK+ +       +S   E    + +  RH+N++  +  
Sbjct: 12  IGKGRFGEVWRGKW-RGEEV-AVKIFS---SREERSWFREAEIYQTVMLRHENILGFI-- 64
Query: 466 CSGVDYKGDDFKA---LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVA 522
               D K +       LV ++  +GSL ++L+  +    TVE          I +A+  A
Sbjct: 65  --AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGM--------IKLALSTA 111
Query: 523 CALKYLHHDC-----QPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
             L +LH +      +P  AH DLK  N+L+    T  +AD GLA     A   T +I +
Sbjct: 112 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA---TDTIDI 168
Query: 578 K-----GTIGYIAPAEYGLGSEVSIN---------GDVYSYGILLLELMTR 614
                 GT  Y+AP       + SIN          D+Y+ G++  E+  R
Sbjct: 169 APNHRVGTKRYMAPEVL----DDSINMKHFESFKRADIYAMGLVFWEIARR 215

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 100/231 (43%), Gaps = 51/231 (22%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNI--RHKNLVKILTV 465
           I  G FG V++G    G+ + AVK+ +       +S   E    + +  RH+N++  +  
Sbjct: 14  IGKGRFGEVWRGKW-RGEEV-AVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFI-- 66
Query: 466 CSGVDYKGDDFKA---LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVA 522
               D K +       LV ++  +GSL ++L+  +    TVE          I +A+  A
Sbjct: 67  --AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGM--------IKLALSTA 113
Query: 523 CALKYLHHDC-----QPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
             L +LH +      +P  AH DLK  N+L+    T  +AD GLA     A   T +I +
Sbjct: 114 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA---TDTIDI 170
Query: 578 K-----GTIGYIAPAEYGLGSEVSIN---------GDVYSYGILLLELMTR 614
                 GT  Y+AP       + SIN          D+Y+ G++  E+  R
Sbjct: 171 APNHRVGTKRYMAPEVL----DDSINMKHFESFKRADIYAMGLVFWEIARR 217

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 92/231 (39%), Gaps = 34/231 (14%)
Query: 411 GSFGSVYKGILD--EGKTI-IAVKVLN---LLHHGASKSSIAECSALRNIRHKNLVKILT 464
           GSFG V +G  D   GKT+ +AVK L    L    A    I E +A+ ++ H+NL+++  
Sbjct: 23  GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG 82
Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
           V      K      +V E    GSL + L    G          L  L R   A+ VA  
Sbjct: 83  VVLTPPMK------MVTELAPLGSLLDRLRKHQGH-------FLLGTLSRY--AVQVAEG 127
Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV-----KG 579
           + YL         H DL   N+LL       + DFGL + LP    Q     V     K 
Sbjct: 128 MGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP----QNDDHYVMQEHRKV 180
Query: 580 TIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHN 630
              + AP      +  S   D + +G+ L E+ T  +   I   G+  LH 
Sbjct: 181 PFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK 230

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 96/218 (44%), Gaps = 24/218 (11%)
Query: 411 GSFGSVYKGI---LDEGKTIIAVKV-LNLLHHGASKSS----IAECSALRNI-RHKNLVK 461
           G+FG V       +D+ K   AV V + +L   A++      ++E   ++ I +HKN++ 
Sbjct: 46  GAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIN 105
Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVS--GADKTVEAPKC----LNFLQRI 515
           +L  C+      D    ++  +   G+L E+L      G + + +  +     + F   +
Sbjct: 106 LLGACTQ-----DGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 516 NIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSI 575
           +    +A  ++YL         H DL   NVL+       +ADFGLA+ +        + 
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 576 GVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             +  + ++AP E       +   DV+S+G+L+ E+ T
Sbjct: 218 NGRLPVKWMAP-EALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 93/234 (39%), Gaps = 34/234 (14%)
Query: 411 GSFGSVYKGILD--EGKTI-IAVKVLN---LLHHGASKSSIAECSALRNIRHKNLVKILT 464
           GSFG V +G  D   GKT+ +AVK L    L    A    I E +A+ ++ H+NL+++  
Sbjct: 19  GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG 78
Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
           V      K      +V E    GSL + L    G          L  L R   A+ VA  
Sbjct: 79  VVLTPPMK------MVTELAPLGSLLDRLRKHQGH-------FLLGTLSRY--AVQVAEG 123
Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV-----KG 579
           + YL         H DL   N+LL       + DFGL + LP    Q     V     K 
Sbjct: 124 MGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP----QNDDHYVMQEHRKV 176
Query: 580 TIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFAR 633
              + AP      +  S   D + +G+ L E+ T  +   I   G+  LH   +
Sbjct: 177 PFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 75/169 (44%), Gaps = 26/169 (15%)
Query: 447 ECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAP 506
           E S L+++ H N++K+  V     ++   +  LV EF   G L E +      D+   A 
Sbjct: 96  EISLLKSLDHPNIIKLFDV-----FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA- 149
Query: 507 KCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHE---MTAHVADFGLAK 563
                    NI   +   + YLH   +    H D+KP N+LL+++   +   + DFGL+ 
Sbjct: 150 ---------NIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSS 197
Query: 564 LLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELM 612
                +     +   GT  YIAP    L  + +   DV+S G+++  L+
Sbjct: 198 FFSKDYKLRDRL---GTAYYIAPE--VLKKKYNEKCDVWSCGVIMYILL 241

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 91/210 (43%), Gaps = 19/210 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA-ECSALRNIRHKNLVKILTVCSGV 469
           G++G V   +    +  +AVK++++        +I  E    + + H+N+VK      G 
Sbjct: 17  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFY----GH 72
Query: 470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH 529
             +G+  + L  E+   G L + + P  G    +  P    F  ++         + YLH
Sbjct: 73  RREGN-IQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQL------MAGVVYLH 121
Query: 530 HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEY 589
                   H D+KP N+LLD      ++DFGLA +    + +     + GT+ Y+AP   
Sbjct: 122 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 590 GLGSEVSINGDVYSYGILLLELMTRKRPSD 619
                 +   DV+S GI+L  ++  + P D
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 67/140 (47%), Gaps = 17/140 (12%)
Query: 478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTA 537
           ++  E M  GSL++ L       + +        L +++IA  V   L YL    Q    
Sbjct: 90  SICMEHMDGGSLDQVLKEAKRIPEEI--------LGKVSIA--VLRGLAYLREKHQ--IM 137
Query: 538 HCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSI 597
           H D+KPSN+L++      + DFG++  L    + + +    GT  Y+AP E   G+  S+
Sbjct: 138 HRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMAP-ERLQGTHYSV 192
Query: 598 NGDVYSYGILLLELMTRKRP 617
             D++S G+ L+EL   + P
Sbjct: 193 QSDIWSMGLSLVELAVGRYP 212

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 91/210 (43%), Gaps = 19/210 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA-ECSALRNIRHKNLVKILTVCSGV 469
           G++G V   +    +  +AVK++++        +I  E    + + H+N+VK      G 
Sbjct: 17  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY----GH 72
Query: 470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH 529
             +G+  + L  E+   G L + + P  G    +  P    F  ++         + YLH
Sbjct: 73  RREGN-IQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQL------MAGVVYLH 121
Query: 530 HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEY 589
                   H D+KP N+LLD      ++DFGLA +    + +     + GT+ Y+AP   
Sbjct: 122 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 590 GLGSEVSINGDVYSYGILLLELMTRKRPSD 619
                 +   DV+S GI+L  ++  + P D
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 97/223 (43%), Gaps = 36/223 (16%)
Query: 408 IDMGSFGSVYKG-ILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNI-----RHKNLVK 461
           I  G+FG V K  I  +G  + A   +  +   ASK    + +    +      H N++ 
Sbjct: 30  IGEGNFGQVLKARIKKDGLRMDAA--IKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 87
Query: 462 ILTVCSGVDYKGDDFKALVY-------EFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQR 514
           +L  C   +++G  + A+ Y       +F+    + E     + A+ T      L+  Q 
Sbjct: 88  LLGAC---EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST---LSSQQL 141
Query: 515 INIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSS 574
           ++ A DVA  + YL    Q    H +L   N+L+     A +ADFGL++           
Sbjct: 142 LHFAADVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSR--------GQE 190
Query: 575 IGVKGTIGYIAPAEYGLG----SEVSINGDVYSYGILLLELMT 613
           + VK T+G +      +     S  + N DV+SYG+LL E+++
Sbjct: 191 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 91/210 (43%), Gaps = 19/210 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA-ECSALRNIRHKNLVKILTVCSGV 469
           G++G V   +    +  +AVK++++        +I  E    + + H+N+VK      G 
Sbjct: 16  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY----GH 71
Query: 470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH 529
             +G+  + L  E+   G L + + P  G    +  P    F  ++         + YLH
Sbjct: 72  RREGN-IQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQL------MAGVVYLH 120
Query: 530 HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEY 589
                   H D+KP N+LLD      ++DFGLA +    + +     + GT+ Y+AP   
Sbjct: 121 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 590 GLGSEVSINGDVYSYGILLLELMTRKRPSD 619
                 +   DV+S GI+L  ++  + P D
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 207

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 91/210 (43%), Gaps = 19/210 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA-ECSALRNIRHKNLVKILTVCSGV 469
           G++G V   +    +  +AVK++++        +I  E    + + H+N+VK      G 
Sbjct: 18  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY----GH 73
Query: 470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH 529
             +G+  + L  E+   G L + + P  G    +  P    F  ++         + YLH
Sbjct: 74  RREGN-IQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQL------MAGVVYLH 122
Query: 530 HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEY 589
                   H D+KP N+LLD      ++DFGLA +    + +     + GT+ Y+AP   
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 590 GLGSEVSINGDVYSYGILLLELMTRKRPSD 619
                 +   DV+S GI+L  ++  + P D
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 91/210 (43%), Gaps = 19/210 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA-ECSALRNIRHKNLVKILTVCSGV 469
           G++G V   +    +  +AVK++++        +I  E    + + H+N+VK      G 
Sbjct: 18  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY----GH 73
Query: 470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH 529
             +G+  + L  E+   G L + + P    D  +  P    F  ++         + YLH
Sbjct: 74  RREGN-IQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQL------MAGVVYLH 122
Query: 530 HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEY 589
                   H D+KP N+LLD      ++DFGLA +    + +     + GT+ Y+AP   
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 590 GLGSEVSINGDVYSYGILLLELMTRKRPSD 619
                 +   DV+S GI+L  ++  + P D
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 91/210 (43%), Gaps = 19/210 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA-ECSALRNIRHKNLVKILTVCSGV 469
           G++G V   +    +  +AVK++++        +I  E    + + H+N+VK      G 
Sbjct: 18  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY----GH 73
Query: 470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH 529
             +G+  + L  E+   G L + + P    D  +  P    F  ++         + YLH
Sbjct: 74  RREGN-IQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQL------MAGVVYLH 122
Query: 530 HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEY 589
                   H D+KP N+LLD      ++DFGLA +    + +     + GT+ Y+AP   
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 590 GLGSEVSINGDVYSYGILLLELMTRKRPSD 619
                 +   DV+S GI+L  ++  + P D
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 91/210 (43%), Gaps = 19/210 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA-ECSALRNIRHKNLVKILTVCSGV 469
           G++G V   +    +  +AVK++++        +I  E    + + H+N+VK      G 
Sbjct: 18  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY----GH 73
Query: 470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH 529
             +G+  + L  E+   G L + + P    D  +  P    F  ++         + YLH
Sbjct: 74  RREGN-IQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQL------MAGVVYLH 122
Query: 530 HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEY 589
                   H D+KP N+LLD      ++DFGLA +    + +     + GT+ Y+AP   
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 590 GLGSEVSINGDVYSYGILLLELMTRKRPSD 619
                 +   DV+S GI+L  ++  + P D
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 56/109 (51%), Gaps = 12/109 (11%)
Query: 516 NIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSI 575
            IA+ +  AL++LH     +  H D+KPSNVL++      + DFG++  L  +  +T   
Sbjct: 157 KIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDA 214
Query: 576 GVKGTIGYIAPAEYGLGSEV-----SINGDVYSYGILLLELMTRKRPSD 619
           G K    Y+AP    +  E+     S+  D++S GI ++EL   + P D
Sbjct: 215 GCK---PYMAPER--INPELNQKGYSVKSDIWSLGITMIELAILRFPYD 258

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/237 (22%), Positives = 99/237 (41%), Gaps = 48/237 (20%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTVCSG 468
           G   + Y  IL+     +A+K L+    +   +K +  E   ++ + HKN++ +L V   
Sbjct: 38  GIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV--- 91
Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAID-------- 520
                         F    SLEE    V    + ++A    N  Q I + +D        
Sbjct: 92  --------------FTPQKSLEE-FQDVYIVMELMDA----NLCQVIQMELDHERMSYLL 132
Query: 521 --VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK 578
             + C +K+LH        H DLKPSN+++  + T  + DFGLA+    + + T  +  +
Sbjct: 133 YQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVVTR 189
Query: 579 GTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV 635
               Y    E  LG     N D++S G ++ E++       ++F G  ++  + + +
Sbjct: 190 ----YYRAPEVILGMGYKENVDIWSVGCIMGEMIK----GGVLFPGTDHIDQWNKVI 238

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 55/121 (45%), Gaps = 11/121 (9%)
Query: 501 KTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFG 560
           K ++ P     L ++ +AI    AL YL    +    H D+KPSN+LLD      + DFG
Sbjct: 115 KRMQGPIPERILGKMTVAI--VKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFG 170
Query: 561 LAKLLPPAHLQTSSIGVKGTIGYIAPAEYG----LGSEVSINGDVYSYGILLLELMTRKR 616
           ++  L     +  S G      Y+AP           +  I  DV+S GI L+EL T + 
Sbjct: 171 ISGRLVDDKAKDRSAGC---AAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQF 227
Query: 617 P 617
           P
Sbjct: 228 P 228

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 91/210 (43%), Gaps = 19/210 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA-ECSALRNIRHKNLVKILTVCSGV 469
           G++G V   +    +  +AVK++++        +I  E    + + H+N+VK      G 
Sbjct: 17  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY----GH 72
Query: 470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH 529
             +G+  + L  E+   G L + + P  G    +  P    F  ++         + YLH
Sbjct: 73  RREGN-IQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQL------MAGVVYLH 121
Query: 530 HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEY 589
                   H D+KP N+LLD      ++DFGLA +    + +     + GT+ Y+AP   
Sbjct: 122 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 590 GLGSEVSINGDVYSYGILLLELMTRKRPSD 619
                 +   DV+S GI+L  ++  + P D
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 30/219 (13%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGA--SKSSIAECSALRNIRHKNLVKILTVCSG 468
           G++GSV   I       +A+K L+        +K +  E   L++++H+N++ +L V + 
Sbjct: 53  GAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTP 112
Query: 469 VDYKGD--DFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALK 526
                +  DF  LV  FM        L  + G + + E  + L +         +   LK
Sbjct: 113 ASSLRNFYDF-YLVMPFMQTD-----LQKIMGMEFSEEKIQYLVY--------QMLKGLK 158
Query: 527 YLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP 586
           Y+H        H DLKP N+ ++ +    + DFGLA+     H      G   T  Y AP
Sbjct: 159 YIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAP 210
Query: 587 AEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGN 625
                    +   D++S G ++ E++T K     +F+G 
Sbjct: 211 EVILSWMHYNQTVDIWSVGCIMAEMLTGK----TLFKGK 245

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 96/217 (44%), Gaps = 36/217 (16%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           I  GS G V    +     ++AVK ++L      +    E   +R+ +H+N+V++     
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN--- 93
Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
              Y   D   +V EF+  G+L + +      ++ + A  CL  LQ          AL  
Sbjct: 94  --SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA-VCLAVLQ----------ALSV 140
Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFG----LAKLLPPAHLQTSSIGVKGTIGY 583
           LH        H D+K  ++LL H+    ++DFG    ++K +P          + GT  +
Sbjct: 141 LHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP------RRKXLVGTPYW 191
Query: 584 IAP---AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
           +AP   +    G EV    D++S GI+++E++  + P
Sbjct: 192 MAPELISRLPYGPEV----DIWSLGIMVIEMVDGEPP 224

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 96/217 (44%), Gaps = 36/217 (16%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           I  GS G V    +     ++AVK ++L      +    E   +R+ +H+N+V++     
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN--- 138
Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
              Y   D   +V EF+  G+L + +      ++ + A  CL  LQ          AL  
Sbjct: 139 --SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA-VCLAVLQ----------ALSV 185
Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFG----LAKLLPPAHLQTSSIGVKGTIGY 583
           LH        H D+K  ++LL H+    ++DFG    ++K +P          + GT  +
Sbjct: 186 LHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP------RRKXLVGTPYW 236
Query: 584 IAP---AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
           +AP   +    G EV    D++S GI+++E++  + P
Sbjct: 237 MAPELISRLPYGPEV----DIWSLGIMVIEMVDGEPP 269

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 63/239 (26%), Positives = 105/239 (43%), Gaps = 32/239 (13%)
Query: 386 AAAIISVLVGILLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKV----LNLLHHGAS 441
           A  I  VLV       ++   ++  G F   ++    + K + A K+    L L  H   
Sbjct: 3   AKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE 62
Query: 442 KSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADK 501
           K S+ E S  R++ H+++V          ++ +DF  +V E     SL E LH      K
Sbjct: 63  KMSM-EISIHRSLAHQHVVGFHGF-----FEDNDFVFVVLELCRRRSLLE-LH---KRRK 112
Query: 502 TVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGL 561
            +  P+   +L++I +        +YLH +      H DLK  N+ L+ ++   + DFGL
Sbjct: 113 ALTEPEARYYLRQIVLGC------QYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGL 163
Query: 562 AKLLPPAHLQTSSIGVKGTIGYIAP---AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
           A  +     +  ++   GT  YIAP   ++ G   EV    DV+S G ++  L+  K P
Sbjct: 164 ATKVEYDGERKKTLC--GTPNYIAPEVLSKKGHSFEV----DVWSIGCIMYTLLVGKPP 216

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 100/237 (42%), Gaps = 48/237 (20%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTVCSG 468
           G   + Y  IL+     +A+K L+    +   +K +  E   ++ + HKN++ +L V   
Sbjct: 38  GIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV--- 91
Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAID-------- 520
                         F    SLEE    V    + ++A    N  Q I + +D        
Sbjct: 92  --------------FTPQKSLEE-FQDVYIVMELMDA----NLCQVIQMELDHERMSYLL 132
Query: 521 --VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK 578
             + C +K+LH        H DLKPSN+++  + T  + DFGLA+    + +    +   
Sbjct: 133 YQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEV--- 186
Query: 579 GTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV 635
            T  Y AP E  LG     N D++S G ++ E++  K    I+F G   +  + + +
Sbjct: 187 VTRYYRAP-EVILGMGYKENVDIWSVGCIMGEMVCHK----ILFPGRDYIDQWNKVI 238

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 91/210 (43%), Gaps = 19/210 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA-ECSALRNIRHKNLVKILTVCSGV 469
           G++G V   +    +  +AVK++++        +I  E    + + H+N+VK      G 
Sbjct: 18  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY----GH 73
Query: 470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH 529
             +G+  + L  E+   G L + + P    D  +  P    F  ++         + YLH
Sbjct: 74  RREGN-IQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQL------MAGVVYLH 122
Query: 530 HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEY 589
                   H D+KP N+LLD      ++DFGLA +    + +     + GT+ Y+AP   
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 590 GLGSEVSINGDVYSYGILLLELMTRKRPSD 619
                 +   DV+S GI+L  ++  + P D
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 96/217 (44%), Gaps = 36/217 (16%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           I  GS G V    +     ++AVK ++L      +    E   +R+ +H+N+V++     
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN--- 95
Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
              Y   D   +V EF+  G+L + +      ++ + A  CL  LQ          AL  
Sbjct: 96  --SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA-VCLAVLQ----------ALSV 142
Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFG----LAKLLPPAHLQTSSIGVKGTIGY 583
           LH        H D+K  ++LL H+    ++DFG    ++K +P          + GT  +
Sbjct: 143 LHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP------RRKXLVGTPYW 193
Query: 584 IAP---AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
           +AP   +    G EV    D++S GI+++E++  + P
Sbjct: 194 MAPELISRLPYGPEV----DIWSLGIMVIEMVDGEPP 226

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 96/217 (44%), Gaps = 36/217 (16%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           I  GS G V    +     ++AVK ++L      +    E   +R+ +H+N+V++     
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN--- 84
Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
              Y   D   +V EF+  G+L + +      ++ + A  CL  LQ          AL  
Sbjct: 85  --SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA-VCLAVLQ----------ALSV 131
Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFG----LAKLLPPAHLQTSSIGVKGTIGY 583
           LH        H D+K  ++LL H+    ++DFG    ++K +P          + GT  +
Sbjct: 132 LHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP------RRKXLVGTPYW 182
Query: 584 IAP---AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
           +AP   +    G EV    D++S GI+++E++  + P
Sbjct: 183 MAPELISRLPYGPEV----DIWSLGIMVIEMVDGEPP 215

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 78/317 (24%), Positives = 131/317 (41%), Gaps = 55/317 (17%)
Query: 407 WIDMGSFGSVYKGILDEGKTIIAVKV----LNLLHHGASKSSIAECSALRNIRHKNLVKI 462
           ++  G F   ++    + K + A K+    L L  H   K S+ E S  R++ H+++V  
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM-EISIHRSLAHQHVVGF 106
Query: 463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVA 522
                   ++ +DF  +V E     SL E LH      K +  P+   +L++I +     
Sbjct: 107 HGF-----FEDNDFVFVVLELCRRRSLLE-LH---KRRKALTEPEARYYLRQIVLGC--- 154
Query: 523 CALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIG 582
              +YLH +      H DLK  N+ L+ ++   + DFGLA  +   +       + GT  
Sbjct: 155 ---QYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKVLCGTPN 206
Query: 583 YIAP---AEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART----- 634
           YIAP   ++ G   EV    DV+S G ++  L+  K P    FE +     + R      
Sbjct: 207 YIAPEVLSKKGHSFEV----DVWSIGCIMYTLLVGKPP----FETSCLKETYLRIKKNEY 258
Query: 635 VLPDHVMDIVDS---TLLADDEDLTITSNQRQRQ---------ARINNIMECLISVVRIG 682
            +P H+  +  S    +L  D     T N+             AR+   + CL    R  
Sbjct: 259 SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLP--ITCLTIPPRFS 316
Query: 683 VACSMESPQDRMNMTIV 699
           +A S   P +R  +T++
Sbjct: 317 IAPSSLDPSNRKPLTVL 333

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 96/218 (44%), Gaps = 24/218 (11%)
Query: 411 GSFGSVYKGI---LDEGKTIIAVKV-LNLLHHGASKSS----IAECSALRNI-RHKNLVK 461
           G+FG V       +D+ K   AV V + +L   A++      ++E   ++ I +HKN++ 
Sbjct: 46  GAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIN 105
Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVS--GADKTVEAPKC----LNFLQRI 515
           +L  C+      D    ++  +   G+L E+L      G + + +  +     + F   +
Sbjct: 106 LLGACTQ-----DGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 516 NIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSI 575
           +    +A  ++YL         H DL   NVL+       +ADFGLA+ +        + 
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 576 GVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             +  + ++AP E       +   DV+S+G+L+ E+ T
Sbjct: 218 NGRLPVKWMAP-EALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 91/210 (43%), Gaps = 19/210 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA-ECSALRNIRHKNLVKILTVCSGV 469
           G++G V   +    +  +AVK++++        +I  E    + + H+N+VK      G 
Sbjct: 17  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY----GH 72
Query: 470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH 529
             +G+  + L  E+   G L + + P    D  +  P    F  ++         + YLH
Sbjct: 73  RREGN-IQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQL------MAGVVYLH 121
Query: 530 HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEY 589
                   H D+KP N+LLD      ++DFGLA +    + +     + GT+ Y+AP   
Sbjct: 122 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 590 GLGSEVSINGDVYSYGILLLELMTRKRPSD 619
                 +   DV+S GI+L  ++  + P D
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 97/224 (43%), Gaps = 33/224 (14%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGAS----KSSIAECSALRNIRHKNLVKILTVC 466
           G++G+V   +  +G+T   V +  L     S    K +  E   L+++RH+N++ +L V 
Sbjct: 36  GAYGAVCSAV--DGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVF 93
Query: 467 SGVDYKGDDFK--ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
           +  D   DDF    LV  FM     +   H   G D+       + FL        +   
Sbjct: 94  TP-DETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDR-------IQFL-----VYQMLKG 140
Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYI 584
           L+Y+H        H DLKP N+ ++ +    + DFGLA+        +   G   T  Y 
Sbjct: 141 LRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMXGXVVTRWYR 192
Query: 585 APAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNL 628
           AP         +   D++S G ++ E++T K     +F+G+ +L
Sbjct: 193 APEVILNWMRYTQTVDIWSVGCIMAEMITGK----TLFKGSDHL 232

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 100/213 (46%), Gaps = 32/213 (15%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKNLVKILTVCSG 468
           G++G VYK I       +A+K + L H   G   ++I E S L+ ++H+N++++ +V   
Sbjct: 45  GTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVI-- 102
Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL 528
                +    L++E+  N  L++++      D ++   K  +FL ++   ++   + + L
Sbjct: 103 ---HHNHRLHLIFEYAEN-DLKKYMD--KNPDVSMRVIK--SFLYQLINGVNFCHSRRCL 154
Query: 529 HHDCQPTTAHCDLKPSNVLL---DHEMTA--HVADFGLAKLLP-PAHLQTSSIGVKGTIG 582
           H          DLKP N+LL   D   T    + DFGLA+    P    T  I    T+ 
Sbjct: 155 HR---------DLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEI---ITLW 202
Query: 583 YIAPAEYGLGSE-VSINGDVYSYGILLLELMTR 614
           Y  P E  LGS   S + D++S   +  E++ +
Sbjct: 203 Y-RPPEILLGSRHYSTSVDIWSIACIWAEMLMK 234

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 78/317 (24%), Positives = 131/317 (41%), Gaps = 55/317 (17%)
Query: 407 WIDMGSFGSVYKGILDEGKTIIAVKV----LNLLHHGASKSSIAECSALRNIRHKNLVKI 462
           ++  G F   ++    + K + A K+    L L  H   K S+ E S  R++ H+++V  
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM-EISIHRSLAHQHVVGF 104
Query: 463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVA 522
                   ++ +DF  +V E     SL E LH      K +  P+   +L++I +     
Sbjct: 105 HGF-----FEDNDFVFVVLELCRRRSLLE-LH---KRRKALTEPEARYYLRQIVLGC--- 152
Query: 523 CALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIG 582
              +YLH +      H DLK  N+ L+ ++   + DFGLA  +   +       + GT  
Sbjct: 153 ---QYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKVLCGTPN 204
Query: 583 YIAP---AEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART----- 634
           YIAP   ++ G   EV    DV+S G ++  L+  K P    FE +     + R      
Sbjct: 205 YIAPEVLSKKGHSFEV----DVWSIGCIMYTLLVGKPP----FETSCLKETYLRIKKNEY 256
Query: 635 VLPDHVMDIVDS---TLLADDEDLTITSNQRQRQ---------ARINNIMECLISVVRIG 682
            +P H+  +  S    +L  D     T N+             AR+   + CL    R  
Sbjct: 257 SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLP--ITCLTIPPRFS 314
Query: 683 VACSMESPQDRMNMTIV 699
           +A S   P +R  +T++
Sbjct: 315 IAPSSLDPSNRKPLTVL 331

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/108 (30%), Positives = 52/108 (48%), Gaps = 14/108 (12%)
Query: 515 INIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLA----------KL 564
           ++I I +A A+++LH        H DLKPSN+    +    V DFGL            +
Sbjct: 167 LHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 565 LPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELM 612
           L P     +  G  GT  Y++P +   G+  S   D++S G++L EL+
Sbjct: 224 LTPMPAYATHXGQVGTKLYMSPEQIH-GNNYSHKVDIFSLGLILFELL 270

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 96/217 (44%), Gaps = 36/217 (16%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           I  GS G V    +     ++AVK ++L      +    E   +R+ +H+N+V++     
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN--- 215
Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
              Y   D   +V EF+  G+L + +      ++ + A  CL  LQ          AL  
Sbjct: 216 --SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA-VCLAVLQ----------ALSV 262
Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFG----LAKLLPPAHLQTSSIGVKGTIGY 583
           LH        H D+K  ++LL H+    ++DFG    ++K +P          + GT  +
Sbjct: 263 LHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP------RRKXLVGTPYW 313
Query: 584 IAP---AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
           +AP   +    G EV    D++S GI+++E++  + P
Sbjct: 314 MAPELISRLPYGPEV----DIWSLGIMVIEMVDGEPP 346

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 96/220 (43%), Gaps = 45/220 (20%)
Query: 428 IAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMH 485
           +AVK L+    +   +K +  E   L+ + HKN++ +L V                 F  
Sbjct: 50  VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV-----------------FTP 92
Query: 486 NGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAID----------VACALKYLHHDCQPT 535
             +LEE    V    + ++A    N  Q I++ +D          + C +K+LH      
Sbjct: 93  QKTLEE-FQDVYLVMELMDA----NLCQVIHMELDHERMSYLLYQMLCGIKHLH---SAG 144
Query: 536 TAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEV 595
             H DLKPSN+++  + T  + DFGLA+      + T  +  +    Y AP E  LG   
Sbjct: 145 IIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTR---YYRAP-EVILGMGY 200
Query: 596 SINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV 635
             N D++S G ++ EL+       ++F+G  ++  + + +
Sbjct: 201 KENVDIWSVGCIMGELVK----GSVIFQGTDHIDQWNKVI 236

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 96/217 (44%), Gaps = 36/217 (16%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           I  GS G V    +     ++AVK ++L      +    E   +R+ +H+N+V++     
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN--- 88
Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
              Y   D   +V EF+  G+L + +      ++ + A  CL  LQ          AL  
Sbjct: 89  --SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA-VCLAVLQ----------ALSV 135
Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFG----LAKLLPPAHLQTSSIGVKGTIGY 583
           LH        H D+K  ++LL H+    ++DFG    ++K +P          + GT  +
Sbjct: 136 LHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP------RRKXLVGTPYW 186
Query: 584 IAP---AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
           +AP   +    G EV    D++S GI+++E++  + P
Sbjct: 187 MAPELISRLPYGPEV----DIWSLGIMVIEMVDGEPP 219

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 97/220 (44%), Gaps = 45/220 (20%)
Query: 428 IAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMH 485
           +AVK L+    +   +K +  E   L+ + HKN++ +L V                 F  
Sbjct: 52  VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV-----------------FTP 94
Query: 486 NGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAID----------VACALKYLHHDCQPT 535
             +LEE    V    + ++A    N  Q I++ +D          + C +K+LH      
Sbjct: 95  QKTLEE-FQDVYLVMELMDA----NLCQVIHMELDHERMSYLLYQMLCGIKHLH---SAG 146
Query: 536 TAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEV 595
             H DLKPSN+++  + T  + DFGLA+      + T  +  +    Y AP E  LG   
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTR---YYRAP-EVILGMGY 202
Query: 596 SINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV 635
           + N D++S G ++ EL+       ++F+G  ++  + + +
Sbjct: 203 AANVDIWSVGCIMGELVK----GCVIFQGTDHIDQWNKVI 238

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 55/230 (23%), Positives = 95/230 (41%), Gaps = 43/230 (18%)
Query: 411 GSFGSVYKGIL-----DEGKTIIAVKVLNLLHHGASKSSI----AECSALRNIRHKNLVK 461
           G FG V K          G T +AVK   +L   AS S +    +E + L+ + H +++K
Sbjct: 34  GEFGKVVKATAFHLKGRAGYTTVAVK---MLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGA------------DKTVEAP--K 507
           +   CS      D    L+ E+   GSL  +L                    +++ P  +
Sbjct: 91  LYGACSQ-----DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 508 CLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPP 567
            L     I+ A  ++  ++YL    + +  H DL   N+L+       ++DFGL++    
Sbjct: 146 ALTMGDLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFGLSR---- 198
Query: 568 AHLQTSSIGVKGTIGYIAPAEYGLGSE----VSINGDVYSYGILLLELMT 613
             +      VK + G I      + S      +   DV+S+G+LL E++T
Sbjct: 199 -DVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 99/233 (42%), Gaps = 48/233 (20%)
Query: 415 SVYKGILDEGKTIIAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYK 472
           + Y  +LD     +A+K L+    +   +K +  E   ++ + HKN++ +L V       
Sbjct: 42  AAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNV------- 91
Query: 473 GDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAID----------VA 522
                     F    +LEE    V    + ++A    N  Q I + +D          + 
Sbjct: 92  ----------FTPQKTLEE-FQDVYLVMELMDA----NLXQVIQMELDHERMSYLLYQML 136
Query: 523 CALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIG 582
             +K+LH        H DLKPSN+++  + T  + DFGLA+    + + T  +    T  
Sbjct: 137 XGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYV---VTRY 190
Query: 583 YIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV 635
           Y AP E  LG     N D++S G ++ E++  K    I+F G   +  + + +
Sbjct: 191 YRAP-EVILGMGYKENVDIWSVGCIMGEMVRHK----ILFPGRDYIDQWNKVI 238

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 54/237 (22%), Positives = 99/237 (41%), Gaps = 48/237 (20%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTVCSG 468
           G   + Y  IL+     +A+K L+    +   +K +  E   ++ + HKN++ +L V   
Sbjct: 38  GIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV--- 91
Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAID-------- 520
                         F    SLEE    V    + ++A    N  Q I + +D        
Sbjct: 92  --------------FTPQKSLEE-FQDVYIVMELMDA----NLCQVIQMELDHERMSYLL 132
Query: 521 --VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK 578
             + C +K+LH        H DLKPSN+++  + T  + DFGLA+    + + T  +  +
Sbjct: 133 YQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 189
Query: 579 GTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV 635
               Y    E  LG     N D++S G ++ E++       ++F G  ++  + + +
Sbjct: 190 ----YYRAPEVILGMGYKENVDIWSVGCIMGEMIK----GGVLFPGTDHIDQWNKVI 238

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 102/218 (46%), Gaps = 28/218 (12%)
Query: 411 GSFGSVYK----GILDEGKTI-IAVKVLNLLHHGASKSSI-AECSALRNI-RHKNLVKIL 463
           G+FG V +    G+  E   + +AVK+L    H   K ++ +E   + ++ +H+N+V +L
Sbjct: 57  GAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLL 116
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKT----VEAPKCLNFLQRINIAI 519
             C+   + G     ++ E+   G L  +L   S   +T      A   L+    ++ + 
Sbjct: 117 GACT---HGGPVL--VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSS 171
Query: 520 DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKG 579
            VA  + +L         H D+   NVLL +   A + DFGLA+ +    +  S+  VKG
Sbjct: 172 QVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI----MNDSNYIVKG 224
Query: 580 T----IGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
                + ++AP E       ++  DV+SYGILL E+ +
Sbjct: 225 NARLPVKWMAP-ESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 54/237 (22%), Positives = 99/237 (41%), Gaps = 48/237 (20%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTVCSG 468
           G   + Y  IL+     +A+K L+    +   +K +  E   ++ + HKN++ +L V   
Sbjct: 39  GIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV--- 92
Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAID-------- 520
                         F    SLEE    V    + ++A    N  Q I + +D        
Sbjct: 93  --------------FTPQKSLEE-FQDVYIVMELMDA----NLCQVIQMELDHERMSYLL 133
Query: 521 --VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK 578
             + C +K+LH        H DLKPSN+++  + T  + DFGLA+    + + T  +  +
Sbjct: 134 YQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 190
Query: 579 GTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV 635
               Y    E  LG     N D++S G ++ E++       ++F G  ++  + + +
Sbjct: 191 ----YYRAPEVILGMGYKENVDIWSVGCIMGEMIK----GGVLFPGTDHIDQWNKVI 239

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 99/231 (42%), Gaps = 22/231 (9%)
Query: 389 IISVLVGILLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVL--NLLHHGASKSSIA 446
           I  VLV       ++   ++  G F   Y+    + K + A KV+  ++L     K  ++
Sbjct: 31  IPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMS 90
Query: 447 ECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAP 506
              A+    HK+L     V     ++ DDF  +V E     SL E LH      K V  P
Sbjct: 91  TEIAI----HKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LH---KRRKAVTEP 142
Query: 507 KCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP 566
           +   F+++          ++YLH++      H DLK  N+ L+ +M   + DFGLA  + 
Sbjct: 143 EARYFMRQ------TIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIE 193
Query: 567 PAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
               +  ++   GT  YIAP E       S   D++S G +L  L+  K P
Sbjct: 194 FDGERKKTLC--GTPNYIAP-EVLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 98/231 (42%), Gaps = 22/231 (9%)
Query: 389 IISVLVGILLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVL--NLLHHGASKSSIA 446
           I  VLV       ++   ++  G F   Y+    + K + A KV+  ++L     K  ++
Sbjct: 15  IPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMS 74
Query: 447 ECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAP 506
              A+    HK+L     V     ++ DDF  +V E     SL E LH      K V  P
Sbjct: 75  TEIAI----HKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LH---KRRKAVTEP 126
Query: 507 KCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP 566
           +   F+++          ++YLH++      H DLK  N+ L+ +M   + DFGLA  + 
Sbjct: 127 EARYFMRQ------TIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIE 177
Query: 567 PAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
               +   +   GT  YIAP E       S   D++S G +L  L+  K P
Sbjct: 178 FDGERKKDLC--GTPNYIAP-EVLCKKGHSFEVDIWSLGCILYTLLVGKPP 225

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 86/209 (41%), Gaps = 32/209 (15%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVL--NLLHHGASKSSIAECSALRNIRHKNLVKILTVCSG 468
           GS+G V K    +   I+A+K    +       K ++ E   L+ +RH+NLV +L VC  
Sbjct: 36  GSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVC-- 93
Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL 528
              K      LV+EF+ +  L++     +G D  V        +Q+    I       + 
Sbjct: 94  ---KKKKRWYLVFEFVDHTILDDLELFPNGLDYQV--------VQKYLFQIINGIGFCHS 142
Query: 529 HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL-PPAHLQTSSIGVKGTIGYIAP- 586
           H        H D+KP N+L+       + DFG A+ L  P  +    +    T  Y AP 
Sbjct: 143 H-----NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEV---ATRWYRAPE 194
Query: 587 ---AEYGLGSEVSINGDVYSYGILLLELM 612
               +   G  V    DV++ G L+ E+ 
Sbjct: 195 LLVGDVKYGKAV----DVWAIGCLVTEMF 219

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 93/212 (43%), Gaps = 23/212 (10%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAE---CSALRNIRHKNLVKILTVCS 467
           G++G V   +    +  +AVK++++        +I +    +A+ N  H+N+VK      
Sbjct: 18  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLN--HENVVKFY---- 71
Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
           G   +G+  + L  E+   G L + + P    D  +  P    F  ++         + Y
Sbjct: 72  GHRREGN-IQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQL------MAGVVY 120
Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPA 587
           LH        H D+KP N+LLD      ++DFGLA +    + +     + GT+ Y+AP 
Sbjct: 121 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 588 EYGLGSEVSINGDVYSYGILLLELMTRKRPSD 619
                   +   DV+S GI+L  ++  + P D
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 100/237 (42%), Gaps = 48/237 (20%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTVCSG 468
           G   + Y  IL+     +A+K L+    +   +K +  E   ++ + HKN++ +L V   
Sbjct: 38  GIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV--- 91
Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAID-------- 520
                         F    SLEE    V    + ++A    N  Q I + +D        
Sbjct: 92  --------------FTPQKSLEE-FQDVYIVMELMDA----NLCQVIQMELDHERMSYLL 132
Query: 521 --VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK 578
             + C +K+LH        H DLKPSN+++  + T  + DFGLA+    + +    +   
Sbjct: 133 YQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEV--- 186
Query: 579 GTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV 635
            T  Y AP E  LG     N D++S G ++ E++  K    I+F G   +  + + +
Sbjct: 187 VTRYYRAP-EVILGMGYKENVDLWSVGCIMGEMVCHK----ILFPGRDYIDQWNKVI 238

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 95/234 (40%), Gaps = 60/234 (25%)
Query: 411 GSFGSVYK----GILDEGKTI-IAVKVLNLLHHGASKSSI-AECSALRNI-RHKNLVKIL 463
           G+FG V +    G+  E   + +AVK+L    H   K ++ +E   + ++ +H+N+V +L
Sbjct: 57  GAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLL 116
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQR--------- 514
             C+                 H G       PV    +       LNFL+R         
Sbjct: 117 GACT-----------------HGG-------PVLVITEYCCYGDLLNFLRRKSRVLETDP 152
Query: 515 -INIAIDVACALKYLHHDCQPTTA----------HCDLKPSNVLLDHEMTAHVADFGLAK 563
              IA   A     LH   Q              H D+   NVLL +   A + DFGLA+
Sbjct: 153 AFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212
Query: 564 LLPPAHLQTSSIGVKGT----IGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
            +    +  S+  VKG     + ++AP E       ++  DV+SYGILL E+ +
Sbjct: 213 DI----MNDSNYIVKGNARLPVKWMAP-ESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 54/237 (22%), Positives = 99/237 (41%), Gaps = 48/237 (20%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTVCSG 468
           G   + Y  IL+     +A+K L+    +   +K +  E   ++ + HKN++ +L V   
Sbjct: 38  GIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV--- 91
Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAID-------- 520
                         F    SLEE    V    + ++A    N  Q I + +D        
Sbjct: 92  --------------FTPQKSLEE-FQDVYIVMELMDA----NLCQVIQMELDHERMSYLL 132
Query: 521 --VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK 578
             + C +K+LH        H DLKPSN+++  + T  + DFGLA+    + + T  +  +
Sbjct: 133 YQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 189
Query: 579 GTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV 635
               Y    E  LG     N D++S G ++ E++       ++F G  ++  + + +
Sbjct: 190 ----YYRAPEVILGMGYKENVDIWSVGCIMGEMIK----GGVLFPGTDHIDQWNKVI 238

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 85/214 (39%), Gaps = 24/214 (11%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGA-SKSSIAECSALRNIRHKNLVKILTVCSGV 469
           G++G V          I+A+K +        +  ++ E   L++ +H+N++ I  +    
Sbjct: 22  GAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPD 81
Query: 470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH 529
            ++  +   ++ E M        LH V       +        Q +        A+K LH
Sbjct: 82  SFENFNEVYIIQELMQTD-----LHRVISTQMLSDDHIQYFIYQTLR-------AVKVLH 129
Query: 530 HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL--------PPAHLQTSSIGVKGTI 581
                   H DLKPSN+L++      V DFGLA+++         P   Q+       T 
Sbjct: 130 GS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATR 186
Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMTRK 615
            Y AP      ++ S   DV+S G +L EL  R+
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 85/193 (44%), Gaps = 19/193 (9%)
Query: 441 SKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGAD 500
           +K ++ E   L++ +H N++ I  +       G+ FK+ VY  +    +E  LH +  + 
Sbjct: 97  AKRTLRELKILKHFKHDNIIAIKDILRPTVPYGE-FKS-VYVVL--DLMESDLHQIIHSS 152
Query: 501 KTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFG 560
           + +       FL ++         LKY+H        H DLKPSN+L++      + DFG
Sbjct: 153 QPLTLEHVRYFLYQL------LRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFG 203
Query: 561 LAKLL--PPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPS 618
           +A+ L   PA  Q        T  Y AP       E +   D++S G +  E++ R++  
Sbjct: 204 MARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ-- 261
Query: 619 DIMFEGNMNLHNF 631
             +F G   +H  
Sbjct: 262 --LFPGKNYVHQL 272

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 85/214 (39%), Gaps = 24/214 (11%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGA-SKSSIAECSALRNIRHKNLVKILTVCSGV 469
           G++G V          I+A+K +        +  ++ E   L++ +H+N++ I  +    
Sbjct: 22  GAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPD 81
Query: 470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH 529
            ++  +   ++ E M        LH V       +        Q +        A+K LH
Sbjct: 82  SFENFNEVYIIQELMQTD-----LHRVISTQMLSDDHIQYFIYQTLR-------AVKVLH 129
Query: 530 HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL--------PPAHLQTSSIGVKGTI 581
                   H DLKPSN+L++      V DFGLA+++         P   Q+       T 
Sbjct: 130 GS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATR 186
Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMTRK 615
            Y AP      ++ S   DV+S G +L EL  R+
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 98/231 (42%), Gaps = 22/231 (9%)
Query: 389 IISVLVGILLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVL--NLLHHGASKSSIA 446
           I  VLV       ++   ++  G F   Y+    + K + A KV+  ++L     K  ++
Sbjct: 31  IPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMS 90
Query: 447 ECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAP 506
              A+    HK+L     V     ++ DDF  +V E     SL E LH      K V  P
Sbjct: 91  TEIAI----HKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LH---KRRKAVTEP 142
Query: 507 KCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP 566
           +   F+++          ++YLH++      H DLK  N+ L+ +M   + DFGLA  + 
Sbjct: 143 EARYFMRQ------TIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIE 193
Query: 567 PAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
               +   +   GT  YIAP E       S   D++S G +L  L+  K P
Sbjct: 194 FDGERKKDLC--GTPNYIAP-EVLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 55/230 (23%), Positives = 94/230 (40%), Gaps = 43/230 (18%)
Query: 411 GSFGSVYKGIL-----DEGKTIIAVKVLNLLHHGASKSSI----AECSALRNIRHKNLVK 461
           G FG V K          G T +AVK   +L   AS S +    +E + L+ + H +++K
Sbjct: 34  GEFGKVVKATAFHLKGRAGYTTVAVK---MLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGA------------DKTVEAP--K 507
           +   CS      D    L+ E+   GSL  +L                    +++ P  +
Sbjct: 91  LYGACSQ-----DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 508 CLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPP 567
            L     I+ A  ++  ++YL    +    H DL   N+L+       ++DFGL++    
Sbjct: 146 ALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR---- 198
Query: 568 AHLQTSSIGVKGTIGYIAPAEYGLGSE----VSINGDVYSYGILLLELMT 613
             +      VK + G I      + S      +   DV+S+G+LL E++T
Sbjct: 199 -DVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV      +    +AVK L+     ++H   +K +  E   L++++H+N++ +L V
Sbjct: 33  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDV 89
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEW-----LHPVSGAD--KTVEAPKCLNFLQRINIA 518
                            F    SLEE+     +  + GAD    V+  K  +    +   
Sbjct: 90  -----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTD--DHVQFL 130
Query: 519 I-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I  +   LKY+H        H DLKPSN+ ++ +    + DFGLA+     H      G 
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDDEMTGY 182
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             T  Y AP         +   D++S G ++ EL+T
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 100/237 (42%), Gaps = 48/237 (20%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTVCSG 468
           G   + Y  +LD     +A+K L+    +   +K +  E   ++ + HKN++ +L V   
Sbjct: 31  GIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV--- 84
Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAID-------- 520
                         F    +LEE    V    + ++A    N  Q I + +D        
Sbjct: 85  --------------FTPQKTLEE-FQDVYLVMELMDA----NLXQVIQMELDHERMSYLL 125
Query: 521 --VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK 578
             +   +K+LH        H DLKPSN+++  + T  + DFGLA+    + + T  +   
Sbjct: 126 YQMLXGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYV--- 179
Query: 579 GTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV 635
            T  Y AP E  LG     N D++S G ++ E++  K    I+F G   +  + + +
Sbjct: 180 VTRYYRAP-EVILGMGYKENVDIWSVGCIMGEMVRHK----ILFPGRDYIDQWNKVI 231

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 100/237 (42%), Gaps = 48/237 (20%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTVCSG 468
           G   + Y  +LD     +A+K L+    +   +K +  E   ++ + HKN++ +L V   
Sbjct: 38  GIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV--- 91
Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAID-------- 520
                         F    +LEE    V    + ++A    N  Q I + +D        
Sbjct: 92  --------------FTPQKTLEE-FQDVYLVMELMDA----NLXQVIQMELDHERMSYLL 132
Query: 521 --VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK 578
             +   +K+LH        H DLKPSN+++  + T  + DFGLA+    + + T  +   
Sbjct: 133 YQMLXGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYV--- 186
Query: 579 GTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV 635
            T  Y AP E  LG     N D++S G ++ E++  K    I+F G   +  + + +
Sbjct: 187 VTRYYRAP-EVILGMGYKENVDIWSVGCIMGEMVRHK----ILFPGRDYIDQWNKVI 238

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 100/233 (42%), Gaps = 48/233 (20%)
Query: 415 SVYKGILDEGKTIIAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYK 472
           + Y  IL+     +A+K L+    +   +K +  E   ++ + HKN++ +L V       
Sbjct: 42  AAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV------- 91
Query: 473 GDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAID----------VA 522
                     F    SLEE    V    + ++A    N  Q I + +D          + 
Sbjct: 92  ----------FTPQKSLEE-FQDVYIVMELMDA----NLSQVIQMELDHERMSYLLYQML 136
Query: 523 CALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIG 582
           C +K+LH        H DLKPSN+++  + T  + DFGLA+    + + T  +    T  
Sbjct: 137 CGIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYV---VTRY 190
Query: 583 YIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV 635
           Y AP E  LG     N D++S G ++ E++       ++F G  ++  + + +
Sbjct: 191 YRAP-EVILGMGYKENVDIWSVGCIMGEMIK----GGVLFPGTDHIDQWNKVI 238

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 92/219 (42%), Gaps = 30/219 (13%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGA--SKSSIAECSALRNIRHKNLVKILTVCSG 468
           G++GSV   I       +A+K L+        +K +  E   L++++H+N++ +L V + 
Sbjct: 35  GAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTP 94
Query: 469 VDYKGD--DFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALK 526
                +  DF  LV  FM        L  + G   + E  + L +         +   LK
Sbjct: 95  ASSLRNFYDF-YLVMPFMQTD-----LQKIMGLKFSEEKIQYLVY--------QMLKGLK 140
Query: 527 YLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP 586
           Y+H        H DLKP N+ ++ +    + DFGLA+     H      G   T  Y AP
Sbjct: 141 YIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAP 192
Query: 587 AEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGN 625
                    +   D++S G ++ E++T K     +F+G 
Sbjct: 193 EVILSWMHYNQTVDIWSVGCIMAEMLTGK----TLFKGK 227

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 100/233 (42%), Gaps = 48/233 (20%)
Query: 415 SVYKGILDEGKTIIAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYK 472
           + Y  IL+     +A+K L+    +   +K +  E   ++ + HKN++ +L V       
Sbjct: 42  AAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV------- 91
Query: 473 GDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAID----------VA 522
                     F    SLEE    V    + ++A    N  Q I + +D          + 
Sbjct: 92  ----------FTPQKSLEE-FQDVYIVMELMDA----NLSQVIQMELDHERMSYLLYQML 136
Query: 523 CALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIG 582
           C +K+LH        H DLKPSN+++  + T  + DFGLA+    + + T  +    T  
Sbjct: 137 CGIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYV---VTRY 190
Query: 583 YIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV 635
           Y AP E  LG     N D++S G ++ E++       ++F G  ++  + + +
Sbjct: 191 YRAP-EVILGMGYKENVDIWSVGCIMGEMIK----GGVLFPGTDHIDQWNKVI 238

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV      +    +AVK L+     ++H   +K +  E   L++++H+N++ +L V
Sbjct: 38  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDV 94
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEW-----LHPVSGAD--KTVEAPKCLNFLQRINIA 518
                            F    SLEE+     +  + GAD    V+  K  +    +   
Sbjct: 95  -----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD--DHVQFL 135
Query: 519 I-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I  +   LKY+H        H DLKPSN+ ++ +    + DFGLA+     H      G 
Sbjct: 136 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDDEMTGY 187
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             T  Y AP         +   D++S G ++ EL+T
Sbjct: 188 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV      +    +AVK L+     ++H   +K +  E   L++++H+N++ +L V
Sbjct: 33  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDV 89
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEW-----LHPVSGAD--KTVEAPKCLNFLQRINIA 518
                            F    SLEE+     +  + GAD    V+  K  +    +   
Sbjct: 90  -----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD--DHVQFL 130
Query: 519 I-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I  +   LKY+H        H DLKPSN+ ++ +    + DFGLA+     H      G 
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 182
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             T  Y AP         +   D++S G ++ EL+T
Sbjct: 183 VATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLT 218

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 98/231 (42%), Gaps = 22/231 (9%)
Query: 389 IISVLVGILLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVL--NLLHHGASKSSIA 446
           I  VLV       ++   ++  G F   Y+    + K + A KV+  ++L     K  ++
Sbjct: 31  IPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMS 90
Query: 447 ECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAP 506
              A+    HK+L     V     ++ DDF  +V E     SL E LH      K V  P
Sbjct: 91  TEIAI----HKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LH---KRRKAVTEP 142
Query: 507 KCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP 566
           +   F+++          ++YLH++      H DLK  N+ L+ +M   + DFGLA  + 
Sbjct: 143 EARYFMRQ------TIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIE 193
Query: 567 PAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
               +   +   GT  YIAP E       S   D++S G +L  L+  K P
Sbjct: 194 FDGERKKXLC--GTPNYIAP-EVLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV      +    +AVK L+     ++H   +K +  E   L++++H+N++ +L V
Sbjct: 44  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDV 100
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEW-----LHPVSGAD--KTVEAPKCLNFLQRINIA 518
                            F    SLEE+     +  + GAD    V+  K  +    +   
Sbjct: 101 -----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD--DHVQFL 141
Query: 519 I-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I  +   LKY+H        H DLKPSN+ ++ +    + DFGLA+     H      G 
Sbjct: 142 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDDEMTGY 193
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             T  Y AP         +   D++S G ++ EL+T
Sbjct: 194 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 229

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 85/193 (44%), Gaps = 19/193 (9%)
Query: 441 SKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGAD 500
           +K ++ E   L++ +H N++ I  +       G+ FK+ VY  +    +E  LH +  + 
Sbjct: 98  AKRTLRELKILKHFKHDNIIAIKDILRPTVPYGE-FKS-VYVVL--DLMESDLHQIIHSS 153
Query: 501 KTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFG 560
           + +       FL ++         LKY+H        H DLKPSN+L++      + DFG
Sbjct: 154 QPLTLEHVRYFLYQL------LRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFG 204
Query: 561 LAKLL--PPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPS 618
           +A+ L   PA  Q        T  Y AP       E +   D++S G +  E++ R++  
Sbjct: 205 MARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ-- 262
Query: 619 DIMFEGNMNLHNF 631
             +F G   +H  
Sbjct: 263 --LFPGKNYVHQL 273

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 105/253 (41%), Gaps = 34/253 (13%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           I  G+FG V    +   + I A+K+LN       K  + + +     R +  V +   C 
Sbjct: 98  IGRGAFGEVAVVKMKNTERIYAMKILN-------KWEMLKRAETACFREERDVLVNGDCQ 150
Query: 468 GVD-----YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVA 522
            +      ++ ++   LV ++   G L   L  +S  +  +       ++  + +AID  
Sbjct: 151 WITALHYAFQDENHLYLVMDYYVGGDL---LTLLSKFEDKLPEDMARFYIGEMVLAIDSI 207
Query: 523 CALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIG 582
             L Y+H D         +KP NVLLD      +ADFG    +       SS+ V GT  
Sbjct: 208 HQLHYVHRD---------IKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAV-GTPD 257
Query: 583 YIAPA-----EYGLGSEVSINGDVYSYGILLLELMTRKRP--SDIMFEGNMNLHNF-ART 634
           YI+P      E G+G +     D +S G+ + E++  + P  ++ + E    + N   R 
Sbjct: 258 YISPEILQAMEDGMG-KYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERF 316
Query: 635 VLPDHVMDIVDST 647
             P HV D+ +  
Sbjct: 317 QFPSHVTDVSEEA 329

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV      +    +AVK L+     ++H   +K +  E   L++++H+N++ +L V
Sbjct: 38  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDV 94
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEW-----LHPVSGAD--KTVEAPKCLNFLQRINIA 518
                            F    SLEE+     +  + GAD    V+  K  +    +   
Sbjct: 95  -----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD--DHVQFL 135
Query: 519 I-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I  +   LKY+H        H DLKPSN+ ++ +    + DFGLA+     H      G 
Sbjct: 136 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDDEMTGY 187
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             T  Y AP         +   D++S G ++ EL+T
Sbjct: 188 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 100/233 (42%), Gaps = 48/233 (20%)
Query: 415 SVYKGILDEGKTIIAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYK 472
           + Y  IL+     +A+K L+    +   +K +  E   ++ + HKN++ +L V       
Sbjct: 42  AAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV------- 91
Query: 473 GDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAID----------VA 522
                     F    SLEE    V    + ++A    N  Q I + +D          + 
Sbjct: 92  ----------FTPQKSLEE-FQDVYIVMELMDA----NLSQVIQMELDHERMSYLLYQML 136
Query: 523 CALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIG 582
           C +K+LH        H DLKPSN+++  + T  + DFGLA+    + + T  +    T  
Sbjct: 137 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTRY 190
Query: 583 YIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV 635
           Y AP E  LG     N D++S G ++ E++       ++F G  ++  + + +
Sbjct: 191 YRAP-EVILGMGYKENVDIWSVGCIMGEMIK----GGVLFPGTDHIDQWNKVI 238

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/230 (23%), Positives = 94/230 (40%), Gaps = 43/230 (18%)
Query: 411 GSFGSVYKGIL-----DEGKTIIAVKVLNLLHHGASKSSI----AECSALRNIRHKNLVK 461
           G FG V K          G T +AVK   +L   AS S +    +E + L+ + H +++K
Sbjct: 34  GEFGKVVKATAFHLKGRAGYTTVAVK---MLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGA------------DKTVEAP--K 507
           +   CS      D    L+ E+   GSL  +L                    +++ P  +
Sbjct: 91  LYGACSQ-----DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 508 CLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPP 567
            L     I+ A  ++  ++YL    +    H DL   N+L+       ++DFGL++    
Sbjct: 146 ALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR---- 198
Query: 568 AHLQTSSIGVKGTIGYIAPAEYGLGSE----VSINGDVYSYGILLLELMT 613
             +      VK + G I      + S      +   DV+S+G+LL E++T
Sbjct: 199 -DVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 85/209 (40%), Gaps = 24/209 (11%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGA--SKSSIAECSALRNIRHKNLVKILTV 465
           I  GS+G V+K    +   I+A+K            K ++ E   L+ ++H NLV +L V
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                ++      LV+E+  +  L E      G  + +        LQ +N         
Sbjct: 71  -----FRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHK----- 120
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP-PAHLQTSSIGVKGTIGYI 584
               H+C     H D+KP N+L+       + DFG A+LL  P+      +    T  Y 
Sbjct: 121 ----HNC----IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV---ATRWYR 169
Query: 585 APAEYGLGSEVSINGDVYSYGILLLELMT 613
           +P      ++     DV++ G +  EL++
Sbjct: 170 SPELLVGDTQYGPPVDVWAIGCVFAELLS 198

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 63/239 (26%), Positives = 104/239 (43%), Gaps = 32/239 (13%)
Query: 386 AAAIISVLVGILLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKV----LNLLHHGAS 441
           A  I  VLV       ++   ++  G F   ++    + K + A K+    L L  H   
Sbjct: 1   AKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE 60
Query: 442 KSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADK 501
           K S+ E S  R++ H+++V          ++ +DF  +V E     SL E LH      K
Sbjct: 61  KMSM-EISIHRSLAHQHVVGFHGF-----FEDNDFVFVVLELCRRRSLLE-LH---KRRK 110
Query: 502 TVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGL 561
            +  P+   +L++I +        +YLH +      H DLK  N+ L+ ++   + DFGL
Sbjct: 111 ALTEPEARYYLRQIVLGC------QYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGL 161
Query: 562 AKLLPPAHLQTSSIGVKGTIGYIAP---AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
           A  +   +       + GT  YIAP   ++ G   EV    DV+S G ++  L+  K P
Sbjct: 162 ATKV--EYDGERKKVLCGTPNYIAPEVLSKKGHSFEV----DVWSIGCIMYTLLVGKPP 214

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 86/199 (43%), Gaps = 33/199 (16%)
Query: 428 IAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMH 485
           +AVK+++   L+  + +    E   ++ + H N+VK+  V      + +    LV E+  
Sbjct: 43  VAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI-----ETEKTLYLVMEYAS 97
Query: 486 NGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSN 545
            G + ++L    G  K  EA     F Q       +  A++Y H   Q    H DLK  N
Sbjct: 98  GGEVFDYL-VAHGRMKEKEAR--AKFRQ-------IVSAVQYCH---QKYIVHRDLKAEN 144
Query: 546 VLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK-----GTIGYIAPAEYGLGSEVSINGD 600
           +LLD +M   +ADFG +           ++G K     G+  Y AP  +          D
Sbjct: 145 LLLDGDMNIKIADFGFSNEF--------TVGNKLDTFCGSPPYAAPELFQGKKYDGPEVD 196
Query: 601 VYSYGILLLELMTRKRPSD 619
           V+S G++L  L++   P D
Sbjct: 197 VWSLGVILYTLVSGSLPFD 215

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 85/199 (42%), Gaps = 33/199 (16%)
Query: 428 IAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMH 485
           +AVK+++   L+  + +    E   ++ + H N+VK+  V      + +    LV E+  
Sbjct: 42  VAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVI-----ETEKTLYLVMEYAS 96
Query: 486 NGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSN 545
            G + ++L    G  K  EA     F Q       +  A++Y H   Q    H DLK  N
Sbjct: 97  GGEVFDYL-VAHGRMKEKEARA--KFRQ-------IVSAVQYCH---QKFIVHRDLKAEN 143
Query: 546 VLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK-----GTIGYIAPAEYGLGSEVSINGD 600
           +LLD +M   +ADFG +           + G K     G+  Y AP  +          D
Sbjct: 144 LLLDADMNIKIADFGFSNEF--------TFGNKLDTFCGSPPYAAPELFQGKKYDGPEVD 195
Query: 601 VYSYGILLLELMTRKRPSD 619
           V+S G++L  L++   P D
Sbjct: 196 VWSLGVILYTLVSGSLPFD 214

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/249 (24%), Positives = 104/249 (41%), Gaps = 34/249 (13%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           I  G+FG V    +   + I A+K+LN       K  + + +     R +  V +   C 
Sbjct: 82  IGRGAFGEVAVVKMKNTERIYAMKILN-------KWEMLKRAETACFREERDVLVNGDCQ 134
Query: 468 GVD-----YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVA 522
            +      ++ ++   LV ++   G L   L  +S  +  +       ++  + +AID  
Sbjct: 135 WITALHYAFQDENHLYLVMDYYVGGDL---LTLLSKFEDKLPEDMARFYIGEMVLAIDSI 191
Query: 523 CALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIG 582
             L Y+H D         +KP NVLLD      +ADFG    +       SS+ V GT  
Sbjct: 192 HQLHYVHRD---------IKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAV-GTPD 241
Query: 583 YIAPA-----EYGLGSEVSINGDVYSYGILLLELMTRKRP--SDIMFEGNMNLHNF-ART 634
           YI+P      E G+G +     D +S G+ + E++  + P  ++ + E    + N   R 
Sbjct: 242 YISPEILQAMEDGMG-KYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERF 300
Query: 635 VLPDHVMDI 643
             P HV D+
Sbjct: 301 QFPSHVTDV 309

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 93/216 (43%), Gaps = 43/216 (19%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV      +    IAVK L+     ++H   +K +  E   L++++H+N++ +L V
Sbjct: 62  GAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDV 118
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEW-----LHPVSGAD--KTVEAPKCLNFLQRINIA 518
                            F    SLEE+     +  + GAD    V+  K  +    +   
Sbjct: 119 -----------------FTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTD--DHVQFL 159
Query: 519 I-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I  +   LKY+H        H DLKPSN+ ++ +    + DFGLA+     H      G 
Sbjct: 160 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 211
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             T  Y AP         ++  D++S G ++ EL+T
Sbjct: 212 VATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLT 247

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV      +    +AVK L+     ++H   +K +  E   L++++H+N++ +L V
Sbjct: 33  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDV 89
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEW-----LHPVSGAD--KTVEAPKCLNFLQRINIA 518
                            F    SLEE+     +  + GAD    V+  K  +    +   
Sbjct: 90  -----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD--DHVQFL 130
Query: 519 I-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I  +   LKY+H        H DLKPSN+ ++ +    + DFGLA+     H      G 
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 182
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             T  Y AP         +   D++S G ++ EL+T
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 68/140 (48%), Gaps = 17/140 (12%)
Query: 478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTA 537
           ++  E M  GSL++ L       K    P+    L +++IA  V   L YL    +    
Sbjct: 99  SICMEHMDGGSLDQVL------KKAGRIPE--QILGKVSIA--VIKGLTYLRE--KHKIM 146
Query: 538 HCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSI 597
           H D+KPSN+L++      + DFG++  L    + + +    GT  Y++P E   G+  S+
Sbjct: 147 HRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSP-ERLQGTHYSV 201
Query: 598 NGDVYSYGILLLELMTRKRP 617
             D++S G+ L+E+   + P
Sbjct: 202 QSDIWSMGLSLVEMAVGRYP 221

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 85/199 (42%), Gaps = 33/199 (16%)
Query: 428 IAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMH 485
           +AVK+++   L+  + +    E   ++ + H N+VK+  V      + +    LV E+  
Sbjct: 35  VAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVI-----ETEKTLYLVMEYAS 89
Query: 486 NGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSN 545
            G + ++L    G  K  EA     F Q       +  A++Y H   Q    H DLK  N
Sbjct: 90  GGEVFDYL-VAHGWMKEKEARA--KFRQ-------IVSAVQYCH---QKFIVHRDLKAEN 136
Query: 546 VLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK-----GTIGYIAPAEYGLGSEVSINGD 600
           +LLD +M   +ADFG +           + G K     G+  Y AP  +          D
Sbjct: 137 LLLDADMNIKIADFGFS--------NEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVD 188
Query: 601 VYSYGILLLELMTRKRPSD 619
           V+S G++L  L++   P D
Sbjct: 189 VWSLGVILYTLVSGSLPFD 207

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV      +    +AVK L+     ++H   +K +  E   L++++H+N++ +L V
Sbjct: 33  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDV 89
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEW-----LHPVSGAD--KTVEAPKCLNFLQRINIA 518
                            F    SLEE+     +  + GAD    V+  K  +    +   
Sbjct: 90  -----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD--DHVQFL 130
Query: 519 I-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I  +   LKY+H        H DLKPSN+ ++ +    + DFGLA+     H      G 
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 182
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             T  Y AP         +   D++S G ++ EL+T
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV      +    +AVK L+     ++H   +K +  E   L++++H+N++ +L V
Sbjct: 33  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDV 89
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEW-----LHPVSGAD--KTVEAPKCLNFLQRINIA 518
                            F    SLEE+     +  + GAD    V+  K  +    +   
Sbjct: 90  -----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD--DHVQFL 130
Query: 519 I-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I  +   LKY+H        H DLKPSN+ ++ +    + DFGLA+     H      G 
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 182
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             T  Y AP         +   D++S G ++ EL+T
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV      +    +AVK L+     ++H   +K +  E   L++++H+N++ +L V
Sbjct: 29  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDV 85
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEW-----LHPVSGAD--KTVEAPKCLNFLQRINIA 518
                            F    SLEE+     +  + GAD    V+  K  +    +   
Sbjct: 86  -----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD--DHVQFL 126
Query: 519 I-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I  +   LKY+H        H DLKPSN+ ++ +    + DFGLA+     H      G 
Sbjct: 127 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 178
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             T  Y AP         +   D++S G ++ EL+T
Sbjct: 179 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 85/199 (42%), Gaps = 33/199 (16%)
Query: 428 IAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMH 485
           +AVK+++   L+  + +    E   ++ + H N+VK+  V      + +    LV E+  
Sbjct: 42  VAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVI-----ETEKTLYLVMEYAS 96
Query: 486 NGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSN 545
            G + ++L    G  K  EA     F Q       +  A++Y H   Q    H DLK  N
Sbjct: 97  GGEVFDYL-VAHGRMKEKEARA--KFRQ-------IVSAVQYCH---QKFIVHRDLKAEN 143
Query: 546 VLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK-----GTIGYIAPAEYGLGSEVSINGD 600
           +LLD +M   +ADFG +           + G K     G+  Y AP  +          D
Sbjct: 144 LLLDADMNIKIADFGFSNEF--------TFGNKLDTFCGSPPYAAPELFQGKKYDGPEVD 195
Query: 601 VYSYGILLLELMTRKRPSD 619
           V+S G++L  L++   P D
Sbjct: 196 VWSLGVILYTLVSGSLPFD 214

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 82/327 (25%), Positives = 131/327 (40%), Gaps = 49/327 (14%)
Query: 402 FLFLCWIDMGSFGSVYKGILDEGKT---IIAVKVLNLLHHGASKSSIA-ECSALRNIRHK 457
           F F   +  G+F  V   +L E K    + AVK +        +SSI  E + LR I+H+
Sbjct: 24  FEFKETLGTGAFSEV---VLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHE 80
Query: 458 NLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINI 517
           N+V +  +     Y+  +   LV + +  G L + +      +K     K  + L R   
Sbjct: 81  NIVALEDI-----YESPNHLYLVMQLVSGGELFDRI-----VEKGFYTEKDASTLIR--- 127
Query: 518 AIDVACALKYLHHDCQPTTAHCDLKPSNVLL---DHEMTAHVADFGLAKLLPPAHLQTSS 574
              V  A+ YLH   +    H DLKP N+L    D E    ++DFGL+K+     + +++
Sbjct: 128 --QVLDAVYYLH---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTA 182
Query: 575 IGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP-----SDIMFEGNMNLH 629
               GT GY+AP E       S   D +S G++   L+    P        +FE  +   
Sbjct: 183 C---GTPGYVAP-EVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAE 238
Query: 630 NFARTVLPDHVMDIVDS---TLLADDEDLTITSNQRQRQARI-------NNIMECLISVV 679
               +   D + D        L+  D +   T  Q  R   I        NI E + + +
Sbjct: 239 YEFDSPYWDDISDSAKDFIRNLMEKDPNKRYTCEQAARHPWIAGDTALNKNIHESVSAQI 298
Query: 680 RIGVACSMESPQDRMNMTIVVHELQSI 706
           R   A S    +   N T VV  ++ +
Sbjct: 299 RKNFAKS--KWRQAFNATAVVRHMRKL 323

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV      +    +AVK L+     ++H   +K +  E   L++++H+N++ +L V
Sbjct: 30  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDV 86
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEW-----LHPVSGAD--KTVEAPKCLNFLQRINIA 518
                            F    SLEE+     +  + GAD    V+  K  +    +   
Sbjct: 87  -----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD--DHVQFL 127
Query: 519 I-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I  +   LKY+H        H DLKPSN+ ++ +    + DFGLA+     H      G 
Sbjct: 128 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 179
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             T  Y AP         +   D++S G ++ EL+T
Sbjct: 180 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 215

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV      +    +AVK L+     ++H   +K +  E   L++++H+N++ +L V
Sbjct: 33  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDV 89
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEW-----LHPVSGAD--KTVEAPKCLNFLQRINIA 518
                            F    SLEE+     +  + GAD    V+  K  +    +   
Sbjct: 90  -----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD--DHVQFL 130
Query: 519 I-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I  +   LKY+H        H DLKPSN+ ++ +    + DFGLA+     H      G 
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 182
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             T  Y AP         +   D++S G ++ EL+T
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV      +    +AVK L+     ++H   +K +  E   L++++H+N++ +L V
Sbjct: 33  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDV 89
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEW-----LHPVSGAD--KTVEAPKCLNFLQRINIA 518
                            F    SLEE+     +  + GAD    V+  K  +    +   
Sbjct: 90  -----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD--DHVQFL 130
Query: 519 I-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I  +   LKY+H        H DLKPSN+ ++ +    + DFGLA+     H      G 
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 182
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             T  Y AP         +   D++S G ++ EL+T
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV      +    +AVK L+     ++H   +K +  E   L++++H+N++ +L V
Sbjct: 39  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDV 95
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEW-----LHPVSGAD--KTVEAPKCLNFLQRINIA 518
                            F    SLEE+     +  + GAD    V+  K  +    +   
Sbjct: 96  -----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD--DHVQFL 136
Query: 519 I-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I  +   LKY+H        H DLKPSN+ ++ +    + DFGLA+     H      G 
Sbjct: 137 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLAR-----HTDDEMTGY 188
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             T  Y AP         +   D++S G ++ EL+T
Sbjct: 189 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV      +    +AVK L+     ++H   +K +  E   L++++H+N++ +L V
Sbjct: 33  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDV 89
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEW-----LHPVSGAD--KTVEAPKCLNFLQRINIA 518
                            F    SLEE+     +  + GAD    V+  K  +    +   
Sbjct: 90  -----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD--DHVQFL 130
Query: 519 I-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I  +   LKY+H        H DLKPSN+ ++ +    + DFGLA+     H      G 
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 182
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             T  Y AP         +   D++S G ++ EL+T
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV      +    +AVK L+     ++H   +K +  E   L++++H+N++ +L V
Sbjct: 33  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDV 89
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEW-----LHPVSGAD--KTVEAPKCLNFLQRINIA 518
                            F    SLEE+     +  + GAD    V+  K  +    +   
Sbjct: 90  -----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTD--DHVQFL 130
Query: 519 I-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I  +   LKY+H        H DLKPSN+ ++ +    + DFGLA+     H      G 
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 182
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             T  Y AP         +   D++S G ++ EL+T
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV      +    +AVK L+     ++H   +K +  E   L++++H+N++ +L V
Sbjct: 31  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDV 87
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEW-----LHPVSGAD--KTVEAPKCLNFLQRINIA 518
                            F    SLEE+     +  + GAD    V+  K  +    +   
Sbjct: 88  -----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD--DHVQFL 128
Query: 519 I-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I  +   LKY+H        H DLKPSN+ ++ +    + DFGLA+     H      G 
Sbjct: 129 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 180
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             T  Y AP         +   D++S G ++ EL+T
Sbjct: 181 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 216

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV      +    +AVK L+     ++H   +K +  E   L++++H+N++ +L V
Sbjct: 33  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDV 89
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEW-----LHPVSGAD--KTVEAPKCLNFLQRINIA 518
                            F    SLEE+     +  + GAD    V+  K  +    +   
Sbjct: 90  -----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD--DHVQFL 130
Query: 519 I-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I  +   LKY+H        H DLKPSN+ ++ +    + DFGLA+     H      G 
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 182
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             T  Y AP         +   D++S G ++ EL+T
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV      +    +AVK L+     ++H   +K +  E   L++++H+N++ +L V
Sbjct: 35  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDV 91
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEW-----LHPVSGAD--KTVEAPKCLNFLQRINIA 518
                            F    SLEE+     +  + GAD    V+  K  +    +   
Sbjct: 92  -----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD--DHVQFL 132
Query: 519 I-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I  +   LKY+H        H DLKPSN+ ++ +    + DFGLA+     H      G 
Sbjct: 133 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 184
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             T  Y AP         +   D++S G ++ EL+T
Sbjct: 185 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 101/223 (45%), Gaps = 36/223 (16%)
Query: 411 GSFGSVYK----GILDEGKTI-IAVKVLNLLHHGASKSSI-AECSALRNI-RHKNLVKIL 463
           G+FG V +    G+  E   + +AVK+L    H   K ++ +E   + ++ +H+N+V +L
Sbjct: 57  GAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLL 116
Query: 464 TVCSG-------VDY--KGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQR 514
             C+         +Y   GD    L  +      LE   +P    ++ + +   L+F   
Sbjct: 117 GACTHGGPVLVITEYCCYGDLLNFLRRK--RPPGLEYSYNPSHNPEEQLSSRDLLHF--- 171
Query: 515 INIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSS 574
              +  VA  + +L         H D+   NVLL +   A + DFGLA+ +    +  S+
Sbjct: 172 ---SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI----MNDSN 221
Query: 575 IGVKGT----IGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             VKG     + ++AP E       ++  DV+SYGILL E+ +
Sbjct: 222 YIVKGNARLPVKWMAP-ESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV      +    +AVK L+     ++H   +K +  E   L++++H+N++ +L V
Sbjct: 38  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDV 94
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEW-----LHPVSGAD--KTVEAPKCLNFLQRINIA 518
                            F    SLEE+     +  + GAD    V+  K  +    +   
Sbjct: 95  -----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD--DHVQFL 135
Query: 519 I-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I  +   LKY+H        H DLKPSN+ ++ +    + DFGLA+     H      G 
Sbjct: 136 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 187
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             T  Y AP         +   D++S G ++ EL+T
Sbjct: 188 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 90/210 (42%), Gaps = 19/210 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA-ECSALRNIRHKNLVKILTVCSGV 469
           G+ G V   +    +  +AVK++++        +I  E    + + H+N+VK      G 
Sbjct: 17  GAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY----GH 72
Query: 470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH 529
             +G+  + L  E+   G L + + P  G    +  P    F  ++         + YLH
Sbjct: 73  RREGN-IQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQL------MAGVVYLH 121
Query: 530 HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEY 589
                   H D+KP N+LLD      ++DFGLA +    + +     + GT+ Y+AP   
Sbjct: 122 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 590 GLGSEVSINGDVYSYGILLLELMTRKRPSD 619
                 +   DV+S GI+L  ++  + P D
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV      +    +AVK L+     ++H   +K +  E   L++++H+N++ +L V
Sbjct: 32  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDV 88
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEW-----LHPVSGAD--KTVEAPKCLNFLQRINIA 518
                            F    SLEE+     +  + GAD    V+  K  +    +   
Sbjct: 89  -----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD--DHVQFL 129
Query: 519 I-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I  +   LKY+H        H DLKPSN+ ++ +    + DFGLA+     H      G 
Sbjct: 130 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 181
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             T  Y AP         +   D++S G ++ EL+T
Sbjct: 182 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 217

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV      +    +AVK L+     ++H   +K +  E   L++++H+N++ +L V
Sbjct: 35  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDV 91
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEW-----LHPVSGAD--KTVEAPKCLNFLQRINIA 518
                            F    SLEE+     +  + GAD    V+  K  +    +   
Sbjct: 92  -----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD--DHVQFL 132
Query: 519 I-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I  +   LKY+H        H DLKPSN+ ++ +    + DFGLA+     H      G 
Sbjct: 133 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 184
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             T  Y AP         +   D++S G ++ EL+T
Sbjct: 185 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV      +    +AVK L+     ++H   +K +  E   L++++H+N++ +L V
Sbjct: 56  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDV 112
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEW-----LHPVSGAD--KTVEAPKCLNFLQRINIA 518
                            F    SLEE+     +  + GAD    V+  K  +    +   
Sbjct: 113 -----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD--DHVQFL 153
Query: 519 I-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I  +   LKY+H        H DLKPSN+ ++ +    + DFGLA+     H      G 
Sbjct: 154 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMXGY 205
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             T  Y AP         +   D++S G ++ EL+T
Sbjct: 206 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 241

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV      +    +AVK L+     ++H   +K +  E   L++++H+N++ +L V
Sbjct: 35  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDV 91
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEW-----LHPVSGAD--KTVEAPKCLNFLQRINIA 518
                            F    SLEE+     +  + GAD    V+  K  +    +   
Sbjct: 92  -----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD--DHVQFL 132
Query: 519 I-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I  +   LKY+H        H DLKPSN+ ++ +    + DFGLA+     H      G 
Sbjct: 133 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLAR-----HTDDEMTGY 184
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             T  Y AP         +   D++S G ++ EL+T
Sbjct: 185 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV      +    +AVK L+     ++H   +K +  E   L++++H+N++ +L V
Sbjct: 53  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDV 109
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEW-----LHPVSGAD--KTVEAPKCLNFLQRINIA 518
                            F    SLEE+     +  + GAD    V+  K  +    +   
Sbjct: 110 -----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD--DHVQFL 150
Query: 519 I-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I  +   LKY+H        H DLKPSN+ ++ +    + DFGLA+     H      G 
Sbjct: 151 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 202
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             T  Y AP         +   D++S G ++ EL+T
Sbjct: 203 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 238

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/83 (33%), Positives = 41/83 (49%), Gaps = 6/83 (7%)
Query: 538 HCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSE--- 594
           H D+KPSN+LLD      + DFG++  L  +  +T   G +    Y+AP      +    
Sbjct: 149 HRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCR---PYMAPERIDPSASRQG 205
Query: 595 VSINGDVYSYGILLLELMTRKRP 617
             +  DV+S GI L EL T + P
Sbjct: 206 YDVRSDVWSLGITLYELATGRFP 228

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV      +    +AVK L+     ++H   +K +  E   L++++H+N++ +L V
Sbjct: 43  GAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDV 99
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEW-----LHPVSGAD--KTVEAPKCLNFLQRINIA 518
                            F    SLEE+     +  + GAD    V+  K  +    +   
Sbjct: 100 -----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD--DHVQFL 140
Query: 519 I-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I  +   LKY+H        H DLKPSN+ ++ +    + DFGLA+     H      G 
Sbjct: 141 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 192
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             T  Y AP         +   D++S G ++ EL+T
Sbjct: 193 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 228

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV      +    +AVK L+     ++H   +K +  E   L++++H+N++ +L V
Sbjct: 45  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDV 101
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEW-----LHPVSGAD--KTVEAPKCLNFLQRINIA 518
                            F    SLEE+     +  + GAD    V+  K  +    +   
Sbjct: 102 -----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD--DHVQFL 142
Query: 519 I-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I  +   LKY+H        H DLKPSN+ ++ +    + DFGLA+     H      G 
Sbjct: 143 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 194
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             T  Y AP         +   D++S G ++ EL+T
Sbjct: 195 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 230

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV      +    +AVK L+     ++H   +K +  E   L++++H+N++ +L V
Sbjct: 40  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDV 96
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEW-----LHPVSGAD--KTVEAPKCLNFLQRINIA 518
                            F    SLEE+     +  + GAD    V+  K  +    +   
Sbjct: 97  -----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD--DHVQFL 137
Query: 519 I-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I  +   LKY+H        H DLKPSN+ ++ +    + DFGLA+     H      G 
Sbjct: 138 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 189
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             T  Y AP         +   D++S G ++ EL+T
Sbjct: 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV      +    +AVK L+     ++H   +K +  E   L++++H+N++ +L V
Sbjct: 45  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDV 101
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEW-----LHPVSGAD--KTVEAPKCLNFLQRINIA 518
                            F    SLEE+     +  + GAD    V+  K  +    +   
Sbjct: 102 -----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD--DHVQFL 142
Query: 519 I-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I  +   LKY+H        H DLKPSN+ ++ +    + DFGLA+     H      G 
Sbjct: 143 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 194
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             T  Y AP         +   D++S G ++ EL+T
Sbjct: 195 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 230

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV      +    +AVK L+     ++H   +K +  E   L++++H+N++ +L V
Sbjct: 44  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDV 100
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEW-----LHPVSGAD--KTVEAPKCLNFLQRINIA 518
                            F    SLEE+     +  + GAD    V+  K  +    +   
Sbjct: 101 -----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD--DHVQFL 141
Query: 519 I-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I  +   LKY+H        H DLKPSN+ ++ +    + DFGLA+     H      G 
Sbjct: 142 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 193
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             T  Y AP         +   D++S G ++ EL+T
Sbjct: 194 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 229

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 60/245 (24%), Positives = 107/245 (43%), Gaps = 39/245 (15%)
Query: 428 IAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNG 487
           +AVK ++L      +    E   +R+  H N+V + +      Y   D   +V EF+  G
Sbjct: 73  VAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYS-----SYLVGDELWVVMEFLEGG 127
Query: 488 SLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVL 547
           +L + +      ++ + A  CL+ L+          AL YLH+       H D+K  ++L
Sbjct: 128 ALTDIVTHTRMNEEQI-ATVCLSVLR----------ALSYLHNQ---GVIHRDIKSDSIL 173
Query: 548 LDHEMTAHVADFG----LAKLLPPAHLQTSSIGVKGTIGYIAP---AEYGLGSEVSINGD 600
           L  +    ++DFG    ++K +P          + GT  ++AP   +    G+EV    D
Sbjct: 174 LTSDGRIKLSDFGFCAQVSKEVP------KRKXLVGTPYWMAPEVISRLPYGTEV----D 223
Query: 601 VYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVD-STLLADDEDLTITS 659
           ++S GI+++E++  + P     E  +      R  LP  V D+   S++L    DL +  
Sbjct: 224 IWSLGIMVIEMIDGEPP--YFNEPPLQAMRRIRDSLPPRVKDLHKVSSVLRGFLDLMLVR 281
Query: 660 NQRQR 664
              QR
Sbjct: 282 EPSQR 286

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV      +    +AVK L+     ++H   +K +  E   L++++H+N++ +L V
Sbjct: 30  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDV 86
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEW-----LHPVSGAD--KTVEAPKCLNFLQRINIA 518
                            F    SLEE+     +  + GAD    V+  K  +    +   
Sbjct: 87  -----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD--DHVQFL 127
Query: 519 I-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I  +   LKY+H        H DLKPSN+ ++ +    + DFGLA+     H      G 
Sbjct: 128 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 179
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             T  Y AP         +   D++S G ++ EL+T
Sbjct: 180 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 215

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV      +    +AVK L+     ++H   +K +  E   L++++H+N++ +L V
Sbjct: 38  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDV 94
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEW-----LHPVSGAD--KTVEAPKCLNFLQRINIA 518
                            F    SLEE+     +  + GAD    V+  K  +    +   
Sbjct: 95  -----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD--DHVQFL 135
Query: 519 I-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I  +   LKY+H        H DLKPSN+ ++ +    + DFGLA+     H      G 
Sbjct: 136 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 187
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             T  Y AP         +   D++S G ++ EL+T
Sbjct: 188 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV      +    +AVK L+     ++H   +K +  E   L++++H+N++ +L V
Sbjct: 29  GAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDV 85
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEW-----LHPVSGAD--KTVEAPKCLNFLQRINIA 518
                            F    SLEE+     +  + GAD    V+  K  +    +   
Sbjct: 86  -----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTD--DHVQFL 126
Query: 519 I-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I  +   LKY+H        H DLKPSN+ ++ +    + DFGLA+     H      G 
Sbjct: 127 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 178
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             T  Y AP         +   D++S G ++ EL+T
Sbjct: 179 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV      +    +AVK L+     ++H   +K +  E   L++++H+N++ +L V
Sbjct: 33  GAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDV 89
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEW-----LHPVSGAD--KTVEAPKCLNFLQRINIA 518
                            F    SLEE+     +  + GAD    V+  K  +    +   
Sbjct: 90  -----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD--DHVQFL 130
Query: 519 I-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I  +   LKY+H        H DLKPSN+ ++ +    + DFGLA+     H      G 
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 182
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             T  Y AP         +   D++S G ++ EL+T
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/235 (23%), Positives = 105/235 (44%), Gaps = 30/235 (12%)
Query: 438 HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVS 497
            G  +    E + L+ + H N+VK++ V   +D   +D   +V+E ++ G + E      
Sbjct: 77  RGPIEQVYQEIAILKKLDHPNVVKLVEV---LDDPNEDHLYMVFELVNQGPVME------ 127
Query: 498 GADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA 557
                V   K L+  Q      D+   ++YLH+       H D+KPSN+L+  +    +A
Sbjct: 128 -----VPTLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIA 179
Query: 558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSING---DVYSYGILLLELMTR 614
           DFG++     +    S+    GT  ++AP       ++  +G   DV++ G+ L   +  
Sbjct: 180 DFGVSNEFKGSDALLSN--TVGTPAFMAPESLSETRKI-FSGKALDVWAMGVTLYCFVFG 236
Query: 615 KRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADD-EDLTITSNQRQRQARI 668
           + P   M E  M LH+  ++      ++  D   +A+D +DL      +  ++RI
Sbjct: 237 QCP--FMDERIMCLHSKIKS----QALEFPDQPDIAEDLKDLITRMLDKNPESRI 285

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 86/199 (43%), Gaps = 33/199 (16%)
Query: 428 IAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMH 485
           +A+K+++   L+  + +    E   ++ + H N+VK+  V      + +    L+ E+  
Sbjct: 40  VAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI-----ETEKTLYLIMEYAS 94
Query: 486 NGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSN 545
            G + ++L    G  K  EA     F Q       +  A++Y H   Q    H DLK  N
Sbjct: 95  GGEVFDYL-VAHGRMKEKEARS--KFRQ-------IVSAVQYCH---QKRIVHRDLKAEN 141
Query: 546 VLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK-----GTIGYIAPAEYGLGSEVSINGD 600
           +LLD +M   +ADFG +           ++G K     G+  Y AP  +          D
Sbjct: 142 LLLDADMNIKIADFGFSNEF--------TVGGKLDTFCGSPPYAAPELFQGKKYDGPEVD 193
Query: 601 VYSYGILLLELMTRKRPSD 619
           V+S G++L  L++   P D
Sbjct: 194 VWSLGVILYTLVSGSLPFD 212

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV      +    +AVK L+     ++H   +K +  E   L++++H+N++ +L V
Sbjct: 52  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDV 108
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEW-----LHPVSGAD--KTVEAPKCLNFLQRINIA 518
                            F    SLEE+     +  + GAD    V+  K  +    +   
Sbjct: 109 -----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD--DHVQFL 149
Query: 519 I-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I  +   LKY+H        H DLKPSN+ ++ +    + DFGLA+     H      G 
Sbjct: 150 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 201
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             T  Y AP         +   D++S G ++ EL+T
Sbjct: 202 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 237

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV      +    +AVK L+     ++H   +K +  E   L++++H+N++ +L V
Sbjct: 33  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDV 89
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEW-----LHPVSGAD--KTVEAPKCLNFLQRINIA 518
                            F    SLEE+     +  + GAD    V+  K  +    +   
Sbjct: 90  -----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD--DHVQFL 130
Query: 519 I-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I  +   LKY+H        H DLKPSN+ ++ +    + DFGLA+     H      G 
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGX 182
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             T  Y AP         +   D++S G ++ EL+T
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV      +    +AVK L+     ++H   +K +  E   L++++H+N++ +L V
Sbjct: 45  GAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDV 101
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEW-----LHPVSGAD--KTVEAPKCLNFLQRINIA 518
                            F    SLEE+     +  + GAD    V+  K  +    +   
Sbjct: 102 -----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD--DHVQFL 142
Query: 519 I-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I  +   LKY+H        H DLKPSN+ ++ +    + DFGLA+     H      G 
Sbjct: 143 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 194
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             T  Y AP         +   D++S G ++ EL+T
Sbjct: 195 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 230

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV      +    +AVK L+     ++H   +K +  E   L++++H+N++ +L V
Sbjct: 56  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDV 112
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEW-----LHPVSGAD--KTVEAPKCLNFLQRINIA 518
                            F    SLEE+     +  + GAD    V+  K  +    +   
Sbjct: 113 -----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD--DHVQFL 153
Query: 519 I-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I  +   LKY+H        H DLKPSN+ ++ +    + DFGLA+     H      G 
Sbjct: 154 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 205
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             T  Y AP         +   D++S G ++ EL+T
Sbjct: 206 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 241

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV      +    +AVK L+     ++H   +K +  E   L++++H+N++ +L V
Sbjct: 33  GAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDV 89
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEW-----LHPVSGAD--KTVEAPKCLNFLQRINIA 518
                            F    SLEE+     +  + GAD    V+  K  +    +   
Sbjct: 90  -----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD--DHVQFL 130
Query: 519 I-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I  +   LKY+H        H DLKPSN+ ++ +    + DFGLA+     H      G 
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMAGF 182
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             T  Y AP         +   D++S G ++ EL+T
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV      +    +AVK L+     ++H   +K +  E   L++++H+N++ +L V
Sbjct: 33  GAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDV 89
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEW-----LHPVSGAD--KTVEAPKCLNFLQRINIA 518
                            F    SLEE+     +  + GAD    V+  K  +    +   
Sbjct: 90  -----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD--DHVQFL 130
Query: 519 I-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I  +   LKY+H        H DLKPSN+ ++ +    + DFGLA+     H      G 
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMAGF 182
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             T  Y AP         +   D++S G ++ EL+T
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV      +    +AVK L+     ++H   +K +  E   L++++H+N++ +L V
Sbjct: 53  GAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDV 109
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEW-----LHPVSGAD--KTVEAPKCLNFLQRINIA 518
                            F    SLEE+     +  + GAD    V+  K  +    +   
Sbjct: 110 -----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD--DHVQFL 150
Query: 519 I-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I  +   LKY+H        H DLKPSN+ ++ +    + DFGLA+     H      G 
Sbjct: 151 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 202
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             T  Y AP         +   D++S G ++ EL+T
Sbjct: 203 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 238

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV      +    +AVK L+     ++H   +K +  E   L++++H+N++ +L V
Sbjct: 29  GAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDV 85
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEW-----LHPVSGAD--KTVEAPKCLNFLQRINIA 518
                            F    SLEE+     +  + GAD    V+  K  +    +   
Sbjct: 86  -----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD--DHVQFL 126
Query: 519 I-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I  +   LKY+H        H DLKPSN+ ++ +    + DFGLA+     H      G 
Sbjct: 127 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 178
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             T  Y AP         +   D++S G ++ EL+T
Sbjct: 179 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV      +    +AVK L+     ++H   +K +  E   L++++H+N++ +L V
Sbjct: 39  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDV 95
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEW-----LHPVSGAD--KTVEAPKCLNFLQRINIA 518
                            F    SLEE+     +  + GAD    V+  K  +    +   
Sbjct: 96  -----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD--DHVQFL 136
Query: 519 I-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I  +   LKY+H        H DLKPSN+ ++ +    + DFGLA+     H      G 
Sbjct: 137 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 188
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             T  Y AP         +   D++S G ++ EL+T
Sbjct: 189 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV      +    +AVK L+     ++H   +K +  E   L++++H+N++ +L V
Sbjct: 35  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDV 91
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEW-----LHPVSGAD--KTVEAPKCLNFLQRINIA 518
                            F    SLEE+     +  + GAD    V+  K  +    +   
Sbjct: 92  -----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD--DHVQFL 132
Query: 519 I-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I  +   LKY+H        H DLKPSN+ ++ +    + DFGLA+     H      G 
Sbjct: 133 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 184
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             T  Y AP         +   D++S G ++ EL+T
Sbjct: 185 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV      +    +AVK L+     ++H   +K +  E   L++++H+N++ +L V
Sbjct: 29  GAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDV 85
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEW-----LHPVSGAD--KTVEAPKCLNFLQRINIA 518
                            F    SLEE+     +  + GAD    V+  K  +    +   
Sbjct: 86  -----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD--DHVQFL 126
Query: 519 I-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I  +   LKY+H        H DLKPSN+ ++ +    + DFGLA+     H      G 
Sbjct: 127 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMAGF 178
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             T  Y AP         +   D++S G ++ EL+T
Sbjct: 179 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV      +    +AVK L+     ++H   +K +  E   L++++H+N++ +L V
Sbjct: 52  GAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDV 108
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEW-----LHPVSGAD--KTVEAPKCLNFLQRINIA 518
                            F    SLEE+     +  + GAD    V+  K  +    +   
Sbjct: 109 -----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD--DHVQFL 149
Query: 519 I-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I  +   LKY+H        H DLKPSN+ ++ +    + DFGLA+     H      G 
Sbjct: 150 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 201
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             T  Y AP         +   D++S G ++ EL+T
Sbjct: 202 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 237

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 68/140 (48%), Gaps = 17/140 (12%)
Query: 478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTA 537
           ++  E M  GSL++ L       K    P+    L +++IA  V   L YL    +    
Sbjct: 80  SICMEHMDGGSLDQVLK------KAGRIPE--QILGKVSIA--VIKGLTYLRE--KHKIM 127
Query: 538 HCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSI 597
           H D+KPSN+L++      + DFG++  L    + + +    GT  Y++P E   G+  S+
Sbjct: 128 HRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSP-ERLQGTHYSV 182
Query: 598 NGDVYSYGILLLELMTRKRP 617
             D++S G+ L+E+   + P
Sbjct: 183 QSDIWSMGLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 68/140 (48%), Gaps = 17/140 (12%)
Query: 478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTA 537
           ++  E M  GSL++ L       K    P+    L +++IA  V   L YL    +    
Sbjct: 80  SICMEHMDGGSLDQVLK------KAGRIPE--QILGKVSIA--VIKGLTYLRE--KHKIM 127
Query: 538 HCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSI 597
           H D+KPSN+L++      + DFG++  L    + + +    GT  Y++P E   G+  S+
Sbjct: 128 HRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSP-ERLQGTHYSV 182
Query: 598 NGDVYSYGILLLELMTRKRP 617
             D++S G+ L+E+   + P
Sbjct: 183 QSDIWSMGLSLVEMAVGRYP 202

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 22/216 (10%)
Query: 411 GSFGSVYKGI---LDEGKTIIAVKVLNLLHHGASKSS----IAECSALRNI-RHKNLVKI 462
           G+FG V +     +D+  T   V V  +L  GA+ S     ++E   L +I  H N+V +
Sbjct: 39  GAFGQVIEADAFGIDKTATCRTVAV-KMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 97
Query: 463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCL--NFL---QRINI 517
           L  C+    K      ++ EF   G+L  +L          + P+ L  +FL     I  
Sbjct: 98  LGACT----KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICY 153
Query: 518 AIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           +  VA  +++L         H DL   N+LL  +    + DFGLA+ +            
Sbjct: 154 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
           +  + ++AP E       +I  DV+S+G+LL E+ +
Sbjct: 211 RLPLKWMAP-ETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 84/199 (42%), Gaps = 33/199 (16%)
Query: 428 IAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMH 485
           +AVK+++   L+  + +    E   ++ + H N+VK+  V      + +    LV E+  
Sbjct: 42  VAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVI-----ETEKTLYLVMEYAS 96
Query: 486 NGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSN 545
            G + ++L    G  K  EA     F Q       +  A++Y H   Q    H DLK  N
Sbjct: 97  GGEVFDYL-VAHGRMKEKEARA--KFRQ-------IVSAVQYCH---QKFIVHRDLKAEN 143
Query: 546 VLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK-----GTIGYIAPAEYGLGSEVSINGD 600
           +LLD +M   +ADFG +           + G K     G   Y AP  +          D
Sbjct: 144 LLLDADMNIKIADFGFSNEF--------TFGNKLDAFCGAPPYAAPELFQGKKYDGPEVD 195
Query: 601 VYSYGILLLELMTRKRPSD 619
           V+S G++L  L++   P D
Sbjct: 196 VWSLGVILYTLVSGSLPFD 214

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 82/197 (41%), Gaps = 14/197 (7%)
Query: 425 KTIIAVKVLNLLHHGASKSSI-AECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEF 483
           K  +A+K +NL     S   +  E  A+    H N+V   T      +   D   LV + 
Sbjct: 40  KEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT-----SFVVKDELWLVMKL 94
Query: 484 MHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKP 543
           +  GS+ + +  +    K       L+      I  +V   L+YLH + Q    H D+K 
Sbjct: 95  LSGGSVLDIIKHIVA--KGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKA 149
Query: 544 SNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK---GTIGYIAPAEYGLGSEVSINGD 600
            N+LL  + +  +ADFG++  L      T +   K   GT  ++AP             D
Sbjct: 150 GNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKAD 209
Query: 601 VYSYGILLLELMTRKRP 617
           ++S+GI  +EL T   P
Sbjct: 210 IWSFGITAIELATGAAP 226

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 68/140 (48%), Gaps = 17/140 (12%)
Query: 478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTA 537
           ++  E M  GSL++ L       K    P+    L +++IA  V   L YL    +    
Sbjct: 107 SICMEHMDGGSLDQVLK------KAGRIPE--QILGKVSIA--VIKGLTYLRE--KHKIM 154
Query: 538 HCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSI 597
           H D+KPSN+L++      + DFG++  L    + + +    GT  Y++P E   G+  S+
Sbjct: 155 HRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSP-ERLQGTHYSV 209
Query: 598 NGDVYSYGILLLELMTRKRP 617
             D++S G+ L+E+   + P
Sbjct: 210 QSDIWSMGLSLVEMAVGRYP 229

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 68/140 (48%), Gaps = 17/140 (12%)
Query: 478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTA 537
           ++  E M  GSL++ L       K    P+    L +++IA  V   L YL    +    
Sbjct: 142 SICMEHMDGGSLDQVLK------KAGRIPE--QILGKVSIA--VIKGLTYLREKHK--IM 189
Query: 538 HCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSI 597
           H D+KPSN+L++      + DFG++  L    + + +    GT  Y++P E   G+  S+
Sbjct: 190 HRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSP-ERLQGTHYSV 244
Query: 598 NGDVYSYGILLLELMTRKRP 617
             D++S G+ L+E+   + P
Sbjct: 245 QSDIWSMGLSLVEMAVGRYP 264

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 82/197 (41%), Gaps = 14/197 (7%)
Query: 425 KTIIAVKVLNLLHHGASKSSI-AECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEF 483
           K  +A+K +NL     S   +  E  A+    H N+V   T      +   D   LV + 
Sbjct: 35  KEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT-----SFVVKDELWLVMKL 89
Query: 484 MHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKP 543
           +  GS+ + +  +    K       L+      I  +V   L+YLH + Q    H D+K 
Sbjct: 90  LSGGSVLDIIKHIVA--KGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKA 144
Query: 544 SNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK---GTIGYIAPAEYGLGSEVSINGD 600
            N+LL  + +  +ADFG++  L      T +   K   GT  ++AP             D
Sbjct: 145 GNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKAD 204
Query: 601 VYSYGILLLELMTRKRP 617
           ++S+GI  +EL T   P
Sbjct: 205 IWSFGITAIELATGAAP 221

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 68/140 (48%), Gaps = 17/140 (12%)
Query: 478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTA 537
           ++  E M  GSL++ L       K    P+    L +++IA  V   L YL    +    
Sbjct: 80  SICMEHMDGGSLDQVLK------KAGRIPE--QILGKVSIA--VIKGLTYLREKHK--IM 127
Query: 538 HCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSI 597
           H D+KPSN+L++      + DFG++  L    + + +    GT  Y++P E   G+  S+
Sbjct: 128 HRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSP-ERLQGTHYSV 182
Query: 598 NGDVYSYGILLLELMTRKRP 617
             D++S G+ L+E+   + P
Sbjct: 183 QSDIWSMGLSLVEMAVGRYP 202

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV      +    +AVK L+     ++H   +K +  E   L++++H+N++ +L V
Sbjct: 53  GAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDV 109
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEW-----LHPVSGAD--KTVEAPKCLNFLQRINIA 518
                            F    SLEE+     +  + GAD    V+  K  +    +   
Sbjct: 110 -----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD--DHVQFL 150
Query: 519 I-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I  +   LKY+H        H DLKPSN+ ++ +    + DFGLA+     H      G 
Sbjct: 151 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMXGX 202
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             T  Y AP         +   D++S G ++ EL+T
Sbjct: 203 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 238

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV      +    +AVK L+     ++H   +K +  E   L++++H+N++ +L V
Sbjct: 40  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDV 96
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEW-----LHPVSGAD--KTVEAPKCLNFLQRINIA 518
                            F    SLEE+     +  + GAD    V+  K  +    +   
Sbjct: 97  -----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD--DHVQFL 137
Query: 519 I-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I  +   LKY+H        H DLKPSN+ ++ +    + DFGLA+     H      G 
Sbjct: 138 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTADEMTGY 189
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             T  Y AP         +   D++S G ++ EL+T
Sbjct: 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 68/140 (48%), Gaps = 17/140 (12%)
Query: 478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTA 537
           ++  E M  GSL++ L       K    P+    L +++IA  V   L YL    +    
Sbjct: 80  SICMEHMDGGSLDQVLK------KAGRIPE--QILGKVSIA--VIKGLTYLRE--KHKIM 127
Query: 538 HCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSI 597
           H D+KPSN+L++      + DFG++  L    + + +    GT  Y++P E   G+  S+
Sbjct: 128 HRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSP-ERLQGTHYSV 182
Query: 598 NGDVYSYGILLLELMTRKRP 617
             D++S G+ L+E+   + P
Sbjct: 183 QSDIWSMGLSLVEMAVGRYP 202

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV      +    +AVK L+     ++H   +K +  E   L++++H+N++ +L V
Sbjct: 40  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDV 96
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEW-----LHPVSGAD--KTVEAPKCLNFLQRINIA 518
                            F    SLEE+     +  + GAD    V+  K  +    +   
Sbjct: 97  -----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD--DHVQFL 137
Query: 519 I-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I  +   LKY+H        H DLKPSN+ ++ +    + DFGLA+     H      G 
Sbjct: 138 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTADEMTGY 189
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             T  Y AP         +   D++S G ++ EL+T
Sbjct: 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 68/140 (48%), Gaps = 17/140 (12%)
Query: 478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTA 537
           ++  E M  GSL++ L       K    P+    L +++IA  V   L YL    +    
Sbjct: 80  SICMEHMDGGSLDQVLK------KAGRIPE--QILGKVSIA--VIKGLTYLRE--KHKIM 127
Query: 538 HCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSI 597
           H D+KPSN+L++      + DFG++  L    + + +    GT  Y++P E   G+  S+
Sbjct: 128 HRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSP-ERLQGTHYSV 182
Query: 598 NGDVYSYGILLLELMTRKRP 617
             D++S G+ L+E+   + P
Sbjct: 183 QSDIWSMGLSLVEMAVGRYP 202

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV      +    +AVK L+     ++H   +K +  E   L++++H+N++ +L V
Sbjct: 40  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDV 96
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEW-----LHPVSGAD--KTVEAPKCLNFLQRINIA 518
                            F    SLEE+     +  + GAD    V+  K  +    +   
Sbjct: 97  -----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD--DHVQFL 137
Query: 519 I-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I  +   LKY+H        H DLKPSN+ ++ +    + DFGLA+     H      G 
Sbjct: 138 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTADEMTGY 189
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             T  Y AP         +   D++S G ++ EL+T
Sbjct: 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 85/199 (42%), Gaps = 33/199 (16%)
Query: 428 IAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMH 485
           +AV++++   L+  + +    E   ++ + H N+VK+  V      + +    LV E+  
Sbjct: 42  VAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVI-----ETEKTLYLVMEYAS 96
Query: 486 NGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSN 545
            G + ++L    G  K  EA     F Q       +  A++Y H   Q    H DLK  N
Sbjct: 97  GGEVFDYL-VAHGRMKEKEARA--KFRQ-------IVSAVQYCH---QKFIVHRDLKAEN 143
Query: 546 VLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK-----GTIGYIAPAEYGLGSEVSINGD 600
           +LLD +M   +ADFG +           + G K     G+  Y AP  +          D
Sbjct: 144 LLLDADMNIKIADFGFSNEF--------TFGNKLDTFCGSPPYAAPELFQGKKYDGPEVD 195
Query: 601 VYSYGILLLELMTRKRPSD 619
           V+S G++L  L++   P D
Sbjct: 196 VWSLGVILYTLVSGSLPFD 214

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 85/221 (38%), Gaps = 37/221 (16%)
Query: 446 AECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEA 505
            E   L+ + H  ++KI       DY       +V E M  G L      V G  +  EA
Sbjct: 203 TEIEILKKLNHPCIIKIKNFFDAEDY------YIVLELMEGGEL---FDKVVGNKRLKEA 253
Query: 506 PKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLL---DHEMTAHVADFGLA 562
              L F Q +        A++YLH +      H DLKP NVLL   + +    + DFG +
Sbjct: 254 TCKLYFYQML-------LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHS 303
Query: 563 KLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSING--DVYSYGILLL----------E 610
           K+L    L  +   + GT  Y+AP           N   D +S G++L           E
Sbjct: 304 KILGETSLMRT---LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 360
Query: 611 LMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLAD 651
             T+    D +  G  N        + +  +D+V   L+ D
Sbjct: 361 HRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVD 401

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 84/204 (41%), Gaps = 20/204 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTV-CSGV 469
           GSFG V++  L E   +   KVL        +    E   +R ++H N+V +     S  
Sbjct: 51  GSFGVVFQAKLVESDEVAIKKVLQ-----DKRFKNRELQIMRIVKHPNVVDLKAFFYSNG 105
Query: 470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH 529
           D K + F  LV E++          P +    +    K    +  + I + +   L+ L 
Sbjct: 106 DKKDEVFLNLVLEYV----------PETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLA 155
Query: 530 HDCQPTTAHCDLKPSNVLLDHEM-TAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAE 588
           +       H D+KP N+LLD       + DFG AK+L       S I  +    Y AP  
Sbjct: 156 YIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSR---YYRAPEL 212
Query: 589 YGLGSEVSINGDVYSYGILLLELM 612
               +  + N D++S G ++ ELM
Sbjct: 213 IFGATNYTTNIDIWSTGCVMAELM 236

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 85/199 (42%), Gaps = 33/199 (16%)
Query: 428 IAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMH 485
           +AV++++   L+  + +    E   ++ + H N+VK+  V      + +    LV E+  
Sbjct: 42  VAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVI-----ETEKTLYLVMEYAS 96
Query: 486 NGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSN 545
            G + ++L    G  K  EA     F Q       +  A++Y H   Q    H DLK  N
Sbjct: 97  GGEVFDYL-VAHGRMKEKEARA--KFRQ-------IVSAVQYCH---QKFIVHRDLKAEN 143
Query: 546 VLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK-----GTIGYIAPAEYGLGSEVSINGD 600
           +LLD +M   +ADFG +           + G K     G+  Y AP  +          D
Sbjct: 144 LLLDADMNIKIADFGFSNEF--------TFGNKLDEFCGSPPYAAPELFQGKKYDGPEVD 195
Query: 601 VYSYGILLLELMTRKRPSD 619
           V+S G++L  L++   P D
Sbjct: 196 VWSLGVILYTLVSGSLPFD 214

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/233 (22%), Positives = 97/233 (41%), Gaps = 48/233 (20%)
Query: 415 SVYKGILDEGKTIIAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYK 472
           + Y  IL+     +A+K L+    +   +K +  E   ++ + HKN++ +L V       
Sbjct: 44  AAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV------- 93
Query: 473 GDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAID----------VA 522
                     F    SLEE    V    + ++A    N  Q I + +D          + 
Sbjct: 94  ----------FTPQKSLEE-FQDVYIVMELMDA----NLCQVIQMELDHERMSYLLYQML 138
Query: 523 CALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIG 582
           C +K+LH        H DLKPSN+++  + T  + DFGLA+    + +    +  +    
Sbjct: 139 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVVTR---- 191
Query: 583 YIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV 635
           Y    E  LG     N D++S G ++ E++       ++F G  ++  + + +
Sbjct: 192 YYRAPEVILGMGYKENVDIWSVGCIMGEMIK----GGVLFPGTDHIDQWNKVI 240

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 85/220 (38%), Gaps = 37/220 (16%)
Query: 447 ECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAP 506
           E   L+ + H  ++KI       DY       +V E M  G L      V G  +  EA 
Sbjct: 64  EIEILKKLNHPCIIKIKNFFDAEDY------YIVLELMEGGEL---FDKVVGNKRLKEAT 114
Query: 507 KCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLL---DHEMTAHVADFGLAK 563
             L F Q +        A++YLH +      H DLKP NVLL   + +    + DFG +K
Sbjct: 115 CKLYFYQML-------LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 164
Query: 564 LLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSING--DVYSYGILLL----------EL 611
           +L    L  +   + GT  Y+AP           N   D +S G++L           E 
Sbjct: 165 ILGETSLMRT---LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH 221
Query: 612 MTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLAD 651
            T+    D +  G  N        + +  +D+V   L+ D
Sbjct: 222 RTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVD 261

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 85/220 (38%), Gaps = 37/220 (16%)
Query: 447 ECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAP 506
           E   L+ + H  ++KI       DY       +V E M  G L      V G  +  EA 
Sbjct: 65  EIEILKKLNHPCIIKIKNFFDAEDY------YIVLELMEGGEL---FDKVVGNKRLKEAT 115
Query: 507 KCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLL---DHEMTAHVADFGLAK 563
             L F Q +        A++YLH +      H DLKP NVLL   + +    + DFG +K
Sbjct: 116 CKLYFYQML-------LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165
Query: 564 LLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSING--DVYSYGILLL----------EL 611
           +L    L  +   + GT  Y+AP           N   D +S G++L           E 
Sbjct: 166 ILGETSLMRT---LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH 222
Query: 612 MTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLAD 651
            T+    D +  G  N        + +  +D+V   L+ D
Sbjct: 223 RTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVD 262

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 85/199 (42%), Gaps = 33/199 (16%)
Query: 428 IAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMH 485
           +A+K+++   L+  + +    E   ++ + H N+VK+  V      + +    L+ E+  
Sbjct: 43  VAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI-----ETEKTLYLIMEYAS 97
Query: 486 NGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSN 545
            G + ++L    G  K  EA     F Q       +  A++Y H   Q    H DLK  N
Sbjct: 98  GGEVFDYL-VAHGRMKEKEARS--KFRQ-------IVSAVQYCH---QKRIVHRDLKAEN 144
Query: 546 VLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK-----GTIGYIAPAEYGLGSEVSINGD 600
           +LLD +M   +ADFG +           ++G K     G   Y AP  +          D
Sbjct: 145 LLLDADMNIKIADFGFSNEF--------TVGGKLDAFCGAPPYAAPELFQGKKYDGPEVD 196
Query: 601 VYSYGILLLELMTRKRPSD 619
           V+S G++L  L++   P D
Sbjct: 197 VWSLGVILYTLVSGSLPFD 215

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 92/218 (42%), Gaps = 31/218 (14%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNI--RHKNLVKILTVCSG 468
           G +G V++G   +G+ + AVK+ +       KS   E      +  RH+N++  +     
Sbjct: 19  GRYGEVWRGSW-QGENV-AVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASDMT 73
Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL 528
             +       L+  +   GSL ++L        T++   CL       I + +A  L +L
Sbjct: 74  SRHSSTQL-WLITHYHEMGSLYDYLQLT-----TLDTVSCLR------IVLSIASGLAHL 121
Query: 529 HHDC-----QPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPA--HLQTSSIGVKGTI 581
           H +      +P  AH DLK  N+L+       +AD GLA +   +   L   +    GT 
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181
Query: 582 GYIAPAEYGLGSEVSI-----NGDVYSYGILLLELMTR 614
            Y+AP       +V         D++++G++L E+  R
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 85/220 (38%), Gaps = 37/220 (16%)
Query: 447 ECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAP 506
           E   L+ + H  ++KI       DY       +V E M  G L      V G  +  EA 
Sbjct: 65  EIEILKKLNHPCIIKIKNFFDAEDY------YIVLELMEGGEL---FDKVVGNKRLKEAT 115
Query: 507 KCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLL---DHEMTAHVADFGLAK 563
             L F Q +        A++YLH +      H DLKP NVLL   + +    + DFG +K
Sbjct: 116 CKLYFYQML-------LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165
Query: 564 LLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSING--DVYSYGILLL----------EL 611
           +L    L  +   + GT  Y+AP           N   D +S G++L           E 
Sbjct: 166 ILGETSLMRT---LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH 222
Query: 612 MTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLAD 651
            T+    D +  G  N        + +  +D+V   L+ D
Sbjct: 223 RTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVD 262

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 92/218 (42%), Gaps = 31/218 (14%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNI--RHKNLVKILTVCSG 468
           G +G V++G   +G+ + AVK+ +       KS   E      +  RH+N++  +     
Sbjct: 19  GRYGEVWRGSW-QGENV-AVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASDMT 73
Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL 528
             +       L+  +   GSL ++L        T++   CL       I + +A  L +L
Sbjct: 74  SRHSSTQL-WLITHYHEMGSLYDYLQLT-----TLDTVSCLR------IVLSIASGLAHL 121
Query: 529 HHDC-----QPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPA--HLQTSSIGVKGTI 581
           H +      +P  AH DLK  N+L+       +AD GLA +   +   L   +    GT 
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181
Query: 582 GYIAPAEYGLGSEVSI-----NGDVYSYGILLLELMTR 614
            Y+AP       +V         D++++G++L E+  R
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 92/218 (42%), Gaps = 31/218 (14%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNI--RHKNLVKILTVCSG 468
           G +G V++G   +G+ + AVK+ +       KS   E      +  RH+N++  +     
Sbjct: 48  GRYGEVWRGSW-QGENV-AVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASDMT 102
Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL 528
             +       L+  +   GSL ++L        T++   CL       I + +A  L +L
Sbjct: 103 SRHSSTQL-WLITHYHEMGSLYDYLQLT-----TLDTVSCLR------IVLSIASGLAHL 150
Query: 529 HHDC-----QPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPA--HLQTSSIGVKGTI 581
           H +      +P  AH DLK  N+L+       +AD GLA +   +   L   +    GT 
Sbjct: 151 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 210
Query: 582 GYIAPAEYGLGSEVSI-----NGDVYSYGILLLELMTR 614
            Y+AP       +V         D++++G++L E+  R
Sbjct: 211 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 248

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 85/221 (38%), Gaps = 37/221 (16%)
Query: 446 AECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEA 505
            E   L+ + H  ++KI       DY       +V E M  G L      V G  +  EA
Sbjct: 189 TEIEILKKLNHPCIIKIKNFFDAEDY------YIVLELMEGGEL---FDKVVGNKRLKEA 239
Query: 506 PKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLL---DHEMTAHVADFGLA 562
              L F Q +        A++YLH +      H DLKP NVLL   + +    + DFG +
Sbjct: 240 TCKLYFYQML-------LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289
Query: 563 KLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSING--DVYSYGILLL----------E 610
           K+L    L  +   + GT  Y+AP           N   D +S G++L           E
Sbjct: 290 KILGETSLMRT---LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 346
Query: 611 LMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLAD 651
             T+    D +  G  N        + +  +D+V   L+ D
Sbjct: 347 HRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVD 387

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 85/220 (38%), Gaps = 37/220 (16%)
Query: 447 ECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAP 506
           E   L+ + H  ++KI       DY       +V E M  G L      V G  +  EA 
Sbjct: 65  EIEILKKLNHPCIIKIKNFFDAEDY------YIVLELMEGGEL---FDKVVGNKRLKEAT 115
Query: 507 KCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLL---DHEMTAHVADFGLAK 563
             L F Q +        A++YLH +      H DLKP NVLL   + +    + DFG +K
Sbjct: 116 CKLYFYQML-------LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165
Query: 564 LLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSING--DVYSYGILLL----------EL 611
           +L    L  +   + GT  Y+AP           N   D +S G++L           E 
Sbjct: 166 ILGETSLMRT---LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH 222
Query: 612 MTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLAD 651
            T+    D +  G  N        + +  +D+V   L+ D
Sbjct: 223 RTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVD 262

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 85/220 (38%), Gaps = 37/220 (16%)
Query: 447 ECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAP 506
           E   L+ + H  ++KI       DY       +V E M  G L      V G  +  EA 
Sbjct: 71  EIEILKKLNHPCIIKIKNFFDAEDY------YIVLELMEGGEL---FDKVVGNKRLKEAT 121
Query: 507 KCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLL---DHEMTAHVADFGLAK 563
             L F Q +        A++YLH +      H DLKP NVLL   + +    + DFG +K
Sbjct: 122 CKLYFYQML-------LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 171
Query: 564 LLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSING--DVYSYGILLL----------EL 611
           +L    L  +   + GT  Y+AP           N   D +S G++L           E 
Sbjct: 172 ILGETSLMRT---LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH 228
Query: 612 MTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLAD 651
            T+    D +  G  N        + +  +D+V   L+ D
Sbjct: 229 RTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVD 268

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV      +    +AVK L+     ++H   +K +  E   L++++H+N++ +L V
Sbjct: 39  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDV 95
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEW-----LHPVSGAD--KTVEAPKCLNFLQRINIA 518
                            F    SLEE+     +  + GAD    V+  K  +    +   
Sbjct: 96  -----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD--DHVQFL 136
Query: 519 I-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I  +   LKY+H        H DLKPSN+ ++ +    + DFGLA+     H      G 
Sbjct: 137 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 188
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             T  Y AP         +   D++S G ++ EL+T
Sbjct: 189 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 54/109 (49%), Gaps = 12/109 (11%)
Query: 516 NIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSI 575
            IA+ +  AL++LH     +  H D+KPSNVL++      + DFG++  L     +    
Sbjct: 113 KIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA 170
Query: 576 GVKGTIGYIAPAEYGLGSEV-----SINGDVYSYGILLLELMTRKRPSD 619
           G K    Y+AP    +  E+     S+  D++S GI ++EL   + P D
Sbjct: 171 GCK---PYMAPER--INPELNQKGYSVKSDIWSLGITMIELAILRFPYD 214

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV      +    +AVK L+     ++H   +K +  E   L++++H+N++ +L V
Sbjct: 39  GAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDV 95
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEW-----LHPVSGAD--KTVEAPKCLNFLQRINIA 518
                            F    SLEE+     +  + GAD    V+  K  +    +   
Sbjct: 96  -----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD--DHVQFL 136
Query: 519 I-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I  +   LKY+H        H DLKPSN+ ++ +    + DFGLA+     H      G 
Sbjct: 137 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 188
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             T  Y AP         +   D++S G ++ EL+T
Sbjct: 189 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 71/148 (47%), Gaps = 19/148 (12%)
Query: 478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTA 537
           ++  E M  GSL++ L       K    P+    L +++IA  V   L YL    +    
Sbjct: 83  SICMEHMDGGSLDQVL------KKAGRIPE--QILGKVSIA--VIKGLTYLRE--KHKIM 130
Query: 538 HCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSI 597
           H D+KPSN+L++      + DFG++  L    +   +    GT  Y++P E   G+  S+
Sbjct: 131 HRDVKPSNILVNSRGEIKLCDFGVSGQL----IDEMANEFVGTRSYMSP-ERLQGTHYSV 185
Query: 598 NGDVYSYGILLLELMTRK--RPSDIMFE 623
             D++S G+ L+E+   +  RP   +FE
Sbjct: 186 QSDIWSMGLSLVEMAVGRYPRPPMAIFE 213

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 27/219 (12%)
Query: 411 GSFGSVYKGI---LDEGKTIIAVKVLNLLHHGASKSS----IAECSALRNIRHK-NLVKI 462
           G+FG V +     +D+  T   V V  +L  GA+ S     ++E   L +I H  N+V +
Sbjct: 40  GAFGQVIEADAFGIDKTATCRTVAV-KMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 98
Query: 463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTV---EAPKCL--NFL---QR 514
           L  C+    K      ++ EF   G+L  +L   S  ++ V   EAP+ L  +FL     
Sbjct: 99  LGACT----KPGGPLMVIVEFCKFGNLSTYLR--SKRNEFVPYKEAPEDLYKDFLTLEHL 152
Query: 515 INIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSS 574
           I  +  VA  +++L         H DL   N+LL  +    + DFGLA+ +         
Sbjct: 153 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 209
Query: 575 IGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
              +  + ++AP E       +I  DV+S+G+LL E+ +
Sbjct: 210 GDARLPLKWMAP-ETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 53/160 (33%), Positives = 85/160 (53%), Gaps = 9/160 (5%)
Query: 105 TLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKL 164
           +++ +I N++ I +S+  GI    N++ L +  N+L      A+ EL NL  L +  N+L
Sbjct: 42  SIDQIIANNSDI-KSV-QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQL 97
Query: 165 SGNIPPSIGNLKKLLQLYLIENFLQVSIPSSL-GQCQSLTTINLSYNNLSGTIPPQLMDL 223
                     L  L +L L+EN LQ S+P  +  +  +LT +NL++N L  ++P  + D 
Sbjct: 98  QSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDK 155
Query: 224 TSLSVGLDLSRNQLVGSLPTEV-GKLINLEILFISRNMLE 262
            +    LDLS NQL  SLP  V  KL  L+ L + +N L+
Sbjct: 156 LTNLTELDLSYNQL-QSLPEGVFDKLTQLKDLRLYQNQLK 194

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV      +    +AVK L+     ++H   +K +  E   L++++H+N++ +L V
Sbjct: 33  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDV 89
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEW-----LHPVSGAD--KTVEAPKCLNFLQRINIA 518
                            F    SLEE+     +  + GAD    V+  K  +    +   
Sbjct: 90  -----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD--DHVQFL 130
Query: 519 I-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I  +   LKY+H        H DLKPSN+ ++ +    + D+GLA+     H      G 
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDYGLAR-----HTDDEMTGY 182
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             T  Y AP         +   D++S G ++ EL+T
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 100/233 (42%), Gaps = 48/233 (20%)
Query: 415 SVYKGILDEGKTIIAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYK 472
           + Y  IL+     +A+K L+    +   +K +  E   ++ + HKN++ +L V       
Sbjct: 42  AAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV------- 91
Query: 473 GDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAID----------VA 522
                     F    SLEE    V    + ++A    N  Q I + +D          + 
Sbjct: 92  ----------FTPQKSLEE-FQDVYIVMELMDA----NLSQVIQMELDHERMSYLLYQML 136
Query: 523 CALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIG 582
             +K+LH        H DLKPSN+++  + T  + DFGLA+    + + T  +    T  
Sbjct: 137 VGIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYV---VTRY 190
Query: 583 YIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV 635
           Y AP E  LG     N D++S G+++ E++       ++F G  ++  + + +
Sbjct: 191 YRAP-EVILGMGYKENVDIWSVGVIMGEMIK----GGVLFPGTDHIDQWNKVI 238

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 100/233 (42%), Gaps = 48/233 (20%)
Query: 415 SVYKGILDEGKTIIAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYK 472
           + Y  IL+     +A+K L+    +   +K +  E   ++ + HKN++ +L V       
Sbjct: 42  AAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV------- 91
Query: 473 GDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAID----------VA 522
                     F    SLEE    V    + ++A    N  Q I + +D          + 
Sbjct: 92  ----------FTPQKSLEE-FQDVYIVMELMDA----NLSQVIQMELDHERMSYLLYQML 136
Query: 523 CALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIG 582
             +K+LH        H DLKPSN+++  + T  + DFGLA+    + + T  +    T  
Sbjct: 137 VGIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYV---VTRY 190
Query: 583 YIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV 635
           Y AP E  LG     N D++S G+++ E++       ++F G  ++  + + +
Sbjct: 191 YRAP-EVILGMGYKENVDIWSVGVIMGEMIK----GGVLFPGTDHIDQWNKVI 238

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV      +    +AVK L+     ++H   +K +  E   L++++H+N++ +L V
Sbjct: 33  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDV 89
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEW-----LHPVSGAD--KTVEAPKCLNFLQRINIA 518
                            F    SLEE+     +  + GAD    V++ K  +    +   
Sbjct: 90  -----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTD--DHVQFL 130
Query: 519 I-DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           I  +   LKY+H        H DLKPSN+ ++ +    + DFGL +     H      G 
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLCR-----HTDDEMTGY 182
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             T  Y AP         +   D++S G ++ EL+T
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 60/242 (24%), Positives = 98/242 (40%), Gaps = 50/242 (20%)
Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKI 462
           I  GS+G V   I ++ + I A+K++N      ++    +    E   ++ + H N+ ++
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKT------------VEAPKC-- 508
             V     Y+ + +  LV E  H G L + L+ V   D T               P+C  
Sbjct: 94  YEV-----YEDEQYICLVMELCHGGHLLDKLN-VFIDDSTGKCAMDVVKTQICPCPECNE 147
Query: 509 -------------LNFLQR----INIAIDVACALKYLHHDCQPTTAHCDLKPSNVLL--D 549
                        L+F+QR     NI   +  AL YLH+       H D+KP N L   +
Sbjct: 148 EAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTN 204
Query: 550 HEMTAHVADFGLAK-LLPPAHLQTSSIGVK-GTIGYIAPAEYGLGSE-VSINGDVYSYGI 606
                 + DFGL+K      + +   +  K GT  ++AP      +E      D +S G+
Sbjct: 205 KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264
Query: 607 LL 608
           LL
Sbjct: 265 LL 266

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 93/210 (44%), Gaps = 29/210 (13%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSI-----AECSALRNIRHKNLVKILTV 465
           G+FG+V KG   + K ++    + +L + A+  ++     AE + ++ + +  +V+++ +
Sbjct: 28  GNFGTVKKGYY-QMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGI 86
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGA-DKTVEAPKCLNFLQRINIAIDVACA 524
           C    +       LV E    G L ++L       DK +           I +   V+  
Sbjct: 87  CEAESW------MLVMEMAELGPLNKYLQQNRHVKDKNI-----------IELVHQVSMG 129
Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL-PPAHLQTSSIGVKGTIGY 583
           +KYL    +    H DL   NVLL  +  A ++DFGL+K L    +   +    K  + +
Sbjct: 130 MKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 186
Query: 584 IAPAEYGLGSEVSINGDVYSYGILLLELMT 613
            AP       + S   DV+S+G+L+ E  +
Sbjct: 187 YAPECINY-YKFSSKSDVWSFGVLMWEAFS 215

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 93/210 (44%), Gaps = 29/210 (13%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSI-----AECSALRNIRHKNLVKILTV 465
           G+FG+V KG   + K ++    + +L + A+  ++     AE + ++ + +  +V+++ +
Sbjct: 16  GNFGTVKKGYY-QMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGI 74
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGA-DKTVEAPKCLNFLQRINIAIDVACA 524
           C    +       LV E    G L ++L       DK +           I +   V+  
Sbjct: 75  CEAESW------MLVMEMAELGPLNKYLQQNRHVKDKNI-----------IELVHQVSMG 117
Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL-PPAHLQTSSIGVKGTIGY 583
           +KYL    +    H DL   NVLL  +  A ++DFGL+K L    +   +    K  + +
Sbjct: 118 MKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 174
Query: 584 IAPAEYGLGSEVSINGDVYSYGILLLELMT 613
            AP       + S   DV+S+G+L+ E  +
Sbjct: 175 YAPECINY-YKFSSKSDVWSFGVLMWEAFS 203

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 91/204 (44%), Gaps = 19/204 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           GSFG VY+  L +   ++A+K   +L   A K+   E   +R + H N+V++        
Sbjct: 31  GSFGVVYQAKLCDSGELVAIK--KVLQGKAFKNR--ELQIMRKLDHCNIVRLRYFFYSSG 86
Query: 471 YKGDD-FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH 529
            K D+ +  LV +++         H  S A +T+       ++ ++        +L Y+H
Sbjct: 87  EKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQL------FRSLAYIH 139
Query: 530 HDCQPTTAHCDLKPSNVLLDHEMTA-HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAE 588
                   H D+KP N+LLD +     + DFG AK L       S I  +    Y AP  
Sbjct: 140 SF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR---YYRAPEL 193
Query: 589 YGLGSEVSINGDVYSYGILLLELM 612
               ++ + + DV+S G +L EL+
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELL 217

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 93/210 (44%), Gaps = 29/210 (13%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSI-----AECSALRNIRHKNLVKILTV 465
           G+FG+V KG   + K ++    + +L + A+  ++     AE + ++ + +  +V+++ +
Sbjct: 38  GNFGTVKKGYY-QMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGI 96
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGA-DKTVEAPKCLNFLQRINIAIDVACA 524
           C    +       LV E    G L ++L       DK +           I +   V+  
Sbjct: 97  CEAESW------MLVMEMAELGPLNKYLQQNRHVKDKNI-----------IELVHQVSMG 139
Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL-PPAHLQTSSIGVKGTIGY 583
           +KYL    +    H DL   NVLL  +  A ++DFGL+K L    +   +    K  + +
Sbjct: 140 MKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 196
Query: 584 IAPAEYGLGSEVSINGDVYSYGILLLELMT 613
            AP       + S   DV+S+G+L+ E  +
Sbjct: 197 YAPECINY-YKFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 93/210 (44%), Gaps = 29/210 (13%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSI-----AECSALRNIRHKNLVKILTV 465
           G+FG+V KG   + K ++    + +L + A+  ++     AE + ++ + +  +V+++ +
Sbjct: 38  GNFGTVKKGYY-QMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGI 96
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGA-DKTVEAPKCLNFLQRINIAIDVACA 524
           C    +       LV E    G L ++L       DK +           I +   V+  
Sbjct: 97  CEAESW------MLVMEMAELGPLNKYLQQNRHVKDKNI-----------IELVHQVSMG 139
Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL-PPAHLQTSSIGVKGTIGY 583
           +KYL    +    H DL   NVLL  +  A ++DFGL+K L    +   +    K  + +
Sbjct: 140 MKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 196
Query: 584 IAPAEYGLGSEVSINGDVYSYGILLLELMT 613
            AP       + S   DV+S+G+L+ E  +
Sbjct: 197 YAPECINY-YKFSSKSDVWSFGVLMWEAFS 225

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 93/210 (44%), Gaps = 29/210 (13%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSI-----AECSALRNIRHKNLVKILTV 465
           G+FG+V KG   + K ++    + +L + A+  ++     AE + ++ + +  +V+++ +
Sbjct: 36  GNFGTVKKGYY-QMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGI 94
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSG-ADKTVEAPKCLNFLQRINIAIDVACA 524
           C    +       LV E    G L ++L       DK +           I +   V+  
Sbjct: 95  CEAESW------MLVMEMAELGPLNKYLQQNRHVKDKNI-----------IELVHQVSMG 137
Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL-PPAHLQTSSIGVKGTIGY 583
           +KYL    +    H DL   NVLL  +  A ++DFGL+K L    +   +    K  + +
Sbjct: 138 MKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 194
Query: 584 IAPAEYGLGSEVSINGDVYSYGILLLELMT 613
            AP       + S   DV+S+G+L+ E  +
Sbjct: 195 YAPECINY-YKFSSKSDVWSFGVLMWEAFS 223

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 93/210 (44%), Gaps = 29/210 (13%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSI-----AECSALRNIRHKNLVKILTV 465
           G+FG+V KG   + K ++    + +L + A+  ++     AE + ++ + +  +V+++ +
Sbjct: 18  GNFGTVKKGYY-QMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGI 76
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGA-DKTVEAPKCLNFLQRINIAIDVACA 524
           C    +       LV E    G L ++L       DK +           I +   V+  
Sbjct: 77  CEAESW------MLVMEMAELGPLNKYLQQNRHVKDKNI-----------IELVHQVSMG 119
Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL-PPAHLQTSSIGVKGTIGY 583
           +KYL    +    H DL   NVLL  +  A ++DFGL+K L    +   +    K  + +
Sbjct: 120 MKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 176
Query: 584 IAPAEYGLGSEVSINGDVYSYGILLLELMT 613
            AP       + S   DV+S+G+L+ E  +
Sbjct: 177 YAPECINY-YKFSSKSDVWSFGVLMWEAFS 205

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 93/210 (44%), Gaps = 29/210 (13%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSI-----AECSALRNIRHKNLVKILTV 465
           G+FG+V KG   + K ++    + +L + A+  ++     AE + ++ + +  +V+++ +
Sbjct: 22  GNFGTVKKGYY-QMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGI 80
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGA-DKTVEAPKCLNFLQRINIAIDVACA 524
           C    +       LV E    G L ++L       DK +           I +   V+  
Sbjct: 81  CEAESW------MLVMEMAELGPLNKYLQQNRHVKDKNI-----------IELVHQVSMG 123
Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL-PPAHLQTSSIGVKGTIGY 583
           +KYL    +    H DL   NVLL  +  A ++DFGL+K L    +   +    K  + +
Sbjct: 124 MKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 180
Query: 584 IAPAEYGLGSEVSINGDVYSYGILLLELMT 613
            AP       + S   DV+S+G+L+ E  +
Sbjct: 181 YAPECINY-YKFSSKSDVWSFGVLMWEAFS 209

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 93/210 (44%), Gaps = 29/210 (13%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSI-----AECSALRNIRHKNLVKILTV 465
           G+FG+V KG   + K ++    + +L + A+  ++     AE + ++ + +  +V+++ +
Sbjct: 22  GNFGTVKKGYY-QMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGI 80
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGA-DKTVEAPKCLNFLQRINIAIDVACA 524
           C    +       LV E    G L ++L       DK +           I +   V+  
Sbjct: 81  CEAESW------MLVMEMAELGPLNKYLQQNRHVKDKNI-----------IELVHQVSMG 123
Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL-PPAHLQTSSIGVKGTIGY 583
           +KYL    +    H DL   NVLL  +  A ++DFGL+K L    +   +    K  + +
Sbjct: 124 MKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKW 180
Query: 584 IAPAEYGLGSEVSINGDVYSYGILLLELMT 613
            AP       + S   DV+S+G+L+ E  +
Sbjct: 181 YAPECINY-YKFSSKSDVWSFGVLMWEAFS 209

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 91/204 (44%), Gaps = 19/204 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           GSFG VY+  L +   ++A+K   +L   A K+   E   +R + H N+V++        
Sbjct: 31  GSFGVVYQAKLCDSGELVAIK--KVLQGKAFKNR--ELQIMRKLDHCNIVRLRYFFYSSG 86
Query: 471 YKGDD-FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH 529
            K D+ +  LV +++         H  S A +T+       ++ ++        +L Y+H
Sbjct: 87  EKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQL------FRSLAYIH 139
Query: 530 HDCQPTTAHCDLKPSNVLLDHEMTA-HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAE 588
                   H D+KP N+LLD +     + DFG AK L       S I  +    Y AP  
Sbjct: 140 SF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR---YYRAPEL 193
Query: 589 YGLGSEVSINGDVYSYGILLLELM 612
               ++ + + DV+S G +L EL+
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELL 217

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 49/104 (47%), Gaps = 15/104 (14%)
Query: 518 AIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLA----KLLPPAHLQTS 573
           A ++   L+++H+       + DLKP+N+LLD      ++D GLA    K  P A +   
Sbjct: 298 AAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--- 351
Query: 574 SIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
                GT GY+AP     G     + D +S G +L +L+    P
Sbjct: 352 -----GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 49/104 (47%), Gaps = 15/104 (14%)
Query: 518 AIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLA----KLLPPAHLQTS 573
           A ++   L+++H+       + DLKP+N+LLD      ++D GLA    K  P A +   
Sbjct: 298 AAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--- 351
Query: 574 SIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
                GT GY+AP     G     + D +S G +L +L+    P
Sbjct: 352 -----GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 49/104 (47%), Gaps = 15/104 (14%)
Query: 518 AIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLA----KLLPPAHLQTS 573
           A ++   L+++H+       + DLKP+N+LLD      ++D GLA    K  P A +   
Sbjct: 298 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--- 351
Query: 574 SIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
                GT GY+AP     G     + D +S G +L +L+    P
Sbjct: 352 -----GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 88/212 (41%), Gaps = 30/212 (14%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA-ECSALRNI-RHKNLVKILTVCSG 468
           G++G VYKG   +   + A+KV+++   G  +  I  E + L+    H+N+         
Sbjct: 35  GTYGQVYKGRHVKTGQLAAIKVMDVT--GDEEEEIKQEINMLKKYSHHRNIATYYGAFIK 92
Query: 469 VDYKG-DDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
            +  G DD   LV EF   GS+ + +    G           N L+   IA      L+ 
Sbjct: 93  KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG-----------NTLKEEWIAYICREILRG 141
Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK----GTIGY 583
           L H  Q    H D+K  NVLL       + DFG++  L        ++G +    GT  +
Sbjct: 142 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL------DRTVGRRNTFIGTPYW 195
Query: 584 IAPA----EYGLGSEVSINGDVYSYGILLLEL 611
           +AP     +    +      D++S GI  +E+
Sbjct: 196 MAPEVIACDENPDATYDFKSDLWSLGITAIEM 227

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 92/217 (42%), Gaps = 41/217 (18%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV        +  +AVK L+     L+H   ++ +  E   L++++H+N++ +L V
Sbjct: 39  GAYGSVCSAYDARLRQKVAVKKLSRPFQSLIH---ARRTYRELRLLKHLKHENVIGLLDV 95
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
            +      D  +  +   +    L   +   + +D+ V+      FL        +   L
Sbjct: 96  FTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQ------FL-----VYQLLRGL 144
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
           KY+H        H DLKPSNV ++ +    + DFGLA+            G   T  Y A
Sbjct: 145 KYIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLAR-----QADEEMTGYVATRWYRA 196
Query: 586 PAEYGLGSEVSING-------DVYSYGILLLELMTRK 615
           P       E+ +N        D++S G ++ EL+  K
Sbjct: 197 P-------EIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 49/104 (47%), Gaps = 15/104 (14%)
Query: 518 AIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLA----KLLPPAHLQTS 573
           A ++   L+++H+       + DLKP+N+LLD      ++D GLA    K  P A +   
Sbjct: 297 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--- 350
Query: 574 SIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
                GT GY+AP     G     + D +S G +L +L+    P
Sbjct: 351 -----GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 389

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/209 (22%), Positives = 86/209 (41%), Gaps = 24/209 (11%)
Query: 408 IDMGSFGSVYKGIL---DEGKTIIAVKVL-NLLHHGASKSSIAECSALRNIRHKNLVKIL 463
           I  G FG V++GI    +     +A+K   N       +  + E   +R   H ++VK++
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            V +      ++   ++ E    G L  +L     +         L+    I  A  ++ 
Sbjct: 78  GVIT------ENPVWIIMELCTLGELRSFLQVRKFS---------LDLASLILYAYQLST 122
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGY 583
           AL YL         H D+   NVL+       + DFGL++ +  +    +S G K  I +
Sbjct: 123 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKG-KLPIKW 178
Query: 584 IAPAEYGLGSEVSINGDVYSYGILLLELM 612
           +AP         S + DV+ +G+ + E++
Sbjct: 179 MAPESINFRRFTSAS-DVWMFGVCMWEIL 206

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 91/204 (44%), Gaps = 19/204 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           GSFG VY+  L +   ++A+K   +L   A K+   E   +R + H N+V++        
Sbjct: 31  GSFGVVYQAKLCDSGELVAIK--KVLQGKAFKNR--ELQIMRKLDHCNIVRLRYFFYSSG 86
Query: 471 YKGDD-FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH 529
            K D+ +  LV +++         H  S A +T+       ++ ++        +L Y+H
Sbjct: 87  EKKDEVYLNLVLDYVPATVYRVARH-YSRAKQTLPVIYVKLYMYQL------FRSLAYIH 139
Query: 530 HDCQPTTAHCDLKPSNVLLDHEMTA-HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAE 588
                   H D+KP N+LLD +     + DFG AK L       S I  +    Y AP  
Sbjct: 140 SF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR---YYRAPEL 193
Query: 589 YGLGSEVSINGDVYSYGILLLELM 612
               ++ + + DV+S G +L EL+
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELL 217

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 82/185 (44%), Gaps = 35/185 (18%)
Query: 411 GSFGSVYKGILDEGK---TIIAVK-VLNLLHHGASKSSIAECSALRNIRHKNLVKILTVC 466
           G+F  V   IL E K    ++A+K +      G   S   E + L  I+H N+V +  + 
Sbjct: 29  GAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDI- 84
Query: 467 SGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQR--INIAIDVACA 524
               Y+      L+ + +  G L          D+ VE      + +R    +   V  A
Sbjct: 85  ----YESGGHLYLIMQLVSGGEL---------FDRIVEKG---FYTERDASRLIFQVLDA 128
Query: 525 LKYLHHDCQPTTAHCDLKPSNVL---LDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTI 581
           +KYLH        H DLKP N+L   LD +    ++DFGL+K+  P  + +++    GT 
Sbjct: 129 VKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC---GTP 182
Query: 582 GYIAP 586
           GY+AP
Sbjct: 183 GYVAP 187

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 45/208 (21%), Positives = 92/208 (44%), Gaps = 10/208 (4%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G  G V+  + ++    +A+K + L    + K ++ E   +R + H N+VK+  +     
Sbjct: 22  GGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSG 81
Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
            +  D    + E      ++E++   +     +E    L    R+     +   LKY+H 
Sbjct: 82  SQLTDDVGSLTELNSVYIVQEYME--TDLANVLEQGPLLEEHARL-FMYQLLRGLKYIH- 137
Query: 531 DCQPTTAHCDLKPSNVLLDHE-MTAHVADFGLAKLLPPAHLQTSSIGVKG--TIGYIAPA 587
                  H DLKP+N+ ++ E +   + DFGLA+++ P +     +  +G  T  Y +P 
Sbjct: 138 --SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS-EGLVTKWYRSPR 194
Query: 588 EYGLGSEVSINGDVYSYGILLLELMTRK 615
                +  +   D+++ G +  E++T K
Sbjct: 195 LLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 82/185 (44%), Gaps = 35/185 (18%)
Query: 411 GSFGSVYKGILDEGK---TIIAVK-VLNLLHHGASKSSIAECSALRNIRHKNLVKILTVC 466
           G+F  V   IL E K    ++A+K +      G   S   E + L  I+H N+V +  + 
Sbjct: 29  GAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDI- 84
Query: 467 SGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQR--INIAIDVACA 524
               Y+      L+ + +  G L          D+ VE      + +R    +   V  A
Sbjct: 85  ----YESGGHLYLIMQLVSGGEL---------FDRIVEKG---FYTERDASRLIFQVLDA 128
Query: 525 LKYLHHDCQPTTAHCDLKPSNVL---LDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTI 581
           +KYLH        H DLKP N+L   LD +    ++DFGL+K+  P  + +++    GT 
Sbjct: 129 VKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC---GTP 182
Query: 582 GYIAP 586
           GY+AP
Sbjct: 183 GYVAP 187

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 47/209 (22%), Positives = 86/209 (41%), Gaps = 24/209 (11%)
Query: 408 IDMGSFGSVYKGIL---DEGKTIIAVKVL-NLLHHGASKSSIAECSALRNIRHKNLVKIL 463
           I  G FG V++GI    +     +A+K   N       +  + E   +R   H ++VK++
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            V +      ++   ++ E    G L  +L     +         L+    I  A  ++ 
Sbjct: 78  GVIT------ENPVWIIMELCTLGELRSFLQVRKYS---------LDLASLILYAYQLST 122
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGY 583
           AL YL         H D+   NVL+       + DFGL++ +  +    +S G K  I +
Sbjct: 123 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-KLPIKW 178
Query: 584 IAPAEYGLGSEVSINGDVYSYGILLLELM 612
           +AP         S + DV+ +G+ + E++
Sbjct: 179 MAPESINFRRFTSAS-DVWMFGVCMWEIL 206

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 82/185 (44%), Gaps = 35/185 (18%)
Query: 411 GSFGSVYKGILDEGK---TIIAVK-VLNLLHHGASKSSIAECSALRNIRHKNLVKILTVC 466
           G+F  V   IL E K    ++A+K +      G   S   E + L  I+H N+V +  + 
Sbjct: 29  GAFSEV---ILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI- 84
Query: 467 SGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQR--INIAIDVACA 524
               Y+      L+ + +  G L          D+ VE      + +R    +   V  A
Sbjct: 85  ----YESGGHLYLIMQLVSGGEL---------FDRIVEKG---FYTERDASRLIFQVLDA 128
Query: 525 LKYLHHDCQPTTAHCDLKPSNVL---LDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTI 581
           +KYLH        H DLKP N+L   LD +    ++DFGL+K+  P  + +++    GT 
Sbjct: 129 VKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC---GTP 182
Query: 582 GYIAP 586
           GY+AP
Sbjct: 183 GYVAP 187

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 93/210 (44%), Gaps = 29/210 (13%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSI-----AECSALRNIRHKNLVKILTV 465
           G+FG+V KG   + K ++    + +L + A+  ++     AE + ++ + +  +V+++ +
Sbjct: 380 GNFGTVKKGYY-QMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGI 438
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSG-ADKTVEAPKCLNFLQRINIAIDVACA 524
           C    +       LV E    G L ++L       DK +           I +   V+  
Sbjct: 439 CEAESW------MLVMEMAELGPLNKYLQQNRHVKDKNI-----------IELVHQVSMG 481
Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL-PPAHLQTSSIGVKGTIGY 583
           +KYL    +    H DL   NVLL  +  A ++DFGL+K L    +   +    K  + +
Sbjct: 482 MKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 538
Query: 584 IAPAEYGLGSEVSINGDVYSYGILLLELMT 613
            AP       + S   DV+S+G+L+ E  +
Sbjct: 539 YAPECINY-YKFSSKSDVWSFGVLMWEAFS 567

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 47/209 (22%), Positives = 86/209 (41%), Gaps = 24/209 (11%)
Query: 408 IDMGSFGSVYKGIL---DEGKTIIAVKVL-NLLHHGASKSSIAECSALRNIRHKNLVKIL 463
           I  G FG V++GI    +     +A+K   N       +  + E   +R   H ++VK++
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            V +      ++   ++ E    G L  +L     +         L+    I  A  ++ 
Sbjct: 106 GVIT------ENPVWIIMELCTLGELRSFLQVRKYS---------LDLASLILYAYQLST 150
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGY 583
           AL YL         H D+   NVL+       + DFGL++ +  +    +S G K  I +
Sbjct: 151 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-KLPIKW 206
Query: 584 IAPAEYGLGSEVSINGDVYSYGILLLELM 612
           +AP         S + DV+ +G+ + E++
Sbjct: 207 MAPESINFRRFTSAS-DVWMFGVCMWEIL 234

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 41/81 (50%), Gaps = 11/81 (13%)
Query: 538 HCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQT-SSIGVKGT----IGYIAPAEYGLG 592
           H DL   N+LL H     + DFGLA+     H++  S+  VKG     + ++AP E    
Sbjct: 191 HRDLAARNILLTHGRITKICDFGLAR-----HIKNDSNYVVKGNARLPVKWMAP-ESIFN 244
Query: 593 SEVSINGDVYSYGILLLELMT 613
              +   DV+SYGI L EL +
Sbjct: 245 CVYTFESDVWSYGIFLWELFS 265

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 82/185 (44%), Gaps = 35/185 (18%)
Query: 411 GSFGSVYKGILDEGK---TIIAVK-VLNLLHHGASKSSIAECSALRNIRHKNLVKILTVC 466
           G+F  V   IL E K    ++A+K +      G   S   E + L  I+H N+V +  + 
Sbjct: 29  GAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDI- 84
Query: 467 SGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQR--INIAIDVACA 524
               Y+      L+ + +  G L          D+ VE      + +R    +   V  A
Sbjct: 85  ----YESGGHLYLIMQLVSGGEL---------FDRIVEKG---FYTERDASRLIFQVLDA 128
Query: 525 LKYLHHDCQPTTAHCDLKPSNVL---LDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTI 581
           +KYLH        H DLKP N+L   LD +    ++DFGL+K+  P  + +++    GT 
Sbjct: 129 VKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC---GTP 182
Query: 582 GYIAP 586
           GY+AP
Sbjct: 183 GYVAP 187

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 94/255 (36%), Gaps = 36/255 (14%)
Query: 405 LCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSS--IAECSALRNIRHKNLVKI 462
           +C +  GSFG V K      +   AVKV+N        +S  + E   L+ + H N++K+
Sbjct: 27  VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQR--INIAID 520
             +                 F   G L       +G +   E  K   F +     I   
Sbjct: 87  FEILEDSS-----------SFYIVGEL------YTGGELFDEIIKRKRFSEHDAARIIKQ 129
Query: 521 VACALKYLHHDCQPTTAHCDLKPSNVLL---DHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           V   + Y+H   +    H DLKP N+LL   + +    + DFGL+            I  
Sbjct: 130 VFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI-- 184
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLP 637
            GT  YIAP    L        DV+S G++L  L++   P    F G        R    
Sbjct: 185 -GTAYYIAPE--VLRGTYDEKCDVWSAGVILYILLSGTPP----FYGKNEYDILKRVETG 237
Query: 638 DHVMDIVDSTLLADD 652
            +  D+     ++DD
Sbjct: 238 KYAFDLPQWRTISDD 252

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 91/218 (41%), Gaps = 27/218 (12%)
Query: 411 GSFGSVYKGI---LDEGKTIIAVKVLNLLHHGASKSS----IAECSALRNI-RHKNLVKI 462
           G+FG V +     +D+  T   V V  +L  GA+ S     ++E   L +I  H N+V +
Sbjct: 40  GAFGQVIEADAFGIDKTATXRTVAV-KMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 98
Query: 463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLH-------PVSGADKTVEAPKCLNFLQRI 515
           L  C+    K      ++ EF   G+L  +L        P    D   +    L     I
Sbjct: 99  LGACT----KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKD---FLTLEHLI 151
Query: 516 NIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSI 575
             +  VA  +++L         H DL   N+LL  +    + DFGLA+ +          
Sbjct: 152 XYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 208
Query: 576 GVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
             +  + ++AP E       +I  DV+S+G+LL E+ +
Sbjct: 209 DARLPLKWMAP-ETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 47/209 (22%), Positives = 86/209 (41%), Gaps = 24/209 (11%)
Query: 408 IDMGSFGSVYKGIL---DEGKTIIAVKVL-NLLHHGASKSSIAECSALRNIRHKNLVKIL 463
           I  G FG V++GI    +     +A+K   N       +  + E   +R   H ++VK++
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            V +      ++   ++ E    G L  +L     +         L+    I  A  ++ 
Sbjct: 78  GVIT------ENPVWIIMELCTLGELRSFLQVRKYS---------LDLASLILYAYQLST 122
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGY 583
           AL YL         H D+   NVL+       + DFGL++ +  +    +S G K  I +
Sbjct: 123 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-KLPIKW 178
Query: 584 IAPAEYGLGSEVSINGDVYSYGILLLELM 612
           +AP         S + DV+ +G+ + E++
Sbjct: 179 MAPESINFRRFTSAS-DVWMFGVCMWEIL 206

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 90/204 (44%), Gaps = 19/204 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           GSFG VY+  L +   ++A+K   +L     K+   E   +R + H N+V++        
Sbjct: 31  GSFGVVYQAKLCDSGELVAIK--KVLQDKRFKNR--ELQIMRKLDHCNIVRLRYFFYSSG 86
Query: 471 YKGDD-FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH 529
            K D+ +  LV +++         H  S A +T+       ++ ++        +L Y+H
Sbjct: 87  EKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQL------FRSLAYIH 139
Query: 530 HDCQPTTAHCDLKPSNVLLDHEMTA-HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAE 588
                   H D+KP N+LLD +     + DFG AK L       S I  +    Y AP  
Sbjct: 140 SF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR---YYRAPEL 193
Query: 589 YGLGSEVSINGDVYSYGILLLELM 612
               ++ + + DV+S G +L EL+
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELL 217

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 90/204 (44%), Gaps = 19/204 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           GSFG VY+  L +   ++A+K   +L     K+   E   +R + H N+V++        
Sbjct: 32  GSFGVVYQAKLCDSGELVAIK--KVLQDKRFKNR--ELQIMRKLDHCNIVRLRYFFYSSG 87
Query: 471 YKGDD-FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH 529
            K D+ +  LV +++         H  S A +T+       ++ ++        +L Y+H
Sbjct: 88  EKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQL------FRSLAYIH 140
Query: 530 HDCQPTTAHCDLKPSNVLLDHEMTA-HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAE 588
                   H D+KP N+LLD +     + DFG AK L       S I  +    Y AP  
Sbjct: 141 SF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR---YYRAPEL 194
Query: 589 YGLGSEVSINGDVYSYGILLLELM 612
               ++ + + DV+S G +L EL+
Sbjct: 195 IFGATDYTSSIDVWSAGCVLAELL 218

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 47/209 (22%), Positives = 86/209 (41%), Gaps = 24/209 (11%)
Query: 408 IDMGSFGSVYKGIL---DEGKTIIAVKVL-NLLHHGASKSSIAECSALRNIRHKNLVKIL 463
           I  G FG V++GI    +     +A+K   N       +  + E   +R   H ++VK++
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            V +      ++   ++ E    G L  +L     +         L+    I  A  ++ 
Sbjct: 78  GVIT------ENPVWIIMELCTLGELRSFLQVRKFS---------LDLASLILYAYQLST 122
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGY 583
           AL YL         H D+   NVL+       + DFGL++ +  +    +S G K  I +
Sbjct: 123 ALAYLESK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKG-KLPIKW 178
Query: 584 IAPAEYGLGSEVSINGDVYSYGILLLELM 612
           +AP         S + DV+ +G+ + E++
Sbjct: 179 MAPESINFRRFTSAS-DVWMFGVCMWEIL 206

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 90/204 (44%), Gaps = 19/204 (9%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           GSFG VY+  L +   ++A+K   +L     K+   E   +R + H N+V++        
Sbjct: 31  GSFGVVYQAKLCDSGELVAIK--KVLQDKRFKNR--ELQIMRKLDHCNIVRLRYFFYSSG 86
Query: 471 YKGDD-FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH 529
            K D+ +  LV +++         H  S A +T+       ++ ++        +L Y+H
Sbjct: 87  EKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQL------FRSLAYIH 139
Query: 530 HDCQPTTAHCDLKPSNVLLDHEMTA-HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAE 588
                   H D+KP N+LLD +     + DFG AK L       S I  +    Y AP  
Sbjct: 140 SF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR---YYRAPEL 193
Query: 589 YGLGSEVSINGDVYSYGILLLELM 612
               ++ + + DV+S G +L EL+
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELL 217

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 47/209 (22%), Positives = 86/209 (41%), Gaps = 24/209 (11%)
Query: 408 IDMGSFGSVYKGIL---DEGKTIIAVKVL-NLLHHGASKSSIAECSALRNIRHKNLVKIL 463
           I  G FG V++GI    +     +A+K   N       +  + E   +R   H ++VK++
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            V +      ++   ++ E    G L  +L     +         L+    I  A  ++ 
Sbjct: 81  GVIT------ENPVWIIMELCTLGELRSFLQVRKYS---------LDLASLILYAYQLST 125
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGY 583
           AL YL         H D+   NVL+       + DFGL++ +  +    +S G K  I +
Sbjct: 126 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-KLPIKW 181
Query: 584 IAPAEYGLGSEVSINGDVYSYGILLLELM 612
           +AP         S + DV+ +G+ + E++
Sbjct: 182 MAPESINFRRFTSAS-DVWMFGVCMWEIL 209

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 47/209 (22%), Positives = 86/209 (41%), Gaps = 24/209 (11%)
Query: 408 IDMGSFGSVYKGIL---DEGKTIIAVKVL-NLLHHGASKSSIAECSALRNIRHKNLVKIL 463
           I  G FG V++GI    +     +A+K   N       +  + E   +R   H ++VK++
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            V +      ++   ++ E    G L  +L     +         L+    I  A  ++ 
Sbjct: 80  GVIT------ENPVWIIMELCTLGELRSFLQVRKYS---------LDLASLILYAYQLST 124
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGY 583
           AL YL         H D+   NVL+       + DFGL++ +  +    +S G K  I +
Sbjct: 125 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-KLPIKW 180
Query: 584 IAPAEYGLGSEVSINGDVYSYGILLLELM 612
           +AP         S + DV+ +G+ + E++
Sbjct: 181 MAPESINFRRFTSAS-DVWMFGVCMWEIL 208

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 94/255 (36%), Gaps = 36/255 (14%)
Query: 405 LCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSS--IAECSALRNIRHKNLVKI 462
           +C +  GSFG V K      +   AVKV+N        +S  + E   L+ + H N++K+
Sbjct: 27  VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQR--INIAID 520
             +                 F   G L       +G +   E  K   F +     I   
Sbjct: 87  FEILEDSS-----------SFYIVGEL------YTGGELFDEIIKRKRFSEHDAARIIKQ 129
Query: 521 VACALKYLHHDCQPTTAHCDLKPSNVLL---DHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           V   + Y+H   +    H DLKP N+LL   + +    + DFGL+            I  
Sbjct: 130 VFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI-- 184
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLP 637
            GT  YIAP    L        DV+S G++L  L++   P    F G        R    
Sbjct: 185 -GTAYYIAPE--VLRGTYDEKCDVWSAGVILYILLSGTPP----FYGKNEYDILKRVETG 237
Query: 638 DHVMDIVDSTLLADD 652
            +  D+     ++DD
Sbjct: 238 KYAFDLPQWRTISDD 252

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 19/215 (8%)
Query: 400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNL 459
           VS+     I  GSFG VY+  L +   ++A+K   +L     K+   E   +R + H N+
Sbjct: 32  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKNR--ELQIMRKLDHCNI 87
Query: 460 VKILTVCSGVDYKGDD-FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIA 518
           V++         K D+ +  LV +++         H  S A +T+       ++ ++   
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQL--- 143
Query: 519 IDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTA-HVADFGLAKLLPPAHLQTSSIGV 577
                +L Y+H        H D+KP N+LLD +     + DFG AK L       S I  
Sbjct: 144 ---FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICS 197
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELM 612
           +    Y AP      ++ + + DV+S G +L EL+
Sbjct: 198 R---YYRAPELIFGATDYTSSIDVWSAGCVLAELL 229

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 94/255 (36%), Gaps = 36/255 (14%)
Query: 405 LCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSS--IAECSALRNIRHKNLVKI 462
           +C +  GSFG V K      +   AVKV+N        +S  + E   L+ + H N++K+
Sbjct: 27  VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQR--INIAID 520
             +                 F   G L       +G +   E  K   F +     I   
Sbjct: 87  FEILEDSS-----------SFYIVGEL------YTGGELFDEIIKRKRFSEHDAARIIKQ 129
Query: 521 VACALKYLHHDCQPTTAHCDLKPSNVLL---DHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           V   + Y+H   +    H DLKP N+LL   + +    + DFGL+            I  
Sbjct: 130 VFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI-- 184
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLP 637
            GT  YIAP    L        DV+S G++L  L++   P    F G        R    
Sbjct: 185 -GTAYYIAPE--VLRGTYDEKCDVWSAGVILYILLSGTPP----FYGKNEYDILKRVETG 237
Query: 638 DHVMDIVDSTLLADD 652
            +  D+     ++DD
Sbjct: 238 KYAFDLPQWRTISDD 252

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 47/209 (22%), Positives = 86/209 (41%), Gaps = 24/209 (11%)
Query: 408 IDMGSFGSVYKGIL---DEGKTIIAVKVL-NLLHHGASKSSIAECSALRNIRHKNLVKIL 463
           I  G FG V++GI    +     +A+K   N       +  + E   +R   H ++VK++
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            V +      ++   ++ E    G L  +L     +         L+    I  A  ++ 
Sbjct: 83  GVIT------ENPVWIIMELCTLGELRSFLQVRKYS---------LDLASLILYAYQLST 127
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGY 583
           AL YL         H D+   NVL+       + DFGL++ +  +    +S G K  I +
Sbjct: 128 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-KLPIKW 183
Query: 584 IAPAEYGLGSEVSINGDVYSYGILLLELM 612
           +AP         S + DV+ +G+ + E++
Sbjct: 184 MAPESINFRRFTSAS-DVWMFGVCMWEIL 211

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 93/210 (44%), Gaps = 29/210 (13%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSI-----AECSALRNIRHKNLVKILTV 465
           G+FG+V KG   + K ++    + +L + A+  ++     AE + ++ + +  +V+++ +
Sbjct: 381 GNFGTVKKGYY-QMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGI 439
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSG-ADKTVEAPKCLNFLQRINIAIDVACA 524
           C    +       LV E    G L ++L       DK +           I +   V+  
Sbjct: 440 CEAESW------MLVMEMAELGPLNKYLQQNRHVKDKNI-----------IELVHQVSMG 482
Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL-PPAHLQTSSIGVKGTIGY 583
           +KYL    +    H DL   NVLL  +  A ++DFGL+K L    +   +    K  + +
Sbjct: 483 MKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 539
Query: 584 IAPAEYGLGSEVSINGDVYSYGILLLELMT 613
            AP       + S   DV+S+G+L+ E  +
Sbjct: 540 YAPECINY-YKFSSKSDVWSFGVLMWEAFS 568

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 98/219 (44%), Gaps = 27/219 (12%)
Query: 411 GSFGSVYKGI---LDEGKTIIAVKVLNLLHHGASKSS----IAECSALRNI-RHKNLVKI 462
           G+FG V +     +D+  T   V V  +L  GA+ S     ++E   L +I  H N+V +
Sbjct: 38  GAFGQVIEADAFGIDKTATCRTVAV-KMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96
Query: 463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVE---APKCL--NFL---QR 514
           L  C+    K      ++ EF   G+L  +L   S  ++ V    AP+ L  +FL     
Sbjct: 97  LGACT----KPGGPLMVIVEFCKFGNLSTYLR--SKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 515 INIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSS 574
           I  +  VA  +++L         H DL   N+LL  +    + DFGLA+ +         
Sbjct: 151 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 207
Query: 575 IGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
              +  + ++AP E       +I  DV+S+G+LL E+ +
Sbjct: 208 GDARLPLKWMAP-ETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 47/209 (22%), Positives = 86/209 (41%), Gaps = 24/209 (11%)
Query: 408 IDMGSFGSVYKGIL---DEGKTIIAVKVL-NLLHHGASKSSIAECSALRNIRHKNLVKIL 463
           I  G FG V++GI    +     +A+K   N       +  + E   +R   H ++VK++
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            V +      ++   ++ E    G L  +L     +         L+    I  A  ++ 
Sbjct: 75  GVIT------ENPVWIIMELCTLGELRSFLQVRKYS---------LDLASLILYAYQLST 119
Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGY 583
           AL YL         H D+   NVL+       + DFGL++ +  +    +S G K  I +
Sbjct: 120 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-KLPIKW 175
Query: 584 IAPAEYGLGSEVSINGDVYSYGILLLELM 612
           +AP         S + DV+ +G+ + E++
Sbjct: 176 MAPESINFRRFTSAS-DVWMFGVCMWEIL 203

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 93/232 (40%), Gaps = 32/232 (13%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVL---NLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           G FG+VY     +   I+A+KVL    +   G       E     ++ H N++++     
Sbjct: 34  GKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLY---- 89
Query: 468 GVDYKGDDFK-ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALK 526
             +Y  D  +  L+ E+   G L + L      D+   A           I  ++A AL 
Sbjct: 90  --NYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTA----------TIMEELADALM 137
Query: 527 YLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP 586
           Y H        H D+KP N+LL  +    +ADFG +   P    +T      GT+ Y+ P
Sbjct: 138 YCHGK---KVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTMC----GTLDYL-P 189
Query: 587 AEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPD 638
            E   G   +   D++  G+L  EL+    P    FE   +   + R V  D
Sbjct: 190 PEMIEGRMHNEKVDLWCIGVLCYELLVGNPP----FESASHNETYRRIVKVD 237

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 19/215 (8%)
Query: 400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNL 459
           VS+     I  GSFG VY+  L +   ++A+K   +L     K+   E   +R + H N+
Sbjct: 39  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKNR--ELQIMRKLDHCNI 94
Query: 460 VKILTVCSGVDYKGDD-FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIA 518
           V++         K D+ +  LV +++         H  S A +T+       ++ ++   
Sbjct: 95  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQL--- 150
Query: 519 IDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTA-HVADFGLAKLLPPAHLQTSSIGV 577
                +L Y+H        H D+KP N+LLD +     + DFG AK L       S I  
Sbjct: 151 ---FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICS 204
Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELM 612
           +    Y AP      ++ + + DV+S G +L EL+
Sbjct: 205 R---YYRAPELIFGATDYTSSIDVWSAGCVLAELL 236

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 92/217 (42%), Gaps = 41/217 (18%)
Query: 411 GSFGSVYKGILDEGKTIIAVKVLN-----LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G++GSV        +  +AVK L+     L+H   ++ +  E   L++++H+N++ +L V
Sbjct: 39  GAYGSVCSAYDARLRQKVAVKKLSRPFQSLIH---ARRTYRELRLLKHLKHENVIGLLDV 95
Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
            +      D  +  +   +    L   +   + +D+ V+      FL        +   L
Sbjct: 96  FTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQ------FL-----VYQLLRGL 144
Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
           KY+H        H DLKPSNV ++ +    + DFGLA+            G   T  Y A
Sbjct: 145 KYIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLAR-----QADEEMTGYVATRWYRA 196
Query: 586 PAEYGLGSEVSING-------DVYSYGILLLELMTRK 615
           P       E+ +N        D++S G ++ EL+  K
Sbjct: 197 P-------EIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	741
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	8e-98
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-84
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-75
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-72
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-54
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-96
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-55
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	8e-25
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-23
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-71
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	8e-63
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-60
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-56
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-55
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	6e-55
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	5e-54
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	7e-54
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-53
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-48
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	7e-43
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-37
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	7e-55
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	9e-52
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-51
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-48
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-43
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-36
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-48
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-47
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-41
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-41
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-37
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-37
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-30
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-48
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	7e-46
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	7e-45
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-40
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-34
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-27
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-23
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-48
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-47
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-47
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-46
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-44
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-31
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	6e-30
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-10
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-07
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-44
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-42
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-42
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	9e-42
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-41
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-41
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-40
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	5e-30
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	7e-25
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-41
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-41
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-37
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-34
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-17
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-40
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-40
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-40
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-39
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-37
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-31
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-29
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-22
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-39
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	5e-39
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	8e-39
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-38
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-35
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-25
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-24
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-38
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	5e-38
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-37
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	7e-35
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-33
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-32
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-29
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-29
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	5e-23
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-21
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	6e-17
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	7e-16
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	7e-09
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	5e-37
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-36
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	5e-33
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-32
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	7e-36
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-35
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-35
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-33
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	5e-31
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-24
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-17
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-35
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	4e-27
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-22
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	7e-35
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-28
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-24
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	8e-10
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-33
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-25
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-21
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-32
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-26
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-25
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-25
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-23
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	7e-32
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	8e-29
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-25
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-25
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-19
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-09
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-31
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-23
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	9e-13
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-31
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-27
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-27
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-23
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-23
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	6e-21
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-08
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-29
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-28
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	7e-28
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	8e-27
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-25
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-25
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-21
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-21
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-20
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-15
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-09
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-28
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-27
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-25
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	9e-07
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-27
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-27
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	7e-07
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-27
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-25
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-10
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	5e-27
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	6e-27
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	7e-27
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	8e-27
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	9e-27
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-26
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-26
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-26
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-26
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-26
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	4e-26
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	5e-26
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	5e-22
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	5e-05
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	8e-26
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-25
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-25
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-25
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	4e-25
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	5e-25
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	6e-25
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	7e-25
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	8e-25
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	8e-25
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	9e-25
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-24
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-24
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-24
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-24
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-24
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-24
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-24
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-24
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	4e-22
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	7e-11
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-04
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-24
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-21
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-18
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-17
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-24
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	4e-24
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-21
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-19
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-24
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	5e-24
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-23
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-23
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-23
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-23
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-23
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	3e-23
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	5e-23
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	6e-19
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	4e-23
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	4e-23
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-23
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	6e-23
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	6e-23
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-20
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-10
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	6e-23
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	9e-19
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-12
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-11
4aoj_A	329	High affinity nerve growth factor receptor; transf	7e-23
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	9e-23
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-21
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	6e-18
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	9e-23
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	9e-23
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-20
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-17
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-22
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-22
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-22
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-22
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	4e-22
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-22
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-22
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	6e-22
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	7e-22
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	8e-22
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-18
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-10
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	8e-22
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	9e-22
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-21
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-21
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-21
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-21
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-21
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	4e-21
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-21
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	5e-21
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	6e-21
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-18
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	5e-15
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-12
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-10
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	7e-07
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	5e-06
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	6e-21
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	7e-21
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	7e-21
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	8e-21
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	8e-21
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-19
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	8e-18
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-16
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-16
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-15
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	8e-13
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-20
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-20
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-20
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-20
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-20
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-20
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	5e-20
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	6e-20
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	8e-20
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	7e-18
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-10
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-19
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-19
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-19
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-19
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-19
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-19
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-19
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	4e-18
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-19
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-19
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-18
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-18
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-18
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-12
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	6e-08
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	4e-18
3fme_A	290	Dual specificity mitogen-activated protein kinase;	6e-18
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-17
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-17
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-17
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-17
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	4e-17
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	7e-12
2dyl_A	318	Dual specificity mitogen-activated protein kinase	5e-17
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	6e-17
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	7e-17
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	7e-17
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-16
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-16
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-16
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	7e-15
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	7e-14
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	7e-13
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-16
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-16
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-16
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	5e-16
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	6e-16
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	7e-16
3niz_A	311	Rhodanese family protein; structural genomics, str	8e-16
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-15
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	1e-15
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	4e-12
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	8e-12
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-15
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-15
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-15
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-13
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-13
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	4e-12
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-15
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-15
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-15
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-15
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	4e-15
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	4e-15
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	2e-12
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	4e-15
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-12
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	4e-12
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-11
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-05
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	5e-15
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	9e-15
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	9e-15
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-14
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-14
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	7e-14
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-14
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-14
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-14
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-14
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-14
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-14
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-14
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-14
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	4e-14
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	5e-14
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	8e-14
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	8e-14
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	9e-14
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-13
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-13
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-13
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-13
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-13
3m19_A	251	Variable lymphocyte receptor A diversity region; a	6e-10
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-09
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-06
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-13
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-13
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-08
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-08
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	4e-08
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-13
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-13
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-13
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	3e-13
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-13
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	4e-09
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-13
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-13
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	4e-13
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	5e-13
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	5e-13
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	6e-13
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	3e-09
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	6e-08
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-06
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	3e-05
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	7e-13
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	8e-13
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	9e-13
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-12
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-12
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-12
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-12
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-12
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-12
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	3e-12
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	1e-08
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-12
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-12
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-12
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-12
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	4e-12
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	5e-12
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	6e-12
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	8e-12
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	9e-12
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-11
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-11
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-11
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-11
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-11
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-11
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-11
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-11
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-11
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-11
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	4e-11
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	5e-11
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	5e-11
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	6e-11
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	7e-11
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	8e-11
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-10
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-10
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-10
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-10
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-10
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-10
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-10
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-10
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-10
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-10
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-10
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-10
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-10
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	6e-10
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-07
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-06
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	6e-05
3uqc_A	286	Probable conserved transmembrane protein; structur	6e-10
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-09
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-09
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-09
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-09
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-09
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-09
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-09
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-09
3e6j_A	229	Variable lymphocyte receptor diversity region; var	3e-09
3e6j_A	229	Variable lymphocyte receptor diversity region; var	4e-06
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-09
3bhy_A	283	Death-associated protein kinase 3; death associate	3e-09
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-09
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	4e-09
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	4e-09
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	5e-09
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	2e-04
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	2e-04
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	6e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-06
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	9e-09
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	3e-07
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-06
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	1e-08
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	6e-04
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	5e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-05
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	4e-05
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	3e-08
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	3e-07
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	3e-07
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	7e-08
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-07
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	3e-07
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	5e-07
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	5e-06
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	2e-07
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-07
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-07
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	8e-04
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	9e-07
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	9e-07
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-06
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-06
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	2e-06
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	4e-04
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	2e-06
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	4e-04
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-06
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	7e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	7e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	1e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-05
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-05
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-05
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-04
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	2e-04
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	2e-04
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-04
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	4e-04
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	6e-04

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  318 bits (817), Expect = 8e-98
 Identities = 104/370 (28%), Positives = 164/370 (44%), Gaps = 23/370 (6%)

Query: 2   DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEV 61
            +  N   G IP         L+ L L FN ++G IPSS+ + SKL   ++  N L GE+
Sbjct: 400 YLQNNGFTGKIPPTLS-NCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEI 458

Query: 62  PSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIP 121
           P E                L+ L ++ N+  G +P  + N +  L  +  ++N++   IP
Sbjct: 459 PQELMYVKT----------LETLILDFNDLTGEIPSGLSNCT-NLNWISLSNNRLTGEIP 507

Query: 122 AGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQL 181
             IG+  NL  L + +N  SG I   +G+ ++L+ L +NTN  +G IP ++      +  
Sbjct: 508 KWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAA 567

Query: 182 YLIENFLQVSIPSSLGQCQSLTTINLSYN--NLSGTIPPQLMDLTSLSVGLDLSRNQLVG 239
               NF+       +         + + N     G    QL  L++ +   +++     G
Sbjct: 568 ----NFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNP-CNITSRVYGG 622

Query: 240 SLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGL 299
                     ++  L +S NML   I   +GS   L  L LG N   G IP  +  LRGL
Sbjct: 623 HTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGL 682

Query: 300 RVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKNASAISVFGNSKLCG 359
            +LDLS N + G IP+ +  L ++  ++LS N+L G IP  G F+         N  LCG
Sbjct: 683 NILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCG 742

Query: 360 GIPEFQLPIC 369
               + LP C
Sbjct: 743 ----YPLPRC 748

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  281 bits (721), Expect = 5e-84
 Identities = 101/363 (27%), Positives = 156/363 (42%), Gaps = 35/363 (9%)

Query: 2   DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIP-SSMFNASKLEVFQVTSNNLTGE 60
           D+  N   G +P  FG +   L  L+L  N  +G +P  ++     L+V  ++ N  +GE
Sbjct: 300 DLSGNHFYGAVPPFFG-SCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGE 358

Query: 61  VPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSIT-LETLIFNSNKIFRS 119
           +P             N +  L  LD+++NNF G +   +C      L+ L   +N     
Sbjct: 359 LPESLT---------NLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGK 409

Query: 120 IPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLL 179
           IP  +     L +LH+  N LSGTI  ++G L  L  L +  N L G IP  +  +K L 
Sbjct: 410 IPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLE 469

Query: 180 QLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVG 239
            L L  N L   IPS L  C +L  I+LS N L+G IP  +  L +L++ L LS N   G
Sbjct: 470 TLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAI-LKLSNNSFSG 528

Query: 240 SLPTEVGKLINLEILFISRNML--------------------ECEILSTLGSCIKLEQLK 279
           ++P E+G   +L  L ++ N+                       +    + +    ++  
Sbjct: 529 NIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECH 588

Query: 280 LGGNL--FQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVI 337
             GNL  FQG     L+ L      +++     G           +  L++SYN L G I
Sbjct: 589 GAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYI 648

Query: 338 PTE 340
           P E
Sbjct: 649 PKE 651

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  257 bits (660), Expect = 2e-75
 Identities = 106/373 (28%), Positives = 158/373 (42%), Gaps = 30/373 (8%)

Query: 2   DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPS--SMFNASKLEVFQVTSNNLTG 59
            +  + + G +   F     +L  L L  N ++G + +  S+ + S L+   V+SN L  
Sbjct: 83  FLSNSHINGSVS-GFK-CSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDF 140

Query: 60  EVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFS--ITLETLIFNSNKIF 117
                 G              L+ LD++ N+  G              L+ L  + NKI 
Sbjct: 141 PGKVSGGL--------KL-NSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKIS 191

Query: 118 RSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKK 177
             +   + + +NL+ L +  N  S  I P +G+   L  L I+ NKLSG+   +I    +
Sbjct: 192 GDVD--VSRCVNLEFLDVSSNNFSTGI-PFLGDCSALQHLDISGNKLSGDFSRAISTCTE 248

Query: 178 LLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLM-DLTSLSVGLDLSRNQ 236
           L  L +  N     IP      +SL  ++L+ N  +G IP  L     +L+  LDLS N 
Sbjct: 249 LKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTG-LDLSGNH 305

Query: 237 LVGSLPTEVGKLINLEILFISRNMLECEI-LSTLGSCIKLEQLKLGGNLFQGPIPLSLSS 295
             G++P   G    LE L +S N    E+ + TL     L+ L L  N F G +P SL++
Sbjct: 306 FYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTN 365

Query: 296 LRG-LRVLDLSQNNISGEIPKFLVELQL--VQNLNLSYNDLEGVIPTEGVFKNASAISV- 351
           L   L  LDLS NN SG I   L +     +Q L L  N   G IP      N S +   
Sbjct: 366 LSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPT--LSNCSELVSL 423

Query: 352 -FGNSKLCGGIPE 363
               + L G IP 
Sbjct: 424 HLSFNYLSGTIPS 436

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  250 bits (641), Expect = 1e-72
 Identities = 100/372 (26%), Positives = 157/372 (42%), Gaps = 24/372 (6%)

Query: 1   SDVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGE 60
           S   +N     +      +L  L  L L  + I G +      ++ L    ++ N+L+G 
Sbjct: 58  SSKPLNVGFSAVSSSLL-SLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGP 115

Query: 61  VPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSI 120
           V +          + +C   LK L++++N               +LE L  ++N I  + 
Sbjct: 116 VTTL-------TSLGSC-SGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGAN 167

Query: 121 PAGI---GKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKK 177
             G         L+ L +  N++SG +   +    NL  L +++N  S  I P +G+   
Sbjct: 168 VVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGI-PFLGDCSA 224

Query: 178 LLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQL 237
           L  L +  N L      ++  C  L  +N+S N   G IPP    L SL   L L+ N+ 
Sbjct: 225 LQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQY-LSLAENKF 281

Query: 238 VGSLPTEV-GKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPL-SLSS 295
            G +P  + G    L  L +S N     +    GSC  LE L L  N F G +P+ +L  
Sbjct: 282 TGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLK 341

Query: 296 LRGLRVLDLSQNNISGEIPKFLVELQL-VQNLNLSYNDLEGVIPTEGVFKNASAISVF-- 352
           +RGL+VLDLS N  SGE+P+ L  L   +  L+LS N+  G I         + +     
Sbjct: 342 MRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYL 401

Query: 353 GNSKLCGGIPEF 364
            N+   G IP  
Sbjct: 402 QNNGFTGKIPPT 413

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  199 bits (508), Expect = 3e-54
 Identities = 74/301 (24%), Positives = 129/301 (42%), Gaps = 22/301 (7%)

Query: 78  NQHLKHLDINNNNF---GGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLH 134
           +  +  +D+++         +   + + +  LE+L  +++ I  S+  G     +L +L 
Sbjct: 49  DDKVTSIDLSSKPLNVGFSAVSSSLLSLT-GLESLFLSNSHINGSVS-GFKCSASLTSLD 106

Query: 135 MWDNQLSGTISPA--IGELQNLVTLAINTNKLSGNIP-PSIGNLKKLLQLYLIENFLQVS 191
           +  N LSG ++    +G    L  L +++N L           L  L  L L  N +  +
Sbjct: 107 LSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGA 166

Query: 192 IPSSL---GQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKL 248
                     C  L  + +S N +SG +   +    +L   LD+S N     +P  +G  
Sbjct: 167 NVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEF-LDVSSNNFSTGIP-FLGDC 222

Query: 249 INLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLS-LSSLRGLRVLDLSQN 307
             L+ L IS N L  +    + +C +L+ L +  N F GPIP   L SL   + L L++N
Sbjct: 223 SALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSL---QYLSLAEN 279

Query: 308 NISGEIPKFLV-ELQLVQNLNLSYNDLEGVIPTE-GVFKNASAISVFGNSKLCGGIPEFQ 365
             +GEIP FL      +  L+LS N   G +P   G      ++++  N+   G +P   
Sbjct: 280 KFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNN-FSGELPMDT 338

Query: 366 L 366
           L
Sbjct: 339 L 339

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  300 bits (772), Expect = 1e-96
 Identities = 84/289 (29%), Positives = 129/289 (44%), Gaps = 10/289 (3%)

Query: 84  LDINNNNFGGLLPGCICNFSITLETLIFNSNKIF--RSIPAGIGKFINLQTLHMWD-NQL 140
            D  N  + G+L       +  +  L  +   +     IP+ +     L  L++   N L
Sbjct: 31  TDCCNRTWLGVLCDTDTQ-TYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNL 89

Query: 141 SGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQ 200
            G I PAI +L  L  L I    +SG IP  +  +K L+ L    N L  ++P S+    
Sbjct: 90  VGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLP 149

Query: 201 SLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNM 260
           +L  I    N +SG IP      + L   + +SRN+L G +P     L NL  + +SRNM
Sbjct: 150 NLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNM 208

Query: 261 LECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVEL 320
           LE +     GS    +++ L  N     +   +   + L  LDL  N I G +P+ L +L
Sbjct: 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQL 267

Query: 321 QLVQNLNLSYNDLEGVIPTEGVFKNASAISVFGNSKLCGGIPEFQLPIC 369
           + + +LN+S+N+L G IP  G  +     +   N  LCG      LP C
Sbjct: 268 KFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP----LPAC 312

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  191 bits (489), Expect = 2e-55
 Identities = 61/261 (23%), Positives = 103/261 (39%), Gaps = 41/261 (15%)

Query: 4   GVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPS 63
           G+N + G IP      L  L +L +    ++G IP  +     L     + N L+G +P 
Sbjct: 85  GINNLVGPIPPAIA-KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPP 143

Query: 64  EFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAG 123
                       +   +L  +  + N   G                         +IP  
Sbjct: 144 SIS---------SL-PNLVGITFDGNRISG-------------------------AIPDS 168

Query: 124 IGKFINLQT-LHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLY 182
            G F  L T + +  N+L+G I P    L NL  + ++ N L G+     G+ K   +++
Sbjct: 169 YGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIH 227

Query: 183 LIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLP 242
           L +N L   +   +G  ++L  ++L  N + GT+P  L  L  L   L++S N L G +P
Sbjct: 228 LAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHS-LNVSFNNLCGEIP 285

Query: 243 TEVGKLINLEILFISRNMLEC 263
              G L   ++   + N   C
Sbjct: 286 QG-GNLQRFDVSAYANNKCLC 305

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  104 bits (263), Expect = 8e-25
 Identities = 43/172 (25%), Positives = 76/172 (44%), Gaps = 17/172 (9%)

Query: 2   DVGVNRVQGGIPLDFGFTLPNLL-FLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGE 60
               NR+ G IP  +G +   L   +++  N++TG IP +  N + L    ++ N L G+
Sbjct: 155 TFDGNRISGAIPDSYG-SFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGD 212

Query: 61  VPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSI 120
               FG           +++ + + +  N+    L   +      L  L   +N+I+ ++
Sbjct: 213 ASVLFGS----------DKNTQKIHLAKNSLAFDLGK-VGLSK-NLNGLDLRNNRIYGTL 260

Query: 121 PAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNK-LSGNIPPS 171
           P G+ +   L +L++  N L G I P  G LQ     A   NK L G+  P+
Sbjct: 261 PQGLTQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDVSAYANNKCLCGSPLPA 311

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  101 bits (253), Expect = 1e-23
 Identities = 44/145 (30%), Positives = 68/145 (46%), Gaps = 5/145 (3%)

Query: 223 LTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNML--ECEILSTLGSCIKLEQLKL 280
           L+S     D      +G L     +   +  L +S   L     I S+L +   L  L +
Sbjct: 24  LSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYI 83

Query: 281 GG-NLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPT 339
           GG N   GPIP +++ L  L  L ++  N+SG IP FL +++ +  L+ SYN L G +P 
Sbjct: 84  GGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPP 143

Query: 340 E-GVFKNASAISVFGNSKLCGGIPE 363
                 N   I+  GN ++ G IP+
Sbjct: 144 SISSLPNLVGITFDGN-RISGAIPD 167

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  235 bits (601), Expect = 2e-71
 Identities = 95/302 (31%), Positives = 146/302 (48%), Gaps = 41/302 (13%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNL-LHHGASKSSIAECSALRNIRHKNLVKILTVCSGV 469
           G FG VYKG L +G T++AVK L      G       E   +    H+NL+++   C   
Sbjct: 41  GGFGKVYKGRLADG-TLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT- 98

Query: 470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH 529
                  + LVY +M NGS+   L     +         L++ +R  IA+  A  L YLH
Sbjct: 99  ----PTERLLVYPYMANGSVASCLRERPESQPP------LDWPKRQRIALGSARGLAYLH 148

Query: 530 HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPA--HLQTSSIGVKGTIGYIAPA 587
             C P   H D+K +N+LLD E  A V DFGLAKL+     H+ T    V+GTIG+IAP 
Sbjct: 149 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT---AVRGTIGHIAP- 204

Query: 588 EYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMF---EGNMNLHNFARTVLPD-HVMDI 643
           EY    + S   DV+ YG++LLEL+T +R  D+     + ++ L ++ + +L +  +  +
Sbjct: 205 EYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEAL 264

Query: 644 VDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHEL 703
           VD  L                  + N   E +  ++++ + C+  SP +R  M+ VV  L
Sbjct: 265 VDVDL------------------QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

Query: 704 QS 705
           + 
Sbjct: 307 EG 308

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  212 bits (541), Expect = 8e-63
 Identities = 83/304 (27%), Positives = 129/304 (42%), Gaps = 42/304 (13%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G FG VYKG+L +G   +A+K          +    E   L   RH +LV ++  C    
Sbjct: 50  GVFGKVYKGVLRDG-AKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE-- 106

Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
               +   L+Y++M NG+L+  L+       +      +++ QR+ I I  A  L YLH 
Sbjct: 107 ---RNEMILIYKYMENGNLKRHLY------GSDLPTMSMSWEQRLEICIGAARGLHYLHT 157

Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPA---HLQTSSIGVKGTIGYIAPA 587
                  H D+K  N+LLD      + DFG++K        HL T    VKGT+GYI P 
Sbjct: 158 RA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST---VVKGTLGYIDP- 210

Query: 588 EYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMF-EGNMNLHNFARTVLPD-HVMDIVD 645
           EY +   ++   DVYS+G++L E++  +           +NL  +A     +  +  IVD
Sbjct: 211 EYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD 270

Query: 646 STLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQS 705
             L                  +I    E L       V C   S +DR +M  V+ +L+ 
Sbjct: 271 PNL----------------ADKIR--PESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312

Query: 706 IKSI 709
              +
Sbjct: 313 ALRL 316

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  205 bits (525), Expect = 1e-60
 Identities = 81/304 (26%), Positives = 130/304 (42%), Gaps = 45/304 (14%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSS----IAECSALRNIRHKNLVKILTVC 466
           G FG VYKG ++   T +AVK L  +    ++        E   +   +H+NLV++L   
Sbjct: 42  GGFGVVYKGYVNN--TTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFS 99

Query: 467 SGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALK 526
           S       D   LVY +M NGSL + L  + G          L++  R  IA   A  + 
Sbjct: 100 SD-----GDDLCLVYVYMPNGSLLDRLSCLDGT-------PPLSWHMRCKIAQGAANGIN 147

Query: 527 YLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP 586
           +LH +      H D+K +N+LLD   TA ++DFGLA+          +  + GT  Y+AP
Sbjct: 148 FLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAP 204

Query: 587 AEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPD--HVMDIV 644
            E   G E++   D+YS+G++LLE++T     D   E    L +    +  +   + D +
Sbjct: 205 -EALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE-PQLLLDIKEEIEDEEKTIEDYI 261

Query: 645 DSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQ 704
           D  +     D   TS +                +  +   C  E    R ++  V   LQ
Sbjct: 262 DKKM----NDADSTSVEA---------------MYSVASQCLHEKKNKRPDIKKVQQLLQ 302

Query: 705 SIKS 708
            + +
Sbjct: 303 EMTA 306

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  195 bits (497), Expect = 1e-56
 Identities = 66/314 (21%), Positives = 123/314 (39%), Gaps = 40/314 (12%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
              G FG V+K  L      +AVK+  +     S  +  E  +L  ++H+N+++ +    
Sbjct: 32  KARGRFGCVWKAQLLN--EYVAVKIFPI-QDKQSWQNEYEVYSLPGMKHENILQFIGAEK 88

Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
                 D    L+  F   GSL ++L               +++ +  +IA  +A  L Y
Sbjct: 89  R-GTSVDVDLWLITAFHEKGSLSDFLKA-----------NVVSWNELCHIAETMARGLAY 136

Query: 528 LHHD-------CQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGT 580
           LH D        +P  +H D+K  NVLL + +TA +ADFGLA           + G  GT
Sbjct: 137 LHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGT 196

Query: 581 IGYIAPAEYGLGSEVSING------DVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART 634
             Y+AP E  L   ++         D+Y+ G++L EL +R   +D   +  M    F   
Sbjct: 197 RRYMAP-EV-LEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM--LPFEEE 252

Query: 635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRM 694
           +     ++ +   ++   +   +    ++           +  +      C     + R+
Sbjct: 253 IGQHPSLEDMQEVVVHKKKRPVLRDYWQKH--------AGMAMLCETIEECWDHDAEARL 304

Query: 695 NMTIVVHELQSIKS 708
           +   V   +  ++ 
Sbjct: 305 SAGCVGERITQMQR 318

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  200 bits (511), Expect = 1e-55
 Identities = 55/354 (15%), Positives = 112/354 (31%), Gaps = 38/354 (10%)

Query: 12  IPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKA 71
           +  D      +L+   +  +     I  S     K       SNN+T  V     + TK 
Sbjct: 150 VDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTK- 207

Query: 72  YCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQ 131
                    L+   + N+ F               E       + +++         +L 
Sbjct: 208 ---------LRQFYMGNSPFVAENICEA------WENENSEYAQQYKTEDLKWDNLKDLT 252

Query: 132 TLHMWDNQLSGTISPAIGELQNLVTLAINTNKL--------SGNIPPSIGNLKKLLQLYL 183
            + +++      +   +  L  +  + +  N+                    +K+  +Y+
Sbjct: 253 DVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYI 312

Query: 184 IENFLQ-VSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLP 242
             N L+   + +SL + + L  +   YN L G   P       L+  L+L+ NQ+     
Sbjct: 313 GYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLAS-LNLAYNQITEIPA 370

Query: 243 TEVGKLINLEILFISRNMLECEILSTL--GSCIKLEQLKLGGNLFQG-------PIPLSL 293
              G    +E L  + N L+  I +     S   +  +    N           P+  + 
Sbjct: 371 NFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTP 429

Query: 294 SSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKNAS 347
                +  ++LS N IS    +       + ++NL  N L  +       +N +
Sbjct: 430 FKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENEN 483

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  198 bits (506), Expect = 6e-55
 Identities = 51/335 (15%), Positives = 111/335 (33%), Gaps = 24/335 (7%)

Query: 20  LPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQ 79
              +  LSL     +G +P ++   ++LEV  + S+           K   A      N 
Sbjct: 80  NGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISA------NM 133

Query: 80  HLKHLDINNNNFGGLLPGCICNFSIT-LETLIFNSNKIFRSIPAGIGKFINLQTLHMWDN 138
             +       ++             + L     NS+   +SI       +    +    N
Sbjct: 134 SDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSN 193

Query: 139 QLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQ 198
            ++  +S A+  L  L    +  +             +        +             
Sbjct: 194 NITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKT-----EDLKWDN 247

Query: 199 CQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLV--------GSLPTEVGKLIN 250
            + LT + +        +P  L  L  + + ++++ N+ +             +      
Sbjct: 248 LKDLTDVEVYNCPNLTKLPTFLKALPEMQL-INVACNRGISGEQLKDDWQALADAPVGEK 306

Query: 251 LEILFISRNMLEC-EILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNI 309
           ++I++I  N L+   + ++L    KL  L+   N  +G +P +  S   L  L+L+ N I
Sbjct: 307 IQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQI 365

Query: 310 SGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFK 344
           +     F    + V+NL+ ++N L+ +        
Sbjct: 366 TEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKS 400

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  196 bits (500), Expect = 5e-54
 Identities = 58/364 (15%), Positives = 113/364 (31%), Gaps = 53/364 (14%)

Query: 10  GGIPLDFGFTLPNLLFLSLGFNQITGV--------IPSSMFNASKLEVFQVTSNNL-TGE 60
             +P      LP +  +++  N+              +      K+++  +  NNL T  
Sbjct: 263 TKLPTFLK-ALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFP 321

Query: 61  VPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSI 120
           V +   K  K          L  L+   N   G LP    +    L +L    N+I   I
Sbjct: 322 VETSLQKMKK----------LGMLECLYNQLEGKLPA-FGSEI-KLASLNLAYNQI-TEI 368

Query: 121 PAGI-GKFINLQTLHMWDNQLSGTISPA-IGELQNLVTLAINTNKLSG-------NIPPS 171
           PA   G    ++ L    N+L    +      +  +  +  + N++          + P+
Sbjct: 369 PANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPT 428

Query: 172 IGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSG-------TIPPQLMDLT 224
                 +  + L  N +             L++INL  N L+               +  
Sbjct: 429 PFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTY 488

Query: 225 SLSVGLDLSRNQLVGSLPTE--VGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGG 282
            L+  +DL  N+L   L  +     L  L  + +S N    +  +   +   L+   +  
Sbjct: 489 LLTS-IDLRFNKL-TKLSDDFRATTLPYLVGIDLSYNSFS-KFPTQPLNSSTLKGFGIRN 545

Query: 283 NL------FQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGV 336
                        P  ++    L  L +  N+I     K    +     L++  N    +
Sbjct: 546 QRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKITPNI---SVLDIKDNPNISI 602

Query: 337 IPTE 340
             + 
Sbjct: 603 DLSY 606

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  195 bits (498), Expect = 7e-54
 Identities = 56/348 (16%), Positives = 100/348 (28%), Gaps = 34/348 (9%)

Query: 6   NRVQGGIPLDFGFTLPNLLFLSLGFNQITG----VIPSSMFNASKLEVFQVTSNNLTGEV 61
               G +P   G  L  L  L+LG +          P  +      E  Q    +     
Sbjct: 91  FGASGRVPDAIG-QLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTF 149

Query: 62  PSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIP 121
                +             L    IN++     +       ++    +   SN I   + 
Sbjct: 150 VDYDPRED--------FSDLIKDCINSDPQQKSIKKSSRI-TLKDTQIGQLSNNIT-FVS 199

Query: 122 AGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQL 181
             + +   L+  +M ++           E +N         +          NLK L  +
Sbjct: 200 KAVMRLTKLRQFYMGNSPFVAENICEAWENENS-----EYAQQYKTEDLKWDNLKDLTDV 254

Query: 182 YLIENFLQVSIPSSLGQCQSLTTINLSYNNL--------SGTIPPQLMDLTSLSVGLDLS 233
            +        +P+ L     +  IN++ N                       + + + + 
Sbjct: 255 EVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQI-IYIG 313

Query: 234 RNQL-VGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLS 292
            N L    + T + K+  L +L    N LE   L   GS IKL  L L  N         
Sbjct: 314 YNNLKTFPVETSLQKMKKLGMLECLYNQLE-GKLPAFGSEIKLASLNLAYNQITEIPANF 372

Query: 293 LSSLRGLRVLDLSQNNISGEIPKFLVELQLV--QNLNLSYNDLEGVIP 338
                 +  L  + N +   IP       +     ++ SYN++  V  
Sbjct: 373 CGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDG 419

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  195 bits (497), Expect = 1e-53
 Identities = 63/348 (18%), Positives = 115/348 (33%), Gaps = 45/348 (12%)

Query: 9   QGGIPLDFGFTLPNLLFLSLGFNQITGV-IPSSMFNASKLEVFQVTSNNLTGEVPSEFGK 67
                 D       +  + +G+N +    + +S+    KL + +   N L G     FG 
Sbjct: 294 DWQALADAPV-GEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGS 351

Query: 68  ATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPA--GIG 125
             K          L  L++  N    +     C F+  +E L F  NK+ + IP      
Sbjct: 352 EIK----------LASLNLAYNQITEIPAN-FCGFTEQVENLSFAHNKL-KYIPNIFDAK 399

Query: 126 KFINLQTLHMWDNQLSG-------TISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKL 178
               +  +    N++          + P   +  N+ ++ ++ N++S            L
Sbjct: 400 SVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPL 459

Query: 179 LQLYLIENFLQ-------VSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMD--LTSLSVG 229
             + L+ N L             +      LT+I+L +N L+  +        L  L   
Sbjct: 460 SSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVG- 517

Query: 230 LDLSRNQLVGSLPTEVGKLINLEILFI------SRNMLECEILSTLGSCIKLEQLKLGGN 283
           +DLS N      PT+      L+   I        N    E    +  C  L QL++G N
Sbjct: 518 IDLSYNSF-SKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSN 576

Query: 284 LFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYN 331
             +  +   +     + VLD+  N        ++          L Y+
Sbjct: 577 DIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYD 621

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  180 bits (458), Expect = 2e-48
 Identities = 50/329 (15%), Positives = 120/329 (36%), Gaps = 38/329 (11%)

Query: 27  SLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDI 86
           +   +        S+ +  ++    +     +G VP   G+ T           L+ L +
Sbjct: 63  NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLT----------ELEVLAL 112

Query: 87  NNNNFGG----LLPGCICNFSITLETLIFNSNKIFRSIPAGIGK--FINLQTLHMWDNQL 140
            ++          P  I   +++ E          ++      +  F +L    +  +  
Sbjct: 113 GSHGEKVNERLFGPKGISA-NMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQ 171

Query: 141 SGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQ 200
             +I  +         +   +N ++  +  ++  L KL Q Y+  +           + +
Sbjct: 172 QKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENE 230

Query: 201 SLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNM 260
                N  Y     T   +  +L  L+  +++     +  LPT +  L  ++++ ++ N 
Sbjct: 231 -----NSEYAQQYKTEDLKWDNLKDLTD-VEVYNCPNLTKLPTFLKALPEMQLINVACNR 284

Query: 261 L--------ECEILSTLGSCIKLEQLKLGGN-LFQGPIPLSLSSLRGLRVLDLSQNNISG 311
                    + + L+      K++ + +G N L   P+  SL  ++ L +L+   N + G
Sbjct: 285 GISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG 344

Query: 312 EIPKF--LVELQLVQNLNLSYNDLEGVIP 338
           ++P F   ++L    +LNL+YN +  +  
Sbjct: 345 KLPAFGSEIKL---ASLNLAYNQITEIPA 370

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  164 bits (416), Expect = 7e-43
 Identities = 48/334 (14%), Positives = 104/334 (31%), Gaps = 54/334 (16%)

Query: 10  GGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKAT 69
             +       +  L  L   +NQ+ G +P +  +  KL    +  N +T    +  G   
Sbjct: 320 FPVETSLQ-KMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTE 377

Query: 70  K----------------AYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSIT------LE 107
           +                 +  ++    +  +D + N  G +          T      + 
Sbjct: 378 QVENLSFAHNKLKYIPNIFDAKSV-SVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVS 436

Query: 108 TLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSG-------TISPAIGELQNLVTLAIN 160
           ++  ++N+I +           L ++++  N L+          +        L ++ + 
Sbjct: 437 SINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLR 496

Query: 161 TNKLSGNIPPSI--GNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTI------NLSYNNL 212
            NKL+  +        L  L+ + L  N      P+      +L         +   N  
Sbjct: 497 FNKLTK-LSDDFRATTLPYLVGIDLSYNSFS-KFPTQPLNSSTLKGFGIRNQRDAQGNRT 554

Query: 213 SGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSC 272
               P  +    SL+  L +  N +   +  ++    N+ +L I  N      LS +   
Sbjct: 555 LREWPEGITLCPSLTQ-LQIGSNDIR-KVNEKI--TPNISVLDIKDNPNISIDLSYVCPY 610

Query: 273 IKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQ 306
           I+     L  +            +RG   LD+ +
Sbjct: 611 IEAGMYMLFYD--------KTQDIRGCDALDIKR 636

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  148 bits (376), Expect = 1e-37
 Identities = 34/232 (14%), Positives = 72/232 (31%), Gaps = 13/232 (5%)

Query: 129 NLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGN----IPPSIGNLKKLLQLYLI 184
            +  L +     SG +  AIG+L  L  LA+ ++    N     P  I       Q   +
Sbjct: 82  RVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKM 141

Query: 185 ENFLQVSIPSSLG--QCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLP 242
               Q +            L    ++ +    +I          +  +    N +   + 
Sbjct: 142 RMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQ-IGQLSNNI-TFVS 199

Query: 243 TEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVL 302
             V +L  L   ++  +    E +         E  +           L   +L+ L  +
Sbjct: 200 KAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKT-----EDLKWDNLKDLTDV 254

Query: 303 DLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKNASAISVFGN 354
           ++       ++P FL  L  +Q +N++ N        +  ++  +   V   
Sbjct: 255 EVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEK 306

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  199 bits (508), Expect = 7e-55
 Identities = 74/356 (20%), Positives = 130/356 (36%), Gaps = 29/356 (8%)

Query: 6   NRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEF 65
           N+++     +F      L  L +GFN I+ + P        L+V  +  N L+      F
Sbjct: 35  NQLRRLPAANFTR-YSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTF 93

Query: 66  GKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIG 125
              T          +L  L + +N+   +           L TL  + N +  +      
Sbjct: 94  AFCT----------NLTELHLMSNSIQKIKNNPFVKQK-NLITLDLSHNGLSSTKLGTQV 142

Query: 126 KFINLQTLHMWDNQLSGTISPAIGELQN--LVTLAINTNKLSGNIPPSIGNLKKLLQLYL 183
           +  NLQ L + +N++    S  +    N  L  L +++N++    P     + +L  L+L
Sbjct: 143 QLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFL 202

Query: 184 IENFLQVSIPSSLG---QCQSLTTINLSYNNLSGTIPPQL--MDLTSLSVGLDLSRNQLV 238
               L  S+   L       S+  ++LS + LS T       +  T+L++ LDLS N L 
Sbjct: 203 NNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTM-LDLSYNNLN 261

Query: 239 GSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNL---------FQGPI 289
                    L  LE  F+  N ++     +L     +  L L  +               
Sbjct: 262 VVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKID 321

Query: 290 PLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKN 345
             S   L+ L  L++  N+I G        L  ++ L+LS +       T   F +
Sbjct: 322 DFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVS 377

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  190 bits (485), Expect = 9e-52
 Identities = 78/349 (22%), Positives = 130/349 (37%), Gaps = 31/349 (8%)

Query: 12  IPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKA 71
           +P D      N+  L+L  NQ+  +  ++    S+L    V  N ++   P    K    
Sbjct: 19  VPDDL---PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQK---- 71

Query: 72  YCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQ 131
                    LK L++ +N    L        +  L  L   SN I +       K  NL 
Sbjct: 72  ------LPMLKVLNLQHNELSQLSDKTFAFCT-NLTELHLMSNSIQKIKNNPFVKQKNLI 124

Query: 132 TLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLK--KLLQLYLIENFLQ 189
           TL +  N LS T      +L+NL  L ++ NK+       +       L +L L  N ++
Sbjct: 125 TLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIK 184

Query: 190 VSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLS--VGLDLSRNQLVGSLPTEVG- 246
              P        L  + L+   L  ++  +L    + +    L LS +QL  +  T    
Sbjct: 185 EFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLG 244

Query: 247 -KLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLS 305
            K  NL +L +S N L      +     +LE   L  N  Q     SL  L  +R L+L 
Sbjct: 245 LKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLK 304

Query: 306 QN---------NISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKN 345
           ++         ++          L+ +++LN+  ND+ G+     +F  
Sbjct: 305 RSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKS--NMFTG 351

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  190 bits (484), Expect = 1e-51
 Identities = 67/339 (19%), Positives = 128/339 (37%), Gaps = 26/339 (7%)

Query: 22  NLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHL 81
           +    S+    +  +   S      LE   +  N++ G   + F              +L
Sbjct: 306 SFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLI----------NL 355

Query: 82  KHLDINNN--NFGGLLPGCICNFSIT-LETLIFNSNKIFRSIPAGIGKFINLQTLHMWDN 138
           K+L ++N+  +   L      + + + L  L    NKI +          +L+ L +  N
Sbjct: 356 KYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLN 415

Query: 139 QLSGTISP-AIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQ--VSIPSS 195
           ++   ++      L+N+  + ++ NK       S   +  L +L L    L+   S PS 
Sbjct: 416 EIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSP 475

Query: 196 LGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQL--------VGSLPTEVGK 247
               ++LT ++LS NN++      L  L  L + LDL  N L         G     +  
Sbjct: 476 FQPLRNLTILDLSNNNIANINDDMLEGLEKLEI-LDLQHNNLARLWKHANPGGPIYFLKG 534

Query: 248 LINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQN 307
           L +L IL +  N  +   +       +L+ + LG N          ++   L+ L+L +N
Sbjct: 535 LSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKN 594

Query: 308 NISGEIPK-FLVELQLVQNLNLSYNDLEGVIPTEGVFKN 345
            I+    K F    + +  L++ +N  +    +   F N
Sbjct: 595 LITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVN 633

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  180 bits (458), Expect = 4e-48
 Identities = 59/347 (17%), Positives = 114/347 (32%), Gaps = 24/347 (6%)

Query: 2   DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEV 61
            + +  +       F   L  L  L++  N I G+  +       L+   ++++  +   
Sbjct: 311 SISLASLPKIDDFSFQ-WLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRT 369

Query: 62  PSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIP 121
            +          V   +  L  L++  N    +           LE L    N+I + + 
Sbjct: 370 LTNET------FVSLAHSPLHILNLTKNKISKIESDAFSWLG-HLEVLDLGLNEIGQELT 422

Query: 122 AG-IGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSG--NIPPSIGNLKKL 178
                   N+  +++  N+       +   + +L  L +    L    + P     L+ L
Sbjct: 423 GQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNL 482

Query: 179 LQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLS--------GTIPPQLMDLTSLSVGL 230
             L L  N +       L   + L  ++L +NNL+        G     L  L+ L + L
Sbjct: 483 TILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHI-L 541

Query: 231 DLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIP 290
           +L  N            L  L+I+ +  N L     S   + + L+ L L  NL      
Sbjct: 542 NLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEK 601

Query: 291 LSLS-SLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGV 336
                + R L  LD+  N               V  +N ++ ++  +
Sbjct: 602 KVFGPAFRNLTELDMRFNPFDCTCESI---AWFVNWINETHTNIPEL 645

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  165 bits (420), Expect = 3e-43
 Identities = 57/271 (21%), Positives = 106/271 (39%), Gaps = 12/271 (4%)

Query: 77  CNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMW 136
           C    +  D ++     +      +    +  L    N++ R   A   ++  L +L + 
Sbjct: 2   CTVSHEVADCSHLKLTQVPD----DLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVG 57

Query: 137 DNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSL 196
            N +S        +L  L  L +  N+LS     +      L +L+L+ N +Q    +  
Sbjct: 58  FNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPF 117

Query: 197 GQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTE--VGKLINLEIL 254
            + ++L T++LS+N LS T     + L +L   L LS N++      E  +    +L+ L
Sbjct: 118 VKQKNLITLDLSHNGLSSTKLGTQVQLENLQE-LLLSNNKIQALKSEELDIFANSSLKKL 176

Query: 255 FISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLS---SLRGLRVLDLSQNNISG 311
            +S N ++        +  +L  L L        +   L    +   +R L LS + +S 
Sbjct: 177 ELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLST 236

Query: 312 EIPKFLVELQLV--QNLNLSYNDLEGVIPTE 340
                 + L+      L+LSYN+L  V    
Sbjct: 237 TSNTTFLGLKWTNLTMLDLSYNNLNVVGNDS 267

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  144 bits (366), Expect = 3e-36
 Identities = 53/306 (17%), Positives = 98/306 (32%), Gaps = 27/306 (8%)

Query: 17  GFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVP-SEFGKATKAYCVQ 75
                 L  L+L  N+I+ +   +      LEV  +  N +  E+   E+          
Sbjct: 377 SLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLE------ 430

Query: 76  NCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKI--FRSIPAGIGKFINLQTL 133
               ++  + ++ N +  L          +L+ L+     +    S P+      NL  L
Sbjct: 431 ----NIFEIYLSYNKYLQLTRNSFALVP-SLQRLMLRRVALKNVDSSPSPFQPLRNLTIL 485

Query: 134 HMWDNQLSGTISPAIGELQNLVTLAINTNKLS--------GNIPPSIGNLKKLLQLYLIE 185
            + +N ++      +  L+ L  L +  N L+        G     +  L  L  L L  
Sbjct: 486 DLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLES 545

Query: 186 NFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEV 245
           N               L  I+L  NNL+        +  SL   L+L +N +        
Sbjct: 546 NGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKS-LNLQKNLITSVEKKVF 604

Query: 246 GK-LINLEILFISRNMLECEI--LSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVL 302
           G    NL  L +  N  +C    ++   + I      +   L    +  +     G  V 
Sbjct: 605 GPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPE-LSSHYLCNTPPHYHGFPVR 663

Query: 303 DLSQNN 308
               ++
Sbjct: 664 LFDTSS 669

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  179 bits (457), Expect = 2e-48
 Identities = 70/348 (20%), Positives = 126/348 (36%), Gaps = 31/348 (8%)

Query: 4   GVNRVQGGIPLDFGFTLPNLLFLSLGFNQIT------GVIPSSMFNASKLEVFQVTSNNL 57
           G  R +G +       L  L  L++   ++         I       + +  F + S  +
Sbjct: 235 GEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTI 294

Query: 58  TGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIF 117
                  +            N   +HL++ N  FG      + +    L+ L F SNK  
Sbjct: 295 ERVKDFSY------------NFGWQHLELVNCKFGQFPTLKLKS----LKRLTFTSNKG- 337

Query: 118 RSIPAGIGKFINLQTLHMWDNQLS--GTISPAIGELQNLVTLAINTNKLSGNIPPSIGNL 175
                      +L+ L +  N LS  G  S +     +L  L ++ N +   +  +   L
Sbjct: 338 -GNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGL 395

Query: 176 KKLLQLYLIENFLQVSIPSS-LGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSR 234
           ++L  L    + L+     S     ++L  +++S+ +           L+SL V L ++ 
Sbjct: 396 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEV-LKMAG 454

Query: 235 NQLVGSLPTEV-GKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSL 293
           N    +   ++  +L NL  L +S+  LE    +   S   L+ L +  N F        
Sbjct: 455 NSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPY 514

Query: 294 SSLRGLRVLDLSQNNISGEIPKFLVEL-QLVQNLNLSYNDLEGVIPTE 340
             L  L+VLD S N+I     + L      +  LNL+ ND       +
Sbjct: 515 KCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQ 562

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  176 bits (449), Expect = 2e-47
 Identities = 61/349 (17%), Positives = 115/349 (32%), Gaps = 27/349 (7%)

Query: 2   DVGVNRVQGGIPLDFGFTLPNLLFLSL------GFNQITGVIPSSMFNASKLEVFQVTSN 55
            +  N     +       L  L    L          +     S++     L + +    
Sbjct: 206 TLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265

Query: 56  NLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNK 115
            L   +            + NC  ++    + +     +      +++   + L   + K
Sbjct: 266 YLDYYLDDIID-------LFNCLTNVSSFSLVSVTIERVKDF---SYNFGWQHLELVNCK 315

Query: 116 IFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLS--GNIPPSIG 173
            F   P       +L+ L        G  + +  +L +L  L ++ N LS  G    S  
Sbjct: 316 -FGQFPTLK--LKSLKRLTF--TSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDF 370

Query: 174 NLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQ-LMDLTSLSVGLDL 232
               L  L L  N +  ++ S+    + L  ++  ++NL         + L +L   LD+
Sbjct: 371 GTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY-LDI 428

Query: 233 SRNQLVGSLPTEVGKLINLEILFISRNMLECEILS-TLGSCIKLEQLKLGGNLFQGPIPL 291
           S      +       L +LE+L ++ N  +   L         L  L L     +   P 
Sbjct: 429 SHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT 488

Query: 292 SLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTE 340
           + +SL  L+VL++S NN           L  +Q L+ S N +      E
Sbjct: 489 AFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQE 537

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  160 bits (406), Expect = 1e-41
 Identities = 57/335 (17%), Positives = 105/335 (31%), Gaps = 31/335 (9%)

Query: 21  PNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQH 80
            +   L L FN +  +   S F+  +L+V  ++   +       +              H
Sbjct: 28  FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQS----------LSH 77

Query: 81  LKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQL 140
           L  L +  N    L  G     S +L+ L+     +       IG    L+ L++  N +
Sbjct: 78  LSTLILTGNPIQSLALGAFSGLS-SLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI 136

Query: 141 -SGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKL----LQLYLIENFLQVSIPSS 195
            S  +      L NL  L +++NK+       +  L ++    L L L  N +    P +
Sbjct: 137 QSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGA 196

Query: 196 LGQCQSLTTINLSYNNLSGTIPPQL------MDLTSLSVGLDLSRNQLVGSLPTEVGKLI 249
             +   L  + L  N  S  +          +++  L +G   +   L     + +  L 
Sbjct: 197 FKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLC 255

Query: 250 NLEILFISRNMLEC---EILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQ 306
           NL I       L+    +I+        +    L     +     S     G + L+L  
Sbjct: 256 NLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY--NFGWQHLELVN 313

Query: 307 NNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEG 341
                     L  L   + L  + N          
Sbjct: 314 CKFGQFPTLKLKSL---KRLTFTSNKGGNAFSEVD 345

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  158 bits (401), Expect = 5e-41
 Identities = 63/377 (16%), Positives = 115/377 (30%), Gaps = 44/377 (11%)

Query: 2   DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEV 61
           D+    +Q      +  +L +L  L L  N I  +   +    S L+       NL    
Sbjct: 58  DLSRCEIQTIEDGAYQ-SLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLE 116

Query: 62  PSEFGKATK----------------AYCVQNCNQHLKHLDINNNNFGGLLPGCICNFS-- 103
               G                         N   +L+HLD+++N    +    +      
Sbjct: 117 NFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT-NLEHLDLSSNKIQSIYCTDLRVLHQM 175

Query: 104 -ITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISP-AIGELQNLVTLAINT 161
            +   +L  + N +   I  G  K I L  L + +N  S  +    I  L  L    +  
Sbjct: 176 PLLNLSLDLSLNPM-NFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVL 234

Query: 162 NKLSGNI---PPSIGNLKKLLQLYLIEN------FLQVSIPSSLGQCQSLTTINLSYNNL 212
            +              L+ L  L + E       +    I        ++++ +L    +
Sbjct: 235 GEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTI 294

Query: 213 SGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSC 272
                            L+L   +       ++  L  L                +    
Sbjct: 295 ERVKD--FSYNFGWQH-LELVNCKFGQFPTLKLKSLKRLTFTSNKGG-----NAFSEVDL 346

Query: 273 IKLEQLKLGGN--LFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSY 330
             LE L L  N   F+G    S      L+ LDLS N +      FL  L+ +++L+  +
Sbjct: 347 PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFL-GLEQLEHLDFQH 405

Query: 331 NDLEGVIPTEGVFKNAS 347
           ++L+ +     VF +  
Sbjct: 406 SNLKQMSE-FSVFLSLR 421

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  147 bits (373), Expect = 2e-37
 Identities = 55/268 (20%), Positives = 100/268 (37%), Gaps = 17/268 (6%)

Query: 77  CNQHLKHL--DINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLH 134
           C + + ++       NF  +      N   + + L  + N +          F  LQ L 
Sbjct: 3   CVEVVPNITYQCMELNFYKIPD----NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLD 58

Query: 135 MWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPS 194
           +   ++      A   L +L TL +  N +      +   L  L +L  +E  L      
Sbjct: 59  LSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENF 118

Query: 195 SLGQCQSLTTINLSYNNL-SGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEI 253
            +G  ++L  +N+++N + S  +P    +LT+L   LDLS N++     T++  L  + +
Sbjct: 119 PIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEH-LDLSSNKIQSIYCTDLRVLHQMPL 177

Query: 254 ----LFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIP-LSLSSLRGLRVLDLSQNN 308
               L +S N +           I+L +L L  N     +    +  L GL V  L    
Sbjct: 178 LNLSLDLSLNPMNFIQPGAF-KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGE 236

Query: 309 ISGEIPKFLVE---LQLVQNLNLSYNDL 333
              E      +   L+ + NL +    L
Sbjct: 237 FRNEGNLEKFDKSALEGLCNLTIEEFRL 264

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  146 bits (371), Expect = 4e-37
 Identities = 53/270 (19%), Positives = 98/270 (36%), Gaps = 19/270 (7%)

Query: 6   NRVQGGIPLDFGFTLPNLLFLSLGFNQIT--GVIPSSMFNASKLEVFQVTSNNLTGEVPS 63
              +GG        LP+L FL L  N ++  G    S F  + L+   ++ N +   + S
Sbjct: 333 TSNKGGNAFSEVD-LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSS 390

Query: 64  EFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAG 123
            F    +          L+HLD  ++N   +    +      L  L  +      +    
Sbjct: 391 NFLGLEQ----------LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 440

Query: 124 IGKFINLQTLHMWDNQLSGTISP-AIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLY 182
                +L+ L M  N       P    EL+NL  L ++  +L    P +  +L  L  L 
Sbjct: 441 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 500

Query: 183 LIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDL-TSLSVGLDLSRNQLVGSL 241
           +  N              SL  ++ S N++  +   +L    +SL+  L+L++N    + 
Sbjct: 501 MSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAF-LNLTQNDFACTC 559

Query: 242 PTE--VGKLINLEILFISRNMLECEILSTL 269
             +  +  + +   L +    +EC   S  
Sbjct: 560 EHQSFLQWIKDQRQLLVEVERMECATPSDK 589

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  126 bits (318), Expect = 2e-30
 Identities = 52/207 (25%), Positives = 77/207 (37%), Gaps = 16/207 (7%)

Query: 146 PAIGELQNLVTL--AINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLT 203
           P +  + N+      +N  K+  N+P S         L L  N L+     S      L 
Sbjct: 2   PCVEVVPNITYQCMELNFYKIPDNLPFS------TKNLDLSFNPLRHLGSYSFFSFPELQ 55

Query: 204 TINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLEC 263
            ++LS   +          L+ LS  L L+ N +          L +L+ L      L  
Sbjct: 56  VLDLSRCEIQTIEDGAYQSLSHLST-LILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS 114

Query: 264 EILSTLGSCIKLEQLKLGGNLFQG-PIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQ- 321
                +G    L++L +  NL Q   +P   S+L  L  LDLS N I       L  L  
Sbjct: 115 LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQ 174

Query: 322 ---LVQNLNLSYNDLEGVIPTEGVFKN 345
              L  +L+LS N +  + P  G FK 
Sbjct: 175 MPLLNLSLDLSLNPMNFIQP--GAFKE 199

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  179 bits (456), Expect = 2e-48
 Identities = 67/330 (20%), Positives = 124/330 (37%), Gaps = 20/330 (6%)

Query: 18  FTLPNLLFLSLGFNQITGVIPSSMFNAS--KLEVFQVTSNNLTGEVPSEFGKATKAYCVQ 75
           F       L+ G  Q   VI   + N++   L +      +     P+ F          
Sbjct: 199 FDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEG-------- 250

Query: 76  NCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHM 135
            C   ++ +++  + F  +       FS  L+ L   +  +   +P+G+     L+ L +
Sbjct: 251 LCEMSVESINLQKHYFFNISSNTFHCFS-GLQELDLTATHL-SELPSGLVGLSTLKKLVL 308

Query: 136 WDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPP-SIGNLKKLLQLYLIENFLQVS--I 192
             N+       +     +L  L+I  N     +    + NL+ L +L L  + ++ S   
Sbjct: 309 SANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCC 368

Query: 193 PSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEV-GKLINL 251
              L     L ++NLSYN           +   L + LDL+  +L           L  L
Sbjct: 369 NLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLEL-LDLAFTRLKVKDAQSPFQNLHLL 427

Query: 252 EILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPL---SLSSLRGLRVLDLSQNN 308
           ++L +S ++L+            L+ L L GN F         SL +L  L +L LS  +
Sbjct: 428 KVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCD 487

Query: 309 ISGEIPKFLVELQLVQNLNLSYNDLEGVIP 338
           +S         L+++ +++LS+N L     
Sbjct: 488 LSSIDQHAFTSLKMMNHVDLSHNRLTSSSI 517

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  172 bits (438), Expect = 7e-46
 Identities = 60/363 (16%), Positives = 110/363 (30%), Gaps = 44/363 (12%)

Query: 12  IPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKA 71
           IP        +   L   FN +  +  ++      L    +T   +       F      
Sbjct: 27  IPGTL---PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQS---- 79

Query: 72  YCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQ 131
                    L  L +  N    +    +      L+ L F    I       +     L+
Sbjct: 80  ------QHRLDTLVLTANPLIFMAETALSGPK-ALKHLFFIQTGISSIDFIPLHNQKTLE 132

Query: 132 TLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQ-V 190
           +L++  N +S    P     + L  L    N +       + +L++   L L  N     
Sbjct: 133 SLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA 192

Query: 191 SIPSSLGQCQSLTTINLSYNNLSGTIPPQLM--DLTSLSVG------------------- 229
            I           ++N         I   L    + SL +G                   
Sbjct: 193 GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLC 252

Query: 230 ------LDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGN 283
                 ++L ++               L+ L ++   L  E+ S L     L++L L  N
Sbjct: 253 EMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSAN 311

Query: 284 LFQGPIPLSLSSLRGLRVLDLSQNNISGEI-PKFLVELQLVQNLNLSYNDLEGVIPTEGV 342
            F+    +S S+   L  L +  N    E+    L  L+ ++ L+LS++D+E        
Sbjct: 312 KFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQ 371

Query: 343 FKN 345
            +N
Sbjct: 372 LRN 374

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  169 bits (430), Expect = 7e-45
 Identities = 66/369 (17%), Positives = 121/369 (32%), Gaps = 26/369 (7%)

Query: 6   NRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEF 65
             +     +        L  L LG N I+ +     F   KL+V    +N +      + 
Sbjct: 115 TGISSIDFIPLHN-QKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDM 173

Query: 66  G---KATKAYCVQNCNQ------------HLKHLDINNNNFGGLLPGCICNFSIT-LETL 109
               +AT      N N               + L+        ++   + N +I  L   
Sbjct: 174 SSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLG 233

Query: 110 IFNSNKI--FRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGN 167
            F                  ++++++++  +      S        L  L +    LS  
Sbjct: 234 TFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-E 292

Query: 168 IPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQ-LMDLTSL 226
           +P  +  L  L +L L  N  +     S     SLT +++  N     +    L +L +L
Sbjct: 293 LPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENL 352

Query: 227 SVGLDLSRNQL--VGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNL 284
              LDLS + +        ++  L +L+ L +S N            C +LE L L    
Sbjct: 353 RE-LDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTR 411

Query: 285 FQGPIPLS-LSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIP-TEGV 342
            +     S   +L  L+VL+LS + +     +    L  +Q+LNL  N            
Sbjct: 412 LKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNS 471

Query: 343 FKNASAISV 351
            +    + +
Sbjct: 472 LQTLGRLEI 480

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  157 bits (398), Expect = 1e-40
 Identities = 61/313 (19%), Positives = 97/313 (30%), Gaps = 22/313 (7%)

Query: 6   NRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEF 65
           +         F      L  L L    ++  +PS +   S L+   +++N          
Sbjct: 264 HYFFNISSNTFH-CFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANKFENLCQISA 321

Query: 66  GKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIG 125
                          L HL I  N     L          L  L  + + I  +      
Sbjct: 322 SNFP----------SLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDI-ETSDCCNL 370

Query: 126 KF---INLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSI-GNLKKLLQL 181
           +     +LQ+L++  N+     + A  E   L  L +   +L      S   NL  L  L
Sbjct: 371 QLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVL 430

Query: 182 YLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTI---PPQLMDLTSLSVGLDLSRNQLV 238
            L  + L +S         +L  +NL  N+           L  L  L + L LS   L 
Sbjct: 431 NLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEI-LVLSFCDLS 489

Query: 239 GSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRG 298
                    L  +  + +S N L    +  L     +  L L  N     +P  L  L  
Sbjct: 490 SIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQ 548

Query: 299 LRVLDLSQNNISG 311
            R ++L QN +  
Sbjct: 549 QRTINLRQNPLDC 561

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  138 bits (350), Expect = 2e-34
 Identities = 51/282 (18%), Positives = 91/282 (32%), Gaps = 14/282 (4%)

Query: 77  CNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMW 136
             +  K  +  N     + PG       + E L F+ N +         + INL  L + 
Sbjct: 10  EKEVNKTYNCENLGLNEI-PG---TLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLT 65

Query: 137 DNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSL 196
             Q+             L TL +  N L      ++   K L  L+ I+  +       L
Sbjct: 66  RCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPL 125

Query: 197 GQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFI 256
              ++L ++ L  N++S    P+      L V LD   N +      ++  L     L +
Sbjct: 126 HNQKTLESLYLGSNHISSIKLPKGFPTEKLKV-LDFQNNAIHYLSKEDMSSLQQATNLSL 184

Query: 257 --SRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIP--LSLSSLRGLRVLDLSQNNISGE 312
             + N +   I          + L  GG      I   L  S+++ L +      +    
Sbjct: 185 NLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDI 243

Query: 313 IPKFLVELQL--VQNLNLSYNDLEGVIPTEGVFKNASAISVF 352
            P     L    V+++NL  +    +      F   S +   
Sbjct: 244 SPAVFEGLCEMSVESINLQKHYFFNISS--NTFHCFSGLQEL 283

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  117 bits (294), Expect = 2e-27
 Identities = 52/311 (16%), Positives = 96/311 (30%), Gaps = 47/311 (15%)

Query: 6   NRVQGGIPLDFGFTLPNLLFLSLGFNQIT--GVIPSSMFNASKLEVFQVTSNNLTGEVPS 63
           N  +  +       L NL  L L  + I         + N S L+   ++ N        
Sbjct: 335 NTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTE 394

Query: 64  EFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAG 123
            F +  +          L+ LD+                              F+++   
Sbjct: 395 AFKECPQ----------LELLDLAFTRLKVKDA-----------------QSPFQNLH-- 425

Query: 124 IGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNI---PPSIGNLKKLLQ 180
                 L+ L++  + L  +       L  L  L +  N           S+  L +L  
Sbjct: 426 -----LLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEI 480

Query: 181 LYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGS 240
           L L    L      +    + +  ++LS+N L+ +    L  L  +   L+L+ N +   
Sbjct: 481 LVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY--LNLASNHISII 538

Query: 241 LPTEVGKLINLEILFISRNMLECEI-LSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGL 299
           LP+ +  L     + + +N L+C            LE  K      +        +   L
Sbjct: 539 LPSLLPILSQQRTINLRQNPLDCTCSNIYF-----LEWYKENMQKLEDTEDTLCENPPLL 593

Query: 300 RVLDLSQNNIS 310
           R + LS   +S
Sbjct: 594 RGVRLSDVTLS 604

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  105 bits (263), Expect = 1e-23
 Identities = 42/208 (20%), Positives = 69/208 (33%), Gaps = 9/208 (4%)

Query: 164 LSGN----IPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQ 219
                   IP ++        L    N L     ++  +  +LT ++L+   +       
Sbjct: 19  CENLGLNEIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDT 76

Query: 220 LMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLK 279
                 L   L L+ N L+    T +     L+ LF  +  +       L +   LE L 
Sbjct: 77  FQSQHRLDT-LVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLY 135

Query: 280 LGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQN--LNLSYNDLEGVI 337
           LG N               L+VLD   N I     + +  LQ   N  LNL+ ND+ G+ 
Sbjct: 136 LGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIE 195

Query: 338 PTEGVFKNASAISVFGNSKLCGGIPEFQ 365
           P         +++  G   L       +
Sbjct: 196 PGAFDSAVFQSLNFGGTQNLLVIFKGLK 223

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  172 bits (437), Expect = 4e-48
 Identities = 70/330 (21%), Positives = 125/330 (37%), Gaps = 49/330 (14%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECS--ALRNIRHKNLVKILTVCSG 468
           G +G+VYKG LDE    +AVKV +  +    ++ I E +   +  + H N+ + +     
Sbjct: 24  GRYGAVYKGSLDE--RPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDER 78

Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL 528
           V   G     LV E+  NGSL ++L                +++    +A  V   L YL
Sbjct: 79  VTADGRMEYLLVMEYYPNGSLXKYLSL-----------HTSDWVSSCRLAHSVTRGLAYL 127

Query: 529 HHD------CQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL------PPAHLQTSSIG 576
           H +       +P  +H DL   NVL+ ++ T  ++DFGL+  L       P     ++I 
Sbjct: 128 HTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAIS 187

Query: 577 VKGTIGYIAPAEY-------GLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLH 629
             GTI Y+AP E                  D+Y+ G++  E+  R   +D+    ++  +
Sbjct: 188 EVGTIRYMAP-EVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC--TDLFPGESVPEY 244

Query: 630 N--FARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSM 687
              F   V      + +   +  + +                     + S+      C  
Sbjct: 245 QMAFQTEVGNHPTFEDMQVLVSREKQRPKFPE-------AWKENSLAVRSLKETIEDCWD 297

Query: 688 ESPQDRMNMTIVVHELQSIKSILLGPKTVS 717
           +  + R+        +  +  I    K+VS
Sbjct: 298 QDAEARLTAQXAEERMAELMMIWERNKSVS 327

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  180 bits (457), Expect = 2e-47
 Identities = 57/353 (16%), Positives = 110/353 (31%), Gaps = 47/353 (13%)

Query: 20  LPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQ 79
              +  LSL      G +P ++   ++L+V    +++ T      FG       +    +
Sbjct: 322 NGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETV-SGRLFGDEELTPDMSEERK 380

Query: 80  HLKHLDINNNNFGGLLPGCICNFS--------------------ITLETLIFNSNKIFRS 119
           H   +              + +                      +    +   +N+I   
Sbjct: 381 HRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRI-TF 439

Query: 120 IPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLL 179
           I   I +   LQ ++  ++  +        E  N      +  K   N   S  NLK L 
Sbjct: 440 ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANS-----DYAKQYENEELSWSNLKDLT 494

Query: 180 QLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSG---------TIPPQLMDLTSLSVGL 230
            + L        +P  L     L ++N++ N              +         + +  
Sbjct: 495 DVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQI-F 553

Query: 231 DLSRNQLVGSLPTEV--GKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGP 288
            +  N L    P      K++ L +L    N +    L   G+ +KL  LKL  N  +  
Sbjct: 554 YMGYNNLE-EFPASASLQKMVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQIEE- 609

Query: 289 IPLSL-SSLRGLRVLDLSQNNISGEIPK--FLVELQLVQNLNLSYNDLEGVIP 338
           IP    +    +  L  S N +   IP       + ++ +++ SYN +     
Sbjct: 610 IPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGR 661

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  179 bits (456), Expect = 3e-47
 Identities = 52/367 (14%), Positives = 105/367 (28%), Gaps = 44/367 (11%)

Query: 6   NRVQGGIPLDFGFTLPNLLFLSLGFNQITGV-----IPSSMFNASKLEVFQVTSNNLTGE 60
           +R++      F      L    L  + I        I      + K       +N +T  
Sbjct: 381 HRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF- 439

Query: 61  VPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSI 120
           +     + TK          L+ +   N+ F           ++  E    +  K + + 
Sbjct: 440 ISKAIQRLTK----------LQIIYFANSPFTYDNI------AVDWEDANSDYAKQYENE 483

Query: 121 PAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSG---------NIPPS 171
                   +L  + +++      +   + +L  L +L I  N+             +   
Sbjct: 484 ELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADD 543

Query: 172 IGNLKKLLQLYLIENFL-QVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGL 230
                K+   Y+  N L +    +SL +   L  ++  +N +             L+  L
Sbjct: 544 EDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKV--RHLEAFGTNVKLTD-L 600

Query: 231 DLSRNQLVGSLPTEVGK-LINLEILFISRNMLEC-EILSTLGSCIKLEQLKLGGNLFQG- 287
            L  NQ+   +P +       +E L  S N L+    +    S   +  +    N     
Sbjct: 601 KLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSE 659

Query: 288 ----PIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVF 343
                  +          + LS N I     +       +  + LS N +   IP   + 
Sbjct: 660 GRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTS-IPENSLK 718

Query: 344 KNASAIS 350
                  
Sbjct: 719 PKDGNYK 725

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  176 bits (449), Expect = 2e-46
 Identities = 61/360 (16%), Positives = 122/360 (33%), Gaps = 47/360 (13%)

Query: 18  FTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNC 77
                   +    N+IT  I  ++   +KL++    ++  T +  +   +   +   +  
Sbjct: 422 RISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQY 480

Query: 78  N---------QHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKI---------FRS 119
                     + L  +++ N      LP  + +    L++L    N+          +  
Sbjct: 481 ENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLP-ELQSLNIACNRGISAAQLKADWTR 539

Query: 120 IPAGIGKFINLQTLHMWDNQLSG-TISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKL 178
           +         +Q  +M  N L     S ++ ++  L  L    NK+      + G   KL
Sbjct: 540 LADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKL 597

Query: 179 LQLYLIENFLQVSIPSSLGQ-CQSLTTINLSYNNLSGTIPP--QLMDLTSLSVGLDLSRN 235
             L L  N ++  IP         +  +  S+N L   IP       +  +   +D S N
Sbjct: 598 TDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGS-VDFSYN 654

Query: 236 QLVGSLPTEVG------KLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQ--- 286
           ++ GS    +       K IN   + +S N ++        +   +  + L  NL     
Sbjct: 655 KI-GSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIP 713

Query: 287 ----GPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLV--QNLNLSYNDLEGVIPTE 340
                P   +  +   L  +DL  N ++  +        L    N+++SYN      PT+
Sbjct: 714 ENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQ 771

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  171 bits (434), Expect = 2e-44
 Identities = 63/369 (17%), Positives = 120/369 (32%), Gaps = 59/369 (15%)

Query: 12  IPLDFGFTLPNLLFLSLGFNQITGVIPSSMF-NASKLEVFQVTSNNLTGEVPSEFGKATK 70
           +  D   T P +    +G+N +     S+      KL +     N +       FG   K
Sbjct: 540 LADDED-TGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVK 596

Query: 71  AYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIP--AGIGKFI 128
                     L  L ++ N    + P   C F+  +E L F+ NK+ + IP         
Sbjct: 597 ----------LTDLKLDYNQIEEI-PEDFCAFTDQVEGLGFSHNKL-KYIPNIFNAKSVY 644

Query: 129 NLQTLHMWDNQLSG-----TISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYL 183
            + ++    N++       + S    +  N  T+ ++ N++             +  + L
Sbjct: 645 VMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIIL 704

Query: 184 IENFLQ-------VSIPSSLGQCQSLTTINLSYNNLSGTIPPQLM--DLTSLSVGLDLSR 234
             N +             +      LTTI+L +N L+ ++        L  LS  +D+S 
Sbjct: 705 SNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSN-MDVSY 762

Query: 235 NQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLS 294
           N    S PT+      L+   I                         GN      P  ++
Sbjct: 763 NCF-SSFPTQPLNSSQLKAFGIRHQ------------------RDAEGNRILRQWPTGIT 803

Query: 295 SLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKNASAISVF-- 352
           +   L  L +  N+I  ++ + L     +  L+++ N    +  T       + + V   
Sbjct: 804 TCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLY 860

Query: 353 -GNSKLCGG 360
                + G 
Sbjct: 861 DKTQDIRGC 869

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  131 bits (330), Expect = 1e-31
 Identities = 35/237 (14%), Positives = 81/237 (34%), Gaps = 11/237 (4%)

Query: 114 NKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIG 173
           +         +     +  L +      G +  AIG+L  L  L+  T+  + +      
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368

Query: 174 NLKKLLQLYLIENFLQVSIPS-SLGQCQSLTTINLSYNNLSG---TIPPQLMDLTSLS-V 228
                      ++ +++      L   Q L   +L  + ++      P +     SL   
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDT 428

Query: 229 GLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGP 288
            +    N++   +   + +L  L+I++ + +       +     +  E            
Sbjct: 429 QIGNLTNRI-TFISKAIQRLTKLQIIYFANSPF-----TYDNIAVDWEDANSDYAKQYEN 482

Query: 289 IPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKN 345
             LS S+L+ L  ++L       ++P FL +L  +Q+LN++ N        +  +  
Sbjct: 483 EELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTR 539

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  125 bits (316), Expect = 6e-30
 Identities = 34/285 (11%), Positives = 78/285 (27%), Gaps = 48/285 (16%)

Query: 76  NCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHM 135
           + N  +  L +      G +P  I   +  L+ L F ++    S      + +       
Sbjct: 320 DNNGRVTGLSLAGFGAKGRVPDAIGQLT-ELKVLSFGTHSETVSGRLFGDEELTPDMSEE 378

Query: 136 WDNQLSGTISP-AIGELQNLVTLAINTNKLSGN-----IPPSIGNLKKLLQLYLIENFLQ 189
             +++        +   Q L    +  + ++ N     I        K  Q+  + N + 
Sbjct: 379 RKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRIT 438

Query: 190 VSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLI 249
             I  ++ +   L  I  + +  +        +        +    +   +       L 
Sbjct: 439 -FISKAIQRLTKLQIIYFANSPFTYDNIAVDWED------ANSDYAKQYENEELSWSNLK 491

Query: 250 NLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNI 309
           +L  +                        +L        +P  L  L  L+ L+++ N  
Sbjct: 492 DLTDV------------------------ELYNCPNMTQLPDFLYDLPELQSLNIACNRG 527

Query: 310 SG---------EIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKN 345
                       +         +Q   + YN+LE   P     + 
Sbjct: 528 ISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEE-FPASASLQK 571

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 62.6 bits (152), Expect = 3e-10
 Identities = 29/197 (14%), Positives = 57/197 (28%), Gaps = 9/197 (4%)

Query: 150 ELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSY 209
           +L     + I   + +  I      LK + +    +N+   S   +          N   
Sbjct: 250 KLTKDANVPIQLKETAEYIKDYKA-LKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKEL 308

Query: 210 NNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEI-LST 268
           +         L +   +  GL L+     G +P  +G+L  L++L    +       L  
Sbjct: 309 DMWGDQPGVDLDNNGRV-TGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFG 367

Query: 269 LGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNIS-----GEIPKFLVELQLV 323
                     +    +      + L   + L + DL Q+ I+       I K        
Sbjct: 368 DEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKD 427

Query: 324 QNLNLSYNDLEGVIPTE 340
             +    N +   I   
Sbjct: 428 TQIGNLTNRITF-ISKA 443

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 53.3 bits (128), Expect = 2e-07
 Identities = 25/131 (19%), Positives = 47/131 (35%), Gaps = 20/131 (15%)

Query: 11  GIPLDFGFT-LPNLLFLSLGFNQITGVIPSSMFNASKLEVFQ------VTSNNLTGEVPS 63
            +  DF  T LP L  + + +N  +   P+   N+S+L+ F          N +  + P+
Sbjct: 742 SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPT 800

Query: 64  EFGKATKAYCVQ-NCNQ----------HLKHLDINNNNFGGLLPGCICNF-SITLETLIF 111
                     +Q   N            L  LDI +N    +    +C +    +  L++
Sbjct: 801 GITTCPSLIQLQIGSNDIRKVDEKLTPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLY 860

Query: 112 NSNKIFRSIPA 122
           +  +  R   A
Sbjct: 861 DKTQDIRGCDA 871

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  161 bits (409), Expect = 2e-44
 Identities = 65/216 (30%), Positives = 107/216 (49%), Gaps = 20/216 (9%)

Query: 404 FLCWIDMGSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNLVK 461
               I  GSFG+V++       + +AVK+L     H       + E + ++ +RH N+V 
Sbjct: 41  IKEKIGAGSFGTVHRAEWHG--SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL 98

Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDV 521
            +   +    +  +  ++V E++  GSL   LH          A + L+  +R+++A DV
Sbjct: 99  FMGAVT----QPPNL-SIVTEYLSRGSLYRLLH-------KSGAREQLDERRRLSMAYDV 146

Query: 522 ACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTI 581
           A  + YLH+   P   H +LK  N+L+D + T  V DFGL++L   A    SS    GT 
Sbjct: 147 AKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK--ASTFLSSKSAAGTP 203

Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
            ++AP E       +   DVYS+G++L EL T ++P
Sbjct: 204 EWMAP-EVLRDEPSNEKSDVYSFGVILWELATLQQP 238

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  155 bits (393), Expect = 1e-42
 Identities = 53/221 (23%), Positives = 87/221 (39%), Gaps = 31/221 (14%)

Query: 404 FLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSS--IAECSALRNIRHKNLVK 461
           FL  ++    G ++KG        I VKVL +      KS     EC  LR   H N++ 
Sbjct: 14  FLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71

Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDV 521
           +L  C            L+  +M  GSL   LH              ++  Q +  A+D+
Sbjct: 72  VLGACQ--SPPAPHP-TLITHWMPYGSLYNVLHE--------GTNFVVDQSQAVKFALDM 120

Query: 522 ACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTI 581
           A  + +LH   +P      L   +V++D +MTA ++   +            S G     
Sbjct: 121 ARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAP 172

Query: 582 GYIAP-----AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
            ++AP              +   D++S+ +LL EL+TR+ P
Sbjct: 173 AWVAPEALQKKPEDTNRRSA---DMWSFAVLLWELVTREVP 210

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  155 bits (394), Expect = 2e-42
 Identities = 74/311 (23%), Positives = 114/311 (36%), Gaps = 55/311 (17%)

Query: 404 FLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKIL 463
               +  G+FG V K         +A+K +        K+ I E   L  + H N+VK+ 
Sbjct: 12  VEEVVGRGAFGVVCKAKWR--AKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIVKLY 67

Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
             C            LV E+   GSL   LH         E          ++  +  + 
Sbjct: 68  GACLNPVC-------LVMEYAEGGSLYNVLH-------GAEPLPYYTAAHAMSWCLQCSQ 113

Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMT-AHVADFGLAKLLPPAHLQTSSIGVKGTIG 582
            + YLH        H DLKP N+LL    T   + DFG A       +QT     KG+  
Sbjct: 114 GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD-----IQTHMTNNKGSAA 168

Query: 583 YIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMD 642
           ++AP E   GS  S   DV+S+GI+L E++TR++P    F+  +    F        +M 
Sbjct: 169 WMAP-EVFEGSNYSEKCDVFSWGIILWEVITRRKP----FDE-IGGPAFR-------IMW 215

Query: 643 IVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE 702
            V +          +  N       I ++M            C  + P  R +M  +V  
Sbjct: 216 AVHNGTR-----PPLIKNL---PKPIESLMT----------RCWSKDPSQRPSMEEIVKI 257

Query: 703 LQSIKSILLGP 713
           +  +     G 
Sbjct: 258 MTHLMRYFPGA 268

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  152 bits (387), Expect = 9e-42
 Identities = 55/237 (23%), Positives = 96/237 (40%), Gaps = 51/237 (21%)

Query: 402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA-------ECSALRNI 454
             +   I  G FG V+KG L + K+++A+K L L         I        E   + N+
Sbjct: 21  IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80

Query: 455 RHKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQR 514
            H N+VK+  +         +   +V EF+  G L   L          +    + +  +
Sbjct: 81  NHPNIVKLYGLMH-------NPPRMVMEFVPCGDLYHRLL---------DKAHPIKWSVK 124

Query: 515 INIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLD-----HEMTAHVADFGLAKLLPPAH 569
           + + +D+A  ++Y+ +   P   H DL+  N+ L        + A VADFGL++      
Sbjct: 125 LRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV--- 180

Query: 570 LQTSSIGVKGTIGYIAPAEYGLGSEVSING---------DVYSYGILLLELMTRKRP 617
              S  G+ G   ++AP       E  I           D YS+ ++L  ++T + P
Sbjct: 181 --HSVSGLLGNFQWMAP-------ET-IGAEEESYTEKADTYSFAMILYTILTGEGP 227

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  152 bits (385), Expect = 1e-41
 Identities = 60/223 (26%), Positives = 91/223 (40%), Gaps = 35/223 (15%)

Query: 407 WIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA----ECSALRNIRHKNLVKI 462
            I +G FG VY+         +AVK            +I     E      ++H N++ +
Sbjct: 14  IIGIGGFGKVYRAFWIG--DEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71

Query: 463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVA 522
             VC     K  +   LV EF   G L   L             K +     +N A+ +A
Sbjct: 72  RGVCL----KEPNL-CLVMEFARGGPLNRVLSG-----------KRIPPDILVNWAVQIA 115

Query: 523 CALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH--------VADFGLAKLLPPAHLQTSS 574
             + YLH +      H DLK SN+L+  ++           + DFGLA+       +T+ 
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH----RTTK 171

Query: 575 IGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
           +   G   ++AP E    S  S   DV+SYG+LL EL+T + P
Sbjct: 172 MSAAGAYAWMAP-EVIRASMFSKGSDVWSYGVLLWELLTGEVP 213

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  153 bits (389), Expect = 3e-41
 Identities = 72/315 (22%), Positives = 134/315 (42%), Gaps = 33/315 (10%)

Query: 20  LPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQ 79
           L NL +L+L  NQIT + P S  N  KL    + +N +T    S     T          
Sbjct: 65  LTNLEYLNLNGNQITDISPLS--NLVKLTNLYIGTNKITD--ISALQNLT---------- 110

Query: 80  HLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQ 139
           +L+ L +N +N   + P  + N +  + +L   +N    S  + +     L  L + +++
Sbjct: 111 NLRELYLNEDNISDISP--LANLT-KMYSLNLGANHN-LSDLSPLSNMTGLNYLTVTESK 166

Query: 140 LSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQC 199
           +       I  L +L +L++N N++    P  + +L  L       N  Q++  + +   
Sbjct: 167 VKD--VTPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVN--QITDITPVANM 220

Query: 200 QSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRN 259
             L ++ +  N ++   P  L +L+ L+  L++  NQ+  S    V  L  L++L +  N
Sbjct: 221 TRLNSLKIGNNKITDLSP--LANLSQLTW-LEIGTNQI--SDINAVKDLTKLKMLNVGSN 275

Query: 260 MLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVE 319
            +    +S L +  +L  L L  N         +  L  L  L LSQN+I+   P  L  
Sbjct: 276 QISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LAS 331

Query: 320 LQLVQNLNLSYNDLE 334
           L  + + + +   ++
Sbjct: 332 LSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  151 bits (384), Expect = 1e-40
 Identities = 67/321 (20%), Positives = 121/321 (37%), Gaps = 35/321 (10%)

Query: 20  LPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQ 79
           L   +   L    +T V+         +    V    +           T          
Sbjct: 21  LAEGIRAVLQKASVTDVVTQE--ELESITKLVVAGEKVAS--IQGIEYLTN--------- 67

Query: 80  HLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQ 139
            L++L++N N    + P  + N    L  L   +NKI  +  + +    NL+ L++ ++ 
Sbjct: 68  -LEYLNLNGNQITDISP--LSNLV-KLTNLYIGTNKI--TDISALQNLTNLRELYLNEDN 121

Query: 140 LSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQC 199
           +S      +  L  + +L +  N    ++ P + N+  L  L + E+  +V   + +   
Sbjct: 122 ISD--ISPLANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTES--KVKDVTPIANL 176

Query: 200 QSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRN 259
             L +++L+YN +    P  L  LTSL        NQ+    P  V  +  L  L I  N
Sbjct: 177 TDLYSLSLNYNQIEDISP--LASLTSLHY-FTAYVNQITDITP--VANMTRLNSLKIGNN 231

Query: 260 MLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVE 319
            +    LS L +  +L  L++G N         +  L  L++L++  N IS      L  
Sbjct: 232 KI--TDLSPLANLSQLTWLEIGTNQISDINA--VKDLTKLKMLNVGSNQISD--ISVLNN 285

Query: 320 LQLVQNLNLSYNDLEGVIPTE 340
           L  + +L L+ N L       
Sbjct: 286 LSQLNSLFLNNNQLGNEDMEV 306

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  120 bits (304), Expect = 5e-30
 Identities = 51/253 (20%), Positives = 99/253 (39%), Gaps = 36/253 (14%)

Query: 106 LETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTIS-------------------- 145
             TL      I +  P             +    ++  ++                    
Sbjct: 2   AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVTQEELESITKLVVAGEKVASI 59

Query: 146 PAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTI 205
             I  L NL  L +N N+++ +I P + NL KL  LY+  N  +++  S+L    +L  +
Sbjct: 60  QGIEYLTNLEYLNLNGNQIT-DISP-LSNLVKLTNLYIGTN--KITDISALQNLTNLREL 115

Query: 206 NLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEI 265
            L+ +N+S   P  L +LT +   L+L  N  + S  + +  +  L  L ++ + +  + 
Sbjct: 116 YLNEDNISDISP--LANLTKMYS-LNLGANHNL-SDLSPLSNMTGLNYLTVTESKV--KD 169

Query: 266 LSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQN 325
           ++ + +   L  L L  N  +   P  L+SL  L       N I+   P  +  +  + +
Sbjct: 170 VTPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNS 225

Query: 326 LNLSYNDLEGVIP 338
           L +  N +  + P
Sbjct: 226 LKIGNNKITDLSP 238

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  105 bits (265), Expect = 7e-25
 Identities = 49/252 (19%), Positives = 91/252 (36%), Gaps = 46/252 (18%)

Query: 6   NRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEF 65
           + +    PL     L  +  L+LG N       S + N + L    VT + +     +  
Sbjct: 120 DNISDISPLA---NLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKD--VTPI 173

Query: 66  GKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIG 125
              T           L  L +N N    + P  + + + +L       N+I   I   + 
Sbjct: 174 ANLTD----------LYSLSLNYNQIEDISP--LASLT-SLHYFTAYVNQI-TDITP-VA 218

Query: 126 KFINLQTLHMWDNQLSGTIS--------------------PAIGELQNLVTLAINTNKLS 165
               L +L + +N+++                         A+ +L  L  L + +N++S
Sbjct: 219 NMTRLNSLKIGNNKITDLSPLANLSQLTWLEIGTNQISDINAVKDLTKLKMLNVGSNQIS 278

Query: 166 GNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTS 225
                 + NL +L  L+L  N L       +G   +LTT+ LS N+++   P  L  L+ 
Sbjct: 279 D--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSK 334

Query: 226 LSVGLDLSRNQL 237
           +    D +   +
Sbjct: 335 MDS-ADFANQVI 345

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  151 bits (383), Expect = 3e-41
 Identities = 61/215 (28%), Positives = 92/215 (42%), Gaps = 25/215 (11%)

Query: 407 WIDMGSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNLVKILT 464
            I  GSFG+VYKG        +AVK+LN+        ++   E   LR  RH N++  + 
Sbjct: 31  RIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87

Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
             +          A+V ++    SL   LH          +       + I+IA   A  
Sbjct: 88  YSTAPQL------AIVTQWCEGSSLYHHLH---------ASETKFEMKKLIDIARQTARG 132

Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYI 584
           + YLH     +  H DLK +N+ L  + T  + DFGLA              + G+I ++
Sbjct: 133 MDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 189

Query: 585 AP--AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
           AP        +  S   DVY++GI+L ELMT + P
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  152 bits (386), Expect = 4e-41
 Identities = 48/311 (15%), Positives = 98/311 (31%), Gaps = 25/311 (8%)

Query: 43  NASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQN---------CNQHLKHLDINNNNFGG 93
           ++S  E      +           +  + Y              N +   ++        
Sbjct: 10  HSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALK 69

Query: 94  LLPGCICNF-SITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQ 152
                + +        L   S  +    P    +  +LQ + +    L   +   + +  
Sbjct: 70  ATADLLEDATQPGRVALELRSVPL-PQFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFA 127

Query: 153 NLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQC---------QSLT 203
            L TL +  N L   +P SI +L +L +L +        +P  L             +L 
Sbjct: 128 GLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQ 186

Query: 204 TINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLEC 263
           ++ L +  +  ++P  + +L +L   L +  + L  +L   +  L  LE L +       
Sbjct: 187 SLRLEWTGIR-SLPASIANLQNLKS-LKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALR 243

Query: 264 EILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLV 323
                 G    L++L L        +PL +  L  L  LDL        +P  + +L   
Sbjct: 244 NYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPAN 303

Query: 324 QNLNLSYNDLE 334
             + +  +   
Sbjct: 304 CIILVPPHLQA 314

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  141 bits (358), Expect = 3e-37
 Identities = 52/308 (16%), Positives = 108/308 (35%), Gaps = 29/308 (9%)

Query: 20  LPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQ 79
           L                      N++  ++   T   L          AT          
Sbjct: 32  LSQWQRHYNADRNRWH-SAWRQANSNNPQIETRTGRALK-ATADLLEDAT--------QP 81

Query: 80  HLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQ 139
               L++ +       P      S  L+ +  ++  +   +P  + +F  L+TL +  N 
Sbjct: 82  GRVALELRSVPLPQF-PDQAFRLS-HLQHMTIDAAGL-MELPDTMQQFAGLETLTLARNP 138

Query: 140 LSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGN---------LKKLLQLYLIENFLQV 190
           L   +  +I  L  L  L+I        +P  + +         L  L  L L    ++ 
Sbjct: 139 LR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR- 196

Query: 191 SIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLIN 250
           S+P+S+   Q+L ++ +  + LS  + P +  L  L   LDL     + + P   G    
Sbjct: 197 SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEE-LDLRGCTALRNYPPIFGGRAP 254

Query: 251 LEILFIS-RNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNI 309
           L+ L +   + L   +   +    +LE+L L G +    +P  ++ L    ++ +   ++
Sbjct: 255 LKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVP-PHL 312

Query: 310 SGEIPKFL 317
             ++ +  
Sbjct: 313 QAQLDQHR 320

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  133 bits (338), Expect = 1e-34
 Identities = 49/242 (20%), Positives = 91/242 (37%), Gaps = 26/242 (10%)

Query: 18  FTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNC 77
           F L +L  +++    +   +P +M   + LE   +  N L   +P+      +       
Sbjct: 101 FRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNR------- 151

Query: 78  NQHLKHLDINNNNFGGLLPGCICNFSIT--------LETLIFNSNKIFRSIPAGIGKFIN 129
              L+ L I        LP  + +   +        L++L      I RS+PA I    N
Sbjct: 152 ---LRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGI-RSLPASIANLQN 207

Query: 130 LQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQ 189
           L++L + ++ LS  + PAI  L  L  L +       N PP  G    L +L L +    
Sbjct: 208 LKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNL 266

Query: 190 VSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRN---QLVGSLPTEVG 246
           +++P  + +   L  ++L        +P  +  L +  + + +  +   QL    P    
Sbjct: 267 LTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCI-ILVPPHLQAQLDQHRPVARP 325

Query: 247 KL 248
             
Sbjct: 326 AE 327

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 83.5 bits (207), Expect = 2e-17
 Identities = 38/198 (19%), Positives = 63/198 (31%), Gaps = 32/198 (16%)

Query: 166 GNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSG----------- 214
           G+      +      LY   +         L Q Q     + +  + +            
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE 61

Query: 215 --------TIPPQLMDLTSLS-VGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEI 265
                        L D T    V L+L    L    P +  +L +L+ + I    L  E+
Sbjct: 62  TRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-EL 119

Query: 266 LSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLV-- 323
             T+     LE L L  N  +  +P S++SL  LR L +       E+P+ L        
Sbjct: 120 PDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGE 178

Query: 324 -------QNLNLSYNDLE 334
                  Q+L L +  + 
Sbjct: 179 HQGLVNLQSLRLEWTGIR 196

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  150 bits (380), Expect = 3e-40
 Identities = 64/310 (20%), Positives = 108/310 (34%), Gaps = 38/310 (12%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G +G V+ G        +AVKV       AS     E      +RH+N++  +       
Sbjct: 48  GRYGEVWMGKWRG--EKVAVKVFFT-TEEASWFRETEIYQTVLMRHENILGFIAADIKGT 104

Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH- 529
                   L+ ++  NGSL ++L               L+    + +A      L +LH 
Sbjct: 105 GSWTQL-YLITDYHENGSLYDYLKS-----------TTLDAKSMLKLAYSSVSGLCHLHT 152

Query: 530 ----HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPA--HLQTSSIGVKGTIGY 583
                  +P  AH DLK  N+L+    T  +AD GLA         +        GT  Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212

Query: 584 IAP-----AEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPD 638
           + P     +      +  I  D+YS+G++L E+  R     I+ E  +  H+    V  D
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL---VPSD 269

Query: 639 HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTI 698
              + +   +       +  +             ECL  + ++   C   +P  R+    
Sbjct: 270 PSYEDMREIVCIKKLRPSFPNRWSSD--------ECLRQMGKLMTECWAHNPASRLTALR 321

Query: 699 VVHELQSIKS 708
           V   L  +  
Sbjct: 322 VKKTLAKMSE 331

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  149 bits (377), Expect = 3e-40
 Identities = 48/225 (21%), Positives = 90/225 (40%), Gaps = 27/225 (12%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G +G V++G        +AVK+ +      S     E      +RH+N++  +       
Sbjct: 19  GRYGEVWRGSWQG--ENVAVKIFSS-RDEKSWFRETELYNTVMLRHENILGFIASDMTSR 75

Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
           +       L+  +   GSL ++L               L+ +  + I + +A  L +LH 
Sbjct: 76  HSSTQL-WLITHYHEMGSLYDYLQL-----------TTLDTVSCLRIVLSIASGLAHLHI 123

Query: 531 D-----CQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPA--HLQTSSIGVKGTIGY 583
           +      +P  AH DLK  N+L+       +AD GLA +   +   L   +    GT  Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183

Query: 584 IAP-----AEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFE 623
           +AP            +     D++++G++L E+  R   + I+ +
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 228

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  155 bits (395), Expect = 3e-40
 Identities = 60/363 (16%), Positives = 116/363 (31%), Gaps = 34/363 (9%)

Query: 2   DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTS------- 54
            +  N     I       L  L    L   +        +F  S +E     +       
Sbjct: 210 TLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLT 269

Query: 55  -NNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNS 113
             N   +   +F          +C  ++  + +   +   L            ++L    
Sbjct: 270 YTNDFSDDIVKF----------HCLANVSAMSLAGVSIKYLEDVP---KHFKWQSLSIIR 316

Query: 114 NKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLS--GNIPPS 171
            ++ +  P        L++L +  N+ S  IS     L +L  L ++ N LS  G    S
Sbjct: 317 CQL-KQFPTL--DLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYS 371

Query: 172 IGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQ-LMDLTSLSVGL 230
                 L  L L  N     + ++    + L  ++  ++ L         + L  L   L
Sbjct: 372 DLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLY-L 429

Query: 231 DLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILS-TLGSCIKLEQLKLGGNLFQGPI 289
           D+S              L +L  L ++ N  +   LS    +   L  L L     +   
Sbjct: 430 DISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQIS 489

Query: 290 PLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKNASAI 349
                +L  L++L++S NN+         +L  +  L+ S+N +E       +     ++
Sbjct: 490 WGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKG--ILQHFPKSL 547

Query: 350 SVF 352
           + F
Sbjct: 548 AFF 550

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  154 bits (391), Expect = 1e-39
 Identities = 54/321 (16%), Positives = 102/321 (31%), Gaps = 24/321 (7%)

Query: 17  GFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQN 76
           G     +    L +              + +    +   ++                   
Sbjct: 257 GLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPK----------- 305

Query: 77  CNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMW 136
            +   + L I            +      L++L    NK   SI        +L  L + 
Sbjct: 306 -HFKWQSLSIIRCQLKQFPTLDLPF----LKSLTLTMNKG--SISFKKVALPSLSYLDLS 358

Query: 137 DNQLSGTISPAIGELQ--NLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIP- 193
            N LS +   +  +L   +L  L ++ N     +  +   L++L  L    + L+     
Sbjct: 359 RNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEF 417

Query: 194 SSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEV-GKLINLE 252
           S+    + L  +++SY N         + LTSL+  L ++ N    +  + V     NL 
Sbjct: 418 SAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNT-LKMAGNSFKDNTLSNVFANTTNLT 476

Query: 253 ILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGE 312
            L +S+  LE        +  +L+ L +  N          + L  L  LD S N I   
Sbjct: 477 FLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETS 536

Query: 313 IPKFLVELQLVQNLNLSYNDL 333
                   + +   NL+ N +
Sbjct: 537 KGILQHFPKSLAFFNLTNNSV 557

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  147 bits (372), Expect = 2e-37
 Identities = 61/353 (17%), Positives = 109/353 (30%), Gaps = 35/353 (9%)

Query: 6   NRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEF 65
           N ++      F      L +L L   +I  +   +      L    +T N +    P  F
Sbjct: 42  NPLKILKSYSFSN-FSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSF 100

Query: 66  GKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFR-SIPAGI 124
                     +    L++L         L    I     TL+ L    N I    +PA  
Sbjct: 101 ----------SGLTSLENLVAVETKLASLESFPIGQLI-TLKKLNVAHNFIHSCKLPAYF 149

Query: 125 GKFINLQTLHMWDNQLSGTISPAIGELQNL----VTLAINTNKLSGNIPPSIGNLKKLLQ 180
               NL  + +  N +       +  L+      ++L ++ N +   I        KL +
Sbjct: 150 SNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHE 208

Query: 181 LYLIENFLQVSIPSSLGQ-CQSLTTINLSYNNLSGTI------PPQLMDLTSLSVG-LDL 232
           L L  NF   +I  +  Q    L    L               P  +  L  +++    L
Sbjct: 209 LTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRL 268

Query: 233 SRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLS 292
           +          +   L N+  + ++   +  + L  +    K + L +     +      
Sbjct: 269 TYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQLKQ---FP 323

Query: 293 LSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKN 345
              L  L+ L L+ N  S  I    V L  +  L+LS N L         + +
Sbjct: 324 TLDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGC--CSYSD 372

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  129 bits (326), Expect = 2e-31
 Identities = 60/299 (20%), Positives = 104/299 (34%), Gaps = 25/299 (8%)

Query: 73  CVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQT 132
           C++            +     +      +   + + +  + N +          F  LQ 
Sbjct: 7   CIEVVPN--ITYQCMDQKLSKVPD----DIPSSTKNIDLSFNPLKILKSYSFSNFSELQW 60

Query: 133 LHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSI 192
           L +   ++      A   L +L  L +  N +    P S   L  L  L  +E  L    
Sbjct: 61  LDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLE 120

Query: 193 PSSLGQCQSLTTINLSYNNLSG-TIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINL 251
              +GQ  +L  +N+++N +    +P    +LT+L   +DLS N +      ++  L   
Sbjct: 121 SFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVH-VDLSYNYIQTITVNDLQFLREN 179

Query: 252 ----EILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIP-LSLSSLRGLRVLDLSQ 306
                 L +S N ++  I       IKL +L L GN     I    L +L GL V  L  
Sbjct: 180 PQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLIL 238

Query: 307 NNISG---------EIPKFLVELQLVQNLNLSYNDLEGVIP-TEGVFKNASAISVFGNS 355
                          I + L ++ +     L+Y +             N SA+S+ G S
Sbjct: 239 GEFKDERNLEIFEPSIMEGLCDVTI-DEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVS 296

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  122 bits (307), Expect = 4e-29
 Identities = 55/293 (18%), Positives = 94/293 (32%), Gaps = 18/293 (6%)

Query: 18  FTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNC 77
             LP L  L+L  N+ +  I         L    ++ N L+      +            
Sbjct: 325 LDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYS--------DLG 374

Query: 78  NQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAG-IGKFINLQTLHMW 136
              L+HLD++ N    ++          L+ L F  + + R            L  L + 
Sbjct: 375 TNSLRHLDLSFNGAI-IMSANFMGLE-ELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDIS 432

Query: 137 DNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSI-GNLKKLLQLYLIENFLQVSIPSS 195
                         L +L TL +  N    N   ++  N   L  L L +  L+      
Sbjct: 433 YTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGV 492

Query: 196 LGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILF 255
                 L  +N+S+NNL          L SLS  LD S N++  S         +L    
Sbjct: 493 FDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLST-LDCSFNRIETSKGILQHFPKSLAFFN 551

Query: 256 ISRNMLECEI-LSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQN 307
           ++ N + C          +K ++  L     +     +   +    VLD + +
Sbjct: 552 LTNNSVACICEHQKFLQWVKEQKQFLVN--VEQMTCATPVEMNTSLVLDFNNS 602

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  101 bits (253), Expect = 2e-22
 Identities = 37/198 (18%), Positives = 64/198 (32%), Gaps = 12/198 (6%)

Query: 17  GFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQN 76
                +L  L L FN    ++ ++     +L+      + L                  +
Sbjct: 372 DLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSA--------FLS 422

Query: 77  CNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGI-GKFINLQTLHM 135
             + L +LDI+  N      G     + +L TL    N    +  + +     NL  L +
Sbjct: 423 L-EKLLYLDISYTNTKIDFDGIFLGLT-SLNTLKMAGNSFKDNTLSNVFANTTNLTFLDL 480

Query: 136 WDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSS 195
              QL          L  L  L ++ N L          L  L  L    N ++ S    
Sbjct: 481 SKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGIL 540

Query: 196 LGQCQSLTTINLSYNNLS 213
               +SL   NL+ N+++
Sbjct: 541 QHFPKSLAFFNLTNNSVA 558

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  146 bits (370), Expect = 8e-39
 Identities = 62/312 (19%), Positives = 113/312 (36%), Gaps = 42/312 (13%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G FG V++G        +AVK+ +      S    AE      +RH+N++  +   +  +
Sbjct: 53  GRFGEVWRGKWRG--EEVAVKIFSS-REERSWFREAEIYQTVMLRHENILGFIAADNKDN 109

Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
                   LV ++  +GSL ++L+              +     I +A+  A  L +LH 
Sbjct: 110 GTWTQL-WLVSDYHEHGSLFDYLNR-----------YTVTVEGMIKLALSTASGLAHLHM 157

Query: 531 D-----CQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPA--HLQTSSIGVKGTIGY 583
           +      +P  AH DLK  N+L+    T  +AD GLA     A   +  +     GT  Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217

Query: 584 IAP-----AEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPD 638
           +AP     +      E     D+Y+ G++  E+  R     I  +  +    +   V  D
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL---PYYDLVPSD 274

Query: 639 HVMDIVDSTLLADDEDLTITSNQRQRQA--RINNIMECLISVVRIGVACSMESPQDRMNM 696
             ++ +   +        I +  +  +A   +  IM            C   +   R+  
Sbjct: 275 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR----------ECWYANGAARLTA 324

Query: 697 TIVVHELQSIKS 708
             +   L  +  
Sbjct: 325 LRIKKTLSQLSQ 336

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  148 bits (377), Expect = 1e-38
 Identities = 78/319 (24%), Positives = 127/319 (39%), Gaps = 37/319 (11%)

Query: 20  LPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQ 79
           L   +   LG   +T  +  +  +  ++   Q     +                      
Sbjct: 23  LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNN--------- 69

Query: 80  HLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQ 139
            L  ++ +NN    + P  + N +  L  ++ N+N+I    P  +    NL  L +++NQ
Sbjct: 70  -LTQINFSNNQLTDITP--LKNLT-KLVDILMNNNQIADITP--LANLTNLTGLTLFNNQ 123

Query: 140 LSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQC 199
           ++      +  L NL  L +++N +S     ++  L  L QL        V+    L   
Sbjct: 124 ITD--IDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQ---VTDLKPLANL 176

Query: 200 QSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRN 259
            +L  +++S N +S      L  LT+L   L  + NQ+    P  +G L NL+ L ++ N
Sbjct: 177 TTLERLDISSNKVSD--ISVLAKLTNLES-LIATNNQISDITP--LGILTNLDELSLNGN 231

Query: 260 MLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVE 319
            L  + + TL S   L  L L  N      P  LS L  L  L L  N IS   P  L  
Sbjct: 232 QL--KDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAG 285

Query: 320 LQLVQNLNLSYNDLEGVIP 338
           L  + NL L+ N LE + P
Sbjct: 286 LTALTNLELNENQLEDISP 304

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  139 bits (352), Expect = 2e-35
 Identities = 86/339 (25%), Positives = 137/339 (40%), Gaps = 38/339 (11%)

Query: 20  LPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQ 79
           L NL  L+L  NQIT + P    N + L   +++SN ++    S     T    +   NQ
Sbjct: 111 LTNLTGLTLFNNQITDIDPLK--NLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQ 166

Query: 80  -----------HLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFI 128
                       L+ LDI++N    +    +   +  LE+LI  +N+I   I   +G   
Sbjct: 167 VTDLKPLANLTTLERLDISSNKVSDISV--LAKLT-NLESLIATNNQI-SDIT-PLGILT 221

Query: 129 NLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFL 188
           NL  L +  NQL       +  L NL  L +  N++S   P  +  L KL +L L  N  
Sbjct: 222 NLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGAN-- 275

Query: 189 QVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKL 248
           Q+S  S L    +LT + L+ N L    P  + +L +L+  L L  N +    P  V  L
Sbjct: 276 QISNISPLAGLTALTNLELNENQLEDISP--ISNLKNLTY-LTLYFNNISDISP--VSSL 330

Query: 249 INLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNN 308
             L+ LF   N +    +S+L +   +  L  G N      PL+  +L  +  L L+   
Sbjct: 331 TKLQRLFFYNNKVS--DVSSLANLTNINWLSAGHNQISDLTPLA--NLTRITQLGLNDQA 386

Query: 309 ISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKNAS 347
            +     +   + +    N   N    +I    +    S
Sbjct: 387 WTNAPVNYKANVSI---PNTVKNVTGALIAPATISDGGS 422

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  109 bits (275), Expect = 2e-25
 Identities = 51/234 (21%), Positives = 91/234 (38%), Gaps = 19/234 (8%)

Query: 105 TLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKL 164
            L +     +     I              +    ++ T+S    +L  + TL  +   +
Sbjct: 2   PLGSATITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI 58

Query: 165 SGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLT 224
                  +  L  L Q+    N  Q++  + L     L  I ++ N ++   P  L +LT
Sbjct: 59  K--SIDGVEYLNNLTQINFSNN--QLTDITPLKNLTKLVDILMNNNQIADITP--LANLT 112

Query: 225 SLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNL 284
           +L+  L L  NQ+    P  +  L NL  L +S N +    +S L     L+QL  G  +
Sbjct: 113 NLTG-LTLFNNQITDIDP--LKNLTNLNRLELSSNTI--SDISALSGLTSLQQLSFGNQV 167

Query: 285 FQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIP 338
                   L++L  L  LD+S N +S      L +L  +++L  + N +  + P
Sbjct: 168 TD---LKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP 216

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  106 bits (268), Expect = 1e-24
 Identities = 55/294 (18%), Positives = 103/294 (35%), Gaps = 36/294 (12%)

Query: 2   DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEV 61
               N++    PL     L NL  LSL  NQ+  +   ++ + + L    + +N ++   
Sbjct: 205 IATNNQISDITPLG---ILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISN-- 257

Query: 62  PSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIP 121
            +     TK          L  L +  N    + P  +   +  L  L  N N++    P
Sbjct: 258 LAPLSGLTK----------LTELKLGANQISNISP--LAGLT-ALTNLELNENQLEDISP 304

Query: 122 AGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQL 181
             I    NL  L ++ N +S      +  L  L  L    NK+S     S+ NL  +  L
Sbjct: 305 --ISNLKNLTYLTLYFNNISD--ISPVSSLTKLQRLFFYNNKVSD--VSSLANLTNINWL 358

Query: 182 YLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSL 241
               N  Q+S  + L     +T + L+    +        +++  +   +++   +    
Sbjct: 359 SAGHN--QISDLTPLANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI---A 413

Query: 242 PTEVGKLINLEILFISRNMLEC--EILSTLGSCIKLEQLKLGGNLFQGPIPLSL 293
           P  +    +     I+ N+     E+  T     +   +  G   F G +   L
Sbjct: 414 PATISDGGSYTEPDITWNLPSYTNEVSYTFS---QPVTIGKGTTTFSGTVTQPL 464

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  143 bits (363), Expect = 3e-38
 Identities = 56/320 (17%), Positives = 105/320 (32%), Gaps = 65/320 (20%)

Query: 407 WIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGAS--KSSIAECSALRNIRHKNLVKILT 464
            I  G FG VY G        +A++++++        K+   E  A R  RH+N+V  + 
Sbjct: 40  LIGKGRFGQVYHGRW---HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96

Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
            C           A++       +L   +          +A   L+  +   IA ++   
Sbjct: 97  ACM----SPPHL-AIITSLCKGRTLYSVVR---------DAKIVLDVNKTRQIAQEIVKG 142

Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKL---LPPAHLQTSSIGVKGTI 581
           + YLH        H DLK  NV  D      + DFGL  +   L     +       G +
Sbjct: 143 MGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWL 198

Query: 582 GYIAP--------AEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFAR 633
            ++AP                 S + DV++ G +  EL  R+ P    F+          
Sbjct: 199 CHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP----FKT-QP------ 247

Query: 634 TVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDR 693
               + ++  +              +  +   ++I         +  I + C     ++R
Sbjct: 248 ---AEAIIWQMG-------------TGMKPNLSQIG----MGKEISDILLFCWAFEQEER 287

Query: 694 MNMTIVVHELQSIKSILLGP 713
              T ++  L+ +       
Sbjct: 288 PTFTKLMDMLEKLPKRNRRL 307

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  143 bits (362), Expect = 5e-38
 Identities = 57/245 (23%), Positives = 92/245 (37%), Gaps = 34/245 (13%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G FG   K    E   ++ +K L        ++ + E   +R + H N++K + V     
Sbjct: 21  GCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL---- 76

Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
           YK       + E++  G+L   +  +              + QR++ A D+A  + YLH 
Sbjct: 77  YKDKRL-NFITEYIKGGTLRGIIKSMDSQ---------YPWSQRVSFAKDIASGMAYLH- 125

Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP------------PAHLQTSSIGVK 578
                  H DL   N L+       VADFGLA+L+                 +     V 
Sbjct: 126 --SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183

Query: 579 GTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNM----NLHNFART 634
           G   ++AP E   G       DV+S+GI+L E++ R           M    N+  F   
Sbjct: 184 GNPYWMAP-EMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR 242

Query: 635 VLPDH 639
             P +
Sbjct: 243 YCPPN 247

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  145 bits (368), Expect = 2e-37
 Identities = 56/331 (16%), Positives = 115/331 (34%), Gaps = 30/331 (9%)

Query: 12  IPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKA 71
                  +  N+  L L  N ++ +  + +   +KLE+  ++SN L      +    +  
Sbjct: 25  ALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TLDLESLST- 81

Query: 72  YCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQ 131
                    L+ LD+NNN    LL G       ++ETL   +N I   +          +
Sbjct: 82  ---------LRTLDLNNNYVQELLVG------PSIETLHAANNNI-SRVSCSR--GQGKK 123

Query: 132 TLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSG-NIPPSIGNLKKLLQLYLIENFLQV 190
            +++ +N+++       G    +  L +  N++   N      +   L  L L  NF+  
Sbjct: 124 NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY- 182

Query: 191 SIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLIN 250
            +   +     L T++LS N L+  + P+      ++  + L  N+LV  +   +    N
Sbjct: 183 DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTW-ISLRNNKLV-LIEKALRFSQN 238

Query: 251 LEILFISRNMLECEILSTLGSCIKLEQLK-LGGNLFQGPIPLSLSSLRGLRVLDLSQNNI 309
           LE   +  N   C  L    S  K ++++ +     +     +        +        
Sbjct: 239 LEHFDLRGNGFHCGTLRDFFS--KNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCC 296

Query: 310 SGEIPKFLVELQLVQNLNLSYNDLEGVIPTE 340
                 F   L  ++    +    +G     
Sbjct: 297 EDLPAPFADRLIALKRKEHALLSGQGSETER 327

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  138 bits (348), Expect = 7e-35
 Identities = 60/316 (18%), Positives = 117/316 (37%), Gaps = 28/316 (8%)

Query: 20  LPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQ 79
                   +  + +   + S   +A  ++   ++ N L+    ++    TK         
Sbjct: 9   GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTK--------- 59

Query: 80  HLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQ 139
            L+ L++++N     L   + + S TL TL  N+N + + +  G     +++TLH  +N 
Sbjct: 60  -LELLNLSSNVLYETLD--LESLS-TLRTLDLNNNYV-QELLVG----PSIETLHAANNN 110

Query: 140 LSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQ-VSIPSSLGQ 198
           +S  +S +    Q    + +  NK++       G   ++  L L  N +  V+       
Sbjct: 111 IS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAAS 167

Query: 199 CQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISR 258
             +L  +NL YN +   +  Q++    L   LDLS N+L   +  E      +  + +  
Sbjct: 168 SDTLEHLNLQYNFIY-DVKGQVV-FAKLKT-LDLSSNKLA-FMGPEFQSAAGVTWISLRN 223

Query: 259 NMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLV 318
           N L   I   L     LE   L GN F           +  RV  +++  +     +   
Sbjct: 224 NKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEE 281

Query: 319 ELQLVQNLNLSYNDLE 334
           E  +    +      E
Sbjct: 282 ECTVPTLGHYGAYCCE 297

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  133 bits (337), Expect = 2e-33
 Identities = 50/279 (17%), Positives = 96/279 (34%), Gaps = 17/279 (6%)

Query: 78  NQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWD 137
               K   + +++    L     +    ++ L  + N + +   A +  F  L+ L++  
Sbjct: 9   GNRYKIEKVTDSSLKQALASLRQSAW-NVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67

Query: 138 NQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLG 197
           N L    +  +  L  L TL +N N +       +     +  L+   N +   +  S G
Sbjct: 68  NVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSRG 119

Query: 198 QCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVG-SLPTEVGKLINLEILFI 256
           Q      I L+ N ++          + +   LDL  N++   +          LE L +
Sbjct: 120 Q--GKKNIYLANNKITMLRDLDEGCRSRVQY-LDLKLNEIDTVNFAELAASSDTLEHLNL 176

Query: 257 SRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKF 316
             N +    +       KL+ L L  N     +     S  G+  + L  N +   I K 
Sbjct: 177 QYNFIY--DVKGQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKA 232

Query: 317 LVELQLVQNLNLSYNDLEGVIPTEGVFKNASAISVFGNS 355
           L   Q +++ +L  N        +   KN    +V   +
Sbjct: 233 LRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQT 271

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  129 bits (327), Expect = 4e-32
 Identities = 52/301 (17%), Positives = 108/301 (35%), Gaps = 28/301 (9%)

Query: 37  IPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLP 96
           I     N ++ ++ +VT ++L   + S    A           ++K LD++ N    +  
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAW----------NVKELDLSGNPLSQISA 51

Query: 97  GCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVT 156
             +  F+  LE L  +SN +       +     L+TL + +N +       +    ++ T
Sbjct: 52  ADLAPFT-KLELLNLSSNVL-YETLD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIET 103

Query: 157 LAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTI 216
           L    N +S  +  S    +    +YL  N + +      G    +  ++L  N +    
Sbjct: 104 LHAANNNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVN 160

Query: 217 PPQLM-DLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKL 275
             +L     +L   L+L  N +   +  +V     L+ L +S N L   +     S   +
Sbjct: 161 FAELAASSDTLEH-LNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGV 216

Query: 276 EQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEG 335
             + L  N     I  +L   + L   DL  N       +     +  +   ++   ++ 
Sbjct: 217 TWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFF-SKNQRVQTVAKQTVKK 274

Query: 336 V 336
           +
Sbjct: 275 L 275

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  121 bits (304), Expect = 3e-29
 Identities = 47/262 (17%), Positives = 95/262 (36%), Gaps = 15/262 (5%)

Query: 106 LETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLS 165
            +      + + +++ +      N++ L +  N LS   +  +     L  L +++N L 
Sbjct: 12  YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY 71

Query: 166 GNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTS 225
                 + +L  L  L L  N++       L    S+ T++ + NN+S     +     +
Sbjct: 72  E--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISRVSCSRGQGKKN 124

Query: 226 LSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLEC-EILSTLGSCIKLEQLKLGGNL 284
               + L+ N++      + G    ++ L +  N ++         S   LE L L  N 
Sbjct: 125 ----IYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF 180

Query: 285 FQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFK 344
               +         L+ LDLS N ++  +         V  ++L  N L  +       +
Sbjct: 181 IYD-VK-GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQ 237

Query: 345 NASAISVFGNSKLCGGIPEFQL 366
           N     + GN   CG + +F  
Sbjct: 238 NLEHFDLRGNGFHCGTLRDFFS 259

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  121 bits (304), Expect = 3e-29
 Identities = 49/325 (15%), Positives = 98/325 (30%), Gaps = 32/325 (9%)

Query: 20  LPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQ 79
           L  L  L L  N +       +     +E     +NN++  V    G            Q
Sbjct: 79  LSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSRG------------Q 120

Query: 80  HLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAG--IGKFINLQTLHMWD 137
             K++ + NN    L        S  ++ L    N+I  ++           L+ L++  
Sbjct: 121 GKKNIYLANNKITMLRDLDEGCRS-RVQYLDLKLNEI-DTVNFAELAASSDTLEHLNLQY 178

Query: 138 NQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLG 197
           N +   +   +     L TL +++NKL+  + P   +   +  + L  N L   I  +L 
Sbjct: 179 NFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALR 234

Query: 198 QCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFIS 257
             Q+L   +L  N             +       +++  +         +     +    
Sbjct: 235 FSQNLEHFDLRGNGFHCGTLRDF--FSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYG 292

Query: 258 RNMLECEILSTLGSCIKLEQLKLGGNLFQG----PIPLSLSSLRGLRVLDLSQNNISGEI 313
               E          I L++ +      QG     +     +    R +D  +      I
Sbjct: 293 AYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVI 352

Query: 314 PKFLVELQLVQNLNLSYNDLEGVIP 338
            +  +  Q    L      L+  + 
Sbjct: 353 DQVTLRKQAKITLEQKKKALDEQVS 377

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  102 bits (255), Expect = 5e-23
 Identities = 42/320 (13%), Positives = 88/320 (27%), Gaps = 21/320 (6%)

Query: 19  TLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCN 78
                  + L  N+IT +        S+++   +  N +     +E             +
Sbjct: 118 RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELA---------ASS 168

Query: 79  QHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDN 138
             L+HL++  N    +           L+TL  +SNK+   +         +  + + +N
Sbjct: 169 DTLEHLNLQYNFIYDVKGQV---VFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNN 224

Query: 139 QLSGTISPAIGELQNLVTLAINTNKLS-GNIPPSIGNLKKLLQLYLIENFLQVSIPSSLG 197
           +L   I  A+   QNL    +  N    G +       +++  +      ++     +  
Sbjct: 225 KLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAK--QTVKKLTGQNEE 281

Query: 198 QCQSLTTINLSYN---NLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEIL 254
           +C   T  +       +L      +L+ L      L   +      L  E         +
Sbjct: 282 ECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREI 341

Query: 255 FISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIP 314
              +      I            L+         +     +   L            E+ 
Sbjct: 342 DALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVG-QIELQ 400

Query: 315 KFLVELQLVQNLNLSYNDLE 334
               E   +Q L       E
Sbjct: 401 HATEEQSPLQLLRAIVKRYE 420

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 98.0 bits (244), Expect = 1e-21
 Identities = 35/174 (20%), Positives = 67/174 (38%), Gaps = 12/174 (6%)

Query: 172 IGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLD 231
             N  +     + ++ L+ ++ S      ++  ++LS N LS      L   T L + L+
Sbjct: 6   KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLEL-LN 64

Query: 232 LSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPL 291
           LS N L      ++  L  L  L ++ N      +  L     +E L    N       +
Sbjct: 65  LSSNVL--YETLDLESLSTLRTLDLNNNY-----VQELLVGPSIETLHAANNNISR---V 114

Query: 292 SLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKN 345
           S S  +G + + L+ N I+            VQ L+L  N+++  +    +  +
Sbjct: 115 SCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAAS 167

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 83.4 bits (206), Expect = 6e-17
 Identities = 31/150 (20%), Positives = 53/150 (35%), Gaps = 11/150 (7%)

Query: 191 SIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLIN 250
           +I              ++ ++L   +        ++   LDLS N L      ++     
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKE-LDLSGNPLSQISAADLAPFTK 59

Query: 251 LEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNIS 310
           LE+L +S N+L       L S   L  L L  N  Q      L     +  L  + NNIS
Sbjct: 60  LELLNLSSNVL--YETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS 112

Query: 311 GEIPKFLVELQLVQNLNLSYNDLEGVIPTE 340
             +       Q  +N+ L+ N +  +   +
Sbjct: 113 -RVSCSR--GQGKKNIYLANNKITMLRDLD 139

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 79.9 bits (197), Expect = 7e-16
 Identities = 32/334 (9%), Positives = 90/334 (26%), Gaps = 47/334 (14%)

Query: 6   NRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEF 65
           N +      +   +   L  L+L +N I   +   +   +KL+   ++SN L   +  EF
Sbjct: 154 NEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVF-AKLKTLDLSSNKLA-FMGPEF 210

Query: 66  GKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIG 125
             A            +  + + NN                              I   + 
Sbjct: 211 QSAAG----------VTWISLRNNK--------------------------LVLIEKALR 234

Query: 126 KFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIE 185
              NL+   +  N      +      +N     +    +      +          +   
Sbjct: 235 FSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGA 293

Query: 186 NFLQVSIPSSLGQCQSLTTINLSYNNLSG----TIPPQLMDLTSLSVGLDLSRNQLVGSL 241
              +        +  +L     +  +  G     +  +  +       +D  + Q    +
Sbjct: 294 YCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQR-EIDALKEQYRTVI 352

Query: 242 PTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRV 301
                +      L   +  L+ ++ +   +  +L+       + Q  +  +      L++
Sbjct: 353 DQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQA-VGQIELQHATEEQSPLQL 411

Query: 302 LDLSQNNIS-GEIPKFLVELQLVQNLNLSYNDLE 334
           L           + +  V+   +++ ++  +   
Sbjct: 412 LRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKET 445

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 57.9 bits (140), Expect = 7e-09
 Identities = 30/257 (11%), Positives = 67/257 (26%), Gaps = 20/257 (7%)

Query: 12  IPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNL-TGEVPSEFGKATK 70
           +  +F  +   + ++SL  N++  +I  ++  +  LE F +  N    G +   F K  +
Sbjct: 206 MGPEFQ-SAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQR 263

Query: 71  AYCVQN---------------CNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNK 115
              V                       +      +        +         L+     
Sbjct: 264 VQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGS 323

Query: 116 IFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNL 175
               +          + +     Q    I       Q  +TL      L   +       
Sbjct: 324 ETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAH 383

Query: 176 KKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRN 235
            + L   L +   Q+ +  +  +   L  +             Q     +     D+ ++
Sbjct: 384 AE-LDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQH 442

Query: 236 QLVGSLPTEVGKLINLE 252
           +    L  E  +L  L 
Sbjct: 443 KET-QLAEENARLKKLN 458

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  137 bits (346), Expect = 7e-36
 Identities = 59/313 (18%), Positives = 115/313 (36%), Gaps = 28/313 (8%)

Query: 20  LPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQ 79
                   +  + +   + S   +A  ++   ++ N L+    ++    TK         
Sbjct: 9   GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTK--------- 59

Query: 80  HLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQ 139
            L+ L++++N     L   + + S TL TL  N+N + + +  G     +++TLH  +N 
Sbjct: 60  -LELLNLSSNVLYETLD--LESLS-TLRTLDLNNNYV-QELLVG----PSIETLHAANNN 110

Query: 140 LSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQ-VSIPSSLGQ 198
           +S  +S +    Q    + +  NK++       G   ++  L L  N +  V+       
Sbjct: 111 IS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAAS 167

Query: 199 CQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISR 258
             +L  +NL YN +   +    +    L   LDLS N+L   +  E      +  + +  
Sbjct: 168 SDTLEHLNLQYNFIY-DVKG-QVVFAKLKT-LDLSSNKLA-FMGPEFQSAAGVTWISLRN 223

Query: 259 NMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLV 318
           N L   I   L     LE   L GN F     L     +  RV  +++  +     +   
Sbjct: 224 NKLV-LIEKALRFSQNLEHFDLRGNGFHC-GTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281

Query: 319 ELQLVQNLNLSYN 331
           E  +    +    
Sbjct: 282 ECTVPTLGHYGAY 294

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  136 bits (344), Expect = 2e-35
 Identities = 57/321 (17%), Positives = 116/321 (36%), Gaps = 32/321 (9%)

Query: 12  IPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKA 71
                  +  N+  L L  N ++ +  + +   +KLE+  ++SN L      +       
Sbjct: 25  ALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TLDLES---- 78

Query: 72  YCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQ 131
                    L+ LD+NNN    LL G       ++ETL   +N I   +          +
Sbjct: 79  ------LSTLRTLDLNNNYVQELLVG------PSIETLHAANNNI-SRVSCSR--GQGKK 123

Query: 132 TLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSG-NIPPSIGNLKKLLQLYLIENFLQV 190
            +++ +N+++       G    +  L +  N++   N      +   L  L L  NF+  
Sbjct: 124 NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY- 182

Query: 191 SIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLIN 250
            +   +     L T++LS N L+  + P+      ++  + L  N+LV  +   +    N
Sbjct: 183 DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTW-ISLRNNKLV-LIEKALRFSQN 238

Query: 251 LEILFISRNMLECEILSTLGSCIKLEQLK-LGGNLFQGPIPLSLSSLRGLRVLDLSQNNI 309
           LE   +  N   C  L    S  K ++++ +     +  +         +  L       
Sbjct: 239 LEHFDLRGNGFHCGTLRDFFS--KNQRVQTVAKQTVKK-LTGQNEEECTVPTLGHYGAYC 295

Query: 310 SGEIPK-FLVELQLVQNLNLS 329
             ++P  F   L  + + +  
Sbjct: 296 CEDLPAPFADRLIALGHHHHH 316

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  135 bits (343), Expect = 2e-35
 Identities = 50/278 (17%), Positives = 96/278 (34%), Gaps = 17/278 (6%)

Query: 79  QHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDN 138
              K   + +++    L     +    ++ L  + N + +   A +  F  L+ L++  N
Sbjct: 10  NRYKIEKVTDSSLKQALASLRQSAW-NVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68

Query: 139 QLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQ 198
            L    +  +  L  L TL +N N +       +     +  L+   N +   +  S GQ
Sbjct: 69  VLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSRGQ 120

Query: 199 CQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVG-SLPTEVGKLINLEILFIS 257
                 I L+ N ++          + +   LDL  N++   +          LE L + 
Sbjct: 121 --GKKNIYLANNKITMLRDLDEGCRSRVQY-LDLKLNEIDTVNFAELAASSDTLEHLNLQ 177

Query: 258 RNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFL 317
            N +    +       KL+ L L  N     +     S  G+  + L  N +   I K L
Sbjct: 178 YNFIY--DVKGQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKAL 233

Query: 318 VELQLVQNLNLSYNDLEGVIPTEGVFKNASAISVFGNS 355
              Q +++ +L  N        +   KN    +V   +
Sbjct: 234 RFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQT 271

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  130 bits (330), Expect = 1e-33
 Identities = 57/297 (19%), Positives = 108/297 (36%), Gaps = 28/297 (9%)

Query: 37  IPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLP 96
           I     N ++ ++ +VT ++L   + S    A           ++K LD++ N    +  
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAW----------NVKELDLSGNPLSQISA 51

Query: 97  GCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVT 156
             +  F+  LE L  +SN +       +     L+TL + +N +       +    ++ T
Sbjct: 52  ADLAPFT-KLELLNLSSNVL-YETLD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIET 103

Query: 157 LAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTI 216
           L    N +S  +  S    +    +YL  N + +      G    +  ++L  N +    
Sbjct: 104 LHAANNNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVN 160

Query: 217 PPQLM-DLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKL 275
             +L     +L   L+L  N +   +  +V     L+ L +S N L   +     S   +
Sbjct: 161 FAELAASSDTLEH-LNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGV 216

Query: 276 EQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNIS-GEIPKFLVELQLVQNLNLSYN 331
             + L  N     I  +L   + L   DL  N    G +  F  + Q VQ +     
Sbjct: 217 TWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTV 272

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  123 bits (310), Expect = 5e-31
 Identities = 48/263 (18%), Positives = 94/263 (35%), Gaps = 17/263 (6%)

Query: 106 LETLIFNSNKIFRSIPAGIGK-FINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKL 164
            +      + + +   A + +   N++ L +  N LS   +  +     L  L +++N L
Sbjct: 12  YKIEKVTDSSL-KQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70

Query: 165 SGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLT 224
                  + +L  L  L L  N++       L    S+ T++ + NN+S  +        
Sbjct: 71  YE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSCSR--GQ 120

Query: 225 SLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLEC-EILSTLGSCIKLEQLKLGGN 283
                + L+ N++      + G    ++ L +  N ++         S   LE L L  N
Sbjct: 121 GKKN-IYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179

Query: 284 LFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVF 343
                +         L+ LDLS N ++  +         V  ++L  N L  +       
Sbjct: 180 FIYD-VK-GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLIEKALRFS 236

Query: 344 KNASAISVFGNSKLCGGIPEFQL 366
           +N     + GN   CG + +F  
Sbjct: 237 QNLEHFDLRGNGFHCGTLRDFFS 259

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  103 bits (259), Expect = 2e-24
 Identities = 39/194 (20%), Positives = 65/194 (33%), Gaps = 12/194 (6%)

Query: 144 ISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLT 203
           I              +  + L   +     +   + +L L  N L     + L     L 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 204 TINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLEC 263
            +NLS N L       L  L++L   LDL+ N +      E+    ++E L  + N +  
Sbjct: 62  LLNLSSNVLYE--TLDLESLSTLRT-LDLNNNYV-----QELLVGPSIETLHAANNNISR 113

Query: 264 EILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISG-EIPKFLVELQL 322
              S        + + L  N       L       ++ LDL  N I      +       
Sbjct: 114 VSCSRGQG---KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170

Query: 323 VQNLNLSYNDLEGV 336
           +++LNL YN +  V
Sbjct: 171 LEHLNLQYNFIYDV 184

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 83.5 bits (207), Expect = 1e-17
 Identities = 31/150 (20%), Positives = 53/150 (35%), Gaps = 11/150 (7%)

Query: 191 SIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLIN 250
           +I              ++ ++L   +        ++   LDLS N L      ++     
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKE-LDLSGNPLSQISAADLAPFTK 59

Query: 251 LEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNIS 310
           LE+L +S N+L       L S   L  L L  N  Q      L     +  L  + NNIS
Sbjct: 60  LELLNLSSNVL--YETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS 112

Query: 311 GEIPKFLVELQLVQNLNLSYNDLEGVIPTE 340
             +       Q  +N+ L+ N +  +   +
Sbjct: 113 -RVSCSR--GQGKKNIYLANNKITMLRDLD 139

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  137 bits (346), Expect = 3e-35
 Identities = 66/357 (18%), Positives = 137/357 (38%), Gaps = 34/357 (9%)

Query: 1   SDVGVNRVQGGIPLDF-GFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTG 59
            DV ++     +   F   TL N   ++   + +  +  + + +  ++E+  +    +  
Sbjct: 24  YDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE- 82

Query: 60  EVPSE-FGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFR 118
           E+ +  F  A            ++ L +  N    L P    N    L  L+   N +  
Sbjct: 83  EIDTYAFAYAH----------TIQKLYMGFNAIRYLPPHVFQNVP-LLTVLVLERNDL-S 130

Query: 119 SIPAGI-GKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKK 177
           S+P GI      L TL M +N L            +L  L +++N+L+ ++      +  
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDL--SLIPS 187

Query: 178 LLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQL 237
           L    +  N L     S+L    ++  ++ S+N+++  +   +     L++ L L  N L
Sbjct: 188 LFHANVSYNLL-----STLAIPIAVEELDASHNSIN-VVRGPV--NVELTI-LKLQHNNL 238

Query: 238 VGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLR 297
                  +     L  + +S N LE  +        +LE+L +  N     + L    + 
Sbjct: 239 T-DTAWLLN-YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIP 295

Query: 298 GLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKNASAISVFGN 354
            L+VLDLS N++   + +   +   ++NL L +N +   +           +++  N
Sbjct: 296 TLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK-LSTHHTLKNLTLSHN 349

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  113 bits (284), Expect = 4e-27
 Identities = 60/300 (20%), Positives = 116/300 (38%), Gaps = 34/300 (11%)

Query: 12  IPLDFGFTLPNLLFLSLGFNQITGVIPSSMF-NASKLEVFQVTSNNLTGEVPSEFGKATK 70
           +P      +P L  L L  N ++  +P  +F N  KL    +++NNL   +  +  +AT 
Sbjct: 108 LPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATT 165

Query: 71  AYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINL 130
                     L++L +++N    +    I +    L     + N +  ++   I     +
Sbjct: 166 ---------SLQNLQLSSNRLTHVDLSLIPS----LFHANVSYNLL-STLAIPI----AV 207

Query: 131 QTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQV 190
           + L    N ++  +   +     L  L +  N L+      + N   L+++ L  N L+ 
Sbjct: 208 EELDASHNSIN-VVRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEK 262

Query: 191 SIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLIN 250
            +     + Q L  + +S N L   +      + +L V LDLS N L+  +     +   
Sbjct: 263 IMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKV-LDLSHNHLL-HVERNQPQFDR 319

Query: 251 LEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNIS 310
           LE L++  N +    LST  +   L+ L L  N +      +L   R +    +   +  
Sbjct: 320 LENLYLDHNSIVTLKLSTHHT---LKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQH 374

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 98.6 bits (246), Expect = 3e-22
 Identities = 44/239 (18%), Positives = 89/239 (37%), Gaps = 17/239 (7%)

Query: 110 IFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIP 169
           +      ++ I + +        +H+               L N   +    + +   +P
Sbjct: 3   VKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLP 61

Query: 170 PSI-GNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQ-LMDLTSLS 227
            ++  + +++  L L +  ++     +     ++  + + +N +   +PP    ++  L+
Sbjct: 62  AALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLT 120

Query: 228 VGLDLSRNQLVGSLPTEV-GKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQ 286
           V L L RN L  SLP  +      L  L +S N LE     T  +   L+ L+L  N   
Sbjct: 121 V-LVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT 178

Query: 287 GPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKN 345
               + LS +  L   ++S N +S      L     V+ L+ S+N +  V     V   
Sbjct: 179 H---VDLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINVV--RGPVNVE 227

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  137 bits (347), Expect = 7e-35
 Identities = 64/349 (18%), Positives = 111/349 (31%), Gaps = 58/349 (16%)

Query: 18  FTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQ-- 75
            +   L       + +T  +P    N      +    +      P   G+  +    +  
Sbjct: 8   VSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLR 66

Query: 76  -NCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLH 134
              ++    L++NN      LP    +    LE+L+ + N +   +P       +L   +
Sbjct: 67  DCLDRQAHELELNNLGLSS-LPELPPH----LESLVASCNSL-TELPELPQSLKSLLVDN 120

Query: 135 MWDNQLSGTIS---------------PAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLL 179
                LS                   P +     L  + ++ N L   +P    +L+   
Sbjct: 121 NNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLPDLPPSLE--- 176

Query: 180 QLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVG 239
            +    N L+  +P  L     LT I    N+L   +P   + L S    +    N L  
Sbjct: 177 FIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK-KLPDLPLSLES----IVAGNNIL-- 227

Query: 240 SLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGL 299
               E+  L  L  ++   N+L+  +     S   LE L +  N     +P    SL  L
Sbjct: 228 EELPELQNLPFLTTIYADNNLLK-TLPDLPPS---LEALNVRDNYLTD-LPELPQSLTFL 282

Query: 300 RVLDLSQNNISGEIPKFLVELQLVQN--------------LNLSYNDLE 334
            V +   + +S   P  L  L    N              LN+S N L 
Sbjct: 283 DVSENIFSGLSELPPN-LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI 330

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  118 bits (299), Expect = 1e-28
 Identities = 68/351 (19%), Positives = 128/351 (36%), Gaps = 79/351 (22%)

Query: 20  LPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQ 79
            P L +L +  NQ+  +    + N+S L++  V +N+L  ++P                 
Sbjct: 130 PPLLEYLGVSNNQLEKL--PELQNSSFLKIIDVDNNSLK-KLPDLPP------------- 173

Query: 80  HLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQ 139
            L+ +   NN    L    + N    L  +  ++N + + +P       +L+++   +N 
Sbjct: 174 SLEFIAAGNNQLEELPE--LQNLP-FLTAIYADNNSL-KKLPDLPL---SLESIVAGNNI 226

Query: 140 LSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQC 199
           L     P +  L  L T+  + N L   +P    +L+ L    + +N+L   +P      
Sbjct: 227 L--EELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEAL---NVRDNYLT-DLPELPQSL 279

Query: 200 Q-----------------SLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLP 242
                             +L  +N S N +  ++      L  L    ++S N+L+  LP
Sbjct: 280 TFLDVSENIFSGLSELPPNLYYLNASSNEIR-SLCDLPPSLEEL----NVSNNKLI-ELP 333

Query: 243 TEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQG--PIPLSLSSLR--- 297
                   LE L  S N L  E+     +   L+QL +  N  +    IP S+  LR   
Sbjct: 334 ALPP---RLERLIASFNHLA-EVPELPQN---LKQLHVEYNPLREFPDIPESVEDLRMNS 386

Query: 298 ----------GLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIP 338
                      L+ L +  N +  E P     ++   +L ++   +     
Sbjct: 387 HLAEVPELPQNLKQLHVETNPLR-EFPDIPESVE---DLRMNSERVVDPYE 433

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  106 bits (267), Expect = 1e-24
 Identities = 54/304 (17%), Positives = 89/304 (29%), Gaps = 57/304 (18%)

Query: 20  LPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQ 79
           LP L  +    N +   +P    +   LE     +N L      E               
Sbjct: 194 LPFLTAIYADNNSLK-KLPDLPLS---LESIVAGNNILE--ELPELQNLPF--------- 238

Query: 80  HLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQ 139
            L  +  +NN    L P    +    LE L    N +   +P        L       + 
Sbjct: 239 -LTTIYADNNLLKTL-PDLPPS----LEALNVRDNYL-TDLPELPQSLTFLDVSENIFSG 291

Query: 140 LSGT-------------ISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIEN 186
           LS               I        +L  L ++ NKL   +P     L++L       N
Sbjct: 292 LSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL---IASFN 347

Query: 187 FLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVG 246
            L   +P       +L  +++ YN L    P     +  L +   L+       +P    
Sbjct: 348 HLA-EVPELPQ---NLKQLHVEYNPLR-EFPDIPESVEDLRMNSHLA------EVPELPQ 396

Query: 247 KLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQ 306
              NL+ L +  N L  E      S   +E L++       P   +  +   L       
Sbjct: 397 ---NLKQLHVETNPLR-EFPDIPES---VEDLRMNSERVVDPYEFAHETTDKLEDDVFEH 449

Query: 307 NNIS 310
           ++  
Sbjct: 450 HHHH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 60.8 bits (148), Expect = 8e-10
 Identities = 32/171 (18%), Positives = 61/171 (35%), Gaps = 33/171 (19%)

Query: 19  TLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCN 78
             P+L  L++  N++   +P+      +LE    + N+L  EVP                
Sbjct: 315 LPPSLEELNVSNNKLI-ELPALP---PRLERLIASFNHLA-EVPELPQ------------ 357

Query: 79  QHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDN 138
            +LK L +  N      P    +    +E L  NS+     +P       NL+ LH+  N
Sbjct: 358 -NLKQLHVEYNPLRE-FPDIPES----VEDLRMNSH--LAEVPELPQ---NLKQLHVETN 406

Query: 139 QLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQ 189
            L          +++   L +N+ ++  +           L+  + E+   
Sbjct: 407 PLR-EFPDIPESVED---LRMNSERVV-DPYEFAHETTDKLEDDVFEHHHH 452

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  135 bits (341), Expect = 2e-33
 Identities = 68/357 (19%), Positives = 137/357 (38%), Gaps = 34/357 (9%)

Query: 1   SDVGVNRVQGGIPLDFGF-TLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTG 59
            DV ++     +   F   TL N   ++   + +  +  + + +  ++E+  +    +  
Sbjct: 30  YDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE- 88

Query: 60  EVPSE-FGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFR 118
           E+ +  F  A            ++ L +  N    L P    N    L  L+   N +  
Sbjct: 89  EIDTYAFAYAHT----------IQKLYMGFNAIRYLPPHVFQNVP-LLTVLVLERNDL-S 136

Query: 119 SIPAGI-GKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKK 177
           S+P GI      L TL M +N L            +L  L +++N+L+ ++      +  
Sbjct: 137 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDL--SLIPS 193

Query: 178 LLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQL 237
           L    +  N L     S+L    ++  ++ S+N+++    P  ++LT     L L  N L
Sbjct: 194 LFHANVSYNLL-----STLAIPIAVEELDASHNSINVVRGPVNVELTI----LKLQHNNL 244

Query: 238 VGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLR 297
                  +     L  + +S N LE  +        +LE+L +  N     + L    + 
Sbjct: 245 T-DTAWLLN-YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIP 301

Query: 298 GLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKNASAISVFGN 354
            L+VLDLS N++   + +   +   ++NL L +N +  +            +++  N
Sbjct: 302 TLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL--KLSTHHTLKNLTLSHN 355

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  110 bits (276), Expect = 3e-25
 Identities = 68/333 (20%), Positives = 122/333 (36%), Gaps = 46/333 (13%)

Query: 20  LPNLLFLSLGFNQITGVIPSSMF-NASKLEVFQVTSNNLTGEVPSE-FGKATKAYCVQNC 77
              +  L +GFN I   +P  +F N   L V  +  N+L+  +P   F            
Sbjct: 98  AHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHN---------- 145

Query: 78  NQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWD 137
              L  L ++NNN   +        + +L+ L  +SN++   +   +    +L   ++  
Sbjct: 146 TPKLTTLSMSNNNLERIEDDTFQATT-SLQNLQLSSNRL-THVDLSL--IPSLFHANVSY 201

Query: 138 NQLSGTISPAI-----------------GELQNLVTLAINTNKLSGNIPPSIGNLKKLLQ 180
           N LS T++  I                      L  L +  N L+      + N   L++
Sbjct: 202 NLLS-TLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTD--TAWLLNYPGLVE 258

Query: 181 LYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGS 240
           + L  N L+  +     + Q L  + +S N L   +      + +L V LDLS N L+  
Sbjct: 259 VDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKV-LDLSHNHLL-H 315

Query: 241 LPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLR 300
           +     +   LE L++  N +    LST  +   L+ L L  N +      +L   R + 
Sbjct: 316 VERNQPQFDRLENLYLDHNSIVTLKLSTHHT---LKNLTLSHNDWDCNSLRAL--FRNVA 370

Query: 301 VLDLSQNNISGEIPKFLVELQLVQNLNLSYNDL 333
              +   +   +I   L      +  +  Y D 
Sbjct: 371 RPAVDDADQHCKIDYQLEHGLCCKESDKPYLDR 403

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 97.7 bits (243), Expect = 2e-21
 Identities = 44/232 (18%), Positives = 88/232 (37%), Gaps = 17/232 (7%)

Query: 117 FRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSI-GNL 175
           ++ I + +        +H+               L N   +    + +   +P ++  + 
Sbjct: 16  YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSF 74

Query: 176 KKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQ-LMDLTSLSVGLDLSR 234
           +++  L L +  ++     +     ++  + + +N +   +PP    ++  L+V L L R
Sbjct: 75  RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTV-LVLER 132

Query: 235 NQLVGSLPTEV-GKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSL 293
           N L  SLP  +      L  L +S N LE     T  +   L+ L+L  N       + L
Sbjct: 133 NDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH---VDL 188

Query: 294 SSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKN 345
           S +  L   ++S N +S      L     V+ L+ S+N +  V     V   
Sbjct: 189 SLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINVV--RGPVNVE 233

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  131 bits (331), Expect = 1e-32
 Identities = 70/317 (22%), Positives = 126/317 (39%), Gaps = 20/317 (6%)

Query: 21  PNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQH 80
                L LG N+I  +      +   LE  ++  N ++   P  F              +
Sbjct: 32  TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLF----------N 81

Query: 81  LKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGI-GKFINLQTLHMWDNQ 139
           L+ L + +N    +  G     S  L  L  + NKI   +   +     NL++L + DN 
Sbjct: 82  LRTLGLRSNRLKLIPLGVFTGLS-NLTKLDISENKI-VILLDYMFQDLYNLKSLEVGDND 139

Query: 140 LSGTISP-AIGELQNLVTLAINTNKLSGNIPP-SIGNLKKLLQLYLIENFLQVSIPSSLG 197
           L   IS  A   L +L  L +    L+ +IP  ++ +L  L+ L L    +      S  
Sbjct: 140 LV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFK 197

Query: 198 QCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEV-GKLINLEILFI 256
           +   L  + +S+     T+ P  +   +L+  L ++   L  ++P      L+ L  L +
Sbjct: 198 RLYRLKVLEISHWPYLDTMTPNCLYGLNLTS-LSITHCNLT-AVPYLAVRHLVYLRFLNL 255

Query: 257 SRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKF 316
           S N +     S L   ++L++++L G       P +   L  LRVL++S N ++      
Sbjct: 256 SYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESV 315

Query: 317 LVELQLVQNLNLSYNDL 333
              +  ++ L L  N L
Sbjct: 316 FHSVGNLETLILDSNPL 332

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  112 bits (281), Expect = 3e-26
 Identities = 68/276 (24%), Positives = 106/276 (38%), Gaps = 14/276 (5%)

Query: 75  QNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGI-GKFINLQTL 133
           +      + LD+  N    L      +F   LE L  N N +  ++  G      NL+TL
Sbjct: 28  EGIPTETRLLDLGKNRIKTLNQDEFASFP-HLEELELNENIV-SAVEPGAFNNLFNLRTL 85

Query: 134 HMWDNQLSGTISPAI-GELQNLVTLAINTNKLSGNIPPSI-GNLKKLLQLYLIENFLQVS 191
            +  N+L   I   +   L NL  L I+ NK+   +   +  +L  L  L + +N L   
Sbjct: 86  GLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVYI 143

Query: 192 IPSSLGQCQSLTTINLSYNNLSGTIPPQ-LMDLTSLSVGLDLSRNQLVGSLPTEV-GKLI 249
              +     SL  + L   NL+ +IP + L  L  L V L L    +  ++      +L 
Sbjct: 144 SHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIV-LRLRHLNIN-AIRDYSFKRLY 200

Query: 250 NLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNI 309
            L++L IS       +       + L  L +          L++  L  LR L+LS N I
Sbjct: 201 RLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPI 260

Query: 310 SGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKN 345
           S      L EL  +Q + L    L  V      F+ 
Sbjct: 261 STIEGSMLHELLRLQEIQLVGGQLAVV--EPYAFRG 294

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  109 bits (274), Expect = 2e-25
 Identities = 62/272 (22%), Positives = 98/272 (36%), Gaps = 22/272 (8%)

Query: 20  LPNLLFLSLGFNQITGVIPSSMF-NASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCN 78
           L NL  L L  N++  +IP  +F   S L    ++ N +   +   F             
Sbjct: 79  LFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLY--------- 128

Query: 79  QHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGI-GKFINLQTLHMWD 137
            +LK L++ +N+   +        + +LE L      +  SIP         L  L +  
Sbjct: 129 -NLKSLEVGDNDLVYISHRAFSGLN-SLEQLTLEKCNL-TSIPTEALSHLHGLIVLRLRH 185

Query: 138 NQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPS-SL 196
             ++     +   L  L  L I+       + P+      L  L +    L  ++P  ++
Sbjct: 186 LNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAV 244

Query: 197 GQCQSLTTINLSYNNLSGTIPPQ-LMDLTSLSVGLDLSRNQLVGSLPTEV-GKLINLEIL 254
                L  +NLSYN +S TI    L +L  L   + L   QL   +       L  L +L
Sbjct: 245 RHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQ-EIQLVGGQL-AVVEPYAFRGLNYLRVL 301

Query: 255 FISRNMLECEILSTLGSCIKLEQLKLGGNLFQ 286
            +S N L     S   S   LE L L  N   
Sbjct: 302 NVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  109 bits (274), Expect = 2e-25
 Identities = 52/253 (20%), Positives = 97/253 (38%), Gaps = 14/253 (5%)

Query: 96  PGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLV 155
           P C C+     +  +    K F ++P GI      + L +  N++            +L 
Sbjct: 5   PRCECSAQ---DRAVLCHRKRFVAVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLE 59

Query: 156 TLAINTNKLSGNIPPSI-GNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSG 214
            L +N N +S  + P    NL  L  L L  N L++          +LT +++S N +  
Sbjct: 60  ELELNENIVS-AVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIV- 117

Query: 215 TIPPQL-MDLTSLSVGLDLSRNQLVGSLPTEV-GKLINLEILFISRNMLECEILSTLGSC 272
            +   +  DL +L   L++  N LV  +       L +LE L + +  L       L   
Sbjct: 118 ILLDYMFQDLYNLKS-LEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHL 175

Query: 273 IKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYND 332
             L  L+L           S   L  L+VL++S       +    +    + +L++++ +
Sbjct: 176 HGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCN 235

Query: 333 LEGVIPTEGVFKN 345
           L   +P     ++
Sbjct: 236 LT-AVP-YLAVRH 246

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  104 bits (260), Expect = 1e-23
 Identities = 59/250 (23%), Positives = 95/250 (38%), Gaps = 24/250 (9%)

Query: 20  LPNLLFLSLGFNQITGVIPSSMF-NASKLEVFQVTSNNLTGEVPSE-FGKATKAYCVQNC 77
           L NL  L +  N+I  ++   MF +   L+  +V  N+L   +    F            
Sbjct: 103 LSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNS------- 153

Query: 78  NQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGI-GKFINLQTLHMW 136
              L+ L +   N   +    + +    L  L      I  +I      +   L+ L + 
Sbjct: 154 ---LEQLTLEKCNLTSIPTEALSHLH-GLIVLRLRHLNI-NAIRDYSFKRLYRLKVLEIS 208

Query: 137 DNQLSGTISPAIGELQNLVTLAINTNKLSGNIPP-SIGNLKKLLQLYLIENFLQVSIPSS 195
                 T++P      NL +L+I    L+  +P  ++ +L  L  L L  N +     S 
Sbjct: 209 HWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSM 267

Query: 196 LGQCQSLTTINLSYNNLSGTIPPQ-LMDLTSLSVGLDLSRNQLVGSLPTEV-GKLINLEI 253
           L +   L  I L    L+  + P     L  L V L++S NQL  +L   V   + NLE 
Sbjct: 268 LHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRV-LNVSGNQLT-TLEESVFHSVGNLET 324

Query: 254 LFISRNMLEC 263
           L +  N L C
Sbjct: 325 LILDSNPLAC 334

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  131 bits (332), Expect = 7e-32
 Identities = 71/363 (19%), Positives = 130/363 (35%), Gaps = 31/363 (8%)

Query: 2   DVGVNRVQGGIPLDF-GFTLPNLLFLSLGFNQITGVIPSSMFNASK------LEVFQVTS 54
           D   N++      +        L F SL  N +   +               LE+  V+ 
Sbjct: 154 DFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSG 213

Query: 55  NNLTGEVPSEFGKATKAYCVQN--CNQHLKHLDINNNNFGGLLPGCICN-FSITLETLIF 111
           N  T ++   F  A       +     H+       +N               ++  L  
Sbjct: 214 NGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDL 273

Query: 112 NSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPS 171
           +   +F           +L+ L++  N+++     A   L NL  L ++ N L      +
Sbjct: 274 SHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSN 333

Query: 172 IGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSG-TIPPQLMDL------- 223
              L K+  + L +N + +    +    + L T++L  N L+     P + D+       
Sbjct: 334 FYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKL 393

Query: 224 TSLSVG------LDLSRNQLVG-SLPTEVGKLINLEILFISRNMLE-CEILSTLGSCIKL 275
            +L         + LS N+L    +   + ++ +L+IL +++N    C    T      L
Sbjct: 394 VTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSL 453

Query: 276 EQLKLGGNLFQGPIPLSL-----SSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSY 330
           EQL LG N+ Q      L       L  L+VL L+ N ++   P     L  ++ L+L+ 
Sbjct: 454 EQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNS 513

Query: 331 NDL 333
           N L
Sbjct: 514 NRL 516

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  122 bits (307), Expect = 8e-29
 Identities = 66/339 (19%), Positives = 120/339 (35%), Gaps = 23/339 (6%)

Query: 2   DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEV 61
           ++G       I  +    LPNL  L LG ++I  + P +      L   ++    L+  V
Sbjct: 54  ELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAV 113

Query: 62  PSEFGKATKAYCVQNCNQHLKHLDINNNNFGGL-LPGCICNFSITLETLIFNSNKIFRSI 120
             +              + L  LD++ N    L L       + +L+++ F+SN+I   +
Sbjct: 114 LKDG--------YFRNLKALTRLDLSKNQIRSLYLHPSFGKLN-SLKSIDFSSNQI-FLV 163

Query: 121 PAGIGKFI---NLQTLHMWDNQLSGTISPAIGELQN-LVTLAINTNKLSGNIPPSIGNLK 176
                + +    L    +  N L   +S   G+  N    + +    +S       GN  
Sbjct: 164 CEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVS-------GNGW 216

Query: 177 KLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVG-LDLSRN 235
            +       N +  S   SL     +      ++N+          L   SV  LDLS  
Sbjct: 217 TVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHG 276

Query: 236 QLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSS 295
            +          L +L++L ++ N +             L+ L L  NL       +   
Sbjct: 277 FVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYG 336

Query: 296 LRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLE 334
           L  +  +DL +N+I+    +    L+ +Q L+L  N L 
Sbjct: 337 LPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT 375

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  111 bits (280), Expect = 2e-25
 Identities = 57/333 (17%), Positives = 110/333 (33%), Gaps = 50/333 (15%)

Query: 20  LPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQ 79
           L     L L FN I  V  SS     +L++ ++ S      +  E               
Sbjct: 23  LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKE---------AFRNLP 73

Query: 80  HLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQ 139
           +L+ LD+ ++    L P                                +L  L ++   
Sbjct: 74  NLRILDLGSSKIYFLHPDAFQGLF-------------------------HLFELRLYFCG 108

Query: 140 LSGTISP--AIGELQNLVTLAINTNKLSG-NIPPSIGNLKKLLQLYLIENFLQVSIPSSL 196
           LS  +        L+ L  L ++ N++    + PS G L  L  +    N + +     L
Sbjct: 109 LSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHEL 168

Query: 197 GQCQ--SLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEIL 254
              Q  +L+  +L+ N+L   +        +    + L    + G+          ++I 
Sbjct: 169 EPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGN-------GWTVDIT 221

Query: 255 FISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLR--GLRVLDLSQNNISGE 312
               N +      +L     +     G +  + P   + + L    +R LDLS   +   
Sbjct: 222 GNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSL 281

Query: 313 IPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKN 345
             +    L+ ++ LNL+YN +  +   +  F  
Sbjct: 282 NSRVFETLKDLKVLNLAYNKINKI--ADEAFYG 312

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  110 bits (277), Expect = 4e-25
 Identities = 78/411 (18%), Positives = 140/411 (34%), Gaps = 46/411 (11%)

Query: 17  GFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQN 76
           G    ++  L L    +  +          L+V  +  N +       F           
Sbjct: 262 GLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLD------- 314

Query: 77  CNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFI-NLQTLHM 135
              +L+ L+++ N  G L           +  +    N I   I     KF+  LQTL +
Sbjct: 315 ---NLQVLNLSYNLLGELYSSNFYGLP-KVAYIDLQKNHI-AIIQDQTFKFLEKLQTLDL 369

Query: 136 WDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQ-VSIPS 194
            DN L+      I  + ++  + ++ NKL   +P           ++L EN L+ + I  
Sbjct: 370 RDNALT-----TIHFIPSIPDIFLSGNKLV-TLPKINLTAN---LIHLSENRLENLDILY 420

Query: 195 SLGQCQSLTTINLSYNNLSGTIPPQL-MDLTSLSVGLDLSRNQLVGSLPTEV-----GKL 248
            L +   L  + L+ N  S     Q   +  SL   L L  N L  +  TE+       L
Sbjct: 421 FLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQ-LFLGENMLQLAWETELCWDVFEGL 479

Query: 249 INLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNN 308
            +L++L+++ N L             L  L L  N         L +   L +LD+S+N 
Sbjct: 480 SHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPAN--LEILDISRNQ 537

Query: 309 ISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEG----VFKNASAISVFGNSKLCG----- 359
           +    P   V L     L++++N              +      I+       C      
Sbjct: 538 LLAPNPDVFVSL---SVLDITHNKFICECELSTFINWLNHTNVTIAGPPADIYCVYPDSF 594

Query: 360 -GIPEFQLPICGLEKSKH-KRLTIAVKLAAAIISVLVGILLFVSFLFLCWI 408
            G+  F L   G ++ +  K L  ++ +   +   L  + +     F  + 
Sbjct: 595 SGVSLFSLSTEGCDEEEVLKSLKFSLFIVCTVTLTLFLMTILTVTKFRGFC 645

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 91.4 bits (227), Expect = 4e-19
 Identities = 38/172 (22%), Positives = 65/172 (37%), Gaps = 9/172 (5%)

Query: 174 NLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQ-LMDLTSLSVGLDL 232
            L    +L L  N+++    SS    + L  + L       TI  +   +L +L + LDL
Sbjct: 22  VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRI-LDL 80

Query: 233 SRNQLVGSLPTEV-GKLINLEILFISRNMLECEILS--TLGSCIKLEQLKLGGNLFQG-P 288
             +++   L  +    L +L  L +    L   +L      +   L +L L  N  +   
Sbjct: 81  GSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLY 139

Query: 289 IPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQL--VQNLNLSYNDLEGVIP 338
           +  S   L  L+ +D S N I       L  LQ   +   +L+ N L   + 
Sbjct: 140 LHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVS 191

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 60.6 bits (147), Expect = 1e-09
 Identities = 27/145 (18%), Positives = 44/145 (30%), Gaps = 28/145 (19%)

Query: 201 SLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNM 260
                   + NL+  +P  L     L     LS N +     +    L  L++L +    
Sbjct: 5   DGRIAFYRFCNLT-QVPQVLNTTERL----LLSFNYIRTVTASSFPFLEQLQLLELGSQY 59

Query: 261 LECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVEL 320
               I                          +  +L  LR+LDL  + I    P     L
Sbjct: 60  TPLTID-----------------------KEAFRNLPNLRILDLGSSKIYFLHPDAFQGL 96

Query: 321 QLVQNLNLSYNDLEGVIPTEGVFKN 345
             +  L L +  L   +  +G F+N
Sbjct: 97  FHLFELRLYFCGLSDAVLKDGYFRN 121

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  128 bits (324), Expect = 3e-31
 Identities = 66/332 (19%), Positives = 116/332 (34%), Gaps = 55/332 (16%)

Query: 22  NLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQN----- 76
               L++G + +T  +P  +     +    +  NNLT  +P+   +        N     
Sbjct: 41  GNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALPPELRTLEVSGNQLTSL 96

Query: 77  -----CNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQ 131
                    L        +   L  G        L  L    N++  S+P        LQ
Sbjct: 97  PVLPPGLLELSIFSNPLTHLPALPSG--------LCKLWIFGNQL-TSLPVLPP---GLQ 144

Query: 132 TLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVS 191
            L + DNQL+ ++     EL  L       N+L+ ++P     L++L    + +N L  S
Sbjct: 145 ELSVSDNQLA-SLPALPSELCKL---WAYNNQLT-SLPMLPSGLQEL---SVSDNQLA-S 195

Query: 192 IPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINL 251
           +P+   +   L  +    N L+ ++P     L  L     +S N+L  SLP        L
Sbjct: 196 LPTLPSE---LYKLWAYNNRLT-SLPALPSGLKEL----IVSGNRL-TSLPVLPS---EL 243

Query: 252 EILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNIS- 310
           + L +S N L   +         L  L +  N     +P SL  L     ++L  N +S 
Sbjct: 244 KELMVSGNRLT-SLPMLPSG---LLSLSVYRNQLTR-LPESLIHLSSETTVNLEGNPLSE 298

Query: 311 --GEIPKFLVELQLVQNLNLSYNDLEGVIPTE 340
              +  + +          + ++      P E
Sbjct: 299 RTLQALREITSAPGYSGPIIRFDMAGASAPRE 330

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  103 bits (259), Expect = 3e-23
 Identities = 58/272 (21%), Positives = 99/272 (36%), Gaps = 36/272 (13%)

Query: 20  LPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQN--- 76
              L  L +  NQ+T  +P        L+   V+ N L   +P+   +  K +   N   
Sbjct: 120 PSGLCKLWIFGNQLT-SLPVLPPG---LQELSVSDNQLA-SLPALPSELCKLWAYNNQLT 174

Query: 77  ----CNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQT 132
                   L+ L +++N    L P         L  L   +N++  S+PA       L+ 
Sbjct: 175 SLPMLPSGLQELSVSDNQLASL-PTLPSE----LYKLWAYNNRL-TSLPALPS---GLKE 225

Query: 133 LHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSI 192
           L +  N+L+ ++     EL+ L    ++ N+L+ ++P     L  L    +  N L   +
Sbjct: 226 LIVSGNRLT-SLPVLPSELKEL---MVSGNRLT-SLPMLPSGLLSL---SVYRNQLT-RL 276

Query: 193 PSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSL--SVGLDLSRNQLVGSLPTEVGKLIN 250
           P SL    S TT+NL  N LS      L ++TS     G  +  +    S P E   L  
Sbjct: 277 PESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHL 336

Query: 251 LEILFISRN----MLECEILSTLGSCIKLEQL 278
               ++           +     G     +  
Sbjct: 337 AAADWLVPAREGEPAPADRWHMFGQEDNADAF 368

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 70.7 bits (173), Expect = 9e-13
 Identities = 38/159 (23%), Positives = 56/159 (35%), Gaps = 35/159 (22%)

Query: 199 CQSLTTINLSYNNLSGTIPPQL-----------MDLTSLSVG------LDLSRNQLVGSL 241
                 +N+  + L+ T+P  L            +LTSL         L++S NQL  SL
Sbjct: 39  NNGNAVLNVGESGLT-TLPDCLPAHITTLVIPDNNLTSLPALPPELRTLEVSGNQLT-SL 96

Query: 242 PTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRV 301
           P     L+ L I       L             L +L + GN     +P       GL+ 
Sbjct: 97  PVLPPGLLELSIFSNPLTHLPALPSG-------LCKLWIFGNQLTS-LP---VLPPGLQE 145

Query: 302 LDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTE 340
           L +S N ++  +P    EL     L    N L   +P  
Sbjct: 146 LSVSDNQLA-SLPALPSEL---CKLWAYNNQLT-SLPML 179

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  128 bits (323), Expect = 3e-31
 Identities = 76/346 (21%), Positives = 119/346 (34%), Gaps = 30/346 (8%)

Query: 18  FTLPNLLFLSLGFNQITGVIPSSMFNA-SKLEVFQVT------SNNLTGEVPSEFGKATK 70
           F    L  L+L  N  +  +  +     + LEV ++         NL     S       
Sbjct: 197 FKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEG--- 253

Query: 71  AYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINL 130
                 CN  ++   +   ++       + N    + +    S  I   +          
Sbjct: 254 -----LCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTI-ERVKDFSY-NFGW 306

Query: 131 QTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQV 190
           Q L + + +     +    +L++L  L   +NK       S  +L  L  L L  N L  
Sbjct: 307 QHLELVNCKFGQFPT---LKLKSLKRLTFTSNKGGN--AFSEVDLPSLEFLDLSRNGLSF 361

Query: 191 S--IPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEV-GK 247
                 S     SL  ++LS+N +  T+    + L  L   LD   + L       V   
Sbjct: 362 KGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEH-LDFQHSNLKQMSEFSVFLS 419

Query: 248 LINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPI-PLSLSSLRGLRVLDLSQ 306
           L NL  L IS                 LE LK+ GN FQ    P   + LR L  LDLSQ
Sbjct: 420 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 479

Query: 307 NNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKNASAISVF 352
             +    P     L  +Q LN++ N L+ V    G+F   +++   
Sbjct: 480 CQLEQLSPTAFNSLSSLQVLNMASNQLKSVPD--GIFDRLTSLQKI 523

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  116 bits (292), Expect = 2e-27
 Identities = 56/299 (18%), Positives = 109/299 (36%), Gaps = 25/299 (8%)

Query: 17  GFTLPNLLFLSLGFNQITGVIPSSMFNA-SKLEVFQVTSNNLTGEVPSEFGKATKAYCVQ 75
           G     +    L +          +FN  + +  F + S  +       +          
Sbjct: 253 GLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY---------- 302

Query: 76  NCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHM 135
             N   +HL++ N  FG      + +    L+ L F SNK   +  + +    +L+ L +
Sbjct: 303 --NFGWQHLELVNCKFGQFPTLKLKS----LKRLTFTSNKG-GNAFSEVD-LPSLEFLDL 354

Query: 136 WDNQLS--GTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIP 193
             N LS  G  S +     +L  L ++ N +   +  +   L++L  L    + L+    
Sbjct: 355 SRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSE 413

Query: 194 SS-LGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEV-GKLINL 251
            S     ++L  +++S+ +           L+SL V L ++ N    +   ++  +L NL
Sbjct: 414 FSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEV-LKMAGNSFQENFLPDIFTELRNL 472

Query: 252 EILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNIS 310
             L +S+  LE    +   S   L+ L +  N  +         L  L+ + L  N   
Sbjct: 473 TFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  115 bits (290), Expect = 4e-27
 Identities = 62/344 (18%), Positives = 112/344 (32%), Gaps = 33/344 (9%)

Query: 20  LPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQ 79
            P L  L L   +I  +   +  + S L    +T N +       F              
Sbjct: 51  FPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG----------LS 100

Query: 80  HLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFR-SIPAGIGKFINLQTLHMWDN 138
            L+ L     N   L    I +   TL+ L    N I    +P       NL+ L +  N
Sbjct: 101 SLQKLVAVETNLASLENFPIGHLK-TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159

Query: 139 QLSGTISPAIGELQNL----VTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPS 194
           ++       +  L  +    ++L ++ N ++  I P      +L +L L  NF  +++  
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMK 218

Query: 195 -SLGQCQSLTTINL------SYNNLSGTIPPQLMDLTSLSV-GLDLSRNQLVGSLPTEV- 245
             +     L    L      +  NL       L  L +L++    L+          ++ 
Sbjct: 219 TCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLF 278

Query: 246 GKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLS 305
             L N+    +    +E   +         + L+L    F     L L S   L+ L  +
Sbjct: 279 NCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQFPTLKLKS---LKRLTFT 333

Query: 306 QNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKNASAI 349
            N          V+L  ++ L+LS N L             +++
Sbjct: 334 SNKGG-NAFSE-VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSL 375

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  104 bits (261), Expect = 2e-23
 Identities = 52/256 (20%), Positives = 98/256 (38%), Gaps = 27/256 (10%)

Query: 13  PLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAY 72
              + F   +L  ++  F Q   +   S+    +L      ++N  G   SE        
Sbjct: 299 DFSYNFGWQHLELVNCKFGQFPTLKLKSL---KRLTF----TSNKGGNAFSEVD------ 345

Query: 73  CVQNCNQHLKHLDINNN--NFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINL 130
                   L+ LD++ N  +F G         + +L+ L  + N +  ++ +       L
Sbjct: 346 -----LPSLEFLDLSRNGLSFKGCCSQSDFGTT-SLKYLDLSFNGV-ITMSSNFLGLEQL 398

Query: 131 QTLHMWDNQLSGTISP-AIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQ 189
           + L    + L           L+NL+ L I+              L  L  L +  N  Q
Sbjct: 399 EHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ 458

Query: 190 VSIPS-SLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEV-GK 247
            +       + ++LT ++LS   L    P     L+SL V L+++ NQL  S+P  +  +
Sbjct: 459 ENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV-LNMASNQLK-SVPDGIFDR 516

Query: 248 LINLEILFISRNMLEC 263
           L +L+ +++  N  +C
Sbjct: 517 LTSLQKIWLHTNPWDC 532

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  104 bits (260), Expect = 2e-23
 Identities = 54/247 (21%), Positives = 96/247 (38%), Gaps = 16/247 (6%)

Query: 101 NFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAIN 160
           N   + + L  + N +          F  LQ L +   ++      A   L +L TL + 
Sbjct: 25  NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILT 84

Query: 161 TNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNL-SGTIPPQ 219
            N +      +   L  L +L  +E  L       +G  ++L  +N+++N + S  +P  
Sbjct: 85  GNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144

Query: 220 LMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFI----SRNMLECEILSTLGSCIKL 275
             +LT+L   LDLS N++     T++  L  + +L +    S N +   I       I+L
Sbjct: 145 FSNLTNLEH-LDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRL 202

Query: 276 EQLKLGGNLFQGPIP-LSLSSLRGLRVLDL------SQNNISGEIPKFLVELQ--LVQNL 326
            +L L  N     +    +  L GL V  L      ++ N+       L  L    ++  
Sbjct: 203 HKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEF 262

Query: 327 NLSYNDL 333
            L+Y D 
Sbjct: 263 RLAYLDY 269

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 96.3 bits (240), Expect = 6e-21
 Identities = 48/203 (23%), Positives = 77/203 (37%), Gaps = 18/203 (8%)

Query: 20  LPNLLFLSLGFNQIT--GVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNC 77
           LP+L FL L  N ++  G    S F  + L+   ++ N +   + S F    +       
Sbjct: 346 LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQ------- 397

Query: 78  NQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGI-GKFINLQTLHMW 136
              L+HLD  ++N   +    +      L  L  +     R    GI     +L+ L M 
Sbjct: 398 ---LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT-RVAFNGIFNGLSSLEVLKMA 453

Query: 137 DNQLSGTISPAI-GELQNLVTLAINTNKLSGNIPPSI-GNLKKLLQLYLIENFLQVSIPS 194
            N       P I  EL+NL  L ++  +L   + P+   +L  L  L +  N L+     
Sbjct: 454 GNSFQENFLPDIFTELRNLTFLDLSQCQLEQ-LSPTAFNSLSSLQVLNMASNQLKSVPDG 512

Query: 195 SLGQCQSLTTINLSYNNLSGTIP 217
              +  SL  I L  N    + P
Sbjct: 513 IFDRLTSLQKIWLHTNPWDCSCP 535

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 55.5 bits (134), Expect = 4e-08
 Identities = 27/143 (18%), Positives = 39/143 (27%), Gaps = 30/143 (20%)

Query: 203 TTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLE 262
            T      N    IP  L    S    LDLS N L             L++L +SR  ++
Sbjct: 10  ITYQCMELNFY-KIPDNLP--FSTKN-LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ 65

Query: 263 CEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQL 322
                            +    +Q         L  L  L L+ N I          L  
Sbjct: 66  ----------------TIEDGAYQS--------LSHLSTLILTGNPIQSLALGAFSGLSS 101

Query: 323 VQNLNLSYNDLEGVIPTEGVFKN 345
           +Q L     +L  +        +
Sbjct: 102 LQKLVAVETNLASLEN--FPIGH 122

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  123 bits (310), Expect = 1e-29
 Identities = 61/347 (17%), Positives = 121/347 (34%), Gaps = 31/347 (8%)

Query: 20  LPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQ 79
             NL  L L  ++I  +   + ++   LE   ++ N+L+    S FG  +          
Sbjct: 49  CANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSS--------- 99

Query: 80  HLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAG-IGKFINLQTLHMWDN 138
            LK+L++  N +  L    +      L+TL   + + F  I         +L  L +   
Sbjct: 100 -LKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKAL 158

Query: 139 QLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQ 198
            L    S ++  ++++  L ++ ++ +  +      L  +  L L +  L     S L  
Sbjct: 159 SLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPV 218

Query: 199 CQSLTTINLSYNNLSGTIPPQLMDLTSLSVG---------LDLSRNQLVGSLPTEVG--- 246
            +  + +       S        +L  L             D + N L    P+E     
Sbjct: 219 DEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVS 278

Query: 247 -----KLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRV 301
                + + +  L I +  L  ++ +      K++++ +  +            L+ L  
Sbjct: 279 ELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEF 338

Query: 302 LDLSQNNISGEIPK---FLVELQLVQNLNLSYNDLEGVIPTEGVFKN 345
           LDLS+N +  E  K          +Q L LS N L  +  T  +   
Sbjct: 339 LDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLT 385

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  119 bits (301), Expect = 2e-28
 Identities = 56/353 (15%), Positives = 124/353 (35%), Gaps = 44/353 (12%)

Query: 20  LPNLLFLSLGFNQITGVIPSSMF-NASKLEVFQVTSNNLTGEVPSE-FGKATKAYCVQNC 77
           L +L +L+L  N    +  +S+F N + L+  ++ +     E+    F   T        
Sbjct: 97  LSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLT-------- 148

Query: 78  NQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGK-FINLQTLHMW 136
              L  L+I   +        + +    +  L  + ++    +         +++ L + 
Sbjct: 149 --SLNELEIKALSLRNYQSQSLKSIR-DIHHLTLHLSES-AFLLEIFADILSSVRYLELR 204

Query: 137 DNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSL 196
           D  L+      +   +    +     + S     S   L KLL+  L  + ++    +  
Sbjct: 205 DTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLN 264

Query: 197 G------------------QCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLV 238
           G                  +  ++  +++    L   +      L  +   + +  +++ 
Sbjct: 265 GLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKR-ITVENSKV- 322

Query: 239 GSLPTEVGK-LINLEILFISRNMLECEILST---LGSCIKLEQLKLGGNLFQ--GPIPLS 292
             +P    + L +LE L +S N++  E L      G+   L+ L L  N  +        
Sbjct: 323 FLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEI 382

Query: 293 LSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKN 345
           L +L+ L  LD+S+N     +P      + ++ LNLS   +  V     + + 
Sbjct: 383 LLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVV--KTCIPQT 432

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  117 bits (296), Expect = 7e-28
 Identities = 54/348 (15%), Positives = 115/348 (33%), Gaps = 34/348 (9%)

Query: 20  LPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQ 79
              +  L L FN+IT +    +   + L+V  + S+ +       F              
Sbjct: 25  TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYS----------LG 74

Query: 80  HLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAG--IGKFINLQTLHMWD 137
            L+HLD+++N+   L        S +L+ L    N   +++          NLQTL + +
Sbjct: 75  SLEHLDLSDNHLSSLSSSWFGPLS-SLKYLNLMGNPY-QTLGVTSLFPNLTNLQTLRIGN 132

Query: 138 NQLSGTISP-AIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSL 196
            +    I       L +L  L I    L      S+ +++ +  L L  +     +    
Sbjct: 133 VETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFA 192

Query: 197 GQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFI 256
               S+  + L   NL+       + +  +S  +     +          +L+ L    +
Sbjct: 193 DILSSVRYLELRDTNLA-RFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYIL 251

Query: 257 SRNMLECEILSTLG------------------SCIKLEQLKLGGNLFQGPIPLSLSSLRG 298
             + +E +  +  G                    + + +L +        +    S L  
Sbjct: 252 ELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEK 311

Query: 299 LRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKNA 346
           ++ + +  + +      F   L+ ++ L+LS N +          K A
Sbjct: 312 VKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGA 359

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  114 bits (287), Expect = 8e-27
 Identities = 63/348 (18%), Positives = 121/348 (34%), Gaps = 43/348 (12%)

Query: 20  LPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQN-CN 78
           + ++  L+L  ++   ++       S +   ++   NL     S       +  ++    
Sbjct: 171 IRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAF 230

Query: 79  QHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIG------KFINLQT 132
           +     D + N    LL   +    +  +    N    F    + +       + + ++ 
Sbjct: 231 RGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRR 290

Query: 133 LHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIG-NLKKLLQLYLIENFLQ-- 189
           LH+    L   +S     L+ +  + +  +K+   +P S   +LK L  L L EN +   
Sbjct: 291 LHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEE 349

Query: 190 -VSIPSSLGQCQSLTTINLSYNNLS--GTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVG 246
            +   +  G   SL T+ LS N+L         L+ L +L+  LD+SRN     +P    
Sbjct: 350 YLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTS-LDISRNTF-HPMPDSCQ 407

Query: 247 KLINLEILFISRNMLECEILSTLGSCI--KLEQLKLGGNLFQGPIPLSLSSLRG------ 298
               +  L +S   +       + +CI   LE L +  N       L L  L+       
Sbjct: 408 WPEKMRFLNLSSTGI-----RVVKTCIPQTLEVLDVSNNNLDS-FSLFLPRLQELYISRN 461

Query: 299 -------------LRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDL 333
                        L V+ +S+N +          L  +Q + L  N  
Sbjct: 462 KLKTLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  110 bits (278), Expect = 1e-25
 Identities = 61/297 (20%), Positives = 109/297 (36%), Gaps = 22/297 (7%)

Query: 19  TLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCN 78
                +     FN++   +   +   S++E    T N L    PSE    ++   V+   
Sbjct: 229 AFRGSVLTDESFNELL-KLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVET-- 285

Query: 79  QHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFI-NLQTLHMWD 137
             ++ L I        L          ++ +   ++K+F  +P    + + +L+ L + +
Sbjct: 286 VTIRRLHIPQFYLFYDLSTVYSLLE-KVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSE 343

Query: 138 NQLSGTI---SPAIGELQNLVTLAINTNKLS--GNIPPSIGNLKKLLQLYLIENFLQVSI 192
           N +       S   G   +L TL ++ N L         +  LK L  L +  N     +
Sbjct: 344 NLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PM 402

Query: 193 PSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLE 252
           P S    + +  +NLS   +   +   +    +L V LD+S N L  S       L  L+
Sbjct: 403 PDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEV-LDVSNNNL-DSFSLF---LPRLQ 454

Query: 253 ILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNI 309
            L+ISRN L+   L        L  +K+  N  +         L  L+ + L  N  
Sbjct: 455 ELYISRNKLKT--LPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  110 bits (277), Expect = 1e-25
 Identities = 64/349 (18%), Positives = 122/349 (34%), Gaps = 44/349 (12%)

Query: 20  LPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQ 79
           L +L  L +    +      S+ +   +    +  +     +              +   
Sbjct: 147 LTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFA----------DILS 196

Query: 80  HLKHLDINNNNFGGL--LPGCICNFSITLETLIFNSNKI----FRSIPAGIGKFINLQTL 133
            +++L++ + N       P  +   S  ++ L F  + +    F  +   +   + L  +
Sbjct: 197 SVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEV 256

Query: 134 HMWDNQLSG------TISPAIGELQNLVTLAINTNKLSGN-----IPPSIGNLKKLLQLY 182
              D  L+G      + S  + EL  + T+ I    +        +      L+K+ ++ 
Sbjct: 257 EFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRIT 316

Query: 183 LIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQ---LMDLTSLSVGLDLSRNQLVG 239
           +  + + +   S     +SL  ++LS N +               SL   L LS+N L  
Sbjct: 317 VENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQT-LVLSQNHLR- 374

Query: 240 SLPTEVG---KLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSL 296
           S+         L NL  L ISRN     +  +     K+  L L     +    +     
Sbjct: 375 SMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV---VKTCIP 430

Query: 297 RGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKN 345
           + L VLD+S NN+      FL  LQ    L +S N L+  +P   +F  
Sbjct: 431 QTLEVLDVSNNNLD-SFSLFLPRLQ---ELYISRNKLK-TLPDASLFPV 474

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 98.3 bits (245), Expect = 1e-21
 Identities = 52/272 (19%), Positives = 100/272 (36%), Gaps = 27/272 (9%)

Query: 20  LPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQ 79
                      ++   V          +    +    L  ++ + +    K         
Sbjct: 261 CTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEK--------- 311

Query: 80  HLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSI---PAGIGKFINLQTLHMW 136
            +K + + N+    +      +   +LE L  + N +        A  G + +LQTL + 
Sbjct: 312 -VKRITVENSKVFLVPCSFSQHLK-SLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLS 369

Query: 137 DNQLS--GTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPS 194
            N L         +  L+NL +L I+ N     +P S    +K+  L L    ++  + +
Sbjct: 370 QNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKT 427

Query: 195 SLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEIL 254
            +   Q+L  +++S NNL  +    L  L  L     +SRN+L  +LP +      L ++
Sbjct: 428 CI--PQTLEVLDVSNNNLD-SFSLFLPRLQEL----YISRNKLK-TLP-DASLFPVLLVM 478

Query: 255 FISRNMLECEILSTLGSCIKLEQLKLGGNLFQ 286
            ISRN L+            L+++ L  N + 
Sbjct: 479 KISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 97.9 bits (244), Expect = 2e-21
 Identities = 43/222 (19%), Positives = 83/222 (37%), Gaps = 7/222 (3%)

Query: 113 SNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSI 172
            ++ F SIP+G+     +++L +  N+++      +    NL  L + +++++  I    
Sbjct: 13  RSRSFTSIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEGDA 69

Query: 173 -GNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSG-TIPPQLMDLTSLSVGL 230
             +L  L  L L +N L     S  G   SL  +NL  N      +     +LT+L   L
Sbjct: 70  FYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQT-L 128

Query: 231 DLSRNQLVGSLPTEV-GKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPI 289
            +   +    +       L +L  L I    L      +L S   +  L L  +     +
Sbjct: 129 RIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLL 188

Query: 290 PLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYN 331
            +    L  +R L+L   N++      L   ++   +     
Sbjct: 189 EIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAF 230

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 95.6 bits (238), Expect = 1e-20
 Identities = 47/251 (18%), Positives = 94/251 (37%), Gaps = 29/251 (11%)

Query: 19  TLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCN 78
               +  L +    +   + +      K++   V ++ +   VP  F +  K        
Sbjct: 284 ETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLK-------- 334

Query: 79  QHLKHLDINNNNFGGLL---PGCICNFSITLETLIFNSNKIFRSIPAGIGKF---INLQT 132
             L+ LD++ N           C   +  +L+TL+ + N + RS+           NL +
Sbjct: 335 -SLEFLDLSENLMVEEYLKNSACKGAWP-SLQTLVLSQNHL-RSMQKTGEILLTLKNLTS 391

Query: 133 LHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSI 192
           L +  N     +  +    + +  L +++  +   +   I   + L  L +  N L  S 
Sbjct: 392 LDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLD-SF 446

Query: 193 PSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLE 252
              L     L  + +S N L  T+P   +    L V + +SRNQL         +L +L+
Sbjct: 447 SLFL---PRLQELYISRNKLK-TLPDASL-FPVLLV-MKISRNQLKSVPDGIFDRLTSLQ 500

Query: 253 ILFISRNMLEC 263
            +++  N  +C
Sbjct: 501 KIWLHTNPWDC 511

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 78.2 bits (193), Expect = 3e-15
 Identities = 45/206 (21%), Positives = 71/206 (34%), Gaps = 26/206 (12%)

Query: 12  IPLDFGFTLPNLLFLSLGFNQITGVIPSSMF---NASKLEVFQVTSNNLT--GEVPSEFG 66
           +P  F   L +L FL L  N +      +         L+   ++ N+L    +      
Sbjct: 325 VPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILL 384

Query: 67  KATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGK 126
                         L  LDI+ N F  +   C   +   +  L  +S  I R +   I  
Sbjct: 385 TLKN----------LTSLDISRNTFHPMPDSC--QWPEKMRFLNLSSTGI-RVVKTCI-- 429

Query: 127 FINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIEN 186
              L+ L + +N L  + S     L  L  L I+ NKL   +P +      LL + +  N
Sbjct: 430 PQTLEVLDVSNNNLD-SFSL---FLPRLQELYISRNKLK-TLPDA-SLFPVLLVMKISRN 483

Query: 187 FLQVSIPSSLGQCQSLTTINLSYNNL 212
            L+        +  SL  I L  N  
Sbjct: 484 QLKSVPDGIFDRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 60.1 bits (146), Expect = 1e-09
 Identities = 29/147 (19%), Positives = 55/147 (37%), Gaps = 29/147 (19%)

Query: 199 CQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISR 258
           C +    +    + + +IP  L    ++   LDLS N++      ++    NL++L +  
Sbjct: 4   CDASGVCDGRSRSFT-SIPSGL--TAAMKS-LDLSFNKITYIGHGDLRACANLQVLILKS 59

Query: 259 NMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLV 318
           + +                  + G+ F          L  L  LDLS N++S     +  
Sbjct: 60  SRIN----------------TIEGDAFYS--------LGSLEHLDLSDNHLSSLSSSWFG 95

Query: 319 ELQLVQNLNLSYNDLEGVIPTEGVFKN 345
            L  ++ LNL  N  +  +    +F N
Sbjct: 96  PLSSLKYLNLMGNPYQ-TLGVTSLFPN 121

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  118 bits (297), Expect = 3e-28
 Identities = 61/237 (25%), Positives = 112/237 (47%), Gaps = 31/237 (13%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSS--IAECSALRNIRHKNLVKILTVCSG 468
           G +G VY+G+  +    +AVK L        +    + E + ++ I+H NLV++L VC+ 
Sbjct: 231 GQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT- 286

Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL 528
              +   F  ++ EFM  G+L ++L             + ++ +  + +A  ++ A++YL
Sbjct: 287 ---REPPFY-IITEFMTYGNLLDYLRE--------CNRQEVSAVVLLYMATQISSAMEYL 334

Query: 529 H-HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPA 587
              +      H +L   N L+       VADFGL++L+      T+  G K  I + AP 
Sbjct: 335 EKKNF----IHRNLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAP- 388

Query: 588 EYGLGSEVSINGDVYSYGILLLELMTR-KRPSDIMFEGNMNLHNFARTVLPDHVMDI 643
           E    ++ SI  DV+++G+LL E+ T    P    + G ++L      +  D+ M+ 
Sbjct: 389 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSP----YPG-IDLSQVYELLEKDYRMER 440

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  113 bits (285), Expect = 1e-27
 Identities = 60/282 (21%), Positives = 106/282 (37%), Gaps = 24/282 (8%)

Query: 75  QNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGI-GKFINLQTL 133
           +  +     LD+ NN+   L           L  L+  +NKI   I          LQ L
Sbjct: 50  KEISPDTTLLDLQNNDISELRKDDFKGLQ-HLYALVLVNNKI-SKIHEKAFSPLRKLQKL 107

Query: 134 HMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSI-GNLKKLLQLYLIENFLQ-VS 191
           ++  N L   I P +    +LV L I+ N++   +P  +   L+ +  + +  N L+   
Sbjct: 108 YISKNHLV-EIPPNL--PSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSG 163

Query: 192 IPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEV-GKLIN 250
                     L  + +S   L+  IP  L    +L+  L L  N++  ++  E   +   
Sbjct: 164 FEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNE-LHLDHNKIQ-AIELEDLLRYSK 218

Query: 251 LEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNIS 310
           L  L +  N +      +L     L +L L  N     +P  L  L+ L+V+ L  NNI+
Sbjct: 219 LYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTNNIT 277

Query: 311 GEIP-------KFLVELQLVQNLNLSYNDLEGVIPTEGVFKN 345
            ++         F V+      ++L  N +         F+ 
Sbjct: 278 -KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRC 318

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  106 bits (267), Expect = 2e-25
 Identities = 58/299 (19%), Positives = 104/299 (34%), Gaps = 34/299 (11%)

Query: 21  PNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQH 80
           P+   L L  N I+ +          L    + +N ++      F               
Sbjct: 54  PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLR----------K 103

Query: 81  LKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGI-GKFINLQTLHMWDNQ 139
           L+ L I+ N+   + P      S +L  L  + N+I R +P G+     N+  + M  N 
Sbjct: 104 LQKLYISKNHLVEIPPNL---PS-SLVELRIHDNRI-RKVPKGVFSGLRNMNCIEMGGNP 158

Query: 140 L-SGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPS-SLG 197
           L +    P   +   L  L I+  KL+  IP      + L +L+L  N +Q +I    L 
Sbjct: 159 LENSGFEPGAFDGLKLNYLRISEAKLT-GIPK--DLPETLNELHLDHNKIQ-AIELEDLL 214

Query: 198 QCQSLTTINLSYNNLSGTIPPQ-LMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFI 256
           +   L  + L +N +   I    L  L +L   L L  N+L   +P  +  L  L+++++
Sbjct: 215 RYSKLYRLGLGHNQIR-MIENGSLSFLPTLRE-LHLDNNKLS-RVPAGLPDLKLLQVVYL 271

Query: 257 SRNMLEC------EILSTLGSCIKLEQLKLGGNLFQGPI--PLSLSSLRGLRVLDLSQN 307
             N +          +           + L  N        P +   +     +     
Sbjct: 272 HTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 50.4 bits (121), Expect = 9e-07
 Identities = 18/127 (14%), Positives = 39/127 (30%), Gaps = 18/127 (14%)

Query: 20  LPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQ 79
              L  L LG NQI  +   S+     L    + +N L+  VP+               +
Sbjct: 216 YSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGL----------PDLK 264

Query: 80  HLKHLDINNNNFGGLLPGCICNFSIT-----LETLIFNSNKI-FRSIPAGI-GKFINLQT 132
            L+ + ++ NN   +     C             +   +N + +  +         +   
Sbjct: 265 LLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLA 324

Query: 133 LHMWDNQ 139
           +   + +
Sbjct: 325 IQFGNYK 331

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  113 bits (284), Expect = 1e-27
 Identities = 59/317 (18%), Positives = 111/317 (35%), Gaps = 45/317 (14%)

Query: 21  PNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQH 80
           P+   L L  N+IT +      N   L    + +N ++   P  F               
Sbjct: 52  PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLV----------K 101

Query: 81  LKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGI-GKFINLQTLHMWDNQ 139
           L+ L ++ N    L          TL+ L  + N+I   +   +      +  + +  N 
Sbjct: 102 LERLYLSKNQLKELPEKM---PK-TLQELRVHENEI-TKVRKSVFNGLNQMIVVELGTNP 156

Query: 140 L-SGTISP-AIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLG 197
           L S  I   A   ++ L  + I    ++  IP   G    L +L+L  N +     +SL 
Sbjct: 157 LKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLK 213

Query: 198 QCQSLTTINLSYNNLSGTIPPQ-LMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFI 256
              +L  + LS+N++S  +    L +   L   L L+ N+LV  +P  +     ++++++
Sbjct: 214 GLNNLAKLGLSFNSIS-AVDNGSLANTPHLRE-LHLNNNKLV-KVPGGLADHKYIQVVYL 270

Query: 257 SRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNIS-GEIPK 315
             N +                  +G N F    P   +       + L  N +   EI  
Sbjct: 271 HNNNIS----------------AIGSNDFCP--PGYNTKKASYSGVSLFSNPVQYWEIQP 312

Query: 316 FL-VELQLVQNLNLSYN 331
                + +   + L   
Sbjct: 313 STFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  113 bits (284), Expect = 2e-27
 Identities = 70/310 (22%), Positives = 124/310 (40%), Gaps = 36/310 (11%)

Query: 47  LEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITL 106
           L V Q +   L  +VP            ++       LD+ NN    +  G   N    L
Sbjct: 33  LRVVQCSDLGLE-KVP------------KDLPPDTALLDLQNNKITEIKDGDFKNLK-NL 78

Query: 107 ETLIFNSNKIFRSIPAGI-GKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLS 165
            TLI  +NKI   I  G     + L+ L++  NQL   +       + L  L ++ N+++
Sbjct: 79  HTLILINNKI-SKISPGAFAPLVKLERLYLSKNQLK-ELPE--KMPKTLQELRVHENEIT 134

Query: 166 GNIPPSI-GNLKKLLQLYLIENFLQVSI--PSSLGQCQSLTTINLSYNNLSGTIPPQLMD 222
             +  S+   L +++ + L  N L+ S     +    + L+ I ++  N++ TIP  L  
Sbjct: 135 -KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL-- 190

Query: 223 LTSLSVGLDLSRNQLVGSLPTEV-GKLINLEILFISRNMLECEILSTLGSCIKLEQLKLG 281
             SL+  L L  N++   +       L NL  L +S N +      +L +   L +L L 
Sbjct: 191 PPSLTE-LHLDGNKI-TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLN 248

Query: 282 GNLFQGPIPLSLSSLRGLRVLDLSQNNISG------EIPKFLVELQLVQNLNLSYNDLEG 335
            N     +P  L+  + ++V+ L  NNIS         P +  +      ++L  N ++ 
Sbjct: 249 NNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQY 307

Query: 336 VIPTEGVFKN 345
                  F+ 
Sbjct: 308 WEIQPSTFRC 317

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 50.8 bits (122), Expect = 7e-07
 Identities = 23/126 (18%), Positives = 43/126 (34%), Gaps = 18/126 (14%)

Query: 20  LPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQ 79
           L NL  L L FN I+ V   S+ N   L    + +N L  +VP               ++
Sbjct: 215 LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGL----------ADHK 263

Query: 80  HLKHLDINNNNFGGLLPGCICNFSIT-----LETLIFNSNKI-FRSIPAGI-GKFINLQT 132
           +++ + ++NNN   +     C             +   SN + +  I             
Sbjct: 264 YIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAA 323

Query: 133 LHMWDN 138
           + + + 
Sbjct: 324 VQLGNY 329

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  116 bits (291), Expect = 3e-27
 Identities = 58/293 (19%), Positives = 96/293 (32%), Gaps = 39/293 (13%)

Query: 53  TSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFN 112
           +  N      +++  A          +       N N    LL  C+ N       L  N
Sbjct: 17  SFYNTISGTYADYFSAWDK------WEKQALPGENRNEAVSLLKECLIN---QFSELQLN 67

Query: 113 SNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSI 172
              +  S+P  +     +  L +  N L  ++        +L  L    N+LS  +P   
Sbjct: 68  RLNL-SSLPDNLPP--QITVLEITQNALI-SLPELPA---SLEYLDACDNRLS-TLPELP 119

Query: 173 GNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDL 232
            +LK L    +  N L   +P        L  IN   N L+  +P     L  L     +
Sbjct: 120 ASLKHL---DVDNNQLT-MLPELPAL---LEYINADNNQLT-MLPELPTSLEVL----SV 167

Query: 233 SRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQ----LKLGGNLFQGP 288
             NQL   LP       +LE L +S N+LE  + +        E+     +   N     
Sbjct: 168 RNNQL-TFLPEL---PESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRITH- 221

Query: 289 IPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEG 341
           IP ++ SL     + L  N +S  I + L +     + +            + 
Sbjct: 222 IPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQN 274

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  110 bits (275), Expect = 2e-25
 Identities = 44/265 (16%), Positives = 91/265 (34%), Gaps = 41/265 (15%)

Query: 20  LPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQ 79
           +     L L    ++  +P ++    ++ V ++T N L   +P                 
Sbjct: 58  INQFSELQLNRLNLS-SLPDNLP--PQITVLEITQNALI-SLPELPA------------- 100

Query: 80  HLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQ 139
            L++LD  +N    L P    +    L+ L  ++N++   +P        L+ ++  +NQ
Sbjct: 101 SLEYLDACDNRLSTL-PELPAS----LKHLDVDNNQL-TMLPELPA---LLEYINADNNQ 151

Query: 140 LSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQC 199
           L  T+ P      +L  L++  N+L+  +P    +L+ L    +  N L+ S+P+   + 
Sbjct: 152 L--TMLPE--LPTSLEVLSVRNNQLTF-LPELPESLEAL---DVSTNLLE-SLPAVPVRN 202

Query: 200 QSLTT----INLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILF 255
                         N ++  IP  ++ L      + L  N L   +   + +        
Sbjct: 203 HHSEETEIFFRCRENRIT-HIPENILSLDPTCT-IILEDNPLSSRIRESLSQQTAQPDYH 260

Query: 256 ISRNMLECEILSTLGSCIKLEQLKL 280
             R                L     
Sbjct: 261 GPRIYFSMSDGQQNTLHRPLADAVT 285

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 63.5 bits (154), Expect = 1e-10
 Identities = 42/234 (17%), Positives = 70/234 (29%), Gaps = 19/234 (8%)

Query: 19  TLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQN-- 76
              +L  L +  NQ+T ++P      + LE     +N LT  +P             N  
Sbjct: 118 LPASLKHLDVDNNQLT-MLPELP---ALLEYINADNNQLT-MLPELPTSLEVLSVRNNQL 172

Query: 77  -----CNQHLKHLDINNNNFGGL--LPGCICNFSITLETLIFNSNKIFRSIPAGIGKFIN 129
                  + L+ LD++ N    L  +P    +   T        N+I   IP  I     
Sbjct: 173 TFLPELPESLEALDVSTNLLESLPAVPVRNHHSEETEIFFRCRENRI-THIPENILSLDP 231

Query: 130 LQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQ 189
             T+ + DN LS  I  ++ +                ++     N         +  +  
Sbjct: 232 TCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYF--SMSDGQQNTLHRPLADAVTAWFP 289

Query: 190 VSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPT 243
            +  S + Q           N  S     +L D  S        R Q+   L  
Sbjct: 290 ENKQSDVSQIWHAFEHEEHANTFS-AFLDRLSDTVSARNTSGF-REQVAAWLEK 341

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  111 bits (279), Expect = 5e-27
 Identities = 54/217 (24%), Positives = 98/217 (45%), Gaps = 29/217 (13%)

Query: 411 GSFGSVYKGIL---DEGKTIIAVKVLNLLHHGASKSS--IAECSALRNIRHKNLVKILTV 465
           G FGSV +G L   D     +AVK + L +    +    ++E + +++  H N++++L V
Sbjct: 45  GEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGV 104

Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
           C  +  +G     ++  FM  G L  +L       +    PK +     +   +D+A  +
Sbjct: 105 CIEMSSQGIPKPMVILPFMKYGDLHTYLL----YSRLETGPKHIPLQTLLKFMVDIALGM 160

Query: 526 KYL-HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYI 584
           +YL + +      H DL   N +L  +MT  VADFGL+K      + +     +G I  +
Sbjct: 161 EYLSNRNF----LHRDLAARNCMLRDDMTVCVADFGLSKK-----IYSGDYYRQGRIAKM 211

Query: 585 -----AP--AEYGLGSEVSINGDVYSYGILLLELMTR 614
                A       + +  S   DV+++G+ + E+ TR
Sbjct: 212 PVKWIAIESLADRVYTSKS---DVWAFGVTMWEIATR 245

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  113 bits (286), Expect = 6e-27
 Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 33/207 (15%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSS-IAECSALRNIRHKNLVKILTVCSGV 469
           G FG V  G        +AVK +    + A+  + +AE S +  +RH NLV++L V    
Sbjct: 204 GEFGDVMLGDYR--GNKVAVKCIK---NDATAQAFLAEASVMTQLRHSNLVQLLGVIV-- 256

Query: 470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL- 528
             +      +V E+M  GSL ++L               L     +  ++DV  A++YL 
Sbjct: 257 --EEKGGLYIVTEYMAKGSLVDYLRS--------RGRSVLGGDCLLKFSLDVCEAMEYLE 306

Query: 529 HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP-- 586
            ++      H DL   NVL+  +  A V+DFGL K        ++    K  + + AP  
Sbjct: 307 GNNF----VHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEA 357

Query: 587 AEYGLGSEVSINGDVYSYGILLLELMT 613
                    S   DV+S+GILL E+ +
Sbjct: 358 LREKK---FSTKSDVWSFGILLWEIYS 381

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  111 bits (279), Expect = 7e-27
 Identities = 53/219 (24%), Positives = 94/219 (42%), Gaps = 37/219 (16%)

Query: 411 GSFGSVYKGIL----DEGKTIIAVKVLNLLHHGASKSS----IAECSALRNIRHKNLVKI 462
           G+FG+VYKG+     ++ K  +A+K L       S  +    + E   + ++ + ++ ++
Sbjct: 26  GAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVA 522
           L +C            L+ + M  G L +++          E    +     +N  + +A
Sbjct: 83  LGICLT------STVQLITQLMPFGCLLDYVR---------EHKDNIGSQYLLNWCVQIA 127

Query: 523 CALKYL-HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTI 581
             + YL          H DL   NVL+       + DFGLAKLL     +  + G K  I
Sbjct: 128 KGMNYLEDRRL----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183

Query: 582 GYIAP--AEYGLGSEVSINGDVYSYGILLLELMTR-KRP 617
            ++A     + + +  S   DV+SYG+ + ELMT   +P
Sbjct: 184 KWMALESILHRIYTHQS---DVWSYGVTVWELMTFGSKP 219

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  110 bits (278), Expect = 8e-27
 Identities = 56/218 (25%), Positives = 94/218 (43%), Gaps = 30/218 (13%)

Query: 411 GSFGSVYKGIL---DEGKTIIAVKVLNLLHHGASKSS--IAECSALRNIRHKNLVKILTV 465
           G FGSV +  L   D     +AVK+L      +S     + E + ++   H ++ K++ V
Sbjct: 34  GEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGV 93

Query: 466 CSGVDYKGDDFKAL-VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
                 KG     + +  FM +G L  +L     A +  E P  L     +   +D+AC 
Sbjct: 94  SLRSRAKGRLPIPMVILPFMKHGDLHAFLL----ASRIGENPFNLPLQTLVRFMVDIACG 149

Query: 525 LKYL-HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGY 583
           ++YL   +      H DL   N +L  +MT  VADFGL++      + +     +G    
Sbjct: 150 MEYLSSRNF----IHRDLAARNCMLAEDMTVCVADFGLSRK-----IYSGDYYRQGCASK 200

Query: 584 I-----AP--AEYGLGSEVSINGDVYSYGILLLELMTR 614
           +     A       L +  S   DV+++G+ + E+MTR
Sbjct: 201 LPVKWLALESLADNLYTVHS---DVWAFGVTMWEIMTR 235

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  111 bits (281), Expect = 9e-27
 Identities = 53/216 (24%), Positives = 82/216 (37%), Gaps = 43/216 (19%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSS----IAECSALRNIRHKNLVKILTVC 466
           G+FG V+ G L    T++AVK                 + E   L+   H N+V+++ VC
Sbjct: 125 GNFGEVFSGRLRADNTLVAVKSCR---ETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181

Query: 467 SGVD--YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
           +     Y       +V E +  G    +L               L     + +  D A  
Sbjct: 182 TQKQPIY-------IVMELVQGGDFLTFLR---------TEGARLRVKTLLQMVGDAAAG 225

Query: 525 LKYLH-HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPP----AHLQTSSIGVKG 579
           ++YL    C     H DL   N L+  +    ++DFG+++        A      + VK 
Sbjct: 226 MEYLESKCC----IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKW 281

Query: 580 TIGYIAP--AEYGLGSEVSINGDVYSYGILLLELMT 613
           T    AP    YG     S   DV+S+GILL E  +
Sbjct: 282 T----APEALNYGR---YSSESDVWSFGILLWETFS 310

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  112 bits (283), Expect = 1e-26
 Identities = 54/208 (25%), Positives = 100/208 (48%), Gaps = 31/208 (14%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSS--IAECSALRNIRHKNLVKILTVCSG 468
           G FG V+    +   T +AVK +     G+      +AE + ++ ++H  LVK+  V + 
Sbjct: 199 GQFGEVWMATYN-KHTKVAVKTM---KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 254

Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL 528
                 +   ++ EFM  GSL ++L    G+             + I+ +  +A  + ++
Sbjct: 255 ------EPIYIITEFMAKGSLLDFLKSDEGSK--------QPLPKLIDFSAQIAEGMAFI 300

Query: 529 -HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP- 586
              +      H DL+ +N+L+   +   +ADFGLA+++   +  T+  G K  I + AP 
Sbjct: 301 EQRNY----IHRDLRAANILVSASLVCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPE 355

Query: 587 -AEYGLGSEVSINGDVYSYGILLLELMT 613
              +G     +I  DV+S+GILL+E++T
Sbjct: 356 AINFGS---FTIKSDVWSFGILLMEIVT 380

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  112 bits (282), Expect = 2e-26
 Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 27/206 (13%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSS--IAECSALRNIRHKNLVKILTVCSG 468
           G FG V+ G    G T +A+K L     G       + E   ++ +RH+ LV++  V S 
Sbjct: 195 GCFGEVWMGTW-NGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS- 249

Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL 528
                ++   +V E+M  GSL ++L          E  K L   Q +++A  +A  + Y+
Sbjct: 250 -----EEPIYIVTEYMSKGSLLDFLKG--------ETGKYLRLPQLVDMAAQIASGMAYV 296

Query: 529 H-HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPA 587
              +      H DL+ +N+L+   +   VADFGLA+L+   +  T+  G K  I + AP 
Sbjct: 297 ERMNY----VHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE 351

Query: 588 EYGLGSEVSINGDVYSYGILLLELMT 613
               G   +I  DV+S+GILL EL T
Sbjct: 352 AALYG-RFTIKSDVWSFGILLTELTT 376

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  109 bits (275), Expect = 2e-26
 Identities = 59/216 (27%), Positives = 94/216 (43%), Gaps = 31/216 (14%)

Query: 411 GSFGSVYKGIL----DEGKTIIAVKVLNLLHHGASKSS-IAECSALRNIRHKNLVKILTV 465
           G FG+V+KG+     +  K  + +KV+       S  +      A+ ++ H ++V++L +
Sbjct: 24  GVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGL 83

Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
           C G          LV +++  GSL + +          +    L     +N  + +A  +
Sbjct: 84  CPG------SSLQLVTQYLPLGSLLDHVR---------QHRGALGPQLLLNWGVQIAKGM 128

Query: 526 KYLH-HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYI 584
            YL  H       H +L   NVLL       VADFG+A LLPP   Q      K  I ++
Sbjct: 129 YYLEEHGM----VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM 184

Query: 585 AP--AEYGLGSEVSINGDVYSYGILLLELMTR-KRP 617
           A     +G  +  S   DV+SYG+ + ELMT    P
Sbjct: 185 ALESIHFGKYTHQS---DVWSYGVTVWELMTFGAEP 217

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  108 bits (272), Expect = 2e-26
 Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 30/213 (14%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSS--IAECSALRNIRHKNLVKILTVCSG 468
           G +G VY+G+  +    +AVK L        +    + E + ++ I+H NLV++L VC+ 
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT- 79

Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL 528
              +   F  ++ EFM  G+L ++L             + ++ +  + +A  ++ A++YL
Sbjct: 80  ---REPPF-YIITEFMTYGNLLDYLRE--------CNRQEVSAVVLLYMATQISSAMEYL 127

Query: 529 -HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP- 586
              +      H DL   N L+       VADFGL++L+      T+  G K  I + AP 
Sbjct: 128 EKKNF----IHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPE 182

Query: 587 -AEYGLGSEVSINGDVYSYGILLLELMTR-KRP 617
              Y      SI  DV+++G+LL E+ T    P
Sbjct: 183 SLAYNK---FSIKSDVWAFGVLLWEIATYGMSP 212

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  108 bits (272), Expect = 3e-26
 Identities = 53/215 (24%), Positives = 88/215 (40%), Gaps = 31/215 (14%)

Query: 411 GSFGSVYKGI-LDEGKTIIAVKVLNLLHHGAS--KSSIAECSALRNIRHKNLVKILTVCS 467
           GSF +VYKG+  +    + A   L       S  +    E   L+ ++H N+V+      
Sbjct: 37  GSFKTVYKGLDTETTVEV-AWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD-SW 94

Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
               KG     LV E M +G+L+ +L          +  K +      +    +   L++
Sbjct: 95  ESTVKGKKCIVLVTELMTSGTLKTYL----------KRFKVMKIKVLRSWCRQILKGLQF 144

Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEM-TAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP 586
           LH    P   H DLK  N+ +     +  + D GLA L   +  +     V GT  ++AP
Sbjct: 145 LH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPEFMAP 199

Query: 587 ----AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
                +Y          DVY++G+ +LE+ T + P
Sbjct: 200 EMYEEKYDESV------DVYAFGMCMLEMATSEYP 228

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  112 bits (281), Expect = 4e-26
 Identities = 63/206 (30%), Positives = 100/206 (48%), Gaps = 27/206 (13%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSS--IAECSALRNIRHKNLVKILTVCSG 468
           G FG V+ G  + G T +A+K L     G       + E   ++ +RH+ LV++  V S 
Sbjct: 278 GCFGEVWMGTWN-GTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS- 332

Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL 528
                ++   +V E+M  GSL ++L          E  K L   Q +++A  +A  + Y+
Sbjct: 333 -----EEPIYIVTEYMSKGSLLDFLKG--------ETGKYLRLPQLVDMAAQIASGMAYV 379

Query: 529 H-HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPA 587
              +      H DL+ +N+L+   +   VADFGLA+L+   +  T+  G K  I + AP 
Sbjct: 380 ERMNY----VHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE 434

Query: 588 EYGLGSEVSINGDVYSYGILLLELMT 613
               G   +I  DV+S+GILL EL T
Sbjct: 435 AALYG-RFTIKSDVWSFGILLTELTT 459

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  108 bits (271), Expect = 5e-26
 Identities = 56/256 (21%), Positives = 99/256 (38%), Gaps = 19/256 (7%)

Query: 96  PGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLV 155
             C C+      T I  ++K   S+P GI    +   L +  N+L         +L  L 
Sbjct: 3   SRCSCS-----GTEIRCNSKGLTSVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLT 55

Query: 156 TLAINTNKLS--GNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLS 213
            L++++N LS  G    S      L  L L  N +  ++ S+    + L  ++  ++NL 
Sbjct: 56  KLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK 114

Query: 214 GTIPPQ--LMDLTSLSVGLDLSRNQLVGSLPTEV-GKLINLEILFISRNMLECEILS-TL 269
             +      + L +L   LD+S           +   L +LE+L ++ N  +   L    
Sbjct: 115 -QMSEFSVFLSLRNLIY-LDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIF 171

Query: 270 GSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLS 329
                L  L L     +   P + +SL  L+VL++S NN           L  +Q L+ S
Sbjct: 172 TELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYS 231

Query: 330 YNDLEGVIPTEGVFKN 345
            N +      +   ++
Sbjct: 232 LNHIMTS--KKQELQH 245

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 96.2 bits (240), Expect = 5e-22
 Identities = 53/261 (20%), Positives = 92/261 (35%), Gaps = 29/261 (11%)

Query: 12  IPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLT--GEVPSEFGKAT 69
           +P        +   L L  N++  +        ++L    ++SN L+  G         T
Sbjct: 22  VPTGI---PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78

Query: 70  KAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGI-GKFI 128
                      LK+LD++ N     +          LE L F  + + +     +     
Sbjct: 79  ----------SLKYLDLSFNGVIT-MSSNFLGLE-QLEHLDFQHSNLKQMSEFSVFLSLR 126

Query: 129 NLQTLHMWDNQLSGTISPAI-GELQNLVTLAINTNKLSGNIPPSI-GNLKKLLQLYLIEN 186
           NL  L +            I   L +L  L +  N    N  P I   L+ L  L L + 
Sbjct: 127 NLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 185

Query: 187 FLQVSIPSSLGQC-QSLTTINLSYNNLSGTIPPQ-LMDLTSLSVGLDLSRNQLVGSLPTE 244
            L+  +  +      SL  +N+S+NN   ++       L SL V LD S N ++ +   +
Sbjct: 186 QLE-QLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQV-LDYSLNHIM-TSKKQ 241

Query: 245 V--GKLINLEILFISRNMLEC 263
                  +L  L +++N   C
Sbjct: 242 ELQHFPSSLAFLNLTQNDFAC 262

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 45.0 bits (107), Expect = 5e-05
 Identities = 24/111 (21%), Positives = 39/111 (35%), Gaps = 10/111 (9%)

Query: 6   NRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEF 65
           N  Q     D    L NL FL L   Q+  + P++  + S L+V  ++ NN        +
Sbjct: 160 NSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPY 219

Query: 66  GKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKI 116
                          L+ LD + N+        + +F  +L  L    N  
Sbjct: 220 KCLNS----------LQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 260

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  106 bits (268), Expect = 8e-26
 Identities = 61/213 (28%), Positives = 107/213 (50%), Gaps = 32/213 (15%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSS--IAECSALRNIRHKNLVKILTVCSG 468
           G FG V+ G    G T +AVK L     G+      +AE + ++ ++H+ LV++  V + 
Sbjct: 24  GQFGEVWMGYY-NGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79

Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL 528
                 +   ++ E+M NGSL ++L   SG          L   + +++A  +A  + ++
Sbjct: 80  ------EPIYIITEYMENGSLVDFLKTPSGIK--------LTINKLLDMAAQIAEGMAFI 125

Query: 529 -HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP- 586
              +      H DL+ +N+L+   ++  +ADFGLA+L+   +  T+  G K  I + AP 
Sbjct: 126 EERNY----IHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPE 180

Query: 587 -AEYGLGSEVSINGDVYSYGILLLELMTR-KRP 617
              YG     +I  DV+S+GILL E++T  + P
Sbjct: 181 AINYGT---FTIKSDVWSFGILLTEIVTHGRIP 210

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  106 bits (266), Expect = 2e-25
 Identities = 47/216 (21%), Positives = 84/216 (38%), Gaps = 35/216 (16%)

Query: 411 GSFGSVYKGIL---DEGKTIIAVKVLNLLHHGASKSSIA----ECSALRNIRHKNLVKIL 463
           G FG VY G      + +   A+K L+          +     E   +R + H N++ ++
Sbjct: 32  GHFGVVYHGEYIDQAQNRIQCAIKSLS---RITEMQQVEAFLREGLLMRGLNHPNVLALI 88

Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            +        +    ++  +M +G L +++             +       I+  + VA 
Sbjct: 89  GIML----PPEGLPHVLLPYMCHGDLLQFIR---------SPQRNPTVKDLISFGLQVAR 135

Query: 524 ALKYL-HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGT-- 580
            ++YL          H DL   N +LD   T  VADFGLA+ +      +          
Sbjct: 136 GMEYLAEQKF----VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLP 191

Query: 581 IGYIAP--AEYGLGSEVSINGDVYSYGILLLELMTR 614
           + + A    +    +  S   DV+S+G+LL EL+TR
Sbjct: 192 VKWTALESLQTYRFTTKS---DVWSFGVLLWELLTR 224

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  104 bits (263), Expect = 3e-25
 Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 33/207 (15%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSS-IAECSALRNIRHKNLVKILTVCSGV 469
           G FG V  G        +AVK +    + A+  + +AE S +  +RH NLV++L V    
Sbjct: 32  GEFGDVMLGDYR--GNKVAVKCIK---NDATAQAFLAEASVMTQLRHSNLVQLLGVIV-- 84

Query: 470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL- 528
             +      +V E+M  GSL ++L               L     +  ++DV  A++YL 
Sbjct: 85  --EEKGGLYIVTEYMAKGSLVDYLRS--------RGRSVLGGDCLLKFSLDVCEAMEYLE 134

Query: 529 HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP-- 586
            ++      H DL   NVL+  +  A V+DFGL K        ++    K  + + AP  
Sbjct: 135 GNNF----VHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEA 185

Query: 587 AEYGLGSEVSINGDVYSYGILLLELMT 613
                    S   DV+S+GILL E+ +
Sbjct: 186 LREKK---FSTKSDVWSFGILLWEIYS 209

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  106 bits (266), Expect = 4e-25
 Identities = 53/219 (24%), Positives = 94/219 (42%), Gaps = 37/219 (16%)

Query: 411 GSFGSVYKGIL----DEGKTIIAVKVLNLLHHGASKSS----IAECSALRNIRHKNLVKI 462
           G+FG+VYKG+     ++ K  +A+K L       S  +    + E   + ++ + ++ ++
Sbjct: 26  GAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVA 522
           L +C            L+ + M  G L +++          E    +     +N  + +A
Sbjct: 83  LGICLT------STVQLITQLMPFGCLLDYVR---------EHKDNIGSQYLLNWCVQIA 127

Query: 523 CALKYL-HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTI 581
             + YL          H DL   NVL+       + DFGLAKLL     +  + G K  I
Sbjct: 128 KGMNYLEDRRL----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183

Query: 582 GYIAP--AEYGLGSEVSINGDVYSYGILLLELMTR-KRP 617
            ++A     + + +  S   DV+SYG+ + ELMT   +P
Sbjct: 184 KWMALESILHRIYTHQS---DVWSYGVTVWELMTFGSKP 219

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  105 bits (264), Expect = 4e-25
 Identities = 57/218 (26%), Positives = 83/218 (38%), Gaps = 33/218 (15%)

Query: 411 GSFGSVYKGIL--DEGKTI-IAVKVLN---LLHHGASKSSIAECSALRNIRHKNLVKILT 464
           GSFG V +G      GKT+ +AVK L    L    A    I E +A+ ++ H+NL+++  
Sbjct: 29  GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG 88

Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
           V      K      +V E    GSL + L          +             A+ VA  
Sbjct: 89  VVLTPPMK------MVTELAPLGSLLDRLR---------KHQGHFLLGTLSRYAVQVAEG 133

Query: 525 LKYL-HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQ-TSSIGVKGTIG 582
           + YL          H DL   N+LL       + DFGL + LP            K    
Sbjct: 134 MGYLESKRF----IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 189

Query: 583 YIAP--AEYGLGSEVSINGDVYSYGILLLELMTR-KRP 617
           + AP   +    S  S   D + +G+ L E+ T  + P
Sbjct: 190 WCAPESLKTRTFSHAS---DTWMFGVTLWEMFTYGQEP 224

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  105 bits (263), Expect = 5e-25
 Identities = 57/212 (26%), Positives = 87/212 (41%), Gaps = 28/212 (13%)

Query: 411 GSFGSVYKGIL----DEGKTIIAVKVLNLLHHGASKSS-IAECSALRNIRHKNLVKILTV 465
           G FG V         D     +AVK L     G   +    E   LRN+ H+N+VK   +
Sbjct: 32  GHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGI 91

Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
           C+     G +   L+ EF+ +GSL+E+L          +    +N  Q++  A+ +   +
Sbjct: 92  CTE---DGGNGIKLIMEFLPSGSLKEYLP---------KNKNKINLKQQLKYAVQICKGM 139

Query: 526 KYLH-HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQ-TSSIGVKGTIGY 583
            YL          H DL   NVL++ E    + DFGL K +       T        + +
Sbjct: 140 DYLGSRQY----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFW 195

Query: 584 IAP--AEYGLGSEVSINGDVYSYGILLLELMT 613
            AP           S   DV+S+G+ L EL+T
Sbjct: 196 YAPECLMQSKFYIAS---DVWSFGVTLHELLT 224

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  104 bits (262), Expect = 6e-25
 Identities = 56/213 (26%), Positives = 90/213 (42%), Gaps = 27/213 (12%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G++G VY G     +  IA+K +       S+    E +  ++++HKN+V+ L    G  
Sbjct: 33  GTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYL----GSF 88

Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
            +    K +  E +  GSL   L    G  K  E                +   LKYLH 
Sbjct: 89  SENGFIK-IFMEQVPGGSLSALLRSKWGPLKDNEQTIG-------FYTKQILEGLKYLHD 140

Query: 531 DCQPTTAHCDLKPSNVLLD-HEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP--- 586
           +      H D+K  NVL++ +     ++DFG +K L  A +   +    GT+ Y+AP   
Sbjct: 141 NQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRL--AGINPCTETFTGTLQYMAPEII 195

Query: 587 --AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
                G G       D++S G  ++E+ T K P
Sbjct: 196 DKGPRGYGKAA----DIWSLGCTIIEMATGKPP 224

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  104 bits (261), Expect = 7e-25
 Identities = 53/218 (24%), Positives = 92/218 (42%), Gaps = 36/218 (16%)

Query: 411 GSFGSVYKGIL--DEGKTIIAVKVLNLLHHGASKSS----IAECSALRNIRHKNLVKILT 464
           G+FGSV +G+    + +  +A+KVL     G  K+     + E   +  + +  +V+++ 
Sbjct: 21  GNFGSVRQGVYRMRKKQIDVAIKVL---KQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
           VC            LV E    G L ++L             + +       +   V+  
Sbjct: 78  VCQAEALM------LVMEMAGGGPLHKFLV---------GKREEIPVSNVAELLHQVSMG 122

Query: 525 LKYL-HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQ-TSSIGVKGTIG 582
           +KYL   +      H DL   NVLL +   A ++DFGL+K L       T+    K  + 
Sbjct: 123 MKYLEEKNF----VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 178

Query: 583 YIAP--AEYGLGSEVSINGDVYSYGILLLELMTR-KRP 617
           + AP    +   S  S   DV+SYG+ + E ++  ++P
Sbjct: 179 WYAPECINFRKFSSRS---DVWSYGVTMWEALSYGQKP 213

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  104 bits (261), Expect = 8e-25
 Identities = 55/213 (25%), Positives = 94/213 (44%), Gaps = 32/213 (15%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSS--IAECSALRNIRHKNLVKILTVCSG 468
           G FG V  G    G+  +A+K++     G+      I E   + N+ H+ LV++  VC+ 
Sbjct: 35  GQFGVVKYGKW-RGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT- 89

Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL 528
              K      ++ E+M NG L  +L          E        Q + +  DV  A++YL
Sbjct: 90  ---KQRPI-FIITEYMANGCLLNYLR---------EMRHRFQTQQLLEMCKDVCEAMEYL 136

Query: 529 -HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP- 586
                     H DL   N L++ +    V+DFGL++ +      TSS+G K  + +  P 
Sbjct: 137 ESKQF----LHRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPE 191

Query: 587 -AEYGLGSEVSINGDVYSYGILLLELMTR-KRP 617
              Y    + S   D++++G+L+ E+ +  K P
Sbjct: 192 VLMYS---KFSSKSDIWAFGVLMWEIYSLGKMP 221

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  104 bits (261), Expect = 8e-25
 Identities = 54/214 (25%), Positives = 90/214 (42%), Gaps = 33/214 (15%)

Query: 411 GSFGSVYKGIL----DEGKTIIAVKVLNLLHHGASKSS---IAECSALRNIRHKNLVKIL 463
           G+FGSV         D    ++AVK L    H   +       E   L++++H N+VK  
Sbjct: 21  GNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQHDNIVKYK 77

Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            VC      G     L+ E++  GSL ++L          +  + ++ ++ +     +  
Sbjct: 78  GVCYS---AGRRNLKLIMEYLPYGSLRDYLQ---------KHKERIDHIKLLQYTSQICK 125

Query: 524 ALKYLH-HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQ-TSSIGVKGTI 581
            ++YL          H DL   N+L+++E    + DFGL K+LP            +  I
Sbjct: 126 GMEYLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPI 181

Query: 582 GYIAP--AEYGLGSEVSINGDVYSYGILLLELMT 613
            + AP        S  S   DV+S+G++L EL T
Sbjct: 182 FWYAPESLTESKFSVAS---DVWSFGVVLYELFT 212

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  103 bits (259), Expect = 9e-25
 Identities = 53/213 (24%), Positives = 84/213 (39%), Gaps = 32/213 (15%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSS--IAECSALRNIRHKNLVKILTVCSG 468
           G FG V+ G     K  +A+K +     GA      I E   +  + H  LV++  VC  
Sbjct: 19  GQFGLVHLGYW-LNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL- 73

Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL 528
              +      LV EFM +G L ++L                     + + +DV   + YL
Sbjct: 74  ---EQAPI-CLVTEFMEHGCLSDYLR---------TQRGLFAAETLLGMCLDVCEGMAYL 120

Query: 529 -HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP- 586
                     H DL   N L+       V+DFG+ + +      TSS G K  + + +P 
Sbjct: 121 EEACV----IHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPE 175

Query: 587 -AEYGLGSEVSINGDVYSYGILLLELMTR-KRP 617
              +      S   DV+S+G+L+ E+ +  K P
Sbjct: 176 VFSFS---RYSSKSDVWSFGVLMWEVFSEGKIP 205

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  104 bits (262), Expect = 1e-24
 Identities = 58/248 (23%), Positives = 95/248 (38%), Gaps = 34/248 (13%)

Query: 411 GSFGSVYKGIL----DEGKTIIAVKVLNLLHHGASKSS---IAECSALRNIRHKNLVKIL 463
           G+FGSV         D    ++AVK L    H           E   L+ +    +VK  
Sbjct: 34  GNFGSVELCRYDPLGDNTGALVAVKQL---QHSGPDQQRDFQREIQILKALHSDFIVKYR 90

Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            V  G    G     LV E++ +G L ++L               L+  + +  +  +  
Sbjct: 91  GVSYG---PGRQSLRLVMEYLPSGCLRDFLQRHRAR---------LDASRLLLYSSQICK 138

Query: 524 ALKYLH-HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAH-LQTSSIGVKGTI 581
            ++YL    C     H DL   N+L++ E    +ADFGLAKLLP            +  I
Sbjct: 139 GMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPI 194

Query: 582 GYIAP--AEYGLGSEVSINGDVYSYGILLLELMTR-KRPSDIMFEGNMNLHNFARTVLPD 638
            + AP      + S  S   DV+S+G++L EL T   +      E    +          
Sbjct: 195 FWYAPESLSDNIFSRQS---DVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALS 251

Query: 639 HVMDIVDS 646
            ++++++ 
Sbjct: 252 RLLELLEE 259

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  103 bits (258), Expect = 1e-24
 Identities = 58/213 (27%), Positives = 90/213 (42%), Gaps = 32/213 (15%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSS--IAECSALRNIRHKNLVKILTVCSG 468
           G FG V  G    G+  +AVK++     G+        E   +  + H  LVK   VCS 
Sbjct: 19  GQFGVVKLGKWK-GQYDVAVKMIK---EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS- 73

Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL 528
              K      +V E++ NG L  +L             K L   Q + +  DV   + +L
Sbjct: 74  ---KEYPI-YIVTEYISNGCLLNYLR---------SHGKGLEPSQLLEMCYDVCEGMAFL 120

Query: 529 -HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP- 586
             H       H DL   N L+D ++   V+DFG+ + +       SS+G K  + + AP 
Sbjct: 121 ESHQF----IHRDLAARNCLVDRDLCVKVSDFGMTRYV-LDDQYVSSVGTKFPVKWSAPE 175

Query: 587 -AEYGLGSEVSINGDVYSYGILLLELMTR-KRP 617
              Y    + S   DV+++GIL+ E+ +  K P
Sbjct: 176 VFHYF---KYSSKSDVWAFGILMWEVFSLGKMP 205

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  107 bits (269), Expect = 2e-24
 Identities = 52/218 (23%), Positives = 93/218 (42%), Gaps = 36/218 (16%)

Query: 411 GSFGSVYKGIL--DEGKTIIAVKVLNLLHHGASKSS----IAECSALRNIRHKNLVKILT 464
           G+FGSV +G+    + +  +A+KVL     G  K+     + E   +  + +  +V+++ 
Sbjct: 347 GNFGSVRQGVYRMRKKQIDVAIKVL---KQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403

Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
           VC        +   LV E    G L ++L             + +       +   V+  
Sbjct: 404 VCQA------EALMLVMEMAGGGPLHKFLV---------GKREEIPVSNVAELLHQVSMG 448

Query: 525 LKYL-HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQ-TSSIGVKGTIG 582
           +KYL   +      H +L   NVLL +   A ++DFGL+K L       T+    K  + 
Sbjct: 449 MKYLEEKNF----VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 504

Query: 583 YIAP--AEYGLGSEVSINGDVYSYGILLLELMTR-KRP 617
           + AP    +   S  S   DV+SYG+ + E ++  ++P
Sbjct: 505 WYAPECINFRKFSSRS---DVWSYGVTMWEALSYGQKP 539

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  103 bits (260), Expect = 2e-24
 Identities = 54/221 (24%), Positives = 98/221 (44%), Gaps = 37/221 (16%)

Query: 411 GSFGSVYKGIL-----DEGKTIIAVKVLNLLHHGASKSSIA----ECSALRNIRHKNLVK 461
           GSFG VY+G+      DE +T +A+K +N     AS         E S ++     ++V+
Sbjct: 36  GSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLNEASVMKEFNCHHVVR 92

Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDV 521
           +L V S    +G     ++ E M  G L+ +L  +  A          +  + I +A ++
Sbjct: 93  LLGVVS----QGQPT-LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147

Query: 522 ACALKYLH-HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGT 580
           A  + YL+ +       H DL   N ++  + T  + DFG+ +      +  +    KG 
Sbjct: 148 ADGMAYLNANKF----VHRDLAARNCMVAEDFTVKIGDFGMTRD-----IYETDYYRKGG 198

Query: 581 IGYI-----AP--AEYGLGSEVSINGDVYSYGILLLELMTR 614
            G +     +P   + G+ +  S   DV+S+G++L E+ T 
Sbjct: 199 KGLLPVRWMSPESLKDGVFTTYS---DVWSFGVVLWEIATL 236

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  103 bits (259), Expect = 2e-24
 Identities = 55/219 (25%), Positives = 96/219 (43%), Gaps = 36/219 (16%)

Query: 411 GSFGSVYKGIL---DEGKTIIAVKVLNLLHHGASKSS----IAECSALRNIRHKNLVKIL 463
           G  G V  G L    +    +A+K L     G ++      ++E S +    H N++++ 
Sbjct: 60  GDSGEVCYGRLRVPGQRDVPVAIKALK---AGYTERQRRDFLSEASIMGQFDHPNIIRLE 116

Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            V +    +G     +V E+M NGSL+ +L    G             +Q + +   V  
Sbjct: 117 GVVT----RGRLA-MIVTEYMENGSLDTFLRTHDGQ---------FTIMQLVGMLRGVGA 162

Query: 524 ALKYL-HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPP-AHLQTSSIGVKGTI 581
            ++YL          H DL   NVL+D  +   V+DFGL+++L        ++ G K  I
Sbjct: 163 GMRYLSDLGY----VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPI 218

Query: 582 GYIAP--AEYGLGSEVSINGDVYSYGILLLELMTR-KRP 617
            + AP    +   S  S   DV+S+G+++ E++   +RP
Sbjct: 219 RWTAPEAIAFRTFSSAS---DVWSFGVVMWEVLAYGERP 254

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  102 bits (256), Expect = 3e-24
 Identities = 55/245 (22%), Positives = 92/245 (37%), Gaps = 43/245 (17%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G FG V+K           +K +       ++ +  E  AL  + H N+V       G D
Sbjct: 22  GGFGQVFKAKHRIDGKTYVIKRVKY----NNEKAEREVKALAKLDHVNIVHYNGCWDGFD 77

Query: 471 YKGDDFKA-----------LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI 519
           Y  +               +  EF   G+LE+W+    G  + ++    L   ++I    
Sbjct: 78  YDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG--EKLDKVLALELFEQI---- 131

Query: 520 DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKG 579
                + Y+H        + DLKPSN+ L       + DFGL   L     +T S    G
Sbjct: 132 --TKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK---G 183

Query: 580 TIGYIAP-----AEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART 634
           T+ Y++P      +YG         D+Y+ G++L EL+         FE +    +    
Sbjct: 184 TLRYMSPEQISSQDYGKEV------DLYALGLILAELLHVCDT---AFETSKFFTDLRDG 234

Query: 635 VLPDH 639
           ++ D 
Sbjct: 235 IISDI 239

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  104 bits (261), Expect = 3e-24
 Identities = 57/223 (25%), Positives = 88/223 (39%), Gaps = 42/223 (18%)

Query: 411 GSFGSVYKGIL---DEGKTIIAVKVLNLLHHGASKSSIA----ECSALRNIRHKNLVKIL 463
           G FG VY G L   D  K   AVK LN          ++    E   +++  H N++ +L
Sbjct: 100 GHFGCVYHGTLLDNDGKKIHCAVKSLN---RITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156

Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            +C     + +    +V  +M +G L  ++                     I   + VA 
Sbjct: 157 GICL----RSEGSPLVVLPYMKHGDLRNFIR---------NETHNPTVKDLIGFGLQVAK 203

Query: 524 ALKYL-HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIG 582
            +K+L          H DL   N +LD + T  VADFGLA+ +   + +        T  
Sbjct: 204 GMKFLASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDM---YDKEFDSVHNKTGA 256

Query: 583 YI-----AP--AEYGLGSEVSINGDVYSYGILLLELMTR-KRP 617
            +     A    +    +  S   DV+S+G+LL ELMTR   P
Sbjct: 257 KLPVKWMALESLQTQKFTTKS---DVWSFGVLLWELMTRGAPP 296

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  105 bits (264), Expect = 3e-24
 Identities = 62/342 (18%), Positives = 108/342 (31%), Gaps = 52/342 (15%)

Query: 20  LPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQN--- 76
             NL +L+   N++T +  + +   +KL      +N LT    S+    T   C +N   
Sbjct: 84  NTNLTYLACDSNKLTNLDVTPL---TKLTYLNCDTNKLTKLDVSQNPLLTYLNCARNTLT 140

Query: 77  -----CNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQ 131
                 N  L  LD + N     L          L TL  + NKI   +   + +   L 
Sbjct: 141 EIDVSHNTQLTELDCHLNKKITKLDVTPQT---QLTTLDCSFNKI-TELD--VSQNKLLN 194

Query: 132 TLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVS 191
            L+   N ++      + +   L  L  ++NKL+  I   +  L +L       N L   
Sbjct: 195 RLNCDTNNIT---KLDLNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-E 247

Query: 192 IPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVG------------------LDLS 233
           +  S      LTT++    +L          L                        LD  
Sbjct: 248 LDVS--TLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQ 305

Query: 234 RNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSL 293
              +   L   + +   L  L+++   L  E+   +    KL+ L       Q     S+
Sbjct: 306 AAGIT-ELD--LSQNPKLVYLYLNNTELT-EL--DVSHNTKLKSLSCVNAHIQD-FS-SV 357

Query: 294 SSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEG 335
             +  L     ++        + L    L   ++    D  G
Sbjct: 358 GKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFG 399

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 99.0 bits (247), Expect = 4e-22
 Identities = 57/326 (17%), Positives = 100/326 (30%), Gaps = 39/326 (11%)

Query: 18  FTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTG-EVPSEFGKATKAYCVQN 76
           F   N         ++      S    + L      ++++T      +    TK  C  N
Sbjct: 15  FPDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTGIEKLTGLTKLICTSN 74

Query: 77  --------CNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFI 128
                    N +L +L  ++N    L           L  L  ++NK+   +   + +  
Sbjct: 75  NITTLDLSQNTNLTYLACDSNKLTNL----DVTPLTKLTYLNCDTNKL-TKLD--VSQNP 127

Query: 129 NLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFL 188
            L  L+   N L+      +     L  L  + NK        +    +L  L    N +
Sbjct: 128 LLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKIT--KLDVTPQTQLTTLDCSFNKI 182

Query: 189 QVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKL 248
              +   + Q + L  +N   NN++  +   L     L+  LD S N+L   +   V  L
Sbjct: 183 T-ELD--VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTF-LDCSSNKLT-EID--VTPL 232

Query: 249 INLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNN 308
             L     S N L    +STL    KL  L            + L+    L         
Sbjct: 233 TQLTYFDCSVNPLTELDVSTL---SKLTTLHCIQTDLLE---IDLTHNTQLIYFQAEGCR 286

Query: 309 ISGEIPKFLVELQLVQNLNLSYNDLE 334
              E+   +     +  L+     + 
Sbjct: 287 KIKELD--VTHNTQLYLLDCQAAGIT 310

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 63.9 bits (156), Expect = 7e-11
 Identities = 29/165 (17%), Positives = 58/165 (35%), Gaps = 18/165 (10%)

Query: 174 NLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLS 233
           N    +               S  Q  +LT+++   ++++  +   +  LT L+  L  +
Sbjct: 19  NFASEVAAAFEMQATD---TISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTK-LICT 72

Query: 234 RNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSL 293
            N +  +L   + +  NL  L    N L   +   +    KL  L    N       L +
Sbjct: 73  SNNIT-TLD--LSQNTNLTYLACDSNKLT-NL--DVTPLTKLTYLNCDTNKLT---KLDV 123

Query: 294 SSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIP 338
           S    L  L+ ++N ++ EI   +     +  L+   N     + 
Sbjct: 124 SQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD 165

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 43.1 bits (102), Expect = 3e-04
 Identities = 35/230 (15%), Positives = 63/230 (27%), Gaps = 53/230 (23%)

Query: 14  LDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYC 73
           +D    L  L +     N +T +  S++   SKL        +L     +   +      
Sbjct: 227 IDVT-PLTQLTYFDCSVNPLTELDVSTL---SKLTTLHCIQTDLLEIDLTHNTQLIYFQA 282

Query: 74  VQN---------CNQHLKHLDINNNNFGGL-LPGC------------ICNFSIT----LE 107
                        N  L  LD        L L               +    ++    L+
Sbjct: 283 EGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTELDVSHNTKLK 342

Query: 108 TLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGN 167
           +L   +  I +   + +GK   L      + Q              +    +  N L+  
Sbjct: 343 SLSCVNAHI-QDFSS-VGKIPALNNNFEAEGQTI-----------TMPKETLTNNSLTIA 389

Query: 168 IPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIP 217
           + P          L    N   ++I    G      T  +++ NLS   P
Sbjct: 390 VSPD--------LLDQFGN--PMNIEPGDGGVYDQATNTITWENLSTDNP 429

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  105 bits (263), Expect = 3e-24
 Identities = 57/259 (22%), Positives = 105/259 (40%), Gaps = 14/259 (5%)

Query: 77  CNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGI-GKFINLQTLHM 135
           C+     +     N   + P      S     L  + N+I + I         +L+ L +
Sbjct: 41  CSNQFSKVICVRKNLREV-PD---GISTNTRLLNLHENQI-QIIKVNSFKHLRHLEILQL 95

Query: 136 WDNQLSGTISP-AIGELQNLVTLAINTNKLSGNIPPSI-GNLKKLLQLYLIENFLQVSIP 193
             N +  TI   A   L NL TL +  N+L+  IP      L KL +L+L  N ++    
Sbjct: 96  SRNHIR-TIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPS 153

Query: 194 SSLGQCQSLTTINLSYNNLSGTIPPQ-LMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLE 252
            +  +  SL  ++L        I       L++L   L+L+   L   +P  +  LI L+
Sbjct: 154 YAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRY-LNLAMCNLR-EIPN-LTPLIKLD 210

Query: 253 ILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGE 312
            L +S N L      +    + L++L +  +  Q     +  +L+ L  ++L+ NN++  
Sbjct: 211 ELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLL 270

Query: 313 IPKFLVELQLVQNLNLSYN 331
                  L  ++ ++L +N
Sbjct: 271 PHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 96.7 bits (241), Expect = 2e-21
 Identities = 61/248 (24%), Positives = 100/248 (40%), Gaps = 23/248 (9%)

Query: 21  PNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQH 80
            N   L+L  NQI  +  +S  +   LE+ Q++ N++       F               
Sbjct: 64  TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLAN---------- 113

Query: 81  LKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGI-GKFINLQTLHMWD-N 138
           L  L++ +N    +  G     S  L+ L   +N I  SIP+    +  +L+ L + +  
Sbjct: 114 LNTLELFDNRLTTIPNGAFVYLS-KLKELWLRNNPI-ESIPSYAFNRIPSLRRLDLGELK 171

Query: 139 QLSGTISP-AIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLG 197
           +LS  IS  A   L NL  L +    L     P++  L KL +L L  N L    P S  
Sbjct: 172 RLS-YISEGAFEGLSNLRYLNLAMCNLRE--IPNLTPLIKLDELDLSGNHLSAIRPGSFQ 228

Query: 198 QCQSLTTINLSYNNLSGTIPPQ-LMDLTSLSVGLDLSRNQLVGSLPTEV-GKLINLEILF 255
               L  + +  + +   I      +L SL   ++L+ N L   LP ++   L +LE + 
Sbjct: 229 GLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVE-INLAHNNLT-LLPHDLFTPLHHLERIH 285

Query: 256 ISRNMLEC 263
           +  N   C
Sbjct: 286 LHHNPWNC 293

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 87.9 bits (218), Expect = 1e-18
 Identities = 58/224 (25%), Positives = 92/224 (41%), Gaps = 23/224 (10%)

Query: 20  LPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSE-FGKATKAYCVQNCN 78
           L +L  L L  N I  +   +    + L   ++  N LT  +P+  F   +K        
Sbjct: 87  LRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSK-------- 137

Query: 79  QHLKHLDINNNNFGGLLPGCICNFSITLETL-IFNSNKIFRSIPAGI-GKFINLQTLHMW 136
             LK L + NN    +          +L  L +    ++   I  G      NL+ L++ 
Sbjct: 138 --LKELWLRNNPIESIPSYAFNRIP-SLRRLDLGELKRL-SYISEGAFEGLSNLRYLNLA 193

Query: 137 DNQLSGTISPAIGELQNLVTLAINTNKLSGNIPP-SIGNLKKLLQLYLIENFLQVSIPSS 195
              L   I P +  L  L  L ++ N LS  I P S   L  L +L++I++ +QV   ++
Sbjct: 194 MCNLR-EI-PNLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNA 250

Query: 196 LGQCQSLTTINLSYNNLSGTIPPQLMD-LTSLSVGLDLSRNQLV 238
               QSL  INL++NNL+  +P  L   L  L   + L  N   
Sbjct: 251 FDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLER-IHLHHNPWN 292

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 84.8 bits (210), Expect = 2e-17
 Identities = 55/254 (21%), Positives = 94/254 (37%), Gaps = 41/254 (16%)

Query: 96  PGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLV 155
             C C+   +   +I     + R +P GI    N + L++ +NQ+               
Sbjct: 37  SVCSCSNQFS--KVICVRKNL-REVPDGI--STNTRLLNLHENQIQ-------------- 77

Query: 156 TLAINTNKLSGNIPPSI-GNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSG 214
                       I  +   +L+ L  L L  N ++     +     +L T+ L  N L+ 
Sbjct: 78  -----------IIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT- 125

Query: 215 TIPPQ-LMDLTSLSVGLDLSRNQLVGSLPTEV-GKLINLEILFISR-NMLECEILSTLGS 271
           TIP    + L+ L   L L  N +  S+P+    ++ +L  L +     L          
Sbjct: 126 TIPNGAFVYLSKLKE-LWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEG 183

Query: 272 CIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYN 331
              L  L L     +  IP +L+ L  L  LDLS N++S   P     L  +Q L +  +
Sbjct: 184 LSNLRYLNLAMCNLRE-IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQS 241

Query: 332 DLEGVIPTEGVFKN 345
            ++ +      F N
Sbjct: 242 QIQVI--ERNAFDN 253

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  101 bits (255), Expect = 4e-24
 Identities = 46/218 (21%), Positives = 84/218 (38%), Gaps = 37/218 (16%)

Query: 411 GSFGSVYKGIL---DEGKTIIAVKVLNLLHHGASKSS----IAECSALRNIRHKNLVKIL 463
           G FG V++GI    +     +A+K      +  S S     + E   +R   H ++VK++
Sbjct: 26  GQFGDVHQGIYMSPENPALAVAIKTCK---NCTSDSVREKFLQEALTMRQFDHPHIVKLI 82

Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            V +       +   ++ E    G L  +L               L+    I  A  ++ 
Sbjct: 83  GVITE------NPVWIIMELCTLGELRSFLQ---------VRKYSLDLASLILYAYQLST 127

Query: 524 ALKYL-HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIG 582
           AL YL          H D+   NVL+       + DFGL++ +        +   K  I 
Sbjct: 128 ALAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIK 182

Query: 583 YIAP--AEYGLGSEVSINGDVYSYGILLLELMTR-KRP 617
           ++AP    +   +  S   DV+ +G+ + E++    +P
Sbjct: 183 WMAPESINFRRFTSAS---DVWMFGVCMWEILMHGVKP 217

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score =  102 bits (257), Expect = 4e-24
 Identities = 53/254 (20%), Positives = 101/254 (39%), Gaps = 23/254 (9%)

Query: 80  HLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQ 139
           +   +    +N    +     +    + TL      +  +I  G+    NL  L + DNQ
Sbjct: 20  NAIKIAAGKSNVTDTVT--QADLD-GITTLSAFGTGV-TTIE-GVQYLNNLIGLELKDNQ 74

Query: 140 LSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQC 199
           ++  ++P +  L  +  L ++ N L  N+   I  L+ +  L L     Q++  + L   
Sbjct: 75  IT-DLAP-LKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTST--QITDVTPLAGL 128

Query: 200 QSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRN 259
            +L  + L  N ++  I P L  LT+L   L +   Q+   L   +  L  L  L    N
Sbjct: 129 SNLQVLYLDLNQIT-NISP-LAGLTNLQY-LSIGNAQVS-DLT-PLANLSKLTTLKADDN 183

Query: 260 MLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKF--- 316
            +    +S L S   L ++ L  N      PL+  +   L ++ L+   I+ +   +   
Sbjct: 184 KISD--ISPLASLPNLIEVHLKNNQISDVSPLA--NTSNLFIVTLTNQTITNQPVFYNNN 239

Query: 317 LVELQLVQNLNLSY 330
           LV   +V+  + + 
Sbjct: 240 LVVPNVVKGPSGAP 253

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 94.4 bits (235), Expect = 2e-21
 Identities = 50/312 (16%), Positives = 110/312 (35%), Gaps = 56/312 (17%)

Query: 20  LPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQ 79
           L N + ++ G + +T  +  +  +                                    
Sbjct: 18  LANAIKIAAGKSNVTDTVTQADLD------------------------------------ 41

Query: 80  HLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQ 139
            +  L         +    +   +  L  L    N+I   +   +     +  L +  N 
Sbjct: 42  GITTLSAFGTGVTTIEG--VQYLN-NLIGLELKDNQI-TDLA-PLKNLTKITELELSGNP 96

Query: 140 LSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQC 199
           L   +S  I  LQ++ TL + + +++ ++ P +  L  L  LYL  N  Q++  S L   
Sbjct: 97  LK-NVSA-IAGLQSIKTLDLTSTQIT-DVTP-LAGLSNLQVLYLDLN--QITNISPLAGL 150

Query: 200 QSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRN 259
            +L  +++    +S  + P L +L+ L+  L    N++  S  + +  L NL  + +  N
Sbjct: 151 TNLQYLSIGNAQVS-DLTP-LANLSKLTT-LKADDNKI--SDISPLASLPNLIEVHLKNN 205

Query: 260 MLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVE 319
            +    +S L +   L  + L             ++L  +    +   + +   P  + +
Sbjct: 206 QISD--VSPLANTSNLFIVTLTNQTITNQPVFYNNNL--VVPNVVKGPSGAPIAPATISD 261

Query: 320 LQLVQNLNLSYN 331
                + NL++N
Sbjct: 262 NGTYASPNLTWN 273

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 89.7 bits (223), Expect = 1e-19
 Identities = 53/229 (23%), Positives = 94/229 (41%), Gaps = 19/229 (8%)

Query: 110 IFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIP 169
           I     I    P       N   +    + ++ T++    +L  + TL+     ++  I 
Sbjct: 3   ITQPTAINVIFP--DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE 57

Query: 170 PSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVG 229
             +  L  L+ L L +N  Q++  + L     +T + LS N L   +   +  L S+   
Sbjct: 58  G-VQYLNNLIGLELKDN--QITDLAPLKNLTKITELELSGNPLK-NVSA-IAGLQSIKT- 111

Query: 230 LDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPI 289
           LDL+  Q+  +  T +  L NL++L++  N +    +S L     L+ L +G        
Sbjct: 112 LDLTSTQI--TDVTPLAGLSNLQVLYLDLNQIT--NISPLAGLTNLQYLSIGNAQVSDLT 167

Query: 290 PLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIP 338
           PL+  +L  L  L    N IS +I   L  L  +  ++L  N +  V P
Sbjct: 168 PLA--NLSKLTTLKADDNKIS-DIS-PLASLPNLIEVHLKNNQISDVSP 212

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  101 bits (255), Expect = 4e-24
 Identities = 52/219 (23%), Positives = 95/219 (43%), Gaps = 38/219 (17%)

Query: 411 GSFGSVYKGIL--DEGKTIIAVKVLNLLHHGASKSS-----IAECSALRNIRHKNLVKIL 463
           G+FG+V KG     +    +AVK+L    + A+  +     +AE + ++ + +  +V+++
Sbjct: 28  GNFGTVKKGYYQMKKVVKTVAVKIL---KNEANDPALKDELLAEANVMQQLDNPYIVRMI 84

Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            +C        +   LV E    G L ++L             + +     I +   V+ 
Sbjct: 85  GICEA------ESWMLVMEMAELGPLNKYLQ----------QNRHVKDKNIIELVHQVSM 128

Query: 524 ALKYL-HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQ-TSSIGVKGTI 581
            +KYL   +      H DL   NVLL  +  A ++DFGL+K L        +    K  +
Sbjct: 129 GMKYLEESNF----VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 184

Query: 582 GYIAP--AEYGLGSEVSINGDVYSYGILLLELMTR-KRP 617
            + AP    Y    + S   DV+S+G+L+ E  +  ++P
Sbjct: 185 KWYAPECINYY---KFSSKSDVWSFGVLMWEAFSYGQKP 220

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  102 bits (257), Expect = 5e-24
 Identities = 54/214 (25%), Positives = 90/214 (42%), Gaps = 33/214 (15%)

Query: 411 GSFGSVYKGIL----DEGKTIIAVKVLNLLHHGASKSS---IAECSALRNIRHKNLVKIL 463
           G+FGSV         D    ++AVK L    H   +       E   L++++H N+VK  
Sbjct: 52  GNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQHDNIVKYK 108

Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            VC      G     L+ E++  GSL ++L          +  + ++ ++ +     +  
Sbjct: 109 GVCYS---AGRRNLKLIMEYLPYGSLRDYLQ---------KHKERIDHIKLLQYTSQICK 156

Query: 524 ALKYLH-HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQ-TSSIGVKGTI 581
            ++YL          H DL   N+L+++E    + DFGL K+LP            +  I
Sbjct: 157 GMEYLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPI 212

Query: 582 GYIAP--AEYGLGSEVSINGDVYSYGILLLELMT 613
            + AP        S  S   DV+S+G++L EL T
Sbjct: 213 FWYAPESLTESKFSVAS---DVWSFGVVLYELFT 243

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  101 bits (253), Expect = 1e-23
 Identities = 59/220 (26%), Positives = 91/220 (41%), Gaps = 36/220 (16%)

Query: 411 GSFGSVYKGIL---DEGKTIIAVKVLNLLHHGASKSSIA----ECSALRNIRHKNLVKIL 463
           G FG VY G L   D  K   AVK LN          ++    E   +++  H N++ +L
Sbjct: 36  GHFGCVYHGTLLDNDGKKIHCAVKSLN---RITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92

Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            +C     + +    +V  +M +G L  ++                     I   + VA 
Sbjct: 93  GICL----RSEGSPLVVLPYMKHGDLRNFIR---------NETHNPTVKDLIGFGLQVAK 139

Query: 524 ALKYLH-HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPA--HLQTSSIGVKGT 580
            +KYL          H DL   N +LD + T  VADFGLA+ +     +   +  G K  
Sbjct: 140 GMKYLASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP 195

Query: 581 IGYIAP--AEYGLGSEVSINGDVYSYGILLLELMTR-KRP 617
           + ++A    +    +  S   DV+S+G+LL ELMTR   P
Sbjct: 196 VKWMALESLQTQKFTTKS---DVWSFGVLLWELMTRGAPP 232

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  101 bits (253), Expect = 2e-23
 Identities = 58/220 (26%), Positives = 104/220 (47%), Gaps = 37/220 (16%)

Query: 411 GSFGSVYKGIL----DEGKTIIAVKVLNLLHHGASKSS----IAECSALRNIRHKNLVKI 462
           G FG VYKG+L     + +  +A+K L     G ++      + E   +    H N++++
Sbjct: 55  GEFGEVYKGMLKTSSGKKEVPVAIKTLK---AGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111

Query: 463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVA 522
             V S    K      ++ E+M NG+L+++L          E     + LQ + +   +A
Sbjct: 112 EGVIS----KYKPM-MIITEYMENGALDKFLR---------EKDGEFSVLQLVGMLRGIA 157

Query: 523 CALKYL-HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP-PAHLQTSSIGVKGT 580
             +KYL + +      H DL   N+L++  +   V+DFGL+++L        ++ G K  
Sbjct: 158 AGMKYLANMNY----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 213

Query: 581 IGYIAP--AEYGLGSEVSINGDVYSYGILLLELMTR-KRP 617
           I + AP    Y    + +   DV+S+GI++ E+MT  +RP
Sbjct: 214 IRWTAPEAISYR---KFTSASDVWSFGIVMWEVMTYGERP 250

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  100 bits (251), Expect = 2e-23
 Identities = 50/224 (22%), Positives = 95/224 (42%), Gaps = 41/224 (18%)

Query: 411 GSFGSVYKGIL-------DEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKIL 463
           G+F  ++KG+           +T + +KVL+  H   S+S     S +  + HK+LV   
Sbjct: 19  GTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNY 78

Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            VC      GD+   LV EF+  GSL+ +L          +   C+N L ++ +A  +A 
Sbjct: 79  GVCV----CGDEN-ILVQEFVKFGSLDTYLK---------KNKNCINILWKLEVAKQLAA 124

Query: 524 ALKYL-HHDCQPTTAHCDLKPSNVLLDHEMTAH--------VADFGLAKLLPPAHLQTSS 574
           A+ +L  +       H ++   N+LL  E            ++D G++  +         
Sbjct: 125 AMHFLEENTL----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV------LPK 174

Query: 575 IGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTR-KRP 617
             ++  I ++ P        +++  D +S+G  L E+ +   +P
Sbjct: 175 DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =   99 bits (250), Expect = 2e-23
 Identities = 52/227 (22%), Positives = 87/227 (38%), Gaps = 45/227 (19%)

Query: 411 GSFGSVYKGIL-----DEGKTIIAVKVLNLLHHGASKSS----IAECSALRNIRHKNLVK 461
             FG VYKG L      E    +A+K L      A          E      ++H N+V 
Sbjct: 20  DRFGKVYKGHLFGPAPGEQTQAVAIKTLK---DKAEGPLREEFRHEAMLRARLQHPNVVC 76

Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLH------PVSGADKTVEAPKCLNFLQRI 515
           +L V +    K     ++++ +  +G L E+L        V   D        L     +
Sbjct: 77  LLGVVT----KDQPL-SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131

Query: 516 NIAIDVACALKYL--HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTS 573
           ++   +A  ++YL  HH       H DL   NVL+  ++   ++D GL +      +  +
Sbjct: 132 HLVAQIAAGMEYLSSHHVV-----HKDLATRNVLVYDKLNVKISDLGLFRE-----VYAA 181

Query: 574 SIGVKGTIGYI-----AP--AEYGLGSEVSINGDVYSYGILLLELMT 613
                     +     AP    YG  S  S   D++SYG++L E+ +
Sbjct: 182 DYYKLLGNSLLPIRWMAPEAIMYGKFSIDS---DIWSYGVVLWEVFS 225

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  101 bits (254), Expect = 2e-23
 Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 36/219 (16%)

Query: 411 GSFGSVYKGIL---DEGKTIIAVKVLNLLHHGASKSS----IAECSALRNIRHKNLVKIL 463
           G FG V  G L    + +  +A+K L     G ++      + E S +    H N++++ 
Sbjct: 56  GEFGEVCSGRLKLPSKKEISVAIKTLK---VGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112

Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            V +    K      +V E+M NGSL+ +L          +       +Q + +   +A 
Sbjct: 113 GVVT----KSKPV-MIVTEYMENGSLDSFLR---------KHDAQFTVIQLVGMLRGIAS 158

Query: 524 ALKYL-HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPP-AHLQTSSIGVKGTI 581
            +KYL          H DL   N+L++  +   V+DFGL ++L        ++ G K  I
Sbjct: 159 GMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPI 214

Query: 582 GYIAP--AEYGLGSEVSINGDVYSYGILLLELMTR-KRP 617
            + +P    Y   +  S   DV+SYGI+L E+M+  +RP
Sbjct: 215 RWTSPEAIAYRKFTSAS---DVWSYGIVLWEVMSYGERP 250

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  100 bits (252), Expect = 3e-23
 Identities = 52/267 (19%), Positives = 98/267 (36%), Gaps = 25/267 (9%)

Query: 81  LKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGI-GKFINLQTLHMWDNQ 139
           +K LD++NN    +    +      L+ L+  SN I  +I         +L+ L +  N 
Sbjct: 54  VKSLDLSNNRITYISNSDLQRCV-NLQALVLTSNGI-NTIEEDSFSSLGSLEHLDLSYNY 111

Query: 140 LSGTISP-AIGELQNLVTLAINTNKLSGNIPPSI--GNLKKLLQLYLIENFLQVSIPS-S 195
           LS  +S      L +L  L +  N     +  +    +L KL  L +        I    
Sbjct: 112 LS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKD 169

Query: 196 LGQCQSLTTINLSYNNLSGTIPPQ-LMDLTSLSVGLDLSRNQLVGSLPTEV-GKLINLEI 253
                 L  + +  ++L  +  P+ L  + ++S  L L   Q +  L         ++E 
Sbjct: 170 FAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSH-LILHMKQHI-LLLEIFVDVTSSVEC 226

Query: 254 LFISRNMLECEILS--------TLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLS 305
           L +    L+    S        +L        +K+        +   L+ + GL  L+ S
Sbjct: 227 LELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFS 285

Query: 306 QNNISGEIPKFLVE-LQLVQNLNLSYN 331
           +N +   +P  + + L  +Q + L  N
Sbjct: 286 RNQLKS-VPDGIFDRLTSLQKIWLHTN 311

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  100 bits (251), Expect = 5e-23
 Identities = 48/256 (18%), Positives = 95/256 (37%), Gaps = 27/256 (10%)

Query: 20  LPNLLFLSLGFNQITGVIPSSMFNA-SKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCN 78
             NL  L L  N I   I    F++   LE   ++ N L+    S F   +         
Sbjct: 75  CVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSS-------- 125

Query: 79  QHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGI-GKFINLQTLHMWD 137
             L  L++  N +  L    + +    L+ L   +   F  I          L+ L +  
Sbjct: 126 --LTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDA 183

Query: 138 NQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSI-GNLKKLLQLYLIENFLQV----SI 192
           + L      ++  +QN+  L ++  +    +          +  L L +  L       +
Sbjct: 184 SDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSEL 242

Query: 193 PS----SLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEV-GK 247
            +    SL +  +   + ++  +L   +   L  ++ L   L+ SRNQL  S+P  +  +
Sbjct: 243 STGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLE-LEFSRNQLK-SVPDGIFDR 299

Query: 248 LINLEILFISRNMLEC 263
           L +L+ +++  N  +C
Sbjct: 300 LTSLQKIWLHTNPWDC 315

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 87.9 bits (218), Expect = 6e-19
 Identities = 50/240 (20%), Positives = 96/240 (40%), Gaps = 21/240 (8%)

Query: 113 SNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISP-AIGELQNLVTLAINTNKLSGNIPPS 171
           S+    SIP+G+     +++L + +N+++  IS   +    NL  L + +N ++  I   
Sbjct: 39  SSGSLNSIPSGL--TEAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGIN-TIEED 94

Query: 172 I-GNLKKLLQLYLIENFLQVSIPSSL-GQCQSLTTINLSYNNLSGTIPPQLM--DLTSLS 227
              +L  L  L L  N+L  ++ SS      SLT +NL  N    T+    +   LT L 
Sbjct: 95  SFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQ 152

Query: 228 VGLDLSRNQLVGSLPTEV-GKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQ 286
           + L +        +  +    L  LE L I  + L+     +L S   +  L L      
Sbjct: 153 I-LRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI 211

Query: 287 GPIPLSLSSLRGLRVLDLSQNNISG----EIPKF----LVELQLVQNLNLSYNDLEGVIP 338
             + + +     +  L+L   ++      E+       L++    +N+ ++   L  V+ 
Sbjct: 212 LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMK 271

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 99.7 bits (249), Expect = 4e-23
 Identities = 52/228 (22%), Positives = 76/228 (33%), Gaps = 42/228 (18%)

Query: 401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGAS--KSSIAECSALRNI-RHK 457
           SF  L  +  GS+G V+K    E   + AVK       G       +AE  +   + +H 
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117

Query: 458 NLVKILTVCSGVDYKG----DDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQ 513
             V+          +          L  E     SL++                 L   Q
Sbjct: 118 CCVR---------LEQAWEEGGILYLQTELC-GPSLQQHCE---------AWGASLPEAQ 158

Query: 514 RINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTS 573
                 D   AL +LH        H D+KP+N+ L       + DFGL   L  A     
Sbjct: 159 VWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV 215

Query: 574 SIGVKGTIGYIAP----AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
               +G   Y+AP      YG  +      DV+S G+ +LE+      
Sbjct: 216 ---QEGDPRYMAPELLQGSYGTAA------DVFSLGLTILEVACNMEL 254

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 99.2 bits (248), Expect = 4e-23
 Identities = 41/218 (18%), Positives = 88/218 (40%), Gaps = 37/218 (16%)

Query: 411 GSFGSVYKGIL---DEGKTIIAVKVLNLLHHGASKSS----IAECSALRNIRHKNLVKIL 463
           G FG VY+G+       K  +AVK         +  +    ++E   ++N+ H ++VK++
Sbjct: 23  GFFGEVYEGVYTNHKGEKINVAVKTCK---KDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79

Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            +         +   ++ E    G L  +L               L  L  +  ++ +  
Sbjct: 80  GIIEE------EPTWIIMELYPYGELGHYLE---------RNKNSLKVLTLVLYSLQICK 124

Query: 524 ALKYL-HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIG 582
           A+ YL   +C     H D+   N+L+       + DFGL++ +        +   +  I 
Sbjct: 125 AMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIEDED-YYKASVTRLPIK 179

Query: 583 YIAP--AEYGLGSEVSINGDVYSYGILLLELMTR-KRP 617
           +++P    +   +  S   DV+ + + + E+++  K+P
Sbjct: 180 WMSPESINFRRFTTAS---DVWMFAVCMWEILSFGKQP 214

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 99.2 bits (248), Expect = 4e-23
 Identities = 52/227 (22%), Positives = 94/227 (41%), Gaps = 46/227 (20%)

Query: 411 GSFGSVYKGIL-----DEGKTIIAVKVLNLLHHGASKSS----IAECSALRNIRHKNLVK 461
           G+FG V+          + K ++AVK L       + ++      E   L N++H+++VK
Sbjct: 26  GAFGKVFLAECYNLSPTKDKMLVAVKALK----DPTLAARKDFQREAELLTNLQHEHIVK 81

Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWL------HPVSGADKTVEAPKCLNFLQRI 515
              VC      GD    +V+E+M +G L ++L        +    +  +A   L   Q +
Sbjct: 82  FYGVCG----DGDPL-IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQML 136

Query: 516 NIAIDVACALKYL--HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTS 573
           +IA  +A  + YL   H       H DL   N L+   +   + DFG+++      + ++
Sbjct: 137 HIASQIASGMVYLASQHFV-----HRDLATRNCLVGANLLVKIGDFGMSRD-----VYST 186

Query: 574 SIGVKGTIGYI-----AP--AEYGLGSEVSINGDVYSYGILLLELMT 613
                G    +      P    Y      +   DV+S+G++L E+ T
Sbjct: 187 DYYRVGGHTMLPIRWMPPESIMYRK---FTTESDVWSFGVILWEIFT 230

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 99.3 bits (248), Expect = 6e-23
 Identities = 57/214 (26%), Positives = 84/214 (39%), Gaps = 34/214 (15%)

Query: 411 GSFGSVYKGIL----DEGKTIIAVKVLNLLHHGASKSS-IAECSALRNIRHKNLVKILTV 465
           G FG V         D    ++AVK L        +S    E   LR + H++++K    
Sbjct: 42  GHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGC 101

Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
           C      G     LV E++  GSL ++L   S           +   Q +  A  +   +
Sbjct: 102 CED---AGAASLQLVMEYVPLGSLRDYLPRHS-----------IGLAQLLLFAQQICEGM 147

Query: 526 KYLHHDCQPTTAHC---DLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQ-TSSIGVKGTI 581
            YLH        H    DL   NVLLD++    + DFGLAK +P  H            +
Sbjct: 148 AYLH------AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV 201

Query: 582 GYIAP--AEYGLGSEVSINGDVYSYGILLLELMT 613
            + AP   +       S   DV+S+G+ L EL+T
Sbjct: 202 FWYAPECLKEYKFYYAS---DVWSFGVTLYELLT 232

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score =  102 bits (256), Expect = 6e-23
 Identities = 53/253 (20%), Positives = 101/253 (39%), Gaps = 20/253 (7%)

Query: 81  LKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQL 140
           +      +     + P     F+            +  ++     +  ++  +   ++ +
Sbjct: 1   MGETITVSTPIKQIFP--DDAFA-ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI 55

Query: 141 SGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQ 200
             ++   I  L N+  L +N NKL+ +I P + NLK L  L+L EN  ++   SSL   +
Sbjct: 56  K-SVQG-IQYLPNVTKLFLNGNKLT-DIKP-LTNLKNLGWLFLDEN--KIKDLSSLKDLK 109

Query: 201 SLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNM 260
            L +++L +N +S  I   L+ L  L   L L  N++  +  T + +L  L+ L +  N 
Sbjct: 110 KLKSLSLEHNGIS-DING-LVHLPQLES-LYLGNNKI--TDITVLSRLTKLDTLSLEDNQ 164

Query: 261 LECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVEL 320
           +    +  L    KL+ L L  N       L+   L+ L VL+L       +       L
Sbjct: 165 ISD--IVPLAGLTKLQNLYLSKNHISDLRALA--GLKNLDVLELFSQECLNKPINHQSNL 220

Query: 321 QLVQNLNLSYNDL 333
            +   +  +   L
Sbjct: 221 VVPNTVKNTDGSL 233

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 95.9 bits (238), Expect = 1e-20
 Identities = 58/316 (18%), Positives = 116/316 (36%), Gaps = 59/316 (18%)

Query: 20  LPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQ 79
               +  +L    +T  +                                     QN   
Sbjct: 20  FAETIKDNLKKKSVTDAVT------------------------------------QNELN 43

Query: 80  HLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQ 139
            +  +  NN++   +    I      +  L  N NK+   I   +    NL  L + +N+
Sbjct: 44  SIDQIIANNSDIKSVQG--IQYLP-NVTKLFLNGNKL-TDIK-PLTNLKNLGWLFLDENK 98

Query: 140 LSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQC 199
           +   +S  + +L+ L +L++  N +S +I   + +L +L  LYL  N  +++  + L + 
Sbjct: 99  IK-DLSS-LKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNN--KITDITVLSRL 152

Query: 200 QSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRN 259
             L T++L  N +S  I P L  LT L   L LS+N +  S    +  L NL++L +   
Sbjct: 153 TKLDTLSLEDNQIS-DIVP-LAGLTKLQN-LYLSKNHI--SDLRALAGLKNLDVLELFSQ 207

Query: 260 MLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVE 319
               + ++   + +    +K        P  +S          D  + N+   +P+F  E
Sbjct: 208 ECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDG-------DYEKPNVKWHLPEFTNE 260

Query: 320 LQLVQNLNLSYNDLEG 335
           +  +    ++    + 
Sbjct: 261 VSFIFYQPVTIGKAKA 276

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 64.0 bits (155), Expect = 1e-10
 Identities = 36/195 (18%), Positives = 73/195 (37%), Gaps = 23/195 (11%)

Query: 19  TLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCN 78
            L NL +L L  N+I  +  SS+ +  KL+   +  N ++ ++            + +  
Sbjct: 85  NLKNLGWLFLDENKIKDL--SSLKDLKKLKSLSLEHNGIS-DING----------LVHLP 131

Query: 79  QHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDN 138
           Q L+ L + NN    +    +   +  L+TL    N+I   I   +     LQ L++  N
Sbjct: 132 Q-LESLYLGNNKITDITV--LSRLT-KLDTLSLEDNQI-SDIV-PLAGLTKLQNLYLSKN 185

Query: 139 QLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQ 198
            +S  +   +  L+NL  L + + +          NL     +   +    +  P  +  
Sbjct: 186 HIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDG--SLVTPEIISD 241

Query: 199 CQSLTTINLSYNNLS 213
                  N+ ++   
Sbjct: 242 DGDYEKPNVKWHLPE 256

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 99.2 bits (247), Expect = 6e-23
 Identities = 57/275 (20%), Positives = 96/275 (34%), Gaps = 23/275 (8%)

Query: 78  NQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFIN---LQTLH 134
            + L++L    +    L        S++L+ L   + +I   I  G  + +    LQ L 
Sbjct: 42  GRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELT 101

Query: 135 MWDNQLSGTISPAIGELQ--NLVTLAINTNKLSG--NIPPSIGNLKK--LLQLYLIENFL 188
           + + +++GT  P + E    +L  L +     +        +    K  L  L + +   
Sbjct: 102 LENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHS 161

Query: 189 QVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLM----DLTSLSVGLDLSRNQ---LVGSL 241
                  +    +L+T++LS N   G              +L V L L         G  
Sbjct: 162 LNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQV-LALRNAGMETPSGVC 220

Query: 242 PTEVGKLINLEILFISRNMLECEILSTLGS-CIKLEQLKLGGNLFQGPIPLSLSSLRGLR 300
                  + L+ L +S N L     +       +L  L L     +  +P  L +   L 
Sbjct: 221 SALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGLPA--KLS 277

Query: 301 VLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEG 335
           VLDLS N +    P    EL  V NL+L  N    
Sbjct: 278 VLDLSYNRLD-RNPSPD-ELPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 86.9 bits (215), Expect = 9e-19
 Identities = 45/277 (16%), Positives = 78/277 (28%), Gaps = 41/277 (14%)

Query: 19  TLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCN 78
           +L  L   +             +   S L+   + +  +TG  P            +   
Sbjct: 69  SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLL--------EATG 120

Query: 79  QHLKHLDINNNNFGGL---LPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHM 135
             L  L++ N ++      L          L+ L              +  F  L TL +
Sbjct: 121 PDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDL 180

Query: 136 WDNQLSGTI----SPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVS 191
            DN   G      +    +   L  LA+    +                           
Sbjct: 181 SDNPELGERGLISALCPLKFPTLQVLALRNAGM---------------------ETPSGV 219

Query: 192 IPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINL 251
             +       L  ++LS+N+L         D  S    L+LS   L   +P  +     L
Sbjct: 220 CSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPA--KL 276

Query: 252 EILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGP 288
            +L +S N L+     +     ++  L L GN F   
Sbjct: 277 SVLDLSYNRLDR--NPSPDELPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 68.4 bits (167), Expect = 1e-12
 Identities = 37/200 (18%), Positives = 63/200 (31%), Gaps = 15/200 (7%)

Query: 157 LAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQS---LTTINLSYNNLS 213
           L     +        I     L +L +    +   I     +      L  + L    ++
Sbjct: 49  LKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT 108

Query: 214 GTIPPQLMDLTSLSV-GLDLSRNQLVG--SLPTEVGKLI--NLEILFISRNMLECEILST 268
           GT PP L++ T   +  L+L         +   E+ + +   L++L I++          
Sbjct: 109 GTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQ 168

Query: 269 LGSCIKLEQLKLGGNLFQGPIPLSLS----SLRGLRVLDLSQNN---ISGEIPKFLVELQ 321
           +     L  L L  N   G   L  +        L+VL L        SG          
Sbjct: 169 VRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARV 228

Query: 322 LVQNLNLSYNDLEGVIPTEG 341
            +Q L+LS+N L        
Sbjct: 229 QLQGLDLSHNSLRDAAGAPS 248

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 64.5 bits (157), Expect = 2e-11
 Identities = 29/187 (15%), Positives = 56/187 (29%), Gaps = 26/187 (13%)

Query: 1   SDVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGE 60
            +V        +     +  P L  LS+            +     L    ++ N   GE
Sbjct: 129 RNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGE 188

Query: 61  -------VPSEFGKATKAYCVQN--------------CNQHLKHLDINNNNFGGLLPGCI 99
                   P +F                             L+ LD+++N+         
Sbjct: 189 RGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPS 248

Query: 100 CNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAI 159
           C++   L +L  +   + + +P G+     L  L +  N+L     P+  EL  +  L++
Sbjct: 249 CDWPSQLNSLNLSFTGL-KQVPKGL--PAKLSVLDLSYNRLDRN--PSPDELPQVGNLSL 303

Query: 160 NTNKLSG 166
             N    
Sbjct: 304 KGNPFLD 310

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 99.3 bits (248), Expect = 7e-23
 Identities = 55/226 (24%), Positives = 95/226 (42%), Gaps = 45/226 (19%)

Query: 411 GSFGSVYKGIL-----DEGKTIIAVKVLNLLHHGASKSS----IAECSALRNIRHKNLVK 461
           G+FG V+         ++ K ++AVK L      AS+S+      E   L  ++H+++V+
Sbjct: 52  GAFGKVFLAECHNLLPEQDKMLVAVKALK----EASESARQDFQREAELLTMLQHQHIVR 107

Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWL-----HPVSGADKTVEAPKCLNFLQRIN 516
              VC+    +G     +V+E+M +G L  +L          A     AP  L   Q + 
Sbjct: 108 FFGVCT----EGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 162

Query: 517 IAIDVACALKYL--HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSS 574
           +A  VA  + YL   H       H DL   N L+   +   + DFG+++ +      ++ 
Sbjct: 163 VASQVAAGMVYLAGLHFV-----HRDLATRNCLVGQGLVVKIGDFGMSRDIY-----STD 212

Query: 575 IGVKGTIGYI-----AP--AEYGLGSEVSINGDVYSYGILLLELMT 613
               G    +      P    Y   +  S   DV+S+G++L E+ T
Sbjct: 213 YYRVGGRTMLPIRWMPPESILYRKFTTES---DVWSFGVVLWEIFT 255

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  100 bits (252), Expect = 9e-23
 Identities = 57/260 (21%), Positives = 101/260 (38%), Gaps = 17/260 (6%)

Query: 96  PGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLV 155
             C C+       ++     +   +P GI    N + L++ +N +    +     L +L 
Sbjct: 48  SVCSCSNQ--FSKVVCTRRGL-SEVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLE 102

Query: 156 TLAINTNKLSGNIPPSI-GNLKKLLQLYLIENFLQVSIPS-SLGQCQSLTTINLSYNNLS 213
            L +  N +   I       L  L  L L +N+L   IPS +      L  + L  N + 
Sbjct: 103 VLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE 160

Query: 214 GTIPPQ-LMDLTSLSVGLDLSRNQLVGSLPTEV-GKLINLEILFISRNMLECEILSTLGS 271
            +IP      + SL   LDL   + +  +       L NL+ L +    ++   +  L  
Sbjct: 161 -SIPSYAFNRVPSLMR-LDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK--DMPNLTP 216

Query: 272 CIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYN 331
            + LE+L++ GN F    P S   L  L+ L +  + +S         L  +  LNL++N
Sbjct: 217 LVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHN 276

Query: 332 DLEGVIPTEGVFKNASAISV 351
           +L   +P   +F     +  
Sbjct: 277 NLS-SLP-HDLFTPLRYLVE 294

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 96.7 bits (241), Expect = 2e-21
 Identities = 59/248 (23%), Positives = 95/248 (38%), Gaps = 23/248 (9%)

Query: 21  PNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQH 80
            N  +L+L  N I  +   +  +   LEV Q+  N++       F               
Sbjct: 75  SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLAS---------- 124

Query: 81  LKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGI-GKFINLQTLHMWD-N 138
           L  L++ +N    +  G     S  L  L   +N I  SIP+    +  +L  L + +  
Sbjct: 125 LNTLELFDNWLTVIPSGAFEYLS-KLRELWLRNNPI-ESIPSYAFNRVPSLMRLDLGELK 182

Query: 139 QLSGTISP-AIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLG 197
           +L   IS  A   L NL  L +    +  ++ P++  L  L +L +  N      P S  
Sbjct: 183 KLE-YISEGAFEGLFNLKYLNLGMCNIK-DM-PNLTPLVGLEELEMSGNHFPEIRPGSFH 239

Query: 198 QCQSLTTINLSYNNLSGTIPPQ-LMDLTSLSVGLDLSRNQLVGSLPTEV-GKLINLEILF 255
              SL  + +  + +S  I       L SL   L+L+ N L  SLP ++   L  L  L 
Sbjct: 240 GLSSLKKLWVMNSQVS-LIERNAFDGLASLVE-LNLAHNNLS-SLPHDLFTPLRYLVELH 296

Query: 256 ISRNMLEC 263
           +  N   C
Sbjct: 297 LHHNPWNC 304

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 86.3 bits (214), Expect = 6e-18
 Identities = 53/224 (23%), Positives = 88/224 (39%), Gaps = 23/224 (10%)

Query: 20  LPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSE-FGKATKAYCVQNCN 78
           L +L  L LG N I  +   +    + L   ++  N LT  +PS  F   +K        
Sbjct: 98  LHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSK-------- 148

Query: 79  QHLKHLDINNNNFGGLLPGCICNFSITLETL-IFNSNKIFRSIPAGI-GKFINLQTLHMW 136
             L+ L + NN    +          +L  L +    K+   I  G      NL+ L++ 
Sbjct: 149 --LRELWLRNNPIESIPSYAFNRVP-SLMRLDLGELKKL-EYISEGAFEGLFNLKYLNLG 204

Query: 137 DNQLSGTISPAIGELQNLVTLAINTNKLSGNIPP-SIGNLKKLLQLYLIENFLQVSIPSS 195
              +     P +  L  L  L ++ N     I P S   L  L +L+++ + + +   ++
Sbjct: 205 MCNI--KDMPNLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSLIERNA 261

Query: 196 LGQCQSLTTINLSYNNLSGTIPPQLMD-LTSLSVGLDLSRNQLV 238
                SL  +NL++NNLS ++P  L   L  L   L L  N   
Sbjct: 262 FDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVE-LHLHHNPWN 303

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 98.1 bits (245), Expect = 9e-23
 Identities = 53/224 (23%), Positives = 85/224 (37%), Gaps = 30/224 (13%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGAS--KSSIAECSALRNIRHKNLVKILTVCSG 468
           GS+G   K        I+  K L+      +  +  ++E + LR ++H N+V+       
Sbjct: 17  GSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD--RI 74

Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL 528
           +D        +V E+   G L   +   +   + ++    L  +        +  ALK  
Sbjct: 75  IDRTNTTLY-IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM------TQLTLALKEC 127

Query: 529 HHDCQPTTA--HCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP 586
           H          H DLKP+NV LD +    + DFGLA++L        +    GT  Y++P
Sbjct: 128 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYMSP 185

Query: 587 -----AEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGN 625
                  Y   S      D++S G LL EL     P    F   
Sbjct: 186 EQMNRMSYNEKS------DIWSLGCLLYELCALMPP----FTAF 219

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  100 bits (252), Expect = 9e-23
 Identities = 71/360 (19%), Positives = 127/360 (35%), Gaps = 42/360 (11%)

Query: 2   DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNA-SKLEVFQVTSNNLTGE 60
            V        I  +    L +L+ L L +NQ    + +  FN  + LEV  +T  NL G 
Sbjct: 60  KVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGA 118

Query: 61  VPSE--FGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFR 118
           V S   F   T           L+ L + +NN   + P            L    NK+ +
Sbjct: 119 VLSGNFFKPLTS----------LEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKV-K 167

Query: 119 SIPAGI---GKFINLQTLHMWDNQL--------SGTISPAIGELQNLVTLAINTNKLSGN 167
           SI        +  +   L +    L                 +  ++ TL ++ N    +
Sbjct: 168 SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKES 227

Query: 168 IPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLS 227
           +     +     ++  +      ++ SS G        N ++  L  +       + +  
Sbjct: 228 MAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEAS------GVKTC- 280

Query: 228 VGLDLSRNQLVGSLPTEV-GKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQ 286
              DLS++++  +L   V     +LE L +++N +     +       L +L L  N   
Sbjct: 281 ---DLSKSKI-FALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLG 336

Query: 287 GPIPLSLSSLRGLRVLDLSQNNISGEIPK-FLVELQLVQNLNLSYNDLEGVIPTEGVFKN 345
                   +L  L VLDLS N+I   +     + L  ++ L L  N L+ V   +G+F  
Sbjct: 337 SIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLKSV--PDGIFDR 393

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 93.3 bits (232), Expect = 3e-20
 Identities = 63/361 (17%), Positives = 116/361 (32%), Gaps = 57/361 (15%)

Query: 21  PNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSE-FGKATKAYCVQNCNQ 79
            ++ ++ L  N I  +  +S      L+  +V        + +  F   +          
Sbjct: 30  AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSS--------- 80

Query: 80  HLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKI-FRSIPAGI-GKFINLQTLHMWD 137
            L  L ++ N F  L  G     +  LE L      +    +         +L+ L + D
Sbjct: 81  -LIILKLDYNQFLQLETGAFNGLA-NLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRD 138

Query: 138 NQLSGTISP--AIGELQNLVTLAINTNKLSGNIPPSI---GNLKKLLQLYLIENFLQ--- 189
           N +   I P      ++    L +  NK+  +I          K    L L    LQ   
Sbjct: 139 NNIK-KIQPASFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMN 196

Query: 190 -----VSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLS------------VGLDL 232
                     +  +  S+TT++LS N    ++  +  D  + +            +G   
Sbjct: 197 EYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSF 256

Query: 233 SRNQLVGSLPTEVGKLI--NLEILFISRNMLECEILSTLGSCI-----KLEQLKLGGNLF 285
                          L    ++   +S++      +  L   +      LEQL L  N  
Sbjct: 257 GHTNFKDPDNFTFKGLEASGVKTCDLSKSK-----IFALLKSVFSHFTDLEQLTLAQNEI 311

Query: 286 QGPIPLSLSSLRGLRVLDLSQNNISGEIPKFL-VELQLVQNLNLSYNDLEGVIPTEGVFK 344
                 +   L  L  L+LSQN +   I   +   L  ++ L+LSYN +  +   +  F 
Sbjct: 312 NKIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRAL--GDQSFL 368

Query: 345 N 345
            
Sbjct: 369 G 369

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 84.0 bits (208), Expect = 3e-17
 Identities = 45/254 (17%), Positives = 81/254 (31%), Gaps = 28/254 (11%)

Query: 119 SIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSI-GNLKK 177
            +PA      ++  + +  N ++     +   LQ+L  L +        I  +    L  
Sbjct: 27  ELPA------HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSS 80

Query: 178 LLQLYLIENFLQVSIPSS-LGQCQSLTTINLSYNNL-SGTIPPQLMD-LTSLSVGLDLSR 234
           L+ L L  N     + +       +L  + L+  NL    +       LTSL + L L  
Sbjct: 81  LIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEM-LVLRD 138

Query: 235 NQLVGSLPTEV-GKLINLEILFISRNMLEC---EILSTLGSCIKLEQLKLGGN------- 283
           N +    P      +    +L ++ N ++    E L           L+L          
Sbjct: 139 NNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQG-KHFTLLRLSSITLQDMNE 197

Query: 284 -LFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKF---LVELQLVQNLNLSYNDLEGVIPT 339
                    +      +  LDLS N     + K     +    +Q+L LS +   G    
Sbjct: 198 YWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFG 257

Query: 340 EGVFKNASAISVFG 353
              FK+    +  G
Sbjct: 258 HTNFKDPDNFTFKG 271

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 98.5 bits (246), Expect = 1e-22
 Identities = 50/231 (21%), Positives = 83/231 (35%), Gaps = 43/231 (18%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASK---SSIAECSALRNIRHKNLVKILTVCS 467
           G F  VY+         +A+K + +     +K     I E   L+ + H N++K      
Sbjct: 43  GQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK------ 96

Query: 468 GVDYKG----DDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
              Y      D+   +V E    G L   +       + +               + +  
Sbjct: 97  ---YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWK------YFVQLCS 147

Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGY 583
           AL+++H        H D+KP+NV +       + D GL +          S  + GT  Y
Sbjct: 148 ALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYY 202

Query: 584 IAP-----AEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGN-MNL 628
           ++P       Y   S      D++S G LL E+   + P    F G+ MNL
Sbjct: 203 MSPERIHENGYNFKS------DIWSLGCLLYEMAALQSP----FYGDKMNL 243

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 98.1 bits (245), Expect = 2e-22
 Identities = 53/224 (23%), Positives = 89/224 (39%), Gaps = 45/224 (20%)

Query: 411 GSFGSVYKGIL-----DEGKTIIAVKVLNLLHHGASKSS----IAECSALRNIRHKNLVK 461
           G+FG VY+G +     D     +AVK L       S+      + E   +    H+N+V+
Sbjct: 41  GAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALIISKFNHQNIVR 97

Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDV 521
            + V      +      ++ E M  G L+ +L            P  L  L  +++A D+
Sbjct: 98  CIGVSL----QSLPR-FILMELMAGGDLKSFLR---ETRPRPSQPSSLAMLDLLHVARDI 149

Query: 522 ACALKYL--HHDCQPTTAHCDLKPSNVLLD---HEMTAHVADFGLAKLLPPAHLQTSSIG 576
           AC  +YL  +H       H D+   N LL        A + DFG+A+ +       +S  
Sbjct: 150 ACGCQYLEENHFI-----HRDIAARNCLLTCPGPGRVAKIGDFGMARDI-----YRASYY 199

Query: 577 VKGTIGYI-----AP--AEYGLGSEVSINGDVYSYGILLLELMT 613
            KG    +      P     G+    +   D +S+G+LL E+ +
Sbjct: 200 RKGGCAMLPVKWMPPEAFMEGI---FTSKTDTWSFGVLLWEIFS 240

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 97.7 bits (244), Expect = 2e-22
 Identities = 53/234 (22%), Positives = 91/234 (38%), Gaps = 51/234 (21%)

Query: 411 GSFGSVYKGIL-----DEGKTIIAVKVLNLLHHGASKSS----IAECSALRNIRHKNLVK 461
           G FG V K          G T +AVK+L      AS S     ++E + L+ + H +++K
Sbjct: 34  GEFGKVVKATAFHLKGRAGYTTVAVKMLK---ENASPSELRDLLSEFNVLKQVNHPHVIK 90

Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWL--------------HPVSGADKTVEAPK 507
           +   CS    +      L+ E+   GSL  +L                 + +       +
Sbjct: 91  LYGACS----QDGPL-LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145

Query: 508 CLNFLQRINIAIDVACALKYL-HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP 566
            L     I+ A  ++  ++YL          H DL   N+L+       ++DFGL++   
Sbjct: 146 ALTMGDLISFAWQISQGMQYLAEMKL----VHRDLAARNILVAEGRKMKISDFGLSRD-- 199

Query: 567 PAHLQTSSIGVKGTIGYI-----AP--AEYGLGSEVSINGDVYSYGILLLELMT 613
              +      VK + G I     A       +    +   DV+S+G+LL E++T
Sbjct: 200 ---VYEEDSYVKRSQGRIPVKWMAIESLFDHI---YTTQSDVWSFGVLLWEIVT 247

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  100 bits (251), Expect = 3e-22
 Identities = 59/246 (23%), Positives = 92/246 (37%), Gaps = 33/246 (13%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA-ECSALRNIRHKNLVKILTVC-SG 468
           G FG V + I  +    +A+K         ++     E   ++ + H N+V    V    
Sbjct: 25  GGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGL 84

Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL 528
                +D   L  E+   G L ++L+        ++       L       D++ AL+YL
Sbjct: 85  QKLAPNDLPLLAMEYCEGGDLRKYLNQ-FENCCGLKEGPIRTLLS------DISSALRYL 137

Query: 529 HHDCQPTTAHCDLKPSNVLLD---HEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
           H   +    H DLKP N++L      +   + D G AK L    L T  +   GT+ Y+A
Sbjct: 138 H---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV---GTLQYLA 191

Query: 586 P-----AEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHV 640
           P      +Y     V    D +S+G L  E +T  RP    F  N     +   V     
Sbjct: 192 PELLEQKKY--TVTV----DYWSFGTLAFECITGFRP----FLPNWQPVQWHGKVREKSN 241

Query: 641 MDIVDS 646
             IV  
Sbjct: 242 EHIVVY 247

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 97.4 bits (243), Expect = 4e-22
 Identities = 58/234 (24%), Positives = 95/234 (40%), Gaps = 51/234 (21%)

Query: 411 GSFGSVYKGIL-----DEGKTIIAVKVLNLLHHGASKSSIA----ECSALRNIRHKNLVK 461
           G+FG V++         E  T++AVK+L      AS    A    E + +    + N+VK
Sbjct: 58  GAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQREAALMAEFDNPNIVK 114

Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWL--------------HPVSGADKTVEAPK 507
           +L VC+     G     L++E+M  G L E+L                 + A  +   P 
Sbjct: 115 LLGVCA----VGKPM-CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169

Query: 508 CLNFLQRINIAIDVACALKYLH-HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP 566
            L+  +++ IA  VA  + YL          H DL   N L+   M   +ADFGL++   
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLSERKF----VHRDLATRNCLVGENMVVKIADFGLSRN-- 223

Query: 567 PAHLQTSSIGVKGTIGYI-----AP--AEYGLGSEVSINGDVYSYGILLLELMT 613
              + ++          I      P    Y   +  S   DV++YG++L E+ +
Sbjct: 224 ---IYSADYYKADGNDAIPIRWMPPESIFYNRYTTES---DVWAYGVVLWEIFS 271

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 96.9 bits (242), Expect = 4e-22
 Identities = 51/226 (22%), Positives = 87/226 (38%), Gaps = 40/226 (17%)

Query: 411 GSFGSVYKGIL-----DEGKTIIAVKVLNLLHHGASKSS-IAECSALRNI-RHKNLVKIL 463
           G+FG V +         +    +AVK+L    H   + + ++E   L  +  H N+V +L
Sbjct: 34  GAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLL 93

Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWL--------HPVSGADKTVEAPKCLNFLQRI 515
             C+     G     ++ E+   G L  +L           +      +    L+    +
Sbjct: 94  GACT----IGGPT-LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 516 NIAIDVACALKYLH-HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSS 574
           + +  VA  + +L   +C     H DL   N+LL H     + DFGLA+      ++  S
Sbjct: 149 SFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARD-----IKNDS 199

Query: 575 IGVKGTIGYI-----AP--AEYGLGSEVSINGDVYSYGILLLELMT 613
             V      +     AP      +    +   DV+SYGI L EL +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCV---YTFESDVWSYGIFLWELFS 242

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 97.1 bits (242), Expect = 4e-22
 Identities = 50/211 (23%), Positives = 81/211 (38%), Gaps = 28/211 (13%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           GSFG V++    +     AVK + L         + E  A   +    +V +     G  
Sbjct: 69  GSFGEVHRMKDKQTGFQCAVKKVRL-----EVFRVEELVACAGLSSPRIVPLY----GAV 119

Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
            +G     +  E +  GSL           + ++   CL   + +         L+YLH 
Sbjct: 120 REGPWVN-IFMELLEGGSLG----------QLIKQMGCLPEDRALYYLGQALEGLEYLHT 168

Query: 531 DCQPTTAHCDLKPSNVLLDHE-MTAHVADFGLAKLLPPAHLQTSSIG---VKGTIGYIAP 586
                  H D+K  NVLL  +   A + DFG A  L P  L  S +    + GT  ++AP
Sbjct: 169 RR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 225

Query: 587 AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
            E  +G       D++S   ++L ++    P
Sbjct: 226 -EVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 96.2 bits (240), Expect = 6e-22
 Identities = 53/227 (23%), Positives = 86/227 (37%), Gaps = 43/227 (18%)

Query: 411 GSFGSVYKGIL-----DEGKTIIAVKVLNLLHHGASKSS----IAECSALRNI-RHKNLV 460
           G+FG V +              +AVK+L     GA+ S     ++E   L +I  H N+V
Sbjct: 38  GAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKILIHIGHHLNVV 94

Query: 461 KILTVCSGVDYKGDDFKALVYEFMHNGSLEEWL------HPVSGADKTVEAPKCLNFLQR 514
            +L  C+    K      ++ EF   G+L  +L                     L     
Sbjct: 95  NLLGACT----KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150

Query: 515 INIAIDVACALKYL-HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTS 573
           I  +  VA  +++L    C     H DL   N+LL  +    + DFGLA+      +   
Sbjct: 151 ICYSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARD-----IYKD 201

Query: 574 SIGVKGTIGYI-----AP--AEYGLGSEVSINGDVYSYGILLLELMT 613
              V+     +     AP      +    +I  DV+S+G+LL E+ +
Sbjct: 202 PDYVRKGDARLPLKWMAPETIFDRV---YTIQSDVWSFGVLLWEIFS 245

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 97.1 bits (242), Expect = 7e-22
 Identities = 52/224 (23%), Positives = 89/224 (39%), Gaps = 45/224 (20%)

Query: 411 GSFGSVYKGIL-----DEGKTIIAVKVLNLLHHGASKSS----IAECSALRNIRHKNLVK 461
           G+FG VY+G +     D     +AVK L       S+      + E   +    H+N+V+
Sbjct: 82  GAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALIISKFNHQNIVR 138

Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDV 521
            + V      +      ++ E M  G L+ +L            P  L  L  +++A D+
Sbjct: 139 CIGVSL----QSLPR-FILLELMAGGDLKSFLR---ETRPRPSQPSSLAMLDLLHVARDI 190

Query: 522 ACALKYL--HHDCQPTTAHCDLKPSNVLLD---HEMTAHVADFGLAKLLPPAHLQTSSIG 576
           AC  +YL  +H       H D+   N LL        A + DFG+A+ +       +   
Sbjct: 191 ACGCQYLEENHFI-----HRDIAARNCLLTCPGPGRVAKIGDFGMARDI-----YRAGYY 240

Query: 577 VKGTIGYI-----AP--AEYGLGSEVSINGDVYSYGILLLELMT 613
            KG    +      P     G+ +  +   D +S+G+LL E+ +
Sbjct: 241 RKGGCAMLPVKWMPPEAFMEGIFTSKT---DTWSFGVLLWEIFS 281

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 95.4 bits (238), Expect = 8e-22
 Identities = 56/259 (21%), Positives = 94/259 (36%), Gaps = 38/259 (14%)

Query: 96  PGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLV 155
             C+C      +       +  +++P GI      Q + +  N++S   + +    +NL 
Sbjct: 4   GACVC--YNEPKVTTSCPQQGLQAVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLT 59

Query: 156 TLAINTNKLSGNIPPSI-GNLKKLLQLYLIENFLQVSIPSS-LGQCQSLTTINLSYNNLS 213
            L +++N L+  I  +    L  L QL L +N    S+  +       L T++L    L 
Sbjct: 60  ILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ 118

Query: 214 GTIPPQ-LMDLTSLSVGLDLSRNQLVGSLPTEV-GKLINLEILFISRNMLECEILSTLGS 271
             + P     L +L   L L  N L  +LP +    L NL  LF+  N +          
Sbjct: 119 -ELGPGLFRGLAALQY-LYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS--------- 166

Query: 272 CIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYN 331
                   +    F+G        L  L  L L QN ++   P    +L  +  L L  N
Sbjct: 167 -------SVPERAFRG--------LHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211

Query: 332 DLEGVIPTEGVFKNASAIS 350
           +L   +P         A+ 
Sbjct: 212 NLS-ALP-TEALAPLRALQ 228

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 85.8 bits (213), Expect = 1e-18
 Identities = 50/232 (21%), Positives = 82/232 (35%), Gaps = 23/232 (9%)

Query: 37  IPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLP 96
           +P  +   +  +   +  N ++    + F              +L  L +++N    +  
Sbjct: 26  VPVGIP--AASQRIFLHGNRISHVPAASFRACR----------NLTILWLHSNVLARIDA 73

Query: 97  GCICNFSITLETLIFNSNKIFRSIPAGI-GKFINLQTLHMWDNQLSGTISP-AIGELQNL 154
                 +  LE L  + N   RS+          L TLH+    L   + P     L  L
Sbjct: 74  AAFTGLA-LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAAL 131

Query: 155 VTLAINTNKLSGNIPPSI-GNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLS 213
             L +  N L   +P     +L  L  L+L  N +      +     SL  + L  N ++
Sbjct: 132 QYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA 190

Query: 214 GTIPPQ-LMDLTSLSVGLDLSRNQLVGSLPTEV-GKLINLEILFISRNMLEC 263
             + P    DL  L   L L  N L  +LPTE    L  L+ L ++ N   C
Sbjct: 191 -HVHPHAFRDLGRLMT-LYLFANNLS-ALPTEALAPLRALQYLRLNDNPWVC 239

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 61.9 bits (151), Expect = 1e-10
 Identities = 43/223 (19%), Positives = 71/223 (31%), Gaps = 67/223 (30%)

Query: 20  LPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQ 79
           L  L  L L  N     +  + F            + L                      
Sbjct: 79  LALLEQLDLSDNAQLRSVDPATF------------HGLG--------------------- 105

Query: 80  HLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGI-GKFINLQTLHMWDN 138
            L  L ++                              + +  G+      LQ L++ DN
Sbjct: 106 RLHTLHLDRCG--------------------------LQELGPGLFRGLAALQYLYLQDN 139

Query: 139 QLSGTISP-AIGELQNLVTLAINTNKLSGNIPPSI-GNLKKLLQLYLIENFLQVSIPSSL 196
            L   +      +L NL  L ++ N++S ++P      L  L +L L +N +    P + 
Sbjct: 140 ALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAF 197

Query: 197 GQCQSLTTINLSYNNLSGTIPPQLMD-LTSLSVGLDLSRNQLV 238
                L T+ L  NNLS  +P + +  L +L   L L+ N  V
Sbjct: 198 RDLGRLMTLYLFANNLS-ALPTEALAPLRALQY-LRLNDNPWV 238

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 96.2 bits (240), Expect = 8e-22
 Identities = 50/222 (22%), Positives = 92/222 (41%), Gaps = 36/222 (16%)

Query: 411 GSFGSVYKGIL-----DEGKTIIAVKVLNLLHHGASKSS-IAECSALRNI-RHKNLVKIL 463
           G+FG V +        ++    +AVK+L    H   K + ++E   + ++ +H+N+V +L
Sbjct: 57  GAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLL 116

Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWL----HPVSGADKTVEAPKCLNFLQRINIAI 519
             C+     G     ++ E+   G L  +L      +        A    +    ++ + 
Sbjct: 117 GACT----HGGPV-LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171

Query: 520 DVACALKYL-HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK 578
            VA  + +L   +C     H D+   NVLL +   A + DFGLA+      +   S  + 
Sbjct: 172 QVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARD-----IMNDSNYIV 222

Query: 579 GTIGYI-----AP--AEYGLGSEVSINGDVYSYGILLLELMT 613
                +     AP      +    ++  DV+SYGILL E+ +
Sbjct: 223 KGNARLPVKWMAPESIFDCV---YTVQSDVWSYGILLWEIFS 261

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 95.5 bits (238), Expect = 9e-22
 Identities = 54/243 (22%), Positives = 92/243 (37%), Gaps = 50/243 (20%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA-ECSALRNIRHKNLVK----ILTV 465
           G FG V++          A+K + L +   ++  +  E  AL  + H  +V+     L  
Sbjct: 16  GGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEK 75

Query: 466 CSGVDYKGDDFKALVY---EFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVA 522
            +    +    K  +Y   +     +L++W++     ++  E   CL+   +I      A
Sbjct: 76  NTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER-ERSVCLHIFLQI------A 128

Query: 523 CALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL----------PPAHLQT 572
            A+++LH        H DLKPSN+    +    V DFGL   +           P     
Sbjct: 129 EAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185

Query: 573 SSIGVKGTIGYIAPAEYGLGSEVSING-------DVYSYGILLLELMTRKRPSDIMFEGN 625
              G  GT  Y++P       E  I+G       D++S G++L EL+         F   
Sbjct: 186 RHTGQVGTKLYMSP-------EQ-IHGNSYSHKVDIFSLGLILFELLYP-------FSTQ 230

Query: 626 MNL 628
           M  
Sbjct: 231 MER 233

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 95.6 bits (238), Expect = 1e-21
 Identities = 51/219 (23%), Positives = 83/219 (37%), Gaps = 28/219 (12%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA-ECSALRNIRHKNLVKILTVCSGV 469
           G+  +V++G   +   + A+KV N +           E   L+ + HKN+VK+  +    
Sbjct: 20  GATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI---E 76

Query: 470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH 529
           +      K L+ EF   GSL   L   S A    E  + L  L+      DV   + +L 
Sbjct: 77  EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPE-SEFLIVLR------DVVGGMNHLR 129

Query: 530 HDCQPTTAHCDLKPSNVLL----DHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
              +    H ++KP N++     D +    + DFG A+ L       S     GT  Y+ 
Sbjct: 130 ---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY---GTEEYLH 183

Query: 586 PAEYGLGSEVSING-------DVYSYGILLLELMTRKRP 617
           P  Y        +        D++S G+      T   P
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 95.8 bits (239), Expect = 1e-21
 Identities = 57/224 (25%), Positives = 90/224 (40%), Gaps = 44/224 (19%)

Query: 411 GSFGSVYKGIL--DEGKTIIAVKVLNLLHHGASKSS----IAECSALRNI-RHKNLVKIL 463
           G+FG V K  +  D  +   A+K +      ASK        E   L  +  H N++ +L
Sbjct: 36  GNFGQVLKARIKKDGLRMDAAIKRMK---EYASKDDHRDFAGELEVLCKLGHHPNIINLL 92

Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWL------HPVSGADKTVEAPKCLNFLQRINI 517
             C    Y       L  E+  +G+L ++L                     L+  Q ++ 
Sbjct: 93  GACEHRGYL-----YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147

Query: 518 AIDVACALKYL-HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIG 576
           A DVA  + YL          H DL   N+L+     A +ADFGL++           + 
Sbjct: 148 AADVARGMDYLSQKQF----IHRDLAARNILVGENYVAKIADFGLSR--------GQEVY 195

Query: 577 VKGTIGYI-----AP--AEYGLGSEVSINGDVYSYGILLLELMT 613
           VK T+G +     A     Y + +  S   DV+SYG+LL E+++
Sbjct: 196 VKKTMGRLPVRWMAIESLNYSVYTTNS---DVWSYGVLLWEIVS 236

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 98.8 bits (246), Expect = 1e-21
 Identities = 45/216 (20%), Positives = 83/216 (38%), Gaps = 42/216 (19%)

Query: 411 GSFGSVYKGIL---DEGKTIIAVKVLNLLHHGASKSS----IAECSALRNIRHKNLVKIL 463
           G FG V++GI    +     +A+K      +  S S     + E   +R   H ++VK++
Sbjct: 401 GQFGDVHQGIYMSPENPAMAVAIKTCK---NCTSDSVREKFLQEALTMRQFDHPHIVKLI 457

Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            V +      ++   ++ E    G L  +L               L+    I  A  ++ 
Sbjct: 458 GVIT------ENPVWIIMELCTLGELRSFLQ---------VRKFSLDLASLILYAYQLST 502

Query: 524 ALKYLH-HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIG---VKG 579
           AL YL          H D+   NVL+       + DFGL++ +  +    +S G   +K 
Sbjct: 503 ALAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 558

Query: 580 TIGYIAP--AEYGLGSEVSINGDVYSYGILLLELMT 613
                AP    +      +   DV+ +G+ + E++ 
Sbjct: 559 M----APESINFR---RFTSASDVWMFGVCMWEILM 587

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 98.8 bits (246), Expect = 2e-21
 Identities = 51/227 (22%), Positives = 81/227 (35%), Gaps = 52/227 (22%)

Query: 411 GSFGSVYKG---ILDEGKTIIAVKVLNLLHHGASKSSIA----ECSALRNIRHKNLVKIL 463
           G  G +Y      ++ G+ +  +K L    H     + A    E   L  + H ++V+I 
Sbjct: 91  GGLGWIYLALDRNVN-GRPV-VLKGL---VHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145

Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLH---PVSGADKTVEAPKCLNFLQRINIAID 520
                 D  GD    +V E++   SL+       PV+ A               I   ++
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEA---------------IAYLLE 190

Query: 521 VACALKYLHHDCQPTTA---HCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           +  AL YLH           + DLKP N++L  E    + D G    +       S   +
Sbjct: 191 ILPALSYLHS------IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI------NSFGYL 237

Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEG 624
            GT G+ AP E       ++  D+Y+ G  L  L            G
Sbjct: 238 YGTPGFQAP-EIVRT-GPTVATDIYTVGRTLAALTLDLPT----RNG 278

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 94.6 bits (236), Expect = 2e-21
 Identities = 59/222 (26%), Positives = 96/222 (43%), Gaps = 37/222 (16%)

Query: 411 GSFGSVYKG---ILDEGKTIIAVKVLNLLHHGASKSSIA----ECSALRNIRHKNLVKIL 463
           G   +VY     IL+     +A+K + +      + ++     E      + H+N+V ++
Sbjct: 22  GGMSTVYLAEDTILNI---KVAIKAIFI-PPREKEETLKRFEREVHNSSQLSHQNIVSMI 77

Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            V    +   DD   LV E++   +L E++            P  L+    IN    +  
Sbjct: 78  DV--DEE---DDCYYLVMEYIEGPTLSEYIES--------HGP--LSVDTAINFTNQILD 122

Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHL-QTSSIGVKGTIG 582
            +K+ H        H D+KP N+L+D   T  + DFG+AK L    L QT+   V GT+ 
Sbjct: 123 GIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH--VLGTVQ 177

Query: 583 YIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEG 624
           Y +P E   G       D+YS GI+L E++  + P    F G
Sbjct: 178 YFSP-EQAKGEATDECTDIYSIGIVLYEMLVGEPP----FNG 214

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 95.1 bits (237), Expect = 4e-21
 Identities = 55/229 (24%), Positives = 94/229 (41%), Gaps = 46/229 (20%)

Query: 411 GSFGSVYKGIL-------DEGKTIIAVKVLNLLHHGASKSS----IAECSALRNI-RHKN 458
           G+FG V                T +AVK+L      A++      I+E   ++ I +HKN
Sbjct: 80  GAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK---SDATEKDLSDLISEMEMMKMIGKHKN 136

Query: 459 LVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWL------HPVSGADKTVEAPKCLNFL 512
           ++ +L  C+    +      ++ E+   G+L E+L            + +    + L+  
Sbjct: 137 IINLLGACT----QDGPL-YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191

Query: 513 QRINIAIDVACALKYL-HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQ 571
             ++ A  VA  ++YL    C     H DL   NVL+  +    +ADFGLA+      + 
Sbjct: 192 DLVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARD-----IH 242

Query: 572 TSSIGVKGTIGYI-----AP--AEYGLGSEVSINGDVYSYGILLLELMT 613
                 K T G +     AP      +    +   DV+S+G+LL E+ T
Sbjct: 243 HIDYYKKTTNGRLPVKWMAPEALFDRI---YTHQSDVWSFGVLLWEIFT 288

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 94.8 bits (236), Expect = 4e-21
 Identities = 50/230 (21%), Positives = 91/230 (39%), Gaps = 51/230 (22%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGAS--KSSIAECSALRNIRHKNLVKILTVCSG 468
           GSFG        E      +K +N+    +   + S  E + L N++H N+V+       
Sbjct: 35  GSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQ------- 87

Query: 469 VDYKGDDFKA-----LVYEFMHNGSLEEWLHPVSGA---DKTVEAPKCLNFLQRINIAID 520
             Y+ + F+      +V ++   G L + ++   G    +  +           ++  + 
Sbjct: 88  --YR-ESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQI-----------LDWFVQ 133

Query: 521 VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGT 580
           +  ALK++H        H D+K  N+ L  + T  + DFG+A++L        +    GT
Sbjct: 134 ICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGT 188

Query: 581 IGYIAP-----AEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGN 625
             Y++P       Y   S      D+++ G +L EL T K      FE  
Sbjct: 189 PYYLSPEICENKPYNNKS------DIWALGCVLYELCTLKHA----FEAG 228

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 93.0 bits (232), Expect = 5e-21
 Identities = 53/215 (24%), Positives = 86/215 (40%), Gaps = 33/215 (15%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLN---LLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           GSF  VY+         +A+K+++   +   G  +    E      ++H +++++     
Sbjct: 22  GSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNY-- 79

Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
              ++  ++  LV E  HNG +  +L       K     +  +F+ +I         + Y
Sbjct: 80  ---FEDSNYVYLVLEMCHNGEMNRYLK---NRVKPFSENEARHFMHQI------ITGMLY 127

Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAH--LQTSSIGVKGTIGYIA 585
           LH        H DL  SN+LL   M   +ADFGLA  L   H    T      GT  YI+
Sbjct: 128 LHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC----GTPNYIS 180

Query: 586 P---AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
           P        G E     DV+S G +   L+  + P
Sbjct: 181 PEIATRSAHGLES----DVWSLGCMFYTLLIGRPP 211

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 90.4 bits (225), Expect = 6e-21
 Identities = 31/155 (20%), Positives = 60/155 (38%), Gaps = 8/155 (5%)

Query: 105 TLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKL 164
           +L  +   +  +   +  GI    N++ L + +   +   +P I  L NL  L I    +
Sbjct: 45  SLTYITLANINV-TDLT-GIEYAHNIKDLTINNIHAT-NYNP-ISGLSNLERLRIMGKDV 100

Query: 165 SGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLT 224
           + +  P++  L  L  L +  +    SI + +     + +I+LSYN     I P L  L 
Sbjct: 101 TSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLP 159

Query: 225 SLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRN 259
            L   L++  + +       +     L  L+    
Sbjct: 160 ELKS-LNIQFDGVHDYRG--IEDFPKLNQLYAFSQ 191

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 83.9 bits (208), Expect = 1e-18
 Identities = 25/165 (15%), Positives = 63/165 (38%), Gaps = 8/165 (4%)

Query: 148 IGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINL 207
             ++ +L  + +    ++ ++   I     +  L +       +  + +    +L  + +
Sbjct: 40  EAQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINNI--HATNYNPISGLSNLERLRI 95

Query: 208 SYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILS 267
              +++    P L  LTSL++ LD+S +    S+ T++  L  +  + +S N      + 
Sbjct: 96  MGKDVTSDKIPNLSGLTSLTL-LDISHSAHDDSILTKINTLPKVNSIDLSYNGA-ITDIM 153

Query: 268 TLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGE 312
            L +  +L+ L +  +       +       L  L      I G+
Sbjct: 154 PLKTLPELKSLNIQFDGVHDYRGIE--DFPKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 73.1 bits (180), Expect = 5e-15
 Identities = 31/165 (18%), Positives = 62/165 (37%), Gaps = 9/165 (5%)

Query: 174 NLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLS 233
             K  L   L ++        +  Q  SLT I L+  N++      +    ++   L ++
Sbjct: 21  TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDLTG--IEYAHNIKD-LTIN 74

Query: 234 RNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSL 293
                 +    +  L NLE L I    +  + +  L     L  L +  +     I   +
Sbjct: 75  NIHA--TNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132

Query: 294 SSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIP 338
           ++L  +  +DLS N    +I   L  L  +++LN+ ++ +     
Sbjct: 133 NTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG 176

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 65.4 bits (160), Expect = 3e-12
 Identities = 34/218 (15%), Positives = 65/218 (29%), Gaps = 67/218 (30%)

Query: 20  LPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQ 79
           + +L +++L    +T                     +LTG        A           
Sbjct: 43  MNSLTYITLANINVT---------------------DLTG-----IEYAHN--------- 67

Query: 80  HLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQ 139
            +K L INN +     P                           I    NL+ L +    
Sbjct: 68  -IKDLTINNIHATNYNP---------------------------ISGLSNLERLRIMGKD 99

Query: 140 LSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQC 199
           ++    P +  L +L  L I+ +    +I   I  L K+  + L  N   ++    L   
Sbjct: 100 VTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYN-GAITDIMPLKTL 158

Query: 200 QSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQL 237
             L ++N+ ++ +       + D   L+  L      +
Sbjct: 159 PELKSLNIQFDGVHDYRG--IEDFPKLNQ-LYAFSQTI 193

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 60.0 bits (146), Expect = 2e-10
 Identities = 23/147 (15%), Positives = 49/147 (33%), Gaps = 16/147 (10%)

Query: 20  LPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQ 79
             N+  L++     T   P S    S LE  ++   ++T +        T          
Sbjct: 65  AHNIKDLTINNIHATNYNPIS--GLSNLERLRIMGKDVTSDKIPNLSGLTS--------- 113

Query: 80  HLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQ 139
            L  LDI+++     +   I      + ++  + N     I   +     L++L++  + 
Sbjct: 114 -LTLLDISHSAHDDSILTKINTLP-KVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDG 170

Query: 140 LSGTISPAIGELQNLVTLAINTNKLSG 166
           +       I +   L  L   +  + G
Sbjct: 171 VH-DYRG-IEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 49.6 bits (119), Expect = 7e-07
 Identities = 17/124 (13%), Positives = 42/124 (33%), Gaps = 14/124 (11%)

Query: 19  TLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCN 78
            L NL  L +    +T     ++   + L +  ++ +     + ++     K        
Sbjct: 86  GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPK-------- 137

Query: 79  QHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDN 138
             +  +D++ N     +   +      L++L    + +      GI  F  L  L+ +  
Sbjct: 138 --VNSIDLSYNGAITDIMP-LKTLP-ELKSLNIQFDGV-HDYR-GIEDFPKLNQLYAFSQ 191

Query: 139 QLSG 142
            + G
Sbjct: 192 TIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 46.9 bits (112), Expect = 5e-06
 Identities = 14/95 (14%), Positives = 39/95 (41%), Gaps = 4/95 (4%)

Query: 246 GKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLS 305
            ++ +L  + ++   +    L+ +     ++ L +         P+S   L  L  L + 
Sbjct: 41  AQMNSLTYITLANINVT--DLTGIEYAHNIKDLTINNIHATNYNPIS--GLSNLERLRIM 96

Query: 306 QNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTE 340
             +++ +    L  L  +  L++S++  +  I T+
Sbjct: 97  GKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 93.6 bits (233), Expect = 6e-21
 Identities = 44/228 (19%), Positives = 81/228 (35%), Gaps = 31/228 (13%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G F  V            A+K +        + +  E    R   H N+++++  C  + 
Sbjct: 40  GGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC--LR 97

Query: 471 YKGDDFKA-LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH 529
            +G   +A L+  F   G+L   +  +      +   + L       + + +   L+ +H
Sbjct: 98  ERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILW------LLLGICRGLEAIH 151

Query: 530 HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSS-------IGVKGTIG 582
                  AH DLKP+N+LL  E    + D G           +            + TI 
Sbjct: 152 ---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208

Query: 583 YIAP-----AEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGN 625
           Y AP       + +  E +   DV+S G +L  +M  + P    ++  
Sbjct: 209 YRAPELFSVQSHCVIDERT---DVWSLGCVLYAMMFGEGP----YDMV 249

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 92.3 bits (230), Expect = 7e-21
 Identities = 51/215 (23%), Positives = 83/215 (38%), Gaps = 36/215 (16%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLN---LLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           G FG+VY     + K I+A+KVL    L   G       E     ++RH N++++     
Sbjct: 20  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 79

Query: 468 GVDYKGDDFKA-LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALK 526
                 D  +  L+ E+   G++   L          +  +   ++  +      A AL 
Sbjct: 80  ------DATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITEL------ANALS 123

Query: 527 YLH-HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
           Y H         H D+KP N+LL       +ADFG +   P +          GT+ Y+ 
Sbjct: 124 YCHSKRVI----HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYLP 175

Query: 586 P---AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
           P          +V    D++S G+L  E +  K P
Sbjct: 176 PEMIEGRMHDEKV----DLWSLGVLCYEFLVGKPP 206

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 93.5 bits (233), Expect = 7e-21
 Identities = 51/229 (22%), Positives = 91/229 (39%), Gaps = 46/229 (20%)

Query: 411 GSFGSVYKGIL-------DEGKTIIAVKVLNLLHHGASKSS----IAECSALRNI-RHKN 458
           G+FG V             +    +AVK+L      A++      ++E   ++ I +HKN
Sbjct: 46  GAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEMEMMKMIGKHKN 102

Query: 459 LVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWL------HPVSGADKTVEAPKCLNFL 512
           ++ +L  C+    +      ++ E+   G+L E+L            D      + + F 
Sbjct: 103 IINLLGACT----QDGPL-YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157

Query: 513 QRINIAIDVACALKYL-HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQ 571
             ++    +A  ++YL    C     H DL   NVL+       +ADFGLA+      + 
Sbjct: 158 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARD-----IN 208

Query: 572 TSSIGVKGTIGYI-----AP--AEYGLGSEVSINGDVYSYGILLLELMT 613
                 K T G +     AP      +    +   DV+S+G+L+ E+ T
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRV---YTHQSDVWSFGVLMWEIFT 254

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 94.5 bits (235), Expect = 8e-21
 Identities = 52/223 (23%), Positives = 85/223 (38%), Gaps = 36/223 (16%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA-ECSALRNIRHKNLVKILTVCSGV 469
           G+  +V++G   +   + A+KV N +           E   L+ + HKN+VK+  +    
Sbjct: 20  GATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI---E 76

Query: 470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH 529
           +      K L+ EF   GSL   L   S A    E  + L  L+      DV   + +L 
Sbjct: 77  EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPE-SEFLIVLR------DVVGGMNHLR 129

Query: 530 HDCQPTTAHCDLKPSNVLL----DHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
              +    H ++KP N++     D +    + DFG A+ L       S     GT  Y+ 
Sbjct: 130 ---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY---GTEEYLH 183

Query: 586 P-----------AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
           P            +   G+ V    D++S G+      T   P
Sbjct: 184 PDMYERAVLRKDHQKKYGATV----DLWSIGVTFYHAATGSLP 222

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 95.7 bits (238), Expect = 8e-21
 Identities = 60/360 (16%), Positives = 115/360 (31%), Gaps = 41/360 (11%)

Query: 20  LPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVP----------------- 62
           +  L FL L    +       + + +  +V  V       +                   
Sbjct: 114 MSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFP 173

Query: 63  -----SEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIF 117
                      +          ++K +  +N     L        +  L  L  N+ +  
Sbjct: 174 TNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETT 233

Query: 118 RSIPAGIGKFI---NLQTLHMWDNQLSG-----TISPAIGELQNLVTLAINTNKLSGNIP 169
            +    I + +    +    + + +L G         +   L+ L    + ++       
Sbjct: 234 WNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQS 293

Query: 170 PSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVG 229
                   +       +  ++       +      ++ S N L+ T+      LT L   
Sbjct: 294 YIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELET- 352

Query: 230 LDLSRNQLVGSLPTEVG---KLINLEILFISRNMLE-CEILSTLGSCIKLEQLKLGGNLF 285
           L L  NQL   L        ++ +L+ L IS+N +   E          L  L +  N+ 
Sbjct: 353 LILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNIL 411

Query: 286 QGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKN 345
              I   L     ++VLDL  N I   IPK +V+L+ +Q LN++ N L+ V   +G+F  
Sbjct: 412 TDTIFRCLPPR--IKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSV--PDGIFDR 466

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 89.9 bits (223), Expect = 5e-19
 Identities = 55/326 (16%), Positives = 99/326 (30%), Gaps = 19/326 (5%)

Query: 19  TLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEV-PSEFGKATKAYCVQNC 77
            L +    SL     T      + + S   V  +  +N+   +  ++             
Sbjct: 159 GLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQT 218

Query: 78  NQHLKHLDINNNNFGGLLPGCICNF-------SITLETLIFNSNKIFRSIPAGIGKFINL 130
           N  L +L +NN          I            ++  +       FR           L
Sbjct: 219 NPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKAL 278

Query: 131 QTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQV 190
               +  +      S       N+       +            +   L L    N L  
Sbjct: 279 SIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTD 338

Query: 191 SIPSSLGQCQSLTTINLSYNNLSGTIPPQ---LMDLTSLSVGLDLSRNQLVGSLPTEV-G 246
           ++  + G    L T+ L  N L   +         + SL   LD+S+N +          
Sbjct: 339 TVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQ-LDISQNSVSYDEKKGDCS 396

Query: 247 KLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQ 306
              +L  L +S N+L   I   L    +++ L L  N  +  IP  +  L  L+ L+++ 
Sbjct: 397 WTKSLLSLNMSSNILTDTIFRCLPP--RIKVLDLHSNKIKS-IPKQVVKLEALQELNVAS 453

Query: 307 NNISGEIPK-FLVELQLVQNLNLSYN 331
           N +   +P      L  +Q + L  N
Sbjct: 454 NQLK-SVPDGIFDRLTSLQKIWLHTN 478

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 86.1 bits (213), Expect = 8e-18
 Identities = 59/302 (19%), Positives = 108/302 (35%), Gaps = 45/302 (14%)

Query: 14  LDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYC 73
           L     L NL   ++     + +    +   + +  F +++  L G++       +    
Sbjct: 216 LQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSG--- 272

Query: 74  VQNCNQHLKHLDINNNNFGGLLPGCICNFS-ITLETLIFNSNKIFRSIPAGI-GKFINLQ 131
                + L    + ++ FG         FS + ++    +  +    +      K     
Sbjct: 273 --TSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTR---MVHMLCPSKISPFL 327

Query: 132 TLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIG---NLKKLLQLYLIENFL 188
            L   +N L+ T+    G L  L TL +  N+L   +         +K L QL + +N +
Sbjct: 328 HLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSV 386

Query: 189 QVSIPSSL-GQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGK 247
                       +SL ++N+S N L+ TI   L     + V LDL  N++  S+P +V K
Sbjct: 387 SYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKV-LDLHSNKIK-SIPKQVVK 442

Query: 248 LINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPL-SLSSLRGLRVLDLSQ 306
           L  L+ L ++ N                 QLK         +P      L  L+ + L  
Sbjct: 443 LEALQELNVASN-----------------QLKS--------VPDGIFDRLTSLQKIWLHT 477

Query: 307 NN 308
           N 
Sbjct: 478 NP 479

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 82.2 bits (203), Expect = 1e-16
 Identities = 52/346 (15%), Positives = 111/346 (32%), Gaps = 37/346 (10%)

Query: 20  LPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQ 79
           L  L  L +  N+I  +  S      +LE   ++ N L  ++                  
Sbjct: 44  LSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KIS--CHPTVN--------- 91

Query: 80  HLKHLDINNNNFGGL-LPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDN 138
            LKHLD++ N F  L +     N S  L+ L  ++  +       +    +L    +   
Sbjct: 92  -LKHLDLSFNAFDALPICKEFGNMS-QLKFLGLSTTHL-EKSS--VLPIAHLNISKVLLV 146

Query: 139 QLSGTISP-AIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQ-------- 189
                        LQ+  T +++    +      I ++       L  + ++        
Sbjct: 147 LGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKC 206

Query: 190 ---VSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLS--VGLDLSRNQLVGSLPTE 244
              +SI + L     L+ + L+    +     +++ L   +      +S  +L G L   
Sbjct: 207 SYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFR 266

Query: 245 VGKLINLEILFISRNMLECEILSTLGSCI-----KLEQLKLGGNLFQGPIPLSLSSLRGL 299
                   +  +S + +  ++     S I      +       +  +    L  S +   
Sbjct: 267 DFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPF 326

Query: 300 RVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKN 345
             LD S N ++  + +    L  ++ L L  N L+ +     +   
Sbjct: 327 LHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQ 372

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 80.7 bits (199), Expect = 5e-16
 Identities = 52/316 (16%), Positives = 102/316 (32%), Gaps = 25/316 (7%)

Query: 21  PNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQH 80
                L++  N I+ +  S + + SKL +  ++ N +     S F            NQ 
Sbjct: 21  QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKF----------NQE 70

Query: 81  LKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAG--IGKFINLQTLHMWDN 138
           L++LD+++N    +     C+ ++ L+ L  + N  F ++P     G    L+ L +   
Sbjct: 71  LEYLDLSHNKLVKI----SCHPTVNLKHLDLSFNA-FDALPICKEFGNMSQLKFLGLSTT 125

Query: 139 QLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQ 198
            L  +    I  L     L +          P    L+      L   F        +  
Sbjct: 126 HLEKSSVLPIAHLNISKVLLVLGETYGEKEDP--EGLQDFNTESLHIVFPTNKEFHFILD 183

Query: 199 CQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISR 258
               T  NL  +N+   +         LS+   L  N  + +L     +      + I +
Sbjct: 184 VSVKTVANLELSNIKCVLEDNKCS-YFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQ 242

Query: 259 NMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLV 318
            +    +         +  +KL G L       S +SL+ L +  +  +           
Sbjct: 243 LVWHTTVW-----YFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYE 297

Query: 319 ELQLVQNLNLSYNDLE 334
               +   N + +   
Sbjct: 298 IFSNMNIKNFTVSGTR 313

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 77.6 bits (191), Expect = 4e-15
 Identities = 50/243 (20%), Positives = 81/243 (33%), Gaps = 10/243 (4%)

Query: 101 NFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAIN 160
           + S     L  + N I     + I     L+ L +  N++           Q L  L ++
Sbjct: 18  DLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLS 77

Query: 161 TNKLSGNIPPSIGNLKKLLQLYLIENFLQ-VSIPSSLGQCQSLTTINLSYNNLSGTIPPQ 219
            NKL   I         L  L L  N    + I    G    L  + LS  +L  +    
Sbjct: 78  HNKLV-KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLP 134

Query: 220 LMDLTSLSVGLDLSRNQLVGSLPTEVGKL--INLEILFISRNMLECEILSTLGSCIKLEQ 277
           +  L    V L L         P  +      +L I+F +       +  ++ +   LE 
Sbjct: 135 IAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLEL 194

Query: 278 LKLGGNLFQGPIPLSLSSL----RGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDL 333
             +   L        LS L       ++ +L+ NNI      F+  LQLV +  + Y  +
Sbjct: 195 SNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSI 254

Query: 334 EGV 336
             V
Sbjct: 255 SNV 257

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 70.7 bits (173), Expect = 8e-13
 Identities = 41/197 (20%), Positives = 72/197 (36%), Gaps = 19/197 (9%)

Query: 20  LPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQ 79
             N+   +   +    V        S       ++N LT  V    G  T+         
Sbjct: 299 FSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTE--------- 349

Query: 80  HLKHLDINNNNFGGLLPGCICNFS--ITLETLIFNSNKIFRSIPAGI-GKFINLQTLHMW 136
            L+ L +  N     L       +   +L+ L  + N +      G      +L +L+M 
Sbjct: 350 -LETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMS 407

Query: 137 DNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIP-SS 195
            N L+ TI   +     +  L +++NK+  +IP  +  L+ L +L +  N L+ S+P   
Sbjct: 408 SNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGI 463

Query: 196 LGQCQSLTTINLSYNNL 212
             +  SL  I L  N  
Sbjct: 464 FDRLTSLQKIWLHTNPW 480

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 91.9 bits (229), Expect = 1e-20
 Identities = 53/217 (24%), Positives = 90/217 (41%), Gaps = 34/217 (15%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLN---LLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           G F   ++    + K + A K++    LL     +    E S  R++ H+++V       
Sbjct: 26  GGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF-- 83

Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
              ++ +DF  +V E     SL E         K +  P+   +L++I          +Y
Sbjct: 84  ---FEDNDFVFVVLELCRRRSLLELHK----RRKALTEPEARYYLRQI------VLGCQY 130

Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAH--LQTSSIGVKGTIGYIA 585
           LH +      H DLK  N+ L+ ++   + DFGLA  +       +       GT  YIA
Sbjct: 131 LHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC----GTPNYIA 183

Query: 586 P---AEYGLGSEVSINGDVYSYGILLLELMTRKRPSD 619
           P   ++ G   EV    DV+S G ++  L+  K P +
Sbjct: 184 PEVLSKKGHSFEV----DVWSIGCIMYTLLVGKPPFE 216

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 92.8 bits (231), Expect = 1e-20
 Identities = 54/231 (23%), Positives = 89/231 (38%), Gaps = 45/231 (19%)

Query: 411 GSFGSVYKGIL-----DEGKTIIAVKVLNLLHHGASKSS-IAECSALRNI-RHKNLVKIL 463
           G+FG V                +AVK+L      + + + ++E   +  +  H+N+V +L
Sbjct: 56  GAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLL 115

Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWL-------------HPVSGADKTVEAPKCLN 510
             C+           L++E+   G L  +L             +      +  E    L 
Sbjct: 116 GACT----LSGPI-YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170

Query: 511 FLQRINIAIDVACALKYL-HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAH 569
           F   +  A  VA  +++L    C     H DL   NVL+ H     + DFGLA+      
Sbjct: 171 FEDLLCFAYQVAKGMEFLEFKSC----VHRDLAARNVLVTHGKVVKICDFGLARD----- 221

Query: 570 LQTSSIGVKGTIGYI-----AP--AEYGLGSEVSINGDVYSYGILLLELMT 613
           + + S  V      +     AP     G+ +  S   DV+SYGILL E+ +
Sbjct: 222 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKS---DVWSYGILLWEIFS 269

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 93.2 bits (232), Expect = 2e-20
 Identities = 51/229 (22%), Positives = 90/229 (39%), Gaps = 46/229 (20%)

Query: 411 GSFGSVYKGIL-------DEGKTIIAVKVLNLLHHGASKSS----IAECSALRNI-RHKN 458
           G FG V             +    +AVK+L      A++      ++E   ++ I +HKN
Sbjct: 92  GCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEMEMMKMIGKHKN 148

Query: 459 LVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWL------HPVSGADKTVEAPKCLNFL 512
           ++ +L  C+    +      ++ E+   G+L E+L            D      + + F 
Sbjct: 149 IINLLGACT----QDGPL-YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203

Query: 513 QRINIAIDVACALKYL-HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQ 571
             ++    +A  ++YL    C     H DL   NVL+       +ADFGLA+      + 
Sbjct: 204 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARD-----IN 254

Query: 572 TSSIGVKGTIGYI-----AP--AEYGLGSEVSINGDVYSYGILLLELMT 613
                 K T G +     AP      +    +   DV+S+G+L+ E+ T
Sbjct: 255 NIDYYKKTTNGRLPVKWMAPEALFDRV---YTHQSDVWSFGVLMWEIFT 300

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 91.9 bits (229), Expect = 2e-20
 Identities = 47/223 (21%), Positives = 85/223 (38%), Gaps = 37/223 (16%)

Query: 411 GSFGSVYKG---ILDEGKTIIAVKVLNLLHHGASKSSIA----ECSALRNIRHKNLVKIL 463
           G  G VY+    + +    I+A+K+++     +          E      ++  ++V I 
Sbjct: 45  GGMGDVYEAEDTVRER---IVALKLMSE-TLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100

Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
               G     D    +    ++   L   L          + P  L   + + I   +  
Sbjct: 101 DF--GEI---DGQLYVDMRLINGVDLAAMLR--------RQGP--LAPPRAVAIVRQIGS 145

Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHL-QTSSIGVKGTIG 582
           AL   H        H D+KP N+L+  +  A++ DFG+A       L Q  +    GT+ 
Sbjct: 146 ALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN--TVGTLY 200

Query: 583 YIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGN 625
           Y+AP E    S  +   D+Y+   +L E +T   P    ++G+
Sbjct: 201 YMAP-ERFSESHATYRADIYALTCVLYECLTGSPP----YQGD 238

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 92.0 bits (229), Expect = 2e-20
 Identities = 53/217 (24%), Positives = 90/217 (41%), Gaps = 34/217 (15%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLN---LLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           G F   ++    + K + A K++    LL     +    E S  R++ H+++V       
Sbjct: 52  GGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF-- 109

Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
              ++ +DF  +V E     SL E         K +  P+   +L++I          +Y
Sbjct: 110 ---FEDNDFVFVVLELCRRRSLLELHK----RRKALTEPEARYYLRQI------VLGCQY 156

Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAH--LQTSSIGVKGTIGYIA 585
           LH +      H DLK  N+ L+ ++   + DFGLA  +       +       GT  YIA
Sbjct: 157 LHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC----GTPNYIA 209

Query: 586 P---AEYGLGSEVSINGDVYSYGILLLELMTRKRPSD 619
           P   ++ G   EV    DV+S G ++  L+  K P +
Sbjct: 210 PEVLSKKGHSFEV----DVWSIGCIMYTLLVGKPPFE 242

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 91.8 bits (228), Expect = 4e-20
 Identities = 51/219 (23%), Positives = 90/219 (41%), Gaps = 27/219 (12%)

Query: 402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA-ECSALRNIRHKNLV 460
           F  +  +  G+ G V+K        ++A K+++L    A ++ I  E   L       +V
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94

Query: 461 KILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAID 520
                  G  Y   +   +  E M  GSL          D+ ++    +       ++I 
Sbjct: 95  G----FYGAFYSDGEIS-ICMEHMDGGSL----------DQVLKKAGRIPEQILGKVSIA 139

Query: 521 VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIG--VK 578
           V   L YL    +    H D+KPSN+L++      + DFG++  L        S+     
Sbjct: 140 VIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL------IDSMANSFV 191

Query: 579 GTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
           GT  Y++P E   G+  S+  D++S G+ L+E+   + P
Sbjct: 192 GTRSYMSP-ERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 91.3 bits (227), Expect = 5e-20
 Identities = 44/244 (18%), Positives = 87/244 (35%), Gaps = 49/244 (20%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLN---LLHHGASKSSIA--------------ECSALRN 453
           G F  +      +     A+K      L        S                E   + +
Sbjct: 42  GKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITD 99

Query: 454 IRHKNLVKILTVCSGVDYKGDDFKA--LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNF 511
           I+++  +    +         ++    ++YE+M N S+ ++       DK       +  
Sbjct: 100 IKNEYCLTCEGII-------TNYDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPI 150

Query: 512 LQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQ 571
                I   V  +  Y+H+  +    H D+KPSN+L+D      ++DFG ++ +    ++
Sbjct: 151 QVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK 208

Query: 572 TSSIGVKGTIGYIAP-----AEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNM 626
            S    +GT  ++ P          G++V    D++S GI L  +     P    F   +
Sbjct: 209 GS----RGTYEFMPPEFFSNESSYNGAKV----DIWSLGICLYVMFYNVVP----FSLKI 256

Query: 627 NLHN 630
           +L  
Sbjct: 257 SLVE 260

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 89.6 bits (223), Expect = 6e-20
 Identities = 52/215 (24%), Positives = 85/215 (39%), Gaps = 36/215 (16%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLN---LLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           G FG+VY     + K I+A+KVL    L   G       E     ++RH N++++     
Sbjct: 25  GKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH 84

Query: 468 GVDYKGDDFKA-LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALK 526
                 D  +  L+ EF   G L + L          +  +   F++ +      A AL 
Sbjct: 85  ------DRKRIYLMLEFAPRGELYKELQ----KHGRFDEQRSATFMEEL------ADALH 128

Query: 527 YLH-HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
           Y H         H D+KP N+L+ ++    +ADFG +   P    +T      GT+ Y+ 
Sbjct: 129 YCHERKV----IHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC----GTLDYLP 180

Query: 586 P---AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
           P          +V    D++  G+L  E +    P
Sbjct: 181 PEMIEGKTHDEKV----DLWCAGVLCYEFLVGMPP 211

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 89.3 bits (222), Expect = 8e-20
 Identities = 52/228 (22%), Positives = 95/228 (41%), Gaps = 17/228 (7%)

Query: 106 LETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLS 165
                     +  ++     +  ++  +   ++ +  ++   I  L N+  L +N NKL+
Sbjct: 26  TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLT 81

Query: 166 GNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTS 225
            +I P + NLK L  L+L EN  +V   SSL   + L +++L +N +S  I   L+ L  
Sbjct: 82  -DIKP-LANLKNLGWLFLDEN--KVKDLSSLKDLKKLKSLSLEHNGIS-DING-LVHLPQ 135

Query: 226 LSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLF 285
           L   L L  N++  +  T + +L  L+ L +  N +    +  L    KL+ L L  N  
Sbjct: 136 LES-LYLGNNKI--TDITVLSRLTKLDTLSLEDNQISD--IVPLAGLTKLQNLYLSKNHI 190

Query: 286 QGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDL 333
                L+   L+ L VL+L       +       L +   +  +   L
Sbjct: 191 SDLRALA--GLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 84.0 bits (208), Expect = 7e-18
 Identities = 55/262 (20%), Positives = 106/262 (40%), Gaps = 30/262 (11%)

Query: 31  NQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNN 90
             I  +     F  ++     +   ++T  V             QN    +  +  NN++
Sbjct: 12  TPIKQIFSDDAF--AETIKDNLKKKSVTDAVT------------QNELNSIDQIIANNSD 57

Query: 91  FGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGE 150
              +    I      +  L  N NK+   I   +    NL  L + +N++   +S  + +
Sbjct: 58  IKSVQG--IQYLP-NVTKLFLNGNKL-TDIK-PLANLKNLGWLFLDENKVK-DLSS-LKD 110

Query: 151 LQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYN 210
           L+ L +L++  N +S +I   + +L +L  LYL  N  +++  + L +   L T++L  N
Sbjct: 111 LKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNN--KITDITVLSRLTKLDTLSLEDN 166

Query: 211 NLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLG 270
            +S  I P L  LT L   L LS+N +  S    +  L NL++L +       + ++   
Sbjct: 167 QIS-DIVP-LAGLTKLQN-LYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQS 221

Query: 271 SCIKLEQLKLGGNLFQGPIPLS 292
           + +    +K        P  +S
Sbjct: 222 NLVVPNTVKNTDGSLVTPEIIS 243

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 46/245 (18%), Positives = 91/245 (37%), Gaps = 54/245 (22%)

Query: 20  LPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQ 79
           LPN+  L L  N++T      +   + L                               +
Sbjct: 67  LPNVTKLFLNGNKLT-----DIKPLANL-------------------------------K 90

Query: 80  HLKHLDINNNNFGGLLPGCICNFS--ITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWD 137
           +L  L ++ N         + +      L++L    N I   I  G+     L++L++ +
Sbjct: 91  NLGWLFLDENKV-----KDLSSLKDLKKLKSLSLEHNGI-SDIN-GLVHLPQLESLYLGN 143

Query: 138 NQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLG 197
           N+++  I+  +  L  L TL++  N++S +I P +  L KL  LYL +N   +S   +L 
Sbjct: 144 NKIT-DITV-LSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKN--HISDLRALA 197

Query: 198 QCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFIS 257
             ++L  + L              +L   +  +  +   LV   P  +    + E   + 
Sbjct: 198 GLKNLDVLELFSQECLNKPINHQSNLVVPN-TVKNTDGSLVT--PEIISDDGDYEKPNVK 254

Query: 258 RNMLE 262
            ++ E
Sbjct: 255 WHLPE 259

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 90.9 bits (225), Expect = 1e-19
 Identities = 27/264 (10%), Positives = 50/264 (18%), Gaps = 49/264 (18%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLN---LLHHGASKSSIAECSALRNIRHKNLV------- 460
           G    V+     E     A+KV            +       A   +  ++         
Sbjct: 73  GDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRR 132

Query: 461 --------------KILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAP 506
                             +  G D        L+        LE      S  D      
Sbjct: 133 LLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLF---STLDFVYVFR 188

Query: 507 KCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP 566
                L    +   +      L         H    P N+ +  +    + D        
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALW-KV 244

Query: 567 PAHLQTSSIGVKGTIGYIAP-----AEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIM 621
                 SS      + Y        +       +    + +  G+ +  +     P    
Sbjct: 245 GTRGPASS----VPVTYAPREFLNASTATFTHAL----NAWQLGLSIYRVWCLFLP---- 292

Query: 622 FEGNMNLHNFARTVLPDHVMDIVD 645
           F         +       V     
Sbjct: 293 FGLVTPGIKGSWKRPSLRVPGTDS 316

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 89.8 bits (223), Expect = 2e-19
 Identities = 55/233 (23%), Positives = 89/233 (38%), Gaps = 27/233 (11%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIR-HKNLVKILTVCSGV 469
           G F  VY+          A+K L       +++ I E   ++ +  H N+V+  +  S  
Sbjct: 39  GGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG 98

Query: 470 DYKGDDFKALVYEFM--HNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
             + D  +A          G L E+L       K +E+   L+    + I      A+++
Sbjct: 99  KEESDTGQAEFLLLTELCKGQLVEFL-------KKMESRGPLSCDTVLKIFYQTCRAVQH 151

Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSS----------IGV 577
           +H   +P   H DLK  N+LL ++ T  + DFG A  +      + S          I  
Sbjct: 152 MHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210

Query: 578 KGTIGYIAPAEYGLGSEVSIN--GDVYSYGILLLELMTRKRPSDIMFEGNMNL 628
             T  Y  P    L S   I    D+++ G +L  L  R+ P    FE    L
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP----FEDGAKL 259

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 88.8 bits (221), Expect = 2e-19
 Identities = 53/226 (23%), Positives = 84/226 (37%), Gaps = 39/226 (17%)

Query: 411 GSFGSVYKG---ILDEGKTIIAVKVLNLLHHGASKSSIA----ECSALRNIRHKNLVKIL 463
           G    V+             +AVKVL         S       E      + H  +V + 
Sbjct: 23  GGMSEVHLARDLRDHR---DVAVKVLRA-DLARDPSFYLRFRREAQNAAALNHPAIVAVY 78

Query: 464 TVCSGVDYKGDDFKA-LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVA 522
               G           +V E++   +L + +H         E P  +   + I +  D  
Sbjct: 79  DT--GEAETPAGPLPYIVMEYVDGVTLRDIVHT--------EGP--MTPKRAIEVIADAC 126

Query: 523 CALKYLHHDCQPTTA---HCDLKPSNVLLDHEMTAHVADFGLAK-LLPPAHLQTSSIGVK 578
            AL + H           H D+KP+N+++       V DFG+A+ +    +  T +  V 
Sbjct: 127 QALNFSHQ------NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 180

Query: 579 GTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEG 624
           GT  Y++P E   G  V    DVYS G +L E++T + P    F G
Sbjct: 181 GTAQYLSP-EQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTG 221

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 90.3 bits (224), Expect = 2e-19
 Identities = 49/223 (21%), Positives = 86/223 (38%), Gaps = 39/223 (17%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA----ECSALRNIRHKNL--VKILT 464
           G    V++  L+E K I A+K +NL    A   ++     E + L  ++  +   +++  
Sbjct: 67  GGSSKVFQV-LNEKKQIYAIKYVNL--EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123

Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
                    D +  +V E   N  L  WL             K ++  +R +   ++  A
Sbjct: 124 Y-----EITDQYIYMVMEC-GNIDLNSWLK----------KKKSIDPWERKSYWKNMLEA 167

Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYI 584
           +  +H   Q    H DLKP+N L+  +    + DFG+A  + P           G + Y+
Sbjct: 168 VHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYM 223

Query: 585 AP----------AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
            P                S++S   DV+S G +L  +   K P
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 89.4 bits (222), Expect = 2e-19
 Identities = 50/223 (22%), Positives = 87/223 (39%), Gaps = 39/223 (17%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA----ECSALRNIRHKNL--VKILT 464
           G    V++  L+E K I A+K +NL    A   ++     E + L  ++  +   +++  
Sbjct: 20  GGSSKVFQV-LNEKKQIYAIKYVNL--EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76

Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
                    D +  +V E   N  L  WL             K ++  +R +   ++  A
Sbjct: 77  Y-----EITDQYIYMVMEC-GNIDLNSWLK----------KKKSIDPWERKSYWKNMLEA 120

Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYI 584
           +  +H   Q    H DLKP+N L+  +    + DFG+A  + P           GT+ Y+
Sbjct: 121 VHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 176

Query: 585 AP----------AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
            P                S++S   DV+S G +L  +   K P
Sbjct: 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 88.5 bits (220), Expect = 2e-19
 Identities = 48/238 (20%), Positives = 83/238 (34%), Gaps = 45/238 (18%)

Query: 402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVK 461
           F  +  +  G+FG V K          A+K +         + ++E   L ++ H+ +V+
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVR 66

Query: 462 ILTVCSGVDYKGDDFKA--------LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQ 513
                           A        +  E+  NG+L + +H  +   +  E        +
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY---WRLFR 123

Query: 514 RINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTS 573
           +I        AL Y+H        H DLKP N+ +D      + DFGLAK +  +     
Sbjct: 124 QI------LEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174

Query: 574 SIGVK------------GTIGYIAP------AEYGLGSEVSINGDVYSYGILLLELMT 613
                            GT  Y+A         Y    ++    D+YS GI+  E++ 
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHY--NEKI----DMYSLGIIFFEMIY 226

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 87.7 bits (218), Expect = 3e-19
 Identities = 50/245 (20%), Positives = 82/245 (33%), Gaps = 24/245 (9%)

Query: 98  CICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISP-AIGELQNLVT 156
           C+                 F  IP  +    + + L +  N L   +   +      L  
Sbjct: 3   CVEVVP---NITYQCMELNFYKIPDNL--PFSTKNLDLSFNPLR-HLGSYSFFSFPELQV 56

Query: 157 LAINTNKLSGNIPPSI-GNLKKLLQLYLIENFLQVSIPSSL-GQCQSLTTINLSYNNLSG 214
           L ++  ++   I      +L  L  L L  N +Q S+         SL  +     NL+ 
Sbjct: 57  LDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA- 113

Query: 215 TIPPQLMD-LTSLSVGLDLSRNQLVGSLPTEVG---KLINLEILFISRN---MLECEILS 267
           ++    +  L +L   L+++ N +  S          L NLE L +S N    + C  L 
Sbjct: 114 SLENFPIGHLKTLKE-LNVAHNLIQ-SFKLP-EYFSNLTNLEHLDLSSNKIQSIYCTDLR 170

Query: 268 TLGSCIKLE-QLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNL 326
            L     L   L L  N      P +   +R L+ L L  N +          L  +Q +
Sbjct: 171 VLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LKELALDTNQLKSVPDGIFDRLTSLQKI 229

Query: 327 NLSYN 331
            L  N
Sbjct: 230 WLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 84.3 bits (209), Expect = 4e-18
 Identities = 49/233 (21%), Positives = 86/233 (36%), Gaps = 31/233 (13%)

Query: 11  GIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATK 70
            +P        +   L L FN +  +   S F+  +L+V  ++   +       +   + 
Sbjct: 25  NLP-------FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLS- 76

Query: 71  AYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGI-GKFIN 129
                    HL  L +  N    L  G     S +L+ L+     +  S+     G    
Sbjct: 77  ---------HLSTLILTGNPIQSLALGAFSGLS-SLQKLVAVETNL-ASLENFPIGHLKT 125

Query: 130 LQTLHMWDNQLSGTISP-AIGELQNLVTLAINTNKLSGNIPPSI-GNLKKL----LQLYL 183
           L+ L++  N +     P     L NL  L +++NK+  +I  +    L ++    L L L
Sbjct: 126 LKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDL 184

Query: 184 IENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMD-LTSLSVGLDLSRN 235
             N +   I     +   L  + L  N L  ++P  + D LTSL   + L  N
Sbjct: 185 SLNPMN-FIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQK-IWLHTN 234

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 90.2 bits (224), Expect = 3e-19
 Identities = 47/220 (21%), Positives = 84/220 (38%), Gaps = 39/220 (17%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNI-RHKNLVKILTVCSGV 469
           G+ G++    + + + + AVK +       +     E   LR    H N+++        
Sbjct: 35  GAEGTIVYRGMFDNRDV-AVKRILPECFSFADR---EVQLLRESDEHPNVIRYFCT---- 86

Query: 470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH 529
             K   F+ +  E     +L+E++          +       L+ I +       L +LH
Sbjct: 87  -EKDRQFQYIAIELC-AATLQEYV---------EQKDFAHLGLEPITLLQQTTSGLAHLH 135

Query: 530 HDCQPTTAHCDLKPSNVLL-----DHEMTAHVADFGLAKLL-PPAHLQTSSIGVKGTIGY 583
                   H DLKP N+L+       ++ A ++DFGL K L    H  +   GV GT G+
Sbjct: 136 SL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192

Query: 584 IAP------AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
           IAP       +      V    D++S G +   +++    
Sbjct: 193 IAPEMLSEDCKENPTYTV----DIFSAGCVFYYVISEGSH 228

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 87.8 bits (218), Expect = 4e-19
 Identities = 50/224 (22%), Positives = 87/224 (38%), Gaps = 41/224 (18%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA----ECSALRNIRHKNL--VKILT 464
           G    V++  L+E K I A+K +NL    A   ++     E + L  ++  +   +++  
Sbjct: 39  GGSSKVFQV-LNEKKQIYAIKYVNL--EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95

Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
                    D +  +V E   N  L  WL             K ++  +R +   ++  A
Sbjct: 96  Y-----EITDQYIYMVMEC-GNIDLNSWLK----------KKKSIDPWERKSYWKNMLEA 139

Query: 525 LKYLH-HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGY 583
           +  +H H       H DLKP+N L+  +    + DFG+A  + P           GT+ Y
Sbjct: 140 VHTIHQHG----IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNY 194

Query: 584 IAP----------AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
           + P                S++S   DV+S G +L  +   K P
Sbjct: 195 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 85.8 bits (213), Expect = 2e-18
 Identities = 47/272 (17%), Positives = 93/272 (34%), Gaps = 72/272 (26%)

Query: 402 FLFLCWIDMGSFGSVYKGI-LDEGKTIIAVKVLNLLHHGAS--KSSIAECSALRNI-RHK 457
           F  L  I  G FGSV+K +   +G  I A+K       G+   ++++ E  A   + +H 
Sbjct: 13  FHELEKIGSGEFGSVFKCVKRLDGC-IYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71

Query: 458 NLVKILTVCSGVDYKG----DDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQ 513
           ++V+         Y      DD   +  E+ + GSL + +          +  +  + L 
Sbjct: 72  HVVR---------YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLL- 121

Query: 514 RINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHE-------------------MTA 554
                + V   L+Y+H     +  H D+KPSN+ +                      +  
Sbjct: 122 -----LQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMF 173

Query: 555 HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSING--------DVYSYGI 606
            + D G    +    ++       G   ++A        EV +          D+++  +
Sbjct: 174 KIGDLGHVTRISSPQVEE------GDSRFLAN-------EV-LQENYTHLPKADIFALAL 219

Query: 607 LLLELMTRKRPSDIMFEGNMNLHNFARTVLPD 638
            ++     +        G+   H   +  LP 
Sbjct: 220 TVVCAAGAEPLP---RNGDQ-WHEIRQGRLPR 247

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 87.4 bits (216), Expect = 2e-18
 Identities = 40/304 (13%), Positives = 82/304 (26%), Gaps = 47/304 (15%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA---ECSALRNIRH----------- 456
               +  +    E      V V        S +      E   LR +R            
Sbjct: 89  EDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHL 148

Query: 457 -----KNLVKILTVCSGVDYKGDDFKA------LVYEFMHNGSLEEWLHPVSGADKTVEA 505
                 +LVK       +  + D+          +Y  M   +L+ +   +         
Sbjct: 149 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSH---SST 204

Query: 506 PKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL 565
            K L    R+ + + V   L  LHH       H  L+P +++LD      +  F      
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261

Query: 566 PPAHLQTSSIGVKGTIGYIAP----AEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIM 621
             + +     G        A           + ++   D ++ G+ +  +     P    
Sbjct: 262 GASAVSPIGRGF-APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP---- 316

Query: 622 FEGNMNLHNFARTV-----LPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLI 676
              +  L            +P  V  +++   L   ++  +   Q         +   L 
Sbjct: 317 NTDDAALGGSEWIFRSCKNIPQPVRALLEG-FLRYPKEDRLLPLQAMETPEYEQLRTELS 375

Query: 677 SVVR 680
           + + 
Sbjct: 376 AALP 379

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 84.3 bits (209), Expect = 3e-18
 Identities = 48/225 (21%), Positives = 81/225 (36%), Gaps = 18/225 (8%)

Query: 109 LIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNI 168
            I     I +  P       N    ++    ++  +     EL  +     + + +  ++
Sbjct: 2   SIQRPTPINQVFP--DPGLANAVKQNLGKQSVT-DLVS-QKELSGVQNFNGDNSNIQ-SL 56

Query: 169 PPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSV 228
              +     L +L+L  N  Q+S  S L     L  ++++ N L          L+ L  
Sbjct: 57  AG-MQFFTNLKELHLSHN--QISDLSPLKDLTKLEELSVNRNRLKNLNGIPSACLSRL-- 111

Query: 229 GLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGP 288
              L  N+L       +  L NLEIL I  N L+   +  LG   KLE L L GN     
Sbjct: 112 --FLDNNEL--RDTDSLIHLKNLEILSIRNNKLK--SIVMLGFLSKLEVLDLHGNEITNT 165

Query: 289 IPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDL 333
             L+   L+ +  +DL+      E  K+  EL +   +       
Sbjct: 166 GGLT--RLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRW 208

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 66.6 bits (163), Expect = 3e-12
 Identities = 47/236 (19%), Positives = 94/236 (39%), Gaps = 26/236 (11%)

Query: 20  LPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQ 79
           L N +  +LG   +T ++       S ++ F   ++N+                +Q    
Sbjct: 18  LANAVKQNLGKQSVTDLVSQKEL--SGVQNFNGDNSNI-----------QSLAGMQFFT- 63

Query: 80  HLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQ 139
           +LK L +++N    L P  + + +  LE L  N N++ +++         L  L + +N+
Sbjct: 64  NLKELHLSHNQISDLSP--LKDLT-KLEELSVNRNRL-KNLNG--IPSACLSRLFLDNNE 117

Query: 140 LSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQC 199
           L       +  L+NL  L+I  NKL  +I   +G L KL  L L  N  +++    L + 
Sbjct: 118 LR-DTDS-LIHLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGN--EITNTGGLTRL 171

Query: 200 QSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILF 255
           + +  I+L+             +L   +   D     +     +  G  ++  +L+
Sbjct: 172 KKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGCVLW 227

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 53.5 bits (129), Expect = 6e-08
 Identities = 35/196 (17%), Positives = 65/196 (33%), Gaps = 24/196 (12%)

Query: 20  LPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQ 79
             NL  L L  NQI+ +  S + + +KLE   V  N L                    + 
Sbjct: 62  FTNLKELHLSHNQISDL--SPLKDLTKLEELSVNRNRLKNLNGIP-------------SA 106

Query: 80  HLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQ 139
            L  L ++NN         + +    LE L   +NK+ +SI   +G    L+ L +  N+
Sbjct: 107 CLSRLFLDNNELRDTDS--LIHLK-NLEILSIRNNKL-KSIV-MLGFLSKLEVLDLHGNE 161

Query: 140 LSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQC 199
           ++      +  L+ +  + +   K           L     +   +   +   P  +   
Sbjct: 162 IT-NTGG-LTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDG--RWISPYYISNG 217

Query: 200 QSLTTINLSYNNLSGT 215
            S     + +     T
Sbjct: 218 GSYVDGCVLWELPVYT 233

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 86.8 bits (215), Expect = 4e-18
 Identities = 50/232 (21%), Positives = 87/232 (37%), Gaps = 44/232 (18%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA--ECSALR-NIRHKNLVKILTVCS 467
           GS G+V      +G+ + AVK + +         IA  E   L  +  H N+++      
Sbjct: 26  GSSGTVVFQGSFQGRPV-AVKRMLI-----DFCDIALMEIKLLTESDDHPNVIRYYCS-- 77

Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
                 D F  +  E   N +L++    V   + + E  K       I++   +A  + +
Sbjct: 78  ---ETTDRFLYIALELC-NLNLQDL---VESKNVSDENLKLQKEYNPISLLRQIASGVAH 130

Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAH-------------VADFGLAKLLPP--AHLQT 572
           LH        H DLKP N+L+                    ++DFGL K L    +  +T
Sbjct: 131 LHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187

Query: 573 SSIGVKGTIGYIAPAEYGLGSEVSING-------DVYSYGILLLELMTRKRP 617
           +     GT G+ AP E    S             D++S G +   ++++ + 
Sbjct: 188 NLNNPSGTSGWRAP-ELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 83.8 bits (208), Expect = 6e-18
 Identities = 48/209 (22%), Positives = 86/209 (41%), Gaps = 28/209 (13%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSI-AECS-ALRNIRHKNLVKILTVCSG 468
           G++G V K        I+AVK +    +   +  +  +   ++R +     V       G
Sbjct: 18  GAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVT----FYG 73

Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL 528
             ++  D   +  E M + SL+++   V    +T+        L +I  A+ +  AL++L
Sbjct: 74  ALFREGDVW-ICMELM-DTSLDKFYKQVIDKGQTIPED----ILGKI--AVSIVKALEHL 125

Query: 529 HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIG---VKGTIGYIA 585
           H        H D+KPSNVL++      + DFG++  L         +      G   Y+A
Sbjct: 126 HSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYL------VDDVAKDIDAGCKPYMA 177

Query: 586 P---AEYGLGSEVSINGDVYSYGILLLEL 611
           P            S+  D++S GI ++EL
Sbjct: 178 PERINPELNQKGYSVKSDIWSLGITMIEL 206

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 84.7 bits (209), Expect = 1e-17
 Identities = 39/285 (13%), Positives = 79/285 (27%), Gaps = 64/285 (22%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSS------IAECSALRNIRHKN------ 458
               +  +    E      V V        S +       +     LR I+++       
Sbjct: 84  EDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHL 143

Query: 459 -------LVKILTVCSGVDYKGDDFKA------LVYEFMH--NGSLEEWLHPVSGADKTV 503
                  LVK       +  + D+          +Y  M     +  E L   S   K++
Sbjct: 144 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSL 203

Query: 504 EAPKCLNFLQRINIAIDVACALKYLH-HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLA 562
                     R+ + + V   L  LH +       H  L+P +++LD      +  F   
Sbjct: 204 V------HHARLQLTLQVIRLLASLHHYGL----VHTYLRPVDIVLDQRGGVFLTGFEHL 253

Query: 563 KLLPPAHLQTSSIGVKGTIGYIAP----------AEYGLGSEVSINGDVYSYGILLLELM 612
                     SS     + G+  P                + ++ + D ++ G+++  + 
Sbjct: 254 V--RDGARVVSS----VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307

Query: 613 TRKRPSDIMFEGNMNLHNFARTV-----LPDHVMDIVDSTLLADD 652
               P       +  L            +P  V  +++   L   
Sbjct: 308 CADLP----ITKDAALGGSEWIFRSCKNIPQPVRALLEG-FLRYP 347

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 83.1 bits (206), Expect = 2e-17
 Identities = 50/209 (23%), Positives = 82/209 (39%), Gaps = 27/209 (12%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSI-AECS-ALRNIRHKNLVKILTVCSG 468
           G++GSV K +      I+AVK +        +  +  +    +R+     +V+      G
Sbjct: 33  GAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQ----FYG 88

Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL 528
             ++  D   +  E M + S +++   V      V   + L       I +    AL +L
Sbjct: 89  ALFREGDCW-ICMELM-STSFDKFYKYVYSVLDDVIPEEILGK-----ITLATVKALNHL 141

Query: 529 HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIG---YIA 585
             + +    H D+KPSN+LLD      + DFG++  L        SI      G   Y+A
Sbjct: 142 KENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQL------VDSIAKTRDAGCRPYMA 193

Query: 586 P---AEYGLGSEVSINGDVYSYGILLLEL 611
           P             +  DV+S GI L EL
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYEL 222

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 82.7 bits (205), Expect = 2e-17
 Identities = 59/231 (25%), Positives = 93/231 (40%), Gaps = 48/231 (20%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLN---LLHHGASKSSIA-ECSALRNIRHKNLVKILTVC 466
           GS+G V + +  E     AVK+L    L      ++++  E   LR +RHKN+++++ V 
Sbjct: 16  GSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVL 75

Query: 467 SGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALK 526
              + K   +  +V E+   G  E             +A     F Q I         L+
Sbjct: 76  YN-EEKQKMY--MVMEYCVCGMQEMLDSVPEKRFPVCQAHGY--FCQLI-------DGLE 123

Query: 527 YLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPA----HLQTSSIGVKGTIG 582
           YLH        H D+KP N+LL    T  ++  G+A+ L P       +TS     G+  
Sbjct: 124 YLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ----GSPA 176

Query: 583 YIAPAEYGLGSEVSING---------DVYSYGILLLELMTRKRPSDIMFEG 624
           +  P       E+  NG         D++S G+ L  + T   P    FEG
Sbjct: 177 FQPP-------EI-ANGLDTFSGFKVDIWSAGVTLYNITTGLYP----FEG 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 81.2 bits (201), Expect = 4e-17
 Identities = 69/225 (30%), Positives = 105/225 (46%), Gaps = 15/225 (6%)

Query: 88  NNNFGGLLPG-CICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISP 146
           N        G C CN      ++  +S K   +IP+ I    + + L +  N+LS   S 
Sbjct: 1   NEALCKKDGGVCSCNN--NKNSVDCSSKK-LTAIPSNI--PADTKKLDLQSNKLSSLPSK 55

Query: 147 AIGELQNLVTLAINTNKLSGNIPPSI-GNLKKLLQLYLIENFLQVSIPSSL-GQCQSLTT 204
           A   L  L  L +N NKL   +P  I   LK L  L++ +N LQ ++P  +  Q  +L  
Sbjct: 56  AFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAE 113

Query: 205 INLSYNNLSGTIPPQLMD-LTSLSVGLDLSRNQLVGSLPTEV-GKLINLEILFISRNMLE 262
           + L  N L  ++PP++ D LT L+  L L  N+L  SLP  V  KL +L+ L +  N L+
Sbjct: 114 LRLDRNQLK-SLPPRVFDSLTKLTY-LSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK 170

Query: 263 CEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQN 307
                      +L+ LKL  N  +     +  SL  L++L L +N
Sbjct: 171 RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 65.4 bits (160), Expect = 7e-12
 Identities = 43/205 (20%), Positives = 80/205 (39%), Gaps = 28/205 (13%)

Query: 11  GIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNA-SKLEVFQVTSNNLTGEVPSEFGKAT 69
            IP        +   L L  N+++  +PS  F+  +KL +  +  N L       F +  
Sbjct: 34  NIP-------ADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELK 85

Query: 70  KAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGI-GKFI 128
                      L+ L + +N     LP  + +  + L  L  + N++ +S+P  +     
Sbjct: 86  N----------LETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQL-KSLPPRVFDSLT 133

Query: 129 NLQTLHMWDNQLSGTISP-AIGELQNLVTLAINTNKLSGNIPPSI-GNLKKLLQLYLIEN 186
            L  L +  N+L  ++      +L +L  L +  N+L   +P      L +L  L L  N
Sbjct: 134 KLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNN 191

Query: 187 FLQVSIP-SSLGQCQSLTTINLSYN 210
            L+  +P  +    + L  + L  N
Sbjct: 192 QLK-RVPEGAFDSLEKLKMLQLQEN 215

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 81.6 bits (202), Expect = 5e-17
 Identities = 48/213 (22%), Positives = 79/213 (37%), Gaps = 26/213 (12%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA-ECSAL-RNIRHKNLVKILTVCSG 468
           G+ G V+K    +   +IAVK +    +      I  +   + ++     +V+    C G
Sbjct: 36  GTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQ----CFG 91

Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL 528
                 D   +  E M   + +          + +             + + +  AL YL
Sbjct: 92  TFITNTDVF-IAMELMGTCAEKLKKRMQGPIPERILGK----------MTVAIVKALYYL 140

Query: 529 HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP-- 586
                    H D+KPSN+LLD      + DFG++  L     +  S    G   Y+AP  
Sbjct: 141 KEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA---GCAAYMAPER 195

Query: 587 --AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
                    +  I  DV+S GI L+EL T + P
Sbjct: 196 IDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 82.3 bits (203), Expect = 6e-17
 Identities = 40/264 (15%), Positives = 74/264 (28%), Gaps = 37/264 (14%)

Query: 411 GSFGSVYKGILDEG-----KTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G+F  VY+    +      K    +KV    +             L+       +K  + 
Sbjct: 76  GAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSA 135

Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                +   +   LV E    G+L   ++            K +     I+ A+ +   +
Sbjct: 136 -----HLFQNGSVLVGELYSYGTLLNAIN-----LYKNTPEKVMPQGLVISFAMRMLYMI 185

Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAH-----------VADFGLA---KLLPPAHLQ 571
           + +H        H D+KP N +L +                + D G +   KL P   + 
Sbjct: 186 EQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIF 242

Query: 572 TSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLH-N 630
           T+      T G+    E       +   D +     +  ++           G       
Sbjct: 243 TAKC---ETSGFQCV-EMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGL 298

Query: 631 FARTVLPDHVMDIVDSTLLADDED 654
           F R    D   +     L   D  
Sbjct: 299 FRRLPHLDMWNEFFHVMLNIPDCH 322

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 82.5 bits (204), Expect = 7e-17
 Identities = 56/226 (24%), Positives = 94/226 (41%), Gaps = 39/226 (17%)

Query: 408 IDMGSFGSVYKGILDEGKT--IIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           +  G++G VYK    +GK     A+K +     G S S+  E + LR ++H N++ +  V
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIE--GTGISMSACREIALLRELKHPNVISLQKV 86

Query: 466 CSGVDYKGDDFKALVYEFM-HNGSLEEWLHPVSGADKTVEAP-------KCLNFLQRINI 517
                   D    L++++  H+  L   +     +    +         K L   Q ++ 
Sbjct: 87  FLS---HADRKVWLLFDYAEHD--LWHIIKFHRASKANKKPVQLPRGMVKSL-LYQILD- 139

Query: 518 AIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH----VADFGLAKLL-PPAHLQT 572
                  + YLH +      H DLKP+N+L+  E        +AD G A+L   P     
Sbjct: 140 ------GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLA 190

Query: 573 SSIGVKGTIGYIAPAEYGLGSE---VSINGDVYSYGILLLELMTRK 615
               V  T  Y AP E  LG+     +I  D+++ G +  EL+T +
Sbjct: 191 DLDPVVVTFWYRAP-ELLLGARHYTKAI--DIWAIGCIFAELLTSE 233

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 82.0 bits (203), Expect = 7e-17
 Identities = 55/229 (24%), Positives = 101/229 (44%), Gaps = 35/229 (15%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           I  G+ G V        +  +A+K L+    +   +K +  E   ++ + HKN++ +L V
Sbjct: 33  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 92

Query: 466 CSGVDYKGDDFKA--LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            +      ++F+   +V E M     +  L  V   +   E  +    L ++       C
Sbjct: 93  FT-PQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHE--RMSYLLYQM------LC 138

Query: 524 ALKYLHHDCQPTTA---HCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGT 580
            +K+LH      +A   H DLKPSN+++  + T  + DFGLA+    + + T  +    T
Sbjct: 139 GIKHLH------SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VT 189

Query: 581 IGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLH 629
             Y AP E  LG     N D++S G ++ E++       ++F G  ++ 
Sbjct: 190 RYYRAP-EVILGMGYKENVDIWSVGCIMGEMIKGG----VLFPGTDHID 233

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 80.3 bits (199), Expect = 1e-16
 Identities = 58/219 (26%), Positives = 99/219 (45%), Gaps = 29/219 (13%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSG 468
           G++G+V+K    E   I+A+K + L     G   S++ E   L+ ++HKN+V++  V   
Sbjct: 13  GTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS 72

Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL 528
                D    LV+EF     L+++    +G        K     Q       +   L + 
Sbjct: 73  -----DKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIV-KSF-LFQ-------LLKGLGFC 117

Query: 529 HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL-PPAHLQTSSIGVKGTIGYIAPA 587
           H        H DLKP N+L++      +A+FGLA+    P    ++ + V  T+ Y  P 
Sbjct: 118 HSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEV-V--TLWYRPP- 170

Query: 588 EYGLGSEV-SINGDVYSYGILLLELMTRKRPSDIMFEGN 625
           +   G+++ S + D++S G +  EL    RP   +F GN
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRP---LFPGN 206

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 82.6 bits (204), Expect = 1e-16
 Identities = 53/298 (17%), Positives = 100/298 (33%), Gaps = 50/298 (16%)

Query: 18  FTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNC 77
            TL ++        ++        F    +E   + +  +T  +  E    ++       
Sbjct: 254 VTLQHIETTWKCSVKLF-----QFFWPRPVEYLNIYNLTITERIDREEFTYSE-----TA 303

Query: 78  NQHLKHLDINNNNFGGLLPGCICNFS-ITLETLIFNSNKIFRSIPAGIGKFINLQTLHMW 136
            + L    + N  F          F+ + ++ L  +       +        +   L+  
Sbjct: 304 LKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPS--PSSFTFLNFT 361

Query: 137 DNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSL 196
            N  + ++      L+ L TL +  N L  N        K +  L  ++  L  S+ S  
Sbjct: 362 QNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLN-SLNSHA 419

Query: 197 GQC-----QSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINL 251
                   +S+  +NLS N L+G++   L     + V LDL  N++  S+P +V  L  L
Sbjct: 420 YDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKV-LDLHNNRI-MSIPKDVTHLQAL 475

Query: 252 EILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPL-SLSSLRGLRVLDLSQNN 308
           + L ++ N                 QLK         +P      L  L+ + L  N 
Sbjct: 476 QELNVASN-----------------QLKS--------VPDGVFDRLTSLQYIWLHDNP 508

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 82.2 bits (203), Expect = 2e-16
 Identities = 59/357 (16%), Positives = 113/357 (31%), Gaps = 26/357 (7%)

Query: 2   DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEV 61
            +   + +    L       + + L L    I G    S        V  +  +  +   
Sbjct: 152 GLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETES-LQIPNTTVLHLVFHPNSLFS 210

Query: 62  PSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNF-SITLETLIFNSNKIFRSI 120
                       +Q     L ++ +N+ N   L+          TL  +     +     
Sbjct: 211 VQVNMSVNALGHLQ-----LSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKC 265

Query: 121 PAGIGKFIN---LQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGN----IPPSIG 173
              + +F     ++ L++++  ++  I             ++    +          ++ 
Sbjct: 266 SVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALY 325

Query: 174 N-LKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDL 232
           +   ++    L  +              S T +N + N  + ++      L  L   L L
Sbjct: 326 SVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQT-LIL 384

Query: 233 SRNQLVGSLPTEVGKLINLEILF---ISRNMLECEILSTL-GSCIKLEQLKLGGNLFQGP 288
            RN L  +         N+  L    +S N L              +  L L  N+  G 
Sbjct: 385 QRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGS 443

Query: 289 IPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKN 345
           +   L     ++VLDL  N I   IPK +  LQ +Q LN++ N L+ V   +GVF  
Sbjct: 444 VFRCLPPK--VKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSV--PDGVFDR 495

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 77.2 bits (190), Expect = 7e-15
 Identities = 56/352 (15%), Positives = 111/352 (31%), Gaps = 31/352 (8%)

Query: 20  LPNLLFLSLGFNQITGVIPSSMFNA-SKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCN 78
           L  L  L L  N+I   +   +F     LE   V+ N L   +                 
Sbjct: 75  LSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQ-NIS--CCPMA--------- 121

Query: 79  QHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQT--LHMW 136
             L+HLD++ N+F  L           L  L  ++ K  R +       ++L    L + 
Sbjct: 122 -SLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKF-RQLDLLPVAHLHLSCILLDLV 179

Query: 137 DNQLSGTISPAIGELQNLVT-LAINTNKLSGNIPPSIGNLKKLLQLYLIE---NFLQVSI 192
              + G  + ++      V  L  + N L         N    LQL  I+      Q  +
Sbjct: 180 SYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLM 239

Query: 193 PSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVG----LDLSRNQLVGSLPTEVGKL 248
                  +  T +N++  ++  T    +             L++    +   +  E    
Sbjct: 240 TFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTY 299

Query: 249 INLEILFISRNMLECEILSTLGSCI-----KLEQLKLGGNLFQGPIPLSLSSLRGLRVLD 303
               +  +    ++ ++       +     ++    L  +       +   S      L+
Sbjct: 300 SETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLN 359

Query: 304 LSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKNASAISVFGNS 355
            +QN  +  + +    L+ +Q L L  N L+       + KN S++     S
Sbjct: 360 FTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVS 411

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 74.1 bits (182), Expect = 7e-14
 Identities = 52/325 (16%), Positives = 100/325 (30%), Gaps = 19/325 (5%)

Query: 18  FTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNC 77
             +PN   L L F+  +        + + L   Q+++  L  E                 
Sbjct: 191 LQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPT 250

Query: 78  NQHLKHLDINNNN------FGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQ 131
             ++    I          F    P  +   +I    L                   +L 
Sbjct: 251 LLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNI--YNLTITERIDREEFTYSETALKSLM 308

Query: 132 TLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVS 191
             H+ +     +          +    ++ +           +      L   +N    S
Sbjct: 309 IEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDS 368

Query: 192 IPSSLGQCQSLTTINLSYNNLSGTIPP---QLMDLTSLSVGLDLSRNQL-VGSLPTEVGK 247
           +       + L T+ L  N L            +++SL   LD+S N L   +       
Sbjct: 369 VFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLET-LDVSLNSLNSHAYDRTCAW 426

Query: 248 LINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQN 307
             ++ +L +S NML   +   L    K++ L L  N     IP  ++ L+ L+ L+++ N
Sbjct: 427 AESILVLNLSSNMLTGSVFRCLPP--KVKVLDLHNNRIMS-IPKDVTHLQALQELNVASN 483

Query: 308 NISGEIPK-FLVELQLVQNLNLSYN 331
            +   +P      L  +Q + L  N
Sbjct: 484 QLK-SVPDGVFDRLTSLQYIWLHDN 507

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 71.1 bits (174), Expect = 7e-13
 Identities = 48/274 (17%), Positives = 95/274 (34%), Gaps = 38/274 (13%)

Query: 94  LLPGCICNFSITLETLIFNSNKIFRSIPAGI----------------------GKFINLQ 131
           L+ G +  FS  LE+++  SN+    +P  +                           L+
Sbjct: 20  LIVGSMTPFSNELESMVDYSNRNLTHVPKDLPPRTKALSLSQNSISELRMPDISFLSELR 79

Query: 132 TLHMWDNQLSGTISPAI-GELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQV 190
            L +  N++  ++   +    Q+L  L ++ N+L  NI      +  L  L L  N    
Sbjct: 80  VLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQ-NISC--CPMASLRHLDLSFNDFD- 134

Query: 191 SIPSS--LGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKL 248
            +P     G    LT + LS           +  L    + LDL    +     TE  ++
Sbjct: 135 VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHI-KGGETESLQI 193

Query: 249 INLEILFISRN------MLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVL 302
            N  +L +  +      +     ++ L   ++L  +KL     Q  +       RG  +L
Sbjct: 194 PNTTVLHLVFHPNSLFSVQVNMSVNAL-GHLQLSNIKLNDENCQRLMTFLSELTRGPTLL 252

Query: 303 DLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGV 336
           +++  +I       +   Q      + Y ++  +
Sbjct: 253 NVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNL 286

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 80.3 bits (198), Expect = 2e-16
 Identities = 51/271 (18%), Positives = 88/271 (32%), Gaps = 74/271 (27%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA-ECSALRNIRHKNLVKILTVCSGV 469
           G FG V++          A+K + L +   ++  +  E  AL  + H  +V+        
Sbjct: 17  GGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLET 76

Query: 470 DYKGDDF-------------------------------------------------KALV 480
             +                                                     K  +
Sbjct: 77  PPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYL 136

Query: 481 Y---EFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTA 537
           Y   +     +L++W++      +  E   CL+   +I      A A+++LH        
Sbjct: 137 YIQMQLCRKENLKDWMNRRCS-LEDREHGVCLHIFIQI------AEAVEFLH---SKGLM 186

Query: 538 HCDLKPSNVLLDHEMTAHVADFGLAKLL----------PPAHLQTSSIGVKGTIGYIAPA 587
           H DLKPSN+    +    V DFGL   +           P     +  G  GT  Y++P 
Sbjct: 187 HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP- 245

Query: 588 EYGLGSEVSINGDVYSYGILLLELMTRKRPS 618
           E   G+  S   D++S G++L EL+      
Sbjct: 246 EQIHGNNYSHKVDIFSLGLILFELLYSFSTQ 276

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 50/213 (23%), Positives = 94/213 (44%), Gaps = 28/213 (13%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           I  G+ G+VY  +       +A++ +NL      +  I E   +R  ++ N+V  L    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYL---- 83

Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
                GD+   +V E++  GSL + +              C++  Q   +  +   AL++
Sbjct: 84  DSYLVGDEL-WVVMEYLAGGSLTDVVTE-----------TCMDEGQIAAVCRECLQALEF 131

Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP- 586
           LH +      H D+K  N+LL  + +  + DFG    + P   + S+  + GT  ++AP 
Sbjct: 132 LHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPE 186

Query: 587 --AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
                  G +V    D++S GI+ +E++  + P
Sbjct: 187 VVTRKAYGPKV----DIWSLGIMAIEMIEGEPP 215

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 78.8 bits (195), Expect = 5e-16
 Identities = 59/212 (27%), Positives = 93/212 (43%), Gaps = 24/212 (11%)

Query: 411 GSFGSVYKGILDEGKT--IIAVKVLNLLH--HGASKSSIAECSALRNIR---HKNLVKIL 463
           G++G V+K   D       +A+K + +     G   S+I E + LR++    H N+V++ 
Sbjct: 22  GAYGKVFKAR-DLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLF 80

Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            VC+      +    LV+E +    L  +L  V       E  K +   Q       +  
Sbjct: 81  DVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDM-MFQ-------LLR 131

Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGY 583
            L +LH        H DLKP N+L+       +ADFGLA++       TS + V  T+ Y
Sbjct: 132 GLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV-V--TLWY 185

Query: 584 IAPAEYGLGSEVSINGDVYSYGILLLELMTRK 615
            AP E  L S  +   D++S G +  E+  RK
Sbjct: 186 RAP-EVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 78.4 bits (194), Expect = 6e-16
 Identities = 55/211 (26%), Positives = 99/211 (46%), Gaps = 26/211 (12%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGV 469
           G++ +VYKG+       +A+K + L    G   ++I E S ++ ++H+N+V++  V    
Sbjct: 16  GTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHT- 74

Query: 470 DYKGDDFKALVYEFMHN---GSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALK 526
               ++   LV+EFM N     ++      +     +   K     Q       +   L 
Sbjct: 75  ----ENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYF-QWQ-------LLQGLA 122

Query: 527 YLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL-PPAHLQTSSIGVKGTIGYIA 585
           + H +      H DLKP N+L++      + DFGLA+    P +  +S + V  T+ Y A
Sbjct: 123 FCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEV-V--TLWYRA 176

Query: 586 PAEYGLGSEV-SINGDVYSYGILLLELMTRK 615
           P +  +GS   S + D++S G +L E++T K
Sbjct: 177 P-DVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 78.5 bits (194), Expect = 7e-16
 Identities = 50/233 (21%), Positives = 92/233 (39%), Gaps = 42/233 (18%)

Query: 405 LCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIR-HKNLVKIL 463
           +  +  G +  V++ I       + VK+L  +     K    E   L N+R   N++ + 
Sbjct: 41  VRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLA 97

Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            +      +     ALV+E ++N   ++    ++  D          ++  I        
Sbjct: 98  DIVKDPVSRTP---ALVFEHVNNTDFKQLYQTLTDYD-------IRFYMYEI------LK 141

Query: 524 ALKYLHHDCQPTTA---HCDLKPSNVLLDHE-MTAHVADFGLAKLLPPAHLQTSSIGVKG 579
           AL Y H      +    H D+KP NV++DHE     + D+GLA+   P       +    
Sbjct: 142 ALDYCH------SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV---A 192

Query: 580 TIGYIAPAEYGLGSE---VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLH 629
           +  +  P E  +  +    S+  D++S G +L  ++ RK P    F G+ N  
Sbjct: 193 SRYFKGP-ELLVDYQMYDYSL--DMWSLGCMLASMIFRKEP---FFHGHDNYD 239

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 78.0 bits (193), Expect = 8e-16
 Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 31/211 (14%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSG 468
           G++G VYK   D    I+A+K + L     G   ++I E S L+ + H N+V ++ V   
Sbjct: 32  GTYGVVYKAK-DSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS 90

Query: 469 VDYKGDDFKALVYEFMHNGSLEEWL--HPVSGADKTVEAPKCLNFLQRINIAIDVACALK 526
                +    LV+EFM    L++ L  +     D  +   K     Q       +   + 
Sbjct: 91  -----ERCLTLVFEFMEK-DLKKVLDENKTGLQDSQI---KIY-LYQ-------LLRGVA 133

Query: 527 YLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL-PPAHLQTSSIGVKGTIGYIA 585
           + H        H DLKP N+L++ +    +ADFGLA+    P    T  + V  T+ Y A
Sbjct: 134 HCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEV-V--TLWYRA 187

Query: 586 PAEYGLGSEV-SINGDVYSYGILLLELMTRK 615
           P +  +GS+  S + D++S G +  E++T K
Sbjct: 188 P-DVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 77.8 bits (192), Expect = 1e-15
 Identities = 48/213 (22%), Positives = 87/213 (40%), Gaps = 28/213 (13%)

Query: 402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVK 461
                 I  GS G V           +AVK+++L      +    E   +R+ +H N+V+
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDV 521
           +          G++   ++ EF+  G+L + +               LN  Q   +   V
Sbjct: 107 MY----KSYLVGEEL-WVLMEFLQGGALTDIVS-----------QVRLNEEQIATVCEAV 150

Query: 522 ACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTI 581
             AL YLH        H D+K  ++LL  +    ++DFG    +     +  S  + GT 
Sbjct: 151 LQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTP 205

Query: 582 GYIAP---AEYGLGSEVSINGDVYSYGILLLEL 611
            ++AP   +     +EV    D++S GI+++E+
Sbjct: 206 YWMAPEVISRSLYATEV----DIWSLGIMVIEM 234

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 75.8 bits (187), Expect = 1e-15
 Identities = 38/237 (16%), Positives = 83/237 (35%), Gaps = 34/237 (14%)

Query: 101 NFSITLETLIFNSNKIFRSIPAGI-GKFINLQTLHMWDNQLSGTISP-AIGELQNLVTLA 158
           +   + +TL      + R+IP+       N+  +++  +     +   +   L  +  + 
Sbjct: 28  SLPPSTQTLKLIETHL-RTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIE 86

Query: 159 INTNKLSGNIPPSI-GNLKKLLQLYLIENFLQVSIP--SSLGQCQSLTTINLSYNNLSGT 215
           I   +    I P     L  L  L +    L+   P  + +        + ++ N    +
Sbjct: 87  IRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTS 145

Query: 216 IPPQ-LMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIK 274
           IP      L + ++ L L  N    S+         L+ +++++N      L+ +     
Sbjct: 146 IPVNAFQGLCNETLTLKLYNNGF-TSVQGYAFNGTKLDAVYLNKNKY----LTVIDK--- 197

Query: 275 LEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNIS---GEIPKFLVELQLVQNLNL 328
                   + F G     + S  G  +LD+SQ +++    +  + L EL       L
Sbjct: 198 --------DAFGG-----VYS--GPSLLDVSQTSVTALPSKGLEHLKELIARNTWTL 239

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 65.8 bits (161), Expect = 4e-12
 Identities = 37/251 (14%), Positives = 68/251 (27%), Gaps = 62/251 (24%)

Query: 20  LPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQ 79
            P+   L L    +   IPS  F            +NL                      
Sbjct: 30  PPSTQTLKLIETHLR-TIPSHAF------------SNLP--------------------- 55

Query: 80  HLKHLDINNNN---------FGGLLPGCICNFSITLETLIFNSNKIFRSIPAGI-GKFIN 129
           ++  + ++ +          F  L           +  +   + +    I      +   
Sbjct: 56  NISRIYVSIDVTLQQLESHSFYNLS---------KVTHIEIRNTRNLTYIDPDALKELPL 106

Query: 130 LQTLHMWDNQLSGTISP--AIGELQNLVTLAINTNKLSGNIPP-SIGNLKKLLQ-LYLIE 185
           L+ L +++  L         +        L I  N    +IP  +   L      L L  
Sbjct: 107 LKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYN 165

Query: 186 NFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQ-LMDLTSLSVGLDLSRNQLVGSLPTE 244
           N    S+         L  + L+ N     I       + S    LD+S+  +  +LP++
Sbjct: 166 NGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSK 223

Query: 245 V-GKLINLEIL 254
               L  L   
Sbjct: 224 GLEHLKELIAR 234

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 64.6 bits (158), Expect = 8e-12
 Identities = 34/188 (18%), Positives = 72/188 (38%), Gaps = 20/188 (10%)

Query: 167 NIPPSIGNLKKLLQLYLIENFLQVSIPS-SLGQCQSLTTINLSYNNLSGTIPPQL-MDLT 224
           ++PPS         L LIE  L+ +IPS +     +++ I +S +     +      +L+
Sbjct: 28  SLPPS------TQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLS 80

Query: 225 SLSVGLDLSRNQLVGSLPTEV-GKLINLEILFISRNMLEC-EILSTLGSCIKLEQLKLGG 282
            ++  +++   + +  +  +   +L  L+ L I    L+    L+ + S      L++  
Sbjct: 81  KVTH-IEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITD 139

Query: 283 NLFQGPIP----LSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIP 338
           N +   IP      L +      L L  N  +  +  +      +  + L+ N    VI 
Sbjct: 140 NPYMTSIPVNAFQGLCNE--TLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVID 196

Query: 339 TEGVFKNA 346
            +  F   
Sbjct: 197 -KDAFGGV 203

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 78.7 bits (194), Expect = 2e-15
 Identities = 57/229 (24%), Positives = 99/229 (43%), Gaps = 35/229 (15%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVK-VLNLLHHGA-SKSSIAECSALRNIRHKNLVKILTV 465
           I  G+ G V           +A+K +     +   +K +  E   ++ + HKN++ +L V
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 129

Query: 466 CSGVDYKGDDFKA--LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            +      ++F+   LV E M     +  L  V   +   E  +    L ++       C
Sbjct: 130 FT-PQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHE--RMSYLLYQM------LC 175

Query: 524 ALKYLHHDCQPTTA---HCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGT 580
            +K+LH      +A   H DLKPSN+++  + T  + DFGLA+    + + T  +    T
Sbjct: 176 GIKHLH------SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VT 226

Query: 581 IGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLH 629
             Y AP E  LG     N D++S G ++ E++  K    I+F G   + 
Sbjct: 227 RYYRAP-EVILGMGYKENVDIWSVGCIMGEMVRHK----ILFPGRDYID 270

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 77.7 bits (192), Expect = 2e-15
 Identities = 45/220 (20%), Positives = 84/220 (38%), Gaps = 33/220 (15%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTV-- 465
              G+FG+V  G        +A+K + +         +     L  + H N+V++ +   
Sbjct: 31  AGQGTFGTVQLGKEKSTGMSVAIKKV-IQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFY 89

Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
             G   + D +  +V E++      + LH         +       ++     +    ++
Sbjct: 90  TLGERDRRDIYLNVVMEYV-----PDTLHRCCRNYYRRQVAPPPILIKVFLFQL--IRSI 142

Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEM-TAHVADFGLAKLLPPAHLQTSSIGVKGTIGYI 584
             LH        H D+KP NVL++    T  + DFG AK L P+    +         YI
Sbjct: 143 GCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA---------YI 192

Query: 585 ------APAEYGLGSE---VSINGDVYSYGILLLELMTRK 615
                 AP E   G++    ++  D++S G +  E+M  +
Sbjct: 193 CSRYYRAP-ELIFGNQHYTTAV--DIWSVGCIFAEMMLGE 229

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 78.5 bits (194), Expect = 2e-15
 Identities = 65/355 (18%), Positives = 110/355 (30%), Gaps = 66/355 (18%)

Query: 19  TLPNLLFLSLGFNQITGVIPSSMFNA-----SKLEVFQVTSNNLTGEVPSEFGKATKAYC 73
           TLP L  L L  N +       +         +LE  Q+   +L+           +A  
Sbjct: 111 TLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRA-- 168

Query: 74  VQNCNQHLKHLDINNNNFGG----LLPGCICNFSITLETLIFNSNKI----FRSIPAGIG 125
                   K L ++NN+       +L   + +    LE L   S  +     R +   + 
Sbjct: 169 ----KPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVA 224

Query: 126 KFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIE 185
              +L+ L +  N+L          +  L    ++ +              +L  L++ E
Sbjct: 225 SKASLRELALGSNKLGDV------GMAELCPGLLHPSS-------------RLRTLWIWE 265

Query: 186 NFLQ----VSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDL-----TSLSVGLDLSRNQ 236
             +       +   L   +SL  ++L+ N L       L +        L   L +    
Sbjct: 266 CGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLES-LWVKSCS 324

Query: 237 L----VGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIK-----LEQLKLGGNLF-- 285
                     + + +   L  L IS N LE   +  L   +      L  L L       
Sbjct: 325 FTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSD 384

Query: 286 QGPIPLS--LSSLRGLRVLDLSQNNISGEIPKFLVEL-----QLVQNLNLSYNDL 333
                L+  L +   LR LDLS N +       LVE       L++ L L     
Sbjct: 385 SSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYW 439

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 72.7 bits (179), Expect = 1e-13
 Identities = 50/346 (14%), Positives = 98/346 (28%), Gaps = 58/346 (16%)

Query: 22  NLLFLSLGFNQIT--GVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQ 79
           ++  L +   +++             + +V ++    LT     +   A +       N 
Sbjct: 4   DIQSLDIQCEELSDARWAELLPLL-QQCQVVRLDDCGLTEARCKDISSALRV------NP 56

Query: 80  HLKHLDINNNNFGG----LLPGCICNFSITLETLIFNSNKI----FRSIPAGIGKFINLQ 131
            L  L++ +N  G      +   +   S  ++ L   +  +       + + +     LQ
Sbjct: 57  ALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQ 116

Query: 132 TLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVS 191
            LH+ DN L       + E        +   +L      +                    
Sbjct: 117 ELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASC---------------EP 161

Query: 192 IPSSLGQCQSLTTINLSYNNLSGT----IPPQLMDLTSLSVGLDLSRNQL----VGSLPT 243
           + S L        + +S N+++      +   L D       L L    +       L  
Sbjct: 162 LASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCG 221

Query: 244 EVGKLINLEILFISRNMLE-------CEILSTLGSCIKLEQLKLGGNLFQGP----IPLS 292
            V    +L  L +  N L        C  L  L    +L  L +            +   
Sbjct: 222 IVASKASLRELALGSNKLGDVGMAELCPGL--LHPSSRLRTLWIWECGITAKGCGDLCRV 279

Query: 293 LSSLRGLRVLDLSQNNISGEIPKFLVELQLVQN-----LNLSYNDL 333
           L +   L+ L L+ N +  E  + L E  L        L +     
Sbjct: 280 LRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSF 325

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 72.7 bits (179), Expect = 1e-13
 Identities = 61/380 (16%), Positives = 118/380 (31%), Gaps = 58/380 (15%)

Query: 20  LPNLLFLSLGFNQIT----GVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQ 75
           L     + L    +T      I S++     L    + SN L                +Q
Sbjct: 27  LQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCV-----LQGLQ 81

Query: 76  NCNQHLKHLDINNNNFGGLLPGCICN---FSITLETLIFNSNKI----FRSIPAGIGK-F 127
             +  ++ L + N    G   G + +      TL+ L  + N +     + +  G+    
Sbjct: 82  TPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQ 141

Query: 128 INLQTLHMWDNQLSGT----ISPAIGELQNLVTLAINTNKLSGNIPPSIG-----NLKKL 178
             L+ L +    LS      ++  +    +   L ++ N ++      +      +  +L
Sbjct: 142 CRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQL 201

Query: 179 LQLYLIENFLQ----VSIPSSLGQCQSLTTINLSYNNLSGT-----IPPQLMDLTSLSVG 229
             L L    +       +   +    SL  + L  N L         P  L   + L   
Sbjct: 202 EALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRT- 260

Query: 230 LDLSRNQL----VGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIK-----LEQLKL 280
           L +    +     G L   +    +L+ L ++ N L  E    L   +      LE L +
Sbjct: 261 LWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWV 320

Query: 281 GGNLF--QGPIPLS--LSSLRGLRVLDLSQNNISGEIPKFLVEL-----QLVQNLNLSYN 331
               F        S  L+  R L  L +S N +     + L +       +++ L L+  
Sbjct: 321 KSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADC 380

Query: 332 DLEGVIPTEGVFKNASAISV 351
           D    +        A+ +  
Sbjct: 381 D----VSDSSCSSLAATLLA 396

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 68.1 bits (167), Expect = 4e-12
 Identities = 51/297 (17%), Positives = 104/297 (35%), Gaps = 41/297 (13%)

Query: 78  NQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKI----FRSIPAGIGKFINLQTL 133
           +  ++ LDI            +       + +  +   +     + I + +     L  L
Sbjct: 2   SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 61

Query: 134 HMWDNQLSGTISPAIGEL-----QNLVTLAINTNKLS----GNIPPSIGNLKKLLQLYLI 184
           ++  N+L       + +        +  L++    L+    G +  ++  L  L +L+L 
Sbjct: 62  NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLS 121

Query: 185 ENFLQVS----IPSSLGQCQS-LTTINLSYNNLSGT----IPPQLMDLTSLSVGLDLSRN 235
           +N L  +    +   L   Q  L  + L Y +LS      +   L         L +S N
Sbjct: 122 DNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKE-LTVSNN 180

Query: 236 QLVGSLPTEVGKLI-----NLEILFISRNMLE---CEILST-LGSCIKLEQLKLGGNLF- 285
            +  +    + + +      LE L +    +    C  L   + S   L +L LG N   
Sbjct: 181 DINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLG 240

Query: 286 -QGPIPLS---LSSLRGLRVLDLSQNNISGE----IPKFLVELQLVQNLNLSYNDLE 334
             G   L    L     LR L + +  I+ +    + + L   + ++ L+L+ N+L 
Sbjct: 241 DVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELG 297

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 77.4 bits (191), Expect = 2e-15
 Identities = 33/104 (31%), Positives = 46/104 (44%), Gaps = 18/104 (17%)

Query: 521 VACALKYLH-HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKG 579
           +  AL YL          H D+KP N+LLD     H+ DF +A +LP     T+   + G
Sbjct: 124 LVMALDYLQNQR----IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT---MAG 176

Query: 580 TIGYIAP------AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
           T  Y+AP         G    V    D +S G+   EL+  +RP
Sbjct: 177 TKPYMAPEMFSSRKGAGYSFAV----DWWSLGVTAYELLRGRRP 216

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 76.2 bits (188), Expect = 3e-15
 Identities = 58/227 (25%), Positives = 93/227 (40%), Gaps = 43/227 (18%)

Query: 402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSI-AECSALRNIRHKNLV 460
           F  L  I  GSFG V+KGI +  + ++A+K+++L         I  E + L       + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 461 KILTVCSGVDYKGDDFKA----LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRIN 516
           K         Y G   K     ++ E++  GS  + L P                L    
Sbjct: 84  K---------YYGSYLKDTKLWIIMEYLGGGSALDLLEP--------------GPLDETQ 120

Query: 517 IAI---DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTS 573
           IA    ++   L YLH +      H D+K +NVLL       +ADFG+A  L    ++ +
Sbjct: 121 IATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN 177

Query: 574 SIGVKGTIGYIAP---AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
           +    GT  ++AP    +    S+     D++S GI  +EL   + P
Sbjct: 178 T--FVGTPFWMAPEVIKQSAYDSKA----DIWSLGITAIELARGEPP 218

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 75.6 bits (187), Expect = 3e-15
 Identities = 60/209 (28%), Positives = 94/209 (44%), Gaps = 27/209 (12%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSG 468
           G++G VYK   +      A+K + L     G   ++I E S L+ ++H N+VK+  V   
Sbjct: 13  GTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT 71

Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL 528
                     LV+E +    L++ L    G  ++V A K    LQ +         + Y 
Sbjct: 72  -----KKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTA-KSF-LLQLL-------NGIAYC 116

Query: 529 HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL-PPAHLQTSSIGVKGTIGYIAPA 587
           H        H DLKP N+L++ E    +ADFGLA+    P    T  I V  T+ Y AP 
Sbjct: 117 HDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEI-V--TLWYRAP- 169

Query: 588 EYGLGSEV-SINGDVYSYGILLLELMTRK 615
           +  +GS+  S   D++S G +  E++   
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 76.1 bits (188), Expect = 4e-15
 Identities = 59/213 (27%), Positives = 94/213 (44%), Gaps = 24/213 (11%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLH-----HGASKSSIAECSALRNIR---HKNLVKI 462
           G++G+VYK         +A+K + + +      G   S++ E + LR +    H N+V++
Sbjct: 20  GAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRL 79

Query: 463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVA 522
           + VC+      +    LV+E +    L  +L          E  K L   Q         
Sbjct: 80  MDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDL-MRQ-------FL 130

Query: 523 CALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIG 582
             L +LH +C     H DLKP N+L+    T  +ADFGLA++       T  + V  T+ 
Sbjct: 131 RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVV-V--TLW 184

Query: 583 YIAPAEYGLGSEVSINGDVYSYGILLLELMTRK 615
           Y AP E  L S  +   D++S G +  E+  RK
Sbjct: 185 YRAP-EVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 77.4 bits (191), Expect = 4e-15
 Identities = 59/225 (26%), Positives = 95/225 (42%), Gaps = 49/225 (21%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVK-VLNLLHHGASKSSIAECSALRNIRHKNLVKILTV- 465
           I  GSFG VY+  L +   ++A+K VL        +    E   +R + H N+V++    
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRLRYFF 116

Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPV----SGADKTVEAPKCLNFLQRINIAIDV 521
            S  + K + +  LV +++      E ++ V    S A +T+       ++ ++      
Sbjct: 117 YSSGEKKDEVYLNLVLDYV-----PETVYRVARHYSRAKQTLPVIYVKLYMYQL------ 165

Query: 522 ACALKYLH-HDCQPTTAHCDLKPSNVLLDHEMTA-HVADFGLAKLLPPAHLQTSSIGVKG 579
             +L Y+H         H D+KP N+LLD +     + DFG AK L       S      
Sbjct: 166 FRSLAYIHSFGI----CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS------ 215

Query: 580 TIGYI------APAEYGLGSE---VSINGDVYSYGILLLELMTRK 615
              YI      AP E   G+     SI  DV+S G +L EL+  +
Sbjct: 216 ---YICSRYYRAP-ELIFGATDYTSSI--DVWSAGCVLAELLLGQ 254

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 77.1 bits (190), Expect = 4e-15
 Identities = 52/291 (17%), Positives = 90/291 (30%), Gaps = 57/291 (19%)

Query: 105 TLETLIFNSNKI----FRSIPAGIGKFINLQTLHMWDNQLSGT----ISPAIGELQNLVT 156
           ++E      + I     +S+ A + +  +++ + +  N +       +S  I   ++L  
Sbjct: 5   SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64

Query: 157 LAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGT- 215
              +              L+ LL               +L +C  L T+ LS N    T 
Sbjct: 65  AEFSDIFTGRVKDEIPEALRLLL--------------QALLKCPKLHTVRLSDNAFGPTA 110

Query: 216 ---IPPQLMDLTSLSVGLDLSRNQL-------------VGSLPTEVGKLINLEILFISRN 259
              +   L   T L   L L  N L               ++  +      L  +   RN
Sbjct: 111 QEPLIDFLSKHTPLEH-LYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRN 169

Query: 260 MLECE----ILSTLGSCIKLEQLKLGGNLF-----QGPIPLSLSSLRGLRVLDLSQNNIS 310
            LE         T  S   L  +K+  N       +  +   L+  + L+VLDL  N  +
Sbjct: 170 RLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT 229

Query: 311 GE----IPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKNASAISVFGNSKL 357
                 +   L     ++ L L+   L       G      A S   N  L
Sbjct: 230 HLGSSALAIALKSWPNLRELGLNDCLLS----ARGAAAVVDAFSKLENIGL 276

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 68.6 bits (168), Expect = 2e-12
 Identities = 53/332 (15%), Positives = 95/332 (28%), Gaps = 77/332 (23%)

Query: 78  NQHLKHLDINNNNFGGLLPGC--ICNF---SITLETLIFNSNKI----------FRSIPA 122
           +  +K + ++ N  G        +         LE   F+               R +  
Sbjct: 31  DDSVKEIVLSGNTIG--TEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQ 88

Query: 123 GIGKFINLQTLHMWDNQLSGT----ISPAIGELQNLVTLAINTNKLS------------- 165
            + K   L T+ + DN    T    +   + +   L  L ++ N L              
Sbjct: 89  ALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQE 148

Query: 166 GNIPPSIGNLKKLLQLYLIENFLQ----VSIPSSLGQCQSLTTINLSYNNL-----SGTI 216
             +     N   L  +    N L+         +    + L T+ +  N +        +
Sbjct: 149 LAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLL 208

Query: 217 PPQLMDLTSLSVGLDLSRNQL----VGSLPTEVGKLINLEILFISRNMLECEILSTLGSC 272
              L     L V LDL  N        +L   +    NL  L ++  +L        G+ 
Sbjct: 209 LEGLAYCQELKV-LDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSAR-----GAA 262

Query: 273 IKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVE-----LQLVQNLN 327
             ++      N              GL+ L L  N I  +  + L       +  +  L 
Sbjct: 263 AVVDAFSKLEN-------------IGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE 309

Query: 328 LSYNDL--EGVIPTEGVFKNASAISVFGNSKL 357
           L+ N    E     + V +     S  G  +L
Sbjct: 310 LNGNRFSEED----DVVDEIREVFSTRGRGEL 337

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 77.9 bits (191), Expect = 4e-15
 Identities = 48/221 (21%), Positives = 83/221 (37%), Gaps = 18/221 (8%)

Query: 106 LETLIFNSNKIFRSIPAGIGKFINLQTL---HMWDNQLSGTISPAIGELQNLVTLAINTN 162
           L     +  K    + + +     LQ L   + W       +  A+  L          +
Sbjct: 351 LFRCELSVEKSTV-LQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFS 409

Query: 163 KLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMD 222
            L    P     L  L   +L+EN           +   +  ++L++ +L  T+   L  
Sbjct: 410 TLKAVDPMRAAYLDDLRSKFLLEN------SVLKMEYADVRVLHLAHKDL--TVLCHLEQ 461

Query: 223 LTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGG 282
           L  ++  LDLS N+L  +LP  +  L  LE+L  S N LE   +  + +  +L++L L  
Sbjct: 462 LLLVTH-LDLSHNRLR-ALPPALAALRCLEVLQASDNALE--NVDGVANLPRLQELLLCN 517

Query: 283 NLFQG-PIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQL 322
           N  Q       L S   L +L+L  N++  +       L  
Sbjct: 518 NRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAE 557

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 69.4 bits (169), Expect = 2e-12
 Identities = 32/143 (22%), Positives = 54/143 (37%), Gaps = 13/143 (9%)

Query: 79  QHLKHLDINNNNFGGLLPGCICNFSITL-------ETLIFNSNKIFRSIPAGIGKFINLQ 131
             LK +D     +   L       +  L         L      +   +   + + + + 
Sbjct: 409 STLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL-TVLC-HLEQLLLVT 466

Query: 132 TLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFL-QV 190
            L +  N+L   + PA+  L+ L  L  + N L  N+   + NL +L +L L  N L Q 
Sbjct: 467 HLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQS 523

Query: 191 SIPSSLGQCQSLTTINLSYNNLS 213
           +    L  C  L  +NL  N+L 
Sbjct: 524 AAIQPLVSCPRLVLLNLQGNSLC 546

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 68.2 bits (166), Expect = 4e-12
 Identities = 35/209 (16%), Positives = 75/209 (35%), Gaps = 12/209 (5%)

Query: 129 NLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFL 188
           + Q   +                + L    ++  K +  +   + + K+L +L     + 
Sbjct: 326 DSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWC 384

Query: 189 QVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSL-SVGLDLSRNQLVGSLPTEVGK 247
            ++I   +     L     +    S      L  +  + +  LD  R++ +        +
Sbjct: 385 LLTIILLMRALDPLLYEKETLQYFS-----TLKAVDPMRAAYLDDLRSKFLLENSVLKME 439

Query: 248 LINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQN 307
             ++ +L ++   L    L  L   + +  L L  N  +  +P +L++LR L VL  S N
Sbjct: 440 YADVRVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDN 496

Query: 308 NISGEIPKFLVELQLVQNLNLSYNDLEGV 336
            +   +   +  L  +Q L L  N L+  
Sbjct: 497 ALE-NVDG-VANLPRLQELLLCNNRLQQS 523

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 67.1 bits (163), Expect = 1e-11
 Identities = 34/194 (17%), Positives = 60/194 (30%), Gaps = 19/194 (9%)

Query: 76  NCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKI--FRSIPAGIGKFINLQTL 133
             +  L+    +      L P         L T+I     +         +  F  L+ +
Sbjct: 359 EKSTVLQSELESCKELQELEP----ENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAV 414

Query: 134 -HMWDNQLSGTISPAIGELQNLVTLAINTNKL--SGNI---PPSIGNLKKLLQLYLIENF 187
             M    L    S  + E   L     +   L  +         +  L  +  L L  N 
Sbjct: 415 DPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVLCHLEQLLLVTHLDLSHNR 474

Query: 188 LQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPT--EV 245
           L+ ++P +L   + L  +  S N L   +   + +L  L   L L  N+L         +
Sbjct: 475 LR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQE-LLLCNNRL-QQSAAIQPL 529

Query: 246 GKLINLEILFISRN 259
                L +L +  N
Sbjct: 530 VSCPRLVLLNLQGN 543

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 47.4 bits (112), Expect = 1e-05
 Identities = 32/222 (14%), Positives = 62/222 (27%), Gaps = 31/222 (13%)

Query: 133 LHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSI 192
               ++QL       I    +     +                ++L +  L      V +
Sbjct: 306 AASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKSTV-L 364

Query: 193 PSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLE 252
            S L  C+ L  +         TI   +  L  L                  +     L+
Sbjct: 365 QSELESCKELQELEPENKWCLLTIILLMRALDPLL------------YEKETLQYFSTLK 412

Query: 253 ILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGE 312
            +   R     ++ S                       +       +RVL L+  +++  
Sbjct: 413 AVDPMRAAYLDDLRSKFLLEN----------------SVLKMEYADVRVLHLAHKDLT-V 455

Query: 313 IPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKNASAISVFGN 354
           +   L +L LV +L+LS+N L  + P     +    +    N
Sbjct: 456 LC-HLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDN 496

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 75.7 bits (187), Expect = 5e-15
 Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 25/208 (12%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGV 469
           G++ +VYKG       ++A+K + L H  GA  ++I E S L++++H N+V +  +    
Sbjct: 13  GTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT- 71

Query: 470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH 529
               +    LV+E++    L+++L             K     Q +         L Y H
Sbjct: 72  ----EKSLTLVFEYLDK-DLKQYLDDCGNIINMHNV-KLF-LFQLLR-------GLAYCH 117

Query: 530 HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL-PPAHLQTSSIGVKGTIGYIAPAE 588
                   H DLKP N+L++      +ADFGLA+    P     + + V  T+ Y  P +
Sbjct: 118 R---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEV-V--TLWYRPP-D 170

Query: 589 YGLGSEV-SINGDVYSYGILLLELMTRK 615
             LGS   S   D++  G +  E+ T +
Sbjct: 171 ILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 75.1 bits (185), Expect = 9e-15
 Identities = 49/235 (20%), Positives = 82/235 (34%), Gaps = 68/235 (28%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLN---LLHHGASKSSIA-----ECSALRNIRHKNLVKI 462
           G+FG V+  +  E    + VK +    +L     +         E + L  + H N++K+
Sbjct: 35  GAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKV 94

Query: 463 LTV--------------CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKC 508
           L +               SG     D F  +      +  L+E              P  
Sbjct: 95  LDIFENQGFFQLVMEKHGSG----LDLFAFID----RHPRLDE--------------PLA 132

Query: 509 LNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPA 568
               +++        A+ YL         H D+K  N+++  + T  + DFG A  L   
Sbjct: 133 SYIFRQL------VSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG 183

Query: 569 H-LQTSSIGVKGTIGYIAP-----AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
               T      GTI Y AP       Y  G E+    +++S G+ L  L+  + P
Sbjct: 184 KLFYTFC----GTIEYCAPEVLMGNPY-RGPEL----EMWSLGVTLYTLVFEENP 229

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 74.2 bits (183), Expect = 9e-15
 Identities = 51/228 (22%), Positives = 89/228 (39%), Gaps = 41/228 (17%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA-ECSALRNIRHKNLVKILTVCSGV 469
           G++G V   +    +  +AVK++++        +I  E    + + H+N+VK        
Sbjct: 18  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH---R 74

Query: 470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH 529
                 +  L  E+   G L + + P        +A +   F Q +         + YLH
Sbjct: 75  REGNIQY--LFLEYCSGGELFDRIEP-DIGMPEPDAQRF--FHQLM-------AGVVYLH 122

Query: 530 HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL----PPAHLQTSSIGVKGTIGYIA 585
                   H D+KP N+LLD      ++DFGLA +         L        GT+ Y+A
Sbjct: 123 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC----GTLPYVA 175

Query: 586 P-----AEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNL 628
           P      E+     V    DV+S GI+L  ++  + P    ++   + 
Sbjct: 176 PELLKRREF-HAEPV----DVWSCGIVLTAMLAGELP----WDQPSDS 214

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 74.7 bits (184), Expect = 1e-14
 Identities = 52/215 (24%), Positives = 85/215 (39%), Gaps = 34/215 (15%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA-ECSALRNIRHKNLVKILTVCSGV 469
           G+   V        K  +A+K +NL     S   +  E  A+    H N+V      S  
Sbjct: 26  GATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYY--TS-- 81

Query: 470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI---DVACALK 526
            +   D   LV + +  GS+ + +  +    +          L    IA    +V   L+
Sbjct: 82  -FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV-----LDESTIATILREVLEGLE 135

Query: 527 YLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIG---Y 583
           YLH + Q    H D+K  N+LL  + +  +ADFG++  L      T +   K  +G   +
Sbjct: 136 YLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192

Query: 584 IAPAEYGLGSEVSING-------DVYSYGILLLEL 611
           +AP       EV           D++S+GI  +EL
Sbjct: 193 MAP-------EVMEQVRGYDFKADIWSFGITAIEL 220

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 74.0 bits (182), Expect = 1e-14
 Identities = 50/257 (19%), Positives = 87/257 (33%), Gaps = 67/257 (26%)

Query: 96  PGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLV 155
           P C  +   +   +  +   +  ++P  +    +   LH+ +N L       +     L 
Sbjct: 2   PICEVSKVASHLEVNCDKRNL-TALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLT 58

Query: 156 TLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGT 215
            L ++  +L+       G L  L  L L  N LQ S+P       +LT +++S+N L+ +
Sbjct: 59  QLNLDRAELT--KLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-S 114

Query: 216 IPPQLMD-LTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIK 274
           +P   +  L  L   L L  N+L  +LP  +                             
Sbjct: 115 LPLGALRGLGELQE-LYLKGNELK-TLPPGL----------------------------- 143

Query: 275 LEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPK--F--LVELQLVQNLNLSY 330
                             L+    L  L L+ NN++ E+P      L  L     L L  
Sbjct: 144 ------------------LTPTPKLEKLSLANNNLT-ELPAGLLNGLENL---DTLLLQE 181

Query: 331 NDLEGVIPTEGVFKNAS 347
           N L  +   +G F +  
Sbjct: 182 NSLYTI--PKGFFGSHL 196

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 71.7 bits (176), Expect = 7e-14
 Identities = 46/231 (19%), Positives = 79/231 (34%), Gaps = 49/231 (21%)

Query: 20  LPNLLFLSLGFNQITGV---IPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQN 76
           + + L ++     +T +   +P          +  ++ N L     +     T       
Sbjct: 9   VASHLEVNCDKRNLTALPPDLPKD------TTILHLSENLLYTFSLATLMPYT------- 55

Query: 77  CNQHLKHLDINNNN------FGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINL 130
               L  L+++          G L           L TL  + N++ +S+P        L
Sbjct: 56  ---RLTQLNLDRAELTKLQVDGTL---------PVLGTLDLSHNQL-QSLPLLGQTLPAL 102

Query: 131 QTLHMWDNQLSGTISPAI-GELQNLVTLAINTNKLSGNIPPSI-GNLKKLLQLYLIENFL 188
             L +  N+L+ ++       L  L  L +  N+L   +PP +     KL +L L  N L
Sbjct: 103 TVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNL 160

Query: 189 QVSIPS----SLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRN 235
              +P+     L     L T+ L  N+L  TIP        L     L  N
Sbjct: 161 T-ELPAGLLNGLEN---LDTLLLQENSLY-TIPKGFFGSHLLPF-AFLHGN 205

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 73.4 bits (181), Expect = 2e-14
 Identities = 65/219 (29%), Positives = 97/219 (44%), Gaps = 38/219 (17%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLN---LLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           G+FG V  G        +AVK+LN   +           E   L+  RH +++K+  V  
Sbjct: 22  GTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQV-- 79

Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVS-GADKTVEAPKCLNFLQRINIAIDVACALK 526
            +    D F  +V E++  G L +++     G  + +EA +   F Q +        A+ 
Sbjct: 80  -ISTPTDFF--MVMEYVSGGELFDYI--CKHGRVEEMEARRL--FQQIL-------SAVD 125

Query: 527 YLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAH-LQTSSIGVKGTIGYIA 585
           Y H        H DLKP NVLLD  M A +ADFGL+ ++     L+TS     G+  Y A
Sbjct: 126 YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC----GSPNYAA 178

Query: 586 P-----AEYGLGSEVSINGDVYSYGILLLELMTRKRPSD 619
           P       Y  G EV    D++S G++L  L+    P D
Sbjct: 179 PEVISGRLY-AGPEV----DIWSCGVILYALLCGTLPFD 212

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 73.9 bits (182), Expect = 2e-14
 Identities = 51/228 (22%), Positives = 89/228 (39%), Gaps = 41/228 (17%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA-ECSALRNIRHKNLVKILTVCSGV 469
           G++G V   +    +  +AVK++++        +I  E    + + H+N+VK        
Sbjct: 18  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH---R 74

Query: 470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH 529
                 +  L  E+   G L + + P        +A +   F Q +         + YLH
Sbjct: 75  REGNIQY--LFLEYCSGGELFDRIEP-DIGMPEPDAQRF--FHQLM-------AGVVYLH 122

Query: 530 HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL----PPAHLQTSSIGVKGTIGYIA 585
                   H D+KP N+LLD      ++DFGLA +         L        GT+ Y+A
Sbjct: 123 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC----GTLPYVA 175

Query: 586 P-----AEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNL 628
           P      E+     V    DV+S GI+L  ++  + P    ++   + 
Sbjct: 176 PELLKRREF-HAEPV----DVWSCGIVLTAMLAGELP----WDQPSDS 214

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 73.8 bits (182), Expect = 3e-14
 Identities = 53/214 (24%), Positives = 94/214 (43%), Gaps = 32/214 (14%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSG 468
           G++G VYK I       +A+K + L H   G   ++I E S L+ ++H+N++++ +V   
Sbjct: 45  GTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH 104

Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL 528
                     L++E+  N  L++++      D ++   K     Q       +   + + 
Sbjct: 105 ---NHRLH--LIFEYAEN-DLKKYMD--KNPDVSMRVIKSF-LYQ-------LINGVNFC 148

Query: 529 HHDCQPTTAHCDLKPSNVLLDHEMTAH-----VADFGLAKLL-PPAHLQTSSIGVKGTIG 582
           H        H DLKP N+LL     +      + DFGLA+    P    T  I +  T+ 
Sbjct: 149 HS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEI-I--TLW 202

Query: 583 YIAPAEYGLGSEV-SINGDVYSYGILLLELMTRK 615
           Y  P E  LGS   S + D++S   +  E++ + 
Sbjct: 203 YRPP-EILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 73.4 bits (181), Expect = 3e-14
 Identities = 49/226 (21%), Positives = 86/226 (38%), Gaps = 42/226 (18%)

Query: 401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLN---LLHHGASKSSIAECSALRNIRHK 457
            F F   +  GSF +V            A+K+L    ++          E   +  + H 
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90

Query: 458 NLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINI 517
             VK+    +   ++ D+       +  NG L                   L ++++I  
Sbjct: 91  FFVKLY--FT---FQDDEKLYFGLSYAKNGEL-------------------LKYIRKIGS 126

Query: 518 ---------AIDVACALKYLH-HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPP 567
                      ++  AL+YLH         H DLKP N+LL+ +M   + DFG AK+L P
Sbjct: 127 FDETCTRFYTAEIVSALEYLHGKGI----IHRDLKPENILLNEDMHIQITDFGTAKVLSP 182

Query: 568 AHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT 613
              Q  +    GT  Y++P E         + D+++ G ++ +L+ 
Sbjct: 183 ESKQARANSFVGTAQYVSP-ELLTEKSACKSSDLWALGCIIYQLVA 227

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 74.2 bits (182), Expect = 3e-14
 Identities = 38/225 (16%), Positives = 74/225 (32%), Gaps = 44/225 (19%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSS--IAECSALRNIRHKNLVKILTVCSG 468
               +V           + V+ +NL        +    E    +   H N+V        
Sbjct: 38  EDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRAT--- 94

Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI---DVACAL 525
             +  D+   +V  FM  GS ++ +               ++ +  + IA     V  AL
Sbjct: 95  --FIADNELWVVTSFMAYGSAKDLIC-----------THFMDGMNELAIAYILQGVLKAL 141

Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK-----GT 580
            Y+HH       H  +K S++L+  +   +++       +     +   +          
Sbjct: 142 DYIHHMGY---VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKV 198

Query: 581 IGYIAPAEYGLGSEV---SING-----DVYSYGILLLELMTRKRP 617
           + +++P       EV   ++ G     D+YS GI   EL     P
Sbjct: 199 LPWLSP-------EVLQQNLQGYDAKSDIYSVGITACELANGHVP 236

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 73.1 bits (180), Expect = 3e-14
 Identities = 56/228 (24%), Positives = 86/228 (37%), Gaps = 39/228 (17%)

Query: 402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVK 461
           +  +  +  G+FG VYK    E   + A KV+        +  I E   L    H  +VK
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI-- 519
           +L    G  Y       ++ EF   G++             +E  + L   Q   I +  
Sbjct: 81  LL----GAYYHDGKL-WIMIEFCPGGAV---------DAIMLELDRGLTEPQ---IQVVC 123

Query: 520 -DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGL-AKLLPPAHLQTSSIGV 577
             +  AL +LH        H DLK  NVL+  E    +ADFG+ AK L     + S I  
Sbjct: 124 RQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-- 178

Query: 578 KGT--------IGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
            GT        +      +     +     D++S GI L+E+   + P
Sbjct: 179 -GTPYWMAPEVVMCETMKDTPYDYKA----DIWSLGITLIEMAQIEPP 221

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 74.8 bits (184), Expect = 4e-14
 Identities = 53/224 (23%), Positives = 88/224 (39%), Gaps = 30/224 (13%)

Query: 402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLN---LLHHGASKSSIAECSALRNIRHKN 458
           FL    +  G FG V+   +     + A K LN   L      + ++ E   L  +  + 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246

Query: 459 LVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIA 518
           +V  L       ++      LV   M+ G +   ++ V   +   + P+          A
Sbjct: 247 IVS-LAYA----FETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA-----IFYTA 296

Query: 519 IDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV--ADFGLAKLLPPAHLQTSSIG 576
             +   L++LH   Q    + DLKP NVLLD +   +V  +D GLA  L     +T    
Sbjct: 297 -QIVSGLEHLH---QRNIIYRDLKPENVLLDDD--GNVRISDLGLAVELKAGQTKTKGYA 350

Query: 577 VKGTIGYIAP---AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
             GT G++AP           V    D ++ G+ L E++  + P
Sbjct: 351 --GTPGFMAPELLLGEEYDFSV----DYFALGVTLYEMIAARGP 388

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 73.4 bits (181), Expect = 4e-14
 Identities = 52/237 (21%), Positives = 95/237 (40%), Gaps = 40/237 (16%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGA-SKSSIAECSALRNIRHKNLVKILTVC 466
           +  G++G V          I+A+K +        +  ++ E   L++ +H+N++ I  + 
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQ 78

Query: 467 SGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALK 526
               ++  +   ++ E M     +  LH V       +        Q +        A+K
Sbjct: 79  RPDSFENFNEVYIIQELM-----QTDLHRVISTQMLSDDHIQYFIYQTL-------RAVK 126

Query: 527 YLHHDCQPTTA---HCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTI-- 581
            LH       +   H DLKPSN+L++      V DFGLA+++  +    S    + +   
Sbjct: 127 VLH------GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180

Query: 582 GYI------APAEYGLGSE---VSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLH 629
            ++      AP E  L S     ++  DV+S G +L EL  R+     +F G    H
Sbjct: 181 EFVATRWYRAP-EVMLTSAKYSRAM--DVWSCGCILAELFLRR----PIFPGRDYRH 230

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 73.0 bits (180), Expect = 4e-14
 Identities = 52/212 (24%), Positives = 91/212 (42%), Gaps = 32/212 (15%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSG 468
           GS+G V K    +   I+A+K            K ++ E   L+ +RH+NLV +L VC  
Sbjct: 36  GSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK 95

Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL 528
              K   +  LV+EF+ + ++ + L         ++      +L +I         + + 
Sbjct: 96  ---KKRWY--LVFEFVDH-TILDDLELFPNG---LDYQVVQKYLFQI------INGIGFC 140

Query: 529 H-HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL-PPAHLQTSSIGVKGTIGYIAP 586
           H H+      H D+KP N+L+       + DFG A+ L  P  +    +    T  Y AP
Sbjct: 141 HSHNI----IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEV---ATRWYRAP 193

Query: 587 AEYGLGSEV---SINGDVYSYGILLLELMTRK 615
            E  +G      ++  DV++ G L+ E+   +
Sbjct: 194 -ELLVGDVKYGKAV--DVWAIGCLVTEMFMGE 222

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 74.1 bits (182), Expect = 5e-14
 Identities = 64/219 (29%), Positives = 96/219 (43%), Gaps = 38/219 (17%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLN---LLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           G+FG V  G  +     +AVK+LN   +           E   L+  RH +++K+  V  
Sbjct: 27  GTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQV-- 84

Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVS-GADKTVEAPKCLNFLQRINIAIDVACALK 526
            +    D F  +V E++  G L +++     G     E+ +     Q+I   +D      
Sbjct: 85  -ISTPSDIF--MVMEYVSGGELFDYI--CKNGRLDEKESRR---LFQQILSGVD------ 130

Query: 527 YLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAH-LQTSSIGVKGTIGYIA 585
           Y H        H DLKP NVLLD  M A +ADFGL+ ++     L+TS     G+  Y A
Sbjct: 131 YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC----GSPNYAA 183

Query: 586 P-----AEYGLGSEVSINGDVYSYGILLLELMTRKRPSD 619
           P       Y  G EV    D++S G++L  L+    P D
Sbjct: 184 PEVISGRLY-AGPEV----DIWSSGVILYALLCGTLPFD 217

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 71.8 bits (177), Expect = 8e-14
 Identities = 50/212 (23%), Positives = 89/212 (41%), Gaps = 32/212 (15%)

Query: 411 GSFGSVYKGILDEGKTIIAVK--VLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSG 468
           GS+G V+K    +   I+A+K  + +       K ++ E   L+ ++H NLV +L V   
Sbjct: 14  GSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR 73

Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL 528
              K      LV+E+  + ++   L       + V      +   +         A+ + 
Sbjct: 74  ---KRRLH--LVFEYCDH-TVLHEL---DRYQRGVPEHLVKSITWQT------LQAVNFC 118

Query: 529 H-HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP-PAHLQTSSIGVKGTIGYIAP 586
           H H+C     H D+KP N+L+       + DFG A+LL  P+      +    T  Y +P
Sbjct: 119 HKHNC----IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV---ATRWYRSP 171

Query: 587 AEYGLGSEV---SINGDVYSYGILLLELMTRK 615
            E  +G       +  DV++ G +  EL++  
Sbjct: 172 -ELLVGDTQYGPPV--DVWAIGCVFAELLSGV 200

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 71.9 bits (177), Expect = 9e-14
 Identities = 54/217 (24%), Positives = 91/217 (41%), Gaps = 35/217 (16%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTVCSG 468
           G+F  V           +A+K+++   L+  + +    E   ++ + H N+VK+  V   
Sbjct: 26  GNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV--- 82

Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL 528
           ++ +   +  L+ E+   G + ++L    G  K  EA       ++I        A++Y 
Sbjct: 83  IETEKTLY--LIMEYASGGEVFDYLVA-HGRMKEKEARS---KFRQI------VSAVQYC 130

Query: 529 HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAH-LQTSSIGVKGTIGYIAPA 587
           H        H DLK  N+LLD +M   +ADFG +        L        G   Y AP 
Sbjct: 131 HQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC----GAPPYAAPE 183

Query: 588 -----EYGLGSEVSINGDVYSYGILLLELMTRKRPSD 619
                +Y  G EV    DV+S G++L  L++   P D
Sbjct: 184 LFQGKKY-DGPEV----DVWSLGVILYTLVSGSLPFD 215

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 71.5 bits (176), Expect = 1e-13
 Identities = 57/253 (22%), Positives = 100/253 (39%), Gaps = 59/253 (23%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLN---LLHHGASKSSIA--------------------- 446
           GS+G V     +   T  A+KVL+   L+                               
Sbjct: 24  GSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQV 83

Query: 447 --ECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVE 504
             E + L+ + H N+VK++ V   +D   +D   +V+E ++ G + E         K + 
Sbjct: 84  YQEIAILKKLDHPNVVKLVEV---LDDPNEDHLYMVFELVNQGPVMEVP-----TLKPLS 135

Query: 505 APKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKL 564
             +   + Q      D+   ++YLH+       H D+KPSN+L+  +    +ADFG++  
Sbjct: 136 EDQARFYFQ------DLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186

Query: 565 LPP--AHLQTSSIGVKGTIGYIAPAEYGLGSEVSING---DVYSYGILLLELMTRKRPSD 619
                A L  +     GT  ++AP E    +    +G   DV++ G+ L   +  + P  
Sbjct: 187 FKGSDALLSNTV----GTPAFMAP-ESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP-- 239

Query: 620 IMFEGN--MNLHN 630
             F     M LH+
Sbjct: 240 --FMDERIMCLHS 250

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 72.2 bits (177), Expect = 1e-13
 Identities = 51/251 (20%), Positives = 82/251 (32%), Gaps = 56/251 (22%)

Query: 411 GSFGSVYKGILDEGKTIIAVKV-----LNLLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           GS+G V   I ++ + I A+K+     +  ++    +    E   ++ + H N+ ++  V
Sbjct: 37  GSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEV 96

Query: 466 CSGVDYKGDDFKALVYEFMHNGSL------------------------------EEWLHP 495
                Y+ + +  LV E  H G L                               E    
Sbjct: 97  -----YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAIN 151

Query: 496 VSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH 555
            S                  NI   +  AL YLH        H D+KP N L     +  
Sbjct: 152 GSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFE 208

Query: 556 V--ADFGLAKLLPPAHLQTSSI--GVKGTIGYIAP-----AEYGLGSEVSINGDVYSYGI 606
           +   DFGL+K     +           GT  ++AP          G +     D +S G+
Sbjct: 209 IKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC----DAWSAGV 264

Query: 607 LLLELMTRKRP 617
           LL  L+    P
Sbjct: 265 LLHLLLMGAVP 275

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 72.3 bits (178), Expect = 1e-13
 Identities = 66/266 (24%), Positives = 109/266 (40%), Gaps = 42/266 (15%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGA-SKSSIAECSALRNIRHKNLVKILTVC 466
           I  G++G V     +  K  +A+K ++   H    + ++ E   L   RH+N++ I  + 
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94

Query: 467 SGVDYKGDDFKA--LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
                  +  K   +V + M     E  L+ +           C    Q       +   
Sbjct: 95  RAPTI--EQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQ-------ILRG 140

Query: 525 LKYLHHDCQPTTA---HCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSI-GVKGT 580
           LKY+H      +A   H DLKPSN+LL+      + DFGLA++  P H  T  +     T
Sbjct: 141 LKYIH------SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194

Query: 581 IGYIAPAEYGLGS-EVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDH 639
             Y AP E  L S   + + D++S G +L E+++ +     +F G   L         +H
Sbjct: 195 RWYRAP-EIMLNSKGYTKSIDIWSVGCILAEMLSNR----PIFPGKHYLDQL------NH 243

Query: 640 VMDIVDSTLLADDEDLTITSNQRQRQ 665
           ++ I+ S      EDL    N + R 
Sbjct: 244 ILGILGS---PSQEDLNCIINLKARN 266

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 71.6 bits (176), Expect = 1e-13
 Identities = 56/235 (23%), Positives = 91/235 (38%), Gaps = 46/235 (19%)

Query: 402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA-ECSALRNI-RHKNL 459
           F  +  +  G++G VYKG   +   + A+KV+++   G  +  I  E + L+    H+N+
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV--TGDEEEEIKQEINMLKKYSHHRNI 83

Query: 460 VKILTVCSGVDYKGDDFKA-----LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQR 514
                   G   K +         LV EF   GS+ + +    G          L     
Sbjct: 84  ATYY----GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--------NTLKEEW- 130

Query: 515 INIAI---DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQ 571
             IA    ++   L +LH        H D+K  NVLL       + DFG++  L      
Sbjct: 131 --IAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL------ 179

Query: 572 TSSIGVKGT-IG---YIAPAEYGLGSEVSING-----DVYSYGILLLELMTRKRP 617
             ++G + T IG   ++AP E     E          D++S GI  +E+     P
Sbjct: 180 DRTVGRRNTFIGTPYWMAP-EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 70.5 bits (173), Expect = 1e-13
 Identities = 53/191 (27%), Positives = 81/191 (42%), Gaps = 14/191 (7%)

Query: 97  GCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVT 156
           GC CN     +  +    K   S+P+GI    + + L +    L+         L  L  
Sbjct: 9   GCTCNEG---KKEVDCQGKSLDSVPSGI--PADTEKLDLQSTGLATLSDATFRGLTKLTW 63

Query: 157 LAINTNKLSGNIPPSI-GNLKKLLQLYLIENFLQVSIPSSL-GQCQSLTTINLSYNNLSG 214
           L ++ N+L   +   +  +L +L  L L  N L  S+P  +      L  + L  N L  
Sbjct: 64  LNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK- 120

Query: 215 TIPPQLMD-LTSLSVGLDLSRNQLVGSLPTEV-GKLINLEILFISRNMLECEILSTLGSC 272
           ++P  + D LT L   L L+ NQL  S+P     KL NL+ L +S N L+          
Sbjct: 121 SLPSGVFDRLTKLKE-LRLNTNQL-QSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRL 178

Query: 273 IKLEQLKLGGN 283
            KL+ + L GN
Sbjct: 179 GKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 59.3 bits (144), Expect = 6e-10
 Identities = 49/165 (29%), Positives = 76/165 (46%), Gaps = 15/165 (9%)

Query: 107 ETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAI-GELQNLVTLAINTNKLS 165
           E L   S  +     A       L  L++  NQL  T+S  +  +L  L TL +  N+L+
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA 96

Query: 166 GNIPPSI-GNLKKLLQLYLIENFLQVSIPS----SLGQCQSLTTINLSYNNLSGTIPPQL 220
            ++P  +  +L +L +LYL  N L+ S+PS     L +   L  + L+ N L  +IP   
Sbjct: 97  -SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTK---LKELRLNTNQLQ-SIPAGA 150

Query: 221 MD-LTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECE 264
            D LT+L   L LS NQL         +L  L+ + +  N  +C 
Sbjct: 151 FDKLTNLQT-LSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 39/162 (24%), Positives = 67/162 (41%), Gaps = 13/162 (8%)

Query: 26  LSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLD 85
           L L    +  +  ++    +KL    +  N L       F   T+          L  L 
Sbjct: 40  LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTE----------LGTLG 89

Query: 86  INNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGI-GKFINLQTLHMWDNQLSGTI 144
           + NN    L  G + +    L+ L    N++ +S+P+G+  +   L+ L +  NQL    
Sbjct: 90  LANNQLASLPLG-VFDHLTQLDKLYLGGNQL-KSLPSGVFDRLTKLKELRLNTNQLQSIP 147

Query: 145 SPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIEN 186
           + A  +L NL TL+++TN+L      +   L KL  + L  N
Sbjct: 148 AGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 42/147 (28%), Positives = 65/147 (44%), Gaps = 19/147 (12%)

Query: 20  LPNLLFLSLGFNQITGVIPSSMFNA-SKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCN 78
           L  L +L+L +NQ+   + + +F+  ++L    + +N L       F   T+        
Sbjct: 58  LTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQ-------- 108

Query: 79  QHLKHLDINNNNFGGLLPGCICNF-SIT-LETLIFNSNKIFRSIPAGI-GKFINLQTLHM 135
             L  L +  N    L  G    F  +T L+ L  N+N++ +SIPAG   K  NLQTL +
Sbjct: 109 --LDKLYLGGNQLKSLPSGV---FDRLTKLKELRLNTNQL-QSIPAGAFDKLTNLQTLSL 162

Query: 136 WDNQLSGTISPAIGELQNLVTLAINTN 162
             NQL      A   L  L T+ +  N
Sbjct: 163 STNQLQSVPHGAFDRLGKLQTITLFGN 189

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 71.5 bits (176), Expect = 1e-13
 Identities = 60/227 (26%), Positives = 94/227 (41%), Gaps = 55/227 (24%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLN---LLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           GSFG V      + +  +A+K ++   L           E S L+ +RH +++K+  V  
Sbjct: 20  GSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDV-- 77

Query: 468 GVDYKGDDFKALVYEF---------MHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIA 518
            +    D    +V E+         +    + E            E  +   F Q I   
Sbjct: 78  -ITTPTDIV--MVIEYAGGELFDYIVEKKRMTE-----------DEGRRF--FQQII--- 118

Query: 519 IDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAH-LQTSSIGV 577
               CA++Y H        H DLKP N+LLD  +   +ADFGL+ ++   + L+TS    
Sbjct: 119 ----CAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC--- 168

Query: 578 KGTIGYIAP-----AEYGLGSEVSINGDVYSYGILLLELMTRKRPSD 619
            G+  Y AP       Y  G EV    DV+S GI+L  ++  + P D
Sbjct: 169 -GSPNYAAPEVINGKLY-AGPEV----DVWSCGIVLYVMLVGRLPFD 209

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 71.4 bits (175), Expect = 2e-13
 Identities = 43/205 (20%), Positives = 67/205 (32%), Gaps = 40/205 (19%)

Query: 113 SNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSI 172
           S +   ++P  +        L +  N LS                          +    
Sbjct: 26  SKQQLPNVPQSL--PSYTALLDLSHNNLS-------------------------RLRAEW 58

Query: 173 --GNLKKLLQLYLIENFLQVSIPS-SLGQCQSLTTINLSYNNLSGTIPPQ-LMDLTSLSV 228
               L  L  L L  N L   I S +     +L  ++LS N+L  T+      DL +L V
Sbjct: 59  TPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEV 116

Query: 229 GLDLSRNQLVGSLPTEV-GKLINLEILFISRNMLEC---EILSTLGSCIKLEQLKLGGNL 284
            L L  N +V  +       +  L+ L++S+N +     E++       KL  L L  N 
Sbjct: 117 -LLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNK 174

Query: 285 FQGPIPLSLSSLRGLRVLDLS-QNN 308
            +      L  L       L   NN
Sbjct: 175 LKKLPLTDLQKLPAWVKNGLYLHNN 199

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 56.4 bits (136), Expect = 1e-08
 Identities = 38/172 (22%), Positives = 66/172 (38%), Gaps = 27/172 (15%)

Query: 26  LSLGFNQITGVIPSSMF-NASKLEVFQVTSNNLTGEVPSE-FGKATKAYCVQNCNQHLKH 83
           L L  N ++ +         + L    ++ N+L   + SE F               L++
Sbjct: 44  LDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPN----------LRY 92

Query: 84  LDINNNNFGGLLPGCICNFS--ITLETLIFNSNKIFRSIPAGI-GKFINLQTLHMWDNQL 140
           LD+++N+   L       FS    LE L+  +N I   +          LQ L++  NQ+
Sbjct: 93  LDLSSNHLHTLDEFL---FSDLQALEVLLLYNNHI-VVVDRNAFEDMAQLQKLYLSQNQI 148

Query: 141 SGTISP----AIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQ--LYLIEN 186
           S            +L  L+ L +++NKL       +  L   ++  LYL  N
Sbjct: 149 S-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 56.0 bits (135), Expect = 2e-08
 Identities = 40/164 (24%), Positives = 64/164 (39%), Gaps = 36/164 (21%)

Query: 191 SIPSSLGQCQSLTTINLSYNNLSGTIPPQ--LMDLTSLSVGLDLSRNQLVGSLPTEV-GK 247
           ++P SL        ++LS+NNLS  +  +     LT+L   L LS N L   + +E    
Sbjct: 32  NVPQSLPS--YTALLDLSHNNLS-RLRAEWTPTRLTNLHS-LLLSHNHL-NFISSEAFVP 86

Query: 248 LINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQN 307
           + NL  L +S N L                  L   LF          L+ L VL L  N
Sbjct: 87  VPNLRYLDLSSNHLH----------------TLDEFLFSD--------LQALEVLLLYNN 122

Query: 308 NISGEIPKF-LVELQLVQNLNLSYNDLEGVIPTEGVFKNASAIS 350
           +I   + +    ++  +Q L LS N +        + K+ + + 
Sbjct: 123 HIV-VVDRNAFEDMAQLQKLYLSQNQISRFPV--ELIKDGNKLP 163

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 55.2 bits (133), Expect = 4e-08
 Identities = 33/163 (20%), Positives = 56/163 (34%), Gaps = 24/163 (14%)

Query: 12  IPLDFGFT-LPNLLFLSLGFNQITGVIPSSMF-NASKLEVFQVTSNNLTGEVPSE-FGKA 68
           +  ++  T L NL  L L  N +   I S  F     L    ++SN+L   +    F   
Sbjct: 54  LRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDL 111

Query: 69  TKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGI---- 124
                       L+ L + NN+   +      + +  L+ L  + N+I    P  +    
Sbjct: 112 QA----------LEVLLLYNNHIVVVDRNAFEDMA-QLQKLYLSQNQI-SRFPVELIKDG 159

Query: 125 GKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGN 167
            K   L  L +  N+L       + +L   V   +    L  N
Sbjct: 160 NKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY---LHNN 199

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 70.8 bits (174), Expect = 2e-13
 Identities = 49/234 (20%), Positives = 77/234 (32%), Gaps = 62/234 (26%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLN---LLHHGASKSSIA---ECSALRNIRHK--NLVKI 462
           G FGSVY GI       +A+K +    +   G   +      E   L+ +      ++++
Sbjct: 54  GGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL 113

Query: 463 LTVCSGVDYKGDDFKALVYEF-----------MHNGSLEEWLHPVSGADKTVEAPKCLNF 511
           L      +        L+ E               G+L+E             A     F
Sbjct: 114 LDW---FERPDSFV--LILERPEPVQDLFDFITERGALQE-----------ELARSF--F 155

Query: 512 LQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHE-MTAHVADFGLAKLLPPAHL 570
            Q       V  A+++ H+       H D+K  N+L+D       + DFG   LL     
Sbjct: 156 WQ-------VLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 205

Query: 571 QTSSIGVKGTIGYIAP-----AEYGLGSEVSINGDVYSYGILLLELMTRKRPSD 619
                   GT  Y  P       Y  G        V+S GILL +++    P +
Sbjct: 206 TDFD----GTRVYSPPEWIRYHRY-HGRSA----AVWSLGILLYDMVCGDIPFE 250

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 71.1 bits (175), Expect = 2e-13
 Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 37/216 (17%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHH-----GASKSSIAECSALRNIRHKNLVKILTV 465
           G F +VYK        I+A+K + L H      G +++++ E   L+ + H N++ +L  
Sbjct: 21  GQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDA 80

Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWL--HPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
                       +LV++FM    LE  +  + +      +   K    L           
Sbjct: 81  FGH-----KSNISLVFDFMET-DLEVIIKDNSLVLTPSHI---KAY-MLM-------TLQ 123

Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL-PPAHLQTSSIGVKGTIG 582
            L+YLH        H DLKP+N+LLD      +ADFGLAK    P    T  + V  T  
Sbjct: 124 GLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-V--TRW 177

Query: 583 YIAPAEYGLGSE---VSINGDVYSYGILLLELMTRK 615
           Y AP E   G+    V +  D+++ G +L EL+ R 
Sbjct: 178 YRAP-ELLFGARMYGVGV--DMWAVGCILAELLLRV 210

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 70.3 bits (173), Expect = 3e-13
 Identities = 53/220 (24%), Positives = 80/220 (36%), Gaps = 60/220 (27%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G+F  V+         + A+K +         S   E + L+ I+H+N+V +  +     
Sbjct: 20  GAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI----- 74

Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRI------------NIA 518
           Y+      LV + +  G L                        RI             + 
Sbjct: 75  YESTTHYYLVMQLVSGGEL----------------------FDRILERGVYTEKDASLVI 112

Query: 519 IDVACALKYLHHDCQPTTAHCDLKPSNVLL-DHEMTAHV--ADFGLAKLLPPAHLQTSSI 575
             V  A+KYLH   +    H DLKP N+L    E  + +   DFGL+K+     + T   
Sbjct: 113 QQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST--- 166

Query: 576 GVKGTIGYIAP---AEYGLGSEVSINGDVYSYG----ILL 608
              GT GY+AP   A+      V    D +S G    ILL
Sbjct: 167 -ACGTPGYVAPEVLAQKPYSKAV----DCWSIGVITYILL 201

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 70.7 bits (174), Expect = 3e-13
 Identities = 54/222 (24%), Positives = 99/222 (44%), Gaps = 40/222 (18%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHH---GASKSSIAECSALRNIRHKNLVKILTVCS 467
           G+FG V+K    +    +A+K + L+ +   G   +++ E   L+ ++H+N+V ++ +C 
Sbjct: 28  GTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITALREIKILQLLKHENVVNLIEICR 86

Query: 468 GVDYKGDDFKA---LVYEFMHN---GSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDV 521
                 +  K    LV++F  +   G L   L   + ++      K +     +N     
Sbjct: 87  TKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI-----KRV-MQMLLN----- 135

Query: 522 ACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL-PPAHLQ----TSSIG 576
              L Y+H +      H D+K +NVL+  +    +ADFGLA+      + Q    T+ + 
Sbjct: 136 --GLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV- 189

Query: 577 VKGTIGYIAPAEYGLGSE---VSINGDVYSYGILLLELMTRK 615
           V  T+ Y  P E  LG       I  D++  G ++ E+ TR 
Sbjct: 190 V--TLWYRPP-ELLLGERDYGPPI--DLWGAGCIMAEMWTRS 226

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 70.6 bits (173), Expect = 3e-13
 Identities = 52/327 (15%), Positives = 108/327 (33%), Gaps = 33/327 (10%)

Query: 1   SDVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMF-NASKLEVFQVTSNNLTG 59
            +  V  +   +P        N + L     ++  VI    F     LE  +++ N++  
Sbjct: 17  QESKVTEIPSDLP-------RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLE 68

Query: 60  EVPSE-FGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFR 118
            + ++ F    K          L  + I   N    +          L+ L+ ++  I +
Sbjct: 69  VIEADVFSNLPK----------LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGI-K 117

Query: 119 SIPAGIGKF-INLQTLHMWDNQLSGTISPAI--GELQNLVTLAINTNKLSGNIPPSIGNL 175
            +P       +    L + DN    TI      G     V L +N N +   I  S  N 
Sbjct: 118 HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNG 176

Query: 176 KKLLQLYLIE-NFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQ-LMDLTSLSVGLDLS 233
            +L +L L + N L+               +++S   +  ++P   L +L  L       
Sbjct: 177 TQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRA-RSTY 234

Query: 234 RNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSL 293
             + + +L     KL+ L    ++     C   +      +L  +     L Q    ++ 
Sbjct: 235 NLKKLPTL----EKLVALMEASLTYPSHCCAFANWRRQISELHPICNKSILRQEVDYMTQ 290

Query: 294 SSLRGLRVLDLSQNNISGEIPKFLVEL 320
           +  +   + + ++++ S        E 
Sbjct: 291 ARGQRSSLAEDNESSYSRGFDMTYTEF 317

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 58.3 bits (141), Expect = 4e-09
 Identities = 39/190 (20%), Positives = 70/190 (36%), Gaps = 15/190 (7%)

Query: 167 NIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQ-LMDLTS 225
           ++P +       ++L  +   L+V    +      L  I +S N++   I      +L  
Sbjct: 27  DLPRN------AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80

Query: 226 LSVGLDLSR-NQLVGSLPTEV-GKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGN 283
           L   + + + N L+  +  E    L NL+ L IS   ++          ++   L +  N
Sbjct: 81  LHE-IRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDN 138

Query: 284 LFQGPIP-LSLSSLRG-LRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEG 341
           +    I   S   L     +L L++N I           QL +      N+LE  +P   
Sbjct: 139 INIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLE-ELP-ND 196

Query: 342 VFKNASAISV 351
           VF  AS   +
Sbjct: 197 VFHGASGPVI 206

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 70.8 bits (174), Expect = 3e-13
 Identities = 58/266 (21%), Positives = 107/266 (40%), Gaps = 47/266 (17%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           +  G++GSV   I       +A+K L+        +K +  E   L++++H+N++ +L V
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91

Query: 466 CSGVDYKGDDFKA--LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            +       +F    LV  FM     +  L  + G   + E  K    + ++        
Sbjct: 92  FT-PASSLRNFYDFYLVMPFM-----QTDLQKIMGLKFSEE--KIQYLVYQM------LK 137

Query: 524 ALKYLHHDCQPTTA---HCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGT 580
            LKY+H      +A   H DLKP N+ ++ +    + DFGLA+     H      G   T
Sbjct: 138 GLKYIH------SAGVVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVT 186

Query: 581 IGYIAPAEYGLGS-EVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDH 639
             Y AP E  L     +   D++S G ++ E++T K     +F+G   L           
Sbjct: 187 RWYRAP-EVILSWMHYNQTVDIWSVGCIMAEMLTGK----TLFKGKDYLDQL------TQ 235

Query: 640 VMDIVDSTLLADDEDLTITSNQRQRQ 665
           ++ +         E +   +++  + 
Sbjct: 236 ILKVTGV---PGTEFVQKLNDKAAKS 258

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 70.1 bits (172), Expect = 4e-13
 Identities = 62/220 (28%), Positives = 93/220 (42%), Gaps = 42/220 (19%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           +  GS+GSVYK I  E   I+A+K + +      +  I E S ++     ++VK      
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPV--ESDLQEIIKEISIMQQCDSPHVVK------ 88

Query: 468 GVDYKGDDFKA----LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI---D 520
              Y G  FK     +V E+   GS+         +D      K L   +   IA     
Sbjct: 89  ---YYGSYFKNTDLWIVMEYCGAGSV---------SDIIRLRNKTLTEDE---IATILQS 133

Query: 521 VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGT 580
               L+YLH        H D+K  N+LL+ E  A +ADFG+A  L     + ++  V GT
Sbjct: 134 TLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGT 188

Query: 581 IGYIAP---AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
             ++AP    E G         D++S GI  +E+   K P
Sbjct: 189 PFWMAPEVIQEIGYNCVA----DIWSLGITAIEMAEGKPP 224

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 70.0 bits (172), Expect = 4e-13
 Identities = 52/237 (21%), Positives = 97/237 (40%), Gaps = 38/237 (16%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTV-- 465
           +  G  G V+  + ++    +A+K + L    + K ++ E   +R + H N+VK+  +  
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78

Query: 466 -----CSGVDYKGDDFKA--LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIA 518
                 +       +  +  +V E+M     E  L  V      +E    L   Q     
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLLEEHARLFMYQ----- 128

Query: 519 IDVACALKYLHHDCQPTTA---HCDLKPSNVLLDHE-MTAHVADFGLAKLLPPAHLQTSS 574
             +   LKY+H      +A   H DLKP+N+ ++ E +   + DFGLA+++ P +     
Sbjct: 129 --LLRGLKYIH------SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGH 180

Query: 575 I-GVKGTIGYIAPAEYGLGS-EVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLH 629
           +     T  Y +P    L     +   D+++ G +  E++T K     +F G   L 
Sbjct: 181 LSEGLVTKWYRSP-RLLLSPNNYTKAIDMWAAGCIFAEMLTGK----TLFAGAHELE 232

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 70.4 bits (173), Expect = 5e-13
 Identities = 59/266 (22%), Positives = 107/266 (40%), Gaps = 46/266 (17%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLL--HHGASKSSIAECSALRNIRHKNLVKILTV 465
           +  G++GSV      +    +AVK L+        +K +  E   L++++H+N++ +L V
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96

Query: 466 CSGVDYKGDDFKA--LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            +      ++F    LV   M        L+ +    K  +        Q +        
Sbjct: 97  FT-PARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDDHVQFLIYQIL-------R 143

Query: 524 ALKYLHHDCQPTTA---HCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGT 580
            LKY+H      +A   H DLKPSN+ ++ +    + DFGLA+        T  +    T
Sbjct: 144 GLKYIH------SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE--MTGYV---AT 192

Query: 581 IGYIAPAEYGLGS-EVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDH 639
             Y AP E  L     +   D++S G ++ EL+T +     +F G  ++           
Sbjct: 193 RWYRAP-EIMLNWMHYNQTVDIWSVGCIMAELLTGR----TLFPGTDHIDQL------KL 241

Query: 640 VMDIVDSTLLADDEDLTITSNQRQRQ 665
           ++ +V +      E L   S++  R 
Sbjct: 242 ILRLVGT---PGAELLKKISSESARN 264

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 70.0 bits (172), Expect = 5e-13
 Identities = 56/277 (20%), Positives = 100/277 (36%), Gaps = 57/277 (20%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA-----------ECSALRNIRH 456
           I  GS+G+V  G+ D     +A+K +          +I            E   L +  H
Sbjct: 30  ISSGSYGAVCAGV-DSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88

Query: 457 KNLVKILTVCSGVDYKGDDFKA--LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFL-- 512
            N++ +  +   V ++        LV E M        L  V    + V +P+ + +   
Sbjct: 89  PNILGLRDIF--VHFEEPAMHKLYLVTELM-----RTDLAQVIHDQRIVISPQHIQYFMY 141

Query: 513 QRINIAIDVACALKYLHHDCQPTTA---HCDLKPSNVLLDHEMTAHVADFGLAKLLPPAH 569
                   +   L  LH       A   H DL P N+LL       + DF LA+      
Sbjct: 142 H-------ILLGLHVLH------EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADA 188

Query: 570 LQTSSIGVKGTIGYIAPAEYGLGS-EVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNL 628
            +T  +       Y AP E  +     +   D++S G ++ E+  RK     +F G+   
Sbjct: 189 NKTHYV---THRWYRAP-ELVMQFKGFTKLVDMWSAGCVMAEMFNRK----ALFRGSTFY 240

Query: 629 HNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQ 665
           +        + ++++V +      ED+ + S+   R 
Sbjct: 241 NQL------NKIVEVVGT---PKIEDVVMFSSPSARD 268

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 67.8 bits (166), Expect = 6e-13
 Identities = 37/193 (19%), Positives = 68/193 (35%), Gaps = 40/193 (20%)

Query: 97  GCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVT 156
            C C+       ++    K    IP  +     +  + +  N +                
Sbjct: 8   ACTCS-----NNIVDCRGKGLTEIPTNL--PETITEIRLEQNTIK--------------- 45

Query: 157 LAINTNKLSGNIPPSI-GNLKKLLQLYLIENFLQVSIPS-SLGQCQSLTTINLSYNNLSG 214
                      IPP      KKL ++ L  N +   +   +    +SL ++ L  N ++ 
Sbjct: 46  ----------VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT- 93

Query: 215 TIPPQLMD-LTSLSVGLDLSRNQLVGSLPTEV-GKLINLEILFISRNMLECEILSTLGSC 272
            +P  L + L SL + L L+ N++   L  +    L NL +L +  N L+     T    
Sbjct: 94  ELPKSLFEGLFSLQL-LLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPL 151

Query: 273 IKLEQLKLGGNLF 285
             ++ + L  N F
Sbjct: 152 RAIQTMHLAQNPF 164

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 57.0 bits (138), Expect = 3e-09
 Identities = 25/131 (19%), Positives = 57/131 (43%), Gaps = 8/131 (6%)

Query: 84  LDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGI-GKFINLQTLHMWDNQLSG 142
           + +  N    + PG    +   L  +  ++N+I   +         +L +L ++ N+++ 
Sbjct: 37  IRLEQNTIKVIPPGAFSPYK-KLRRIDLSNNQI-SELAPDAFQGLRSLNSLVLYGNKIT- 93

Query: 143 TISPAI-GELQNLVTLAINTNKLSGNIPPSI-GNLKKLLQLYLIENFLQVSIPSSLGQCQ 200
            +  ++   L +L  L +N NK++  +      +L  L  L L +N LQ     +    +
Sbjct: 94  ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLR 152

Query: 201 SLTTINLSYNN 211
           ++ T++L   N
Sbjct: 153 AIQTMHL-AQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 53.1 bits (128), Expect = 6e-08
 Identities = 35/143 (24%), Positives = 56/143 (39%), Gaps = 7/143 (4%)

Query: 191 SIPSSLGQCQSLTTINLSYNNLSGTIPPQLMD-LTSLSVGLDLSRNQLVGSLPTEV-GKL 248
            IP++L +  ++T I L  N +   IPP        L   +DLS NQ+   L  +    L
Sbjct: 25  EIPTNLPE--TITEIRLEQNTIK-VIPPGAFSPYKKLRR-IDLSNNQIS-ELAPDAFQGL 79

Query: 249 INLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNN 308
            +L  L +  N +     S       L+ L L  N        +   L  L +L L  N 
Sbjct: 80  RSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNK 139

Query: 309 ISGEIPKFLVELQLVQNLNLSYN 331
           +          L+ +Q ++L+ N
Sbjct: 140 LQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 32/141 (22%), Positives = 51/141 (36%), Gaps = 19/141 (13%)

Query: 26  LSLGFNQITGVIPSSMF-NASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHL 84
           + L  N I  VIP   F    KL    +++N ++   P  F               L  L
Sbjct: 37  IRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLR----------SLNSL 85

Query: 85  DINNNNFGGLLPGCICNFS--ITLETLIFNSNKIFRSIPAGI-GKFINLQTLHMWDNQLS 141
            +  N    L       F    +L+ L+ N+NKI   +         NL  L ++DN+L 
Sbjct: 86  VLYGNKITELPKSL---FEGLFSLQLLLLNANKI-NCLRVDAFQDLHNLNLLSLYDNKLQ 141

Query: 142 GTISPAIGELQNLVTLAINTN 162
                    L+ + T+ +  N
Sbjct: 142 TIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 45.0 bits (107), Expect = 3e-05
 Identities = 26/121 (21%), Positives = 40/121 (33%), Gaps = 15/121 (12%)

Query: 20  LPNLLFLSLGFNQITGVIPSSMFN-ASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCN 78
              L  + L  NQI+  +    F     L    +  N +T    S F             
Sbjct: 55  YKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFS-------- 105

Query: 79  QHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGI-GKFINLQTLHMWD 137
             L+ L +N N    L      +    L  L    NK+ ++I  G       +QT+H+  
Sbjct: 106 --LQLLLLNANKINCLRVDAFQDLH-NLNLLSLYDNKL-QTIAKGTFSPLRAIQTMHLAQ 161

Query: 138 N 138
           N
Sbjct: 162 N 162

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 69.7 bits (171), Expect = 7e-13
 Identities = 59/266 (22%), Positives = 105/266 (39%), Gaps = 46/266 (17%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTV 465
           +  G++G+V   +       +A+K L         +K +  E   L+++RH+N++ +L V
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92

Query: 466 CSGVDYKGDDFKA--LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            +  D   DDF    LV  FM        L  +   +K  E        Q +        
Sbjct: 93  FT-PDETLDDFTDFYLVMPFM-----GTDLGKLMKHEKLGEDRIQFLVYQML-------K 139

Query: 524 ALKYLHHDCQPTTA---HCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGT 580
            L+Y+H       A   H DLKP N+ ++ +    + DFGLA+        T  +    T
Sbjct: 140 GLRYIH------AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM--TGYV---VT 188

Query: 581 IGYIAPAEYGLGS-EVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDH 639
             Y AP E  L     +   D++S G ++ E++T K     +F+G+ +L           
Sbjct: 189 RWYRAP-EVILNWMRYTQTVDIWSVGCIMAEMITGK----TLFKGSDHLDQL------KE 237

Query: 640 VMDIVDSTLLADDEDLTITSNQRQRQ 665
           +M +  +      E +    +   + 
Sbjct: 238 IMKVTGT---PPAEFVQRLQSDEAKN 260

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 68.9 bits (169), Expect = 8e-13
 Identities = 47/236 (19%), Positives = 78/236 (33%), Gaps = 64/236 (27%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLN---LLHHGASKSSIA---ECSALRNIR----HKNLV 460
           G FG+V+ G     +  +A+KV+    +L       S+    E + L  +     H  ++
Sbjct: 42  GGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVI 101

Query: 461 KILTVCSGVDYKGDDFKALVYEF-----------MHNGSLEEWLHPVSGADKTVEAPKCL 509
           ++L      + +      LV E               G L E                  
Sbjct: 102 RLLDW---FETQEGFM--LVLERPLPAQDLFDYITEKGPLGE--------------GPSR 142

Query: 510 NFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEM-TAHVADFGLAKLLPPA 568
            F  ++        A+++ H        H D+K  N+L+D     A + DFG   LL   
Sbjct: 143 CFFGQV------VAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE 193

Query: 569 HLQTSSIGVKGTIGYIAP-----AEYGLGSEVSINGDVYSYGILLLELMTRKRPSD 619
                     GT  Y  P      +Y           V+S GILL +++    P +
Sbjct: 194 PYTDFD----GTRVYSPPEWISRHQY-HALPA----TVWSLGILLYDMVCGDIPFE 240

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 70.6 bits (173), Expect = 9e-13
 Identities = 52/220 (23%), Positives = 83/220 (37%), Gaps = 33/220 (15%)

Query: 402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLN---LLHHGASKSSIAECSALRNIRHKN 458
           F     +  G FG V    +     + A K L    +        ++ E   L  +  + 
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245

Query: 459 LVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIA 518
           +V  L       Y+  D   LV   M+ G L+  ++ + G     EA            A
Sbjct: 246 VVS-LAYA----YETKDALCLVLTLMNGGDLKFHIYHM-GQAGFPEA------RAVFYAA 293

Query: 519 IDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV--ADFGLAKLLPPAHLQTSSIG 576
            ++ C L+ LH   +    + DLKP N+LLD     H+  +D GLA  +P        + 
Sbjct: 294 -EICCGLEDLH---RERIVYRDLKPENILLDDH--GHIRISDLGLAVHVPEGQTIKGRV- 346

Query: 577 VKGTIGYIAP---AEYGLGSEVSINGDVYSYGILLLELMT 613
             GT+GY+AP                D ++ G LL E++ 
Sbjct: 347 --GTVGYMAPEVVKNERYTFSP----DWWALGCLLYEMIA 380

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 69.9 bits (171), Expect = 1e-12
 Identities = 37/160 (23%), Positives = 65/160 (40%), Gaps = 22/160 (13%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLL--HHGASKSSIAECSALRNIRHKNLVKILTV 465
           I  GS+G V +      K ++A+K +  +       K  + E + L  + H ++VK+L +
Sbjct: 61  IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDI 120

Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
               D +  D   +V E       +     +      +        L  +         +
Sbjct: 121 VIPKDVEKFDELYVVLEIA-----DSDFKKLFRTPVYLTELHIKTLLYNL------LVGV 169

Query: 526 KYLHHDCQPTTA---HCDLKPSNVLLDHEMTAHVADFGLA 562
           KY+H      +A   H DLKP+N L++ + +  V DFGLA
Sbjct: 170 KYVH------SAGILHRDLKPANCLVNQDCSVKVCDFGLA 203

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 69.0 bits (169), Expect = 2e-12
 Identities = 38/196 (19%), Positives = 76/196 (38%), Gaps = 30/196 (15%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G+FG V++ +      +   K +N  +     +   E S +  + H  L+ +        
Sbjct: 62  GAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA----- 116

Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
           ++      L+ EF+  G L          D+       ++  + IN        LK++H 
Sbjct: 117 FEDKYEMVLILEFLSGGEL---------FDRIAAEDYKMSEAEVINYMRQACEGLKHMH- 166

Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHV--ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAE 588
             + +  H D+KP N++ + +  + V   DFGLA  L P  +   +     T  + AP  
Sbjct: 167 --EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAP-- 219

Query: 589 YGLGSEVSINGDVYSY 604
                E+ ++ +   +
Sbjct: 220 -----EI-VDREPVGF 229

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 68.9 bits (169), Expect = 2e-12
 Identities = 59/221 (26%), Positives = 94/221 (42%), Gaps = 42/221 (19%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVK-VLNLLHHGASKSSIAECSALRNIRHKNLVKILTV- 465
           I  GSFG V++  L E    +A+K VL        +    E   +R ++H N+V +    
Sbjct: 48  IGNGSFGVVFQAKLVESD-EVAIKKVLQ-----DKRFKNRELQIMRIVKHPNVVDLKAFF 101

Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPV----SGADKTVEAPKCLNFL-QRINIAID 520
            S  D K + F  LV E++      E ++      +   +T+       ++ Q       
Sbjct: 102 YSNGDKKDEVFLNLVLEYV-----PETVYRASRHYAKLKQTMPMLLIKLYMYQ------- 149

Query: 521 VACALKYLHHD--CQPTTAHCDLKPSNVLLDHEMTA-HVADFGLAKLLPPAHLQTSSIGV 577
           +  +L Y+H    C     H D+KP N+LLD       + DFG AK+L       S I  
Sbjct: 150 LLRSLAYIHSIGIC-----HRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYI-- 202

Query: 578 KGTIGYIAPAEYGLGSE---VSINGDVYSYGILLLELMTRK 615
             +  Y AP E   G+     +I  D++S G ++ ELM  +
Sbjct: 203 -CSRYYRAP-ELIFGATNYTTNI--DIWSTGCVMAELMQGQ 239

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 69.3 bits (170), Expect = 2e-12
 Identities = 48/218 (22%), Positives = 81/218 (37%), Gaps = 40/218 (18%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNLVKILTVCSG 468
           G++G V            A+K++    +   ++   + E + L+ + H N++K+      
Sbjct: 48  GAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF--- 104

Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL 528
             ++      LV E    G L +           +      N +    I   V   + YL
Sbjct: 105 --FEDKRNYYLVMECYKGGELFDE----------IIHRMKFNEVDAAVIIKQVLSGVTYL 152

Query: 529 HHDCQPTTAHCDLKPSNVLL---DHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
           H        H DLKP N+LL   + +    + DFGL+ +          +   GT  YIA
Sbjct: 153 HKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL---GTAYYIA 206

Query: 586 PAEYGLGSEVSING------DVYSYGILLLELMTRKRP 617
           P       EV +        DV+S G++L  L+    P
Sbjct: 207 P-------EV-LRKKYDEKCDVWSIGVILFILLAGYPP 236

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 69.0 bits (169), Expect = 2e-12
 Identities = 55/236 (23%), Positives = 90/236 (38%), Gaps = 40/236 (16%)

Query: 402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVL---NLLHHGASKSSIAECSALRNIRHKN 458
           F +L  +  G+FG V            A+K+L    ++       ++ E   L+N RH  
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 209

Query: 459 LVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQ---RI 515
           L   L       ++  D    V E+ + G L   L             +   F +   R 
Sbjct: 210 LTA-LKYS----FQTHDRLCFVMEYANGGELFFHLS------------RERVFSEDRARF 252

Query: 516 NIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSI 575
             A ++  AL YLH +      + DLK  N++LD +    + DFGL K          + 
Sbjct: 253 YGA-EIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF 309

Query: 576 GVKGTIGYIAP---AEYGLGSEVSINGDVYSYGILLLELMTRKRP-----SDIMFE 623
              GT  Y+AP    +   G  V    D +  G+++ E+M  + P      + +FE
Sbjct: 310 C--GTPEYLAPEVLEDNDYGRAV----DWWGLGVVMYEMMCGRLPFYNQDHEKLFE 359

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 68.6 bits (168), Expect = 2e-12
 Identities = 55/215 (25%), Positives = 86/215 (40%), Gaps = 43/215 (20%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLN---LLHHGASKSSIA-----ECSALRNIRHKNLVKI 462
           G+ G V      +    +A+++++        A ++  A     E   L+ + H  ++KI
Sbjct: 146 GACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKI 205

Query: 463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVA 522
                  DY       +V E M  G L +    V G  +  EA   L F Q       + 
Sbjct: 206 KNFFDAEDY------YIVLELMEGGELFDK---VVGNKRLKEATCKLYFYQ-------ML 249

Query: 523 CALKYLHHDCQPTTAHCDLKPSNVLL---DHEMTAHVADFGLAKLLPPAHLQTSSIGVKG 579
            A++YLH   +    H DLKP NVLL   + +    + DFG +K+L    L  +     G
Sbjct: 250 LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---G 303

Query: 580 TIGYIAP------AEYGLGSEVSINGDVYSYGILL 608
           T  Y+AP         G    V    D +S G++L
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAV----DCWSLGVIL 334

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 67.0 bits (164), Expect = 3e-12
 Identities = 56/190 (29%), Positives = 92/190 (48%), Gaps = 16/190 (8%)

Query: 76  NCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHM 135
           +        ++   +    +        +     I  +N   +S+  GI    N++ L +
Sbjct: 16  DAFAETIKANLKKKSVTDAVTQ----NELNSIDQIIANNSDIKSVQ-GIQYLPNVRYLAL 70

Query: 136 WDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSI-GNLKKLLQLYLIENFLQVSIPS 194
             N+L      A+ EL NL  L +  N+L  ++P  +   L  L +L L+EN LQ S+P 
Sbjct: 71  GGNKL--HDISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPD 126

Query: 195 SL-GQCQSLTTINLSYNNLSGTIPPQLMD-LTSLSVGLDLSRNQLVGSLPTEV-GKLINL 251
            +  +  +LT +NL++N L  ++P  + D LT+L+  LDLS NQL  SLP  V  KL  L
Sbjct: 127 GVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTE-LDLSYNQL-QSLPEGVFDKLTQL 183

Query: 252 EILFISRNML 261
           + L + +N L
Sbjct: 184 KDLRLYQNQL 193

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 48/200 (24%), Positives = 84/200 (42%), Gaps = 52/200 (26%)

Query: 19  TLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCN 78
            LPN+ +L+LG N++             +         LT                    
Sbjct: 61  YLPNVRYLALGGNKLH-----------DISAL----KELT-------------------- 85

Query: 79  QHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGI-GKFINLQTLHMWD 137
            +L +L +  N    L  G + +    L+ L+   N++ +S+P G+  K  NL  L++  
Sbjct: 86  -NLTYLILTGNQLQSLPNG-VFDKLTNLKELVLVENQL-QSLPDGVFDKLTNLTYLNLAH 142

Query: 138 NQLSGTISPAI-GELQNLVTLAINTNKLSGNIPPSI-GNLKKLLQLYLIENFLQVSIPS- 194
           NQL  ++   +  +L NL  L ++ N+L  ++P  +   L +L  L L +N L+ S+P  
Sbjct: 143 NQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLK-SVPDG 199

Query: 195 ---SLGQCQSLTTINLSYNN 211
               L    SL  I L ++N
Sbjct: 200 VFDRLT---SLQYIWL-HDN 215

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 68.2 bits (167), Expect = 3e-12
 Identities = 45/196 (22%), Positives = 77/196 (39%), Gaps = 30/196 (15%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G FG V+K         +A K++        +    E S +  + H NL+++        
Sbjct: 100 GRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDA----- 154

Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
           ++  +   LV E++  G L          D+ ++    L  L  I     +   ++++H 
Sbjct: 155 FESKNDIVLVMEYVDGGEL---------FDRIIDESYNLTELDTILFMKQICEGIRHMH- 204

Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHV--ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAE 588
             Q    H DLKP N+L  +     +   DFGLA+   P      +    GT  ++AP  
Sbjct: 205 --QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF---GTPEFLAP-- 257

Query: 589 YGLGSEVSINGDVYSY 604
                EV +N D  S+
Sbjct: 258 -----EV-VNYDFVSF 267

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 66.9 bits (164), Expect = 3e-12
 Identities = 47/207 (22%), Positives = 77/207 (37%), Gaps = 33/207 (15%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA-ECSALRNIRHKNLVKILTVCSGV 469
           G+FG V+            +K +N          I  E   L+++ H N++KI  V    
Sbjct: 33  GAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV---- 88

Query: 470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFL---QRINIAIDVACALK 526
            ++      +V E    G L          ++ V A      L       +   +  AL 
Sbjct: 89  -FEDYHNMYIVMETCEGGEL---------LERIVSAQARGKALSEGYVAELMKQMMNALA 138

Query: 527 YLHHDCQPTTAHCDLKPSNVLL---DHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGY 583
           Y H        H DLKP N+L           + DFGLA+L       T++    GT  Y
Sbjct: 139 YFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA---GTALY 192

Query: 584 IAP--AEYGLGSEVSINGDVYSYGILL 608
           +AP   +  +  +     D++S G+++
Sbjct: 193 MAPEVFKRDVTFKC----DIWSAGVVM 215

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 66.9 bits (164), Expect = 3e-12
 Identities = 49/229 (21%), Positives = 79/229 (34%), Gaps = 68/229 (29%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA---------ECSALRNI-RHKNLV 460
           G    V + I        AVK++++   G+  +            E   LR +  H N++
Sbjct: 28  GVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNII 87

Query: 461 KILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRI----- 515
           ++        Y+ + F  LV++ M  G L                         +     
Sbjct: 88  QLKDT-----YETNTFFFLVFDLMKKGEL----------------------FDYLTEKVT 120

Query: 516 -------NIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPA 568
                   I   +   +  LH   +    H DLKP N+LLD +M   + DFG +  L P 
Sbjct: 121 LSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG 177

Query: 569 HLQTSSIGVKGTIGYIAP---------AEYGLGSEVSINGDVYSYGILL 608
                     GT  Y+AP            G G EV    D++S G+++
Sbjct: 178 EKLREVC---GTPSYLAPEIIECSMNDNHPGYGKEV----DMWSTGVIM 219

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 67.3 bits (165), Expect = 3e-12
 Identities = 56/215 (26%), Positives = 86/215 (40%), Gaps = 43/215 (20%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLN---LLHHGASKSSIA-----ECSALRNIRHKNLVKI 462
           G+ G V      +    +A+K+++        A ++  A     E   L+ + H  ++KI
Sbjct: 21  GACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKI 80

Query: 463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVA 522
                  DY       +V E M  G L +    V G  +  EA   L F Q       + 
Sbjct: 81  KNFFDAEDY------YIVLELMEGGELFDK---VVGNKRLKEATCKLYFYQ-------ML 124

Query: 523 CALKYLHHDCQPTTAHCDLKPSNVLL---DHEMTAHVADFGLAKLLPPAHLQTSSIGVKG 579
            A++YLH +      H DLKP NVLL   + +    + DFG +K+L    L  +     G
Sbjct: 125 LAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---G 178

Query: 580 TIGYIAP------AEYGLGSEVSINGDVYSYGILL 608
           T  Y+AP         G    V    D +S G++L
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAV----DCWSLGVIL 209

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 68.7 bits (168), Expect = 4e-12
 Identities = 43/196 (21%), Positives = 73/196 (37%), Gaps = 30/196 (15%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G+FG V++          A K +   H    ++   E   +  +RH  LV +        
Sbjct: 168 GAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA----- 222

Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
           ++ D+   ++YEFM  G L          +K  +    ++  + +     V   L ++H 
Sbjct: 223 FEDDNEMVMIYEFMSGGEL---------FEKVADEHNKMSEDEAVEYMRQVCKGLCHMH- 272

Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHV--ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAE 588
             +    H DLKP N++   + +  +   DFGL   L P      +    GT  + AP  
Sbjct: 273 --ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAP-- 325

Query: 589 YGLGSEVSINGDVYSY 604
                EV   G    Y
Sbjct: 326 -----EV-AEGKPVGY 335

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 67.4 bits (165), Expect = 5e-12
 Identities = 48/234 (20%), Positives = 81/234 (34%), Gaps = 53/234 (22%)

Query: 402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLN---LLHHGASKSSIAECSALRNIRHKN 458
           F  L  I  G+F  V    + +   + A+K++N   +L  G       E   L N   + 
Sbjct: 63  FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122

Query: 459 LVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIA 518
           + ++    +   ++ +++  LV E+   G L                   L  L +    
Sbjct: 123 ITQLH--FA---FQDENYLYLVMEYYVGGDL-------------------LTLLSKFGER 158

Query: 519 ID----------VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV--ADFGLAKLLP 566
           I           +  A+  +H   +    H D+KP N+LLD     H+  ADFG    L 
Sbjct: 159 IPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRC--GHIRLADFGSCLKLR 213

Query: 567 PAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVY-------SYGILLLELMT 613
                 S + V GT  Y++P E             Y       + G+   E+  
Sbjct: 214 ADGTVRSLVAV-GTPDYLSP-EILQAVGGGPGTGSYGPECDWWALGVFAYEMFY 265

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 66.0 bits (162), Expect = 6e-12
 Identities = 46/212 (21%), Positives = 79/212 (37%), Gaps = 41/212 (19%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTVCSG 468
           G+F  V + +        A K++N   L     +    E    R ++H N+V++      
Sbjct: 17  GAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS--- 73

Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRI--NIAIDVACALK 526
              + + F  LV++ +  G L          +  V       + +    +    +  ++ 
Sbjct: 74  --IQEESFHYLVFDLVTGGEL---------FEDIVAREF---YSEADASHCIQQILESIA 119

Query: 527 YLHHDCQPTTAHCDLKPSNVLL-DHEMTAHV--ADFGLAKLLPPAHLQTSSIGVKGTIGY 583
           Y H        H +LKP N+LL      A V  ADFGLA  +  +          GT GY
Sbjct: 120 YCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA---GTPGY 173

Query: 584 IAP---AEYGLGSEVSINGDVYSYG----ILL 608
           ++P    +      V    D+++ G    ILL
Sbjct: 174 LSPEVLKKDPYSKPV----DIWACGVILYILL 201

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 67.1 bits (164), Expect = 8e-12
 Identities = 56/225 (24%), Positives = 89/225 (39%), Gaps = 37/225 (16%)

Query: 402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLN---LLHHGASKSSIAECSALRNIRHKN 458
           F  L  I  G+FG V    L     + A+K+LN   +L    +     E   L N   K 
Sbjct: 76  FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135

Query: 459 LVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIA 518
           +  +    +   ++ D+   LV ++   G L   L   S  +  +          R  +A
Sbjct: 136 ITTLH--YA---FQDDNNLYLVMDYYVGGDLLTLL---SKFEDRLPEEMA-----RFYLA 182

Query: 519 IDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV--ADFGLAKLLPPAHLQTSSIG 576
            ++  A+  +H   Q    H D+KP N+L+D     H+  ADFG    L       SS+ 
Sbjct: 183 -EMVIAIDSVH---QLHYVHRDIKPDNILMDMN--GHIRLADFGSCLKLMEDGTVQSSVA 236

Query: 577 VKGTIGYIAP--------AEYGLGSEVSINGDVYSYGILLLELMT 613
           V GT  YI+P         +   G E     D +S G+ + E++ 
Sbjct: 237 V-GTPDYISPEILQAMEGGKGRYGPEC----DWWSLGVCMYEMLY 276

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 66.2 bits (162), Expect = 9e-12
 Identities = 55/234 (23%), Positives = 83/234 (35%), Gaps = 50/234 (21%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA------ECSALRNIRHKNLVKILT 464
           G+FG          K ++AVK +        + +        E    R++RH N+V+   
Sbjct: 31  GNFGVARLMRDKLTKELVAVKYIE-------RGAAIDENVQREIINHRSLRHPNIVRFKE 83

Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
           V     +      A++ E+   G L E    +  A +  E      F Q +         
Sbjct: 84  VILTPTHL-----AIIMEYASGGELYER---ICNAGRFSEDEARFFFQQLL-------SG 128

Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH--VADFGLAKLLPPAHLQTSSIGVKGTIG 582
           + Y H        H DLK  N LLD        + DFG +K         S++   GT  
Sbjct: 129 VSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV---GTPA 182

Query: 583 YIAP-----AEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNF 631
           YIAP      EY  G       DV+S G+ L  ++    P    FE      ++
Sbjct: 183 YIAPEVLLRQEYD-GKIA----DVWSCGVTLYVMLVGAYP----FEDPEEPRDY 227

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 65.8 bits (161), Expect = 1e-11
 Identities = 52/223 (23%), Positives = 81/223 (36%), Gaps = 70/223 (31%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA----ECSALRNIR-HKNLVKILTV 465
           GSF    K +  +     AVK+++       K   A    E +AL+    H N+VK+  V
Sbjct: 22  GSFSICRKCVHKKSNQAFAVKIIS-------KRMEANTQKEITALKLCEGHPNIVKLHEV 74

Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRI---------- 515
                +       LV E ++ G L                       +RI          
Sbjct: 75  -----FHDQLHTFLVMELLNGGEL----------------------FERIKKKKHFSETE 107

Query: 516 --NIAIDVACALKYLHHDCQPTTAHCDLKPSNVLL---DHEMTAHVADFGLAKLLPPA-- 568
              I   +  A+ ++H        H DLKP N+L    +  +   + DFG A+L PP   
Sbjct: 108 ASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164

Query: 569 HLQTSSIGVKGTIGYIAP---AEYGLGSEVSINGDVYSYGILL 608
            L+T       T+ Y AP    + G         D++S G++L
Sbjct: 165 PLKT----PCFTLHYAAPELLNQNGYDESC----DLWSLGVIL 199

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 66.6 bits (163), Expect = 1e-11
 Identities = 54/219 (24%), Positives = 87/219 (39%), Gaps = 41/219 (18%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLN---LLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           GSFG V            AVKV++   +      +S + E   L+ + H N++K+     
Sbjct: 37  GSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEF-- 94

Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
              ++   +  LV E    G L +           + + K  + +    I   V   + Y
Sbjct: 95  ---FEDKGYFYLVGEVYTGGELFDE----------IISRKRFSEVDAARIIRQVLSGITY 141

Query: 528 LHHDCQPTTAHCDLKPSNVLL---DHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYI 584
           +H +      H DLKP N+LL     +    + DFGL+     +      I   GT  YI
Sbjct: 142 MHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI---GTAYYI 195

Query: 585 APAEYGLGSEVSING------DVYSYGILLLELMTRKRP 617
           AP       EV ++G      DV+S G++L  L++   P
Sbjct: 196 AP-------EV-LHGTYDEKCDVWSTGVILYILLSGCPP 226

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 65.3 bits (160), Expect = 2e-11
 Identities = 39/197 (19%), Positives = 75/197 (38%), Gaps = 33/197 (16%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA-ECSALRNIRHKNLVKILTVCSGV 469
           G FG V++ +    K     K + +   G  +  +  E S L   RH+N++ +       
Sbjct: 16  GEFGIVHRCVETSSKKTYMAKFVKV--KGTDQVLVKKEISILNIARHRNILHLHES---- 69

Query: 470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH 529
            ++  +   +++EF+    +          ++   +   LN  + ++    V  AL++LH
Sbjct: 70  -FESMEELVMIFEFISGLDI---------FERINTSAFELNEREIVSYVHQVCEALQFLH 119

Query: 530 HDCQPTTAHCDLKPSNVLLDHEMTAHV--ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPA 587
                   H D++P N++     ++ +   +FG A+ L P               Y AP 
Sbjct: 120 ---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF---TAPEYYAP- 172

Query: 588 EYGLGSEVSINGDVYSY 604
                 EV    DV S 
Sbjct: 173 ------EV-HQHDVVST 182

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 45/219 (20%), Positives = 71/219 (32%), Gaps = 60/219 (27%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSAL-RNIRHKNLVKILTVCSGV 469
           G  G V +          A+K+L       S  +  E     +     ++V IL V   +
Sbjct: 40  GVNGKVLECFHRRTGQKCALKLLY-----DSPKARQEVDHHWQASGGPHIVCILDVYENM 94

Query: 470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRI-------------- 515
            +       ++ E M  G L                        RI              
Sbjct: 95  HHGKRCL-LIIMECMEGGEL----------------------FSRIQERGDQAFTEREAA 131

Query: 516 NIAIDVACALKYLHHDCQPTTAHCDLKPSNVLL---DHEMTAHVADFGLAKLLPPAHLQT 572
            I  D+  A+++LH       AH D+KP N+L    + +    + DFG AK      LQT
Sbjct: 132 EIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT 188

Query: 573 SSIGVKGTIGYIAP---AEYGLGSEVSINGDVYSYGILL 608
                  T  Y+AP                D++S G+++
Sbjct: 189 ----PCYTPYYVAPEVLGPEKYDKSC----DMWSLGVIM 219

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 65.5 bits (160), Expect = 2e-11
 Identities = 48/233 (20%), Positives = 84/233 (36%), Gaps = 54/233 (23%)

Query: 401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLN---LLHHGASKSSIAECSALRNIRHK 457
            +  +  I  G+FG V        + + A+K+L+   ++    S     E   +      
Sbjct: 70  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 129

Query: 458 NLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINI 517
            +V++    +   ++ D +  +V E+M  G L                   +N +   ++
Sbjct: 130 WVVQLF--YA---FQDDRYLYMVMEYMPGGDL-------------------VNLMSNYDV 165

Query: 518 AIDVA--------CALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV--ADFGLAKLLPP 567
               A         AL  +H        H D+KP N+LLD     H+  ADFG    +  
Sbjct: 166 PEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNK 220

Query: 568 AHLQTSSIGVKGTIGYIAP-------AEYGLGSEVSINGDVYSYGILLLELMT 613
             +      V GT  YI+P        +   G E     D +S G+ L E++ 
Sbjct: 221 EGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGREC----DWWSVGVFLYEMLV 268

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 62/228 (27%), Positives = 92/228 (40%), Gaps = 43/228 (18%)

Query: 402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGAS---KSSIAECSALRNIRHKN 458
           F  L  I  GSFG+VY         ++A+K ++     ++   +  I E   L+ +RH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 459 LVKILTVCSGVDYKGDDFKA----LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQR 514
            ++         Y+G   +     LV E+   GS          +D      K L  ++ 
Sbjct: 116 TIQ---------YRGCYLREHTAWLVMEYC-LGSA---------SDLLEVHKKPLQEVE- 155

Query: 515 INIAI---DVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQ 571
             IA         L YLH        H D+K  N+LL       + DFG A ++ PA   
Sbjct: 156 --IAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 207

Query: 572 TSSIGVKGTIGYIAPAEYGLGSEVSING--DVYSYGILLLELMTRKRP 617
            S +   GT  ++AP       E   +G  DV+S GI  +EL  RK P
Sbjct: 208 NSFV---GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 65.5 bits (160), Expect = 2e-11
 Identities = 33/160 (20%), Positives = 59/160 (36%), Gaps = 22/160 (13%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVK-VLNLLHHGAS-KSSIAECSALRNIRHKNLVKILTV 465
           I  GS+G VY       +  +A+K V  +       K  + E + L  ++   ++++  +
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDL 93

Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
               D    D   +V E       +  L  +      +        L  +          
Sbjct: 94  IIPDDLLKFDELYIVLEIA-----DSDLKKLFKTPIFLTEEHIKTILYNL------LLGE 142

Query: 526 KYLHHDCQPTTA---HCDLKPSNVLLDHEMTAHVADFGLA 562
            ++H       +   H DLKP+N LL+ + +  V DFGLA
Sbjct: 143 NFIH------ESGIIHRDLKPANCLLNQDCSVKVCDFGLA 176

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 64.6 bits (158), Expect = 3e-11
 Identities = 46/212 (21%), Positives = 79/212 (37%), Gaps = 41/212 (19%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTVCSG 468
           G+F  V + +        A K++N   L     +    E    R ++H N+V++      
Sbjct: 40  GAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS--- 96

Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQR--INIAIDVACALK 526
              + + F  LV++ +  G L          +  V       + +    +    +  ++ 
Sbjct: 97  --IQEESFHYLVFDLVTGGEL---------FEDIVAREF---YSEADASHCIQQILESIA 142

Query: 527 YLHHDCQPTTAHCDLKPSNVLL-DHEMTAHV--ADFGLAKLLPPAHLQTSSIGVKGTIGY 583
           Y H        H +LKP N+LL      A V  ADFGLA  +  +          GT GY
Sbjct: 143 YCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA---GTPGY 196

Query: 584 IAP---AEYGLGSEVSINGDVYSYG----ILL 608
           ++P    +      V    D+++ G    ILL
Sbjct: 197 LSPEVLKKDPYSKPV----DIWACGVILYILL 224

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 66.1 bits (161), Expect = 3e-11
 Identities = 30/103 (29%), Positives = 43/103 (41%), Gaps = 19/103 (18%)

Query: 521 VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV--ADFGLAKLLPPAHLQTSSIGVK 578
           +   L+++H        + DLKP+N+LLD     HV  +D GLA          S     
Sbjct: 301 IILGLEHMH---NRFVVYRDLKPANILLDEH--GHVRISDLGLACDFSKKKPHASV---- 351

Query: 579 GTIGYIAP----AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
           GT GY+AP          S      D +S G +L +L+    P
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSA----DWFSLGCMLFKLLRGHSP 390

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 64.6 bits (158), Expect = 3e-11
 Identities = 50/213 (23%), Positives = 81/213 (38%), Gaps = 39/213 (18%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLN----LLHHGASKSSIA-ECSALRNIRHKNLVKILTV 465
           G F  V + I  E     AVK+++        G S   +  E S    ++H ++V++L  
Sbjct: 35  GPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLET 94

Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFL---QRINIAIDVA 522
                Y  D    +V+EFM    L           + V+              +    + 
Sbjct: 95  -----YSSDGMLYMVFEFMDGADL---------CFEIVKRADAGFVYSEAVASHYMRQIL 140

Query: 523 CALKYLH-HDCQPTTAHCDLKPSNVLL---DHEMTAHVADFGLAKLLPPAHLQTSSIGVK 578
            AL+Y H ++      H D+KP  VLL   ++     +  FG+A  L  + L     G  
Sbjct: 141 EALRYCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAG--GRV 194

Query: 579 GTIGYIAP---AEYGLGSEVSINGDVYSYGILL 608
           GT  ++AP        G  V    DV+  G++L
Sbjct: 195 GTPHFMAPEVVKREPYGKPV----DVWGCGVIL 223

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 63.4 bits (155), Expect = 4e-11
 Identities = 47/221 (21%), Positives = 75/221 (33%), Gaps = 62/221 (28%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           GS+G V   +    +   A K +             E   ++++ H N++++        
Sbjct: 20  GSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET----- 74

Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRI------------NIA 518
           ++ +    LV E    G L                       +R+             I 
Sbjct: 75  FEDNTDIYLVMELCTGGEL----------------------FERVVHKRVFRESDAARIM 112

Query: 519 IDVACALKYLHHDCQPTTAHCDLKPSNVLL---DHEMTAHVADFGLAKLLPPAHLQTSSI 575
            DV  A+ Y H   +   AH DLKP N L      +    + DFGLA    P  +  + +
Sbjct: 113 KDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV 169

Query: 576 GVKGTIGYIAP----AEYGLGSEVSINGDVYSYG----ILL 608
              GT  Y++P      YG   E     D +S G    +LL
Sbjct: 170 ---GTPYYVSPQVLEGLYGP--EC----DEWSAGVMMYVLL 201

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 64.7 bits (158), Expect = 5e-11
 Identities = 52/229 (22%), Positives = 86/229 (37%), Gaps = 51/229 (22%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA-------------ECSALRNIRHK 457
           G++G V       G +  A+KV+        + S               E S L+++ H 
Sbjct: 47  GAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHP 106

Query: 458 NLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINI 517
           N++K+  V     ++   +  LV EF   G L E +                +     NI
Sbjct: 107 NIIKLFDV-----FEDKKYFYLVTEFYEGGELFEQI----------INRHKFDECDAANI 151

Query: 518 AIDVACALKYLHHDCQPTTAHCDLKPSNVLL---DHEMTAHVADFGLAKLLPPAHLQTSS 574
              +   + YLH   +    H D+KP N+LL   +  +   + DFGL+      +     
Sbjct: 152 MKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDR 208

Query: 575 IGVKGTIGYIAPAEYGLGSEVSING------DVYSYGILLLELMTRKRP 617
           +   GT  YIAP       EV +        DV+S G+++  L+    P
Sbjct: 209 L---GTAYYIAP-------EV-LKKKYNEKCDVWSCGVIMYILLCGYPP 246

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 64.7 bits (158), Expect = 5e-11
 Identities = 54/230 (23%), Positives = 81/230 (35%), Gaps = 64/230 (27%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNLVKILTVCSG 468
           GSFG V K      +   AVKV+N     +  + + + E   L+ + H N++K+  +   
Sbjct: 33  GSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI--- 89

Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRI------------N 516
              +      +V E    G L                         I             
Sbjct: 90  --LEDSSSFYIVGELYTGGEL----------------------FDEIIKRKRFSEHDAAR 125

Query: 517 IAIDVACALKYLHHDCQPTTAHCDLKPSNVLL---DHEMTAHVADFGLAKLLPPAHLQTS 573
           I   V   + Y+H        H DLKP N+LL   + +    + DFGL+           
Sbjct: 126 IIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD 182

Query: 574 SIGVKGTIGYIAPAEYGLGSEVSING------DVYSYGILLLELMTRKRP 617
            I   GT  YIAP       EV + G      DV+S G++L  L++   P
Sbjct: 183 RI---GTAYYIAP-------EV-LRGTYDEKCDVWSAGVILYILLSGTPP 221

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 63.5 bits (155), Expect = 6e-11
 Identities = 33/120 (27%), Positives = 50/120 (41%), Gaps = 28/120 (23%)

Query: 521 VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV--ADFGLAKL-LPPAHLQTSSIGV 577
           +  AL++LH   +    + D+K  N+LLD     HV   DFGL+K  +     +      
Sbjct: 168 IVLALEHLH---KLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADETERAYDFC- 221

Query: 578 KGTIGYIAP-----AEYGLGSEVSINGDVYSYGILLLELMT---------RKRPSDIMFE 623
            GTI Y+AP      + G    V    D +S G+L+ EL+T          K     +  
Sbjct: 222 -GTIEYMAPDIVRGGDSGHDKAV----DWWSLGVLMYELLTGASPFTVDGEKNSQAEISR 276

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 63.6 bits (155), Expect = 7e-11
 Identities = 51/242 (21%), Positives = 88/242 (36%), Gaps = 51/242 (21%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVK-VLNLLHHGASKSSIAECSALRNIRHKNLVKILTV- 465
           +  GSFG V +    E     A+K VL        +    E   ++ + H N++K++   
Sbjct: 15  LGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPRYKNRELDIMKVLDHVNIIKLVDYF 69

Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNF--------LQRINI 517
            +  D +    +         G      +            K LN         L ++  
Sbjct: 70  YTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLK 129

Query: 518 AIDVA-----------------CALKYLHHDCQPTTA---HCDLKPSNVLLDHEM-TAHV 556
           +   +                  A+ ++H      +    H D+KP N+L++ +  T  +
Sbjct: 130 SFIRSGRSIPMNLISIYIYQLFRAVGFIH------SLGICHRDIKPQNLLVNSKDNTLKL 183

Query: 557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSE---VSINGDVYSYGILLLELMT 613
            DFG AK L P+    + I    +  Y AP E  LG+     SI  D++S G +  EL+ 
Sbjct: 184 CDFGSAKKLIPSEPSVAYI---CSRFYRAP-ELMLGATEYTPSI--DLWSIGCVFGELIL 237

Query: 614 RK 615
            K
Sbjct: 238 GK 239

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 63.1 bits (154), Expect = 8e-11
 Identities = 42/197 (21%), Positives = 67/197 (34%), Gaps = 51/197 (25%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIR-HKNLVKILTVCSGV 469
           G+   V   I        AVK++             E   L   + H+N+++++      
Sbjct: 24  GAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF---- 79

Query: 470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRI------------NI 517
            ++ +D   LV+E M  GS+                      L  I             +
Sbjct: 80  -FEEEDRFYLVFEKMRGGSI----------------------LSHIHKRRHFNELEASVV 116

Query: 518 AIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHE---MTAHVADFGLAKLLPPAHLQTSS 574
             DVA AL +LH       AH DLKP N+L +H        + DF L   +      +  
Sbjct: 117 VQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPI 173

Query: 575 IGVK-----GTIGYIAP 586
              +     G+  Y+AP
Sbjct: 174 STPELLTPCGSAEYMAP 190

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 63.1 bits (154), Expect = 1e-10
 Identities = 56/215 (26%), Positives = 85/215 (39%), Gaps = 51/215 (23%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSS-----IAECSALRNIRHKNLVKILTV 465
           G+   VY+      +   A+KVL        K+        E   L  + H N++K+  +
Sbjct: 64  GATSIVYRCKQKGTQKPYALKVLK-------KTVDKKIVRTEIGVLLRLSHPNIIKLKEI 116

Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQR--INIAIDVAC 523
                ++     +LV E +  G L          D+ VE      + +R   +    +  
Sbjct: 117 -----FETPTEISLVLELVTGGEL---------FDRIVEKGY---YSERDAADAVKQILE 159

Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLL-DHEMTAHV--ADFGLAKLLPPAHLQTSSIGVKGT 580
           A+ YLH   +    H DLKP N+L       A +  ADFGL+K++    L  +     GT
Sbjct: 160 AVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC---GT 213

Query: 581 IGYIAP---AEYGLGSEVSINGDVYSYG----ILL 608
            GY AP        G EV    D++S G    ILL
Sbjct: 214 PGYCAPEILRGCAYGPEV----DMWSVGIITYILL 244

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 62.2 bits (152), Expect = 1e-10
 Identities = 53/213 (24%), Positives = 82/213 (38%), Gaps = 44/213 (20%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTVCSG 468
           GSFG V K      +   AVKV+N     +  + + + E   L+ + H N++K+  +   
Sbjct: 33  GSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI--- 89

Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRI--NIAIDVACALK 526
              +      +V E    G L          D+ ++  +   F +     I   V   + 
Sbjct: 90  --LEDSSSFYIVGELYTGGEL---------FDEIIKRKR---FSEHDAARIIKQVFSGIT 135

Query: 527 YLHHDCQPTTAHCDLKPSNVLL---DHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGY 583
           Y+H   +    H DLKP N+LL   + +    + DFGL+            I   GT  Y
Sbjct: 136 YMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI---GTAYY 189

Query: 584 IAP----AEYGLGSEVSINGDVYSYG----ILL 608
           IAP      Y    +     DV+S G    ILL
Sbjct: 190 IAPEVLRGTYDE--KC----DVWSAGVILYILL 216

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 62.6 bits (153), Expect = 1e-10
 Identities = 61/237 (25%), Positives = 96/237 (40%), Gaps = 66/237 (27%)

Query: 402 FLFLCWIDMGSFGSVY---KGILDEGKTIIAVKVLNLLHHGASKSSI---------AECS 449
           F  L  +  GSFG V+   K    + + + A+KVL        K+++          E  
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL-------KKATLKVRDRVRTKMERD 78

Query: 450 ALRNIRHKNLVKILTVCSGVDYKGDDFKA-----LVYEFMHNGSLEEWLHPVSGADKTVE 504
            L  + H  +VK L            F+      L+ +F+  G L   L           
Sbjct: 79  ILVEVNHPFIVK-LHYA---------FQTEGKLYLILDFLRGGDLFTRLS---------- 118

Query: 505 APKCLNFLQ---RINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV--ADF 559
             K + F +   +  +A ++A AL +LH        + DLKP N+LLD E   H+   DF
Sbjct: 119 --KEVMFTEEDVKFYLA-ELALALDHLH---SLGIIYRDLKPENILLDEE--GHIKLTDF 170

Query: 560 GLAKLLPPAHLQTSSIGVKGTIGYIAP---AEYGLGSEVSINGDVYSYGILLLELMT 613
           GL+K       +  S    GT+ Y+AP      G         D +S+G+L+ E++T
Sbjct: 171 GLSKESIDHEKKAYSFC--GTVEYMAPEVVNRRGHTQSA----DWWSFGVLMFEMLT 221

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 62.7 bits (153), Expect = 1e-10
 Identities = 54/238 (22%), Positives = 86/238 (36%), Gaps = 65/238 (27%)

Query: 402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSI----------AECSAL 451
           F  +  +  GSFG V      E     A+K+L        K  +           E   L
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL-------DKQKVVKLKQIEHTLNEKRIL 95

Query: 452 RNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNF 511
           + +    LVK+    S   +K +    +V E++  G +  + H                 
Sbjct: 96  QAVNFPFLVKLE--FS---FKDNSNLYMVMEYVAGGEM--FSH----------------- 131

Query: 512 LQRINI---------AIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLA 562
           L+RI           A  +    +YLH        + DLKP N+L+D +    V DFG A
Sbjct: 132 LRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFA 188

Query: 563 KLLPPAHLQTSSIGVKGTIGYIAP---AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
           K +     +T ++   GT   +AP      G    V    D ++ G+L+ E+     P
Sbjct: 189 KRVKG---RTWTLC--GTPEALAPEIILSKGYNKAV----DWWALGVLIYEMAAGYPP 237

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 63/250 (25%), Positives = 107/250 (42%), Gaps = 56/250 (22%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVK-VLNLLHHGA-SKSSIAECSALRNIR-HKNLVKILT 464
           +  G++G V+K I      ++AVK + +   +   ++ +  E   L  +  H+N+V +L 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76

Query: 465 VCSGVDYKGDDFKA--LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVA 522
           V      + D+ +   LV+++M     E  LH V  A+      K     Q I       
Sbjct: 77  V-----LRADNDRDVYLVFDYM-----ETDLHAVIRANILEPVHKQYVVYQLI------- 119

Query: 523 CALKYLHHDCQPTTA---HCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKG 579
             +KYLH      +    H D+KPSN+LL+ E    VADFGL++        T++I +  
Sbjct: 120 KVIKYLH------SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSI 173

Query: 580 TIG-------------------YIAPAEYGLGS-EVSINGDVYSYGILLLELMTRKRPSD 619
                                 Y AP E  LGS + +   D++S G +L E++  K    
Sbjct: 174 NENTENFDDDQPILTDYVATRWYRAP-EILLGSTKYTKGIDMWSLGCILGEILCGK---- 228

Query: 620 IMFEGNMNLH 629
            +F G+  ++
Sbjct: 229 PIFPGSSTMN 238

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 62.3 bits (152), Expect = 1e-10
 Identities = 50/223 (22%), Positives = 77/223 (34%), Gaps = 70/223 (31%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA---ECSAL-RNIRHKNLVKILTVC 466
           GS+    + I        AVK+++       KS      E   L R  +H N++ +  V 
Sbjct: 33  GSYSVCKRCIHKATNMEFAVKIID-------KSKRDPTEEIEILLRYGQHPNIITLKDV- 84

Query: 467 SGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRI----------- 515
               Y    +  +V E M  G L                      L +I           
Sbjct: 85  ----YDDGKYVYVVTELMKGGEL----------------------LDKILRQKFFSEREA 118

Query: 516 -NIAIDVACALKYLHHDCQPTTAHCDLKPSNVLL----DHEMTAHVADFGLAKLLPPAH- 569
             +   +   ++YLH        H DLKPSN+L      +  +  + DFG AK L   + 
Sbjct: 119 SAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG 175

Query: 570 -LQTSSIGVKGTIGYIAP---AEYGLGSEVSINGDVYSYGILL 608
            L T       T  ++AP      G  +      D++S G+LL
Sbjct: 176 LLMT----PCYTANFVAPEVLERQGYDAAC----DIWSLGVLL 210

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 62.2 bits (152), Expect = 1e-10
 Identities = 58/232 (25%), Positives = 94/232 (40%), Gaps = 54/232 (23%)

Query: 402 FLFLCWIDMGSFGSVY---KGILDEGKTIIAVKVLN----LLHHGASKSSIAECSALRNI 454
           F  L  +  G +G V+   K        I A+KVL     + +   +  + AE + L  +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78

Query: 455 RHKNLVKILTVCSGVDYKGDDFKA-----LVYEFMHNGSLEEWLHPVSGADKTVEAPKCL 509
           +H  +V  L            F+      L+ E++  G L   L             +  
Sbjct: 79  KHPFIVD-LIYA---------FQTGGKLYLILEYLSGGELFMQLE------------REG 116

Query: 510 NFLQ---RINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV--ADFGLAKL 564
            F++      +A +++ AL +LH   Q    + DLKP N++L+H+   HV   DFGL K 
Sbjct: 117 IFMEDTACFYLA-EISMALGHLH---QKGIIYRDLKPENIMLNHQ--GHVKLTDFGLCKE 170

Query: 565 LPPAHLQTSSIGVKGTIGYIAP---AEYGLGSEVSINGDVYSYGILLLELMT 613
                  T +    GTI Y+AP      G    V    D +S G L+ +++T
Sbjct: 171 SIHDGTVTHTFC--GTIEYMAPEILMRSGHNRAV----DWWSLGALMYDMLT 216

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 62.4 bits (152), Expect = 2e-10
 Identities = 46/206 (22%), Positives = 77/206 (37%), Gaps = 43/206 (20%)

Query: 411 GSFGSVYKGILDEGKT-------IIAVKVLNLLHHGASKSSI-AECSALRNIRHKNLVKI 462
           G F  V K    E  T        I  +       G  +  I  E S LR + H N++ +
Sbjct: 23  GQFAIVKKCR--EKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITL 80

Query: 463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVA 522
             V     Y+      L+ E +  G L ++L       +++   +  +F+++I       
Sbjct: 81  HDV-----YENRTDVVLILELVSGGELFDFLA----QKESLSEEEATSFIKQI------L 125

Query: 523 CALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH----VADFGLAKLLPPAHLQTSSIGVK 578
             + YLH       AH DLKP N++L  +        + DFGLA  +       +     
Sbjct: 126 DGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF--- 179

Query: 579 GTIGYIAPAEYGLGSEVSINGDVYSY 604
           GT  ++AP       E+ +N +    
Sbjct: 180 GTPEFVAP-------EI-VNYEPLGL 197

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 62.4 bits (152), Expect = 2e-10
 Identities = 49/232 (21%), Positives = 79/232 (34%), Gaps = 71/232 (30%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNL--------LHHGASKSSIAECSALRNIR-HKNLVK 461
           G    V + +        AVK++ +              +++  E   LR +  H +++ 
Sbjct: 105 GVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164

Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRI------ 515
           ++       Y+   F  LV++ M  G L                         +      
Sbjct: 165 LIDS-----YESSSFMFLVFDLMRKGEL----------------------FDYLTEKVAL 197

Query: 516 ------NIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAH 569
                 +I   +  A+ +LH        H DLKP N+LLD  M   ++DFG +  L P  
Sbjct: 198 SEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE 254

Query: 570 LQTSSIGVKGTIGYIAP---------AEYGLGSEVSINGDVYSYG----ILL 608
                    GT GY+AP            G G EV    D+++ G     LL
Sbjct: 255 KLRELC---GTPGYLAPEILKCSMDETHPGYGKEV----DLWACGVILFTLL 299

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 62.7 bits (153), Expect = 2e-10
 Identities = 45/213 (21%), Positives = 77/213 (36%), Gaps = 42/213 (19%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTVCSG 468
           G+F  V + +        A  ++N   L     +    E    R ++H N+V++      
Sbjct: 22  GAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS--- 78

Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQR--INIAIDVACALK 526
                +    L+++ +  G L          +  V       + +    +    +  A+ 
Sbjct: 79  --ISEEGHHYLIFDLVTGGEL---------FEDIVAREY---YSEADASHCIQQILEAVL 124

Query: 527 YLH-HDCQPTTAHCDLKPSNVLL-DHEMTAHV--ADFGLAKLLPPAHLQTSSIGVKGTIG 582
           + H         H +LKP N+LL      A V  ADFGLA  +          G  GT G
Sbjct: 125 HCHQMG----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF--GFAGTPG 178

Query: 583 YIAP---AEYGLGSEVSINGDVYSYG----ILL 608
           Y++P    +   G  V    D+++ G    ILL
Sbjct: 179 YLSPEVLRKDPYGKPV----DLWACGVILYILL 207

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 61.5 bits (150), Expect = 3e-10
 Identities = 55/238 (23%), Positives = 91/238 (38%), Gaps = 45/238 (18%)

Query: 402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVL---NLLHHGASKSSIAECSALRNIRHKN 458
           F +L  +  G+FG V            A+K+L    ++       ++ E   L+N RH  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66

Query: 459 LVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQ---RI 515
           L   L       ++  D    V E+ + G L   L             +   F +   R 
Sbjct: 67  LTA-LKYA----FQTHDRLCFVMEYANGGELFFHLS------------RERVFTEERARF 109

Query: 516 NIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV--ADFGLAKLLPPAHLQTS 573
             A ++  AL+YLH        + D+K  N++LD +   H+   DFGL K          
Sbjct: 110 YGA-EIVSALEYLH---SRDVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMK 163

Query: 574 SIGVKGTIGYIAP---AEYGLGSEVSINGDVYSYGILLLELMTRKRP-----SDIMFE 623
           +    GT  Y+AP    +   G  V    D +  G+++ E+M  + P      + +FE
Sbjct: 164 TFC--GTPEYLAPEVLEDNDYGRAV----DWWGLGVVMYEMMCGRLPFYNQDHERLFE 215

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 61.1 bits (149), Expect = 4e-10
 Identities = 47/206 (22%), Positives = 78/206 (37%), Gaps = 43/206 (20%)

Query: 411 GSFGSVYKGILDEGKT-------IIAVKVLNLLHHGASKSSIA-ECSALRNIRHKNLVKI 462
           G F  V K    E  T        I  +       G S+  I  E S LR + H N++ +
Sbjct: 23  GQFAIVKKCR--EKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITL 80

Query: 463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVA 522
             V     Y+      L+ E +  G L ++L       +++   +  +F+++I       
Sbjct: 81  HDV-----YENRTDVVLILELVSGGELFDFLA----QKESLSEEEATSFIKQI------L 125

Query: 523 CALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH----VADFGLAKLLPPAHLQTSSIGVK 578
             + YLH       AH DLKP N++L  +        + DFGLA  +       +     
Sbjct: 126 DGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF--- 179

Query: 579 GTIGYIAPAEYGLGSEVSINGDVYSY 604
           GT  ++AP       E+ +N +    
Sbjct: 180 GTPEFVAP-------EI-VNYEPLGL 197

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 61.1 bits (148), Expect = 5e-10
 Identities = 55/266 (20%), Positives = 86/266 (32%), Gaps = 71/266 (26%)

Query: 411 GSFGSVYKGIL-----DEGKTIIAVKVLNLLHHGASKSSIAECSALRNI-----RHKNLV 460
           G+FG V +              +AVK+L     GA+ S      +   I      H N+V
Sbjct: 33  GAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKILIHIGHHLNVV 89

Query: 461 KILTVC-----------------------------------------SGVDYKGD---DF 476
            +L  C                                          G DY G    D 
Sbjct: 90  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDL 149

Query: 477 KA---LVYEFMHNGSLEEWLHPVSGADKTVEAPKC-----LNFLQRINIAIDVACALKYL 528
           K     +     + S            +  EAP+      L     I  +  VA  +++L
Sbjct: 150 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL 209

Query: 529 -HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPA 587
               C     H DL   N+LL  +    + DFGLA+ +            +  + ++AP 
Sbjct: 210 ASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP- 264

Query: 588 EYGLGSEVSINGDVYSYGILLLELMT 613
           E       +I  DV+S+G+LL E+ +
Sbjct: 265 ETIFDRVYTIQSDVWSFGVLLWEIFS 290

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 58.9 bits (143), Expect = 6e-10
 Identities = 35/180 (19%), Positives = 62/180 (34%), Gaps = 38/180 (21%)

Query: 113 SNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAI-GELQNLVTLAINTNKLSGNIPPS 171
           SN+    IP  I        L + +N+ +   +  I  +L  L  +  + NK++ +I   
Sbjct: 19  SNQKLNKIPEHI--PQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEE- 74

Query: 172 IGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMD-LTSLSVGL 230
            G  +                         +  I L+ N L   +  ++   L SL   L
Sbjct: 75  -GAFEGA---------------------SGVNEILLTSNRLE-NVQHKMFKGLESLKT-L 110

Query: 231 DLSRNQLVGSLPTEV-GKLINLEILFISRNMLEC---EILSTLGSCIKLEQLKLGGNLFQ 286
            L  N++   +  +    L ++ +L +  N +         TL S   L  L L  N F 
Sbjct: 111 MLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHS---LSTLNLLANPFN 166

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 52.0 bits (125), Expect = 1e-07
 Identities = 28/181 (15%), Positives = 62/181 (34%), Gaps = 51/181 (28%)

Query: 11  GIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATK 70
            IP            L L  N+ T +  + +F              L             
Sbjct: 29  HIP-------QYTAELRLNNNEFTVLEATGIF------------KKLP------------ 57

Query: 71  AYCVQNCNQHLKHLDINNNNFGGLLPGCICNFS--ITLETLIFNSNKIFRSIPAGI-GKF 127
                     L+ ++ +NN    +  G    F     +  ++  SN++  ++   +    
Sbjct: 58  ---------QLRKINFSNNKITDIEEGA---FEGASGVNEILLTSNRL-ENVQHKMFKGL 104

Query: 128 INLQTLHMWDNQLSGTISP-AIGELQNLVTLAINTNKLSGNIPPSI-GNLKKLLQLYLIE 185
            +L+TL +  N+++  +   +   L ++  L++  N+++  + P     L  L  L L+ 
Sbjct: 105 ESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLA 162

Query: 186 N 186
           N
Sbjct: 163 N 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 23/123 (18%), Positives = 42/123 (34%), Gaps = 8/123 (6%)

Query: 191 SIPSSLGQCQSLTTINLSYNNLSGTIPPQLM--DLTSLSVGLDLSRNQLVGSLPTEV-GK 247
            IP  + Q      + L+ N  +  +    +   L  L   ++ S N++   +       
Sbjct: 25  KIPEHIPQ--YTAELRLNNNEFT-VLEATGIFKKLPQLRK-INFSNNKIT-DIEEGAFEG 79

Query: 248 LINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQN 307
              +  + ++ N LE            L+ L L  N        S   L  +R+L L  N
Sbjct: 80  ASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDN 139

Query: 308 NIS 310
            I+
Sbjct: 140 QIT 142

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 44.3 bits (105), Expect = 6e-05
 Identities = 28/123 (22%), Positives = 44/123 (35%), Gaps = 15/123 (12%)

Query: 20  LPNLLFLSLGFNQITGVIPSSMFN-ASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCN 78
           LP L  ++   N+IT  I    F  AS +    +TSN L       F             
Sbjct: 56  LPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLES-------- 106

Query: 79  QHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGI-GKFINLQTLHMWD 137
             LK L + +N    +        S ++  L    N+I  ++  G      +L TL++  
Sbjct: 107 --LKTLMLRSNRITCVGNDSFIGLS-SVRLLSLYDNQI-TTVAPGAFDTLHSLSTLNLLA 162

Query: 138 NQL 140
           N  
Sbjct: 163 NPF 165

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 59.8 bits (145), Expect = 6e-10
 Identities = 30/214 (14%), Positives = 54/214 (25%), Gaps = 61/214 (28%)

Query: 411 GSFGSVYKG---ILDEGKTIIAVKVLNLLHHGASKSSIA----ECSALRNIRHKNLVKIL 463
                 ++     LD     +A+  +           +         L  I    + ++L
Sbjct: 42  VPPLQFWQALDTALDR---QVALTFV-DPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97

Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
            V   V  +      +V E++  GSL+E           +                 +A 
Sbjct: 98  DV---VHTRAGGL--VVAEWIRGGSLQEVADTSPSPVGAIR------------AMQSLAA 140

Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGY 583
           A    H       A     PS V +  +    +A       +P A+ Q            
Sbjct: 141 AADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPAT---MPDANPQD----------- 183

Query: 584 IAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
                           D+   G  L  L+  + P
Sbjct: 184 ----------------DIRGIGASLYALLVNRWP 201

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 59.9 bits (146), Expect = 1e-09
 Identities = 34/110 (30%), Positives = 56/110 (50%), Gaps = 15/110 (13%)

Query: 521 VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV--ADFGLAKLLPPAHLQTSSIGVK 578
           +   L++LH        + DLK  N+LLD +   H+  ADFG+ K       +T++    
Sbjct: 127 IILGLQFLH---SKGIVYRDLKLDNILLDKD--GHIKIADFGMCKENMLGDAKTNTFC-- 179

Query: 579 GTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP-----SDIMFE 623
           GT  YIAP E  LG + + + D +S+G+LL E++  + P      + +F 
Sbjct: 180 GTPDYIAP-EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 228

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 59.9 bits (146), Expect = 1e-09
 Identities = 36/110 (32%), Positives = 51/110 (46%), Gaps = 20/110 (18%)

Query: 521 VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV--ADFGLAKLLPPAHLQTSSIGVK 578
           +A  L +L         + DLK  NV+LD E   H+  ADFG+ K      + T +    
Sbjct: 130 IAIGLFFLQ---SKGIIYRDLKLDNVMLDSE--GHIKIADFGMCKENIWDGVTTKTFC-- 182

Query: 579 GTIGYIAP---AEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGN 625
           GT  YIAP   A    G  V    D +++G+LL E++  + P    FEG 
Sbjct: 183 GTPDYIAPEIIAYQPYGKSV----DWWAFGVLLYEMLAGQAP----FEGE 224

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 60.8 bits (147), Expect = 1e-09
 Identities = 60/236 (25%), Positives = 94/236 (39%), Gaps = 45/236 (19%)

Query: 402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVL---NLLHHGASKSSIAECSAL-RNIRHK 457
           F FL  +  GSFG V          + AVK+L    ++     + ++ E   L    +  
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 402

Query: 458 NLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQ---R 514
            L + L  C    ++  D    V E+++ G L   +             +   F +    
Sbjct: 403 FLTQ-LHSC----FQTMDRLYFVMEYVNGGDLMYHIQ------------QVGRFKEPHAV 445

Query: 515 INIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV--ADFGLAKLLPPAHLQT 572
              A ++A  L +L         + DLK  NV+LD E   H+  ADFG+ K      + T
Sbjct: 446 FYAA-EIAIGLFFLQ---SKGIIYRDLKLDNVMLDSE--GHIKIADFGMCKENIWDGVTT 499

Query: 573 SSIGVKGTIGYIAP---AEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGN 625
            +    GT  YIAP   A    G  V    D +++G+LL E++  + P    FEG 
Sbjct: 500 KTFC--GTPDYIAPEIIAYQPYGKSV----DWWAFGVLLYEMLAGQAP----FEGE 545

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 59.5 bits (145), Expect = 1e-09
 Identities = 54/237 (22%), Positives = 89/237 (37%), Gaps = 71/237 (29%)

Query: 402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSI----------AECSAL 451
           F  L  +  GSFG V+           A+KVL        K  +           E   L
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVL-------KKEIVVRLKQVEHTNDERLML 60

Query: 452 RNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNF 511
             + H  ++++    +   ++      ++ +++  G L  +                   
Sbjct: 61  SIVTHPFIIRMW--GT---FQDAQQIFMIMDYIEGGEL--FSL----------------- 96

Query: 512 LQRINI---------AIDVACALKYLH-HDCQPTTAHCDLKPSNVLLDHEMTAHV--ADF 559
           L++            A +V  AL+YLH  D      + DLKP N+LLD     H+   DF
Sbjct: 97  LRKSQRFPNPVAKFYAAEVCLALEYLHSKD----IIYRDLKPENILLDKN--GHIKITDF 150

Query: 560 GLAKLLPPAHLQTSSIGVKGTIGYIAP---AEYGLGSEVSINGDVYSYGILLLELMT 613
           G AK +P     T ++   GT  YIAP   +       +    D +S+GIL+ E++ 
Sbjct: 151 GFAKYVPD---VTYTLC--GTPDYIAPEVVSTKPYNKSI----DWWSFGILIYEMLA 198

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 59.6 bits (145), Expect = 1e-09
 Identities = 32/98 (32%), Positives = 45/98 (45%), Gaps = 16/98 (16%)

Query: 521 VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV--ADFGLAKLLPPAHLQTSSIGVK 578
           +A AL YLH        + DLKP N+LLD +   H+   DFGL K     +  TS+    
Sbjct: 148 IASALGYLH---SLNIVYRDLKPENILLDSQ--GHIVLTDFGLCKENIEHNSTTSTFC-- 200

Query: 579 GTIGYIAP---AEYGLGSEVSINGDVYSYGILLLELMT 613
           GT  Y+AP    +      V    D +  G +L E++ 
Sbjct: 201 GTPEYLAPEVLHKQPYDRTV----DWWCLGAVLYEMLY 234

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 58.8 bits (143), Expect = 2e-09
 Identities = 39/113 (34%), Positives = 52/113 (46%), Gaps = 21/113 (18%)

Query: 521 VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV--ADFGLAKLLPPAHLQTSSIGVK 578
           +  AL +LH        + DLK  NVLLDHE   H   ADFG+ K      + T++    
Sbjct: 133 IISALMFLH---DKGIIYRDLKLDNVLLDHE--GHCKLADFGMCKEGICNGVTTATFC-- 185

Query: 579 GTIGYIAP---AEYGLGSEVSINGDVYSYGILLLELMTRKRP-----SDIMFE 623
           GT  YIAP    E   G  V    D ++ G+LL E++    P      D +FE
Sbjct: 186 GTPDYIAPEILQEMLYGPAV----DWWAMGVLLYEMLCGHAPFEAENEDDLFE 234

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 58.9 bits (143), Expect = 2e-09
 Identities = 34/106 (32%), Positives = 50/106 (47%), Gaps = 24/106 (22%)

Query: 521 VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV--ADFGLAKLLPPAHLQTSSIGVK 578
           ++ AL YLH   +    + DLK  NVLLD E   H+   D+G+ K        TS+    
Sbjct: 162 ISLALNYLH---ERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGDTTSTFC-- 214

Query: 579 GTIGYIAPAEYGLGSEVSINGDVY-------SYGILLLELMTRKRP 617
           GT  YIAP       E+ + G+ Y       + G+L+ E+M  + P
Sbjct: 215 GTPNYIAP-------EI-LRGEDYGFSVDWWALGVLMFEMMAGRSP 252

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 58.8 bits (143), Expect = 2e-09
 Identities = 34/102 (33%), Positives = 48/102 (47%), Gaps = 16/102 (15%)

Query: 521 VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV--ADFGLAKLLPPAHLQTSSIGVK 578
           ++ AL YLH   +    + DLK  NVLLD E   H+   D+G+ K        TS+    
Sbjct: 119 ISLALNYLH---ERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGDTTSTFC-- 171

Query: 579 GTIGYIAP---AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
           GT  YIAP        G  V    D ++ G+L+ E+M  + P
Sbjct: 172 GTPNYIAPEILRGEDYGFSV----DWWALGVLMFEMMAGRSP 209

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 57.0 bits (138), Expect = 3e-09
 Identities = 44/173 (25%), Positives = 66/173 (38%), Gaps = 32/173 (18%)

Query: 113 SNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSI 172
            +K   S+PAGI    N Q L++ DNQ++         L NL  L + +N+L   +P  +
Sbjct: 27  RSKRHASVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGV 83

Query: 173 -GNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMD-LTSLSVGL 230
             +L +L  L L  N           Q   L              P  + D L  L   L
Sbjct: 84  FDSLTQLTVLDLGTN-----------QLTVL--------------PSAVFDRLVHLKE-L 117

Query: 231 DLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGN 283
            +  N+L   LP  + +L +L  L + +N L+            L    L GN
Sbjct: 118 FMCCNKL-TELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 47.4 bits (113), Expect = 4e-06
 Identities = 35/139 (25%), Positives = 49/139 (35%), Gaps = 16/139 (11%)

Query: 26  LSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLD 85
           L L  NQIT + P    +   L+   + SN L       F   T+          L  LD
Sbjct: 45  LYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQ----------LTVLD 94

Query: 86  INNNNFGGLLPGCICNF-SIT-LETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGT 143
           +  N    L       F  +  L+ L    NK    +P GI +  +L  L +  NQL   
Sbjct: 95  LGTNQLTVLPSAV---FDRLVHLKELFMCCNK-LTELPRGIERLTHLTHLALDQNQLKSI 150

Query: 144 ISPAIGELQNLVTLAINTN 162
              A   L +L    +  N
Sbjct: 151 PHGAFDRLSSLTHAYLFGN 169

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 58.0 bits (141), Expect = 3e-09
 Identities = 41/204 (20%), Positives = 70/204 (34%), Gaps = 41/204 (20%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSS--IAECSALRNIRH-KNLVKILTVCS 467
           G F  V + I        A K L     G    +  + E + L   +    ++ +  V  
Sbjct: 40  GKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV-- 97

Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEA---PKCLNFLQRINIAIDVAC- 523
              Y+      L+ E+   G +           +  E       +  +++I         
Sbjct: 98  ---YENTSEIILILEYAAGGEIFSLC-----LPELAEMVSENDVIRLIKQI-------LE 142

Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH---VADFGLAKLLPPAHLQTSSIGVKGT 580
            + YLH   Q    H DLKP N+LL          + DFG+++ +  A      +   GT
Sbjct: 143 GVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIM---GT 196

Query: 581 IGYIAPAEYGLGSEVSINGDVYSY 604
             Y+AP       E+ +N D  + 
Sbjct: 197 PEYLAP-------EI-LNYDPITT 212

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 57.6 bits (140), Expect = 3e-09
 Identities = 49/211 (23%), Positives = 79/211 (37%), Gaps = 38/211 (18%)

Query: 411 GSFGSVYKGILDEGKTIIAVKV-----LNLLHHGASKSSIA-ECSALRNIRHKNLVKILT 464
           G F  V K          A K      L+    G S+  I  E + LR IRH N++ +  
Sbjct: 16  GQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHD 75

Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
           +     ++      L+ E +  G L          D   E  + L   +       +   
Sbjct: 76  I-----FENKTDVVLILELVSGGEL---------FDFLAEK-ESLTEDEATQFLKQILDG 120

Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH----VADFGLAKLLPPAHLQTSSIGVKGT 580
           + YLH       AH DLKP N++L  +   +    + DFG+A  +   +   +     GT
Sbjct: 121 VHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF---GT 174

Query: 581 IGYIAP---AEYGLGSEVSINGDVYSYGILL 608
             ++AP       LG E     D++S G++ 
Sbjct: 175 PEFVAPEIVNYEPLGLEA----DMWSIGVIT 201

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 58.6 bits (142), Expect = 3e-09
 Identities = 49/240 (20%), Positives = 89/240 (37%), Gaps = 56/240 (23%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVL-NLLHHGASKSSIAECSALRNIR--------HKNLVK 461
           G F +V+        T +A+K++     +   +++  E   L+ +               
Sbjct: 30  GHFSTVWLAKDMVNNTHVAMKIVRGDKVYT--EAAEDEIKLLQRVNDADNTKEDSMGANH 87

Query: 462 ILTVCSGVDYKGDDFK--ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNF----LQRI 515
           IL +    ++KG +     +V+E +   +L   +             K        L  +
Sbjct: 88  ILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALI-------------KKYEHRGIPLIYV 133

Query: 516 -NIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH------VADFGLAKLLPPA 568
             I+  +   L Y+H  C     H D+KP NVL++   +        +AD G A      
Sbjct: 134 KQISKQLLLGLDYMHRRCGII--HTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH 191

Query: 569 H---LQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGN 625
           +   +QT          Y +P E  LG+      D++S   L+ EL+T     D +FE +
Sbjct: 192 YTNSIQTRE--------YRSP-EVLLGAPWGCGADIWSTACLIFELITG----DFLFEPD 238

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 57.6 bits (140), Expect = 4e-09
 Identities = 48/211 (22%), Positives = 77/211 (36%), Gaps = 38/211 (18%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA------ECSALRNIRHKNLVKILT 464
           G F  V K          A K +      +S+  ++      E S L+ I+H N++ +  
Sbjct: 22  GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 81

Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
           V     Y+      L+ E +  G L          D   E  + L   +       +   
Sbjct: 82  V-----YENKTDVILILELVAGGEL---------FDFLAEK-ESLTEEEATEFLKQILNG 126

Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH----VADFGLAKLLPPAHLQTSSIGVKGT 580
           + YLH       AH DLKP N++L           + DFGLA  +   +   +     GT
Sbjct: 127 VYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GT 180

Query: 581 IGYIAP---AEYGLGSEVSINGDVYSYGILL 608
             ++AP       LG E     D++S G++ 
Sbjct: 181 PEFVAPEIVNYEPLGLEA----DMWSIGVIT 207

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 58.2 bits (141), Expect = 4e-09
 Identities = 45/222 (20%), Positives = 69/222 (31%), Gaps = 65/222 (29%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA--ECSALRNI-RHKNLVKILTVCS 467
           G  G V +      +   A+K+L            A  E        +  ++V+I+ V  
Sbjct: 73  GINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIVDVYE 125

Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRI------------ 515
              Y G     +V E +  G L                        RI            
Sbjct: 126 N-LYAGRKCLLIVMECLDGGEL----------------------FSRIQDRGDQAFTERE 162

Query: 516 --NIAIDVACALKYLHHDCQPTTAHCDLKPSNVLL---DHEMTAHVADFGLAKLLPPAH- 569
              I   +  A++YLH       AH D+KP N+L           + DFG AK     + 
Sbjct: 163 ASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 219

Query: 570 LQTSSIGVKGTIGYIAP---AEYGLGSEVSINGDVYSYGILL 608
           L T       T  Y+AP                D++S G+++
Sbjct: 220 LTT----PCYTPYYVAPEVLGPEKYDKSC----DMWSLGVIM 253

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 57.8 bits (140), Expect = 5e-09
 Identities = 47/303 (15%), Positives = 98/303 (32%), Gaps = 46/303 (15%)

Query: 78  NQHLKHLDINNNNFGG----LLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFI----- 128
              +  LD++ NN        L     N   ++ +L  + N +       + + +     
Sbjct: 21  PHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPA 80

Query: 129 NLQTLHMWDNQLSGTISPAIGEL-----QNLVTLAINTNKLSGNIPPSIGNL-----KKL 178
           N+ +L++  N LS   S  + +        +  L +  N  S                 +
Sbjct: 81  NVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASI 140

Query: 179 LQLYLIENFLQVSIPSSLGQC-----QSLTTINLSYNNLSGTIPPQLMDL-----TSLSV 228
             L L  N L +     L Q       ++ ++NL  NNL+     +L         S++ 
Sbjct: 141 TSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTS 200

Query: 229 GLDLSRNQLVGSLPTEVGKLI-----NLEILFISRNMLECE----ILSTLGSCIKLEQLK 279
            LDLS N L      E+  +      ++  L +  N L       +     S   L+ + 
Sbjct: 201 -LDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVY 259

Query: 280 LGGNLFQGP-------IPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYND 332
           L  ++ +         +  +  +++ + ++D +   I       +  L    +       
Sbjct: 260 LDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPS 319

Query: 333 LEG 335
           L  
Sbjct: 320 LLN 322

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 43.5 bits (103), Expect = 2e-04
 Identities = 30/221 (13%), Positives = 68/221 (30%), Gaps = 35/221 (15%)

Query: 22  NLLFLSLGFNQIT--GVIP-SSMFNA--SKLEVFQVTSNNLTGEVPSEFGKATKAYCVQN 76
           ++  L+L  N +          +  A  + +    +  NNL  +  +E  K      + +
Sbjct: 139 SITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKF-----LAS 193

Query: 77  CNQHLKHLDINNNNFG----GLLPGCICNFSITLETLIFNSNKI----FRSIPAGIGKFI 128
               +  LD++ N  G      L     +    + +L    N +      ++        
Sbjct: 194 IPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLK 253

Query: 129 NLQTLHMWDNQLSGT-------ISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQL 181
           +LQT+++  + +          +  A   +Q ++ +  N  ++  +    I NL + L  
Sbjct: 254 HLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSG 313

Query: 182 YLIENFL----------QVSIPSSLGQCQSLTTINLSYNNL 212
                 L            +    L     L     +   L
Sbjct: 314 KADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 43.2 bits (102), Expect = 2e-04
 Identities = 35/164 (21%), Positives = 62/164 (37%), Gaps = 28/164 (17%)

Query: 196 LGQCQSLTTINLSYNNLSGTIPPQLMDL-----TSLSVGLDLSRNQL----VGSLPTEVG 246
                 +T+++LS NNL      +L+        S++  L+LS N L       L  ++ 
Sbjct: 18  TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTS-LNLSGNSLGFKNSDEL-VQIL 75

Query: 247 KLIN--LEILFISRNMLECEILSTLGSCIK-----LEQLKLGGNLFQ--GPIPLS---LS 294
             I   +  L +S N L  +    L   +      +  L LG N F             +
Sbjct: 76  AAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSN 135

Query: 295 SLRGLRVLDLSQNNISGEIPKFLVEL-----QLVQNLNLSYNDL 333
               +  L+L  N++  +    L+++       V +LNL  N+L
Sbjct: 136 LPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNL 179

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 58.7 bits (141), Expect = 6e-09
 Identities = 100/653 (15%), Positives = 176/653 (26%), Gaps = 209/653 (32%)

Query: 48  EVFQVTSNNLTGEVPSEFGK--ATKAYCVQNCNQHLKHLDINNNNF--GGLLPGC--ICN 101
            ++    + L  +    F K   ++        Q L  L    N    G  + G      
Sbjct: 110 RMYIEQRDRLYNDNQV-FAKYNVSRLQPYLKLRQALLELRPAKNVLIDG--VLGSGKTW- 165

Query: 102 FSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPA--IGELQNLVTLAI 159
             + L+     S K+   +   I  F        W N L    SP   +  LQ L+   I
Sbjct: 166 --VALDVC--LSYKVQCKMDFKI--F--------WLN-LKNCNSPETVLEMLQKLLYQ-I 209

Query: 160 NTNKLSG-----NIPPSIGNLKKLLQLYLIENFLQ--------VSIPSSL----GQCQSL 202
           + N  S      NI   I +++  L+  L     +        V    +       C+ L
Sbjct: 210 DPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKIL 269

Query: 203 TTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRN-QLVGSLPTEVGKLINLEILFISRNML 261
            T                            +R  Q+   L       I+L+    S  + 
Sbjct: 270 LT----------------------------TRFKQVTDFLSAATTTHISLD--HHSMTLT 299

Query: 262 ECEILSTLGSCIKLEQLKL-----GGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKF 316
             E+ S L   +      L       N      P  LS +    + D             
Sbjct: 300 PDEVKSLLLKYLDCRPQDLPREVLTTN------PRRLSII-AESIRD--GLATWDNWKHV 350

Query: 317 LVELQLVQNLNLSYNDLEGVIPTE--GVFKNASAISVFGNSKLCGGIPEFQLPICGLEKS 374
             + +L   +  S N LE   P E   +F     +SVF         P            
Sbjct: 351 NCD-KLTTIIESSLNVLE---PAEYRKMFD---RLSVF---------PP----------- 383

Query: 375 KHKRLTIAVKLAAAIISVLVGILLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLN 434
                  +  +   ++S++             W D+                   + V+N
Sbjct: 384 -------SAHIPTILLSLI-------------WFDV--------------IKSDVMVVVN 409

Query: 435 LLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLH 494
            LH    K S+ E     +      + +         K ++  AL     H   ++ +  
Sbjct: 410 KLH----KYSLVEKQPKESTISIPSIYLELKV-----KLENEYAL-----HRSIVDHY-- 453

Query: 495 PVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTA 554
                      PK  +    I   +D     +Y +        H        +  H    
Sbjct: 454 ---------NIPKTFDSDDLIPPYLD-----QYFYS-------H--------IGHHLKNI 484

Query: 555 HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTR 614
              +     L     L    +  K  I + + A    GS ++    +  Y       +  
Sbjct: 485 EHPE--RMTLFRMVFLDFRFLEQK--IRHDSTAWNASGSILNTLQQLKFYK----PYICD 536

Query: 615 KRPSDIMFEGNM--NLHNFARTVLPDHVMDIVDSTLLADDEDLTITSN-QRQR 664
             P        +   L      ++     D++   L+A+DE +   ++ Q QR
Sbjct: 537 NDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALMAEDEAIFEEAHKQVQR 589

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 51.0 bits (121), Expect = 1e-06
 Identities = 80/516 (15%), Positives = 163/516 (31%), Gaps = 142/516 (27%)

Query: 241 LPTEVG--KLINLEILFISRNM----LEC-EILSTLGSCIKLEQLKLGGNLFQGPIPLSL 293
           +  E G  +    +IL +  +      +C ++     S +  E++    ++      +S 
Sbjct: 7   MDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEID---HIIMSKDAVS- 62

Query: 294 SSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKNASAISVFG 353
            +LR    L   Q  +   + KF+ E+     L ++Y  L   I TE   +  S ++   
Sbjct: 63  GTLRLFWTLLSKQEEM---VQKFVEEV-----LRINYKFLMSPIKTE--QRQPSMMTRMY 112

Query: 354 NS---KLCGGIPEF-QLPICGLEKSKHKRLTIAV-KLAAAIISVLVGILLFVSFLFLCWI 408
                +L      F +  +  L+   + +L  A+ +L  A   ++ G             
Sbjct: 113 IEQRDRLYNDNQVFAKYNVSRLQP--YLKLRQALLELRPAKNVLIDG------------- 157

Query: 409 DMGSFGSVYKGILDEGKTIIAVKVLN---LLHHGASKS---SIAECSALRNIRHKNLVKI 462
            +   GS        GKT +A+ V     +      K    ++  C+       + ++++
Sbjct: 158 -VL--GS--------GKTWVALDVCLSYKVQCKMDFKIFWLNLKNCN-----SPETVLEM 201

Query: 463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVA 522
           L             + L+Y+   N +        S +D +           RI+      
Sbjct: 202 L-------------QKLLYQIDPNWT--------SRSDHSSNIK------LRIHSIQA-- 232

Query: 523 CALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGL-AKLLPPAHLQTSSIGVKGTI 581
             L+ L         +C L    VLL+ +       F L  K+L    L T    V   +
Sbjct: 233 -ELRRLL--KSKPYENCLL----VLLNVQNAKAWNAFNLSCKIL----LTTRFKQVTDFL 281

Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILL--LELMTRKRPSDI-------------MFEGNM 626
                    L              +LL  L+   +  P ++                  +
Sbjct: 282 SAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGL 341

Query: 627 NLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARIN------NIMECLISVV- 679
              +  + V  D +  I++S+L      L   +  R+   R++      +I   L+S++ 
Sbjct: 342 ATWDNWKHVNCDKLTTIIESSL----NVLE-PAEYRKMFDRLSVFPPSAHIPTILLSLIW 396

Query: 680 ---------RIGVACSMES--PQDRMNMTIVVHELQ 704
                     +       S   +     TI +  + 
Sbjct: 397 FDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIY 432

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 55.0 bits (133), Expect = 9e-09
 Identities = 33/138 (23%), Positives = 64/138 (46%), Gaps = 20/138 (14%)

Query: 96  PGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLV 155
             C C      +T++  SNK  + +P GI    ++  L++  NQ +  +   +   ++L 
Sbjct: 6   TECTCL-----DTVVRCSNKGLKVLPKGI--PRDVTELYLDGNQFT-LVPKELSNYKHLT 57

Query: 156 TLAINTNKLSGNIPPSI-GNLKKLLQLYLIENFLQVSIPS----SLGQCQSLTTINLSYN 210
            + ++ N++S  +      N+ +LL L L  N L+  IP      L     L  ++L  N
Sbjct: 58  LIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR-CIPPRTFDGLKS---LRLLSLHGN 112

Query: 211 NLSGTIPPQLMD-LTSLS 227
           ++S  +P    + L++LS
Sbjct: 113 DIS-VVPEGAFNDLSALS 129

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 50.4 bits (121), Expect = 3e-07
 Identities = 29/97 (29%), Positives = 42/97 (43%), Gaps = 12/97 (12%)

Query: 167 NIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMD-LTS 225
            IP  +  L      YL  N     +P  L   + LT I+LS N +S T+  Q    +T 
Sbjct: 28  GIPRDVTEL------YLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQ 79

Query: 226 LSVGLDLSRNQLVGSLPTEV-GKLINLEILFISRNML 261
           L   L LS N+L   +P      L +L +L +  N +
Sbjct: 80  LLT-LILSYNRL-RCIPPRTFDGLKSLRLLSLHGNDI 114

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 48.4 bits (116), Expect = 2e-06
 Identities = 25/110 (22%), Positives = 50/110 (45%), Gaps = 8/110 (7%)

Query: 105 TLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAI-GELQNLVTLAINTNK 163
            +  L  + N+    +P  +  + +L  + + +N++S T+S      +  L+TL ++ N+
Sbjct: 32  DVTELYLDGNQF-TLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNR 89

Query: 164 LSGNIPPSI-GNLKKLLQLYLIENFLQVSIP-SSLGQCQSLTTINLSYNN 211
           L   IPP     LK L  L L  N +   +P  +     +L+ + +   N
Sbjct: 90  LR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAI-GAN 136

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 55.1 bits (133), Expect = 1e-08
 Identities = 48/159 (30%), Positives = 74/159 (46%), Gaps = 17/159 (10%)

Query: 113 SNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSI 172
            ++   S+P GI        L +  N L    +    EL +L  L +  NKL  ++P  +
Sbjct: 15  YSQGRTSVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGV 71

Query: 173 GN-LKKLLQLYLIENFLQVSIPS----SLGQCQSLTTINLSYNNLSGTIPPQLMD-LTSL 226
            N L  L  L L  N LQ S+P+     L Q   L  + L+ N L  ++P  + D LT L
Sbjct: 72  FNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQ---LKELALNTNQLQ-SLPDGVFDKLTQL 126

Query: 227 SVGLDLSRNQLVGSLPTEV-GKLINLEILFISRNMLECE 264
              L L +NQL  S+P  V  +L +L+ +++  N  +C 
Sbjct: 127 KD-LRLYQNQL-KSVPDGVFDRLTSLQYIWLHDNPWDCT 163

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 40.8 bits (96), Expect = 6e-04
 Identities = 36/158 (22%), Positives = 60/158 (37%), Gaps = 24/158 (15%)

Query: 8   VQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGK 67
           V  GIP           +L L  N +  +        + L    +  N L       F K
Sbjct: 22  VPTGIPAQ-------TTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNK 74

Query: 68  ATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNF-SIT-LETLIFNSNKIFRSIPAGI- 124
            T           L +L+++ N    L  G    F  +T L+ L  N+N++ +S+P G+ 
Sbjct: 75  LTS----------LTYLNLSTNQLQSLPNGV---FDKLTQLKELALNTNQL-QSLPDGVF 120

Query: 125 GKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTN 162
            K   L+ L ++ NQL          L +L  + ++ N
Sbjct: 121 DKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDN 158

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 56.3 bits (135), Expect = 1e-08
 Identities = 23/105 (21%), Positives = 41/105 (39%), Gaps = 5/105 (4%)

Query: 161 TNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPS-SLGQCQSLTTINLSYNNLSGTIPPQ 219
           T   + +    +   + L +LY+        +    L     L  + +  + L   + P 
Sbjct: 16  TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPD 74

Query: 220 -LMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLEC 263
                  LS  L+LS N L  SL  +  + ++L+ L +S N L C
Sbjct: 75  AFHFTPRLSR-LNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHC 117

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 51.7 bits (123), Expect = 5e-07
 Identities = 22/94 (23%), Positives = 42/94 (44%), Gaps = 3/94 (3%)

Query: 146 PAIGELQNLVTLAINTNKLSGNIPP-SIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTT 204
             +   +NL  L I   +   ++    +  L +L  L ++++ L+   P +      L+ 
Sbjct: 25  HHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSR 84

Query: 205 INLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLV 238
           +NLS+N L  ++  + +   SL   L LS N L 
Sbjct: 85  LNLSFNALE-SLSWKTVQGLSLQE-LVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 45.5 bits (107), Expect = 3e-05
 Identities = 20/95 (21%), Positives = 36/95 (37%), Gaps = 5/95 (5%)

Query: 191 SIPSSLGQCQSLTTINLSYNNLSGTIPPQ-LMDLTSLSVGLDLSRNQLVGSLPTEV-GKL 248
                L   ++LT + +        +  + L  L  L   L + ++ L   +  +     
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN-LTIVKSGLR-FVAPDAFHFT 79

Query: 249 INLEILFISRNMLECEILSTLGSCIKLEQLKLGGN 283
             L  L +S N LE     T+   + L++L L GN
Sbjct: 80  PRLSRLNLSFNALESLSWKTVQG-LSLQELVLSGN 113

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 45.5 bits (107), Expect = 4e-05
 Identities = 25/136 (18%), Positives = 40/136 (29%), Gaps = 28/136 (20%)

Query: 199 CQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEV-GKLINLEILFIS 257
               + +  + +         L    +L+  L +   Q +  L       L  L  L I 
Sbjct: 7   PHGSSGLRCTRDGAL-DSLHHLPGAENLTE-LYIENQQHLQHLELRDLRGLGELRNLTIV 64

Query: 258 RNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFL 317
           ++ L                  +  + F             L  L+LS N +     K +
Sbjct: 65  KSGLRF----------------VAPDAFHF--------TPRLSRLNLSFNALESLSWKTV 100

Query: 318 VELQLVQNLNLSYNDL 333
             L L Q L LS N L
Sbjct: 101 QGLSL-QELVLSGNPL 115

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 53.5 bits (129), Expect = 3e-08
 Identities = 34/122 (27%), Positives = 57/122 (46%), Gaps = 15/122 (12%)

Query: 113 SNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAI-GELQNLVTLAINTNKLSGNIPPS 171
           + +  + IP  I   ++   L + DN+L    S  + G L +LV L +  N+L+  I P+
Sbjct: 16  TGRGLKEIPRDI--PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPN 72

Query: 172 I-GNLKKLLQLYLIENFLQVSIPS----SLGQCQSLTTINLSYNNLSGTIPPQLMD-LTS 225
                  + +L L EN ++  I +     L Q   L T+NL  N +S  + P   + L S
Sbjct: 73  AFEGASHIQELQLGENKIK-EISNKMFLGLHQ---LKTLNLYDNQIS-CVMPGSFEHLNS 127

Query: 226 LS 227
           L+
Sbjct: 128 LT 129

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 50.4 bits (121), Expect = 3e-07
 Identities = 23/105 (21%), Positives = 41/105 (39%), Gaps = 4/105 (3%)

Query: 84  LDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGI-GKFINLQTLHMWDNQLSG 142
           L +N+N  G +    +      L  L    N++   I         ++Q L + +N++  
Sbjct: 34  LLLNDNELGRISSDGLFGRLPHLVKLELKRNQL-TGIEPNAFEGASHIQELQLGENKIKE 92

Query: 143 TISPAIGELQNLVTLAINTNKLSGNIPPSI-GNLKKLLQLYLIEN 186
             +     L  L TL +  N++S  + P    +L  L  L L  N
Sbjct: 93  ISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 50.4 bits (121), Expect = 3e-07
 Identities = 29/111 (26%), Positives = 49/111 (44%), Gaps = 12/111 (10%)

Query: 107 ETLIFNSNKIFRSIPAGI-GKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLS 165
             L+ N N++ R    G+ G+  +L  L +  NQL+G    A     ++  L +  NK+ 
Sbjct: 32  TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK 91

Query: 166 GNIPPSI-GNLKKLLQLYLIENFLQVSIPS----SLGQCQSLTTINLSYNN 211
             I   +   L +L  L L +N +   +       L    SLT++NL  +N
Sbjct: 92  -EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHL---NSLTSLNL-ASN 136

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 54.1 bits (129), Expect = 7e-08
 Identities = 33/195 (16%), Positives = 56/195 (28%), Gaps = 57/195 (29%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVL--------NLLHHGASKSSIAECSALRNI-------- 454
           G FG V++ I D   T +A+K++        N  H    +  + E    + +        
Sbjct: 31  GVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVC 88

Query: 455 -RHKNLVKILTVC-------------------------SGVDYKGDDFKALVYEFMHNGS 488
            R +  + + +V                             D+  DD   +V EF   G 
Sbjct: 89  NRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGI 148

Query: 489 LEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLL 548
             E +             K  +     +I   +  +L       +    H DL   NVLL
Sbjct: 149 DLEQMR-----------TKLSSLATAKSILHQLTASLAVAEASLRFE--HRDLHWGNVLL 195

Query: 549 DHEMTAHVADFGLAK 563
                  +      K
Sbjct: 196 KKTSLKKLHYTLNGK 210

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 51.6 bits (124), Expect = 1e-07
 Identities = 38/158 (24%), Positives = 65/158 (41%), Gaps = 22/158 (13%)

Query: 183 LIENFLQVSIPSSLGQCQSLTTINL--SYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGS 240
            I++ +++              + L      +   +   L  L +    L LS N +   
Sbjct: 6   TIKDAIRIFEERKSVVATEAEKVELHGMIPPIEK-MDATLSTLKACKH-LALSTNNI--- 60

Query: 241 LPTEV---GKLINLEILFISRNMLE-CEILSTLGSCIKLEQLKLGGNLFQGPIPLS-LSS 295
              ++     + NL IL + RN+++  E L  +     LE+L +  N       LS +  
Sbjct: 61  --EKISSLSGMENLRILSLGRNLIKKIENLDAV--ADTLEELWISYNQIAS---LSGIEK 113

Query: 296 LRGLRVLDLSQNNIS--GEIPKFLVELQLVQNLNLSYN 331
           L  LRVL +S N I+  GEI   L  L  +++L L+ N
Sbjct: 114 LVNLRVLYMSNNKITNWGEI-DKLAALDKLEDLLLAGN 150

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 50.5 bits (121), Expect = 3e-07
 Identities = 30/140 (21%), Positives = 61/140 (43%), Gaps = 8/140 (5%)

Query: 177 KLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQ 236
           + ++L+ +   ++  + ++L   ++   + LS NN+   I   L  + +L + L L RN 
Sbjct: 26  EKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KISS-LSGMENLRI-LSLGRNL 81

Query: 237 LVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLS-LSS 295
           +   +         LE L+IS N +    LS +   + L  L +  N       +  L++
Sbjct: 82  IK-KIENLDAVADTLEELWISYNQIAS--LSGIEKLVNLRVLYMSNNKITNWGEIDKLAA 138

Query: 296 LRGLRVLDLSQNNISGEIPK 315
           L  L  L L+ N +  +  +
Sbjct: 139 LDKLEDLLLAGNPLYNDYKE 158

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 50.1 bits (120), Expect = 5e-07
 Identities = 27/131 (20%), Positives = 52/131 (39%), Gaps = 8/131 (6%)

Query: 109 LIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNI 168
           L      I   + A +      + L +  N +   IS  +  ++NL  L++  N +   I
Sbjct: 30  LHGMIPPI-EKMDATLSTLKACKHLALSTNNIE-KISS-LSGMENLRILSLGRNLIK-KI 85

Query: 169 PPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSG-TIPPQLMDLTSLS 227
                    L +L++  N  Q++  S + +  +L  + +S N ++      +L  L  L 
Sbjct: 86  ENLDAVADTLEELWISYN--QIASLSGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLE 143

Query: 228 VGLDLSRNQLV 238
             L L+ N L 
Sbjct: 144 D-LLLAGNPLY 153

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 47.0 bits (112), Expect = 5e-06
 Identities = 24/115 (20%), Positives = 42/115 (36%), Gaps = 6/115 (5%)

Query: 106 LETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLS 165
            + L  ++N I   I + +    NL+ L +  N +   I         L  L I+ N+++
Sbjct: 50  CKHLALSTNNI-EKI-SSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA 106

Query: 166 GNIPPSIGNLKKLLQLYLIENFLQ-VSIPSSLGQCQSLTTINLSYNNLSGTIPPQ 219
            ++   I  L  L  LY+  N +        L     L  + L+ N L       
Sbjct: 107 -SLSG-IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKEN 159

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 53.2 bits (128), Expect = 2e-07
 Identities = 38/308 (12%), Positives = 90/308 (29%), Gaps = 55/308 (17%)

Query: 43  NASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGC--IC 100
               L+   + S  L                +       + L +  N+ G     C  + 
Sbjct: 99  GRHALDEVNLASCQLDPAG---------LRTLLPVFLRARKLGLQLNSLGP--EACKDLR 147

Query: 101 NFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGT----ISPAIGELQNLVT 156
                 + L+ +                 + TL + +N L+      +   +    ++  
Sbjct: 148 ------DLLLHDQ--------------CQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTH 187

Query: 157 LAINTNKLSGN----IPPSIGNLKKLLQLYLIENFLQ----VSIPSSLGQCQSLTTINLS 208
           L++    L       +   +   ++L +L +  N       +++  +  +  SL  ++L 
Sbjct: 188 LSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLY 247

Query: 209 YNNLSGTIPPQLMD-LTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILS 267
           +N LS      L D   +   G  +  +   G+  +E   +I  E+     +     +  
Sbjct: 248 FNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSEYWSVILSEVQRNLNSWDRARVQR 307

Query: 268 TLGSCIKLEQLKLGGNLFQ--GPIPLS--LSSLRGLRVLDLSQNNISGEIPKFLVELQLV 323
            L    +L    L  +      P   +  L     +R L     +       +    Q  
Sbjct: 308 HL----ELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSSGSPSGSWSHP-QFE 362

Query: 324 QNLNLSYN 331
           +     ++
Sbjct: 363 KGAGHHHH 370

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 53.2 bits (128), Expect = 2e-07
 Identities = 52/237 (21%), Positives = 89/237 (37%), Gaps = 48/237 (20%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVL-NLLHHGASKSSIAECSALRNIRHK---NLVKILTVC 466
           GSFG V K    +    +A+K++ N       + +  E   L ++R +   N + ++ + 
Sbjct: 108 GSFGQVVKAYDHKVHQHVALKMVRN--EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHML 165

Query: 467 SGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNF----LQRI-NIAIDV 521
               ++      + +E +   +L E +             K   F    L  +   A  +
Sbjct: 166 ENFTFRN--HICMTFELLSM-NLYELI-------------KKNKFQGFSLPLVRKFAHSI 209

Query: 522 ACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH--VADFGLAKLLPPAH---LQTSSIG 576
              L  L H  +    HCDLKP N+LL  +  +   V DFG +          +Q+    
Sbjct: 210 LQCLDAL-HKNRII--HCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF-- 264

Query: 577 VKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFAR 633
                 Y AP E  LG+   +  D++S G +L EL+T       +  G       A 
Sbjct: 265 ------YRAP-EVILGARYGMPIDMWSLGCILAELLTGY----PLLPGEDEGDQLAC 310

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 49.3 bits (118), Expect = 3e-07
 Identities = 28/139 (20%), Positives = 48/139 (34%), Gaps = 16/139 (11%)

Query: 174 NLKKLLQLYLIEN-FLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDL 232
               + +L L  +   +  +     + + L  ++     L+ +I   L  L  L   L+L
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIA-NLPKLNKLKK-LEL 71

Query: 233 SRNQLVGSLPTEVGKLINLEILFISRNMLEC-EILSTLGSCIKLEQLKLGGNLFQGPI-- 289
           S N++ G L     K  NL  L +S N ++    +  L     L+ L L        +  
Sbjct: 72  SDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC----EVTN 127

Query: 290 -----PLSLSSLRGLRVLD 303
                      L  L  LD
Sbjct: 128 LNDYRENVFKLLPQLTYLD 146

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 39.7 bits (93), Expect = 8e-04
 Identities = 24/110 (21%), Positives = 47/110 (42%), Gaps = 9/110 (8%)

Query: 250 NLEILFISRNML-ECEILSTLGSCIKLEQLKLGGNLFQGPIPLS-LSSLRGLRVLDLSQN 307
           +++ L +  +   E ++        +LE L            ++ L  L  L+ L+LS N
Sbjct: 18  DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS---IANLPKLNKLKKLELSDN 74

Query: 308 NISGEIPKFLVELQLVQNLNLSYN---DLEGVIPTEGVFKNASAISVFGN 354
            +SG +     +   + +LNLS N   DL  + P +   +N  ++ +F  
Sbjct: 75  RVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKK-LENLKSLDLFNC 123

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 48.8 bits (117), Expect = 9e-07
 Identities = 37/121 (30%), Positives = 58/121 (47%), Gaps = 14/121 (11%)

Query: 113 SNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSI 172
           ++K   S+P GI    +   L +  N+L         +L  L  L+++ N++  ++P  +
Sbjct: 15  NSKGLTSVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGV 71

Query: 173 -GNLKKLLQLYLIENFLQVSIPS----SLGQCQSLTTINLSYNNLSGTIPPQLMD-LTSL 226
              L KL  LYL EN LQ S+P+     L Q   L  + L  N L  ++P  + D LTSL
Sbjct: 72  FDKLTKLTILYLHENKLQ-SLPNGVFDKLTQ---LKELALDTNQLK-SVPDGIFDRLTSL 126

Query: 227 S 227
            
Sbjct: 127 Q 127

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 50.9 bits (122), Expect = 9e-07
 Identities = 36/178 (20%), Positives = 67/178 (37%), Gaps = 40/178 (22%)

Query: 408 IDMGSFGSVYKGILDEG-----KTIIAVKV-----------LNLLHHGASKSSIAECSAL 451
           I  G FG +Y   ++            VKV           L      A    I +    
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102

Query: 452 RNIRHKNLVKILTVCSGV-DYKGDDFKALVYEFMHNG-SLEEWLHPVSGA--DKTVEAPK 507
           R +++  + K     SG+ D  G  ++ ++ +    G  L++     +     KTV    
Sbjct: 103 RKLKYLGVPKY--WGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTV---- 154

Query: 508 CLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLD--HEMTAHVADFGLAK 563
                  + +++ +   L+Y+H        H D+K SN+LL+  +    ++ D+GLA 
Sbjct: 155 -------LQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 50.1 bits (120), Expect = 1e-06
 Identities = 27/180 (15%), Positives = 58/180 (32%), Gaps = 44/180 (24%)

Query: 408 IDMGSFGSVYKGILDEGKTI--------IAVKV----------LNLLHHGASKSSIAECS 449
               + G +Y+       T          ++K+           N     A    + +  
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 450 ALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNG-SLEEWLHPVSGAD---KTVEA 505
            L +     +     +  GV    D ++ LV   +  G SL+  L          ++V  
Sbjct: 110 KLYSTPLLAIPTC--MGFGVH--QDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSV-- 161

Query: 506 PKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLL--DHEMTAHVADFGLAK 563
                    + +A  +  AL++LH +      H ++   N+ +  + +    +A +G A 
Sbjct: 162 ---------LQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 50.1 bits (120), Expect = 2e-06
 Identities = 51/244 (20%), Positives = 90/244 (36%), Gaps = 48/244 (19%)

Query: 405 LCWIDMGSFGSVYKGILDEGKTIIAVKVL--NLLHHGASKSSIAECSALRNIRHK---NL 459
              I  GSFG V K      +  +A+K++         ++    E   L  +        
Sbjct: 59  DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQI---EVRLLELMNKHDTEMK 115

Query: 460 VKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNF----LQRI 515
             I+ +     ++      LV+E +   +L + L             +  NF    L   
Sbjct: 116 YYIVHLKRHFMFRN--HLCLVFEMLSY-NLYDLL-------------RNTNFRGVSLNLT 159

Query: 516 -NIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH--VADFGLAKLLPPAH--- 569
              A  +  AL +L    + +  HCDLKP N+LL +   +   + DFG +  L       
Sbjct: 160 RKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQY 218

Query: 570 LQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLH 629
           +Q+          Y +P E  LG    +  D++S G +L+E+ T     + +F G   + 
Sbjct: 219 IQSRF--------YRSP-EVLLGMPYDLAIDMWSLGCILVEMHT----GEPLFSGANEVD 265

Query: 630 NFAR 633
              +
Sbjct: 266 QMNK 269

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 48.0 bits (115), Expect = 2e-06
 Identities = 40/105 (38%), Positives = 55/105 (52%), Gaps = 15/105 (14%)

Query: 113 SNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAI-GELQNLVTLAINTNKLSGNIPPS 171
            N    S+PAGI    + Q L + +NQ++  + P +   L NL  L  N+NKL+  IP  
Sbjct: 20  QNIRLASVPAGI--PTDKQRLWLNNNQIT-KLEPGVFDHLVNLQQLYFNSNKLT-AIPTG 75

Query: 172 I-GNLKKLLQLYLIENFLQVSIPS----SLGQCQSLTTINLSYNN 211
           +   L +L QL L +N L+ SIP     +L    SLT I L YNN
Sbjct: 76  VFDKLTQLTQLDLNDNHLK-SIPRGAFDNLK---SLTHIYL-YNN 115

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 41.1 bits (97), Expect = 4e-04
 Identities = 26/84 (30%), Positives = 40/84 (47%), Gaps = 4/84 (4%)

Query: 105 TLETLIFNSNKIFRSIPAGI-GKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNK 163
             + L  N+N+I   +  G+    +NLQ L+   N+L+   +    +L  L  L +N N 
Sbjct: 34  DKQRLWLNNNQI-TKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNH 92

Query: 164 LSGNIPPSI-GNLKKLLQLYLIEN 186
           L  +IP     NLK L  +YL  N
Sbjct: 93  LK-SIPRGAFDNLKSLTHIYLYNN 115

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 47.6 bits (114), Expect = 2e-06
 Identities = 35/104 (33%), Positives = 51/104 (49%), Gaps = 13/104 (12%)

Query: 113 SNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSI 172
           S K   S+P GI      Q L+++DNQ++         L  L  L ++ N+L+  +P  +
Sbjct: 17  SGKSLASVPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGV 73

Query: 173 -GNLKKLLQLYLIENFLQVSIPS----SLGQCQSLTTINLSYNN 211
              L +L QL L +N L+ SIP     +L    SLT I L  NN
Sbjct: 74  FDKLTQLTQLSLNDNQLK-SIPRGAFDNLK---SLTHIWL-LNN 112

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 40.7 bits (96), Expect = 4e-04
 Identities = 24/84 (28%), Positives = 41/84 (48%), Gaps = 4/84 (4%)

Query: 105 TLETLIFNSNKIFRSIPAGI-GKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNK 163
           T + L    N+I   +  G+  +   L  L + +NQL+   +    +L  L  L++N N+
Sbjct: 31  TTQVLYLYDNQI-TKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQ 89

Query: 164 LSGNIPPSI-GNLKKLLQLYLIEN 186
           L  +IP     NLK L  ++L+ N
Sbjct: 90  LK-SIPRGAFDNLKSLTHIWLLNN 112

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 49.0 bits (117), Expect = 3e-06
 Identities = 36/176 (20%), Positives = 67/176 (38%), Gaps = 39/176 (22%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKV--------------LNLLHHGASKSSIAECSALRN 453
           I  G FG +Y           A  V              L      A K  I +    + 
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104

Query: 454 IRHKNLVKILTVCSGV-DYKGDDFKALVYEFMHNG-SLEEWLHPVSGA--DKTVEAPKCL 509
           + +  +       SG+ ++KG  ++ +V E +  G  L++ +   +G     TV      
Sbjct: 105 LDYLGIPLF--YGSGLTEFKGRSYRFMVMERL--GIDLQK-ISGQNGTFKKSTV------ 153

Query: 510 NFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLD--HEMTAHVADFGLAK 563
                + + I +   L+Y+H +      H D+K +N+LL   +    ++AD+GL+ 
Sbjct: 154 -----LQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 47.8 bits (114), Expect = 7e-06
 Identities = 40/170 (23%), Positives = 60/170 (35%), Gaps = 42/170 (24%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           I  G+FG +  G        +A+K+             +    L         K L    
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKLE---------PMKSRAPQLH--LEYRFYKQLGSGD 65

Query: 468 G---VDYKG--DDFKALVYEFMHNG-SLEEWLHPVSGA--DKTVEAPKCLNFLQRINIAI 519
           G   V Y G    + A+V E +  G SLE+           KTV           + IAI
Sbjct: 66  GIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTV-----------LMIAI 112

Query: 520 DVACALKYLH-HDCQPTTAHCDLKPSNVLLDHEMTA-----HVADFGLAK 563
            +   ++Y+H  +      + D+KP N L+           H+ DF LAK
Sbjct: 113 QLISRMEYVHSKNL----IYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 45.9 bits (109), Expect = 7e-06
 Identities = 28/115 (24%), Positives = 43/115 (37%), Gaps = 9/115 (7%)

Query: 200 QSLTTINLSYNNLS-GTIPPQLMDLTSLSVGLDLSRNQL--VGSLPTEVGKLINLEILFI 256
            ++  + L     + G I     +  +L   L L    L  V +LP    KL  L+ L +
Sbjct: 24  AAVRELVLDNCKSNDGKIEGLTAEFVNLEF-LSLINVGLISVSNLP----KLPKLKKLEL 78

Query: 257 SRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLS-LSSLRGLRVLDLSQNNIS 310
           S N +   +         L  L L GN  +    L  L  L  L+ LDL    ++
Sbjct: 79  SENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT 133

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 45.8 bits (109), Expect = 1e-05
 Identities = 22/120 (18%), Positives = 42/120 (35%), Gaps = 9/120 (7%)

Query: 194 SSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQL--VGSLPTEVGKLINL 251
           +          ++L    +   I      L      +D S N++  +   P     L  L
Sbjct: 13  AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDA-IDFSDNEIRKLDGFP----LLRRL 66

Query: 252 EILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLS-LSSLRGLRVLDLSQNNIS 310
           + L ++ N +         +   L +L L  N       L  L+SL+ L  L + +N ++
Sbjct: 67  KTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 126

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 45.0 bits (107), Expect = 2e-05
 Identities = 25/128 (19%), Positives = 47/128 (36%), Gaps = 13/128 (10%)

Query: 112 NSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLS--GNIP 169
            +  I ++  A     +  + L +   ++   I      L     +  + N++      P
Sbjct: 5   TAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP 61

Query: 170 PSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLS--GTIPPQLMDLTSLS 227
                L++L  L +  N +             LT + L+ N+L   G + P L  L SL+
Sbjct: 62  ----LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDP-LASLKSLT 116

Query: 228 VGLDLSRN 235
             L + RN
Sbjct: 117 Y-LCILRN 123

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 46.9 bits (112), Expect = 1e-05
 Identities = 42/202 (20%), Positives = 61/202 (30%), Gaps = 68/202 (33%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA--ECSALRNI-RHKNLVKILTVCS 467
           G  G V +      +   A+K+L            A  E        +  ++V+I+ V  
Sbjct: 29  GINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIVDVYE 81

Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRI------------ 515
              Y G     +V E +  G L                        RI            
Sbjct: 82  N-LYAGRKCLLIVMECLDGGEL----------------------FSRIQDRGDQAFTERE 118

Query: 516 --NIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHE---MTAHVADFGLAKLLPPAHL 570
              I   +  A++YLH       AH D+KP N+L   +       + DFG AK       
Sbjct: 119 ASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET----T 171

Query: 571 QTS--------SIGVKGTIGYI 584
                      S+GV   I YI
Sbjct: 172 GEKYDKSCDMWSLGV---IMYI 190

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 45.8 bits (109), Expect = 3e-05
 Identities = 43/173 (24%), Positives = 67/173 (38%), Gaps = 50/173 (28%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNL---VKILT 464
           I  GSFG +Y G        +A+K+              EC      +H  L    KI  
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKL--------------EC---VKTKHPQLHIESKIYK 59

Query: 465 VCSG------VDYKG--DDFKALVYEFMHNG-SLEEWLHPVSG--ADKTVEAPKCLNFLQ 513
           +  G      + + G   D+  +V E +  G SLE+  +  S   + KTV          
Sbjct: 60  MMQGGVGIPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTV---------- 107

Query: 514 RINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH---VADFGLAK 563
            + +A  +   ++Y+H        H D+KP N L+      +   + DFGLAK
Sbjct: 108 -LLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 43.5 bits (103), Expect = 1e-04
 Identities = 39/169 (23%), Positives = 62/169 (36%), Gaps = 40/169 (23%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           I  GSFG +++G        +A+K          +   ++   LR        K+L  C+
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIK---------FEPRRSDAPQLR--DEYRTYKLLAGCT 66

Query: 468 G---VDYKG--DDFKALVYEFMHNG-SLEEWLHPVSGA--DKTVEAPKCLNFLQRINIAI 519
           G   V Y G       LV + +  G SLE+ L         KTV              A 
Sbjct: 67  GIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTV-----------AMAAK 113

Query: 520 DVACALKYLHHDCQPTTAHCDLKPSNVLL-----DHEMTAHVADFGLAK 563
            +   ++ +H        + D+KP N L+      +    +V DFG+ K
Sbjct: 114 QMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 43.4 bits (101), Expect = 2e-04
 Identities = 37/242 (15%), Positives = 74/242 (30%), Gaps = 38/242 (15%)

Query: 111 FNSNKIFRSIPAGIGKFINLQTLHMWDNQLS---------GTISPAIGELQNLVTLAINT 161
            + + I   I     KF + + L   D               +SP +  +  L  L I  
Sbjct: 122 EDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKG 181

Query: 162 NKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQ--SLTTINLSYNNLSGTIPPQ 219
                N+         L  L +I   L  S+   +      +L  + L            
Sbjct: 182 T---NNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGD 238

Query: 220 LMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLK 279
           +     L                    +  NL+ L I     +  ++        L QL+
Sbjct: 239 MNVFRPLFSK----------------DRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLE 282

Query: 280 ---LGGNLF--QGPIPL--SLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYND 332
              +   +   +G   L   +  ++ L+ +++  N +S E+ K L +  L   +++S + 
Sbjct: 283 TMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKS-LPMKIDVSDSQ 341

Query: 333 LE 334
             
Sbjct: 342 EY 343

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 43.3 bits (102), Expect = 2e-04
 Identities = 35/259 (13%), Positives = 87/259 (33%), Gaps = 47/259 (18%)

Query: 74  VQNCNQHLKHLDINNNNFGGLLPGCICNFSI---TLETLIFN--SNKI-FRSIPAGIGKF 127
              C ++LK LD+  ++   +    + +F     +L +L  +  ++++ F ++   + + 
Sbjct: 152 AATC-RNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRC 210

Query: 128 INLQTLHMWDNQLSGTISPAIGELQNLVTLAIN------TNKLSGNIPPSIGNLKKLLQL 181
            NL++L +        ++  +     L  L            +   +  ++   K+L  L
Sbjct: 211 PNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCL 270

Query: 182 YLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSL 241
               + +   +P+    C  LTT+NLSY  +                       +L+   
Sbjct: 271 SGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQ-----------------SYDLVKLLCQC 313

Query: 242 PTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLS--------- 292
           P        L+ L++   + +  +     +C  L +L++  +      P           
Sbjct: 314 P-------KLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVS 366

Query: 293 -LSSLRGLRVLDLSQNNIS 310
                  L  +      ++
Sbjct: 367 VSMGCPKLESVLYFCRQMT 385

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 42.6 bits (100), Expect = 3e-04
 Identities = 36/158 (22%), Positives = 65/158 (41%), Gaps = 39/158 (24%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIR--------HKNLVKI 462
           G F +V+     +GK  +A+KV+    H    +   E   L+++R         + +V++
Sbjct: 48  GHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD-EIRLLKSVRNSDPNDPNREMVVQL 106

Query: 463 LTVCSGVDYKGDDFK---------ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQ 513
           L          DDFK          +V+E + +  L +W+       + +  P     +Q
Sbjct: 107 L----------DDFKISGVNGTHICMVFEVLGH-HLLKWII--KSNYQGLPLPCVKKIIQ 153

Query: 514 RINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHE 551
           ++   +D      YLH  C+    H D+KP N+LL   
Sbjct: 154 QVLQGLD------YLHTKCR--IIHTDIKPENILLSVN 183

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 42.3 bits (100), Expect = 4e-04
 Identities = 39/152 (25%), Positives = 59/152 (38%), Gaps = 37/152 (24%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVL--NLLHHGASKSSIAECSALRNIRH-----KNLVKIL 463
           G+FG V      + K   AVKV+     +  ++K    E   L+ I++      N+VK  
Sbjct: 46  GTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI---EADILKKIQNDDINNNNIVKYH 102

Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNF----LQRI-NIA 518
                  Y       L++E +   SL E +                N+    ++ I    
Sbjct: 103 GK---FMYYD--HMCLIFEPLGP-SLYEII-------------TRNNYNGFHIEDIKLYC 143

Query: 519 IDVACALKYLHHDCQPTTAHCDLKPSNVLLDH 550
           I++  AL YL      T  H DLKP N+LLD 
Sbjct: 144 IEILKALNYLR-KMSLT--HTDLKPENILLDD 172

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 41.9 bits (98), Expect = 6e-04
 Identities = 43/173 (24%), Positives = 70/173 (40%), Gaps = 50/173 (28%)

Query: 408 IDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLV------K 461
           I  GSFG +Y G   +    +A+K+              E       +H  L+      +
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKL--------------EN---VKTKHPQLLYESKIYR 57

Query: 462 ILTVCSG---VDYKG--DDFKALVYEFMHNG-SLEEWLHPVSGA--DKTVEAPKCLNFLQ 513
           IL   +G   V + G   D+  LV + +  G SLE+  +  S     KTV          
Sbjct: 58  ILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTV---------- 105

Query: 514 RINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH---VADFGLAK 563
            + +A  +   ++++H     +  H D+KP N L+     A+   + DFGLAK
Sbjct: 106 -LMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	741
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	100.0
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.98
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.98
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.98
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	99.98
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.97
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.97
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.97
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.97
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.97
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.97
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.97
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.97
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.97
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.97
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.97
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.96
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.96
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.96
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.96
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.96
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.96
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.95
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.95
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.95
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.94
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.94
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.94
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.94
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.93
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.93
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.93
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.93
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.92
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.92
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.92
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.92
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.92
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.92
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.91
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.91
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.91
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.91
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.91
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.91
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.91
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.91
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.9
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.9
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.9
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.88
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.88
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.88
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.87
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.86
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.86
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.86
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.86
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.86
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.85
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.85
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.85
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.85
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.84
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.84
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.84
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.84
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.82
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.82
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.82
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.81
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.81
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.81
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.81
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.8
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.8
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.79
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.78
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.78
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.78
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.78
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.78
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.78
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.76
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.74
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.72
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.71
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.71
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.7
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.68
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.67
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.67
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.66
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.66
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.63
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.63
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.61
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.61
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.58
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.55
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.55
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.54
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.53
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.51
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.48
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.44
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.41
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.39
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.37
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.32
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.29
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.24
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.03
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	99.01
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.98
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.95
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.73
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.49
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.47
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.47
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.44
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.44
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.32
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.32
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.29
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.12
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.07
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.94
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.94
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.87
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.76
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.48
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.47
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.32
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.31
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.28
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.26
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.19
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.17
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.13
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.07
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.02
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.96
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.82
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.79
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.74
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.4
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.99
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.76
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	95.63
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.08

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=9.9e-53  Score=433.84  Aligned_cols=262  Identities=26%  Similarity=0.397  Sum_probs=199.5

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc--CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      .+++.++||+|+||+||+|++..   .||||+++....  ...+.+.+|+.++++++|||||+++++|.      ++..|
T Consensus        37 ~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~------~~~~~  107 (307)
T 3omv_A           37 EVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT------KDNLA  107 (307)
T ss_dssp             SCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSSCE
T ss_pred             HeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE------CCeEE
Confidence            45678899999999999998752   489999874332  23467889999999999999999999863      23579


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      +|||||++|+|.+++...         ...+++.++..|+.||++||+|||++   +||||||||+|||+++++.+||+|
T Consensus       108 iVmEy~~gGsL~~~l~~~---------~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~D  175 (307)
T 3omv_A          108 IVTQWCEGSSLYKHLHVQ---------ETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGD  175 (307)
T ss_dssp             EEEECCSSCBHHHHHHTS---------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECC
T ss_pred             EEEEcCCCCCHHHHHhhc---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEee
Confidence            999999999999999643         24589999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccC--CCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhh-c
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGL--GSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART-V  635 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~--~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~-~  635 (741)
                      ||+|+...............||+.|||||.+..  .+.|+.++|||||||++|||+||+.||....... .+...+.. .
T Consensus       176 FGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~-~~~~~~~~~~  254 (307)
T 3omv_A          176 FGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD-QIIFMVGRGY  254 (307)
T ss_dssp             CSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHHHHHHTTC
T ss_pred             ccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH-HHHHHHhcCC
Confidence            999987654433333344679999999965542  3468999999999999999999999986321111 11111111 1


Q ss_pred             CCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHhhc
Q 037916          636 LPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSILL  711 (741)
Q Consensus       636 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~  711 (741)
                      ..+...        .                   ...++++.+.+|+.+||+.||++||||.||++.|+.+...++
T Consensus       255 ~~p~~~--------~-------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp  303 (307)
T 3omv_A          255 ASPDLS--------K-------------------LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP  303 (307)
T ss_dssp             CCCCST--------T-------------------SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred             CCCCcc--------c-------------------ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence            111000        0                   012456778899999999999999999999999998875543

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=4.3e-52  Score=435.34  Aligned_cols=267  Identities=24%  Similarity=0.355  Sum_probs=201.4

Q ss_pred             HHHhhhcccCceeeEEEEEEc-----CCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCce
Q 037916          402 FLFLCWIDMGSFGSVYKGILD-----EGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      |.+.++||+|+||.||+|+++     .+++.||||+++.......+++.+|+++|++++|||||+++++|.     +...
T Consensus        43 ~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~-----~~~~  117 (329)
T 4aoj_A           43 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCT-----EGRP  117 (329)
T ss_dssp             EEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SSSS
T ss_pred             eEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCE
Confidence            455678999999999999875     368899999998655555678999999999999999999999964     4557


Q ss_pred             EEEEEecccCCChhhhccCCCCCCc-----ccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCC
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADK-----TVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHE  551 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~-----~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~  551 (741)
                      .|+|||||++|+|.++++.......     .......+++.+++.|+.||++||+|||+.   +||||||||+|||++++
T Consensus       118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~  194 (329)
T 4aoj_A          118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQG  194 (329)
T ss_dssp             EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETT
T ss_pred             EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCC
Confidence            8999999999999999975432111     111235689999999999999999999999   99999999999999999


Q ss_pred             CceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhh
Q 037916          552 MTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHN  630 (741)
Q Consensus       552 ~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~  630 (741)
                      +.+||+|||+|+...............||+.|||| |+..+..++.++|||||||++|||+| |+.||......  ....
T Consensus       195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAP-E~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~--~~~~  271 (329)
T 4aoj_A          195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPP-ESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT--EAID  271 (329)
T ss_dssp             TEEEECCCC----------------CCCCGGGCCH-HHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH--HHHH
T ss_pred             CcEEEcccccceeccCCCcceecCcccccccccCh-hhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH--HHHH
Confidence            99999999999876554443333446799999999 55677889999999999999999999 89998632111  1111


Q ss_pred             hhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHh
Q 037916          631 FARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSI  709 (741)
Q Consensus       631 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  709 (741)
                      .+....                              +...+..+++.+.+|+.+||+.||++||||+||++.|+.+.+.
T Consensus       272 ~i~~g~------------------------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          272 CITQGR------------------------------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             HHHHTC------------------------------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHHcCC------------------------------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence            110000                              0011124567788999999999999999999999999998764

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=9.5e-53  Score=434.21  Aligned_cols=269  Identities=23%  Similarity=0.358  Sum_probs=208.8

Q ss_pred             HHHHhhhcccCceeeEEEEEEc-----CCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          401 SFLFLCWIDMGSFGSVYKGILD-----EGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      .|.+.++||+|+||.||+|++.     .++..||||+++.......+++.+|+++|++++|||||+++++|.     +++
T Consensus        14 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~-----~~~   88 (299)
T 4asz_A           14 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV-----EGD   88 (299)
T ss_dssp             GEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SSS
T ss_pred             HeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEe-----eCC
Confidence            4567789999999999999875     357899999998655555678999999999999999999999963     455


Q ss_pred             eEEEEEecccCCChhhhccCCCCC---CcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCC
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGA---DKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEM  552 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~---~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~  552 (741)
                      ..|+|||||++|+|.++++..+..   .........+++.+++.|+.||++||+|||++   +||||||||+|||++.++
T Consensus        89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~  165 (299)
T 4asz_A           89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENL  165 (299)
T ss_dssp             SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCC
Confidence            789999999999999999743100   00011235689999999999999999999999   999999999999999999


Q ss_pred             ceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhh
Q 037916          553 TAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNF  631 (741)
Q Consensus       553 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~  631 (741)
                      .+||+|||+|+...............||+.|||| |+..+..++.++|||||||++|||+| |+.||......  .+...
T Consensus       166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAP-E~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~--~~~~~  242 (299)
T 4asz_A          166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPP-ESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--EVIEC  242 (299)
T ss_dssp             CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCH-HHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHHH
T ss_pred             cEEECCcccceecCCCCceeecCceecChhhcCH-HHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHH
Confidence            9999999999876554433333345699999999 55566789999999999999999999 89998632111  11111


Q ss_pred             hhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHhh
Q 037916          632 ARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSIL  710 (741)
Q Consensus       632 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  710 (741)
                      +.           ....                   ...+..+++.+.+|+.+||+.||++|||++||.+.|+++.+..
T Consensus       243 i~-----------~~~~-------------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~  291 (299)
T 4asz_A          243 IT-----------QGRV-------------------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS  291 (299)
T ss_dssp             HH-----------HTCC-------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred             HH-----------cCCC-------------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence            10           0000                   0011245677889999999999999999999999999987643

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=4.5e-52  Score=434.10  Aligned_cols=249  Identities=22%  Similarity=0.291  Sum_probs=204.4

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALV  480 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv  480 (741)
                      .|+++++||+|+||.||+|+++.+|+.||||+++.......+.+.+|+.+|++++|||||+++++     +.+++..|+|
T Consensus        75 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~-----~~~~~~~~iv  149 (346)
T 4fih_A           75 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS-----YLVGDELWVV  149 (346)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEE-----EEETTEEEEE
T ss_pred             hcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEE-----EEECCEEEEE
Confidence            48889999999999999999999999999999987666667788999999999999999999999     4556789999


Q ss_pred             EecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecc
Q 037916          481 YEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFG  560 (741)
Q Consensus       481 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg  560 (741)
                      ||||+||+|.+++..           ..+++.++..++.||+.||+|||++   +||||||||+|||++.+|.+||+|||
T Consensus       150 mEy~~gg~L~~~l~~-----------~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFG  215 (346)
T 4fih_A          150 MEFLEGGALTDIVTH-----------TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFG  215 (346)
T ss_dssp             ECCCTTEEHHHHHHH-----------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCT
T ss_pred             EeCCCCCcHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCc
Confidence            999999999999863           3488999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcch
Q 037916          561 LAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHV  640 (741)
Q Consensus       561 ~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  640 (741)
                      +|+........  ....+||+.||||| +..+..|+.++||||+||++|||++|+.||....  .......+....+...
T Consensus       216 la~~~~~~~~~--~~~~~GTp~YmAPE-vl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--~~~~~~~i~~~~~~~~  290 (346)
T 4fih_A          216 FCAQVSKEVPR--RKSLVGTPYWMAPE-LISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMIRDNLPPRL  290 (346)
T ss_dssp             TCEECCSSSCC--BCCCCSCGGGCCHH-HHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSSCCCC
T ss_pred             CceecCCCCCc--ccccccCcCcCCHH-HHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--HHHHHHHHHcCCCCCC
Confidence            99877544322  23367999999995 5677789999999999999999999999986321  1111111111111000


Q ss_pred             hHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          641 MDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       641 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                                                  .....+.+.+.+++.+||+.||++|||+.|+++
T Consensus       291 ----------------------------~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          291 ----------------------------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             ----------------------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ----------------------------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                                        001123456789999999999999999999875

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.1e-51  Score=429.92  Aligned_cols=257  Identities=21%  Similarity=0.262  Sum_probs=204.0

Q ss_pred             HHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEEE
Q 037916          402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVY  481 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv~  481 (741)
                      |++.++||+|+||.||+|+++.+|+.||||+++...     ...+|+.++++++|||||+++++     +.++...|+||
T Consensus        60 ~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~-----~~~~~~~~ivm  129 (336)
T 4g3f_A           60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGA-----VREGPWVNIFM  129 (336)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEE-----EEETTEEEEEE
T ss_pred             eEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEE-----EEECCEEEEEE
Confidence            667788999999999999999999999999997432     22479999999999999999999     45567899999


Q ss_pred             ecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCC-ceEEeecc
Q 037916          482 EFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEM-TAHVADFG  560 (741)
Q Consensus       482 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~-~~kL~DFg  560 (741)
                      |||+||+|.++++..          ..+++.+++.++.||+.||+|||++   +||||||||+|||++.+| ++||+|||
T Consensus       130 Ey~~gg~L~~~l~~~----------~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFG  196 (336)
T 4g3f_A          130 ELLEGGSLGQLIKQM----------GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFG  196 (336)
T ss_dssp             CCCTTCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCT
T ss_pred             eccCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCC
Confidence            999999999999643          4689999999999999999999999   999999999999999987 69999999


Q ss_pred             cccccCCCCccc---ccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCC
Q 037916          561 LAKLLPPAHLQT---SSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       561 ~a~~~~~~~~~~---~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      +|+.........   .....+||+.|||| |+..+..|+.++||||+||++|||++|+.||........ +....... +
T Consensus       197 la~~~~~~~~~~~~~~~~~~~GT~~YmAP-E~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~i~~~~-~  273 (336)
T 4g3f_A          197 HALCLQPDGLGKSLLTGDYIPGTETHMAP-EVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL-CLKIASEP-P  273 (336)
T ss_dssp             TCEEC------------CCCCCCGGGCCH-HHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC-HHHHHHSC-C
T ss_pred             CCeEccCCCcccceecCCccccCccccCH-HHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-HHHHHcCC-C
Confidence            998775443211   12235799999999 555678899999999999999999999999974322211 11111100 0


Q ss_pred             cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHhhcC
Q 037916          638 DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSILLG  712 (741)
Q Consensus       638 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~  712 (741)
                       ...                           ..+..+++.+.+++.+||+.||++|||+.|+++.|....+....
T Consensus       274 -~~~---------------------------~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~  320 (336)
T 4g3f_A          274 -PIR---------------------------EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGG  320 (336)
T ss_dssp             -GGG---------------------------GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTS
T ss_pred             -Cch---------------------------hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhh
Confidence             000                           00123456788999999999999999999999999988876553

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.4e-51  Score=427.39  Aligned_cols=265  Identities=22%  Similarity=0.318  Sum_probs=205.7

Q ss_pred             HHHHhhhcccCceeeEEEEEEc-----CCCeEEEEEEeeccCc-CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCC
Q 037916          401 SFLFLCWIDMGSFGSVYKGILD-----EGKTIIAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGD  474 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~  474 (741)
                      .+++.++||+|+||.||+|++.     .+++.||||+++.... ...+.+.+|+.++++++|||||+++++|.     .+
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-----~~  101 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT-----KD  101 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SS
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEE-----EC
Confidence            3567889999999999999974     3678999999974332 33567899999999999999999999964     34


Q ss_pred             ceEEEEEecccCCChhhhccCCCCCCc------ccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEe
Q 037916          475 DFKALVYEFMHNGSLEEWLHPVSGADK------TVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLL  548 (741)
Q Consensus       475 ~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll  548 (741)
                      ...++|||||++|+|.+++........      .......+++.++.+|+.||++||+|||++   +||||||||+|||+
T Consensus       102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl  178 (308)
T 4gt4_A          102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLV  178 (308)
T ss_dssp             SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEE
Confidence            578999999999999999964321110      111235689999999999999999999999   99999999999999


Q ss_pred             CCCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcc
Q 037916          549 DHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMN  627 (741)
Q Consensus       549 ~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~  627 (741)
                      ++++.+||+|||+|+...............||+.||||| +..++.++.++|||||||++|||+| |..||.....  ..
T Consensus       179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE-~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~--~~  255 (308)
T 4gt4_A          179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPE-AIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--QD  255 (308)
T ss_dssp             CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHH-HHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH--HH
T ss_pred             CCCCCEEECCcccceeccCCCceeEecccccCCcccCHH-HHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH--HH
Confidence            999999999999998765444333344467999999995 5566789999999999999999998 8999863211  11


Q ss_pred             hhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHH
Q 037916          628 LHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSI  706 (741)
Q Consensus       628 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  706 (741)
                      +...+..           ....                   +.+.++++.+.+|+.+||+.||++||||.||++.|+.+
T Consensus       256 ~~~~i~~-----------~~~~-------------------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          256 VVEMIRN-----------RQVL-------------------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             HHHHHHT-----------TCCC-------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             HHHHHHc-----------CCCC-------------------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            1111110           0000                   01124567789999999999999999999999999764

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1e-51  Score=424.99  Aligned_cols=250  Identities=20%  Similarity=0.269  Sum_probs=204.4

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeecc---CcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCce
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLL---HHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      ..|++++.||+|+||+||+|+++.+++.||+|++++.   .....+.+.+|++++++++|||||+++++     ++++..
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~-----~~~~~~  106 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFT-----FQDDEK  106 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEE-----EECSSE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEE-----EEeCCE
Confidence            3589999999999999999999999999999999742   23445678999999999999999999999     566779


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .|+|||||+||+|.+++...          ..+++.+++.++.||+.||+|||++   +|+||||||+|||++.++.+||
T Consensus       107 ~yivmEy~~gG~L~~~i~~~----------~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl  173 (311)
T 4aw0_A          107 LYFGLSYAKNGELLKYIRKI----------GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQI  173 (311)
T ss_dssp             EEEEECCCTTEEHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEE
T ss_pred             EEEEEecCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEE
Confidence            99999999999999999643          5689999999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcC
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVL  636 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  636 (741)
                      +|||+|+..............+||+.||||| +..+..|+.++||||+||++|||++|+.||....     .......  
T Consensus       174 ~DFGla~~~~~~~~~~~~~~~~GTp~YmAPE-vl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~-----~~~~~~~--  245 (311)
T 4aw0_A          174 TDFGTAKVLSPESKQARANSFVGTAQYVSPE-LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN-----EGLIFAK--  245 (311)
T ss_dssp             CCCTTCEECCTTTTCCCBCCCCSCGGGCCHH-HHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHH--
T ss_pred             EEcCCceecCCCCCcccccCcccCcccCCHH-HHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHH--
Confidence            9999999876544333344567999999995 5567789999999999999999999999996321     1111111  


Q ss_pred             CcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          637 PDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       637 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                            +..    ....                .+....+.+.+++.+||+.||++|||++|++.
T Consensus       246 ------i~~----~~~~----------------~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~  284 (311)
T 4aw0_A          246 ------IIK----LEYD----------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  284 (311)
T ss_dssp             ------HHH----TCCC----------------CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred             ------HHc----CCCC----------------CCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence                  110    0000                00122345779999999999999999999753

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=4.1e-51  Score=414.95  Aligned_cols=247  Identities=21%  Similarity=0.302  Sum_probs=187.2

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCce
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      ++|++++.||+|+||.||+|++..+++.||+|+++...   ....+.+.+|+.++++++|||||+++++     +.+++.
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~-----~~~~~~   87 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDV-----IKSKDE   87 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEE-----EECSSE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEE-----EEECCE
Confidence            68999999999999999999999999999999997432   2334578899999999999999999999     556778


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .|+||||+ +|+|.+++...          ..+++.+++.++.||+.||+|||++   +|+||||||+|||++.++.+||
T Consensus        88 ~~ivmEy~-~g~L~~~l~~~----------~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl  153 (275)
T 3hyh_A           88 IIMVIEYA-GNELFDYIVQR----------DKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKI  153 (275)
T ss_dssp             EEEEEECC-CEEHHHHHHHS----------CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEE
T ss_pred             EEEEEeCC-CCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEE
Confidence            99999999 78999998643          4689999999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcC
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVL  636 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  636 (741)
                      +|||+|+........   ...+||+.|||||.+.....++.++||||+||++|+|++|+.||...     ........  
T Consensus       154 ~DFGla~~~~~~~~~---~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~-----~~~~~~~~--  223 (275)
T 3hyh_A          154 ADFGLSNIMTDGNFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE-----SIPVLFKN--  223 (275)
T ss_dssp             CCSSCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHH--
T ss_pred             eecCCCeecCCCCcc---CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC-----CHHHHHHH--
Confidence            999999876543322   23579999999965544445678999999999999999999999632     11111111  


Q ss_pred             CcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          637 PDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       637 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                            +....    ..                .+...++.+.+++.+||+.||++|||++|+++
T Consensus       224 ------i~~~~----~~----------------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          224 ------ISNGV----YT----------------LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             ------HHHTC----CC----------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ------HHcCC----CC----------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                  00000    00                00122456789999999999999999999986

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.2e-51  Score=431.62  Aligned_cols=250  Identities=21%  Similarity=0.298  Sum_probs=195.6

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc--CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      +|+++++||+|+||.||+|++..+++.||||+++....  ...+.+.+|+.++++++|||||+++++     +.++...|
T Consensus        25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~-----~~~~~~~y   99 (350)
T 4b9d_A           25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES-----FEENGSLY   99 (350)
T ss_dssp             CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEE-----EEETTEEE
T ss_pred             ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEE-----EEECCEEE
Confidence            58899999999999999999999999999999975332  234678899999999999999999999     45667899


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      +|||||+||+|.+++...+        ...+++.+++.|+.||+.||+|||++   |||||||||+|||++.+|.+||+|
T Consensus       100 iVmEy~~gg~L~~~i~~~~--------~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~D  168 (350)
T 4b9d_A          100 IVMDYCEGGDLFKRINAQK--------GVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGD  168 (350)
T ss_dssp             EEEECCTTCBHHHHHHHTT--------TCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECS
T ss_pred             EEEeCCCCCcHHHHHHHcC--------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcc
Confidence            9999999999999996431        24578889999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCc
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      ||+|+.......  .....+||+.|||| |+..+..|+.++||||+||++|||++|+.||....     ..+....    
T Consensus       169 FGla~~~~~~~~--~~~~~~GT~~YmAP-E~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~-----~~~~~~~----  236 (350)
T 4b9d_A          169 FGIARVLNSTVE--LARACIGTPYYLSP-EICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS-----MKNLVLK----  236 (350)
T ss_dssp             TTEESCCCHHHH--HHHHHHSCCTTCCH-HHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHH----
T ss_pred             cccceeecCCcc--cccccCCCccccCH-HHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-----HHHHHHH----
Confidence            999987643221  12235699999999 55667789999999999999999999999996321     1111111    


Q ss_pred             chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          639 HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       639 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                          +........                   ...+++.+.+|+.+||+.||++|||+.|+++
T Consensus       237 ----i~~~~~~~~-------------------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          237 ----IISGSFPPV-------------------SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             ----HHHTCCCCC-------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----HHcCCCCCC-------------------CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                111000000                   0123456789999999999999999999985

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=6.9e-51  Score=435.64  Aligned_cols=249  Identities=22%  Similarity=0.294  Sum_probs=204.4

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALV  480 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv  480 (741)
                      .|+++++||+|+||.||+|+++.+|+.||||+++.......+.+.+|+.+|++++|||||+++++     +.+++..|+|
T Consensus       152 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~-----~~~~~~~~iV  226 (423)
T 4fie_A          152 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS-----YLVGDELWVV  226 (423)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEE-----EEETTEEEEE
T ss_pred             hcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEE-----EEECCEEEEE
Confidence            48899999999999999999999999999999987666667789999999999999999999999     4556789999


Q ss_pred             EecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecc
Q 037916          481 YEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFG  560 (741)
Q Consensus       481 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg  560 (741)
                      ||||+||+|.++++.           ..+++.++..++.||+.||+|||++   +||||||||+|||++.+|.+||+|||
T Consensus       227 mEy~~gG~L~~~i~~-----------~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFG  292 (423)
T 4fie_A          227 MEFLEGGALTDIVTH-----------TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFG  292 (423)
T ss_dssp             EECCTTEEHHHHHHH-----------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCT
T ss_pred             EeCCCCCcHHHHHhc-----------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCc
Confidence            999999999999863           3488999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcch
Q 037916          561 LAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHV  640 (741)
Q Consensus       561 ~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  640 (741)
                      +|+........  ....+||+.|||| |+..+..|+.++||||+||++|||++|+.||....  .......+....+...
T Consensus       293 la~~~~~~~~~--~~~~~GTp~YmAP-Evl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--~~~~~~~i~~~~~~~~  367 (423)
T 4fie_A          293 FCAQVSKEVPR--RKSLVGTPYWMAP-ELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMIRDNLPPRL  367 (423)
T ss_dssp             TCEECCSSCCC--BCCCEECTTTCCH-HHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSCCCCC
T ss_pred             cceECCCCCcc--ccccccCcCcCCH-HHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--HHHHHHHHHcCCCCCC
Confidence            99877544322  2336799999999 45677789999999999999999999999986221  1111111111111000


Q ss_pred             hHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          641 MDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       641 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                               .                   ....+.+.+.+|+.+||+.||++|||+.|+++
T Consensus       368 ---------~-------------------~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          368 ---------K-------------------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             ---------S-------------------CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---------c-------------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                     0                   00123456789999999999999999999875

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=9.2e-51  Score=416.13  Aligned_cols=249  Identities=25%  Similarity=0.340  Sum_probs=194.5

Q ss_pred             HHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC--cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEE
Q 037916          403 LFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALV  480 (741)
Q Consensus       403 ~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv  480 (741)
                      ++.++||+|+||.||+|++..++..||+|++....  ....+.+.+|+.++++++|||||+++++|.... ..+...|+|
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~~~~~lv  107 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCCcEEEEE
Confidence            56678999999999999999999999999997432  223456889999999999999999999864321 234568999


Q ss_pred             EecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCC--ceecCCCCCCeEeCC-CCceEEe
Q 037916          481 YEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPT--TAHCDLKPSNVLLDH-EMTAHVA  557 (741)
Q Consensus       481 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~--ivHrDlkp~NIll~~-~~~~kL~  557 (741)
                      ||||+||+|.+++...          ..+++..+..++.||+.||+|||++   +  ||||||||+|||++. ++.+||+
T Consensus       108 mEy~~gg~L~~~l~~~----------~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~  174 (290)
T 3fpq_A          108 TELMTSGTLKTYLKRF----------KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIG  174 (290)
T ss_dssp             EECCCSCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEEC
T ss_pred             EeCCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEE
Confidence            9999999999999643          5689999999999999999999998   6  999999999999984 7899999


Q ss_pred             ecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCC
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      |||+|+......    ....+||+.|||||.+ . +.|+.++|||||||++|||+||+.||....    ...........
T Consensus       175 DFGla~~~~~~~----~~~~~GTp~YmAPE~~-~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~----~~~~~~~~i~~  244 (290)
T 3fpq_A          175 DLGLATLKRASF----AKAVIGTPEFMAPEMY-E-EKYDESVDVYAFGMCMLEMATSEYPYSECQ----NAAQIYRRVTS  244 (290)
T ss_dssp             CTTGGGGCCTTS----BEESCSSCCCCCGGGG-G-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCS----SHHHHHHHHTT
T ss_pred             eCcCCEeCCCCc----cCCcccCccccCHHHc-C-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCC----cHHHHHHHHHc
Confidence            999998644322    2235799999999644 4 469999999999999999999999986321    11111111111


Q ss_pred             cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          638 DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       638 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ......+                          ...+.+.+.+++.+||+.||++|||+.|+++
T Consensus       245 ~~~~~~~--------------------------~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          245 GVKPASF--------------------------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             TCCCGGG--------------------------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCCCCC--------------------------CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0000000                          0112345789999999999999999999875

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=4.5e-50  Score=423.33  Aligned_cols=272  Identities=20%  Similarity=0.234  Sum_probs=209.9

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcC-----CCeEEEEEEeeccCc-CcchhHHHHHHHHHhcCC-CceeeEeeeecCcccc
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDE-----GKTIIAVKVLNLLHH-GASKSSIAECSALRNIRH-KNLVKILTVCSGVDYK  472 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~~  472 (741)
                      ..|++.+.||+|+||.||+|++..     +++.||||+++.... ...+.+.+|+.+|+++.| ||||+++++|.    .
T Consensus        64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~----~  139 (353)
T 4ase_A           64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT----K  139 (353)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC----C
T ss_pred             HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEE----e
Confidence            457788999999999999999864     346899999974332 234578899999999965 99999999973    3


Q ss_pred             CCceEEEEEecccCCChhhhccCCCCCCc------ccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCe
Q 037916          473 GDDFKALVYEFMHNGSLEEWLHPVSGADK------TVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNV  546 (741)
Q Consensus       473 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NI  546 (741)
                      .+...|+|||||++|+|.++++..+....      .......+++.+++.++.||++||+|||++   +||||||||+||
T Consensus       140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NI  216 (353)
T 4ase_A          140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNI  216 (353)
T ss_dssp             TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccce
Confidence            44578999999999999999975422100      011234589999999999999999999999   999999999999


Q ss_pred             EeCCCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCC
Q 037916          547 LLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGN  625 (741)
Q Consensus       547 ll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~  625 (741)
                      |+++++.+||+|||+|+...............||+.||||| +..+..|+.++|||||||++|||+| |+.||...... 
T Consensus       217 Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE-~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~-  294 (353)
T 4ase_A          217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE-TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-  294 (353)
T ss_dssp             EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHH-HHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS-
T ss_pred             eeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHH-HHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH-
Confidence            99999999999999998776554433344467999999995 5566789999999999999999998 89998632111 


Q ss_pred             cchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHH
Q 037916          626 MNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQS  705 (741)
Q Consensus       626 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  705 (741)
                      ..+...+..            ....                  ..+..+++.+.+++.+||+.||++|||+.||++.|++
T Consensus       295 ~~~~~~i~~------------g~~~------------------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~  344 (353)
T 4ase_A          295 EEFCRRLKE------------GTRM------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  344 (353)
T ss_dssp             HHHHHHHHH------------TCCC------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHHHHc------------CCCC------------------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence            111111111            0000                  0112345678899999999999999999999999999


Q ss_pred             HHHhh
Q 037916          706 IKSIL  710 (741)
Q Consensus       706 i~~~~  710 (741)
                      +.+..
T Consensus       345 llq~~  349 (353)
T 4ase_A          345 LLQAN  349 (353)
T ss_dssp             HHHHT
T ss_pred             HHHHh
Confidence            98653

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.7e-49  Score=413.01  Aligned_cols=281  Identities=22%  Similarity=0.257  Sum_probs=200.0

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALV  480 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv  480 (741)
                      .|.+.++||+|+||.||+|++.  |+.||||+++.... .......|+..+.+++|||||+++++|.... ......|+|
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~~~lV   79 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLV   79 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceEEEEE
Confidence            3566789999999999999984  89999999964321 1122334666667889999999999985321 122368999


Q ss_pred             EecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhc-----CCCCceecCCCCCCeEeCCCCceE
Q 037916          481 YEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHD-----CQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       481 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-----~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ||||++|+|.++++.           ..+++..+.+++.|++.||+|||++     ..++||||||||+|||++.++.+|
T Consensus        80 ~Ey~~~gsL~~~l~~-----------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~K  148 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNR-----------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC  148 (303)
T ss_dssp             EECCTTCBHHHHHHH-----------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred             ecCCCCCcHHHHHHh-----------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEE
Confidence            999999999999963           3588999999999999999999975     245899999999999999999999


Q ss_pred             EeecccccccCCCCcc--cccccccccccccCcccccCC-----CCCCCccCchhHHHHHHHHHcCCCCCCccccCCcch
Q 037916          556 VADFGLAKLLPPAHLQ--TSSIGVKGTIGYIAPAEYGLG-----SEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNL  628 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~--~~~~~~~gt~~y~aPEe~~~~-----~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~  628 (741)
                      |+|||+|+........  .......||+.|||||.+...     ..++.++|||||||++|||+||..||.........+
T Consensus       149 i~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~  228 (303)
T 3hmm_A          149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY  228 (303)
T ss_dssp             ECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred             EEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccc
Confidence            9999999876543221  122335699999999654322     246789999999999999999998876433222222


Q ss_pred             hhhhhhcCCc-chh-HhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHH
Q 037916          629 HNFARTVLPD-HVM-DIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSI  706 (741)
Q Consensus       629 ~~~~~~~~~~-~~~-~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  706 (741)
                      ..+....... ... .+.+....+...             ......+++..+.+|+.+||+.||++||||.||++.|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~rp~~p-------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l  295 (303)
T 3hmm_A          229 YDLVPSDPSVEEMRKVVCEQKLRPNIP-------------NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSCCCCCCC-------------GGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhcccccchHHHHHHHHhcccCCCCCC-------------ccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence            2111110000 011 111111111111             0001125667889999999999999999999999999998


Q ss_pred             HHh
Q 037916          707 KSI  709 (741)
Q Consensus       707 ~~~  709 (741)
                      .+.
T Consensus       296 ~~~  298 (303)
T 3hmm_A          296 SQQ  298 (303)
T ss_dssp             HHC
T ss_pred             HHH
Confidence            764

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=7.5e-50  Score=411.28  Aligned_cols=243  Identities=23%  Similarity=0.267  Sum_probs=187.5

Q ss_pred             HHHHHhhhcccCceeeEEEEEEc---CCCeEEEEEEeeccC--cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCC
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILD---EGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGD  474 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~  474 (741)
                      ..|++++.||+|+||+||+|++.   .+++.||+|+++...  ......+.+|+.++++++|||||+++++     ++++
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~-----~~~~   98 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYA-----FQTE   98 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEE-----EEET
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEE-----EEEC
Confidence            35889999999999999999983   467899999997432  2234567889999999999999999999     4566


Q ss_pred             ceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCce
Q 037916          475 DFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTA  554 (741)
Q Consensus       475 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~  554 (741)
                      ...|+|||||+||+|.+++...          ..+++.++..++.||+.||+|||++   +|+||||||+|||++.+|.+
T Consensus        99 ~~~~ivmEy~~gg~L~~~l~~~----------~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~v  165 (304)
T 3ubd_A           99 GKLYLILDFLRGGDLFTRLSKE----------VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHI  165 (304)
T ss_dssp             TEEEEEECCCTTCEEHHHHHHH----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCE
Confidence            7899999999999999999643          5689999999999999999999999   99999999999999999999


Q ss_pred             EEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhh
Q 037916          555 HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       555 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  634 (741)
                      ||+|||+|+........  ....+||+.|||| |+..+..|+.++||||+||++|||++|+.||.....     .+....
T Consensus       166 Kl~DFGla~~~~~~~~~--~~~~~GT~~YmAP-E~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-----~~~~~~  237 (304)
T 3ubd_A          166 KLTDFGLSKESIDHEKK--AYSFCGTVEYMAP-EVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR-----KETMTM  237 (304)
T ss_dssp             EEESSEEEEC-----CC--CCSCCCCGGGCCH-HHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHH
T ss_pred             EecccccceeccCCCcc--ccccccCcccCCH-HHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH-----HHHHHH
Confidence            99999999865443222  2236799999999 455677899999999999999999999999963211     111111


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCH
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNM  696 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  696 (741)
                              +.....    .                .+..+++.+.+++.+||+.||++|||+
T Consensus       238 --------i~~~~~----~----------------~p~~~s~~~~~li~~~L~~dP~~R~ta  271 (304)
T 3ubd_A          238 --------ILKAKL----G----------------MPQFLSPEAQSLLRMLFKRNPANRLGA  271 (304)
T ss_dssp             --------HHHCCC----C----------------CCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred             --------HHcCCC----C----------------CCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence                    110000    0                001234567899999999999999996

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=6.9e-49  Score=406.14  Aligned_cols=258  Identities=20%  Similarity=0.288  Sum_probs=187.4

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc-CcchhHHHHHHHHHhcCCCceeeEeeeecCcc-------
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKILTVCSGVD-------  470 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-------  470 (741)
                      ...|++++.||+|+||.||+|+++.+++.||||+++.... ...+.+.+|+.+|++++|||||++++++....       
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            3568999999999999999999999999999999975432 23457889999999999999999999874322       


Q ss_pred             ccCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCC
Q 037916          471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDH  550 (741)
Q Consensus       471 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~  550 (741)
                      .....+.|+|||||++|+|.+++....       .....++..++.++.||++||+|||++   +|+||||||+|||++.
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~-------~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~  153 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRC-------TIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTM  153 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCC-------SGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcC-------CCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECC
Confidence            112335799999999999999997541       113345667889999999999999999   9999999999999999


Q ss_pred             CCceEEeecccccccCCCCccc----------ccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCc
Q 037916          551 EMTAHVADFGLAKLLPPAHLQT----------SSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDI  620 (741)
Q Consensus       551 ~~~~kL~DFg~a~~~~~~~~~~----------~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~  620 (741)
                      ++.+||+|||+|+.........          .....+||+.|||| |+..+..|+.++||||+||++|||++   ||..
T Consensus       154 ~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAP-E~~~~~~y~~~~DiwSlGvilyell~---Pf~~  229 (299)
T 4g31_A          154 DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSP-EQIHGNSYSHKVDIFSLGLILFELLY---PFST  229 (299)
T ss_dssp             TCCEEECCCCCC--------------------------CCCTTSCH-HHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred             CCcEEEccCccceecCCCccccccccccccccccCCcccCccccCH-HHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC
Confidence            9999999999998765432211          12235699999999 55567789999999999999999996   7652


Q ss_pred             cccCCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHH
Q 037916          621 MFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVV  700 (741)
Q Consensus       621 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  700 (741)
                      ..+.    ......        +.    .....               ....+..+.+.+++.+||+.||++|||+.|++
T Consensus       230 ~~~~----~~~~~~--------~~----~~~~p---------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil  278 (299)
T 4g31_A          230 QMER----VRTLTD--------VR----NLKFP---------------PLFTQKYPCEYVMVQDMLSPSPMERPEAINII  278 (299)
T ss_dssp             HHHH----HHHHHH--------HH----TTCCC---------------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             ccHH----HHHHHH--------Hh----cCCCC---------------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence            1110    000000        00    00000               01123344567899999999999999999987


Q ss_pred             H
Q 037916          701 H  701 (741)
Q Consensus       701 ~  701 (741)
                      +
T Consensus       279 ~  279 (299)
T 4g31_A          279 E  279 (299)
T ss_dssp             T
T ss_pred             c
Confidence            6

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=1.7e-47  Score=450.77  Aligned_cols=357  Identities=32%  Similarity=0.523  Sum_probs=325.9

Q ss_pred             CCCCCcccccCChhhhhCCCCCcEEEcccCcccccCCcc-CCCCCCCcEEEeecCcCcccCCchhhhhh-hhhhc--ccc
Q 037916            2 DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSS-MFNASKLEVFQVTSNNLTGEVPSEFGKAT-KAYCV--QNC   77 (741)
Q Consensus         2 dl~~n~~~~~ip~~~~~~l~~L~~L~L~~n~i~~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~~~~~--~~~   77 (741)
                      ||++|++.+.+|..+. .+++|++|+|++|++++.+|.. |.++++|++|+|++|++++.+|..+..++ ++..+  ..|
T Consensus       300 ~Ls~n~l~~~~p~~~~-~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N  378 (768)
T 3rgz_A          300 DLSGNHFYGAVPPFFG-SCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSN  378 (768)
T ss_dssp             ECCSSEEEECCCGGGG-GCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSS
T ss_pred             ECcCCcCCCccchHHh-cCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCC
Confidence            6888999988898887 8999999999999998777765 88999999999999999988888887765 32211  111


Q ss_pred             --------------CCCccEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEccccccccc
Q 037916           78 --------------NQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGT  143 (741)
Q Consensus        78 --------------~~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~  143 (741)
                                    ..+|++|+|++|++++..|..+..++ +|++|+|++|++.+..|..|..+++|++|+|++|++++.
T Consensus       379 ~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~  457 (768)
T 3rgz_A          379 NFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCS-ELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGE  457 (768)
T ss_dssp             EEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCT-TCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSC
T ss_pred             CcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCC-CCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCc
Confidence                          34699999999999989999999998 999999999999999999999999999999999999999


Q ss_pred             CCccccCCCcCcEEEcccCCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCcccccc
Q 037916          144 ISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDL  223 (741)
Q Consensus       144 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  223 (741)
                      .|..|..+++|++|+|++|++++.+|..|.++++|++|+|++|++++.+|.+|+.+++|++|+|++|++++.+|..+.++
T Consensus       458 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l  537 (768)
T 3rgz_A          458 IPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDC  537 (768)
T ss_dssp             CCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGC
T ss_pred             CCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccceeEEEcCCCccCCCCChhh----------------------------------------------------------
Q 037916          224 TSLSVGLDLSRNQLVGSLPTEV----------------------------------------------------------  245 (741)
Q Consensus       224 ~~L~~~L~Ls~N~l~~~~p~~~----------------------------------------------------------  245 (741)
                      ++|+. |++++|.+++.+|..+                                                          
T Consensus       538 ~~L~~-L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~  616 (768)
T 3rgz_A          538 RSLIW-LDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNIT  616 (768)
T ss_dssp             TTCCE-EECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTT
T ss_pred             CCCCE-EECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccc
Confidence            99998 9999999987777543                                                          


Q ss_pred             ------------cCCCCCcEEEeccccccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCcc
Q 037916          246 ------------GKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEI  313 (741)
Q Consensus       246 ------------~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  313 (741)
                                  +.+++|+.|||++|++++.+|..|+.+++|+.|+|++|++++.+|..|+++++|+.|||++|+++|.+
T Consensus       617 ~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~i  696 (768)
T 3rgz_A          617 SRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRI  696 (768)
T ss_dssp             SCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECC
T ss_pred             cceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcC
Confidence                        33578999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             chhhhccccCCcccccCcccccccCCccccCCcccccccCCCCccccC
Q 037916          314 PKFLVELQLVQNLNLSYNDLEGVIPTEGVFKNASAISVFGNSKLCGGI  361 (741)
Q Consensus       314 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~  361 (741)
                      |..+..++.|+.|+|++|+++|.+|..++|..+....+.||+.+||.+
T Consensus       697 p~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~  744 (768)
T 3rgz_A          697 PQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP  744 (768)
T ss_dssp             CGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTT
T ss_pred             ChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCC
Confidence            999999999999999999999999999999999999999999999975

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.3e-48  Score=415.53  Aligned_cols=274  Identities=19%  Similarity=0.183  Sum_probs=202.6

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc--CcchhHHHHHHHHHhcCCCceeeEeeeecCc-cccCCceE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKNLVKILTVCSGV-DYKGDDFK  477 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~~~~~~  477 (741)
                      +|++++.||+|+||.||+|+++.+|+.||||+++....  ...+.+.+|+.+|++++|||||++++++... .+.+....
T Consensus        55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~  134 (398)
T 4b99_A           55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSV  134 (398)
T ss_dssp             SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCE
T ss_pred             CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEE
Confidence            58999999999999999999999999999999974322  2245678999999999999999999987543 24456789


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      |+|||||+ |+|.+++...          ..+++.+++.+++||+.||+|||++   |||||||||+|||++.++.+||+
T Consensus       135 ~ivmE~~~-g~L~~~i~~~----------~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~  200 (398)
T 4b99_A          135 YVVLDLME-SDLHQIIHSS----------QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIG  200 (398)
T ss_dssp             EEEEECCS-EEHHHHHTSS----------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEEC
T ss_pred             EEEEeCCC-CCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEe
Confidence            99999995 6899998643          5689999999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCc--ccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhc
Q 037916          558 DFGLAKLLPPAHL--QTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV  635 (741)
Q Consensus       558 DFg~a~~~~~~~~--~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~  635 (741)
                      |||+|+.......  .......+||+.|+|||.+....+++.++||||+||++|||++|+.||...... ..+.......
T Consensus       201 DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~-~~l~~I~~~~  279 (398)
T 4b99_A          201 DFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV-HQLQLIMMVL  279 (398)
T ss_dssp             CCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHHHHH
T ss_pred             ecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhc
Confidence            9999987643321  222334679999999966665667899999999999999999999999632111 1111111111


Q ss_pred             CCcc-----------hhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          636 LPDH-----------VMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       636 ~~~~-----------~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ....           ....+.........            ..........+.+.+|+.+||..||++|||+.|+++
T Consensus       280 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          280 GTPSPAVIQAVGAERVRAYIQSLPPRQPV------------PWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             CCCCGGGTC-----CHHHHHHSSCCCCCC------------CHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCChHHhhhhhhhhhhhhhhcCCCcCCC------------CHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            0000           00000000000000            000001123456789999999999999999999886

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.1e-46  Score=400.47  Aligned_cols=197  Identities=24%  Similarity=0.319  Sum_probs=166.8

Q ss_pred             HHHHHhhhcccCceeeEEEEEEc---CCCeEEEEEEeeccCcCcchhHHHHHHHHHhc-CCCceeeEeeeecCccccCCc
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILD---EGKTIIAVKVLNLLHHGASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~---~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      ..|++.++||+|+||.||+|+++   .+++.||+|++...  ....++.+|+.+++.+ +|||||+++++     +.+.+
T Consensus        21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~-----~~~~~   93 (361)
T 4f9c_A           21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYC-----FRKND   93 (361)
T ss_dssp             GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEE-----EEETT
T ss_pred             CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEE-----EEECC
Confidence            46999999999999999999874   46789999998643  3345678999999998 69999999998     55677


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCC-Cce
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHE-MTA  554 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~-~~~  554 (741)
                      +.|+||||+++|+|.+++.             .+++.+++.+++|++.||+|||++   ||+||||||+|||++.+ +.+
T Consensus        94 ~~~lvmE~~~g~~L~~~~~-------------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~  157 (361)
T 4f9c_A           94 HVVIAMPYLEHESFLDILN-------------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKY  157 (361)
T ss_dssp             EEEEEEECCCCCCHHHHHT-------------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEE
T ss_pred             EEEEEEeCCCcccHHHHHc-------------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeE
Confidence            9999999999999999984             378889999999999999999999   99999999999999876 799


Q ss_pred             EEeecccccccCCCCcc--------------------------cccccccccccccCcccccCCCCCCCccCchhHHHHH
Q 037916          555 HVADFGLAKLLPPAHLQ--------------------------TSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILL  608 (741)
Q Consensus       555 kL~DFg~a~~~~~~~~~--------------------------~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il  608 (741)
                      ||+|||+|+........                          ......+||+.|+|||.+.....|+.++||||+||++
T Consensus       158 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il  237 (361)
T 4f9c_A          158 ALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIF  237 (361)
T ss_dssp             EECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHH
T ss_pred             EECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHH
Confidence            99999999865433211                          0112346999999996665556799999999999999


Q ss_pred             HHHHcCCCCCC
Q 037916          609 LELMTRKRPSD  619 (741)
Q Consensus       609 ~elltg~~p~~  619 (741)
                      |||++|+.||.
T Consensus       238 ~ell~G~~Pf~  248 (361)
T 4f9c_A          238 LSLLSGRYPFY  248 (361)
T ss_dssp             HHHHHTCSSSS
T ss_pred             HHHHHCCCCCC
Confidence            99999999985

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=4.9e-45  Score=429.84  Aligned_cols=359  Identities=33%  Similarity=0.470  Sum_probs=300.6

Q ss_pred             CCCCCcccccCChhhhhCCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCch-hhhhhhhhhc------
Q 037916            2 DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSE-FGKATKAYCV------   74 (741)
Q Consensus         2 dl~~n~~~~~ip~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~~~~~------   74 (741)
                      ||++|++.+.+|..++..+++|++|+|++|++++..|..|.++++|++|+|++|++++.+|.. |..++++..+      
T Consensus       275 ~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~  354 (768)
T 3rgz_A          275 SLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNE  354 (768)
T ss_dssp             ECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSE
T ss_pred             ECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCc
Confidence            689999999999999855699999999999999999999999999999999999999888866 8887763211      


Q ss_pred             ---------cccCCCccEEECcCCcCcccCCchhhc--ccccccEEEccCCcccccCCccccCCCCccEEEccccccccc
Q 037916           75 ---------QNCNQHLKHLDINNNNFGGLLPGCICN--FSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGT  143 (741)
Q Consensus        75 ---------~~~~~~L~~L~Ls~N~l~~~~~~~~~~--l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~  143 (741)
                               ..+..+|++|+|++|++++..|..+..  +. +|++|++++|++.+..|..|..+++|++|+|++|++++.
T Consensus       355 l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~  433 (768)
T 3rgz_A          355 FSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKN-TLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGT  433 (768)
T ss_dssp             EEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTC-CCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESC
T ss_pred             cCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccC-CccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCc
Confidence                     011124555555555555555554444  44 688888888888778888888888999999999999888


Q ss_pred             CCccccCCCcCcEEEcccCCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCcccccc
Q 037916          144 ISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDL  223 (741)
Q Consensus       144 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  223 (741)
                      .|..|.++++|++|+|++|++++.+|..|..+++|++|+|++|++++.+|..|..+++|++|+|++|++++.+|..+..+
T Consensus       434 ~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l  513 (768)
T 3rgz_A          434 IPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRL  513 (768)
T ss_dssp             CCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGC
T ss_pred             ccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcC
Confidence            88888889999999999999988888889889999999999999988888889999999999999999988899999999


Q ss_pred             ccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccchhhhh-----------------------------------
Q 037916          224 TSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILST-----------------------------------  268 (741)
Q Consensus       224 ~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~-----------------------------------  268 (741)
                      ++|+. |+|++|++++.+|..++.+++|+.|+|++|++++..|..                                   
T Consensus       514 ~~L~~-L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (768)
T 3rgz_A          514 ENLAI-LKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGN  592 (768)
T ss_dssp             TTCCE-EECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEE
T ss_pred             CCCCE-EECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccccccccccccccccccccccc
Confidence            99987 999999998888889999999999999999887554433                                   


Q ss_pred             -----------------------------------ccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCcc
Q 037916          269 -----------------------------------LGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEI  313 (741)
Q Consensus       269 -----------------------------------~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  313 (741)
                                                         |+.+++|+.|+|++|++++.+|..|+++++|+.|+|++|+++|.+
T Consensus       593 ~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~i  672 (768)
T 3rgz_A          593 LLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSI  672 (768)
T ss_dssp             EEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCC
T ss_pred             ccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCC
Confidence                                               334577889999999999999999999999999999999999999


Q ss_pred             chhhhccccCCcccccCcccccccCCc-cccCCcccccccCCCCccccCCC
Q 037916          314 PKFLVELQLVQNLNLSYNDLEGVIPTE-GVFKNASAISVFGNSKLCGGIPE  363 (741)
Q Consensus       314 ~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~~~~~~~~~n~~~c~~~~~  363 (741)
                      |..|.++++|+.|||++|+++|.+|.. ..+..++.+++.+| .+.|.+|.
T Consensus       673 p~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N-~l~g~iP~  722 (768)
T 3rgz_A          673 PDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNN-NLSGPIPE  722 (768)
T ss_dssp             CGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSS-EEEEECCS
T ss_pred             ChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCC-cccccCCC
Confidence            999999999999999999999888865 55677888898888 46677765

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3.2e-45  Score=408.75  Aligned_cols=249  Identities=20%  Similarity=0.229  Sum_probs=194.5

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHH---HHHHHHHhcCCCceeeEeeeecCccccCC
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSI---AECSALRNIRHKNLVKILTVCSGVDYKGD  474 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~---~E~~~l~~l~hpnIv~~~~~~~~~~~~~~  474 (741)
                      .|++++.||+|+||.||+|+++.+|+.||+|++++..   ........   .++.+++.++|||||+++++     +++.
T Consensus       190 df~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~-----f~~~  264 (689)
T 3v5w_A          190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA-----FHTP  264 (689)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEE-----EECS
T ss_pred             HeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEE-----EEEC
Confidence            4666778999999999999999999999999997422   12222233   34566777899999999999     5677


Q ss_pred             ceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCce
Q 037916          475 DFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTA  554 (741)
Q Consensus       475 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~  554 (741)
                      ...|+|||||+||+|.+++...          ..+++..++.++.||+.||+|||++   |||||||||+|||++.+|++
T Consensus       265 ~~lylVmEy~~GGdL~~~l~~~----------~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~v  331 (689)
T 3v5w_A          265 DKLSFILDLMNGGDLHYHLSQH----------GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHV  331 (689)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHH----------CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCE
T ss_pred             CEEEEEEecCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCE
Confidence            7999999999999999999643          5689999999999999999999999   99999999999999999999


Q ss_pred             EEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhh
Q 037916          555 HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       555 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  634 (741)
                      ||+|||+|+.......    ...+||+.|||||.+..+..|+.++||||+||++|||++|..||......+  .......
T Consensus       332 KL~DFGlA~~~~~~~~----~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~--~~~i~~~  405 (689)
T 3v5w_A          332 RISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDRM  405 (689)
T ss_dssp             EECCCTTCEECSSCCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC--HHHHHHH
T ss_pred             EecccceeeecCCCCC----CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHh
Confidence            9999999987654432    235799999999666556789999999999999999999999996322111  1111110


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCC-----HHHHHH
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMN-----MTIVVH  701 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  701 (741)
                              +......                    .+....+.+.+|+.+||+.||++|++     ++||++
T Consensus       406 --------i~~~~~~--------------------~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          406 --------TLTMAVE--------------------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             --------HHHCCCC--------------------CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             --------hcCCCCC--------------------CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence                    0000000                    00123456789999999999999998     577664

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.2e-43  Score=392.49  Aligned_cols=346  Identities=21%  Similarity=0.222  Sum_probs=319.7

Q ss_pred             CCCCCcccccCChhhhhCCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCc
Q 037916            2 DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHL   81 (741)
Q Consensus         2 dl~~n~~~~~ip~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L   81 (741)
                      |.+++.+. .||..++   +++++|+|++|+|+++.+..|.++++|++|+|++|+|++..|..|.++++          |
T Consensus        17 ~c~~~~l~-~ip~~~~---~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~----------L   82 (477)
T 2id5_A           17 LCHRKRFV-AVPEGIP---TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFN----------L   82 (477)
T ss_dssp             ECCSCCCS-SCCSCCC---TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTT----------C
T ss_pred             EeCCCCcC-cCCCCCC---CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCcc----------C
Confidence            34566676 7888876   79999999999999999999999999999999999999999999999987          9


Q ss_pred             cEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEccc
Q 037916           82 KHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINT  161 (741)
Q Consensus        82 ~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~  161 (741)
                      ++|+|++|+|+++.+..|..+. +|++|+|++|++....+..|..+++|++|+|++|.++++.+..|.++++|++|+|++
T Consensus        83 ~~L~L~~n~l~~~~~~~~~~l~-~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~  161 (477)
T 2id5_A           83 RTLGLRSNRLKLIPLGVFTGLS-NLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEK  161 (477)
T ss_dssp             CEEECCSSCCCSCCTTSSTTCT-TCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEES
T ss_pred             CEEECCCCcCCccCcccccCCC-CCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCC
Confidence            9999999999988888888988 999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCCC
Q 037916          162 NKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSL  241 (741)
Q Consensus       162 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~  241 (741)
                      |+++++.+..|.++++|+.|+|++|.+.+..+..|..+++|++|++++|++.+.+|..+....+|+. |+|++|+|++..
T Consensus       162 n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~-L~l~~n~l~~~~  240 (477)
T 2id5_A          162 CNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTS-LSITHCNLTAVP  240 (477)
T ss_dssp             CCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSE-EEEESSCCCSCC
T ss_pred             CcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccE-EECcCCcccccC
Confidence            9999888888999999999999999999999999999999999999999988888888888889998 999999999766


Q ss_pred             ChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccchhhhccc
Q 037916          242 PTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQ  321 (741)
Q Consensus       242 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  321 (741)
                      +..|..+++|+.|+|++|.++++.+..|..+++|+.|+|++|++++..|.+|.++++|+.|+|++|+|++..+..|..++
T Consensus       241 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  320 (477)
T 2id5_A          241 YLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVG  320 (477)
T ss_dssp             HHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGG
T ss_pred             HHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCc
Confidence            67899999999999999999999999999999999999999999999999999999999999999999998888999999


Q ss_pred             cCCcccccCcccccccCCccccCCcccccccCCCCccccCCC
Q 037916          322 LVQNLNLSYNDLEGVIPTEGVFKNASAISVFGNSKLCGGIPE  363 (741)
Q Consensus       322 ~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~~~  363 (741)
                      +|+.|+|++|++.+..+..+.+.......+.++...|..++.
T Consensus       321 ~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p~~  362 (477)
T 2id5_A          321 NLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATPEF  362 (477)
T ss_dssp             GCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEESGG
T ss_pred             ccCEEEccCCCccCccchHhHHhhhhccccCccCceeCCchH
Confidence            999999999999987765555555556677888888987654

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.9e-44  Score=406.43  Aligned_cols=252  Identities=22%  Similarity=0.283  Sum_probs=203.1

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      .+|++++.||+|+||.||+|+++.+|+.||+|+++.......+.+.+|+.+|+.++|||||+++++     +.+....|+
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~-----~~~~~~~~i  231 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA-----FEDDNEMVM  231 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEE-----EECSSEEEE
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEE-----EEECCEEEE
Confidence            568999999999999999999999999999999976554556678899999999999999999999     566779999


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCC--CceEEe
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHE--MTAHVA  557 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~--~~~kL~  557 (741)
                      |||||+||+|.+++...         ...+++.++..+++||+.||+|||++   +|+||||||+|||++.+  +.+||+
T Consensus       232 v~E~~~gg~L~~~i~~~---------~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~  299 (573)
T 3uto_A          232 IYEFMSGGELFEKVADE---------HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLI  299 (573)
T ss_dssp             EEECCCCCBHHHHHTCT---------TSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEEC
T ss_pred             EEeecCCCcHHHHHHHh---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEe
Confidence            99999999999998632         24588999999999999999999999   99999999999999854  799999


Q ss_pred             ecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCC
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      |||+|+........   ...+||+.|||| |+..+..|+.++||||+||++|||++|..||....... .+.........
T Consensus       300 DFG~a~~~~~~~~~---~~~~GT~~y~AP-Ev~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~-~~~~i~~~~~~  374 (573)
T 3uto_A          300 DFGLTAHLDPKQSV---KVTTGTAEFAAP-EVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-TLRNVKSCDWN  374 (573)
T ss_dssp             CCSSCEECCTTSEE---EEECSSGGGCCH-HHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHTTCCC
T ss_pred             eccceeEccCCCce---eeeEECccccCH-HHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-HHHHHHhCCCC
Confidence            99999987654332   235699999999 55667889999999999999999999999986321110 01100000000


Q ss_pred             cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          638 DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       638 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                                  ....                ......+.+.+|+.+||+.||++|||+.|+++
T Consensus       375 ------------~~~~----------------~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          375 ------------MDDS----------------AFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             ------------CCSG----------------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ------------CCcc----------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                        0000                00122355779999999999999999999986

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=1.3e-42  Score=385.30  Aligned_cols=342  Identities=20%  Similarity=0.231  Sum_probs=256.3

Q ss_pred             CCCCcccccCChhhhhCCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcc-cCCchhhhhhhhhhccccCCCc
Q 037916            3 VGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTG-EVPSEFGKATKAYCVQNCNQHL   81 (741)
Q Consensus         3 l~~n~~~~~ip~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~~~~~~~~~~~L   81 (741)
                      .+++.+. .+|. +.   ++|++|+|++|+|+++.|..|.++++|++|+|++|.+.+ +.+..|.++++          |
T Consensus        17 c~~~~l~-~lp~-l~---~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~----------L   81 (455)
T 3v47_A           17 CINRGLH-QVPE-LP---AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSS----------L   81 (455)
T ss_dssp             CCSSCCS-SCCC-CC---TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTT----------C
T ss_pred             cCCCCcc-cCCC-CC---CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECccccccccc----------C
Confidence            4455555 6675 43   778888888888888888888888888888888888864 34567777765          8


Q ss_pred             cEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCcc--ccCCCCccEEEcccccccccCCcc-ccCCCcCcEEE
Q 037916           82 KHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAG--IGKFINLQTLHMWDNQLSGTISPA-IGELQNLVTLA  158 (741)
Q Consensus        82 ~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~--~~~l~~L~~L~L~~N~i~~~~~~~-~~~l~~L~~L~  158 (741)
                      ++|+|++|++++..|..|..+. +|++|+|++|++.+..+..  |..+++|++|+|++|+|+++.|.. |.++++|++|+
T Consensus        82 ~~L~Ls~n~l~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~  160 (455)
T 3v47_A           82 IILKLDYNQFLQLETGAFNGLA-NLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLD  160 (455)
T ss_dssp             CEEECTTCTTCEECTTTTTTCT-TCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEE
T ss_pred             CEEeCCCCccCccChhhccCcc-cCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEe
Confidence            8888888888888888888887 8888888888887644443  888888888888888888776665 78888888888


Q ss_pred             cccCCCCCcCcccccCC--cccceeeccCcccccccCccc--------ccCCCCCEEeccCccccccCCccccc------
Q 037916          159 INTNKLSGNIPPSIGNL--KKLLQLYLIENFLQVSIPSSL--------GQCQSLTTINLSYNNLSGTIPPQLMD------  222 (741)
Q Consensus       159 L~~N~l~~~~~~~~~~l--~~L~~L~L~~N~i~~~~~~~~--------~~l~~L~~L~L~~N~l~~~~p~~~~~------  222 (741)
                      |++|++++..+..+..+  .+|+.|++++|.+.+..+..+        ..+++|++|++++|++++..|..+..      
T Consensus       161 L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~  240 (455)
T 3v47_A          161 LTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTK  240 (455)
T ss_dssp             CTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCC
T ss_pred             CCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccc
Confidence            88888887777777665  456666666666554433322        23455566666666555433332221      


Q ss_pred             ---------------------------------cccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccchhhhhc
Q 037916          223 ---------------------------------LTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTL  269 (741)
Q Consensus       223 ---------------------------------l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~  269 (741)
                                                       .++|+. |++++|.+.+..|..|+.+++|++|+|++|+++++.+..|
T Consensus       241 L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~-L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~  319 (455)
T 3v47_A          241 IQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKT-CDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAF  319 (455)
T ss_dssp             EEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCE-EECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTT
T ss_pred             eeeEeeccccccccccchhhhccCcccccccccccCceE-EEecCccccccchhhcccCCCCCEEECCCCcccccChhHh
Confidence                                             146776 8888888887778888888888888888888888888888


Q ss_pred             cccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccchhhhccccCCcccccCcccccccCCc-cccCCccc
Q 037916          270 GSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTE-GVFKNASA  348 (741)
Q Consensus       270 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~~~~  348 (741)
                      ..+++|++|+|++|++++..+..|.++++|++|+|++|++++..|..|..+++|+.|+|++|++++.++.. ..++.++.
T Consensus       320 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  399 (455)
T 3v47_A          320 WGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQK  399 (455)
T ss_dssp             TTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCE
T ss_pred             cCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccE
Confidence            88888888888888888777888888888888888888888777888888888888888888888776654 45677888


Q ss_pred             ccccCCCCccccC
Q 037916          349 ISVFGNSKLCGGI  361 (741)
Q Consensus       349 ~~~~~n~~~c~~~  361 (741)
                      +++.+|++.|..+
T Consensus       400 L~l~~N~l~~~~~  412 (455)
T 3v47_A          400 IWLHTNPWDCSCP  412 (455)
T ss_dssp             EECCSSCBCCCTT
T ss_pred             EEccCCCcccCCC
Confidence            8888888877654

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=2.7e-42  Score=397.10  Aligned_cols=346  Identities=19%  Similarity=0.176  Sum_probs=264.4

Q ss_pred             CCCCCcccccCChhhhhCCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCc
Q 037916            2 DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHL   81 (741)
Q Consensus         2 dl~~n~~~~~ip~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L   81 (741)
                      ||++|++.+..|..|. .+++|++|+|++|+|+++.|.+|.++++|++|+|++|++++..|..|.++++          |
T Consensus        38 ~Ls~n~l~~~~~~~~~-~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~----------L  106 (606)
T 3vq2_A           38 DLSFNPLKILKSYSFS-NFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTS----------L  106 (606)
T ss_dssp             ECTTSCCCEECTTTTT-TCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTT----------C
T ss_pred             ECCCCCcCEeChhhcc-CCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCccc----------C
Confidence            6788888855555655 8888888888888888888888888888888888888888777888888876          7


Q ss_pred             cEEECcCCcCcccCCchhhcccccccEEEccCCcccc-cCCccccCCCCccEEEcccccccccCCccccC----------
Q 037916           82 KHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFR-SIPAGIGKFINLQTLHMWDNQLSGTISPAIGE----------  150 (741)
Q Consensus        82 ~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~-~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~----------  150 (741)
                      ++|+|++|++++..+..+..+. +|++|++++|++.+ .+|..|.++++|++|+|++|+++++.+..|..          
T Consensus       107 ~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~  185 (606)
T 3vq2_A          107 ENLVAVETKLASLESFPIGQLI-TLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLS  185 (606)
T ss_dssp             CEEECTTSCCCCSSSSCCTTCT-TCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCE
T ss_pred             CEEEccCCccccccccccCCCC-CCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccce
Confidence            7777777777766666677776 77777777777755 34677777777777777777766554433222          


Q ss_pred             --------------------------------------------------------------------------------
Q 037916          151 --------------------------------------------------------------------------------  150 (741)
Q Consensus       151 --------------------------------------------------------------------------------  150 (741)
                                                                                                      
T Consensus       186 L~l~~n~l~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~  265 (606)
T 3vq2_A          186 LDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDE  265 (606)
T ss_dssp             EECTTCCCCEECTTTTTTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEE
T ss_pred             eeccCCCcceeCcccccCceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhh
Confidence                                                                                            


Q ss_pred             --------------------------------------------------------------------------------
Q 037916          151 --------------------------------------------------------------------------------  150 (741)
Q Consensus       151 --------------------------------------------------------------------------------  150 (741)
                                                                                                      
T Consensus       266 l~l~~~~~~~~~~~~~~~l~~L~~L~l~~~~~~~l~~l~~~~~L~~L~l~~n~l~~lp~~~l~~L~~L~l~~n~~~~~~~  345 (606)
T 3vq2_A          266 FRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFK  345 (606)
T ss_dssp             EEECCCTTCCGGGGSCGGGTTCSEEEEESCCCCCCCCCCTTCCCSEEEEESCCCSSCCCCCCSSCCEEEEESCSSCEECC
T ss_pred             eeccccccccccccccccCCCCCEEEecCccchhhhhccccccCCEEEcccccCcccccCCCCccceeeccCCcCccchh
Confidence                                                                                            


Q ss_pred             ---CCcCcEEEcccCCCCCc--CcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCC-ccccccc
Q 037916          151 ---LQNLVTLAINTNKLSGN--IPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIP-PQLMDLT  224 (741)
Q Consensus       151 ---l~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~  224 (741)
                         +++|++|+|++|++++.  .+..+..+++|++|+|++|.+++ +|..|..+++|++|++++|++++..| ..|.+++
T Consensus       346 ~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~  424 (606)
T 3vq2_A          346 KVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLE  424 (606)
T ss_dssp             CCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCT
T ss_pred             hccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccc
Confidence               12223333333333322  13344444555555555555543 34667777777777777777776666 5778888


Q ss_pred             cceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccc-hhhhhccccccccEEEeCCCccCCCCChhcccCccCCeee
Q 037916          225 SLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLEC-EILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLD  303 (741)
Q Consensus       225 ~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  303 (741)
                      +|+. |++++|.+.+..|..|+.+++|++|++++|.+++ ..+..|+.+++|+.|+|++|++++..|..|.++++|+.|+
T Consensus       425 ~L~~-L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~  503 (606)
T 3vq2_A          425 KLLY-LDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLN  503 (606)
T ss_dssp             TCCE-EECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred             cCCE-EECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEE
Confidence            8887 8888888888888888899999999999999987 4788899999999999999999998899999999999999


Q ss_pred             CCCCcCCCccchhhhccccCCcccccCcccccccCCccccC-CcccccccCCCCccccC
Q 037916          304 LSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFK-NASAISVFGNSKLCGGI  361 (741)
Q Consensus       304 Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-~~~~~~~~~n~~~c~~~  361 (741)
                      |++|++++..|..|..+++|+.|+|++|+++.+++....+. +++.+++.+|++.|.+.
T Consensus       504 Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~c~  562 (606)
T 3vq2_A          504 MSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICE  562 (606)
T ss_dssp             CCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred             CCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCcccCCc
Confidence            99999999889999999999999999999998777765665 58999999999999755

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.9e-43  Score=371.16  Aligned_cols=270  Identities=25%  Similarity=0.375  Sum_probs=214.4

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      ..|.+.+.||+|+||.||+|.+..+++.||+|++........+.+.+|+.++++++||||+++++++     .++...++
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~l   84 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL-----YKDKRLNF   84 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTEEEE
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEE-----ecCCeeEE
Confidence            4678889999999999999999999999999998655555567788999999999999999999995     34568999


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      ||||+++++|.+++...         ...+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        85 v~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Df  152 (310)
T 3s95_A           85 ITEYIKGGTLRGIIKSM---------DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADF  152 (310)
T ss_dssp             EEECCTTCBHHHHHHHC---------CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCC
T ss_pred             EEEecCCCcHHHHHHhc---------cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeec
Confidence            99999999999999743         24588999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCccc------------ccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcc
Q 037916          560 GLAKLLPPAHLQT------------SSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMN  627 (741)
Q Consensus       560 g~a~~~~~~~~~~------------~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~  627 (741)
                      |.+..........            ......||+.|+|| |+..+..++.++|||||||++|||++|..||.........
T Consensus       153 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP-E~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~  231 (310)
T 3s95_A          153 GLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP-EMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD  231 (310)
T ss_dssp             TTCEECC--------------------CCCCSCGGGCCH-HHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT
T ss_pred             ccceecccccccccccccccccccccccccCCCcceeCH-HHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH
Confidence            9998765432211            01135699999999 5556778999999999999999999999998643222111


Q ss_pred             hhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHH
Q 037916          628 LHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIK  707 (741)
Q Consensus       628 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  707 (741)
                      ...        ......+...                      +..+++.+.+++.+||+.||++|||+.|+++.|+.++
T Consensus       232 ~~~--------~~~~~~~~~~----------------------~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~  281 (310)
T 3s95_A          232 FGL--------NVRGFLDRYC----------------------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR  281 (310)
T ss_dssp             SSB--------CHHHHHHHTC----------------------CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             Hhh--------hhhccccccC----------------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            110        0111111111                      1133456889999999999999999999999999999


Q ss_pred             HhhcCCcccc
Q 037916          708 SILLGPKTVS  717 (741)
Q Consensus       708 ~~~~~~~~~~  717 (741)
                      .......+..
T Consensus       282 ~~~~~~~~~~  291 (310)
T 3s95_A          282 MHLAGHLPLG  291 (310)
T ss_dssp             HHHHHCCCCH
T ss_pred             HhccCcccCC
Confidence            8877544443

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=3.9e-42  Score=363.00  Aligned_cols=277  Identities=29%  Similarity=0.424  Sum_probs=215.4

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      ..|.+.+.||+|+||.||+|++. +++.||+|++........+.+.+|+.+++.++||||+++++++     ......++
T Consensus        39 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~l  112 (321)
T 2qkw_B           39 NNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFC-----DERNEMIL  112 (321)
T ss_dssp             CCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEEC-----CCTTCCEE
T ss_pred             hccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----cCCCeEEE
Confidence            35778889999999999999976 6889999998765555567889999999999999999999995     45568899


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      ||||+++|+|.+++.....      ....+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus       113 v~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Df  183 (321)
T 2qkw_B          113 IYKYMENGNLKRHLYGSDL------PTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDF  183 (321)
T ss_dssp             EEECCTTCBTGGGSSSSCC------CSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCC
T ss_pred             EEEcCCCCcHHHHHhccCC------CccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeec
Confidence            9999999999999864421      124588999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCC-cchhhhhhhc-CC
Q 037916          560 GLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGN-MNLHNFARTV-LP  637 (741)
Q Consensus       560 g~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~-~~~~~~~~~~-~~  637 (741)
                      |.+................||+.|+||| +..+..++.++|||||||++|||++|+.||....... .....+.... ..
T Consensus       184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE-~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  262 (321)
T 2qkw_B          184 GISKKGTELDQTHLSTVVKGTLGYIDPE-YFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN  262 (321)
T ss_dssp             TTCEECSSSSCCCCBCCCEEETTTCCHH-HHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTT
T ss_pred             ccccccccccccccccccCCCccccCHH-HhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccc
Confidence            9998755433332233356899999995 4456678999999999999999999999987433221 1122221111 11


Q ss_pred             cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHhh
Q 037916          638 DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSIL  710 (741)
Q Consensus       638 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  710 (741)
                      ......+++.....                  ...+++..+.+++.+||+.||++|||+.||++.|+.+.+..
T Consensus       263 ~~~~~~~~~~~~~~------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~  317 (321)
T 2qkw_B          263 GQLEQIVDPNLADK------------------IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ  317 (321)
T ss_dssp             TCCCSSSSSSCTTC------------------SCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             ccHHHhcChhhccc------------------cCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence            11111122111111                  12366788999999999999999999999999999988643

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=7.7e-42  Score=379.07  Aligned_cols=326  Identities=19%  Similarity=0.187  Sum_probs=291.7

Q ss_pred             CCCCCcccccCChhhhhCCCCCcEEEcccCcccc-cCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCC
Q 037916            2 DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITG-VIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQH   80 (741)
Q Consensus         2 dl~~n~~~~~ip~~~~~~l~~L~~L~L~~n~i~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~   80 (741)
                      ||++|++.+..|..+. .+++|++|+|++|.+.+ +.+..|.++++|++|+|++|++++..|..|.++++          
T Consensus        36 ~Ls~n~i~~~~~~~~~-~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~----------  104 (455)
T 3v47_A           36 DLSLNSIAELNETSFS-RLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLAN----------  104 (455)
T ss_dssp             ECCSSCCCEECTTTTS-SCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTT----------
T ss_pred             EecCCccCcCChhHhc-cCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCccc----------
Confidence            7899999977787777 89999999999999974 55788999999999999999999888999999987          


Q ss_pred             ccEEECcCCcCcccCCch--hhcccccccEEEccCCcccccCCcc-ccCCCCccEEEcccccccccCCccccCC--CcCc
Q 037916           81 LKHLDINNNNFGGLLPGC--ICNFSITLETLIFNSNKIFRSIPAG-IGKFINLQTLHMWDNQLSGTISPAIGEL--QNLV  155 (741)
Q Consensus        81 L~~L~Ls~N~l~~~~~~~--~~~l~~~L~~L~L~~n~i~~~~~~~-~~~l~~L~~L~L~~N~i~~~~~~~~~~l--~~L~  155 (741)
                      |++|+|++|++++..+..  |..+. +|++|+|++|++.+..|.. |.++++|++|+|++|++++..+..+..+  .+|+
T Consensus       105 L~~L~L~~n~l~~~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~  183 (455)
T 3v47_A          105 LEVLTLTQCNLDGAVLSGNFFKPLT-SLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFT  183 (455)
T ss_dssp             CCEEECTTSCCBTHHHHSSTTTTCT-TCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEE
T ss_pred             CCEEeCCCCCCCccccCcccccCcc-cCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhcccccccc
Confidence            999999999999755443  88888 9999999999999887876 8999999999999999999999888876  6788


Q ss_pred             EEEcccCCCCCcCcccc--------cCCcccceeeccCcccccccCccccc-----------------------------
Q 037916          156 TLAINTNKLSGNIPPSI--------GNLKKLLQLYLIENFLQVSIPSSLGQ-----------------------------  198 (741)
Q Consensus       156 ~L~L~~N~l~~~~~~~~--------~~l~~L~~L~L~~N~i~~~~~~~~~~-----------------------------  198 (741)
                      .|++++|.+.+..+..+        ..+++|++|+|++|.+++..|..+..                             
T Consensus       184 ~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~  263 (455)
T 3v47_A          184 LLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKD  263 (455)
T ss_dssp             EEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCC
T ss_pred             ccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhcc
Confidence            88888888886554432        35678888888888887665554432                             


Q ss_pred             ----------CCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccchhhhh
Q 037916          199 ----------CQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILST  268 (741)
Q Consensus       199 ----------l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~  268 (741)
                                .++|++|++++|++++..|..|..+++|+. |+|++|++.+..|..|..+++|++|+|++|.++++.+..
T Consensus       264 ~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~-L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~  342 (455)
T 3v47_A          264 PDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQ-LTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRM  342 (455)
T ss_dssp             CCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCE-EECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGG
T ss_pred             CcccccccccccCceEEEecCccccccchhhcccCCCCCE-EECCCCcccccChhHhcCcccCCEEECCCCccCCcChhH
Confidence                      268999999999999999999999999998 999999999888999999999999999999999999999


Q ss_pred             ccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccchhhhccccCCcccccCcccccccCCc
Q 037916          269 LGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTE  340 (741)
Q Consensus       269 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~  340 (741)
                      |..+++|++|+|++|++++..|.+|.++++|++|+|++|+|++..+..|..+++|+.|+|++|++++.+|..
T Consensus       343 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~  414 (455)
T 3v47_A          343 FENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI  414 (455)
T ss_dssp             GTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred             hcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCcc
Confidence            999999999999999999999999999999999999999999888888999999999999999999998854

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.6e-42  Score=361.46  Aligned_cols=250  Identities=21%  Similarity=0.268  Sum_probs=202.2

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      .+|++.++||+|+||.||+|.+..+++.||+|++........+.+.+|+.++++++||||+++++++     ..+...++
T Consensus        20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~l   94 (297)
T 3fxz_A           20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY-----LVGDELWV   94 (297)
T ss_dssp             GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTEEEE
T ss_pred             hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEE-----EECCEEEE
Confidence            4688999999999999999999999999999999866666667788999999999999999999995     44568999


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      ||||+++|+|.+++..           ..+++..+..++.|++.||+|||+.   ||+||||||+||+++.++.+||+||
T Consensus        95 v~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Df  160 (297)
T 3fxz_A           95 VMEYLAGGSLTDVVTE-----------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDF  160 (297)
T ss_dssp             EEECCTTCBHHHHHHH-----------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCC
T ss_pred             EEECCCCCCHHHHHhh-----------cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeC
Confidence            9999999999999863           3478899999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcc
Q 037916          560 GLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDH  639 (741)
Q Consensus       560 g~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  639 (741)
                      |++.........  .....||+.|+||| +..+..++.++||||+||++|+|++|+.||....... ..........+. 
T Consensus       161 g~~~~~~~~~~~--~~~~~gt~~y~aPE-~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~-  235 (297)
T 3fxz_A          161 GFCAQITPEQSK--RSTMVGTPYWMAPE-VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYLIATNGTPE-  235 (297)
T ss_dssp             TTCEECCSTTCC--BCCCCSCGGGCCHH-HHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHHCSCC-
T ss_pred             CCceecCCcccc--cCCccCCcCccChh-hhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCCC-
Confidence            999876544322  22356999999995 5566788999999999999999999999986321110 000000000000 


Q ss_pred             hhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          640 VMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       640 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                                  .                ..+...+..+.+++.+||+.||++|||+.|+++
T Consensus       236 ------------~----------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          236 ------------L----------------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             ------------C----------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ------------C----------------CCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence                        0                001123456789999999999999999999986

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2e-42  Score=364.92  Aligned_cols=257  Identities=19%  Similarity=0.258  Sum_probs=202.3

Q ss_pred             HHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc-CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCce
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      +..+|++.+.||+|+||.||+|++..+++.||+|+++.... ...+.+.+|+.+++.++||||+++++++     ..+..
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~   79 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-----REGNI   79 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred             HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEE-----ecCCe
Confidence            34578999999999999999999999999999999974332 2346788999999999999999999994     45668


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .|+||||+++++|.+++...          ..+++..++.++.|++.||+|||+.   ||+||||||+||+++.++.+||
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl  146 (323)
T 3tki_A           80 QYLFLEYCSGGELFDRIEPD----------IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKI  146 (323)
T ss_dssp             EEEEEECCTTEEGGGGSBTT----------TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEE
T ss_pred             EEEEEEcCCCCcHHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEE
Confidence            99999999999999998643          4588999999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcC
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVL  636 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  636 (741)
                      +|||.+................||+.|+|||.+.....++.++||||+||++|+|++|+.||.........+..+.....
T Consensus       147 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~  226 (323)
T 3tki_A          147 SDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT  226 (323)
T ss_dssp             CCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT
T ss_pred             EEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc
Confidence            99999986643333232334569999999966655555588999999999999999999999743222222222111110


Q ss_pred             CcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          637 PDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       637 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      ...                              ........+.+++.+||+.||++|||+.|+++.
T Consensus       227 ~~~------------------------------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          227 YLN------------------------------PWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             TST------------------------------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             cCC------------------------------ccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            000                              001234567799999999999999999999864

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.7e-42  Score=365.69  Aligned_cols=250  Identities=20%  Similarity=0.251  Sum_probs=199.8

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc--CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCce
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      .+.|++.+.||+|+||.||+|++..+++.||+|++.....  ...+.+.+|+.+++.++||||+++++++     .....
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-----~~~~~   88 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI-----ETEKT   88 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECCE
Confidence            3568899999999999999999998999999999974322  2345678999999999999999999994     45668


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .|+||||+++|+|.+++...          ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl  155 (328)
T 3fe3_A           89 LYLIMEYASGGEVFDYLVAH----------GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKI  155 (328)
T ss_dssp             EEEEECCCTTCBHHHHHHHH----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEE
T ss_pred             EEEEEECCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEE
Confidence            99999999999999998633          4588999999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcC
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVL  636 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  636 (741)
                      +|||++........   .....||+.|+|||.+......+.++||||+||++|+|++|+.||....     .......  
T Consensus       156 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~--  225 (328)
T 3fe3_A          156 ADFGFSNEFTVGGK---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-----LKELRER--  225 (328)
T ss_dssp             CSTTCCGGGSSSCG---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHH--
T ss_pred             eeccCceecCCCCc---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC-----HHHHHHH--
Confidence            99999987654432   2235699999999665544445689999999999999999999986321     1111110  


Q ss_pred             CcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          637 PDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       637 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                                ...+...                .+......+.+++.+||+.||++|||+.|+++.
T Consensus       226 ----------i~~~~~~----------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          226 ----------VLRGKYR----------------IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             ----------HHHCCCC----------------CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             ----------HHhCCCC----------------CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                      0000000                001123557799999999999999999999863

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=9.4e-42  Score=392.78  Aligned_cols=301  Identities=19%  Similarity=0.229  Sum_probs=136.9

Q ss_pred             CCccCC--CCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCccEEECcCCc-Ccc-cCCchhhcc------cccc
Q 037916           37 IPSSMF--NASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNN-FGG-LLPGCICNF------SITL  106 (741)
Q Consensus        37 ~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~-l~~-~~~~~~~~l------~~~L  106 (741)
                      +|..++  ++++|++|+|++|++.+.+|..|.++++          |++|+|++|+ +++ .+|..+..+      + +|
T Consensus       239 ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~----------L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~-~L  307 (636)
T 4eco_A          239 KTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPE----------MQLINVACNRGISGEQLKDDWQALADAPVGE-KI  307 (636)
T ss_dssp             TTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSS----------CCEEECTTCTTSCHHHHHHHHHHHHHSGGGG-TC
T ss_pred             CchhhhhcccCCCCEEEecCCcCCccChHHHhcCCC----------CCEEECcCCCCCccccchHHHHhhhccccCC-CC
Confidence            444444  4444444444444444444444444433          4444444444 444 344444433      3 44


Q ss_pred             cEEEccCCcccccCCc--cccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCcccccCCcc-cceeec
Q 037916          107 ETLIFNSNKIFRSIPA--GIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKK-LLQLYL  183 (741)
Q Consensus       107 ~~L~L~~n~i~~~~~~--~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~L  183 (741)
                      ++|+|++|++. .+|.  .|.++++|++|+|++|++++.+| .|..+++|++|+|++|+++ .+|..|.++++ |++|+|
T Consensus       308 ~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~L  384 (636)
T 4eco_A          308 QIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSF  384 (636)
T ss_dssp             CEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEEC
T ss_pred             CEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEc
Confidence            44444444443 3333  44444444444444444443334 4444444444444444444 34444444444 444444


Q ss_pred             cCcccccccCcccccCC--CCCEEeccCccccccCCcccc-------ccccceeEEEcCCCccCCCCChhhcCCCCCcEE
Q 037916          184 IENFLQVSIPSSLGQCQ--SLTTINLSYNNLSGTIPPQLM-------DLTSLSVGLDLSRNQLVGSLPTEVGKLINLEIL  254 (741)
Q Consensus       184 ~~N~i~~~~~~~~~~l~--~L~~L~L~~N~l~~~~p~~~~-------~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L  254 (741)
                      ++|.++ .+|..+..++  +|++|++++|++++.+|..|.       .+++|+. |+|++|+++...+..+..+++|++|
T Consensus       385 s~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~-L~Ls~N~l~~lp~~~~~~l~~L~~L  462 (636)
T 4eco_A          385 AHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSS-INLSNNQISKFPKELFSTGSPLSSI  462 (636)
T ss_dssp             CSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEE-EECCSSCCCSCCTHHHHTTCCCSEE
T ss_pred             cCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCE-EECcCCccCcCCHHHHccCCCCCEE
Confidence            444444 3344443332  444444444444444444444       4444444 5555555543333333444555555


Q ss_pred             Eeccccccchhhhhccccc-------cccEEEeCCCccCCCCChhcc--cCccCCeeeCCCCcCCCccchhhhccccCCc
Q 037916          255 FISRNMLECEILSTLGSCI-------KLEQLKLGGNLFQGPIPLSLS--SLRGLRVLDLSQNNISGEIPKFLVELQLVQN  325 (741)
Q Consensus       255 ~Ls~N~l~~~~~~~~~~l~-------~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  325 (741)
                      +|++|+++.+....+..+.       +|+.|+|++|+++ .+|..+.  .+++|+.|+|++|+|++ +|..+..+++|+.
T Consensus       463 ~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~  540 (636)
T 4eco_A          463 NLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKG  540 (636)
T ss_dssp             ECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCE
T ss_pred             ECCCCCCCCcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCE
Confidence            5555555433333333222       4555555555555 3333333  45555555555555554 4444445555555


Q ss_pred             ccc------cCcccccccCCc-cccCCcccccccCCC
Q 037916          326 LNL------SYNDLEGVIPTE-GVFKNASAISVFGNS  355 (741)
Q Consensus       326 L~l------~~N~l~~~~~~~-~~~~~~~~~~~~~n~  355 (741)
                      |+|      ++|.+.+.+|.. ..++.++.+++.+|.
T Consensus       541 L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~  577 (636)
T 4eco_A          541 FGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSND  577 (636)
T ss_dssp             EECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSC
T ss_pred             EECCCCcccccCcccccChHHHhcCCCCCEEECCCCc
Confidence            555      234444433322 334445555555543

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.9e-41  Score=379.89  Aligned_cols=334  Identities=22%  Similarity=0.247  Sum_probs=251.2

Q ss_pred             CCCCCcccccCChhhhhCCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCc
Q 037916            2 DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHL   81 (741)
Q Consensus         2 dl~~n~~~~~ip~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L   81 (741)
                      |+++|++. .||..++   ++|++|+|++|+|+++.|..|.++++|++|+|++|+|++..|..|.++++          |
T Consensus         6 ~ls~n~l~-~ip~~~~---~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~----------L   71 (520)
T 2z7x_B            6 DRSKNGLI-HVPKDLS---QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQE----------L   71 (520)
T ss_dssp             ECTTSCCS-SCCCSCC---TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTT----------C
T ss_pred             ecCCCCcc-ccccccc---ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccC----------C
Confidence            78899998 7998876   89999999999999888888999999999999999999888889988876          9


Q ss_pred             cEEECcCCcCcccCCchhhcccccccEEEccCCcccc-cCCccccCCCCccEEEcccccccccCCccccCCCcC--cEEE
Q 037916           82 KHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFR-SIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNL--VTLA  158 (741)
Q Consensus        82 ~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~-~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L--~~L~  158 (741)
                      ++|+|++|+|+++.+.   .+. +|++|+|++|++.+ ..|..|+++++|++|+|++|+|++   ..|..+++|  ++|+
T Consensus        72 ~~L~Ls~N~l~~lp~~---~l~-~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~  144 (520)
T 2z7x_B           72 EYLDLSHNKLVKISCH---PTV-NLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVL  144 (520)
T ss_dssp             CEEECCSSCCCEEECC---CCC-CCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEE
T ss_pred             CEEecCCCceeecCcc---ccC-CccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEE
Confidence            9999999998854443   566 89999999998877 367888888999999999888875   345666666  7777


Q ss_pred             cccCCC--CCcCcccccCCc------------------------------------------------------------
Q 037916          159 INTNKL--SGNIPPSIGNLK------------------------------------------------------------  176 (741)
Q Consensus       159 L~~N~l--~~~~~~~~~~l~------------------------------------------------------------  176 (741)
                      |++|++  .+..|..|..+.                                                            
T Consensus       145 l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~  224 (520)
T 2z7x_B          145 LVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSN  224 (520)
T ss_dssp             EEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCE
T ss_pred             eecccccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhh
Confidence            777777  555555554422                                                            


Q ss_pred             -----------------------ccceeeccCcccccccCccc-------------------------------------
Q 037916          177 -----------------------KLLQLYLIENFLQVSIPSSL-------------------------------------  196 (741)
Q Consensus       177 -----------------------~L~~L~L~~N~i~~~~~~~~-------------------------------------  196 (741)
                                             +|++|++++|++++.+|..+                                     
T Consensus       225 L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~~~p~~~~~~~~~~~~L  304 (520)
T 2z7x_B          225 LTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNI  304 (520)
T ss_dssp             EEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCCCSCTHHHHHHHHTCCC
T ss_pred             ccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccceecchhhhhcccccCce
Confidence                                   45556666666655555444                                     


Q ss_pred             ----------------ccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCC--CCChhhcCCCCCcEEEecc
Q 037916          197 ----------------GQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVG--SLPTEVGKLINLEILFISR  258 (741)
Q Consensus       197 ----------------~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~  258 (741)
                                      ..+++|++|++++|++++.+|..+.++++|+. |+|++|++++  .+|..++.+++|++|+|++
T Consensus       305 ~~L~l~~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~-L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~  383 (520)
T 2z7x_B          305 KNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELET-LILQMNQLKELSKIAEMTTQMKSLQQLDISQ  383 (520)
T ss_dssp             SEEEEESSCCCCCCCCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCE-EECCSSCCCBHHHHHHHHTTCTTCCEEECCS
T ss_pred             eEEEcCCCccccccchhhCCcccEEEeECCccChhhhhhhccCCCCCE-EEccCCccCccccchHHHhhCCCCCEEECCC
Confidence                            45667777777777777667777777777776 7777777775  3445677777777777777


Q ss_pred             ccccc-hhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccchhhhccccCCcccccCccccccc
Q 037916          259 NMLEC-EILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVI  337 (741)
Q Consensus       259 N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~  337 (741)
                      |.+++ +....|..+++|+.|++++|++++..|..+.  ++|+.|+|++|+|+ .+|..+..+++|+.|+|++|++++++
T Consensus       384 N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~  460 (520)
T 2z7x_B          384 NSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVP  460 (520)
T ss_dssp             SCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCC
T ss_pred             CcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccC
Confidence            77776 4445577777777777777777766655543  67888888888887 56666668888888888888888766


Q ss_pred             CC-ccccCCcccccccCCCCcccc
Q 037916          338 PT-EGVFKNASAISVFGNSKLCGG  360 (741)
Q Consensus       338 ~~-~~~~~~~~~~~~~~n~~~c~~  360 (741)
                      +. ...++.++.+++.+|++.|.+
T Consensus       461 ~~~~~~l~~L~~L~l~~N~~~c~c  484 (520)
T 2z7x_B          461 DGIFDRLTSLQKIWLHTNPWDCSC  484 (520)
T ss_dssp             TTTTTTCTTCCEEECCSSCBCCCH
T ss_pred             HHHhccCCcccEEECcCCCCcccC
Confidence            55 445677888888888887753

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=5e-41  Score=386.74  Aligned_cols=345  Identities=18%  Similarity=0.213  Sum_probs=301.1

Q ss_pred             CCCCCccccc-----------------CChhhh-hCCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCc-Ccc-cC
Q 037916            2 DVGVNRVQGG-----------------IPLDFG-FTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNN-LTG-EV   61 (741)
Q Consensus         2 dl~~n~~~~~-----------------ip~~~~-~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~-l~~-~~   61 (741)
                      ||++|++.+.                 +|..++ .++++|++|+|++|++.+.+|..|+++++|++|+|++|+ +++ .+
T Consensus       212 ~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~l  291 (636)
T 4eco_A          212 YMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQL  291 (636)
T ss_dssp             EEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHH
T ss_pred             ECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccc
Confidence            6788999975                 998876 269999999999999999999999999999999999999 998 88


Q ss_pred             CchhhhhhhhhhccccCCCccEEECcCCcCcccCCc--hhhcccccccEEEccCCcccccCCccccCCCCccEEEccccc
Q 037916           62 PSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPG--CICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQ  139 (741)
Q Consensus        62 ~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~--~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~  139 (741)
                      |..++.+...    .+..+|++|+|++|+++ .+|.  .+..++ +|++|++++|++.+.+| .|..+++|++|+|++|+
T Consensus       292 p~~~~~L~~~----~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~-~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~  364 (636)
T 4eco_A          292 KDDWQALADA----PVGEKIQIIYIGYNNLK-TFPVETSLQKMK-KLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQ  364 (636)
T ss_dssp             HHHHHHHHHS----GGGGTCCEEECCSSCCS-SCCCHHHHTTCT-TCCEEECCSCCCEEECC-CCEEEEEESEEECCSSE
T ss_pred             hHHHHhhhcc----ccCCCCCEEECCCCcCC-ccCchhhhccCC-CCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCc
Confidence            9999887210    00123999999999999 7777  899998 99999999999987888 99999999999999999


Q ss_pred             ccccCCccccCCCc-CcEEEcccCCCCCcCcccccCCc--ccceeeccCcccccccCcccc-------cCCCCCEEeccC
Q 037916          140 LSGTISPAIGELQN-LVTLAINTNKLSGNIPPSIGNLK--KLLQLYLIENFLQVSIPSSLG-------QCQSLTTINLSY  209 (741)
Q Consensus       140 i~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~L~~N~i~~~~~~~~~-------~l~~L~~L~L~~  209 (741)
                      ++ .+|..|.++++ |++|+|++|+++ .+|..+..+.  +|++|+|++|.+++..|..|.       .+++|++|+|++
T Consensus       365 l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~  442 (636)
T 4eco_A          365 IT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSN  442 (636)
T ss_dssp             EE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCS
T ss_pred             cc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcC
Confidence            99 66778999999 999999999999 7788887755  999999999999999999998       888999999999


Q ss_pred             ccccccCCcc-ccccccceeEEEcCCCccCCCCChhhcCCC-------CCcEEEeccccccchhhhhcc--ccccccEEE
Q 037916          210 NNLSGTIPPQ-LMDLTSLSVGLDLSRNQLVGSLPTEVGKLI-------NLEILFISRNMLECEILSTLG--SCIKLEQLK  279 (741)
Q Consensus       210 N~l~~~~p~~-~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~-------~L~~L~Ls~N~l~~~~~~~~~--~l~~L~~L~  279 (741)
                      |+++ .+|.. +..+++|+. |+|++|+|+...+..+..+.       +|+.|+|++|+|+. .|..+.  .+++|+.|+
T Consensus       443 N~l~-~lp~~~~~~l~~L~~-L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~~~~~~l~~L~~L~  519 (636)
T 4eco_A          443 NQIS-KFPKELFSTGSPLSS-INLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGID  519 (636)
T ss_dssp             SCCC-SCCTHHHHTTCCCSE-EECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCCB-CCGGGSTTTCTTCCEEE
T ss_pred             CccC-cCCHHHHccCCCCCE-EECCCCCCCCcCHHHhccccccccccCCccEEECcCCcCCc-cChhhhhccCCCcCEEE
Confidence            9999 55655 556899998 99999999955544555443       99999999999995 455555  999999999


Q ss_pred             eCCCccCCCCChhcccCccCCeeeC------CCCcCCCccchhhhccccCCcccccCcccccccCCccccCCcccccccC
Q 037916          280 LGGNLFQGPIPLSLSSLRGLRVLDL------SQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKNASAISVFG  353 (741)
Q Consensus       280 L~~N~l~~~~~~~~~~l~~L~~L~L------s~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~  353 (741)
                      |++|++++ +|..+..+++|+.|+|      ++|++.+.+|..+..+++|+.|+|++|+++.++..  .++.++.+++.+
T Consensus       520 Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ip~~--~~~~L~~L~Ls~  596 (636)
T 4eco_A          520 LSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEK--ITPNISVLDIKD  596 (636)
T ss_dssp             CCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCCCBCCSC--CCTTCCEEECCS
T ss_pred             CCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcCCccCHh--HhCcCCEEECcC
Confidence            99999997 8889999999999999      56888899999999999999999999999655443  348899999999


Q ss_pred             CCCccccC
Q 037916          354 NSKLCGGI  361 (741)
Q Consensus       354 n~~~c~~~  361 (741)
                      |++.|-.+
T Consensus       597 N~l~~~~~  604 (636)
T 4eco_A          597 NPNISIDL  604 (636)
T ss_dssp             CTTCEEEC
T ss_pred             CCCccccH
Confidence            99988554

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=5.8e-41  Score=381.87  Aligned_cols=334  Identities=22%  Similarity=0.221  Sum_probs=277.7

Q ss_pred             CCCCCcccccCChhhhhCCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCc
Q 037916            2 DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHL   81 (741)
Q Consensus         2 dl~~n~~~~~ip~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L   81 (741)
                      |+++|++. .||..++   ++|++|+|++|+|+++.+.+|.++++|++|+|++|+|++..|+.|.++++          |
T Consensus        37 ~ls~~~L~-~ip~~~~---~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~----------L  102 (562)
T 3a79_B           37 DYSNRNLT-HVPKDLP---PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQD----------L  102 (562)
T ss_dssp             ECTTSCCC-SCCTTSC---TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTT----------C
T ss_pred             EcCCCCCc-cCCCCCC---CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCC----------C
Confidence            78999999 6998876   89999999999999888899999999999999999999888999999886          9


Q ss_pred             cEEECcCCcCcccCCchhhcccccccEEEccCCccccc-CCccccCCCCccEEEcccccccccCCccccCCCcC--cEEE
Q 037916           82 KHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRS-IPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNL--VTLA  158 (741)
Q Consensus        82 ~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~-~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L--~~L~  158 (741)
                      ++|+|++|+|+.+.+.   .+. +|++|+|++|++.+. .|..|.++++|++|+|++|+|++.   .|.++++|  ++|+
T Consensus       103 ~~L~Ls~N~l~~lp~~---~l~-~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~  175 (562)
T 3a79_B          103 EYLDVSHNRLQNISCC---PMA-SLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCIL  175 (562)
T ss_dssp             CEEECTTSCCCEECSC---CCT-TCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEE
T ss_pred             CEEECCCCcCCccCcc---ccc-cCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEE
Confidence            9999999999955444   666 899999999999774 468999999999999999999864   34555555  9999


Q ss_pred             cccCCC--CCcCcccccCCc------------------------------------------------------------
Q 037916          159 INTNKL--SGNIPPSIGNLK------------------------------------------------------------  176 (741)
Q Consensus       159 L~~N~l--~~~~~~~~~~l~------------------------------------------------------------  176 (741)
                      |++|++  ++..|..|..+.                                                            
T Consensus       176 L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~  255 (562)
T 3a79_B          176 LDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVT  255 (562)
T ss_dssp             EEESSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEE
T ss_pred             eecccccccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEE
Confidence            999998  777777666543                                                            


Q ss_pred             ---------------------ccceeeccCcccccccCccc---------------------------------------
Q 037916          177 ---------------------KLLQLYLIENFLQVSIPSSL---------------------------------------  196 (741)
Q Consensus       177 ---------------------~L~~L~L~~N~i~~~~~~~~---------------------------------------  196 (741)
                                           +|++|++++|.+++.+|..+                                       
T Consensus       256 L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~  335 (562)
T 3a79_B          256 LQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKM  335 (562)
T ss_dssp             EEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSE
T ss_pred             ecCCcCcHHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceE
Confidence                                 67777777787776666554                                       


Q ss_pred             --------------ccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCCC--ChhhcCCCCCcEEEecccc
Q 037916          197 --------------GQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSL--PTEVGKLINLEILFISRNM  260 (741)
Q Consensus       197 --------------~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N~  260 (741)
                                    ..+++|++|++++|++++..|..+.++++|+. |+|++|++++..  |..|..+++|++|+|++|+
T Consensus       336 L~l~~n~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~-L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~  414 (562)
T 3a79_B          336 LSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQT-LILQRNGLKNFFKVALMTKNMSSLETLDVSLNS  414 (562)
T ss_dssp             EEEESSCCCCCCCCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCE-EECCSSCCCBTTHHHHTTTTCTTCCEEECTTSC
T ss_pred             EEccCCCcccccCccCCCCceEEECCCCccccchhhhhcccCCCCE-EECCCCCcCCcccchhhhcCCCCCCEEECCCCc
Confidence                          56788899999999998888888889999987 999999988643  4568888999999999999


Q ss_pred             ccc-hhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccchhhhccccCCcccccCcccccccCC
Q 037916          261 LEC-EILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPT  339 (741)
Q Consensus       261 l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~  339 (741)
                      +++ +....|..+++|++|+|++|++++..|..+.  ++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+++++++.
T Consensus       415 l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~  491 (562)
T 3a79_B          415 LNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDG  491 (562)
T ss_dssp             CBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTT
T ss_pred             CCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHH
Confidence            987 6666788889999999999998876665543  68999999999998 4555555899999999999999977766


Q ss_pred             -ccccCCcccccccCCCCcccc
Q 037916          340 -EGVFKNASAISVFGNSKLCGG  360 (741)
Q Consensus       340 -~~~~~~~~~~~~~~n~~~c~~  360 (741)
                       ...++.++.+++.+|++.|.+
T Consensus       492 ~~~~l~~L~~L~l~~N~~~c~c  513 (562)
T 3a79_B          492 VFDRLTSLQYIWLHDNPWDCTC  513 (562)
T ss_dssp             STTTCTTCCCEECCSCCBCCCH
T ss_pred             HHhcCCCCCEEEecCCCcCCCc
Confidence             456778889999999998853

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.7e-42  Score=361.55  Aligned_cols=265  Identities=26%  Similarity=0.359  Sum_probs=196.4

Q ss_pred             HHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc--CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      .+..|++.+.||+|+||.||+|++  +++.||+|++.....  ...+.+.+|+.++++++||||+++++++     ....
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~  107 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV-----TQPP  107 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSTT
T ss_pred             ChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECC
Confidence            346788899999999999999988  488899999874332  2235678999999999999999999995     4555


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCC--ceecCCCCCCeEeCCCCc
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPT--TAHCDLKPSNVLLDHEMT  553 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~--ivHrDlkp~NIll~~~~~  553 (741)
                      ..++||||+++|+|.+++...       .....+++..++.++.|++.||+|||+.   +  |+||||||+||+++.++.
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~  177 (309)
T 3p86_A          108 NLSIVTEYLSRGSLYRLLHKS-------GAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYT  177 (309)
T ss_dssp             CCEEEEECCTTCBHHHHHHST-------THHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCC
T ss_pred             ceEEEEecCCCCcHHHHHhhc-------CCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCc
Confidence            789999999999999998743       1123488999999999999999999999   8  999999999999999999


Q ss_pred             eEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhh
Q 037916          554 AHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFAR  633 (741)
Q Consensus       554 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~  633 (741)
                      +||+|||+++.......  ......||+.|+|| |+..+..++.++||||+||++|+|++|+.||.......  ......
T Consensus       178 ~kL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aP-E~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~--~~~~~~  252 (309)
T 3p86_A          178 VKVCDFGLSRLKASTFL--SSKSAAGTPEWMAP-EVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ--VVAAVG  252 (309)
T ss_dssp             EEECCCC-------------------CCTTSCH-HHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH--HHHHHH
T ss_pred             EEECCCCCCcccccccc--ccccCCCCccccCh-hhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH
Confidence            99999999976543321  12235689999999 55567778999999999999999999999986321110  000000


Q ss_pred             hcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHhhcCC
Q 037916          634 TVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSILLGP  713 (741)
Q Consensus       634 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~  713 (741)
                      ..           .....                  .+..+++.+.+++.+||+.||++|||+.|+++.|+.+.+...++
T Consensus       253 ~~-----------~~~~~------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~  303 (309)
T 3p86_A          253 FK-----------CKRLE------------------IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP  303 (309)
T ss_dssp             HS-----------CCCCC------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred             hc-----------CCCCC------------------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence            00           00000                  01123456889999999999999999999999999998765433

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1e-41  Score=359.73  Aligned_cols=284  Identities=23%  Similarity=0.328  Sum_probs=207.4

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALV  480 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv  480 (741)
                      .|++.+.||+|+||.||+|++.  ++.||+|+++... .......+|+.++++++||||+++++++.... ......++|
T Consensus        25 ~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~~~~~lv  100 (322)
T 3soc_A           25 PLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGT-SVDVDLWLI  100 (322)
T ss_dssp             EEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEE
T ss_pred             hchhhheecccCceEEEEEEEC--CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCC-CCCceEEEE
Confidence            4778899999999999999986  7899999996432 22344566888899999999999999975322 123457999


Q ss_pred             EecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhc-------CCCCceecCCCCCCeEeCCCCc
Q 037916          481 YEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHD-------CQPTTAHCDLKPSNVLLDHEMT  553 (741)
Q Consensus       481 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-------~~~~ivHrDlkp~NIll~~~~~  553 (741)
                      |||+++|+|.++++.           ..+++..++.++.|++.||+|||+.       +.++|+||||||+||+++.++.
T Consensus       101 ~e~~~~g~L~~~l~~-----------~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~  169 (322)
T 3soc_A          101 TAFHEKGSLSDFLKA-----------NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT  169 (322)
T ss_dssp             EECCTTCBHHHHHHH-----------CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCC
T ss_pred             EecCCCCCHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCe
Confidence            999999999999963           3488999999999999999999975       2348999999999999999999


Q ss_pred             eEEeecccccccCCCCcccccccccccccccCcccccCC----CCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchh
Q 037916          554 AHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLG----SEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLH  629 (741)
Q Consensus       554 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~----~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~  629 (741)
                      +||+|||.++...............||+.|+|||.+...    ..++.++|||||||++|||++|+.||.........  
T Consensus       170 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~--  247 (322)
T 3soc_A          170 ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML--  247 (322)
T ss_dssp             EEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCC--
T ss_pred             EEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhcc--
Confidence            999999999877654443333445699999999655432    35667889999999999999999999743322111  


Q ss_pred             hhhhhc-CCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHH
Q 037916          630 NFARTV-LPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKS  708 (741)
Q Consensus       630 ~~~~~~-~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  708 (741)
                      .+.... ......++.+......... .        .........+++.+.+++.+||+.||++|||+.||++.|+++.+
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~--------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~  318 (322)
T 3soc_A          248 PFEEEIGQHPSLEDMQEVVVHKKKRP-V--------LRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR  318 (322)
T ss_dssp             TTHHHHCSSCCHHHHHHHHTTSCCCC-C--------CCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             chhhhhccCCchhhhhhhhhcccCCC-C--------ccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            111110 0111111111111000000 0        00000112456679999999999999999999999999999986


Q ss_pred             hh
Q 037916          709 IL  710 (741)
Q Consensus       709 ~~  710 (741)
                      ..
T Consensus       319 ~~  320 (322)
T 3soc_A          319 LT  320 (322)
T ss_dssp             HC
T ss_pred             Hh
Confidence            53

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1e-41  Score=366.35  Aligned_cols=271  Identities=20%  Similarity=0.316  Sum_probs=208.8

Q ss_pred             HHHHHhhhcccCceeeEEEEEEc-------CCCeEEEEEEeeccCc-CcchhHHHHHHHHHhc-CCCceeeEeeeecCcc
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILD-------EGKTIIAVKVLNLLHH-GASKSSIAECSALRNI-RHKNLVKILTVCSGVD  470 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~-------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~  470 (741)
                      ..|++.+.||+|+||.||+|++.       .++..||+|+++.... ...+.+.+|+.+++++ +||||++++++|    
T Consensus        81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~----  156 (370)
T 2psq_A           81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC----  156 (370)
T ss_dssp             GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE----
T ss_pred             HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE----
Confidence            46788899999999999999974       3567899999974322 2345688999999999 899999999995    


Q ss_pred             ccCCceEEEEEecccCCChhhhccCCCCCCc------ccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCC
Q 037916          471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADK------TVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPS  544 (741)
Q Consensus       471 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~  544 (741)
                       ......|+||||+++|+|.+++...+....      .......+++.+++.++.||+.||+|||++   +|+||||||+
T Consensus       157 -~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~  232 (370)
T 2psq_A          157 -TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR  232 (370)
T ss_dssp             -CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGG
T ss_pred             -ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccchh
Confidence             445578999999999999999975422100      001224578999999999999999999999   9999999999


Q ss_pred             CeEeCCCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCcccc
Q 037916          545 NVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFE  623 (741)
Q Consensus       545 NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~  623 (741)
                      ||+++.++.+||+|||+++...............+|+.|+||| +..+..++.++|||||||++|||++ |..||.....
T Consensus       233 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE-~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~  311 (370)
T 2psq_A          233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV  311 (370)
T ss_dssp             GEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHH-HHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             hEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHh-HhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            9999999999999999998766544333333355788999995 4456789999999999999999999 9999863211


Q ss_pred             CCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHH
Q 037916          624 GNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHEL  703 (741)
Q Consensus       624 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  703 (741)
                           .....         .+.......                  .+..++..+.+++.+||+.||++|||+.|+++.|
T Consensus       312 -----~~~~~---------~~~~~~~~~------------------~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L  359 (370)
T 2psq_A          312 -----EELFK---------LLKEGHRMD------------------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL  359 (370)
T ss_dssp             -----GGHHH---------HHHTTCCCC------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             -----HHHHH---------HHhcCCCCC------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence                 11111         010000000                  0113456788999999999999999999999999


Q ss_pred             HHHHHhhc
Q 037916          704 QSIKSILL  711 (741)
Q Consensus       704 ~~i~~~~~  711 (741)
                      +.+.....
T Consensus       360 ~~il~~~~  367 (370)
T 2psq_A          360 DRILTLTT  367 (370)
T ss_dssp             HHHHHHHC
T ss_pred             HHHHHHhc
Confidence            99987654

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=2e-40  Score=386.64  Aligned_cols=357  Identities=21%  Similarity=0.226  Sum_probs=300.7

Q ss_pred             CCCCCcccccCChhhhhCCC--CCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhcc----
Q 037916            2 DVGVNRVQGGIPLDFGFTLP--NLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQ----   75 (741)
Q Consensus         2 dl~~n~~~~~ip~~~~~~l~--~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~----   75 (741)
                      +|++|++.+..|..+. .++  +|++|+|++|+++++.+..|.++++|++|+|++|++++..|..|..++++..+.    
T Consensus       228 ~L~~n~l~~~~~~~~~-~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~  306 (680)
T 1ziw_A          228 SLSNSQLSTTSNTTFL-GLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRS  306 (680)
T ss_dssp             ECTTSCCCEECTTTTG-GGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTC
T ss_pred             EccCCcccccChhHhh-ccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccch
Confidence            5778888877777776 564  499999999999988888999999999999999999988888887776532111    


Q ss_pred             -------------------ccCCCccEEECcCCcCcccCCchhhcccccccEEEccCCccc--ccCCccccCC--CCccE
Q 037916           76 -------------------NCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIF--RSIPAGIGKF--INLQT  132 (741)
Q Consensus        76 -------------------~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~--~~~~~~~~~l--~~L~~  132 (741)
                                         ...++|++|++++|++++..+..|..++ +|++|++++|.+.  ......|..+  ++|++
T Consensus       307 ~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~  385 (680)
T 1ziw_A          307 FTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLI-NLKYLSLSNSFTSLRTLTNETFVSLAHSPLHI  385 (680)
T ss_dssp             BCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCT-TCCEEECTTCBSCCCEECTTTTGGGTTSCCCE
T ss_pred             hhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHhcccc-CCcEEECCCCchhhhhcchhhhcccccCcCce
Confidence                               1124577888888888877777777777 7888888877642  2233334333  47888


Q ss_pred             EEcccccccccCCccccCCCcCcEEEcccCCCCCcCc-ccccCCcccceeeccCcccccccCcccccCCCCCEEeccCcc
Q 037916          133 LHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIP-PSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNN  211 (741)
Q Consensus       133 L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~  211 (741)
                      |+|++|+++++.+..|..+++|++|+|++|++++.+| ..|.++++|++|+|++|++.+..+..|..+++|+.|++++|.
T Consensus       386 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~  465 (680)
T 1ziw_A          386 LNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVA  465 (680)
T ss_dssp             EECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSC
T ss_pred             EECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhcccc
Confidence            8888888988888999999999999999999986555 688999999999999999998889999999999999999999


Q ss_pred             cc--ccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccchhhh--------hccccccccEEEeC
Q 037916          212 LS--GTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILS--------TLGSCIKLEQLKLG  281 (741)
Q Consensus       212 l~--~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~--------~~~~l~~L~~L~L~  281 (741)
                      ++  +.+|..|.++++|+. |+|++|+|++..+..|..+++|++|+|++|+++++...        .|.++++|+.|+|+
T Consensus       466 l~~~~~~p~~~~~l~~L~~-L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~  544 (680)
T 1ziw_A          466 LKNVDSSPSPFQPLRNLTI-LDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLE  544 (680)
T ss_dssp             CBCTTCSSCTTTTCTTCCE-EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECC
T ss_pred             ccccccCCcccccCCCCCE-EECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECC
Confidence            87  578999999999998 99999999988888899999999999999999976433        37899999999999


Q ss_pred             CCccCCCCChhcccCccCCeeeCCCCcCCCccchhhhccccCCcccccCcccccccCCcc--ccCCcccccccCCCCccc
Q 037916          282 GNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEG--VFKNASAISVFGNSKLCG  359 (741)
Q Consensus       282 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~--~~~~~~~~~~~~n~~~c~  359 (741)
                      +|+++.+.+..|.++++|+.|+|++|+|+++.+..|..+++|+.|+|++|.+++.++...  .++.+..+++.+|||.|+
T Consensus       545 ~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~  624 (680)
T 1ziw_A          545 SNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCT  624 (680)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBC
T ss_pred             CCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccC
Confidence            999997777789999999999999999998888889999999999999999999877642  578899999999999997


Q ss_pred             cC
Q 037916          360 GI  361 (741)
Q Consensus       360 ~~  361 (741)
                      +.
T Consensus       625 c~  626 (680)
T 1ziw_A          625 CE  626 (680)
T ss_dssp             CC
T ss_pred             Cc
Confidence            64

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.8e-42  Score=361.04  Aligned_cols=278  Identities=23%  Similarity=0.331  Sum_probs=205.7

Q ss_pred             HHHHHhhhcccCceeeEEEEE----EcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          400 VSFLFLCWIDMGSFGSVYKGI----LDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      ..|++++.||+|+||.||+|+    +..+++.||+|+++.......+.+.+|+.++++++||||+++++++..   .+..
T Consensus        10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~   86 (295)
T 3ugc_A           10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AGRR   86 (295)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH---HHHT
T ss_pred             HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCCC
Confidence            468889999999999999999    456899999999975554455678899999999999999999998642   2334


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..++||||+++++|.+++...         ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+|
T Consensus        87 ~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~k  154 (295)
T 3ugc_A           87 NLKLIMEYLPYGSLRDYLQKH---------KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVK  154 (295)
T ss_dssp             SCEEEEECCTTCBHHHHHHHC---------GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEE
T ss_pred             ceEEEEEeCCCCCHHHHHHhc---------ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEE
Confidence            689999999999999998643         24588999999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcc-cccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhh
Q 037916          556 VADFGLAKLLPPAHLQ-TSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~-~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  634 (741)
                      |+|||.+......... .......++..|+||| ...+..++.++||||+||++|||++|..||......   .......
T Consensus       155 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~  230 (295)
T 3ugc_A          155 IGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPE-SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE---FMRMIGN  230 (295)
T ss_dssp             ECCCCSCC-------------CTTCGGGGCCHH-HHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH---HHHHHCT
T ss_pred             EccCcccccccCCcceeeeccCCCCccceeCcH-HhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH---HHhhhcC
Confidence            9999999876543221 1222344788899995 445667899999999999999999999998632111   0001000


Q ss_pred             cCCcc--hhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHhhc
Q 037916          635 VLPDH--VMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSILL  711 (741)
Q Consensus       635 ~~~~~--~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~  711 (741)
                      .....  .....+....               ......+..+++.+.+++.+||+.||++|||+.|+++.|+++++.+.
T Consensus       231 ~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~  294 (295)
T 3ugc_A          231 DKQGQMIVFHLIELLKN---------------NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA  294 (295)
T ss_dssp             TCCTHHHHHHHHHHHHT---------------TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             ccccchhHHHHHHHHhc---------------cCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence            00000  0000000000               00011122456778999999999999999999999999999987653

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3.8e-41  Score=359.60  Aligned_cols=251  Identities=19%  Similarity=0.212  Sum_probs=199.7

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcC------cchhHHHHHHHHHhcCCCceeeEeeeecCccccC
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG------ASKSSIAECSALRNIRHKNLVKILTVCSGVDYKG  473 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  473 (741)
                      ..|++.+.||+|+||.||+|++..+++.||+|+++.....      ..+.+.+|+.++++++||||+++++++     .+
T Consensus        12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~~   86 (361)
T 2yab_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY-----EN   86 (361)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE-----EC
T ss_pred             hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE-----Ee
Confidence            4588899999999999999999999999999999753322      235688999999999999999999994     55


Q ss_pred             CceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCC-
Q 037916          474 DDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEM-  552 (741)
Q Consensus       474 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~-  552 (741)
                      ....|+||||+++|+|.+++...          ..+++..+..++.||+.||.|||+.   ||+||||||+||+++.++ 
T Consensus        87 ~~~~~lv~e~~~gg~L~~~l~~~----------~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~  153 (361)
T 2yab_A           87 RTDVVLILELVSGGELFDFLAQK----------ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNI  153 (361)
T ss_dssp             SSEEEEEEECCCSCBHHHHHTTC----------SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTS
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCC
Confidence            66899999999999999998643          4588999999999999999999999   999999999999998876 


Q ss_pred             ---ceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchh
Q 037916          553 ---TAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLH  629 (741)
Q Consensus       553 ---~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~  629 (741)
                         .+||+|||++.........   ....||+.|+||| +..+..++.++||||+||++|+|++|..||.....     .
T Consensus       154 ~~~~vkl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE-~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~-----~  224 (361)
T 2yab_A          154 PIPHIKLIDFGLAHEIEDGVEF---KNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-----Q  224 (361)
T ss_dssp             SSCCEEECCCSSCEECCTTCCC---CCCCSCGGGCCHH-HHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-----H
T ss_pred             CccCEEEEecCCceEcCCCCcc---ccCCCCccEECch-HHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-----H
Confidence               7999999999876554322   2356999999995 55667889999999999999999999999863211     0


Q ss_pred             hhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          630 NFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       630 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      .....        +.....  ...              ........+.+.+++.+||..||++|||+.|+++
T Consensus       225 ~~~~~--------i~~~~~--~~~--------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          225 ETLAN--------ITAVSY--DFD--------------EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             HHHHH--------HHTTCC--CCC--------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHH--------HHhcCC--CCC--------------chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            01100        000000  000              0001123456789999999999999999999884

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.2e-41  Score=358.04  Aligned_cols=278  Identities=33%  Similarity=0.514  Sum_probs=216.2

Q ss_pred             HHHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc-CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          397 LLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       397 ~~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      +....|.+.+.||+|+||.||+|++. +++.||+|+++.... .....+.+|+.+++.++||||+++++++     ....
T Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~  100 (326)
T 3uim_A           27 VASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC-----MTPT  100 (326)
T ss_dssp             TTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE-----CCSS
T ss_pred             HHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE-----ecCC
Confidence            34567999999999999999999865 688999999974332 2344788999999999999999999995     4455


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..++||||+++|+|.+++.....      ....+++..+..++.|++.||+|||+.+.++|+||||||+||+++.++.+|
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k  174 (326)
T 3uim_A          101 ERLLVYPYMANGSVASCLRERPE------SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV  174 (326)
T ss_dssp             CCEEEEECCTTCBHHHHHHCCST------TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred             ceEEEEEeccCCCHHHHHHhccc------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence            78999999999999999975422      224589999999999999999999998777999999999999999999999


Q ss_pred             EeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccc---cCCcchhhhh
Q 037916          556 VADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMF---EGNMNLHNFA  632 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~---~~~~~~~~~~  632 (741)
                      |+|||.+.......... .....||+.|+||| +..+..++.++||||+||++|+|++|+.||+...   ........+.
T Consensus       175 l~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE-~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  252 (326)
T 3uim_A          175 VGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPE-YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV  252 (326)
T ss_dssp             ECCCSSCEECCSSSSCE-ECCCCSCGGGCCHH-HHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH
T ss_pred             eccCccccccCcccccc-cccccCCcCccCHH-HhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHH
Confidence            99999998765433222 22345999999995 4456678999999999999999999999996432   2222333343


Q ss_pred             hhcCCcc-hhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHH
Q 037916          633 RTVLPDH-VMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSI  706 (741)
Q Consensus       633 ~~~~~~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  706 (741)
                      ....... .....+.......                  ..++...+.+++.+||+.||++|||+.||++.|++.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          253 KGLLKEKKLEALVDVDLQGNY------------------KDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             TTTTSSCCSTTSSCTTCTTSC------------------CHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             HHHhhchhhhhhcChhhcccc------------------CHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            3333322 2223332222222                  235678899999999999999999999999999863

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=3e-40  Score=380.02  Aligned_cols=340  Identities=20%  Similarity=0.186  Sum_probs=213.7

Q ss_pred             CCCCCcccccCChhhhhCCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCc
Q 037916            2 DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHL   81 (741)
Q Consensus         2 dl~~n~~~~~ip~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L   81 (741)
                      ||++|+|.+..|..|. .+++|++|+|++|+|+++.|.+|.++++|++|+|++|++++..|..|.++++          |
T Consensus        39 ~Ls~n~i~~~~~~~~~-~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~----------L  107 (606)
T 3t6q_A           39 EFSFNVLPTIQNTTFS-RLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKA----------L  107 (606)
T ss_dssp             ECTTCCCSEECTTTST-TCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTT----------C
T ss_pred             EccCCccCcCChhHhc-cCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhccccc----------c
Confidence            5666666644454554 6666666666666666666666666666666666666666666666666654          6


Q ss_pred             cEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCc--EEEc
Q 037916           82 KHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLV--TLAI  159 (741)
Q Consensus        82 ~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~--~L~L  159 (741)
                      ++|+|++|++++..+..+..+. +|++|++++|++.+.....+..+++|++|+|++|+|+++.+..|..+++|+  .|++
T Consensus       108 ~~L~L~~n~i~~l~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l  186 (606)
T 3t6q_A          108 KHLFFIQTGISSIDFIPLHNQK-TLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNL  186 (606)
T ss_dssp             CEEECTTSCCSCGGGSCCTTCT-TCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEEC
T ss_pred             cEeeccccCcccCCcchhccCC-cccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEec
Confidence            6666666666665555566665 666666666666554444444466666666666666666666666666666  6666


Q ss_pred             ccCCCCCcCcccccCC---------------------------------------------------cccceeeccCccc
Q 037916          160 NTNKLSGNIPPSIGNL---------------------------------------------------KKLLQLYLIENFL  188 (741)
Q Consensus       160 ~~N~l~~~~~~~~~~l---------------------------------------------------~~L~~L~L~~N~i  188 (741)
                      ++|+++++.|..|...                                                   .+|+.|++++|.+
T Consensus       187 ~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l  266 (606)
T 3t6q_A          187 NGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYF  266 (606)
T ss_dssp             TTCCCCEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCC
T ss_pred             CCCccCccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCcc
Confidence            6666665555444321                                                   0455566666666


Q ss_pred             ccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccc-hhhh
Q 037916          189 QVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLEC-EILS  267 (741)
Q Consensus       189 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~~~  267 (741)
                      ++..+..|..+++|++|++++|+++ .+|..+.++++|+. |++++|.+.+..|..+..+++|++|++++|.+.+ +.+.
T Consensus       267 ~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~-L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~  344 (606)
T 3t6q_A          267 FNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKK-LVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTG  344 (606)
T ss_dssp             SSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCE-EECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSS
T ss_pred             CccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCE-EECccCCcCcCchhhhhccCcCCEEECCCCCcccccchh
Confidence            6555556666666666666666666 56666666666665 6666666665556666666666666666666653 3334


Q ss_pred             hccccccccEEEeCCCccCCCC--ChhcccCccCCeeeCCCCcCCCccchhhhccccCCcccccCcccccccCC--cccc
Q 037916          268 TLGSCIKLEQLKLGGNLFQGPI--PLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPT--EGVF  343 (741)
Q Consensus       268 ~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~--~~~~  343 (741)
                      .|..+++|++|++++|++++..  +..+..+++|+.|+|++|++++..|..|..+++|+.|++++|.+++..+.  ...+
T Consensus       345 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l  424 (606)
T 3t6q_A          345 CLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNL  424 (606)
T ss_dssp             TTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTC
T ss_pred             hhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCc
Confidence            4666666666666666666544  55666666666666666666666666666666666666666666655443  2345


Q ss_pred             CCcccccccCCC
Q 037916          344 KNASAISVFGNS  355 (741)
Q Consensus       344 ~~~~~~~~~~n~  355 (741)
                      +.++.+++.+|.
T Consensus       425 ~~L~~L~l~~n~  436 (606)
T 3t6q_A          425 HLLKVLNLSHSL  436 (606)
T ss_dssp             TTCCEEECTTCC
T ss_pred             ccCCEEECCCCc
Confidence            566666666664

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-40  Score=379.47  Aligned_cols=346  Identities=24%  Similarity=0.240  Sum_probs=264.0

Q ss_pred             CCCCCcccccCChhhhhCCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCc
Q 037916            2 DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHL   81 (741)
Q Consensus         2 dl~~n~~~~~ip~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L   81 (741)
                      ||++|++.+..|..|. .+++|++|+|++|+|+++.+.+|.++++|++|+|++|++++..|..|.++++          |
T Consensus        34 ~Ls~n~l~~~~~~~~~-~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~----------L  102 (570)
T 2z63_A           34 DLSFNPLRHLGSYSFF-SFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSS----------L  102 (570)
T ss_dssp             ECCSCCCCEECTTTTT-TCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTT----------C
T ss_pred             EccCCccCccChhHhh-CCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccc----------c
Confidence            6888998855555555 8999999999999999888888999999999999999999888888888876          7


Q ss_pred             cEEECcCCcCcccCCchhhcccccccEEEccCCccccc-CCccccCCCCccEEEcccccccccCCccccCCCcC----cE
Q 037916           82 KHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRS-IPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNL----VT  156 (741)
Q Consensus        82 ~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~-~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L----~~  156 (741)
                      ++|++++|++++..+..+..+. +|++|++++|.+.+. .|..|.++++|++|++++|+++++.+..|..+++|    +.
T Consensus       103 ~~L~L~~n~l~~l~~~~~~~l~-~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~  181 (570)
T 2z63_A          103 QKLVAVETNLASLENFPIGHLK-TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS  181 (570)
T ss_dssp             CEEECTTSCCCCSTTCSCTTCT-TCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCE
T ss_pred             ccccccccccccCCCccccccc-cccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhh
Confidence            7777777777766655677776 777777777777653 57777777777777777777766555544444444    34


Q ss_pred             EEcccCCCCCcC--------------------------------------------------------------------
Q 037916          157 LAINTNKLSGNI--------------------------------------------------------------------  168 (741)
Q Consensus       157 L~L~~N~l~~~~--------------------------------------------------------------------  168 (741)
                      |++++|.++++.                                                                    
T Consensus       182 L~l~~n~l~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~  261 (570)
T 2z63_A          182 LDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEE  261 (570)
T ss_dssp             EECTTCCCCEECTTTTTTCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEE
T ss_pred             cccCCCCceecCHHHhccCcceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhh
Confidence            444444333222                                                                    


Q ss_pred             ------------------------------------cccc----------------------------------------
Q 037916          169 ------------------------------------PPSI----------------------------------------  172 (741)
Q Consensus       169 ------------------------------------~~~~----------------------------------------  172 (741)
                                                          |..+                                        
T Consensus       262 l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~~l~~~~~~~~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~  341 (570)
T 2z63_A          262 FRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAF  341 (570)
T ss_dssp             EEEEETTEEESCSTTTTGGGTTCSEEEEESCEECSCCBCCSCCCCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBC
T ss_pred             hhhhcchhhhhhchhhhcCcCcccEEEecCccchhhhhhhccCCccEEeeccCcccccCcccccccCEEeCcCCcccccc
Confidence                                                2111                                        


Q ss_pred             --cCCcccceeeccCccccccc--CcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCCCC-hhhcC
Q 037916          173 --GNLKKLLQLYLIENFLQVSI--PSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLP-TEVGK  247 (741)
Q Consensus       173 --~~l~~L~~L~L~~N~i~~~~--~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p-~~~~~  247 (741)
                        ..+++|++|++++|.+++..  |..+..+++|++|++++|++++. |..+..+++|+. |++++|.+.+..| ..|..
T Consensus       342 ~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~-~~~~~~l~~L~~-L~l~~n~l~~~~~~~~~~~  419 (570)
T 2z63_A          342 SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITM-SSNFLGLEQLEH-LDFQHSNLKQMSEFSVFLS  419 (570)
T ss_dssp             CCCBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEE-EEEEETCTTCCE-EECTTSEEESCTTSCTTTT
T ss_pred             ccccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCccccc-cccccccCCCCE-EEccCCccccccchhhhhc
Confidence              23344555555555555332  45566677777777777777743 334788888887 8999988887665 57888


Q ss_pred             CCCCcEEEeccccccchhhhhccccccccEEEeCCCccC-CCCChhcccCccCCeeeCCCCcCCCccchhhhccccCCcc
Q 037916          248 LINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQ-GPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNL  326 (741)
Q Consensus       248 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  326 (741)
                      +++|++|++++|.+.+..+..|.++++|++|++++|+++ +.+|..|..+++|+.|+|++|++++..|..|..+++|+.|
T Consensus       420 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L  499 (570)
T 2z63_A          420 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL  499 (570)
T ss_dssp             CTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred             CCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEE
Confidence            999999999999999888889999999999999999987 5688889999999999999999998889999999999999


Q ss_pred             cccCcccccccCCc-cccCCcccccccCCCCccccC
Q 037916          327 NLSYNDLEGVIPTE-GVFKNASAISVFGNSKLCGGI  361 (741)
Q Consensus       327 ~l~~N~l~~~~~~~-~~~~~~~~~~~~~n~~~c~~~  361 (741)
                      ++++|++++.++.. ..++.++.+++.+|++.|..+
T Consensus       500 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  535 (570)
T 2z63_A          500 NMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  535 (570)
T ss_dssp             ECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred             eCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCc
Confidence            99999999887754 557788999999999988654

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.3e-41  Score=354.05  Aligned_cols=268  Identities=21%  Similarity=0.302  Sum_probs=205.0

Q ss_pred             HHHHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcC---cchhHHHHHHHHHhcCCCceeeEeeeecCcccc
Q 037916          396 ILLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG---ASKSSIAECSALRNIRHKNLVKILTVCSGVDYK  472 (741)
Q Consensus       396 ~~~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  472 (741)
                      .++..+|++.+.||+|+||.||+|++..+++.||+|++......   ..+.+.+|+.++++++||||+++++++     .
T Consensus         7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~   81 (294)
T 4eqm_A            7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD-----E   81 (294)
T ss_dssp             SCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE-----E
T ss_pred             hHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee-----e
Confidence            34456799999999999999999999999999999998643322   235678999999999999999999994     5


Q ss_pred             CCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCC
Q 037916          473 GDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEM  552 (741)
Q Consensus       473 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~  552 (741)
                      .....|+||||+++++|.+++...          ..+++..++.++.|++.||+|||+.   ||+||||||+||+++.++
T Consensus        82 ~~~~~~lv~e~~~g~~L~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~  148 (294)
T 4eqm_A           82 EDDCYYLVMEYIEGPTLSEYIESH----------GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNK  148 (294)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHH----------CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTS
T ss_pred             eCCeEEEEEeCCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCC
Confidence            566899999999999999998633          4588999999999999999999999   999999999999999999


Q ss_pred             ceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhh
Q 037916          553 TAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFA  632 (741)
Q Consensus       553 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~  632 (741)
                      .+||+|||.+.......... .....||+.|+||| ...+..++.++||||+||++|+|++|+.||.......... ...
T Consensus       149 ~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE-~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~-~~~  225 (294)
T 4eqm_A          149 TLKIFDFGIAKALSETSLTQ-TNHVLGTVQYFSPE-QAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAI-KHI  225 (294)
T ss_dssp             CEEECCCSSSTTC--------------CCSSCCHH-HHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHH-HHH
T ss_pred             CEEEEeCCCccccccccccc-cCccccCccccCHh-HhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHh
Confidence            99999999998765432221 22356899999995 4556778999999999999999999999986321110000 000


Q ss_pred             hhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCC-CHHHHHHHHHHHHHhhc
Q 037916          633 RTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRM-NMTIVVHELQSIKSILL  711 (741)
Q Consensus       633 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~i~~~~~  711 (741)
                      ....+....                           ......++.+.+++.+||+.||++|| +++++.+.|+.+.....
T Consensus       226 ~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~  278 (294)
T 4eqm_A          226 QDSVPNVTT---------------------------DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR  278 (294)
T ss_dssp             SSCCCCHHH---------------------------HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred             hccCCCcch---------------------------hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence            000000000                           00113456788999999999999999 99999999988765443

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=6.5e-41  Score=398.78  Aligned_cols=88  Identities=25%  Similarity=0.249  Sum_probs=49.9

Q ss_pred             cccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccchhhhccccCCcccccCcccccccCCccccCCcccc
Q 037916          270 GSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKNASAI  349 (741)
Q Consensus       270 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~  349 (741)
                      .++++|+.|+|++|++++..|..|.++++|+.|+|++|+|++..+..+.  ++|+.|+|++|++++.+|..  +..+..+
T Consensus       477 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~--~~~L~~l  552 (844)
T 3j0a_A          477 EGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDV--FVSLSVL  552 (844)
T ss_dssp             SCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCC--CSSCCEE
T ss_pred             cCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhH--hCCcCEE
Confidence            3344444444444444444444455555555555555555544444433  45555555555555555533  6678899


Q ss_pred             cccCCCCccccC
Q 037916          350 SVFGNSKLCGGI  361 (741)
Q Consensus       350 ~~~~n~~~c~~~  361 (741)
                      ++.+|++.|.+.
T Consensus       553 ~l~~Np~~C~c~  564 (844)
T 3j0a_A          553 DITHNKFICECE  564 (844)
T ss_dssp             EEEEECCCCSSS
T ss_pred             EecCCCcccccc
Confidence            999999999664

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=3e-40  Score=379.94  Aligned_cols=356  Identities=20%  Similarity=0.223  Sum_probs=242.7

Q ss_pred             CCCCCcccccCChhhhhCCCCCcEEEcccCcccccCCccCCCCCCCc--EEEeecCcCcccCCchhhhhh----------
Q 037916            2 DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLE--VFQVTSNNLTGEVPSEFGKAT----------   69 (741)
Q Consensus         2 dl~~n~~~~~ip~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~--~L~L~~N~l~~~~~~~~~~l~----------   69 (741)
                      ||++|++.+.-++.+. .+++|++|+|++|+|+++.+..|..+++|+  +|++++|++++..|..|....          
T Consensus       135 ~L~~n~l~~~~~~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~  213 (606)
T 3t6q_A          135 YLGSNHISSIKLPKGF-PTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQ  213 (606)
T ss_dssp             ECCSSCCCCCCCCTTC-CCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEECTTCS
T ss_pred             ECCCCcccccCccccc-CCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCccChhHhhhccccccccCCch
Confidence            6788999863334444 489999999999999988888888999998  889999999887776654310          


Q ss_pred             ----------hh---------------------hhccccCCCccEEECcCCcCcccCCchhhccc---------------
Q 037916           70 ----------KA---------------------YCVQNCNQHLKHLDINNNNFGGLLPGCICNFS---------------  103 (741)
Q Consensus        70 ----------~~---------------------~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~---------------  103 (741)
                                ..                     .....+..+|+.|++++|+++++.+..|..++               
T Consensus       214 ~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~l  293 (606)
T 3t6q_A          214 NLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSEL  293 (606)
T ss_dssp             CHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCSCC
T ss_pred             hHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccCCC
Confidence                      00                     00000001344444444444444444444444               


Q ss_pred             -------ccccEEEccCCcccccCCccccCCCCccEEEccccccccc-CCccccCCCcCcEEEcccCCCCCcC--ccccc
Q 037916          104 -------ITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGT-ISPAIGELQNLVTLAINTNKLSGNI--PPSIG  173 (741)
Q Consensus       104 -------~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~-~~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~  173 (741)
                             .+|++|++++|++.+..|..+..+++|++|+|++|.+.+. .+..|.++++|++|++++|++++..  +..|.
T Consensus       294 p~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~  373 (606)
T 3t6q_A          294 PSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLR  373 (606)
T ss_dssp             CSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTT
T ss_pred             ChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcc
Confidence                   0455555555555444444455555555555555554422 2233555666666666666665444  55566


Q ss_pred             CCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCcc-ccccccceeEEEcCCCccCCCCChhhcCCCCCc
Q 037916          174 NLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQ-LMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLE  252 (741)
Q Consensus       174 ~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~  252 (741)
                      ++++|++|++++|.+.+..|..|..+++|++|++++|++++..|.. |.++++|+. |++++|.+.+..|..|..+++|+
T Consensus       374 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~-L~l~~n~l~~~~~~~~~~l~~L~  452 (606)
T 3t6q_A          374 NLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKV-LNLSHSLLDISSEQLFDGLPALQ  452 (606)
T ss_dssp             TCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCE-EECTTCCCBTTCTTTTTTCTTCC
T ss_pred             cCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCE-EECCCCccCCcCHHHHhCCCCCC
Confidence            6777777777777776666777777777777777777777555443 677777776 88888887777777788888888


Q ss_pred             EEEeccccccch---hhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccchhhhccccCCccccc
Q 037916          253 ILFISRNMLECE---ILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLS  329 (741)
Q Consensus       253 ~L~Ls~N~l~~~---~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~  329 (741)
                      +|+|++|++++.   .+..+..+++|+.|++++|++++..|.+|.++++|+.|+|++|++++..|..|..++.| .|+++
T Consensus       453 ~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~  531 (606)
T 3t6q_A          453 HLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLA  531 (606)
T ss_dssp             EEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECC
T ss_pred             EEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECc
Confidence            888888887763   22567788888888888888888778888888888888888888888888888888888 88888


Q ss_pred             CcccccccCCc-cccCCcccccccCCCCcccc
Q 037916          330 YNDLEGVIPTE-GVFKNASAISVFGNSKLCGG  360 (741)
Q Consensus       330 ~N~l~~~~~~~-~~~~~~~~~~~~~n~~~c~~  360 (741)
                      +|++++.+|.. ..++.++.+++.+|++.|.+
T Consensus       532 ~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c  563 (606)
T 3t6q_A          532 SNHISIILPSLLPILSQQRTINLRQNPLDCTC  563 (606)
T ss_dssp             SSCCCCCCGGGHHHHHTSSEEECTTCCEECSG
T ss_pred             CCcccccCHhhcccCCCCCEEeCCCCCccccC
Confidence            88888777654 45677888889999888854

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=5.8e-42  Score=369.57  Aligned_cols=259  Identities=23%  Similarity=0.325  Sum_probs=204.4

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc-CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      .|++.+.||+|+||.||+|++..+++.||+|+++.... ...+.+.+|+.++++++||||++++++|     ......|+
T Consensus       115 ~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~~~~l  189 (377)
T 3cbl_A          115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC-----TQKQPIYI  189 (377)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEE-----CSSSSCEE
T ss_pred             HeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----ecCCCcEE
Confidence            46778899999999999999998999999999874321 2235678899999999999999999995     34557899


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      ||||+++|+|.+++...         ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus       190 v~e~~~~g~L~~~l~~~---------~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~Df  257 (377)
T 3cbl_A          190 VMELVQGGDFLTFLRTE---------GARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDF  257 (377)
T ss_dssp             EEECCTTCBHHHHHHHH---------GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCG
T ss_pred             EEEcCCCCCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcC
Confidence            99999999999998632         24588999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcCCc
Q 037916          560 GLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       560 g~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      |+++...............+++.|+||| ...+..++.++|||||||++|||++ |..||......  ...         
T Consensus       258 G~s~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~--~~~---------  325 (377)
T 3cbl_A          258 GMSREEADGVYAASGGLRQVPVKWTAPE-ALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ--QTR---------  325 (377)
T ss_dssp             GGCEECTTSEEECCSSCCEEEGGGSCHH-HHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH--HHH---------
T ss_pred             CCceecCCCceeecCCCCCCCcCcCCHh-HhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHH---------
Confidence            9998655432222222233677899995 4456678999999999999999998 99998632111  111         


Q ss_pred             chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHh
Q 037916          639 HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSI  709 (741)
Q Consensus       639 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  709 (741)
                         +.+.......                  .+..+++.+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus       326 ---~~~~~~~~~~------------------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          326 ---EFVEKGGRLP------------------CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             ---HHHHTTCCCC------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---HHHHcCCCCC------------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence               1111100000                  0113456788999999999999999999999999998764

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1e-41  Score=359.92  Aligned_cols=263  Identities=23%  Similarity=0.325  Sum_probs=203.9

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCC---CeEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCC
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEG---KTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGD  474 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~  474 (741)
                      ..+|++.+.||+|+||.||+|.+..+   +..||+|+++... ....+.+.+|+.++++++||||+++++++     .++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~  122 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVV-----TRG  122 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CGG
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeC
Confidence            35688899999999999999999744   4469999997432 22345688999999999999999999995     445


Q ss_pred             ceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCce
Q 037916          475 DFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTA  554 (741)
Q Consensus       475 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~  554 (741)
                      ...++||||+++++|.+++...         ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~  190 (325)
T 3kul_A          123 RLAMIVTEYMENGSLDTFLRTH---------DGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVC  190 (325)
T ss_dssp             GCCEEEEECCTTCBHHHHHHTT---------TTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred             CccEEEeeCCCCCcHHHHHHhc---------ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCE
Confidence            6789999999999999998633         24588999999999999999999999   99999999999999999999


Q ss_pred             EEeecccccccCCCCcc-cccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhh
Q 037916          555 HVADFGLAKLLPPAHLQ-TSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFA  632 (741)
Q Consensus       555 kL~DFg~a~~~~~~~~~-~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~  632 (741)
                      ||+|||++......... .......+|+.|+||| +..+..++.++||||+||++|||++ |..||......  .   ..
T Consensus       191 kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE-~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~---~~  264 (325)
T 3kul_A          191 KVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPE-AIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR--D---VI  264 (325)
T ss_dssp             EECCCSSCEECC----CCEECC---CCGGGSCHH-HHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--H---HH
T ss_pred             EECCCCcccccccCccceeeccCCCCcccccCHh-HhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH--H---HH
Confidence            99999999877544221 1222234678899995 4556778999999999999999999 99998632111  0   00


Q ss_pred             hhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHhhc
Q 037916          633 RTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSILL  711 (741)
Q Consensus       633 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~  711 (741)
                      .         .+.......                  .+..++..+.+++.+||..||++|||+.||++.|+.+.+...
T Consensus       265 ~---------~~~~~~~~~------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~  316 (325)
T 3kul_A          265 S---------SVEEGYRLP------------------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE  316 (325)
T ss_dssp             H---------HHHTTCCCC------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred             H---------HHHcCCCCC------------------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence            0         000000000                  011345678899999999999999999999999999987544

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.9e-41  Score=352.98  Aligned_cols=253  Identities=20%  Similarity=0.210  Sum_probs=201.0

Q ss_pred             HHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcC------cchhHHHHHHHHHhcCCCceeeEeeeecCccc
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG------ASKSSIAECSALRNIRHKNLVKILTVCSGVDY  471 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  471 (741)
                      +...|.+.+.||+|+||.||+|++..+++.||+|+++.....      ..+.+.+|+.++++++||||+++++++     
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----   83 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-----   83 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----
Confidence            346789999999999999999999999999999999743322      245688999999999999999999994     


Q ss_pred             cCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCC
Q 037916          472 KGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHE  551 (741)
Q Consensus       472 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~  551 (741)
                      ......++||||+++++|.+++...          ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.+
T Consensus        84 ~~~~~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~  150 (326)
T 2y0a_A           84 ENKTDVILILELVAGGELFDFLAEK----------ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDR  150 (326)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHTTS----------SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCS
T ss_pred             EeCCEEEEEEEcCCCCCHHHHHHhc----------CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecC
Confidence            4566899999999999999998643          4588999999999999999999999   99999999999999888


Q ss_pred             C----ceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcc
Q 037916          552 M----TAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMN  627 (741)
Q Consensus       552 ~----~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~  627 (741)
                      +    .+||+|||++.........   ....||+.|+||| +..+..++.++||||+||++|+|++|..||....... .
T Consensus       151 ~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE-~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~  225 (326)
T 2y0a_A          151 NVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-T  225 (326)
T ss_dssp             SSSSCCEEECCCTTCEECCTTSCC---CCCCSCTTTCCHH-HHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-H
T ss_pred             CCCCCCEEEEECCCCeECCCCCcc---ccccCCcCcCCce-eecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-H
Confidence            7    8999999999876543222   2356999999994 5567789999999999999999999999986321100 0


Q ss_pred             hhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          628 LHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       628 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      +.........              ..              .......+..+.+++.+||+.||++|||+.|+++
T Consensus       226 ~~~~~~~~~~--------------~~--------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          226 LANVSAVNYE--------------FE--------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             HHHHHHTCCC--------------CC--------------HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHhcCCC--------------cC--------------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            0000000000              00              0001123456789999999999999999999986

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.9e-41  Score=358.23  Aligned_cols=248  Identities=22%  Similarity=0.288  Sum_probs=197.5

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeecc---CcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCce
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLL---HHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      +.|.+.+.||+|+||.||+|.+..+++.||+|+++..   .......+.+|+.+++.++||||+++++++     .....
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-----~~~~~   83 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVI-----TTPTD   83 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCE
Confidence            5788999999999999999999989999999999732   223356788999999999999999999995     45568


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .++||||+ +|+|.+++...          ..+++.+++.++.|++.||.|||+.   ||+||||||+||+++.++.+||
T Consensus        84 ~~lv~E~~-~g~l~~~l~~~----------~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl  149 (336)
T 3h4j_B           84 IVMVIEYA-GGELFDYIVEK----------KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKI  149 (336)
T ss_dssp             EEEEECCC-CEEHHHHHHHH----------CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEE
T ss_pred             EEEEEECC-CCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEE
Confidence            99999999 78999888532          4588999999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcC
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVL  636 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  636 (741)
                      +|||++.........   ....||+.|+|||.+......+.++||||+||++|+|++|+.||.......     ......
T Consensus       150 ~DFG~s~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~-----~~~~i~  221 (336)
T 3h4j_B          150 ADFGLSNIMTDGNFL---KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN-----LFKKVN  221 (336)
T ss_dssp             CCSSCTBTTTTSBTT---CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT-----CBCCCC
T ss_pred             EEeccceeccCCccc---ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH-----HHHHHH
Confidence            999999876554322   224699999999655433334789999999999999999999996321111     111000


Q ss_pred             CcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          637 PDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       637 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      ... ..        .                   +...++.+.+++.+||+.||++|||+.|+++-
T Consensus       222 ~~~-~~--------~-------------------p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          222 SCV-YV--------M-------------------PDFLSPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             SSC-CC--------C-------------------CTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             cCC-CC--------C-------------------cccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            000 00        0                   00123557799999999999999999999864

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=3.6e-41  Score=352.18  Aligned_cols=268  Identities=22%  Similarity=0.322  Sum_probs=200.0

Q ss_pred             HHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHh--cCCCceeeEeeeecCccccCCc
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRN--IRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      +...|++.+.||+|+||.||+|++  +++.||+|+++.   .....+..|.+++..  ++||||+++++++.... ....
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~~~~   79 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASDMTSR-HSST   79 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECG---GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-TTEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecc---ccchhhHHHHHHHHHhhccCcCeeeEEEeecccc-CCCc
Confidence            345788999999999999999998  588999999863   234555667777666  79999999999864322 3345


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHH--------hcCCCCceecCCCCCCeE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH--------HDCQPTTAHCDLKPSNVL  547 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--------~~~~~~ivHrDlkp~NIl  547 (741)
                      ..++||||+++|+|.++++.           ..+++..++.++.|++.||+|||        +.   +|+||||||+||+
T Consensus        80 ~~~lv~e~~~~g~L~~~l~~-----------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nil  145 (301)
T 3q4u_A           80 QLWLITHYHEMGSLYDYLQL-----------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNIL  145 (301)
T ss_dssp             EEEEEECCCTTCBHHHHHTT-----------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEE
T ss_pred             eeEEehhhccCCCHHHHHhh-----------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEE
Confidence            68999999999999999952           35889999999999999999999        77   9999999999999


Q ss_pred             eCCCCceEEeecccccccCCCCccc--ccccccccccccCcccccCCC-----CCCCccCchhHHHHHHHHHcC------
Q 037916          548 LDHEMTAHVADFGLAKLLPPAHLQT--SSIGVKGTIGYIAPAEYGLGS-----EVSINGDVYSYGILLLELMTR------  614 (741)
Q Consensus       548 l~~~~~~kL~DFg~a~~~~~~~~~~--~~~~~~gt~~y~aPEe~~~~~-----~~~~~~DIwSlG~il~elltg------  614 (741)
                      ++.++.+||+|||++..........  ......||+.|+|||.+....     .++.++|||||||++|||++|      
T Consensus       146 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~  225 (301)
T 3q4u_A          146 VKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGI  225 (301)
T ss_dssp             ECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred             EcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccc
Confidence            9999999999999997655432211  122346999999996554332     455799999999999999999      


Q ss_pred             ----CCCCCccccCCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCC
Q 037916          615 ----KRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESP  690 (741)
Q Consensus       615 ----~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP  690 (741)
                          ..||.....................        ......             .......++..+.+++.+||+.||
T Consensus       226 ~~~~~~pf~~~~~~~~~~~~~~~~~~~~~--------~~~~~~-------------~~~~~~~~~~~l~~li~~cl~~dP  284 (301)
T 3q4u_A          226 VEDYKPPFYDVVPNDPSFEDMRKVVCVDQ--------QRPNIP-------------NRWFSDPTLTSLAKLMKECWYQNP  284 (301)
T ss_dssp             CCCCCCTTTTTSCSSCCHHHHHHHHTTSC--------CCCCCC-------------GGGGGSHHHHHHHHHHHHHCCSSG
T ss_pred             cccccccccccCCCCcchhhhhHHHhccC--------CCCCCC-------------hhhccCccHHHHHHHHHHHhhcCh
Confidence                6666533332222222211111000        000000             000112456789999999999999


Q ss_pred             CCCCCHHHHHHHHHHH
Q 037916          691 QDRMNMTIVVHELQSI  706 (741)
Q Consensus       691 ~~RPs~~evl~~L~~i  706 (741)
                      ++|||+.||++.|+++
T Consensus       285 ~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          285 SARLTALRIKKTLTKI  300 (301)
T ss_dssp             GGSCCHHHHHHHHHHH
T ss_pred             hhCCCHHHHHHHHhcc
Confidence            9999999999999876

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=4.1e-41  Score=356.02  Aligned_cols=249  Identities=20%  Similarity=0.228  Sum_probs=199.4

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeecc---CcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCce
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLL---HHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      ..|++++.||+|+||.||+|++..+++.||+|+++..   .......+.+|+.+++.++||||+++++++     .....
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~-----~~~~~   79 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDR   79 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSSE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEE-----EeCCE
Confidence            4688899999999999999999999999999999743   233456778999999999999999999994     55668


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .|+||||+++|+|.+++...          ..+++..++.++.||+.||+|||++   ||+||||||+||+++.++.+||
T Consensus        80 ~~lv~E~~~gg~L~~~l~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL  146 (337)
T 1o6l_A           80 LCFVMEYANGGELFFHLSRE----------RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKI  146 (337)
T ss_dssp             EEEEEECCTTCBHHHHHHHH----------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEE
T ss_pred             EEEEEeCCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEE
Confidence            99999999999999988632          4588999999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcC
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVL  636 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  636 (741)
                      +|||+++.......  ......||+.|+||| +..+..++.++||||+||++|||++|+.||.....     .....   
T Consensus       147 ~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE-~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~---  215 (337)
T 1o6l_A          147 TDFGLCKEGISDGA--TMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----ERLFE---  215 (337)
T ss_dssp             CCCTTCBCSCCTTC--CBCCCEECGGGCCGG-GGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH---
T ss_pred             eeccchhhcccCCC--cccccccChhhCChh-hhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH-----HHHHH---
Confidence            99999986433221  122356999999994 55677889999999999999999999999863211     11110   


Q ss_pred             CcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCC-----CHHHHHHH
Q 037916          637 PDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRM-----NMTIVVHE  702 (741)
Q Consensus       637 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  702 (741)
                           .+......  .                  +....+.+.+++.+||+.||++||     ++.|+++-
T Consensus       216 -----~i~~~~~~--~------------------p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          216 -----LILMEEIR--F------------------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             -----HHHHCCCC--C------------------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             -----HHHcCCCC--C------------------CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence                 00000000  0                  012345678999999999999999     89998763

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=4.5e-41  Score=356.24  Aligned_cols=265  Identities=17%  Similarity=0.183  Sum_probs=206.9

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhc-CCCceeeEeeeecCccccCCceEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      ..|++.+.||+|+||.||+|++..+++.||+|++...  ...+.+.+|+.+++++ +||||+++++++     ..+...+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~~h~~i~~~~~~~-----~~~~~~~   81 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMK--SRAPQLHLEYRFYKQLGSGDGIPQVYYFG-----PCGKYNA   81 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETT--CSSCCHHHHHHHHHHHCSCTTSCCEEEEE-----EETTEEE
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccc--cchHHHHHHHHHHHHhhCCCCCCEEEEEE-----ecCCccE
Confidence            4688999999999999999999889999999998743  2345788999999999 999999999994     4466889


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCc-----
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMT-----  553 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~-----  553 (741)
                      +||||+ +++|.+++...         ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.     
T Consensus        82 lv~e~~-~~~L~~~~~~~---------~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~  148 (330)
T 2izr_A           82 MVLELL-GPSLEDLFDLC---------DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQV  148 (330)
T ss_dssp             EEEECC-CCBHHHHHHHT---------TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTS
T ss_pred             EEEEeC-CCCHHHHHHHc---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCce
Confidence            999999 99999998643         24689999999999999999999999   9999999999999998887     


Q ss_pred             eEEeecccccccCCCCccc-----ccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcch
Q 037916          554 AHVADFGLAKLLPPAHLQT-----SSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNL  628 (741)
Q Consensus       554 ~kL~DFg~a~~~~~~~~~~-----~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~  628 (741)
                      +||+|||+++.........     ......||+.|+|| |+..+..++.++|||||||++|||++|+.||......  ..
T Consensus       149 ~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aP-E~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~--~~  225 (330)
T 2izr_A          149 IHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSI-NTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKAD--TL  225 (330)
T ss_dssp             EEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCH-HHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCS--SH
T ss_pred             EEEEEcccceeeecCCCCccccccccCCcCCCccccCh-HHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccc--cH
Confidence            9999999998765432211     12345699999999 5556778899999999999999999999999733111  11


Q ss_pred             hhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHH
Q 037916          629 HNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKS  708 (741)
Q Consensus       629 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  708 (741)
                      ......        +.+.....               ........++ .+.+++..||+.||++||++.+|.+.|+++.+
T Consensus       226 ~~~~~~--------i~~~~~~~---------------~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~  281 (330)
T 2izr_A          226 KERYQK--------IGDTKRAT---------------PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFD  281 (330)
T ss_dssp             HHHHHH--------HHHHHHHS---------------CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             HHHHHH--------HHhhhccC---------------CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence            111110        00000000               0000001123 78899999999999999999999999999987


Q ss_pred             hhc
Q 037916          709 ILL  711 (741)
Q Consensus       709 ~~~  711 (741)
                      ...
T Consensus       282 ~~~  284 (330)
T 2izr_A          282 RKG  284 (330)
T ss_dssp             HTT
T ss_pred             HcC
Confidence            653

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1e-40  Score=344.11  Aligned_cols=258  Identities=19%  Similarity=0.255  Sum_probs=204.3

Q ss_pred             HHHHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCC
Q 037916          396 ILLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGD  474 (741)
Q Consensus       396 ~~~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~  474 (741)
                      ..+...|++.+.||+|+||.||+|.+..+++.||+|+++... ....+.+.+|+.+++.++||||+++++++     ..+
T Consensus         3 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~   77 (276)
T 2yex_A            3 VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-----REG   77 (276)
T ss_dssp             HHHHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEE-----EET
T ss_pred             CceecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEE-----EcC
Confidence            346789999999999999999999999899999999997433 23346788999999999999999999994     455


Q ss_pred             ceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCce
Q 037916          475 DFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTA  554 (741)
Q Consensus       475 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~  554 (741)
                      ...++||||+++++|.+++...          ..+++..+..++.|++.||.|||+.   ||+||||||+||+++.++.+
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~  144 (276)
T 2yex_A           78 NIQYLFLEYCSGGELFDRIEPD----------IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNL  144 (276)
T ss_dssp             TEEEEEEECCTTEEGGGGSBTT----------TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred             CEEEEEEEecCCCcHHHHHhhc----------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCE
Confidence            6889999999999999998643          4588999999999999999999999   99999999999999999999


Q ss_pred             EEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhh
Q 037916          555 HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       555 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  634 (741)
                      ||+|||.+................||+.|+|||.+.....++.++||||+|+++|+|++|..||.........+..+...
T Consensus       145 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  224 (276)
T 2yex_A          145 KISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK  224 (276)
T ss_dssp             EECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTT
T ss_pred             EEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhc
Confidence            99999999865433222222335689999999655444445789999999999999999999997433222222221111


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ....            .                  .....+..+.+++.+||+.||++|||+.|+++
T Consensus       225 ~~~~------------~------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          225 KTYL------------N------------------PWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             CTTS------------T------------------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cccc------------C------------------chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence            0000            0                  00123456789999999999999999999876

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.9e-42  Score=368.58  Aligned_cols=268  Identities=23%  Similarity=0.354  Sum_probs=204.4

Q ss_pred             HHHHHhhhcccCceeeEEEEEE-----cCCCeEEEEEEeecc-CcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccC
Q 037916          400 VSFLFLCWIDMGSFGSVYKGIL-----DEGKTIIAVKVLNLL-HHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKG  473 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~-----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  473 (741)
                      ..|++.+.||+|+||.||+|++     ..+++.||+|+++.. .......+.+|+.++++++||||+++++++     ..
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~  145 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS-----LQ  145 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CS
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEE-----ec
Confidence            4578889999999999999994     456789999998632 223345678899999999999999999995     44


Q ss_pred             CceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCC-
Q 037916          474 DDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEM-  552 (741)
Q Consensus       474 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~-  552 (741)
                      ....++||||+++|+|.+++...+...   .....+++.+++.++.||+.||+|||+.   +|+||||||+|||++.++ 
T Consensus       146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~---~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~  219 (367)
T 3l9p_A          146 SLPRFILLELMAGGDLKSFLRETRPRP---SQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGP  219 (367)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHSCCS---SSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSST
T ss_pred             CCCCEEEEEeCCCCCHHHHHHhhcccc---CccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCC
Confidence            557899999999999999997542211   1234588999999999999999999999   999999999999999555 


Q ss_pred             --ceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchh
Q 037916          553 --TAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLH  629 (741)
Q Consensus       553 --~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~  629 (741)
                        .+||+|||+++...............||+.|+||| +..+..++.++|||||||++|||++ |..||.....  ....
T Consensus       220 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE-~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~--~~~~  296 (367)
T 3l9p_A          220 GRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPE-AFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEVL  296 (367)
T ss_dssp             TCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHH-HHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHH
T ss_pred             CceEEECCCccccccccccccccCCCcCCcccEECHH-HhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHH
Confidence              59999999997654332222233355899999995 4456678999999999999999998 9999863211  1111


Q ss_pred             hhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHh
Q 037916          630 NFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSI  709 (741)
Q Consensus       630 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  709 (741)
                      ..+..            ......                  ...++..+.+++.+||+.||++|||+.||++.|+.+.+.
T Consensus       297 ~~i~~------------~~~~~~------------------~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~  346 (367)
T 3l9p_A          297 EFVTS------------GGRMDP------------------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  346 (367)
T ss_dssp             HHHHT------------TCCCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHc------------CCCCCC------------------CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence            11110            000000                  113345688999999999999999999999999998875


Q ss_pred             hc
Q 037916          710 LL  711 (741)
Q Consensus       710 ~~  711 (741)
                      ..
T Consensus       347 ~~  348 (367)
T 3l9p_A          347 PD  348 (367)
T ss_dssp             HH
T ss_pred             hh
Confidence            54

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=4.7e-41  Score=353.84  Aligned_cols=287  Identities=20%  Similarity=0.258  Sum_probs=189.4

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceE
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      ...|++++.||+|+||.||+|.+..+++.||+|+++... ....+.+.+|+.++++++||||+++++++     ..+...
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~   78 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI-----HTENKL   78 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEE-----CCTTEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEE-----EECCeE
Confidence            457999999999999999999999899999999997543 23446788999999999999999999994     456689


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      ++||||++ ++|.+++......    .....+++..+..++.|++.||.|||+.   ||+||||||+||+++.++.+||+
T Consensus        79 ~lv~e~~~-~~L~~~l~~~~~~----~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~  150 (317)
T 2pmi_A           79 TLVFEFMD-NDLKKYMDSRTVG----NTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLG  150 (317)
T ss_dssp             EEEEECCC-CBHHHHHHHHHSS----SCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEEC
T ss_pred             EEEEEecC-CCHHHHHHhcccc----ccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEEC
Confidence            99999997 6999988643111    1124588899999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcC-
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVL-  636 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-  636 (741)
                      |||.+.........  .....||+.|+|||.+.....++.++||||+||++|||++|+.||...... ..+........ 
T Consensus       151 Dfg~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~  227 (317)
T 2pmi_A          151 DFGLARAFGIPVNT--FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE-EQLKLIFDIMGT  227 (317)
T ss_dssp             CCSSCEETTSCCCC--CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCS
T ss_pred             cCccceecCCCccc--CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCC
Confidence            99999876533221  223468999999966655567899999999999999999999999633211 11111111000 


Q ss_pred             C-cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          637 P-DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       637 ~-~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      + ........................................+.+++.+||+.||++|||+.|+++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          228 PNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             CCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            0 0000000000000000000000000000000001123457889999999999999999999886

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.5e-40  Score=346.86  Aligned_cols=267  Identities=28%  Similarity=0.414  Sum_probs=205.9

Q ss_pred             HHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC----cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          403 LFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH----HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       403 ~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      ...+.||+|+||.||+|.+  +++.||+|++....    ....+.+.+|+.++++++||||+++++++     ......+
T Consensus        34 ~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~  106 (307)
T 2nru_A           34 VGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFS-----SDGDDLC  106 (307)
T ss_dssp             TTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSCE
T ss_pred             ccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEE-----ecCCceE
Confidence            3457899999999999987  47889999986422    22345678999999999999999999995     4456789


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      +||||+++++|.+++....       ....+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|
T Consensus       107 lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~D  176 (307)
T 2nru_A          107 LVYVYMPNGSLLDRLSCLD-------GTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISD  176 (307)
T ss_dssp             EEEECCTTCBHHHHHHTGG-------GCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECC
T ss_pred             EEEEecCCCcHHHHHHhcc-------CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcCCCcEEEee
Confidence            9999999999999986431       124588999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhc--C
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV--L  636 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~--~  636 (741)
                      ||.+................||+.|+|||.+ . +.++.++||||+||++|+|++|..||....... ....+....  .
T Consensus       177 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~-~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~  253 (307)
T 2nru_A          177 FGLARASEKFAQTVMTSRIVGTTAYMAPEAL-R-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ-LLLDIKEEIEDE  253 (307)
T ss_dssp             CTTCEECCSCSSCEECSSCCSCGGGCCHHHH-T-TEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS-BTTHHHHHHHTT
T ss_pred             cccccccccccccccccccCCCcCcCChHHh-c-CCCCccchhHHHHHHHHHHHHCCCCcccCcchH-HHHHHHHHhhhh
Confidence            9999876544332223335689999999654 3 358899999999999999999999987432221 111111111  1


Q ss_pred             CcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHH
Q 037916          637 PDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKS  708 (741)
Q Consensus       637 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  708 (741)
                      .....++++..+...                   ...+++.+.+++.+||+.||++|||+.||++.|+++..
T Consensus       254 ~~~~~~~~~~~~~~~-------------------~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          254 EKTIEDYIDKKMNDA-------------------DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             SCCHHHHSCSSCSCC-------------------CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             hhhhhhhcccccccc-------------------chHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            112233333322211                   23567789999999999999999999999999998864

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.4e-41  Score=354.20  Aligned_cols=252  Identities=20%  Similarity=0.270  Sum_probs=200.4

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      ..|++.+.||+|+||.||+|.+..+++.||+|+++.. ......+.+|+.+++.++||||+++++++     .+....++
T Consensus         5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~~~l   78 (321)
T 1tki_A            5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESF-----ESMEELVM   78 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEE-----EETTEEEE
T ss_pred             hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEE-----ecCCEEEE
Confidence            4688899999999999999999999999999998743 23345678999999999999999999994     45668999


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCC--CCceEEe
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDH--EMTAHVA  557 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~--~~~~kL~  557 (741)
                      ||||+++++|.+++...         ...+++..+..++.|++.||.|||+.   ||+||||||+||+++.  ++.+||+
T Consensus        79 v~e~~~g~~L~~~l~~~---------~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~  146 (321)
T 1tki_A           79 IFEFISGLDIFERINTS---------AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKII  146 (321)
T ss_dssp             EECCCCCCBHHHHHTSS---------SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEEC
T ss_pred             EEEeCCCCCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEE
Confidence            99999999999998643         23588999999999999999999999   9999999999999987  7899999


Q ss_pred             ecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCC
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      |||.+.........   ....||+.|+|| |+..+..++.++||||+||++|+|++|..||......     ....    
T Consensus       147 Dfg~a~~~~~~~~~---~~~~gt~~y~aP-E~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~~~----  213 (321)
T 1tki_A          147 EFGQARQLKPGDNF---RLLFTAPEYYAP-EVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-----QIIE----  213 (321)
T ss_dssp             CCTTCEECCTTCEE---EEEESCGGGSCH-HHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHH----
T ss_pred             ECCCCeECCCCCcc---ccccCChhhcCc-HHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH-----HHHH----
Confidence            99999877544322   234689999999 5556677899999999999999999999998632110     0100    


Q ss_pred             cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          638 DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       638 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                          .+.........                ......+..+.+++.+||..||++|||+.|+++.
T Consensus       214 ----~i~~~~~~~~~----------------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          214 ----NIMNAEYTFDE----------------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             ----HHHHTCCCCCH----------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ----HHHcCCCCCCh----------------hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                11110000000                0011335668899999999999999999999873

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.7e-41  Score=362.46  Aligned_cols=272  Identities=20%  Similarity=0.244  Sum_probs=207.1

Q ss_pred             HHHHHhhhcccCceeeEEEEE-----EcCCCeEEEEEEeeccCc-CcchhHHHHHHHHHhc-CCCceeeEeeeecCcccc
Q 037916          400 VSFLFLCWIDMGSFGSVYKGI-----LDEGKTIIAVKVLNLLHH-GASKSSIAECSALRNI-RHKNLVKILTVCSGVDYK  472 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~-----~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~  472 (741)
                      .+|++.+.||+|+||.||+|+     ...+++.||+|+++.... ...+.+.+|+.+++++ +||||++++++|.    .
T Consensus        22 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~----~   97 (359)
T 3vhe_A           22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT----K   97 (359)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC----S
T ss_pred             cceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeee----c
Confidence            468888999999999999999     456779999999974322 2345688999999999 7899999999973    3


Q ss_pred             CCceEEEEEecccCCChhhhccCCCCCCcc--------------------------------------------------
Q 037916          473 GDDFKALVYEFMHNGSLEEWLHPVSGADKT--------------------------------------------------  502 (741)
Q Consensus       473 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~--------------------------------------------------  502 (741)
                      .+...++||||+++|+|.+++.........                                                  
T Consensus        98 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (359)
T 3vhe_A           98 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE  177 (359)
T ss_dssp             TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------
T ss_pred             CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhh
Confidence            344689999999999999999754321000                                                  


Q ss_pred             ------cCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecccccccCCCCccccccc
Q 037916          503 ------VEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIG  576 (741)
Q Consensus       503 ------~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~  576 (741)
                            ......+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++..............
T Consensus       178 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  254 (359)
T 3vhe_A          178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD  254 (359)
T ss_dssp             ------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--
T ss_pred             hcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccc
Confidence                  00122388999999999999999999999   999999999999999999999999999987654433333344


Q ss_pred             ccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcCCcchhHhhhhcccCCcchh
Q 037916          577 VKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDL  655 (741)
Q Consensus       577 ~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  655 (741)
                      ..||+.|+||| +..+..++.++|||||||++|||++ |..||....... .+......            ......   
T Consensus       255 ~~~t~~y~aPE-~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-~~~~~~~~------------~~~~~~---  317 (359)
T 3vhe_A          255 ARLPLKWMAPE-TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFCRRLKE------------GTRMRA---  317 (359)
T ss_dssp             CEECGGGCCHH-HHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-HHHHHHHH------------TCCCCC---
T ss_pred             cCCCceeEChh-hhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH-HHHHHHHc------------CCCCCC---
Confidence            56899999995 4456778999999999999999998 999986322111 11111110            000000   


Q ss_pred             hhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHhh
Q 037916          656 TITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSIL  710 (741)
Q Consensus       656 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  710 (741)
                                     +..+++.+.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus       318 ---------------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  357 (359)
T 3vhe_A          318 ---------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  357 (359)
T ss_dssp             ---------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ---------------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence                           0123456889999999999999999999999999998653

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=9.9e-41  Score=365.71  Aligned_cols=256  Identities=17%  Similarity=0.187  Sum_probs=200.6

Q ss_pred             HHHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc--CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCC
Q 037916          397 LLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGD  474 (741)
Q Consensus       397 ~~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~  474 (741)
                      .+...|++.+.||+|+||.||+|.+..+++.||+|++.....  ...+.+.+|+.++++++||||++++++     +.++
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~-----~~~~   82 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS-----ISEE   82 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEE-----EECS
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEE-----EEEC
Confidence            456789999999999999999999999999999999974332  234567899999999999999999999     4566


Q ss_pred             ceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeC---CC
Q 037916          475 DFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLD---HE  551 (741)
Q Consensus       475 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~---~~  551 (741)
                      ...|+||||+.+|+|.+++...          ..+++..+..++.||+.||.|||+.   ||+||||||+||+++   .+
T Consensus        83 ~~~~lv~E~~~gg~L~~~i~~~----------~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~  149 (444)
T 3soa_A           83 GHHYLIFDLVTGGELFEDIVAR----------EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKG  149 (444)
T ss_dssp             SEEEEEECCCBCCBHHHHHHHC----------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTT
T ss_pred             CEEEEEEEeCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCC
Confidence            7899999999999999988643          4588999999999999999999999   999999999999998   46


Q ss_pred             CceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhh
Q 037916          552 MTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNF  631 (741)
Q Consensus       552 ~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~  631 (741)
                      +.+||+|||++.........  .....||+.|+|| |+..+..++.++||||+||++|+|++|..||.....  ......
T Consensus       150 ~~vkL~DFG~a~~~~~~~~~--~~~~~gt~~Y~AP-E~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~--~~~~~~  224 (444)
T 3soa_A          150 AAVKLADFGLAIEVEGEQQA--WFGFAGTPGYLSP-EVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ--HRLYQQ  224 (444)
T ss_dssp             CCEEECCCSSCBCCCTTCCB--CCCSCSCGGGCCH-HHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHH
T ss_pred             CcEEEccCceeEEecCCCce--eecccCCcccCCH-HHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH--HHHHHH
Confidence            78999999999876544322  2235699999999 455667899999999999999999999999852211  111000


Q ss_pred             hhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          632 ARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       632 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      +..           ........                .....++.+.+++.+||+.||++|||+.|+++-
T Consensus       225 i~~-----------~~~~~~~~----------------~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          225 IKA-----------GAYDFPSP----------------EWDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             HHH-----------TCCCCCTT----------------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHh-----------CCCCCCcc----------------ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            000           00000000                001234567899999999999999999999863

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.2e-40  Score=351.14  Aligned_cols=249  Identities=21%  Similarity=0.242  Sum_probs=199.8

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALV  480 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv  480 (741)
                      .|...++||+|+||.||+|++..+|+.||||+++.......+.+.+|+.++++++||||+++++++     ......++|
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~lv  120 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY-----LVGEELWVL  120 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTEEEEE
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEE-----EECCEEEEE
Confidence            366677899999999999999989999999999866555667788999999999999999999995     345589999


Q ss_pred             EecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecc
Q 037916          481 YEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFG  560 (741)
Q Consensus       481 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg  560 (741)
                      |||+++++|.+++..           ..+++..+..++.|++.||.|||+.   ||+||||||+||+++.++.+||+|||
T Consensus       121 ~e~~~~~~L~~~l~~-----------~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg  186 (321)
T 2c30_A          121 MEFLQGGALTDIVSQ-----------VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFG  186 (321)
T ss_dssp             ECCCCSCBHHHHHTT-----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCT
T ss_pred             EecCCCCCHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCcEEEeeee
Confidence            999999999999863           3478999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcch
Q 037916          561 LAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHV  640 (741)
Q Consensus       561 ~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  640 (741)
                      ++.........  .....||+.|+||| +..+..++.++||||+||++|+|++|+.||.....  .............. 
T Consensus       187 ~~~~~~~~~~~--~~~~~gt~~y~aPE-~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~--~~~~~~~~~~~~~~-  260 (321)
T 2c30_A          187 FCAQISKDVPK--RKSLVGTPYWMAPE-VISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP--VQAMKRLRDSPPPK-  260 (321)
T ss_dssp             TCEECCSSSCC--BCCCCSCGGGCCHH-HHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHSSCCC-
T ss_pred             eeeecccCccc--cccccCCccccCHh-hhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhcCCCCC-
Confidence            99876543222  22356999999995 55677889999999999999999999999863211  01100111000000 


Q ss_pred             hHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          641 MDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       641 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                             ..                    .....++.+.+++.+||+.||++|||+.|+++
T Consensus       261 -------~~--------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          261 -------LK--------------------NSHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             -------CT--------------------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -------cC--------------------ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                   00                    00123456789999999999999999999986

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=3.1e-41  Score=351.05  Aligned_cols=278  Identities=21%  Similarity=0.237  Sum_probs=197.5

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcC--cchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG--ASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      +|+++++||+|+||.||+|++..+++.||+|+++.....  ....+.+|+.++++++||||+++++++     .++...+
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~   77 (292)
T 3o0g_A            3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKLT   77 (292)
T ss_dssp             SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTEEE
T ss_pred             CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEE-----EeCCEEE
Confidence            478899999999999999999999999999999743322  236678999999999999999999995     4566899


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      +||||+++ ++.+++...         ...+++..+..++.|++.||+|||+.   ||+||||||+||+++.++.+||+|
T Consensus        78 lv~e~~~~-~l~~~~~~~---------~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~D  144 (292)
T 3o0g_A           78 LVFEFCDQ-DLKKYFDSC---------NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLAN  144 (292)
T ss_dssp             EEEECCSE-EHHHHHHHT---------TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred             EEEecCCC-CHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEee
Confidence            99999965 666655422         24588999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCc
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      ||.+.........  .....||+.|+|||.+.....++.++||||+||++|+|++|..||.........+..........
T Consensus       145 fg~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~  222 (292)
T 3o0g_A          145 FGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP  222 (292)
T ss_dssp             CTTCEECCSCCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             cccceecCCcccc--ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCC
Confidence            9999876533222  22346899999996665555689999999999999999999888642221111122221111110


Q ss_pred             chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          639 HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       639 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ....+..............   .................+.+++.+||+.||++|||++|+++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          223 TEEQWPSMTKLPDYKPYPM---YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CTTTCTTGGGSTTCCCCCC---CCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             Chhhhhhhccccccccccc---ccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            0000000000000000000   00000000011133456789999999999999999999985

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=8.6e-41  Score=358.77  Aligned_cols=252  Identities=24%  Similarity=0.346  Sum_probs=200.0

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeecc---CcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLL---HHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      +..|++++.||+|+||.||+|++..+++.||+|+++..   .....+.+.+|+.+++.++|||||++++++     .+..
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~   88 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF-----QDEE   88 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeCC
Confidence            45788999999999999999999999999999999742   233456778999999999999999999994     5566


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..|+||||+.+|+|.+++...          ..+++..++.++.||+.||.|||+.   ||+||||||+||+++.++.+|
T Consensus        89 ~~~lv~e~~~gg~L~~~l~~~----------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vk  155 (384)
T 4fr4_A           89 DMFMVVDLLLGGDLRYHLQQN----------VHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVH  155 (384)
T ss_dssp             EEEEEECCCTTEEHHHHHHTT----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEE
T ss_pred             EEEEEEecCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEE
Confidence            899999999999999998643          4588999999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcccccccccccccccCcccccC--CCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhh
Q 037916          556 VADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGL--GSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFAR  633 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~--~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~  633 (741)
                      |+|||++........   .....||+.|+|||.+..  +..++.++||||+||++|||++|+.||......  .......
T Consensus       156 L~DFG~a~~~~~~~~---~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~--~~~~~~~  230 (384)
T 4fr4_A          156 ITDFNIAAMLPRETQ---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST--SSKEIVH  230 (384)
T ss_dssp             ECCCTTCEECCTTCC---BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS--CHHHHHH
T ss_pred             EeccceeeeccCCCc---eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc--cHHHHHH
Confidence            999999987654322   223569999999965543  346899999999999999999999998632111  1111111


Q ss_pred             hcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCC-HHHHHH
Q 037916          634 TVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMN-MTIVVH  701 (741)
Q Consensus       634 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~  701 (741)
                      .         +.......                   +......+.+++.+||+.||++||+ +.++++
T Consensus       231 ~---------~~~~~~~~-------------------p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          231 T---------FETTVVTY-------------------PSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             H---------HHHCCCCC-------------------CTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             H---------HhhcccCC-------------------CCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence            0         00000000                   0123456889999999999999998 666653

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=9.1e-41  Score=357.66  Aligned_cols=255  Identities=18%  Similarity=0.212  Sum_probs=200.7

Q ss_pred             HHHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc--CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCC
Q 037916          397 LLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGD  474 (741)
Q Consensus       397 ~~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~  474 (741)
                      .+...|++.+.||+|+||.||+|.+..+++.||+|+++....  ...+.+.+|+.++++++||||+++++++     .+.
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~  100 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEE  100 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeC
Confidence            456789999999999999999999999999999999974332  2345678999999999999999999994     556


Q ss_pred             ceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCC---
Q 037916          475 DFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHE---  551 (741)
Q Consensus       475 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~---  551 (741)
                      ...|+||||+++|+|.+++...          ..+++..+..++.||+.||.|||+.   +|+||||||+||+++.+   
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~----------~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~  167 (362)
T 2bdw_A          101 SFHYLVFDLVTGGELFEDIVAR----------EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKG  167 (362)
T ss_dssp             SEEEEEECCCCSCBHHHHHTTC----------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTT
T ss_pred             CEEEEEEecCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCC
Confidence            6899999999999999988643          4588999999999999999999999   99999999999999865   


Q ss_pred             CceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhh
Q 037916          552 MTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNF  631 (741)
Q Consensus       552 ~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~  631 (741)
                      +.+||+|||++........   .....||+.|+||| +..+..++.++||||+||++|+|++|..||.....  ......
T Consensus       168 ~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE-~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--~~~~~~  241 (362)
T 2bdw_A          168 AAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--HRLYAQ  241 (362)
T ss_dssp             CCEEECCCTTCBCCTTCCS---CCCSCSCTTTCCHH-HHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHH
T ss_pred             CCEEEeecCcceEecCCcc---cccCCCCccccCHH-HHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHH
Confidence            4699999999987654332   22356999999995 55667899999999999999999999999863211  011000


Q ss_pred             hhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          632 ARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       632 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      +...           ......                .....+++.+.+++.+||+.||++|||+.|+++.
T Consensus       242 i~~~-----------~~~~~~----------------~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          242 IKAG-----------AYDYPS----------------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             HHHT-----------CCCCCT----------------TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             HHhC-----------CCCCCc----------------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0000           000000                0001234567899999999999999999998753

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.2e-40  Score=358.91  Aligned_cols=253  Identities=22%  Similarity=0.255  Sum_probs=195.0

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhc-CCCceeeEeeeecCccccCC
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKGD  474 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~  474 (741)
                      ...|++++.||+|+||.||+|++..+++.||+|+++...   ....+.+.+|..+++++ +||||++++++     +.+.
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~-----~~~~  125 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC-----FQTE  125 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEE-----EECS
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEE-----EEEC
Confidence            357899999999999999999999999999999997532   23345678899999887 89999999999     4566


Q ss_pred             ceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCce
Q 037916          475 DFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTA  554 (741)
Q Consensus       475 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~  554 (741)
                      ...|+||||+++|+|..++...          ..+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+
T Consensus       126 ~~~~lV~E~~~gg~L~~~l~~~----------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~i  192 (396)
T 4dc2_A          126 SRLFFVIEYVNGGDLMFHMQRQ----------RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHI  192 (396)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCE
T ss_pred             CEEEEEEEcCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCE
Confidence            7899999999999999998643          4589999999999999999999999   99999999999999999999


Q ss_pred             EEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhh
Q 037916          555 HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       555 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  634 (741)
                      ||+|||+|+.......  .....+||+.|+|| |+..+..++.++||||+||++|||++|+.||...........     
T Consensus       193 kL~DFGla~~~~~~~~--~~~~~~gt~~Y~aP-E~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~-----  264 (396)
T 4dc2_A          193 KLTDYGMCKEGLRPGD--TTSTFCGTPNYIAP-EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-----  264 (396)
T ss_dssp             EECCCTTCBCCCCTTC--CBCCCCBCGGGCCH-HHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC-----------
T ss_pred             EEeecceeeecccCCC--ccccccCCcccCCc-hhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccch-----
Confidence            9999999986433222  12335799999999 555677899999999999999999999999963321111000     


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCH
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNM  696 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  696 (741)
                         .....+.........                ..+......+.+++.+||+.||++||++
T Consensus       265 ---~~~~~~~~~i~~~~~----------------~~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          265 ---NTEDYLFQVILEKQI----------------RIPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             ---CCHHHHHHHHHHCCC----------------CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             ---hhHHHHHHHHhcccc----------------CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence               000000000000000                0011234567899999999999999996

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.2e-40  Score=347.67  Aligned_cols=253  Identities=22%  Similarity=0.266  Sum_probs=193.8

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc--------------------------CcchhHHHHHHHHH
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH--------------------------GASKSSIAECSALR  452 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~  452 (741)
                      ...|++.+.||+|+||.||+|++..+++.||+|+++....                          ...+.+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            4578999999999999999999999999999999974321                          12356789999999


Q ss_pred             hcCCCceeeEeeeecCccccCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcC
Q 037916          453 NIRHKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDC  532 (741)
Q Consensus       453 ~l~hpnIv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~  532 (741)
                      +++||||+++++++..   ......++||||+++++|.+++..           ..+++..+..++.|++.||+|||+. 
T Consensus        92 ~l~h~~iv~~~~~~~~---~~~~~~~lv~e~~~~~~l~~~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~-  156 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDD---PNEDHLYMVFELVNQGPVMEVPTL-----------KPLSEDQARFYFQDLIKGIEYLHYQ-  156 (298)
T ss_dssp             TCCCTTBCCEEEEEEC---SSSSEEEEEEECCTTCBSCCSSCS-----------SCCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             hCCCCCCCeEEEEEEc---CCCCEEEEEEecCCCCcHHHHhhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            9999999999999642   235688999999999999887542           4588999999999999999999999 


Q ss_pred             CCCceecCCCCCCeEeCCCCceEEeecccccccCCCCcccccccccccccccCcccccCCCC--CCCccCchhHHHHHHH
Q 037916          533 QPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSE--VSINGDVYSYGILLLE  610 (741)
Q Consensus       533 ~~~ivHrDlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~--~~~~~DIwSlG~il~e  610 (741)
                        +|+||||||+||+++.++.+||+|||++.........  .....||+.|+|||.+.....  ++.++||||+||++|+
T Consensus       157 --~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~  232 (298)
T 2zv2_A          157 --KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYC  232 (298)
T ss_dssp             --TEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSCE--ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHH
T ss_pred             --CeeccCCCHHHEEECCCCCEEEecCCCcccccccccc--ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHH
Confidence              9999999999999999999999999999876543221  223569999999965543332  4788999999999999


Q ss_pred             HHcCCCCCCccccCCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCC
Q 037916          611 LMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESP  690 (741)
Q Consensus       611 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP  690 (741)
                      |++|+.||....     ......        .+.........                  ....++.+.+++.+||+.||
T Consensus       233 l~~g~~pf~~~~-----~~~~~~--------~~~~~~~~~~~------------------~~~~~~~l~~li~~~l~~dp  281 (298)
T 2zv2_A          233 FVFGQCPFMDER-----IMCLHS--------KIKSQALEFPD------------------QPDIAEDLKDLITRMLDKNP  281 (298)
T ss_dssp             HHHSSCSSCCSS-----HHHHHH--------HHHHCCCCCCS------------------SSCCCHHHHHHHHHHTCSCT
T ss_pred             HHHCCCCCCCcc-----HHHHHH--------HHhcccCCCCC------------------ccccCHHHHHHHHHHhhcCh
Confidence            999999986321     111100        00000000000                  01234568899999999999


Q ss_pred             CCCCCHHHHHH
Q 037916          691 QDRMNMTIVVH  701 (741)
Q Consensus       691 ~~RPs~~evl~  701 (741)
                      ++|||+.|+++
T Consensus       282 ~~R~s~~e~l~  292 (298)
T 2zv2_A          282 ESRIVVPEIKL  292 (298)
T ss_dssp             TTSCCHHHHTT
T ss_pred             hhCCCHHHHhc
Confidence            99999999874

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=5.9e-40  Score=383.96  Aligned_cols=307  Identities=17%  Similarity=0.203  Sum_probs=156.6

Q ss_pred             CCccCC--CCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCccEEECcCCc-Ccc-cCCchhhccc------ccc
Q 037916           37 IPSSMF--NASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNN-FGG-LLPGCICNFS------ITL  106 (741)
Q Consensus        37 ~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~-l~~-~~~~~~~~l~------~~L  106 (741)
                      +|..++  ++++|++|+|++|++.+.+|..|.++++          |++|+|++|+ +++ .+|..+..+.      .+|
T Consensus       481 iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~----------L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L  550 (876)
T 4ecn_A          481 ENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPE----------LQSLNIACNRGISAAQLKADWTRLADDEDTGPKI  550 (876)
T ss_dssp             TTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSS----------CCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTC
T ss_pred             CChhhhhccCCCCCEEECcCCCCCccChHHHhCCCC----------CCEEECcCCCCcccccchHHHHhhhhcccccCCc
Confidence            444433  4444444444444444444444444433          5555555554 444 3443333221      145


Q ss_pred             cEEEccCCcccccCCc--cccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCcccccCCcc-cceeec
Q 037916          107 ETLIFNSNKIFRSIPA--GIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKK-LLQLYL  183 (741)
Q Consensus       107 ~~L~L~~n~i~~~~~~--~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~L  183 (741)
                      +.|+|++|++. .+|.  .|.++++|++|+|++|+|+ .+| .|..+++|+.|+|++|+++ .+|..|.++++ |++|+|
T Consensus       551 ~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~L  626 (876)
T 4ecn_A          551 QIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGF  626 (876)
T ss_dssp             CEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEEC
T ss_pred             cEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEEC
Confidence            55555555544 3444  4555555555555555554 233 4455555555555555554 44444555554 555555


Q ss_pred             cCcccccccCcccccCCC--CCEEeccCccccccCCccc---c--ccccceeEEEcCCCccCCCCChhhcCCCCCcEEEe
Q 037916          184 IENFLQVSIPSSLGQCQS--LTTINLSYNNLSGTIPPQL---M--DLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFI  256 (741)
Q Consensus       184 ~~N~i~~~~~~~~~~l~~--L~~L~L~~N~l~~~~p~~~---~--~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  256 (741)
                      ++|.++ .+|..+..++.  |+.|+|++|++++.+|...   .  .+.+|+. |+|++|+|...++..+..+++|+.|+|
T Consensus       627 s~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~-L~Ls~N~L~~lp~~~~~~l~~L~~L~L  704 (876)
T 4ecn_A          627 SHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINAST-VTLSYNEIQKFPTELFATGSPISTIIL  704 (876)
T ss_dssp             CSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEE-EECCSSCCCSCCHHHHHTTCCCSEEEC
T ss_pred             cCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCE-EEccCCcCCccCHHHHccCCCCCEEEC
Confidence            555554 34444443332  5555555555544333221   1  2224554 666666665333333445666666666


Q ss_pred             ccccccchhhhhcccc-------ccccEEEeCCCccCCCCChhcc--cCccCCeeeCCCCcCCCccchhhhccccCCccc
Q 037916          257 SRNMLECEILSTLGSC-------IKLEQLKLGGNLFQGPIPLSLS--SLRGLRVLDLSQNNISGEIPKFLVELQLVQNLN  327 (741)
Q Consensus       257 s~N~l~~~~~~~~~~l-------~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  327 (741)
                      ++|+|+.++...+...       ++|+.|+|++|+|+ .+|..+.  .+++|+.|+|++|+|++ +|..+..+++|+.|+
T Consensus       705 s~N~L~~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~  782 (876)
T 4ecn_A          705 SNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFG  782 (876)
T ss_dssp             CSCCCSCCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEE
T ss_pred             CCCcCCccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEE
Confidence            6666665444444332       26666666666666 4555554  66666666666666665 455566666666666


Q ss_pred             ccC------cccccccCCc-cccCCcccccccCCCCccccCCC
Q 037916          328 LSY------NDLEGVIPTE-GVFKNASAISVFGNSKLCGGIPE  363 (741)
Q Consensus       328 l~~------N~l~~~~~~~-~~~~~~~~~~~~~n~~~c~~~~~  363 (741)
                      |++      |.+.+.+|.. ..++.++.+++.+|..  +.+|.
T Consensus       783 Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L--~~Ip~  823 (876)
T 4ecn_A          783 IRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI--RKVDE  823 (876)
T ss_dssp             CCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC--CBCCS
T ss_pred             CCCCCCcccccccccChHHHhcCCCCCEEECCCCCC--CccCH
Confidence            654      5555555433 4456666666666654  44444

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.6e-40  Score=346.65  Aligned_cols=269  Identities=15%  Similarity=0.140  Sum_probs=210.1

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhc-CCCceeeEeeeecCccccCCceE
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      ...|++.+.||+|+||.||+|++..+++.||+|++..  ....+.+.+|+.+++.+ +|++|+++++++     ......
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~~   81 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGLHN   81 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEEC--CTTSCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETTEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEecc--CCccHHHHHHHHHHHHHhcCCCCCeEEeec-----CCCcee
Confidence            3568899999999999999999988999999999863  23456788999999999 799999999984     456689


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCc----
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMT----  553 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~----  553 (741)
                      ++||||+ +++|.+++...         ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.    
T Consensus        82 ~lv~e~~-~~~L~~~l~~~---------~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~  148 (298)
T 1csn_A           82 VLVIDLL-GPSLEDLLDLC---------GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNAN  148 (298)
T ss_dssp             EEEEECC-CCBHHHHHHHT---------TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTT
T ss_pred             EEEEEec-CCCHHHHHHHh---------ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCC
Confidence            9999999 99999999643         23588999999999999999999999   9999999999999987765    


Q ss_pred             -eEEeecccccccCCCCcc-----cccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcc
Q 037916          554 -AHVADFGLAKLLPPAHLQ-----TSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMN  627 (741)
Q Consensus       554 -~kL~DFg~a~~~~~~~~~-----~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~  627 (741)
                       +||+|||.+.........     .......||+.|+||| ...+..++.++|||||||++|||++|+.||........ 
T Consensus       149 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE-~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-  226 (298)
T 1csn_A          149 MIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN-THLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN-  226 (298)
T ss_dssp             CEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHH-HHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH-
T ss_pred             eEEEEECccccccccccccccccccCccCCCCCcccCCch-hhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcccc-
Confidence             999999999876544221     1223456999999995 55677789999999999999999999999974321110 


Q ss_pred             hhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHH
Q 037916          628 LHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIK  707 (741)
Q Consensus       628 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  707 (741)
                       .....        .+......               .........+++.+.+++.+||+.||++|||+.||++.|+++.
T Consensus       227 -~~~~~--------~~~~~~~~---------------~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~  282 (298)
T 1csn_A          227 -KQKYE--------RIGEKKQS---------------TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL  282 (298)
T ss_dssp             -HHHHH--------HHHHHHHH---------------SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             -HHHHH--------HHHhhccC---------------ccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence             00000        00000000               0000001134567899999999999999999999999999999


Q ss_pred             HhhcCC
Q 037916          708 SILLGP  713 (741)
Q Consensus       708 ~~~~~~  713 (741)
                      +....+
T Consensus       283 ~~~~~~  288 (298)
T 1csn_A          283 ERLNTT  288 (298)
T ss_dssp             HHTTCC
T ss_pred             HhcCCC
Confidence            876543

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=8.9e-41  Score=343.19  Aligned_cols=257  Identities=25%  Similarity=0.360  Sum_probs=203.8

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      ..|++.+.||+|+||.||+|.+. ++..||+|+++... ...+.+.+|+.++++++||||+++++++     .+....++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   82 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVC-----LEQAPICL   82 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSSEEE
T ss_pred             hhceeeheecCCCccEEEEEEec-CCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCceEE
Confidence            45788899999999999999997 57789999997432 3346788999999999999999999995     45567899


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      ||||+++++|.+++...         ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        83 v~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Df  150 (269)
T 4hcu_A           83 VFEFMEHGCLSDYLRTQ---------RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDF  150 (269)
T ss_dssp             EEECCTTCBHHHHHHTT---------TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCT
T ss_pred             EEEeCCCCcHHHHHHhc---------CcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccc
Confidence            99999999999998643         24588999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcCCc
Q 037916          560 GLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       560 g~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      |.+......... ......+|+.|+||| +..+..++.++||||+|+++|+|++ |+.||......     .....    
T Consensus       151 g~~~~~~~~~~~-~~~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~-----~~~~~----  219 (269)
T 4hcu_A          151 GMTRFVLDDQYT-SSTGTKFPVKWASPE-VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----EVVED----  219 (269)
T ss_dssp             TGGGGBCCHHHH-STTSTTCCGGGCCHH-HHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHHH----
T ss_pred             cccccccccccc-cccCcccccccCCHH-HhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH-----HHHHH----
Confidence            999876543221 222345788899995 4556778999999999999999999 99998632111     11110    


Q ss_pred             chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHh
Q 037916          639 HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSI  709 (741)
Q Consensus       639 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  709 (741)
                          +... .....                  +...++.+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus       220 ----~~~~-~~~~~------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          220 ----ISTG-FRLYK------------------PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             ----HHTT-CCCCC------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             ----HhcC-ccCCC------------------CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence                0000 00000                  011235688999999999999999999999999998763

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=7.1e-41  Score=357.41  Aligned_cols=258  Identities=21%  Similarity=0.241  Sum_probs=200.7

Q ss_pred             HHHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC-----cCcchhHHHHHHHHHhcCCCceeeEeeeecCccc
Q 037916          397 LLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH-----HGASKSSIAECSALRNIRHKNLVKILTVCSGVDY  471 (741)
Q Consensus       397 ~~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  471 (741)
                      .+...|++.+.||+|+||.||+|.+..+++.||+|+++...     ....+.+.+|+.+++.++||||+++++++     
T Consensus        21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----   95 (351)
T 3c0i_A           21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETY-----   95 (351)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred             ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEE-----
Confidence            35578999999999999999999999999999999996321     12356788999999999999999999994     


Q ss_pred             cCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCC
Q 037916          472 KGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHE  551 (741)
Q Consensus       472 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~  551 (741)
                      ......|+||||+++++|.+++....      .....+++..+..++.||+.||+|||++   +|+||||||+||+++.+
T Consensus        96 ~~~~~~~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~  166 (351)
T 3c0i_A           96 SSDGMLYMVFEFMDGADLCFEIVKRA------DAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASK  166 (351)
T ss_dssp             EETTEEEEEEECCSSCBHHHHHHHHH------HTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSS
T ss_pred             EeCCEEEEEEeCCCCCCHHHHHHHhc------ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecC
Confidence            45668999999999999988875321      1123478999999999999999999999   99999999999999866


Q ss_pred             C---ceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcch
Q 037916          552 M---TAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNL  628 (741)
Q Consensus       552 ~---~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~  628 (741)
                      +   .+||+|||++.........  .....||+.|+||| +..+..++.++||||+||++|+|++|..||.....  ..+
T Consensus       167 ~~~~~vkl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE-~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~  241 (351)
T 3c0i_A          167 ENSAPVKLGGFGVAIQLGESGLV--AGGRVGTPHFMAPE-VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--RLF  241 (351)
T ss_dssp             STTCCEEECCCTTCEECCTTSCB--CCCCCSCGGGCCHH-HHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--HHH
T ss_pred             CCCCcEEEecCcceeEecCCCee--ecCCcCCcCccCHH-HHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH--HHH
Confidence            5   4999999999877654322  22356999999994 55667789999999999999999999999863210  000


Q ss_pred             hhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          629 HNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       629 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      .            .+.........                ......++.+.+++.+||+.||++|||+.|+++
T Consensus       242 ~------------~i~~~~~~~~~----------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          242 E------------GIIKGKYKMNP----------------RQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             H------------HHHHTCCCCCH----------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             H------------HHHcCCCCCCc----------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            0            01100000000                001123466889999999999999999999985

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=8.9e-41  Score=358.88  Aligned_cols=275  Identities=16%  Similarity=0.189  Sum_probs=204.2

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCC-----CeEEEEEEeeccCcC-----------cchhHHHHHHHHHhcCCCceeeEee
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEG-----KTIIAVKVLNLLHHG-----------ASKSSIAECSALRNIRHKNLVKILT  464 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~-----~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~hpnIv~~~~  464 (741)
                      .|++.+.||+|+||.||+|.+..+     ++.||+|++......           .......|+..++.++||||+++++
T Consensus        36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~  115 (364)
T 3op5_A           36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWG  115 (364)
T ss_dssp             EEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEE
T ss_pred             eEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEe
Confidence            588899999999999999999754     578999998643211           1122334555666778999999999


Q ss_pred             eecCccccCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCC
Q 037916          465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPS  544 (741)
Q Consensus       465 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~  544 (741)
                      ++.... .+..+.|+||||+ +++|.+++...         ...+++..++.++.||+.||+|||+.   +|+||||||+
T Consensus       116 ~~~~~~-~~~~~~~lv~e~~-g~~L~~~~~~~---------~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~  181 (364)
T 3op5_A          116 SGLHDK-NGKSYRFMIMDRF-GSDLQKIYEAN---------AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKAS  181 (364)
T ss_dssp             EEEEEE-TTEEEEEEEEECE-EEEHHHHHHHT---------TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGG
T ss_pred             eeeecc-CCcceEEEEEeCC-CCCHHHHHHhc---------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHH
Confidence            975421 2235689999999 99999998642         24589999999999999999999999   9999999999


Q ss_pred             CeEeC--CCCceEEeecccccccCCCCccc-----ccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCC
Q 037916          545 NVLLD--HEMTAHVADFGLAKLLPPAHLQT-----SSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP  617 (741)
Q Consensus       545 NIll~--~~~~~kL~DFg~a~~~~~~~~~~-----~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p  617 (741)
                      |||++  .++.+||+|||+++.........     ......||+.|+||| +..+..++.++|||||||++|||++|+.|
T Consensus       182 Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE-~~~~~~~~~~~Di~slG~~l~el~~g~~P  260 (364)
T 3op5_A          182 NLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSID-AHNGVAPSRRGDLEILGYCMIQWLTGHLP  260 (364)
T ss_dssp             GEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHH-HHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred             HEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHH-HhCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            99999  88999999999998765432211     112345999999994 55677799999999999999999999999


Q ss_pred             CCccccCCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHH
Q 037916          618 SDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMT  697 (741)
Q Consensus       618 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  697 (741)
                      |...... ................++++..+..                     ..++..+.+++..||+.||++|||+.
T Consensus       261 f~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~li~~cl~~~p~~RP~~~  318 (364)
T 3op5_A          261 WEDNLKD-PKYVRDSKIRYRENIASLMDKCFPA---------------------ANAPGEIAKYMETVKLLDYTEKPLYE  318 (364)
T ss_dssp             TGGGTTC-HHHHHHHHHHHHHCHHHHHHHHSCT---------------------TCCCHHHHHHHHHHHTCCTTCCCCHH
T ss_pred             ccccccC-HHHHHHHHHHhhhhHHHHHHHhccc---------------------ccCHHHHHHHHHHHhcCCCCCCCCHH
Confidence            9732211 1111111111111222222222110                     12356788999999999999999999


Q ss_pred             HHHHHHHHHHHhhcC
Q 037916          698 IVVHELQSIKSILLG  712 (741)
Q Consensus       698 evl~~L~~i~~~~~~  712 (741)
                      +|++.|+++.+....
T Consensus       319 ~l~~~l~~~~~~~~~  333 (364)
T 3op5_A          319 NLRDILLQGLKAIGS  333 (364)
T ss_dssp             HHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHcCC
Confidence            999999999986553

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2e-40  Score=351.53  Aligned_cols=259  Identities=20%  Similarity=0.275  Sum_probs=197.8

Q ss_pred             HHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc-CcchhHHHHHHHHHhcCCCceeeEeeeecCccc-----
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKILTVCSGVDY-----  471 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~-----  471 (741)
                      +...|++.+.||+|+||.||+|++..+++.||+|+++.... ...+.+.+|+.++++++||||++++++|.....     
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            46789999999999999999999998999999999974332 345678899999999999999999998743210     


Q ss_pred             -----------------------------------------------cCCceEEEEEecccCCChhhhccCCCCCCcccC
Q 037916          472 -----------------------------------------------KGDDFKALVYEFMHNGSLEEWLHPVSGADKTVE  504 (741)
Q Consensus       472 -----------------------------------------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~  504 (741)
                                                                     ....+.++||||+++++|.+++....       
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-------  156 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-------  156 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-------
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-------
Confidence                                                           11234899999999999999997541       


Q ss_pred             cccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecccccccCCCCcc----------ccc
Q 037916          505 APKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQ----------TSS  574 (741)
Q Consensus       505 ~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~----------~~~  574 (741)
                      .....++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.........          ...
T Consensus       157 ~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~  233 (332)
T 3qd2_B          157 SLEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATH  233 (332)
T ss_dssp             SGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CC
T ss_pred             CccchhhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccc
Confidence            223456677899999999999999999   9999999999999999999999999999877654211          122


Q ss_pred             ccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcchhHhhhhcccCCcch
Q 037916          575 IGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDED  654 (741)
Q Consensus       575 ~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  654 (741)
                      ....||+.|+||| +..+..++.++||||+||++|||++|..|+....                   ............ 
T Consensus       234 ~~~~gt~~y~aPE-~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~-------------------~~~~~~~~~~~~-  292 (332)
T 3qd2_B          234 TGQVGTKLYMSPE-QIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV-------------------RIITDVRNLKFP-  292 (332)
T ss_dssp             CSCC-CGGGSCHH-HHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH-------------------HHHHHHHTTCCC-
T ss_pred             cccCCCcCccChH-HhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH-------------------HHHHHhhccCCC-
Confidence            3356999999995 5556788999999999999999999877642110                   000000000000 


Q ss_pred             hhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          655 LTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       655 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                                    .......+.+.+++.+||+.||++|||+.|+++
T Consensus       293 --------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          293 --------------LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             --------------HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             --------------cccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence                          111234456789999999999999999999986

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=3e-41  Score=374.07  Aligned_cols=204  Identities=24%  Similarity=0.312  Sum_probs=160.4

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC--cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      .+|++++.||+|+||.||+|++..+++.||||++....  ....+.+.+|+.+++.++||||+++++++.....+.....
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            46899999999999999999999999999999986422  2234567899999999999999999999865544556789


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      |+||||+ +++|.+++...          ..+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+
T Consensus       133 ~lv~e~~-~~~L~~~~~~~----------~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~  198 (458)
T 3rp9_A          133 YVVLEIA-DSDFKKLFRTP----------VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVC  198 (458)
T ss_dssp             EEEECCC-SEEHHHHHHSS----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEEC
T ss_pred             EEEEecc-ccchhhhcccC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeec
Confidence            9999998 67999988643          4589999999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCcc-------------------------cccccccccccccCcccccCCCCCCCccCchhHHHHHHHHH
Q 037916          558 DFGLAKLLPPAHLQ-------------------------TSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELM  612 (741)
Q Consensus       558 DFg~a~~~~~~~~~-------------------------~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ell  612 (741)
                      |||+|+........                         .......||+.|+|||.+..+..++.++||||+||++|||+
T Consensus       199 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ell  278 (458)
T 3rp9_A          199 DFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL  278 (458)
T ss_dssp             CCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred             ccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHH
Confidence            99999876532211                         12234568999999976667778999999999999999999


Q ss_pred             cCCCC
Q 037916          613 TRKRP  617 (741)
Q Consensus       613 tg~~p  617 (741)
                      +|..|
T Consensus       279 tg~~~  283 (458)
T 3rp9_A          279 NMIKE  283 (458)
T ss_dssp             TTSTT
T ss_pred             Hhccc
Confidence            95433

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=8.8e-40  Score=376.07  Aligned_cols=157  Identities=18%  Similarity=0.263  Sum_probs=144.0

Q ss_pred             CCCCCcccccCChhhhhCCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCc
Q 037916            2 DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHL   81 (741)
Q Consensus         2 dl~~n~~~~~ip~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L   81 (741)
                      |.+++.++ .+|..++   ++|++|+|++|+|+++.+..|.++++|++|+|++|+++++.|.+|.++++          |
T Consensus        17 ~c~~~~l~-~ip~~~~---~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~----------L   82 (606)
T 3vq2_A           17 QCMDQKLS-KVPDDIP---SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHH----------L   82 (606)
T ss_dssp             ECTTSCCS-SCCTTSC---TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTT----------C
T ss_pred             EccCCCcc-cCCCCCC---CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhh----------c
Confidence            45677777 8898876   89999999999999999999999999999999999999988999999986          9


Q ss_pred             cEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEccccccccc-CCccccCCCcCcEEEcc
Q 037916           82 KHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGT-ISPAIGELQNLVTLAIN  160 (741)
Q Consensus        82 ~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~-~~~~~~~l~~L~~L~L~  160 (741)
                      ++|+|++|++++..|..|.++. +|++|+|++|++.+..+..|.++++|++|+|++|+++++ .|..|.++++|++|+|+
T Consensus        83 ~~L~Ls~n~l~~~~p~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls  161 (606)
T 3vq2_A           83 SNLILTGNPIQSFSPGSFSGLT-SLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLS  161 (606)
T ss_dssp             CEEECTTCCCCCCCTTSSTTCT-TCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECC
T ss_pred             CEeECCCCcccccChhhcCCcc-cCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEcc
Confidence            9999999999999999999998 999999999999988889999999999999999999874 58999999999999999


Q ss_pred             cCCCCCcCccccc
Q 037916          161 TNKLSGNIPPSIG  173 (741)
Q Consensus       161 ~N~l~~~~~~~~~  173 (741)
                      +|+++++.+..|+
T Consensus       162 ~n~l~~~~~~~~~  174 (606)
T 3vq2_A          162 YNYIQTITVNDLQ  174 (606)
T ss_dssp             SSCCCEECTTTTH
T ss_pred             CCcceecChhhhh
Confidence            9999877665443

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=7.1e-41  Score=353.83  Aligned_cols=259  Identities=24%  Similarity=0.309  Sum_probs=200.5

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeE----EEEEEeecc-CcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTI----IAVKVLNLL-HHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      .|++.+.||+|+||.||+|++..+++.    ||+|++... .......+.+|+.++++++||||++++++|.      +.
T Consensus        14 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~~   87 (325)
T 3kex_A           14 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP------GS   87 (325)
T ss_dssp             TEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC------BS
T ss_pred             HceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc------CC
Confidence            577889999999999999999877765    777776532 2334466788999999999999999999852      34


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..++||||+.+|+|.+++...         ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+|
T Consensus        88 ~~~~v~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~k  155 (325)
T 3kex_A           88 SLQLVTQYLPLGSLLDHVRQH---------RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQ  155 (325)
T ss_dssp             SEEEEEECCTTCBSHHHHHSS---------GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEE
T ss_pred             ccEEEEEeCCCCCHHHHHHHc---------cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEE
Confidence            589999999999999998643         24678889999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhh
Q 037916          556 VADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  634 (741)
                      |+|||+++...............||..|+||| ...+..++.++||||+||++|+|++ |..||.....  .........
T Consensus       156 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~  232 (325)
T 3kex_A          156 VADFGVADLLPPDDKQLLYSEAKTPIKWMALE-SIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL--AEVPDLLEK  232 (325)
T ss_dssp             ECSCSGGGGSCCCTTCCC-----CCTTTSCHH-HHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT--THHHHHHHT
T ss_pred             ECCCCcccccCcccccccccCCCCcccccChH-HhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH--HHHHHHHHc
Confidence            99999999876554433334456888999995 4456678999999999999999999 9999863211  111111111


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHhh
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSIL  710 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  710 (741)
                      ..            ....                  +..++..+.+++.+||+.||++|||+.|+++.|+.+.+..
T Consensus       233 ~~------------~~~~------------------~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~  278 (325)
T 3kex_A          233 GE------------RLAQ------------------PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP  278 (325)
T ss_dssp             TC------------BCCC------------------CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred             CC------------CCCC------------------CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence            00            0000                  0012334678999999999999999999999999987543

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.8e-40  Score=347.42  Aligned_cols=281  Identities=19%  Similarity=0.235  Sum_probs=208.2

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      +|++.+.||+|+||.||+|++..+++.||+|+++... ....+.+.+|+.++++++||||+++++++..   ......++
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~~~~l   86 (319)
T 4euu_A           10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE---TTTRHKVL   86 (319)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC---TTTCCEEE
T ss_pred             CEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeec---CCCceEEE
Confidence            5788899999999999999999999999999997433 2335667899999999999999999998642   23447899


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEe----CCCCceE
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLL----DHEMTAH  555 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll----~~~~~~k  555 (741)
                      ||||+++++|.+++....       ....+++.+++.++.|++.||+|||+.   +|+||||||+||++    +.++.+|
T Consensus        87 v~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~k  156 (319)
T 4euu_A           87 IMEFCPCGSLYTVLEEPS-------NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYK  156 (319)
T ss_dssp             EEECCTTCBHHHHHHSGG-------GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEE
T ss_pred             EEeCCCCCCHHHHHHHhc-------cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEE
Confidence            999999999999997431       123389999999999999999999999   99999999999999    7778899


Q ss_pred             EeecccccccCCCCcccccccccccccccCccccc-------CCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcch
Q 037916          556 VADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG-------LGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNL  628 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~-------~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~  628 (741)
                      |+|||.++........   ....||+.|+|||.+.       .+..++.++||||+||++|||++|+.||..........
T Consensus       157 L~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~  233 (319)
T 4euu_A          157 LTDFGAARELEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK  233 (319)
T ss_dssp             ECCCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCH
T ss_pred             EccCCCceecCCCCce---eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhH
Confidence            9999999876554322   2246899999996543       15778999999999999999999999986332221111


Q ss_pred             hhhh--hhcCCcc-hhHh---hhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          629 HNFA--RTVLPDH-VMDI---VDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       629 ~~~~--~~~~~~~-~~~~---~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      ..+.  ....+.. ...+   ..........          ..............+.+++.+||+.||++|||+.|+++.
T Consensus       234 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h  303 (319)
T 4euu_A          234 EVMYKIITGKPSGAISGVQKAENGPIDWSGD----------MPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (319)
T ss_dssp             HHHHHHHHHCCTTCCEEEECSTTCCEEEESS----------CCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             HHHHHHhcCCCcccchhhhcccCCccccCcc----------CCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhc
Confidence            1111  0011100 0000   0000000000          000001124567788999999999999999999999998


Q ss_pred             HHHHH
Q 037916          703 LQSIK  707 (741)
Q Consensus       703 L~~i~  707 (741)
                      ..+..
T Consensus       304 ~~d~~  308 (319)
T 4euu_A          304 TSDIL  308 (319)
T ss_dssp             HHHHT
T ss_pred             cHHHh
Confidence            87654

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=3.6e-41  Score=356.33  Aligned_cols=259  Identities=24%  Similarity=0.351  Sum_probs=196.4

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeE----EEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCC
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTI----IAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGD  474 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~  474 (741)
                      ..|++.+.||+|+||.||+|++..+++.    ||+|.++... ....+.+.+|+.++++++||||++++++|..      
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------   88 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------   88 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES------
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec------
Confidence            4578889999999999999999777665    4777765322 2345678899999999999999999999642      


Q ss_pred             ceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCce
Q 037916          475 DFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTA  554 (741)
Q Consensus       475 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~  554 (741)
                      ...++||||+.+|+|.+++...         ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus        89 ~~~~~v~e~~~~g~L~~~l~~~---------~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~  156 (327)
T 3poz_A           89 STVQLITQLMPFGCLLDYVREH---------KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHV  156 (327)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHS---------TTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEE
T ss_pred             CCeEEEEEecCCCcHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCE
Confidence            2378999999999999998643         24588999999999999999999999   99999999999999999999


Q ss_pred             EEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhh
Q 037916          555 HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFAR  633 (741)
Q Consensus       555 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~  633 (741)
                      ||+|||+++...............+|+.|+||| +..+..++.++|||||||++|||++ |+.||......  .......
T Consensus       157 kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE-~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~~  233 (327)
T 3poz_A          157 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE-SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILE  233 (327)
T ss_dssp             EECCTTHHHHHTTTCC-------CCCGGGSCHH-HHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHH
T ss_pred             EEccCcceeEccCCcccccccCCCccccccChH-HhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH--HHHHHHH
Confidence            999999998776554333333445788999995 4456788999999999999999999 99998632111  1111111


Q ss_pred             hcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHh
Q 037916          634 TVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSI  709 (741)
Q Consensus       634 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  709 (741)
                      .            ......                  ...++..+.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus       234 ~------------~~~~~~------------------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          234 K------------GERLPQ------------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             T------------TCCCCC------------------CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred             c------------CCCCCC------------------CccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence            1            100000                  112345688999999999999999999999999998754

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.7e-40  Score=346.95  Aligned_cols=272  Identities=22%  Similarity=0.245  Sum_probs=199.6

Q ss_pred             HHHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc--CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCC
Q 037916          397 LLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGD  474 (741)
Q Consensus       397 ~~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~  474 (741)
                      .+..+|+++++||+|+||.||+|++. +++.||+|+++....  .....+.+|+.++++++||||+++++++     .++
T Consensus        18 ~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~   91 (311)
T 3niz_A           18 GLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI-----HSE   91 (311)
T ss_dssp             CSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CCS
T ss_pred             chHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEE-----ccC
Confidence            34567899999999999999999996 589999999974322  2245678999999999999999999994     456


Q ss_pred             ceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCce
Q 037916          475 DFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTA  554 (741)
Q Consensus       475 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~  554 (741)
                      ...++||||++ ++|.+++...         ...+++..+..++.|++.||+|||+.   ||+||||||+||+++.++.+
T Consensus        92 ~~~~lv~e~~~-~~l~~~~~~~---------~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~  158 (311)
T 3niz_A           92 RCLTLVFEFME-KDLKKVLDEN---------KTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGAL  158 (311)
T ss_dssp             SCEEEEEECCS-EEHHHHHHTC---------TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCE
T ss_pred             CEEEEEEcCCC-CCHHHHHHhc---------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCE
Confidence            68999999996 5888877533         24588999999999999999999999   99999999999999999999


Q ss_pred             EEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhh
Q 037916          555 HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       555 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  634 (741)
                      ||+|||.+.........  .....||+.|+|||.+.....++.++||||+||++|+|++|+.||......+ ........
T Consensus       159 kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~  235 (311)
T 3niz_A          159 KLADFGLARAFGIPVRS--YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD-QLPKIFSI  235 (311)
T ss_dssp             EECCCTTCEETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT-HHHHHHHH
T ss_pred             EEccCcCceecCCCccc--ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHH
Confidence            99999999876533221  2224589999999766555778999999999999999999999997432221 11111111


Q ss_pred             cCC---cchhHh------hhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          635 VLP---DHVMDI------VDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       635 ~~~---~~~~~~------~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ...   ......      .+.... ...          ............+.+.+++.+||+.||++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~----------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          236 LGTPNPREWPQVQELPLWKQRTFQ-VFE----------KKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             HCCCCTTTSGGGTTSHHHHSCCCC-CCC----------CCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HCCCChHHhhhhhccchhhhcccc-ccc----------CCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            111   000000      000000 000          00001111233456789999999999999999999985

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=4.9e-41  Score=361.25  Aligned_cols=262  Identities=24%  Similarity=0.368  Sum_probs=193.5

Q ss_pred             HHHHHhhhcccCceeeEEEEEEc---CCCeEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILD---EGKTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~---~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      ..|.+.+.||+|+||.||+|++.   .++..||+|+++... ....+.+.+|+.++++++||||+++++++     ....
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~  119 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVV-----TKSK  119 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CSSS
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----eeCC
Confidence            35788899999999999999986   467789999997432 22345788999999999999999999995     4456


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..++||||+++|+|.+++...         ...+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+|
T Consensus       120 ~~~lv~e~~~~~sL~~~l~~~---------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~k  187 (373)
T 2qol_A          120 PVMIVTEYMENGSLDSFLRKH---------DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCK  187 (373)
T ss_dssp             SCEEEEECCTTCBHHHHHHTT---------TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEE
T ss_pred             ceEEEEeCCCCCcHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEE
Confidence            789999999999999999643         24588999999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCccc-ccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhh
Q 037916          556 VADFGLAKLLPPAHLQT-SSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFAR  633 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~~-~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~  633 (741)
                      |+|||+++......... ......+++.|+||| +..+..++.++|||||||++||+++ |+.||......     ..  
T Consensus       188 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~-----~~--  259 (373)
T 2qol_A          188 VSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPE-AIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ-----DV--  259 (373)
T ss_dssp             ECCC----------------------CTTSCHH-HHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH-----HH--
T ss_pred             ECcCccccccccCCccceeccCCCcCCCccChh-hhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-----HH--
Confidence            99999998765432211 112223577899995 4456778999999999999999998 99998632110     01  


Q ss_pred             hcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHhhc
Q 037916          634 TVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSILL  711 (741)
Q Consensus       634 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~  711 (741)
                             ...+........                  ...++..+.+++.+||+.||++|||+.||++.|+.+.+...
T Consensus       260 -------~~~i~~~~~~~~------------------~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~  312 (373)
T 2qol_A          260 -------IKAVDEGYRLPP------------------PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG  312 (373)
T ss_dssp             -------HHHHHTTEECCC------------------CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGG
T ss_pred             -------HHHHHcCCCCCC------------------CccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCcc
Confidence                   111111100000                  11345678899999999999999999999999999987543

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-40  Score=349.75  Aligned_cols=286  Identities=23%  Similarity=0.277  Sum_probs=199.2

Q ss_pred             HHHHHHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC-----cCcchhHHHHHHHHHhc---CCCceeeEeee
Q 037916          394 VGILLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH-----HGASKSSIAECSALRNI---RHKNLVKILTV  465 (741)
Q Consensus       394 ~~~~~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l---~hpnIv~~~~~  465 (741)
                      +|.++..+|++.++||+|+||.||+|++..+++.||+|+++...     ........+|+.+++++   +||||++++++
T Consensus         3 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~   82 (308)
T 3g33_A            3 LGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDV   82 (308)
T ss_dssp             -------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred             CCcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeee
Confidence            35567789999999999999999999999899999999997432     12234677888887776   49999999999


Q ss_pred             ecCccccCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCC
Q 037916          466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSN  545 (741)
Q Consensus       466 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~N  545 (741)
                      |...........++||||+. ++|.+++....        ...+++..++.++.|++.||+|||+.   +|+||||||+|
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~--------~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~N  150 (308)
T 3g33_A           83 CATSRTDREIKVTLVFEHVD-QDLRTYLDKAP--------PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPEN  150 (308)
T ss_dssp             EEECCSSSEEEEEEEEECCC-CBHHHHHHTCC--------TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTT
T ss_pred             eeccCCCCceeEEEEehhhh-cCHHHHHhhcc--------CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHH
Confidence            75433233336899999995 69999987441        23489999999999999999999999   99999999999


Q ss_pred             eEeCCCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCC
Q 037916          546 VLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGN  625 (741)
Q Consensus       546 Ill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~  625 (741)
                      |+++.++.+||+|||.+........   .....||+.|+||| +..+..++.++||||+||++|+|++|+.||.......
T Consensus       151 il~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE-~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~  226 (308)
T 3g33_A          151 ILVTSGGTVKLADFGLARIYSYQMA---LTPVVVTLWYRAPE-VLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD  226 (308)
T ss_dssp             EEECTTSCEEECSCSCTTTSTTCCC---SGGGGCCCSSCCHH-HHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH
T ss_pred             EEEcCCCCEEEeeCccccccCCCcc---cCCccccccccCch-HHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            9999999999999999986654322   22356899999995 4456678999999999999999999999986322111


Q ss_pred             cchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          626 MNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       626 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                       .+..............+........     ................+..+.+.+++.+||+.||++|||+.|+++
T Consensus       227 -~~~~i~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          227 -QLGKIFDLIGLPPEDDWPRDVSLPR-----GAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             -HHHHHHHHHCCCCTTTSCSSCSSCG-----GGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -HHHHHHHHhCCCChhhccchhhccc-----cccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence             1111111100000000000000000     000000000000111234567889999999999999999999885

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-40  Score=359.80  Aligned_cols=274  Identities=22%  Similarity=0.321  Sum_probs=210.7

Q ss_pred             HHHHHhhhcccCceeeEEEEEEc-------CCCeEEEEEEeeccCc-CcchhHHHHHHHHHhc-CCCceeeEeeeecCcc
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILD-------EGKTIIAVKVLNLLHH-GASKSSIAECSALRNI-RHKNLVKILTVCSGVD  470 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~-------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~  470 (741)
                      .+|.+.+.||+|+||.||+|++.       ..+..||+|+++.... .....+.+|+.+++++ +||||++++++|    
T Consensus        69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~----  144 (382)
T 3tt0_A           69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC----  144 (382)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred             hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee----
Confidence            45778889999999999999974       2446899999974322 2335678999999999 999999999995    


Q ss_pred             ccCCceEEEEEecccCCChhhhccCCCCCCc------ccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCC
Q 037916          471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADK------TVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPS  544 (741)
Q Consensus       471 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~  544 (741)
                       ......++||||+++|+|.+++........      .......+++..++.++.|++.||+|||+.   +|+||||||+
T Consensus       145 -~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~  220 (382)
T 3tt0_A          145 -TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR  220 (382)
T ss_dssp             -CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGG
T ss_pred             -ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcc
Confidence             445578999999999999999975432110      111234689999999999999999999999   9999999999


Q ss_pred             CeEeCCCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCcccc
Q 037916          545 NVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFE  623 (741)
Q Consensus       545 NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~  623 (741)
                      ||+++.++.+||+|||+++...............+|+.|+||| +..+..++.++|||||||++|+|++ |..||.... 
T Consensus       221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE-~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~-  298 (382)
T 3tt0_A          221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPE-ALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-  298 (382)
T ss_dssp             GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHH-HHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-
T ss_pred             eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHH-HhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC-
Confidence            9999999999999999998776544333333455789999995 4456789999999999999999999 999986221 


Q ss_pred             CCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHH
Q 037916          624 GNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHEL  703 (741)
Q Consensus       624 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  703 (741)
                          ......         .+........                  +..++..+.+++.+||+.||++|||+.||++.|
T Consensus       299 ----~~~~~~---------~~~~~~~~~~------------------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  347 (382)
T 3tt0_A          299 ----VEELFK---------LLKEGHRMDK------------------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL  347 (382)
T ss_dssp             ----HHHHHH---------HHHTTCCCCC------------------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             ----HHHHHH---------HHHcCCCCCC------------------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence                111111         1100000000                  012345688999999999999999999999999


Q ss_pred             HHHHHhhcCCc
Q 037916          704 QSIKSILLGPK  714 (741)
Q Consensus       704 ~~i~~~~~~~~  714 (741)
                      +++.......+
T Consensus       348 ~~~~~~~~~~~  358 (382)
T 3tt0_A          348 DRIVALTSNQE  358 (382)
T ss_dssp             HHHHHHSCSCC
T ss_pred             HHHHHHHhcCC
Confidence            99997765444

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1e-40  Score=350.88  Aligned_cols=268  Identities=21%  Similarity=0.321  Sum_probs=205.7

Q ss_pred             HHHHHhhhcccCceeeEEEEEEc-----CCCeEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccC
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILD-----EGKTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKG  473 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  473 (741)
                      ..|.+.+.||+|+||.||+|.+.     .++..||+|+++... ....+.+.+|+.++++++||||+++++++     ..
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~   97 (314)
T 2ivs_A           23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC-----SQ   97 (314)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CS
T ss_pred             hheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE-----ec
Confidence            35777889999999999999983     456899999997432 22345678999999999999999999995     44


Q ss_pred             CceEEEEEecccCCChhhhccCCCCCCc--------------ccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceec
Q 037916          474 DDFKALVYEFMHNGSLEEWLHPVSGADK--------------TVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHC  539 (741)
Q Consensus       474 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~--------------~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHr  539 (741)
                      ....++||||+++++|.+++........              .......+++.+++.++.|+++||.|||+.   +|+||
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~  174 (314)
T 2ivs_A           98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHR  174 (314)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECC
T ss_pred             CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCccc
Confidence            5678999999999999999875422100              001124588999999999999999999999   99999


Q ss_pred             CCCCCCeEeCCCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCC
Q 037916          540 DLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPS  618 (741)
Q Consensus       540 Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~  618 (741)
                      ||||+||+++.++.+||+|||.+................+|+.|+|||. ..+..++.++||||+||++|||++ |..||
T Consensus       175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~~~~Di~slG~il~el~t~g~~p~  253 (314)
T 2ivs_A          175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIES-LFDHIYTTQSDVWSFGVLLWEIVTLGGNPY  253 (314)
T ss_dssp             CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHH-HHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhh-hcCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence            9999999999999999999999987755443333333457889999954 456678999999999999999999 99998


Q ss_pred             CccccCCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHH
Q 037916          619 DIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTI  698 (741)
Q Consensus       619 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  698 (741)
                      ......  ........            ......                  +..+++.+.+++.+||+.||++|||+.|
T Consensus       254 ~~~~~~--~~~~~~~~------------~~~~~~------------------~~~~~~~~~~li~~~l~~dp~~Rps~~~  301 (314)
T 2ivs_A          254 PGIPPE--RLFNLLKT------------GHRMER------------------PDNCSEEMYRLMLQCWKQEPDKRPVFAD  301 (314)
T ss_dssp             TTCCGG--GHHHHHHT------------TCCCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCHH--HHHHHhhc------------CCcCCC------------------CccCCHHHHHHHHHHccCChhhCcCHHH
Confidence            632111  11111110            000000                  0133466889999999999999999999


Q ss_pred             HHHHHHHHHH
Q 037916          699 VVHELQSIKS  708 (741)
Q Consensus       699 vl~~L~~i~~  708 (741)
                      +++.|+++..
T Consensus       302 l~~~l~~~~~  311 (314)
T 2ivs_A          302 ISKDLEKMMV  311 (314)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHHHHHHHHh
Confidence            9999999875

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=3.9e-41  Score=358.55  Aligned_cols=249  Identities=24%  Similarity=0.296  Sum_probs=194.5

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeecc---CcCcchhHHHHHHHHHhc-CCCceeeEeeeecCccccCC
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLL---HHGASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKGD  474 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~  474 (741)
                      ...|++++.||+|+||.||+|++..+++.||+|+++..   .....+...+|..+++.+ +||||++++++     +.+.
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~-----~~~~   96 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCC-----FQTP   96 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEE-----EECS
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEE-----EEeC
Confidence            45789999999999999999999999999999999743   223445677899999988 79999999999     4566


Q ss_pred             ceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCce
Q 037916          475 DFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTA  554 (741)
Q Consensus       475 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~  554 (741)
                      ...|+||||+++|+|.+++...          ..+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+
T Consensus        97 ~~~~lv~E~~~gg~L~~~l~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~i  163 (353)
T 3txo_A           97 DRLFFVMEFVNGGDLMFHIQKS----------RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHC  163 (353)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCE
T ss_pred             CEEEEEEeCCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCE
Confidence            6899999999999999998643          4588999999999999999999999   99999999999999999999


Q ss_pred             EEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhh
Q 037916          555 HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       555 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  634 (741)
                      ||+|||+|+.......  .....+||+.|+||| +..+..++.++||||+||++|||++|+.||.....     ..... 
T Consensus       164 kL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE-~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----~~~~~-  234 (353)
T 3txo_A          164 KLADFGMCKEGICNGV--TTATFCGTPDYIAPE-ILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE-----DDLFE-  234 (353)
T ss_dssp             EECCCTTCBCSCC-----------CCGGGCCHH-HHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH-
T ss_pred             EEccccceeecccCCc--cccccCCCcCeEChh-hcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH-----HHHHH-
Confidence            9999999986433322  122356999999995 55566789999999999999999999999863211     11111 


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCH------HHHHH
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNM------TIVVH  701 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~  701 (741)
                             .+......  .                  +......+.+++.+||+.||++||++      .|+++
T Consensus       235 -------~i~~~~~~--~------------------p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          235 -------AILNDEVV--Y------------------PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             -------HHHHCCCC--C------------------CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             -------HHHcCCCC--C------------------CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence                   11110000  0                  01123557799999999999999998      66664

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=9.7e-41  Score=361.85  Aligned_cols=207  Identities=25%  Similarity=0.336  Sum_probs=164.3

Q ss_pred             HHHHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeecc--CcCcchhHHHHHHHHHhcC-CCceeeEeeeecCcccc
Q 037916          396 ILLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLL--HHGASKSSIAECSALRNIR-HKNLVKILTVCSGVDYK  472 (741)
Q Consensus       396 ~~~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~  472 (741)
                      ..+..+|++++.||+|+||.||+|.+..+++.||+|++...  .........+|+.+++++. ||||+++++++..   .
T Consensus         5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~---~   81 (388)
T 3oz6_A            5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRA---D   81 (388)
T ss_dssp             HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC---T
T ss_pred             CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEec---C
Confidence            45667899999999999999999999999999999998632  2233456778999999997 9999999999642   3


Q ss_pred             CCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCC
Q 037916          473 GDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEM  552 (741)
Q Consensus       473 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~  552 (741)
                      +....|+||||++ ++|.+++..           ..+++..+..++.|++.||+|||+.   ||+||||||+|||++.++
T Consensus        82 ~~~~~~lv~e~~~-~~L~~~~~~-----------~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~  146 (388)
T 3oz6_A           82 NDRDVYLVFDYME-TDLHAVIRA-----------NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAEC  146 (388)
T ss_dssp             TSSCEEEEEECCS-EEHHHHHHH-----------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTC
T ss_pred             CCCEEEEEecccC-cCHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCC
Confidence            3457899999996 689988852           3578889999999999999999999   999999999999999999


Q ss_pred             ceEEeecccccccCCCCc-------------------ccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc
Q 037916          553 TAHVADFGLAKLLPPAHL-------------------QTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT  613 (741)
Q Consensus       553 ~~kL~DFg~a~~~~~~~~-------------------~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt  613 (741)
                      .+||+|||+|+.......                   ........||+.|+|||.+.....++.++||||+||++|||++
T Consensus       147 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~  226 (388)
T 3oz6_A          147 HVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILC  226 (388)
T ss_dssp             CEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH
T ss_pred             CEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHh
Confidence            999999999986543110                   1112335699999999766555789999999999999999999


Q ss_pred             CCCCCCc
Q 037916          614 RKRPSDI  620 (741)
Q Consensus       614 g~~p~~~  620 (741)
                      |+.||..
T Consensus       227 g~~pf~~  233 (388)
T 3oz6_A          227 GKPIFPG  233 (388)
T ss_dssp             SSCSCCC
T ss_pred             CCCCCCC
Confidence            9999863

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=7.4e-41  Score=367.44  Aligned_cols=206  Identities=21%  Similarity=0.274  Sum_probs=170.7

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC--cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      .+|++.+.||+|+||.||+|++..+++.||||+++...  ....+.+.+|+.++++++||||+++++++...........
T Consensus        26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  105 (432)
T 3n9x_A           26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL  105 (432)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence            46888999999999999999999999999999997432  2234577899999999999999999999755443344679


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      |+||||+. ++|.+++...          ..+++..++.++.||+.||+|||+.   ||+||||||+|||++.++.+||+
T Consensus       106 ~lv~e~~~-~~L~~~~~~~----------~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~  171 (432)
T 3n9x_A          106 YIVLEIAD-SDLKKLFKTP----------IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVC  171 (432)
T ss_dssp             EEEEECCS-EEHHHHHHSS----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEEC
T ss_pred             EEEEecCC-cCHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEc
Confidence            99999995 6999998643          4589999999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCcc--------------------cccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCC
Q 037916          558 DFGLAKLLPPAHLQ--------------------TSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP  617 (741)
Q Consensus       558 DFg~a~~~~~~~~~--------------------~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p  617 (741)
                      |||+|+........                    .......||+.|+|||.+.....++.++||||+||++|||++|..|
T Consensus       172 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p  251 (432)
T 3n9x_A          172 DFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS  251 (432)
T ss_dssp             CCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTT
T ss_pred             cCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccc
Confidence            99999876543211                    1123466999999997666777899999999999999999997777


Q ss_pred             CC
Q 037916          618 SD  619 (741)
Q Consensus       618 ~~  619 (741)
                      |.
T Consensus       252 ~~  253 (432)
T 3n9x_A          252 HI  253 (432)
T ss_dssp             TC
T ss_pred             cc
Confidence            64

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=3.2e-41  Score=356.97  Aligned_cols=281  Identities=24%  Similarity=0.275  Sum_probs=208.7

Q ss_pred             HHHHHhhhcccCceeeEEEEE----EcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          400 VSFLFLCWIDMGSFGSVYKGI----LDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      ..|++.+.||+|+||.||+|+    +..+++.||+|++........+.+.+|+.++++++||||+++++++..   .+..
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~   99 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYG---PGRQ   99 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC---SSSC
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEec---CCCc
Confidence            468888999999999999999    466899999999976554555678999999999999999999998642   3456


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..++||||+++++|.+++...         ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+|
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~k  167 (327)
T 3lxl_A          100 SLRLVMEYLPSGCLRDFLQRH---------RARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVK  167 (327)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH---------GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEE
T ss_pred             eEEEEEeecCCCCHHHHHHhc---------ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEE
Confidence            789999999999999998632         24589999999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcc-cccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhh
Q 037916          556 VADFGLAKLLPPAHLQ-TSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~-~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  634 (741)
                      |+|||.+......... .......||+.|+||| +..+..++.++||||+||++|+|++|..||........  ..+...
T Consensus       168 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~--~~~~~~  244 (327)
T 3lxl_A          168 IADFGLAKLLPLDKDYYVVREPGQSPIFWYAPE-SLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFL--RMMGCE  244 (327)
T ss_dssp             ECCGGGCEECCTTCSEEECSSCCCSCGGGSCHH-HHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH--HHCC--
T ss_pred             EcccccceecccCCccceeeccCCccccccCHH-HhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhh--hhcccc
Confidence            9999999877544321 1222345888999995 44566789999999999999999999999763221100  000000


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHhhcCC
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSILLGP  713 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~  713 (741)
                      ..........+......               ....+..+++.+.+++.+||+.||++|||+.|+++.|+.+.......
T Consensus       245 ~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~  308 (327)
T 3lxl_A          245 RDVPALSRLLELLEEGQ---------------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGC  308 (327)
T ss_dssp             --CCHHHHHHHHHHTTC---------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-------
T ss_pred             cccccHHHHHHHhhccc---------------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCc
Confidence            00011111111000000               00111244567889999999999999999999999999998765543

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.2e-39  Score=361.40  Aligned_cols=323  Identities=20%  Similarity=0.187  Sum_probs=300.4

Q ss_pred             CcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCccEEECcCCcCcccCCchhhcc
Q 037916           23 LLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNF  102 (741)
Q Consensus        23 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l  102 (741)
                      -+.++.++++++ .+|..+.  ++|++|+|++|+|++..+..|.++++          |++|+|++|+|+++.|..|.++
T Consensus        13 ~~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~----------L~~L~L~~n~i~~~~~~~~~~l   79 (477)
T 2id5_A           13 DRAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPH----------LEELELNENIVSAVEPGAFNNL   79 (477)
T ss_dssp             TTEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTT----------CCEEECTTSCCCEECTTTTTTC
T ss_pred             CCEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCC----------CCEEECCCCccCEeChhhhhCC
Confidence            467999999998 5566553  68999999999999988999999986          9999999999999999999999


Q ss_pred             cccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCcccccCCcccceee
Q 037916          103 SITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLY  182 (741)
Q Consensus       103 ~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  182 (741)
                      . +|++|+|++|++..+.+..|.++++|++|+|++|+|+++.+..|.++++|++|+|++|+++++.+..|.++++|++|+
T Consensus        80 ~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  158 (477)
T 2id5_A           80 F-NLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLT  158 (477)
T ss_dssp             T-TCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEE
T ss_pred             c-cCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEE
Confidence            8 999999999999888888899999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEecccccc
Q 037916          183 LIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLE  262 (741)
Q Consensus       183 L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  262 (741)
                      |++|.+++..+..|..+++|+.|+|++|++++..+..|..+++|+. |++++|.+.+.+|..+....+|+.|+|++|+++
T Consensus       159 l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~-L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~  237 (477)
T 2id5_A          159 LEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKV-LEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT  237 (477)
T ss_dssp             EESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCE-EEEECCTTCCEECTTTTTTCCCSEEEEESSCCC
T ss_pred             CCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccce-eeCCCCccccccCcccccCccccEEECcCCccc
Confidence            9999999888888999999999999999999888889999999998 999999988778777777779999999999999


Q ss_pred             chhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccchhhhccccCCcccccCcccccccCCc-c
Q 037916          263 CEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTE-G  341 (741)
Q Consensus       263 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~  341 (741)
                      .+....|..+++|+.|+|++|++++..+..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|.+++.++.. .
T Consensus       238 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  317 (477)
T 2id5_A          238 AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFH  317 (477)
T ss_dssp             SCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBS
T ss_pred             ccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcC
Confidence            988889999999999999999999998999999999999999999999999999999999999999999999887754 4


Q ss_pred             ccCCcccccccCCCCcccc
Q 037916          342 VFKNASAISVFGNSKLCGG  360 (741)
Q Consensus       342 ~~~~~~~~~~~~n~~~c~~  360 (741)
                      .++.++.+++.+|++.|.+
T Consensus       318 ~l~~L~~L~l~~N~l~c~c  336 (477)
T 2id5_A          318 SVGNLETLILDSNPLACDC  336 (477)
T ss_dssp             CGGGCCEEECCSSCEECSG
T ss_pred             CCcccCEEEccCCCccCcc
Confidence            5678999999999999864

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=6e-41  Score=354.23  Aligned_cols=273  Identities=23%  Similarity=0.374  Sum_probs=190.8

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCe---EEEEEEeecc--CcCcchhHHHHHHHHHhcCCCceeeEeeeecCcccc-
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKT---IIAVKVLNLL--HHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYK-  472 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~---~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~-  472 (741)
                      ...|++.+.||+|+||.||+|++..++.   .||+|+++..  .....+.+.+|+.++++++||||+++++++...... 
T Consensus        22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (323)
T 3qup_A           22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG  101 (323)
T ss_dssp             ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred             hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence            3568899999999999999999876664   8999998743  233456788999999999999999999996432211 


Q ss_pred             CCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCC
Q 037916          473 GDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEM  552 (741)
Q Consensus       473 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~  552 (741)
                      .....++||||+++|+|.+++......    .....+++..++.++.|++.||+|||+.   ||+||||||+||+++.++
T Consensus       102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~  174 (323)
T 3qup_A          102 RLPIPMVILPFMKHGDLHAFLLASRIG----ENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDM  174 (323)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHHHC-------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTS
T ss_pred             CCCccEEEEEeccCCcHHHHHHhhhcc----ccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCC
Confidence            111348999999999999998643111    1123588999999999999999999999   999999999999999999


Q ss_pred             ceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhh
Q 037916          553 TAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNF  631 (741)
Q Consensus       553 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~  631 (741)
                      .+||+|||.+................+++.|+||| ...+..++.++||||+||++|+|++ |..||......  .....
T Consensus       175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~  251 (323)
T 3qup_A          175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALE-SLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA--EIYNY  251 (323)
T ss_dssp             CEEECCCCC-----------------CCGGGCCHH-HHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHH
T ss_pred             CEEEeeccccccccccccccccccccCcccccCch-hhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH--HHHHH
Confidence            99999999998765544333333445788999995 4456678999999999999999999 89998632211  11100


Q ss_pred             hhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHhhc
Q 037916          632 ARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSILL  711 (741)
Q Consensus       632 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~  711 (741)
                                 +........                   ...+++.+.+++.+||+.||++|||+.|+++.|+++.....
T Consensus       252 -----------~~~~~~~~~-------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~  301 (323)
T 3qup_A          252 -----------LIGGNRLKQ-------------------PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS  301 (323)
T ss_dssp             -----------HHTTCCCCC-------------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             -----------HhcCCCCCC-------------------CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence                       000000000                   11334568899999999999999999999999999987544

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.2e-40  Score=341.92  Aligned_cols=256  Identities=23%  Similarity=0.360  Sum_probs=203.1

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      ..|++.+.||+|+||.||+|.+. ++..||+|+++... ...+.+.+|+.++++++||||+++++++     ......++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   80 (268)
T 3sxs_A            8 EEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVC-----SKEYPIYI   80 (268)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSEEE
T ss_pred             hheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCceEE
Confidence            35788899999999999999887 67789999997533 2346788999999999999999999995     45567899


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      ||||+++++|.+++...         ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        81 v~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Df  148 (268)
T 3sxs_A           81 VTEYISNGCLLNYLRSH---------GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDF  148 (268)
T ss_dssp             EEECCTTCBHHHHHHHH---------GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCT
T ss_pred             EEEccCCCcHHHHHHHc---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccC
Confidence            99999999999998632         24589999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcCCc
Q 037916          560 GLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       560 g~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      |.+.......... .....+|+.|+||| ...+..++.++||||+|+++|+|++ |..||.......     ....    
T Consensus       149 g~~~~~~~~~~~~-~~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----~~~~----  217 (268)
T 3sxs_A          149 GMTRYVLDDQYVS-SVGTKFPVKWSAPE-VFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE-----VVLK----  217 (268)
T ss_dssp             TCEEECCTTCEEE-CCSCCCCGGGCCHH-HHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH-----HHHH----
T ss_pred             ccceecchhhhhc-ccCCCcCcccCCHH-HHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH-----HHHH----
Confidence            9998765543222 23345778899995 4556678999999999999999999 999986321110     0000    


Q ss_pred             chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHH
Q 037916          639 HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKS  708 (741)
Q Consensus       639 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  708 (741)
                          .........                   +...++.+.+++.+||+.||++|||+.|+++.|+.+.+
T Consensus       218 ----~~~~~~~~~-------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          218 ----VSQGHRLYR-------------------PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             ----HHTTCCCCC-------------------CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             ----HHcCCCCCC-------------------CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence                000000000                   00123467899999999999999999999999988864

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=4.4e-40  Score=342.99  Aligned_cols=273  Identities=18%  Similarity=0.183  Sum_probs=206.6

Q ss_pred             HHHHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          396 ILLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       396 ~~~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      ..+..+|++.+.||+|+||.||+|++..+++.||+|++...  .....+.+|+.+++.++|++++..+.++    .....
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~l~~l~~~~~i~~~~~~----~~~~~   78 (296)
T 4hgt_A            5 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWC----GAEGD   78 (296)
T ss_dssp             ------CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEE----EEETT
T ss_pred             cccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccc--ccchHHHHHHHHHHHhcCCCCCCeeeee----cCCCC
Confidence            34557899999999999999999999889999999987642  3345688999999999988877777665    34566


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEe---CCCC
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLL---DHEM  552 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll---~~~~  552 (741)
                      ..++||||+ +++|.+++...         ...+++..+..++.|++.||.|||+.   +|+||||||+||++   +.++
T Consensus        79 ~~~lv~e~~-~~~L~~~~~~~---------~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~  145 (296)
T 4hgt_A           79 YNVMVMELL-GPSLEDLFNFC---------SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGN  145 (296)
T ss_dssp             EEEEEEECC-CCBHHHHHHHT---------TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTT
T ss_pred             ceEEEEEcc-CCCHHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCC
Confidence            889999999 99999998632         24589999999999999999999999   99999999999999   7888


Q ss_pred             ceEEeecccccccCCCCcc-----cccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcc
Q 037916          553 TAHVADFGLAKLLPPAHLQ-----TSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMN  627 (741)
Q Consensus       553 ~~kL~DFg~a~~~~~~~~~-----~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~  627 (741)
                      .+||+|||.+.........     .......||+.|+|| |...+..++.++||||+||++|+|++|+.||.........
T Consensus       146 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aP-E~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  224 (296)
T 4hgt_A          146 LVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI-NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR  224 (296)
T ss_dssp             CEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCH-HHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS
T ss_pred             eEEEecCccceeccCcccCccCCCCcccccCCCccccch-HHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhh
Confidence            9999999999876544221     112235699999999 5556777999999999999999999999999743221110


Q ss_pred             hhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHH
Q 037916          628 LHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIK  707 (741)
Q Consensus       628 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  707 (741)
                        ...        ..+........               .......+++.+.+++.+||+.||++|||+.||++.|+++.
T Consensus       225 --~~~--------~~~~~~~~~~~---------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~  279 (296)
T 4hgt_A          225 --QKY--------ERISEKKMSTP---------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF  279 (296)
T ss_dssp             --SHH--------HHHHHHHHHSC---------------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred             --hhh--------hhhhcccccch---------------hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence              000        00000000000               00000123567889999999999999999999999999999


Q ss_pred             HhhcCC
Q 037916          708 SILLGP  713 (741)
Q Consensus       708 ~~~~~~  713 (741)
                      +....+
T Consensus       280 ~~~~~~  285 (296)
T 4hgt_A          280 HRQGFS  285 (296)
T ss_dssp             HHHTCC
T ss_pred             HHhCCC
Confidence            877643

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2e-40  Score=357.21  Aligned_cols=252  Identities=19%  Similarity=0.246  Sum_probs=200.2

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      ..|++.+.||+|+||.||+|.+..+++.||+|++..........+.+|+.++++++||||+++++++     .+....++
T Consensus        51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~~~l  125 (387)
T 1kob_A           51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYEMVL  125 (387)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSSEEEE
T ss_pred             cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEE-----EeCCEEEE
Confidence            4688999999999999999999999999999999754444455788999999999999999999994     45668999


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCC--CCceEEe
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDH--EMTAHVA  557 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~--~~~~kL~  557 (741)
                      ||||+++|+|.+++...         ...+++..+..++.||+.||+|||+.   ||+||||||+||+++.  ++.+||+
T Consensus       126 v~E~~~gg~L~~~l~~~---------~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~  193 (387)
T 1kob_A          126 ILEFLSGGELFDRIAAE---------DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKII  193 (387)
T ss_dssp             EEECCCCCBHHHHTTCT---------TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEEC
T ss_pred             EEEcCCCCcHHHHHHhh---------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEE
Confidence            99999999999998643         23588999999999999999999999   9999999999999974  4689999


Q ss_pred             ecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCC
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      |||++.........   ....||+.|+|| |+..+..++.++||||+||++|||++|..||...... ..+.........
T Consensus       194 DFG~a~~~~~~~~~---~~~~gt~~y~aP-E~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-~~~~~i~~~~~~  268 (387)
T 1kob_A          194 DFGLATKLNPDEIV---KVTTATAEFAAP-EIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-ETLQNVKRCDWE  268 (387)
T ss_dssp             CCTTCEECCTTSCE---EEECSSGGGCCH-HHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHHCCCC
T ss_pred             ecccceecCCCcce---eeeccCCCccCc-hhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCC
Confidence            99999876544322   224589999999 5556778899999999999999999999998632110 000000000000


Q ss_pred             cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          638 DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       638 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                                  ....                .....+..+.+++.+||+.||++|||+.|+++
T Consensus       269 ------------~~~~----------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          269 ------------FDED----------------AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             ------------CCSS----------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ------------CCcc----------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                        0000                00123456889999999999999999999986

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.5e-40  Score=350.62  Aligned_cols=246  Identities=20%  Similarity=0.259  Sum_probs=200.3

Q ss_pred             HHHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc--------CcchhHHHHHHHHHhcCCCceeeEeeeecC
Q 037916          397 LLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH--------GASKSSIAECSALRNIRHKNLVKILTVCSG  468 (741)
Q Consensus       397 ~~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  468 (741)
                      .+..+|++.+.||+|+||.||+|++..+++.||+|+++....        .....+.+|+.++++++||||+++++++  
T Consensus        21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~--   98 (335)
T 3dls_A           21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF--   98 (335)
T ss_dssp             HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE--
T ss_pred             ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE--
Confidence            466889999999999999999999999999999999975321        1334667899999999999999999994  


Q ss_pred             ccccCCceEEEEEecccCC-ChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeE
Q 037916          469 VDYKGDDFKALVYEFMHNG-SLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVL  547 (741)
Q Consensus       469 ~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIl  547 (741)
                         .+....++||||+.+| +|.+++...          ..+++..+..++.|++.||+|||+.   +|+||||||+||+
T Consensus        99 ---~~~~~~~lv~e~~~~g~~l~~~~~~~----------~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIl  162 (335)
T 3dls_A           99 ---ENQGFFQLVMEKHGSGLDLFAFIDRH----------PRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIV  162 (335)
T ss_dssp             ---ECSSEEEEEEECCTTSCBHHHHHHTC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred             ---eeCCEEEEEEEeCCCCccHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEE
Confidence               5566899999998766 999998643          4588999999999999999999999   9999999999999


Q ss_pred             eCCCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcc
Q 037916          548 LDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMN  627 (741)
Q Consensus       548 l~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~  627 (741)
                      ++.++.+||+|||.+.........   ....||+.|+|||.+.....++.++||||+||++|+|++|..||.....    
T Consensus       163 l~~~~~~kL~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----  235 (335)
T 3dls_A          163 IAEDFTIKLIDFGSAAYLERGKLF---YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE----  235 (335)
T ss_dssp             ECTTSCEEECCCTTCEECCTTCCB---CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG----
T ss_pred             EcCCCcEEEeecccceECCCCCce---eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH----
Confidence            999999999999999876554322   2256899999996554444458899999999999999999999863211    


Q ss_pred             hhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          628 LHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       628 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                         .......            ..                    ..+.+.+.+++.+||+.||++|||+.|+++.
T Consensus       236 ---~~~~~~~------------~~--------------------~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          236 ---TVEAAIH------------PP--------------------YLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             ---GTTTCCC------------CS--------------------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             ---HHhhccC------------CC--------------------cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               0000000            00                    0123457899999999999999999999875

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.9e-40  Score=342.79  Aligned_cols=254  Identities=25%  Similarity=0.400  Sum_probs=198.6

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCc-------chhHHHHHHHHHhcCCCceeeEeeeecCcccc
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGA-------SKSSIAECSALRNIRHKNLVKILTVCSGVDYK  472 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  472 (741)
                      ..|++.+.||+|+||.||+|++..+++.||+|++.......       .+.+.+|+.++++++||||+++++++.     
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----   93 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH-----   93 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET-----
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeec-----
Confidence            45788899999999999999999899999999986433222       257789999999999999999999953     


Q ss_pred             CCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCC--ceecCCCCCCeEeCC
Q 037916          473 GDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPT--TAHCDLKPSNVLLDH  550 (741)
Q Consensus       473 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~--ivHrDlkp~NIll~~  550 (741)
                      +..  ++||||+++++|.+++...         ...+++..++.++.|++.||+|||+.   +  |+||||||+||+++.
T Consensus        94 ~~~--~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~  159 (287)
T 4f0f_A           94 NPP--RMVMEFVPCGDLYHRLLDK---------AHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQS  159 (287)
T ss_dssp             TTT--EEEEECCTTCBHHHHHHCT---------TSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESC
T ss_pred             CCC--eEEEEecCCCCHHHHHhcc---------cCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEec
Confidence            222  6999999999998887533         24588999999999999999999999   8  999999999999988


Q ss_pred             CCc-----eEEeecccccccCCCCcccccccccccccccCccccc-CCCCCCCccCchhHHHHHHHHHcCCCCCCccccC
Q 037916          551 EMT-----AHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG-LGSEVSINGDVYSYGILLLELMTRKRPSDIMFEG  624 (741)
Q Consensus       551 ~~~-----~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~-~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~  624 (741)
                      ++.     +||+|||.++.....     .....||+.|+|||.+. ....++.++||||+||++|+|++|+.||......
T Consensus       160 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~  234 (287)
T 4f0f_A          160 LDENAPVCAKVADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG  234 (287)
T ss_dssp             CCTTCSCCEEECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC
T ss_pred             cCCCCceeEEeCCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccccc
Confidence            776     999999999754332     22356899999996553 3456789999999999999999999998633222


Q ss_pred             CcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHH
Q 037916          625 NMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQ  704 (741)
Q Consensus       625 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  704 (741)
                      ..........           .......                  +..+++.+.+++.+||+.||++|||+.|+++.|+
T Consensus       235 ~~~~~~~~~~-----------~~~~~~~------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~  285 (287)
T 4f0f_A          235 KIKFINMIRE-----------EGLRPTI------------------PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS  285 (287)
T ss_dssp             HHHHHHHHHH-----------SCCCCCC------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHHhc-----------cCCCCCC------------------CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence            1111111110           0000000                  1133467889999999999999999999999998


Q ss_pred             HH
Q 037916          705 SI  706 (741)
Q Consensus       705 ~i  706 (741)
                      ++
T Consensus       286 ~l  287 (287)
T 4f0f_A          286 EL  287 (287)
T ss_dssp             TC
T ss_pred             hC
Confidence            64

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.3e-40  Score=356.42  Aligned_cols=254  Identities=20%  Similarity=0.204  Sum_probs=189.1

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      .+|++.+.||+|+||.||+|++..+++.||+|++... ....+.+.+|+.+++.++||||+++++++     ......++
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~~~~l   93 (361)
T 3uc3_A           20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERG-AAIDENVQREIINHRSLRHPNIVRFKEVI-----LTPTHLAI   93 (361)
T ss_dssp             TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESS-TTSCHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSEEEE
T ss_pred             CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecC-ccccHHHHHHHHHHHhCCCCCCCcEEEEE-----eeCCEEEE
Confidence            4688999999999999999999999999999999753 23356788999999999999999999995     45668999


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCc--eEEe
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMT--AHVA  557 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~--~kL~  557 (741)
                      ||||+++|+|.+++...          ..+++..++.++.|++.||+|||+.   ||+||||||+||+++.++.  +||+
T Consensus        94 v~e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~  160 (361)
T 3uc3_A           94 IMEYASGGELYERICNA----------GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKIC  160 (361)
T ss_dssp             EEECCCSCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEEC
T ss_pred             EEEeCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEe
Confidence            99999999999998532          4588999999999999999999999   9999999999999987765  9999


Q ss_pred             ecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCC
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      |||+++.......   .....||+.|+|||.+......+.++||||+||++|+|++|+.||....... .+.......  
T Consensus       161 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~~~~~~--  234 (361)
T 3uc3_A          161 DFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR-DYRKTIQRI--  234 (361)
T ss_dssp             CCCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC-CHHHHHHHH--
T ss_pred             ecCccccccccCC---CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH-HHHHHHHHH--
Confidence            9999875433221   1234699999999655444444555999999999999999999997432211 111111111  


Q ss_pred             cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          638 DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       638 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                            .........                  .....+.+.+++.+||+.||++|||+.|+++-
T Consensus       235 ------~~~~~~~~~------------------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          235 ------LSVKYSIPD------------------DIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             ------HTTCCCCCT------------------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             ------hcCCCCCCC------------------cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence                  000000000                  00123567899999999999999999999864

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=6e-41  Score=357.41  Aligned_cols=272  Identities=24%  Similarity=0.355  Sum_probs=205.4

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEc-----CCCeEEEEEEeeccCc-CcchhHHHHHHHHHhcCCCceeeEeeeecCcccc
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILD-----EGKTIIAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKILTVCSGVDYK  472 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  472 (741)
                      ...|++.+.||+|+||.||+|++.     .+++.||+|+++.... ...+.+.+|+.++++++||||+++++++     .
T Consensus        46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~  120 (343)
T 1luf_A           46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC-----A  120 (343)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----C
T ss_pred             HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----c
Confidence            356888999999999999999996     3558999999974322 2345688999999999999999999995     4


Q ss_pred             CCceEEEEEecccCCChhhhccCCCCCC--------------cccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCcee
Q 037916          473 GDDFKALVYEFMHNGSLEEWLHPVSGAD--------------KTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAH  538 (741)
Q Consensus       473 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------------~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH  538 (741)
                      .....++||||+++|+|.+++.......              ........+++.+++.++.||++||.|||+.   +|+|
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH  197 (343)
T 1luf_A          121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVH  197 (343)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence            4567899999999999999987532110              0000125689999999999999999999999   9999


Q ss_pred             cCCCCCCeEeCCCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCC
Q 037916          539 CDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRP  617 (741)
Q Consensus       539 rDlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p  617 (741)
                      |||||+||+++.++.+||+|||.+................+|+.|+|||. ..+..++.++|||||||++|||++ |..|
T Consensus       198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~-~~~~~~~~~~Di~slG~il~el~t~g~~p  276 (343)
T 1luf_A          198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPES-IFYNRYTTESDVWAYGVVLWEIFSYGLQP  276 (343)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHH-HHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhh-hccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence            99999999999999999999999987654433233333568899999954 455678999999999999999999 9999


Q ss_pred             CCccccCCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHH
Q 037916          618 SDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMT  697 (741)
Q Consensus       618 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  697 (741)
                      |.....     ......        +.+......                   +..++..+.+++.+||+.||++|||+.
T Consensus       277 ~~~~~~-----~~~~~~--------~~~~~~~~~-------------------~~~~~~~l~~li~~~l~~~p~~Rps~~  324 (343)
T 1luf_A          277 YYGMAH-----EEVIYY--------VRDGNILAC-------------------PENCPLELYNLMRLCWSKLPADRPSFC  324 (343)
T ss_dssp             TTTSCH-----HHHHHH--------HHTTCCCCC-------------------CTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCCCh-----HHHHHH--------HhCCCcCCC-------------------CCCCCHHHHHHHHHHcccCcccCCCHH
Confidence            863211     111100        000000000                   013345688999999999999999999


Q ss_pred             HHHHHHHHHHHhhc
Q 037916          698 IVVHELQSIKSILL  711 (741)
Q Consensus       698 evl~~L~~i~~~~~  711 (741)
                      |+++.|+++.+.+.
T Consensus       325 ~~~~~L~~~~~~~~  338 (343)
T 1luf_A          325 SIHRILQRMCERAE  338 (343)
T ss_dssp             HHHHHHHHTTC---
T ss_pred             HHHHHHHHHHhhhh
Confidence            99999999886554

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=7.1e-41  Score=351.71  Aligned_cols=277  Identities=19%  Similarity=0.218  Sum_probs=197.0

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcC--cchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG--ASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      .+|++++.||+|+||.||+|++..+++.||+|++......  ..+.+.+|+.++++++||||+++++++     ......
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~   77 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVF-----RRKRRL   77 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhhee-----ecCCeE
Confidence            4688899999999999999999989999999998643222  235567899999999999999999995     455689


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      ++||||+++++|.+++...          ..+++..+..++.|++.||+|||+.   ||+||||||+||+++.++.+||+
T Consensus        78 ~lv~e~~~~~~l~~~~~~~----------~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~  144 (311)
T 4agu_A           78 HLVFEYCDHTVLHELDRYQ----------RGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLC  144 (311)
T ss_dssp             EEEEECCSEEHHHHHHHTS----------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred             EEEEEeCCCchHHHHHhhh----------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEe
Confidence            9999999999999887533          4588999999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCC
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      |||.+.........  .....||+.|+|||.+.....++.++||||+||++|+|++|..||......+  ..........
T Consensus       145 Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~  220 (311)
T 4agu_A          145 DFGFARLLTGPSDY--YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVD--QLYLIRKTLG  220 (311)
T ss_dssp             CCTTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHC
T ss_pred             eCCCchhccCcccc--cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhc
Confidence            99999876543222  1234689999999766556788999999999999999999999986432111  1111111000


Q ss_pred             ---cchhHhhhh-cccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          638 ---DHVMDIVDS-TLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       638 ---~~~~~~~d~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                         +.....+.. ...............    .........+..+.+++.+||+.||++|||+.|+++-
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          221 DLIPRHQQVFSTNQYFSGVKIPDPEDME----PLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             SCCHHHHHHHHTCGGGTTCCCCCCSSCC----CHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccccccccCcCCCccccc----hhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence               000011100 000000000000000    0000012345668899999999999999999999853

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.9e-40  Score=346.09  Aligned_cols=260  Identities=25%  Similarity=0.334  Sum_probs=196.4

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      ..|++.+.||+|+||.||+|++.  ++.||+|+++.  ....+.+.+|+.++++++||||+++++++.       +..++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-------~~~~l   76 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACL-------NPVCL   76 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT-------TTTEE
T ss_pred             hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc-------CCcEE
Confidence            45778899999999999999985  78899999863  334567889999999999999999999853       23689


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCc-eEEee
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMT-AHVAD  558 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~-~kL~D  558 (741)
                      ||||+++++|.+++....       ....+++..++.++.|+++||+|||+....+|+||||||+||+++.++. +||+|
T Consensus        77 v~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~D  149 (307)
T 2eva_A           77 VMEYAEGGSLYNVLHGAE-------PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICD  149 (307)
T ss_dssp             EEECCTTCBHHHHHHCSS-------SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECC
T ss_pred             EEEcCCCCCHHHHHhccC-------CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcc
Confidence            999999999999997441       1234788889999999999999999921129999999999999998886 79999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCc
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      ||.+.......     ....||+.|+||| +..+..++.++|||||||++|||++|+.||....................
T Consensus       150 fg~~~~~~~~~-----~~~~gt~~y~aPE-~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  223 (307)
T 2eva_A          150 FGTACDIQTHM-----TNNKGSAAWMAPE-VFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP  223 (307)
T ss_dssp             CCC-----------------CCTTSSCHH-HHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCC
T ss_pred             ccccccccccc-----ccCCCCCceEChh-hhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCC
Confidence            99997554321     2245899999994 55677889999999999999999999999863221111000000000000


Q ss_pred             chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHhhcCC
Q 037916          639 HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSILLGP  713 (741)
Q Consensus       639 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~  713 (741)
                                  .                  ....++..+.+++.+||+.||++|||+.|+++.|+.+.+..+..
T Consensus       224 ------------~------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~  268 (307)
T 2eva_A          224 ------------P------------------LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGA  268 (307)
T ss_dssp             ------------C------------------CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCT
T ss_pred             ------------C------------------cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCC
Confidence                        0                  00123456789999999999999999999999999998877643

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=4.4e-40  Score=340.74  Aligned_cols=257  Identities=23%  Similarity=0.359  Sum_probs=201.0

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      ..|++.+.||+|+||.||+|.+. ++..||+|+++... ...+.+.+|+.++++++||||+++++++     .+....++
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   96 (283)
T 3gen_A           24 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC-----TKQRPIFI   96 (283)
T ss_dssp             GGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSSEEE
T ss_pred             HHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEE-----ecCCCeEE
Confidence            35788899999999999999987 67889999997432 2346788999999999999999999995     45668999


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      ||||+++++|.+++...         ...+++.+++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+||
T Consensus        97 v~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Df  164 (283)
T 3gen_A           97 ITEYMANGCLLNYLREM---------RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDF  164 (283)
T ss_dssp             EECCCTTCBHHHHHHCG---------GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECST
T ss_pred             EEeccCCCcHHHHHHHh---------ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccc
Confidence            99999999999998642         24588999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcCCc
Q 037916          560 GLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       560 g~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      |.+......... ......+|+.|+||| +..+..++.++||||+|+++|+|++ |+.||......  ........    
T Consensus       165 g~~~~~~~~~~~-~~~~~~~~~~y~aPE-~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~----  236 (283)
T 3gen_A          165 GLSRYVLDDEYT-SSVGSKFPVRWSPPE-VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETAEHIAQ----  236 (283)
T ss_dssp             TGGGGBCCHHHH-STTSTTSCGGGCCHH-HHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHHHHHT----
T ss_pred             cccccccccccc-cccCCccCcccCCHH-HhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh--HHHHHHhc----
Confidence            999876543221 222344788999995 4456678999999999999999998 99998632111  00000000    


Q ss_pred             chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHh
Q 037916          639 HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSI  709 (741)
Q Consensus       639 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  709 (741)
                              ......                  +...++.+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus       237 --------~~~~~~------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          237 --------GLRLYR------------------PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             --------TCCCCC------------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --------ccCCCC------------------CCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence                    000000                  011235678999999999999999999999999998764

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=5.7e-41  Score=352.30  Aligned_cols=267  Identities=19%  Similarity=0.233  Sum_probs=194.6

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcC---cchhHHHHHHHHHhcCCCceeeEeeeecCccccCCce
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG---ASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      .+|++.+.||+|+||.||+|++..+++.||+|+++.....   ....+.+|+.++++++||||+++++++.... ..+..
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~~~   90 (311)
T 3ork_A           12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGPL   90 (311)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-TTEEE
T ss_pred             CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-CCCcc
Confidence            4688999999999999999999989999999999753222   2346788999999999999999999864322 12235


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .|+||||+++++|.+++...          ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl  157 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTE----------GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKV  157 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHH----------CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEE
T ss_pred             cEEEEecCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEE
Confidence            69999999999999998632          4588999999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcc-cccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhc
Q 037916          557 ADFGLAKLLPPAHLQ-TSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV  635 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~-~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~  635 (741)
                      +|||.+......... .......||+.|+||| +..+..++.++||||+||++|+|++|+.||........... .....
T Consensus       158 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE-~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~-~~~~~  235 (311)
T 3ork_A          158 MDFGIARAIADSGNSVTQTAAVIGTAQYLSPE-QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ-HVRED  235 (311)
T ss_dssp             CCCSCC------------------CCTTCCHH-HHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-HHHCC
T ss_pred             eeccCcccccccccccccccccCcCcccCCHH-HhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH-HhcCC
Confidence            999999876543221 1222355899999995 44567889999999999999999999999863211110000 00000


Q ss_pred             CCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHH-HHHHHHHHHHhh
Q 037916          636 LPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTI-VVHELQSIKSIL  710 (741)
Q Consensus       636 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e-vl~~L~~i~~~~  710 (741)
                      ... .                           .......+..+.+++.+||+.||++||++.+ +.+.+..+....
T Consensus       236 ~~~-~---------------------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~  283 (311)
T 3ork_A          236 PIP-P---------------------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGE  283 (311)
T ss_dssp             CCC-H---------------------------HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTC
T ss_pred             CCC-c---------------------------ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCC
Confidence            000 0                           0001123466889999999999999996555 555666665443

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.3e-40  Score=353.00  Aligned_cols=250  Identities=22%  Similarity=0.236  Sum_probs=183.6

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      ..|++.+.||+|+||.||+|++..+++.||+|+++..  ...+.+.+|+.++++++||||+++++++     ......++
T Consensus        53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~l  125 (349)
T 2w4o_A           53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIF-----ETPTEISL  125 (349)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEE-----ECSSEEEE
T ss_pred             CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc--hhHHHHHHHHHHHHhCCCCCCcceeeeE-----ecCCeEEE
Confidence            4588899999999999999999989999999999743  2345678899999999999999999995     45568999


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCC---CCceEE
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDH---EMTAHV  556 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~---~~~~kL  556 (741)
                      ||||+++++|.+++...          ..+++.++..++.|++.||.|||+.   +|+||||||+||+++.   ++.+||
T Consensus       126 v~e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl  192 (349)
T 2w4o_A          126 VLELVTGGELFDRIVEK----------GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKI  192 (349)
T ss_dssp             EECCCCSCBHHHHHTTC----------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEE
T ss_pred             EEEeCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEE
Confidence            99999999999998643          4588999999999999999999999   9999999999999975   789999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcC
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVL  636 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  636 (741)
                      +|||+++.......   .....||+.|+||| +..+..++.++|||||||++|||++|..||.........+........
T Consensus       193 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE-~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~  268 (349)
T 2w4o_A          193 ADFGLSKIVEHQVL---MKTVCGTPGYCAPE-ILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEY  268 (349)
T ss_dssp             CCCC-------------------CGGGSCHH-HHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCC
T ss_pred             ccCccccccCcccc---cccccCCCCccCHH-HhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCC
Confidence            99999986644322   12356899999995 556678899999999999999999999998632211111111111000


Q ss_pred             CcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          637 PDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       637 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ..     ..+                       ...+.+..+.+++.+||+.||++|||+.|+++
T Consensus       269 ~~-----~~~-----------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          269 YF-----ISP-----------------------WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             CC-----CTT-----------------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             cc-----CCc-----------------------hhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00     000                       00123456789999999999999999999986

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1e-39  Score=344.38  Aligned_cols=253  Identities=19%  Similarity=0.205  Sum_probs=201.0

Q ss_pred             HHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcC------cchhHHHHHHHHHhcCCCceeeEeeeecCccc
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG------ASKSSIAECSALRNIRHKNLVKILTVCSGVDY  471 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  471 (741)
                      +...|++.+.||+|+||.||+|++..+++.||+|+++.....      ..+.+.+|+.++++++||||+++++++     
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----   84 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVY-----   84 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEE-----
Confidence            456799999999999999999999999999999999753322      245688999999999999999999994     


Q ss_pred             cCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCC
Q 037916          472 KGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHE  551 (741)
Q Consensus       472 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~  551 (741)
                      .+....++||||+++++|.+++...          ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.+
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~  151 (321)
T 2a2a_A           85 ENRTDVVLILELVSGGELFDFLAQK----------ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDK  151 (321)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHTC----------SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCT
T ss_pred             ecCCEEEEEEEcCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecC
Confidence            4566899999999999999998643          4578899999999999999999999   99999999999999988


Q ss_pred             C----ceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcc
Q 037916          552 M----TAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMN  627 (741)
Q Consensus       552 ~----~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~  627 (741)
                      +    .+||+|||.+.........   ....||+.|+||| +..+..++.++||||+||++|+|++|..||......   
T Consensus       152 ~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE-~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---  224 (321)
T 2a2a_A          152 NIPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---  224 (321)
T ss_dssp             TSSSCCEEECCCTTCEECCTTCCC---CCCCSCGGGCCHH-HHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---
T ss_pred             CCCcCCEEEccCccceecCccccc---cccCCCCCccCcc-cccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH---
Confidence            7    7999999999876554322   2345899999995 556678899999999999999999999998632110   


Q ss_pred             hhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          628 LHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       628 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                        .....        +.....  ...              .......++.+.+++.+||+.||++|||+.|+++
T Consensus       225 --~~~~~--------i~~~~~--~~~--------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          225 --ETLAN--------ITSVSY--DFD--------------EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             --HHHHH--------HHTTCC--CCC--------------HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             --HHHHH--------HHhccc--ccC--------------hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence              01000        000000  000              0001123456889999999999999999999986

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=3.7e-40  Score=350.30  Aligned_cols=251  Identities=23%  Similarity=0.270  Sum_probs=193.9

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcC---cchhHHHHHHHHHhc-CCCceeeEeeeecCccccCCc
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG---ASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      ..|++++.||+|+||.||+|++..+++.||+|+++.....   ..+.+.+|..+++++ +||||+++++++     .+..
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~~~   83 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTES   83 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSS
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE-----EeCC
Confidence            4688899999999999999999999999999999754322   234567899999887 899999999994     5566


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..|+||||+++|+|.+++...          ..+++..++.++.||+.||+|||+.   +|+||||||+||+++.++.+|
T Consensus        84 ~~~lv~e~~~gg~L~~~l~~~----------~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~k  150 (345)
T 3a8x_A           84 RLFFVIEYVNGGDLMFHMQRQ----------RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIK  150 (345)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEE
T ss_pred             EEEEEEeCCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEE
Confidence            899999999999999998632          4588999999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhc
Q 037916          556 VADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV  635 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~  635 (741)
                      |+|||+++.......  ......||+.|+|| |+..+..++.++||||+||++|||++|+.||.............    
T Consensus       151 L~DFG~a~~~~~~~~--~~~~~~gt~~y~aP-E~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~----  223 (345)
T 3a8x_A          151 LTDYGMCKEGLRPGD--TTSTFCGTPNYIAP-EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT----  223 (345)
T ss_dssp             ECCGGGCBCSCCTTC--CBCCCCSCGGGCCH-HHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------C----
T ss_pred             EEeccccccccCCCC--cccccCCCccccCc-cccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccccc----
Confidence            999999986433221  12235699999999 45566788999999999999999999999996322111000000    


Q ss_pred             CCcchh-HhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCH
Q 037916          636 LPDHVM-DIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNM  696 (741)
Q Consensus       636 ~~~~~~-~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  696 (741)
                       ..... .+......                    .+......+.+++.+||+.||++||++
T Consensus       224 -~~~~~~~i~~~~~~--------------------~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          224 -EDYLFQVILEKQIR--------------------IPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             -HHHHHHHHHHCCCC--------------------CCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             -HHHHHHHHHcCCCC--------------------CCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence             00000 01110000                    011234567899999999999999996

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=1.2e-39  Score=370.32  Aligned_cols=155  Identities=22%  Similarity=0.254  Sum_probs=76.8

Q ss_pred             CCCCcccccCChhhhhCCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCcc
Q 037916            3 VGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLK   82 (741)
Q Consensus         3 l~~n~~~~~ip~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~   82 (741)
                      ++.|.++ .||..++   ++|++|+|++|+|+++.|..|.++++|++|+|++|+|++..|.+|.++++          |+
T Consensus        12 ~~~~~l~-~ip~~~~---~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~----------L~   77 (549)
T 2z81_A           12 GRSRSFT-SIPSGLT---AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGS----------LE   77 (549)
T ss_dssp             CTTSCCS-SCCSCCC---TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTT----------CC
T ss_pred             CCCCccc-cccccCC---CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhcccccc----------CC
Confidence            3444444 4554443   45555555555555555555555555555555555555544455555443          55


Q ss_pred             EEECcCCcCcccCCchhhcccccccEEEccCCccccc-CCccccCCCCccEEEccccc-ccccCCccccCCCcCcEEEcc
Q 037916           83 HLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRS-IPAGIGKFINLQTLHMWDNQ-LSGTISPAIGELQNLVTLAIN  160 (741)
Q Consensus        83 ~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~-~~~~~~~l~~L~~L~L~~N~-i~~~~~~~~~~l~~L~~L~L~  160 (741)
                      +|+|++|++++..|..|..+. +|++|+|++|++.+. .|..|.++++|++|+|++|+ ++.+.+..|.++++|++|+|+
T Consensus        78 ~L~Ls~n~l~~~~~~~~~~l~-~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~  156 (549)
T 2z81_A           78 HLDLSDNHLSSLSSSWFGPLS-SLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIK  156 (549)
T ss_dssp             EEECTTSCCCSCCHHHHTTCT-TCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEE
T ss_pred             EEECCCCccCccCHHHhccCC-CCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeecc
Confidence            555555555544444454444 555555555555432 23445555555555555554 333333444555555555555


Q ss_pred             cCCCCCcCcccc
Q 037916          161 TNKLSGNIPPSI  172 (741)
Q Consensus       161 ~N~l~~~~~~~~  172 (741)
                      +|++++..|..|
T Consensus       157 ~n~l~~~~~~~l  168 (549)
T 2z81_A          157 ALSLRNYQSQSL  168 (549)
T ss_dssp             ETTCCEECTTTT
T ss_pred             CCcccccChhhh
Confidence            555544444443

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=9.1e-41  Score=346.94  Aligned_cols=263  Identities=25%  Similarity=0.357  Sum_probs=192.0

Q ss_pred             HHHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc--CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCC
Q 037916          397 LLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGD  474 (741)
Q Consensus       397 ~~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~  474 (741)
                      +....|++.++||+|+||.||+|++..   .||+|+++....  ...+.+.+|+.++++++||||+++++++      ..
T Consensus        21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~------~~   91 (289)
T 3og7_A           21 IPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS------TA   91 (289)
T ss_dssp             CCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE------CS
T ss_pred             cCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec------cC
Confidence            344568889999999999999998753   499999974332  2345678999999999999999999974      23


Q ss_pred             ceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCce
Q 037916          475 DFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTA  554 (741)
Q Consensus       475 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~  554 (741)
                      ...++||||+++++|.+++...         ...+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+
T Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~  159 (289)
T 3og7_A           92 PQLAIVTQWCEGSSLYHHLHAS---------ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTV  159 (289)
T ss_dssp             SSCEEEEECCCEEEHHHHHTTC------------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEE
T ss_pred             CccEEEEEecCCCcHHHHHhhc---------cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCE
Confidence            4579999999999999998633         24588999999999999999999999   99999999999999999999


Q ss_pred             EEeecccccccCCCCcccccccccccccccCccccc--CCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhh
Q 037916          555 HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG--LGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFA  632 (741)
Q Consensus       555 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~--~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~  632 (741)
                      ||+|||.+................||+.|+|||.+.  .+..++.++||||+||++|+|++|+.||....... ......
T Consensus       160 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~  238 (289)
T 3og7_A          160 KIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-QIIEMV  238 (289)
T ss_dssp             EECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH-HHHHHH
T ss_pred             EEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH-HHHHHh
Confidence            999999998655432222233356899999996553  25678889999999999999999999986332111 111111


Q ss_pred             hh-cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHH
Q 037916          633 RT-VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKS  708 (741)
Q Consensus       633 ~~-~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  708 (741)
                      .. ........        .                   ...+++.+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus       239 ~~~~~~~~~~~--------~-------------------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          239 GRGSLSPDLSK--------V-------------------RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             HHTSCCCCTTS--------S-------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             cccccCcchhh--------c-------------------cccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            11 11110000        0                   01345678899999999999999999999999998764

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.2e-40  Score=353.33  Aligned_cols=248  Identities=22%  Similarity=0.297  Sum_probs=197.0

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhc-CCCceeeEeeeecCccccCC
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKGD  474 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~  474 (741)
                      ...|++.+.||+|+||.||+|+++.+++.||+|+++...   ....+....|..+++.+ +||||++++++     +.+.
T Consensus        16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~-----~~~~   90 (345)
T 1xjd_A           16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCT-----FQTK   90 (345)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEE-----EECS
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEE-----EEeC
Confidence            357889999999999999999999999999999997432   23445677899999876 99999999999     4556


Q ss_pred             ceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCce
Q 037916          475 DFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTA  554 (741)
Q Consensus       475 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~  554 (741)
                      ...|+||||+++|+|.+++...          ..+++..+..++.||+.||+|||+.   ||+||||||+||+++.++.+
T Consensus        91 ~~~~lv~E~~~gg~L~~~l~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~v  157 (345)
T 1xjd_A           91 ENLFFVMEYLNGGDLMYHIQSC----------HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHI  157 (345)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCE
T ss_pred             CEEEEEEeCCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCE
Confidence            6899999999999999998642          4588999999999999999999999   99999999999999999999


Q ss_pred             EEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhh
Q 037916          555 HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       555 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  634 (741)
                      ||+|||+++........  .....||+.|+|| |+..+..++.++||||+||++|||++|..||.....     ......
T Consensus       158 kL~DFG~a~~~~~~~~~--~~~~~gt~~y~aP-E~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~~  229 (345)
T 1xjd_A          158 KIADFGMCKENMLGDAK--TNTFCGTPDYIAP-EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-----EELFHS  229 (345)
T ss_dssp             EECCCTTCBCCCCTTCC--BCCCCSCGGGCCH-HHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHH
T ss_pred             EEeEChhhhhcccCCCc--ccCCCCCcccCCh-hhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH-----HHHHHH
Confidence            99999999864332221  2335699999999 555667789999999999999999999999863211     111100


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHH-HHH
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMT-IVV  700 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl  700 (741)
                              +.....  ..                  +......+.+++.+||..||++||++. |++
T Consensus       230 --------i~~~~~--~~------------------p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          230 --------IRMDNP--FY------------------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             --------HHHCCC--CC------------------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             --------HHhCCC--CC------------------CcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence                    000000  00                  001235678999999999999999997 654

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-40  Score=346.15  Aligned_cols=245  Identities=23%  Similarity=0.234  Sum_probs=198.0

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCce
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      ..|++++.||+|+||.||+|++..+++.||+|+++...   ....+.+.+|+.+++.++||||+++++++     .+...
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~~   80 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQQ   80 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSSE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEE-----EeCCE
Confidence            46888999999999999999999999999999997432   23455678899999999999999999994     55668


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .|+||||+++|+|.+++...          ..+++..++.++.||+.||+|||+.   +|+||||||+||+++.++.+||
T Consensus        81 ~~lv~e~~~gg~L~~~l~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL  147 (318)
T 1fot_A           81 IFMIMDYIEGGELFSLLRKS----------QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKI  147 (318)
T ss_dssp             EEEEECCCCSCBHHHHHHHT----------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEE
T ss_pred             EEEEEeCCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEE
Confidence            99999999999999998643          4578899999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcC
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVL  636 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  636 (741)
                      +|||+++......     ....||+.|+||| +..+..++.++||||+||++|||++|+.||.....     ....    
T Consensus       148 ~Dfg~a~~~~~~~-----~~~~gt~~y~aPE-~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~----  212 (318)
T 1fot_A          148 TDFGFAKYVPDVT-----YTLCGTPDYIAPE-VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-----MKTY----  212 (318)
T ss_dssp             CCCSSCEECSSCB-----CCCCSCTTTCCHH-HHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHH----
T ss_pred             eecCcceecCCcc-----ccccCCccccCHh-HhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----HHHH----
Confidence            9999998754321     2356999999995 55677899999999999999999999999863211     0000    


Q ss_pred             CcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCC-----CHHHHHH
Q 037916          637 PDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRM-----NMTIVVH  701 (741)
Q Consensus       637 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  701 (741)
                          ..+......  .                  +......+.+++.+||..||++||     +++|+++
T Consensus       213 ----~~i~~~~~~--~------------------p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          213 ----EKILNAELR--F------------------PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             ----HHHHHCCCC--C------------------CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ----HHHHhCCCC--C------------------CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence                111111000  0                  012235678999999999999999     8888874

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=3.9e-41  Score=349.75  Aligned_cols=255  Identities=23%  Similarity=0.347  Sum_probs=198.4

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCC-------eEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCcccc
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGK-------TIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYK  472 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  472 (741)
                      ..|++.+.||+|+||.||+|++..++       ..||+|+++.......+.+.+|+.++++++||||+++++++     .
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~   82 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVC-----V   82 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEE-----C
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEE-----E
Confidence            45788899999999999999997655       57999999765556667889999999999999999999995     4


Q ss_pred             CCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCC
Q 037916          473 GDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEM  552 (741)
Q Consensus       473 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~  552 (741)
                      .+...++||||+++++|.+++...         ...+++..++.++.|++.||.|||+.   +|+||||||+||+++.++
T Consensus        83 ~~~~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~  150 (289)
T 4fvq_A           83 CGDENILVQEFVKFGSLDTYLKKN---------KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREE  150 (289)
T ss_dssp             CTTCCEEEEECCTTCBHHHHHHHT---------GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECC
T ss_pred             eCCCCEEEEECCCCCCHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCC
Confidence            455789999999999999999743         23488999999999999999999999   999999999999998887


Q ss_pred             c--------eEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccC
Q 037916          553 T--------AHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEG  624 (741)
Q Consensus       553 ~--------~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~  624 (741)
                      .        +||+|||.+......      ....||+.|+|||.+.....++.++||||+||++|||++|..|+......
T Consensus       151 ~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~  224 (289)
T 4fvq_A          151 DRKTGNPPFIKLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS  224 (289)
T ss_dssp             BGGGTBCCEEEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             cccccccceeeeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch
Confidence            6        999999998754332      12347889999966554477899999999999999999965543211111


Q ss_pred             CcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHH
Q 037916          625 NMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQ  704 (741)
Q Consensus       625 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  704 (741)
                      .. .......            .....                    ...+..+.+++.+||+.||++|||+.|+++.|+
T Consensus       225 ~~-~~~~~~~------------~~~~~--------------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~  271 (289)
T 4fvq_A          225 QR-KLQFYED------------RHQLP--------------------APKAAELANLINNCMDYEPDHRPSFRAIIRDLN  271 (289)
T ss_dssp             HH-HHHHHHT------------TCCCC--------------------CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             HH-HHHHhhc------------cCCCC--------------------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            00 0000000            00000                    011234679999999999999999999999999


Q ss_pred             HHHHhh
Q 037916          705 SIKSIL  710 (741)
Q Consensus       705 ~i~~~~  710 (741)
                      ++....
T Consensus       272 ~l~~p~  277 (289)
T 4fvq_A          272 SLFTPD  277 (289)
T ss_dssp             TCC---
T ss_pred             HhcCCC
Confidence            887533

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=7.3e-40  Score=337.93  Aligned_cols=252  Identities=19%  Similarity=0.232  Sum_probs=202.4

Q ss_pred             HHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceE
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      +..+|++.+.||+|+||.||+|.+..++..||+|++........+.+.+|+.++++++||||+++++++     .+....
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~   81 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF-----EDNTDI   81 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCeE
Confidence            457899999999999999999999999999999999866556677889999999999999999999995     456689


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEe---CCCCce
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLL---DHEMTA  554 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll---~~~~~~  554 (741)
                      ++||||+++++|.+++...          ..+++..+..++.|++.||+|||+.   +|+||||||+||++   +.++.+
T Consensus        82 ~lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~  148 (277)
T 3f3z_A           82 YLVMELCTGGELFERVVHK----------RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPL  148 (277)
T ss_dssp             EEEEECCCSCBHHHHHHHH----------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCE
T ss_pred             EEEEeccCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcE
Confidence            9999999999999988632          4588999999999999999999999   99999999999999   778899


Q ss_pred             EEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhh
Q 037916          555 HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       555 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  634 (741)
                      ||+|||.+.........   ....||+.|+|||.+ . +.++.++||||+|+++|+|++|+.||....... ........
T Consensus       149 ~l~Dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~-~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~  222 (277)
T 3f3z_A          149 KLIDFGLAARFKPGKMM---RTKVGTPYYVSPQVL-E-GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSE-VMLKIREG  222 (277)
T ss_dssp             EECCCTTCEECCTTSCB---CCCCSCTTTCCHHHH-T-TCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHC
T ss_pred             EEEecccceeccCccch---hccCCCCCccChHHh-c-ccCCchhhehhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhC
Confidence            99999999876544322   224589999999654 3 348999999999999999999999986321110 00000000


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ......                            ......++.+.+++.+||+.||++|||+.|+++
T Consensus       223 ~~~~~~----------------------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          223 TFTFPE----------------------------KDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             CCCCCH----------------------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCCCCc----------------------------hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            000000                            000123467889999999999999999999986

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=4.6e-40  Score=362.69  Aligned_cols=248  Identities=23%  Similarity=0.307  Sum_probs=199.5

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCce
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      +.|.+.+.||+|+||.||+|++..+|+.||+|+++...   ....+.+.+|+.+++.++||||+++++++     .....
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~-----~~~~~   90 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI-----STPSD   90 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCE
Confidence            46888999999999999999999999999999997432   23345788999999999999999999995     45568


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .|+||||+++|+|.+++...          ..+++..++.++.||+.||+|||+.   +|+||||||+||+++.++.+||
T Consensus        91 ~~lv~E~~~gg~L~~~l~~~----------~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL  157 (476)
T 2y94_A           91 IFMVMEYVSGGELFDYICKN----------GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKI  157 (476)
T ss_dssp             EEEEEECCSSEEHHHHTTSS----------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEE
T ss_pred             EEEEEeCCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEE
Confidence            99999999999999998643          4588999999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcC
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVL  636 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  636 (741)
                      +|||++.........   ....||+.|+|||.+......+.++||||+||++|+|++|+.||....     ......   
T Consensus       158 ~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~-----~~~~~~---  226 (476)
T 2y94_A          158 ADFGLSNMMSDGEFL---RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH-----VPTLFK---  226 (476)
T ss_dssp             CCCSSCEECCTTCCB---CCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS-----SHHHHH---
T ss_pred             Eeccchhhccccccc---cccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC-----HHHHHH---
Confidence            999999876554322   234699999999655444455789999999999999999999986321     111111   


Q ss_pred             CcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          637 PDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       637 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                           .+.+.... .                   +....+.+.+++.+||+.||++|||+.|+++
T Consensus       227 -----~i~~~~~~-~-------------------p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          227 -----KICDGIFY-T-------------------PQYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             -----HHHTTCCC-C-------------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -----HHhcCCcC-C-------------------CccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence                 11110000 0                   0012346789999999999999999999986

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.2e-40  Score=345.79  Aligned_cols=272  Identities=21%  Similarity=0.249  Sum_probs=194.5

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC--cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      +|++++.||+|+||.||+|++ .+++.||+|+++...  ....+.+.+|+.++++++||||+++++++     ......+
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~   76 (288)
T 1ob3_A            3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI-----HTKKRLV   76 (288)
T ss_dssp             SEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEE-----ECSSCEE
T ss_pred             cchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEE-----ccCCeEE
Confidence            478889999999999999999 478999999996432  22346788999999999999999999995     4556899


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      +||||+++ +|.+++...         ...+++..+..++.|++.||+|||+.   ||+||||||+||+++.++.+||+|
T Consensus        77 lv~e~~~~-~l~~~~~~~---------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~D  143 (288)
T 1ob3_A           77 LVFEHLDQ-DLKKLLDVC---------EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIAD  143 (288)
T ss_dssp             EEEECCSE-EHHHHHHTS---------TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECC
T ss_pred             EEEEecCC-CHHHHHHhc---------ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeE
Confidence            99999964 999888643         24578889999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCc
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      ||.+.........  .....||+.|+|||.+.....++.++||||+||++|+|++|+.||......+ .+..........
T Consensus       144 fg~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~  220 (288)
T 1ob3_A          144 FGLARAFGIPVRK--YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILGTP  220 (288)
T ss_dssp             TTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCC
T ss_pred             CccccccCccccc--cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHHCCC
Confidence            9999876433211  1224589999999766555678999999999999999999999986432111 111111110000


Q ss_pred             c---hhHhhh-hcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          639 H---VMDIVD-STLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       639 ~---~~~~~d-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      .   .....+ +.........       .............+.+.+++.+||+.||++|||+.|+++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          221 NSKNWPNVTELPKYDPNFTVY-------EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             CTTTSTTGGGSTTCCTTCCCC-------CCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             Chhhchhhhcccccccccccc-------cCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            0   000000 0000000000       000000001123456789999999999999999999875

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=5.7e-40  Score=362.63  Aligned_cols=282  Identities=20%  Similarity=0.166  Sum_probs=195.7

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeecc--CcCcchhHHHHHHHHHhcCCCceeeEeeeecCcc-ccCCc
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLL--HHGASKSSIAECSALRNIRHKNLVKILTVCSGVD-YKGDD  475 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~~~~  475 (741)
                      ..+|++++.||+|+||.||+|.+..+++.||+|++...  .....+.+.+|+.+++.++||||+++++++.... .++..
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            35789999999999999999999999999999999743  2233566789999999999999999999975432 13345


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..|+||||+++ ++.+.+.            ..+++..+..++.|++.||+|||+.   ||+||||||+|||++.++.+|
T Consensus       141 ~~~lv~E~~~~-~l~~~~~------------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~k  204 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQ------------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLK  204 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHT------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEE
T ss_pred             eEEEEEeCCCC-CHHHHHh------------hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEE
Confidence            78999999965 5666664            2378889999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhc
Q 037916          556 VADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV  635 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~  635 (741)
                      |+|||+|+.......   .....||+.|+||| +..+..++.++||||+||++|||++|+.||...... ..+.......
T Consensus       205 l~DFG~a~~~~~~~~---~~~~~gt~~y~aPE-~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~-~~~~~i~~~l  279 (464)
T 3ttj_A          205 ILDFGLARTAGTSFM---MTPYVVTRYYRAPE-VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQL  279 (464)
T ss_dssp             ECCCCCC-----CCC---C----CCCTTCCHH-HHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHH
T ss_pred             EEEEEeeeecCCCcc---cCCCcccccccCHH-HHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhc
Confidence            999999987654322   22356999999995 556678999999999999999999999998632111 1111111111


Q ss_pred             CC----------cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          636 LP----------DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       636 ~~----------~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ..          .....+++..............................+.+.+++.+||+.||++|||+.|+++
T Consensus       280 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          280 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             CSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00          0011111110000000000000000000000111233567899999999999999999999986

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.5e-40  Score=358.82  Aligned_cols=282  Identities=17%  Similarity=0.159  Sum_probs=199.6

Q ss_pred             HHHHHhhhcccC--ceeeEEEEEEcCCCeEEEEEEeeccCc--CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          400 VSFLFLCWIDMG--SFGSVYKGILDEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       400 ~~y~~~~~ig~G--~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      .+|++.+.||+|  +||.||+|++..+++.||+|+++....  ...+.+.+|+.++++++|||||++++++     ....
T Consensus        25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~   99 (389)
T 3gni_B           25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF-----IADN   99 (389)
T ss_dssp             GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETT
T ss_pred             CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEE-----EECC
Confidence            468899999999  999999999999999999999975332  2345677899999999999999999995     4566


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..|+||||+++|+|.+++...        ....+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+|
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~k  168 (389)
T 3gni_B          100 ELWVVTSFMAYGSAKDLICTH--------FMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVY  168 (389)
T ss_dssp             EEEEEEECCTTCBHHHHHHHT--------CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEE
T ss_pred             EEEEEEEccCCCCHHHHHhhh--------cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEE
Confidence            899999999999999998643        124488999999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCc-----ccccccccccccccCcccccCC-CCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchh
Q 037916          556 VADFGLAKLLPPAHL-----QTSSIGVKGTIGYIAPAEYGLG-SEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLH  629 (741)
Q Consensus       556 L~DFg~a~~~~~~~~-----~~~~~~~~gt~~y~aPEe~~~~-~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~  629 (741)
                      |+|||.+........     ........||+.|+|||.+... ..++.++||||+||++|||++|+.||.......... 
T Consensus       169 l~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-  247 (389)
T 3gni_B          169 LSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL-  247 (389)
T ss_dssp             ECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHH-
T ss_pred             EcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHH-
Confidence            999998865432211     1111224689999999665443 578999999999999999999999996432221111 


Q ss_pred             hhhhhcCCcchhHhhhhcccCC---------------cch---hhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCC
Q 037916          630 NFARTVLPDHVMDIVDSTLLAD---------------DED---LTITSNQRQRQARINNIMECLISVVRIGVACSMESPQ  691 (741)
Q Consensus       630 ~~~~~~~~~~~~~~~d~~l~~~---------------~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~  691 (741)
                      .......+    .+.+......               ..+   .....................+.+.+++.+||+.||+
T Consensus       248 ~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~  323 (389)
T 3gni_B          248 EKLNGTVP----CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPD  323 (389)
T ss_dssp             HC------------------------------------------------------------CCHHHHHHHHHHTCSCTT
T ss_pred             HHhcCCCC----ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcc
Confidence            11110000    0000000000               000   0000000000011112234456789999999999999


Q ss_pred             CCCCHHHHHHH
Q 037916          692 DRMNMTIVVHE  702 (741)
Q Consensus       692 ~RPs~~evl~~  702 (741)
                      +|||+.|+++-
T Consensus       324 ~Rpta~ell~h  334 (389)
T 3gni_B          324 ARPSASTLLNH  334 (389)
T ss_dssp             TSCCHHHHTTS
T ss_pred             cCCCHHHHhcC
Confidence            99999999854

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=8.2e-40  Score=357.42  Aligned_cols=255  Identities=20%  Similarity=0.235  Sum_probs=191.6

Q ss_pred             HHHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC--------cCcchhHHHHHHHHHhcCCCceeeEeeeecC
Q 037916          397 LLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH--------HGASKSSIAECSALRNIRHKNLVKILTVCSG  468 (741)
Q Consensus       397 ~~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  468 (741)
                      .+...|.+.+.||+|+||.||+|.+..+++.||+|++....        ......+.+|+.++++++||||+++++++  
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~--  209 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF--  209 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEE--
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEE--
Confidence            34567999999999999999999999999999999997432        11234578999999999999999999985  


Q ss_pred             ccccCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEe
Q 037916          469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLL  548 (741)
Q Consensus       469 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll  548 (741)
                         . ....|+||||+++|+|.+++...          ..+++..+..++.|++.||+|||+.   +|+||||||+||++
T Consensus       210 ---~-~~~~~lv~e~~~~g~L~~~l~~~----------~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll  272 (419)
T 3i6u_A          210 ---D-AEDYYIVLELMEGGELFDKVVGN----------KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLL  272 (419)
T ss_dssp             ---E-SSEEEEEEECCTTCBGGGGTSSS----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred             ---e-cCceEEEEEcCCCCcHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEE
Confidence               2 23579999999999999988643          4588999999999999999999999   99999999999999


Q ss_pred             CCCC---ceEEeecccccccCCCCcccccccccccccccCcccccC--CCCCCCccCchhHHHHHHHHHcCCCCCCcccc
Q 037916          549 DHEM---TAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGL--GSEVSINGDVYSYGILLLELMTRKRPSDIMFE  623 (741)
Q Consensus       549 ~~~~---~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~--~~~~~~~~DIwSlG~il~elltg~~p~~~~~~  623 (741)
                      +.++   .+||+|||+++........   ....||+.|+|||.+..  ...++.++||||+||++|+|++|..||.....
T Consensus       273 ~~~~~~~~~kl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~  349 (419)
T 3i6u_A          273 SSQEEDCLIKITDFGHSKILGETSLM---RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT  349 (419)
T ss_dssp             SSSSSSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS
T ss_pred             ecCCCcceEEEeecccceecCCCccc---cccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc
Confidence            7544   5999999999876543222   23569999999965532  46788999999999999999999999863221


Q ss_pred             CCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          624 GNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       624 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      . ..+.............+                           .....++.+.+++.+||+.||++|||+.|+++
T Consensus       350 ~-~~~~~~i~~~~~~~~~~---------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          350 Q-VSLKDQITSGKYNFIPE---------------------------VWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             S-CCHHHHHHTTCCCCCHH---------------------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             h-HHHHHHHhcCCCCCCch---------------------------hhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            1 11111111110000000                           01123466889999999999999999999886

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.4e-40  Score=347.85  Aligned_cols=273  Identities=24%  Similarity=0.321  Sum_probs=203.2

Q ss_pred             HHHHhhhcccCceeeEEEEE----EcCCCeEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          401 SFLFLCWIDMGSFGSVYKGI----LDEGKTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      .|++.+.||+|+||.||+|+    +..+++.||+|+++... ....+.+.+|+.++++++||||+++++++..   .+..
T Consensus        22 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~   98 (302)
T 4e5w_A           22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE---DGGN   98 (302)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC------C
T ss_pred             hhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEec---CCCc
Confidence            36778899999999999999    46689999999997433 2334678899999999999999999999642   2235


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..++||||+++++|.+++...         ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+|
T Consensus        99 ~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~k  166 (302)
T 4e5w_A           99 GIKLIMEFLPSGSLKEYLPKN---------KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVK  166 (302)
T ss_dssp             CEEEEEECCTTCBHHHHHHHH---------TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEE
T ss_pred             eEEEEEEeCCCCcHHHHHHhc---------cccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEE
Confidence            689999999999999998532         24588999999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcc-cccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhh
Q 037916          556 VADFGLAKLLPPAHLQ-TSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~-~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  634 (741)
                      |+|||.+......... .......||..|+||| ...+..++.++||||+||++|+|++|..|+......   .......
T Consensus       167 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~  242 (302)
T 4e5w_A          167 IGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPE-CLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL---FLKMIGP  242 (302)
T ss_dssp             ECCCTTCEECCTTCCEEECCCCTTCCGGGCCHH-HHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH---HHHHHCS
T ss_pred             ECcccccccccCCCcceeccCCCCCCccccCCe-eecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhH---HhhccCC
Confidence            9999999877654321 2223355888999995 445667889999999999999999999986422110   0000000


Q ss_pred             cCCcc-hhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHH
Q 037916          635 VLPDH-VMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIK  707 (741)
Q Consensus       635 ~~~~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  707 (741)
                      ..... ...........               .....+..+++.+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus       243 ~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          243 THGQMTVTRLVNTLKEG---------------KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             CCGGGHHHHHHHHHHTT---------------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cccccCHHHHHHHHhcc---------------CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            00000 01111100000               000111234567889999999999999999999999999875

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=4.3e-40  Score=346.10  Aligned_cols=272  Identities=23%  Similarity=0.364  Sum_probs=195.5

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcC---CCeEEEEEEeeccCc--CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCC
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDE---GKTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGD  474 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~  474 (741)
                      ..|.+.+.||+|+||.||+|.+..   ++..||+|+++....  ...+.+.+|+.++++++||||+++++++........
T Consensus        34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  113 (313)
T 3brb_A           34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGI  113 (313)
T ss_dssp             GGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC------
T ss_pred             HHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCC
Confidence            457788899999999999998864   566899999874322  234567899999999999999999999754432233


Q ss_pred             ceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCce
Q 037916          475 DFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTA  554 (741)
Q Consensus       475 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~  554 (741)
                      ...++||||+++++|.+++......    .....+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+
T Consensus       114 ~~~~~v~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~  186 (313)
T 3brb_A          114 PKPMVILPFMKYGDLHTYLLYSRLE----TGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTV  186 (313)
T ss_dssp             -CEEEEEECCTTCBHHHHHHHTTBT----TSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCE
T ss_pred             cccEEEEecccCCCHHHHHHHhhhh----cCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcE
Confidence            4579999999999999998432110    1235689999999999999999999999   99999999999999999999


Q ss_pred             EEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhh
Q 037916          555 HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFAR  633 (741)
Q Consensus       555 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~  633 (741)
                      ||+|||.+................+++.|+||| ...+..++.++|||||||++|+|++ |..||......  .......
T Consensus       187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~  263 (313)
T 3brb_A          187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIE-SLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH--EMYDYLL  263 (313)
T ss_dssp             EECSCSCC----------------CCGGGSCHH-HHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHHH
T ss_pred             EEeecCcceecccccccCcccccCCCccccCch-hhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH--HHHHHHH
Confidence            999999998765443323333345788999995 4556778999999999999999999 88898632111  1111100


Q ss_pred             hcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHhhc
Q 037916          634 TVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSILL  711 (741)
Q Consensus       634 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~  711 (741)
                                 .......                   +..+++.+.+++.+||+.||++|||+.|+++.|+++.+..+
T Consensus       264 -----------~~~~~~~-------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp  311 (313)
T 3brb_A          264 -----------HGHRLKQ-------------------PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP  311 (313)
T ss_dssp             -----------TTCCCCC-------------------BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             -----------cCCCCCC-------------------CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence                       0000000                   01334568899999999999999999999999999987654

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=9.2e-40  Score=340.59  Aligned_cols=269  Identities=18%  Similarity=0.190  Sum_probs=207.9

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      .+|++.+.||+|+||.||+|++..+++.||+|++...  ...+.+.+|+.+++.++|++++..+.++    .......++
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~l~~l~~~~~i~~~~~~----~~~~~~~~l   82 (296)
T 3uzp_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWC----GAEGDYNVM   82 (296)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESC--SSCCHHHHHHHHHHHHTTSTTCCCEEEE----EEETTEEEE
T ss_pred             cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCC--cchhHHHHHHHHHHHhhcCCCCCccccc----cCCCCceEE
Confidence            4688999999999999999999889999999998743  3346788999999999998877666665    345668899


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeC---CCCceEE
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLD---HEMTAHV  556 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~---~~~~~kL  556 (741)
                      ||||+ +++|.+++...         ...+++..+..++.|++.||+|||+.   +|+||||||+||+++   .++.+||
T Consensus        83 v~e~~-~~~L~~~~~~~---------~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl  149 (296)
T 3uzp_A           83 VMELL-GPSLEDLFNFC---------SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYI  149 (296)
T ss_dssp             EEECC-CCBHHHHHHHT---------TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEE
T ss_pred             EEEec-CCCHHHHHHhh---------ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEE
Confidence            99999 89999998632         24588999999999999999999999   999999999999994   7889999


Q ss_pred             eecccccccCCCCcc-----cccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhh
Q 037916          557 ADFGLAKLLPPAHLQ-----TSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNF  631 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~-----~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~  631 (741)
                      +|||.+.........     .......||+.|+|| |...+..++.++|||||||++|+|++|+.||.........  ..
T Consensus       150 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP-E~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~  226 (296)
T 3uzp_A          150 IDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI-NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR--QK  226 (296)
T ss_dssp             CCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCH-HHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS--SH
T ss_pred             eeCCCcccccccccccccccccccccccccccCCh-hhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhh--hh
Confidence            999999876544321     112335699999999 5556777899999999999999999999999743211100  00


Q ss_pred             hhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHhhc
Q 037916          632 ARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSILL  711 (741)
Q Consensus       632 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~  711 (741)
                              ...+........               .......+++.+.+++.+||+.||++|||+.||++.|+.+.+...
T Consensus       227 --------~~~~~~~~~~~~---------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~  283 (296)
T 3uzp_A          227 --------YERISEKKMSTP---------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             --------HHHHHHHHHHSC---------------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             --------hhhhcccccCCc---------------hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence                    000000000000               000011335678899999999999999999999999999998766


Q ss_pred             CC
Q 037916          712 GP  713 (741)
Q Consensus       712 ~~  713 (741)
                      .+
T Consensus       284 ~~  285 (296)
T 3uzp_A          284 FS  285 (296)
T ss_dssp             CC
T ss_pred             Cc
Confidence            43

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-40  Score=351.30  Aligned_cols=272  Identities=21%  Similarity=0.284  Sum_probs=202.9

Q ss_pred             HHHHHhhhcccCceeeEEEEEE-----cCCCeEEEEEEeecc-CcCcchhHHHHHHHHHhc-CCCceeeEeeeecCcccc
Q 037916          400 VSFLFLCWIDMGSFGSVYKGIL-----DEGKTIIAVKVLNLL-HHGASKSSIAECSALRNI-RHKNLVKILTVCSGVDYK  472 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~-----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~  472 (741)
                      ..|.+.+.||+|+||.||+|++     ..++..||+|+++.. .....+.+.+|+.+++++ +||||+++++++     .
T Consensus        45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-----~  119 (344)
T 1rjb_A           45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC-----T  119 (344)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----C
T ss_pred             HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE-----e
Confidence            3577888999999999999997     346778999999743 233456788999999999 899999999995     4


Q ss_pred             CCceEEEEEecccCCChhhhccCCCCCCc-------------ccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceec
Q 037916          473 GDDFKALVYEFMHNGSLEEWLHPVSGADK-------------TVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHC  539 (741)
Q Consensus       473 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~-------------~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHr  539 (741)
                      .....++||||+++|+|.+++........             .......+++..++.++.|++.||+|||+.   ||+||
T Consensus       120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~  196 (344)
T 1rjb_A          120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR  196 (344)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred             eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccC
Confidence            45578999999999999999975422100             001123478999999999999999999999   99999


Q ss_pred             CCCCCCeEeCCCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCC
Q 037916          540 DLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPS  618 (741)
Q Consensus       540 Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~  618 (741)
                      ||||+||+++.++.+||+|||.+................||+.|+||| ...+..++.++|||||||++|+|++ |..||
T Consensus       197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE-~~~~~~~~~~~Di~slG~il~el~t~g~~p~  275 (344)
T 1rjb_A          197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPE-SLFEGIYTIKSDVWSYGILLWEIFSLGVNPY  275 (344)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHH-HHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHH-HhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence            999999999999999999999998665443333333355788999995 4456678999999999999999998 99998


Q ss_pred             CccccCCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHH
Q 037916          619 DIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTI  698 (741)
Q Consensus       619 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  698 (741)
                      ...... ..+......            ......                  +..+++.+.+++.+||+.||++|||+.|
T Consensus       276 ~~~~~~-~~~~~~~~~------------~~~~~~------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~  324 (344)
T 1rjb_A          276 PGIPVD-ANFYKLIQN------------GFKMDQ------------------PFYATEEIYIIMQSCWAFDSRKRPSFPN  324 (344)
T ss_dssp             TTCCCS-HHHHHHHHT------------TCCCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             ccCCcH-HHHHHHHhc------------CCCCCC------------------CCCCCHHHHHHHHHHcCCCchhCcCHHH
Confidence            633111 111111111            100000                  0123456889999999999999999999


Q ss_pred             HHHHHHHHHHhhc
Q 037916          699 VVHELQSIKSILL  711 (741)
Q Consensus       699 vl~~L~~i~~~~~  711 (741)
                      +++.|+.+.....
T Consensus       325 l~~~l~~~~~~~~  337 (344)
T 1rjb_A          325 LTSFLGCQLADAE  337 (344)
T ss_dssp             HHHHHHHHC----
T ss_pred             HHHHHHHHHHHHH
Confidence            9999998876554

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.9e-40  Score=346.35  Aligned_cols=272  Identities=21%  Similarity=0.291  Sum_probs=208.3

Q ss_pred             HHHHHhhhcccCceeeEEEEEE-----cCCCeEEEEEEeeccCc-CcchhHHHHHHHHHhc-CCCceeeEeeeecCcccc
Q 037916          400 VSFLFLCWIDMGSFGSVYKGIL-----DEGKTIIAVKVLNLLHH-GASKSSIAECSALRNI-RHKNLVKILTVCSGVDYK  472 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~  472 (741)
                      .+|++.+.||+|+||.||+|++     ..+++.||+|+++.... ...+.+.+|+.+++++ +||||+++++++     .
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~-----~   97 (313)
T 1t46_A           23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC-----T   97 (313)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----C
T ss_pred             hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEE-----e
Confidence            3577888999999999999985     45788999999974332 2346788999999999 999999999995     4


Q ss_pred             CCceEEEEEecccCCChhhhccCCCCCCc--------ccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCC
Q 037916          473 GDDFKALVYEFMHNGSLEEWLHPVSGADK--------TVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPS  544 (741)
Q Consensus       473 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~--------~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~  544 (741)
                      .+...++||||+++|+|.+++........        .......+++..++.++.|++.||+|||+.   +|+||||||+
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~  174 (313)
T 1t46_A           98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAAR  174 (313)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred             cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccc
Confidence            45578999999999999999875421100        001123589999999999999999999999   9999999999


Q ss_pred             CeEeCCCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCcccc
Q 037916          545 NVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFE  623 (741)
Q Consensus       545 NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~  623 (741)
                      ||+++.++.+||+|||.+................+|+.|+||| ...+..++.++||||+||++|+|++ |..||.....
T Consensus       175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~  253 (313)
T 1t46_A          175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPE-SIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (313)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHH-HHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChH-HhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence            9999999999999999998776554333333355788999995 4456678999999999999999999 9999863221


Q ss_pred             CCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHH
Q 037916          624 GNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHEL  703 (741)
Q Consensus       624 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  703 (741)
                      .. ...            ..+........                  ...++..+.+++.+||+.||++|||+.|+++.|
T Consensus       254 ~~-~~~------------~~~~~~~~~~~------------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L  302 (313)
T 1t46_A          254 DS-KFY------------KMIKEGFRMLS------------------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI  302 (313)
T ss_dssp             SH-HHH------------HHHHHTCCCCC------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             hh-HHH------------HHhccCCCCCC------------------cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence            11 111            11111100000                  012345688999999999999999999999999


Q ss_pred             HHHHHhhc
Q 037916          704 QSIKSILL  711 (741)
Q Consensus       704 ~~i~~~~~  711 (741)
                      +++.+...
T Consensus       303 ~~~~~~~~  310 (313)
T 1t46_A          303 EKQISEST  310 (313)
T ss_dssp             HHHHHHTC
T ss_pred             HHHHHHhh
Confidence            99887654

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2e-39  Score=342.35  Aligned_cols=255  Identities=20%  Similarity=0.227  Sum_probs=196.4

Q ss_pred             HHHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc--------CcchhHHHHHHHHHhcCCCceeeEeeeecC
Q 037916          397 LLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH--------GASKSSIAECSALRNIRHKNLVKILTVCSG  468 (741)
Q Consensus       397 ~~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  468 (741)
                      .+...|++.+.||+|+||.||+|.+..+++.||+|+++....        .....+.+|+.++++++||||+++++++. 
T Consensus         7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-   85 (322)
T 2ycf_A            7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-   85 (322)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE-
T ss_pred             hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc-
Confidence            456789999999999999999999999999999999864221        22345789999999999999999999852 


Q ss_pred             ccccCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEe
Q 037916          469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLL  548 (741)
Q Consensus       469 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll  548 (741)
                          .+ ..|+||||+++++|.+++...          ..+++..+..++.|++.||.|||+.   +|+||||||+||++
T Consensus        86 ----~~-~~~lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~  147 (322)
T 2ycf_A           86 ----AE-DYYIVLELMEGGELFDKVVGN----------KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLL  147 (322)
T ss_dssp             ----SS-SEEEEEECCTTEETHHHHSTT----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEE
T ss_pred             ----CC-ceEEEEecCCCCcHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEE
Confidence                22 379999999999999988643          4588999999999999999999999   99999999999999


Q ss_pred             CCCC---ceEEeecccccccCCCCcccccccccccccccCccccc--CCCCCCCccCchhHHHHHHHHHcCCCCCCcccc
Q 037916          549 DHEM---TAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG--LGSEVSINGDVYSYGILLLELMTRKRPSDIMFE  623 (741)
Q Consensus       549 ~~~~---~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~--~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~  623 (741)
                      +.++   .+||+|||.+.........   ....||+.|+|||.+.  ....++.++||||+||++|+|++|..||.....
T Consensus       148 ~~~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  224 (322)
T 2ycf_A          148 SSQEEDCLIKITDFGHSKILGETSLM---RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT  224 (322)
T ss_dssp             SSSSSSCCEEECCCTTCEECCCCHHH---HHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC
T ss_pred             ecCCCCCeEEEccCccceeccccccc---ccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch
Confidence            8765   4999999999876543221   2245899999996552  356789999999999999999999999863221


Q ss_pred             CCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          624 GNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       624 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      .. .+.............                           ......++.+.+++.+||+.||++|||+.|+++
T Consensus       225 ~~-~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          225 QV-SLKDQITSGKYNFIP---------------------------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             SS-CHHHHHHHTCCCCCH---------------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HH-HHHHHHHhCccccCc---------------------------hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            11 111111110000000                           001123467889999999999999999999984

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.4e-40  Score=351.70  Aligned_cols=259  Identities=24%  Similarity=0.344  Sum_probs=194.7

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEE----EEEEeecc-CcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCC
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTII----AVKVLNLL-HHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGD  474 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~v----avK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~  474 (741)
                      ..|++++.||+|+||.||+|++..+++.|    |+|.++.. .....+.+.+|+.++++++||||++++++|.     ..
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~   89 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL-----TS   89 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEE-----SS
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEe-----cC
Confidence            46888999999999999999998777655    66666432 2334567889999999999999999999963     22


Q ss_pred             ceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCce
Q 037916          475 DFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTA  554 (741)
Q Consensus       475 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~  554 (741)
                       ..++||||+.+|+|.+++...         ...+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+
T Consensus        90 -~~~~v~~~~~~g~L~~~l~~~---------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~  156 (327)
T 3lzb_A           90 -TVQLITQLMPFGCLLDYVREH---------KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHV  156 (327)
T ss_dssp             -SEEEEECCCSSCBHHHHHHHT---------TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEE
T ss_pred             -CceEEEEecCCCcHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCE
Confidence             378999999999999998643         24588899999999999999999999   99999999999999999999


Q ss_pred             EEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhh
Q 037916          555 HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFAR  633 (741)
Q Consensus       555 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~  633 (741)
                      ||+|||.++...............+|+.|+||| ...+..++.++||||+||++|||++ |..||......  .+.....
T Consensus       157 kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE-~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~~~  233 (327)
T 3lzb_A          157 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE-SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILE  233 (327)
T ss_dssp             EECCTTC----------------CCCGGGSCHH-HHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHH
T ss_pred             EEccCcceeEccCccccccccCCCccccccCHH-HHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHHHHH
Confidence            999999998765543333333345788999995 4456778999999999999999999 99998632111  1111111


Q ss_pred             hcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHh
Q 037916          634 TVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSI  709 (741)
Q Consensus       634 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  709 (741)
                      .            ......                  +..++..+.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus       234 ~------------~~~~~~------------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          234 K------------GERLPQ------------------PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             T------------TCCCCC------------------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             c------------CCCCCC------------------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            1            000000                  012345688999999999999999999999999999853

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=4.3e-39  Score=376.65  Aligned_cols=343  Identities=15%  Similarity=0.200  Sum_probs=293.5

Q ss_pred             CCCCCcccc-----------------cCChhh-hhCCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCc-Ccc-cC
Q 037916            2 DVGVNRVQG-----------------GIPLDF-GFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNN-LTG-EV   61 (741)
Q Consensus         2 dl~~n~~~~-----------------~ip~~~-~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~-l~~-~~   61 (741)
                      ||++|++.+                 .||..+ |..+++|++|+|++|++.+.+|..|.++++|++|+|++|+ +++ .+
T Consensus       454 ~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~i  533 (876)
T 4ecn_A          454 YFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQL  533 (876)
T ss_dssp             EEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHH
T ss_pred             ECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccc
Confidence            578888887                 499887 3479999999999999999999999999999999999998 998 78


Q ss_pred             CchhhhhhhhhhccccCCCccEEECcCCcCcccCCc--hhhcccccccEEEccCCcccccCCccccCCCCccEEEccccc
Q 037916           62 PSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPG--CICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQ  139 (741)
Q Consensus        62 ~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~--~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~  139 (741)
                      |..|+.++.   ...+.++|++|+|++|+|+ .+|.  .+..++ +|+.|+|++|++. .+| .|..+++|++|+|++|+
T Consensus       534 P~~i~~L~~---~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~-~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~  606 (876)
T 4ecn_A          534 KADWTRLAD---DEDTGPKIQIFYMGYNNLE-EFPASASLQKMV-KLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQ  606 (876)
T ss_dssp             HHHHHHHHH---CTTTTTTCCEEECCSSCCC-BCCCHHHHTTCT-TCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSC
T ss_pred             hHHHHhhhh---cccccCCccEEEeeCCcCC-ccCChhhhhcCC-CCCEEECCCCCcc-cch-hhcCCCcceEEECcCCc
Confidence            998888761   1112235999999999999 7777  899998 9999999999997 677 99999999999999999


Q ss_pred             ccccCCccccCCCc-CcEEEcccCCCCCcCcccccCCcc--cceeeccCcccccccCccc---c--cCCCCCEEeccCcc
Q 037916          140 LSGTISPAIGELQN-LVTLAINTNKLSGNIPPSIGNLKK--LLQLYLIENFLQVSIPSSL---G--QCQSLTTINLSYNN  211 (741)
Q Consensus       140 i~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~l~~--L~~L~L~~N~i~~~~~~~~---~--~l~~L~~L~L~~N~  211 (741)
                      |+ .+|..|.++++ |++|+|++|+|+ .+|..|..++.  |+.|+|++|++.+.+|...   .  .+++|+.|+|++|+
T Consensus       607 l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~  684 (876)
T 4ecn_A          607 IE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNE  684 (876)
T ss_dssp             CS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSC
T ss_pred             cc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCc
Confidence            99 67788999999 999999999999 67888887755  9999999999998766433   2  34589999999999


Q ss_pred             ccccCCcccc-ccccceeEEEcCCCccCCCCChhhcCC-------CCCcEEEeccccccchhhhhcc--ccccccEEEeC
Q 037916          212 LSGTIPPQLM-DLTSLSVGLDLSRNQLVGSLPTEVGKL-------INLEILFISRNMLECEILSTLG--SCIKLEQLKLG  281 (741)
Q Consensus       212 l~~~~p~~~~-~l~~L~~~L~Ls~N~l~~~~p~~~~~l-------~~L~~L~Ls~N~l~~~~~~~~~--~l~~L~~L~L~  281 (741)
                      |+ .+|..+. .+++|+. |+|++|+|....+..+...       ++|+.|+|++|+|+. .|..+.  .+++|+.|+|+
T Consensus       685 L~-~lp~~~~~~l~~L~~-L~Ls~N~L~~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~~-lp~~l~~~~l~~L~~L~Ls  761 (876)
T 4ecn_A          685 IQ-KFPTELFATGSPIST-IILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVS  761 (876)
T ss_dssp             CC-SCCHHHHHTTCCCSE-EECCSCCCSCCCTTSSSCTTSCCTTGGGCCEEECCSSCCCC-CCGGGSTTTCTTCCEEECC
T ss_pred             CC-ccCHHHHccCCCCCE-EECCCCcCCccChHHhccccccccccCCccEEECCCCCCcc-chHHhhhccCCCcCEEEeC
Confidence            99 6776655 8899998 9999999994444444332       399999999999995 556665  99999999999


Q ss_pred             CCccCCCCChhcccCccCCeeeCCC------CcCCCccchhhhccccCCcccccCcccccccCCccccCCcccccccCCC
Q 037916          282 GNLFQGPIPLSLSSLRGLRVLDLSQ------NNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKNASAISVFGNS  355 (741)
Q Consensus       282 ~N~l~~~~~~~~~~l~~L~~L~Ls~------N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~n~  355 (741)
                      +|+|++ +|..+.++++|+.|+|++      |++.+.+|..|..+++|+.|+|++|++.. +|.. .++.++.+++.+|+
T Consensus       762 ~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L~~-Ip~~-l~~~L~~LdLs~N~  838 (876)
T 4ecn_A          762 YNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEK-LTPQLYILDIADNP  838 (876)
T ss_dssp             SSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCCCB-CCSC-CCSSSCEEECCSCT
T ss_pred             CCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCCCc-cCHh-hcCCCCEEECCCCC
Confidence            999997 788899999999999977      88888999999999999999999999954 4443 34789999999998


Q ss_pred             Cccc
Q 037916          356 KLCG  359 (741)
Q Consensus       356 ~~c~  359 (741)
                      +..-
T Consensus       839 l~~i  842 (876)
T 4ecn_A          839 NISI  842 (876)
T ss_dssp             TCEE
T ss_pred             CCcc
Confidence            7543

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=9.2e-40  Score=360.46  Aligned_cols=253  Identities=26%  Similarity=0.333  Sum_probs=201.2

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      ..|++.+.||+|+||.||+|.+.  ++.||||+++..  ...+.+.+|+.++++++||||+++++++.    ......|+
T Consensus       193 ~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~----~~~~~~~i  264 (450)
T 1k9a_A          193 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLYI  264 (450)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSC--TTSHHHHHHHHHHHTCCCTTBCCEEEEEE----CTTSCEEE
T ss_pred             HHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCc--hHHHHHHHHHHHHHhccCCCEEEEEEEEE----cCCCceEE
Confidence            45778899999999999999986  779999999743  35678899999999999999999999963    33447899


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      ||||+++|+|.+++....        ...+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+||
T Consensus       265 v~e~~~~g~L~~~l~~~~--------~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~Df  333 (450)
T 1k9a_A          265 VTEYMAKGSLVDYLRSRG--------RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDF  333 (450)
T ss_dssp             EEECCTTCBHHHHHHHHC--------TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCC
T ss_pred             EEEecCCCcHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeC
Confidence            999999999999997431        13368889999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcCCc
Q 037916          560 GLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       560 g~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      |+++.......     ...+++.|+||| ...+..++.++|||||||++|||++ |+.||......  .....+..    
T Consensus       334 G~a~~~~~~~~-----~~~~~~~y~aPE-~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--~~~~~i~~----  401 (450)
T 1k9a_A          334 GLTKEASSTQD-----TGKLPVKWTAPE-ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEK----  401 (450)
T ss_dssp             TTCEECC-----------CCCTTTSCHH-HHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT--THHHHHHT----
T ss_pred             CCccccccccc-----CCCCCcceeCHH-HhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHc----
Confidence            99985533211     124688999995 5556789999999999999999998 99998632111  11111110    


Q ss_pred             chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHh
Q 037916          639 HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSI  709 (741)
Q Consensus       639 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  709 (741)
                              ....                  ..+..+++.+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus       402 --------~~~~------------------~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          402 --------GYKM------------------DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             --------TCCC------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             --------CCCC------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence                    0000                  01123456788999999999999999999999999998754

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.8e-40  Score=350.76  Aligned_cols=249  Identities=22%  Similarity=0.271  Sum_probs=197.1

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeecc---CcCcchhHHHHHHHHHhc-CCCceeeEeeeecCccccCC
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLL---HHGASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKGD  474 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~  474 (741)
                      ...|++++.||+|+||.||+|++..+++.||+|+++..   .....+.+..|..+++.+ +||+|++++++     +.+.
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~-----~~~~   93 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSC-----FQTM   93 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEE-----EECS
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEE-----EEcC
Confidence            35688999999999999999999989999999999743   223456678899999887 89999999999     4566


Q ss_pred             ceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCce
Q 037916          475 DFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTA  554 (741)
Q Consensus       475 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~  554 (741)
                      ...|+||||++||+|.+++...          ..+++..++.++.||+.||+|||+.   ||+||||||+||+++.++.+
T Consensus        94 ~~~~lv~E~~~gg~L~~~l~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~v  160 (353)
T 2i0e_A           94 DRLYFVMEYVNGGDLMYHIQQV----------GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHI  160 (353)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCE
T ss_pred             CEEEEEEeCCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcE
Confidence            7899999999999999998633          4588999999999999999999999   99999999999999999999


Q ss_pred             EEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhh
Q 037916          555 HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       555 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  634 (741)
                      ||+|||+++.......  ......||+.|+||| +..+..++.++||||+||++|||++|+.||.....     ..... 
T Consensus       161 kL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE-~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----~~~~~-  231 (353)
T 2i0e_A          161 KIADFGMCKENIWDGV--TTKTFCGTPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----DELFQ-  231 (353)
T ss_dssp             EECCCTTCBCCCCTTC--CBCCCCSCGGGCCHH-HHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH-
T ss_pred             EEEeCCcccccccCCc--ccccccCCccccChh-hhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH-----HHHHH-
Confidence            9999999986433221  122356999999994 55677889999999999999999999999863211     11111 


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCH-----HHHHH
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNM-----TIVVH  701 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~  701 (741)
                             .+......  .                  +......+.+++.+||..||++||++     .|+++
T Consensus       232 -------~i~~~~~~--~------------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          232 -------SIMEHNVA--Y------------------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             -------HHHHCCCC--C------------------CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             -------HHHhCCCC--C------------------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence                   11110000  0                  01234567899999999999999964     66654

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.7e-40  Score=355.09  Aligned_cols=286  Identities=18%  Similarity=0.226  Sum_probs=205.1

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      .+|++++.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.++++++||||+++++++...........|
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  106 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY  106 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence            46889999999999999999999999999999997432 22336678999999999999999999998655444556789


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      +||||+. ++|.+++..           ..+++.++..++.|++.||+|||+.   ||+||||||+||+++.++.+||+|
T Consensus       107 iv~e~~~-~~L~~~l~~-----------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~D  171 (364)
T 3qyz_A          107 IVQDLME-TDLYKLLKT-----------QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICD  171 (364)
T ss_dssp             EEEECCS-EEHHHHHHH-----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECC
T ss_pred             EEEcccC-cCHHHHHHh-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEe
Confidence            9999995 599998852           3488999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCccc-ccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCC
Q 037916          559 FGLAKLLPPAHLQT-SSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       559 Fg~a~~~~~~~~~~-~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      ||.+.......... ......||+.|+|||.+..+..++.++||||+||++|+|++|+.||......+ .+.........
T Consensus       172 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~  250 (364)
T 3qyz_A          172 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-QLNHILGILGS  250 (364)
T ss_dssp             CTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG-HHHHHHHHHCS
T ss_pred             CcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH-HHHHHHHHhCC
Confidence            99998765432221 12335699999999766666778999999999999999999999986322111 11111111111


Q ss_pred             cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          638 DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       638 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      .. .+...................................+.+++.+||+.||++|||+.|+++-
T Consensus       251 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          251 PS-QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             CC-HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CC-HHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            10 00000000000000000000000000001112334678899999999999999999999863

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=3.7e-40  Score=349.86  Aligned_cols=273  Identities=20%  Similarity=0.317  Sum_probs=206.2

Q ss_pred             HHHHHhhhcccCceeeEEEEEEc-------CCCeEEEEEEeeccCc-CcchhHHHHHHHHHhc-CCCceeeEeeeecCcc
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILD-------EGKTIIAVKVLNLLHH-GASKSSIAECSALRNI-RHKNLVKILTVCSGVD  470 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~-------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~  470 (741)
                      ..|++.+.||+|+||.||+|++.       .++..||+|+++.... ...+.+.+|+.+++++ +||||+++++++    
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~----  110 (334)
T 2pvf_A           35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC----  110 (334)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred             hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE----
Confidence            45788899999999999999985       3577899999974322 2345678999999999 899999999995    


Q ss_pred             ccCCceEEEEEecccCCChhhhccCCCCCCcc------cCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCC
Q 037916          471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKT------VEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPS  544 (741)
Q Consensus       471 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~------~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~  544 (741)
                       ......++||||+++|+|.+++.........      ......+++..++.++.|++.||+|||+.   +|+||||||+
T Consensus       111 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~  186 (334)
T 2pvf_A          111 -TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR  186 (334)
T ss_dssp             -CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred             -ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccc
Confidence             4455789999999999999999754321100      01123588999999999999999999999   9999999999


Q ss_pred             CeEeCCCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCcccc
Q 037916          545 NVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFE  623 (741)
Q Consensus       545 NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~  623 (741)
                      ||+++.++.+||+|||.+................+|+.|+|||. ..+..++.++||||+||++|+|++ |..||.....
T Consensus       187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~  265 (334)
T 2pvf_A          187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEA-LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV  265 (334)
T ss_dssp             GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHH-HHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHH-hcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence            99999999999999999987765443333333457889999954 456678999999999999999999 9999863211


Q ss_pred             CCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHH
Q 037916          624 GNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHEL  703 (741)
Q Consensus       624 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  703 (741)
                           .....         .+.......                  .+..++..+.+++.+||+.||++|||+.|+++.|
T Consensus       266 -----~~~~~---------~~~~~~~~~------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L  313 (334)
T 2pvf_A          266 -----EELFK---------LLKEGHRMD------------------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL  313 (334)
T ss_dssp             -----HHHHH---------HHHHTCCCC------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             -----HHHHH---------HHhcCCCCC------------------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence                 11110         000000000                  0113345688999999999999999999999999


Q ss_pred             HHHHHhhcCC
Q 037916          704 QSIKSILLGP  713 (741)
Q Consensus       704 ~~i~~~~~~~  713 (741)
                      +++.......
T Consensus       314 ~~l~~~~~~~  323 (334)
T 2pvf_A          314 DRILTLTTNE  323 (334)
T ss_dssp             HHHHHHHC--
T ss_pred             HHHHhccccC
Confidence            9999876644

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=5e-40  Score=349.81  Aligned_cols=245  Identities=20%  Similarity=0.203  Sum_probs=197.8

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCce
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      ..|++++.||+|+||.||+|++..+++.||+|+++...   ....+.+.+|+.+++.++||||++++++     +.+...
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~-----~~~~~~  115 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS-----FKDNSN  115 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEE-----EECSSE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEE-----EEcCCE
Confidence            46788899999999999999999999999999997432   2345677889999999999999999999     455668


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .|+||||+++|+|.+++...          ..+++..++.++.||+.||+|||+.   ||+||||||+||+++.++.+||
T Consensus       116 ~~lv~e~~~gg~L~~~l~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL  182 (350)
T 1rdq_E          116 LYMVMEYVAGGEMFSHLRRI----------GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQV  182 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHH----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEE
T ss_pred             EEEEEcCCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEE
Confidence            99999999999999998643          4588999999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcC
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVL  636 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  636 (741)
                      +|||+++......     ....||+.|+||| +..+..++.++||||+||++|||++|..||.....     .....   
T Consensus       183 ~DFg~a~~~~~~~-----~~~~gt~~y~aPE-~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~---  248 (350)
T 1rdq_E          183 TDFGFAKRVKGRT-----WTLCGTPEALAPE-IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-----IQIYE---  248 (350)
T ss_dssp             CCCTTCEECSSCB-----CCCEECGGGCCHH-HHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH---
T ss_pred             cccccceeccCCc-----ccccCCccccCHH-HhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH-----HHHHH---
Confidence            9999998764321     2356999999995 55567889999999999999999999999863211     11110   


Q ss_pred             CcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCC-----HHHHHH
Q 037916          637 PDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMN-----MTIVVH  701 (741)
Q Consensus       637 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  701 (741)
                           .+......  .                  +......+.+++.+||+.||++||+     +.||++
T Consensus       249 -----~i~~~~~~--~------------------p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          249 -----KIVSGKVR--F------------------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             -----HHHHCCCC--C------------------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             -----HHHcCCCC--C------------------CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence                 01110000  0                  0123456789999999999999998     777764

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.1e-40  Score=349.10  Aligned_cols=270  Identities=19%  Similarity=0.251  Sum_probs=205.7

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      ..|++.+.||+|+||.||+|.+..+++.||+|++........+.+.+|+.+++.++||||+++++++.... ......++
T Consensus        29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~l  107 (317)
T 2buj_A           29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKHEAWL  107 (317)
T ss_dssp             EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEEEEEE
T ss_pred             eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCceeEE
Confidence            46889999999999999999998899999999987655555677889999999999999999999874211 23457899


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      ||||+++|+|.+++.....      ....+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus       108 v~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~df  178 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKD------KGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDL  178 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHT------TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred             EEEeCCCCcHHHHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEec
Confidence            9999999999999864211      125588999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCccc-------ccccccccccccCcccccCCC--CCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhh
Q 037916          560 GLAKLLPPAHLQT-------SSIGVKGTIGYIAPAEYGLGS--EVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHN  630 (741)
Q Consensus       560 g~a~~~~~~~~~~-------~~~~~~gt~~y~aPEe~~~~~--~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~  630 (741)
                      |.+..........       ......||+.|+|||.+....  .++.++|||||||++|+|++|+.||............
T Consensus       179 g~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~  258 (317)
T 2buj_A          179 GSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL  258 (317)
T ss_dssp             SSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH
T ss_pred             CcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH
Confidence            9987654221100       011234799999996553322  3689999999999999999999998643222222211


Q ss_pred             hhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHh
Q 037916          631 FARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSI  709 (741)
Q Consensus       631 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  709 (741)
                      .......           ...                   ....+..+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus       259 ~~~~~~~-----------~~~-------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  307 (317)
T 2buj_A          259 AVQNQLS-----------IPQ-------------------SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP  307 (317)
T ss_dssp             HHHCC-------------CCC-------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred             HhhccCC-----------CCc-------------------cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence            1111000           000                   012345688999999999999999999999999887643

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=4.9e-40  Score=341.28  Aligned_cols=261  Identities=24%  Similarity=0.379  Sum_probs=208.5

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      ..|++.+.||+|+||.||+|.+..++..||+|+++.. ....+.+.+|+.++++++||||+++++++     .+....++
T Consensus        13 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~~   86 (288)
T 3kfa_A           13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPFYI   86 (288)
T ss_dssp             GGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSEEE
T ss_pred             cceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCCEEE
Confidence            3577888999999999999999989999999999742 33456788999999999999999999995     45567899


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      ||||+++++|.+++...        ....+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        87 v~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Df  155 (288)
T 3kfa_A           87 ITEFMTYGNLLDYLREC--------NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADF  155 (288)
T ss_dssp             EEECCTTEEHHHHHHHC--------CTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCC
T ss_pred             EEEcCCCCcHHHHHHhc--------ccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccC
Confidence            99999999999998643        124588999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcCCc
Q 037916          560 GLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       560 g~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      |.+........ .......+|+.|+||| ...+..++.++||||+|+++|+|++ |..||......  ...         
T Consensus       156 g~~~~~~~~~~-~~~~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~--~~~---------  222 (288)
T 3kfa_A          156 GLSRLMTGDTY-TAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVY---------  222 (288)
T ss_dssp             CGGGTSCSSSS-EEETTEEECGGGCCHH-HHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHH---------
T ss_pred             ccceeccCCcc-ccccCCccccCcCChh-hhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHH---------
Confidence            99987654432 2223345788999995 4456678999999999999999999 99998632111  111         


Q ss_pred             chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHhhc
Q 037916          639 HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSILL  711 (741)
Q Consensus       639 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~  711 (741)
                         +.+........                  +..+++.+.+++.+||..||++|||+.|+++.|+.+.+...
T Consensus       223 ---~~~~~~~~~~~------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~  274 (288)
T 3kfa_A          223 ---ELLEKDYRMER------------------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS  274 (288)
T ss_dssp             ---HHHHTTCCCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             ---HHHhccCCCCC------------------CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence               11111100000                  01334668899999999999999999999999999887654

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.4e-40  Score=350.47  Aligned_cols=280  Identities=23%  Similarity=0.301  Sum_probs=208.3

Q ss_pred             HHHH-HHhhhcccCceeeEEEEEE----cCCCeEEEEEEeeccCc-CcchhHHHHHHHHHhcCCCceeeEeeeecCcccc
Q 037916          399 FVSF-LFLCWIDMGSFGSVYKGIL----DEGKTIIAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKILTVCSGVDYK  472 (741)
Q Consensus       399 ~~~y-~~~~~ig~G~~g~V~~a~~----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  472 (741)
                      ..+| +++++||+|+||.||+|.+    ..+++.||+|+++.... ...+.+.+|+.++++++||||+++++++..   .
T Consensus        29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~  105 (318)
T 3lxp_A           29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCED---A  105 (318)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---T
T ss_pred             cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEec---C
Confidence            3455 8899999999999988865    35789999999974322 234567899999999999999999999742   2


Q ss_pred             CCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCC
Q 037916          473 GDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEM  552 (741)
Q Consensus       473 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~  552 (741)
                      +....++||||+++++|.+++...           .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++
T Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~  171 (318)
T 3lxp_A          106 GAASLQLVMEYVPLGSLRDYLPRH-----------SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDR  171 (318)
T ss_dssp             TTTEEEEEECCCTTCBHHHHGGGS-----------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTC
T ss_pred             CCceEEEEEecccCCcHHHHHhhC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCC
Confidence            356789999999999999998632           378899999999999999999999   999999999999999999


Q ss_pred             ceEEeecccccccCCCCcc-cccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhh
Q 037916          553 TAHVADFGLAKLLPPAHLQ-TSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNF  631 (741)
Q Consensus       553 ~~kL~DFg~a~~~~~~~~~-~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~  631 (741)
                      .+||+|||.+......... .......+|+.|+||| +..+..++.++||||+||++|+|++|..||............+
T Consensus       172 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~  250 (318)
T 3lxp_A          172 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE-CLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI  250 (318)
T ss_dssp             CEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHH-HHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCS
T ss_pred             CEEECCccccccccccccccccccCCCCCceeeChH-HhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcc
Confidence            9999999999877654321 1222345788999995 4556678899999999999999999999986332111000000


Q ss_pred             hhhcCC-cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHhh
Q 037916          632 ARTVLP-DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSIL  710 (741)
Q Consensus       632 ~~~~~~-~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  710 (741)
                      ...... ....+.++....                  ......++..+.+++.+||+.||++|||+.|+++.|+.+.+.+
T Consensus       251 ~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  312 (318)
T 3lxp_A          251 AQGQMTVLRLTELLERGER------------------LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY  312 (318)
T ss_dssp             CCHHHHHHHHHHHHHTTCC------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             cccchhHHHHHHHHhcccC------------------CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence            000000 001111111110                  0111234567899999999999999999999999999999888


Q ss_pred             cCCc
Q 037916          711 LGPK  714 (741)
Q Consensus       711 ~~~~  714 (741)
                      ..++
T Consensus       313 ~~~~  316 (318)
T 3lxp_A          313 QGQA  316 (318)
T ss_dssp             HC--
T ss_pred             ccCC
Confidence            7554

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=3.9e-40  Score=351.13  Aligned_cols=271  Identities=18%  Similarity=0.196  Sum_probs=197.3

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcC---CCeEEEEEEeeccCcC-----------cchhHHHHHHHHHhcCCCceeeEeee
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDE---GKTIIAVKVLNLLHHG-----------ASKSSIAECSALRNIRHKNLVKILTV  465 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~---~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~hpnIv~~~~~  465 (741)
                      ..|++.+.||+|+||.||+|++..   ++..||+|+.......           ....+.+|+..++.++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            357888999999999999999986   7889999998743221           12345678888899999999999999


Q ss_pred             ecCccccCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCC
Q 037916          466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSN  545 (741)
Q Consensus       466 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~N  545 (741)
                      +... +.+....|+||||+ +++|.+++...          ..+++.+++.++.||+.||+|||+.   +|+||||||+|
T Consensus       117 ~~~~-~~~~~~~~lv~e~~-~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N  181 (345)
T 2v62_A          117 GLTE-FKGRSYRFMVMERL-GIDLQKISGQN----------GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAAN  181 (345)
T ss_dssp             EEEE-SSSCEEEEEEEECE-EEEHHHHCBGG----------GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred             cccc-cCCCcEEEEEEecc-CCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHH
Confidence            7432 13366899999999 99999999743          3689999999999999999999999   99999999999


Q ss_pred             eEeCCCC--ceEEeecccccccCCCCcc-----cccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCC
Q 037916          546 VLLDHEM--TAHVADFGLAKLLPPAHLQ-----TSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPS  618 (741)
Q Consensus       546 Ill~~~~--~~kL~DFg~a~~~~~~~~~-----~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~  618 (741)
                      |+++.++  .+||+|||+++........     .......||+.|+||| +..+..++.++|||||||++|||++|+.||
T Consensus       182 Ill~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE-~~~~~~~~~~~Di~slG~il~ell~g~~pf  260 (345)
T 2v62_A          182 LLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLD-AHKGVALSRRSDVEILGYCMLRWLCGKLPW  260 (345)
T ss_dssp             EEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHH-HHHTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             EEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHH-HhcCCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence            9998877  9999999999876533211     1113356999999995 555678899999999999999999999998


Q ss_pred             CccccCCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHH
Q 037916          619 DIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTI  698 (741)
Q Consensus       619 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  698 (741)
                      .................... ....+....                     ....+++.+.+++.+||+.||++|||+.|
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~  318 (345)
T 2v62_A          261 EQNLKDPVAVQTAKTNLLDE-LPQSVLKWA---------------------PSGSSCCEIAQFLVCAHSLAYDEKPNYQA  318 (345)
T ss_dssp             GGGTTCHHHHHHHHHHHHHT-TTHHHHHHS---------------------CTTSCCHHHHHHHHHHHTCCTTCCCCHHH
T ss_pred             cccccccHHHHHHHHhhccc-ccHHHHhhc---------------------cccccHHHHHHHHHHHhhcCcccCCCHHH
Confidence            63211111111111100000 000000000                     00034567899999999999999999999


Q ss_pred             HHHHHHHHHH
Q 037916          699 VVHELQSIKS  708 (741)
Q Consensus       699 vl~~L~~i~~  708 (741)
                      |++.|+++.-
T Consensus       319 l~~~L~~~~~  328 (345)
T 2v62_A          319 LKKILNPHGI  328 (345)
T ss_dssp             HHHHHCTTCC
T ss_pred             HHHHHhccCC
Confidence            9999987654

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.2e-39  Score=345.32  Aligned_cols=277  Identities=19%  Similarity=0.218  Sum_probs=201.7

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcC-CCceeeEeeeecCccccCCceEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIR-HKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      ..|++.+.||+|+||.||+|++..+++.||+|+++.   ...+.+.+|+.++++++ ||||+++++++..   ......+
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~---~~~~~~~  109 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKD---PVSRTPA  109 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCCEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeecc---CCCCceE
Confidence            468889999999999999999998999999999863   34567889999999997 9999999999642   2256789


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCC-ceEEe
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEM-TAHVA  557 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~-~~kL~  557 (741)
                      +||||+.+++|.+++.             .+++..+..++.|++.||+|||+.   ||+||||||+||+++.++ .+||+
T Consensus       110 lv~e~~~~~~l~~~~~-------------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~  173 (330)
T 3nsz_A          110 LVFEHVNNTDFKQLYQ-------------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLI  173 (330)
T ss_dssp             EEEECCCCCCHHHHGG-------------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEEC
T ss_pred             EEEeccCchhHHHHHH-------------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEE
Confidence            9999999999999874             378888999999999999999999   999999999999999776 89999


Q ss_pred             ecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCC
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      |||.+.........   ....||+.|+|||.+.....++.++||||+||++|+|++|+.||.........+.........
T Consensus       174 Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~  250 (330)
T 3nsz_A          174 DWGLAEFYHPGQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT  250 (330)
T ss_dssp             CCTTCEECCTTCCC---CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCH
T ss_pred             eCCCceEcCCCCcc---ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCC
Confidence            99999876544322   224589999999766555789999999999999999999999985332221222221111111


Q ss_pred             cchhHhhhhcccCCcchhhhhh-----hhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          638 DHVMDIVDSTLLADDEDLTITS-----NQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       638 ~~~~~~~d~~l~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ....+.++..............     ................+.+.+++.+||++||++|||++|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          251 EDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             chhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            1111111111100000000000     000000000001123567889999999999999999999986

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=5.1e-40  Score=346.85  Aligned_cols=258  Identities=21%  Similarity=0.252  Sum_probs=183.0

Q ss_pred             HHHHHHHh---hhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcC-CCceeeEeeeecCccccC
Q 037916          398 LFVSFLFL---CWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIR-HKNLVKILTVCSGVDYKG  473 (741)
Q Consensus       398 ~~~~y~~~---~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~  473 (741)
                      ++..|.+.   +.||+|+||.||+|.+..+++.||+|+++.   .......+|+.+++.+. ||||+++++++     .+
T Consensus         6 f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~-----~~   77 (325)
T 3kn6_A            6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVF-----HD   77 (325)
T ss_dssp             HHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEE-----EC
T ss_pred             chhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEE-----Ec
Confidence            34567665   679999999999999999999999999963   23467788999999996 99999999994     55


Q ss_pred             CceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCC-
Q 037916          474 DDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEM-  552 (741)
Q Consensus       474 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~-  552 (741)
                      +...|+||||+++|+|.+++...          ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++ 
T Consensus        78 ~~~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~  144 (325)
T 3kn6_A           78 QLHTFLVMELLNGGELFERIKKK----------KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDEND  144 (325)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHC----------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC---
T ss_pred             CCEEEEEEEccCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCC
Confidence            66899999999999999998643          4589999999999999999999999   999999999999997765 


Q ss_pred             --ceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhh
Q 037916          553 --TAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHN  630 (741)
Q Consensus       553 --~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~  630 (741)
                        .+||+|||++.........  .....||+.|+|| |+..+..++.++||||+||++|+|++|+.||.........   
T Consensus       145 ~~~~kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aP-E~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---  218 (325)
T 3kn6_A          145 NLEIKIIDFGFARLKPPDNQP--LKTPCFTLHYAAP-ELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC---  218 (325)
T ss_dssp             -CEEEECCCTTCEECCC-------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------C---
T ss_pred             cccEEEeccccceecCCCCCc--ccccCCCcCccCH-HHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccccc---
Confidence              8999999999866543222  2234589999999 5556778999999999999999999999999743221100   


Q ss_pred             hhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          631 FARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       631 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                             ....+..+....+....            .........+.+.+++.+||+.||++|||+.|+++
T Consensus       219 -------~~~~~~~~~i~~~~~~~------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          219 -------TSAVEIMKKIKKGDFSF------------EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             -------CCHHHHHHHHTTTCCCC------------CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             -------ccHHHHHHHHHcCCCCC------------CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence                   00111111111111100            00011234567889999999999999999999874

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.2e-39  Score=350.37  Aligned_cols=247  Identities=20%  Similarity=0.228  Sum_probs=191.7

Q ss_pred             hhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEEEecc
Q 037916          405 LCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFM  484 (741)
Q Consensus       405 ~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv~e~~  484 (741)
                      .+.||+|+||.||+|.+..+++.||+|+++.......+.+.+|+.++++++||||+++++++     ......++||||+
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~~~lv~E~~  168 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAF-----ESKNDIVLVMEYV  168 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEEEEEEECC
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEEEEEeCC
Confidence            46799999999999999989999999999865444567788999999999999999999995     4556899999999


Q ss_pred             cCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEe--CCCCceEEeecccc
Q 037916          485 HNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLL--DHEMTAHVADFGLA  562 (741)
Q Consensus       485 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll--~~~~~~kL~DFg~a  562 (741)
                      ++++|.+++...         ...+++..++.++.||+.||+|||+.   +|+||||||+||++  +.++.+||+|||++
T Consensus       169 ~~~~L~~~l~~~---------~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a  236 (373)
T 2x4f_A          169 DGGELFDRIIDE---------SYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLA  236 (373)
T ss_dssp             TTCEEHHHHHHT---------GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSC
T ss_pred             CCCcHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCc
Confidence            999999988532         24588999999999999999999999   99999999999999  56789999999999


Q ss_pred             cccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcchhH
Q 037916          563 KLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMD  642 (741)
Q Consensus       563 ~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  642 (741)
                      ..........   ...||+.|+||| +..+..++.++|||||||++|||++|..||...... ..+.........     
T Consensus       237 ~~~~~~~~~~---~~~gt~~y~aPE-~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~-----  306 (373)
T 2x4f_A          237 RRYKPREKLK---VNFGTPEFLAPE-VVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-ETLNNILACRWD-----  306 (373)
T ss_dssp             EECCTTCBCC---CCCSSCTTCCHH-HHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHTCCC-----
T ss_pred             eecCCccccc---cccCCCcEeChh-hccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccCC-----
Confidence            8775443222   245899999995 556778899999999999999999999998632111 011111111000     


Q ss_pred             hhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          643 IVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       643 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                             ....                ......+.+.+++.+||+.||++|||+.|+++
T Consensus       307 -------~~~~----------------~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          307 -------LEDE----------------EFQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             -------SCSG----------------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -------CChh----------------hhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                   0000                01123456889999999999999999999987

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=1.6e-38  Score=367.61  Aligned_cols=347  Identities=21%  Similarity=0.207  Sum_probs=245.0

Q ss_pred             CCCCCcccccCChhhhhCCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCc
Q 037916            2 DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHL   81 (741)
Q Consensus         2 dl~~n~~~~~ip~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L   81 (741)
                      |||+|+|+ .||+..|.++++|++|||++|+|+++.+++|.++++|++|+|++|+|++..+..|.++++          |
T Consensus        58 dLs~N~i~-~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~----------L  126 (635)
T 4g8a_A           58 DLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSS----------L  126 (635)
T ss_dssp             ECTTSCCC-EECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTT----------C
T ss_pred             EeeCCCCC-CCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCC----------C
Confidence            56666666 333332336677777777777776666666666777777777777766555566666655          6


Q ss_pred             cEEECcCCcCcccCCchhhcccccccEEEccCCccccc-CCccccCCCCccEEEcccccccccCCccccCCCc-------
Q 037916           82 KHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRS-IPAGIGKFINLQTLHMWDNQLSGTISPAIGELQN-------  153 (741)
Q Consensus        82 ~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~-~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~-------  153 (741)
                      ++|+|++|+|+++.+..|.+++ +|++|+|++|++... .|..+..+++|++|+|++|+|+++.+..|..+.+       
T Consensus       127 ~~L~Ls~N~l~~l~~~~~~~L~-~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~  205 (635)
T 4g8a_A          127 QKLVAVETNLASLENFPIGHLK-TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS  205 (635)
T ss_dssp             CEEECTTSCCCCSTTCCCTTCT-TCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCE
T ss_pred             CEEECCCCcCCCCChhhhhcCc-ccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhh
Confidence            7777777776666666666666 677777777666543 4556666666777776666666554443322211       


Q ss_pred             --------------------------------------------------------------------------------
Q 037916          154 --------------------------------------------------------------------------------  153 (741)
Q Consensus       154 --------------------------------------------------------------------------------  153 (741)
                                                                                                      
T Consensus       206 ~~ls~n~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~  285 (635)
T 4g8a_A          206 LDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEE  285 (635)
T ss_dssp             EECTTCCCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEE
T ss_pred             hhcccCcccccCcccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhh
Confidence                                                                                            


Q ss_pred             --------------------------------------------CcEEEcccCCCCCcCcc-------------------
Q 037916          154 --------------------------------------------LVTLAINTNKLSGNIPP-------------------  170 (741)
Q Consensus       154 --------------------------------------------L~~L~L~~N~l~~~~~~-------------------  170 (741)
                                                                  |+.|++.+|.+....+.                   
T Consensus       286 l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~  365 (635)
T 4g8a_A          286 FRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAF  365 (635)
T ss_dssp             EEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBC
T ss_pred             hhhhhhcccccchhhhhhhhcccccccccccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCc
Confidence                                                        11222222222111110                   


Q ss_pred             cccCCcccceeeccCcccccc--cC-----------------------cccccCCCCCEEeccCccccccCC-ccccccc
Q 037916          171 SIGNLKKLLQLYLIENFLQVS--IP-----------------------SSLGQCQSLTTINLSYNNLSGTIP-PQLMDLT  224 (741)
Q Consensus       171 ~~~~l~~L~~L~L~~N~i~~~--~~-----------------------~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~  224 (741)
                      .+..+++|+.|++++|.+...  .+                       ..+..+++|+.+++++|++....+ ..|..+.
T Consensus       366 ~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~  445 (635)
T 4g8a_A          366 SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR  445 (635)
T ss_dssp             CCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCT
T ss_pred             ccccccccccchhhccccccccccccchhhhhhhhhhhccccccccccccccccccccchhhhhcccccccccccccccc
Confidence            112345677777777776432  22                       334455666666666666554433 4567788


Q ss_pred             cceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccc-cchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeee
Q 037916          225 SLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNML-ECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLD  303 (741)
Q Consensus       225 ~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l-~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  303 (741)
                      ++.. ++++.|.+.+..+..+..++.|+.|+|++|.+ ..+.+..|..+++|++|+|++|+|+++.|.+|.++++|++|+
T Consensus       446 ~l~~-l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~  524 (635)
T 4g8a_A          446 NLIY-LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN  524 (635)
T ss_dssp             TCCE-EECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred             cccc-ccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEE
Confidence            8887 99999999988999999999999999999975 456788999999999999999999999999999999999999


Q ss_pred             CCCCcCCCccchhhhccccCCcccccCcccccccCCc-ccc-CCcccccccCCCCccccC
Q 037916          304 LSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTE-GVF-KNASAISVFGNSKLCGGI  361 (741)
Q Consensus       304 Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~-~~~~~~~~~~n~~~c~~~  361 (741)
                      |++|+|++..|..|..+++|+.|+|++|+|++.+|.. ..+ ..++.+++.+|||.|.+-
T Consensus       525 Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~  584 (635)
T 4g8a_A          525 MSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE  584 (635)
T ss_dssp             CTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred             CCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence            9999999999999999999999999999999998875 233 578999999999999753

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4e-40  Score=353.72  Aligned_cols=264  Identities=25%  Similarity=0.389  Sum_probs=194.1

Q ss_pred             HHHhhhcccCceeeEEEEEEcCC---CeEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceE
Q 037916          402 FLFLCWIDMGSFGSVYKGILDEG---KTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      |.+.+.||+|+||.||+|++..+   +..||+|.++... ....+.+.+|+.++++++||||++++++|    ...+...
T Consensus        91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~----~~~~~~~  166 (373)
T 3c1x_A           91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC----LRSEGSP  166 (373)
T ss_dssp             EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEE----CCCSSCC
T ss_pred             eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE----EcCCCCe
Confidence            45677899999999999997532   3568999986432 23356788999999999999999999986    3445578


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      ++||||+++|+|.+++...         ...+++..++.++.|+++||+|||+.   +|+||||||+||+++.++.+||+
T Consensus       167 ~lv~e~~~~g~L~~~l~~~---------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~  234 (373)
T 3c1x_A          167 LVVLPYMKHGDLRNFIRNE---------THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVA  234 (373)
T ss_dssp             EEEEECCTTCBHHHHHHCT---------TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEEC
T ss_pred             EEEEECCCCCCHHHHHhhc---------ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEe
Confidence            9999999999999999643         23477888999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCccc--ccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhh
Q 037916          558 DFGLAKLLPPAHLQT--SSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       558 DFg~a~~~~~~~~~~--~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  634 (741)
                      |||+++.........  ......+|+.|+||| ...+..++.++|||||||++|||++ |.+||......  ........
T Consensus       235 DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~--~~~~~~~~  311 (373)
T 3c1x_A          235 DFGLARDMYDKEFDSVHNKTGAKLPVKWMALE-SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLLQ  311 (373)
T ss_dssp             CC---------------------CCGGGSCHH-HHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS--CHHHHHHT
T ss_pred             eccccccccccccccccccCCCCCcccccChH-HhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH--HHHHHHHc
Confidence            999998664432211  122345788999995 4456778999999999999999999 67777532111  11111110


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHhhcCCc
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSILLGPK  714 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~  714 (741)
                      ...           ...                   +..++..+.+++.+||+.||++|||+.|+++.|+.+...+....
T Consensus       312 ~~~-----------~~~-------------------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~  361 (373)
T 3c1x_A          312 GRR-----------LLQ-------------------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH  361 (373)
T ss_dssp             TCC-----------CCC-------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCC
T ss_pred             CCC-----------CCC-------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccccc
Confidence            000           000                   01234568899999999999999999999999999998777544

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.4e-40  Score=355.56  Aligned_cols=283  Identities=18%  Similarity=0.233  Sum_probs=209.8

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      +|++.+.||+|+||.||+|++..+++.||+|+++... ....+.+.+|+.++++++||||+++++++..   ......++
T Consensus        10 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~---~~~~~~~l   86 (396)
T 4eut_A           10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE---TTTRHKVL   86 (396)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC---TTTCCEEE
T ss_pred             ceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeecc---CCCCeeEE
Confidence            5788899999999999999999999999999997433 2334667899999999999999999998642   23447899


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEe----CCCCceE
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLL----DHEMTAH  555 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll----~~~~~~k  555 (741)
                      ||||+++|+|.+++....       ....+++..++.++.|++.||+|||+.   +|+||||||+||++    +.++.+|
T Consensus        87 v~e~~~~g~L~~~l~~~~-------~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~k  156 (396)
T 4eut_A           87 IMEFCPCGSLYTVLEEPS-------NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYK  156 (396)
T ss_dssp             EECCCTTEEHHHHTTSGG-------GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEE
T ss_pred             EEecCCCCCHHHHHHhhh-------cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEE
Confidence            999999999999997431       123389999999999999999999999   99999999999999    7778899


Q ss_pred             EeecccccccCCCCcccccccccccccccCcccccC-------CCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcch
Q 037916          556 VADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGL-------GSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNL  628 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~-------~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~  628 (741)
                      |+|||.++........   ....||+.|+|||.+..       ...++.++|||||||++|||++|+.||..........
T Consensus       157 L~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~  233 (396)
T 4eut_A          157 LTDFGAARELEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK  233 (396)
T ss_dssp             ECCGGGCEECCCGGGS---SCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCH
T ss_pred             EecCCCceEccCCCcc---ccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchH
Confidence            9999999876554322   23569999999965432       1467889999999999999999999986432222211


Q ss_pred             hhhhhh--cCCcc-hhHh---hhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          629 HNFART--VLPDH-VMDI---VDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       629 ~~~~~~--~~~~~-~~~~---~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      ..+...  ..+.. ....   .+........          ..............+.+++.+||++||++|||+.|+++.
T Consensus       234 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~----------~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          234 EVMYKIITGKPSGAISGVQKAENGPIDWSGD----------MPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             HHHHHHHHSCCTTCCEEEECSTTCCEEEESS----------CCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             HHHHHHhcCCCcccchhheeccCCCcccCcc----------CCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence            111111  11110 0000   0000000000          000001124567788999999999999999999999999


Q ss_pred             HHHHHHh
Q 037916          703 LQSIKSI  709 (741)
Q Consensus       703 L~~i~~~  709 (741)
                      ++++.+.
T Consensus       304 l~~il~~  310 (396)
T 4eut_A          304 TSDILHR  310 (396)
T ss_dssp             HHHHHTC
T ss_pred             HHHHhhc
Confidence            9998863

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.8e-40  Score=340.78  Aligned_cols=259  Identities=20%  Similarity=0.278  Sum_probs=192.0

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcC---CCeEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDE---GKTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      .+|++.+.||+|+||.||+|.+..   .+..||+|+++... ....+.+.+|+.++++++||||+++++++.      ++
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~~   88 (281)
T 1mp8_A           15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------EN   88 (281)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC------SS
T ss_pred             HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc------cC
Confidence            468888999999999999999864   35679999986432 223456789999999999999999999852      34


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..++||||+++++|.+++...         ...+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+|
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~k  156 (281)
T 1mp8_A           89 PVWIIMELCTLGELRSFLQVR---------KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVK  156 (281)
T ss_dssp             SCEEEEECCTTEEHHHHHHHT---------TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEE
T ss_pred             ccEEEEecCCCCCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEE
Confidence            578999999999999998633         23588999999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhh
Q 037916          556 VADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  634 (741)
                      |+|||.+.......... .....+|+.|+||| ...+..++.++||||+||++|||++ |..||......  .....+  
T Consensus       157 l~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~--~~~~~i--  230 (281)
T 1mp8_A          157 LGDFGLSRYMEDSTYYK-ASKGKLPIKWMAPE-SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRI--  230 (281)
T ss_dssp             ECC--------------------CCGGGCCHH-HHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHH--
T ss_pred             ECccccccccCcccccc-cccCCCcccccChh-hcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH--HHHHHH--
Confidence            99999998765433221 12234678999995 4456678999999999999999996 99998632211  111000  


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHhh
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSIL  710 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  710 (741)
                               .......                   .+..+++.+.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus       231 ---------~~~~~~~-------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  278 (281)
T 1mp8_A          231 ---------ENGERLP-------------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  278 (281)
T ss_dssp             ---------HTTCCCC-------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ---------HcCCCCC-------------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence                     0000000                   01133567889999999999999999999999999998654

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-39  Score=338.51  Aligned_cols=266  Identities=24%  Similarity=0.340  Sum_probs=202.5

Q ss_pred             HHHhhhcccCceeeEEEEEEcCCC---eEEEEEEeeccCc-CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceE
Q 037916          402 FLFLCWIDMGSFGSVYKGILDEGK---TIIAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      |.+.+.||+|+||.||+|.+..++   ..||+|+++.... ...+.+.+|+.++++++||||+++++++.    ..+...
T Consensus        23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~~~~~~   98 (298)
T 3pls_A           23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIML----PPEGLP   98 (298)
T ss_dssp             EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEC----CSSSCC
T ss_pred             EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEe----cCCCCc
Confidence            344578999999999999975443   3799999874322 23467789999999999999999999963    233445


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      ++||||+.+++|.+++...         ...+++..+..++.|++.||+|||+.   ||+||||||+||+++.++.+||+
T Consensus        99 ~~v~e~~~~~~L~~~~~~~---------~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~  166 (298)
T 3pls_A           99 HVLLPYMCHGDLLQFIRSP---------QRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVA  166 (298)
T ss_dssp             EEEECCCTTCBHHHHHHCT---------TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEEC
T ss_pred             EEEEecccCCCHHHHHhcc---------ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeC
Confidence            8999999999999998642         24578889999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCc--ccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhc
Q 037916          558 DFGLAKLLPPAHL--QTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV  635 (741)
Q Consensus       558 DFg~a~~~~~~~~--~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~  635 (741)
                      |||.+........  ........+|+.|+|| |...+..++.++||||+||++|+|++|..|+..... ...........
T Consensus       167 Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~-~~~~~~~~~~~  244 (298)
T 3pls_A          167 DFGLARDILDREYYSVQQHRHARLPVKWTAL-ESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID-PFDLTHFLAQG  244 (298)
T ss_dssp             CTTSSCTTTTGGGGCSCCSSCTTCGGGGSCH-HHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-GGGHHHHHHTT
T ss_pred             cCCCcccccCCcccccccCcCCCCCccccCh-hhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC-HHHHHHHhhcC
Confidence            9999986654321  1122334588999999 555677889999999999999999996665431111 11111111110


Q ss_pred             CCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHhhcCCcc
Q 037916          636 LPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSILLGPKT  715 (741)
Q Consensus       636 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~  715 (741)
                      ...            ..                  ...+++.+.+++.+||+.||++|||+.|+++.|+++.+.+.....
T Consensus       245 ~~~------------~~------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~~  294 (298)
T 3pls_A          245 RRL------------PQ------------------PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDHY  294 (298)
T ss_dssp             CCC------------CC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCCB
T ss_pred             CCC------------CC------------------CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccch
Confidence            000            00                  012345688999999999999999999999999999988775543

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=5.9e-40  Score=348.70  Aligned_cols=287  Identities=23%  Similarity=0.301  Sum_probs=202.3

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHH--HHhcCCCceeeEeeeecCccccCCce
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSA--LRNIRHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      ...|++.+.||+|+||.||+|++  +++.||+|+++..   ....+..|..+  +..++||||+++++++......+...
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   86 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME   86 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence            35688899999999999999987  5899999999743   23344444444  45589999999998665444555667


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcC------CCCceecCCCCCCeEeCC
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDC------QPTTAHCDLKPSNVLLDH  550 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~------~~~ivHrDlkp~NIll~~  550 (741)
                      .++||||+++|+|.+++...           ..++..+..++.|++.||+|||+.+      .++|+||||||+||+++.
T Consensus        87 ~~lv~e~~~~g~L~~~l~~~-----------~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~  155 (336)
T 3g2f_A           87 YLLVMEYYPNGSLXKYLSLH-----------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKN  155 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHHC-----------CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECT
T ss_pred             EEEEEecCCCCcHHHHHhhc-----------ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcC
Confidence            89999999999999998632           3478889999999999999999763      338999999999999999


Q ss_pred             CCceEEeecccccccCCCCc------ccccccccccccccCcccccCC------CCCCCccCchhHHHHHHHHHcCCCCC
Q 037916          551 EMTAHVADFGLAKLLPPAHL------QTSSIGVKGTIGYIAPAEYGLG------SEVSINGDVYSYGILLLELMTRKRPS  618 (741)
Q Consensus       551 ~~~~kL~DFg~a~~~~~~~~------~~~~~~~~gt~~y~aPEe~~~~------~~~~~~~DIwSlG~il~elltg~~p~  618 (741)
                      ++.+||+|||++........      ........||+.|+|||.+...      ..++.++|||||||++|||++|..||
T Consensus       156 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~  235 (336)
T 3g2f_A          156 DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL  235 (336)
T ss_dssp             TSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred             CCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcC
Confidence            99999999999987654321      1112234699999999654332      45678899999999999999998776


Q ss_pred             CccccCCcchhhhhhhcC-CcchhH---hhh-hcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCC
Q 037916          619 DIMFEGNMNLHNFARTVL-PDHVMD---IVD-STLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDR  693 (741)
Q Consensus       619 ~~~~~~~~~~~~~~~~~~-~~~~~~---~~d-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  693 (741)
                      ............+..... .....+   ... ........            ........+++.+.+++.+||+.||++|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~l~~li~~cl~~dP~~R  303 (336)
T 3g2f_A          236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFP------------EAWKENSLAVRSLKETIEDCWDQDAEAR  303 (336)
T ss_dssp             STTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCC------------TTCCCCSHHHHHHHHHHHHHSCSSGGGS
T ss_pred             CCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCC------------cccccccchHHHHHHHHHHHhcCChhhC
Confidence            432211111111111111 111111   000 00000000            0001112456679999999999999999


Q ss_pred             CCHHHHHHHHHHHHHhhcCC
Q 037916          694 MNMTIVVHELQSIKSILLGP  713 (741)
Q Consensus       694 Ps~~evl~~L~~i~~~~~~~  713 (741)
                      ||+.|+++.|+++...+..-
T Consensus       304 ps~~e~l~~L~~ll~~~~~~  323 (336)
T 3g2f_A          304 LTAQXAEERMAELMMIWERN  323 (336)
T ss_dssp             CCHHHHHHHHHHHHHCCCC-
T ss_pred             cchHHHHHHHHHHHHHHHhc
Confidence            99999999999999777633

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=8.8e-40  Score=341.12  Aligned_cols=264  Identities=25%  Similarity=0.378  Sum_probs=200.2

Q ss_pred             HHHHhhhcccCceeeEEEEEEcC---CCeEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCce
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDE---GKTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      .|++.+.||+|+||.||+|++..   ....||+|.++... ....+.+.+|+.++++++||||++++++|    +..+..
T Consensus        26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~----~~~~~~  101 (298)
T 3f66_A           26 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC----LRSEGS  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEE----CCSSSC
T ss_pred             ehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEE----EcCCCc
Confidence            46778899999999999999753   33468999986422 22346678999999999999999999986    344567


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .++||||+++|+|.+++...         ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||
T Consensus       102 ~~~v~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl  169 (298)
T 3f66_A          102 PLVVLPYMKHGDLRNFIRNE---------THNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKV  169 (298)
T ss_dssp             CEEEEECCTTCBHHHHHHCT---------TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEE
T ss_pred             eEEEEeCCCCCCHHHHHHhc---------ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEE
Confidence            89999999999999999643         24578889999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcc--cccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhh
Q 037916          557 ADFGLAKLLPPAHLQ--TSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFAR  633 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~--~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~  633 (741)
                      +|||.+.........  .......+|+.|+||| ...+..++.++||||+||++|+|++ |.+||......  .......
T Consensus       170 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~--~~~~~~~  246 (298)
T 3f66_A          170 ADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE-SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLL  246 (298)
T ss_dssp             CSCGGGCCCSCGGGCBC-----CCBCGGGSCHH-HHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT--THHHHHH
T ss_pred             CcccccccccccchhccccccCCCCCccccChH-HhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH--HHHHHHh
Confidence            999999876544321  1223345788999995 4456678999999999999999999 55555422111  1111110


Q ss_pred             hcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHhhcCC
Q 037916          634 TVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSILLGP  713 (741)
Q Consensus       634 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~  713 (741)
                      ...           ....                   +..++..+.+++.+||+.||++|||+.|+++.|+++...+...
T Consensus       247 ~~~-----------~~~~-------------------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~~  296 (298)
T 3f66_A          247 QGR-----------RLLQ-------------------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE  296 (298)
T ss_dssp             TTC-----------CCCC-------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCCS
T ss_pred             cCC-----------CCCC-------------------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccC
Confidence            000           0000                   0122456889999999999999999999999999998876543

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.4e-39  Score=342.08  Aligned_cols=287  Identities=23%  Similarity=0.291  Sum_probs=201.8

Q ss_pred             HHHHHHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhc--CCCceeeEeeeecCccc
Q 037916          394 VGILLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNI--RHKNLVKILTVCSGVDY  471 (741)
Q Consensus       394 ~~~~~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~hpnIv~~~~~~~~~~~  471 (741)
                      .+..+...|++.+.||+|+||.||+|++.  ++.||+|++...   .......|.+++...  +||||+++++++.... 
T Consensus        31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~-  104 (337)
T 3mdy_A           31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGT-  104 (337)
T ss_dssp             HHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC-
T ss_pred             cccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC-
Confidence            34566789999999999999999999986  899999998632   234455566666554  9999999999864321 


Q ss_pred             cCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcC-----CCCceecCCCCCCe
Q 037916          472 KGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDC-----QPTTAHCDLKPSNV  546 (741)
Q Consensus       472 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-----~~~ivHrDlkp~NI  546 (741)
                      ......++||||+++|+|.++++.           ..+++..++.++.|++.||+|||+..     .++|+||||||+||
T Consensus       105 ~~~~~~~lv~e~~~~g~L~~~l~~-----------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Ni  173 (337)
T 3mdy_A          105 GSWTQLYLITDYHENGSLYDYLKS-----------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNI  173 (337)
T ss_dssp             GGGCEEEEEECCCTTCBHHHHHHH-----------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGE
T ss_pred             CCCCceEEEEeccCCCcHHHHhhc-----------cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHE
Confidence            122578999999999999999853           34889999999999999999999752     34899999999999


Q ss_pred             EeCCCCceEEeecccccccCCCCccc--ccccccccccccCcccccCCCCCCCc------cCchhHHHHHHHHHcCCCCC
Q 037916          547 LLDHEMTAHVADFGLAKLLPPAHLQT--SSIGVKGTIGYIAPAEYGLGSEVSIN------GDVYSYGILLLELMTRKRPS  618 (741)
Q Consensus       547 ll~~~~~~kL~DFg~a~~~~~~~~~~--~~~~~~gt~~y~aPEe~~~~~~~~~~------~DIwSlG~il~elltg~~p~  618 (741)
                      +++.++.+||+|||.+..........  ......||+.|+|||.+ .+..++.+      +|||||||++|||++|..|+
T Consensus       174 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~  252 (337)
T 3mdy_A          174 LVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVL-DESLNRNHFQSYIMADMYSFGLILWEVARRCVSG  252 (337)
T ss_dssp             EECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHH-TTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred             EECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhc-ccccCCccccCccccchHHHHHHHHHHHhccCcc
Confidence            99999999999999997665432221  11234699999999544 44444444      99999999999999995554


Q ss_pred             CccccCCcchhhhhhhcCCc-chhHhhh-hcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCH
Q 037916          619 DIMFEGNMNLHNFARTVLPD-HVMDIVD-STLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNM  696 (741)
Q Consensus       619 ~~~~~~~~~~~~~~~~~~~~-~~~~~~d-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  696 (741)
                      .........+.......... ....... ........             ......++++.+.+++.+||+.||++|||+
T Consensus       253 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~  319 (337)
T 3mdy_A          253 GIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFP-------------NRWSSDECLRQMGKLMTECWAHNPASRLTA  319 (337)
T ss_dssp             TBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCC-------------GGGGGSHHHHHHHHHHHHHSCSSGGGSCCH
T ss_pred             cccccccccHhhhcCCCCchhhhHHHHhhhccCcccc-------------ccchhhHHHHHHHHHHHHhhhhChhhCCCH
Confidence            32211111111110000000 0001000 00000000             000122677889999999999999999999


Q ss_pred             HHHHHHHHHHHHhhc
Q 037916          697 TIVVHELQSIKSILL  711 (741)
Q Consensus       697 ~evl~~L~~i~~~~~  711 (741)
                      .||++.|+.+.+...
T Consensus       320 ~ell~~L~~l~~~~~  334 (337)
T 3mdy_A          320 LRVKKTLAKMSESQD  334 (337)
T ss_dssp             HHHHHHHHHHHHTTT
T ss_pred             HHHHHHHHHHHhhcc
Confidence            999999999987653

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=4.4e-39  Score=342.82  Aligned_cols=276  Identities=22%  Similarity=0.290  Sum_probs=207.4

Q ss_pred             HHHHHHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHh--cCCCceeeEeeeecCccc
Q 037916          394 VGILLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRN--IRHKNLVKILTVCSGVDY  471 (741)
Q Consensus       394 ~~~~~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~~~~~~~~~~~  471 (741)
                      .+..+...|++.+.||+|+||.||+|++.  ++.||+|+++.   .....+.+|.++++.  ++||||+++++++.... 
T Consensus        36 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~-  109 (342)
T 1b6c_B           36 VQRTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDN-  109 (342)
T ss_dssp             HHHHHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC-
T ss_pred             ecccccccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC-
Confidence            45667789999999999999999999984  89999999863   234567788888887  79999999999964321 


Q ss_pred             cCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHH--------hcCCCCceecCCCC
Q 037916          472 KGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH--------HDCQPTTAHCDLKP  543 (741)
Q Consensus       472 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--------~~~~~~ivHrDlkp  543 (741)
                      ......++||||+++|+|.+++..           ..+++.+++.++.|++.||+|||        +.   +|+||||||
T Consensus       110 ~~~~~~~lv~e~~~~g~L~~~l~~-----------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp  175 (342)
T 1b6c_B          110 GTWTQLWLVSDYHEHGSLFDYLNR-----------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKS  175 (342)
T ss_dssp             SSCCCEEEEECCCTTCBHHHHHHH-----------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSG
T ss_pred             CccceeEEEEeecCCCcHHHHHhc-----------cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCH
Confidence            112378999999999999999863           34789999999999999999999        77   999999999


Q ss_pred             CCeEeCCCCceEEeecccccccCCCCccc--ccccccccccccCcccccCCC-----CCCCccCchhHHHHHHHHHcC--
Q 037916          544 SNVLLDHEMTAHVADFGLAKLLPPAHLQT--SSIGVKGTIGYIAPAEYGLGS-----EVSINGDVYSYGILLLELMTR--  614 (741)
Q Consensus       544 ~NIll~~~~~~kL~DFg~a~~~~~~~~~~--~~~~~~gt~~y~aPEe~~~~~-----~~~~~~DIwSlG~il~elltg--  614 (741)
                      +||+++.++.+||+|||.+..........  ......||+.|+|||.+....     .++.++|||||||++|||++|  
T Consensus       176 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~  255 (342)
T 1b6c_B          176 KNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS  255 (342)
T ss_dssp             GGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBC
T ss_pred             HHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccC
Confidence            99999999999999999997765433211  123346999999996554332     234789999999999999999  


Q ss_pred             --------CCCCCccccCCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhccc
Q 037916          615 --------KRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACS  686 (741)
Q Consensus       615 --------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  686 (741)
                              ..||............+......        .........             .....+++..+.+++.+||
T Consensus       256 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~-------------~~~~~~~~~~l~~li~~cl  314 (342)
T 1b6c_B          256 IGGIHEDYQLPYYDLVPSDPSVEEMRKVVCE--------QKLRPNIPN-------------RWQSCEALRVMAKIMRECW  314 (342)
T ss_dssp             BTTBCCCCCCTTTTTSCSSCCHHHHHHHHTT--------SCCCCCCCG-------------GGGTSHHHHHHHHHHHHHC
T ss_pred             cCCcccccccCccccCcCcccHHHHHHHHHH--------HHhCCCCcc-------------cccchhHHHHHHHHHHHHh
Confidence                    56665332222222222211111        011111000             0011256778999999999


Q ss_pred             ccCCCCCCCHHHHHHHHHHHHHhh
Q 037916          687 MESPQDRMNMTIVVHELQSIKSIL  710 (741)
Q Consensus       687 ~~dP~~RPs~~evl~~L~~i~~~~  710 (741)
                      +.||++|||+.||++.|+++.+..
T Consensus       315 ~~dp~~Rps~~~i~~~L~~i~~~~  338 (342)
T 1b6c_B          315 YANGAARLTALRIKKTLSQLSQQE  338 (342)
T ss_dssp             CSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             ccChhhCCCHHHHHHHHHHHHHHh
Confidence            999999999999999999998654

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.2e-39  Score=355.60  Aligned_cols=257  Identities=19%  Similarity=0.177  Sum_probs=199.6

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeecc---CcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCce
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLL---HHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      ..|++++.||+|+||.||+|++..+++.||+|+++..   .......+.+|..+++.++||||++++++|     .+...
T Consensus        74 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-----~~~~~  148 (437)
T 4aw2_A           74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF-----QDDNN  148 (437)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE-----ECSSE
T ss_pred             hheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----eeCCE
Confidence            3577888999999999999999999999999999742   223345688999999999999999999994     55668


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .|+||||+++|+|.+++...         ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||
T Consensus       149 ~~lV~Ey~~gg~L~~~l~~~---------~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL  216 (437)
T 4aw2_A          149 LYLVMDYYVGGDLLTLLSKF---------EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRL  216 (437)
T ss_dssp             EEEEECCCTTCBHHHHHHTT---------TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEE
T ss_pred             EEEEEecCCCCcHHHHHHHc---------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEE
Confidence            99999999999999999742         24588999999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccccccCccccc----CCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhh
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG----LGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFA  632 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~----~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~  632 (741)
                      +|||+|+......... .....||+.|+|||.+.    ....++.++||||+||++|||++|+.||......+ .+....
T Consensus       217 ~DFGla~~~~~~~~~~-~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~-~~~~i~  294 (437)
T 4aw2_A          217 ADFGSCLKLMEDGTVQ-SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE-TYGKIM  294 (437)
T ss_dssp             CCCTTCEECCTTSCEE-CCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHH
T ss_pred             cchhhhhhcccCCCcc-cccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH-HHHhhh
Confidence            9999998765443222 22356999999996554    25678999999999999999999999986321100 011110


Q ss_pred             hhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCC--CCCHHHHHHH
Q 037916          633 RTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQD--RMNMTIVVHE  702 (741)
Q Consensus       633 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  702 (741)
                      ..    . ..+    ..+..                  .....+.+.+++.+||..+|++  ||+++|+++-
T Consensus       295 ~~----~-~~~----~~p~~------------------~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          295 NH----K-ERF----QFPTQ------------------VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             TH----H-HHC----CCCSS------------------CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             hc----c-ccc----cCCcc------------------cccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence            00    0 000    00000                  0013456789999999988888  9999999863

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=5.1e-40  Score=366.61  Aligned_cols=257  Identities=24%  Similarity=0.394  Sum_probs=205.2

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALV  480 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv  480 (741)
                      .|++.++||+|+||.||+|.+..++..||||+++... ...+.+.+|+.++++++||||++++++|.     .....++|
T Consensus       221 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~-----~~~~~~lv  294 (495)
T 1opk_A          221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPFYII  294 (495)
T ss_dssp             GEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSCEEE
T ss_pred             HceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEe-----cCCcEEEE
Confidence            4677889999999999999999889999999997532 34577899999999999999999999963     44578999


Q ss_pred             EecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecc
Q 037916          481 YEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFG  560 (741)
Q Consensus       481 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg  560 (741)
                      |||+++|+|.+++....        ...+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||
T Consensus       295 ~E~~~~g~L~~~l~~~~--------~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG  363 (495)
T 1opk_A          295 TEFMTYGNLLDYLRECN--------RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFG  363 (495)
T ss_dssp             EECCTTCBHHHHHHHSC--------TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTT
T ss_pred             EEccCCCCHHHHHHhcC--------cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecc
Confidence            99999999999996431        24578889999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcCCcc
Q 037916          561 LAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVLPDH  639 (741)
Q Consensus       561 ~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  639 (741)
                      +++....... .......+++.|+||| +..+..++.++|||||||++|||++ |..||......  ...          
T Consensus       364 ~a~~~~~~~~-~~~~~~~~~~~y~aPE-~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--~~~----------  429 (495)
T 1opk_A          364 LSRLMTGDTY-TAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVY----------  429 (495)
T ss_dssp             CEECCTTCCE-ECCTTCCCCGGGCCHH-HHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHH----------
T ss_pred             cceeccCCce-eecCCCcCCcceeCHh-HHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--HHH----------
Confidence            9987654322 2222344678999995 4456678999999999999999999 99998632111  111          


Q ss_pred             hhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHH
Q 037916          640 VMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKS  708 (741)
Q Consensus       640 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  708 (741)
                        +.+.......                  .+..+++.+.+++.+||+.||++|||+.||++.|+.+.+
T Consensus       430 --~~~~~~~~~~------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          430 --ELLEKDYRME------------------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             --HHHHTTCCCC------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             --HHHHcCCCCC------------------CCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence              1111111000                  012345678899999999999999999999999988753

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=6.1e-40  Score=345.34  Aligned_cols=273  Identities=20%  Similarity=0.242  Sum_probs=206.9

Q ss_pred             HHHHHhhhcccCceeeEEEEEE-----cCCCeEEEEEEeeccCc-CcchhHHHHHHHHHhc-CCCceeeEeeeecCcccc
Q 037916          400 VSFLFLCWIDMGSFGSVYKGIL-----DEGKTIIAVKVLNLLHH-GASKSSIAECSALRNI-RHKNLVKILTVCSGVDYK  472 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~  472 (741)
                      .+|++.+.||+|+||.||+|.+     ..+++.||+|+++.... ...+.+.+|+.+++++ +||||+++++++.    .
T Consensus        27 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~----~  102 (316)
T 2xir_A           27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT----K  102 (316)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC----C
T ss_pred             hheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEe----c
Confidence            5688899999999999999985     35678999999974322 2345678999999999 7999999999963    3


Q ss_pred             CCceEEEEEecccCCChhhhccCCCCCCcc------cCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCe
Q 037916          473 GDDFKALVYEFMHNGSLEEWLHPVSGADKT------VEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNV  546 (741)
Q Consensus       473 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~------~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NI  546 (741)
                      .+...++||||+++++|.+++.........      ......+++..++.++.|++.||.|||+.   +|+||||||+||
T Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Ni  179 (316)
T 2xir_A          103 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNI  179 (316)
T ss_dssp             TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceE
Confidence            345689999999999999999754221000      00112378899999999999999999999   999999999999


Q ss_pred             EeCCCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCC
Q 037916          547 LLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGN  625 (741)
Q Consensus       547 ll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~  625 (741)
                      +++.++.+||+|||.+................||+.|+||| +..+..++.++||||+||++|+|++ |..||.......
T Consensus       180 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE-~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~  258 (316)
T 2xir_A          180 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE-TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  258 (316)
T ss_dssp             EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHH-HHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred             EECCCCCEEECCCccccccccCccceeccCCCcceeecCch-hhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH
Confidence            99999999999999998765443333333455788999995 4456778999999999999999998 999986322111


Q ss_pred             cchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHH
Q 037916          626 MNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQS  705 (741)
Q Consensus       626 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  705 (741)
                       .+.........            ...                  +..+++.+.+++.+||+.||++|||+.|+++.|+.
T Consensus       259 -~~~~~~~~~~~------------~~~------------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~  307 (316)
T 2xir_A          259 -EFCRRLKEGTR------------MRA------------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  307 (316)
T ss_dssp             -HHHHHHHHTCC------------CCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -HHHHHhccCcc------------CCC------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence             11101100000            000                  01224568899999999999999999999999999


Q ss_pred             HHHhhc
Q 037916          706 IKSILL  711 (741)
Q Consensus       706 i~~~~~  711 (741)
                      +.+...
T Consensus       308 ~~~~~~  313 (316)
T 2xir_A          308 LLQANA  313 (316)
T ss_dssp             HHHHHC
T ss_pred             HHhhhc
Confidence            986543

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=1.4e-38  Score=378.78  Aligned_cols=334  Identities=20%  Similarity=0.204  Sum_probs=295.2

Q ss_pred             CCCCCcccccCChhhhhCCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCccc-CCchhhhhhhhhhccccCCC
Q 037916            2 DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGE-VPSEFGKATKAYCVQNCNQH   80 (741)
Q Consensus         2 dl~~n~~~~~ip~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~~~~~~~~~~~   80 (741)
                      |.++++++ .||. +.   ++|++|||++|+|+++.+..|.++++|++|+|++|.+.+. .|.+|.++++          
T Consensus        10 dcs~~~L~-~vP~-lp---~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~----------   74 (844)
T 3j0a_A           10 FYRFCNLT-QVPQ-VL---NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPN----------   74 (844)
T ss_dssp             EESCCCSS-CCCS-SC---TTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTT----------
T ss_pred             EccCCCCC-CCCC-CC---CCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCC----------
Confidence            45667777 7887 44   8999999999999999999999999999999999965544 4888999886          


Q ss_pred             ccEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCcc--ccCCCCccEEEcccccccccCC-ccccCCCcCcEE
Q 037916           81 LKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAG--IGKFINLQTLHMWDNQLSGTIS-PAIGELQNLVTL  157 (741)
Q Consensus        81 L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~--~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L  157 (741)
                      |++|+|++|+|++..|..|..+. +|++|+|++|++.+..|..  |.++++|++|+|++|.+++..+ ..|.++++|++|
T Consensus        75 L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L  153 (844)
T 3j0a_A           75 LRILDLGSSKIYFLHPDAFQGLF-HLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSI  153 (844)
T ss_dssp             CCEEECTTCCCCEECTTSSCSCS-SCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEE
T ss_pred             CCEEECCCCcCcccCHhHccCCc-ccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEE
Confidence            99999999999999999999998 9999999999998766655  9999999999999999998765 579999999999


Q ss_pred             EcccCCCCCcCcccccCC--cccceeeccCcccccccCcccccCCC------CCEEeccCccccccCCcccccc------
Q 037916          158 AINTNKLSGNIPPSIGNL--KKLLQLYLIENFLQVSIPSSLGQCQS------LTTINLSYNNLSGTIPPQLMDL------  223 (741)
Q Consensus       158 ~L~~N~l~~~~~~~~~~l--~~L~~L~L~~N~i~~~~~~~~~~l~~------L~~L~L~~N~l~~~~p~~~~~l------  223 (741)
                      +|++|++++..+..|..+  ++|+.|+|++|.+.+..|..+..+++      |+.|+|++|++++..|..+...      
T Consensus       154 ~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l  233 (844)
T 3j0a_A          154 DFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQA  233 (844)
T ss_dssp             EEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCB
T ss_pred             ECCCCcCCeeCHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccc
Confidence            999999999999999888  89999999999999888887776665      9999999998887666555432      


Q ss_pred             --------------------------------ccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccchhhhhccc
Q 037916          224 --------------------------------TSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGS  271 (741)
Q Consensus       224 --------------------------------~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  271 (741)
                                                      ++++. |+|++|.+.+..|..|..+++|+.|+|++|+++++.+..|.+
T Consensus       234 ~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~-L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~  312 (844)
T 3j0a_A          234 FSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRH-LDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYG  312 (844)
T ss_dssp             SEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCE-EECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTT
T ss_pred             cceecccccccccccccccCCCChhhhhccccCCccE-EECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcC
Confidence                                            56777 999999999888999999999999999999999999999999


Q ss_pred             cccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccchhhhccccCCcccccCcccccccCCccccCCcccccc
Q 037916          272 CIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKNASAISV  351 (741)
Q Consensus       272 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~  351 (741)
                      +++|++|+|++|++++..+..|.++++|+.|+|++|++++..+..|..+++|+.|+|++|.+++...    ++.+..+.+
T Consensus       313 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~----~~~L~~L~l  388 (844)
T 3j0a_A          313 LDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHF----IPSIPDIFL  388 (844)
T ss_dssp             CSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSS----CCSCSEEEE
T ss_pred             CCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccC----CCCcchhcc
Confidence            9999999999999998889999999999999999999998888889999999999999999987543    566777777


Q ss_pred             cCCCC
Q 037916          352 FGNSK  356 (741)
Q Consensus       352 ~~n~~  356 (741)
                      .+|..
T Consensus       389 ~~N~l  393 (844)
T 3j0a_A          389 SGNKL  393 (844)
T ss_dssp             ESCCC
T ss_pred             CCCCc
Confidence            77754

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.1e-39  Score=337.88  Aligned_cols=255  Identities=24%  Similarity=0.286  Sum_probs=194.5

Q ss_pred             HHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCce
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      +...|.+.++||+|+||.||+|.+..++..||+|++.... ....+.+.+|+.++++++||||+++++++     .+...
T Consensus        20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~   94 (285)
T 3is5_A           20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF-----EDYHN   94 (285)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred             hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhe-----ecCCe
Confidence            4567999999999999999999999999999999997543 23456788999999999999999999995     45668


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEe---CCCCc
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLL---DHEMT  553 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll---~~~~~  553 (741)
                      .++||||+++++|.+++....      .....+++..+..++.|++.||+|||+.   +|+||||||+||++   +.++.
T Consensus        95 ~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~  165 (285)
T 3is5_A           95 MYIVMETCEGGELLERIVSAQ------ARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSP  165 (285)
T ss_dssp             EEEEECCCSCCBHHHHHHHHH------HHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCC
T ss_pred             EEEEEEeCCCCcHHHHHHhhh------hcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCC
Confidence            999999999999999885321      1124588999999999999999999999   99999999999999   44578


Q ss_pred             eEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhh
Q 037916          554 AHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFAR  633 (741)
Q Consensus       554 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~  633 (741)
                      +||+|||.+........   .....||+.|+|||.+  ...++.++||||+||++|+|++|+.||......  .......
T Consensus       166 ~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~--~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~--~~~~~~~  238 (285)
T 3is5_A          166 IKIIDFGLAELFKSDEH---STNAAGTALYMAPEVF--KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE--EVQQKAT  238 (285)
T ss_dssp             EEECCCCCCCC-------------CTTGGGCCHHHH--TTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHH
T ss_pred             EEEEeeecceecCCccc---CcCcccccCcCChHHh--ccCCCcccCeehHHHHHHHHHhCCCCCCCCCHH--HHHhhhc
Confidence            99999999976554322   2234589999999654  356889999999999999999999998632111  0000000


Q ss_pred             hcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          634 TVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       634 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ...+.         .....                   ....+.+.+++.+||+.||++|||+.|+++
T Consensus       239 ~~~~~---------~~~~~-------------------~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          239 YKEPN---------YAVEC-------------------RPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             HCCCC---------CCC---------------------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             cCCcc---------ccccc-------------------CcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00000         00000                   012356779999999999999999999985

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=5.4e-40  Score=344.81  Aligned_cols=271  Identities=18%  Similarity=0.253  Sum_probs=197.8

Q ss_pred             HHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCC
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGD  474 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~  474 (741)
                      .+..|++.+.||+|+||.||+|.+..+++.||+|+++...   ......+.+|+.++++++||||+++++++     ...
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~  104 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASF-----IED  104 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----EET
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcC
Confidence            3457899999999999999999998899999999997432   22345678999999999999999999995     345


Q ss_pred             ceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCce
Q 037916          475 DFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTA  554 (741)
Q Consensus       475 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~  554 (741)
                      ...++||||+++++|.+++.....      ....+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+
T Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~  175 (310)
T 2wqm_A          105 NELNIVLELADAGDLSRMIKHFKK------QKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVV  175 (310)
T ss_dssp             TEEEEEEECCCSCBHHHHHHHHHH------TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCE
T ss_pred             CcEEEEEecCCCCCHHHHHHHhcc------cccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCE
Confidence            589999999999999999863210      124578899999999999999999999   99999999999999999999


Q ss_pred             EEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhh
Q 037916          555 HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       555 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  634 (741)
                      ||+|||.+.........  .....|++.|+||| +..+..++.++||||||+++|+|++|..||.....   ........
T Consensus       176 kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE-~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~  249 (310)
T 2wqm_A          176 KLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPE-RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLYSLCKK  249 (310)
T ss_dssp             EECCC--------------------CCSSCCHH-HHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C---CHHHHHHH
T ss_pred             EEEeccceeeecCCCcc--ccccCCCeeEeChH-HhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch---hHHHHHHH
Confidence            99999998765443221  12245899999995 55567789999999999999999999999863211   11111110


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHhhcCCc
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSILLGPK  714 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~  714 (741)
                      ....        ......                  ....++.+.+++.+||+.||++|||+.||++.|+++....+.|.
T Consensus       250 ~~~~--------~~~~~~------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~  303 (310)
T 2wqm_A          250 IEQC--------DYPPLP------------------SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL  303 (310)
T ss_dssp             HHTT--------CSCCCC------------------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred             hhcc--------cCCCCc------------------ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence            0000        000000                  01234568899999999999999999999999999998887664

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=7e-40  Score=343.61  Aligned_cols=264  Identities=18%  Similarity=0.192  Sum_probs=196.2

Q ss_pred             HHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcC---cchhHHHHHHHHHhcCCCceeeEeeeecCccccCC
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG---ASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGD  474 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~  474 (741)
                      .+..|++.+.||+|+||.||+|++..+++.||+|+++.....   ..+.+.+|+.++++++||||+++++++     ..+
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~  106 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFG-----EID  106 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----EET
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEE-----eeC
Confidence            456799999999999999999999989999999999743222   235678999999999999999999995     445


Q ss_pred             ceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCce
Q 037916          475 DFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTA  554 (741)
Q Consensus       475 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~  554 (741)
                      ...|+||||+++++|.+++...          ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~  173 (309)
T 2h34_A          107 GQLYVDMRLINGVDLAAMLRRQ----------GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFA  173 (309)
T ss_dssp             TEEEEEEECCCCEEHHHHHHHH----------CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCE
T ss_pred             CeEEEEEEecCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCE
Confidence            6899999999999999998632          4588999999999999999999999   99999999999999999999


Q ss_pred             EEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhh
Q 037916          555 HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       555 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  634 (741)
                      ||+|||.+......... ......|++.|+||| +..+..++.++||||||+++|+|++|+.||......  .+......
T Consensus       174 kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~  249 (309)
T 2h34_A          174 YLVDFGIASATTDEKLT-QLGNTVGTLYYMAPE-RFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAHINQ  249 (309)
T ss_dssp             EECSCCC-----------------CCGGGCCGG-GTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHHHHS
T ss_pred             EEecCccCccccccccc-cccccCCCcCccCHH-HHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHHhcc
Confidence            99999999766543221 122345899999995 556678899999999999999999999998632111  11111111


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCC-CHHHHHHHHHHHHHhhc
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRM-NMTIVVHELQSIKSILL  711 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~i~~~~~  711 (741)
                      ..+.. .                           .....++..+.+++.+||+.||++|| |++|+++.|+.+.....
T Consensus       250 ~~~~~-~---------------------------~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~  299 (309)
T 2h34_A          250 AIPRP-S---------------------------TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD  299 (309)
T ss_dssp             CCCCG-G---------------------------GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred             CCCCc-c---------------------------ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence            00000 0                           00113345688999999999999999 99999999988775554

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2e-39  Score=345.86  Aligned_cols=268  Identities=20%  Similarity=0.261  Sum_probs=198.9

Q ss_pred             HHHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeecc-----CcCcchhHHHHHHHHHhcCCCceeeEeeeecCccc
Q 037916          397 LLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLL-----HHGASKSSIAECSALRNIRHKNLVKILTVCSGVDY  471 (741)
Q Consensus       397 ~~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  471 (741)
                      .+..+|++.+.||+|+||.||+|.+..+++.||+|+++..     .....+.+.+|+.++++++||||+++++++     
T Consensus        23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----   97 (345)
T 3hko_A           23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY-----   97 (345)
T ss_dssp             HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred             hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhh-----
Confidence            4667899999999999999999999999999999999743     234456788999999999999999999995     


Q ss_pred             cCCceEEEEEecccCCChhhhccCCCCCCc------------------------------ccCcccccCHHHHHHHHHHH
Q 037916          472 KGDDFKALVYEFMHNGSLEEWLHPVSGADK------------------------------TVEAPKCLNFLQRINIAIDV  521 (741)
Q Consensus       472 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------------------------------~~~~~~~~~~~~~~~i~~qi  521 (741)
                      .+....++||||+++|+|.+++........                              .......+++..++.++.|+
T Consensus        98 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi  177 (345)
T 3hko_A           98 EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI  177 (345)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred             ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence            456689999999999999999852110000                              00012334677788999999


Q ss_pred             HHHHHHHHhcCCCCceecCCCCCCeEeCCCC--ceEEeecccccccCCCCc--ccccccccccccccCcccccC-CCCCC
Q 037916          522 ACALKYLHHDCQPTTAHCDLKPSNVLLDHEM--TAHVADFGLAKLLPPAHL--QTSSIGVKGTIGYIAPAEYGL-GSEVS  596 (741)
Q Consensus       522 ~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~--~~kL~DFg~a~~~~~~~~--~~~~~~~~gt~~y~aPEe~~~-~~~~~  596 (741)
                      +.||+|||+.   +|+||||||+||+++.++  .+||+|||.+........  ........||+.|+|||.+.. ...++
T Consensus       178 ~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  254 (345)
T 3hko_A          178 FSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYG  254 (345)
T ss_dssp             HHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCC
T ss_pred             HHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCC
Confidence            9999999999   999999999999998776  899999999986533211  112233569999999965543 36789


Q ss_pred             CccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHH
Q 037916          597 INGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLI  676 (741)
Q Consensus       597 ~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (741)
                      .++|||||||++|||++|+.||......+ ...            .+..........                ......+
T Consensus       255 ~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~------------~~~~~~~~~~~~----------------~~~~~~~  305 (345)
T 3hko_A          255 PKCDAWSAGVLLHLLLMGAVPFPGVNDAD-TIS------------QVLNKKLCFENP----------------NYNVLSP  305 (345)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHH------------HHHHCCCCTTSG----------------GGGGSCH
T ss_pred             cHHHHHHHHHHHHHHHHCCCCCCCCChHH-HHH------------HHHhcccccCCc----------------ccccCCH
Confidence            99999999999999999999986321111 011            111111100000                0012345


Q ss_pred             HHHHHhhcccccCCCCCCCHHHHHH
Q 037916          677 SVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       677 ~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      .+.+++.+||+.||++|||+.|+++
T Consensus       306 ~~~~li~~~l~~~p~~Rps~~~~l~  330 (345)
T 3hko_A          306 LARDLLSNLLNRNVDERFDAMRALQ  330 (345)
T ss_dssp             HHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred             HHHHHHHHHcCCChhHCCCHHHHhc
Confidence            6889999999999999999999986

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=4.8e-40  Score=338.10  Aligned_cols=250  Identities=26%  Similarity=0.363  Sum_probs=187.1

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc----CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH----GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      ..|++.+.||+|+||.||+|.+.  +..||+|+++....    ...+.+.+|+.+++.++||||+++++++     ..+.
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   79 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVC-----LKEP   79 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----CCC-
T ss_pred             hheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----ecCC
Confidence            45788899999999999999985  78999999864322    2245778999999999999999999995     4455


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCC---ceecCCCCCCeEeCC--
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPT---TAHCDLKPSNVLLDH--  550 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~---ivHrDlkp~NIll~~--  550 (741)
                      ..++||||+++++|.+++..           ..+++..+..++.|++.||+|||+.   +   |+||||||+||+++.  
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~-----------~~~~~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~~~  145 (271)
T 3dtc_A           80 NLCLVMEFARGGPLNRVLSG-----------KRIPPDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQKV  145 (271)
T ss_dssp             -CEEEEECCTTEEHHHHHTS-----------SCCCHHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESSCC
T ss_pred             ceEEEEEcCCCCCHHHHhhc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEeccc
Confidence            78999999999999999852           3578899999999999999999999   7   999999999999986  


Q ss_pred             ------CCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccC
Q 037916          551 ------EMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEG  624 (741)
Q Consensus       551 ------~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~  624 (741)
                            ++.+||+|||.+.........    ...||+.|+||| ...+..++.++||||+|+++|+|++|+.||......
T Consensus       146 ~~~~~~~~~~kl~Dfg~~~~~~~~~~~----~~~~~~~y~aPE-~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~  220 (271)
T 3dtc_A          146 ENGDLSNKILKITDFGLAREWHRTTKM----SAAGAYAWMAPE-VIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL  220 (271)
T ss_dssp             SSSCCSSCCEEECCCCC-----------------CCGGGSCHH-HHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH
T ss_pred             ccccccCcceEEccCCccccccccccc----CCCCccceeCHH-HhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence                  678999999999865543221    245899999995 445667899999999999999999999998632111


Q ss_pred             CcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHH
Q 037916          625 NMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQ  704 (741)
Q Consensus       625 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  704 (741)
                      ....             ...........                  +..+++.+.+++.+||+.||++|||+.|+++.|+
T Consensus       221 ~~~~-------------~~~~~~~~~~~------------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~  269 (271)
T 3dtc_A          221 AVAY-------------GVAMNKLALPI------------------PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLT  269 (271)
T ss_dssp             HHHH-------------HHHTSCCCCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHH-------------hhhcCCCCCCC------------------CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHh
Confidence            0000             00000000000                  0123456889999999999999999999999997


Q ss_pred             HH
Q 037916          705 SI  706 (741)
Q Consensus       705 ~i  706 (741)
                      ++
T Consensus       270 ~l  271 (271)
T 3dtc_A          270 TI  271 (271)
T ss_dssp             C-
T ss_pred             cC
Confidence            64

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=4.8e-40  Score=363.39  Aligned_cols=258  Identities=23%  Similarity=0.370  Sum_probs=203.5

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      ..|.+.+.||+|+||.||+|.+. ++..||||+++... ...+.+.+|+.++++++||||+++++++.      ....++
T Consensus       188 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~------~~~~~l  259 (454)
T 1qcf_A          188 ESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT------KEPIYI  259 (454)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSSCEE
T ss_pred             HHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe------CCccEE
Confidence            35778889999999999999997 57889999997533 34678899999999999999999999863      346799


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      ||||+++|+|.+++...        ....+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+||
T Consensus       260 v~e~~~~g~L~~~l~~~--------~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DF  328 (454)
T 1qcf_A          260 ITEFMAKGSLLDFLKSD--------EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADF  328 (454)
T ss_dssp             EECCCTTCBHHHHHHSH--------HHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECST
T ss_pred             EEeecCCCcHHHHHHhc--------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeC
Confidence            99999999999999643        113578889999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcCCc
Q 037916          560 GLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       560 g~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      |+++........ ......+++.|+||| +.....++.++|||||||++|||++ |+.||......  .....       
T Consensus       329 G~a~~~~~~~~~-~~~~~~~~~~y~aPE-~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~--~~~~~-------  397 (454)
T 1qcf_A          329 GLARVIEDNEYT-AREGAKFPIKWTAPE-AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRA-------  397 (454)
T ss_dssp             TGGGGBCCHHHH-TTCSSSSCGGGSCHH-HHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHHH-------
T ss_pred             CCceEcCCCcee-ccCCCcccccccCHH-HhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHH-------
Confidence            999876543211 122234678999995 4456678999999999999999999 99998632111  11000       


Q ss_pred             chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHhh
Q 037916          639 HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSIL  710 (741)
Q Consensus       639 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  710 (741)
                           +.....                  ...+..+++.+.+++.+||+.||++|||+.+|++.|+++....
T Consensus       398 -----i~~~~~------------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~  446 (454)
T 1qcf_A          398 -----LERGYR------------------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT  446 (454)
T ss_dssp             -----HHHTCC------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred             -----HHcCCC------------------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence                 100000                  0001234567889999999999999999999999999886543

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=4.9e-40  Score=352.37  Aligned_cols=247  Identities=25%  Similarity=0.272  Sum_probs=187.5

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc---CcchhHHHHHHH-HHhcCCCceeeEeeeecCccccCCc
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH---GASKSSIAECSA-LRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      ..|++++.||+|+||.||+|++..+++.||+|+++....   .....+..|..+ ++.++||||++++++     +.+..
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~-----~~~~~  112 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFS-----FQTAD  112 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEE-----EECSS
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEE-----EEeCC
Confidence            468899999999999999999999999999999975332   223445667666 567899999999999     45566


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..|+||||++||+|.+++...          ..+++..++.++.||+.||+|||++   ||+||||||+||+++.++++|
T Consensus       113 ~~~lv~E~~~gg~L~~~l~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ik  179 (373)
T 2r5t_A          113 KLYFVLDYINGGELFYHLQRE----------RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIV  179 (373)
T ss_dssp             EEEEEEECCCSCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEE
T ss_pred             EEEEEEeCCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEE
Confidence            899999999999999998633          4578889999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhc
Q 037916          556 VADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV  635 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~  635 (741)
                      |+|||+++.......  ......||+.|+|| |+..+..++.++||||+||++|||++|..||.....     ....   
T Consensus       180 L~DFG~a~~~~~~~~--~~~~~~gt~~y~aP-E~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----~~~~---  248 (373)
T 2r5t_A          180 LTDFGLCKENIEHNS--TTSTFCGTPEYLAP-EVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-----AEMY---  248 (373)
T ss_dssp             ECCCCBCGGGBCCCC--CCCSBSCCCCCCCH-HHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH-----HHHH---
T ss_pred             EeeCccccccccCCC--ccccccCCccccCH-HHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----HHHH---
Confidence            999999986433221  12235699999999 555677899999999999999999999999863211     1111   


Q ss_pred             CCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHH
Q 037916          636 LPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVV  700 (741)
Q Consensus       636 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  700 (741)
                           ..+.......                    +......+.+++.+||+.||++||++.+.+
T Consensus       249 -----~~i~~~~~~~--------------------~~~~~~~~~~li~~lL~~dp~~R~~~~~~~  288 (373)
T 2r5t_A          249 -----DNILNKPLQL--------------------KPNITNSARHLLEGLLQKDRTKRLGAKDDF  288 (373)
T ss_dssp             -----HHHHHSCCCC--------------------CSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred             -----HHHHhcccCC--------------------CCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence                 1111111000                    012235678999999999999999986433

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1e-39  Score=353.66  Aligned_cols=254  Identities=19%  Similarity=0.173  Sum_probs=198.0

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeecc---CcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCce
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLL---HHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      ..|++++.||+|+||.||+|++..+++.||+|+++..   .....+.+.+|+.+++.++|||||++++++     .+...
T Consensus        69 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~~  143 (410)
T 3v8s_A           69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QDDRY  143 (410)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred             cccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCE
Confidence            3577788999999999999999999999999999742   233456688999999999999999999994     55678


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .|+||||++||+|.+++..           ..+++..++.++.||+.||+|||+.   ||+||||||+|||++.++.+||
T Consensus       144 ~~lV~E~~~gg~L~~~l~~-----------~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL  209 (410)
T 3v8s_A          144 LYMVMEYMPGGDLVNLMSN-----------YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKL  209 (410)
T ss_dssp             EEEEECCCTTEEHHHHHHH-----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEE
T ss_pred             EEEEEeCCCCCcHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEE
Confidence            9999999999999999863           2478889999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccCCC---CCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhh
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGS---EVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFAR  633 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~---~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~  633 (741)
                      +|||+|+......... .....||+.|+|||.+....   .++.++||||+||++|||++|+.||.....     .....
T Consensus       210 ~DFG~a~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----~~~~~  283 (410)
T 3v8s_A          210 ADFGTCMKMNKEGMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-----VGTYS  283 (410)
T ss_dssp             CCCTTCEECCTTSEEE-CCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHH
T ss_pred             eccceeEeeccCCccc-ccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh-----hhHHH
Confidence            9999998765443221 22356999999996554332   288999999999999999999999862211     11111


Q ss_pred             hcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCC--CCCHHHHHHH
Q 037916          634 TVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQD--RMNMTIVVHE  702 (741)
Q Consensus       634 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  702 (741)
                              .+.........                +........+.+++.+||..+|.+  ||++.||++-
T Consensus       284 --------~i~~~~~~~~~----------------p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          284 --------KIMNHKNSLTF----------------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             --------HHHTHHHHCCC----------------CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             --------HHHhccccccC----------------CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence                    11100000000                000123456789999999999988  9999998864

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.9e-39  Score=339.55  Aligned_cols=253  Identities=21%  Similarity=0.242  Sum_probs=198.1

Q ss_pred             HHHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCce
Q 037916          397 LLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       397 ~~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      .+...|.+.+.||+|+||.||+|++..+++.||+|+++.......+.+.+|+.++++++||||+++++++     .+...
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~   80 (304)
T 2jam_A            6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY-----ESTTH   80 (304)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred             chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhc-----ccCCE
Confidence            3567899999999999999999999989999999999865444556788999999999999999999994     45668


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEe---CCCCc
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLL---DHEMT  553 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll---~~~~~  553 (741)
                      .++||||+++++|.+++...          ..+++..+..++.|++.||.|||+.   ||+||||||+||++   +.++.
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~  147 (304)
T 2jam_A           81 YYLVMQLVSGGELFDRILER----------GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSK  147 (304)
T ss_dssp             EEEEECCCCSCBHHHHHHHH----------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCC
T ss_pred             EEEEEEcCCCccHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCC
Confidence            99999999999999988532          4578899999999999999999999   99999999999999   77889


Q ss_pred             eEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhh
Q 037916          554 AHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFAR  633 (741)
Q Consensus       554 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~  633 (741)
                      +||+|||.+.......    .....||+.|+||| +..+..++.++||||+||++|+|++|..||......  .....+.
T Consensus       148 ~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~i~  220 (304)
T 2jam_A          148 IMITDFGLSKMEQNGI----MSTACGTPGYVAPE-VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES--KLFEKIK  220 (304)
T ss_dssp             EEBCSCSTTCCCCCBT----THHHHSCCCBCCTT-TBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHH
T ss_pred             EEEccCCcceecCCCc----cccccCCCCccChH-HhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHH
Confidence            9999999987544321    12245899999994 556778899999999999999999999998632110  0000000


Q ss_pred             hcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          634 TVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       634 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ..           ......                ......+..+.+++.+||+.||++|||+.|+++
T Consensus       221 ~~-----------~~~~~~----------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          221 EG-----------YYEFES----------------PFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             HC-----------CCCCCT----------------TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             cC-----------CCCCCc----------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            00           000000                000123456889999999999999999999986

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.4e-40  Score=352.54  Aligned_cols=280  Identities=18%  Similarity=0.178  Sum_probs=193.6

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc--CcchhHHHHHHHHHhcCCCceeeEeeeecCcc-ccCCceE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKNLVKILTVCSGVD-YKGDDFK  477 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~~~~~~  477 (741)
                      .|++++.||+|+||.||+|.+..+++.||+|++.....  ...+.+.+|+.+++.++||||+++++++.... ..+....
T Consensus        26 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~  105 (367)
T 1cm8_A           26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF  105 (367)
T ss_dssp             SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred             eEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceE
Confidence            47888999999999999999999999999999864222  22456789999999999999999999975432 1122457


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      |+||||+ +++|.+++..           ..+++..+..++.|++.||+|||+.   ||+||||||+||+++.++.+||+
T Consensus       106 ~lv~e~~-~~~L~~~~~~-----------~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~  170 (367)
T 1cm8_A          106 YLVMPFM-GTDLGKLMKH-----------EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKIL  170 (367)
T ss_dssp             EEEEECC-SEEHHHHHHH-----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEEC
T ss_pred             EEEEecC-CCCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEE
Confidence            9999999 8899999862           3478889999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCC
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      |||+++.....     .....||+.|+|||.+.....++.++||||+||++|||++|+.||...... ..+.........
T Consensus       171 Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~l~~i~~~~g~  244 (367)
T 1cm8_A          171 DFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-DQLKEIMKVTGT  244 (367)
T ss_dssp             CCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCC
T ss_pred             eeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCC
Confidence            99999875432     223468999999976665578999999999999999999999998632111 111111111000


Q ss_pred             cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          638 DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       638 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                       ...++................................+.+.+++.+||..||++|||+.|+++-
T Consensus       245 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          245 -PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             -CCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             -CCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence             0001110000000000000000000000000112335678899999999999999999999873

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.4e-39  Score=357.68  Aligned_cols=265  Identities=19%  Similarity=0.231  Sum_probs=203.5

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCC-CceeeEeeeecCccccCCceEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRH-KNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      ..|++.++||+|+||.||+|++..+++.||||+++..  .....+.+|+.+++.+.| ++|+.+..+     .......+
T Consensus         7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~--~~~~~~~~E~~il~~L~~~~~i~~i~~~-----~~~~~~~~   79 (483)
T 3sv0_A            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLLYESKIYRILQGGTGIPNVRWF-----GVEGDYNV   79 (483)
T ss_dssp             TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETT--CSSCCHHHHHHHHHHTTTSTTCCCEEEE-----EEETTEEE
T ss_pred             CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccc--cccHHHHHHHHHHHHhcCCCCCCeEEEE-----EeeCCEEE
Confidence            4688999999999999999999989999999998743  334568899999999987 455555544     34456889


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEe---CCCCceE
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLL---DHEMTAH  555 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll---~~~~~~k  555 (741)
                      +||||+ +++|.+++...         ...+++..++.|+.||+.||+|||+.   +|+||||||+|||+   +.++.+|
T Consensus        80 lvme~~-g~sL~~ll~~~---------~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vk  146 (483)
T 3sv0_A           80 LVMDLL-GPSLEDLFNFC---------SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVY  146 (483)
T ss_dssp             EEEECC-CCBHHHHHHHT---------TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEE
T ss_pred             EEEECC-CCCHHHHHHhh---------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEE
Confidence            999999 99999998632         24589999999999999999999999   99999999999999   5788999


Q ss_pred             EeecccccccCCCCcc-----cccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhh
Q 037916          556 VADFGLAKLLPPAHLQ-----TSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHN  630 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~-----~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~  630 (741)
                      |+|||+++........     .......||+.|+|| |+..+..++.++|||||||++|||++|+.||........  ..
T Consensus       147 L~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aP-E~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~--~~  223 (483)
T 3sv0_A          147 IIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASV-NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK--KQ  223 (483)
T ss_dssp             ECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCH-HHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSH--HH
T ss_pred             EEeCCcceeccCCccccccccccccccCCCccccCH-HHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhH--HH
Confidence            9999999876544321     112245699999999 555677899999999999999999999999974322110  00


Q ss_pred             hhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHhh
Q 037916          631 FARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSIL  710 (741)
Q Consensus       631 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  710 (741)
                      .+.        .+.+......               .......++..+.+++..||+.||++||++.+|++.|+++....
T Consensus       224 ~~~--------~i~~~~~~~~---------------~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~  280 (483)
T 3sv0_A          224 KYE--------KISEKKVATS---------------IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE  280 (483)
T ss_dssp             HHH--------HHHHHHHHSC---------------HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HHH--------HHhhcccccc---------------HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence            000        0000000000               00011234567899999999999999999999999999997643

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1e-39  Score=338.11  Aligned_cols=260  Identities=22%  Similarity=0.308  Sum_probs=205.7

Q ss_pred             HHHHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccc----
Q 037916          396 ILLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDY----  471 (741)
Q Consensus       396 ~~~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~----  471 (741)
                      ..+...|++.+.||+|+||.||+|.+..+++.||+|+++..    .+.+.+|+.++++++||||+++++++....+    
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (284)
T 2a19_B            7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN----NEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET   82 (284)
T ss_dssp             HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECC----SGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred             chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence            45667899999999999999999999989999999999743    2467789999999999999999998643211    


Q ss_pred             -------cCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCC
Q 037916          472 -------KGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPS  544 (741)
Q Consensus       472 -------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~  544 (741)
                             ......++||||+++++|.+++...        ....+++..++.++.|++.||.|||+.   +|+||||||+
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~  151 (284)
T 2a19_B           83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--------RGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPS  151 (284)
T ss_dssp             ------CCEEEEEEEEECCCCSCBHHHHHHHG--------GGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred             ccccccccCcceEEEEEeccCCCCHHHHHhhc--------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHH
Confidence                   1244689999999999999998643        124588899999999999999999999   9999999999


Q ss_pred             CeEeCCCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccC
Q 037916          545 NVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEG  624 (741)
Q Consensus       545 NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~  624 (741)
                      ||+++.++.+||+|||.+.........   ....||+.|+||| +..+..++.++||||+||++|+|++|..|+....  
T Consensus       152 Nil~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--  225 (284)
T 2a19_B          152 NIFLVDTKQVKIGDFGLVTSLKNDGKR---TRSKGTLRYMSPE-QISSQDYGKEVDLYALGLILAELLHVCDTAFETS--  225 (284)
T ss_dssp             GEEEEETTEEEECCCTTCEESSCCSCC---CCCCSCCTTSCHH-HHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--
T ss_pred             HEEEcCCCCEEECcchhheeccccccc---cccCCcccccChh-hhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--
Confidence            999999999999999999876554322   2245899999995 4456778999999999999999999998864110  


Q ss_pred             CcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHH
Q 037916          625 NMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQ  704 (741)
Q Consensus       625 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  704 (741)
                           ...        ..+.+....                      ...+..+.+++.+||+.||++|||+.|+++.|+
T Consensus       226 -----~~~--------~~~~~~~~~----------------------~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~  270 (284)
T 2a19_B          226 -----KFF--------TDLRDGIIS----------------------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLT  270 (284)
T ss_dssp             -----HHH--------HHHHTTCCC----------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -----HHH--------HHhhccccc----------------------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence                 000        000000000                      012345779999999999999999999999999


Q ss_pred             HHHHhhc
Q 037916          705 SIKSILL  711 (741)
Q Consensus       705 ~i~~~~~  711 (741)
                      .+.+...
T Consensus       271 ~~~~~~~  277 (284)
T 2a19_B          271 VWKKSPE  277 (284)
T ss_dssp             HHTC---
T ss_pred             HHhhCCC
Confidence            8876544

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-39  Score=341.71  Aligned_cols=248  Identities=23%  Similarity=0.244  Sum_probs=190.4

Q ss_pred             HHHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcC--cchhHHHHHHHHHhc-CCCceeeEeeeecCccccC
Q 037916          397 LLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG--ASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKG  473 (741)
Q Consensus       397 ~~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~  473 (741)
                      ++..+|++.++||+|+||.||+|++..+++.||||++......  .......|+..+.++ +||||++++++|     ..
T Consensus        54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~-----~~  128 (311)
T 3p1a_A           54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAW-----EE  128 (311)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EE
T ss_pred             hhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEE-----Ee
Confidence            3557899999999999999999999989999999998643222  223444556555555 899999999995     45


Q ss_pred             CceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCc
Q 037916          474 DDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMT  553 (741)
Q Consensus       474 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~  553 (741)
                      +...++||||+ +++|.+++...         ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.
T Consensus       129 ~~~~~lv~e~~-~~~L~~~~~~~---------~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~  195 (311)
T 3p1a_A          129 GGILYLQTELC-GPSLQQHCEAW---------GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGR  195 (311)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHH---------CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGC
T ss_pred             CCEEEEEEecc-CCCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCC
Confidence            66899999999 77999887633         24589999999999999999999999   9999999999999999999


Q ss_pred             eEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhh
Q 037916          554 AHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFAR  633 (741)
Q Consensus       554 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~  633 (741)
                      +||+|||++.........   ....||+.|+|||.+ .+ .++.++|||||||++|||++|..|+...    ........
T Consensus       196 ~kl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~-~~-~~~~~~DiwslG~il~el~~g~~~~~~~----~~~~~~~~  266 (311)
T 3p1a_A          196 CKLGDFGLLVELGTAGAG---EVQEGDPRYMAPELL-QG-SYGTAADVFSLGLTILEVACNMELPHGG----EGWQQLRQ  266 (311)
T ss_dssp             EEECCCTTCEECC---------CCCCCGGGCCGGGG-GT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----HHHHHHTT
T ss_pred             EEEccceeeeecccCCCC---cccCCCccccCHhHh-cC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----cHHHHHhc
Confidence            999999999876543322   224589999999654 33 6899999999999999999997665311    11111111


Q ss_pred             hcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          634 TVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       634 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ...+.                              ......++.+.+++.+||+.||++|||+.|+++
T Consensus       267 ~~~~~------------------------------~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          267 GYLPP------------------------------EFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             TCCCH------------------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cCCCc------------------------------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            11000                              001133567889999999999999999999985

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.8e-39  Score=335.10  Aligned_cols=249  Identities=24%  Similarity=0.333  Sum_probs=180.6

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCce
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      ..|++.+.||+|+||.||+|++..+++.||+|+++...   ....+.+.+|+.++++++||||+++++++     .+...
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~   85 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYF-----EDSNY   85 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEE-----ECSSE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEE-----ccCCe
Confidence            56889999999999999999998899999999996422   22346788999999999999999999994     45668


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .++||||+++++|.+++...         ...+++..++.++.|+++||.|||+.   +|+||||||+||+++.++.+||
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl  153 (278)
T 3cok_A           86 VYLVLEMCHNGEMNRYLKNR---------VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKI  153 (278)
T ss_dssp             EEEEEECCTTEEHHHHHHTC---------SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEE
T ss_pred             EEEEEecCCCCcHHHHHhhc---------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEE
Confidence            99999999999999998643         24588999999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcC
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVL  636 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  636 (741)
                      +|||.+.........  .....||+.|+||| ...+..++.++||||+||++|+|++|+.||.......     ......
T Consensus       154 ~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~  225 (278)
T 3cok_A          154 ADFGLATQLKMPHEK--HYTLCGTPNYISPE-IATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN-----TLNKVV  225 (278)
T ss_dssp             CCCTTCEECC-------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------CC
T ss_pred             EeecceeeccCCCCc--ceeccCCCCcCCcc-hhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH-----HHHHHh
Confidence            999999876533221  12245899999995 5566778999999999999999999999986321111     000000


Q ss_pred             CcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          637 PDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       637 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ..            ...                .+...+..+.+++.+||+.||++|||+.|+++
T Consensus       226 ~~------------~~~----------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          226 LA------------DYE----------------MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             SS------------CCC----------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hc------------ccC----------------CccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            00            000                00012345779999999999999999999885

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=3e-39  Score=335.70  Aligned_cols=250  Identities=24%  Similarity=0.337  Sum_probs=194.7

Q ss_pred             HHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC--cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      |.+.+.||+|+||.||+|.+..++..||+|++....  ....+.+.+|+.++++++||||+++++++.... .+....++
T Consensus        28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~l  106 (290)
T 1t4h_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEEE
T ss_pred             EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CCCceEEE
Confidence            566778999999999999999999999999997432  223456789999999999999999999864321 34567899


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCC--ceecCCCCCCeEeC-CCCceEE
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPT--TAHCDLKPSNVLLD-HEMTAHV  556 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~--ivHrDlkp~NIll~-~~~~~kL  556 (741)
                      ||||+++++|.+++...          ..+++..++.++.|++.||.|||+.   +  |+||||||+||+++ .++.+||
T Consensus       107 v~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl  173 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKRF----------KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKI  173 (290)
T ss_dssp             EEECCCSCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEE
T ss_pred             EEEecCCCCHHHHHHHc----------cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEE
Confidence            99999999999998632          4578899999999999999999999   8  99999999999997 7889999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcC
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVL  636 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  636 (741)
                      +|||.+........    ....||+.|+|||.+ . +.++.++||||+||++|+|++|+.||......    ........
T Consensus       174 ~Dfg~~~~~~~~~~----~~~~~t~~y~aPE~~-~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----~~~~~~~~  243 (290)
T 1t4h_A          174 GDLGLATLKRASFA----KAVIGTPEFMAPEMY-E-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA----AQIYRRVT  243 (290)
T ss_dssp             CCTTGGGGCCTTSB----EESCSSCCCCCGGGG-G-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH----HHHHHHHT
T ss_pred             eeCCCccccccccc----ccccCCcCcCCHHHH-h-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH----HHHHHHHh
Confidence            99999976544322    224589999999654 3 45899999999999999999999998632111    11111111


Q ss_pred             CcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          637 PDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       637 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ........                          .....+.+.+++.+||+.||++|||+.|+++
T Consensus       244 ~~~~~~~~--------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          244 SGVKPASF--------------------------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             TTCCCGGG--------------------------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccCCcccc--------------------------CCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            00000000                          0112346889999999999999999999985

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=3.7e-39  Score=333.77  Aligned_cols=260  Identities=19%  Similarity=0.244  Sum_probs=201.3

Q ss_pred             HHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcC------cchhHHHHHHHHHhcCCCceeeEeeeecCccc
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG------ASKSSIAECSALRNIRHKNLVKILTVCSGVDY  471 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  471 (741)
                      +...|++.+.||+|+||.||+|++..+++.||+|+++.....      ..+.+.+|+.++++++||||+++++++     
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----   77 (283)
T 3bhy_A            3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIF-----   77 (283)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred             hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhhee-----
Confidence            446799999999999999999999989999999999743221      246788999999999999999999995     


Q ss_pred             cCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCC
Q 037916          472 KGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHE  551 (741)
Q Consensus       472 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~  551 (741)
                      ......++||||+++++|.+++...          ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.+
T Consensus        78 ~~~~~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~  144 (283)
T 3bhy_A           78 ENKTDVVLILELVSGGELFDFLAEK----------ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDK  144 (283)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCS
T ss_pred             cCCCeEEEEEeecCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecC
Confidence            4556899999999999999998632          4588999999999999999999999   99999999999999887


Q ss_pred             C----ceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcc
Q 037916          552 M----TAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMN  627 (741)
Q Consensus       552 ~----~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~  627 (741)
                      +    .+||+|||.+.........   ....||+.|+||| +..+..++.++||||+|+++|+|++|..||....... .
T Consensus       145 ~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~  219 (283)
T 3bhy_A          145 NVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE-T  219 (283)
T ss_dssp             SSSSCCEEECCCTTCEECC-----------CCCGGGCCHH-HHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-H
T ss_pred             CCCCCceEEEecccceeccCCCcc---cccCCCcCccCcc-eecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH-H
Confidence            7    8999999999876543221   2245899999995 5566788999999999999999999999986321100 0


Q ss_pred             hhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH--HHHH
Q 037916          628 LHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH--ELQS  705 (741)
Q Consensus       628 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~  705 (741)
                      ....... ..             ...              .......++.+.+++.+||..||++|||+.|+++  -++.
T Consensus       220 ~~~~~~~-~~-------------~~~--------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~  271 (283)
T 3bhy_A          220 LTNISAV-NY-------------DFD--------------EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA  271 (283)
T ss_dssp             HHHHHTT-CC-------------CCC--------------HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred             HHHhHhc-cc-------------CCc--------------chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence            0000000 00             000              0001123456889999999999999999999997  3555


Q ss_pred             HHH
Q 037916          706 IKS  708 (741)
Q Consensus       706 i~~  708 (741)
                      +..
T Consensus       272 ~~~  274 (283)
T 3bhy_A          272 IRR  274 (283)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            543

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.7e-39  Score=342.04  Aligned_cols=268  Identities=21%  Similarity=0.227  Sum_probs=194.4

Q ss_pred             HHHHh-hhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhc-CCCceeeEeeeecCccccCCceEE
Q 037916          401 SFLFL-CWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       401 ~y~~~-~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      .|++. +.||+|+||.||+|.+..+++.||+|+++.........+.+|+.+++++ +||||+++++++     .+....|
T Consensus        13 ~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~-----~~~~~~~   87 (316)
T 2ac3_A           13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF-----EEEDRFY   87 (316)
T ss_dssp             SCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEE-----EETTEEE
T ss_pred             eEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEE-----eeCCEEE
Confidence            46664 6799999999999999989999999999865555567788999999885 799999999995     4566899


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCc---eE
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMT---AH  555 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~---~k  555 (741)
                      +||||+++++|.+++...          ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.   +|
T Consensus        88 lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~k  154 (316)
T 2ac3_A           88 LVFEKMRGGSILSHIHKR----------RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVK  154 (316)
T ss_dssp             EEEECCTTCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEE
T ss_pred             EEEEcCCCCcHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceE
Confidence            999999999999998643          4578999999999999999999999   9999999999999988765   99


Q ss_pred             EeecccccccCCCCc-----ccccccccccccccCcccccC----CCCCCCccCchhHHHHHHHHHcCCCCCCccccCCc
Q 037916          556 VADFGLAKLLPPAHL-----QTSSIGVKGTIGYIAPAEYGL----GSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNM  626 (741)
Q Consensus       556 L~DFg~a~~~~~~~~-----~~~~~~~~gt~~y~aPEe~~~----~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~  626 (741)
                      |+|||++........     ........||+.|+|||.+..    ...++.++||||+||++|+|++|+.||......+.
T Consensus       155 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~  234 (316)
T 2ac3_A          155 ICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDC  234 (316)
T ss_dssp             ECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCS
T ss_pred             EEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccc
Confidence            999999876542211     111122458999999965532    24578999999999999999999999974432221


Q ss_pred             chhhhhhhcCCcc-hhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          627 NLHNFARTVLPDH-VMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       627 ~~~~~~~~~~~~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ...   ....... ...+.+.........            ........+..+.+++.+||+.||++|||+.|+++
T Consensus       235 ~~~---~~~~~~~~~~~~~~~i~~~~~~~------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          235 GWD---RGEACPACQNMLFESIQEGKYEF------------PDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             CC-------CCHHHHHHHHHHHHHCCCCC------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ccc---ccccchhHHHHHHHHHhccCccc------------CchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            110   0000000 001111100000000            00001123567889999999999999999999986

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-39  Score=345.58  Aligned_cols=262  Identities=24%  Similarity=0.366  Sum_probs=195.7

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCC----CeEEEEEEeeccCc-CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEG----KTIIAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      .|.+.+.||+|+||.||+|.+..+    +..||+|+++.... .....+.+|+.++++++||||+++++++     ....
T Consensus        45 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~  119 (333)
T 1mqb_A           45 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI-----SKYK  119 (333)
T ss_dssp             TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSS
T ss_pred             HhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----ecCC
Confidence            456678899999999999998644    35699999974322 2344678999999999999999999995     4556


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..++||||+++++|.+++...         ...+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+|
T Consensus       120 ~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~k  187 (333)
T 1mqb_A          120 PMMIITEYMENGALDKFLREK---------DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCK  187 (333)
T ss_dssp             SEEEEEECCTTEEHHHHHHHT---------TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEE
T ss_pred             CcEEEEeCCCCCcHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEE
Confidence            899999999999999998632         24588999999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCccc-ccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhh
Q 037916          556 VADFGLAKLLPPAHLQT-SSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFAR  633 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~~-~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~  633 (741)
                      |+|||.+.......... ......+|+.|+||| ...+..++.++|||||||++|||++ |+.||......  .....+.
T Consensus       188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--~~~~~~~  264 (333)
T 1mqb_A          188 VSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE-AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--EVMKAIN  264 (333)
T ss_dssp             ECCCCC-----------------CCCGGGSCHH-HHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHH
T ss_pred             ECCCCcchhhccccccccccCCCCccccccCch-hcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHH
Confidence            99999998765432211 112234678899995 4456778999999999999999999 99998632110  0000000


Q ss_pred             hcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHhhcC
Q 037916          634 TVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSILLG  712 (741)
Q Consensus       634 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~  712 (741)
                                 +......                   ...++..+.+++.+||+.||++|||+.|+++.|+++.+....
T Consensus       265 -----------~~~~~~~-------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~  313 (333)
T 1mqb_A          265 -----------DGFRLPT-------------------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS  313 (333)
T ss_dssp             -----------TTCCCCC-------------------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred             -----------CCCcCCC-------------------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence                       0000000                   012346688999999999999999999999999999875543

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=6.3e-40  Score=348.09  Aligned_cols=255  Identities=20%  Similarity=0.258  Sum_probs=196.2

Q ss_pred             HHHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhc-CCCceeeEeeeecCccccCCc
Q 037916          397 LLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       397 ~~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      .+...|++.+.||+|+||.||+|.+..+++.||+|+++...    ....+|++++.++ +||||++++++     +.++.
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~E~~~l~~~~~hp~iv~~~~~-----~~~~~   89 (342)
T 2qr7_A           19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----RDPTEEIEILLRYGQHPNIITLKDV-----YDDGK   89 (342)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT----CCCHHHHHHHHHHTTSTTBCCEEEE-----EECSS
T ss_pred             CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc----CChHHHHHHHHHhcCCCCcCeEEEE-----EEcCC
Confidence            45678999999999999999999999999999999997432    2345788888887 79999999999     45667


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCC----
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHE----  551 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~----  551 (741)
                      ..|+||||+++|+|.+++...          ..+++..+..++.||+.||+|||+.   ||+||||||+||++.++    
T Consensus        90 ~~~lv~E~~~gg~L~~~i~~~----------~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~  156 (342)
T 2qr7_A           90 YVYVVTELMKGGELLDKILRQ----------KFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNP  156 (342)
T ss_dssp             EEEEEECCCCSCBHHHHHHTC----------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSG
T ss_pred             EEEEEEeCCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCc
Confidence            899999999999999998643          4588999999999999999999999   99999999999998543    


Q ss_pred             CceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhh
Q 037916          552 MTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNF  631 (741)
Q Consensus       552 ~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~  631 (741)
                      +.+||+|||++.........  .....||+.|+||| +..+..++.++||||+||++|||++|..||.....  ......
T Consensus       157 ~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE-~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~  231 (342)
T 2qr7_A          157 ESIRICDFGFAKQLRAENGL--LMTPCYTANFVAPE-VLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD--DTPEEI  231 (342)
T ss_dssp             GGEEECCCTTCEECBCTTCC--BCCSSCCSSCCCHH-HHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT--SCHHHH
T ss_pred             CeEEEEECCCcccCcCCCCc--eeccCCCccccCHH-HhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc--CCHHHH
Confidence            35999999999876543221  22356899999995 44455688999999999999999999999863211  111111


Q ss_pred             hhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          632 ARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       632 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      ...        +..........                ......+.+.+++.+||..||++|||+.|+++-
T Consensus       232 ~~~--------i~~~~~~~~~~----------------~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  278 (342)
T 2qr7_A          232 LAR--------IGSGKFSLSGG----------------YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH  278 (342)
T ss_dssp             HHH--------HHHCCCCCCST----------------TTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             HHH--------HccCCcccCcc----------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            111        00000000000                001234567899999999999999999998863

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=4.3e-40  Score=348.37  Aligned_cols=278  Identities=18%  Similarity=0.228  Sum_probs=193.1

Q ss_pred             HHHHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc--CcchhHHHHHHHHHhcCCCceeeEeeeecCccccC
Q 037916          396 ILLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKG  473 (741)
Q Consensus       396 ~~~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  473 (741)
                      .....+|++.++||+|+||.||+|++..+++.||+|+++....  ...+.+.+|+.++++++||||+++++++     ..
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~  104 (329)
T 3gbz_A           30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVI-----HH  104 (329)
T ss_dssp             --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEE-----EE
T ss_pred             ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEE-----ec
Confidence            3455789999999999999999999999999999999974332  2244567899999999999999999994     45


Q ss_pred             CceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeC----
Q 037916          474 DDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLD----  549 (741)
Q Consensus       474 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~----  549 (741)
                      +...++||||++ |+|.+++...          ..+++..++.++.|++.||+|||+.   +|+||||||+||+++    
T Consensus       105 ~~~~~lv~e~~~-~~L~~~~~~~----------~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~  170 (329)
T 3gbz_A          105 NHRLHLIFEYAE-NDLKKYMDKN----------PDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDA  170 (329)
T ss_dssp             TTEEEEEEECCS-EEHHHHHHHC----------TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC---
T ss_pred             CCEEEEEEecCC-CCHHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCC
Confidence            668999999996 5999998643          4588999999999999999999999   999999999999994    


Q ss_pred             -CCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcch
Q 037916          550 -HEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNL  628 (741)
Q Consensus       550 -~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~  628 (741)
                       ..+.+||+|||.+.........  .....||+.|+|||.+.....++.++||||+||++|||++|..||......+ .+
T Consensus       171 ~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~  247 (329)
T 3gbz_A          171 SETPVLKIGDFGLARAFGIPIRQ--FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID-QL  247 (329)
T ss_dssp             --CCEEEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HH
T ss_pred             CccceEEECcCCCccccCCcccc--cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH-HH
Confidence             4556999999999876533221  2224589999999766555678999999999999999999999986332111 11


Q ss_pred             hhhhhhc-CCcc--hhHhhh-hcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          629 HNFARTV-LPDH--VMDIVD-STLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       629 ~~~~~~~-~~~~--~~~~~d-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ....... .+..  ...... +..........      .............+.+.+++.+||+.||++|||+.|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          248 FKIFEVLGLPDDTTWPGVTALPDWKQSFPKFR------GKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             HHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCC------CCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhCCCchhhhhhhhhhhhhhhhhhhhc------cccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            1111110 0000  000000 00000000000      000000011123466789999999999999999999975

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=4.2e-38  Score=367.10  Aligned_cols=338  Identities=24%  Similarity=0.234  Sum_probs=199.8

Q ss_pred             CCCCCcccccCChhhhhCCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCc
Q 037916            2 DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHL   81 (741)
Q Consensus         2 dl~~n~~~~~ip~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L   81 (741)
                      |.+++++. .||..+.   +++++|+|++|+|+++.+..|.++++|++|+|++|++++..|..|.++++          |
T Consensus        10 ~cs~~~L~-~ip~~~~---~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~----------L   75 (680)
T 1ziw_A           10 DCSHLKLT-QVPDDLP---TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPM----------L   75 (680)
T ss_dssp             ECCSSCCS-SCCSCSC---TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTT----------C
T ss_pred             ECCCCCcc-ccccccC---CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccC----------c
Confidence            45556665 5666554   56677777777766666666666677777777777766666666666654          6


Q ss_pred             cEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEccc
Q 037916           82 KHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINT  161 (741)
Q Consensus        82 ~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~  161 (741)
                      ++|+|++|+++++.+..|..+. +|++|+|++|++.++.|..|.++++|++|+|++|.+++..+..|.++++|++|+|++
T Consensus        76 ~~L~L~~n~l~~l~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~  154 (680)
T 1ziw_A           76 KVLNLQHNELSQLSDKTFAFCT-NLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSN  154 (680)
T ss_dssp             CEEECCSSCCCCCCTTTTTTCT-TCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCS
T ss_pred             CEEECCCCccCccChhhhccCC-CCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccC
Confidence            6666666666655555566666 666666666666666666666666666666666666666666666666666666666


Q ss_pred             CCCCCcCccccc--CCcccceeeccCcccccccCcccccC---------------------------CCCCEEeccCccc
Q 037916          162 NKLSGNIPPSIG--NLKKLLQLYLIENFLQVSIPSSLGQC---------------------------QSLTTINLSYNNL  212 (741)
Q Consensus       162 N~l~~~~~~~~~--~l~~L~~L~L~~N~i~~~~~~~~~~l---------------------------~~L~~L~L~~N~l  212 (741)
                      |++++..+..|.  .+++|++|++++|.+++..|..|..+                           ++|+.|++++|++
T Consensus       155 n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l  234 (680)
T 1ziw_A          155 NKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQL  234 (680)
T ss_dssp             SCCCCBCHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCC
T ss_pred             CcccccCHHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcc
Confidence            666655555443  34566666666666665555544433                           3445555555555


Q ss_pred             cccCCcccccccc--ceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccchhhhh----------------------
Q 037916          213 SGTIPPQLMDLTS--LSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILST----------------------  268 (741)
Q Consensus       213 ~~~~p~~~~~l~~--L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~----------------------  268 (741)
                      ++..|..|.+++.  |+. |+|++|++++..|..|+.+++|++|+|++|.++++.+..                      
T Consensus       235 ~~~~~~~~~~l~~~~L~~-L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~  313 (680)
T 1ziw_A          235 STTSNTTFLGLKWTNLTM-LDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSIS  313 (680)
T ss_dssp             CEECTTTTGGGGGSCCCE-EECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC---
T ss_pred             cccChhHhhccCcCCCCE-EECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccc
Confidence            5555555555543  554 666666655555555555666666666666555554444                      


Q ss_pred             -----------ccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCC--ccchhhhcc--ccCCcccccCccc
Q 037916          269 -----------LGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISG--EIPKFLVEL--QLVQNLNLSYNDL  333 (741)
Q Consensus       269 -----------~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~l--~~L~~L~l~~N~l  333 (741)
                                 |..+++|++|++++|++++..+..|.++++|++|+|++|.++.  ..+..|..+  ++|+.|++++|.+
T Consensus       314 ~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l  393 (680)
T 1ziw_A          314 LASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKI  393 (680)
T ss_dssp             ---CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCC
T ss_pred             cccccccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCC
Confidence                       4445555555555566655555555555555555555554321  111222222  2455555555666


Q ss_pred             ccccCCc-cccCCcccccccCCC
Q 037916          334 EGVIPTE-GVFKNASAISVFGNS  355 (741)
Q Consensus       334 ~~~~~~~-~~~~~~~~~~~~~n~  355 (741)
                      ++.+|.. ..+++++.+++.+|.
T Consensus       394 ~~~~~~~~~~l~~L~~L~L~~N~  416 (680)
T 1ziw_A          394 SKIESDAFSWLGHLEVLDLGLNE  416 (680)
T ss_dssp             CEECTTTTTTCTTCCEEECCSSC
T ss_pred             CeEChhhhhCCCCCCEEeCCCCc
Confidence            6555433 345667777777774

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=7.3e-40  Score=350.15  Aligned_cols=269  Identities=14%  Similarity=0.152  Sum_probs=202.9

Q ss_pred             HHHHhhhcccCceeeEEEEEEcC--------CCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeE----------
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDE--------GKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKI----------  462 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~----------  462 (741)
                      .|++.+.||+|+||.||+|++..        .++.||+|+++..     +.+.+|+.++++++||||+++          
T Consensus        43 ~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  117 (352)
T 2jii_A           43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL  117 (352)
T ss_dssp             EEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred             eEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence            57888999999999999999986        3889999998632     578899999999999999984          


Q ss_pred             -----eeeecCccccCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCce
Q 037916          463 -----LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTA  537 (741)
Q Consensus       463 -----~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~iv  537 (741)
                           ++++    ...+...++||||+ +++|.+++...        ....+++..++.++.||+.||+|||+.   +|+
T Consensus       118 ~i~~~~~~~----~~~~~~~~lv~e~~-~~~L~~~l~~~--------~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iv  181 (352)
T 2jii_A          118 AIPTCMGFG----VHQDKYRFLVLPSL-GRSLQSALDVS--------PKHVLSERSVLQVACRLLDALEFLHEN---EYV  181 (352)
T ss_dssp             SCCCCCEEE----EETTTEEEEEEECC-CEEHHHHHHHS--------GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCB
T ss_pred             Cccchhhcc----ccCCcEEEEEecCC-CcCHHHHHHhC--------CcCCCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence                 4443    22356889999999 99999999743        125689999999999999999999999   999


Q ss_pred             ecCCCCCCeEeCCCC--ceEEeecccccccCCCCcc-----cccccccccccccCcccccCCCCCCCccCchhHHHHHHH
Q 037916          538 HCDLKPSNVLLDHEM--TAHVADFGLAKLLPPAHLQ-----TSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLE  610 (741)
Q Consensus       538 HrDlkp~NIll~~~~--~~kL~DFg~a~~~~~~~~~-----~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~e  610 (741)
                      ||||||+||+++.++  .+||+|||+++........     .......||+.|+|| |+..+..++.++|||||||++||
T Consensus       182 H~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aP-E~~~~~~~~~~~Di~slG~il~e  260 (352)
T 2jii_A          182 HGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISM-DLHKGCGPSRRSDLQSLGYCMLK  260 (352)
T ss_dssp             CSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCH-HHHTTCCCCHHHHHHHHHHHHHH
T ss_pred             CCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCH-HHHccCCCCchhhHHHHHHHHHH
Confidence            999999999999998  9999999999876543211     111234699999999 55566789999999999999999


Q ss_pred             HHcCCCCCCccccCCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCC
Q 037916          611 LMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESP  690 (741)
Q Consensus       611 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP  690 (741)
                      |++|+.||.........+......... ....+.+....                     ....++.+.+++.+||+.||
T Consensus       261 l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---------------------~~~~~~~l~~li~~~l~~dp  318 (352)
T 2jii_A          261 WLYGFLPWTNCLPNTEDIMKQKQKFVD-KPGPFVGPCGH---------------------WIRPSETLQKYLKVVMALTY  318 (352)
T ss_dssp             HHHSCCTTGGGTTCHHHHHHHHHHHHH-SCCCEECTTSC---------------------EECCCHHHHHHHHHHHTCCT
T ss_pred             HHhCCCCcccCCcCHHHHHHHHHhccC-Chhhhhhhccc---------------------cCCCcHHHHHHHHHHHhCCh
Confidence            999999997432221111111110000 00000000000                     00124668899999999999


Q ss_pred             CCCCCHHHHHHHHHHHHHhhcCC
Q 037916          691 QDRMNMTIVVHELQSIKSILLGP  713 (741)
Q Consensus       691 ~~RPs~~evl~~L~~i~~~~~~~  713 (741)
                      ++|||+.||++.|+++.+.....
T Consensus       319 ~~Rps~~~l~~~L~~~~~~~~~~  341 (352)
T 2jii_A          319 EEKPPYAMLRNNLEALLQDLRVS  341 (352)
T ss_dssp             TCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             hhCCCHHHHHHHHHHHHHhcCCC
Confidence            99999999999999999877644

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.5e-40  Score=351.07  Aligned_cols=270  Identities=20%  Similarity=0.271  Sum_probs=192.7

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc-CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      .|+++++||+|+||.||+|++..+++.||+|+++.... .....+.+|+.++++++||||+++++++     ......++
T Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~l   77 (324)
T 3mtl_A            3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII-----HTEKSLTL   77 (324)
T ss_dssp             SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEE-----ECSSCEEE
T ss_pred             ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEE-----eeCCEEEE
Confidence            47888999999999999999998999999999974322 2223455799999999999999999995     45668999


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      ||||++ |+|.+++...         ...+++..+..++.|++.||.|||+.   ||+||||||+||+++.++.+||+||
T Consensus        78 v~e~~~-~~l~~~~~~~---------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Df  144 (324)
T 3mtl_A           78 VFEYLD-KDLKQYLDDC---------GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADF  144 (324)
T ss_dssp             EEECCS-EEHHHHHHHT---------TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSS
T ss_pred             Eecccc-cCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccC
Confidence            999996 5998888643         24588899999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcC---
Q 037916          560 GLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVL---  636 (741)
Q Consensus       560 g~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~---  636 (741)
                      |.+.........  .....||+.|+|||.+.....++.++||||+||++|+|++|+.||......+ ..........   
T Consensus       145 g~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~  221 (324)
T 3mtl_A          145 GLARAKSIPTKT--YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE-QLHFIFRILGTPT  221 (324)
T ss_dssp             SEEECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCC
T ss_pred             cccccccCCccc--cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCC
Confidence            999865433221  2234589999999766555778999999999999999999999996432111 1111111000   


Q ss_pred             CcchhHhhhh-----cccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          637 PDHVMDIVDS-----TLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       637 ~~~~~~~~d~-----~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ..........     .......          ............+.+.+++.+||+.||++|||+.|+++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          222 EETWPGILSNEEFKTYNYPKYR----------AEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             TTTSTTGGGCHHHHHTCCCCCC----------CCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hHhchhhhcchhhccccccccc----------chhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            0000000000     0000000          00001111234466789999999999999999999987

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.4e-39  Score=343.94  Aligned_cols=248  Identities=21%  Similarity=0.213  Sum_probs=186.7

Q ss_pred             HHHHHhhhcccCceeeEEEEEEc---CCCeEEEEEEeeccC----cCcchhHHHHHHHHHhcCCCceeeEeeeecCcccc
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILD---EGKTIIAVKVLNLLH----HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYK  472 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  472 (741)
                      ..|++.+.||+|+||.||+|++.   .+++.||+|+++...    ......+.+|+.++++++||||+++++++     .
T Consensus        17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~   91 (327)
T 3a62_A           17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF-----Q   91 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE-----E
T ss_pred             HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE-----E
Confidence            56889999999999999999984   588999999997432    22345577899999999999999999994     4


Q ss_pred             CCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCC
Q 037916          473 GDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEM  552 (741)
Q Consensus       473 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~  552 (741)
                      .....|+||||+++++|.+++...          ..+++..+..++.||+.||.|||+.   ||+||||||+||+++.++
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~  158 (327)
T 3a62_A           92 TGGKLYLILEYLSGGELFMQLERE----------GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQG  158 (327)
T ss_dssp             CSSCEEEEEECCTTEEHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTS
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCC
Confidence            566899999999999999998632          4578889999999999999999999   999999999999999999


Q ss_pred             ceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhh
Q 037916          553 TAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFA  632 (741)
Q Consensus       553 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~  632 (741)
                      .+||+|||+++........  .....||+.|+||| +..+..++.++||||+||++|+|++|+.||......     ...
T Consensus       159 ~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE-~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~  230 (327)
T 3a62_A          159 HVKLTDFGLCKESIHDGTV--THTFCGTIEYMAPE-ILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK-----KTI  230 (327)
T ss_dssp             CEEECCCSCC------------CTTSSCCTTSCHH-HHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHH
T ss_pred             cEEEEeCCcccccccCCcc--ccccCCCcCccCHh-hCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH-----HHH
Confidence            9999999998764432211  22356999999995 556677899999999999999999999998632110     000


Q ss_pred             hhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCC-----CHHHHHH
Q 037916          633 RTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRM-----NMTIVVH  701 (741)
Q Consensus       633 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  701 (741)
                              ..+......  .                  +......+.+++.+||+.||++||     ++.|+++
T Consensus       231 --------~~i~~~~~~--~------------------p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          231 --------DKILKCKLN--L------------------PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             --------HHHHHTCCC--C------------------CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             --------HHHHhCCCC--C------------------CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence                    011110000  0                  012245678999999999999999     6777765

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=9.4e-40  Score=347.92  Aligned_cols=251  Identities=22%  Similarity=0.320  Sum_probs=187.9

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcC--cchhHHHHHHHHHhcCC--CceeeEeeeecCccccCCce
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG--ASKSSIAECSALRNIRH--KNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~~~~~~~~~  476 (741)
                      .|++.+.||+|+||.||+|.+. +++.||+|+++.....  ..+.+.+|+.++++++|  |||+++++++     ..+..
T Consensus        10 ~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~-----~~~~~   83 (343)
T 3dbq_A           10 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-----ITDQY   83 (343)
T ss_dssp             EEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSSE
T ss_pred             EEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeE-----eeCCE
Confidence            4788999999999999999986 6889999999743322  23567899999999976  9999999994     45668


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .++|||+ .+++|.+++...          ..+++.++..++.|++.||+|||+.   +|+||||||+|||++ ++.+||
T Consensus        84 ~~lv~e~-~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl  148 (343)
T 3dbq_A           84 IYMVMEC-GNIDLNSWLKKK----------KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKL  148 (343)
T ss_dssp             EEEEECC-CSEEHHHHHHHS----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEE
T ss_pred             EEEEEeC-CCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEE
Confidence            9999995 588999998643          4588899999999999999999999   999999999999997 678999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccC----------CCCCCCccCchhHHHHHHHHHcCCCCCCccccCCc
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGL----------GSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNM  626 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~----------~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~  626 (741)
                      +|||++................||+.|+|||.+..          ...++.++|||||||++|||++|+.||........
T Consensus       149 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~  228 (343)
T 3dbq_A          149 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS  228 (343)
T ss_dssp             CCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH
T ss_pred             eecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH
Confidence            99999987655433323334569999999965432          26789999999999999999999999863211111


Q ss_pred             chhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          627 NLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       627 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      .+            ...++........                  ......+.+++.+||+.||++|||+.|+++.
T Consensus       229 ~~------------~~~~~~~~~~~~~------------------~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          229 KL------------HAIIDPNHEIEFP------------------DIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             HH------------HHHHCTTSCCCCC------------------CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HH------------HHHhcCCcccCCc------------------ccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            11            1111111111110                  0113457799999999999999999999864

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.3e-39  Score=346.33  Aligned_cols=286  Identities=20%  Similarity=0.238  Sum_probs=200.1

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc--CcchhHHHHHHHHHhcCCCceeeEeeeecCccc---cCC
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKNLVKILTVCSGVDY---KGD  474 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~---~~~  474 (741)
                      .+|++++.||+|+||.||+|++..+++.||+|++.....  .....+.+|+.+++.++||||+++++++.....   ...
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            568899999999999999999998999999999864332  234567899999999999999999999754221   114


Q ss_pred             ceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCce
Q 037916          475 DFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTA  554 (741)
Q Consensus       475 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~  554 (741)
                      ...++||||+++ ++.+.+...         ...+++.+++.++.|++.||+|||+.   ||+||||||+||+++.++.+
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~~---------~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~  163 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSNV---------LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVL  163 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHCT---------TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCE
T ss_pred             ceEEEEEeccCC-CHHHHHhhc---------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCE
Confidence            578999999964 777776532         24588999999999999999999999   99999999999999999999


Q ss_pred             EEeecccccccCCCCc--ccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhh
Q 037916          555 HVADFGLAKLLPPAHL--QTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFA  632 (741)
Q Consensus       555 kL~DFg~a~~~~~~~~--~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~  632 (741)
                      ||+|||.+........  ........||+.|+|||.+.....++.++||||+||++|+|++|..||....... ......
T Consensus       164 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~  242 (351)
T 3mi9_A          164 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-QLALIS  242 (351)
T ss_dssp             EECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHH
T ss_pred             EEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHH
Confidence            9999999987653221  1222335689999999766555678999999999999999999999987432111 111111


Q ss_pred             hh--cCCcchhHhhhh-cccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          633 RT--VLPDHVMDIVDS-TLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       633 ~~--~~~~~~~~~~d~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      ..  ..+.......+. ........   ..................+.+.+++.+||+.||++|||+.|+++-
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          243 QLCGSITPEVWPNVDNYELYEKLEL---VKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             HHHCCCCTTTSTTGGGCGGGTSSCC---CSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHhCCCChhhccccccchhhccccc---ccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            00  011110000000 00000000   000000000000001124568899999999999999999999873

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.8e-39  Score=336.36  Aligned_cols=252  Identities=19%  Similarity=0.223  Sum_probs=198.2

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc--CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      ..|++.+.||+|+||.||+|.+..+++.||+|++.....  ...+.+.+|+.++++++||||+++++++     ......
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   80 (284)
T 3kk8_A            6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESFH   80 (284)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSEE
T ss_pred             hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE-----EcCCEE
Confidence            468899999999999999999999999999999974332  2335677899999999999999999994     456688


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCc---e
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMT---A  554 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~---~  554 (741)
                      ++||||+++++|.+++...          ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.   +
T Consensus        81 ~~v~e~~~~~~l~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~  147 (284)
T 3kk8_A           81 YLVFDLVTGGELFEDIVAR----------EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAV  147 (284)
T ss_dssp             EEEECCCCSCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCE
T ss_pred             EEEEecCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcE
Confidence            9999999999998887532          4588999999999999999999999   9999999999999986654   9


Q ss_pred             EEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhh
Q 037916          555 HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       555 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  634 (741)
                      ||+|||.+.........   ....||+.|+|| |+..+..++.++||||+|+++|+|++|+.||....... ........
T Consensus       148 kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~  222 (284)
T 3kk8_A          148 KLADFGLAIEVNDSEAW---HGFAGTPGYLSP-EVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-LYAQIKAG  222 (284)
T ss_dssp             EECCCTTCEECCSSCBC---CCSCSCGGGCCH-HHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHT
T ss_pred             EEeeceeeEEcccCccc---cCCCCCcCCcCc-hhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH-HHHHHHhc
Confidence            99999999876544322   235689999999 45567778999999999999999999999985321110 00000000


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      ....            ..                ......++.+.+++.+||+.||++|||+.|+++.
T Consensus       223 ~~~~------------~~----------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          223 AYDY------------PS----------------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             CCCC------------CT----------------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             cccC------------Cc----------------hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            0000            00                0001234567899999999999999999999873

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.2e-39  Score=352.74  Aligned_cols=251  Identities=22%  Similarity=0.317  Sum_probs=188.3

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc--CcchhHHHHHHHHHhcC--CCceeeEeeeecCccccCCce
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIR--HKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      .|.+.+.||+|+||.||+|.+.. ++.||||+++....  ...+.+.+|+.+++++.  ||||+++++++     .....
T Consensus        57 ~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~-----~~~~~  130 (390)
T 2zmd_A           57 IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-----ITDQY  130 (390)
T ss_dssp             EEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSSE
T ss_pred             ceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEE-----ecCCE
Confidence            38889999999999999999874 89999999974332  23467789999999996  59999999995     44557


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .|+||| +.+++|.+++...          ..+++.++..++.||+.||.|||+.   +|+||||||+|||++ ++.+||
T Consensus       131 ~~lv~E-~~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl  195 (390)
T 2zmd_A          131 IYMVME-CGNIDLNSWLKKK----------KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKL  195 (390)
T ss_dssp             EEEEEE-CCSEEHHHHHHHC----------SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEE
T ss_pred             EEEEEe-cCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEE
Confidence            999999 5588999998643          3578888999999999999999999   999999999999995 579999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccC----------CCCCCCccCchhHHHHHHHHHcCCCCCCccccCCc
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGL----------GSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNM  626 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~----------~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~  626 (741)
                      +|||++................||+.|+|||.+..          ...++.++|||||||++|||++|+.||........
T Consensus       196 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~  275 (390)
T 2zmd_A          196 IDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS  275 (390)
T ss_dssp             CCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH
T ss_pred             EecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH
Confidence            99999987654433222334569999999965532          24689999999999999999999999863211100


Q ss_pred             chhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          627 NLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       627 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      .+            ..+++........                  ......+.+++.+||+.||++|||+.|+++.
T Consensus       276 ~~------------~~~~~~~~~~~~~------------------~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          276 KL------------HAIIDPNHEIEFP------------------DIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             HH------------HHHHCTTSCCCCC------------------CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HH------------HHHhCccccCCCC------------------ccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            11            1111111111100                  0113457899999999999999999999864

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.4e-39  Score=336.12  Aligned_cols=247  Identities=22%  Similarity=0.276  Sum_probs=195.4

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCce
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      ..|++.+.||+|+||.||+|.+..++..||+|++....   ......+.+|+.++++++||||+++++++     .+...
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~   83 (279)
T 3fdn_A            9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HDATR   83 (279)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred             ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheE-----ecCCE
Confidence            46888999999999999999999999999999986322   23345678999999999999999999995     45568


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .++||||+++++|.+++...          ..+++..+..++.|++.||+|||+.   ||+||||||+||+++.++.+||
T Consensus        84 ~~lv~e~~~~~~l~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l  150 (279)
T 3fdn_A           84 VYLILEYAPLGTVYRELQKL----------SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKI  150 (279)
T ss_dssp             EEEEECCCTTEEHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEE
T ss_pred             EEEEEecCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEE
Confidence            99999999999999998633          4578899999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcC
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVL  636 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  636 (741)
                      +|||.+........    ....||+.|+||| +..+..++.++||||+|+++|+|++|..||.....     .....   
T Consensus       151 ~Dfg~~~~~~~~~~----~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~---  217 (279)
T 3fdn_A          151 ADFGWSVHAPSSRR----TDLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-----QETYK---  217 (279)
T ss_dssp             CSCCEESCC------------CCCCTTCCHH-HHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHH---
T ss_pred             EeccccccCCcccc----cccCCCCCccCHh-HhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH-----HHHHH---
Confidence            99999865443321    2246899999994 55677889999999999999999999999862211     00000   


Q ss_pred             CcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          637 PDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       637 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                           .+.....  ..                  +...++.+.+++.+||+.||++|||+.|+++.
T Consensus       218 -----~~~~~~~--~~------------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          218 -----RISRVEF--TF------------------PDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             -----HHHHTCC--CC------------------CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             -----HHHhCCC--CC------------------CCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                 0000000  00                  01234567799999999999999999999975

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=6.2e-39  Score=344.17  Aligned_cols=256  Identities=20%  Similarity=0.298  Sum_probs=200.5

Q ss_pred             HHHHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcC--------cchhHHHHHHHHHhc-CCCceeeEeeee
Q 037916          396 ILLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG--------ASKSSIAECSALRNI-RHKNLVKILTVC  466 (741)
Q Consensus       396 ~~~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l-~hpnIv~~~~~~  466 (741)
                      ..+...|.+.+.||+|+||.||+|++..+|+.||||+++.....        ..+.+.+|+.+++++ +||||+++++++
T Consensus        90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  169 (365)
T 2y7j_A           90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY  169 (365)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence            45667899999999999999999999888999999999753321        134567899999999 899999999994


Q ss_pred             cCccccCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCe
Q 037916          467 SGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNV  546 (741)
Q Consensus       467 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NI  546 (741)
                           ......|+||||+++++|.+++...          ..+++..+..++.||+.||.|||+.   ||+||||||+||
T Consensus       170 -----~~~~~~~lv~e~~~g~~L~~~l~~~----------~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NI  231 (365)
T 2y7j_A          170 -----ESSSFMFLVFDLMRKGELFDYLTEK----------VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENI  231 (365)
T ss_dssp             -----EBSSEEEEEECCCTTCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred             -----eeCCEEEEEEEeCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHE
Confidence                 4566899999999999999998632          4588999999999999999999999   999999999999


Q ss_pred             EeCCCCceEEeecccccccCCCCcccccccccccccccCcccccC-----CCCCCCccCchhHHHHHHHHHcCCCCCCcc
Q 037916          547 LLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGL-----GSEVSINGDVYSYGILLLELMTRKRPSDIM  621 (741)
Q Consensus       547 ll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~-----~~~~~~~~DIwSlG~il~elltg~~p~~~~  621 (741)
                      +++.++.+||+|||++.........   ....||+.|+|||.+..     ...++.++|||||||++|+|++|..||...
T Consensus       232 l~~~~~~ikl~DfG~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~  308 (365)
T 2y7j_A          232 LLDDNMQIRLSDFGFSCHLEPGEKL---RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR  308 (365)
T ss_dssp             EECTTCCEEECCCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             EECCCCCEEEEecCcccccCCCccc---ccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC
Confidence            9999999999999999876544322   23569999999965432     346889999999999999999999998632


Q ss_pred             ccCCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          622 FEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       622 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ..  ......+           ........                .......+..+.+++.+||+.||++|||+.|+++
T Consensus       309 ~~--~~~~~~i-----------~~~~~~~~----------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          309 RQ--ILMLRMI-----------MEGQYQFS----------------SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             SH--HHHHHHH-----------HHTCCCCC----------------HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CH--HHHHHHH-----------HhCCCCCC----------------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11  0000000           00000000                0001123456889999999999999999999986

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2e-39  Score=348.58  Aligned_cols=260  Identities=13%  Similarity=0.085  Sum_probs=201.0

Q ss_pred             HHHHhhhcccCceeeEEEEE-----EcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcC---CCceeeEeeeecCcccc
Q 037916          401 SFLFLCWIDMGSFGSVYKGI-----LDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIR---HKNLVKILTVCSGVDYK  472 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~-----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~~~~  472 (741)
                      .|.+.+.||+|+||.||+|.     +..+++.||+|+++.   .....+..|+.++++++   |+||+++++++     .
T Consensus        66 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~-----~  137 (365)
T 3e7e_A           66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP---ANPWEFYIGTQLMERLKPSMQHMFMKFYSAH-----L  137 (365)
T ss_dssp             EEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESS---CCHHHHHHHHHHHHHSCGGGGGGBCCEEEEE-----E
T ss_pred             EEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCC---CChhHHHHHHHHHHHhhhhhhhhhhhhheee-----e
Confidence            47788899999999999994     566889999999963   34556778888888886   99999999995     4


Q ss_pred             CCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCC--
Q 037916          473 GDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDH--  550 (741)
Q Consensus       473 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~--  550 (741)
                      ..+..|+||||+++|+|.+++...+.     .....+++..++.++.||+.||+|||+.   +|+||||||+|||++.  
T Consensus       138 ~~~~~~lv~e~~~~g~L~~~l~~~~~-----~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~  209 (365)
T 3e7e_A          138 FQNGSVLVGELYSYGTLLNAINLYKN-----TPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGF  209 (365)
T ss_dssp             CSSCEEEEECCCCSCBHHHHHHHHHT-----STTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGG
T ss_pred             cCCCcEEEEeccCCCcHHHHHHHhhc-----ccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccc
Confidence            45578999999999999999964211     1235689999999999999999999999   9999999999999988  


Q ss_pred             ---------CCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCcc
Q 037916          551 ---------EMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIM  621 (741)
Q Consensus       551 ---------~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~  621 (741)
                               ++.+||+|||+|+...............||+.|+|| |+..+..++.++|||||||++|||++|+.||...
T Consensus       210 ~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aP-E~~~~~~~~~~~DiwslG~il~elltg~~pf~~~  288 (365)
T 3e7e_A          210 LEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCV-EMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKN  288 (365)
T ss_dssp             TCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCH-HHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEE
T ss_pred             cCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCCh-HHhcCCCCCccccHHHHHHHHHHHHhCCCccccC
Confidence                     899999999999765422222233446699999999 5556677999999999999999999999998633


Q ss_pred             ccCCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCC-CCHHHHH
Q 037916          622 FEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDR-MNMTIVV  700 (741)
Q Consensus       622 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~evl  700 (741)
                      ..+...........                .                     ..+.+.+++..|++.+|.+| |++.++.
T Consensus       289 ~~~~~~~~~~~~~~----------------~---------------------~~~~~~~~~~~~l~~~p~~r~~~~~~l~  331 (365)
T 3e7e_A          289 EGGECKPEGLFRRL----------------P---------------------HLDMWNEFFHVMLNIPDCHHLPSLDLLR  331 (365)
T ss_dssp             ETTEEEECSCCTTC----------------S---------------------SHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred             CCCceeechhcccc----------------C---------------------cHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence            22211111100000                0                     12345688889999999999 6889999


Q ss_pred             HHHHHHHHhhcCCc
Q 037916          701 HELQSIKSILLGPK  714 (741)
Q Consensus       701 ~~L~~i~~~~~~~~  714 (741)
                      +.|+++.+......
T Consensus       332 ~~l~~~l~~~~~~~  345 (365)
T 3e7e_A          332 QKLKKVFQQHYTNK  345 (365)
T ss_dssp             HHHHHHHHHHTTTT
T ss_pred             HHHHHHHHHhhhhc
Confidence            99999887755443

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.9e-39  Score=332.77  Aligned_cols=256  Identities=25%  Similarity=0.357  Sum_probs=202.2

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      ..|++.+.||+|+||.||+|.+. ++..||+|+++... ...+.+.+|+.++++++||||+++++++     ......++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   80 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVC-----LEQAPICL   80 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSSCEE
T ss_pred             hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCCeEE
Confidence            35788899999999999999997 67889999997533 2346788999999999999999999995     44557899


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      ||||+++++|.+++...         ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+||
T Consensus        81 v~e~~~~~~L~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~df  148 (267)
T 3t9t_A           81 VTEFMEHGCLSDYLRTQ---------RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDF  148 (267)
T ss_dssp             EECCCTTCBHHHHHHHT---------TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCT
T ss_pred             EEeCCCCCcHHHHHhhC---------cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccc
Confidence            99999999999998643         23578899999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcCCc
Q 037916          560 GLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       560 g~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      |.+........ .......+++.|+||| ...+..++.++||||+|+++|+|++ |+.||.....     ......    
T Consensus       149 g~~~~~~~~~~-~~~~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~~----  217 (267)
T 3t9t_A          149 GMTRFVLDDQY-TSSTGTKFPVKWASPE-VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-----SEVVED----  217 (267)
T ss_dssp             TGGGGBCCHHH-HSTTSTTCCGGGCCHH-HHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHH----
T ss_pred             ccccccccccc-cccccccccccccChh-hhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH-----HHHHHH----
Confidence            99987654321 1122345788999995 4456678999999999999999999 8999863211     111100    


Q ss_pred             chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHH
Q 037916          639 HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKS  708 (741)
Q Consensus       639 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  708 (741)
                          +... .....                  +...+..+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus       218 ----i~~~-~~~~~------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          218 ----ISTG-FRLYK------------------PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             ----HHTT-CCCCC------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----HhcC-CcCCC------------------CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                0000 00000                  01223567899999999999999999999999999875

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.6e-39  Score=351.08  Aligned_cols=257  Identities=19%  Similarity=0.208  Sum_probs=189.9

Q ss_pred             HHHHHh-hhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHh-cCCCceeeEeeeecCccccCCceE
Q 037916          400 VSFLFL-CWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRN-IRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       400 ~~y~~~-~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      ..|.+. +.||+|+||.||+|.+..+++.||+|+++.     .....+|+.++.+ .+||||+++++++... +.+....
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~-~~~~~~~  134 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKCL  134 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeec-ccCCcEE
Confidence            456665 689999999999999999999999999862     3467788888744 5899999999986421 1335678


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCC---CCce
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDH---EMTA  554 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~---~~~~  554 (741)
                      |+||||+++|+|.+++...        ....+++..+..++.||+.||.|||+.   +|+||||||+|||++.   ++.+
T Consensus       135 ~lv~E~~~gg~L~~~l~~~--------~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~  203 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDR--------GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAIL  203 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC-----------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCE
T ss_pred             EEEEEeCCCCcHHHHHHHh--------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccE
Confidence            9999999999999999743        124588999999999999999999999   9999999999999987   7899


Q ss_pred             EEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhh
Q 037916          555 HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       555 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  634 (741)
                      ||+|||+++.......   .....||+.|+|| |+..+..++.++|||||||++|||++|+.||.......... ..   
T Consensus       204 kl~DFG~a~~~~~~~~---~~~~~gt~~y~aP-E~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-~~---  275 (400)
T 1nxk_A          204 KLTDFGFAKETTSHNS---LTTPCYTPYYVAP-EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-GM---  275 (400)
T ss_dssp             EECCCTTCEECC--------------CTTCCG-GGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCC-SH---
T ss_pred             EEEecccccccCCCCc---cccCCCCCCccCH-hhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccH-HH---
Confidence            9999999987654322   2235689999999 55567789999999999999999999999996432211100 00   


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                           ...+.........                .....+...+.+++.+||+.||++|||+.|+++-
T Consensus       276 -----~~~i~~~~~~~~~----------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          276 -----KTRIRMGQYEFPN----------------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             -----HHHHHHTCCCCCT----------------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -----HHHHHcCcccCCC----------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                 0000000000000                0001234568899999999999999999999864

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.4e-38  Score=363.32  Aligned_cols=344  Identities=20%  Similarity=0.203  Sum_probs=265.8

Q ss_pred             CCCCCcccccCChhhhhCCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCc
Q 037916            2 DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHL   81 (741)
Q Consensus         2 dl~~n~~~~~ip~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L   81 (741)
                      ||++|++.+..|..|. .+++|++|+|++|+|+++.|.+|.++++|++|+|++|++++..+..|+++++          |
T Consensus        58 ~Ls~n~i~~i~~~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~----------L  126 (570)
T 2z63_A           58 DLSRCEIQTIEDGAYQ-SLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKT----------L  126 (570)
T ss_dssp             ECTTCCCCEECTTTTT-TCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTT----------C
T ss_pred             ECCCCcCCccCccccc-CchhCCEEeCcCCcCCccCHhhhcCccccccccccccccccCCCcccccccc----------c
Confidence            6788888754444444 7888888888888888777788888888888888888887655556777665          6


Q ss_pred             cEEECcCCcCccc-CCchhhcccccccEEEccCCcccccCCcccc-----------------------------------
Q 037916           82 KHLDINNNNFGGL-LPGCICNFSITLETLIFNSNKIFRSIPAGIG-----------------------------------  125 (741)
Q Consensus        82 ~~L~Ls~N~l~~~-~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~-----------------------------------  125 (741)
                      ++|+|++|.+++. .|..|.+++ +|++|++++|++.+..+..|.                                   
T Consensus       127 ~~L~L~~n~l~~~~lp~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~~L~~L  205 (570)
T 2z63_A          127 KELNVAHNLIQSFKLPEYFSNLT-NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKL  205 (570)
T ss_dssp             CEEECCSSCCCCCCCCGGGGGCT-TCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEE
T ss_pred             cEEecCCCccceecChhhhcccC-CCCEEeCcCCccceecHHHccchhccchhhhhcccCCCCceecCHHHhccCcceeE
Confidence            6666666666653 456666665 666666666655443333222                                   


Q ss_pred             --------------------------------------------------------------------------CCCCcc
Q 037916          126 --------------------------------------------------------------------------KFINLQ  131 (741)
Q Consensus       126 --------------------------------------------------------------------------~l~~L~  131 (741)
                                                                                                .+++|+
T Consensus       206 ~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~  285 (570)
T 2z63_A          206 TLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVS  285 (570)
T ss_dssp             EEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCS
T ss_pred             ecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCccc
Confidence                                                                                      234455


Q ss_pred             EEEcccccccccCCccc------------------------------------------cCCCcCcEEEcccCCCCCcC-
Q 037916          132 TLHMWDNQLSGTISPAI------------------------------------------GELQNLVTLAINTNKLSGNI-  168 (741)
Q Consensus       132 ~L~L~~N~i~~~~~~~~------------------------------------------~~l~~L~~L~L~~N~l~~~~-  168 (741)
                      +|++++|.++++ |..+                                          ..+++|++|++++|++++.. 
T Consensus       286 ~L~l~~~~l~~l-~~~~~~~~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~~~~~~~L~~L~l~~n~l~~~~~  364 (570)
T 2z63_A          286 SFSLVSVTIERV-KDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGC  364 (570)
T ss_dssp             EEEEESCEECSC-CBCCSCCCCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBCCCCBCTTCCEEECCSSCCBEEEE
T ss_pred             EEEecCccchhh-hhhhccCCccEEeeccCcccccCcccccccCEEeCcCCccccccccccCCCCCEEeCcCCccCcccc
Confidence            555555554432 2111                                          34567888888888887554 


Q ss_pred             -cccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCC-ccccccccceeEEEcCCCccCCCCChhhc
Q 037916          169 -PPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIP-PQLMDLTSLSVGLDLSRNQLVGSLPTEVG  246 (741)
Q Consensus       169 -~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~  246 (741)
                       +..+.++++|++|++++|.+.+..+. |..+++|++|++++|++++..| ..+.++++|+. |++++|.+.+..|..|.
T Consensus       365 ~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~-L~l~~n~l~~~~~~~~~  442 (570)
T 2z63_A          365 CSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY-LDISHTHTRVAFNGIFN  442 (570)
T ss_dssp             EEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCE-EECTTSCCEECCTTTTT
T ss_pred             ccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCE-EeCcCCcccccchhhhh
Confidence             67889999999999999999976555 9999999999999999997766 57889999998 99999999999999999


Q ss_pred             CCCCCcEEEecccccc-chhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccchhhhccccCCc
Q 037916          247 KLINLEILFISRNMLE-CEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQN  325 (741)
Q Consensus       247 ~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  325 (741)
                      .+++|++|+|++|.++ +..|..|..+++|+.|++++|++++..|.+|..+++|+.|+|++|++++..|..|..+++|+.
T Consensus       443 ~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~  522 (570)
T 2z63_A          443 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQK  522 (570)
T ss_dssp             TCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCE
T ss_pred             cCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcE
Confidence            9999999999999998 567899999999999999999999998999999999999999999999998899999999999


Q ss_pred             ccccCcccccccCCcccc-CC--cccccccCCCCccccC
Q 037916          326 LNLSYNDLEGVIPTEGVF-KN--ASAISVFGNSKLCGGI  361 (741)
Q Consensus       326 L~l~~N~l~~~~~~~~~~-~~--~~~~~~~~n~~~c~~~  361 (741)
                      |++++|++++.+|..... ..  .....+.+.+ .|..+
T Consensus       523 L~l~~N~~~~~~~~~~~~~~wl~~~~~~~~~~~-~C~~~  560 (570)
T 2z63_A          523 IWLHTNPWDCSCPRIDYLSRWLNKNSQKEQGSA-KCSGS  560 (570)
T ss_dssp             EECCSSCBCCCTTTTHHHHHHHHHTGGGEESCC-BBTTT
T ss_pred             EEecCCcccCCCcchHHHHHHHHhccccCCCch-hhCCC
Confidence            999999999988865332 11  1122344444 77655

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=4.5e-40  Score=348.73  Aligned_cols=280  Identities=20%  Similarity=0.254  Sum_probs=198.1

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcC--cchhHHHHHHHHHhcCCCceeeEeeeecCccccCCce
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG--ASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      ..+|++.+.||+|+||.||+|++..+++.||+|++......  ..+.+.+|+.++++++||||+++++++     .....
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~   98 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVC-----KKKKR   98 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEe-----ecCCE
Confidence            45788999999999999999999999999999998643322  234567899999999999999999995     45668


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .++||||+++++|.++....          ..+++..+..++.|++.||.|||+.   ||+||||||+||+++.++.+||
T Consensus        99 ~~lv~e~~~~~~l~~~~~~~----------~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl  165 (331)
T 4aaa_A           99 WYLVFEFVDHTILDDLELFP----------NGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKL  165 (331)
T ss_dssp             EEEEEECCSEEHHHHHHHST----------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEE
T ss_pred             EEEEEecCCcchHHHHHhhc----------cCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEE
Confidence            99999999998888876532          4588999999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhc-
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV-  635 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~-  635 (741)
                      +|||.+.........  .....||+.|+|||.+.....++.++||||+||++|+|++|+.||....... ......... 
T Consensus       166 ~Dfg~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~  242 (331)
T 4aaa_A          166 CDFGFARTLAAPGEV--YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID-QLYHIMMCLG  242 (331)
T ss_dssp             CCCTTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHC
T ss_pred             EeCCCceeecCCccc--cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhC
Confidence            999999766543221  1224589999999666555578999999999999999999999986332111 111111110 


Q ss_pred             -CCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          636 -LPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       636 -~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                       ..+.....+...............   ...........+++.+.+++.+||+.||++|||+.|+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          243 NLIPRHQELFNKNPVFAGVRLPEIK---EREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             SCCHHHHHHHHHCGGGTTCCCCCCS---SCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             CCChhhhhHhhhccccccccCcccc---ccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence             011111111100000000000000   0000001112345678999999999999999999998863

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.3e-39  Score=342.96  Aligned_cols=265  Identities=21%  Similarity=0.213  Sum_probs=191.4

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcC-CCceeeEeeeecCcc---ccCCce
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIR-HKNLVKILTVCSGVD---YKGDDF  476 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~---~~~~~~  476 (741)
                      +|++.+.||+|+||.||+|++..+++.||+|++........+.+.+|+.+++++. ||||+++++++....   ......
T Consensus        29 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~  108 (337)
T 3ll6_A           29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAE  108 (337)
T ss_dssp             EEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEE
T ss_pred             eEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCce
Confidence            4778899999999999999999899999999987555455667889999999995 999999999873211   134556


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCC--ceecCCCCCCeEeCCCCce
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPT--TAHCDLKPSNVLLDHEMTA  554 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~--ivHrDlkp~NIll~~~~~~  554 (741)
                      .++||||+. |+|.+++...       .....+++..++.++.|++.||+|||+.   +  |+||||||+||+++.++.+
T Consensus       109 ~~lv~e~~~-g~L~~~l~~~-------~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~  177 (337)
T 3ll6_A          109 FLLLTELCK-GQLVEFLKKM-------ESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTI  177 (337)
T ss_dssp             EEEEEECCS-EEHHHHHHHH-------HTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCE
T ss_pred             EEEEEEecC-CCHHHHHHHh-------hccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCE
Confidence            899999995 7999888632       1124589999999999999999999999   8  9999999999999999999


Q ss_pred             EEeecccccccCCCCccc----------ccccccccccccCccccc--CCCCCCCccCchhHHHHHHHHHcCCCCCCccc
Q 037916          555 HVADFGLAKLLPPAHLQT----------SSIGVKGTIGYIAPAEYG--LGSEVSINGDVYSYGILLLELMTRKRPSDIMF  622 (741)
Q Consensus       555 kL~DFg~a~~~~~~~~~~----------~~~~~~gt~~y~aPEe~~--~~~~~~~~~DIwSlG~il~elltg~~p~~~~~  622 (741)
                      ||+|||.+..........          ......||+.|+|||.+.  .+..++.++|||||||++|+|++|+.||....
T Consensus       178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~  257 (337)
T 3ll6_A          178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA  257 (337)
T ss_dssp             EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence            999999998765432211          111345899999996542  45678899999999999999999999986321


Q ss_pred             cCCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          623 EGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       623 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      ...     .........            ..                  ......+.+++.+||+.||++|||+.|+++.
T Consensus       258 ~~~-----~~~~~~~~~------------~~------------------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  302 (337)
T 3ll6_A          258 KLR-----IVNGKYSIP------------PH------------------DTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ  302 (337)
T ss_dssp             -------------CCCC------------TT------------------CCSSGGGHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             HHH-----hhcCcccCC------------cc------------------cccchHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            110     000000000            00                  0112336689999999999999999999999


Q ss_pred             HHHHHHhhc
Q 037916          703 LQSIKSILL  711 (741)
Q Consensus       703 L~~i~~~~~  711 (741)
                      |+.+.....
T Consensus       303 l~~~~~~~~  311 (337)
T 3ll6_A          303 LQEIAAARN  311 (337)
T ss_dssp             HHHHHHHTT
T ss_pred             HHHHHhccC
Confidence            999987655

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.7e-40  Score=349.08  Aligned_cols=268  Identities=19%  Similarity=0.314  Sum_probs=203.0

Q ss_pred             HHHHHhhhcccCceeeEEEEEEc-----CCCeEEEEEEeeccCc-CcchhHHHHHHHHHhcCCCceeeEeeeecCccccC
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILD-----EGKTIIAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKG  473 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  473 (741)
                      ..|++.+.||+|+||.||+|.+.     .+++.||+|+++.... .....+.+|+.++++++||||+++++++     ..
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~   99 (322)
T 1p4o_A           25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV-----SQ   99 (322)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE-----CS
T ss_pred             hheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE-----cc
Confidence            45788899999999999999886     3578899999874322 2334678999999999999999999995     44


Q ss_pred             CceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCc
Q 037916          474 DDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMT  553 (741)
Q Consensus       474 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~  553 (741)
                      ....++||||+++|+|.+++...+...........+++..++.++.|++.||.|||+.   ||+||||||+||+++.++.
T Consensus       100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~  176 (322)
T 1p4o_A          100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT  176 (322)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCC
T ss_pred             CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCe
Confidence            5678999999999999999864211000001113468899999999999999999999   9999999999999999999


Q ss_pred             eEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhh
Q 037916          554 AHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFA  632 (741)
Q Consensus       554 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~  632 (741)
                      +||+|||.+................+|+.|+||| +..+..++.++||||+||++|+|++ |..||.....     ....
T Consensus       177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----~~~~  250 (322)
T 1p4o_A          177 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE-SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-----EQVL  250 (322)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHH-HHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-----HHHH
T ss_pred             EEECcCccccccccccccccccCCCCCCCccChh-hhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH-----HHHH
Confidence            9999999998665433222223345788999995 4456678999999999999999999 8899863211     1111


Q ss_pred             hhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHH
Q 037916          633 RTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKS  708 (741)
Q Consensus       633 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  708 (741)
                      ..        +........                   ...++..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus       251 ~~--------~~~~~~~~~-------------------~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          251 RF--------VMEGGLLDK-------------------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             HH--------HHTTCCCCC-------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HH--------HHcCCcCCC-------------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            10        000000000                   01334668899999999999999999999999988754

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-39  Score=345.77  Aligned_cols=280  Identities=22%  Similarity=0.225  Sum_probs=196.1

Q ss_pred             HHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc-----CcchhHHHHHHHHHhcCCCceeeEeeeecCcccc
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH-----GASKSSIAECSALRNIRHKNLVKILTVCSGVDYK  472 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  472 (741)
                      ...+|++.+.||+|+||.||+|++..+++.||+|+++....     ...+.+.+|+.++++++||||+++++++     .
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~   82 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-----G   82 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-----C
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEE-----e
Confidence            34689999999999999999999998999999999874222     1235678999999999999999999995     4


Q ss_pred             CCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCC
Q 037916          473 GDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEM  552 (741)
Q Consensus       473 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~  552 (741)
                      .....++||||+++ +|.+++...         ...+++..+..++.|+++||+|||+.   +|+||||||+||+++.++
T Consensus        83 ~~~~~~lv~e~~~~-~l~~~~~~~---------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~  149 (346)
T 1ua2_A           83 HKSNISLVFDFMET-DLEVIIKDN---------SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENG  149 (346)
T ss_dssp             CTTCCEEEEECCSE-EHHHHHTTC---------CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTC
T ss_pred             eCCceEEEEEcCCC-CHHHHHHhc---------CcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCC
Confidence            55688999999965 888888643         23577888999999999999999999   999999999999999999


Q ss_pred             ceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhh
Q 037916          553 TAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFA  632 (741)
Q Consensus       553 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~  632 (741)
                      .+||+|||.+.........  .....||+.|+|||.+.....++.++||||+||++|+|++|..||...... ..+....
T Consensus       150 ~~kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~-~~~~~i~  226 (346)
T 1ua2_A          150 VLKLADFGLAKSFGSPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-DQLTRIF  226 (346)
T ss_dssp             CEEECCCGGGSTTTSCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHH
T ss_pred             CEEEEecccceeccCCccc--CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHH
Confidence            9999999999876543221  223568999999966655566899999999999999999999998632111 1111111


Q ss_pred             hhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          633 RTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       633 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      ..........+.+.....+..........    ............+.+++.+||+.||++|||+.|+++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          227 ETLGTPTEEQWPDMCSLPDYVTFKSFPGI----PLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             HHHCCCCTTTSSSTTSSTTCCCCCCCCCC----CHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             HHcCCCChhhhhhhccCcccccccccCCC----ChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            11100000000000000000000000000    0000112334678899999999999999999999874

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=7e-40  Score=346.46  Aligned_cols=275  Identities=22%  Similarity=0.333  Sum_probs=207.8

Q ss_pred             HHHHHhhhcccCceeeEEEEEE----cCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          400 VSFLFLCWIDMGSFGSVYKGIL----DEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      ..|++++.||+|+||.||+|++    ..+++.||+|+++.......+.+.+|+.++++++||||+++++++..   .+..
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~  117 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AGRR  117 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-------
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe---cCCC
Confidence            3578889999999999999994    56899999999976555556678899999999999999999998642   2344


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..++||||+++++|.+++...         ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+|
T Consensus       118 ~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~k  185 (326)
T 2w1i_A          118 NLKLIMEYLPYGSLRDYLQKH---------KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVK  185 (326)
T ss_dssp             CCEEEECCCTTCBHHHHHHHS---------TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEE
T ss_pred             ceEEEEECCCCCCHHHHHHhc---------ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEE
Confidence            689999999999999998643         23478899999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcc-cccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhh
Q 037916          556 VADFGLAKLLPPAHLQ-TSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~-~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  634 (741)
                      |+|||.+......... .......++..|+||| ...+..++.++||||+||++|+|++|..||......   +......
T Consensus       186 L~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~---~~~~~~~  261 (326)
T 2w1i_A          186 IGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPE-SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE---FMRMIGN  261 (326)
T ss_dssp             ECCCTTCEECCSSCSEEECSSCCSCCGGGCCHH-HHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH---HHHHHCT
T ss_pred             EecCcchhhccccccccccccCCCCceeEECch-hhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH---HHHhhcc
Confidence            9999999877654321 1122244778899995 445567889999999999999999999987522110   0000000


Q ss_pred             cCCcc-----hhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHh
Q 037916          635 VLPDH-----VMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSI  709 (741)
Q Consensus       635 ~~~~~-----~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  709 (741)
                      .....     ..+.+.....                  ...+..++..+.+++.+||+.||++|||+.||++.|+++++.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~  323 (326)
T 2w1i_A          262 DKQGQMIVFHLIELLKNNGR------------------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ  323 (326)
T ss_dssp             TCCTHHHHHHHHHHHHTTCC------------------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ccchhhhHHHHHHHhhcCCC------------------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            00000     0011110000                  011123456788999999999999999999999999999876


Q ss_pred             hc
Q 037916          710 LL  711 (741)
Q Consensus       710 ~~  711 (741)
                      +.
T Consensus       324 l~  325 (326)
T 2w1i_A          324 MA  325 (326)
T ss_dssp             HH
T ss_pred             hc
Confidence            53

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-39  Score=352.89  Aligned_cols=255  Identities=18%  Similarity=0.165  Sum_probs=197.5

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeecc---CcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCce
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLL---HHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      ..|++++.||+|+||.||+|+++.+++.||+|+++..   .....+.+.+|..++..++||||++++++     +.+...
T Consensus        61 ~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~-----~~~~~~  135 (412)
T 2vd5_A           61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFA-----FQDENY  135 (412)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEE-----EECSSE
T ss_pred             hhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEE-----EeeCCE
Confidence            4577888999999999999999999999999999742   22334568899999999999999999999     456678


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .|+||||+++|+|.+++...         ...+++..++.++.||+.||+|||+.   +|+||||||+|||++.++++||
T Consensus       136 ~~lVmE~~~gg~L~~~l~~~---------~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL  203 (412)
T 2vd5_A          136 LYLVMEYYVGGDLLTLLSKF---------GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRL  203 (412)
T ss_dssp             EEEEECCCCSCBHHHHHHHH---------SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEE
T ss_pred             EEEEEcCCCCCcHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEE
Confidence            99999999999999998632         13588999999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccC------CCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhh
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGL------GSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHN  630 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~------~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~  630 (741)
                      +|||+++......... .....||+.|+|||.+..      ...++.++||||+||++|||++|+.||.....     ..
T Consensus       204 ~DFGla~~~~~~~~~~-~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----~~  277 (412)
T 2vd5_A          204 ADFGSCLKLRADGTVR-SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST-----AE  277 (412)
T ss_dssp             CCCTTCEECCTTSCEE-CSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH-----HH
T ss_pred             eechhheeccCCCccc-cceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH-----HH
Confidence            9999998765443221 223569999999965542      45789999999999999999999999863211     00


Q ss_pred             hhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCC---CCHHHHHH
Q 037916          631 FARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDR---MNMTIVVH  701 (741)
Q Consensus       631 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~evl~  701 (741)
                      ...        .+..........               ......+..+.+++.+||. +|++|   |+++|+++
T Consensus       278 ~~~--------~i~~~~~~~~~p---------------~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          278 TYG--------KIVHYKEHLSLP---------------LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             HHH--------HHHTHHHHCCCC-------------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             HHH--------HHHhcccCcCCC---------------ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            100        000000000000               0001234668899999999 99998   58888865

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=6.2e-40  Score=347.05  Aligned_cols=270  Identities=23%  Similarity=0.338  Sum_probs=199.8

Q ss_pred             HHHHHHHhhhcccCceeeEEEEE-----EcCCCeEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccc
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGI-----LDEGKTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDY  471 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~-----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  471 (741)
                      ....|++.+.||+|+||.||+|+     +..++..||+|++.... ......+.+|+.++++++||||+++++++     
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----  102 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS-----  102 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEE-----
Confidence            34568899999999999999999     44578899999996322 23345678899999999999999999995     


Q ss_pred             cCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCC-
Q 037916          472 KGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDH-  550 (741)
Q Consensus       472 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~-  550 (741)
                      ......|+||||+++++|.+++.......   .....+++..++.++.|++.||.|||+.   +|+||||||+||+++. 
T Consensus       103 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~---~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~  176 (327)
T 2yfx_A          103 LQSLPRFILMELMAGGDLKSFLRETRPRP---SQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCP  176 (327)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHTSCCS---SSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCS
T ss_pred             cCCCCcEEEEecCCCCcHHHHHHhhcccc---cccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecC
Confidence            44557899999999999999997542211   1224588999999999999999999999   9999999999999984 


Q ss_pred             --CCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcc
Q 037916          551 --EMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMN  627 (741)
Q Consensus       551 --~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~  627 (741)
                        +..+||+|||.+................||+.|+||| +..+..++.++|||||||++|+|++ |..||.....  ..
T Consensus       177 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~  253 (327)
T 2yfx_A          177 GPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE-AFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QE  253 (327)
T ss_dssp             STTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHH-HHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HH
T ss_pred             CCcceEEECccccccccccccccccCCCcCCCcceeCHh-HhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH--HH
Confidence              4469999999997654433322233345789999995 4455678999999999999999998 9999863211  01


Q ss_pred             hhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHH
Q 037916          628 LHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIK  707 (741)
Q Consensus       628 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  707 (741)
                      ....+...            .....                  ...++..+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus       254 ~~~~~~~~------------~~~~~------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          254 VLEFVTSG------------GRMDP------------------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             HHHHHHTT------------CCCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHhcC------------CCCCC------------------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence            11111000            00000                  0123456889999999999999999999999999888


Q ss_pred             Hhhc
Q 037916          708 SILL  711 (741)
Q Consensus       708 ~~~~  711 (741)
                      +...
T Consensus       304 ~~~~  307 (327)
T 2yfx_A          304 QDPD  307 (327)
T ss_dssp             HCHH
T ss_pred             cCHH
Confidence            6443

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=5.2e-40  Score=352.27  Aligned_cols=270  Identities=20%  Similarity=0.189  Sum_probs=184.4

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC--cCcchhHHHHHHHHHhcCCCceeeEeeeecCc-cccCCce
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSGV-DYKGDDF  476 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~~~~~  476 (741)
                      .+|++++.||+|+||.||+|.+..+++.||+|++....  ....+.+.+|+.+++.++||||+++++++... .......
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  108 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND  108 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence            46889999999999999999999999999999986422  22345677999999999999999999997542 1223356


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .|+|||++ +++|.+++..           ..+++..+..++.||++||+|||+.   ||+||||||+||+++.++.+||
T Consensus       109 ~~lv~e~~-~~~L~~~~~~-----------~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL  173 (367)
T 2fst_X          109 VYLVTHLM-GADLNNIVKC-----------QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKI  173 (367)
T ss_dssp             CEEEEECC-CEECC----------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred             EEEEeccc-CCCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEE
Confidence            89999999 7899988852           3488999999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcC
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVL  636 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  636 (741)
                      +|||+++.....     .....||+.|+|||.+.....++.++||||+||++|||++|+.||...... ..+........
T Consensus       174 ~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~l~~i~~~~g  247 (367)
T 2fst_X          174 LDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVG  247 (367)
T ss_dssp             CC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHC
T ss_pred             eecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhC
Confidence            999999865432     223568999999976655578999999999999999999999998632111 11111111110


Q ss_pred             Cc-----------chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          637 PD-----------HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       637 ~~-----------~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      .+           ....++.........            ..........+.+.+|+.+||..||++|||+.|+++-
T Consensus       248 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          248 TPGAELLKKISSESARNYIQSLTQMPKM------------NFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             SCCHHHHTTCCCHHHHHHHHTSCCCCCC------------CHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCCHHHHHHhhhHHHHHHHhccCCCCCC------------CHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            00           011111100000000            0000111234668899999999999999999999863

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.5e-39  Score=334.28  Aligned_cols=259  Identities=24%  Similarity=0.389  Sum_probs=203.4

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      ..|++.+.||+|+||.||+|.+. ++..||+|+++... ...+.+.+|+.++++++||||+++++++.      ....++
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~~   84 (279)
T 1qpc_A           13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPIYI   84 (279)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC------SSSCEE
T ss_pred             HhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc------CCCcEE
Confidence            45788899999999999999987 67789999997432 34567889999999999999999999852      235799


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      ||||+++++|.+++...        ....+++..+..++.|++.||+|||+.   ||+||||||+||+++.++.+||+||
T Consensus        85 v~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Df  153 (279)
T 1qpc_A           85 ITEYMENGSLVDFLKTP--------SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADF  153 (279)
T ss_dssp             EEECCTTCBHHHHTTSH--------HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred             EEecCCCCCHHHHHhcC--------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCC
Confidence            99999999999998632        113588999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcCCc
Q 037916          560 GLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       560 g~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      |.+.......... .....+++.|+||| ...+..++.++||||+||++|||++ |+.||......  ........    
T Consensus       154 g~~~~~~~~~~~~-~~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~----  225 (279)
T 1qpc_A          154 GLARLIEDNEYTA-REGAKFPIKWTAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQNLER----  225 (279)
T ss_dssp             TTCEECSSSCEEC-CTTCCCCTTTSCHH-HHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHT----
T ss_pred             cccccccCccccc-ccCCCCccCccChh-hhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH--HHHHHHhc----
Confidence            9998765443221 22344788999995 4456678999999999999999999 89998632111  00000000    


Q ss_pred             chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHhhc
Q 037916          639 HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSILL  711 (741)
Q Consensus       639 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~  711 (741)
                              ......                  ...+++.+.+++.+||+.||++|||+.|+++.|+++.....
T Consensus       226 --------~~~~~~------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  272 (279)
T 1qpc_A          226 --------GYRMVR------------------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE  272 (279)
T ss_dssp             --------TCCCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             --------ccCCCC------------------cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence                    000000                  01234678899999999999999999999999999987654

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.2e-39  Score=345.80  Aligned_cols=270  Identities=21%  Similarity=0.280  Sum_probs=203.5

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCe-----EEEEEEeeccCc-CcchhHHHHHHHHHhc-CCCceeeEeeeecCccccC
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKT-----IIAVKVLNLLHH-GASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKG  473 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~-----~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~  473 (741)
                      .|.+.+.||+|+||.||+|.+..++.     .||+|+++.... ...+.+.+|+.+++++ +||||+++++++     ..
T Consensus        47 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~-----~~  121 (333)
T 2i1m_A           47 NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC-----TH  121 (333)
T ss_dssp             SEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CS
T ss_pred             HceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE-----ec
Confidence            46778899999999999999975554     799999974322 2345678999999999 899999999995     44


Q ss_pred             CceEEEEEecccCCChhhhccCCCCC----CcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeC
Q 037916          474 DDFKALVYEFMHNGSLEEWLHPVSGA----DKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLD  549 (741)
Q Consensus       474 ~~~~~lv~e~~~~gsL~~~l~~~~~~----~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~  549 (741)
                      ....++||||+++|+|.+++......    .........+++..++.++.|++.||+|||+.   +|+||||||+||+++
T Consensus       122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLT  198 (333)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEE
T ss_pred             CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEEC
Confidence            55789999999999999998642100    00000123578999999999999999999999   999999999999999


Q ss_pred             CCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcch
Q 037916          550 HEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNL  628 (741)
Q Consensus       550 ~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~  628 (741)
                      .++.+||+|||++................+|+.|+||| ...+..++.++|||||||++|+|++ |..||....... .+
T Consensus       199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-~~  276 (333)
T 2i1m_A          199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPE-SIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS-KF  276 (333)
T ss_dssp             GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHH-HHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH-HH
T ss_pred             CCCeEEECccccccccccccceeecCCCCCCccccCHH-HhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH-HH
Confidence            99999999999998664433322233345788999995 4456678999999999999999998 999986321111 11


Q ss_pred             hhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHH
Q 037916          629 HNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKS  708 (741)
Q Consensus       629 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  708 (741)
                      .            ...........                  +..+++.+.+++.+||+.||++|||+.||++.|+++.+
T Consensus       277 ~------------~~~~~~~~~~~------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~  326 (333)
T 2i1m_A          277 Y------------KLVKDGYQMAQ------------------PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ  326 (333)
T ss_dssp             H------------HHHHHTCCCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             H------------HHHhcCCCCCC------------------CCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence            1            11111100000                  01224568899999999999999999999999998876


Q ss_pred             hh
Q 037916          709 IL  710 (741)
Q Consensus       709 ~~  710 (741)
                      ..
T Consensus       327 ~~  328 (333)
T 2i1m_A          327 ED  328 (333)
T ss_dssp             HH
T ss_pred             hh
Confidence            54

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=6.9e-40  Score=361.61  Aligned_cols=249  Identities=20%  Similarity=0.221  Sum_probs=189.7

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeecc---CcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLL---HHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      ...|++++.||+|+||.||+|.+..+++.||+|+++..   .......+.+|+.+++.++||||+++++++     ....
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~-----~~~~  221 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHD  221 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEE-----EETT
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEE-----eeCC
Confidence            35688999999999999999999999999999999742   233345677899999999999999999995     4556


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHh-cCCCCceecCCCCCCeEeCCCCce
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH-DCQPTTAHCDLKPSNVLLDHEMTA  554 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivHrDlkp~NIll~~~~~~  554 (741)
                      ..|+||||+++|+|.+++...          ..+++..+..++.|++.||+|||+ .   ||+||||||+|||++.++.+
T Consensus       222 ~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~  288 (446)
T 4ejn_A          222 RLCFVMEYANGGELFFHLSRE----------RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHI  288 (446)
T ss_dssp             EEEEEECCCSSCBHHHHHHHH----------SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCE
T ss_pred             EEEEEEeeCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCE
Confidence            899999999999999988633          458899999999999999999998 8   99999999999999999999


Q ss_pred             EEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhh
Q 037916          555 HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       555 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  634 (741)
                      ||+|||+|+........  .....||+.|+||| +..+..++.++||||+||++|||++|+.||.....     ..... 
T Consensus       289 kl~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE-~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~-  359 (446)
T 4ejn_A          289 KITDFGLCKEGIKDGAT--MKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFE-  359 (446)
T ss_dssp             EECCCCCCCTTCC-------CCSSSCGGGCCHH-HHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH-
T ss_pred             EEccCCCceeccCCCcc--cccccCCccccCHh-hcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-----HHHHH-
Confidence            99999999864433221  22356999999995 55677899999999999999999999999863211     00100 


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCC-----CHHHHHH
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRM-----NMTIVVH  701 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  701 (741)
                             .+......  .                  +....+.+.+++.+||+.||++||     |+.|+++
T Consensus       360 -------~i~~~~~~--~------------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          360 -------LILMEEIR--F------------------PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             -------HHHHCCCC--C------------------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             -------HHHhCCCC--C------------------CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence                   00000000  0                  012245678999999999999999     9999986

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.5e-39  Score=346.30  Aligned_cols=249  Identities=26%  Similarity=0.286  Sum_probs=195.6

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcC---cchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG---ASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      ...|.+.+.||+|+||.||+|++..+++.||+|+++.....   ..+.+.+|+.++++++||||+++++++     ..+.
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~  127 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY-----LREH  127 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETT
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECC
Confidence            35688899999999999999999889999999999743322   234678999999999999999999995     4456


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..++||||+. |++.+++...         ...+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+|
T Consensus       128 ~~~lv~e~~~-g~l~~~l~~~---------~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~k  194 (348)
T 1u5q_A          128 TAWLVMEYCL-GSASDLLEVH---------KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVK  194 (348)
T ss_dssp             EEEEEEECCS-EEHHHHHHHH---------TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEE
T ss_pred             eEEEEEecCC-CCHHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEE
Confidence            8999999996 6888877522         24588999999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcccccccccccccccCccccc--CCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhh
Q 037916          556 VADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG--LGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFAR  633 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~--~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~  633 (741)
                      |+|||++......      ....||+.|+|||.+.  ....++.++|||||||++|||++|+.||....... .......
T Consensus       195 L~DfG~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-~~~~~~~  267 (348)
T 1u5q_A          195 LGDFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQ  267 (348)
T ss_dssp             ECCCTTCBSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHH
T ss_pred             EeeccCceecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHh
Confidence            9999999765432      2246899999996553  35678999999999999999999999986321100 0000100


Q ss_pred             hcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          634 TVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       634 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      ...+.         ..                     ....++.+.+++.+||+.||++|||+.|+++.
T Consensus       268 ~~~~~---------~~---------------------~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          268 NESPA---------LQ---------------------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             SCCCC---------CC---------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             cCCCC---------CC---------------------CCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            00000         00                     00223567899999999999999999999864

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=4e-39  Score=345.71  Aligned_cols=198  Identities=28%  Similarity=0.341  Sum_probs=168.5

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcC-----CCceeeEeeeecCccccC
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIR-----HKNLVKILTVCSGVDYKG  473 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----hpnIv~~~~~~~~~~~~~  473 (741)
                      ..+|+++++||+|+||.||+|++..+++.||+|+++.. .........|+.+++.+.     ||||+++++++     ..
T Consensus        34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~-----~~  107 (360)
T 3llt_A           34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKF-----MY  107 (360)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEE-----EE
T ss_pred             cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeeccccee-----eE
Confidence            35688999999999999999999989999999999632 233456678999999886     99999999995     44


Q ss_pred             CceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCC---
Q 037916          474 DDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDH---  550 (741)
Q Consensus       474 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~---  550 (741)
                      ....++||||+ +++|.+++....        ...+++..++.++.||+.||+|||+.   ||+||||||+|||++.   
T Consensus       108 ~~~~~lv~e~~-~~~L~~~~~~~~--------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~  175 (360)
T 3llt_A          108 YDHMCLIFEPL-GPSLYEIITRNN--------YNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYF  175 (360)
T ss_dssp             TTEEEEEECCC-CCBHHHHHHHTT--------TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTC
T ss_pred             CCeeEEEEcCC-CCCHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccc
Confidence            56899999999 899999987431        13488899999999999999999999   9999999999999975   


Q ss_pred             ----------------------CCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHH
Q 037916          551 ----------------------EMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILL  608 (741)
Q Consensus       551 ----------------------~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il  608 (741)
                                            ++.+||+|||++.......     ....||+.|+|| |+..+..++.++||||+||++
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aP-E~~~~~~~~~~~DiwslG~il  249 (360)
T 3llt_A          176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAP-EVILNLGWDVSSDMWSFGCVL  249 (360)
T ss_dssp             CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCH-HHHTTCCCCTTHHHHHHHHHH
T ss_pred             cccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCc-HHHcCCCCCCccchHHHHHHH
Confidence                                  7899999999998654322     234689999999 555677899999999999999


Q ss_pred             HHHHcCCCCCCc
Q 037916          609 LELMTRKRPSDI  620 (741)
Q Consensus       609 ~elltg~~p~~~  620 (741)
                      |+|++|+.||..
T Consensus       250 ~ell~g~~pf~~  261 (360)
T 3llt_A          250 AELYTGSLLFRT  261 (360)
T ss_dssp             HHHHHSSCSCCC
T ss_pred             HHHHHCCCCCCC
Confidence            999999999963

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=4.9e-39  Score=359.41  Aligned_cols=258  Identities=19%  Similarity=0.235  Sum_probs=197.7

Q ss_pred             HHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC--cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      +...|+++++||+|+||.||+|++..++..||+|+++...  ......+.+|+.+++.++||||++++++|     .+..
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~  109 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF-----EDKR  109 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCC
Confidence            4567999999999999999999999999999999997432  33456788999999999999999999995     4566


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCC---C
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHE---M  552 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~---~  552 (741)
                      ..|+||||+++|+|.+++...          ..+++..+..++.||+.||.|||+.   ||+||||||+||+++..   +
T Consensus       110 ~~~lv~e~~~~g~L~~~~~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~  176 (494)
T 3lij_A          110 NYYLVMECYKGGELFDEIIHR----------MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDA  176 (494)
T ss_dssp             EEEEEEECCCSCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTC
T ss_pred             EEEEEEecCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCC
Confidence            899999999999999887532          4588999999999999999999999   99999999999999764   4


Q ss_pred             ceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhh
Q 037916          553 TAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFA  632 (741)
Q Consensus       553 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~  632 (741)
                      .+||+|||++........   .....||+.|+|||.+ . ..++.++||||+||++|+|++|..||......  .+...+
T Consensus       177 ~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l-~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i  249 (494)
T 3lij_A          177 LIKIVDFGLSAVFENQKK---MKERLGTAYYIAPEVL-R-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ--EILRKV  249 (494)
T ss_dssp             CEEECCCTTCEECBTTBC---BCCCCSCTTTCCHHHH-T-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHH
T ss_pred             cEEEEECCCCeECCCCcc---ccccCCCcCeeCHHHH-c-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHH
Confidence            699999999987654332   2235699999999654 3 56899999999999999999999998632111  110000


Q ss_pred             hhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH--HHHHH
Q 037916          633 RTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE--LQSIK  707 (741)
Q Consensus       633 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i~  707 (741)
                      .           .........                .....++.+.+++.+||+.||++|||+.|+++-  +.+..
T Consensus       250 ~-----------~~~~~~~~~----------------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  299 (494)
T 3lij_A          250 E-----------KGKYTFDSP----------------EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMC  299 (494)
T ss_dssp             H-----------HTCCCCCSG----------------GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHH
T ss_pred             H-----------hCCCCCCch----------------hcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCc
Confidence            0           000000000                001234567899999999999999999999864  44443

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.9e-39  Score=333.50  Aligned_cols=255  Identities=23%  Similarity=0.328  Sum_probs=197.6

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc--CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCce
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      ...|++.+.||+|+||.||+|++.  ++.||+|+++....  ...+.+.+|+.++++++||||+++++++..   .....
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~~   83 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQS---PPAPH   83 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECT---TTSSS
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEcc---CCCCC
Confidence            356888999999999999999995  88899999975332  234568899999999999999999999643   22367


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCC--ceecCCCCCCeEeCCCCce
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPT--TAHCDLKPSNVLLDHEMTA  554 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~--ivHrDlkp~NIll~~~~~~  554 (741)
                      .++||||+++|+|.+++....        ...+++..++.++.|++.||+|||+.   +  |+||||||+||+++.++.+
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~  152 (271)
T 3kmu_A           84 PTLITHWMPYGSLYNVLHEGT--------NFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTA  152 (271)
T ss_dssp             CEEEEECCTTCBHHHHHHSCS--------SCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCE
T ss_pred             eEeeecccCCCcHHHHHhhcc--------cCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcce
Confidence            899999999999999997431        13589999999999999999999998   8  9999999999999999999


Q ss_pred             EEeecccccccCCCCcccccccccccccccCcccccCCCCC---CCccCchhHHHHHHHHHcCCCCCCccccCCcchhhh
Q 037916          555 HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEV---SINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNF  631 (741)
Q Consensus       555 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~---~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~  631 (741)
                      +|+|||++.....       ....||+.|+|||.+. +..+   +.++||||+||++|||++|+.||........ ... 
T Consensus       153 ~l~~~~~~~~~~~-------~~~~~t~~y~aPE~~~-~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~-  222 (271)
T 3kmu_A          153 RISMADVKFSFQS-------PGRMYAPAWVAPEALQ-KKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI-GMK-  222 (271)
T ss_dssp             EEEGGGSCCTTSC-------TTCBSCGGGSCHHHHH-SCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH-HHH-
T ss_pred             eEEeccceeeecc-------cCccCCccccChhhhc-cCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH-HHH-
Confidence            9999988754322       1245899999996554 3333   3379999999999999999999863211110 000 


Q ss_pred             hhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHH
Q 037916          632 ARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKS  708 (741)
Q Consensus       632 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  708 (741)
                                 ..........                  +..++..+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus       223 -----------~~~~~~~~~~------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          223 -----------VALEGLRPTI------------------PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             -----------HHHSCCCCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             -----------HHhcCCCCCC------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                       0000000000                  01234568899999999999999999999999998753

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.4e-39  Score=335.96  Aligned_cols=254  Identities=27%  Similarity=0.336  Sum_probs=194.1

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      ..|++.+.||+|+||.||+|.+.  ++.||+|+++..  ...+.+.+|+.++++++||||+++++++.    ......++
T Consensus        21 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~~~~~~~l   92 (278)
T 1byg_A           21 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLYI   92 (278)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEEC----CC--CCEE
T ss_pred             hhceEEeEEecCCCceEEEEEEc--CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEE----cCCCceEE
Confidence            46888899999999999999985  889999998742  34567889999999999999999999863    34457899


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      ||||+++++|.+++...        ....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        93 v~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Df  161 (278)
T 1byg_A           93 VTEYMAKGSLVDYLRSR--------GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDF  161 (278)
T ss_dssp             EECCCTTEEHHHHHHHH--------HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCC
T ss_pred             EEecCCCCCHHHHHHhc--------ccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeec
Confidence            99999999999998632        113378889999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcCCc
Q 037916          560 GLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       560 g~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      |.+........     ...+++.|+||| ...+..++.++||||+|+++|+|++ |..||.....     ......... 
T Consensus       162 g~~~~~~~~~~-----~~~~~~~y~aPE-~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-----~~~~~~~~~-  229 (278)
T 1byg_A          162 GLTKEASSTQD-----TGKLPVKWTAPE-ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----KDVVPRVEK-  229 (278)
T ss_dssp             CC-----------------CCTTTSCHH-HHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-----GGHHHHHTT-
T ss_pred             ccccccccccc-----CCCccccccCHH-HhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHhc-
Confidence            99876543221     134788999995 4456678999999999999999998 9999863211     111111000 


Q ss_pred             chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHhh
Q 037916          639 HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSIL  710 (741)
Q Consensus       639 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  710 (741)
                              ......                  ...+++.+.+++.+||+.||++|||+.|+++.|+.+....
T Consensus       230 --------~~~~~~------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~  275 (278)
T 1byg_A          230 --------GYKMDA------------------PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE  275 (278)
T ss_dssp             --------TCCCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             --------CCCCCC------------------cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence                    000000                  1133467889999999999999999999999999998643

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=6.7e-39  Score=357.71  Aligned_cols=253  Identities=23%  Similarity=0.288  Sum_probs=198.8

Q ss_pred             HHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeecc--CcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLL--HHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      +..+|++.+.||+|+||.||+|++..+++.||+|+++..  .......+.+|+.++++++||||+++++++     .+..
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~   94 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----EDSS   94 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEE-----EcCC
Confidence            567899999999999999999999999999999999632  233456788999999999999999999994     5566


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeC---CCC
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLD---HEM  552 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~---~~~  552 (741)
                      ..|+||||+.+|+|.+++...          ..+++..+..++.|++.||.|||+.   ||+||||||+||+++   .++
T Consensus        95 ~~~lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~  161 (486)
T 3mwu_A           95 SFYIVGELYTGGELFDEIIKR----------KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDC  161 (486)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTC
T ss_pred             EEEEEEEcCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCC
Confidence            899999999999999988533          4588999999999999999999999   999999999999995   456


Q ss_pred             ceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhh
Q 037916          553 TAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFA  632 (741)
Q Consensus       553 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~  632 (741)
                      .+||+|||++........   .....||+.|+|||.+ .+ .++.++||||+||++|+|++|..||.....  ..   ..
T Consensus       162 ~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~-~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~---~~  231 (486)
T 3mwu_A          162 DIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVL-RG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--YD---IL  231 (486)
T ss_dssp             CEEECSCSCTTTBCCC-------CCTTGGGGCCGGGG-GS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HH---HH
T ss_pred             CEEEEECCcCeECCCCCc---cCCCcCCCCCCCHHHh-CC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HH---HH
Confidence            899999999986654322   2235699999999654 33 589999999999999999999999863211  00   00


Q ss_pred             hhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          633 RTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       633 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      .        .+.........                +.....++.+.+++.+||+.||++|||+.|+++.
T Consensus       232 ~--------~i~~~~~~~~~----------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          232 K--------RVETGKYAFDL----------------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             H--------HHHHTCCCSCS----------------GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             H--------HHHhCCCCCCC----------------cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0        00000000000                0011234567899999999999999999999874

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=4.3e-38  Score=358.16  Aligned_cols=317  Identities=21%  Similarity=0.214  Sum_probs=268.9

Q ss_pred             CCCCCcccccCChhhhhCCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCc
Q 037916            2 DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHL   81 (741)
Q Consensus         2 dl~~n~~~~~ip~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L   81 (741)
                      ||++|++.+..|..|. .+++|++|+|++|+|+++.|++|.++++|++|+|++|+|+ .+|..  .+++          |
T Consensus        58 ~Ls~N~i~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~----------L  123 (562)
T 3a79_B           58 SLSQNSISELRMPDIS-FLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMAS----------L  123 (562)
T ss_dssp             ECCSSCCCCCCGGGTT-TCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTT----------C
T ss_pred             ECCCCCccccChhhhc-cCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--cccc----------C
Confidence            7899999965556666 9999999999999999999999999999999999999999 45554  5655          9


Q ss_pred             cEEECcCCcCcccC-CchhhcccccccEEEccCCcccccCCccccCCCCc--cEEEcccccc--cccCCccccCCC----
Q 037916           82 KHLDINNNNFGGLL-PGCICNFSITLETLIFNSNKIFRSIPAGIGKFINL--QTLHMWDNQL--SGTISPAIGELQ----  152 (741)
Q Consensus        82 ~~L~Ls~N~l~~~~-~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L--~~L~L~~N~i--~~~~~~~~~~l~----  152 (741)
                      ++|+|++|++++.. |..|.+++ +|++|+|++|++...   .+..+++|  ++|+|++|++  ++..+..|..+.    
T Consensus       124 ~~L~Ls~N~l~~l~~p~~~~~l~-~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l  199 (562)
T 3a79_B          124 RHLDLSFNDFDVLPVCKEFGNLT-KLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVL  199 (562)
T ss_dssp             SEEECCSSCCSBCCCCGGGGGCT-TCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEE
T ss_pred             CEEECCCCCccccCchHhhcccC-cccEEecCCCccccC---chhhhhhceeeEEEeecccccccccCcccccccCcceE
Confidence            99999999999754 68899998 999999999999764   34445555  9999999998  666666665543    


Q ss_pred             -----------------------------------------------------------------------------cCc
Q 037916          153 -----------------------------------------------------------------------------NLV  155 (741)
Q Consensus       153 -----------------------------------------------------------------------------~L~  155 (741)
                                                                                                   +|+
T Consensus       200 ~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~  279 (562)
T 3a79_B          200 HLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVE  279 (562)
T ss_dssp             EEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEE
T ss_pred             EEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhccccc
Confidence                                                                                         677


Q ss_pred             EEEcccCCCCCcCcccc-----------------------------------------------------cCCcccceee
Q 037916          156 TLAINTNKLSGNIPPSI-----------------------------------------------------GNLKKLLQLY  182 (741)
Q Consensus       156 ~L~L~~N~l~~~~~~~~-----------------------------------------------------~~l~~L~~L~  182 (741)
                      +|++++|++++.+|..+                                                     ..+++|++|+
T Consensus       280 ~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~l~~L~~L~  359 (562)
T 3a79_B          280 YLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLN  359 (562)
T ss_dssp             EEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEE
T ss_pred             EEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCcccccCccCCCCceEEE
Confidence            78888888876666654                                                     6788999999


Q ss_pred             ccCcccccccCcccccCCCCCEEeccCccccc--cCCccccccccceeEEEcCCCccCCCCC-hhhcCCCCCcEEEeccc
Q 037916          183 LIENFLQVSIPSSLGQCQSLTTINLSYNNLSG--TIPPQLMDLTSLSVGLDLSRNQLVGSLP-TEVGKLINLEILFISRN  259 (741)
Q Consensus       183 L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N  259 (741)
                      |++|.+++..|..|..+++|++|+|++|++++  .+|..|.++++|+. |+|++|++++.+| ..|..+++|++|+|++|
T Consensus       360 l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~-L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n  438 (562)
T 3a79_B          360 FTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLET-LDVSLNSLNSHAYDRTCAWAESILVLNLSSN  438 (562)
T ss_dssp             CCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCE-EECTTSCCBSCCSSCCCCCCTTCCEEECCSS
T ss_pred             CCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCE-EECCCCcCCCccChhhhcCcccCCEEECCCC
Confidence            99999999899999999999999999999995  33467899999998 9999999998444 56899999999999999


Q ss_pred             cccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccchhhhccccCCcccccCcccccccCC
Q 037916          260 MLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPT  339 (741)
Q Consensus       260 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~  339 (741)
                      ++++..+..+.  ++|+.|+|++|+|+. +|..+..+++|+.|+|++|+|+++.+..|..+++|+.|++++|++++..+.
T Consensus       439 ~l~~~~~~~l~--~~L~~L~L~~N~l~~-ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~  515 (562)
T 3a79_B          439 MLTGSVFRCLP--PKVKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPG  515 (562)
T ss_dssp             CCCGGGGSSCC--TTCSEEECCSSCCCC-CCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCCHHH
T ss_pred             CCCcchhhhhc--CcCCEEECCCCcCcc-cChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCCcch
Confidence            99876665544  789999999999994 565566999999999999999965555599999999999999999987664


Q ss_pred             c
Q 037916          340 E  340 (741)
Q Consensus       340 ~  340 (741)
                      .
T Consensus       516 ~  516 (562)
T 3a79_B          516 I  516 (562)
T ss_dssp             H
T ss_pred             H
Confidence            3

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=2.1e-38  Score=360.09  Aligned_cols=178  Identities=19%  Similarity=0.201  Sum_probs=159.2

Q ss_pred             CCCCCcccccCChhhhhCCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCc
Q 037916            2 DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHL   81 (741)
Q Consensus         2 dl~~n~~~~~ip~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L   81 (741)
                      ||++|++.+..|..|. .+++|++|+|++|+|+++.|++|.++++|++|+|++|++++..|..|.++++          |
T Consensus        32 ~Ls~n~l~~~~~~~~~-~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~----------L  100 (549)
T 2z81_A           32 DLSFNKITYIGHGDLR-ACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSS----------L  100 (549)
T ss_dssp             ECCSSCCCEECSSTTS-SCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTT----------C
T ss_pred             ECcCCccCccChhhhh-cCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCC----------C
Confidence            7899999977777776 8999999999999999999999999999999999999999887778999876          9


Q ss_pred             cEEECcCCcCccc-CCchhhcccccccEEEccCCc-ccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEc
Q 037916           82 KHLDINNNNFGGL-LPGCICNFSITLETLIFNSNK-IFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAI  159 (741)
Q Consensus        82 ~~L~Ls~N~l~~~-~~~~~~~l~~~L~~L~L~~n~-i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L  159 (741)
                      ++|+|++|++++. .|..+..+. +|++|++++|+ +....+..|.++++|++|+|++|++++..|..|..+++|++|++
T Consensus       101 ~~L~Ls~n~l~~~~~~~~~~~l~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l  179 (549)
T 2z81_A          101 KYLNLMGNPYQTLGVTSLFPNLT-NLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTL  179 (549)
T ss_dssp             CEEECTTCCCSSSCSSCSCTTCT-TCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEE
T ss_pred             cEEECCCCcccccchhhhhhccC-CccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEec
Confidence            9999999999974 567888888 99999999998 54555578999999999999999999999999999999999999


Q ss_pred             ccCCCCCcCcccccCCcccceeeccCcccccc
Q 037916          160 NTNKLSGNIPPSIGNLKKLLQLYLIENFLQVS  191 (741)
Q Consensus       160 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~  191 (741)
                      ++|.+....+..+..+++|++|++++|.+++.
T Consensus       180 ~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~  211 (549)
T 2z81_A          180 HLSESAFLLEIFADILSSVRYLELRDTNLARF  211 (549)
T ss_dssp             ECSBSTTHHHHHHHSTTTBSEEEEESCBCTTC
T ss_pred             ccCcccccchhhHhhcccccEEEccCCccccc
Confidence            99999854444456799999999999998863

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-39  Score=334.38  Aligned_cols=262  Identities=23%  Similarity=0.324  Sum_probs=204.0

Q ss_pred             HHHHhh-hcccCceeeEEEEEEc--CCCeEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCce
Q 037916          401 SFLFLC-WIDMGSFGSVYKGILD--EGKTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       401 ~y~~~~-~ig~G~~g~V~~a~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      .|.+.+ .||+|+||.||+|.+.  .++..||+|+++... ....+.+.+|+.++++++||||+++++++.      ...
T Consensus        10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~   83 (287)
T 1u59_A           10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ------AEA   83 (287)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE------SSS
T ss_pred             HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec------CCC
Confidence            345555 8999999999999864  467889999997532 223566889999999999999999999952      235


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .++||||+++++|.+++...         ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl  151 (287)
T 1u59_A           84 LMLVMEMAGGGPLHKFLVGK---------REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKI  151 (287)
T ss_dssp             EEEEEECCTTEEHHHHHTTC---------TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEE
T ss_pred             cEEEEEeCCCCCHHHHHHhC---------CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEE
Confidence            89999999999999998632         24588999999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcc-cccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhh
Q 037916          557 ADFGLAKLLPPAHLQ-TSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~-~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  634 (741)
                      +|||.+......... .......+|+.|+||| +..+..++.++||||+||++|+|++ |+.||.....  ......+..
T Consensus       152 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~~~i~~  228 (287)
T 1u59_A          152 SDFGLSKALGADDSYYTARSAGKWPLKWYAPE-CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFIEQ  228 (287)
T ss_dssp             CCCTTCEECTTCSCEECCCCSSCCCGGGCCHH-HHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--HHHHHHHHT
T ss_pred             CcccceeeeccCcceeeccccccccccccCHH-HhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHhc
Confidence            999999877543321 1222344788999995 4456678999999999999999998 9999863211  111111110


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHhhcCC
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSILLGP  713 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~  713 (741)
                      ..            ...                  .+..+++.+.+++.+||+.||++|||+.|+++.|+.+..+...+
T Consensus       229 ~~------------~~~------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~  277 (287)
T 1u59_A          229 GK------------RME------------------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK  277 (287)
T ss_dssp             TC------------CCC------------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred             CC------------cCC------------------CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence            00            000                  01134567889999999999999999999999999999877644

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=5.4e-38  Score=340.65  Aligned_cols=314  Identities=18%  Similarity=0.209  Sum_probs=240.2

Q ss_pred             CCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCccEEECcCCcCcccCCch
Q 037916           19 TLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGC   98 (741)
Q Consensus        19 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~   98 (741)
                      .++++++|++++|.++.+.+..|..+++|++|+|++|++++..+..|..+++          |++|+|++|++++..|..
T Consensus        43 ~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~----------L~~L~L~~n~l~~~~~~~  112 (390)
T 3o6n_A           43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHT----------IQKLYMGFNAIRYLPPHV  112 (390)
T ss_dssp             GGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTT----------CCEEECCSSCCCCCCTTT
T ss_pred             ccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCC----------cCEEECCCCCCCcCCHHH
Confidence            3678888888888888766666778888888888888888777777877765          888888888888777777


Q ss_pred             hhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCcccccCCccc
Q 037916           99 ICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKL  178 (741)
Q Consensus        99 ~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  178 (741)
                      |..++ +|++|+|++|++....+..|..+++|++|+|++|+|+++.+..|.++++|++|+|++|++++.   .+..+++|
T Consensus       113 ~~~l~-~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L  188 (390)
T 3o6n_A          113 FQNVP-LLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSL  188 (390)
T ss_dssp             TTTCT-TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTC
T ss_pred             hcCCC-CCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---cccccccc
Confidence            77777 888888888888766666678888888888888888877777888888888888888888754   35667778


Q ss_pred             ceeeccCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEecc
Q 037916          179 LQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISR  258 (741)
Q Consensus       179 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  258 (741)
                      +.|++++|.+++.     ...++|++|++++|+++.. |..+  .++|+. |++++|.+++.  ..+..+++|++|+|++
T Consensus       189 ~~L~l~~n~l~~~-----~~~~~L~~L~l~~n~l~~~-~~~~--~~~L~~-L~l~~n~l~~~--~~l~~l~~L~~L~Ls~  257 (390)
T 3o6n_A          189 FHANVSYNLLSTL-----AIPIAVEELDASHNSINVV-RGPV--NVELTI-LKLQHNNLTDT--AWLLNYPGLVEVDLSY  257 (390)
T ss_dssp             SEEECCSSCCSEE-----ECCSSCSEEECCSSCCCEE-ECCC--CSSCCE-EECCSSCCCCC--GGGGGCTTCSEEECCS
T ss_pred             ceeeccccccccc-----CCCCcceEEECCCCeeeec-cccc--cccccE-EECCCCCCccc--HHHcCCCCccEEECCC
Confidence            8888888877642     3345788888888888743 3332  356776 88888888743  4677888888888888


Q ss_pred             ccccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccchhhhccccCCcccccCcccccccC
Q 037916          259 NMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIP  338 (741)
Q Consensus       259 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  338 (741)
                      |.++++.+..|..+++|+.|+|++|++++ +|..+..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|+++..+ 
T Consensus       258 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~~-  334 (390)
T 3o6n_A          258 NELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK-  334 (390)
T ss_dssp             SCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC-
T ss_pred             CcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccceeC-
Confidence            88888778888888888888888888875 4555677788888888888887 45566777888888888888887764 


Q ss_pred             CccccCCcccccccCCCCccccC
Q 037916          339 TEGVFKNASAISVFGNSKLCGGI  361 (741)
Q Consensus       339 ~~~~~~~~~~~~~~~n~~~c~~~  361 (741)
                       ...++.++.+++.+|++.|...
T Consensus       335 -~~~~~~L~~L~l~~N~~~~~~~  356 (390)
T 3o6n_A          335 -LSTHHTLKNLTLSHNDWDCNSL  356 (390)
T ss_dssp             -CCTTCCCSEEECCSSCEEHHHH
T ss_pred             -chhhccCCEEEcCCCCccchhH
Confidence             3446778888888888877543

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.6e-39  Score=358.81  Aligned_cols=258  Identities=28%  Similarity=0.424  Sum_probs=197.4

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALV  480 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv  480 (741)
                      .|++.++||+|+||.||+|.+. .+..||||+++... ...+.+.+|+.++++++||||+++++++.     + ...++|
T Consensus       185 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~-~~~~iv  256 (452)
T 1fmk_A          185 SLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-----E-EPIYIV  256 (452)
T ss_dssp             GEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----S-SSCEEE
T ss_pred             HceeeeeecCCCCeEEEEEEEC-CCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEc-----C-CceEEE
Confidence            4677889999999999999997 45779999997533 33567899999999999999999999863     2 457999


Q ss_pred             EecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecc
Q 037916          481 YEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFG  560 (741)
Q Consensus       481 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg  560 (741)
                      |||+++|+|.+++...        ....+++.++..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||
T Consensus       257 ~e~~~~gsL~~~l~~~--------~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG  325 (452)
T 1fmk_A          257 TEYMSKGSLLDFLKGE--------TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFG  325 (452)
T ss_dssp             ECCCTTCBHHHHHSHH--------HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred             ehhhcCCCHHHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCc
Confidence            9999999999999632        123478899999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcCCcc
Q 037916          561 LAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVLPDH  639 (741)
Q Consensus       561 ~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  639 (741)
                      +++....... .......++..|+||| ...+..++.++|||||||++|||++ |+.||......     +...      
T Consensus       326 ~a~~~~~~~~-~~~~~~~~~~~y~aPE-~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~-----~~~~------  392 (452)
T 1fmk_A          326 LARLIEDNEY-TARQGAKFPIKWTAPE-AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----EVLD------  392 (452)
T ss_dssp             TTC---------------CCGGGSCHH-HHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----HHHH------
T ss_pred             cceecCCCce-ecccCCcccccccCHh-HHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH-----HHHH------
Confidence            9987654322 1222344788999995 4456678999999999999999999 99998632111     0100      


Q ss_pred             hhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHhhc
Q 037916          640 VMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSILL  711 (741)
Q Consensus       640 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~  711 (741)
                         .+......                  ..+..+++.+.+++.+||+.||++|||+.++++.|+++.....
T Consensus       393 ---~i~~~~~~------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~  443 (452)
T 1fmk_A          393 ---QVERGYRM------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  443 (452)
T ss_dssp             ---HHHTTCCC------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             ---HHHcCCCC------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence               00000000                  0012345678899999999999999999999999998875443

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=6.9e-39  Score=338.82  Aligned_cols=258  Identities=18%  Similarity=0.222  Sum_probs=198.0

Q ss_pred             HHHHHHHHHh-hhcccCceeeEEEEEEcCCCeEEEEEEeeccCc--CcchhHHHHHHHHHhc-CCCceeeEeeeecCccc
Q 037916          396 ILLFVSFLFL-CWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH--GASKSSIAECSALRNI-RHKNLVKILTVCSGVDY  471 (741)
Q Consensus       396 ~~~~~~y~~~-~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~  471 (741)
                      ..+...|.+. +.||+|+||.||+|.+..+++.||+|+++....  .....+.+|+.+++.+ +||||+++++++     
T Consensus        24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~-----   98 (327)
T 3lm5_A           24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY-----   98 (327)
T ss_dssp             HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE-----
T ss_pred             HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE-----
Confidence            4566778887 889999999999999999999999999974332  2346778999999999 569999999994     


Q ss_pred             cCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCC-
Q 037916          472 KGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDH-  550 (741)
Q Consensus       472 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~-  550 (741)
                      ......++||||+++|+|.+++...        ....+++.+++.++.|++.||+|||+.   ||+||||||+||+++. 
T Consensus        99 ~~~~~~~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~  167 (327)
T 3lm5_A           99 ENTSEIILILEYAAGGEIFSLCLPE--------LAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSI  167 (327)
T ss_dssp             ECSSEEEEEEECCTTEEGGGGGSSC--------C-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCB
T ss_pred             EeCCeEEEEEEecCCCcHHHHHHHh--------cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecC
Confidence            5566899999999999999998532        124588999999999999999999999   9999999999999988 


Q ss_pred             --CCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcch
Q 037916          551 --EMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNL  628 (741)
Q Consensus       551 --~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~  628 (741)
                        ++.+||+|||.+.........   ....||+.|+|| |+..+..++.++||||+||++|+|++|+.||....... ..
T Consensus       168 ~~~~~~kL~Dfg~a~~~~~~~~~---~~~~gt~~y~aP-E~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~  242 (327)
T 3lm5_A          168 YPLGDIKIVDFGMSRKIGHACEL---REIMGTPEYLAP-EILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE-TY  242 (327)
T ss_dssp             TTBCCEEECCGGGCEEC------------CCCGGGCCH-HHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HH
T ss_pred             CCCCcEEEeeCccccccCCcccc---ccccCCcCccCC-eeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-HH
Confidence              789999999999876543222   224689999999 55567788999999999999999999999986321110 00


Q ss_pred             hhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          629 HNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       629 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      ..........            ..                .....+++.+.+++.+||+.||++|||+.|+++-
T Consensus       243 ~~i~~~~~~~------------~~----------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          243 LNISQVNVDY------------SE----------------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             HHHHHTCCCC------------CT----------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             HHHHhccccc------------Cc----------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence            0000000000            00                0001234567899999999999999999999753

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=5.8e-38  Score=359.13  Aligned_cols=312  Identities=18%  Similarity=0.205  Sum_probs=198.0

Q ss_pred             CCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCccEEECcCCcCcccCCchh
Q 037916           20 LPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCI   99 (741)
Q Consensus        20 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~   99 (741)
                      +++++.|++++|.++.+.+..|.++++|++|+|++|.|++..|..|..+++          |++|+|++|.|++..|..|
T Consensus        50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~----------L~~L~L~~n~l~~~~~~~~  119 (597)
T 3oja_B           50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHT----------IQKLYMGFNAIRYLPPHVF  119 (597)
T ss_dssp             GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTT----------CCEEECCSSCCCCCCTTTT
T ss_pred             CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCC----------CCEEECCCCcCCCCCHHHH
Confidence            466667777777666665556666667777777777776666666666654          6777777777766666666


Q ss_pred             hcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCcccccCCcccc
Q 037916          100 CNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLL  179 (741)
Q Consensus       100 ~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  179 (741)
                      ..++ +|++|+|++|.|....+..|.++++|++|+|++|.|+++.+..|.++++|++|+|++|++++..   +..+++|+
T Consensus       120 ~~l~-~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~  195 (597)
T 3oja_B          120 QNVP-LLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLF  195 (597)
T ss_dssp             TTCT-TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCS
T ss_pred             cCCC-CCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhh
Confidence            6666 6777777777666555555666667777777777776666666666677777777777666542   44456666


Q ss_pred             eeeccCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccc
Q 037916          180 QLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRN  259 (741)
Q Consensus       180 ~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  259 (741)
                      .|++++|.+++     +...++|+.|++++|.++...+ .+.  ++|+. |+|++|.+++  +..++.+++|+.|+|++|
T Consensus       196 ~L~l~~n~l~~-----l~~~~~L~~L~ls~n~l~~~~~-~~~--~~L~~-L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N  264 (597)
T 3oja_B          196 HANVSYNLLST-----LAIPIAVEELDASHNSINVVRG-PVN--VELTI-LKLQHNNLTD--TAWLLNYPGLVEVDLSYN  264 (597)
T ss_dssp             EEECCSSCCSE-----EECCTTCSEEECCSSCCCEEEC-SCC--SCCCE-EECCSSCCCC--CGGGGGCTTCSEEECCSS
T ss_pred             hhhcccCcccc-----ccCCchhheeeccCCccccccc-ccC--CCCCE-EECCCCCCCC--ChhhccCCCCCEEECCCC
Confidence            66666666653     2234566666666666663322 221  35555 6666666664  345666666666666666


Q ss_pred             cccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccchhhhccccCCcccccCcccccccCC
Q 037916          260 MLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPT  339 (741)
Q Consensus       260 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~  339 (741)
                      .++++.+..|+.+++|+.|+|++|++++ +|..+..+++|+.|+|++|.++ .+|..+..+++|+.|+|++|.+++.+. 
T Consensus       265 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~~-  341 (597)
T 3oja_B          265 ELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKL-  341 (597)
T ss_dssp             CCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCCC-
T ss_pred             ccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcCh-
Confidence            6666666666666666666666666664 3445555666666666666666 345556666666666666666665532 


Q ss_pred             ccccCCcccccccCCCCcccc
Q 037916          340 EGVFKNASAISVFGNSKLCGG  360 (741)
Q Consensus       340 ~~~~~~~~~~~~~~n~~~c~~  360 (741)
                       ..++.+..+++.+|++.|.+
T Consensus       342 -~~~~~L~~L~l~~N~~~~~~  361 (597)
T 3oja_B          342 -STHHTLKNLTLSHNDWDCNS  361 (597)
T ss_dssp             -CTTCCCSEEECCSSCEEHHH
T ss_pred             -hhcCCCCEEEeeCCCCCChh
Confidence             33566666666666666643

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=4e-39  Score=334.24  Aligned_cols=249  Identities=17%  Similarity=0.232  Sum_probs=195.7

Q ss_pred             HHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC--cCcchhHHHHHHHHHhc-CCCceeeEeeeecCccccCC
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKGD  474 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~  474 (741)
                      +...|++.+.||+|+||.||+|.+..+++.||+|+++...  ......+.+|+..+..+ +||||+++++++     ...
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~-----~~~   83 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAW-----AED   83 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEE-----EET
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeee-----ecC
Confidence            4578999999999999999999999899999999997432  22345677899999998 999999999995     445


Q ss_pred             ceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCC---
Q 037916          475 DFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHE---  551 (741)
Q Consensus       475 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~---  551 (741)
                      ...++||||+++++|.+++....      .....+++..++.++.|++.||+|||+.   +|+||||||+||+++.+   
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~  154 (289)
T 1x8b_A           84 DHMLIQNEYCNGGSLADAISENY------RIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIP  154 (289)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHHH------HHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----
T ss_pred             CeEEEEEEecCCCcHHHHHHhhc------ccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCC
Confidence            68999999999999999986321      0114578999999999999999999999   99999999999999844   


Q ss_pred             ----------------CceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCC
Q 037916          552 ----------------MTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRK  615 (741)
Q Consensus       552 ----------------~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~  615 (741)
                                      ..+||+|||.+........      ..||+.|+|||.+.....++.++||||+||++|+|++|.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~------~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~  228 (289)
T 1x8b_A          155 NAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV------EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE  228 (289)
T ss_dssp             ---------------CCCEEECCCTTCEETTCSCC------CCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCC
T ss_pred             cccccccccccccCCceEEEEcccccccccCCccc------cCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCC
Confidence                            4799999999987654321      348999999976655557778999999999999999998


Q ss_pred             CCCCccccCCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCC
Q 037916          616 RPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMN  695 (741)
Q Consensus       616 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs  695 (741)
                      .|+...    ...........+            ...                   ..+++.+.+++.+||+.||++|||
T Consensus       229 ~~~~~~----~~~~~~~~~~~~------------~~~-------------------~~~~~~~~~li~~~l~~dp~~Rps  273 (289)
T 1x8b_A          229 PLPRNG----DQWHEIRQGRLP------------RIP-------------------QVLSQEFTELLKVMIHPDPERRPS  273 (289)
T ss_dssp             CCCSSS----HHHHHHHTTCCC------------CCS-------------------SCCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             CCCcch----hHHHHHHcCCCC------------CCC-------------------cccCHHHHHHHHHHhCCCcccCCC
Confidence            875411    111111111000            000                   122456889999999999999999


Q ss_pred             HHHHHH
Q 037916          696 MTIVVH  701 (741)
Q Consensus       696 ~~evl~  701 (741)
                      +.|+++
T Consensus       274 ~~~ll~  279 (289)
T 1x8b_A          274 AMALVK  279 (289)
T ss_dssp             HHHHHT
T ss_pred             HHHHhh
Confidence            999875

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2.6e-39  Score=334.48  Aligned_cols=259  Identities=19%  Similarity=0.289  Sum_probs=198.6

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcC---CCeEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDE---GKTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      ..|++.+.||+|+||.||+|++..   ++..||+|+++... ....+.+.+|+.++++++||||+++++++.     + .
T Consensus        12 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~-~   85 (281)
T 3cc6_A           12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE-----E-E   85 (281)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC-----S-S
T ss_pred             cceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEc-----C-C
Confidence            467888999999999999999753   34579999987432 223567889999999999999999999853     2 3


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..++||||+++++|.+++...         ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+|
T Consensus        86 ~~~~v~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~k  153 (281)
T 3cc6_A           86 PTWIIMELYPYGELGHYLERN---------KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVK  153 (281)
T ss_dssp             SCEEEEECCTTCBHHHHHHHH---------TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEE
T ss_pred             CCEEEEecCCCCCHHHHHHhc---------cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEE
Confidence            468999999999999998632         24478899999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhh
Q 037916          556 VADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  634 (741)
                      |+|||.+.......... .....+++.|+||| ...+..++.++|||||||++|+|++ |+.||......  ........
T Consensus       154 l~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~--~~~~~~~~  229 (281)
T 3cc6_A          154 LGDFGLSRYIEDEDYYK-ASVTRLPIKWMSPE-SINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK--DVIGVLEK  229 (281)
T ss_dssp             ECCCCGGGCC----------CCCCCGGGCCHH-HHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG--GHHHHHHH
T ss_pred             eCccCCCcccccccccc-cccCCCCcceeCch-hhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH--HHHHHHhc
Confidence            99999998765433221 12244788999995 4456678999999999999999998 99998632111  11111110


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHhh
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSIL  710 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  710 (741)
                      ...           ...                   +..+++.+.+++.+||..||++|||+.|+++.|+++.+..
T Consensus       230 ~~~-----------~~~-------------------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  275 (281)
T 3cc6_A          230 GDR-----------LPK-------------------PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME  275 (281)
T ss_dssp             TCC-----------CCC-------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCC-----------CCC-------------------CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence            000           000                   0123456889999999999999999999999999988654

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=6.1e-39  Score=330.81  Aligned_cols=250  Identities=22%  Similarity=0.283  Sum_probs=191.2

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      ...|++.+.||+|+||.||+|.+..+++.||+|+++...   ....+.+.+|+.+++.++||||+++++++     ....
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   84 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI-----STPT   84 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEE-----ecCC
Confidence            456889999999999999999999899999999997432   23345788999999999999999999995     4556


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..++||||+++++|.+++...          ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+|
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~  151 (276)
T 2h6d_A           85 DFFMVMEYVSGGELFDYICKH----------GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAK  151 (276)
T ss_dssp             EEEEEEECCCSCBHHHHHHHH----------CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEE
T ss_pred             eEEEEEeccCCCcHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEE
Confidence            899999999999999998633          4578899999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhc
Q 037916          556 VADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV  635 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~  635 (741)
                      |+|||.+.........   ....|++.|+|||.+......+.++||||+|+++|+|++|+.||.....     .....  
T Consensus       152 l~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~~--  221 (276)
T 2h6d_A          152 IADFGLSNMMSDGEFL---RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV-----PTLFK--  221 (276)
T ss_dssp             ECCCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH--
T ss_pred             EeecccccccCCCcce---ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH-----HHHHH--
Confidence            9999999876543221   2245899999996554444457899999999999999999999863211     11100  


Q ss_pred             CCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          636 LPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       636 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                             .+.......                   +......+.+++.+||+.||++|||+.|+++.
T Consensus       222 -------~~~~~~~~~-------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          222 -------KIRGGVFYI-------------------PEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             -------HHHHCCCCC-------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             -------HhhcCcccC-------------------chhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                   000000000                   01223567899999999999999999999873

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.5e-39  Score=361.31  Aligned_cols=252  Identities=21%  Similarity=0.305  Sum_probs=198.7

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeecc---CcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLL---HHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      .|++.+.||+|+||.||+|++..+++.||+|+++..   .......+.+|+.+++.++||||++++++     +.+....
T Consensus       185 ~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~-----~~~~~~l  259 (576)
T 2acx_A          185 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYA-----YETKDAL  259 (576)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEE-----EECSSEE
T ss_pred             ceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEE-----EeeCCEE
Confidence            467778899999999999999999999999999742   22334567899999999999999999998     4556689


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      |+||||++||+|.+++....        ...+++..++.++.||+.||+|||+.   ||+||||||+|||++.++.+||+
T Consensus       260 ~lVmEy~~gg~L~~~l~~~~--------~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~  328 (576)
T 2acx_A          260 CLVLTLMNGGDLKFHIYHMG--------QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRIS  328 (576)
T ss_dssp             EEEECCCCSCBHHHHHHSSS--------SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEEC
T ss_pred             EEEEEcCCCCcHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEE
Confidence            99999999999999986431        23488999999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCC
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      |||++.........   ....||+.|+||| +..+..++.++||||+||++|||++|+.||....... ......     
T Consensus       329 DFGla~~~~~~~~~---~~~~GT~~Y~APE-vl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~-~~~~i~-----  398 (576)
T 2acx_A          329 DLGLAVHVPEGQTI---KGRVGTVGYMAPE-VVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KREEVE-----  398 (576)
T ss_dssp             CCTTCEECCTTCCE---ECCCSCGGGCCHH-HHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC-CHHHHH-----
T ss_pred             ecccceecccCccc---cccCCCccccCHH-HHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch-hHHHHH-----
Confidence            99999876544322   2246999999995 5566789999999999999999999999997432111 101010     


Q ss_pred             cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCC-----CHHHHHH
Q 037916          638 DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRM-----NMTIVVH  701 (741)
Q Consensus       638 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  701 (741)
                          ..+..... ..                  +......+.+++.+||+.||++||     ++.||++
T Consensus       399 ----~~i~~~~~-~~------------------p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          399 ----RLVKEVPE-EY------------------SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             ----HHHHHCCC-CC------------------CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             ----HHhhcccc-cC------------------CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence                00000000 00                  012345678999999999999999     6788875

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=3e-39  Score=335.87  Aligned_cols=259  Identities=22%  Similarity=0.292  Sum_probs=199.9

Q ss_pred             HHHHhh-hcccCceeeEEEEEE--cCCCeEEEEEEeeccCc--CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          401 SFLFLC-WIDMGSFGSVYKGIL--DEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       401 ~y~~~~-~ig~G~~g~V~~a~~--~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      .|.+.+ .||+|+||.||+|.+  ..+++.||+|+++....  ...+.+.+|+.+++.++||||+++++++      ...
T Consensus        17 ~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~------~~~   90 (291)
T 1xbb_A           17 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC------EAE   90 (291)
T ss_dssp             GEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE------ESS
T ss_pred             hhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE------CCC
Confidence            466666 899999999999955  55678999999974322  2246788999999999999999999985      234


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..++||||+++++|.+++...          ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+|
T Consensus        91 ~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~k  157 (291)
T 1xbb_A           91 SWMLVMEMAELGPLNKYLQQN----------RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAK  157 (291)
T ss_dssp             SEEEEEECCTTEEHHHHHHHC----------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEE
T ss_pred             CcEEEEEeCCCCCHHHHHHhC----------cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEE
Confidence            679999999999999998643          4578899999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcc-cccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhh
Q 037916          556 VADFGLAKLLPPAHLQ-TSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFAR  633 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~-~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~  633 (741)
                      |+|||.+......... .......+++.|+|||. ..+..++.++||||+|+++|+|++ |+.||......  .......
T Consensus       158 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~  234 (291)
T 1xbb_A          158 ISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC-INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLE  234 (291)
T ss_dssp             ECCCTTCEECCTTCSEEEC----CCCGGGCCHHH-HHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHH
T ss_pred             EccCCcceeeccCCCcccccccCCCCceeeChHH-hccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHH
Confidence            9999999876544321 11222346788999954 456678899999999999999999 99998632111  1111111


Q ss_pred             hcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHhhc
Q 037916          634 TVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSILL  711 (741)
Q Consensus       634 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~  711 (741)
                      ...            ....                  +..++..+.+++.+||+.||++|||+.|+++.|+++....+
T Consensus       235 ~~~------------~~~~------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  282 (291)
T 1xbb_A          235 KGE------------RMGC------------------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV  282 (291)
T ss_dssp             TTC------------CCCC------------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred             cCC------------CCCC------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence            000            0000                  01334678899999999999999999999999999986654

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.7e-38  Score=355.62  Aligned_cols=316  Identities=21%  Similarity=0.269  Sum_probs=254.0

Q ss_pred             CCCCCcccccCChhhhhCCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCc
Q 037916            2 DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHL   81 (741)
Q Consensus         2 dl~~n~~~~~ip~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L   81 (741)
                      ||++|++.+..|..|. .+++|++|+|++|+|+++.|+.|.++++|++|+|++|+|+. +|..  .+++          |
T Consensus        27 ~Ls~n~i~~~~~~~~~-~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~--~l~~----------L   92 (520)
T 2z7x_B           27 NISQNYISELWTSDIL-SLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVK-ISCH--PTVN----------L   92 (520)
T ss_dssp             ECCSSCCCCCCHHHHT-TCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCE-EECC--CCCC----------C
T ss_pred             ECCCCcccccChhhcc-ccccccEEecCCCccCCcChHHhhcccCCCEEecCCCceee-cCcc--ccCC----------c
Confidence            6899999965555665 89999999999999998889999999999999999999994 4444  5544          9


Q ss_pred             cEEECcCCcCccc-CCchhhcccccccEEEccCCcccccCCccccCCCCc--cEEEcccccc--cccCCccccCCC----
Q 037916           82 KHLDINNNNFGGL-LPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINL--QTLHMWDNQL--SGTISPAIGELQ----  152 (741)
Q Consensus        82 ~~L~Ls~N~l~~~-~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L--~~L~L~~N~i--~~~~~~~~~~l~----  152 (741)
                      ++|+|++|++++. .|..|..+. +|++|++++|++.+   ..|..+++|  ++|+|++|.+  ++..|..|..+.    
T Consensus        93 ~~L~L~~N~l~~~~~p~~~~~l~-~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l  168 (520)
T 2z7x_B           93 KHLDLSFNAFDALPICKEFGNMS-QLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESL  168 (520)
T ss_dssp             SEEECCSSCCSSCCCCGGGGGCT-TCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEE
T ss_pred             cEEeccCCccccccchhhhccCC-cceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccccceE
Confidence            9999999999874 678888888 88888888888754   334444444  5555555555  333333333321    


Q ss_pred             -------------------------------------------------------------------------------c
Q 037916          153 -------------------------------------------------------------------------------N  153 (741)
Q Consensus       153 -------------------------------------------------------------------------------~  153 (741)
                                                                                                     +
T Consensus       169 ~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~  248 (520)
T 2z7x_B          169 HIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTT  248 (520)
T ss_dssp             EEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSS
T ss_pred             EEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCc
Confidence                                                                                           4


Q ss_pred             CcEEEcccCCCCCcCcccc-----------------------------------------------------cCCcccce
Q 037916          154 LVTLAINTNKLSGNIPPSI-----------------------------------------------------GNLKKLLQ  180 (741)
Q Consensus       154 L~~L~L~~N~l~~~~~~~~-----------------------------------------------------~~l~~L~~  180 (741)
                      |++|++++|++++.+|..+                                                     ..+++|++
T Consensus       249 L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~  328 (520)
T 2z7x_B          249 VWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLH  328 (520)
T ss_dssp             CSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCCCSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCE
T ss_pred             ccEEEeecccccCccccchhhcccccCceeEeccccccceecchhhhhcccccCceeEEEcCCCccccccchhhCCcccE
Confidence            4455555555544333332                                                     67889999


Q ss_pred             eeccCcccccccCcccccCCCCCEEeccCccccc--cCCccccccccceeEEEcCCCccCCCCCh-hhcCCCCCcEEEec
Q 037916          181 LYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSG--TIPPQLMDLTSLSVGLDLSRNQLVGSLPT-EVGKLINLEILFIS  257 (741)
Q Consensus       181 L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls  257 (741)
                      |+|++|++++..|..|..+++|++|+|++|++++  .+|..+..+++|+. |+|++|.+.+.+|. .|..+++|++|+|+
T Consensus       329 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~-L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls  407 (520)
T 2z7x_B          329 LDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQ-LDISQNSVSYDEKKGDCSWTKSLLSLNMS  407 (520)
T ss_dssp             EECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCE-EECCSSCCBCCGGGCSCCCCTTCCEEECC
T ss_pred             EEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCE-EECCCCcCCcccccchhccCccCCEEECc
Confidence            9999999998899999999999999999999996  56678999999998 99999999984554 58899999999999


Q ss_pred             cccccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccchhhhccccCCcccccCccccccc
Q 037916          258 RNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVI  337 (741)
Q Consensus       258 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~  337 (741)
                      +|++++..+..+.  ++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..|..+++|+.|++++|++++..
T Consensus       408 ~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c  484 (520)
T 2z7x_B          408 SNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC  484 (520)
T ss_dssp             SSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred             CCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccC
Confidence            9999877776654  78999999999999 67777779999999999999999655555999999999999999999876


Q ss_pred             CC
Q 037916          338 PT  339 (741)
Q Consensus       338 ~~  339 (741)
                      +.
T Consensus       485 ~~  486 (520)
T 2z7x_B          485 PR  486 (520)
T ss_dssp             HH
T ss_pred             Cc
Confidence            53

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.4e-39  Score=342.48  Aligned_cols=269  Identities=22%  Similarity=0.308  Sum_probs=202.6

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEE--EEEEeecc-CcCcchhHHHHHHHHHhc-CCCceeeEeeeecCccccCC
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTII--AVKVLNLL-HHGASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKGD  474 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~v--avK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~  474 (741)
                      +..|++.+.||+|+||.||+|++..++..+  |+|.++.. .....+.+.+|+.+++++ +||||+++++++     ...
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-----~~~   98 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHR   98 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEE-----EET
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceee-----eeC
Confidence            456888999999999999999998788765  99988742 233456788999999999 999999999995     455


Q ss_pred             ceEEEEEecccCCChhhhccCCCCCCc------ccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEe
Q 037916          475 DFKALVYEFMHNGSLEEWLHPVSGADK------TVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLL  548 (741)
Q Consensus       475 ~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll  548 (741)
                      ...++||||+++++|.+++...+....      .......+++..++.++.|++.||.|||+.   ||+||||||+||++
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~  175 (327)
T 1fvr_A           99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILV  175 (327)
T ss_dssp             TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred             CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEE
Confidence            689999999999999999975410000      001124688999999999999999999999   99999999999999


Q ss_pred             CCCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcc
Q 037916          549 DHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMN  627 (741)
Q Consensus       549 ~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~  627 (741)
                      +.++.+||+|||++.......   ......+++.|+||| +..+..++.++||||+||++|+|++ |..||.....    
T Consensus       176 ~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~----  247 (327)
T 1fvr_A          176 GENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIE-SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC----  247 (327)
T ss_dssp             CGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHH-HHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH----
T ss_pred             cCCCeEEEcccCcCccccccc---cccCCCCCccccChh-hhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH----
Confidence            999999999999987443221   112234688999995 4456678999999999999999998 9999863211    


Q ss_pred             hhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHH
Q 037916          628 LHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIK  707 (741)
Q Consensus       628 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  707 (741)
                       .......         ........                  +..+++.+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus       248 -~~~~~~~---------~~~~~~~~------------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  299 (327)
T 1fvr_A          248 -AELYEKL---------PQGYRLEK------------------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  299 (327)
T ss_dssp             -HHHHHHG---------GGTCCCCC------------------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -HHHHHHh---------hcCCCCCC------------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence             1111100         00000000                  0123456889999999999999999999999999998


Q ss_pred             Hhhc
Q 037916          708 SILL  711 (741)
Q Consensus       708 ~~~~  711 (741)
                      +...
T Consensus       300 ~~~~  303 (327)
T 1fvr_A          300 EERK  303 (327)
T ss_dssp             HSSS
T ss_pred             Hhhc
Confidence            7654

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=6.9e-39  Score=331.89  Aligned_cols=246  Identities=23%  Similarity=0.265  Sum_probs=197.9

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCce
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      ..|++.+.||+|+||.||+|++..+++.||+|++....   ......+.+|+.++++++||||+++++++     .+...
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~   88 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF-----HDRKR   88 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEE-----EcCCE
Confidence            56888999999999999999999999999999996421   23346788999999999999999999995     45668


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .++||||+++++|.+++...          ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl  155 (284)
T 2vgo_A           89 IYLMLEFAPRGELYKELQKH----------GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKI  155 (284)
T ss_dssp             EEEEECCCTTEEHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEE
T ss_pred             EEEEEEeCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEE
Confidence            99999999999999998633          4578999999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcC
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVL  636 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  636 (741)
                      +|||.+........    ....|++.|+||| +..+..++.++||||+|+++|+|++|..||......     ....   
T Consensus       156 ~Dfg~~~~~~~~~~----~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~---  222 (284)
T 2vgo_A          156 ADFGWSVHAPSLRR----RTMCGTLDYLPPE-MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT-----ETHR---  222 (284)
T ss_dssp             CCCTTCEECSSSCB----CCCCSCGGGCCHH-HHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHH---
T ss_pred             ecccccccCccccc----ccccCCCCcCCHH-HhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh-----HHHH---
Confidence            99999876543221    2346899999994 556677899999999999999999999998632111     0000   


Q ss_pred             CcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          637 PDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       637 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                           .+......  .                  +...+..+.+++.+||+.||++|||+.|+++
T Consensus       223 -----~~~~~~~~--~------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          223 -----RIVNVDLK--F------------------PPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             -----HHHTTCCC--C------------------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -----HHhccccC--C------------------CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence                 01000000  0                  0122356789999999999999999999986

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=5.4e-39  Score=358.57  Aligned_cols=254  Identities=22%  Similarity=0.254  Sum_probs=201.4

Q ss_pred             HHHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccC
Q 037916          397 LLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKG  473 (741)
Q Consensus       397 ~~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  473 (741)
                      .+..+|++.+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|+.++++++||||+++++++     .+
T Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~   97 (484)
T 3nyv_A           23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF-----ED   97 (484)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE-----EC
T ss_pred             cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE-----Ee
Confidence            35678999999999999999999999999999999996432   23456788999999999999999999994     55


Q ss_pred             CceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEe---CC
Q 037916          474 DDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLL---DH  550 (741)
Q Consensus       474 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll---~~  550 (741)
                      ....|+||||+.+|+|.+++...          ..+++..+..++.|++.||.|||+.   +|+||||||+||++   +.
T Consensus        98 ~~~~~lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~  164 (484)
T 3nyv_A           98 KGYFYLVGEVYTGGELFDEIISR----------KRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSK  164 (484)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHTC----------SCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSST
T ss_pred             CCEEEEEEecCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCC
Confidence            66899999999999999988643          4588999999999999999999999   99999999999999   46


Q ss_pred             CCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhh
Q 037916          551 EMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHN  630 (741)
Q Consensus       551 ~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~  630 (741)
                      ++.+||+|||++.........   ....||+.|+|||.+ .+ .++.++||||+||++|+|++|..||.....  .....
T Consensus       165 ~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~-~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~  237 (484)
T 3nyv_A          165 DANIRIIDFGLSTHFEASKKM---KDKIGTAYYIAPEVL-HG-TYDEKCDVWSTGVILYILLSGCPPFNGANE--YDILK  237 (484)
T ss_dssp             TCCEEECCTTHHHHBCCCCSH---HHHTTGGGTCCHHHH-HT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHH
T ss_pred             CCcEEEEeeeeeEEccccccc---ccCCCCccccCceee-cC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH--HHHHH
Confidence            789999999999876544322   224599999999654 33 689999999999999999999999863211  11100


Q ss_pred             hhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          631 FARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       631 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      .+.           ........                +.....++.+.+++.+||+.||++|||+.|+++-
T Consensus       238 ~i~-----------~~~~~~~~----------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          238 KVE-----------KGKYTFEL----------------PQWKKVSESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             HHH-----------HCCCCCCS----------------GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHH-----------cCCCCCCC----------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence            000           00000000                0011234567899999999999999999999863

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1e-38  Score=357.78  Aligned_cols=252  Identities=21%  Similarity=0.275  Sum_probs=196.4

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc-------------CcchhHHHHHHHHHhcCCCceeeEeee
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH-------------GASKSSIAECSALRNIRHKNLVKILTV  465 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~hpnIv~~~~~  465 (741)
                      ...|.++++||+|+||.||+|++..+++.||+|+++....             ...+.+.+|+.++++++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            3568899999999999999999999999999999974321             234567899999999999999999999


Q ss_pred             ecCccccCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCC
Q 037916          466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSN  545 (741)
Q Consensus       466 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~N  545 (741)
                      +     .+....|+||||+++|+|.+++...          ..+++..+..++.||+.||+|||+.   +|+||||||+|
T Consensus       115 ~-----~~~~~~~lv~e~~~gg~L~~~l~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~N  176 (504)
T 3q5i_A          115 F-----EDKKYFYLVTEFYEGGELFEQIINR----------HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPEN  176 (504)
T ss_dssp             E-----ECSSEEEEEEECCTTCBHHHHHHHH----------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred             E-----EcCCEEEEEEecCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHH
Confidence            4     5566899999999999999988532          4589999999999999999999999   99999999999


Q ss_pred             eEeCCCC---ceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccc
Q 037916          546 VLLDHEM---TAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMF  622 (741)
Q Consensus       546 Ill~~~~---~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~  622 (741)
                      |+++.++   .+||+|||++.........   ....||+.|+|||.+ . ..++.++||||+||++|+|++|..||....
T Consensus       177 il~~~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~-~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~  251 (504)
T 3q5i_A          177 ILLENKNSLLNIKIVDFGLSSFFSKDYKL---RDRLGTAYYIAPEVL-K-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN  251 (504)
T ss_dssp             EEESSTTCCSSEEECCCTTCEECCTTSCB---CCCCSCTTTCCHHHH-T-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             EEEecCCCCccEEEEECCCCEEcCCCCcc---ccccCCcCCCCHHHh-c-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            9998775   6999999999877554322   235699999999654 3 468999999999999999999999986321


Q ss_pred             cCCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          623 EGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       623 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      .  ......+..           ......                .......++.+.+++.+||+.||++|||+.|+++-
T Consensus       252 ~--~~~~~~i~~-----------~~~~~~----------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          252 D--QDIIKKVEK-----------GKYYFD----------------FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             H--HHHHHHHHH-----------CCCCCC----------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             H--HHHHHHHHc-----------CCCCCC----------------ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            1  011000000           000000                00011334668899999999999999999999863

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.1e-38  Score=343.41  Aligned_cols=282  Identities=18%  Similarity=0.150  Sum_probs=191.5

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC--cCcchhHHHHHHHHHhcCCCceeeEeeeecCcc-ccCCce
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSGVD-YKGDDF  476 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~~~~~  476 (741)
                      .+|++++.||+|+||.||+|.+..+++.||+|+++...  ....+.+.+|+.+++.++||||+++++++.... ......
T Consensus        25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  104 (371)
T 2xrw_A           25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD  104 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred             hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence            56889999999999999999999999999999997432  223456789999999999999999999975322 123347


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .|+||||++ ++|.+++.            ..+++..+..++.|++.||+|||+.   ||+||||||+||+++.++.+||
T Consensus       105 ~~lv~e~~~-~~l~~~~~------------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl  168 (371)
T 2xrw_A          105 VYIVMELMD-ANLCQVIQ------------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKI  168 (371)
T ss_dssp             EEEEEECCS-EEHHHHHH------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEE
T ss_pred             eEEEEEcCC-CCHHHHHh------------hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEE
Confidence            899999996 57888775            2378889999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcC
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVL  636 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  636 (741)
                      +|||++........   .....||+.|+||| +..+..++.++||||+||++|+|++|+.||...... ..+........
T Consensus       169 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE-~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~  243 (371)
T 2xrw_A          169 LDFGLARTAGTSFM---MTPYVVTRYYRAPE-VILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI-DQWNKVIEQLG  243 (371)
T ss_dssp             CCCCC-------------------CTTCCHH-HHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHC-CC
T ss_pred             EEeecccccccccc---cCCceecCCccCHH-HhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhC
Confidence            99999986643321   22346899999995 455677899999999999999999999998632111 01111111100


Q ss_pred             C----------cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          637 P----------DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       637 ~----------~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      .          ........................................+.+++.+||+.||++|||+.|+++-
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          244 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             CCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             CCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence            0          00001110000000000000000000000001122346778999999999999999999999874

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=8.7e-39  Score=334.43  Aligned_cols=248  Identities=25%  Similarity=0.325  Sum_probs=199.0

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      .|++++.||+|+||.||+|++..+++.||+|+++... ....+.+.+|+.++++++||||+++++++     ......++
T Consensus        23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   97 (303)
T 3a7i_A           23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKDTKLWI   97 (303)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTEEEE
T ss_pred             HHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEE-----ecCCeEEE
Confidence            4778899999999999999999899999999997543 23456788999999999999999999995     34568999


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      ||||+++++|.+++..           ..+++..+..++.|++.||.|||+.   ||+||||||+||+++.++.+||+||
T Consensus        98 v~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Df  163 (303)
T 3a7i_A           98 IMEYLGGGSALDLLEP-----------GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADF  163 (303)
T ss_dssp             EEECCTTEEHHHHHTT-----------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             EEEeCCCCcHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeec
Confidence            9999999999999852           3578999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcc
Q 037916          560 GLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDH  639 (741)
Q Consensus       560 g~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  639 (741)
                      |.+.........  .....||+.|+|| |+..+..++.++|||||||++|+|++|+.||......  ..........+. 
T Consensus       164 g~~~~~~~~~~~--~~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~-  237 (303)
T 3a7i_A          164 GVAGQLTDTQIK--RNTFVGTPFWMAP-EVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM--KVLFLIPKNNPP-  237 (303)
T ss_dssp             TTCEECBTTBCC--BCCCCSCGGGCCH-HHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSCCC-
T ss_pred             ccceecCccccc--cCccCCCcCccCH-HHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH--HHHHHhhcCCCC-
Confidence            999876543322  2235689999999 5556678899999999999999999999998632111  000000000000 


Q ss_pred             hhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          640 VMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       640 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                             ...                      ..++..+.+++.+||+.||++|||+.|+++.
T Consensus       238 -------~~~----------------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          238 -------TLE----------------------GNYSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             -------CCC----------------------SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             -------CCc----------------------cccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                   000                      1223568899999999999999999999875

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5e-39  Score=347.65  Aligned_cols=288  Identities=16%  Similarity=0.153  Sum_probs=200.1

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccc--------
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDY--------  471 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~--------  471 (741)
                      .+|++.+.||+|+||.||+|++..+++.||+|++....    ....+|+.+++.++||||+++++++.....        
T Consensus         7 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~   82 (383)
T 3eb0_A            7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQP   82 (383)
T ss_dssp             TTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC----------
T ss_pred             ceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCccccccccc
Confidence            46889999999999999999999999999999986432    223479999999999999999999743221        


Q ss_pred             -------------------------cCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHH
Q 037916          472 -------------------------KGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALK  526 (741)
Q Consensus       472 -------------------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~  526 (741)
                                               .+..+.++||||++ ++|.+.+....      .....+++..+..++.||+.||+
T Consensus        83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~------~~~~~l~~~~~~~i~~qi~~aL~  155 (383)
T 3eb0_A           83 PDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFI------RSGRSIPMNLISIYIYQLFRAVG  155 (383)
T ss_dssp             ---------------------------CCEEEEEECCCS-EEHHHHHHHHH------HTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHH------hcCCCCCHHHHHHHHHHHHHHHH
Confidence                                     33456899999996 58777765210      11256889999999999999999


Q ss_pred             HHHhcCCCCceecCCCCCCeEeC-CCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHH
Q 037916          527 YLHHDCQPTTAHCDLKPSNVLLD-HEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYG  605 (741)
Q Consensus       527 ~LH~~~~~~ivHrDlkp~NIll~-~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG  605 (741)
                      |||+.   ||+||||||+||+++ .++.+||+|||.|+........   ....||+.|+|||.+.....++.++||||+|
T Consensus       156 ~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG  229 (383)
T 3eb0_A          156 FIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAPELMLGATEYTPSIDLWSIG  229 (383)
T ss_dssp             HHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC---CCCCCCSSCCCHHHHTTCSSCCTHHHHHHHH
T ss_pred             HHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC---cCcccCCCccCHHHhcCCCCCCcchhhhhHH
Confidence            99999   999999999999997 6889999999999876544322   2245899999996665556799999999999


Q ss_pred             HHHHHHHcCCCCCCccccCCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcc
Q 037916          606 ILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVAC  685 (741)
Q Consensus       606 ~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  685 (741)
                      |++|||++|+.||...... ..+...+.....+....+....  ......... ...........+...+..+.+++.+|
T Consensus       230 ~il~ell~g~~pf~~~~~~-~~~~~i~~~~g~p~~~~~~~~~--~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~  305 (383)
T 3eb0_A          230 CVFGELILGKPLFSGETSI-DQLVRIIQIMGTPTKEQMIRMN--PHYTEVRFP-TLKAKDWRKILPEGTPSLAIDLLEQI  305 (383)
T ss_dssp             HHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHHHHC--TTC--CCCC-CCCCCCHHHHSCTTCCHHHHHHHHHH
T ss_pred             HHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHHHhC--cccccccCC-ccCcccHHhhCCCCCCHHHHHHHHHH
Confidence            9999999999998632111 1122222211111111111000  000000000 00000000001112456688999999


Q ss_pred             cccCCCCCCCHHHHHHH--HHHHHH
Q 037916          686 SMESPQDRMNMTIVVHE--LQSIKS  708 (741)
Q Consensus       686 l~~dP~~RPs~~evl~~--L~~i~~  708 (741)
                      |++||++|||+.|+++-  +++++.
T Consensus       306 L~~dP~~R~t~~e~l~hp~f~~~~~  330 (383)
T 3eb0_A          306 LRYEPDLRINPYEAMAHPFFDHLRN  330 (383)
T ss_dssp             CCSSGGGSCCHHHHHTSGGGHHHHH
T ss_pred             ccCChhhCCCHHHHhcCHHHHHHHh
Confidence            99999999999999853  555554

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=5.2e-39  Score=334.60  Aligned_cols=248  Identities=20%  Similarity=0.227  Sum_probs=197.9

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc---CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH---GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      +|.+.+.||+|+||.||+|.+..+++.||+|++.....   ...+.+.+|+.+++.++||||+++++++     .+....
T Consensus        16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~   90 (294)
T 2rku_A           16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF-----EDNDFV   90 (294)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSEE
T ss_pred             ceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeee-----ccCCEE
Confidence            47788999999999999999999999999999874322   2345678899999999999999999995     456689


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      ++||||+++++|.+++...          ..+++.++..++.|+++||+|||+.   ||+||||||+||+++.++.+||+
T Consensus        91 ~lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~  157 (294)
T 2rku_A           91 FVVLELCRRRSLLELHKRR----------KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIG  157 (294)
T ss_dssp             EEEEECCTTCBHHHHHHHH----------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEEC
T ss_pred             EEEEecCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEE
Confidence            9999999999999988532          4588999999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCC
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      |||.+.........  .....||+.|+||| +..+..++.++||||+|+++|+|++|+.||......     ....    
T Consensus       158 dfg~~~~~~~~~~~--~~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~----  225 (294)
T 2rku_A          158 DFGLATKVEYDGER--KKVLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-----ETYL----  225 (294)
T ss_dssp             CCTTCEECCSTTCC--BCCCCSCCSSCCHH-HHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHH----
T ss_pred             eccCceecccCccc--cccccCCCCcCCcc-hhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHH----
Confidence            99999876533221  22356899999995 556677899999999999999999999998632111     0000    


Q ss_pred             cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          638 DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       638 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                          .+...... .                   +......+.+++.+||+.||++|||+.|+++.
T Consensus       226 ----~~~~~~~~-~-------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          226 ----RIKKNEYS-I-------------------PKHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             ----HHHTTCCC-C-------------------CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ----HHhhccCC-C-------------------ccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence                00000000 0                   01223457899999999999999999999874

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=9.9e-39  Score=355.87  Aligned_cols=250  Identities=22%  Similarity=0.323  Sum_probs=195.6

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      .|.+.+.||+|+||.||+|++..+++.||+|+++...   ......+.+|+.++++++||||++++++     +......
T Consensus       186 ~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~-----~~~~~~l  260 (543)
T 3c4z_A          186 WFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYA-----FETKTDL  260 (543)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEE-----EECSSEE
T ss_pred             heEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEE-----EeeCCEE
Confidence            4556677999999999999999899999999997432   2334567899999999999999999998     4556689


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      |+||||++||+|.+++.....      ....+++..++.++.||+.||.|||+.   ||+||||||+||+++.+|.+||+
T Consensus       261 ~lVmE~~~gg~L~~~l~~~~~------~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~  331 (543)
T 3c4z_A          261 CLVMTIMNGGDIRYHIYNVDE------DNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRIS  331 (543)
T ss_dssp             EEEECCCTTCBHHHHHHTSST------TSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEEC
T ss_pred             EEEEEeccCCCHHHHHHHhhc------ccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEe
Confidence            999999999999999864321      124588999999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCC
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      |||+++........  .....||+.|+|| |+..+..++.++||||+||++|||++|+.||....... ....+..    
T Consensus       332 DFGla~~~~~~~~~--~~~~~GT~~Y~AP-E~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~-~~~~~~~----  403 (543)
T 3c4z_A          332 DLGLAVELKAGQTK--TKGYAGTPGFMAP-ELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQ----  403 (543)
T ss_dssp             CCTTCEECCTTCCC--BCCCCSCTTTSCH-HHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC-CHHHHHH----
T ss_pred             ecceeeeccCCCcc--cccccCCccccCh-hhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch-hHHHHHH----
Confidence            99999876544322  2234699999999 45566789999999999999999999999996332111 1111111    


Q ss_pred             cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCH
Q 037916          638 DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNM  696 (741)
Q Consensus       638 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  696 (741)
                          .+......                    .+...+..+.+++.+||+.||++||++
T Consensus       404 ----~i~~~~~~--------------------~p~~~s~~~~~li~~lL~~dP~~R~~~  438 (543)
T 3c4z_A          404 ----RVLEQAVT--------------------YPDKFSPASKDFCEALLQKDPEKRLGF  438 (543)
T ss_dssp             ----HHHHCCCC--------------------CCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred             ----HHhhcccC--------------------CCcccCHHHHHHHHHhccCCHhHCCCC
Confidence                01110000                    001234567899999999999999976

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.1e-38  Score=334.00  Aligned_cols=257  Identities=22%  Similarity=0.271  Sum_probs=196.2

Q ss_pred             HHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC----cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccC
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH----HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKG  473 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  473 (741)
                      +..+|++.+.||+|+||.||+|.+..+++.||+|+++...    ....+.+.+|+.++++++||||+++++++..   .+
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~   79 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYN---EE   79 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC---C-
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEc---CC
Confidence            3467999999999999999999999899999999997432    2335678899999999999999999998632   34


Q ss_pred             CceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCc
Q 037916          474 DDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMT  553 (741)
Q Consensus       474 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~  553 (741)
                      ....++||||++++ +.+++...        ....+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.
T Consensus        80 ~~~~~lv~e~~~~~-l~~~~~~~--------~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~  147 (305)
T 2wtk_C           80 KQKMYMVMEYCVCG-MQEMLDSV--------PEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGT  147 (305)
T ss_dssp             --CEEEEEECCSEE-HHHHHHHS--------TTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCC
T ss_pred             CCeEEEEehhccCC-HHHHHHhC--------cccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCc
Confidence            55789999999765 76766532        124588999999999999999999999   9999999999999999999


Q ss_pred             eEEeecccccccCCCCcccccccccccccccCcccccCC-CCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhh
Q 037916          554 AHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLG-SEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFA  632 (741)
Q Consensus       554 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~-~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~  632 (741)
                      +||+|||.+................||+.|+|||.+... ..++.++||||+||++|+|++|+.||....     .....
T Consensus       148 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~  222 (305)
T 2wtk_C          148 LKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-----IYKLF  222 (305)
T ss_dssp             EEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHH
T ss_pred             EEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch-----HHHHH
Confidence            999999999876543333333345689999999654332 234789999999999999999999986321     11111


Q ss_pred             hhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          633 RTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       633 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      ..        +..... .                   .+..++..+.+++.+||+.||++|||+.|+++.
T Consensus       223 ~~--------i~~~~~-~-------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          223 EN--------IGKGSY-A-------------------IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             HH--------HHHCCC-C-------------------CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             HH--------HhcCCC-C-------------------CCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            00        000000 0                   001234567899999999999999999999874

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=4.6e-39  Score=341.40  Aligned_cols=249  Identities=20%  Similarity=0.225  Sum_probs=198.3

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc---CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCce
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH---GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      .+|.+.+.||+|+||.||+|++..+++.||+|++.....   ...+.+.+|+.+++.++||||+++++++     .+...
T Consensus        41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~  115 (335)
T 2owb_A           41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF-----EDNDF  115 (335)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred             CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----ecCCe
Confidence            357788999999999999999999999999999974322   2345678899999999999999999995     45668


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .|+||||+++++|.+++...          ..+++.+++.++.|++.||.|||+.   +|+||||||+||+++.++.+||
T Consensus       116 ~~lv~e~~~~~~L~~~~~~~----------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl  182 (335)
T 2owb_A          116 VFVVLELCRRRSLLELHKRR----------KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKI  182 (335)
T ss_dssp             EEEEECCCTTCBHHHHHHHH----------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEE
T ss_pred             EEEEEecCCCCCHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEE
Confidence            99999999999999988632          4588999999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcC
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVL  636 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  636 (741)
                      +|||.+.........  .....||+.|+||| +..+..++.++|||||||++|+|++|+.||......     ....   
T Consensus       183 ~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE-~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~---  251 (335)
T 2owb_A          183 GDFGLATKVEYDGER--KKVLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-----ETYL---  251 (335)
T ss_dssp             CCCTTCEECCSTTCC--BCCCCSCCSSCCHH-HHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHH---
T ss_pred             eeccCceecccCccc--ccccCCCccccCHH-HhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH-----HHHH---
Confidence            999999876533221  22356899999995 445667899999999999999999999998632110     0000   


Q ss_pred             CcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          637 PDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       637 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                           .+......                    .+......+.+++.+||+.||++|||+.|+++.
T Consensus       252 -----~~~~~~~~--------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          252 -----RIKKNEYS--------------------IPKHINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             -----HHHHTCCC--------------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             -----HHhcCCCC--------------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                 00000000                    001223457799999999999999999999874

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.5e-38  Score=361.17  Aligned_cols=257  Identities=23%  Similarity=0.322  Sum_probs=198.3

Q ss_pred             hcccCceeeEEEEEEc--CCCeEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEEEec
Q 037916          407 WIDMGSFGSVYKGILD--EGKTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEF  483 (741)
Q Consensus       407 ~ig~G~~g~V~~a~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv~e~  483 (741)
                      +||+|+||.||+|.++  .++..||||+++... ....+.+.+|+.++++++|||||+++++|.     . ...++||||
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~-----~-~~~~lv~E~  416 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-----A-EALMLVMEM  416 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEE-----S-SSEEEEEEC
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEec-----c-CCeEEEEEe
Confidence            6999999999999875  456789999997543 234577899999999999999999999963     2 358999999


Q ss_pred             ccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeeccccc
Q 037916          484 MHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAK  563 (741)
Q Consensus       484 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~a~  563 (741)
                      +++|+|.+++...         ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus       417 ~~~g~L~~~l~~~---------~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~  484 (613)
T 2ozo_A          417 AGGGPLHKFLVGK---------REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSK  484 (613)
T ss_dssp             CTTCBHHHHHTTC---------TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTT
T ss_pred             CCCCcHHHHHhhc---------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcc
Confidence            9999999998643         24588999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCc-ccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcCCcchh
Q 037916          564 LLPPAHL-QTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVLPDHVM  641 (741)
Q Consensus       564 ~~~~~~~-~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  641 (741)
                      ....... ........+++.|+||| +..+..++.++|||||||++|||++ |+.||.....  ......+..       
T Consensus       485 ~~~~~~~~~~~~~~~~~~~~y~APE-~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--~~~~~~i~~-------  554 (613)
T 2ozo_A          485 ALGADDSYYTARSAGKWPLKWYAPE-CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFIEQ-------  554 (613)
T ss_dssp             TCC--------------CCTTSCHH-HHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS--HHHHHHHHT-------
T ss_pred             cccCCCceeeeccCCCCccceeCHh-hhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH--HHHHHHHHc-------
Confidence            7654322 11122233568899995 4556789999999999999999998 9999863211  111111110       


Q ss_pred             HhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHhhcCCc
Q 037916          642 DIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSILLGPK  714 (741)
Q Consensus       642 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~  714 (741)
                           ....                  ..+..+++.+.+++.+||+.||++|||+.||++.|+.+........
T Consensus       555 -----~~~~------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~  604 (613)
T 2ozo_A          555 -----GKRM------------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV  604 (613)
T ss_dssp             -----TCCC------------------CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSC
T ss_pred             -----CCCC------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcccc
Confidence                 0000                  0012345778899999999999999999999999999987765443

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=3.2e-39  Score=345.45  Aligned_cols=274  Identities=19%  Similarity=0.220  Sum_probs=201.6

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc-CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      ..|.+.+.||+|+||.||+|++..+++.||+|+++.... .....+.+|+.++++++||||+++++++....+......+
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   90 (353)
T 2b9h_A           11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY   90 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEE
T ss_pred             cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEE
Confidence            468889999999999999999999999999999964322 2245667899999999999999999997655455567899


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      +||||+. ++|.+++..           ..+++..+..++.|++.||+|||+.   ||+||||||+||+++.++.+||+|
T Consensus        91 lv~e~~~-~~L~~~~~~-----------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~D  155 (353)
T 2b9h_A           91 IIQELMQ-TDLHRVIST-----------QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCD  155 (353)
T ss_dssp             EEECCCS-EEHHHHHHH-----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECC
T ss_pred             EEEeccC-ccHHHHHhh-----------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEe
Confidence            9999995 699998852           3578999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCccc--------ccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhh
Q 037916          559 FGLAKLLPPAHLQT--------SSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHN  630 (741)
Q Consensus       559 Fg~a~~~~~~~~~~--------~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~  630 (741)
                      ||.+..........        ......||+.|+|||.+..+..++.++||||+||++|+|++|+.||....... .+..
T Consensus       156 fg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~  234 (353)
T 2b9h_A          156 FGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH-QLLL  234 (353)
T ss_dssp             CTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHH
T ss_pred             cccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHH
Confidence            99998765432111        11234689999999766666789999999999999999999999986332110 0000


Q ss_pred             hhhhcC------------CcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHH
Q 037916          631 FARTVL------------PDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTI  698 (741)
Q Consensus       631 ~~~~~~------------~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  698 (741)
                      ......            .....+...........            .........+..+.+++.+||+.||++|||+.|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  302 (353)
T 2b9h_A          235 IFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAA------------PLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKE  302 (353)
T ss_dssp             HHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCC------------CHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             HHHHhCCCchhccccccccchhhHHhhcccCCCCc------------chhhhcccCCHHHHHHHHHhcCcCcccCCCHHH
Confidence            000000            00001111100000000            000011234567889999999999999999999


Q ss_pred             HHH
Q 037916          699 VVH  701 (741)
Q Consensus       699 vl~  701 (741)
                      +++
T Consensus       303 ll~  305 (353)
T 2b9h_A          303 ALE  305 (353)
T ss_dssp             HHT
T ss_pred             Hhc
Confidence            987

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2.2e-39  Score=338.79  Aligned_cols=253  Identities=22%  Similarity=0.258  Sum_probs=194.1

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      ..|++.+.||+|+||.||+|.+..+++.||+|++........+.+.+|+.+++.++||||+++++++     ......++
T Consensus        19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   93 (302)
T 2j7t_A           19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY-----YHDGKLWI   93 (302)
T ss_dssp             GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECC-CEEE
T ss_pred             cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeee-----eeCCeEEE
Confidence            4588899999999999999999989999999999765555667889999999999999999999995     34558899


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      ||||+++++|.+++...         ...+++..+..++.|++.||.|||+.   ||+||||||+||+++.++.+||+||
T Consensus        94 v~e~~~~~~l~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Df  161 (302)
T 2j7t_A           94 MIEFCPGGAVDAIMLEL---------DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADF  161 (302)
T ss_dssp             EEECCTTEEHHHHHHHH---------TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCC
T ss_pred             EEEeCCCCcHHHHHHhh---------ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEEC
Confidence            99999999999987532         24588999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccccccCccccc----CCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhc
Q 037916          560 GLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG----LGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV  635 (741)
Q Consensus       560 g~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~----~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~  635 (741)
                      |.+.......  .......||+.|+|||.+.    .+..++.++||||+||++|+|++|..||....... .........
T Consensus       162 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~  238 (302)
T 2j7t_A          162 GVSAKNLKTL--QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKSD  238 (302)
T ss_dssp             HHHHHHHHHH--HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSC
T ss_pred             CCCccccccc--cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH-HHHHHhccC
Confidence            9875432111  1112245899999996543    46678999999999999999999999986321110 000000000


Q ss_pred             CCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          636 LPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       636 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      .+.         .                    .....++..+.+++.+||+.||++|||+.|+++
T Consensus       239 ~~~---------~--------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          239 PPT---------L--------------------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             CCC---------C--------------------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             Ccc---------c--------------------CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            000         0                    001123456889999999999999999999875

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=2.1e-37  Score=336.07  Aligned_cols=330  Identities=22%  Similarity=0.205  Sum_probs=287.9

Q ss_pred             CCCCCcccccCChhhhhCCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCc
Q 037916            2 DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHL   81 (741)
Q Consensus         2 dl~~n~~~~~ip~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L   81 (741)
                      |+++|.+. .+|..++..+++|++|+|++|+|+++.+..|.++++|++|+|++|++++..|..|.++++          |
T Consensus        51 ~l~~~~l~-~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~----------L  119 (390)
T 3o6n_A           51 TFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPL----------L  119 (390)
T ss_dssp             EEESCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTT----------C
T ss_pred             EecCCchh-hCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCC----------C
Confidence            45677776 789888779999999999999999999999999999999999999999888888999986          9


Q ss_pred             cEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEccc
Q 037916           82 KHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINT  161 (741)
Q Consensus        82 ~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~  161 (741)
                      ++|+|++|+++++.+..|..++ +|++|++++|++.+..+..|..+++|++|+|++|+++++.   +..+++|+.|++++
T Consensus       120 ~~L~L~~n~l~~l~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~---~~~l~~L~~L~l~~  195 (390)
T 3o6n_A          120 TVLVLERNDLSSLPRGIFHNTP-KLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSY  195 (390)
T ss_dssp             CEEECCSSCCCCCCTTTTTTCT-TCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC---GGGCTTCSEEECCS
T ss_pred             CEEECCCCccCcCCHHHhcCCC-CCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccc---cccccccceeeccc
Confidence            9999999999977777778888 9999999999999999999999999999999999999763   66788999999999


Q ss_pred             CCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCCC
Q 037916          162 NKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSL  241 (741)
Q Consensus       162 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~  241 (741)
                      |.+++     +...++|++|++++|.+..... .+  .++|+.|++++|++++.  ..+..+++|+. |+|++|.+.+..
T Consensus       196 n~l~~-----~~~~~~L~~L~l~~n~l~~~~~-~~--~~~L~~L~l~~n~l~~~--~~l~~l~~L~~-L~Ls~n~l~~~~  264 (390)
T 3o6n_A          196 NLLST-----LAIPIAVEELDASHNSINVVRG-PV--NVELTILKLQHNNLTDT--AWLLNYPGLVE-VDLSYNELEKIM  264 (390)
T ss_dssp             SCCSE-----EECCSSCSEEECCSSCCCEEEC-CC--CSSCCEEECCSSCCCCC--GGGGGCTTCSE-EECCSSCCCEEE
T ss_pred             ccccc-----cCCCCcceEEECCCCeeeeccc-cc--cccccEEECCCCCCccc--HHHcCCCCccE-EECCCCcCCCcC
Confidence            99984     3455789999999999986533 32  47999999999999853  67899999998 999999999888


Q ss_pred             ChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccchhhhccc
Q 037916          242 PTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQ  321 (741)
Q Consensus       242 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  321 (741)
                      |..|..+++|++|+|++|+++++ +..+..+++|++|+|++|++++ +|..+..+++|+.|+|++|+|++..   +..++
T Consensus       265 ~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~N~i~~~~---~~~~~  339 (390)
T 3o6n_A          265 YHPFVKMQRLERLYISNNRLVAL-NLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIVTLK---LSTHH  339 (390)
T ss_dssp             SGGGTTCSSCCEEECCSSCCCEE-ECSSSCCTTCCEEECCSSCCCC-CGGGHHHHTTCSEEECCSSCCCCCC---CCTTC
T ss_pred             hhHccccccCCEEECCCCcCccc-CcccCCCCCCCEEECCCCccee-cCccccccCcCCEEECCCCccceeC---chhhc
Confidence            99999999999999999999975 5566789999999999999994 6677889999999999999999653   67788


Q ss_pred             cCCcccccCcccccccCCccccCCcccccccCCCCccccCCC
Q 037916          322 LVQNLNLSYNDLEGVIPTEGVFKNASAISVFGNSKLCGGIPE  363 (741)
Q Consensus       322 ~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~~~  363 (741)
                      +|+.|++++|++++.... ..+..+....+.+++..|..+..
T Consensus       340 ~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~c~~~~~  380 (390)
T 3o6n_A          340 TLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKIDYQ  380 (390)
T ss_dssp             CCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCSCCCTTCE
T ss_pred             cCCEEEcCCCCccchhHH-HHHHHHHhhcccccCceeccccc
Confidence            999999999999986432 34566667777888888875533

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.4e-38  Score=341.43  Aligned_cols=289  Identities=17%  Similarity=0.156  Sum_probs=191.1

Q ss_pred             HHHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccc--cCC
Q 037916          397 LLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDY--KGD  474 (741)
Q Consensus       397 ~~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~--~~~  474 (741)
                      ....+|++.+.||+|+||.||+|++..+++.||+|++... ........+|+..++.++||||+++++++.....  ...
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~   98 (360)
T 3e3p_A           20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD   98 (360)
T ss_dssp             HHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred             hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence            4567899999999999999999999989999999998643 3344567788888899999999999999754321  223


Q ss_pred             ceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHH--hcCCCCceecCCCCCCeEeCC-C
Q 037916          475 DFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH--HDCQPTTAHCDLKPSNVLLDH-E  551 (741)
Q Consensus       475 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~~~~ivHrDlkp~NIll~~-~  551 (741)
                      .+.++||||+++ ++.+.+...      ......+++..+..++.|++.||.|||  +.   +|+||||||+||+++. +
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~~------~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~  168 (360)
T 3e3p_A           99 IYLNVVMEYVPD-TLHRCCRNY------YRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEAD  168 (360)
T ss_dssp             EEEEEEEECCSC-BHHHHHHHH------HTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTT
T ss_pred             eeEEEEeecccc-cHHHHHHHH------hhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCC
Confidence            347899999976 554443211      011245788899999999999999999  88   9999999999999997 8


Q ss_pred             CceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhh
Q 037916          552 MTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNF  631 (741)
Q Consensus       552 ~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~  631 (741)
                      +.+||+|||++.........   ....||+.|+|||.+.....++.++||||+||++|+|++|+.||...... ..+...
T Consensus       169 ~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-~~~~~~  244 (360)
T 3e3p_A          169 GTLKLCDFGSAKKLSPSEPN---VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA-GQLHEI  244 (360)
T ss_dssp             TEEEECCCTTCBCCCTTSCC---CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHH
T ss_pred             CcEEEeeCCCceecCCCCCc---ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH-HHHHHH
Confidence            99999999999876544322   23458999999966655666899999999999999999999998642111 111222


Q ss_pred             hhhcCCcc--hhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          632 ARTVLPDH--VMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       632 ~~~~~~~~--~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      ........  .....++.......  ....................+.+.+++.+||+.||++|||+.|+++-
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          245 VRVLGCPSREVLRKLNPSHTDVDL--YNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             HHHHCCCCHHHHHHHCTTCCCGGG--GCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHHcCCCCHHHHHhcccchhhccc--cccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            21111110  11111100000000  00000000000001111245678999999999999999999999864

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1e-38  Score=332.44  Aligned_cols=250  Identities=22%  Similarity=0.271  Sum_probs=191.4

Q ss_pred             hhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEEEecc
Q 037916          405 LCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVYEFM  484 (741)
Q Consensus       405 ~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv~e~~  484 (741)
                      ...||+|+||.||+|.+..+++.||+|+++.......+.+.+|+.+++.++||||+++++++     ......++||||+
T Consensus        27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~  101 (295)
T 2clq_A           27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF-----SENGFIKIFMEQV  101 (295)
T ss_dssp             BCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEE-----EETTEEEEEEECC
T ss_pred             cEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEE-----EeCCcEEEEEEeC
Confidence            34799999999999999989999999999865555567889999999999999999999995     4456889999999


Q ss_pred             cCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCC-CCceEEeeccccc
Q 037916          485 HNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDH-EMTAHVADFGLAK  563 (741)
Q Consensus       485 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~-~~~~kL~DFg~a~  563 (741)
                      ++++|.+++....       ....+++..+..++.|++.||.|||+.   +|+||||||+||+++. ++.+||+|||.+.
T Consensus       102 ~~~~L~~~l~~~~-------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~  171 (295)
T 2clq_A          102 PGGSLSALLRSKW-------GPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSK  171 (295)
T ss_dssp             SEEEHHHHHHHTT-------CCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCE
T ss_pred             CCCCHHHHHHhhc-------cCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeeccccc
Confidence            9999999986431       123467888899999999999999999   9999999999999987 8899999999998


Q ss_pred             ccCCCCcccccccccccccccCcccccCC-CCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcchhH
Q 037916          564 LLPPAHLQTSSIGVKGTIGYIAPAEYGLG-SEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMD  642 (741)
Q Consensus       564 ~~~~~~~~~~~~~~~gt~~y~aPEe~~~~-~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  642 (741)
                      ........  .....||+.|+|||.+..+ ..++.++||||||+++|+|++|+.||................        
T Consensus       172 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--------  241 (295)
T 2clq_A          172 RLAGINPC--TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMF--------  241 (295)
T ss_dssp             ESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHH--------
T ss_pred             ccCCCCCc--ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccc--------
Confidence            76543211  1234689999999655433 247899999999999999999999986321111000000000        


Q ss_pred             hhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          643 IVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       643 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                          .....                  .+..++..+.+++.+||+.||++|||+.|+++
T Consensus       242 ----~~~~~------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          242 ----KVHPE------------------IPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             ----CCCCC------------------CCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             ----ccccc------------------ccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                00000                  00123456789999999999999999999975

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.4e-38  Score=331.90  Aligned_cols=254  Identities=21%  Similarity=0.285  Sum_probs=199.5

Q ss_pred             HHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc---------CcchhHHHHHHHHHhcC-CCceeeEeeeec
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH---------GASKSSIAECSALRNIR-HKNLVKILTVCS  467 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~  467 (741)
                      +...|++.+.||+|+||.||+|.+..+++.||+|+++....         ...+.+.+|+.+++++. ||||+++++++ 
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~-   93 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY-   93 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE-
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee-
Confidence            45678999999999999999999999999999999974331         11345678999999995 99999999994 


Q ss_pred             CccccCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeE
Q 037916          468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVL  547 (741)
Q Consensus       468 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIl  547 (741)
                          ......++||||+++++|.+++...          ..+++..+..++.|++.||.|||+.   ||+||||||+||+
T Consensus        94 ----~~~~~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil  156 (298)
T 1phk_A           94 ----ETNTFFFLVFDLMKKGELFDYLTEK----------VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENIL  156 (298)
T ss_dssp             ----ECSSEEEEEEECCTTCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred             ----ccCCeEEEEEeccCCCcHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEE
Confidence                4566899999999999999998632          4588999999999999999999999   9999999999999


Q ss_pred             eCCCCceEEeecccccccCCCCcccccccccccccccCccccc-----CCCCCCCccCchhHHHHHHHHHcCCCCCCccc
Q 037916          548 LDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG-----LGSEVSINGDVYSYGILLLELMTRKRPSDIMF  622 (741)
Q Consensus       548 l~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~-----~~~~~~~~~DIwSlG~il~elltg~~p~~~~~  622 (741)
                      ++.++.+||+|||.+.........   ....|++.|+|||.+.     ....++.++||||+|+++|+|++|..||....
T Consensus       157 ~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~  233 (298)
T 1phk_A          157 LDDDMNIKLTDFGFSCQLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK  233 (298)
T ss_dssp             ECTTCCEEECCCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             EcCCCcEEEecccchhhcCCCccc---ccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc
Confidence            999999999999999876543322   2345899999996543     35568899999999999999999999986321


Q ss_pred             cCCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          623 EGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       623 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      .  ......           +.........                ......+..+.+++.+||+.||++|||+.|+++
T Consensus       234 ~--~~~~~~-----------~~~~~~~~~~----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          234 Q--MLMLRM-----------IMSGNYQFGS----------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             H--HHHHHH-----------HHHTCCCCCT----------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             H--HHHHHH-----------HhcCCcccCc----------------ccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            1  000000           0000000000                000133456889999999999999999999975

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=5.1e-39  Score=345.92  Aligned_cols=268  Identities=18%  Similarity=0.174  Sum_probs=194.0

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc--CcchhHHHHHHHHHhcCCCceeeEeeeecCccc-cCCceE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKNLVKILTVCSGVDY-KGDDFK  477 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~-~~~~~~  477 (741)
                      .|.+.+.||+|+||.||+|.+..+++.||+|+++....  ...+.+.+|+.+++.++||||+++++++..... ......
T Consensus        43 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  122 (371)
T 4exu_A           43 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF  122 (371)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCC
T ss_pred             cEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeE
Confidence            57788999999999999999999999999999974322  224567899999999999999999999753321 111234


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      ++||||+. ++|.+++.            ..+++..+..++.|++.||+|||+.   ||+||||||+||+++.++.+||+
T Consensus       123 ~lv~e~~~-~~l~~~~~------------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~  186 (371)
T 4exu_A          123 YLVMPFMQ-TDLQKIMG------------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKIL  186 (371)
T ss_dssp             EEEEECCC-EEHHHHTT------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEEC
T ss_pred             EEEEcccc-ccHHHHhh------------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEE
Confidence            99999996 68888874            3388999999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCC
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      |||.+......     .....||+.|+|||.+.....++.++||||+||++|+|++|+.||...... ..+.........
T Consensus       187 Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~  260 (371)
T 4exu_A          187 DFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKVTGV  260 (371)
T ss_dssp             STTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCC
T ss_pred             ecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCC
Confidence            99999865432     123458999999966655578999999999999999999999999632111 111111111000


Q ss_pred             c-----------chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          638 D-----------HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       638 ~-----------~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      .           ...............            ........+.+.+.+++.+||+.||++|||+.|+++-
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          261 PGTEFVQKLNDKAAKSYIQSLPQTPRK------------DFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             CCHHHHTTCSCHHHHHHHHHSCCCCCC------------CHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             CcHHHHHHhhhhhhhhhhhccCCCcch------------hHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence            0           000111000000000            0001112345678899999999999999999999864

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.4e-39  Score=334.42  Aligned_cols=257  Identities=21%  Similarity=0.240  Sum_probs=197.7

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc--CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      ..|++.+.||+|+||.||+|.+..+++.||+|+++....  ...+.+.+|+.++++++||||+++++++..   ......
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~~~   82 (279)
T 2w5a_A            6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNTTL   82 (279)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---GGGTEE
T ss_pred             hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEec---CCCceE
Confidence            468889999999999999999999999999999974332  234567899999999999999999998642   345678


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCC-----ceecCCCCCCeEeCCCC
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPT-----TAHCDLKPSNVLLDHEM  552 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~-----ivHrDlkp~NIll~~~~  552 (741)
                      ++||||+++++|.+++.....      ....+++..++.++.|++.||+|||+.   +     |+||||||+||+++.++
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~  153 (279)
T 2w5a_A           83 YIVMEYCEGGDLASVITKGTK------ERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQ  153 (279)
T ss_dssp             EEEEECCTTEEHHHHHHHHHH------TTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSS
T ss_pred             EEEEeCCCCCCHHHHHHhhcc------cCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCC
Confidence            999999999999999864311      123488999999999999999999999   8     99999999999999999


Q ss_pred             ceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhh
Q 037916          553 TAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFA  632 (741)
Q Consensus       553 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~  632 (741)
                      .+||+|||.+.........  .....||+.|+||| ...+..++.++||||+|+++|+|++|..||.....  .......
T Consensus       154 ~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~i  228 (279)
T 2w5a_A          154 NVKLGDFGLARILNHDTSF--AKTFVGTPYYMSPE-QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KELAGKI  228 (279)
T ss_dssp             CEEECCCCHHHHC---CHH--HHHHHSCCTTCCHH-HHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHH
T ss_pred             CEEEecCchheeecccccc--ccccCCCccccChH-HhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH--HHHHHHH
Confidence            9999999999876543211  12245899999995 44566789999999999999999999999863211  0110000


Q ss_pred             hhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHH
Q 037916          633 RTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHEL  703 (741)
Q Consensus       633 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  703 (741)
                                 ........                   +..++..+.+++.+||+.||++|||+.|+++.+
T Consensus       229 -----------~~~~~~~~-------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~  269 (279)
T 2w5a_A          229 -----------REGKFRRI-------------------PYRYSDELNEIITRMLNLKDYHRPSVEEILENP  269 (279)
T ss_dssp             -----------HHTCCCCC-------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred             -----------hhcccccC-------------------CcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence                       00000000                   012345688999999999999999999999854

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=4.3e-39  Score=336.70  Aligned_cols=269  Identities=21%  Similarity=0.256  Sum_probs=180.5

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      ..|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.++++++||||+++++++     ......+
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   89 (303)
T 2vwi_A           15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF-----VVKDELW   89 (303)
T ss_dssp             CCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEE-----ESSSCEE
T ss_pred             hhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEE-----eecCCcE
Confidence            46888999999999999999998889999999986432 23356678899999999999999999995     4455789


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      +||||+++++|.+++.......  ......+++..+..++.|++.||.|||+.   ||+||||||+||+++.++.+||+|
T Consensus        90 lv~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~d  164 (303)
T 2vwi_A           90 LVMKLLSGGSVLDIIKHIVAKG--EHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIAD  164 (303)
T ss_dssp             EEEECCTTCBHHHHHHHHHHTT--TTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECC
T ss_pred             EEehhccCCchHHHHHHHhhcc--ccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEe
Confidence            9999999999999986311000  01124588999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCc---ccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhc
Q 037916          559 FGLAKLLPPAHL---QTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV  635 (741)
Q Consensus       559 Fg~a~~~~~~~~---~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~  635 (741)
                      ||.+........   ........||+.|+|||.+.....++.++||||+||++|+|++|+.||......... .......
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~  243 (303)
T 2vwi_A          165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL-MLTLQND  243 (303)
T ss_dssp             CHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH-HHHHTSS
T ss_pred             ccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH-HHHhccC
Confidence            999976654321   111223458999999965544356889999999999999999999998643211110 0000000


Q ss_pred             CCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          636 LPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       636 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      .+.......+....                      ...+..+.+++.+||+.||++|||+.|+++
T Consensus       244 ~~~~~~~~~~~~~~----------------------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          244 PPSLETGVQDKEML----------------------KKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             CCCTTC-----CCC----------------------CCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCccccccccchhh----------------------hhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            00000000000010                      122356789999999999999999999986

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.2e-38  Score=331.89  Aligned_cols=253  Identities=25%  Similarity=0.260  Sum_probs=194.7

Q ss_pred             HHHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCce
Q 037916          397 LLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       397 ~~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      .....|++.+.||+|+||.||+|.+..+++.||+|+++..  ...+.+.+|+.++++++||||+++++++     .....
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~   98 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSY-----FKNTD   98 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEE-----EETTE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEE-----EeCCE
Confidence            3456788999999999999999999989999999999743  3457788999999999999999999995     34568


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .++||||+++++|.+++...         ...+++..+..++.|++.||.|||+.   ||+||||||+||+++.++.+||
T Consensus        99 ~~lv~e~~~~~~L~~~~~~~---------~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl  166 (314)
T 3com_A           99 LWIVMEYCGAGSVSDIIRLR---------NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKL  166 (314)
T ss_dssp             EEEEEECCTTEEHHHHHHHH---------TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEE
T ss_pred             EEEEeecCCCCCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEE
Confidence            89999999999999998522         24588999999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcC
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVL  636 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  636 (741)
                      +|||.+.........  .....||+.|+|| |+..+..++.++||||+||++|+|++|..||.......  .........
T Consensus       167 ~dfg~~~~~~~~~~~--~~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~  241 (314)
T 3com_A          167 ADFGVAGQLTDTMAK--RNTVIGTPFWMAP-EVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR--AIFMIPTNP  241 (314)
T ss_dssp             CCCTTCEECBTTBSC--BCCCCSCGGGCCH-HHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHSC
T ss_pred             eecccchhhhhhccc--cCccCCCCCccCh-hhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHhcCC
Confidence            999999776543221  2234689999999 45566678999999999999999999999986321100  000000000


Q ss_pred             CcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          637 PDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       637 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ..            ..                ......+..+.+++.+||+.||++|||+.|+++
T Consensus       242 ~~------------~~----------------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          242 PP------------TF----------------RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             CC------------CC----------------SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             Cc------------cc----------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            00            00                001122456889999999999999999999986

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=4.3e-39  Score=345.38  Aligned_cols=199  Identities=24%  Similarity=0.322  Sum_probs=169.8

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceE
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      ...|++.+.||+|+||.||+|.+..+++.||+|+++... ....+.+.+|+.++++++||||+++++++     ..+...
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~  106 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDGEI  106 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEE-----EETTEE
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEE-----EECCEE
Confidence            456888899999999999999999999999999997532 22345678999999999999999999995     445689


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHh-cCCCCceecCCCCCCeEeCCCCceEE
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH-DCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      ++||||+++++|.+++...          ..+++..+..++.|++.||.|||+ .   ||+||||||+||+++.++.+||
T Consensus       107 ~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl  173 (360)
T 3eqc_A          107 SICMEHMDGGSLDQVLKKA----------GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKL  173 (360)
T ss_dssp             EEEECCCTTCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEE
T ss_pred             EEEEECCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEcCCccHHHEEECCCCCEEE
Confidence            9999999999999998643          457889999999999999999998 5   8999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCc
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDI  620 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~  620 (741)
                      +|||.+.......    .....||+.|+|| |+..+..++.++||||+||++|+|++|+.||..
T Consensus       174 ~Dfg~~~~~~~~~----~~~~~gt~~y~aP-E~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  232 (360)
T 3eqc_A          174 CDFGVSGQLIDSM----ANSFVGTRSYMSP-ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP  232 (360)
T ss_dssp             CCCCCCHHHHHHC--------CCCCTTCCH-HHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred             EECCCCccccccc----ccCCCCCCCeECH-HHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9999987543221    1224689999999 555677899999999999999999999999974

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=5.7e-39  Score=344.76  Aligned_cols=278  Identities=18%  Similarity=0.159  Sum_probs=197.0

Q ss_pred             HHHHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCc-----------chhHHHHHHHHHhcCCCceeeEee
Q 037916          396 ILLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGA-----------SKSSIAECSALRNIRHKNLVKILT  464 (741)
Q Consensus       396 ~~~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~hpnIv~~~~  464 (741)
                      ..+...|++.+.||+|+||.||+|.+. +++.||+|++.......           .+.+.+|+.++++++||||+++++
T Consensus        18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   96 (362)
T 3pg1_A           18 HAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRD   96 (362)
T ss_dssp             HHTTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred             HHhccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceee
Confidence            345578999999999999999999987 48999999986422211           267889999999999999999999


Q ss_pred             eecCccccCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCC
Q 037916          465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPS  544 (741)
Q Consensus       465 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~  544 (741)
                      ++...........|+||||+. |+|.+++...         ...+++..+..++.|++.||.|||+.   +|+||||||+
T Consensus        97 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~  163 (362)
T 3pg1_A           97 IFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ---------RIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPG  163 (362)
T ss_dssp             EEEECCTTTCCEEEEEEECCS-EEHHHHHHCT---------TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGG
T ss_pred             eEEeccCCCcceEEEEEccCC-CCHHHHHHhc---------ccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChH
Confidence            975443345567899999996 6888887632         24588999999999999999999999   9999999999


Q ss_pred             CeEeCCCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccC
Q 037916          545 NVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEG  624 (741)
Q Consensus       545 NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~  624 (741)
                      ||+++.++.+||+|||.+........   .....||+.|+|||.+.....++.++||||+||++|+|++|+.||......
T Consensus       164 NIl~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~  240 (362)
T 3pg1_A          164 NILLADNNDITICDFNLAREDTADAN---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY  240 (362)
T ss_dssp             GEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             HEEEcCCCCEEEEecCcccccccccc---cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence            99999999999999999975543322   223458999999966655578999999999999999999999998632111


Q ss_pred             CcchhhhhhhcCCcc-----------hhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCC
Q 037916          625 NMNLHNFARTVLPDH-----------VMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDR  693 (741)
Q Consensus       625 ~~~~~~~~~~~~~~~-----------~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  693 (741)
                       ..............           ..+.+.........           ...........+.+.+++.+||+.||++|
T Consensus       241 -~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~li~~~L~~dP~~R  308 (362)
T 3pg1_A          241 -NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPA-----------RAWTAVVPTADPVALDLIAKMLEFNPQRR  308 (362)
T ss_dssp             -HHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCC-----------CCHHHHSTTSCHHHHHHHHHHTCSSGGGS
T ss_pred             -HHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCCh-----------hhHHhhCCCCCHHHHHHHHHHhcCChhhC
Confidence             11111111111111           11111111110000           00011112335668899999999999999


Q ss_pred             CCHHHHHHH
Q 037916          694 MNMTIVVHE  702 (741)
Q Consensus       694 Ps~~evl~~  702 (741)
                      ||+.|+++.
T Consensus       309 pt~~ell~h  317 (362)
T 3pg1_A          309 ISTEQALRH  317 (362)
T ss_dssp             CCHHHHHTS
T ss_pred             CCHHHHHcC
Confidence            999999863

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=3.8e-39  Score=334.84  Aligned_cols=255  Identities=20%  Similarity=0.213  Sum_probs=182.2

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcC-c-chhHHHHHHHHHhcCCCceeeEeeeecCccccCCceE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG-A-SKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      ..|++.+.||+|+||.||+|++..+++.||+|+++..... . .+.+.++...++.++||||+++++++     ..+...
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-----~~~~~~   81 (290)
T 3fme_A            7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGAL-----FREGDV   81 (290)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSSE
T ss_pred             HhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeee-----eccCCE
Confidence            4688899999999999999999989999999999743221 1 22233444557788999999999995     445689


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      ++||||++ |+|.+++....      .....+++..++.++.|++.||+|||++.  ||+||||||+||+++.++.+||+
T Consensus        82 ~lv~e~~~-~~l~~~l~~~~------~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~  152 (290)
T 3fme_A           82 WICMELMD-TSLDKFYKQVI------DKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMC  152 (290)
T ss_dssp             EEEEECCS-EEHHHHHHHHH------HTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBC
T ss_pred             EEEEehhc-cchHHHHHHHH------hcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEe
Confidence            99999996 58877765310      11246899999999999999999999843  89999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccccccCcccc---cCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhh
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEY---GLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~---~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  634 (741)
                      |||.+.........   ....||+.|+|||.+   ..+..++.++||||+||++|+|++|+.||................
T Consensus       153 Dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  229 (290)
T 3fme_A          153 DFGISGYLVDDVAK---DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEE  229 (290)
T ss_dssp             CC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHS
T ss_pred             ecCCcccccccccc---cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhcc
Confidence            99999876543222   223589999999654   356678999999999999999999999986321111111111111


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ..+..            .                  ....+..+.+++.+||+.||++|||+.|+++
T Consensus       230 ~~~~~------------~------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          230 PSPQL------------P------------------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             CCCCC------------C------------------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCc------------c------------------cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            10000            0                  0123456889999999999999999999987

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.6e-38  Score=364.40  Aligned_cols=249  Identities=23%  Similarity=0.275  Sum_probs=199.4

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeecc---CcCcchhHHHHHHHHHhc-CCCceeeEeeeecCccccCC
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLL---HHGASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKGD  474 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~  474 (741)
                      ...|++++.||+|+||.||+|++..+++.||||+++..   .....+....|..++..+ +||+|++++++     +++.
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~-----~~~~  414 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSC-----FQTM  414 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEE-----CBCS
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE-----EEeC
Confidence            45688999999999999999999999999999999742   234456778899999887 79999999998     5667


Q ss_pred             ceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCce
Q 037916          475 DFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTA  554 (741)
Q Consensus       475 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~  554 (741)
                      ...|+||||+++|+|.+++...          ..+++..++.++.||+.||+|||+.   +|+||||||+|||++.++++
T Consensus       415 ~~~~lV~E~~~gg~L~~~l~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~i  481 (674)
T 3pfq_A          415 DRLYFVMEYVNGGDLMYHIQQV----------GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHI  481 (674)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCE
T ss_pred             CEEEEEEeCcCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcE
Confidence            7899999999999999998643          4588999999999999999999999   99999999999999999999


Q ss_pred             EEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhh
Q 037916          555 HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       555 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  634 (741)
                      ||+|||+|+........  .....||+.|+|| |+..+..++.++|||||||++|||++|+.||.....     ......
T Consensus       482 kL~DFGla~~~~~~~~~--~~~~~GT~~Y~AP-E~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~-----~~~~~~  553 (674)
T 3pfq_A          482 KIADFGMCKENIWDGVT--TKTFCGTPDYIAP-EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----DELFQS  553 (674)
T ss_dssp             EECCCTTCEECCCTTCC--BCCCCSCSSSCCH-HHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHH
T ss_pred             EEeecceeeccccCCcc--cccccCCCcccCH-hhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH-----HHHHHH
Confidence            99999999864433222  2335799999999 555677899999999999999999999999863211     111111


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCH-----HHHHH
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNM-----TIVVH  701 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~  701 (741)
                              +......  .                  +......+.+|+.+||+.||++||++     +||++
T Consensus       554 --------i~~~~~~--~------------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          554 --------IMEHNVA--Y------------------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             --------HHSSCCC--C------------------CTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             --------HHhCCCC--C------------------CccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence                    1110000  0                  01234567899999999999999998     55553

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.7e-38  Score=363.53  Aligned_cols=253  Identities=22%  Similarity=0.307  Sum_probs=195.4

Q ss_pred             hhcccCceeeEEEEEE--cCCCeEEEEEEeeccCc--CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEEE
Q 037916          406 CWIDMGSFGSVYKGIL--DEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVY  481 (741)
Q Consensus       406 ~~ig~G~~g~V~~a~~--~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv~  481 (741)
                      ++||+|+||.||+|.+  ..+++.||||+++....  ...+.+.+|+.++++++|||||+++++|.      ....++||
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~------~~~~~lv~  448 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE------AESWMLVM  448 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE------SSSEEEEE
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe------cCCEEEEE
Confidence            4699999999999965  45678999999974322  23467899999999999999999999962      23478999


Q ss_pred             ecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeeccc
Q 037916          482 EFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGL  561 (741)
Q Consensus       482 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~  561 (741)
                      ||+++|+|.+++...          ..+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus       449 E~~~~g~L~~~l~~~----------~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGl  515 (635)
T 4fl3_A          449 EMAELGPLNKYLQQN----------RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGL  515 (635)
T ss_dssp             ECCTTEEHHHHHHHC----------TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTH
T ss_pred             EccCCCCHHHHHhhC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCC
Confidence            999999999999643          4588999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCc-ccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcCCcc
Q 037916          562 AKLLPPAHL-QTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVLPDH  639 (741)
Q Consensus       562 a~~~~~~~~-~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  639 (741)
                      ++....... ........+|+.|+||| +..+..++.++|||||||++|||++ |+.||......  .....+..     
T Consensus       516 a~~~~~~~~~~~~~~~~~~t~~y~APE-~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~~~~i~~-----  587 (635)
T 4fl3_A          516 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEK-----  587 (635)
T ss_dssp             HHHTTC-------------CGGGSCHH-HHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHT-----
T ss_pred             ccccccCccccccccCCCCceeeeChh-hhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHc-----
Confidence            987654432 12222344678999995 5566789999999999999999998 99998632111  11111111     


Q ss_pred             hhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHhh
Q 037916          640 VMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSIL  710 (741)
Q Consensus       640 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  710 (741)
                             ......                  +..+++.+.+++.+||+.||++|||+.+|++.|+++....
T Consensus       588 -------~~~~~~------------------p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l  633 (635)
T 4fl3_A          588 -------GERMGC------------------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  633 (635)
T ss_dssp             -------TCCCCC------------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             -------CCCCCC------------------CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence                   000000                  1134567889999999999999999999999999887543

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.3e-39  Score=351.38  Aligned_cols=257  Identities=14%  Similarity=0.110  Sum_probs=186.9

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeecc---CcCcchhHHHHHH---HHHhcCCCceeeEeeeecCcc--cc
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLL---HHGASKSSIAECS---ALRNIRHKNLVKILTVCSGVD--YK  472 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~---~l~~l~hpnIv~~~~~~~~~~--~~  472 (741)
                      .|++.+.||+|+||.||+|++..+++.||||+++..   .....+.+.+|+.   .+++++|||||++++.+....  +.
T Consensus        74 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~  153 (377)
T 3byv_A           74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK  153 (377)
T ss_dssp             EEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEE
T ss_pred             eEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhh
Confidence            367788999999999999999888999999999742   2334467789995   455568999999984332100  11


Q ss_pred             CC------------c-----eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 037916          473 GD------------D-----FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPT  535 (741)
Q Consensus       473 ~~------------~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~  535 (741)
                      ..            .     ..|+||||+ +|+|.+++......   ......+++..++.++.||+.||+|||+.   +
T Consensus       154 ~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~---~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~  226 (377)
T 3byv_A          154 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSH---SSTHKSLVHHARLQLTLQVIRLLASLHHY---G  226 (377)
T ss_dssp             CTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHT---TTTTHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             ccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhcccc---ccccccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence            11            1     378999999 68999998743110   01123455688889999999999999999   9


Q ss_pred             ceecCCCCCCeEeCCCCceEEeecccccccCCCCcccccccccccccccCcccccCCC-----------CCCCccCchhH
Q 037916          536 TAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGS-----------EVSINGDVYSY  604 (741)
Q Consensus       536 ivHrDlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~-----------~~~~~~DIwSl  604 (741)
                      |+||||||+|||++.++.+||+|||+++.....     .....| +.|+|||.+ .+.           .++.++|||||
T Consensus       227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~-~~~~~~~~~~~~~~~~~~~~DvwSl  299 (377)
T 3byv_A          227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR-----VVSSVS-RGFEPPELE-ARRATISYHRDRRTLMTFSFDAWAL  299 (377)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTCE-----EECCCC-TTCCCHHHH-HHHTSTHHHHCCEEECCHHHHHHHH
T ss_pred             eecCCCCHHHEEEcCCCCEEEEechhheecCCc-----ccCCCC-cCccChhhh-cccccccccccccccCChhhhHHHH
Confidence            999999999999999999999999999864331     223457 999999554 444           78999999999


Q ss_pred             HHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhc
Q 037916          605 GILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVA  684 (741)
Q Consensus       605 G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  684 (741)
                      ||++|||++|+.||........ . ...           .. .    .                   ..+++.+.+++.+
T Consensus       300 G~il~elltg~~Pf~~~~~~~~-~-~~~-----------~~-~----~-------------------~~~~~~~~~li~~  342 (377)
T 3byv_A          300 GLVIYWIWCADLPITKDAALGG-S-EWI-----------FR-S----C-------------------KNIPQPVRALLEG  342 (377)
T ss_dssp             HHHHHHHHHSSCCC------CC-S-GGG-----------GS-S----C-------------------CCCCHHHHHHHHH
T ss_pred             HHHHHHHHHCCCCCcccccccc-h-hhh-----------hh-h----c-------------------cCCCHHHHHHHHH
Confidence            9999999999999863221110 0 000           00 0    0                   0223567899999


Q ss_pred             ccccCCCCCCCHHHHHH--HHHHHHH
Q 037916          685 CSMESPQDRMNMTIVVH--ELQSIKS  708 (741)
Q Consensus       685 cl~~dP~~RPs~~evl~--~L~~i~~  708 (741)
                      ||+.||++|||+.|+++  -++++.+
T Consensus       343 ~L~~dp~~Rpt~~e~l~hp~f~~~~~  368 (377)
T 3byv_A          343 FLRYPKEDRLLPLQAMETPEYEQLRT  368 (377)
T ss_dssp             HTCSSGGGCCCHHHHHTSHHHHHHHH
T ss_pred             HcCCCchhCCCHHHHhhChHHHHHHH
Confidence            99999999999999986  4555544

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.4e-38  Score=331.64  Aligned_cols=285  Identities=18%  Similarity=0.194  Sum_probs=196.2

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCcc--------
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD--------  470 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--------  470 (741)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|++........+.+.+|+.++++++||||+++++++....        
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            357889999999999999999999899999999997655555677889999999999999999999864321        


Q ss_pred             -ccCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeC
Q 037916          471 -YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLD  549 (741)
Q Consensus       471 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~  549 (741)
                       .......++||||++ |+|.+++..           ..+++..++.++.|++.||+|||+.   ||+||||||+||+++
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~  154 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQ-----------GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFIN  154 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTT-----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhhc-----------CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEc
Confidence             134567899999996 699999853           3478889999999999999999999   999999999999997


Q ss_pred             -CCCceEEeecccccccCCCCc-ccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcc
Q 037916          550 -HEMTAHVADFGLAKLLPPAHL-QTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMN  627 (741)
Q Consensus       550 -~~~~~kL~DFg~a~~~~~~~~-~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~  627 (741)
                       +++.+||+|||.+........ ........+|..|+|||.+.....++.++|||||||++|||++|+.||...... ..
T Consensus       155 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-~~  233 (320)
T 2i6l_A          155 TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL-EQ  233 (320)
T ss_dssp             TTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HH
T ss_pred             CCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH-HH
Confidence             567999999999987643211 111223457899999976666678999999999999999999999998633211 01


Q ss_pred             hhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          628 LHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       628 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ....... .+....+.................. ............++..+.+++.+||+.||++|||+.|+++
T Consensus       234 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          234 MQLILES-IPVVHEEDRQELLSVIPVYIRNDMT-EPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             HHHHHHH-SCCCCHHHHHHHHTTSCHHHHHHTT-SCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHh-cCCCchhhhhhhhhcCccccccccc-CCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            1111111 1100000000000000000000000 0000000111234567899999999999999999999986

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2.8e-38  Score=345.35  Aligned_cols=280  Identities=19%  Similarity=0.176  Sum_probs=194.3

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccc-cCCceEEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDY-KGDDFKAL  479 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~-~~~~~~~l  479 (741)
                      .|++.+.||+|+||.||+|++..+++.||||++....    ....+|+.++++++|||||++++++..... .+..+.++
T Consensus        55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l  130 (420)
T 1j1b_A           55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL  130 (420)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred             eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence            3778899999999999999999899999999986422    233479999999999999999998754221 23345779


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCC-CceEEee
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHE-MTAHVAD  558 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~-~~~kL~D  558 (741)
                      ||||+++ ++.+.+....      .....+++..++.++.||++||+|||+.   +|+||||||+|||++.+ +.+||+|
T Consensus       131 v~e~~~~-~l~~~~~~~~------~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~D  200 (420)
T 1j1b_A          131 VLDYVPE-TVYRVARHYS------RAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCD  200 (420)
T ss_dssp             EEECCCE-EHHHHHHHHH------HTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECC
T ss_pred             ehhcccc-cHHHHHHHHh------hccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEecc
Confidence            9999965 6666553210      1125688999999999999999999999   99999999999999965 5789999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCc
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      ||+++........   ....||+.|+|||.+.....++.++||||+||++|||++|+.||..... ...+...+...-..
T Consensus       201 FG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~-~~~l~~i~~~lg~p  276 (420)
T 1j1b_A          201 FGSAKQLVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG-VDQLVEIIKVLGTP  276 (420)
T ss_dssp             CTTCEECCTTCCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCSC
T ss_pred             chhhhhcccCCCc---eeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCC
Confidence            9999876543322   2246899999996665556899999999999999999999999863211 11122222211111


Q ss_pred             chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          639 HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       639 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ....+.. . ........... ..............+..+.+|+.+||+.||++|||+.|+++
T Consensus       277 ~~~~~~~-~-~~~~~~~~~p~-~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          277 TREQIRE-M-NPNYTEFKFPQ-IKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             CHHHHHH-H-CSCCCCCCCCC-CCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CHHHHHh-h-ChhhhhhccCc-cCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence            1111100 0 00000000000 00000000001123467889999999999999999999985

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=5.8e-39  Score=361.33  Aligned_cols=259  Identities=28%  Similarity=0.423  Sum_probs=202.5

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      ..|++.++||+|+||.||+|.+. .+..||||+++... ...+.+.+|+.+|++++||||+++++++.     + ...|+
T Consensus       267 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~-~~~~l  338 (535)
T 2h8h_A          267 ESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-----E-EPIYI  338 (535)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----S-SSCEE
T ss_pred             hhhhhheecccCCCeEEEEEEEC-CCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEe-----e-ccceE
Confidence            34677889999999999999997 45779999997533 34567899999999999999999999863     2 46799


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      ||||+++|+|.+++...        ....+++.+++.++.||+.||+|||++   +|+||||||+|||++.++.+||+||
T Consensus       339 v~e~~~~gsL~~~l~~~--------~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DF  407 (535)
T 2h8h_A          339 VTEYMSKGSLLDFLKGE--------TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADF  407 (535)
T ss_dssp             EECCCTTEEHHHHHSHH--------HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCT
T ss_pred             eeehhcCCcHHHHHhhc--------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEccc
Confidence            99999999999999632        123478899999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcCCc
Q 037916          560 GLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       560 g~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      |+++....... .......++..|+|||. ..+..++.++|||||||++|||++ |+.||......     +...     
T Consensus       408 G~a~~~~~~~~-~~~~~~~~~~~y~aPE~-~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~-----~~~~-----  475 (535)
T 2h8h_A          408 GLARLIEDNEY-TARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----EVLD-----  475 (535)
T ss_dssp             TSTTTCCCHHH-HTTCSTTSCGGGSCHHH-HHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH-----HHHH-----
T ss_pred             ccceecCCCce-ecccCCcCcccccCHHH-hccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHH-----
Confidence            99987654321 11223447789999954 455678999999999999999999 99998632111     1110     


Q ss_pred             chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHhhc
Q 037916          639 HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSILL  711 (741)
Q Consensus       639 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~  711 (741)
                          .+......                  .....+++.+.+++.+||+.||++|||+.||++.|+++.....
T Consensus       476 ----~i~~~~~~------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~  526 (535)
T 2h8h_A          476 ----QVERGYRM------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  526 (535)
T ss_dssp             ----HHHTTCCC------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred             ----HHHcCCCC------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence                00000000                  0011345678899999999999999999999999998765433

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.9e-39  Score=342.11  Aligned_cols=255  Identities=22%  Similarity=0.270  Sum_probs=195.7

Q ss_pred             HHHHHhhhcccCceeeEEEEEEc---CCCeEEEEEEeeccC----cCcchhHHHHHHHHHhc-CCCceeeEeeeecCccc
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILD---EGKTIIAVKVLNLLH----HGASKSSIAECSALRNI-RHKNLVKILTVCSGVDY  471 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~  471 (741)
                      ..|++.+.||+|+||.||+|++.   .+++.||+|+++...    ....+.+.+|+.+++++ +||||+++++++     
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~-----  128 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----  128 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE-----
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE-----
Confidence            46889999999999999999984   478999999986422    23345667899999999 699999999984     


Q ss_pred             cCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCC
Q 037916          472 KGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHE  551 (741)
Q Consensus       472 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~  551 (741)
                      ......++||||+++++|.+++...          ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.+
T Consensus       129 ~~~~~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~  195 (355)
T 1vzo_A          129 QTETKLHLILDYINGGELFTHLSQR----------ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSN  195 (355)
T ss_dssp             EETTEEEEEECCCCSCBHHHHHHHH----------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT
T ss_pred             eeCceEEEEeecCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCC
Confidence            4556899999999999999998633          4588999999999999999999999   99999999999999999


Q ss_pred             CceEEeecccccccCCCCcccccccccccccccCcccccCC-CCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhh
Q 037916          552 MTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLG-SEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHN  630 (741)
Q Consensus       552 ~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~-~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~  630 (741)
                      +.+||+|||+++......... .....||+.|+|||.+..+ ..++.++|||||||++|||++|+.||....... ....
T Consensus       196 ~~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~  273 (355)
T 1vzo_A          196 GHVVLTDFGLSKEFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-SQAE  273 (355)
T ss_dssp             SCEEESCSSEEEECCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-CHHH
T ss_pred             CcEEEeeCCCCeecccCCCCc-ccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc-hHHH
Confidence            999999999998664332221 2235699999999655432 457899999999999999999999986322111 1111


Q ss_pred             hhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCC-----CHHHHHHH
Q 037916          631 FARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRM-----NMTIVVHE  702 (741)
Q Consensus       631 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  702 (741)
                      +...        +..    ....                .+.+....+.+++.+||+.||++||     |+.|+++.
T Consensus       274 ~~~~--------~~~----~~~~----------------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          274 ISRR--------ILK----SEPP----------------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             HHHH--------HHH----CCCC----------------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             HHHH--------Hhc----cCCC----------------CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence            1110        000    0000                0012345678999999999999999     88988864

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=3.8e-38  Score=345.17  Aligned_cols=197  Identities=23%  Similarity=0.282  Sum_probs=165.6

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhc------CCCceeeEeeeecCccccC
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNI------RHKNLVKILTVCSGVDYKG  473 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~hpnIv~~~~~~~~~~~~~  473 (741)
                      .+|++++.||+|+||.||+|.+..+++.||||+++.. ......+.+|+.+++.+      +|+||+++++++     ..
T Consensus        97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~-----~~  170 (429)
T 3kvw_A           97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENF-----TF  170 (429)
T ss_dssp             TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEE-----EE
T ss_pred             CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeec-----cc
Confidence            4688899999999999999999999999999999642 22345667788888776      578999999995     44


Q ss_pred             CceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCc
Q 037916          474 DDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMT  553 (741)
Q Consensus       474 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~  553 (741)
                      ....++||||+. ++|.+++....        ...+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.
T Consensus       171 ~~~~~lv~e~~~-~~L~~~l~~~~--------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~  238 (429)
T 3kvw_A          171 RNHICMTFELLS-MNLYELIKKNK--------FQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGR  238 (429)
T ss_dssp             TTEEEEEECCCC-CBHHHHHHHTT--------TCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTS
T ss_pred             CCeEEEEEeccC-CCHHHHHHhcc--------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCC
Confidence            568999999995 69999886431        13488999999999999999999999   9999999999999999887


Q ss_pred             --eEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCc
Q 037916          554 --AHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDI  620 (741)
Q Consensus       554 --~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~  620 (741)
                        +||+|||++.......     ....||+.|+||| +..+..++.++|||||||++|||++|..||..
T Consensus       239 ~~vkL~DFG~a~~~~~~~-----~~~~gt~~y~aPE-~~~~~~~~~~~DiwSlG~il~elltG~~pf~~  301 (429)
T 3kvw_A          239 SGIKVIDFGSSCYEHQRV-----YTYIQSRFYRAPE-VILGARYGMPIDMWSLGCILAELLTGYPLLPG  301 (429)
T ss_dssp             CCEEECCCTTCEETTCCC-----CSSCSCGGGCCHH-HHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cceEEeecccceecCCcc-----cccCCCCCccChH-HHhCCCCCchHHHHhHHHHHHHHHhCCCCCCC
Confidence              9999999997654322     2246899999995 44566789999999999999999999999864

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.3e-38  Score=343.93  Aligned_cols=211  Identities=23%  Similarity=0.297  Sum_probs=155.6

Q ss_pred             HHHHH-hhhcccCceeeEEEEEEc--CCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCce
Q 037916          400 VSFLF-LCWIDMGSFGSVYKGILD--EGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       400 ~~y~~-~~~ig~G~~g~V~~a~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      ..|.+ .++||+|+||.||+|++.  .+++.||+|+++.  ......+.+|+.++++++||||+++++++..   .....
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~~~   94 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEG--TGISMSACREIALLRELKHPNVISLQKVFLS---HADRK   94 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSS--SSCCHHHHHHHHHHHHCCCTTBCCCCEEEEE---TTTTE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECC--CCCCHHHHHHHHHHHhcCCCCeeeEeeEEec---CCCCe
Confidence            45666 457999999999999975  4688999999863  2345678899999999999999999999632   34668


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEe----CCCC
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLL----DHEM  552 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll----~~~~  552 (741)
                      .|+||||+. ++|.+++...+... .......+++..++.++.||+.||+|||+.   +|+||||||+|||+    +.++
T Consensus        95 ~~lv~e~~~-~~l~~~~~~~~~~~-~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~  169 (405)
T 3rgf_A           95 VWLLFDYAE-HDLWHIIKFHRASK-ANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERG  169 (405)
T ss_dssp             EEEEEECCS-EEHHHHHHHHHHHC--------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTT
T ss_pred             EEEEEeCCC-CCHHHHHHHhcccc-ccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCC
Confidence            999999995 58888775321100 001123488999999999999999999999   99999999999999    6778


Q ss_pred             ceEEeecccccccCCCCc-ccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCc
Q 037916          553 TAHVADFGLAKLLPPAHL-QTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDI  620 (741)
Q Consensus       553 ~~kL~DFg~a~~~~~~~~-~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~  620 (741)
                      .+||+|||+|+....... ........||+.|+|||.+.....++.++||||+||++|+|++|+.||..
T Consensus       170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  238 (405)
T 3rgf_A          170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  238 (405)
T ss_dssp             CEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCC
Confidence            999999999987654321 12223356899999996665556799999999999999999999999964

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=3.6e-38  Score=329.54  Aligned_cols=260  Identities=21%  Similarity=0.234  Sum_probs=192.0

Q ss_pred             HHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCcc-------
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD-------  470 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-------  470 (741)
                      +...|++.+.||+|+||.||+|++..+++.||+|+++.. ....+.+.+|+.++++++||||+++++++....       
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            456899999999999999999999989999999999642 233467789999999999999999999864321       


Q ss_pred             -ccCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeC
Q 037916          471 -YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLD  549 (741)
Q Consensus       471 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~  549 (741)
                       .......|+||||+++++|.+++...         ...+++..++.++.|++.||+|||+.   +|+||||||+||+++
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~  150 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSE---------NLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFID  150 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHS---------CGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhcc---------ccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEc
Confidence             12356789999999999999999632         24577888999999999999999999   999999999999999


Q ss_pred             CCCceEEeecccccccCCCCc------------ccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCC
Q 037916          550 HEMTAHVADFGLAKLLPPAHL------------QTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP  617 (741)
Q Consensus       550 ~~~~~kL~DFg~a~~~~~~~~------------~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p  617 (741)
                      .++.+||+|||.+........            ........||+.|+|||.+.....++.++||||+||++|+|++   |
T Consensus       151 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p  227 (303)
T 1zy4_A          151 ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---P  227 (303)
T ss_dssp             TTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---C
T ss_pred             CCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---c
Confidence            999999999999986643210            1112234589999999666555578999999999999999998   5


Q ss_pred             CCccccCCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHH
Q 037916          618 SDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMT  697 (741)
Q Consensus       618 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  697 (741)
                      |............ ......         ......                  ....+..+.+++.+||+.||++|||+.
T Consensus       228 ~~~~~~~~~~~~~-~~~~~~---------~~~~~~------------------~~~~~~~~~~li~~~l~~dp~~Rps~~  279 (303)
T 1zy4_A          228 FSTGMERVNILKK-LRSVSI---------EFPPDF------------------DDNKMKVEKKIIRLLIDHDPNKRPGAR  279 (303)
T ss_dssp             CSSHHHHHHHHHH-HHSTTC---------CCCTTC------------------CTTTSHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             cCCchhHHHHHHh-cccccc---------ccCccc------------------cccchHHHHHHHHHHHhcCcccCcCHH
Confidence            4321111000000 000000         000000                  012345678999999999999999999


Q ss_pred             HHHH
Q 037916          698 IVVH  701 (741)
Q Consensus       698 evl~  701 (741)
                      |+++
T Consensus       280 ~ll~  283 (303)
T 1zy4_A          280 TLLN  283 (303)
T ss_dssp             HHHH
T ss_pred             HHhC
Confidence            9986

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=3.5e-38  Score=341.79  Aligned_cols=277  Identities=19%  Similarity=0.174  Sum_probs=191.6

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccc-cCCceEEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDY-KGDDFKAL  479 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~-~~~~~~~l  479 (741)
                      .|++.+.||+|+||.||+|++..++. ||+|++....    ....+|+.+++.++||||+++++++..... .+..+.++
T Consensus        41 ~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  115 (394)
T 4e7w_A           41 AYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL  115 (394)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred             eEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCc----chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence            47889999999999999999986665 7888775322    222379999999999999999999754321 33445789


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeC-CCCceEEee
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLD-HEMTAHVAD  558 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~-~~~~~kL~D  558 (741)
                      ||||++++ +.+.+....      .....+++..++.++.||+.||+|||+.   ||+||||||+||+++ .++.+||+|
T Consensus       116 v~e~~~~~-l~~~~~~~~------~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~D  185 (394)
T 4e7w_A          116 VLEYVPET-VYRASRHYA------KLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLID  185 (394)
T ss_dssp             EEECCSEE-HHHHHHHHH------HTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECC
T ss_pred             EeeccCcc-HHHHHHHHH------hhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEee
Confidence            99999764 433332110      1124588899999999999999999999   999999999999999 789999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCc
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      ||+|+........   ....||+.|+|||.+.....++.++||||+||++|||++|+.||...... ..+..........
T Consensus       186 FG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~l~~i~~~~g~p  261 (394)
T 4e7w_A          186 FGSAKILIAGEPN---VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI-DQLVEIIKVLGTP  261 (394)
T ss_dssp             CTTCEECCTTCCC---CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCC
T ss_pred             CCCcccccCCCCC---cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCC
Confidence            9999876544322   23468999999976655567999999999999999999999998632111 1122222111111


Q ss_pred             chhHh--hhhcc-cCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          639 HVMDI--VDSTL-LADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       639 ~~~~~--~d~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      ....+  .++.. ........      ............++.+.+++.+||++||++|||+.|+++-
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          262 SREQIKTMNPNYMEHKFPQIR------PHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             CHHHHHHHCGGGSSSCCCCCC------CCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             CHHHHHhhChhhhhhcccccc------CCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence            11110  00000 00000000      0000000011244678899999999999999999999864

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.3e-38  Score=343.01  Aligned_cols=257  Identities=10%  Similarity=-0.021  Sum_probs=175.0

Q ss_pred             HHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc---CcchhHHHHHHHHHhc--CCCceeeEeeeec-------Cc
Q 037916          402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH---GASKSSIAECSALRNI--RHKNLVKILTVCS-------GV  469 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~hpnIv~~~~~~~-------~~  469 (741)
                      |.+.+.||+|+||.||+|++..+++.||+|+++....   ...+.+.+|+.+++.+  +||||++++..+.       ..
T Consensus        64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~  143 (371)
T 3q60_A           64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ  143 (371)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEET
T ss_pred             eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecC
Confidence            6678899999999999999999999999999985432   2234556775544444  6999888653321       10


Q ss_pred             cc------------cCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHH------HHHHHHHHHHHHHHHhc
Q 037916          470 DY------------KGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQR------INIAIDVACALKYLHHD  531 (741)
Q Consensus       470 ~~------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~------~~i~~qi~~aL~~LH~~  531 (741)
                      ..            ......|+||||++ |+|.+++...         ...+.+..+      ..++.||+.||+|||++
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---------~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~  213 (371)
T 3q60_A          144 SQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---------DFVYVFRGDEGILALHILTAQLIRLAANLQSK  213 (371)
T ss_dssp             TSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---------HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             CCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---------ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC
Confidence            00            00145899999997 8999999743         122344444      67789999999999999


Q ss_pred             CCCCceecCCCCCCeEeCCCCceEEeecccccccCCCCcccccccccccccccCcccccCC--CCCCCccCchhHHHHHH
Q 037916          532 CQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLG--SEVSINGDVYSYGILLL  609 (741)
Q Consensus       532 ~~~~ivHrDlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~--~~~~~~~DIwSlG~il~  609 (741)
                         +|+||||||+|||++.++.+||+|||+|+.......     ...+|+.|+|||.+ .+  ..++.++||||+||++|
T Consensus       214 ---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~-----~~~~t~~y~aPE~~-~~~~~~~~~~~DiwSlG~il~  284 (371)
T 3q60_A          214 ---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP-----ASSVPVTYAPREFL-NASTATFTHALNAWQLGLSIY  284 (371)
T ss_dssp             ---TEEETTCSGGGEEECTTSCEEECCGGGEEETTCEEE-----GGGSCGGGCCHHHH-TCSEEECCHHHHHHHHHHHHH
T ss_pred             ---CCccCcCCHHHEEECCCCCEEEEecceeeecCCCcc-----CccCCcCCcChhhc-cCCCCCcCccccHHHHHHHHH
Confidence               999999999999999999999999999987643221     23467999999554 44  57899999999999999


Q ss_pred             HHHcCCCCCCccccCCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccC
Q 037916          610 ELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMES  689 (741)
Q Consensus       610 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d  689 (741)
                      ||++|+.||.........  .+........    .......                  .....+++.+.+++.+||+.|
T Consensus       285 elltg~~Pf~~~~~~~~~--~~~~~~~~~~----~~~~~~~------------------~~~~~~~~~~~~li~~~L~~d  340 (371)
T 3q60_A          285 RVWCLFLPFGLVTPGIKG--SWKRPSLRVP----GTDSLAF------------------GSCTPLPDFVKTLIGRFLNFD  340 (371)
T ss_dssp             HHHHSSCSTTBCCTTCTT--CCCBCCTTSC----CCCSCCC------------------TTSSCCCHHHHHHHHHHTCSS
T ss_pred             HHHhCCCCCCCcCccccc--chhhhhhhhc----cccccch------------------hhccCCCHHHHHHHHHHcCCC
Confidence            999999999744222111  0000000000    0000000                  000123456889999999999


Q ss_pred             CCCCCCHHHHHH
Q 037916          690 PQDRMNMTIVVH  701 (741)
Q Consensus       690 P~~RPs~~evl~  701 (741)
                      |++|||+.|+++
T Consensus       341 P~~Rpt~~e~l~  352 (371)
T 3q60_A          341 RRRRLLPLEAME  352 (371)
T ss_dssp             TTTCCCHHHHTT
T ss_pred             hhhCCCHHHHhc
Confidence            999999999975

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=4.9e-38  Score=335.60  Aligned_cols=271  Identities=16%  Similarity=0.189  Sum_probs=197.6

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCc---c--------------hhHHHHHHHHHhcCCCceeeE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGA---S--------------KSSIAECSALRNIRHKNLVKI  462 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~---~--------------~~~~~E~~~l~~l~hpnIv~~  462 (741)
                      .+|++.+.||+|+||.||+|.+  +++.||+|++.......   .              +.+.+|+.++++++||||+++
T Consensus        31 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           31 NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             TTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             CceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            4688999999999999999999  79999999997432211   1              778999999999999999999


Q ss_pred             eeeecCccccCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHh-cCCCCceecCC
Q 037916          463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH-DCQPTTAHCDL  541 (741)
Q Consensus       463 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivHrDl  541 (741)
                      ++++     ......++||||+++++|.+++........  .....+++..++.++.|++.||.|||+ .   ||+||||
T Consensus       109 ~~~~-----~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl  178 (348)
T 2pml_X          109 EGII-----TNYDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDV  178 (348)
T ss_dssp             SEEE-----ESSSEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCC
T ss_pred             EEEE-----eeCCeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCC
Confidence            9995     445689999999999999999431100000  113568999999999999999999999 8   9999999


Q ss_pred             CCCCeEeCCCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCC-ccCchhHHHHHHHHHcCCCCCCc
Q 037916          542 KPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSI-NGDVYSYGILLLELMTRKRPSDI  620 (741)
Q Consensus       542 kp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~-~~DIwSlG~il~elltg~~p~~~  620 (741)
                      ||+||+++.++.+||+|||.+......    ......||+.|+|||.+.....++. ++||||+||++|+|++|..||..
T Consensus       179 ~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  254 (348)
T 2pml_X          179 KPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL  254 (348)
T ss_dssp             CGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCC
Confidence            999999999999999999999876443    1223568999999966554436665 99999999999999999999873


Q ss_pred             cccCCcchhhhhhhcC--CcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHH
Q 037916          621 MFEGNMNLHNFARTVL--PDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTI  698 (741)
Q Consensus       621 ~~~~~~~~~~~~~~~~--~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  698 (741)
                      ................  +.....+.....               ...........+..+.+++.+||+.||++|||+.|
T Consensus       255 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e  319 (348)
T 2pml_X          255 KISLVELFNNIRTKNIEYPLDRNHFLYPLT---------------NKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSED  319 (348)
T ss_dssp             SSCSHHHHHHHTSCCCCCCCSSSSSTTTTC---------------C--------CCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             CCcHHHHHHHHhccCcCCccchhhhhcccc---------------ccccccchhhcCHHHHHHHHHHccCChhhCCCHHH
Confidence            3221111111111100  000000000000               00000111234567889999999999999999999


Q ss_pred             HHH
Q 037916          699 VVH  701 (741)
Q Consensus       699 vl~  701 (741)
                      +++
T Consensus       320 ~l~  322 (348)
T 2pml_X          320 ALK  322 (348)
T ss_dssp             HHT
T ss_pred             Hhc
Confidence            986

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=7.3e-37  Score=350.01  Aligned_cols=337  Identities=22%  Similarity=0.209  Sum_probs=294.5

Q ss_pred             CCCCCcccccCChhhhhCCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCc
Q 037916            2 DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHL   81 (741)
Q Consensus         2 dl~~n~~~~~ip~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L   81 (741)
                      |++.|.+. .+|..++..+++|++|+|++|.|+++.+..|.++++|++|+|++|.|++..|..|+++++          |
T Consensus        57 ~l~~~~l~-~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~----------L  125 (597)
T 3oja_B           57 TFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPL----------L  125 (597)
T ss_dssp             EESSCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTT----------C
T ss_pred             EeeCCCCC-CcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCC----------C
Confidence            46677776 788888779999999999999999999999999999999999999999988888999986          9


Q ss_pred             cEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEccc
Q 037916           82 KHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINT  161 (741)
Q Consensus        82 ~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~  161 (741)
                      ++|+|++|.|+++++..|..++ +|++|+|++|.+.+..|..|..+++|++|+|++|.|+++.   +..+++|+.|++++
T Consensus       126 ~~L~L~~n~l~~l~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~  201 (597)
T 3oja_B          126 TVLVLERNDLSSLPRGIFHNTP-KLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSY  201 (597)
T ss_dssp             CEEECCSSCCCCCCTTTTTTCT-TCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCS
T ss_pred             CEEEeeCCCCCCCCHHHhccCC-CCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhccc
Confidence            9999999999988777788888 9999999999999999999999999999999999999764   56678999999999


Q ss_pred             CCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCCC
Q 037916          162 NKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSL  241 (741)
Q Consensus       162 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~  241 (741)
                      |.+++     +...++|+.|++++|.+....+..   .++|+.|+|++|++++  +..+..+++|+. |+|++|.|.+..
T Consensus       202 n~l~~-----l~~~~~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~--~~~l~~l~~L~~-L~Ls~N~l~~~~  270 (597)
T 3oja_B          202 NLLST-----LAIPIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLTD--TAWLLNYPGLVE-VDLSYNELEKIM  270 (597)
T ss_dssp             SCCSE-----EECCTTCSEEECCSSCCCEEECSC---CSCCCEEECCSSCCCC--CGGGGGCTTCSE-EECCSSCCCEEE
T ss_pred             Ccccc-----ccCCchhheeeccCCccccccccc---CCCCCEEECCCCCCCC--ChhhccCCCCCE-EECCCCccCCCC
Confidence            99984     455678999999999998655433   2689999999999985  478999999998 999999999999


Q ss_pred             ChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccchhhhccc
Q 037916          242 PTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQ  321 (741)
Q Consensus       242 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  321 (741)
                      |..|+.+++|+.|+|++|.++++ +..+..+++|+.|+|++|.++ .+|..+..+++|+.|+|++|.|++..   +..++
T Consensus       271 ~~~~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~---~~~~~  345 (597)
T 3oja_B          271 YHPFVKMQRLERLYISNNRLVAL-NLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK---LSTHH  345 (597)
T ss_dssp             SGGGTTCSSCCEEECTTSCCCEE-ECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC---CCTTC
T ss_pred             HHHhcCccCCCEEECCCCCCCCC-CcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcC---hhhcC
Confidence            99999999999999999999975 566678999999999999999 57778899999999999999999653   66778


Q ss_pred             cCCcccccCcccccccCCccccCCcccccccCCCCccccCCCCCCCccC
Q 037916          322 LVQNLNLSYNDLEGVIPTEGVFKNASAISVFGNSKLCGGIPEFQLPICG  370 (741)
Q Consensus       322 ~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~~~~~~~~~~  370 (741)
                      +|+.|+|++|++++.... ..+.......+.++...|+..+......|.
T Consensus       346 ~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~C~~~~~~~~~~cc  393 (597)
T 3oja_B          346 TLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKIDYQLEHGLCC  393 (597)
T ss_dssp             CCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCCCCCTTCEEETTEEE
T ss_pred             CCCEEEeeCCCCCChhHH-HHHHHHhhhccccccccCCcchhccCCccc
Confidence            999999999999987533 335666667778888899876555444443

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=9.6e-38  Score=323.82  Aligned_cols=255  Identities=22%  Similarity=0.263  Sum_probs=199.7

Q ss_pred             HHHHHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC--cCcchhHHHHHHHHHhcCCCceeeEeeeecCcccc
Q 037916          395 GILLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYK  472 (741)
Q Consensus       395 ~~~~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  472 (741)
                      ...+..+|++.+.||+|+||.||+|++..+++.||+|+++...  ....+.+.+|+.++++++||||+++++++     .
T Consensus        17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~   91 (287)
T 2wei_A           17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----E   91 (287)
T ss_dssp             THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----E
T ss_pred             HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEE-----e
Confidence            3556789999999999999999999999899999999997432  23456788999999999999999999995     4


Q ss_pred             CCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCC-
Q 037916          473 GDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHE-  551 (741)
Q Consensus       473 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~-  551 (741)
                      .....++||||+++++|.+++...          ..+++..++.++.|++.||.|||+.   ||+||||||+||+++.+ 
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~  158 (287)
T 2wei_A           92 DSSSFYIVGELYTGGELFDEIIKR----------KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKE  158 (287)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSS
T ss_pred             CCCeEEEEEEccCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCC
Confidence            556899999999999999887532          4578999999999999999999999   99999999999999764 


Q ss_pred             --CceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchh
Q 037916          552 --MTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLH  629 (741)
Q Consensus       552 --~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~  629 (741)
                        +.+||+|||.+.........   ....||+.|+|||.+ .+ .++.++||||+|+++|+|++|..||......  ...
T Consensus       159 ~~~~~kL~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~-~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~  231 (287)
T 2wei_A          159 KDCDIKIIDFGLSTCFQQNTKM---KDRIGTAYYIAPEVL-RG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY--DIL  231 (287)
T ss_dssp             TTCCEEECSTTGGGTBCCCSSC---SCHHHHHTTCCHHHH-TT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH
T ss_pred             CcccEEEeccCcceeecCCCcc---ccccCcccccChHHh-cC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH--HHH
Confidence              47999999999866543221   224589999999654 33 4889999999999999999999998632111  110


Q ss_pred             hhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          630 NFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       630 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ..           +.........                ......+..+.+++.+||+.||++|||+.|+++
T Consensus       232 ~~-----------~~~~~~~~~~----------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          232 KR-----------VETGKYAFDL----------------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             HH-----------HHHCCCCCCS----------------GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HH-----------HHcCCCCCCc----------------hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            00           0000000000                001123456889999999999999999999987

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.1e-38  Score=339.04  Aligned_cols=269  Identities=19%  Similarity=0.191  Sum_probs=193.9

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc--CcchhHHHHHHHHHhcCCCceeeEeeeecCccc-cCCce
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKNLVKILTVCSGVDY-KGDDF  476 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~-~~~~~  476 (741)
                      ..|.+.+.||+|+||.||+|++..+|+.||+|++.....  ...+.+.+|+.+++.++||||+++++++..... .....
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            357788999999999999999999999999999964322  224567889999999999999999999643221 11124


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .|+||||+. ++|.+++.            ..+++..+..++.||+.||+|||+.   ||+||||||+||+++.++.+||
T Consensus       104 ~~lv~e~~~-~~l~~~~~------------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl  167 (353)
T 3coi_A          104 FYLVMPFMQ-TDLQKIMG------------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKI  167 (353)
T ss_dssp             CEEEEECCS-EEGGGTTT------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEE
T ss_pred             EEEEecccc-CCHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEE
Confidence            599999996 68888774            2378899999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhc-
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV-  635 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~-  635 (741)
                      +|||.+......     .....||+.|+|||.+.....++.++||||+||++|+|++|+.||...... ..+....... 
T Consensus       168 ~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~  241 (353)
T 3coi_A          168 LDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKVTG  241 (353)
T ss_dssp             CSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH-HHHHHHHHHHC
T ss_pred             eecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhC
Confidence            999999765432     122458999999966655578899999999999999999999998632211 0111111100 


Q ss_pred             CC----------cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          636 LP----------DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       636 ~~----------~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      .+          ......+.........            ............+.+++.+||+.||++|||+.|+++-
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          242 VPGTEFVQKLNDKAAKSYIQSLPQTPRK------------DFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             BCCHHHHTTCSCHHHHHHHHTSCBCSSC------------CTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             CCCHHHHHHHhhHHHHHHHHhCcCCCCc------------cHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            00          0000111000000000            0000111345678899999999999999999999863

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.2e-37  Score=322.28  Aligned_cols=237  Identities=13%  Similarity=0.074  Sum_probs=182.8

Q ss_pred             HHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcC---cchhHHHHHHHHHhcCCCceeeEeeeecCccccCC
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG---ASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGD  474 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~  474 (741)
                      +.++|++.+.||+|+||.||+|++..+++.||+|+++.....   ..+.+.+|+.++++++||||+++++++     ...
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~  103 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVV-----HTR  103 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----EET
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEE-----EEC
Confidence            446799999999999999999999989999999999753322   236788999999999999999999995     445


Q ss_pred             ceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCce
Q 037916          475 DFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTA  554 (741)
Q Consensus       475 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~  554 (741)
                      +..|+||||++|++|.++++..            ....++..++.|++.||+|||+.   ||+||||||+||+++.++.+
T Consensus       104 ~~~~lv~e~~~g~~L~~~l~~~------------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~  168 (286)
T 3uqc_A          104 AGGLVVAEWIRGGSLQEVADTS------------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDV  168 (286)
T ss_dssp             TEEEEEEECCCEEEHHHHHTTC------------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCE
T ss_pred             CcEEEEEEecCCCCHHHHHhcC------------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCE
Confidence            6899999999999999998532            24456788999999999999999   99999999999999999999


Q ss_pred             EEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhh
Q 037916          555 HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       555 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  634 (741)
                      ||+++|                      |++|        ++.++|||||||++|||++|+.||........ +..... 
T Consensus       169 kl~~~~----------------------~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~-~~~~~~-  216 (286)
T 3uqc_A          169 VLAYPA----------------------TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSG-LAPAER-  216 (286)
T ss_dssp             EECSCC----------------------CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCC-SEECCB-
T ss_pred             EEEecc----------------------ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchh-hHHHHH-
Confidence            998443                      3333        57899999999999999999999974322110 000000 


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHhhc
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSILL  711 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~  711 (741)
                      .........                        ......+++.+.+++.+||+.||++| |+.|+++.|+++.....
T Consensus       217 ~~~~~~~~~------------------------~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~  268 (286)
T 3uqc_A          217 DTAGQPIEP------------------------ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD  268 (286)
T ss_dssp             CTTSCBCCH------------------------HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred             HhccCCCCh------------------------hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence            000000000                        00011334668899999999999999 99999999999886554

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.5e-38  Score=331.29  Aligned_cols=246  Identities=20%  Similarity=0.246  Sum_probs=190.0

Q ss_pred             HHHHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc------CcchhHHHHHHHHHhc----CCCceeeEeee
Q 037916          396 ILLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH------GASKSSIAECSALRNI----RHKNLVKILTV  465 (741)
Q Consensus       396 ~~~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~hpnIv~~~~~  465 (741)
                      ..+..+|++.+.||+|+||.||+|++..+++.||+|+++....      .....+.+|+.+++++    +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            4566789999999999999999999998999999999964322      1234456799999888    89999999999


Q ss_pred             ecCccccCCceEEEEEec-ccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCC
Q 037916          466 CSGVDYKGDDFKALVYEF-MHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPS  544 (741)
Q Consensus       466 ~~~~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~  544 (741)
                      +     ......++|||| +.+++|.+++...          ..+++..++.++.|++.||+|||+.   +|+||||||+
T Consensus       107 ~-----~~~~~~~~v~e~~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~  168 (312)
T 2iwi_A          107 F-----ETQEGFMLVLERPLPAQDLFDYITEK----------GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDE  168 (312)
T ss_dssp             C----------CEEEEECCSSEEEHHHHHHHH----------CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGG
T ss_pred             E-----ecCCeEEEEEEecCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChh
Confidence            4     455678999999 7889999998642          4588999999999999999999999   9999999999


Q ss_pred             CeEeC-CCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCcccc
Q 037916          545 NVLLD-HEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFE  623 (741)
Q Consensus       545 NIll~-~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~  623 (741)
                      ||+++ .++.+||+|||.+........    ....||+.|+|||.+......+.++||||+||++|+|++|+.||.....
T Consensus       169 Nil~~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  244 (312)
T 2iwi_A          169 NILIDLRRGCAKLIDFGSGALLHDEPY----TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE  244 (312)
T ss_dssp             GEEEETTTTEEEECCCSSCEECCSSCB----CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH
T ss_pred             hEEEeCCCCeEEEEEcchhhhcccCcc----cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH
Confidence            99999 789999999999987654322    2345899999996655445556789999999999999999999863210


Q ss_pred             CCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          624 GNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       624 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                                         ..+.....                    .......+.+++.+||+.||++|||+.|+++.
T Consensus       245 -------------------~~~~~~~~--------------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          245 -------------------ILEAELHF--------------------PAHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             -------------------HHHTCCCC--------------------CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             -------------------HhhhccCC--------------------cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                               00000000                    01223567899999999999999999999863

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2e-38  Score=329.64  Aligned_cols=259  Identities=24%  Similarity=0.279  Sum_probs=190.4

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcC-C--CeEEEEEEeeccC---cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccC
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDE-G--KTIIAVKVLNLLH---HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKG  473 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~-~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  473 (741)
                      ..|++.+.||+|+||.||+|++.. +  +..||+|+++...   ....+.+.+|+.++++++||||+++++++.     .
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~   92 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-----T   92 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----S
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEc-----c
Confidence            468889999999999999998642 2  3369999987432   233467789999999999999999999953     2


Q ss_pred             CceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCc
Q 037916          474 DDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMT  553 (741)
Q Consensus       474 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~  553 (741)
                      . ..++||||+++++|.+++...         ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.
T Consensus        93 ~-~~~~v~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~  159 (291)
T 1u46_A           93 P-PMKMVTELAPLGSLLDRLRKH---------QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDL  159 (291)
T ss_dssp             S-SCEEEEECCTTCBHHHHHHHH---------GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTE
T ss_pred             C-CceeeEecccCCCHHHHHHhc---------cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCC
Confidence            2 378999999999999998632         24588999999999999999999999   9999999999999999999


Q ss_pred             eEEeecccccccCCCCccc-ccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhh
Q 037916          554 AHVADFGLAKLLPPAHLQT-SSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNF  631 (741)
Q Consensus       554 ~kL~DFg~a~~~~~~~~~~-~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~  631 (741)
                      +||+|||.+.......... ......+|+.|+||| +..+..++.++||||+|+++|+|++ |+.||......     ..
T Consensus       160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~  233 (291)
T 1u46_A          160 VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE-SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-----QI  233 (291)
T ss_dssp             EEECCCTTCEECCC-CCEEEC-----CCGGGCCHH-HHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HH
T ss_pred             EEEccccccccccccccchhhhccCCCCceeeCch-hhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH-----HH
Confidence            9999999998775443211 122345788999995 4456678899999999999999999 99998632111     11


Q ss_pred             hhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHH
Q 037916          632 ARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKS  708 (741)
Q Consensus       632 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  708 (741)
                      ...        +........                  ....++..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus       234 ~~~--------~~~~~~~~~------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          234 LHK--------IDKEGERLP------------------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             HHH--------HHTSCCCCC------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             HHH--------HHccCCCCC------------------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence            110        000000000                  001334678899999999999999999999999988764

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=5.2e-38  Score=331.05  Aligned_cols=245  Identities=20%  Similarity=0.223  Sum_probs=196.3

Q ss_pred             HHHHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcC------cchhHHHHHHHHHhcC--CCceeeEeeeec
Q 037916          396 ILLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG------ASKSSIAECSALRNIR--HKNLVKILTVCS  467 (741)
Q Consensus       396 ~~~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--hpnIv~~~~~~~  467 (741)
                      ..+...|++.+.||+|+||.||+|++..+++.||+|+++.....      ....+.+|+.++++++  ||||+++++++ 
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~-  117 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF-  117 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE-
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE-
Confidence            44556799999999999999999999999999999999754322      2355678999999996  59999999994 


Q ss_pred             CccccCCceEEEEEecccC-CChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCe
Q 037916          468 GVDYKGDDFKALVYEFMHN-GSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNV  546 (741)
Q Consensus       468 ~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NI  546 (741)
                          ......++|||++.+ ++|.+++...          ..+++..++.++.|++.||+|||+.   +|+||||||+||
T Consensus       118 ----~~~~~~~lv~e~~~~~~~L~~~l~~~----------~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NI  180 (320)
T 3a99_A          118 ----ERPDSFVLILERPEPVQDLFDFITER----------GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENI  180 (320)
T ss_dssp             ----ECSSEEEEEEECCSSEEEHHHHHHHH----------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred             ----ecCCcEEEEEEcCCCCccHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHE
Confidence                456689999999976 8999998632          4578899999999999999999999   999999999999


Q ss_pred             EeC-CCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCC
Q 037916          547 LLD-HEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGN  625 (741)
Q Consensus       547 ll~-~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~  625 (741)
                      +++ .++.+||+|||.+........    ....||+.|+|||.+.....++.++|||||||++|||++|+.||.....  
T Consensus       181 ll~~~~~~~kL~Dfg~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--  254 (320)
T 3a99_A          181 LIDLNRGELKLIDFGSGALLKDTVY----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--  254 (320)
T ss_dssp             EEETTTTEEEECCCTTCEECCSSCB----CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--
T ss_pred             EEeCCCCCEEEeeCccccccccccc----cCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh--
Confidence            999 778999999999987654322    2245899999996655455557899999999999999999999863210  


Q ss_pred             cchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          626 MNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       626 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                           .            ........                    ...++.+.+++.+||+.||++|||+.|+++
T Consensus       255 -----~------------~~~~~~~~--------------------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          255 -----I------------IRGQVFFR--------------------QRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             -----H------------HHCCCCCS--------------------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----h------------hccccccc--------------------ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                 0            00000000                    012356789999999999999999999986

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.9e-38  Score=330.03  Aligned_cols=257  Identities=21%  Similarity=0.266  Sum_probs=192.2

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhc-CCCceeeEeeeecCccc-cCCceE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNI-RHKNLVKILTVCSGVDY-KGDDFK  477 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~-~~~~~~  477 (741)
                      ..|++.+.||+|+||.||+|++..+++.||+|++... ....+.+.+|+.+++++ +||||+++++++..... ......
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~  102 (326)
T 2x7f_A           24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL  102 (326)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEE
T ss_pred             CcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceE
Confidence            4588889999999999999999889999999999753 23456788999999999 89999999999753211 114578


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      ++||||+++++|.+++...        ....+++..+..++.|++.||.|||+.   ||+||||||+||+++.++.+||+
T Consensus       103 ~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~  171 (326)
T 2x7f_A          103 WLVMEFCGAGSVTDLIKNT--------KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLV  171 (326)
T ss_dssp             EEEEECCTTEEHHHHHHHS--------GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEEC
T ss_pred             EEEEEcCCCCcHHHHHHhc--------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEe
Confidence            9999999999999998643        124578889999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccccccCcccccC----CCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhh
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGL----GSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFAR  633 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~----~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~  633 (741)
                      |||.+.........  .....||+.|+|||.+..    +..++.++|||||||++|+|++|..||....... .......
T Consensus       172 Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~  248 (326)
T 2x7f_A          172 DFGVSAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-ALFLIPR  248 (326)
T ss_dssp             CCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHH
T ss_pred             eCcCceecCcCccc--cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH-HHHHhhc
Confidence            99998865433211  122458999999965532    4668899999999999999999999986321110 0000000


Q ss_pred             hcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          634 TVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       634 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ...+         ...                     ...++..+.+++.+||..||++|||+.|+++
T Consensus       249 ~~~~---------~~~---------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          249 NPAP---------RLK---------------------SKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             SCCC---------CCS---------------------CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             Cccc---------cCC---------------------ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            0000         000                     0022356789999999999999999999987

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.7e-37  Score=337.58  Aligned_cols=284  Identities=18%  Similarity=0.184  Sum_probs=200.0

Q ss_pred             HHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcC--------CCceeeEeeeecCc
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIR--------HKNLVKILTVCSGV  469 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------hpnIv~~~~~~~~~  469 (741)
                      +..+|++.++||+|+||.||+|++..+++.||+|+++.. ....+.+.+|+.+++.++        ||||+++++++...
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~  113 (397)
T 1wak_A           35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS  113 (397)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred             cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence            346799999999999999999999999999999999632 223466788999999885        78899999986421


Q ss_pred             cccCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeC
Q 037916          470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLD  549 (741)
Q Consensus       470 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~  549 (741)
                      . ......++||||+ ++++.+++...        ....+++..++.++.||+.||+|||+++  ||+||||||+|||++
T Consensus       114 ~-~~~~~~~lv~e~~-~~~l~~~~~~~--------~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~  181 (397)
T 1wak_A          114 G-VNGTHICMVFEVL-GHHLLKWIIKS--------NYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLS  181 (397)
T ss_dssp             E-TTEEEEEEEECCC-CCBHHHHHHHT--------TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEEC
T ss_pred             C-CCCceEEEEEecc-CccHHHHHHhc--------ccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEe
Confidence            1 2456889999999 56766665432        1245889999999999999999999853  899999999999998


Q ss_pred             CCC-------------------------------------------------ceEEeecccccccCCCCccccccccccc
Q 037916          550 HEM-------------------------------------------------TAHVADFGLAKLLPPAHLQTSSIGVKGT  580 (741)
Q Consensus       550 ~~~-------------------------------------------------~~kL~DFg~a~~~~~~~~~~~~~~~~gt  580 (741)
                      .++                                                 .+||+|||.+......     .....||
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt  256 (397)
T 1wak_A          182 VNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQT  256 (397)
T ss_dssp             CCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSC
T ss_pred             ccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCC
Confidence            775                                                 7999999999876432     1224689


Q ss_pred             ccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcc-----hhhhhhhcCCcchhHh----------hh
Q 037916          581 IGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMN-----LHNFARTVLPDHVMDI----------VD  645 (741)
Q Consensus       581 ~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~~----------~d  645 (741)
                      +.|+||| +..+..++.++|||||||++|||++|+.||.........     ...... .........          +.
T Consensus       257 ~~y~aPE-~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~p~~~~~~~~~~~~~~~  334 (397)
T 1wak_A          257 RQYRSLE-VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIE-LLGKVPRKLIVAGKYSKEFFT  334 (397)
T ss_dssp             GGGCCHH-HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHH-HHCSCCHHHHHHCTTGGGTBC
T ss_pred             CcccCCh-hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHH-hcCCCChHHhhcccccccccC
Confidence            9999995 555667899999999999999999999999743222110     111110 000000000          00


Q ss_pred             hccc-CCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          646 STLL-ADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       646 ~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      .... .......................+....+.+++.+||+.||++|||+.|+++
T Consensus       335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          335 KKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             TTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             CccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence            0000 0000000000000111112233566788999999999999999999999985

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=3.2e-37  Score=326.13  Aligned_cols=280  Identities=22%  Similarity=0.288  Sum_probs=198.0

Q ss_pred             HHHHHhhhcccCceeeEEEEEEc-CCCeEEEEEEeeccC--cCcchhHHHHHHHHHhc---CCCceeeEeeeecCccccC
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILD-EGKTIIAVKVLNLLH--HGASKSSIAECSALRNI---RHKNLVKILTVCSGVDYKG  473 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~~~~~~  473 (741)
                      ..|++.+.||+|+||.||+|++. .+++.||+|+++...  ......+.+|+.+++.+   +||||+++++++.......
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~   90 (326)
T 1blx_A           11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   90 (326)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred             hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCC
Confidence            46889999999999999999995 678999999997432  22345677888887776   8999999999975332235


Q ss_pred             CceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCc
Q 037916          474 DDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMT  553 (741)
Q Consensus       474 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~  553 (741)
                      ....++||||+. |+|.+++....        ...+++..+..++.|++.||.|||+.   ||+||||||+||+++.++.
T Consensus        91 ~~~~~lv~e~~~-~~L~~~l~~~~--------~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~  158 (326)
T 1blx_A           91 ETKLTLVFEHVD-QDLTTYLDKVP--------EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQ  158 (326)
T ss_dssp             EEEEEEEEECCS-CBHHHHHHHSC--------TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCC
T ss_pred             CceEEEEEecCC-CCHHHHHHhcc--------cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCC
Confidence            567899999996 69999986431        23478999999999999999999999   9999999999999999999


Q ss_pred             eEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhh
Q 037916          554 AHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFAR  633 (741)
Q Consensus       554 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~  633 (741)
                      +||+|||.+.......   ......||+.|+||| +..+..++.++||||+||++|+|++|+.||....... .+.....
T Consensus       159 ~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~  233 (326)
T 1blx_A          159 IKLADFGLARIYSFQM---ALTSVVVTLWYRAPE-VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILD  233 (326)
T ss_dssp             EEECSCCSCCCCCGGG---GGCCCCCCCTTCCHH-HHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHH
T ss_pred             EEEecCcccccccCCC---CccccccccceeCHH-HHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHH
Confidence            9999999998654322   122356899999995 5556678999999999999999999999986332111 1111111


Q ss_pred             hcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          634 TVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       634 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      .........+........     ..................+..+.+++.+||+.||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          234 VIGLPGEEDWPRDVALPR-----QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             HHCCCCGGGSCTTCSSCG-----GGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HcCCCCcccCccccccch-----hhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            000000000000000000     000000000000011133466789999999999999999999985

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.2e-37  Score=329.06  Aligned_cols=278  Identities=18%  Similarity=0.201  Sum_probs=197.2

Q ss_pred             HHHHHHHhhhcccCceeeEEEEEE-cCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCC------ceeeEeeeecCcc
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGIL-DEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHK------NLVKILTVCSGVD  470 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp------nIv~~~~~~~~~~  470 (741)
                      +..+|++.+.||+|+||.||+|.+ ..+++.||+|+++.. ....+.+.+|+.+++.++|+      +|+++++++    
T Consensus        12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~----   86 (339)
T 1z57_A           12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF----   86 (339)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE----
T ss_pred             ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc----
Confidence            345789999999999999999998 557899999999642 22345678899999888654      599999984    


Q ss_pred             ccCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCC
Q 037916          471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDH  550 (741)
Q Consensus       471 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~  550 (741)
                       ......++||||+ +++|.+++....        ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.
T Consensus        87 -~~~~~~~lv~e~~-~~~l~~~l~~~~--------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~  153 (339)
T 1z57_A           87 -EHHGHICIVFELL-GLSTYDFIKENG--------FLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQ  153 (339)
T ss_dssp             -EETTEEEEEEECC-CCBHHHHHHHTT--------TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESC
T ss_pred             -ccCCcEEEEEcCC-CCCHHHHHHhcC--------CCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEec
Confidence             4556899999999 889999986431        13578899999999999999999999   9999999999999987


Q ss_pred             -------------------CCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHH
Q 037916          551 -------------------EMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLEL  611 (741)
Q Consensus       551 -------------------~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~el  611 (741)
                                         ++.+||+|||.+.......     ....||+.|+||| +..+..++.++||||+||++|||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE-~~~~~~~~~~~Di~slG~il~el  227 (339)
T 1z57_A          154 SDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPE-VILALGWSQPCDVWSIGCILIEY  227 (339)
T ss_dssp             CCEEEEEC----CEEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHH-HHTTSCCCTHHHHHHHHHHHHHH
T ss_pred             cccccccCCccccccccccCCCceEeeCcccccCcccc-----ccccCCccccChH-HhhCCCCCcchhhHHHHHHHHHH
Confidence                               6689999999998654322     2246899999995 55567789999999999999999


Q ss_pred             HcCCCCCCccccCCcchhhhhhhcCCcchhHhhhhcccC--------Ccchhhhhhhh-----HHHHHhHhhHHHHHHHH
Q 037916          612 MTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLA--------DDEDLTITSNQ-----RQRQARINNIMECLISV  678 (741)
Q Consensus       612 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~--------~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l  678 (741)
                      ++|..||......  .....+..........+.......        ...........     ............+.+.+
T Consensus       228 ~~g~~pf~~~~~~--~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  305 (339)
T 1z57_A          228 YLGFTVFPTHDSK--EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERL  305 (339)
T ss_dssp             HHSSCSCCCSCHH--HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHH
T ss_pred             HhCCCCCCCCChH--HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHH
Confidence            9999998632211  111111111111001110000000        00000000000     00000001122456789


Q ss_pred             HHHhhcccccCCCCCCCHHHHHH
Q 037916          679 VRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       679 ~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      .+++.+||+.||++|||+.|+++
T Consensus       306 ~~li~~~L~~dP~~Rpt~~ell~  328 (339)
T 1z57_A          306 FDLIQKMLEYDPAKRITLREALK  328 (339)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHhCcCcccccCHHHHhc
Confidence            99999999999999999999985

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=6.2e-38  Score=330.53  Aligned_cols=260  Identities=21%  Similarity=0.251  Sum_probs=191.7

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC--cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      ..|++.+.||+|+||.||+|.+..   .||+|+++...  ....+.+.+|+.++++++||||+++++++     ......
T Consensus        33 ~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~  104 (319)
T 2y4i_B           33 EQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC-----MSPPHL  104 (319)
T ss_dssp             SCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEE-----ECSSCE
T ss_pred             HHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEE-----ecCCce
Confidence            357788999999999999999863   38999987432  23345677899999999999999999995     345579


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      ++||||+++++|.+++...         ...+++..+..++.|++.||+|||+.   +|+||||||+||+++ ++.+||+
T Consensus       105 ~iv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~  171 (319)
T 2y4i_B          105 AIITSLCKGRTLYSVVRDA---------KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVIT  171 (319)
T ss_dssp             EEECBCCCSEEHHHHTTSS---------CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEEC
T ss_pred             EEEeecccCCcHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEe
Confidence            9999999999999999643         23578899999999999999999999   999999999999998 6799999


Q ss_pred             ecccccccCCCC---cccccccccccccccCcccccC--------CCCCCCccCchhHHHHHHHHHcCCCCCCccccCCc
Q 037916          558 DFGLAKLLPPAH---LQTSSIGVKGTIGYIAPAEYGL--------GSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNM  626 (741)
Q Consensus       558 DFg~a~~~~~~~---~~~~~~~~~gt~~y~aPEe~~~--------~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~  626 (741)
                      |||++.......   .........||+.|+|||.+..        ...++.++|||||||++|||++|+.||....... 
T Consensus       172 Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-  250 (319)
T 2y4i_B          172 DFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA-  250 (319)
T ss_dssp             CCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH-
T ss_pred             ecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence            999987653221   1112223458999999965543        3457899999999999999999999986321110 


Q ss_pred             chhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHH
Q 037916          627 NLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSI  706 (741)
Q Consensus       627 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  706 (741)
                       ...........        ....                     ..++..+.+++.+||..||++|||+.|+++.|+.+
T Consensus       251 -~~~~~~~~~~~--------~~~~---------------------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l  300 (319)
T 2y4i_B          251 -IIWQMGTGMKP--------NLSQ---------------------IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKL  300 (319)
T ss_dssp             -HHHHHHTTCCC--------CCCC---------------------SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC
T ss_pred             -HHHHhccCCCC--------CCCc---------------------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence             00000000000        0000                     01234577999999999999999999999999998


Q ss_pred             HHhhc
Q 037916          707 KSILL  711 (741)
Q Consensus       707 ~~~~~  711 (741)
                      .+...
T Consensus       301 ~~~~~  305 (319)
T 2y4i_B          301 PKRNR  305 (319)
T ss_dssp             -----
T ss_pred             HHhhc
Confidence            86543

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.5e-37  Score=326.59  Aligned_cols=251  Identities=22%  Similarity=0.314  Sum_probs=186.3

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc--CcchhHHHHHHHHHhcC--CCceeeEeeeecCccccCCce
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIR--HKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      .|++.+.||+|+||.||+|.+. +++.||+|+++....  ...+.+.+|+.++++++  ||||+++++++     .....
T Consensus        29 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~-----~~~~~  102 (313)
T 3cek_A           29 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-----ITDQY  102 (313)
T ss_dssp             EEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE-----ECSSE
T ss_pred             eEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe-----ecCCE
Confidence            4788899999999999999986 588999999974322  23466789999999996  59999999995     44568


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .++||| +.+++|.+++...          ..+++..++.++.|++.||.|||+.   +|+||||||+||++++ +.+||
T Consensus       103 ~~lv~e-~~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL  167 (313)
T 3cek_A          103 IYMVME-CGNIDLNSWLKKK----------KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKL  167 (313)
T ss_dssp             EEEEEC-CCSEEHHHHHHHC----------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEE
T ss_pred             EEEEEe-cCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEE
Confidence            999999 4588999998643          4578889999999999999999999   9999999999999964 89999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccC----------CCCCCCccCchhHHHHHHHHHcCCCCCCccccCCc
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGL----------GSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNM  626 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~----------~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~  626 (741)
                      +|||.+................||+.|+|||.+..          ...++.++|||||||++|+|++|+.||........
T Consensus       168 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  247 (313)
T 3cek_A          168 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS  247 (313)
T ss_dssp             CCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH
T ss_pred             eeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH
Confidence            99999987654433222233568999999965532          24688999999999999999999999863221111


Q ss_pred             chhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          627 NLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       627 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      .+            ....+........                  ...+..+.+++.+||+.||++|||+.|+++.
T Consensus       248 ~~------------~~~~~~~~~~~~~------------------~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          248 KL------------HAIIDPNHEIEFP------------------DIPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             HH------------HHHHCTTSCCCCC------------------CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HH------------HHHHhcccccCCc------------------ccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence            11            1111111110000                  0123467899999999999999999999864

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=7.6e-36  Score=331.47  Aligned_cols=319  Identities=26%  Similarity=0.312  Sum_probs=224.2

Q ss_pred             CCCCCcccccCChhhhhCCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCc
Q 037916            2 DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHL   81 (741)
Q Consensus         2 dl~~n~~~~~ip~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L   81 (741)
                      ++++|.+. .+|. +. .+++|++|+|++|+|+++.+  |.++++|++|+|++|++++..+  |.++++          |
T Consensus        52 ~l~~~~i~-~l~~-~~-~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~----------L  114 (466)
T 1o6v_A           52 QADRLGIK-SIDG-VE-YLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTN----------L  114 (466)
T ss_dssp             ECCSSCCC-CCTT-GG-GCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTT----------C
T ss_pred             ecCCCCCc-cCcc-hh-hhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCC----------C
Confidence            35566665 4553 43 57777777777777775543  7777777777777777775443  666654          7


Q ss_pred             cEEECcCCcCcccCCchhhcccccccEEEccCCcccccCC-------------------ccccCCCCccEEEcccccccc
Q 037916           82 KHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIP-------------------AGIGKFINLQTLHMWDNQLSG  142 (741)
Q Consensus        82 ~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~-------------------~~~~~l~~L~~L~L~~N~i~~  142 (741)
                      ++|+|++|++++..+  +..++ +|++|++++|.+.....                   ..+..+++|++|++++|.+++
T Consensus       115 ~~L~L~~n~l~~~~~--~~~l~-~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~  191 (466)
T 1o6v_A          115 TGLTLFNNQITDIDP--LKNLT-NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSD  191 (466)
T ss_dssp             CEEECCSSCCCCCGG--GTTCT-TCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCC
T ss_pred             CEEECCCCCCCCChH--HcCCC-CCCEEECCCCccCCChhhccCCcccEeecCCcccCchhhccCCCCCEEECcCCcCCC
Confidence            777777777775533  56665 67777777776654311                   125566677777777777765


Q ss_pred             cCCccccCCCcCcEEEcccCCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCccccc
Q 037916          143 TISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMD  222 (741)
Q Consensus       143 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  222 (741)
                      +  ..+..+++|++|++++|++++..+  ++.+++|++|++++|.+++.  ..+..+++|++|++++|++++..|  +..
T Consensus       192 ~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~  263 (466)
T 1o6v_A          192 I--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSG  263 (466)
T ss_dssp             C--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTT
T ss_pred             C--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhc
Confidence            4  346777777777777777775544  66677777777777777643  356777788888888887775443  777


Q ss_pred             cccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCee
Q 037916          223 LTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVL  302 (741)
Q Consensus       223 l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  302 (741)
                      +++|+. |++++|.+++..+  +..+++|+.|+|++|+++++.+  +..+++|+.|+|++|++++..|  +..+++|+.|
T Consensus       264 l~~L~~-L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L  336 (466)
T 1o6v_A          264 LTKLTE-LKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRL  336 (466)
T ss_dssp             CTTCSE-EECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEE
T ss_pred             CCCCCE-EECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEe
Confidence            777776 8888888775443  7777888888888888876544  6777888888888888886655  6778888888


Q ss_pred             eCCCCcCCCccchhhhccccCCcccccCcccccccCCccccCCcccccccCCCCcc
Q 037916          303 DLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKNASAISVFGNSKLC  358 (741)
Q Consensus       303 ~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c  358 (741)
                      ++++|++++.  ..+..+++|+.|++++|++++.+| ...++.+..+++.+|++..
T Consensus       337 ~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~~~~  389 (466)
T 1o6v_A          337 FFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQAWTN  389 (466)
T ss_dssp             ECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG-GTTCTTCCEEECCCEEEEC
T ss_pred             ECCCCccCCc--hhhccCCCCCEEeCCCCccCccch-hhcCCCCCEEeccCCcccC
Confidence            8888888764  357778888888888888887776 5566777888888886654

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=8.4e-38  Score=331.63  Aligned_cols=258  Identities=19%  Similarity=0.220  Sum_probs=174.0

Q ss_pred             HHHHHHHhh-hcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHH-HHHHhcCCCceeeEeeeecCccccCCc
Q 037916          398 LFVSFLFLC-WIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAEC-SALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       398 ~~~~y~~~~-~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~-~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      +..+|.+.+ .||+|+||.||+|.+..+++.||+|++...     ....+|+ ..++.+.||||+++++++.... .+..
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~   99 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMH-HGKR   99 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhcc-CCCc
Confidence            345677765 599999999999999999999999998632     2233333 3456679999999999964321 2345


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCC---CC
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDH---EM  552 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~---~~  552 (741)
                      ..++||||+++|+|.+++....        ...+++.+++.++.|++.||.|||+.   +|+||||||+||+++.   ++
T Consensus       100 ~~~lv~e~~~gg~L~~~l~~~~--------~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~  168 (336)
T 3fhr_A          100 CLLIIMECMEGGELFSRIQERG--------DQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDA  168 (336)
T ss_dssp             EEEEEEECCTTEEHHHHHHTC---------CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTC
T ss_pred             eEEEEEeccCCCCHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCc
Confidence            6899999999999999997431        24588999999999999999999999   9999999999999976   45


Q ss_pred             ceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhh
Q 037916          553 TAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFA  632 (741)
Q Consensus       553 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~  632 (741)
                      .+||+|||.+........    ....||+.|+|| |+..+..++.++||||+||++|+|++|..||.......... .. 
T Consensus       169 ~~kl~Dfg~~~~~~~~~~----~~~~~t~~y~aP-E~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~-  241 (336)
T 3fhr_A          169 VLKLTDFGFAKETTQNAL----QTPCYTPYYVAP-EVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP-GM-  241 (336)
T ss_dssp             CEEECCCTTCEEC---------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------
T ss_pred             eEEEeccccceecccccc----ccCCCCcCccCh-hhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh-hH-
Confidence            699999999986654322    224589999999 55567788999999999999999999999986332211100 00 


Q ss_pred             hhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          633 RTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       633 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      .............    .                   ....++..+.+++.+||+.||++|||+.|+++-
T Consensus       242 ~~~~~~~~~~~~~----~-------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  288 (336)
T 3fhr_A          242 KRRIRLGQYGFPN----P-------------------EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH  288 (336)
T ss_dssp             ---------CCCT----T-------------------TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HHhhhccccccCc----h-------------------hhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            0000000000000    0                   001234568899999999999999999999973

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=1.3e-35  Score=316.54  Aligned_cols=304  Identities=21%  Similarity=0.313  Sum_probs=260.1

Q ss_pred             CCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCccEEECcCCcCcccCCch
Q 037916           19 TLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGC   98 (741)
Q Consensus        19 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~   98 (741)
                      .+++|++|++++|.++.+ + .|..+++|++|+|++|++++..+  |..+++          |++|+|++|.+++.  ..
T Consensus        42 ~l~~L~~L~l~~~~i~~~-~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~----------L~~L~L~~n~i~~~--~~  105 (347)
T 4fmz_A           42 ELESITKLVVAGEKVASI-Q-GIEYLTNLEYLNLNGNQITDISP--LSNLVK----------LTNLYIGTNKITDI--SA  105 (347)
T ss_dssp             HHTTCSEEECCSSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTT----------CCEEECCSSCCCCC--GG
T ss_pred             hcccccEEEEeCCccccc-h-hhhhcCCccEEEccCCccccchh--hhcCCc----------CCEEEccCCcccCc--hH
Confidence            569999999999999854 3 48889999999999999995543  777765          99999999999864  35


Q ss_pred             hhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCcccccCCccc
Q 037916           99 ICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKL  178 (741)
Q Consensus        99 ~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  178 (741)
                      +..++ +|++|++++|++....+  +..+++|++|++++|...... ..+..+++|++|++++|.+.+..+  +..+++|
T Consensus       106 ~~~l~-~L~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~-~~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L  179 (347)
T 4fmz_A          106 LQNLT-NLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDL-SPLSNMTGLNYLTVTESKVKDVTP--IANLTDL  179 (347)
T ss_dssp             GTTCT-TCSEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCC-GGGTTCTTCCEEECCSSCCCCCGG--GGGCTTC
T ss_pred             HcCCC-cCCEEECcCCcccCchh--hccCCceeEEECCCCCCcccc-cchhhCCCCcEEEecCCCcCCchh--hccCCCC
Confidence            78887 99999999999976544  889999999999999665443 448999999999999999986544  8899999


Q ss_pred             ceeeccCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEecc
Q 037916          179 LQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISR  258 (741)
Q Consensus       179 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  258 (741)
                      ++|++++|.+.+..+  +..+++|+.|++++|++++..+  +..+++|+. |++++|.+++..+  +..+++|++|++++
T Consensus       180 ~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~-L~l~~n~l~~~~~--~~~l~~L~~L~l~~  252 (347)
T 4fmz_A          180 YSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNS-LKIGNNKITDLSP--LANLSQLTWLEIGT  252 (347)
T ss_dssp             SEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCE-EECCSSCCCCCGG--GTTCTTCCEEECCS
T ss_pred             CEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCE-EEccCCccCCCcc--hhcCCCCCEEECCC
Confidence            999999999986544  8889999999999999985444  888999997 9999999985544  88999999999999


Q ss_pred             ccccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccchhhhccccCCcccccCcccccccC
Q 037916          259 NMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIP  338 (741)
Q Consensus       259 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  338 (741)
                      |.++.+  ..+..+++|+.|++++|++++.  ..+..+++|+.|+|++|.+++..|..|..+++|+.|++++|++++.+|
T Consensus       253 n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~  328 (347)
T 4fmz_A          253 NQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP  328 (347)
T ss_dssp             SCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG
T ss_pred             CccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC
Confidence            999875  5688999999999999999975  468899999999999999998889999999999999999999998877


Q ss_pred             CccccCCcccccccCCCC
Q 037916          339 TEGVFKNASAISVFGNSK  356 (741)
Q Consensus       339 ~~~~~~~~~~~~~~~n~~  356 (741)
                       ...++.++.+++.+|+.
T Consensus       329 -~~~l~~L~~L~l~~N~i  345 (347)
T 4fmz_A          329 -LASLSKMDSADFANQVI  345 (347)
T ss_dssp             -GGGCTTCSEESSSCC--
T ss_pred             -hhhhhccceeehhhhcc
Confidence             66788999999999863

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2e-37  Score=355.82  Aligned_cols=258  Identities=21%  Similarity=0.289  Sum_probs=198.5

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcC---CCeEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDE---GKTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      ..|++.+.||+|+||.||+|.+..   .+..||+|+++... ....+.+.+|+.++++++||||+++++++.      ++
T Consensus       390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~------~~  463 (656)
T 2j0j_A          390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------EN  463 (656)
T ss_dssp             GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC------SS
T ss_pred             ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe------cC
Confidence            467888999999999999999854   35679999986432 223467889999999999999999999852      23


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..|+||||+++|+|.+++...         ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+|
T Consensus       464 ~~~lv~E~~~~g~L~~~l~~~---------~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vk  531 (656)
T 2j0j_A          464 PVWIIMELCTLGELRSFLQVR---------KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVK  531 (656)
T ss_dssp             SCEEEEECCTTCBHHHHHHHT---------TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEE
T ss_pred             ceEEEEEcCCCCcHHHHHHhc---------cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEE
Confidence            579999999999999998633         23578899999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhh
Q 037916          556 VADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  634 (741)
                      |+|||++.......... .....+|+.|+||| +..+..++.++|||||||++|||++ |..||......  .....   
T Consensus       532 L~DFG~a~~~~~~~~~~-~~~~~~t~~y~aPE-~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--~~~~~---  604 (656)
T 2j0j_A          532 LGDFGLSRYMEDSTYYK-ASKGKLPIKWMAPE-SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGR---  604 (656)
T ss_dssp             ECCCCCCCSCCC-----------CCGGGCCHH-HHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHH---
T ss_pred             EEecCCCeecCCCccee-ccCCCCCcceeCHH-HhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH--HHHHH---
Confidence            99999998765443222 12234778999995 4456688999999999999999997 99998632111  00000   


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHh
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSI  709 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  709 (741)
                              +.+.....                   .+..+++.+.+++.+||..||++|||+.|+++.|+.+.+.
T Consensus       605 --------i~~~~~~~-------------------~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~  652 (656)
T 2j0j_A          605 --------IENGERLP-------------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  652 (656)
T ss_dssp             --------HHHTCCCC-------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --------HHcCCCCC-------------------CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence                    00000000                   0113456788999999999999999999999999998764

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=2.3e-36  Score=316.98  Aligned_cols=254  Identities=30%  Similarity=0.459  Sum_probs=188.8

Q ss_pred             cccEEEccCCcccc--cCCccccCCCCccEEEccc-ccccccCCccccCCCcCcEEEcccCCCCCcCcccccCCccccee
Q 037916          105 TLETLIFNSNKIFR--SIPAGIGKFINLQTLHMWD-NQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQL  181 (741)
Q Consensus       105 ~L~~L~L~~n~i~~--~~~~~~~~l~~L~~L~L~~-N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  181 (741)
                      +++.|+|++|++.+  .+|..|.++++|++|+|++ |.+++..|..|.++++|++|+|++|++++..|..|.++++|++|
T Consensus        51 ~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L  130 (313)
T 1ogq_A           51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL  130 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred             eEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEE
Confidence            56666666666655  5666666666777777763 66666666667777777777777777766666667777777777


Q ss_pred             eccCcccccccCcccccCCCCCEEeccCccccccCCccccccc-cceeEEEcCCCccCCCCChhhcCCCCCcEEEecccc
Q 037916          182 YLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLT-SLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNM  260 (741)
Q Consensus       182 ~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  260 (741)
                      +|++|.+++.+|..|..+++|++|+|++|++++.+|..+..++ +|+. |+|++|++++..|..|..++ |++|+|++|.
T Consensus       131 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~-L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~  208 (313)
T 1ogq_A          131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTS-MTISRNRLTGKIPPTFANLN-LAFVDLSRNM  208 (313)
T ss_dssp             ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCE-EECCSSEEEEECCGGGGGCC-CSEEECCSSE
T ss_pred             eCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcE-EECcCCeeeccCChHHhCCc-ccEEECcCCc
Confidence            7777777666677777777777777777777767777777776 6665 77777777767777777776 7777777777


Q ss_pred             ccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccchhhhccccCCcccccCcccccccCCc
Q 037916          261 LECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTE  340 (741)
Q Consensus       261 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~  340 (741)
                      +++..+..|..+++|+.|+|++|++++.+|. +..+++|++|+|++|+|++.+|..|..+++|+.|+|++|++++.+|..
T Consensus       209 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~  287 (313)
T 1ogq_A          209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG  287 (313)
T ss_dssp             EEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS
T ss_pred             ccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC
Confidence            7777777777777888888888888765554 777788888888888888788888888888888888888888888877


Q ss_pred             cccCCcccccccCCCCccccC
Q 037916          341 GVFKNASAISVFGNSKLCGGI  361 (741)
Q Consensus       341 ~~~~~~~~~~~~~n~~~c~~~  361 (741)
                      +.++.+..+++.+|++.|+.+
T Consensus       288 ~~l~~L~~l~l~~N~~lc~~p  308 (313)
T 1ogq_A          288 GNLQRFDVSAYANNKCLCGSP  308 (313)
T ss_dssp             TTGGGSCGGGTCSSSEEESTT
T ss_pred             ccccccChHHhcCCCCccCCC
Confidence            777888888888888888864

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.5e-37  Score=327.12  Aligned_cols=258  Identities=21%  Similarity=0.237  Sum_probs=173.4

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc-CcchhHHHHHH-HHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH-GASKSSIAECS-ALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      .|++.+.||+|+||.||+|.+..+++.||+|+++.... .....+..|+. +++.++||||+++++++     ......+
T Consensus        23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~-----~~~~~~~   97 (327)
T 3aln_A           23 DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGAL-----FREGDCW   97 (327)
T ss_dssp             SEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEE-----ECSSEEE
T ss_pred             HhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEE-----EeCCceE
Confidence            47788899999999999999998999999999974322 22334555665 66778999999999995     4456889


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      +||||+++ +|.+++.....     .....+++..+..++.|++.||.|||+..  +|+||||||+||+++.++.+||+|
T Consensus        98 lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~D  169 (327)
T 3aln_A           98 ICMELMST-SFDKFYKYVYS-----VLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCD  169 (327)
T ss_dssp             EEECCCSE-EHHHHHHHHHH-----TTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECC
T ss_pred             EEEeecCC-ChHHHHHHHHh-----hhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEcc
Confidence            99999964 88777642100     01245888999999999999999999842  899999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCccccc---CCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhc
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG---LGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV  635 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~---~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~  635 (741)
                      ||.+.........   ....||+.|+|||.+.   .+..++.++|||||||++|+|++|+.||.........+.......
T Consensus       170 fg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  246 (327)
T 3aln_A          170 FGISGQLVDSIAK---TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGD  246 (327)
T ss_dssp             CSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSC
T ss_pred             CCCceeccccccc---ccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCC
Confidence            9999866543221   2235899999996542   456689999999999999999999999864322111111111100


Q ss_pred             CCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          636 LPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       636 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      .+.    +.. ...                      ..++..+.+++.+||+.||++|||+.|+++
T Consensus       247 ~~~----~~~-~~~----------------------~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          247 PPQ----LSN-SEE----------------------REFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCC----CCC-CSS----------------------CCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCC----CCC-ccc----------------------ccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            000    000 000                      022456889999999999999999999976

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=3.2e-35  Score=311.50  Aligned_cols=299  Identities=18%  Similarity=0.223  Sum_probs=244.1

Q ss_pred             cCChhhhhCCC-----CCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCccEEE
Q 037916           11 GIPLDFGFTLP-----NLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLD   85 (741)
Q Consensus        11 ~ip~~~~~~l~-----~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~   85 (741)
                      .+|..+....|     +++.+++++|.++ .+|..+.  ++|++|+|++|+|++..|..|.++++          |++|+
T Consensus        18 ~lp~~~~~~cp~~c~c~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~----------L~~L~   84 (332)
T 2ft3_A           18 SLPPTYSAMCPFGCHCHLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQH----------LYALV   84 (332)
T ss_dssp             -------CCCCSSCEEETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTT----------CCEEE
T ss_pred             cCCCcccCCCCCCCcccCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCC----------CcEEE
Confidence            57766654333     6899999999998 5566553  68999999999999888888888876          99999


Q ss_pred             CcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCC
Q 037916           86 INNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLS  165 (741)
Q Consensus        86 Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~  165 (741)
                      |++|+|++..|..|..++ +|++|+|++|++.. +|..+.  ++|++|+|++|+|+++.+..|.++++|++|++++|.++
T Consensus        85 L~~n~l~~~~~~~~~~l~-~L~~L~L~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~  160 (332)
T 2ft3_A           85 LVNNKISKIHEKAFSPLR-KLQKLYISKNHLVE-IPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLE  160 (332)
T ss_dssp             CCSSCCCEECGGGSTTCT-TCCEEECCSSCCCS-CCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCB
T ss_pred             CCCCccCccCHhHhhCcC-CCCEEECCCCcCCc-cCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccc
Confidence            999999988888898888 89999999999864 444444  68999999999999888888999999999999999996


Q ss_pred             C--cCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCCCCh
Q 037916          166 G--NIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPT  243 (741)
Q Consensus       166 ~--~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~  243 (741)
                      .  ..+..|..+ +|++|++++|++++ +|..+.  ++|++|+|++|++++..+..|.++++|+. |+|++|++++..+.
T Consensus       161 ~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~-L~L~~N~l~~~~~~  235 (332)
T 2ft3_A          161 NSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYR-LGLGHNQIRMIENG  235 (332)
T ss_dssp             GGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSC-CBCCSSCCCCCCTT
T ss_pred             cCCCCcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCE-EECCCCcCCcCChh
Confidence            3  677888888 99999999999985 455443  78999999999999777788999999987 99999999988888


Q ss_pred             hhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCccCCCCChhcccC------ccCCeeeCCCCcCC--Cccch
Q 037916          244 EVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSL------RGLRVLDLSQNNIS--GEIPK  315 (741)
Q Consensus       244 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l------~~L~~L~Ls~N~l~--~~~~~  315 (741)
                      .|..+++|+.|+|++|+++. .|..+..+++|+.|++++|+|++..+..|..+      +.|+.|++++|.+.  +..|.
T Consensus       236 ~~~~l~~L~~L~L~~N~l~~-lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~  314 (332)
T 2ft3_A          236 SLSFLPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPA  314 (332)
T ss_dssp             GGGGCTTCCEEECCSSCCCB-CCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGG
T ss_pred             HhhCCCCCCEEECCCCcCee-cChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcc
Confidence            89999999999999999984 56668889999999999999998877777653      67889999999987  67788


Q ss_pred             hhhccccCCcccccCcc
Q 037916          316 FLVELQLVQNLNLSYND  332 (741)
Q Consensus       316 ~~~~l~~L~~L~l~~N~  332 (741)
                      .|..+++|+.+++++|.
T Consensus       315 ~~~~l~~L~~l~l~~n~  331 (332)
T 2ft3_A          315 TFRCVTDRLAIQFGNYK  331 (332)
T ss_dssp             GGTTBCCSTTEEC----
T ss_pred             cccccchhhhhhccccc
Confidence            88899999999998884

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=9.4e-37  Score=329.69  Aligned_cols=200  Identities=23%  Similarity=0.279  Sum_probs=163.7

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcC-CC-----ceeeEeeeecCcccc
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIR-HK-----NLVKILTVCSGVDYK  472 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp-----nIv~~~~~~~~~~~~  472 (741)
                      ..+|++.+.||+|+||.||+|++..+++.||||+++.. ......+..|+.+++.+. |+     +|+++++++     .
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~-----~  126 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF-----M  126 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE-----E
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeee-----c
Confidence            35688999999999999999999999999999999632 223456677888888874 44     499999984     4


Q ss_pred             CCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeC--C
Q 037916          473 GDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLD--H  550 (741)
Q Consensus       473 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~--~  550 (741)
                      .....|+||||+. ++|.+++....        ...+++..+..++.|++.||.|||+. ..||+||||||+|||++  .
T Consensus       127 ~~~~~~lv~e~~~-~~L~~~l~~~~--------~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~  196 (382)
T 2vx3_A          127 FRNHLCLVFEMLS-YNLYDLLRNTN--------FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPK  196 (382)
T ss_dssp             ETTEEEEEEECCC-CBHHHHHHHTT--------TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTT
T ss_pred             cCCceEEEEecCC-CCHHHHHhhcC--------cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCC
Confidence            4568999999995 59999986431        13478999999999999999999942 22999999999999995  4


Q ss_pred             CCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCc
Q 037916          551 EMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDI  620 (741)
Q Consensus       551 ~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~  620 (741)
                      ++.+||+|||++.......     ....||+.|+||| +..+..++.++||||+||++|||++|+.||..
T Consensus       197 ~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE-~~~~~~~~~~~DiwSlG~il~elltg~~pf~~  260 (382)
T 2vx3_A          197 RSAIKIVDFGSSCQLGQRI-----YQYIQSRFYRSPE-VLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG  260 (382)
T ss_dssp             SCCEEECCCTTCEETTCCC-----CSSCSCGGGCCHH-HHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCcEEEEeccCceeccccc-----ccccCCccccChH-HHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            7789999999998764332     2246899999995 55666799999999999999999999999974

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=5.6e-35  Score=311.75  Aligned_cols=297  Identities=24%  Similarity=0.363  Sum_probs=259.6

Q ss_pred             CCCCCcccccCChhhhhCCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCc
Q 037916            2 DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHL   81 (741)
Q Consensus         2 dl~~n~~~~~ip~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L   81 (741)
                      ++++|.+. .+|. +. .+++|++|+|++|+|+++.+  |.++++|++|+|++|+++..  ..|..+++          |
T Consensus        50 ~l~~~~i~-~~~~-~~-~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~--~~~~~l~~----------L  112 (347)
T 4fmz_A           50 VVAGEKVA-SIQG-IE-YLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI--SALQNLTN----------L  112 (347)
T ss_dssp             ECCSSCCC-CCTT-GG-GCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTT----------C
T ss_pred             EEeCCccc-cchh-hh-hcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccCc--hHHcCCCc----------C
Confidence            57788887 6664 55 79999999999999996544  99999999999999999953  36777766          9


Q ss_pred             cEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEccc
Q 037916           82 KHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINT  161 (741)
Q Consensus        82 ~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~  161 (741)
                      ++|++++|++++..+  +..+. +|++|++++|...... ..+..+++|++|++++|.+++..+  +..+++|++|++++
T Consensus       113 ~~L~l~~n~i~~~~~--~~~l~-~L~~L~l~~n~~~~~~-~~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~  186 (347)
T 4fmz_A          113 RELYLNEDNISDISP--LANLT-KMYSLNLGANHNLSDL-SPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNY  186 (347)
T ss_dssp             SEEECTTSCCCCCGG--GTTCT-TCCEEECTTCTTCCCC-GGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTT
T ss_pred             CEEECcCCcccCchh--hccCC-ceeEEECCCCCCcccc-cchhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccC
Confidence            999999999996644  77887 9999999999765544 449999999999999999986654  89999999999999


Q ss_pred             CCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCCC
Q 037916          162 NKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSL  241 (741)
Q Consensus       162 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~  241 (741)
                      |++++..+  +..+++|+.|++++|.+.+..+  +..+++|++|++++|++++. +. +..+++|+. |++++|.+++. 
T Consensus       187 n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~-~~-~~~l~~L~~-L~l~~n~l~~~-  258 (347)
T 4fmz_A          187 NQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDL-SP-LANLSQLTW-LEIGTNQISDI-  258 (347)
T ss_dssp             SCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCE-EECCSSCCCCC-
T ss_pred             Cccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCC-cc-hhcCCCCCE-EECCCCccCCC-
Confidence            99986544  8999999999999999986655  88999999999999999854 44 899999998 99999999854 


Q ss_pred             ChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccchhhhccc
Q 037916          242 PTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQ  321 (741)
Q Consensus       242 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  321 (741)
                       ..+..+++|++|++++|+++++  ..+..+++|+.|++++|++++..+..|..+++|+.|+|++|++++..|  +..++
T Consensus       259 -~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~  333 (347)
T 4fmz_A          259 -NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLS  333 (347)
T ss_dssp             -GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCT
T ss_pred             -hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhh
Confidence             4789999999999999999976  568999999999999999999999999999999999999999998766  88999


Q ss_pred             cCCcccccCcccc
Q 037916          322 LVQNLNLSYNDLE  334 (741)
Q Consensus       322 ~L~~L~l~~N~l~  334 (741)
                      +|+.|++++|+++
T Consensus       334 ~L~~L~l~~N~i~  346 (347)
T 4fmz_A          334 KMDSADFANQVIK  346 (347)
T ss_dssp             TCSEESSSCC---
T ss_pred             ccceeehhhhccc
Confidence            9999999999986

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=6.8e-37  Score=330.01  Aligned_cols=283  Identities=17%  Similarity=0.232  Sum_probs=197.9

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcC-----------CCceeeEeeeecC
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIR-----------HKNLVKILTVCSG  468 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------hpnIv~~~~~~~~  468 (741)
                      .+|++.+.||+|+||.||+|++..+++.||+|+++.. ....+.+.+|+.+++++.           ||||+++++++..
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~   97 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   97 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence            4688899999999999999999989999999999632 223456778999998875           8999999998643


Q ss_pred             ccccCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEe
Q 037916          469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLL  548 (741)
Q Consensus       469 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll  548 (741)
                      .. .+....++||||+ +++|.+++....        ...+++..+..++.||+.||+|||+++  ||+||||||+||++
T Consensus        98 ~~-~~~~~~~lv~e~~-~~~L~~~~~~~~--------~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll  165 (373)
T 1q8y_A           98 KG-PNGVHVVMVFEVL-GENLLALIKKYE--------HRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLM  165 (373)
T ss_dssp             EE-TTEEEEEEEECCC-CEEHHHHHHHTT--------TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEE
T ss_pred             cC-CCCceEEEEEecC-CCCHHHHHHHhh--------ccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEE
Confidence            21 2334789999999 889999986431        234888999999999999999999843  89999999999999


Q ss_pred             C------CCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccc
Q 037916          549 D------HEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMF  622 (741)
Q Consensus       549 ~------~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~  622 (741)
                      +      ..+.+||+|||.+.......     ....||+.|+||| +..+..++.++||||+||++|||++|+.||....
T Consensus       166 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE-~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  239 (373)
T 1q8y_A          166 EIVDSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPE-VLLGAPWGCGADIWSTACLIFELITGDFLFEPDE  239 (373)
T ss_dssp             EEEETTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHH-HHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             eccCCCcCcceEEEcccccccccCCCC-----CCCCCCccccCcH-HHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence            4      34589999999998764321     2246899999995 4556678999999999999999999999997432


Q ss_pred             cCC-----cchhhhhhhc--CCcc-------hhHhhhhc-ccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccc
Q 037916          623 EGN-----MNLHNFARTV--LPDH-------VMDIVDST-LLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSM  687 (741)
Q Consensus       623 ~~~-----~~~~~~~~~~--~~~~-------~~~~~d~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  687 (741)
                      ...     ..+.......  .+..       ...+++.. ..........................+.+.+.+++.+||+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  319 (373)
T 1q8y_A          240 GHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQ  319 (373)
T ss_dssp             -----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGC
T ss_pred             ccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhc
Confidence            111     0111111100  0000       00000000 0000000000001111112222345677889999999999


Q ss_pred             cCCCCCCCHHHHHH
Q 037916          688 ESPQDRMNMTIVVH  701 (741)
Q Consensus       688 ~dP~~RPs~~evl~  701 (741)
                      .||++|||+.|+++
T Consensus       320 ~dP~~Rpt~~ell~  333 (373)
T 1q8y_A          320 LDPRKRADAGGLVN  333 (373)
T ss_dssp             SSTTTCBCHHHHHT
T ss_pred             cCccccCCHHHHhh
Confidence            99999999999987

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=4.9e-37  Score=345.92  Aligned_cols=288  Identities=22%  Similarity=0.237  Sum_probs=201.3

Q ss_pred             HHHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeecc-CcCcchhHHHHHHHHHhcCCCceeeEeeeecCcc-ccCC
Q 037916          397 LLFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLL-HHGASKSSIAECSALRNIRHKNLVKILTVCSGVD-YKGD  474 (741)
Q Consensus       397 ~~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~~~  474 (741)
                      ..+++|++.+.||+|+||.||+|.+..+++.||+|+++.. .....+.+.+|+.++++++||||+++++++.... +...
T Consensus        11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~   90 (676)
T 3qa8_A           11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN   90 (676)
T ss_dssp             ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred             CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence            4458999999999999999999999989999999998643 2223456788999999999999999999865422 2236


Q ss_pred             ceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCc-
Q 037916          475 DFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMT-  553 (741)
Q Consensus       475 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~-  553 (741)
                      ...++||||+++|+|.+++....       ....+++..++.++.|++.||+|||+.   ||+||||||+||+++.++. 
T Consensus        91 ~~~~LVmEy~~ggsL~~~L~~~~-------~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~  160 (676)
T 3qa8_A           91 DLPLLAMEYCEGGDLRKYLNQFE-------NCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQR  160 (676)
T ss_dssp             SSCCCEEECCSSCBHHHHHHSSS-------CTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSS
T ss_pred             CeEEEEEEeCCCCCHHHHHHhcc-------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCc
Confidence            67899999999999999987541       123578889999999999999999999   9999999999999987664 


Q ss_pred             --eEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhh
Q 037916          554 --AHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNF  631 (741)
Q Consensus       554 --~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~  631 (741)
                        +||+|||.+.........   ....||+.|+|| |+..+..++.++||||+||++|+|++|..||....    ....|
T Consensus       161 ~~vKL~DFG~a~~~~~~~~~---~~~~gt~~Y~AP-E~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~----~~~~~  232 (676)
T 3qa8_A          161 LIHKIIDLGYAKELDQGELC---TEFVGTLQYLAP-ELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW----QPVQW  232 (676)
T ss_dssp             CEEEECSCCCCCBTTSCCCC---CCCCSCCTTCSS-CSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC----HHHHS
T ss_pred             eeEEEccccccccccccccc---ccccCCcccCCh-HHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc----chhhh
Confidence              999999999876544322   235689999999 55567789999999999999999999999986321    11111


Q ss_pred             hhhcCCcchhH-hhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHH-----HHHHHHH
Q 037916          632 ARTVLPDHVMD-IVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTI-----VVHELQS  705 (741)
Q Consensus       632 ~~~~~~~~~~~-~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e-----vl~~L~~  705 (741)
                      ........... .......+..........      ........++.+.+++.+||.+||++|||+.|     ..+.+++
T Consensus       233 ~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~------p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~  306 (676)
T 3qa8_A          233 HGKVREKSNEHIVVYDDLTGAVKFSSVLPT------PNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDS  306 (676)
T ss_dssp             STTCC------CCSCCCCSSSCCCCSSSCC------SCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHH
T ss_pred             hhhhhcccchhhhhhhhhccccccccccCC------chhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHH
Confidence            11111100000 000000000000000000      00011134567889999999999999999988     4566666


Q ss_pred             HHH
Q 037916          706 IKS  708 (741)
Q Consensus       706 i~~  708 (741)
                      +.+
T Consensus       307 iL~  309 (676)
T 3qa8_A          307 ILS  309 (676)
T ss_dssp             HHC
T ss_pred             HHh
Confidence            664

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=2.9e-35  Score=340.30  Aligned_cols=332  Identities=23%  Similarity=0.258  Sum_probs=274.8

Q ss_pred             cCChhhhhCCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCccEEECcCCc
Q 037916           11 GIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNN   90 (741)
Q Consensus        11 ~ip~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~   90 (741)
                      .||+++.   +++++|||++|+|+++.+.+|.++++|++|+|++|+|+++.|++|.++++          |++|+|++|+
T Consensus        45 ~vP~~lp---~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~----------L~~L~Ls~N~  111 (635)
T 4g8a_A           45 KIPDNLP---FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSH----------LSTLILTGNP  111 (635)
T ss_dssp             SCCSSSC---TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTT----------CCEEECTTCC
T ss_pred             ccCCCCC---cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCC----------CCEEEccCCc
Confidence            6777766   78999999999999999999999999999999999999888999999987          9999999999


Q ss_pred             CcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEccccccccc-CCccccCCCcCcEEEcccCCCCCcCc
Q 037916           91 FGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGT-ISPAIGELQNLVTLAINTNKLSGNIP  169 (741)
Q Consensus        91 l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~  169 (741)
                      |+++.+..|.++. +|++|+|++|++.++.+..|+++++|++|+|++|+|+++ .|..+..+++|++|+|++|+|+++.+
T Consensus       112 l~~l~~~~f~~L~-~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  190 (635)
T 4g8a_A          112 IQSLALGAFSGLS-SLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC  190 (635)
T ss_dssp             CCEECGGGGTTCT-TCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECG
T ss_pred             CCCCCHHHhcCCC-CCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCcccccccc
Confidence            9988888999998 999999999999998888999999999999999999875 47888999999999999999987766


Q ss_pred             ccccCCccc-----------------------------------------------------------------------
Q 037916          170 PSIGNLKKL-----------------------------------------------------------------------  178 (741)
Q Consensus       170 ~~~~~l~~L-----------------------------------------------------------------------  178 (741)
                      ..|..+.++                                                                       
T Consensus       191 ~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~  270 (635)
T 4g8a_A          191 TDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKF  270 (635)
T ss_dssp             GGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCC
T ss_pred             ccccchhhhhhhhhhhhcccCcccccCcccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccc
Confidence            655433222                                                                       


Q ss_pred             ------------------------------------------------------------ceeeccCcccccccCc----
Q 037916          179 ------------------------------------------------------------LQLYLIENFLQVSIPS----  194 (741)
Q Consensus       179 ------------------------------------------------------------~~L~L~~N~i~~~~~~----  194 (741)
                                                                                  +.|++.+|.+....+.    
T Consensus       271 ~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~  350 (635)
T 4g8a_A          271 DKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKS  350 (635)
T ss_dssp             CTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTT
T ss_pred             cccccccccchhhhhhhhhhhcccccchhhhhhhhcccccccccccccccccccccchhhhhhhcccccccCcCcccchh
Confidence                                                                        2222222222211111    


Q ss_pred             ---------------ccccCCCCCEEeccCccccc-------------------------cCCccccccccceeEEEcCC
Q 037916          195 ---------------SLGQCQSLTTINLSYNNLSG-------------------------TIPPQLMDLTSLSVGLDLSR  234 (741)
Q Consensus       195 ---------------~~~~l~~L~~L~L~~N~l~~-------------------------~~p~~~~~l~~L~~~L~Ls~  234 (741)
                                     .+..+++|+.|++++|.+..                         ..+..+..+++|+. ++++.
T Consensus       351 L~~l~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~-l~l~~  429 (635)
T 4g8a_A          351 LKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVITMSSNFLGLEQLEH-LDFQH  429 (635)
T ss_dssp             CCEEEEESCCSCCBCCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEEECSCCTTCTTCCE-EECTT
T ss_pred             hhhcccccccCCCCcccccccccccchhhccccccccccccchhhhhhhhhhhccccccccccccccccccccc-hhhhh
Confidence                           11245678888888887742                         12334556677776 78877


Q ss_pred             CccCCCCC-hhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCcc-CCCCChhcccCccCCeeeCCCCcCCCc
Q 037916          235 NQLVGSLP-TEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLF-QGPIPLSLSSLRGLRVLDLSQNNISGE  312 (741)
Q Consensus       235 N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l-~~~~~~~~~~l~~L~~L~Ls~N~l~~~  312 (741)
                      |++....+ ..|..+++++.+++++|.+....+..+..+++|+.|+|++|.+ .+..|..|..+++|++|+|++|+|++.
T Consensus       430 ~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l  509 (635)
T 4g8a_A          430 SNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQL  509 (635)
T ss_dssp             SEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEE
T ss_pred             ccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCc
Confidence            77665544 4688899999999999999999999999999999999999975 456788999999999999999999999


Q ss_pred             cchhhhccccCCcccccCcccccccCCc-cccCCcccccccCCCCc
Q 037916          313 IPKFLVELQLVQNLNLSYNDLEGVIPTE-GVFKNASAISVFGNSKL  357 (741)
Q Consensus       313 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~~~~~~~~~n~~~  357 (741)
                      .|..|.++++|+.|+|++|+|++.++.. ..++.++.+++.+|...
T Consensus       510 ~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~  555 (635)
T 4g8a_A          510 SPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM  555 (635)
T ss_dssp             CTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCC
T ss_pred             ChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCC
Confidence            9999999999999999999999988764 45678999999999543

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=7.9e-37  Score=327.05  Aligned_cols=198  Identities=22%  Similarity=0.290  Sum_probs=163.4

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCC-eEEEEEEeeccCcCcchhHHHHHHHHHhcCCCc------eeeEeeeecCccc
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGK-TIIAVKVLNLLHHGASKSSIAECSALRNIRHKN------LVKILTVCSGVDY  471 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn------Iv~~~~~~~~~~~  471 (741)
                      ..+|++.+.||+|+||.||+|.+..++ +.||+|+++.. ....+.+.+|+.++++++|++      ++.+++++     
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~-----   91 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF-----   91 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE-----
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee-----
Confidence            456889999999999999999997666 79999999642 233456778999999886655      88888884     


Q ss_pred             cCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEe---
Q 037916          472 KGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLL---  548 (741)
Q Consensus       472 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll---  548 (741)
                      ......++||||+ ++++.+++...        ....+++..++.++.||+.||+|||+.   +|+||||||+||++   
T Consensus        92 ~~~~~~~lv~e~~-~~~l~~~l~~~--------~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~  159 (355)
T 2eu9_A           92 NFHGHMCIAFELL-GKNTFEFLKEN--------NFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNS  159 (355)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHT--------TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCC
T ss_pred             eeCCeEEEEEecc-CCChHHHHHhc--------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecc
Confidence            4556899999999 66777776532        113588999999999999999999999   99999999999999   


Q ss_pred             ----------------CCCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHH
Q 037916          549 ----------------DHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELM  612 (741)
Q Consensus       549 ----------------~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ell  612 (741)
                                      +.++.+||+|||.+.......     ....||+.|+||| +..+..++.++||||+||++|||+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE-~~~~~~~~~~~Di~slG~il~el~  233 (355)
T 2eu9_A          160 EFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPE-VILELGWAQPCDVWSIGCILFEYY  233 (355)
T ss_dssp             CEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHH-HHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCe-eeecCCCCCccchHHHHHHHHHHH
Confidence                            567899999999998654322     2246899999994 555778899999999999999999


Q ss_pred             cCCCCCCc
Q 037916          613 TRKRPSDI  620 (741)
Q Consensus       613 tg~~p~~~  620 (741)
                      +|..||..
T Consensus       234 ~g~~pf~~  241 (355)
T 2eu9_A          234 RGFTLFQT  241 (355)
T ss_dssp             HSSCSCCC
T ss_pred             hCCCCCCC
Confidence            99999973

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=2.7e-35  Score=312.03  Aligned_cols=283  Identities=20%  Similarity=0.248  Sum_probs=253.6

Q ss_pred             CCCCCcccccCChhhhhCCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCc
Q 037916            2 DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHL   81 (741)
Q Consensus         2 dl~~n~~~~~ip~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L   81 (741)
                      |+++|.+. .+|..++   ++|++|+|++|+|+++.+..|.++++|++|+|++|+|++..|..|.++++          |
T Consensus        39 ~~~~~~l~-~ip~~~~---~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~----------L  104 (332)
T 2ft3_A           39 QCSDLGLK-AVPKEIS---PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRK----------L  104 (332)
T ss_dssp             ECCSSCCS-SCCSCCC---TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTT----------C
T ss_pred             ECCCCCcc-ccCCCCC---CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCC----------C
Confidence            57788887 8898876   89999999999999998999999999999999999999888999999986          9


Q ss_pred             cEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccc--cCCccccCCCcCcEEEc
Q 037916           82 KHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSG--TISPAIGELQNLVTLAI  159 (741)
Q Consensus        82 ~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~--~~~~~~~~l~~L~~L~L  159 (741)
                      ++|+|++|+++.+ |..+.  . +|++|++++|++....+..|..+++|++|+|++|.++.  ..+..|..+ +|++|++
T Consensus       105 ~~L~L~~n~l~~l-~~~~~--~-~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l  179 (332)
T 2ft3_A          105 QKLYISKNHLVEI-PPNLP--S-SLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRI  179 (332)
T ss_dssp             CEEECCSSCCCSC-CSSCC--T-TCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBC
T ss_pred             CEEECCCCcCCcc-Ccccc--c-cCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEEC
Confidence            9999999999954 44433  3 89999999999998888889999999999999999964  778889988 9999999


Q ss_pred             ccCCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCC
Q 037916          160 NTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVG  239 (741)
Q Consensus       160 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~  239 (741)
                      ++|++++ +|..+.  ++|++|+|++|.+++..+..|..+++|++|+|++|++++..+..|..+++|+. |+|++|+++ 
T Consensus       180 ~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~-L~L~~N~l~-  254 (332)
T 2ft3_A          180 SEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRE-LHLDNNKLS-  254 (332)
T ss_dssp             CSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCE-EECCSSCCC-
T ss_pred             cCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCE-EECCCCcCe-
Confidence            9999996 455544  78999999999999988899999999999999999999888889999999998 999999999 


Q ss_pred             CCChhhcCCCCCcEEEeccccccchhhhhcccc------ccccEEEeCCCccC--CCCChhcccCccCCeeeCCCCc
Q 037916          240 SLPTEVGKLINLEILFISRNMLECEILSTLGSC------IKLEQLKLGGNLFQ--GPIPLSLSSLRGLRVLDLSQNN  308 (741)
Q Consensus       240 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l------~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~Ls~N~  308 (741)
                      .+|..+..+++|++|++++|+|+.+.+..|...      .+|+.|++++|.+.  +..|.+|..+++|+.|+|++|+
T Consensus       255 ~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~  331 (332)
T 2ft3_A          255 RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK  331 (332)
T ss_dssp             BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred             ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence            778889999999999999999999988888764      67999999999998  7888999999999999999985

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=6.5e-36  Score=313.56  Aligned_cols=253  Identities=32%  Similarity=0.495  Sum_probs=231.2

Q ss_pred             CCccEEECcCCcCcc--cCCchhhcccccccEEEccC-CcccccCCccccCCCCccEEEcccccccccCCccccCCCcCc
Q 037916           79 QHLKHLDINNNNFGG--LLPGCICNFSITLETLIFNS-NKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLV  155 (741)
Q Consensus        79 ~~L~~L~Ls~N~l~~--~~~~~~~~l~~~L~~L~L~~-n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~  155 (741)
                      .+++.|+|++|++++  .+|..+..++ +|++|+|++ |++.+.+|..|.++++|++|+|++|+|++..|..|.++++|+
T Consensus        50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~-~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~  128 (313)
T 1ogq_A           50 YRVNNLDLSGLNLPKPYPIPSSLANLP-YLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLV  128 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGGGGCT-TCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCC
T ss_pred             ceEEEEECCCCCccCCcccChhHhCCC-CCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCC
Confidence            358899999999988  7888888888 899999995 888888899999999999999999999988899999999999


Q ss_pred             EEEcccCCCCCcCcccccCCcccceeeccCcccccccCcccccCC-CCCEEeccCccccccCCccccccccceeEEEcCC
Q 037916          156 TLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQ-SLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSR  234 (741)
Q Consensus       156 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~  234 (741)
                      +|+|++|++++.+|..|..+++|++|+|++|++++.+|..|..++ +|++|+|++|++++.+|..+..+. |+. |+|++
T Consensus       129 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~-L~Ls~  206 (313)
T 1ogq_A          129 TLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAF-VDLSR  206 (313)
T ss_dssp             EEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSE-EECCS
T ss_pred             EEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccE-EECcC
Confidence            999999999988999999999999999999999988999999998 999999999999999999999887 887 99999


Q ss_pred             CccCCCCChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccc
Q 037916          235 NQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIP  314 (741)
Q Consensus       235 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  314 (741)
                      |.+++..|..|..+++|+.|+|++|.+++..+. +..+++|++|+|++|++++.+|..|..+++|+.|+|++|++++.+|
T Consensus       207 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip  285 (313)
T 1ogq_A          207 NMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP  285 (313)
T ss_dssp             SEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECC
T ss_pred             CcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCC
Confidence            999989999999999999999999999876665 8889999999999999999999999999999999999999998888


Q ss_pred             hhhhccccCCcccccCcc-cccc
Q 037916          315 KFLVELQLVQNLNLSYND-LEGV  336 (741)
Q Consensus       315 ~~~~~l~~L~~L~l~~N~-l~~~  336 (741)
                      .. ..+++|+.|++++|+ +.+.
T Consensus       286 ~~-~~l~~L~~l~l~~N~~lc~~  307 (313)
T 1ogq_A          286 QG-GNLQRFDVSAYANNKCLCGS  307 (313)
T ss_dssp             CS-TTGGGSCGGGTCSSSEEEST
T ss_pred             CC-ccccccChHHhcCCCCccCC
Confidence            86 889999999999998 5554

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=4e-37  Score=324.12  Aligned_cols=253  Identities=21%  Similarity=0.237  Sum_probs=174.5

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcC-cc-hhHHHHHHHHHhcCCCceeeEeeeecCccccCCceE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG-AS-KSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~-~~-~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      ..|++.+.||+|+||.||+|.+..+++.||+|+++..... .. +.+..+..+++.++||||+++++++     ......
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~-----~~~~~~   99 (318)
T 2dyl_A           25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTF-----ITNTDV   99 (318)
T ss_dssp             GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSSEE
T ss_pred             ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEE-----ecCCcE
Confidence            4678889999999999999999989999999999743321 11 2233444567788999999999995     445689


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHh-cCCCCceecCCCCCCeEeCCCCceEE
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH-DCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      ++||||+ ++.+..+....         ...+++..+..++.|++.||.|||+ .   ||+||||||+||+++.++.+||
T Consensus       100 ~lv~e~~-~~~~~~l~~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl  166 (318)
T 2dyl_A          100 FIAMELM-GTCAEKLKKRM---------QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKL  166 (318)
T ss_dssp             EEEECCC-SEEHHHHHHHH---------TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEE
T ss_pred             EEEEecc-CCcHHHHHHHh---------ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEE
Confidence            9999999 55665554321         2457889999999999999999998 6   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccccccCccccc----CCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhh
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG----LGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFA  632 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~----~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~  632 (741)
                      +|||.+.........   ....||+.|+|||.+.    ....++.++||||+||++|+|++|+.||.........+....
T Consensus       167 ~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  243 (318)
T 2dyl_A          167 CDFGISGRLVDDKAK---DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVL  243 (318)
T ss_dssp             CCCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred             EECCCchhccCCccc---cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHh
Confidence            999999765443221   2245899999996553    355688999999999999999999999863211111111111


Q ss_pred             hhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          633 RTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       633 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      ....+          .....                   ..++..+.+++.+||+.||++|||+.|+++.
T Consensus       244 ~~~~~----------~~~~~-------------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          244 QEEPP----------LLPGH-------------------MGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             HSCCC----------CCCSS-------------------SCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ccCCC----------CCCcc-------------------CCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            10000          00000                   0224568899999999999999999999863

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=5.6e-35  Score=309.39  Aligned_cols=289  Identities=18%  Similarity=0.246  Sum_probs=239.1

Q ss_pred             CCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCccEEECcCCcCcccCCchhhc
Q 037916           22 NLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICN  101 (741)
Q Consensus        22 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~  101 (741)
                      ++++++++++.++ .+|..+.  ++|++|+|++|+|++..+..|.++++          |++|+|++|++++..|..|..
T Consensus        32 ~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~----------L~~L~L~~n~l~~~~~~~~~~   98 (330)
T 1xku_A           32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKN----------LHTLILINNKISKISPGAFAP   98 (330)
T ss_dssp             ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTT----------CCEEECCSSCCCCBCTTTTTT
T ss_pred             CCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCC----------CCEEECCCCcCCeeCHHHhcC
Confidence            7888999999888 4565553  68889999999999777778888876          999999999999888888888


Q ss_pred             ccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCC--cCcccccCCcccc
Q 037916          102 FSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSG--NIPPSIGNLKKLL  179 (741)
Q Consensus       102 l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~  179 (741)
                      +. +|++|+|++|++.. +|..+.  ++|++|++++|+|+++.+..|.++++|++|+|++|+++.  ..+..|.++++|+
T Consensus        99 l~-~L~~L~Ls~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~  174 (330)
T 1xku_A           99 LV-KLERLYLSKNQLKE-LPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLS  174 (330)
T ss_dssp             CT-TCCEEECCSSCCSB-CCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCC
T ss_pred             CC-CCCEEECCCCcCCc-cChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcC
Confidence            88 89999999998864 444443  689999999999998888888999999999999999864  6777888899999


Q ss_pred             eeeccCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccc
Q 037916          180 QLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRN  259 (741)
Q Consensus       180 ~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  259 (741)
                      +|++++|.++. +|..+.  ++|++|++++|++++..|..|..+++|+. |+|++|.+++..+..|..+++|++|+|++|
T Consensus       175 ~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~-L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N  250 (330)
T 1xku_A          175 YIRIADTNITT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAK-LGLSFNSISAVDNGSLANTPHLRELHLNNN  250 (330)
T ss_dssp             EEECCSSCCCS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCE-EECCSSCCCEECTTTGGGSTTCCEEECCSS
T ss_pred             EEECCCCcccc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCE-EECCCCcCceeChhhccCCCCCCEEECCCC
Confidence            99999999884 454443  78999999999998888888999999987 999999998877778889999999999999


Q ss_pred             cccchhhhhccccccccEEEeCCCccCCCCChhcccC------ccCCeeeCCCCcCCC--ccchhhhccccCCcccccCc
Q 037916          260 MLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSL------RGLRVLDLSQNNISG--EIPKFLVELQLVQNLNLSYN  331 (741)
Q Consensus       260 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l------~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~l~~N  331 (741)
                      +++ ..|..+..+++|++|++++|+|+++.+..|...      +.|+.|++++|.+..  ..|..|..+..++.++|++|
T Consensus       251 ~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N  329 (330)
T 1xku_A          251 KLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY  329 (330)
T ss_dssp             CCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC---
T ss_pred             cCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEeccc
Confidence            998 456678888999999999999998877777543      788899999999864  67788999999999999998


Q ss_pred             c
Q 037916          332 D  332 (741)
Q Consensus       332 ~  332 (741)
                      +
T Consensus       330 ~  330 (330)
T 1xku_A          330 K  330 (330)
T ss_dssp             -
T ss_pred             C
Confidence            5

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=8.6e-37  Score=335.09  Aligned_cols=255  Identities=19%  Similarity=0.219  Sum_probs=179.1

Q ss_pred             HHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhc-CCCceeeEeeeecCccccCCceEEEEE
Q 037916          403 LFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKGDDFKALVY  481 (741)
Q Consensus       403 ~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~~~~lv~  481 (741)
                      .+.+.||+|+||+||.+.. .+|+.||||++...   ..+.+.+|+.+++++ +||||++++++     +.++...|+||
T Consensus        18 ~~~~~LG~G~~g~V~~~~~-~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~-----~~~~~~~~lv~   88 (434)
T 2rio_A           18 VSEKILGYGSSGTVVFQGS-FQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCS-----ETTDRFLYIAL   88 (434)
T ss_dssp             EEEEEEEECSTTCEEEEEE-SSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEE-----EECSSEEEEEE
T ss_pred             eccCeEeeCCCeEEEEEEE-ECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEE-----EecCCeEEEEE
Confidence            3457799999999987644 47899999998642   245678899999876 89999999998     45567899999


Q ss_pred             ecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCC----------
Q 037916          482 EFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHE----------  551 (741)
Q Consensus       482 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~----------  551 (741)
                      ||+. |+|.+++........   .....++..++.++.||+.||+|||+.   +|+||||||+||+++.+          
T Consensus        89 E~~~-gsL~~~l~~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~  161 (434)
T 2rio_A           89 ELCN-LNLQDLVESKNVSDE---NLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTG  161 (434)
T ss_dssp             CCCS-EEHHHHHHTC---------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTC
T ss_pred             ecCC-CCHHHHHhccCCCch---hhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccC
Confidence            9995 699999975421110   001123345678999999999999999   99999999999999654          


Q ss_pred             ---CceEEeecccccccCCCCccc--ccccccccccccCcccccC------CCCCCCccCchhHHHHHHHHHc-CCCCCC
Q 037916          552 ---MTAHVADFGLAKLLPPAHLQT--SSIGVKGTIGYIAPAEYGL------GSEVSINGDVYSYGILLLELMT-RKRPSD  619 (741)
Q Consensus       552 ---~~~kL~DFg~a~~~~~~~~~~--~~~~~~gt~~y~aPEe~~~------~~~~~~~~DIwSlG~il~ellt-g~~p~~  619 (741)
                         +.+||+|||++..........  ......||+.|+|||.+..      ...++.++||||+||++|||++ |..||.
T Consensus       162 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~  241 (434)
T 2rio_A          162 AENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG  241 (434)
T ss_dssp             CCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred             CCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCC
Confidence               489999999998776543211  1223569999999965533      2678999999999999999999 999986


Q ss_pred             ccccCCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHH
Q 037916          620 IMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIV  699 (741)
Q Consensus       620 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev  699 (741)
                      ......   ...........       .. ...                 .....+..+.+++.+||+.||++|||+.||
T Consensus       242 ~~~~~~---~~i~~~~~~~~-------~~-~~~-----------------~~~~~~~~~~~li~~~L~~dP~~Rps~~ei  293 (434)
T 2rio_A          242 DKYSRE---SNIIRGIFSLD-------EM-KCL-----------------HDRSLIAEATDLISQMIDHDPLKRPTAMKV  293 (434)
T ss_dssp             STTTHH---HHHHHTCCCCC-------CC-TTC-----------------CCHHHHHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CchhhH---HHHhcCCCCcc-------cc-ccc-----------------ccccchHHHHHHHHHHhhCChhhCCCHHHH
Confidence            322111   11111110000       00 000                 012455678899999999999999999999


Q ss_pred             HH
Q 037916          700 VH  701 (741)
Q Consensus       700 l~  701 (741)
                      ++
T Consensus       294 l~  295 (434)
T 2rio_A          294 LR  295 (434)
T ss_dssp             HT
T ss_pred             Hh
Confidence            85

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.9e-36  Score=331.34  Aligned_cols=249  Identities=22%  Similarity=0.250  Sum_probs=177.3

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhc-CCCceeeEeeeecCccccCCceEEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      .|.+.+.||+|+||.||.... .+++.||||++..   .......+|+.+++.+ +|||||++++++     .+....|+
T Consensus        25 ~y~~~~~LG~G~~G~V~~~~~-~~~~~vAvK~~~~---~~~~~~~~E~~~l~~l~~HpnIv~l~~~~-----~~~~~~~l   95 (432)
T 3p23_A           25 SFCPKDVLGHGAEGTIVYRGM-FDNRDVAVKRILP---ECFSFADREVQLLRESDEHPNVIRYFCTE-----KDRQFQYI   95 (432)
T ss_dssp             EEEEEEEEEECGGGCEEEEEE-SSSSEEEEEEECT---TTEEECHHHHHHHHHSCCCTTBCCEEEEE-----EETTEEEE
T ss_pred             EEecCCeeecCcCEEEEEEEE-eCCeEEEEEEECH---HHHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCEEEE
Confidence            367778999999999764333 3688999999863   2234567899999999 799999999984     45668999


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCC-----CCce
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDH-----EMTA  554 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~-----~~~~  554 (741)
                      ||||+. |+|.+++....         ....+..++.++.||+.||+|||+.   +|+||||||+||+++.     ...+
T Consensus        96 v~E~~~-g~L~~~l~~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~  162 (432)
T 3p23_A           96 AIELCA-ATLQEYVEQKD---------FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKA  162 (432)
T ss_dssp             EEECCS-EEHHHHHHSSS---------CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCE
T ss_pred             EEECCC-CCHHHHHHhcC---------CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeE
Confidence            999995 69999987542         1233345678999999999999999   9999999999999953     2368


Q ss_pred             EEeecccccccCCCCc-ccccccccccccccCcccccC--CCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhh
Q 037916          555 HVADFGLAKLLPPAHL-QTSSIGVKGTIGYIAPAEYGL--GSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHN  630 (741)
Q Consensus       555 kL~DFg~a~~~~~~~~-~~~~~~~~gt~~y~aPEe~~~--~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~  630 (741)
                      ||+|||+|+....... ........||+.|+|||.+..  ...++.++||||+||++|||++ |..||.......   ..
T Consensus       163 kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~---~~  239 (432)
T 3p23_A          163 MISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ---AN  239 (432)
T ss_dssp             EECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH---HH
T ss_pred             EEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH---HH
Confidence            8999999987654321 122233569999999965543  4567889999999999999999 899985221110   00


Q ss_pred             hhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          631 FARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       631 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ........   ...    .                    ........+.+++.+||+.||++|||+.||++
T Consensus       240 ~~~~~~~~---~~~----~--------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          240 ILLGACSL---DCL----H--------------------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             HHTTCCCC---TTS----C--------------------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHhccCCc---ccc----C--------------------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            00000000   000    0                    00123445779999999999999999999983

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=6.9e-35  Score=323.72  Aligned_cols=301  Identities=28%  Similarity=0.365  Sum_probs=258.9

Q ss_pred             CCCCCcccccCChhhhhCCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCc
Q 037916            2 DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHL   81 (741)
Q Consensus         2 dl~~n~~~~~ip~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L   81 (741)
                      ||++|.+.+ +|. +. .+++|++|+|++|++++..+  |.++++|++|+|++|++++..+  |..+++          |
T Consensus        74 ~Ls~n~l~~-~~~-~~-~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~----------L  136 (466)
T 1o6v_A           74 NFSNNQLTD-ITP-LK-NLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTN----------L  136 (466)
T ss_dssp             ECCSSCCCC-CGG-GT-TCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTT----------C
T ss_pred             ECCCCccCC-chh-hh-ccccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCCChH--HcCCCC----------C
Confidence            688999884 454 54 89999999999999986655  8999999999999999986533  777765          8


Q ss_pred             cEEECcCCcCcccCC-------------------chhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccc
Q 037916           82 KHLDINNNNFGGLLP-------------------GCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSG  142 (741)
Q Consensus        82 ~~L~Ls~N~l~~~~~-------------------~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~  142 (741)
                      ++|++++|++++...                   ..+..++ +|++|++++|.+...  ..+..+++|++|++++|.+++
T Consensus       137 ~~L~l~~n~l~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~-~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~  213 (466)
T 1o6v_A          137 NRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLT-TLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISD  213 (466)
T ss_dssp             SEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCT-TCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCC
T ss_pred             CEEECCCCccCCChhhccCCcccEeecCCcccCchhhccCC-CCCEEECcCCcCCCC--hhhccCCCCCEEEecCCcccc
Confidence            888888888775321                   1255666 899999999998664  458999999999999999997


Q ss_pred             cCCccccCCCcCcEEEcccCCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCccccc
Q 037916          143 TISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMD  222 (741)
Q Consensus       143 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  222 (741)
                      ..+  +..+++|++|++++|+++++  +.+..+++|++|++++|.+++..+  +..+++|++|++++|++++..+  +..
T Consensus       214 ~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~  285 (466)
T 1o6v_A          214 ITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAG  285 (466)
T ss_dssp             CGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTT
T ss_pred             ccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccC
Confidence            765  78899999999999999864  478999999999999999997665  8899999999999999995444  889


Q ss_pred             cccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCee
Q 037916          223 LTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVL  302 (741)
Q Consensus       223 l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  302 (741)
                      +++|+. |++++|++.+..+  ++.+++|+.|+|++|++++..+  +..+++|+.|++++|++++.  ..+..+++|+.|
T Consensus       286 l~~L~~-L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L  358 (466)
T 1o6v_A          286 LTALTN-LELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWL  358 (466)
T ss_dssp             CTTCSE-EECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEE
T ss_pred             CCccCe-EEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEE
Confidence            999998 9999999997554  8899999999999999998766  78999999999999999975  478999999999


Q ss_pred             eCCCCcCCCccchhhhccccCCcccccCcccccccCC
Q 037916          303 DLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPT  339 (741)
Q Consensus       303 ~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~  339 (741)
                      ++++|++++..|  +..+++|+.|++++|++++.+..
T Consensus       359 ~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~~p~~  393 (466)
T 1o6v_A          359 SAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVN  393 (466)
T ss_dssp             ECCSSCCCBCGG--GTTCTTCCEEECCCEEEECCCBC
T ss_pred             eCCCCccCccch--hhcCCCCCEEeccCCcccCCchh
Confidence            999999998877  88999999999999999986543

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=2.2e-34  Score=304.74  Aligned_cols=288  Identities=23%  Similarity=0.267  Sum_probs=224.4

Q ss_pred             CCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCccEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccc
Q 037916           45 SKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGI  124 (741)
Q Consensus        45 ~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~  124 (741)
                      .+|++++++++.++ .+|..+..            +|++|+|++|+|++..+..|..++ +|++|+|++|++.+..|..|
T Consensus        31 c~l~~l~~~~~~l~-~lp~~~~~------------~l~~L~L~~n~i~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~   96 (330)
T 1xku_A           31 CHLRVVQCSDLGLE-KVPKDLPP------------DTALLDLQNNKITEIKDGDFKNLK-NLHTLILINNKISKISPGAF   96 (330)
T ss_dssp             EETTEEECTTSCCC-SCCCSCCT------------TCCEEECCSSCCCCBCTTTTTTCT-TCCEEECCSSCCCCBCTTTT
T ss_pred             CCCeEEEecCCCcc-ccCccCCC------------CCeEEECCCCcCCEeChhhhccCC-CCCEEECCCCcCCeeCHHHh
Confidence            46888888888888 55655432            388888888888887777888887 88888888888888888888


Q ss_pred             cCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCcccccCCcccceeeccCccccc--ccCcccccCCCC
Q 037916          125 GKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQV--SIPSSLGQCQSL  202 (741)
Q Consensus       125 ~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~--~~~~~~~~l~~L  202 (741)
                      ..+++|++|+|++|+|+.+....+   ++|++|++++|+++++.+..|.++++|++|++++|.++.  ..+..|..+++|
T Consensus        97 ~~l~~L~~L~Ls~n~l~~l~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L  173 (330)
T 1xku_A           97 APLVKLERLYLSKNQLKELPEKMP---KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKL  173 (330)
T ss_dssp             TTCTTCCEEECCSSCCSBCCSSCC---TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTC
T ss_pred             cCCCCCCEEECCCCcCCccChhhc---ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCc
Confidence            888888888888888885544333   678888888888887777788888888888888888853  667788888888


Q ss_pred             CEEeccCccccccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCC
Q 037916          203 TTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGG  282 (741)
Q Consensus       203 ~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  282 (741)
                      ++|++++|+++ .+|..+.  ++|+. |++++|++++..|..|..+++|++|+|++|.++++.+..|..+++|++|+|++
T Consensus       174 ~~L~l~~n~l~-~l~~~~~--~~L~~-L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~  249 (330)
T 1xku_A          174 SYIRIADTNIT-TIPQGLP--PSLTE-LHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNN  249 (330)
T ss_dssp             CEEECCSSCCC-SCCSSCC--TTCSE-EECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCS
T ss_pred             CEEECCCCccc-cCCcccc--ccCCE-EECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCC
Confidence            88888888887 5666554  67776 88888888877788888888888888888888888878888888888888888


Q ss_pred             CccCCCCChhcccCccCCeeeCCCCcCCCccchhhhcc------ccCCcccccCcccccc--cCCc-cccCCcccccccC
Q 037916          283 NLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVEL------QLVQNLNLSYNDLEGV--IPTE-GVFKNASAISVFG  353 (741)
Q Consensus       283 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l------~~L~~L~l~~N~l~~~--~~~~-~~~~~~~~~~~~~  353 (741)
                      |+++ .+|..+..+++|++|+|++|+|++..+..|...      ..++.|++++|++...  .|.. .....+..+++.+
T Consensus       250 N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~  328 (330)
T 1xku_A          250 NKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGN  328 (330)
T ss_dssp             SCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC--
T ss_pred             CcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecc
Confidence            8888 567778888888888888888887777766543      6778888888888642  2221 2234566676666


Q ss_pred             C
Q 037916          354 N  354 (741)
Q Consensus       354 n  354 (741)
                      |
T Consensus       329 N  329 (330)
T 1xku_A          329 Y  329 (330)
T ss_dssp             -
T ss_pred             c
Confidence            5

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=4.5e-36  Score=327.16  Aligned_cols=249  Identities=16%  Similarity=0.105  Sum_probs=177.4

Q ss_pred             HHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc---CcchhHHHHHHHHHhcCC-CceeeE----------------
Q 037916          403 LFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH---GASKSSIAECSALRNIRH-KNLVKI----------------  462 (741)
Q Consensus       403 ~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-pnIv~~----------------  462 (741)
                      ...+.||+|+||.||+|++..+++.||||+++....   ...+.+.+|+.+++.+.| +++..+                
T Consensus        81 ~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  160 (413)
T 3dzo_A           81 VRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP  160 (413)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECC
T ss_pred             EEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccC
Confidence            445789999999999999999999999999873222   235678899999999977 321111                


Q ss_pred             -----eeeecCccccCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCce
Q 037916          463 -----LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTA  537 (741)
Q Consensus       463 -----~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~iv  537 (741)
                           ..++...........+++|+++ +++|.++++.....   ......+++..++.++.|+++||+|||+.   +|+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~---~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ii  233 (413)
T 3dzo_A          161 QKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSH---SSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV  233 (413)
T ss_dssp             C---------------CCSEEEEEECC-SEEHHHHHHHHHHH---TTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             CCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcc---cccCCCCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence                 1110000000122467788876 67999888421000   01235678889999999999999999999   999


Q ss_pred             ecCCCCCCeEeCCCCceEEeecccccccCCCCcccccccccccccccCccccc---------CCCCCCCccCchhHHHHH
Q 037916          538 HCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG---------LGSEVSINGDVYSYGILL  608 (741)
Q Consensus       538 HrDlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~---------~~~~~~~~~DIwSlG~il  608 (741)
                      ||||||+|||++.++.+||+|||+++.....     .....| +.|+|||.+.         .+..++.++|||||||++
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil  307 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI  307 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence            9999999999999999999999998865433     223457 9999996552         556688999999999999


Q ss_pred             HHHHcCCCCCCccccCCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhccccc
Q 037916          609 LELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSME  688 (741)
Q Consensus       609 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  688 (741)
                      |||++|+.||........     ..        .++.     ...                   .+++.+.+++.+||+.
T Consensus       308 ~elltg~~Pf~~~~~~~~-----~~--------~~~~-----~~~-------------------~~~~~~~~li~~~l~~  350 (413)
T 3dzo_A          308 YWIWCADLPNTDDAALGG-----SE--------WIFR-----SCK-------------------NIPQPVRALLEGFLRY  350 (413)
T ss_dssp             HHHHHSSCCCCTTGGGSC-----SG--------GGGS-----SCC-------------------CCCHHHHHHHHHHTCS
T ss_pred             HHHHHCCCCCCCcchhhh-----HH--------HHHh-----hcc-------------------cCCHHHHHHHHHHccC
Confidence            999999999863321110     00        0000     000                   1235688999999999


Q ss_pred             CCCCCCCHHHHHH
Q 037916          689 SPQDRMNMTIVVH  701 (741)
Q Consensus       689 dP~~RPs~~evl~  701 (741)
                      ||++|||+.|+++
T Consensus       351 dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          351 PKEDRLLPLQAME  363 (413)
T ss_dssp             SGGGSCCHHHHTT
T ss_pred             ChhhCcCHHHHHh
Confidence            9999999877753

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.9e-36  Score=349.80  Aligned_cols=247  Identities=21%  Similarity=0.280  Sum_probs=192.1

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcC-CCeEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCce
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDE-GKTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      ..+|++.+.||+|+||.||+|.+.. +++.||||++.... ......+.+|+.++++++||||+++++++......+...
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            4679999999999999999999975 68999999986422 223456789999999999999999999975433222233


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .|+||||+++++|.+++.            ..+++.+++.++.||+.||.|||+.   ||+||||||+||+++.+ .+||
T Consensus       159 ~~lv~E~~~g~~L~~~~~------------~~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl  222 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKG------------QKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKL  222 (681)
T ss_dssp             EEEEEECCCCEECC----------------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEE
T ss_pred             eEEEEEeCCCCcHHHHHh------------CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEE
Confidence            799999999999988764            2588999999999999999999999   99999999999999875 8999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcC
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVL  636 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  636 (741)
                      +|||+++.....      ....||+.|+|||.+. +. ++.++|||||||++|+|++|..||........          
T Consensus       223 ~DFG~a~~~~~~------~~~~gt~~y~aPE~~~-~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----------  284 (681)
T 2pzi_A          223 IDLGAVSRINSF------GYLYGTPGFQAPEIVR-TG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------  284 (681)
T ss_dssp             CCCTTCEETTCC------SCCCCCTTTSCTTHHH-HC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC----------
T ss_pred             EecccchhcccC------CccCCCccccCHHHHc-CC-CCCceehhhhHHHHHHHHhCCCCCcccccccc----------
Confidence            999999876543      2246999999996553 33 48899999999999999999888753211100          


Q ss_pred             CcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCC-CHHHHHHHHHHHHH
Q 037916          637 PDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRM-NMTIVVHELQSIKS  708 (741)
Q Consensus       637 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~i~~  708 (741)
                      +..            .                 ......+.+.+++.+||+.||++|| +++++.+.+..+..
T Consensus       285 ~~~------------~-----------------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  328 (681)
T 2pzi_A          285 PED------------D-----------------PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR  328 (681)
T ss_dssp             CTT------------C-----------------HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred             ccc------------c-----------------cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence            000            0                 0112345678999999999999999 56777777777654

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.4e-35  Score=309.37  Aligned_cols=236  Identities=19%  Similarity=0.253  Sum_probs=178.3

Q ss_pred             HHHHHh-hhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHH-HhcCCCceeeEeeeecCccccCCceE
Q 037916          400 VSFLFL-CWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSAL-RNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       400 ~~y~~~-~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      ..|.+. +.||+|+||.||+|.+..+++.||+|+++.     .....+|+.++ +..+||||+++++++... ..+....
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~-~~~~~~~   90 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKCL   90 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhh-cCCCceE
Confidence            456666 679999999999999998999999999863     35677888888 556999999999986431 1235678


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCC---CCce
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDH---EMTA  554 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~---~~~~  554 (741)
                      ++||||+++|+|.+++....        ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.   ++.+
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~  159 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDRG--------DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAIL  159 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHCT--------TCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCE
T ss_pred             EEEEeecCCCcHHHHHHhcc--------CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcE
Confidence            99999999999999987431        23588999999999999999999999   9999999999999998   7899


Q ss_pred             EEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhh
Q 037916          555 HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       555 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  634 (741)
                      ||+|||++....                         +..++.++||||+||++|||++|+.||......... ......
T Consensus       160 kl~Dfg~a~~~~-------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-~~~~~~  213 (299)
T 3m2w_A          160 KLTDFGFAKETT-------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-PGMKTR  213 (299)
T ss_dssp             EECCCTTCEECT-------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------CCSCCS
T ss_pred             EEeccccccccc-------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-HHHHHH
Confidence            999999885321                         234677899999999999999999998633211100 000000


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                       .........                       ......+++.+.+++.+||+.||++|||+.|+++-
T Consensus       214 -~~~~~~~~~-----------------------~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          214 -IRMGQYEFP-----------------------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             -SCTTCCSSC-----------------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -HhhccccCC-----------------------chhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence             000000000                       00011335678899999999999999999999873

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=1.4e-33  Score=310.78  Aligned_cols=291  Identities=21%  Similarity=0.191  Sum_probs=167.9

Q ss_pred             CCCCCcccccCChhhhhCCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCc
Q 037916            2 DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHL   81 (741)
Q Consensus         2 dl~~n~~~~~ip~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L   81 (741)
                      ||++|.+.+ +| .+. .+++|++|+|++|+|+++ |  |+.+++|++|+|++|+|++. +  |+.+++          |
T Consensus        48 ~Ls~n~l~~-~~-~l~-~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~----------L  108 (457)
T 3bz5_A           48 DCHNSSITD-MT-GIE-KLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTK----------L  108 (457)
T ss_dssp             ECCSSCCCC-CT-TGG-GCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTT----------C
T ss_pred             EccCCCccc-Ch-hhc-ccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCc----------C
Confidence            456666663 44 344 566666666666666653 2  56666666666666666643 2  555544          6


Q ss_pred             cEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEccc
Q 037916           82 KHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINT  161 (741)
Q Consensus        82 ~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~  161 (741)
                      ++|+|++|+++++ +  +..++ +|++|++++|++.+.   .+..+++|++|++++|+..+..  .+..+++|++|++++
T Consensus       109 ~~L~L~~N~l~~l-~--~~~l~-~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~  179 (457)
T 3bz5_A          109 TYLNCDTNKLTKL-D--VSQNP-LLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSF  179 (457)
T ss_dssp             CEEECCSSCCSCC-C--CTTCT-TCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCS
T ss_pred             CEEECCCCcCCee-c--CCCCC-cCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCcCCEEECCC
Confidence            6666666666653 2  45555 666666666666553   2556666666666666332222  355666666666666


Q ss_pred             CCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCCC
Q 037916          162 NKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSL  241 (741)
Q Consensus       162 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~  241 (741)
                      |+++++ |  +..+++|+.|++++|.+++.   .+..+++|++|++++|++++ +|  +..+++|+. |++++|++++..
T Consensus       180 n~l~~l-~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~-L~l~~N~l~~~~  249 (457)
T 3bz5_A          180 NKITEL-D--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTY-FDCSVNPLTELD  249 (457)
T ss_dssp             SCCCCC-C--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSE-EECCSSCCSCCC
T ss_pred             Ccccee-c--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCE-EEeeCCcCCCcC
Confidence            666643 2  56666666666666666643   25566666666666666664 44  556666665 666666666554


Q ss_pred             ChhhcCCC-------CCcEEEeccccccchhhhhccccccccEEEeCCCccCCCCCh--------hcccCccCCeeeCCC
Q 037916          242 PTEVGKLI-------NLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPL--------SLSSLRGLRVLDLSQ  306 (741)
Q Consensus       242 p~~~~~l~-------~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~--------~~~~l~~L~~L~Ls~  306 (741)
                      +..+.++.       +|+.|++++|.+.+..+  ++.+++|+.|++++|...+.+|.        .+.++++|+.|+|++
T Consensus       250 ~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~  327 (457)
T 3bz5_A          250 VSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNN  327 (457)
T ss_dssp             CTTCTTCCEEECTTCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTT
T ss_pred             HHHCCCCCEEeccCCCCCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccCCCcceEechhhcccCCEEECCC
Confidence            43333332       33334444443333222  34556666666666655443332        244556666777777


Q ss_pred             CcCCCccchhhhccccCCcccccCccccc
Q 037916          307 NNISGEIPKFLVELQLVQNLNLSYNDLEG  335 (741)
Q Consensus       307 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~  335 (741)
                      |+|++. +  +..+++|+.|++++|++++
T Consensus       328 N~l~~l-~--l~~l~~L~~L~l~~N~l~~  353 (457)
T 3bz5_A          328 TELTEL-D--VSHNTKLKSLSCVNAHIQD  353 (457)
T ss_dssp             CCCSCC-C--CTTCTTCSEEECCSSCCCB
T ss_pred             Cccccc-c--cccCCcCcEEECCCCCCCC
Confidence            777653 2  6666677777777777665

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=2.3e-33  Score=309.22  Aligned_cols=306  Identities=21%  Similarity=0.170  Sum_probs=258.0

Q ss_pred             cccCChhhhhCCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCccEEECcC
Q 037916            9 QGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINN   88 (741)
Q Consensus         9 ~~~ip~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~Ls~   88 (741)
                      .+..+..+. .+++|++|+|++|.|+++ | .|..+++|++|+|++|+|++. |  |..+++          |++|+|++
T Consensus        31 ~~~~~~~~~-~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~----------L~~L~Ls~   94 (457)
T 3bz5_A           31 QATDTISEE-QLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTN----------LTYLACDS   94 (457)
T ss_dssp             CTTSEEEHH-HHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTT----------CSEEECCS
T ss_pred             CcccccChh-HcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCC----------CCEEECcC
Confidence            334455666 789999999999999975 5 799999999999999999965 4  777765          99999999


Q ss_pred             CcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcC
Q 037916           89 NNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNI  168 (741)
Q Consensus        89 N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~  168 (741)
                      |+|++. +  +..++ +|++|++++|++.+. +  +..+++|++|+|++|+|+++   .+..+++|++|++++|+..+.+
T Consensus        95 N~l~~~-~--~~~l~-~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~  164 (457)
T 3bz5_A           95 NKLTNL-D--VTPLT-KLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL  164 (457)
T ss_dssp             SCCSCC-C--CTTCT-TCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC
T ss_pred             CCCcee-e--cCCCC-cCCEEECCCCcCCee-c--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc
Confidence            999976 3  77887 999999999999774 3  89999999999999999985   3889999999999999655454


Q ss_pred             cccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCCCChhhcCC
Q 037916          169 PPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKL  248 (741)
Q Consensus       169 ~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l  248 (741)
                        .+..+++|++|++++|++++. |  +..+++|+.|++++|++++.   .+..+++|+. |++++|++++ +|  ++.+
T Consensus       165 --~~~~l~~L~~L~ls~n~l~~l-~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~-L~Ls~N~l~~-ip--~~~l  232 (457)
T 3bz5_A          165 --DVTPQTQLTTLDCSFNKITEL-D--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTF-LDCSSNKLTE-ID--VTPL  232 (457)
T ss_dssp             --CCTTCTTCCEEECCSSCCCCC-C--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSE-EECCSSCCSC-CC--CTTC
T ss_pred             --ccccCCcCCEEECCCCcccee-c--cccCCCCCEEECcCCcCCee---ccccCCCCCE-EECcCCcccc-cC--cccc
Confidence              588999999999999999974 4  88899999999999999964   4889999998 9999999997 55  8899


Q ss_pred             CCCcEEEeccccccchhhhhccccc-------cccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccch------
Q 037916          249 INLEILFISRNMLECEILSTLGSCI-------KLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPK------  315 (741)
Q Consensus       249 ~~L~~L~Ls~N~l~~~~~~~~~~l~-------~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~------  315 (741)
                      ++|+.|++++|+++++.+..+..+.       +|+.|++++|.+.+.+|  +..+++|+.|+|++|.+.+.+|.      
T Consensus       233 ~~L~~L~l~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~  310 (457)
T 3bz5_A          233 TQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQAAGIT  310 (457)
T ss_dssp             TTCSEEECCSSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTTCCCS
T ss_pred             CCCCEEEeeCCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccCCCcce
Confidence            9999999999999998766655554       45666666666665555  56789999999999987766654      


Q ss_pred             --hhhccccCCcccccCcccccccCCccccCCcccccccCCCC
Q 037916          316 --FLVELQLVQNLNLSYNDLEGVIPTEGVFKNASAISVFGNSK  356 (741)
Q Consensus       316 --~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~  356 (741)
                        .+..+++|+.|++++|++++. + ...++.++.+++.+|..
T Consensus       311 ~L~l~~~~~L~~L~L~~N~l~~l-~-l~~l~~L~~L~l~~N~l  351 (457)
T 3bz5_A          311 ELDLSQNPKLVYLYLNNTELTEL-D-VSHNTKLKSLSCVNAHI  351 (457)
T ss_dssp             CCCCTTCTTCCEEECTTCCCSCC-C-CTTCTTCSEEECCSSCC
T ss_pred             EechhhcccCCEEECCCCccccc-c-cccCCcCcEEECCCCCC
Confidence              256678899999999999996 3 56688899999999854

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=7.1e-35  Score=309.37  Aligned_cols=197  Identities=19%  Similarity=0.165  Sum_probs=157.7

Q ss_pred             HHHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc--------CcchhHHHHHHHHHhcC---------CCcee
Q 037916          398 LFVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH--------GASKSSIAECSALRNIR---------HKNLV  460 (741)
Q Consensus       398 ~~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---------hpnIv  460 (741)
                      ....|++.+.||+|+||.||+|++  +++.||+|+++....        ...+.+.+|+.+++.++         ||||+
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv   95 (336)
T 2vuw_A           18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI   95 (336)
T ss_dssp             CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred             ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence            457899999999999999999998  579999999975422        12367889999998885         77777


Q ss_pred             eEeeeecCc-------------------------cccCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHH
Q 037916          461 KILTVCSGV-------------------------DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRI  515 (741)
Q Consensus       461 ~~~~~~~~~-------------------------~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~  515 (741)
                      ++.+++...                         ++.+....|+||||+++|++.+.+..           ..+++..++
T Consensus        96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----------~~~~~~~~~  164 (336)
T 2vuw_A           96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----------KLSSLATAK  164 (336)
T ss_dssp             CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----------TCCCHHHHH
T ss_pred             hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----------cCCCHHHHH
Confidence            666653210                         01136689999999999976666532           347899999


Q ss_pred             HHHHHHHHHHHHHH-hcCCCCceecCCCCCCeEeCCCC--------------------ceEEeecccccccCCCCccccc
Q 037916          516 NIAIDVACALKYLH-HDCQPTTAHCDLKPSNVLLDHEM--------------------TAHVADFGLAKLLPPAHLQTSS  574 (741)
Q Consensus       516 ~i~~qi~~aL~~LH-~~~~~~ivHrDlkp~NIll~~~~--------------------~~kL~DFg~a~~~~~~~~~~~~  574 (741)
                      .++.||+.||+||| +.   +|+||||||+|||++.++                    .+||+|||+|+.....      
T Consensus       165 ~i~~qi~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------  235 (336)
T 2vuw_A          165 SILHQLTASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------  235 (336)
T ss_dssp             HHHHHHHHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------
T ss_pred             HHHHHHHHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------
Confidence            99999999999999 89   999999999999999887                    8999999999865432      


Q ss_pred             ccccccccccCcccccCCCCCCCccCchhHHHH-HHHHHcCCCCCC
Q 037916          575 IGVKGTIGYIAPAEYGLGSEVSINGDVYSYGIL-LLELMTRKRPSD  619 (741)
Q Consensus       575 ~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~i-l~elltg~~p~~  619 (741)
                       ...||+.|+|||.+ .+.. +.++||||+|++ .+++++|..||.
T Consensus       236 -~~~gt~~y~aPE~~-~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~  278 (336)
T 2vuw_A          236 -IVVFCDVSMDEDLF-TGDG-DYQFDIYRLMKKENNNRWGEYHPYS  278 (336)
T ss_dssp             -EEECCCCTTCSGGG-CCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred             -cEEEeecccChhhh-cCCC-ccceehhhhhCCCCcccccccCCCc
Confidence             24699999999654 4444 889999998777 777888999974

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=100.00  E-value=4.9e-33  Score=291.14  Aligned_cols=281  Identities=22%  Similarity=0.205  Sum_probs=206.1

Q ss_pred             cCCCccEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccC--CccccCCCcC
Q 037916           77 CNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTI--SPAIGELQNL  154 (741)
Q Consensus        77 ~~~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~--~~~~~~l~~L  154 (741)
                      |...-+.++++++.++. +|..+.   .+|++|+|++|++..+.+..|.++++|++|+|++|+|+.+.  +..+.++++|
T Consensus         5 C~C~~~~l~c~~~~l~~-ip~~~~---~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L   80 (306)
T 2z66_A            5 CSCSGTEIRCNSKGLTS-VPTGIP---SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSL   80 (306)
T ss_dssp             CEEETTEEECCSSCCSS-CCSCCC---TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCC
T ss_pred             CeeCCCEEEcCCCCccc-CCCCCC---CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCccccccccccc
Confidence            33345677888877774 343332   27788888888877666666778888888888888877432  5666777888


Q ss_pred             cEEEcccCCCCCcCcccccCCcccceeeccCcccccccC-cccccCCCCCEEeccCccccccCCccccccccceeEEEcC
Q 037916          155 VTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIP-SSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLS  233 (741)
Q Consensus       155 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls  233 (741)
                      ++|+|++|.++ .+|..|.++++|++|++++|.+++..+ ..|..+++|++|++++|++++..|..|.++++|+. |+++
T Consensus        81 ~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~-L~l~  158 (306)
T 2z66_A           81 KYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEV-LKMA  158 (306)
T ss_dssp             CEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCE-EECT
T ss_pred             CEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCE-EECC
Confidence            88888888887 456667788888888888888876554 56777888888888888888777777888888876 8888


Q ss_pred             CCccCC-CCChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCc
Q 037916          234 RNQLVG-SLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGE  312 (741)
Q Consensus       234 ~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  312 (741)
                      +|.+.+ ..|..|..+++|++|+|++|+++++.+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|++++.
T Consensus       159 ~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  238 (306)
T 2z66_A          159 GNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTS  238 (306)
T ss_dssp             TCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBC
T ss_pred             CCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCccc
Confidence            888775 4677788888888888888888877778888888888888888888877777788888888888888888877


Q ss_pred             cchhhhccc-cCCcccccCcccccccCCccc---cCCcccccccCCCCccccCCC
Q 037916          313 IPKFLVELQ-LVQNLNLSYNDLEGVIPTEGV---FKNASAISVFGNSKLCGGIPE  363 (741)
Q Consensus       313 ~~~~~~~l~-~L~~L~l~~N~l~~~~~~~~~---~~~~~~~~~~~n~~~c~~~~~  363 (741)
                      .|..+..++ +|+.|+|++|++++..+....   ......+.+..+...|..++.
T Consensus       239 ~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~~  293 (306)
T 2z66_A          239 KKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSD  293 (306)
T ss_dssp             SSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESGG
T ss_pred             CHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCchh
Confidence            777777774 788888888888776543211   223344455566677766544

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.8e-33  Score=298.13  Aligned_cols=278  Identities=15%  Similarity=0.137  Sum_probs=162.5

Q ss_pred             CCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCccEEECcCCcCcccCCchhh
Q 037916           21 PNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCIC  100 (741)
Q Consensus        21 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~  100 (741)
                      +.....++++|+++ .+|..+.  ++|++|+|++|+|++..+..|.++++          |++|+|++|+|++..+..|.
T Consensus        31 ~~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~----------L~~L~L~~n~l~~~~~~~~~   97 (353)
T 2z80_A           31 DRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVN----------LQALVLTSNGINTIEEDSFS   97 (353)
T ss_dssp             CTTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTT----------CCEEECTTSCCCEECTTTTT
T ss_pred             CCCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCC----------CCEEECCCCccCccCHhhcC
Confidence            33344555555555 2333332  24555555555555444444554443          55555555555554455555


Q ss_pred             cccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCC-ccccCCCcCcEEEcccC-CCCCcCcccccCCccc
Q 037916          101 NFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTIS-PAIGELQNLVTLAINTN-KLSGNIPPSIGNLKKL  178 (741)
Q Consensus       101 ~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L  178 (741)
                      .++ +|++|+|++|++.+..+..|.++++|++|+|++|+|+++.. ..|.++++|++|++++| .++.+.+..|.++++|
T Consensus        98 ~l~-~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L  176 (353)
T 2z80_A           98 SLG-SLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFL  176 (353)
T ss_dssp             TCT-TCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEE
T ss_pred             CCC-CCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCC
Confidence            554 55555555555544444445555555555555555554433 34555555555555555 3444444555555555


Q ss_pred             ceeeccCcccccccCcccccCCCCCEEeccCccccccCCcc-ccccccceeEEEcCCCccCCCCChhh---cCCCCCcEE
Q 037916          179 LQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQ-LMDLTSLSVGLDLSRNQLVGSLPTEV---GKLINLEIL  254 (741)
Q Consensus       179 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~~L~Ls~N~l~~~~p~~~---~~l~~L~~L  254 (741)
                      ++|++++|.+++..|..|..+++|++|++++|+++ .+|.. +..+++|+. |++++|.+++..+..+   .....++.+
T Consensus       177 ~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~-~~~~~~~~~~~~L~~-L~L~~n~l~~~~~~~l~~~~~~~~l~~l  254 (353)
T 2z80_A          177 EELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVEC-LELRDTDLDTFHFSELSTGETNSLIKKF  254 (353)
T ss_dssp             EEEEEEETTCCEECTTTTTTCSEEEEEEEECSCST-THHHHHHHHTTTEEE-EEEESCBCTTCCCC------CCCCCCEE
T ss_pred             CEEECCCCCcCccCHHHHhccccCCeecCCCCccc-cchhhhhhhcccccE-EECCCCccccccccccccccccchhhcc
Confidence            55555555555555555555555555555555554 22222 233555554 6666666554443332   235667888


Q ss_pred             Eeccccccc----hhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccc
Q 037916          255 FISRNMLEC----EILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIP  314 (741)
Q Consensus       255 ~Ls~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  314 (741)
                      +|++|.+++    ..+..+..+++|+.|+|++|+++.+.+..|..+++|++|+|++|.+++..|
T Consensus       255 ~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~  318 (353)
T 2z80_A          255 TFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  318 (353)
T ss_dssp             EEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             ccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence            888887775    356778899999999999999996665667999999999999999997654

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=1.9e-32  Score=301.57  Aligned_cols=255  Identities=22%  Similarity=0.237  Sum_probs=121.4

Q ss_pred             CCCCCcccccCChhhhhCCCCCcEEEcccCcccccCCccCCCCCCC-------------cEEEeecCcCcccCCchhhhh
Q 037916            2 DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKL-------------EVFQVTSNNLTGEVPSEFGKA   68 (741)
Q Consensus         2 dl~~n~~~~~ip~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L-------------~~L~L~~N~l~~~~~~~~~~l   68 (741)
                      +++.|++ +.||.+++ +|++|++|+|++|++++.+|..++++++|             ++|++++|++++ +|....++
T Consensus        17 ~l~~n~l-~~iP~~i~-~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp~~~~~L   93 (454)
T 1jl5_A           17 LRHSSNL-TEMPVEAE-NVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LPELPPHL   93 (454)
T ss_dssp             -------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CCSCCTTC
T ss_pred             hcccCch-hhCChhHh-cccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CCCCcCCC
Confidence            6788999 79999987 89999999999999999999999988764             888888888874 33322111


Q ss_pred             hhhhhcc-------ccCCCccEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEccccccc
Q 037916           69 TKAYCVQ-------NCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLS  141 (741)
Q Consensus        69 ~~~~~~~-------~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~  141 (741)
                      ..+....       ....+|++|++++|+++++..     +..+|++|++++|++.+ +| .|.++++|++|++++|+++
T Consensus        94 ~~L~l~~n~l~~lp~~~~~L~~L~l~~n~l~~l~~-----~~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~  166 (454)
T 1jl5_A           94 ESLVASCNSLTELPELPQSLKSLLVDNNNLKALSD-----LPPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLK  166 (454)
T ss_dssp             SEEECCSSCCSSCCCCCTTCCEEECCSSCCSCCCS-----CCTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCS
T ss_pred             CEEEccCCcCCccccccCCCcEEECCCCccCcccC-----CCCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCc
Confidence            1100000       000234444444444443211     11245555555555543 33 3555555555555555555


Q ss_pred             ccCCccccCCCcCcEEEcccCCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCcccc
Q 037916          142 GTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLM  221 (741)
Q Consensus       142 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~  221 (741)
                      ++ |..   ..+|++|++++|++++ +| .|+++++|++|++++|.+++ +|...   ++|++|++++|+++ .+|. +.
T Consensus       167 ~l-p~~---~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp~-~~  234 (454)
T 1jl5_A          167 KL-PDL---PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP---LSLESIVAGNNILE-ELPE-LQ  234 (454)
T ss_dssp             CC-CCC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC---TTCCEEECCSSCCS-SCCC-CT
T ss_pred             cc-CCC---cccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc---CcccEEECcCCcCC-cccc-cC
Confidence            42 221   1355555555555554 23 35555555555555555553 22211   34555555555555 4442 55


Q ss_pred             ccccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCccCC
Q 037916          222 DLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQG  287 (741)
Q Consensus       222 ~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  287 (741)
                      .+++|+. |++++|++++ +|..   +++|+.|++++|+++++. .   .+++|+.|++++|++++
T Consensus       235 ~l~~L~~-L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~l~-~---~~~~L~~L~ls~N~l~~  291 (454)
T 1jl5_A          235 NLPFLTT-IYADNNLLKT-LPDL---PPSLEALNVRDNYLTDLP-E---LPQSLTFLDVSENIFSG  291 (454)
T ss_dssp             TCTTCCE-EECCSSCCSS-CCSC---CTTCCEEECCSSCCSCCC-C---CCTTCCEEECCSSCCSE
T ss_pred             CCCCCCE-EECCCCcCCc-cccc---ccccCEEECCCCcccccC-c---ccCcCCEEECcCCccCc
Confidence            5555554 5555555553 2221   245555555555554421 1   12445555555555543

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.98  E-value=6e-32  Score=297.75  Aligned_cols=258  Identities=21%  Similarity=0.225  Sum_probs=227.2

Q ss_pred             ccCCCccEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCc
Q 037916           76 NCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLV  155 (741)
Q Consensus        76 ~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~  155 (741)
                      .|....+.++.+++.++ .+|..+.   .+++.|+|++|+|..+.+..|.++++|++|+|++|+|+++.+..|.++++|+
T Consensus        40 ~C~~~~~~v~c~~~~l~-~iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~  115 (440)
T 3zyj_A           40 SCSNQFSKVICVRKNLR-EVPDGIS---TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLN  115 (440)
T ss_dssp             EECTTSCEEECCSCCCS-SCCSCCC---TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCC
T ss_pred             EeCCCCCEEEeCCCCcC-cCCCCCC---CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCC
Confidence            34456788999999998 4554443   3889999999999888889999999999999999999988889999999999


Q ss_pred             EEEcccCCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccC-ccccccCCccccccccceeEEEcCC
Q 037916          156 TLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSY-NNLSGTIPPQLMDLTSLSVGLDLSR  234 (741)
Q Consensus       156 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~~L~Ls~  234 (741)
                      +|+|++|+|+.+.+..|.++++|++|+|++|.|+...+..|..+++|++|+|++ |.+....+..|.++++|+. |+|++
T Consensus       116 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~-L~L~~  194 (440)
T 3zyj_A          116 TLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRY-LNLAM  194 (440)
T ss_dssp             EEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCE-EECTT
T ss_pred             EEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCe-ecCCC
Confidence            999999999988788899999999999999999988888999999999999998 4555455557889999997 99999


Q ss_pred             CccCCCCChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccc
Q 037916          235 NQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIP  314 (741)
Q Consensus       235 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  314 (741)
                      |+|+ .+| .+..+++|+.|+|++|+|+++.+..|.++++|+.|+|++|++++..+..|.++++|+.|+|++|+|++..+
T Consensus       195 n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  272 (440)
T 3zyj_A          195 CNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPH  272 (440)
T ss_dssp             SCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCT
T ss_pred             CcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccCh
Confidence            9998 445 48889999999999999999999999999999999999999999999999999999999999999998888


Q ss_pred             hhhhccccCCcccccCcccccccCCc
Q 037916          315 KFLVELQLVQNLNLSYNDLEGVIPTE  340 (741)
Q Consensus       315 ~~~~~l~~L~~L~l~~N~l~~~~~~~  340 (741)
                      ..|..+++|+.|+|++|++.+.....
T Consensus       273 ~~~~~l~~L~~L~L~~Np~~CdC~l~  298 (440)
T 3zyj_A          273 DLFTPLHHLERIHLHHNPWNCNCDIL  298 (440)
T ss_dssp             TTTSSCTTCCEEECCSSCEECSSTTH
T ss_pred             hHhccccCCCEEEcCCCCccCCCCch
Confidence            88999999999999999998766543

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.98  E-value=8.7e-33  Score=295.36  Aligned_cols=283  Identities=19%  Similarity=0.185  Sum_probs=245.8

Q ss_pred             CCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCccEEECcCCcCcccCCchhhcccccccEEEccCCcccccCC
Q 037916           42 FNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIP  121 (741)
Q Consensus        42 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~  121 (741)
                      ..++...+.++++|.++ .+|..+..            +|++|+|++|+|+++.+..|..++ +|++|+|++|++.+..+
T Consensus        28 ~~C~~~~~c~~~~~~l~-~iP~~~~~------------~L~~L~l~~n~i~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~   93 (353)
T 2z80_A           28 LSCDRNGICKGSSGSLN-SIPSGLTE------------AVKSLDLSNNRITYISNSDLQRCV-NLQALVLTSNGINTIEE   93 (353)
T ss_dssp             CEECTTSEEECCSTTCS-SCCTTCCT------------TCCEEECTTSCCCEECTTTTTTCT-TCCEEECTTSCCCEECT
T ss_pred             CCCCCCeEeeCCCCCcc-cccccccc------------cCcEEECCCCcCcccCHHHhccCC-CCCEEECCCCccCccCH
Confidence            34566777999999999 56665543            399999999999988888899998 99999999999999889


Q ss_pred             ccccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCc-ccccCCcccceeeccCc-ccccccCcccccC
Q 037916          122 AGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIP-PSIGNLKKLLQLYLIEN-FLQVSIPSSLGQC  199 (741)
Q Consensus       122 ~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N-~i~~~~~~~~~~l  199 (741)
                      ..|.++++|++|+|++|+|+++.+..|.++++|++|+|++|+++++.+ ..|.++++|++|++++| .+....+..|.++
T Consensus        94 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l  173 (353)
T 2z80_A           94 DSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGL  173 (353)
T ss_dssp             TTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTC
T ss_pred             hhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCC
Confidence            999999999999999999998877779999999999999999996655 58999999999999999 5887788899999


Q ss_pred             CCCCEEeccCccccccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccchhhhhcc---cccccc
Q 037916          200 QSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLG---SCIKLE  276 (741)
Q Consensus       200 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~---~l~~L~  276 (741)
                      ++|++|++++|++++..|..|..+++|+. |++++|.+....+..+..+++|+.|+|++|.+++..+..+.   ....++
T Consensus       174 ~~L~~L~l~~n~l~~~~~~~l~~l~~L~~-L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~  252 (353)
T 2z80_A          174 TFLEELEIDASDLQSYEPKSLKSIQNVSH-LILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIK  252 (353)
T ss_dssp             CEEEEEEEEETTCCEECTTTTTTCSEEEE-EEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCC
T ss_pred             CCCCEEECCCCCcCccCHHHHhccccCCe-ecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhh
Confidence            99999999999999888999999999998 99999999855445566799999999999999986655443   466788


Q ss_pred             EEEeCCCccCC----CCChhcccCccCCeeeCCCCcCCCccchhhhccccCCcccccCcccccccCC
Q 037916          277 QLKLGGNLFQG----PIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPT  339 (741)
Q Consensus       277 ~L~L~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~  339 (741)
                      .++|++|.+.+    .+|..+..+++|+.|+|++|+|+...+..|..+++|+.|+|++|++++.+|.
T Consensus       253 ~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~~  319 (353)
T 2z80_A          253 KFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  319 (353)
T ss_dssp             EEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred             ccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCCC
Confidence            99999998876    3677889999999999999999965555579999999999999999988764

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.98  E-value=8.2e-32  Score=297.75  Aligned_cols=257  Identities=19%  Similarity=0.181  Sum_probs=224.8

Q ss_pred             cCCCccEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcE
Q 037916           77 CNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVT  156 (741)
Q Consensus        77 ~~~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~  156 (741)
                      |......++.+++.++. +|..+.   .+|+.|+|++|+|.++.+..|.++++|++|+|++|+|+++.+..|.++++|++
T Consensus        52 C~~~~~~v~c~~~~l~~-iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~  127 (452)
T 3zyi_A           52 CSNQFSKVVCTRRGLSE-VPQGIP---SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNT  127 (452)
T ss_dssp             ECSSSCEEECCSSCCSS-CCSCCC---TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCE
T ss_pred             ECCCCcEEEECCCCcCc-cCCCCC---CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCE
Confidence            44457889999999984 454433   38999999999998888999999999999999999999988899999999999


Q ss_pred             EEcccCCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccC-ccccccCCccccccccceeEEEcCCC
Q 037916          157 LAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSY-NNLSGTIPPQLMDLTSLSVGLDLSRN  235 (741)
Q Consensus       157 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~~L~Ls~N  235 (741)
                      |+|++|+|+.+.+..|.++++|++|+|++|.|+...+..|..+++|++|+|++ |.+....+..|.++++|+. |+|++|
T Consensus       128 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~-L~L~~n  206 (452)
T 3zyi_A          128 LELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKY-LNLGMC  206 (452)
T ss_dssp             EECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCE-EECTTS
T ss_pred             EECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCE-EECCCC
Confidence            99999999988888899999999999999999988888899999999999998 5565445557889999997 999999


Q ss_pred             ccCCCCChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccch
Q 037916          236 QLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPK  315 (741)
Q Consensus       236 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  315 (741)
                      ++++. | .+..+++|+.|+|++|.|+++.+..|.++++|+.|+|++|++++..+..|.++++|+.|+|++|+|++..+.
T Consensus       207 ~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  284 (452)
T 3zyi_A          207 NIKDM-P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHD  284 (452)
T ss_dssp             CCSSC-C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred             ccccc-c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChH
Confidence            99854 4 588899999999999999999999999999999999999999998899999999999999999999988888


Q ss_pred             hhhccccCCcccccCcccccccCCc
Q 037916          316 FLVELQLVQNLNLSYNDLEGVIPTE  340 (741)
Q Consensus       316 ~~~~l~~L~~L~l~~N~l~~~~~~~  340 (741)
                      .|..+++|+.|+|++|++.+.....
T Consensus       285 ~~~~l~~L~~L~L~~Np~~CdC~~~  309 (452)
T 3zyi_A          285 LFTPLRYLVELHLHHNPWNCDCDIL  309 (452)
T ss_dssp             SSTTCTTCCEEECCSSCEECSTTTH
T ss_pred             HhccccCCCEEEccCCCcCCCCCch
Confidence            8899999999999999998776543

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=99.98  E-value=3.3e-31  Score=291.68  Aligned_cols=263  Identities=27%  Similarity=0.338  Sum_probs=137.6

Q ss_pred             CCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCccEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccc
Q 037916           45 SKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGI  124 (741)
Q Consensus        45 ~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~  124 (741)
                      ++|++|+|++|++++ +| .|.++++          |++|++++|++++ +|..+   . +|++|++++|++.+ +| .|
T Consensus       131 ~~L~~L~L~~n~l~~-lp-~~~~l~~----------L~~L~l~~N~l~~-lp~~~---~-~L~~L~L~~n~l~~-l~-~~  191 (454)
T 1jl5_A          131 PLLEYLGVSNNQLEK-LP-ELQNSSF----------LKIIDVDNNSLKK-LPDLP---P-SLEFIAAGNNQLEE-LP-EL  191 (454)
T ss_dssp             TTCCEEECCSSCCSS-CC-CCTTCTT----------CCEEECCSSCCSC-CCCCC---T-TCCEEECCSSCCSS-CC-CC
T ss_pred             CCCCEEECcCCCCCC-Cc-ccCCCCC----------CCEEECCCCcCcc-cCCCc---c-cccEEECcCCcCCc-Cc-cc
Confidence            345555555555553 33 3444443          5555555555553 22211   1 45555555555544 23 35


Q ss_pred             cCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCE
Q 037916          125 GKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTT  204 (741)
Q Consensus       125 ~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~  204 (741)
                      .++++|++|++++|+++++. ..   .++|++|++++|+++ .+| .|..+++|++|++++|++++ +|..   +++|++
T Consensus       192 ~~l~~L~~L~l~~N~l~~l~-~~---~~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~  261 (454)
T 1jl5_A          192 QNLPFLTAIYADNNSLKKLP-DL---PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEA  261 (454)
T ss_dssp             TTCTTCCEEECCSSCCSSCC-CC---CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCE
T ss_pred             cCCCCCCEEECCCCcCCcCC-CC---cCcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCE
Confidence            55555555555555555422 11   135555555555555 333 25556666666666666553 2321   245666


Q ss_pred             EeccCccccccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccchhhhhcccc-ccccEEEeCCC
Q 037916          205 INLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSC-IKLEQLKLGGN  283 (741)
Q Consensus       205 L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~~L~~L~L~~N  283 (741)
                      |++++|++++ +|..+   ++|+. |++++|++++. |.   -.++|+.|++++|+++++     ..+ ++|+.|++++|
T Consensus       262 L~l~~N~l~~-l~~~~---~~L~~-L~ls~N~l~~l-~~---~~~~L~~L~l~~N~l~~i-----~~~~~~L~~L~Ls~N  327 (454)
T 1jl5_A          262 LNVRDNYLTD-LPELP---QSLTF-LDVSENIFSGL-SE---LPPNLYYLNASSNEIRSL-----CDLPPSLEELNVSNN  327 (454)
T ss_dssp             EECCSSCCSC-CCCCC---TTCCE-EECCSSCCSEE-SC---CCTTCCEEECCSSCCSEE-----CCCCTTCCEEECCSS
T ss_pred             EECCCCcccc-cCccc---CcCCE-EECcCCccCcc-cC---cCCcCCEEECcCCcCCcc-----cCCcCcCCEEECCCC
Confidence            6666666553 44322   44554 66666666541 11   014566666666666542     123 47888888888


Q ss_pred             ccCCCCChhcccCccCCeeeCCCCcCCCccchhhhccccCCcccccCccccc--ccCCc-ccc-------------CCcc
Q 037916          284 LFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEG--VIPTE-GVF-------------KNAS  347 (741)
Q Consensus       284 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~--~~~~~-~~~-------------~~~~  347 (741)
                      ++++ +|..   +++|+.|+|++|++++ +|.   .+++|+.|++++|++++  .+|.. ...             .+++
T Consensus       328 ~l~~-lp~~---~~~L~~L~L~~N~l~~-lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~~~i~~~~~~L~  399 (454)
T 1jl5_A          328 KLIE-LPAL---PPRLERLIASFNHLAE-VPE---LPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLK  399 (454)
T ss_dssp             CCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSSCCCCCTTCCEEECCC-------------
T ss_pred             cccc-cccc---CCcCCEEECCCCcccc-ccc---hhhhccEEECCCCCCCcCCCChHHHHhhhhcccccccccccCcCC
Confidence            8886 4433   5788888998888885 444   46788888888888888  33332 222             5677


Q ss_pred             cccccCCCCcc
Q 037916          348 AISVFGNSKLC  358 (741)
Q Consensus       348 ~~~~~~n~~~c  358 (741)
                      .+++.+|+...
T Consensus       400 ~L~ls~N~l~~  410 (454)
T 1jl5_A          400 QLHVETNPLRE  410 (454)
T ss_dssp             -----------
T ss_pred             EEECCCCcCCc
Confidence            88888886543

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.97  E-value=1.1e-31  Score=280.83  Aligned_cols=279  Identities=20%  Similarity=0.215  Sum_probs=175.0

Q ss_pred             cEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCccEEECcCCcCcccCCchhhccc
Q 037916           24 LFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFS  103 (741)
Q Consensus        24 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~  103 (741)
                      +.++++++.++ .+|..+.  ++|++|+|++|+++.+.+..|.++++          |++|+|++|+++...        
T Consensus        10 ~~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~----------L~~L~L~~n~l~~~~--------   68 (306)
T 2z66_A           10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQ----------LTKLSLSSNGLSFKG--------   68 (306)
T ss_dssp             TEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTT----------CSEEECCSSCCCEEE--------
T ss_pred             CEEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhcccc----------CCEEECCCCccCccc--------
Confidence            35566666665 3333332  45666666666666443344555544          666666666555221        


Q ss_pred             ccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCc-ccccCCcccceee
Q 037916          104 ITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIP-PSIGNLKKLLQLY  182 (741)
Q Consensus       104 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~  182 (741)
                                     ..+..+..+++|++|+|++|.++. .+..|.++++|++|+|++|++++..+ ..|..+++|++|+
T Consensus        69 ---------------~~~~~~~~~~~L~~L~Ls~n~i~~-l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~  132 (306)
T 2z66_A           69 ---------------CCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLD  132 (306)
T ss_dssp             ---------------EEEHHHHSCSCCCEEECCSCSEEE-EEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEE
T ss_pred             ---------------CcccccccccccCEEECCCCcccc-ChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEE
Confidence                           113334445555555555555553 23345555666666666666654433 3556666666666


Q ss_pred             ccCcccccccCcccccCCCCCEEeccCccccc-cCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccc
Q 037916          183 LIENFLQVSIPSSLGQCQSLTTINLSYNNLSG-TIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNML  261 (741)
Q Consensus       183 L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  261 (741)
                      +++|.+.+..+..|..+++|++|+|++|++++ ..|..+..+++|+. |+|++|++++..|..|..+++|++|+|++|++
T Consensus       133 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~-L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l  211 (306)
T 2z66_A          133 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF-LDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNF  211 (306)
T ss_dssp             CTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCE-EECTTSCCCEECTTTTTTCTTCCEEECTTSCC
T ss_pred             CCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCE-EECCCCCcCCcCHHHhcCCCCCCEEECCCCcc
Confidence            66666666666666666666666666666664 46666667777766 77777777766667777777777777777777


Q ss_pred             cchhhhhccccccccEEEeCCCccCCCCChhcccCc-cCCeeeCCCCcCCCccc--hhhhccccCCcccccCcccccccC
Q 037916          262 ECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLR-GLRVLDLSQNNISGEIP--KFLVELQLVQNLNLSYNDLEGVIP  338 (741)
Q Consensus       262 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~--~~~~~l~~L~~L~l~~N~l~~~~~  338 (741)
                      +++.+..|..+++|+.|+|++|++++..+..+..++ +|++|+|++|.+++.-+  .....+...+.+.+..+.+.+..|
T Consensus       212 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p  291 (306)
T 2z66_A          212 FSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATP  291 (306)
T ss_dssp             SBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEES
T ss_pred             CccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCc
Confidence            777676777788888888888888887888888874 88888888888875422  223334556667777788877766


Q ss_pred             Cc
Q 037916          339 TE  340 (741)
Q Consensus       339 ~~  340 (741)
                      ..
T Consensus       292 ~~  293 (306)
T 2z66_A          292 SD  293 (306)
T ss_dssp             GG
T ss_pred             hh
Confidence            54

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.97  E-value=3.5e-34  Score=318.07  Aligned_cols=347  Identities=17%  Similarity=0.112  Sum_probs=268.4

Q ss_pred             CCCCCcccccCChhhhhCCCCCcEEEcccCccccc----CCccCCCCCCCcEEEeecCcCcccCCchhhh-hhhhhhccc
Q 037916            2 DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGV----IPSSMFNASKLEVFQVTSNNLTGEVPSEFGK-ATKAYCVQN   76 (741)
Q Consensus         2 dl~~n~~~~~ip~~~~~~l~~L~~L~L~~n~i~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-l~~~~~~~~   76 (741)
                      ||+.|++.......++..+++|++|+|++|+|++.    ++..|..+++|++|+|++|+++...+..+.. +.      .
T Consensus         9 ~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~------~   82 (461)
T 1z7x_W            9 DIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQ------T   82 (461)
T ss_dssp             EEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTC------S
T ss_pred             hhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHh------h
Confidence            67888888665566556899999999999999853    4677888899999999999998654444433 22      1


Q ss_pred             cCCCccEEECcCCcCcc----cCCchhhcccccccEEEccCCcccccCCccc-----cCCCCccEEEcccccccccC---
Q 037916           77 CNQHLKHLDINNNNFGG----LLPGCICNFSITLETLIFNSNKIFRSIPAGI-----GKFINLQTLHMWDNQLSGTI---  144 (741)
Q Consensus        77 ~~~~L~~L~Ls~N~l~~----~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~-----~~l~~L~~L~L~~N~i~~~~---  144 (741)
                      +..+|++|+|++|+|+.    .++..+..++ +|++|+|++|.+....+..+     ..+++|++|+|++|++++..   
T Consensus        83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~-~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~  161 (461)
T 1z7x_W           83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLP-TLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEP  161 (461)
T ss_dssp             TTCCCCEEECTTSCCBGGGHHHHHHHTTSCT-TCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHH
T ss_pred             CCCceeEEEccCCCCCHHHHHHHHHHHccCC-ceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHH
Confidence            11259999999999984    4577788888 99999999999865544433     23568999999999998644   


Q ss_pred             -CccccCCCcCcEEEcccCCCCCcCccccc-----CCcccceeeccCcccccc----cCcccccCCCCCEEeccCccccc
Q 037916          145 -SPAIGELQNLVTLAINTNKLSGNIPPSIG-----NLKKLLQLYLIENFLQVS----IPSSLGQCQSLTTINLSYNNLSG  214 (741)
Q Consensus       145 -~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-----~l~~L~~L~L~~N~i~~~----~~~~~~~l~~L~~L~L~~N~l~~  214 (741)
                       +..+..+++|++|+|++|.++...+..+.     ..++|++|+|++|.++..    ++..+..+++|++|+|++|++++
T Consensus       162 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~  241 (461)
T 1z7x_W          162 LASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGD  241 (461)
T ss_dssp             HHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHH
T ss_pred             HHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCCh
Confidence             56677789999999999999765555553     366899999999999864    47778889999999999999875


Q ss_pred             cC-----CccccccccceeEEEcCCCccCCC----CChhhcCCCCCcEEEeccccccchhhhhcccc-----ccccEEEe
Q 037916          215 TI-----PPQLMDLTSLSVGLDLSRNQLVGS----LPTEVGKLINLEILFISRNMLECEILSTLGSC-----IKLEQLKL  280 (741)
Q Consensus       215 ~~-----p~~~~~l~~L~~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-----~~L~~L~L  280 (741)
                      ..     +..+..+++|+. |++++|.++..    ++..+..+++|++|+|++|.++...+..+...     ++|++|+|
T Consensus       242 ~~~~~l~~~~~~~~~~L~~-L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L  320 (461)
T 1z7x_W          242 VGMAELCPGLLHPSSRLRT-LWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWV  320 (461)
T ss_dssp             HHHHHHHHHHTSTTCCCCE-EECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEEC
T ss_pred             HHHHHHHHHHhcCCCCceE-EECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEc
Confidence            32     223335788987 99999998854    56677889999999999999987666555543     68999999


Q ss_pred             CCCccCCC----CChhcccCccCCeeeCCCCcCCCccchhhhc-----cccCCcccccCccccc----ccC-CccccCCc
Q 037916          281 GGNLFQGP----IPLSLSSLRGLRVLDLSQNNISGEIPKFLVE-----LQLVQNLNLSYNDLEG----VIP-TEGVFKNA  346 (741)
Q Consensus       281 ~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-----l~~L~~L~l~~N~l~~----~~~-~~~~~~~~  346 (741)
                      ++|.+++.    ++..+..+++|+.|+|++|.+++..+..+..     .++|+.|+|++|.+++    .++ .....+++
T Consensus       321 ~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L  400 (461)
T 1z7x_W          321 KSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSL  400 (461)
T ss_dssp             TTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCC
T ss_pred             CCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCc
Confidence            99999865    4566778899999999999998665555543     5789999999999985    333 33456888


Q ss_pred             ccccccCCCC
Q 037916          347 SAISVFGNSK  356 (741)
Q Consensus       347 ~~~~~~~n~~  356 (741)
                      +.+++.+|+.
T Consensus       401 ~~L~l~~N~i  410 (461)
T 1z7x_W          401 RELDLSNNCL  410 (461)
T ss_dssp             CEEECCSSSC
T ss_pred             cEEECCCCCC
Confidence            9999988853

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.97  E-value=8.4e-31  Score=289.66  Aligned_cols=247  Identities=19%  Similarity=0.169  Sum_probs=143.5

Q ss_pred             CcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCccEEECcCCcCcccCCchhhcc
Q 037916           23 LLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNF  102 (741)
Q Consensus        23 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l  102 (741)
                      ...++.+++.++ .+|..+.  ++|++|+|++|+|+++.|..|.++++          |++|+|++|+|+++.+..|..+
T Consensus        56 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~----------L~~L~Ls~n~i~~~~~~~~~~l  122 (452)
T 3zyi_A           56 FSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHH----------LEVLQLGRNSIRQIEVGAFNGL  122 (452)
T ss_dssp             SCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTT----------CCEEECCSSCCCEECTTTTTTC
T ss_pred             CcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCC----------CCEEECCCCccCCcChhhccCc
Confidence            345555555555 2343332  45555666666655555555555544          5666666666555555555555


Q ss_pred             cccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEccc-CCCCCcCcccccCCccccee
Q 037916          103 SITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINT-NKLSGNIPPSIGNLKKLLQL  181 (741)
Q Consensus       103 ~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L  181 (741)
                      . +|++|+|++|+|....+..|..+++|++|+|++|+|+.+.+..|.++++|++|+|++ |.+..+.+..|.++++|++|
T Consensus       123 ~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L  201 (452)
T 3zyi_A          123 A-SLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYL  201 (452)
T ss_dssp             T-TCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEE
T ss_pred             c-cCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEE
Confidence            5 566666666665555555555666666666666666655555566666666666665 34444444455666666666


Q ss_pred             eccCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccc
Q 037916          182 YLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNML  261 (741)
Q Consensus       182 ~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  261 (741)
                      +|++|.+++. | .+..+++|++|+|++|+|++..|..|.++++|+. |+|++|++++..+..|..+++|+.|+|++|+|
T Consensus       202 ~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~-L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l  278 (452)
T 3zyi_A          202 NLGMCNIKDM-P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKK-LWVMNSQVSLIERNAFDGLASLVELNLAHNNL  278 (452)
T ss_dssp             ECTTSCCSSC-C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCE-EECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred             ECCCCccccc-c-cccccccccEEECcCCcCcccCcccccCccCCCE-EEeCCCcCceECHHHhcCCCCCCEEECCCCcC
Confidence            6666666532 2 3555566666666666666555666666666665 66666666655556666666666666666666


Q ss_pred             cchhhhhccccccccEEEeCCCccC
Q 037916          262 ECEILSTLGSCIKLEQLKLGGNLFQ  286 (741)
Q Consensus       262 ~~~~~~~~~~l~~L~~L~L~~N~l~  286 (741)
                      +++.+..|..+++|+.|+|++|.+.
T Consensus       279 ~~~~~~~~~~l~~L~~L~L~~Np~~  303 (452)
T 3zyi_A          279 SSLPHDLFTPLRYLVELHLHHNPWN  303 (452)
T ss_dssp             SCCCTTSSTTCTTCCEEECCSSCEE
T ss_pred             CccChHHhccccCCCEEEccCCCcC
Confidence            6666666666666666666666554

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.97  E-value=3.5e-31  Score=274.02  Aligned_cols=252  Identities=21%  Similarity=0.178  Sum_probs=161.7

Q ss_pred             cEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEccc
Q 037916           82 KHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINT  161 (741)
Q Consensus        82 ~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~  161 (741)
                      +.++++++.++. +|..+   ..+|++|++++|++....+..|..+++|++|+|++|+|+++.+..|.++++|++|+|++
T Consensus        14 ~~~~c~~~~l~~-ip~~~---~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~   89 (285)
T 1ozn_A           14 VTTSCPQQGLQA-VPVGI---PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD   89 (285)
T ss_dssp             CEEECCSSCCSS-CCTTC---CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             eEEEcCcCCccc-CCcCC---CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCC
Confidence            677888888774 34332   22677777777777776667777777777777777777777677777777777777777


Q ss_pred             CC-CCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCC
Q 037916          162 NK-LSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGS  240 (741)
Q Consensus       162 N~-l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~  240 (741)
                      |+ ++.+.+..|.++++|++|+|++|.+++..|..|..+++|++|+|++|++++..+..|..+++|+. |+|++|++++.
T Consensus        90 n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~-L~l~~n~l~~~  168 (285)
T 1ozn_A           90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTH-LFLHGNRISSV  168 (285)
T ss_dssp             CTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE-EECCSSCCCEE
T ss_pred             CCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccE-EECCCCccccc
Confidence            76 66555666777777777777777777666666666777777777777766555555666666665 66666666655


Q ss_pred             CChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccchhhhcc
Q 037916          241 LPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVEL  320 (741)
Q Consensus       241 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  320 (741)
                      .+..|..+++|++|+|++|.++++.+..|..+++|+.|++++|++++..+..|..+++|+.|+|++|.+....+.. .-+
T Consensus       169 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~-~~~  247 (285)
T 1ozn_A          169 PERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLW  247 (285)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-HHH
T ss_pred             CHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH-HHH
Confidence            5555666666666666666666666666666666666666666666555555666666666666666665332211 122


Q ss_pred             ccCCcccccCcccccccCC
Q 037916          321 QLVQNLNLSYNDLEGVIPT  339 (741)
Q Consensus       321 ~~L~~L~l~~N~l~~~~~~  339 (741)
                      ..++.+..+.|.+.+..|.
T Consensus       248 ~~l~~~~~~~~~~~c~~p~  266 (285)
T 1ozn_A          248 AWLQKFRGSSSEVPCSLPQ  266 (285)
T ss_dssp             HHHHHCCSEECCCBEEESG
T ss_pred             HHHHhcccccCccccCCch
Confidence            3344445555555555444

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.97  E-value=1.2e-30  Score=287.38  Aligned_cols=247  Identities=19%  Similarity=0.200  Sum_probs=143.7

Q ss_pred             CcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCccEEECcCCcCcccCCchhhcc
Q 037916           23 LLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNF  102 (741)
Q Consensus        23 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l  102 (741)
                      ...++.+++.++ .+|..+.  +++++|+|++|+|+++.+..|.++++          |++|+|++|+|+++.+..|.++
T Consensus        45 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~----------L~~L~Ls~n~i~~i~~~~~~~l  111 (440)
T 3zyj_A           45 FSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRH----------LEILQLSRNHIRTIEIGAFNGL  111 (440)
T ss_dssp             SCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSS----------CCEEECCSSCCCEECGGGGTTC
T ss_pred             CCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCC----------CCEEECCCCcCCccChhhccCC
Confidence            345555555555 3343332  45555566666555555555555544          5566666665555555555555


Q ss_pred             cccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEccc-CCCCCcCcccccCCccccee
Q 037916          103 SITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINT-NKLSGNIPPSIGNLKKLLQL  181 (741)
Q Consensus       103 ~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L  181 (741)
                      . +|++|+|++|+|..+.+..|..+++|++|+|++|+|+.+.+..|.++++|++|+|++ |.+..+.+..|.++++|++|
T Consensus       112 ~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L  190 (440)
T 3zyj_A          112 A-NLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYL  190 (440)
T ss_dssp             S-SCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEE
T ss_pred             c-cCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCee
Confidence            5 566666666665555555566666666666666666655555566666666666665 34443444455666666666


Q ss_pred             eccCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccc
Q 037916          182 YLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNML  261 (741)
Q Consensus       182 ~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  261 (741)
                      +|++|.++. +| .+..+++|++|+|++|+|++..|..|.++++|+. |+|++|+|++..+..|..+++|+.|+|++|+|
T Consensus       191 ~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~-L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l  267 (440)
T 3zyj_A          191 NLAMCNLRE-IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQK-LWMIQSQIQVIERNAFDNLQSLVEINLAHNNL  267 (440)
T ss_dssp             ECTTSCCSS-CC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCE-EECTTCCCCEECTTSSTTCTTCCEEECTTSCC
T ss_pred             cCCCCcCcc-cc-ccCCCcccCEEECCCCccCccChhhhccCccCCE-EECCCCceeEEChhhhcCCCCCCEEECCCCCC
Confidence            666666652 23 2555566666666666666555666666666665 66666666655556666666666666666666


Q ss_pred             cchhhhhccccccccEEEeCCCccC
Q 037916          262 ECEILSTLGSCIKLEQLKLGGNLFQ  286 (741)
Q Consensus       262 ~~~~~~~~~~l~~L~~L~L~~N~l~  286 (741)
                      +.+.+..|..+++|+.|+|++|.+.
T Consensus       268 ~~~~~~~~~~l~~L~~L~L~~Np~~  292 (440)
T 3zyj_A          268 TLLPHDLFTPLHHLERIHLHHNPWN  292 (440)
T ss_dssp             CCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred             CccChhHhccccCCCEEEcCCCCcc
Confidence            6666666666666666666666554

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.97  E-value=1.5e-31  Score=297.29  Aligned_cols=234  Identities=21%  Similarity=0.234  Sum_probs=182.4

Q ss_pred             CccEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEc
Q 037916           80 HLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAI  159 (741)
Q Consensus        80 ~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L  159 (741)
                      +|++|+|++|.|++..|..|..++ +|++|+|++|.+.+..|  |..+++|++|+|++|.|+++.+.     ++|++|+|
T Consensus        35 ~L~~L~Ls~n~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~-----~~L~~L~L  106 (487)
T 3oja_A           35 NVKELDLSGNPLSQISAADLAPFT-KLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVG-----PSIETLHA  106 (487)
T ss_dssp             GCCEEECCSSCCCCCCGGGGTTCT-TCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEEC-----TTCCEEEC
T ss_pred             CccEEEeeCCcCCCCCHHHHhCCC-CCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCC-----CCcCEEEC
Confidence            477888888888777777777777 78888888887766554  77888888888888888765432     67888888


Q ss_pred             ccCCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCcccc-ccccceeEEEcCCCccC
Q 037916          160 NTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLM-DLTSLSVGLDLSRNQLV  238 (741)
Q Consensus       160 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~~L~Ls~N~l~  238 (741)
                      ++|.|++..+..   +++|+.|+|++|.+++..|..|..+++|++|+|++|+|++..|..+. .+++|+. |+|++|.|+
T Consensus       107 ~~N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~-L~Ls~N~l~  182 (487)
T 3oja_A          107 ANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEH-LNLQYNFIY  182 (487)
T ss_dssp             CSSCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCE-EECTTSCCC
T ss_pred             cCCcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccE-EecCCCccc
Confidence            888887665543   46788888888888877777888888888888888888877777776 6788887 888888887


Q ss_pred             CCCChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCC-Cccchhh
Q 037916          239 GSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNIS-GEIPKFL  317 (741)
Q Consensus       239 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~  317 (741)
                      +..+  +..+++|+.|+|++|.|+++++. |..+++|+.|+|++|.|++ +|..+..+++|+.|+|++|.+. +.+|..+
T Consensus       183 ~~~~--~~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~  258 (487)
T 3oja_A          183 DVKG--QVVFAKLKTLDLSSNKLAFMGPE-FQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFF  258 (487)
T ss_dssp             EEEC--CCCCTTCCEEECCSSCCCEECGG-GGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHH
T ss_pred             cccc--cccCCCCCEEECCCCCCCCCCHh-HcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHH
Confidence            5532  33588888888888888876555 8888889999999998885 6667888889999999999887 5677788


Q ss_pred             hccccCCccccc
Q 037916          318 VELQLVQNLNLS  329 (741)
Q Consensus       318 ~~l~~L~~L~l~  329 (741)
                      ..++.|+.++++
T Consensus       259 ~~l~~L~~l~~~  270 (487)
T 3oja_A          259 SKNQRVQTVAKQ  270 (487)
T ss_dssp             TTCHHHHHHHHH
T ss_pred             HhCCCCcEEecc
Confidence            888888888876

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.97  E-value=1.5e-33  Score=313.00  Aligned_cols=342  Identities=18%  Similarity=0.151  Sum_probs=269.4

Q ss_pred             CCCCCcccc----cCChhhhhCCCCCcEEEcccCcccccCCccCC-CCC----CCcEEEeecCcCcc----cCCchhhhh
Q 037916            2 DVGVNRVQG----GIPLDFGFTLPNLLFLSLGFNQITGVIPSSMF-NAS----KLEVFQVTSNNLTG----EVPSEFGKA   68 (741)
Q Consensus         2 dl~~n~~~~----~ip~~~~~~l~~L~~L~L~~n~i~~~~~~~~~-~l~----~L~~L~L~~N~l~~----~~~~~~~~l   68 (741)
                      ||++|++..    .+|..+. .+++|++|+|++|+|++..+..+. .++    +|++|+|++|+|+.    .++..|..+
T Consensus        34 ~L~~~~l~~~~~~~l~~~l~-~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~  112 (461)
T 1z7x_W           34 RLDDCGLTEARCKDISSALR-VNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTL  112 (461)
T ss_dssp             EEESSCCCHHHHHHHHHHHH-TCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSC
T ss_pred             EccCCCCCHHHHHHHHHHHH-hCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHHHccC
Confidence            567888774    4565565 789999999999999875444433 354    79999999999994    446667776


Q ss_pred             hhhhhccccCCCccEEECcCCcCcccCCchhhc-----ccccccEEEccCCcccccC----CccccCCCCccEEEccccc
Q 037916           69 TKAYCVQNCNQHLKHLDINNNNFGGLLPGCICN-----FSITLETLIFNSNKIFRSI----PAGIGKFINLQTLHMWDNQ  139 (741)
Q Consensus        69 ~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~-----l~~~L~~L~L~~n~i~~~~----~~~~~~l~~L~~L~L~~N~  139 (741)
                      ++          |++|+|++|.+++..+..+..     .. +|++|+|++|++....    +..+..+++|++|+|++|.
T Consensus       113 ~~----------L~~L~Ls~n~i~~~~~~~l~~~l~~~~~-~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~  181 (461)
T 1z7x_W          113 PT----------LQELHLSDNLLGDAGLQLLCEGLLDPQC-RLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNND  181 (461)
T ss_dssp             TT----------CCEEECCSSBCHHHHHHHHHHHHTSTTC-CCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSB
T ss_pred             Cc----------eeEEECCCCcCchHHHHHHHHHHhcCCC-cceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCC
Confidence            65          999999999998665554443     23 7999999999997644    5667778999999999999


Q ss_pred             ccccCCcccc-----CCCcCcEEEcccCCCCCc----CcccccCCcccceeeccCccccccc-----CcccccCCCCCEE
Q 037916          140 LSGTISPAIG-----ELQNLVTLAINTNKLSGN----IPPSIGNLKKLLQLYLIENFLQVSI-----PSSLGQCQSLTTI  205 (741)
Q Consensus       140 i~~~~~~~~~-----~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~i~~~~-----~~~~~~l~~L~~L  205 (741)
                      ++...+..+.     .+++|++|+|++|+++..    ++..+..+++|++|+|++|.++...     +..+..+++|++|
T Consensus       182 i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L  261 (461)
T 1z7x_W          182 INEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTL  261 (461)
T ss_dssp             CHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEE
T ss_pred             cchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEE
Confidence            9866555543     367999999999999864    4777888999999999999988643     3334468999999


Q ss_pred             eccCcccccc----CCccccccccceeEEEcCCCccCCCCChhhcC-----CCCCcEEEeccccccch----hhhhcccc
Q 037916          206 NLSYNNLSGT----IPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGK-----LINLEILFISRNMLECE----ILSTLGSC  272 (741)
Q Consensus       206 ~L~~N~l~~~----~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~~~----~~~~~~~l  272 (741)
                      +|++|++++.    ++..+..+++|+. |+|++|.+.+..+..+..     .++|++|+|++|.++..    .+..+..+
T Consensus       262 ~L~~n~l~~~~~~~l~~~l~~~~~L~~-L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~  340 (461)
T 1z7x_W          262 WIWECGITAKGCGDLCRVLRAKESLKE-LSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQN  340 (461)
T ss_dssp             ECTTSCCCHHHHHHHHHHHHHCTTCCE-EECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHC
T ss_pred             ECcCCCCCHHHHHHHHHHHhhCCCcce-EECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhC
Confidence            9999999854    6777888999998 999999997554444443     37999999999999976    46667788


Q ss_pred             ccccEEEeCCCccCCCCChhccc-----CccCCeeeCCCCcCCC----ccchhhhccccCCcccccCcccccccCCc---
Q 037916          273 IKLEQLKLGGNLFQGPIPLSLSS-----LRGLRVLDLSQNNISG----EIPKFLVELQLVQNLNLSYNDLEGVIPTE---  340 (741)
Q Consensus       273 ~~L~~L~L~~N~l~~~~~~~~~~-----l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~l~~N~l~~~~~~~---  340 (741)
                      ++|++|+|++|++++..+..+..     .++|+.|+|++|.+++    .+|..+..+++|+.|++++|++++.....   
T Consensus       341 ~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~  420 (461)
T 1z7x_W          341 RFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE  420 (461)
T ss_dssp             SSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHH
T ss_pred             CCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHH
Confidence            99999999999998766655543     6799999999999986    67888999999999999999998652111   


Q ss_pred             ---cccCCcccccccCCCC
Q 037916          341 ---GVFKNASAISVFGNSK  356 (741)
Q Consensus       341 ---~~~~~~~~~~~~~n~~  356 (741)
                         .....++.+.+.++.+
T Consensus       421 ~l~~~~~~L~~L~~~~~~~  439 (461)
T 1z7x_W          421 SVRQPGCLLEQLVLYDIYW  439 (461)
T ss_dssp             HHTSTTCCCCEEECTTCCC
T ss_pred             HhccCCcchhheeeccccc
Confidence               1123566677766654

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.97  E-value=1.8e-30  Score=268.59  Aligned_cols=254  Identities=22%  Similarity=0.184  Sum_probs=197.7

Q ss_pred             ccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCcccccCCcccceeeccC
Q 037916          106 LETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIE  185 (741)
Q Consensus       106 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  185 (741)
                      -++++++++.+.. +|..+  .++|++|+|++|+|+++.+..|..+++|++|+|++|+++++.+..|.++++|++|+|++
T Consensus        13 ~~~~~c~~~~l~~-ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~   89 (285)
T 1ozn_A           13 KVTTSCPQQGLQA-VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD   89 (285)
T ss_dssp             SCEEECCSSCCSS-CCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CeEEEcCcCCccc-CCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCC
Confidence            3677788887744 44444  35788888888888877777888888888888888888877778888888888888888


Q ss_pred             cc-cccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccch
Q 037916          186 NF-LQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECE  264 (741)
Q Consensus       186 N~-i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  264 (741)
                      |. ++...|..|..+++|++|+|++|++++..|..|.++++|+. |++++|++++..+..|+.+++|++|+|++|+++++
T Consensus        90 n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~-L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~  168 (285)
T 1ozn_A           90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQY-LYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSV  168 (285)
T ss_dssp             CTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCE-EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEE
T ss_pred             CCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCE-EECCCCcccccCHhHhccCCCccEEECCCCccccc
Confidence            86 77666778888888888888888888777777888888887 88888888876667788888888888888888877


Q ss_pred             hhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccchhhhccccCCcccccCcccccccCCccccC
Q 037916          265 ILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFK  344 (741)
Q Consensus       265 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~  344 (741)
                      .+..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..+..+..+++|+.|++++|++.+..+..+.+.
T Consensus       169 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~~~~~  248 (285)
T 1ozn_A          169 PERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWA  248 (285)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHH
T ss_pred             CHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcHHHHH
Confidence            77778888888888888888887778888888888888888888887777778888888888888888887666544444


Q ss_pred             CcccccccCCCCccccCCC
Q 037916          345 NASAISVFGNSKLCGGIPE  363 (741)
Q Consensus       345 ~~~~~~~~~n~~~c~~~~~  363 (741)
                      .+..+....+...|..++.
T Consensus       249 ~l~~~~~~~~~~~c~~p~~  267 (285)
T 1ozn_A          249 WLQKFRGSSSEVPCSLPQR  267 (285)
T ss_dssp             HHHHCCSEECCCBEEESGG
T ss_pred             HHHhcccccCccccCCchH
Confidence            5555666667777766544

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.97  E-value=1.1e-29  Score=267.92  Aligned_cols=227  Identities=25%  Similarity=0.354  Sum_probs=166.7

Q ss_pred             CCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCccEEECcCCcCcccCCch
Q 037916           19 TLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGC   98 (741)
Q Consensus        19 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~   98 (741)
                      ..++++.|+|++|+|+ .+|..++++++|++|+|++|+|+ .+|..|..+++          |++|+|++|+++ .+|..
T Consensus        79 ~~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~----------L~~L~Ls~n~l~-~lp~~  145 (328)
T 4fcg_A           79 TQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAG----------LETLTLARNPLR-ALPAS  145 (328)
T ss_dssp             TSTTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTT----------CSEEEEESCCCC-CCCGG
T ss_pred             cccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCC----------CCEEECCCCccc-cCcHH
Confidence            3478999999999998 66777888999999999999998 78888888876          999999999988 66778


Q ss_pred             hhcccccccEEEccCCcccccCCccccC---------CCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCc
Q 037916           99 ICNFSITLETLIFNSNKIFRSIPAGIGK---------FINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIP  169 (741)
Q Consensus        99 ~~~l~~~L~~L~L~~n~i~~~~~~~~~~---------l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  169 (741)
                      +..+. +|++|+|++|++.+..|..+..         +++|++|+|++|+|+ .+|..|.++++|++|+|++|++++ +|
T Consensus       146 l~~l~-~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~  222 (328)
T 4fcg_A          146 IASLN-RLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LG  222 (328)
T ss_dssp             GGGCT-TCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CC
T ss_pred             HhcCc-CCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-Cc
Confidence            88887 8888888888887888776654         667777777777766 445566666777777777777764 44


Q ss_pred             ccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCCCChhhcCCC
Q 037916          170 PSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLI  249 (741)
Q Consensus       170 ~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~  249 (741)
                      ..|..+++|++|+|++|.+.+.+|..|..+++|++|+|++|++.+.+|..+.++++|+. |+|++|++.+.+|..++.++
T Consensus       223 ~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~-L~L~~n~~~~~iP~~l~~L~  301 (328)
T 4fcg_A          223 PAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEK-LDLRGCVNLSRLPSLIAQLP  301 (328)
T ss_dssp             GGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCE-EECTTCTTCCCCCGGGGGSC
T ss_pred             hhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCE-EeCCCCCchhhccHHHhhcc
Confidence            45666666666666666666666666666666666666666666666666666666665 66666666666666666666


Q ss_pred             CCcEEEecccccc
Q 037916          250 NLEILFISRNMLE  262 (741)
Q Consensus       250 ~L~~L~Ls~N~l~  262 (741)
                      +|+.+++..|.+.
T Consensus       302 ~L~~l~l~~~~~~  314 (328)
T 4fcg_A          302 ANCIILVPPHLQA  314 (328)
T ss_dssp             TTCEEECCGGGSC
T ss_pred             CceEEeCCHHHHH
Confidence            6666666655544

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.97  E-value=2.1e-31  Score=280.02  Aligned_cols=243  Identities=21%  Similarity=0.229  Sum_probs=179.2

Q ss_pred             ccEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcc
Q 037916           81 LKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAIN  160 (741)
Q Consensus        81 L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~  160 (741)
                      |++|+|++|+|++..|..|..+. +|++|+|++|++.+..+  |..+++|++|+|++|+|+++.     ..++|++|+++
T Consensus        36 L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~-----~~~~L~~L~l~  107 (317)
T 3o53_A           36 VKELDLSGNPLSQISAADLAPFT-KLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIETLHAA  107 (317)
T ss_dssp             CSEEECTTSCCCCCCHHHHTTCT-TCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEE-----ECTTCCEEECC
T ss_pred             CCEEECcCCccCcCCHHHhhCCC-cCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcccccc-----CCCCcCEEECC
Confidence            66666666666666556666666 66677776666655443  667777777777777776543     22677777777


Q ss_pred             cCCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCcccc-ccccceeEEEcCCCccCC
Q 037916          161 TNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLM-DLTSLSVGLDLSRNQLVG  239 (741)
Q Consensus       161 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~~L~Ls~N~l~~  239 (741)
                      +|++++..+..   +++|++|+|++|++++..+..|..+++|++|+|++|++++..+..+. .+++|+. |+|++|.|++
T Consensus       108 ~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~-L~L~~N~l~~  183 (317)
T 3o53_A          108 NNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEH-LNLQYNFIYD  183 (317)
T ss_dssp             SSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCE-EECTTSCCCE
T ss_pred             CCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCE-EECCCCcCcc
Confidence            77777554433   45677777777777776676777777777777777777766666554 5677776 8888887774


Q ss_pred             CCChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCC-Cccchhhh
Q 037916          240 SLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNIS-GEIPKFLV  318 (741)
Q Consensus       240 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~  318 (741)
                      . + ....+++|++|+|++|+|+++.+. |..+++|+.|+|++|++++ +|..+..+++|+.|+|++|.++ +.+|..+.
T Consensus       184 ~-~-~~~~l~~L~~L~Ls~N~l~~l~~~-~~~l~~L~~L~L~~N~l~~-l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~  259 (317)
T 3o53_A          184 V-K-GQVVFAKLKTLDLSSNKLAFMGPE-FQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFS  259 (317)
T ss_dssp             E-E-CCCCCTTCCEEECCSSCCCEECGG-GGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCCBHHHHHHHHH
T ss_pred             c-c-cccccccCCEEECCCCcCCcchhh-hcccCcccEEECcCCcccc-hhhHhhcCCCCCEEEccCCCccCcCHHHHHh
Confidence            4 2 233478899999999999876554 8889999999999999994 6778899999999999999998 77888999


Q ss_pred             ccccCCcccccC-cccccccCC
Q 037916          319 ELQLVQNLNLSY-NDLEGVIPT  339 (741)
Q Consensus       319 ~l~~L~~L~l~~-N~l~~~~~~  339 (741)
                      .+++|+.|++++ +.+++..+.
T Consensus       260 ~~~~L~~l~l~~~~~l~~~~~~  281 (317)
T 3o53_A          260 KNQRVQTVAKQTVKKLTGQNEE  281 (317)
T ss_dssp             TCHHHHHHHHHHHHHHHSSSSC
T ss_pred             ccccceEEECCCchhccCCchh
Confidence            999999999994 456665543

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.97  E-value=1.3e-31  Score=281.49  Aligned_cols=253  Identities=20%  Similarity=0.198  Sum_probs=151.5

Q ss_pred             CCCCCcccccCChhhhhCCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCc
Q 037916            2 DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHL   81 (741)
Q Consensus         2 dl~~n~~~~~ip~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L   81 (741)
                      |++.+.+. .++..++..+++|++|+|++|+|+++.|..|.++++|++|+|++|++++..+  |..+++          |
T Consensus        16 ~ls~~~l~-~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~----------L   82 (317)
T 3o53_A           16 KVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLST----------L   82 (317)
T ss_dssp             SCCTTTHH-HHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTT----------C
T ss_pred             eccccchh-hhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCC----------C
Confidence            56666665 3444555466677777777777777666777777777777777777775543  556554          7


Q ss_pred             cEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEccc
Q 037916           82 KHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINT  161 (741)
Q Consensus        82 ~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~  161 (741)
                      ++|+|++|+|++..+.     + +|++|++++|++.+..+..   +++|++|+|++|+|+++.+..|..+++|++|+|++
T Consensus        83 ~~L~Ls~n~l~~l~~~-----~-~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~  153 (317)
T 3o53_A           83 RTLDLNNNYVQELLVG-----P-SIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKL  153 (317)
T ss_dssp             CEEECCSSEEEEEEEC-----T-TCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTT
T ss_pred             CEEECcCCccccccCC-----C-CcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCC
Confidence            7777777777644321     2 6666666666665544433   34566666666666666566666666666666666


Q ss_pred             CCCCCcCccccc-CCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCC
Q 037916          162 NKLSGNIPPSIG-NLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGS  240 (741)
Q Consensus       162 N~l~~~~~~~~~-~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~  240 (741)
                      |++++..+..+. .+++|++|+|++|.|++..+  ...+++|++|+|++|+|+ .+|..+..+++|+. |+|++|+|+ .
T Consensus       154 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~-L~L~~N~l~-~  228 (317)
T 3o53_A          154 NEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTW-ISLRNNKLV-L  228 (317)
T ss_dssp             SCCCEEEGGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCC-EECGGGGGGTTCSE-EECTTSCCC-E
T ss_pred             CCCCcccHHHHhhccCcCCEEECCCCcCccccc--ccccccCCEEECCCCcCC-cchhhhcccCcccE-EECcCCccc-c
Confidence            666655555543 45666666666666654422  223556666666666665 33334555555555 666666655 3


Q ss_pred             CChhhcCCCCCcEEEecccccc-chhhhhccccccccEEEeC
Q 037916          241 LPTEVGKLINLEILFISRNMLE-CEILSTLGSCIKLEQLKLG  281 (741)
Q Consensus       241 ~p~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~  281 (741)
                      +|..+..+++|+.|+|++|.+. +..+..+..+++|+.|+++
T Consensus       229 l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~  270 (317)
T 3o53_A          229 IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ  270 (317)
T ss_dssp             ECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHH
T ss_pred             hhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECC
Confidence            4445555555555555555555 4444555555555555555

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.96  E-value=1.8e-29  Score=266.07  Aligned_cols=235  Identities=18%  Similarity=0.265  Sum_probs=147.6

Q ss_pred             CccEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEc
Q 037916           80 HLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAI  159 (741)
Q Consensus        80 ~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L  159 (741)
                      +++.|+|++|+|+ .+|..+..+. +|++|+|++|.+. .+|..|..+++|++|+|++|+|+ .+|..|.++++|++|+|
T Consensus        82 ~l~~L~L~~n~l~-~lp~~l~~l~-~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L  157 (328)
T 4fcg_A           82 GRVALELRSVPLP-QFPDQAFRLS-HLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSI  157 (328)
T ss_dssp             TCCEEEEESSCCS-SCCSCGGGGT-TCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEE
T ss_pred             ceeEEEccCCCch-hcChhhhhCC-CCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEEC
Confidence            3555555555554 3333344444 4555555555543 44444455555555555555554 33444555555555555


Q ss_pred             ccCCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCC
Q 037916          160 NTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVG  239 (741)
Q Consensus       160 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~  239 (741)
                      ++|++.+.+|..+...               ..+..|.++++|++|+|++|+|+ .+|..+.++++|+. |+|++|++++
T Consensus       158 ~~n~~~~~~p~~~~~~---------------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~-L~L~~N~l~~  220 (328)
T 4fcg_A          158 RACPELTELPEPLAST---------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKS-LKIRNSPLSA  220 (328)
T ss_dssp             EEETTCCCCCSCSEEE---------------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCE-EEEESSCCCC
T ss_pred             CCCCCccccChhHhhc---------------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCE-EEccCCCCCc
Confidence            5544444444433320               01122344777777777777777 67777777777776 7777777774


Q ss_pred             CCChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccchhhhc
Q 037916          240 SLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVE  319 (741)
Q Consensus       240 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  319 (741)
                       +|..++.+++|++|+|++|.+.+..+..|+.+++|+.|+|++|.+.+.+|..+.++++|+.|+|++|++.+.+|..+..
T Consensus       221 -l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~  299 (328)
T 4fcg_A          221 -LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQ  299 (328)
T ss_dssp             -CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGG
T ss_pred             -CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhh
Confidence             4456777777777777777777777777777777888888887777777777888888888888888877778888888


Q ss_pred             cccCCcccccCcccccc
Q 037916          320 LQLVQNLNLSYNDLEGV  336 (741)
Q Consensus       320 l~~L~~L~l~~N~l~~~  336 (741)
                      +++|+.+++..|.+...
T Consensus       300 L~~L~~l~l~~~~~~~l  316 (328)
T 4fcg_A          300 LPANCIILVPPHLQAQL  316 (328)
T ss_dssp             SCTTCEEECCGGGSCC-
T ss_pred             ccCceEEeCCHHHHHHH
Confidence            88888887777766543

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.96  E-value=6.5e-29  Score=281.63  Aligned_cols=263  Identities=24%  Similarity=0.307  Sum_probs=190.4

Q ss_pred             CCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCccEEECcCCcCcccCCchhh
Q 037916           21 PNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCIC  100 (741)
Q Consensus        21 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~  100 (741)
                      .++++|++++|.|+ .+|..+.  ++|++|+|++|+|+ .+|.   .++          +|++|+|++|+|+++.+    
T Consensus        40 ~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~----------~L~~L~Ls~N~l~~lp~----   98 (622)
T 3g06_A           40 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPP----------ELRTLEVSGNQLTSLPV----   98 (622)
T ss_dssp             HCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCT----------TCCEEEECSCCCSCCCC----
T ss_pred             CCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCC----------CCCEEEcCCCcCCcCCC----
Confidence            45788888888887 5566554  78888888888888 4444   233          38888888888875433    


Q ss_pred             cccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCcccccCCcccce
Q 037916          101 NFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQ  180 (741)
Q Consensus       101 ~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  180 (741)
                      .+. +|++|+|++|+|.+..+    .+++|++|+|++|+|+++..    .+++|++|+|++|+|+++ |.   .+.+|+.
T Consensus        99 ~l~-~L~~L~Ls~N~l~~l~~----~l~~L~~L~L~~N~l~~lp~----~l~~L~~L~Ls~N~l~~l-~~---~~~~L~~  165 (622)
T 3g06_A           99 LPP-GLLELSIFSNPLTHLPA----LPSGLCKLWIFGNQLTSLPV----LPPGLQELSVSDNQLASL-PA---LPSELCK  165 (622)
T ss_dssp             CCT-TCCEEEECSCCCCCCCC----CCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSCC-CC---CCTTCCE
T ss_pred             CCC-CCCEEECcCCcCCCCCC----CCCCcCEEECCCCCCCcCCC----CCCCCCEEECcCCcCCCc-CC---ccCCCCE
Confidence            344 78888888888865433    45678888888888886443    247788888888888753 33   3467888


Q ss_pred             eeccCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEecccc
Q 037916          181 LYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNM  260 (741)
Q Consensus       181 L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  260 (741)
                      |++++|.|++ +|   ..+++|+.|+|++|+|+ .+|..   +++|+. |++++|.|+. +|.   .+++|+.|+|++|+
T Consensus       166 L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~-~l~~~---~~~L~~-L~L~~N~l~~-l~~---~~~~L~~L~Ls~N~  232 (622)
T 3g06_A          166 LWAYNNQLTS-LP---MLPSGLQELSVSDNQLA-SLPTL---PSELYK-LWAYNNRLTS-LPA---LPSGLKELIVSGNR  232 (622)
T ss_dssp             EECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCCC---CTTCCE-EECCSSCCSS-CCC---CCTTCCEEECCSSC
T ss_pred             EECCCCCCCC-Cc---ccCCCCcEEECCCCCCC-CCCCc---cchhhE-EECcCCcccc-cCC---CCCCCCEEEccCCc
Confidence            8888888875 44   34578888888888887 45543   356666 8888888874 443   24778888888888


Q ss_pred             ccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccchhhhccccCCcccccCcccccccCC
Q 037916          261 LECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPT  339 (741)
Q Consensus       261 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~  339 (741)
                      |+++.    ..+++|+.|+|++|+|+. +|.   .+++|+.|+|++|+|+ .+|..|..+++|+.|+|++|++++.+|.
T Consensus       233 L~~lp----~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~  302 (622)
T 3g06_A          233 LTSLP----VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ  302 (622)
T ss_dssp             CSCCC----CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHH
T ss_pred             cCcCC----CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHH
Confidence            88644    456778888888888885 443   5678888888888888 5677788888888888888888877654

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.96  E-value=1.2e-28  Score=279.30  Aligned_cols=264  Identities=26%  Similarity=0.268  Sum_probs=222.3

Q ss_pred             CCCCCcccccCChhhhhCCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCc
Q 037916            2 DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHL   81 (741)
Q Consensus         2 dl~~n~~~~~ip~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L   81 (741)
                      |+++|.+. .||..++   ++|++|+|++|+|+. +|.   .+++|++|+|++|+|++ +|.   .++          +|
T Consensus        46 ~ls~n~L~-~lp~~l~---~~L~~L~L~~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~----------~L  103 (622)
T 3g06_A           46 NVGESGLT-TLPDCLP---AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTS-LPV---LPP----------GL  103 (622)
T ss_dssp             ECCSSCCS-CCCSCCC---TTCSEEEECSCCCSC-CCC---CCTTCCEEEECSCCCSC-CCC---CCT----------TC
T ss_pred             EecCCCcC-ccChhhC---CCCcEEEecCCCCCC-CCC---cCCCCCEEEcCCCcCCc-CCC---CCC----------CC
Confidence            68999998 9998887   899999999999995 454   57999999999999994 554   344          49


Q ss_pred             cEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEccc
Q 037916           82 KHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINT  161 (741)
Q Consensus        82 ~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~  161 (741)
                      ++|+|++|+|+++.+    .+. +|+.|++++|+|.. +|..   +++|++|+|++|+|+++. .   .+++|+.|++++
T Consensus       104 ~~L~Ls~N~l~~l~~----~l~-~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~l~-~---~~~~L~~L~L~~  170 (622)
T 3g06_A          104 LELSIFSNPLTHLPA----LPS-GLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLASLP-A---LPSELCKLWAYN  170 (622)
T ss_dssp             CEEEECSCCCCCCCC----CCT-TCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSCCC-C---CCTTCCEEECCS
T ss_pred             CEEECcCCcCCCCCC----CCC-CcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCCcC-C---ccCCCCEEECCC
Confidence            999999999996544    344 89999999999976 4443   489999999999999654 3   357899999999


Q ss_pred             CCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCCC
Q 037916          162 NKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSL  241 (741)
Q Consensus       162 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~  241 (741)
                      |+|++ +|   ..+++|+.|+|++|.|++ +|..   +++|+.|++++|+|+ .+|..   +++|+. |+|++|+|++ +
T Consensus       171 N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~-~l~~~---~~~L~~-L~Ls~N~L~~-l  236 (622)
T 3g06_A          171 NQLTS-LP---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SLPAL---PSGLKE-LIVSGNRLTS-L  236 (622)
T ss_dssp             SCCSC-CC---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-SCCCC---CTTCCE-EECCSSCCSC-C
T ss_pred             CCCCC-Cc---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCccc-ccCCC---CCCCCE-EEccCCccCc-C
Confidence            99996 44   457899999999999985 4433   479999999999998 66654   467887 9999999996 5


Q ss_pred             ChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccchhhhccc
Q 037916          242 PTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQ  321 (741)
Q Consensus       242 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  321 (741)
                      |   ..+++|+.|+|++|+|+.++.    .+++|+.|+|++|+|+ .+|..|.++++|+.|+|++|.+++..|..+..++
T Consensus       237 p---~~l~~L~~L~Ls~N~L~~lp~----~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~  308 (622)
T 3g06_A          237 P---VLPSELKELMVSGNRLTSLPM----LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT  308 (622)
T ss_dssp             C---CCCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred             C---CCCCcCcEEECCCCCCCcCCc----ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence            5   567899999999999997554    6789999999999999 6688899999999999999999998888887776


Q ss_pred             c
Q 037916          322 L  322 (741)
Q Consensus       322 ~  322 (741)
                      .
T Consensus       309 ~  309 (622)
T 3g06_A          309 S  309 (622)
T ss_dssp             H
T ss_pred             c
Confidence            3

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.96  E-value=3.7e-31  Score=277.42  Aligned_cols=202  Identities=23%  Similarity=0.239  Sum_probs=102.9

Q ss_pred             CCCccEEEcccccccccCCccc--cCCCcCcEEEcccCCCCCcCcccccCC-----cccceeeccCcccccccCcccccC
Q 037916          127 FINLQTLHMWDNQLSGTISPAI--GELQNLVTLAINTNKLSGNIPPSIGNL-----KKLLQLYLIENFLQVSIPSSLGQC  199 (741)
Q Consensus       127 l~~L~~L~L~~N~i~~~~~~~~--~~l~~L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~L~~N~i~~~~~~~~~~l  199 (741)
                      +++|++|+|++|+|++..|..+  ..+++|++|+|++|++++. |..|..+     ++|++|+|++|++++..|..|..+
T Consensus        94 l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l  172 (312)
T 1wwl_A           94 ISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVF  172 (312)
T ss_dssp             TSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCC
T ss_pred             cCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccC
Confidence            4444444444444444333332  4444444444444444433 3444433     444444444444444444444444


Q ss_pred             CCCCEEeccCcccccc--CCccc--cccccceeEEEcCCCccCCC---CChhhcCCCCCcEEEeccccccchhh-hhccc
Q 037916          200 QSLTTINLSYNNLSGT--IPPQL--MDLTSLSVGLDLSRNQLVGS---LPTEVGKLINLEILFISRNMLECEIL-STLGS  271 (741)
Q Consensus       200 ~~L~~L~L~~N~l~~~--~p~~~--~~l~~L~~~L~Ls~N~l~~~---~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~  271 (741)
                      ++|++|+|++|++.+.  .|..+  ..+++|+. |+|++|+|++.   ....+..+++|++|+|++|++++..+ ..+..
T Consensus       173 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~-L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~  251 (312)
T 1wwl_A          173 PALSTLDLSDNPELGERGLISALCPLKFPTLQV-LALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDW  251 (312)
T ss_dssp             SSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCE-EECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCC
T ss_pred             CCCCEEECCCCCcCcchHHHHHHHhccCCCCCE-EECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhh
Confidence            4555555555544332  11122  44455554 55555555421   11233455666666666666665442 34455


Q ss_pred             cccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccchhhhccccCCcccccCccccc
Q 037916          272 CIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEG  335 (741)
Q Consensus       272 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~  335 (741)
                      +++|++|+|++|+|+ .+|..+.  ++|++|+|++|+|++. |. +..+++|+.|+|++|++++
T Consensus       252 l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~  310 (312)
T 1wwl_A          252 PSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD  310 (312)
T ss_dssp             CTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred             cCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence            566666666666666 3444444  5666666666666654 44 6666666777777776654

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.96  E-value=2.1e-30  Score=271.61  Aligned_cols=248  Identities=18%  Similarity=0.171  Sum_probs=190.5

Q ss_pred             hCCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCc-ccCCchhh-------hhhhhhhccccCCCccEEECcCC
Q 037916           18 FTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLT-GEVPSEFG-------KATKAYCVQNCNQHLKHLDINNN   89 (741)
Q Consensus        18 ~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~-------~l~~~~~~~~~~~~L~~L~Ls~N   89 (741)
                      ..+++|++|++++|.+  .+|..+...  |++|+|++|+++ ...|..+.       +++          +|++|+|++|
T Consensus        40 ~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~----------~L~~L~L~~n  105 (312)
T 1wwl_A           40 GGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGIS----------GLQELTLENL  105 (312)
T ss_dssp             EEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTS----------CCCEEEEEEE
T ss_pred             ccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcC----------CccEEEccCC
Confidence            3567788888888888  566655544  888888888884 34555443       344          3888888888


Q ss_pred             cCcccCCchh--hcccccccEEEccCCcccccCCccccCC-----CCccEEEcccccccccCCccccCCCcCcEEEcccC
Q 037916           90 NFGGLLPGCI--CNFSITLETLIFNSNKIFRSIPAGIGKF-----INLQTLHMWDNQLSGTISPAIGELQNLVTLAINTN  162 (741)
Q Consensus        90 ~l~~~~~~~~--~~l~~~L~~L~L~~n~i~~~~~~~~~~l-----~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N  162 (741)
                      ++++..|..+  ..++ +|++|+|++|++.+. |..+..+     ++|++|+|++|+|+++.+..|.++++|++|+|++|
T Consensus       106 ~l~~~~~~~~~~~~l~-~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  183 (312)
T 1wwl_A          106 EVTGTAPPPLLEATGP-DLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDN  183 (312)
T ss_dssp             BCBSCCCCCSSSCCSC-CCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSC
T ss_pred             cccchhHHHHHHhcCC-CccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCC
Confidence            8887777765  6666 888888888888776 7777766     78888888888888888888888888888888888


Q ss_pred             CCCCc--Ccccc--cCCcccceeeccCccccc---ccCcccccCCCCCEEeccCccccccCC-ccccccccceeEEEcCC
Q 037916          163 KLSGN--IPPSI--GNLKKLLQLYLIENFLQV---SIPSSLGQCQSLTTINLSYNNLSGTIP-PQLMDLTSLSVGLDLSR  234 (741)
Q Consensus       163 ~l~~~--~~~~~--~~l~~L~~L~L~~N~i~~---~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~~L~Ls~  234 (741)
                      ++.+.  .+..+  ..+++|++|+|++|+|++   .....+..+++|++|+|++|+|++..| ..+..+++|+. |+|++
T Consensus       184 ~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~-L~Ls~  262 (312)
T 1wwl_A          184 PELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNS-LNLSF  262 (312)
T ss_dssp             TTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCE-EECTT
T ss_pred             CcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCE-EECCC
Confidence            87654  23333  788888888888888873   223445677889999999999887665 45666788887 99999


Q ss_pred             CccCCCCChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCccCC
Q 037916          235 NQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQG  287 (741)
Q Consensus       235 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  287 (741)
                      |+|+ .+|..+.  ++|++|+|++|+|+++ |. +..+++|++|+|++|++++
T Consensus       263 N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~  310 (312)
T 1wwl_A          263 TGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD  310 (312)
T ss_dssp             SCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred             CccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence            9988 5666655  7899999999999877 44 8888999999999998875

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.96  E-value=1.2e-29  Score=282.07  Aligned_cols=234  Identities=21%  Similarity=0.211  Sum_probs=150.6

Q ss_pred             CCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCccEEECcCCcCcccCCchhh
Q 037916           21 PNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCIC  100 (741)
Q Consensus        21 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~  100 (741)
                      ++|++|+|++|.|+++.|..|.++++|++|+|++|.|++..|  |..+++          |++|+|++|.|+++.+.   
T Consensus        34 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~----------L~~L~Ls~N~l~~l~~~---   98 (487)
T 3oja_A           34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLST----------LRTLDLNNNYVQELLVG---   98 (487)
T ss_dssp             GGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTT----------CCEEECCSSEEEEEEEC---
T ss_pred             CCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCC----------CCEEEecCCcCCCCCCC---
Confidence            378888888888888777888888888888888888886654  666665          88888888888755432   


Q ss_pred             cccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCccccc-CCcccc
Q 037916          101 NFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIG-NLKKLL  179 (741)
Q Consensus       101 ~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~  179 (741)
                        + +|++|++++|.|.+..+..   +++|++|+|++|.|+++.+..|.++++|++|+|++|+|++..|..|. .+++|+
T Consensus        99 --~-~L~~L~L~~N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~  172 (487)
T 3oja_A           99 --P-SIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLE  172 (487)
T ss_dssp             --T-TCCEEECCSSCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCC
T ss_pred             --C-CcCEEECcCCcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCccc
Confidence              3 6777777777776554432   35667777777777666666666666777777777777666666654 566666


Q ss_pred             eeeccCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccc
Q 037916          180 QLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRN  259 (741)
Q Consensus       180 ~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  259 (741)
                      +|+|++|.|++..+  +..+++|++|+|++|+|++ +|..|..+++|+. |+|++|.|++ +|..+..+++|+.|++++|
T Consensus       173 ~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~-L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N  247 (487)
T 3oja_A          173 HLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTW-ISLRNNKLVL-IEKALRFSQNLEHFDLRGN  247 (487)
T ss_dssp             EEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSE-EECTTSCCCE-ECTTCCCCTTCCEEECTTC
T ss_pred             EEecCCCccccccc--cccCCCCCEEECCCCCCCC-CCHhHcCCCCccE-EEecCCcCcc-cchhhccCCCCCEEEcCCC
Confidence            66666666665422  2235666666666666663 3333556666665 6666666653 4444555556666666665


Q ss_pred             ccc-chhhhhccccccccEEEe
Q 037916          260 MLE-CEILSTLGSCIKLEQLKL  280 (741)
Q Consensus       260 ~l~-~~~~~~~~~l~~L~~L~L  280 (741)
                      .+. +..+..+..+++|+.|++
T Consensus       248 ~l~c~~~~~~~~~l~~L~~l~~  269 (487)
T 3oja_A          248 GFHCGTLRDFFSKNQRVQTVAK  269 (487)
T ss_dssp             CBCHHHHHHHHTTCHHHHHHHH
T ss_pred             CCcCcchHHHHHhCCCCcEEec
Confidence            555 334444444444444444

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.95  E-value=9e-28  Score=247.12  Aligned_cols=209  Identities=21%  Similarity=0.177  Sum_probs=117.4

Q ss_pred             CccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEecc
Q 037916          129 NLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLS  208 (741)
Q Consensus       129 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~  208 (741)
                      +|++|+|++|+|+++.+..|.++++|++|+|++|+++++.+..|.++++|++|+|++|.+++..+..|.++++|++|+++
T Consensus        29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~  108 (276)
T 2z62_A           29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV  108 (276)
T ss_dssp             TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred             CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence            34444444444444444444444445555555554444444444445555555555555544444455555555555555


Q ss_pred             CccccccCCccccccccceeEEEcCCCccCCC-CChhhcCCCCCcEEEeccccccchhhhhcccccccc----EEEeCCC
Q 037916          209 YNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGS-LPTEVGKLINLEILFISRNMLECEILSTLGSCIKLE----QLKLGGN  283 (741)
Q Consensus       209 ~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~----~L~L~~N  283 (741)
                      +|++++..+..+.++++|+. |++++|.+++. +|..|..+++|++|+|++|+++++.+..|..+++|+    .|++++|
T Consensus       109 ~n~l~~~~~~~~~~l~~L~~-L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n  187 (276)
T 2z62_A          109 ETNLASLENFPIGHLKTLKE-LNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN  187 (276)
T ss_dssp             TSCCCCSTTCCCTTCTTCCE-EECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSS
T ss_pred             CCCccccCchhcccCCCCCE-EECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCC
Confidence            55555444444555555554 55555555542 355666666666666666666665555565555555    6666777


Q ss_pred             ccCCCCChhcccCccCCeeeCCCCcCCCccchhhhccccCCcccccCcccccccCC
Q 037916          284 LFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPT  339 (741)
Q Consensus       284 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~  339 (741)
                      ++++..+..+... +|+.|+|++|++++..+..|..+++|+.|+|++|++++..+.
T Consensus       188 ~l~~~~~~~~~~~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~  242 (276)
T 2z62_A          188 PMNFIQPGAFKEI-RLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  242 (276)
T ss_dssp             CCCEECTTSSCSC-CEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTT
T ss_pred             cccccCccccCCC-cccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCc
Confidence            6665555444433 677777777777766556666677777777777777766553

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.95  E-value=7.8e-30  Score=287.42  Aligned_cols=187  Identities=16%  Similarity=-0.003  Sum_probs=129.3

Q ss_pred             hcccCceeeEEEEEEcCCCeEEEEEEeeccCc----------CcchhHHHHHHHHHhc-CCCceeeEeeeecCccccCCc
Q 037916          407 WIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH----------GASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       407 ~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      ..+.|++|.+..++....|+.||+|++.....          ...+++.+|+++|+++ .|+||++++++     ++++.
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~-----~ed~~  315 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAH-----GENAQ  315 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEE-----EECSS
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEE-----EEECC
Confidence            35567777777777666788999999974311          1235688999999999 79999999999     67778


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..||||||++|++|.+++...          ..++..   +|+.||+.||+|+|++   |||||||||+|||++++|.+|
T Consensus       316 ~~yLVMEyv~G~~L~d~i~~~----------~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vK  379 (569)
T 4azs_A          316 SGWLVMEKLPGRLLSDMLAAG----------EEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHAR  379 (569)
T ss_dssp             EEEEEEECCCSEEHHHHHHTT----------CCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEE
T ss_pred             EEEEEEecCCCCcHHHHHHhC----------CCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEE
Confidence            999999999999999999744          334443   5899999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCC
Q 037916          556 VADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPS  618 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~  618 (741)
                      |+|||+|+........  ....+||+.|+|||.+ . +.+..++|+||+|++++++.++..++
T Consensus       380 L~DFGlAr~~~~~~~~--~~t~vGTp~YmAPE~l-~-g~~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          380 LIDFGSIVTTPQDCSW--PTNLVQSFFVFVNELF-A-ENKSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             ECCCTTEESCC---CC--SHHHHHHHHHHHHHHC-------------------CCCCTTHHHH
T ss_pred             EeecccCeeCCCCCcc--ccCceechhhccHHHh-C-CCCCCcccccccccchhhhccccchh
Confidence            9999999876544322  2235699999999654 3 35677899999999999887766553

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.95  E-value=1.5e-27  Score=245.49  Aligned_cols=226  Identities=20%  Similarity=0.199  Sum_probs=183.0

Q ss_pred             cEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEccc
Q 037916           82 KHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINT  161 (741)
Q Consensus        82 ~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~  161 (741)
                      ...+.++.++. .+|..+.   .+|++|++++|++.+..+..|.++++|++|+|++|+|+++.+..|.++++|++|+|++
T Consensus        10 ~~~~c~~~~l~-~ip~~l~---~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~   85 (276)
T 2z62_A           10 ITYQCMELNFY-KIPDNLP---FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTG   85 (276)
T ss_dssp             TEEECTTSCCS-SCCSSSC---TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTT
T ss_pred             ceEEecCCCcc-ccCCCCC---CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCC
Confidence            45666777776 3444332   2688888888888777777888888888888888888877777888888888888888


Q ss_pred             CCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCcccccc-CCccccccccceeEEEcCCCccCCC
Q 037916          162 NKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGT-IPPQLMDLTSLSVGLDLSRNQLVGS  240 (741)
Q Consensus       162 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~~L~Ls~N~l~~~  240 (741)
                      |++++..+..|.++++|++|++++|.+++..+..|..+++|++|+|++|++++. +|..|.++++|+. |+|++|++++.
T Consensus        86 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~-L~Ls~N~l~~~  164 (276)
T 2z62_A           86 NPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEH-LDLSSNKIQSI  164 (276)
T ss_dssp             CCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCE-EECCSSCCCEE
T ss_pred             CccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCE-EECCCCCCCcC
Confidence            888877777888888888888888888877776788888888888888888753 5788888888887 88888888877


Q ss_pred             CChhhcCCCCCc----EEEeccccccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCcc
Q 037916          241 LPTEVGKLINLE----ILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEI  313 (741)
Q Consensus       241 ~p~~~~~l~~L~----~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  313 (741)
                      .+..|..+++|+    .|++++|.++++.+..+... +|+.|+|++|++++..+..|..+++|+.|+|++|.+++.-
T Consensus       165 ~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c  240 (276)
T 2z62_A          165 YCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC  240 (276)
T ss_dssp             CGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCSC-CEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCT
T ss_pred             CHHHhhhhhhccccceeeecCCCcccccCccccCCC-cccEEECCCCceeecCHhHhcccccccEEEccCCcccccC
Confidence            777777777777    89999999998777777654 7999999999999888888899999999999999998644

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.94  E-value=1.5e-26  Score=237.08  Aligned_cols=207  Identities=26%  Similarity=0.274  Sum_probs=123.8

Q ss_pred             ccCCCccEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCc
Q 037916           76 NCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLV  155 (741)
Q Consensus        76 ~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~  155 (741)
                      .|..+++.+++++|+++. +|..+.   .+|+.|+|++|++....+..|.++++|++|+|++|+|+.+.+..|.++++|+
T Consensus        13 ~c~~~~~~l~~~~~~l~~-ip~~~~---~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~   88 (270)
T 2o6q_A           13 SCNNNKNSVDCSSKKLTA-IPSNIP---ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLE   88 (270)
T ss_dssp             EEETTTTEEECTTSCCSS-CCSCCC---TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCC
T ss_pred             EeCCCCCEEEccCCCCCc-cCCCCC---CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCC
Confidence            444567778888877774 343322   2566666666666655555666666666666666666655555556666666


Q ss_pred             EEEcccCCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCC
Q 037916          156 TLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRN  235 (741)
Q Consensus       156 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N  235 (741)
                      +|+|++|+++++.+..|.++++|++|+|++|.+++..+..|..+++|++                         |+|++|
T Consensus        89 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~-------------------------L~Ls~n  143 (270)
T 2o6q_A           89 TLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTY-------------------------LSLGYN  143 (270)
T ss_dssp             EEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCE-------------------------EECCSS
T ss_pred             EEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCE-------------------------EECCCC
Confidence            6666666665554445555555555555555555444444444444444                         555555


Q ss_pred             ccCCCCChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCC
Q 037916          236 QLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISG  311 (741)
Q Consensus       236 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  311 (741)
                      .|++..+..|..+++|+.|+|++|+++.+.+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|.+..
T Consensus       144 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c  219 (270)
T 2o6q_A          144 ELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDC  219 (270)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred             cCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeC
Confidence            5544444445555566666666666665555556666666666666666666666667777777777777777654

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.94  E-value=2.3e-26  Score=235.63  Aligned_cols=207  Identities=23%  Similarity=0.237  Sum_probs=163.1

Q ss_pred             CccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEecc
Q 037916          129 NLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLS  208 (741)
Q Consensus       129 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~  208 (741)
                      +++++++++|.++.+ |..+.  ++|++|+|++|+|+++.+.+|.++++|++|+|++|.++...+..|..+++|++|+|+
T Consensus        17 ~~~~l~~~~~~l~~i-p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~   93 (270)
T 2o6q_A           17 NKNSVDCSSKKLTAI-PSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT   93 (270)
T ss_dssp             TTTEEECTTSCCSSC-CSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECC
T ss_pred             CCCEEEccCCCCCcc-CCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECC
Confidence            345566666665533 22222  356666666666665555566666666666666666665555566677777777777


Q ss_pred             CccccccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCccCCC
Q 037916          209 YNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGP  288 (741)
Q Consensus       209 ~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  288 (741)
                      +|++++..+..|.++++|+. |+|++|++++..+..|..+++|++|+|++|.|+.+.+..|..+++|+.|+|++|++++.
T Consensus        94 ~n~l~~~~~~~~~~l~~L~~-L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~  172 (270)
T 2o6q_A           94 DNKLQALPIGVFDQLVNLAE-LRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRV  172 (270)
T ss_dssp             SSCCCCCCTTTTTTCSSCCE-EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred             CCcCCcCCHhHcccccCCCE-EECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEe
Confidence            77777655666777888887 88888888877888899999999999999999999888899999999999999999998


Q ss_pred             CChhcccCccCCeeeCCCCcCCCccchhhhccccCCcccccCcccccccCC
Q 037916          289 IPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPT  339 (741)
Q Consensus       289 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~  339 (741)
                      .+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++.+....
T Consensus       173 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~  223 (270)
T 2o6q_A          173 PEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCNG  223 (270)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSSS
T ss_pred             ChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCcc
Confidence            888899999999999999999988888899999999999999999877653

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.94  E-value=2.5e-26  Score=237.47  Aligned_cols=198  Identities=23%  Similarity=0.184  Sum_probs=95.3

Q ss_pred             cccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCcccccCCcccceeecc
Q 037916          105 TLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLI  184 (741)
Q Consensus       105 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  184 (741)
                      +++++++++|++.. +|..+.  ++|++|+|++|+|+++.+..|.++++|++|+|++|+|+++.+  ...+++|++|+|+
T Consensus        11 ~l~~l~~~~~~l~~-ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~Ls   85 (290)
T 1p9a_G           11 SHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV--DGTLPVLGTLDLS   85 (290)
T ss_dssp             TCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC--CSCCTTCCEEECC
T ss_pred             CccEEECCCCCCCc-CCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC--CCCCCcCCEEECC
Confidence            55555555555533 233332  355555555555555555555555555555555555553322  1444555555555


Q ss_pred             CcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccch
Q 037916          185 ENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECE  264 (741)
Q Consensus       185 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  264 (741)
                      +|+|+ .+|..+..+++|++|+|++|+|++..|..|.++++|+. |+|++|+|++..+..|..+++|+.|+|++|+|+.+
T Consensus        86 ~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~-L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l  163 (290)
T 1p9a_G           86 HNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQE-LYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTEL  163 (290)
T ss_dssp             SSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCE-EECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCC
T ss_pred             CCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCE-EECCCCCCCccChhhcccccCCCEEECCCCcCCcc
Confidence            55554 33444444455555555555554333344444444444 44444444444444444444444444444444444


Q ss_pred             hhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCC
Q 037916          265 ILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNIS  310 (741)
Q Consensus       265 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  310 (741)
                      .+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|.+.
T Consensus       164 ~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~  208 (290)
T 1p9a_G          164 PAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL  208 (290)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred             CHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCcc
Confidence            4444444444444444444444 23333333344444444444443

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.94  E-value=4.3e-26  Score=235.77  Aligned_cols=207  Identities=24%  Similarity=0.186  Sum_probs=180.4

Q ss_pred             cccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCcccccCCcccceeeccCcccccccCcccccCCCC
Q 037916          123 GIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSL  202 (741)
Q Consensus       123 ~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L  202 (741)
                      .+.++++|+++++++|.|+.+++..+   ++|+.|+|++|+|+++.+..|.++++|++|+|++|.|++..+.  ..+++|
T Consensus         5 ~~~~l~~l~~l~~~~~~l~~ip~~~~---~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L   79 (290)
T 1p9a_G            5 EVSKVASHLEVNCDKRNLTALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVL   79 (290)
T ss_dssp             EEECSTTCCEEECTTSCCSSCCSCCC---TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTC
T ss_pred             cccccCCccEEECCCCCCCcCCCCCC---CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcC
Confidence            36778899999999999996654433   6899999999999988888999999999999999999866543  788999


Q ss_pred             CEEeccCccccccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCC
Q 037916          203 TTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGG  282 (741)
Q Consensus       203 ~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  282 (741)
                      ++|+|++|+|+ .+|..+..+++|+. |+|++|+|++..+..|..+++|++|+|++|+|+.+.+..|..+++|+.|+|++
T Consensus        80 ~~L~Ls~N~l~-~l~~~~~~l~~L~~-L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  157 (290)
T 1p9a_G           80 GTLDLSHNQLQ-SLPLLGQTLPALTV-LDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLAN  157 (290)
T ss_dssp             CEEECCSSCCS-SCCCCTTTCTTCCE-EECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred             CEEECCCCcCC-cCchhhccCCCCCE-EECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCC
Confidence            99999999998 78888899999997 99999999988888899999999999999999988888899999999999999


Q ss_pred             CccCCCCChhcccCccCCeeeCCCCcCCCccchhhhccccCCcccccCccccccc
Q 037916          283 NLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVI  337 (741)
Q Consensus       283 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~  337 (741)
                      |+|++..+..|..+++|+.|+|++|+|+ .+|..+..+.+|+.|+|++|++.+..
T Consensus       158 N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c  211 (290)
T 1p9a_G          158 NNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC  211 (290)
T ss_dssp             SCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred             CcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCcC
Confidence            9999887788889999999999999998 56666777788899999999887654

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.93  E-value=3.5e-26  Score=234.49  Aligned_cols=204  Identities=23%  Similarity=0.214  Sum_probs=139.7

Q ss_pred             cCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCE
Q 037916          125 GKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTT  204 (741)
Q Consensus       125 ~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~  204 (741)
                      ..+++|+.|++++|.++.+  ..+..+++|++|+|++|++++.  ..+..+++|++|+|++|.+++..+..|..+++|++
T Consensus        38 ~~l~~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~  113 (272)
T 3rfs_A           38 NELNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKE  113 (272)
T ss_dssp             HHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCE
T ss_pred             ccccceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCE
Confidence            3444555555555555532  2355555666666666665542  25556666666666666666555555666666666


Q ss_pred             EeccCccccccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCc
Q 037916          205 INLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNL  284 (741)
Q Consensus       205 L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  284 (741)
                      |+|++|++++..+..|.++++|+. |+|++|++++..+..|+.+++|++|+|++|+++++.+..|..+++|+.|++++|+
T Consensus       114 L~L~~n~l~~~~~~~~~~l~~L~~-L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~  192 (272)
T 3rfs_A          114 LVLVENQLQSLPDGVFDKLTNLTY-LNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQ  192 (272)
T ss_dssp             EECTTSCCCCCCTTTTTTCTTCCE-EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EECCCCcCCccCHHHhccCCCCCE-EECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCc
Confidence            666666666555555666667765 7777777776666667777777777777777777777777778888888888888


Q ss_pred             cCCCCChhcccCccCCeeeCCCCcCCCccchhhhccccCCcccccCcccccccCCc
Q 037916          285 FQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTE  340 (741)
Q Consensus       285 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~  340 (741)
                      +++..+..|..+++|+.|+|++|.+.+.       ++.|+.|++..|.++|.+|..
T Consensus       193 l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~  241 (272)
T 3rfs_A          193 LKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNS  241 (272)
T ss_dssp             CSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCT
T ss_pred             CCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCc
Confidence            8877777788888888888888887753       446888888889998887765

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.93  E-value=6e-26  Score=232.80  Aligned_cols=229  Identities=19%  Similarity=0.192  Sum_probs=176.6

Q ss_pred             CCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCccEEECcCCcCcccCCchhh
Q 037916           21 PNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCIC  100 (741)
Q Consensus        21 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~  100 (741)
                      .++..++++++.+.+..  .+..+++|+.|++++|.++. ++ .+..+++          |++|+|++|++++.  ..+.
T Consensus        19 ~~l~~l~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~-~~-~l~~l~~----------L~~L~l~~n~l~~~--~~l~   82 (272)
T 3rfs_A           19 AETIKANLKKKSVTDAV--TQNELNSIDQIIANNSDIKS-VQ-GIQYLPN----------VRYLALGGNKLHDI--SALK   82 (272)
T ss_dssp             HHHHHHHHTCSCTTSEE--CHHHHTTCCEEECTTSCCCC-CT-TGGGCTT----------CCEEECTTSCCCCC--GGGT
T ss_pred             HHHHHHHhcCccccccc--ccccccceeeeeeCCCCccc-cc-ccccCCC----------CcEEECCCCCCCCc--hhhc
Confidence            55666777777776543  35567788888888888773 22 4666654          88888888888753  3566


Q ss_pred             cccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCcccccCCcccce
Q 037916          101 NFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQ  180 (741)
Q Consensus       101 ~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  180 (741)
                      .++ +|++|+|++|++.+..+..|..+++|++|+|++|+++++.+..|.++++|++|+|++|++++..+..|..+++|++
T Consensus        83 ~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~  161 (272)
T 3rfs_A           83 ELT-NLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTE  161 (272)
T ss_dssp             TCT-TCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred             CCC-CCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCE
Confidence            776 7888888888887777777888888888888888888777777888888888888888888777777888888888


Q ss_pred             eeccCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEecccc
Q 037916          181 LYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNM  260 (741)
Q Consensus       181 L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  260 (741)
                      |+|++|++++..+..|..+++|++|+|++|++++..|..|..+++|+. |+|++|.+.+.       +++|+.|+++.|.
T Consensus       162 L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~-L~l~~N~~~~~-------~~~l~~l~~~~n~  233 (272)
T 3rfs_A          162 LDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQY-IWLHDNPWDCT-------CPGIRYLSEWINK  233 (272)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCE-EECCSSCBCCC-------TTTTHHHHHHHHH
T ss_pred             EECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCE-EEccCCCcccc-------CcHHHHHHHHHHh
Confidence            888888888777777788888888888888888777777788888887 88888887643       4478888888888


Q ss_pred             ccchhhhhcccccc
Q 037916          261 LECEILSTLGSCIK  274 (741)
Q Consensus       261 l~~~~~~~~~~l~~  274 (741)
                      +++..|..++.+..
T Consensus       234 ~~g~ip~~~~~~~~  247 (272)
T 3rfs_A          234 HSGVVRNSAGSVAP  247 (272)
T ss_dssp             TGGGBBCTTSCBCG
T ss_pred             CCCcccCcccccCC
Confidence            88888887776654

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.93  E-value=4.8e-26  Score=228.82  Aligned_cols=196  Identities=17%  Similarity=0.169  Sum_probs=99.4

Q ss_pred             cccEEEccCCcccccCCccccCCCCccEEEccccc-ccccCCccccCCCcCcEEEccc-CCCCCcCcccccCCcccceee
Q 037916          105 TLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQ-LSGTISPAIGELQNLVTLAINT-NKLSGNIPPSIGNLKKLLQLY  182 (741)
Q Consensus       105 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~-i~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~  182 (741)
                      +|++|++++|++.++.+..|.++++|++|+|++|+ ++++.+..|.++++|++|+|++ |+|+++.+..|.++++|++|+
T Consensus        32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~  111 (239)
T 2xwt_C           32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG  111 (239)
T ss_dssp             TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred             cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence            45555555555544444445555555555555553 4444444455555555555554 455444444444444444444


Q ss_pred             ccCcccccccCcccccCCCCCEEeccCccccccCCccccccccce---eEEEcCCC-ccCCCCChhhcCCCCCc-EEEec
Q 037916          183 LIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLS---VGLDLSRN-QLVGSLPTEVGKLINLE-ILFIS  257 (741)
Q Consensus       183 L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~---~~L~Ls~N-~l~~~~p~~~~~l~~L~-~L~Ls  257 (741)
                      |++|.+++                         +|. |..+++|+   . |++++| .+++..+..|..+++|+ .|+++
T Consensus       112 l~~n~l~~-------------------------lp~-~~~l~~L~~L~~-L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~  164 (239)
T 2xwt_C          112 IFNTGLKM-------------------------FPD-LTKVYSTDIFFI-LEITDNPYMTSIPVNAFQGLCNETLTLKLY  164 (239)
T ss_dssp             EEEECCCS-------------------------CCC-CTTCCBCCSEEE-EEEESCTTCCEECTTTTTTTBSSEEEEECC
T ss_pred             CCCCCCcc-------------------------ccc-cccccccccccE-EECCCCcchhhcCcccccchhcceeEEEcC
Confidence            44444443                         333 44444443   4 555555 55544444455555555 55555


Q ss_pred             cccccchhhhhccccccccEEEeCCCc-cCCCCChhcccC-ccCCeeeCCCCcCCCccchhhhccccCCcccccCc
Q 037916          258 RNMLECEILSTLGSCIKLEQLKLGGNL-FQGPIPLSLSSL-RGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYN  331 (741)
Q Consensus       258 ~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N  331 (741)
                      +|+++.+.+..|.. ++|+.|+|++|+ ++++.+..|.++ ++|+.|+|++|+|++..+.   .+++|+.|+++++
T Consensus       165 ~n~l~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~  236 (239)
T 2xwt_C          165 NNGFTSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNT  236 (239)
T ss_dssp             SCCCCEECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred             CCCCcccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCc
Confidence            55555444444444 556666666663 555555555555 6666666666666543333   3445555555544

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.93  E-value=1.1e-25  Score=226.26  Aligned_cols=197  Identities=18%  Similarity=0.172  Sum_probs=152.0

Q ss_pred             cCcEEEcccCCCCCcCcccccCCcccceeeccCcc-cccccCcccccCCCCCEEeccC-ccccccCCccccccccceeEE
Q 037916          153 NLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENF-LQVSIPSSLGQCQSLTTINLSY-NNLSGTIPPQLMDLTSLSVGL  230 (741)
Q Consensus       153 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-i~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~~L  230 (741)
                      +|++|+|++|+|+++.+..|.++++|++|++++|. ++.+.+..|.++++|++|+|++ |+|++..+..|.++++|+. |
T Consensus        32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~-L  110 (239)
T 2xwt_C           32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKF-L  110 (239)
T ss_dssp             TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCE-E
T ss_pred             cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCE-E
Confidence            44455555555554444455555555555555554 5545555666666677777776 6776555667777888887 8


Q ss_pred             EcCCCccCCCCChhhcCCCCCc---EEEeccc-cccchhhhhcccccccc-EEEeCCCccCCCCChhcccCccCCeeeCC
Q 037916          231 DLSRNQLVGSLPTEVGKLINLE---ILFISRN-MLECEILSTLGSCIKLE-QLKLGGNLFQGPIPLSLSSLRGLRVLDLS  305 (741)
Q Consensus       231 ~Ls~N~l~~~~p~~~~~l~~L~---~L~Ls~N-~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  305 (741)
                      ++++|++++ +|. |..+++|+   +|++++| .++.+.+..|.++++|+ .|++++|+++.+.+..|.. ++|+.|+|+
T Consensus       111 ~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~  187 (239)
T 2xwt_C          111 GIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLN  187 (239)
T ss_dssp             EEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECT
T ss_pred             eCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcC
Confidence            889999886 555 88888888   9999999 99999999999999999 9999999999666666766 899999999


Q ss_pred             CCc-CCCccchhhhcc-ccCCcccccCcccccccCCccccCCcccccccCCC
Q 037916          306 QNN-ISGEIPKFLVEL-QLVQNLNLSYNDLEGVIPTEGVFKNASAISVFGNS  355 (741)
Q Consensus       306 ~N~-l~~~~~~~~~~l-~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~n~  355 (741)
                      +|+ +++..+..|..+ ++|+.|++++|++++.++.  .+..+..+.+.++.
T Consensus       188 ~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~--~~~~L~~L~l~~~~  237 (239)
T 2xwt_C          188 KNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK--GLEHLKELIARNTW  237 (239)
T ss_dssp             TCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT--TCTTCSEEECTTC-
T ss_pred             CCCCcccCCHHHhhccccCCcEEECCCCccccCChh--HhccCceeeccCcc
Confidence            995 998888899999 9999999999999987665  58889998887663

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.92  E-value=1.3e-26  Score=248.20  Aligned_cols=256  Identities=18%  Similarity=0.169  Sum_probs=116.1

Q ss_pred             EEeecCcCcccCCchhhhhhhhhhccccCCCccEEECcCCcCcccCC----chhhcccccccEEEccCCcccccCCcccc
Q 037916           50 FQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLP----GCICNFSITLETLIFNSNKIFRSIPAGIG  125 (741)
Q Consensus        50 L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~----~~~~~l~~~L~~L~L~~n~i~~~~~~~~~  125 (741)
                      +.|++|++++.+|..+....+          |++|||++|+|++..+    ..+..++.+|++|+|++|+|....+..|.
T Consensus         3 ~~ls~n~~~~~~~~~~~~~~~----------L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~   72 (362)
T 3goz_A            3 YKLTLHPGSNPVEEFTSIPHG----------VTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELV   72 (362)
T ss_dssp             EECCCCTTCCHHHHHHTSCTT----------CCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHH
T ss_pred             cccccccchHHHHHHHhCCCC----------ceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHH
Confidence            455556665554443333322          5566666665554444    33333332455555555555444444443


Q ss_pred             CC-----CCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCcccccCC-cccceeeccCcccccccCccccc-
Q 037916          126 KF-----INLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNL-KKLLQLYLIENFLQVSIPSSLGQ-  198 (741)
Q Consensus       126 ~l-----~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~L~~N~i~~~~~~~~~~-  198 (741)
                      .+     ++|++|+|++|+|++..+..+...                    +..+ ++|++|+|++|.|+...+..+.. 
T Consensus        73 ~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~--------------------l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~  132 (362)
T 3goz_A           73 QILAAIPANVTSLNLSGNFLSYKSSDELVKT--------------------LAAIPFTITVLDLGWNDFSSKSSSEFKQA  132 (362)
T ss_dssp             HHHHTSCTTCCEEECCSSCGGGSCHHHHHHH--------------------HHTSCTTCCEEECCSSCGGGSCHHHHHHH
T ss_pred             HHHhccCCCccEEECcCCcCChHHHHHHHHH--------------------HHhCCCCccEEECcCCcCCcHHHHHHHHH
Confidence            32     445555555555444333322211                    1222 44444444444444333332221 


Q ss_pred             ----CCCCCEEeccCccccccCC----ccccccc-cceeEEEcCCCccCCCCChhhc----CC-CCCcEEEeccccccch
Q 037916          199 ----CQSLTTINLSYNNLSGTIP----PQLMDLT-SLSVGLDLSRNQLVGSLPTEVG----KL-INLEILFISRNMLECE  264 (741)
Q Consensus       199 ----l~~L~~L~L~~N~l~~~~p----~~~~~l~-~L~~~L~Ls~N~l~~~~p~~~~----~l-~~L~~L~Ls~N~l~~~  264 (741)
                          .++|++|+|++|+|++..+    ..+..++ +|+. |+|++|+|++..+..+.    .+ ++|++|+|++|.|+..
T Consensus       133 l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~-L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~  211 (362)
T 3goz_A          133 FSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNS-LNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLK  211 (362)
T ss_dssp             HTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCE-EECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGS
T ss_pred             HHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccE-eeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChh
Confidence                1345555555555542221    1222222 4444 55555555444433222    22 3555555555555542


Q ss_pred             ----hhhhccc-cccccEEEeCCCccCCCCCh----hcccCccCCeeeCCCCcCCCccc-------hhhhccccCCcccc
Q 037916          265 ----ILSTLGS-CIKLEQLKLGGNLFQGPIPL----SLSSLRGLRVLDLSQNNISGEIP-------KFLVELQLVQNLNL  328 (741)
Q Consensus       265 ----~~~~~~~-l~~L~~L~L~~N~l~~~~~~----~~~~l~~L~~L~Ls~N~l~~~~~-------~~~~~l~~L~~L~l  328 (741)
                          .+..+.. .++|++|+|++|++++..+.    .+..+++|+.|+|++|.+.+..+       ..+..+++|+.||+
T Consensus       212 ~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL  291 (362)
T 3goz_A          212 SYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDK  291 (362)
T ss_dssp             CHHHHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECT
T ss_pred             HHHHHHHHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEec
Confidence                2223333 23566666666655544332    23444556666666665433222       23445555666666


Q ss_pred             cCcccccc
Q 037916          329 SYNDLEGV  336 (741)
Q Consensus       329 ~~N~l~~~  336 (741)
                      ++|++...
T Consensus       292 ~~N~l~~~  299 (362)
T 3goz_A          292 NGKEIHPS  299 (362)
T ss_dssp             TSCBCCGG
T ss_pred             CCCcCCCc
Confidence            66665544

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.92  E-value=8.7e-27  Score=249.51  Aligned_cols=233  Identities=15%  Similarity=0.170  Sum_probs=122.0

Q ss_pred             CCCCCcccccCChhhhhCCCCCcEEEcccCcccccCC----ccCCCCC-CCcEEEeecCcCcccCCchhhhhhhhhhccc
Q 037916            2 DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIP----SSMFNAS-KLEVFQVTSNNLTGEVPSEFGKATKAYCVQN   76 (741)
Q Consensus         2 dl~~n~~~~~ip~~~~~~l~~L~~L~L~~n~i~~~~~----~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~   76 (741)
                      +|++|.+.+.+|..+. ..++|++|+|++|+|++..+    +.|.+++ +|++|+|++|+|++..+..|..+-.     .
T Consensus         4 ~ls~n~~~~~~~~~~~-~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~-----~   77 (362)
T 3goz_A            4 KLTLHPGSNPVEEFTS-IPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILA-----A   77 (362)
T ss_dssp             ECCCCTTCCHHHHHHT-SCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHH-----T
T ss_pred             ccccccchHHHHHHHh-CCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHh-----c
Confidence            4677777777665444 45557777777777776665    6666777 7777777777777666666665411     0


Q ss_pred             cCCCccEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCC-CCccEEEcccccccccCCcccc----C-
Q 037916           77 CNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKF-INLQTLHMWDNQLSGTISPAIG----E-  150 (741)
Q Consensus        77 ~~~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l-~~L~~L~L~~N~i~~~~~~~~~----~-  150 (741)
                      +..+|++|+|++|+|++..+..+...                     +..+ ++|++|+|++|+|++..+..+.    . 
T Consensus        78 ~~~~L~~L~Ls~n~l~~~~~~~l~~~---------------------l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~  136 (362)
T 3goz_A           78 IPANVTSLNLSGNFLSYKSSDELVKT---------------------LAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNL  136 (362)
T ss_dssp             SCTTCCEEECCSSCGGGSCHHHHHHH---------------------HHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTS
T ss_pred             cCCCccEEECcCCcCChHHHHHHHHH---------------------HHhCCCCccEEECcCCcCCcHHHHHHHHHHHhC
Confidence            11237777777777765555433332                     1112 3455555555555444333322    2 


Q ss_pred             CCcCcEEEcccCCCCCcCc----ccccCCc-ccceeeccCcccccccCcccc----cC-CCCCEEeccCcccccc----C
Q 037916          151 LQNLVTLAINTNKLSGNIP----PSIGNLK-KLLQLYLIENFLQVSIPSSLG----QC-QSLTTINLSYNNLSGT----I  216 (741)
Q Consensus       151 l~~L~~L~L~~N~l~~~~~----~~~~~l~-~L~~L~L~~N~i~~~~~~~~~----~l-~~L~~L~L~~N~l~~~----~  216 (741)
                      .++|++|+|++|+|++...    ..+..++ +|++|+|++|.|++..+..+.    .+ ++|++|+|++|+|++.    +
T Consensus       137 ~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l  216 (362)
T 3goz_A          137 PASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAEL  216 (362)
T ss_dssp             CTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHH
T ss_pred             CCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHH
Confidence            1355555555555543222    2223333 555555555555544433222    22 3566666666665531    2


Q ss_pred             Ccccccc-ccceeEEEcCCCccCCCCCh----hhcCCCCCcEEEecccccc
Q 037916          217 PPQLMDL-TSLSVGLDLSRNQLVGSLPT----EVGKLINLEILFISRNMLE  262 (741)
Q Consensus       217 p~~~~~l-~~L~~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~Ls~N~l~  262 (741)
                      +..+..+ ++|+. |+|++|.|.+..+.    .+..+++|++|+|++|.+.
T Consensus       217 ~~~l~~~~~~L~~-L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~  266 (362)
T 3goz_A          217 AYIFSSIPNHVVS-LNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVK  266 (362)
T ss_dssp             HHHHHHSCTTCCE-EECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHT
T ss_pred             HHHHhcCCCCceE-EECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCcc
Confidence            3333332 24554 55555555543332    2344455666666666533

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.92  E-value=1.8e-25  Score=236.96  Aligned_cols=251  Identities=16%  Similarity=0.226  Sum_probs=194.0

Q ss_pred             CccEEECcCCcCcccCCchhhcc--cccccEEEccCCcccccCCccccCCCCccEEEccccccccc-CCccccCCCcCcE
Q 037916           80 HLKHLDINNNNFGGLLPGCICNF--SITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGT-ISPAIGELQNLVT  156 (741)
Q Consensus        80 ~L~~L~Ls~N~l~~~~~~~~~~l--~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~-~~~~~~~l~~L~~  156 (741)
                      .++.|++++|.+.   +..+..+  . +++.|++++|.+.+..+. +..+++|++|+|++|.+++. .+..+..+++|++
T Consensus        48 ~~~~l~l~~~~~~---~~~~~~~~~~-~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~  122 (336)
T 2ast_B           48 LWQTLDLTGKNLH---PDVTGRLLSQ-GVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQN  122 (336)
T ss_dssp             TSSEEECTTCBCC---HHHHHHHHHT-TCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSE
T ss_pred             hheeeccccccCC---HHHHHhhhhc-cceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCE
Confidence            3777777777765   3444444  4 778888888887666554 55678888888888888765 6677888888888


Q ss_pred             EEcccCCCCCcCcccccCCcccceeeccCc-ccccc-cCcccccCCCCCEEeccCc-ccccc-CCccccccc-cceeEEE
Q 037916          157 LAINTNKLSGNIPPSIGNLKKLLQLYLIEN-FLQVS-IPSSLGQCQSLTTINLSYN-NLSGT-IPPQLMDLT-SLSVGLD  231 (741)
Q Consensus       157 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N-~i~~~-~~~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~-~L~~~L~  231 (741)
                      |+|++|++++..+..|+.+++|++|+|++| .+++. ++..+..+++|++|++++| .+++. ++..+..++ +|+. |+
T Consensus       123 L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~-L~  201 (336)
T 2ast_B          123 LSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQ-LN  201 (336)
T ss_dssp             EECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCE-EE
T ss_pred             EeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCE-EE
Confidence            888888888777788888888888888888 67653 5666788889999999998 88754 566778888 8887 99


Q ss_pred             cCCCc--cC-CCCChhhcCCCCCcEEEecccc-ccchhhhhccccccccEEEeCCCc-cCCCCChhcccCccCCeeeCCC
Q 037916          232 LSRNQ--LV-GSLPTEVGKLINLEILFISRNM-LECEILSTLGSCIKLEQLKLGGNL-FQGPIPLSLSSLRGLRVLDLSQ  306 (741)
Q Consensus       232 Ls~N~--l~-~~~p~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~Ls~  306 (741)
                      +++|.  ++ +.+|..+..+++|++|+|++|. ++...+..+..+++|+.|++++|. +.......+..+++|+.|+|++
T Consensus       202 l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~  281 (336)
T 2ast_B          202 LSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFG  281 (336)
T ss_dssp             CCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTT
T ss_pred             eCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccC
Confidence            99984  44 3456778889999999999998 777778888999999999999995 3322223688899999999999


Q ss_pred             CcCCCccchhhhcc-ccCCcccccCcccccccCCc
Q 037916          307 NNISGEIPKFLVEL-QLVQNLNLSYNDLEGVIPTE  340 (741)
Q Consensus       307 N~l~~~~~~~~~~l-~~L~~L~l~~N~l~~~~~~~  340 (741)
                      | ++   ...+..+ ..+..|++++|.+++..|..
T Consensus       282 ~-i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~~  312 (336)
T 2ast_B          282 I-VP---DGTLQLLKEALPHLQINCSHFTTIARPT  312 (336)
T ss_dssp             S-SC---TTCHHHHHHHSTTSEESCCCSCCTTCSS
T ss_pred             c-cC---HHHHHHHHhhCcceEEecccCccccCCc
Confidence            9 44   2344455 35888899999999988765

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.92  E-value=4.8e-25  Score=230.70  Aligned_cols=199  Identities=20%  Similarity=0.127  Sum_probs=122.7

Q ss_pred             cccEEEccCCcccccCCccc--cCCCCccEEEcccccccccCC----ccccCCCcCcEEEcccCCCCCcCcccccCCccc
Q 037916          105 TLETLIFNSNKIFRSIPAGI--GKFINLQTLHMWDNQLSGTIS----PAIGELQNLVTLAINTNKLSGNIPPSIGNLKKL  178 (741)
Q Consensus       105 ~L~~L~L~~n~i~~~~~~~~--~~l~~L~~L~L~~N~i~~~~~----~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  178 (741)
                      +|++|++++|++.+..|..+  ..+++|++|+|++|+|++..+    ..+..+++|++|+|++|++++..+..|.++++|
T Consensus        92 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L  171 (310)
T 4glp_A           92 RLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPAL  171 (310)
T ss_dssp             CCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTC
T ss_pred             ceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCC
Confidence            46666666666655555555  566666666666666664333    233456666666666666666666666666666


Q ss_pred             ceeeccCcccccc---c-CcccccCCCCCEEeccCccccccCCc----cccccccceeEEEcCCCccCCCCChhhcCC--
Q 037916          179 LQLYLIENFLQVS---I-PSSLGQCQSLTTINLSYNNLSGTIPP----QLMDLTSLSVGLDLSRNQLVGSLPTEVGKL--  248 (741)
Q Consensus       179 ~~L~L~~N~i~~~---~-~~~~~~l~~L~~L~L~~N~l~~~~p~----~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l--  248 (741)
                      ++|+|++|++.+.   . +..+..+++|++|+|++|+++ .++.    .+.++++|+. |+|++|+|.+..|..+..+  
T Consensus       172 ~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~-L~Ls~N~l~~~~p~~~~~~~~  249 (310)
T 4glp_A          172 TSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHS-LDLSHNSLRATVNPSAPRCMW  249 (310)
T ss_dssp             CEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSS-EECTTSCCCCCCCSCCSSCCC
T ss_pred             CEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCE-EECCCCCCCccchhhHHhccC
Confidence            6666666665431   1 222355666666666666665 2222    2345566665 7777777766656555555  


Q ss_pred             -CCCcEEEeccccccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCC
Q 037916          249 -INLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNIS  310 (741)
Q Consensus       249 -~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  310 (741)
                       ++|++|+|++|+|+.+ |..+.  ++|+.|+|++|+|++. |. +..+++|+.|+|++|+|+
T Consensus       250 ~~~L~~L~Ls~N~l~~l-p~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~  307 (310)
T 4glp_A          250 SSALNSLNLSFAGLEQV-PKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFL  307 (310)
T ss_dssp             CTTCCCEECCSSCCCSC-CSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTS
T ss_pred             cCcCCEEECCCCCCCch-hhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCC
Confidence             5777777777777744 33332  5777777777777754 32 567778888888888776

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.92  E-value=7.1e-25  Score=233.45  Aligned_cols=243  Identities=16%  Similarity=0.123  Sum_probs=149.9

Q ss_pred             CccEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccc-cCCccccCCCcCcE-E
Q 037916           80 HLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSG-TISPAIGELQNLVT-L  157 (741)
Q Consensus        80 ~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~-~~~~~~~~l~~L~~-L  157 (741)
                      .-++++.++|+|+ .+|..+   ..++++|+|++|+|..+.+.+|.++++|++|+|++|+|.+ +.+++|.++++|.+ +
T Consensus        10 ~~~~v~C~~~~Lt-~iP~~l---~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l   85 (350)
T 4ay9_X           10 SNRVFLCQESKVT-EIPSDL---PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIR   85 (350)
T ss_dssp             ETTEEEEESTTCC-SCCTTC---CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEE
T ss_pred             eCCEEEecCCCCC-ccCcCc---CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhh
Confidence            3467777777777 344433   2267777777777766666677777777777777777644 34456777777654 5


Q ss_pred             EcccCCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccC-ccccccCCcccccccc-ceeEEEcCCC
Q 037916          158 AINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSY-NNLSGTIPPQLMDLTS-LSVGLDLSRN  235 (741)
Q Consensus       158 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~-L~~~L~Ls~N  235 (741)
                      .+++|+|+.+.|++|.++++|++|++++|+|+...+..+....++..|++.+ |++....+..|..+.. ++. |+|++|
T Consensus        86 ~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~-L~L~~N  164 (350)
T 4ay9_X           86 IEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVI-LWLNKN  164 (350)
T ss_dssp             EEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEE-EECCSS
T ss_pred             cccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhh-hccccc
Confidence            5566777766677777777777777777777766666666666666676644 4565444455555543 444 777777


Q ss_pred             ccCCCCChhhcCCCCCcEEEec-cccccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccc
Q 037916          236 QLVGSLPTEVGKLINLEILFIS-RNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIP  314 (741)
Q Consensus       236 ~l~~~~p~~~~~l~~L~~L~Ls-~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  314 (741)
                      +|+.+.+..| ...+|+.|+++ +|.++.+.++.|.++++|++|+|++|+|+.+.+..|.++++|+.+++  ++++ .+|
T Consensus       165 ~i~~i~~~~f-~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~--~~l~-~lP  240 (350)
T 4ay9_X          165 GIQEIHNSAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLP  240 (350)
T ss_dssp             CCCEECTTSS-TTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTC--TTCC-CCC
T ss_pred             cccCCChhhc-cccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhccC--CCcC-cCC
Confidence            7764443333 34566666665 35666666666677777777777777776555555554444443332  2233 344


Q ss_pred             hhhhccccCCcccccCcc
Q 037916          315 KFLVELQLVQNLNLSYND  332 (741)
Q Consensus       315 ~~~~~l~~L~~L~l~~N~  332 (741)
                       .+..+++|+.++++++.
T Consensus       241 -~l~~l~~L~~l~l~~~~  257 (350)
T 4ay9_X          241 -TLEKLVALMEASLTYPS  257 (350)
T ss_dssp             -CTTTCCSCCEEECSCHH
T ss_pred             -CchhCcChhhCcCCCCc
Confidence             25566666666666543

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.92  E-value=1.7e-26  Score=249.67  Aligned_cols=265  Identities=18%  Similarity=0.202  Sum_probs=156.6

Q ss_pred             cCCccCCCCCCCcEEEeecCcCcccCCch----hhhhhhhhhccccCCCccEEECcCCcCc---ccCCchhhcccccccE
Q 037916           36 VIPSSMFNASKLEVFQVTSNNLTGEVPSE----FGKATKAYCVQNCNQHLKHLDINNNNFG---GLLPGCICNFSITLET  108 (741)
Q Consensus        36 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~----~~~l~~~~~~~~~~~~L~~L~Ls~N~l~---~~~~~~~~~l~~~L~~  108 (741)
                      .++..+..+++|++|+|++|+|+...+..    |..++          +|++|+|++|.+.   +..|..+..+      
T Consensus        23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~----------~L~~L~Ls~~~~~~l~~~~~~~~~~l------   86 (386)
T 2ca6_A           23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKK----------DLEIAEFSDIFTGRVKDEIPEALRLL------   86 (386)
T ss_dssp             TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCT----------TCCEEECCSCCTTSCGGGSHHHHHHH------
T ss_pred             HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCC----------CccEEeCcccccCccccchhHHHHHH------
Confidence            34555666677777777777776543333    22333          3677777665333   2233322111      


Q ss_pred             EEccCCcccccCCccccCCCCccEEEcccccccc----cCCccccCCCcCcEEEcccCCCCCcCcccccC----C-----
Q 037916          109 LIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSG----TISPAIGELQNLVTLAINTNKLSGNIPPSIGN----L-----  175 (741)
Q Consensus       109 L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~----l-----  175 (741)
                                  ...|..+++|++|+|++|+|+.    .++..+..+++|++|+|++|.|+...+..+..    +     
T Consensus        87 ------------~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~  154 (386)
T 2ca6_A           87 ------------LQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKK  154 (386)
T ss_dssp             ------------HHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             ------------HHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhh
Confidence                        1233556667777777776665    34556666667777777777765433333332    2     


Q ss_pred             ----cccceeeccCcccc-cccC---cccccCCCCCEEeccCccccc-----cCCccccccccceeEEEcCCCccC----
Q 037916          176 ----KKLLQLYLIENFLQ-VSIP---SSLGQCQSLTTINLSYNNLSG-----TIPPQLMDLTSLSVGLDLSRNQLV----  238 (741)
Q Consensus       176 ----~~L~~L~L~~N~i~-~~~~---~~~~~l~~L~~L~L~~N~l~~-----~~p~~~~~l~~L~~~L~Ls~N~l~----  238 (741)
                          ++|++|+|++|+++ ...+   ..|..+++|++|+|++|+|+.     ..|..+..+++|+. |+|++|.|+    
T Consensus       155 ~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~-L~Ls~n~l~~~g~  233 (386)
T 2ca6_A          155 AKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKV-LDLQDNTFTHLGS  233 (386)
T ss_dssp             HHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCE-EECCSSCCHHHHH
T ss_pred             cccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccE-EECcCCCCCcHHH
Confidence                66777777777665 2333   355566777777777777652     33445666677766 777777764    


Q ss_pred             CCCChhhcCCCCCcEEEeccccccch----hhhhcc--ccccccEEEeCCCccCC----CCChhc-ccCccCCeeeCCCC
Q 037916          239 GSLPTEVGKLINLEILFISRNMLECE----ILSTLG--SCIKLEQLKLGGNLFQG----PIPLSL-SSLRGLRVLDLSQN  307 (741)
Q Consensus       239 ~~~p~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~--~l~~L~~L~L~~N~l~~----~~~~~~-~~l~~L~~L~Ls~N  307 (741)
                      ..+|..+..+++|++|+|++|.|+..    .+..+.  .+++|+.|+|++|.+++    .+|..+ .++++|+.|+|++|
T Consensus       234 ~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N  313 (386)
T 2ca6_A          234 SALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGN  313 (386)
T ss_dssp             HHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTS
T ss_pred             HHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCC
Confidence            34566677777777777777777755    344442  36777777777777775    355555 55777777777777


Q ss_pred             cCCCccc--hh-hhccccCCccccc
Q 037916          308 NISGEIP--KF-LVELQLVQNLNLS  329 (741)
Q Consensus       308 ~l~~~~~--~~-~~~l~~L~~L~l~  329 (741)
                      .+++..+  .. ...+++++.+++.
T Consensus       314 ~l~~~~~~~~~l~~~l~~~~~~~l~  338 (386)
T 2ca6_A          314 RFSEEDDVVDEIREVFSTRGRGELD  338 (386)
T ss_dssp             BSCTTSHHHHHHHHHHHHHTCCEEC
T ss_pred             cCCcchhHHHHHHHHhhhcCcchhh
Confidence            7776553  22 2234444444443

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.91  E-value=5.1e-25  Score=230.52  Aligned_cols=200  Identities=22%  Similarity=0.217  Sum_probs=128.4

Q ss_pred             CCccEEEcccccccccCCccc--cCCCcCcEEEcccCCCCCcCc----ccccCCcccceeeccCcccccccCcccccCCC
Q 037916          128 INLQTLHMWDNQLSGTISPAI--GELQNLVTLAINTNKLSGNIP----PSIGNLKKLLQLYLIENFLQVSIPSSLGQCQS  201 (741)
Q Consensus       128 ~~L~~L~L~~N~i~~~~~~~~--~~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~  201 (741)
                      ++|++|+|++|.+++..|..+  ..+++|++|+|++|++++..+    ..+..+++|++|+|++|.+.+..+..|..+++
T Consensus        91 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~  170 (310)
T 4glp_A           91 SRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPA  170 (310)
T ss_dssp             SCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTT
T ss_pred             CceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCC
Confidence            457777777777776666666  667777777777777765433    23445667777777777777666667777777


Q ss_pred             CCEEeccCcccccc--C--CccccccccceeEEEcCCCccCCCCCh----hhcCCCCCcEEEeccccccchhhhhcccc-
Q 037916          202 LTTINLSYNNLSGT--I--PPQLMDLTSLSVGLDLSRNQLVGSLPT----EVGKLINLEILFISRNMLECEILSTLGSC-  272 (741)
Q Consensus       202 L~~L~L~~N~l~~~--~--p~~~~~l~~L~~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-  272 (741)
                      |++|+|++|++.+.  +  +..+..+++|++ |+|++|+++ .++.    .++.+++|++|+|++|+|++..|..+..+ 
T Consensus       171 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~-L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~  248 (310)
T 4glp_A          171 LTSLDLSDNPGLGERGLMAALCPHKFPAIQN-LALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCM  248 (310)
T ss_dssp             CCEEECCSCTTCHHHHHHTTSCTTSSCCCCS-CBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCC
T ss_pred             CCEEECCCCCCccchhhhHHHhhhcCCCCCE-EECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhcc
Confidence            77777777766531  1  222356666766 777777775 2232    24566777777777777776655555554 


Q ss_pred             --ccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccchhhhccccCCcccccCcccc
Q 037916          273 --IKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLE  334 (741)
Q Consensus       273 --~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  334 (741)
                        ++|++|+|++|+|+ .+|..+.  ++|+.|+|++|+|++. |. +..+++|+.|+|++|+|+
T Consensus       249 ~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~  307 (310)
T 4glp_A          249 WSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFL  307 (310)
T ss_dssp             CCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTS
T ss_pred             CcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCC
Confidence              57777777777777 3444443  5777777777777753 22 456677777777777765

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.91  E-value=3.5e-26  Score=247.23  Aligned_cols=242  Identities=18%  Similarity=0.191  Sum_probs=188.2

Q ss_pred             CCchhhcccccccEEEccCCcccccC----CccccCCCCccEEEcccccc---cccCCcc-------ccCCCcCcEEEcc
Q 037916           95 LPGCICNFSITLETLIFNSNKIFRSI----PAGIGKFINLQTLHMWDNQL---SGTISPA-------IGELQNLVTLAIN  160 (741)
Q Consensus        95 ~~~~~~~l~~~L~~L~L~~n~i~~~~----~~~~~~l~~L~~L~L~~N~i---~~~~~~~-------~~~l~~L~~L~L~  160 (741)
                      ++..+..++ +|++|+|++|++....    +..|..+++|++|+|++|.+   ++..|..       |..+++|++|+|+
T Consensus        24 l~~~l~~~~-~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls  102 (386)
T 2ca6_A           24 VFAVLLEDD-SVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS  102 (386)
T ss_dssp             TSHHHHHCS-CCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred             HHHHHhcCC-CccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence            334444444 5666666666665442    23466788888888888644   3344444       4788999999999


Q ss_pred             cCCCCC----cCcccccCCcccceeeccCcccccccCccccc----C---------CCCCEEeccCcccc-ccCC---cc
Q 037916          161 TNKLSG----NIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQ----C---------QSLTTINLSYNNLS-GTIP---PQ  219 (741)
Q Consensus       161 ~N~l~~----~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~----l---------~~L~~L~L~~N~l~-~~~p---~~  219 (741)
                      +|+++.    .++..+..+++|++|+|++|.++...+..+..    +         ++|++|+|++|+|+ +.+|   ..
T Consensus       103 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~  182 (386)
T 2ca6_A          103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT  182 (386)
T ss_dssp             SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHH
T ss_pred             CCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHH
Confidence            999987    46778899999999999999997554444443    3         89999999999997 3444   46


Q ss_pred             ccccccceeEEEcCCCccCC-----CCChhhcCCCCCcEEEecccccc----chhhhhccccccccEEEeCCCccCCC--
Q 037916          220 LMDLTSLSVGLDLSRNQLVG-----SLPTEVGKLINLEILFISRNMLE----CEILSTLGSCIKLEQLKLGGNLFQGP--  288 (741)
Q Consensus       220 ~~~l~~L~~~L~Ls~N~l~~-----~~p~~~~~l~~L~~L~Ls~N~l~----~~~~~~~~~l~~L~~L~L~~N~l~~~--  288 (741)
                      +..+++|+. |+|++|+|..     ..|..+..+++|++|+|++|.|+    ...+..+..+++|+.|+|++|++++.  
T Consensus       183 l~~~~~L~~-L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~  261 (386)
T 2ca6_A          183 FQSHRLLHT-VKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGA  261 (386)
T ss_dssp             HHHCTTCCE-EECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHH
T ss_pred             HHhCCCcCE-EECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhH
Confidence            678889997 9999999872     34447889999999999999996    56778889999999999999999865  


Q ss_pred             --CChhcc--cCccCCeeeCCCCcCCC----ccchhh-hccccCCcccccCcccccccC
Q 037916          289 --IPLSLS--SLRGLRVLDLSQNNISG----EIPKFL-VELQLVQNLNLSYNDLEGVIP  338 (741)
Q Consensus       289 --~~~~~~--~l~~L~~L~Ls~N~l~~----~~~~~~-~~l~~L~~L~l~~N~l~~~~~  338 (741)
                        ++.++.  .+++|+.|+|++|.|++    .+|..+ .++++|+.|+|++|++++..+
T Consensus       262 ~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~  320 (386)
T 2ca6_A          262 AAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD  320 (386)
T ss_dssp             HHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred             HHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence              455663  38999999999999997    377766 668999999999999987654

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.91  E-value=2.7e-24  Score=228.98  Aligned_cols=221  Identities=18%  Similarity=0.101  Sum_probs=145.9

Q ss_pred             ccEEECcCCcCcccCCchhhcccccccEEEccCCccccc-CCccccCCCCccE-EEcccccccccCCccccCCCcCcEEE
Q 037916           81 LKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRS-IPAGIGKFINLQT-LHMWDNQLSGTISPAIGELQNLVTLA  158 (741)
Q Consensus        81 L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~-~~~~~~~l~~L~~-L~L~~N~i~~~~~~~~~~l~~L~~L~  158 (741)
                      +++|+|++|+|+.+.++.|.+++ +|++|+|++|++.+. .+.+|.++++|++ +.+++|+|+.+.++.|.++++|++|+
T Consensus        32 l~~L~Ls~N~i~~i~~~~f~~l~-~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~  110 (350)
T 4ay9_X           32 AIELRFVLTKLRVIQKGAFSGFG-DLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL  110 (350)
T ss_dssp             CSEEEEESCCCSEECTTSSTTCT-TCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEE
T ss_pred             CCEEEccCCcCCCcCHHHHcCCC-CCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhcccccccc
Confidence            55666666666555555555555 566666666665443 3345666666654 55566777777777777777777777


Q ss_pred             cccCCCCCcCcccccCCcccceeeccC-cccccccCcccccCC-CCCEEeccCccccccCCccccccccceeEEEcCC-C
Q 037916          159 INTNKLSGNIPPSIGNLKKLLQLYLIE-NFLQVSIPSSLGQCQ-SLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSR-N  235 (741)
Q Consensus       159 L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~i~~~~~~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~-N  235 (741)
                      +++|+|+...+..+....++..|++.+ |.+..+.+..|..+. .++.|+|++|+|+ .+|...+..++++. |++++ |
T Consensus       111 l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~-~i~~~~f~~~~L~~-l~l~~~n  188 (350)
T 4ay9_X          111 ISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDE-LNLSDNN  188 (350)
T ss_dssp             EEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-EECTTSSTTEEEEE-EECTTCT
T ss_pred             ccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc-CCChhhccccchhH-HhhccCC
Confidence            777777766666666666677777754 566666666666654 5777888888887 45555555667776 88764 6


Q ss_pred             ccCCCCChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCc
Q 037916          236 QLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNN  308 (741)
Q Consensus       236 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  308 (741)
                      .++.+.+..|..+++|++|+|++|+|+.+++..|.++++|+.+++  +.++ .+| .+..+++|+.++++++.
T Consensus       189 ~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~--~~l~-~lP-~l~~l~~L~~l~l~~~~  257 (350)
T 4ay9_X          189 NLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLP-TLEKLVALMEASLTYPS  257 (350)
T ss_dssp             TCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTC--TTCC-CCC-CTTTCCSCCEEECSCHH
T ss_pred             cccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhccC--CCcC-cCC-CchhCcChhhCcCCCCc
Confidence            676555567888888888888888888777666665554444433  3344 445 47788888888887653

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.91  E-value=1.4e-25  Score=237.65  Aligned_cols=257  Identities=21%  Similarity=0.188  Sum_probs=206.2

Q ss_pred             CCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCccEEECcCCcCcccCCchhhcccccccEEEccCCccccc-CCcc
Q 037916           45 SKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRS-IPAG  123 (741)
Q Consensus        45 ~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~-~~~~  123 (741)
                      ..++.|++++|.+.   +..+..+..        ++++.|++++|.+.+..+. +..+. +|++|+|++|.+... .+..
T Consensus        47 ~~~~~l~l~~~~~~---~~~~~~~~~--------~~l~~L~l~~n~l~~~~~~-~~~~~-~L~~L~L~~~~l~~~~~~~~  113 (336)
T 2ast_B           47 SLWQTLDLTGKNLH---PDVTGRLLS--------QGVIAFRCPRSFMDQPLAE-HFSPF-RVQHMDLSNSVIEVSTLHGI  113 (336)
T ss_dssp             TTSSEEECTTCBCC---HHHHHHHHH--------TTCSEEECTTCEECSCCCS-CCCCB-CCCEEECTTCEECHHHHHHH
T ss_pred             hhheeeccccccCC---HHHHHhhhh--------ccceEEEcCCccccccchh-hccCC-CCCEEEccCCCcCHHHHHHH
Confidence            34788999998887   455666521        2499999999999877666 44566 899999999998765 7778


Q ss_pred             ccCCCCccEEEcccccccccCCccccCCCcCcEEEcccC-CCCCc-CcccccCCcccceeeccCc-ccccc-cCcccccC
Q 037916          124 IGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTN-KLSGN-IPPSIGNLKKLLQLYLIEN-FLQVS-IPSSLGQC  199 (741)
Q Consensus       124 ~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~l~~L~~L~L~~N-~i~~~-~~~~~~~l  199 (741)
                      +..+++|++|+|++|.+++..+..+..+++|++|+|++| .+++. ++..+.++++|++|+|++| .+++. ++..+..+
T Consensus       114 ~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l  193 (336)
T 2ast_B          114 LSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHV  193 (336)
T ss_dssp             HTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHS
T ss_pred             HhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhc
Confidence            889999999999999998888888899999999999999 67753 5666888999999999999 88864 57778889


Q ss_pred             C-CCCEEeccCc--ccc-ccCCccccccccceeEEEcCCCc-cCCCCChhhcCCCCCcEEEecccc-ccchhhhhccccc
Q 037916          200 Q-SLTTINLSYN--NLS-GTIPPQLMDLTSLSVGLDLSRNQ-LVGSLPTEVGKLINLEILFISRNM-LECEILSTLGSCI  273 (741)
Q Consensus       200 ~-~L~~L~L~~N--~l~-~~~p~~~~~l~~L~~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~  273 (741)
                      + +|++|+|++|  .++ +.+|..+..+++|+. |++++|. +++..+..+..+++|++|++++|. +.......+..++
T Consensus       194 ~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~-L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~  272 (336)
T 2ast_B          194 SETITQLNLSGYRKNLQKSDLSTLVRRCPNLVH-LDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIP  272 (336)
T ss_dssp             CTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSE-EECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCT
T ss_pred             ccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCE-EeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCC
Confidence            9 9999999999  454 456777788999997 9999999 776777788999999999999994 4433344688899


Q ss_pred             cccEEEeCCCccCCCCChhcccC-ccCCeeeCCCCcCCCccchhhhc
Q 037916          274 KLEQLKLGGNLFQGPIPLSLSSL-RGLRVLDLSQNNISGEIPKFLVE  319 (741)
Q Consensus       274 ~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~  319 (741)
                      +|+.|++++| +.   ...+..+ ..|..|++++|++++..|..+..
T Consensus       273 ~L~~L~l~~~-i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~~~~~  315 (336)
T 2ast_B          273 TLKTLQVFGI-VP---DGTLQLLKEALPHLQINCSHFTTIARPTIGN  315 (336)
T ss_dssp             TCCEEECTTS-SC---TTCHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred             CCCEEeccCc-cC---HHHHHHHHhhCcceEEecccCccccCCcccc
Confidence            9999999999 43   3344454 34888889999999988877654

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.91  E-value=6.1e-24  Score=215.08  Aligned_cols=182  Identities=24%  Similarity=0.269  Sum_probs=106.1

Q ss_pred             ccCCCccEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCc
Q 037916           76 NCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLV  155 (741)
Q Consensus        76 ~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~  155 (741)
                      .|....++++++++.++. +|..+.   .+|+.|+|++|++.+..+..|.++++|++|+|++|+|+++.+..|.++++|+
T Consensus        11 ~C~~~~~~l~~~~~~l~~-~p~~~~---~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~   86 (251)
T 3m19_A           11 TCNEGKKEVDCQGKSLDS-VPSGIP---ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELG   86 (251)
T ss_dssp             EEEGGGTEEECTTCCCSS-CCSCCC---TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC
T ss_pred             EcCCCCeEEecCCCCccc-cCCCCC---CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCC
Confidence            344457778888877773 343322   2566667777666666666666666666666666666666666666666666


Q ss_pred             EEEcccCCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCC
Q 037916          156 TLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRN  235 (741)
Q Consensus       156 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N  235 (741)
                      +|+|++|+|+++.+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|+. |+|++|
T Consensus        87 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~-L~L~~N  165 (251)
T 3m19_A           87 TLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQT-LSLSTN  165 (251)
T ss_dssp             EEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE-EECCSS
T ss_pred             EEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCE-EECCCC
Confidence            6666666666555555666666666666666665555555555555555555555555443334555555554 555555


Q ss_pred             ccCCCCChhhcCCCCCcEEEecccccc
Q 037916          236 QLVGSLPTEVGKLINLEILFISRNMLE  262 (741)
Q Consensus       236 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~  262 (741)
                      +|++..+..|..+++|+.|+|++|.+.
T Consensus       166 ~l~~~~~~~~~~l~~L~~L~l~~N~~~  192 (251)
T 3m19_A          166 QLQSVPHGAFDRLGKLQTITLFGNQFD  192 (251)
T ss_dssp             CCSCCCTTTTTTCTTCCEEECCSCCBC
T ss_pred             cCCccCHHHHhCCCCCCEEEeeCCcee
Confidence            555444444444444444444444443

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.91  E-value=6.6e-24  Score=214.84  Aligned_cols=180  Identities=22%  Similarity=0.206  Sum_probs=97.3

Q ss_pred             cccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCcccccCCcccceeecc
Q 037916          105 TLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLI  184 (741)
Q Consensus       105 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  184 (741)
                      ..++++++++.+. .+|..+.  ++|++|+|++|+|+++.+..|.++++|++|+|++|+|+++.+..|.++++|++|+|+
T Consensus        15 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~   91 (251)
T 3m19_A           15 GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA   91 (251)
T ss_dssp             GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred             CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence            3455555555553 2333333  245555555555555555555555555555555555554444444444444444444


Q ss_pred             CcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccch
Q 037916          185 ENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECE  264 (741)
Q Consensus       185 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  264 (741)
                      +|.|++..+.                        .|..+++|+. |+|++|+|++..+..|..+++|++|+|++|+|+++
T Consensus        92 ~n~l~~~~~~------------------------~~~~l~~L~~-L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  146 (251)
T 3m19_A           92 NNQLASLPLG------------------------VFDHLTQLDK-LYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSI  146 (251)
T ss_dssp             TSCCCCCCTT------------------------TTTTCTTCCE-EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred             CCcccccChh------------------------HhcccCCCCE-EEcCCCcCCCcChhHhccCCcccEEECcCCcCCcc
Confidence            4444444334                        4444444444 55555555444444455555555555555555555


Q ss_pred             hhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCc
Q 037916          265 ILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGE  312 (741)
Q Consensus       265 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  312 (741)
                      .+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|.+++.
T Consensus       147 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  194 (251)
T 3m19_A          147 PAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS  194 (251)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred             CHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence            555566666666666666666666666666666777777777766644

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.91  E-value=4.1e-24  Score=223.14  Aligned_cols=211  Identities=21%  Similarity=0.281  Sum_probs=133.8

Q ss_pred             ccEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcc
Q 037916           81 LKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAIN  160 (741)
Q Consensus        81 L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~  160 (741)
                      +..+.+..+.+.+...  +..+. +|++|++++|.+... + .+..+++|++|+|++|+|+++.+  +..+++|++|+|+
T Consensus        21 ~~~~~l~~~~~~~~~~--~~~l~-~L~~L~l~~~~i~~l-~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~   93 (308)
T 1h6u_A           21 AIKIAAGKSNVTDTVT--QADLD-GITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELS   93 (308)
T ss_dssp             HHHHHTTCSSTTSEEC--HHHHH-TCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECC
T ss_pred             HHHHHhCCCCcCceec--HHHcC-CcCEEEeeCCCccCc-h-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEcc
Confidence            3344566666664433  33455 777788887777543 3 57777777777777777776544  7777777777777


Q ss_pred             cCCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCC
Q 037916          161 TNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGS  240 (741)
Q Consensus       161 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~  240 (741)
                      +|++++.  ..|..+++|++|+|++|.+++..  .+..+++|++|+|++|++++..+  +..+++|+. |+|++|.+++.
T Consensus        94 ~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~~--~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~-L~l~~n~l~~~  166 (308)
T 1h6u_A           94 GNPLKNV--SAIAGLQSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQY-LSIGNAQVSDL  166 (308)
T ss_dssp             SCCCSCC--GGGTTCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCE-EECCSSCCCCC
T ss_pred             CCcCCCc--hhhcCCCCCCEEECCCCCCCCch--hhcCCCCCCEEECCCCccCcCcc--ccCCCCccE-EEccCCcCCCC
Confidence            7777743  25777777777777777776532  26667777777777777763322  666666665 66666666643


Q ss_pred             CChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCC
Q 037916          241 LPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISG  311 (741)
Q Consensus       241 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  311 (741)
                      .+  +..+++|+.|+|++|+++++.+  +..+++|+.|+|++|++++..+  +..+++|+.|+|++|.+++
T Consensus       167 ~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~  231 (308)
T 1h6u_A          167 TP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN  231 (308)
T ss_dssp             GG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEEC
T ss_pred             hh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeec
Confidence            32  6666666666666666665443  5566666666666666664432  5566666666666666653

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.91  E-value=3.9e-26  Score=261.56  Aligned_cols=271  Identities=13%  Similarity=-0.001  Sum_probs=149.9

Q ss_pred             ccEEECcCCcCcccCCchhhcccccccEEEccCCccc---ccCCccccCCCCccEEEcccccccccCCccccCCCcCcEE
Q 037916           81 LKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIF---RSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTL  157 (741)
Q Consensus        81 L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~---~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L  157 (741)
                      |++|+|++|.+.+ .+..+..++ +|++|+++.+...   ...+..+..+++|+.|+++++... ..+..+..+++|++|
T Consensus       222 L~~L~L~~~~~~~-l~~~~~~~~-~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L  298 (592)
T 3ogk_B          222 LVSVKVGDFEILE-LVGFFKAAA-NLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKL  298 (592)
T ss_dssp             CCEEECSSCBGGG-GHHHHHHCT-TCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEE
T ss_pred             CcEEeccCccHHH-HHHHHhhhh-HHHhhcccccccccchHHHHHHhhccccccccCccccchh-HHHHHHhhcCCCcEE
Confidence            4444444444443 233344443 4444444432211   112233444455555555554322 344556666677777


Q ss_pred             EcccCCCCCcCc-ccccCCcccceeeccCcccccccCcccccCCCCCEEecc-----------Ccccccc-CCccccccc
Q 037916          158 AINTNKLSGNIP-PSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLS-----------YNNLSGT-IPPQLMDLT  224 (741)
Q Consensus       158 ~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~-----------~N~l~~~-~p~~~~~l~  224 (741)
                      +|++|.+++... ..+..+++|++|+|+++.....++..+..+++|++|+|+           .|.+++. ++..+..++
T Consensus       299 ~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~  378 (592)
T 3ogk_B          299 DLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQ  378 (592)
T ss_dssp             EETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCT
T ss_pred             ecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCc
Confidence            777777654332 234666777777776332222333344556777777777           2455432 112233466


Q ss_pred             cceeEEEcCCCccCCCCChhhcC-CCCCcEEEec----cccccch-----hhhhccccccccEEEeCCC--ccCCCCChh
Q 037916          225 SLSVGLDLSRNQLVGSLPTEVGK-LINLEILFIS----RNMLECE-----ILSTLGSCIKLEQLKLGGN--LFQGPIPLS  292 (741)
Q Consensus       225 ~L~~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls----~N~l~~~-----~~~~~~~l~~L~~L~L~~N--~l~~~~~~~  292 (741)
                      +|+. |+++.|.+++..+..+.. +++|+.|+|+    .|.+++.     .+..+.++++|+.|+|++|  .+++.....
T Consensus       379 ~L~~-L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~  457 (592)
T 3ogk_B          379 ELEY-MAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSY  457 (592)
T ss_dssp             TCSE-EEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHH
T ss_pred             cCeE-EEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHH
Confidence            6765 777777766555555544 6777777775    5666642     3344566777777777643  244443333


Q ss_pred             cc-cCccCCeeeCCCCcCCC-ccchhhhccccCCcccccCcccccccCC--ccccCCcccccccCCC
Q 037916          293 LS-SLRGLRVLDLSQNNISG-EIPKFLVELQLVQNLNLSYNDLEGVIPT--EGVFKNASAISVFGNS  355 (741)
Q Consensus       293 ~~-~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~--~~~~~~~~~~~~~~n~  355 (741)
                      +. .+++|++|+|++|++++ .++..+..+++|+.|+|++|+++.....  ...+++++.+++.+|.
T Consensus       458 ~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~  524 (592)
T 3ogk_B          458 IGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYR  524 (592)
T ss_dssp             HHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCB
T ss_pred             HHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCc
Confidence            33 36778888888887765 2445556777888888888877643221  1346677777777775

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.90  E-value=1.1e-23  Score=219.89  Aligned_cols=193  Identities=27%  Similarity=0.373  Sum_probs=97.7

Q ss_pred             CCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEE
Q 037916          126 KFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTI  205 (741)
Q Consensus       126 ~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L  205 (741)
                      .+++|++|++++|.|+.+ + .+..+++|++|+|++|+++++.+  |..+++|++|+|++|.+++.  ..+..+++|++|
T Consensus        39 ~l~~L~~L~l~~~~i~~l-~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L  112 (308)
T 1h6u_A           39 DLDGITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKTL  112 (308)
T ss_dssp             HHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEE
T ss_pred             HcCCcCEEEeeCCCccCc-h-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCCEE
Confidence            344555555555555532 1 34555555555555555553322  55555555555555555432  235555555555


Q ss_pred             eccCccccccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCcc
Q 037916          206 NLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLF  285 (741)
Q Consensus       206 ~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l  285 (741)
                      +|++|++++ ++. +..+++|+. |++++|.+++..+  ++.+++|+.|+|++|+++.+.+  +..+++|+.|++++|++
T Consensus       113 ~l~~n~l~~-~~~-l~~l~~L~~-L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l  185 (308)
T 1h6u_A          113 DLTSTQITD-VTP-LAGLSNLQV-LYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKI  185 (308)
T ss_dssp             ECTTSCCCC-CGG-GTTCTTCCE-EECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred             ECCCCCCCC-chh-hcCCCCCCE-EECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCcc
Confidence            555555553 222 555555554 5555555553322  5555555555555555554333  55555555555555555


Q ss_pred             CCCCChhcccCccCCeeeCCCCcCCCccchhhhccccCCcccccCccccc
Q 037916          286 QGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEG  335 (741)
Q Consensus       286 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~  335 (741)
                      ++..+  +..+++|+.|+|++|++++..+  +..+++|+.|++++|++++
T Consensus       186 ~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~  231 (308)
T 1h6u_A          186 SDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN  231 (308)
T ss_dssp             CCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEEC
T ss_pred             CcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeec
Confidence            54332  4555555555555555554332  4555555555555555544

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.90  E-value=8.1e-26  Score=258.95  Aligned_cols=319  Identities=13%  Similarity=0.032  Sum_probs=237.7

Q ss_pred             CCCCCccccc----CChhhhhCCCCCcEEEcccCcccc----cCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhh
Q 037916            2 DVGVNRVQGG----IPLDFGFTLPNLLFLSLGFNQITG----VIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYC   73 (741)
Q Consensus         2 dl~~n~~~~~----ip~~~~~~l~~L~~L~L~~n~i~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~   73 (741)
                      ||++|.+.+.    ++. +...+++|++|+|++|.+++    .++..+.++++|++|+|++|.+.+ +|..+..+++   
T Consensus       170 ~L~~~~~~~~~~~~l~~-~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~---  244 (592)
T 3ogk_B          170 LMEESSFSEKDGKWLHE-LAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAAN---  244 (592)
T ss_dssp             ECTTCEEECCCSHHHHH-HHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTT---
T ss_pred             ECccccccCcchhHHHH-HHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhH---
Confidence            5667776544    332 33367888888888888763    334445577888888888888874 5566777765   


Q ss_pred             ccccCCCccEEECcCCcCc---ccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCC-cccc
Q 037916           74 VQNCNQHLKHLDINNNNFG---GLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTIS-PAIG  149 (741)
Q Consensus        74 ~~~~~~~L~~L~Ls~N~l~---~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~-~~~~  149 (741)
                             |++|+++.+...   +..+..+..+. +|+.|.++++.. ...|..+..+++|++|+|++|.+++... ..+.
T Consensus       245 -------L~~L~l~~~~~~~~~~~~~~~l~~~~-~L~~L~l~~~~~-~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~  315 (592)
T 3ogk_B          245 -------LEEFCGGSLNEDIGMPEKYMNLVFPR-KLCRLGLSYMGP-NEMPILFPFAAQIRKLDLLYALLETEDHCTLIQ  315 (592)
T ss_dssp             -------CCEEEECBCCCCTTCTTSSSCCCCCT-TCCEEEETTCCT-TTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHT
T ss_pred             -------HHhhcccccccccchHHHHHHhhccc-cccccCccccch-hHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHH
Confidence                   999999864433   22334455666 899999998754 5677888899999999999999875444 4468


Q ss_pred             CCCcCcEEEcccCCCCC-cCcccccCCcccceeecc-----------Cccccccc-CcccccCCCCCEEeccCccccccC
Q 037916          150 ELQNLVTLAINTNKLSG-NIPPSIGNLKKLLQLYLI-----------ENFLQVSI-PSSLGQCQSLTTINLSYNNLSGTI  216 (741)
Q Consensus       150 ~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~-----------~N~i~~~~-~~~~~~l~~L~~L~L~~N~l~~~~  216 (741)
                      ++++|++|+|+ |.+.. .++..+..+++|++|+|+           .|.++... +..+..+++|++|+++.|++++..
T Consensus       316 ~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~  394 (592)
T 3ogk_B          316 KCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNES  394 (592)
T ss_dssp             TCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHH
T ss_pred             hCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHH
Confidence            89999999999 55543 334444678999999999           36676442 333556899999999999998777


Q ss_pred             Cccccc-cccceeEEEcC----CCccCCC-----CChhhcCCCCCcEEEeccc--cccchhhhhcc-ccccccEEEeCCC
Q 037916          217 PPQLMD-LTSLSVGLDLS----RNQLVGS-----LPTEVGKLINLEILFISRN--MLECEILSTLG-SCIKLEQLKLGGN  283 (741)
Q Consensus       217 p~~~~~-l~~L~~~L~Ls----~N~l~~~-----~p~~~~~l~~L~~L~Ls~N--~l~~~~~~~~~-~l~~L~~L~L~~N  283 (741)
                      +..+.. +++|+. |+++    .|.+++.     ++..+.++++|++|+|++|  .++......+. .+++|+.|+|++|
T Consensus       395 ~~~l~~~~~~L~~-L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n  473 (592)
T 3ogk_B          395 LESIGTYLKNLCD-FRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYV  473 (592)
T ss_dssp             HHHHHHHCCSCCE-EEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSC
T ss_pred             HHHHHhhCCCCcE-EEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCC
Confidence            666665 888987 9996    7888864     3334778999999999854  46665555554 4899999999999


Q ss_pred             ccCCC-CChhcccCccCCeeeCCCCcCCCc-cchhhhccccCCcccccCcccccc
Q 037916          284 LFQGP-IPLSLSSLRGLRVLDLSQNNISGE-IPKFLVELQLVQNLNLSYNDLEGV  336 (741)
Q Consensus       284 ~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~  336 (741)
                      ++++. .+..+.++++|+.|+|++|.+++. ++..+..+++|+.|+|++|+++..
T Consensus       474 ~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~  528 (592)
T 3ogk_B          474 GESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMT  528 (592)
T ss_dssp             CSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred             CCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHH
Confidence            99863 345567899999999999998754 455567899999999999998765

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.90  E-value=6.2e-25  Score=246.07  Aligned_cols=185  Identities=15%  Similarity=0.097  Sum_probs=138.7

Q ss_pred             HhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcC--------cchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          404 FLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG--------ASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       404 ~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      ..+.||+|+||.||+|..  .+..+|+|+.......        ..+++.+|+.++++++||||+++..++.     ...
T Consensus       340 ~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~-----~~~  412 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDV-----DLD  412 (540)
T ss_dssp             --------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEE-----ETT
T ss_pred             CCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEE-----eCC
Confidence            356899999999999955  4778899987532211        1234689999999999999994444322     233


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..|+||||+++++|.+++..                  +..++.|+++||+|||++   +|+||||||+|||++.  .+|
T Consensus       413 ~~~lVmE~~~ggsL~~~l~~------------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~k  469 (540)
T 3en9_A          413 NKRIMMSYINGKLAKDVIED------------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLY  469 (540)
T ss_dssp             TTEEEEECCCSEEHHHHSTT------------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEE
T ss_pred             ccEEEEECCCCCCHHHHHHH------------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEE
Confidence            56999999999999999862                  357999999999999999   9999999999999998  999


Q ss_pred             EeecccccccCCCCccc-----ccccccccccccCcccccCC--CCCCCccCchhHHHHHHHHHcCCCCCC
Q 037916          556 VADFGLAKLLPPAHLQT-----SSIGVKGTIGYIAPAEYGLG--SEVSINGDVYSYGILLLELMTRKRPSD  619 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~~-----~~~~~~gt~~y~aPEe~~~~--~~~~~~~DIwSlG~il~elltg~~p~~  619 (741)
                      |+|||+++.........     ......||+.|+|||.+ ..  ..|+..+|+||..+-..+-+.++.+|.
T Consensus       470 L~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~-~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          470 IIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIW-ERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             ECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHH-HHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             EEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHH-HHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            99999999876542211     11235699999999544 33  457888999999999998888777653

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.88  E-value=2.1e-22  Score=197.56  Aligned_cols=181  Identities=18%  Similarity=0.241  Sum_probs=112.3

Q ss_pred             cEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCccEEECcCCcCcccCCchhhccc
Q 037916           24 LFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFS  103 (741)
Q Consensus        24 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~  103 (741)
                      +.++++++.++. +|..+  .++|++|+|++|++++..+..|..+++          |++|+|++|+|+++.+..|..+.
T Consensus        10 ~~v~c~~~~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~----------L~~L~l~~n~l~~~~~~~~~~l~   76 (208)
T 2o6s_A           10 TTVECYSQGRTS-VPTGI--PAQTTYLDLETNSLKSLPNGVFDELTS----------LTQLYLGGNKLQSLPNGVFNKLT   76 (208)
T ss_dssp             TEEECCSSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTT----------CSEEECCSSCCCCCCTTTTTTCT
T ss_pred             CEEEecCCCccC-CCCCC--CCCCcEEEcCCCccCcCChhhhccccc----------CcEEECCCCccCccChhhcCCCC
Confidence            345555565553 23222  235666666666666554445555544          66666666666655555555555


Q ss_pred             ccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCcccccCCcccceeec
Q 037916          104 ITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYL  183 (741)
Q Consensus       104 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  183 (741)
                       +|++|+|++|++.+..+..|..+++|++|+|++|+|+++.+..|.++++|++|+|++|+++++.+..|..+++|++|+|
T Consensus        77 -~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l  155 (208)
T 2o6s_A           77 -SLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWL  155 (208)
T ss_dssp             -TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEEC
T ss_pred             -CcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEe
Confidence             6666666666666555555666667777777777776666666666777777777777776665556666777777777


Q ss_pred             cCcccccccCcccccCCCCCEEeccCccccccCCcccccccc
Q 037916          184 IENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTS  225 (741)
Q Consensus       184 ~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  225 (741)
                      ++|.+.       +.+++|+.|+++.|+++|.+|..++.++.
T Consensus       156 ~~N~~~-------~~~~~l~~L~~~~n~~~g~ip~~~~~l~~  190 (208)
T 2o6s_A          156 HDNPWD-------CTCPGIRYLSEWINKHSGVVRNSAGSVAP  190 (208)
T ss_dssp             CSCCBC-------CCTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred             cCCCee-------cCCCCHHHHHHHHHhCCceeeccCccccC
Confidence            777554       23456777777777777777776666543

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.88  E-value=8.2e-25  Score=250.66  Aligned_cols=324  Identities=13%  Similarity=0.108  Sum_probs=185.4

Q ss_pred             hhCCCCCcEEEcccCcccccCCccCC-CCCCCcEEEeecC-cCccc-CCchhhhhhhhhhccccCCCccEEECcCCcCcc
Q 037916           17 GFTLPNLLFLSLGFNQITGVIPSSMF-NASKLEVFQVTSN-NLTGE-VPSEFGKATKAYCVQNCNQHLKHLDINNNNFGG   93 (741)
Q Consensus        17 ~~~l~~L~~L~L~~n~i~~~~~~~~~-~l~~L~~L~L~~N-~l~~~-~~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~~   93 (741)
                      ...+++|++|+|++|.+++..+..+. .+++|++|+|++| .++.. ++..+..++          +|++|+|++|.+++
T Consensus       101 ~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~----------~L~~L~L~~~~i~~  170 (594)
T 2p1m_B          101 SSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCR----------NLKELDLRESDVDD  170 (594)
T ss_dssp             HHHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCT----------TCCEEECTTCEEEC
T ss_pred             HHhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCC----------CCCEEeCcCCccCC
Confidence            34678888888888888776666664 5788888888888 55532 222233444          38888888888776


Q ss_pred             cCCchhh----cccccccEEEccCCcccccCCcc----ccCCCCccEEEcccc-cccccCCccccCCCcCcEEEcccCC-
Q 037916           94 LLPGCIC----NFSITLETLIFNSNKIFRSIPAG----IGKFINLQTLHMWDN-QLSGTISPAIGELQNLVTLAINTNK-  163 (741)
Q Consensus        94 ~~~~~~~----~l~~~L~~L~L~~n~i~~~~~~~----~~~l~~L~~L~L~~N-~i~~~~~~~~~~l~~L~~L~L~~N~-  163 (741)
                      ..+..+.    .++ +|++|++++|. .......    +..+++|++|+|++| .+++ .+..+..+++|+.|+++.+. 
T Consensus       171 ~~~~~l~~~~~~~~-~L~~L~l~~~~-~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~  247 (594)
T 2p1m_B          171 VSGHWLSHFPDTYT-SLVSLNISCLA-SEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTA  247 (594)
T ss_dssp             CCGGGGGGSCTTCC-CCCEEECTTCC-SCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCC
T ss_pred             cchHHHHHHhhcCC-cCcEEEecccC-CcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccC
Confidence            5544443    333 78888888876 1111122    234578888888877 3333 44555556666666644431 


Q ss_pred             -------------------------CCC----cCcccccCCcccceeeccCcccccccC-cccccCCCCCEEeccCcccc
Q 037916          164 -------------------------LSG----NIPPSIGNLKKLLQLYLIENFLQVSIP-SSLGQCQSLTTINLSYNNLS  213 (741)
Q Consensus       164 -------------------------l~~----~~~~~~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~  213 (741)
                                               +..    .++..+..+++|++|+|++|.++.... ..+..+++|++|++++| ++
T Consensus       248 ~~~~~~~~~l~~~l~~~~~L~~Ls~~~~~~~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~  326 (594)
T 2p1m_B          248 EVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IE  326 (594)
T ss_dssp             CCCHHHHHHHHHHHHTCTTCCEEECCBTCCGGGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GH
T ss_pred             ccchhhHHHHHHHHhcCCCcccccCCcccchhhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cC
Confidence                                     111    122223356777788887777654322 22456777777777777 43


Q ss_pred             cc-CCccccccccceeEEEcC---------CCccCCCCChhh-cCCCCCcEEEeccccccchhhhhcc-ccccccEEEeC
Q 037916          214 GT-IPPQLMDLTSLSVGLDLS---------RNQLVGSLPTEV-GKLINLEILFISRNMLECEILSTLG-SCIKLEQLKLG  281 (741)
Q Consensus       214 ~~-~p~~~~~l~~L~~~L~Ls---------~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~L~  281 (741)
                      .. ++.....+++|+. |+++         .|.+++.....+ ..+++|+.|+++.|.++......+. .+++|+.|+|+
T Consensus       327 ~~~l~~l~~~~~~L~~-L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~  405 (594)
T 2p1m_B          327 DAGLEVLASTCKDLRE-LRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLC  405 (594)
T ss_dssp             HHHHHHHHHHCTTCCE-EEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEE
T ss_pred             HHHHHHHHHhCCCCCE-EEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEee
Confidence            21 2222224566665 7663         234432222222 2367777777777777665555554 46777777777


Q ss_pred             --C----CccCCCCC-----hhcccCccCCeeeCCCCcCCCccchhhhc-cccCCcccccCcccccccCCc--cccCCcc
Q 037916          282 --G----NLFQGPIP-----LSLSSLRGLRVLDLSQNNISGEIPKFLVE-LQLVQNLNLSYNDLEGVIPTE--GVFKNAS  347 (741)
Q Consensus       282 --~----N~l~~~~~-----~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-l~~L~~L~l~~N~l~~~~~~~--~~~~~~~  347 (741)
                        +    |.+++...     ..+..+++|+.|+|++ .+++..+..+.. +++|+.|+|++|.+++.....  ..+++++
T Consensus       406 ~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~  484 (594)
T 2p1m_B          406 IIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLR  484 (594)
T ss_dssp             ESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCC
T ss_pred             cccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcC
Confidence              3    45552221     1245566677777755 555444444443 566777777777665432211  2255666


Q ss_pred             cccccCCCC
Q 037916          348 AISVFGNSK  356 (741)
Q Consensus       348 ~~~~~~n~~  356 (741)
                      .+++.+|+.
T Consensus       485 ~L~L~~n~~  493 (594)
T 2p1m_B          485 KLEIRDCPF  493 (594)
T ss_dssp             EEEEESCSC
T ss_pred             EEECcCCCC
Confidence            666666653

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.88  E-value=2.5e-22  Score=197.04  Aligned_cols=183  Identities=20%  Similarity=0.215  Sum_probs=95.2

Q ss_pred             CccEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEc
Q 037916           80 HLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAI  159 (741)
Q Consensus        80 ~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L  159 (741)
                      .-+.++++++.++.+ |..+   ..+|++|++++|++.+..+..|..+++|++|+|++|+|+++.+..|.++++|++|+|
T Consensus         8 ~~~~v~c~~~~l~~~-p~~~---~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L   83 (208)
T 2o6s_A            8 SGTTVECYSQGRTSV-PTGI---PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNL   83 (208)
T ss_dssp             ETTEEECCSSCCSSC-CSCC---CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCEEEecCCCccCC-CCCC---CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEEC
Confidence            455666666666633 2221   114555555555554444444455555555555555555444444444555555555


Q ss_pred             ccCCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCC
Q 037916          160 NTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVG  239 (741)
Q Consensus       160 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~  239 (741)
                      ++|+|+++.+                        ..|..+++|++|+|++|+|++..+..|..+++|+. |+|++|++++
T Consensus        84 s~n~l~~~~~------------------------~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~-L~l~~N~l~~  138 (208)
T 2o6s_A           84 STNQLQSLPN------------------------GVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKD-LRLYQNQLKS  138 (208)
T ss_dssp             CSSCCCCCCT------------------------TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE-EECCSSCCSC
T ss_pred             CCCcCCccCH------------------------hHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCE-EECCCCccce
Confidence            5555444433                        34444444444455545444333334445555554 5555555554


Q ss_pred             CCChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCccCCCCChhcccCcc
Q 037916          240 SLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRG  298 (741)
Q Consensus       240 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  298 (741)
                      ..+..|..+++|++|+|++|.+.+       .+++|+.|+++.|++++.+|..++.++.
T Consensus       139 ~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~l~~  190 (208)
T 2o6s_A          139 VPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVAP  190 (208)
T ss_dssp             CCTTTTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred             eCHHHhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccCccccC
Confidence            444445555666666666665442       3445666666777777777766665544

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.87  E-value=7.8e-22  Score=220.82  Aligned_cols=191  Identities=28%  Similarity=0.312  Sum_probs=103.3

Q ss_pred             CccEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEc
Q 037916           80 HLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAI  159 (741)
Q Consensus        80 ~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L  159 (741)
                      +|+.|+|++|+|++ +|..+.  + +|++|+|++|+|. .+|   ..+++|++|+|++|+|+++ |. |.+  +|++|+|
T Consensus        60 ~L~~L~Ls~n~L~~-lp~~l~--~-~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~i-p~-l~~--~L~~L~L  127 (571)
T 3cvr_A           60 QFSELQLNRLNLSS-LPDNLP--P-QITVLEITQNALI-SLP---ELPASLEYLDACDNRLSTL-PE-LPA--SLKHLDV  127 (571)
T ss_dssp             TCSEEECCSSCCSC-CCSCCC--T-TCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSCC-CC-CCT--TCCEEEC
T ss_pred             CccEEEeCCCCCCc-cCHhHc--C-CCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCCc-ch-hhc--CCCEEEC
Confidence            36666666666664 333221  2 4555555555554 233   2244555555555555542 22 332  4555555


Q ss_pred             ccCCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCC
Q 037916          160 NTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVG  239 (741)
Q Consensus       160 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~  239 (741)
                      ++|+|++ +|.   .++                        +|+.|+|++|+|++ +|.   .+++|+. |+|++|+|++
T Consensus       128 s~N~l~~-lp~---~l~------------------------~L~~L~Ls~N~l~~-lp~---~l~~L~~-L~Ls~N~L~~  174 (571)
T 3cvr_A          128 DNNQLTM-LPE---LPA------------------------LLEYINADNNQLTM-LPE---LPTSLEV-LSVRNNQLTF  174 (571)
T ss_dssp             CSSCCSC-CCC---CCT------------------------TCCEEECCSSCCSC-CCC---CCTTCCE-EECCSSCCSC
T ss_pred             CCCcCCC-CCC---cCc------------------------cccEEeCCCCccCc-CCC---cCCCcCE-EECCCCCCCC
Confidence            5555543 222   344                        44444555554442 333   2344444 5555555553


Q ss_pred             CCChhhcCCCCCcEEEeccccccchhhhhccc-----cccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccc
Q 037916          240 SLPTEVGKLINLEILFISRNMLECEILSTLGS-----CIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIP  314 (741)
Q Consensus       240 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-----l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  314 (741)
                       +|. |.  ++|+.|+|++|+|+.++.  |..     .+.|+.|+|++|+|+ .+|..+..+++|+.|+|++|.|++..|
T Consensus       175 -lp~-l~--~~L~~L~Ls~N~L~~lp~--~~~~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p  247 (571)
T 3cvr_A          175 -LPE-LP--ESLEALDVSTNLLESLPA--VPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIR  247 (571)
T ss_dssp             -CCC-CC--TTCCEEECCSSCCSSCCC--CC--------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHH
T ss_pred             -cch-hh--CCCCEEECcCCCCCchhh--HHHhhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCH
Confidence             333 33  455555555555553322  332     122388888888888 466677778889999999999988888


Q ss_pred             hhhhcccc
Q 037916          315 KFLVELQL  322 (741)
Q Consensus       315 ~~~~~l~~  322 (741)
                      ..+..+..
T Consensus       248 ~~l~~l~~  255 (571)
T 3cvr_A          248 ESLSQQTA  255 (571)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHhhc
Confidence            88777654

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.86  E-value=6.2e-22  Score=211.53  Aligned_cols=185  Identities=25%  Similarity=0.248  Sum_probs=133.9

Q ss_pred             hccccCCCccEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCcccc-CCCCccEEEcccccccccCCccccCC
Q 037916           73 CVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIG-KFINLQTLHMWDNQLSGTISPAIGEL  151 (741)
Q Consensus        73 ~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~-~l~~L~~L~L~~N~i~~~~~~~~~~l  151 (741)
                      |...|...-+.+++++|+|+. +|..+.   ..++.|+|++|+|.+..+..|. ++++|++|+|++|+|+++.+..|.++
T Consensus        12 Cp~~C~C~~~~l~c~~~~l~~-iP~~~~---~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l   87 (361)
T 2xot_A           12 CPANCLCASNILSCSKQQLPN-VPQSLP---SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPV   87 (361)
T ss_dssp             CCTTCEEETTEEECCSSCCSS-CCSSCC---TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTC
T ss_pred             CCCCCEECCCEEEeCCCCcCc-cCccCC---CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCC
Confidence            444555556788899888884 454333   2678888888888777777777 88888888888888888777788888


Q ss_pred             CcCcEEEcccCCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCccc---ccccccee
Q 037916          152 QNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQL---MDLTSLSV  228 (741)
Q Consensus       152 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~---~~l~~L~~  228 (741)
                      ++|++|+|++|+|+.+.+..|.++++|++|+|++|+|+...|..|.++++|++|+|++|+|++..+..|   ..+++|+.
T Consensus        88 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~  167 (361)
T 2xot_A           88 PNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLML  167 (361)
T ss_dssp             TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCE
T ss_pred             CCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCE
Confidence            888888888888887777778888888888888888887777778888888888888888774333333   35666665


Q ss_pred             EEEcCCCccCCCCChhhcCCCC--CcEEEecccccc
Q 037916          229 GLDLSRNQLVGSLPTEVGKLIN--LEILFISRNMLE  262 (741)
Q Consensus       229 ~L~Ls~N~l~~~~p~~~~~l~~--L~~L~Ls~N~l~  262 (741)
                       |+|++|+|++..+..|..++.  |+.|+|++|.+.
T Consensus       168 -L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~  202 (361)
T 2xot_A          168 -LDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE  202 (361)
T ss_dssp             -EECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred             -EECCCCCCCccCHHHhhhccHhhcceEEecCCCcc
Confidence             777777777555556666665  366666666665

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.86  E-value=1.9e-23  Score=239.36  Aligned_cols=344  Identities=10%  Similarity=0.094  Sum_probs=240.0

Q ss_pred             CCCCCcccccCChhhhhCCCCCcEEEcccC-ccccc-CCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCC
Q 037916            2 DVGVNRVQGGIPLDFGFTLPNLLFLSLGFN-QITGV-IPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQ   79 (741)
Q Consensus         2 dl~~n~~~~~ip~~~~~~l~~L~~L~L~~n-~i~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~   79 (741)
                      ||++|.+.+..+..+...+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+..+..      ..+
T Consensus       111 ~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~------~~~  184 (594)
T 2p1m_B          111 RLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPD------TYT  184 (594)
T ss_dssp             EEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCT------TCC
T ss_pred             EeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhh------cCC
Confidence            567888887777777656899999999999 66543 3444457899999999999988665555554331      123


Q ss_pred             CccEEECcCCcCcccCCchh----hcccccccEEEccCCcccccCCccccCCCCccEEEccccc----------------
Q 037916           80 HLKHLDINNNNFGGLLPGCI----CNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQ----------------  139 (741)
Q Consensus        80 ~L~~L~Ls~N~l~~~~~~~~----~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~----------------  139 (741)
                      +|+.|+|++|. .......+    ..++ +|++|++++|.-.+.++..+..+++|++|+++.+.                
T Consensus       185 ~L~~L~l~~~~-~~~~~~~l~~l~~~~~-~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~  262 (594)
T 2p1m_B          185 SLVSLNISCLA-SEVSFSALERLVTRCP-NLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALS  262 (594)
T ss_dssp             CCCEEECTTCC-SCCCHHHHHHHHHHCT-TCCEEECCTTSCHHHHHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHH
T ss_pred             cCcEEEecccC-CcCCHHHHHHHHHhCC-CCcEEecCCCCcHHHHHHHHhcCCcceEcccccccCccchhhHHHHHHHHh
Confidence            59999999887 21222222    2335 89999999883323366667777788888755442                


Q ss_pred             ----------ccc----cCCccccCCCcCcEEEcccCCCCCcCcc-cccCCcccceeeccCcccccc-cCcccccCCCCC
Q 037916          140 ----------LSG----TISPAIGELQNLVTLAINTNKLSGNIPP-SIGNLKKLLQLYLIENFLQVS-IPSSLGQCQSLT  203 (741)
Q Consensus       140 ----------i~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~N~i~~~-~~~~~~~l~~L~  203 (741)
                                +..    ..+..+..+++|++|+|++|.+++.... .+..+++|++|++++| +... ++.....+++|+
T Consensus       263 ~~~~L~~Ls~~~~~~~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~  341 (594)
T 2p1m_B          263 GCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLR  341 (594)
T ss_dssp             TCTTCCEEECCBTCCGGGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCC
T ss_pred             cCCCcccccCCcccchhhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCC
Confidence                      111    1233334678999999999998753322 3568899999999998 4422 333344689999


Q ss_pred             EEec---------cCccccccCCcccc-ccccceeEEEcCCCccCCCCChhhc-CCCCCcEEEec--c----ccccc---
Q 037916          204 TINL---------SYNNLSGTIPPQLM-DLTSLSVGLDLSRNQLVGSLPTEVG-KLINLEILFIS--R----NMLEC---  263 (741)
Q Consensus       204 ~L~L---------~~N~l~~~~p~~~~-~l~~L~~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls--~----N~l~~---  263 (741)
                      +|++         +.|.+++.....+. ++++|+. |+++.|.+++.....+. .+++|+.|+|+  +    |.++.   
T Consensus       342 ~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~-L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~  420 (594)
T 2p1m_B          342 ELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLES-VLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPL  420 (594)
T ss_dssp             EEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCE-EEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCT
T ss_pred             EEEEecCcccccccCCCCCHHHHHHHHHhchhHHH-HHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCch
Confidence            9998         34556543333333 4788887 99999998865555554 58999999999  4    56662   


Q ss_pred             --hhhhhccccccccEEEeCCCccCCCCChhccc-CccCCeeeCCCCcCCCccchhh-hccccCCcccccCcccccccCC
Q 037916          264 --EILSTLGSCIKLEQLKLGGNLFQGPIPLSLSS-LRGLRVLDLSQNNISGEIPKFL-VELQLVQNLNLSYNDLEGVIPT  339 (741)
Q Consensus       264 --~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~l~~N~l~~~~~~  339 (741)
                        ..+..+..+++|+.|+|++ .+++.....+.. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|+++.....
T Consensus       421 ~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~  499 (594)
T 2p1m_B          421 DIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALL  499 (594)
T ss_dssp             HHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHH
T ss_pred             hhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHH
Confidence              2233467889999999987 666555555555 8899999999999986555555 6789999999999999654332


Q ss_pred             --ccccCCcccccccCCCC
Q 037916          340 --EGVFKNASAISVFGNSK  356 (741)
Q Consensus       340 --~~~~~~~~~~~~~~n~~  356 (741)
                        ...+++++.+++.+|+.
T Consensus       500 ~~~~~l~~L~~L~l~~~~~  518 (594)
T 2p1m_B          500 ANASKLETMRSLWMSSCSV  518 (594)
T ss_dssp             HTGGGGGGSSEEEEESSCC
T ss_pred             HHHHhCCCCCEEeeeCCCC
Confidence              23467899999988864

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.86  E-value=2.3e-22  Score=206.40  Aligned_cols=131  Identities=19%  Similarity=0.149  Sum_probs=105.6

Q ss_pred             HHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcC------------------cchhHHHHHHHHHhcCCCceeeEe
Q 037916          402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG------------------ASKSSIAECSALRNIRHKNLVKIL  463 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~------------------~~~~~~~E~~~l~~l~hpnIv~~~  463 (741)
                      |.+.+.||+|+||.||+|.+ .+++.||+|+++.....                  ....+.+|+.++++++|   +++.
T Consensus        92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~  167 (282)
T 1zar_A           92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVP  167 (282)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSC
T ss_pred             EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcC
Confidence            44558999999999999999 68999999999642211                  23457899999999984   5555


Q ss_pred             eeecCccccCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCC
Q 037916          464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKP  543 (741)
Q Consensus       464 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp  543 (741)
                      +++.      .+..|+||||++|++|.+ +..                .....++.|++.||.|||+.   ||+||||||
T Consensus       168 ~~~~------~~~~~lvmE~~~g~~L~~-l~~----------------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp  221 (282)
T 1zar_A          168 KVYA------WEGNAVLMELIDAKELYR-VRV----------------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQ  221 (282)
T ss_dssp             CEEE------EETTEEEEECCCCEEGGG-CCC----------------SCHHHHHHHHHHHHHHHHHT---TEECSCCST
T ss_pred             eEEe------ccceEEEEEecCCCcHHH-cch----------------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCH
Confidence            5421      135699999999999998 431                12346999999999999999   999999999


Q ss_pred             CCeEeCCCCceEEeeccccc
Q 037916          544 SNVLLDHEMTAHVADFGLAK  563 (741)
Q Consensus       544 ~NIll~~~~~~kL~DFg~a~  563 (741)
                      +|||++ ++.+||+|||+|.
T Consensus       222 ~NILl~-~~~vkl~DFG~a~  240 (282)
T 1zar_A          222 YNVLVS-EEGIWIIDFPQSV  240 (282)
T ss_dssp             TSEEEE-TTEEEECCCTTCE
T ss_pred             HHEEEE-CCcEEEEECCCCe
Confidence            999999 9999999999986

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.86  E-value=1.1e-21  Score=219.69  Aligned_cols=189  Identities=22%  Similarity=0.285  Sum_probs=144.1

Q ss_pred             CCcEEEeecCcCcccCCchhhhhhhhhhccccCCCccEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCcccc
Q 037916           46 KLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIG  125 (741)
Q Consensus        46 ~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~  125 (741)
                      +|+.|+|++|+|++ +|..+.  +          +|++|+|++|+|+ .+|   ..+. +|++|+|++|+|++ +|. |.
T Consensus        60 ~L~~L~Ls~n~L~~-lp~~l~--~----------~L~~L~Ls~N~l~-~ip---~~l~-~L~~L~Ls~N~l~~-ip~-l~  119 (571)
T 3cvr_A           60 QFSELQLNRLNLSS-LPDNLP--P----------QITVLEITQNALI-SLP---ELPA-SLEYLDACDNRLST-LPE-LP  119 (571)
T ss_dssp             TCSEEECCSSCCSC-CCSCCC--T----------TCSEEECCSSCCS-CCC---CCCT-TCCEEECCSSCCSC-CCC-CC
T ss_pred             CccEEEeCCCCCCc-cCHhHc--C----------CCCEEECcCCCCc-ccc---cccC-CCCEEEccCCCCCC-cch-hh
Confidence            78888888888875 554442  2          3888888888887 344   2233 78888888888866 454 65


Q ss_pred             CCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEE
Q 037916          126 KFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTI  205 (741)
Q Consensus       126 ~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L  205 (741)
                      +  +|++|+|++|+|+++.+    .+++|++|+|++|+|++ +|.   .+++|++|+|++|+|++ +|. |.  ++|+.|
T Consensus       120 ~--~L~~L~Ls~N~l~~lp~----~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L  185 (571)
T 3cvr_A          120 A--SLKHLDVDNNQLTMLPE----LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEAL  185 (571)
T ss_dssp             T--TCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEE
T ss_pred             c--CCCEEECCCCcCCCCCC----cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEE
Confidence            5  88888888888887443    57888888888888886 444   56788888888888886 555 65  889999


Q ss_pred             eccCccccccCCccccccccc-------eeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccchhhhhcccccc
Q 037916          206 NLSYNNLSGTIPPQLMDLTSL-------SVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIK  274 (741)
Q Consensus       206 ~L~~N~l~~~~p~~~~~l~~L-------~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  274 (741)
                      +|++|+|+ .+|. |..  +|       +. |+|++|+|+ .+|..+..+++|+.|+|++|.|++..|..+..++.
T Consensus       186 ~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~-L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~  255 (571)
T 3cvr_A          186 DVSTNLLE-SLPA-VPV--RNHHSEETEIF-FRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA  255 (571)
T ss_dssp             ECCSSCCS-SCCC-CC----------CCEE-EECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred             ECcCCCCC-chhh-HHH--hhhcccccceE-EecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence            99999998 6776 554  66       77 999999999 57777778999999999999999999998887654

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.86  E-value=1.1e-21  Score=209.50  Aligned_cols=176  Identities=21%  Similarity=0.210  Sum_probs=131.5

Q ss_pred             cEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhh-hhhhhhhccccCCCccEEECcCCcCcccCCchhhcc
Q 037916           24 LFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFG-KATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNF  102 (741)
Q Consensus        24 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l  102 (741)
                      +.+++++|+|+. +|..+.  ..+++|+|++|+|++..+..|. ++++          |++|+|++|+|+++.+..|..+
T Consensus        21 ~~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~----------L~~L~L~~N~i~~i~~~~~~~l   87 (361)
T 2xot_A           21 NILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTN----------LHSLLLSHNHLNFISSEAFVPV   87 (361)
T ss_dssp             TEEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTT----------CCEEECCSSCCCEECTTTTTTC
T ss_pred             CEEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccc----------cCEEECCCCcCCccChhhccCC
Confidence            567777777773 454443  3577777777777766666665 6654          7777777777777777777777


Q ss_pred             cccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCcccc---cCCcccc
Q 037916          103 SITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSI---GNLKKLL  179 (741)
Q Consensus       103 ~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~---~~l~~L~  179 (741)
                      . +|++|+|++|+|..+.+..|.++++|++|+|++|+|+++.+..|.++++|+.|+|++|+|+++.+..|   ..+++|+
T Consensus        88 ~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~  166 (361)
T 2xot_A           88 P-NLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLM  166 (361)
T ss_dssp             T-TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCC
T ss_pred             C-CCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCC
Confidence            7 78888888888777777778888888888888888887778888888888888888888886655555   5678888


Q ss_pred             eeeccCcccccccCcccccCCC--CCEEeccCcccc
Q 037916          180 QLYLIENFLQVSIPSSLGQCQS--LTTINLSYNNLS  213 (741)
Q Consensus       180 ~L~L~~N~i~~~~~~~~~~l~~--L~~L~L~~N~l~  213 (741)
                      .|+|++|+|+...+..|..++.  |+.|+|++|.+.
T Consensus       167 ~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~  202 (361)
T 2xot_A          167 LLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE  202 (361)
T ss_dssp             EEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred             EEECCCCCCCccCHHHhhhccHhhcceEEecCCCcc
Confidence            8888888888766677777776  478888888886

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.85  E-value=1.1e-21  Score=194.01  Aligned_cols=153  Identities=21%  Similarity=0.226  Sum_probs=98.2

Q ss_pred             cEEEcccCCCCCcCcccccCCcccceeeccCcccccccC-cccccCCCCCEEeccCccccccCCccccccccceeEEEcC
Q 037916          155 VTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIP-SSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLS  233 (741)
Q Consensus       155 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls  233 (741)
                      +.+++++|.++. +|..+.  ..+++|+|++|.|++..+ ..|..+++|++|+|++|+|++..+..|.++++|+. |+|+
T Consensus        14 ~~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~-L~Ls   89 (220)
T 2v70_A           14 TTVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNE-ILLT   89 (220)
T ss_dssp             TEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCE-EECC
T ss_pred             CEeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCE-EECC
Confidence            477777887774 454443  345677777777776543 44667777777777777777655556666666665 6666


Q ss_pred             CCccCCCCChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCC
Q 037916          234 RNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISG  311 (741)
Q Consensus       234 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  311 (741)
                      +|+|++..+..|..+++|++|+|++|+|+++.+..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|.+.+
T Consensus        90 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c  167 (220)
T 2v70_A           90 SNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNC  167 (220)
T ss_dssp             SSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEEC
T ss_pred             CCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcC
Confidence            666666666666666666666666666666656666666666666666666665556666666666666666666554

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.85  E-value=1.7e-21  Score=192.53  Aligned_cols=153  Identities=24%  Similarity=0.336  Sum_probs=113.2

Q ss_pred             cEEEcccCCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCC
Q 037916          155 VTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSR  234 (741)
Q Consensus       155 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~  234 (741)
                      +.+++++|.++. +|..+.  ++|+.|+|++|.|+++.+..|..+++|++|+|++|+|++..|..|.++++|+. |+|++
T Consensus        14 ~~v~c~~~~l~~-iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~-L~Ls~   89 (220)
T 2v9t_B           14 NIVDCRGKGLTE-IPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNS-LVLYG   89 (220)
T ss_dssp             TEEECTTSCCSS-CCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCE-EECCS
T ss_pred             CEEEcCCCCcCc-CCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCE-EECCC
Confidence            578888888874 455443  57888888888888777777888888888888888887777777777777776 77777


Q ss_pred             CccCCCCChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCC
Q 037916          235 NQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISG  311 (741)
Q Consensus       235 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  311 (741)
                      |+|+...+..|..+++|++|+|++|+|+++.+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|.+..
T Consensus        90 N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c  166 (220)
T 2v9t_B           90 NKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC  166 (220)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred             CcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence            77776666667777777777777777777777777777777777777777776666667777777777777776653

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.85  E-value=3.8e-21  Score=190.06  Aligned_cols=161  Identities=20%  Similarity=0.242  Sum_probs=85.0

Q ss_pred             hccccCCCccEEECcCCcCcccCCchhhcccccccEEEccCCcccccCC-ccccCCCCccEEEcccccccccCCccccCC
Q 037916           73 CVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIP-AGIGKFINLQTLHMWDNQLSGTISPAIGEL  151 (741)
Q Consensus        73 ~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~-~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l  151 (741)
                      |...|...-+.+++++|.++. +|..+..   .+++|+|++|+|.+..+ ..|..+++|++|+|++|+|+++.+..|.++
T Consensus         5 CP~~C~C~~~~l~~s~n~l~~-iP~~~~~---~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l   80 (220)
T 2v70_A            5 CPEKCRCEGTTVDCSNQKLNK-IPEHIPQ---YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGA   80 (220)
T ss_dssp             CCTTCEEETTEEECCSSCCSS-CCSCCCT---TCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTC
T ss_pred             CCCCCEECCCEeEeCCCCccc-CccCCCC---CCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCC
Confidence            344454456677777777774 3433222   45566666666655533 335555566666666666655555555555


Q ss_pred             CcCcEEEcccCCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEE
Q 037916          152 QNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLD  231 (741)
Q Consensus       152 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~  231 (741)
                      ++|++|+|++|+|+++.+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|+. |+
T Consensus        81 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~-L~  159 (220)
T 2v70_A           81 SGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLST-LN  159 (220)
T ss_dssp             TTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCE-EE
T ss_pred             CCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCE-EE
Confidence            55555555555555555555555555555555555555444455555555555555555444433444444444443 44


Q ss_pred             cCCCccC
Q 037916          232 LSRNQLV  238 (741)
Q Consensus       232 Ls~N~l~  238 (741)
                      |++|.+.
T Consensus       160 L~~N~l~  166 (220)
T 2v70_A          160 LLANPFN  166 (220)
T ss_dssp             CCSCCEE
T ss_pred             ecCcCCc
Confidence            4444433

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.85  E-value=7e-21  Score=196.78  Aligned_cols=169  Identities=21%  Similarity=0.325  Sum_probs=83.2

Q ss_pred             CCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCccEEECcCCcCcccCCchh
Q 037916           20 LPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCI   99 (741)
Q Consensus        20 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~   99 (741)
                      +++|++|++++|.|+.+ + .+..+++|++|+|++|++++..+  +..+++          |++|+|++|++++. + .+
T Consensus        45 l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~----------L~~L~l~~n~l~~~-~-~l  108 (291)
T 1h6t_A           45 LNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKN----------LGWLFLDENKVKDL-S-SL  108 (291)
T ss_dssp             HHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTT----------CCEEECCSSCCCCG-G-GG
T ss_pred             cCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCC----------CCEEECCCCcCCCC-h-hh
Confidence            45555555555555533 2 25555555555555555554322  444443          55555555555532 1 24


Q ss_pred             hcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCcccccCCcccc
Q 037916          100 CNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLL  179 (741)
Q Consensus       100 ~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  179 (741)
                      ..+. +|++|+|++|++...  ..+..+++|++|+|++|+|+++  ..+..+++|++|+|++|+|++..+  +..+++|+
T Consensus       109 ~~l~-~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~  181 (291)
T 1h6t_A          109 KDLK-KLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQ  181 (291)
T ss_dssp             TTCT-TCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCC
T ss_pred             ccCC-CCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccC
Confidence            4444 555555555555332  3344555555555555555443  344455555555555555543332  44555555


Q ss_pred             eeeccCcccccccCcccccCCCCCEEeccCcccc
Q 037916          180 QLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLS  213 (741)
Q Consensus       180 ~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~  213 (741)
                      +|+|++|.|+.. + .+..+++|+.|++++|+++
T Consensus       182 ~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~  213 (291)
T 1h6t_A          182 NLYLSKNHISDL-R-ALAGLKNLDVLELFSQECL  213 (291)
T ss_dssp             EEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEE
T ss_pred             EEECCCCcCCCC-h-hhccCCCCCEEECcCCccc
Confidence            555555555432 2 2444555555555555544

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.84  E-value=3.5e-21  Score=199.08  Aligned_cols=166  Identities=25%  Similarity=0.348  Sum_probs=80.4

Q ss_pred             ccEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcc
Q 037916           81 LKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAIN  160 (741)
Q Consensus        81 L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~  160 (741)
                      +..+.+..+.+++..+  +..+. +|+.|++++|.+...  ..+..+++|++|+|++|+|+++.+  +.++++|++|+|+
T Consensus        26 ~~~~~l~~~~~~~~~~--~~~l~-~L~~L~l~~~~i~~~--~~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~   98 (291)
T 1h6t_A           26 TIKDNLKKKSVTDAVT--QNELN-SIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLD   98 (291)
T ss_dssp             HHHHHTTCSCTTSEEC--HHHHH-TCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECC
T ss_pred             HHHHHhcCCCcccccc--hhhcC-cccEEEccCCCcccC--hhHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECC
Confidence            3344455555543322  12333 555666666555433  235555666666666666654433  5556666666666


Q ss_pred             cCCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCC
Q 037916          161 TNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGS  240 (741)
Q Consensus       161 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~  240 (741)
                      +|++++.  ..+..+++|++|+|++|++++.  ..+..+++|++|+|++|++++.  ..+..+++|+. |+|++|+|++.
T Consensus        99 ~n~l~~~--~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~-L~L~~N~l~~~  171 (291)
T 1h6t_A           99 ENKVKDL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDT-LSLEDNQISDI  171 (291)
T ss_dssp             SSCCCCG--GGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSE-EECCSSCCCCC
T ss_pred             CCcCCCC--hhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCE-EEccCCccccc
Confidence            6665532  2255555555555555555432  2344455555555555555422  33444444443 44444444432


Q ss_pred             CChhhcCCCCCcEEEecccccc
Q 037916          241 LPTEVGKLINLEILFISRNMLE  262 (741)
Q Consensus       241 ~p~~~~~l~~L~~L~Ls~N~l~  262 (741)
                      .+  +..+++|+.|+|++|.|+
T Consensus       172 ~~--l~~l~~L~~L~L~~N~i~  191 (291)
T 1h6t_A          172 VP--LAGLTKLQNLYLSKNHIS  191 (291)
T ss_dssp             GG--GTTCTTCCEEECCSSCCC
T ss_pred             hh--hcCCCccCEEECCCCcCC
Confidence            22  444444444444444444

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.84  E-value=8.2e-21  Score=187.64  Aligned_cols=161  Identities=19%  Similarity=0.262  Sum_probs=85.8

Q ss_pred             ccccCCCccEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCc
Q 037916           74 VQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQN  153 (741)
Q Consensus        74 ~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~  153 (741)
                      ...|...-+.+++++|.++. +|..+.   .+|+.|+|++|+|..+.+..|..+++|++|+|++|+|+++.+..|.++++
T Consensus         6 P~~C~C~~~~v~c~~~~l~~-iP~~l~---~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~   81 (220)
T 2v9t_B            6 PAACTCSNNIVDCRGKGLTE-IPTNLP---ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRS   81 (220)
T ss_dssp             CTTSEEETTEEECTTSCCSS-CCSSCC---TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSS
T ss_pred             CCCCEECCCEEEcCCCCcCc-CCCccC---cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcC
Confidence            33444445677777777763 333222   25555555555555555555555555555555555555555555555555


Q ss_pred             CcEEEcccCCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcC
Q 037916          154 LVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLS  233 (741)
Q Consensus       154 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls  233 (741)
                      |++|+|++|+|+.+.+..|.+                        +++|++|+|++|+|++..|..|.++++|+. |+|+
T Consensus        82 L~~L~Ls~N~l~~l~~~~f~~------------------------l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~-L~L~  136 (220)
T 2v9t_B           82 LNSLVLYGNKITELPKSLFEG------------------------LFSLQLLLLNANKINCLRVDAFQDLHNLNL-LSLY  136 (220)
T ss_dssp             CCEEECCSSCCCCCCTTTTTT------------------------CTTCCEEECCSSCCCCCCTTTTTTCTTCCE-EECC
T ss_pred             CCEEECCCCcCCccCHhHccC------------------------CCCCCEEECCCCCCCEeCHHHcCCCCCCCE-EECC
Confidence            555555555555444444444                        444445555555554444444555555554 5555


Q ss_pred             CCccCCCCChhhcCCCCCcEEEeccccccc
Q 037916          234 RNQLVGSLPTEVGKLINLEILFISRNMLEC  263 (741)
Q Consensus       234 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  263 (741)
                      +|+|++..+..|..+++|+.|+|++|.+..
T Consensus       137 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c  166 (220)
T 2v9t_B          137 DNKLQTIAKGTFSPLRAIQTMHLAQNPFIC  166 (220)
T ss_dssp             SSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred             CCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence            555555555555666666666666666653

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.84  E-value=1.4e-21  Score=221.28  Aligned_cols=168  Identities=20%  Similarity=0.290  Sum_probs=81.2

Q ss_pred             CCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCccEEECcCCcCcccCCchhh
Q 037916           21 PNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCIC  100 (741)
Q Consensus        21 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~  100 (741)
                      .++..++|+.+.++++.+  +..|++|+.|+|++|.|+.. + .|..+++          |+.|+|++|+|++..+  +.
T Consensus        21 ~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l-~-~l~~l~~----------L~~L~Ls~N~l~~~~~--l~   84 (605)
T 1m9s_A           21 AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPN----------VTKLFLNGNKLTDIKP--LT   84 (605)
T ss_dssp             HHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCC-T-TGGGCTT----------CCEEECTTSCCCCCGG--GG
T ss_pred             HHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCC-h-HHccCCC----------CCEEEeeCCCCCCChh--hc
Confidence            334455555555554432  34555566666666665532 2 3444443          5566666655554433  44


Q ss_pred             cccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCcccccCCcccce
Q 037916          101 NFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQ  180 (741)
Q Consensus       101 ~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  180 (741)
                      .+. +|+.|+|++|.|...  ..+..+++|++|+|++|+|+++  ..|..+++|+.|+|++|+|+++  ..|..+++|+.
T Consensus        85 ~l~-~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~  157 (605)
T 1m9s_A           85 NLK-NLGWLFLDENKIKDL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDT  157 (605)
T ss_dssp             GCT-TCCEEECCSSCCCCC--TTSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSE
T ss_pred             cCC-CCCEEECcCCCCCCC--hhhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCE
Confidence            444 555555555555331  2445555555555555555532  2344555555555555555433  33444444444


Q ss_pred             eeccCcccccccCcccccCCCCCEEeccCcccc
Q 037916          181 LYLIENFLQVSIPSSLGQCQSLTTINLSYNNLS  213 (741)
Q Consensus       181 L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~  213 (741)
                      |+|++|.|++..|  +..+++|+.|+|++|+|+
T Consensus       158 L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~  188 (605)
T 1m9s_A          158 LSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS  188 (605)
T ss_dssp             EECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred             EECcCCcCCCchh--hccCCCCCEEECcCCCCC
Confidence            4444444443333  444444444444444443

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.84  E-value=1.4e-20  Score=213.08  Aligned_cols=192  Identities=19%  Similarity=0.290  Sum_probs=163.7

Q ss_pred             CCCCcccccCChhhhhCCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCcc
Q 037916            3 VGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLK   82 (741)
Q Consensus         3 l~~n~~~~~ip~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~   82 (741)
                      |+.+.+...++..   .|++|+.|+|++|.|+.+ + .|..+++|+.|+|++|+|++..|  |..+++          |+
T Consensus        28 l~~~~i~~~~~~~---~L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~----------L~   90 (605)
T 1m9s_A           28 LKKKSVTDAVTQN---ELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKN----------LG   90 (605)
T ss_dssp             TTCSCTTSEECHH---HHTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTT----------CC
T ss_pred             ccCCCcccccchh---cCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCC----------CC
Confidence            5667777665543   579999999999999864 3 58999999999999999996654  777765          99


Q ss_pred             EEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcccC
Q 037916           83 HLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTN  162 (741)
Q Consensus        83 ~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N  162 (741)
                      .|+|++|+|++. | .+..+. +|+.|+|++|+|...  ..+..+++|+.|+|++|+|+++  ..|..+++|+.|+|++|
T Consensus        91 ~L~Ls~N~l~~l-~-~l~~l~-~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N  163 (605)
T 1m9s_A           91 WLFLDENKIKDL-S-SLKDLK-KLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDN  163 (605)
T ss_dssp             EEECCSSCCCCC-T-TSTTCT-TCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSS
T ss_pred             EEECcCCCCCCC-h-hhccCC-CCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCC
Confidence            999999999964 3 678888 999999999999764  5699999999999999999976  78999999999999999


Q ss_pred             CCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCccccc
Q 037916          163 KLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMD  222 (741)
Q Consensus       163 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  222 (741)
                      +|++..|  |..+++|+.|+|++|.|++.  ..+..+++|+.|+|++|++++.....+..
T Consensus       164 ~l~~~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p~~~~~~  219 (605)
T 1m9s_A          164 QISDIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSN  219 (605)
T ss_dssp             CCCCCGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCCCCCCSS
T ss_pred             cCCCchh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCccccccc
Confidence            9997766  99999999999999999964  46899999999999999998543333333

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.82  E-value=1.2e-20  Score=198.96  Aligned_cols=286  Identities=12%  Similarity=0.037  Sum_probs=173.4

Q ss_pred             CCCCcEEEcccCcccccCCccCCC-CCCCcEEEeecCcCc--ccCCchhhhhhhhhhccccCCCccEEECcCCcCcccCC
Q 037916           20 LPNLLFLSLGFNQITGVIPSSMFN-ASKLEVFQVTSNNLT--GEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLP   96 (741)
Q Consensus        20 l~~L~~L~L~~n~i~~~~~~~~~~-l~~L~~L~L~~N~l~--~~~~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~   96 (741)
                      +++++.|.++++ +....-..+.. +++|++|||++|+|+  ...+..+..             ++.+.+..|.   +.+
T Consensus        24 ~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~~~-------------~~~~~~~~~~---I~~   86 (329)
T 3sb4_A           24 ANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTYPN-------------GKFYIYMANF---VPA   86 (329)
T ss_dssp             HHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSSGG-------------GCCEEECTTE---ECT
T ss_pred             hCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccccccc-------------cccccccccc---cCH
Confidence            366788888765 32222223333 677888888888877  333222221             3444444553   344


Q ss_pred             chhhc--------ccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCC----C
Q 037916           97 GCICN--------FSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNK----L  164 (741)
Q Consensus        97 ~~~~~--------l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~----l  164 (741)
                      .+|.+        +. +|+.|+|.+ ++..+.+.+|.++++|++|+|++|.++.+.+.+|.++.++..+.+..+.    .
T Consensus        87 ~aF~~~~~~~~~g~~-~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~  164 (329)
T 3sb4_A           87 YAFSNVVNGVTKGKQ-TLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFK  164 (329)
T ss_dssp             TTTEEEETTEEEECT-TCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTS
T ss_pred             HHhcccccccccccC-CCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcc
Confidence            55655        66 777777777 6666677777777777777777777776777777776666666655522    2


Q ss_pred             CCcCcccccCCcccc-eeeccCcc-cccccCcccccCCCCCEEeccCccccccCCccc-cccccceeEEEcCCCccCCCC
Q 037916          165 SGNIPPSIGNLKKLL-QLYLIENF-LQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQL-MDLTSLSVGLDLSRNQLVGSL  241 (741)
Q Consensus       165 ~~~~~~~~~~l~~L~-~L~L~~N~-i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~~L~Ls~N~l~~~~  241 (741)
                      ..+...+|.++.+|+ .+.+.... +.......-....+++.+.+.++-.. .....+ ..+++|+. |+|++|+++.+.
T Consensus       165 ~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~-l~L~~n~i~~I~  242 (329)
T 3sb4_A          165 NRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVS-LDISKTNATTIP  242 (329)
T ss_dssp             TTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCE-EECTTBCCCEEC
T ss_pred             ccccccccccccccceeEEecCCCcHHHHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeE-EECCCCCcceec
Confidence            333444555555555 33333221 10000000011234445554443211 111111 12567776 888887777666


Q ss_pred             ChhhcCCCCCcEEEeccccccchhhhhcccccccc-EEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccchhhhcc
Q 037916          242 PTEVGKLINLEILFISRNMLECEILSTLGSCIKLE-QLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVEL  320 (741)
Q Consensus       242 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  320 (741)
                      +..|.++++|+.|+|++| ++.+...+|.++++|+ .|++.+ .++.+.+.+|.++++|+.|++++|+++.+.+.+|.++
T Consensus       243 ~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~  320 (329)
T 3sb4_A          243 DFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNG  320 (329)
T ss_dssp             TTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTT
T ss_pred             HhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCC
Confidence            777888888888888877 7777778888888887 888877 6766777788888888888888888877777788888


Q ss_pred             ccCCcccc
Q 037916          321 QLVQNLNL  328 (741)
Q Consensus       321 ~~L~~L~l  328 (741)
                      ++|+.++.
T Consensus       321 ~~L~~ly~  328 (329)
T 3sb4_A          321 VPSKLIYK  328 (329)
T ss_dssp             CCCCEEEC
T ss_pred             cchhhhcc
Confidence            88877653

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.82  E-value=5.4e-23  Score=231.52  Aligned_cols=204  Identities=19%  Similarity=0.158  Sum_probs=151.8

Q ss_pred             CCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCccEEECcCCc-------------CcccCCchhhcccccccE
Q 037916           42 FNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNN-------------FGGLLPGCICNFSITLET  108 (741)
Q Consensus        42 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~-------------l~~~~~~~~~~l~~~L~~  108 (741)
                      ...++|+.|+|++|+|+ .+|..++.+++          |+.|++++|.             +.+..|..+..+. +|+.
T Consensus       346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~----------L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~-~L~~  413 (567)
T 1dce_A          346 ATDEQLFRCELSVEKST-VLQSELESCKE----------LQELEPENKWCLLTIILLMRALDPLLYEKETLQYFS-TLKA  413 (567)
T ss_dssp             STTTTSSSCCCCHHHHH-HHHHHHHHHHH----------HHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHH-HHHH
T ss_pred             ccCccceeccCChhhHH-hhHHHHHHHHH----------HHHhccccchhhhhHHHHHHhcccccCCHHHHHHHH-hccc
Confidence            45677788888888887 66777777776          7777776664             4455566666666 6666


Q ss_pred             EE-ccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCcccccCCcccceeeccCcc
Q 037916          109 LI-FNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENF  187 (741)
Q Consensus       109 L~-L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  187 (741)
                      |+ ++.|.+           .+|+.+.+++|.|+.+.+.      .|+.|+|++|+|++ +|. |+.+++|+.|+|++|.
T Consensus       414 L~~l~~n~~-----------~~L~~l~l~~n~i~~l~~~------~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~  474 (567)
T 1dce_A          414 VDPMRAAYL-----------DDLRSKFLLENSVLKMEYA------DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNR  474 (567)
T ss_dssp             HCGGGHHHH-----------HHHHHHHHHHHHHHHHHHT------TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSC
T ss_pred             Ccchhhccc-----------chhhhhhhhcccccccCcc------CceEEEecCCCCCC-CcC-ccccccCcEeecCccc
Confidence            66 555543           2455666667776654332      47888888888885 454 8888888888888888


Q ss_pred             cccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCCC-ChhhcCCCCCcEEEeccccccchhh
Q 037916          188 LQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSL-PTEVGKLINLEILFISRNMLECEIL  266 (741)
Q Consensus       188 i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~~  266 (741)
                      |+ .+|..|+.+++|++|+|++|+|++ +| .+.++++|+. |+|++|+|++.. |..|+.+++|+.|+|++|.|++.++
T Consensus       475 l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~-L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~  550 (567)
T 1dce_A          475 LR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQE-LLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG  550 (567)
T ss_dssp             CC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCE-EECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred             cc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcE-EECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence            88 677888888888888888888884 66 7888888887 888888888776 8888888888888888888887654


Q ss_pred             h---hccccccccEEEe
Q 037916          267 S---TLGSCIKLEQLKL  280 (741)
Q Consensus       267 ~---~~~~l~~L~~L~L  280 (741)
                      .   .+..+++|+.|++
T Consensus       551 ~~~~l~~~lp~L~~L~l  567 (567)
T 1dce_A          551 IQERLAEMLPSVSSILT  567 (567)
T ss_dssp             CTTHHHHHCTTCSEEEC
T ss_pred             HHHHHHHHCcccCccCC
Confidence            3   3445788888864

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.82  E-value=1.3e-19  Score=180.19  Aligned_cols=132  Identities=26%  Similarity=0.278  Sum_probs=65.4

Q ss_pred             CccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEecc
Q 037916          129 NLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLS  208 (741)
Q Consensus       129 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~  208 (741)
                      +|++|+|++|+|+++.+..|.++++|++|+|++|+|+.+.+..|.++++|++|+|++|+|++..+..|..+++|++|+|+
T Consensus        41 ~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls  120 (229)
T 3e6j_A           41 NAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMC  120 (229)
T ss_dssp             TCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEecc
Confidence            44444444444444444444444444444554444444434444444445555555554444444444455555555555


Q ss_pred             CccccccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEecccccc
Q 037916          209 YNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLE  262 (741)
Q Consensus       209 ~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  262 (741)
                      +|+|+ .+|..+..+++|+. |+|++|+|++..+..|..+++|+.|+|++|.+.
T Consensus       121 ~N~l~-~lp~~~~~l~~L~~-L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~  172 (229)
T 3e6j_A          121 CNKLT-ELPRGIERLTHLTH-LALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWD  172 (229)
T ss_dssp             SSCCC-SCCTTGGGCTTCSE-EECCSSCCCCCCTTTTTTCTTCCEEECTTSCBC
T ss_pred             CCccc-ccCcccccCCCCCE-EECCCCcCCccCHHHHhCCCCCCEEEeeCCCcc
Confidence            55554 44444555555554 555555555444444555555555555555544

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.81  E-value=1.1e-19  Score=180.72  Aligned_cols=152  Identities=22%  Similarity=0.332  Sum_probs=94.9

Q ss_pred             cEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCccEEECcCCcCcccCCchhhccc
Q 037916           24 LFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFS  103 (741)
Q Consensus        24 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~  103 (741)
                      +.++.++++++ .+|..+.  ++|++|+|++|+|++..|..|..+++          |++|+|++|+|+++.+..|..+.
T Consensus        22 ~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~----------L~~L~L~~N~l~~i~~~~~~~l~   88 (229)
T 3e6j_A           22 TTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLIN----------LKELYLGSNQLGALPVGVFDSLT   88 (229)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTT----------CCEEECCSSCCCCCCTTTTTTCT
T ss_pred             CEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccC----------CcEEECCCCCCCCcChhhcccCC
Confidence            45666666665 3333332  56666666666666555666666554          66666666666655555555555


Q ss_pred             ccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCcccccCCcccceeec
Q 037916          104 ITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYL  183 (741)
Q Consensus       104 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  183 (741)
                       +|+.|+|++|+|.+..+..|..+++|++|+|++|+|+ .+|..+..+++|++|+|++|+|+++.+..|..+++|+.|+|
T Consensus        89 -~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l  166 (229)
T 3e6j_A           89 -QLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYL  166 (229)
T ss_dssp             -TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             -CcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEe
Confidence             6666666666666665666666666777777777666 34555666667777777777776655566666677777777


Q ss_pred             cCccccc
Q 037916          184 IENFLQV  190 (741)
Q Consensus       184 ~~N~i~~  190 (741)
                      ++|.+..
T Consensus       167 ~~N~~~c  173 (229)
T 3e6j_A          167 FGNPWDC  173 (229)
T ss_dssp             TTSCBCT
T ss_pred             eCCCccC
Confidence            7776653

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.81  E-value=4.4e-22  Score=224.08  Aligned_cols=200  Identities=23%  Similarity=0.231  Sum_probs=160.6

Q ss_pred             CccEEECcCCcCcccCCchhhcccccccEEEccCCc-------------ccccCCccccCCCCccEEE-cccccccccCC
Q 037916           80 HLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNK-------------IFRSIPAGIGKFINLQTLH-MWDNQLSGTIS  145 (741)
Q Consensus        80 ~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~-------------i~~~~~~~~~~l~~L~~L~-L~~N~i~~~~~  145 (741)
                      +|+.|+|++|+|+ .+|..+..+. +|+.|++++|.             +.+..|..+..+++|+.|+ ++.|.+.    
T Consensus       350 ~L~~L~Ls~n~L~-~Lp~~i~~l~-~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~----  423 (567)
T 1dce_A          350 QLFRCELSVEKST-VLQSELESCK-ELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD----  423 (567)
T ss_dssp             TSSSCCCCHHHHH-HHHHHHHHHH-HHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH----
T ss_pred             cceeccCChhhHH-hhHHHHHHHH-HHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc----
Confidence            5999999999998 6788888888 89999997765             3455566666677777776 5665442    


Q ss_pred             ccccCCCcCcEEEcccCCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCcccccccc
Q 037916          146 PAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTS  225 (741)
Q Consensus       146 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  225 (741)
                             +|..+.+++|.|+.+.+      ..|+.|+|++|.|++ +|. |+.+++|+.|+|++|+|+ .+|..|.++++
T Consensus       424 -------~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~  487 (567)
T 1dce_A          424 -------DLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRC  487 (567)
T ss_dssp             -------HHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTT
T ss_pred             -------hhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCC
Confidence                   45556667777764322      248899999999986 565 899999999999999998 88999999999


Q ss_pred             ceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccchh-hhhccccccccEEEeCCCccCCCCCh---hcccCccCCe
Q 037916          226 LSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEI-LSTLGSCIKLEQLKLGGNLFQGPIPL---SLSSLRGLRV  301 (741)
Q Consensus       226 L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~~---~~~~l~~L~~  301 (741)
                      |+. |+|++|+|++ +| .|+.+++|+.|+|++|+|+++. |..|+.+++|+.|+|++|++++.+|.   .+..+++|+.
T Consensus       488 L~~-L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~  564 (567)
T 1dce_A          488 LEV-LQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSS  564 (567)
T ss_dssp             CCE-EECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSE
T ss_pred             CCE-EECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCc
Confidence            997 9999999996 56 8999999999999999999887 88999999999999999999876553   2445889998


Q ss_pred             eeC
Q 037916          302 LDL  304 (741)
Q Consensus       302 L~L  304 (741)
                      |+|
T Consensus       565 L~l  567 (567)
T 1dce_A          565 ILT  567 (567)
T ss_dssp             EEC
T ss_pred             cCC
Confidence            875

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.81  E-value=1.7e-20  Score=217.75  Aligned_cols=192  Identities=24%  Similarity=0.269  Sum_probs=113.8

Q ss_pred             EEcccccccccCCccccCCCcCcEEEcccCCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccc
Q 037916          133 LHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNL  212 (741)
Q Consensus       133 L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l  212 (741)
                      ++++.|++. +.+..|..+++|+.|+|++|+|. .+|..+.++++|++|+|++|.|+ .+|..|.++++|++|+|++|+|
T Consensus       206 ~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l  282 (727)
T 4b8c_D          206 DDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRL  282 (727)
T ss_dssp             -----------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCC
T ss_pred             cccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcC
Confidence            355566665 66777888888888888888887 55656667888888888888888 6778888888888888888888


Q ss_pred             cccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccchhhhhcccccc-ccEEEeCCCccCCCCCh
Q 037916          213 SGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIK-LEQLKLGGNLFQGPIPL  291 (741)
Q Consensus       213 ~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~  291 (741)
                      + .+|..|.++++|+. |+|++|.|+ .+|..|+.+++|++|+|++|.|++.++..+..+.. +..|+|++|.+++.+|.
T Consensus       283 ~-~lp~~~~~l~~L~~-L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~  359 (727)
T 4b8c_D          283 T-SLPAELGSCFQLKY-FYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH  359 (727)
T ss_dssp             S-SCCSSGGGGTTCSE-EECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_pred             C-ccChhhcCCCCCCE-EECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc
Confidence            8 77888888888887 888888887 56767888888888888888888888887766532 33578889998887775


Q ss_pred             hcccCccCCeeeCCCC--------cCCCccchhhhccccCCcccccCcccccc
Q 037916          292 SLSSLRGLRVLDLSQN--------NISGEIPKFLVELQLVQNLNLSYNDLEGV  336 (741)
Q Consensus       292 ~~~~l~~L~~L~Ls~N--------~l~~~~~~~~~~l~~L~~L~l~~N~l~~~  336 (741)
                            .|+.|++++|        .|.+..+..+..+..+....+++|-+...
T Consensus       360 ------~l~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~~~  406 (727)
T 4b8c_D          360 ------ERRFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLCQH  406 (727)
T ss_dssp             ------C-----------------------------------------CCCGG
T ss_pred             ------ccceeEeecccccccccCCccccccchhhcccccceeeeeccccccc
Confidence                  4556667766        44444455556666667777777777643

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.81  E-value=1.2e-20  Score=198.89  Aligned_cols=272  Identities=14%  Similarity=0.082  Sum_probs=201.7

Q ss_pred             CCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCccEEECcCCcCc--ccCCchhhcccccccEEEccCCcccccCC
Q 037916           44 ASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFG--GLLPGCICNFSITLETLIFNSNKIFRSIP  121 (741)
Q Consensus        44 l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~--~~~~~~~~~l~~~L~~L~L~~n~i~~~~~  121 (741)
                      +.+|+.|.++++ +.   ...+..+..      ...+|+.|||++|+|.  ...+..+   . .+..+.+..|.   +.+
T Consensus        24 ~~~l~~L~l~g~-i~---~~~~~~l~~------~l~~L~~LdLs~n~i~~~~~~~~~~---~-~~~~~~~~~~~---I~~   86 (329)
T 3sb4_A           24 ANSITHLTLTGK-LN---AEDFRHLRD------EFPSLKVLDISNAEIKMYSGKAGTY---P-NGKFYIYMANF---VPA   86 (329)
T ss_dssp             HHHCSEEEEEEE-EC---HHHHHHHHH------SCTTCCEEEEEEEEECCEEESSSSS---G-GGCCEEECTTE---ECT
T ss_pred             hCceeEEEEecc-cc---HHHHHHHHH------hhccCeEEecCcceeEEecCccccc---c-ccccccccccc---cCH
Confidence            667999999875 22   122333322      1245999999999998  3333222   2 24556666663   456


Q ss_pred             ccccC--------CCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCcccccCCcccceeeccCcc----cc
Q 037916          122 AGIGK--------FINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENF----LQ  189 (741)
Q Consensus       122 ~~~~~--------l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~----i~  189 (741)
                      .+|.+        +++|++|+|.+ .++.+...+|.++++|+.|++++|.+..+.+.+|.+..++..+.+..+.    ..
T Consensus        87 ~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~  165 (329)
T 3sb4_A           87 YAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKN  165 (329)
T ss_dssp             TTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTST
T ss_pred             HHhcccccccccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccc
Confidence            77888        99999999999 8888999999999999999999999988888999998888888777642    23


Q ss_pred             cccCcccccCCCCC-EEeccCccccccCCccc----cccccceeEEEcCCCccCCCCChhh-cCCCCCcEEEeccccccc
Q 037916          190 VSIPSSLGQCQSLT-TINLSYNNLSGTIPPQL----MDLTSLSVGLDLSRNQLVGSLPTEV-GKLINLEILFISRNMLEC  263 (741)
Q Consensus       190 ~~~~~~~~~l~~L~-~L~L~~N~l~~~~p~~~----~~l~~L~~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~  263 (741)
                      .....+|.++.+|+ .+.+....   .++..+    ....++.. +.+.++-.. .....+ ..+++|+.|+|++|+++.
T Consensus       166 ~i~~~~f~~~~~L~~~i~~~~~~---~l~~~~~~~~~~~~~~~~-l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~  240 (329)
T 3sb4_A          166 RWEHFAFIEGEPLETTIQVGAMG---KLEDEIMKAGLQPRDINF-LTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATT  240 (329)
T ss_dssp             TTTTSCEEESCCCEEEEEECTTC---CHHHHHHHTTCCGGGCSE-EEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCE
T ss_pred             cccccccccccccceeEEecCCC---cHHHHHhhcccCccccce-EEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcce
Confidence            34456677777777 55554431   122211    12344444 555554222 111122 248999999999999999


Q ss_pred             hhhhhccccccccEEEeCCCccCCCCChhcccCccCC-eeeCCCCcCCCccchhhhccccCCcccccCcccccccCCc
Q 037916          264 EILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLR-VLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTE  340 (741)
Q Consensus       264 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~  340 (741)
                      +...+|.++++|+.|+|.+| ++.+.+.+|.++++|+ .++|.+ .++.+.+.+|.++++|+.|++++|.++.+.+..
T Consensus       241 I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~a  316 (329)
T 3sb4_A          241 IPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDEL  316 (329)
T ss_dssp             ECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTT
T ss_pred             ecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhh
Confidence            99999999999999999998 8888999999999999 999998 788788899999999999999999999887654

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.80  E-value=3.1e-20  Score=188.79  Aligned_cols=78  Identities=23%  Similarity=0.357  Sum_probs=34.7

Q ss_pred             ccEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcc
Q 037916           81 LKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAIN  160 (741)
Q Consensus        81 L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~  160 (741)
                      ++.+++++|.+++..  .+..+. +|+.|++++|+|... + .+..+++|++|+|++|+|+++.+  |.++++|++|+|+
T Consensus        21 l~~l~l~~~~i~~~~--~~~~l~-~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~   93 (263)
T 1xeu_A           21 AVKQNLGKQSVTDLV--SQKELS-GVQNFNGDNSNIQSL-A-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVN   93 (263)
T ss_dssp             HHHHHHTCSCTTSEE--CHHHHT-TCSEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECC
T ss_pred             HHHHHhcCCCccccc--chhhcC-cCcEEECcCCCcccc-h-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECC
Confidence            444455555554332  233343 444444444444322 2 34444444444444444443332  4444444444444


Q ss_pred             cCCCC
Q 037916          161 TNKLS  165 (741)
Q Consensus       161 ~N~l~  165 (741)
                      +|+++
T Consensus        94 ~N~l~   98 (263)
T 1xeu_A           94 RNRLK   98 (263)
T ss_dssp             SSCCS
T ss_pred             CCccC
Confidence            44444

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.80  E-value=2.7e-20  Score=189.33  Aligned_cols=166  Identities=23%  Similarity=0.272  Sum_probs=75.6

Q ss_pred             ccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccC
Q 037916          130 LQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSY  209 (741)
Q Consensus       130 L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~  209 (741)
                      +..+++++|.++++.  .+..+++|++|++++|+|+.+ + .+..+++|++|+|++|+|++..+  |..+++|++|+|++
T Consensus        21 l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~   94 (263)
T 1xeu_A           21 AVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQSL-A-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNR   94 (263)
T ss_dssp             HHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCS
T ss_pred             HHHHHhcCCCccccc--chhhcCcCcEEECcCCCcccc-h-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCC
Confidence            334444444444322  234444444444444444422 2 34444444444444444443322  44444444444444


Q ss_pred             ccccccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCccCCCC
Q 037916          210 NNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPI  289 (741)
Q Consensus       210 N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  289 (741)
                      |++++ +|....  ++|+. |+|++|+|++. + .+..+++|+.|+|++|+|+++.  .+..+++|+.|+|++|++++. 
T Consensus        95 N~l~~-l~~~~~--~~L~~-L~L~~N~l~~~-~-~l~~l~~L~~L~Ls~N~i~~~~--~l~~l~~L~~L~L~~N~i~~~-  165 (263)
T 1xeu_A           95 NRLKN-LNGIPS--ACLSR-LFLDNNELRDT-D-SLIHLKNLEILSIRNNKLKSIV--MLGFLSKLEVLDLHGNEITNT-  165 (263)
T ss_dssp             SCCSC-CTTCCC--SSCCE-EECCSSCCSBS-G-GGTTCTTCCEEECTTSCCCBCG--GGGGCTTCCEEECTTSCCCBC-
T ss_pred             CccCC-cCcccc--CcccE-EEccCCccCCC-h-hhcCcccccEEECCCCcCCCCh--HHccCCCCCEEECCCCcCcch-
Confidence            44442 222111  44444 55555555432 2 3455555555555555555431  345555555555555555543 


Q ss_pred             ChhcccCccCCeeeCCCCcCCC
Q 037916          290 PLSLSSLRGLRVLDLSQNNISG  311 (741)
Q Consensus       290 ~~~~~~l~~L~~L~Ls~N~l~~  311 (741)
                       ..+..+++|+.|+|++|.+++
T Consensus       166 -~~l~~l~~L~~L~l~~N~~~~  186 (263)
T 1xeu_A          166 -GGLTRLKKVNWIDLTGQKCVN  186 (263)
T ss_dssp             -TTSTTCCCCCEEEEEEEEEEC
T ss_pred             -HHhccCCCCCEEeCCCCcccC
Confidence             345555555555555555553

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.79  E-value=2.7e-19  Score=173.62  Aligned_cols=105  Identities=20%  Similarity=0.238  Sum_probs=45.1

Q ss_pred             CCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEe
Q 037916          127 FINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTIN  206 (741)
Q Consensus       127 l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~  206 (741)
                      +++|++|++++|.|+.+.  .+..+++|++|++++|.++.  +..|..+++|++|++++|.+++..+..|..+++|++|+
T Consensus        43 l~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~  118 (197)
T 4ezg_A           43 MNSLTYITLANINVTDLT--GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLD  118 (197)
T ss_dssp             HHTCCEEEEESSCCSCCT--TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEE
T ss_pred             cCCccEEeccCCCccChH--HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEE
Confidence            344444444444444222  34444444444444444431  12344444444444444444443444444444444444


Q ss_pred             ccCccccccCCccccccccceeEEEcCCCc
Q 037916          207 LSYNNLSGTIPPQLMDLTSLSVGLDLSRNQ  236 (741)
Q Consensus       207 L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~  236 (741)
                      |++|++++..|..+..+++|+. |++++|.
T Consensus       119 Ls~n~i~~~~~~~l~~l~~L~~-L~L~~n~  147 (197)
T 4ezg_A          119 ISHSAHDDSILTKINTLPKVNS-IDLSYNG  147 (197)
T ss_dssp             CCSSBCBGGGHHHHTTCSSCCE-EECCSCT
T ss_pred             ecCCccCcHhHHHHhhCCCCCE-EEccCCC
Confidence            4444444333333444444443 4444443

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.78  E-value=2.3e-20  Score=216.71  Aligned_cols=190  Identities=21%  Similarity=0.245  Sum_probs=68.4

Q ss_pred             cCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCccccc
Q 037916           94 LLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIG  173 (741)
Q Consensus        94 ~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  173 (741)
                      ..+..|..+. .|+.|+|++|.+. .+|..+..+++|++|+|++|.|+ .+|..|.+|++|++|+|++|+|+ .+|..|.
T Consensus       215 ~~~~~~~~l~-~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~  290 (727)
T 4b8c_D          215 MPKDSKYDDQ-LWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELG  290 (727)
T ss_dssp             -------CCC-CCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGG
T ss_pred             cChhhhccCC-CCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhc
Confidence            3344444444 4555555555543 33333444555555555555555 33444555555555555555555 3344555


Q ss_pred             CCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcE
Q 037916          174 NLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEI  253 (741)
Q Consensus       174 ~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~  253 (741)
                      ++++|++|+|++|.|+ .+|..|..+++|++|+|++|+|++.+|..+..+......|+|++|.+++.+|.      .|+.
T Consensus       291 ~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~------~l~~  363 (727)
T 4b8c_D          291 SCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH------ERRF  363 (727)
T ss_dssp             GGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC------C---
T ss_pred             CCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc------ccce
Confidence            5555555555555554 33444555555555555555555444444443322111144555555544442      2333


Q ss_pred             EEeccccccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCC
Q 037916          254 LFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNIS  310 (741)
Q Consensus       254 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  310 (741)
                      |+++.|...   .             ...+.+.+..+..+..+..+....++.|-+.
T Consensus       364 l~l~~n~~~---~-------------~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~  404 (727)
T 4b8c_D          364 IEINTDGEP---Q-------------REYDSLQQSTEHLATDLAKRTFTVLSYNTLC  404 (727)
T ss_dssp             ------------------------------------------------------CCC
T ss_pred             eEeeccccc---c-------------cccCCccccccchhhcccccceeeeeccccc
Confidence            334433100   0             0011334444445556666667777777665

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.78  E-value=4.5e-18  Score=183.10  Aligned_cols=267  Identities=11%  Similarity=0.103  Sum_probs=193.5

Q ss_pred             CCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCccEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCcc
Q 037916           44 ASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAG  123 (741)
Q Consensus        44 l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~  123 (741)
                      ...++.+.+.+ .++.+...+|.+. +          |+.++|.+| ++.+...+|.+ . +|+.+.+.. .+..+.+.+
T Consensus       112 ~~~l~~i~ip~-~i~~I~~~aF~~~-~----------L~~i~l~~~-i~~I~~~aF~~-~-~L~~i~lp~-~l~~I~~~a  175 (401)
T 4fdw_A          112 LKGYNEIILPN-SVKSIPKDAFRNS-Q----------IAKVVLNEG-LKSIGDMAFFN-S-TVQEIVFPS-TLEQLKEDI  175 (401)
T ss_dssp             CSSCSEEECCT-TCCEECTTTTTTC-C----------CSEEECCTT-CCEECTTTTTT-C-CCCEEECCT-TCCEECSST
T ss_pred             cCCccEEEECC-ccCEehHhhcccC-C----------ccEEEeCCC-ccEECHHhcCC-C-CceEEEeCC-CccEehHHH
Confidence            45666666643 4554555556542 2          777777655 66666666666 2 577777765 566667777


Q ss_pred             ccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCC
Q 037916          124 IGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLT  203 (741)
Q Consensus       124 ~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~  203 (741)
                      |.++++|+.++|++|+++.+...+|. ..+|+.+.|.+| ++.+...+|.++++|+.+++..| ++.+...+|.+ .+|+
T Consensus       176 F~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~  251 (401)
T 4fdw_A          176 FYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGIT  251 (401)
T ss_dssp             TTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCS
T ss_pred             hhCcccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCcc
Confidence            77777777777777777777777776 467777777744 66677777777777777777765 55566677776 6777


Q ss_pred             EEeccCccccccCCccccccccceeEEEcCCCccC-----CCCChhhcCCCCCcEEEeccccccchhhhhccccccccEE
Q 037916          204 TINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLV-----GSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQL  278 (741)
Q Consensus       204 ~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  278 (741)
                      .+.| .|.++...+.+|.++++|+. +++.+|.+.     .+.+..|.++++|+.++|. |.++.+...+|.++++|+.|
T Consensus       252 ~i~l-p~~i~~I~~~aF~~c~~L~~-l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l  328 (401)
T 4fdw_A          252 TVKL-PNGVTNIASRAFYYCPELAE-VTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQL  328 (401)
T ss_dssp             EEEE-ETTCCEECTTTTTTCTTCCE-EEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEE
T ss_pred             EEEe-CCCccEEChhHhhCCCCCCE-EEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEE
Confidence            7777 44566566677777777776 777777654     3566788888899999988 45888888889999999999


Q ss_pred             EeCCCccCCCCChhcccCccCCeeeCCCCcCCCccchhhhccc-cCCcccccCccccc
Q 037916          279 KLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQ-LVQNLNLSYNDLEG  335 (741)
Q Consensus       279 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~l~~N~l~~  335 (741)
                      .|..| ++.+...+|.++ +|+.+++++|.+....+..|.+++ .++.|++..|.+..
T Consensus       329 ~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~~  384 (401)
T 4fdw_A          329 TIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVEK  384 (401)
T ss_dssp             EECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHHH
T ss_pred             EECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHHH
Confidence            99655 776778889888 899999999988877777888774 67888888777653

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.78  E-value=2.3e-19  Score=173.28  Aligned_cols=174  Identities=19%  Similarity=0.207  Sum_probs=116.9

Q ss_pred             ceeeccCcccccccCcccccCCCCCEEeccCccccccCCc-cccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEec
Q 037916          179 LQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPP-QLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFIS  257 (741)
Q Consensus       179 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  257 (741)
                      +.+++++|.++ .+|..+.  .+|++|+|++|+|++..+. .|..+++|+. |+|++|+|++..|..|..+++|++|+|+
T Consensus        11 ~~l~~s~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~-L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls   86 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVK-LELKRNQLTGIEPNAFEGASHIQELQLG   86 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCE-EECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             CEEEcCCCCcC-cCccCCC--CCCCEEECCCCcCCccCCccccccCCCCCE-EECCCCCCCCcCHhHcCCcccCCEEECC
Confidence            67788888886 4555443  3788888888888755543 3777888876 8888888887777788888888888888


Q ss_pred             cccccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccch-hhhccccCCcccccCcccccc
Q 037916          258 RNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPK-FLVELQLVQNLNLSYNDLEGV  336 (741)
Q Consensus       258 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~l~~N~l~~~  336 (741)
                      +|+|+++.+..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+++..+- ++.  ..++...+.++...+.
T Consensus        87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~--~~l~~~~~~~~~~~C~  164 (192)
T 1w8a_A           87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFA--EWLRKKSLNGGAARCG  164 (192)
T ss_dssp             SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHH--HHHHHHCCSGGGCBBC
T ss_pred             CCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHH--HHHHHcCCCCCCCCCC
Confidence            8888877777788888888888888888877777788888888888888887765432 111  1233334444544444


Q ss_pred             cCCccccCCcccccccCCCCcccc
Q 037916          337 IPTEGVFKNASAISVFGNSKLCGG  360 (741)
Q Consensus       337 ~~~~~~~~~~~~~~~~~n~~~c~~  360 (741)
                      .|..  +....-.++..+...|..
T Consensus       165 ~P~~--l~~~~l~~l~~~~~~C~~  186 (192)
T 1w8a_A          165 APSK--VRDVQIKDLPHSEFKCSS  186 (192)
T ss_dssp             SSTT--TTTSBGGGSCTTTCCCCC
T ss_pred             CChH--HcCCChhhCcHhhcCcCC
Confidence            3432  333333444455555543

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.78  E-value=2.2e-19  Score=181.99  Aligned_cols=138  Identities=21%  Similarity=0.124  Sum_probs=105.0

Q ss_pred             HHHhhhcccCceeeEEEEEEcCCCeE--EEEEEeeccCcCc------------------------chhHHHHHHHHHhcC
Q 037916          402 FLFLCWIDMGSFGSVYKGILDEGKTI--IAVKVLNLLHHGA------------------------SKSSIAECSALRNIR  455 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~~~~~~--vavK~~~~~~~~~------------------------~~~~~~E~~~l~~l~  455 (741)
                      |.+.+.||+|+||.||+|.+..+|+.  ||||+++......                        ...+.+|+.+++++.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            45667899999999999999667888  9999976321110                        125678999999998


Q ss_pred             CCce--eeEeeeecCccccCCceEEEEEecccC-C----ChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHH
Q 037916          456 HKNL--VKILTVCSGVDYKGDDFKALVYEFMHN-G----SLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL  528 (741)
Q Consensus       456 hpnI--v~~~~~~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L  528 (741)
                      |++|  +.++++         ...++||||+.+ |    +|.++...             .++..+..++.|++.||.||
T Consensus       129 ~~~i~~p~~~~~---------~~~~lVmE~~g~~g~~~~~L~~~~~~-------------~~~~~~~~i~~qi~~~l~~l  186 (258)
T 1zth_A          129 EAGVSVPQPYTY---------MKNVLLMEFIGEDELPAPTLVELGRE-------------LKELDVEGIFNDVVENVKRL  186 (258)
T ss_dssp             HTTCCCCCEEEE---------ETTEEEEECCEETTEECCBHHHHGGG-------------GGGSCHHHHHHHHHHHHHHH
T ss_pred             hCCCCCCeEEEc---------CCCEEEEEecCCCCCccccHHHHhhc-------------cChHHHHHHHHHHHHHHHHH
Confidence            8754  344432         245899999942 3    56555321             22345678999999999999


Q ss_pred             H-hcCCCCceecCCCCCCeEeCCCCceEEeecccccccC
Q 037916          529 H-HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLP  566 (741)
Q Consensus       529 H-~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~a~~~~  566 (741)
                      | +.   ||+||||||+|||++.  .++|+|||+|....
T Consensus       187 H~~~---givHrDlkp~NILl~~--~~~liDFG~a~~~~  220 (258)
T 1zth_A          187 YQEA---ELVHADLSEYNIMYID--KVYFIDMGQAVTLR  220 (258)
T ss_dssp             HHTS---CEECSSCSTTSEEESS--SEEECCCTTCEETT
T ss_pred             HHHC---CEEeCCCCHHHEEEcC--cEEEEECcccccCC
Confidence            9 88   9999999999999988  99999999997643

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.78  E-value=5.7e-18  Score=182.29  Aligned_cols=268  Identities=12%  Similarity=0.092  Sum_probs=226.6

Q ss_pred             hCCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCccEEECcCCcCcccCCc
Q 037916           18 FTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPG   97 (741)
Q Consensus        18 ~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~   97 (741)
                      .....++.+.+.++ ++.+...+|.+. +|+.+.|.+| ++.+...+|.+.           +|+.++|.+ .++.+.+.
T Consensus       110 ~~~~~l~~i~ip~~-i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-----------~L~~i~lp~-~l~~I~~~  174 (401)
T 4fdw_A          110 EILKGYNEIILPNS-VKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-----------TVQEIVFPS-TLEQLKED  174 (401)
T ss_dssp             EECSSCSEEECCTT-CCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-----------CCCEEECCT-TCCEECSS
T ss_pred             EecCCccEEEECCc-cCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-----------CceEEEeCC-CccEehHH
Confidence            34577888888764 777888899885 7999999776 776777788763           399999986 78878888


Q ss_pred             hhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCcccccCCcc
Q 037916           98 CICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKK  177 (741)
Q Consensus        98 ~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  177 (741)
                      +|.++. +|+.++|.+|++..+...+|. ..+|+.+.|..+ ++.+...+|.++++|+.++|..| ++.+...+|.+ .+
T Consensus       175 aF~~c~-~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~  249 (401)
T 4fdw_A          175 IFYYCY-NLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SG  249 (401)
T ss_dssp             TTTTCT-TCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CC
T ss_pred             HhhCcc-cCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CC
Confidence            998888 899999999999888888887 589999999855 88888999999999999999875 67688888988 88


Q ss_pred             cceeeccCcccccccCcccccCCCCCEEeccCcccc-----ccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCc
Q 037916          178 LLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLS-----GTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLE  252 (741)
Q Consensus       178 L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~-----~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~  252 (741)
                      |+.+.| .|.++.+...+|.++++|+.+++.+|.+.     ...+..|.++++|+. ++|. |.++.+...+|.++++|+
T Consensus       250 L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~-l~l~-~~i~~I~~~aF~~c~~L~  326 (401)
T 4fdw_A          250 ITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLAR-FEIP-ESIRILGQGLLGGNRKVT  326 (401)
T ss_dssp             CSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCE-ECCC-TTCCEECTTTTTTCCSCC
T ss_pred             ccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCe-EEeC-CceEEEhhhhhcCCCCcc
Confidence            999999 45577788889999999999999988775     467788999999997 9999 458777788999999999


Q ss_pred             EEEeccccccchhhhhccccccccEEEeCCCccCCCCChhcccCc-cCCeeeCCCCcCC
Q 037916          253 ILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLR-GLRVLDLSQNNIS  310 (741)
Q Consensus       253 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~  310 (741)
                      .|+|..| ++.+...+|.++ +|+.|++++|.+....+..|.+++ ++..|++..+.+.
T Consensus       327 ~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~  383 (401)
T 4fdw_A          327 QLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE  383 (401)
T ss_dssp             EEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred             EEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence            9999665 888899999999 999999999999988888999885 7889998887654

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.78  E-value=1e-18  Score=169.57  Aligned_cols=153  Identities=19%  Similarity=0.288  Sum_probs=119.0

Q ss_pred             hcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCcccccCCcccc
Q 037916          100 CNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLL  179 (741)
Q Consensus       100 ~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  179 (741)
                      ..+. +|+.|++++|.+. .+| .+..+++|++|++++|.++.  +..+..+++|++|+|++|++++..+..|+.+++|+
T Consensus        41 ~~l~-~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~  115 (197)
T 4ezg_A           41 AQMN-SLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT  115 (197)
T ss_dssp             HHHH-TCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCC
T ss_pred             hhcC-CccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCC
Confidence            4555 7888888888885 344 67888888888888887763  34788888899999999998877788888889999


Q ss_pred             eeeccCcccccccCcccccCCCCCEEeccCcc-ccccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEecc
Q 037916          180 QLYLIENFLQVSIPSSLGQCQSLTTINLSYNN-LSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISR  258 (741)
Q Consensus       180 ~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  258 (741)
                      +|+|++|.+++..|..|..+++|++|+|++|+ ++ .+| .+..+++|+. |++++|.+++ ++ .+..+++|++|++++
T Consensus       116 ~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~-L~l~~n~i~~-~~-~l~~l~~L~~L~l~~  190 (197)
T 4ezg_A          116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKS-LNIQFDGVHD-YR-GIEDFPKLNQLYAFS  190 (197)
T ss_dssp             EEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCE-EECTTBCCCC-CT-TGGGCSSCCEEEECB
T ss_pred             EEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCE-EECCCCCCcC-hH-HhccCCCCCEEEeeC
Confidence            99999999887778888889999999999998 65 455 5777888876 8888888874 33 677777777777777


Q ss_pred             cccc
Q 037916          259 NMLE  262 (741)
Q Consensus       259 N~l~  262 (741)
                      |+|.
T Consensus       191 N~i~  194 (197)
T 4ezg_A          191 QTIG  194 (197)
T ss_dssp             C---
T ss_pred             cccC
Confidence            7765

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.76  E-value=3.6e-18  Score=164.80  Aligned_cols=155  Identities=24%  Similarity=0.246  Sum_probs=77.3

Q ss_pred             CEEeccCccccccCCccccccccceeEEEcCCCccCCCCCh-hhcCCCCCcEEEeccccccchhhhhccccccccEEEeC
Q 037916          203 TTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPT-EVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLG  281 (741)
Q Consensus       203 ~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  281 (741)
                      ++|++++|+++ .+|..+..  +++. |+|++|+|++..+. .|+.+++|++|+|++|+|+++.+..|.++++|++|+|+
T Consensus        11 ~~l~~s~~~l~-~ip~~~~~--~l~~-L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls   86 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIPL--HTTE-LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG   86 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCCT--TCSE-EECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             CEEEcCCCCcC-cCccCCCC--CCCE-EECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECC
Confidence            44555555554 44443332  4443 55555555544432 25555555555555555555555555555555555555


Q ss_pred             CCccCCCCChhcccCccCCeeeCCCCcCCCccchhhhccccCCcccccCcccccccCCccccCCcccccccCCCCccccC
Q 037916          282 GNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKNASAISVFGNSKLCGGI  361 (741)
Q Consensus       282 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~  361 (741)
                      +|+|++..+..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|++++..+..+....+....+.++...|+.+
T Consensus        87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P  166 (192)
T 1w8a_A           87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP  166 (192)
T ss_dssp             SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred             CCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCC
Confidence            55555555555555555555555555555555555555555555555555555444332222222222333444445444

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.74  E-value=4e-18  Score=164.49  Aligned_cols=130  Identities=23%  Similarity=0.279  Sum_probs=77.0

Q ss_pred             CEEeccCccccccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCC
Q 037916          203 TTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGG  282 (741)
Q Consensus       203 ~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  282 (741)
                      +.+++++|+++ .+|..+.  .+++. |+|++|+|+ .+|..|..+++|+.|+|++|.|+++.+..|.++++|++|+|++
T Consensus        13 ~~l~~~~~~l~-~ip~~~~--~~l~~-L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~   87 (193)
T 2wfh_A           13 TVVRCSNKGLK-VLPKGIP--RDVTE-LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSY   87 (193)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCCE-EECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCCC-cCCCCCC--CCCCE-EECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCC
Confidence            34555555555 4444332  24444 566666655 4445566666666666666666665556666666666666666


Q ss_pred             CccCCCCChhcccCccCCeeeCCCCcCCCccchhhhccccCCcccccCccccccc
Q 037916          283 NLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVI  337 (741)
Q Consensus       283 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~  337 (741)
                      |+|+++.+..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|++.+..
T Consensus        88 N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c  142 (193)
T 2wfh_A           88 NRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDC  142 (193)
T ss_dssp             SCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred             CccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCC
Confidence            6666666666666666666666666666555555666666666666666665543

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.72  E-value=1.5e-17  Score=160.42  Aligned_cols=136  Identities=21%  Similarity=0.321  Sum_probs=100.9

Q ss_pred             hccccCCCccEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCC
Q 037916           73 CVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQ  152 (741)
Q Consensus        73 ~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~  152 (741)
                      |...|...-+.+++++|+|+. +|..+.   .+|++|+|++|+|. .+|..|..+++|++|+|++|+|+++.+..|.+++
T Consensus         4 CP~~C~C~~~~l~~~~~~l~~-ip~~~~---~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~   78 (193)
T 2wfh_A            4 CPTECTCLDTVVRCSNKGLKV-LPKGIP---RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMT   78 (193)
T ss_dssp             CCTTCEEETTEEECTTSCCSS-CCSCCC---TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred             CCCCCEeCCCEEEcCCCCCCc-CCCCCC---CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCC
Confidence            334444446788888888884 444332   27888888888875 4557788888888888888888877777788888


Q ss_pred             cCcEEEcccCCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCcccc
Q 037916          153 NLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLS  213 (741)
Q Consensus       153 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~  213 (741)
                      +|++|+|++|+|+++.+.+|.++++|++|+|++|.|+...+..|..+++|+.|+|++|.+.
T Consensus        79 ~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~  139 (193)
T 2wfh_A           79 QLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY  139 (193)
T ss_dssp             TCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred             CCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence            8888888888888777777777888888888888877666667777777777777777775

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.71  E-value=2.4e-17  Score=156.89  Aligned_cols=137  Identities=22%  Similarity=0.220  Sum_probs=100.7

Q ss_pred             cccCCCccEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcC
Q 037916           75 QNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNL  154 (741)
Q Consensus        75 ~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L  154 (741)
                      ..|....+.+++++|+++.+ |..+.   .+|+.|++++|++.+..+..|..+++|++|+|++|+|+++.+..|.++++|
T Consensus         3 ~~C~C~~~~l~~~~~~l~~~-p~~~~---~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L   78 (177)
T 2o6r_A            3 SRCSCSGTEIRCNSKGLTSV-PTGIP---SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKL   78 (177)
T ss_dssp             TTCEEETTEEECCSSCCSSC-CTTCC---TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTC
T ss_pred             CCCEeCCCEEEecCCCCccC-CCCCC---CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCcc
Confidence            44555678888888888844 43322   277888888888877777777778888888888888887777777778888


Q ss_pred             cEEEcccCCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCcccccc
Q 037916          155 VTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGT  215 (741)
Q Consensus       155 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~  215 (741)
                      ++|+|++|+|+++.+..|..+++|++|+|++|.+++..+..|..+++|++|+|++|++++.
T Consensus        79 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~  139 (177)
T 2o6r_A           79 TILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS  139 (177)
T ss_dssp             CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred             CEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeecc
Confidence            8888888888776666677777777777777777766666667777777777777777643

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.71  E-value=3.4e-17  Score=154.38  Aligned_cols=135  Identities=21%  Similarity=0.236  Sum_probs=90.2

Q ss_pred             CccEEECcCCcCc-ccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEE
Q 037916           80 HLKHLDINNNNFG-GLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLA  158 (741)
Q Consensus        80 ~L~~L~Ls~N~l~-~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~  158 (741)
                      +|++|+|++|+++ +.+|..+..+. +|+.|++++|.+...  ..|..+++|++|+|++|+|++.+|..+..+++|++|+
T Consensus        25 ~L~~L~l~~n~l~~~~i~~~~~~l~-~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  101 (168)
T 2ell_A           25 AVRELVLDNCKSNDGKIEGLTAEFV-NLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN  101 (168)
T ss_dssp             SCSEEECCSCBCBTTBCSSCCGGGG-GCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred             cCCEEECCCCCCChhhHHHHHHhCC-CCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence            4666666666665 44555555555 666666666666554  5667777777777777777766666666677777777


Q ss_pred             cccCCCCCcCc-ccccCCcccceeeccCcccccccC---cccccCCCCCEEeccCccccccCCc
Q 037916          159 INTNKLSGNIP-PSIGNLKKLLQLYLIENFLQVSIP---SSLGQCQSLTTINLSYNNLSGTIPP  218 (741)
Q Consensus       159 L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~i~~~~~---~~~~~l~~L~~L~L~~N~l~~~~p~  218 (741)
                      |++|+|+++.. ..|..+++|++|++++|.+++..+   ..|..+++|++|++++|.+. .+|.
T Consensus       102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~  164 (168)
T 2ell_A          102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPD  164 (168)
T ss_dssp             CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCS
T ss_pred             ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hccc
Confidence            77777775422 567777777777777777775544   46677777777777777766 4443

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.70  E-value=4e-17  Score=153.92  Aligned_cols=136  Identities=19%  Similarity=0.171  Sum_probs=94.6

Q ss_pred             CCCCEEeccCcccc-ccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccchhhhhccccccccEE
Q 037916          200 QSLTTINLSYNNLS-GTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQL  278 (741)
Q Consensus       200 ~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  278 (741)
                      ++|++|++++|+++ +.+|..+..+++|+. |+|++|.|++.  ..|..+++|++|+|++|++++..+..+..+++|+.|
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~-L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  100 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEF-LSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL  100 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSSCCGGGGGCCE-EEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred             ccCCEEECCCCCCChhhHHHHHHhCCCCCE-EeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence            56677777777766 566666667777766 77777777644  566677777777777777776666666667777777


Q ss_pred             EeCCCccCCCCC-hhcccCccCCeeeCCCCcCCCccc---hhhhccccCCcccccCcccccccC
Q 037916          279 KLGGNLFQGPIP-LSLSSLRGLRVLDLSQNNISGEIP---KFLVELQLVQNLNLSYNDLEGVIP  338 (741)
Q Consensus       279 ~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~---~~~~~l~~L~~L~l~~N~l~~~~~  338 (741)
                      +|++|++++... ..+..+++|+.|+|++|.+++..+   ..+..+++|+.|++++|.+...+.
T Consensus       101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~  164 (168)
T 2ell_A          101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEAPD  164 (168)
T ss_dssp             ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBCCS
T ss_pred             eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhccc
Confidence            777777775432 567777777777777777775554   467777777777777777765543

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.68  E-value=1.1e-16  Score=147.59  Aligned_cols=127  Identities=21%  Similarity=0.149  Sum_probs=62.9

Q ss_pred             cccceeeccCcccc-cccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEE
Q 037916          176 KKLLQLYLIENFLQ-VSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEIL  254 (741)
Q Consensus       176 ~~L~~L~L~~N~i~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L  254 (741)
                      ++|+.|++++|.++ +.+|..+..+++|++|++++|++++.  ..+..+++|+. |+|++|.+++.+|..+..+++|++|
T Consensus        17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~-L~Ls~n~i~~~~~~~~~~l~~L~~L   93 (149)
T 2je0_A           17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKK-LELSDNRVSGGLEVLAEKCPNLTHL   93 (149)
T ss_dssp             GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCE-EECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred             ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCE-EECCCCcccchHHHHhhhCCCCCEE
Confidence            34444444444444 33444444455555555555555432  44445555554 5555555554445555555555555


Q ss_pred             Eeccccccch-hhhhccccccccEEEeCCCccCCCCC---hhcccCccCCeeeCC
Q 037916          255 FISRNMLECE-ILSTLGSCIKLEQLKLGGNLFQGPIP---LSLSSLRGLRVLDLS  305 (741)
Q Consensus       255 ~Ls~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~Ls  305 (741)
                      ++++|+++++ .+..+..+++|++|++++|++++..+   ..+..+++|+.|+++
T Consensus        94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~  148 (149)
T 2je0_A           94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY  148 (149)
T ss_dssp             ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred             ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence            5555555543 22445555555555555555554433   344555555555543

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.67  E-value=1.6e-16  Score=151.15  Aligned_cols=109  Identities=24%  Similarity=0.209  Sum_probs=54.6

Q ss_pred             EEcCCCccCCCCChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcC
Q 037916          230 LDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNI  309 (741)
Q Consensus       230 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  309 (741)
                      |++++|++++..+..|+.+++|++|+|++|+|+++.+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|++
T Consensus        33 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l  112 (177)
T 2o6r_A           33 LELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQL  112 (177)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred             EEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcc
Confidence            44444444444444444445555555555555544444445555555555555555544444455555555555555555


Q ss_pred             CCccchhhhccccCCcccccCcccccccC
Q 037916          310 SGEIPKFLVELQLVQNLNLSYNDLEGVIP  338 (741)
Q Consensus       310 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  338 (741)
                      ++..+..|..+++|+.|+|++|++++.++
T Consensus       113 ~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  141 (177)
T 2o6r_A          113 KSVPDGIFDRLTSLQKIWLHTNPWDCSCP  141 (177)
T ss_dssp             SCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             eEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence            54444444455555555555555554433

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.67  E-value=2.6e-17  Score=172.79  Aligned_cols=138  Identities=12%  Similarity=0.130  Sum_probs=100.2

Q ss_pred             HHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcC--------------cchh--------HHHHHHHHHhcCCCce
Q 037916          402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG--------------ASKS--------SIAECSALRNIRHKNL  459 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~--------------~~~~--------~~~E~~~l~~l~hpnI  459 (741)
                      |.+.+.||+|++|.||+|.+. +|+.||||+++.....              ....        ..+|...|.++.+.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            788889999999999999986 6899999998632110              0011        1345666666644433


Q ss_pred             e--eEeeeecCccccCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCce
Q 037916          460 V--KILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTA  537 (741)
Q Consensus       460 v--~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~iv  537 (741)
                      .  ..+++         ...++||||++|++|.++...                .....++.|++.+|.+||+.   |||
T Consensus       176 ~vp~p~~~---------~~~~LVME~i~G~~L~~l~~~----------------~~~~~l~~qll~~l~~lH~~---gIV  227 (397)
T 4gyi_A          176 PVPEPIAQ---------SRHTIVMSLVDALPMRQVSSV----------------PDPASLYADLIALILRLAKH---GLI  227 (397)
T ss_dssp             SCCCEEEE---------ETTEEEEECCSCEEGGGCCCC----------------SCHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             CCCeeeec---------cCceEEEEecCCccHhhhccc----------------HHHHHHHHHHHHHHHHHHHC---CCc
Confidence            2  22222         124799999999888776431                12346889999999999999   999


Q ss_pred             ecCCCCCCeEeCCCC----------ceEEeecccccccCCC
Q 037916          538 HCDLKPSNVLLDHEM----------TAHVADFGLAKLLPPA  568 (741)
Q Consensus       538 HrDlkp~NIll~~~~----------~~kL~DFg~a~~~~~~  568 (741)
                      ||||||.|||+++++          .+.|+||+.+.....+
T Consensus       228 HrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~hp  268 (397)
T 4gyi_A          228 HGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSMDHP  268 (397)
T ss_dssp             CSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEETTST
T ss_pred             CCCCCHHHEEEeCCCCcccccccccceEEEEeCCcccCCCC
Confidence            999999999998776          3899999988765433

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.66  E-value=1.3e-16  Score=147.14  Aligned_cols=129  Identities=19%  Similarity=0.195  Sum_probs=115.4

Q ss_pred             CCCCCEEeccCcccc-ccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccchhhhhccccccccE
Q 037916          199 CQSLTTINLSYNNLS-GTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQ  277 (741)
Q Consensus       199 l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  277 (741)
                      .++|+.|++++|+++ +.+|..+..+++|+. |++++|.+++.  ..++.+++|++|+|++|.+++..+..+..+++|++
T Consensus        16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~-L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~   92 (149)
T 2je0_A           16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEF-LSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH   92 (149)
T ss_dssp             GGGCSEEECTTCBCBTTBCCSCCTTCTTCCE-EECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCE
T ss_pred             CccCeEEEccCCcCChhHHHHHHhhcCCCcE-EECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCE
Confidence            368999999999998 788999999999998 99999999966  78899999999999999999878888888999999


Q ss_pred             EEeCCCccCCC-CChhcccCccCCeeeCCCCcCCCccc---hhhhccccCCcccccC
Q 037916          278 LKLGGNLFQGP-IPLSLSSLRGLRVLDLSQNNISGEIP---KFLVELQLVQNLNLSY  330 (741)
Q Consensus       278 L~L~~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~---~~~~~l~~L~~L~l~~  330 (741)
                      |++++|++++. .+..+..+++|++|++++|.+++..+   ..+..+++|+.|++++
T Consensus        93 L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d  149 (149)
T 2je0_A           93 LNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD  149 (149)
T ss_dssp             EECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred             EECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence            99999999974 34789999999999999999997766   5789999999999874

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.66  E-value=1.4e-15  Score=164.29  Aligned_cols=293  Identities=10%  Similarity=0.016  Sum_probs=170.2

Q ss_pred             cCChhhhhCCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCccEEECcCCc
Q 037916           11 GIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNN   90 (741)
Q Consensus        11 ~ip~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~   90 (741)
                      +|+...|.++.+|+.+.|.. .++.+...+|.++++|+.++|.++ ++.+...+|.+..+          |+.+.+..+ 
T Consensus        61 sIg~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~----------L~~i~~p~~-  127 (394)
T 4fs7_A           61 SIGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYA----------LKSILLPLM-  127 (394)
T ss_dssp             EECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTT----------CCCCCCCTT-
T ss_pred             EhHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhccccc----------chhhcccCc-
Confidence            46777777889999999975 488788889999999999999755 66677778887765          776666543 


Q ss_pred             CcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCcc
Q 037916           91 FGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPP  170 (741)
Q Consensus        91 l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  170 (741)
                      +..+...+|....  +...... +.+..+...+|.++.+|+.+.+.++. ..+...+|.++.+|+.+.+..| ++.+...
T Consensus       128 l~~i~~~aF~~~~--~~~~~~~-~~~~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~  202 (394)
T 4fs7_A          128 LKSIGVEAFKGCD--FKEITIP-EGVTVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDY  202 (394)
T ss_dssp             CCEECTTTTTTCC--CSEEECC-TTCCEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTT
T ss_pred             eeeecceeeeccc--ccccccC-ccccccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCch
Confidence            4445555665543  2222222 22234556677777777777776553 4466777777777777777666 5546666


Q ss_pred             cccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCCCCh-------
Q 037916          171 SIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPT-------  243 (741)
Q Consensus       171 ~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~-------  243 (741)
                      +|.+...|+.+.+..+...  +...+....+|+.+.+..+ ++......|.+...++. +.+..+... +...       
T Consensus       203 ~F~~~~~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~-~~~~~~~~~-i~~~~F~~~~~  277 (394)
T 4fs7_A          203 CFAECILLENMEFPNSLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLES-ISIQNNKLR-IGGSLFYNCSG  277 (394)
T ss_dssp             TTTTCTTCCBCCCCTTCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCE-EEECCTTCE-ECSCTTTTCTT
T ss_pred             hhccccccceeecCCCceE--eehhhcccCCCceEEECCC-ceeccccccccccccee-EEcCCCcce-eeccccccccc
Confidence            7777777777766655332  1122222344444444322 22233334444444443 444443322 3333       


Q ss_pred             --------------hhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcC
Q 037916          244 --------------EVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNI  309 (741)
Q Consensus       244 --------------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  309 (741)
                                    .|..+.+|+.+.+..+ ++.+...+|.++.+|+.++|..+ ++.+...+|.++.+|+.+++..| +
T Consensus       278 l~~~~~~~~~i~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l  354 (394)
T 4fs7_A          278 LKKVIYGSVIVPEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-L  354 (394)
T ss_dssp             CCEEEECSSEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-C
T ss_pred             cceeccCceeeccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-c
Confidence                          4445555555555433 44455555555555555555433 44444555555555555555544 4


Q ss_pred             CCccchhhhccccCCccccc
Q 037916          310 SGEIPKFLVELQLVQNLNLS  329 (741)
Q Consensus       310 ~~~~~~~~~~l~~L~~L~l~  329 (741)
                      +.+...+|.++.+|+.+++.
T Consensus       355 ~~I~~~aF~~C~~L~~i~lp  374 (394)
T 4fs7_A          355 RKIGANAFQGCINLKKVELP  374 (394)
T ss_dssp             CEECTTTBTTCTTCCEEEEE
T ss_pred             cEehHHHhhCCCCCCEEEEC
Confidence            44444555555555555554

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.63  E-value=4.6e-16  Score=147.77  Aligned_cols=134  Identities=16%  Similarity=0.153  Sum_probs=89.2

Q ss_pred             cccCCCCccEEEcccccccccCCccccCCC-cCcEEEcccCCCCCcCcccccCCcccceeeccCcccccccCcccccCCC
Q 037916          123 GIGKFINLQTLHMWDNQLSGTISPAIGELQ-NLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQS  201 (741)
Q Consensus       123 ~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~  201 (741)
                      .+..+.+|++|+|++|+|+.+ +. +..+. +|++|+|++|+|+++  ..|..+++|++|+|++|.|++..+..|..+++
T Consensus        14 ~~~~~~~L~~L~l~~n~l~~i-~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~   89 (176)
T 1a9n_A           14 QYTNAVRDRELDLRGYKIPVI-EN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD   89 (176)
T ss_dssp             EEECTTSCEEEECTTSCCCSC-CC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred             hcCCcCCceEEEeeCCCCchh-HH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence            345566777777777777744 33 33333 777777777777754  56777777777777777777655555677777


Q ss_pred             CCEEeccCccccccCCc--cccccccceeEEEcCCCccCCCCCh----hhcCCCCCcEEEeccccccc
Q 037916          202 LTTINLSYNNLSGTIPP--QLMDLTSLSVGLDLSRNQLVGSLPT----EVGKLINLEILFISRNMLEC  263 (741)
Q Consensus       202 L~~L~L~~N~l~~~~p~--~~~~l~~L~~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~Ls~N~l~~  263 (741)
                      |++|+|++|+|+ .+|.  .+..+++|+. |++++|.+.. .|.    .+..+++|+.|++++|.+..
T Consensus        90 L~~L~L~~N~i~-~~~~~~~l~~l~~L~~-L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~~~  154 (176)
T 1a9n_A           90 LTELILTNNSLV-ELGDLDPLASLKSLTY-LCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKLKE  154 (176)
T ss_dssp             CCEEECCSCCCC-CGGGGGGGGGCTTCCE-EECCSSGGGG-STTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred             CCEEECCCCcCC-cchhhHhhhcCCCCCE-EEecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCHHH
Confidence            777777777775 4554  5666777776 7777777763 343    36777777777777777654

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.63  E-value=1.5e-17  Score=161.50  Aligned_cols=153  Identities=22%  Similarity=0.216  Sum_probs=94.1

Q ss_pred             CcccceeeccCcccccccCc------ccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCCCChhhcCC
Q 037916          175 LKKLLQLYLIENFLQVSIPS------SLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKL  248 (741)
Q Consensus       175 l~~L~~L~L~~N~i~~~~~~------~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l  248 (741)
                      ...++.++++.|.+.+..|.      .|..+++|++|+|++|+|++ +| .+.++++|+. |++++|.|+ .+|..+..+
T Consensus        17 ~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~-L~l~~n~l~-~l~~~~~~~   92 (198)
T 1ds9_A           17 RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRI-LSLGRNLIK-KIENLDAVA   92 (198)
T ss_dssp             TTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCE-EEEEEEEEC-SCSSHHHHH
T ss_pred             cccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCE-EECCCCCcc-cccchhhcC
Confidence            34444444444444444443      56666666666666666663 45 5666666665 666666666 455556666


Q ss_pred             CCCcEEEeccccccchhhhhccccccccEEEeCCCccCCCCC-hhcccCccCCeeeCCCCcCCCccch----------hh
Q 037916          249 INLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIP-LSLSSLRGLRVLDLSQNNISGEIPK----------FL  317 (741)
Q Consensus       249 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~----------~~  317 (741)
                      ++|++|+|++|+++++.  .+..+++|+.|++++|++++..+ ..+..+++|++|++++|.+++..|.          .+
T Consensus        93 ~~L~~L~L~~N~l~~l~--~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~  170 (198)
T 1ds9_A           93 DTLEELWISYNQIASLS--GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVV  170 (198)
T ss_dssp             HHCSEEEEEEEECCCHH--HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHH
T ss_pred             CcCCEEECcCCcCCcCC--ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHH
Confidence            67777777777776532  46666777777777777764332 3566777777777777777655443          26


Q ss_pred             hccccCCcccccCccccc
Q 037916          318 VELQLVQNLNLSYNDLEG  335 (741)
Q Consensus       318 ~~l~~L~~L~l~~N~l~~  335 (741)
                      ..+++|+.||  +|+++.
T Consensus       171 ~~l~~L~~Ld--~~~i~~  186 (198)
T 1ds9_A          171 KRLPNLKKLD--GMPVDV  186 (198)
T ss_dssp             HHCSSCSEEC--CGGGTT
T ss_pred             HhCCCcEEEC--CcccCH
Confidence            6777777765  666653

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.61  E-value=1.1e-17  Score=162.42  Aligned_cols=151  Identities=28%  Similarity=0.348  Sum_probs=93.3

Q ss_pred             CcCcEEEcccCCCCCcCcc------cccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCcccccccc
Q 037916          152 QNLVTLAINTNKLSGNIPP------SIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTS  225 (741)
Q Consensus       152 ~~L~~L~L~~N~l~~~~~~------~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  225 (741)
                      .+++.++++.|.+++..|.      .|..+++|++|+|++|.+++ +| .+..+++|++|+|++|+|+ .+|..+..+++
T Consensus        18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~   94 (198)
T 1ds9_A           18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADT   94 (198)
T ss_dssp             TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHH
T ss_pred             ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCc
Confidence            3444444444444444333      56666666666666666654 34 5666666666666666666 55665666666


Q ss_pred             ceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccchhh-hhccccccccEEEeCCCccCCCCCh----------hcc
Q 037916          226 LSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEIL-STLGSCIKLEQLKLGGNLFQGPIPL----------SLS  294 (741)
Q Consensus       226 L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~----------~~~  294 (741)
                      |+. |+|++|++++ +| .+..+++|++|+|++|+++.+.. ..+..+++|++|++++|.+.+..|.          .+.
T Consensus        95 L~~-L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~  171 (198)
T 1ds9_A           95 LEE-LWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVK  171 (198)
T ss_dssp             CSE-EEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHH
T ss_pred             CCE-EECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHH
Confidence            665 7777776664 33 56667777777777777765443 5666777777777777777655443          267


Q ss_pred             cCccCCeeeCCCCcCC
Q 037916          295 SLRGLRVLDLSQNNIS  310 (741)
Q Consensus       295 ~l~~L~~L~Ls~N~l~  310 (741)
                      .+++|+.||  +|.++
T Consensus       172 ~l~~L~~Ld--~~~i~  185 (198)
T 1ds9_A          172 RLPNLKKLD--GMPVD  185 (198)
T ss_dssp             HCSSCSEEC--CGGGT
T ss_pred             hCCCcEEEC--CcccC
Confidence            777888776  66665

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.61  E-value=4.4e-16  Score=147.93  Aligned_cols=134  Identities=17%  Similarity=0.154  Sum_probs=80.3

Q ss_pred             cccCCCCCEEeccCccccccCCccccccc-cceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccchhhhhcccccc
Q 037916          196 LGQCQSLTTINLSYNNLSGTIPPQLMDLT-SLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIK  274 (741)
Q Consensus       196 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  274 (741)
                      +.++.+|+.|++++|+++ .+|. +..+. +|+. |+|++|.|++.  ..|+.+++|++|+|++|+|+++.+..|..+++
T Consensus        15 ~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~-L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~   89 (176)
T 1a9n_A           15 YTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDA-IDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD   89 (176)
T ss_dssp             EECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSE-EECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred             cCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCE-EECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence            344455555555555555 3333 33333 5554 66666655543  35566666666666666666655555566666


Q ss_pred             ccEEEeCCCccCCCCCh--hcccCccCCeeeCCCCcCCCccch----hhhccccCCcccccCcccccc
Q 037916          275 LEQLKLGGNLFQGPIPL--SLSSLRGLRVLDLSQNNISGEIPK----FLVELQLVQNLNLSYNDLEGV  336 (741)
Q Consensus       275 L~~L~L~~N~l~~~~~~--~~~~l~~L~~L~Ls~N~l~~~~~~----~~~~l~~L~~L~l~~N~l~~~  336 (741)
                      |++|+|++|+|+. +|.  .+..+++|+.|+|++|.++. .|.    .+..+++|+.||+++|.+...
T Consensus        90 L~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~~~~  155 (176)
T 1a9n_A           90 LTELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKLKER  155 (176)
T ss_dssp             CCEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETTEECCHHHH
T ss_pred             CCEEECCCCcCCc-chhhHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCHHHH
Confidence            7777777776653 333  56677777777777777763 343    367777777777777776543

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.58  E-value=4.4e-15  Score=139.94  Aligned_cols=113  Identities=24%  Similarity=0.372  Sum_probs=74.3

Q ss_pred             hccccCCCccEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCC
Q 037916           73 CVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQ  152 (741)
Q Consensus        73 ~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~  152 (741)
                      |...|....+.|++++|.|+. +|..+.   .+|++|+|++|+|.++.|..|.++++|++|+|++|+|+++.+..|.+++
T Consensus         3 CP~~C~C~~~~l~~s~n~l~~-ip~~~~---~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~   78 (170)
T 3g39_A            3 CPSQCSCSGTTVDCSGKSLAS-VPTGIP---TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLT   78 (170)
T ss_dssp             CC-CCEEETTEEECTTSCCSS-CCSCCC---TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCT
T ss_pred             CcCcCCcCCCEEEeCCCCcCc-cCccCC---CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCC
Confidence            445565567888888888884 443332   2677777777777666666677777777777777777666666666666


Q ss_pred             cCcEEEcccCCCCCcCcccccCCcccceeeccCcccc
Q 037916          153 NLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQ  189 (741)
Q Consensus       153 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~  189 (741)
                      +|++|+|++|+|+++.+..|.++++|++|+|++|.++
T Consensus        79 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~  115 (170)
T 3g39_A           79 QLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNNPWD  115 (170)
T ss_dssp             TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             CCCEEECCCCccCEeCHHHhcCCCCCCEEEeCCCCCC
Confidence            6666666666666555555666666666666666555

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.55  E-value=3.4e-14  Score=153.40  Aligned_cols=292  Identities=10%  Similarity=0.020  Sum_probs=195.3

Q ss_pred             cccccCChhhhhCCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCccEEEC
Q 037916            7 RVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDI   86 (741)
Q Consensus         7 ~~~~~ip~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L   86 (741)
                      .+. .|+...|.++++|+.++|..+ ++.+...+|.++++|+.+.+..+ ++.+...+|.+..           +....+
T Consensus        81 ~i~-~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~-----------~~~~~~  146 (394)
T 4fs7_A           81 TVR-EIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCD-----------FKEITI  146 (394)
T ss_dssp             TCC-EECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCC-----------CSEEEC
T ss_pred             Ccc-CcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeeccc-----------cccccc
Confidence            344 678888888999999999866 77788899999999999887654 4445555665543           222221


Q ss_pred             cCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCC---
Q 037916           87 NNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNK---  163 (741)
Q Consensus        87 s~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~---  163 (741)
                      . +.+..+...+|.+.. +|+.+.+.++ +..+....|.++.+|+.+++..| ++.+...+|.++..|+.+.+..+.   
T Consensus       147 ~-~~~~~i~~~aF~~c~-~L~~i~l~~~-~~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~i  222 (394)
T 4fs7_A          147 P-EGVTVIGDEAFATCE-SLEYVSLPDS-METLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYYL  222 (394)
T ss_dssp             C-TTCCEECTTTTTTCT-TCCEEECCTT-CCEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCEE
T ss_pred             C-ccccccchhhhcccC-CCcEEecCCc-cceeccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceEe
Confidence            1 112223334444444 4555555433 22344444555555555555444 333444444444444444443322   


Q ss_pred             ------------------CCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCcccccccc
Q 037916          164 ------------------LSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTS  225 (741)
Q Consensus       164 ------------------l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  225 (741)
                                        ++.+...+|.+..+|+.+.+..+... +....|..+..++.+.+..+.+   ....|.+..+
T Consensus       223 ~~~~~~~~~l~~i~ip~~~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i---~~~~F~~~~~  298 (394)
T 4fs7_A          223 GDFALSKTGVKNIIIPDSFTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIV---PEKTFYGCSS  298 (394)
T ss_dssp             CTTTTTTCCCCEEEECTTCCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEE---CTTTTTTCTT
T ss_pred             ehhhcccCCCceEEECCCceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceee---cccccccccc
Confidence                              23344556677777777777766443 5666777777777777766543   3456778888


Q ss_pred             ceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCC
Q 037916          226 LSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLS  305 (741)
Q Consensus       226 L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  305 (741)
                      |+. +.+..+ ++.+...+|.++.+|+.++|.++ ++.+...+|.++.+|+.+.+..| ++.+...+|.++++|+.+++.
T Consensus       299 L~~-i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp  374 (394)
T 4fs7_A          299 LTE-VKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELP  374 (394)
T ss_dssp             CCE-EEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEE
T ss_pred             ccc-cccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEEC
Confidence            887 888765 66577789999999999999755 88889999999999999999887 777888999999999999997


Q ss_pred             CCcCCCccchhhhccccCCcc
Q 037916          306 QNNISGEIPKFLVELQLVQNL  326 (741)
Q Consensus       306 ~N~l~~~~~~~~~~l~~L~~L  326 (741)
                      .+ ++ .....|.++++|+.+
T Consensus       375 ~~-~~-~~~~~F~~c~~L~~I  393 (394)
T 4fs7_A          375 KR-LE-QYRYDFEDTTKFKWI  393 (394)
T ss_dssp             GG-GG-GGGGGBCTTCEEEEE
T ss_pred             CC-CE-EhhheecCCCCCcEE
Confidence            65 44 345678888777654

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.55  E-value=1.2e-13  Score=149.15  Aligned_cols=301  Identities=10%  Similarity=0.061  Sum_probs=213.1

Q ss_pred             cCChhhhhCCC-CCcEEEcccCcccccCCccCCCCCCCcEEEeecCc---CcccCCchhhhhhhhhhccccCCCccEEEC
Q 037916           11 GIPLDFGFTLP-NLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNN---LTGEVPSEFGKATKAYCVQNCNQHLKHLDI   86 (741)
Q Consensus        11 ~ip~~~~~~l~-~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~---l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L   86 (741)
                      .|+...|.+.. .|+.+.|-.+ ++.+...+|.++++|+.+.+..|.   ++.+-..+|....+          |+.+.+
T Consensus        53 ~Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~----------L~~i~~  121 (394)
T 4gt6_A           53 KIGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSE----------LTDIPI  121 (394)
T ss_dssp             EECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTT----------CCBCGG
T ss_pred             EcCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhccc----------ceeecc
Confidence            56666665554 5899999765 777888999999999999998774   66666777877665          777776


Q ss_pred             cCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCC
Q 037916           87 NNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSG  166 (741)
Q Consensus        87 s~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~  166 (741)
                      ..+ ++.+...+|.... +|+.+.+..+ +..+....|....+|+.+.+..+ ++.+...+|.+ .+|+.+.+..+-.. 
T Consensus       122 ~~~-~~~I~~~aF~~c~-~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-  195 (394)
T 4gt6_A          122 LDS-VTEIDSEAFHHCE-ELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-  195 (394)
T ss_dssp             GTT-CSEECTTTTTTCT-TCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-
T ss_pred             CCc-cceehhhhhhhhc-ccccccccce-eeeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccc-
Confidence            554 5556667777777 8888888754 45677778888888888888765 56577777765 56888888766443 


Q ss_pred             cCcccccCCcccceeeccCcccccccCccc-------------ccCCCCCEEeccCccccccCCccccccccceeEEEcC
Q 037916          167 NIPPSIGNLKKLLQLYLIENFLQVSIPSSL-------------GQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLS  233 (741)
Q Consensus       167 ~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~-------------~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls  233 (741)
                      +...+|.+..+|.......+.........+             .....+..+.+. +.++..-..+|.+...|+. +.+.
T Consensus       196 i~~~af~~c~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~-i~lp  273 (394)
T 4gt6_A          196 IGTNAFSECFALSTITSDSESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIP-NGVARIETHAFDSCAYLAS-VKMP  273 (394)
T ss_dssp             ECTTTTTTCTTCCEEEECCSSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECC-TTEEEECTTTTTTCSSCCE-EECC
T ss_pred             cccchhhhccccceecccccccccccceeecccccccccccccccccccceEEcC-CcceEcccceeeecccccE-Eecc
Confidence            666778887777777666554432211111             112233444443 2344355567777788876 8877


Q ss_pred             CCccCCCCChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCcc
Q 037916          234 RNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEI  313 (741)
Q Consensus       234 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  313 (741)
                      .+... +...+|.++++|+.+.+. +.++.+...+|.++.+|+.+.|..+ ++.+...+|.++.+|+.+.|..+ ++.+.
T Consensus       274 ~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~  349 (394)
T 4gt6_A          274 DSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIP  349 (394)
T ss_dssp             TTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCC
T ss_pred             cccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEh
Confidence            66544 566778888888888885 5567777888888888888888765 66677788888888888888654 66667


Q ss_pred             chhhhccccCCcccccCcccc
Q 037916          314 PKFLVELQLVQNLNLSYNDLE  334 (741)
Q Consensus       314 ~~~~~~l~~L~~L~l~~N~l~  334 (741)
                      ..+|.++++|+.+++.+|...
T Consensus       350 ~~aF~~C~~L~~i~~~~~~~~  370 (394)
T 4gt6_A          350 ESAFSNCTALNNIEYSGSRSQ  370 (394)
T ss_dssp             GGGGTTCTTCCEEEESSCHHH
T ss_pred             HhHhhCCCCCCEEEECCceee
Confidence            778888888888888887644

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.54  E-value=1.5e-14  Score=136.74  Aligned_cols=113  Identities=26%  Similarity=0.390  Sum_probs=64.4

Q ss_pred             hccccCCCccEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCC
Q 037916           73 CVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQ  152 (741)
Q Consensus        73 ~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~  152 (741)
                      |...|...-+.+++++|+++. +|..+.   .+|+.|+|++|+|.+..|..|.++++|++|+|++|+|+++.+..|.+++
T Consensus         6 CP~~C~C~~~~l~~~~n~l~~-iP~~~~---~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~   81 (174)
T 2r9u_A            6 CPSQCSCDQTLVNCQNIRLAS-VPAGIP---TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLT   81 (174)
T ss_dssp             SCTTSEECSSEEECCSSCCSS-CCSCCC---TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred             CCCCCEECCcEEEeCCCCCCc-cCCCcC---CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcc
Confidence            344444456777777777763 343322   2566666666666555555666666666666666666655555555555


Q ss_pred             cCcEEEcccCCCCCcCcccccCCcccceeeccCcccc
Q 037916          153 NLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQ  189 (741)
Q Consensus       153 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~  189 (741)
                      +|++|+|++|+|+++.+..|..+++|++|+|++|.+.
T Consensus        82 ~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~  118 (174)
T 2r9u_A           82 QLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNNPWD  118 (174)
T ss_dssp             TCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred             hhhEEECCCCccceeCHHHhccccCCCEEEeCCCCcc
Confidence            6666666666555444444555555555555555544

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.53  E-value=1.7e-14  Score=135.84  Aligned_cols=106  Identities=25%  Similarity=0.241  Sum_probs=63.5

Q ss_pred             CCEEeccCccccccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeC
Q 037916          202 LTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLG  281 (741)
Q Consensus       202 L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  281 (741)
                      .+.|++++|+++ .+|..+.  ++++. |+|++|+|++..|..|..+++|++|+|++|+|+++.+..|..+++|++|+|+
T Consensus        11 ~~~l~~s~n~l~-~ip~~~~--~~l~~-L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~   86 (170)
T 3g39_A           11 GTTVDCSGKSLA-SVPTGIP--TTTQV-LYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN   86 (170)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSE-EECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCEEEeCCCCcC-ccCccCC--CCCcE-EEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence            456666666666 4554442  45554 6666666665556666666666666666666666555556666666666666


Q ss_pred             CCccCCCCChhcccCccCCeeeCCCCcCCC
Q 037916          282 GNLFQGPIPLSLSSLRGLRVLDLSQNNISG  311 (741)
Q Consensus       282 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  311 (741)
                      +|+|+++.+..|..+++|+.|+|++|.++.
T Consensus        87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c  116 (170)
T 3g39_A           87 DNQLKSIPRGAFDNLKSLTHIWLLNNPWDC  116 (170)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCBCT
T ss_pred             CCccCEeCHHHhcCCCCCCEEEeCCCCCCC
Confidence            666665555556666666666666666553

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.51  E-value=2.9e-14  Score=134.80  Aligned_cols=105  Identities=29%  Similarity=0.311  Sum_probs=81.3

Q ss_pred             ccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCcccccCCcccceeeccC
Q 037916          106 LETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIE  185 (741)
Q Consensus       106 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  185 (741)
                      -+.+++++|++ +.+|..+.  ++|++|+|++|+|+++.+..|.++++|++|+|++|+|+++.+..|.++++|++|+|++
T Consensus        14 ~~~l~~~~n~l-~~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~   90 (174)
T 2r9u_A           14 QTLVNCQNIRL-ASVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND   90 (174)
T ss_dssp             SSEEECCSSCC-SSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CcEEEeCCCCC-CccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence            36788888887 44555554  6788888888888887788888888888888888888876666677888888888888


Q ss_pred             cccccccCcccccCCCCCEEeccCcccc
Q 037916          186 NFLQVSIPSSLGQCQSLTTINLSYNNLS  213 (741)
Q Consensus       186 N~i~~~~~~~~~~l~~L~~L~L~~N~l~  213 (741)
                      |+|+++.+..|..+++|++|+|++|++.
T Consensus        91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~  118 (174)
T 2r9u_A           91 NHLKSIPRGAFDNLKSLTHIYLYNNPWD  118 (174)
T ss_dssp             SCCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred             CccceeCHHHhccccCCCEEEeCCCCcc
Confidence            8888666666777888888888888776

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.48  E-value=1e-12  Score=141.78  Aligned_cols=300  Identities=11%  Similarity=0.134  Sum_probs=229.3

Q ss_pred             cccccCCccCCCCC-CCcEEEeecCcCcccCCchhhhhhhhhhccccCCCccEEECcCCc---CcccCCchhhccccccc
Q 037916           32 QITGVIPSSMFNAS-KLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNN---FGGLLPGCICNFSITLE  107 (741)
Q Consensus        32 ~i~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~---l~~~~~~~~~~l~~~L~  107 (741)
                      .++.+...+|.+.. .|+.+.|-.+ ++.+-..+|.++++          |+.+.++.|.   ++.+...+|.... +|+
T Consensus        50 ~Vt~Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~----------L~~i~~~~n~p~~l~~Ig~~aF~~c~-~L~  117 (394)
T 4gt6_A           50 PVSKIGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTS----------LKRVTIQDNKPSCVKKIGRQAFMFCS-ELT  117 (394)
T ss_dssp             EEEEECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTT----------CCEEEEGGGCCCCCCEECTTTTTTCT-TCC
T ss_pred             eeeEcCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCcc----------CceEeecCCCCCeeeEechhhchhcc-cce
Confidence            35667778898884 6999999754 88788889998876          9999998874   7777778888877 888


Q ss_pred             EEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCcccccCCcccceeeccCcc
Q 037916          108 TLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENF  187 (741)
Q Consensus       108 ~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  187 (741)
                      .+.+..+ +..+...+|..+.+|+.+.+..+ ++.+...+|.++.+|+.+.+..+ ++.+...+|.+ .+|+.+.+..+-
T Consensus       118 ~i~~~~~-~~~I~~~aF~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~  193 (394)
T 4gt6_A          118 DIPILDS-VTEIDSEAFHHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKV  193 (394)
T ss_dssp             BCGGGTT-CSEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTC
T ss_pred             eeccCCc-cceehhhhhhhhcccccccccce-eeeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcc
Confidence            8887765 66778888999999999999755 55588899999999999999866 55577778876 679999987764


Q ss_pred             cccccCcccccCCCCCEEeccCccccccCCcccccc--------------ccceeEEEcCCCccCCCCChhhcCCCCCcE
Q 037916          188 LQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDL--------------TSLSVGLDLSRNQLVGSLPTEVGKLINLEI  253 (741)
Q Consensus       188 i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l--------------~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~  253 (741)
                      . .....+|.++.+|.......+... .....+...              ..+.. +.+. +.+..+...+|.++.+|+.
T Consensus       194 ~-~i~~~af~~c~~l~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ip-~~v~~i~~~aF~~c~~L~~  269 (394)
T 4gt6_A          194 T-RIGTNAFSECFALSTITSDSESYP-AIDNVLYEKSANGDYALIRYPSQREDPA-FKIP-NGVARIETHAFDSCAYLAS  269 (394)
T ss_dssp             C-EECTTTTTTCTTCCEEEECCSSSC-BSSSCEEEECTTSCEEEEECCTTCCCSE-EECC-TTEEEECTTTTTTCSSCCE
T ss_pred             c-ccccchhhhccccceecccccccc-cccceeecccccccccccccccccccce-EEcC-CcceEcccceeeecccccE
Confidence            4 367788999999998887776654 333322211              11111 2222 2344355678999999999


Q ss_pred             EEeccccccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccchhhhccccCCcccccCccc
Q 037916          254 LFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDL  333 (741)
Q Consensus       254 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l  333 (741)
                      +.+..+.. .+...+|.++++|+.+.+. +.++.+...+|.++.+|+.++|..+ ++.+...+|.++.+|+.+.|..+ +
T Consensus       270 i~lp~~~~-~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v  345 (394)
T 4gt6_A          270 VKMPDSVV-SIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-V  345 (394)
T ss_dssp             EECCTTCC-EECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-C
T ss_pred             Eecccccc-eecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-c
Confidence            99987654 4888999999999999996 5677688899999999999999865 77677889999999999999654 6


Q ss_pred             ccccCCc-cccCCcccccccCCC
Q 037916          334 EGVIPTE-GVFKNASAISVFGNS  355 (741)
Q Consensus       334 ~~~~~~~-~~~~~~~~~~~~~n~  355 (741)
                      +.+.... ..+.++..+.+.++.
T Consensus       346 ~~I~~~aF~~C~~L~~i~~~~~~  368 (394)
T 4gt6_A          346 TKIPESAFSNCTALNNIEYSGSR  368 (394)
T ss_dssp             CBCCGGGGTTCTTCCEEEESSCH
T ss_pred             CEEhHhHhhCCCCCCEEEECCce
Confidence            5443322 234668888888774

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.44  E-value=3.5e-15  Score=158.96  Aligned_cols=134  Identities=14%  Similarity=0.150  Sum_probs=68.3

Q ss_pred             ccEEECcCCcCcccCCchhhc-ccccccEEEccCCcccccCCccc-----cCCCCccEEEcccccccccC----CccccC
Q 037916           81 LKHLDINNNNFGGLLPGCICN-FSITLETLIFNSNKIFRSIPAGI-----GKFINLQTLHMWDNQLSGTI----SPAIGE  150 (741)
Q Consensus        81 L~~L~Ls~N~l~~~~~~~~~~-l~~~L~~L~L~~n~i~~~~~~~~-----~~l~~L~~L~L~~N~i~~~~----~~~~~~  150 (741)
                      |++|+|++|.|+......+.. +. +|+.|+|++|+|.......+     ...++|++|+|++|.|+...    +..+..
T Consensus       103 L~~L~Ls~n~l~~~~~~~l~~~L~-~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~  181 (372)
T 3un9_A          103 LDEVNLASCQLDPAGLRTLLPVFL-RARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAG  181 (372)
T ss_dssp             EEEEECTTCCCCHHHHHHTHHHHH-TEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHT
T ss_pred             ceEEEecCCCCCHHHHHHHHHHHH-hccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhc
Confidence            555555555544322222221 22 45555555555533322222     23455666666666665322    233355


Q ss_pred             CCcCcEEEcccCCCCCcC----cccccCCcccceeeccCcccccc----cCcccccCCCCCEEeccCcccccc
Q 037916          151 LQNLVTLAINTNKLSGNI----PPSIGNLKKLLQLYLIENFLQVS----IPSSLGQCQSLTTINLSYNNLSGT  215 (741)
Q Consensus       151 l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~N~i~~~----~~~~~~~l~~L~~L~L~~N~l~~~  215 (741)
                      +++|++|+|++|+|+...    +..+...++|++|+|++|.|+..    ++..+...++|++|+|++|.|+..
T Consensus       182 ~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~  254 (372)
T 3un9_A          182 NTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSE  254 (372)
T ss_dssp             CSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHH
T ss_pred             CCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHH
Confidence            566666666666665321    33455556666666666666542    223344456677777777776643

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.41  E-value=1.3e-14  Score=154.50  Aligned_cols=184  Identities=15%  Similarity=0.184  Sum_probs=131.0

Q ss_pred             CCccEEECcCCcCcccCCchhhcc----cccccEEEccCCcccccCCccc-cCCCCccEEEcccccccccCCccc-----
Q 037916           79 QHLKHLDINNNNFGGLLPGCICNF----SITLETLIFNSNKIFRSIPAGI-GKFINLQTLHMWDNQLSGTISPAI-----  148 (741)
Q Consensus        79 ~~L~~L~Ls~N~l~~~~~~~~~~l----~~~L~~L~L~~n~i~~~~~~~~-~~l~~L~~L~L~~N~i~~~~~~~~-----  148 (741)
                      .+|+.|+|++|.|+......+...    ..+|++|+|++|.|.......+ ..+++|++|+|++|.|+......+     
T Consensus        72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~  151 (372)
T 3un9_A           72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL  151 (372)
T ss_dssp             TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred             hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence            359999999999886555554443    1289999999999865433333 346789999999999986555554     


Q ss_pred             cCCCcCcEEEcccCCCCCc----CcccccCCcccceeeccCccccccc----CcccccCCCCCEEeccCcccccc----C
Q 037916          149 GELQNLVTLAINTNKLSGN----IPPSIGNLKKLLQLYLIENFLQVSI----PSSLGQCQSLTTINLSYNNLSGT----I  216 (741)
Q Consensus       149 ~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~i~~~~----~~~~~~l~~L~~L~L~~N~l~~~----~  216 (741)
                      ...++|++|+|++|.|+..    ++..+..+++|++|+|++|.|+...    +..+...++|++|+|++|.|+..    +
T Consensus       152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l  231 (372)
T 3un9_A          152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALAL  231 (372)
T ss_dssp             STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHH
T ss_pred             hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHH
Confidence            3467899999999999753    3445577889999999999987543    55677788999999999999743    3


Q ss_pred             CccccccccceeEEEcCCCccCCCCChhhcCCCC-----CcEEE--eccccccc
Q 037916          217 PPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLIN-----LEILF--ISRNMLEC  263 (741)
Q Consensus       217 p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~-----L~~L~--Ls~N~l~~  263 (741)
                      ...+...++|+. |+|++|.|+......+..+..     |+.+.  +..|.+..
T Consensus       232 ~~~L~~~~~L~~-L~Ls~N~i~~~g~~~L~~~~~~~~~~L~~l~~ll~~~~~~~  284 (372)
T 3un9_A          232 ARAAREHPSLEL-LHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSE  284 (372)
T ss_dssp             HHHHHHCSSCCE-EECTTSSCCHHHHHHHHHCC------CEEECCCC----CHH
T ss_pred             HHHHHhCCCCCE-EeccCCCCCHHHHHHHHHHhcCCCccchhhHhhhcCCccCH
Confidence            344556688887 999999988554445544322     66777  66776654

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.39  E-value=5.2e-13  Score=141.54  Aligned_cols=104  Identities=17%  Similarity=0.136  Sum_probs=58.8

Q ss_pred             cEEECcCC-cCcccCCchhhcccccccEEEccC-CcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEc
Q 037916           82 KHLDINNN-NFGGLLPGCICNFSITLETLIFNS-NKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAI  159 (741)
Q Consensus        82 ~~L~Ls~N-~l~~~~~~~~~~l~~~L~~L~L~~-n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L  159 (741)
                      ..++++++ +|++ +|. +..+. +|+.|+|++ |+|.++.+..|.+|++|++|+|++|+|+++.+..|.+|++|+.|+|
T Consensus        11 ~~v~~~~~n~l~~-ip~-l~~~~-~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l   87 (347)
T 2ifg_A           11 SGLRCTRDGALDS-LHH-LPGAE-NLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL   87 (347)
T ss_dssp             SCEECCSSCCCTT-TTT-SCSCS-CCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred             CEEEcCCCCCCCc-cCC-CCCCC-CeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeC
Confidence            45566665 5663 333 55554 566666654 5555555555666666666666666666555555666666666666


Q ss_pred             ccCCCCCcCcccccCCcccceeeccCcccc
Q 037916          160 NTNKLSGNIPPSIGNLKKLLQLYLIENFLQ  189 (741)
Q Consensus       160 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~  189 (741)
                      ++|+|+++.+..|..++ |+.|+|.+|.+.
T Consensus        88 ~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~  116 (347)
T 2ifg_A           88 SFNALESLSWKTVQGLS-LQELVLSGNPLH  116 (347)
T ss_dssp             CSSCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred             CCCccceeCHHHcccCC-ceEEEeeCCCcc
Confidence            66666554444444444 555555555554

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.37  E-value=1.2e-12  Score=138.83  Aligned_cols=102  Identities=20%  Similarity=0.164  Sum_probs=53.2

Q ss_pred             EeccCc-cccccCCccccccccceeEEEcCC-CccCCCCChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCC
Q 037916          205 INLSYN-NLSGTIPPQLMDLTSLSVGLDLSR-NQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGG  282 (741)
Q Consensus       205 L~L~~N-~l~~~~p~~~~~l~~L~~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  282 (741)
                      ++++++ +|+ .+|. +..+++|+. |+|++ |.|++..+..|+.+++|+.|+|++|+|+++.+..|.++++|+.|+|++
T Consensus        13 v~~~~~n~l~-~ip~-l~~~~~L~~-L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~   89 (347)
T 2ifg_A           13 LRCTRDGALD-SLHH-LPGAENLTE-LYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF   89 (347)
T ss_dssp             EECCSSCCCT-TTTT-SCSCSCCSE-EECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred             EEcCCCCCCC-ccCC-CCCCCCeeE-EEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence            344444 444 3444 445555554 55553 555544445555555555555555555555555555555555555555


Q ss_pred             CccCCCCChhcccCccCCeeeCCCCcCC
Q 037916          283 NLFQGPIPLSLSSLRGLRVLDLSQNNIS  310 (741)
Q Consensus       283 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  310 (741)
                      |+|+++.+..|..++ |+.|+|++|.+.
T Consensus        90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~  116 (347)
T 2ifg_A           90 NALESLSWKTVQGLS-LQELVLSGNPLH  116 (347)
T ss_dssp             SCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred             CccceeCHHHcccCC-ceEEEeeCCCcc
Confidence            555554444444444 555555555554

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.32  E-value=1e-10  Score=125.43  Aligned_cols=292  Identities=9%  Similarity=0.056  Sum_probs=214.7

Q ss_pred             CCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCccEEECcCCcCcccCCch
Q 037916           19 TLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGC   98 (741)
Q Consensus        19 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~   98 (741)
                      ...+|+.+.+.. .++.+...+|.++.+|+.++|..+ ++.+-..+|.+. +          |+.+.+..+ ++.+...+
T Consensus        44 ~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~----------l~~i~~~~~-l~~I~~~a  109 (379)
T 4h09_A           44 DRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-K----------LQSYTGMER-VKKFGDYV  109 (379)
T ss_dssp             GGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-C----------CCEEEECTT-CCEECTTT
T ss_pred             cccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-C----------CceEECCce-eeEeccce
Confidence            457899999975 488788899999999999999754 776777788765 2          777777644 66566666


Q ss_pred             hhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCC------------
Q 037916           99 ICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSG------------  166 (741)
Q Consensus        99 ~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~------------  166 (741)
                      |.. . +|+.+.+..+ +..+...+|.+. +|+.+.+..+ ++.+...+|....+|+.+.+..+....            
T Consensus       110 F~~-~-~L~~i~lp~~-~~~i~~~~F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  184 (379)
T 4h09_A          110 FQG-T-DLDDFEFPGA-TTEIGNYIFYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNK  184 (379)
T ss_dssp             TTT-C-CCSEEECCTT-CCEECTTTTTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTS
T ss_pred             ecc-C-CcccccCCCc-cccccccccccc-eeeeeeccce-eeccccchhcccccccccccccccceeecccceeccccc
Confidence            655 3 7999999765 445556666654 6777776654 566778888888889888887665432            


Q ss_pred             cCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCCCChhhc
Q 037916          167 NIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVG  246 (741)
Q Consensus       167 ~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~  246 (741)
                      .....+.....+..+.+..+. .......|....+|+.+.+..+ +.......|.+...|+. +.+..+ ++.+....|.
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~-~~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~-i~lp~~-v~~I~~~aF~  260 (379)
T 4h09_A          185 TILESYPAAKTGTEFTIPSTV-KTVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDE-IAIPKN-VTSIGSFLLQ  260 (379)
T ss_dssp             SEEEECCTTCCCSEEECCTTC-CEECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCE-EEECTT-CCEECTTTTT
T ss_pred             ceeccccccccccccccccce-eEEeecccccccccceeeeccc-eeEEccccccCCccceE-EEcCCC-ccEeCccccc
Confidence            122234445556665555443 2355667777888888888765 44466677888888886 888766 5556677888


Q ss_pred             CCCCCcEEEeccccccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccchhhhccccCCcc
Q 037916          247 KLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNL  326 (741)
Q Consensus       247 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  326 (741)
                      ++.+|+.+.+..+ ++.+...+|.++.+|+.+.+.++.++.+...+|.++.+|+.+.|..+ ++.+...+|.++.+|+.+
T Consensus       261 ~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i  338 (379)
T 4h09_A          261 NCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTI  338 (379)
T ss_dssp             TCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCC
T ss_pred             eeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEE
Confidence            8889999988654 66677888999999999999888888788888999999999999755 766677888899999998


Q ss_pred             cccCcccccc
Q 037916          327 NLSYNDLEGV  336 (741)
Q Consensus       327 ~l~~N~l~~~  336 (741)
                      .+..+ ++.+
T Consensus       339 ~ip~~-v~~I  347 (379)
T 4h09_A          339 SYPKS-ITLI  347 (379)
T ss_dssp             CCCTT-CCEE
T ss_pred             EECCc-cCEE
Confidence            88654 4433

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.29  E-value=2.5e-10  Score=122.33  Aligned_cols=286  Identities=11%  Similarity=0.058  Sum_probs=180.7

Q ss_pred             cCChhhhhCCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCccEEECcCCc
Q 037916           11 GIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNN   90 (741)
Q Consensus        11 ~ip~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~   90 (741)
                      .|+...|.++.+|+.++|..+ ++.+...+|.+. +|+.+.+..+ ++.+...+|...           +|+.+++..+ 
T Consensus        59 ~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~~-----------~L~~i~lp~~-  123 (379)
T 4h09_A           59 SIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQGT-----------DLDDFEFPGA-  123 (379)
T ss_dssp             EECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTTC-----------CCSEEECCTT-
T ss_pred             ChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceeccC-----------CcccccCCCc-
Confidence            566666767777888887654 666777777775 5777766543 554555555432           2777777654 


Q ss_pred             CcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEccccccccc------------CCccccCCCcCcEEE
Q 037916           91 FGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGT------------ISPAIGELQNLVTLA  158 (741)
Q Consensus        91 l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~------------~~~~~~~l~~L~~L~  158 (741)
                      +..+...+|.+-  +|+.+.+-.+ +..+....|....+++.+.+..+.....            ....+.....+..+.
T Consensus       124 ~~~i~~~~F~~~--~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  200 (379)
T 4h09_A          124 TTEIGNYIFYNS--SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTEFT  200 (379)
T ss_dssp             CCEECTTTTTTC--CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSEEE
T ss_pred             cccccccccccc--eeeeeeccce-eeccccchhcccccccccccccccceeecccceecccccceeccccccccccccc
Confidence            333444555443  4666655543 4456666777777777777665543211            112334444555555


Q ss_pred             cccCCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccC
Q 037916          159 INTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLV  238 (741)
Q Consensus       159 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~  238 (741)
                      +..+.-. +...+|....+|+.+.+..+ +..+...+|.++..|+.+.+..+ ++......|.+..+++. +.+..+ +.
T Consensus       201 ~~~~~~~-i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~-i~l~~~-i~  275 (379)
T 4h09_A          201 IPSTVKT-VTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKT-LNFYAK-VK  275 (379)
T ss_dssp             CCTTCCE-ECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCE-EEECCC-CS
T ss_pred             cccceeE-Eeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcc-cccccc-ce
Confidence            5443332 45556677777777777655 44456667777777777777665 55455666777777776 777544 44


Q ss_pred             CCCChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccchhhh
Q 037916          239 GSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLV  318 (741)
Q Consensus       239 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  318 (741)
                      .+....|.++.+|+.+.+.++.++.+...+|.++.+|+.+.|..+ ++.+...+|.++.+|+.+.+..+ ++.+-..+|.
T Consensus       276 ~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~  353 (379)
T 4h09_A          276 TVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFE  353 (379)
T ss_dssp             EECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTT
T ss_pred             eccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhh
Confidence            455567777778888888777777777777877778888877654 66566677777777877777654 5545556666


Q ss_pred             ccc
Q 037916          319 ELQ  321 (741)
Q Consensus       319 ~l~  321 (741)
                      ++.
T Consensus       354 ~c~  356 (379)
T 4h09_A          354 GSS  356 (379)
T ss_dssp             TSS
T ss_pred             CCC
Confidence            553

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.24  E-value=1.3e-11  Score=125.15  Aligned_cols=142  Identities=15%  Similarity=0.087  Sum_probs=108.7

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcC-CCceeeEeeeecCccccCCceEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIR-HKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      ..|++...++.|+.+.||++...  +..+++|+...........+.+|+.+++.+. +..++++++++     ......|
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~-----~~~~~~~   86 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE-----RHDGWSN   86 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE-----EETTEEE
T ss_pred             ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEE-----ecCCceE
Confidence            45778888888999999999864  6789999986432233457889999999884 66788888884     3455789


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcC--------------------------
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDC--------------------------  532 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--------------------------  532 (741)
                      +||||++|.++.+.+..               ......++.++++++..||+..                          
T Consensus        87 lv~e~i~G~~l~~~~~~---------------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (263)
T 3tm0_A           87 LLMSEADGVLCSEEYED---------------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLA  151 (263)
T ss_dssp             EEEECCSSEEHHHHCCT---------------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCS
T ss_pred             EEEEecCCeehhhccCC---------------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccc
Confidence            99999999998876421               1122467889999999999810                          


Q ss_pred             ------------------------------CCCceecCCCCCCeEeCCCCceEEeeccccc
Q 037916          533 ------------------------------QPTTAHCDLKPSNVLLDHEMTAHVADFGLAK  563 (741)
Q Consensus       533 ------------------------------~~~ivHrDlkp~NIll~~~~~~kL~DFg~a~  563 (741)
                                                    .+.++|+|++|.||+++++..+.|+||+.+.
T Consensus       152 ~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          152 DVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             CCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                          1359999999999999876566799998764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.03  E-value=6.5e-10  Score=112.31  Aligned_cols=128  Identities=17%  Similarity=0.076  Sum_probs=92.6

Q ss_pred             ccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCc--eeeEeeeecCccccCCceEEEEEecccC
Q 037916          409 DMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKN--LVKILTVCSGVDYKGDDFKALVYEFMHN  486 (741)
Q Consensus       409 g~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~~~~~~~~~~~~~~~~~~lv~e~~~~  486 (741)
                      +.|..+.||++... +|..+++|+....   ....+.+|+.+++.+.+.+  +++++++.     ..+...++||||++|
T Consensus        29 ~gg~~~~v~~~~~~-~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~-----~~~~~~~~v~e~i~G   99 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQ-GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVV-----TEAGRDWLLLGEVPG   99 (264)
T ss_dssp             CTTSSCEEEEEECT-TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEE-----ECSSCEEEEEECCSS
T ss_pred             cCCCCceEEEEecC-CCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEec-----cCCCCCEEEEEecCC
Confidence            35666999999764 5778999997532   3356789999999885434  55688773     334568999999999


Q ss_pred             CChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcC----------------------------------
Q 037916          487 GSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDC----------------------------------  532 (741)
Q Consensus       487 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~----------------------------------  532 (741)
                      .++.  ...             .+   ...++.++++.|..||+..                                  
T Consensus       100 ~~l~--~~~-------------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (264)
T 1nd4_A          100 QDLL--SSH-------------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE  161 (264)
T ss_dssp             EETT--TSC-------------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred             cccC--cCc-------------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhh
Confidence            8884  211             01   1246777788888888641                                  


Q ss_pred             ---------------------CCCceecCCCCCCeEeCCCCceEEeeccccc
Q 037916          533 ---------------------QPTTAHCDLKPSNVLLDHEMTAHVADFGLAK  563 (741)
Q Consensus       533 ---------------------~~~ivHrDlkp~NIll~~~~~~kL~DFg~a~  563 (741)
                                           ...++|+|++|.||++++++.+.|+|||.+.
T Consensus       162 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          162 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                                 1139999999999999877667799999874

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=99.01  E-value=2.2e-10  Score=120.83  Aligned_cols=203  Identities=17%  Similarity=0.168  Sum_probs=108.4

Q ss_pred             cccEEEccCCcccc-c-------CCccccCCCCccEEEcccccccc---------cCCccccCCCcCcEEEcccCC-CCC
Q 037916          105 TLETLIFNSNKIFR-S-------IPAGIGKFINLQTLHMWDNQLSG---------TISPAIGELQNLVTLAINTNK-LSG  166 (741)
Q Consensus       105 ~L~~L~L~~n~i~~-~-------~~~~~~~l~~L~~L~L~~N~i~~---------~~~~~~~~l~~L~~L~L~~N~-l~~  166 (741)
                      .++.|.+......+ .       +..+...+++|+.|.+..+....         .+...+..+++|+.|+|++|. +. 
T Consensus       108 ~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l~-  186 (362)
T 2ra8_A          108 SLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLS-  186 (362)
T ss_dssp             GCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTCB-
T ss_pred             hcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCce-
Confidence            46677777654321 1       12224456677777776543210         122334555666666666652 21 


Q ss_pred             cCcccccCCcccceeeccCcccccccCcccc--cCCCCCEEeccCc--cccccCCccccccccceeEEEcCCCccCCCCC
Q 037916          167 NIPPSIGNLKKLLQLYLIENFLQVSIPSSLG--QCQSLTTINLSYN--NLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLP  242 (741)
Q Consensus       167 ~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~--~l~~L~~L~L~~N--~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p  242 (741)
                       ++. +. +++|++|+|..|.+.......+.  .+++|++|+|+.+  ...+.  ..+..+.                  
T Consensus       187 -l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~--~~~~~l~------------------  243 (362)
T 2ra8_A          187 -IGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFD--GDMNVFR------------------  243 (362)
T ss_dssp             -CCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCC--SCGGGTG------------------
T ss_pred             -ecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccc--hhHHHHH------------------
Confidence             121 22 55666666665555433222332  4555665555421  11100  0000000                  


Q ss_pred             hhh--cCCCCCcEEEeccccccchhhhhcc---ccccccEEEeCCCccCCCC----ChhcccCccCCeeeCCCCcCCCcc
Q 037916          243 TEV--GKLINLEILFISRNMLECEILSTLG---SCIKLEQLKLGGNLFQGPI----PLSLSSLRGLRVLDLSQNNISGEI  313 (741)
Q Consensus       243 ~~~--~~l~~L~~L~Ls~N~l~~~~~~~~~---~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~~  313 (741)
                      ..+  ..+++|++|+|++|.+.......+.   .+++|++|+|+.|.|.+..    +..+..+++|+.|+|++|.|+...
T Consensus       244 ~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~  323 (362)
T 2ra8_A          244 PLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEM  323 (362)
T ss_dssp             GGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHH
T ss_pred             HHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHH
Confidence            111  2467888888888888754433332   4788999999888887643    233356788999999988877433


Q ss_pred             chhhhccccCCcccccCcc
Q 037916          314 PKFLVELQLVQNLNLSYND  332 (741)
Q Consensus       314 ~~~~~~l~~L~~L~l~~N~  332 (741)
                      -..+...- ...+++++|+
T Consensus       324 ~~~l~~al-g~~~~~~~~~  341 (362)
T 2ra8_A          324 KKELQKSL-PMKIDVSDSQ  341 (362)
T ss_dssp             HHHHHHHC-CSEEECCSBC
T ss_pred             HHHHHHHc-CCEEEecCCc
Confidence            33333210 2567888776

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.98  E-value=2.8e-10  Score=119.95  Aligned_cols=88  Identities=17%  Similarity=0.123  Sum_probs=46.0

Q ss_pred             ccccCCCCccEEEccccc-ccccCCccccCCCcCcEEEcccCCCCCcCccccc--CCcccceeeccC--cccccc-----
Q 037916          122 AGIGKFINLQTLHMWDNQ-LSGTISPAIGELQNLVTLAINTNKLSGNIPPSIG--NLKKLLQLYLIE--NFLQVS-----  191 (741)
Q Consensus       122 ~~~~~l~~L~~L~L~~N~-i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~L~~--N~i~~~-----  191 (741)
                      ..+..+++|+.|+|++|. ++ .. . +. +++|+.|+|..|.++......+.  .+++|+.|+|+.  |...+.     
T Consensus       166 ~ll~~~P~L~~L~L~g~~~l~-l~-~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~  241 (362)
T 2ra8_A          166 PVLDAMPLLNNLKIKGTNNLS-IG-K-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNV  241 (362)
T ss_dssp             HHHHTCTTCCEEEEECCBTCB-CC-S-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGG
T ss_pred             HHHhcCCCCcEEEEeCCCCce-ec-c-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHH
Confidence            344556677777776663 22 21 1 32 66777777777766543333333  567777777653  221110     


Q ss_pred             cCccc--ccCCCCCEEeccCcccc
Q 037916          192 IPSSL--GQCQSLTTINLSYNNLS  213 (741)
Q Consensus       192 ~~~~~--~~l~~L~~L~L~~N~l~  213 (741)
                      +...+  ..+++|++|+|.+|.+.
T Consensus       242 l~~~l~~~~~p~Lr~L~L~~~~i~  265 (362)
T 2ra8_A          242 FRPLFSKDRFPNLKWLGIVDAEEQ  265 (362)
T ss_dssp             TGGGSCTTTCTTCCEEEEESCTTH
T ss_pred             HHHHHhcCCCCCcCEEeCCCCCCc
Confidence            00111  13566666666666665

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.95  E-value=2.2e-09  Score=113.94  Aligned_cols=145  Identities=12%  Similarity=0.117  Sum_probs=104.3

Q ss_pred             hhhcccCceeeEEEEEEcCCCeEEEEEEee--ccCc-CcchhHHHHHHHHHhcC--CCceeeEeeeecCccccCCceEEE
Q 037916          405 LCWIDMGSFGSVYKGILDEGKTIIAVKVLN--LLHH-GASKSSIAECSALRNIR--HKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       405 ~~~ig~G~~g~V~~a~~~~~~~~vavK~~~--~~~~-~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      ++.|+.|.++.||+....  +..+++|+..  .... .....+.+|+.+++.+.  +..+++++.++.+..  .....|+
T Consensus        43 ~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~--~~g~~~~  118 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDES--VIGRAFY  118 (359)
T ss_dssp             EEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTT--TTSSCEE
T ss_pred             EEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCC--ccCCeEE
Confidence            457899999999999875  4578888765  3221 22457788999999886  455788888864321  1135789


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcC---------------------------
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDC---------------------------  532 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---------------------------  532 (741)
                      ||||++|.++.+...            ..++..+...++.+++++|+.||+..                           
T Consensus       119 vme~v~G~~l~~~~~------------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  186 (359)
T 3dxp_A          119 IMEFVSGRVLWDQSL------------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQY  186 (359)
T ss_dssp             EEECCCCBCCCCTTC------------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHH
T ss_pred             EEEecCCeecCCCcc------------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHH
Confidence            999999877754221            23567778889999999999999731                           


Q ss_pred             ----------------------------CCCceecCCCCCCeEeCCCCc--eEEeeccccccc
Q 037916          533 ----------------------------QPTTAHCDLKPSNVLLDHEMT--AHVADFGLAKLL  565 (741)
Q Consensus       533 ----------------------------~~~ivHrDlkp~NIll~~~~~--~kL~DFg~a~~~  565 (741)
                                                  .+.++|+|++|.||+++.++.  +.|+||+.+...
T Consensus       187 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          187 KLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             HhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                                        247999999999999987753  689999988643

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.73  E-value=3e-09  Score=110.12  Aligned_cols=190  Identities=16%  Similarity=0.115  Sum_probs=117.8

Q ss_pred             hhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhc-CCCc--eeeEeeeecCccccCCceEEEEE
Q 037916          405 LCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNI-RHKN--LVKILTVCSGVDYKGDDFKALVY  481 (741)
Q Consensus       405 ~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpn--Iv~~~~~~~~~~~~~~~~~~lv~  481 (741)
                      ++.++.|.+..||+..     ..+++|+....  .....+.+|+.+++.+ .+..  +.+++.....  .......|+||
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~--~~~~~~~~~vm   95 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMP--SETYQMSFAGF   95 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCC--CSSCSCSCEEE
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCC--CCCCCcceEEE
Confidence            3458889999999864     34888986422  2345678899999887 3322  4455554211  01112458999


Q ss_pred             ecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhc------------------------------
Q 037916          482 EFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHD------------------------------  531 (741)
Q Consensus       482 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~------------------------------  531 (741)
                      |+++|.++.+...            ..++..++..++.++++.++.||+.                              
T Consensus        96 ~~i~G~~l~~~~~------------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (304)
T 3sg8_A           96 TKIKGVPLTPLLL------------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSR  163 (304)
T ss_dssp             ECCCCEECCHHHH------------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTT
T ss_pred             cccCCeECCcccc------------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcc
Confidence            9999988765321            2355666677788888888888861                              


Q ss_pred             -------------------------CCCCceecCCCCCCeEeCC--CCceEEeecccccccCCCCcccccccc---cccc
Q 037916          532 -------------------------CQPTTAHCDLKPSNVLLDH--EMTAHVADFGLAKLLPPAHLQTSSIGV---KGTI  581 (741)
Q Consensus       532 -------------------------~~~~ivHrDlkp~NIll~~--~~~~kL~DFg~a~~~~~~~~~~~~~~~---~gt~  581 (741)
                                               ..+.++|+|++|.||++++  ...+.|+||+.+...............   .+..
T Consensus       164 ~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~  243 (304)
T 3sg8_A          164 ELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGME  243 (304)
T ss_dssp             TSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHH
T ss_pred             cCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHH
Confidence                                     1135899999999999988  456889999998764332110000000   0000


Q ss_pred             -------cc--cC-cccccCCCCCCCccCchhHHHHHHHHHcCCCCC
Q 037916          582 -------GY--IA-PAEYGLGSEVSINGDVYSYGILLLELMTRKRPS  618 (741)
Q Consensus       582 -------~y--~a-PEe~~~~~~~~~~~DIwSlG~il~elltg~~p~  618 (741)
                             .|  .. | ++.  .......+.|++|.++|.+.+|..+|
T Consensus       244 ~~~~~l~~Y~~~~~~-~~~--~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          244 FVSKILNHYKHKDIP-TVL--EKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHHHHTCSCHH-HHH--HHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHHHHHcCCCCcH-HHH--HHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence                   01  11 1 000  00112258999999999999998875

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.49  E-value=1.6e-08  Score=100.90  Aligned_cols=62  Identities=26%  Similarity=0.235  Sum_probs=26.1

Q ss_pred             CCCCcEEEeccccccchh--hhhccccccccEEEeCCCccCCCCChhcccCc--cCCeeeCCCCcCCC
Q 037916          248 LINLEILFISRNMLECEI--LSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLR--GLRVLDLSQNNISG  311 (741)
Q Consensus       248 l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~Ls~N~l~~  311 (741)
                      +++|+.|+|++|+|+++.  +..+..+++|+.|+|++|+|++.  ..+..+.  +|++|+|++|.+++
T Consensus       169 l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~  234 (267)
T 3rw6_A          169 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCD  234 (267)
T ss_dssp             CTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGG
T ss_pred             CCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCcc
Confidence            344444444444444321  23334444444444444444432  1122222  45555555555543

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.47  E-value=4.7e-08  Score=92.84  Aligned_cols=121  Identities=14%  Similarity=0.169  Sum_probs=55.8

Q ss_pred             CcccccCCCCCEEeccCc-ccccc----CCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccchhhh
Q 037916          193 PSSLGQCQSLTTINLSYN-NLSGT----IPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILS  267 (741)
Q Consensus       193 ~~~~~~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~  267 (741)
                      ...+...++|++|+|++| .|...    +...+...++|++ |+|++|.|......                    ....
T Consensus        29 ~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~-L~Ls~n~i~~~g~~--------------------~l~~   87 (185)
T 1io0_A           29 KRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKK-FSIVGTRSNDPVAF--------------------ALAE   87 (185)
T ss_dssp             HHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCE-EECTTSCCCHHHHH--------------------HHHH
T ss_pred             HHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCE-EECcCCCCChHHHH--------------------HHHH
Confidence            344556677777777777 66521    1222333344444 55555554321100                    1122


Q ss_pred             hccccccccEEEeCCCccCCC----CChhcccCccCCeeeC--CCCcCCCc----cchhhhccccCCcccccCcccc
Q 037916          268 TLGSCIKLEQLKLGGNLFQGP----IPLSLSSLRGLRVLDL--SQNNISGE----IPKFLVELQLVQNLNLSYNDLE  334 (741)
Q Consensus       268 ~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L--s~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~  334 (741)
                      .+...++|++|+|++|.|...    +..++...+.|++|+|  ++|.|...    +...+...+.|+.|+|++|.+.
T Consensus        88 ~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A           88 MLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence            223334455555555554432    1233344455555555  55555432    2223333455555666555554

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.44  E-value=4.1e-08  Score=93.24  Aligned_cols=122  Identities=12%  Similarity=0.088  Sum_probs=73.4

Q ss_pred             CcccccCCcccceeeccCc-ccccc----cCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCCCC
Q 037916          168 IPPSIGNLKKLLQLYLIEN-FLQVS----IPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLP  242 (741)
Q Consensus       168 ~~~~~~~l~~L~~L~L~~N-~i~~~----~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p  242 (741)
                      +...+...++|++|+|++| .|...    +...+...++|++|+|++|+|.......+                     .
T Consensus        28 l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l---------------------~   86 (185)
T 1io0_A           28 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFAL---------------------A   86 (185)
T ss_dssp             HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHH---------------------H
T ss_pred             HHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHH---------------------H
Confidence            3456677899999999999 88743    34456667899999999999974211111                     1


Q ss_pred             hhhcCCCCCcEEEeccccccch----hhhhccccccccEEEe--CCCccCCCC----ChhcccCccCCeeeCCCCcCC
Q 037916          243 TEVGKLINLEILFISRNMLECE----ILSTLGSCIKLEQLKL--GGNLFQGPI----PLSLSSLRGLRVLDLSQNNIS  310 (741)
Q Consensus       243 ~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L--~~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~  310 (741)
                      ..+...++|++|+|++|.|...    ....+...++|++|+|  ++|.|....    ...+...++|+.|+|++|.+.
T Consensus        87 ~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A           87 EMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence            1222333444444444444432    2334444555666666  556665432    233444567777777777764

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.44  E-value=5.7e-08  Score=97.02  Aligned_cols=79  Identities=34%  Similarity=0.361  Sum_probs=41.6

Q ss_pred             cccceeEEEcCCCccCCC--CChhhcCCCCCcEEEeccccccch-hhhhccccccccEEEeCCCccCCCCC-------hh
Q 037916          223 LTSLSVGLDLSRNQLVGS--LPTEVGKLINLEILFISRNMLECE-ILSTLGSCIKLEQLKLGGNLFQGPIP-------LS  292 (741)
Q Consensus       223 l~~L~~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~-------~~  292 (741)
                      +++|+. |+|++|+|++.  +|..+..+++|+.|+|++|+|++. ....+..+ +|++|+|++|.+.+..|       ..
T Consensus       169 l~~L~~-L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~~~l~~l~~l-~L~~L~L~~Npl~~~~~~~~~y~~~i  246 (267)
T 3rw6_A          169 IPELLS-LNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGL-KLEELWLDGNSLCDTFRDQSTYISAI  246 (267)
T ss_dssp             CTTCCE-EECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSGGGGGGGTTS-CCSEEECTTSTTGGGCSSHHHHHHHH
T ss_pred             CCCCCE-EECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCchhhhhcccC-CcceEEccCCcCccccCcchhHHHHH
Confidence            334443 44444444431  234445556666666666666544 11222223 67777777777665444       23


Q ss_pred             cccCccCCeee
Q 037916          293 LSSLRGLRVLD  303 (741)
Q Consensus       293 ~~~l~~L~~L~  303 (741)
                      +..+++|+.||
T Consensus       247 l~~~P~L~~LD  257 (267)
T 3rw6_A          247 RERFPKLLRLD  257 (267)
T ss_dssp             HHHCTTCCEES
T ss_pred             HHHCcccCeEC
Confidence            56677777775

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.32  E-value=1.5e-06  Score=87.96  Aligned_cols=135  Identities=17%  Similarity=0.103  Sum_probs=92.9

Q ss_pred             hcccCcee-eEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcC-CCceeeEeeeecCccccCCceEEEEEecc
Q 037916          407 WIDMGSFG-SVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIR-HKNLVKILTVCSGVDYKGDDFKALVYEFM  484 (741)
Q Consensus       407 ~ig~G~~g-~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~~~~lv~e~~  484 (741)
                      .+..|..+ .||+.....++..+++|+-..   .....+.+|...|+.+. +--|.++++++     .+.+..++|||++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~-----~~~~~~~lvme~l  102 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFI-----RTPDDAWLLTTAI  102 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEE-----EETTEEEEEEECC
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEE-----EECCeEEEEEEee
Confidence            45556655 689988877778899998753   23456778999988773 32366777774     3345789999999


Q ss_pred             cCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcC--------------------------------
Q 037916          485 HNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDC--------------------------------  532 (741)
Q Consensus       485 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--------------------------------  532 (741)
                      +|.++.+....              .......+..++++.|.-||+..                                
T Consensus       103 ~G~~~~~~~~~--------------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (272)
T 4gkh_A          103 PGKTAFQVLEE--------------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFD  168 (272)
T ss_dssp             CSEEHHHHHHH--------------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCC
T ss_pred             CCccccccccC--------------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcc
Confidence            98877665421              11122345556666666666420                                


Q ss_pred             -----------------------CCCceecCCCCCCeEeCCCCceEEeeccccc
Q 037916          533 -----------------------QPTTAHCDLKPSNVLLDHEMTAHVADFGLAK  563 (741)
Q Consensus       533 -----------------------~~~ivHrDlkp~NIll~~~~~~kL~DFg~a~  563 (741)
                                             .+.++|+|+.+.||+++.++.+-|+||+.+.
T Consensus       169 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          169 DERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             GGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                                   1237899999999999987777799998775

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.29  E-value=2e-06  Score=88.65  Aligned_cols=135  Identities=16%  Similarity=0.092  Sum_probs=88.3

Q ss_pred             hhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCC---ceeeEeeeecCccccCCceEEEEEe
Q 037916          406 CWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHK---NLVKILTVCSGVDYKGDDFKALVYE  482 (741)
Q Consensus       406 ~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp---nIv~~~~~~~~~~~~~~~~~~lv~e  482 (741)
                      +.++.|....||+.     +..+++|+..  .......+.+|..+++.+.+.   .|.+++.++.    ......++|||
T Consensus        25 ~~l~~G~~n~v~~v-----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~----~~~g~~~~v~e   93 (306)
T 3tdw_A           25 ESLGEGFRNYAILV-----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK----RSDGNPFVGYR   93 (306)
T ss_dssp             EEEEECSSEEEEEE-----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE----CTTSCEEEEEE
T ss_pred             eecCCCcceeEEEE-----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc----cCCCceEEEEe
Confidence            45778888899988     3457888853  122345778999999998642   3566666642    22345789999


Q ss_pred             cccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhc-------------------------------
Q 037916          483 FMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHD-------------------------------  531 (741)
Q Consensus       483 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-------------------------------  531 (741)
                      |++|.++.+..-            ..++..+...++.++.+.|..||+.                               
T Consensus        94 ~i~G~~l~~~~~------------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~  161 (306)
T 3tdw_A           94 KVQGQILGEDGM------------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVF  161 (306)
T ss_dssp             CCCSEECHHHHH------------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTG
T ss_pred             ccCCeECchhhh------------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcc
Confidence            999988765311            1123333344444444444444432                               


Q ss_pred             --------------------------CCCCceecCCCCCCeEeCC---CCc-eEEeeccccc
Q 037916          532 --------------------------CQPTTAHCDLKPSNVLLDH---EMT-AHVADFGLAK  563 (741)
Q Consensus       532 --------------------------~~~~ivHrDlkp~NIll~~---~~~-~kL~DFg~a~  563 (741)
                                                ..+.++|+|++|.||+++.   ++. +.|+||+.+.
T Consensus       162 ~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~  223 (306)
T 3tdw_A          162 PLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA  223 (306)
T ss_dssp             GGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred             cccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence                                      2335799999999999987   455 4899999775

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.07  E-value=1.6e-05  Score=83.94  Aligned_cols=84  Identities=5%  Similarity=-0.063  Sum_probs=55.3

Q ss_pred             hhc-ccCceeeEEEEEEc---C---CCeEEEEEEeeccC---cCcchhHHHHHHHHHhcC-C--CceeeEeeeecCcccc
Q 037916          406 CWI-DMGSFGSVYKGILD---E---GKTIIAVKVLNLLH---HGASKSSIAECSALRNIR-H--KNLVKILTVCSGVDYK  472 (741)
Q Consensus       406 ~~i-g~G~~g~V~~a~~~---~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--pnIv~~~~~~~~~~~~  472 (741)
                      +.| +.|....+|+....   .   ++..+++|+.....   ......+.+|+.+++.+. +  -.+.+++.++.+..  
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~--  103 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD--  103 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST--
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC--
Confidence            456 88889999988753   1   15678899865322   112356788999988873 2  35677887753221  


Q ss_pred             CCceEEEEEecccCCChhh
Q 037916          473 GDDFKALVYEFMHNGSLEE  491 (741)
Q Consensus       473 ~~~~~~lv~e~~~~gsL~~  491 (741)
                      .....++||||++|.++.+
T Consensus       104 ~~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          104 VLGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             TTSSCEEEEECCCCBCCCB
T ss_pred             ccCCceEEEEecCCCChhh
Confidence            1134689999998877654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.94  E-value=2e-05  Score=84.42  Aligned_cols=76  Identities=14%  Similarity=0.034  Sum_probs=49.2

Q ss_pred             hhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc-------CcchhHHHHHHHHHhcCC--C-ceeeEeeeecCccccCC
Q 037916          405 LCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH-------GASKSSIAECSALRNIRH--K-NLVKILTVCSGVDYKGD  474 (741)
Q Consensus       405 ~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--p-nIv~~~~~~~~~~~~~~  474 (741)
                      .+.||.|.++.||++....+++.|++|.......       ....+...|.++++.+..  | .+++++.+.       .
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d-------~  107 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-------T  107 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-------T
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc-------C
Confidence            4579999999999997765677899998653211       123456789999887732  3 445666541       2


Q ss_pred             ceEEEEEecccCC
Q 037916          475 DFKALVYEFMHNG  487 (741)
Q Consensus       475 ~~~~lv~e~~~~g  487 (741)
                      ...++|||++++.
T Consensus       108 ~~~~lvmE~l~g~  120 (397)
T 2olc_A          108 EMAVTVMEDLSHL  120 (397)
T ss_dssp             TTTEEEECCCTTS
T ss_pred             CccEEEEEeCCCc
Confidence            2357999999764

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.94  E-value=4.2e-06  Score=77.34  Aligned_cols=83  Identities=14%  Similarity=0.111  Sum_probs=47.5

Q ss_pred             CccEEEcccccccccCCccccCCCcCcEEEcccCC-CCCcCcccccCC----cccceeeccCcc-cccccCcccccCCCC
Q 037916          129 NLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNK-LSGNIPPSIGNL----KKLLQLYLIENF-LQVSIPSSLGQCQSL  202 (741)
Q Consensus       129 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l----~~L~~L~L~~N~-i~~~~~~~~~~l~~L  202 (741)
                      +|++|||+++.|+......+.++++|+.|+|++|. |+..--..++.+    ++|++|+|++|. |+...-..+..+++|
T Consensus        62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L  141 (176)
T 3e4g_A           62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL  141 (176)
T ss_dssp             CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred             eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence            56666666666655555555666666666666663 543333334443    256666666653 554434445566777


Q ss_pred             CEEeccCcc
Q 037916          203 TTINLSYNN  211 (741)
Q Consensus       203 ~~L~L~~N~  211 (741)
                      ++|+|+++.
T Consensus       142 ~~L~L~~c~  150 (176)
T 3e4g_A          142 KYLFLSDLP  150 (176)
T ss_dssp             CEEEEESCT
T ss_pred             CEEECCCCC
Confidence            777777663

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.87  E-value=7.1e-06  Score=75.83  Aligned_cols=83  Identities=14%  Similarity=0.129  Sum_probs=52.9

Q ss_pred             cceeEEEcCCCccCCCCChhhcCCCCCcEEEecccc-ccchhhhhcccc----ccccEEEeCCC-ccCCCCChhcccCcc
Q 037916          225 SLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNM-LECEILSTLGSC----IKLEQLKLGGN-LFQGPIPLSLSSLRG  298 (741)
Q Consensus       225 ~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l----~~L~~L~L~~N-~l~~~~~~~~~~l~~  298 (741)
                      .|+. ||++++.|+..--..+..+++|++|+|++|. |+......++.+    ++|++|+|++| +|++..-..+..+++
T Consensus        62 ~L~~-LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~  140 (176)
T 3e4g_A           62 KIQA-IDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN  140 (176)
T ss_dssp             CEEE-EEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred             eEeE-EeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence            4554 6666666654444455667777777777773 665555555554    36777777776 366544455666777


Q ss_pred             CCeeeCCCCc
Q 037916          299 LRVLDLSQNN  308 (741)
Q Consensus       299 L~~L~Ls~N~  308 (741)
                      |+.|+|+++.
T Consensus       141 L~~L~L~~c~  150 (176)
T 3e4g_A          141 LKYLFLSDLP  150 (176)
T ss_dssp             CCEEEEESCT
T ss_pred             CCEEECCCCC
Confidence            7777777764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.76  E-value=0.00019  Score=74.89  Aligned_cols=151  Identities=20%  Similarity=0.150  Sum_probs=79.0

Q ss_pred             hcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcC--CCceeeEeeeecCcc-ccCCceEEEEEec
Q 037916          407 WIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIR--HKNLVKILTVCSGVD-YKGDDFKALVYEF  483 (741)
Q Consensus       407 ~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~~-~~~~~~~~lv~e~  483 (741)
                      .|+.|..+.||+.... ++ .+++|+...    .......|..+++.+.  .-.+++++....+.. .......+++|||
T Consensus        39 ~l~gG~~n~~~~v~~~-~~-~~vlk~~~~----~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           39 VIQGNQMALVWKVHTD-SG-AVCLKRIHR----PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             ECC----CEEEEEEET-TE-EEEEEEECS----CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eccccccCcEEEEEeC-CC-CEEEEecCC----CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            4566778899999875 33 588999863    1234445666665552  113344443211100 1124467899999


Q ss_pred             ccCCChhh--------------hccCCCC-C--Cccc-CcccccCHHH-------------------------------H
Q 037916          484 MHNGSLEE--------------WLHPVSG-A--DKTV-EAPKCLNFLQ-------------------------------R  514 (741)
Q Consensus       484 ~~~gsL~~--------------~l~~~~~-~--~~~~-~~~~~~~~~~-------------------------------~  514 (741)
                      ++|.++..              .++.... .  .... .......|..                               .
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            98865420              0111000 0  0000 0000111211                               1


Q ss_pred             HHHHHHHHHHHHHHHh----------cCCCCceecCCCCCCeEeCCCCceEEeeccccc
Q 037916          515 INIAIDVACALKYLHH----------DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAK  563 (741)
Q Consensus       515 ~~i~~qi~~aL~~LH~----------~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~a~  563 (741)
                      ..+..++..++.+|++          .....++|+|+++.||+++.++.+.|+||+.+.
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            1122234456666653          124589999999999999888899999998764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.48  E-value=0.0005  Score=70.44  Aligned_cols=74  Identities=12%  Similarity=0.040  Sum_probs=55.2

Q ss_pred             hhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcC---CCceeeEeeeecCccccCCceEEEEEe
Q 037916          406 CWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIR---HKNLVKILTVCSGVDYKGDDFKALVYE  482 (741)
Q Consensus       406 ~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~~~~~~~~~~lv~e  482 (741)
                      +.|+.|.+..+|+...  ++..+++|+....   ....+..|...|+.+.   ...|++++.++.     .....++|||
T Consensus        42 ~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~-----~~g~~~lvme  111 (312)
T 3jr1_A           42 EKLYSGEMNEIWLIND--EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGN-----SQGHSFLLLE  111 (312)
T ss_dssp             EEECCSSSSEEEEEES--SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEE-----CSSEEEEEEE
T ss_pred             EEeCCccceeeeEEEE--CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEee-----cCCceEEEEE
Confidence            4688999999999986  3667888987532   3456788988888873   356778887742     2357899999


Q ss_pred             cccCCCh
Q 037916          483 FMHNGSL  489 (741)
Q Consensus       483 ~~~~gsL  489 (741)
                      |++|..+
T Consensus       112 ~l~G~~~  118 (312)
T 3jr1_A          112 ALNKSKN  118 (312)
T ss_dssp             CCCCCCC
T ss_pred             eccCCCC
Confidence            9988754

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.47  E-value=0.00037  Score=70.87  Aligned_cols=75  Identities=15%  Similarity=0.007  Sum_probs=54.0

Q ss_pred             HhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCC---CceeeEeeeecCccccCCceEEEE
Q 037916          404 FLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRH---KNLVKILTVCSGVDYKGDDFKALV  480 (741)
Q Consensus       404 ~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---pnIv~~~~~~~~~~~~~~~~~~lv  480 (741)
                      -++.+|.|..+.||+.+.. +|+.|++|+...........+..|+..|+.+.-   --+++++++.         ..++|
T Consensus        19 ~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~---------~~~lv   88 (288)
T 3f7w_A           19 AVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD---------DRTLA   88 (288)
T ss_dssp             EEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE---------TTEEE
T ss_pred             EEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc---------CceEE
Confidence            3567899999999999986 688899998764433344567889999988732   2355666552         23789


Q ss_pred             EecccCCC
Q 037916          481 YEFMHNGS  488 (741)
Q Consensus       481 ~e~~~~gs  488 (741)
                      |||++++.
T Consensus        89 ~e~l~~~~   96 (288)
T 3f7w_A           89 MEWVDERP   96 (288)
T ss_dssp             EECCCCCC
T ss_pred             EEeecccC
Confidence            99987654

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.32  E-value=5.7e-05  Score=71.14  Aligned_cols=86  Identities=13%  Similarity=0.172  Sum_probs=37.0

Q ss_pred             CCCccEEEcccccccccC----CccccCCCcCcEEEcccCCCCCcC----cccccCCcccceeeccCcc---ccc----c
Q 037916          127 FINLQTLHMWDNQLSGTI----SPAIGELQNLVTLAINTNKLSGNI----PPSIGNLKKLLQLYLIENF---LQV----S  191 (741)
Q Consensus       127 l~~L~~L~L~~N~i~~~~----~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~N~---i~~----~  191 (741)
                      -+.|++|+|++|+|....    ..++..-+.|++|+|++|+|+..-    .+++..-+.|++|+|++|.   +..    .
T Consensus        69 N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~  148 (197)
T 1pgv_A           69 SKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMD  148 (197)
T ss_dssp             CSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHH
T ss_pred             CCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHH
Confidence            344555555555554222    222333445555555555554321    1223333445555554432   221    1


Q ss_pred             cCcccccCCCCCEEeccCccc
Q 037916          192 IPSSLGQCQSLTTINLSYNNL  212 (741)
Q Consensus       192 ~~~~~~~l~~L~~L~L~~N~l  212 (741)
                      +...+..-+.|+.|+++.|.+
T Consensus       149 ia~aL~~N~tL~~L~l~~~~~  169 (197)
T 1pgv_A          149 MMMAIEENESLLRVGISFASM  169 (197)
T ss_dssp             HHHHHHHCSSCCEEECCCCCH
T ss_pred             HHHHHHhCCCcCeEeccCCCc
Confidence            222333445555555555443

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.31  E-value=0.00016  Score=63.69  Aligned_cols=52  Identities=19%  Similarity=0.224  Sum_probs=26.6

Q ss_pred             CCCccc-ccCChhhhhCCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCc
Q 037916            4 GVNRVQ-GGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLT   58 (741)
Q Consensus         4 ~~n~~~-~~ip~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~   58 (741)
                      +++.++ ..+|..+.   ++|++|+|++|+|+.+.++.|..+++|++|+|++|.+.
T Consensus        16 s~~~L~~~~vP~~lp---~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           16 GRRGLTWASLPTAFP---VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             CSSCCCTTTSCSCCC---TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             CCCCCccccCCCCCC---cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            344443 24454444   44555555555555555555555555555555555443

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.28  E-value=5.7e-05  Score=71.12  Aligned_cols=84  Identities=17%  Similarity=0.123  Sum_probs=42.0

Q ss_pred             cccEEEccCCcccccC----CccccCCCCccEEEcccccccccC----CccccCCCcCcEEEcccC---CCCCc----Cc
Q 037916          105 TLETLIFNSNKIFRSI----PAGIGKFINLQTLHMWDNQLSGTI----SPAIGELQNLVTLAINTN---KLSGN----IP  169 (741)
Q Consensus       105 ~L~~L~L~~n~i~~~~----~~~~~~l~~L~~L~L~~N~i~~~~----~~~~~~l~~L~~L~L~~N---~l~~~----~~  169 (741)
                      .|+.|+|++|+|....    ...+..-+.|++|+|++|+|+...    ..++..-+.|++|+|++|   .+...    +.
T Consensus        71 ~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia  150 (197)
T 1pgv_A           71 HIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMM  150 (197)
T ss_dssp             CCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHH
T ss_pred             CcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHH
Confidence            4555555555543221    122223445666666666665322    223444455777777654   23221    22


Q ss_pred             ccccCCcccceeeccCccc
Q 037916          170 PSIGNLKKLLQLYLIENFL  188 (741)
Q Consensus       170 ~~~~~l~~L~~L~L~~N~i  188 (741)
                      .++..-+.|+.|+++.|.+
T Consensus       151 ~aL~~N~tL~~L~l~~~~~  169 (197)
T 1pgv_A          151 MAIEENESLLRVGISFASM  169 (197)
T ss_dssp             HHHHHCSSCCEEECCCCCH
T ss_pred             HHHHhCCCcCeEeccCCCc
Confidence            3444556677777766654

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.26  E-value=0.00098  Score=68.16  Aligned_cols=71  Identities=11%  Similarity=0.071  Sum_probs=43.6

Q ss_pred             hhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCce-eeEeeeecCccccCCceEEEEEec
Q 037916          405 LCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNL-VKILTVCSGVDYKGDDFKALVYEF  483 (741)
Q Consensus       405 ~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~~~~~~lv~e~  483 (741)
                      ++.|+.|....+|+.      ..+++|+...... ...+..+|+.+++.+....+ .++++++       ...-++++||
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~-~~~~r~~E~~~l~~l~~~g~~P~~~~~~-------~~~~~~v~e~   88 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTE-EYINRANEAVAAREAAKAGVSPEVLHVD-------PATGVMVTRY   88 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC-------TTTCCEEEEC
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCcc-ceeCHHHHHHHHHHHHHcCCCCceEEEE-------CCCCEEEEee
Confidence            456888999999999      3488898764322 22344578888777632222 4666552       1124789999


Q ss_pred             c-cCCCh
Q 037916          484 M-HNGSL  489 (741)
Q Consensus       484 ~-~~gsL  489 (741)
                      + +|.++
T Consensus        89 i~~g~~l   95 (301)
T 3dxq_A           89 IAGAQTM   95 (301)
T ss_dssp             CTTCEEC
T ss_pred             cCCCccC
Confidence            9 66544

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.19  E-value=0.00049  Score=60.48  Aligned_cols=37  Identities=19%  Similarity=0.195  Sum_probs=24.3

Q ss_pred             CccEEEcccccccccCCccccCCCcCcEEEcccCCCC
Q 037916          129 NLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLS  165 (741)
Q Consensus       129 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~  165 (741)
                      +|++|+|++|+|+.+.++.|..+++|++|+|++|.+.
T Consensus        32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             CCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            4666666666666666666666666666666666664

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.17  E-value=0.0025  Score=68.91  Aligned_cols=74  Identities=16%  Similarity=0.054  Sum_probs=48.1

Q ss_pred             hhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCce-eeEeeeecCccccCCceEEEEEecc
Q 037916          406 CWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNL-VKILTVCSGVDYKGDDFKALVYEFM  484 (741)
Q Consensus       406 ~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~~~~~~lv~e~~  484 (741)
                      +.|+.|-...+|++....++..|++|+..... ...-+..+|..+++.+...++ +++++++     .+    ..||||+
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~-----~~----G~v~e~I  183 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFF-----TN----GRIEEFM  183 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEE-----TT----EEEEECC
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEe-----CC----eEEEEee
Confidence            45778888999999886445788999875322 222234689999988854433 5777763     21    2599999


Q ss_pred             cCCCh
Q 037916          485 HNGSL  489 (741)
Q Consensus       485 ~~gsL  489 (741)
                      +|.++
T Consensus       184 ~G~~l  188 (458)
T 2qg7_A          184 DGYAL  188 (458)
T ss_dssp             CSEEC
T ss_pred             CCccC
Confidence            87554

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.13  E-value=0.00065  Score=73.18  Aligned_cols=81  Identities=11%  Similarity=0.085  Sum_probs=46.2

Q ss_pred             CCCceecCCCCCCeEeCCCCceEEeecccccccCCCCcccccccccccccccCcccccC--CCCCCCccCchhHHHHHHH
Q 037916          533 QPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGL--GSEVSINGDVYSYGILLLE  610 (741)
Q Consensus       533 ~~~ivHrDlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~--~~~~~~~~DIwSlG~il~e  610 (741)
                      .+.++|+|++|.||+++.++ ++++||+.+............. ..-...|++|+....  +.......++.+....+|+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYL-GNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHH-HHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHH-HHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            34899999999999998776 9999999887543221100000 001134555522210  0111122345577777777


Q ss_pred             HHcCC
Q 037916          611 LMTRK  615 (741)
Q Consensus       611 lltg~  615 (741)
                      .+++.
T Consensus       309 ~y~~~  313 (420)
T 2pyw_A          309 LFNKR  313 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            77653

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.07  E-value=0.0021  Score=66.24  Aligned_cols=154  Identities=14%  Similarity=0.047  Sum_probs=79.3

Q ss_pred             hhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCc--eeeEeeeecCcc-ccCCceEEEEEe
Q 037916          406 CWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKN--LVKILTVCSGVD-YKGDDFKALVYE  482 (741)
Q Consensus       406 ~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~~~~~~~~~~-~~~~~~~~lv~e  482 (741)
                      +.|+.|....+|+.... ++ .+++|+....  ...+.+..|+.+++.+....  +.+++....+.. ....+..+++|+
T Consensus        28 ~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~  103 (322)
T 2ppq_A           28 KGIAEGVENSNFLLHTT-KD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS  103 (322)
T ss_dssp             EEECC---EEEEEEEES-SC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred             eccCCCcccceEEEEeC-Cc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence            45677888899998875 33 5889988642  23455667888877763211  344443211000 011245689999


Q ss_pred             cccCCChhhh--------------ccCC-CCCCccc-CcccccCHHHHHH------------HHHHHHHHHHHHHhc---
Q 037916          483 FMHNGSLEEW--------------LHPV-SGADKTV-EAPKCLNFLQRIN------------IAIDVACALKYLHHD---  531 (741)
Q Consensus       483 ~~~~gsL~~~--------------l~~~-~~~~~~~-~~~~~~~~~~~~~------------i~~qi~~aL~~LH~~---  531 (741)
                      |++|..+...              ++.. ....... .......|.....            +...+.+.+++++..   
T Consensus       104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~  183 (322)
T 2ppq_A          104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK  183 (322)
T ss_dssp             CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred             eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence            9988654210              1110 0000000 0000011211000            011234455555532   


Q ss_pred             -CCCCceecCCCCCCeEeCCCCceEEeeccccc
Q 037916          532 -CQPTTAHCDLKPSNVLLDHEMTAHVADFGLAK  563 (741)
Q Consensus       532 -~~~~ivHrDlkp~NIll~~~~~~kL~DFg~a~  563 (741)
                       ...+++|+|+.+.||++++++.+.|+||+.+.
T Consensus       184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             SSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence             13479999999999999887666899998764

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.02  E-value=0.0017  Score=69.90  Aligned_cols=74  Identities=15%  Similarity=0.159  Sum_probs=49.2

Q ss_pred             hhhcccCceeeEEEEEEcC-------CCeEEEEEEeeccCcCcchhHHHHHHHHHhcC-CCceeeEeeeecCccccCCce
Q 037916          405 LCWIDMGSFGSVYKGILDE-------GKTIIAVKVLNLLHHGASKSSIAECSALRNIR-HKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       405 ~~~ig~G~~g~V~~a~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      ++.|+.|....+|++....       ++..|++|+....  ...+.+..|..+++.+. +.-.+++++.+     .+   
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~-----~~---  147 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIF-----SG---  147 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT---
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEe-----CC---
Confidence            3467888889999998752       2567899988421  11155668998888874 32235677653     22   


Q ss_pred             EEEEEecccCCCh
Q 037916          477 KALVYEFMHNGSL  489 (741)
Q Consensus       477 ~~lv~e~~~~gsL  489 (741)
                       .+||||++|.++
T Consensus       148 -g~v~e~l~G~~l  159 (429)
T 1nw1_A          148 -GRLEEYIPSRPL  159 (429)
T ss_dssp             -EEEECCCCEEEC
T ss_pred             -CEEEEEeCCccc
Confidence             389999986444

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.96  E-value=0.0011  Score=69.71  Aligned_cols=148  Identities=12%  Similarity=0.132  Sum_probs=81.1

Q ss_pred             hhcccCceeeEEEEEEcC-------CCeEEEEEEeeccCcCcchhHHHHHHHHHhcC-CCceeeEeeeecCccccCCceE
Q 037916          406 CWIDMGSFGSVYKGILDE-------GKTIIAVKVLNLLHHGASKSSIAECSALRNIR-HKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       406 ~~ig~G~~g~V~~a~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      +.|..|-...+|++....       +++.|++|+.... ........+|..+++.+. +.-..++++++     ++    
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~-----~~----  125 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVF-----PE----  125 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEE-----TT----
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEc-----CC----
Confidence            346778888999998742       3467899986321 123455668999988773 32235777663     22    


Q ss_pred             EEEEecccCCChhhh-cc-------------CCCCCCcccCcccccCHHHHHHHHHHHHH-------------------H
Q 037916          478 ALVYEFMHNGSLEEW-LH-------------PVSGADKTVEAPKCLNFLQRINIAIDVAC-------------------A  524 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~-l~-------------~~~~~~~~~~~~~~~~~~~~~~i~~qi~~-------------------a  524 (741)
                      .+||||++|.++..- +.             ...............-+.++.++..++..                   .
T Consensus       126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~  205 (379)
T 3feg_A          126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE  205 (379)
T ss_dssp             EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred             ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence            289999988655321 00             00000000000011113444444443321                   2


Q ss_pred             HHHHHh----c-CCCCceecCCCCCCeEeCCC----CceEEeeccccc
Q 037916          525 LKYLHH----D-CQPTTAHCDLKPSNVLLDHE----MTAHVADFGLAK  563 (741)
Q Consensus       525 L~~LH~----~-~~~~ivHrDlkp~NIll~~~----~~~kL~DFg~a~  563 (741)
                      +.+|.+    . ....++|+|+.+.||+++.+    +.+.++||..|.
T Consensus       206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            333322    1 12369999999999999876    689999998764

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.82  E-value=0.0061  Score=63.18  Aligned_cols=32  Identities=34%  Similarity=0.336  Sum_probs=27.4

Q ss_pred             CCCceecCCCCCCeEeCCC----CceEEeecccccc
Q 037916          533 QPTTAHCDLKPSNVLLDHE----MTAHVADFGLAKL  564 (741)
Q Consensus       533 ~~~ivHrDlkp~NIll~~~----~~~kL~DFg~a~~  564 (741)
                      ...++|||+.+.||+++.+    +.+.|+||+.+..
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            3479999999999999874    6899999998764

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.79  E-value=0.0035  Score=64.82  Aligned_cols=79  Identities=10%  Similarity=0.076  Sum_probs=47.5

Q ss_pred             hcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCC--ceeeEeeeecCcc-ccCCceEEEEEec
Q 037916          407 WIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHK--NLVKILTVCSGVD-YKGDDFKALVYEF  483 (741)
Q Consensus       407 ~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--nIv~~~~~~~~~~-~~~~~~~~lv~e~  483 (741)
                      .++ |....||+.... +|+.+++|+..... .....+..|..+++.+...  .+++++.. .+.. ....+..+++|||
T Consensus        33 ~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~-~g~~~~~~~g~~~~l~~~  108 (328)
T 1zyl_A           33 PLN-SYENRVYQFQDE-DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAF-NGQTLLNHQGFYFAVFPS  108 (328)
T ss_dssp             EEC-CSSSEEEEECCT-TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCB-TTBSCEEETTEEEEEEEC
T ss_pred             eec-CcccceEEEEcC-CCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeec-CCcEEEEECCEEEEEEEe
Confidence            455 777889987664 45678999986321 2345667788888777321  24444443 1110 1123466889999


Q ss_pred             ccCCCh
Q 037916          484 MHNGSL  489 (741)
Q Consensus       484 ~~~gsL  489 (741)
                      ++|.++
T Consensus       109 i~G~~~  114 (328)
T 1zyl_A          109 VGGRQF  114 (328)
T ss_dssp             CCCEEC
T ss_pred             cCCCCC
Confidence            987543

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.74  E-value=0.0045  Score=65.23  Aligned_cols=75  Identities=13%  Similarity=0.155  Sum_probs=44.4

Q ss_pred             hhhcccCceeeEEEEEEcC--------CCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCc-eeeEeeeecCccccCCc
Q 037916          405 LCWIDMGSFGSVYKGILDE--------GKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKN-LVKILTVCSGVDYKGDD  475 (741)
Q Consensus       405 ~~~ig~G~~g~V~~a~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~~~~~~~~~~~~~~~  475 (741)
                      ++.|+.|..-.+|+.....        .+..+++|+...... ...+...|..+++.+...+ ++++++..     .   
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~-----~---  108 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF-----N---  108 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE-----T---
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec-----C---
Confidence            3457778888999998753        126788998753221 1223467888888774222 44666552     1   


Q ss_pred             eEEEEEecccCCCh
Q 037916          476 FKALVYEFMHNGSL  489 (741)
Q Consensus       476 ~~~lv~e~~~~gsL  489 (741)
                       -++||||++|.++
T Consensus       109 -~~~v~e~i~G~~l  121 (369)
T 3c5i_A          109 -GGRIEEWLYGDPL  121 (369)
T ss_dssp             -TEEEEECCCSEEC
T ss_pred             -CcEEEEEecCCcC
Confidence             2689999987544

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.40  E-value=0.019  Score=59.63  Aligned_cols=31  Identities=26%  Similarity=0.390  Sum_probs=27.5

Q ss_pred             CCceecCCCCCCeEeCCCCceEEeecccccc
Q 037916          534 PTTAHCDLKPSNVLLDHEMTAHVADFGLAKL  564 (741)
Q Consensus       534 ~~ivHrDlkp~NIll~~~~~~kL~DFg~a~~  564 (741)
                      ..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4799999999999999888899999987754

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.76  E-value=0.036  Score=59.12  Aligned_cols=75  Identities=15%  Similarity=0.115  Sum_probs=48.9

Q ss_pred             hhhcccCceeeEEEEEEcCC-------CeEEEEEEeeccCcCcchhHHHHHHHHHhcC-CCceeeEeeeecCccccCCce
Q 037916          405 LCWIDMGSFGSVYKGILDEG-------KTIIAVKVLNLLHHGASKSSIAECSALRNIR-HKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       405 ~~~ig~G~~g~V~~a~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      ++.+..|-...+|+......       +..|++|+..... ...-+..+|..+++.+. +.-..++++.+     .    
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~-----~----  144 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF-----P----  144 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE-----T----
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc-----C----
Confidence            34577788889999987521       5778999875322 22334568888888774 33345666542     1    


Q ss_pred             EEEEEecccCCCh
Q 037916          477 KALVYEFMHNGSL  489 (741)
Q Consensus       477 ~~lv~e~~~~gsL  489 (741)
                      -+.||||++|.++
T Consensus       145 ~~~I~efI~G~~l  157 (424)
T 3mes_A          145 EGRIEEFIDGEPL  157 (424)
T ss_dssp             TEEEEECCCSEEC
T ss_pred             CCEEEEEeCCccC
Confidence            2689999988654

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=95.63  E-value=0.014  Score=55.10  Aligned_cols=102  Identities=16%  Similarity=0.065  Sum_probs=65.1

Q ss_pred             ChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecccccccCC
Q 037916          488 SLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPP  567 (741)
Q Consensus       488 sL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~a~~~~~  567 (741)
                      +|.+.++..         ..++++.+++.++.|.+.+|.-+-..-  .-..+=+.|..|++..+|.|.+.+ +.+.    
T Consensus        34 SL~eIL~~~---------~~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~----   97 (229)
T 2yle_A           34 SLEEILRLY---------NQPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD----   97 (229)
T ss_dssp             EHHHHHHHH---------TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C-------
T ss_pred             cHHHHHHHc---------CCCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc----
Confidence            788888633         578999999999999999987762110  111222347899999999888764 1111    


Q ss_pred             CCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCC
Q 037916          568 AHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP  617 (741)
Q Consensus       568 ~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p  617 (741)
                                .....+.|||..  ....+.+.=|||+|+++|..+--..|
T Consensus        98 ----------~~~~~~~~pe~~--~~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 ----------AGEPPPVAGKLG--YSQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             -------------------CCS--SSSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ----------ccccCCCChhhc--cccchHHHHHHHHHHHHHHHhhcCCC
Confidence                      012346688543  24556788999999999999886555

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=93.08  E-value=0.41  Score=50.67  Aligned_cols=28  Identities=25%  Similarity=0.403  Sum_probs=23.9

Q ss_pred             ceecCCCCCCeEe------CCCCceEEeeccccc
Q 037916          536 TAHCDLKPSNVLL------DHEMTAHVADFGLAK  563 (741)
Q Consensus       536 ivHrDlkp~NIll------~~~~~~kL~DFg~a~  563 (741)
                      ++|+|+.+.||++      +++..++++||..|.
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            5799999999999      445689999998775

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	741
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	9e-50
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	6e-45
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-44
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-43
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	9e-43
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-42
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-42
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-41
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-41
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-41
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	4e-41
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	6e-41
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	5e-40
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-39
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-39
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	5e-39
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-38
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-38
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-38
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-38
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-37
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-37
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	5e-37
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	5e-37
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-36
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-36
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-36
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	7e-36
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-35
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	7e-35
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-34
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-33
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	5e-33
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-32
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	8e-32
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	5e-31
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-30
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-30
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	4e-30
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	7e-30
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	8e-30
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	9e-30
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-29
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-29
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-28
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	6e-28
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	6e-28
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-27
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	5e-27
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	7e-27
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	8e-27
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-26
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-26
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-25
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-25
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-25
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-24
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	7e-24
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-23
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-22
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-22
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	4e-17
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	6e-14
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-21
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	7e-21
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-16
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	8e-08
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-04
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-20
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-19
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	4e-08
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-07
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-04
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-04
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	5e-19
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-18
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	8e-13
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	3e-09
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	3e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	3e-06
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	4e-09
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	5e-09
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-07
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	2e-08
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	0.002
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	9e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.001
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.001
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.002
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	3e-07
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	5e-06
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	8e-07
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	9e-06
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	0.001
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	4e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	6e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.002
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.003
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	5e-05
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	4e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.001
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.003
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.002
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.002

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 9e-50
 Identities = 71/308 (23%), Positives = 119/308 (38%), Gaps = 54/308 (17%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGAS--KSSIAECSALRNIRHKNLVKILTVCSG 468
           GSFG+VYKG        +AVK+LN+        ++   E   LR  RH N++  +   + 
Sbjct: 19  GSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST- 74

Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL 528
                    A+V ++    SL   LH                 ++ I+IA   A  + YL
Sbjct: 75  -----APQLAIVTQWCEGSSLYHHLH---------IIETKFEMIKLIDIARQTAQGMDYL 120

Query: 529 HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP-- 586
           H        H DLK +N+ L  ++T  + DFGLA +            + G+I ++AP  
Sbjct: 121 HAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177

Query: 587 AEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDS 646
                 +  S   DVY++GI+L ELMT + P             ++     D ++ +V  
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-------------YSNINNRDQIIFMVGR 224

Query: 647 TLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSI 706
             L+ D                     C  ++ R+   C  +   +R     ++  ++ +
Sbjct: 225 GYLSPDLS--------------KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270

Query: 707 KSILLGPK 714
              L  PK
Sbjct: 271 ARSL--PK 276

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (407), Expect = 6e-45
 Identities = 62/309 (20%), Positives = 114/309 (36%), Gaps = 38/309 (12%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G FG V++G        +AVK+ +      S    AE      +RH+N++  +   +  +
Sbjct: 14  GRFGEVWRGKWR--GEEVAVKIFSS-REERSWFREAEIYQTVMLRHENILGFIAADNKDN 70

Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
                   LV ++  +GSL ++L+              +     I +A+  A  L +LH 
Sbjct: 71  GTWTQL-WLVSDYHEHGSLFDYLNR-----------YTVTVEGMIKLALSTASGLAHLHM 118

Query: 531 DC-----QPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPA--HLQTSSIGVKGTIGY 583
           +      +P  AH DLK  N+L+    T  +AD GLA     A   +  +     GT  Y
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178

Query: 584 IAP-----AEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPD 638
           +AP     +      E     D+Y+ G++  E+  R     I  +  +  ++    V  D
Sbjct: 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL---VPSD 235

Query: 639 HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTI 698
             ++ +   +        I +  +          E L  + +I   C   +   R+    
Sbjct: 236 PSVEEMRKVVCEQKLRPNIPNRWQS--------CEALRVMAKIMRECWYANGAARLTALR 287

Query: 699 VVHELQSIK 707
           +   L  + 
Sbjct: 288 IKKTLSQLS 296

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 2e-44
 Identities = 64/305 (20%), Positives = 124/305 (40%), Gaps = 52/305 (17%)

Query: 402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVK 461
              +  +  G FG V+ G  +   T +AVK L      +  + +AE + ++ ++H+ LV+
Sbjct: 15  LKLVERLGAGQFGEVWMGYYNGH-TKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVR 72

Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDV 521
           +  V +       +   ++ E+M NGSL ++L   SG          L   + +++A  +
Sbjct: 73  LYAVVT------QEPIYIITEYMENGSLVDFLKTPSG--------IKLTINKLLDMAAQI 118

Query: 522 ACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTI 581
           A  + ++         H DL+ +N+L+   ++  +ADFGLA+L+          G K  I
Sbjct: 119 AEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPI 174

Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM 641
            + AP         +I  DV+S+GILL E++T  R              +     P+ + 
Sbjct: 175 KWTAPEAI-NYGTFTIKSDVWSFGILLTEIVTHGRIP------------YPGMTNPEVIQ 221

Query: 642 DIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH 701
           ++     +   ++                   C   + ++   C  E P+DR     +  
Sbjct: 222 NLERGYRMVRPDN-------------------CPEELYQLMRLCWKERPEDRPTFDYLRS 262

Query: 702 ELQSI 706
            L+  
Sbjct: 263 VLEDF 267

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 2e-43
 Identities = 48/217 (22%), Positives = 86/217 (39%), Gaps = 23/217 (10%)

Query: 402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNL-LHHGASKSSIAECSALRNIRHKNLV 460
           F  +  +  G+ G V+K        ++A K+++L +        I E   L       +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67

Query: 461 KILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAID 520
                        D   ++  E M  GSL++ L               +       ++I 
Sbjct: 68  GFYGAF-----YSDGEISICMEHMDGGSLDQVLK----------KAGRIPEQILGKVSIA 112

Query: 521 VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGT 580
           V   L YL    +    H D+KPSN+L++      + DFG++  L  +   +      GT
Sbjct: 113 VIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS----FVGT 166

Query: 581 IGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
             Y++P E   G+  S+  D++S G+ L+E+   + P
Sbjct: 167 RSYMSP-ERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (389), Expect = 9e-43
 Identities = 58/248 (23%), Positives = 98/248 (39%), Gaps = 25/248 (10%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNLVKILTVCSG 468
           GSF +VYKG+  E    +A   L    L     +    E   L+ ++H N+V+       
Sbjct: 20  GSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWES 79

Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL 528
              KG     LV E M +G+L+ +L             K +      +    +   L++L
Sbjct: 80  TV-KGKKCIVLVTELMTSGTLKTYLK----------RFKVMKIKVLRSWCRQILKGLQFL 128

Query: 529 HHDCQPTTAHCDLKPSNVLLDHE-MTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPA 587
           H    P   H DLK  N+ +     +  + D GLA L   +  +     V GT  ++AP 
Sbjct: 129 HTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPEFMAP- 182

Query: 588 EYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDST 647
           E     +   + DVY++G+ +LE+ T + P    +    N     R V         D  
Sbjct: 183 EM-YEEKYDESVDVYAFGMCMLEMATSEYP----YSECQNAAQIYRRVTSGVKPASFDKV 237

Query: 648 LLADDEDL 655
            + + +++
Sbjct: 238 AIPEVKEI 245

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 3e-42
 Identities = 70/298 (23%), Positives = 114/298 (38%), Gaps = 56/298 (18%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G FG V  G        +AVK +   +   +++ +AE S +  +RH NLV++L V     
Sbjct: 18  GEFGDVMLGDYR--GNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVI---- 69

Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
            +      +V E+M  GSL ++L               L     +  ++DV  A++YL  
Sbjct: 70  VEEKGGLYIVTEYMAKGSLVDYLRS--------RGRSVLGGDCLLKFSLDVCEAMEYLEG 121

Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
           +      H DL   NVL+  +  A V+DFGL K        ++    K  + + AP E  
Sbjct: 122 NN---FVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAP-EAL 172

Query: 591 LGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTLLA 650
              + S   DV+S+GILL E+ +  R         + L +    V   + MD  D     
Sbjct: 173 REKKFSTKSDVWSFGILLWEIYSFGRV----PYPRIPLKDVVPRVEKGYKMDAPD----- 223

Query: 651 DDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKS 708
                                  C  +V  +   C       R +   +  +L+ IK+
Sbjct: 224 ----------------------GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  153 bits (387), Expect = 4e-42
 Identities = 62/303 (20%), Positives = 116/303 (38%), Gaps = 56/303 (18%)

Query: 411 GSFGSVYKGIL---DEGKTIIAVKVLNL-LHHGASKSSIAECSALRNIRHKNLVKILTVC 466
           G FG V  G L    + +  +A+K L         +  ++E S +    H N++ +  V 
Sbjct: 37  GEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVV 96

Query: 467 SGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALK 526
           +           ++ EFM NGSL+ +L          +       +Q + +   +A  +K
Sbjct: 97  TK-----STPVMIITEFMENGSLDSFLR---------QNDGQFTVIQLVGMLRGIAAGMK 142

Query: 527 YLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPA---HLQTSSIGVKGTIGY 583
           YL         H DL   N+L++  +   V+DFGL++ L         TS++G K  I +
Sbjct: 143 YLADMNYV---HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRW 199

Query: 584 IAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDI 643
            AP E     + +   DV+SYGI++ E+M+        +   M   +    +  D+ +  
Sbjct: 200 TAP-EAIQYRKFTSASDVWSYGIVMWEVMSYGERP---YWD-MTNQDVINAIEQDYRLPP 254

Query: 644 VDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHEL 703
                                       M+C  ++ ++ + C  +    R     +V+ L
Sbjct: 255 ---------------------------PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287

Query: 704 QSI 706
             +
Sbjct: 288 DKM 290

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 1e-41
 Identities = 59/300 (19%), Positives = 107/300 (35%), Gaps = 54/300 (18%)

Query: 411 GSFGSVYKGILDEGKT--IIAVKVLNL-LHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           G+FGSV +G+    K    +A+KVL        ++  + E   +  + +  +V+++ VC 
Sbjct: 20  GNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ 79

Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
                      LV E    G L ++L             + +       +   V+  +KY
Sbjct: 80  AEAL------MLVMEMAGGGPLHKFLV---------GKREEIPVSNVAELLHQVSMGMKY 124

Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPA-HLQTSSIGVKGTIGYIAP 586
           L         H DL   NVLL +   A ++DFGL+K L       T+    K  + + AP
Sbjct: 125 LEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 181

Query: 587 AEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDS 646
            E     + S   DV+SYG+ + E ++  +     ++  M        +     M+    
Sbjct: 182 -ECINFRKFSSRSDVWSYGVTMWEALSYGQKP---YKK-MKGPEVMAFIEQGKRMECPP- 235

Query: 647 TLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSI 706
                                     EC   +  +   C +   +DR +   V   +++ 
Sbjct: 236 --------------------------ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 2e-41
 Identities = 59/263 (22%), Positives = 100/263 (38%), Gaps = 22/263 (8%)

Query: 402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNL 459
           +  L  I  GS+G   K        I+  K L+   +     +  ++E + LR ++H N+
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65

Query: 460 VKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAI 519
           V+          + +    +V E+   G L   +       K  +  + L+    + +  
Sbjct: 66  VRYYDRIID---RTNTTLYIVMEYCEGGDLASVIT------KGTKERQYLDEEFVLRVMT 116

Query: 520 DVACALKYLH--HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
            +  ALK  H   D   T  H DLKP+NV LD +    + DFGLA++L        +   
Sbjct: 117 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--F 174

Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNM--NLHNFARTV 635
            GT  Y++P E       +   D++S G LL EL     P     +  +   +       
Sbjct: 175 VGTPYYMSP-EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR 233

Query: 636 LPDHV----MDIVDSTLLADDED 654
           +P        +I+   L   D  
Sbjct: 234 IPYRYSDELNEIITRMLNLKDYH 256

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 2e-41
 Identities = 74/306 (24%), Positives = 125/306 (40%), Gaps = 52/306 (16%)

Query: 401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLV 460
           S      +  G FG V+ G  +     +A+K L      + ++ + E   ++ +RH+ LV
Sbjct: 18  SLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 75

Query: 461 KILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAID 520
           ++  V S      ++   +V E+M  GSL ++L          E  K L   Q +++A  
Sbjct: 76  QLYAVVS------EEPIYIVTEYMSKGSLLDFLKG--------ETGKYLRLPQLVDMAAQ 121

Query: 521 VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGT 580
           +A  + Y+         H DL+ +N+L+   +   VADFGLA+L+          G K  
Sbjct: 122 IASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ-GAKFP 177

Query: 581 IGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHV 640
           I + AP E  L    +I  DV+S+GILL EL T+ R     + G +             V
Sbjct: 178 IKWTAP-EAALYGRFTIKSDVWSFGILLTELTTKGRV---PYPGMV----------NREV 223

Query: 641 MDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVV 700
           +D V+                     R+    EC  S+  +   C  + P++R     + 
Sbjct: 224 LDQVERGY------------------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQ 265

Query: 701 HELQSI 706
             L+  
Sbjct: 266 AFLEDY 271

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 4e-41
 Identities = 65/308 (21%), Positives = 113/308 (36%), Gaps = 54/308 (17%)

Query: 411 GSFGSVYKGILDEG---KTIIAVKVLNLL-HHGASKSSIAECSALRNIRHKNLVKILTVC 466
           G FG VY G L +    K   AVK LN +   G     + E   +++  H N++ +L +C
Sbjct: 38  GHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC 97

Query: 467 SGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALK 526
                + +    +V  +M +G L  ++                     I   + VA  + 
Sbjct: 98  ----LRSEGSPLVVLPYMKHGDLRNFIRN---------ETHNPTVKDLIGFGLQVAKGM- 143

Query: 527 YLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPP--AHLQTSSIGVKGTIGYI 584
                      H DL   N +LD + T  VADFGLA+ +         +  G K  + ++
Sbjct: 144 --KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201

Query: 585 APAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIV 644
           A  E     + +   DV+S+G+LL ELMTR  P       ++N  +    +L    +   
Sbjct: 202 AL-ESLQTQKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITVYLLQGRRLLQP 256

Query: 645 DSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQ 704
           +                            C   +  + + C     + R + + +V  + 
Sbjct: 257 E---------------------------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289

Query: 705 SIKSILLG 712
           +I S  +G
Sbjct: 290 AIFSTFIG 297

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  149 bits (378), Expect = 6e-41
 Identities = 67/325 (20%), Positives = 121/325 (37%), Gaps = 60/325 (18%)

Query: 402 FLFLCWIDMGSFGSVYKGIL-----DEGKTIIAVKVLNL-LHHGASKSSIAECSALRNIR 455
             ++  I  G+FG V++         E  T++AVK+L              E + +    
Sbjct: 15  IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD 74

Query: 456 HKNLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLH--------------PVSGADK 501
           + N+VK+L VC            L++E+M  G L E+L                 + A  
Sbjct: 75  NPNIVKLLGVC-----AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 129

Query: 502 TVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGL 561
           +   P  L+  +++ IA  VA  + YL         H DL   N L+   M   +ADFGL
Sbjct: 130 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFV---HRDLATRNCLVGENMVVKIADFGL 186

Query: 562 AKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIM 621
           ++ +  A    +       I ++ P E    +  +   DV++YG++L E+ +        
Sbjct: 187 SRNIYSADYYKADGNDAIPIRWMPP-ESIFYNRYTTESDVWAYGVVLWEIFSYGLQ---P 242

Query: 622 FEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRI 681
           + G  +          + +  + D  +LA  E+                   C + +  +
Sbjct: 243 YYGMAH---------EEVIYYVRDGNILACPEN-------------------CPLELYNL 274

Query: 682 GVACSMESPQDRMNMTIVVHELQSI 706
              C  + P DR +   +   LQ +
Sbjct: 275 MRLCWSKLPADRPSFCSIHRILQRM 299

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 5e-40
 Identities = 59/301 (19%), Positives = 104/301 (34%), Gaps = 56/301 (18%)

Query: 411 GSFGSVYKGILDEGKT--IIAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTVC 466
           G+FG+V KG     K    +AVK+L             +AE + ++ + +  +V+++ +C
Sbjct: 18  GNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC 77

Query: 467 SGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALK 526
                   +   LV E    G L ++L             + +     I +   V+  +K
Sbjct: 78  E------AESWMLVMEMAELGPLNKYLQQ----------NRHVKDKNIIELVHQVSMGMK 121

Query: 527 YLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAH-LQTSSIGVKGTIGYIA 585
           YL         H DL   NVLL  +  A ++DFGL+K L        +    K  + + A
Sbjct: 122 YLEESNFV---HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 178

Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVD 645
           P E     + S   DV+S+G+L+ E  +  +     + G M        +     M    
Sbjct: 179 P-ECINYYKFSSKSDVWSFGVLMWEAFSYGQK---PYRG-MKGSEVTAMLEKGERMGCPA 233

Query: 646 STLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQS 705
                                       C   +  +   C     ++R     V   L++
Sbjct: 234 ---------------------------GCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266

Query: 706 I 706
            
Sbjct: 267 Y 267

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 1e-39
 Identities = 62/314 (19%), Positives = 118/314 (37%), Gaps = 55/314 (17%)

Query: 411 GSFGSVYKGILDEG----KTIIAVKVLNL-LHHGASKSSIAECSALRNIRHKNLVKILTV 465
           G FG VYKG+L       +  +A+K L            + E   +    H N++++  V
Sbjct: 18  GEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGV 77

Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                        ++ E+M NG+L+++L          E     + LQ + +   +A  +
Sbjct: 78  I-----SKYKPMMIITEYMENGALDKFLR---------EKDGEFSVLQLVGMLRGIAAGM 123

Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQT-SSIGVKGTIGYI 584
               +       H DL   N+L++  +   V+DFGL+++L      T ++ G K  I + 
Sbjct: 124 ---KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180

Query: 585 APAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIV 644
           AP E     + +   DV+S+GI++ E+MT                          VM  +
Sbjct: 181 AP-EAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-------------NHEVMKAI 226

Query: 645 DSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQ 704
           +                     R+   M+C  ++ ++ + C  +    R     +V  L 
Sbjct: 227 NDGF------------------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILD 268

Query: 705 SIKSILLGPKTVSN 718
            +       KT+++
Sbjct: 269 KLIRAPDSLKTLAD 282

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 4e-39
 Identities = 62/305 (20%), Positives = 114/305 (37%), Gaps = 52/305 (17%)

Query: 402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVK 461
             FL  +  G FG V  G    G+  +A+K++      +    I E   + N+ H+ LV+
Sbjct: 6   LTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQ 63

Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDV 521
           +  VC+           ++ E+M NG L  +L  +                Q + +  DV
Sbjct: 64  LYGVCTK-----QRPIFIITEYMANGCLLNYLREMRH---------RFQTQQLLEMCKDV 109

Query: 522 ACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTI 581
             A++YL         H DL   N L++ +    V+DFGL++ +      TSS+G K  +
Sbjct: 110 CEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPV 165

Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM 641
            +  P E  + S+ S   D++++G+L+ E+ +  +     +E                  
Sbjct: 166 RWSPP-EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP---YERFT----------NSETA 211

Query: 642 DIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH 701
           + +   L      L                      V  I  +C  E   +R    I++ 
Sbjct: 212 EHIAQGLRLYRPHL------------------ASEKVYTIMYSCWHEKADERPTFKILLS 253

Query: 702 ELQSI 706
            +  +
Sbjct: 254 NILDV 258

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 5e-39
 Identities = 64/305 (20%), Positives = 108/305 (35%), Gaps = 52/305 (17%)

Query: 402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVK 461
             F+  I  G FG V+ G        +A+K +      + +  I E   +  + H  LV+
Sbjct: 7   LTFVQEIGSGQFGLVHLGYWLNKD-KVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQ 64

Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDV 521
           +  VC            LV+EFM +G L ++L                     + + +DV
Sbjct: 65  LYGVCLE-----QAPICLVFEFMEHGCLSDYLR---------TQRGLFAAETLLGMCLDV 110

Query: 522 ACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTI 581
              + YL   C     H DL   N L+       V+DFG+ + +      TSS G K  +
Sbjct: 111 CEGMAYLEEACV---IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPV 166

Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM 641
            + +P E    S  S   DV+S+G+L+ E+ +  +                       V+
Sbjct: 167 KWASP-EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-------------NSEVV 212

Query: 642 DIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH 701
           + + +        L                      V +I   C  E P+DR   + ++ 
Sbjct: 213 EDISTGFRLYKPRL------------------ASTHVYQIMNHCWKERPEDRPAFSRLLR 254

Query: 702 ELQSI 706
           +L  I
Sbjct: 255 QLAEI 259

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (360), Expect = 3e-38
 Identities = 60/315 (19%), Positives = 103/315 (32%), Gaps = 59/315 (18%)

Query: 411 GSFGSVYKGIL-----DEGKTIIAVKVLNL-LHHGASKSSIAECSALRNI-RHKNLVKIL 463
           G+FG V                +AVK+L         ++ ++E   +  +  H+N+V +L
Sbjct: 48  GAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLL 107

Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLH-------------PVSGADKTVEAPKCLN 510
             C+           L++E+   G L  +L                    +  E    L 
Sbjct: 108 GACTL-----SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 162

Query: 511 FLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHL 570
           F   +  A  VA  +++L      +  H DL   NVL+ H     + DFGLA+ +     
Sbjct: 163 FEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 219

Query: 571 QTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHN 630
                  +  + ++AP E       +I  DV+SYGILL E+ +        + G     N
Sbjct: 220 YVVRGNARLPVKWMAP-ESLFEGIYTIKSDVWSYGILLWEIFSLGVN---PYPGIPVDAN 275

Query: 631 FARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESP 690
           F + +     MD                                   +  I  +C     
Sbjct: 276 FYKLIQNGFKMDQPF---------------------------YATEEIYIIMQSCWAFDS 308

Query: 691 QDRMNMTIVVHELQS 705
           + R +   +   L  
Sbjct: 309 RKRPSFPNLTSFLGC 323

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 3e-38
 Identities = 52/211 (24%), Positives = 83/211 (39%), Gaps = 23/211 (10%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G+FG VYK    E   + A KV++       +  + E   L +  H N+VK+L       
Sbjct: 23  GAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF---- 78

Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
              ++   ++ EF   G+++  +          E  + L   Q   +      AL YLH 
Sbjct: 79  -YYENNLWILIEFCAGGAVDAVML---------ELERPLTESQIQVVCKQTLDALNYLH- 127

Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP---- 586
                  H DLK  N+L   +    +ADFG++        +  S    GT  ++AP    
Sbjct: 128 --DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVM 183

Query: 587 AEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
            E           DV+S GI L+E+   + P
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEPP 214

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  141 bits (357), Expect = 3e-38
 Identities = 65/305 (21%), Positives = 126/305 (41%), Gaps = 50/305 (16%)

Query: 402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVK 461
                 +  G +G VY+G+  +    +AVK L        +  + E + ++ I+H NLV+
Sbjct: 19  ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQ 77

Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDV 521
           +L VC+      +    ++ EFM  G+L ++L   +         + ++ +  + +A  +
Sbjct: 78  LLGVCTR-----EPPFYIITEFMTYGNLLDYLRECN--------RQEVSAVVLLYMATQI 124

Query: 522 ACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTI 581
           + A++YL    +    H DL   N L+       VADFGL++L+        + G K  I
Sbjct: 125 SSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-GAKFPI 180

Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVM 641
            + AP      ++ SI  DV+++G+LL E+ T        + G               V 
Sbjct: 181 KWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMS---PYPGID----------LSQVY 226

Query: 642 DIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH 701
           ++++               +  R  R     E +  ++R   AC   +P DR +   +  
Sbjct: 227 ELLE---------------KDYRMERPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 268

Query: 702 ELQSI 706
             +++
Sbjct: 269 AFETM 273

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (355), Expect = 3e-38
 Identities = 58/256 (22%), Positives = 94/256 (36%), Gaps = 39/256 (15%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLN---LLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           G FG+VY     + K I+A+KVL    L   G       E     ++RH N++++     
Sbjct: 17  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 76

Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
                      L+ E+   G++   L                +  +      ++A AL Y
Sbjct: 77  D-----ATRVYLILEYAPLGTVYRELQK----------LSKFDEQRTATYITELANALSY 121

Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPA 587
            H        H D+KP N+LL       +ADFG +   P +   T    + GT+ Y+ P 
Sbjct: 122 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDYLPP- 173

Query: 588 EYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV---------LPD 638
           E   G       D++S G+L  E +  K P    FE N     + R           + +
Sbjct: 174 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFVTE 229

Query: 639 HVMDIVDSTLLADDED 654
              D++   L  +   
Sbjct: 230 GARDLISRLLKHNPSQ 245

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (350), Expect = 2e-37
 Identities = 50/250 (20%), Positives = 97/250 (38%), Gaps = 19/250 (7%)

Query: 402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSI-AECSALRNIRHKNLV 460
           +  +  +  G++G V   +    +  +AVK++++        +I  E    + + H+N+V
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66

Query: 461 KILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAID 520
           K          +  + + L  E+   G L + + P             +           
Sbjct: 67  KFYGHR-----REGNIQYLFLEYCSGGELFDRIEP----------DIGMPEPDAQRFFHQ 111

Query: 521 VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGT 580
           +   + YLH        H D+KP N+LLD      ++DFGLA +    + +     + GT
Sbjct: 112 LMAGVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 168

Query: 581 IGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHV 640
           + Y+AP         +   DV+S GI+L  ++  + P D   +      ++       + 
Sbjct: 169 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP 228

Query: 641 MDIVDSTLLA 650
              +DS  LA
Sbjct: 229 WKKIDSAPLA 238

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  139 bits (351), Expect = 3e-37
 Identities = 51/212 (24%), Positives = 81/212 (38%), Gaps = 29/212 (13%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNL---LHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           GSFG+VY         ++A+K ++      +   +  I E   L+ +RH N ++      
Sbjct: 26  GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 85

Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
                 +    LV E+    + +                K L  ++   +       L Y
Sbjct: 86  R-----EHTAWLVMEYCLGSASDLLEV----------HKKPLQEVEIAAVTHGALQGLAY 130

Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPA 587
           LH        H D+K  N+LL       + DFG A ++ PA+         GT  ++AP 
Sbjct: 131 LH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------SFVGTPYWMAPE 181

Query: 588 EYGLGSEVSING--DVYSYGILLLELMTRKRP 617
                 E   +G  DV+S GI  +EL  RK P
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPP 213

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 5e-37
 Identities = 54/311 (17%), Positives = 99/311 (31%), Gaps = 54/311 (17%)

Query: 411 GSFGSVYKGIL-----DEGKTIIAVKVLNLLHHGASKSSI-AECSALRNI-RHKNLVKIL 463
           G+FG V +         +    +AVK+L    H   + ++ +E   L  +  H N+V +L
Sbjct: 34  GAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLL 93

Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLH--------PVSGADKTVEAPKCLNFLQRI 515
             C+           ++ E+   G L  +L           +      +    L+    +
Sbjct: 94  GACTI-----GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 516 NIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSI 575
           + +  VA  + +L         H DL   N+LL H     + DFGLA+ +          
Sbjct: 149 SFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205

Query: 576 GVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV 635
             +  + ++AP E       +   DV+SYGI L EL +                      
Sbjct: 206 NARLPVKWMAP-ESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP------------ 252

Query: 636 LPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMN 695
           +      ++                      R+ +       +  I   C    P  R  
Sbjct: 253 VDSKFYKMIKEGF------------------RMLSPEHAPAEMYDIMKTCWDADPLKRPT 294

Query: 696 MTIVVHELQSI 706
              +V  ++  
Sbjct: 295 FKQIVQLIEKQ 305

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 5e-37
 Identities = 56/303 (18%), Positives = 114/303 (37%), Gaps = 46/303 (15%)

Query: 411 GSFGSVYKGIL-----DEGKTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILT 464
           GSFG VY+G+      DE +T +A+K +N           + E S ++     ++V++L 
Sbjct: 31  GSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG 90

Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
           V S           ++ E M  G L+ +L  +  A          +  + I +A ++A  
Sbjct: 91  VVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 145

Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYI 584
           + YL+        H DL   N ++  + T  + DFG+ + +               + ++
Sbjct: 146 MAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 202

Query: 585 APAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIV 644
           +P E       +   DV+S+G++L E+ T        ++G ++     R V+   ++D  
Sbjct: 203 SP-ESLKDGVFTTYSDVWSFGVVLWEIATLAEQP---YQG-LSNEQVLRFVMEGGLLDKP 257

Query: 645 DSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQ 704
           D                            C   +  +   C   +P+ R +   ++  ++
Sbjct: 258 D---------------------------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 290

Query: 705 SIK 707
              
Sbjct: 291 EEM 293

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 1e-36
 Identities = 65/302 (21%), Positives = 111/302 (36%), Gaps = 55/302 (18%)

Query: 411 GSFGSVYKGIL----DEGKTIIAVKVLNLLHHGASKSSI-AECSALRNIRHKNLVKILTV 465
           G+FG+VYKG+     ++ K  +A+K L       +   I  E   + ++ + ++ ++L +
Sbjct: 20  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 79

Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
           C            L+ + M  G L +++          E    +     +N  + +A  +
Sbjct: 80  CL------TSTVQLITQLMPFGCLLDYVR---------EHKDNIGSQYLLNWCVQIAKGM 124

Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
            YL         H DL   NVL+       + DFGLAKLL     +  + G K  I ++A
Sbjct: 125 NYLEDRRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181

Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVD 645
             E  L    +   DV+SYG+ + ELMT        ++G               +  I++
Sbjct: 182 L-ESILHRIYTHQSDVWSYGVTVWELMTFGSK---PYDGIPA----------SEISSILE 227

Query: 646 STLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQS 705
                                R+     C I V  I V C M     R     ++ E   
Sbjct: 228 KGE------------------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269

Query: 706 IK 707
           + 
Sbjct: 270 MA 271

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  138 bits (348), Expect = 2e-36
 Identities = 57/262 (21%), Positives = 103/262 (39%), Gaps = 33/262 (12%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G+FG V++          A K +   H    ++   E   +  +RH  LV +        
Sbjct: 37  GAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF---- 92

Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
            + D+   ++YEFM  G L E +          +    ++  + +     V   L ++H 
Sbjct: 93  -EDDNEMVMIYEFMSGGELFEKVA---------DEHNKMSEDEAVEYMRQVCKGLCHMHE 142

Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHV--ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAE 588
           +      H DLKP N++   + +  +   DFGL   L P   + S     GT  + AP E
Sbjct: 143 NNY---VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP---KQSVKVTTGTAEFAAP-E 195

Query: 589 YGLGSEVSINGDVYSYGILLLELMTRKRP------SDIMF---EGNMNLHNFARTVLPDH 639
              G  V    D++S G+L   L++   P       + +      + N+ + A + + + 
Sbjct: 196 VAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED 255

Query: 640 VMDIVDSTLLADDEDLTITSNQ 661
             D +   LL  D +  +T +Q
Sbjct: 256 GKDFIRK-LLLADPNTRMTIHQ 276

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 3e-36
 Identities = 47/207 (22%), Positives = 89/207 (42%), Gaps = 22/207 (10%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G+ G+VY  +       +A++ +NL      +  I E   +R  ++ N+V  L       
Sbjct: 31  GASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL--- 87

Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
               D   +V E++  GSL + +              C++  Q   +  +   AL++LH 
Sbjct: 88  --VGDELWVVMEYLAGGSLTDVVT-----------ETCMDEGQIAAVCRECLQALEFLHS 134

Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG 590
           +      H D+K  N+LL  + +  + DFG    + P   + S++   GT  ++AP E  
Sbjct: 135 NQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM--VGTPYWMAP-EVV 188

Query: 591 LGSEVSINGDVYSYGILLLELMTRKRP 617
                    D++S GI+ +E++  + P
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 7e-36
 Identities = 55/275 (20%), Positives = 100/275 (36%), Gaps = 28/275 (10%)

Query: 402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLN---LLHHGASKSSIAECSALRNIRHKN 458
           F F   +  GSF +V            A+K+L    ++          E   +  + H  
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69

Query: 459 LVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIA 518
            VK+         + D+       +  NG L +++                +        
Sbjct: 70  FVKLYFTF-----QDDEKLYFGLSYAKNGELLKYIRK----------IGSFDETCTRFYT 114

Query: 519 IDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK 578
            ++  AL+YLH        H DLKP N+LL+ +M   + DFG AK+L P   Q  +    
Sbjct: 115 AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV 171

Query: 579 GTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP-----SDIMFEGNMNLHNFAR 633
           GT  Y++P E         + D+++ G ++ +L+    P       ++F+  + L     
Sbjct: 172 GTAQYVSP-ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP 230

Query: 634 TVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARI 668
                   D+V+  LL  D    +   + +    +
Sbjct: 231 EKFFPKARDLVEK-LLVLDATKRLGCEEMEGYGPL 264

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (339), Expect = 1e-35
 Identities = 58/306 (18%), Positives = 109/306 (35%), Gaps = 53/306 (17%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGAS---KSSIAECSALRNI-RHKNLVKILTVC 466
           G+FG V K  + +    +   +  +  + +    +    E   L  +  H N++ +L  C
Sbjct: 21  GNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC 80

Query: 467 SGVDYKGDDFKALVYEFMHNGSLEEWLH------PVSGADKTVEAPKCLNFLQRINIAID 520
                +   +  L  E+  +G+L ++L                     L+  Q ++ A D
Sbjct: 81  -----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 135

Query: 521 VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGT 580
           VA  + YL    Q    H DL   N+L+     A +ADFGL++       +T     +  
Sbjct: 136 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM---GRLP 189

Query: 581 IGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHV 640
           + ++A  E    S  + N DV+SYG+LL E+++        + G M        +   + 
Sbjct: 190 VRWMAI-ESLNYSVYTTNSDVWSYGVLLWEIVSLGGT---PYCG-MTCAELYEKLPQGYR 244

Query: 641 MDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVV 700
           ++                               C   V  +   C  E P +R +   ++
Sbjct: 245 LEKPL---------------------------NCDDEVYDLMRQCWREKPYERPSFAQIL 277

Query: 701 HELQSI 706
             L  +
Sbjct: 278 VSLNRM 283

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 7e-35
 Identities = 62/304 (20%), Positives = 95/304 (31%), Gaps = 56/304 (18%)

Query: 411 GSFGSVYKGILDEGK---TIIAVKVLN---LLHHGASKSSIAECSALRNIRHKNLVKILT 464
           GSFG V +G  D        +AVK L    L    A    I E +A+ ++ H+NL+++  
Sbjct: 19  GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG 78

Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
           V             +V E    GSL + L    G                   A+ VA  
Sbjct: 79  VVL------TPPMKMVTELAPLGSLLDRLRKHQGH---------FLLGTLSRYAVQVAEG 123

Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQ-TSSIGVKGTIGY 583
           + YL         H DL   N+LL       + DFGL + LP            K    +
Sbjct: 124 MGYLESKRFI---HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180

Query: 584 IAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDI 643
            AP E       S   D + +G+ L E+ T  +     + G        +       +  
Sbjct: 181 CAP-ESLKTRTFSHASDTWMFGVTLWEMFTYGQE---PWIGLNGSQILHKIDKEGERLPR 236

Query: 644 VDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHEL 703
            +                           +C   +  + V C    P+DR     +   L
Sbjct: 237 PE---------------------------DCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269

Query: 704 QSIK 707
              +
Sbjct: 270 LEAQ 273

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 1e-34
 Identities = 55/300 (18%), Positives = 104/300 (34%), Gaps = 55/300 (18%)

Query: 411 GSFGSVYKGIL---DEGKTIIAVKVLNLL-HHGASKSSIAECSALRNIRHKNLVKILTVC 466
           G FG V++GI    +     +A+K           +  + E   +R   H ++VK++ V 
Sbjct: 18  GQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI 77

Query: 467 SGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALK 526
           +      ++   ++ E    G L  +L               L+    I  A  ++ AL 
Sbjct: 78  T------ENPVWIIMELCTLGELRSFLQ---------VRKYSLDLASLILYAYQLSTALA 122

Query: 527 YLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAP 586
           YL         H D+   NVL+       + DFGL++ +  +    +S G    I ++AP
Sbjct: 123 YLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK-LPIKWMAP 178

Query: 587 AEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDS 646
            E       +   DV+ +G+ + E++          +              + V+  ++ 
Sbjct: 179 -ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-------------NNDVIGRIE- 223

Query: 647 TLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSI 706
                           +R     N    L S++     C    P  R   T +  +L +I
Sbjct: 224 --------------NGERLPMPPNCPPTLYSLMT---KCWAYDPSRRPRFTELKAQLSTI 266

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  129 bits (325), Expect = 3e-33
 Identities = 43/209 (20%), Positives = 80/209 (38%), Gaps = 23/209 (11%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G+FG V++ +      +   K +N  +     +   E S +  + H  L+ +        
Sbjct: 40  GAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF---- 95

Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
            +      L+ EF+  G L + +               ++  + IN        LK++H 
Sbjct: 96  -EDKYEMVLILEFLSGGELFDRIA---------AEDYKMSEAEVINYMRQACEGLKHMH- 144

Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHV--ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAE 588
             + +  H D+KP N++ + +  + V   DFGLA  L P            T  + AP E
Sbjct: 145 --EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP---DEIVKVTTATAEFAAP-E 198

Query: 589 YGLGSEVSINGDVYSYGILLLELMTRKRP 617
                 V    D+++ G+L   L++   P
Sbjct: 199 IVDREPVGFYTDMWAIGVLGYVLLSGLSP 227

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 5e-33
 Identities = 59/308 (19%), Positives = 100/308 (32%), Gaps = 49/308 (15%)

Query: 411 GSFGSVYKGIL-----DEGKTIIAVKVLNL-LHHGASKSSIAECSALRNIRHKNLVKILT 464
           G+FG V +              +AVK+L     H   ++ ++E   L +I H   V  L 
Sbjct: 24  GAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 83

Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLH------PVSGADKTVEAPKCLNFLQRINIA 518
              G   K      ++ EF   G+L  +L                     L     I  +
Sbjct: 84  ---GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 140

Query: 519 IDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVK 578
             VA  +++L         H DL   N+LL  +    + DFGLA+ +            +
Sbjct: 141 FQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 197

Query: 579 GTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPD 638
             + ++AP E       +I  DV+S+G+LL E+ +        + G      F R +   
Sbjct: 198 LPLKWMAP-ETIFDRVYTIQSDVWSFGVLLWEIFSLGAS---PYPGVKIDEEFCRRLKEG 253

Query: 639 HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTI 698
             M   D                                + +  + C    P  R   + 
Sbjct: 254 TRMRAPD---------------------------YTTPEMYQTMLDCWHGEPSQRPTFSE 286

Query: 699 VVHELQSI 706
           +V  L ++
Sbjct: 287 LVEHLGNL 294

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  125 bits (314), Expect = 1e-32
 Identities = 58/276 (21%), Positives = 102/276 (36%), Gaps = 24/276 (8%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLN---LLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           G    V+          +AVKVL                E      + H  +V +     
Sbjct: 18  GGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGE 77

Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
                G     +V E++   +L + +H              +   + I +  D   AL +
Sbjct: 78  AETPAGPLP-YIVMEYVDGVTLRDIVHT----------EGPMTPKRAIEVIADACQALNF 126

Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLL-PPAHLQTSSIGVKGTIGYIAP 586
                Q    H D+KP+N+++       V DFG+A+ +    +  T +  V GT  Y++P
Sbjct: 127 S---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183

Query: 587 AEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDS 646
            E   G  V    DVYS G +L E++T + P    F G+  +    + V  D +      
Sbjct: 184 -EQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQHVREDPIPPSARH 238

Query: 647 TLLADD-EDLTITSNQRQRQARINNIMECLISVVRI 681
             L+ D + + + +  +  + R     E    +VR+
Sbjct: 239 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 8e-32
 Identities = 63/314 (20%), Positives = 113/314 (35%), Gaps = 55/314 (17%)

Query: 411 GSFGSVYKGIL-------DEGKTIIAVKVLNL-LHHGASKSSIAECSALRNI-RHKNLVK 461
           G+FG V                T +AVK+L            I+E   ++ I +HKN++ 
Sbjct: 24  GAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIIN 83

Query: 462 ILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHP------VSGADKTVEAPKCLNFLQRI 515
           +L  C+      D    ++ E+   G+L E+L            + +    + L+    +
Sbjct: 84  LLGACTQ-----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138

Query: 516 NIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSI 575
           + A  VA  ++YL         H DL   NVL+  +    +ADFGLA+ +        + 
Sbjct: 139 SCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195

Query: 576 GVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV 635
             +  + ++AP E       +   DV+S+G+LL E+ T        + G + +    + +
Sbjct: 196 NGRLPVKWMAP-EALFDRIYTHQSDVWSFGVLLWEIFTLGGS---PYPG-VPVEELFKLL 250

Query: 636 LPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMN 695
              H MD                               C   +  +   C    P  R  
Sbjct: 251 KEGHRMDKPS---------------------------NCTNELYMMMRDCWHAVPSQRPT 283

Query: 696 MTIVVHELQSIKSI 709
              +V +L  I ++
Sbjct: 284 FKQLVEDLDRIVAL 297

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  121 bits (305), Expect = 5e-31
 Identities = 48/261 (18%), Positives = 89/261 (34%), Gaps = 30/261 (11%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNL-LHHGASKSSIAECSALRNIRHKNLVKILTVCSGV 469
           G+F  V        + ++A+K +      G   S   E + L  I+H N+V +  +    
Sbjct: 20  GAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY--- 76

Query: 470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH 529
             +      L+ + +  G L + +                       +   V  A+KYLH
Sbjct: 77  --ESGGHLYLIMQLVSGGELFDRIV----------EKGFYTERDASRLIFQVLDAVKYLH 124

Query: 530 HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEY 589
                             LD +    ++DFGL+K+  P  + +++    GT GY+AP   
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC---GTPGYVAPEVL 181

Query: 590 GLGSEVSINGDVYSYGILLLELMTRKRP---------SDIMFEGNMNLHNFARTVLPDHV 640
                 S   D +S G++   L+    P          + + +      +     + D  
Sbjct: 182 -AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA 240

Query: 641 MDIVDSTLLADDEDLTITSNQ 661
            D +   L+  D +   T  Q
Sbjct: 241 KDFIRH-LMEKDPEKRFTCEQ 260

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 2e-30
 Identities = 58/289 (20%), Positives = 105/289 (36%), Gaps = 21/289 (7%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKILTVCSGV 469
           G++G V     +  K  +A+K ++   H    + ++ E   L   RH+N++ I  +    
Sbjct: 19  GAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAP 78

Query: 470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH 529
             +      LV   M    L + L             + L+          +   LKY+H
Sbjct: 79  TIEQMKDVYLVTHLM-GADLYKLLKT-----------QHLSNDHICYFLYQILRGLKYIH 126

Query: 530 HDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIG-VKGTIGYIAPAE 588
                   H DLKPSN+LL+      + DFGLA++  P H  T  +     T  Y AP  
Sbjct: 127 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183

Query: 589 YGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTL 648
                  + + D++S G +L E+++ +         +   H       P          L
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243

Query: 649 LADDEDLTITSNQRQRQARI-NNIMECLISVVRIGVACSMESPQDRMNM 696
            A +  L++    +    R+  N     + ++         +P  R+ +
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLD---KMLTFNPHKRIEV 289

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  119 bits (298), Expect = 2e-30
 Identities = 53/272 (19%), Positives = 94/272 (34%), Gaps = 40/272 (14%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSS---------IAECSALRNIR-HKNLV 460
           G    V + I        AVK++++   G+  +          + E   LR +  H N++
Sbjct: 14  GVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNII 73

Query: 461 KILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAID 520
           ++         + + F  LV++ M  G L ++L               L+  +   I   
Sbjct: 74  QLKDTY-----ETNTFFFLVFDLMKKGELFDYLT----------EKVTLSEKETRKIMRA 118

Query: 521 VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGT 580
           +   +  LH        H DLKP N+LLD +M   + DFG +  L P        G    
Sbjct: 119 LLEVICALHKLNI---VHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSY 175

Query: 581 IG--YIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSD---------IMFEGNMNLH 629
           +    I  +            D++S G+++  L+    P           ++  GN    
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG 235

Query: 630 NFARTVLPDHVMDIVDSTLLADDEDLTITSNQ 661
           +       D V D+V    L        T+ +
Sbjct: 236 SPEWDDYSDTVKDLVSR-FLVVQPQKRYTAEE 266

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 4e-30
 Identities = 42/209 (20%), Positives = 82/209 (39%), Gaps = 24/209 (11%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G FG V++ +    K     K +  +          E S L   RH+N++ +        
Sbjct: 16  GEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHESF---- 70

Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
            +  +   +++EF+    + E ++          +   LN  + ++    V  AL++LH 
Sbjct: 71  -ESMEELVMIFEFISGLDIFERIN---------TSAFELNEREIVSYVHQVCEALQFLH- 119

Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAHV--ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAE 588
                  H D++P N++     ++ +   +FG A+ L P         +     Y AP  
Sbjct: 120 --SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEV 174

Query: 589 YGLGSEVSINGDVYSYGILLLELMTRKRP 617
           +     VS   D++S G L+  L++   P
Sbjct: 175 HQ-HDVVSTATDMWSLGTLVYVLLSGINP 202

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (298), Expect = 7e-30
 Identities = 52/227 (22%), Positives = 90/227 (39%), Gaps = 23/227 (10%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           GSFG VY+  L +   ++A+K +        +    E   +R + H N+V++        
Sbjct: 31  GSFGVVYQAKLCDSGELVAIKKVLQ----DKRFKNRELQIMRKLDHCNIVRLRYFFYSSG 86

Query: 471 YKGDD-FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLH 529
            K D+ +  LV +++         H          A + L  +        +  +L Y+H
Sbjct: 87  EKKDEVYLNLVLDYVPETVYRVARH-------YSRAKQTLPVIYVKLYMYQLFRSLAYIH 139

Query: 530 HDCQPTTAHCDLKPSNVLLDHE-MTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAE 588
                   H D+KP N+LLD +     + DFG AK L       S I  +    Y AP  
Sbjct: 140 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR---YYRAPEL 193

Query: 589 YGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV 635
               ++ + + DV+S G +L EL+  +      F G+  +      +
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPI----FPGDSGVDQLVEII 236

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (295), Expect = 8e-30
 Identities = 62/293 (21%), Positives = 107/293 (36%), Gaps = 28/293 (9%)

Query: 411 GSFGSVYKGI-LDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNI---RHKNLVKILT 464
           G++G V+K   L  G   +A+K + +     G   S+I E + LR++    H N+V++  
Sbjct: 18  GAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFD 77

Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
           VC+      +    LV+E +                        +      ++   +   
Sbjct: 78  VCTVSRTDRETKLTLVFEHVDQDLTTYLDK---------VPEPGVPTETIKDMMFQLLRG 128

Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYI 584
           L +LH        H DLKP N+L+       +ADFGLA++       TS +    T+ Y 
Sbjct: 129 LDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV---VTLWYR 182

Query: 585 APAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIV 644
           AP E  L S  +   D++S G +  E+  RK       + +          LP       
Sbjct: 183 AP-EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241

Query: 645 DSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMT 697
           D  L              +    I+ + + L+        C   +P  R++  
Sbjct: 242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLL------KCLTFNPAKRISAY 288

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 9e-30
 Identities = 56/262 (21%), Positives = 103/262 (39%), Gaps = 30/262 (11%)

Query: 402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLN---LLHHGASKSSIAECSAL-RNIRHK 457
           F+    +  GSFG V+     +     A+K L    +L     + ++ E   L     H 
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 458 NLVKILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINI 517
            L  +         +  +    V E+++ G L   +           +    +  +    
Sbjct: 64  FLTHMFCTF-----QTKENLFFVMEYLNGGDLMYHIQ----------SCHKFDLSRATFY 108

Query: 518 AIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGV 577
           A ++   L++LH        + DLK  N+LLD +    +ADFG+ K       +T++   
Sbjct: 109 AAEIILGLQFLHSKGI---VYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF-- 163

Query: 578 KGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP-----SDIMFEGNMNLHNFA 632
            GT  YIAP E  LG + + + D +S+G+LL E++  + P      + +F      + F 
Sbjct: 164 CGTPDYIAP-EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY 222

Query: 633 RTVLPDHVMDIVDSTLLADDED 654
              L     D++    + + E 
Sbjct: 223 PRWLEKEAKDLLVKLFVREPEK 244

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  118 bits (297), Expect = 2e-29
 Identities = 47/266 (17%), Positives = 86/266 (32%), Gaps = 37/266 (13%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLH------HGASKSSIAECSALRNIRHKNLVKILT 464
           G FG VY     +   + A+K L+            + +     S +       +V +  
Sbjct: 15  GGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSY 74

Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
                     D  + + + M+ G L   L                +       A ++   
Sbjct: 75  AF-----HTPDKLSFILDLMNGGDLHYHLS----------QHGVFSEADMRFYAAEIILG 119

Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYI 584
           L+++H        + DLKP+N+LLD      ++D GLA                GT GY+
Sbjct: 120 LEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK----KKPHASVGTHGYM 172

Query: 585 APAEYGLGSEVSINGDVYSYGILLLELMTRKRPSD--------IMFEGNMNLHNFARTVL 636
           AP     G     + D +S G +L +L+    P           +    + +        
Sbjct: 173 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF 232

Query: 637 PDHVMDIVDSTLLADDEDLTITSNQR 662
              +  +++  LL  D +  +    R
Sbjct: 233 SPELRSLLEG-LLQRDVNRRLGCLGR 257

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (290), Expect = 3e-29
 Identities = 55/228 (24%), Positives = 83/228 (36%), Gaps = 29/228 (12%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSI-----AECSALRNIRHKNLVKILTV 465
           G F +VYK        I+A+K + L H   +K  I      E   L+ + H N++ +L  
Sbjct: 9   GQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDA 68

Query: 466 CSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                       +LV++FM                        L         +     L
Sbjct: 69  F-----GHKSNISLVFDFMETDLEVIIKDN----------SLVLTPSHIKAYMLMTLQGL 113

Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIA 585
           +YLH        H DLKP+N+LLD      +ADFGLAK     +   +      T  Y A
Sbjct: 114 EYLHQHWI---LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV--VTRWYRA 168

Query: 586 PAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFAR 633
           P          +  D+++ G +L EL+ R         G+ +L    R
Sbjct: 169 PELLFGARMYGVGVDMWAVGCILAELLLRVPF----LPGDSDLDQLTR 212

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 2e-28
 Identities = 45/230 (19%), Positives = 88/230 (38%), Gaps = 24/230 (10%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNLVKILTVCSG 468
           G+FG V+K    +    +A+K + +     G   +++ E   L+ ++H+N+V ++ +C  
Sbjct: 21  GTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 80

Query: 469 VDYKGDDFKA---LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACAL 525
                +  K    LV++F  +       +                  +   +   +   L
Sbjct: 81  KASPYNRCKGSIYLVFDFCEHDLAGLLSNV----------LVKFTLSEIKRVMQML---L 127

Query: 526 KYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAH--LQTSSIGVKGTIGY 583
             L++  +    H D+K +NVL+  +    +ADFGLA+    A             T+ Y
Sbjct: 128 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187

Query: 584 IAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFAR 633
             P       +     D++  G ++ E+ TR        +GN   H  A 
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI----MQGNTEQHQLAL 233

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  112 bits (282), Expect = 6e-28
 Identities = 50/210 (23%), Positives = 81/210 (38%), Gaps = 27/210 (12%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLN---LLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           GSFG V+           A+KVL    ++     + +  E   L  + H  ++++     
Sbjct: 15  GSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ 74

Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
                      ++ +++  G L   L             +          A +V  AL+Y
Sbjct: 75  D-----AQQIFMIMDYIEGGELFSLLRK----------SQRFPNPVAKFYAAEVCLALEY 119

Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPA 587
           LH        + DLKP N+LLD      + DFG AK +P          + GT  YIAP 
Sbjct: 120 LHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT-----LCGTPDYIAP- 170

Query: 588 EYGLGSEVSINGDVYSYGILLLELMTRKRP 617
           E       + + D +S+GIL+ E++    P
Sbjct: 171 EVVSTKPYNKSIDWWSFGILIYEMLAGYTP 200

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 6e-28
 Identities = 58/288 (20%), Positives = 105/288 (36%), Gaps = 25/288 (8%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNLVKILTVCSG 468
           G++G+V+K    E   I+A+K + L     G   S++ E   L+ ++HKN+V++  V   
Sbjct: 13  GTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-- 70

Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL 528
                D    LV+EF      + +                L+     +    +   L + 
Sbjct: 71  ---HSDKKLTLVFEFCDQDLKKYFDSC----------NGDLDPEIVKSFLFQLLKGLGFC 117

Query: 529 HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAE 588
           H        H DLKP N+L++      +A+FGLA+         S+  V  T+ Y  P  
Sbjct: 118 HSRNVL---HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV--TLWYRPPDV 172

Query: 589 YGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTL 648
                  S + D++S G +  EL    RP     + +  L    R +           T 
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232

Query: 649 LADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNM 696
           L D +   +          +  +      +++        +P  R++ 
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQ---NLLKCNPVQRISA 277

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 1e-27
 Identities = 44/210 (20%), Positives = 77/210 (36%), Gaps = 23/210 (10%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G  G V +      +   A+K+L        +  +      R  +  ++V+I+ V   + 
Sbjct: 23  GINGKVLQIFNKRTQEKFALKMLQDCPKARREVELH----WRASQCPHIVRIVDVYENL- 77

Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
           Y G     +V E +  G L   +             +     +   I   +  A++YLH 
Sbjct: 78  YAGRKCLLIVMECLDGGELFSRIQD--------RGDQAFTEREASEIMKSIGEAIQYLH- 128

Query: 531 DCQPTTAHCDLKPSNVLLDHEM---TAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPA 587
                 AH D+KP N+L   +       + DFG AK         S      T  Y+AP 
Sbjct: 129 --SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS---HNSLTTPCYTPYYVAP- 182

Query: 588 EYGLGSEVSINGDVYSYGILLLELMTRKRP 617
           E     +   + D++S G+++  L+    P
Sbjct: 183 EVLGPEKYDKSCDMWSLGVIMYILLCGYPP 212

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  109 bits (274), Expect = 5e-27
 Identities = 41/224 (18%), Positives = 74/224 (33%), Gaps = 28/224 (12%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           GSFG +Y G        +A+K+  +           E    + ++    +  +  C    
Sbjct: 18  GSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVGIPTIRWC---- 71

Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
               D+  +V E +     + +              +  +    + +A  +   ++Y+H 
Sbjct: 72  GAEGDYNVMVMELLGPSLEDLFNFC----------SRKFSLKTVLLLADQMISRIEYIH- 120

Query: 531 DCQPTTAHCDLKPSNVL---LDHEMTAHVADFGLAKLLPPAHLQT-----SSIGVKGTIG 582
                  H D+KP N L          ++ DFGLAK    A          +  + GT  
Sbjct: 121 --SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178

Query: 583 YIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNM 626
           Y +     LG E S   D+ S G +L+       P   +     
Sbjct: 179 YASI-NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK 221

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (272), Expect = 7e-27
 Identities = 43/217 (19%), Positives = 81/217 (37%), Gaps = 32/217 (14%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIA------ECSALRNIRHKNLVKILT 464
           G F  V K          A K +      +S+  ++      E S L+ I+H N++ +  
Sbjct: 21  GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 80

Query: 465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACA 524
           V      +      L+ E +  G L ++L             + L   +       +   
Sbjct: 81  VY-----ENKTDVILILELVAGGELFDFLA----------EKESLTEEEATEFLKQILNG 125

Query: 525 LKYLHHDCQPTTAHCDLKPSNVLLDHEMTA----HVADFGLAKLLPPAHLQTSSIGVKGT 580
              +++      AH DLKP N++L           + DFGLA  +   +   +   + GT
Sbjct: 126 ---VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGT 179

Query: 581 IGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRP 617
             ++AP E      + +  D++S G++   L++   P
Sbjct: 180 PEFVAP-EIVNYEPLGLEADMWSIGVITYILLSGASP 215

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (272), Expect = 8e-27
 Identities = 62/289 (21%), Positives = 105/289 (36%), Gaps = 25/289 (8%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNLVKILTVCSG 468
           G++G VYK        ++A+K + L     G   ++I E S L+ + H N+VK+L V   
Sbjct: 13  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-- 70

Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL 528
                ++   LV+EF+H    +              A   +      +    +   L + 
Sbjct: 71  ---HTENKLYLVFEFLHQDLKKFMDA---------SALTGIPLPLIKSYLFQLLQGLAFC 118

Query: 529 HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAE 588
           H        H DLKP N+L++ E    +ADFGLA+         +      T+ Y AP  
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV--VTLWYRAPEI 173

Query: 589 YGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTL 648
                  S   D++S G +  E++TR+      F G+  +    R        D V    
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRAL----FPGDSEIDQLFRIFRTLGTPDEVVWPG 229

Query: 649 LADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMT 697
           +    D   +  +  RQ     +         +        P  R++  
Sbjct: 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAK 278

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (267), Expect = 2e-26
 Identities = 49/263 (18%), Positives = 81/263 (30%), Gaps = 38/263 (14%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSS------IAECSALRNIR--HKNLVKI 462
           G FGSVY GI       +A+K +                   E   L+ +      ++++
Sbjct: 15  GGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL 74

Query: 463 LTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVA 522
           L        +  D   L+ E                    +     L      +    V 
Sbjct: 75  LDWF-----ERPDSFVLILERPEPVQDLFDF---------ITERGALQEELARSFFWQVL 120

Query: 523 CALKYLHHDCQPTTAHCDLKPSNVLLDHE-MTAHVADFGLAKLLPPAHLQTSSIGVKGTI 581
            A+++ H+       H D+K  N+L+D       + DFG   LL             GT 
Sbjct: 121 EAVRHCHNCGV---LHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD----FDGTR 173

Query: 582 GYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGN---MNLHNFARTVLPD 638
            Y  P           +  V+S GILL +++    P    FE +   +    F R  +  
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP----FEHDEEIIRGQVFFRQRVSS 229

Query: 639 HVMDIVDSTLLADDEDLTITSNQ 661
               ++    LA       T  +
Sbjct: 230 ECQHLIRW-CLALRPSDRPTFEE 251

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  106 bits (266), Expect = 3e-26
 Identities = 57/288 (19%), Positives = 104/288 (36%), Gaps = 27/288 (9%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNL--LHHGASKSSIAECSALRNIRHKNLVKILTVCSG 468
           G++G VYK   + G+   A+K + L     G   ++I E S L+ ++H N+VK+  V   
Sbjct: 13  GTYGVVYKAQNNYGE-TFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI-- 69

Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL 528
                     LV+E +     +                 C   L+ +     +   L  +
Sbjct: 70  ---HTKKRLVLVFEHLDQDLKKLLD-------------VCEGGLESVTAKSFLLQLLNGI 113

Query: 529 HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAE 588
            +       H DLKP N+L++ E    +ADFGLA+                T+ Y AP  
Sbjct: 114 AYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--VRKYTHEIVTLWYRAPDV 171

Query: 589 YGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHVMDIVDSTL 648
                + S   D++S G +  E++        + E +  L    R +   +  +  + T 
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRIFRILGTPNSKNWPNVTE 230

Query: 649 LADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNM 696
           L   +           ++ +  + E  I ++          P  R+  
Sbjct: 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLS---KMLKLDPNQRITA 275

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (265), Expect = 2e-25
 Identities = 47/225 (20%), Positives = 86/225 (38%), Gaps = 25/225 (11%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTVCSG 468
           G++GSV      +    +AVK L+        +K +  E   L++++H+N++ +L V + 
Sbjct: 29  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 88

Query: 469 VDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYL 528
                +     +   +    L   +             + L       +   +   LKY+
Sbjct: 89  ARSLEEFNDVYLVTHLMGADLNNIVK-----------CQKLTDDHVQFLIYQILRGLKYI 137

Query: 529 HHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAE 588
           H        H DLKPSN+ ++ +    + DFGLA+     H      G   T  Y AP  
Sbjct: 138 HSADII---HRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEI 189

Query: 589 YGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFAR 633
                  +   D++S G ++ EL+T +      F G  ++     
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTL----FPGTDHIDQLKL 230

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (263), Expect = 3e-25
 Identities = 53/294 (18%), Positives = 109/294 (37%), Gaps = 35/294 (11%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTVCSG 468
           G++G+V   +       +A+K L         +K +  E   L+++RH+N++ +L V + 
Sbjct: 29  GAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTP 88

Query: 469 VDYKGDDFK-ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
            +   D     LV  FM     +   H            + L   +   +   +   L+Y
Sbjct: 89  DETLDDFTDFYLVMPFMGTDLGKLMKH------------EKLGEDRIQFLVYQMLKGLRY 136

Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPA 587
           +H        H DLKP N+ ++ +    + DFGLA+        +   G   T  Y AP 
Sbjct: 137 IHAAGII---HRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWYRAPE 188

Query: 588 EYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV-----LPDHVMD 642
                   +   D++S G ++ E++T K      F+G+ +L      +      P   + 
Sbjct: 189 VILNWMRYTQTVDIWSVGCIMAEMITGKTL----FKGSDHLDQLKEIMKVTGTPPAEFVQ 244

Query: 643 IVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNM 696
            + S    +         ++   + + N     ++++       +   + R+  
Sbjct: 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLE---KMLVLDAEQRVTA 295

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  105 bits (262), Expect = 3e-25
 Identities = 50/266 (18%), Positives = 95/266 (35%), Gaps = 27/266 (10%)

Query: 402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIR-HKNLV 460
           +  +  +  G +  V++ I       + VK+L  +     K    E   L N+R   N++
Sbjct: 37  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNII 93

Query: 461 KILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAID 520
            +  +            ALV+E ++N   ++                 L          +
Sbjct: 94  TLADIV---KDPVSRTPALVFEHVNNTDFKQLYQT-------------LTDYDIRFYMYE 137

Query: 521 VACALKYLHHDCQPTTAHCDLKPSNVLLDHE-MTAHVADFGLAKLLPPAHLQTSSIGVKG 579
           +  AL Y H        H D+KP NV++DHE     + D+GLA+   P       +    
Sbjct: 138 ILKALDYCHSMGIM---HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV---A 191

Query: 580 TIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDH 639
           +  +  P           + D++S G +L  ++ RK P     +    L   A+ +  + 
Sbjct: 192 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 251

Query: 640 VMDIVDSTLLADDEDLTITSNQRQRQ 665
           + D +D   +  D        +  R+
Sbjct: 252 LYDYIDKYNIELDPRFNDILGRHSRK 277

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (254), Expect = 4e-24
 Identities = 41/210 (19%), Positives = 74/210 (35%), Gaps = 24/210 (11%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLN---LLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           G+FG V            A+K+L    ++       ++ E   L+N RH  L  +     
Sbjct: 16  GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF- 74

Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
               +  D    V E+ + G L   L             +     +      ++  AL  
Sbjct: 75  ----QTHDRLCFVMEYANGGELFFHLSR----------ERVFTEERARFYGAEIVSAL-- 118

Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPA 587
             +       + D+K  N++LD +    + DFGL K         +     GT  Y+AP 
Sbjct: 119 -EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPE 175

Query: 588 EYGLGSEVSINGDVYSYGILLLELMTRKRP 617
                ++     D +  G+++ E+M  + P
Sbjct: 176 VL-EDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (252), Expect = 7e-24
 Identities = 50/228 (21%), Positives = 91/228 (39%), Gaps = 27/228 (11%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLN--LLHHGASKSSIAECSALRNIRHKNLVKILTVCSG 468
           G+ G V           +A+K L+    +   +K +  E   ++ + HKN++ +L V + 
Sbjct: 28  GAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP 87

Query: 469 VDYKGDDFK-ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
                +     LV E M     +     +                +   +   + C +K+
Sbjct: 88  QKTLEEFQDVYLVMELMDANLCQVIQMELDHE-------------RMSYLLYQMLCGIKH 134

Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPA 587
           LH        H DLKPSN+++  + T  + DFGLA+    + + T  +    T  Y AP 
Sbjct: 135 LHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTRYYRAP- 187

Query: 588 EYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV 635
           E  LG     N D++S G ++ E++  K      F G   +  + + +
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMVRHKIL----FPGRDYIDQWNKVI 231

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 99.9 bits (248), Expect = 1e-23
 Identities = 34/226 (15%), Positives = 72/226 (31%), Gaps = 30/226 (13%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           GSFG +++G        +A+K         +     E    + +     +  +       
Sbjct: 16  GSFGVIFEGTNLLNNQQVAIKFEP--RRSDAPQLRDEYRTYKLLAGCTGIPNV-----YY 68

Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH 530
           +  +    ++   +   SLE+ L             +  +       A  +   ++ +H 
Sbjct: 69  FGQEGLHNVLVIDLLGPSLEDLLD---------LCGRKFSVKTVAMAAKQMLARVQSIHE 119

Query: 531 DCQPTTAHCDLKPSNVLLDHEMTAH-----VADFGLAKLLPPAHLQTSSI-----GVKGT 580
                  + D+KP N L+    + +     V DFG+ K       +          + GT
Sbjct: 120 KS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176

Query: 581 IGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNM 626
             Y++     LG E S   D+ + G + +  +    P   +     
Sbjct: 177 ARYMSI-NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN 221

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 97.6 bits (242), Expect = 1e-22
 Identities = 46/210 (21%), Positives = 78/210 (37%), Gaps = 27/210 (12%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLN---LLHHGASKSSIAECSALRNIRHKNLVKILTVCS 467
           GSFG V      E     A+K+L+   ++     + ++ E   L+ +    LVK+     
Sbjct: 52  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111

Query: 468 GVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKY 527
                       V E++  G +   L                +       A  +    +Y
Sbjct: 112 DNSNLYM-----VMEYVAGGEMFSHLR----------RIGRFSEPHARFYAAQIVLTFEY 156

Query: 528 LHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPA 587
           LH        + DLKP N+L+D +    V DFG AK      ++  +  + GT   +AP 
Sbjct: 157 LHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAP- 207

Query: 588 EYGLGSEVSINGDVYSYGILLLELMTRKRP 617
           E  L    +   D ++ G+L+ E+     P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.0 bits (237), Expect = 2e-22
 Identities = 51/261 (19%), Positives = 83/261 (31%), Gaps = 5/261 (1%)

Query: 75  QNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLH 134
                  + + ++ N    +               + ++        A  G  +  Q   
Sbjct: 28  VGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDL 87

Query: 135 MWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPS 194
             + QL          L  L TL ++   L    P     L  L  LYL +N LQ     
Sbjct: 88  SDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDD 147

Query: 195 SLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEIL 254
           +     +LT + L  N +S         L SL     L +N++    P     L  L  L
Sbjct: 148 TFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRL-LLHQNRVAHVHPHAFRDLGRLMTL 206

Query: 255 FISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIP 314
           ++  N L       L     L+ L+L  N +             L+    S + +   +P
Sbjct: 207 YLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLP 265

Query: 315 KFLVELQLVQNLNLSYNDLEG 335
           + L    L     L+ NDL+G
Sbjct: 266 QRLAGRDL---KRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 80.2 bits (196), Expect = 4e-17
 Identities = 62/311 (19%), Positives = 101/311 (32%), Gaps = 46/311 (14%)

Query: 1   SDVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGE 60
              G+  V  GIP            + L  N+I+ V  +S      L +  + SN L   
Sbjct: 19  PQQGLQAVPVGIP-------AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARI 71

Query: 61  VPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSI 120
                               L+ LD+++N     +     +    L TL  +   +    
Sbjct: 72  D----------AAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELG 121

Query: 121 PAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQ 180
           P        LQ L++ DN L         +L NL  L ++ N++S     +   L  L +
Sbjct: 122 PGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDR 181

Query: 181 LYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGS 240
           L L +N +    P +      L T+ L  NNLS      L  L +L   L L+ N  V  
Sbjct: 182 LLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQY-LRLNDNPWVCD 240

Query: 241 LPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLR 300
                                 C           L++ +   +     +P     L G  
Sbjct: 241 ----------------------CRARPLWA---WLQKFRGSSSEVPCSLP---QRLAGRD 272

Query: 301 VLDLSQNNISG 311
           +  L+ N++ G
Sbjct: 273 LKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 70.6 bits (171), Expect = 6e-14
 Identities = 54/271 (19%), Positives = 91/271 (33%), Gaps = 6/271 (2%)

Query: 96  PGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLV 155
             C+C     + T      +  +++P GI      Q + +  N++S   + +    +NL 
Sbjct: 4   GACVCYNEPKVTTSC--PQQGLQAVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLT 59

Query: 156 TLAINTNKLSGNIPPSIGNLKKLLQ-LYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSG 214
            L +++N L+     +   L  L Q        L+   P++      L T++L    L  
Sbjct: 60  ILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQE 119

Query: 215 TIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIK 274
             P     L +L     L  N L          L NL  LF+  N +             
Sbjct: 120 LGPGLFRGLAALQYL-YLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHS 178

Query: 275 LEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLE 334
           L++L L  N      P +   L  L  L L  NN+S    + L  L+ +Q L L+ N   
Sbjct: 179 LDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238

Query: 335 GVIPTEGVFKNASAISVFGNSKLCGGIPEFQ 365
                  ++          +   C       
Sbjct: 239 CDCRARPLWAWLQKFRGSSSEVPCSLPQRLA 269

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 93.6 bits (231), Expect = 4e-21
 Identities = 38/209 (18%), Positives = 75/209 (35%), Gaps = 6/209 (2%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD 470
           G F +V+        T +A+K++       ++++  E   L+ +   +  K  ++ +   
Sbjct: 24  GHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHI 82

Query: 471 YKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRI-NIAIDVACALKYLH 529
            K  D          +  +   +   +      +       L  +  I+  +   L Y+H
Sbjct: 83  LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH 142

Query: 530 HDCQPTTAHCDLKPSNVLLDHE-MTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAE 588
             C     H D+KP NVL++      ++    +A L               T  Y +P E
Sbjct: 143 RRCGI--IHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSP-E 199

Query: 589 YGLGSEVSINGDVYSYGILLLELMTRKRP 617
             LG+      D++S   L+ EL+T    
Sbjct: 200 VLLGAPWGCGADIWSTACLIFELITGDFL 228

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 93.1 bits (230), Expect = 7e-21
 Identities = 68/336 (20%), Positives = 118/336 (35%), Gaps = 41/336 (12%)

Query: 20  LPNLLFLSLGFNQITGVIPSS--------MFNASKLEVFQVTSNNLTGEVPSEFGKATKA 71
           L NL  ++   NQ+T + P          + N +++      +N       + F      
Sbjct: 65  LNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITD 124

Query: 72  YCVQNCNQHLKHLDINNNNFGGLLPGCICN----------------FSITLETLIFNSNK 115
                   +L  L++++N    +                        +        + + 
Sbjct: 125 IDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISS 184

Query: 116 IFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNL 175
              S  + + K  NL++L   +NQ+S      I    NL  L++N N+L      ++ +L
Sbjct: 185 NKVSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASL 240

Query: 176 KKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRN 235
             L  L L  N +    P  L     LT + L  N +S   P     L  L+   +L  N
Sbjct: 241 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP-----LAGLTALTNLELN 293

Query: 236 QLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSS 295
           +      + +  L NL  L +  N +    +S + S  KL++L    N        SL++
Sbjct: 294 ENQLEDISPISNLKNLTYLTLYFNNISD--ISPVSSLTKLQRLFFANNKVSDVS--SLAN 349

Query: 296 LRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYN 331
           L  +  L    N IS   P  L  L  +  L L+  
Sbjct: 350 LTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 79.3 bits (194), Expect = 2e-16
 Identities = 53/218 (24%), Positives = 84/218 (38%), Gaps = 28/218 (12%)

Query: 18  FTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNC 77
             L NL  L    NQI+ + P  +   + L+   +  N L           T        
Sbjct: 194 AKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLT-------- 241

Query: 78  NQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWD 137
             +L  LD+ NN    L P         L  L   +N+I    P  +     L  L + +
Sbjct: 242 --NLTDLDLANNQISNLAPLSGLT---KLTELKLGANQISNISP--LAGLTALTNLELNE 294

Query: 138 NQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLG 197
           NQ        I  L+NL  L +  N +S   P  + +L KL +L+   N +  S  SSL 
Sbjct: 295 NQ--LEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKV--SDVSSLA 348

Query: 198 QCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRN 235
              ++  ++  +N +S   P  L +LT ++  L L+  
Sbjct: 349 NLTNINWLSAGHNQISDLTP--LANLTRITQ-LGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 52.7 bits (125), Expect = 8e-08
 Identities = 58/249 (23%), Positives = 100/249 (40%), Gaps = 22/249 (8%)

Query: 105 TLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKL 164
            + TL  +   I +SI  G+    NL  ++  +NQL+      +  L  LV + +N N++
Sbjct: 45  QVTTLQADRLGI-KSID-GVEYLNNLTQINFSNNQLTD--ITPLKNLTKLVDILMNNNQI 100

Query: 165 SGNIPPSIGNLKKLLQLYLIENFLQVSIP------------SSLGQCQSLTTINLSYNNL 212
           +   P +       L L+  +      +             +++    +L+ +       
Sbjct: 101 ADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLS 160

Query: 213 SGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSC 272
            G     L  L +L+    L  +    S  + + KL NLE L  + N +    ++ LG  
Sbjct: 161 FGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISD--ITPLGIL 218

Query: 273 IKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYND 332
             L++L L GN  +     +L+SL  L  LDL+ N IS   P  L  L  +  L L  N 
Sbjct: 219 TNLDELSLNGNQLKDIG--TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQ 274

Query: 333 LEGVIPTEG 341
           +  + P  G
Sbjct: 275 ISNISPLAG 283

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.1 bits (95), Expect = 3e-04
 Identities = 17/76 (22%), Positives = 32/76 (42%), Gaps = 6/76 (7%)

Query: 151 LQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYN 210
           L   +   +    ++  +  +  +L ++  L      ++ SI   +    +LT IN S N
Sbjct: 21  LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNN 76

Query: 211 NLSGTIPPQLMDLTSL 226
            L+   P  L +LT L
Sbjct: 77  QLTDITP--LKNLTKL 90

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.1 bits (225), Expect = 1e-20
 Identities = 44/230 (19%), Positives = 79/230 (34%), Gaps = 28/230 (12%)

Query: 411 GSFGSVYKGILDEGK---TIIAVKVLNLLH----HGASKSSIAECSALRNIRHKNLVKIL 463
           G++G V+      G     + A+KVL           ++ +  E   L +IR    +  L
Sbjct: 35  GAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTL 94

Query: 464 TVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVAC 523
                  ++ +    L+ ++++ G L   L                       + I V  
Sbjct: 95  HYA----FQTETKLHLILDYINGGELFTHLSQRER-------------FTEHEVQIYVGE 137

Query: 524 ALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGY 583
            +  L H  +    + D+K  N+LLD      + DFGL+K       + +          
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197

Query: 584 IAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFAR 633
                 G  S      D +S G+L+ EL+T   P    F  +   ++ A 
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP----FTVDGEKNSQAE 243

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 86.7 bits (213), Expect = 3e-19
 Identities = 72/291 (24%), Positives = 112/291 (38%), Gaps = 30/291 (10%)

Query: 80  HLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDN- 138
            + +LD++  N     P                       IP+ +     L  L++    
Sbjct: 51  RVNNLDLSGLNLPKPYP-----------------------IPSSLANLPYLNFLYIGGIN 87

Query: 139 QLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQ 198
            L G I PAI +L  L  L I    +SG IP  +  +K L+ L    N L  ++P S+  
Sbjct: 88  NLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISS 147

Query: 199 CQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISR 258
             +L  I    N +SG IP      + L   + +SRN+L G +P     L    +     
Sbjct: 148 LPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRN 207

Query: 259 NMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLV 318
            +     +         +      +L      + LS       LDL  N I G +P+ L 
Sbjct: 208 MLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNL--NGLDLRNNRIYGTLPQGLT 265

Query: 319 ELQLVQNLNLSYNDLEGVIPTEGVFKNASAISVFGNSKLCGGIPEFQLPIC 369
           +L+ + +LN+S+N+L G IP  G  +     +   N  LCG      LP C
Sbjct: 266 QLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCG----SPLPAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 53.2 bits (126), Expect = 4e-08
 Identities = 36/157 (22%), Positives = 53/157 (33%), Gaps = 14/157 (8%)

Query: 28  LGFNQITGVIPSSMFNASKLEVFQVTSNN------------LTGEVPSEFGKATKAYCVQ 75
              N+I+G IP S  + SKL      S N            L            +     
Sbjct: 156 FDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASV 215

Query: 76  NCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHM 135
                     I+               S  L  L   +N+I+ ++P G+ +   L +L++
Sbjct: 216 LFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNV 275

Query: 136 WDNQLSGTISPAIGELQNLVTLAINTNK-LSGNIPPS 171
             N L G I P  G LQ     A   NK L G+  P+
Sbjct: 276 SFNNLCGEI-PQGGNLQRFDVSAYANNKCLCGSPLPA 311

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 50.5 bits (119), Expect = 3e-07
 Identities = 24/80 (30%), Positives = 30/80 (37%), Gaps = 13/80 (16%)

Query: 21  PNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQH 80
            NL  L L  N+I G +P  +     L    V+ NNL GE+P + G            Q 
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGN----------LQR 292

Query: 81  LKHLDINNNNF--GGLLPGC 98
                  NN    G  LP C
Sbjct: 293 FDVSAYANNKCLCGSPLPAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 42.4 bits (98), Expect = 1e-04
 Identities = 38/123 (30%), Positives = 52/123 (42%), Gaps = 2/123 (1%)

Query: 194 SSLGQCQSLTTINLSYNNLSG--TIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINL 251
            +  Q   +  ++LS  NL     IP  L +L  L+       N LVG +P  + KL  L
Sbjct: 44  DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103

Query: 252 EILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISG 311
             L+I+   +   I   L     L  L    N   G +P S+SSL  L  +    N ISG
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163

Query: 312 EIP 314
            IP
Sbjct: 164 AIP 166

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 42.0 bits (97), Expect = 2e-04
 Identities = 16/57 (28%), Positives = 24/57 (42%), Gaps = 2/57 (3%)

Query: 6   NRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVP 62
           NR+ G +P      L  L  L++ FN + G IP    N  + +V    +N      P
Sbjct: 254 NRIYGTLPQGLT-QLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGSP 308

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 86.2 bits (212), Expect = 5e-19
 Identities = 55/312 (17%), Positives = 109/312 (34%), Gaps = 32/312 (10%)

Query: 1   SDVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGE 60
           SD+G+ +V   +P       P+   L L  N+IT +      N   L    + +N ++  
Sbjct: 18  SDLGLEKVPKDLP-------PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKI 70

Query: 61  VPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSI 120
            P  F               L+ L ++ N     LP  +      L        K+ +S+
Sbjct: 71  SPGAFAPLV----------KLERLYLSKNQLKE-LPEKMPKTLQELRVHENEITKVRKSV 119

Query: 121 PAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQ 180
             G+ + I ++ L     + SG  + A   ++ L  + I    ++  IP  +     L +
Sbjct: 120 FNGLNQMIVVE-LGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTE 175

Query: 181 LYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGS 240
           L+L  N +     +SL    +L  + LS+N++S      L +   L        N  +  
Sbjct: 176 LHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHL--NNNKLVK 233

Query: 241 LPTEVGKLINLEILFISRNMLEC------EILSTLGSCIKLEQLKLGGNLFQ--GPIPLS 292
           +P  +     ++++++  N +                      + L  N  Q     P +
Sbjct: 234 VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPST 293

Query: 293 LSSLRGLRVLDL 304
              +     + L
Sbjct: 294 FRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 84.3 bits (207), Expect = 2e-18
 Identities = 58/286 (20%), Positives = 104/286 (36%), Gaps = 12/286 (4%)

Query: 96  PGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLV 155
             C C+       ++  S+     +P  +    +   L + +N+++         L+NL 
Sbjct: 6   FRCQCH-----LRVVQCSDLGLEKVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLH 58

Query: 156 TLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGT 215
           TL +  NK+S   P +   L KL +LYL +N L+          Q L         +  +
Sbjct: 59  TLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKS 118

Query: 216 IPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKL 275
           +   L  +  +   L  +  +  G        +  L  + I+   +         S   L
Sbjct: 119 VFNGLNQMIVVE--LGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPS---L 173

Query: 276 EQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEG 335
            +L L GN        SL  L  L  L LS N+IS      L     ++ L+L+ N L  
Sbjct: 174 TELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK 233

Query: 336 VIPTEGVFKNASAISVFGNSKLCGGIPEFQLPICGLEKSKHKRLTI 381
           V       K    + +  N+    G  +F  P    +K+ +  +++
Sbjct: 234 VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSL 279

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 65.6 bits (159), Expect = 8e-13
 Identities = 19/163 (11%), Positives = 39/163 (23%), Gaps = 33/163 (20%)

Query: 411 GSFGSVYKGILDEGKTIIAVKVLNL----------LHHGASKSSIAECSALRNIRHKNLV 460
           G   +V+    ++      VK   +                               + L 
Sbjct: 11  GKESAVFNCYSEKFG-ECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQ 69

Query: 461 KILTVCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAID 520
           K+  +     Y  +   A++ E +                        +       +   
Sbjct: 70  KLQGLAVPKVYAWEGN-AVLMELIDAKE-----------------LYRVRVENPDEVLDM 111

Query: 521 VACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGLAK 563
           +   +   +H       H DL   NVL+  E    + DF  + 
Sbjct: 112 ILEEVAKFYHRG---IVHGDLSQYNVLV-SEEGIWIIDFPQSV 150

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 53.6 bits (128), Expect = 3e-09
 Identities = 32/125 (25%), Positives = 59/125 (47%), Gaps = 7/125 (5%)

Query: 204 TINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLEC 263
            ++L++ +L  T+   L  L  ++  LDLS N+L    P  +  L  LE+L  S N    
Sbjct: 2   VLHLAHKDL--TVLCHLEQLLLVTH-LDLSHNRLRALPP-ALAALRCLEVLQASDNA--L 55

Query: 264 EILSTLGSCIKLEQLKLGGN-LFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQL 322
           E +  + +  +L++L L  N L Q      L S   L +L+L  N++  E        ++
Sbjct: 56  ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115

Query: 323 VQNLN 327
           + +++
Sbjct: 116 LPSVS 120

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 47.8 bits (113), Expect = 3e-07
 Identities = 23/108 (21%), Positives = 43/108 (39%), Gaps = 6/108 (5%)

Query: 108 TLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGN 167
            L      +  ++   + + + +  L +  N+L     PA+  L+ L    +  +  +  
Sbjct: 2   VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALP-PALAALRCLEV--LQASDNALE 56

Query: 168 IPPSIGNLKKLLQLYLIENFLQ-VSIPSSLGQCQSLTTINLSYNNLSG 214
               + NL +L +L L  N LQ  +    L  C  L  +NL  N+L  
Sbjct: 57  NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 44.7 bits (105), Expect = 3e-06
 Identities = 24/108 (22%), Positives = 42/108 (38%), Gaps = 6/108 (5%)

Query: 230 LDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPI 289
           L L+   L  ++   + +L+ +  L +S N L       L +   LE L+   +      
Sbjct: 3   LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALP-PALAALRCLEVLQ--ASDNALEN 57

Query: 290 PLSLSSLRGLRVLDLSQNNI-SGEIPKFLVELQLVQNLNLSYNDLEGV 336
              +++L  L+ L L  N +      + LV    +  LNL  N L   
Sbjct: 58  VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.9 bits (133), Expect = 4e-09
 Identities = 45/220 (20%), Positives = 78/220 (35%), Gaps = 20/220 (9%)

Query: 44  ASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFS 103
           AS LEV      NLT  +P +  K                L ++ N         +  ++
Sbjct: 10  ASHLEV-NCDKRNLT-ALPPDLPK------------DTTILHLSENLLYTFSLATLMPYT 55

Query: 104 ITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNK 163
             L  L  +  ++ +         + +       +    ++      L  L  L ++ N+
Sbjct: 56  -RLTQLNLDRAELTKLQV---DGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNR 111

Query: 164 LSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDL 223
           L+     ++  L +L +LYL  N L+   P  L     L  ++L+ NNL+      L  L
Sbjct: 112 LTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGL 171

Query: 224 TSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLEC 263
            +L   L L  N L  ++P        L   F+  N   C
Sbjct: 172 ENLDT-LLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.5 bits (132), Expect = 5e-09
 Identities = 30/202 (14%), Positives = 57/202 (28%), Gaps = 20/202 (9%)

Query: 12  IPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKA 71
           +P D      +   L L  N +     +++   ++L    +                   
Sbjct: 25  LPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE--------------- 66

Query: 72  YCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQ 131
                 +  L  L   + +   L    +   ++   T++  S     S+P G  + +   
Sbjct: 67  LTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGEL 126

Query: 132 TLHMWDNQLSGTISPAIGELQNLVTLAI-NTNKLSGNIPPSIGNLKKLLQLYLIENFLQV 190
                      T+ P +      +       N L+      +  L+ L  L L EN L  
Sbjct: 127 QELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY- 185

Query: 191 SIPSSLGQCQSLTTINLSYNNL 212
           +IP        L    L  N  
Sbjct: 186 TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.5 bits (119), Expect = 2e-07
 Identities = 41/238 (17%), Positives = 69/238 (28%), Gaps = 32/238 (13%)

Query: 96  PGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLV 155
           P C  +   +   +  +   +  ++P  + K  +   LH+ +N L       +     L 
Sbjct: 2   PICEVSKVASHLEVNCDKRNL-TALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLT 58

Query: 156 TLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGT 215
            L      L       +     L  L  ++          L          L  +     
Sbjct: 59  QL-----NLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSF---- 109

Query: 216 IPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKL 275
                              N+L       +  L  L+ L++  N L+      L    KL
Sbjct: 110 -------------------NRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKL 150

Query: 276 EQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDL 333
           E+L L  N         L+ L  L  L L +N++   IPK      L+    L  N  
Sbjct: 151 EKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 52.9 bits (125), Expect = 2e-08
 Identities = 34/194 (17%), Positives = 64/194 (32%), Gaps = 18/194 (9%)

Query: 53  TSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFN 112
           T   L  E+P +               H   L +N+N  G +    +      L  L   
Sbjct: 16  TGRGLK-EIPRDIP------------LHTTELLLNDNELGRISSDGLFGRLPHLVKLELK 62

Query: 113 SNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSI 172
            N++    P       ++Q L + +N++    +     L  L TL +  N++S  +P S 
Sbjct: 63  RNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSF 122

Query: 173 GNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDL 232
            +L   L    + +             + L   +L+        P ++ D+       DL
Sbjct: 123 EHLNS-LTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKVRDVQI----KDL 177

Query: 233 SRNQLVGSLPTEVG 246
             ++   S     G
Sbjct: 178 PHSEFKCSSENSEG 191

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 37.9 bits (86), Expect = 0.002
 Identities = 40/214 (18%), Positives = 72/214 (33%), Gaps = 37/214 (17%)

Query: 96  PGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAI-GELQNL 154
             C C       T +  + +  + IP  I   ++   L + DN+L    S  + G L +L
Sbjct: 4   AMCHCE-----GTTVDCTGRGLKEIPRDI--PLHTTELLLNDNELGRISSDGLFGRLPHL 56

Query: 155 VTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSG 214
           V L +  N+L+G  P +      + +L L EN ++            L T+NL  N +S 
Sbjct: 57  VKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISC 116

Query: 215 TIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIK 274
            +P     L SL+     S             + +      ++     C           
Sbjct: 117 VMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRK--KSLNGGAARCG---------- 164

Query: 275 LEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNN 308
                            + S +R +++ DL  + 
Sbjct: 165 -----------------APSKVRDVQIKDLPHSE 181

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.7 bits (124), Expect = 1e-07
 Identities = 12/92 (13%), Positives = 31/92 (33%), Gaps = 5/92 (5%)

Query: 249 INLEILFISRNMLECEILSTLGSCIK-LEQLKLGGNLFQG----PIPLSLSSLRGLRVLD 303
           ++++ L I    L     + L   ++  + ++L            I  +L     L  L+
Sbjct: 2   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61

Query: 304 LSQNNISGEIPKFLVELQLVQNLNLSYNDLEG 335
           L  N +       +++     +  +    L+ 
Sbjct: 62  LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.5 bits (108), Expect = 9e-06
 Identities = 15/97 (15%), Positives = 32/97 (32%), Gaps = 21/97 (21%)

Query: 128 INLQTLHMWDNQLSGT-ISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIEN 186
           +++Q+L +   +LS    +  +  LQ    + ++   L+      I              
Sbjct: 2   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDI-------------- 47

Query: 187 FLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDL 223
                  S+L    +L  +NL  N L       ++  
Sbjct: 48  ------SSALRVNPALAELNLRSNELGDVGVHCVLQG 78

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.1 bits (107), Expect = 1e-05
 Identities = 17/81 (20%), Positives = 28/81 (34%), Gaps = 9/81 (11%)

Query: 250 NLEILFISRNMLECE----ILSTLGSCIKLEQLKLGGNLFQGPIPLSLSS-----LRGLR 300
            L +L+++   +       + +TL +   L +L L  N       L L          L 
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429

Query: 301 VLDLSQNNISGEIPKFLVELQ 321
            L L     S E+   L  L+
Sbjct: 430 QLVLYDIYWSEEMEDRLQALE 450

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.1 bits (107), Expect = 1e-05
 Identities = 12/85 (14%), Positives = 29/85 (34%), Gaps = 6/85 (7%)

Query: 201 SLTTINLSYNNLSGTIPPQLMD-LTSLSVGLDLSRNQL----VGSLPTEVGKLINLEILF 255
            + ++++    LS     +L+  L    V + L    L       + + +     L  L 
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQV-VRLDDCGLTEARCKDISSALRVNPALAELN 61

Query: 256 ISRNMLECEILSTLGSCIKLEQLKL 280
           +  N L    +  +   ++    K+
Sbjct: 62  LRSNELGDVGVHCVLQGLQTPSCKI 86

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.2 bits (102), Expect = 5e-05
 Identities = 17/77 (22%), Positives = 24/77 (31%), Gaps = 9/77 (11%)

Query: 271 SCIKLEQLKLGGNLFQG----PIPLSLSSLRGLRVLDLSQNNISGEIPKFLVE-----LQ 321
               L  L L            +  +L +   LR LDLS N +       LVE       
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 322 LVQNLNLSYNDLEGVIP 338
           L++ L L        + 
Sbjct: 427 LLEQLVLYDIYWSEEME 443

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.4 bits (100), Expect = 7e-05
 Identities = 13/98 (13%), Positives = 35/98 (35%), Gaps = 11/98 (11%)

Query: 22  NLLFLSLGFNQITGVIPSSMFNA-SKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQH 80
           ++  L +   +++    + +     + +V ++    LT     +   A +       N  
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALR------VNPA 56

Query: 81  LKHLDINNNNFGGLLPGCIC----NFSITLETLIFNSN 114
           L  L++ +N  G +   C+       S  ++ L   + 
Sbjct: 57  LAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.3 bits (97), Expect = 2e-04
 Identities = 10/91 (10%), Positives = 26/91 (28%), Gaps = 4/91 (4%)

Query: 81  LKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKI----FRSIPAGIGKFINLQTLHMW 136
           ++ LDI            +       + +  +   +     + I + +     L  L++ 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 137 DNQLSGTISPAIGELQNLVTLAINTNKLSGN 167
            N+L       + +     +  I    L   
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.9 bits (96), Expect = 2e-04
 Identities = 18/94 (19%), Positives = 33/94 (35%), Gaps = 14/94 (14%)

Query: 174 NLKKLLQLYLIENFLQ----VSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMD-----LT 224
               L  L+L +  +      S+ ++L    SL  ++LS N L      QL++       
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 225 SLSVGLDLSRNQLVGSLPTEVGKLI----NLEIL 254
            L   L L        +   +  L     +L ++
Sbjct: 427 LLEQ-LVLYDIYWSEEMEDRLQALEKDKPSLRVI 459

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.1 bits (94), Expect = 4e-04
 Identities = 9/80 (11%), Positives = 27/80 (33%), Gaps = 9/80 (11%)

Query: 21  PNLLFLSLGFNQITGV----IPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQN 76
             L  L L    ++      + +++     L    +++N L      +  ++     V+ 
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVES-----VRQ 423

Query: 77  CNQHLKHLDINNNNFGGLLP 96
               L+ L + +  +   + 
Sbjct: 424 PGCLLEQLVLYDIYWSEEME 443

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.6 bits (90), Expect = 0.001
 Identities = 19/117 (16%), Positives = 33/117 (28%), Gaps = 11/117 (9%)

Query: 72  YCVQNCNQHLKHLDINNNNFGGLLPGCICNFS--ITLETLIFNSNKI----FRSIPAGIG 125
              QN       +  N     G+   C         L  L      +      S+ A + 
Sbjct: 335 VLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLL 394

Query: 126 KFINLQTLHMWDNQLSGTISPAIGE-----LQNLVTLAINTNKLSGNIPPSIGNLKK 177
              +L+ L + +N L       + E        L  L +     S  +   +  L+K
Sbjct: 395 ANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEK 451

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.2 bits (89), Expect = 0.001
 Identities = 15/99 (15%), Positives = 29/99 (29%), Gaps = 9/99 (9%)

Query: 134 HMWDNQLSGTISPAIGELQNLVTLAINTNKLSGN----IPPSIGNLKKLLQLYLIENFLQ 189
            + D  +             L  L +    +S +    +  ++     L +L L  N L 
Sbjct: 351 RLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 410

Query: 190 VSIPSSLGQ-----CQSLTTINLSYNNLSGTIPPQLMDL 223
            +    L +        L  + L     S  +  +L  L
Sbjct: 411 DAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.2 bits (89), Expect = 0.002
 Identities = 21/142 (14%), Positives = 39/142 (27%), Gaps = 9/142 (6%)

Query: 2   DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGV----IPSSMFNASKLEVFQVTSNNL 57
           D+    +      +    L     + L    +T      I S++     L    + SN L
Sbjct: 8   DIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNEL 67

Query: 58  TGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIF 117
                    +      +Q  +  ++ L + N    G   G + +   TL TL        
Sbjct: 68  GDVGVHCVLQG-----LQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDN 122

Query: 118 RSIPAGIGKFINLQTLHMWDNQ 139
               AG+              +
Sbjct: 123 LLGDAGLQLLCEGLLDPQCRLE 144

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 49.6 bits (117), Expect = 3e-07
 Identities = 32/218 (14%), Positives = 62/218 (28%), Gaps = 9/218 (4%)

Query: 20  LPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTG-EVPSEFGKATKAYCVQNCN 78
           L N + ++ G + +T  +  +  +   +         +T  E               N  
Sbjct: 18  LANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTIEGVQYLNNLIGLELKDNQI 75

Query: 79  QHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDN 138
             L  L          L G        +  L         S        +   +      
Sbjct: 76  TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLY 135

Query: 139 QLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQ 198
                I+             ++      +    + NL KL  L   +N +    P  L  
Sbjct: 136 LDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LAS 193

Query: 199 CQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQ 236
             +L  ++L  N +S   P  L + ++L + + L+ NQ
Sbjct: 194 LPNLIEVHLKNNQISDVSP--LANTSNLFI-VTLT-NQ 227

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.8 bits (107), Expect = 5e-06
 Identities = 41/216 (18%), Positives = 77/216 (35%), Gaps = 21/216 (9%)

Query: 127 FINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIEN 186
             N   +    + ++ T++ A  +L  + TL+     ++  I   +  L  L+ L L +N
Sbjct: 18  LANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDN 73

Query: 187 FLQVSIPSS------LGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGS 240
            +    P          +       N+S      +I    +  T ++    L+    +  
Sbjct: 74  QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133

Query: 241 LPTEVGKLINLEILFI-------SRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSL 293
           L  ++ ++ N+  L         S    +   L+ L +  KL  LK   N      PL+ 
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPLA- 192

Query: 294 SSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLS 329
            SL  L  + L  N IS   P  L     +  + L+
Sbjct: 193 -SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.9 bits (115), Expect = 8e-07
 Identities = 23/102 (22%), Positives = 44/102 (43%), Gaps = 4/102 (3%)

Query: 203 TTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLE 262
            T++L+  NL   +  +L+    ++      R+ +   L  E      ++ + +S +++E
Sbjct: 3   QTLDLTGKNLHPDVTGRLLSQGVIA--FRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIE 59

Query: 263 CEILST-LGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLD 303
              L   L  C KL+ L L G     PI  +L+    L  L+
Sbjct: 60  VSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 101

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.9 bits (107), Expect = 9e-06
 Identities = 36/239 (15%), Positives = 75/239 (31%), Gaps = 20/239 (8%)

Query: 77  CNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMW 136
               ++H+D++N+         I +    L+ L     ++   I   + K  NL  L++ 
Sbjct: 44  SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLS 103

Query: 137 DNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSL 196
                                +    +   +    +  L         E  +QV++    
Sbjct: 104 GCSG----------------FSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVS 147

Query: 197 GQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFI 256
                L       N     +   +    +L          L      E  +L  L+ L +
Sbjct: 148 ETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSL 207

Query: 257 SR-NMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIP 314
           SR   +  E L  LG    L+ L++ G +  G + L   +L  L++   + ++ +    
Sbjct: 208 SRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQI---NCSHFTTIAR 263

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.3 bits (90), Expect = 0.001
 Identities = 21/110 (19%), Positives = 38/110 (34%), Gaps = 27/110 (24%)

Query: 230 LDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPI 289
           LDL+   L    P   G+L++  ++                        +   +    P+
Sbjct: 5   LDLTGKNL---HPDVTGRLLSQGVIA----------------------FRCPRSFMDQPL 39

Query: 290 PLSLSSLRGLRVLDLSQNNISGE-IPKFLVELQLVQNLNLSYNDLEGVIP 338
               S  R ++ +DLS + I    +   L +   +QNL+L    L   I 
Sbjct: 40  AEHFSPFR-VQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIV 88

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 47.5 bits (111), Expect = 4e-06
 Identities = 22/92 (23%), Positives = 31/92 (33%), Gaps = 11/92 (11%)

Query: 182 YLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSL 241
               N     I S      SL  +N+S N L   +P     L      L  S N L   +
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLER----LIASFNHL-AEV 319

Query: 242 PTEVGKLINLEILFISRNMLEC--EILSTLGS 271
           P       NL+ L +  N L    +I  ++  
Sbjct: 320 PELPQ---NLKQLHVEYNPLREFPDIPESVED 348

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 46.7 bits (109), Expect = 6e-06
 Identities = 22/131 (16%), Positives = 47/131 (35%), Gaps = 9/131 (6%)

Query: 72  YCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQ 131
                 N      ++  +     +   I +    L   ++  N     I +      +L+
Sbjct: 228 ALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLE 287

Query: 132 TLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVS 191
            L++ +N+L   +      L+ L+    + N L+  +P    NLK+   L++  N L+  
Sbjct: 288 ELNVSNNKLI-ELPALPPRLERLI---ASFNHLA-EVPELPQNLKQ---LHVEYNPLR-E 338

Query: 192 IPSSLGQCQSL 202
            P      + L
Sbjct: 339 FPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 45.2 bits (105), Expect = 2e-05
 Identities = 50/312 (16%), Positives = 92/312 (29%), Gaps = 26/312 (8%)

Query: 20  LPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQ 79
            P+L  L    N +T  +P    +   L+   V +NNL                    + 
Sbjct: 57  PPHLESLVASCNSLT-ELPELPQS---LKSLLVDNNNLKA-----LSDLPPLLEYLGVSN 107

Query: 80  HLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQ 139
           +         N   L    + N S+     +  S +   +    + +   LQ L      
Sbjct: 108 NQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAI 167

Query: 140 LSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQC 199
            +   S        L   +I          P + NL  L  +Y   N L+          
Sbjct: 168 YADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKTLPDLPPSLE 227

Query: 200 QSLTTINLSYNNLSGTIPPQLMDLTSLSV-------GLDLSRNQLVGSLPTEVGKLINLE 252
                 N   +          +D++                 N     + +      +LE
Sbjct: 228 ALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLE 287

Query: 253 ILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISG- 311
            L +S N L  E+ +       LE+L    N     +P      + L+ L +  N +   
Sbjct: 288 ELNVSNNKLI-ELPALPPR---LERLIASFNHLAE-VP---ELPQNLKQLHVEYNPLREF 339

Query: 312 -EIPKFLVELQL 322
            +IP+ + +L++
Sbjct: 340 PDIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 38.7 bits (88), Expect = 0.002
 Identities = 15/65 (23%), Positives = 23/65 (35%), Gaps = 6/65 (9%)

Query: 199 CQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISR 258
            +    + L+   LS ++P     L S    L  S N L   LP     L +L +   + 
Sbjct: 37  DRQAHELELNNLGLS-SLPELPPHLES----LVASCNSLT-ELPELPQSLKSLLVDNNNL 90

Query: 259 NMLEC 263
             L  
Sbjct: 91  KALSD 95

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 37.9 bits (86), Expect = 0.003
 Identities = 22/96 (22%), Positives = 36/96 (37%), Gaps = 23/96 (23%)

Query: 18  FTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNC 77
              P+L  L++  N++   +P+      +LE    + N+L  EVP               
Sbjct: 281 DLPPSLEELNVSNNKLIE-LPALP---PRLERLIASFNHLA-EVPELP------------ 323

Query: 78  NQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNS 113
            Q+LK L +  N      P    +    +E L  NS
Sbjct: 324 -QNLKQLHVEYNPLRE-FPDIPES----VEDLRMNS 353

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.4 bits (100), Expect = 5e-05
 Identities = 27/232 (11%), Positives = 59/232 (25%), Gaps = 14/232 (6%)

Query: 12  IPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKA 71
           IP D      N + L     ++  +   +           +    ++     E  +A   
Sbjct: 23  IPSDL---PRNAIELRFVLTKLRVIQKGAFSGFG-----DLEKIEISQNDVLEVIEADVF 74

Query: 72  YCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQ 131
             +   ++       N           + N    L +     +         + K +   
Sbjct: 75  SNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDI 134

Query: 132 TLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVS 191
             ++  +      +  +G     V L +N N +      +    +         N L+  
Sbjct: 135 QDNINIHT--IERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEEL 192

Query: 192 IPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPT 243
                        +++S   +       L +L  L      S   L   LPT
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRA---RSTYNL-KKLPT 240

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 41.0 bits (94), Expect = 4e-04
 Identities = 41/320 (12%), Positives = 79/320 (24%), Gaps = 23/320 (7%)

Query: 26  LSLGFNQITGV----IPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHL 81
            SL  + IT      + + +     ++   ++ N +  E      +           + L
Sbjct: 8   KSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIA------SKKDL 61

Query: 82  KHLDINNNNFGGLLPGCICNFSITLETLIFNSN--KIFRSIPAGIGKFINLQTLHMWDNQ 139
           +  + ++   G +         + L+ L+       +  S  A            +  + 
Sbjct: 62  EIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHT 121

Query: 140 LSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQC 199
               +      L       I        +     N   L  +    N L+        + 
Sbjct: 122 PLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT 181

Query: 200 QSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRN 259
              +   L    +             L  GL   +   V  L       +    L I+  
Sbjct: 182 FQ-SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALK 240

Query: 260 MLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVE 319
                    L  C     L   G         S     GL+ L L  N I  +  + L  
Sbjct: 241 SWPNLRELGLNDC----LLSARGAAAVVD-AFSKLENIGLQTLRLQYNEIELDAVRTLKT 295

Query: 320 -----LQLVQNLNLSYNDLE 334
                +  +  L L+ N   
Sbjct: 296 VIDEKMPDLLFLELNGNRFS 315

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.0 bits (87), Expect = 0.001
 Identities = 12/63 (19%), Positives = 20/63 (31%), Gaps = 3/63 (4%)

Query: 279 KLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIP 338
           KL   L +       ++    R LDL    I   I      L     ++ S N++  +  
Sbjct: 2   KLTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDG 58

Query: 339 TEG 341
              
Sbjct: 59  FPL 61

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.8 bits (84), Expect = 0.003
 Identities = 27/151 (17%), Positives = 48/151 (31%), Gaps = 11/151 (7%)

Query: 163 KLSGNI---PPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQ 219
           KL+  +        N  +  +L L    +   I +          I+ S N +       
Sbjct: 2   KLTAELIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDG 58

Query: 220 LMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLEC-EILSTLGSCIKLEQL 278
              L  L   L ++ N++          L +L  L ++ N L     L  L S   L  L
Sbjct: 59  FPLLRRLKT-LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYL 117

Query: 279 KLGG---NLFQGPIPLSLSSLRGLRVLDLSQ 306
            +        +      +  +  +RVLD  +
Sbjct: 118 CILRNPVTNKKHYRLYVIYKVPQVRVLDFQK 148

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.7 bits (86), Expect = 0.002
 Identities = 31/217 (14%), Positives = 62/217 (28%), Gaps = 29/217 (13%)

Query: 20  LPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQ 79
               +  +L    +T  +  +    + ++     ++++                +Q    
Sbjct: 23  FAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG-----------IQYL-P 68

Query: 80  HLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQ 139
           ++  L +N N                L  L                  +         + 
Sbjct: 69  NVTKLFLNGNKLTD---------IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSL 119

Query: 140 LSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQC 199
               IS   G +      ++            +  L KL  L L +N +   +P  L   
Sbjct: 120 EHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGL 177

Query: 200 QSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQ 236
             L  + LS N++S      L  L +L V L+L  +Q
Sbjct: 178 TKLQNLYLSKNHISD--LRALAGLKNLDV-LELF-SQ 210

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.7 bits (86), Expect = 0.002
 Identities = 40/217 (18%), Positives = 77/217 (35%), Gaps = 23/217 (10%)

Query: 119 SIPAGIGK------FINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSI 172
           ++P  I +      F      ++    ++  ++    EL ++  +  N + +       I
Sbjct: 9   TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--I 64

Query: 173 GNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDL 232
             L  + +L+L  N L    P +          NL           ++ DL+SL     L
Sbjct: 65  QYLPNVTKLFLNGNKLTDIKPLA----------NLKNLGWLFLDENKVKDLSSLKDLKKL 114

Query: 233 SRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLS 292
               L  +  +++  L++L  L             T+ S +         +     I   
Sbjct: 115 KSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIV-P 173

Query: 293 LSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLS 329
           L+ L  L+ L LS+N+IS    + L  L+ +  L L 
Sbjct: 174 LAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELF 208

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	741
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.98
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.97
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.97
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.96
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.96
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.95
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.95
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.95
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.92
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.92
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.86
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.85
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.85
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.85
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.83
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.83
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.83
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.82
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.8
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.78
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.78
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.77
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.77
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.74
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.73
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.62
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.6
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.6
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.59
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.59
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.58
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.57
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.55
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.48
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.44
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.42
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.42
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.67
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.66
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.28
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.84
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.68
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.65
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.61
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.1
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.0
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.99
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.54
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	94.86

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-51  Score=417.55  Aligned_cols=254  Identities=19%  Similarity=0.253  Sum_probs=201.6

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      ..|++++.||+|+||+||+|+++.+++.||||+++... ....+.+.+|+.++++++|||||++++++     .++...|
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~-----~~~~~~~   79 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-----REGNIQY   79 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEE-----EETTEEE
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeee-----ccCceeE
Confidence            45889999999999999999999999999999997533 23356789999999999999999999994     5567899


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      +||||+++|+|.+++...          ..+++.+++.++.||+.||+|||++   ||+||||||+|||++.++.+||+|
T Consensus        80 ivmEy~~gg~L~~~l~~~----------~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~D  146 (271)
T d1nvra_          80 LFLEYCSGGELFDRIEPD----------IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISD  146 (271)
T ss_dssp             EEEECCTTEEGGGGSBTT----------TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECC
T ss_pred             EEEeccCCCcHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEcc
Confidence            999999999999999643          5689999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCc
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      ||+|+...............||+.|+|||.+.....++.++||||+||++|||++|+.||.........+..........
T Consensus       147 FG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~  226 (271)
T d1nvra_         147 FGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL  226 (271)
T ss_dssp             CTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTS
T ss_pred             chhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC
Confidence            99998775444333344567999999996555444567889999999999999999999964322221111111110000


Q ss_pred             chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          639 HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       639 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      .                              ......+.+.+++.+||+.||++|||++|+++
T Consensus       227 ~------------------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         227 N------------------------------PWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             T------------------------------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             C------------------------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            0                              00122355778999999999999999999864

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-51  Score=416.15  Aligned_cols=263  Identities=25%  Similarity=0.376  Sum_probs=200.7

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC--cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      ..|++.++||+|+||.||+|+++   ..||||+++...  ....+.+.+|+.++++++|||||++++++.      ....
T Consensus         8 ~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~------~~~~   78 (276)
T d1uwha_           8 GQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST------APQL   78 (276)
T ss_dssp             TCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSSC
T ss_pred             ccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe------ccEE
Confidence            34778899999999999999875   249999997432  334567889999999999999999999853      2357


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      ++||||+++|+|.+++...         ...+++..+..++.||++||+|||++   +||||||||+|||++.++.+||+
T Consensus        79 ~lv~Ey~~~g~L~~~l~~~---------~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~  146 (276)
T d1uwha_          79 AIVTQWCEGSSLYHHLHII---------ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIG  146 (276)
T ss_dssp             EEEEECCCEEEHHHHHHTS---------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEEC
T ss_pred             EEEEecCCCCCHHHHHhhc---------cCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEc
Confidence            9999999999999998643         24589999999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccccccCcccccC--CCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhh-h
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGL--GSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFAR-T  634 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~--~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~-~  634 (741)
                      |||+|+...............||+.|+|||.+..  ...++.++|||||||++|||+||+.||....... .+..... .
T Consensus       147 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~-~~~~~~~~~  225 (276)
T d1uwha_         147 DFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-QIIFMVGRG  225 (276)
T ss_dssp             CCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHHHHHHHT
T ss_pred             cccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH-HHHHHHhcC
Confidence            9999987655433333344679999999965543  3458999999999999999999999986321111 1111111 1


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHhhc
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSILL  711 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~  711 (741)
                      ..++....                           ...++++.+.+++.+||+.||++||||+||++.|+.+.+..+
T Consensus       226 ~~~p~~~~---------------------------~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P  275 (276)
T d1uwha_         226 YLSPDLSK---------------------------VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP  275 (276)
T ss_dssp             SCCCCGGG---------------------------SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             CCCCcchh---------------------------ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence            11111100                           012345678899999999999999999999999999987543

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-50  Score=411.57  Aligned_cols=249  Identities=21%  Similarity=0.279  Sum_probs=202.5

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALV  480 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv  480 (741)
                      +|+++++||+|+||.||+|++..+|+.||+|+++.......+.+.+|+.++++++|||||++++++     .+++..|+|
T Consensus        21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~iv   95 (293)
T d1yhwa1          21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY-----LVGDELWVV   95 (293)
T ss_dssp             TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTEEEEE
T ss_pred             ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEE-----EECCEEEEE
Confidence            589999999999999999999999999999999866656667889999999999999999999994     556689999


Q ss_pred             EecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecc
Q 037916          481 YEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFG  560 (741)
Q Consensus       481 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg  560 (741)
                      |||++||+|.+++..           ..+++.+++.++.||+.||+|||++   ||+||||||+|||++.++.+||+|||
T Consensus        96 mEy~~gg~L~~~~~~-----------~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG  161 (293)
T d1yhwa1          96 MEYLAGGSLTDVVTE-----------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG  161 (293)
T ss_dssp             EECCTTCBHHHHHHH-----------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCT
T ss_pred             EEecCCCcHHHHhhc-----------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccch
Confidence            999999999998752           3588999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcch
Q 037916          561 LAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHV  640 (741)
Q Consensus       561 ~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  640 (741)
                      +|+........  .....||+.|+||| +..+..++.++||||+||++|+|++|+.||....... .+........+.  
T Consensus       162 ~a~~~~~~~~~--~~~~~gt~~Y~aPE-~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~~~~~~~~~--  235 (293)
T d1yhwa1         162 FCAQITPEQSK--RSTMVGTPYWMAPE-VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYLIATNGTPE--  235 (293)
T ss_dssp             TCEECCSTTCC--BCCCCSCGGGCCHH-HHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHHCSCC--
T ss_pred             hheeecccccc--ccccccCCCccChh-hhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH-HHHHHHhCCCCC--
Confidence            99876544322  23356999999995 5566788999999999999999999999986321110 000000000000  


Q ss_pred             hHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          641 MDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       641 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                                                 ...+..+++.+.+++.+||+.||++|||+.|+++
T Consensus       236 ---------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         236 ---------------------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             ---------------------------CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ---------------------------CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                                       0001133456889999999999999999999864

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-50  Score=404.23  Aligned_cols=246  Identities=22%  Similarity=0.279  Sum_probs=200.9

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeecc---CcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCce
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLL---HHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      ..|++.+.||+|+||.||+|+++.+++.||+|++...   .....+.+.+|+.++++++|||||++++++     .++..
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~   80 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HDATR   80 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEE-----EECCE
Confidence            4688899999999999999999999999999998632   234456788999999999999999999994     56678


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .|+||||+++|+|.+++...          ..+++..++.++.||++||+|||++   +|+||||||+|||++.++.+||
T Consensus        81 ~~ivmEy~~~g~L~~~l~~~----------~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl  147 (263)
T d2j4za1          81 VYLILEYAPLGTVYRELQKL----------SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKI  147 (263)
T ss_dssp             EEEEEECCTTCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEE
T ss_pred             EEEEEeecCCCcHHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEee
Confidence            99999999999999998643          4689999999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcC
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVL  636 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  636 (741)
                      +|||+|........    ....||+.|+|| |+..+..++.++||||+||++|||++|+.||....     ..+..... 
T Consensus       148 ~DFG~a~~~~~~~~----~~~~Gt~~Y~AP-E~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-----~~~~~~~i-  216 (263)
T d2j4za1         148 ADFGWSVHAPSSRR----TTLCGTLDYLPP-EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-----YQETYKRI-  216 (263)
T ss_dssp             CCCCSCSCCCCCCC----EETTEEGGGCCH-HHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHH-
T ss_pred             cccceeeecCCCcc----cccCCCCcccCH-HHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC-----HHHHHHHH-
Confidence            99999987654322    235699999999 45567788999999999999999999999986321     11111110 


Q ss_pred             CcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          637 PDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       637 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                             ..    ....                .+..+++.+.+++.+||+.||++|||++|+++
T Consensus       217 -------~~----~~~~----------------~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         217 -------SR----VEFT----------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             -------HT----TCCC----------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -------Hc----CCCC----------------CCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence                   00    0000                00123456789999999999999999999975

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-50  Score=409.10  Aligned_cols=252  Identities=21%  Similarity=0.272  Sum_probs=201.9

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALV  480 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv  480 (741)
                      .|++++.||+|+||.||+|+++.+++.||+|+++.......+.+.+|+.++++++|||||++++++     .+++..|+|
T Consensus        13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~~~lv   87 (288)
T d2jfla1          13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF-----YYENNLWIL   87 (288)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEE-----EETTEEEEE
T ss_pred             CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----eeCCeEEEE
Confidence            378889999999999999999999999999999866666678899999999999999999999994     456689999


Q ss_pred             EecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecc
Q 037916          481 YEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFG  560 (741)
Q Consensus       481 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg  560 (741)
                      |||+++|+|.+++...         ...+++.++..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus        88 mEy~~~g~L~~~~~~~---------~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG  155 (288)
T d2jfla1          88 IEFCAGGAVDAVMLEL---------ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFG  155 (288)
T ss_dssp             EECCTTEEHHHHHHHH---------TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             EecCCCCcHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEech
Confidence            9999999999987532         24589999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccccccccCccccc----CCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcC
Q 037916          561 LAKLLPPAHLQTSSIGVKGTIGYIAPAEYG----LGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVL  636 (741)
Q Consensus       561 ~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~----~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  636 (741)
                      +|........  ......||+.|+|||.+.    .+..|+.++||||+||++|||++|+.||......+ .+....... 
T Consensus       156 ~a~~~~~~~~--~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-~~~~i~~~~-  231 (288)
T d2jfla1         156 VSAKNTRTIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-VLLKIAKSE-  231 (288)
T ss_dssp             TCEECHHHHH--HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-HHHHHHHSC-
T ss_pred             hhhccCCCcc--cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH-HHHHHHcCC-
Confidence            9976533211  122356999999996553    34568999999999999999999999986321111 011111000 


Q ss_pred             CcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          637 PDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       637 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      +..                            ...+..+++.+.+++.+||+.||++|||+.|+++
T Consensus       232 ~~~----------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         232 PPT----------------------------LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             CCC----------------------------CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCC----------------------------CCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000                            0001133466889999999999999999999875

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-49  Score=400.74  Aligned_cols=256  Identities=24%  Similarity=0.354  Sum_probs=193.3

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALV  480 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv  480 (741)
                      .|+++++||+|+||.||+|++. +++.||||+++.. ....+++.+|+.++++++|||||+++++|.     .++..++|
T Consensus         6 ~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-----~~~~~~lv   78 (263)
T d1sm2a_           6 ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAPICLV   78 (263)
T ss_dssp             CEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSCEEE
T ss_pred             HcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceec-----cCCceEEE
Confidence            3677889999999999999997 5778999999753 334577899999999999999999999963     34578999


Q ss_pred             EecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecc
Q 037916          481 YEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFG  560 (741)
Q Consensus       481 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg  560 (741)
                      |||+++|+|.+++...         ...+++..+..++.||++||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        79 ~E~~~~g~L~~~l~~~---------~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFG  146 (263)
T d1sm2a_          79 FEFMEHGCLSDYLRTQ---------RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFG  146 (263)
T ss_dssp             EECCTTCBHHHHHHTT---------TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC
T ss_pred             EEecCCCcHHHHhhcc---------ccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccc
Confidence            9999999999998643         24578899999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCC-CCCCccccCCcchhhhhhhcCCcc
Q 037916          561 LAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRK-RPSDIMFEGNMNLHNFARTVLPDH  639 (741)
Q Consensus       561 ~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~  639 (741)
                      +|+......... .....||+.|+||| +..+..++.++|||||||++|||+|+. +||...  ....+...+.....  
T Consensus       147 la~~~~~~~~~~-~~~~~gt~~y~aPE-~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~--~~~~~~~~i~~~~~--  220 (263)
T d1sm2a_         147 MTRFVLDDQYTS-STGTKFPVKWASPE-VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR--SNSEVVEDISTGFR--  220 (263)
T ss_dssp             -------------------CTTSCCHH-HHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC--CHHHHHHHHHHTCC--
T ss_pred             hheeccCCCcee-ecceecCcccCChH-HhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC--CHHHHHHHHHhcCC--
Confidence            998765443222 22356899999995 556778999999999999999999954 444311  11111111111000  


Q ss_pred             hhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHh
Q 037916          640 VMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSI  709 (741)
Q Consensus       640 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  709 (741)
                                ..                  .+..+++.+.+++.+||+.||++||||+||++.|++|+++
T Consensus       221 ----------~~------------------~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es  262 (263)
T d1sm2a_         221 ----------LY------------------KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES  262 (263)
T ss_dssp             ----------CC------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----------CC------------------CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence                      00                  0113346788999999999999999999999999999764

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-49  Score=398.18  Aligned_cols=249  Identities=24%  Similarity=0.333  Sum_probs=194.2

Q ss_pred             HHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC--cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEE
Q 037916          403 LFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALV  480 (741)
Q Consensus       403 ~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv  480 (741)
                      ++.++||+|+||+||+|++..+++.||+|+++...  ....+.+.+|++++++++|||||++++++.... .+....|+|
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~~~~iv   90 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCCEEEEE
Confidence            56678999999999999999999999999987432  223456789999999999999999999874321 335578999


Q ss_pred             EecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCC--ceecCCCCCCeEeC-CCCceEEe
Q 037916          481 YEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPT--TAHCDLKPSNVLLD-HEMTAHVA  557 (741)
Q Consensus       481 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~--ivHrDlkp~NIll~-~~~~~kL~  557 (741)
                      |||+++|+|.+++...          ..+++..++.++.||+.||+|||++   +  |+||||||+|||++ +++.+||+
T Consensus        91 mE~~~~g~L~~~l~~~----------~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~  157 (270)
T d1t4ha_          91 TELMTSGTLKTYLKRF----------KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIG  157 (270)
T ss_dssp             EECCCSCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEEC
T ss_pred             EeCCCCCcHHHHHhcc----------ccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEe
Confidence            9999999999998643          4688999999999999999999998   7  99999999999996 57899999


Q ss_pred             ecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCC
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      |||+|+.......    ....||+.|+|||.+ . +.++.++||||+||++|||++|+.||.....    ..........
T Consensus       158 DFGla~~~~~~~~----~~~~GT~~Y~aPE~~-~-~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~----~~~~~~~i~~  227 (270)
T d1t4ha_         158 DLGLATLKRASFA----KAVIGTPEFMAPEMY-E-EKYDESVDVYAFGMCMLEMATSEYPYSECQN----AAQIYRRVTS  227 (270)
T ss_dssp             CTTGGGGCCTTSB----EESCSSCCCCCGGGG-G-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS----HHHHHHHHTT
T ss_pred             ecCcceeccCCcc----CCcccCccccCHHHh-C-CCCCCcCchhhHHHHHHHHHHCCCCCCCccc----HHHHHHHHHc
Confidence            9999986543321    235699999999654 3 3589999999999999999999999863211    1111111111


Q ss_pred             cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          638 DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       638 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ......+                          .....+.+.+++.+||+.||++|||+.|+++
T Consensus       228 ~~~~~~~--------------------------~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         228 GVKPASF--------------------------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             TCCCGGG--------------------------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCCccc--------------------------CccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            0000000                          0112345789999999999999999999975

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.2e-49  Score=406.29  Aligned_cols=258  Identities=24%  Similarity=0.391  Sum_probs=205.8

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALV  480 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv  480 (741)
                      .|++.++||+|+||.||+|++..+++.||||+++.. ....+++.+|+.++++++|||||+++++|     .+++..++|
T Consensus        18 ~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~iv   91 (287)
T d1opja_          18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPFYII   91 (287)
T ss_dssp             GEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSCEEE
T ss_pred             HeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccE-----eeCCeeEEE
Confidence            467788999999999999999989999999998753 33456789999999999999999999995     445678999


Q ss_pred             EecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecc
Q 037916          481 YEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFG  560 (741)
Q Consensus       481 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg  560 (741)
                      |||+++|+|.+++...        ....+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||
T Consensus        92 ~E~~~~g~l~~~l~~~--------~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG  160 (287)
T d1opja_          92 TEFMTYGNLLDYLREC--------NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFG  160 (287)
T ss_dssp             EECCTTCBHHHHHHHS--------CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred             eecccCcchHHHhhhc--------cccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEcccc
Confidence            9999999999998643        125689999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcch
Q 037916          561 LAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHV  640 (741)
Q Consensus       561 ~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  640 (741)
                      +|+........ ......||+.|+||| +..+..++.++|||||||++|||++|..||....    .....         
T Consensus       161 ~a~~~~~~~~~-~~~~~~g~~~y~aPE-~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~----~~~~~---------  225 (287)
T d1opja_         161 LSRLMTGDTYT-AHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI----DLSQV---------  225 (287)
T ss_dssp             CTTTCCSSSSE-EETTEEECGGGCCHH-HHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC----CHHHH---------
T ss_pred             ceeecCCCCce-eeccccccccccChH-HHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc----hHHHH---------
Confidence            99876554322 223355899999995 4456788999999999999999999877754211    11111         


Q ss_pred             hHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHH
Q 037916          641 MDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKS  708 (741)
Q Consensus       641 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  708 (741)
                      .+.+.......                  .+..+++.+.+|+.+||+.||++|||++||++.|+.+.+
T Consensus       226 ~~~i~~~~~~~------------------~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         226 YELLEKDYRME------------------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             HHHHHTTCCCC------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             HHHHhcCCCCC------------------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            11111111100                  011345678899999999999999999999999988754

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-49  Score=404.96  Aligned_cols=250  Identities=20%  Similarity=0.282  Sum_probs=198.9

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeecc---CcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLL---HHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      .|++++.||+|+||.||+|++..+++.||||+++..   .....+.+.+|+.++++++|||||+++++     +.+++..
T Consensus         9 dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~-----~~~~~~~   83 (288)
T d1uu3a_           9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFT-----FQDDEKL   83 (288)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEE-----EECSSEE
T ss_pred             CCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEE-----EEECCEE
Confidence            588999999999999999999999999999999742   23345678899999999999999999999     4566789


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      |+||||+++|+|.+++...          ..+++..++.++.|++.||+|||+.   +|+||||||+|||+++++.+||+
T Consensus        84 ~ivmEy~~gg~L~~~~~~~----------~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~  150 (288)
T d1uu3a_          84 YFGLSYAKNGELLKYIRKI----------GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQIT  150 (288)
T ss_dssp             EEEECCCTTEEHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEEC
T ss_pred             EEEEEccCCCCHHHhhhcc----------CCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEec
Confidence            9999999999999988643          5689999999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCC
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      |||+|+...............||+.|+|| |+..+..++.++||||+||++|||++|+.||.....     ......   
T Consensus       151 DFG~a~~~~~~~~~~~~~~~~GT~~Y~AP-E~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----~~~~~~---  221 (288)
T d1uu3a_         151 DFGTAKVLSPESKQARANSFVGTAQYVSP-ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-----YLIFQK---  221 (288)
T ss_dssp             CCTTCEECC----------CCCCGGGCCH-HHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHH---
T ss_pred             ccccceecccCCcccccccccCCccccCc-eeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH-----HHHHHH---
Confidence            99999887654433333446799999999 555677899999999999999999999999863211     111111   


Q ss_pred             cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          638 DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       638 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                           +..    ....                .+....+.+.+++.+||+.||++|||++|+++.
T Consensus       222 -----i~~----~~~~----------------~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         222 -----IIK----LEYD----------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             -----HHT----TCCC----------------CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             -----HHc----CCCC----------------CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence                 000    0000                001234567899999999999999999997653

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-50  Score=404.98  Aligned_cols=257  Identities=22%  Similarity=0.266  Sum_probs=189.1

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc--CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      .|++++.||+|+||.||+|+++.+|+.||+|+++....  ...+.+.+|+.++++++|||||++++++.+   +.....|
T Consensus         5 dy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~---~~~~~~~   81 (269)
T d2java1           5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNTTLY   81 (269)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------CEE
T ss_pred             hCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEe---CCCCEEE
Confidence            58889999999999999999999999999999975432  224567899999999999999999998642   2345689


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcC--CCCceecCCCCCCeEeCCCCceEE
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDC--QPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      +||||+++|+|.+++....      .....+++..++.++.|++.||+|||+..  ..+|+||||||+|||++.++.+||
T Consensus        82 ivmEy~~~g~L~~~i~~~~------~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl  155 (269)
T d2java1          82 IVMEYCEGGDLASVITKGT------KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKL  155 (269)
T ss_dssp             EEEECCTTEEHHHHHHHHH------HHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEE
T ss_pred             EEEecCCCCcHHHHHHhcc------ccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEE
Confidence            9999999999999986321      11246899999999999999999999971  113999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcC
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVL  636 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  636 (741)
                      +|||+|+........  .....||+.|+|| |+..+..++.++||||+||++|||++|+.||.....     .+...   
T Consensus       156 ~DFG~a~~~~~~~~~--~~~~~gt~~Y~AP-E~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~-----~~~~~---  224 (269)
T d2java1         156 GDFGLARILNHDTSF--AKAFVGTPYYMSP-EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-----KELAG---  224 (269)
T ss_dssp             CCHHHHHHC-------------CCCSCCCH-HHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHH---
T ss_pred             eeccceeecccCCCc--cccCCCCcccCCH-HHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH-----HHHHH---
Confidence            999999877543322  2235699999999 555677899999999999999999999999863211     11111   


Q ss_pred             CcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          637 PDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       637 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                           .+.+......                   +..+++.+.+++.+||+.||++|||+.|+++
T Consensus       225 -----~i~~~~~~~~-------------------~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         225 -----KIREGKFRRI-------------------PYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             -----HHHHTCCCCC-------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----HHHcCCCCCC-------------------CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                 0111000000                   0123456889999999999999999999875

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.3e-49  Score=404.49  Aligned_cols=260  Identities=24%  Similarity=0.365  Sum_probs=192.9

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCe---EEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKT---IIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      ..|++.+.||+|+||+||+|+++.+++   .||||.+.... ....+.+.+|+.+|++++|||||+++++|     ..+.
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~-----~~~~  100 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVV-----TKST  100 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CSSS
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEE-----eeCC
Confidence            457778899999999999999975554   68889876422 23345789999999999999999999996     3455


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..++||||+++|+|.+++...         ...+++.++..++.||++||+|||++   +|+||||||+|||++.++.+|
T Consensus       101 ~~~iv~Ey~~~g~L~~~~~~~---------~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~K  168 (299)
T d1jpaa_         101 PVMIITEFMENGSLDSFLRQN---------DGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCK  168 (299)
T ss_dssp             SCEEEEECCTTEEHHHHHHTT---------TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEE
T ss_pred             EEEEEEEecCCCcceeeeccc---------cCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEE
Confidence            789999999999999988643         24589999999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCccc---ccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhh
Q 037916          556 VADFGLAKLLPPAHLQT---SSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNF  631 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~~---~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~  631 (741)
                      |+|||+|+.........   ......||+.|+||| ...+..++.++|||||||++|||+| |+.||.....  ..+...
T Consensus       169 l~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE-~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~--~~~~~~  245 (299)
T d1jpaa_         169 VSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE-AIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN--QDVINA  245 (299)
T ss_dssp             ECCC-----------------------CGGGSCHH-HHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHH
T ss_pred             ECCcccceEccCCCCcceeeecccccCCccccCHH-HHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH--HHHHHH
Confidence            99999998765432221   222345799999995 5556789999999999999999998 8999863211  111111


Q ss_pred             hhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHh
Q 037916          632 ARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSI  709 (741)
Q Consensus       632 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  709 (741)
                      +..            ....                  +.+.++++.+.+++.+||+.||++||||.||++.|+++.+.
T Consensus       246 i~~------------~~~~------------------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         246 IEQ------------DYRL------------------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             HHT------------TCCC------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHc------------CCCC------------------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence            110            0000                  01123456788999999999999999999999999998764

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-49  Score=410.50  Aligned_cols=198  Identities=24%  Similarity=0.331  Sum_probs=171.7

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      ..|+++++||+|+||.||+|++..+|+.||+|+++... ......+.+|+.++++++|||||+++++|     .++...|
T Consensus         6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~~~   80 (322)
T d1s9ja_           6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDGEIS   80 (322)
T ss_dssp             GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEE-----ECSSEEE
T ss_pred             cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEE
Confidence            35888999999999999999999999999999997533 23346788999999999999999999995     4566899


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHh-cCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH-DCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      +||||+++|+|.+++...          ..+++..++.++.|++.||.|||+ +   ||+||||||+|||++.++.+||+
T Consensus        81 iVmEy~~gg~L~~~l~~~----------~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~  147 (322)
T d1s9ja_          81 ICMEHMDGGSLDQVLKKA----------GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLC  147 (322)
T ss_dssp             EEEECCTTEEHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEEC
T ss_pred             EEEEcCCCCcHHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEe
Confidence            999999999999998643          458899999999999999999996 6   89999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCc
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDI  620 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~  620 (741)
                      |||+|+......    .....||+.|+|| |+..+..|+.++||||+||++|||++|+.||..
T Consensus       148 DFGla~~~~~~~----~~~~~GT~~Y~AP-Evl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~  205 (322)
T d1s9ja_         148 DFGVSGQLIDSM----ANSFVGTRSYMSP-ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP  205 (322)
T ss_dssp             CCCCCHHHHHHT----C---CCSSCCCCH-HHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred             eCCCccccCCCc----cccccCCccccCc-hHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            999998654321    2235799999999 555677899999999999999999999999964

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-48  Score=396.96  Aligned_cols=256  Identities=24%  Similarity=0.390  Sum_probs=201.2

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALV  480 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv  480 (741)
                      .|++.++||+|+||.||+|+++ +++.||||+++.. ....+.+.+|+.++++++|||||+++++|.      ++..++|
T Consensus        14 ~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~------~~~~~iv   85 (272)
T d1qpca_          14 TLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPIYII   85 (272)
T ss_dssp             GEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC------SSSCEEE
T ss_pred             HeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeec------cCCeEEE
Confidence            5678889999999999999987 6788999999753 334567899999999999999999999863      2356899


Q ss_pred             EecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecc
Q 037916          481 YEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFG  560 (741)
Q Consensus       481 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg  560 (741)
                      |||+++|+|.+++...        ....+++..++.|+.||++||.|||++   +|+||||||+|||+++++.+||+|||
T Consensus        86 ~Ey~~~g~L~~~~~~~--------~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG  154 (272)
T d1qpca_          86 TEYMENGSLVDFLKTP--------SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFG  154 (272)
T ss_dssp             EECCTTCBHHHHTTSH--------HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             EEeCCCCcHHHHHhhc--------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeecccc
Confidence            9999999999987533        124589999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcch
Q 037916          561 LAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDHV  640 (741)
Q Consensus       561 ~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  640 (741)
                      +|+........ ......||+.|+||| +..++.++.++|||||||++|||+||..|+...... ......+...     
T Consensus       155 la~~~~~~~~~-~~~~~~gt~~y~APE-~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~-~~~~~~i~~~-----  226 (272)
T d1qpca_         155 LARLIEDNEYT-AREGAKFPIKWTAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-PEVIQNLERG-----  226 (272)
T ss_dssp             TCEECSSSCEE-CCTTCCCCTTTSCHH-HHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHHHHTT-----
T ss_pred             ceEEccCCccc-cccccCCcccccChH-HHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH-HHHHHHHHhc-----
Confidence            99887654322 223356899999995 455678899999999999999999976654321111 0111111100     


Q ss_pred             hHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHH
Q 037916          641 MDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKS  708 (741)
Q Consensus       641 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  708 (741)
                             ....                  .+..+++.+.+++.+||+.||++||||+||++.|+++-.
T Consensus       227 -------~~~~------------------~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         227 -------YRMV------------------RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             -------CCCC------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -------CCCC------------------CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence                   0000                  011345668899999999999999999999999988753

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.5e-48  Score=401.85  Aligned_cols=250  Identities=22%  Similarity=0.281  Sum_probs=184.5

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      .|++.+.||+|+||.||+|+++.+++.||||++.... ......+.+|+.++++++|||||+++++     +.++...|+
T Consensus        10 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~-----~~~~~~~~l   84 (307)
T d1a06a_          10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI-----YESGGHLYL   84 (307)
T ss_dssp             TEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEE-----EECSSEEEE
T ss_pred             ceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEE-----EEECCEEEE
Confidence            4888999999999999999999999999999997433 2234567789999999999999999999     456678999


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeC---CCCceEE
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLD---HEMTAHV  556 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~---~~~~~kL  556 (741)
                      ||||++||+|.+++...          ..+++..+..++.||+.||+|||+.   +|+||||||+||++.   +++.+||
T Consensus        85 vmE~~~gg~L~~~l~~~----------~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl  151 (307)
T d1a06a_          85 IMQLVSGGELFDRIVEK----------GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMI  151 (307)
T ss_dssp             EECCCCSCBHHHHHHTC----------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEE
T ss_pred             EEeccCCCcHHHhhhcc----------cCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEE
Confidence            99999999999999643          5689999999999999999999999   999999999999994   5789999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcC
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVL  636 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  636 (741)
                      +|||+|+........   ....||+.|+|| |+..+..++.++||||+||++|||++|+.||......  ..   ...  
T Consensus       152 ~DFG~a~~~~~~~~~---~~~~GT~~y~AP-E~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--~~---~~~--  220 (307)
T d1a06a_         152 SDFGLSKMEDPGSVL---STACGTPGYVAP-EVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA--KL---FEQ--  220 (307)
T ss_dssp             CCC---------------------CTTSCH-HHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HH---HHH--
T ss_pred             eccceeEEccCCCee---eeeeeCccccCc-HHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH--HH---HHH--
Confidence            999999866543322   235699999999 4556778999999999999999999999998632111  11   110  


Q ss_pred             CcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          637 PDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       637 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                            +.........                ......++.+.+++.+||+.||++|||+.|+++
T Consensus       221 ------i~~~~~~~~~----------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         221 ------ILKAEYEFDS----------------PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             ------HHTTCCCCCT----------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ------HhccCCCCCC----------------ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence                  0000000000                001123456889999999999999999999976

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.4e-48  Score=400.85  Aligned_cols=246  Identities=25%  Similarity=0.275  Sum_probs=196.7

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcC---cchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG---ASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFK  477 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  477 (741)
                      .|+++++||+|+||.||+|++..+++.||||+++.....   ..+.+.+|+.++++++|||||++++++     .+++..
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~~   90 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY-----LREHTA   90 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEE-----EECCEE
Confidence            588899999999999999999999999999999754322   234678999999999999999999995     456689


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      |+|||||.+|++..++...          ..+++.+++.++.||+.||.|||++   ||+||||||+|||++.++.+||+
T Consensus        91 ~iv~E~~~~g~l~~~~~~~----------~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~  157 (309)
T d1u5ra_          91 WLVMEYCLGSASDLLEVHK----------KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLG  157 (309)
T ss_dssp             EEEEECCSEEHHHHHHHHT----------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEEC
T ss_pred             EEEEEecCCCchHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEe
Confidence            9999999999987766432          5689999999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccccccCcccccC--CCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhc
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGL--GSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV  635 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~--~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~  635 (741)
                      |||+|......      ....||+.|+|||.+..  .+.|+.++||||+||++|||++|..||....... .+.......
T Consensus       158 DFG~a~~~~~~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~-~~~~i~~~~  230 (309)
T d1u5ra_         158 DFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNE  230 (309)
T ss_dssp             CCTTCBSSSSB------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSC
T ss_pred             ecccccccCCC------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhCC
Confidence            99999865432      22469999999966543  3568999999999999999999999986321110 010001100


Q ss_pred             CCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          636 LPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       636 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      .+.         ..                     ...+++.+.+++.+||+.||++|||+.|+++
T Consensus       231 ~~~---------~~---------------------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         231 SPA---------LQ---------------------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             CCC---------CS---------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCC---------CC---------------------CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            000         00                     0123456889999999999999999999975

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-47  Score=386.90  Aligned_cols=253  Identities=24%  Similarity=0.371  Sum_probs=203.2

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALV  480 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv  480 (741)
                      .|++.++||+|+||+||+|+++ +++.||||+++... ...+++.+|+.++++++||||++++++|     .++...++|
T Consensus         5 ~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~-----~~~~~~~iv   77 (258)
T d1k2pa_           5 DLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC-----TKQRPIFII   77 (258)
T ss_dssp             CCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEE-----CCSSSEEEE
T ss_pred             HCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEE-----eeCCceEEE
Confidence            3678899999999999999996 78899999998543 3457899999999999999999999996     345579999


Q ss_pred             EecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecc
Q 037916          481 YEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFG  560 (741)
Q Consensus       481 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg  560 (741)
                      |||+++|+|.+++...         ...+++..+++++.|+++||+|||++   ||+||||||+||+++.++.+||+|||
T Consensus        78 ~Ey~~~g~l~~~~~~~---------~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG  145 (258)
T d1k2pa_          78 TEYMANGCLLNYLREM---------RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFG  145 (258)
T ss_dssp             EECCTTEEHHHHHHSG---------GGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCS
T ss_pred             EEccCCCcHHHhhhcc---------ccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcch
Confidence            9999999999987532         35688899999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcCCcc
Q 037916          561 LAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVLPDH  639 (741)
Q Consensus       561 ~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  639 (741)
                      +++........ ......||+.|+||| +..+..++.++|||||||++|||+| |+.||......  .....+.....  
T Consensus       146 ~a~~~~~~~~~-~~~~~~~t~~y~aPE-~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~--~~~~~i~~~~~--  219 (258)
T d1k2pa_         146 LSRYVLDDEYT-SSVGSKFPVRWSPPE-VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETAEHIAQGLR--  219 (258)
T ss_dssp             SCCBCSSSSCC-CCCCSCCCGGGCCHH-HHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--HHHHHHHTTCC--
T ss_pred             hheeccCCCce-eecccCCCCCcCCcH-HhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH--HHHHHHHhCCC--
Confidence            99876554332 233356899999994 5556778999999999999999998 89998633211  11111111000  


Q ss_pred             hhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHH
Q 037916          640 VMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSI  706 (741)
Q Consensus       640 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  706 (741)
                                ..                  .+..+++.+.+++.+||+.||++|||++||++.|.+|
T Consensus       220 ----------~~------------------~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         220 ----------LY------------------RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             ----------CC------------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             ----------CC------------------CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence                      00                  0113345788999999999999999999999998654

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=5.1e-48  Score=406.73  Aligned_cols=252  Identities=19%  Similarity=0.255  Sum_probs=202.5

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      ..|++++.||+|+||.||+|++..+|+.||||+++.......+.+.+|+.++++++|||||+++++     +.++...|+
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~-----~~~~~~~~i  103 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA-----FEDKYEMVL  103 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEE-----EECSSEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEE-----EEECCEEEE
Confidence            468999999999999999999999999999999976544445677899999999999999999999     456778999


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeC--CCCceEEe
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLD--HEMTAHVA  557 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~--~~~~~kL~  557 (741)
                      |||||+||+|.+++...         ...+++.+++.++.||+.||+|||++   ||+||||||+|||++  .++.+||+
T Consensus       104 vmE~~~gg~L~~~~~~~---------~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~  171 (352)
T d1koba_         104 ILEFLSGGELFDRIAAE---------DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKII  171 (352)
T ss_dssp             EEECCCCCBHHHHTTCT---------TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEEC
T ss_pred             EEEcCCCChHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEe
Confidence            99999999999887533         24589999999999999999999999   999999999999998  56899999


Q ss_pred             ecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCC
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      |||+|.........   ....||+.|+|| |+..+..++.++||||+||++|||++|+.||....... .+.........
T Consensus       172 DFGla~~~~~~~~~---~~~~gt~~y~aP-E~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~i~~~~~~  246 (352)
T d1koba_         172 DFGLATKLNPDEIV---KVTTATAEFAAP-EIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-TLQNVKRCDWE  246 (352)
T ss_dssp             CCTTCEECCTTSCE---EEECSSGGGCCH-HHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHHCCCC
T ss_pred             ecccceecCCCCce---eeccCcccccCH-HHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCC
Confidence            99999887654322   225689999999 55677789999999999999999999999986321110 01111110000


Q ss_pred             cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          638 DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       638 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      .            ..                ......++.+.+++.+||+.||++|||+.|+++
T Consensus       247 ~------------~~----------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         247 F------------DE----------------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             C------------CS----------------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             C------------Cc----------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0            00                000123456789999999999999999999986

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-47  Score=391.75  Aligned_cols=257  Identities=23%  Similarity=0.326  Sum_probs=201.4

Q ss_pred             Hhh-hcccCceeeEEEEEEc--CCCeEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          404 FLC-WIDMGSFGSVYKGILD--EGKTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       404 ~~~-~ig~G~~g~V~~a~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      +.. +||+|+||.||+|.++  .++..||||+++... ....+.+.+|++++++++|||||+++++|.     + +..|+
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~-----~-~~~~l   85 (285)
T d1u59a_          12 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-----A-EALML   85 (285)
T ss_dssp             EEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----S-SSEEE
T ss_pred             ECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeec-----c-CeEEE
Confidence            444 4999999999999875  345689999997433 233567889999999999999999999863     2 25799


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      ||||+++|+|.+++...         ...+++.++..++.||++||+|||++   +|+||||||+||+++.++.+||+||
T Consensus        86 vmE~~~~g~L~~~l~~~---------~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DF  153 (285)
T d1u59a_          86 VMEMAGGGPLHKFLVGK---------REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDF  153 (285)
T ss_dssp             EEECCTTEEHHHHHTTC---------TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCC
T ss_pred             EEEeCCCCcHHHHhhcc---------ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccc
Confidence            99999999999987533         24589999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcc-cccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcCC
Q 037916          560 GLAKLLPPAHLQ-TSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       560 g~a~~~~~~~~~-~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      |+|+........ .......||+.|+||| +..+..++.++|||||||++|||+| |+.||.....  ..+...+.....
T Consensus       154 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE-~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~--~~~~~~i~~~~~  230 (285)
T d1u59a_         154 GLSKALGADDSYYTARSAGKWPLKWYAPE-CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFIEQGKR  230 (285)
T ss_dssp             TTCEECTTCSCEECCCCSSCCCGGGCCHH-HHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--HHHHHHHHTTCC
T ss_pred             hhhhcccccccccccccccccCccccChH-HHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCC
Confidence            999887654322 2223356899999995 4556789999999999999999998 8999863211  111111111000


Q ss_pred             cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHhhc
Q 037916          638 DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSILL  711 (741)
Q Consensus       638 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~  711 (741)
                                                    ...+..+++.+.+|+.+||+.||++|||+.+|++.|+.+-....
T Consensus       231 ------------------------------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~  274 (285)
T d1u59a_         231 ------------------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA  274 (285)
T ss_dssp             ------------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             ------------------------------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence                                          00112345678899999999999999999999999988775544

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=6.2e-48  Score=405.72  Aligned_cols=252  Identities=21%  Similarity=0.266  Sum_probs=202.1

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      .+|++++.||+|+||.||+|+++.+|+.||||++........+.+.+|+.++++++|||||++++++     .+++..|+
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~i  100 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMVM  100 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----EETTEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEEE
Confidence            4789999999999999999999999999999999765545566788999999999999999999994     55678999


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCC--CCceEEe
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDH--EMTAHVA  557 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~--~~~~kL~  557 (741)
                      |||||+||+|.+++...         ...+++..+..++.||+.||+|||++   |||||||||+|||++.  ++.+||+
T Consensus       101 vmE~~~gg~L~~~l~~~---------~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~  168 (350)
T d1koaa2         101 IYEFMSGGELFEKVADE---------HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLI  168 (350)
T ss_dssp             EECCCCSCBHHHHHTCT---------TSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEEC
T ss_pred             EEEcCCCCCHHHHHHhh---------cCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEe
Confidence            99999999999998532         24589999999999999999999999   9999999999999964  5789999


Q ss_pred             ecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCC
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      |||+|+........   ....||+.|+||| +..+..++.++||||+||++|||++|+.||...... ..+.........
T Consensus       169 DFG~a~~~~~~~~~---~~~~gT~~Y~aPE-v~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~i~~~~~~  243 (350)
T d1koaa2         169 DFGLTAHLDPKQSV---KVTTGTAEFAAPE-VAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-ETLRNVKSCDWN  243 (350)
T ss_dssp             CCTTCEECCTTSCE---EEECSCTTTCCHH-HHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCCC
T ss_pred             ecchheeccccccc---ceecCcccccCHH-HHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCC
Confidence            99999877654332   2356999999995 556778899999999999999999999998632110 001111110000


Q ss_pred             cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          638 DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       638 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                                  ....                ....+++.+.+++.+||+.||++|||+.|+++
T Consensus       244 ------------~~~~----------------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         244 ------------MDDS----------------AFSGISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             ------------SCCG----------------GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ------------CCcc----------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                        0000                00123456789999999999999999999986

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-47  Score=391.39  Aligned_cols=250  Identities=22%  Similarity=0.312  Sum_probs=194.7

Q ss_pred             hhcccCceeeEEEEEEc--CCCeEEEEEEeeccC--cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEEE
Q 037916          406 CWIDMGSFGSVYKGILD--EGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALVY  481 (741)
Q Consensus       406 ~~ig~G~~g~V~~a~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv~  481 (741)
                      ++||+|+||.||+|.++  .+++.||||+++...  ....+.+.+|+.++++++|||||+++++|.     + +..++||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~-----~-~~~~lvm   86 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-----A-ESWMLVM   86 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----S-SSEEEEE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEec-----c-CCEEEEE
Confidence            46999999999999874  356789999996432  223457889999999999999999999963     2 2468999


Q ss_pred             ecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeeccc
Q 037916          482 EFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFGL  561 (741)
Q Consensus       482 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg~  561 (741)
                      ||+++|+|.+++...          ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+
T Consensus        87 E~~~~g~L~~~l~~~----------~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGl  153 (277)
T d1xbba_          87 EMAELGPLNKYLQQN----------RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGL  153 (277)
T ss_dssp             ECCTTEEHHHHHHHC----------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred             EcCCCCcHHHHHhhc----------cCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhh
Confidence            999999999998643          5589999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCc-ccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcCCcc
Q 037916          562 AKLLPPAHL-QTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVLPDH  639 (741)
Q Consensus       562 a~~~~~~~~-~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  639 (741)
                      |+....... ........||+.|+||| ...+..++.++|||||||++|||++ |+.||.....  ..+...+....   
T Consensus       154 a~~~~~~~~~~~~~~~~~gt~~y~APE-~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~--~~~~~~i~~~~---  227 (277)
T d1xbba_         154 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAMLEKGE---  227 (277)
T ss_dssp             CEECCTTCSEEEC----CCCGGGCCHH-HHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHTTC---
T ss_pred             hhhccccccccccccccCCCceecCch-hhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH--HHHHHHHHcCC---
Confidence            987654432 22223356899999995 4456778999999999999999998 8999863211  11111111100   


Q ss_pred             hhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHH
Q 037916          640 VMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIK  707 (741)
Q Consensus       640 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  707 (741)
                               ..                  ..+..+++.+.+|+.+||+.||++|||++||++.|+..-
T Consensus       228 ---------~~------------------~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~  268 (277)
T d1xbba_         228 ---------RM------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  268 (277)
T ss_dssp             ---------CC------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             ---------CC------------------CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence                     00                  011234567889999999999999999999999887764

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-47  Score=392.80  Aligned_cols=251  Identities=20%  Similarity=0.224  Sum_probs=200.1

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc------CcchhHHHHHHHHHhcCCCceeeEeeeecCccccC
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH------GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKG  473 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  473 (741)
                      .+|++++.||+|+||.||+|+++.+|+.||||+++....      ...+.+.+|+.++++++|||||+++++     +.+
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~-----~~~   84 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEV-----YEN   84 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE-----EEC
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEE-----EEE
Confidence            358899999999999999999999999999999974322      124568899999999999999999999     456


Q ss_pred             CceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCC-
Q 037916          474 DDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEM-  552 (741)
Q Consensus       474 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~-  552 (741)
                      ....|+|||||++|+|.+++...          ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++ 
T Consensus        85 ~~~~~iv~E~~~gg~L~~~i~~~----------~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~  151 (293)
T d1jksa_          85 KTDVILILELVAGGELFDFLAEK----------ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNV  151 (293)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSS
T ss_pred             CCEEEEEEEcCCCccccchhccc----------cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCC
Confidence            67899999999999999998643          4689999999999999999999999   999999999999998776 


Q ss_pred             ---ceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchh
Q 037916          553 ---TAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLH  629 (741)
Q Consensus       553 ---~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~  629 (741)
                         .+||+|||+|.........   ....||+.|+||| +..+..++.++||||+||++|||++|+.||......+ .+.
T Consensus       152 ~~~~vkl~DfG~a~~~~~~~~~---~~~~~t~~y~APE-~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-~~~  226 (293)
T d1jksa_         152 PKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLA  226 (293)
T ss_dssp             SSCCEEECCCTTCEECTTSCBC---SCCCCCGGGCCHH-HHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHH
T ss_pred             cccceEecchhhhhhcCCCccc---cccCCCCcccCHH-HHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH-HHH
Confidence               5999999999877554322   2356899999995 5566789999999999999999999999986321100 000


Q ss_pred             hhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          630 NFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       630 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ........              ..              ......+++.+.+++.+||+.||++|||++|+++
T Consensus       227 ~i~~~~~~--------------~~--------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         227 NVSAVNYE--------------FE--------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             HHHTTCCC--------------CC--------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHhcCCC--------------CC--------------chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00000000              00              0011133456789999999999999999999975

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-48  Score=402.73  Aligned_cols=264  Identities=22%  Similarity=0.300  Sum_probs=200.6

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCC-----eEEEEEEeecc-CcCcchhHHHHHHHHHhc-CCCceeeEeeeecCccccC
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGK-----TIIAVKVLNLL-HHGASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKG  473 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~  473 (741)
                      .|++.+.||+|+||.||+|++...+     ..||+|++... .......+.+|+.+++++ +|||||+++++|     .+
T Consensus        38 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~-----~~  112 (325)
T d1rjba_          38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC-----TL  112 (325)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----CS
T ss_pred             HeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE-----ee
Confidence            4678889999999999999986443     37999998632 334456788999999998 899999999995     45


Q ss_pred             CceEEEEEecccCCChhhhccCCCCCCcc-------------cCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecC
Q 037916          474 DDFKALVYEFMHNGSLEEWLHPVSGADKT-------------VEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCD  540 (741)
Q Consensus       474 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~-------------~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrD  540 (741)
                      .+..|+||||+++|+|.++++..+.....             ......+++..++.++.||++||+|||++   +|||||
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRD  189 (325)
T d1rjba_         113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRD  189 (325)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred             CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecc
Confidence            56889999999999999999754321100             11224589999999999999999999999   999999


Q ss_pred             CCCCCeEeCCCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCC
Q 037916          541 LKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSD  619 (741)
Q Consensus       541 lkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~  619 (741)
                      |||+||+++.++.+||+|||+|+...............||+.|+||| +..+..++.++|||||||++|||+| |+.||.
T Consensus       190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE-~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~  268 (325)
T d1rjba_         190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPE-SLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  268 (325)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHH-HHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChH-HHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence            99999999999999999999998765544333333456899999995 4556789999999999999999998 899986


Q ss_pred             ccccCCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHH
Q 037916          620 IMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIV  699 (741)
Q Consensus       620 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev  699 (741)
                      ..... ..+...+...            ....                  .+..+++.+.+|+.+||+.||++|||++||
T Consensus       269 ~~~~~-~~~~~~~~~~------------~~~~------------------~p~~~~~~l~~li~~cl~~dP~~RPt~~ei  317 (325)
T d1rjba_         269 GIPVD-ANFYKLIQNG------------FKMD------------------QPFYATEEIYIIMQSCWAFDSRKRPSFPNL  317 (325)
T ss_dssp             TCCCS-HHHHHHHHTT------------CCCC------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCHH-HHHHHHHhcC------------CCCC------------------CCCcCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence            32111 1111111111            1000                  011345678899999999999999999999


Q ss_pred             HHHHH
Q 037916          700 VHELQ  704 (741)
Q Consensus       700 l~~L~  704 (741)
                      ++.|.
T Consensus       318 ~~~L~  322 (325)
T d1rjba_         318 TSFLG  322 (325)
T ss_dssp             HHHHH
T ss_pred             HHHHh
Confidence            99985

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-47  Score=393.40  Aligned_cols=260  Identities=23%  Similarity=0.364  Sum_probs=194.2

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCC----eEEEEEEeeccCc-CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGK----TIIAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      .|++.+.||+|+||.||+|.++.++    ..||||+++.... .....+.+|+.++++++|||||+++++|     ....
T Consensus         8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~-----~~~~   82 (283)
T d1mqba_           8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI-----SKYK   82 (283)
T ss_dssp             TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSS
T ss_pred             HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEE-----ecCC
Confidence            3567788999999999999987544    5799999964322 2345688999999999999999999996     3455


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..++||||+.++++.+++...         ...+++.+++.++.||+.||+|||+.   +|+||||||+|||++.++.+|
T Consensus        83 ~~~~v~e~~~~~~l~~~~~~~---------~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~K  150 (283)
T d1mqba_          83 PMMIITEYMENGALDKFLREK---------DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCK  150 (283)
T ss_dssp             SEEEEEECCTTEEHHHHHHHT---------TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEE
T ss_pred             ceEEEEEecccCcchhhhhcc---------cccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEE
Confidence            789999999999998887533         25689999999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcc-cccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhh
Q 037916          556 VADFGLAKLLPPAHLQ-TSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~-~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  634 (741)
                      |+|||+|+........ .......||+.|+||| +..+..++.++|||||||++|||++|..|+......    .+..  
T Consensus       151 l~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE-~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~----~~~~--  223 (283)
T d1mqba_         151 VSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE-AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN----HEVM--  223 (283)
T ss_dssp             ECCCCC-----------------CCCGGGSCHH-HHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHHH--
T ss_pred             EcccchhhcccCCCccceEeccCCCCccccCHH-HHccCCCCCcccccccHHHHHHHHhCCCCccccCCH----HHHH--
Confidence            9999999876543221 2223355899999995 556778999999999999999999976665321111    1111  


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHh
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSI  709 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  709 (741)
                             ..+.......                  .+.+++..+.+|+.+||+.||++||||.||++.|+++.+.
T Consensus       224 -------~~i~~~~~~~------------------~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         224 -------KAINDGFRLP------------------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             -------HHHHTTCCCC------------------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             -------HHHhccCCCC------------------CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence                   1111111000                  1113456788999999999999999999999999988864

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-47  Score=394.32  Aligned_cols=248  Identities=21%  Similarity=0.248  Sum_probs=201.1

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeecc---CcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCce
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLL---HHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      ..|++++.||+|+||.||+|+++.+++.||+|++++.   .....+.+.+|+.++++++|||||+++++     +.+...
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~-----~~~~~~   79 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYA-----FQTHDR   79 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEE-----EECSSE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEee-----eccccc
Confidence            4688999999999999999999999999999999743   23345678899999999999999999999     566779


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .|+||||++||+|.+++...          ..+++..++.++.||+.||+|||++   ||+||||||+|||++.+|.+||
T Consensus        80 ~~iv~ey~~gg~L~~~~~~~----------~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl  146 (337)
T d1o6la_          80 LCFVMEYANGGELFFHLSRE----------RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKI  146 (337)
T ss_dssp             EEEEEECCTTCBHHHHHHHH----------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEE
T ss_pred             cccceeccCCCchhhhhhcc----------cCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEE
Confidence            99999999999999998643          5688999999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcC
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVL  636 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  636 (741)
                      +|||+|+........  ....+||+.|+|| |+..+..|+.++||||+||++|||++|+.||.....     ......  
T Consensus       147 ~DFG~a~~~~~~~~~--~~~~~GT~~Y~aP-E~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~-----~~~~~~--  216 (337)
T d1o6la_         147 TDFGLCKEGISDGAT--MKTFCGTPEYLAP-EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----ERLFEL--  216 (337)
T ss_dssp             CCCTTCBCSCCTTCC--BCCCEECGGGCCG-GGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHH--
T ss_pred             eecccccccccCCcc--cccceeCHHHhhh-hhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH-----HHHHHH--
Confidence            999999876543222  2236799999999 566677899999999999999999999999863211     111110  


Q ss_pred             CcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCC-----HHHHHH
Q 037916          637 PDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMN-----MTIVVH  701 (741)
Q Consensus       637 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  701 (741)
                            +.    .....                .+....+.+.+++.+||+.||++||+     ++|+++
T Consensus       217 ------i~----~~~~~----------------~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         217 ------IL----MEEIR----------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ------HH----HCCCC----------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ------Hh----cCCCC----------------CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence                  00    00000                01123456779999999999999995     778775

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-47  Score=383.17  Aligned_cols=252  Identities=26%  Similarity=0.340  Sum_probs=193.7

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALV  480 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv  480 (741)
                      .|+++++||+|+||.||+|+++  |..||||+++.  ....+.+.+|+.++++++||||++++++|.    ++....|+|
T Consensus         8 ~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~----~~~~~~~lv   79 (262)
T d1byga_           8 ELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLYIV   79 (262)
T ss_dssp             GEEEEEEEEECSSCEEEEEEET--TEEEEEEECCC--CC--HHHHHTHHHHTTCCCTTBCCEEEEEC----CC--CCEEE
T ss_pred             HeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEE----ecCCcEEEE
Confidence            4678899999999999999995  78899999964  344578999999999999999999999873    344567999


Q ss_pred             EecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecc
Q 037916          481 YEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFG  560 (741)
Q Consensus       481 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg  560 (741)
                      |||+++|+|.+++...        ....+++..+++++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        80 ~ey~~~g~L~~~l~~~--------~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg  148 (262)
T d1byga_          80 TEYMAKGSLVDYLRSR--------GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFG  148 (262)
T ss_dssp             ECCCTTEEHHHHHHHH--------HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCC
T ss_pred             EeccCCCCHHHHHHhc--------CCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccc
Confidence            9999999999998632        124589999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhhcCCcc
Q 037916          561 LAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFARTVLPDH  639 (741)
Q Consensus       561 ~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  639 (741)
                      .++......     ....+|+.|+|||. ..+..++.++|||||||++|||+| |+.||.....  .+....+...... 
T Consensus       149 ~s~~~~~~~-----~~~~~~~~y~aPE~-l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~--~~~~~~i~~~~~~-  219 (262)
T d1byga_         149 LTKEASSTQ-----DTGKLPVKWTAPEA-LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVEKGYKM-  219 (262)
T ss_dssp             C-----------------CCTTTSCHHH-HHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--GGHHHHHTTTCCC-
T ss_pred             cceecCCCC-----ccccccccCCChHH-HhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH--HHHHHHHHcCCCC-
Confidence            998654332     12357899999954 456688999999999999999998 6777753211  1111111110000 


Q ss_pred             hhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHh
Q 037916          640 VMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSI  709 (741)
Q Consensus       640 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  709 (741)
                                                   +.+..+++.+.+++.+||+.||++||||.||++.|++++..
T Consensus       220 -----------------------------~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~  260 (262)
T d1byga_         220 -----------------------------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  260 (262)
T ss_dssp             -----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----------------------------CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence                                         00113346788999999999999999999999999998753

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-47  Score=392.06  Aligned_cols=271  Identities=20%  Similarity=0.240  Sum_probs=197.0

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcC-----CCeEEEEEEeeccC-cCcchhHHHHHHHHHhc-CCCceeeEeeeecCcccc
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDE-----GKTIIAVKVLNLLH-HGASKSSIAECSALRNI-RHKNLVKILTVCSGVDYK  472 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~  472 (741)
                      ..|++.++||+|+||.||+|++..     +++.||||+++... ....+.+.+|...+.++ +|+|||.+++++    ..
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~----~~   88 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC----TK   88 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE----CS
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeee----cc
Confidence            457888999999999999999753     45789999987422 22345667788888776 689999999986    34


Q ss_pred             CCceEEEEEecccCCChhhhccCCCCCCc------ccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCe
Q 037916          473 GDDFKALVYEFMHNGSLEEWLHPVSGADK------TVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNV  546 (741)
Q Consensus       473 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NI  546 (741)
                      .+...++||||+++|+|.++++..+....      .......+++.+++.++.||++||+|||++   +|+||||||+||
T Consensus        89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NI  165 (299)
T d1ywna1          89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNI  165 (299)
T ss_dssp             TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred             CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccce
Confidence            45578999999999999999864421100      011234589999999999999999999999   999999999999


Q ss_pred             EeCCCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCC-CCCCccccCC
Q 037916          547 LLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRK-RPSDIMFEGN  625 (741)
Q Consensus       547 ll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~-~p~~~~~~~~  625 (741)
                      |++.++.+||+|||+|+...............||+.|+||| +..+..++.++|||||||++|||++|. .||.... ..
T Consensus       166 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE-~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~-~~  243 (299)
T d1ywna1         166 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE-TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK-ID  243 (299)
T ss_dssp             EECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHH-HHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-CS
T ss_pred             eECCCCcEEEccCcchhhccccccccccCceeeCccccchh-HhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC-HH
Confidence            99999999999999998766554444444567999999995 445678999999999999999999975 5665221 11


Q ss_pred             cchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHH
Q 037916          626 MNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQS  705 (741)
Q Consensus       626 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  705 (741)
                      ..+.........            ...                  +..+++.+.+++.+||+.||++|||+.||++.|++
T Consensus       244 ~~~~~~~~~~~~------------~~~------------------~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~  293 (299)
T d1ywna1         244 EEFCRRLKEGTR------------MRA------------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  293 (299)
T ss_dssp             HHHHHHHHHTCC------------CCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHHHhcCCC------------CCC------------------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            111111111110            000                  11234568899999999999999999999999999


Q ss_pred             HHHh
Q 037916          706 IKSI  709 (741)
Q Consensus       706 i~~~  709 (741)
                      +.++
T Consensus       294 ilq~  297 (299)
T d1ywna1         294 LLQA  297 (299)
T ss_dssp             HHHH
T ss_pred             HHhC
Confidence            8754

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=5e-47  Score=388.04  Aligned_cols=264  Identities=19%  Similarity=0.232  Sum_probs=199.3

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcC---cchhHHHHHHHHHhcCCCceeeEeeeecCccccCCce
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG---ASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      .+|++.+.||+|+||.||+|++..+++.||||+++.....   ..+.+.+|+.++++++|||||++++++.... .....
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~~~   85 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGPL   85 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSSEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCCce
Confidence            4688999999999999999999999999999999753322   2346789999999999999999999864322 22345


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .|+||||++|++|.+++...          ..+++.+++.++.||+.||+|||+.   ||+||||||+||+++.++.+++
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~----------~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l  152 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTE----------GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKV  152 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHH----------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEE
T ss_pred             EEEEEECCCCCEehhhhccc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCcccccee
Confidence            89999999999999988633          5689999999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCc-ccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhc
Q 037916          557 ADFGLAKLLPPAHL-QTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV  635 (741)
Q Consensus       557 ~DFg~a~~~~~~~~-~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~  635 (741)
                      +|||.+........ ........||+.|+||| +..+..++.++||||+||++|||++|+.||........ ........
T Consensus       153 ~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE-~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-~~~~~~~~  230 (277)
T d1o6ya_         153 MDFGIARAIADSGNSVTQTAAVIGTAQYLSPE-QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-AYQHVRED  230 (277)
T ss_dssp             CCCTTCEECC----------------TTCCHH-HHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHCC
T ss_pred             ehhhhhhhhccccccccccccccCcccccCHH-HHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH-HHHHHhcC
Confidence            99999876543322 22233456999999995 45677899999999999999999999999863211100 00000000


Q ss_pred             CCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCC-CHHHHHHHHHHHH
Q 037916          636 LPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRM-NMTIVVHELQSIK  707 (741)
Q Consensus       636 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~i~  707 (741)
                      ... . .                          ......++.+.+++.+||+.||++|| |++|+++.|.+++
T Consensus       231 ~~~-~-~--------------------------~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         231 PIP-P-S--------------------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             CCC-G-G--------------------------GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             CCC-C-c--------------------------hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence            000 0 0                          00012346688999999999999999 8999999998875

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-46  Score=392.15  Aligned_cols=258  Identities=24%  Similarity=0.347  Sum_probs=198.4

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCe----EEEEEEeecc-CcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKT----IIAVKVLNLL-HHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      .|++++.||+|+||.||+|.+..+|+    +||+|.++.. .....+.+.+|+.++++++|||||+++++|..      .
T Consensus        10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~------~   83 (317)
T d1xkka_          10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------S   83 (317)
T ss_dssp             TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES------S
T ss_pred             HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------C
Confidence            47889999999999999999987765    5888887632 23445678999999999999999999999742      2


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..+++|||+.+|+|.+++...         ...+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+|
T Consensus        84 ~~~~v~e~~~~~~l~~~~~~~---------~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~k  151 (317)
T d1xkka_          84 TVQLITQLMPFGCLLDYVREH---------KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVK  151 (317)
T ss_dssp             SEEEEEECCTTCBHHHHHHHT---------SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEE
T ss_pred             CeeEEEEeccCCccccccccc---------ccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeE
Confidence            467889999999999887633         35688999999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhh
Q 037916          556 VADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  634 (741)
                      |+|||+|+...............||+.|+||| +..++.++.++|||||||++|||+| |..||+....  ..+...+..
T Consensus       152 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE-~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~--~~~~~~i~~  228 (317)
T d1xkka_         152 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE-SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEK  228 (317)
T ss_dssp             ECCCSHHHHTTTTCC--------CCTTTSCHH-HHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG--GGHHHHHHH
T ss_pred             eeccccceecccccccccccccccCccccChH-HHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH--HHHHHHHHc
Confidence            99999999876554433334456899999995 4456689999999999999999998 7888763211  111111111


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHh
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSI  709 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  709 (741)
                      ...            .                  ..+..+++.+.+++.+||+.||++|||+.||++.|+.+.+.
T Consensus       229 ~~~------------~------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~  273 (317)
T d1xkka_         229 GER------------L------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  273 (317)
T ss_dssp             TCC------------C------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             CCC------------C------------------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence            100            0                  01123456788999999999999999999999999988753

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.8e-47  Score=393.41  Aligned_cols=268  Identities=24%  Similarity=0.370  Sum_probs=203.9

Q ss_pred             HHHHHhhhcccCceeeEEEEEEc-----CCCeEEEEEEeeccCc-CcchhHHHHHHHHHhcCCCceeeEeeeecCccccC
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILD-----EGKTIIAVKVLNLLHH-GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKG  473 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  473 (741)
                      ..|+++++||+|+||.||+|+++     .+++.||||+++.... ...+++.+|+.++++++||||++++++|     ..
T Consensus        13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~-----~~   87 (301)
T d1lufa_          13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC-----AV   87 (301)
T ss_dssp             GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----CS
T ss_pred             HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee-----cc
Confidence            35788999999999999999975     3568899999874322 2346789999999999999999999996     34


Q ss_pred             CceEEEEEecccCCChhhhccCCCCCCc--------------ccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceec
Q 037916          474 DDFKALVYEFMHNGSLEEWLHPVSGADK--------------TVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHC  539 (741)
Q Consensus       474 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~--------------~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHr  539 (741)
                      ....+++|||+++|+|.+++........              .......+++..++.++.|++.||+|||+.   +||||
T Consensus        88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHr  164 (301)
T d1lufa_          88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHR  164 (301)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEee
Confidence            5578999999999999999864321110              111223588999999999999999999999   99999


Q ss_pred             CCCCCCeEeCCCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCC-CCC
Q 037916          540 DLKPSNVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRK-RPS  618 (741)
Q Consensus       540 Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~-~p~  618 (741)
                      ||||+|||++.++.+||+|||+|+...............||+.|+||| +..+..++.++|||||||++|||++|. +||
T Consensus       165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~  243 (301)
T d1lufa_         165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPE-SIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  243 (301)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHH-HHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHH-HHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence            999999999999999999999998765544444444466899999995 456778999999999999999999986 566


Q ss_pred             CccccCCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHH
Q 037916          619 DIMFEGNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTI  698 (741)
Q Consensus       619 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  698 (741)
                      ......  .....+...           ...                   ..+..+++.+.+|+.+||+.||++||||.|
T Consensus       244 ~~~~~~--e~~~~v~~~-----------~~~-------------------~~p~~~~~~~~~li~~cl~~~P~~RPt~~e  291 (301)
T d1lufa_         244 YGMAHE--EVIYYVRDG-----------NIL-------------------ACPENCPLELYNLMRLCWSKLPADRPSFCS  291 (301)
T ss_dssp             TTSCHH--HHHHHHHTT-----------CCC-------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCHH--HHHHHHHcC-----------CCC-------------------CCCccchHHHHHHHHHHcCCChhHCcCHHH
Confidence            522111  111111100           000                   001134567889999999999999999999


Q ss_pred             HHHHHHHHHH
Q 037916          699 VVHELQSIKS  708 (741)
Q Consensus       699 vl~~L~~i~~  708 (741)
                      |++.|++|++
T Consensus       292 v~~~L~~i~~  301 (301)
T d1lufa_         292 IHRILQRMCE  301 (301)
T ss_dssp             HHHHHHHTTC
T ss_pred             HHHHHHHhcC
Confidence            9999998863

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2e-46  Score=381.53  Aligned_cols=252  Identities=22%  Similarity=0.278  Sum_probs=200.4

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCc---------chhHHHHHHHHHhcC-CCceeeEeeeecCc
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGA---------SKSSIAECSALRNIR-HKNLVKILTVCSGV  469 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~  469 (741)
                      .+|++.+.||+|+||+||+|++..+++.||||+++......         .+.+.+|+.++++++ |||||+++++    
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~----   78 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT----   78 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE----
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEee----
Confidence            46889999999999999999999999999999997543221         235778999999996 9999999999    


Q ss_pred             cccCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeC
Q 037916          470 DYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLD  549 (741)
Q Consensus       470 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~  549 (741)
                       +.++...|+||||+++|+|.++++..          ..+++.+++.++.||++||+|||++   +|+||||||+||+++
T Consensus        79 -~~~~~~~~ivmE~~~~g~L~~~l~~~----------~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~  144 (277)
T d1phka_          79 -YETNTFFFLVFDLMKKGELFDYLTEK----------VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLD  144 (277)
T ss_dssp             -EECSSEEEEEEECCTTCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred             -cccCcceEEEEEcCCCchHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEc
Confidence             45677999999999999999999643          5689999999999999999999999   999999999999999


Q ss_pred             CCCceEEeecccccccCCCCcccccccccccccccCccccc-----CCCCCCCccCchhHHHHHHHHHcCCCCCCccccC
Q 037916          550 HEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYG-----LGSEVSINGDVYSYGILLLELMTRKRPSDIMFEG  624 (741)
Q Consensus       550 ~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~-----~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~  624 (741)
                      .++.+||+|||+|+........   ....||+.|+|||.+.     ....++.++||||+||++|||++|+.||......
T Consensus       145 ~~~~~kl~DFG~a~~~~~~~~~---~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~  221 (277)
T d1phka_         145 DDMNIKLTDFGFSCQLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM  221 (277)
T ss_dssp             TTCCEEECCCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             CCCCeEEccchheeEccCCCce---eeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH
Confidence            9999999999999887654322   2356999999996553     2445789999999999999999999999632111


Q ss_pred             CcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          625 NMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       625 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      . ........            ......                ......++.+.+++.+||+.||++|||+.||++
T Consensus       222 ~-~~~~i~~~------------~~~~~~----------------~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         222 L-MLRMIMSG------------NYQFGS----------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             H-HHHHHHHT------------CCCCCT----------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             H-HHHHHHhC------------CCCCCC----------------cccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            0 01001110            000000                001134467889999999999999999999864

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-47  Score=387.59  Aligned_cols=259  Identities=26%  Similarity=0.397  Sum_probs=196.7

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      ..|++.++||+|+||.||+|+++. ++.||||+++.. ....+.+.+|+.++++++|||||+++++|.      ++..++
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~------~~~~~l   88 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEPIYI   88 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC------SSSCEE
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECC-CCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEe------cCCeEE
Confidence            457889999999999999999974 467999999743 334577999999999999999999999963      234789


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      ||||+++|+|..++...        ....+++.+++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus        89 v~Ey~~~g~l~~~~~~~--------~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~Df  157 (285)
T d1fmka3          89 VTEYMSKGSLLDFLKGE--------TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADF  157 (285)
T ss_dssp             EECCCTTCBHHHHHSHH--------HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCC
T ss_pred             EEEecCCCchhhhhhhc--------ccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEccc
Confidence            99999999999887632        124589999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcc
Q 037916          560 GLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDH  639 (741)
Q Consensus       560 g~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  639 (741)
                      |+|+........ ......||+.|+||| +...+.++.++|||||||++|||++|..|+...... ......+.....  
T Consensus       158 Gla~~~~~~~~~-~~~~~~gt~~y~aPE-~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-~~~~~~i~~~~~--  232 (285)
T d1fmka3         158 GLARLIEDNEYT-ARQGAKFPIKWTAPE-AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYR--  232 (285)
T ss_dssp             CTTC---------------CCGGGSCHH-HHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHHHHTTCC--
T ss_pred             chhhhccCCCce-eeccccccccccChH-HHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-HHHHHHHHhcCC--
Confidence            999876544322 223356899999995 445677899999999999999999977665422111 111111110000  


Q ss_pred             hhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHhh
Q 037916          640 VMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSIL  710 (741)
Q Consensus       640 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  710 (741)
                                .                  +.+..+++.+.+++.+||+.||++|||++||++.|+......
T Consensus       233 ----------~------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         233 ----------M------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             ----------C------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             ----------C------------------CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence                      0                  001234567889999999999999999999999988866443

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-46  Score=389.96  Aligned_cols=272  Identities=22%  Similarity=0.225  Sum_probs=194.0

Q ss_pred             hhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc-----CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          405 LCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH-----GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       405 ~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      ++.||+|+||+||+|+++.+|+.||||+++....     ...+.+.+|+.++++++|||||++++++     ..+...|+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~-----~~~~~~~i   77 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-----GHKSNISL   77 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-----CCTTCCEE
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeee-----ccCCceee
Confidence            5789999999999999999999999999864322     1245688999999999999999999994     55668999


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeec
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADF  559 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF  559 (741)
                      ||||+.++++..+....          ..+++..+..+++||+.||+|||++   ||+||||||+|||++.++.+||+||
T Consensus        78 vmE~~~~~~~~~~~~~~----------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DF  144 (299)
T d1ua2a_          78 VFDFMETDLEVIIKDNS----------LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADF  144 (299)
T ss_dssp             EEECCSEEHHHHHTTCC----------SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC
T ss_pred             hhhhhcchHHhhhhhcc----------cCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccC
Confidence            99999887777665422          4578889999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCcc
Q 037916          560 GLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPDH  639 (741)
Q Consensus       560 g~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  639 (741)
                      |.|+........  .....||+.|+|||.+..+..++.++||||+||++|||++|..||....+.+ .+...........
T Consensus       145 G~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~l~~i~~~~~~~~  221 (299)
T d1ua2a_         145 GLAKSFGSPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTRIFETLGTPT  221 (299)
T ss_dssp             GGGSTTTSCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCC
T ss_pred             ccccccCCCccc--ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH-HHHHHHHhcCCCC
Confidence            999876544322  2235699999999777667788999999999999999999999986321111 1111111100000


Q ss_pred             hhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          640 VMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       640 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ...+.+..-.............    ..........+.+.+++.+||+.||++|||++|+++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         222 EEQWPDMCSLPDYVTFKSFPGI----PLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             TTTSSSTTSSTTCCCCCCCCCC----CHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhhccchhccchhhhhccCCCC----ChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            0000000000000000000000    000001123456889999999999999999999875

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.8e-46  Score=397.04  Aligned_cols=249  Identities=20%  Similarity=0.231  Sum_probs=195.5

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC---cCcchhHH---HHHHHHHhcCCCceeeEeeeecCccccCC
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH---HGASKSSI---AECSALRNIRHKNLVKILTVCSGVDYKGD  474 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~---~E~~~l~~l~hpnIv~~~~~~~~~~~~~~  474 (741)
                      .|++++.||+|+||.||+|++..+|+.||||++....   ......+.   .|+.+++.++|||||+++++     +.+.
T Consensus         5 dy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~-----~~~~   79 (364)
T d1omwa3           5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA-----FHTP   79 (364)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEE-----EECS
T ss_pred             hCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEE-----EEEC
Confidence            5888999999999999999999999999999986321   12222333   44667777899999999999     4556


Q ss_pred             ceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCce
Q 037916          475 DFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTA  554 (741)
Q Consensus       475 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~  554 (741)
                      +..|+||||++||+|.+++...          ..+++..++.++.||+.||+|||++   +||||||||+|||++.+|.+
T Consensus        80 ~~~~ivmE~~~gg~L~~~l~~~----------~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~i  146 (364)
T d1omwa3          80 DKLSFILDLMNGGDLHYHLSQH----------GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHV  146 (364)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHH----------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCE
T ss_pred             CEEEEEEEecCCCcHHHHHHhc----------ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcE
Confidence            7899999999999999998643          5578899999999999999999999   99999999999999999999


Q ss_pred             EEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhh
Q 037916          555 HVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       555 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  634 (741)
                      ||+|||+|+.......    ....||+.|+|||.+..+..++.++||||+||++|||++|+.||......  ........
T Consensus       147 Kl~DFGla~~~~~~~~----~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~~~~~  220 (364)
T d1omwa3         147 RISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--DKHEIDRM  220 (364)
T ss_dssp             EECCCTTCEECSSSCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS--CHHHHHHH
T ss_pred             EEeeeceeeecCCCcc----cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHh
Confidence            9999999987654432    22569999999977666778999999999999999999999999632211  11111111


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCC-----HHHHHH
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMN-----MTIVVH  701 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  701 (741)
                      .....            ..                .+..+++.+.+++.+||+.||++|||     ++|+++
T Consensus       221 ~~~~~------------~~----------------~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         221 TLTMA------------VE----------------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             SSSCC------------CC----------------CCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             cccCC------------CC----------------CCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            11100            00                00123456789999999999999999     677764

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.8e-46  Score=388.00  Aligned_cols=245  Identities=23%  Similarity=0.249  Sum_probs=199.3

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeecc---CcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCce
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLL---HHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      ..|++++.||+|+||+||+|+++.+|+.||||+++..   .....+.+.+|+.++++++|||||+++++     +.++..
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~-----~~~~~~   78 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGT-----FQDAQQ   78 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEE-----EECSSE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeee-----EeeCCe
Confidence            3588999999999999999999999999999999732   23445678899999999999999999999     456679


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .|+||||++||++..++...          ..+++..++.++.||+.||+|||++   +|+||||||+|||++.+|.+||
T Consensus        79 ~~ivmE~~~gg~l~~~~~~~----------~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL  145 (316)
T d1fota_          79 IFMIMDYIEGGELFSLLRKS----------QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKI  145 (316)
T ss_dssp             EEEEECCCCSCBHHHHHHHT----------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEE
T ss_pred             eeeEeeecCCcccccccccc----------ccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEE
Confidence            99999999999999988643          5578888899999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcC
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVL  636 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  636 (741)
                      +|||+|+......     ....||+.|+||| +..+..++.++||||+||++|||++|+.||.....     .....   
T Consensus       146 ~DFG~a~~~~~~~-----~~~~Gt~~Y~APE-~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~-----~~~~~---  211 (316)
T d1fota_         146 TDFGFAKYVPDVT-----YTLCGTPDYIAPE-VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-----MKTYE---  211 (316)
T ss_dssp             CCCSSCEECSSCB-----CCCCSCTTTCCHH-HHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHH---
T ss_pred             ecCccceEecccc-----ccccCcccccCHH-HHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH-----HHHHH---
Confidence            9999998765432     2357999999995 55677899999999999999999999999863211     11111   


Q ss_pred             CcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCC-----CHHHHHH
Q 037916          637 PDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRM-----NMTIVVH  701 (741)
Q Consensus       637 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  701 (741)
                           .+..    ....                .+...++.+.+++.+||+.||++||     |++|+++
T Consensus       212 -----~i~~----~~~~----------------~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         212 -----KILN----AELR----------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             -----HHHH----CCCC----------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             -----HHHc----CCCC----------------CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence                 0110    0000                0012345678999999999999996     8999875

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-46  Score=389.95  Aligned_cols=252  Identities=19%  Similarity=0.280  Sum_probs=200.2

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      +.+|++.+.||+|+||+||+|.+..+++.||+|+++... .....+.+|+.+|++++|||||+++++     ++++...|
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~-----~~~~~~~~   77 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHES-----FESMEELV   77 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEE-----EEETTEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEE-----EEECCEEE
Confidence            457899999999999999999999999999999997532 233457899999999999999999999     55667899


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCC--CceEE
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHE--MTAHV  556 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~--~~~kL  556 (741)
                      +|||||+||+|.+++...         ...+++.+++.++.||+.||+|||+.   ||+||||||+|||++.+  +.+||
T Consensus        78 lvmE~~~gg~L~~~i~~~---------~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl  145 (321)
T d1tkia_          78 MIFEFISGLDIFERINTS---------AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKI  145 (321)
T ss_dssp             EEECCCCCCBHHHHHTSS---------SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEE
T ss_pred             EEEecCCCCcHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEE
Confidence            999999999999999643         23589999999999999999999999   99999999999999854  48999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcC
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVL  636 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  636 (741)
                      +|||.+.........   ....||+.|+||| ...+..++.++||||+||++|+|++|..||......     ....   
T Consensus       146 ~DFG~~~~~~~~~~~---~~~~~t~~y~ape-~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~-----~~~~---  213 (321)
T d1tkia_         146 IEFGQARQLKPGDNF---RLLFTAPEYYAPE-VHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-----QIIE---  213 (321)
T ss_dssp             CCCTTCEECCTTCEE---EEEESCGGGSCHH-HHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHH---
T ss_pred             cccchhhccccCCcc---cccccccccccch-hccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH-----HHHH---
Confidence            999999876543322   2245899999995 556778999999999999999999999998632110     0100   


Q ss_pred             CcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          637 PDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       637 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                           .+.........                .......+.+.+++.+||..||++|||+.|+++
T Consensus       214 -----~i~~~~~~~~~----------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         214 -----NIMNAEYTFDE----------------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             -----HHHHTCCCCCH----------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -----HHHhCCCCCCh----------------hhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 11110000000                001123456789999999999999999999986

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-46  Score=383.61  Aligned_cols=258  Identities=20%  Similarity=0.266  Sum_probs=192.5

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCC---CeEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCc
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEG---KTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDD  475 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  475 (741)
                      ..|++.+.||+|+||.||+|++..+   +..||+|+++... ....+.+.+|+.++++++|||||+++++|.      .+
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~------~~   80 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------EN   80 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC------SS
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe------cC
Confidence            3578889999999999999998643   4578899886432 223456889999999999999999999862      24


Q ss_pred             eEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceE
Q 037916          476 FKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAH  555 (741)
Q Consensus       476 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k  555 (741)
                      ..|+||||+++|++.+++...         ...+++..++.++.||++||+|||+.   +|+||||||+||+++.++.+|
T Consensus        81 ~~~iv~E~~~~g~l~~~~~~~---------~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~K  148 (273)
T d1mp8a_          81 PVWIIMELCTLGELRSFLQVR---------KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVK  148 (273)
T ss_dssp             SCEEEEECCTTEEHHHHHHHT---------TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEE
T ss_pred             eEEEEEEeccCCcHHhhhhcc---------CCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEE
Confidence            679999999999999987533         24588999999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhhhh
Q 037916          556 VADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFART  634 (741)
Q Consensus       556 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  634 (741)
                      |+|||+|+......... .....||+.|+||| +..+..++.++|||||||++|||++ |.+||......  .+...+..
T Consensus       149 l~DfG~a~~~~~~~~~~-~~~~~gt~~y~apE-~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~--~~~~~i~~  224 (273)
T d1mp8a_         149 LGDFGLSRYMEDSTYYK-ASKGKLPIKWMAPE-SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIEN  224 (273)
T ss_dssp             ECC--------------------CCGGGCCHH-HHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHT
T ss_pred             EccchhheeccCCccee-ccceecCcccchhh-HhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH--HHHHHHHc
Confidence            99999998765433222 22355899999995 5566789999999999999999998 88898633211  11111111


Q ss_pred             cCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHh
Q 037916          635 VLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSI  709 (741)
Q Consensus       635 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  709 (741)
                      ....                              ..+..+++.+.+++.+||+.||++|||+.||++.|+.+.+.
T Consensus       225 ~~~~------------------------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         225 GERL------------------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             TCCC------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCC------------------------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            0000                              01123456788999999999999999999999999998765

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-46  Score=390.87  Aligned_cols=257  Identities=19%  Similarity=0.206  Sum_probs=197.1

Q ss_pred             HHHHHHhh-hcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhc-CCCceeeEeeeecCccccCCce
Q 037916          399 FVSFLFLC-WIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       399 ~~~y~~~~-~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      ...|.+++ .||+|+||.||+|++..+++.||||+++.     .....+|+.++.++ +|||||++++++... +.....
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~-~~~~~~   83 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC   83 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeec-ccCCCE
Confidence            35688875 49999999999999999999999999863     35677899987655 899999999986431 133567


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCC---CCc
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDH---EMT  553 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~---~~~  553 (741)
                      .|+|||||+||+|.+++...        ....+++.+++.++.||+.||+|||+.   ||+||||||+|||++.   .+.
T Consensus        84 ~~ivmEy~~gg~L~~~i~~~--------~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~  152 (335)
T d2ozaa1          84 LLIVMECLDGGELFSRIQDR--------GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAI  152 (335)
T ss_dssp             EEEEEECCCSEEHHHHHHSC--------SCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCC
T ss_pred             EEEEEECCCCCcHHHHHHhc--------CCCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccc
Confidence            89999999999999999643        124689999999999999999999999   9999999999999985   457


Q ss_pred             eEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhh
Q 037916          554 AHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFAR  633 (741)
Q Consensus       554 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~  633 (741)
                      +||+|||+|+........   ....||+.|+|| |+..+..|+.++||||+||++|+|++|+.||....... .......
T Consensus       153 ~Kl~DFG~a~~~~~~~~~---~~~~gt~~y~aP-E~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~-~~~~~~~  227 (335)
T d2ozaa1         153 LKLTDFGFAKETTSHNSL---TTPCYTPYYVAP-EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-ISPGMKT  227 (335)
T ss_dssp             EEECCCTTCEECCCCCCC---CCCSCCCSSCCC-CCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------
T ss_pred             ccccccceeeeccCCCcc---ccccCCcccCCc-HHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH-HHHHHHH
Confidence            999999999876654322   235699999999 55667789999999999999999999999996321111 0110100


Q ss_pred             hcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          634 TVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       634 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ...... ..         ..              .......++.+.+++.+||+.||++|||+.|+++
T Consensus       228 ~i~~~~-~~---------~~--------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         228 RIRMGQ-YE---------FP--------------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             CCCSCS-SS---------CC--------------TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHhcCC-CC---------CC--------------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            000000 00         00              0011234567889999999999999999999986

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-46  Score=383.80  Aligned_cols=264  Identities=25%  Similarity=0.381  Sum_probs=203.6

Q ss_pred             hhhcccCceeeEEEEEEcCC---CeEEEEEEeecc-CcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEE
Q 037916          405 LCWIDMGSFGSVYKGILDEG---KTIIAVKVLNLL-HHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALV  480 (741)
Q Consensus       405 ~~~ig~G~~g~V~~a~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv  480 (741)
                      .++||+|+||+||+|++..+   ...||||+++.. .....+++.+|++++++++|||||+++++|.    ..+...++|
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~----~~~~~~~lv  107 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL----RSEGSPLVV  107 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE----ETTTEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEE----ecCCceEEE
Confidence            35799999999999998643   346999998742 3334567899999999999999999999973    344578999


Q ss_pred             EecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEeecc
Q 037916          481 YEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVADFG  560 (741)
Q Consensus       481 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFg  560 (741)
                      |||+++|+|.+++...         ....++..++.++.|++.||.|+|+.   +|+||||||+|||+++++.+||+|||
T Consensus       108 ~E~~~~g~l~~~~~~~---------~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG  175 (311)
T d1r0pa_         108 LPYMKHGDLRNFIRNE---------THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFG  175 (311)
T ss_dssp             EECCTTCBHHHHHHCT---------TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSG
T ss_pred             EEEeecCchhhhhccc---------cccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEeccc
Confidence            9999999999988643         24467788899999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCcc--cccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCc
Q 037916          561 LAKLLPPAHLQ--TSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       561 ~a~~~~~~~~~--~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      +++........  .......||+.|+|||. ..+..++.++|||||||++|||++|..||....... .....+......
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~-~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-~~~~~i~~g~~~  253 (311)
T d1r0pa_         176 LARDMYDKEFDSVHNKTGAKLPVKWMALES-LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVYLLQGRRL  253 (311)
T ss_dssp             GGCCTTTTTCCCTTCTTCSSCCGGGSCHHH-HHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHTTCCC
T ss_pred             chhhccccccccceecccccccccccChHH-HhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-HHHHHHHcCCCC
Confidence            99877544322  22233568999999954 456778999999999999999999888875322111 111111111000


Q ss_pred             chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHhhcCCccc
Q 037916          639 HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSILLGPKTV  716 (741)
Q Consensus       639 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~  716 (741)
                      .                              .+..+++.+.+++.+||+.||++||||.||++.|+++.+........
T Consensus       254 ~------------------------------~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~~~~  301 (311)
T d1r0pa_         254 L------------------------------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYV  301 (311)
T ss_dssp             C------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCCBC
T ss_pred             C------------------------------CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhhhch
Confidence            0                              01123456889999999999999999999999999999876655443

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-45  Score=382.22  Aligned_cols=279  Identities=22%  Similarity=0.261  Sum_probs=200.1

Q ss_pred             HHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHH--HHHHHHHhcCCCceeeEeeeecCccccCCceEEE
Q 037916          402 FLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSI--AECSALRNIRHKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       402 y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~--~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      |.+.++||+|+||.||+|++  +|+.||||+++..   ..+.+.  .|+..+.+++|||||+++++|.... ......|+
T Consensus         5 ~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~~l   78 (303)
T d1vjya_           5 IVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWL   78 (303)
T ss_dssp             EEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEE
T ss_pred             EEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEEEE
Confidence            56678899999999999997  4889999998632   223333  4555556789999999999985432 23346899


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhc-----CCCCceecCCCCCCeEeCCCCce
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHD-----CQPTTAHCDLKPSNVLLDHEMTA  554 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-----~~~~ivHrDlkp~NIll~~~~~~  554 (741)
                      ||||+++|+|.++++.           ..+++.+++.++.|++.||+|+|+.     ..++|+||||||+|||++.++.+
T Consensus        79 v~Ey~~~g~L~~~l~~-----------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~  147 (303)
T d1vjya_          79 VSDYHEHGSLFDYLNR-----------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC  147 (303)
T ss_dssp             EEECCTTCBHHHHHHH-----------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCE
T ss_pred             EEecccCCCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCe
Confidence            9999999999999963           3588999999999999999999963     12499999999999999999999


Q ss_pred             EEeecccccccCCCCcc--cccccccccccccCcccccCCC-----CCCCccCchhHHHHHHHHHcCCCCCCccccCCcc
Q 037916          555 HVADFGLAKLLPPAHLQ--TSSIGVKGTIGYIAPAEYGLGS-----EVSINGDVYSYGILLLELMTRKRPSDIMFEGNMN  627 (741)
Q Consensus       555 kL~DFg~a~~~~~~~~~--~~~~~~~gt~~y~aPEe~~~~~-----~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~  627 (741)
                      ||+|||+++........  .......||+.|+|||.+....     .++.++|||||||++|||+||..||.........
T Consensus       148 Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~  227 (303)
T d1vjya_         148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP  227 (303)
T ss_dssp             EECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred             EEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccc
Confidence            99999999877543321  1223466999999996443221     3678899999999999999999887643322222


Q ss_pred             hhhhhhhcCCcc--hhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHH
Q 037916          628 LHNFARTVLPDH--VMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQS  705 (741)
Q Consensus       628 ~~~~~~~~~~~~--~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  705 (741)
                      ............  .....+....+...             ......+....+.+++.+||+.||++|||+.||++.|++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~-------------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~  294 (303)
T d1vjya_         228 YYDLVPSDPSVEEMRKVVCEQKLRPNIP-------------NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ  294 (303)
T ss_dssp             TTTTSCSSCCHHHHHHHHTTSCCCCCCC-------------GGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred             hhhcccccchHHHHHHHHhccccCCCCC-------------cccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence            221111111000  11111111111111             011122456778999999999999999999999999999


Q ss_pred             HHHhh
Q 037916          706 IKSIL  710 (741)
Q Consensus       706 i~~~~  710 (741)
                      +.+..
T Consensus       295 i~~~~  299 (303)
T d1vjya_         295 LSQQE  299 (303)
T ss_dssp             HHHHH
T ss_pred             HHHhc
Confidence            98654

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.4e-46  Score=389.75  Aligned_cols=245  Identities=20%  Similarity=0.202  Sum_probs=199.5

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeecc---CcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCce
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLL---HHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      .+|++++.||+|+||.||+|+++.+|+.||||+++..   .....+.+.+|+.+++.++|||||+++++     +.+...
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~-----~~~~~~  115 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS-----FKDNSN  115 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEE-----EECSSE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccc-----cccccc
Confidence            4688999999999999999999999999999999632   23345678899999999999999999999     456668


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .++||||+.+|+|.+++...          ..+++..++.++.||+.||.|||++   +||||||||+|||++.++.+||
T Consensus       116 ~~~v~e~~~~g~l~~~l~~~----------~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL  182 (350)
T d1rdqe_         116 LYMVMEYVAGGEMFSHLRRI----------GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQV  182 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHH----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEE
T ss_pred             cccccccccccchhhhHhhc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEe
Confidence            99999999999999998643          4689999999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcC
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVL  636 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  636 (741)
                      +|||+|+......     ....||+.|+||| +..+..++.++||||+||++|||++|+.||....     .......  
T Consensus       183 ~DFG~a~~~~~~~-----~~~~Gt~~Y~APE-~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~-----~~~~~~~--  249 (350)
T d1rdqe_         183 TDFGFAKRVKGRT-----WTLCGTPEALAPE-IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PIQIYEK--  249 (350)
T ss_dssp             CCCTTCEECSSCB-----CCCEECGGGCCHH-HHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHH--
T ss_pred             eeceeeeeccccc-----ccccCccccCCHH-HHcCCCCCccccccchhHHHHHHHhCCCCCCCcC-----HHHHHHH--
Confidence            9999998765332     2356999999995 5567789999999999999999999999986321     1111110  


Q ss_pred             CcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCC-----CHHHHHH
Q 037916          637 PDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRM-----NMTIVVH  701 (741)
Q Consensus       637 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  701 (741)
                            +......                    .+...++.+.+++.+||+.||++|+     |++|+++
T Consensus       250 ------i~~~~~~--------------------~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         250 ------IVSGKVR--------------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ------HHHCCCC--------------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ------HhcCCCC--------------------CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence                  0000000                    0012345678999999999999994     8999875

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-46  Score=383.33  Aligned_cols=269  Identities=23%  Similarity=0.323  Sum_probs=202.1

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCC-------CeEEEEEEeeccCc-CcchhHHHHHHHHHhc-CCCceeeEeeeecCcc
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEG-------KTIIAVKVLNLLHH-GASKSSIAECSALRNI-RHKNLVKILTVCSGVD  470 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~-------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~  470 (741)
                      ..|++++.||+|+||.||+|++..+       +..||||+++.... .....+.+|...+.++ +|||||+++++|.   
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~---   89 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT---   89 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC---
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc---
Confidence            4578889999999999999997543       35799999974332 2346678898888888 8999999999963   


Q ss_pred             ccCCceEEEEEecccCCChhhhccCCCCCC------cccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCC
Q 037916          471 YKGDDFKALVYEFMHNGSLEEWLHPVSGAD------KTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPS  544 (741)
Q Consensus       471 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~  544 (741)
                        ++...++||||+++|+|.+++.......      ........+++.+++.++.||+.||+|||+.   +||||||||+
T Consensus        90 --~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~  164 (299)
T d1fgka_          90 --QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR  164 (299)
T ss_dssp             --SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred             --cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeeccc
Confidence              4557899999999999999997543211      1112235689999999999999999999999   9999999999


Q ss_pred             CeEeCCCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCcccc
Q 037916          545 NVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFE  623 (741)
Q Consensus       545 NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~  623 (741)
                      |||++.++.+||+|||.++...............||+.|+|||. ..++.++.++|||||||++|||++ |..||.....
T Consensus       165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~-l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~  243 (299)
T d1fgka_         165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEA-LFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  243 (299)
T ss_dssp             GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHH-HHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhH-hcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence            99999999999999999987765544444445679999999954 456789999999999999999998 6888752211


Q ss_pred             CCcchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHH
Q 037916          624 GNMNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHEL  703 (741)
Q Consensus       624 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  703 (741)
                        ......            +........                  +..+++.+.+++.+||+.||++||||.||++.|
T Consensus       244 --~~~~~~------------i~~~~~~~~------------------p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L  291 (299)
T d1fgka_         244 --EELFKL------------LKEGHRMDK------------------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL  291 (299)
T ss_dssp             --HHHHHH------------HHTTCCCCC------------------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             --HHHHHH------------HHcCCCCCC------------------CccchHHHHHHHHHHccCCHhHCcCHHHHHHHH
Confidence              111111            111100000                  112345688999999999999999999999999


Q ss_pred             HHHHHh
Q 037916          704 QSIKSI  709 (741)
Q Consensus       704 ~~i~~~  709 (741)
                      +++...
T Consensus       292 ~~i~a~  297 (299)
T d1fgka_         292 DRIVAL  297 (299)
T ss_dssp             HHHHHH
T ss_pred             HHHhhc
Confidence            998653

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-45  Score=382.26  Aligned_cols=275  Identities=25%  Similarity=0.284  Sum_probs=198.4

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC--cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      .|+++++||+|+||.||+|++..+++.||||+++...  ....+.+.+|+.++++++|||||++++++     .++...|
T Consensus         3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~-----~~~~~~~   77 (298)
T d1gz8a_           3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY   77 (298)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTEEE
T ss_pred             CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccc-----cccccee
Confidence            5788999999999999999999999999999996432  23456788999999999999999999994     5567899


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      +||||+.+ ++.+++...        ....+++..++.++.||+.||+|||++   |||||||||+|||++.++.+||+|
T Consensus        78 iv~e~~~~-~~~~~~~~~--------~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~D  145 (298)
T d1gz8a_          78 LVFEFLHQ-DLKKFMDAS--------ALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLAD  145 (298)
T ss_dssp             EEEECCSE-EHHHHHHHT--------TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECS
T ss_pred             EEEeecCC-chhhhhhhh--------cccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceecc
Confidence            99999965 444444221        124589999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhc-CC
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTV-LP  637 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~-~~  637 (741)
                      ||.|+........  .....||+.|+|||.+.....++.++||||+||++|+|++|+.||......+ .+....... .+
T Consensus       146 FG~a~~~~~~~~~--~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~-~~~~i~~~~~~~  222 (298)
T d1gz8a_         146 FGLARAFGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTP  222 (298)
T ss_dssp             TTHHHHHCCCSBC--TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCC
T ss_pred             CCcceeccCCccc--ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH-HHHHHHHhcCCC
Confidence            9999877544322  2235699999999777777778999999999999999999999996321111 111111110 00


Q ss_pred             cc-hhHhhhhc--ccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          638 DH-VMDIVDST--LLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       638 ~~-~~~~~d~~--l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      .. ........  ......       ...............+.+.+++.+||+.||++|||++|+++-
T Consensus       223 ~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         223 DEVVWPGVTSMPDYKPSFP-------KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             CTTTSTTGGGSTTCCTTSC-------CCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             chhhccccccccccccccc-------cccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            00 00000000  000000       000000001111234567899999999999999999999863

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-45  Score=383.70  Aligned_cols=270  Identities=20%  Similarity=0.277  Sum_probs=207.6

Q ss_pred             HHHHhhhcccCceeeEEEEEEc-----CCCeEEEEEEeeccCc-CcchhHHHHHHHHHhc-CCCceeeEeeeecCccccC
Q 037916          401 SFLFLCWIDMGSFGSVYKGILD-----EGKTIIAVKVLNLLHH-GASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKG  473 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~  473 (741)
                      .|++.++||+|+||.||+|++.     .+++.||||+++.... .....+.+|+.+++++ +|||||+++++|     .+
T Consensus        24 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~-----~~   98 (311)
T d1t46a_          24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC-----TI   98 (311)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CS
T ss_pred             HeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE-----ee
Confidence            4667889999999999999863     4678999999975332 2345678999999999 699999999996     34


Q ss_pred             CceEEEEEecccCCChhhhccCCCCCCc--------ccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCC
Q 037916          474 DDFKALVYEFMHNGSLEEWLHPVSGADK--------TVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSN  545 (741)
Q Consensus       474 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~--------~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~N  545 (741)
                      ....++||||+++|+|.++++.......        .......+++..+..++.||++||+|||++   +||||||||+|
T Consensus        99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~N  175 (311)
T d1t46a_          99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN  175 (311)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccc
Confidence            5578999999999999999875432110        111234689999999999999999999999   99999999999


Q ss_pred             eEeCCCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCC
Q 037916          546 VLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGN  625 (741)
Q Consensus       546 Ill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~  625 (741)
                      |+++.++.+|++|||.++...............||+.|+||| +..+..++.++|||||||++|||+|+..|+.......
T Consensus       176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE-~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~  254 (311)
T d1t46a_         176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPE-SIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (311)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHH-HHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             ccccccCcccccccchheeccCCCcceEeeecccChHHcCHH-HhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence            999999999999999999876655444445567999999994 4566789999999999999999999555543222222


Q ss_pred             cchhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHH
Q 037916          626 MNLHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQS  705 (741)
Q Consensus       626 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  705 (741)
                      ..+...+....+            ...                  +..+++.+.+|+.+||+.||++||||.||++.|++
T Consensus       255 ~~~~~~i~~~~~------------~~~------------------~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~  304 (311)
T d1t46a_         255 SKFYKMIKEGFR------------MLS------------------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK  304 (311)
T ss_dssp             HHHHHHHHHTCC------------CCC------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHHHhcCCC------------CCC------------------cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            222222221111            111                  11234668899999999999999999999999998


Q ss_pred             HHHh
Q 037916          706 IKSI  709 (741)
Q Consensus       706 i~~~  709 (741)
                      +.+.
T Consensus       305 ~i~~  308 (311)
T d1t46a_         305 QISE  308 (311)
T ss_dssp             HHHH
T ss_pred             hhcc
Confidence            7754

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-46  Score=384.72  Aligned_cols=247  Identities=22%  Similarity=0.311  Sum_probs=196.5

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeecc---CcCcchhHHHHHHHHH-hcCCCceeeEeeeecCccccCCce
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLL---HHGASKSSIAECSALR-NIRHKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      .|++++.||+|+||+||+|++..+++.||||+++..   .....+.+..|..++. .++|||||+++++     +.++..
T Consensus         3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~-----~~~~~~   77 (320)
T d1xjda_           3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCT-----FQTKEN   77 (320)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEE-----EECSSE
T ss_pred             CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEE-----EccCCc
Confidence            478899999999999999999999999999999742   2333456667777765 6899999999999     456678


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .|+||||+++|+|.+++...          ..+++.+++.++.||+.||+|||++   +|+||||||+|||+++++.+||
T Consensus        78 ~yivmEy~~~g~L~~~i~~~----------~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl  144 (320)
T d1xjda_          78 LFFVMEYLNGGDLMYHIQSC----------HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKI  144 (320)
T ss_dssp             EEEEEECCTTCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEE
T ss_pred             eeEEEeecCCCcHHHHhhcc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceec
Confidence            99999999999999999643          4578899999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcC
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVL  636 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  636 (741)
                      +|||.|+........  .....||+.|+|| |+..+..++.++||||+||++|||++|+.||.....  ..+...+... 
T Consensus       145 ~DFG~a~~~~~~~~~--~~~~~gt~~y~aP-E~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~--~~~~~~i~~~-  218 (320)
T d1xjda_         145 ADFGMCKENMLGDAK--TNTFCGTPDYIAP-EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--EELFHSIRMD-  218 (320)
T ss_dssp             CCCTTCBCCCCTTCC--BCCCCSCGGGCCH-HHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHC-
T ss_pred             cccchhhhccccccc--ccccCCCCCcCCH-HHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH--HHHHHHHHcC-
Confidence            999999866543322  2335699999999 555677899999999999999999999999863211  1111000000 


Q ss_pred             CcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHH-HHHH
Q 037916          637 PDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMT-IVVH  701 (741)
Q Consensus       637 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~  701 (741)
                                    ...                .+..+++.+.+++.+||+.||++|||+. |+++
T Consensus       219 --------------~~~----------------~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         219 --------------NPF----------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             --------------CCC----------------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             --------------CCC----------------CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence                          000                0012345678999999999999999995 6753

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-46  Score=377.33  Aligned_cols=241  Identities=20%  Similarity=0.234  Sum_probs=193.3

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcC------cchhHHHHHHHHHhcC--CCceeeEeeeecCccc
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG------ASKSSIAECSALRNIR--HKNLVKILTVCSGVDY  471 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~~~  471 (741)
                      ++|++.+.||+|+||.||+|++..+++.||||+++.....      ...++.+|+.++++++  |||||+++++     +
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~-----~   78 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW-----F   78 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE-----E
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEE-----E
Confidence            4688999999999999999999999999999999743221      2244678999999986  8999999999     4


Q ss_pred             cCCceEEEEEecccC-CChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCC
Q 037916          472 KGDDFKALVYEFMHN-GSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDH  550 (741)
Q Consensus       472 ~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~  550 (741)
                      .+.+..++||||+.+ +++.+++...          ..+++.+++.++.||++||+|||+.   +|+||||||+|||++.
T Consensus        79 ~~~~~~~lv~e~~~~~~~l~~~~~~~----------~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~  145 (273)
T d1xwsa_          79 ERPDSFVLILERPEPVQDLFDFITER----------GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDL  145 (273)
T ss_dssp             ECSSEEEEEEECCSSEEEHHHHHHHH----------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEET
T ss_pred             eeCCeEEEEEEeccCcchHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEec
Confidence            566789999999976 5777777532          5689999999999999999999999   9999999999999985


Q ss_pred             C-CceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchh
Q 037916          551 E-MTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLH  629 (741)
Q Consensus       551 ~-~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~  629 (741)
                      + +.+||+|||+|+.......    ....||+.|+|||.+.....++.++||||+||++|||++|+.||....       
T Consensus       146 ~~~~vkl~DFG~a~~~~~~~~----~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------  214 (273)
T d1xwsa_         146 NRGELKLIDFGSGALLKDTVY----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------  214 (273)
T ss_dssp             TTTEEEECCCTTCEECCSSCB----CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------
T ss_pred             CCCeEEECccccceecccccc----cccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------
Confidence            4 7999999999987654322    235699999999666555566788999999999999999999986321       


Q ss_pred             hhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          630 NFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       630 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      .....            .....                    ...++++.+++.+||+.||++|||++|+++
T Consensus       215 ~i~~~------------~~~~~--------------------~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         215 EIIRG------------QVFFR--------------------QRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             HHHHC------------CCCCS--------------------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHhhc------------ccCCC--------------------CCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            00000            00000                    012356789999999999999999999875

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-46  Score=376.95  Aligned_cols=256  Identities=23%  Similarity=0.278  Sum_probs=190.1

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCC---CeEEEEEEeeccC---cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCC
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEG---KTIIAVKVLNLLH---HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGD  474 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~---~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~  474 (741)
                      .|++++.||+|+||.||+|++...   ...||||+++...   ....+++.+|+.++++++|||||+++++|..      
T Consensus         9 d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~------   82 (273)
T d1u46a_           9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT------   82 (273)
T ss_dssp             GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS------
T ss_pred             HeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee------
Confidence            578899999999999999987432   3479999986432   2234678999999999999999999999632      


Q ss_pred             ceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCce
Q 037916          475 DFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTA  554 (741)
Q Consensus       475 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~  554 (741)
                      ...++||||+++|++.+++...         ...+++..++.++.||+.||.|||++   +|+||||||+||+++.++.+
T Consensus        83 ~~~~lv~e~~~~~~l~~~~~~~---------~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~v  150 (273)
T d1u46a_          83 PPMKMVTELAPLGSLLDRLRKH---------QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLV  150 (273)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHH---------GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEE
T ss_pred             cchheeeeeecCcchhhhhhcc---------cCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccce
Confidence            2568999999999999887532         35689999999999999999999999   99999999999999999999


Q ss_pred             EEeecccccccCCCCccc-ccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHc-CCCCCCccccCCcchhhhh
Q 037916          555 HVADFGLAKLLPPAHLQT-SSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMT-RKRPSDIMFEGNMNLHNFA  632 (741)
Q Consensus       555 kL~DFg~a~~~~~~~~~~-~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~  632 (741)
                      ||+|||+++......... ......|+..|+||| +..+..++.++|||||||++|||+| |+.||......     +..
T Consensus       151 kl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE-~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~-----~~~  224 (273)
T d1u46a_         151 KIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE-SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-----QIL  224 (273)
T ss_dssp             EECCCTTCEECCC-CCEEEC-----CCGGGCCHH-HHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHH
T ss_pred             eeccchhhhhcccCCCcceecCccccCcccCCHH-HHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH-----HHH
Confidence            999999999875543322 222345788999995 4556789999999999999999998 89998632111     111


Q ss_pred             hhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHH
Q 037916          633 RTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSI  706 (741)
Q Consensus       633 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  706 (741)
                      ......        ....                  +.+..++..+.+++.+||+.||++||||.||.+.|++.
T Consensus       225 ~~i~~~--------~~~~------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         225 HKIDKE--------GERL------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             HHHHTS--------CCCC------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHhC--------CCCC------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            110000        0000                  00113346688999999999999999999999988764

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-45  Score=381.40  Aligned_cols=269  Identities=22%  Similarity=0.307  Sum_probs=201.8

Q ss_pred             HHHHHHhhhcccCceeeEEEEEEcCCCeE--EEEEEeecc-CcCcchhHHHHHHHHHhc-CCCceeeEeeeecCccccCC
Q 037916          399 FVSFLFLCWIDMGSFGSVYKGILDEGKTI--IAVKVLNLL-HHGASKSSIAECSALRNI-RHKNLVKILTVCSGVDYKGD  474 (741)
Q Consensus       399 ~~~y~~~~~ig~G~~g~V~~a~~~~~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~  474 (741)
                      +..|++.+.||+|+||.||+|+++.++..  ||||.++.. .....+.+.+|+.+++++ +|||||+++++|     .++
T Consensus         9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~-----~~~   83 (309)
T d1fvra_           9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHR   83 (309)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEE-----EET
T ss_pred             HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEE-----ecC
Confidence            35678889999999999999999877764  677777532 334566789999999998 799999999996     345


Q ss_pred             ceEEEEEecccCCChhhhccCCCCCC------cccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEe
Q 037916          475 DFKALVYEFMHNGSLEEWLHPVSGAD------KTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLL  548 (741)
Q Consensus       475 ~~~~lv~e~~~~gsL~~~l~~~~~~~------~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll  548 (741)
                      +..++||||+++|+|.++++......      ........+++..+.+++.||+.||.|+|+.   +|+||||||+|||+
T Consensus        84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~  160 (309)
T d1fvra_          84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILV  160 (309)
T ss_dssp             TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred             CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEE
Confidence            68999999999999999986431000      0011235689999999999999999999999   99999999999999


Q ss_pred             CCCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCC-CCCccccCCcc
Q 037916          549 DHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKR-PSDIMFEGNMN  627 (741)
Q Consensus       549 ~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~-p~~~~~~~~~~  627 (741)
                      +.++.+||+|||+|+........   ....||..|+|||.+ .++.++.++|||||||++|||++|.. ||...     .
T Consensus       161 ~~~~~~kl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~l-~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~-----~  231 (309)
T d1fvra_         161 GENYVAKIADFGLSRGQEVYVKK---TMGRLPVRWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-----T  231 (309)
T ss_dssp             CGGGCEEECCTTCEESSCEECCC-------CCTTTCCHHHH-HHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-----C
T ss_pred             cCCCceEEccccccccccccccc---cceecCCcccchHHh-ccCCCCccceeehhHHHHHHHHhcCCCCCCCC-----C
Confidence            99999999999999765433221   224589999999654 56788999999999999999999765 55421     1


Q ss_pred             hhhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHH
Q 037916          628 LHNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIK  707 (741)
Q Consensus       628 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  707 (741)
                      ..+......         .....                  ..+..+++.+.+++.+||+.||++||||+||++.|+++.
T Consensus       232 ~~~~~~~i~---------~~~~~------------------~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~  284 (309)
T d1fvra_         232 CAELYEKLP---------QGYRL------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  284 (309)
T ss_dssp             HHHHHHHGG---------GTCCC------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHH---------hcCCC------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            111111100         00000                  001134567889999999999999999999999999998


Q ss_pred             Hhhc
Q 037916          708 SILL  711 (741)
Q Consensus       708 ~~~~  711 (741)
                      +...
T Consensus       285 ~~~~  288 (309)
T d1fvra_         285 EERK  288 (309)
T ss_dssp             HSSS
T ss_pred             hcCc
Confidence            7543

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-46  Score=384.64  Aligned_cols=268  Identities=19%  Similarity=0.314  Sum_probs=204.2

Q ss_pred             HHHHHhhhcccCceeeEEEEEEc-----CCCeEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccC
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILD-----EGKTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKG  473 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  473 (741)
                      ..|++.++||+|+||.||+|.++     .+++.||||+++... ......+.+|+.++++++|||||+++++|     ..
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~-----~~   94 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV-----SQ   94 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE-----CS
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEE-----ec
Confidence            45677889999999999999985     235789999997432 22334678999999999999999999996     34


Q ss_pred             CceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCc
Q 037916          474 DDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMT  553 (741)
Q Consensus       474 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~  553 (741)
                      +...++||||+++|+|.+++...+...........+++..+..++.|+++||.|||++   +|+||||||+|||++++++
T Consensus        95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~  171 (308)
T d1p4oa_          95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT  171 (308)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCC
T ss_pred             CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCce
Confidence            5578999999999999999864321111111224478899999999999999999999   9999999999999999999


Q ss_pred             eEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCC-CCCCccccCCcchhhhh
Q 037916          554 AHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRK-RPSDIMFEGNMNLHNFA  632 (741)
Q Consensus       554 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~-~p~~~~~~~~~~~~~~~  632 (741)
                      +||+|||+|+...............||+.|+|||. ..+..++.++|||||||++|||+||. .||...     ...+..
T Consensus       172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~-l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~-----~~~~~~  245 (308)
T d1p4oa_         172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES-LKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL-----SNEQVL  245 (308)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHH-HHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-----CHHHHH
T ss_pred             EEEeecccceeccCCcceeeccceecccccCCHHH-HccCCCCcccccccHHHHHHHHHhCCCCCCCCC-----CHHHHH
Confidence            99999999987765544343444568999999954 45677899999999999999999985 665421     111111


Q ss_pred             hhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHH
Q 037916          633 RTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKS  708 (741)
Q Consensus       633 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  708 (741)
                      ..        +.+....                   +.+..+++.+.+++.+||+.||++|||+.||++.|++..+
T Consensus       246 ~~--------i~~~~~~-------------------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         246 RF--------VMEGGLL-------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             HH--------HHTTCCC-------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HH--------HHhCCCC-------------------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            11        1110000                   0011345678999999999999999999999999877643

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=3.3e-45  Score=376.63  Aligned_cols=276  Identities=21%  Similarity=0.218  Sum_probs=197.6

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC--cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH--HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      +|+++++||+|+||.||+|+++ +++.||||+++...  ....+.+.+|+.++++++|||||++++++     .+....+
T Consensus         3 ~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~~~   76 (286)
T d1ob3a_           3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI-----HTKKRLV   76 (286)
T ss_dssp             SEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEE-----ECSSCEE
T ss_pred             CceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeec-----ccCCcee
Confidence            5788999999999999999997 78999999997432  33457889999999999999999999994     5566899


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      ++|||+.++.+..+....          ..+++..+..++.||+.||+|||+.   +||||||||+|||++.++.+||+|
T Consensus        77 i~~e~~~~~~~~~~~~~~----------~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~D  143 (286)
T d1ob3a_          77 LVFEHLDQDLKKLLDVCE----------GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIAD  143 (286)
T ss_dssp             EEEECCSEEHHHHHHTST----------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECC
T ss_pred             EEEEeehhhhHHHHHhhc----------CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecc
Confidence            999999777666665432          5689999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCc
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      ||.|..........  ....|++.|+|||.+.....++.++||||+||++|||++|+.||......+ .+..........
T Consensus       144 fG~a~~~~~~~~~~--~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~-~~~~i~~~~~~~  220 (286)
T d1ob3a_         144 FGLARAFGIPVRKY--THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILGTP  220 (286)
T ss_dssp             TTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCC
T ss_pred             cccceecccCcccc--ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH-HHHHHHHhhCCC
Confidence            99998765443222  224589999999887777888999999999999999999999996432111 111111111000


Q ss_pred             chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          639 HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       639 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ....+.+..-......   ..................+.+.+++.+||+.||++|||++|+++
T Consensus       221 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         221 NSKNWPNVTELPKYDP---NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CTTTSTTGGGSTTCCT---TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             Chhhccchhhhhhccc---ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0000000000000000   00000000000011123356789999999999999999999974

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-45  Score=377.96  Aligned_cols=280  Identities=21%  Similarity=0.248  Sum_probs=197.5

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCC-CeEEEEEEeeccC--cCcchhHHHHHHHHHhc---CCCceeeEeeeecCccccC
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEG-KTIIAVKVLNLLH--HGASKSSIAECSALRNI---RHKNLVKILTVCSGVDYKG  473 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~~~~~~  473 (741)
                      .+|+++++||+|+||.||+|++..+ ++.||||+++...  ......+.+|+.+++.+   +||||++++++|.......
T Consensus         7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~   86 (305)
T d1blxa_           7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   86 (305)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred             CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence            3688999999999999999999654 7789999997432  23345677888887766   7999999999986544455


Q ss_pred             CceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCc
Q 037916          474 DDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMT  553 (741)
Q Consensus       474 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~  553 (741)
                      ....+++|||+.++++.......         ...+++..++.++.|++.||+|||++   +|+||||||+|||++.++.
T Consensus        87 ~~~~~~~~e~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~  154 (305)
T d1blxa_          87 ETKLTLVFEHVDQDLTTYLDKVP---------EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQ  154 (305)
T ss_dssp             EEEEEEEEECCSCBHHHHHHHSC---------TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCC
T ss_pred             CceEEEEEEeccCCchhhhhhcc---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCC
Confidence            66889999999887665443321         25588999999999999999999999   9999999999999999999


Q ss_pred             eEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhh
Q 037916          554 AHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFAR  633 (741)
Q Consensus       554 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~  633 (741)
                      +||+|||.++......   ......||+.|+|| |+..+..|+.++||||+||++|||++|+.||...... ..+.....
T Consensus       155 ~kl~dfg~~~~~~~~~---~~~~~~gT~~Y~AP-E~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~  229 (305)
T d1blxa_         155 IKLADFGLARIYSFQM---ALTSVVVTLWYRAP-EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILD  229 (305)
T ss_dssp             EEECSCCSCCCCCGGG---GGCCCCCCCTTCCH-HHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHH
T ss_pred             eeecchhhhhhhcccc---cCCCcccChhhcCc-chhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH-HHHHHHHH
Confidence            9999999988654332   22335699999999 5556788999999999999999999999999633111 11111111


Q ss_pred             hcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          634 TVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       634 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      .........+..........     .................+.+.+|+.+||++||++|||+.|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         230 VIGLPGEEDWPRDVALPRQA-----FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             HHCCCCGGGSCTTCSSCGGG-----SCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhCCCchhcccccccchhhh-----hccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            11100000000000000000     0000000000001123456779999999999999999999875

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-44  Score=374.11  Aligned_cols=208  Identities=21%  Similarity=0.278  Sum_probs=169.3

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeecc--CcCcchhHHHHHHHHHhcCCCceeeEeeeecCcc---ccCC
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLL--HHGASKSSIAECSALRNIRHKNLVKILTVCSGVD---YKGD  474 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---~~~~  474 (741)
                      ++|+++++||+|+||+||+|++..+|+.||||+++..  .....+++.+|+.+|++++||||+++++++....   ....
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            5789999999999999999999999999999998643  2334567889999999999999999999875422   1234


Q ss_pred             ceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCce
Q 037916          475 DFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTA  554 (741)
Q Consensus       475 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~  554 (741)
                      ...|+||||+.++.+..+...          ...+++..++.++.|++.||.|||+.   ||+||||||+|||++.++.+
T Consensus        90 ~~~~iv~e~~~~~~~~~~~~~----------~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~  156 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLSNV----------LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVL  156 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHTCT----------TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCE
T ss_pred             ceEEEEEeccCCCccchhhhc----------ccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcE
Confidence            568999999987766655432          25578889999999999999999999   99999999999999999999


Q ss_pred             EEeecccccccCCCCc--ccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCc
Q 037916          555 HVADFGLAKLLPPAHL--QTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDI  620 (741)
Q Consensus       555 kL~DFg~a~~~~~~~~--~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~  620 (741)
                      ||+|||++........  ........||+.|+|||.+.....++.++||||+||++|||++|+.||..
T Consensus       157 kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~  224 (318)
T d3blha1         157 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG  224 (318)
T ss_dssp             EECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             EeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCC
Confidence            9999999987654322  11222356999999997776667899999999999999999999999863

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-44  Score=381.97  Aligned_cols=275  Identities=19%  Similarity=0.210  Sum_probs=199.3

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccC-cCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLH-HGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      .+|+++++||+|+||+||+|++..+|+.||||+++... ....+.+.+|+.+|++++||||+++++++....+......+
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            36889999999999999999999999999999997433 23345778999999999999999999998655444445566


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      ++|+ +.+|+|.+++..           ..+++..++.++.|++.||+|||++   |||||||||+|||++.++.+||+|
T Consensus        88 l~~~-~~~g~L~~~l~~-----------~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~D  152 (345)
T d1pmea_          88 LVTH-LMGADLYKLLKT-----------QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICD  152 (345)
T ss_dssp             EEEE-CCCEEHHHHHHH-----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECC
T ss_pred             EEEe-ecCCchhhhhhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcc
Confidence            6655 558999999852           3588999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCccc-ccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCC
Q 037916          559 FGLAKLLPPAHLQT-SSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       559 Fg~a~~~~~~~~~~-~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      ||+|.......... ......||+.|+|||.+..+..++.++||||+||++|+|++|+.||......+. ..........
T Consensus       153 fG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~-~~~~~~~~~~  231 (345)
T d1pmea_         153 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ-LNHILGILGS  231 (345)
T ss_dssp             CTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCS
T ss_pred             cCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH-HHHHhhhccC
Confidence            99998765443221 223356999999997766777889999999999999999999999964321111 1111111111


Q ss_pred             cch-----------hHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          638 DHV-----------MDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       638 ~~~-----------~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                      ...           .............            ............+.+++.+||+.||++|||+.|+++-
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         232 PSQEDLNCIINLKARNYLLSLPHKNKV------------PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             CCHHHHHTCCCHHHHHHHHTSCCCCCC------------CHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CChhhhhhhhhhhhhcccccCCccCCC------------CHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            000           0000000000000            0000011223467899999999999999999999863

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-44  Score=380.92  Aligned_cols=282  Identities=18%  Similarity=0.165  Sum_probs=198.5

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCcc-ccCCceEEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVD-YKGDDFKAL  479 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~~~~~~~l  479 (741)
                      .|..++.||+|+||+||+|++..+++.||||+++...    ....+|+.++++++||||++++++|.... ..+..+.|+
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc----hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            3677889999999999999999999999999997432    23347999999999999999999975432 234557899


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCC-ceEEee
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEM-TAHVAD  558 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~-~~kL~D  558 (741)
                      ||||++++.+..+....       .....+++.+++.++.||+.||+|||++   ||+||||||+|||++.++ .+||+|
T Consensus        97 v~Ey~~~~~~~~l~~~~-------~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~D  166 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYS-------RAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCD  166 (350)
T ss_dssp             EEECCSEEHHHHHHHHH-------HTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECC
T ss_pred             EEeccCCccHHHHHhhh-------hccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEec
Confidence            99999765433332211       1225689999999999999999999999   999999999999999775 899999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCc
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      ||++..........   ...||+.|+|||++.....++.++||||+||++|||++|+.||...... ..+..........
T Consensus       167 FG~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~-~~l~~i~~~~g~~  242 (350)
T d1q5ka_         167 FGSAKQLVRGEPNV---SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTP  242 (350)
T ss_dssp             CTTCEECCTTSCCC---SCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHHHHHCCC
T ss_pred             ccchhhccCCcccc---cccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH-HHHHHHHHHhCCC
Confidence            99998765543222   2468999999988877788999999999999999999999998632211 1111111111111


Q ss_pred             chhHhhhhc----ccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH--HHHHH
Q 037916          639 HVMDIVDST----LLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE--LQSIK  707 (741)
Q Consensus       639 ~~~~~~d~~----l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i~  707 (741)
                      . .+.....    ............  .    .........+.+.+|+.+||++||++|||+.|+++-  ++++.
T Consensus       243 ~-~~~~~~~~~~~~~~~~~~~~~~~--~----~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  310 (350)
T d1q5ka_         243 T-REQIREMNPNYTEFKFPQIKAHP--W----TKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  310 (350)
T ss_dssp             C-HHHHHHHCC---CCCCCCCCCCC--G----GGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             h-HHhhhhhccchhhccccccccCc--h----hhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence            0 0000000    000000000000  0    000011234567899999999999999999999863  44443

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=9.3e-44  Score=373.34  Aligned_cols=277  Identities=19%  Similarity=0.221  Sum_probs=199.3

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcC-CCceeeEeeeecCccccCCceEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIR-HKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      .+|+++++||+|+||+||+|++..+++.||||+++.   ...+++.+|+.+|+.+. ||||+++++++..   ......+
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~---~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~---~~~~~~~  108 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKD---PVSRTPA  108 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---SCHHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCSEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH---HHHHHHHHHHHHHHhccCCCCCcEEEEEEEe---cCCCcee
Confidence            368899999999999999999999999999999863   34567889999999995 9999999998642   3455789


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCC-ceEEe
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEM-TAHVA  557 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~-~~kL~  557 (741)
                      +||||+.+++|..+.             +.+++..++.++.||+.||+|||++   ||+||||||+|||++.++ .+||+
T Consensus       109 ~v~e~~~~~~L~~~~-------------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~  172 (328)
T d3bqca1         109 LVFEHVNNTDFKQLY-------------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLI  172 (328)
T ss_dssp             EEEECCCSCBGGGTT-------------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEEC
T ss_pred             EEEeecCCCcHHHHh-------------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeec
Confidence            999999999997764             3478999999999999999999999   999999999999998655 69999


Q ss_pred             ecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCC
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      |||.|.........   ....||+.|+|||.+.....++.++||||+||++||+++|+.||...................
T Consensus       173 DFG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~  249 (328)
T d3bqca1         173 DWGLAEFYHPGQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT  249 (328)
T ss_dssp             CGGGCEECCTTCCC---CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCH
T ss_pred             ccccceeccCCCcc---cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCC
Confidence            99999876554322   235689999999777766778999999999999999999999986332211111111110000


Q ss_pred             cchhHhhhhcccCCcchhhhh-----hhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          638 DHVMDIVDSTLLADDEDLTIT-----SNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       638 ~~~~~~~d~~l~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      +....................     .................+.+.+|+.+||..||++|||++|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         250 EDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             HHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             chhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            001111110000000000000     0000000000011123456789999999999999999999975

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-44  Score=380.30  Aligned_cols=285  Identities=18%  Similarity=0.187  Sum_probs=196.9

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc--CcchhHHHHHHHHHhcCCCceeeEeeeecCcc-ccCCceE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKNLVKILTVCSGVD-YKGDDFK  477 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~~~~~~  477 (741)
                      +|+++++||+|+||.||+|++..+|+.||||+++....  ...+.+.+|+.+|++++|||||+++++|.... .....+.
T Consensus        19 ~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~   98 (346)
T d1cm8a_          19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF   98 (346)
T ss_dssp             SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred             cEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceE
Confidence            58889999999999999999999999999999974322  23456789999999999999999999975432 1234467


Q ss_pred             EEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEe
Q 037916          478 ALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVA  557 (741)
Q Consensus       478 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~  557 (741)
                      |+||||+ +.+|..+++.           ..+++..++.++.||+.||+|||++   ||+||||||+|||++.++.+|++
T Consensus        99 ~lv~e~~-~~~l~~~~~~-----------~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~  163 (346)
T d1cm8a_          99 YLVMPFM-GTDLGKLMKH-----------EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKIL  163 (346)
T ss_dssp             EEEEECC-SEEHHHHHHH-----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEEC
T ss_pred             EEEEecc-cccHHHHHHh-----------ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccc
Confidence            9999999 6688877642           4589999999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCC
Q 037916          558 DFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLP  637 (741)
Q Consensus       558 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  637 (741)
                      |||.|+......     ....||+.|+|||.+.....++.++||||+||++|+|++|+.||...... ..+.........
T Consensus       164 Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~-~~~~~~~~~~~~  237 (346)
T d1cm8a_         164 DFGLARQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-DQLKEIMKVTGT  237 (346)
T ss_dssp             CCTTCEECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCC
T ss_pred             cccceeccCCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH-HHHHHHHhccCC
Confidence            999998765432     23569999999987776778899999999999999999999998633111 111111111000


Q ss_pred             cchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH--HHHHH
Q 037916          638 DHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE--LQSIK  707 (741)
Q Consensus       638 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i~  707 (741)
                      .. .++................................+.+.+|+.+||..||++|||+.|+++-  ++++.
T Consensus       238 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         238 PP-AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             CC-HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             Cc-HHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence            00 00000000000000000000000000000011234567899999999999999999999874  44443

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-44  Score=368.92  Aligned_cols=276  Identities=20%  Similarity=0.193  Sum_probs=201.4

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc--CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      +|+++++||+|+||+||+|++..+++.||||+++....  ....++.+|+.+++.++||||+++++++     .+....+
T Consensus         3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~-----~~~~~~~   77 (292)
T d1unla_           3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKLT   77 (292)
T ss_dssp             SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEEE
T ss_pred             CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccc-----cccccee
Confidence            58889999999999999999999999999999974332  3356788999999999999999999994     5566899


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      +|||++.++++..++...          ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|
T Consensus        78 iv~~~~~~~~l~~~~~~~----------~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~D  144 (292)
T d1unla_          78 LVFEFCDQDLKKYFDSCN----------GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLAN  144 (292)
T ss_dssp             EEEECCSEEHHHHHHHTT----------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECC
T ss_pred             EEeeeccccccccccccc----------cccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeee
Confidence            999999998888877643          5678889999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCc
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      ||.|+.........  ....+++.|+|||.+.....++.++||||+||++|||++|+.||.........+..........
T Consensus       145 FG~a~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  222 (292)
T d1unla_         145 FGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP  222 (292)
T ss_dssp             CTTCEECCSCCSCC--CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             cchhhcccCCCccc--eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCC
Confidence            99998876543322  2245778889997666666789999999999999999999999743222111111111111110


Q ss_pred             chh--HhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          639 HVM--DIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       639 ~~~--~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                      ...  ................     .............+.+.+++.+||+.||.+||||+|+++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         223 TEEQWPSMTKLPDYKPYPMYP-----ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CTTTCTTGGGSTTCCCCCCCC-----TTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             Chhhhhhhhhccccccccccc-----ccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000  0000000000000000     000000111123356789999999999999999999875

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.6e-43  Score=362.37  Aligned_cols=263  Identities=18%  Similarity=0.208  Sum_probs=199.2

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEEEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKALV  480 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~lv  480 (741)
                      +|++.+.||+|+||.||+|++..+++.||||+++..  ...+.+..|+++++.++|++++..+..+    ...+...++|
T Consensus         8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~--~~~~~~~~E~~i~~~l~~~~~i~~~~~~----~~~~~~~~iv   81 (299)
T d1ckia_           8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWC----GAEGDYNVMV   81 (299)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESC--TTSCCHHHHHHHHHHSTTSTTCCCEEEE----EEETTEEEEE
T ss_pred             EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchh--ccCHHHHHHHHHHHHccCCCcccEEEEE----EecCCEEEEE
Confidence            588999999999999999999999999999998743  3345688999999999877766555544    4456688999


Q ss_pred             EecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCC---CCceEEe
Q 037916          481 YEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDH---EMTAHVA  557 (741)
Q Consensus       481 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~---~~~~kL~  557 (741)
                      |||+ ++++.+.+...         ...+++..+..++.|++.||+|||++   +|+||||||+||+++.   +..+||+
T Consensus        82 me~~-~~~l~~~~~~~---------~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~  148 (299)
T d1ckia_          82 MELL-GPSLEDLFNFC---------SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYII  148 (299)
T ss_dssp             EECC-CCBHHHHHHHT---------TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEEC
T ss_pred             EEEc-CCchhhhhhhc---------cCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeee
Confidence            9999 56776665422         24689999999999999999999999   9999999999999864   4579999


Q ss_pred             ecccccccCCCCcc-----cccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcch--hh
Q 037916          558 DFGLAKLLPPAHLQ-----TSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNL--HN  630 (741)
Q Consensus       558 DFg~a~~~~~~~~~-----~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~--~~  630 (741)
                      |||+|+........     .......||+.|+|| |...+..++.++|||||||++|||++|+.||..........  ..
T Consensus       149 DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aP-E~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~  227 (299)
T d1ckia_         149 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASI-NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER  227 (299)
T ss_dssp             CCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCH-HHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHH
T ss_pred             ccCcceeccccccccceeccccCCcCCCccccCH-HHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHH
Confidence            99999887543221     122345699999999 55567789999999999999999999999996432211110  00


Q ss_pred             hhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHHhh
Q 037916          631 FARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKSIL  710 (741)
Q Consensus       631 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  710 (741)
                      .........                           .......+++.+.+++..||+.||++||++.++.+.|+.+....
T Consensus       228 ~~~~~~~~~---------------------------~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         228 ISEKKMSTP---------------------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             HHHHHHHSC---------------------------HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             hhcccCCCC---------------------------hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence            000000000                           00011234567889999999999999999999999999886543

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.3e-42  Score=355.69  Aligned_cols=267  Identities=15%  Similarity=0.138  Sum_probs=205.8

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCC-CceeeEeeeecCccccCCceEE
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRH-KNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      .+|++.++||+|+||.||+|++..+++.||||+++..  ...+.+.+|++.++.+.| +||+.+++++     ..+...+
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~~~   77 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGLHNV   77 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETTEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccc--cCcHHHHHHHHHHHHhcCCCCCCEEEEEe-----ecCCccE
Confidence            4689999999999999999999999999999998643  334567889999999965 8999999984     4566889


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCC-----CCc
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDH-----EMT  553 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~-----~~~  553 (741)
                      +||||+ +++|.+++...         ...+++.++..++.|++.||+|||+.   ||+||||||+||+++.     ++.
T Consensus        78 ~vme~~-~~~l~~~~~~~---------~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~  144 (293)
T d1csna_          78 LVIDLL-GPSLEDLLDLC---------GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANM  144 (293)
T ss_dssp             EEEECC-CCBHHHHHHHT---------TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTC
T ss_pred             EEEEec-CCCHHHHHHhh---------ccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCc
Confidence            999999 78999988643         24588999999999999999999999   9999999999999974     568


Q ss_pred             eEEeecccccccCCCCc-----ccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcch
Q 037916          554 AHVADFGLAKLLPPAHL-----QTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNL  628 (741)
Q Consensus       554 ~kL~DFg~a~~~~~~~~-----~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~  628 (741)
                      +||+|||+|+.......     ........||+.|+||| ...+..++.++||||+||++|||++|+.||......... 
T Consensus       145 vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE-~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~-  222 (293)
T d1csna_         145 IYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN-THLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK-  222 (293)
T ss_dssp             EEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHH-HHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH-
T ss_pred             eEEcccceeEEcccCccccceeecccCceEEchhhcCHH-HhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHH-
Confidence            99999999987654321     11233456999999995 556778999999999999999999999999632211110 


Q ss_pred             hhhhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHHHHHH
Q 037916          629 HNFARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHELQSIKS  708 (741)
Q Consensus       629 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  708 (741)
                       ....        .+.+....               .........+++.+.+++..|+..+|++||+++.+.+.|+++.+
T Consensus       223 -~~~~--------~i~~~~~~---------------~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~  278 (293)
T d1csna_         223 -QKYE--------RIGEKKQS---------------TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE  278 (293)
T ss_dssp             -HHHH--------HHHHHHHH---------------SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             -HHHH--------HHHhccCC---------------CChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence             0000        00000000               00000112345678899999999999999999999999999876


Q ss_pred             hhcC
Q 037916          709 ILLG  712 (741)
Q Consensus       709 ~~~~  712 (741)
                      ....
T Consensus       279 ~~~~  282 (293)
T d1csna_         279 RLNT  282 (293)
T ss_dssp             HTTC
T ss_pred             HcCC
Confidence            5543

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-43  Score=374.21  Aligned_cols=269  Identities=19%  Similarity=0.182  Sum_probs=195.3

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc--CcchhHHHHHHHHHhcCCCceeeEeeeecCccccCCceEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKNLVKILTVCSGVDYKGDDFKA  478 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  478 (741)
                      +|+++++||+|+||+||+|++..+|+.||||+++....  ...+.+.+|+.++++++|||||++++++......+....+
T Consensus        19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~   98 (348)
T d2gfsa1          19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV   98 (348)
T ss_dssp             TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCC
T ss_pred             CeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceE
Confidence            68899999999999999999999999999999974332  2345678999999999999999999997543322333445


Q ss_pred             EEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEEee
Q 037916          479 LVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHVAD  558 (741)
Q Consensus       479 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D  558 (741)
                      ++|+|+.+|+|.+++..           ..+++..++.++.||+.||+|||++   ||+||||||+|||++.++.+|++|
T Consensus        99 ~i~~~~~gg~L~~~~~~-----------~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~d  164 (348)
T d2gfsa1          99 YLVTHLMGADLNNIVKC-----------QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILD  164 (348)
T ss_dssp             EEEEECCSEEHHHHHTT-----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred             EEEEeecCCchhhhccc-----------ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccc
Confidence            66677779999999852           3589999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcCCc
Q 037916          559 FGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVLPD  638 (741)
Q Consensus       559 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  638 (741)
                      ||.|......     .....||+.|+|||+......++.++||||+||++|+|++|+.||...... .............
T Consensus       165 fg~a~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~-~~~~~i~~~~~~~  238 (348)
T d2gfsa1         165 FGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTP  238 (348)
T ss_dssp             C----CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCC
T ss_pred             cchhcccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCC
Confidence            9999755332     223568999999987777777899999999999999999999998632111 0111111110000


Q ss_pred             -----------chhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 037916          639 -----------HVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVH  701 (741)
Q Consensus       639 -----------~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  701 (741)
                                 ...............            ..........+.+.+|+.+||..||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         239 GAELLKKISSESARNYIQSLTQMPKM------------NFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             CHHHHTTCCCHHHHHHHTTSCCCCCC------------CHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ChHHhhhccchhhhhhhhhcccCCCc------------chhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence                       000000000000000            000001123456789999999999999999999986

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-42  Score=366.27  Aligned_cols=282  Identities=19%  Similarity=0.157  Sum_probs=192.4

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCc--CcchhHHHHHHHHHhcCCCceeeEeeeecCcc-ccCCce
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHH--GASKSSIAECSALRNIRHKNLVKILTVCSGVD-YKGDDF  476 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~~~~~  476 (741)
                      -+|+++++||+|+||+||+|++..+|+.||||+++....  ....++.+|+.++++++|||||++++++.... .+...+
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            468899999999999999999999999999999974322  23346789999999999999999999975432 235578


Q ss_pred             EEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCCCceEE
Q 037916          477 KALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHEMTAHV  556 (741)
Q Consensus       477 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL  556 (741)
                      .|+||||+.++.+ +.+.            ..+++..++.++.||+.||+|||+.   ||+||||||+|||++.++.+|+
T Consensus        97 ~~iv~Ey~~~~l~-~~~~------------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl  160 (355)
T d2b1pa1          97 VYLVMELMDANLC-QVIQ------------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKI  160 (355)
T ss_dssp             EEEEEECCSEEHH-HHHT------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEE
T ss_pred             eEEEEeccchHHH-Hhhh------------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceee
Confidence            9999999966544 4443            3478899999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhhhhhhcC
Q 037916          557 ADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHNFARTVL  636 (741)
Q Consensus       557 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  636 (741)
                      +|||.++........   ....||+.|+||| +..+..++.++||||+||++|+|++|+.||...... ...........
T Consensus       161 ~df~~~~~~~~~~~~---~~~~~t~~y~aPE-~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~-~~~~~i~~~~~  235 (355)
T d2b1pa1         161 LDFGLARTAGTSFMM---TPYVVTRYYRAPE-VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQLG  235 (355)
T ss_dssp             CCCCC------------------CCTTCCHH-HHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHC
T ss_pred             echhhhhcccccccc---ccccccccccChh-hhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHH-HHHHHHHHhcc
Confidence            999998866543322   2356899999995 556778999999999999999999999998632111 11111111110


Q ss_pred             ----------CcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 037916          637 ----------PDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMNMTIVVHE  702 (741)
Q Consensus       637 ----------~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  702 (741)
                                ........+..............................+.+.+++.+||..||++||||+|+++-
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         236 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             CCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                      011111111111111000000000000001111233456678899999999999999999999854

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-43  Score=363.07  Aligned_cols=254  Identities=22%  Similarity=0.280  Sum_probs=197.1

Q ss_pred             HHHHHhhhcccCceeeEEEEEE---cCCCeEEEEEEeeccC----cCcchhHHHHHHHHHhcCC-CceeeEeeeecCccc
Q 037916          400 VSFLFLCWIDMGSFGSVYKGIL---DEGKTIIAVKVLNLLH----HGASKSSIAECSALRNIRH-KNLVKILTVCSGVDY  471 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~---~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~  471 (741)
                      .+|++++.||+|+||+||+|++   +.+|+.||||+++...    ....+.+.+|+.++++++| |||++++++     +
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~-----~   98 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA-----F   98 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE-----E
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeee-----e
Confidence            5699999999999999999997   3468999999986322    2335667899999999976 899999999     5


Q ss_pred             cCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEeCCC
Q 037916          472 KGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPSNVLLDHE  551 (741)
Q Consensus       472 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~NIll~~~  551 (741)
                      .+....+++|||+.+|+|.+++...          ..+++..+..++.||+.||+|+|+.   +|+||||||+||+++.+
T Consensus        99 ~~~~~~~~v~e~~~~~~L~~~i~~~----------~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~  165 (322)
T d1vzoa_          99 QTETKLHLILDYINGGELFTHLSQR----------ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSN  165 (322)
T ss_dssp             EETTEEEEEECCCCSCBHHHHHHHH----------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT
T ss_pred             ccCCceeeeeecccccHHHHHHHhc----------ccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCC
Confidence            5667899999999999999998643          4567888999999999999999999   99999999999999999


Q ss_pred             CceEEeecccccccCCCCcccccccccccccccCcccccCCC-CCCCccCchhHHHHHHHHHcCCCCCCccccCCcchhh
Q 037916          552 MTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGS-EVSINGDVYSYGILLLELMTRKRPSDIMFEGNMNLHN  630 (741)
Q Consensus       552 ~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~-~~~~~~DIwSlG~il~elltg~~p~~~~~~~~~~~~~  630 (741)
                      +.+||+|||+|+......... .....|++.|+|||++.... .++.++||||+||++|||++|+.||........ ...
T Consensus       166 ~~vkL~DFG~a~~~~~~~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~-~~~  243 (322)
T d1vzoa_         166 GHVVLTDFGLSKEFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAE  243 (322)
T ss_dssp             SCEEESCSSEEEECCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHH
T ss_pred             CCEEEeeccchhhhccccccc-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHH
Confidence            999999999998765443322 23356999999997775443 578899999999999999999999974322211 111


Q ss_pred             hhhhcCCcchhHhhhhcccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcccccCCCCCCC-----HHHHHH
Q 037916          631 FARTVLPDHVMDIVDSTLLADDEDLTITSNQRQRQARINNIMECLISVVRIGVACSMESPQDRMN-----MTIVVH  701 (741)
Q Consensus       631 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  701 (741)
                      .....            .....                ..+..+.+.+.+++.+||++||++|||     ++|+++
T Consensus       244 i~~~~------------~~~~~----------------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         244 ISRRI------------LKSEP----------------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             HHHHH------------HHCCC----------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             HHHhc------------ccCCC----------------CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence            11100            00000                001134567889999999999999995     778764

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.1e-37  Score=329.90  Aligned_cols=281  Identities=17%  Similarity=0.191  Sum_probs=189.1

Q ss_pred             HHHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcC-----------CCceeeEeeeecC
Q 037916          400 VSFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIR-----------HKNLVKILTVCSG  468 (741)
Q Consensus       400 ~~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------hpnIv~~~~~~~~  468 (741)
                      ++|+++++||+|+||.||+|++..+|+.||||+++... ...+...+|+.+++.++           |+||+++++++. 
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~-   90 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN-   90 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE-
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee-
Confidence            46999999999999999999999999999999997422 23456778998888774           578999998864 


Q ss_pred             ccccCCceEEEEEecccCCCh-hhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHh-cCCCCceecCCCCCCe
Q 037916          469 VDYKGDDFKALVYEFMHNGSL-EEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHH-DCQPTTAHCDLKPSNV  546 (741)
Q Consensus       469 ~~~~~~~~~~lv~e~~~~gsL-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivHrDlkp~NI  546 (741)
                        .......+.+|+++..+.. ......        .....+++..+..++.||+.||+|||+ .   ||+||||||+||
T Consensus        91 --~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NI  157 (362)
T d1q8ya_          91 --HKGPNGVHVVMVFEVLGENLLALIKK--------YEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENV  157 (362)
T ss_dssp             --EEETTEEEEEEEECCCCEEHHHHHHH--------TTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGE
T ss_pred             --eccccceeeeeeeccccccccccccc--------ccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHe
Confidence              2334566677776644432 222211        123567888999999999999999998 6   999999999999


Q ss_pred             EeCCCC------ceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHHHHHHcCCCCCCc
Q 037916          547 LLDHEM------TAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILLLELMTRKRPSDI  620 (741)
Q Consensus       547 ll~~~~------~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il~elltg~~p~~~  620 (741)
                      |++.++      .+|++|||.+.......     ....||+.|+||| +..+..++.++||||+||++++|++|+.||..
T Consensus       158 ll~~~~~~~~~~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE-~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~  231 (362)
T d1q8ya_         158 LMEIVDSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPE-VLLGAPWGCGADIWSTACLIFELITGDFLFEP  231 (362)
T ss_dssp             EEEEEETTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHH-HHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             eeeccCcccccceeeEeeccccccccccc-----ccccccccccChh-hccccCCCccccccchHHHHHHHHHCCCCCCC
Confidence            997654      49999999997654322     2356999999995 44567789999999999999999999999864


Q ss_pred             cccCC-c----chhhhhhhcC--Ccc-------hhHhhhhc-ccCCcchhhhhhhhHHHHHhHhhHHHHHHHHHHHhhcc
Q 037916          621 MFEGN-M----NLHNFARTVL--PDH-------VMDIVDST-LLADDEDLTITSNQRQRQARINNIMECLISVVRIGVAC  685 (741)
Q Consensus       621 ~~~~~-~----~~~~~~~~~~--~~~-------~~~~~d~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  685 (741)
                      ..... .    .....+...-  +..       ....++.. ............................+.+.+++.+|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~m  311 (362)
T d1q8ya_         232 DEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPM  311 (362)
T ss_dssp             -------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGG
T ss_pred             CccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHH
Confidence            32111 0    0111111100  000       00111100 00000000000111111122223356677899999999


Q ss_pred             cccCCCCCCCHHHHHH
Q 037916          686 SMESPQDRMNMTIVVH  701 (741)
Q Consensus       686 l~~dP~~RPs~~evl~  701 (741)
                      |++||++|||++|+++
T Consensus       312 L~~dP~~Rpta~e~L~  327 (362)
T d1q8ya_         312 LQLDPRKRADAGGLVN  327 (362)
T ss_dssp             GCSSTTTCBCHHHHHT
T ss_pred             CCCChhHCcCHHHHhc
Confidence            9999999999999875

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.98  E-value=1.8e-32  Score=285.29  Aligned_cols=254  Identities=30%  Similarity=0.453  Sum_probs=158.8

Q ss_pred             ccEEEccCCcccc--cCCccccCCCCccEEEccc-ccccccCCccccCCCcCcEEEcccCCCCCcCcccccCCcccceee
Q 037916          106 LETLIFNSNKIFR--SIPAGIGKFINLQTLHMWD-NQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLY  182 (741)
Q Consensus       106 L~~L~L~~n~i~~--~~~~~~~~l~~L~~L~L~~-N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  182 (741)
                      ++.|+|++|.+.+  .+|..+++|++|++|+|++ |++++.+|..|.+|++|++|+|++|++.+..+..+..+.+|+.++
T Consensus        52 v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~  131 (313)
T d1ogqa_          52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLD  131 (313)
T ss_dssp             EEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEE
T ss_pred             EEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccc
Confidence            4445555544443  2455566666666666654 555555555666666666666666666655555566666666666


Q ss_pred             ccCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEecccccc
Q 037916          183 LIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLE  262 (741)
Q Consensus       183 L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  262 (741)
                      +++|.+.+.+|..|..++.|+.+++++|.+++.+|..+..+..+...+++++|++++..|..+..+..+ .+++++|.+.
T Consensus       132 l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~  210 (313)
T d1ogqa_         132 FSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLE  210 (313)
T ss_dssp             CCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEE
T ss_pred             cccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-cccccccccc
Confidence            666666556666666666666666666666666666666655553336666666666666666555433 4666666666


Q ss_pred             chhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccchhhhccccCCcccccCcccccccCCccc
Q 037916          263 CEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGV  342 (741)
Q Consensus       263 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~  342 (741)
                      +..+..+..+++|+.|++++|.+.+.++ .+..+++|+.|+|++|++++.+|..|.++++|++|+|++|+|+|.+|..+.
T Consensus       211 ~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~  289 (313)
T d1ogqa_         211 GDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN  289 (313)
T ss_dssp             ECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTT
T ss_pred             cccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCccc
Confidence            6666666666666666666666665433 466667777777777777766777777777777777777777776666656


Q ss_pred             cCCcccccccCCCCccccC
Q 037916          343 FKNASAISVFGNSKLCGGI  361 (741)
Q Consensus       343 ~~~~~~~~~~~n~~~c~~~  361 (741)
                      +..++.+++.||+.+||.|
T Consensus       290 L~~L~~l~l~~N~~l~g~p  308 (313)
T d1ogqa_         290 LQRFDVSAYANNKCLCGSP  308 (313)
T ss_dssp             GGGSCGGGTCSSSEEESTT
T ss_pred             CCCCCHHHhCCCccccCCC
Confidence            6667777777777777754

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.97  E-value=4.4e-32  Score=282.32  Aligned_cols=253  Identities=32%  Similarity=0.496  Sum_probs=230.8

Q ss_pred             CccEEECcCCcCccc--CCchhhcccccccEEEccC-CcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcE
Q 037916           80 HLKHLDINNNNFGGL--LPGCICNFSITLETLIFNS-NKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVT  156 (741)
Q Consensus        80 ~L~~L~Ls~N~l~~~--~~~~~~~l~~~L~~L~L~~-n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~  156 (741)
                      +++.|||++|++++.  +|..+.+++ +|++|+|++ |++.+.+|..|++|++|++|+|++|+|++..+..+..+.+|+.
T Consensus        51 ~v~~L~L~~~~l~g~~~lp~~l~~L~-~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~  129 (313)
T d1ogqa_          51 RVNNLDLSGLNLPKPYPIPSSLANLP-YLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT  129 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCT-TCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred             EEEEEECCCCCCCCCCCCChHHhcCc-cccccccccccccccccccccccccccchhhhccccccccccccccchhhhcc
Confidence            588899999988873  678889988 899999986 8888889999999999999999999999999999999999999


Q ss_pred             EEcccCCCCCcCcccccCCcccceeeccCcccccccCcccccCCCC-CEEeccCccccccCCccccccccceeEEEcCCC
Q 037916          157 LAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSL-TTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRN  235 (741)
Q Consensus       157 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L-~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N  235 (741)
                      ++++.|++.+.+|..|.++++|+.+++++|.+.+.+|..+..+..+ +.+++++|++++..|..+..+..+ . +++++|
T Consensus       130 l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~-l~l~~~  207 (313)
T d1ogqa_         130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-F-VDLSRN  207 (313)
T ss_dssp             EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-E-EECCSS
T ss_pred             cccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-c-cccccc
Confidence            9999999999999999999999999999999999999999988876 899999999999999988888665 4 999999


Q ss_pred             ccCCCCChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccch
Q 037916          236 QLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPK  315 (741)
Q Consensus       236 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  315 (741)
                      .+.+.+|..+..+++|+.|++++|.+.+.+ ..+..+++|+.|+|++|++++.+|..|.++++|++|+|++|+|+|.+|.
T Consensus       208 ~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~-~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~  286 (313)
T d1ogqa_         208 MLEGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ  286 (313)
T ss_dssp             EEEECCGGGCCTTSCCSEEECCSSEECCBG-GGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC
T ss_pred             cccccccccccccccccccccccccccccc-cccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC
Confidence            999999999999999999999999998754 4688899999999999999999999999999999999999999998885


Q ss_pred             hhhccccCCcccccCcc-ccccc
Q 037916          316 FLVELQLVQNLNLSYND-LEGVI  337 (741)
Q Consensus       316 ~~~~l~~L~~L~l~~N~-l~~~~  337 (741)
                       +.++++|+.+++++|+ +.|.|
T Consensus       287 -~~~L~~L~~l~l~~N~~l~g~p  308 (313)
T d1ogqa_         287 -GGNLQRFDVSAYANNKCLCGSP  308 (313)
T ss_dssp             -STTGGGSCGGGTCSSSEEESTT
T ss_pred             -cccCCCCCHHHhCCCccccCCC
Confidence             6789999999999998 56653

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.97  E-value=1.9e-29  Score=270.13  Aligned_cols=314  Identities=25%  Similarity=0.305  Sum_probs=230.3

Q ss_pred             CCCCcccccCChhhhhCCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCcc
Q 037916            3 VGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLK   82 (741)
Q Consensus         3 l~~n~~~~~ip~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~   82 (741)
                      ++.+.+.+.++..   .+.+|++|++++|.|+.+  +.+..+++|++|+|++|+|++..  .|.++++          |+
T Consensus        29 l~~~~~~~~~~~~---~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l~--~l~~L~~----------L~   91 (384)
T d2omza2          29 LGKTNVTDTVSQT---DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDIT--PLKNLTK----------LV   91 (384)
T ss_dssp             TTCSSTTSEECHH---HHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCCG--GGTTCTT----------CC
T ss_pred             hCCCCCCCccCHH---HhCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCCCc--cccCCcc----------cc
Confidence            5667777766643   468899999999999864  46788999999999999999553  3777776          99


Q ss_pred             EEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccc--------------------
Q 037916           83 HLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSG--------------------  142 (741)
Q Consensus        83 ~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~--------------------  142 (741)
                      +|++++|+|.+..+  +..++ +|+.|++++|.+.+..+  ......+..+....|.+..                    
T Consensus        92 ~L~L~~n~i~~i~~--l~~l~-~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  166 (384)
T d2omza2          92 DILMNNNQIADITP--LANLT-NLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVT  166 (384)
T ss_dssp             EEECCSSCCCCCGG--GTTCT-TCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCC
T ss_pred             cccccccccccccc--ccccc-ccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccc
Confidence            99999999986543  67777 89999999988865433  2333445555544444321                    


Q ss_pred             ---------------------cCCccccCCCcCcEEEcccCCCCCcCcccccCCcccceeeccCcccccccCcccccCCC
Q 037916          143 ---------------------TISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQS  201 (741)
Q Consensus       143 ---------------------~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~  201 (741)
                                           .....+..+++++.|++++|.+++..|  +...++|++|++++|.++..  ..+..+++
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~  242 (384)
T d2omza2         167 DLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTN  242 (384)
T ss_dssp             CCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTT
T ss_pred             hhhhhccccccccccccccccccccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccc
Confidence                                 122456667788888888888876543  45667888888888888742  35777888


Q ss_pred             CCEEeccCccccccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeC
Q 037916          202 LTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLG  281 (741)
Q Consensus       202 L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  281 (741)
                      |+.|++++|++++..  .+..+++|+. |++++|++++..  .+..++.++.+++++|.++++  ..+..+++++.|+++
T Consensus       243 L~~L~l~~n~l~~~~--~~~~~~~L~~-L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls  315 (384)
T d2omza2         243 LTDLDLANNQISNLA--PLSGLTKLTE-LKLGANQISNIS--PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLY  315 (384)
T ss_dssp             CSEEECCSSCCCCCG--GGTTCTTCSE-EECCSSCCCCCG--GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECC
T ss_pred             cchhccccCccCCCC--cccccccCCE-eeccCcccCCCC--ccccccccccccccccccccc--cccchhcccCeEECC
Confidence            888888888887543  3677788876 888888887443  367788888888888888753  357778888888888


Q ss_pred             CCccCCCCChhcccCccCCeeeCCCCcCCCccchhhhccccCCcccccCcccccccCCccccCCcccccccCC
Q 037916          282 GNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKNASAISVFGN  354 (741)
Q Consensus       282 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~n  354 (741)
                      +|++++..  .+..+++|+.|+|++|+|++ ++ .+.++++|++|++++|++++.+| ...++.++.+++.+|
T Consensus       316 ~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~-l~~l~~L~~L~L~~N  383 (384)
T d2omza2         316 FNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQ  383 (384)
T ss_dssp             SSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG-GTTCTTCSEEECCCE
T ss_pred             CCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh-hccCCCCCEeeCCCC
Confidence            88888654  37788888888888888874 33 57788888888888888887765 445677777777766

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.96  E-value=5e-29  Score=258.03  Aligned_cols=280  Identities=20%  Similarity=0.269  Sum_probs=186.0

Q ss_pred             CCcccccCChhhhhCCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCccEE
Q 037916            5 VNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHL   84 (741)
Q Consensus         5 ~n~~~~~ip~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L   84 (741)
                      +++++ ++|++++   +++++|+|++|+|+.+.+.+|.++++|++|++++|.++.+.|..|.++++          |++|
T Consensus        19 ~~~L~-~lP~~l~---~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~----------L~~L   84 (305)
T d1xkua_          19 DLGLE-KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVK----------LERL   84 (305)
T ss_dssp             TSCCC-SCCCSCC---TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTT----------CCEE
T ss_pred             CCCCC-ccCCCCC---CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCc----------cCEe
Confidence            34455 7777776   67888888888888777778888888888888888888777788888776          8888


Q ss_pred             ECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEccccccc--ccCCccccCCCcCcEEEcccC
Q 037916           85 DINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLS--GTISPAIGELQNLVTLAINTN  162 (741)
Q Consensus        85 ~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~--~~~~~~~~~l~~L~~L~L~~N  162 (741)
                      ++++|+|+.+ |..+.  . .+..|++.+|.+....+..+.....+..++...|...  ...+..|..+++|+.+++++|
T Consensus        85 ~l~~n~l~~l-~~~~~--~-~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n  160 (305)
T d1xkua_          85 YLSKNQLKEL-PEKMP--K-TLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADT  160 (305)
T ss_dssp             ECCSSCCSBC-CSSCC--T-TCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSS
T ss_pred             cccCCccCcC-ccchh--h-hhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccC
Confidence            8888888844 33222  2 6777778888777766666777777777777777543  233456777777777777777


Q ss_pred             CCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCCCC
Q 037916          163 KLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLP  242 (741)
Q Consensus       163 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p  242 (741)
                      +++. +|..+  +++|++|++++|.+....+..|.+++.++.|++++|++++..+..|.++++|++ |+|++|+|+ .+|
T Consensus       161 ~l~~-l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~-L~L~~N~L~-~lp  235 (305)
T d1xkua_         161 NITT-IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRE-LHLNNNKLV-KVP  235 (305)
T ss_dssp             CCCS-CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCE-EECCSSCCS-SCC
T ss_pred             Cccc-cCccc--CCccCEEECCCCcCCCCChhHhhcccccccccccccccccccccccccccccee-eeccccccc-ccc
Confidence            7763 33322  456777777777776666667777777777777777776666666666666665 666666666 345


Q ss_pred             hhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCC--Cccchhhhcc
Q 037916          243 TEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNIS--GEIPKFLVEL  320 (741)
Q Consensus       243 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~--~~~~~~~~~l  320 (741)
                      ..|..+++|++|+|++|+|+.+....|..                  +..+..+.+|+.|+|++|.++  ...|.+|..+
T Consensus       236 ~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~------------------~~~~~~~~~L~~L~L~~N~~~~~~~~~~~f~~~  297 (305)
T d1xkua_         236 GGLADHKYIQVVYLHNNNISAIGSNDFCP------------------PGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCV  297 (305)
T ss_dssp             TTTTTCSSCCEEECCSSCCCCCCTTSSSC------------------SSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTC
T ss_pred             cccccccCCCEEECCCCccCccChhhccC------------------cchhcccCCCCEEECCCCcCccCcCCHhHhccc
Confidence            56666666666666666666544433321                  122334556666777777654  3455555544


Q ss_pred             ccCCc
Q 037916          321 QLVQN  325 (741)
Q Consensus       321 ~~L~~  325 (741)
                      .....
T Consensus       298 ~~~~~  302 (305)
T d1xkua_         298 YVRAA  302 (305)
T ss_dssp             CCGGG
T ss_pred             ccCcc
Confidence            44333

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.96  E-value=5.5e-28  Score=250.10  Aligned_cols=245  Identities=24%  Similarity=0.276  Sum_probs=114.9

Q ss_pred             ccEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcc
Q 037916           81 LKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAIN  160 (741)
Q Consensus        81 L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~  160 (741)
                      |++|+|++|+|+.+.+..|.++. +|++|++++|.+..+.|..|.++++|++|+|++|+|+.+....   ...|..|+++
T Consensus        33 l~~L~Ls~N~i~~l~~~~f~~l~-~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~~l~~~~---~~~l~~L~~~  108 (305)
T d1xkua_          33 TALLDLQNNKITEIKDGDFKNLK-NLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKM---PKTLQELRVH  108 (305)
T ss_dssp             CCEEECCSSCCCCBCTTTTTTCT-TCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSBCCSSC---CTTCCEEECC
T ss_pred             CCEEECcCCcCCCcChhHhhccc-cccccccccccccccchhhhhCCCccCEecccCCccCcCccch---hhhhhhhhcc
Confidence            44444444444433333444443 4444444444444444444444444555555555444332221   1234444445


Q ss_pred             cCCCCCcCcccccCCcccceeeccCcccc--cccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccC
Q 037916          161 TNKLSGNIPPSIGNLKKLLQLYLIENFLQ--VSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLV  238 (741)
Q Consensus       161 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~--~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~  238 (741)
                      +|.+.++.+..+.....+..++...|...  ...+..|..+++|+.+++++|+++ .+|..+  .++++. |++++|.+.
T Consensus       109 ~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~-L~l~~n~~~  184 (305)
T d1xkua_         109 ENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTE-LHLDGNKIT  184 (305)
T ss_dssp             SSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSE-EECTTSCCC
T ss_pred             ccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc-ccCccc--CCccCE-EECCCCcCC
Confidence            55554444444444444444444444322  222334445555555555555554 333322  234444 555555555


Q ss_pred             CCCChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccchhh-
Q 037916          239 GSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFL-  317 (741)
Q Consensus       239 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~-  317 (741)
                      +..+..|.+++.++.|++++|.++++.+..|.++++|++|+|++|+|+. +|.+|..+++|++|+|++|+|+.+....| 
T Consensus       185 ~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~-lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~  263 (305)
T d1xkua_         185 KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSNDFC  263 (305)
T ss_dssp             EECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSS-CCTTTTTCSSCCEEECCSSCCCCCCTTSSS
T ss_pred             CCChhHhhccccccccccccccccccccccccccccceeeecccccccc-cccccccccCCCEEECCCCccCccChhhcc
Confidence            4555555555555555555555555555555555555555555555552 34455555555555555555554332222 


Q ss_pred             -----hccccCCcccccCcccc
Q 037916          318 -----VELQLVQNLNLSYNDLE  334 (741)
Q Consensus       318 -----~~l~~L~~L~l~~N~l~  334 (741)
                           ..+.+|+.|+|++|+++
T Consensus       264 ~~~~~~~~~~L~~L~L~~N~~~  285 (305)
T d1xkua_         264 PPGYNTKKASYSGVSLFSNPVQ  285 (305)
T ss_dssp             CSSCCTTSCCCSEEECCSSSSC
T ss_pred             CcchhcccCCCCEEECCCCcCc
Confidence                 22344455555555543

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.95  E-value=1.6e-27  Score=255.04  Aligned_cols=294  Identities=28%  Similarity=0.326  Sum_probs=239.8

Q ss_pred             CCCCCcccccCChhhhhCCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCc
Q 037916            2 DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHL   81 (741)
Q Consensus         2 dl~~n~~~~~ip~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L   81 (741)
                      ++++|.|. .+. .+. .|++|++|+|++|+|+++.  .|+++++|++|+|++|+|++..  .+..+++          |
T Consensus        50 ~l~~~~I~-~l~-gl~-~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i~~i~--~l~~l~~----------L  112 (384)
T d2omza2          50 QADRLGIK-SID-GVE-YLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIADIT--PLANLTN----------L  112 (384)
T ss_dssp             ECCSSCCC-CCT-TGG-GCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCG--GGTTCTT----------C
T ss_pred             ECCCCCCC-Ccc-ccc-cCCCCCEEeCcCCcCCCCc--cccCCccccccccccccccccc--ccccccc----------c
Confidence            57888887 453 565 7999999999999999764  3999999999999999999653  3677765          9


Q ss_pred             cEEECcCCcCcccCCchhhcccccccEEEccCCccc-----------------------------------------ccC
Q 037916           82 KHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIF-----------------------------------------RSI  120 (741)
Q Consensus        82 ~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~-----------------------------------------~~~  120 (741)
                      +.|++++|.+++..+...  .. .+..+....|.+.                                         ...
T Consensus       113 ~~L~~~~~~~~~~~~~~~--~~-~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (384)
T d2omza2         113 TGLTLFNNQITDIDPLKN--LT-NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSD  189 (384)
T ss_dssp             CEEECCSSCCCCCGGGTT--CT-TCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCC
T ss_pred             cccccccccccccccccc--cc-cccccccccccccccccccccccccccccccccchhhhhcccccccccccccccccc
Confidence            999999999886543322  11 3444444433321                                         123


Q ss_pred             CccccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCcccccCCcccceeeccCcccccccCcccccCC
Q 037916          121 PAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQ  200 (741)
Q Consensus       121 ~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~  200 (741)
                      ...+..+++++.|++++|.++++.+  +...++|++|++++|+++..  +.+..+++|+.|++++|.+++..+  +..++
T Consensus       190 ~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~  263 (384)
T d2omza2         190 ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLT  263 (384)
T ss_dssp             CGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCT
T ss_pred             ccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCCc--ccccc
Confidence            3556778899999999999997654  56778999999999999853  478899999999999999986554  78899


Q ss_pred             CCCEEeccCccccccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccchhhhhccccccccEEEe
Q 037916          201 SLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKL  280 (741)
Q Consensus       201 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  280 (741)
                      +|++|++++|++++..  .+..+..+.. ++++.|.+.+  ...+..+++++.|++++|+++++.  .+..+++|++|++
T Consensus       264 ~L~~L~l~~~~l~~~~--~~~~~~~l~~-l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L  336 (384)
T d2omza2         264 KLTELKLGANQISNIS--PLAGLTALTN-LELNENQLED--ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFF  336 (384)
T ss_dssp             TCSEEECCSSCCCCCG--GGTTCTTCSE-EECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEEC
T ss_pred             cCCEeeccCcccCCCC--cccccccccc-cccccccccc--ccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEEC
Confidence            9999999999998543  3778888887 9999999985  335889999999999999999764  4889999999999


Q ss_pred             CCCccCCCCChhcccCccCCeeeCCCCcCCCccchhhhccccCCcccccCcc
Q 037916          281 GGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYND  332 (741)
Q Consensus       281 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~  332 (741)
                      ++|+|+++ + .+.++++|++|+|++|+|++..|  +.++++|+.|+|++|.
T Consensus       337 ~~n~l~~l-~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~Na  384 (384)
T d2omza2         337 ANNKVSDV-S-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQA  384 (384)
T ss_dssp             CSSCCCCC-G-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCEE
T ss_pred             CCCCCCCC-h-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCCc
Confidence            99999953 3 69999999999999999997665  8899999999999983

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=3.8e-28  Score=248.49  Aligned_cols=252  Identities=20%  Similarity=0.166  Sum_probs=145.5

Q ss_pred             ccEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEc-
Q 037916           81 LKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAI-  159 (741)
Q Consensus        81 L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L-  159 (741)
                      ...+++++++++ .+|..+.   .++++|+|++|+|+++.+.+|.++++|++|++++|+|..+.+..+.++..++.+.. 
T Consensus        13 ~~~v~c~~~~L~-~iP~~ip---~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~   88 (284)
T d1ozna_          13 KVTTSCPQQGLQ-AVPVGIP---AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS   88 (284)
T ss_dssp             SCEEECCSSCCS-SCCTTCC---TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CeEEEcCCCCCC-ccCCCCC---CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccc
Confidence            345667777776 3343322   25666666666666666666666666666666666666666666666666666654 


Q ss_pred             ccCCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCC
Q 037916          160 NTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVG  239 (741)
Q Consensus       160 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~  239 (741)
                      ..|.++.+.+.+|.++++|++|++++|.+....+..+..+++|+.+++++|+|++..+..|..+++|+. |++++|+|++
T Consensus        89 ~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~-L~l~~N~l~~  167 (284)
T d1ozna_          89 DNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTH-LFLHGNRISS  167 (284)
T ss_dssp             SCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE-EECCSSCCCE
T ss_pred             cccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhh-cccccCcccc
Confidence            344555555566666666666666666665555555555666666666666666444455555555554 6666666655


Q ss_pred             CCChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccchhhhc
Q 037916          240 SLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVE  319 (741)
Q Consensus       240 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  319 (741)
                      ..+..|.++++|+.|++++|+++++.+..|..+++|++|++++|++.+..+.+|.++++|++|+|++|.+...-+ .-.-
T Consensus       168 l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~-~~~l  246 (284)
T d1ozna_         168 VPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPL  246 (284)
T ss_dssp             ECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG-GHHH
T ss_pred             cchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc-chHH
Confidence            555555566666666666666665555556666666666666666655555555555566666666665553222 1111


Q ss_pred             cccCCcccccCcccccccC
Q 037916          320 LQLVQNLNLSYNDLEGVIP  338 (741)
Q Consensus       320 l~~L~~L~l~~N~l~~~~~  338 (741)
                      ...++.+....+++.+..|
T Consensus       247 ~~~l~~~~~~~~~~~C~~p  265 (284)
T d1ozna_         247 WAWLQKFRGSSSEVPCSLP  265 (284)
T ss_dssp             HHHHHHCCSEECCCBEEES
T ss_pred             HHHHHhCcCCCCceEeCCc
Confidence            1233444444555554433

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.8e-27  Score=243.41  Aligned_cols=253  Identities=22%  Similarity=0.181  Sum_probs=192.2

Q ss_pred             ccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCcccccCCcccceeecc-
Q 037916          106 LETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLI-  184 (741)
Q Consensus       106 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~-  184 (741)
                      ...++.+++++. .+|..+.  +++++|+|++|+|+++.+.+|.++++|++|++++|+|..+.+..+.+++.+..++.. 
T Consensus        13 ~~~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~   89 (284)
T d1ozna_          13 KVTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD   89 (284)
T ss_dssp             SCEEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CeEEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccc
Confidence            345567777764 4455554  367888888888887777788888888888888888887777778888888887654 


Q ss_pred             CcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccch
Q 037916          185 ENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECE  264 (741)
Q Consensus       185 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  264 (741)
                      .|.++...+..|.++++|++|++++|.+....+..+....+|+. +++++|+|+++.+..|..+++|+.|++++|+|+.+
T Consensus        90 ~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~-l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l  168 (284)
T d1ozna_          90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQY-LYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSV  168 (284)
T ss_dssp             CTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCE-EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEE
T ss_pred             ccccccccchhhcccccCCEEecCCcccccccccccchhcccch-hhhccccccccChhHhccccchhhcccccCccccc
Confidence            56677677778888888888888888887666667777778876 88888888877777788888888888888888888


Q ss_pred             hhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccchhhhccccCCcccccCcccccccCCccccC
Q 037916          265 ILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFK  344 (741)
Q Consensus       265 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~  344 (741)
                      .+.+|.++++|+.|++++|+++++.|..|.++++|++|++++|++++..+..|..+++|+.|+|++|++.+..+..+...
T Consensus       169 ~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~~l~~  248 (284)
T d1ozna_         169 PERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWA  248 (284)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHH
T ss_pred             chhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccchHHHH
Confidence            88888888888888888888888888888888888888888888888777888888888888888888887655433333


Q ss_pred             CcccccccCCCCccccCC
Q 037916          345 NASAISVFGNSKLCGGIP  362 (741)
Q Consensus       345 ~~~~~~~~~n~~~c~~~~  362 (741)
                      .++......+...|..+.
T Consensus       249 ~l~~~~~~~~~~~C~~p~  266 (284)
T d1ozna_         249 WLQKFRGSSSEVPCSLPQ  266 (284)
T ss_dssp             HHHHCCSEECCCBEEESG
T ss_pred             HHHhCcCCCCceEeCCch
Confidence            344455555556665443

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=2.6e-25  Score=224.63  Aligned_cols=205  Identities=25%  Similarity=0.203  Sum_probs=181.6

Q ss_pred             cCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCE
Q 037916          125 GKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTT  204 (741)
Q Consensus       125 ~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~  204 (741)
                      .+...+.+.+.+++.|+.+ |..+.  ++|++|+|++|+|+++.+.+|.++++|++|+|++|+|+.+.  .++.+++|++
T Consensus         7 ~~~~~~~~v~C~~~~L~~i-P~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~--~~~~l~~L~~   81 (266)
T d1p9ag_           7 SKVASHLEVNCDKRNLTAL-PPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQ--VDGTLPVLGT   81 (266)
T ss_dssp             ECSTTCCEEECTTSCCSSC-CSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEE--CCSCCTTCCE
T ss_pred             cccCCCeEEEccCCCCCee-CcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccccc--cccccccccc
Confidence            4556778889999999965 54443  57999999999999888889999999999999999998543  3578999999


Q ss_pred             EeccCccccccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCc
Q 037916          205 INLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNL  284 (741)
Q Consensus       205 L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  284 (741)
                      |+|++|+++ ..+..+.++++|+. |++++|.+.+..+..+..+.++++|++++|.++.+.+..+..+++|+.|++++|+
T Consensus        82 L~Ls~N~l~-~~~~~~~~l~~L~~-L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~  159 (266)
T d1p9ag_          82 LDLSHNQLQ-SLPLLGQTLPALTV-LDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN  159 (266)
T ss_dssp             EECCSSCCS-SCCCCTTTCTTCCE-EECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred             ccccccccc-cccccccccccccc-ccccccccceeeccccccccccccccccccccceeccccccccccchhccccccc
Confidence            999999998 67888999999998 9999999998888899999999999999999999999999999999999999999


Q ss_pred             cCCCCChhcccCccCCeeeCCCCcCCCccchhhhccccCCcccccCccccccc
Q 037916          285 FQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVI  337 (741)
Q Consensus       285 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~  337 (741)
                      |++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|++.+..
T Consensus       160 l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC  211 (266)
T d1p9ag_         160 LTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC  211 (266)
T ss_dssp             CSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred             ccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCc
Confidence            99988899999999999999999999 67777778999999999999987643

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=3.9e-25  Score=223.35  Aligned_cols=199  Identities=23%  Similarity=0.184  Sum_probs=181.1

Q ss_pred             cccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCcccccCCcccceeecc
Q 037916          105 TLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLI  184 (741)
Q Consensus       105 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  184 (741)
                      .+.+++.++++++. +|..+.  ++|++|+|++|+|+++.+.+|.++++|++|+|++|+|+.+ + .++.+++|++|+|+
T Consensus        11 ~~~~v~C~~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~Ls   85 (266)
T d1p9ag_          11 SHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGTLDLS   85 (266)
T ss_dssp             TCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCEEECC
T ss_pred             CCeEEEccCCCCCe-eCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-c-cccccccccccccc
Confidence            67788999999965 576665  4899999999999999889999999999999999999854 3 46889999999999


Q ss_pred             CcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccch
Q 037916          185 ENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECE  264 (741)
Q Consensus       185 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  264 (741)
                      +|+++ ..+..+.++++|+.|++++|.+.+..+..+..+.++.. |++++|.+....+..+..+++|+.|++++|+|+++
T Consensus        86 ~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~-L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~  163 (266)
T d1p9ag_          86 HNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQE-LYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTEL  163 (266)
T ss_dssp             SSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCE-EECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCC
T ss_pred             ccccc-ccccccccccccccccccccccceeecccccccccccc-ccccccccceeccccccccccchhccccccccccc
Confidence            99998 45778999999999999999999888888899999998 99999999988888999999999999999999999


Q ss_pred             hhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCC
Q 037916          265 ILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISG  311 (741)
Q Consensus       265 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  311 (741)
                      .+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|.+..
T Consensus       164 ~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~C  209 (266)
T d1p9ag_         164 PAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC  209 (266)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred             CccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCC
Confidence            9999999999999999999999 677778889999999999999874

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.86  E-value=5.9e-23  Score=195.99  Aligned_cols=169  Identities=17%  Similarity=0.107  Sum_probs=118.4

Q ss_pred             HHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcC------------------cchhHHHHHHHHHhcCCCceeeEee
Q 037916          403 LFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHG------------------ASKSSIAECSALRNIRHKNLVKILT  464 (741)
Q Consensus       403 ~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~------------------~~~~~~~E~~~l~~l~hpnIv~~~~  464 (741)
                      .+.++||+|+||.||+|++. +|+.||||+++.....                  ......+|...+.++.|++++..++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             hhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            46789999999999999986 6899999987632110                  0122346788899999999998887


Q ss_pred             eecCccccCCceEEEEEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCC
Q 037916          465 VCSGVDYKGDDFKALVYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDCQPTTAHCDLKPS  544 (741)
Q Consensus       465 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDlkp~  544 (741)
                      +.         ..+++|||+++..+.++                 +......++.|+++|++|||+.   ||+||||||+
T Consensus        82 ~~---------~~~lvme~~~~~~~~~l-----------------~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~  132 (191)
T d1zara2          82 WE---------GNAVLMELIDAKELYRV-----------------RVENPDEVLDMILEEVAKFYHR---GIVHGDLSQY  132 (191)
T ss_dssp             EE---------TTEEEEECCCCEEGGGC-----------------CCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTT
T ss_pred             ec---------CCEEEEEeeccccccch-----------------hhHHHHHHHHHHHHHHHHHhhC---CEEEccCChh
Confidence            62         23799999987655432                 2233467899999999999999   9999999999


Q ss_pred             CeEeCCCCceEEeecccccccCCCCcccccccccccccccCcccccCCCCCCCccCchhHHHHH
Q 037916          545 NVLLDHEMTAHVADFGLAKLLPPAHLQTSSIGVKGTIGYIAPAEYGLGSEVSINGDVYSYGILL  608 (741)
Q Consensus       545 NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPEe~~~~~~~~~~~DIwSlG~il  608 (741)
                      |||++++ .++|+|||.|.....+.......   .....+ . ++ ....|+.++|+||..--+
T Consensus       133 NILv~~~-~~~liDFG~a~~~~~~~~~~~l~---rd~~~~-~-~~-f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         133 NVLVSEE-GIWIIDFPQSVEVGEEGWREILE---RDVRNI-I-TY-FSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             SEEEETT-EEEECCCTTCEETTSTTHHHHHH---HHHHHH-H-HH-HHHHHCCCCCHHHHHHHH
T ss_pred             heeeeCC-CEEEEECCCcccCCCCCcHHHHH---HHHHHH-H-HH-HcCCCCCcccHHHHHHHH
Confidence            9999865 58999999997654332111000   000000 0 11 135678889999975443

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.85  E-value=3.9e-21  Score=190.93  Aligned_cols=223  Identities=14%  Similarity=0.063  Sum_probs=118.4

Q ss_pred             CccEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccc-cCCccccCCCcCcEEE
Q 037916           80 HLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSG-TISPAIGELQNLVTLA  158 (741)
Q Consensus        80 ~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~-~~~~~~~~l~~L~~L~  158 (741)
                      ..+.++.++++++ .+|..+.   .++++|+|++|+|..+.+.+|.++++|++|+|++|.+.. +.+.+|.+++++++|.
T Consensus         9 ~~~~i~c~~~~l~-~iP~~l~---~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~   84 (242)
T d1xwdc1           9 SNRVFLCQESKVT-EIPSDLP---RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIR   84 (242)
T ss_dssp             CSSEEEEESCSCS-SCCSCSC---SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEE
T ss_pred             cCCEEEEeCCCCC-CcCCCCC---CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccc
Confidence            3567777777776 3333222   245566666666655555555556666666666655543 2344555555555555


Q ss_pred             cc-cCCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCcc
Q 037916          159 IN-TNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQL  237 (741)
Q Consensus       159 L~-~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l  237 (741)
                      +. .|++....+..|.++++|++|++++|.+....+..                       .+..+..+.. +..+++.+
T Consensus        85 ~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~-----------------------~~~~l~~l~~-~~~~n~~l  140 (242)
T d1xwdc1          85 IEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVH-----------------------KIHSLQKVLL-DIQDNINI  140 (242)
T ss_dssp             EECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCT-----------------------TTCBSSCEEE-EEESCTTC
T ss_pred             ccccccccccccccccccccccccccchhhhccccccc-----------------------cccccccccc-cccccccc
Confidence            43 24454444455555555555555555544222111                       1122333332 44444444


Q ss_pred             CCCCChhhcCCC-CCcEEEeccccccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccchh
Q 037916          238 VGSLPTEVGKLI-NLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKF  316 (741)
Q Consensus       238 ~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~  316 (741)
                      ....+..|..++ .++.|++++|+++.+....|.....++.+++++|+++.+.+..|.++++|++|+|++|+|+...+..
T Consensus       141 ~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~  220 (242)
T d1xwdc1         141 HTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYG  220 (242)
T ss_dssp             CEECTTSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSS
T ss_pred             ccccccccccccccceeeecccccccccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHH
Confidence            444444444433 5556666666666555555444333334455666666555556677777777777777777555556


Q ss_pred             hhccccCCcccccC
Q 037916          317 LVELQLVQNLNLSY  330 (741)
Q Consensus       317 ~~~l~~L~~L~l~~  330 (741)
                      |.++++|+.+++.+
T Consensus       221 ~~~l~~L~~l~~~~  234 (242)
T d1xwdc1         221 LENLKKLRARSTYN  234 (242)
T ss_dssp             CTTCCEEESSSEES
T ss_pred             HcCCcccccCcCCC
Confidence            66666666666543

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.85  E-value=1.9e-21  Score=193.17  Aligned_cols=220  Identities=19%  Similarity=0.109  Sum_probs=169.8

Q ss_pred             CcEEEeecCcCcccCCchhhhhhhhhhccccCCCccEEECcCCcCcccCCchhhcccccccEEEccCCccccc-CCcccc
Q 037916           47 LEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRS-IPAGIG  125 (741)
Q Consensus        47 L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~-~~~~~~  125 (741)
                      .++++.++++++ .+|..+.  +          ++++|+|++|+|+.+.+..|.++. +|++|++++|.+... .+..|.
T Consensus        10 ~~~i~c~~~~l~-~iP~~l~--~----------~l~~L~Ls~n~i~~l~~~~f~~l~-~L~~L~ls~n~~~~~i~~~~f~   75 (242)
T d1xwdc1          10 NRVFLCQESKVT-EIPSDLP--R----------NAIELRFVLTKLRVIQKGAFSGFG-DLEKIEISQNDVLEVIEADVFS   75 (242)
T ss_dssp             SSEEEEESCSCS-SCCSCSC--S----------CCSEEEEESCCCCEECTTTTTTCT-TCCEEEEESCTTCCEECSSSEE
T ss_pred             CCEEEEeCCCCC-CcCCCCC--C----------CCCEEECcCCcCCccChhHhhccc-hhhhhhhccccccceeeccccc
Confidence            468999999999 6665543  1          499999999999988888899998 999999999998764 566799


Q ss_pred             CCCCccEEEcc-cccccccCCccccCCCcCcEEEcccCCCCCcCccc-ccCCcccceeeccCcccccccCcccccCC-CC
Q 037916          126 KFINLQTLHMW-DNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPS-IGNLKKLLQLYLIENFLQVSIPSSLGQCQ-SL  202 (741)
Q Consensus       126 ~l~~L~~L~L~-~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~L~~N~i~~~~~~~~~~l~-~L  202 (741)
                      +++++++|++. .|.+....+..|.++++|++|++++|++....+.. +..+..+..+..+++.+....+..|.+++ .+
T Consensus        76 ~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l  155 (242)
T d1xwdc1          76 NLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFES  155 (242)
T ss_dssp             SCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSC
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccc
Confidence            99999999986 47898899999999999999999999998554332 44566777777788888877777887764 78


Q ss_pred             CEEeccCccccccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeC
Q 037916          203 TTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLG  281 (741)
Q Consensus       203 ~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  281 (741)
                      +.|++++|+++ .++...+..+++...+++++|+|+.+.+..|.++++|++|+|++|+|+.+++..|.++++|+.|++.
T Consensus       156 ~~L~l~~n~l~-~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~  233 (242)
T d1xwdc1         156 VILWLNKNGIQ-EIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY  233 (242)
T ss_dssp             EEEECCSSCCC-EECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEE
T ss_pred             eeeeccccccc-ccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCC
Confidence            88888888888 4444445555655535677778876556667777777777777777776666666666666665553

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.85  E-value=3.4e-20  Score=194.68  Aligned_cols=267  Identities=27%  Similarity=0.302  Sum_probs=139.7

Q ss_pred             CCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCccEEECcCCcCcccCCchhhc
Q 037916           22 NLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICN  101 (741)
Q Consensus        22 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~  101 (741)
                      ++++|||++|.|+ .+|+.   +++|++|+|++|+|+ .+|..++             +|+.|++++|+++.+ +    .
T Consensus        39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~~-------------~L~~L~l~~n~l~~l-~----~   95 (353)
T d1jl5a_          39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELPQ-------------SLKSLLVDNNNLKAL-S----D   95 (353)
T ss_dssp             TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCCT-------------TCCEEECCSSCCSCC-C----S
T ss_pred             CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccchh-------------hhhhhhhhhcccchh-h----h
Confidence            5667777777776 34532   456677777777776 4454432             266677777766632 2    2


Q ss_pred             ccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCcccccCCccccee
Q 037916          102 FSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQL  181 (741)
Q Consensus       102 l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  181 (741)
                      ++..|++|++++|.+... | .+..+++|++|++++|.++....    ....+..|.+..+...  ....+..++.++.|
T Consensus        96 lp~~L~~L~L~~n~l~~l-p-~~~~l~~L~~L~l~~~~~~~~~~----~~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L  167 (353)
T d1jl5a_          96 LPPLLEYLGVSNNQLEKL-P-ELQNSSFLKIIDVDNNSLKKLPD----LPPSLEFIAAGNNQLE--ELPELQNLPFLTAI  167 (353)
T ss_dssp             CCTTCCEEECCSSCCSSC-C-CCTTCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCS--SCCCCTTCTTCCEE
T ss_pred             hccccccccccccccccc-c-chhhhccceeecccccccccccc----ccccccchhhcccccc--ccccccccccceec
Confidence            233567777777766433 3 24566677777777766653321    1223344444443332  12233444444444


Q ss_pred             eccCccccc-------------------ccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCCCC
Q 037916          182 YLIENFLQV-------------------SIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLP  242 (741)
Q Consensus       182 ~L~~N~i~~-------------------~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p  242 (741)
                      ++++|.+..                   ..+ .+..++.|+.+++++|... ..|....   ++.. +.++.|.+... +
T Consensus       168 ~l~~n~~~~~~~~~~~~~~l~~~~~~~~~~~-~~~~l~~L~~l~l~~n~~~-~~~~~~~---~l~~-~~~~~~~~~~~-~  240 (353)
T d1jl5a_         168 YADNNSLKKLPDLPLSLESIVAGNNILEELP-ELQNLPFLTTIYADNNLLK-TLPDLPP---SLEA-LNVRDNYLTDL-P  240 (353)
T ss_dssp             ECCSSCCSSCCCCCTTCCEEECCSSCCSSCC-CCTTCTTCCEEECCSSCCS-SCCSCCT---TCCE-EECCSSCCSCC-C
T ss_pred             ccccccccccccccccccccccccccccccc-ccccccccccccccccccc-ccccccc---cccc-ccccccccccc-c
Confidence            444443332                   122 2445667777777777665 3443332   3333 55666665522 1


Q ss_pred             hhhcCCCCCcEEEeccccccchh----------------hhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCC
Q 037916          243 TEVGKLINLEILFISRNMLECEI----------------LSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQ  306 (741)
Q Consensus       243 ~~~~~l~~L~~L~Ls~N~l~~~~----------------~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  306 (741)
                      .   ....+..+++..|.+.++.                ......+++|++|+|++|+|+. +|.   .+++|+.|+|++
T Consensus       241 ~---~~~~l~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~-lp~---~~~~L~~L~L~~  313 (353)
T d1jl5a_         241 E---LPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPA---LPPRLERLIASF  313 (353)
T ss_dssp             C---CCTTCCEEECCSSCCSEESCCCTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCS
T ss_pred             c---ccccccccccccccccccccccchhcccccccCccccccccCCCCCEEECCCCccCc-ccc---ccCCCCEEECCC
Confidence            1   1223333343333322110                0112234667777777777773 443   345677777777


Q ss_pred             CcCCCccchhhhccccCCcccccCccccccc
Q 037916          307 NNISGEIPKFLVELQLVQNLNLSYNDLEGVI  337 (741)
Q Consensus       307 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~  337 (741)
                      |+|+ .+|..   +++|+.|+|++|+++..+
T Consensus       314 N~L~-~l~~~---~~~L~~L~L~~N~L~~lp  340 (353)
T d1jl5a_         314 NHLA-EVPEL---PQNLKQLHVEYNPLREFP  340 (353)
T ss_dssp             SCCS-CCCCC---CTTCCEEECCSSCCSSCC
T ss_pred             CcCC-ccccc---cCCCCEEECcCCcCCCCC
Confidence            7776 34432   346777777777776543

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.83  E-value=8.3e-21  Score=186.45  Aligned_cols=205  Identities=22%  Similarity=0.270  Sum_probs=104.3

Q ss_pred             ccEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcc
Q 037916           81 LKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAIN  160 (741)
Q Consensus        81 L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~  160 (741)
                      +..++++.+++++..  .+..+. +|++|++.+|+|...  ..+..+++|++|+|++|+|+++.+  |.++++|++|+++
T Consensus        21 ~~~~~l~~~~~~d~~--~~~~l~-~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~   93 (227)
T d1h6ua2          21 AIKIAAGKSNVTDTV--TQADLD-GITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELS   93 (227)
T ss_dssp             HHHHHTTCSSTTSEE--CHHHHH-TCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECC
T ss_pred             HHHHHhCCCCcCCcC--CHHHcC-CcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeecccc--ccccccccccccc
Confidence            344556666666543  233444 666666666666443  246666666666666666664432  5666666666666


Q ss_pred             cCCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCC
Q 037916          161 TNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGS  240 (741)
Q Consensus       161 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~  240 (741)
                      +|.++.+  ..|.++++|+.+++++|.+.+.  ..+...+.+..+.++++.+...  ..+.+                  
T Consensus        94 ~n~~~~i--~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~------------------  149 (227)
T d1h6ua2          94 GNPLKNV--SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAG------------------  149 (227)
T ss_dssp             SCCCSCC--GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGG------------------
T ss_pred             ccccccc--cccccccccccccccccccccc--chhccccchhhhhchhhhhchh--hhhcc------------------
Confidence            6666532  2355556666666655555432  1233444555555555544321  12334                  


Q ss_pred             CChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCCCccchhhhcc
Q 037916          241 LPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVEL  320 (741)
Q Consensus       241 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  320 (741)
                             +++|+.|++++|.+...  ..++++++|+.|+|++|+++++.  .+.++++|++|+|++|+|++..|  +.++
T Consensus       150 -------~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l~~l~--~l~~l~~L~~L~Ls~N~lt~i~~--l~~l  216 (227)
T d1h6ua2         150 -------LTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKISDIS--PLASLPNLIEVHLKNNQISDVSP--LANT  216 (227)
T ss_dssp             -------CTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECTTSCCCBCGG--GTTC
T ss_pred             -------ccccccccccccccccc--hhhcccccceecccCCCccCCCh--hhcCCCCCCEEECcCCcCCCCcc--cccC
Confidence                   44444444444444322  12444455555555555554321  24455555555555555553322  4455


Q ss_pred             ccCCccccc
Q 037916          321 QLVQNLNLS  329 (741)
Q Consensus       321 ~~L~~L~l~  329 (741)
                      ++|+.|+++
T Consensus       217 ~~L~~L~ls  225 (227)
T d1h6ua2         217 SNLFIVTLT  225 (227)
T ss_dssp             TTCCEEEEE
T ss_pred             CCCCEEEee
Confidence            555555554

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.83  E-value=2.5e-19  Score=187.99  Aligned_cols=274  Identities=25%  Similarity=0.271  Sum_probs=181.7

Q ss_pred             CCCCCcccccCChhhhhCCCCCcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCc
Q 037916            2 DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHL   81 (741)
Q Consensus         2 dl~~n~~~~~ip~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L   81 (741)
                      ||++|.++ ++|..    +++|++|+|++|+|+ .+|+.   +.+|+.|++++|+++. ++.    ++.         .|
T Consensus        44 dLs~~~L~-~lp~~----~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~~-l~~----lp~---------~L  100 (353)
T d1jl5a_          44 ELNNLGLS-SLPEL----PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLKA-LSD----LPP---------LL  100 (353)
T ss_dssp             ECTTSCCS-CCCSC----CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSC-CCS----CCT---------TC
T ss_pred             EeCCCCCC-CCCCC----CCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccch-hhh----hcc---------cc
Confidence            78999998 78843    489999999999999 55765   4589999999999983 332    222         49


Q ss_pred             cEEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEccc
Q 037916           82 KHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINT  161 (741)
Q Consensus        82 ~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~  161 (741)
                      ++|++++|.|..+ |. +..+. +|+.|++++|.+..... .   ...+..|.+..+...  ....+..++.++.|++++
T Consensus       101 ~~L~L~~n~l~~l-p~-~~~l~-~L~~L~l~~~~~~~~~~-~---~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~  171 (353)
T d1jl5a_         101 EYLGVSNNQLEKL-PE-LQNSS-FLKIIDVDNNSLKKLPD-L---PPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADN  171 (353)
T ss_dssp             CEEECCSSCCSSC-CC-CTTCT-TCCEEECCSSCCSCCCC-C---CTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCS
T ss_pred             ccccccccccccc-cc-hhhhc-cceeecccccccccccc-c---cccccchhhcccccc--ccccccccccceeccccc
Confidence            9999999999955 43 45666 89999999998854332 1   234455555554443  223344555555555555


Q ss_pred             CCCCCc------------------CcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCcccccc
Q 037916          162 NKLSGN------------------IPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDL  223 (741)
Q Consensus       162 N~l~~~------------------~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  223 (741)
                      |.+...                  ....+..++.|+.+++++|.... .+.   ...++..+.+.+|.+. ..+.....+
T Consensus       172 n~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~L~~l~l~~n~~~~-~~~---~~~~l~~~~~~~~~~~-~~~~~~~~l  246 (353)
T d1jl5a_         172 NSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKT-LPD---LPPSLEALNVRDNYLT-DLPELPQSL  246 (353)
T ss_dssp             SCCSSCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSS-CCS---CCTTCCEEECCSSCCS-CCCCCCTTC
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccc-ccc---cccccccccccccccc-ccccccccc
Confidence            544321                  11235667888999999887763 333   2356777888887776 233222221


Q ss_pred             cc----------------ceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCccCC
Q 037916          224 TS----------------LSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQG  287 (741)
Q Consensus       224 ~~----------------L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  287 (741)
                      ..                .....++..|.+.    .....+++|++|+|++|+|+.++ .   .+++|+.|+|++|+|+.
T Consensus       247 ~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~----~~~~~~~~L~~L~Ls~N~l~~lp-~---~~~~L~~L~L~~N~L~~  318 (353)
T d1jl5a_         247 TFLDVSENIFSGLSELPPNLYYLNASSNEIR----SLCDLPPSLEELNVSNNKLIELP-A---LPPRLERLIASFNHLAE  318 (353)
T ss_dssp             CEEECCSSCCSEESCCCTTCCEEECCSSCCS----EECCCCTTCCEEECCSSCCSCCC-C---CCTTCCEEECCSSCCSC
T ss_pred             cccccccccccccccccchhcccccccCccc----cccccCCCCCEEECCCCccCccc-c---ccCCCCEEECCCCcCCc
Confidence            11                0111344444443    22334689999999999999654 2   46789999999999995


Q ss_pred             CCChhcccCccCCeeeCCCCcCCCccchhhhccccCCcccc
Q 037916          288 PIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNL  328 (741)
Q Consensus       288 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l  328 (741)
                       +|.   .+++|+.|+|++|+|+ .+|....   .|+.|.+
T Consensus       319 -l~~---~~~~L~~L~L~~N~L~-~lp~~~~---~L~~L~~  351 (353)
T d1jl5a_         319 -VPE---LPQNLKQLHVEYNPLR-EFPDIPE---SVEDLRM  351 (353)
T ss_dssp             -CCC---CCTTCCEEECCSSCCS-SCCCCCT---TCCEEEC
T ss_pred             -ccc---ccCCCCEEECcCCcCC-CCCcccc---ccCeeEC
Confidence             553   3568999999999998 4565433   4555554

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.83  E-value=3.3e-21  Score=183.81  Aligned_cols=180  Identities=21%  Similarity=0.257  Sum_probs=129.0

Q ss_pred             ccccCCCccEEECcCCcCcccCCchhhcccccccEEEccCCcccc-cCCccccCCCCccEEEcccccccccCCccccCCC
Q 037916           74 VQNCNQHLKHLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFR-SIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQ  152 (741)
Q Consensus        74 ~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~-~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~  152 (741)
                      +..|....+++++++|+|+. +|..+   +.++++|+|++|+|+. ..+..|.++++|++|+|++|+|+.+.++.|..++
T Consensus         3 P~~C~C~~~~v~Cs~~~L~~-iP~~l---p~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~   78 (192)
T d1w8aa_           3 PAMCHCEGTTVDCTGRGLKE-IPRDI---PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGAS   78 (192)
T ss_dssp             CTTSEEETTEEECTTSCCSS-CCSCC---CTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCT
T ss_pred             CCCCEEcCCEEEEeCCCcCc-cCCCC---CCCCCEEEeCCCCCcccccccccCCCceEeeeecccccccccccccccccc
Confidence            33454457888999999884 45433   2378888888888865 4566778888888888888888888888888888


Q ss_pred             cCcEEEcccCCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEc
Q 037916          153 NLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDL  232 (741)
Q Consensus       153 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~L  232 (741)
                      +|++|+|++|+|+.+.+.+|.++++|++|+|++|+|+++.+++|..+++|++|+|++|.+.... ....-...+.. +.+
T Consensus        79 ~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~-~~~~~~~~l~~-~~l  156 (192)
T d1w8aa_          79 HIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC-HLAWFAEWLRK-KSL  156 (192)
T ss_dssp             TCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG-GGHHHHHHHHH-HCC
T ss_pred             ccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccccc-chHHHhhhhhh-hcc
Confidence            8888888888888888888888888888888888888888888888888888888888886322 21111222333 556


Q ss_pred             CCCccCCCCChhhcCCCCCcEEEecccccc
Q 037916          233 SRNQLVGSLPTEVGKLINLEILFISRNMLE  262 (741)
Q Consensus       233 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  262 (741)
                      ..|.++...|..   +..++.++|+.|.++
T Consensus       157 ~~~~~~c~~p~~---l~~~~l~~L~~n~l~  183 (192)
T d1w8aa_         157 NGGAARCGAPSK---VRDVQIKDLPHSEFK  183 (192)
T ss_dssp             SGGGCBBCSSTT---TTTSBGGGSCTTTCC
T ss_pred             cCCCeEeCCChh---hcCCEeeecCHhhCc
Confidence            666665444433   334455556666554

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.82  E-value=4.3e-20  Score=181.22  Aligned_cols=202  Identities=23%  Similarity=0.322  Sum_probs=137.2

Q ss_pred             EEcccccccccCCccccCCCcCcEEEcccCCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccc
Q 037916          133 LHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNL  212 (741)
Q Consensus       133 L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l  212 (741)
                      ++++.+++++..  .+..+.+|+.|++++|+|+.+  +.+..+++|++|++++|.+++..|  +..+++|++|++++|.+
T Consensus        24 ~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~   97 (227)
T d1h6ua2          24 IAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPL   97 (227)
T ss_dssp             HHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCC
T ss_pred             HHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeecccc--ccccccccccccccccc
Confidence            444444444332  334445555555555555532  235555555555555555554332  55566666666666666


Q ss_pred             cccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCccCCCCChh
Q 037916          213 SGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPLS  292 (741)
Q Consensus       213 ~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  292 (741)
                      + .++ .+.+++.|+. +++++|...+.  ..+...+.++.++++++.+...  ..+..+++|+.|++++|.+.+..  .
T Consensus        98 ~-~i~-~l~~l~~L~~-l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~--~  168 (227)
T d1h6ua2          98 K-NVS-AIAGLQSIKT-LDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLT--P  168 (227)
T ss_dssp             S-CCG-GGTTCTTCCE-EECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCCG--G
T ss_pred             c-ccc-cccccccccc-ccccccccccc--chhccccchhhhhchhhhhchh--hhhccccccccccccccccccch--h
Confidence            5 222 3556666765 77777766532  2456678888889988888743  34778899999999999998543  4


Q ss_pred             cccCccCCeeeCCCCcCCCccchhhhccccCCcccccCcccccccCCccccCCccccccc
Q 037916          293 LSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKNASAISVF  352 (741)
Q Consensus       293 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~  352 (741)
                      +.++++|+.|+|++|++++. + .+.++++|++|+|++|++++++| ...++++..+++.
T Consensus       169 l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~~-l~~l~~L~~L~ls  225 (227)
T d1h6ua2         169 LANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDVSP-LANTSNLFIVTLT  225 (227)
T ss_dssp             GTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBCGG-GTTCTTCCEEEEE
T ss_pred             hcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCCcc-cccCCCCCEEEee
Confidence            88999999999999999964 3 38899999999999999998764 4557777777664

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.80  E-value=1.1e-19  Score=173.03  Aligned_cols=156  Identities=19%  Similarity=0.180  Sum_probs=80.7

Q ss_pred             CCCEEeccCcccccc-CCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccchhhhhccccccccEEE
Q 037916          201 SLTTINLSYNNLSGT-IPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLK  279 (741)
Q Consensus       201 ~L~~L~L~~N~l~~~-~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  279 (741)
                      ++++|+|++|+|++. .+..|.++++|+. |+|++|.+....+..|..+++|++|+|++|+|+.+.+.+|.++++|++|+
T Consensus        30 ~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~-L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~  108 (192)
T d1w8aa_          30 HTTELLLNDNELGRISSDGLFGRLPHLVK-LELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLN  108 (192)
T ss_dssp             TCSEEECCSCCCCSBCCSCSGGGCTTCCE-EECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEE
T ss_pred             CCCEEEeCCCCCcccccccccCCCceEee-eeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccc
Confidence            444444444444432 2333444555554 55555555545555555555555555555555555555555555566666


Q ss_pred             eCCCccCCCCChhcccCccCCeeeCCCCcCCCccchhhhccccCCcccccCcccccccCCccccCCcccccccCCCCccc
Q 037916          280 LGGNLFQGPIPLSLSSLRGLRVLDLSQNNISGEIPKFLVELQLVQNLNLSYNDLEGVIPTEGVFKNASAISVFGNSKLCG  359 (741)
Q Consensus       280 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~  359 (741)
                      |++|+|+++.+++|..+++|++|+|++|.+....+. ..-...++.+.+..|.+++..|..  +....-.++..|...|.
T Consensus       109 L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~-~~~~~~l~~~~l~~~~~~c~~p~~--l~~~~l~~L~~n~l~C~  185 (192)
T d1w8aa_         109 LYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL-AWFAEWLRKKSLNGGAARCGAPSK--VRDVQIKDLPHSEFKCS  185 (192)
T ss_dssp             CCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG-HHHHHHHHHHCCSGGGCBBCSSTT--TTTSBGGGSCTTTCCCC
T ss_pred             cCCccccccCHHHhcCCcccccccccccccccccch-HHHhhhhhhhcccCCCeEeCCChh--hcCCEeeecCHhhCcCC
Confidence            666666655555566666666666666665532221 111223455556666665544432  34444455555555554


Q ss_pred             c
Q 037916          360 G  360 (741)
Q Consensus       360 ~  360 (741)
                      .
T Consensus       186 ~  186 (192)
T d1w8aa_         186 S  186 (192)
T ss_dssp             C
T ss_pred             C
Confidence            3

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.78  E-value=3.6e-19  Score=170.50  Aligned_cols=164  Identities=27%  Similarity=0.347  Sum_probs=79.9

Q ss_pred             EEECcCCcCcccCCchhhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcccC
Q 037916           83 HLDINNNNFGGLLPGCICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTN  162 (741)
Q Consensus        83 ~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N  162 (741)
                      .+.++.+++++..+.  ..+. ++++|++++|+|...  ..+..+++|++|+|++|+|+++.+  +.++++|++|++++|
T Consensus        22 ~~~l~~~~~~~~~~~--~~l~-~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n   94 (199)
T d2omxa2          22 KTVLGKTNVTDTVSQ--TDLD-QVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNN   94 (199)
T ss_dssp             HHHTTCSSTTSEECH--HHHT-TCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSS
T ss_pred             HHHhCCCCCCCccCH--HHhc-CCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCccccccccccc
Confidence            344555555543322  2333 556666666655432  235555666666666666654432  556666666666666


Q ss_pred             CCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCCCC
Q 037916          163 KLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLP  242 (741)
Q Consensus       163 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p  242 (741)
                      .+..+ + .+.++++|+.|++++|.+...  ..+..+++|+.|++++|++. .+ +.+..+++++. |++++|++++. +
T Consensus        95 ~~~~~-~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~-~~-~~l~~~~~L~~-L~l~~n~l~~l-~  166 (199)
T d2omxa2          95 QIADI-T-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTIS-DI-SALSGLTSLQQ-LNFSSNQVTDL-K  166 (199)
T ss_dssp             CCCCC-G-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCC-CC-GGGTTCTTCSE-EECCSSCCCCC-G
T ss_pred             ccccc-c-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhc-cc-ccccccccccc-cccccccccCC-c
Confidence            65532 2 255555555555555555432  22444555555555555544 22 12444444443 44444444422 1


Q ss_pred             hhhcCCCCCcEEEecccccc
Q 037916          243 TEVGKLINLEILFISRNMLE  262 (741)
Q Consensus       243 ~~~~~l~~L~~L~Ls~N~l~  262 (741)
                       .++++++|++|++++|+++
T Consensus       167 -~l~~l~~L~~L~ls~N~i~  185 (199)
T d2omxa2         167 -PLANLTTLERLDISSNKVS  185 (199)
T ss_dssp             -GGTTCTTCCEEECCSSCCC
T ss_pred             -cccCCCCCCEEECCCCCCC
Confidence             2444444444444444443

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.78  E-value=1e-18  Score=168.76  Aligned_cols=181  Identities=21%  Similarity=0.298  Sum_probs=97.3

Q ss_pred             EEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCccEEECcCCcCcccCCchhhcccc
Q 037916           25 FLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNFSI  104 (741)
Q Consensus        25 ~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~  104 (741)
                      ..+++.+.+++.++.  ..+.+|+.|++++|+|+...  .+..+++          |++|+|++|+|+++.+  +..+. 
T Consensus        28 ~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~--~l~~l~~----------L~~L~L~~n~i~~l~~--~~~l~-   90 (210)
T d1h6ta2          28 KDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQ--GIQYLPN----------VTKLFLNGNKLTDIKP--LANLK-   90 (210)
T ss_dssp             HHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCCT--TGGGCTT----------CCEEECCSSCCCCCGG--GTTCT-
T ss_pred             HHHhCcCccCCccCH--HHhcCccEEECcCCCCCCch--hHhhCCC----------CCEEeCCCccccCccc--cccCc-
Confidence            334555555544332  23445555666666555322  2444443          5666666665554322  34444 


Q ss_pred             cccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCcccccCCcccceeecc
Q 037916          105 TLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLI  184 (741)
Q Consensus       105 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  184 (741)
                      +|++|++++|+|..+ + .+..+++|+.|++++|.+..+  ..+.++++|+.+++++|.+++  +..+..+++|++++++
T Consensus        91 ~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~l~~~~~~~~--~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~  164 (210)
T d1h6ta2          91 NLGWLFLDENKVKDL-S-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLE  164 (210)
T ss_dssp             TCCEEECCSSCCCCG-G-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECC
T ss_pred             ccccccccccccccc-c-ccccccccccccccccccccc--ccccccccccccccccccccc--cccccccccccccccc
Confidence            566666666665432 2 355566666666666665532  345566666666666666653  2245556666666666


Q ss_pred             CcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcC
Q 037916          185 ENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLS  233 (741)
Q Consensus       185 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls  233 (741)
                      +|++++..  .+.++++|+.|+|++|+|+ .+| .+.++++|++ |+|+
T Consensus       165 ~n~l~~i~--~l~~l~~L~~L~Ls~N~i~-~l~-~l~~l~~L~~-L~Ls  208 (210)
T d1h6ta2         165 DNQISDIV--PLAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDV-LELF  208 (210)
T ss_dssp             SSCCCCCG--GGTTCTTCCEEECCSSCCC-BCG-GGTTCTTCSE-EEEE
T ss_pred             cccccccc--cccCCCCCCEEECCCCCCC-CCh-hhcCCCCCCE-EEcc
Confidence            66665432  2556666666666666665 333 3566666665 6654

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.77  E-value=8.8e-19  Score=169.29  Aligned_cols=180  Identities=26%  Similarity=0.346  Sum_probs=92.8

Q ss_pred             EEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCcccccCCcccceeeccCccc
Q 037916          109 LIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFL  188 (741)
Q Consensus       109 L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i  188 (741)
                      ..+..+.+...++.  ..|.+|++|++++|.|+.+.  .+..+++|++|+|++|+|+++.  .++.+++|++|++++|+|
T Consensus        29 ~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i  102 (210)
T d1h6ta2          29 DNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKV  102 (210)
T ss_dssp             HHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCC
T ss_pred             HHhCcCccCCccCH--HHhcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccc
Confidence            34555555443332  23456677777777766432  2566666777777777666432  255666666666666666


Q ss_pred             ccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccchhhhh
Q 037916          189 QVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILST  268 (741)
Q Consensus       189 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~  268 (741)
                      ++ +| .+.++++|+.|++++|.+. .+ ..+..++.++. +++++|.+++  +..+..+++|+++++++|+++++.  .
T Consensus       103 ~~-l~-~l~~l~~L~~L~l~~~~~~-~~-~~l~~l~~l~~-l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~--~  173 (210)
T d1h6ta2         103 KD-LS-SLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLES-LYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIV--P  173 (210)
T ss_dssp             CC-GG-GGTTCTTCCEEECTTSCCC-CC-GGGGGCTTCCE-EECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCG--G
T ss_pred             cc-cc-ccccccccccccccccccc-cc-ccccccccccc-cccccccccc--cccccccccccccccccccccccc--c
Confidence            53 22 3555666666666666554 22 23445555554 5555555542  223444455555555555544322  2


Q ss_pred             ccccccccEEEeCCCccCCCCChhcccCccCCeeeCC
Q 037916          269 LGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLS  305 (741)
Q Consensus       269 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  305 (741)
                      ++++++|++|+|++|+|+++ + .+.++++|++|+|+
T Consensus       174 l~~l~~L~~L~Ls~N~i~~l-~-~l~~l~~L~~L~Ls  208 (210)
T d1h6ta2         174 LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELF  208 (210)
T ss_dssp             GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEE
T ss_pred             ccCCCCCCEEECCCCCCCCC-h-hhcCCCCCCEEEcc
Confidence            44444444444444444422 2 24444444444443

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.77  E-value=1.4e-18  Score=166.36  Aligned_cols=179  Identities=22%  Similarity=0.350  Sum_probs=98.6

Q ss_pred             CcEEEcccCcccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCccEEECcCCcCcccCCchhhcc
Q 037916           23 LLFLSLGFNQITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGCICNF  102 (741)
Q Consensus        23 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l  102 (741)
                      +..+.++.+.+++..+  ...+.+|++|++++|.|+..  +.+..+++          |++|+|++|+|++..+  +.++
T Consensus        20 ~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l--~~l~~l~n----------L~~L~Ls~N~l~~~~~--l~~l   83 (199)
T d2omxa2          20 KMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNN----------LTQINFSNNQLTDITP--LKNL   83 (199)
T ss_dssp             HHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCC--TTGGGCTT----------CCEEECCSSCCCCCGG--GTTC
T ss_pred             HHHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCCc--cccccCCC----------cCcCccccccccCccc--ccCC
Confidence            3344555555554332  22455566666666665532  12444433          6666666666654332  4555


Q ss_pred             cccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCCCcCcccccCCcccceee
Q 037916          103 SITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLY  182 (741)
Q Consensus       103 ~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  182 (741)
                      + +|++|++++|.+....  .+.++++|+.|++++|.+...  ..+.++++|+.|++++|++...  +.+..+++|++|+
T Consensus        84 ~-~L~~L~l~~n~~~~~~--~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~  156 (199)
T d2omxa2          84 T-KLVDILMNNNQIADIT--PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISDI--SALSGLTSLQQLN  156 (199)
T ss_dssp             T-TCCEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEE
T ss_pred             c-cccccccccccccccc--ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhccc--ccccccccccccc
Confidence            5 5666666666553322  356666666666666666532  2355666666666666666532  2466666666666


Q ss_pred             ccCcccccccCcccccCCCCCEEeccCccccccCCcccccccccee
Q 037916          183 LIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSV  228 (741)
Q Consensus       183 L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  228 (741)
                      +.+|++++..  .|.++++|++|++++|+|++ ++ .+.++++|+.
T Consensus       157 l~~n~l~~l~--~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~  198 (199)
T d2omxa2         157 FSSNQVTDLK--PLANLTTLERLDISSNKVSD-IS-VLAKLTNLES  198 (199)
T ss_dssp             CCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSE
T ss_pred             cccccccCCc--cccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCc
Confidence            6666665432  35666666666666666663 32 3555655553

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.74  E-value=3.5e-20  Score=201.93  Aligned_cols=349  Identities=17%  Similarity=0.102  Sum_probs=210.6

Q ss_pred             CCCCCcccccCChhhhhCCCCCcEEEcccCccccc----CCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhcccc
Q 037916            2 DVGVNRVQGGIPLDFGFTLPNLLFLSLGFNQITGV----IPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNC   77 (741)
Q Consensus         2 dl~~n~~~~~ip~~~~~~l~~L~~L~L~~n~i~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~   77 (741)
                      |+++|+|...-=..+...++++++|+|++|.|+..    +...+..+++|++|+|++|+|+...-..+...     +...
T Consensus         8 d~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~-----l~~~   82 (460)
T d1z7xw1           8 DIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQG-----LQTP   82 (460)
T ss_dssp             EEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHT-----TCST
T ss_pred             EeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHH-----HhcC
Confidence            67777777543233334678888888888888732    34456678888888888888863211111111     0111


Q ss_pred             CCCccEEECcCCcCcccC----CchhhcccccccEEEccCCcccccCCcc------------------------------
Q 037916           78 NQHLKHLDINNNNFGGLL----PGCICNFSITLETLIFNSNKIFRSIPAG------------------------------  123 (741)
Q Consensus        78 ~~~L~~L~Ls~N~l~~~~----~~~~~~l~~~L~~L~L~~n~i~~~~~~~------------------------------  123 (741)
                      ..+|++|+|++|+|++..    +..+...+ +|++|+|++|.|.......                              
T Consensus        83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~-~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  161 (460)
T d1z7xw1          83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLP-TLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL  161 (460)
T ss_dssp             TCCCCEEECTTSCCBGGGHHHHHHHTTSCT-TCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred             CCCCCEEECCCCCccccccccccchhhccc-cccccccccccchhhhhhhhhhcccccccccccccccccccchhhhccc
Confidence            135888888888887542    33444555 7888888888764321000                              


Q ss_pred             ---ccCCCCccEEEcccccccccCCc----cc-cCCCcCcEEEcccCCCCCcC----cccccCCcccceeeccCccccc-
Q 037916          124 ---IGKFINLQTLHMWDNQLSGTISP----AI-GELQNLVTLAINTNKLSGNI----PPSIGNLKKLLQLYLIENFLQV-  190 (741)
Q Consensus       124 ---~~~l~~L~~L~L~~N~i~~~~~~----~~-~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~N~i~~-  190 (741)
                         +.....++.++++++.+......    .+ ........|++..+.+....    ...+...+.++.+++++|.+.. 
T Consensus       162 ~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~  241 (460)
T d1z7xw1         162 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV  241 (460)
T ss_dssp             HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhcccccc
Confidence               11234566777776665421111    11 12234566777777665321    1234556778888888887642 


Q ss_pred             ----ccCcccccCCCCCEEeccCcccccc----CCccccccccceeEEEcCCCccCCCCChhh-----cCCCCCcEEEec
Q 037916          191 ----SIPSSLGQCQSLTTINLSYNNLSGT----IPPQLMDLTSLSVGLDLSRNQLVGSLPTEV-----GKLINLEILFIS  257 (741)
Q Consensus       191 ----~~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~-----~~l~~L~~L~Ls  257 (741)
                          ..+..+.....|+.|++++|.+...    ....+...+.+.. +++++|.+.......+     .....|+.++++
T Consensus       242 ~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~-l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~  320 (460)
T d1z7xw1         242 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKE-LSLAGNELGDEGARLLCETLLEPGCQLESLWVK  320 (460)
T ss_dssp             HHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCE-EECTTCCCHHHHHHHHHHHHTSTTCCCCEEECT
T ss_pred             ccchhhcccccccccccccccccccccccccccccccccccccccc-cccccccccccccchhhcccccccccccccccc
Confidence                2233444567888999998887632    2223445667776 8888888763222221     234578889999


Q ss_pred             cccccchhhhhc----cccccccEEEeCCCccCCCC----Chhc-ccCccCCeeeCCCCcCCCc----cchhhhccccCC
Q 037916          258 RNMLECEILSTL----GSCIKLEQLKLGGNLFQGPI----PLSL-SSLRGLRVLDLSQNNISGE----IPKFLVELQLVQ  324 (741)
Q Consensus       258 ~N~l~~~~~~~~----~~l~~L~~L~L~~N~l~~~~----~~~~-~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~  324 (741)
                      +|.++......+    ...++|++|+|++|+|.+..    +..+ ...+.|++|+|++|+|+..    +...+..+++|+
T Consensus       321 ~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~  400 (460)
T d1z7xw1         321 SCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLR  400 (460)
T ss_dssp             TSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCC
T ss_pred             ccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCC
Confidence            888876544433    44567899999998886432    2223 2456788899999988742    345566778889


Q ss_pred             cccccCcccccccCCc------cccCCcccccccCCCCc
Q 037916          325 NLNLSYNDLEGVIPTE------GVFKNASAISVFGNSKL  357 (741)
Q Consensus       325 ~L~l~~N~l~~~~~~~------~~~~~~~~~~~~~n~~~  357 (741)
                      +|+|++|+++......      .....++.+.+.+|.+.
T Consensus       401 ~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~  439 (460)
T d1z7xw1         401 ELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS  439 (460)
T ss_dssp             EEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCC
T ss_pred             EEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCC
Confidence            9999999886431111      01224677777777543

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.73  E-value=7.1e-20  Score=199.44  Aligned_cols=325  Identities=17%  Similarity=0.129  Sum_probs=219.6

Q ss_pred             CCCcEEEcccCcccccC-CccCCCCCCCcEEEeecCcCcccC----CchhhhhhhhhhccccCCCccEEECcCCcCcccC
Q 037916           21 PNLLFLSLGFNQITGVI-PSSMFNASKLEVFQVTSNNLTGEV----PSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLL   95 (741)
Q Consensus        21 ~~L~~L~L~~n~i~~~~-~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~   95 (741)
                      ++|+.||+++|+|++.. .+.+..+++|++|+|++|+|+...    ...+...+          +|++|||++|+|+...
T Consensus         2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~----------~L~~LdLs~N~i~~~~   71 (460)
T d1z7xw1           2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNP----------ALAELNLRSNELGDVG   71 (460)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCT----------TCCEEECTTCCCHHHH
T ss_pred             CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCC----------CCCEEECcCCcCChHH
Confidence            46899999999998642 344566899999999999998432    22233333          4999999999997432


Q ss_pred             Cchhh----cccccccEEEccCCccccc----CCccccCCCCccEEEcccccccccCCcc--------------------
Q 037916           96 PGCIC----NFSITLETLIFNSNKIFRS----IPAGIGKFINLQTLHMWDNQLSGTISPA--------------------  147 (741)
Q Consensus        96 ~~~~~----~l~~~L~~L~L~~n~i~~~----~~~~~~~l~~L~~L~L~~N~i~~~~~~~--------------------  147 (741)
                      -..+.    ....+|++|+|++|+++..    ++..+..+++|++|+|++|.|+......                    
T Consensus        72 ~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~  151 (460)
T d1z7xw1          72 VHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYC  151 (460)
T ss_dssp             HHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred             HHHHHHHHhcCCCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhccccccccccccccccc
Confidence            22222    2223799999999999654    3566788999999999999986421111                    


Q ss_pred             -------------ccCCCcCcEEEcccCCCCCcC----cccc-cCCcccceeeccCcccccc----cCcccccCCCCCEE
Q 037916          148 -------------IGELQNLVTLAINTNKLSGNI----PPSI-GNLKKLLQLYLIENFLQVS----IPSSLGQCQSLTTI  205 (741)
Q Consensus       148 -------------~~~l~~L~~L~L~~N~l~~~~----~~~~-~~l~~L~~L~L~~N~i~~~----~~~~~~~l~~L~~L  205 (741)
                                   +.....++.++++++.+....    ...+ ........+++..+.+...    ....+...+.++.+
T Consensus       152 ~~~~~~~~~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l  231 (460)
T d1z7xw1         152 SLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLREL  231 (460)
T ss_dssp             CCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEE
T ss_pred             ccchhhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhccccccccccccccc
Confidence                         122345666777766654211    0111 1223456677777765422    12234567899999


Q ss_pred             eccCccccc-----cCCccccccccceeEEEcCCCccCCCC----ChhhcCCCCCcEEEeccccccchhhhhc-----cc
Q 037916          206 NLSYNNLSG-----TIPPQLMDLTSLSVGLDLSRNQLVGSL----PTEVGKLINLEILFISRNMLECEILSTL-----GS  271 (741)
Q Consensus       206 ~L~~N~l~~-----~~p~~~~~l~~L~~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~~~~~~~-----~~  271 (741)
                      ++++|++..     ..+..+.....+.. +++++|.+....    ...+...+.++.+++++|.++......+     ..
T Consensus       232 ~~~~n~~~~~~~~~~~~~~~~~~~~l~~-l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~  310 (460)
T d1z7xw1         232 ALGSNKLGDVGMAELCPGLLHPSSRLRT-LWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEP  310 (460)
T ss_dssp             ECCSSBCHHHHHHHHHHHHTSTTCCCCE-EECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTST
T ss_pred             chhhccccccccchhhcccccccccccc-cccccccccccccccccccccccccccccccccccccccccchhhcccccc
Confidence            999998742     22333445667877 999999987332    2335678899999999999985444333     23


Q ss_pred             cccccEEEeCCCccCCCCChhc----ccCccCCeeeCCCCcCCCc----cchhhh-ccccCCcccccCcccccccC----
Q 037916          272 CIKLEQLKLGGNLFQGPIPLSL----SSLRGLRVLDLSQNNISGE----IPKFLV-ELQLVQNLNLSYNDLEGVIP----  338 (741)
Q Consensus       272 l~~L~~L~L~~N~l~~~~~~~~----~~l~~L~~L~Ls~N~l~~~----~~~~~~-~l~~L~~L~l~~N~l~~~~~----  338 (741)
                      ...|+.+++++|.++......+    ...++|++|+|++|+|++.    ++..+. ..+.|+.|+|++|+++....    
T Consensus       311 ~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~  390 (460)
T d1z7xw1         311 GCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLA  390 (460)
T ss_dssp             TCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHH
T ss_pred             ccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHH
Confidence            4689999999999986544433    4557899999999999743    223332 45679999999999975311    


Q ss_pred             -CccccCCcccccccCCCC
Q 037916          339 -TEGVFKNASAISVFGNSK  356 (741)
Q Consensus       339 -~~~~~~~~~~~~~~~n~~  356 (741)
                       .....++++.+++.+|+.
T Consensus       391 ~~l~~~~~L~~L~Ls~N~i  409 (460)
T d1z7xw1         391 ATLLANHSLRELDLSNNCL  409 (460)
T ss_dssp             HHHHHCCCCCEEECCSSSC
T ss_pred             HHHhcCCCCCEEECCCCcC
Confidence             112357899999999964

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.62  E-value=2.2e-16  Score=159.74  Aligned_cols=227  Identities=17%  Similarity=0.205  Sum_probs=140.4

Q ss_pred             ccEEEccCCcccccCCccccCCCCccEEEccccccccc-CCccccCCCcCcEEEcccCCCCCcCcccccCCcccceeecc
Q 037916          106 LETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGT-ISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLI  184 (741)
Q Consensus       106 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  184 (741)
                      +..+.+....+.... .......+|++|||++|.++.. ....+..+++|++|+|++|.+++..+..++.+++|++|+|+
T Consensus        25 ~~~lrl~~~~~~~~~-~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls  103 (284)
T d2astb2          25 VIAFRCPRSFMDQPL-AEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLS  103 (284)
T ss_dssp             CSEEECTTCEECSCC-CSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECT
T ss_pred             ceEeeccccccccch-hhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCcccc
Confidence            344445444432222 2223445677777777776533 23446677777777777777776666677777777777777


Q ss_pred             Cc-ccccc-cCcccccCCCCCEEeccCc-ccccc-CCccccc-cccceeEEEcCCCc--cCCC-CChhhcCCCCCcEEEe
Q 037916          185 EN-FLQVS-IPSSLGQCQSLTTINLSYN-NLSGT-IPPQLMD-LTSLSVGLDLSRNQ--LVGS-LPTEVGKLINLEILFI  256 (741)
Q Consensus       185 ~N-~i~~~-~~~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~-l~~L~~~L~Ls~N~--l~~~-~p~~~~~l~~L~~L~L  256 (741)
                      ++ .++.. +...+.++++|++|+++++ .++.. +...+.. .+.|+. |+++++.  ++.. +...+.++++|++|++
T Consensus       104 ~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~-L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L  182 (284)
T d2astb2         104 GCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQ-LNLSGYRKNLQKSDLSTLVRRCPNLVHLDL  182 (284)
T ss_dssp             TCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCE-EECCSCGGGSCHHHHHHHHHHCTTCSEEEC
T ss_pred             ccccccccccchhhHHHHhccccccccccccccccchhhhcccccccch-hhhccccccccccccccccccccccccccc
Confidence            74 45422 1222456778888888775 34321 1112222 245665 7777642  3311 2233456788999999


Q ss_pred             ccc-cccchhhhhccccccccEEEeCC-CccCCCCChhcccCccCCeeeCCCCcCCC-ccchhhhccccCCcccccCccc
Q 037916          257 SRN-MLECEILSTLGSCIKLEQLKLGG-NLFQGPIPLSLSSLRGLRVLDLSQNNISG-EIPKFLVELQLVQNLNLSYNDL  333 (741)
Q Consensus       257 s~N-~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~l~~N~l  333 (741)
                      ++| .++......+..+++|++|+|++ +.+++.....+..+++|+.|+++++ ++. ..+....   .+..|.+..+.+
T Consensus       183 ~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~d~~l~~l~~---~lp~L~i~~~~l  258 (284)
T d2astb2         183 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPDGTLQLLKE---ALPHLQINCSHF  258 (284)
T ss_dssp             TTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCTTCHHHHHH---HSTTSEESCCCS
T ss_pred             ccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC-CCHHHHHHHHH---hCccccccCccC
Confidence            885 57767777888889999999998 4677666677888899999999887 332 2222223   344556677777


Q ss_pred             ccccC
Q 037916          334 EGVIP  338 (741)
Q Consensus       334 ~~~~~  338 (741)
                      +.+.+
T Consensus       259 s~~~~  263 (284)
T d2astb2         259 TTIAR  263 (284)
T ss_dssp             CCTTC
T ss_pred             CCCCC
Confidence            76543

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.60  E-value=7.1e-16  Score=141.39  Aligned_cols=128  Identities=19%  Similarity=0.131  Sum_probs=60.4

Q ss_pred             ccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCCCChhhcCCCCC
Q 037916          172 IGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINL  251 (741)
Q Consensus       172 ~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L  251 (741)
                      |.+..+|++|+|++|+|+. ++..+..+++|++|+|++|+|+ .++ .|                         ..+++|
T Consensus        14 ~~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~-------------------------~~l~~L   65 (162)
T d1a9na_          14 YTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIR-KLD-GF-------------------------PLLRRL   65 (162)
T ss_dssp             EECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCC-EEC-CC-------------------------CCCSSC
T ss_pred             ccCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCC-ccC-Cc-------------------------ccCcch
Confidence            4444455555555555542 2344444555555555555554 221 24                         444445


Q ss_pred             cEEEeccccccchhhhhccccccccEEEeCCCccCCCCC-hhcccCccCCeeeCCCCcCCCcc---chhhhccccCCccc
Q 037916          252 EILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIP-LSLSSLRGLRVLDLSQNNISGEI---PKFLVELQLVQNLN  327 (741)
Q Consensus       252 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~---~~~~~~l~~L~~L~  327 (741)
                      ++|++++|+++.+.+..+..+++|+.|++++|+|+.... ..+..+++|+.|++++|.++...   +..+..+++|+.||
T Consensus        66 ~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          66 KTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             CEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred             hhhhcccccccCCCccccccccccccceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence            555555555444444444445555555555555543221 23445555555555555554221   12344555555554

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.60  E-value=9.2e-16  Score=140.62  Aligned_cols=113  Identities=18%  Similarity=0.099  Sum_probs=83.8

Q ss_pred             ccccCCCcCcEEEcccCCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCcccccccc
Q 037916          146 PAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTS  225 (741)
Q Consensus       146 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  225 (741)
                      ..|.++.+|++|+|++|+|+.+ +..+..+++|+.|+|++|.|+..  +.|..+++|++|++++|+|+...+..+..+++
T Consensus        12 ~~~~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~   88 (162)
T d1a9na_          12 AQYTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD   88 (162)
T ss_dssp             CEEECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred             HhccCcCcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCccccccccc
Confidence            3477888999999999999955 67778899999999999999955  35888999999999999998544444556777


Q ss_pred             ceeEEEcCCCccCCCCC-hhhcCCCCCcEEEecccccc
Q 037916          226 LSVGLDLSRNQLVGSLP-TEVGKLINLEILFISRNMLE  262 (741)
Q Consensus       226 L~~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~  262 (741)
                      |+. |++++|+|+.... ..+..+++|++|++++|.++
T Consensus        89 L~~-L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~  125 (162)
T d1a9na_          89 LTE-LILTNNSLVELGDLDPLASLKSLTYLCILRNPVT  125 (162)
T ss_dssp             CCE-EECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred             ccc-ceeccccccccccccccccccccchhhcCCCccc
Confidence            776 7777777763221 24455555555555555554

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.59  E-value=1.4e-16  Score=166.46  Aligned_cols=259  Identities=18%  Similarity=0.222  Sum_probs=130.0

Q ss_pred             CChhhhhCCCCCcEEEcccCccccc----CCccCCCCCCCcEEEeecCcCcccC---CchhhhhhhhhhccccCCCccEE
Q 037916           12 IPLDFGFTLPNLLFLSLGFNQITGV----IPSSMFNASKLEVFQVTSNNLTGEV---PSEFGKATKAYCVQNCNQHLKHL   84 (741)
Q Consensus        12 ip~~~~~~l~~L~~L~L~~n~i~~~----~~~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~l~~~~~~~~~~~~L~~L   84 (741)
                      +...+. ...+|++|+|++|+|...    +...+...++|+.|+++++.+....   +..+..+.+  .+.. .++|+.|
T Consensus        23 l~~~L~-~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~--~l~~-~~~L~~L   98 (344)
T d2ca6a1          23 VFAVLL-EDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQ--ALLK-CPKLHTV   98 (344)
T ss_dssp             TSHHHH-HCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHH--HHTT-CTTCCEE
T ss_pred             HHHHHh-hCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHH--HHhh-CCCcccc
Confidence            444554 578888888888887542    3345667788888888877654222   222222211  0111 2358888


Q ss_pred             ECcCCcCcccCCchh----hcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcc
Q 037916           85 DINNNNFGGLLPGCI----CNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAIN  160 (741)
Q Consensus        85 ~Ls~N~l~~~~~~~~----~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~  160 (741)
                      +|++|.++......+    ...+ +|+.|++++|.+.......+..  .|..+         .........+.|+.|+++
T Consensus        99 ~L~~n~i~~~~~~~l~~~l~~~~-~L~~L~l~~n~l~~~~~~~l~~--~l~~~---------~~~~~~~~~~~L~~l~l~  166 (344)
T d2ca6a1          99 RLSDNAFGPTAQEPLIDFLSKHT-PLEHLYLHNNGLGPQAGAKIAR--ALQEL---------AVNKKAKNAPPLRSIICG  166 (344)
T ss_dssp             ECCSCCCCTTTHHHHHHHHHHCT-TCCEEECCSSCCHHHHHHHHHH--HHHHH---------HHHHHHHTCCCCCEEECC
T ss_pred             cccccccccccccchhhhhcccc-cchheecccccccccccccccc--ccccc---------ccccccccCcccceeecc
Confidence            888887765322222    2333 5666666666542211111100  00000         000001223344444554


Q ss_pred             cCCCCCc----CcccccCCcccceeeccCcccccc-----cCcccccCCCCCEEeccCcccccc----CCccccccccce
Q 037916          161 TNKLSGN----IPPSIGNLKKLLQLYLIENFLQVS-----IPSSLGQCQSLTTINLSYNNLSGT----IPPQLMDLTSLS  227 (741)
Q Consensus       161 ~N~l~~~----~~~~~~~l~~L~~L~L~~N~i~~~-----~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~  227 (741)
                      +|+++..    +...+...+.|++|+|++|.|...     +...+..+++|+.|+|++|.++..    +...+...+.|+
T Consensus       167 ~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~  246 (344)
T d2ca6a1         167 RNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR  246 (344)
T ss_dssp             SSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCC
T ss_pred             cccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccch
Confidence            4444321    111223344455555555554321     222344455566666666655421    223344555565


Q ss_pred             eEEEcCCCccCCCCCh----hhc--CCCCCcEEEeccccccchhh----hhc-cccccccEEEeCCCccCC
Q 037916          228 VGLDLSRNQLVGSLPT----EVG--KLINLEILFISRNMLECEIL----STL-GSCIKLEQLKLGGNLFQG  287 (741)
Q Consensus       228 ~~L~Ls~N~l~~~~p~----~~~--~l~~L~~L~Ls~N~l~~~~~----~~~-~~l~~L~~L~L~~N~l~~  287 (741)
                      . |+|++|.|.+....    .+.  ..+.|++|++++|+|+....    ..+ ..+++|+.|+|++|++..
T Consensus       247 ~-L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~  316 (344)
T d2ca6a1         247 E-LGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE  316 (344)
T ss_dssp             E-EECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred             h-hhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence            5 66666665532222    222  23568888888888875332    223 256789999999999874

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.59  E-value=5.2e-16  Score=156.93  Aligned_cols=209  Identities=21%  Similarity=0.186  Sum_probs=118.5

Q ss_pred             cccEEEccCCccccc-CCccccCCCCccEEEcccccccccCCccccCCCcCcEEEcccC-CCCCcC-cccccCCccccee
Q 037916          105 TLETLIFNSNKIFRS-IPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTN-KLSGNI-PPSIGNLKKLLQL  181 (741)
Q Consensus       105 ~L~~L~L~~n~i~~~-~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N-~l~~~~-~~~~~~l~~L~~L  181 (741)
                      +|++|+|+++.+... ....+..+++|++|+|++|.++......+..+++|++|+|+++ .++... ...+.++++|++|
T Consensus        47 ~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L  126 (284)
T d2astb2          47 RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDEL  126 (284)
T ss_dssp             CCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEE
T ss_pred             CCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhcccc
Confidence            566666666555432 2333555666666666666666555556666666666666663 444211 1123456667777


Q ss_pred             eccCc-ccccc-cCccccc-CCCCCEEeccCc--ccccc-CCccccccccceeEEEcCCC-ccCCCCChhhcCCCCCcEE
Q 037916          182 YLIEN-FLQVS-IPSSLGQ-CQSLTTINLSYN--NLSGT-IPPQLMDLTSLSVGLDLSRN-QLVGSLPTEVGKLINLEIL  254 (741)
Q Consensus       182 ~L~~N-~i~~~-~~~~~~~-l~~L~~L~L~~N--~l~~~-~p~~~~~l~~L~~~L~Ls~N-~l~~~~p~~~~~l~~L~~L  254 (741)
                      +++++ .++.. ....+.. .++|+.|+++++  .++.. +...+.++++|+. |++++| .+++.....+.++++|++|
T Consensus       127 ~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~-L~L~~~~~itd~~~~~l~~~~~L~~L  205 (284)
T d2astb2         127 NLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVH-LDLSDSVMLKNDCFQEFFQLNYLQHL  205 (284)
T ss_dssp             ECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSE-EECTTCTTCCGGGGGGGGGCTTCCEE
T ss_pred             ccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccc-cccccccCCCchhhhhhcccCcCCEE
Confidence            77664 33321 1122222 356777777754  23321 2222345667776 777775 3555556667778888888


Q ss_pred             Eecc-ccccchhhhhccccccccEEEeCCCccCCCC-ChhcccCccCCeeeCCCCcCCCccchhhh
Q 037916          255 FISR-NMLECEILSTLGSCIKLEQLKLGGNLFQGPI-PLSLSSLRGLRVLDLSQNNISGEIPKFLV  318 (741)
Q Consensus       255 ~Ls~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  318 (741)
                      +|++ +.++......++.+++|+.|+++++ ++... ......+++   |.++.++++...+..+.
T Consensus       206 ~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~d~~l~~l~~~lp~---L~i~~~~ls~~~~~~~~  267 (284)
T d2astb2         206 SLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPDGTLQLLKEALPH---LQINCSHFTTIARPTIG  267 (284)
T ss_dssp             ECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCTTCHHHHHHHSTT---SEESCCCSCCTTCSSCS
T ss_pred             ECCCCCCCChHHHHHHhcCCCCCEEeeeCC-CCHHHHHHHHHhCcc---ccccCccCCCCCCCccC
Confidence            8888 4676666667778888888888877 33211 111233444   45567777765554443

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.58  E-value=2.7e-16  Score=164.10  Aligned_cols=243  Identities=19%  Similarity=0.181  Sum_probs=121.4

Q ss_pred             CccEEECcCCcCcccCCch----hhcccccccEEEccCCcccccC----------CccccCCCCccEEEcccccccccC-
Q 037916           80 HLKHLDINNNNFGGLLPGC----ICNFSITLETLIFNSNKIFRSI----------PAGIGKFINLQTLHMWDNQLSGTI-  144 (741)
Q Consensus        80 ~L~~L~Ls~N~l~~~~~~~----~~~l~~~L~~L~L~~n~i~~~~----------~~~~~~l~~L~~L~L~~N~i~~~~-  144 (741)
                      .|+.|+|++|.|.......    +...+ +|+.|+++++.+....          ...+...++|++|+|++|.++... 
T Consensus        32 ~l~~L~Ls~n~i~~~~~~~l~~~l~~~~-~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~  110 (344)
T d2ca6a1          32 SVKEIVLSGNTIGTEAARWLSENIASKK-DLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQ  110 (344)
T ss_dssp             CCCEEECTTSEECHHHHHHHHHTTTTCT-TCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTH
T ss_pred             CCCEEECcCCcCCHHHHHHHHHHHHhCC-CCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccccccccc
Confidence            3788888888775432222    22333 6666666655432111          122334455555555555554321 


Q ss_pred             ---CccccCCCcCcEEEcccCCCCCcCcccccCCcccceeeccCcccccccCcccccCCCCCEEeccCcccccc----CC
Q 037916          145 ---SPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGT----IP  217 (741)
Q Consensus       145 ---~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~----~p  217 (741)
                         ...+...++|+.|++++|.+.......++.  .|..+.         ........+.|+.|++++|+++..    +.
T Consensus       111 ~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~--~l~~~~---------~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~  179 (344)
T d2ca6a1         111 EPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIAR--ALQELA---------VNKKAKNAPPLRSIICGRNRLENGSMKEWA  179 (344)
T ss_dssp             HHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHH--HHHHHH---------HHHHHHTCCCCCEEECCSSCCTGGGHHHHH
T ss_pred             cchhhhhcccccchheecccccccccccccccc--cccccc---------cccccccCcccceeeccccccccccccccc
Confidence               122334455555555555543111111100  000000         000112344566666666655421    11


Q ss_pred             ccccccccceeEEEcCCCccCCC-----CChhhcCCCCCcEEEeccccccch----hhhhccccccccEEEeCCCccCCC
Q 037916          218 PQLMDLTSLSVGLDLSRNQLVGS-----LPTEVGKLINLEILFISRNMLECE----ILSTLGSCIKLEQLKLGGNLFQGP  288 (741)
Q Consensus       218 ~~~~~l~~L~~~L~Ls~N~l~~~-----~p~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~  288 (741)
                      ..+...+.++. |+|++|.|...     +...+..+++|+.|+|++|.++..    ....+..+++|++|+|++|.|++.
T Consensus       180 ~~l~~~~~L~~-L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~  258 (344)
T d2ca6a1         180 KTFQSHRLLHT-VKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSAR  258 (344)
T ss_dssp             HHHHHCTTCCE-EECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHH
T ss_pred             chhhhhhhhcc-cccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCch
Confidence            22334455555 66666665421     223355667777777777776543    234456677777777777777643


Q ss_pred             CChhc----cc--CccCCeeeCCCCcCCCcc----chhhh-ccccCCcccccCccccc
Q 037916          289 IPLSL----SS--LRGLRVLDLSQNNISGEI----PKFLV-ELQLVQNLNLSYNDLEG  335 (741)
Q Consensus       289 ~~~~~----~~--l~~L~~L~Ls~N~l~~~~----~~~~~-~l~~L~~L~l~~N~l~~  335 (741)
                      ....+    ..  .+.|+.|+|++|+|+..-    ...+. +++.|+.|+|++|.+..
T Consensus       259 g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~  316 (344)
T d2ca6a1         259 GAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE  316 (344)
T ss_dssp             HHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred             hhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence            22222    22  256777777777776322    22222 45667777777777754

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.57  E-value=6e-15  Score=128.42  Aligned_cols=101  Identities=31%  Similarity=0.377  Sum_probs=48.4

Q ss_pred             EEeccCccccccCCccccccccceeEEEcCCCccCCCCChhhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCC
Q 037916          204 TINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGN  283 (741)
Q Consensus       204 ~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  283 (741)
                      .|+|++|+|+ .++ .+.+++.|++ |++++|+|+ .+|..|+.+++|++|++++|+|+.+.  .+..+++|+.|++++|
T Consensus         2 ~L~Ls~n~l~-~l~-~l~~l~~L~~-L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l~--~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           2 VLHLAHKDLT-VLC-HLEQLLLVTH-LDLSHNRLR-ALPPALAALRCLEVLQASDNALENVD--GVANLPRLQELLLCNN   75 (124)
T ss_dssp             EEECTTSCCS-SCC-CGGGGTTCCE-EECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCG--GGTTCSSCCEEECCSS
T ss_pred             EEEcCCCCCC-CCc-ccccCCCCCE-EECCCCccC-cchhhhhhhhcccccccccccccccC--ccccccccCeEECCCC
Confidence            4455555554 232 2444455544 555555554 23334455555555555555554331  2445555555555555


Q ss_pred             ccCCCCC-hhcccCccCCeeeCCCCcCC
Q 037916          284 LFQGPIP-LSLSSLRGLRVLDLSQNNIS  310 (741)
Q Consensus       284 ~l~~~~~-~~~~~l~~L~~L~Ls~N~l~  310 (741)
                      +|++... ..+..+++|+.|++++|+++
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~  103 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC  103 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred             ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence            5543321 34455555555555555554

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.55  E-value=1.1e-14  Score=126.61  Aligned_cols=40  Identities=25%  Similarity=0.387  Sum_probs=15.8

Q ss_pred             ccCCCCccEEEcccccccccCCccccCCCcCcEEEcccCCCC
Q 037916          124 IGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAINTNKLS  165 (741)
Q Consensus       124 ~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~  165 (741)
                      |+.+++|++|++++|+|+++  +.|..+++|++|++++|+|+
T Consensus        39 ~~~l~~L~~L~l~~N~i~~l--~~~~~l~~L~~L~l~~N~i~   78 (124)
T d1dcea3          39 LAALRCLEVLQASDNALENV--DGVANLPRLQELLLCNNRLQ   78 (124)
T ss_dssp             GGGCTTCCEEECCSSCCCCC--GGGTTCSSCCEEECCSSCCC
T ss_pred             hhhhhccccccccccccccc--CccccccccCeEECCCCccC
Confidence            33344444444444444322  12334444444444444443

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.48  E-value=1.4e-15  Score=144.46  Aligned_cols=112  Identities=29%  Similarity=0.315  Sum_probs=56.5

Q ss_pred             cccccCCcccceeeccCcccccccCcccccCCCCCEEeccCccccccCCccccccccceeEEEcCCCccCCCCChhhcCC
Q 037916          169 PPSIGNLKKLLQLYLIENFLQVSIPSSLGQCQSLTTINLSYNNLSGTIPPQLMDLTSLSVGLDLSRNQLVGSLPTEVGKL  248 (741)
Q Consensus       169 ~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l  248 (741)
                      +.+|..+++|++|+|++|+|+.+ + .|.++++|++|+|++|+|+ .+|..+..+++|+. |++++|+|+. + ..+..+
T Consensus        41 ~~sl~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~-L~l~~N~i~~-l-~~~~~l  114 (198)
T d1m9la_          41 DATLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEE-LWISYNQIAS-L-SGIEKL  114 (198)
T ss_dssp             HHHHHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCE-EECSEEECCC-H-HHHHHH
T ss_pred             hhHHhcccccceeECcccCCCCc-c-cccCCccccChhhcccccc-cccccccccccccc-cccccccccc-c-cccccc
Confidence            34455555555555555555532 2 3555555555555555554 34433333444554 5555555552 2 234555


Q ss_pred             CCCcEEEeccccccchhh-hhccccccccEEEeCCCccC
Q 037916          249 INLEILFISRNMLECEIL-STLGSCIKLEQLKLGGNLFQ  286 (741)
Q Consensus       249 ~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~  286 (741)
                      ++|+.|+|++|+|+.+.. ..+..+++|+.|+|++|.+.
T Consensus       115 ~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~  153 (198)
T d1m9la_         115 VNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY  153 (198)
T ss_dssp             HHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred             ccccccccccchhccccccccccCCCccceeecCCCccc
Confidence            555555555555554322 34555555555555555544

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.44  E-value=3.7e-15  Score=141.54  Aligned_cols=145  Identities=20%  Similarity=0.231  Sum_probs=98.1

Q ss_pred             CCCcEEEcccC--cccccCCccCCCCCCCcEEEeecCcCcccCCchhhhhhhhhhccccCCCccEEECcCCcCcccCCch
Q 037916           21 PNLLFLSLGFN--QITGVIPSSMFNASKLEVFQVTSNNLTGEVPSEFGKATKAYCVQNCNQHLKHLDINNNNFGGLLPGC   98 (741)
Q Consensus        21 ~~L~~L~L~~n--~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~   98 (741)
                      ..++.++++++  .|+ .++.+|..+++|++|+|++|+|+.+ + .|..+++          |++|+|++|+|+. +|..
T Consensus        23 ~~~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~----------L~~L~Ls~N~i~~-i~~~   88 (198)
T d1m9la_          23 TEAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEKI-S-SLSGMEN----------LRILSLGRNLIKK-IENL   88 (198)
T ss_dssp             TTCSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEESCC-C-CHHHHTT----------CCEEECCEEEECS-CSSH
T ss_pred             cccceeeeecccCchh-hhhhHHhcccccceeECcccCCCCc-c-cccCCcc----------ccChhhccccccc-cccc
Confidence            34555666654  233 3456677778888888888887743 3 4666665          8888888888774 3444


Q ss_pred             hhcccccccEEEccCCcccccCCccccCCCCccEEEcccccccccCC-ccccCCCcCcEEEcccCCCCCcCccc------
Q 037916           99 ICNFSITLETLIFNSNKIFRSIPAGIGKFINLQTLHMWDNQLSGTIS-PAIGELQNLVTLAINTNKLSGNIPPS------  171 (741)
Q Consensus        99 ~~~l~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~------  171 (741)
                      +..+. +|+.|++++|+|..+  ..+..+++|++|+|++|+|+.+.. ..|..+++|++|+|++|.+....+..      
T Consensus        89 ~~~~~-~L~~L~l~~N~i~~l--~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~  165 (198)
T d1m9la_          89 DAVAD-TLEELWISYNQIASL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEY  165 (198)
T ss_dssp             HHHHH-HCCEEECSEEECCCH--HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHH
T ss_pred             ccccc-ccccccccccccccc--ccccccccccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhH
Confidence            44444 688888888877553  346777788888888888875532 46778888888888888876443332      


Q ss_pred             ----ccCCcccceee
Q 037916          172 ----IGNLKKLLQLY  182 (741)
Q Consensus       172 ----~~~l~~L~~L~  182 (741)
                          +..+++|+.||
T Consensus       166 r~~vi~~lp~L~~LD  180 (198)
T d1m9la_         166 RIEVVKRLPNLKKLD  180 (198)
T ss_dssp             HHHHHHHCSSCCEES
T ss_pred             HHHHHHHCCCcCEeC
Confidence                56678888876

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.42  E-value=1.6e-13  Score=124.52  Aligned_cols=92  Identities=23%  Similarity=0.109  Sum_probs=47.5

Q ss_pred             CccccCCCCccEEEcccc-cccccCCccccCCCcCcEEEcccCCCCCcCcccccCCcccceeeccCcccccccCcccccC
Q 037916          121 PAGIGKFINLQTLHMWDN-QLSGTISPAIGELQNLVTLAINTNKLSGNIPPSIGNLKKLLQLYLIENFLQVSIPSSLGQC  199 (741)
Q Consensus       121 ~~~~~~l~~L~~L~L~~N-~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l  199 (741)
                      |..+..+++|++|+|++| .|+.+.+++|.++++|+.|+|++|+|+.+.+.+|.++++|++|+|++|+|+.+.++.|..+
T Consensus        24 p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~~  103 (156)
T d2ifga3          24 LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGL  103 (156)
T ss_dssp             TTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSC
T ss_pred             cccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCcccChhhhccc
Confidence            334444555555555433 2555555555555555555555555555555555555555555555555554444444332


Q ss_pred             CCCCEEeccCcccc
Q 037916          200 QSLTTINLSYNNLS  213 (741)
Q Consensus       200 ~~L~~L~L~~N~l~  213 (741)
                       +|++|+|++|.+.
T Consensus       104 -~l~~L~L~~Np~~  116 (156)
T d2ifga3         104 -SLQELVLSGNPLH  116 (156)
T ss_dssp             -CCCEEECCSSCCC
T ss_pred             -cccccccCCCccc
Confidence             4555555555553

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.42  E-value=1.4e-13  Score=124.98  Aligned_cols=106  Identities=16%  Similarity=0.060  Sum_probs=82.6

Q ss_pred             ccEEECcCCcCcccCCchhhcccccccEEEccCC-cccccCCccccCCCCccEEEcccccccccCCccccCCCcCcEEEc
Q 037916           81 LKHLDINNNNFGGLLPGCICNFSITLETLIFNSN-KIFRSIPAGIGKFINLQTLHMWDNQLSGTISPAIGELQNLVTLAI  159 (741)
Q Consensus        81 L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n-~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L  159 (741)
                      .+.++++++++. ..|..+..++ +|++|++++| .|..+.+.+|.++++|+.|+|++|+|+.+.+.+|.++++|++|+|
T Consensus        10 ~~~l~c~~~~~~-~~p~~l~~l~-~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L   87 (156)
T d2ifga3          10 SSGLRCTRDGAL-DSLHHLPGAE-NLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL   87 (156)
T ss_dssp             SSCEECCSSCCC-TTTTTSCSCS-CCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred             CCeEEecCCCCc-cCcccccCcc-ccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceec
Confidence            567888888887 4566666776 7888888765 477777778888888888888888888888888888888888888


Q ss_pred             ccCCCCCcCcccccCCcccceeeccCcccc
Q 037916          160 NTNKLSGNIPPSIGNLKKLLQLYLIENFLQ  189 (741)
Q Consensus       160 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~  189 (741)
                      ++|+|+.+.+..|..+ +|++|+|++|.+.
T Consensus        88 s~N~l~~l~~~~~~~~-~l~~L~L~~Np~~  116 (156)
T d2ifga3          88 SFNALESLSWKTVQGL-SLQELVLSGNPLH  116 (156)
T ss_dssp             CSSCCSCCCSTTTCSC-CCCEEECCSSCCC
T ss_pred             cCCCCcccChhhhccc-cccccccCCCccc
Confidence            8888886666666554 6888888888774

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.67  E-value=8.6e-10  Score=100.15  Aligned_cols=65  Identities=26%  Similarity=0.148  Sum_probs=29.2

Q ss_pred             cCCCCCcEEEeccccccchh--hhhccccccccEEEeCCCccCCCCChhcccCccCCeeeCCCCcCC
Q 037916          246 GKLINLEILFISRNMLECEI--LSTLGSCIKLEQLKLGGNLFQGPIPLSLSSLRGLRVLDLSQNNIS  310 (741)
Q Consensus       246 ~~l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  310 (741)
                      ..+++|++|+|++|+|+.+.  +..+..+++|+.|+|++|+|+...+..+.....|+.|+|++|.++
T Consensus        62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~  128 (162)
T d1koha1          62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS  128 (162)
T ss_dssp             HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTS
T ss_pred             HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcC
Confidence            34444444444444444321  233444445555555555554433333333344555555555554

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.66  E-value=1.6e-09  Score=98.21  Aligned_cols=60  Identities=33%  Similarity=0.241  Sum_probs=33.6

Q ss_pred             hhcCCCCCcEEEeccccccchhhhhccccccccEEEeCCCccCCCCCh-------hcccCccCCeee
Q 037916          244 EVGKLINLEILFISRNMLECEILSTLGSCIKLEQLKLGGNLFQGPIPL-------SLSSLRGLRVLD  303 (741)
Q Consensus       244 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-------~~~~l~~L~~L~  303 (741)
                      .+..+++|+.|+|++|.|+.+..-.+....+|+.|++++|.+......       .+..+|+|+.||
T Consensus        86 ~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD  152 (162)
T d1koha1          86 IVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD  152 (162)
T ss_dssp             HHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred             HHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence            345556666666666666654443444444566677777766644332       244566666664

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.28  E-value=1e-06  Score=86.20  Aligned_cols=141  Identities=16%  Similarity=0.089  Sum_probs=91.1

Q ss_pred             HHHHhhhcccCceeeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcC-CCceeeEeeeecCccccCCceEEE
Q 037916          401 SFLFLCWIDMGSFGSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIR-HKNLVKILTVCSGVDYKGDDFKAL  479 (741)
Q Consensus       401 ~y~~~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~~~~l  479 (741)
                      .|++.+..+.++.+.||+...  +++.+++|+...........+.+|...++.+. +--+.+++.++     .+++..++
T Consensus        15 ~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~-----~~~~~~~l   87 (263)
T d1j7la_          15 KYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE-----RHDGWSNL   87 (263)
T ss_dssp             TSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE-----EETTEEEE
T ss_pred             ceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEE-----ecCCceEE
Confidence            344444444455578998864  45667889886555555567788988887763 33356666663     34557899


Q ss_pred             EEecccCCChhhhccCCCCCCcccCcccccCHHHHHHHHHHHHHHHHHHHhcC---------------------------
Q 037916          480 VYEFMHNGSLEEWLHPVSGADKTVEAPKCLNFLQRINIAIDVACALKYLHHDC---------------------------  532 (741)
Q Consensus       480 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---------------------------  532 (741)
                      ||++++|.++.+.....               .....++.++++.+..||+..                           
T Consensus        88 v~~~l~G~~~~~~~~~~---------------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (263)
T d1j7la_          88 LMSEADGVLCSEEYEDE---------------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLAD  152 (263)
T ss_dssp             EEECCSSEEHHHHTTTC---------------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSC
T ss_pred             EEEeccccccccccccc---------------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhh
Confidence            99999988776543211               011223444555555555310                           


Q ss_pred             -----------------------------CCCceecCCCCCCeEeCCCCceEEeeccccc
Q 037916          533 -----------------------------QPTTAHCDLKPSNVLLDHEMTAHVADFGLAK  563 (741)
Q Consensus       533 -----------------------------~~~ivHrDlkp~NIll~~~~~~kL~DFg~a~  563 (741)
                                                   ...++|+|+.|.||++++++.+-|+||+.+.
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         153 VDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             CCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             hhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                         1237899999999999877666799998775

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.84  E-value=2.9e-05  Score=75.07  Aligned_cols=75  Identities=16%  Similarity=0.102  Sum_probs=50.1

Q ss_pred             cccCce-eeEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCC--CceeeEeeeecCccccCCceEEEEEecc
Q 037916          408 IDMGSF-GSVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRH--KNLVKILTVCSGVDYKGDDFKALVYEFM  484 (741)
Q Consensus       408 ig~G~~-g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~~~~~~~~~~~lv~e~~  484 (741)
                      +..|.. +.||+.... ++..+++|.....   ....+..|...++.+..  -.+.+++.++     .++...++||+++
T Consensus        18 ~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~-----~~~~~~~~v~~~i   88 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQ-GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVV-----TEAGRDWLLLGEV   88 (255)
T ss_dssp             CSCTTSSCEEEEEECT-TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEE-----ECSSCEEEEEECC
T ss_pred             cCCcccCCeEEEEEeC-CCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeec-----ccccceEEEEEee
Confidence            444543 678998875 5667888986532   34457788888877632  2356777763     3445789999999


Q ss_pred             cCCChhh
Q 037916          485 HNGSLEE  491 (741)
Q Consensus       485 ~~gsL~~  491 (741)
                      +|.++.+
T Consensus        89 ~G~~~~~   95 (255)
T d1nd4a_          89 PGQDLLS   95 (255)
T ss_dssp             SSEETTT
T ss_pred             ecccccc
Confidence            8866544

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.68  E-value=1.5e-05  Score=71.65  Aligned_cols=40  Identities=18%  Similarity=0.168  Sum_probs=18.9

Q ss_pred             CCCCCcEEEeccccccchh----hhhccccccccEEEeCCCccC
Q 037916          247 KLINLEILFISRNMLECEI----LSTLGSCIKLEQLKLGGNLFQ  286 (741)
Q Consensus       247 ~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~  286 (741)
                      ..+.|++|+|++|.|+...    ...+...+.|++|+|++|.+.
T Consensus        70 ~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~  113 (167)
T d1pgva_          70 TSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQS  113 (167)
T ss_dssp             HCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSC
T ss_pred             hcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCC
Confidence            3445555555555555322    222334445555555555443

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.65  E-value=1.4e-05  Score=71.97  Aligned_cols=91  Identities=10%  Similarity=0.092  Sum_probs=63.5

Q ss_pred             hhcCCCCCcEEEeccccccchhh----hhccccccccEEEeCCCccCCCC----ChhcccCccCCeeeCCCCcCCCc---
Q 037916          244 EVGKLINLEILFISRNMLECEIL----STLGSCIKLEQLKLGGNLFQGPI----PLSLSSLRGLRVLDLSQNNISGE---  312 (741)
Q Consensus       244 ~~~~l~~L~~L~Ls~N~l~~~~~----~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~---  312 (741)
                      .+...++|++|+|++|.+.....    ..+...+.|++|+|++|.|....    ..++...+.|+.|+|++|.+...   
T Consensus        39 ~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~  118 (167)
T d1pgva_          39 AACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQ  118 (167)
T ss_dssp             HHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHH
T ss_pred             HHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHH
Confidence            45566778888888888874333    34456788999999999887532    23455668899999999876633   


Q ss_pred             ----cchhhhccccCCcccccCcccc
Q 037916          313 ----IPKFLVELQLVQNLNLSYNDLE  334 (741)
Q Consensus       313 ----~~~~~~~l~~L~~L~l~~N~l~  334 (741)
                          +...+...+.|+.|+++.+...
T Consensus       119 ~~~~l~~~L~~n~sL~~l~l~~~~~~  144 (167)
T d1pgva_         119 VEMDMMMAIEENESLLRVGISFASME  144 (167)
T ss_dssp             HHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred             HHHHHHHHHHhCCCccEeeCcCCCch
Confidence                3344555678888888776543

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.61  E-value=6.2e-05  Score=77.70  Aligned_cols=77  Identities=16%  Similarity=0.053  Sum_probs=49.7

Q ss_pred             hhhcccCceeeEEEEEEcCCCeEEEEEEeecc----C---cCcchhHHHHHHHHHhcC-C--CceeeEeeeecCccccCC
Q 037916          405 LCWIDMGSFGSVYKGILDEGKTIIAVKVLNLL----H---HGASKSSIAECSALRNIR-H--KNLVKILTVCSGVDYKGD  474 (741)
Q Consensus       405 ~~~ig~G~~g~V~~a~~~~~~~~vavK~~~~~----~---~~~~~~~~~E~~~l~~l~-h--pnIv~~~~~~~~~~~~~~  474 (741)
                      .+.||.|....||+.....+++.|++|.-...    .   .....+...|..+++.+. +  ..+++++.+.       +
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d-------~  103 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-------T  103 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-------T
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc-------C
Confidence            45799999999999998777888999975421    1   112345667888887662 2  3566777652       2


Q ss_pred             ceEEEEEecccCCC
Q 037916          475 DFKALVYEFMHNGS  488 (741)
Q Consensus       475 ~~~~lv~e~~~~gs  488 (741)
                      ...++|||++.+..
T Consensus       104 ~~~~lvmE~L~~~~  117 (392)
T d2pula1         104 EMAVTVMEDLSHLK  117 (392)
T ss_dssp             TTTEEEECCCTTSE
T ss_pred             CCCEEEEeccCCcc
Confidence            24478999997644

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.10  E-value=2.7e-05  Score=69.86  Aligned_cols=16  Identities=6%  Similarity=0.227  Sum_probs=6.9

Q ss_pred             CCCCCcEEEeecCcCc
Q 037916           43 NASKLEVFQVTSNNLT   58 (741)
Q Consensus        43 ~l~~L~~L~L~~N~l~   58 (741)
                      ..++|++|+|++|.++
T Consensus        44 ~n~~L~~L~Ls~n~l~   59 (166)
T d1io0a_          44 TNTYVKKFSIVGTRSN   59 (166)
T ss_dssp             TCCSCCEEECTTSCCC
T ss_pred             cCCccCeeeccCCccc
Confidence            3344444444444443

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.00  E-value=0.0009  Score=66.77  Aligned_cols=72  Identities=10%  Similarity=0.049  Sum_probs=44.6

Q ss_pred             eEEEEEEcCCCeEEEEEEeeccCcCcchhHHHHHHHHHhcCCCc--eeeEeeeecCccccCCceEEEEEecccCCC
Q 037916          415 SVYKGILDEGKTIIAVKVLNLLHHGASKSSIAECSALRNIRHKN--LVKILTVCSGVDYKGDDFKALVYEFMHNGS  488 (741)
Q Consensus       415 ~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~~~~~~~~~~~~~~~~~~lv~e~~~~gs  488 (741)
                      .||+++.. +|+.|++|+.+... ...+++..|...+..|....  ++.............+...+.+++++.|..
T Consensus        37 ~vy~v~~~-dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~  110 (325)
T d1zyla1          37 RVYQFQDE-DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ  110 (325)
T ss_dssp             EEEEECCT-TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred             eeEEEEcC-CCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence            69999886 68889999987432 23456778888887773221  222222211222334556788999997643

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.99  E-value=0.00014  Score=64.95  Aligned_cols=88  Identities=15%  Similarity=0.144  Sum_probs=43.1

Q ss_pred             cCCCCCcEEEeccccccchh----hhhccccccccEEEeCCCccCCCC----ChhcccCccCCeeeC--CCCcCCC----
Q 037916          246 GKLINLEILFISRNMLECEI----LSTLGSCIKLEQLKLGGNLFQGPI----PLSLSSLRGLRVLDL--SQNNISG----  311 (741)
Q Consensus       246 ~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L--s~N~l~~----  311 (741)
                      ...++|++|+|++|.++...    ...+...+.|+.|++++|.+....    ...+...++|+.++|  ++|.+..    
T Consensus        43 ~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~  122 (166)
T d1io0a_          43 KTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEM  122 (166)
T ss_dssp             TTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHH
T ss_pred             hcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHH
Confidence            34455555555555554322    223344555666666666554321    233444556665333  3455542    


Q ss_pred             ccchhhhccccCCcccccCccc
Q 037916          312 EIPKFLVELQLVQNLNLSYNDL  333 (741)
Q Consensus       312 ~~~~~~~~l~~L~~L~l~~N~l  333 (741)
                      .+...+...+.|+.|+++.+..
T Consensus       123 ~La~~L~~n~~L~~L~l~~~~~  144 (166)
T d1io0a_         123 EIANMLEKNTTLLKFGYHFTQQ  144 (166)
T ss_dssp             HHHHHHHHCSSCCEEECCCSSH
T ss_pred             HHHHHHHhCCCcCEEeCcCCCC
Confidence            1233444556666666665543

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.54  E-value=0.0043  Score=63.49  Aligned_cols=74  Identities=16%  Similarity=0.174  Sum_probs=49.7

Q ss_pred             hhhcccCceeeEEEEEEcC-------CCeEEEEEEeeccCcCcchhHHHHHHHHHhcC-CCceeeEeeeecCccccCCce
Q 037916          405 LCWIDMGSFGSVYKGILDE-------GKTIIAVKVLNLLHHGASKSSIAECSALRNIR-HKNLVKILTVCSGVDYKGDDF  476 (741)
Q Consensus       405 ~~~ig~G~~g~V~~a~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~~  476 (741)
                      ++.|+.|-.=.+|++....       ..+.|++++.-.  .....+..+|..+++.+. +.-..++++++.     +   
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~-----~---  116 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFS-----G---  116 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEET-----T---
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcC-----C---
Confidence            3568888888999998753       245677777642  222345668888888874 444458888742     1   


Q ss_pred             EEEEEecccCCCh
Q 037916          477 KALVYEFMHNGSL  489 (741)
Q Consensus       477 ~~lv~e~~~~gsL  489 (741)
                       ++||||++|.++
T Consensus       117 -g~I~efi~g~~l  128 (395)
T d1nw1a_         117 -GRLEEYIPSRPL  128 (395)
T ss_dssp             -EEEECCCCEEEC
T ss_pred             -ceEEEEeccccC
Confidence             689999987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=94.86  E-value=0.054  Score=52.86  Aligned_cols=31  Identities=26%  Similarity=0.277  Sum_probs=27.4

Q ss_pred             CCCceecCCCCCCeEeCCCCceEEeeccccc
Q 037916          533 QPTTAHCDLKPSNVLLDHEMTAHVADFGLAK  563 (741)
Q Consensus       533 ~~~ivHrDlkp~NIll~~~~~~kL~DFg~a~  563 (741)
                      +.|+||+|+.++||+++.+...-|+||+.+.
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccccCCcchhhhhcccccceeEecccccc
Confidence            4589999999999999988777899999874